<SEC-DOCUMENT>0001493152-23-016741.txt : 20230512
<SEC-HEADER>0001493152-23-016741.hdr.sgml : 20230512
<ACCEPTANCE-DATETIME>20230512171905
ACCESSION NUMBER:		0001493152-23-016741
CONFORMED SUBMISSION TYPE:	S-4
PUBLIC DOCUMENT COUNT:		95
FILED AS OF DATE:		20230512
DATE AS OF CHANGE:		20230512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Murphy Canyon Acquisition Corp.
		CENTRAL INDEX KEY:			0001896212
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				873272543
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271903
		FILM NUMBER:		23917065

	BUSINESS ADDRESS:	
		STREET 1:		4995 MURPHY CANYON ROAD, SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
		BUSINESS PHONE:		(760) 471 8536

	MAIL ADDRESS:	
		STREET 1:		4995 MURPHY CANYON ROAD, SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4
<SEQUENCE>1
<FILENAME>forms-4.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:MURFU="http://bloomberg.com/20221231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_MURFU_bloomberg.com_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001896212 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCentralIndexKey">0001896212</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0050" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredCosts" contextRef="AsOf2022-12-31" id="xdx2ixbrl0052" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl0070" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:DeferredCommissionPayableNonCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0077" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31" id="xdx2ixbrl0082" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0086" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0095" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0096" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0115" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" id="xdx2ixbrl0159" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:AdministrationFeeRelatedParty" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0184" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0193" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0199" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0202" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-18_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0222" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-18_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0223" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0226" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0228" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0230" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-10-192021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0233" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0239" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-10-192021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0240" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0244" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0250" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0257" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0261" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0263" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0269" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0281" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0287" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0288" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0294" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0323" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-10-18" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:DeferredOfferingCostsIncludedInAccruedOfferingCosts" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:PrepaidExpensesPaidByNotePayable" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:DeferredOfferingCostsPaidByNotePayable" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:DeferredUnderwritingCommissionPayable" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MURFU:ClassASharesSubjectToRedemption" contextRef="From2021-10-192021-12-31" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0515" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0519" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-12-31" id="xdx2ixbrl0728" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0742" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="murfu-20221231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-062022-02-07_us-gaap_OverAllotmentOptionMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-06</xbrli:startDate>
        <xbrli:endDate>2022-02-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-252022-01-26_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MURFU:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-25</xbrli:startDate>
        <xbrli:endDate>2022-01-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-18_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-18_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-062022-02-07_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-06</xbrli:startDate>
        <xbrli:endDate>2022-02-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-06</xbrli:startDate>
        <xbrli:endDate>2022-02-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-07_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-072022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">MURFU:ConduitPharmaceuticalsLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-07</xbrli:startDate>
        <xbrli:endDate>2022-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">MURFU:ConduitPharmaceuticalsLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-072022-11-08_custom_SubscriptionAgreementsMember_custom_ConduitPharmaceuticalsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">MURFU:ConduitPharmaceuticalsLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-07</xbrli:startDate>
        <xbrli:endDate>2022-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TransactionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:TransactionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassAMember_custom_PublicWarrantMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PublicWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CapitalUnitClassAMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CapitalUnitClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-142021-11-16_custom_SponsorMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MURFU:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-14</xbrli:startDate>
        <xbrli:endDate>2021-11-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-242022-01-26_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MURFU:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-24</xbrli:startDate>
        <xbrli:endDate>2022-01-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-16_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UnderwriterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MURFU:UnderwriterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputDiscountRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FinancialServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-252023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-25</xbrli:startDate>
        <xbrli:endDate>2023-01-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-252023-01-26_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-25</xbrli:startDate>
        <xbrli:endDate>2023-01-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-26_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-06_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-072023-03-07_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001896212</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-07</xbrli:startDate>
        <xbrli:endDate>2023-03-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000207" toRefs="Footnote000211 Footnote000214"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0230" toRefs="Footnote000301 Footnote000304"></ix:relationship>
  <ix:relationship fromRefs="Fact000231" toRefs="Footnote000301 Footnote000304"></ix:relationship>
  <ix:relationship fromRefs="Fact000232" toRefs="Footnote000301 Footnote000304"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0233" toRefs="Footnote000301 Footnote000304"></ix:relationship>
  <ix:relationship fromRefs="Fact000234" toRefs="Footnote000301 Footnote000304"></ix:relationship>
  <ix:relationship fromRefs="Fact000236" toRefs="Footnote000301 Footnote000304"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on May 12, 2023.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333 -&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 4pt solid; font: 1pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Washington, D.C. 20549</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_906_edei--DocumentType_c20220101__20221231_zx7T3heOaG18"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentType">S-4</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION STATEMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDER</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE SECURITIES ACT OF 1933</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20220101__20221231_zTeP8hF2dqQe"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityRegistrantName">MURPHY
CANYON ACQUISITION CORP</ix:nonNumeric></span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact Name of Each Registrant
as Specified in its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20220101__20221231_zk1WOY5Sjs3k"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6770</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20220101__20221231_zGtAzz2jmHP2"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityTaxIdentificationNumber">87-3272543</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of Incorporation or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    standard industrial classification code number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
                                                                             <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
                                            Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Murphy
Canyon Acquisition Corp.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20220101__20221231_zhHB2x5iR4F2"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressAddressLine1">4995
Murphy Canyon Road</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20220101__20221231_zLFMAWoun5Gg"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20220101__20221231_zcmG25WJY5c5"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressCityOrTown">San Diego</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20220101__20221231_zGoD22KMK0gk"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20220101__20221231_z6jrG2Lnh1Uf"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressPostalZipCode">92123</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone: <span><span id="xdx_904_edei--CityAreaCode_c20220101__20221231_z4FaNEuAowwe"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:CityAreaCode">760</ix:nonNumeric></span>-<span id="xdx_900_edei--LocalPhoneNumber_c20220101__20221231_zywS1dl1k0Y2"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:LocalPhoneNumber">471-8536</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of each registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--ContactPersonnelName_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z2OSB4FUAtUg"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:ContactPersonnelName">Jack
K. Heilbron</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zay94sAHXV9k"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine1">4995 Murphy Canyon Road</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zKV4hdBxBZb1"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressCityOrTown_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zj0H9SLkLnF9"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:EntityAddressCityOrTown">San
Diego</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zIvVShcIvBbi"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zvmYjZtKsyBh"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:EntityAddressPostalZipCode">92123</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span>Telephone:
<span id="xdx_90C_edei--CityAreaCode_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zZR7eHLeB0g5"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:CityAreaCode">760</ix:nonNumeric></span>-<span id="xdx_901_edei--LocalPhoneNumber_c20220101__20221231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zpEK7ZGi1De1"><ix:nonNumeric contextRef="From2022-01-012022-12-31_dei_BusinessContactMember" name="dei:LocalPhoneNumber">471-8536</ix:nonNumeric></span></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>With
copies to:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Darrin
                                            M. Ocasio, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Arthur
    Marcus, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Avital
    Perlman, Esq.<br />
    Sichenzia Ross Ference LLP<br />
    1185 Avenue of the Americas, 31<sup>st</sup> Floor<br />
    New York, NY 10036<br />
    (212) 930-9700</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Todd
                                            Mason, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corby
    Baumann, Esq.<br />
    Thompson Hine LLP<br />
    335 Madison Ave, 12<sup>th</sup> Floor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, NY 10017-4611<br />
    (212) 344-5680</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale of the securities to the public:</b> As soon as practicable after this Registration Statement becomes
effective and all other conditions to the transactions contemplated by the Agreement and Plan of Merger described in the included proxy
statement/prospectus have been satisfied or waived.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance
with General Instruction G, check the following box: &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityFilerCategory_c20220101__20221231_z7oKsWPyRMUd"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntitySmallBusiness_c20220101__20221231_zLSRoKDjuJM7"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20220101__20221231_zet4yS9dpcC1"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span id="xdx_900_edei--EntityExTransitionPeriod_c20220101__20221231_zNyB3dOIZ5Eb"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective
on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: red"><b>PRELIMINARY PROXY
STATEMENT/PROSPECTUS<br />
SUBJECT TO COMPLETION, DATED MAY 12, 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP.<br />
4995 Murphy Canyon Road, Suite 300</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>San
Diego, CA 92123</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICE
OF </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SPECIAL
MEETING OF STOCKHOLDERS<br />
TO BE HELD ON &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
THE STOCKHOLDERS OF MURPHY CANYON ACQUISITION CORP.:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN that a special meeting of stockholders of Murphy Canyon Acquisition Corp. (&#8220;MURF&#8221;), a Delaware
corporation, will be held at &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a.m., Eastern Time, on
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023, via webcast (the &#8220;Special Meeting&#8221;). MURF stockholders
can attend, vote and examine the list of MURF stockholders entitled to vote at the live webcast of the Special Meeting by visiting
[_____] and entering the control number found on their proxy card, voting instruction form or notice they previously received. In
light of public health concerns regarding the novel coronavirus (COVID-19), the Special Meeting will be held in a virtual meeting
format only. You will not be able to attend the Special Meeting physically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to virtually attend the Special Meeting, which will be held for the following purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    consider and vote upon a proposal to approve the business combination (the &#8220;Business Combination&#8221;) described in this
    proxy statement/prospectus, including the Agreement and Plan of Merger, dated as of November 8, 2022 and as amended by that certain
    Amendment to Agreement and Plan of Merger dated as of January 27, 2023 (the &#8220;Merger Agreement&#8221;), by and among
    MURF, Conduit Pharmaceuticals Limited, a Cayman Islands exempted company (&#8220;Conduit&#8221;) and Conduit Merger Sub, Inc., a
    Cayman Islands exempted company and a wholly-owned subsidiary of MURF (&#8220;Merger Sub&#8221;), which, among other things, provides
    for the merger of Merger Sub with and into Conduit, with Conduit surviving the merger as a wholly-owned subsidiary of MURF &#8212;
    we refer to this proposal as the &#8220;business combination proposal&#8221;;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">to consider and vote upon separate proposals to approve
amendments to MURF&#8217;s current amended and restated certificate of incorporation to: </td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal A &#8211; change the name of the public entity from &#8220;<span style="background-color: white">Murphy Canyon Acquisition
  Corp.</span>&#8221; to &#8220;<span style="background-color: white">Conduit Pharmaceuticals Inc.</span>&#8221; (&#8220;New Conduit&#8221;);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Charter
  Amendment Proposal B &#8211; provide for one class of authorized common stock;</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal C &#8211; delete the various provisions in MURF&#8217;s current amended and restated certificate of incorporation
  applicable only to special purpose acquisition corporations (such as the obligation to dissolve and liquidate if a business combination
  is not consummated within a certain period of time);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal D &#8211; increase the number of authorized shares of common stock to 250,000,000; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal E &#8211; fix the number of directors at seven (7), a majority of whom shall be independent directors in accordance
  with The Nasdaq Stock Market LLC&#8217;s requirements &#8212; we refer to these proposals collectively as the &#8220;charter amendment
  proposals&#8221;;</span></td></tr>
</table>

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">to
    consider and vote upon, on a non-binding advisory basis, certain governance provisions in the Proposed Charter, presented separately
    in accordance with U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) requirements </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;
    we refer to this proposal as the &#8220;advisory charter amendments proposals&#8221;<span style="background-color: white">;</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">to elect seven (7) directors who, upon consummation of the Business Combination,
will be the directors of New Conduit &#8212; we refer to this proposal as the &#8220;director election proposal&#8221;;</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    consider and vote upon a proposal to approve the Conduit Pharmaceuticals Inc. 2023 Stock Incentive Plan (named in anticipation of
    the Business Combination), which is an incentive compensation plan for employees of New Conduit and its subsidiaries, including Conduit
    &#8212; we refer to this proposal as the &#8220;incentive plan proposal&#8221;;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    consider and vote upon a proposal to approve, for purposes of complying with applicable listing rules of Nasdaq, the issuance of New
    Conduit common stock and warrants to purchase New Conduit common stock, par value $0.0001 per share, to Prospect Science Ventures
    Limited (the &#8220;Private Placement Investor&#8221;) in the Private Placement, the proceeds of which will be used to finance the Business
    Combination and related transactions and the costs and expenses incurred in connection therewith with any balance used for working
    capital purposes &#8212; we refer to this proposal as the &#8220;Nasdaq proposal&#8221;; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    consider and vote upon a proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation
    and vote of proxies if MURF does not have sufficient proxies to approve one or more of the foregoing proposals &#8212; we refer to
    this proposal as the &#8220;adjournment proposal.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
items of business are described in the attached proxy statement/prospectus, which we encourage you to read in its entirety before
voting. Only holders of record of MURF common stock at the close of business on
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023, (the &#8220;Record Date&#8221;) are entitled to notice of the
Special Meeting and to vote and have their votes counted at the Special Meeting and any adjournments or postponements of the Special
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
careful consideration, the MURF Board has determined that the business combination proposal, the charter amendment proposals, the
advisory charter amendments proposals, the director election proposal, the incentive plan proposal, the Nasdaq proposal and the
adjournment proposal are fair to and in the best interests of MURF and its stockholders and unanimously recommends that you vote or
give instruction to vote &#8220;FOR&#8221; the business combination proposal, &#8220;FOR&#8221; each of the charter amendment
proposals, &#8220;FOR&#8221; each of the advisory charter amendments proposals, &#8220;FOR&#8221; the election of all of the persons
nominated by MURF&#8217;s management for election as directors, &#8220;FOR&#8221; the incentive plan proposal, &#8220;FOR&#8221; the
Nasdaq proposal and &#8220;FOR&#8221; the adjournment proposal, if presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation
of the Transactions (as described in the attached proxy statement/prospectus) is conditioned on approval of each of the business
combination proposal, the charter amendment proposals, the director election proposal, the incentive plan proposal, and the Nasdaq
proposal. If any of the proposals is not approved, the other proposals will not be presented to stockholders for a vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
MURF stockholders are cordially invited to virtually attend the Special Meeting, which will be held via live webcast. To ensure your
representation at the Special Meeting, however, you are urged to complete, sign, date and return the enclosed proxy card as soon as possible.
If you are a stockholder of record of MURF common stock, you may also cast your vote at the Special Meeting electronically by visiting
&#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . If your shares are held in an account at a brokerage firm or bank,
you must instruct your broker or bank on how to vote your shares or, if you wish to virtually attend the Special Meeting and vote electronically,
obtain a proxy from your broker or bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
complete list of MURF stockholders of record entitled to vote at the Special Meeting will be available for ten days before the Special
Meeting at the principal executive offices of MURF for inspection by stockholders during ordinary business hours for any purpose germane
to the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
vote is important regardless of the number of shares you own. Whether you plan to virtually attend the Special Meeting or not, please
sign, date and return the enclosed proxy card as soon as possible in the envelope provided. If your shares are held in &#8220;street
name&#8221; or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially
own are properly counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for your participation. We look forward to your continued support.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President, and Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    , 2023</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
IF YOU ARE A HOLDER OF PUBLIC SHARES AND WISH TO EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST DEMAND THAT MURF REDEEM YOUR SHARES FOR
CASH BY DELIVERING YOUR STOCK ELECTRONICALLY TO MURF&#8217;S TRANSFER AGENT USING DEPOSITORY TRUST COMPANY&#8217;S DWAC (DEPOSIT
WITHDRAWAL AT CUSTODIAN) SYSTEM. MURF&#8217;S TRANSFER AGENT MUST RECEIVE YOUR INSTRUCTION TO REDEEM BY 5:00 PM EASTERN TIME ON
____, 2023 (TWO (2) BUSINESS DAYS BEFORE THE SPECIAL MEETING) IN ORDER FOR YOUR REDEMPTION DEMAND TO BE VALID. SEE &#8220;<i>SPECIAL
MEETING OF MURF STOCKHOLDERS &#8212; REDEMPTION RIGHTS</i>&#8221; FOR MORE SPECIFIC INSTRUCTIONS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">NEITHER
THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED
IN THIS JOINT PROXY STATEMENT/PROSPECTUS, PASSED UPON THE MERITS OR FAIRNESS OF THE MERGER OR RELATED TRANSACTIONS OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS  PROXY STATEMENT/PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL
OFFENSE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus is dated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023 and is first being mailed
to <span style="background-color: white">Murphy Canyon Acquisition Corp.</span> stockholders on or about &#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important
Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on &#8239;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023. MURF&#8217;s proxy statement/prospectus are available at&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The
information in this proxy statement/prospectus is not complete and may be changed. We may not issue these securities until the registration
statement filed with the Securities and Exchange Commissions is effective. This proxy statement/prospectus is not an offer to sell these
securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
TO COMPLETION, DATED MAY 12, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY
STATEMENT FOR SPECIAL MEETING OF STOCKHOLDERS OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS
65,000,000 SHARES OF COMMON STOCK<br />
OF<br />
MURPHY CANYON ACQUISITION CORP. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors of Murphy Canyon Acquisition Corp., a Delaware corporation (&#8220;MURF&#8221;), has unanimously approved the Agreement
and Plan of Merger, dated as of November 8, 2022 and as amended by that certain Amendment to Agreement and Plan of Merger, dated as of
January 27, 2023 (the &#8220;Merger Agreement&#8221;), by and among MURF, Conduit Pharmaceuticals Limited, a Cayman Islands exempted
company (&#8220;Conduit&#8221;) and Conduit Merger Sub Inc., a Cayman Islands exempted company and a wholly-owned subsidiary of MURF
(&#8220;Merger Sub&#8221;). As a result of and upon consummation of the transactions contemplated by the Merger Agreement, Conduit will
become a wholly-owned subsidiary of MURF, which will change its name to &#8220;Conduit Pharmaceuticals Inc.&#8221; as described in this
proxy statement/prospectus, with the former shareholders of Conduit becoming stockholders of MURF (such transaction, the &#8220;Business
Combination,&#8221; and the post-Business Combination entity being referred to as &#8220;MURF&#8221; or the &#8220;New Conduit&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, the shareholders of Conduit will receive as merger consideration shares of New Conduit common stock that shall
have an aggregate value equal to Six Hundred Fifty Million Dollars ($650,000,000). The base-case valuation of Conduit, according to a
valuation advisory and consulting firm engaged by MURF, is Six Hundred Eighty-Two Million Dollars ($682,000,000). For further information
about the valuation, see the section <i>&#8220;Special Meeting of MURF Stockholders &#8211; Opinion of ValueScope, Inc. &#8211; Overview
of Global Biotechnology Industry&#8221;. </i></span><span style="font-size: 10pt">With each share of New Conduit common stock being valued
at $10.00, Conduit&#8217;s <span style="font-family: Times New Roman, Times, Serif">outstanding ordinary shares (including the ordinary
shares issued upon conversion of all outstanding convertible debt, which conversion shall have occurred prior to the consummation of
the Business Combination) will be converted into an aggregate of 65,000,000 shares of New Conduit common stock (the &#8220;Closing Payment
Shares&#8221;) following the Business Combination, with each such outstanding Conduit ordinary share converted into shares of New Conduit
common stock on a pro rata basis. Additionally, immediately prior to the Business Combination, MURF&#8217;s Class A common stock shall
automatically convert on a one-to-one basis into shares of New Conduit common stock without any action on the part of any of MURF&#8217;s
Public Stockholders. Upon the consummation of the Business Combination, MURF&#8217;s Public Warrants shall, by their terms, entitle the
holders to purchase shares of New Conduit common stock at a purchase price of $11.50 per share. See the section entitled &#8220;<i>The
Business Combination</i>&#8221; for further information on the consideration being paid to Conduit shareholders.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">It
is anticipated that, upon completion of the Business Combination, assuming that no holders exercise their warrants to purchase shares
of New Conduit common stock: (i) assuming there are no redemptions by MURF&#8217;s Public Stockholders, the Public Stockholders will
own approximately 2.9% of the outstanding shares of New Conduit common stock, Conduit&#8217;s shareholders will own approximately 90%
of the outstanding shares of New Conduit common stock (which reflects 65,000,000 shares of New Conduit common stock to be issued to the
Conduit shareholders as consideration in the merger plus the 2,700,000 shares of New Conduit common stock to be issued to the Private
Placement Investor in connection with the Private Placement as the Private Placement Investor is an affiliate of one of Conduit&#8217;s
existing shareholders) and MURF&#8217;s initial stockholder, our Sponsor, will own approximately 5.3% of the outstanding shares of New
Conduit common stock. Under this scenario, on a pro forma basis, it is estimated that New Conduit will have total stockholders&#8217;
equity of approximately $25.8 million, which results in a value per share of $0.34. Alternatively, assuming 100% of MURF&#8217;s Public
Shares are redeemed, the Public Stockholders not hold any of the outstanding shares of New Conduit common stock, Conduit&#8217;s shareholders
will own approximately 92.6% of the outstanding shares of New Conduit common stock (which reflects 65,000,000 shares of New Conduit common
stock to be issued to the Conduit shareholders as consideration in the merger plus the 2,700,000 shares of New Conduit common stock to
be issued to the Private Placement Investor), and our Sponsor will own approximately 5.5% of the outstanding shares of New Conduit common
stock. Under this alternative scenario, on a pro forma basis, it is estimated that New Conduit will have total stockholders&#8217; equity
of approximately $3.0 million, which results in a value per share of $0.04. For more information about the ownership of New Conduit,
see the question &#8220;What equity stake will current MURF stockholders and Conduit shareholders have in New Conduit after the closing
of the Business Combination?&#8221; in the section entitled &#8220;Questions and Answers About the Business Combination and Proposals&#8221;
and see the section entitled &#8220;Unaudited Pro Forma Condensed Combined Financial Information&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposals
to approve the Merger Agreement and the other matters discussed in this proxy statement/prospectus will be presented at the virtual
Special Meeting of stockholders of MURF scheduled to be held on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">MURF&#8217;s units, Class A Common
Stock and warrants are currently listed on The Nasdaq Global Market under the symbols MURFU, MURF and MURFW, respectively. MURF intends
to apply for listing under the name &#8220;Conduit Pharmaceuticals Inc.&#8221;, to be effective at the time of the Business Combination,
of its shares of common stock and warrants on The Nasdaq Stock Market under the proposed symbols CDT and CDTTW, respectively. MURF will
not have units traded following consummation of the Business Combination. It is a condition of the consummation of the Business Combination
that MURF&#8217;s shares of common stock are approved for listing on The Nasdaq Stock Market, but there can be no assurance such listing
condition will be met. If such listing condition is not met, the Transactions will not be consummated unless the listing condition set
forth in the Merger Agreement is waived by the parties.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected to comply with
certain reduced public company reporting requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus provides you with detailed information about the Transactions and other matters to be considered at the Special
Meeting of MURF&#8217;s stockholders. We encourage you to carefully read this entire document. <b>You should also carefully consider
the risk factors described in &#8220;<i>Risk Factors</i>&#8221; beginning on page 24 of this proxy statement/prospectus. These
securities have not been approved or disapproved by the Securities and Exchange Commission or any state securities commission nor has
the Securities and Exchange Commission or any state securities commission passed upon the accuracy or adequacy of this proxy statement/prospectus.
Any representation to the contrary is a criminal offense. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus incorporates important business and financial information about MURF that is not included in or delivered
with this proxy statement/prospectus. You can obtain such information by visiting the Securities and Exchange Commission&#8217;s website
at <i>www.sec.gov</i> or requesting such information in writing or by telephone from MURF at the following address:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
K. Heilbron<br />
Murphy Canyon Acquisition Corp.<br />
4995 Murphy Canyon Road, Suite 300<br />
San Diego, CA 92123<br />
Tel: 760-471-8536</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
will not be charged for any of the documents that you request. Stockholders requesting documents should do so by &#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023 (five business days prior to the meeting date) in order to receive them before the Special Meeting of MURF stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus is dated &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, and is first being mailed to MURF stockholders
on or about &#160;&#160;&#160;&#160;&#160;&#160; , 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_001">ABOUT THIS PROXY STATEMENT/PROSPECTUS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_002">FREQUENTLY USED TERMS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_003">SUMMARY OF THE MATERIAL TERMS OF THE TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#ap_001">QUESTIONS AND ANSWERS ABOUT THE BUSINESS COMBINATION AND PROPOSALS</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">6</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_004">SUMMARY OF THE PROXY STATEMENT/PROSPECTUS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">13</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_006">FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">22</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_007">RISK FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_008">SPECIAL MEETING OF MURF STOCKHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">52</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_009">THE BUSINESS COMBINATION PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">66</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_010">THE MERGER AGREEMENT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">73</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_011">CERTAIN AGREEMENTS RELATED TO THE BUSINESS COMBINATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">80</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_012">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">81</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_013">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">87</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><a href="#ap_002">COMPARATIVE PER SHARE DATA</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">98</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_014">THE CHARTER AMENDMENTS PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">99</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_015">THE ADVISORY CHARTER AMENDMENTS PROPOSALS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">102</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_016">THE DIRECTOR ELECTION PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">104</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_017">MANAGEMENT OF NEW CONDUIT FOLLOWING THE BUSINESS COMBINATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">105</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_018">THE INCENTIVE PLAN PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">110</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_019">EXECUTIVE AND DIRECTOR COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">116</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_020">THE NASDAQ PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">117</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_021">THE ADJOURNMENT PROPOSAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">118</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_022">INFORMATION ABOUT MURF</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">119</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_023">MANAGEMENT&#8217;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS MURPHY CANYON ACQUISITION CORP.</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">128</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_024">BUSINESS OF CONDUIT PHARMACEUTICALS LIMITED</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">134</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_025">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS CONDUIT PHARMACEUTICALS LIMITED</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">158</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_026">BENEFICIAL OWNERSHIP OF SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">166</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_027">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">170</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_028">COMPARISON OF STOCKHOLDERS&#8217; RIGHTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">173</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_029">DESCRIPTION OF NEW CONDUIT SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">176</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_030">MURF SECURITIES AND DIVIDENDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">180</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_031">OTHER STOCKHOLDER COMMUNICATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">181</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_032">LEGAL MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">181</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_033">EXPERTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">181</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_034">DELIVERY OF DOCUMENTS TO STOCKHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">181</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_035">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">181</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#md_036">INDEX TO FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEXES</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_001">Agreement and Plan of Merger</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</span>-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-2
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_002">Amendment to Agreement and Plan of Merger</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-2</span>-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">A-3</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#A3_001">Second Amendment to Agreement and Plan of Merger</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">A-3-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_003">Second Amended and Restated Certificate of Incorporation of Conduit Pharmaceuticals Inc.</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_004">Conduit Pharmaceuticals Inc. 2023 Stock Incentive Plan</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_005">Opinion of ValueScope, Inc.</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">D-1</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="md_001"></span>ABOUT
THIS PROXY STATEMENT/PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus, which forms part of a registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission
(the &#8220;SEC&#8221;) by MURF, constitutes a prospectus of MURF under Section 5 of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), with respect to shares of common stock to be issued by MURF to the Conduit shareholders in connection with the Business
Combination. This document also constitutes a notice of meeting and a proxy statement under Section 14(a) of the U.S. Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;) with respect to the Special Meeting of MURF stockholders at which MURF stockholders
will be asked to consider and vote upon a proposal to approve the Business Combination by the approval and adoption of the Merger Agreement,
among other matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained or incorporated by reference into this proxy statement/prospectus. No one has been authorized
to provide you with information that is different from that contained in, or incorporated by reference into, this proxy statement/prospectus.
This proxy statement/prospectus is dated as of the date set forth on the cover hereof. You should not assume that the information contained
in this proxy statement/prospectus is accurate as of any date other than that date. You should not assume that the information incorporated
by reference into this proxy statement/prospectus is accurate as of any date other than the date of such incorporated document. Neither
the mailing of this proxy statement/prospectus to MURF stockholders nor the issuance by Conduit of its ordinary shares in connection
with the Business Combination will create any implication to the contrary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities, or the solicitation
of a proxy or consent, in any jurisdiction to or from any person to whom it is unlawful to make any such offer or solicitation in such
jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRADEMARKS,
TRADE NAMES AND SERVICE MARKS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document contains references to trademarks, trade names and service marks belonging to other entities. Solely for convenience, trademarks,
trade names and service marks referred to in this proxy statement/prospectus may appear without the &#174; or TM symbols, but such references
are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its
rights to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or
service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARKET
AND INDUSTRY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement/prospectus includes industry position and industry data and forecasts that Conduit obtained or derived from internal
company reports, independent third-party publications and other industry data. Some data are also based on good faith estimates, which
are derived from internal company analyses or review of internal company reports as well as the independent sources referred to above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
Conduit believes that the information on which it has based these estimates of industry position and industry data are generally reliable,
the accuracy and completeness of this information is not guaranteed and Conduit has not independently verified any of the data from third-party
sources nor have they ascertained the underlying economic assumptions relied upon therein. Statements as to industry opportunities and
information are based on market data currently available. While Conduit is not aware of any misstatements regarding the industry data
presented herein, these estimates involve risks and uncertainties and are subject to change based on various factors, including those
discussed under the heading &#8220;Risk Factors&#8221; in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="md_002"></span>FREQUENTLY
USED TERMS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this proxy statement/prospectus:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>2023
Plan</i>&#8221; means the Conduit Pharmaceuticals Inc. 2023 Stock Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>AstraZeneca</i>&#8221; means AstraZeneca AB (PUBL).&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Business
Combination</i>&#8221; means the Merger and the other transactions contemplated by the Merger Agreement and related agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Class
A common stock</i>&#8221; means shares of Class A common stock, par value $0.0001 per share, of Murphy Canyon Acquisition Corp., which,
following an automatic conversion pursuant to the Business Combination, is referred to herein as the <i>New Conduit common stock</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Class
B common stock</i>&#8221; means shares of Class B common stock, par value $0.0001 per share, of Murphy Canyon Acquisition Corp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Closing
Payment Shares</i>&#8221; means 65,000,000 shares of New Conduit common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Code</i>&#8221;
means the Internal Revenue Code of 1986, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Companies
Act</i>&#8221; means the Companies Act of the Cayman Islands (Revised).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;Conduit&#8221;
</i>means Conduit Pharmaceuticals Limited, a Cayman Islands exempted company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Conduit
convertible debt</i>&#8221; means all of the issued and outstanding indebtedness of Conduit set forth on the allocation schedule in the
Merger Agreement, which indebtedness will be converted into Conduit Shares prior to consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Conduit
shares</i>&#8221; means collectively, Conduit&#8217;s ordinary shares, par value GBP0.0001 per share, including ordinary shares issued
upon conversion of the Conduit convertible debt, which conversion shall occur prior to consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>DGCL</i>&#8221;
means the General Corporation Law of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Exchange
Act</i>&#8221; means the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>FASB</i>&#8221;
means the Financial Accounting Standards Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Founder
Shares</i>&#8221; means the 3,306,250 shares of Class B common stock, which are the remaining shares from the initial 4,312,500 shares
of Class B common stock issued to the Sponsor prior to MURF&#8217;s initial public offering, of which 1,006,250 shares were forfeited
for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>HSR
Act</i>&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>JOBS
Act</i>&#8221; means the Jumpstart Our Business Startups Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Marcum</i>&#8221;
means Marcum LLP, an independent registered public accounting firm, serving as MURF and Conduit&#8217;s auditors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Merger</i>&#8221;
means the merger of Merger Sub with and into Conduit with Conduit surviving the merger as a wholly-owned subsidiary of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Merger
Agreement</i>&#8221; means the Agreement and Plan of Merger, dated as of November 8, 2022, by and among MURF, Merger Sub and Conduit,
a copy of which is attached to this proxy statement/prospectus as <span style="text-decoration: underline">Annex A-1</span> and as amended by that certain Amendment to Agreement
and Plan of Merger, dated as of January 27, 2023, a copy of which is attached to this proxy statement/prospectus as Annex A-2, and
as further amended by that certain Second Amendment to Agreement and Plan of Merger, dated as of May 11, 2023, a copy of which is attached
to this proxy statement/prospectus as <span style="text-decoration: underline">Annex A-3</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;Merger
Sub</i>&#8221; means Conduit Merger Sub, Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands
and wholly-owned subsidiary of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>MURF</i>&#8221;
means Murphy Canyon Acquisition Corp., a Delaware corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>MURF
Board</i>&#8221; means the board of directors of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>MURF
common stock</i>&#8221; means the Class A common stock and Class B common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>New
Conduit</i>&#8221; means Murphy Canyon Acquisition Corp., a Delaware corporation, after the Business Combination, which is expected to
be renamed &#8220;Conduit Pharmaceuticals Inc.&#8221; upon the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>New
Conduit common stock</i>&#8221; means shares of common stock, par value $0.0001 per share, of New Conduit, after the filing of the Proposed
Charter upon the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Private
Placement</i>&#8221; means the private placement of an aggregate of 2,700,000 units, with each unit consisting of one share of Class A
common stock together with one warrant exercisable into one share of Class A common stock, with the Private Placement Investor pursuant
to Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, for a purchase price of $10.00 per unit, or an aggregate
amount of $27 million in gross cash proceeds, pursuant to the Subscription Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Private
Placement Investor</i>&#8221; means Prospect Science Ventures Limited, a New Zealand limited company, the accredited investor
with whom MURF entered into the Subscription Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Private
Shares</i>&#8221; means (i) the Founder Shares and (ii) the 754,000 shares of Class A common stock included in the units purchased by
the Sponsor in connection with MURF&#8217;s initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Private
Warrants</i>&#8221; means the 754,000 warrants of MURF included in the units purchased by the Sponsor in connection with MURF&#8217;s
initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;Proposed
Charter&#8221;</i> means the Second Amended and Restated Certificate of Incorporation of New Conduit, a copy of which is attached to
this proxy statement/prospectus as <span style="text-decoration: underline">Annex B</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Public
Shares</i>&#8221; means the shares of Class A common stock included in the units issued in MURF&#8217;s initial public offering (excluding
the Private Shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Public
Stockholder</i>&#8221; means a holder of Public Shares, including the Sponsor to the extent it holds Public Shares, provided, that the
Sponsor will be considered a &#8220;Public Stockholder&#8221; only with respect to any Public Shares held by it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Public
Warrants</i>&#8221; means the warrants included in the units issued in MURF&#8217;s initial public offering (excluding the Private Warrants).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>SEC</i>&#8221;
means the Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Securities
Act</i>&#8221; means the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Special
Meeting</i>&#8221; means the special meeting of the stockholders of MURF that is the subject of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Sponsor</i>&#8221;
means Murphy Canyon Acquisition Sponsor, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>St
George Street</i>&#8221; means St George Street Capital, a biomedical charity based in the United Kingdom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Subscription
Agreement</i>&#8221; means the subscription agreement, dated November 8, 2022, by and between MURF and the Private Placement Investor,
as amended by that certain amendment to the Subscription Agreement, dated January 27, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><i>&#8220;Supporting Conduit
Shareholders&#8221;</i> means Corvus Capital Limited, St George Street and Algo Holdings, Inc.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;Transactions</i>&#8221;
means the Business Combination and the Private Placement, taken together.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>U.S.
GAAP</i>&#8221; means generally accepted accounting principles in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;ValueScope&#8221;
</i>means ValueScope, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="md_003"></span>SUMMARY
OF THE MATERIAL TERMS OF THE TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    parties to the Business Combination are MURF, Merger Sub and Conduit. Pursuant to the Merger Agreement, Merger Sub will merge with
    and into Conduit, with Conduit surviving as a wholly-owned subsidiary of MURF. See the section entitled &#8220;<i>The Merger Agreement.</i>&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the Merger Agreement, the shareholders of Conduit will receive the number of New Conduit common stock that shall have an aggregate
    value equal to Six Hundred Fifty Million Dollars ($650,000,000). With each share of New Conduit common stock being valued at $10.00,
    Conduit&#8217;s outstanding ordinary shares (including the ordinary shares issued upon conversion of all outstanding convertible
    debt, which conversion shall have occurred prior to the consummation of the Business Combination) will be converted into an aggregate
    of 65,000,000 shares of New Conduit common stock following the Business Combination, with each such outstanding Conduit ordinary
    share converted into shares of New Conduit common stock on a pro rata basis. Additionally, immediately prior to the Business Combination,
    MURF&#8217;s Class A common stock shall automatically convert on a one-to-one basis into shares of New Conduit common stock without
    any action on the part of any of MURF&#8217;s Public Stockholders. See the section entitled &#8220;<i>The Business Combination Proposal
    &#8212; Structure of the Transactions</i>&#8221; for further information on the consideration being paid to Conduit shareholders.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">It
                                            is anticipated that, immediately after the closing of the Business Combination, assuming
                                            that no Public Stockholders exercise their redemption rights and that no warrants to purchase
                                            New Conduit common stock are exercised, MURF&#8217;s initial stockholder, our Sponsor, will
                                            retain an ownership interest of 4,015,250 shares of New Conduit common stock or approximately
                                            5.3% of New Conduit common stock, MURF&#8217;s Public Stockholders will retain an ownership
                                            interest of 2,187,728 shares of New Conduit common stock or approximately 2.9% of New Conduit
                                            common stock, MURF&#8217;s directors will own 45,000 shares of New Conduit common stock or
                                            approximately 0.1% of New Conduit common stock, A.G.P. will own 1,300,000 shares of New Conduit
                                            common stock or approximately 1.7% of New Conduit common stock, and Conduit&#8217;s shareholders
                                            will own 67,700,000 shares of New Conduit common stock or approximately 90.0% of New Conduit
                                            common stock, which reflects 65,000,000 shares of New Conduit common stock to be issued to
                                            the Conduit shareholders as consideration in the merger plus the 2,700,000 shares of New
                                            Conduit common stock to be issued to the Private Placement Investor in connection with the
                                            Private Placement as the Private Placement Investor is an affiliate of one of Conduit&#8217;s
                                            existing shareholders.<sup>1</sup> Under this scenario, on a pro forma basis, it is estimated
                                            that New Conduit will have total stockholders&#8217; equity of approximately $25.8 million,
                                            which results in a value per share of $0.34, which is calculated as $25.8 million divided
                                            by 75,247,978 shares of New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assuming
                                            the same facts as above except that 50% of MURF&#8217;s Public Stockholders redeem their
                                            shares (a redemption of 1,093,864 shares), New Conduit will have total stockholders&#8217;
                                            equity of approximately $14.4 million, which results in a value per share of $0.19, which
                                            is calculated as $14.4 million divided by 74,154,114 shares of New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assuming
                                            the same facts as above except that 100% of MURF&#8217;s Public Stockholders redeem their
                                            shares (a redemption of 2,187,728 shares), New Conduit will have total stockholders&#8217;
                                            equity of approximately $3.0 million, which results in a value per share of $0.04, which
                                            is calculated as $3.0 million divided by 73,060,250 shares of New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immediately
                                            after the closing of the Business Combination, assuming that no Public Stockholders exercise
                                            their redemption rights and excluding all shares that will be held by our Sponsor and MURF
                                            directors and assuming that no warrants to purchase New Conduit common stock are exercised,
                                            MURF&#8217;s Public Stockholders will retain an ownership interest of 2,187,728 shares of
                                            New Conduit common stock or approximately 3.1% of New Conduit common stock, A.G.P. will own
                                            1,300,000 shares of New Conduit common stock or approximately 1.8% of New Conduit common
                                            stock, and Conduit&#8217;s shareholders will own 67,700,000 shares of New Conduit common
                                            stock or approximately 95.1% of New Conduit common stock, which reflects 65,000,000 shares
                                            of New Conduit common stock to be issued to the Conduit shareholders as consideration in
                                            the merger plus the 2,700,000 shares of New Conduit common stock to be issued to the Private
                                            Placement Investor in connection with the Private Placement as the Private Placement Investor
                                            is an affiliate of one of Conduit&#8217;s existing shareholders.<sup>2</sup> Under this scenario,
                                            on a pro forma basis, it is estimated that New Conduit will have total stockholders&#8217;
                                            equity of approximately $25.8 million, which results in a value per share of $0.36, which
                                            is calculated as $25.8 million divided by 71,187,728 shares of New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assuming
                                            the same facts as above except that 50% of MURF&#8217;s Public Stockholders redeem their
                                            shares (a redemption of 1,093,864 shares), New Conduit will have total stockholders&#8217;
                                            equity of approximately $14.4 million, which results in a value per share of $0.21, which
                                            is calculated as $14.4 million divided by 70,093,864 shares of New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assuming
                                            the same facts as above except that 100% of MURF&#8217;s Public Stockholders redeem their
                                            shares (a redemption of 2,187,728 shares), New Conduit will have total stockholders&#8217;
                                            equity of approximately $3.0 million, which results in a value per share of $0.04, which
                                            is calculated as $3.0 million divided by 69,000,000 shares of New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immediately
                                            after the closing of the Business Combination, assuming that no public stockholders exercise
                                            their redemption rights and that all warrants to purchase New Conduit common stock are exercised,
                                            MURF&#8217;s initial stockholder, our Sponsor, will retain an ownership interest of 4,724,250
                                            shares of New Conduit common stock or approximately 5.1% of New Conduit common stock, MURF&#8217;s
                                            Public Stockholders will retain an ownership interest of 15,412,728 shares of New Conduit
                                            common stock or approximately 16.8% of New Conduit common stock, MURF&#8217;s Directors will
                                            own 90,000 shares of New Conduit common stock or approximately 0.1% of New Conduit common
                                            stock, A.G.P. will own 1,354,000 shares of New Conduit common stock or approximately 1.5%
                                            of New Conduit common stock, and Conduit&#8217;s shareholders will own 70,400,000 shares
                                            of New Conduit common stock or approximately 76.5% of New Conduit common stock, which reflects
                                            65,000,000 shares of New Conduit common stock to be issued to the Conduit shareholders as
                                            consideration in the merger plus 5,400,000 shares of New Conduit common stock to be issued
                                            to the Private Placement Investor in connection with the Private Placement as the Private
                                            Placement Investor is an affiliate of one of Conduit&#8217;s existing shareholders.<sup>3
                                            </sup>Under this scenario, on a pro forma basis, it is estimated that New Conduit will have
                                            total stockholders&#8217; equity of approximately $25.8 million, which results in a value
                                            per share of $0.28, which is calculated as $25.8 million divided by 91,980,978 shares of
                                            New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assuming
                                            the same facts as above except that 50% of MURF&#8217;s Public Stockholders redeem their
                                            shares (a redemption of 1,093,864 shares), New Conduit will have total stockholders&#8217;
                                            equity of approximately $14.4 million, which results in a value per share of $0.16, which
                                            is calculated as $14.4 million divided by 90,887,114 shares of New Conduit common stock.</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Assuming the same facts as above except that 100% of
    MURF&#8217;s Public Stockholders redeem their shares (a redemption of 2,187,728 shares), New Conduit will have total stockholders&#8217;
    equity of approximately $3.0 million, which results in a value per share of $0.03, which is calculated as $3.0 million divided by
    89,793,250 shares of New Conduit common stock.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    Merger Agreement may be terminated as follows: (i) by the mutual consent of MURF and Conduit; (ii) by MURF, if any of the representations
    or warranties of Conduit set forth in the Merger Agreement is not true and correct, or if Conduit has failed to perform any covenant
    or agreement set forth in the Merger Agreement (including an obligation to consummate the Business Combination), in each case such
    that the conditions to closing would not be satisfied and the breach or breaches causing such representations or warranties not to
    be true and correct, or the failure to perform any covenant or agreement, as applicable, are not cured (or waived by MURF) by the
    earlier of (a) the Outside Date (as defined below) or (b) 20 days after written notice thereof is delivered to Conduit; provided,
    however that MURF is not then in material breach of any representation, warranty, covenant, or obligation in the Merger Agreement,
    which breach has not been cured; (iii) by Conduit, if any of the representations or warranties of MURF or Merger Sub set forth in
    the Merger Agreement is not true and correct, or if MURF or Merger Sub has failed to perform any covenant or agreement set forth
    in the Merger Agreement (including an obligation to consummate the Business Combination), in each case such that the conditions to
    closing would not be satisfied and the breach or breaches causing such representations or warranties not to be true and correct,
    or the failure to perform any covenant or agreement, as applicable, are not cured (or waived by Conduit) by the earlier of (a) the
    Outside Date or (b) 20 business days after written notice thereof is delivered to MURF; provided, however that Conduit is not then
    in material breach of any representation, warranty, covenant, or obligation in the Merger Agreement, which breach has not been cured;
    (iv) by either MURF or Conduit: (a) on or after February 7, 2024 (the &#8220;Outside Date&#8221;), if the Business Combination
    has not been consummated prior to the Outside Date; provided, however, that this right to terminate the Merger Agreement will not
    be available to a party if the failure of the merger to have been consummated before the Outside Date was due to such party&#8217;s
    breach of or failure to perform any of its covenants or agreements set forth in the Merger Agreement, (b) if any applicable law or
    order that makes the transactions contemplated by the Merger Agreement illegal or otherwise prohibits consummation of such transactions
    becomes final and non-appealable, or (C) if MURF has not received approval from its stockholders of the Business Combination and
    related transactions at the Special Meeting; (v) by MURF if the Conduit shareholders&#8217; written consent approving the Business
    Combination and related transactions have not have been obtained within 10 business days after the date of the Merger Agreement;
    and (vi) if there is a material adverse effect on behalf of the other party. See the section entitled &#8220;<i>The Merger Agreement
    &#8212; Termination.</i>&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to voting on the business combination proposal, MURF stockholders will vote on separate proposals to approve amendments to MURF&#8217;s
current amended and restated certificate of incorporation to: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify; width: 0.75in">&#160;</td>
  <td style="text-align: justify; width: 0.5in">(i) </td>
  <td style="text-align: justify">Charter Amendment Proposal A &#8211; change the name of the public entity from &#8220;Murphy Canyon Acquisition Corp.&#8221; to
  &#8220;Conduit Pharmaceuticals Inc.&#8221;;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(ii) </td>
  <td style="text-align: justify">Charter Amendment Proposal B &#8211; provide for one class of authorized common stock;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(iii) </td>
  <td style="text-align: justify">Charter Amendment Proposal C &#8211; delete the various provisions in MURF&#8217;s current amended
  and restated certificate of incorporation applicable only to special purpose acquisition corporations (such as the obligation to
  dissolve and liquidate if a business combination is not consummated within a certain period of time);</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(iv) </td>
  <td style="text-align: justify">Charter Amendment Proposal D &#8211; increase the number of authorized shares of common stock to
  250,000,000; and</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(v) </td>
  <td style="text-align: justify">Charter Amendment Proposal D &#8211; fix the number of directors at seven (7),
a majority of whom shall be independent directors in accordance with The Nasdaq Stock Market LLC&#8217;s requirements. See the section
entitled &#8220;<i>The Charter Amendment Proposals</i>.&#8221;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1
</sup>Shares outstanding at closing does not include any shares related to Cizzle PLC exercising its option to exchange its economic
interest in an asset of Conduit Pharmaceuticals Limited for shares as the option is not expected to be exercised prior to or at the closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
Shares outstanding at closing does not include any shares related to Cizzle PLC exercising its option to exchange its economic
interest in an asset of Conduit Pharmaceuticals Limited for shares as the option is not expected to be exercised prior to or at the closing.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3
</sup>Shares outstanding at closing does not include any shares related to Cizzle PLC exercising its option to exchange its economic
interest in an asset of Conduit Pharmaceuticals Limited for shares as the option is not expected to be exercised prior to or at the closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition to voting on the business combination proposal, MURF stockholders will vote on separate proposals to consider and vote upon,
    on a non-binding advisory basis, certain governance provisions in the Proposed Charter, presented separately in accordance with SEC
    requirements. See the section entitled &#8220;<i>The Advisory Charter Amendments Proposals</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stockholders of MURF will also consider and vote upon a proposal to approve, for purposes of complying with applicable listing rules
    of Nasdaq, the issuance of shares of common stock, par value $0.0001 per share, and warrants to purchase common stock, to the Private
    Placement Investor in the Private Placement, the proceeds of which will be used to finance the Business Combination and related transactions
    and the costs and expenses incurred in connection therewith with any balance used for working capital purposes. Pursuant to the Subscription
    Agreement, the Private Placement Investor agreed to subscribe for and purchase and MURF agreed to issue and sell to the Private Placement
    Investor an aggregate of 2,700,000 units, with each unit consisting of one share of Class A common stock together with one warrant
    exercisable into one share of Class A common stock, or an aggregate of $27 million in gross cash proceeds, in the Private Placement.
    See the section entitled &#8220;<i>The Nasdaq Proposal</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF stockholders will also vote on proposals (x) to approve of the appointment
of seven (7) directors who, upon consummation of the Business Combination, will become the directors of New Conduit, (y) to approve the
Conduit Pharmaceuticals Inc. 2023 Stock Incentive Plan and (z) to approve, if necessary, an adjournment of the Special Meeting. See the
sections entitled &#8220;<i>The Incentive Plan Proposal</i>&#8221; and &#8220;<i>The Adjournment Proposal</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Upon completion of the Business Combination, if management&#8217;s
    nominees are elected, the directors of New Conduit will be (i) Dr. Freda Lewis-Hall, Chairman of New Conduit&#8217;s board of directors,
    (ii) Dr. David Tapolczay, a current director of Conduit and the Chief Executive Officer of New Conduit, (iii) James Bligh, an employee
    of Conduit, (iv) Faith L. Charles, (v) Chele Chiavacci Farley, a current director of MURF, (vi) Jennifer I. McNealey, and (vii) Dr.
    Andrew Regan, a current director and shareholder of Conduit (Dr. Regan also undertakes duties typically associated with an executive
    officer in connection with his service as a director of Conduit).</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    completion of the Business Combination, the executive officers of New Conduit will include Dr. David Tapolczay as Chief Executive
    Officer and Adam Sragovicz, MURF&#8217;s Chief Financial Officer and director, as Chief Financial Officer, and the other persons
    described under the section entitled &#8220;<i>Management of New Conduit Following the Business Combination</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Chief Executive Officer of MURF, Jack Heilbron,
    is the sole and managing member of the Sponsor, Murphy Canyon Acquisition Sponsor LLC. The Sponsor and the directors and officers
    of MURF have each waived their redemption rights with respect to any Founder Shares and Class A common stock held by them (other
    than relating to liquidating distributions to Public Shares from the trust account if MURF fails to complete its initial business
    combination by the time required prior to MURF&#8217;s liquidation in accordance with its amended and restated certificate of incorporation),
    which waiver was provided in connection with the initial public offering and without any separate consideration paid in connection
    with providing such waiver.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
    with the execution of the Merger Agreement, the Sponsor and its affiliates, which own 4,060,250 shares of MURF common stock (representing
    approximately 65% of the issued and outstanding shares of MURF common stock, consisting of the Private Shares, or 754,000
    shares of Class A common stock and 3,306,250 shares of Class B common stock) and certain Conduit shareholders, which own in aggregate
    1,670 Conduit shares (representing 83.6% of the issued and outstanding shares of Conduit ordinary shares), have entered into
    support agreements with MURF and Conduit pursuant to which they have agreed to vote all of their respective shares in favor of the
    Business Combination, including any additional shares of MURF common stock or Conduit shares, as applicable, any may acquire ownership
    of or the power to vote, subject to the terms and conditions set forth in such support agreements. See the sections entitled
    &#8220;<i>Certain Agreements Related to the Business Combination &#8212; Sponsor Support Agreement,&#8221; &#8220;Certain Agreements
    Related to the Business Combination&#8221; and &#8220;Shareholder Support Agreements</i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, the
    record date, the Sponsor beneficially owned and was entitled to vote an aggregate of 4,060,250 shares of MURF common stock (consisting
    of 754,000 shares of Class A common stock and 3,306,250 shares of Class B common stock) that were issued prior to or concurrently
    with MURF&#8217;s initial public offering (collectively, the &#8220;Private Shares&#8221;). As of the date of this proxy statement/prospectus,
    such shares constitute approximately 65% of the issued and outstanding shares of MURF common stock. Concurrently with
    the execution of the Merger Agreement, the Sponsor and MURF entered into a support agreement, pursuant to which the Sponsor agreed
    to vote all of its Private Shares, including any additional shares of MURF common stock it acquires ownership of or the power to
    vote, in favor of the Business Combination and related transactions. See the section entitled &#8220;<i>Special Meeting of MURF Stockholders
    &#8212; Sponsor</i>.&#8221;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and its affiliates&#8217; paid an aggregate of $7,565,000 for the Private Shares (comprised of the Founder Shares and the
    754,000 units (each such unit comprised of one share of Class A common stock and one warrant to purchase one share of Class A common
    stock) purchased by the Sponsor in connection with MURF&#8217;s initial public offering), which has an approximate aggregate market
    value of $49,130,000 (assuming that the future value of New Conduit common stock and the Private Warrants will be the same
    as the current value of MURF&#8217;s Class A common stock).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and its affiliates&#8217; total potential ownership interest in New Conduit, assuming the exercise and conversion of all
    securities following the closing of the Business Combination, including the Private Shares, is estimated to comprise approximately
    5.1% of the outstanding New Conduit common stock in a no redemption scenario (or a transaction value of approximately $33,884,000
    or a market value of approximately $49,130,000), approximately 5.2% of outstanding New Conduit common stock in a 50% redemption
    scenario (or a transaction value of approximately $33,787,000 or a market value of approximately $49,130,000), and approximately
    5.3% of outstanding New Conduit common stock in a 100% maximum redemption scenario (or a transaction value of approximately
    $34,198,000 or a market value of approximately $49,130,000).&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and its affiliates can earn a positive rate of return on their overall investment in MURF and Conduit after the Business
    Combination, even if other holders of MURF common stock experience a negative rate of return, due to having purchased the Founder
    Shares, as described above, for $25,000 or approximately $0.006 per share. &#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 7, 2023, MURF issued to Sponsor an unsecured promissory note in the principal amount of $1,500,000, portions of which may be
    withdrawn by MURF from time to time (the &#8220;Promissory Note&#8221;). &#160;As of April 30, 2023, MURF has submitted
    drawdown requests in an aggregate amount of $500,000.&#160;&#160;The Promissory Note bears no interest and outstanding principal
    is due and payable upon the earlier of the consummation of the initial business combination or the date of the liquidation of MURF.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate dollar amount that the Sponsor and its affiliates have at risk that depends on the completion of an initial business combination,
    including the Business Combination, is approximately $8,065,000, as of April 30, 2023, which is the current value of securities
    held (assuming that the current value of each of the securities held, whether publicly traded shares of Class A common stock or Private
    Warrants, are in each case valued at the current price of Class A common stock) and consists of (i) the Founders Shares, (ii)
    the 754,000 private placement units (each such unit comprised of one share of Class A common stock and one warrant to purchase one
    share of Class A common stock) purchased in connection with MURF&#8217;s initial public offering, and (iii) the Promissory Note.
    &#160;There are no fees due or out of pocket expenses for which Sponsor and its affiliates are awaiting reimbursement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate dollar amount that the directors of MURF have at risk that depends on the completion of an initial business combination,
    including the Business Combination, is approximately $942,300, as of April 30, 2023, which is the current value of the
    Independent Director Units. There are no loans, fees due or out of pocket expenses for which directors are awaiting
    reimbursement.</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_001"></span>QUESTIONS
AND ANSWERS ABOUT THE BUSINESS COMBINATION AND PROPOSALS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
questions and answers below highlight only selected information from this proxy statement/prospectus and only briefly address some commonly
asked questions about the Special Meeting and the proposals to be presented at the Special Meeting, including with respect to the proposed
business combination. The following questions and answers do not include all the information that is important to MURF stockholders.
Stockholders are urged to read carefully this entire proxy statement/prospectus, including the Annexes and the other documents referred
to herein, to fully understand the proposed business combination and the voting procedures for the Special Meeting.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            am I receiving this proxy statement/prospectus?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
                                            and Conduit have agreed to a business combination under the terms of the Merger Agreement
                                            that is described in this proxy statement/prospectus. A copy of the Merger Agreement is attached
                                            to this proxy statement/prospectus as <span style="text-decoration: underline">Annexes A-1  through A-3</span>,
                                            and MURF encourages its stockholders to read it in its entirety. MURF&#8217;s stockholders
                                            are being asked to consider and vote upon a proposal to adopt the Merger Agreement, which,
                                            among other things, provides for Merger Sub to merge with and into Conduit, with Conduit
                                            continuing as the surviving company and a wholly-owned subsidiary of MURF. See the section
                                            entitled &#8220;<i>The Business Combination Proposal</i>.&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Are
                                            there any other matters being presented to stockholders at the meeting?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition to voting on the Business Combination, the stockholders of MURF will vote on the
                                            following:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">1.</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
consider and vote upon separate proposals to approve amendments to MURF&#8217;s current amended and restated certificate of incorporation
to:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal A &#8211; change the name of the public entity from &#8220;<span style="background-color: white">Murphy Canyon Acquisition
  Corp.</span>&#8221; to &#8220;<span style="background-color: white">Conduit Pharmaceuticals Inc.</span>&#8221;;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal B &#8211; provide for one class of authorized common stock;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal C &#8211; delete the various provisions in MURF&#8217;s current amended and restated certificate of incorporation
  applicable only to special purpose acquisition corporations (such as the obligation to dissolve and liquidate if a business combination
  is not consummated within a certain period of time);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal D &#8211; increase the number of authorized shares of common stock to 250,000,000; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
  Amendment Proposal E &#8211; fix the number of directors at seven (7), a majority of whom shall be independent directors in
  accordance with The Nasdaq Stock Market LLC&#8217;s requirements. See the section entitled &#8220;<i>The Charter Amendment
  Proposals</i>.&#8221;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            consider and vote upon, on a non-binding advisory basis, certain governance provisions in
                                            the Proposed Charter, presented separately in accordance with SEC requirements. See the section
                                            entitled &#8220;<i>The Advisory Charter Amendments Proposals.</i>&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">3.</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">To elect seven (7) directors who, upon consummation of the Transactions,
will be the directors of New Conduit. See the section entitled &#8220;<i>The Director Election Proposal</i>.&#8221;</p></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">4.</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            approve the 2023 Plan. See the section entitled &#8220;<i>The Incentive Plan Proposal</i>.&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            approve the issuance of New Conduit common stock for purposes of complying with applicable
                                            Nasdaq listing rules. See the section entitled &#8220;<i>The Nasdaq Proposal</i>.&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">6.</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            adjourn the meeting to a later date or dates to permit further solicitation and vote of proxies
                                            if MURF would not have been able to consummate the Business Combination. See the section
                                            entitled &#8220;<i>The Adjournment Proposal</i>.&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
will hold the Special Meeting of its stockholders to consider and vote upon these proposals. This proxy statement/prospectus contains
important information about the proposed business combination and the other matters to be acted upon at the Special Meeting. Stockholders
should read it carefully.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation
of the Business Combination is conditioned on approval of each of the business combination proposal, the charter amendment
proposals, the advisory charter amendments proposals, director election proposal, the Nasdaq proposal and the incentive plan
proposal. If any of the proposals is not approved, the other proposals will not be presented to stockholders for a vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
vote of stockholders is important. Stockholders are encouraged to vote as soon as possible after carefully reviewing this proxy statement/prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            will Conduit shareholders and receive in the Business Combination?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Business Combination is completed, the outstanding Conduit shares (including the ordinary
                                            shares issued upon conversion of all of Conduit&#8217;s outstanding convertible debt, which
                                            conversion shall have occurred prior to the consummation of the Business Combination) shall
                                            be converted into an aggregate of 65,000,000 shares of New Conduit common stock following
                                            the Transactions.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I
                                            am a MURF warrant holder. Why am I receiving this proxy statement/prospectus?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            consummation of the Transactions, MURF&#8217;s Public Warrants shall, by their terms, entitle the holders
                                            to purchase New Conduit common stock at a purchase price of $11.50 per share. This proxy
                                            statement/prospectus includes important information about MURF and the business of MURF following
                                            consummation of the Transactions. As holders of MURF warrants will be entitled to purchase
                                            shares of New Conduit common stock upon consummation of the Transactions, you are encouraged
                                            to read the information contained in this proxy statement/prospectus carefully.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            is MURF proposing the Business Combination?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
                                            was organized to effect a merger, capital stock exchange, asset acquisition or other similar
                                            business combination with one or more businesses or entities.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2022, MURF completed its initial public offering of units, with each unit consisting of one share of Class A common stock
and one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of Class A common stock for $11.50
per share, raising <span style="background-color: white">total proceeds of $132,250,000</span> (including a full exercise of the over-allotment
option). Since the initial public offering, MURF&#8217;s activity has been limited to the evaluation of business combination candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals is a clinical-stage specialty biopharmaceutical company that began operations in early 2019, to facilitate the
development and commercialization of clinical assets that have not been, or are not being, prioritized by leading biopharmaceutical companies
in order to develop pharmaceutical products that meet the unmet medical needs of patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">For information about the Board&#8217;s reasons for approving the Transactions,
see <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>The
Business Combination Proposal &#8212; The MURF Board&#8217;s Reasons for Approval of the Transactions</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            equity stake will current MURF stockholders and Conduit shareholders have in New Conduit after the
                                            closing of the Business Combination?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.25in"><b>A.</b></td>
  <td style="text-align: justify">The equity stake held by non-redeeming Public Stockholders, Conduit shareholders and
  the Sponsor in New Conduit immediately following consummation of the Business Combination will depend on the number of redemptions
  from the trust account by Public Stockholders as well as various other factors, as described in the assumptions set forth below. </td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">Approximate equity stakes for each of these shareholder groups upon consummation of the Business
  Combination, and their corresponding approximate collective voting power in New Conduit, are set forth in the table below in respect
  of three redemption scenarios: (1) &#8220;Scenario A,&#8221; in which there are no redemptions of Public Shares; (2) &#8220;Scenario
  B,&#8221; in which 50% of Public Shares are redeemed; and (3) &#8220;Scenario C,&#8221; in which 100% of Public Shares are redeemed.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td></td>
  <td style="text-align: justify">All else being equal, if any Public Stockholders exercise their redemption rights, then the
  percentage of New Conduit common stock held collectively by all non-redeeming Public Stockholders will decrease and the percentage
  of New Conduit common stock held by Conduit Shareholders and the Sponsor will increase, in each case, relative to the percentage held
  if no Public Shares are redeemed. &#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In an effort to present
  possible sources of dilution and the extent of such dilution that non-redeeming Public Stockholders could experience, each of the scenarios
  below assumes (i) that no additional shares of MURF common stock are issued prior to the closing of the Business Combination, (ii)
  there is no exercise of any options to purchase New Conduit common stock that will be outstanding immediately following the Business
  Combination, whether such options are issued under the 2023 Incentive Plan or otherwise, (iii) the consummation of the Private Placement
  by the Private Placement Investor and related issuance of New Conduit common stock (iv) the issuance of Conduit&#8217;s ordinary shares
  upon the conversion of all outstanding convertible debt of Conduit prior to the closing of the Business Combination.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table set forth below
  also states the anticipated pro forma equity value of New Conduit for each of the scenarios described above. These pro forma equity
  values reflect an assumed price for New Conduit common stock of $10.00 per share, being the price per share negotiated with Conduit
  and set forth in the Merger Agreement for New Conduit common stock to be issued to the existing Conduit shareholders immediately prior
  to the closing of the Business Combination.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">The pro forma equity values include the equity consideration to be issued to Conduit shareholders
  at the closing of the Business Combination (being 65,000,000 share of New Conduit common stock, or approximately $650,000,000). The
  number of Public Shares redeemed by Public Stockholders with cash from the trust account at closing is not, all else being equal, expected
  to materially affect the equity value per share of New Conduit common stock held by non-redeeming Public Stockholders at the time immediately
  following the closing of the Business Combination, as each redemption will result in (x) the cancellation of one Public Share, and
  (y) the payment of approximately $10.52 to the redeeming Public Stockholder (given that, based on assumed funds in the trust account
  of approximately $23.3 million on the Record Date, the estimated per share redemption price would have been approximately $10.52) and,
  accordingly, such funds will not be available to New Conduit or reflected in its financial statements following the closing. You should
  note, however, that the level of redemptions of Public Shares from the trust account may affect the market price for New Conduit common
  stock following the closing of the Business Combination in ways which we cannot predict.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td style="text-align: justify">The ownership percentages set forth below for non-redeeming Public Stockholders and all other New
  Conduit shareholders may be further diluted, all else being equal, in the event that options for New Conduit common stock outstanding
  following the closing are exercised. The issuance of any shares or other awards in connection with the 2023 Incentive Plan following
  the Business Combination would also have a dilutive effect on New Conduit shareholders&#8217; ownership percentages, all else being
  equal, however, the magnitude of any such potential issuances is not known as of the date of this proxy statement/prospectus.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">No Redemption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">50% Redemption(1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">100% Redemption(2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Percentage(3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Percentage(3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Percentage(3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares held
    by Conduit Shareholders<sup>(4)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">65,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">70.67</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">65,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">71.52</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;65,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">72.39</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Shares held by Public Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,728</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.38</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,093,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.20</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Shares underlying Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.38</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.55</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.73</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued to Sponsor<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,015,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.37</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,015,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.42</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,015,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.47</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Shares underlying Private Warrants held by Sponsor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">709,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">709,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">709,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Shares issued to Private Placement Investor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.94</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.97</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.01</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Shares underlying warrants issued&#160;&#160;to Private Placement Investor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.94</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.97</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.01</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Shares issued to MURF Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Shares underlying warrants issued to MURF Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Shares issued to A.G.P.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,300,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.41</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,300,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,300,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.45</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Shares underlying warrants issued to A.G.P.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Shares Outstanding at Closing(6)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">91,980,978</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">90,887,114</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">89,793,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1%. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    scenario assumes that 1,093,864 Public Shares, or 50% of the Public Shares as of the date of this proxy statement/prospectus, are
    redeemed for an aggregate payment of approximately $11.5 million from the trust account as of April 30, 2023, which is a redemptions
    scenario that could occur. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    scenario assumes that 2,187,728 Public Shares, or 100% of the Public Shares as of the date of this proxy statement/prospectus, are
    redeemed for an aggregate payment of approximately $23.7 million from the trust account as of April 30, 2023, which is a redemptions
    scenario that could occur. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    voting power percentages in this table are approximate and have been rounded to two decimal places.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not include shares issued to the Private Placement Investor, who is also a Conduit shareholder.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares issued to the Sponsor consist of (i) 3,306,250 shares of Class B common stock and (ii) 754,000 shares of Class A common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(6)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Shares outstanding at closing does not include any shares
    related to Cizzle PLC exercising its option to exchange its economic interest in an asset of Conduit Pharmaceuticals Limited for
    shares as the option is not expected to be exercised prior to or at the closing.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.25in">&#160;</td>
  <td style="width: 0.25in">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The anticipated ownership
  of New Conduit&#8217;s securities set forth above, including the potential effect of any dilutive events, is accurate, subject to the
  assumptions and exclusions set forth above, as of the date of filing of this proxy statement/prospectus, and does not take into account
  any transactions that may be entered into after the date hereof unless explicitly set forth above. If the actual facts differ from
  these assumptions, the numbers of shares and ownership percentages set forth above, including the anticipated equity stake of non-redeeming
  Public Stockholders in New Conduit following the Business Combination, will be different.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You should read the section
  of this proxy statement/prospectus entitled &#8220;<i>Unaudited Pro Forma Condensed Combined Financial Information</i>&#8221; for further
  information.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to the changes in percentage ownership
depicted above, variation in the levels of redemptions will impact the dilutive effect of certain equity issuances related to the Business
Combination, which would not otherwise be present in an underwritten public offering. Increasing levels of redemptions will increase
the dilutive effect of these issuances on non-redeeming holders of our public shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The following table
shows the dilutive effect and the effect on the per share value of New Conduit common stock held by non-redeeming holders under a range
of scenarios at closing as described below:</span><span style="font-size: 8pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    No Redemptions<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    50% Redemptions<sup>(2)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    Maximum Redemptions<sup>(3)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="22" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(shares
    in thousands)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
    Per Share <sup>(4)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
    Per Share <sup>(5)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
    Per Share <sup>(6)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
    scenario<sup>(10)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,248</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,060</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.04</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
    scenario less shares held by MURF Sponsor and MURF Directors<sup>(10)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,188</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,094</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.04</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
    scenario plus assumed exercise of all warrants<sup>(8)(9)(10)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,981</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,887</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,793</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that no shares of MURF Common Stock are redeemed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that 1,093,864 shares of MURF Common Stock, or 50% of our public shares outstanding are redeemed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that 2,187,728 shares of MURF Common Stock, or 100% of the shares outstanding are redeemed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on a post-transaction equity value of New Conduit of $25.8 million.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on a post-transaction equity value of New Conduit of $14.4 million.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on a post-transaction equity value of New Conduit of $3.0 million.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Base scenario represents the post-Closing share ownership of New Conduit assuming various levels of redemption by holders of MURF
    Common Stock. The Base scenario (assuming no redemptions) includes 67,700,000 shares to be held by Conduit shareholders (comprised
    of 65,000,000 shares to be issued to Conduit shareholders in exchange for the Ordinary shares they hold in Conduit prior to the Business
    Combination and 2,700,000 shares to be issued as part of the PIPE Financing), 2,187,728 shares to be held by MURF Public Stockholders,
    45,000 shares to be held by MURF Directors, 4,015,250 shares to be held by the MURF Sponsor, and 1,300,000 shares to be held by A.G.P.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the Base scenario plus the Public Warrants, which consist of 13,225,000 warrants issued to MURF Public Stockholders in connection
    with MURF&#8217;s initial public offering, 2,700,000 warrants to be issued in connection with the PIPE Financing, and 54,000 warrants to
    be issued to A.G.P. upon the closing of the Business Combination. In addition, this includes the Private Warrants, which consist
    of 709,000 warrants issued to the Sponsor in connection with MURF&#8217;s initial public offering and 45,000 warrants originally issued
    to the MURF Sponsor prior to MURF&#8217;s initial public offering that will be transferred to MURF Directors upon the closing of the Business
    Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not account for any proceeds being paid to New Conduit in connection with the payment of the exercise prices for any warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Shares outstanding at closing does not include any shares
    related to Cizzle PLC exercising its option to exchange its economic interest in an asset of Conduit Pharmaceuticals Limited for
    shares as the option is not expected to be exercised prior to or at the closing.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-size: 10pt"><b>Q.</b></span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><b>How is the payment
    of the deferred underwriting commissions going to affect the amount left in the upon the completion of the Business Combination?</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.25in"><b>A.</b></td>
  <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The deferred underwriting commissions in
      connection with MURF&#8217;s initial public offering will be released to the underwriters only on completion of the Business Combination.
      The deferred underwriting commission is payable if a business combination is consummated without regard to the number of Public
      Shares redeemed by holders in connection wit<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h a business
      combination. The following table presents the deferred underwriting commission as a percentage of the cash left in the trust account
      following redemptions across a range of varying redemption scenarios.</span></p>
</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>50%</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>100%</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    Underwriting Commission</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,628,750</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,628,750</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,628,750</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    Underwriting Commission as a percentage of cash left in the Trust Account Following Redemptions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.25</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0pt 0pt 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the section of this proxy statement/prospectus entitled &#8220;<i>Unaudited Pro Forma Condensed Combined Financial Information</i>&#8221;
for further information.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            will be the directors and officers of New Conduit after the closing of the Business Combination?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
                                            following the consummation of the Business Combination, if management&#8217;s nominees are
                                            elected, the board of directors of Ne</span>w Conduit will consist of (i) Dr. Freda Lewis-Hall,
                                            Chairman of New Conduit&#8217;s board of directors, (ii) Dr. David Tapolczay, a current director
                                            of Conduit and the Chief Executive Officer of New Conduit, (iii) James Bligh, an employee
                                            of Conduit, (iv) Faith L. Charles, (v) Chele Chiavacci Farley, a current director of MURF,
                                            (vi) Jennifer I. McNealey, and (vii) Dr. Andrew Regan, a current director and shareholder
                                            of Conduit (Dr. Regan also undertakes duties typically associated with an executive officer
                                            in connection with his service as a director of Conduit). In addition, the executive
                                            officers of New Conduit will be Dr. David Tapolczay, Conduit&#8217;s current Chief Executive
                                            Officer and director, as Chief Executive Officer, and Adam Sragovicz, MURF&#8217;s current
                                            Chief Financial Officer and a director, as Chief Financial Officer.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Do
                                            I have redemption rights?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a holder of Public Shares, you have the right to demand that MURF redeem such shares
                                            into a pro rata portion of the cash held in MURF&#8217;s trust account. We sometimes refer
                                            to these rights to demand redemption of the Public Shares as &#8220;redemption rights.&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
MURF&#8217;s amended and restated certificate of incorporation, the Business Combination may only be consummated if MURF <span style="background-color: white">(i) is exempt from the provisions
of Rule 419 promulgated under the Securities Act other than through its net tangible assets or (ii) </span>has at least
$5,000,001 of net tangible assets either immediately prior to or upon consummation of the Business Combination. However, Conduit is not
required to consummate the Transactions if there is not at least $27 million of cash available to be released from MURF&#8217;s trust
account and/or received by MURF under the Subscription Agreement after giving effect to payment of amounts that MURF will be required
to pay to redeeming stockholders upon consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            do I exercise my redemption rights?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a holder of Public Shares and wish to exercise your redemption rights, you must, prior
                                            to 5:00 p.m., Eastern Time, on _________, 2023 (two (2) business days before the Special
                                            Meeting), tender your shares electronically by using the Depository Trust Company&#8217;s
                                            DWAC (Deposit/Withdrawal At Custodian) System and submit a request in writing that we redeem
                                            your Public Shares for cash to Vstock Transfer, LLC, our transfer agent, at the following
                                            email address:</span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td>
</tr></table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
                                            Lafayette Place</span></td></tr>
     <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
NY 11598</span></td></tr>
     <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Attn:</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">E-mail: info@vstocktransfer.com</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;S
                                            transfer agent must receive your instruction to redeem by 5:00 pm Eastern Time on &#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                            , 2023 in order for your redemption demand to be valid. Any holder of Public Shares, regardless
                                            of whether they vote for or against the business combination proposal or do not vote at all,
                                            will be entitled to demand that such holder&#8217;s shares be redeemed for a pro rata portion
                                            of the amount then in the trust account (which, for illustrative purposes, was $23,306,540,
                                            or approximately $10.52 per Public Share, as of April 30, 2023). Such amount,
                                            less any owed but unpaid taxes on the funds in the trust account, will be paid promptly upon
                                            consummation of the Business Combination. There are currently no owed but unpaid income taxes
                                            on the funds in the trust account. However, under Delaware law, the proceeds held in the
                                            trust account could be subject to claims which could take priority over those of a Public
                                            Stockholder exercising redemption rights, regardless of whether such holders vote for or
                                            against the business combination proposal or do not vote at all. Therefore, the per-share
                                            distribution from the trust account in such a situation may be less than originally anticipated
                                            due to such claims. Your vote will have no impact on the amount you will receive upon exercise
                                            of your redemption rights.</span></td></tr>
     </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
request for redemption, once made by a Public Stockholder, may be withdrawn at any time up to 5:00 pm Eastern Time on &#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023. If you deliver your shares for redemption to MURF&#8217;s transfer agent
and later decide prior to the Special Meeting not to elect redemption, you may request that MURF&#8217;s transfer agent return the shares
(electronically). You may make such request by contacting MURF&#8217;s transfer agent at the email address above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
corrected or changed proxy card or written demand of redemption rights must be received by MURF&#8217;s transfer agent prior to the Special Meeting. No demand for redemption will be honored unless the holder&#8217;s
stock has been delivered electronically to the transfer agent by 5:00 pm Eastern Time on &#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
demand is properly made by a Public Stockholder as described above, then, if the Business Combination is consummated, MURF will redeem
these shares into a pro rata portion of funds deposited in the trust account. If you exercise your redemption rights, then you will be
exchanging your shares of MURF Class A common stock for cash and you will not be entitled to shares of New Conduit common stock upon
consummation of the Business Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a holder of Public Shares and you exercise your redemption rights, it will not result in the loss of any MURF warrants that you
may also hold. Your whole warrants will become exercisable to purchase one share of New Conduit common stock for a purchase price of
$11.50 upon consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Do
                                            I have appraisal rights if I object to the proposed business combination?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
                                            Neither MURF stockholders nor its unit or warrant holders have appraisal rights in connection
                                            with the Business Combination under the DGCL. See the section entitled &#8220;<i>Special
                                            Meeting of MURF Stockholders</i> &#8212; <i>Appraisal Rights.</i>&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens to the funds deposited in the trust account after consummation of the Business Combination?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Following
                                            the closing of the initial public offering on February 7, 2022, an amount of $139,790,000
                                            from the net proceeds of the sale of the units in the initial public offering and the private
                                            placement of units to the Sponsor was placed in the trust account. This resulted in an overfunding
                                            of the trust account of $4,895,000. As such, subsequent to the initial funding of the trust
                                            account, $2,000,000 was transferred to MURF&#8217;s operating cash account and $2,895,000
                                            was used to pay offering costs. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
                                            consummation of the Business Combination, the funds in the trust account will be used to
                                            pay holders of the Public Shares who exercise redemption rights, to pay fees and expenses
                                            incurred in connection with the Business Combination and for MURF&#8217;s working capital
                                            and general corporate purposes.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if a substantial number of Public Stockholders vote in favor of the business combination
                                            proposal and exercise their redemption rights?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
                                            Public Stockholders may vote in favor of the Business Combination and still exercise their
                                            redemption rights. Accordingly, the Business Combination may be consummated even though the
                                            funds available from the trust account and the number of Public Stockholders are substantially
                                            reduced as a result of redemptions by Public Stockholders. However, Conduit is not required
                                            to consummate the Business Combination if there is not at least $27,000,000 of cash available for release from MURF&#8217;s trust account and/or received by MURF under the Private Placement, after giving effect to payment of amounts that MURF will be required to pay to
                                            redeeming stockholders upon consummation of the Business Combination. Also, with fewer Public Shares
                                            and Public Stockholders, the trading market for New Conduit common stock may be less liquid
                                            than the market for MURF&#8217;s shares of Class A common stock prior to the Transactions
                                            and MURF may not be able to meet the listing standards of a national securities exchange.
                                            In addition, with fewer funds available from the trust account, the capital infusion from
                                            the trust account into Conduit&#8217;s business will be reduced and Conduit may not be able
                                            to achieve its plan of reducing its outstanding indebtedness.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if the Business Combination is not consummated?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            MURF does not complete the Business Combination with Conduit for whatever reason, MURF would
                                            search for another target business with which to complete a business combination. If MURF
                                            does not complete the Business Combination with Conduit or another business combination by
                                            February 7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation), MURF
                                            must redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash,
                                            equal to an amount then held in the trust account. The Sponsor has no redemption rights in
                                            the event a business combination is not effected in the required time period, and, accordingly,
                                            its Private Shares will be worthless. Additionally, in the event of such liquidation, there
                                            will be no distribution with respect to the outstanding warrants. Accordingly, the warrants
                                            will expire worthless.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            does the Sponsor of MURF intend to vote on the proposals?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 15pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023, the record date, the Sponsor
                                            beneficially owned and was entitled to vote an aggregate of 4,060,250 Private Shares that
                                            were issued prior to or concurrently with MURF&#8217;s initial public offering. Such shares
                                            currently constitute approximately 65% of the outstanding shares of MURF common stock.
                                            The Sponsor has agreed to vote such Private Shares, as well as any shares of MURF common
                                            stock acquired in the aftermarket, in favor of the business combination proposal. The Sponsor
                                            also intends to vote its Private Shares in favor of all other proposals being presented at
                                            the meeting.</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 15pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Do
                                            any of MURF&#8217;s directors or officers have interests in the Business Combination that
                                            may differ from or be in addition to the interests of the MURF stockholders?</b></span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Sponsor and the directors and officers of MURF have interests in the
Business Combination that are different from or in addition to (and which may conflict with) your interest. These interests include, among
other things:</p></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the Business Combination with Conduit or another business combination is not consummated by February 7, 2024 (or such later date
    as may be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation), then MURF will (i) cease
    all operations except for the purpose of winding up, (ii) redeem the Public Shares, at a per-share price, payable in cash, equal
    to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and
    not previously released to MURF to pay MURF&#8217;s franchise and income taxes (less up to $100,000 of interest to pay dissolution
    expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#8217;
    rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and
    (iii) subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case
    to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor (including its representatives and affiliates) and MURF&#8217;s directors and officers, are, or may in the future become,
    affiliated with entities that are engaged in a similar business to MURF&#8217;s and the Sponsor and MURF&#8217;s directors and officers
    are not prohibited from sponsoring, or otherwise becoming involved with, any other blank check companies prior to MURF completing
    its initial business combination, and as result of which, the Sponsor and MURF&#8217;s officers and directors may become aware of
    business opportunities which may be appropriate for presentation to MURF, and the other entities to which they owe fiduciary or contractual
    duties, and may have conflicts of interests in determining to which entity a particular business opportunity should be presented
    (and these conflicts may include presentation to other entities prior to their presentation, if at all, to MURF, and may not always
    be resolved in the favor of MURF, subject to applicable fiduciary duties under Delaware law, in that MURF has provided in its amended
    and restated certificate of incorporation that MURF has renounced its interest in any corporate opportunity presented to MURF).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and the directors and officers of MURF have each waived their redemption rights with respect to any Founder Shares and Class
    A common stock held by them (other than relating to liquidating distributions to Public Shares from the trust account if MURF fails
    to complete its initial business combination by the time required prior to MURF&#8217;s liquidation in accordance with its amended
    and restated certificate of incorporation), which waiver was provided in connection with the initial public offering and without
    any separate consideration paid in connection with providing such waiver.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Merger Agreement contemplates that Adam Sragovicz, MURF&#8217;s current Chief Financial Officer and a director, will be the Chief
    Financial Officer of New Conduit after the closing of the Business Combination. Although the terms of Mr. Sragovicz&#8217;s employment
    have not yet been finalized, it is anticipated that he will be entitled to compensation consisting of an annual salary and
    a bonus opportunity and, in the future, Mr. Sragovicz could receive any additional cash compensation, stock options, stock awards
    or other benefits that New Conduit&#8217;s board of directors determines to pay to Mr. Sragovicz.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Heilbron, the Chief Executive Officer and Chairman of MURF is also the sole and managing member of the Sponsor.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor paid an aggregate of approximately $25,000 for the Founder Shares and the market value of such securities as of April 30,
    2023 was approximately $34,616,000, and such securities should have a significantly higher value than $20,000 at the time of the
    Business Combination, and if MURF does not complete an initial business combination will expire worthless.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor paid $<span style="background-color: white">7,540,000</span> for the 745,000 private placement units (consisting of 745,000
    shares of Class A common stock and the Private Warrants) in connection with MURF&#8217;s initial public offering, at a price of $10.00
    per unit, the market value of such securities as of April 30, 2023 was approximately $14,513,000, and such securities should
    have a higher value at the time of the Business Combination than $7,540,000. If MURF does not complete an initial business combination
    by February 7, 2024, then the Private Warrants received as part of the private placement units will expire worthless.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and its affiliates&#8217; total potential ownership interest in New Conduit, assuming the exercise and conversion of all
    securities following the closing of the Business Combination, including the Private Shares, is estimated to comprise approximately
    5.1% of the outstanding New Conduit common stock in a no redemption scenario (or a transaction value of approximately $33,884,000
    or a market value of approximately $49,130,000), approximately 5.2% of outstanding New Conduit common stock in a 50% redemption
    scenario (or a transaction value of approximately $33,787,000 or a market value of approximately $49,130,000), and 5.3% of
    outstanding New Conduit common stock in a 100% maximum redemption scenario (or a transaction value of approximately $34,198,000
    or a market value of approximately $49,130,000).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
    following the closing of the Business Combination, the independent directors of the MURF Board will receive from the Sponsor an aggregate
    of 45,000 private placement units, consisting of, in aggregate, 45,000 shares of MURF Class A common stock and 45,000 Private Warrants,
    which, assuming conversion and exercise, will be 90,000 shares of New Conduit common stock of an aggregate value of approximately
    $942,300 (assuming that the future value of New Conduit common stock will be the same as the current value of MURF&#8217;s Class
    A common stock) (the &#8220;Independent Director Units&#8221;). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and its affiliates can earn a positive rate of return on their overall investment in MURF and Conduit after the Business
    Combination, even if other holders of MURF common stock experience a negative rate of return, due to having purchased the Founder
    Shares, as described above, for $25,000 or approximately $0.006 per share. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 7, 2023, MURF has issued to Sponsor an unsecured promissory note in the principal amount of $1,500,000, portions of which may
    be withdrawn by MURF from time to time (the &#8220;Promissory Note&#8221;).&#160;&#160;As of April 30, 2023, MURF has submitted
    drawdown requests in an aggregate amount of $500,000. The Promissory Note bears no interest and outstanding principal is due and
    payable upon the earlier of the consummation of the initial business combination or the date of the liquidation of MURF.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate dollar amount that the Sponsor and its affiliates have at risk that depends on the completion of an initial business combination,
    including the Business Combination, is approximately $8,065,000, as of April 30, 2023, which is the current value of securities
    held (assuming that the current value of each of the securities held, whether publicly traded shares of MURF Class A common stock
    or Private Warrants, are in each case valued at the current price of MURF&#8217;s Class A common stock) and consists of (i) the Founders
    Shares and (ii) the 754,000 private placement units (each such unit comprised of one share of MURF&#8217;s Class A common stock and
    one warrant to purchase one share of MURF&#8217;s Class A common stock) purchased in connection with MURF&#8217;s initial public
    offering, and the Promissory Note. &#160;There are no fees due or out of pocket expenses for which Sponsor and its affiliates are
    awaiting reimbursement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate dollar amount that the directors of MURF have at risk that depends on the completion of an initial business combination,
    including the Business Combination, is approximately $942,300, as of April 30, 2023, which is the current value of the Independent
    Director Units.&#160;&#160;There are no loans, fees due or out of pocket expenses for which directors are awaiting reimbursement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    a result of the foregoing, the Sponsor, and directors and officers of MURF, including Mr. Heilbron, will benefit from the
    completion of an initial business combination, including the Business Combination, and may be incentivized to complete an acquisition
    or business combination of a less favorable target company or on terms less favorable to stockholders of MURF rather than
    liquidate.&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    MURF is unable to complete a business combination within the required time period, its executive officers will be personally liable
    under certain circumstances described herein to ensure that the proceeds in the trust account are not reduced by the claims of target
    businesses or claims of vendors or other entities that are owed money by MURF for services rendered or contracted for or products
    sold to MURF. If MURF consummates a business combination, on the other hand, MURF will be liable for all such claims.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
    Sponsor, including its officers and directors, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred
    by them in connection with certain activities on MURF&#8217;s behalf, such as identifying and investigating possible business
    targets and business combinations. However, if MURF fails to consummate a business combination within the required period, they will
    not have any claim against the trust account for reimbursement. Accordingly, MURF may not be able to reimburse these expenses if the
    Business Combination with Conduit, or another business combination, is not completed by February 7, 2023 (or such later date as may
    be extended by means of amendment to MURF&#8217;s its amended and restated certificate of incorporation). </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    continued indemnification of current directors and officers and the continuation of directors and officers&#8217; liability insurance.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele
    Chiavacci Farley, a current director of the MURF Board, will be appointed to the Board of Directors of New Conduit upon the closing
    of the Business Combination.</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>When
                                            do you expect the Business Combination to be completed?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is currently anticipated that the Business Combination will be consummated promptly following
                                            the Special Meeting, which is scheduled for &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                            , 2023; however, such meeting could be adjourned or postponed, as described above. For a
                                            description of the conditions to the completion of the Business Combination, see the section
                                            entitled &#8220;<i>The Merger Agreement &#8212; Conditions to the Closing of the Business
                                            Combination.</i>&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            do I need to do now?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
                                            urges you to read carefully and consider the information contained in this proxy statement/prospectus,
                                            including the annexes, and to consider how the Business Combination will affect you as a
                                            stockholder and/or warrant holder of MURF. Stockholders should then vote as soon as possible
                                            in accordance with the instructions provided in this proxy statement/prospectus and on the
                                            enclosed proxy card.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            do I vote?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a holder of record of MURF common stock on the record date, you may vote in person
                                            (by virtual attendance) at the Special Meeting or by submitting a proxy for the Special Meeting. You
                                            may submit your proxy by completing, signing, dating and returning the enclosed proxy card
                                            in the accompanying pre-addressed postage paid envelope. If you hold your shares in &#8220;street
                                            name,&#8221; which means your shares are held of record by a broker, bank or nominee, you
                                            should contact your broker to ensure that votes related to the shares you beneficially own
                                            are properly counted. In this regard, you must provide the broker, bank or nominee with instructions
                                            on how to vote your shares or, if you wish to attend the virtual meeting and vote at the meeting, obtain
                                            a proxy from your broker, bank or nominee.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
                                            my shares are held in &#8220;street name,&#8221; will my broker, bank or nominee automatically
                                            vote my shares for me?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
                                            Your broker, bank or nominee cannot vote your shares unless you provide instructions on how
                                            to vote in accordance with the information and procedures provided to you by your broker,
                                            bank or nominee.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>May
                                            I change my vote after I have mailed my signed proxy card?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
                                            Stockholders may send a later-dated, signed proxy card to MURF&#8217;s transfer agent at
                                            the address set forth at the end of this section so that it is received prior to the Special
                                            Meeting or virtually attend the Special Meeting and vote. Stockholders also may revoke their
                                            proxy by sending a notice of revocation to MURF&#8217;s transfer agent, which must be received
                                            prior to the Special Meeting. You will not be able to attend the Special Meeting physically.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if I fail to take any action with respect to the meeting?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you fail to take any action with respect to the meeting and the Business Combination is approved
                                            by stockholders and consummated, you will remain a stockholder of MURF (to be renamed Conduit
                                            Pharmaceuticals Inc., which we refer to as New Conduit) and/or your warrants will continue
                                            to entitle you to purchase shares of New Conduit common stock.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            should I do with my stock and/or warrants certificates?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Those
                                            stockholders who do not elect to redeem their Class A common stock should not submit their
                                            stock certificates to MURF or our transfer agent. After the consummation of the Business
                                            Combination, MURF stockholders who do not redeem their Class A common stock will retain their
                                            shares, which will be automatically converted into New Conduit common stock. MURF stockholders
                                            who exercise their redemption rights must deliver their stock certificates to MURF&#8217;s
                                            transfer agent electronically prior to the vote at the meeting as
                                            described above.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Transactions, MURF&#8217;s warrants, by their terms, will entitle holders to purchase shares of New Conduit common
stock. Therefore, warrant holders need not deliver their warrants to MURF at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            should I do if I receive more than one set of voting materials?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
                                            may receive more than one set of voting materials, including multiple copies of this proxy
                                            statement/prospectus and multiple proxy cards or voting instruction cards. For example, if
                                            you hold your shares in more than one brokerage account, you will receive a separate voting
                                            instruction card for each brokerage account in which you hold shares. If you are a holder
                                            of record and your shares are registered in more than one name, you will receive more than
                                            one proxy card. Please complete, sign, date and return each proxy card and voting instruction
                                            card that you receive in order to cast a vote with respect to all of your shares of MURF
                                            common stock.</span></td>
    </tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            can help answer my questions?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you have questions about the Merger or if you need additional copies of the proxy statement/prospectus
                                            or the enclosed proxy card you should contact:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, California 92123</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Jack K. Heilbron, CEO</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
jheilbron@presidiopt.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 23.75pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.F.
King &amp; Co., Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48
Wall Street, 22nd Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 23.75pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10005</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
(800) 207-3159</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
MURF@dfking.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may also obtain additional information about MURF from documents filed with the SEC by following the instructions in the section entitled
&#8220;<i>Where You Can Find More Information.</i>&#8221; If you are a holder of Public Shares and you intend to seek redemption of your
shares, you will need to deliver your stock electronically to MURF&#8217;s transfer agent prior to 5:00 p.m., Eastern Time, on , 2023 (two (2) business days before
the Special Meeting) at the email address below. If you have questions regarding the certification of your position or delivery of your stock,
please contact:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vstock
Transfer, LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
Lafayette Place</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
NY 11598</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">Attn:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
info@vstocktransfer.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="md_004"></span>SUMMARY
OF THE PROXY STATEMENT/PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary highlights selected information from this proxy statement/prospectus and does not contain all of the information that is important
to you. To better understand the proposals to be submitted for a vote at the Special Meeting, including the Business Combination, you
should read this entire document carefully, including the Merger Agreement attached as <span style="text-decoration: underline">Annexes A-1 through A-3</span>
to this proxy statement/prospectus. The Merger Agreement is the legal document that governs the Transactions that will be undertaken
in connection with the Business Combination. It is also described in detail in this proxy statement/prospectus in the section entitled
&#8220;<i>The Merger Agreement</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Parties to the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>MURF</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Murphy
Canyon Acquisition Corp.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is a <span style="background-color: white">blank
check company incorporated on October 19, 2021 as a Delaware corporation formed for the purpose of effecting a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2022, MURF consummated its initial public offering of an aggregate of 13,225,000 units, including full exercise of the underwriters&#8217;
over-allotment option, at $10.00 per unit. The gross proceeds of the offering were $132.25 million. Simultaneously with the consummation
of the initial public offering, MURF consummated the private placement of 754,000 units to the Sponsor, which amount included 69,000
private placement units purchased by the sponsor in connection with the underwriters&#8217; exercise of their overallotment option in
full, at a price of $10.00 per private placement unit, generating gross proceeds of approximately $7.54 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Following
the closing of the initial public offering on February 7, 2022, an aggregate amount of $139,790,000 from the net proceeds of the sale
of the units in the initial public offering and the private placement was placed in the trust account. This resulted in an overfunding
of the trust account of $4,895,000. As such, subsequent to the initial funding of the trust account, $2,000,000 was transferred to MURF&#8217;s
operating cash account and $2,895,000 was used to pay offering costs. Except with respect to interest earned on the funds held in the
trust account that may be released to us to pay our taxes (less up to $100,000 interest to pay dissolution expenses), the funds held
in the trust account will not be released from the trust account until the earliest of (a) the completion of our initial business combination,
(b) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend our certificate of incorporation
(A) to modify the substance or timing of our obligation to allow redemption in connection with MURF&#8217;s initial business combination
or certain amendments to our charter prior thereto or to redeem 100% of our public shares if we do not complete our initial business
combination within 12 months from the consummation of MURF&#8217;s initial public offering or up to 18 months if we extend the period
of time to consummate a business combination, at MURF&#8217;s election by two separate three month extensions, subject to satisfaction
of certain conditions, including the deposit of up to $1,322,500 for each three month extension, into the trust account, or as extended
by MURF&#8217;s stockholders in accordance with MURF&#8217;s certificate of incorporation) or (ii) with respect to any other provision
relating to stockholders&#8217; rights or pre-initial business combination activity, and (c) the redemption of our public shares if MURF
is unable to complete its initial business combination within 12 months from the consummation of its initial public offering or up to
18 months if we extend the period of time to consummate a business combination, at MURF&#8217;s election by two separate three month
extensions, subject to satisfaction of certain conditions, including the deposit of up to $1,322,500 for each three month extension,
into the trust account, or as extended by MURF&#8217;s stockholders in accordance with our Certificate of Incorporation), subject to
applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
<span style="background-color: white">units, Class A common stock and warrants are traded on the Nasdaq Global Market under the symbols
&#8220;MURFU,&#8221; &#8220;MURF,&#8221; and &#8220;MURFW,&#8221; respectively. Our units commenced public trading on February 3, 2022
and our Class A common stock and warrants commenced public trading on March 28, 2022</span>. As of November 8, 2022, the date of the
Merger Agreement, the closing price of MURF&#8217;s Class A common stock was $10.13 per share, the closing price of MURF&#8217;s units
was $10.21 per unit and the closing price of MURF&#8217;s public warrants was $0.0566 per warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mailing address of MURF&#8217;s principal executive office is <span style="background-color: white">4995 Murphy Canyon Road, Suite 300,
San Diego, CA 92123, and its telephone number is 760-471-8536</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Sponsor</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">Murphy Canyon Acquisition Sponsor,
LLC, a Delaware limited liability company, is the sponsor of MURF. The Sponsor&#8217;s executive office is located at <span style="background-color: white">4995
Murphy Canyon Road, Suite 300, San Diego, CA 92123, and its telephone number is 760-471-8536.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">As of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023, the record date, the Sponsor beneficially owned and was entitled to vote an aggregate of 4,060,250 shares of MURF common stock
(consisting of 754,000 shares of Class A common stock and 3,306,250 shares of Class B common stock) that were issued prior to or concurrently
with MURF&#8217;s initial public offering. Such shares currently constitute approximately 65% of the outstanding shares of MURF common
stock. The Sponsor has agreed to vote such Private Shares, as well as any shares of MURF common stock acquired in the aftermarket, in
favor of the business combination proposal. The Sponsor also intends to vote its shares in favor of all other proposals being presented
at the meeting. The Private Shares held by the Sponsor have no right to participate in any redemption distribution and will be worthless
if no business combination is effected by MURF.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger
Sub</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Conduit
Merger Sub, Inc. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is a wholly-owned subsidiary of MURF
formed solely for the purpose of effectuating the Merger described herein. Merger Sub was incorporated under the laws of the Cayman Islands
on October 31, 2022. Merger Sub owns no material assets and does not operate any business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mailing address of Merger Sub&#8217;s principal executive office is <span style="background-color: white">4995 Murphy Canyon Road, Suite
300, San Diego, CA 92123 and its telephone number is 760-471-8536</span>. Merger Sub&#8217;s registered office is c/o Ogier Global (Cayman)
Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009 Cayman Islands. After the consummation of the Business Combination, it will
cease to exist as a stand-alone company and will instead be merged with and into Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals Limited, a Cayman Islands exempted company, is a clinical-stage specialty biopharmaceutical company that was incorporated
in 2019 to facilitate the development and commercialization of clinical assets that have not been, or are not being, prioritized by leading
biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mailing address of Conduit&#8217;s principal executive office/registered office is c/o Ogier Global (Cayman) Limited, 89 Nexus Way, Camana
Bay, Grand Cayman, KY1-9009 Cayman Islands<span style="background-color: white">. </span>After the consummation of the Business Combination,
Conduit will be a wholly-owned subsidiary of MURF (which will be renamed Conduit Pharmaceuticals Inc.).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is an &#8220;emerging growth company,&#8221; as defined under the JOBS Act. As an emerging growth company, MURF is eligible to take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth
companies. These include, but are not limited to, not being required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy
statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and the requirement
to obtain stockholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of an extended transition period provided
in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. MURF has elected to take advantage
of such extended transition period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
will remain an emerging growth company until the earliest of (i) the last day of MURF&#8217;s fiscal year following February 7, 2027
(the fifth anniversary of the consummation of its initial public offering), (ii) the last day of the fiscal year in which the market
value of its shares of Class A common stock that are held by non-affiliates exceeds $700 million as of June 30 of that fiscal year, (iii)
the last day of the fiscal year in which it has total annual gross revenue of $1.07 billion or more during such fiscal year (as indexed
for inflation) or (iv) the date on which it has issued more than $1.0 billion in non-convertible debt in the prior three-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Business Combination Proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Structure
of the Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, Merger Sub will merge with and into Conduit, with Conduit surviving the merger. As a result of the Transactions,
Conduit will become a wholly-owned subsidiary of MURF with the shareholders of Conduit becoming stockholders of MURF, which will be renamed
Conduit Pharmaceuticals Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Merger Agreement, the shareholders of Conduit will receive the number of New Conduit common stock that shall have an aggregate value
equal to Six Hundred Fifty Million Dollars ($650,000,000). With each share of New Conduit common stock being valued at $10.00, Conduit&#8217;s
outstanding ordinary shares (including the ordinary shares issued upon conversion of all outstanding convertible debt, which conversion
shall have occurred prior to the consummation of the Business Combination) will be converted into an aggregate of 65,000,000 shares of
the common stock of New Conduit following the Business Combination, with each such outstanding Conduit share converted into shares of
the common stock of New Conduit on a pro rata basis. Accordingly, this proxy statement/prospectus covers 65,000,000 shares of
New Conduit common stock. Upon the consummation of the Business Combination, MURF&#8217;s Public Warrants shall, by their terms, entitle
the holders to purchase shares of New Conduit common stock at a purchase price of $11.50 per share.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, each outstanding share of MURF common stock immediately prior to the Merger, including each
outstanding share of Class B common stock, shall automatically convert into and become one share of the common stock of New Conduit without
any action on the part of any holders of MURF common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pro
Forma Ownership of Former Holders of Conduit Shares and MURF Stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is anticipated that, immediately after the closing of the Business Combination, assuming that no Public Stockholders exercise their redemption
rights and that no warrants to purchase New Conduit common stock are exercised, MURF&#8217;s Public Stockholders will retain an ownership
interest of 2,187,728 shares of New Conduit common stock or approximately 2.9% of New Conduit common stock, and Conduit&#8217;s shareholders
will own 67,700,000 shares of New Conduit common stock or approximately 90.0% of New Conduit common stock, which reflects 65,000,000
shares of New Conduit common stock to be issued to the Conduit shareholders as consideration in the merger plus the 2,700,000 shares
of New Conduit common stock to be issued to the Private Placement Investor in connection with the Private Placement as the Private Placement
Investor is an affiliate of one of Conduit&#8217;s existing shareholders.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
After consideration of the factors identified and discussed in the section entitled &#8220;<i>The Business Combination Proposal &#8212;
The MURF Board&#8217;s Reasons for Approval of the Transactions</i>,&#8221; the MURF Board concluded that the Transactions met all of
the requirements disclosed in the prospectus for its initial public offering, including that such business had a fair market value of
at least 80% of the balance of the funds in the trust account at the time of execution of the Merger Agreement (excluding the deferred
underwriting commissions and taxes payable on the income earned on the trust account). See the section entitled &#8220;<i>The Business
Combination Proposal &#8212; Structure of the Transactions</i>&#8221; for more information.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional
Matters Being Voted On</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Charter A<b><i>mendment</i></b> Proposals</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to voting on the business combination proposal, MURF stockholders will vote on separate proposals to approve amendments to MURF&#8217;s
current amended and restated certificate of incorporation to: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in">(i)</td>
  <td style="text-align: justify">Charter Amendment Proposal A &#8211; change the name of the public entity from &#8220;<span style="background-color: white">Murphy Canyon Acquisition Corp.</span>&#8221; to
&#8220;<span style="background-color: white">Conduit Pharmaceuticals Inc.</span>&#8221;;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(ii) </td>
  <td style="text-align: justify">Charter Amendment Proposal B &#8211; provide for one class of authorized common stock;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(iii)</td>
  <td style="text-align: justify">Charter Amendment Proposal C &#8211; delete the
various provisions in MURF&#8217;s current amended and restated certificate of incorporation applicable only to special purpose acquisition
corporations (such as the obligation to dissolve and liquidate if a business combination is not consummated within a certain period of
time);</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(iv)</td>
  <td style="text-align: justify">Charter Amendment Proposal D &#8211; increase the number of authorized shares of common stock to 250,000,000; and</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(v)</td>
  <td style="text-align: justify">Charter Amendment Proposal E &#8211; fix the number of directors at seven (7),
a majority of whom shall be independent directors in accordance with The Nasdaq Stock Market LLC&#8217;s requirements. See the section
entitled &#8220;<i>The Charter Amendment Proposals</i>.&#8221;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Advisory Charter Amendments Proposals</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to voting on the business combination proposal, MURF stockholders will vote on separate proposals to consider and vote upon,
on a non-binding advisory basis, certain governance provisions in the Proposed Charter, presented separately in accordance with SEC requirements.
See the section entitled &#8220;<i>The Advisory Charter Amendments Proposals</i>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Director Election Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stockholders of MURF will also vote to elect seven (7) directors who, upon consummation of the Transactions, will be the directors of
New Conduit. If management&#8217;s nominees are elected, such directors will serve until the general meeting to be held in 2024 and,
in each case, until their successors are elected and qualified or their earlier resignation or removal. See the section entitled &#8220;<i>The
Director Election Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Incentive Plan Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">The proposed 2023 Plan will reserve up to 11,497,622 shares of common stock
of New Conduit for issuance in accordance with the plan&#8217;s terms, subject to certain adjustments. The purpose of the plan is to provide
New Conduit&#8217;s and its subsidiaries&#8217; officers, directors, employees and consultants who, by their position, ability and diligence
are able to make important contributions to New Conduit&#8217;s growth and profitability, with an incentive to assist New Conduit in achieving
its long-term corporate objectives, to attract and retain executive officers and other employees of outstanding competence and to provide
such persons with an opportunity to acquire an equity interest in New Conduit. The 2023 Plan is attached as <span style="text-decoration: underline">Annex C</span> to this proxy
statement/prospectus. You are encouraged to read the plan in its entirety. See the section entitled &#8220;<i>The Incentive Plan Proposal</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Nasdaq Issuance Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stockholders will consider and vote upon a proposal to approve, for purposes of complying with applicable listing rules of Nasdaq, the
issuance of New Conduit common stock, par value $0.0001 per share, to the Private Placement Investor in the Private Placement, the proceeds
of which will be used to finance the Business Combination and related transactions and the costs and expenses incurred in connection
therewith with any balance used for working capital purposes. See the section entitled &#8220;<i>The Nasdaq Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Adjournment Proposal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
MURF does not have sufficient proxies to approve one or more of the foregoing proposals, the MURF Board may submit a proposal to adjourn
the Special Meeting to a later date or dates, if necessary to permit further solicitation and vote of proxies. See the section entitled
&#8220;<i>The Adjournment Proposal</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date,
Time and Place of Special Meeting of MURF&#8217;s Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Special Meeting of stockholders of MURF will be held at &#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a.m., Eastern Time,
on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023, via live webcast, to consider and vote upon the business combination
proposal, the charter a<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">mendment</span> proposals, the
advisory charter amendments proposals, the incentive plan proposal, the director election proposal, the Nasdaq proposal and/or if
necessary, the adjournment proposal to permit further solicitation and vote of proxies if MURF does not have sufficient proxies to
approve the foregoing proposals. MURF stockholders may virtually attend, vote and examine the list of MURF stockholders entitled to
vote at the Special Meeting by visiting and entering the control number found on their proxy card, voting instruction form or notice
they previously received. In light of public health concerns regarding the novel coronavirus (COVID-19), the Special Meeting will be
held in a virtual meeting format only. You will not be able to attend the Special Meeting physically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
Power; Record Date</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
will be entitled to vote or direct votes to be cast at the Special Meeting if they owned shares of MURF common stock at the close of
business on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023, which is the record date for the Special Meeting. Stockholders will have one vote for each share of MURF common stock owned at
the close of business on the record date. If your shares are held in &#8220;street name&#8221; or are in a margin or similar account,
you should contact your broker to ensure that votes related to the shares you beneficially own are properly counted. MURF warrants do
not have voting rights. On the record date, there were: (i) 2,941,728 shares of Class A common stock issued and outstanding and (ii)
3,306,250 shares of Class B common stock issued and outstanding, of which 4,060,250 shares (consisting of 754,000 shares of Class A common
stock and 3,306,250 shares of Class B common stock) are held by the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quorum
and Vote of MURF Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum of MURF stockholders is necessary to hold a valid meeting. A quorum will be present at the Special Meeting if a majority of
the outstanding shares entitled to vote at the meeting are represented in person (by virtual attendance) or by proxy. Abstentions
and broker non-votes will count as present for the purposes of establishing a quorum. The Sponsor holds approximately 65% of the
outstanding shares of MURF common stock. Such shares, as well as any shares of Class A common stock acquired in the aftermarket by
the Sponsor, will be voted in favor of the proposals presented at the Special Meeting. The proposals presented at the Special
Meeting will require the following votes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval of the business combination proposal will require the affirmative vote of the holders
                                            of a majority of the outstanding shares of MURF common stock on the record date. There are
                                            currently (i) 2,941,728 shares of Class A common stock issued and outstanding, and (ii)
                                            3,306,250 shares of Class B common stock are issued and outstanding; therefore, at least
                                            3,123,990 shares of MURF common stock must be voted in favor to pass the proposal. The Sponsor
                                            owns an aggregate of 4,060,250 shares of MURF common stock (consisting of 754,000 shares
                                            of Class A common stock and 3,306,250 shares of Class B common stock) and has agreed to vote
                                            in favor of the proposal; therefore, only 3,123,990 Public Shares are required to be voted
                                            in favor of the proposal for it to be approved.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The approval of the charter amendment proposals will require the affirmative
vote of a majority of the issued and outstanding shares of each of the Class A common stock and Class B common stock, voting separately,
as well as the vote of a majority of the issued and outstanding shares of Class A common stock and Class B common stock, voting together
as a single class.</p></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval of each of the advisory charter amendments proposals will require the affirmative
                                            vote of the holders of a majority of the outstanding shares of MURF common stock on the record
                                            date.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            election of directors requires a plurality vote of the shares of MURF common stock present
                                            in person (by virtual attendance) or represented by proxy and entitled to vote at the Special
                                            Meeting. &#8220;Plurality&#8221; means that the individuals who receive the largest number
                                            of votes cast &#8220;FOR&#8221; are elected as directors. Consequently, any shares not voted
                                            &#8220;FOR&#8221; a particular nominee (whether as a result of an abstention, a direction
                                            to withhold authority or a broker non-vote) will not be counted in the nominee&#8217;s favor.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval of the incentive plan proposal will require the affirmative vote of the holders
                                            of a majority of the then outstanding shares of MURF common stock present and entitled to
                                            vote at the meeting.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval of the Nasdaq proposal will require the affirmative vote of the holders of a majority
                                            of the then outstanding shares of MURF common stock present and entitled to vote at the meeting.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            approval of the adjournment proposal will require the affirmative vote of the holders of
                                            a majority of the then outstanding shares of MURF common stock present and entitled to vote
                                            at the meeting.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
and broker non-votes will have the same effect as a vote &#8220;against&#8221; the business combination proposal, the charter
amendment proposals, and the advisory charter amendments proposals. With respect to the incentive plan proposal and adjournment
proposal, if presented, abstentions will have the same effect as a vote &#8220;against&#8221; such proposals while broker non-votes
will have no effect on such proposals. With respect to the director election proposal, abstentions and broker non-votes will have no
effect on such proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation
of the Transactions is conditioned on approval of each of the business combination proposal, the charter amendment proposals and
director election proposal. If any proposal is not approved, the other proposals will not be presented to the stockholders for a
vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to MURF&#8217;s amended and restated certificate of incorporation, a holder of Public Shares may demand that MURF redeem such shares
for cash if the Business Combination is consummated. Holders of Public Shares will be entitled to receive cash for these shares only
if they demand that MURF redeem their shares for cash no later than 5:00pm Eastern Time on
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, by electronically
delivering their shares and a written request to redeem such shares to MURF&#8217;s transfer agent. MURF&#8217;S transfer agent must
receive instruction to redeem by 5:00 pm Eastern Time on
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023, in order for such
redemption demands to be valid. If the Business Combination is not completed, these shares will not be redeemed for cash. If a
holder of Public Shares properly demands redemption, MURF will redeem each Public Share into a pro rata portion of the trust
account, calculated as of two business days prior to the anticipated consummation of the Business Combination. As of
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, the record date, this would
amount to approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per Public Share. If a holder of Public
Shares exercises its redemption rights, then it will be exchanging its shares of MURF common stock for cash and will no longer own
the shares. See the section entitled &#8220;<i>Special Meeting of MURF Stockholders &#8212; Redemption Rights</i>&#8221; for a
detailed description of the procedures to be followed if you wish to redeem your shares for cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination will not be consummated if MURF has net tangible assets of less than $5,000,001 after taking into account
holders of Public Shares that have properly demanded redemption of their shares into cash <span style="background-color: white">or is not otherwise exempt from the provisions of Rule 419 promulgated under
the Securities Act</span>. Further, the Merger Agreement provides
that Conduit is not required to consummate the Transactions if immediately prior to the consummation of the Transactions, MURF does
not have at least $27 million of cash available to be released from the trust account and/or received by MURF under the Subscription
Agreement after giving effect to payment of amounts that MURF will be required to pay to redeeming stockholders upon consummation of
the Transactions. If Conduit does not waive its termination right and MURF has less than the required amount in trust and/or from
the Subscription Agreement, the Transactions will not be consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of MURF warrants will not have redemption rights with respect to such securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appraisal
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
stockholders and MURF warrant holders do not have appraisal rights in connection with the Transactions under the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Solicitation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxies
may be solicited by mail, telephone or in person. MURF has engaged D.F. King &amp; Co., Inc. to assist in the solicitation of proxies.
If a stockholder grants a proxy, it may still vote its shares at the Special Meeting if it revokes its proxy before the Special Meeting.
A stockholder may also change its vote by submitting a later-dated proxy as described in the section entitled &#8220;<i>Special Meeting
of MURF Stockholders &#8212; Revoking Your Proxy</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of MURF&#8217;s Directors and Officers in the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
you consider the recommendation of the MURF Board in favor of approval of the business combination proposal, you should keep in mind
that MURF&#8217;s Sponsor and its directors and executive officers have interests in such proposal that are different from, or in addition
to, your interests as a stockholder or warrant holder. These interests include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Business Combination with Conduit or another business combination is not consummated
                                            by February 7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s
                                            amended and restated certificate of incorporation), then MURF will (i) cease all operations
                                            except for the purpose of winding up, (ii) redeem the Public Shares, at a per-share price,
                                            payable in cash, equal to the aggregate amount then on deposit in the trust account including
                                            interest earned on the funds held in the trust account and not previously released to MURF
                                            to pay MURF&#8217;s franchise and income taxes (less up to $100,000 of interest to pay dissolution
                                            expenses), divided by the number of then outstanding Public Shares, which redemption will
                                            completely extinguish Public Stockholders&#8217; rights as stockholders (including the right
                                            to receive further liquidating distributions, if any), subject to applicable law, and (iii)
                                            subject to the approval of our remaining stockholders and our board of directors, dissolve
                                            and liquidate, subject in each case to our obligations under Delaware law to provide for
                                            claims of creditors and the requirements of other applicable law.</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor (including its representatives and affiliates) and MURF&#8217;s directors and officers, are, or may in the future become,
    affiliated with entities that are engaged in a similar business to MURF&#8217;s and the Sponsor and MURF&#8217;s directors and officers
    are not prohibited from sponsoring, or otherwise becoming involved with, any other blank check companies prior to MURF completing
    its initial business combination, and as result of which, the Sponsor and MURF&#8217;s officers and directors may become aware of
    business opportunities which may be appropriate for presentation to MURF, and the other entities to which they owe fiduciary or contractual
    duties, and may have conflicts of interests in determining to which entity a particular business opportunity should be presented
    (and these conflicts may include presentation to other entities prior to their presentation, if at all, to MURF, and may not always
    be resolved in the favor of MURF, subject to applicable fiduciary duties under Delaware law, in that MURF has provided in its amended
    and restated certificate of incorporation that MURF has renounced its interest in any corporate opportunity presented to MURF).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and the directors and officers of MURF have each waived their redemption rights with respect to any Founder Shares and Class
    A common stock held by them (other than relating to liquidating distributions to public shares from the trust account if MURF fails
    to complete its initial business combination by the time required prior to MURF&#8217;s liquidation in accordance with its amended
    and restated certificate of incorporation), which waiver was provided in connection with the initial public offering and without
    any separate consideration paid in connection with providing such waiver.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Chele Chiavacci Farley, a current director of MURF, will be a director
of New Conduit.</p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Merger Agreement contemplates that Adam Sragovicz, MURF&#8217;s current Chief Financial Officer
                                            and a director, will be the Chief Financial Officer of New Conduit after the closing of the
                                            Business Combination. Although the terms of Mr. Sragovicz&#8217;s employment have not yet
                                            been finalized, it is anticipated that he will be entitled to compensation consisting
                                            of an annual salary and a bonus opportunity and, in the future, Mr. Sragovicz could receive
                                            any additional cash compensation, stock options, stock awards or other benefits that New
                                            Conduit&#8217;s board of directors determines to pay to Mr. Sragovicz.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Mr. Heilbron, the Chief Executive Officer and Chairman of MURF is also the sole and managing member of the Sponsor.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The Sponsor paid an aggregate of approximately $25,000 for the Founder
    Shares and the market value of such securities as of April 30, 2023 was approximately $34,352,000, and such securities
    should have a significantly higher value than $20,000 at the time of the Business Combination, and if MURF does not complete an initial
    business combination will expire worthless.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Sponsor paid $<span style="background-color: white">7,540,000</span> for the 745,000 private
                                            placement units (consisting of 745,000 shares of Class A common stock and the Private Warrants)
                                            in connection with MURF&#8217;s initial public offering, at a price of $10.00 per unit, the
                                            market value of such securities as of April 30, 2023 was approximately $14,457,000,
                                            and such securities should have a higher value at the time of the Business Combination than
                                            $7,540,000. If MURF does not complete an initial business combination by February 7, 2024,
                                            then the Private Warrants received as part of the private placement units will expire worthless.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The Sponsor and its affiliates&#8217; total potential ownership interest
    in New Conduit, assuming the exercise and conversion of all securities following the closing of the Business Combination, including
    the Private Shares, is estimated to comprise approximately 5.1% of the outstanding New Conduit common stock in a no redemption scenario
    (or a transaction value of approximately $33,884,000 or a market value of approximately $49,130,000), approximately 5.2% of
    outstanding New Conduit common stock in a 50% redemption scenario (or a transaction value of approximately $33,787,000 or a market
    value of approximately $49,130,000), and 5.3% of outstanding New Conduit common stock in a 100% maximum redemption
    scenario (or a transaction value of approximately $34,198,000 or a market value of approximately $49,130,000).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Immediately following the closing of the Business Combination, the independent directors of the MURF Board will receive from the Sponsor an aggregate of 45,000 private placement units, consisting of, in aggregate, 45,000 shares of MURF Class A common stock and 45,000 Private Warrants, which, assuming conversion and exercise, will be 90,000 shares of New Conduit common stock of an aggregate value of approximately $942,300 (assuming that the future value of New Conduit common stock will be the same as the current value of MURF&#8217;s Class A common stock) (the &#8220;Independent Director Units&#8221;). </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The Sponsor and its affiliates can earn a positive rate of
    return on their overall investment in MURF and Conduit after the Business Combination, even if other holders of MURF common stock
    experience a negative rate of return, due to having purchased the Founder Shares, as described above, for $25,000 or approximately
    $0.006 per share. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">On March 7, 2023, MURF has issued to Sponsor an unsecured promissory note in the principal amount of $1,500,000, portions of which may be withdrawn by MURF from time to time (the &#8220;Promissory Note&#8221;).&#160;&#160;As of April 30, 2023, MURF has submitted drawdown requests in an aggregate amount of $500,000.&#160;&#160;The Promissory Note bears no interest and is due and payable upon the earlier of the consummation of the initial business combination or the date of the liquidation of MURF.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The aggregate dollar amount that the Sponsor and its affiliates have at risk that depends on the completion of an initial business combination, including the Business Combination, is approximately $8,065,000, as of April 30, 2023, which is the current value of securities held (assuming that the current value of each of the securities held, whether publicly traded shares of MURF Class A common stock or Private Warrants, are in each case valued at the current price of MURF&#8217;s Class A common stock) and consists of (i) the Founders Shares and (ii) the 754,000 private placement units (each such unit comprised of one share of MURF&#8217;s Class A common stock and one warrant to purchase one share of MURF&#8217;s Class A common stock) purchased in connection with MURF&#8217;s initial public offering, and the Promissory Note. &#160;There are no fees due or out of pocket expenses for which Sponsor and its affiliates are awaiting reimbursement.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The aggregate dollar amount that the directors of MURF have at risk that depends on the completion of an initial business combination, including the Business Combination, is approximately $942,300, as of April 30, 2023, which is the current value of the Independent Director Units.&#160;&#160;There are no loans, fees due or out of pocket expenses for which directors are awaiting reimbursement.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">As a result of the foregoing, the Sponsor, and directors and officers
    of MURF, including Mr. Heilbron, will benefit from the completion of an initial business combination, including the Business Combination,
    and may be incentivized to complete an acquisition or business combination of a less favorable target company or on terms less favorable
    to stockholders of MURF rather than liquidate.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            MURF is unable to complete a business combination within the required time period, its executive
                                            officers will be personally liable under certain circumstances described herein to ensure
                                            that the proceeds in the trust account are not reduced by the claims of target businesses
                                            or claims of vendors or other entities that are owed money by MURF for services rendered
                                            or contracted for or products sold to MURF. If MURF consummates a business combination, on
                                            the other hand, MURF will be liable for all such claims.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
                                            Sponsor, including its officers and directors, and their affiliates are entitled to reimbursement
                                            of out-of-pocket expenses incurred by them in connection with certain activities on MURF&#8217;s
                                            behalf, such as identifying and investigating possible business targets and business combinations.
                                            However, if MURF fails to consummate a business combination within the required period, they
                                            will not have any claim against the trust account for reimbursement. Accordingly, MURF may
                                            not be able to reimburse these expenses if the Business Combination with Conduit, or another
                                            business combination, is not completed by February 7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s amended and restated
                                            certificate of incorporation). </span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            continued indemnification of current directors and officers and the continuation of directors
                                            and officers&#8217; liability insurance.</span></td>
</tr><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font-family: Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">Chele Chiavacci Farley, a current director of the MURF Board, will be appointed to the Board of Directors of New Conduit upon the closing of the Business Combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time prior to the Special Meeting, during a period when they are not then aware of any material nonpublic information regarding MURF
or its securities, the Sponsor, Conduit or Conduit&#8217;s shareholders and/or their respective affiliates may purchase MURF common stock
from institutional and other investors who vote, or indicate an intention to vote, against the business combination proposal, or execute
agreements to purchase shares from such investors in the future, or they may enter into transactions with such investors and others to
provide them with incentives to acquire shares of MURF common stock or vote their shares in favor of the business combination proposal.
The purpose of such share purchases and other transactions would be to increase the likelihood of satisfaction of the requirements that
the holders of a majority of MURF common stock entitled to vote at the Special Meeting to approve the business combination proposal vote
in its favor and that MURF has sufficient proxies to approve the proposals set forth herein, where it appears that such requirements
would otherwise not be met, or that aggregate cash proceeds available to MURF from the Private Placement
and the funds remaining in the Trust Account after redemptions will not be less than $27,000,000. While the exact nature of any such incentives has not been determined as of the date of this proxy statement/prospectus,
they might include, without limitation, arrangements to protect such investors or holders against potential loss in value of their shares,
including the granting of put options and the transfer to such investors or holders of shares or warrants owned by the Sponsor for nominal
value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement/prospectus, with respect to the private purchase of Public Shares by the persons described above,
no agreements have been entered into with any such investor or holder. In the event of any such newly purchased shares (i) the Sponsor
or its affiliates will purchase the MURF common stock at a price no higher than the price offered through the redemption process; (ii)
any such purchases by Sponsor or its affiliates will not be voted in favor of approving the Business Combination; and (iii) the Sponsor
and its affiliates have waived their redemption rights to such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">Prior to the Special Meeting to approve
the Business Combination, MURF will disclose in a Form 8-K (i) the amount of Public Shares purchased outside of the redemption offer by
the Sponsor or its affiliates, along with the purchase price; (ii) the purpose of the purchases by the Sponsor or its affiliates; (iii)
the impact, if any, of the purchases by the Sponsor or its affiliates on the likelihood that the Business Combination transaction will
be approved; (iv) the identities of stockholders who sold to the Sponsor or its affiliates (if not purchased on the open market) or the
nature of stockholders (e.g., 5% security holders) who sold to the Sponsor or its affiliates; and (v) the number of shares of MURF common
stock for which MURF has received redemption requests pursuant to its redemption offer.</span><span style="font-size: 8pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
to Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MURF Board believes that the business combination proposal and the other proposals to be presented at the Special Meeting are fair
to and in the best interest of MURF&#8217;s stockholders and unanimously recommends that its stockholders vote &#8220;FOR&#8221; the
business combination proposal, &#8220;FOR&#8221; each of the charter amendment proposals, &#8220;FOR&#8221; each of the advisor
charter amendments proposals, &#8220;FOR&#8221; the director election proposal, &#8220;FOR&#8221; the incentive plan proposal,
&#8220;FOR&#8221; the Nasdaq proposal and &#8220;FOR&#8221; the adjournment proposal, if presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions
to the Closing of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Conditions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
consummation of the Merger is conditioned upon, among other things, (i) the absence of any applicable law or order that makes the
transactions contemplated by the Merger Agreement illegal or otherwise prohibits consummation of such transactions; (ii) the
registration statement becoming effective under the Securities Act; (iii) the approval by MURF&#8217;s stockholders of the Business
Combination and related transactions; (iv) the approval by Conduit&#8217;s shareholders of the Business Combination and related
transactions; (v) the aggregate cash available to MURF at the Closing (after giving effect to any redemptions by MURF&#8217;s
stockholders and the payment of all authorized transaction expenses) being at least $27,000,000; (vi) after giving effect to the
Business Combination, MURF shall have at least $5,000,001 in net tangible assets (as determined in accordance with Rule 3a51-1(g)(1)
of the Exchange Act) or shall not otherwise be exempt from the provisions of Rule 419 promulgated under the Securities Act; (vii) all ancillary agreements having been executed by all parties thereto; (viii) MURF and Conduit having
cooperated in good faith to negotiate and execute new employment agreements with David Tapolczay and Adam Sragovicz, the current
Chief Financial Officer and a director of MURF; and (ix) all required filings under the Hart-Scott-Rodino Antitrust Improvements Act
of 1976, as amended, and any other governmental authority having been completed and cleared. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please see the section entitled &#8220;<i>The Business Combination Proposal &#8212; The Merger Agreement &#8212;
Conditions to the Closing of the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
Conditions to the Closing of the Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of Conduit to consummate the Business Combination are also conditioned upon, among other things: <span style="background-color: white">(i)
MURF and Merger Sub having duly performed or complied with all of its obligations under the Merger Agreement in all material respects;
(ii) the representations and warranties of MURF and Merger Sub being true and correct in all material respects; (iii) no event having
occurred that would result in a Murphy Material Adverse Effect (as defined in the Merger Agreement); (iv) MURF providing Conduit a certificate
from an authorized officer of MURF as to the accuracy of the foregoing conditions; and (v) MURF&#8217;s establishment of an equity incentive
plan to be in place following the closing of the Business Combination. </span>For more information, please see the section entitled &#8220;<i>The
Business Combination Proposal &#8212; The Merger Agreement &#8212; Conditions to the Closing of the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>MURF&#8217;s
and Merger Sub&#8217;s Conditions to the Closing of the Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of MURF and Merger Sub to consummate the Transactions are also conditioned upon, among other things, <span style="background-color: white">(i)
Conduit having duly performed or complied with all of their obligations under the Merger Agreement in all material respects; (ii) the
representations and warranties of </span>MURF and Merger Sub <span style="background-color: white">being true and correct in all material
respects; (iii) no event having occurred that would result in a Company Material Adverse Effect (as defined in the Merger Agreement);
(iv) Conduit providing MURF a certificate from an authorized officer as to the accuracy of the foregoing conditions; and (v) </span>Conduit
UK Management Ltd. Will be transferred to Conduit and become a wholly-owned subsidiary of Conduit, and certain intellectual property
having been assigned to Conduit UK Management Ltd<span style="background-color: white">. </span>For more information, please see the
section entitled &#8220;<i>The Merger Agreement &#8212; Conditions to the Closing of the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Waiver</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
permitted under applicable law, MURF or Conduit may waive any inaccuracies in the representations and warranties made to such party and
contained in the Merger Agreement and waive compliance with any agreements or conditions for the benefit of such party contained in the
Merger Agreement. The parties may also waive the condition to list with Nasdaq as of the closing date, that the minimum proceeds requirement
of $27,000,000 and the related condition concerning the Private Placement. However, pursuant to MURF&#8217;s existing amended and restated
certificate of incorporation, the condition requiring that MURF have at least $5,000,001 of net tangible assets <span style="background-color: white">or
otherwise be exempt from the provisions of Rule 419 promulgated under the Securities Act </span>may not be waived.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Merger Agreement may be terminated as follows: (i) by the mutual consent of MURF and Conduit; (ii) by MURF, if any of the representations
or warranties of Conduit set forth in the Merger Agreement is not true and correct, or if Conduit has failed to perform any covenant
or agreement set forth in the Merger Agreement (including an obligation to consummate the Business Combination), in each case such that
the conditions to closing would not be satisfied and the breach or breaches causing such representations or warranties not to be true
and correct, or the failure to perform any covenant or agreement, as applicable, are not cured (or waived by MURF) by the earlier of
(a) the Outside Date (as defined below) or (b) 20 days after written notice thereof is delivered to Conduit; provided, however that MURF
is not then in material breach of any representation, warranty, covenant, or obligation in the Merger Agreement, which breach has not
been cured; (iii) by Conduit, if any of the representations or warranties of MURF or Merger Sub set forth in the Merger Agreement is
not true and correct, or if MURF or Merger Sub has failed to perform any covenant or agreement set forth in the Merger Agreement (including
an obligation to consummate the Business Combination), in each case such that the conditions to closing would not be satisfied and the
breach or breaches causing such representations or warranties not to be true and correct, or the failure to perform any covenant or agreement,
as applicable, are not cured (or waived by Conduit) by the earlier of (a) the Outside Date or (b) 20 business days after written notice
thereof is delivered to MURF; provided, however that Conduit is not then in material breach of any representation, warranty, covenant,
or obligation in the Merger Agreement, which breach has not been cured; (iv) by either MURF or Conduit: (a) on or after February 7,
2024 (the &#8220;Outside Date&#8221;), if the Business Combination has not been consummated prior to the Outside Date; provided,
however, that this right to terminate the Merger Agreement will not be available to a party if the failure of the merger to have been
consummated before the Outside Date was due to such party&#8217;s breach of or failure to perform any of its covenants or agreements
set forth in the Merger Agreement, (b) if any applicable law or order that makes the transactions contemplated by the Merger Agreement
illegal or otherwise prohibits consummation of such transactions becomes final and non-appealable, or (C) if MURF has not received approval
from its stockholders of the Business Combination and related transactions at the Special Meeting; (v) by MURF if the Conduit shareholders&#8217;
written consent approving the Business Combination and related transactions have not have been obtained within 10 business days after
the date of the Merger Agreement; and (vi) if there is a material adverse effect on behalf of the other party. See the section entitled
&#8220;<i>The Merger Agreement &#8212; Termination.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
Support Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
with the execution of the Merger Agreement, the Supporting Conduit Shareholders, who are the three largest shareholders of Conduit, have
entered into support agreements with MURF and Conduit pursuant to which each Supporting Conduit Shareholder has agreed, among other things,
to approve or vote in favor of the Business Combination, against any action or proposal involving MURF that is intended to, or would
reasonably be expected to, prevent, impede or adversely affect the Transactions in any material respect, and promptly execute the definitive
documents, agreements and filings (including with applicable governmental authorities) related to the Business Combination reasonably
required to be executed by such Supporting Conduit Shareholder in furtherance of the Business Combination subject to the terms and conditions
set forth therein. Under the support agreement, each Supporting Conduit Shareholder has also agreed that, with limited exceptions, prior
to the termination of the applicable support agreement, such Supporting Conduit Shareholder will not transfer or otherwise enter into
any agreement or understanding with respect to a transfer relating to any Claims (as defined in the applicable support agreement) owned
by such Supporting Conduit Shareholder. The support agreements will terminate on the earlier of the closing of the Business Combination
or the termination of the Merger Agreement. No such termination will relieve any shareholders, MURF or Conduit from any liability resulting
from a breach of the support agreement occurring prior to such termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
Consequences of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of the material U.S. federal income tax consequences of the Business Combination to holders of Conduit&#8217;s shares,
please see the information set forth in the section entitled &#8220;<i>Material U.S. Federal Income Tax Considerations &#8212; Material
Tax Considerations of the Business Combination to Holders of Conduit Capital Stock</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of the material U.S. federal income tax consequences of the exercise of redemption rights, please see the information set
forth in the section entitled &#8220;<i>Material U.S. Federal Income Tax Considerations &#8212; Material Tax Considerations Related to
a Redemption of Public Shares</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anticipated
Accounting Treatment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination will be accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, MURF
has been treated as the &#8220;acquired&#8221; company for financial reporting purposes. Conduit was determined to be the accounting
acquirer primarily because Conduit stakeholders will collectively own a majority of the outstanding shares of the combined company as
of the closing of the merger, they have nominated four of the seven (7) members of the board of directors as of the closing of the merger,
and Conduit&#8217;s Chief Executive Officer will continue to manage the combined company. Additionally, Conduit&#8217;s business will
comprise the ongoing operations of the combined company immediately following the consummation of the Business Combination. Accordingly,
for accounting purposes, the financial statements of the combined entity will represent a continuation of the financial statements of
Conduit with the acquisition being treated as the equivalent of Conduit issuing stock for the net assets of MURF, accompanied by a recapitalization.
The net assets of MURF will be stated at historical cost, with no goodwill or other intangible assets recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination is not subject to any additional federal or state regulatory requirement or approval, except for the filings with
the State of Delaware necessary to effectuate the Business Combination and the filing of required notifications and the expiration or
termination of the required waiting periods under the HSR Act. MURF and Conduit have made the appropriate filings pursuant to the HSR
Act with the DOJ and FTC. The waiting period under the HSR Act expires on December 8, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Factor Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
evaluating the proposals to be presented at the Special Meeting, a stockholder should carefully read this proxy statement/prospectus
and especially consider the factors discussed in the section entitled &#8220;<i>Risk Factors</i>.&#8221; These risks include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            business is dependent on the successful development, regulatory approval and commercialization
                                            of our clinical assets, in particular a glucokinase activator which we believe is active
                                            in a range of autoimmune diseases including uveitis, Hashimoto&#8217;s Thyroiditis, preterm
                                            labor and renal transplant, which we refer to as AZD1656, and a potent, irreversible inhibitor
                                            of human myeloperoxidase that has the potential to treat idiopathic male infertility,
                                            which we refer to as AZD5904.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
                                            drug development for Conduit&#8217;s clinical assets AZD1656 and AZD5904 is very expensive,
                                            time-consuming and uncertain. Conduit&#8217;s preclinical trials may fail to adequately demonstrate
                                            pharmacologic activity in therapeutic areas of interest; cause unintended short- or long-term
                                            effects in other bodily systems; or produce unexpected toxicity that may alter or risk benefit
                                            assessment.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is difficult to predict the time and cost of development and of subsequently obtaining regulatory
                                            approval for AZD1656 as it employs newly developed technology.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            may not be successful in its efforts to use and expand its development platform to build
                                            a pipeline of clinical assets.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
                                            drug development for Conduit&#8217;s clinical assets is very expensive, time-consuming, difficult
                                            to design and implement, and uncertain. Conduit&#8217;s clinical trials may fail to adequately
                                            demonstrate the safety and efficacy of its clinical assets, which could prevent or delay
                                            regulatory approval and commercialization.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            may be unable to obtain regulatory approval for its early-stage clinical assets under applicable
                                            regulatory requirements. The FDA and foreign regulatory bodies have substantial discretion
                                            in the approval process, including the ability to delay, limit or deny approval of clinical
                                            assets. The delay, limitation or denial of any regulatory approval would adversely impact
                                            commercialization, Conduit&#8217;s potential to generate revenue, Conduit&#8217;s business
                                            and its operating results.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may face product liability exposure, and if successful claims are brought against us, we
                                            may incur substantial liability if our insurance coverage for those claims is inadequate.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            currently relies on, and expects to continue to rely on, third-party CROs and other third
                                            parties to conduct and oversee Conduit&#8217;s clinical trials and other aspects of product
                                            development. If these third parties do not meet Conduit&#8217;s requirements or otherwise
                                            conduct the trials as required, Conduit may not be able to satisfy its contractual obligations
                                            or obtain regulatory approval for, or commercialize, its clinical assets when expected or
                                            at all.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            currently relies on agreements with third parties for the purpose of licensing its clinical
                                            assets. In the near-term Conduit intends to rely on third parties for the licensing of clinical
                                            assets and those which may arise through future partnerships.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Conduit fails to attract and retain management and other key personnel, it may be unable
                                            to continue to successfully develop or commercialize its clinical assets or otherwise implement
                                            its business plan.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
                                            and supply of the APIs and other substances and materials used in Conduit&#8217;s clinical
                                            assets is a complex and technically challenging undertaking, and there is potential for failure
                                            at many points in the manufacturing, testing, quality assurance and distribution supply chain,
                                            as well as the potential for latent defects after products have been manufactured and distributed.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
                                            to adequately protect Conduit&#8217;s intellectual property could adversely affect Conduit&#8217;s
                                            business, financial condition, and operating results.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            may not be able to protect its intellectual property rights throughout the world.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
                                            the consummation of the Business Combination, our only significant asset will be ownership
                                            of 100% of Conduit&#8217;s capital shares, and we do not currently intend to pay dividends
                                            on our common stock and, consequently, your ability to achieve a return on your investment
                                            will depend on appreciation in the price of our common stock.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Sponsor owns shares of MURF common stock and warrants that will be worthless and has made
                                            loans that may not be reimbursed or repaid if the Business Combination is not approved. Such
                                            interests may have influenced its decision to approve the Business Combination with Conduit.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam
                                            Sragovicz, MURF&#8217;s current Chief Financial Officer and director, will be the Chief Financial
                                            Officer of New Conduit following the Business Combination and will be entitled to compensation
                                            in connection with such employment. Such personal and financial interests may have influenced
                                            his decision to approve the Business Combination with Conduit.</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            exercise of MURF&#8217;s directors&#8217; and officers&#8217; discretion in agreeing to changes
                                            or waivers in the terms of the Business Combination may result in a conflict of interest
                                            when determining whether such changes to the terms of the Business Combination or waivers
                                            of conditions are appropriate and in MURF&#8217;s stockholders&#8217; best interest.</span></td>
</tr>
     <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
     <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif">If
                                            the Business Combination does not qualify as a tax-free reorganization, U.S. holders of Conduit
                                            shares will be required to recognize gain or loss for U.S. federal income tax purposes upon
                                            the exchange of their Conduit shares for the New Conduit common stock in the Business Combination
                                            which could result in such U.S. holder incurring substantially greater U.S. federal income
                                            tax liability as a result of the Business Combination.</span></p></td></tr>
     </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="md_006"></span>FORWARD-LOOKING
STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
believes that some of the information in this proxy statement/prospectus constitutes &#8220;forward-looking statements&#8221; for purposes
of the federal securities laws. Forward-looking statements include, but are not limited to, statements regarding MURF&#8217;s, MURF management
team&#8217;s, Conduit&#8217;s and Conduit management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the
future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances,
including any underlying assumptions, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;contemplate,&#8221;
&#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221;
&#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221;
&#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the
absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this proxy statement/prospectus
may include, for example, statements that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discuss
                                            future expectations;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">contain
                                            projections of future results of operations or financial condition; or</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">state
                                            other &#8220;forward-looking&#8221; information.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
believes it is important to communicate its expectations to its security holders. However, there may be events in the future that MURF
is not able to predict accurately or over which it has no control. The risk factors and cautionary language discussed in this proxy statement/prospectus
provide examples of risks, uncertainties and events that may cause actual results to differ materially from the expectations described
by MURF or Conduit in such forward-looking statements, including among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timing to complete the Transactions;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number and percentage of its Public Stockholders voting against the business combination
                                            proposal and/or seeking redemption;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            occurrence of any event, change or other circumstances that could give rise to the termination
                                            of the Merger Agreement;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            anticipated costs associated with the proposed Business Combination;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            outcome of any known and unknown litigation and regulatory proceedings, including the occurrence
                                            of any event, change or other circumstances, including the outcome of any legal proceedings
                                            that may be instituted against MURF and Conduit that could give rise to the termination of
                                            the Merger Agreement;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability to maintain the listing of MURF&#8217;s securities on a national securities exchange
                                            following the Business Combination;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            inability to recognize the anticipated benefits of the proposed business combination, which
                                            may be affected by, among other things, the amount of cash available following any redemption
                                            of Public Shares by MURF stockholders;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            adversely affecting the business in which Conduit is engaged;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to execute on its plans to develop and commercialize its current clinical assets,
                                            as well as any future clinical assets that it licenses, and the timing of any such commercialization;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            reliance on the license agreement between AstraZeneca and St George Street;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to identify future clinical assets to develop and obtain licenses to such clinical
                                            assets;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            projected financial information, growth rate, strategies, and market opportunities for Conduit;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to meet its future capital requirements to fund its operations, which may involve
                                            debt and/or equity financing, and to obtain such debt and/or equity financing on favorable
                                            terms, and its sources and uses of cash;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            success of Conduit&#8217;s research and development strategies;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability, assessment of and strategies to compete with its competitors;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            reliance on third-party service providers;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to maintain and protect its intellectual property;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to attract and retain talent and the effectiveness of its compensation strategies
                                            and leadership;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            potential business or economic disruptions caused by current and future pandemics, such as
                                            the COVID-19 pandemic;</span></td></tr>
</table>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to prevent and guard against cybersecurity attacks;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in applicable laws or regulations affecting Conduit and/or its business;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            business disruptions due to political or economic instability, pandemics, or armed hostilities
                                            (including the ongoing conflict between Russia and Ukraine);</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">geopolitical
                                            risk and general economic conditions;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            potential impact of climate change on Conduit, including higher regulatory and compliance
                                            costs, reputational risks, and availability of capital on attractive terms; and</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                            factors detailed under the section entitled &#8220;<i>Risk Factors</i>.&#8221;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements included herein attributable to any of MURF, Conduit or any person acting on either party&#8217;s behalf are
expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Except to the extent required
by applicable laws and regulations, MURF and Conduit undertake no obligations to update these forward-looking statements to reflect events
or circumstances after the date of this proxy statement/prospectus or to reflect the occurrence of unanticipated events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
a stockholder grants its proxy or instructs how its vote should be cast or vote on the business combination proposal, charter
amendment proposals, advisory charter amendments proposals, director election proposal, the incentive plan proposal, the Nasdaq
proposal or the adjournment proposal, it should be aware that the occurrence of the events described in the &#8220;<i>Risk
Factors</i>&#8221; section and elsewhere in this proxy statement/prospectus may adversely affect MURF and/or Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="md_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK
FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholders
should carefully consider the following risk factors, together with all other information in this proxy statement/prospectus, before
deciding whether to vote or instruct that their vote be cast to approve the proposals described in this proxy statement/prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Conduit&#8217;s Business and Industry </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
business is dependent on the successful development, regulatory approval and commercialization of our clinical assets, in particular
a glucokinase activator which we believe is active in a range of autoimmune diseases including uveitis, Hashimoto&#8217;s Thyroiditis,
preterm labor and renal transplant, which we refer to as AZD1656, and a potent, irreversible inhibitor of human Myeloperoxidase that
has the potential to treat idiopathic male infertility, which we refer to as AZD5904.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of Conduit&#8217;s business, including its ability to finance its operations and generate any revenue in the future, will primarily
depend on the successful development, regulatory approval and commercialization or partnering of Conduit&#8217;s clinical assets. In
the future, Conduit may also become dependent on just one of its clinical assets or any future clinical assets that Conduit may in-license,
acquire or develop. The preclinical and clinical and commercial success of Conduit&#8217;s clinical assets will depend on a number of
factors, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability to raise additional capital on acceptable terms, or at all;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timely completion of Conduit&#8217;s clinical trials, which may be significantly slower or
                                            cost more than Conduit currently anticipates and will depend substantially upon the performance
                                            of third-party contractors;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            Conduit is required by the United States Food and Drug Administration (&#8220;FDA&#8221;)
                                            or similar foreign regulatory agencies to conduct additional preclinical or clinical trials
                                            beyond those planned to support the approval and commercialization of Conduit&#8217;s clinical
                                            assets or any future clinical assets;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            acceptance of Conduit&#8217;s proposed indications and primary endpoint assessments relating
                                            to the proposed indications of Conduit&#8217;s clinical assets by the FDA or similar foreign
                                            regulatory authorities;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to demonstrate to the satisfaction of the FDA and similar foreign regulatory authorities,
                                            the safety and efficacy of Conduit&#8217;s clinical assets or any future clinical assets;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            prevalence, duration and severity of potential side effects experienced in connection with
                                            Conduit&#8217;s clinical assets or future approved products, if any;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timely receipt of necessary marketing approvals from the FDA and similar foreign regulatory
                                            authorities;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">achieving
                                            and maintaining, and, where applicable, ensuring that Conduit&#8217;s third-party contractors
                                            achieve and maintain, compliance with Conduit&#8217;s contractual obligations and with all
                                            regulatory requirements applicable to Conduit&#8217;s clinical assets or any future clinical
                                            assets or approved products, if any;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability of third parties with whom Conduit contracts to manufacture clinical trial and commercial
                                            supplies of Conduit&#8217;s clinical assets or any future clinical assets, remain in good
                                            standing with regulatory agencies and develop, validate and maintain commercially viable
                                            manufacturing processes that are compliant with current good manufacturing practices (&#8220;cGMP&#8221;);</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            continued acceptable safety profile during preclinical and clinical development and following
                                            approval of Conduit&#8217;s clinical assets or any future clinical assets;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to successfully commercialize its clinical assets or any future clinical assets in
                                            the U.S. and internationally, if approved for marketing, sale and distribution in such countries
                                            and territories, whether alone or in collaboration with others;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            acceptance by physicians, patients and payors of the benefits, safety and efficacy of Conduit&#8217;s
                                            clinical assets or any future clinical assets, if approved, including relative to alternative
                                            and competing treatments;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to comply with numerous post-approval regulatory requirements;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            and its partners&#8217; ability to establish and enforce intellectual property rights in
                                            and to Conduit&#8217;s clinical assets or any future clinical assets;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            and its partners&#8217; ability to avoid third-party patent interference or intellectual
                                            property infringement claims; and</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
                                            ability to in-license or acquire additional clinical assets or commercial-stage products
                                            that it believes that it can successfully develop and commercialize.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Conduit is unable to achieve one or more of the above factors, many of which are beyond our control, in a timely manner or at all, Conduit
could experience significant delays and increased costs or an inability to obtain regulatory approvals or commercialize its clinical
assets. Even if regulatory approvals are obtained, Conduit may never be able to successfully commercialize any of its clinical assets.
Accordingly, Conduit cannot assure you that Conduit will be able to generate sufficient revenue through the sale of its clinical assets
or any future clinical assets to continue operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preclinical
drug development for Conduit&#8217;s clinical assets AZD1656 and AZD5904 is very expensive, time-consuming and uncertain. Conduit&#8217;s
preclinical trials may fail to adequately demonstrate pharmacologic activity in therapeutic areas of interest; cause unintended short-
or long-term effects in other bodily systems; or produce unexpected toxicity that may alter or risk benefit assessment. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scientific discoveries that form the basis for Conduit&#8217;s efforts to generate and develop its clinical assets are relatively recent.
AZD1656 is a glucokinase activator that is in a number of Phase II ready autoimmune diseases including uveitis, Hashimoto&#8217;s Thyroiditis,
preterm labor and renal transplant, and the successful development of AZD1656 may require additional studies and efforts to optimize
its therapeutic potential. In addition, Conduit&#8217;s development pipeline includes what Conduit believes to be a potent irreversible
inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility, which we refer to as AZD5904. AZD5904
may not demonstrate in patients the therapeutic properties ascribed to it in the laboratory or preclinical studies, and may interact
with human biological systems in unforeseen, ineffective or even harmful ways. If Conduit is not able to successfully develop and commercialize
its clinical assets, including AZD1656 and AZD5904, it may never become profitable and the value of its capital stock may decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>It
is difficult to predict the time and cost of development and of subsequently obtaining regulatory approval for AZD1656 as it employs
newly developed technology.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
uses a novel mechanism to reduce inflammation in many of the immune pathways. Conduit has concentrated its research and development efforts
of AZD1656 on a limited number of initial targeted disease indications for AZD1656, including the coronavirus disease. There can be no
assurance that Conduit will not experience problems or delays in developing its current or future indications for AZD1656 and that such
problems or delays will not cause unanticipated costs, or that any such development problems can be solved. Moreover, AZD1656 would also
represent a novel approach for the treatment of uveitis as steroids are currently the most common treatment for uveitis even though there
are numerous side effects associated with the use of steroids. The clinical development of these novel technologies will require review
and allowance by the FDA under an Investigational New Drug Application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
may not be successful in its efforts to use and expand its development platform to build a pipeline of clinical assets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
key element of Conduit&#8217;s strategy is to use its experienced management and scientific team to build a pipeline of clinical assets
that address a broad range of human diseases in order to treat unmet medical needs. Conduit&#8217;s current clinical assets and pipeline
address the areas of autoimmune disease and idiopathic male infertility. Although Conduit&#8217;s research and development efforts to
date have resulted in potential clinical assets, Conduit may not be able to continue to identify and develop additional clinical assets.
Even if Conduit is successful in continuing to build its pipeline, the potential clinical assets that Conduit identifies may not be suitable
for clinical development. For example, these potential clinical assets may be shown to have harmful side effects or other characteristics
that indicate that they are unlikely to receive marketing approval and achieve market acceptance. If Conduit does not successfully develop
and commercialize clinical assets based upon its approach, Conduit will not be able to obtain product revenue in future periods, which
likely would result in significant harm to its financial position. There is no assurance that Conduit will be successful in its preclinical
and clinical development of its current or future clinical assets, and the process of obtaining regulatory approvals will, in any event,
require the expenditure of substantial time and financial resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Clinical
drug development for Conduit&#8217;s clinical assets is very expensive, time-consuming, difficult to design and implement, and uncertain.
Conduit&#8217;s clinical trials may fail to adequately demonstrate the safety and efficacy of its clinical assets, which could prevent
or delay regulatory approval and commercialization.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
drug development for our clinical assets is very expensive, time-consuming, difficult to design and implement and its outcome is inherently
uncertain. Before obtaining regulatory approval for the commercial sale of a clinical asset, Conduit must demonstrate through clinical
trials that a clinical asset is both safe and effective for use in the target indication, which is impossible to predict. Most clinical
assets that commence clinical trials are never approved by regulatory authorities for commercialization. Conduit&#8217;s clinical assets
are in various stages of development and a failure of one more clinical trial can occur at any stage of testing or at any time during
the trial process. Conduit expects that clinical trials for these clinical assets will continue for several years but may take significantly
longer than expected to complete. Not all of Conduit&#8217;s clinical assets have been tested in humans and the first use in humans may
reveal unexpected effects. Conduit has not completed all clinical trials for the approval of any of its clinical assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
may experience delays in ongoing and future clinical trials for its clinical assets and Conduit does not know if future clinical trials,
if any, will begin on time, need to be redesigned, enroll adequate number of patients on time or be completed on schedule, if at all.
In addition, Conduit, any partner with which Conduit currently or may in the future collaborate, the FDA, an Institutional Review Board
(or IRB) or other regulatory authorities, including state and local agencies and counterpart agencies in foreign countries, may suspend,
delay, require modifications to or terminate Conduit&#8217;s clinical trials at any time, for various reasons, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discovery
                                            of safety or tolerability concerns, such as serious or unexpected toxicities or side effects
                                            or exposure to otherwise unacceptable health risks, experienced by study participants or
                                            other safety issues;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
                                            of effectiveness of any clinical asset during clinical trials or the failure of Conduit&#8217;s
                                            clinical assets to meet specified endpoints;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">slower
                                            than expected rates of subject recruitment and enrollment rates or inability to enroll a
                                            sufficient number of patients in clinical trials resulting from numerous factors, including
                                            the prevalence of other companies&#8217; clinical trials for their clinical assets for the
                                            same indication, or clinical trials for indications for which patients do not as commonly
                                            seek treatment;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            or difficulties in Conduit&#8217;s clinical trials due to quarantines or other restrictions
                                            resulting from the COVID-19 pandemic or any other pandemic;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
                                            in retaining subjects who have initiated a clinical trial but may withdraw at any time due
                                            to adverse side effects from the therapy, insufficient efficacy, fatigue with the clinical
                                            trial process or for any other reason;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
                                            in obtaining IRB approval for studies to be conducted at each clinical trial site;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            in manufacturing or obtaining, or inability to manufacture or obtain, sufficient quantities
                                            of materials for use in clinical trials;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inadequacy
                                            of or changes in Conduit&#8217;s manufacturing process or the product formulation or method
                                            of delivery;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in applicable laws, regulations and regulatory policies;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            or failure in reaching agreement on acceptable terms in clinical trial contracts or protocols
                                            with prospective Contract Research Organizations, which we refer to as CROs, clinical trial
                                            sites and other third-party contractors;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
                                            to add a sufficient number of clinical trial sites;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">uncertainty
                                            regarding proper formulation and dosing;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            by Conduit, its employees, its CROs or their employees or other third-party contractors to
                                            comply with contractual and applicable regulatory requirements or to perform their services
                                            in a timely or acceptable manner;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            by Conduit, its employees, its CROs or their employees or any partner with which Conduit
                                            may collaborate or their employees to comply with applicable FDA or other regulatory requirements
                                            relating to the conduct of clinical trials or the handling, storage, security and recordkeeping
                                            for drug and biologic products;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">scheduling
                                            conflicts with participating clinicians and clinical institutions;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to design appropriate clinical trial protocols;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficient
                                            data to support regulatory approval;</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
                                            or unwillingness of medical investigators to follow Conduit&#8217;s clinical protocols; or</span></td>
</tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
                                            in maintaining contact with subjects during or after treatment, which may result in incomplete
                                            data.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
or any partner with which Conduit may collaborate may suffer significant setbacks in their clinical trials similar to the experience
of a number of other companies in the pharmaceutical and biotechnology industries, even after receiving promising results in earlier
trials. In the event that Conduit or its potential partners abandon or are delayed in the clinical development efforts related to Conduit&#8217;s
clinical assets, Conduit may not be able to execute on its business plan effectively and its business, financial condition, operating
results and prospects would be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
may be unable to obtain regulatory approval for its early-stage clinical assets under applicable regulatory requirements. The FDA and
foreign regulatory bodies have substantial discretion in the approval process, including the ability to delay, limit or deny approval
of clinical assets. The delay, limitation or denial of any regulatory approval would adversely impact commercialization, Conduit&#8217;s
potential to generate revenue, Conduit&#8217;s business and its operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
currently has no products approved for sale, and Conduit may never obtain regulatory approval to commercialize any of its current or
future clinical assets. The research, testing, manufacturing, safety surveillance, efficacy, quality control, recordkeeping, labeling,
packaging, storage, approval, sale, marketing, distribution, import, export, and reporting of safety and other post-market information
related to Conduit&#8217;s drug products are subject to extensive regulation by the FDA and other regulatory authorities in the U.S.
and in foreign countries, and such regulations differ from country to country. Conduit is not permitted to market any of its current
clinical assets in the U.S. until Conduit receives approval of a New Drug Application (&#8220;NDA&#8221;), Biologics License Application
(a &#8220;BLA&#8221;), or other applicable regulatory filing from the FDA. Conduit is also not permitted to market any of its current
clinical assets in any foreign countries until Conduit or its partners receive the requisite approval from the applicable regulatory
authorities of such countries. To gain approval to market a new drug such as AZD1656 and AZD5904, the FDA and/or foreign regulatory authorities
must receive, among other things, preclinical and clinical data that adequately demonstrate the safety, purity, potency, efficacy, and
compliant manufacturing of the drug product for the intended indication applied for in a NDA, BLA or other applicable regulatory filing.
The development and approval of new drug products involves a long, expensive and uncertain process, and delay or failure can occur at
any stage. A number of companies in the pharmaceutical and biopharmaceutical industry have suffered significant setbacks in nonclinical
development, clinical trials, including in Phase III clinical development, even after promising results in earlier preclinical studies
or clinical trials. These setbacks have been caused by, among other things, findings made while clinical trials were underway and safety
or efficacy observations made in clinical trials, including previously unreported adverse events. Success in clinical trials does not
ensure that later clinical trials will be successful, or that nonclinical studies will be successful. The results of clinical trials
by other parties may not be indicative of the results in trials that Conduit or its partners may conduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA and foreign regulatory bodies have substantial discretion in the drug development and approval process, including the ability to
delay, limit drug development or limit or deny approval of clinical assets for many reasons. The FDA or the applicable foreign regulatory
body may:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disagree
  with the design or implementation of one or more clinical trials;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
  deem a clinical asset safe and effective for its proposed indication, or may deem a clinical asset&#8217;s safety or other perceived
  risks to outweigh its clinical or other benefits;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
  find the data from preclinical studies and clinical trials sufficient to support approval, or the results of clinical trials may not
  meet the level of statistical or clinical significance required by the FDA or the applicable foreign regulatory body for approval;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disagree
  with Conduit&#8217;s interpretation of data from preclinical studies or clinical trials performed by Conduit or third parties, or with
  the interpretation of any partner with which Conduit may collaborate;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
  the data collected from preclinical or clinical trials may not be sufficient to support the submission of an Investigational New Drug
  Application (&#8220;IND&#8221;) or NDA, or other applicable regulatory filing;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
  additional preclinical studies or clinical trials;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
  deficiencies in the formulation, quality control, labeling or specifications of Conduit&#8217;s current or future clinical assets;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
  clinical trials in pediatric patients in order to establish pharmacokinetics or safety for this more drug-sensitive population;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">grant
  approval contingent on the performance of costly additional post-approval clinical trials;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approve
  Conduit&#8217;s current or any future clinical assets for a more limited indication or a narrower patient population than Conduit originally
  requested or with strong warnings that may affect marketability;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
  approve the labeling that Conduit believe is necessary or desirable for the successful commercialization of Conduit&#8217;s clinical
  assets;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
  approve of the manufacturing processes, controls or facilities of third-party manufacturers or testing labs with which Conduit contracts;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider
  Conduit products a device instead of a drug requiring a different approval process and manufacturing needs;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider
  one of Conduit&#8217;s products a combination product instead of a singular drug requiring additional clinical trials or increased
  number of patients per study; or</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">change
  its approval policies or adopt new regulations in a manner rendering Conduit&#8217;s clinical data or regulatory filings insufficient
  for approval.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
delay, limitation or denial in any applicable regulatory approval for any of Conduit&#8217;s clinical assets would delay or adversely
impact commercialization of Conduit&#8217;s clinical assets and would harm Conduit&#8217;s business, financial condition, operating results
and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
report of Conduit&#8217;s independent registered public accounting firm included a &#8220;going concern&#8221; explanatory paragraph.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
report of Conduit&#8217;s independent registered public accounting firm on Conduit&#8217;s financial statements as of and for the year
ended December 31, 2022, included an explanatory paragraph indicating that there is substantial doubt about Conduit&#8217;s ability
to continue as a going concern. Conduit has financed its working capital requirements to date by raising capital through private placements
of its ordinary shares and issuing of short-term and convertible notes. If Conduit is unable to raise sufficient capital as and when
needed, Conduit&#8217;s business, financial condition and results of operations will be materially and adversely affected, and Conduit
will need to significantly modify its operational plans to continue as a going concern. If Conduit is unable to continue as a going concern,
it may have to liquidate its assets, and the values Conduit may receive for its assets in liquidation or dissolution could be significantly
lower than the values reflected in Conduit&#8217;s financial statements. The inclusion of a going concern explanatory paragraph by Conduit&#8217;s
independent registered public accounting firm, Conduit&#8217;s lack of cash resources and Conduit&#8217;s potential inability to continue
as a going concern may materially adversely affect the share price of New Conduit&#8217;s common stock following the Business Combination
and New Conduit&#8217;s ability to raise new capital, enter into critical contractual relations with third parties and otherwise execute
its development strategy following the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is a risk that New Conduit will fail to maintain an effective system of internal controls and our ability to produce timely and accurate
financial statements or comply with applicable regulations could be adversely affected. We may identify material weaknesses in our internal
controls over financing reporting which we may not be able to remedy in a timely manner.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, New Conduit will operate in an increasingly demanding regulatory environment, which requires it to comply with the&#160;Sarbanes-Oxley
Act, the regulations of Nasdaq, the rules and regulations of the SEC, expanded disclosure requirements, accelerated reporting requirements
and more complex accounting rules. Responsibilities required by the&#160;Sarbanes-Oxley Act&#160;include establishing corporate oversight
and adequate internal control over financial reporting and disclosure controls and procedures. Effective internal controls are necessary
for us to produce reliable financial reports and are important to help prevent financial fraud. Prior to the closing of the Business
Combination, we have never been required to test our internal controls within a specified period and, as a result, we may experience
difficulty in meeting these reporting requirements in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that the process of building our accounting and financial functions and infrastructure will require significant additional
professional fees, internal costs and management efforts. We may need to enhance and/or implement a new internal system to combine and
streamline the management of our financial, accounting, human resources and other functions. However, the enhancement and/or implementation
of a system may result in substantial costs. Any disruptions or difficulties in implementing or using such a system could adversely affect
our controls and harm our business. Moreover, such disruption or difficulties could result in unanticipated costs and diversion of management&#8217;s
attention. In addition, we may discover additional weaknesses in our system of internal financial and accounting controls and procedures
that could result in a material misstatement of our financial statements. Our internal control over financial reporting will not prevent
or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute,
assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation
of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances
of fraud will be detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain
proper and effective internal controls, we may not be able to produce timely and accurate financial statements. If we cannot provide
reliable financial reports or prevent fraud, our business and results of operations could be harmed, investors could lose confidence
in our reported financial information and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have identified material weaknesses in our internal control over financial reporting. If we fail to remedy these weaknesses or maintain
an effective system of internal controls, then our ability to produce timely and accurate financial statements or comply with applicable
regulations could be adversely affected. We may identify additional material weaknesses in our internal controls over financing reporting
which we may not be able to remedy in a timely manner.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the preparation and audit of Conduit&#8217;s financial statements as of and for the fiscal years ended December 31, 2022
and 2021, material weaknesses were identified in Conduit&#8217;s internal control over financial reporting. A material weakness
is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility
that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis. These
material weaknesses primarily relate to the following matters that are relevant to the preparation of our financial statements:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
  </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has a limited segregation of duties. For the periods
  under audit, Conduit did not have any internal personnel in the financial accounting and reporting department, using third party
  consultants to perform these activities.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lacked
                                            a formal process for review and approval of Conduit&#8217;s financial statements.
                                            For the periods under audit, numerous, recurring errors in account balances and disclosures
                                            were detected in the financial statements that resulted in a reasonable possibility that
                                            a material misstatement would not have been detected on a timely basis.</span></p>
</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">did
                                            not design adequate and appropriate internal controls, including monitoring controls, to
                                            review and evaluate the accounting implications of all material transactions that occurred
                                            in the audit period.</span></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">If
these material weaknesses are not remediated, it could result in a misstatement of account balances or disclosures that would result
in a material misstatement to the annual or interim financial statements that would not be prevented or detected. We are
implementing measures designed to improve our internal control over financial reporting to remediate these material weaknesses.
As a part of these measures, Conduit anticipates entering into an employment agreement with Mr. Sragovicz, who is the current Chief
Financial Officer of MURF, which will provide that Mr. Sragovicz will serve as New Conduit&#8217;s Chief Financial Officer upon the closing
of the Business Combination. In addition, Conduit anticipates hiring additional qualified accounting personnel with experience
with complex GAAP and SEC rules, meanwhile, continuing to engage consultants to assist with Conduit&#8217;s financial
statement close process, segregating duties among accounting personnel to enable adequate review controls, further developing and
documenting our accounting policies, and designing, implementing, and/or expanding IT systems and application
controls in our systems relevant to the preparation of the consolidated financial statements and as further amended by that
certain Second Amendment to Agreement and Plan of Merger, dated as of May 11, 2023, a copy of which is attached to this proxy
statement/prospectus as <span style="text-decoration: underline">Annex A-3</span>, to appropriately incorporate Conduit therein. Conduit also expects to engaging an
external advisor to assist with evaluating and documenting the design and operating effectiveness of internal controls and assisting
with the remediation of deficiencies, as necessary. The primary costs associated with such measures are corresponding recruiting and
additional salary and consulting costs, which are difficult to estimate but which may be significant. These additional resources and
procedures are intended to enable us to broaden the scope and quality of our internal review of underlying information related to
financial reporting and to formalize and enhance our internal control procedures.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material weakness will not be considered remediated until our remediation plan has been fully implemented, the applicable controls operate
for a sufficient period of time, and we have concluded, through testing, that the newly implemented and enhanced controls are operating
effectively. We currently expect to commence the remediation plan by documenting and implementing such plan, followed with testing
such controls over time. We cannot predict the success of such efforts or the outcome of its assessment of the remediation efforts.
Our efforts may not remediate this material weakness in our internal control over financial reporting, or additional material weaknesses
may be identified in the future. A failure to implement and maintain effective internal control over financial reporting could result
in errors in our financial statements that could result in a restatement of our financial statements and could cause us to fail to meet
our reporting obligations, any of which could diminish investor confidence in us and cause a decline in the price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent registered public accounting firm will not be required to formally attest to the effectiveness of our internal control over
financial reporting until after we are no longer an &#8220;emerging growth company,&#8221; as defined in the&#160;JOBS Act. At such time,
our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level
at which our internal control over financial reporting is documented, designed or operating.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may face product liability exposure, and if successful claims are brought against us, we may incur substantial liability if our insurance
coverage for those claims is inadequate.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face an inherent risk of product liability as a result of the clinical testing of our clinical assets and will face an even greater risk
if we commercialize any products. This risk exists even if a product is approved for commercial sale by the FDA and manufactured in facilities
licensed and regulated by the FDA or an applicable foreign regulatory authority. Our products and clinical assets are designed to affect
important bodily functions and processes. Any side effects, manufacturing defects, misuse or abuse associated with our clinical assets
could result in injury to a patient or even death. We cannot offer any assurance that we will not face product liability suits in the
future, nor can we assure you that our insurance coverage will be sufficient to cover our liability under any such cases. In addition,
a liability claim may be brought against us even if our clinical assets merely appear to have caused an injury. Product liability claims
may be brought against us by consumers, health care providers, pharmaceutical companies or others selling or otherwise coming into contact
with our clinical assets, among others. If we cannot successfully defend ourselves against product liability claims we will incur substantial
liabilities and reputational harm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
currently relies on, and expects to continue to rely on, third-party CROs and other third parties to conduct and oversee Conduit&#8217;s
clinical trials and other aspects of product development. If these third parties do not meet Conduit&#8217;s requirements or otherwise
conduct the trials as required, Conduit may not be able to satisfy its contractual obligations or obtain regulatory approval for, or
commercialize, its clinical assets when expected or at all.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
has in the past relied and expects to continue to rely on third-party CROs to conduct and oversee its clinical trials and other aspects
of product development. Conduit also relies upon various medical institutions, clinical investigators and contract laboratories to conduct
its trials in accordance with its clinical protocols and all applicable regulatory requirements, including the FDA&#8217;s regulations
and GCPs, which are an international standard meant to protect the rights and health of patients and to define the roles of clinical
trial sponsors, administrators and monitors, and state regulations governing the handling, storage, security and recordkeeping for drug
and biologic products. These CROs and other third parties play a significant role in the conduct of these trials and the subsequent collection
and analysis of data from the clinical trials. Conduit relies heavily on these parties for the execution of Conduit&#8217;s clinical
trials and preclinical studies, and control only certain aspects of their activities. Conduit, its CROs, and other third-party contractors
are required to comply with GCP, GLP, and GACP requirements, which are regulations and guidelines enforced by the FDA and comparable
foreign regulatory authorities for products in clinical development. Regulatory authorities enforce these GCP, GLP and GACP requirements
through periodic inspections of trial sponsors, principal investigators and trial sites. If Conduit or any of these third parties fail
to comply with applicable GCP, GLP and GACP requirements, the clinical data generated in Conduit&#8217;s clinical trials may be deemed
unreliable and the FDA or other regulatory authority may require Conduit to perform additional clinical trials before approving Conduit&#8217;s
or its partners&#8217; marketing applications. Conduit cannot assure you that upon inspection by a given regulatory authority, such regulatory
authority will determine that any of Conduit&#8217;s clinical or preclinical trials complies with applicable GCP and GLP requirements.
In addition, Conduit&#8217;s clinical trials must generally be conducted with product produced under cGMP regulations. Conduit&#8217;s
failure to comply with these regulations and policies may require Conduit to repeat clinical trials, which would delay the regulatory
approval process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
CROs are not Conduit employees, and Conduit does not control whether or not they devote sufficient time and resources to Conduit&#8217;s
clinical trials. Conduit&#8217;s CROs may also have relationships with other commercial entities, including Conduit&#8217;s competitors,
for whom they may also be conducting clinical trials, or other drug development activities, which could harm Conduit&#8217;s competitive
position. Conduit faces the risk of potential unauthorized disclosure or misappropriation of its intellectual property by CROs, which
may reduce Conduit&#8217;s trade secret protection and allow potential competitors to access and exploit Conduit&#8217;s proprietary
technology. If Conduit&#8217;s CROs do not successfully carry out their contractual duties or obligations, fail to meet expected deadlines,
or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to Conduit&#8217;s clinical
protocols or regulatory requirements or for any other reason, Conduit&#8217;s clinical trials may be extended, delayed or terminated,
and Conduit may not be able to obtain regulatory approval for, or successfully commercialize any clinical asset that Conduit develops.
As a result, Conduit&#8217;s financial results and the commercial prospects for any clinical asset that it develops would be harmed,
Conduit&#8217;s costs could increase, and Conduit&#8217;s ability to generate revenue could be delayed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of Conduit&#8217;s CROs or clinical trial sites terminate their involvement in one of Conduit&#8217;s clinical trials for any reason,
Conduit may not be able to enter into arrangements with alternative CROs or clinical trial sites, or do so on commercially reasonable
terms. In addition, if Conduit&#8217;s relationship with clinical trial sites is terminated, Conduit may experience the loss of follow-up
information on patients enrolled in Conduit&#8217;s ongoing clinical trials unless we are able to transfer the care of those patients
to another qualified clinical trial site. In addition, principal investigators for our clinical trials may serve as scientific advisors
or consultants to us from time to time and could receive cash or equity compensation in connection with such services. If these relationships
and any related compensation result in perceived or actual conflicts of interest, the integrity of the data generated at the applicable
clinical trial site may be questioned by the FDA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
relies completely on third-party contractors to supply, manufacture and distribute clinical drug supplies for its clinical assets, including
certain sole-source suppliers and manufacturers. Conduit intends to rely on third parties for commercial supply, manufacturing and distribution
if any of its clinical assets receive regulatory approval and Conduit expects to rely on third parties for supply, manufacturing and
distribution of preclinical, clinical and commercial supplies of any future clinical assets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
does not currently have, nor does it plan to acquire, the infrastructure or capability to supply, manufacture or distribute preclinical,
clinical or commercial quantities of drug substances or products. Conduit&#8217;s ability to develop its clinical assets depends and
its ability to commercially supply our products will depend, in part, on Conduit&#8217;s ability to successfully obtain the raw materials
and active pharmaceutical ingredients (&#8220;APIs&#8221;) and other substances and materials used in its clinical assets from third
parties and to have finished products manufactured by third parties in accordance with regulatory requirements and in sufficient quantities
for preclinical and clinical testing and commercialization. If Conduit fails to develop and maintain supply relationships with these
third parties, Conduit may be unable to continue to develop or commercialize its clinical assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
relies and will continue to rely on certain third parties as the sole source of the materials they supply or the finished products they
manufacture. Any of Conduit&#8217;s existing suppliers or manufacturers may:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fail
  to supply Conduit with product on a timely basis or in the requested amount due to unexpected damage to or destruction of facilities
  or equipment or otherwise;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fail
  to increase manufacturing capacity and produce drug product and components in larger quantities and at higher yields in a timely or
  cost-effective manner, or at all, to sufficiently meet Conduit&#8217;s commercial needs;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
  unable to meet Conduit&#8217;s production demands due to issues related to their reliance on sole-source suppliers and manufacturers;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">supply
  Conduit with product that fails to meet regulatory requirements;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">become
  unavailable through business interruption or financial insolvency;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lose
  regulatory status as an approved source;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
  unable or unwilling to renew current supply agreements when such agreements expire on a timely basis, on acceptable terms or at all;
  or</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discontinue
  production or manufacturing of necessary drug substances or products.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any of the foregoing, if Conduit does not have an alternative supplier or manufacturer in place, Conduit would be required
to expend substantial management time and expense to identify, qualify and transfer processes to alternative suppliers or manufacturers.
Transferring technology to other sites may require additional processes, technologies and validation studies, which are costly, may take
considerable amounts of time, may not be successful and, in most cases, require review and approval by the FDA. Any need to find and
qualify new suppliers or manufacturers could significantly delay production of Conduit&#8217;s clinical assets, adversely impact our
ability to market Conduit&#8217;s clinical assets and adversely affect our business. Replacements may not be available to us on a timely
basis, on acceptable terms or at all. Additionally, Conduit and its manufacturers do not currently maintain significant inventory of
drug substances and other materials. Any interruption in the supply of a drug substance or other material or in the manufacture of Conduit&#8217;s
clinical assets could have a material adverse effect on its business, financial condition, operating results and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
does not have direct control over the ability of its contract suppliers and manufacturers to maintain adequate capacity and capabilities
to serve Conduit&#8217;s needs, including quality control, quality assurance and qualified personnel. Although Conduit is ultimately
responsible for ensuring compliance with regulatory requirements such as cGMPs and GACP, Conduit is dependent on our contract suppliers
and manufacturers for day-to-day compliance with cGMPs or GACP for production of raw materials, APIs, and finished products. Facilities
used by Conduit&#8217;s contract suppliers and manufacturers to produce the APIs and other substances and materials or finished products
for commercial sale must pass inspection and be approved by the FDA and other relevant regulatory authorities. Conduit&#8217;s contract
suppliers and manufacturers must comply with cGMP and GACP requirements enforced by the FDA through its facilities inspection program
and review of submitted technical information. If the safety of any product or clinical asset or component is compromised due to a failure
to adhere to applicable laws or for other reasons, Conduit may not be able to successfully commercialize or obtain regulatory approval
for the affected product or clinical asset, and Conduit may be held liable for injuries sustained as a result. Any of these factors could
cause a delay or termination of preclinical studies, clinical trials or regulatory submissions or approvals of Conduit&#8217;s clinical
assets, and could entail higher costs or result in Conduit being unable to effectively commercialize its approved products on a timely
basis, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, these contract manufacturers are engaged with other companies to supply and manufacture materials or products for such companies,
which also exposes Conduit&#8217;s suppliers and manufacturers to regulatory risks for the production of such materials and products.
As a result, failure to meet the regulatory requirements for the production of those materials and products may also affect the regulatory
clearance of a contract supplier&#8217;s or manufacturer&#8217;s facility. If the FDA or a comparable foreign regulatory agency does
not approve these facilities for the supply or manufacture of Conduit&#8217;s clinical assets, or if it withdraws its approval in the
future, Conduit may need to find alternative supply or manufacturing facilities, which would negatively impact Conduit&#8217;s ability
to develop, obtain regulatory approval of or market its clinical assets, if approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any of Conduit&#8217;s third-party contractors terminate their involvement
in the supply, manufacture or distribution of clinical drug supplies for Conduit for any reason, Conduit may not be able to enter into
arrangements with alternative third party-contractors, or do so on commercially reasonable terms. In addition, if Conduit&#8217;s relationship
with such third-party contractors is terminated, Conduit may experience a negative impact to the respective licenses on which Conduit
relies and, therefore, on Conduit&#8217;s ability to obtain regulatory approval for, or commercialize, its clinical assets when expected
or at all.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
reliance on contract manufacturers and suppliers further exposes Conduit to the possibility that they, or third parties with access to
their facilities, will have access to and may misappropriate Conduit&#8217;s trade secrets or other proprietary information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the manufacturing facilities of certain of Conduit&#8217;s suppliers are located outside of the U.S. This may give rise to
difficulties in importing Conduit&#8217;s products or clinical assets or their components into the U.S. or other countries as a result
of, among other things, regulatory agency approval requirements or import inspections, incomplete or inaccurate import documentation
or defective packaging.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
currently relies on agreements with third parties for the purpose of licensing its clinical assets. In the near-term Conduit intends
to rely on third parties for the licensing of clinical assets and those which may arise through future partnerships. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit currently relies on agreements with third parties for the purpose
of licensing clinical assets from large pharmaceutical companies. For example, Conduit has agreements with St George Street pursuant to
which Conduit licenses clinical assets from St George Street and, in turn, St George Street licenses such assets from AstraZeneca. If
Conduit is in breach of the agreements, the termination of such agreement(s) could materially adversely affect Conduit&#8217;s business,
financial condition, operating results, and prospects. Conduit&#8217;s business strategy heavily depends on Conduit&#8217;s ability to
commercialize its clinical assets and Conduit&#8217;s ability to enter into license agreements relating to such clinical assets is critical
to the success of Conduit&#8217;s operations. In addition, Conduit is not a party to the license agreements between St George Street and
AstraZeneca and St George Street may have other agreements with third parties relating to the development of the clinical assets that
it licenses. A termination of such third-party agreements could have a material impact on or materially disrupt Conduit&#8217;s operations.
While Conduit holds its own intellectual property outside of the scope of Conduit&#8217;s agreements with third parties, a termination
of the agreement could adversely affect Conduit&#8217;s business and ability to commercialize its clinical assets. These third parties
play a significant role in the conduct of these trials and the subsequent collection and analysis of data from the clinical trials. Conduit
relies heavily on these parties for the execution of Conduit&#8217;s clinical trials and preclinical studies, and control only certain
aspects of their activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
may choose not to continue developing or commercializing any of its clinical assets at any time during development or after
approval, which would reduce or eliminate our potential return on investment for those clinical assets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
may decide to discontinue the development of any of its clinical assets or not to continue commercializing one or more of its approved
clinical assets for a variety of reasons, including the appearance of new technologies that make its product obsolete, competition from
a competing product or changes in or failure to comply with applicable regulatory requirements at any time. If Conduit terminates a program
in which Conduit has invested significant resources, Conduit will not receive any return on its investment and it will have missed the
opportunity to have allocated those resources to potentially more productive uses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
Conduit fails to attract and retain management and other key personnel, it may be unable to continue to successfully develop or commercialize
its clinical assets or otherwise implement its business plan.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
ability to compete in the highly competitive pharmaceuticals industry depends upon its ability to attract and retain highly qualified
managerial, scientific, medical, sales and marketing and other personnel. Conduit is highly dependent on its management, including its
Chief Executive Officer, David Tapolczay. The loss of the services of any of these individuals could impede, delay or prevent the successful
development of Conduit&#8217;s product pipeline, completion of Conduit&#8217;s planned clinical trials, commercialization of Conduit&#8217;s
clinical assets or in-licensing or acquisition of new assets and could negatively impact Conduit&#8217;s ability to successfully implement
its business plan. If Conduit loses the services of any of these individuals, Conduit might not be able to find suitable replacements
on a timely basis or at all, and its business could be harmed as a result. Conduit does not maintain &#8220;key man&#8221; insurance
policies on the lives of these individuals or the lives of any of its other employees. In order to retain valuable employees at Conduit,
in addition to salary and cash incentives, Conduit provides stock options that vest over time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
might not be able to attract or retain qualified management and other key personnel in the future due to the intense competition for
qualified personnel among biotechnology, pharmaceutical and other businesses. Conduit could have difficulty attracting experienced personnel
to Conduit and may be required to expend significant financial resources in Conduit&#8217;s employee recruitment and retention efforts.
Many of the other pharmaceutical companies with whom Conduit competes for qualified personnel have greater financial and other resources,
different risk profiles and longer histories in the industry than Conduit does. They also may provide more diverse opportunities and
better chances for career advancement. If Conduit is not able to attract and retain the necessary personnel to accomplish its business
objectives, it may experience constraints that will harm its ability to implement its business strategy and achieve its business objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Conduit has scientific and clinical advisors who assist us Conduit in formulating its development and clinical strategies.
These advisors are not Conduit&#8217;s employees and may have commitments to, or consulting or advisory contracts with, other entities
that may limit their availability to Conduit. In addition, Conduit&#8217;s advisors may have arrangements with other companies to assist
those companies in developing products or technologies that may compete with those of Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
currently has limited marketing capabilities and no sales organization. If Conduit is unable to establish sales and marketing capabilities
on its own or through third parties, Conduit will be unable to successfully commercialize its clinical assets, if approved, or generate
product revenue.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
currently has limited marketing capabilities and no sales organization. To commercialize Conduit&#8217;s clinical assets, if approved,
in the U.S., Canada, the European Union and other jurisdictions that Conduit seeks to enter, Conduit must build its marketing, sales,
distribution, managerial and other non-technical capabilities or make arrangements with third parties to perform these services, and
Conduit may not be successful in doing so. Although Conduit&#8217;s management team has experience in the marketing, sale and distribution
of pharmaceutical products from prior employment at other companies, Conduit as a company have no prior experience in the marketing,
sale and distribution of pharmaceutical products and there are significant risks involved in building and managing a sales organization,
including Conduit&#8217;s ability to hire, retain and incentivize qualified individuals, generate sufficient sales leads, provide adequate
training to sales and marketing personnel and effectively manage a geographically dispersed sales and marketing team. Any failure or
delay in the development of Conduit&#8217;s internal sales, marketing and distribution capabilities would adversely impact the commercialization
of these products. Conduit may choose to collaborate with additional third parties that have direct sales forces and established distribution
systems, either to augment Conduit&#8217;s own sales force and distribution systems or in lieu of its own sales force and distribution
systems. If Conduit is unable to enter into such arrangements on acceptable terms or at all, Conduit may not be able to successfully
commercialize its clinical assets. If Conduit is unable to successfully commercialize its clinical assets, either on its own or through
collaborations with one or more third parties, Conduit&#8217;s business, financial condition, operating results and prospects would suffer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
failure to successfully in-license, acquire, develop, and market additional clinical assets or approved products would impair its ability
to grow its business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
intends to in-license, acquire, develop and market additional products and clinical assets and Conduit may in-license or acquire commercial-stage
products or engage in other strategic transactions. Because Conduit&#8217;s internal research and development capabilities are limited,
Conduit may be dependent upon pharmaceutical companies, academic scientists and other researchers to sell or license products or technology
to Conduit. The success of this strategy depends partly upon Conduit&#8217;s ability to identify and select promising pharmaceutical
clinical assets and products, negotiate licensing or acquisition agreements with their current owners and finance these arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process of proposing, negotiating and implementing a license or acquisition of a clinical asset or approved product is lengthy and complex.
Other companies, including some with substantially greater financial, marketing, sales and other resources, may compete with Conduit
for the license or acquisition of clinical assets and approved products. Conduit has limited resources to identify and execute the acquisition
or in-licensing of third-party products, businesses and technologies and integrate them into Conduit&#8217;s current infrastructure.
Moreover, Conduit may devote resources to potential acquisitions or licensing opportunities that are never completed, or Conduit may
fail to realize the anticipated benefits of such efforts. Conduit may not be able to acquire the rights to additional clinical assets
on terms that it finds acceptable, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
any clinical asset that Conduit acquires may require additional development efforts prior to commercial sale, including preclinical or
clinical testing and approval by the FDA and applicable foreign regulatory authorities. All clinical assets are prone to risks of failure
typical of pharmaceutical product development, including the possibility that a clinical asset will not be shown to be sufficiently safe
and effective for approval by regulatory authorities. In addition, Conduit cannot provide assurance that any approved products that Conduit
acquires will be manufactured or sold profitably or achieve market acceptance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
potential transactions that Conduit may consider include a variety of different business arrangements, including spin-offs, strategic
partnerships, joint ventures, restructurings, divestitures, business combinations and investments. Any such transaction may require Conduit
to incur non-recurring or other charges, may increase Conduit&#8217;s near- and long-term expenditures and may pose significant integration
challenges or disrupt Conduit&#8217;s management or business, which could adversely affect Conduit&#8217;s operations and financial results.
For example, these transactions entail numerous potential operational and financial risks, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exposure
  to unknown liabilities;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption
  of Conduit&#8217;s business and diversion of our management&#8217;s time and attention in order to develop acquired products, clinical
  assets or technologies;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incurrence
  of substantial debt or dilutive issuances of equity securities to pay for acquisitions;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
  acquisition and integration costs;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">write-downs
  of assets or impairment charges;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
  amortization expenses;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
  and cost in combining the operations and personnel of any acquired businesses with Conduit&#8217;s operations and personnel;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairment
  of relationships with key suppliers, partners or customers of any acquired businesses due to changes in management and ownership; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
  to retain Conduit&#8217;s key employees or those of any acquired businesses.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
there can be no assurance that Conduit will undertake or successfully complete any transactions of the nature described above, and any
transaction that Conduit does complete could harm its business, financial condition, operating results and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Manufacturing
and supply of the APIs and other substances and materials used in Conduit&#8217;s clinical assets is a complex and technically challenging
undertaking, and there is potential for failure at many points in the manufacturing, testing, quality assurance and distribution supply
chain, as well as the potential for latent defects after products have been manufactured and distributed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
and supply of APIs, other substances and materials and finished drug products is technically challenging. Changes beyond Conduit&#8217;s
direct control can impact the quality, volume, price and successful delivery of Conduit&#8217;s clinical assets and can impede, delay,
limit or prevent the successful development and commercialization of Conduit&#8217;s clinical assets. Mistakes and mishandling are not
uncommon and can affect successful production and supply. Some of these risks include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
  of Conduit&#8217;s manufacturers to follow cGMP or GACP requirements or mishandling of product while in production or in preparation
  for transit;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
  of Conduit&#8217;s contract suppliers and manufacturers to efficiently and cost-effectively increase and maintain high yields and batch
  quality, consistency and stability;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  inability to develop an FDA approved bioassay for release of any future product;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
  in establishing optimal drug delivery substances and techniques, production and storage methods and packaging and shipment processes;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transportation
  and import/export risk, particularly given the global nature of Conduit&#8217;s supply chain;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
  in analytical results or failure of analytical techniques that Conduit depends on for quality control and release of any future product;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">natural
  disasters, pandemics, labor disputes, financial distress, lack of raw material supply, issues with facilities and equipment or other
  forms of disruption to business operations of Conduit&#8217;s contract manufacturers and suppliers; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">latent
  defects that may become apparent after the product has been released and which may result in recall and destruction of product.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these factors could result in delays or higher costs in connection with Conduit&#8217;s clinical trials, regulatory submissions, required
approvals or commercialization of Conduit&#8217;s clinical assets, which could harm Conduit&#8217;s business, financial condition, operating
results and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
operating results may fluctuate significantly, which makes Conduit&#8217;s future operating results difficult to predict and could cause
Conduit&#8217;s operating results to fall below expectations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
operations to date have been primarily limited to researching and developing its clinical assets and undertaking preclinical studies
and clinical trials of its clinical assets. Conduit has not yet obtained regulatory approvals for any of its clinical assets. Consequently,
any predictions you make about Conduit&#8217;s future success or viability may not be as accurate as they could be if Conduit had a longer
operating history or approved products on the market. Furthermore, Conduit&#8217;s operating results may fluctuate due to a variety of
other factors, many of which are outside of Conduit&#8217;s control and may be difficult to predict, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
  in the commencement, enrollment and the timing of clinical testing for Conduit&#8217;s clinical assets;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  timing and success or failure of clinical trials for Conduit&#8217;s clinical assets or competing clinical assets, or any other change
  in the competitive landscape of our industry, including consolidation among our competitors or partners;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
  delays in regulatory review and approval of clinical assets in clinical development;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  timing and cost of, and level of investment in, research and development activities relating to Conduit&#8217;s clinical assets, which
  may change from time to time;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  cost of manufacturing Conduit&#8217;s clinical assets, which may vary depending on FDA guidelines and requirements, and the quantity
  of production;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability to obtain additional funding to develop its clinical assets;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenditures
  that Conduit will or may incur to acquire or develop additional clinical assets and technologies;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  level of demand for Conduit&#8217;s clinical assets, should they receive approval, which may vary significantly;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
  side effects of Conduit&#8217;s clinical assets that could delay or prevent commercialization or cause an approved drug to be taken
  off the market;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for Conduit&#8217;s clinical assets,
  if approved;</span></td></tr>

</table>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  dependency on third-party manufacturers to supply or manufacture Conduit&#8217;s clinical assets;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability to establish an effective sales, marketing and distribution infrastructure in a timely manner;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
  acceptance of Conduit&#8217;s clinical assets, if approved, and Conduit&#8217;s ability to forecast demand for those clinical assets;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability to receive approval and commercialize its clinical assets outside of the U.S.;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability to establish and maintain collaborations, licensing or other arrangements;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability and third parties&#8217; abilities to protect intellectual property rights;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
  related to and outcomes of potential litigation or other disputes;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability to adequately support future growth;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability to attract and retain key personnel to manage Conduit&#8217;s business effectively;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
  liabilities associated with hazardous materials;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
  ability to maintain adequate insurance policies; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
  accounting pronouncements or changes in our accounting policies.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
operating results and liquidity needs could be negatively affected by market fluctuations and economic downturn.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
operating results and liquidity could be negatively affected by economic conditions generally, both in the U.S. and elsewhere around
the world. The market for discretionary medical products and procedures may be particularly vulnerable to unfavorable economic conditions.
Some patients may consider certain of Conduit&#8217;s clinical assets to be discretionary, and if full reimbursement for such products
is not available, demand for these products may be tied to the discretionary spending levels of Conduit&#8217;s targeted patient populations.
Domestic and international equity and debt markets have experienced and may continue to experience heightened volatility and turmoil
based on domestic and international economic conditions and concerns. In the event these economic conditions and concerns continue or
worsen and the markets continue to remain volatile, Conduit&#8217;s operating results and liquidity could be adversely affected by those
factors in many ways, including weakening demand for certain of Conduit&#8217;s products and making it more difficult for Conduit to
raise funds if necessary. Additionally, although we plan to market our products primarily in the U.S., we could in the future have partners
with extensive global operations, indirectly exposing us to risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">Conduit
maintains its cash and cash equivalents with high quality, accredited financial institutions. However, some of these accounts exceed
the government-insured limits, and, while Conduit believes that it is not exposed to significant credit risk due to the financial strength
of these depository institutions or investments, the failure or collapse of one or more of these depository institutions or default on
these investments could materially adversely affect Conduit&#8217;s ability to recover these assets and/or materially harm Conduit&#8217;s
financial condition.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
is increasingly dependent on information technology, and Conduit&#8217;s systems and infrastructure face certain risks, including cybersecurity
and data leakage risks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
disruptions to Conduit&#8217;s information technology systems or breaches of information security could adversely affect Conduit&#8217;s
business. In the ordinary course of business, Conduit collects, stores and transmits large amounts of confidential information, and it
is critical that Conduit do so in a secure manner to maintain the confidentiality and integrity of such confidential information. The
size and complexity of Conduit&#8217;s information technology systems, and those of its third-party vendors with whom it contracts, make
such systems potentially vulnerable to service interruptions and security breaches from inadvertent or intentional actions by Conduit&#8217;s
employees, partners or vendors, from attacks by malicious third parties, or from intentional or accidental physical damage to Conduit&#8217;s
systems infrastructure maintained by Conduit or by third parties. Maintaining the secrecy of this confidential, proprietary, or trade
secret information is important to Conduit&#8217;s competitive business position. While Conduit has taken steps to protect such information
and invested in information technology, there can be no assurance that Conduit&#8217;s efforts will prevent service interruptions or
security breaches in Conduit&#8217;s systems or the unauthorized or inadvertent wrongful use or disclosure of confidential information
that could adversely affect Conduit&#8217;s business operations or result in the loss, dissemination, or misuse of critical or sensitive
information. A breach of Conduit&#8217;s security measures or the accidental loss, inadvertent disclosure, unapproved dissemination,
misappropriation or misuse of trade secrets, proprietary information, or other confidential information, whether as a result of theft,
hacking, fraud, trickery or other forms of deception, or for any other reason, could enable others to produce competing products, use
Conduit&#8217;s proprietary technology or information, or adversely affect Conduit&#8217;s business or financial condition. Further,
any such interruption, security breach, loss or disclosure of confidential information, could result in financial, legal, business, and
reputational harm to Conduit and could have a material adverse effect on Conduit&#8217;s business, financial position, results of operations
or cash flow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
business and operations would suffer in the event of failures in our internal computer systems.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the implementation of security measures, Conduit&#8217;s computer systems and those of Conduit&#8217;s current and any future partners,
contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and
telecommunication and electrical failures. While Conduit has not experienced any such material system failure, accident, or security
breach to date, if such an event were to occur and cause interruptions in Conduit&#8217;s operations, it could result in a material disruption
of Conduit&#8217;s manufacturing activities, development programs and business operations. For example, the loss of manufacturing records
or clinical trial data from completed or future clinical trials could result in delays in Conduit&#8217;s regulatory approval efforts
and significantly increase Conduit&#8217;s costs to recover or reproduce the data. While Conduit has not experienced a security breach,
its online sources being hacked or a data leak to date, if such an event were to occur, it could result in confidential clinical trial
data being leaked to competitors and the market. To the extent that any disruption or security breach were to result in a loss of, or
damage to, Conduit&#8217;s data or applications, or inappropriate disclosure of confidential or proprietary information, Conduit could
incur liability and the further commercialization and development of its products and clinical assets could be delayed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to adequately protect Conduit&#8217;s intellectual property could adversely affect Conduit&#8217;s business, financial condition, and
operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
business depends on its intellectual property and proprietary technology, the protection of which is crucial to the success of its business.
Conduit relies on a combination of trademark, copyright, and trade secret laws, license agreements, intellectual property assignment
agreements, and confidentiality procedures to protect its intellectual property. Additionally, Conduit relies on proprietary information
(such as trade secrets, know-how and confidential information) to protect intellectual property that may not be patentable, or that Conduit
believes is best protected by means that do not require public disclosure. Conduit generally attempts to protect its intellectual property,
technology, and confidential information by requiring its employees and consultants who develop intellectual property on Conduit&#8217;s
behalf to enter into confidentiality and invention assignment agreements and third parties that Conduit shares information with to enter
into nondisclosure agreements. These agreements may not effectively prevent unauthorized use or disclosure of Conduit&#8217;s confidential
information, intellectual property, or technology and may not provide an adequate remedy in the event of unauthorized use or disclosure
of Conduit&#8217;s confidential information or technology, or infringement of Conduit&#8217;s intellectual property. For example, Conduit
may fail to enter into the necessary agreements, and even if entered into, these agreements may be willfully breached or may otherwise
fail to prevent disclosure, third-party infringement or misappropriation of Conduit&#8217;s proprietary information, may be limited as
to their term and may not provide an adequate remedy in the event of unauthorized disclosure or use of proprietary information. In addition,
Conduit&#8217;s proprietary information may otherwise become known or be independently developed by Conduit&#8217;s competitors or other
third parties. To the extent that Conduit&#8217;s employees, consultants, contractors, and other third parties use intellectual property
owned by others in their work for Conduit, disputes may arise as to the rights in related or resulting know-how and inventions. Costly
and time-consuming litigation could be necessary to enforce and determine the scope of Conduit&#8217;s intellectual property rights and
other proprietary rights, and failure to obtain or maintain protection for Conduit&#8217;s proprietary information could adversely affect
Conduit&#8217;s competitive business position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
Conduit&#8217;s efforts to protect its proprietary rights, other parties may unintentionally or willfully disclose, obtain or use Conduit&#8217;s
technologies or systems, which may allow unauthorized parties to copy aspects of Conduit&#8217;s platform or other software, technology,
and functionality or obtain and use information that Conduit considers proprietary. In addition, unauthorized parties may also attempt,
or successfully endeavor, to obtain Conduit&#8217;s intellectual property, confidential information and trade secrets through various
methods, including through scraping of public data or other content from Conduit&#8217;s website or mobile applications, cybersecurity
attacks, and legal or other methods of protecting this data may be inadequate. Monitoring unauthorized use and disclosures of Conduit&#8217;s
intellectual property, proprietary technology, or confidential information can be difficult and expensive and Conduit cannot be sure
that the steps it has taken will prevent misappropriation or infringement of its intellectual property or proprietary rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
has registered the domain name for the website that it uses in its business, which is www.conduitpharma.com. The inclusion of the website
address in this proxy statement/prospectus does not include or incorporate by reference the information on the Conduit website into this
proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
have and may continue to adopt service names similar to Conduit&#8217;s, thereby harming Conduit&#8217;s ability to build brand identity
and possibly leading to user confusion. In addition, there could be potential trade name or trademark infringement claims brought by
owners of other trademarks that are similar to Conduit&#8217;s trademarks. Further, litigation or proceedings before the U.S. Patent
and Trademark Office or other governmental authorities and administrative bodies in the U.S. and abroad may be necessary in the future
to enforce Conduit&#8217;s intellectual property rights and to determine the validity and scope of the proprietary rights of others.
Any litigation initiated by Conduit concerning the violation by third parties of its intellectual property rights is likely to be expensive
and time-consuming and could lead to the invalidation of, or render unenforceable, its intellectual property, or could otherwise have
negative consequences for Conduit. Even when Conduit sues other parties for such infringement, that suit may have adverse consequences
for Conduit&#8217;s business. In addition, Conduit may not timely or successfully apply for a patent or register its trademarks or otherwise
secure its intellectual property, which could result in negative effects to its market share, financial condition and results of operations.
Conduit&#8217;s efforts to protect, maintain, or enforce its proprietary rights may not be respected in the future or may be invalidated,
circumvented, or challenged, and could result in substantial costs and diversion of resources, which could adversely affect Conduit&#8217;s
business, financial condition, and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
may be unable to continue to use the domain name that it uses in its business or prevent third parties from acquiring and using domain
names that infringe on, are similar to, or otherwise decrease the value of Conduit&#8217;s brand, trademarks, or service marks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
has registered the domain name that it uses in its business. If Conduit loses the ability to use that domain name, whether due to trademark
claims, failure to renew the applicable registration, or any other cause, Conduit may be forced to market its offerings under a new domain
name, which could cause Conduit substantial harm, or to incur significant expense in order to purchase rights to the domain name in question.
Conduit may not be able to obtain preferred domain names outside the U.S. due to a variety of reasons, including because they are already
held by others. In addition, Conduit&#8217;s competitors and others could attempt to capitalize on Conduit&#8217;s brand recognition
by using domain names similar to Conduit&#8217;s domain name. Conduit may be unable to prevent third parties from acquiring and using
domain names that infringe on, are similar to, or otherwise decrease the value of Conduit&#8217;s brand or Conduit&#8217;s trademarks
or service marks. Protecting, maintaining, and enforcing Conduit&#8217;s rights in its domain names may require litigation, which could
result in substantial costs and diversion of resources, which could in turn adversely affect Conduit&#8217;s business, financial condition,
and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
may not be able to protect its intellectual property rights throughout the world.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing,
prosecuting and defending patents on Conduit&#8217;s clinical assets in all countries throughout the world would be prohibitively expensive.
The requirements for patentability may differ in certain countries, particularly developing countries. In addition, the laws of some
foreign countries do not protect intellectual property rights to the same extent as laws in the U.S. Consequently, Conduit may not be
able to prevent third parties from practicing Conduit&#8217;s inventions in all countries outside the U.S. Competitors may use Conduit&#8217;s
technologies in jurisdictions where Conduit has not obtained patent protection to develop their own products and, further, may export
otherwise infringing products to territories where Conduit has patent protection, but enforcement on infringing activities is inadequate.
These products may compete with Conduit&#8217;s products, and Conduit&#8217;s patents or other intellectual property rights may not be
effective or sufficient to prevent them from competing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The
legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual
property protection, particularly those relating to pharmaceuticals, which could make it difficult for us to stop the infringement of
Conduit&#8217;s patents or marketing of competing products in violation of Conduit&#8217;s proprietary rights generally. Proceedings
to enforce Conduit&#8217;s patent rights in foreign jurisdictions could result in substantial costs and divert Conduit&#8217;s efforts
and attention from other aspects of its business, could put its patents at risk of being invalidated or interpreted narrowly and its
patent applications at risk of not issuing, and could provoke third parties to assert claims against Conduit. Conduit may not prevail
in any lawsuits that it initiates, and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition,
certain countries in Europe and certain developing countries have compulsory licensing laws under which a patent owner may be compelled
to grant licenses to third parties. In those countries, Conduit may have limited remedies if its patents are infringed or if it is compelled
to grant a license to its patents to a third party, which could materially diminish the value of those patents. This could limit Conduit&#8217;s
potential revenue opportunities. Accordingly, Conduit&#8217;s efforts to enforce its intellectual property rights around the world may
be inadequate to obtain a significant commercial advantage from the intellectual property that Conduit owns or licenses. Conduit&#8217;s
ability to protect and enforce its intellectual property rights may also be adversely affected by unforeseen changes in foreign intellectual
property laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Obtaining
and maintaining Conduit&#8217;s patent protection depends on compliance with various procedural, document submission, fee payment and
other requirements imposed by governmental patent agencies, and Conduit&#8217;s patent protection could be reduced or eliminated for
non-compliance with these requirements.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodic
maintenance and annuity fees on any issued patent are due to be paid to the United States Patent and Trademark Office (&#8220;USPTO&#8221;)
and foreign patent agencies in several stages over the lifetime of the patent. The USPTO and various foreign governmental patent agencies
require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process.
While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules,
there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial
or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a
patent or patent application include failure to respond to official actions within prescribed time limits, non-payment of fees and failure
to properly legalize and submit formal documents. If Conduit or its licensors fail to maintain the patents and patent applications covering
Conduit&#8217;s clinical assets, Conduit&#8217;s competitors might be able to enter the market, which would have an adverse effect on
Conduit&#8217;s business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
Conduit fails to comply with its obligations under its intellectual property license agreements, Conduit could lose license rights that
are important to its business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
is a party to certain license agreements that impose various diligence, milestone, royalty, insurance and other obligations on Conduit.
If Conduit fails to comply with these obligations, the respective licensors may have the right to terminate the license, in which event
Conduit may not be able to develop or market the affected clinical asset. Conduit&#8217;s business strategy depends on Conduit&#8217;s
ability to commercialize its clinical assets and Conduit&#8217;s ability to enter into license agreements relating to such clinical assets
is critical to the success of Conduit&#8217;s operations. The loss of such rights could materially adversely affect Conduit&#8217;s business,
financial condition, operating results and prospects. For more information about these license arrangements, see &#8220;<i>Business &#8212;Strategic
Alliances and Arrangements</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
Conduit is sued for infringing intellectual property rights of third parties, it will be costly and time-consuming, and an unfavorable
outcome in that litigation could have a material adverse effect on Conduit&#8217;s business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
commercial success depends upon its ability to develop, manufacture, market and sell its clinical assets and use its proprietary technologies
without infringing the proprietary rights of third parties. Conduit cannot guarantee that marketing and selling such candidates and using
such technologies will not infringe existing or future patents. Numerous U.S. and foreign issued patents and pending patent applications
owned by third parties exist in the fields relating to Conduit&#8217;s clinical assets. As the biotechnology and pharmaceutical industries
expand and more patents are issued, the risk increases that others may assert that Conduit&#8217;s clinical assets, technologies or methods
of delivery or use infringe their patent rights. Moreover, it is not always clear to industry participants, including Conduit, which
patents cover various drugs, biologics, drug delivery systems or their methods of use, and which of these patents may be valid and enforceable.
Thus, because of the large number of patents issued and patent applications filed in Conduit&#8217;s fields, there may be a risk that
third parties may allege they have patent rights encompassing Conduit&#8217;s clinical assets, technologies or methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there may be issued patents of third parties that are infringed or are alleged to be infringed by Conduit&#8217;s clinical
assets or proprietary technologies. Because some patent applications in the U.S. may be maintained in secrecy until the patents are issued,
because patent applications in the U.S. and many foreign jurisdictions are typically not published until eighteen months after filing
and because publications in the scientific literature often lag behind actual discoveries, Conduit cannot be certain that others have
not filed patent applications for technology covered by Conduit&#8217;s own and in-licensed issued patents or Conduit&#8217;s pending
applications. Conduit&#8217;s competitors may have filed, and may in the future file, patent applications covering Conduit&#8217;s clinical
assets or technology similar to Conduit&#8217;s. Any such patent application may have priority over Conduit&#8217;s own and in-licensed
patent applications or patents, which could further require Conduit to obtain rights to issued patents covering such technologies. If
another party has filed a U.S. patent application on inventions similar to those owned or in-licensed to Conduit, Conduit or, in the
case of in-licensed technology, the licensor may have to participate, in the U.S., in an interference proceeding to determine priority
of invention.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
may be exposed to, or threatened with, future litigation by third parties having patent or other intellectual property rights alleging
that Conduit&#8217;s clinical assets or proprietary technologies infringe such third parties&#8217; intellectual property rights, including
litigation. These lawsuits could claim that there are existing patent rights for such drug and this type of litigation can be costly
and could adversely affect Conduit&#8217;s operating results and divert the attention of managerial and technical personnel, even if
Conduit does not infringe such patents or the patents asserted against Conduit are ultimately established as invalid. There is a risk
that a court would decide that Conduit is infringing the third party&#8217;s patents and would order Conduit to stop the activities covered
by the patents. In addition, there is a risk that a court will order Conduit to pay the other party damages for having violated the other
party&#8217;s patents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of patent infringement claims, or to avoid potential claims, Conduit may choose or be required to seek licenses from third parties.
These licenses may not be available on commercially acceptable terms, or at all. Even if Conduit is able to obtain a license, the license
would likely obligate Conduit to pay license fees or royalties or both, and the rights granted to Conduit might be nonexclusive, which
could result in Conduit&#8217;s competitors gaining access to the same intellectual property, or such rights might be restrictive and
limit Conduit&#8217;s present and future activities. Ultimately, Conduit or a licensee could be prevented from commercializing a product
or be forced to cease some aspect of Conduit&#8217;s business operations, if, as a result of actual or threatened patent infringement
claims, Conduit is unable to enter into licenses on acceptable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to possible infringement claims against Conduit, Conduit may become a party to other patent litigation and other proceedings,
including interference, derivation, re-examination or other post-grant proceedings declared or granted by the USPTO, and similar proceedings
in foreign countries, regarding intellectual property rights with respect to Conduit&#8217;s current or future products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a substantial amount of litigation involving patent and other intellectual property rights in the biotechnology and pharmaceutical
industries generally. To date, no litigation asserting infringement claims has ever been brought against Conduit. If a third-party claims
that Conduit infringes its intellectual property rights, Conduit may face a number of issues, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">infringement
  and other intellectual property claims which, regardless of merit, may be expensive and time-consuming to litigate and may divert Conduit&#8217;s
  management&#8217;s attention from Conduit&#8217;s core business;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
  damages for infringement, which Conduit may have to pay if a court decides that the product or technology at issue infringes or violates
  the third party&#8217;s rights, and if the court finds that the infringement was willful, Conduit could be ordered to pay treble damages
  and the patent owner&#8217;s attorneys&#8217; fees;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
  court prohibiting Conduit from selling or licensing the product or using the technology unless the third party licenses its intellectual
  property rights to Conduit, which it is not required to do;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
  a license is available from a third party, Conduit may have to pay substantial royalties or upfront fees or grant cross-licenses to
  intellectual property rights for Conduit&#8217;s products or technologies; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">redesigning
  Conduit&#8217;s products or processes so they do not infringe, which may not be possible or may require substantial monetary expenditures
  and time.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of Conduit&#8217;s competitors may be able to sustain the costs of complex patent litigation more effectively than Conduit can because
they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation
could harm Conduit&#8217;s ability to raise additional funds or otherwise adversely affect Conduit&#8217;s business, financial condition,
operating results and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
Conduit relies on certain third-party licensors and partners, and will continue to do so in the future, if one of Conduit&#8217;s licensors
or partners is sued for infringing a third party&#8217;s intellectual property rights, Conduit&#8217;s business, financial condition,
operating results and prospects could suffer in the same manner as if Conduit were sued directly. In addition to facing litigation risks,
Conduit has agreed to indemnify certain third-party licensors and partners against claims of infringement caused by Conduit&#8217;s proprietary
technologies, and Conduit has entered or may enter into cost-sharing agreements with some its licensors and partners that could require
Conduit to pay some of the costs of patent litigation brought against those third parties whether or not the alleged infringement is
caused by Conduit&#8217;s proprietary technologies. In certain instances, these cost-sharing agreements could also require Conduit to
assume greater responsibility for infringement damages than would be assumed just on the basis of Conduit&#8217;s technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
occurrence of any of the foregoing could adversely affect Conduit&#8217;s business, financial condition or operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
may become involved in lawsuits to protect or enforce its patents or other intellectual property or the patents of its licensors, which
could be expensive and time-consuming.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
may infringe Conduit&#8217;s intellectual property, including Conduit&#8217;s patents or the patents of its licensors. As a result, Conduit
may be required to file infringement claims to stop third-party infringement or unauthorized use. This can be expensive and time-consuming,
particularly for a company of Conduit&#8217;s size. In addition, in an infringement proceeding, a court may decide that a patent of Conduit
is not valid or is unenforceable or may refuse to stop the other party from using the technology at issue on the grounds that Conduit&#8217;s
patent claims do not cover its technology or that the factors necessary to grant an injunction against an infringer are not satisfied.
An adverse determination of any litigation or other proceedings could put one or more of Conduit&#8217;s patents at risk of being invalidated,
interpreted narrowly or amended such that they do not cover Conduit&#8217;s clinical assets. Moreover, such adverse determinations could
put Conduit&#8217;s patent applications at risk of not issuing or issuing with limited and potentially inadequate scope to cover Conduit&#8217;s
clinical assets or to prevent others from marketing similar products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interference,
derivation or other proceedings brought at the USPTO may be necessary to determine the priority or patentability of inventions with respect
to Conduit&#8217;s patent applications or those of Conduit&#8217;s licensors or potential partners. Litigation or USPTO proceedings brought
by Conduit may fail or may be invoked against Conduit by third parties. Even if Conduit is successful, domestic or foreign litigation
or USPTO or foreign patent office proceedings may result in substantial costs and distraction to Conduit&#8217;s management. Conduit
may not be able, alone or with its licensors or potential partners, to prevent misappropriation of its proprietary rights, particularly
in countries where the laws may not protect such rights as fully as in the U.S.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation or other proceedings, there
is a risk that some of Conduit&#8217;s confidential information could be compromised by disclosure during this type of litigation or
other proceedings. In addition, during the course of this kind of litigation or proceedings, there could be public announcements of the
results of hearings, motions or other interim proceedings or developments or public access to related documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
reliance on third parties requires Conduit to share its trade secrets, which increases the possibility that its trade secrets will be
misappropriated or disclosed, and confidentiality agreements with employees and third parties may not adequately prevent disclosure of
trade secrets and protect other proprietary information.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
considers proprietary trade secrets or confidential know-how and unpatented know-how to be important to its business. Conduit may rely
on trade secrets or confidential know-how to protect Conduit&#8217;s technology, especially where patent protection is believed by Conduit
to be of limited value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
protect this type of information against disclosure or appropriation by competitors, Conduit&#8217;s policy is to require its employees,
consultants, collaborators, contractors and advisors to enter into confidentiality agreements and, if applicable, material transfer agreements,
consulting agreements or other similar agreements with Conduit prior to beginning research or disclosing proprietary information. These
agreements typically limit the rights of the third parties to use or disclose Conduit&#8217;s confidential information, including its
trade secrets. However, current or former employees, consultants, collaborators, contractors and advisors may unintentionally or willfully
disclose Conduit&#8217;s confidential information to competitors, and confidentiality agreements may not provide an adequate remedy in
the event of unauthorized disclosure of confidential information. The need to share trade secrets and other confidential information
increases the risk that such trade secrets become known by Conduit&#8217;s competitors, are inadvertently incorporated into the technology
of others, or are disclosed or used in violation of these agreements. Given that Conduit&#8217;s proprietary position is based, in part,
on Conduit&#8217;s know-how and trade secrets, a competitor&#8217;s discovery of Conduit&#8217;s trade secrets or other unauthorized
use or disclosure would impair Conduit&#8217;s competitive position and may have an adverse effect on Conduit&#8217;s business and results
of operations. Enforcing a claim that a third party obtained illegally and is using trade secrets or confidential know-how is expensive,
time consuming and unpredictable. The enforceability of confidentiality agreements may vary from jurisdiction to jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, these agreements typically restrict the ability of Conduit&#8217;s employees, consultants, collaborators, contractors and advisors
to publish data potentially relating to Conduit&#8217;s trade secrets, although Conduit&#8217;s agreements may contain certain limited
publication rights. Despite Conduit&#8217;s efforts to protect its trade secrets, Conduit&#8217;s competitors may discover Conduit&#8217;s
trade secrets, either through breach of our agreements with third parties, independent development or publication of information by any
of Conduit&#8217;s third-party collaborators. A competitor&#8217;s discovery of Conduit&#8217;s trade secrets would impair Conduit&#8217;s
competitive position and have an adverse impact on Conduit&#8217;s business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
may be subject to claims that its employees, consultants or independent contractors have wrongfully used or disclosed to Conduit alleged
trade secrets of their former employers or their former or current customers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
is common in the biotechnology and pharmaceutical industries, certain of Conduit&#8217;s employees were formerly employed by other biotechnology
or pharmaceutical companies, including Conduit&#8217;s competitors or potential competitors. Moreover, Conduit engages the services of
consultants to assist it in the development of its products and clinical assets, many of whom were previously employed at or may have
previously been or are currently providing consulting services to, other biotechnology or pharmaceutical companies, including Conduit&#8217;s
competitors or potential competitors. Conduit may be subject to claims that these employees and consultants or Conduit has inadvertently
or otherwise used or disclosed trade secrets or other proprietary information of their former employers or their former or current customers.
Although Conduit has no knowledge of any such claims being alleged to date, if such claims were to arise, litigation may be necessary
to defend against any such claims. Even if Conduit is successful in defending against any such claims, any such litigation could be protracted,
expensive, a distraction to Conduit&#8217;s management team, not viewed favorably by investors and other third parties and may potentially
result in an unfavorable outcome.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
Conduit&#8217;s trademarks and trade names are not adequately protected, then Conduit may not be able to build name recognition in its
markets of interest and its business may be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing
on other marks. Conduit may not be able to protect its rights to these trademarks and trade names, which Conduit needs to build name
recognition among potential collaborators or customers in Conduit&#8217;s markets of interest. At times, competitors may adopt trade
names or trademarks similar to those of Conduit, thereby impeding Conduit&#8217;s ability to build brand identity and possibly leading
to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered
trademarks or trademarks that incorporate variations of Conduit&#8217;s unregistered trademarks or trade names. Over the long term, if
Conduit is unable to successfully register its trademarks and trade names and establish name recognition based on its trademarks and
trade names, then Conduit may not be able to compete effectively, and its business may be adversely affected. Conduit&#8217;s efforts
to enforce or protect its proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property
may be ineffective and could result in substantial costs and diversion of resources and could adversely impact Conduit&#8217;s financial
condition or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
proprietary information may be lost, or Conduit may suffer security breaches.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of our business, Conduit collects and store sensitive data, including intellectual property, clinical trial data,
proprietary business information, personal data and personally identifiable information of Conduit&#8217;s clinical trial subjects and
employees, in Conduit&#8217;s data centers and on its networks. The secure processing, maintenance and transmission of this information
is critical to Conduit&#8217;s operations. Despite Conduit&#8217;s security measures, Conduit&#8217;s information technology and infrastructure
may be vulnerable to attacks by hackers or breached due to employee error, malfeasance or other disruptions. Although, to Conduit&#8217;s
knowledge, Conduit has not experienced any such material security breach to date, any such breach could compromise Conduit&#8217;s networks
and the information stored there could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of
information could result in legal claims or proceedings, liability under laws that protect the privacy of personal information, significant
regulatory penalties, disrupt Conduit&#8217;s operations, damage Conduit&#8217;s reputation and cause a loss of confidence in Conduit
and its ability to conduct clinical trials, which could adversely affect Conduit&#8217;s reputation and delay its clinical development
of its clinical assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
does not currently maintain insurance and will need to obtain insurance to cover its business and operations, including directors and
officers&#8217; insurance, property and casualty insurance, general liability, product liability insurance, and health and welfare insurance.
</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our formation, we have been operating as a virtual company and we do not currently maintain insurance coverage for our business. Prior
to the closing of the Business Combination, we will have to obtain and bind suitable insurance coverage at reasonable rates on a timely
basis or at all. If we are not able to bind insurance at reasonable rates or on a timely basis, it could harm our business. In addition,
we will need to continue to evaluate and potentially adjust our insurance coverages as we expand our business and operations and, as
a result, our costs of obtaining insurance coverage may increase over time. Any increase in the costs of our insurance coverage could
negatively impact our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to the Business Combination and New Conduit Common Stock Following the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>The process of taking a company public by means
of a business combination with a special purpose acquisition company (a &#8220;SPAC&#8221;) is different from taking a company public
through an underwritten public offering and may create material risks for unaffiliated investors.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">An underwritten
offering involves a company engaging underwriters to purchase its shares and resell them to the public. An underwritten offering imposes
statutory liability on the underwriters for material misstatements or omissions contained in the registration statement unless they are
able to sustain the burden of providing that they did not know and could not reasonably have discovered such material misstatements or
omissions. This is referred to as a &#8220;due diligence&#8221; defense and results in the underwriters undertaking a detailed review
of the company&#8217;s business, financial condition and results of operations. Going public via a business combination with a SPAC does
not involve any underwriters and, therefore, there is an absence of due diligence conducted by an underwriter that would be subject to
liability for any material misstatements or omissions in a registration statement, and so does not generally necessitate the level of
review required to establish a &#8220;due diligence&#8221; defense as would be customary in an underwritten offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">In
addition, going public via a business combination with a SPAC does not involve a book-building process as is the case in an underwritten
public offering. In any underwritten public offering, the initial value of a company is set by investors who indicate the price at which
they are prepared to purchase shares from the underwriters. In the case of a SPAC transaction, the value of the company is established
by means of negotiations between the target company, the SPAC and, in some cases, other investors who agree to purchase shares at the
time of the business combination. The process of establishing the value of a company in a SPAC business combination may be less effective
than the book-building process in an underwritten public offering and also does not reflect events that may have occurred between the
date of the business combination agreement and the closing of the transaction. In addition, underwritten public offerings are frequently
oversubscribed resulting in additional potential demand for shares in the aftermarket following the underwritten public offering. There
is no such book of demand built up in connection with a SPAC transaction and no underwriters with the responsibility of stabilizing the
share price which may result in the share price being harder to sustain after the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>The Sponsor, certain members of our board of
directors and our officers have interests in the Business Combination that may conflict with those of other stockholders in recommending
that stockholders vote in favor of approval of the Business Combination and the other proposals described in this proxy statement/prospectus.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">When
considering our board of directors&#8217; recommendation that our stockholders vote in favor of the approval of the Business Combination,
our stockholders should be aware that our Sponsor and certain of our directors and officers have interests in the Business Combination
that may conflict with the interests of other stockholders generally. Accordingly, our Sponsor may be incentivized to complete the Business
Combination, or an alternative initial business combination with a less favorable company or on terms less favorable to stockholders,
rather than to liquidate, in which case our Sponsor would lose its entire investment. As a result, our Sponsor may have a conflict of
interest in determining whether Conduit is an appropriate business with which to effectuate a business combination and/or in evaluating
the terms of the Business Combination. Our directors were aware of and considered these interests, among other matters, in evaluating
the Business Combination, and in recommending to stockholders that they approve the Business Combination. MURF&#8221;s Public Stockholders
should take these interests into account in deciding whether to approve the Business Combination. For a description of these interests,
see &#8220;<i>The Business Combination Proposal &#8212; Interests of MURF&#8217;s Directors and Officers in the Business Combination</i>&#8221;.</span><span style="font-size: 8pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Following
the consummation of the Business Combination, our only significant asset will be ownership of 100% of Conduit&#8217;s capital shares,
and we do not currently intend to pay dividends on New Conduit common stock and, consequently, your ability to achieve a return on your
investment will depend on appreciation in the price of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination, New Conduit will have no direct operations and no significant assets other than the ownership
of 100% of Conduit&#8217;s capital stock. We will depend on Conduit for distributions, loans and other payments to generate the funds
necessary to meet our financial obligations, including our expenses as a publicly traded company, and to pay any dividends with respect
to New Conduit common stock. Applicable state law and contractual restrictions, including in agreements governing the current or future
indebtedness of Conduit, as well as the financial condition and operating requirements of Conduit, may limit our ability to obtain cash
from Conduit. Thus, we do not expect to pay cash dividends on New Conduit common stock. Any future dividend payments are within the absolute
discretion of our board of directors and will depend on, among other things, our results of operations, working capital requirements,
capital expenditure requirements, financial condition, level of indebtedness, contractual restrictions with respect to payment of dividends,
business opportunities, anticipated cash needs, provisions of applicable law and other factors that our board of directors may deem relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nasdaq
may delist MURF&#8217;s securities from trading on its exchange prior to consummation of the Business Combination. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
Class A common stock was listed on the Nasdaq Global Market upon consummation of its initial public offering. Although MURF met the minimum
initial listing standards of Nasdaq, which generally only requires that it meet certain requirements relating to shareholders&#8217;
equity, market capitalization, aggregate market value of publicly held shares and distribution requirements, MURF cannot assure you that
its securities will continue to be listed on Nasdaq in the future prior to an initial business combination. The Nasdaq Global Market&#8217;s
requirements for continued listing include a public float of 1,100,000, a market value of public float of $15,000,000, a market value
of listed securities of $50,000,000, and 400 shareholders. The inability to comply with Nasdaq&#8217;s continued requirements or standards
could result in the delisting of MURF&#8217;s Class A common stock, which could have a material adverse effect on MURF&#8217;s financial
condition and could cause the value of its Class A common stock to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 10, 2023, MURF received written notice (the &#8220;Notice&#8221;) from Nasdaq indicating that MURF was no longer in compliance
with the minimum Market Value of Listed Securities (&#8220;MVLS&#8221;) of $50,000,000 required for continued listing on the Nasdaq Global
Market (the &#8220;MVLS Requirement&#8221;). In accordance with Nasdaq rules, MURF has 180 calendar days, or until October 9, 2023 (the
&#8220;Compliance Date&#8221;), to regain compliance with the MVLS Requirement. If, at any time before the Compliance Date, the market
value of MURF&#8217;s listed securities closes at $50,000,000 or more for a minimum of 10 consecutive business days, Nasdaq will provide
written notification to MURF that it has regained compliance with the MVLS Requirement. If MURF does not regain compliance with the MVLS
Requirement by the Compliance Date, MURF will receive written notification that its securities are subject to delisting. At that time,
MURF may appeal the delisting determination to a Nasdaq Listing Qualifications Panel. There can be no assurance that such appeal would
be successful and Nasdaq would grant MURF&#8217;s request for continued listing. If MURF does not regain compliance with the MVLS Requirement
by the Compliance Date, MURF may also be able to transfer the listing of its Class A common stock to the Nasdaq Capital Market, provided
that MURF then meets the applicable requirements for continued listing on the Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
MURF&#8217;s Class A common stock is delisted from Nasdaq, the New Conduit common stock will not be approved for listing on Nasdaq and
Conduit may choose not to consummate the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
can be no assurance that New Conduit common stock will be approved for listing on Nasdaq or that New Conduit will be able to comply with
the continued listing standards of Nasdaq. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination, we intend to list the common stock of New Conduit on Nasdaq under the symbol
&#8220;CDT.&#8221; If, after the Business Combination, Nasdaq delists New Conduit&#8217;s shares from trading on its exchange for failure
to meet the applicable listing standards, we and our stockholders could face significant material adverse consequences including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
  limited availability of market quotations for our securities;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
  liquidity for our securities;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
  determination that New Conduit common stock is a &#8220;penny stock&#8221; which will require brokers trading in New Conduit common
  stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market
  for shares of New Conduit common stock;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
  limited amount of news and analyst coverage; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
  decreased ability to issue additional securities or obtain additional financing in the future.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subsequent
to the consummation of the Business Combination, New Conduit may be required to take write-downs or write-offs, or New Conduit may be
subject to restructuring, impairment or other charges that could have a significant negative effect on New Conduit&#8217;s business,
prospects, financial condition, results of operations and the trading price of New Conduit&#8217;s securities, which could cause you
to lose some or all of your investment. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
MURF has conducted due diligence on Conduit, this diligence may not surface all material issues that may be present with Conduit&#8217;s
business. Factors outside of Conduit&#8217;s and MURF&#8217;s control may arise at any time. As a result of these factors, New Conduit
may be forced to later write-down or write-off assets, restructure its operations, or incur impairment or other charges that could result
in New Conduit reporting losses. Even if MURF&#8217;s due diligence successfully identified certain risks, unexpected risks may arise,
and previously known risks may materialize in a manner not consistent with MURF&#8217;s preliminary risk analysis. Even though these
charges may be non-cash items and therefore not have an immediate impact on New Conduit&#8217;s liquidity, the fact that New Conduit
reports charges of this nature could contribute to negative market perceptions about New Conduit or its securities. In addition, charges
of this nature may cause New Conduit to be unable to obtain future financing on favorable terms, including the interest rates and fees
associated with any such financing, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the Business Combination&#8217;s benefits do not meet the expectations of investors or securities analysts, the market price of New Conduit&#8217;s
securities may decline. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the perceived benefits of the Business Combination do not meet the expectations of investors or securities analysts, the market price
of MURF&#8217;s securities prior to the completion of the Business Combination may decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, following the Business Combination, fluctuations in the trading
price of New Conduit&#8217;s securities could contribute to the loss of all or part of your investment. Prior to the Business Combination,
there has not been a public market for Conduit shares. Accordingly, the valuation ascribed to Conduit may not be indicative of the price
that will prevail in the trading market following the Business Combination. If an active market for New Conduit&#8217;s securities develops
and continues, the trading price of New Conduit&#8217;s securities following the Business Combination could be volatile and subject to
wide fluctuations in response to various factors, some of which are beyond New Conduit&#8217;s control. While we are not currently aware
of any litigation relating to Merger Agreement or the Business Combination, any threatened or actual litigation relating could have a
material adverse effect on New Conduit&#8217;s securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of the factors listed below could have a material adverse effect on your investment in New Conduit&#8217;s securities, and New Conduit&#8217;s
securities may trade at prices significantly below the price paid by you. In such circumstances, the trading price of New Conduit&#8217;s
securities may not recover and may experience a further decline. Factors affecting the trading price of New Conduit&#8217;s securities
may include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
  or anticipated fluctuations in New Conduit&#8217;s financial results or the financial results of companies perceived to be similar
  to it;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
  in the market&#8217;s expectations about New Conduit&#8217;s operating results;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">success
  of competitors;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
  Conduit&#8217;s operating results failing to meet the expectation of securities analysts or investors in a particular period;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
  Conduit&#8217;s ability to attract and retain senior management or key operating personnel, and the addition or departure of key personnel;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
  in financial estimates and recommendations by securities analysts concerning New Conduit or the transportation industry in general;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
  and share price performance of other companies that investors deem comparable to New Conduit;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
  in laws and regulations affecting New Conduit&#8217;s business;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencement
  of, or involvement in, threatened or actual litigation and government investigations;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
  in New Conduit&#8217;s capital structure, such as future issuances of securities or the incurrence of additional debt;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  volume of New Conduit common stock available for public sale;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
  change in New Conduit&#8217;s board of directors or management;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
  taken by New Conduit&#8217;s directors, executive officers or significant stockholders such as sales of New Conduit common stock, or
  the perception that such actions could occur; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
  economic and political conditions such as recessions, inflation, interest rates, fuel prices, international currency fluctuations and
  acts of war or terrorism.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broad
market and industry factors may materially harm the market price of New Conduit&#8217;s securities irrespective of New Conduit&#8217;s
operating performance. The stock markets in general have experienced price and volume fluctuations that have often been unrelated or
disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks,
and of New Conduit&#8217;s securities, may not be predictable. A loss of investor confidence in the market for pharmaceutical stocks
or the stocks of other companies which investors perceive to be similar to New Conduit could depress the share price of New Conduit common
stock regardless of New Conduit&#8217;s business, prospects, financial conditions or results of operations. A decline in the market price
of New Conduit&#8217;s securities also could adversely affect New Conduit&#8217;s ability to issue additional securities and New Conduit&#8217;s
ability to obtain additional financing in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fluctuations
in foreign currency could have an effect on Conduit&#8217;s and New Conduit&#8217;s reported results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
exposure to fluctuations in foreign currency rates results primarily from the translation exposure associated with the preparation of
its consolidated financial statements, as well as from transaction exposure associated with transactions in currencies other than Conduit&#8217;s
functional currency. While the financial statements are reported in U.S. dollars, the financial statements of Conduit are prepared using
the British pound sterling as the functional currency and translated into U.S. dollars. Conduit plans to continue using the British pound
sterling as its functional currency following the Business Combination. Conduit cannot accurately predict the nature or extent of future
exchange rate variability of the British pound sterling or the exchange rate relative to the U.S. dollar. Foreign exchange rates are
sensitive to factors beyond the Company&#8217;s control. In addition, Brexit has caused, and may continue to cause, significant volatility
in currency exchange rates, especially between the U.S. dollar and the British pound sterling. These fluctuations in foreign currency
exchange rates could negatively affect Conduit&#8217;s and New Conduit&#8217;s results of operations and impact reported financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the Business Combination does not qualify as a tax-free reorganization under Section 368(a) of the Code, U.S. Holders of Conduit shares
will be required to recognize gain or loss for U.S. federal income tax purposes upon the exchange of their Conduit shares for the New
Conduit common stock in the Business Combination which could result in such U.S. holder incurring substantially greater U.S. federal
income tax liability as a result of the Business Combination.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of Thompson Hine LLP, the Business Combination should qualify as a &#8220;reorganization&#8221; within the meaning of Section
368(a) of the Code. This opinion is based on the facts and representations contained in representation letters provided to Thompson Hine
LLP by MURF, Merger Sub and Conduit and certain assumptions, including that the Business Combination will be completed in the manner
set forth in the Merger Agreement and the Registration Statement on Form S-4 of which this proxy statement/prospectus forms a part. If
any assumption or representation is or becomes inaccurate, the U.S. federal income tax consequences of the Business Combination could
be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination qualifies for such tax-free treatment, U.S. Holders of Conduit shares should not recognize gain or loss upon
their exchange of Conduit shares for New Conduit common stock. Neither Conduit nor MURF has requested, or intends to request, a ruling
from the U.S. Internal Revenue Service (&#8220;IRS&#8221;) with respect to the U.S. federal income tax consequences of the Business Combination.
A tax opinion represents the legal judgment of counsel rendering the opinion and is not binding on the IRS. Consequently, no assurance
can be given that the IRS will not assert, or that a court would not sustain a position to the contrary. Accordingly, if the IRS or a
court determines that the Business Combination does not qualify for such treatment and Is therefore a fully taxable transaction
for U.S. federal income tax purposes, a U.S. Holder of Conduit shares would recognize gain or loss for U.S. federal income tax purposes
on each share of Conduit common stock surrendered in exchange for New Conduit common stock which could result in such U.S. holder incurring
substantially greater U.S. federal income tax liability as a result of the Business Combination. For a more complete discussion of the
material U.S. federal income tax consequences of the Business Combination, please carefully review the information set forth in the section
entitled &#8220;<i>Material U.S. Federal Income Tax Considerations&#8212;Material Tax Considerations of the Business Combination to Holders
of Conduit Capital Stock</i>.&#8221;&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Most
or all of Conduit&#8217;s earnings following the merger will be taxed by the United States.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Business Combination, Conduit will be classified as a controlled foreign corporation (&#8220;CFC&#8221;) for U.S. federal
income tax purposes within the meaning of Section 957(a) of the Code. Under the applicable CFC tax rules, most or all of Conduit&#8217;s
income following the Business Combination will be included as taxable income by New Conduit and therefore subject to U.S. taxation, even
if the CFC has made no distributions to its shareholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a result of the Business Combination, New Conduit&#8217;s tax obligations and related filings may become significantly more complex and
subject to greater risk of audit or examination by taxing authorities, and outcomes resulting from such audits or examinations could
adversely impact our business, prospects, financial condition and results of operations, including our after-tax profitability and financial
results. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Business Combination, New Conduit&#8217;s operations may be subject to significant income, withholding and other tax obligations
in the United States and may become subject to taxes in numerous additional state, local and non-U.S. jurisdictions with respect to our
income, operations and subsidiaries related to those jurisdictions. In addition, New Conduit will have international supplier and customer
relationships and may expand operations to multiple jurisdictions, including jurisdictions in which the tax laws, their interpretation
or their administration may not be favorable. Additionally, future changes in tax law or regulations in any jurisdiction in which New
Conduit will operate could result in changes to the taxation of New Conduit&#8217;s income and operations, which could cause our after-tax
profitability to be lower than anticipated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s after-tax profitability could be subject to volatility or affected by numerous factors, including (a) the availability
of tax deductions, credits, exemptions, refunds (including refunds of value added taxes) and other benefits to reduce New Conduit&#8217;s
tax liabilities, (b) changes in the valuation of New Conduit&#8217;s deferred tax assets and liabilities, (c) expected timing and amount
of the release of any tax valuation allowances, (d) tax treatment of stock-based compensation, (e) changes in the relative amount of
our earnings subject to tax in the various jurisdictions in which New Conduit operates or has subsidiaries, (f) the potential expansion
of New Conduit&#8217;s business into or otherwise becoming subject to tax in additional jurisdictions, (g) changes to New Conduit&#8217;s
existing intercompany structure (and any costs related thereto) and business operations, (h) the extent of New Conduit&#8217;s intercompany
transactions and the extent to which taxing authorities in the relevant jurisdictions respect those intercompany transactions and (i)
New Conduit&#8217;s ability to structure its operations in an efficient and competitive manner. Due to the complexity of multinational
tax obligations and filings, New Conduit may have a heightened risk related to audits or examinations by U.S. federal, state, local and
non-U.S. taxing authorities. Outcomes from these audits or examinations could have an adverse effect on our business, prospects, financial
condition and results of operations, including our after-tax profitability and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s after-tax profitability may also be adversely impacted by changes in the relevant tax laws and tax rates, treaties, regulations,
administrative practices and principles, judicial decisions and interpretations thereof, in each case, possibly with retroactive effect.
Additionally, the Multilateral Convention to Implement Tax Treaty Related Measures to Prevent BEPS recently entered into force among
the jurisdictions that have ratified it, although the United States has not yet entered into this convention. These recent changes could
negatively impact New Conduit&#8217;s taxation, especially if New Conduit expands its relationships and operations internationally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Conduit&#8217;s failure to timely and effectively implement controls and procedures required by Section 404(a) of the Sarbanes-Oxley
Act that will be applicable to it after the Business Combination is consummated could have a material adverse effect on its business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
is currently not subject to Section 404 of the Sarbanes-Oxley Act. However, following the consummation of the Business Combination, New
Conduit will be required to provide management&#8217;s attestation on internal controls commencing with New Conduit&#8217;s annual report
for the year ending December 31, 2022, in accordance with applicable SEC guidance. The standards required for a public company under
Section 404(a) of the Sarbanes-Oxley Act are significantly more stringent than those required of Conduit as a privately-held company.
Management may not be able to effectively and timely implement controls and procedures that adequately respond to the increased regulatory
compliance and reporting requirements that will be applicable after the Business Combination. If New Conduit is not able to implement
the additional requirements of Section 404(a) in a timely manner or with adequate compliance, it may not be able to assess whether its
internal controls over financial reporting are effective, which may subject it to adverse regulatory consequences and could harm investor
confidence and the market price of its securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Conduit will qualify as an &#8220;emerging growth company&#8221; within the meaning of the Securities Act as of the closing of the Business
Combination, and if it takes advantage of certain exemptions from disclosure requirements available to emerging growth companies, it
could make New Conduit&#8217;s securities less attractive to investors and may make it more difficult to compare New Conduit&#8217;s
performance to the performance of other public companies.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit will qualify as an &#8220;emerging growth company&#8221; as defined in Section 2(a)(19) of the Securities Act, as modified by
the JOBS Act, as of the closing of the Business Combination. As such, New Conduit will be eligible for and intends to take advantage
of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies
for as long as it continues to be an emerging growth company, including, but not limited to, (a) not being required to comply with the
auditor attestation requirements of Section 404 of the Sarbanes- Oxley Act, (b) reduced disclosure obligations regarding executive compensation
in New Conduit&#8217;s periodic reports and proxy statements and (c) exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, New Conduit&#8217;s
stockholders may not have access to certain information they may deem important. New Conduit will remain an emerging growth company until
the earliest of (i) the last day of the fiscal year in which the market value of New Conduit common stock held by non-affiliates exceeds
$700 million as of June 30 of that fiscal year, (ii) the last day of the fiscal year in which it has total annual gross revenue of $1.07
billion or more during such fiscal year (as indexed for inflation), (iii) the date on which it has issued more than $1 billion in non-convertible
debt in the prior three-year period or (iv) the last day of the fiscal year following the fifth anniversary of the date of the first
sale of MURF common stock in the IPO<b><i>.</i></b> We cannot predict whether investors will find New Conduit&#8217;s securities less
attractive because it will rely on these exemptions. If some investors find New Conduit&#8217;s securities less attractive as a result
of its reliance on these exemptions, the trading prices of New Conduit&#8217;s securities may be lower than they otherwise would be,
there may be a less active trading market for New Conduit&#8217;s securities and the trading prices of New Conduit&#8217;s securities
may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non- emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of New Conduit&#8217;s financial statements with another public company which is neither
an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible
because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
unaudited pro forma condensed financial information included herein may not be indicative of what New Conduit&#8217;s actual financial
position or results of operations would have been.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed financial information included herein is presented for illustrative purposes only and is not necessarily
indicative of what New Conduit&#8217;s actual financial position or results of operations would have been had the Business Combination
been completed on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Following
the consummation of the Business Combination, New Conduit will incur significant increased expenses and administrative burdens as a public
company, which could have an adverse effect on its business, financial condition and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination, New Conduit will face increased legal, accounting, administrative and other costs and expenses
as a public company that Conduit does not incur as a private company. The Sarbanes-Oxley Act of 2002 or the Sarbanes-Oxley Act, including
the requirements of Section 404, to the extent applicable to New Conduit, as well as rules and regulations subsequently implemented by
the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated
thereunder, the PCAOB and the securities exchanges, impose additional reporting and other obligations on public companies. Compliance
with public company requirements will increase costs and make certain activities more time-consuming. A number of those requirements
will require that we carry out activities Conduit has not done previously. For example, New Conduit will create new board committees
and adopt new internal controls and disclosure controls and procedures. In addition, expenses associated with SEC reporting requirements
will be incurred. Furthermore, if any issues in complying with those requirements are identified (for example, if New Conduit identifies
a material weakness or significant deficiency in the internal control over financial reporting), we could incur additional costs rectifying
those issues, and the existence of those issues could adversely affect our reputation or investor perceptions of it. It may also be more
expensive to obtain director and officer liability insurance. Risks associated with our status as a public company may make it more difficult
to attract and retain qualified persons to serve on our board of directors or as executive officers. The additional reporting and other
obligations imposed by these rules and regulations will increase legal and financial compliance costs and the costs of related legal,
accounting and administrative activities. These increased costs will require us to divert a significant amount of money that could otherwise
be used to expand the business and achieve strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional
changes in governance and reporting requirements, which could further increase costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Conduit may issue additional shares of common stock or preferred shares under an employee incentive plan upon or after consummation of
the Business Combination, which would dilute the interest of our stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit may issue a substantial number of additional shares of common or preferred stock under an employee incentive plan after consummation
of the Business Combination (although our current amended and restated certificate of incorporation provides that we may not issue securities
that can vote with common stockholders on matters related to our pre-initial business combination activity). The issuance of additional
shares of common or preferred stock:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
  significantly dilute the equity interest of investors;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
  subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">could
  cause a change of control if a substantial number of shares of our common stock are issued, which may affect, among other things, our
  ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers
  and directors; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
  adversely affect prevailing market prices for New Conduit common stock.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
certificate of incorporation provides, subject to limited exceptions, that the Court of Chancery of the State of Delaware will be the
sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders&#8217; ability to obtain a chosen
judicial forum for disputes with us or our directors, officers, employees or stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our certificate of incorporation requires to the fullest extent permitted
by law, that derivative actions brought in our name, actions against directors, officers and employees for breach of fiduciary duty and
other similar actions may be brought in the Court of Chancery in the State of Delaware or, if that court lacks subject matter jurisdiction,
another federal or state court situated in the State of Delaware. Any person or entity purchasing or otherwise acquiring any interest
in shares of our capital stock shall be deemed to have notice of and consented to the forum provisions in our certificate of incorporation.
In addition, our certificate of incorporation and Bylaws provide that the federal district courts of the United States shall be the exclusive
forum for the resolution of any complaint asserting a cause of action under the Securities Act and the Exchange Act. Neither the exclusive
forum provisions nor the federal securities laws (and the rules and regulations thereunder) may be waived by a stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the Delaware Supreme Court issued a decision in <i>Salzburg et al. v. Sciabacucchi</i>, which found that an exclusive forum
provision providing for claims under the Securities Act to be brought in federal court is facially valid under Delaware law. It is unclear
whether this decision will be appealed, or what the final outcome of this case will be. We intend to enforce this provision, but we do
not know whether courts in other jurisdictions will agree with this decision or enforce it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">This choice of forum provision may limit a stockholder&#8217;s ability
to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, other employees or stockholders,
which may discourage lawsuits with respect to such claims and, if a stockholder were to bring such a claim, the choice of forum provision
may result in the stockholder incurring increased costs in connection with bring such a claim as such stockholder will be required to
bring the claim in the state or federal courts located in the State of Delaware. Alternatively, if a court were to find the choice of
forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional
costs associated with resolving such action in other jurisdictions, which could harm its business, operating results and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Charter
documents and Delaware law could prevent a takeover that stockholders consider favorable and could also reduce the market price of New
Conduit common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation and Bylaws contain provisions that could delay or prevent a change in control of New Conduit. These provisions
could also make it more difficult for stockholders to elect directors and take other corporate actions. These provisions include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorizing
  our board of directors to issue preferred stock with voting or other rights or preferences that could discourage a takeover attempt
  or delay changes in control;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prohibiting
  cumulative voting in the election of directors;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
  that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prohibiting
  stockholder action by written consent;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
  the persons who may call special meetings of stockholders; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify">&#160;</td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
  advance notification of stockholder nominations and proposals.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult
for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. These
and other provisions in our certificate of incorporation and Bylaws and under Delaware law could discourage potential takeover attempts,
reduce the price investors might be willing to pay in the future for shares of common stock and result in the market price of common
stock being lower than it would be without these provisions. For more information, see the section of this registration statement captioned
&#8220;<i>Description of New Conduit Securities &#8212; Certain Anti-Takeover Provisions of Delaware Law and MURF&#8217;s Proposed Second
Amended and Restated Certificate of Incorporation</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Claims
for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us
and may reduce the amount of money available to us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation and Bylaws provides that we will indemnify our directors and officers, in each case to the fullest extent
permitted by Delaware law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as permitted by Section 145 of the DGCL, our Bylaws and our indemnification agreements that we entered into with our directors
and officers provide that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
  will indemnify our directors and officers for serving New Conduit in those capacities or for serving other business enterprises at
  our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if
  such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the
  registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
  may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
  will be required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except
  that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled
  to indemnification;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
  will not be obligated pursuant to our Bylaws to indemnify a person with respect to proceedings initiated by that person against New
  Conduit or our other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right
  to indemnification;</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  rights conferred in our Bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors,
  officers, employees and agents and to obtain insurance to indemnify such persons; and</span></td></tr>

<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
  may not retroactively amend our amended and restated bylaw provisions to reduce our indemnification obligations to directors, officers,
  employees and agents.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
future exercise of registration rights may adversely affect the market price of New Conduit common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our stockholders will have registration rights for restricted securities. We are obligated to register certain securities, including
(i) all of the shares of MURF common stock and Private Warrants held by the Sponsor, and MURF Class A common stock issuable upon exercise
of the Public Warrants (all of which, after the closing of the Business Combination, will automatically convert into New Conduit common
stock and warrants to shares of New Conduit common stock), and (ii) the shares of New Conduit common stock and New Conduit common stock
underlying warrants to be issued in the Private Placement. We are obligated to (i) to file a resale registration statement to register
such securities within 15 business days after the closing of the Business Combination and (ii) use reasonable best efforts to cause such
registration statement to be declared effective by the SEC within 60 business days after the closing of the Business Combination. Sales
of a substantial number of shares of New Conduit common stock pursuant to the resale registration statement in the public market could
occur at any time the registration statement remains effective. These sales, or the perception in the market that the holders of a large
number of shares intend to sell shares, could reduce the market price of New Conduit common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration
of ownership after the Business Combination may have the effect of delaying or preventing a change in control.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">It
is anticipated that, following the completion of the Business Combination and assuming (for illustrative purposes) no redemptions of
outstanding Public Shares, MURF&#8217;s initial stockholder, our Sponsor, will retain an ownership interest of 4,015,250 shares
of New Conduit common stock or approximately 5% of New Conduit common stock and Conduit&#8217;s shareholders will own 67,700,000
shares of New Conduit common stock or approximately 90% of the New Conduit common stock, which reflects 65,000,000 shares of New
Conduit common stock to be issued to the Conduit shareholders as consideration in the merger plus the 2,700,000 shares of New Conduit
common stock to be issued to the Private Placement Investor in connection with the Private Placement as the Private Placement Investor
is an affiliate of one of Conduit&#8217;s existing shareholders. As a result, Conduit&#8217;s equity holders may have the ability to
determine the outcome of corporate actions of New Conduit requiring stockholder approval. This concentration of ownership may have the
effect of delaying or preventing a change in control and might adversely affect the market price of New Conduit common stock. See the
section entitled &#8220;<i>Unaudited Pro Forma Condensed Combined Financial Information</i>&#8221; for further information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the Private Placement fails to close and sufficient Public Stockholders exercise their redemption rights in connection with the Business
Combination, we may lack sufficient funds to consummate the Business Combination.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 24pt; margin-bottom: 0pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 24pt; margin-bottom: 0pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">In
connection with the merger agreement, MURF entered into the Subscription Agreement with the Private Placement Investor, which provides
for the purchase of an aggregate of 2,700,000 units, with each unit consisting of one share of Class A common stock together with one
warrant exercisable into one share of Class A common stock, for a purchase price of $10.00 per unit, or an aggregate amount of $27 million
in gross cash proceeds immediately prior to the closing of the Business Combination. Conduit is not required to consummate the Transactions
if there is not at least $27 million of cash available to be released from MURF&#8217;s trust account and/or received by MURF under the
Subscription Agreement after giving effect to payment of amounts that MURF will be required to pay to redeeming stockholders upon consummation
of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">As
the trust account only had approximately $23 million as of April 30, 2023, if the Private Placement does not close by reason of the failure
by the Private Placement Investor to fund the purchase price for the Private Placement securities, we may lack sufficient funds to consummate
the Business Combination. The Private Placement Investor&#8217;s obligations to purchase the Private Placement Securities are subject
to fulfilment of customary closing conditions, including that the Business Combination must be consummated substantially concurrently
with, and immediately following, the purchase of the Private Placement securities. In the event of any such failure to fund, or if any
such condition is not satisfied and not waived, we may not be able to obtain additional funds to account for such shortfall on terms
favorable to us or at all. While the Private Placement Investor has informed us that it has sufficient funds to satisfy its obligations
under the Subscription Agreement, we have not obligated the Private Placement Investor to reserve funds for such obligations. Further,
the Private Placement Investor is based in a foreign jurisdiction and it is uncertain to what extent we can successfully enforce such
investor&#8217;s commitments in the Private Placement in such foreign jurisdiction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 24pt; margin-bottom: 0pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 24pt; margin-bottom: 0pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or reports about our business or publish negative reports about our business,
our share price and trading volume could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for New Conduit common stock will depend on the research and reports that securities or industry analysts publish about
New Conduit or its business. Currently, New Conduit does not have any analyst coverage and may not obtain analyst coverage in the future.
In the event New Conduit obtains analyst coverage, it will not have any control over such analysts. If one or more of the analysts who
cover New Conduit downgrade New Conduit common stock or change their opinion of such shares, the share price of New Conduit common stock
would likely decline. If one or more of these analysts cease coverage of New Conduit or fail to regularly publish reports on New Conduit,
we could lose visibility in the financial markets, which could cause the share price or trading volume of New Conduit common stock to
decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Conduit&#8217;s ability to pay dividends in the future will be subject to its subsidiaries&#8217; ability to distribute cash to it.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not anticipate that New Conduit&#8217;s board of directors will declare dividends in the foreseeable future. If New Conduit decides
to declare dividends in the future, as a holding company, it will require dividends and other payments from its subsidiaries to meet
such cash requirements. In addition, minimum capital requirements may indirectly restrict the amount of dividends paid upstream, and
repatriations of cash from New Conduit&#8217;s subsidiaries may be subject to withholding, income and other taxes in various applicable
jurisdictions. If New Conduit&#8217;s subsidiaries are unable to distribute cash to it and it is unable to pay dividends, New Conduit
common stock may become less attractive to investors and the price of its shares of common stock may become volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Conduit, as a combined company, will incur increased costs and obligations as a result of being a public company. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a privately held company, Conduit has not been required to comply with certain corporate governance and financial reporting practices
and policies required of a publicly traded company. As a publicly traded company, New Conduit will incur significant legal, accounting
and other expenses that we were not required to incur in the recent past, particularly after we are no longer an &#8220;emerging growth
company&#8221; as defined under the JOBS Act. In addition, new and changing laws, regulations and standards relating to corporate governance
and public disclosure, including the Dodd Frank Wall Street Reform and Consumer Protection Act and the rules and regulations promulgated
and to be promulgated thereunder, as well as under the Sarbanes-Oxley Act, the JOBS Act, and the rules and regulations of the SEC and
national securities exchanges have created uncertainty for public companies and increased the costs and the time that New Conduit&#8217;s
board of directors and management must devote to complying with these rules and regulations. We expect these rules and regulations to
increase our legal and financial compliance costs and lead to a diversion of management time and attention from revenue generating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the need to establish the corporate infrastructure demanded of a public company may divert management&#8217;s attention from implementing
our growth strategy, which could prevent us from improving our business, results of operations and financial condition. We have made,
and will continue to make, changes to our internal controls and procedures for financial reporting and accounting systems to meet our
reporting obligations as a publicly traded company. However, the measures we take may not be sufficient to satisfy our obligations as
a publicly traded company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
as long as we remain an &#8220;emerging growth company&#8221; as defined in the JOBS Act, we may take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies.&#8221;
We may remain an &#8220;emerging growth company&#8221; until the earliest of (i) the last day of our fiscal year following February 7,
2027 (the fifth anniversary of the consummation of MURF&#8217;s initial public offering), (ii) the last day of the fiscal year in which
the market value of our shares of common stock that are held by non-affiliates exceeds $700 million as of June 30 of that fiscal year,
(iii) the last day of the fiscal year in which we have total annual gross revenue of $1.07 billion or more during such fiscal year (as
indexed for inflation) or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt in the prior three-year
period. Further, there is no guarantee that the exemptions available to us under the JOBS Act will result in significant savings. To
the extent we choose not to use exemptions from various reporting requirements under the JOBS Act, we will incur additional compliance
costs, which may impact earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
an &#8220;emerging growth company,&#8221; we cannot be certain if the reduced disclosure requirements applicable to &#8220;emerging growth
companies&#8221; will make our shares of common stock less attractive to investors. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and we may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited
to, not being required to obtain an assessment of the effectiveness of our internal controls over financial reporting from our independent
registered public accounting firm pursuant to Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote
on executive compensation and stockholder approval of any golden parachute payments not previously approved. In addition, the JOBS Act
provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting
standards. This allows an emerging growth company to delay the adoption of these accounting standards until they would otherwise apply
to private companies. MURF has elected not to opt out of such extended transition period. We cannot predict if investors will find our
shares of common stock less attractive because we will rely on these exemptions. If some investors find our shares of common stock less
attractive as a result, there may be a less active market for our shares of common stock and our share price may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we do not develop and implement all required accounting practices and policies, we may be unable to provide the financial information
required of a U.S. publicly traded company in a timely and reliable manner. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to develop and maintain effective internal controls and procedures and disclosure procedures and controls, we may be unable to
provide financial information and required SEC reports that a U.S. publicly traded company is required to provide in a timely and reliable
fashion. Any such delays or deficiencies could penalize us, including by limiting our ability to obtain financing, either in the public
capital markets or from private sources and hurt our reputation and could thereby impede our ability to implement our growth strategy.
In addition, any such delays or deficiencies could result in our failure to meet the requirements for listing of our shares of common
stock on a national securities exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
MURF&#8217;s stockholders fail to properly demand redemption rights, they will not be entitled to redeem their shares of New Conduit
common stock into a pro rata portion of the trust account.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
stockholders holding Public Shares may demand that MURF redeem their shares into a pro rata portion of the trust account, calculated
as of two business days prior to the anticipated consummation of the Business Combination. MURF stockholders who seek to exercise this
conversion right must deliver their stock (either physically or electronically) to MURF&#8217;s transfer agent prior to the vote at the
meeting. MURF&#8217;S transfer agent must receive instruction to redeem by 5:00 pm Eastern Time on , 2023, in order for such redemption
demands to be valid. Any MURF stockholder who fails to properly demand redemption rights will not be entitled to redeem his or her shares
into a pro rata portion of the trust account for redemption of his shares. See the section entitled &#8220;<i>Special Meeting of MURF
Stockholders &#8212; Redemption Rights</i>&#8221; for the procedures to be followed if you wish to redeem your shares for cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Sponsor and MURF&#8217;s officers and directors own shares of MURF common stock and warrants that will be worthless and the Sponsor has
made loans that may not be reimbursed or repaid if the Business Combination is not approved. Such interests may have influenced their
decision to approve the Business Combination with Conduit.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor and MURF&#8217;s officers and directors and/or their affiliates beneficially own or have a pecuniary interest in Private Shares
and Private Warrants that they purchased prior to, or simultaneously with, MURF&#8217;s initial public offering. The holders have no
redemption rights with respect to these securities in the event a business combination is not effected in the required time period. Therefore,
if the Business Combination with Conduit, or another business combination, is not approved within the required time period, such securities
held by such persons will be worthless. Such shares had an estimated aggregate market value of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
based upon the closing price of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per Public Share on Nasdaq on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2023, and an estimated aggregate market value of $&#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160; based upon the closing price of $
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per Public Share on Nasdaq on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023, the record date. Such warrants had an estimated aggregate market value of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;based
upon the closing price of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160; per Public Warrant on Nasdaq on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023, and an estimated aggregate market value of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; based upon the closing price of
$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per Public Warrant on Nasdaq on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2023, the record date. See the section entitled &#8220;<i>The Business Combination Proposal &#8212; Interests of MURF&#8217;s Directors
and Officers in the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial interests may have influenced the decision of MURF&#8217;s directors to approve the Business Combination with Conduit and to
continue to pursue such Business Combination. In considering the recommendations of the MURF Board to vote for the business combination
proposal and other proposals, its stockholders should consider these interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
exercise of MURF&#8217;s directors&#8217; and officers&#8217; discretion in agreeing to changes or waivers in the terms of the Business
Combination may result in a conflict of interest when determining whether such changes to the terms of the Business Combination or waivers
of conditions are appropriate and in MURF&#8217;s stockholders&#8217; best interest.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the period leading up to the closing of the Business Combination, events may occur that, pursuant to the Merger Agreement, would require
MURF to agree to amend the Merger Agreement, to consent to certain actions taken by Conduit or to waive rights that MURF is entitled
to under the Merger Agreement. Such events could arise because of changes in the course of Conduit&#8217;s business, a request by Conduit
to undertake actions that would otherwise be prohibited by the terms of the Merger Agreement or the occurrence of other events that would
have a material adverse effect on Conduit&#8217;s business and would entitle MURF to terminate the Merger Agreement. In any of such circumstances,
it would be at MURF&#8217;s discretion, acting through its board of directors, to grant its consent or waive those rights. The existence
of the financial and personal interests of the directors described in the preceding risk factors may result in a conflict of interest
on the part of one or more of the directors between what he or they may believe is best for MURF and what he or they may believe is best
for themselves in determining whether or not to take the requested action. As of the date of this proxy statement/prospectus, MURF does
not believe there will be any material changes or waivers that MURF&#8217;s directors and officers would be likely to make after the
mailing of this proxy statement/prospectus. MURF will circulate a new or amended proxy statement/prospectus if changes to the terms of
the Transactions that would have a material impact on its stockholders are required prior to the vote on the business combination proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit intends to enter into an employment agreement with MURF&#8217;s
Chief Financial Officer and director, Adam Sragovicz, and <span style="text-decoration: line-through"></span>the prospect of such future employment may have created
a conflict of interest for Mr. Sragovicz in determining whether the Business Combination is in MURF and its stockholders&#8217; best interests. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit anticipates entering into an employment agreement with Mr. Sragovicz,
which will provide that Mr. Sragovicz will serve as New Conduit&#8217;s Chief Financial Officer upon the closing of the Business Combination.
Conduit anticipates that Mr. Sragovicz will be entitled to an annual salary and bonus opportunity, a portion of which may be payable in
securities of New Conduit. While MURF and Conduit were negotiating the terms for the Merger Agreement, they and Mr. Sragovicz also discussed
the prospect of Mr. Sragovicz&#8217;s employment as the Chief Financial Officer of New Conduit, and therefore, Mr. Sragovicz&#8217;s personal
and financial interests may have influenced his motivation in identifying, selecting and approving a target business for MURF. However,
Mr. Sragovicz&#8217;s ability to remain with the combined company upon completion of the Business Combination was not a determining factor
in his or MURF&#8217;s evaluation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>A.G.P./Alliance
Global Partners acted as a financial advisor to both MURF and Conduit, which potential conflict of interest could affect its advice to
both parties.</i></b></span><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">A.G.P./Alliance
Global Partners (&#8220;A.G.P.&#8221;) is a financial advisor to both MURF and Conduit in connection with the Business Combination
transaction. Upon the closing of the Business Combination, A.G.P. is entitled to receive (i) a cash fee of $6,500,000, 1,300,000
shares of New Conduit common stock and warrants to purchase 54,000 shares of New Conduit common stock at an exercise price of $11.00
per share pursuant to its engagement agreement with Conduit entered into on August 2, 2022 and (ii) $<span style="background-color: white">4,628,750
of deferred underwriting fees</span> as a result of its engagement for MURF&#8217;s initial public offering. Upon learning of Conduit&#8217;s
engagement of A.G.P. and the potential conflict of interest created by such engagement, MURF took steps to mitigate any potential conflict,
as further described in the section titled &#8220;<i>Background of the Business Combination</i>&#8221; beginning on page 66, including
conducting all substantive negotiations through MURF management and MURF counsel without the substantive participation of A.G.P. and
engaging an independent financial advisor to provide a fairness opinion for the Business Combination. There can be no assurance that
the fact that A.G.P. acted as the financial advisor to both parties to the Business Combination did not impact the advice that A.G.P.
delivered to either or both parties, or that certain terms of the Merger were not impacted by the potential conflict of interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="margin: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
MURF is unable to complete the Business Combination with Conduit, or another business combination by February 7, 2024 (or such
later date as may be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation), MURF will cease
all operations except for the purpose of winding up, redeeming 100% of the outstanding Public Shares and, subject to the approval of
its remaining stockholders and its board of directors, dissolving and liquidating. In such event, third parties may bring claims against
MURF and, as a result, the proceeds held in the trust account could be reduced and the per-share liquidation price received by stockholders
could be less than $10.52 per Public Share.</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of MURF&#8217;s amended and restated certificate of incorporation, MURF must complete the Business Combination with Conduit,
or another business combination, by February 7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s amended
and restated certificate of incorporation), or MURF must cease all operations except for the purpose of winding up, redeeming 100% of
the outstanding Public Shares and, subject to the approval of its remaining stockholders and its board of directors, dissolving and liquidating.
In such event, third parties may bring claims against MURF. Although MURF has obtained waiver agreements from the prospective target
businesses it has negotiated with, whereby such parties have waived any right, title, interest or claim of any kind they may have in
or to any monies held in the trust account, there is no guarantee that they or other vendors who did not execute such waivers will not
seek recourse against the trust account notwithstanding such agreements. Furthermore, there is no guarantee that a court will uphold
the validity of such agreements. Accordingly, the proceeds held in the trust account could be subject to claims which could take priority
over those of MURF&#8217;s Public Stockholders. Therefore, the per-share distribution from the trust account in such a situation may
be less than $10.52 due to such claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if MURF is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against it which is not dismissed, or if MURF
otherwise enters compulsory or court supervised liquidation, the proceeds held in the trust account could be subject to applicable bankruptcy
law, and may be included in its bankruptcy estate and subject to the claims of third parties with priority over the claims of its stockholders.
To the extent any bankruptcy claims deplete the trust account, MURF may not be able to return to its Public Stockholders at least $10.52
per Public Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>MURF&#8217;s
Sponsor has agreed to vote in favor of the Business Combination, regardless of how our public stockholders&#8217; vote.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Sponsor has agreed to vote its shares in favor of the Business Combination. The Sponsor owns approximately 65% of the outstanding
shares of MURF common stock prior to the Business Combination. Accordingly, it is more likely that the necessary stockholder approval
for the Business Combination will be received than would be the case if our Sponsor had agreed to vote its shares in accordance with
the majority of the votes cast by our public stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-size: 10pt"><b><i>The
Sponsor and the directors and officers of MURF have agreed to vote in favor of MURF&#8217;s initial business combination, regardless of
how Public Stockholders vote and, because the Sponsor owns approximately 65% of MURF common stock, Sponsor&#8217;s vote on most proposals
will be determinative.</i></b></span><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Unlike many other blank check companies in which the
founders agree to vote their founder shares in accordance with the majority of the votes cast by the public stockholders in connection
with an initial business combination, the Sponsor and the directors and officers of MURF have agreed to vote their shares of MURF common
stock, including Sponsor&#8217;s Class A common stock purchased in connection with MURF&#8217;s initial public offering and its Founder
Shares, in favor of the initial business combination of MURF. Our Sponsor currently owns 754,000 shares of Class A common stock and 3,306,250
shares of Class B common stock, which together represents 64.99% of the 6,247,978 issued and outstanding shares of MURF common stock.
None of MURF&#8217;s directors and officers own any shares of Class A common stock or Class B common stock. Accordingly, it is likely
that the necessary stockholder approval will be received than would be the case if MURF&#8217;s Sponsor, directors and officers agreed
to vote their MURF common stock in accordance with the majority of the votes cast by its public stockholders on those proposals where
both Class A common stock and Class B common stock vote as a single class.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">However, because the Sponsor owns 754,000 shares of
Class A common stock, which represents approximately 25% of the 2,941,728 issued and outstanding shares of Class A common stock, the vote
of the Public Stockholders will determine the outcome of those proposals where each of Class A common stock and Class B common stock will
vote separately. Those proposals are (i) the Charter Amendment Proposal B, which will remove the designations of Class A and Class B by
reclassifying each outstanding share of Class A common stock and Class B common stock into a share of common stock and (ii) the Charter
Amendment Proposal D, which will increase the number of (newly) authorized shares of common stock to 250,000,000. See the section of this
proxy statement/prospectus titled &#8220;<i>Charter Amendments Proposals.</i>&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Sponsor, MURF&#8217;s officers and directors, Conduit or Conduit&#8217;s shareholders and/or their respective affiliates may elect
to purchase shares from holders of MURF public shares in connection with the Business Combination, which may influence the vote on the
Business Combination or could have a depressive effect on MURF public shares.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time prior to the Special Meeting, during a period when they are not then aware of any material nonpublic information regarding
MURF or its securities, the Sponsor, MURF&#8217;s officers and directors, Conduit or Conduit&#8217;s shareholders and/or their
respective affiliates may purchase shares from institutional and other investors who vote, or indicate an intention to vote, against
the business combination proposal, or execute agreements to purchase such shares from such investors in the future, or they may
enter into transactions with such investors and others to provide them with incentives to acquire shares of MURF common stock or
vote their shares in favor of the business combination proposal. The purpose of such share purchases and other transactions could be
to increase the likelihood of MURF obtaining sufficient proxies to vote in favor of the proposals set forth herein where it appears
that such proposal would otherwise not be approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, entering into any such arrangements may have a depressive effect on MURF common stock. For example, as a result of these
arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market value and may
therefore be more likely to sell shares, either prior to or immediately after the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">As of the date of this proxy
statement/prospectus, no agreements with respect to the private purchase of public shares by the persons described above have been entered
into with any such investor or holder. In the event of any such newly purchases shares (i) the Sponsor or its affiliates will purchase
the MURF common stock at a price no higher than the price offered through the redemption process; (ii) any such purchases by Sponsor or
its affiliates will not be voted in favor of approving the Business Combination; and (iii) the Sponsor and its affiliates have waived
their redemption rights to such shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">Prior to the special meeting to approve the Business Combination, MURF
will disclose in a Form 8-K (i) the amount of public shares purchased outside of the redemption offer by the Sponsor or its affiliates,
along with the purchase price; (ii) the purpose of the purchases by the Sponsor or its affiliates; (iii) the impact, if any, of the purchases
by the Sponsor or its affiliates on the likelihood that the Business Combination transaction will be approved; (iv) the identities of
stockholders who sold to the Sponsor or its affiliates (if not purchased on the open market) or the nature of stockholders (e.g., 5% security
holders) who sold to the Sponsor or its affiliates; and (v) the number of shares of MURF common stock for which MURF has received redemption
requests pursuant to its redemption offer.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to the Redemption</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no guarantee that a stockholder&#8217;s decision whether to redeem their shares for a pro rata portion of the trust account will put
the stockholder in a better future economic position.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
can give no assurance as to the price at which a stockholder may be able to sell its Public Shares in the future following the completion
of the Business Combination or any alternative business combination. Certain events following the consummation of any initial business
combination, including the Business Combination, may cause an increase in MURF&#8217;s share price, and may result in a lower value realized
now than a stockholder of MURF might realize in the future had the stockholder redeemed their shares. Similarly, if a stockholder does
not redeem their shares, the stockholder will bear the risk of ownership of the Public Shares after the consummation of any initial business
combination, including the Business Combination, and there can be no assurance that a stockholder can sell its shares in the future for
a greater amount than the redemption price set forth in this proxy statement/prospectus. A stockholder should consult the stockholder&#8217;s
own tax and/or financial advisor for assistance on how this may affect his, her or its individual situation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Under
certain circumstances a redemption of a MURF stockholder&#8217;s Public Shares may be treated as a corporate distribution subject to
tax at regular ordinary income tax rates instead of the preferential tax rates that apply to qualified dividend income. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that a MURF stockholder&#8217;s Public Shares are redeemed pursuant to the redemption provisions described in this proxy statement/prospectus,
the treatment of the transaction for U.S. federal income tax purposes will depend on whether the redemption qualifies as a sale of the
Public Shares or a corporate distribution under Section 302 of the Code based on the facts and circumstances applicable to such stockholder.
If the redemption is treated as a corporate distribution, such a distribution generally will be includable in a U.S. Holder&#8217;s gross
income, in accordance with such U.S. Holder&#8217;s method of accounting for U.S. federal income tax purposes, as dividend income, but
only to the extent that such distributions are paid out of MURF&#8217;s current or accumulated earnings and profits as determined under
U.S. federal income tax principles. Dividends will be taxable to a corporate U.S. Holder at regular rates and will generally be eligible
for the dividends-received deduction if the requisite holding period is satisfied. With respect to non-corporate U.S. Holders and with
certain exceptions, dividends may be &#8220;qualified dividend income,&#8221; which is taxed at the lower applicable long-term capital
gain rate provided that the U.S. Holder satisfies certain holding period requirements and the U.S. Holder is not under an obligation
to make related payments with respect to positions in substantially similar or related property. It is unclear whether the redemption
rights with respect to the Public Shares may prevent a U.S. Holder from satisfying the applicable holding period requirements with respect
to the dividends received deduction or the preferential tax rate on qualified dividend income, as the case may be, because there is no
authority directly on-point with respect to whether such redemption rights diminish a U.S. Holder&#8217;s risk of loss with respect to
Public Shares in a manner that suspends the holding period for such Public Shares under the applicable holding period requirements. If
the holding period requirements are not satisfied, non-corporate U.S. Holders may be subject to tax on such dividends at regular ordinary
income tax rates instead of the preferential rate that applies to qualified dividend income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>MURF
may be subject to the Excise Tax included in the Inflation Reduction Act of 2022 in the event of a liquidation or in connection with
redemptions of its Class A common stock after December 31, 2022.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">Under the Inflation Reduction
Act of 2022 (the &#8220;IRA&#8221;), adding Section 4501 to the Code, a domestic corporation whose stock is traded on an established
securities market (a &#8220;covered corporation&#8221; under the IRA) is subject to an excise tax of 1% on repurchases (redemptions)
of its stock after December 31, 2022 (the &#8220;Excise Tax&#8221;). Because MURF is a Delaware corporation and its securities trade
on the Nasdaq Global Market, it is a &#8220;covered corporation&#8221; within the meaning of the IRA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">The
IRA became law on August 16, 2022. On December 27, 2022, the IRS published Notice 2023-2, providing &#8220;Initial Guidance&#8221; regarding
the application of the Excise Tax on repurchases of corporate stock under Section 4501. Under these authorities MURF expects the Excise
Tax to be imposed on the fair market value of stock repurchased by us. Under a &#8220;netting rule&#8221;, the fair market value of stock
repurchased by MURF may be reduced by the fair market value of securities issued by it in the same taxable year, with the 1% Excise Tax
then imposed on the excess, if any, of the value of redemptions over the value of issuances. Therefore, issuances of stock by MURF in
connection with its initial business combination transaction (including any PIPE transaction at the time of our initial business combination)
will reduce the amount of the Excise Tax in connection with redemptions occurring in the same taxable year. However, a business combination
may not be completed during 2023 and, even if a business combination is completed, the fair market value of the securities redeemed may
exceed the fair market value of the securities issued in such a combination or otherwise. (The fair market value of securities that are
redeemed is determined by the market price of the stock on the day of redemption, regardless of the actual redemption amount.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">Further,
while the authorities indicate that as a general rule the Excise Tax does not apply in the event of a complete liquidation of a covered
corporation, the availability of this exemption under circumstances that might surround the liquidation of a SPAC is not entirely clear.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">While
excise tax returns are generally filed on a quarterly basis, the IRS expects to issue regulations providing that reports of Excise Tax
liability are due with the first quarterly excise tax return filed after the close of the taxable year. Except for franchise taxes and
income taxes, the proceeds placed in the trust account and the interest earned thereon shall not be used to pay for possible excise tax
or any other fees or taxes that may be levied on MURF pursuant to any current, pending or future rules or laws, including without limitation
any excise tax due under the IRA on any redemptions or stock buybacks by MURF (except in the case of proceeds that are delivered to MURF
following a business combination).</p>

<p style="margin: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholders
who wish to redeem their Public Shares in connection with the Business Combination must comply with specific requirements for redemption
that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Public Stockholder will have the right, regardless of whether he, she, or it is voting for or against the Business Combination or does
not vote at all, to demand that MURF redeem such holder&#8217;s shares into a pro rata share of the trust account as of two business
days prior to the consummation of the Business Combination. Public Stockholders who wish to redeem their shares must either (i) tender
their certificates to MURF&#8217;s transfer agent physically or (ii) deliver their shares to the transfer agent electronically using
the Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System, at the holders&#8217; option, in each case prior
to the Special Meeting. MURF&#8217;S transfer agent must receive instruction to redeem by 5:00 pm Eastern Time on , 2023, in order for
such redemption demands to be valid. In order to obtain a physical stock certificate, a stockholder&#8217;s broker and/or clearing broker,
DTC and MURF&#8217;s transfer agent will need to act to facilitate this request. It is MURF&#8217;s understanding that stockholders should
generally allot at least two weeks to obtain physical certificates from the transfer agent. However, because MURF does not have any control
over this process or over the brokers or DTC, it may take significantly longer than two weeks to obtain a physical stock certificate.
While MURF has been advised that it takes a short time to deliver shares through the DWAC System, MURF cannot assure you of this fact.
Accordingly, if it takes longer than MURF anticipates for stockholders to deliver their shares, stockholders who wish to redeem may be
unable to meet the deadline for exercising their redemption rights and thus may be unable to redeem their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
Public Stockholders who wish to redeem their shares tender their certificates to MURF&#8217;s transfer agent physically, such redeeming
stockholders may be unable to sell their securities when they wish to in the event that the Business Combination is not approved.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Public Stockholders who wish to redeem their shares tender their certificates to MURF&#8217;s transfer agent physically and the Business
Combination is not consummated, MURF will promptly return such certificates to the tendering Public Stockholders. Accordingly, investors
who attempted to redeem their shares in such a circumstance will be unable to sell their securities after the failed acquisition until
MURF has returned their securities to them. The market price for MURF&#8217;s shares of Class A common stock may decline during this
time and you may not be able to sell your securities when you wish to, even while other stockholders that did not seek redemption may
be able to sell their securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
third parties bring claims against MURF, the proceeds held in the trust account could be reduced and the per share redemption amount
received by stockholders may be less than $10.52 per Public Share.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
placing of funds in trust may not protect those funds from third party claims against us. Although MURF will seek to have all vendors
and service providers it engages and prospective target businesses with which it negotiates execute agreements waiving any right, title,
interest or claim of any kind in or to any monies held in the trust account for the benefit of MURF&#8217;s Public Stockholders, they
may not execute such agreements. Furthermore, even if such entities execute such agreements with us, they may seek recourse against the
trust account. A court may not uphold the validity of such agreements. Accordingly, the proceeds held in trust could be subject to claims
which could take priority over those of MURF&#8217;s Public Stockholders. If MURF is unable to complete a business combination and distribute
the proceeds held in trust to MURF&#8217;s Public Stockholders, its Sponsor has agreed (subject to certain exceptions described elsewhere
in this proxy statement/prospectus) that it will be liable to ensure that the proceeds in the trust account are not reduced below
$10.52 per Public Share by the claims of target businesses or claims of vendors or other entities that are owed money by us for
services rendered or contracted for or products sold to us. However, MURF has not asked its Sponsor to reserve for such indemnification
obligations, nor has MURF independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe
that its Sponsor&#8217;s only assets are securities of MURF. Therefore, MURF believes it is unlikely that its Sponsor will be able to
satisfy its indemnification obligations if it is required to do so. As a result, the per-share distribution from the trust account may
be less than $10.52, plus interest, due to such claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if MURF is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against us which is not dismissed, the proceeds
held in the trust account could be subject to applicable bankruptcy law, and may be included in its bankruptcy estate and subject to
the claims of third parties with priority over the claims of MURF stockholders. To the extent any bankruptcy claims deplete the trust
account, MURF may not be able to return to Public Stockholders at least $10.52 per Public Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
If the Adjournment Proposal Is Not Approved</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the adjournment proposal is not approved, and an insufficient number of votes have been obtained to authorize the consummation of the
Business Combination, the MURF Board will not have the ability to adjourn the Special Meeting to a later date in order to solicit further
votes, and, therefore, the Business Combination will not be approved.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MURF Board is seeking approval to adjourn the Special Meeting to a later date or dates if, at the Special Meeting, MURF does not have
sufficient proxies to approve one or more of the other proposals. If the adjournment proposal is not approved, the MURF Board will not
have the ability to adjourn the Special Meeting to a later date and, therefore, the Business Combination would not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="md_008"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>SPECIAL
MEETING OF murf STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is furnishing this proxy statement/prospectus to MURF&#8217;s stockholders as part of the solicitation of proxies by the MURF Board for
use at the Special Meeting of MURF stockholders to be held on&#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023,
and at any adjournment or postponement thereof. This proxy statement/prospectus provides MURF stockholders with information they need
to know to be able to vote or instruct their vote to be cast at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date,
Time and Place</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Special Meeting of stockholders will be held on&#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023, at &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
a.m., Eastern Time, via live webcast. MURF stockholders may attend, vote and examine the list of MURF stockholders entitled to vote
at the Special Meeting by visiting and entering the control number found on their proxy card, voting instruction form or notice they
previously received. In light of public health concerns regarding the novel coronavirus (COVID-19), the Special Meeting will be held
in a virtual meeting format only. You will not be able to attend the Special Meeting physically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purpose
of the Special Meeting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Special Meeting, MURF is asking holders of MURF common stock to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider
                                            and vote upon a proposal to approve the business combination (the &#8220;Business Combination&#8221;)
                                            described in this proxy statement/prospectus, including the Agreement and Plan of Merger,
                                            dated as of November 8, 2022 (&#8220;Merger Agreement&#8221;), by and among MURF, Conduit
                                            Pharmaceuticals Limited, a Cayman Islands exempted company (&#8220;Conduit&#8221;) and Conduit
                                            Merger Sub, Inc., a Cayman Islands exempted company and a wholly-owned subsidiary of MURF
                                            (&#8220;Merger Sub&#8221;), which, among other things, provides for the merger of Merger
                                            Sub with and into Conduit, with Conduit surviving the merger as a wholly-owned subsidiary
                                            of MURF &#8212; we refer to this proposal as the &#8220;business combination proposal&#8221;;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider
and vote upon separate proposals to approve amendments to MURF&#8217;s current amended and restated certificate of incorporation to: </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify; width: 0.5in">&#160;</td>
  <td style="text-align: justify; width: 0.5in">(i)</td>
  <td style="text-align: justify"> Charter Amendment Proposal A &#8211; change the name of the public entity from &#8220;<span style="background-color: white">Murphy
  Canyon Acquisition Corp.</span>&#8221; to &#8220;<span style="background-color: white">Conduit Pharmaceuticals
  Inc.</span>&#8221;;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(ii) </td>
  <td style="text-align: justify">Charter Amendment Proposal B &#8211; provide for one class of authorized common stock;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(iii) </td>
  <td style="text-align: justify">Charter Amendment Proposal C &#8211; delete the various provisions in MURF&#8217;s current amended
  and restated certificate of incorporation applicable only to special purpose acquisition corporations (such as the obligation to
  dissolve and liquidate if a business combination is not consummated within a certain period of time);</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(iv) </td>
  <td style="text-align: justify">Charter Amendment Proposal D &#8211; increase the number of authorized shares of common
stock to 250,000,000; and</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">(v) </td>
  <td style="text-align: justify">Charter Amendment Proposal E &#8211; fix the number of directors at seven (7), a majority of whom
  shall be independent directors in accordance with The Nasdaq Stock Market LLC&#8217;s requirements &#8212; we refer to these
  proposals collectively as the &#8220;charter amendment proposals&#8221;;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">to
                                            consider and vote upon, on a non-binding advisory basis, certain governance provisions in
                                            the Proposed Charter, presented separately in accordance with U.S. Securities and Exchange
                                            Commission (&#8220;SEC&#8221;) requirements </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;
                                            we refer to this proposal as the &#8220;advisory charter amendments proposals&#8221;<span style="background-color: white">;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">elect seven (7) directors who, upon consummation of the Business Combination,
will be the directors of New Conduit &#8212; we refer to this proposal as the &#8220;director election proposal&#8221;;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider
                                            and vote upon a proposal to approve the Conduit Pharmaceuticals Inc. 2023 Stock Incentive
                                            Plan, which is an incentive compensation plan for employees of New Conduit &#8212; we refer
                                            to this proposal as the &#8220;incentive plan proposal&#8221;; </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider
                                            and vote upon a proposal to approve, for purposes of complying with applicable listing rules
                                            of Nasdaq, the issuance of New Conduit common stock, par value $0.0001 per share, to the
                                            Private Placement Investor in connection with the Private Placement, the proceeds of which will be used to
                                            finance the Business Combination and related transactions and the costs and expenses incurred
                                            in connection therewith with any balance used for working capital purposes &#8212; we refer
                                            to this proposal as the &#8220;Nasdaq proposal&#8221;; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider
                                            and vote upon a proposal to adjourn the Special Meeting to a later date or dates, if necessary,
                                            to permit further solicitation and vote of proxies if MURF does not have sufficient proxies
                                            to approve one or more of the foregoing proposals &#8212; we refer to this proposal as the
                                            &#8220;adjournment proposal.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of MURF Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MURF Board has unanimously determined that the business combination proposal, the charter amendment proposals, the advisory charter
amendments proposals, the director election proposal, the incentive plan proposal, the Nasdaq proposal and the adjournment proposal are
fair to and in the best interests of MURF and its stockholders and unanimously recommends that you vote or give instruction to vote &#8220;FOR&#8221;
the business combination proposal, &#8220;FOR&#8221; each of the charter amendment proposals, &#8220;FOR&#8221; each of the advisory
charter amendments proposals, &#8220;FOR&#8221; the election of all of the persons nominated by MURF&#8217;s management for election
as directors, &#8220;FOR&#8221; the incentive plan proposal, &#8220;FOR&#8221; the Nasdaq proposal and &#8220;FOR&#8221; the adjournment
proposal, if presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record
Date; Persons Entitled to Vote</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
has fixed the close of business on &#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, as the record date for determining MURF stockholders
entitled to notice of and to attend and vote at the Special Meeting. As of the close of business on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2023, there were 6,247,978 shares of MURF common stock outstanding and entitled to vote. Each share of MURF common stock is
entitled to one vote per share at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to agreements with MURF, the 4,060,250 Private Shares held by the Sponsor will be voted in favor of the business combination proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
of ValueScope, Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
of Financial Advisor to the MURF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
was retained by MURF to provide its opinion as to the fairness, from a financial point of view, to the stockholders of MURF regarding
the Business Combination. On November 4, 2022, ValueScope delivered its opinion to the MURF Board, to the effect that, based on financial,
business and operating information available to it as of September 30, 2022, the total consideration to be paid by MURF in the Business
Combination is fair to the MURF stockholders from a financial perspective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
summary of the opinion in this proxy statement/prospectus is qualified in its entirety by reference to the full text of the written opinion,
which is included as <span style="text-decoration: underline">Annex D</span> to this proxy statement/prospectus and sets forth the procedures followed, assumptions made, qualifications
and limitations on the review undertaken and other matters considered by ValueScope in preparing its opinion. However, neither ValueScope&#8217;s
written opinion nor the summary of its opinion and the related analyses set forth in this proxy statement/prospectus are intended to
be, and do not constitute, advice or a recommendation to any stockholder as to how such stockholder should act or vote with respect to
any matter relating to the proposed Business Combination or otherwise, including, without limitation, whether any such stockholder should
redeem its shares.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion was addressed to the MURF Board for the use and benefit of the members of the MURF Board (in their capacities as such) in connection
with its evaluation of the Business Combination. ValueScope&#8217;s opinion was just one of the several factors the MURF Board took into
account in making its determination to approve the Business Combination, including those described elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope&#8217;s
opinion only addressed whether, as of the date of the opinion, the Merger shares to be issued in the Business Combination in the aggregate
pursuant to the Merger Agreement was fair, from a financial point of view, to MURF. It did not address any other terms, aspects, or implications
of the Business Combination, the Merger Agreement or any related or other transaction or agreement, including, without limitation, (i)
other than assuming the consummation thereof, the Private Placement; (ii) the shareholder support agreement and the lock-up agreements
to entered into in connection with the Merger Agreement, (iii) any term or aspect of the Business Combination that is not susceptible
to financial analysis, (iv) the fairness of the Business Combination, or all or any portion of the Merger shares, to any security holders
of MURF, Conduit or any other person or any creditors or other constituencies of MURF, Conduit or any other person, (v) the appropriate
capital structure of MURF or Conduit or whether MURF should be issuing debt or equity securities or a combination of both in the Business
Combination, (vi) any capital raising or financing transaction contemplated by MURF, including, without limitation, the Private Placement,
nor (vi) the fairness of the amount or nature, or any other aspect, of any compensation or consideration payable to or received by any
officers, directors, or employees of any parties to the Business Combination, or any class of such persons, relative to the Merger shares,
or otherwise. ValueScope did not express any opinion as to what the value of shares of MURF&#8217;s Class A common stock, MURF&#8217;s
Class B common stock or any other security of MURF actually will be when issued in the Business Combination or the prices at which shares
of MURF Class A common stock, MURF Class B common stock, or any other securities of MURF or Conduit could trade, be purchased or sold
at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope&#8217;s
opinion did not address the relative merits of the Business Combination as compared to any alternative transaction or business strategy
that might have existed for MURF, or the merits of the underlying decision by the MURF Board or MURF to engage in or consummate the Business
Combination. The financial and other terms of the Business Combination were determined pursuant to negotiations between the parties to
the Merger Agreement and were not determined by or pursuant to any recommendation from ValueScope. In addition, ValueScope was not authorized
to, and did not, solicit indications of interest from third parties regarding a potential transaction involving MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
was not requested to, and did not, (a) initiate or participate in any discussions or negotiations with respect to the Merger, the securities,
assets, businesses or operations of MURF, Conduit or any other party, or any alternatives to the Merger, (b) negotiate the terms of the
Business Combination, or (c) advise the MURF Board, MURF or any other party with respect to alternatives to the Business Combination.
ValueScope&#8217;s analyses and opinion were necessarily based upon market, economic, and other conditions as they existed on, and could
be evaluated as of, the date of ValueScope&#8217;s opinion and upon certain assumptions regarding such financial, economic, market and
other conditions, which were subject to unusual volatility and which, if different than assumed, could have a material impact on ValueScope&#8217;s
analyses and opinion. Accordingly, although subsequent developments could arise that would otherwise affect its opinion, ValueScope did
not assume any obligation to update, review, or reaffirm its opinion to MURF or any other person or otherwise to comment on or consider
events occurring or coming to ValueScope&#8217;s attention after the date of its opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">ValueScope
received a fee of $82,398.03 for rendering its opinion, no portion of which was contingent upon the completion of the Business Combination.
In addition, MURF agreed to reimburse certain ValueScope expenses and to indemnify ValueScope and certain related parties for certain
liabilities that may arise out of its engagement or the rendering of its opinion. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with its analysis, ValueScope has made such reviews, analyses, and inquiries as it deemed necessary and appropriate under
the circumstances. ValueScope also took into account its assessment of general economic, market, and financial conditions, as well as
its experience in business valuation in general, and with respect to similar transactions, in particular. ValueScope&#8217;s procedures,
investigations, and financial analyses included, but were not limited to a review of the letter of intent entered into on July 29, 2022,
between MURF and Conduit, forward-looking projections provided by Conduit, industry and market research, discussions with the management
teams of MURF and the Conduit, and other documents related to the Business Combination and Conduit. ValueScope performed certain valuation
analyses using generally accepted valuation and analysis techniques, including a discounted cash flow analysis. ValueScope conducted
such other analyses and considered such other factors as it deemed appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ValueScope
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
is a valuation advisory and consulting firm based in Southlake, Texas. As a firm, ValueScope completes over 300 projects per year, most
requiring valuation opinions or conclusions of value. ValueScope&#8217;s principals and senior staff have been retained
over 100 times by federal agencies to assist in valuation matters and dispute resolutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope&#8217;s
principals and senior staff have issued numerous fairness opinions (as well as solvency opinions) for boards of directors and company
shareholders for a period of 35 years. Within the last few years ValueScope has issued multiple opinions relating to SPAC and &#8220;de-SPAC&#8221;
transactions. In the second half of 2022, ValueScope has completed, or is currently engaged to complete, eight de-SPAC fairness opinions.
Additionally, ValueScope has extensive experience with SPACs outside of fairness opinions and has recently conducted valuations on warrants
for approximately a dozen SPACs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
of Global Biotechnology Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
estimated the probability of each of Conduit&#8217;s indications success based on a review of academic studies, which analyzed historical
data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_001.jpg" alt="" style="height: 365px; width: 412px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Base-Case
probability of success figures for each phase calculated based on average of selected datapoints from two studies: Chi HeemWong, KienWei
Siah, Andrew W Lo, Estimation of clinical trial success rates and related parameters, Biostatistics, Volume 20, Issue 2, April 2019,Pages
273&#8211;286</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Biotechnology
Innovation Organization, Informa Pharma Intelligence, QLS, Clinical Development Success Rates and Contributing Factors 2011-2020, February
2021</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
considered the global biotechnology industry, which comprises a large range of companies engaged in diverse activities, such as biopharmaceutical
development. Industry companies also span across a wide spectrum of operational models. Some small, dedicated biotechnology companies
are research and development intensive and operate primarily with venture capital, grants, initial public offerings and collaborative
agreements. Conversely, large, diversified companies hold significant in-house research and development resources and well-established
production, commercialization and distribution processes. Industry revenue is expected to increase at an annualized rate of 3.1% to $358.2
billion over the next five years, with more profound growth tempered by the pandemic. Increased research and development funding and
consumer spending in 2022 are expected to catalyze revenue growing 2.9% the same year. Global investor confidence has fallen during the
period, which served to somewhat subdue revenue growth. However, global investment in research and development has grown strongly and
consistently in recent years, with much of this funding funneled into medical biotechnology development, aimed at providing better care
for the aging global population, thus bolstering industry revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_002.jpg" alt="" style="height: 367px; width: 386px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>IBISWorld
Industry Report L6724-GL &#8211; Global Biotechnology, May 2021</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the previous five years, pharmaceutical companies have benefited from an aging population in developed economies and a growing middle
class in emerging economies. Many companies have also tapped into regional demand for pharmaceuticals that may differ from developed
markets and have expanded their global presence to tap into regional market needs. To this end, the global spread of COVID-19 (coronavirus)
offers pharmaceutical and medicine manufacturers an opportunity for growth moving forward should operators successfully develop medications
and vaccines to treat the virus, which several companies have successfully done.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
cliffs occur when the patent expires on a product and its market share faces a steep and rapid decline. Patent cliffs have continued
to hamper industry revenue during the current period. When drugs lose patent exclusivity, the market is inundated with low-cost generic
drugs. As manufacturers contend with more price-based competition from generics, many operators respond by lowering their research &amp;
development expenditures, which limits the industry&#8217;s drug pipelines. Additionally, many governments and health insurance organizations
have reduced their drug reimbursements to control healthcare costs, such as implementing incentives for patients to use generic drugs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
considered that industry revenue is estimated to grow an annualized 3.2% to $1.3 trillion over the next five years amid an anticipated
persistence of global demand for industry products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_003.jpg" alt="" style="height: 348px; width: 366px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>IBISWorld
Industry Report C1933-GL &#8211; Global Pharmaceuticals &amp; Medicine Manufacturing, June 2021</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Valuation
Methodology &#8211; Income Approach</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income and market approaches are most appropriate when conducting a valuation of a going-concern. Due to the stage of Conduit and reliance
on future cash flows from new products, ValueScope believed the market approach would not provide a meaningful estimate of value. Therefore,
ValueScope relied on the income approach to determine the intrinsic value of Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
assessed the enterprise value of Conduit utilizing the Sum of the Parts (&#8220;SOTP&#8221;) approach to the application of a discounted
cash flow (&#8220;DCF&#8221;) analysis. ValueScope determined a SOTP approach was appropriate as each product of Conduit is subject to
unique risks and projections. The DCF methodology is based on a multi-period analysis that seeks to approximate the present value of
projected free cash flows. Under the SOTP approach, each product&#8217;s performance and value was forecasted on a stand-alone basis.
Each therapeutic application&#8217;s revenue was forecasted using development and launch timing assumptions, market size forecasts, market
share and penetration rates, and licensing royalty rates. The forecasted revenue was then adjusted based on each application&#8217;s
probability of success (&#8220;PoS&#8221;). Each potential product&#8217;s associated development costs were forecasted as well, based
on the expected development timeline. The resulting future net cash flow was then discounted to the present value, using an appropriate
discount rate to arrive at stand-alone product values. Corporate overhead and operating expenses (&#8220;G&amp;A&#8221;) were also projected
and discounted to present value. The G&amp;A value was netted against the sum of the valuations of each product, resulting in an enterprise
valuation of Conduit as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
of Key Assumptions and Inputs</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current development stage of each application was provided by Conduit, which estimated that completion of Phase I clinical trials would
take approximately 1 year, Phase II clinical trials would take approximately 2 years, Phase III clinical trials would take about 1 year,
and approval from the FDA (or comparable foreign regulatory authorities) would take an additional 1 year. ValueScope researched development
timelines by phase in the pharmaceutical industry and determined that the estimates provided by Conduit management were reasonable. In
assessing the reasonableness of these development timelines, ValueScope compared Conduit&#8217;s timelines against guidance from the
FDA regarding the length of each clinical trial phase. The FDA estimates the following clinical trial timelines by phase:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
                                            I can last several months</span></td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
                                            II can last from several months to approximately two years</span></td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
                                            III can last from approximately one year to four years </span></td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
                                            post Phase III can take from 60 days to a year. </span></td></tr></table>

<p style="margin: 0; font-family: Times New Roman, Times, Serif">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">Other factors considered in evaluating
the estimates provided by Conduit included (i) review of the license agreement between St George Street Capital and AstraZeneca, which
includes the right to existing active pharmaceutical ingredients, removing much of the development time in Phase II as no drug manufacturing
is required, (ii) Conduit&#8217;s use of contract research organizations, which is intended to deliver clinical trials with speed and
efficiency and (iii) Conduit&#8217;s ability to complete the Phase II ARCADIA trial in less than one year. </span><span style="font-size: 8pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
reviewed industry and market research reports for each of the six indications that are currently in Conduit&#8217;s initial pipeline (COVID-19, uveitis, Hashimoto&#8217;s Thyroiditis,
renal transplant, preterm labor, renal transplant and idiopathic male infertility) and eight indications that may be addressed by potential
future product candidates (glioma, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">psoriasis, Crohn&#8217;s
disease, lupus, sarcoidosis, diabetic wound healing, idiopathic pulmonary fibrosis and nonalcoholic steatohepatitis). </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each individual therapeutic area was subject to its own specific future performance variables. As a result, ValueScope projected market
sizes by product are based on the individual market research reports. The research reports for each therapeutic area contained the estimated
current total market size as well as the forecasted compound annual growth rate (&#8220;CAGR&#8221;) of each market. For periods beyond
the time frame covered in the market research reports, ValueScope forecasted that the markets would continue grow in line with long-term
inflation expectations, 2.8% per the latest Federal Reserve projections as of September 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
estimated peak market share percentages for each indication based on its total addressable market size, market growth rate, existing
treatments available, product uniqueness, and input from Conduit and MURF. ValueScope assumed straight-line market share growth upon
approval based on a 5-year to peak market penetration rate as this was consistent with industry research it reviewed. ValueScope forecasted
a patent cliff when the patents expire in 2030.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
reviewed two industry studies to determine the appropriate PoS for each application by stage. ValueScope selected the PoS data it deemed
most appropriate from each study based on the therapeutic area involved and averaged the two data points to form its base-case PoS assumptions
for each indication. ValueScope estimated the PoS of each indication based on the base-case assumption and the indication&#8217;s current
stage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
intends to leverage its clinical assets to enter into advantageous licensing agreements with large global pharmaceutical companies. Conduit
intends to license the clinical assets upon successful Phase II completion. Conduit expects that the licensing agreements would provide
Conduit with development success driven milestone payments and a royalty on future revenue generated by the products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
cost estimates were provided by Conduit per stage for each product. ValueScope distributed these expected costs per phase on an annual
basis based upon its development timeline assumptions for each stage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
expects future licensing agreements to contain a royalty rate of 15.0% of revenue. ValueScope reviewed industry data and observed a range
of 12.5% to 18.0% within similar licensing agreements and used a 15.0% royalty rate in its base case. The royalty rates were applied
to all forecasted product revenue, excluding milestone payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
forecasted certain milestone payments for each product including an initial upfront payment and two additional success milestone awards
based on development success. Conduit intends to license the products upon successful completion of Phase II, whereupon Conduit will
receive an initial payment. The first milestone is contingent upon successful completion of Phase III trials. The second milestone is
contingent upon the product being approved and successfully launched to market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
determined milestone payments through discussions with Conduit and a review of industry milestone payments in historical licensing deals
with large pharmaceutical companies. The upfront payment was estimated at $115,000,000. Milestone 1 was estimated at $30,000,000 Milestone
2 was estimated at $60,000,000. ValueScope assumed all milestones were achieved in its base case and adjusted the resulting revenue for
PoS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
reviewed industry data to determine the effect of the patent cliff on pharmaceutical products. ValueScope estimated that 70% of the product&#8217;s
existing market share would be ceded within the first year to new entrants. ValueScope forecasted that 85% of existing market share would
be lost within two years and 90% would be permanently lost beyond two years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
determine an appropriate discount rate, ValueScope calculated the weighted average cost of capital (&#8220;WACC&#8221;) of Conduit as
a whole. The WACC approximates the expected return required by debt and equity holders on invested capital within the industry. Equity
return assumptions were determined using the capital asset pricing model (&#8220;CAPM&#8221;) and debt assumptions were based on the
yield of Moody&#8217;s Baa corporate bonds as of the Valuation Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
selected its terminal growth rate based on a review of long-term inflation expectations. The Philadelphia Federal Reserve&#8217;s Survey
of Professional Forecasters, published in August 2022, indicated a 2.8% long-term inflation forecast. As a mature product in a stable
market, ValueScope believes this is an appropriate expectation of long-term performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Comparable
Public Companies Selected for Beta Analysis</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to determine the industry beta to use in the WACC calculation, ValueScope selected eighteen publicly traded companies that operate
in the biopharmaceutical product development industry. ValueScope determined that these companies have similar suppliers, customers,
and face similar business and economic risks relative to Conduit. In its selection of the comparable public companies, ValueScope researched
and analyzed the U.S. pharmaceutical products industry, the global pharmaceutical products industry, and the biotechnology and therapeutics
industry. ValueScope believes that these three industries together encompass a comparable universe of companies. Conduit is engaged in
the business of developing treatments with target distribution and approval markets of both U.S. and global communities. Therefore, it
was necessary to consider companies in both the U.S. pharmaceutical market as well as the global pharmaceutical market. Conduit&#8217;s
product line is currently still in development and as such faces additional risks. Therefore, to encompass this factor, ValueScope included
companies in the biotechnology and therapeutics industry which it believes have the same risk profile. ValueScope believes that the publicly
traded companies selected from these three industries comprehensively represent a similar business profile as Conduit. </span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Pharmaceutical Companies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bristol
                                            Myers Squibb Company</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eli
                                            Lilly and Company</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pfizer
                                            Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merck
                                            &amp; Co., Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalty
                                            Pharma PLC</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vertex,
                                            Inc.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
Pharmaceutical Companies</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AstraZeneca
                                            PLC</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSK
                                            PLC</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roche
                                            Holding Ltd (Roche)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeda
                                            Pharmaceutical Company Limited</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Novartis
                                            AG</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanofi
                                            S.A.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Biotechnology
and Therapeutics Companies</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SpringWorks
                                            Therapeutics, Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fate
                                            Therapeutics, Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relay
                                            Therapeutics, Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuvation
                                            Bio, Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Replimune
                                            Group, Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xencor,
                                            Inc.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_004.jpg" alt="" style="height: 314px; width: 557px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Market
data source: S&amp;P Capital IQ as of September 30, 2022.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Levered
beta data based on 2-year weekly performance of comparable companies relative to the S&amp;P 500 Index.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unlevered
betas calculated as levered beta / [1 + (1 - tax rate) x (Debt / Equity)]. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_005.jpg" alt="" style="height: 376px; width: 514px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Probability
of Success (&#8220;PoS&#8221;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope
reviewed two studies to determine the appropriate PoS for each application by stage. ValueScope selected the most appropriate PoS data
from each study based on the therapeutic area involved and averaged the two data points to form its base-case PoS assumptions for each
indication. ValueScope estimated the PoS of each indication based on the base-case assumption and the indication&#8217;s current stage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_006.jpg" alt="" style="height: 272px; width: 550px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chi
Heem Wong, Kien Wei Siah, Andrew W Lo, Estimation of clinical trial success rates and related parameters, Biostatistics, Volume 20, Issue
2, April 2019, Pages 273&#8211;286</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Biotechnology
Innovation Organization, Informa Pharma Intelligence, QLS, Clinical Development Success Rates and Contributing Factors 2011-2020, February
2021</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">The
percentages in the &#8220;Total PoS&#8221; column in the table above indicate the probability that each indication will successfully complete
the applicable phase of development. The figures are not cumulative or conditional probabilities and assume that the preceding phase has
been completed. The Total PoS column indicates the cumulative probability of each indication successfully completing all remaining phases
of development</span><span style="font-size: 8pt"></span><span style="font-size: 10pt; color: #000099">.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63pt 0pt 1in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_007.jpg" alt="" style="height: 321px; width: 463px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above chart provides the concluded present value of each therapeutic. These values are then summed and netted against the general and
administrative expenses to determine the enterprise value of Conduit. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.6pt; margin-bottom: 6pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            &#8220;2022 Est. Market Size&#8221; column identifies the estimated total addressable market
                                            size of each therapeutic in 2022.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            &#8220;20-Year Market CAGR&#8221; column identifies the indicated estimated annual market
                                            growth over the next 20 years.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            &#8220;Peak Market Share&#8221; column identifies the peak estimated market share obtained
                                            by each therapeutic over the forecast period.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            &#8220;Probability of Success (PoS)&#8221; column restates each therapeutic&#8217;s estimated
                                            cumulative probability of success identified in the previous chart.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            &#8220;Projected 2030 Revenue&#8221; column identifies each therapeutic&#8217;s estimated
                                            revenue earned in the year 2030. It is calculated by multiplying the 2030 market size by
                                            the 2030 market share of the therapeutic.&#160;</span></td></tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_008.jpg" alt="" style="height: 323px; width: 364px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; color: #000099">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The above chart shows the value per therapeutic in graph form. This chart
is based on the same information as the immediately prior Sum of the Parts DCF Analysis Chart.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
                                            date of September 30, 2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stub
                                            period plus 20 years discounted cash flow model</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terminal
                                            value based on 90% reduction in market share due to patent expiration</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
                                            rate = WACC of 8.0%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base-case
                                            assumptions</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
                                            corporate income tax rate of 21.0% assumed</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concluded
                                            product portfolio value of $748.4 million</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
                                            and administrative expenses projected to grow annually with inflation at 2.8% and valued
                                            at negative $66.4 million</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base-case
                                            enterprise value of $682.2 million</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplementary
                                            information is presented in the appendices.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concluded
Valuation Range</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following chart depicts the range of the concluded value per therapeutic based on the concluded WACC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_009.jpg" alt="" style="height: 238px; width: 524px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
determine a reasonable range of value for Conduit, ValueScope sensitized the WACC and conducted a low case and a high case analysis.
WACC has an inverse relationship with present value as a greater required return reduces the value to investors. The WACC used in the
low-case was 8.6% and the WACC used in the high-case was 7.4%. Based on this analysis, ValueScope concluded that the enterprise value
range of Conduit is approximately $660.4 million to $706.9 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional
Valuation Scenario Analysis</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#8220;Royalty Rate Sensitivity&#8221; horizontal bar chart depicts the range of the concluded value per therapeutic based on the selected
royalty rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#8220;Probability of Success Sensitivity&#8221; horizontal bar chart depicts the range of the concluded value per therapeutic based
on the selected probability of success.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-4_010.jpg" alt="" style="height: 350px; width: 670px" /><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
ValueScope&#8217;s industry research, Phase II licensing deals with large pharmaceutical companies had royalty rates which ranged from
approximately 12.5% to 18.0%. ValueScope used this royalty range to sensitize the expected enterprise value of the Company. Using the
royalty rate range of 12.5% to 18.0%, the implied enterprise value of Conduit ranged from $642.8 million to $728.9 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low
case values calculated solely using data from Biotechnology Innovation Organization, Informa Pharma Intelligence, Quantitative Life Sciences
Advisors, Clinical Development Success Rates and Contributing Factors 2011&#8211;2020, February 2021. High case values calculated solely
using Chi Heem Wong, Kien Wei Siah, Andrew W Lo, Estimation of clinical trial success rates and related parameters, Biostatistics, Volume
20, Issue 2, April 2019, Pages 273&#8211;286. ValueScope sensitized the implied enterprise value of the Company using these probabilities
of success. This resulted in a range of value of the Company of $477.2 million to $882.4 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Unaudited Conduit Prospective Financial Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
MURF nor Conduit, as a matter of course, makes public projections as to future projected revenue, earnings, or other results. On August
1, 2022, Conduit provided to MURF certain internal market assessments previously prepared by Conduit. These market assessments were provided
to MURF in connection with the evaluation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Conduit management created limited financial projections regarding expenses and operating losses of Conduit, as summarized
in the table below. These expenses represented general operating expenses needed to operate the Company. Such information was provided
to MURF which MURF provided to ValueScope in connection with its fairness opinion described in this proxy statement/prospectus under
&#8220;&#8212; Opinion of ValueScope, Inc.&#8221; Conduit management prepared such market assessments and projected expenses and operating
losses based on its judgment and assumptions, as summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_011.jpg" alt="" style="height: 68px; width: 624px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">The
projections in the above chart identify the projected general and administrative expenses for the years 2022 through 2032. The general
and administrative expenses are netted against the value of the therapeutics to determine the value of the Company.</span><span style="font-size: 8pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_012.jpg" alt="" style="height: 292px; width: 670px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above chart depicts the projected income statement for the Company if ValueScope did not probability of success weight the projections.
This assumes that every therapeutic was 100% approved. This forecast was subsequently PoS adjusted in the conclusion of fairness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in the above two tables represent the 2022 stub period (Q4) plus the first ten years of its 20-Year DCF model on a base-case non-probability adjusted
basis. In its valuation, ValueScope adjusted the pre-tax income of each product for the probability of its success at that point in time.
We projected licensing revenue for each product as well as milestone payments. ValueScope also forecasted development costs and general
and administrative expenses for Conduit. Conduit&#8217;s revenue was projected to grow rapidly once several products launch to market,
after which, revenue was projected to grow steadily until the product&#8217;s patents are expected to expire in 2030. After patent expiry,
the products lose exclusivity and are forecasted to cede significant market share to new entrants. This results in declining revenue
over the three years after expiry. Thereafter, revenue is forecasted to grow steadily at a low rate as the total addressable market expands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above estimates are based on the assumption that Conduit would complete the Business Combination and become a publicly traded company
in fiscal year 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inclusion of the above information should not be regarded as an indication that MURF, Conduit, or any of their respective financial advisors
or any other recipient of this information, considered &#8212; or now considers &#8212; it to be predictive of actual future results.
The information regarding projected expenses and operating losses is speculative in many respects. As a result, there can be no assurance
that the actual results will not be significantly lower than estimated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
information was not prepared with a view toward public disclosure, or with a view toward complying with the guidelines of the SEC, or
the guidelines established by the American Institute of Certified Public Accountants with respect to projected financial information.
This information was prepared exclusively by Conduit. Neither MURF&#8217;s nor Conduit&#8217;s independent auditors, independent accountants
nor any other financial advisors of MURF or Conduit, have compiled, examined or performed any procedures with respect to the information
contained in this section, nor have they expressed any opinion, representation or any other form of assurance on such information or
its achievability, and assume no responsibility for, and disclaim any association with, this information. The audit reports included
in this proxy statement/prospectus relate to historical financial information. They do not extend to the projected information and should
not be read to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summary of the information included above is not being included to influence your decision whether to vote to approve the Business Combination.
It is being provided solely because it was made available by Conduit in connection with the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conclusion
&amp; Opinion </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValueScope&#8217;s
analysis provided a fair market valuation range of Conduit of approximately $660.4 million to $706.9 million, exclusive of debt and cash.
ValueScope&#8217;s base-case valuation is $682.0 million, and the offer price is $650.0 million. Based on ValueScope&#8217;s analysis,
it is their opinion that the Business Combination is &#8220;fair&#8221; to shareholders of MURF from a financial perspective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quorum</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
presence, in person (by virtual attendance) or by proxy, of a majority of all the outstanding shares of MURF
common stock entitled to vote constitutes a quorum at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstentions
and Broker Non-Votes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxies
that are marked &#8220;abstain&#8221; and proxies relating to &#8220;street name&#8221; shares that are returned to MURF but marked
by brokers as &#8220;not voted&#8221; will be treated as shares present for purposes of determining the presence of a quorum on all
matters. The latter will not be treated as shares entitled to vote on the matter as to which authority to vote is withheld from the
broker. If a stockholder does not give the broker voting instructions, under applicable self-regulatory organization rules, its
broker may not vote its shares on &#8220;non-routine&#8221; proposals, such as the business combination proposal, the charter
amendment proposals, the advisory charter amendments proposals, and the incentive plan proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the business combination proposal, and the advisory charter amendments proposals will require the
affirmative vote for the proposal by the holders of a majority of the then outstanding shares of MURF common stock. The approval of the charter amendment proposals requires the affirmative
vote of a majority of the issued and outstanding shares of each of the Class A common stock and Class B common stock, voting separately,
as well as the vote of a majority of the issued and outstanding shares of Class A common stock and Class B common stock, voting together
as a single class. Abstentions and broker
non-votes have the same effect as a vote against the proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the incentive plan proposal, the Nasdaq proposal and adjournment proposal, if presented, will require the affirmative vote
of the holders of a majority of MURF common stock represented and entitled to vote thereon at the meeting. Abstentions are deemed entitled
to vote on such proposals. Therefore, they have the same effect as a vote against the proposals. Broker non-votes are not deemed entitled
to vote on such proposals and, therefore, they will have no effect on the vote on such proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are elected by a plurality. &#8220;Plurality&#8221; means that the individuals who receive the largest number of votes cast &#8220;FOR&#8221;
are elected as directors. Consequently, any shares not voted &#8220;FOR&#8221; a particular nominee (whether as a result of an abstention,
a direction to withhold authority or a broker non-vote) will not be counted in the nominee&#8217;s favor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
Your Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of MURF common stock that you own in your name entitles you to one vote. Your proxy card shows the number of shares of MURF common
stock that you own. If your shares are held in &#8220;street name&#8221; or are in a margin or similar account, you should contact your
broker to ensure that votes related to the shares you beneficially own are properly counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
stockholders may vote electronically at the Special Meeting by proxy or by visiting &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and entering the control number found on their proxy
card, voting instruction form or notice they previously received. If you vote by proxy, you may change your vote by submitting a later
dated proxy before the deadline or by voting electronically at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revoking
Your Proxy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a stockholder and you give a proxy, you may revoke it at any time before it is exercised by doing any one of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
you may send another proxy card with a later date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
you may notify MURF&#8217;s Secretary in writing before the Special Meeting that you have revoked your proxy; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
you may virtually attend the Special Meeting, revoke your proxy, and vote at the meeting, as indicated above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
Can Answer Your Questions About Voting Your Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a stockholder and have any questions about how to vote or direct a vote in respect of your shares of MURF common stock, you may
call D.F. King &amp; Co., Inc., MURF&#8217;s proxy solicitor, at (800) 207-3159, or Jack K. Heilbron, MURF&#8217;s Chief Executive
Officer, at (760) 471-8536.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Public Shares may seek to redeem their shares to cash, regardless of whether they vote for or against the business combination proposal
or do not vote at all. Any stockholder holding Public Shares as of the record date may demand that MURF redeem such shares into a pro
rata portion of the trust account (which, for illustrative purposes, was approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per Public Share as of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, the record
date), calculated as of two business days prior to the anticipated consummation of the Business Combination. If a holder properly seeks
redemption as described in this section and the Business Combination is consummated, MURF will redeem these shares into a pro rata portion
of funds deposited in the trust account and the holder will no longer own these shares following the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
Sponsor will not have redemption rights with respect to any shares of MURF common stock owned by them, directly or indirectly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
may demand redemption by delivering their stock, either physically or electronically using Depository Trust Company&#8217;s DWAC System,
to MURF&#8217;s transfer agent prior to the vote at the meeting. MURF&#8217;S transfer agent must receive instruction to redeem by 5:00
pm Eastern Time on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, in order for such redemption demands to be valid. If you hold the shares in street name, you will have to
coordinate with your broker to have your shares certificated or delivered electronically. Certificates that have not been tendered (either
physically or electronically) in accordance with these procedures will not be redeemed for cash. There is a nominal cost associated with
this tendering process and the act of certificating the shares or delivering them through the DWAC system. The transfer agent will typically
charge the tendering broker $45 and it would be up to the broker whether or not to pass this cost on to the redeeming stockholder. In
the event the proposed business combination is not consummated this may result in an additional cost to stockholders for the return of
their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
request to redeem such shares, once made, may be withdrawn at any time up to the vote on the business combination proposal. Furthermore,
if a holder of a Public Share delivered its certificate in connection with an election of its redemption and subsequently decides prior
to the applicable date not to elect to exercise such rights, it may simply request that the transfer agent return the certificate (physically
or electronically).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination is not approved or completed for any reason, then MURF&#8217;s Public Stockholders who elected to exercise their
redemption rights will not be entitled to redeem their shares into a pro rata portion of the trust account, as applicable. In such case,
MURF will promptly return any shares delivered by public holders. If MURF would be left with less than $5,000,001 of net tangible assets
as a result of the holders of Public Shares properly demanding redemption of their shares for cash, <span style="background-color: white">or otherwise not be exempt from the
provisions of Rule 419 promulgated under the Securities Act, </span> MURF will not be able to consummate
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing price of MURF common stock on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, the record date, was $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . The cash held in the trust account on such date was $ (approximately
$ per Public Share). Prior to exercising redemption rights, stockholders should verify the market price of MURF common stock as they
may receive higher proceeds from the sale of their MURF common stock in the public market than from exercising their redemption rights
if the market price per share is higher than the redemption price. MURF cannot assure its stockholders that they will be able to sell
their shares of MURF common stock in the open market, even if the market price per share is higher than the redemption price stated above,
as there may not be sufficient liquidity in its securities when its stockholders wish to sell their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a holder of Public Shares exercises its redemption rights, then it will be exchanging its shares of MURF common stock for cash and will
no longer own those shares. You will be entitled to receive cash for these shares only if you properly demand redemption no later than
5:00 p.m., Eastern Time, on , 2023 (two (2) business days before the Special Meeting) by tendering your shares electronically using the
Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System and submitting a request in writing that MURF redeem your
Public Shares for cash to Vstock Transfer, LLC, our transfer agent, at the following email address:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">18 Lafayette Place</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">Woodmere, NY 11598</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">Attn:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">E-mail: info@vstocktransfer.com</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">MURF&#8217;S transfer agent must receive your instruction to redeem by
5:00 pm Eastern Time on &#8239;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023 in order for your redemption demand to be
valid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appraisal
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
stockholders, unitholders nor warrant holders of MURF have appraisal rights in connection with the Business Combination under the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Solicitation Costs</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is soliciting proxies on behalf of the MURF Board. This solicitation is being made by mail but also may be made by telephone or in person.
MURF and its directors, officers and employees may also solicit proxies in person, by telephone or by other electronic means. MURF will
bear the cost of the solicitation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
has hired D.F. King &amp; Co., Inc. to assist in the proxy solicitation process. MURF will pay the firm a fee of $25,000 and a discretionary
fee, if warranted in MURF&#8217;s sole discretion. In addition, MURF agreed to pay the firm additional charges for any incoming/outgoing
stockholder telephone calls on a per unit basis of $5.00. Such payments will be made from non-trust account funds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
will ask banks, brokers and other institutions, nominees and fiduciaries to forward the proxy materials to their principals and to obtain
their authority to execute proxies and voting instructions. MURF will reimburse them for their reasonable expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sponsor</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, the record date, the Sponsor beneficially owned and was entitled to vote an aggregate of 4,060,250 Private Shares that were
issued prior to or concurrently with MURF&#8217;s initial public offering. Such shares currently constitute approximately 23.49% of the
outstanding shares of MURF common stock. The Sponsor has agreed to vote such Private Shares, as well as any shares of MURF common stock
acquired in the aftermarket, in favor of the business combination proposal. The Sponsor also intends to vote its shares in favor of all
other proposals being presented at the meeting. The Private Shares held by the Sponsor have no right to participate in any redemption
distribution and will be worthless if no business combination is effected by MURF. In connection with MURF&#8217;s initial public offering,
the Sponsor entered into a letter agreement containing certain lock-up provisions which provide that the Founder Shares may not be transferred
(subject to limited exceptions) until the earlier to occur of: (A) six months after the completion of MURF&#8217;s initial business combination,
and (B) subsequent to the initial business combination if MURF completes a liquidation, merger, stock exchange or other similar transaction
that results in all of our public stockholders having the right to exchange their public shares for cash, securities or other property.
Also, and notwithstanding the foregoing, if subsequent to MURF&#8217;s initial business combination the reported last sale price of its
Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 90 days after MURF&#8217;s initial business
combination, all of the founder shares will be released from the lock-up. The Sponsor agreed not to transfer any Private Shares or MURF
common stock issuable upon exercise of the Private Warrants until 30 days after completion of MURF&#8217;s initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time prior to the Special Meeting, during a period when they are not then aware of any material nonpublic information regarding
MURF or its securities, the Sponsor, MURF&#8217;s officers or directors, Conduit or its shareholders and/or their respective
affiliates may purchase shares from institutional and other investors who vote, or indicate an intention to vote, against the
business combination proposal, or execute agreements to purchase such shares from such investors in the future, or they may enter
into transactions with such investors and others to provide them with incentives to acquire shares of MURF common stock or vote
their shares in favor of the business combination proposal. The purpose of such share purchases and other transactions could be to
increase the likelihood of satisfaction of the requirements to complete the Business Combination where it appears that such
requirements would otherwise not be met. While the exact nature of any such incentives has not been determined as of the date of
this proxy statement/prospectus, they might include, without limitation, arrangements to protect such investors or holders against
potential loss in value of their shares, including the granting of put options and the transfer to such investors or holders of
shares or rights owned by the Sponsor for nominal value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entering
into any such arrangements may have a depressive effect on MURF common stock. For example, as a result of these arrangements, an investor
or holder may have the ability to effectively purchase shares at a price lower than market value and may therefore be more likely to
sell shares, either prior to or immediately after the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
such transactions are effected, the consequence could be to cause the Business Combination to be approved in circumstances where such
approval could not otherwise be obtained. Purchases of shares by the persons described above would allow them to exert more influence
over the approval of the business combination proposal and other proposals and would likely increase the chances that such proposals
would be approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the date of this proxy statement/prospectus, no agreements with respect to the private purchase of public shares by the persons
described above have been entered into with any such investor or holder. In the event of any such newly purchases shares (i) the Sponsor
or its affiliates will purchase the MURF common stock at a price no higher than the price offered through the redemption process; (ii)
any such purchases by Sponsor or its affiliates will not be voted in favor of approving the Business Combination; and (iii) the Sponsor
and its affiliates have waived their redemption rights to such shares. Prior to the special meeting to approve the Business Combination,
MURF will disclose in a Form 8-K (i) the amount of public shares purchased outside of the redemption offer by the Sponsor or its affiliates,
along with the purchase price; (ii) the purpose of the purchases by the Sponsor or its affiliates; (iii) the impact, if any, of the purchases
by the Sponsor or its affiliates on the likelihood that the Business Combination transaction will be approved; (iv) the identities of
stockholders who sold to the Sponsor or its affiliates (if not purchased on the open market) or the nature of stockholders (e.g., 5% security
holders) who sold to the Sponsor or its affiliates; and (v) the number of shares of MURF common stock for which MURF has received redemption
requests pursuant to its redemption offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_009"></span>THE
BUSINESS COMBINATION PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion in this proxy statement/prospectus of the Business Combination and the principal terms of the Merger Agreement is subject
to, and is qualified in its entirety by reference to, the Merger Agreement. A copy of the Merger Agreement is attached as Annexes A-1
through A-3 to this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Structure
of the Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement provides, among other things, for Merger Sub to merge with and into Conduit, with Conduit surviving as a wholly-owned
subsidiary of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Merger Agreement, the shareholders of Conduit will receive the number of New Conduit common stock that shall have an aggregate
value equal to Six Hundred Fifty Million Dollars ($650,000,000). With each share of New Conduit common stock being valued at $10.00,
Conduit&#8217;s outstanding ordinary shares (including the ordinary shares issued upon conversion of all outstanding convertible
debt, which conversion shall have occurred prior to the consummation of the Business Combination) will be converted into
an aggregate of 65,000,000 shares of the common stock of New Conduit following the Business Combination, with each such outstanding
Conduit ordinary share converted into shares of the common stock of New Conduit
on a pro rata basis. Each outstanding share of MURF common stock immediately prior to the Business Combination shall automatically convert into
and become one share of the common stock of New Conduit without any action on the part of any holders of such common
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
this proxy statement/prospectus covers up to an aggregate of 65,000,000 shares of common stock of New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, each outstanding share of MURF common stock, by its terms, will automatically convert into
one share of common stock of New Conduit upon consummation of the Business Combination. Each outstanding warrant of MURF entitles the
holder thereof to purchase shares of New Conduit common stock beginning on the later of 30 days after the consummation of a business
combination and 12 months from the closing of the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
after the closing of the Business Combination, assuming no Public Stockholder exercises its redemption rights, MURF&#8217;s initial
stockholder, our Sponsor, will retain an ownership interest of 17,285,250 shares of New Conduit common stock or approximately 20% of
New Conduit common stock and Conduit&#8217;s shareholders (including holders of ordinary shares issued upon conversion of all
outstanding convertible debt, which conversion shall have occurred prior to the consummation of the Business Combination) will own
67,700,000 shares of New Conduit common stock or approximately 80% of the New Conduit common stock, which reflects 65,000,000 shares
of New Conduit common stock to be issued to the Conduit shareholders as consideration in the merger plus the 2,700,000 shares of New
Conduit common stock to be issued to the Private Placement Investor in connection with the Private Placement as the Private
Placement Investor is an affiliate of one of Conduit&#8217;s existing shareholders, in each case, based on the number of shares of
MURF common stock outstanding as of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conduit
Headquarters; Stock Symbols</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
completion of the Business Combination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            corporate headquarters and principal executive offices of New Conduit will be located at
                                            4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123, which is MURF&#8217;s corporate
                                            headquarters; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the parties&#8217; application for listing is approved, New Conduit common stock and warrants
                                            will be traded on the Nasdaq Stock Market under the symbols &#8220;CDT&#8221; and &#8220;CDTTW&#8221;,
                                            respectively.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Background
of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is a blank check company formed in order to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization
or other similar business combination with one or more businesses or entities. MURF was incorporated under the laws of the State of Delaware
on October 19, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2022, MURF closed its initial public offering. Prior to the consummation of its initial public offering, neither MURF, nor
anyone on its behalf, contacted any prospective target businesses or had any substantive discussions, formal or otherwise, with respect
to a transaction with MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination with Conduit is the result of an extensive search for a potential transaction and business combination utilizing
the network and investing and transaction experience of MURF&#8217;s management team and the MURF Board. The terms of the Merger Agreement
are the result of arm&#8217;s-length negotiations between representatives of MURF and Conduit. The following is a brief discussion of
the background of these negotiations, the Merger Agreement and the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date of the initial public offering through the signing of the Merger Agreement with Conduit on November 8, 2022, representatives
of MURF contacted and were contacted by a number of individuals and entities with respect to business combination opportunities and engaged
in discussions with several possible target businesses regarding potential transactions. During that period, MURF&#8217;s officers and
directors identified and met with over 100 potential target businesses from a wide range of industry segments and had in person and/or
virtual and telephonic meetings with many target management teams, owners, and their representatives. MURF executed 11 non-disclosure
agreements to learn about targets&#8217; financial conditions, state of corporate governance, and business prospects in greater detail.
The decision not to pursue any particular target business that MURF analyzed was generally the result of one or more of (i) MURF&#8217;s
determination that such business did not have a realistic sense of its likely public market valuation, (ii) a potential target&#8217;s
unwillingness to abide by public company disclosure, compliance, and governance requirements, and (iii) a potential target&#8217;s lack
of team members with public market experience, including their inability to produce audited financial statements in a timely manner.
This list is not considered to be exhaustive but rather to enumerate the most common reasons for MURF not pursuing a particular target.
MURF conducted weekly meetings with the MURF Board to review target information and analysis, which included A.G.P., the underwriter of its initial public offering and its investment banking advisor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2022, A.G.P. asked MURF if its management was available to speak with representatives of
Conduit, and scheduled a call for July 29, 2022, on which day a non-disclosure agreement between MURF and Conduit was executed. The non-disclosure
agreement contained customary agreements by MURF and Conduit to hold information provided by the other in confidence and use such information
solely to explore their collaboration on a business combination. On July 29, 2022, Conduit conducted a management presentation for MURF
and that same day began uploading diligence items to MURF&#8217;s data room.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">Conduit</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt">entered
into an engagement letter with A.G.P. on August 2, 2022, pursuant to which Conduit engaged A.G.P. as its exclusive financial advisor
relating to the purchase or sale of all, or substantially all, of Conduit&#8217;s securities to any Nasdaq or NYSE listed vehicle introduced
to Conduit by A.G.P. At the time that A.G.P. introduced Conduit to MURF, A.G.P. informed Conduit that A.G.P. had a prior relationship
with MURF and its Sponsor, relating to an initial underwritten public offering of MURF. In addition, Conduit informed its legal counsel
of A.G.P.&#8217;s past relationship with MURF. As exclusive financial advisor to Conduit in connection with the consummation
of the Business Combination, it is anticipated that A.G.P. will be paid a cash fee of $6,500,000 and reimbursement of certain costs
and expenses and will be issued 1,300,000 shares of New Conduit common stock and warrants to purchase 54,000 shares of New Conduit common
stock at an exercise price of $11.00 per share. </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">A.G.P. does not have a written
engagement letter with MURF relating to the Business Combination; however, in connection with the consummation of the Business
Combination, A.G.P. will be entitled to the payment of <span style="background-color: white">$4,628,750 </span>in deferred underwriting
fees that it was entitled to as a result of its engagement in connection with MURF&#8217;s initial underwritten public offering. On August
17, 2022, MURF learned of the financial advisory relationship between Conduit and A.G.P. and the cash fees due to A.G.P. from Conduit.
On or around April 25, 2023, the MURF Board reviewed and approved the A.G.P. additional compensation of 1,300,000 shares of New
Conduit common stock and warrants to purchase 54,000 shares of New Conduit common stock at an exercise price of $11.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">Throughout the negotiation
and drafting of the Merger Agreement and private placement documents and continuing through the date of this proxy statement/prospectus,
MURF took steps to mitigate the risks resulting from potential conflicts of interest relating to A.G.P.&#8217;s role as an advisor
to both MURF and Conduit by engaging ValueScope to prepare the fairness opinion, tasking MURF&#8217;s independent legal, tax, intellectual
property and other advisors with due diligence responsibilities, ensuring that MURF&#8217;s legal counsel was present during planning
and strategy calls with A.G.P., discussing with its legal counsel the reasonableness of A.G.P.&#8217;s advice, and discussing the Merger
with the MURF Board on a weekly basis, relying on the MURF Board&#8217;s commercial experience in evaluating financial advice.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
Conduit&#8217;s prompt population of the data room, institutional support, and experienced management team, MURF proposed a letter of
intent on August 1, 2022, which was fully executed by all parties on August 5, 2022, for exclusivity of negotiations between the parties
until September 15, 2022. Material terms of the letter of intent provided for (i) a valuation of Conduit equal to the greater of $650
million or the valuation derived by investors in the private placement, (ii) a $50 million private placement to close concurrently with
the closing of the Business Combination, and (iii) registration rights for the Sponsor&#8217;s MURF common stock and Private Warrants.
Additionally, certain material terms in the original draft version of the letter of intent, including the Sponsor&#8217;s agreement to
waive its anti-dilution protection with respect to its MURF common stock provided by MURF&#8217;s Amended and Restated Certificate of
Incorporation, the exclusion of holders of less than 5% of Conduit&#8217;s shares from the 180 day lockup period, the Sponsor&#8217;s
designation of two directors to the board of New Conduit (instead of one director as set forth in the final letter of intent), and MURF&#8217;s
establishment of an equity incentive plan to be in place following the closing of the Business Combination, were not included in the
final version of the letter of intent. Subsequently, the parties amended the letter of intent several times to extend the expiration
date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 11, 2022, MURF and Conduit, together with their respective legal, accounting, and financial advisors, held an &#8220;all hands&#8221;
organizational call. Attending the call were representatives from A.G.P., MURF&#8217;s auditor Marcum LLP, MURF&#8217;s accounting advisor
Brio Financial Group, MURF&#8217;s corporate counsel Sichenzia Ross Ference LLP (&#8220;SRF&#8221;), Conduit&#8217;s former auditor RSM,
Conduit&#8217;s financial advisors CFGI and Conduit&#8217;s corporate counsel Thompson Hine LLP (&#8220;Thompson Hine&#8221;). At that
point, MURF began more intensive due diligence, including its legal, tax, intellectual property and other advisors to review information
being uploaded to the data room and shared by Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
diligence efforts included a review of the operations, corporate governance documents, regulatory and other healthcare matters, financial
condition, intellectual property, material contracts, pre-clinical data, clinical study reports, investigators&#8217; brochures, peer-reviewed
and other publications, clinical development plans, a clinical study protocol and clinical study report, technology, suppliers, team
members, and corporate structure of Conduit and such other customary areas of due diligence for a potential business combination. MURF&#8217;s
legal advisor, Sichenzia Ross Ference LLP, and intellectual property counsel, commenced legal and intellectual property diligence on
Conduit on behalf of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial draft of the Merger Agreement was provided by SRF to Thompson Hine on September 8, 2022 and provided for, among other things: (i) a transaction structure which required
soliciting and obtaining the approval of MURF and Conduit shareholders after the execution of the merger agreement, (ii) the issuance
of MURF common stock as consideration in the merger pursuant to a registration statement, (iii) a mutual closing condition in favor of
both MURF and Conduit providing that MURF&#8217;s cash at closing (the funds contained in the trust account as of immediately prior to
the effective time, plus all other cash and cash equivalents of MURF, minus the aggregate amount of cash proceeds that would be required
to satisfy the redemption of any shares of MURF common stock pursuant to the redemption offer (to the extent not already paid), plus
the cash proceeds from the private placement) would equal or exceed or $27 million, (iv) regulatory efforts and covenants requiring the
parties to use reasonable best efforts to take all actions necessary in order to obtain regulatory clearance, (v) the entry into certain
ancillary agreements concurrently with the execution of the merger agreement, and (vi) representations, warranties and covenants customary
for transactions of this type.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thompson
Hine sent comments back on the Merger Agreement on September 22, 2022, primarily relating to Conduit&#8217;s employee benefit plans,
real property, intellectual property, taxation, environmental matters, insurance and Conduit&#8217;s organizational structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 16, 2022, SRF sent a diligence request list to Conduit and Thompson Hine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 23, 2022, MURF requested additional diligence items related to Conduit&#8217;s products, intellectual property, clinical investigation
and trial record, correspondence with regulators and ongoing, planned or terminated clinical research.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">The MURF Board discussed the
need to obtain additional financing for the combined company at regular intervals since the introduction to Conduit, viewing Conduit as
an early-stage company which will require funding to advance its assets through clinical trials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-size: 10pt">The
negotiation and marketing of the private placement was led by Conduit&#8217;s management, with minimal input from A.G.P. or MURF, other
than MURF&#8217;s approval of the proposed terms. The Private Placement Investor, an owner of certain of Conduit&#8217;s outstanding convertible
debt, was identified by Conduit on or around September 18, 2022. The initial terms of the private placement (a unit comprised of one share
of common stock and one warrant to purchase a share of common stock at $10.00 per unit with a warrant exercise price of $11.50 per share)
were proposed by A.G.P. and were intended to be substantially similar to the terms of MURF&#8217;s initial public offering. The MURF Board
viewed the private placement terms as described in the term sheet favorably, as they were substantially similar to the terms of the units
sold in the initial public offering, despite worsening market conditions since the initial public offering that favored investor-friendly
terms, and have no repricing for future lower-priced issuances. </span><span style="font-size: 8pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 26, 2022, MURF, Conduit and the Private Placement Investor who signed a term sheet for the private placement, setting the amount
to be raised at $27 million at a purchase price of $10.00 per share together with 100% warrant coverage with the warrants having an exercise
price of $11.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2022, Conduit responded to SRF&#8217;s diligence questions related to investor brochures, pre-clinical pharmacology, pre-clinical
safety pharmacology study reports, GLP toxicology (pre-clinical) study reports and minutes of meetings with regulatory agencies. In addition,
Conduit provided the documentation requested by the due diligence request list that was sent on September 16, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">On or around the first two
weeks of October 2022, Mr. Sragovicz discussed remaining with MURF as Chief Financial Officer following the closing the Business Combination
first with A.G.P. and then with Conduit. Mr. Sragovicz and Conduit discussed that his compensation should be commensurate with the compensation
of similarly situated public companies in the same industry. On May 1, 2023 Conduit proposed compensation consisting of (i) an annual
base salary of $400,000, and (ii) a target annual bonus opportunity equal to 40% of the base salary, payable based on the achievement
of performance objectives as determined by the New Conduit board of directors. In addition, Conduit&#8217;s proposed employment letter
provides that he will be entitled to receive a sign-on stock option award to purchase 0.15% of the shares of common stock of New Conduit
pursuant to the terms of the 2023 Stock Incentive Plan, which shall vest in equal annual installments on the first four anniversaries
of the Merger. (The terms of Mr. Sragovicz&#8217;s compensation have not been finalized as of the date of this proxy statement/prospectus.)</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2022, MURF requested additional diligence information and circulated a revised Merger Agreement with changes primarily relating
to Conduit&#8217;s convertible debt, the fairness opinion, and the Outside Date. In addition. Thompson Hine circulated drafts of the
private placement subscription agreement and warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2022, MURF, Conduit, St George Street Capital and CNF Pharma, LLC, MURF&#8217;s scientific advisors, executed a mutual non-disclosure
agreement and St George Street Capital commenced providing diligence material to MURF and its advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Throughout
October 2022 and through early November 2022 until the signing of the Merger Agreement, MURF and its advisors conducted due diligence
on Conduit and engaged in several phone calls with Conduit&#8217;s management relating to Conduit&#8217;s products, material products
and intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">On October 6, 2022, Thompson
Hine circulated initial drafts of the subscription agreement and warrant for the private placement, with terms substantially similar to
those set forth in the September 26, 2022 term sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">On October 11, 2022, SRF circulated
revised drafts of the subscription agreement and warrant for the private placement, with changes primarily related to descriptions of
MURF&#8217;s capital structure, public information failure penalties, the Private Placement Investor&#8217;s registration rights and,
in the warrant, a 4.99% ownership blocker.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify">On October 14, 2022, Thompson
Hine circulated revised drafts of the subscription agreement and warrant for the private placement, incorporating SRF&#8217;s changes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 14, 2022, Thompson Hine circulated a revised Merger Agreement with changes primarily relating to defined terms, the truthfulness
of statements included in the disclosure schedules, and the timing for delivery of the fairness opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 28, 2022, SRF circulated drafts of the each of the Sponsor Support Agreement and the Shareholder Support Agreement, as well as
drafts of the Proposed Charter and bylaws for New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 3, 2022, Thompson Hine circulated a revised Merger Agreement with changes primarily relating to defined terms and Conduit&#8217;s
and Merger Sub&#8217;s capitalizations, and circulated revised ancillary documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">On November 3, 2022, Thompson
Hine circulated a revised subscription agreement and warrant for the private placement with minor, non-substantive changes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2022, SRF circulated a revised Merger Agreement with changes primarily related to closing conditions and revised ancillary
documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
and its advisors arrived at the proposed valuation for Conduit by using a discounted cash flow sum of the parts valuation. This analysis
included assumptions about development timeline, addressable market size, market share and launch curve, probability of success, licensing
agreements, development costs, royalty rates, milestone hurdles, milestone payments, patent cliffs, and applicable discount and terminal
growth rates. MURF also considered qualitative differences, based on the experience of its management team, in the operating and financial
characteristics of similar companies, as well as other factors that could affect the public trading values of the companies reviewed,
to provide a context in which to consider the results of the quantitative analysis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
compared to the pro forma enterprise value determined in accordance with MURF&#8217;s analysis, and using market information available
at the time, the comparative analysis showed that Conduit&#8217;s pro forma enterprise value was reasonable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2022, MURF engaged ValueScope Inc. (&#8220;ValueScope&#8221;) to evaluate the proposed transaction and render to the MURF
Board an opinion as to whether the consideration to be paid or issued by MURF in the transaction is fair, from a financial point of view
to MURF&#8217;s stockholders. The MURF Board determined to seek this opinion in order to obtain a view from a third party with experience
in de-SPAC transactions regarding the fairness, from a financial point of view, to MURF stockholders of the consideration paid by MURF
to Conduit pursuant to the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fall of 2022, the draft Merger Agreement and progress on due diligence was discussed at an all weekly MURF Board meetings,
held virtually on each Thursdays.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the November 3, 2022 meeting, the full MURF Board had a robust discussion about the transaction, valuation, closing conditions, potential
conflicts of interest posed by A.G.P.&#8217;s role as a financial advisor to both parties, and by Mr. Sragovicz&#8217;s
employment with New Conduit following the closing and due diligence process, which included a number of MURF&#8217;s advisors, including
A.G.P., as well as representatives of ValueScope. Messrs. Benjamin Westcott, Martin Hanan, Nathan Hoelscher, and Jason Wainwright each
from ValueScope provided ValueScope&#8217;s draft opinion to the MURF Board that the 65,000,000 new shares of common stock to be issued
by MURF (under the new corporate name of Conduit Pharmaceuticals Inc.) in the Business Combination pursuant to the Merger Agreement was
fair to MURF&#8217;s stockholders from a financial point of view. The representatives of ValueScope confirmed that ValueScope&#8217;s
signed opinion would be identical to the draft opinion. After further discussion of the Merger Agreement, the Private Placement, the
ValueScope fairness opinion and related documents and agreements, the MURF Board approved a motion giving MURF management authority to
finalize all transaction documentation and to circulate all final documentation to the MURF Board. Following distribution of final transaction
documentation later on November 3, 2022, the MURF Board executed a written consent dated November 4, 2022, approving the Private Placement,
the Merger Agreement, all ancillary agreements and resolving to submit for approval of its stockholders the Merger Agreement and the
transactions contemplated thereby, including the issuance of common stock of MURF necessary to consummate the Private Placement and the
Business Combination. On November 4, 2022, ValueScope issued its fairness opinion, which was identical to the draft opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement was signed on the evening of November 8, 2022. Also on November 8, 2022, MURF and Conduit jointly issued a press release
announcing the signing of the Merger Agreement, and MURF filed a Current Report on Form 8-K announcing the execution of the Merger Agreement
and discussing the key terms of the Merger Agreement. On November 14, 2022, MURF filed a Current Report on Form 8-K disclosing the materials
terms of the Merger Agreement and ancillary agreements, including filing such agreements as exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br />
Recommendation of the MURF Board and Reasons for the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MURF management and Board, in evaluating the Business Combination, reviewed a number of materials, including the investor presentation
and analyses therein, the transaction documentation, and certain due diligence summary materials prepared by MURF&#8217;s management
team, and consulted with MURF&#8217;s management team and legal advisors. The investor presentation included a summary of the transaction
structure as well as a description of Conduit, its asset pipeline, market opportunity, management, and results of the Phase II clinical
trial of AZD1656 to treat diabetic patients suffering from COVID-19. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> In reaching its resolution (i) that the Merger Agreement and
the transactions contemplated thereby are advisable and in the best interests of MURF and its shareholders and (ii) to recommend that
MURF public stockholders adopt the Merger Agreement and approve the Business Combination and the transactions contemplated thereby, the
MURF Board considered a range of factors, including, but not limited to, the factors discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the number and wide variety of factors considered in connection with its evaluation of the Business Combination, the MURF Board
did not consider it practicable to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that
it considered in reaching its determination and supporting its decision. The MURF Board viewed its decision as being based on all of
the information available and the factors presented to and considered by it. In addition, individual directors may have given different
weight to different factors. This explanation of MURF&#8217;s reasons for the Business Combination and all other information presented
in this section is forward-looking in nature and, therefore, should be read in light of the factors discussed under &#8220;Cautionary
Note Regarding Forward-Looking Statements.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
approving the Business Combination, MURF Board obtained a fairness opinion from ValueScope, Inc. The officers and directors of MURF have
substantial experience in evaluating the operating and financial merits of companies from a wide range of industries and concluded that
their experience and background enabled them to make the necessary analyses and determinations regarding the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, MURF&#8217;s officers, directors and advisors have substantial experience with mergers and acquisitions across a variety of
different industries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
evaluating the Business Combination, the MURF Board considered criteria and guidelines to evaluate prospective business opportunities
including, but not limited to these general guidelines:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accomplished
                                            leadership;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scalable
                                            platform with public company readiness;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
                                            of value accretion via the infusion of capital/access to the capital markets;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compelling
                                            underlying value proposition(s) and a compelling risk/reward proposition;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attractiveness
                                            of the company&#8217;s assets to other larger companies/acquirors/licensees;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addressing
                                            unmet market need;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
                                            growth potential;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitive
                                            advantages;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barriers
                                            to entry;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
                                            MURF&#8217;s management team&#8217;s experiences; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            criteria.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
criteria above are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination
may be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that MURF&#8217;s
management and the MURF Board deemed relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
a presentation from Conduit&#8217;s management team and due diligence, the MURF Board determined that Conduit meets many of the above
criteria, including having:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accomplished
                                            leadership. </i>The MURF Board considered the fact that New Conduit&#8217;s Chair of the
                                            board of directors, Dr. Freda Lewis-Hall, previously served as Pfizer&#8217;s Chief Medical
                                            Officer and Executive Vice President, experience which the MURF Board believes will be of significant
                                            value to MURF shareholders. The MURF Board also considered the background of Dr. David Tapolczay,
                                            Conduit&#8217;s CEO, and his experience in the pharmaceutical industry as well as his tenure
                                            leading LifeArc, a United-Kingdom based charity advancing lab-based scientific discoveries
                                            to a point at which they can be developed into the next generation of diagnostics, treatments
                                            and cures. Dr. Lewis-Hall and Dr. Tapolczay were both instrumental in the successful launch
                                            of SpringWorks Therapeutics (Nasdaq: SWTX), a clinical-stage biopharmaceutical company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Scalable
platform with public company readiness.</i> The MURF Board considered the fact that Conduit&#8217;s leadership team has experience licensing
deprioritized assets from large pharmaceutical companies and developing them through the clinical trial process, creating a platform,
or &#8220;Conduit,&#8221; suited to drug development with great potential for scale. Conduit&#8217;s proposed leadership, including its
proposed board of directors, has extensive public company experience.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Potential
                                            of value accretion via the infusion of capital/access to the capital markets</i>. The MURF
                                            Board reviewed a list of proposed indications set forth below to be addressed by Conduit&#8217;s
                                            current assets and evaluated the estimates of Phase II investments compared to possible returns.
                                            While there can be no assurance that any of these returns will be realized, additional investments
                                            for clinical investigation are required to realize potential value, and the MURF Board believes
                                            that Conduit would be able to fund those additional investments more efficiently as a publicly
                                            traded company with capital markets access.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Licensed
    indication</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; white-space: nowrap; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conduit
    Asset</b></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Idiopathic
    male infertility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD5904</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renal
    Transplant</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COVID-19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uveitis</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Premature
    Labor</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hashimoto&#8217;s
    Thyroiditis</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Addressing
                                                                                                                                                                                                                                         unmet market need.</i> The MURF Board reviewed the indications for which Conduit has licensed assets, and determined that there are
                                                                                                                                                                                                                                         still significant market opportunities that are not currently being fully addressed, especially in the areas of
idiopathic male infertility
                                                                                                                                                                                                                                         and uveitis.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Barriers
                                                                                                                                                                                                                                         to entry. </i>The MURF Board considered that Conduit has licensing rights to the above-referenced clinical-stage pharmaceuticals for
                                                                                                                                                                                                                                         significant major pharmaceutical markets.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
                                            Condition. </i>The MURF Board also considered factors such as Conduit&#8217;s historical
                                            financial results, outlook and expansion opportunities, and financial plan. In considering
                                            those factors, the MURF Board reviewed Conduit&#8217;s historical finances and its current
                                            prospects for growth if Conduit achieves its business plan. In reviewing those factors, the
                                            MURF Board determined that Conduit has significant growth prospects.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MURF Board also considered a number of other factors pertaining to the Business Combination as generally supporting its decision to enter
into the Merger Agreement and the transactions contemplated thereby, including, but not limited to, the following material factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Due
                                            Diligence</i>. Due diligence examinations of Conduit, and discussions with Conduit&#8217;s
                                            management and MURF&#8217;s management team, business advisors and legal advisors concerning
                                            MURF&#8217;s due diligence examination of Conduit;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Negotiated
                                            Transaction.</i> The financial and other terms of the Merger Agreement and the fact that
                                            such terms and conditions are reasonable and were the product of arm&#8217;s-length negotiations
                                            between MURF and Conduit;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lock-Up</i>.
                                            The Conduit founders and senior management of Conduit have agreed to be subject to a 180-day
                                            lock-up in respect of their Conduit shares subject to early release upon achievement of a
                                            specified price target for New Conduit shares (see &#8220;The Merger Agreement&#8221;, &#8220;Certain
                                            Agreements Related to the Business Combination&#8221; and &#8220;Description of New Conduit
                                            Securities&#8221;);</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fairness
                                            Opinion</i>. The financial analyses of ValueScope, reviewed with the MURF Board on November 3,
                                            2022, and opinion dated as of November 4, 2022, as to the fairness, from a financial point
                                            of view, of the shares to be issued by MURF, in the aggregate, in the Business Combination
                                            pursuant to the Merger Agreement; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
                                            Alternatives</i>. The MURF Board believes, after a thorough review of other business combination
                                            opportunities reasonably available to MURF, that the proposed Business Combination represents
                                            the best potential business combination for MURF and the most attractive opportunity for
                                            MURF&#8217;s management to accelerate its business plan based upon the process utilized to
                                            evaluate and assess other potential acquisition targets, and the MURF Board believes that
                                            such process has not presented a better alternative.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MURF Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business Combination,
including, but not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Early-Stage
                                            Company and Limited Operating History</i>. The fact that Conduit is an early-stage company
                                            with a history of losses and a limited operating history;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Growth
                                            Initiatives May Not be Achieved.</i> The risk that Conduit&#8217;s growth initiatives may
                                            not be fully achieved or may not be achieved within the expected timeframe;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intellectual
                                            Property Risk</i>. The risk that Conduit may not have adequate intellectual property rights
                                            to carry out its business, may need to defend itself against patent, copyright, trademark,
                                            trade secret or other intellectual property infringement or misappropriation claims, and
                                            may need to enforce its intellectual property rights from unauthorized use by third parties;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clinical
                                            Development Risk</i>. The risks that are associated with clinical development. Clinical development
                                            involves a lengthy and expensive process, with an uncertain outcome. Conduit may incur additional
                                            costs or experience delays in completing, or ultimately be unable to complete, the development
                                            and commercialization of its product candidates;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regulatory
                                            Risk</i>. The risks that are associated with Conduit operating in the highly regulated healthcare
                                            industry. Failure to comply with regulations or laws could subject Conduit to significant
                                            regulatory risk, including the risk of litigation, regulatory actions and compliance issues
                                            that could subject Conduit to significant fines, penalties, judgments, remediation costs,
                                            negative publicity and requirements resulting in increased expenses;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Macroeconomic
                                            Risks</i>. Macroeconomic uncertainty, including the continuing impacts of the COVID-19 pandemic,
                                            and the effects it could have on the Post-Combination Company&#8217;s revenues;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
                                            Risk</i>. The potential that a significant number of MURF public stockholders elect to redeem
                                            their shares prior to the consummation of the Business Combination and pursuant to the existing
                                            organizational documents, which would potentially make the Business Combination more difficult
                                            or impossible to complete;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
                                            Vote</i>. The risk that MURF public stockholders may fail to provide the respective votes
                                            necessary to effect the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Closing
                                            Conditions</i>. The fact that the completion of the Business Combination is conditioned on
                                            the satisfaction of certain closing conditions that are not within MURF&#8217;s control;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i>.
                                            The possibility of litigation challenging the Business Combination or that an adverse judgment
                                            granting permanent injunctive relief could indefinitely enjoin consummation of the Business
                                            Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Listing
                                            Risks.</i> The challenges associated with preparing Conduit, a private entity, for the applicable
                                            disclosure and listing requirements to which New Conduit will be subject as a publicly traded
                                            company on Nasdaq;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Benefits
                                            May Not Be Achieved</i>. The risks that the potential benefits of the Business Combination
                                            may not be fully achieved or may not be achieved within the expected timeframe;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
                                            of MURF</i>. The risks and costs to MURF if the Business Combination is not completed, including
                                            the risk of diverting management focus and resources from other business combination opportunities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Costs
                                            Savings and Growth Initiatives May Not be Achieved</i>. The risk that the cost savings and
                                            growth initiatives may not be fully achieved or may not be achieved within the expected timeframe;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>MURF
                                            Public Stockholders Receiving a Minority Position in New Conduit</i>. The risk that MURF
                                            public stockholders will hold a minority position in New Conduit;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Evolving
                                            Regulatory Regime Governing Special Purpose Acquisition Companies</i>. The risk that regulation
                                            of special purpose acquisition companies continues to evolve, and the SEC, Nasdaq and other
                                            regulators may revisit and update their laws, regulations and policies; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fees
                                            and Expenses</i>. The fees and expenses that are associated with completing the Business
                                            Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to considering the factors described above, the MURF Board also considered other factors including, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i>Interests
                                            of Certain Persons.</i> Some officers and directors of MURF may have interests in the Business
                                            Combination (see &#8220;<i>&#8212; Interests of MURF&#8217;s Directors and Officers in the
                                            Business Combination</i>&#8221; and &#8220;<i>Risk Factors &#8212; Risks Related to the Business
                                            Combination and New Conduit Common Stock Following the Business Combination</i>&#8221; );
                                            and</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
                                            Risk Factors</i>. Various other risk factors associated with the business of Conduit, as
                                            described in the section entitled &#8220;<i>Risk Factors</i>&#8221; appearing elsewhere in
                                            this proxy statement/prospectus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MURF Board concluded that the potential benefits that it expects MURF and its shareholders to achieve as a result of the Business Combination
outweighed the potentially negative and other factors associated with the Business Combination. The MURF Board also noted that MURF public
stockholders would have a substantial economic interest in Conduit (depending on the level of MURF public stockholders that sought redemption
of their public shares for cash). Accordingly, the MURF Board determined that the Business Combination and the transactions contemplated
by the Merger Agreement were advisable and in the best interests of MURF and its shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br />
Approval of the Transactions by Conduit&#8217;s Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with signing the Merger Agreement, Conduit&#8217;s board of directors unanimously approved, under written resolutions, the
Merger Agreement and the Merger, upon the terms and subject to the conditions set forth in the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of MURF&#8217;s Directors and Officers in the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
considering the recommendation of the MURF Board to vote in favor of approval of the business combination proposal, the charter amendments
proposal, the advisory charter amendments proposals, and the other proposals, stockholders should keep in mind that MURF&#8217;s Sponsor
and its directors and executive officers have interests in such proposals that are different from, or in addition to, those of MURF stockholders
generally. In particular:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
  the Business Combination with Conduit, or another business combination, is not consummated by February 7, 2024 (or such later date
  as may be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation), then MURF will (i) cease
  all operations except for the purpose of winding up, (ii) redeem the Public Shares, at a per-share price, payable in cash, equal to
  the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not
  previously released to MURF to pay MURF&#8217;s franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses),
  divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#8217; rights
  as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) subject
  to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations
  under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor (including its representatives and affiliates) and MURF&#8217;s directors and officers, are, or may in the future become,
    affiliated with entities that are engaged in a similar business to MURF&#8217;s and the Sponsor and MURF&#8217;s directors and officers
    are not prohibited from sponsoring, or otherwise becoming involved with, any other blank check companies prior to MURF completing
    its initial business combination, and as result of which, the Sponsor and MURF&#8217;s officers and directors may become aware of
    business opportunities which may be appropriate for presentation to MURF, and the other entities to which they owe fiduciary or contractual
    duties, and may have conflicts of interests in determining to which entity a particular business opportunity should be presented
    (and these conflicts may include presentation to other entities prior to their presentation, if at all, to MURF, and may not always
    be resolved in the favor of MURF, subject to applicable fiduciary duties under Delaware law, in that MURF has provided in its amended
    and restated certificate of incorporation that MURF has renounced its interest in any corporate opportunity presented to MURF).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor and the directors and officers of MURF have each waived their redemption rights with respect to any Founder Shares and Class
    A common stock held by them (other than relating to liquidating distributions to public shares from the trust account if MURF fails
    to complete its initial business combination by the time required prior to MURF&#8217;s liquidation in accordance with its amended
    and restated certificate of incorporation), which waiver was provided in connection with the initial public offering and without
    any separate consideration paid in connection with providing such waiver.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Merger Agreement contemplates that Adam Sragovicz, MURF&#8217;s current Chief Financial Officer and a director, will be the Chief
    Financial Officer of New Conduit after the closing of the Business Combination. Although the terms of Mr. Sragovicz&#8217;s employment
    have not yet been finalized, it is anticipated that he will be entitled to compensation consisting of an annual salary and
    a bonus opportunity and, in the future, Mr. Sragovicz could receive any additional cash compensation, stock options, stock awards
    or other benefits that New Conduit&#8217;s board of directors determines to pay to Mr. Sragovicz.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Heilbron, the Chief Executive Officer and Chairman of MURF is also the sole and managing member of the Sponsor.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Sponsor paid an aggregate of approximately $25,000 for the Founder Shares and the market value of such securities as of April 30,
    2023 was approximately $34,352,000, and such securities should have a significantly higher value than $20,000 at the time of
    the Business Combination, and if MURF does not complete an initial business combination will expire worthless.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The
                                            Sponsor paid $<span style="background-color: white">7,540,000</span> for the 745,000 private
                                            placement units (consisting of 745,000 shares of Class A common stock and the Private Warrants)
                                            in connection with MURF&#8217;s initial public offering, at a price of $10.00 per unit, the
                                            market value of such securities as of April 30, 2023 was approximately $14,457,000,
                                            and such securities should have a higher value at the time of the Business Combination than
                                            $7,540,000. If MURF does not complete an initial business combination by February 7, 2024,
                                            then the Private Warrants received as part of the private placement units will expire worthless.</p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The Sponsor and its affiliates&#8217; total potential ownership interest
    in New Conduit, assuming the exercise and conversion of all securities following the closing of the Business Combination, including
    the Private Shares, is estimated to comprise approximately 5.1% of the outstanding New Conduit common stock in a no redemption scenario
    (or a transaction value of approximately $33,884,000 or a market value of approximately $49,130,000), approximately 5.2% of
    outstanding New Conduit common stock in a 50% redemption scenario (or a transaction value of approximately $33,787,000 or a market
    value of approximately $49,130,000), and 5.3% of outstanding New Conduit common stock in a 100% maximum redemption
    scenario (or a transaction value of approximately $34,198,000 or a market value of approximately $49,130,000).</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Immediately following the closing of the Business Combination, the independent directors of the MURF Board will receive from the Sponsor an aggregate of 45,000 private placement units, consisting of, in aggregate, 45,000 shares of MURF Class A common stock and 45,000 Private Warrants, which, assuming conversion and exercise, will be 90,000 shares of New Conduit common stock of an aggregate value of approximately $942,300 (assuming that the future value of New Conduit common stock will be the same as the current value of MURF&#8217;s Class A common stock) (the &#8220;Independent Director Units&#8221;). </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The Sponsor and its affiliates can earn a positive rate of
    return on their overall investment in MURF and Conduit after the Business Combination, even if other holders of MURF common stock
    experience a negative rate of return, due to having purchased the Founder Shares, as described above, for $25,000 or approximately
    $0.006 per share. </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">On March 7, 2023, MURF has issued to Sponsor an unsecured promissory note in the principal amount of $1,500,000, portions of which may be withdrawn by MURF from time to time (the &#8220;Promissory Note&#8221;).&#160;&#160;As of April 30, 2023, MURF has submitted drawdown requests in an aggregate amount of $500,000.&#160;&#160;The Promissory Note bears no interest and is due and payable upon the earlier of the consummation of the initial business combination or the date of the liquidation of MURF.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The aggregate dollar amount that the Sponsor and its affiliates have at risk that depends on the completion of an initial business combination, including the Business Combination, is approximately $8,065,000, as of April 30, 2023, which is the current value of securities held (assuming that the current value of each of the securities held, whether publicly traded shares of MURF Class A common stock or Private Warrants, are in each case valued at the current price of MURF&#8217;s Class A common stock) and consists of (i) the Founders Shares and (ii) the 754,000 private placement units (each such unit comprised of one share of MURF&#8217;s Class A common stock and one warrant to purchase one share of MURF&#8217;s Class A common stock) purchased in connection with MURF&#8217;s initial public offering, and the Promissory Note. &#160;There are no fees due or out of pocket expenses for which Sponsor and its affiliates are awaiting reimbursement.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The aggregate dollar amount that the directors of MURF have at risk that depends on the completion of an initial business combination, including the Business Combination, is approximately $942,300, as of April 30, 2023, which is the current value of the Independent Director Units.&#160;&#160;There are no loans, fees due or out of pocket expenses for which directors are awaiting reimbursement.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">As a result of the foregoing, the Sponsor, and directors and
    officers of MURF, including Mr. Heilbron, will benefit from the completion of an initial business combination, including the Business
    Combination, and may be incentivized to complete an acquisition or business combination of a less favorable target company or on
    terms less favorable to stockholders of MURF rather than liquidate.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
  MURF is unable to complete a business combination within the required time period, its executive officers will be personally liable
  under certain circumstances described herein to ensure that the proceeds in the trust account are not reduced by the claims of target
  businesses or claims of vendors or other entities that are owed money by MURF for services rendered or contracted for or products sold
  to MURF. If MURF consummates a business combination, on the other hand, MURF will be liable for all such claims.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
  Sponsor, including its officers and directors, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred
  by them in connection with certain activities on MURF&#8217;s behalf, such as identifying and investigating possible business targets
  and business combinations. However, if MURF fails to consummate a business combination within the required period, they will not have
  any claim against the trust account for reimbursement. Accordingly, MURF may not be able to reimburse these expenses if the Business
  Combination with Conduit, or another business combination, is not completed by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation).</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The continued indemnification of current directors and officers
and the continuation of directors and officers liability insurance.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele Chiavacci Farley, a current director of the MURF Board, will be appointed
to the Board of Directors of New Conduit upon the closing of the Business Combination.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">The
MURF Board determined that Mr. Heilbron&#8217;s control of the Sponsor and the financial benefits he would individually gain as a result
of the Merger does not entitle him to benefits different from those that would be enjoyed by the Sponsor, except as disclosed above. In
evaluating the Business Combination, the MURF Board did not consider the cash bonus payable to Mr. Heilbron from Presidio Property Trust,
Inc. because the Merger Agreement was executed prior to the determination of this</span><span style="font-size: 8pt"></span> <span style="font-size: 10pt">bonus</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt">.
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">MURF&#8217;s
existing charter waives the corporate opportunities doctrine with respect to MURF or any of its officers, directors or respective affiliates.
While this may result in a potential conflict of interest as between the fiduciary duties or contractual obligations of our officers or
directors and the interests of MURF and its stockholders, the MURF Board determined that it did not impact MURF&#8217;s search for an
initial business combination target, including Conduit, <span style="background-color: white">and MURF was not prevented from reviewing
any opportunities as a result of such waiver</span></span><span style="font-size: 8pt"></span><span style="font-size: 10pt; background-color: white">.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation
of MURF Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
careful consideration of the matters described above, particularly Conduit&#8217;s accomplished leadership, scalable platform with
public company readiness, potential of value accretion, addressing of unmet market need and significant growth prospects, the MURF
Board determined unanimously that each of the business combination proposal, the charter amendment proposals, the advisory charter
amendments proposals, the director election proposal, the incentive plan proposal, the Nasdaq proposal and the adjournment proposal,
if presented, is fair to and in the best interests of MURF and its stockholders. The MURF Board has approved and declared advisable
and unanimously recommend that you vote or give instructions to vote &#8220;FOR&#8221; each of these proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing discussion of the information and factors considered by the MURF Board is not meant to be exhaustive but includes the material
information and factors considered by the MURF Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anticipated
Accounting Treatment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination will be accounted for as a reverse recapitalization
in accordance with GAAP. Under this method of accounting, MURF has been treated as the &#8220;acquired&#8221; company for financial reporting
purposes. Conduit was determined to be the accounting acquirer primarily because Conduit stakeholders will collectively own a majority
of outstanding shares of the combined company as of the closing of the merger, they have nominated four of the seven (7) board of directors
as of the closing of the merger and Conduit&#8217;s Chief Executive Officer will continue to manage the combined company. Additionally,
Conduit&#8217;s business will comprise the ongoing operations of the combined company immediately following the consummation of the Business
Combination. Accordingly, for accounting purposes, the financial statements of the combined entity will represent a continuation of the
financial statements of Conduit with the acquisition being treated as the equivalent of Conduit issuing stock for the net assets of MURF,
accompanied by a recapitalization. The net assets of MURF will be stated at historical cost, with no goodwill or other intangible assets
recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination is not subject to any additional federal or state regulatory requirement or approval, except for the filings with
the State of Delaware necessary to effectuate the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the business combination proposal will require the affirmative vote of the holders of a majority of the then outstanding
shares of MURF common stock entitled to vote at the meeting. Additionally, the Business Combination will not be consummated if MURF has
less than $5,000,001 of net tangible assets after taking into account the holders of Public Shares that properly demanded that MURF convert
their Public Shares into their pro rata share of the trust account, <span style="background-color: white">or is otherwise not exempt from
the provisions of Rule 419 promulgated under the Securities Act</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the business combination proposal is a condition to the consummation of the Business Combination. If the business combination
proposal is not approved, the other proposals (except an adjournment proposal, as described below) will not be presented to the stockholders
for a vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MURF BOARD UNANIMOUSLY RECOMMENDS THAT THE MURF STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE BUSINESS COMBINATION PROPOSAL.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_010"></span>THE
MERGER AGREEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of the merger structure and merger consideration provisions of the Merger Agreement, see the section entitled &#8220;<i>The
Business Combination Proposal</i>.&#8221; Such discussion and the following summary of other material provisions of the Merger Agreement
is qualified by reference to the complete text of the Merger Agreement, a copy of which is attached as <span style="text-decoration: underline">Annexes A-1</span>, <span style="text-decoration: underline">A-2
</span>and <span style="text-decoration: underline">A-3</span> to this proxy statement/prospectus. All stockholders are encouraged to read the Merger Agreement in its entirety
for a more complete description of the terms and conditions of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2022, MURF entered into a Merger Agreement by and among MURF, Merger Sub and Conduit, the terms of which are reflected in
the summary of the Merger Agreement below. Pursuant to and subject to the terms and conditions of the Merger Agreement, Merger Sub will
merge with and into Conduit, with Conduit surviving the merger. As a result of the Business Combination, Conduit will become a wholly-owned
subsidiary of MURF, with the shareholders of Conduit becoming stockholders of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, the shareholders of Conduit will receive the number of New Conduit common stock that shall have an
aggregate value equal to Six Hundred Fifty Million Dollars ($650,000,000). With each share of New Conduit common stock being valued
at $10.00, Conduit&#8217;s outstanding ordinary shares (including the shares issued upon conversion of all outstanding convertible
debt, which conversion shall have occurred prior to the consummation of the Business Combination) will be converted into
an aggregate of 65,000,000 shares of the common stock of New Conduit following the Business Combination, with each such outstanding
Conduit share converted into shares of the common stock of New Conduit on a pro rata basis. Additionally, each outstanding share of
MURF common stock immediately prior to the Merger, including all outstanding shares of Class B common stock, shall automatically
convert into and become one share of the common stock of New Conduit without any action on the part of any holders of such common
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination is expected to be consummated in the second quarter of 2023, following the receipt of the required approval by the
stockholders of MURF and the shareholders of Conduit and the satisfaction of certain other customary closing conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Closing
and Effective Time of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Business Combination will take place on a date no later than the third business day following the satisfaction or waiver
of the conditions described below under the subsection entitled &#8220;&#8212; <i>Conditions to the Closing of the Business Combination</i>,&#8221;
or waiver of all the conditions that are required to be satisfied prior to the closing. The Business Combination is expected to be consummated
as soon as practicable after the Special Meeting of MURF stockholders described in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Representations
and Warranties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement contains customary representations and warranties of Conduit with respect to, among other things: (i) organization and
qualification; (ii) organizational documents; (iii) capitalization; (iv) authorization to enter into the Merger Agreement and related
transactions; (v) no conflicts and non-contravention; (vi) permits and compliance; (vii) financial statements; (viii) no undisclosed
liabilities; (ix) absence of certain changes; (x) absence of litigation; (xi) employee benefit plans; (xii) labor matters; (xiii) real
property and title to and sufficiency of assets; (xiv) intellectual property; (xv) taxes; (xvi) environmental matters; (xvii) material
contracts; (xviii) insurance; (xix) internal controls; (xx) accuracy of statements; (xxi) delivery of support agreement; (xxii) board
approval; (xxiii) brokers and finders&#8217; fees; (xxiv) takeover laws; (xxv) international trade matters and anti-bribery compliance;
(xxvi) related party transactions; (xxvii) that Conduit is not an investment company; (xxviii) exclusivity of representations and warranties;
and (xxix) full disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement contains customary representations and warranties of MURF and Merger Sub with respect to, among other things: (i) corporate
organization and power; (ii) organizational documents; (iii) capitalization; (iv) authorization to enter into the Merger Agreement and
related transactions; (v) no conflicts and non-contravention; (vi) compliance; (vii) MURF publicly filed documents and financial statements;
(viii) absence of certain changes; (ix) absence of litigation; (x) board approval; (xi) no prior operations of Merger Sub; (xii) amount
in the trust account; (xiii) employees; (xiv) taxes; (xv) listing of MURF securities; (xvi) that MURF is not an investment company; (xvii)
statements in public filings; (xviii) contracts; (xix) brokers and finders&#8217; fees; (xx) delivery of support agreement; (xxi) MURF
and Merger Sub&#8217;s investigation and reliance; and (xxii) full disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Covenants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement includes customary covenants of the parties with respect to operation of their respective businesses prior to consummation
of the Business Combination and efforts to satisfy conditions to consummation of the Business Combination. The Merger Agreement also
contains additional covenants of the parties, including, among others, access to information, cooperation in the preparation of the registration
statement on Form S-4 and proxy statement required to be filed in connection with the Business Combination and to obtain all requisite
approvals of MURF&#8217;s stockholders. MURF has also agreed to include in the proxy statement the recommendation of its board that its
stockholders approve all of the proposals to be presented at the special meeting of MURF&#8217;s stockholders that will be called in
order to approve the Merger and related transactions. Conduit has agreed that, unless otherwise required or permitted under the Merger
Agreement, and subject to certain exceptions, neither it nor its subsidiaries will take the following actions, among others, without
the prior written consent of MURF (which consent will not be unreasonably conditioned, withheld, delayed or denied):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend or otherwise change its or any subsidiary&#8217;s certificate
of incorporation or bylaws or equivalent organizational documents;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue, sell, pledge, dispose of, grant or encumber, or authorize
the issuance, sale, pledge, disposition, grant or encumbrance of, any shares of any class of capital stock or other securities of Conduit
or of any subsidiary or any options, warrants, convertible securities or other rights of any kind to acquire any shares of such capital
stock, or any other ownership interest (including any phantom interest), of Conduit or any subsidiary;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) fail to maintain its or any subsidiary&#8217;s existence;
or (b) adopt or enter into a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization
or other reorganization of Conduit or any subsidiary (other than the transactions contemplated by the Merger Agreement);</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">declare, set aside, make or pay any dividend or other distribution,
payable in cash, stock, property or otherwise;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reclassify, combine, split, subdivide or redeem, or purchase
or otherwise acquire, directly or indirectly;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) acquire (including by merger, consolidation, or acquisition
of stock or assets or any other business combination), whether in whole or in part or via an equity or asset acquisition, any other corporation,
limited liability company, partnership, other business organization or any division thereof; (b) incur or guarantee any indebtedness
for borrowed money or issue any debt securities or assume, guarantee or endorse, or otherwise become responsible for, the obligations
of any person, or make any loans or advances, or intentionally grant any security interest in any of its assets, other than additional
extensions or borrowings as permitted under existing credit facilities or (c) enter into any new line of business;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make any loans, advances or capital contributions to, or investments
in, any other person (including to any of its officers, directors, agents or consultants), make any material change in its existing borrowing
or lending arrangements for or on behalf of such persons, or enter into any &#8220;keep well&#8221; or similar agreement to maintain
the financial condition of any other person, except as required under any indemnification agreement to which Conduit is a party as of
the date of the Merger Agreement and which has been disclosed in Conduit&#8217;s disclosure schedules to the Merger Agreement;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">except as otherwise permitted by the Merger Agreement, (a)
adopt, enter into or materially amend any employee benefit plan or any collective bargaining or similar agreement (including agreements
with works councils and trade unions and side letters) to which Conduit is a party or by which it is bound, (b) grant or provide any
severance, termination payments, bonus, change of control, retention, or benefits to any employee of Conduit, except in connection with
the promotion or hiring (to the extent permitted under the Merger Agreement) or separation of any employee in the ordinary course of
business, (c) hire any employee of Conduit or any other individual who is providing or will provide services to the Conduit other than
any employee with an annual base salary of less than $150,000 or any employee hired to replace terminated employees in the ordinary course
of business, (d) adopt, enter into or materially amend contracts with any consultants or natural person independent contractors that
involve consideration of more than $150,000 in the aggregate or (e) take any action to accelerate the vesting, payment or funding of
any cash or equity-based compensation, payment or benefit other than as contemplated by the Merger Agreement;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">grant any material increase in the compensation, incentives
or benefits payable or to become payable to any current or former director, officer, employee or consultant of Conduit as of the date
of the Merger Agreement, other than (a) increases in the ordinary course of business, or (b) increases required by the terms of an employee
benefit plan or applicable law;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make any change in any method of financial accounting or financial
accounting principles, policies, procedures or practices, except as required by a concurrent amendment in GAAP or applicable law made
subsequent to the date of the Merger Agreement, as agreed to by its independent accountants;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make, change or revoke any material tax election, adopt or
change any material tax accounting method or period, file any amendment to a material tax return, enter into any agreement with a governmental
authority with respect to a material amount of taxes, settle or compromise any examination, audit or other action with a governmental
authority of or relating to any material United States federal, state, local or non-United States income tax liability, consent to any
extension or waiver of the statutory period of limitations applicable to any claim or assessment in respect of taxes, or enter into any
tax sharing or similar agreement (excluding any commercial contract not primarily related to taxes) ;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">take any action, or knowingly fail to take any action, which
action or failure to act would reasonably be expected to prevent or impede the transactions from qualifying for the intended tax treatment;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter into, modify in any material respect or terminate any
contract that is (or would be if entered into prior to the date of the Merger Agreement) a material contract), other than in the ordinary
course of business;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquire any fee interest in real property;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">settle any cause of action, litigation, suit, hearing, arbitration
or other similar proceeding of any nature, civil, criminal, regulatory, administrative or otherwise, whether in equity or at law, in
contract, in tort or otherwise (a) if such settlement would require payment by Conduit in an amount greater than $200,000 or (b) to the
extent such settlement is adverse to Conduit and involves an action brought by a governmental authority or alleged criminal wrongdoing;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make or authorize any payment of, or accrual or commitment
for, capital expenditures in excess of $100,000 for any individual capital expenditure or series of related capital expenditures or $300,000
in the aggregate;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter into, renew, or materially amend, any agreement between
Conduit and a related party;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make any payment, distribution, loan or other transfer of value
to any related party, other than (a) payments to employees in the ordinary course of business, and (b) payments pursuant to agreements
between Conduit and a related party set forth on Conduit&#8217;s disclosure schedule to the Merger Agreement;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fail to maintain, cancel or materially change coverage under
any insurance policy in form and amount equivalent in all material respects to the insurance coverage currently maintained with respect
to Conduit and its assets, properties and businesses;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">permit any material item of Conduit&#8217;s intellectual property
rights to lapse or to be abandoned, invalidated, dedicated to the public, or disclaimed, or otherwise become unenforceable;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fail to conduct Conduit&#8217;s business in the ordinary course
of business consistent with past practice; and</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter into any agreement or otherwise make a binding commitment
to do any of the foregoing.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement also contains additional covenants of the parties, including covenants in connection with:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the preparation and filing by MURF of this registration statement
on Form S-4 and including the proxy statement in connection with the registration under the Securities Act of MURF&#8217;s common stock
to be issued in connection with the Business Combination;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the protection of confidential information of the parties and,
subject to confidentiality, attorney-client privilege and legal requirements, the provision of reasonable access to information;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exclusivity of discussions or negotiations, directly or
indirectly, any inquiries, proposals or offers with respect to acquire or purchase any equity ownership in Conduit or any of its controlled
affiliates or all or a material portion of assets or businesses of Conduit;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the cooperation in good faith to negotiate certain employment
agreements, to be effective on the closing date of the Business Combination;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">survival of all exculpation and indemnification rights for
all current and former directors and officers of MURF, Merger Sub and Conduit in effect as of the date of the Merger Agreement in accordance
with their respective terms; Conduit maintaining a six-year directors&#8217; and officers&#8217; liability policy covering directors
and officers currently covered by liability insurance, and covering directors of Conduit following the effective time of the Merger;
and MURF and Conduit being permitted to obtain &#8220;tail&#8221; insurance policy that provides coverage up to six years from the effective
time of the Merger for events occurring prior thereto;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            required notification of any litigation against MURF or its directors or officers by any
                                            of MURF&#8217;s stockholders or by a governmental authority prior to the closing of the Business
                                            Combination;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            party&#8217;s obligation to use reasonable best efforts to effect the intended tax treatment
                                            of the Business Combination;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that MURF will use reasonable best efforts to keep MURF&#8217;s
Class A common stock and warrants listed on Nasdaq until the closing of the Business Combination and cause New Conduit common stock issued
in connection with the Business Combination to be approved for listing on Nasdaq;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that MURF use reasonable best efforts to keep current and timely
file all reports required to be filed or furnished with the SEC and otherwise to comply in all material respects with its reporting obligations
under applicable securities laws;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each party&#8217;s obligation to use its best efforts to cause
to be done such things as are necessary, proper or advisable under applicable laws to consummate and make effective the Business Combination;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s obligation to provide notice to make appropriate
arrangements to cause the funds in the trust account to be disbursed in accordance with the terms of the Business Combination;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s obligation to adopt a resolution to make the acquisition
of MURF common stock pursuant to the Merger Agreement an exempt transaction for purposes of Section 16(b) of the Exchange Act pursuant
to Rule 16b-3 thereunder; and</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s obligation to as soon as reasonably practicable
following the date of the Merger Agreement, deliver to MURF audited financial statements for the years ending December 31, 2020 and 2021
and unaudited financial statements for subsequent interim periods.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions
to the Closing of the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Conditions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
consummation of the Merger is conditioned upon, among other things, (i) the absence of any applicable law or order that makes the
transactions contemplated by the Merger Agreement illegal or otherwise prohibits consummation of such transactions; (ii) the
registration statement becoming effective under the Securities Act; (iii) the approval by MURF&#8217;s stockholders of the Business
Combination and related transactions; (iv) the approval by Conduit&#8217;s shareholders of the Business Combination and related
transactions; (v) the aggregate cash available to MURF at the Closing (after giving effect to any redemptions by MURF&#8217;s
stockholders and the payment of all authorized transaction expenses) being at least $27,000,000; (vi) after giving effect to the
Business Combination, MURF shall have at least $5,000,001 in net tangible assets (as determined in accordance with Rule 3a51-1(g)(1)
of the Exchange Act) or shall otherwise be exempt from the provisions of Rule 419 promulgated under the Securities Act; (vii) all ancillary agreements having been executed by all parties thereto; (viii) MURF and Conduit having
cooperated in good faith to negotiate and execute new employment agreements with David Tapolczay and Adam Sragovicz, the current
Chief Financial Officer and a director of MURF; and (ix) all required filings under the Hart-Scott-Rodino Antitrust Improvements Act
of 1976, as amended, and any other governmental authority having been completed and cleared.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit&#8217;s
Conditions to the Closing of the Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of Conduit to consummate the Business Combination are subject to the satisfaction, among other things, of the following at
or prior to the Closing of the Business Combination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
and Merger Sub having duly performed or complied with all of its obligations under the Merger Agreement in all material respects; (ii)
the representations and warranties of MURF and Merger Sub being true and correct in all material respects;</span></td></tr>
                                                                                                                                                               </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            event having occurred that would result in a Murphy Material Adverse Effect;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
                                            providing Conduit a certificate from an authorized officer of MURF as to the accuracy of
                                            the foregoing conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
                                            establishment of an equity incentive plan to be in place following the closing of the Business
                                            Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
                                            and Conduit having cooperated in good faith to negotiate and execute new employment agreements
                                            with David Tapolczay and Adam Sragovicz, the current Chief Financial Officer and a director
                                            of MURF; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">certain
                                            intellectual property</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
                                            been assigned to Conduit UK Management Ltd, an entity that will be a wholly-owned subsidiary
                                            of Conduit as of the consummation of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>MURF&#8217;s
and Merger Sub&#8217;s Conditions to the Closing of the Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of MURF and Merger Sub to consummate the Business Combination are subject to the satisfaction, among other things, of the
following at or prior to the Closing of the Business Combination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            having duly performed or complied with all of their obligations under the Merger Agreement
                                            in all material respects;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            representations and warranties of Conduit being true and correct in all material respects;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            event having occurred that would result in a Company Material Adverse Effect; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            providing MURF a certificate from an authorized officer as to the accuracy of the foregoing
                                            conditions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            UK Management Ltd. will be transferred to the Company and become a wholly-owned subsidiary
                                            of the Company, and certain intellectual property having been assigned to Conduit UK Management
                                            Ltd.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Waiver</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
permitted under applicable law, MURF or Conduit may waive any inaccuracies in the representations and warranties made to such party and
contained in the Merger Agreement and waive compliance with any agreements or conditions for the benefit of such party contained in the
Merger Agreement. However, pursuant to MURF&#8217;s existing amended and restated certificate of incorporation, the condition requiring
that MURF have at least $5,000,001 of net tangible assets <span style="background-color: white">or otherwise be exempt from the provisions
of Rule 419 promulgated under the Securities Act </span> may not be waived.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement may be terminated at any time, but not later than the closing of the Business Combination, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b<span>y
                                            the mutual consent of MURF and Conduit; </span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            MURF, if any of the representations or warranties of Conduit set forth in the Merger Agreement
                                            is not true and correct, or if Conduit has failed to perform any covenant or agreement set
                                            forth in the Merger Agreement (including an obligation to consummate the </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
                                            Combination<span>), in each case such that the conditions
                                            to closing would not be satisfied and the breach or breaches causing such representations
                                            or warranties not to be true and correct, or the failure to perform any covenant or agreement,
                                            as applicable, are not cured (or waived by MURF) by the earlier of (i) the Outside Date (as
                                            defined below) or (ii) 20 days after written notice thereof is delivered to Conduit; provided,
                                            however that MURF is not then in material breach of any representation, warranty, covenant,
                                            or obligation in the Merger Agreement, which breach has not been cured; </span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            Conduit, if any of the representations or warranties of MURF or Merger Sub set forth in the
                                            Merger Agreement is not true and correct, or if MURF or Merger Sub has failed to perform
                                            any covenant or agreement set forth in the Merger Agreement (including an obligation to consummate
                                            the </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
                                            Combination<span>), in each case such that the conditions
                                            to closing would not be satisfied and the breach or breaches causing such representations
                                            or warranties not to be true and correct, or the failure to perform any covenant or agreement,
                                            as applicable, are not cured (or waived by Conduit) by the earlier of (i) the Outside Date
                                            or (ii) 20 business days after written notice thereof is delivered to MURF; provided, however
                                            that Conduit is not then in material breach of any representation, warranty, covenant, or
                                            obligation in the Merger Agreement, which breach has not been cured; </span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            either MURF or Conduit: (A) on or after February 7, 2024 (the &#8220;Outside Date&#8221;),
                                            if the Business Combination has not been consummated prior to the Outside Date; provided,
                                            however, that this right to terminate the Merger Agreement will not be available to a party
                                            if the failure of the merger to have been consummated before the Outside Date was due to
                                            such party&#8217;s breach of or failure to perform any of its covenants or agreements set
                                            forth in the Merger Agreement; or; (B) if any applicable law or order that makes the transactions
                                            contemplated by the Merger Agreement illegal or otherwise prohibits consummation of such
                                            transactions becomes final and non-appealable; (C) if MURF has not received approval from
                                            its stockholders of the Business Combination <span style="background-color: white">and related
                                            transactions at the Special Meeting; </span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            MURF if the Conduit shareholders&#8217; written consent approving the </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
                                            Combination <span style="background-color: white">and related transactions have not been
                                            obtained within 10 business days after the date of the Merger Agreement; and </span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            there is a material adverse effect on behalf of the other party.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
of Termination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of proper termination by any of the parties, the Merger Agreement will be of no further force or effect (other than with respect
to certain surviving obligations specified in the Merger Agreement), without any liability on the part of any party thereto or its respective
affiliates, officers, directors or stockholders, other than liability of any party thereto for any intentional and willful breach of
the Merger Agreement by such party occurring prior to such termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
and Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise set forth in the Merger Agreement, all fees and expenses incurred in connection with the Merger Agreement and the transactions
contemplated thereby will be paid by the party incurring such expenses whether or not the transactions are consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of MURF, Merger Sub and Conduit agreed that, for U.S. federal income
tax purposes, (a) the Merger Agreement shall be adopted as a &#8220;plan of reorganization&#8221; within the meaning of Section 368 of
the Code and Treasury Regulations Section 1.368-2(g) and (b) they shall report the Business Combination as an integrated transaction that
qualifies as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code and the Treasury Regulations to which the
MURF, Merger Sub and Conduit are parties within the meaning of Section 368(b) of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Confidentiality;
Access to Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party to the Merger Agreement will afford to the other parties and their financial advisors, accountants, counsel and other representatives
reasonable access during normal business hours, upon reasonable notice, to all of their respective properties, books, records and personnel
during the period prior to the closing of the Business Combination to obtain all information concerning the business, including the status
of business development efforts, properties, results of operations and personnel, as each party may reasonably request. The parties agree
to maintain in confidence any non-public information received from the other party, and to use such non-public information only for purposes
of consummating the transactions contemplated by the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement may be amended by the parties thereto at any time prior to the closing of the Business Combination by execution of an
instrument in writing signed on behalf of each of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governing
Law; Consent to Jurisdiction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement is governed by and construed in accordance with the law of the state of Delaware, regardless of the law that might otherwise
govern under applicable principles of the conflicts of laws of Delaware. However, the following matters arising out of or relating to
Merger Agreement shall be construed, performed and enforced in accordance with the Companies Act: the Business Combination, the vesting
of the rights, property, choses in action, business, undertaking, goodwill, benefits, immunities and privileges, contracts, obligations,
claims, debts and liabilities of Merger Sub and Conduit in Conduit, the cancellation of the shares of Conduit, the rights provided in
Section 238 of the Companies Act, the fiduciary or other duties of the Conduit board of directors and the board of directors of Merger
Sub and the internal corporate affairs of Conduit and Merger Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="md_011"></span><b>CERTAIN
AGREEMENTS RELATED TO THE BUSINESS COMBINATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section describes the material provisions of certain additional agreements entered into or to be entered into pursuant to or in connection
with the transactions contemplated by the Merger Agreement, which are referred to as the &#8220;Related Agreements.&#8221; Such discussion
and the following summary of other material provisions of the Related Agreements are qualified by reference to the complete texts of
the Related Agreement, copies of which are filed as exhibits to this proxy statement/prospectus. All stockholders are encouraged to read
the Related Agreements in their entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sponsor
Support Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Concurrently
with the execution of the Merger Agreement, the Sponsor and MURF entered into a certain sponsor support agreement dated November 8, 2022,
pursuant to which the Sponsor agreed to vote all shares of MURF common stock beneficially owned by it, including any additional shares
of MURF it acquires ownership of or the power to vote, in favor of the Business Combination and related transactions. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the support agreement, the Sponsor also agreed that, prior to the termination of the support agreement, the Sponsor will not transfer
or otherwise enter into any agreement or understanding with respect to a transfer relating to any shares of MURF common stock legally
and beneficially owned by it. The support agreement will terminate upon the earliest to occur of: (a) the effective time of the Business
Combination; (b) the termination of the Merger Agreement in accordance with its terms; and (c) the mutual agreement of Conduit and the
Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
Support Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Concurrently
with the execution of the Merger Agreement, MURF, Conduit, and certain shareholders of Conduit entered into a certain shareholder support
agreement dated November 8, 2022, pursuant to which the Conduit Shareholders agreed to vote all Conduit shares beneficially owned by
them, including any additional shares of Conduit they acquire ownership of or the power to vote, in favor of the Business Combination
and related transactions. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the support agreements,
each Conduit shareholder has also agreed that, prior to the termination of the applicable support agreement, such shareholder will not
transfer or otherwise enter into any agreement or understanding with respect to a transfer relating to any ordinary shares of Conduit
owned by such shareholder. The support agreements will terminate automatically without any further required actions or notice upon the
earliest to occur: (a) the effective time of the Business Combination; (b) the termination of the Merger Agreement in accordance with
its terms; and (c) the mutual agreement of Conduit and the shareholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lock-up
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Merger Agreement, certain shareholders of Conduit entered into lock-up agreements with MURF, pursuant to which the
shareholders are subject to a lock-up period commencing from the date of the closing of the Business Combination and ending on the earlier
of (x) one hundred and eighty (180) days after the date of the closing of the Business Combination, and (y) the date on which MURF consummates
a liquidation, merger, share exchange or other similar transaction with an unaffiliated third party that results in all of MURF&#8217;s
shareholders having the right to exchange their equity holdings in MURF for cash, securities or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with the transactions contemplated by the Merger Agreement, MURF entered into a subscription agreement with t</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
Private Placement Investor <span style="background-color: white">for units that are materially the same as those purchased by the Sponsor
at the time of the initial public offering. MURF&#8217;s directors, officers, Sponsor or their affiliates will not be participating in
the private placement.</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">Pursuant to the Subscription Agreement, the </span>Private Placement
Investor <span style="background-color: white">has agreed to purchase 2,700,000 units of MURF, with each unit consisting of (i) one share
of MURF&#8217;s Class A common stock and (ii) one warrant to purchase one share of Class A common stock, for a purchase price of $10.00
per unit in the Private Placement. The Subscription Agreement contains registration rights, pursuant to which within fifteen (15) business
days after the closing of the Private Placement, MURF will use reasonable best efforts to file with the SEC a registration statement
registering the resale of shares of MURF common stock included in the Units and the shares of MURF common stock issued and issuable upon
exercise of the warrants. The closing of the Private Placement is conditioned on there not being a suspension of the qualification of
MURF common stock for offering or sale or trading in any jurisdiction, or the initiation or threatening of any legal proceeding, no legal
prohibitions to consummate the Business Combination, and all conditions precedent to the closing of the Business Combination set forth
in the Merger Agreement having been satisfied or waived.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrant will be exercisable for a period of five years after the completion of the Business Combination and will have an exercise price
of $11.50 per share, subject to adjustment as set forth in the Warrant for stock splits, stock dividends, recapitalizations and similar
customary adjustments. The Private Placement Investor may exercise each warrant on a cashless basis if the shares underlying the warrants
are not then registered pursuant to an effective registration statement. The Private Placement Investor has contractually agreed to restrict
its ability to exercise the warrants such that the number of shares of MURF common stock held by the investor and its affiliates after
such exercise does not exceed the beneficial ownership limitation set forth in the warrant which may not exceed 4.99% of the then issued
and outstanding shares of MURF common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the amendment to the Subscription Agreement dated January
27, 2023, the Private Placement Investor agreed to receive and be issued shares of New Conduit common stock. Upon the closing of the Business
Combination, and specifically the filing of the Proposed Charter, MURF&#8217;s Class A common stock and Class B common stock will be reclassified
as a single class of common stock, and MURF&#8217;s company name will change to &#8220;Conduit Pharmaceuticals Inc.&#8221; also referred
to as New Conduit. The underlying terms of the Class A common stock and the single class of common stock are materially the same as each
has or will have the same voting right of one vote per each share, same dividend rights and same liquidation rights.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Private Placement will occur immediately prior to the consummation of the Business Combination. The common stock to be
issued pursuant to the Subscription Agreement has not been registered under the Securities Act, and will be issued in reliance upon the
exemption provided under Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Subscription Agreement
will terminate and be void and of no further force and effect, and all rights and obligations of the parties without any further liability
on the part of any party in respect thereof, upon the earlier to occur of: (a) the mutual written agreement of each of the parties to
terminate the Subscription Agreement; (b) such date and time as the Merger Agreement is terminated in accordance with its terms; (c)
if any of the conditions to the closing of the Private Placement are not satisfied or waived on or prior to the closing of the Private
Placement and, as a result thereof, the transactions contemplated by the Subscription Agreement are not consummated at the closing of
the Private Placement or (d) written notice by either party to the other party to terminate the Subscription Agreement if the transactions
contemplated by the Subscription Agreement are not consummated on or prior to February 7, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="md_012"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>MATERIAL
U.S. FEDERAL INCOME TAX CONSIDERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a summary of the material U.S. federal income tax considerations relevant to (i) Non-U.S. Holders (as defined
below) of shares of Conduit that hold New Conduit Common Stock in connection with the Business Combination and (ii) U.S. Holders and
Non-U.S. Holders (as defined below) of Public Shares electing to have their Public Shares redeemed for cash upon the closing of the Business
Combination. This discussion applies only to Conduit shares and Public Shares that are held as &#8220;capital assets&#8221; within the
meaning of Section 1221 of the Code (generally, property held for investment).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion does not address the effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable
state, local or non-U.S. tax laws. This discussion is based on the Code, Treasury regulations promulgated thereunder, judicial decisions
and published rulings and administrative pronouncements of the IRS, in each case in
effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation
may be applied retroactively in a manner that could adversely affect the tax consequences discussed below. Neither Conduit nor MURF has
sought or will seek any rulings from that the IRS regarding the matters discussed below. There can be no assurance the IRS or a court
will not take a position contrary to that set forth below in this discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion does not address the tax considerations for any beneficial owners of Private Warrants or Founder Shares. Further, this discussion
does not address all U.S. federal income tax consequences relevant to a holder&#8217;s particular circumstances, including the impact
of the Medicare contribution tax on net investment income. In addition, it does not address consequences relevant to holders subject
to special rules, including, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks, insurance companies and certain other financial institutions;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated investment companies and real estate investment trusts;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers, dealers or traders in securities;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders in securities who elect to apply a mark-to-market method
of accounting;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt organizations or governmental organizations;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons subject to the alternative minimum tax;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. expatriates and former citizens or long-term residents
of the United States;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons holding shares as part of a hedge, straddle, constructive
sale or other risk reduction strategy or as part of a conversion transaction or other integrated investment;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons subject to special tax accounting rules as a result
of any item of gross income with respect to Public Shares being taken into account in an applicable financial statement;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons deemed to sell shares under the constructive sale provisions
of the Code;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons who elect to apply the provisions of Section 1400Z-2
of the Code to any gain realized;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;controlled foreign corporations,&#8221; &#8220;passive
foreign investment companies&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S corporations, partnerships or other entities or arrangements
treated as partnerships or other flow-through entities for U.S. federal income tax purposes (and investors therein);</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. Holders having a functional currency other than the U.S.
dollar;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons who hold or received shares pursuant to the exercise
of any employee stock option, through a tax qualified retirement plan or otherwise as compensation;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-qualified retirement plans; and</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pension plans, including any &#8220;qualified foreign pension
funds&#8221; as defined in Section 897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign pension
funds.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, a &#8220;U.S. Holder&#8221; is any beneficial owner of shares of Public Shares that is for U.S. federal
income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an individual who is a citizen or resident of the United States;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a corporation (or other entity taxable as a corporation) created
or organized under the laws of the United States, any state thereof, or the District of Columbia;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an estate, the income of which is subject to U.S. federal income
tax regardless of its source; or</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a trust that (1) is subject to the primary supervision of a
U.S. court and the control of one or more &#8220;United States persons&#8221; (within the meaning of Section 7701(a)(30) of the Code),
or (2) has a valid election in effect under applicable Treasury Regulations to be treated as a United States person for U.S. federal
income tax purposes.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, a &#8220;Non-U.S. Holder&#8221; is any beneficial owner of shares of Conduit or Public Shares that is not
a U.S. Holder for U.S. federal income tax purposes including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a non-resident alien individual;</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a foreign corporation; or</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a foreign estate or trust.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an entity or arrangement that is treated as a partnership for U.S. federal income tax purposes holds shares, the U.S. federal income
tax treatment of the entity or an owner of such entity will depend on the status of the owners, the activities of the entity and certain
determinations made at the owner level. Accordingly, entities treated as partnerships for U.S. federal income tax purposes and the partners
in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them of the Business Combination
or a redemption of Public Shares, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTORS
SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS
AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S.
TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
U.S. Tax Considerations of the Business Combination to Holders of Conduit Capital Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Treatment
of the Business Combination to U.S. Holders</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of Thompson Hine LLP, the Business Combination should qualify
as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. This opinion is based on the facts and representations
contained in representation letters provided to Thompson Hine LLP by MURF, Merger Sub and Conduit and certain assumptions, including that
the Business Combination will be completed in the manner set forth in the Merger Agreement and the Registration Statement on Form S-4
of which this proxy statement/prospectus forms a part. The accuracy of such facts, representations and assumptions could affect the conclusions
set forth in the opinion. The opinion will not be binding on the IRS or the courts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The material U.S. federal income tax consequences of a U.S. Holder of Conduit
should be as follows: (1) a U.S. Holder should not recognize gain or loss upon the exchange of Conduit shares for shares of New Conduit
Common Stock; (2) a U.S. Holder should obtain an aggregate tax basis in the shares of New Conduit Common Stock that such U.S. Holder receives
in the Business Combination equal to such U.S. Holder&#8217;s aggregate tax basis in the Conduit shares exchanged therefor; and (3) the
holding period of the shares of New Conduit Common Stock received by a U.S. Holder in the Business Combination should include the holding
period of the Conduit shares surrendered in exchange therefor. Treasury Regulations provide detailed rules for allocating the tax basis
and holding period of the Conduit shares surrendered to the shares of New Conduit Common Stock received. U.S. Holders of Conduit shares
acquired at different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding
period of such shares.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Business Combination does not qualify as a &#8220;reorganization&#8221;
within the meaning of Section 368(a) of the Code, each U.S. Holder of Conduit shares would recognize gain or loss on the exchange of the
Conduit shares for shares of New Conduit Common Stock in the Business Combination equal to the difference between (a) the fair market
value of the shares of New Conduit Common Stock received in exchange for the Conduit shares and (b) such U.S. Holder&#8217;s adjusted
tax basis in the Conduit shares surrendered. U.S. Holders should consult their own tax advisors regarding the application of the foregoing
rules in light of their particular facts and circumstances.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><i>Treatment of the Business
Combination to Non-U.S. Holders</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
that the Business Combination qualifies as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, a Non-U.S.
Holder of Conduit shares is not expected to recognize any gain or loss under U.S. federal income tax laws upon the exchange of their
Conduit shares for New Conduit Common Stock. It is expected that each such holder would have the same basis in its New Conduit Common
Stock as that holder has in their Conduit shares exchanged therefor, and such holder&#8217;s holding period in the New Conduit Common
Stock would include the holder&#8217;s holding period in the Conduit shares surrendered in exchange therefor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consequences
if the Business Combination Does Not Qualify as a Tax-Free Reorganization</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination does not qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, Non-U.S.
Holders should not be subject to U.S. federal income tax on any gain recognized as a result of the Business Combination unless any of
the conditions described below in the bullets under the section entitled &#8220;<i>Material Tax Considerations Related to a Redemption
of Public Shares&#8212;Non U.S. Holders&#8212;Gain on Redemption Treated as a Sale of Public Shares</i>&#8221; are satisfied with respect
to gain recognized by a Non-U.S. Holder on the Conduit shares. With respect to the third bullet, Conduit believes that it is not, and
has not been at any time since its formation, a U.S. real property holding corporation and neither Conduit nor New Conduit expects to
be a United States real property holding corporation immediately after the Business Combination is completed. Non-U.S. Holders should
consult their own tax advisors regarding the application of the foregoing rules in light of their particular facts and circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>HOLDERS
OF CONDUIT SHARES ARE ENCOURAGED TO CONSULT THEIR TAX ADVISORS TO DETERMINE THE SPECIFIC TAX CONSEQUENCES TO THEM OF THE BUSINESS COMBINATION,
INCLUDING THE EFFECT OF ANY U.S. FEDERAL, STATE, LOCAL, NON-U.S. OR OTHER TAX LAWS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ownership
and Disposition of New Conduit Common Stock by a Non-U.S. Holder</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions,
if any, made on New Conduit Common Stock will constitute dividends for U.S. federal income tax purposes to the extent they are paid out
of New Conduit&#8217;s accumulated or current earnings and profits, as determined for U.S. federal income tax purposes. Non-U.S. Holders
will be treated in the same manner as described below under &#8220;<i>Material Tax Considerations Related to a Redemption of Public Shares&#8212;Non
U.S. Holders&#8212;Taxation of Redemption Treated as a Distribution</i>&#8221; with respect to distributions made on New Conduit Common
Stock that constitute dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax consequences of a sale, exchange or other disposition of New Conduit Common Stock by a Non-U.S. Holder are generally
the same as those discussed above concerning a Non-U.S. Holder&#8217;s disposition of Conduit shares pursuant to the Business Combination
under the heading &#8220;&#8212;<i>Consequences if the Business Combination Does Not Qualify as a Tax-Free Reorganization</i>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Withholding</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
any taxable proceeds received by a Non-U.S. Holder in connection with the Business Combination, any distributions made by New Conduit
(or its paying agent) to a Non-U.S. Holder with respect to its New Conduit Common Stock, and any payments of the proceeds of the sale
of New Conduit Common Stock by a Non-U.S. Holder are generally subject to the same information reporting and backup withholding rules
as described below under &#8220;<i>Material Tax Considerations Related to a Redemption of Public Shares&#8212;Non U.S. Holders&#8212;Information
Reporting and Backup Withholding</i>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
U.S. FEDERAL INCOME TAX CONSEQUENCES DESCRIBED ABOVE ARE NOT INTENDED TO CONSTITUTE A COMPLETE DESCRIPTION OF ALL TAX CONSEQUENCES RELATING
TO THE BUSINESS COMBINATION OR THE HOLDING AND DISPOSING OF NEW CONDUIT COMMON STOCK. BECAUSE INDIVIDUAL CIRCUMSTANCES MAY DIFFER, EACH
SHAREHOLDER SHOULD CONSULT THE SHAREHOLDER&#8217;S TAX ADVISOR REGARDING THE APPLICABILITY OF THE RULES DISCUSSED ABOVE TO THE SHAREHOLDER
AND THE PARTICULAR TAX EFFECTS TO THE SHAREHOLDER OF THE BUSINESS COMBINATION AND THE HOLDING OR DISPOSING OF NEW CONDUIT COMMON STOCK
IN LIGHT OF SUCH SHAREHOLDER&#8217;S PARTICULAR CIRCUMSTANCES AND THE APPLICATION OF STATE, LOCAL AND FOREIGN TAX LAWS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
Tax Considerations Related to a Redemption of Public Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of Public Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that a U.S. Holder&#8217;s Public Shares are redeemed pursuant to the redemption provisions described in this proxy statement/prospectus
under the section entitled &#8220;<i>Special Meeting of MURF Stockholders &#8212; Redemption Rights</i>,&#8221; the treatment of the
transaction for U.S. federal income tax purposes will depend on whether the redemption qualifies as a sale of the Public Shares under
Section 302 of the Code. If the redemption qualifies as a sale of the Public Shares, the U.S. Holder will be treated as described under
&#8220;<i>&#8212; U.S. Holders &#8212; Gain or Loss on Redemption Treated as Sale of Public Shares</i>&#8221; below. Whether a redemption
qualifies for sale treatment will depend largely on the total number of shares of MURF common stock treated as held by the U.S. Holder
(including any stock constructively owned by the U.S. Holder as a result of owning warrants) relative to all of MURF&#8217;s shares outstanding
both before and after the redemption. The redemption of MURF common stock generally will be treated as a sale of the Public Shares (rather
than a corporate distribution) if the redemption or purchase by MURF (i) is &#8220;substantially disproportionate&#8221; with respect
to the U.S. Holder, (ii) results in a &#8220;complete termination&#8221; of the U.S. Holder&#8217;s interest in MURF or (iii) is &#8220;not
essentially equivalent to a dividend&#8221; with respect to the U.S. Holder. These tests are explained more fully below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining whether any of the foregoing tests are satisfied, a U.S. Holder takes into account not only stock actually owned by the U.S.
Holder, but also shares of MURF common stock that are constructively owned by it. A U.S. Holder may constructively own, in addition to
stock owned directly, stock owned by certain related individuals and entities in which the U.S. Holder has an interest or that have an
interest in such U.S. Holder, as well as any stock the U.S. Holder has a right to acquire by exercise of an option, which would generally
include MURF common stock which could be acquired pursuant to the exercise of the warrants. In order to meet the substantially disproportionate
test, the percentage of MURF&#8217;s outstanding voting stock actually and constructively owned by the U.S. Holder immediately following
the redemption of Public Shares must, among other requirements, be less than 80% of the percentage of MURF&#8217;s outstanding voting
stock actually and constructively owned by the U.S. Holder immediately before the redemption. There will be a complete termination of
a U.S. Holder&#8217;s interest if either (i) all of the shares of MURF common stock actually and constructively owned by the U.S. Holder
are redeemed or (ii) all of the shares of MURF common stock actually owned by the U.S. Holder are redeemed and the U.S. Holder is eligible
to waive, and effectively waives in accordance with specific rules, the attribution of stock owned by certain family members and the
U.S. Holder does not constructively own any other MURF common stock. The redemption of Public Shares will not be essentially equivalent
to a dividend if a U.S. Holder&#8217;s conversion results in a &#8220;meaningful reduction&#8221; of the U.S. Holder&#8217;s proportionate
interest in MURF. Whether the redemption will result in a meaningful reduction in a U.S. Holder&#8217;s proportionate interest in MURF
will depend on the particular facts and circumstances. However, the IRS has indicated in a published ruling that even a small reduction
in the proportionate interest of a small minority stockholder in a publicly held corporation who exercises no control over corporate
affairs may constitute such a &#8220;meaningful reduction.&#8221; A U.S. Holder should consult with its own tax advisors as to the tax
consequences of a redemption or purchase by MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
none of the foregoing tests is satisfied, then the redemption will be treated as a corporate distribution and the tax effects will be
as described under &#8220;<i>&#8212; U.S. Holders &#8212; Taxation of Redemption Treated as a Distribution</i>&#8221; below. After the
application of those rules, any remaining tax basis of the U.S. Holder in the redeemed Public Shares will be added to the U.S. Holder&#8217;s
adjusted tax basis in its remaining stock, or, if it has none, to the U.S. Holder&#8217;s adjusted tax basis in its warrants or possibly
in other stock constructively owned by it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gain
or Loss on Redemption Treated as Sale of Public Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the redemption qualifies as a sale or other taxable disposition of Public Shares, a U.S. Holder generally will recognize capital gain
or loss in an amount equal to the difference between the amount realized and the U.S. Holder&#8217;s adjusted tax basis in the Public
Shares. Any such capital gain or loss generally will be long-term capital gain or loss if the U.S. Holder&#8217;s holding period for
the Public Shares so disposed of exceeds one year. The initial public offering of the Public Shares closed on February 7, 2022, and any
redemption is expected to occur prior to the one-year anniversary of such date. If that is the case, any such capital gain will be short-term
capital gain which will be taxed at regular ordinary income tax rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the amount of gain or loss recognized by a U.S. Holder is an amount equal to the difference between (i) the sum of the amount of cash
and the fair market value of any property received in such disposition and (ii) the U.S. Holder&#8217;s adjusted tax basis in its Public
Shares so disposed of. A U.S. Holder&#8217;s adjusted tax basis in its Public Shares generally will equal the U.S. Holder&#8217;s adjusted
cost less any prior distributions treated as a return of capital for U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Redemption Treated as a Distribution.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the redemption does not qualify as a sale of Public Shares, a U.S. Holder will generally be treated as receiving a distribution. Such
distributions generally will be included in a U.S. Holder&#8217;s gross income, in accordance with such U.S. Holder&#8217;s method of
accounting for U.S. federal income tax purposes, as dividend income, but only to the extent that such distributions are paid out of MURF&#8217;s
current or accumulated earnings and profits as determined under U.S. federal income tax principles. Dividends will be taxable to a corporate
U.S. Holder at regular rates and will generally be eligible for the dividends received deduction if the requisite holding period is satisfied.
Distributions in excess of such earnings and profits generally will be applied against and reduce the U.S. Holder&#8217;s basis in its
MURF common stock (but not below zero) and, to the extent in excess of such basis, will be treated as gain from the sale or exchange
of such MURF common stock in the manner described above under &#8220;<i>&#8212; U.S. Holders &#8212; Gain or Loss on Redemption Treated
as a Sale of Public Shares</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to non-corporate U.S. Holders and with certain exceptions, dividends may be &#8220;qualified dividend income,&#8221; which is
taxed at the lower applicable long-term capital gain rate provided that the U.S. Holder satisfies certain holding period requirements
and the U.S. Holder is not under an obligation to make related payments with respect to positions in substantially similar or related
property. It is unclear whether the redemption rights with respect to the Public Shares may prevent a U.S. Holder from satisfying the
applicable holding period requirements with respect to the dividends received deduction or the preferential tax rate on qualified dividend
income, as the case may be, because there is no authority directly on-point with respect to whether such redemption rights diminish a
U.S. Holder&#8217;s risk of loss with respect to Public Shares in a manner that suspends the holding period for such Public Shares under
the applicable holding period requirements. If the holding period requirements are not satisfied, then non-corporate U.S. Holders may
be subject to tax on such dividends at regular ordinary income tax rates instead of the preferential rate that applies to qualified dividend
income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Information Reporting and Backup Withholding.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
with respect to the MURF common stock to a U.S. Holder, whether or not such distributions qualify as dividends for U.S. federal income
tax purposes, and proceeds from the sale, exchange or redemption of the MURF common stock by a U.S. Holder generally are subject to information
reporting to the IRS and possible U.S. backup withholding, unless the U.S. Holder is an exempt recipient. Backup withholding may apply
to such payments if a U.S. Holder fails to furnish a correct taxpayer identification number, a certification of exempt status or has
been notified by the IRS that it is subject to backup withholding (and such notification has not been withdrawn).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. Amounts withheld as backup withholding may be credited against a U.S. Holder&#8217;s U.S. federal
income tax liability, and such holder may obtain a refund of any excess amounts withheld under the backup withholding rules by timely
filing the appropriate claim for refund with the IRS and furnishing any required information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-U.S.
Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of Public Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
characterization for U.S. federal income tax purposes of the redemption of a Non-U.S. Holder&#8217;s Public Shares pursuant to the redemption
provisions described in the section of this proxy statement/prospectus entitled &#8220;<i>Special Meeting of MURF Stockholders &#8212;
Redemption Rights</i>&#8221; generally will follow the U.S. federal income tax characterization of such a redemption of a U.S. Holder&#8217;s
Public Shares, as described under &#8220;<i>&#8212; U.S. Holders &#8212; Redemption of Public Shares</i>&#8221; above, and the consequences
of the redemption to the Non-U.S. Holder will be as described below under &#8220;&#8212; <i>Non-U.S. Holders &#8212; Gain on Redemption
Treated as a Sale of Public Shares</i>&#8221; and &#8220;&#8212; <i>Non-U.S. Holders &#8212; Taxation of Redemption Treated as a Distribution</i>,&#8221;
as applicable. It is possible that because the applicable withholding agent may not be able to determine the proper characterization
of a redemption of a Non-U.S. Holder&#8217;s Public Shares, the withholding agent might treat the redemption as a distribution subject
to withholding tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gain
on Redemption Treated as a Sale of Public Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Non-U.S. Holder generally will not be subject to U.S. federal income or withholding tax in respect of any gain realized upon the redemption
of Public Shares unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the gain is effectively connected with the Non-U.S. Holder&#8217;s
conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains
a permanent establishment in the United States to which such gain is attributable);</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Non-U.S. Holder is a nonresident alien individual present
in the United States for 183 days or more during the taxable year of the disposition and certain other requirements are met; or</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Public Shares constitute a U.S. real property interest
(&#8220;USRPI&#8221;) by reason of MURF&#8217;s status as a U.S. real property holding corporation (&#8220;USRPHC&#8221;) for U.S. federal
income tax purposes.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular graduated
rates applicable to a U.S. Holder, unless an applicable tax treaty provides otherwise. A Non-U.S. Holder that is a corporation also may
be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively
connected gain, as adjusted for certain items.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified
by an applicable income tax treaty), which may be offset by U.S. source capital losses of the Non-U.S. Holder (even though the individual
is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with
respect to such losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the third bullet above, MURF believes that it is not and has not been at any time since its formation, and does not expect
to be immediately after the Business Combination is completed, a USRPHC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
Holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Redemption Treated as a Distribution.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a redemption does not qualify as a sale of Public Shares, Non-U.S. Holders will generally be treated as receiving a distribution. Such
distributions to the extent paid out of MURF&#8217;s current or accumulated earnings and profits (as determined under U.S. federal income
tax principles) will constitute dividends for U.S. federal income tax purposes. Amounts not treated as dividends for U.S. federal income
tax purposes will constitute a return of capital and first be applied against and reduce a Non-U.S. Holder&#8217;s adjusted tax basis
in its MURF common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described above under
&#8220;&#8212; <i>Non-U.S. Holders &#8212; Gain on Redemption Treated as a Sale of Public Shares</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below on effectively connected income, dividends paid to a Non-U.S. Holder of MURF common stock will be subject to
U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income
tax treaty, provided the Non-U.S. Holder furnishes a valid IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) certifying
qualification for the lower treaty rate). A Non-U.S. Holder that does not timely furnish the required documentation, but that qualifies
for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the
IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within
the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the
United States to which such dividends are attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described
above. To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI, certifying
that the dividends are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the same regular graduated U.S.
tax rates that apply to United States persons. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at
a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted
for certain items. Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different
rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Withholding.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
of dividends on MURF common stock will not be subject to backup withholding, provided the applicable withholding agent does not have
actual knowledge or reason to know that the holder is a United States person and the holder either certifies its non-U.S. status, such
as by furnishing a valid IRS Form W-8BEN, W-8BEN-E or W-8ECI, or otherwise establishes an exemption. However, information returns are
required to be filed with the IRS in connection with any dividends on MURF common stock paid to the Non-U.S. Holder, regardless of whether
any tax was actually withheld. In addition, proceeds from a sale or other taxable disposition of MURF common stock within the United
States or conducted through certain U.S.-related brokers generally will not be subject to backup withholding or information reporting
if the applicable withholding agent receives the certification described above and does not have actual knowledge or reason to know that
such holder is a United States person, or the holder otherwise establishes an exemption. Proceeds from a disposition of MURF common stock
conducted through a non-U.S. office of a non-U.S. broker generally will not be subject to backup withholding or information reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement
to the tax authorities of the country in which the Non-U.S. Holder resides or is established. Backup withholding is not an additional
tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a Non-U.S. Holder&#8217;s
U.S. federal income tax liability, provided the required information is timely furnished to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Additional
Withholding Tax on Payments Made to Foreign Accounts.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withholding
taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance
Act, or &#8220;FATCA&#8221;) on certain types of payments made to non-U.S. financial institutions and certain other non-U.S. entities.
Specifically, a 30% withholding tax may be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below)
gross proceeds from the sale or disposition of MURF common stock paid to a &#8220;foreign financial institution&#8221; or a &#8220;non-financial
foreign entity&#8221; (each as defined in the Code), unless (1) the foreign financial institution undertakes certain diligence and reporting
obligations, (2) the non-financial foreign entity either certifies it does not have any &#8220;substantial United States owners&#8221;
(as defined in the Code) or furnishes identifying information regarding each substantial United States owner, or (3) the foreign financial
institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial
institution and is subject to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department
of the Treasury requiring, among other things, that it undertake to identify accounts held by certain &#8220;specified United States
persons&#8221; or &#8220;United States-owned foreign entities&#8221; (each as defined in the Code), annually report certain information
about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders.
Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA
may be subject to different rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the applicable Treasury regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on
MURF common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition
of MURF common stock on or after January 1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds
entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
Holders should consult their tax advisors regarding the potential application of withholding under FATCA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="md_013"></span><b>UNAUDITED
PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Defined
terms included below have the same meaning as terms defined and included elsewhere in this proxy statement/prospectus. All dollar amounts
are expressed in thousands of United States dollars (&#8220;$&#8221;), unless otherwise indicated.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Introduction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma condensed combined financial statements are provided to aid you in your analysis of the financial aspects
of the Transactions and adjustments for other material events. These other material events are referred to herein as &#8220;Material
Events&#8221; and the pro forma adjustments for the Material Events are referred to herein as &#8220;Adjustments for Material Events.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial statements have been prepared based on MURF&#8217;s historical financial statements
and Conduit&#8217;s historical financial statements as adjusted to give effect to the Transactions and Material Events. The unaudited
pro forma condensed combined balance sheet as of December 31, 2022 gives pro forma effect to the Transactions and Material Events as
if they had occurred on December 31, 2022. The unaudited pro forma condensed combined statement of operations for the year ended December
31, 2022 gives effect to the Transactions and Material Events as if they had occurred on January 1, 2022. The unaudited pro forma condensed
combined statement of operations for the year ended December 31, 2022 gives effect to the Transactions and Material Events
as if they had occurred on January 1, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial statements have been presented for illustrative purposes only and do not necessarily
reflect what New Conduit&#8217;s financial condition or results of operations would have been had the Transactions and Material Events
occurred on the dates indicated. Further, the pro forma condensed combined financial information may not be useful in predicting the
future financial condition and results of operations of New Conduit. The actual financial position and results of operations may differ
significantly from the pro forma amounts reflected herein due to a variety of factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial statements have been derived from and should be read in conjunction with:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    accompanying notes to the unaudited pro forma condensed combined financial statements&#894;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    historical audited financial statements of MURF as of and for the year ended December 31, 2022, and the related notes included elsewhere
    in this proxy statement/prospectus;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    historical audited financial statements of Conduit as of and for the year ended December 31, 2022, and the related notes included
    elsewhere in this proxy statement/prospectus; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sections entitled &#8220;MURF&#8217;s Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;,
    &#8220;Conduit&#8217;s Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, and other
    financial information relating to each of MURF and Conduit included elsewhere in this proxy statement/prospectus.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Description
of the Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2022, Murphy Canyon Acquisition Corp., a Delaware corporation, Conduit Pharmaceuticals Limited, a Cayman Islands exempt company,
and Conduit Merger Sub, Inc., a Cayman Islands exempt company and wholly-owned subsidiary of MURF (&#8220;Merger Sub&#8221;), entered
into the Merger Agreement, which contains customary representations and warranties, covenants, closing conditions, termination provisions
and other terms relating to the transactions contemplated thereby. Pursuant to the Merger Agreement, Merger Sub will merge with and into
Conduit with Conduit surviving the merger (the &#8220;Merger&#8221;). As a result of the Merger, Conduit will become a wholly-owned subsidiary
of MURF, with the shareholders of Conduit becoming stockholders of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Merger, all of the issued and outstanding MURF Class A common stock (including the MURF Class B common stock that is
automatically converted on a one-for-one basis into MURF Class A common stock upon the consummation of the Business Combination) will
be converted into one class of New Conduit common stock and each issued and outstanding warrant to purchase a share of MURF Class A common
stock will become exercisable for one share of New Conduit common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement provides, among other things, that, upon consummation of the Business Combination, each Conduit ordinary share that
is issued and outstanding immediately prior to the consummation of the Business Combination shall be canceled and automatically converted
into the right to receive a number of shares of New Conduit common stock equal to the Exchange Ratio of (A) $650.0 million, divided by
(B) the number of Conduit ordinary shares issued and outstanding immediately prior to the consummation of the Business Combination on
a full dilution basis (which will include the conversion of all outstanding Conduit convertible notes into Conduit ordinary shares),
divided by (C) ten dollars ($10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information about the Business Combination, please see the section entitled &#8220;The Business Combination Proposal.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Pro Forma Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial statements were prepared in accordance with Article 11 of SEC Regulation S-X, as amended
by the final rule, Release No. 33-10786, <i>Amendments to Financial Disclosures about Acquired and Disposed Businesses</i>. Release No.
33-10786 replaces the historical pro forma adjustments criteria with simplified requirements to depict the accounting for the transaction
<i>(</i>&#8220;Transaction Accounting Adjustments&#8221;) and present the reasonably estimable synergies and other transaction effects
that have occurred or are reasonably expected to occur (&#8220;Management&#8217;s Adjustments&#8221;). MURF has elected not to present
Management&#8217;s Adjustments and will only be presenting Transaction Accounting Adjustments in the unaudited pro forma condensed combined
financial information. The adjustments presented in the unaudited pro forma condensed combined financial statements have been identified
and presented to provide relevant information necessary for an understanding of the combined company upon consummation of the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined balance sheet as of December 31, 2022, was derived from the unaudited historical balance sheet
of MURF as of December 31, 2022, and the unaudited historical balance sheet of Conduit as of December 31, 2022 and gives effect to the
Transactions and Material Events as if they had occurred on December 31, 2022. The unaudited pro forma condensed combined statement of
operations for the year ended December 31, 2022, combines the historical statement of operations of MURF for the year ended
December 31, 2022, and the historical statement of operations of Conduit for the year ended December 31, 2022, and gives
effect to the Transactions and Material Events as if they had occurred on January 1, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has made significant estimates and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma condensed
combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially
from the information presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma adjustments reflecting the consummation of the Transactions and Material Events are based on certain currently available information
and certain assumptions and methodologies that each of MURF and Conduit believes are reasonable under the circumstances. The pro forma
adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated.
Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments, and it is possible the differences may
be material. Each of MURF and Conduit believes that its assumptions and methodologies provide a reasonable basis for presenting all the
significant effects of the Transactions and Material Events based on information available to management at this time and that the pro
forma adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined
financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies,
tax savings, or cost savings that may be associated with the Transactions. MURF and Conduit have not had any historical relationship
prior to the Transactions. Accordingly, no pro forma adjustments were required to eliminate activities between the companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information presents two redemption scenarios as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    No Redemption Scenario</b>: This scenario, which we refer to as the &#8220;No Redemption Scenario&#8221; assumes that no MURF Public
    Stockholders exercise their right to have their MURF Class A common stock converted into their pro rata share of the Trust Account
    and thus the full amount held in the Trust Account as of the closing is available for the Business Combination&#894; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
    Maximum Redemption Scenario</b>: This scenario, which we refer to as the &#8220;Maximum Redemption Scenario&#8221; assumes that all
    2,187,728 shares of MURF Class A common stock subject to possible are redeemed, resulting in an aggregate cash payment of approximately
    $22.8 million out of the Trust Account based on an assumed redemption price of $10.42 per share. The Maximum Redemption Scenario
    includes all adjustments contained in the No Redemption Scenario and presents additional adjustments to reflect the effect of the
    Maximum Redemption Scenario. The 2,187,728 shares assumed redeemed in the maximum redemption scenario is calculated as the 13,225,000
    shares of MURF Class A common stock subject to possible redemption outstanding as of December 31, 2022 less the redemption in February
    2023 of 11,037,272 shares of MURF Class A common stock subject to possible redemption (refer to section below titled, &#8220;Material
    Events and Background Relevant to Material Events&#8221;).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing scenarios are for illustrative purposes as MURF does not have, as of the date of this proxy statement/prospectus, a meaningful
way of providing any certainty regarding the number of redemptions by Public Stockholders that may occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included
in the shares outstanding and weighted-average shares outstanding as presented in the unaudited pro forma condensed combined financial
statements are the shares of New Conduit common stock to be issued to legacy Conduit shareholders under the No Redemption Scenario and
the Maximum Redemption Scenario on the closing date of the Business Combination, the shares of New Conduit common stock that are held
by existing MURF investors (as adjusted, where applicable, for the Maximum Redemption Scenario), and the shares of New Conduit common
stock to be issued in respect of the PIPE Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Transactions, assuming no Public Stockholders elect to redeem their shares for cash, Conduit&#8217;s shareholders
will own approximately 90.0% of the shares of New Conduit common stock, MURF&#8217;s Public Stockholders will own approximately 2.9%
of the shares of New Conduit common stock, MURF Directors will own approximately 0.1% of the shares of New Conduit common stock, MURF&#8217;s
Sponsor will own approximately 5.3% of the shares of New Conduit common stock, and A.G.P. will own approximately 1.7% of the shares of
New Conduit common stock, based on the number of shares of MURF Class A common stock and MURF Class B common stock outstanding as of
December 31, 2022 (in each case, not giving effect to any shares of New Conduit common stock issuable upon the exercise of any warrants).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="color: #231F20; font-weight: bold; text-align: justify">&#160;</td><td style="color: #231F20; font-weight: bold">&#160;</td>
    <td colspan="6" style="color: #231F20; font-weight: bold; text-align: center">Scenario 1</td><td style="color: #231F20; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: #231F20; font-weight: bold; text-align: justify">&#160;</td><td style="color: #231F20; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; color: #231F20; font-weight: bold; text-align: center">Assuming No Redemptions</td><td style="padding-bottom: 1.5pt; color: #231F20; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: #231F20; font-weight: bold; text-align: justify">&#160;</td><td style="color: #231F20; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #231F20; font-weight: bold; text-align: center">Number of Shares
    Owned</td><td style="padding-bottom: 1.5pt; color: #231F20; font-weight: bold">&#160;</td><td style="color: #231F20; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #231F20; font-weight: bold; text-align: center">% Ownership</td><td style="padding-bottom: 1.5pt; color: #231F20; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; color: #231F20; font-weight: bold; text-align: justify">(Shares in thousands)</td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">&#160;</td><td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">&#160;</td><td style="color: #231F20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; color: #231F20; text-align: justify">Conduit shareholders</td><td style="width: 2%; color: #231F20">&#160;</td>
    <td style="width: 1%; color: #231F20; text-align: left">&#160;</td><td style="width: 16%; color: #231F20; text-align: right">67,700</td><td style="width: 1%; color: #231F20; text-align: left">&#160;</td><td style="width: 2%; color: #231F20">&#160;</td>
    <td style="width: 1%; color: #231F20; text-align: left">&#160;</td><td style="width: 16%; color: #231F20; text-align: right">90.0</td><td style="width: 1%; color: #231F20; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: #231F20; text-align: justify">MURF Public stockholders</td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">2,188</td><td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">2.9</td><td style="color: #231F20; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
    Directors<sup>(1)</sup></span></td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">45</td><td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">0.1</td><td style="color: #231F20; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
    Sponsor<sup>(1)</sup></span></td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">4,015</td><td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20">&#160;</td>
    <td style="color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; text-align: right">5.3</td><td style="color: #231F20; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: #231F20; text-align: justify; padding-bottom: 1.5pt">A.G.P.</td><td style="color: #231F20; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: #231F20; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: #231F20; text-align: right">1,300</td><td style="padding-bottom: 1.5pt; color: #231F20; text-align: left">&#160;</td><td style="color: #231F20; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: #231F20; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: #231F20; text-align: right">1.7</td><td style="padding-bottom: 1.5pt; color: #231F20; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: #231F20; font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="color: #231F20; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231F20; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: #231F20; font-weight: bold; text-align: right">75,248</td><td style="padding-bottom: 2.5pt; color: #231F20; font-weight: bold; text-align: left">&#160;</td><td style="color: #231F20; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231F20; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: #231F20; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; color: #231F20; font-weight: bold; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    connection with the Business Combination, 3,306 shares of MURF Class B common stock held by the Sponsor will be converted into 3,306
    shares of MURF Class A common stock. The 4,015 shares of New Conduit common stock that will be held by the MURF Sponsor (as reflected
    in the table above) will come from the MURF Sponsor exchanging the 3,306 shares of MURF Class A common stock for 3,306 shares of
    New Conduit common stock upon the closing of the Business Combination and from the MURF Sponsor exchanging an additional 709 shares
    of MURF Class A common stock that it will hold (prior to the closing of the Business Combination) for 709 shares of New Conduit common
    stock upon the closing of the Business Combination. The 709 shares taking part in the above-mentioned exchange were originally issued
    to the MURF Sponsor as part of the Private Placement and the 3,306 shares taking part in the above-mentioned exchange were originally
    issued to the MURF Sponsor prior to MURF&#8217;s initial public offering. The 45 shares of New Conduit common stock that will be
    held by MURF Directors will come from the MURF Sponsor transferring (upon the closing of the Business Combination) to the MURF Directors
    45 shares of MURF Class A common stock. The 45 shares of MURF Class A common stock will be exchanged for 45 shares of New Conduit
    common stock upon the closing of the Business Combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
upon consummation of the Transactions, 2,187,728 shares of MURF Class A common stock (which represents 100.0% of the shares of MURF Class
A common stock subject to possible redemption) are redeemed for cash, Conduit&#8217;s shareholders will own approximately 92.6% of the
shares of New Conduit common stock, MURF&#8217;s Public Stockholders will not own any of the shares of New Conduit common stock, MURF
Directors will own approximately 0.1% of the shares of New Conduit common stock, MURF&#8217;s Sponsor will own approximately 5.5% of
the shares of New Conduit common stock, and A.G.P. will own approximately 1.8% of the shares of New Conduit common stock, based on the
number of shares of MURF Class A common stock and MURF Class B common stock outstanding as of December 31, 2022 (in each case, not giving
effect to any shares of New Conduit common stock issuable upon the exercise of any warrants).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Scenario 2</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assuming Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Ownership</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: justify">(Shares in thousands)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: justify">Conduit shareholders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">67,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">92.6</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">MURF Public stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF Directors<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF Sponsor<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">A.G.P.</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,300</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">73,060</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Business Combination, 3,306 shares of MURF Class B common stock held by the Sponsor will be converted into 3,306
shares of MURF Class A common stock. The 4,015 shares of New Conduit common stock that will be held by the MURF Sponsor (as reflected
in the table above) will come from the MURF Sponsor exchanging the 3,306 shares of MURF Class A common stock for 3,306 shares of New Conduit
common stock upon the closing of the Business Combination and from the MURF Sponsor exchanging an additional 709 shares of MURF Class
A common stock that it will hold (prior to the closing of the Business Combination) for 709 shares of New Conduit common stock upon the
closing of the Business Combination. The 709 shares taking part in the above-mentioned exchange were originally issued to the MURF Sponsor
as part of the Private Placement and the 3,306 shares taking part in the above-mentioned exchange were originally issued to the MURF Sponsor
prior to MURF's initial public offering. The 45 shares of New Conduit common stock that will be held by MURF Directors will come from
the MURF Sponsor transferring (in connection with the closing of the Business Combination) to the MURF Directors 45 shares of MURF Class
A common stock. The 45 shares of MURF Class A common stock will be exchanged for 45 shares of New Conduit common stock upon the closing
of the Business Combination. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Material
Events and Background Relevant to Material Events</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January and February 2023, under the terms of the 2022 Convertible Loan Note Instrument, the Company issued convertible notes payable
with an aggregate principal amount of $0.5 million (&#163;0.4 million) to a related party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January and February 2023, under the terms of the 2022 Convertible Loan Note Instrument, the Company issued convertible notes payable
with an aggregate principal amount of $0.9 million (&#163;0.8 million) to non-related third parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
February 2023, MURF Public Stockholders redeemed 11,037,272 shares of MURF Class A common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During March 2023, Conduit
issued promissory convertible notes payable with an aggregate principal amount of $0.8 million to a non-related third party. The note
matures and is payable in full 18 months from the date of the note. The note carries 20% interest and is payable every six months from
the date of the note until the maturity date. The note is subject to conversion of MURF common stock upon consummation of the Business
Combination prior to the maturity date. Conduit notes that this issuance was outside of the terms of the 2022 Convertible Loan Note Instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exchange
of Conduit Shares for Shares of New Conduit</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on 383,389 Conduit ordinary shares outstanding immediately prior to the closing of the Business Combination, the estimated Exchange Ratio
determined in accordance with the terms of the Merger Agreement is approximately 169.5408, subject to variation related to an increase
(or decrease) in shares outstanding prior to Closing. We are not expecting a material increase (or decrease) in shares outstanding prior
to Closing. New Conduit expects to issue 65,000,000 shares of New Conduit common stock to legacy Conduit shareholders (including holders
of Conduit&#8217;s convertible notes) in the Business Combination, determined as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conduit shares outstanding as
    of December 31, 2022<br /> (Historical)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conversion of Convertible notes
    payable, carried at fair value and conversion of Convertible notes payable, carried at fair value - related party into Conduit ordinary
    shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conduit ordinary shares assumed
    outstanding prior to Closing</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; padding-bottom: 2.5pt">Ordinary shares, par value &#163;0.0001 per share</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right">2,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right">381,389</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right">383,389</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="8" style="text-align: right">Conduit ordinary shares assumed outstanding prior to Closing</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">383,389</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="8" style="text-align: right; padding-bottom: 1.5pt">Assumed Exchange Ratio</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">169.5408</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="8" style="text-align: right; padding-bottom: 2.5pt">Estimated shares of New Conduit common stock issued to Conduit shareholders upon Closing</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">65,000,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
381,389 shares resulting from the conversion of the convertible notes payable was calculated by taking the principal of the convertible
notes payable outstanding in Great British Pounds (&#8220;GBP&#8221;) of &#163;2.4 million and applying the GBP-to-United States Dollars
(&#8220;USD&#8221;) exchange rate as of May 3, 2023 to convert the principal to approximately $3.0 million USD. The Conversion Price
is equal to the $10.00 price per share per the PIPE Financing discounted by 20% for the Change of Control ($10.00 * 20% discount = $8.00).
The 381,389 shares resulting from the conversion are calculated by taking the approximately $3.0 million outstanding principal and dividing
this amount by $8.00.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting
for the Business Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the legal form, the Business Combination will be accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this
method of accounting, MURF, will be treated as the acquired company for accounting purposes, whereas Conduit will be treated as the accounting
acquirer. In accordance with this method of accounting, the Business Combination will be treated as the equivalent of Conduit issuing
shares for the net assets of MURF, accompanied by a recapitalization. The net assets of Conduit will be stated at historical cost, with
no goodwill or other intangible assets recorded, and operations prior to the Business Combination will be those of Conduit. Conduit has
been determined to be the accounting acquirer for purposes of the Business Combination based on an evaluation of the following facts
and circumstances:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
    shareholders will have a majority of the voting interest in New Conduit under both the No Redemption Scenario and the Maximum Redemption
    Scenario;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    largest single shareholder of New Conduit will be a legacy shareholder of Conduit;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
    will designate a majority of the governing body of New Conduit.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    individual from Conduit will be designated as the chairman of the governing body of New Conduit and the Chief Executive Officer of
    New Conduit; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
    operations will comprise the ongoing operations of New Conduit.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED BALANCE SHEET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AS
OF DECEMBER 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
thousands)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 1 <br /> Assuming No <br />
    Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 2 <br /> Assuming Maximum
    <br /> Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">MURF Historical</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conduit Historical</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustments for Material Events</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Transaction <br /> Accounting <br />
    Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Balance Sheet</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Transaction <br /> Accounting <br />
    Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro Forma Balance Sheet</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 3%; text-align: right">346</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 3%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%; text-align: right">908</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 5%">&#160;a</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 3%; text-align: right">(4,629</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 5%">&#160;e</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 3%; text-align: right">34,031</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 3%; text-align: right">(22,803</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 5%">&#160;n</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 3%; text-align: right">11,228</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">520</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;b</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">136,871</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;d</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;a</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;g</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(114,068</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;c</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,717</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;l</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid expenses - current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">301</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">301</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">301</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">647</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(111,840</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">145,525</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,332</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,803</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,529</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid expenses and other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Investments held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">136,871</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(136,871</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;d</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loans receivable - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Intangible assets - research and development</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136,871</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(136,871</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">137,518</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(111,840</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,654</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,337</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(22,803</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,534</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued expenses and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">418</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;l</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">393</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">393</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,144</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;l</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,102</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Option liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,417</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,417</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,417</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">418</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,001</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,169</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes payable, carried at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">908</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;a</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(908</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;k</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;a</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,835</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;i</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes payable, carried at fair value - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">520</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;b</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(520</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;k</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred commission payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,629</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,629</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;e</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,083</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,083</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,083</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Derivative warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;g</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Notes payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">175</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">175</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">175</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,629</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,093</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,228</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,703</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,247</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,247</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the unaudited pro forma condensed combined financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED BALANCE SHEET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AS
OF DECEMBER 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
thousands)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            1</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            No</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions
                                            into Cash</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            2 &#160;</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
                                            Maximum Redemptions into Cash</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
    Historical</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
    Historical</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
    for Material Events</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Accounting Adjustments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    Forma Balance Sheet</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Accounting Adjustments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    Forma Balance Sheet</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock subject to possible redemption at redemption value (13,225,000 shares)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,771</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(114,068</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,703</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders&#8217;
    equity/(deficit):</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
    ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
    Class A common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
    Class B common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Conduit common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid-in capital</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,703</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,439</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,803</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,636</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,703</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,891</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,307</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,336</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,785</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    deficit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,300</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,764</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,281</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,281</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,300</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,212</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(357</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumluated
    other comprehensive income</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">675</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">675</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">675</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    stockholders&#8217; equity (deficit):</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,300</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,089</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,229</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,840</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,803</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities and stockholders&#8217; equity (deficit)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137,518</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(111,840</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,654</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,337</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,803</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,534</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the unaudited pro forma condensed combined financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS<br />
FOR THE YEAR ENDED DECEMBER 31, 2022<br />
(in thousands, except share and per share amounts)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            1 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
No </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions
into Cash</b></span></p>

</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scenario
                                            2 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assuming
Maximum </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemptions
into Cash</b></span></p>

</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-style: italic">(In thousands, except per share and weighted-average
    share data)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">MURF Historical</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Conduit Historical</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments</b></span></p></td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Notes</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Pro Forma Statement of Operations</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments</b></span></p></td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Notes</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pro
                                            Forma </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement
                                            of Operations</b></span></p></td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Notes</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 28%; text-align: left">Research and devlopment expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">37</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">37</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">37</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,356</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;c</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,516</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,516</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Administration fee - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Funding expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">74</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">74</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">74</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,204</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,160</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,356</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,720</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,720</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,204</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,356.00</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,720</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,720</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other income (expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss on extinguishment of debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(357</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;a</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(413</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(413</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(56</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;d</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income - Investments held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,976</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;b</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;f</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Other income (expense), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,727</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">108</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;e</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,619</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,619</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total other income (expense), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,976</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,727</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,441</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,192</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,192</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Income (loss) before taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">772</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,887</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,797</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Income tax expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(375</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(375</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(375</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">397</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,887</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,797</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,287</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,287</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net loss per share, Conduit ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,444</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted weighted average shares outstanding, Conduit ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net loss attributable to MURF Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted weighted average shares outstanding, MURF Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,077,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net loss per share attributable to MURF Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.01</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted net loss attributable to MURF Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(35</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted weighted average shares outstanding, MURF Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,306,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted net loss per share attributable to MURF Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.01</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted net loss per share attributable to New Conduit common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.14</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.14</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted weighted average shares outstanding attributable to New Conduit common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,247,978</td><td style="text-align: left">g</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,060,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>g</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the unaudited pro forma condensed combined financial information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adjustments
to Unaudited Pro Forma Condensed Combined Balance Sheet as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma notes and adjustments, based on preliminary estimates that could change materially as additional information is obtained, are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pro
Forma Adjustments for Material Events:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the issuance of $0.9 million of convertible notes subsequent to December 31, 2022 in accordance with the terms of the 2022
    Convertible Loan Note Instrument and the issuance of $0.8 million of convertible notes subsequent to December 31, 2022 that were
    not issued under the 2022 Convertible Loan Note Instrument.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the issuance of $0.5 million of convertible notes to a related party subsequent to December 31, 2022 in accordance with the
    terms of the 2022 Convertible Loan Note Instrument.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the aggregate redemption payment of $114.1 million from the trust account for a pre-combination redemption of 11,037,272
    shares of MURF Class A common stock subject to possible redemption for a redemption price of $10.33 per share subsequent to December
    31, 2022.</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pro
Forma Transaction Accounting Adjustments:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the release of the investments held in the Trust Account to cash and cash equivalents, assuming no Public Stockholders exercise
    their right to have their Common stock subject to possible redemption redeemed for their pro rata share of the Trust Account.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the payment of deferred underwriting fees incurred in connection with MURF&#8217;s initial public offering.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the conversion of 3,306,250 shares of MURF Class B common stock to MURF Class A common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the issuance of an aggregate of 2,700,000 shares of New Conduit common stock to the Subscription Investors at a price of
    $10.00 per share, for an aggregate purchase price of $27.0 million. The adjustment reflects the recording of a derivative warrant
    liability of $0.2 million for the warrant to purchase up to 2,700,000 shares of New Conduit issued to the Private Placement Investor.
    The warrant is classified as a derivative liability because it does not meet the criteria in Accounting Standards Codification (&#8220;ASC&#8221;)
    815-40 to be considered indexed to the entity&#8217;s own stock as the warrant could be settled for an amount that is not equal to
    the difference between the fair value of a fixed number of the entity&#8217;s shares and a fixed monetary amount. In addition, the
    adjustment reflects a reduction to accumulated deficit of $0.1 million. The reduction to accumulated deficit is due to remeasurement
    of the derivative warrant liability for the unaudited pro forma condensed combined statement of operations as if the Transactions
    had occurred and the warrant was issued on January 1, 2022. The derivative warrant liability was measured based on the quoted market
    price for MURF&#8217;s publicly traded warrants, which, for valuation purposes, have materially similar terms as the warrant issued
    to the Private Placement Investor. The adjustment also increases additional paid-in capital by $26.7 million and increases New Conduit
    common stock by an immaterial dollar amount (2,700,000 shares multiplied by par value of $0.0001 is less than $1 thousand).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
terms of the warrant issued to the Private Placement Investor include the following<sup>1</sup>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price of $11.50; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable
    from 30 days after completion of the Business Combination through 5 years after the completion of the Business Combination.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; width: 25%; margin-right: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-right: 0pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1
</sup>Capitalized terms in the bullet points below are defined in the warrant agreement. For all of the terms of the warrant,
refer to the warrant agreement, which is attached as an exhibit to this registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    30 days of the occurrence of a Fundamental Transaction that is within the control of New Conduit, the holder of the warrant can exercise
    and as compensation for exercise receive a cash payment equal to the Black Scholes Value. The inputs to the Black Scholes Value are
    as follows:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
    of the applicable Fundamental Transaction and the Termination Date;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined
    utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental
    Transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash,
    if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest
    VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction
    (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&#8217;s request
    pursuant to Section 3(d) of the warrant agreement;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and
    the Termination Date;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zero
    cost of borrow.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the volatility input is based on the greater of 1) a fixed volatility assumption (100%) and 2) an estimate of current volatility at the
time of settlement (the 100 day volatility obtained from the HVT function on Bloomberg), this input could result in a settlement amount
that is greater than the settlement amount of a fixed-for-fixed option on the entity&#8217;s equity shares. Therefore, the settlement
amount is not considered fixed-for-fixed and thus the warrant is not considered indexed to the entity&#8217;s own stock under ASC 815-40.
As the warrant is not considered indexed to the entity&#8217;s own stock, it cannot be equity-classified and is thus classified as a
derivative liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the reclassification of common stock subject to possible redemption of $22.7 million to an immaterial dollar amount (2,187,728
    shares multiplied by par value of $0.0001 is less than $1 thousand) of New Conduit common stock and $22.7 million of additional paid-in
    capital.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the automatic conversion of $1.8 million of convertible notes issued prior to December 31, 2022 at fair value into Conduit
    ordinary shares at a 20% discount in accordance with the terms of the 2021 Convertible Loan Note Instrument.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the recapitalization of Conduit through the Business Combination and the issuance of 65,000,000 shares of New Conduit common
    stock and the elimination of the accumulated deficit of MURF, the accounting acquiree. As a result of the recapitalization, MURF&#8217;s
    accumulated deficit of $4.3 million and Conduit&#8217;s ordinary shares consisting of an immaterial dollar amount (2,000 shares multiplied
    by par value of &#163;0.0001 is less than $1 thousand) were derecognized. The shares of New Conduit common stock issued in exchange
    for Conduit&#8217;s capital were recorded as an increase to New Conduit common stock of $7.0 thousand and a decrease to additional
    paid-in capital of $4.3 million.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the automatic conversion of $1.4 million of convertible notes issued subsequent to December 31, 2022 at fair value into Conduit
    ordinary shares at a 20% discount in accordance with the terms of the 2022 Convertible Loan Note Instrument and the 2021 Convertible
    Loan Note Instrument.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the payment of MURF&#8217;s and Conduit&#8217;s total estimated transaction costs payable in cash of $13.7 million. The adjustment
    reflects estimated advisory, legal, and other professional fees of $10.3 million which are deemed to be direct and incremental costs
    of the Business Combination, and additional estimated transaction costs of $2.2 million that are not deemed to be direct and incremental
    to the Business Combination and are not expected to recur, and the payment of transaction costs of $1.2 million that were incurred
    and expensed in MURF&#8217;s and Conduit&#8217;s historical financial statements and that are not expected to recur. These expenses
    were recorded as accrued professional fees of $1.1 million in Conduit&#8217;s historical balance sheet and as accrued expenses and
    other current liabilities of $25 thousand in MURF&#8217;s historical balance sheet. The $10.3 million in total estimated costs that
    are direct and incremental to the Business Combination are recorded as a reduction to additional paid-in capital, and the $2.2 million
    in estimated costs that are not direct and incremental to the Business Combination are recorded as an increase to accumulated deficit.
    The total transaction costs are comprised of $9.9 million of Conduit transaction costs recorded as a reduction to additional paid-in
    capital, $1.0 million of Conduit transaction costs recorded as expense, $0.4 million of MURF transaction costs recorded as a reduction
    to additional paid-in capital, and $2.4 million of MURF transaction costs recorded as expense. The adjustment also increases New
    Conduit common stock for an immaterial dollar amount (1,300,000 shares multiplied by par value of $0.0001 is less than $1 thousand)
    as a result of the issuance of 1,300,000 shares of New Conduit common stock to A.G.P. upon the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the conversion of MURF Class A common stock to New Conduit common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect, in Scenario 2, the assumption that MURF Public Stockholders exercise their redemption rights with respect to a maximum of
    2,187,728 shares of common stock subject to possible redemption prior to the consummation of the Transactions at a redemption price
    of $10.42 per share, or $22.8 million in cash.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adjustments
to Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December 31, 2022 </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma notes and adjustments, based on preliminary estimates that could change materially as additional information is obtained, are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pro
Forma Transaction Accounting Adjustments:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect a loss on extinguishment of Conduit&#8217;s convertible notes payable, carried at fair value and convertible notes payable,
    carried at fair value &#8211; related party that were issued subsequent to December 31, 2022. The convertible notes are automatically
    converted immediately prior to the closing of the Business Combination into Conduit ordinary shares at a 20% discount in accordance
    with the terms of the 2022 Convertible Note Loan Instrument and the 2021 Convertible Note Loan Instrument.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect the elimination of interest income earned on the investments held in the Trust Account.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    estimated transaction costs for MURF and Conduit for certain accounting, auditing, and other professional fees that are not deemed
    to be direct and incremental costs of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect a loss on extinguishment of convertible notes payable, carried at fair value that were issued prior to December 31, 2022.
    The convertible notes are automatically converted into Conduit ordinary shares at a 20% discount in accordance with the terms of
    the 2021 Convertible Note Loan Instrument.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect remeasurement of the derivative warrant liability issued to the Private Placement Investor as if the Transactions had occurred
    and the warrant was issued on January 1, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    record interest expense on the $0.8 million of convertible notes issued subsequent to December 31, 2022 that were not issued under
    the 2022 Convertible Loan Note Instrument as if the Business Combination had occurred and the convertible notes had been issued on
    January 1, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    pro forma basic and diluted net loss per share amounts presented in the unaudited pro forma condensed combined statements of operations
    are based on the number of New Conduit shares outstanding as if the Business Combination had occurred on January 1, 2022. The calculation
    of weighted-average shares outstanding for pro forma basic and diluted net loss per share assumes that the shares issuable in connection
    with the Transactions and Material Events have been outstanding for the entirety of the periods presented.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ap_002"></span>COMPARATIVE
PER SHARE DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
Forma weighted-average shares outstanding&#8212;basic and diluted is calculated as follows for the year ended December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-average shares calculation - basic and diluted</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assuming No Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assuming Maximum Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Assume conversion of MURF Class B common stock into New Conduit common stock effective January 1, 2022 as a result of assuming closing of the Business Combination on January 1, 2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">3,306,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">3,306,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Assume reclassification of common stock subject to possible redemption to New Conduit common stock effective January 1, 2022 as a result of assuming closing of the Business Combination on January 1, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,728</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Assume January 1, 2022 issuance of New Conduit common stock in connection with the closing of the PIPE Financing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Assume January 1, 2022 issuance of New Conduit common stock to A.G.P. as a result of assuming closing of the Business Combination on January 1, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,300,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,300,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Assume conversion of MURF Class A common stock into New Conduit common stock effective January 1, 2022 as a result of assuming closing of the Business Combination on January 1, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">754,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">754,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Assume January 1, 2022 issuance of New Conduit common stock to Conduit shareholders as a result of assuming closing of the Business Combination on January 1, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">65,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">65,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Pro forma weighted-average shares outstanding&#8212;basic and diluted</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">75,247,978</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">73,060,250</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following potentially dilutive instruments were not included in the calculation of weighted-average shares outstanding, as their
effects would have been anti-dilutive:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Scenario 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assuming No Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assuming Maximum Redemptions into Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Warrants<sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">15,979,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">15,979,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Warrants<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">754,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">754,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Cizzle PLC option(3)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">439,474</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">439,474</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">17,172,474</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">17,172,474</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Public Warrants will consist of 13,225,000 warrants issued to MURF Public Stockholders in connection with MURF&#8217;s initial public
    offering, 2,700,000 warrants to be issued in connection with the PIPE Financing, and 54,000 warrants to be issued to A.G.P. in connection
    with the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Private Warrants will consist of 709,000 warrants issued to the Sponsor in connection with MURF&#8217;s initial public offering and
    45,000 warrants originally issued to the MURF Sponsor prior to MURF&#8217;s initial public offering that will be transferred to MURF
    Directors upon the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cizzle
    PLC holds an option whereby it can exchange its economic interest in an asset of Conduit Pharmaceuticals Limited for shares worth
    &#163;3.25 million valued at $10.00 per share. Assuming that the Business Combination closed and that the option was exercised on
    January 1, 2022, Cizzle PLC would be issued approximately 439,474 shares based on the GBP-to-USD exchange rate in effect as of January
    1, 2022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="md_014"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
CHARTER AMENDMENTS PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of the principal changes proposed to be made between MURF&#8217;s existing amended and restated
certificate of incorporation and New Conduit&#8217;s Proposed Charter. This summary is qualified by reference to the complete text of the Proposed
Charter, a copy of which is attached to this proxy statement/prospectus as <span style="text-decoration: underline">Annex B</span>. All stockholders are encouraged to read the
Proposed Charter in its entirety for a more complete description of its terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURF
    Amended and Restated Certificate of Incorporation</b></span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURF
    Second Amended and Restated Certificate of Incorporation</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#8220;Murphy
    Canyon Acquisition Corp.&#8221;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#8220;<span>Conduit
    Pharmaceuticals Inc.</span>&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    existing amended and restated certificate of incorporation authorizes two classes of common stock &#8211; Class A common stock and
    Class B common stock. MURF has 111,000,000 authorized shares of common stock, par value $0.0001 per share comprised of 100,000,000
    shares of Class A common stock and 11,000,000 shares of Class B common stock</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Conduit will have 250,000,000 authorized shares of common stock, par value $0.0001 per share. Upon the filing and effectiveness of
    the Second Amended and Restated Certificate, or the effective time, each share of MURF common stock issued and outstanding immediately
    prior to the Effective Time shall, automatically and without any further action by the public entity or any stockholder, be reclassified
    into one fully paid and nonassessable share of New Conduit common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Directors</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of directors, other than those who may be elected by the holders of one or more series of preferred stock voting separately
    by class or series, shall be fixed from time to time exclusively by the board pursuant to a resolution adopted by a majority of the
    board.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total number constituting the board of directors of New Conduit following
the Closing will initially consist of seven (7) individuals, a majority of whom shall be independent directors in accordance with Nasdaq
requirements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholder
    Actions</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    existing amended and restated certificate of incorporation provides that any action required or permitted to be taken by the stockholders
    of MURF must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written consent
    of the stockholders other than with respect to the Class B common stock; action with respect to such stock may be taken by written
    consent.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Conduit stockholders may not act by written consent in lieu of a meeting.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provisions
    Specific to a Special Purpose Acquisition Company</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    existing amended and restated certificate of incorporation sets forth various provisions related to its operations as a blank check
    special purpose acquisition company prior to the consummation of an initial business combination.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    provisions are not applicable to an operating company, and so the Proposed Charter does not include the blank check special purpose
    acquisition company provisions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the amendments above is referred to as a &#8220;charter amendment&#8221; and collectively, the &#8220;charter amendments.&#8221; These
consist of the following separable proposals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.5in">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Charter Amendment
  Proposal A</i></b> &#8212; To change MURF&#8217;s name to &#8220;<span style="background-color: white">Conduit Pharmaceuticals
  Inc</span>.&#8221;;</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Charter Amendment
  Proposal B</i></b> &#8212; To provide for the reclassification of each outstanding share of MURF common stock, including each
  outstanding share of Class A common stock and Class B common stock, into one fully paid and nonassessable share of common stock and
  to remove the designations of Class A and Class B common stock entirely;</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Charter Amendment Proposal
  C &#8212; </i></b><span style="font-style: normal; font-weight: normal">To establish that the board of directors of MURF following
  the closing of the Business Combination shall be initially fixed at seven (7), a majority of whom shall be independent directors in
  accordance with Nasdaq requirements;</span></span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Charter Amendment
  Proposal D </i></b>&#8212; To increase the number of authorized shares of common stock to 250,000,000;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.75in; text-align: justify; text-indent: -2.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.75in; text-align: justify; text-indent: -2.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.5in"></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Charter Amendment Proposal
  E &#8212;</b> To require that stockholders only act at annual and special meetings of the corporation and not by written consent; and</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Charter Amendment
  Proposal F</i></b> &#8212; To remove various provisions applicable to special purpose acquisition corporations.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, upon the closing of the Business Combination, MURF&#8217;s bylaws will be amended and restated promptly to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reflect
                                            necessary changes and to be consistent with the proposed charter amendments described herein;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
                                            certain other changes that the board of directors of MURF deems appropriate for a public
                                            operating company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Charter Amendments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Name</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changing
the post-Business Combination corporate name from &#8220;Murphy Canyon Acquisition Corp.&#8221; to &#8220;Conduit Pharmaceuticals Inc.&#8221;
is desirable to reflect the Business Combination with Conduit. Additionally, the MURF Board believes the name of New Conduit should more
closely align with the name of the existing operating business of Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purpose of this charter amendment is to reclassify each outstanding share of MURF common stock, including each outstanding
share of Class A common stock and Class B common stock, into one fully paid and nonassessable share of common stock. The MURF Board believes
that a single class of common stock provides a cleaner capital structure and that this suits New Conduit&#8217;s requirements following
the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Number
of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
charter amendment is being made to ensure stockholders understand the exact number of directors of New Conduit as of the consummation
of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
directors and officers have interests in the Business Combination that may conflict with your interests as a stockholder. See the section
entitled &#8220;<i>Business Combination Proposal &#8212; Interests of MURF&#8217;s Directors and Officers in the Business Combination</i>&#8221;
for a further discussion of these considerations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Number
of Shares of Authorized Common Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purpose of this charter amendment is to approve an increase in the number of authorized shares of common stock available for
issuance following the consummation of the Business Combination to 250,000,000. Under MURF&#8217;s existing amended and restated certificate
of incorporation, there are 100,000,000 shares of Class A common stock authorized and 10,000,000 shares of Class B common stock
authorized. The Proposed Charter provides for 250,000,000 shares of common stock to be authorized. The MURF Board believes that the greater
number of authorized shares of capital stock is desirable for New Conduit to have sufficient shares to issue in order to complete the
Business Combination and have additional authorized shares for financing its business, for acquiring other businesses, for forming strategic
partnerships and alliances and for stock dividends and stock splits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholder
Actions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Charter provides that any action to be taken by MURF&#8217;s stockholders may not be taken by written consent. The MURF Board
believes that each decision of the stockholders should be made by all stockholders and only after thoughtful consideration of complete
information. Information is provided to stockholders through a proxy statement, and the period between delivery of the proxy statement
and the stockholder meeting provides time for consideration of stockholder proposals. The MURF Board believes that all stockholders,
not just stockholders executing a written consent, should have the opportunity to participate in the decision-making process. This allows
minority stockholders to take whatever action they deem appropriate to protect their interests, including seeking to persuade majority
stockholders to follow a different course, or selling their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposed charter amendment will have the effect of preventing MURF stockholders from taking action at any time other than an annual meeting
or a special meeting to replace directors or take any other action authorized to be taken by stockholders under the DGCL. This charter
amendment may make more difficult, or delay, actions by a person or a group seeking to acquire a substantial percentage of MURF common
stock, to replace directors or to take other action to influence or control its management or policies, even though the holders of a
majority of the outstanding shares of MURF common stock might desire those actions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provisions
Specific to a Special Purpose Acquisition Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
elimination of certain provisions related to MURF&#8217;s status as a special purpose acquisition company is desirable because these
provisions will serve no purpose following the Business Combination. For example, the Proposed Charter does not include the requirement
to dissolve MURF after a certain time period and allows it to continue as a corporate entity with perpetual existence following consummation
of the Business Combination. Perpetual existence is the usual period of existence for corporations, and the MURF Board believes it is
the most appropriate period for MURF. In addition, certain other provisions in the existing amended and restated certificate of incorporation
require that proceeds from MURF&#8217;s initial public offering be held in the trust account until the completion of a business combination
or redemption of 100% of the outstanding public shares has occurred. These provisions cease to apply once the Business Combination is
consummated and are therefore not included in the Proposed Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Proposed Charter, as will be in effect assuming approval of the charter amendments Proposal and upon consummation of the
Business Combination and filing with the Delaware Secretary of State, is attached to this proxy statement/prospectus as <span style="text-decoration: underline">Annex B</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the business combination proposal is not approved, the charter amendment proposals will not be presented at the Special
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of each of Charter A<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">mendment</span> Proposal A,
Charter Amendment Proposal B, Charter Amendment Proposal C, Charter Amendment Proposal E and Charter Amendment Proposal F will
require the affirmative vote of the majority of the issued and outstanding shares of Class A common stock and Class B common stock
, voting as a single class. The approval of Charter Amendment Proposal
D will require the affirmative vote of a majority of the issued and outstanding shares of each of the Class A common stock and Class B
common stock, voting separately. Accordingly, a MURF public stockholder&#8217;s failure to vote by proxy or to vote in person (which would
include presence at a virtual meeting) at the Special Meeting or an abstention will have the same effect as a vote &#8220;AGAINST&#8221;
the Charter Amendment Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Merger Agreement, the approval of the charter amendment proposals is a condition to the adoption of the business combination
proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MURF BOARD RECOMMENDS THAT STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF EACH OF THE CHARTER AMENDMENT
PROPOSALS</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="md_015"></span>THE
ADVISORY CHARTER AMENDMENTS PROPOSALS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, MURF is asking its stockholders to vote upon, on a non-binding advisory basis, proposals
to approve certain governance provisions contained in the Proposed Charter. This separate vote is not otherwise required by Delaware
law separate and apart from the charter amendments proposal but, pursuant to SEC guidance, MURF is required to submit these
provisions to its stockholders separately for approval, allowing stockholders the opportunity to present their separate views on
important governance provisions. However, the stockholder votes regarding these proposals are advisory votes, and are not binding on
MURF or the MURF Board (separate and apart from the approval of the charter amendment proposals). In the judgment of the MURF Board,
these provisions are necessary to adequately address the needs of MURF. Furthermore, the Business Combination is not conditioned on
the separate approval of the advisory charter amendments proposals (separate and apart from approval of the charter amendments
proposal).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
stockholders will be asked to approve, on a non-binding advisory basis, the following material differences between the Proposed Charter
of New Conduit and the existing amended and restated certificate of incorporation, which are being presented in accordance with the requirements
of the SEC as six separate sub-proposals (the &#8220;Advisory charter amendments Proposals&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory Charter Amendment
  Proposal A &#8212;</i></b> To change MURF&#8217;s name to &#8220;<span style="background-color: white">Conduit Pharmaceuticals Inc</span>.&#8221;;</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory Charter Amendment
  Proposal B &#8212;</i></b> To provide for the reclassification of each outstanding share of MURF common stock, including each outstanding
  share of Class A common stock and Class B common stock, into one fully paid and nonassessable share of common stock and to remove the
  designations of Class A and Class B common stock entirely;</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"></td>
  <td style="text-align: justify"><b><i>Advisory Charter Amendment Proposal C &#8212;</i></b> To establish that the board of directors
  of MURF following the closing of the Business Combination shall be initially fixed at seven (7), a majority of whom shall be independent
  directors in accordance with Nasdaq requirements;</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory Charter Amendment
  Proposal D &#8212;</i></b> To increase the number of authorized shares of common stock to 250,000,000;</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory Charter Amendment
  Proposal E &#8212;</i></b>To require that stockholders only act at annual and special meetings of the corporation and not by written
  consent; and</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory Charter Amendment
  Proposal F &#8212;</i></b> To remove various provisions applicable to special purpose acquisition corporations.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Advisory Charter Amendments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory
Charter Amendment Proposal A</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changing
the post-Business Combination corporate name from &#8220;Murphy Canyon Acquisition Corp.&#8221; to &#8220;Conduit Pharmaceuticals Inc.&#8221;
is desirable to reflect the Business Combination with Conduit. Additionally, the MURF Board believes the name of New Conduit should more
closely align with the name of the existing operating business of Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory
Charter Amendment Proposal B</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purpose of this charter amendment is to reclassify each outstanding share of common stock, including each outstanding share
of Class A common stock and Class B common stock, into one fully paid and nonassessable share of common stock. The MURF Board believes
that a single class of common stock provides a cleaner capital structure and that this suits New Conduit&#8217;s requirements following
the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory
Charter Amendment Proposal C</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The total number constituting the MURF Board following the closing of the
Business Combination will initially consist of seven (7) individuals, a majority of whom shall be independent directors in accordance
with Nasdaq requirements. It is in the interests of stockholders of New Conduit to know the size of its board of directors, and such provisions
are also in accordance with the DGCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
directors and officers have interests in the Business Combination that may conflict with your interests as a stockholder. See the section
entitled &#8220;<i>Business Combination Proposal &#8212; Interests of MURF&#8217;s Directors and Officers in the Business Combination</i>&#8221;
for a further discussion of these considerations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory
Charter Amendment Proposal D</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purpose of this charter amendment is to approve an increase in the number of authorized shares of common stock available for
issuance following the consummation of the Business Combination to 250,000,000. Under MURF&#8217;s existing amended and restated certificate
of incorporation, there are 100,000,000 shares of Class A common stock authorized and 10,000,000 shares of Class B common stock
authorized. The Proposed Charter provides for 250,000,000 shares of common stock to be authorized. The MURF Board believes that the greater
number of authorized shares of capital stock is desirable for New Conduit to have sufficient shares to issue in order to complete the
Business Combination and have additional authorized shares for financing its business, for acquiring other businesses, for forming strategic
partnerships and alliances and for stock dividends and stock splits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory
Charter Amendment Proposal E</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Charter provides that any action to be taken by the MURF stockholders may not be taken by written consent. The MURF Board believes
that each decision of the stockholders should be made by all stockholders and only after thoughtful consideration of complete information.
Information is provided to stockholders through a proxy statement, and the period between delivery of the proxy statement and the stockholder
meeting provides time for consideration of stockholder proposals. The MURF Board believes that all stockholders, not just stockholders
executing a written consent, should have the opportunity to participate in the decision-making process. This allows minority stockholders
to take whatever action they deem appropriate to protect their interests, including seeking to persuade majority stockholders to follow
a different course, or selling their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposed charter amendment will have the effect of preventing MURF stockholders from taking action at any time other than an annual meeting
or a special meeting to replace directors or take any other action authorized to be taken by stockholders under the DGCL. This charter
amendment may make more difficult, or delay, actions by a person or a group seeking to acquire a substantial percentage of MURF common
stock, to replace directors or to take other action to influence or control its management or policies, even though the holders of a
majority of the outstanding shares of MURF common stock might desire those actions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory
Charter Amendment Proposal F</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
elimination of certain provisions related to MURF&#8217;s status as a special purpose acquisition company is desirable because these
provisions will serve no purpose following the Business Combination. For example, the Proposed Charter does not include the requirement
to dissolve MURF after a certain time period and allows it to continue as a corporate entity with perpetual existence following consummation
of the Business Combination. Perpetual existence is the usual period of existence for corporations, and the MURF Board believes it is
the most appropriate period for MURF. In addition, certain other provisions in the existing amended and restated certificate of incorporation
require that proceeds from MURF&#8217;s initial public offering be held in the trust account until the completion of a business combination
or redemption of 100% of the outstanding public shares has occurred. These provisions cease to apply once the Business Combination is
consummated and are therefore not included in the Proposed Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Proposed Charter, as will be in effect assuming approval of the charter amendments Proposal and upon consummation of the
Business Combination and filing with the Delaware Secretary of State, is attached to this proxy statement/prospectus as <span style="text-decoration: underline">Annex B</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
advisory charter amendments proposals require the affirmative vote of a majority of the votes cast by stockholders present in person
(by virtual attendance) or represented by proxy and entitled to vote thereon at the Special Meeting (which would include presence by
virtual attendance at the Special Meeting). An abstention will be counted towards the quorum requirement but will not count as a
vote cast at the Special Meeting. A broker non-vote will neither be counted towards the quorum requirement (as the proposals we
believe will be considered as non-discretionary) nor count as a vote cast in the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval and adoption of the advisory charter amendments proposals is non-binding and not conditioned on any other proposal at the Special
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MURF BOARD RECOMMENDS THAT STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF EACH OF THE ADVISORY CHARTER PROPOSALS</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="md_016"></span><b>THE
DIRECTOR ELECTION PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Election
of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Special Meeting, seven (7) directors will be elected who will be the directors of New Conduit upon consummation of the Transactions.
New Conduit&#8217;s board of directors will be of a single class serving a term of one year. If management&#8217;s nominees are elected,
such nominees will serve as directors until the general meeting to be held in 2024 and, in each case, until their successors are elected
and qualified or their earlier resignation or removal. New Conduit&#8217;s board of directors will consist of (i) Dr. Freda Lewis-Hall,
Chairman of New Conduit&#8217;s board of directors, (ii) Dr. David Tapolczay, a current director of Conduit and the Chief Executive Officer
of New Conduit, (iii) James Bligh, an employee of Conduit, (iv) Faith L. Charles, (v) Chele Chiavacci Farley, a current director of MURF,
(vi) Jennifer I. McNealey, and (vii) Dr. Andrew Regan, a current director and shareholder of Conduit (Dr. Regan also undertakes duties
typically associated with an executive officer in connection with his service as a director of Conduit). Information regarding each
nominee is set forth in the section entitled &#8220;<i>Management of New Conduit Following the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware law, the election of directors requires a plurality vote of the shares of common stock present in person (by virtual attendance)
or represented by proxy and entitled to vote at the Special Meeting. &#8220;Plurality&#8221; means that the individuals who receive the
largest number of votes cast &#8220;FOR&#8221; are elected as directors. Consequently, any shares not voted &#8220;FOR&#8221; a particular
nominee (whether as a result of an abstention, a direction to withhold authority or a broker non-vote) will not be counted in the nominee&#8217;s
favor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
authority is withheld or the shares are subject to a broker non-vote, the proxies solicited by the MURF Board will be voted &#8220;FOR&#8221;
the election of these nominees. In case any of the nominees becomes unavailable for election to the MURF Board, due to an event that
is not anticipated, the persons named as proxies, or their substitutes, will have full discretion and authority to vote or refrain from
voting for any other candidate in accordance with their judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the business combination proposal is not approved or any of the charter amendment proposals is not approved and the applicable
condition in the Merger Agreement is not waived, the director election proposal will not be presented at the meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
consummation of the Transactions, the election of directors of New Conduit will be governed by its charter documents, the bylaws, and
the DGCL of New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MURF BOARD UNANIMOUSLY RECOMMENDS THAT MURF&#8217;S STOCKHOLDERS VOTE &#8220;FOR&#8221; EACH OF THE NOMINEES LISTED IN THIS PROXY STATEMENT/PROSPECTUS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="md_017"></span><b>MANAGEMENT
OF NEW CONDUIT FOLLOWING THE BUSINESS COMBINATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, the existing members of the board of directors of MURF, other than Chele Chiavacci Farley,
will resign and, if management&#8217;s nominees are elected, the board of directors of New Conduit will consist of a total of seven (7)&#160;individuals,
which will initially be (i) Dr. Freda Lewis-Hall, Chairman of New Conduit&#8217;s board of directors, (ii) Dr. David Tapolczay, a current
director of Conduit and the Chief Executive Officer of New Conduit, (iii) James Bligh, an employee of Conduit, (iv) Faith L. Charles,
(v) Chele Chiavacci Farley, a current director of MURF, (vi) Jennifer I. McNealey, and (vii) Dr. Andrew Regan, a current director and
shareholder of Conduit (Dr. Regan also undertakes duties typically associated with an executive officer in connection with his service
as a director of Conduit).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of the Business Combination, the executive officers of New Conduit will include Dr. David Tapolczay as the Chief Executive
Officer of New Conduit and Adam Sragovicz, MURF&#8217;s Chief Financial Officer and director, as the Chief Financial Officer of New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
following the Business Combination, the directors and executive officers of New Conduit will be:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom"><td style="border-bottom: black 1.5pt solid; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="white-space: nowrap; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Tapolczay </span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam Sragovicz</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freda Lewis-Hall</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Bligh</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faith L. Charles</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele Chiavacci Farley</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jennifer I. McNealey</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Regan </span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>David
Tapolczay </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Tapolczay has more than 20 years of experience in research and development management. He was a co-founder and has been the Chief Executive
Officer of Conduit since 2019 and a member of Conduit&#8217;s board of directors since 2019. He also currently serves as Chief Executive
Officer of St George Street Capital, a United Kingdom-based medical research charity that is also a scientific advisor to MURF and a
business partner to Conduit, a position which he has held since July 2018, and as Chief Executive Officer of Medeor Pharma Ltd, a pharmaceutical
consultancy company, a position which he has held since 2006.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
February 2008 to December 2018, he served as Chief Executive Officer at LifeArc (formerly the Medical Research Counsel Technology Group
(MRCT)), a United-Kingdom based charity advancing lab-based scientific discoveries to a point at which they can be developed into the
next generation of diagnostics, treatments and cures. He previously served as joint worldwide head of chemistry for Zeneca Agrochemicals,
a research and development unit of AstraZeneca, and as senior manager of chemical development for GlaxoSmithKlein plc, a pharmaceutical
and biotechnology company. Dr. Tapolczay served as Executive Vice President at Cambridge Discovery Chemistry, where he was responsible
for the rapid growth of Cambridge Discovery Chemistry and was a key figure in two successful sales of that company, the first to Oxford
Molecular and the second to Millennium Pharmaceuticals. After this last acquisition, Dr. Tapolczay was Senior Vice President of Pharmaceutical
Sciences at Millennium Pharmaceuticals, with responsibility for over 230 scientists. On leaving Millennium, Dr. Tapolczay was a founder
and Chairman of Pharmorphix Ltd., which was acquired by Sigma Aldrich Fine Chemicals in August 2006. He has also been involved with the
start-up of five companies, all of which are still trading and one of which has been AIM listed. He was VP of Technology Development
for GSK Pharmaceuticals from December 2005 to April 2007. He was awarded visiting Professorial Chair in Chemistry at Sussex University
from August 1999 to May 2007 and has previously held the position of visiting lecturer at Nottingham, Reading and Durham Universities
and a member of both the Technical Opportunities Panel and the User Panel of the EPSRC. He holds a BSc Hons and PhD in Chemistry from
the University of Southampton. Dr. Tapolczay also completed his Post-Doctoral Experience in Organic Chemistry from the University of
Oxford. Dr. Tapolczay was selected to serve on the board of New Conduit following the Business Combination based on his deep knowledge
of Conduit, his extensive experience in research and development of clinical assets, and his in-depth knowledge of the pharmaceutical
industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adam
Sragovicz</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Sragovicz has been MURF&#8217;s Chief Financial Officer since MURF&#8217;s inception. Mr. Sragovicz has been a director of the Company
since December 2021. Mr. Sragovicz has been the Chief Financial Officer of Presidio Property Trust, Inc. since January 11, 2018. He previously
served as Senior Vice President, Finance of Presidio Property Trust, Inc. since May 2017. Before joining Presidio Property Trust, Inc.,
Mr. Sragovicz served as Treasurer of Encore Capital Group from 2011 to 2017, where he was responsible for global capital raising, foreign
exchange risk management and cash management. Mr. Sragovicz has also held capital markets, finance, and treasury management positions
with KPMG, Union Bank of California / MUFG and Bank of America Merrill Lynch. Mr. Sragovicz is the Director of the Yale Alumni Schools
Committee in San Diego and previously sat on the board of Congregation Adat Yeshurun. Mr. Sragovicz is a graduate of Yale University
with a Bachelor of Arts degree in Soviet and Eastern European Studies, with a concentration in Economics. Upon the consummation of the
Business Combination, Mr. Sragovicz will be appointed Chief Financial Officer of New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Freda
Lewis-Hall, M.D., DFAPA</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lewis-Hall served as Senior Medical Advisor to the CEO of Pfizer Inc., or Pfizer, from December 2019 until her retirement in March 2020.
Before assuming that responsibility, from January 2019, Dr. Lewis-Hall served as Chief Patient Officer and Executive Vice President of
Pfizer, beginning January 2019. Dr. Lewis-Hall began her service with Pfizer as its Chief Medical Officer from 2009 to January 2019.
Prior to joining Pfizer in 2009, Dr. Lewis-Hall held various senior leadership positions including Chief Medical Officer and Executive
Vice President, Medicines Development at Vertex Pharmaceuticals Incorporated from June 2008 to May 2009; Senior Vice President, U.S.
Pharmaceuticals, Medical Affairs for Bristol-Myers Squibb Company from 2003 until May 2008; Vice President Research and Development at
Pharmacia Corporation from 2002-2003; Product Team Leader at Pharmacia and Eli Lilly and Company from 1998 to 2002; Director of Lilly
Center for Women&#8217;s Health from 1996-1999, and Clinical Research Physician at Eli Lilly from 1994 through 1996. In October 2021,
Dr. Lewis-Hall became a member of the board of directors for Pyxis Oncology (PYXS), (where she serves as a member of the Nominating and
Corporate Governance Committee. She has been a member of the board of directors for Exact Sciences Corporation (EXAS) since April 2020,
where she serves as a member of the Human Capital and Innovation, Technology and Pipeline Committees; a member of 1LifeHealthCare, Inc.(ONEM)
board since November 2019, serving as a member of the Nominating and Corporate Governance Committee; a member of the board of directors
for Milliken &amp; Company since July 2019, as a member of the Audit and HR and Compensation Committees;, and as a member of the board
of directors of SpringWorks Therapeutics, Inc. (SWTX) since 2017, serving as the chair of the Nominating and Governance Committee. Dr.
Lewis-Hall served as a member of the board of directors for Tenet Healthcare Corporation (THC) from 2014 to 2017. Dr. Lewis-Hall holds
an M.D. from Howard University College of Medicine and a B.A. in natural sciences from the Johns Hopkins University. Conduit believes
Dr. Lewis-Hall is qualified to serve on the board of directors based on her expertise and experience in the biopharmaceutical industry
and her leadership experience as a senior executive at various biopharmaceutical companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>James
(&#8220;Jamie&#8221;) Bligh</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Bligh was a co-founder of Conduit Pharmaceuticals Limited in 2019. From 2008 to 2019, Mr. Bligh worked closely with investment vehicle
Corvus Capital Limited, including as a Partner, where he led a number of reverse takeover transactions, stock market listings, initial
public offerings, secondary fundraisings, and merger transactions. Mr. Bligh&#8217;s prior transaction experience includes advising several
special purpose acquisition vehicles in listing on the London Stock Exchange, including the listing of Bermele Plc, a special purpose
acquisition vehicle, and the subsequent acquisition of Bermele by East Imperial Pte. Ltd., a global purveyor of ultra-premium beverages,
in June 2019; the listing of Leverett Plc, which subsequently acquired Nuformix Plc, a pharmaceutical development company targeting unmet
medical needs in fibrosis and oncology via drug repurposing; and Cizzle Biotechnology Holdings Plc, a UK-based diagnostics developer.
Jamie previously served as a director of Bermele Plc from June 2021 through February 2022; Mertz Plc from January 2021 through March
2022; and East Imperial Pte. Ltd. from September 2017 through April 2018. Jamie graduated from the University of Bristol with a BSc in
Economics &amp; Finance. Mr. Bligh was selected to serve on the board of New Conduit following the Business Combination based on his
past experience with business development, capital raising, financings, public offerings and other strategic transactions, including
mergers and acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Faith L. Charles</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Faith L. Charles, has been a
corporate transactions and securities partner at the law firm of Thompson Hine LLP, since 2010. She leads Thompson Hine&#8217;s Life Sciences
practice and co-heads the securities practice, advising public and emerging biotech and pharmaceutical companies in the U.S. and internationally.
Ms. Charles negotiates complex private and public financing transactions, mergers and acquisitions, licensing transactions and strategic
collaborations. She serves as outside counsel to a myriad of life sciences companies and is known in the industry as an astute business
advisor, providing valuable insights into capital markets, corporate governance and strategic development. Ms. Charles has been a member
of the board of directors of: CNS Pharmaceuticals, Inc. (Nasdaq: CNSP), a biotechnology company developing novel treatments for cancers
of the brain and central nervous system, since December 2022; Avenue Therapeutics, Inc. (Nasdaq: ATXI), a specialty pharmaceutical company
specializing in developing and commercializing therapies for the treatment of the central nervous system, since May 2022; and Abeona Therapeutics,
Inc. (Nasdaq: ABEO), a fully integrated gene and cell therapy company, since March 2021. Ms. Charles serves as Chair of CNS Pharmaceuticals,
on the Audit Committee of Avenue Therapeutics and on the Audit Committee and as the Chair of the Nominating and Governance Committee of
Abeona Therapeutics. From 2018 until October 2021, Ms. Charles served on the Board of Directors and as a member of the Audit Committee
and Chair of the Compensation Committee of Entera Bio Ltd., a publicly-traded biotechnology company. Ms. Charles founded the Women in
Bio Metro New York chapter and chaired the chapter for five years. She also served on the national board of Women in Bio. Ms. Charles
is also a member of the board of Red Door Community (formerly Gilda&#8217;s Club New York City.) She has been recognized as a Life Sciences
Star by Euromoney&#8217;s LMG Life Sciences, has been named a BTI Client Service All-Star, and was named by Crain&#8217;s New York Business
to the list of 2020 Notable Women in the Law. Ms. Charles holds a J.D degree from <span id="OLE_LINK85"></span>The George Washington University
Law School and a B.A. in Psychology from Barnard College, Columbia University. Ms. Charles is a graduate of Women in Bio&#8217;s Boardroom
Ready Program, an Executive Education Program taught by The George Washington University School of Business. Ms. Charles&#8217; qualifications
to serve on our Board include her leadership skills and her vast legal experience representing companies in the biotech and pharmaceutical
field.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Chele Chiavacci Farley</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Chele Chiavacci Farley has served
on the MURF Board since the closing of its initial public offering and currently serves as a partner and managing director of Mistral
Capital International (&#8220;Mistral&#8221;), a private equity firm, since 1995. In her role as Partner and Managing Director of Mistral,
Ms. Farley originates, evaluates and executes equity investment opportunities, creates and implements deal and financial structures, negotiates
with banks for credit facilities, and oversees management. Ms. Farley is the President and a member of the Board of Directors and Management
Committee of Palmilla San Jose Inmobiliaria, the Master Developer of the luxury Palmilla resort development in Cabo San Lucas, Mexico.
Prior to Mistral, Ms. Farley was Vice President of Tricap International from 1994 to 1995. From 1992 to 1994, Ms. Farley was an Associate
at UBS Capital Corporation, and analyzed and evaluated principal investment and financing opportunities for the firm&#8217;s internal
$1 billion fund. Ms. Farley began her career as a Financial Analyst in the Global Finance department - Energy and Telecom Group of Goldman,
Sachs &amp; Co. Ms. Farley has also had an active political career. In 2020, Ms. Farley ran for election to the U.S. House of Representatives
to represent New York&#8217;s 18th Congressional district. In 2018, Ms. Farley ran for election to the U.S. Senate to represent New York.
Ms. Farley graduated from Stanford University with a B.S. and M.S. in Industrial Engineering. She is a member of YPO - <span id="OLE_LINK86"></span>Young
Presidents&#8217; Organization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="OLE_LINK4"></span>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Jennifer I. McNealey</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Jennifer I. McNealey
currently serves as CFO of Abdera Therapeutics Inc., a biotechnology company developing targeted radiotherapeutics. Prior to Abdera,
Ms. McNealey served as CFO of Codex DNA, Inc. (now Telesis Bio Inc.) from March 2021 through its IPO in 2021. Prior to Codex DNA she
was a member of the senior management team at Calithera Biosciences, Inc., a development stage biotechnology company. Ms. McNealey
guided Calithera through multiple equity raises including the IPO and secondary raises. Ms. McNealey is currently a director at
Antibe Therapeutics Inc. where she serves on the Audit and Governance committees. Antibe Therapeutics is a development-stage
biotechnology company building a pipeline of safer, non-addictive therapeutics for pain and inflammation. Previously she served on
the board of Enzon Pharmaceuticals, Inc. from November 2013 to November 2021. Ms. McNealey founded and launched Laurient, an equity
research and competitive intelligence tool for the biotechnology investment community. Prior to founding Laurient, Ms. McNealey
served as an equity analyst and portfolio manager at Franklin Templeton and Morgan Stanley, each with a focus in investing in
public biotechnology companies. Ms. McNealey earned an MHA from the Sloan Program in healthcare administration and a BA in
psychology from Cornell University.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Andrew
Regan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Regan is a British born polar explorer and entrepreneur. He was a co-founder of Conduit Pharmaceuticals Limited and has served as a
Board member since 2019. Dr. Regan also founded Corvus Capital Limited and has been its Chief Executive Officer since 2008. Corvus
Capital is an investment vehicle that was previously listed on the London Stock Exchange prior to being taken private in 2008.
Corvus Capital continues to invest in a number of industries and sectors. Dr. Regan also has experience as an investor in a number
of public and private companies, including ASOS.com Ltd, a global online fashion and beauty retailer, Virtual Internet, an IT
services company that specializes in hosting infrastructure such as VMWare cloud hosting and Managed and Dedicated Servers, and <span style="background-color: white">Imperial
Energy Corporation plc, an upstream oil and gas exploration and production company.</span> Prior to that, Dr. Regan was the Chief
Executive Officer of Hobson Plc, which was listed on the London Stock Exchange, until its sale in 1996 through a cash takeover. Dr.
Regan has a strong interest in the use of bio-inspired science to create solutions for present day problems. In 2014, he was awarded
a PhD from Oxford Brookes University for his research in writing and developing a bio-inspired algorithm for forecasting the
financial markets. He is passionate about the polar regions and is an accomplished polar explorer having led a number of expeditions
to both the Arctic and Antarctica. Dr. Regan was selected to serve on the board of New Conduit following the Business Combination
based on his knowledge of Conduit and his extensive experience in investing, financing, overseeing and developing companies. In
2003, Dr. Regan, in his capacity as Chief Executive Officer of Hobson Plc, was prosecuted in the United Kingdom in relation to his
conduct during the failed &#163;1.2 Billion takeover bid of Co-operative Wholesale Society by Hobson Plc in 1997. Dr. Regan was
acquitted by a jury and the judge awarded him his costs and expenses. Civil claims relating to certain costs associated with the
failed takeover by Dr. Regan were settled in 2005.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="OLE_LINK10"></span>Executive Compensation
Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Employment Arrangements with Executive Officers
of New Conduit</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">New Conduit will enter into employment
letters with each of Dr. Tapolczay and Mr. Sragovicz, which will become effective upon completion the consummation of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Dr. Tapolczay </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The employment letter with Dr.
Tapolczay provides that he will serve as the Chief Executive Officer of New Conduit and shall be appointed to the New Conduit board of
directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Under the letter agreement, Dr.
Tapolczay will be entitled to (i) an annual base salary of $550,000, and (ii) a target annual bonus opportunity equal to 50% of his base
salary, payable based on the achievement of performance objectives as determined by the New Conduit board of directors. In addition, the
employment letter provides that he will be entitled to receive a sign-on stock option award to purchase 0.40% of the shares of common
stock of New Conduit pursuant to the terms of the 2023 Stock Incentive Plan, which shall vest in equal annual installments on the first
four anniversaries of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The employment letter provides
that if New Conduit terminates Dr. Tapolczay&#8217;s employment other than for cause or disability, or if he terminates his employment
for good reason, in either case other than the change in control protection period (described below), he would be entitled to receive
(i) continued payment of his annual base salary for 12 months following the date of termination, (ii) a lump sum payment of his annual
cash performance bonus that had been earned by him for a completed fiscal year or other measuring period but that had not yet been paid
to him as of the date of termination, (iii) a lump sum payment equal to his then target annual bonus opportunity, pro-rated based on the
total number of days elapsed in the calendar year through the date of termination, (iv) payment or reimbursement of the COBRA premiums
for him and his eligible dependents, or if COBRA is not available under our group health plan, a cash amount equal to such payments or
reimbursements (in either case, less the premiums he was paying for such coverage while employed), until the earliest of (x) the last
day of the applicable salary continuation period specified above, or (y) the date he becomes eligible for comparable health insurance
coverage under a subsequent employer&#8217;s group health plan; and (v) accelerated vesting of such number of his unvested equity awards
as would have vested had he remained employed during the 12-month period following his date of termination (provided, however, that, any
equity awards that vest in whole or in part based on the attainment of performance-vesting conditions shall be governed by the terms of
the applicable award agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The employment letter provides
that if New Conduit terminates Dr. Tapolczay&#8217;s employment other than for cause or disability, or if he terminates his employment
for good reason, in either case within three months prior to or 12 months after a change in control (such period, the change in control
period), he would be entitled to receive (i) continued payment of his annual base salary for 18 months following the date of termination,
(ii) a lump sum payment of his annual cash performance bonus that had been earned by him for a completed fiscal year or other measuring
period but that had not yet been paid to him as of the date of termination, (iii) a lump sum payment equal to 150% of his then target
annual bonus opportunity (without pro-ration), (iv) payment or reimbursement of the COBRA premiums for him and his eligible dependents,
or if COBRA is not available under our group health plan, a cash amount equal to such payments or reimbursements (in either case, less
the premiums he was paying for such coverage while employed), until the earliest of (x) the last day of the applicable salary continuation
period specified above, or (y) the date he becomes eligible for comparable health insurance coverage under a subsequent employer&#8217;s
group health plan; and (v) accelerated vesting of 100% of his unvested equity awards (provided, however, that, any equity awards that
vest in whole or in part based on the attainment of performance-vesting conditions shall be governed by the terms of the applicable award
agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Additionally, to the extent that
any payment or benefit received in connection with a change in control would be subject to an excise tax under Section 4999 of the Code, such payments and/or benefits will be subject to a &#8220;best pay cap&#8221; reduction if such reduction would result in
a greater net after-tax benefit to the executive than receiving the full amount of such payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In exchange for the severance
benefits described above, Dr. Tapolczay must (i) sign and not revoke a release of claims in favor of New Conduit, (ii) comply with his
proprietary information and inventions assignment agreement, (iii) refrain from soliciting employees of New Conduit for a period of 1
year after his termination of employment, and (iv) comply with the other provisions of his employment letter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><i>Mr. Sragovicz </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.25in">The proposed employment
letter under negotiation with Mr. Sragovicz provides that he will serve as the Chief Financial Officer of New Conduit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.25in">Under the proposed
letter agreement, Mr. Sragovicz will be entitled to (i) an annual base salary of $400,000, and (ii) a target annual bonus opportunity
equal to 40% of his base salary, payable based on the achievement of performance objectives as determined by the New Conduit board of
directors. In addition, the proposed letter agreement provides that he will be entitled to receive a sign-on equity
grant of New Conduit&#8217;s securities pursuant to the terms of the 2023 Stock Incentive Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The employment letter provides
that if New Conduit terminates Mr. Sragovicz&#8217;s employment other than for cause or disability, or if he terminates his employment
for good reason, in either case other than the change in control protection period (described below), he would be entitled to receive
(i) continued payment of his annual base salary for 9 months following the date of termination, (ii) a lump sum payment of his
annual cash performance bonus that had been earned by him for a completed fiscal year or other measuring period but that had not yet
been paid to him as of the date of termination, (iii) a lump sum payment equal to his then target annual bonus opportunity, pro-rated
based on the total number of days elapsed in the calendar year through the date of termination, (iv) payment or reimbursement of the
COBRA premiums for him and his eligible dependents, or if COBRA is not available under our group health plan, a cash amount equal to
such payments or reimbursements (in either case, less the premiums he was paying for such coverage while employed), until the earliest
of (x) the last day of the applicable salary continuation period specified above, or (y) the date he becomes eligible for comparable
health insurance coverage under a subsequent employer&#8217;s group health plan; and (v) accelerated vesting of such number of his unvested
equity awards as would have vested had he remained employed during the 9-month period following his date of termination (provided,
however, that, any equity awards that vest in whole or in part based on the attainment of performance-vesting conditions shall be governed
by the terms of the applicable award agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.25in">The employment letter
provides that if New Conduit terminates Mr. Sragovicz&#8217;s employment other than for cause or disability, or if he terminates his employment
for good reason, in either case within three months prior to or 12 months after a change in control (such period, the change in control
period), he would be entitled to receive (i) continued payment of his annual base salary for 12 months following the date of termination,
(ii) a lump sum payment of his annual cash performance bonus that had been earned by him for a completed fiscal year or other measuring
period but that had not yet been paid to him as of the date of termination, (iii) a lump sum payment equal to 100% of his then target
annual bonus opportunity (without pro-ration), (iv) payment or reimbursement of the COBRA premiums for him and his eligible dependents,
or if COBRA is not available under our group health plan, a cash amount equal to such payments or reimbursements (in either case, less
the premiums he was paying for such coverage while employed), until the earliest of (x) the last day of the applicable salary continuation
period specified above, or (y) the date he becomes eligible for comparable health insurance coverage under a subsequent employer&#8217;s
group health plan; and (v) accelerated vesting of 100% of his unvested equity awards (provided, however, that, any equity awards that
vest in whole or in part based on the attainment of performance-vesting conditions shall be governed by the terms of the applicable award
agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.25in">Additionally, to the extent
that any payment or benefit received in connection with a change in control would be subject to an excise tax under Section 4999 of the Code, such payments and/or benefits will be subject to a &#8220;best pay cap&#8221; reduction if such reduction would
result in a greater net after-tax benefit to the executive than receiving the full amount of such payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.25in">In exchange for the severance
benefits described above, Mr. Sragovicz must (i) sign and not revoke a release of claims in favor of New Conduit, (ii) comply with his
proprietary information and inventions assignment agreement, (iii) refrain from soliciting employees of New Conduit for a period of 1
year after his termination of employment, and (iv) comply with the other provisions of his employment letter.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b></b></span></p>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Director Compensation Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Compensation Program for the New Conduit Board
of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">New Conduit will adopt
a compensation program for the New Conduit board of directors, which will become effective upon completion the consummation of the Business
Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under the new program, the non-employee directors
will receive the following annual cash retainers for their service on the New Conduit board of directors and its committees:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="vertical-align: top; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$35,000 for each non-employee director;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$30,000 for the Chairman of the New Conduit board of directors; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$15,000 for the chair of the Audit Committee and $7,500 for each of the other members of that committee; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10,000 for the chair of the Compensation Committee and $5,000 for each of the other members of that committee; and </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$8,000 for the chair of the Nominating and Corporate Governance Committee and $4,000 for each of the other members of that committee.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In addition, each non-employee
director who is initially elected or appointed to the board on or after the completion of the Business Combination shall automatically
be granted on the day of such first election or appointment a stock option to purchase 65,000 shares of New Conduit common stock (the
&#8220;Initial Award&#8221;) (provided that the Initial Award with respect to each non-employee director who initially is elected
or appointed to the board at the closing of the Business Combination shall be granted upon the effectiveness of the Form S-8 with respect
to the New Conduit common stock issuable under the 2023 Stock Incentive Plan). Each Initial Award shall vest and become exercisable
in substantially equal installments on each of the first three anniversaries of the date of grant, subject to the non-employee director
continuing in service on the New Conduit board of directors through each such vesting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A non-employee director who is serving on the board
as of the date of any annual meeting after the effective date of the new program, and who will continue to serve as a non-employee director
immediately following such meeting, shall automatically be granted on the date of such annual meeting a stock option to purchase 32,500
shares of New Conduit common stock, which amount is pro-rated for new directors to reflect their service since the last annual meeting
(the &#8220;Annual Award&#8221;). Each Annual Award shall vest and become exercisable on the earlier of (i) the first anniversary of the
date of grant, or (ii) the date immediately prior to the next annual meeting of the Company&#8217;s stockholders following the date of
grant, subject to the non-employee director continuing in service on the New Conduit board through such vesting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Upon a change in control, all outstanding equity awards
that are held by a non-employee director shall become fully vested and exercisable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Board Composition </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">New Conduit&#8217;s business and affairs will be organized
under the direction of its board of directors. The board of directors of New Conduit will meet on a regular basis and additionally as
required. In accordance with the terms of the amended and restated certificate of incorporation, which will be effective upon the consummation
of the Business Combination, New Conduit&#8217;s board of directors may establish the authorized number of directors from time to time
by resolution. New Conduit&#8217;s board of directors will consist of seven (7) directors upon the consummation of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="background-color: white">Under
the Nasdaq listing standards, a majority of the members of New Conduit&#8217;s board of directors must qualify as &#8220;independent,&#8221;
as affirmatively determined by the board of directors. The MURF Board  affirmatively determined that all of the presently expected
directors, except for Messrs. Bligh, Tapolczay, and Regan are independent directors within
the meaning of the applicable Nasdaq listing standards. A majority of the members of the board of New Conduit and all members of the
New Conduit&#8217;s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee will be independent directors
under the applicable Nasdaq listing standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Board Leadership Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="background-color: white">The
New Conduit&#8217;s board will be responsible for the control and direction of New Conduit, the combined company following the Business
Combination. It is anticipated that New Conduit will separate the positions of Chairman and Chief Executive Officer. Dr. Freda Lewis-Hall
will serve as the Chairman of New Conduit&#8217;s board of directors and </span>Dr. David <span id="OLE_LINK17"></span>Tapolczay will serve
as the Chief Executive Officer of New Conduit and as a member of New Conduit&#8217;s board of directors. The MURF Board and the
Conduit board believe that this <span style="background-color: white">structure will serve New Conduit well by maintaining a link between
management, through Dr. </span>Tapolczay<span style="background-color: white">&#8217;s membership on New Conduit&#8217;s board of directors,
and the non-executive directors led by Dr. Lewis-Hall in her role as a non-executive Chairman.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Board Oversight of Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span id="OLE_LINK24"></span>Upon the consummation of
the Business Combination, one of the key functions of New Conduit&#8217;s board of directors will be to conduct informed oversight of
New Conduit&#8217;s risk management process. New Conduit&#8217;s board of directors does not anticipate having a standing risk management
committee, but rather anticipates administering this oversight function directly through New Conduit&#8217;s board of directors as a whole,
as well as through various standing committees of the board of directors that address risks inherent in their respective areas of oversight.
In particular, the board of directors will be responsible for monitoring and assessing strategic risk exposure and New Conduit&#8217;s
Audit Committee will have the responsibility to consider and discuss New Conduit&#8217;s major financial risk exposures and the steps
its management will take to monitor and control such exposures, including guidelines and policies to govern the process by which risk
assessment and management is undertaken. The Audit Committee will also monitor compliance with legal and regulatory requirements. New
Conduit&#8217;s Compensation Committee will also assess and monitor whether New Conduit&#8217;s compensation plans, policies and programs
comply with applicable legal and regulatory requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Board Committees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><i>Audit Committee</i>.<span id="OLE_LINK25"></span> Upon
the consummation of the Business Combination, New Conduit will establish an Audit Committee. The Audit Committee assists the board of
directors with its oversight of the integrity of the financial statements; the compliance with legal and regulatory requirements; the
qualifications, independence and performance of the independent registered public accounting firm; the design and implementation of the
financial risk assessment and risk management. Among other things, the Audit Committee is responsible for reviewing and discussing with
management the adequacy and effectiveness of disclosure controls and procedures. The Audit Committee also discusses with management and
independent registered public accounting firm the annual audit plan and scope of audit activities, scope and timing of the annual audit
of the financial statements, and the results of the audit, quarterly reviews of the financial statements and, as appropriate, initiates
inquiries into certain aspects of the financial affairs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Audit Committee is responsible for establishing
and overseeing procedures for the receipt, retention and treatment of any complaints regarding accounting, internal accounting controls
or auditing matters, as well as for the confidential and anonymous submissions by employees of concerns regarding questionable accounting
or auditing matters. In addition, the Audit Committee has direct responsibility for the appointment, compensation, retention and oversight
of the work of the independent registered public accounting firm. The Audit Committee has sole authority to approve the hiring and discharging
of the independent registered public accounting firm, all audit engagement terms and fees and all permissible non-audit engagements with
the independent auditor. The Audit Committee reviews and oversees all related person transactions in accordance with policies and procedures.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b></b></span></p>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Audit Committee of New Conduit
will undertake these responsibilities following completion of the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span id="OLE_LINK14"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">New Conduit&#8217;s Audit Committee
will be comprised of three members, Ms.<span id="OLE_LINK22"></span> Farley (Chairman), Ms. Lewis-Hall and Ms. McNealey. Each member of the
Audit Committee of New Conduit will meet the <span style="background-color: white">requirements for independence under the current Nasdaq
and SEC rules and regulations and each member is financially literate. In addition, the board of directors has determined that each of
Ms.</span> Farley and Ms. McNealey <span style="background-color: white">is an &#8220;audit committee financial expert&#8221; as defined
in Item 407(d)(5)(ii) of Regulation S-K promulgated under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><i>Compensation Committee</i>.
<span id="OLE_LINK26"></span> Upon the consummation of the Business Combination, New Conduit will establish a Compensation Committee. The
Compensation Committee assists New Conduit&#8217;s board of directors with its oversight of the forms and amount of compensation for executive
officers (including officers reporting under Section 16 of the Exchange Act), the administration of equity and non-equity incentive plans
for employees and other service providers and certain other matters related to compensation programs. The Compensation Committee, among
other responsibilities, evaluates the performance of the New Conduit&#8217;s chief executive officer and, in consultation with him, evaluates
the performance of other executive officers (including officers reporting under Section 16 of the Exchange Act). <span id="OLE_LINK27"></span>The
Compensation Committee of the New Conduit will undertake these responsibilities following completion of the Business Combination. New
Conduit&#8217;s Compensation Committee will be comprised of three members, Ms. Charles (Chairperson), Ms. Farley, and Ms. McNealy. The
composition of the Compensation Committee of New Conduit will meet the requirements for independence under the current Nasdaq and SEC
rules and regulations. Each member of the Compensation Committee of New Conduit will be a &#8220;non-employee&#8221; director within the
meaning of Rule 16b-3 promulgated under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><i>Nominating and Governance
Committee</i>. Upon the consummation of Business Combination, New Conduit will establish a Nominating and Corporate Governance Committee.
The Nominating and Corporate Governance Committee assists the board of directors with its oversight of and identification of individuals
qualified to become members of the board of directors, consistent with criteria approved by the board of directors, and selects, or recommends
that the board of directors selects, director nominees; develops and recommends to the board of directors a set of corporate governance
guidelines; oversees the evaluation of the board of directors; and reviews the environmental, safety, sustainability and corporate social
responsibility policies, objectives and practices on a periodic basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Nominating and Corporate
Governance Committee of the New Conduit will undertake these responsibilities following completion of the Business Combination. New Conduit&#8217;s
Nominating and Corporate Governance Committee will be comprised of two members, Ms. Lewis-Hall (Chairman) and Ms. Charles. The composition
of the Nominating and Corporate Governance Committee will meet the requirements for independence under the current Nasdaq and SEC rules
and regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The board of directors of New
Conduit may from time to time establish other committees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Compensation Committee Interlocks and Insider Participation
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">None
of the proposed executive officers of New Conduit will serve as a member of the board of directors or compensation committee of any entity
that has one or more executive officers who is proposed to serve on New Conduit&#8217;s board of directors or compensation committee following
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="OLE_LINK20"></span>Family Relationships</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">There are no family relationships
among the New Conduit directors and executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Code of Ethics</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">In
connection with the consummation of the Business Combination, New Conduit will adopt a written Code of Business Conduct and Ethics (the
&#8220;Code of Conduct&#8221;) applicable to all of its employees, executive officers and directors. The Code of Conduct will cover fundamental
ethical and compliance-related principles and practices such as accurate accounting records and financial reporting, avoiding conflicts
of interest, the protection and use of its property and information and compliance with legal and regulatory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-right: 0; margin-bottom: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Director and Officer Liability
and Indemnification</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white">New
Conduit will purchase directors&#8217; and officers&#8217; liability insurance and will enter into indemnification agreements with each
of its directors and executive officers. The indemnification agreements and New Conduit&#8217;s amended and restated certificate of incorporation
and amended and restated bylaws will require it to indemnify the directors and officers to the fullest extent permitted by Delaware law.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_018"></span>THE
INCENTIVE PLAN PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is asking its stockholders to approve the Conduit Pharmaceuticals Inc. 2023 Stock Incentive Plan (named in anticipation of the Business
Combination) (the &#8220;2023 Plan&#8221;). The MURF Board approved the 2023 Plan, prior to the Special Meeting, subject to stockholder
approval at the Special Meeting. The 2023 Plan will become effective as of the date immediately prior to the Closing, subject to approval
by the MURF stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Plan is described in more detail below. A copy of the 2023 Plan is attached to this proxy statement/prospectus as <span style="text-decoration: underline">Annex C</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
2023 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purpose of the 2023 Plan is to attract, retain and motivate selected employees, consultants and directors through the granting
of stock-based compensation awards and cash-based awards. Equity awards and equity-linked compensatory opportunities
are intended to motivate high levels of performance and align the interests of directors, employees and consultants with those of stockholders
by giving directors, employees and consultants the perspective of an owner with an equity or equity-linked stake in our company and providing
a means of recognizing their contributions to our success. The MURF Board believes that equity awards are necessary for New Conduit to
remain competitive in its industry and are essential to recruiting and retaining highly qualified employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of the 2023 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section summarizes certain principal features of the 2023 Plan. The summary is qualified in its entirety by reference to the complete
text of the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility
and Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options,
restricted stock units and other stock-based and cash-based awards under the 2023 Plan may be granted to individuals who are then officers,
employees or consultants or are the officers, employees or consultants of New Conduit of certain of New Conduit&#8217;s subsidiaries.
Such awards also may be granted to directors of the New Conduit Board. Only employees of our company or certain of our subsidiaries may
be granted incentive stock options (&#8220;ISOs&#8221;). Following the consummation of the Business Combination, New Conduit is expected
to have approximately [&#9679;] employees, [&#9679;] consultants and [&#9679;] non-employee directors who will be eligible to receive
awards under the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation committee of the New Conduit Board is expected to administer the 2023 Plan unless the New Conduit Board assumes authority
for administration. The 2023 Plan provides that the board or compensation committee may delegate its authority to grant awards to employees
other than executive officers and certain senior executives of New Conduit to a committee consisting of one or more members of New Conduit
Board or one or more of our officers, other than awards made to our non-employee directors, which must be approved by our full board
of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of the 2023 Plan, the plan administrator has the authority to select the persons to whom awards are to be
made, to determine the number of shares to be subject to awards and the terms and conditions of awards, and to make all other determinations
and to take all other actions necessary or advisable for the administration of the 2023 Plan. The plan administrator is also authorized
to adopt, amend or rescind rules relating to administration of the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shares
Available for Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The aggregate number of shares of New Conduit common stock initially reserved
for issuance pursuant to awards under the 2023 Plan will be 11,497,622 shares, which is intended to represent approximately 12.5% of the
fully diluted shares of New Conduit common stock outstanding immediately after Closing, plus an annual increase on the first day of each
calendar year beginning in 2024 and ending in 2033 equal to the lesser of (i) 5% of the shares of New Conduit common stock outstanding
on the last day of the immediately preceding calendar year and (ii) such smaller number of shares of common stock as determined by the
New Conduit Board; provided, however, that no more than 57,488,110 shares of common stock may be issued upon the exercise of ISOs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following counting provisions will be in effect for the share reserve under the 2023 Plan:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the extent that an award terminates, expires or lapses for any reason or an award is settled
                                            in cash without the delivery of shares, any shares subject to the award at such time will
                                            be available for future grants under the 2023 Plan;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            payment of dividend equivalents in cash in conjunction with any outstanding awards will not
                                            be counted against the shares available for issuance under the 2023 Plan; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the extent permitted by applicable law or any exchange rule, shares issued in assumption
                                            of, or in substitution for, any outstanding awards of any entity acquired in any form of
                                            combination by us or any of our subsidiaries will not be counted against the shares available
                                            for issuance under the 2023 Plan.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, the following
shares issued or delivered under the 2023 Plan shall not again be available for future grants of awards: (i) shares that are tendered
or withheld to satisfy the exercise price or tax withholding obligation with respect to any award under the 2023 Plan; (ii) shares that
are repurchased by us with option proceeds; and (iii) shares subject to a stock appreciation right that are not issued in connection
with the stock settlement of the stock appreciation right on exercise thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Plan also provides that the sum of the grant date fair value of all equity-based awards and the maximum amount of cash that
may become payable to any individual for services as a non-employee director during any calendar year
may not exceed $750,000, increased to $1,000,000 in the calendar year of a non-employee director&#8217;s initial service as a non-employee
director of the New Conduit Board. The plan administrator may make exceptions to this limit for individual non-employee directors in
extraordinary circumstances, as the plan administrator may determine in its discretion, provided that the non-employee director receiving
such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation
decisions involving non-employee directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Types
of Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Plan provides that the plan administrator may grant or issue stock options, including ISOs and nonqualified stock options (&#8220;NSOs&#8221;),
stock appreciation rights (&#8220;SARs&#8221;), restricted stock, restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;), other stock- or cash-based awards and dividend equivalents, or any combination thereof.
Certain awards under the 2023 Plan may constitute or provide for payment of &#8220;nonqualified deferred compensation&#8221; under Section
409A of the Code, which may impose additional requirements on the terms and conditions of such awards. All awards under the 2023 Plan
will be evidenced by award agreements, which will detail the terms and conditions of awards, including any applicable vesting and payment
terms and post-termination exercise limitations. Awards other than cash awards generally will be settled in shares of New Conduit common
stock, but the applicable award agreement may provide for cash settlement of any award. A brief description of each award type follows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
                                            Options and SARs</i>. Stock options provide for the purchase of shares of New Conduit common
                                            stock at a specified price set on the grant date. ISOs, in contrast to NSOs, may provide
                                            tax deferral beyond exercise and favorable capital gains tax treatment to their holders if
                                            certain holding period and other requirements of the Code are satisfied. Upon exercise, holders
                                            of SARs will receive from New Conduit an amount equal to the appreciation of the shares subject
                                            to the award between the grant date and the exercise date. Unless otherwise determined by
                                            the plan administrator, the exercise price of a stock option or SAR may not be less than
                                            100% of the fair market value of the underlying share of common stock on the grant date (or
                                            110% in the case of ISOs granted to certain significant stockholders), except with respect
                                            to certain substitute awards granted in connection with a corporate transaction. Unless otherwise
                                            determined by the plan administrator, the term of a stock option or SAR may not be longer
                                            than ten years (or five years in the case of ISOs granted to certain significant stockholders).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
                                            Stock</i>. Restricted stock is an award of non-transferable shares of New Conduit common
                                            stock that are subject to certain vesting conditions and other restrictions as may be determined
                                            by the plan administrator. Restricted stock, typically, may be forfeited for no consideration
                                            or repurchased by us at the original purchase price if the conditions or restrictions on
                                            vesting are not met. In general, restricted stock may not be sold or otherwise transferred
                                            until restrictions are removed or expire. Holders of restricted stock, unlike recipients
                                            of stock options, will have voting rights and will have the right to receive dividends, if
                                            any, prior to the time when the restrictions lapse, however, dividends will not be released
                                            until restrictions are removed or expire.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>RSUs</i>.
                                            RSUs are contractual promises to deliver shares of New Conduit common stock in the future
                                            or an equivalent in cash and other consideration determined by the plan administrator, which
                                            may also remain forfeitable unless and until specified conditions are met and may be accompanied
                                            by the right to receive the equivalent value of dividends paid on shares of New Conduit common
                                            stock prior to the delivery of the underlying shares (i.e., dividend equivalent rights).
                                            Like restricted stock, restricted stock units may not be sold, or otherwise transferred or
                                            hypothecated, until vesting conditions are removed or expire. Unlike restricted stock, stock
                                            underlying restricted stock units will not be issued until the restricted stock units have
                                            vested, and recipients of restricted stock units generally will have no voting or dividend
                                            rights prior to the time when vesting conditions are satisfied.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i>PSUs</i>.
                                            PSUs are performance awards denominated in cash or shares/unit equivalents, respectively,
                                            and may be linked to one or more performance or other criteria as determined by the plan
                                            administrator.</td></tr>
                                                                                                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
                                            Stock or Cash Based Awards</i>. Other stock or cash-based awards are awards of cash, fully
                                            vested shares of New Conduit common stock and other awards valued wholly or partially by
                                            referring to, or otherwise based on, shares of New Conduit common stock. Other stock or cash-based
                                            awards may be granted to participants and may also be available as a payment form in the
                                            settlement of other awards, as standalone payments and as payment in lieu of compensation
                                            to which a participant is otherwise entitled. The plan administrator will determine the terms
                                            and conditions of other stock or cash based awards, which may include vesting conditions
                                            based on continued service, performance and/or other conditions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
                                            Equivalents</i>. Dividend equivalents represent the right to receive the equivalent value
                                            of dividends paid on shares of New Conduit common stock and may be granted alone or in tandem
                                            with awards other than stock options or SARs. Dividend equivalents are converted to cash
                                            or shares by such formula and such time as determined by the plan administrator. In addition,
                                            dividend equivalents with respect to an award subject to vesting will either (i) to the extent
                                            permitted by applicable law, not be paid or credited or (ii) be accumulated and subject to
                                            vesting to the same extent as the related award.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
award may be granted as a performance award, meaning that the award will be subject to vesting and/or payment based on the attainment
of specified performance goals. Performance goals or performance criteria established by the plan administrator for any award may be
described in terms of company-wide objectives or objectives that are related to the performance of a subsidiary, division, business unit,
department, region or function in which the participant is employed or in terms of the performance of the individual participant and
may be based on the following criteria: revenues, earnings from operations, operating income, income before taxes, net income, cash flow,
earnings per share, return on total capital, return on invested capital, return on equity, return on assets, total return to shareholders,
earnings before or after interest, taxes, depreciation, amortization or extraordinary or special items, return on investment, free cash
flow, cash conversion cycle, cash flow return on investment (discounted or otherwise), net cash provided by operations, cash flow in
excess of cost of capital, operating margin, profit margin, contribution margin, stock price, new customers, order intake, cost controls,
operating efficiencies, strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property, milestones
related to research development (including, but not limited to, preclinical and clinical studies), product development and manufacturing,
implementation or completion of projects or processes (including, without limitation, clinical trial initiation, clinical trial enrollment
and dates, clinical trial results, regulatory filing submissions, regulatory filing acceptances, regulatory or advisory committee interactions,
regulatory approvals, and product supply), submission to, or approval by, a regulatory body (including, but not limited to the U.S. Food
and Drug Administration) of an applicable filing or a product, market penetration, geographic business expansion, cost targets, productivity,
corporate value and sustainability metrics (including, without limitation, environmental, social and governance matters), human capital
metrics (including, without limitation, employee satisfaction, management of employment practices, employee benefits, retention and safety),
supervision of litigation or labor negotiations, dealings with regulatory bodies, acquisitions or divestitures, customer satisfaction,
strategic business criteria related to a participant&#8217;s area or areas of responsibility, or other criteria established by the plan
administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
Transactions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any stock dividend or other distribution, stock split, reverse stock split, reorganization, combination or exchange of shares,
merger, consolidation, split-up, spin-off, recapitalization, repurchase or any other corporate event affecting the number of outstanding
shares of New Conduit common stock or the share price of New Conduit common stock that would require adjustments to the 2023 Plan or
any awards under the 2023 Plan in order to prevent the dilution or enlargement of the potential benefits intended to be made available
thereunder, the plan administrator will make appropriate, proportionate adjustments to: (i) the aggregate number and type of shares subject
to the 2023 Plan; (ii) the number and kind of shares subject to outstanding awards and terms and conditions of outstanding awards (including,
without limitation, any applicable performance targets or criteria with respect to such awards); and (iii) the grant or exercise price
per share of any outstanding awards under the 2023 Plan; as well as granting new awards or making cash payments to participants. The
administrator is also authorized to provide for the cancellation, exchange, accelerated vesting or exercisability, replacement or termination
of outstanding awards in the event of a corporate transaction or event affecting New Conduit or any change in applicable law or accounting
principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event of a change
in control (as defined in the 2023 Plan), to the extent that the successor entity does not assume or substitute outstanding awards, the
administrator will cause all such awards to become fully vested and, if applicable, exercisable immediately prior to the consummation
of such transaction, and with respect to awards with performance-based vesting, all performance goals or other vesting criteria will
be deemed achieved at the greater of (i) one hundred percent (100%) of target levels, or (ii) the actual level of achievement
of all relevant performance goals against target measured through the date immediately prior to the change in control (or as close to
such date as administratively practicable), unless specifically provided otherwise under the applicable award agreement or otherwise
determined by the administrator, and all forfeiture restrictions on such awards will lapse and, to the extent unexercised upon the consummation
of such transaction, will be terminated in exchange for cash, rights or other property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Repricing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
plan administrator will, without the approval from the New Conduit stockholders, have the authority to amend any outstanding stock option
or SAR to reduce its exercise price per share or cancel any outstanding stock option or SAR in exchange for cash or another award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment
and Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Conduit Board may terminate, amend or suspend the 2023 Plan at any time and from time to time. However, we must generally obtain
stockholder approval to the extent required by applicable law, rule or regulation (including any applicable stock exchange rule). No
amendments to outstanding awards that materially and adversely affect a participant&#8217;s rights under the award may be made without
the affected participant&#8217;s consent, except in connection with certain transactions (such as equity restructurings, corporate transactions,
or a change in control) or to preserve the intended tax treatment of the participant&#8217;s award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
awards may be granted pursuant to the 2023 Plan on or after the tenth anniversary of the date the New Conduit Board approved the 2023
Plan. Any award that is outstanding on the termination date of the 2023 Plan will remain in force according to the terms of the 2023
Plan and the applicable award agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Participants, Claw-Back Provisions, Transferability and Participant Payments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
plan administrator may modify awards granted to participants who are foreign nationals or employed outside the United States or establish
subplans or procedures to address, among other things, differences in laws, rules, regulations or customs of such foreign jurisdictions.
All awards will be subject to any New Conduit claw-back policy as set forth in such claw-back policy or the applicable award agreement.
Except as the plan administrator may determine or provide in an award agreement, awards under the 2023 Plan are generally non-transferrable,
except by will or the laws of descent and distribution, or, subject to the plan administrator&#8217;s consent, pursuant to a domestic
relations order, and are generally exercisable only by the participant. With regard to tax withholding obligations arising in connection
with awards under the 2023 Plan, and exercise price obligations arising in connection with the exercise of stock options under the 2023
Plan, the plan administrator may, in its discretion, accept cash, wire transfer or check, shares of common stock that meet specified
conditions, a &#8220;market sell order,&#8221; or such other consideration as the plan administrator deems suitable
or any combination of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
Federal Income Tax Consequences Related to Awards Under the 2023 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary is based on an analysis of the Code as currently in effect, existing laws, judicial decisions, administrative rulings,
regulations and proposed regulations, all of which are subject to change. Moreover, the following is only a summary of United States
federal income tax consequences. Actual tax consequences to participants in the 2023 Plan may be either more or less favorable than those
described below depending on the participants&#8217; particular circumstances. State and local tax consequences may in some cases differ
from the U.S. federal income tax consequences. The following summary of the income tax consequences in respect of the 2023 Plan is for
general information only. Interested parties should consult their own advisors as to the specific tax consequences of their awards, including
the applicability and effect of state, local and foreign laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Incentive
Stock Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
income will be recognized by a participant for United States federal income tax purposes upon the grant or exercise of an ISO under the
2023 Plan. The basis of shares transferred to a participant upon exercise of an ISO is the price paid for the shares. If the participant
holds the shares for at least one year after the transfer of the shares to the participant and two years after the grant of the ISO,
the participant generally will recognize capital gain or loss upon sale of the shares received upon exercise equal to the difference
between the amount realized on the sale and the basis of the stock. Generally, if the shares are not held for that period, the participant
will recognize ordinary income upon disposition in an amount equal to the excess of the fair market value of the shares on the date of
exercise over the amount paid for the shares, or if less (and if the disposition is a transaction in which loss, if any, will be recognized),
the gain on disposition. Any additional gain realized by the participant upon the disposition will be a capital gain. The excess of the
fair market value of shares received upon the exercise of an incentive stock option over the option price for the shares is an item of
adjustment for the participant for purposes of the alternative minimum tax. Therefore, although no income is recognized upon exercise
of an incentive stock option, a participant may be subject to alternative minimum tax as a result of the exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-statutory
Stock Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
income is expected to be recognized by a participant for United States federal income tax purposes upon the grant of a NSO. Upon exercise
of a NSO, the participant will recognize ordinary income in an amount equal to the excess of the fair market value of the shares on the
date of exercise over the amount paid for the shares. Income recognized upon the exercise of a NSO will be considered compensation subject
to withholding at the time the income is recognized, and, therefore, the participant&#8217;s employer must make the necessary arrangements
with the participant to ensure that the amount of the tax required to be withheld is available for payment. NSOs are designed to provide
the employer with a deduction equal to the amount of ordinary income recognized by the participant at the time of the recognition by
the participant, subject to the deduction limitations described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are expected to be no United States federal income tax consequences to either the participant or the employer upon the grant of SARs.
Generally, the participant will recognize ordinary income subject to withholding upon the receipt of payment pursuant to SARs in an amount
equal to the aggregate amount of cash and the fair market value of any common stock received. Subject to the deduction limitations described
below, the employer generally will be entitled to a corresponding tax deduction equal to the amount includible in the participant&#8217;s
income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the restrictions on an award of shares of restricted stock are of a nature that the shares are both subject to a substantial risk of
forfeiture and are not freely transferable (within the meaning of Section 83 of the Code), the participant will not recognize income
for United States federal income tax purposes at the time of the award unless the participant affirmatively elects to include the fair
market value of the shares of restricted stock on the date of the award, less any amount paid for the shares, in gross income for the
year of the award pursuant to Section 83(b) of the Code. In the absence of this election, the participant will be required to include
in income for United States federal income tax purposes on the date the shares either become freely transferable or are no longer subject
to a substantial risk of forfeiture (within the meaning of Section 83 of the Code), the fair market value of the shares of restricted
stock on such date, less any amount paid for the shares. The employer will be entitled to a deduction at the time of income recognition
to the participant in an amount equal to the amount the participant is required to include in income with respect to the shares, subject
to the deduction limitations described below. If a Section 83(b) election is made within 30 days after the date the restricted stock
is received, the participant will recognize ordinary income at the time of the receipt of the restricted stock, and the employer will
be entitled to a corresponding deduction, equal to the fair market value of the shares at the time, less the amount paid, if any, by
the participant for the restricted stock. If a Section 83(b) election is made, no additional income will be recognized by the participant
upon the lapse of restrictions on the restricted stock, but, if the restricted stock is subsequently forfeited, the participant may not
deduct the income that was recognized pursuant to the Section 83(b) election at the time of the receipt of the restricted stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
paid to a participant holding restricted stock before the expiration of the restriction period will be additional compensation taxable
as ordinary income to the participant subject to withholding, unless the participant made an election under Section 83(b) of the Code.
Subject to the deduction limitations described below, the employer generally will be entitled to a corresponding tax deduction equal
to the dividends includible in the participant&#8217;s income as compensation. If the participant has made a Section 83(b) election,
the dividends will be dividend income, rather than additional compensation, to the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the restrictions on an award of restricted stock are not of a nature that the shares are both subject to a substantial risk of forfeiture
and not freely transferable, within the meaning of Section 83 of the Code, the participant will recognize ordinary income for United
States federal income tax purposes at the time of the transfer of the shares in an amount equal to the fair market value of the shares
of restricted stock on the date of the transfer, less any amount paid therefor. The employer will be entitled to a deduction at that
time in an amount equal to the amount the participant is required to include in income with respect to the restricted shares, subject
to the deduction limitations described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
generally will be no United States federal income tax consequences to either the participant or the employer upon the grant of RSUs.
Generally, the participant will recognize ordinary income subject to withholding upon the receipt of cash and/or transfer of shares of
common stock in payment of the RSUs in an amount equal to the aggregate of the cash received and the fair market value of the common
stock so transferred. Subject to the deduction limitations described below, the employer generally will be entitled to a corresponding
tax deduction equal to the amount includible in the participant&#8217;s income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a participant will recognize ordinary income subject to withholding upon the payment of any dividend equivalents paid with respect to
an award in an amount equal to the cash and the fair market value of any common stock the participant receives. Subject to the deduction
limitations described below, the employer generally will be entitled to a corresponding tax deduction equal to the amount includible
in the participant&#8217;s income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitation
on the Employer&#8217;s Compensation Deduction</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
162(m) of the Code limits the deduction certain employers may take for otherwise deductible compensation payable to certain executive
officers of the employer to the extent the compensation paid to such an officer for the year exceeds $1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Excess
Parachute Payments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
280G of the Code limits the deduction that the employer may take for otherwise deductible compensation payable to certain individuals
if the compensation constitutes an &#8220;excess parachute payment.&#8221; Excess parachute payments arise from payments made to disqualified
individuals that are in the nature of compensation and are contingent on changes in ownership or control of the employer or certain affiliates.
Accelerated vesting or payment of awards under the 2023 Plan upon a change in ownership or control of the employer or its affiliates
could result in excess parachute payments. In addition to the deduction limitation applicable to the employer, a disqualified individual
receiving an excess parachute payment is subject to a 20% excise tax on the amount thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
409A of the Code</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
types of awards under the 2023 Plan may constitute, or provide for, a deferral of compensation subject to Section 409A of the Code. Unless
certain requirements set forth in Section 409A of the Code are complied with, holders of such awards may be taxed earlier than would
otherwise be the case (<i>e.g.,</i> at the time of vesting instead of the time of payment) and may be subject to an additional 20% penalty
tax (and, potentially, certain interest, penalties and additional state taxes). To the extent applicable, the 2023 Plan and awards granted
under the 2023 Plan are intended to be structured and interpreted in a manner intended to either comply with or be exempt from Section
409A of the Code and the Department of Treasury regulations and other interpretive guidance that may be issued under Section 409A of
the Code. To the extent determined necessary or appropriate by the plan administrator, the 2023 Plan and applicable award agreements
may be amended to further comply with Section 409A of the Code or to exempt the applicable awards from Section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Plan Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
benefits or amounts that may be received by or allocated to participants under the 2023 Plan will be determined at the discretion of
the plan administrator and are not currently determinable. The value of future awards granted under the 2023 Plan will depend on a number
of factors, including the fair market value of the common stock on future dates, the exercise decisions made by the participants and
the extent to which any applicable performance goals necessary for vesting or payment are achieved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Statement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit intends to file with the SEC a registration statement on Form S-8 covering some or all of the shares of New Conduit Common Stock
issuable under the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination Proposal is not approved, the Incentive Plan Proposal will not be presented at the Special Meeting. The
Incentive Plan Proposal will be approved and adopted only if a majority of the votes cast by the MURF stockholders present in person
(by virtual attendance) or represented by proxy at the Special Meeting and entitled to vote thereon, assuming a quorum is present,
vote &#8220;FOR&#8221; the Incentive Plan Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
to submit a proxy or to vote virtually at the Special Meeting, an abstention from voting or a broker non-vote will have no effect on
the Incentive Plan Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination is conditioned upon the approval of the Incentive Plan Proposal. Notwithstanding the approval of the Incentive Plan
Proposal, if the Business Combination is not consummated for any reason, the actions contemplated by the Incentive Plan Proposal will
not be effected. Each of the Condition Precedent Proposals is cross-conditioned on the approval of each other. The Sponsor agreed to
vote such shares in favor of the business combination proposal. See the section entitled &#8220;<i>Special Meeting of MURF Stockholders
&#8212; Sponsor</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MURF BOARD UNANIMOUSLY RECOMMENDS THAT THE MURF&#8217;S STOCKHOLDERS VOTE &#8220;FOR&#8221; THE INCENTIVE PLAN PROPOSAL.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_019"></span>EXECUTIVE
AND DIRECTOR COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Conduit Executive and Director Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In connection with the Business
Combination, the existing members of the board of directors of MURF, other than Chele Chiavacci Farley, will resign and, if management&#8217;s
nominees are elected, the board of directors of New Conduit will consist of a total of seven (7) individuals, which will initially be:
(i) Dr. Freda Lewis-Hall, Chairman of New Conduit&#8217;s board of directors, (ii) Dr. David Tapolczay, a current director of Conduit
and the Chief Executive Officer of New Conduit, (iii) James Bligh, an employee of Conduit, (iv) Faith L. Charles, (v) Chele Chiavacci
Farley, a current director of MURF, (vi) Jennifer I. McNealey, and (vii) Dr. Andrew Regan, a current director and shareholder of Conduit
(Dr. Regan also undertakes duties typically associated with an executive officer in connection with his service as a director of Conduit).
The compensation for directors of New Conduit following the closing of the Business Combination has not yet been determined. We intend
to include such information in an amendment to this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of the Business Combination, the executive officers of New Conduit will include Dr. David Tapolczay as Chief Executive Officer
and Adam Sragovicz, MURF&#8217;s Chief Financial Officer and director, as Chief Financial Officer. The compensation payable to the executive
officers of New Conduit following the closing of the Business Combination has not yet been determined. We intend to include such information
in an amendment to this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURF
Executive and Director Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
executive officer of MURF has received any cash compensation for services rendered to us. Starting February 2022, MURF will pay Murphy
Canyon Management Group, Inc., an affiliate of the sponsor, $10,000 per month for providing us with office space and certain office and
secretarial services. However, this arrangement is solely for MURF&#8217;s benefit and is not intended to provide MURF&#8217;s officers
or directors compensation in lieu of a salary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than the $10,000 per month administrative fee, the payment of consulting, success or finder fees to the Sponsor, officers, directors or their affiliates in connection with the consummation of MURF&#8217;s initial business combination, and the
transfer of 15,000 placement units to each of the three independent directors following the closing of our initial public offering,
no compensation or fees of any kind will be paid to the Sponsor, members of our management team or their
respective affiliates, for services rendered prior to or in connection with the consummation of MURF&#8217;s initial business
combination (regardless of the type of transaction that it is). However, they will receive reimbursement for any out-of-pocket
expenses incurred by them in connection with activities on our behalf, such as identifying potential target businesses, performing
business due diligence on suitable target businesses and business combinations as well as traveling to and from the offices, plants
or similar locations of prospective target businesses to examine their operations. There is no limit on the amount of consulting,
success or finder fees payable by MURF upon consummation of an initial business combination. Additionally, there is no limit on the
amount of out-of-pocket expenses reimbursable by MURF; provided, however, that to the extent such expenses exceed the available
proceeds not deposited in the Trust Account, such expenses would not be reimbursed unless MURF consummates an initial business
combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_020"></span>THE
NASDAQ PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, MURF intends to issue (subject to customary terms and conditions) up to 2,700,000 units, with
each unit consisting of one share of New Conduit common stock together with one warrant exercisable into one share of New Conduit common
stock, to the Private Placement Investor pursuant to the Subscription Agreement and 65,000,000 shares of New Conduit common stock pursuant
to the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
MURF Needs Stockholder Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are seeking stockholder approval in order to comply with Nasdaq Listing Rules 5635(a), (b) and (d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rule 5635(a), stockholder approval is required prior to the issuance of securities in connection with the acquisition
of another company if such securities are not issued in a public offering and (A) have, or will have upon issuance, voting power equal
to or in excess of 20% of the voting power outstanding before the issuance of common stock (or securities convertible into or exercisable
for common stock) or (B) the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of
shares of common stock outstanding before the issuance of the stock or securities. MURF will issue shares (including shares exercisable
upon warrants) representing 20% or more of the number of outstanding shares of MURF common stock prior to the issuance, or 20% or more
of its voting power prior to the issuance, pursuant to the Merger Agreement and the Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rule 5635(b), stockholder approval is required prior to the issuance of securities when the issuance or potential issuance
will result in a change of control of the registrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rule 5635(d), stockholder approval is required for a transaction other than a public offering involving the sale, issuance
or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) at a price that is
less than the lower of: (i) the Nasdaq official closing price immediately preceding the signing of the binding agreement; or (ii) the
average Nasdaq official closing price of the common stock for the five trading days immediately preceding the signing of the binding
agreement if the number of shares of common stock to be issued is or may be equal to 20% or more of the common stock, or 20% or more
of the voting power, outstanding before the issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
of Proposal on Current Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Nasdaq proposal is adopted, up to 70,400,000 shares of New Conduit common stock, (including up to 2,700,000 shares of New Conduit
common stock issuable upon exercise of warrants) may be issued pursuant to the terms of the Merger Agreement and the Subscription Agreement,
which would result in significant dilution to MURF&#8217;s stockholders, and would afford stockholders a smaller percentage interest
in the voting power, liquidation value and aggregate book value of MURF after the closing of the Business Combination</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that this proposal is not approved by MURF stockholders, the Business Combination may not be consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Nasdaq proposal requires the affirmative vote of a majority in voting power of the outstanding shares of MURF common stock present
in person (by virtual attendance) or by proxy at the Special Meeting. Assuming a valid quorum is otherwise established, failure to vote
and broker non-votes will have no effect on the outcome of any vote on the Nasdaq proposal. Abstentions are deemed entitled to vote on
such proposals. Therefore, they have the same effect as a vote against the proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nasdaq proposal is conditioned upon the approval and completion of the business combination proposal. If the business combination proposal
is not approved, the Nasdaq proposal will have no effect, even if approved by the MURF stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MURF BOARD UNANIMOUSLY RECOMMENDS THAT MURF STOCKHOLDERS VOTE &#8220;FOR&#8221; THE NASDAQ PROPOSAL.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_021"></span>THE
ADJOURNMENT PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
adjournment proposal allows the MURF Board to submit a proposal to adjourn the Special Meeting to a later date or dates, if necessary,
to permit further solicitation and vote of proxies in the event MURF does not have sufficient proxies to approve one or more of the foregoing
proposals. In no event will MURF solicit proxies to adjourn the Special Meeting or consummate the Business Combination beyond the date
by which it may properly do so under its amended and restated certificate of incorporation and Delaware law. See the section entitled
&#8220;<i>The Business Combination Proposal &#8212; Interests of MURF&#8217;s Directors and Officers in the Business Combination</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to an adjournment of the Special Meeting upon approval of an adjournment proposal, the MURF Board is empowered under Delaware
law to postpone the meeting at any time prior to the meeting being called to order. In such event, MURF will issue a press release and
take such other steps as it believes are necessary and practical in the circumstances to inform its stockholders of the postponement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consequences
if the Adjournment Proposal is not Approved</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an adjournment proposal is presented to the meeting and is not approved by the stockholders, the MURF Board may not be able to adjourn
the Special Meeting to a later date if MURF is unable to consummate the Business Combination (because either the business combination
proposal is not approved or the conditions to consummating the Business Combination have not been met). In such event, the Business Combination
would not be completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adoption
of the adjournment proposal requires the affirmative vote of a majority of the issued and outstanding shares of MURF common stock represented
in person (by virtual attendance) or by proxy at the meeting and entitled to vote thereon. Adoption of the adjournment proposal is not
conditioned upon the adoption of any of the other proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MURF BOARD UNANIMOUSLY RECOMMENDS THAT MURF STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF THE ADJOURNMENT PROPOSAL.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="md_022"></span><b>INFORMATION
ABOUT murf</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Introduction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
was incorporated on October 19, 2021, for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization,
reorganization or other similar business combination with one or more businesses or entities. MURF&#8217;s efforts to identify a prospective
target business were not limited to any particular industry or geographic region. Prior to executing the Merger Agreement, MURF&#8217;s
efforts were limited to organizational activities, completion of its initial public offering and the evaluation of possible business
combinations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
Public Offering and Simultaneous Private Placement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2022, MURF closed its initial public offering of 13,225,000 units, with each unit consisting of one share of its Class A
common stock and one warrant, with each whole warrant entitling the holder thereof to purchase one share of its Class A common stock
at a purchase price of $11.50. The units from the initial public offering were sold at an offering price of $10.00 per unit, generating
total gross proceeds of $132.25 million. Simultaneously with the consummation of the initial public offering, MURF consummated the private
sale of 754,000 private units at $10.00 per unit for gross proceeds of approximately $7.54 million. A total of $139,790,000 was deposited
into the trust account. This resulted in an overfunding of the trust account by $4,895,000. As such, subsequent to the initial funding
of the trust account, $2,000,000 was transferred to MURF&#8217;s operating cash account and $2,895,000 was used to pay offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described in the prospectus for MURF&#8217;s initial public offering and described in the subsections below entitled
&#8220;<i>&#8212; </i>January 2023 Extension&#8221; and &#8220;<i>&#8212; MURF&#8217;s Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations</i>,&#8221; these proceeds will not be released until the earlier of the completion of
an initial business combination and MURF&#8217;s redemption of 100% of the outstanding Public Shares upon its failure to consummate
a business combination within the required time period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>January 2023 Extension</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">Initially,
MURF was required to complete its initial business combination transaction by 12 months from the consummation of its initial public offering
or up to 18 months if it extended the period of time to consummate a business combination in accordance with its amended and restated
certificate of incorporation. On January 26, 2023, at a special meeting of its stockholders, MURF&#8217;s stockholders approved a proposal
to amend the amended and restated certificate of incorporation to allow it to extend the date by which it has to consummate a business
combination up to 12 times, each such extension for an additional one month period, from February 7, 2023, to February 7, 2024. MURF&#8217;s
stockholders also approved a related proposal to amend the trust agreement allowing MURF to deposit into the trust account, for each
one-month extension, one-third of 1% of the funds remaining in the trust account following the redemptions made in connection with the
approval of the extension proposal at the special meeting. At the special meeting MURF&#8217;s stockholders also approved a proposal
to amend its amended and restated certificate of incorporation to expand the methods that it may employ to not become subject to the
&#8220;penny stock&#8221; rules of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">In connection
with such proposals, MURF&#8217;s public stockholders had the right to redeem their shares for cash equal to their pro rata share of the
aggregate amount on deposit in the trust account as of two days prior to such stockholder vote. The public stockholders holding 11,037,272
shares of Class A common stock (out of a total of 13,979,000 shares of Class A common stock) exercised their right to redeem such shares
at a redemption price of approximately $10.33 per share. Approximately $114 million in cash was removed from the trust account to pay
such stockholders and, accordingly, after giving effect to such redemptions, the balance in the trust account was approximately $23 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">As a
result of the approval of such proposals, MURF agreed to deposit into the trust account one-third of 1% of the funds then on deposit in
the trust account for each month of the extension period, resulting in a monthly contribution of approximately $0.035 per share that was
not redeemed in connection with the Special Meeting (approximately $77,000 in the aggregate per month), or an aggregate of $924,000 (the
&#8220;Maximum Contribution&#8221;) if the date MURF has to consummate a business combination is extended 12 times, each assuming no interest
is earned on the funds in the trust account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Market Value of Target Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
target business or businesses that MURF acquires must collectively have a fair market value equal to at least 80% of the balance of the
funds in the trust account (excluding the deferred underwriting commissions and taxes payable on the income earned on the trust account)
at the time of the execution of a definitive agreement for its initial business combination, although MURF may acquire a target business
whose fair market value significantly exceeds 80% of the trust account balance. The MURF Board determined that this test was met in connection
with the proposed business combination with Conduit as described in the section titled &#8220;<i>The Business Combination Proposal</i>&#8221;
above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
Rights for Public Stockholders upon Completion of MURF&#8217;s Initial Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white">MURF
will provide its public stockholders with the opportunity to redeem all or a portion of their shares of Class A common stock upon the
completion of MURF&#8217;s initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the trust account as of two business days prior to the consummation of the initial business combination including interest
earned on the funds held in the trust account and not previously released to MURF to pay MURF&#8217;s taxes, divided by the number of
then outstanding public shares, subject to the limitations described herein. The amount in the trust account is anticipated to be approximately
$10.52 per public share. MURF&#8217;s Sponsor, officers and directors entered into a letter agreement with MURF, pursuant to which they
agreed to waive their redemption rights with respect to any founder shares and any public shares held by them in connection with the
completion of MURF&#8217;s initial business combination.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manner
of Conducting Redemptions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
will provide its public stockholders with the opportunity to redeem all or a portion of their public shares of Class A common stock upon
the completion of MURF&#8217;s initial business combination either (i) in connection with a stockholder meeting called to approve the
initial business combination or (ii) by means of a tender offer. The decision as to whether MURF will seek stockholder approval of a
proposed initial business combination or conduct a tender offer will be made by MURF, in its sole discretion, and will be based on a
variety of factors such as the timing of the transaction and whether the terms of the transaction would require MURF to seek stockholder
approval under the law or stock exchange listing requirement. Under Nasdaq rules, asset acquisitions and stock purchases would not typically
require stockholder approval while direct mergers with the company where it does not survive and any transactions in which the company
issues more than 20% of its outstanding common stock or seeks to amend its certificate of incorporation would require stockholder approval.
MURF may conduct redemptions without a stockholder vote pursuant to the tender offer rules of the SEC unless stockholder approval is
required by law or stock exchange listing requirements or MURF chooses to seek stockholder approval for business or other legal reasons.
So long as MURF obtain and maintain a listing for MURF&#8217;s securities on the Nasdaq, it will be required to comply with such rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
stockholder approval of the transaction is required by law or stock exchange listing requirement, or MURF decides to obtain stockholder
approval for business or other legal reasons, MURF will, pursuant to its certificate of incorporation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conduct
    the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation
    of proxies, and not pursuant to the tender offer rules, and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">file
    proxy materials with the SEC.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that MURF seeks stockholder approval of its initial business combination, it will distribute proxy materials and, in connection
therewith, provide its public stockholders with the redemption rights described above upon completion of the initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">If
MURF seeks stockholder approval, it will complete its initial business combination only if a majority of the outstanding shares of MURF
common stock present and entitled to vote at the meeting to approve the initial business combination when a quorum is present are voted
in favor of the initial business combination. A quorum for such meeting will consist of the holders present in person (by virtual attendance)
or by proxy of shares of outstanding capital stock of MURF representing a majority of the voting power of all outstanding shares of capital
stock of MURF entitled to vote at such meeting. MURF&#8217;s initial stockholder, our Sponsor, will count toward this quorum and pursuant
to the letter agreement, its Sponsor, officers and directors have agreed to vote any founder shares held by them and any public shares
acquired during or after its initial public offering (including in open market and privately negotiated transactions) in favor of its
initial business combination. For purposes of seeking approval of the majority of the outstanding shares of MURF common stock voted,
non-votes will have no effect on the approval of its initial business combination once a quorum is obtained. MURF intends to give approximately
30 days (but not less than 10 days nor more than 60 days) prior written notice of any such meeting, if required, at which a vote shall
be taken to approve its initial business combination. These quorum and voting thresholds, and the support agreement between MURF and
the Sponsor, may make it more likely that MURF will consummate its initial business combination. Each public stockholder may elect to
redeem its public shares irrespective of whether they vote for or against the proposed transaction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a stockholder vote is not required and MURF does not decide to hold a stockholder vote for business or other legal reasons, MURF will,
pursuant to its certificate of incorporation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conduct
    the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">file
    tender offer documents with the SEC prior to completing its initial business combination which contain substantially the same financial
    and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the
    Exchange Act, which regulates the solicitation of proxies.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the public announcement of MURF&#8217;s initial business combination, MURF or its Sponsor will terminate any plan established in accordance
with Rule 10b5-1 to purchase shares of Class A common stock in the open market if MURF elects to redeem its public shares through a tender
offer, to comply with Rule 14e-5 under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event MURF conducts redemptions pursuant to the tender offer rules, MURF&#8217;s offer to redeem will remain open for at least 20
business days, in accordance with Rule 14e-1(a) under the Exchange Act, and MURF will not be permitted to complete its initial business
combination until the expiration of the tender offer period. <span style="background-color: white">&#160;In addition, so that MURF is
not subject to the SEC&#8217;s &#8220;penny stock&#8221; rules, it will not redeem any public shares unless (i) its net tangible assets
will be at least $5,000,001 either immediately prior to or upon consummation of the initial business combination and after payment of
underwriters&#8217; fees and commissions or (ii) it is otherwise exempt from the provisions of Rule 419 promulgated under the Securities
Act. If public stockholders tender more shares than MURF has offered to purchase, it will withdraw the tender offer and not complete
the initial business combination.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
certificate of incorporation provides that MURF may not redeem its public shares <span style="background-color: white">unless (i) it
is exempt from the provisions of Rule 419 promulgated under the Securities Act other than through its net tangible assets or (ii)
its net tangible assets are at least $5,000,001 either immediately prior to or upon consummation of its initial business combination
and after payment of underwriters&#8217; fees and commissions (so that it is not subject to the SEC&#8217;s &#8220;penny
stock&#8221; rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to the
initial business combination</span>. For example, the proposed initial business combination may
require: (i) cash consideration to be paid to the target or its owners, (ii) cash to be transferred to the target for working
capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions in accordance with the terms
of the proposed initial business combination. In the event the aggregate cash consideration MURF would be required to pay for all
shares of Class A common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions
pursuant to the terms of the proposed initial business combination exceeds the aggregate amount of cash available to MURF, it will
not complete the initial business combination or redeem any shares, and all shares of Class A common stock submitted for redemption
will be returned to the holders thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitation
on Redemption upon Completion of MURF&#8217;s Initial Business Combination if MURF Seeks Stockholder Approval</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if MURF seeks stockholder approval of its initial business combination and MURF does not conduct redemptions in connection
with its initial business combination pursuant to the tender offer rules, MURF&#8217;s certificate of incorporation provides that a public
stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as
a &#8220;group&#8221; (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect
to more than an aggregate of 15% of the shares sold in MURF&#8217;s initial public offering, which MURF refers to as the &#8220;Excess
Shares.&#8221; Such restriction shall also be applicable to MURF&#8217;s affiliates. MURF believes this restriction will discourage stockholders
from accumulating large blocks of shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights
against a proposed initial business combination as a means to force MURF or its management to purchase their shares at a significant
premium to the then-current market price or on other undesirable terms. By limiting MURF&#8217;s stockholders&#8217; ability to redeem
no more than 15% of the shares sold in its initial public offering without MURF&#8217;s prior consent, MURF believes it will limit the
ability of a small group of stockholders to unreasonably attempt to block MURF&#8217;s ability to complete its initial business combination,
particularly in connection with an initial business combination with a target that requires as a closing condition that MURF has a minimum
net worth or a certain amount of cash. However, MURF would not be restricting its stockholders&#8217; ability to vote all of their shares
(including Excess Shares) for or against its initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tendering
Stock Certificates in Connection with Redemption Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
may require public stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in
&#8220;street name,&#8221; to either tender their certificates to MURF&#8217;s transfer agent up to two business days prior to the vote
on the proposal to approve the initial business combination, or to deliver their shares to the transfer agent electronically using the
Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System, at the holder&#8217;s option. The proxy materials that
MURF will furnish to holders of public shares in connection with its initial business combination will indicate whether MURF is requiring
public stockholders to satisfy such delivery requirements. Accordingly, a public stockholder would have up to two days prior to the vote
on the initial business combination to tender its shares if it wishes to seek to exercise its redemption rights. Given the relatively
short exercise period, it is advisable for stockholders to use electronic delivery of their public shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through
the DWAC System. The transfer agent will typically charge the tendering broker $80.00 and it would be up to the broker whether or not
to pass this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not MURF requires holders
seeking to exercise redemption rights to tender their shares. The need to deliver shares is a requirement of exercising redemption rights
regardless of the timing of when such delivery must be effectuated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing is different from the procedures used by many special purpose acquisition companies. In order to perfect redemption rights
in connection with their business combinations, many blank check companies would distribute proxy materials for the stockholders&#8217;
vote on an initial business combination, and a holder could simply vote against a proposed initial business combination and check a box
on the proxy card indicating such holder was seeking to exercise his or her redemption rights. After the initial business combination
was approved, the company would contact such stockholder to arrange for him or her to deliver his or her certificate to verify ownership.
As a result, the stockholder then had an &#8220;option window&#8221; after the completion of the initial business combination during
which he or she could monitor the price of the company&#8217;s stock in the market. If the price rose above the redemption price, he
or she could sell his or her shares in the open market before actually delivering his or her shares to the company for cancellation.
As a result, the redemption rights, to which stockholders were aware they needed to commit before the stockholder meeting, would become
&#8220;option&#8221; rights surviving past the completion of the initial business combination until the redeeming holder delivered its
certificate. The requirement for physical or electronic delivery prior to the meeting ensures that a redeeming holder&#8217;s election
to redeem is irrevocable once the initial business combination is approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
request to redeem such shares, once made, may be withdrawn at any time up to the date of the stockholder meeting. Furthermore, if a holder
of a public share delivered its certificate in connection with an election of redemption rights and subsequently decides prior to the
applicable date not to elect to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically
or electronically). It is anticipated that the funds to be distributed to holders of MURF&#8217;s public shares electing to redeem their
shares will be distributed promptly after the completion of MURF&#8217;s initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
MURF&#8217;s initial business combination is not approved or completed for any reason, then its public stockholders who elected to exercise
their redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the trust Account. In
such case, MURF will promptly return any certificates delivered by public holders who elected to redeem their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
MURF&#8217;s initial proposed initial business combination is not completed, MURF may continue to try to complete an initial business
combination with a different target until </span>February 7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s
amended and restated certificate of incorporation)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of Public Shares and Liquidation if No Business Combination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">MURF&#8217;s amended and
restated certificate of incorporation provides that it will have until February 7, 2024 (or such later date as may be extended by means
of amendment to MURF&#8217;s amended and restated certificate of incorporation), to complete its initial business combination. If MURF
is unable to complete its initial business combination by then, it will: (i) cease all operations except for the purpose of winding up,
(ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the
trust account and not previously released to MURF to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided
by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders
(including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of MURF&#8217;s remaining stockholders and board of directors, dissolve and
liquidate, subject in the case of clauses (ii) and (iii) above to MURF&#8217;s obligations under Delaware law to provide for claims of
creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect
to MURF&#8217;s warrants, which will expire worthless if MURF fails to complete its initial business combination by February 7, 2024
(or such later date as may be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">MURF&#8217;s Sponsor, officers
and directors entered into a letter agreement with MURF, pursuant to which they waived their rights to liquidating distributions from
the trust account with respect to any founder shares held by them if MURF fails to complete its initial business combination by February
7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation).
However, if MURF&#8217;s Sponsor, officers or directors acquired public shares in or after MURF&#8217;s initial public offering, they
will be entitled to liquidating distributions from the trust account with respect to such public shares if MURF fails to complete its
initial business combination by February 7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s amended
and restated certificate of incorporation).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
Sponsor, officers and directors will agree, pursuant to a written agreement, that they will not propose any amendment to MURF&#8217;s
amended and restated certificate of incorporation (i) to modify the substance or timing of MURF&#8217;s obligation to allow redemption
in connection with MURF&#8217;s initial business combination or certain amendments to MURF&#8217;s charter prior thereto or to redeem
100% of MURF&#8217;s public shares if it does not complete its initial business combination by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation), or (ii) with respect to
any other provision relating to stockholders&#8217; rights or pre-initial business combination activity, unless MURF provides its public
stockholders with the opportunity to redeem their shares of Class A common stock upon approval of any such amendment at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the
trust account and not previously released to MURF to pay its taxes divided by the number of then outstanding public shares. However,
MURF may not redeem its public shares unless its net tangible assets are at least $5,000,001 either immediately prior to or upon consummation
of the initial business combination and after payment of underwriters&#8217; fees and commissions <span style="background-color: white">or is not otherwise exempt from the provisions of Rule 419 promulgated under
the Securities Act</span> (so that MURF is not subject to the
SEC&#8217;s &#8220;penny stock&#8221; rules). If this optional redemption right is exercised with respect to an excessive number of public
shares such that MURF cannot satisfy the net tangible asset requirement (described above), MURF would not proceed with the amendment
or the related redemption of its public shares at such time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">MURF expects that all costs
and expenses associated with implementing its plan of dissolution, as well as payments to any creditors, will be funded from amounts
remaining out of the funds held outside the trust account, although it cannot assure that there will be sufficient funds for such purpose.
As of December 31, 2022, MURF had approximately $346,000 in cash remaining. It will depend on sufficient interest being earned on the
proceeds held in the trust account to pay any tax obligations it may owe.&#160;However, if those funds are not sufficient to cover the
costs and expenses associated with implementing MURF&#8217;s plan of dissolution, to the extent that there is any interest accrued in
the trust account not required to pay taxes, MURF may request the trustee to release to it an additional amount of up to $100,000 of
such accrued interest to pay those costs and expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If MURF were to expend all
of the net proceeds of its initial public offering and the sale of the placement units, other than the proceeds deposited in the trust
account, and without taking into account interest, if any, earned on the trust account between April 30, 2023 and the date of distribution,
the per-share redemption amount received by stockholders upon MURF&#8217;s dissolution would be approximately $10.52. The proceeds deposited
in the trust account could, however, become subject to the claims of MURF&#8217;s creditors who would have higher priority than the claims
of MURF&#8217;s public stockholders. MURF cannot assure you that the actual per-share redemption amount received by stockholders will
not be substantially less than $10.52. Under Section 281(b) of the DGCL, MURF&#8217;s plan of dissolution must provide for all claims
against it to be paid in full or make provision for payments to be made in full, as applicable, if there are sufficient assets. These
claims must be paid or provided for before MURF makes any distribution of its remaining assets to its stockholders. While MURF intends
to pay such amounts, if any, MURF cannot assure you that it will have funds sufficient to pay or provide for all creditors&#8217; claims.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
MURF will seek to have all vendors, service providers, prospective target businesses or other entities with which it does business execute
agreements waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of MURF&#8217;s
public stockholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would
be prevented from bringing claims against the trust account including but not limited to fraudulent inducement, breach of fiduciary responsibility
or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with
respect to a claim against MURF&#8217;s assets, including the funds held in the trust account. If any third party refuses to execute
an agreement waiving such claims to the monies held in the trust account, MURF&#8217;s management will perform an analysis of the alternatives
available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such
third party&#8217;s engagement would be significantly more beneficial to MURF than any alternative. Examples of possible instances where
MURF may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise
or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver
or in cases where management is unable to find a service provider willing to execute a waiver. MURF&#8217;s independent registered public
accounting firm and the underwriters of the initial public offering did not execute agreements with MURF waiving such claims to the monies
held in the trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In addition, there is no
guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations,
contracts or agreements with MURF and will not seek recourse against the trust account for any reason. MURF&#8217;s Sponsor has agreed
that it will be liable to MURF if and to the extent any claims by a third party for services rendered or products sold to MURF, or a
prospective target business with which MURF has entered into a written letter of intent, confidentiality or similar agreement or business
combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.20 per public share and (ii) the
actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.20
per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any
claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account
(whether or not such waiver is enforceable) nor will it apply to any claims under MURF&#8217;s indemnity of the underwriters of this
offering against certain liabilities, including liabilities under the Securities Act. However, MURF has not asked its Sponsor to reserve
for such indemnification obligations, nor has MURF independently verified whether the Sponsor has sufficient funds to satisfy its indemnity
obligations. Further, MURF believes that its Sponsor&#8217;s only assets are MURF securities. Therefore, MURF cannot assure you that
the Sponsor would be able to satisfy those obligations. None of MURF&#8217;s officers or directors will indemnify MURF for claims by
third parties including, without limitation, claims by vendors and prospective target businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In the event that the proceeds
in the trust account are reduced below (i) $10.20 per public share or (ii) such lesser amount per public share held in the trust account
as of the date of the liquidation of the trust account, due to reductions in value of the trust assets, in each case net of the amount
of interest which may be withdrawn to pay taxes, and the Sponsor asserts that it is unable to satisfy its indemnification obligations
or that it has no indemnification obligations related to a particular claim, MURF&#8217;s independent directors would determine whether
to take legal action against the Sponsor to enforce its indemnification obligations. While MURF currently expects that its independent
directors would take legal action on its behalf against the Sponsor to enforce its indemnification obligations to MURF, it is possible
that MURF&#8217;s independent directors in exercising their business judgment may choose not to do so if, for example, the cost of such
legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent directors
determine that a favorable outcome is not likely. MURF has not asked the Sponsor to reserve for such indemnification obligations and
MURF cannot assure you that the Sponsor would be able to satisfy those obligations. Accordingly, MURF cannot assure you that due to claims
of creditors the actual value of the per-share redemption price will not be less than $10.20 per public share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">MURF will seek to reduce
the possibility that its Sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors,
service providers, prospective target businesses or other entities with which MURF does business execute agreements with MURF waiving
any right, title, interest or claim of any kind in or to monies held in the trust account. The Sponsor will also not be liable as to
any claims under our indemnity of the underwriters of MURF&#8217;s initial public offering against certain liabilities, including liabilities
under the Securities Act. MURF will have access to up to approximately $1,500,000 from loans from the Sponsor with which to pay any such
potential claims (including costs and expenses incurred in connection with our liquidation, currently estimated to be no more than approximately
$100,000). In the event that MURF liquidates and it is subsequently determined that the reserve for claims and liabilities is insufficient,
stockholders who received funds from MURF&#8217;s trust account could be liable for claims made by creditors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
will seek to reduce the possibility that its Sponsor will have to indemnify the trust account due to claims of creditors by endeavoring
to have all vendors, service providers, prospective target businesses or other entities with which MURF does business execute agreements
with MURF waiving any right, title, interest or claim of any kind in or to monies held in the trust account. MURF&#8217;s Sponsor will
also not be liable as to any claims under MURF&#8217;s indemnity of the underwriters of this offering against certain liabilities, including
liabilities under the Securities Act. MURF will have access to up to approximately $1,565,000 from the proceeds of this offering and
the sale of the placement units with which to pay any such potential claims (including costs and expenses incurred in connection with
MURF&#8217;s liquidation, currently estimated to be no more than approximately $100,000). In the event that MURF liquidates and it is
subsequently determined that the reserve for claims and liabilities is insufficient, stockholders who received funds from MURF&#8217;s
trust account could be liable for claims made by creditors. In the event that MURF&#8217;s offering expenses exceed MURF&#8217;s estimate
of $1,565,000, MURF may fund such excess with funds from the funds not to be held in the trust account. In such case, the amount of funds
MURF intends to be held outside the trust account would decrease by a corresponding amount. Conversely, in the event that the offering
expenses are less than MURF&#8217;s estimate of $1,565,000, the amount of funds MURF intends to be held outside the trust account would
increase by a corresponding amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by
them in a dissolution. The pro rata portion of MURF&#8217;s trust account distributed to its stockholders upon the redemption of MURF&#8217;s
public shares in the event MURF does not complete its initial business combination by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation), may be considered a liquidating
distribution under Delaware law. If the corporation complies with certain procedures set forth in Section 280 of the DGCL intended to
ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party claims
can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional
150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a
liquidating distribution is limited to the lesser of such stockholder&#8217;s pro rata share of the claim or the amount distributed to
the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if the pro rata portion of MURF&#8217;s trust account distributed to MURF&#8217;s public stockholders upon the redemption of MURF&#8217;s
public shares in the event MURF does not complete its initial business combination by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation), is not considered a liquidating
distribution under Delaware law and such redemption distribution is deemed to be unlawful (potentially due to the imposition of legal
proceedings that a party may bring or due to other circumstances that are currently unknown), then pursuant to Section 174 of the DGCL,
the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three
years, as in the case of a liquidating distribution. If MURF is unable to complete its initial business combination by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation),
it will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten
business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the trust account including interest earned on the funds held in the trust account and not previously released to MURF to pay its
taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption
will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
MURF&#8217;s remaining stockholders and the MURF Board, dissolve and liquidate, subject in the case of clauses (ii) and (iii) above to
MURF&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Accordingly,
it is MURF&#8217;s intention to redeem its public shares as soon as reasonably possible following February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation), and, therefore, MURF
does not intend to comply with those procedures. As such, MURF&#8217;s stockholders could potentially be liable for any claims to the
extent of distributions received by them (but no more) and any liability of MURF&#8217;s stockholders may extend well beyond the third
anniversary of such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
MURF will not be complying with Section 280, Section 281(b) of the DGCL requires it to adopt a plan, based on facts known to MURF at
such time that will provide for MURF&#8217;s payment of all existing and pending claims or claims that may be potentially brought against
MURF within the subsequent 10 years. However, because MURF is a blank check company, rather than an operating company and its operations
will be limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from MURF&#8217;s
vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. As described above, pursuant to the obligation
contained in MURF&#8217;s underwriting agreement, MURF will seek to have all vendors, service providers, prospective target businesses
or other entities with which MURF does business execute agreements with MURF waiving any right, title, interest or claim of any kind
in or to any monies held in the trust account. As a result of this obligation, the claims that could be made against MURF are significantly
limited and the likelihood that any claim that would result in any liability extending to the trust account is remote. Further, MURF&#8217;s
Sponsor may be liable only to the extent necessary to ensure that the amounts in the trust account are not reduced below (i) $10.20
per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust
account, due to reductions in value of the trust assets, in each case net of the amount of interest withdrawn to pay taxes and will not
be liable as to any claims under MURF&#8217;s indemnity of the underwriters of its initial public offering against certain liabilities,
including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party,
the Sponsor will not be responsible to the extent of any liability for such third-party claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
MURF files a bankruptcy petition or an involuntary bankruptcy petition is filed against MURF that is not dismissed, the proceeds held
in the trust account could be subject to applicable bankruptcy law, and may be included in MURF&#8217;s bankruptcy estate and subject
to the claims of third parties with priority over the claims of MURF stockholders. To the extent any bankruptcy claims deplete the trust
account, MURF cannot assure you it will be able to return $10.52 per share to its public stockholders. Additionally, if MURF files
a bankruptcy petition or an involuntary bankruptcy petition is filed against MURF that is not dismissed, any distributions received by
stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a &#8220;preferential transfer&#8221;
or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy court could seek to recover some or all amounts received by MURF
stockholders. Furthermore, the MURF Board may be viewed as having breached its fiduciary duty to MURF&#8217;s creditors and/or may have
acted in bad faith, thereby exposing itself and MURF to claims of punitive damages, by paying public stockholders from the trust account
prior to addressing the claims of creditors. MURF cannot assure you that claims will not be brought against MURF for these reasons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
public stockholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) the completion of
MURF&#8217;s initial business combination, (ii) the redemption of any public shares properly tendered in connection with a stockholder
vote to amend any provisions of MURF&#8217;s amended and restated certificate of incorporation (A) to modify the substance or timing
of its obligation to allow redemption in connection with its initial business combination or certain amendments to MURF&#8217;s charter
prior thereto or to redeem 100% of MURF&#8217;s public shares if MURF does not complete its initial business combination by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation), or (B) with respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity,
and (iii) the redemption of all of MURF public shares if MURF is unable to complete its business combination by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation), subject
to applicable law. In no other circumstances will a stockholder have any right or interest of any kind to or in the trust account. In
the event MURF seeks stockholder approval in connection with its initial business combination, a stockholder&#8217;s voting in connection
with the initial business combination alone will not result in a stockholder&#8217;s redeeming its shares to MURF for an applicable pro
rata share of the trust account. Such stockholder must have also exercised its redemption rights as described above. These provisions
of MURF&#8217;s amended and restated certificate of incorporation, like all provisions of its amended and restated certificate of incorporation,
may be amended with a stockholder vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
executive offices are located at 4995 Murphy Canyon Road, Suite 300 San Diego, CA 92123, and our telephone number is 760-471-8536. Its
executive offices are provided to it by the Sponsor. MURF pays Murphy Canyon Management
Group, Inc., an affiliate of the Sponsor, a total of $10,000 per month for office space, utilities and secretarial and administrative
support.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
has three executive officers. These individuals are not obligated to devote any specific number of hours to MURF&#8217;s matters and
intend to devote only as much time as they deem necessary to its affairs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
and Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
current directors and executive officers are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President, and Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam
    Sragovicz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer, Treasurer, and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ed
    Bentzen</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Accounting Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis
    Knuettel II</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele
    Chiavacci Farley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    E. Feinberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Jack
K. Heilbron</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Heilbron has been MURF&#8217;s Chief Executive Officer since its inception. Mr. Heilbron has served as a director and Chief Executive
Officer and President of Presidio Property Trusty Inc. since its inception in February 2010. Mr. Heilbron also has served as Chairman,
CEO and President of NetREIT Dubose since its inception, and has served as CEO and/or President of NetREIT Advisors, LLC, Dubose Advisors,
LLC, and NTR Property Management, Inc. since their inceptions, all of which are Company affiliated entities. Mr. Heilbron was a founding
officer, director, and stockholder of the former CI Holding Group, Inc. and of its subsidiary corporations (Centurion Counsel, Inc.,
Bishop Crown Investment Research Inc., PIM Financial Securities Inc., Centurion Institutional Services Inc. and CHG Properties, Inc.)
and currently serves as Chairman and CEO of Centurion Counsel, Inc., a licensed investment advisor. He also served as a director of the
Centurion Counsel Funds, an investment company registered under the Investment Company Act of 1940, from 2001 until 2005. From 1994 until
its dissolution in 1999, Mr. Heilbron served as the Chairman and/or director of Clover Income and Growth REIT. Mr. Heilbron graduated
with a B.S. degree in Business Administration from California Polytechnic College, San Luis Obispo, California. Based on his experience
as a director and his experience with other REITs, the Nominating and Corporate Governance Committee determined that Mr. Heilbron is
qualified to serve on the MURF Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adam
Sragovicz</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Sragovicz has been MURF&#8217;s Chief Financial Officer since MURF&#8217;s inception. Mr. Sragovicz has been a director of the Company
since December 2021. Mr. Sragovicz has been the Chief Financial Officer of Presidio Property Trust, Inc. since January 11, 2018. He previously
served as Senior Vice President, Finance of Presidio Property Trust, Inc. since May 2017. Before joining Presidio Property Trust, Inc.,
Mr. Sragovicz served as Treasurer of Encore Capital Group from 2011 to 2017, where he was responsible for global capital raising, foreign
exchange risk management and cash management. Mr. Sragovicz has also held capital markets, finance, and treasury management positions
with KPMG, Union Bank of California / MUFG and Bank of America Merrill Lynch. Mr. Sragovicz is the Director of the Yale Alumni Schools
Committee in San Diego and previously sat on the board of Congregation Adat Yeshurun. Mr. Sragovicz is a graduate of Yale University
with a Bachelor of Arts degree in Soviet and Eastern European Studies, with a concentration in Economics. Upon the consummation of the
Business Combination, Mr. Sragovicz will be appointed Chief Financial Officer of New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ed
Bentzen</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Bentzen has been MURF&#8217;s Chief Accounting Officer since its inception. Mr. Bentzen has been the Chief Accounting Officer of Presidio
Property Trust, Inc. March 2021. Prior to that, Mr. Bentzen served as Chief Financial Officer and Chief Operations Officer for Crystal
View Capital Management in 2020, as a Chief Financial Officer / Finance consultant for various clients (including real estate development
companies) from 2018 to 2020, and as Chief Financial Officer for The Parking REIT (formerly MVP REIT and MVP REIT II) from 2016 to 2018.
Prior to these roles, Mr. Bentzen held senior and/or accounting roles at Western Funding, Inc., Vestin Group, Inc., and a local CPA firm
in Las Vegas, Nevada. In addition, Mr. Bentzen worked as a Senior Internal Auditor at Ameristar Casinos, Inc. (formerly Nasdaq: ASCA).
He holds a Bachelor of Science degree in Hotel Administration, with an emphasis in Gaming, and a Master of Science degree in Accountancy,
from University of Nevada, Las Vegas, and is licensed as a Certified Internal Auditor (inactive).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Francis
Knuettel II</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Knuettel II has served on the MURF Board since the closing of its initial public offering. From December 2020 to 2022, he served as the
Chief Executive Officer and board member of Unrivaled Brands, Inc. (OTCQX: UNRV). In 2022, Mr. Knuettel joined Chromocell Therapeutics
Corp., where he serves as the Chief Financial and Strategy Officer. Mr. Knuettel was formerly a Restructuring Advisory Consultant at
Viridian Capital Advisors from May 2020 to November 2020. Mr. Knuettel joined Viridian while at One Cannabis Group (&#8220;OCG&#8221;)
where Mr. Knuettel was the Chief Financial Officer from June 2019 to January 2021 and was integral to the sale of the company to Item
9 Labs Corp. (OTCQX: INLB). Prior to OCG, Mr. Knuettel was CFO at MJardin, a Denver-based cannabis cultivation and dispensary management
company, from August 2018 to June 2019 where he led the company&#8217;s IPO on the Canadian Securities Exchange. Following the IPO, Mr.
Knuettel managed MJardin&#8217;s merger with GrowForce, a Toronto-based cannabis cultivator, after which he moved over to the Chief Strategy
Role. In his role as CSO, he managed the acquisition of several private companies before recommending and executing the consolidation
of management and other operations to Toronto and the closure of the executive office in Denver. Prior to MJardin, Mr. Knuettel held
numerous CFO and CEO positions at early-stage and NASDAQ-listed companies where he had significant experience both building and restructuring
businesses. Mr. Knuettel serves on several corporate boards, including on the Board of Directors of 180 Life Sciences, an early-stage
therapeutic biotech company, since July 2021, on the Board of Directors of Sanatio BioScience Corp., an early-stage anti-viral platform,
since September 2020 (where he is the chair of the company&#8217;s audit committee) and on the Board of Directors of ECOM Medical, Inc.,
a developer of endotracheal patient monitoring systems, since July 2019 (where he is the chair of the company&#8217;s audit committee).
Mr. Knuettel has advised that he will be named as a director nominee of a special purpose acquisition company Relativity Acquisition
Corp., and may be named a director nominee of additional special purpose acquisition companies. Each such appointment will not take effect
until the consummation of the initial public offering for the applicable company. If such appointment becomes effective, Mr. Knuettel
will have fiduciary duties equivalent to and on the same level of priority as those obligations owed to MURF. MURF do not believe this
gives rise to any theoretical or actual conflict of interest with respect to such other special purpose acquisition companies and MURF,
since each of these entities intends to target business combinations in a different industry than those targeted by us. Accordingly,
while any such companies, businesses or investments may present additional conflicts of interest in pursuing an initial business combination,
MURF does not believe that any such potential conflicts would materially affect its ability to complete its initial business combination.
Mr. Knuettel graduated cum laude from Tufts University with a B.A. degree in Economics and from The Wharton School of Business at the
University of Pennsylvania with an MBA in Finance and Entrepreneurial Management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chele
Chiavacci Farley</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele
Chiavacci Farley has served on the MURF Board since the closing of its initial public offering and currently serves as a partner and
managing director of Mistral Capital International (&#8220;Mistral&#8221;), a private equity firm, since 1995. In her role as Partner
and Managing Director of Mistral, Ms. Farley originates, evaluates and executes equity investment opportunities, creates and implements
deal and financial structures, negotiates with banks for credit facilities, and oversees management. Ms. Farley is the President and
a member of the Board of Directors and Management Committee of Palmilla San Jose Inmobiliaria, the Master Developer of the luxury Palmilla
resort development in Cabo San Lucas, Mexico. Prior to Mistral, Ms. Farley was Vice President of Tricap International from 1994 to 1995.
From 1992 to 1994, Ms. Farley was an Associate at UBS Capital Corporation, and analyzed and evaluated principal investment and financing
opportunities for the firm&#8217;s internal $1 billion fund. Ms. Farley began her career as a Financial Analyst in the Global Finance
department - Energy and Telecom Group of Goldman, Sachs &amp; Co. Ms. Farley has also had an active political career. In 2020, Ms. Farley
ran for election to the U.S. House of Representatives to represent New York&#8217;s 18<sup>th </sup>Congressional district. In 2018,
Ms. Farley ran for election to the U.S. Senate to represent New York. Ms. Farley graduated from Stanford University with a B.S. and M.S.
in Industrial Engineering. She is a member of YPO - Young Presidents&#8217; Organization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Richard
E. Feinberg</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
E. Feinberg has served on the MURF Board since the closing of its initial public offering. Mr. Feinberg has been a Professor of International
Political Economy at the University of California, San Diego, since 1996 and an Emeritus Professor since 2021. Previously, Mr. Feinberg
served as Special Assistant to the President for National Security Affairs and as a Senior Director for the Office of Inter-American
Affairs, National Security Council, the White House, from 1993 to 1996. Mr. Feinberg was integral to architecture of the 1994 Miami Summit
of the Americas and of the proposed Free Trade Area of the Americas (FTAA). Mr. Feinberg has worked in various other governmental roles
including: (i) Member of the Policy Planning Staff of the Department of State (1977-1980); and (ii) international economist for the U.S.
Treasury Department (1975-1977). Mr. Feinberg served in executive positions at various public policy institutes including: (i) as president
of the Inter-American Dialogue (1992-1993); (ii) as executive vice president and director of studies of the Overseas Development Council
(1982-1991). Mr. Feinberg taught a graduate-level course on international financial institutions as an adjunct professor at Georgetown
University School of Foreign Service from 1980 to 1985. Mr. Feinberg holds a Ph.D. in international economics from Stanford University
and a B.A. in European history from Brown University. Mr. Feinberg is well-qualified to serve on the MURF Board due to his expertise
in political relations, public policies, financial and economic management internationally, which enable him to provide accurate and
reliable expertise on international economic policies and trends including as they may relate to international acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation and Director Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of MURF&#8217;s executive officers or directors have received any cash compensation for services rendered to MURF. MURF pays Murphy Canyon Management Group, Inc., an affiliate of the Sponsor, $10,000 per month for office space, utilities and secretarial
and administrative support. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly
fees. No compensation of any kind, including any finder&#8217;s fee, reimbursement, consulting fee or monies in respect of any payment
of a loan, will be paid by us to our sponsor, officers or directors or any affiliate of our sponsor, officers or directors, prior to,
or in connection with any services rendered in order to effectuate, the consummation of our initial business combination (regardless
of the type of transaction that it is). However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection
with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
Our audit committee reviews on a quarterly basis all payments that were made to our Sponsor, officers or directors or our or their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the completion of the Business Combination, officers or directors who remain with MURF may be paid consulting, management or other fees
from the combined company, New Conduit. The directors of New Conduit will be responsible for determining officer and director compensation.
Any compensation to be paid will be determined by a compensation committee constituted solely by independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is not party to any agreements with its officers and directors that provide for benefits upon termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no material litigation, arbitration, governmental proceeding or any other legal proceeding currently pending or known to be contemplated
against MURF, and MURF has not been subject to any such proceeding in the 10 years preceding the date of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Periodic
Reporting and Audited Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
has registered its securities under the Exchange Act and has reporting obligations, including the requirement to file annual and quarterly
reports with the SEC. In accordance with the requirements of the Exchange Act, MURF&#8217;s annual reports contain financial statements
audited and reported on by MURF&#8217;s independent registered public accounting firm. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_023"></span>MURF&#8217;s
Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion of MURF&#8217;s financial condition and results of operations should be read in conjunction with MURF&#8217;s consolidated
financial statements and notes to those statements included in this proxy statement/prospectus. This discussion contains forward-looking
statements that involve risks and uncertainties. Please see the sections entitled &#8220;<i>Forward-Looking Statements</i>&#8221; and
&#8220;<i>Risk Factors</i>&#8221; in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
is a newly organized blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. MURF intends
to effectuate its initial business combination using cash from the proceeds of the initial public offering and the sale of the placement
units, the proceeds of the sale of its shares in connection with its initial business combination (including pursuant to backstop agreements
MURF may enter into), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or
a combination of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of additional shares in connection with an initial business combination to the owners of the target or other investors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    significantly dilute the equity interest of existing shareholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    subordinate the rights of holders of its common stock if preferred stock is issued with rights senior to those afforded our common
    stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">could
    cause a change in control if a substantial number of shares of its common stock is issued, which may affect, among other things,
    our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of its present officers
    and directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    have the effect of delaying or preventing a change of control of MURF by diluting the stock ownership or voting rights of a person
    seeking to obtain control of us; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    adversely affect prevailing market prices for its common stock and warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similarly,
if MURF issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result
in:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">default
    and foreclosure on its assets if its operating revenues after an initial business combination are insufficient to repay our debt
    obligations;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceleration
    of its obligations to repay the indebtedness even if MURF make all principal and interest payments when due if MURF breach certain
    covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
    immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
    inability to obtain necessary additional financing if the debt contains covenants restricting its ability to obtain such financing
    while the debt is outstanding;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
    inability to pay dividends on its common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">using
    a substantial portion of its cash flow to pay principal and interest on its debt, which will reduce the funds available for dividends
    on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general
    corporate purposes;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on its flexibility in planning for and reacting to changes in its business and in the industry in which MURF operate;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
    vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on its ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution
    of our strategy; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    purposes and other disadvantages compared to its competitors who have less debt.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
indicated in the accompanying financial statements, at December 31, 2022 and December 31, 2021, MURF had $345,777 and $48,555 in cash,
respectively and deferred offering costs of $0 and $108,962, respectively. Additionally, the underwriters are entitled to a deferred
fee of $0.35 per Unit, or $4,628,750. The deferred fee will become payable to the underwriters from the amounts held in the trust account
solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Further, MURF
expect to continue to incur significant costs in the pursuit of its initial business combination plans. We cannot assure you that its
plans to raise capital or to complete its initial business combination will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Merger
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2022, MURF entered into the Merger Agreement by and among MURF, Merger Sub and Conduit. If the Merger Agreement is approved
by MURF&#8217;s stockholders and the transactions under the Merger Agreement are consummated, Merger Sub will merge with and into Conduit,
with Conduit surviving the merger as its wholly owned subsidiary. Upon the closing of the Merger, it is anticipated that MURF will change
its name to &#8220;Conduit Pharmaceuticals Inc.&#8221; The MURF Board has (i) approved and declared advisable the Merger Agreement, the
related ancillary agreements thereto and the transactions contemplated thereby and (ii) resolved to recommend approval of the Merger
Agreement and related transactions by its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 33.75pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, the shareholders of Conduit will receive the number of New Conduit common stock that shall have an aggregate
value equal to Six Hundred Fifty Million Dollars ($650,000,000). With each share of New Conduit common stock being valued at $10.00,
Conduit&#8217;s outstanding ordinary shares (including the shares issued upon conversion of all outstanding convertible debt, which conversion
shall have occurred prior to the consummation of the Business Combination) will be converted into an aggregate of 65,000,000 shares of
the common stock of New Conduit following the Business Combination, with each such outstanding Conduit share converted into shares of
the common stock of New Conduit on a pro rata basis. Additionally, each outstanding share of MURF common stock immediately prior to the
Merger, including all outstanding shares of Class B common stock, shall automatically convert into and become one share of the common
stock of New Conduit without any action on the part of any holders of such common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with the transactions contemplated by the Merger Agreement, MURF entered into a subscription agreement with t</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
Private Placement Investor for units that are materially the same as those purchased by the Sponsor at the time of the initial public
offering<span style="background-color: white">. MURF&#8217;s directors, officers, Sponsor or their affiliates will not be participating
in the private placement.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Subscription Agreement, the </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Placement
Investor <span style="background-color: white">has agreed to purchase 2,700,000 units of MURF, with each unit consisting of (i) one share
of MURF&#8217;s Class A common stock and (ii) one warrant to purchase one share of Class A common stock, for a purchase price of $10.00
per unit in the Private Placement. The Subscription Agreement contains registration rights, pursuant to which within fifteen (15) business
days after the closing of the Private Placement, MURF will use reasonable best efforts to file with the SEC a registration statement
registering the resale of shares of MURF common stock included in the Units and the shares of MURF common stock issued and issuable upon
exercise of the warrants. The closing of the Private Placement is conditioned on there not being a suspension of the qualification of
MURF common stock for offering or sale or trading in any jurisdiction, or the initiation or threatening of any legal proceeding, no legal
prohibitions to consummate the Business Combination, and all conditions precedent to the closing of the Business Combination set forth
in the Merger Agreement having been satisfied or waived.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrant will be exercisable for a period of five years after the completion of the Business Combination and will have an exercise price
of $11.50 per share, subject to adjustment as set forth in the Warrant for stock splits, stock dividends, recapitalizations and similar
customary adjustments. The Private Placement Investor may exercise each warrant on a cashless basis if the shares underlying the warrants
are not then registered pursuant to an effective registration statement. The Private Placement Investor has contractually agreed to restrict
its ability to exercise the warrants such that the number of shares of MURF common stock held by the investor and its affiliates after
such exercise does not exceed the beneficial ownership limitation set forth in the warrant which may not exceed 4.99% of the then issued
and outstanding shares of MURF common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the amendment to the Subscription Agreement dated January 27, 2023, the Private Placement Investor agreed to receive
and be issued shares of New Conduit common stock. Upon the closing of the Business Combination, and specifically the filing of the Proposed
Charter, MURF&#8217;s Class A common stock and Class B common stock will be reclassified as a single class of common stock, and MURF&#8217;s
company name will change to &#8220;Conduit Pharmaceuticals Inc.&#8221; also referred to as New Conduit. The underlying terms of the Class
A common stock and the single class of common stock are materially the same as each has or will have the same voting right of one vote
per each share, same dividend rights and same liquidation rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 33.75pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January
2023 Extension</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initially,
MURF was required to complete its initial business combination transaction by 12 months from the consummation of its initial public offering
or up to 18 months if it extended the period of time to consummate a business combination in accordance with its amended and restated
certificate of incorporation. On January 26, 2023, at a special meeting of its stockholders, MURF&#8217;s stockholders approved a proposal
to amend the amended and restated certificate of incorporation to allow it to extend the date by which it has to consummate a business
combination up to 12 times, each such extension for an additional one month period, from February 7, 2023, to February 7, 2024. MURF&#8217;s
stockholders also approved a related proposal to amend the trust agreement allowing MURF to deposit into the Trust Account, for each
one-month extension, one-third of 1% of the funds remaining in the trust account following the redemptions made in connection with the
approval of the extension proposal at the special meeting. At the special meeting MURF&#8217;s stockholders also approved a proposal
to amend its certificate of incorporation to expand the methods that it may employ to not become subject to the &#8220;penny stock&#8221;
rules of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with such proposals, MURF&#8217;s public stockholders had the right to redeem their shares for cash equal to their pro rata
share of the aggregate amount on deposit in the trust account as of two days prior to such stockholder vote. The public stockholders
holding 11,037,272 shares of Class A common stock (out of a total of 13,979,000 shares of Class A common stock) exercised their right
to redeem such shares at a redemption price of approximately $10.33 per share. Approximately $114 million in cash was removed from the
trust account to pay such stockholders and, accordingly, after giving effect to such redemptions, the balance in the trust account was
approximately $23 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the approval of such proposals, MURF agreed to deposit into the trust account one-third of 1% of the funds then on deposit
in the trust account for each month of the extension period, resulting in a monthly contribution of approximately $0.035 per share that
was not redeemed in connection with the Special Meeting (approximately $77,000 in the aggregate per month), or an aggregate of $924,000
(the &#8220;Maximum Contribution&#8221;) if the date MURF has to consummate a business combination is extended 12 times, each assuming
no interest is earned on the funds in the trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations and Known Trends or Future Events</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its
entire activity since inception up to December 31, 2022 relates to its formation, its initial public offering and, since the closing
of the initial public offering, a search for a business combination candidate. MURF will not be generating any operating revenues until
the closing and completion of its initial business combination, at the earliest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2022 and during the period from October 19, 2021 (inception) through December 31, 2021, MURF had net income
and a loss of $398,639 and $4,381, respectively. For the year ended December 31, 2022 this consisted primarily of general and administrative
expenses of approximately $1.20 million and income tax expense of $374,862. This was offset by interest income of approximately $1.98
million earned on Trust assets during the year ended December 31, 2022. There was no interest income earned and during the period from
October 19, 2021 (inception) through December 31, 2021, and the net loss consisted of formation costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2023, its public stockholders had the right to redeem their shares for cash equal to their pro rata share of the aggregate amount
on deposit in the trust account. Its public stockholders holding 11,037,272 shares of Class A common stock (out of a total of 13,979,000
shares of Class A common stock) exercised their right to redeem such shares at a redemption price of approximately $10.33 per share.
Approximately $114 million in cash was removed from the trust account to pay such stockholders and, accordingly, after giving effect
to such redemptions, the balance in the trust account was approximately $23 million. As a result of less fund in the trust account, MURF
does not expect the same level of interest income in 2023 as MURF experienced during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity,
Capital Resources and Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
indicated in the accompanying financial statements, at December 31, 2022, MURF had $345,777 in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2022, the net increase in cash was $297,222. Cash used in operating activities was $1,311,310 and was mainly
the result of a net income of $398,639, interest income earned on trust assets $1,976,183, cash used in accrued expenses of $27,664,
and cash used in prepaid expenses of $245,254 partially offset by change in deferred offering costs of $108,962 and accrued income taxes
payable of $374,862. Cash used in investing activities was $134,895,000 and was the result of funds deposited into the trust account.
Cash provided by financing activities was $136,503,532 and was primarily related to the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2022 Company consummated its initial public offering of 11,500,000 units (the &#8220;Units&#8221;). Each Unit consists of
one share of Class A common stock of the Company, par value $0.0001 per share (&#8220;Class A Common Stock&#8221;), and one redeemable
warrant of the Company (&#8220;Warrant&#8221;), with each whole Warrant entitling the holder thereof to purchase one share of Class A
Common Stock for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $115,000,000
the Company granted the Underwriters in the Offering a 45-day option to purchase up to 1,725,000 additional Units solely to cover over-allotments,
if any (the &#8220;Option&#8221;). The Underwriters exercised the Option in full, resulting in the sale of 13,225,000 Units in total
and total gross proceeds of $132.25 million, which were placed in a U.S.-based trust account, maintained by Wilmington Trust Company,
acting as trustee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2022, simultaneously with the consummation of the Offering, the Company consummated the private placement of 754,000 units
(the &#8220;Private Placement Units&#8221;) to the Sponsor, which amount includes 69,000 Private Placement Units purchased by the Sponsor
in connection with the Underwriters&#8217; exercise of the Option in full, at a price of $10.00 per Private Placement Unit, generating
gross proceeds of approximately $7.54 million (the &#8220;Private Placement&#8221;) a portion of the proceeds of were placed in the trust
account and a portion was used to pay offering expenses including the non-deferred underwriting discount related to the Offering. See
&#8220;<b><i>January 2023 Extension</i></b>&#8221; as noted above for additional information regarding proceeds currently in the trust
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&#8217;s assessment of going concern considerations in accordance with Accounting Standards Update (&#8220;ASU&#8221;)
2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined
that the Combination Period is less than one year from the date of the issuance of the financial statements. There is no assurance that
the Company&#8217;s plans to consummate a Business Combination will be successful within the Combination Period. As a result, these factors
raise substantial doubt about the Company&#8217;s ability to continue as a going concern for the next twelve months from the issuance
of these financial statements. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2021, the Sponsor purchased 4,312,500 founder shares for an aggregate purchase price of $25,000, or approximately $0.006
per share. On January 26, 2022, the sponsor surrendered and forfeited 1,006,250 Founder Shares for no consideration, following which
the sponsor holds 3,306,250 founder shares at approximately $0.008 per share. The founder shares (including the Class A common stock
issuable upon exercise thereof) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the date of its initial public offering, MURF pays an affiliate of the Sponsor a total of $10,000 per month for office space, utilities
and secretarial and administrative support. For the year ended December 31, 2022, total payments to Murphy Canyon Management Group were
$110,000. Upon completion of its initial business combination or its liquidation, MURF will cease paying these monthly fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its
sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in
connection with activities on its behalf such as identifying potential target businesses and performing due diligence on suitable business
combinations. Its audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers or directors
or its or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling
on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on its behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021 the Sponsor loaned MURF $300,000 to be used for a portion of the expenses of the initial public offering. These loans
are non-interest bearing, unsecured and were repaid upon the closing of the initial public offering in February 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in order to finance transaction costs in connection with an intended initial business combination, the Sponsor or an affiliate
of the Sponsor or certain of its officers and directors may, but are not obligated to, loan MURF funds as may be required. If MURF complete
its initial business combination, MURF would repay such loaned amounts. In the event that its initial business combination does not close,
MURF may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from its trust
account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit
at the option of the lender, upon consummation of its initial business combination. The units would be identical to the placement units.
The terms of such loans by its officers and directors, if any, have not been determined and no written agreements exist with respect
to such loans. MURF does not expect to seek loans from parties other than the Sponsor or an affiliate of the Sponsor as MURF does not
believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in its
trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the initial public offering, the Sponsor purchased 754,000 placement units for an aggregate purchase price of $7,540,000.
Each whole warrant is exercisable to purchase one whole share of Class A common stock at $11.50 per share. Its Sponsor has agreed to
transfer, but has not yet transferred, an aggregate of 45,000 placement units (15,000 each) to each of its three independent directors.
There will be no redemption rights or liquidating distributions from the trust account with respect to the founder shares, or placement
units, which will expire worthless if MURF does not consummate a business combination by February 7, 2024 (or such later date as may
be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation). The placement units are identical
to the units sold in the initial public offering except that the placement units and their component securities will not be transferable,
assignable or saleable until 30 days after the consummation of its initial business combination except to permitted transferees, the
purchasers of the placement units waive any and all rights and claims that they may have to any proceeds, and any interest thereon, held
in the trust account in respect of the common stock underlying such placement units in the event that a business combination is not consummated.
The placement units are entitled registration rights. Additionally, the warrants underlying the placement units contain a cashless exercise
provision and shall be non-redeemable while held by the initial purchasers thereof or their permitted assignees. There will be no underwriting
fees or commissions due with the respect to the private placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed to waive its redemption rights with respect to its founder shares (i) in connection with the consummation of a business
combination, (ii) in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the
substance or timing of its obligation to allow redemption in connection with its initial business combination or certain amendments to
its charter prior thereto or to redeem 100% of its public shares if MURF does not complete its initial business combination by February
7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s amended and restated certificate of incorporation)
and (iii) if MURF fails to consummate a business combination by February 7, 2024 (or such later date as may be extended by means of amendment
to MURF&#8217;s amended and restated certificate of incorporation)or if MURF liquidates prior to the expiration of such period. However,
its initial stockholders will be entitled to redemption rights with respect to any public shares held by them if MURF fails to consummate
a business combination or liquidate by February 7, 2024 (or such later date as may be extended by means of amendment to MURF&#8217;s
amended and restated certificate of incorporation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement MURF entered into with its initial stockholders, MURF may be required to register certain securities
for sale under the Securities Act. These holders, and holders of units issued upon conversion of working capital loans, if any, are entitled
under the registration rights agreement to make up to three demands that MURF register certain of its securities held by them for sale
under the Securities Act and to have the securities covered thereby registered for resale pursuant to Rule 415 under the Securities Act.
In addition, these holders have the right to include their securities in other registration statements filed by us. MURF will bear the
costs and expenses of filing any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 7, 2023 the Sponsor loaned MURF $300,000 to be used to fund the trust account and for its operating expenses, and may lend up to
$1,500,000 in total. These loans are non-interest bearing, unsecured and will be repayable in full upon the earlier of (i) the date on
which MURF consummates its initial business combination and (ii) the date that its winding up is effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements; Commitments and Contractual Obligations; Quarterly Results</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, MURF did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did
not have any commitments or contractual obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JOBS
Act</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements
for qualifying public companies. MURF will qualify as an &#8220;emerging growth company&#8221; and under the JOBS Act will be allowed
to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. MURF
is electing to delay the adoption of new or revised accounting standards, and as a result, MURF may not comply with new or revised accounting
standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, its financial
statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective
dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
MURF is in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject
to certain conditions set forth in the JOBS Act, if, as an &#8220;emerging growth company&#8221;, MURF chooses to rely on such exemptions
MURF may not be required to, among other things, (i) provide an independent registered public accounting firm&#8217;s attestation report
on its system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure
that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii)
comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the report of
independent registered public accounting firm providing additional information about the audit and the financial statements (auditor
discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation
and performance and comparisons of the Chief Executive Officer&#8217;s compensation to median employee compensation. These exemptions
will apply for a period of five years following the completion of the initial public offering or until MURF is no longer an &#8220;emerging
growth company,&#8221; whichever is earlier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_024"></span>BUSINESS
OF Conduit PHARMACEUTICALS LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;We,&#8221;
&#8220;us,&#8221; and &#8220;our&#8221; in this section generally refer to Conduit Pharmaceuticals Limited (&#8220;Conduit&#8221;) prior
to the consummation of the Business Combination, which will be the business of the post-combination company following the consummation
of the Business Combination. Unless otherwise indicated or the context otherwise requires, references in this Conduit&#8217;s Business
section to &#8220;Conduit,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to Conduit prior
to the Business Combination and to the Company after giving effect to the Business Combination. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview and Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals is a clinical-stage specialty biopharmaceutical company that began operations in early 2019, to facilitate
the development and commercialization of clinical assets to address the unmet medical needs of patients, through our exclusive
relationships. Our unique approach allows us to act as a &#8220;conduit&#8221; whereby we focus on clinical assets from pharmaceutical
companies that have otherwise been deprioritized and fulfil our mission to accelerate the development of new treatments for patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
is led by highly experienced pharmaceutical executives: Dr. Freda Lewis-Hall, former Chief Medical Officer of Pfizer Inc.,
and Dr. David Tapolczay, former Chief Executive Officer of the United Kingdom-based medical research charity LifeArc. Our management
team includes active senior clinicians who have an extensive understanding of the pharmaceuticals market, which supports our strategy
of developing clinical assets in a cost-efficient manner while focusing on therapeutic efficacy and patient safety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Conduit has an exclusive
relationship and partnership with St George Street Capital (&#8220;St George Street&#8221;), a biomedical charity based in the United
Kingdom. Conduit has the option to fund 100% of the development of clinical assets that are initially licensed by St George Street from
AstraZeneca AB (PUBL) (&#8220;AstraZeneca&#8221;). In most instances, AstraZeneca has conducted initial pre-clinical and, in some instances,
clinical trials on these assets, but has decided to license them for further development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Conduit evaluates the clinical
assets held by St George Street to determine which assets to fund for further development. In connection with the funding and development
of clinical assets, Conduit evaluates and selects the specific clinical assets to be developed and collaborates with external Contract
Research Organizations (&#8220;CROs&#8221;) to run clinical trials that are managed, funded and overseen by Conduit. We intend to leverage
our comprehensive clinical and scientific expertise in order to facilitate development of clinical assets through Phase IIb trials in
an efficient manner by using CROs and third-party service providers. Conduit believes that successful Phase IIb trials of the clinical
assets in its pipeline will increase the value of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Conduit will seek to  license
assets following successful clinical trials to large biotech or pharmaceutical companies, typically for milestone payments and retain
a royalty income stream for the life of the asset patent. Conduit anticipates using any future royalty income stream to develop its asset
portfolio in order to balance its potential future income streams with new debt or equity financings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Outside of our relationship
with St George Street, Conduit is free, and intends, to pursue additional relationships and/or partnerships with third parties for the
licensing of further assets which are currently deprioritized. We plan to focus our efforts on developing clinical assets to address
diseases that impact a large population where there is no present treatment or the present treatment carries significant unwanted side
effects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Our initial licensed clinical
assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, premature labor,
renal transplant rejection and Hashimotos Thyroiditis. Our initial assets which were licensed from Astra Zeneca to St George that will
be developed by Conduit are known as AZD5904 (a Myeloperoxidase Inhibitor) and AZD1656 (a Glucokinase Activator). As the clinical assets
have undergone initial pre-clinical and clinical testing conducted by AstraZeneca, Conduit is able to assess the safety data generated
in these clinical trials to assess which clinical assets to further develop and for which indications.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Initially, Conduit will focus
on assets to which it has access, through its relationship with St George Street and St George Street&#8217;s relationship with AstraZeneca,
to the active pharmaceutical ingredients (&#8220;API&#8221;) that were used by AstraZeneca in conducting its clinical trials. As a result,
Conduit does not have to develop the API, which is often a time consuming and expensive process, and benefits from the fact that the
API was produced by a reputable pharmaceutical company, which is subject to rigorous quality control measures so that the API that is
used by Conduit for additional clinical trials is likely to be more consistent in terms of the quality and performance.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Strategic
Alliances and Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Global
Funding Agreement &#8211; St George Street</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
and St George Street entered into an Exclusive Funding Agreement on March 26, 2021 (the &#8220;Global Funding Agreement&#8221;), pursuant
to which St George Street granted Conduit the exclusive first right to provide to St George Street, or procure the provision of, all
funding for the performance of a drug discovery and/or development project in consideration for a share of the net revenue in respect
of such project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
and St George Street have entered into five project funding agreements, which are subject to the terms of the Global Funding Agreement,
to develop certain clinical assets that have been licensed to St George Street by AstraZeneca. The project funding agreements relate
to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
    for use in renal transplant,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
    for use in pre-term labor, </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
    for use in Hashimoto&#8217;s Thyroiditis and Graves&#8217; Disease,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
    for use in uveitis, and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD5904
    for use in idiopathic male infertility.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Global Funding Agreement provides that it will remain in effect for each project until the expiration of the right of a party to receive
a share of the net revenue under the agreement for such project. Conduit may terminate the Global Funding Agreement with respect to a
particular project if St George Street ceases to develop such project, provided that the termination is only effective with respect to
the specified project and the Global Funding Agreement continues in effect for all other projects. Subject to the terms of the Global
Funding Agreement, St George Street may seek funding for projects from third parties (other than Conduit).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
may be additional opportunities for us to partner with St George Street to fund the development of additional clinical assets in the
future, licensed from Astra Zeneca.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy is to generate value through the development of new medicines, or clinical assets, for patients where our research indicates
that there are not effective pharmaceutical treatments available or such existing pharmaceutical treatments are not adequate due to,
among other things, cost of such pharmaceuticals and side effects. We are working to develop new medicines in diseases where competitive
treatments carry a high incidence of unacceptable side effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our relationship with St George Street, which in turn has a relationship with AstraZeneca, allows us to bypass certain traditional
hurdles to development of clinical assets. For example, through St George Street&#8217;s existing relationship with AstraZeneca, the
clinical assets that we have licensed from St George Street have already undergone initial pre-clinical and, in some instances, clinical testing conducted
by AstraZeneca, which means that Conduit is able to use the safety data generated in the prior trials in order to assess which assets
to continue to develop. Conduit regularly assesses its asset portfolio to identify potential risks and take steps to mitigate those risks,
such as the repurposing of assets, which reduces development costs and timelines, as the clinical asset has already undergone safety
and toxicity testing in humans. If a clinical asset is used for a new indication, the early stages of drug development, including preclinical
studies and Phase I clinical trials, do not need to be conducted again, which allows for Conduit to begin its development of such clinical
assets at a later stage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
prior preclinical and clinical studies conducted by AstraZeneca may allow Conduit to reduce the costs, expenses and time associated with
the early stages of drug development by allowing Conduit to continue the development of the clinical assets at the Phase Ib or Phase
II stage, rather than the preclinical or Phase I stage, even if Conduit is investigating the assets for a new indication. For example,
if a clinical asset was subject to a Phase I trial, such clinical asset may be advanced to a Phase II trial even if the clinical asset
is being investigated for a different indication.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Conduit has access, through its relationship with St George Street and St George Street&#8217;s relationship with AstraZeneca,
to the API that were used by AstraZeneca in conducting its clinical trials. As a result, Conduit does not have to develop the API, which
is often a time consuming and expensive process, and benefits from the fact that the API was produced by a reputable pharmaceutical company,
which is subject to rigorous quality control measures so that the API that is used by Conduit for additional clinical trials is likely
to be more consistent in terms of the quality and performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
its relationship with St George Street, Conduit believes that it will be able to more efficiently advance the development of its clinical
assets because pre-clinical and, in some instances, clinical studies have already been completed and it has access to existing API. Conduit intends to enter
into other agreements with third parties (other than St George Street) to fund and develop additional clinical assets in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
successful clinical trials, Conduit anticipates that the clinical assets in its pipeline will be commercialized through licensing arrangements
with larger pharmaceuticals companies, which may include up-front milestone payments and/or royalties during the time at which such clinical
asset is subject to patents. Conduit intends to use the income received from licensing clinical assets in its pipeline to fund the development
of additional clinical assets, which will allow Conduit to use the existing income stream from clinical assets that have been licensed
to fund our on-going operations, including the development and commercialization of additional clinical assets, without having to rely
solely on debt and/or equity financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>License
Agreement &#8211; St George Street and AstraZeneca </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2019, St George Street entered into a license agreement with AstraZeneca (the &#8220;AZ License Agreement&#8221;), pursuant to
which AstraZeneca granted an exclusive worldwide license to St George Street, under certain AstraZeneca patents and know-how, to exploit
the pharmaceutical compounds known individually and together as AZD5904 (Myeloperoxidase Inhibitor) and AZD1656 (Glucokinase Activator).
The AZ License Agreement also included any additional compounds to be developed by St George Street and any product that is comprised
of or contains any such licensed compound pertaining to the field of idiopathic male infertility for the licensed compound AZD5904 and
in the field of renal transplant for the licensed compound for AZD1656.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the AZ License Agreement, for a period of sixty (60) days following AstraZeneca&#8217;s receipt of a proof of concept study for any licensed
compound, AstraZeneca retains an exclusive right of first negotiation to transfer all development, commercialization, or other ongoing
planned activities related to such licensed compound, to AstraZeneca or any of its affiliates, and to undertake future exploitation of
such licensed compound. Subject to the foregoing negotiation right, St George Street has the right and obligation to develop each licensed
compound at its sole cost and expense in accordance with the development plan set forth in the AZ License Agreement, and the right to
grant sublicenses to its affiliates and other persons with respect to each licensed compound. Any sublicense shall be consistent with,
and expressly made subject and subordinate to, the terms and conditions of the AZ License Agreement, and St George Street shall cause
each sublicensee to comply with the applicable terms and conditions of the AZ License Agreement. The development plan for each licensed
compound shall be managed by a joint coordination committee consisting of representatives from each party to the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">St
George Street is required to pay AstraZeneca a share of any revenue payable to St George Street by any sublicensee according to
the relevant sublicense (the &#8220;Sublicense Revenue&#8221;), which shall be calculated based on the amounts payable to St George Street
by the sublicensee gross of tax, and shall include any upfront, milestone, or royalty payments payable. The percentage of Sublicense
Revenue payable to AstraZeneca is sixty percent (60%) for Sublicense Revenue that is less than $10 million; fifty percent (50%) for Sublicense
Revenue that is greater than $10 million but less than $15 million; and forty percent (40%) for Sublicense Revenue that is greater than
$15 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the AstraZeneca License Agreement commences on the effective date of that agreement and, unless earlier terminated in accordance
therewith, continues until the date of expiration of the last royalty term for the last licensed product. Following the expiration (but
not earlier termination) of the royalty term for a licensed product in a country, the license grant set forth in this agreement shall
become non-exclusive, fully-paid, and irrevocable for such licensed product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
AZ Agreement is terminable by either party if the other party is in material breach of the agreement, and has not cured the breach within
ninety (90) days of notice (or ten (10) days of notice with respect to a payment breach).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AstraZeneca
may immediately terminate the agreement, including the rights of any sublicensees, upon written notice if St George Street or any of
its affiliates or sublicensees, anywhere in the territory, institutes, prosecutes or otherwise participates in any claim, demand, action
or cause of action for declaratory relief, damages or any other remedy or for an enjoinment, injunction or any other equitable remedy
alleging that any claim in an AstraZeneca patent is invalid, unenforceable or otherwise not patentable or would not be infringed by St
George Street&#8217;s activities absent the rights and licenses granted under the agreement. AstraZeneca may also terminate the agreement
upon thirty (30) days&#8217; prior written notice if St George Street ceases development of all licensed compounds and all licensed products
and a licensed product is not being commercialized in the territory by or on behalf of St George Street.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">St George Street may terminate
its activities under the agreement for convenience, on a project-by-project basis, upon reasonable notice to AstraZeneca. St George
Street may also cease its activities under any development plan of a licensed compound if the joint commercialization committee determines
that it is in appropriate to continue such plan for scientific, safety, or for ethical reasons, or that a licensed product no longer
meets an unmet medical need.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2020, St George Street and AstraZeneca entered into an amendment to the AZ License Agreement to add Covid-19 to the field for licensed
compound AZD1656. In 2021, St George Street and AstraZeneca entered into a second amendment and a third amendment to the AZ License Agreement.
The second amendment to the AZ License Agreement added Schedule 1.36(a) to the AZ License Agreement, which describes additional terms
and conditions that apply only to the parties with respect to Covid-19 for the licensed compound AZD1656. The third amendment added Hashimoto&#8217;s
thyroiditis, uveitis, preterm labor, and Covid-19 to the field for AZD1656 and added Schedule 1.42(a) to the AZ License Agreement, which
describes additional terms and conditions that apply to the parties (i) only with respect to Hashimoto&#8217;s thyroiditis, uveitis,
and preterm labor for the licensed compound AZD1656, and (ii) with respect to all other indications and Licensed Compounds (as defined
in the AZ License Agreement) as set forth in the AZ License Agreement, except with respect to Covid-19 for AZD1656, for which Schedule
1.36(a) of the AZ License Agreement applies. The terms and conditions contained in the second and third amendments to the AZ License
Agreement also sets forth the obligations and responsibilities of the parties regarding supply of study drugs, conducting studies, and
other matters. The foregoing summary does not purport to be a complete description of all of the provisions of the AZ License Agreement
and the amendments to the AZ License Agreement, and is qualified by reference to the full text of the AZ License Agreement and its amendments,
which are filed as exhibits to the registration statement of which this proxy statement/prospectus is a part, and which are incorporated
by reference in their entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2
</sup>Reference is made to the section <i>&#8220;Special Meeting of MURF Stockholders &#8211; Opinion of ValueScope, Inc. &#8211; Overview
of Global Biotechnology Industry&#8221;.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
Asset Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the exclusive rights to develop AZD1656 and AZD5904 through our Global Funding Agreement with St George Street, we also wholly
own the intellectual property and the rights to further develop certain co-crystals of AZD1656 (AZD1656 Co-Crystal PCT/US22/75883 - Patent
Expires 02/09/2042). We will seek to develop the AZD1656 Co-Crystal in</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Psoriasis,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crohn&#8217;s
    disease,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lupus,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sarcoidosis,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diabetic
    wound healing,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Idiopathic
    pulmonary fibrosis, and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonalcoholic
    steatohepatitis (NASH).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Overview </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Global
Biotechnology Industry</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global biotechnology industry comprises a large range of companies engaged in diverse activities, such as biopharmaceutical development.
The industry companies also span across a wide spectrum of operational models. Some small, dedicated biotechnology companies are research
and development (&#8220;R&amp;D&#8221;) intensive and operate primarily with venture capital, grants, initial public offerings
and collaborative agreements. Conversely, large, diversified companies hold significant in-house R&amp;D resources and well-established
production, commercialization, and distribution processes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
industry revenue is expected to increase at an annualized rate of 3.1% to $358.2 billion over the next five years, with more profound
growth tempered by the pandemic. Increased R&amp;D funding and consumer spending in 2022 are expected to catalyze revenue growing 2.9%
the same year.<sup>1</sup></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
investor confidence has fallen during the period, which served to somewhat subdue revenue growth. However, global investment in R&amp;D
has grown strongly and consistently in recent years, with much of this funding funneled into medical biotechnology development, aimed
at providing better care for the aging global population, thus bolstering industry revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_013.jpg" alt="" style="height: 359.15pt; width: 374.7pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1
</sup>Reference is made to the section <i>&#8220;Special Meeting of MURF Stockholders &#8211; Opinion of ValueScope, Inc. &#8211; Overview
of Global Biotechnology Industry&#8221;.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Global
Pharmaceutical Industry</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the previous five years, pharmaceutical companies have benefited from an aging population in developed economies and a growing middle
class in emerging economies. Many companies have also tapped into regional demand for pharmaceuticals that may differ from developed
markets and have expanded their global presence to tap into regional market needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
cliffs have continued to hamper industry revenue during the current period. When drugs lose patent exclusivity, the market is inundated
with low-cost generic drugs. As manufacturers contend with more price-based competition from generics, many operators respond by lowering
their research &amp; development expenditures, which limits the industry&#8217;s drug pipelines. Additionally, many governments and health
insurance organizations have reduced their drug reimbursements to control healthcare costs, such as implementing incentives for patients
to use generic drugs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moving
forward, revenue is forecast to grow an annualized 3.2% to $1.3 trillion over the next five years amid an anticipated persistence of
global demand for industry products.<sup>2</sup></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_014.jpg" alt="" style="height: 479px; width: 502px" /><br /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial Pipeline: AZD1656 and AZD5904</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have the exclusive rights to develop clinical assets, AZD1656 and AZD5904, which are licensed to St George Street by AstraZeneca,
in six indications. The table below sets forth the anticipated stage for the further development of these clinical assets in each of
the specific therapeutic areas. The table does not reflect the pre-clinical or clinical trials that have been conducted by third parties
to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-4_015.jpg" alt="" style="width: 624px; height: 153px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>AZ1656
in Autoimmune Diseases.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autoimmune
diseases refers to a broad group of diseases and conditions that arise from an abnormal immune response to a functioning body part. For
example, autoimmune diseases may arise from an abnormal immune response of major organs (<i>i.e.</i>, the heart, kidneys, bladder, liver,
lungs, and skin), glands (<i>i.e.</i>, the adrenal gland, pancreas, thyroid or reproductive organs), digestive system, and tissue (<i>i.e.</i>,
blood, connective tissue, muscle, eyes, ears, or vascular system). Management believes that there are over 80 types of autoimmune diseases
that have been identified, including lupus, celiac disease, multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel
disease. Autoimmune diseases are often difficult to diagnose and often the cause of the disease is not known.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is estimated by the American Autoimmune Related Diseases Association (&#8220;AARDA&#8221;) that as many as 50 million Americans are living
with an autoimmune disease &#8211; at a cost of $86 billion a year and there is presently no totally effective treatment known to management.
The currently available treatments for autoimmune diseases include non-steroidal anti-inflammatory drugs (&#8220;NSAIDS&#8221;) or immune
suppressants. These treatments often improve the symptoms but ultimately do not cure the disease and often involve side effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
is a highly specific glucokinase activator; originally developed by AstraZeneca for use in diabetes mellitus. It has now been tested
in over 1,000 patients with both type I and II diabetes and no significant safety concerns have been raised. It was most recently tested
in the ARCADIA phase II trial in diabetic patients hospitalized with Covid-19 on the basis of new research into immunometabolic modulation.
We believe that AZD1656 may be used to activate a patient&#8217;s own immune system in order to limit harmful inflation. We have identified
several autoimmune diseases, which reflects good market potential, with a high level of need that may be treatable using AZD1656. We
believe that our clinical assets have the potential to treat numerous autoimmune diseases. We intend to initially focus on the indications
below in order to maximize the commercial potential of our clinical assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Thyroid
Disease: Hashimoto&#8217;s Thyroiditis and Graves&#8217; Disease</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
Hashimoto&#8217;s Thyroiditis (&#8220;HT&#8221;) and Graves&#8217; disease are autoimmune diseases involving the improper functioning
of the thyroid. HT is an autoimmune disease driven by T cells, which are one of the types of white blood cells, where the immune system
attacks the thyroid gland. Graves&#8217; disease is an autoimmune disorder in which antibodies result in the hyperfunction of the tissue
and an increase in the amount of thyroid hormones. Patients with Graves&#8217; disease may develop an enlargement of the thyroid called
a goitre and often have eye problems due to lymphocyte, a type of immune cell, infiltrating into the muscles of the eye.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
believes that HT is the most prevalent autoimmune thyroid disease worldwide and around 2% of adults in the United States are sufferers
and that HT is 15-20 times more likely to occur in women compared to men. We anticipate that the prevalence of HT will continue to increase
due to rising obesity and the rising prevalence of other autoimmune disorders that made patients more susceptible to HT. Graves&#8217;
disease is the most common cause of persistent hyperthyroidism, which is an over production of hormones by the thyroid gland located
in the front of the neck, in adults. It is estimated that approximately 3% of women and 0.5% of men will develop Graves&#8217; disease
during their lifetime.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current treatment for HT involves hormone replacement therapy with levothyroxine. However, determining the appropriate dose for each
individual is complex with the individual needing to continue hormone replacement therapy for the rest of his or her life while still
suffering with some symptoms of HT. Under the current treatment, the patient is monitored by measuring Thyroid-Stimulating Hormone levels
(&#8220;TSH&#8221;). Studies have shown up to 27% of patients have TSH that are too high and 41% of patients have TSH levels that are
too low, which reflects the difficulty in treating the disease. In addition, this difficulty in titrating the appropriate dose of levothyroxine
leads to a high burden of medical appointments and the risk of development of comorbidities, including cardiovascular disease. Graves&#8217;
disease is also difficult to control with carbimazole and steroids, both of which have numerous side effects. Another common treatment
is using radioactive iodine (&#8220;RAI&#8221;) to destroy the thyroid gland. After using RAI, patients are left dependent upon levothyroxine
hormone replacement treatment. It is also believed that the use of RAI has also been associated with the development or worsening of
thyroid eye disease in approximately 15% to 20% of patients. The alternative treatment is surgical removal of the thyroid gland following
which the patient will need lifelong replacement therapy with levothyroxine which involves the same problems described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
published by news sources, management believes that the thyroid gland disorder treatment market is set to grow by approximately $632
million at a compound annual growth rate (&#8220;CAGR&#8221;) of 4.63% from 2020 to 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
was previously subject to preclinical and clinical trials, including Phase I and Phase II trials, conducted by AstraZeneca relating to
its potential to treat type 2 diabetes. Conduit intends to conduct further trials on AZD1656 relating to HT and Graves&#8217;
disease. Conduit believes that both HT and Graves&#8217; disease may be investigated separately with relatively short clinical
trials of approximately 3-4 months in duration. Conduit intends to conduct further development of AZD1656 because its management believes
that AZD1656 may provide a treatment option for HT and/or Graves&#8217; disease with fewer negative side effects when compared to the
currently available treatment options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
companies typically find market entry for HT clinical assets challenging due to the manufacturing complexities and careful consideration
of manufacturing product, which are usually patented or trade secrets of companies. Due to its relationship with St George Street, Conduit
has sufficient API to conduct Phase II clinical trials on AZD1656 for the treatment of HT and Graves&#8217; disease.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Uveitis</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uveitis
is an autoimmune disease of the eye that refers to a number of intraocular inflammatory conditions and involves the swelling of the uvea,
the colored portion of the eyes. Management believes that in the U.S. uveitis causes an estimated approximately 30,000 new cases of blindness
per year and may be the third leading cause of blindness worldwide. Unlike other leading causes of blindness, uveitis is particularly
prevalent in younger working-age people. Uveitis has a prevalence of around 40-100 per 100,000 persons, and can be subdivided into specific
conditions, so it qualifies as a rare disease. Management believes that the global uveitis market could reach at least approximately
$1.7 billion for 2023 and may be expected to grow at a CAGR of 6.6%, potentially reaching $2.5 billion by 2028. We believe that a treatment
for non-infectious uveitis would be eligible for orphan drug designation, which provides for market exclusivity of 10 years in the European
Union and 7 years in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steroids,
which can cause elevated intraocular pressures and cataracts, are often used to manage uveitis. Most patients develop elevated intraocular
pressures and/or cataracts after long-term treatment with steroids and may have to switch therapies or the disease may become resistant
to steroid treatment. Biological drugs have been developed but these are expensive and not always effective as many patients still go
blind every year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
was previously subject to preclinical and clinical trials, including Phase I and Phase II trials, conducted by AstraZeneca relating to
its potential to treat type 2 diabetes. Conduit intends to conduct further trials on AZD1656 relating to uveitis. Specifically, Conduit
plans to conduct a Phase II clinical trial to use AZD1656 for the treatment of uveitis. We believe that AZD1656 has the potential to
treat uveitis without the serious side effects of the current treatment using steroids.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Renal
Transplant Failure</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Renal
transplant failure occurs when a patient&#8217;s body rejects a kidney transplant and involves the gradual decrease in kidney function
that starts following a kidney transplant surgery and often results in organ failure. According to the United Network for Organ Sharing,
there are over 100,000 patients waiting for a kidney transplant in the U.S. The prevalence of chronic kidney disease is rising due to
other conditions, such as diabetes, and as a result of an aging population. During 2021, over 24,000 individuals received a kidney transplant.
According to the Organ Procurement &amp; Transplantation Network, approximately 13 people die each day in the U.S. while waiting for
a life-saving kidney transplant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
current treatment for renal transplant failure involves using immunosuppressives to suppress the patient&#8217;s immune system, which
has numerous side effects including high blood pressure, weight gain, diabetes, dyslipidemia and some cancers. Malignancy, which refers
to uncontrolled growth and division of abnormal cells, is one of the most common causes of death in kidney transplant recipients. Immunosuppressives
are a major contributing factor to malignancy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">AZD1656
was previously subject to preclinical and clinical trials, including Phase I and Phase II trials, conducted by AstraZeneca relating to
its potential to impact on renal transplant patients with type 2 diabetes. We believe that AZD1656 has the potential to decrease rejection
in kidney transplant patients as we believe AZD1656 facilitates the immune system in tolerating or accepting the transplanted kidney.
Conduit intends to conduct additional Phase II studies on AZD1656 relating to renal transplant failure. Large pharmaceutical companies
are exploring alternative treatments for renal transplant failure using expensive cell therapy techniques; however, we believe AZD1656
potentially provides a scalable small molecule solution.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Preterm
Labor</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Preterm
labor refers to giving birth to babies that are born alive before 37 weeks of pregnancy. Preterm labor may result in premature birth
and the earlier premature birth happens, the great of health risks for the baby. Preterm labor is a condition that may result in the
death of the baby and/or the mother. There is no effective treatment for preterm labor that is known to us. Management believes that
approximately 60,000 babies per year in the U.K. and approximately 380,000 per year in the U.S. are born preterm. Globally, prematurity
is the leading cause of death in children under the age of 5 years, and preterm labor rates are increasing. For example, according to
the Centers for Disease Control and Prevention, in the U.S., the preterm labor rate rose for the fifth straight year in 2019. For 2021,
the preterm labor rate in the U.S. was approximately 10.5%. According to the World Health Organization, the rates of preterm labor by
country range from approximately 5% to approximately 18%. Management believes that the preterm birth and PROM testing market size was
valued at approximately $1.6 billion in 2021 and is anticipated to be over $2.2 billion by 2030 with a CAGR of 3.2% from 2022 to 2030.
Preterm labor results in increases costs, both higher costs of labor and neonatal care, and often results in additional medical care
during the child&#8217;s lifetime for those that are born prematurely. Accordingly, the reduction in preterm labor would have a significant
health and economic impact.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">AZD1656
was previously subject to preclinical and clinical trials, including Phase I and Phase II trials, conducted by AstraZeneca relating to
its potential to treat type 2 diabetes. Conduit intends to conduct further trials on AZD1656 relating to use to treat preterm labor.
Specially, Conduit intends to conduct a Phase II study on the use of AZD1656 to assist in maintaining pregnancy beyond 37 weeks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Most
drugs for preterm labor are only used for about 24-48 hours once a woman is already in labor, so that the patients can be treated with
corticosteroids to promote the functioning of the baby&#8217;s lungs. These drugs are unable to sustain a pregnancy beyond this and are
not safe to be used for prolonged periods. We believe that AZD1656 may be able to help maintain a pregnancy for longer, which would reduce
the number of babies that are born prematurely and thereby reduce the costs and expenses associated with preterm labor for both the mother
and child.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>AZD1656
in Infectious Diseases &#8211; Covid-19 and Long Covid</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Covid-19 is a disease caused
by a virus named SARS-CoV-2, which refers to severe acute respiratory syndrome coronavirus 2, and is a strain of the coronavirus, which
is a respiratory illness. Conduit continues to have an economic interest in AZD1656 for treatment of Covid-19 and has included AZD1656
for the treatment of Covid-19 in its pipeline. However, at this time, Conduit does not intend to continue to fund or otherwise further
develop AZD1656 for Covid-19. In the event that any third party were to fund and develop AZD1656 for the treatment of Covid-19, Conduit
may be entitled to receive compensation from those development activities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #3C4245"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>AZD5904
in Idiopathic Male Infertility</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Idiopathic
Male Infertility (&#8220;IMI&#8221;) is defined as failure of a couple to conceive after one year of regular sexual intercourse where
the physical examination and endocrine laboratory testing of the male are normal but semen analysis reveals sperm abnormalities. Based
on publicly available information, Conduit&#8217;s management believes that approximately 15% of couples globally, or 48.5 million couples
globally, are infertile and that 30% of infertility cases can be attributed solely to the female, 30% can be attributed solely to the
male, 30% can be attributed to a combination of both partners, and 10% of cases have an unknown cause. Male sperm counts have declined
approximately 50% over the last 40 years in Western men, which is believed due, in part, to increasing rates of diseases such as obesity
and diabetes that can reduce fertility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">IMI
affects families worldwide and is inherent in problems of reproduction. Currently, there are no specific treatment for male infertility,
and we are not aware of any other company that is developing a treatment for male infertility. There are no approved pharmacotherapies
for idiopathic male infertility. Lifestyle medicine and unproven supplements are often used. Intracytoplasmic sperm injection, a form
of in vitro fertilization, is the only treatment currently available for male infertility. This process is not a treatment of male infertility
but rather is an alternative means of fertilizing the egg. In vitro fertilization places a significant burden on the woman as it requires
the induction of egg production and harvesting of eggs. In vitro fertilization is costly and time consuming and has modest success rates.
Management believes that the male infertility market (including diagnostic testing) is predicted to reach approximately $6 billion by
2030.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Damaged
sperm are unable to successfully fertilize eggs due to factors including impaired motility, impaired ability to penetrate and/or DNA
damaged sperm that is unable to form a viable fetus. Our development pipeline for AZD5904 includes a potent, irreversible inhibitor of
human myeloperoxidase, which we refer to as MPO, that has the potential to treat idiopathic male infertility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">AZD5904
was investigated by AstraZeneca for the treatment of indiopathic male infertility in Phase I trials, which confirmed the suitability
to progress to Phase II trials. While AZD 5904 is Phase II ready, Conduit&#8217;s management intends to conduct a Phase Ib &#8220;proof
of mechanism&#8221; trial to verify AZD5904 has the intended biological effect in semen (as well as in blood) prior to commencing a Phase
II trial for the use of AZD5904 to treat idiopathic male infertility. Specifically, Conduit&#8217;s management intends to conduct the
Phase Ib study in order to see if the trial will provide evidence that AZD5904 has its intended effect of inhibiting myeloperoxidase
and reduce oxidative stress in semen. We believe that AZD5904 has the potential to be used to create a tablet that could treat IMI and
would be the first drug developed to directly treat IMI.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 147; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Future
Product Candidates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that there is clinical and biological evidence that suggests AZD1656 may be effective treating other autoimmune diseases, include
systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, motor neuron disease and amyotrophic lateral sclerosis. As part
of our strategic planning process, we intend to explore the efficacy of using AZD1656 to treat other diseases. We also plan to further
develop the co-crystals that we own from our prior development work on AZD1656, including to research the ability of the co-crystals
developed from AZD1656 to treat psoriasis, Crohn&#8217;s disease, lupus, sarcoidosis, diabetic wound healing, idiopathic pulmonary fibrosis
and nonalcoholic steatohepatitis. In addition, we currently intend to explore the use of AZD5904 for the treatment of glioma. Due to
our on-going relationship with St George Street, from time to time, there may be additional clinical assets that we are able to partner
with St George Street to develop.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manufacturing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
does not currently own or operate any facilities to formulate, manufacture, test, store, package or distribute any of the product candidates
that we are developing or may seek to develop and do not currently have the capabilities to conduct such activities. We currently rely
on third parties to manufacture, store and test the product candidates that we seek to develop. We will depend on third-party suppliers
and manufacturing organizations for all our required raw materials and drug substance and to formulate, manufacture, test, store, package
and distribute clinical trial quantities of product candidates that we may seek to develop. We plan to continue to use third-party suppliers
and manufacturing organizations and we anticipate expanding our network of third-party suppliers and manufacturing organizations as our
operations expand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have internal personnel and utilizes consultants with extensive technical, manufacturing, analytical and quality experience to oversee
our contract manufacturing and testing activities. Manufacturing is subject to extensive regulations that impose procedural and documentation
requirements, including, but not limited to, record-keeping, manufacturing processes and controls, personnel, quality control, and quality
assurance. Our systems, procedures, and contractors are required to be in compliance with these regulations and are assessed through
regular monitoring and formal audits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research
and Development</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
spent approximately $28,000 on research and development activities during the year ended December 31, 2021, and $38,000 during
the year ended December&#160;31, 2022. Our research and development activities were wholly focused on developing co-crystals of AZD1656
to increase patent life. Some of this work was completed by third-party CROs but all intellectual property is retained by Conduit. We
currently have one pending international patent application and two pending national patent applications. The successful completion
of clinical trials increases the value of clinical assets and may lead to the commercialization and/or licensing of such assets to other
pharmaceutical companies.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
and Marketing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently have marketing, sales, or distribution capabilities. In order to commercialize any clinical asset that is approved for
commercial sale, we must either develop our own sales, marketing, and distribution infrastructure or collaborate with third parties that
have such commercial infrastructure and relevant marketing and sales experience. We anticipate relying on licensing, co-sale, co-promotion,
and distribution agreements with strategic partners for the commercialization of our products. We do not currently anticipate that we
would develop our own internal sales force organization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in the highly competitive pharmaceutical and biotechnology industry. Our competitors may include public and private companies,
universities, governmental agencies, and other research organizations actively engaged in the research and development of clinical assets
and biopharmaceutical products. Our competitors may have greater financial, technical, and human resources than we currently have and/or
may be better equipped to develop, manufacture, and market their products. Our competitors may be developing product candidates for products
for similar indications. However, we believe that we have an unprecedented advantage in novelty. As discussed above AZD1656 is an activator
(not an inhibitor) of a metabolic process. We anticipate that the number of companies seeking to develop clinical assets, biopharmaceutical
products and therapies will continue to increase. As a result, the competition we face may also increase, however both in the treatment
of autoimmune disease and idiopathic male infertility the competition is currently expected to come in years, even if biopharmaceutical
products that we develop and/or commercialize were not to compete with products of our competitors based on the product efficacy, safety,
ease of use, price, demonstrated cost-effectiveness, marketing effectiveness, service, reputation, and access to technical information.
However, we believe that our ability to focus on clinical assets that have been deprioritized by larger pharmaceutical companies is a
competitive advantage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hold exclusive rights to develop AZD1656 and AZD5904 through our Global Funding Agreement with St George Street and we also own the intellectual
property and the rights to further develop co-crystals resulting from our prior development work on AZD1656.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have one pending international patent application and two pending national patent applications. Even though we have filed patent
applications, there is no guarantee that the validity of the patents will be upheld if challenged by a third party, that patents will
be granted on the applications filed in the respective jurisdictions, or that once granted, the patents will contain claims that encompass
our commercial products. There can be no assurance that any of our intellectual property rights will afford us any protection from competition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following patent applications are relevant to the operation of Conduit&#8217;s business:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
    Product Candidate</b></span></td>
    <td style="text-align: center; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mechanism
    of Action</b></span></td>
    <td style="text-align: center; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Patent
    Information and Number</b></span></td>
    <td style="text-align: center; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Patent
    Ownership/Licensing Status; Patent Status</b></span></td>
    <td style="text-align: center; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdictions
    Protected</b></span></td>
    <td style="text-align: center; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucokinase
    Activator</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition
    of Matter Patent; 101901 (family number)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed
    to St George Street Capital from AstraZeneca for use in thyroiditis, uveitis, pre-term labor, renal transplant failure. Granted
    and In force.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia,
    Brazil, Canada, Switzerland, China, Germany, European Procedure, Spain, France, United Kingdom, Hong Kong, India, Japan, South Korea,
    Mexico, Netherlands, Russian Federation, Sweden, Turkey, United States</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires
                                            July 3, 2026.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucokinase
    Activator</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Polymorph
    Patent; 103631 (family number)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed
                                            to St George Street Capital from AstraZeneca for use in thyroiditis, uveitis, pre-term labor,
                                            renal transplant failure.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted
    and In force.</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
    and United States</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires
    February 2030.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucokinase
    Activator</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-crystal
    PCT/US22/75883</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
                                            by Conduit Pharmaceuticals.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    September 2, 2022.</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
                                            date September 2, 2022. If granted, will expire September 2, 2042.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD5904</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MPO
    Inhibitor</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Idiopathic
                                            Male Infertility; AZD5904 use patent; 200644 (family number)</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[WO/2019/016074]</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed
    to St George Street Capital from AstraZeneca.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International
    Description</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires
                                            July 12, 2038.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not filed any application for trademark protection of any names or logos for products or technologies in development. We plan to
seek trademark protection inside and outside of the United States where and when appropriate and if available. We intend to use these
registered marks in connection with our pharmaceutical research and development, including proprietary technologies, as well as our product
candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to seek to protect our products and technologies through a combination of patents, regulatory exclusivity, potentially confidential
and proprietary know-how. We intend to actively seek to obtain, where appropriate, the broadest commercially reasonable intellectual
property protection possible for our product candidates and technologies, including any future product candidates and technologies under
development, our proprietary information, and our proprietary technology through a combination of contractual arrangements and patents,
in the United States and abroad. However, we cannot guarantee that patent protection will provide complete protection against competitors
who seek to circumvent our patents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
Regulation and Product Approval </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
authorities in the United States, at the federal, state and local level, and in other countries, extensively regulate, among other things,
the research, development, clinical trials, testing, manufacture, including any manufacturing changes, authorization, pharmacovigilance,
adverse event reporting, recalls, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, import
and export of pharmaceutical products and product candidates, including clinical assets such as those we are developing. The processes
for obtaining regulatory approvals in the United States and in foreign countries, along with subsequent compliance with applicable statutes
and regulations have no guaranteed outcomes and require the expenditure of substantial time and financial resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>United
States Government Regulation </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) regulates drugs under the Federal Food, Drug, and Cosmetic
Act (&#8220;FDCA&#8221;) and implementing regulations. Failure to comply with the applicable United States requirements at any time during
the product development process, approval process or after approval, may subject an applicant to a variety of administrative or judicial
sanctions, such as the FDA&#8217;s refusal to approve pending New Drug Applications (&#8220;NDAs&#8221;), withdrawal of an approval,
imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production
or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement or civil and/or criminal penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process required by the FDA before a drug may be marketed in the United States generally involves the following steps, each of which
requires the expenditure of substantial time and financial resources:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">completion
    of preclinical laboratory tests, animal studies and formulation studies in compliance with good laboratory practices (&#8220;GLPs&#8221;)
    and other applicable regulations; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
    to the FDA of an Investigational New Drug Application (&#8220;IND&#8221;), which must become effective before human clinical trials
    may begin; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
    by an independent institutional review board (&#8220;IRB&#8221;) at each clinical site before each trial may be initiated; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performance
    of well-controlled human clinical trials in accordance with good clinical practices (&#8220;GCPs&#8221;), which may include placebo
    controls, to establish the safety and efficacy of the proposed drug product for each indication; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
    to the FDA of a New Drug Application (&#8220;NDA&#8221;) and payment of fees; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
    completion of an FDA advisory committee review, if applicable; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
    completion of an FDA pre-approval inspection of the manufacturing facility or facilities at which the product is produced to assess
    compliance with current good manufacturing practices (&#8220;cGMPs&#8221;) and to assure that the facilities, methods and controls
    are adequate to preserve the drug&#8217;s identity, strength, quality and purity; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
    completion of audits of clinical trial sites conducted by FDA to assure compliance with GCPs and the integrity of clinical data;
    and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
    review and approval of the NDA. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preclinical
Studies </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
studies include laboratory evaluation of product chemistry, toxicity and formulation, as well as animal studies to assess potential safety
and efficacy. Preclinical tests intended for submission to the FDA to support the safety of a product candidate must be conducted in
compliance with GLP regulations and the U.S. Department of Agriculture&#8217;s Animal Welfare Act. A drug sponsor must submit the results
of the preclinical tests, together with manufacturing information, analytical data and any available ex-U.S. clinical data or relevant
literature, among other things, to the FDA as part of an IND. Some nonclinical testing may continue even after the IND is submitted.
An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions
related to one or more proposed clinical trials and places the clinical trial on a clinical hold. In such a case, the IND sponsor and
the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may not result in
the FDA allowing clinical trials to commence. A clinical hold may occur at any time during the life of an IND and may affect one or more
specific studies or all studies conducted under the IND.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the FDA or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research
subjects are being exposed to an unacceptable health risk. Similarly, an Institutional Review Board (&#8220;IRB&#8221;) can suspend or
terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#8217;s
requirements or if the drug candidate has been associated with unexpected serious harm to patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Clinical
Trials </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators
in accordance with GCP requirements, which include the requirement that all research subjects provide their informed consent in writing
for their participation in any clinical trial along with the requirement to ensure that the data and results reported from the clinical
trials are credible and accurate. Clinical trials are conducted under protocols detailing, among other things, the objectives of the
trial, the criteria for determining subject eligibility, the dosing plan, the parameters to be used in monitoring safety, the procedure
for timely reporting of adverse events, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent
protocol amendments must be submitted to the FDA as part of the IND. In addition, an IRB at each institution participating in the clinical
trial must review and approve the plan for any clinical trial before it commences at that institution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about certain clinical trials and clinical trial results must be submitted within specific timeframes to the National Institutes of Health
for public dissemination on the Clinicaltrials.gov registry. Failure to timely register a covered clinical study or to submit study results
as provided for in the law can give rise to civil monetary penalties and also prevent the non-compliant party from receiving future grant
funds from the federal government. The government has recently begun enforcing these registration and results reporting requirements
against non-compliant clinical trial sponsors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human
clinical trials are typically conducted in at least three sequential phases and occasionally four or more, which may require repetition,
or overlap or be combined:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Phase
I</i></b>: The drug candidate is initially introduced into healthy human subjects or patients with the target disease or condition and
tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of
its effectiveness. During Phase I clinical trials, sufficient information about the investigational drug&#8217;s pharmacokinetics and
pharmacological effects may be obtained to permit the design of well-controlled and scientifically valid Phase II clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Phase
II</i></b>: The drug candidate is administered to a larger, but still limited patient population to identify possible adverse effects
and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted indications and to determine dosage tolerance
and optimal dosage. Phase II clinical trials are typically well-controlled and closely monitored.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Phase
III</i></b>: The drug candidate is administered to an expanded patient population, generally at geographically dispersed clinical trial
sites, in well-controlled clinical trials to generate enough data to statistically evaluate the efficacy and safety of the product for
approval, to establish the overall risk-benefit profile of the product, and to provide adequate information for the labeling of the product.
Phase 3III clinical trials usually involve a larger number of participants than a Phase II clinical trial.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no guarantee that a product candidate will successfully complete any such clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interactions
with FDA During the Clinical Development Program</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the clearance of an IND and the commencement of clinical trials, the sponsor of such trial will continue to have interactions with the
FDA. Progress reports detailing the results of clinical trials must be submitted at least annually to the FDA and more frequently if
serious adverse events occur. In addition, IND safety reports must be submitted to the FDA for any of the following: serious and unexpected
suspected adverse reactions; findings from other studies or animal or in vitro testing that suggest a significant risk in humans exposed
to the product; and any clinically important increase in the occurrence of a serious suspected adverse reaction over that listed in the
protocol or investigator brochure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
addition, sponsors are given opportunities to meet with the FDA at certain points in the clinical development program. Specifically,
sponsors may meet with the FDA prior to the submission of an IND (&#8220;pre-IND meeting&#8221;), at the end of Phase II clinical trial
(&#8220;EOP2&#8221; meeting) and before an NDA is submitted (&#8220;pre-NDA meeting&#8221;). Meetings at other times may also be requested.
These meetings provide an opportunity for the sponsor to share information about the data gathered to date with the FDA and for the FDA
to provide advice on the next phase of development. For example, at an EOP2, a sponsor may discuss its Phase II clinical results and
present its plans for the pivotal Phase III clinical trial(s) that it believes will support the approval of the new product. Such meetings
may be conducted in person, via teleconference/videoconference or written response only with minutes reflecting the questions that the
sponsor posed to the FDA and the agency&#8217;s responses. The FDA has indicated that its responses, as conveyed in meeting minutes and
advice letters, only constitute recommendations and/or advice made to a sponsor and, as such, sponsors are not bound by such recommendations
and/or advice. Nonetheless, from a practical perspective, a sponsor&#8217;s failure to follow the FDA&#8217;s recommendations for design
of a clinical program may put the program at significant risk of failure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Acceptance
of NDAs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
successful completion of the required clinical testing, the results of the preclinical studies and clinical trials, along with information
relating to the product&#8217;s chemistry, manufacturing, controls, safety updates, patent information, abuse information and proposed
labeling, are submitted to the FDA as part of an application requesting approval to market the product candidate for one or more indications.
Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#8217;s use or from a number
of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient
in quality and quantity to establish the safety and efficacy of a drug product. The fee required for the submission and review of an
application under the Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) is substantial, and the sponsor of an approved application
is also subject to an annual program fee assessed based on eligible prescription drug products. These fees are typically adjusted annually,
and exemptions and waivers may be available under certain circumstances, such as where a waiver is necessary to protect the public health,
where the fee would present a significant barrier to innovation, or where the applicant is a small business submitting its first human
therapeutic application for review.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA conducts a preliminary review of all applications within 60 days of receipt and must inform the sponsor at that time or before whether
an application is sufficiently complete to permit substantive review. In pertinent part, the FDA&#8217;s regulations state that an application
&#8220;shall not be considered as filed until all pertinent information and data have been received&#8221; by the FDA. In the event that
the FDA determines that an application does not satisfy this standard, it will issue a Refuse to File (&#8220;RTF&#8221;) determination
to the applicant. Typically, an RTF will be based on administrative incompleteness, such as clear omission of information or sections
of required information; scientific incompleteness, such as omission of critical data, information or analyses needed to evaluate safety
and efficacy or provide adequate directions for use; or inadequate content, presentation, or organization of information such that substantive
and meaningful review is precluded. The FDA may request additional information rather than accept an application for filing. In this
event, the application must be resubmitted with the additional information. The resubmitted application is also subject to review before
the FDA accepts it for filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Review
of NDAs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the submission is accepted for filing, the FDA begins an in-depth substantive review of the application. The FDA reviews the application
to determine, among other things, whether the proposed product is safe and effective for its intended use, whether it has an acceptable
purity profile and whether the product is being manufactured in accordance with cGMP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the goals and policies agreed to by the FDA under PDUFA, the FDA has ten months from the filing date in which to complete its initial
review of a standard application that is a new molecular entity, and six months from the filing date for an application with &#8220;priority
review.&#8221; The review process may be extended by the FDA for three additional months to consider new information or in the case of
a clarification provided by the applicant to address an outstanding deficiency identified by the FDA following the original submission.
Despite these review goals, the NDA review process can be very lengthy, and it is not uncommon for FDA review of an application to extend
beyond the PDUFA target action date. Most innovative drug products (other than biological products) obtain FDA marketing approval pursuant
to an NDA submitted under Section 505(b)(1) of the FDCA, commonly referred to as a traditional or &#8220;full NDA.&#8221; In 1984, with
passage of the Drug Price Competition and Patent Term Restoration Act, informally known as the Hatch-Waxman Act, that established an
abbreviated regulatory scheme authorizing the FDA to approve generic drugs based on an innovator or &#8220;reference&#8221; product,
Congress also enacted Section 505(b)(2) of the FDCA, which provides a hybrid pathway combining features of a traditional NDA and a generic
drug application. Section 505(b)(2) enables the applicant to rely, in part, on the FDA&#8217;s prior findings of safety and efficacy
data for an existing product, or published literature, in support of its application. Section 505(b)(2) NDAs may provide an alternate
path to FDA approval for new or improved formulations or new uses of previously approved products that would require new clinical data
to demonstrate safety or effectiveness. Section 505(b)(2) permits the filing of an NDA in which the applicant relies, at least in part,
on information from studies made to show whether a drug is safe or effective that were not conducted by or for the applicant and for
which the applicant has not obtained a right of reference or use. A Section 505(b)(2) applicant may eliminate or reduce the need to conduct
certain preclinical or clinical studies, if it can establish that reliance on studies conducted for a previously approved product is
scientifically appropriate. The FDA may also require companies to perform additional studies or measurements, including nonclinical and
clinical studies, to support the change from the approved product. The FDA may then approve the new product candidate for all or some
of the labeled indications for which the referenced product has been approved, as well as for any new indication for which the Section
505(b)(2) NDA applicant has submitted data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with its review of an application, the FDA will typically submit information requests to the applicant and set deadlines for
responses thereto. The FDA will also conduct a pre-approval inspection of the manufacturing facilities for the new product to determine
whether the manufacturing processes and facilities comply with cGMPs. The FDA will not approve the product unless it determines that
the manufacturing processes and facilities are in compliance with cGMP requirements and are adequate to assure consistent production
of the product within required specifications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA also may inspect the sponsor and one or more clinical trial sites to assure compliance with IND and GCP requirements and the integrity
of the clinical data submitted to the FDA. To ensure cGMP and GCP compliance by its employees and third-party contractors, an applicant
may incur significant expenditure of time, money and effort in the areas of training, record keeping, production and quality control.
The FDA generally accepts data from foreign clinical trials in support of an NDA if the trials were conducted under an IND. If a foreign
clinical trial is not conducted under an IND, the FDA nevertheless may accept the data in support of an NDA if the study was conducted
in accordance with GCPs and the FDA is able to validate the data through an on-site inspection, if deemed necessary. Although the FDA
generally requests that marketing applications be supported by some data from domestic clinical trials, the FDA may accept foreign data
as the sole basis for marketing approval if (1) the foreign data are applicable to the United States population and United States medical
practice, (2) the studies were performed by clinical investigators with recognized competence, and (3) the data may be considered valid
without the need for an on-site inspection or, if the FDA considers the inspection to be necessary, the FDA is able to validate the data
through an on-site inspection or other appropriate means.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA may also refer an application, including applications for novel product candidates which present difficult questions of safety or
efficacy, to an advisory committee for review, evaluation and recommendation as to whether the application should be approved and under
what conditions. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts,
that reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The
FDA is not bound by the recommendation of an advisory committee, but it considers such recommendations when making final decisions on
approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
from clinical trials are not always conclusive, and the FDA or its advisory committee may interpret data differently than the sponsor
interprets the same data. The FDA may also re-analyze the clinical trial data, which could result in extensive discussions between the
FDA and the applicant during the review process or delay, limit or prevent regulatory approval. The FDA may not grant approval on a timely
basis or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA also may require submission of a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) if it determines that a REMS is necessary
to ensure that the benefits of the drug product outweigh its risks and to assure the safe use of the product. The REMS could include
medication guides, physician communication plans, assessment plans and/or elements to assure safe use, such as restricted distribution
methods, patient registries or other risk minimization tools. The FDA determines the requirement for a REMS, as well as the specific
REMS provisions, on a case-by-case basis. If the FDA concludes a REMS is needed, the sponsor of the application must submit a proposed
REMS and the FDA will not approve the application without a REMS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Decisions
on NDAs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA reviews an applicant to determine, among other things, whether the product is safe and whether it is effective for its intended use(s),
with the latter determination being made on the basis of substantial evidence. The term &#8220;substantial evidence&#8221; is defined
under the FDCA as &#8220;evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts
qualified by scientific training and experience to evaluate the effectiveness of the product involved, on the basis of which it could
fairly and responsibly be concluded by such experts that the product will have the effect it purports or is represented to have under
the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has interpreted this evidentiary standard to require at least two adequate and well-controlled clinical investigations to establish
effectiveness of a new product. Under certain circumstances, however, the FDA has indicated that a single trial with certain characteristics
and additional information may satisfy this standard. This approach was subsequently endorsed by Congress in 1998 with legislation providing,
in pertinent part, that &#8220;If [the FDA] determines, based on relevant science, that data from one adequate and well-controlled clinical
investigation and confirmatory evidence (obtained prior to or after such investigation) are sufficient to establish effectiveness, the
FDA may consider such data and evidence to constitute substantial evidence.&#8221; This modification to the law recognized the potential
for the FDA to find that one adequate and well controlled clinical investigation with confirmatory evidence, including supportive data
outside of a controlled trial, is sufficient to establish effectiveness. In December 2019, the FDA issued draft guidance further explaining
the studies that are needed to establish substantial evidence of effectiveness. It has not yet finalized that guidance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
evaluating the application and all related information, including the advisory committee recommendations, if any, and inspection reports
of manufacturing facilities and clinical trial sites, the FDA will issue either a Complete Response Letter (&#8220;CRL&#8221;) or an
approval letter. To reach this determination, the FDA must determine that the drug is effective and that its expected benefits outweigh
its potential risks to patients. This &#8220;benefit-risk&#8221; assessment is informed by the extensive body of evidence about the product&#8217;s
safety and efficacy in the NDA. This assessment is also informed by other factors, including: the severity of the underlying condition
and how well patients&#8217; medical needs are addressed by currently available therapies; uncertainty about how the premarket clinical
trial evidence will extrapolate to real-world use of the product in the post-market setting; and whether risk management tools are necessary
to manage specific risks. In connection with this assessment, the FDA review team will assemble all individual reviews and other documents
into an &#8220;action package,&#8221; which becomes the record for FDA review. The review team then issues a recommendation, and a senior
FDA official makes a decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
CRL indicates that the review cycle of the application is complete, and the application will not be approved in its present form. A CRL
generally outlines the deficiencies in the submission and may require substantial additional testing or information in order for the
FDA to reconsider the application. The CRL may require additional clinical or other data, additional pivotal Phase III clinical trial(s)
and/or other significant and time- consuming requirements related to clinical trials, preclinical studies or manufacturing. If a CRL
is issued, the applicant will have one year to respond to the deficiencies identified by the FDA, at which time the FDA can deem the
application withdrawn or, in its discretion, grant the applicant an additional six-month extension to respond. The FDA has committed
to reviewing resubmissions in response to an issued CRL in either two or six months depending on the type of information included. Even
with the submission of this additional information, however, the FDA ultimately may decide that the application does not satisfy the
regulatory criteria for approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
approval letter, on the other hand, authorizes commercial marketing of the product with specific prescribing information for specific
indications. That is, the approval will be limited to the conditions of use (<i>e.g.</i>, patient population, indication) described in
the FDA-approved labeling. Further, depending on the specific risk(s) to be addressed, the FDA may require that contraindications, warnings
or precautions be included in the product labeling, require that post-approval trials, including Phase 4 clinical trials, be conducted
to further assess a product&#8217;s safety after approval, require testing and surveillance programs to monitor the product after commercialization
or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS which can materially
affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the
results of post-marketing trials or surveillance programs. After approval, some types of changes to the approved product, such as adding
new indications, manufacturing changes and additional labeling claims, are subject to further testing requirements and FDA review and
approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Special
FDA Expedited Review Programs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA is authorized to designate certain products for expedited development or review if they are intended to address an unmet medical
need in the treatment of a serious or life-threatening disease or condition. These programs include fast track designation, breakthrough
therapy designation, and priority review designation. The purpose of these programs is to provide important new drugs to patients earlier
than under standard FDA review procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
be eligible for a fast-track designation, the FDA must determine, based on the request of a sponsor, that a product is intended to treat
a serious or life-threatening disease or condition and demonstrates the potential to address an unmet medical need. The FDA will determine
that a product will fill an unmet medical need if it will provide a therapy where none exists or provide a therapy that may be potentially
superior to existing therapy based on efficacy or safety factors. Fast track designation provides additional opportunities for interaction
with the FDA&#8217;s review team and may allow for a rolling review of NDA components before the completed application is submitted,
if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA and determines
that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA. In addition,
fast track designation may be withdrawn by the sponsor or rescinded by the FDA if the designation is no longer supported by data emerging
in the clinical trial process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, with the enactment of the FDA Safety and Innovation Act (&#8220;FDASIA&#8221;) in 2012, Congress created a new regulatory program
for therapeutic candidates designated by FDA as &#8220;breakthrough therapies&#8221; upon a request made by the IND sponsors. A breakthrough
therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening
disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing
therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.
The FDA must take certain actions with respect to breakthrough therapies, such as holding timely meetings with and providing advice to
the product sponsor, intended to expedite the development and review of an application for approval of a breakthrough therapy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
the FDA may designate a product for priority review if it is a drug that treats a serious condition and, if approved, would provide a
significant improvement in safety or effectiveness. The FDA determines at the time that the marketing application is submitted, on a
case-by-case basis, whether the proposed drug represents a significant improvement in treatment, prevention or diagnosis of disease when
compared with other available therapies. Significant improvement may be illustrated by evidence of increased effectiveness in the treatment
of a condition, elimination or substantial reduction of a treatment-limiting drug reaction, documented enhancement of patient compliance
that may lead to improvement in serious outcomes, or evidence of safety and effectiveness in a new subpopulation. A priority review designation
is intended to direct overall attention and resources to the evaluation of such applications, and to shorten the FDA&#8217;s goal for
taking action on a marketing application from ten months to six months for an NDA for a new molecular entity from the date of filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 153; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for
qualification or decide that the time period for FDA review or approval will not be shortened. Furthermore, fast track designation, breakthrough
therapy designation and priority review do not change the standards for approval and may not ultimately expedite the development or approval
process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accelerated
Approval Pathway</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, a product studied for its safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful
therapeutic benefit over existing treatments may receive accelerated approval, meaning that it may be approved on (i) the basis of adequate
and well-controlled clinical trials establishing that the drug product has an effect on a surrogate endpoint that is reasonably likely
to predict clinical benefit, or (ii) on an intermediate clinical endpoint that can be measured earlier than irreversible morbidity or
mortality (&#8220;IMM&#8221;) and that is reasonably likely to predict an effect on IMM or other clinical benefits, taking into account
the severity, rarity or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval,
the FDA may require a sponsor of a drug receiving accelerated approval to perform post-marketing studies to verify and describe the predicted
effect on IMM or other clinical endpoints, and the drug may be subject to expedited withdrawal procedures. Drugs granted accelerated
approval must meet the same statutory standards for safety and effectiveness as those granted traditional approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accelerated approval pathway is usually contingent on a sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval
confirmatory studies to verify and describe the drug&#8217;s clinical benefit. As a result, a therapeutic candidate approved on this
basis is subject to rigorous post-marketing compliance requirements, including the completion of Phase 4 or post-approval clinical trials
to confirm the effect on the clinical endpoint. Failure to conduct required post-approval studies, or to confirm the predicted clinical
benefit of the product during post-marketing studies, would allow the FDA to withdraw approval of the drug. All promotional materials
for drug products being considered and approved under the accelerated approval program are subject to prior review by the FDA. Lawmakers,
FDA officials, and other stakeholders have recently been evaluating the accelerated approval program and have proposed potential reforms
to improve certain aspects. Scrutiny of the accelerated approval pathway is likely to continue and may lead to legislative and/or administrative
changes in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Post-Approval
Requirements </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drugs
manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among
other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion
and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications
or other labeling claims, are subject to prior FDA review and approval. Certain modifications to the product, including changes in indications
or manufacturing processes or facilities, may require the applicant to develop additional data or conduct additional preclinical studies
and clinical trials to support the submission to FDA. As previously noted, there also are continuing, annual user fee requirements for
any marketed products, as well as new application fees for supplemental applications with clinical data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing
testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#8217;s safety and effectiveness
after commercialization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, FDA regulations require that products be manufactured in specific approved facilities and in accordance with cGMPs. The cGMP
regulations include requirements relating to the organization of personnel, buildings and facilities, equipment, control of components
and drug product containers and closures, production and process controls, packaging and labeling controls, holding and distribution,
laboratory controls, records and reports and returned or salvaged products. Drug manufacturers and other entities involved in the manufacture
and distribution of approved drugs are required to register their establishments with the FDA and some state agencies and are subject
to periodic unannounced inspections by the FDA for compliance with cGMP requirements and other laws. Changes to the manufacturing process
are strictly regulated and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA
regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements
upon the sponsor and any third-party manufacturers. Accordingly, manufacturers must continue to expend time, money, and effort in production
and quality control to maintain compliance with cGMP and other aspects of quality control and quality assurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA strictly regulates the marketing, labeling, advertising and promotion of drug products that are placed on the market. A product cannot
be commercially promoted before it is approved, and approved drugs may generally be promoted only for their approved indications and
for use in patient populations described in the product&#8217;s approved labeling. Promotional claims must also be consistent with the
product&#8217;s FDA-approved label, including claims related to safety and effectiveness. The government closely scrutinizes the promotion
of prescription drugs in specific contexts such as direct-to-consumer advertising, industry-sponsored scientific and educational activities,
and promotional activities involving the Internet and social media. Although physicians may prescribe legally available products for
off-label uses, manufacturers may not market or promote such uses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 154; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Later
discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing
processes, or failure to comply with regulatory requirements, may result in mandatory revisions to the approved labeling to add new safety
information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other
restrictions under a REMS program. Other potential consequences of regulatory non-compliance include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on, or suspensions of, the marketing or manufacturing of the product, complete withdrawal of the product from the market or product
    recalls; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
    of production processes, including the shutdown of manufacturing facilities or production lines or the imposition of new manufacturing
    requirements; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines,
    warning letters or other enforcement letters or clinical holds on post-approval clinical trials;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">mandated
    modification of promotional materials and labeling and the issuance of corrective information; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product approvals; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizure or detention, or refusal to permit the import or export of products; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions
    or the imposition of civil or criminal penalties; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consent
    decrees, corporate integrity agreements, debarment, or exclusion from federal healthcare programs. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the distribution of prescription pharmaceutical products is subject to the Prescription Drug Marketing Act (&#8220;PDMA&#8221;)
which regulates the distribution of drugs and drug samples at the federal level and sets minimum standards for the registration and regulation
of drug distributors by the states. Both the PDMA and state laws limit the distribution of prescription pharmaceutical product samples
and impose requirements to ensure accountability in distribution. More recently, the Drug Supply Chain Security Act (the &#8220;DSCSA&#8221;),
was enacted with the aim of building an electronic system to identify and trace certain prescription drugs distributed in the United
States. The DSCSA mandates phased-in and resource-intensive obligations for pharmaceutical manufacturers, wholesale distributors, and
dispensers over a 10-year period that is expected to culminate in November 2023. From time to time, new legislation and regulations may
be implemented that could significantly change the statutory provisions governing the approval, manufacturing and marketing of products
regulated by the FDA. For example, FDA released proposed regulations in February 2022 to amend the national standards for licensing of
wholesale drug distributors by the states; establish new minimum standards for state licensing third-party logistics providers; and create
a federal system for licensure for use in the absence of a state program, each of which is mandated by the DSCSA. It is impossible to
predict whether further legislative or regulatory changes will be enacted, or FDA regulations, guidance or interpretations will be
changed or what the impact of such potential changes, if any, may be.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regulatory
Exclusivity and Approval of Follow-on Products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hatch-Waxman
Exclusivity </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to enacting Section 505(b)(2) of the FDCA as part of the Hatch-Waxman Amendments to the FDCA, Congress also established an abbreviated
regulatory scheme authorizing the FDA to approve generic drugs that are shown to contain the same active ingredients as, and to be bioequivalent
to, drugs previously approved by the FDA pursuant to NDAs. To obtain approval of a generic drug, an applicant must submit an abbreviated
new drug application (&#8220;ANDA&#8221;) to the agency. An ANDA is a comprehensive submission that contains, among other things, data
and information pertaining to the active pharmaceutical ingredient, bioequivalence, drug product formulation, specifications and stability
of the generic drug, as well as analytical methods, manufacturing process validation data and quality control procedures. ANDAs are &#8220;abbreviated&#8221;
because they cannot include preclinical and clinical data to demonstrate safety and effectiveness. Instead, in support of such applications,
a generic manufacturer must rely on the preclinical and clinical testing previously conducted for a drug product previously approved
under an NDA, known as the reference listed drug (&#8220;RLD&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order for an ANDA to be approved, the FDA must find that the generic version is identical to the RLD with respect to the active ingredients,
the route of administration, the dosage form, the strength of the drug and the conditions of use of the drug. At the same time, the FDA
must also determine that the generic drug is &#8220;bioequivalent&#8221; to the innovator drug. Under the statute, a generic drug is
bioequivalent to an RLD if &#8220;the rate and extent of absorption of the drug do not show a significant difference from the rate and
extent of absorption of the listed drug.&#8221; Unlike the 505(b)(2) NDA pathway that permits a follow-on applicant to conduct and submit
data from additional clinical trials or nonclinical studies in order to support the proposed change(s) to the reference product, the
ANDA regulatory pathway does not allow applicants to submit new clinical data other than bioavailability or bioequivalence data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 155; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
approval of an ANDA, the FDA indicates whether the generic product is &#8220;therapeutically equivalent&#8221; to the RLD in its publication
&#8220;Approved Drug Products with Therapeutic Equivalence Evaluations,&#8221; also referred to as the &#8220;Orange Book.&#8221; Physicians
and pharmacists consider a therapeutic equivalent generic drug to be fully substitutable for the RLD. In addition, by operation of certain
state laws and numerous health insurance programs, the FDA&#8217;s designation of therapeutic equivalence often results in substitution
of the generic drug without the knowledge or consent of either the prescribing physician or patient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the NDA review and approval process, applicants are required to list with the FDA each patent that has claims that cover the
applicant&#8217;s product or method of therapeutic use. Upon approval of a new drug, each of the patents listed in the application for
the drug is then published in the Orange Book. Drugs listed in the Orange Book can, in turn, be cited by potential follow-on competitors
in support of approval of an ANDA or 505(b)(2) NDA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
an ANDA applicant submits its application to the FDA, it is required to certify to the FDA concerning any patents listed for the reference
product in the FDA&#8217;s Orange Book. Specifically, the applicant must certify that: (i) the required patent information has not been
filed; (ii) the listed patent has expired; (iii) the listed patent has not expired but will expire on a particular date and approval
is sought after patent expiration; or (iv) the listed patent is invalid or will not be infringed by the new product. Moreover, to the
extent that the Section 505(b)(2) NDA applicant is relying on studies conducted for an already approved product, the applicant also is
required to certify to the FDA concerning any patents listed for the NDA-approved product in the Orange Book to the same extent that
an ANDA applicant would.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the follow-on applicant does not challenge the innovator&#8217;s listed patents, the FDA will not approve the ANDA or 505(b)(2) application
until all the listed patents claiming the referenced product have expired. A certification that the new product will not infringe the
already approved product&#8217;s listed patents, or that such patents are invalid, is called a Paragraph IV certification. If the follow-on
applicant has provided a Paragraph IV certification to the FDA, the applicant must also send notice of the Paragraph IV certification
to the NDA and patent holders once the ANDA has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent
infringement lawsuit in response to the notice of the Paragraph IV certification. The filing of a patent infringement lawsuit within
45 days of the receipt of a Paragraph IV certification automatically prevents the FDA from approving the ANDA or 505(b)(2) NDA until
the earlier of 30 months, expiration of the patent, settlement of the lawsuit, or a decision in the infringement case that is favorable
to the ANDA or 505(b)(2) applicant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
ANDA or 505(b)(2) application also will not be approved until any applicable non-patent exclusivities listed in the Orange Book for the
referenced product have expired. The Hatch-Waxman Amendments to the FDCA provided a five-year period of non-patent data exclusivity within
the United States to the first applicant to gain approval of an NDA for a new chemical entity (&#8220;NCE&#8221;). For the purposes of
this provision, an NCE is a drug that contains no active moiety that has previously been approved by the FDA in any other NDA. An active
moiety is the molecule or ion responsible for the physiological or pharmacological action of the drug substance. In cases where such
NCE exclusivity has been granted, an ANDA or 505(b)(2) NDA may not be filed with the FDA until the expiration of five years unless the
submission is accompanied by a Paragraph IV certification, in which case the applicant may submit its application four years following
the original product approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDCA also provides for a period of three years of data exclusivity if an NDA or NDA supplement includes reports of one or more new clinical
investigations, other than bioavailability or bioequivalence studies, that were conducted or sponsored by the applicant are deemed by
the FDA to be essential to the approval of the application. This three-year exclusivity period often protects changes to a previously
approved drug product, such as new indications, dosage forms, route of administration or combination of ingredients. Three-year exclusivity
would be available for a drug product that contains a previously approved active moiety, provided the statutory requirement for a new
clinical investigation is satisfied. Unlike five-year NCE exclusivity, an award of three-year exclusivity does not block the FDA from
accepting ANDAs or 505(b)(2) NDAs seeking approval for generic versions of the drug as of the date of approval of the original drug product;
rather, this three-year exclusivity covers only the conditions of use associated with the new clinical investigations and, as a general
matter, does not prohibit the FDA from approving follow-on applications for drugs containing the original active ingredient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Five-year
and three-year exclusivity also will not delay the submission or approval of a traditional NDA filed under Section 505(b)(1) of the FDCA;
however, an applicant submitting a traditional NDA would be required to conduct or obtain a right of reference to all of the preclinical
studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Orphan
Drug Designation and Exclusivity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Orphan Drug Act, the FDA may grant orphan drug designation to a drug intended to treat a rare disease or condition, which is generally
a disease or condition that affects either (i) fewer than 200,000 individuals in the United States, or (ii) more than 200,000 individuals
in the United States and for which there is no reasonable expectation that the cost of developing and making available in the United
States a drug for this type of disease or condition will be recovered from sales in the United States for that drug. Legislative proposals
are currently being considered that would revise or revoke the second option available for a drug candidate to receive an orphan designation,
the so-called &#8220;cost recovery&#8221; pathway. Orphan drug designation must be requested before submitting an NDA. After the FDA
grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use will be disclosed publicly by the
FDA; the posting will also indicate whether a drug is no longer designated as an orphan drug.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 156; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">More
than one product candidate may receive an orphan drug designation for the same indication, and the same product candidate can be designated
for more than one qualified orphan indication. The benefits of orphan drug designation include research and development tax credits and
exemption from FDA prescription drug user fees. Orphan drug designation does not convey any advantage in or shorten the duration of the
regulatory review and approval process if or when an NDA for the drug candidate is filed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a product that has orphan drug designation subsequently receives the first FDA approval for the indication for which it has such designation,
the product is entitled to orphan product exclusivity, which means that for seven years, the FDA may not approve any other marketing
applications for the same drug for the same indication, except under limited circumstances described further below. Orphan exclusivity
does not block the approval of a different drug for the same rare disease or condition, nor does it block the approval of the same drug
for different conditions. As a result, the FDA can still approve different drugs for use in treating the same indication or disease.
Additionally, if a drug designated as an orphan product receives marketing approval for an indication broader than what was designated,
it may not be entitled to orphan drug exclusivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orphan
exclusivity will not bar approval of another product with the same drug for the same condition under certain circumstances, including
if a subsequent product with the same drug for the same condition is shown to be clinically superior to the approved product on the basis
of greater efficacy or safety or a major contribution to patient care, or if the company with orphan drug exclusivity cannot assure the
availability of sufficient quantities of the drug to meet the needs of persons with the disease or condition for which the drug was designated.
The FDA is now required to publish a summary of the clinical superiority findings when a drug is eligible for orphan product exclusivity
on the basis of a demonstration of clinical superiority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Patent
Term Extension</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
patent claiming a prescription drug for which FDA approval is granted may be eligible for a limited patent term extension under the FDCA,
which permits a patent restoration of up to five years for patent term lost during product development and the FDA regulatory review
provided that certain statutory and regulatory requirements are met. The length of the patent term extension is related to the length
of time the drug is under regulatory review while the patent is in force. The restoration period granted on a patent covering a new FDA-regulated
medical product is typically one-half the time between the date a clinical investigation on human beings is begun and the submission
date of an application for premarket approval of the product, plus the time between the submission date of an application for approval
of the product and the ultimate approval date. Patent term restoration cannot be used to extend the remaining term of a patent past a
total of 14 years from the product&#8217;s approval date. Only one patent applicable to an approved drug product is eligible for the
extension, and the application for the extension must be submitted prior to the expiration of the patent in question. A patent that covers
multiple products for which approval is sought can only be extended in connection with one of the marketing approvals. The USPTO reviews
and approves the application for any patent term extension or restoration in consultation with the FDA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
U.S. Healthcare Laws and Regulations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing,
sales, promotion and other activities following product approval may also be subject to regulation by other regulatory authorities in
the United States in addition to the FDA. Depending on the nature of the product, those authorities may include the Centers for Medicare
and Medicaid Services (&#8220;CMS&#8221;), other divisions of the Department of Health and Human Services (&#8220;HHS&#8221;), the Department
of Justice, the Drug Enforcement Administration, the Federal Trade Commission, the Occupational Safety and Health Administration, and
state and local governments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, in the United States, sales and marketing for prescription biopharmaceutical products must comply with state and federal fraud
and abuse laws. These laws include the federal Anti-Kickback Statute, which makes it illegal for any person, including a prescription
drug manufacturer (or a party acting on its behalf), to knowingly and willfully solicit, receive, offer or pay any remuneration that
is intended to induce or reward referrals, including the purchase, recommendation, order or prescription of a particular drug, for which
payment may be made under a federal healthcare program, such as Medicare or Medicaid. Violations of this law are punishable by up to
ten years in prison, criminal fines, administrative civil money penalties and exclusion from participation in federal healthcare programs.
In addition, the Patient Protection and Affordable Care Act, or ACA, among other things, amended the intent requirement of the federal
Anti-Kickback Statute and two of the five criminal healthcare fraud statutes created by the Health Insurance Portability and Accountability
Act of 1996, or HIPAA. A person or entity no longer needs to have actual knowledge of these two provisions in the statute or specific
intent to violate them; specifically with respect to the prohibition on executing or attempting to execute a scheme or artifice to defraud
or to fraudulently obtain money or property of any healthcare benefit program and the prohibition on disposing of assets to enable a
person to become eligible for Medicaid. Moreover, the government may now assert that a claim including items or services resulting from
a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 157; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing
and rebate programs must comply with the Medicaid rebate requirements of the U.S. Omnibus Budget Reconciliation Act of 1990 and more
recent requirements in the ACA. If products are made available to authorized users of the Federal Supply Schedule of the General Services
Administration, additional laws and requirements apply. There also are federal transparency requirements under the Physician Payments
Sunshine Act that require manufacturers of FDA-approved drugs, devices, biologics and medical supplies covered by Medicare or Medicaid
to report, on an annual basis, to CMS information related to payments and other transfers of value to physicians, teaching hospitals,
and certain advanced non-physician healthcare practitioners and physician ownership and investment interests. Prescription drug products
also must meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing,
sales, promotion and other activities also are potentially subject to federal and state consumer protection and unfair competition laws.
Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines,
or the relevant compliance guidance promulgated by the federal government, in addition to requiring drug manufacturers to report information
related to payments to physicians and other healthcare providers or marketing expenditures to the extent that those laws impose requirements
that are more stringent than the Physician Payments Sunshine Act. State and foreign laws also govern the privacy and security of health
information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus
complicating compliance efforts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
failure to comply with any of these laws or regulatory requirements subjects firms to possible legal or regulatory action. Depending
on the circumstances, failure to meet applicable regulatory requirements can result in criminal prosecution, fines or other penalties,
injunctions, requests for recall, seizure of products, total or partial suspension of production, denial or withdrawal of product approvals
or refusal to allow a firm to enter into supply contracts, including government contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Government
Regulation Outside the U.S. </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to regulations in the United States, we will be subject to a variety of foreign regulations that govern, among other things,
clinical trials and any commercial sales and distribution of our products, if approved, either directly or through distribution partners.
Whether or not we obtain FDA approval for a product candidate, we must obtain the requisite approvals from regulatory authorities in
foreign countries or economic areas, such as the European Union and the United Kingdom, among other foreign countries, before we may
commence clinical trials or market products in those countries or areas. The foreign regulatory approval process includes all of the
risks associated with the FDA approval described above, and the time required to obtain approval in other countries and jurisdictions
might differ from and be longer than that required to obtain FDA approval. Some foreign jurisdictions have a drug product approval process
similar to that in the U.S., which requires the submission of a clinical trial application much like the IND prior to the commencement
of clinical studies. In Europe, for example, a clinical trial application, or CTA, must be submitted to each country&#8217;s national
health authority and an independent ethics committee, much like the FDA and IRB, respectively. Once the CTA is approved in accordance
with a country&#8217;s requirements, clinical trial development may proceed. To obtain regulatory approval of a medicinal product candidate
under European Union regulatory systems, we would be required to submit a Marketing Authorisation Application, or MAA, which is similar
to the NDA, except that, among other things, there are country-specific document requirements. For countries outside of the European
Union, such as countries in Eastern Europe, Latin America or Asia, and recently the United Kingdom, the requirements governing the conduct
of clinical trials, product approval, pricing and reimbursement vary from country to country. Regulatory approval in one country or jurisdiction
does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction
may negatively impact the regulatory process in others. Moreover, some nations may not accept clinical studies performed for U.S. approval
to support approval in their countries or require that additional studies be performed on natives of their countries. In addition, in
certain foreign markets, the pricing of drug products is subject to government control and reimbursement may in some cases be unavailable
or insufficient. If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines,
suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions, and criminal prosecution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of January 31, 2020, the United Kingdom is no longer a member state of the European Union, and therefore a separate marketing authorization
application and approval will be required to market a medicinal product in the U.K. The Medicines and Healthcare products Regulatory
Agency, or the MHRA, is the U.K.&#8217;s standalone pharmaceutical regulator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Clinical
Trials and Regulation of Medicinal Products in Europe</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
in the United States, medicinal products can be marketed in the European Union only if a marketing authorization from the competent regulatory
agencies has been obtained. Similar to the United States, the various phases of preclinical and clinical research in the European Union
are subject to significant regulatory controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 158; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the European Clinical Trials Directive, a system for the approval of clinical trials in the European Union has been implemented through
national legislation of the member states. Under this system, an applicant must obtain approval from the competent national authority
of an European Union member state in which the clinical trial is to be conducted. Furthermore, the applicant may only start a clinical
trial after a competent ethics committee has issued a favorable opinion. Clinical trial applications must be accompanied by an investigational
medicinal product dossier with supporting information prescribed by the European Clinical Trials Directive and corresponding national
laws of the member states and further detailed in applicable guidance documents. In April 2014, the new Clinical Trials Regulation, (EU)
No 536/2014 (Clinical Trials Regulation) was adopted and became effective on January 31, 2022. The Clinical Trials Regulation is directly
applicable in all the European Union Member States, repealing the prior Clinical Trials Directive 2001/20/EC. The extent to which ongoing
clinical trials will be governed by the Clinical Trials Regulation will depend on the duration of the individual clinical trial; if a
clinical trial continues for more than three years from the day on which the Clinical Trials Regulation becomes applicable the Clinical
Trials Regulation will at that time begin to apply to the clinical trial.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new Clinical Trials Regulation aims to simplify and streamline the approval of clinical trials in the European Union. The main characteristics
of the regulation include: a streamlined application procedure via a single entry point; a single set of documents to be prepared and
submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for
the assessment of applications for clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
obtain marketing approval of a drug in the European Union, an applicant must submit a MAA either under a centralized or decentralized
procedure. The centralized procedure provides for the grant of a single marketing authorization by the European Commission that is valid
for all European Union member states, Iceland, Lichtenstein and Norway. The centralized procedure is compulsory for specific products,
including for medicines produced by certain biotechnological processes, products designated as orphan medicinal products, advanced therapy
products (such as gene-therapy, somatic cell-therapy or tissue-engineered medicines) and products with a new active substance indicated
for the treatment of certain diseases. For products with a new active substance indicated for the treatment of certain diseases and products
that are highly innovative or for which a centralized process is in the interest of patients, the centralized procedure may be optional.
Under the centralized procedure the maximum timeframe for the evaluation of an MAA by the European Medicines Agency (&#8220;EMA&#8221;)
is 210 days, excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions
asked by the Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;). Accelerated assessment might be granted by the CHMP
in exceptional cases, when a medicinal product is expected to be of a major public health interest, particularly from the point of view
of therapeutic innovation. The timeframe for the evaluation of an MAA under the accelerated assessment procedure is of 150 days, excluding
stop-clocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decentralized procedure is available to applicants who wish to market a product in specific European Union member states where such product
has not received marketing approval in any European Union member states before. The decentralized procedure provides for an applicant
to apply to one-member state to assess the application (the reference member state) and specifically list other member states in which
it wishes to obtain approval (concerned member states).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the European Union, only products for which marketing authorizations have been granted may be promoted. A marketing authorization is
valid for five years in principle and the marketing authorization may be renewed after five years on the basis of a re-evaluation of
the risk-benefit balance by the EMA or by the competent authority of the authorizing member state. To this end, the marketing authorization
holder must provide the EMA or the competent authority with a consolidated version of the file in respect of quality, safety and efficacy,
including all variations introduced since the marketing authorization was granted, at least six months before the marketing authorization
ceases to be valid. Once renewed, the marketing authorization is valid for an unlimited period, unless the European Commission or the
competent authority decides, on justified grounds relating to pharmacovigilance, to proceed with one additional five-year renewal. Any
authorization which is not followed by the actual placing of the drug on the European Union market (in case of centralized procedure)
or on the market of the authorizing member state within three years after authorization ceases to be valid (the so-called sunset clause).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
even if authorized to be marketed in the European Union, prescription medicines may only be promoted to healthcare professionals, not
the general public. All promotion should be in accordance with the particulars listed in the summary of product characteristics. Promotional
materials must also comply with various laws, and codes of conduct developed by pharmaceutical industry bodies in the European Union
which govern (among other things) the training of sales staff, promotional claims and their justification, comparative advertising, misleading
advertising, endorsements, and (where permitted) advertising to the general public. Failure to comply with these requirements could lead
to the imposition of penalties by the competent authorities of the European Union member states. The penalties could include warnings,
orders to discontinue the promotion of the drug product, seizure of promotional materials, fines and possible imprisonment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regulation
of New Drugs in the United Kingdom </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United Kingdom left the European Union on January 31, 2020 (commonly referred to as &#8220;Brexit&#8221;), with a transitional period
that expired on December 31, 2020. The United Kingdom and the European Union entered into a trade agreement known as the Trade and Cooperation
Agreement, which went into effect on January 1, 2021. It remains to be seen how, if at all, Brexit and the Trade and Cooperation Agreement
will impact regulatory requirements for product candidates and products in the United Kingdom. We are currently evaluating the potential
impacts on our business of the Trade and Cooperation Agreement and guidance issued to date by the United Kingdom&#8217;s MHRA regarding
the requirements for licensing and marketing medicinal products in the United Kingdom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 159; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the regulatory framework for pharmaceutical products in the United Kingdom covering the quality, safety and efficacy of pharmaceutical
products, clinical trials, marketing authorization, commercial sales and distribution of medicinal products is derived from EU Directives
and Regulations, Brexit could materially impact the future regulatory regime which applies to such products and the approval of product
candidates in the United Kingdom. Such outcomes could make it more difficult and expensive for us to do business in Europe, complicate
our clinical, manufacturing and regulatory strategies and impair our ability to obtain and maintain regulatory approval for, and, if
approved, commercialize, our products and product candidates in Europe.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pharmaceutical
Coverage, Pricing and Reimbursement &amp; Healthcare Reform </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of our products, if approved for marketing, will depend, in part, on the availability and extent of coverage and reimbursement by third-party
payors, such as government health programs, including Medicare and Medicaid, commercial insurance and managed healthcare organizations.
These third-party payors are increasingly challenging the price and limiting the coverage and reimbursement amounts for medical products
and services. There may be significant delays in obtaining coverage and reimbursement for approved products, and coverage may be more
limited than the purposes for which the product is approved by the FDA or regulatory authorities in other countries. It is time-consuming
and expensive to seek reimbursement from third-party payors. Moreover, eligibility for reimbursement does not imply that any product
will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale and distribution.
Interim payments for new products, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Payment
rates may vary according to the use of the product and the clinical setting in which it is used, may be based on payments allowed for
lower-cost products that are already reimbursed and may be incorporated into existing payments for other services. Net prices for products
may be reduced by mandatory discounts or rebates required by third-party payors and by any future relaxation of laws that presently restrict
imports of products from countries where they may be sold at lower prices than in the United States. In the United States, third-party
payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies, but they also have
their own methods and approval process apart from Medicare coverage and reimbursement determinations. Accordingly, one third-party payor&#8217;s
determination to provide coverage for a product does not assure that other payors will also provide coverage for the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the containment of healthcare costs has become a priority for federal and state governments, and the prices of drugs have been
a focus in this effort. The U.S. government, state legislatures and foreign governments have shown significant interest in implementing
cost-containment programs, including price controls, restrictions on coverage and reimbursement, and requirements for substitution of
generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions
with existing controls and measures, could further limit our net revenue and results. Decreases in third-party reimbursement for our
product candidates or a decision by a third-party payor to not cover our product candidates could reduce physician usage of the product
candidate and have a material adverse effect on our sales, results of operations and financial condition. Moreover, there has been heightened
governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional
inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product
pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies
for drug products. Individual states in the United States have also increasingly passed legislation and implemented regulations designed
to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product
access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries
and bulk purchasing. In December 2020, the U.S. Supreme Court held unanimously that federal law does not preempt the states&#8217; ability
to regulate pharmaceutical benefit managers (&#8220;PBMs&#8221;) and other members of the healthcare and pharmaceutical supply chain,
an important decision that has led to further and more aggressive efforts by states in this area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
recently, on August 16, 2022, President Biden signed into the law the Inflation Reduction Act of 2022, or the IRA. Among other things,
the IRA has multiple provisions that may impact the prices of drug products that are both sold into the Medicare program and throughout
the United States. Starting in 2023, a manufacturer of drugs covered by Medicare Parts B or D must pay a rebate to the federal government
if their drug product&#8217;s price increases faster than the rate of inflation. This calculation is made on a drug product by drug product
basis and the amount of the rebate owed to the federal government is directly dependent on the volume of a drug product that is paid
for by Medicare Parts B or D. Additionally, starting for payment year 2026, CMS will negotiate drug prices annually for a select number
of single source Part D drugs without generic or biosimilar competition. CMS will also negotiate drug prices for a select number of Part
B drugs starting for payment year 2028. If a drug product is selected by CMS for negotiation, it is expected that the revenue generated
from such drug will decrease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in some foreign countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements
governing drug pricing vary widely from country to country. For example, in the European Union, the sole legal instrument at the European
Union level governing the pricing and reimbursement of medicinal products is Council Directive 89/105/EEC (the &#8220;Price Transparency
Directive&#8221;). The aim of the Price Transparency Directive is to ensure that pricing and reimbursement mechanisms established in
the European Union Member States are transparent and objective, do not hinder the free movement of and trade in medicinal products in
the European Union, and do not hinder, prevent or distort competition on the market. The Price Transparency Directive does not provide
any guidance concerning the specific criteria on the basis of which pricing and reimbursement decisions are to be made in the individual
European Union Member States, nor does it have any direct consequence for pricing or reimbursement levels in the individual European
Union Member States. The European Union Member States are free to restrict the range of medicinal products for which their national health
insurance systems provide reimbursement, and to control the prices and/or reimbursement levels of medicinal products for human use. A
European Union Member State may approve a specific price or level of reimbursement for the medicinal product, or alternatively adopt
a system of direct or indirect controls on the profitability of the company responsible for placing the medicinal product on the market,
including volume-based arrangements, caps and reference pricing mechanisms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 160; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
Technology Assessment (&#8220;HTA&#8221;) of medicinal products is becoming an increasingly common part of the pricing and reimbursement
procedures in some European Union Member States, including France, Germany, Ireland, Italy and Sweden. The HTA process in the European
Union Member States is governed by the national laws of these countries. HTA is the procedure according to which the assessment of the
public health impact, therapeutic impact, and the economic and societal impact of the use of a given medicinal product in the national
healthcare systems of the individual country is conducted. HTA generally focuses on the clinical efficacy and effectiveness, safety,
cost, and cost-effectiveness of individual medicinal products as well as their potential implications for the healthcare system. Those
elements of medicinal products are compared with other treatment options available on the market. The outcome of HTA regarding specific
medicinal products will often influence the pricing and reimbursement status granted to these medicinal products by the competent authorities
of individual European Union Member States. The extent to which pricing and reimbursement decisions are influenced by the HTA of the
specific medicinal product vary between the European Union Member States. For example, European Union Member States that have not yet
developed HTA mechanisms could rely to some extent on the HTA performed in countries with a developed HTA framework when adopting decisions
concerning the pricing and reimbursement of a specific medicinal product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separately
from cost containment efforts, in the United States and some foreign jurisdictions, there also have been, and continue to be, several
legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval
of product candidates or restrict or regulate post-approval activities. The FDA&#8217;s and other regulatory authorities&#8217; policies
may change, and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our current
or future product candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Data
Privacy and the Protection of Personal Information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to laws and regulations governing data privacy and the protection of personal information including health information. The
legislative and regulatory landscape for privacy and data protection continues to evolve, and there has been an increasing focus on privacy
and data protection issues which will continue to affect our business. In the United States, we may be subject to state security breach
notification laws, state laws protecting the privacy of health and personal information and federal and state consumer protections laws
that regulate the collection, use, disclosure and transmission of personal information. These laws overlap and often conflict and each
of these laws is subject to varying interpretations by courts and government agencies, creating complex compliance issues. If we fail
to comply with applicable laws and regulations we could be subject to penalties or sanctions, including criminal penalties. Our customers
and research partners must comply with laws governing the privacy and security of health information, including HIPAA and state health
information privacy laws. If we knowingly obtain health information that is protected under HIPAA, called &#8220;protected health information,&#8221;
our customers or research collaborators may be subject to enforcement, and we may have direct liability for the unlawful receipt
of protected health information or for aiding and abetting a HIPAA violation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
laws protecting health and personal information are becoming increasingly stringent. For example, California has implemented the California
Confidentiality of Medical Information Act that imposes restrictive requirements regulating the use and disclosure of health information
and other personally identifiable information, and California has recently adopted the California Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;).
The CCPA mirrors a number of the key provisions of the EU General Data Protection Regulation (&#8220;GDPR&#8221;) described below. The
CCPA establishes a new privacy framework for covered businesses by creating an expanded definition of personal information, establishing
new data privacy rights for consumers in the State of California, imposing special rules on the collection of consumer data from minors,
and creating a new and potentially severe statutory damages framework for violations of the CCPA and for businesses that fail to implement
reasonable security procedures and practices to prevent data breaches. Since passage of the CCPA, several other states (Connecticut,
Colorado, Virginia, and Utah) have also enacted comprehensive consumer privacy laws that include key differences from California&#8217;s
law, further complicating compliance by industry and other stakeholders. Other states in the U.S. are considering privacy laws similar
to the CCPA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Europe, the GDPR went into effect in May 2018, implementing a broad data protection framework that expanded the scope of European Union
data protection law, including to non- European Union entities that process, or control the processing of, personal data relating to
individuals located in the European Union, including clinical trial data. The GDPR sets out a number of requirements that must be complied
with when handling the personal data of European Union-based data subjects including: providing expanded disclosures about how their
personal data will be used; higher standards for organizations to demonstrate that they have obtained valid consent or have another legal
basis in place to justify their data processing activities; the obligation to appoint data protection officers in certain circumstances;
new rights for individuals to be &#8220;forgotten&#8221; and rights to data portability, as well as enhanced current rights (e.g. access
requests); the principal of accountability and demonstrating compliance through policies, procedures, training and audit; and a new mandatory
data breach regime. In particular, medical or health data, genetic data and biometric data where the latter is used to uniquely identify
an individual are all classified as &#8220;special category&#8221; data under the GDPR and afforded greater protection and require additional
compliance obligations. Further, European Union member states have a broad right to impose additional conditions &#8211; including restrictions
&#8211; on these data categories. This is because the GDPR allows European Union member states to derogate from the requirements of the
GDPR mainly in regard to specific processing situations (including special category data and processing for scientific or statistical
purposes). As the European Union states continue to reframe their national legislation to harmonize with the GDPR, we will need to monitor
compliance with all relevant European Union member states&#8217; laws and regulations, including where permitted derogations from the
GDPR are introduced. We will also be subject to evolving European Union laws on data export, if we transfer data outside the European
Union to ourselves or third parties outside of the European Union.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 161; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Islands Government enacted the Data Protection Act on May 18, 2017 (as amended, the &#8220;DPA&#8221;). The DPA regulates the
processing of personal data in the Cayman Islands. Under the DPA, Conduit is a &#8220;data controller&#8221; and Conduit&#8217;s affiliates
and/or its delegates may be &#8220;data processors&#8221; (or, in some circumstances, data controllers in their own right), in respect
of such personal data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>U.S.
Foreign Corrupt Practices Act and Anti-bribery Regulations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, the Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, prohibits offering to pay, paying, promising to pay, or
authorizing the payment of money or anything of value to a foreign official in order to influence any act or decision of the foreign
official in his or her official capacity or to secure any other improper advantage in order to obtain or retain business for or with,
or in order to direct business to, any person. The prohibitions apply not only to payments made to &#8220;any foreign official,&#8221;
but also those made to &#8220;any foreign political party or official thereof,&#8221; to &#8220;any candidate for foreign political office&#8221;
or to any person, while knowing that all or a portion of the payment will be offered, given, or promised to anyone in any of the foregoing
categories. &#8220;Foreign officials&#8221; under the FCPA include officers or employees of a department, agency, or instrumentality
of a foreign government. The term &#8220;instrumentality&#8221; is broad and can include state-owned or state-controlled entities. Importantly,
United States authorities deem most healthcare professionals and other employees of foreign hospitals, clinics, research facilities and
medical schools in countries with public healthcare and/or public education systems to be &#8220;foreign officials&#8221; under the FCPA.
When we interact with foreign healthcare professionals and researchers in testing and marketing our products abroad, should any of our
product candidates receive foreign regulatory approval in the future, we must have policies and procedures in place sufficient to prevent
us and agents acting on our behalf from providing any bribe, gift or gratuity, including excessive or lavish meals, travel or entertainment
in connection with marketing our products and services or securing required permits and approvals. The FCPA also obligates companies
whose securities are listed in the United States to comply with accounting provisions requiring us to maintain books and records that
accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an
adequate system of internal accounting controls for international operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to U.K. Bribery Act of 2010, which prohibits both domestic and international bribery, as well as bribery across both
private and public sectors. In addition, an organization that &#8220;fails to prevent bribery&#8221; committed by anyone associated with
the organization can be charged under the U.K. Bribery Act unless the organization can establish the defense of having implemented &#8220;adequate
procedures&#8221; to prevent bribery. As we expand our operations, we are likely to be subject to additional laws and restrictions relating
to anti-bribery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Environmental,
Health and Safety Regulation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to numerous federal, state and local environmental, health and safety (&#8220;EHS&#8221;) laws and regulations relating to,
among other matters, safe working conditions, product stewardship, environmental protection, and handling or disposition of products,
including those governing the generation, storage, handling, use, transportation, release, and disposal of hazardous or potentially hazardous
materials, medical waste, and infectious materials that may be handled by our partner research laboratories. Some of these laws and regulations
also require us to obtain licenses or permits to conduct our operations. If we fail to comply with such laws or obtain and comply with
the applicable permits, we could face substantial fines or possible revocation of our permits or limitations on our ability to conduct
our operations. Certain of our development and manufacturing activities may involve, from time to time, use of hazardous materials, and
we believe we are in compliance with the applicable environmental laws, regulations, permits, and licenses. However, we cannot ensure
that EHS liabilities will not develop in the future. EHS laws and regulations are complex, change frequently and have tended to become
more stringent over time. Although the costs to comply with applicable laws and regulations, have not been material, we cannot predict
the impact on our business of new or amended laws or regulations or any changes in the way existing and future laws and regulations are
interpreted or enforced, nor can we ensure we will be able to obtain or maintain any required licenses or permits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Properties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently operate as a virtual company and do not own or lease any real property. Instead, our employees work remotely. We anticipate
that we will need to enter into one or more leases for office space in both the United Kingdom and United States in connection with the
anticipated expansion of our staff.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently expect to have a total of 16 full or part-time employees on completion of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently rely on several consultants who provide services to our Company. None of our employees are represented by a labor union or
covered by collective bargaining agreements. We consider our relationship with our employees to be good. We anticipate that the number
of employees will increase as we continue to develop the assets in our pipeline and other product candidates that we seek to develop.
Additionally, we utilize and expect to continue to utilize clinical research organizations and third parties to perform our pre-clinical
studies, clinical studies and manufacturing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently party to or aware of being subject to any material legal proceedings. However, we may from time to time become a party
to various legal proceedings arising in the ordinary course of our business, which could have a material adverse effect on our business,
financial condition or results of operations. Regardless of outcome, litigation could impact our business due to defense and settlement
costs, diversion of management resources and other factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals Limited was incorporated under the laws of the Cayman Islands in 2019. Our registered office is currently located at
c/o Ogier Global (Cayman) Limited 89 Nexus Way, Camana Bay Grand Cayman, KY1-9009 Cayman Islands. Our website can be found at <i><span style="text-decoration: underline">https://www.conduitpharma.com</span></i>.
Following the Business Combination, our principal executive offices will be located at MURF&#8217;s current principal executive offices,
which are located at 4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 162; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="md_025"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF CONDUIT PHARMACEUTICALS LIMITED</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should read the following discussion and analysis of our financial condition and results of operations with our audited financial statements
for the years ended December 31, 2022 and December 31, 2021 together with related notes thereto, included elsewhere in this proxy statement/prospectus.
The discussion and the analysis should also be<span style="background-color: white">&#160;read together with the section of this proxy
statement/prospectus entitled &#8220;Business of Conduit Pharmaceuticals Limited&#8221;&#160;and the unaudited pro forma combined financial
information as of and for the years ended December 31, 2022 and December 31, 2021 (in the section of this proxy statement/prospectus
entitled &#8220;Summary Unaudited Pro Forma Condensed Combined Financial Information&#8221;). The following discussion contains forward-looking
statements based upon current expectations that involve risks, uncertainties and assumptions. Our actual results may differ materially
from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the section
titled &#8220;Risk factors&#8221; or in other parts of this proxy statement/prospectus. Our historical results are not necessarily indicative
of the results that may be expected for any period in the future. In this section, unless otherwise specified, the terms &#8220;we&#8221;,
&#8220;our&#8221;, &#8220;us&#8221; and&#160;&#8220;Conduit&#8221;&#160;refer to&#160;Conduit Pharmaceuticals Limited. All dollar amounts
are expressed in thousands of United States dollars (&#8220;$&#8221;), unless otherwise indicated.</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Conduit Pharmaceuticals is
a clinical-stage specialty biopharmaceutical company that began operations in early 2019, to facilitate the development and commercialization
of clinical assets to address the unmet medical needs of patients, through our exclusive relationships. Our unique approach allows us
to act as a &#8220;conduit&#8221; whereby we focus on clinical assets from pharmaceutical companies that have otherwise been deprioritized
and fulfil our mission to accelerate the development of new treatments for patients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Conduit is led by highly
experienced pharmaceutical executives: Dr. Freda Lewis-Hall, former Chief Medical Officer of Pfizer Inc., and Dr. David Tapolczay, former
Chief Executive Officer of the United Kingdom-based medical research charity LifeArc. Our management team includes active senior clinicians
who have an extensive understanding of the pharmaceuticals market, which supports our strategy of developing clinical assets in a cost-efficient
manner while focusing on therapeutic efficacy and patient safety.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Conduit has an exclusive
relationship and partnership with St George Street Capital (&#8220;St George Street&#8221;), a biomedical charity based in the United
Kingdom. Conduit has the option to fund 100% of the development of clinical assets that are initially licensed by St George Street from
AstraZeneca AB (PUBL) (&#8220;AstraZeneca&#8221;). In most instances, AstraZeneca has conducted initial pre-clinical and, in some instances,
clinical trials on these assets, but has decided to license them for further development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Our initial licensed clinical
assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, premature labor,
renal transplant rejection and Hashimotos Thyroiditis. Our initial assets which were licensed from Astra Zeneca to St George that will
be developed by Conduit are known as AZD5904 (a Myeloperoxidase Inhibitor) and AZD1656 (a Glucokinase Activator). As the clinical assets
have undergone initial pre-clinical and clinical testing conducted by AstraZeneca, Conduit is able to assess the safety data generated
in these clinical trials to assess which clinical assets to further develop and for which indications.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
successful clinical trials, we expect to commercialize the clinical assets in our pipeline through licensing arrangements with larger
pharmaceuticals companies, which may include up-front milestone payments and/or royalties during the time at which such clinical asset
is subject to patents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the income received from licensing our clinical assets to fund the development of additional clinical assets. This will
allow us to use the existing income stream from clinical assets that have been licenses to fund our on-going operations without having
to rely solely on debt and/or equity financing. We initially intend to focus on assets that have been deprioritized by larger pharmaceuticals
companies and that have a high unmet medical need in order to develop these assets through the Phase IIb stage. We also believe that
we may be able to apply our business strategy and approach to arrangements to pharmaceutical companies in addition to AstraZeneca.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred significant operating losses since inception. For the years ended December 31, 2022 and 2021, our net loss was $4.9 million
and $3.7 million, respectively and we expect to continue to incur significant losses for the foreseeable future as we continue to invest
in a number of research and development programs. As of December 31, 2022 and December 31, 2021, we had an accumulated deficit of $10.8
million and $5.9 million, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Merger Agreement and PIPE Financing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
a comprehensive review of strategic alternatives, including identifying and reviewing potential candidates for a strategic transaction,
on November 8, 2022, we entered into the Merger Agreement by and among Conduit, MURF and Merger Sub, which, among
other things, provides for the merger of Merger Sub with and into Conduit, with Conduit surviving the merger as a wholly-owned subsidiary
of MURF (the &#8220;Business Combination&#8221;). Following the Business Combination, MURF will be renamed &#8220;Conduit Pharmaceuticals
Inc.&#8221; and will continue as a public company and a registrant with the SEC (&#8220;New Conduit&#8221;). Conduit and MURF believe
that the Business Combination and related proceeds will result in the ability for combined business, through New Conduit, to access the
capital markets, increased exposure for the clinical assets that Conduit is currently developing, and an enhanced ability to attract
collaboration, partnering and/or license arrangements as more information will be readily available about New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 163; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Business Combination will be accounted for a reverse recapitalization in accordance with U.S. GAAP. Under the reverse recapitalization
method, MURF will be treated as the acquired company for financial reporting purposes, and Conduit, the accounting acquirer, will be
assumed to have issued shares for the net assets of MURF, with no goodwill or other intangible assets recorded. This determination is
primarily based on the following predominant factors: (i) post-closing, our shareholders are expected to have a majority of the voting
power of the combined company and ability to elect the members of the combined company Board of Directors; (ii) the on-going operations
post-merger will comprise those of Conduit; and (iii) all of the senior management of the combined company except for the Chief Financial
Officer will be members of the management of Conduit. The board of directors of each of MURF and Conduit have approved the Business
Combination. The completion of the Business Combination, which is expected to occur in the second quarter of 2023, is subject to approval
of the stockholders of MURF and the satisfaction or waiver of certain other customary closing conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination and the closing of the PIPE Financing, the most significant change in our future reported
financial position and result of operations is expected to be an estimated increase in cash (as compared to our balance sheet as of December
31, 2022) to approximately $20.1 million, assuming the Maximum Redemption Scenario, or to $33.5 million, assuming the No
Redemption Scenario, including $27.0 million in gross proceeds from the PIPE Financing. Total direct transaction costs of MURF and Conduit
are estimated at approximately $13.6 million, substantially all of which will be recorded as a reduction to additional paid-in-capital
as costs related to the reverse recapitalization. For additional information refer to the section of this proxy statement/prospectus
titled <i>&#8220;Unaudited Pro Forma Condensed Combined Financial Information.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of the Business Combination, MURF will change its name to &#8220;Conduit Pharmaceuticals Inc.&#8221; which we refer to as
New Conduit and New Conduit will be an SEC registrant and its common stock and Public Warrants will be listed on the Nasdaq Stock Market
(&#8220;Nasdaq&#8221;) under the proposed symbols &#8220;CDT&#8221; and &#8220;CDTTW&#8221;, respectively. As a public company, New Conduit
will need to hire additional personnel and implement procedures and processes to address applicable regulatory requirements and customary
practices. We expect that New Conduit will incur additional annual expenses as a public company for, among other things, directors&#8217;
and officers&#8217; liability insurance, director fees and additional internal and external accounting, legal and administrative resources,
including increased audit, legal and filing fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impact
of COVID-19, the Russia and Ukraine Conflict, and Global Economic Conditions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">As
a result of the spread of the&#160;COVID-19&#160;pandemic, economic uncertainties have arisen which may negatively affect our financial
position, results of operations and cash flows. We have assessed that the&#160;COVID-19&#160;pandemic has not so far had a material or
direct impact on our operations or financial position. Nevertheless, in light of the ongoing&#160;COVID-19&#160;pandemic, we have implemented
measures to protect employees and take social responsibilities while at the same time attempting to limit any negative effects on our
business.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full impact of the&#160;COVID-19&#160;pandemic continues to evolve as of the date of this proxy statement/prospectus. As such, the full
magnitude of the pandemic&#8217;s effect on our financial condition, liquidity and future results of operations is uncertain. Management
continues to actively monitor our financial condition, liquidity, operations, suppliers, industry and workforce. See <i>&#8220;Risk Factors&#8212;Risks
Related to&#160;Conduit&#8217;s&#160;Business and Industry&#8212;We may in the future be adversely affected by continuation or worsening
of the global&#160;COVID-19&#160;pandemic, its various strains or future pandemics.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Due
to the pandemic, all clinical trials in the United Kingdom that were not related to COVID-19 were put on hiatus for significant portions
of the year ended December 31, 2021. As a result, during the hiatus, the Company shifted its activities to focus on clinical trials related
to COVID-19. The hiatus on clinical trials not related to COVID-19 was lifted at the end of the year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
conflict between Russia and Ukraine has caused major macroeconomic disruptions that have impacted the global trade and economies. As
such increasing inflation around the globe has forced national banks to increase their interest rates, consequently impacting interest
yields around the globe. We have assessed the impact of these measures and concluded that as of today, no material impact has been identified
on our business or our ability to continue as a going concern.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
Component of Result of Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">Research
and development expenses consist primarily of costs incurred in connection with the research and development of our product candidates
and programs. We expense research and development costs and intangible assets acquired that have no alternative future use as incurred.
These expenses include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">personnel-related
                                            expenses, including salaries, bonuses, benefits and stock-based compensation for employees
                                            engaged in research and development functions;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
                                            incurred in connection with the clinical development and regulatory approval of our product
                                            candidates, including under agreements with third parties, such as consultants, contractors
                                            and CROs;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">license
                                            fees with no alternative use; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                            expenses related to research and development.</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 164; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expense research and development costs as incurred. Advance payments that we make for goods or services to be received in the future
for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the benefits are
consumed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we do not track our research and development expenses on a program-by-program basis as we only worked on one program related to
COVID-19 treatment. Our direct external research and development expenses consist primarily of external costs, such as fees paid to outside
consultants, CROs, CMOs and research laboratories in connection with our preclinical development, process development, manufacturing
and clinical development activities. We do not allocate employee costs, costs associated with our discovery efforts, laboratory supplies,
and facilities, including depreciation or other indirect costs, to specific programs because these costs are deployed across multiple
programs and, as such, are not separately classified. We use internal resources primarily to conduct its research and discovery as well
as for managing its preclinical development, process development, manufacturing and clinical development activities. These employees
work across multiple programs and, therefore, we do not track their costs by program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development activities have historically been central to our business model. We anticipate that our research and development expenses
will increase for the foreseeable future in connection with our planned clinical development activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, we cannot reasonably estimate or know the nature, timing and costs of the efforts that would be necessary to complete the
preclinical and clinical development of any of our product candidates or when, if ever, material net cash inflows may commence from any
of our product candidates. The successful development and commercialization of any of our product candidates is highly uncertain. This
uncertainty is due to the numerous risks and uncertainties associated with product development and commercialization, including the uncertainty
of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            scope, progress, timing, outcome and costs of any continued preclinical development activities,
                                            clinical trials and other related development activities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays,
                                            suspensions, or other setbacks or interruptions encountered, including as a result of the
                                            ongoing COVID-19 pandemic;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successful
                                            patient enrollment in and the initiation and completion of any clinical trials;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timing, receipt and terms of any marketing approvals from applicable regulatory authorities
                                            including the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and non-U.S. regulatory
                                            authorities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            extent of any required post-marketing approval commitments to applicable regulatory authorities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            clinical and commercial manufacturing capabilities or making arrangements with third-party
                                            manufacturers in order to ensure that us or our third-party manufacturers are able to make
                                            and scale our products successfully;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">development
                                            and timely delivery of clinical-grade and commercial-grade drug formulations that can be
                                            used in Conduit&#8217;s clinical trials and for commercial launch;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining,
                                            maintaining, defending and enforcing patent claims and other intellectual property rights;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            and changing government regulation;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">launching
                                            commercial sales of Conduit&#8217;s clinical assets, if and when approved,
                                            whether alone or in collaboration with others; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintaining
                                            a continued acceptable safety profile of Conduit&#8217;s clinical assets following
                                            approval, if any, of Conduit&#8217;s clinical assets.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">A
change in any of these variables with respect to any of Conduit&#8217;s programs would significantly change the costs, timing
and viability associated with that program.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
and Administrative Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist of salaries and other related costs, legal fees relating to intellectual property and corporate matters,
professional fees for accounting, auditing, tax and consulting services, insurance costs, travel, and other operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that our general and administrative expenses will increase substantially for the foreseeable future as we increase our administrative
headcount to operate as a public company and as we advance product candidates through clinical development. We also will incur additional
expenses as a result of operating as a public company, including expenses related to compliance with the rules and regulations of the
SEC and the Nasdaq listing rules, additional insurance expenses, investor relations activities and other administrative and professional
services. In addition, if regulatory approval is obtained for product candidates, we expect to incur expenses associated with building
a sales and marketing team.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 165; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense consists of proceeds from the sale of equity securities, unrealized foreign currency transaction loss, loss on the change in
fair value of convertible notes, write-off of long-term debt- related party, donations to a related party and commission on the placement
of equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table set forth our results of operations for the periods indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">(In thousands, except
    share and per share data)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating expenses:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,049</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,890</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Funding expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">74</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">255</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,160</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,173</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,173</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other expense:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other expense, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,727</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total other expense,
    net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,727</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,887</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,657</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation
    adjustment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">753</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    comprehensive loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,134</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,578</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Comparison
of the Years Ended December 31, 2022 and 2021</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif"><i>Research
and development expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development
    expenses</span></td><td style="width: 2%; font-size: 9pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; font-size: 9pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37</span></td><td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; font-size: 9pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; font-size: 9pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; font-size: 9pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 9pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; font-size: 9pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; font-size: 9pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="width: 1%; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Research
and development expenses increased by $9,000, or 100%, to $37,000 for the year ended December 31, 2022, as compared to $28,000 for the
year ended December 31, 2021. The increase was primarily driven by expenses incurred for our clinical research into COVID-19 treatment
during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif"><i>General
and administrative expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">(In thousands)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,049</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,890</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">General
and administrative expenses increased by $0.2 million, or 6%, to $3.0 million for the year ended December 31, 2022, as compared to $2.9
million for the year ended December 31, 2021. The increase was primarily driven by an increase of $0.3 million in the reserve for loans
receivable, partially offset by a decrease of $0.1 million in legal fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Funding
expenses</i></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">(In thousands)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Funding expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">74</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">255</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(181</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(71</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Funding
expenses decreased by $0.2 million, or 71%, to $0.1 million for the year ended December 31, 2022, as compared to $0.3 million for the
year ended December 31, 2021. The decrease was primarily driven by a decrease of $0.2 million in funding requirements from St George
Street for research and development expenses incurred which we agreed to fund.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
expense, net</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">(In thousands)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other expense</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,727</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(484</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,243</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(254</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense increased by $1.2 million, or 257%, to other expense of $1.7 million for the year ended December 31, 2022, as compared
to other expense, net for $0.5 million for the year ended December 31, 2021. The decrease was driven primarily by an increase of $1.3
million on the loss incurred through the issuance of the Option to Cizzle and a $0.2 million increase in the loss on the change in fair
value of convertible notes payable, partially offset by a decrease in placement fees on the sale of equity securities of $0.3 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further details refer to Note 11 &#8211; <i>Other Expense</i> in the audited financial statements as of and for the year ended December
31, 2022 and 2021 included elsewhere in this proxy statement/prospectus.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 166; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
and Capital Resources</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Since
our inception, and in line with our growth strategy, we have prepared our financial statements assuming we will continue as a going concern.
Since our inception, we have incurred net losses and experienced negative cash flows from operations. To date, our primary sources of
capital have been through private placements of equity securities and convertible debt During the years ended December 31, 2022 and 2021,
we incurred net losses of $4.9 million and $3.7 million, respectively. <span style="background-color: white">We expect to incur additional
losses and higher operating expenses for the foreseeable future as we continue to invest in research and development programs. We have
determined that additional financing will be required to fund our operations for the next 12 months and our ability to continue as a
going concern is dependent upon obtaining additional capital and financing, including through the consummation of the Business Combination.
</span>In the fourth quarter of 2022 the Company approved approximately $3 million of Convertible Notes, of which approximately $1.8
million was issued and funded in full.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary uses of cash are to fund our operations as we continue to grow our business. We will require a significant amount of cash for
expenditures as we invest in ongoing research and development and business operations. Until such time as we can generate significant
revenue from commercialization of our product, we expect to finance our cash needs through public or private equity or debt financings
or other capital sources, including strategic partnerships. However, we may be unable to raise additional funds or enter into such other
arrangements, when needed, on favorable terms or at all. To the extent that we raise additional capital through the sale of equity or
convertible debt securities, the ownership interest of our shareholders will be, or could be, diluted, and the terms of these securities
may include liquidation or other preferences that adversely affect the rights of our common shareholders. Debt financing and equity financing,
if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring
additional debt, making capital expenditures or declaring dividends. If we are unable to raise additional funds through equity or debt
financings when needed, we may be required to delay, limit, or substantially reduce research and development efforts. While the Company
believes in the viability of its ability to raise additional funds, there can be no assurances to that effect. There is currently no
public market for the Company&#8217;s ordinary shares. These matters raise substantial doubt about the Company&#8217;s ability to continue
as a going concern for a period of twelve months from the issue date of this report. These financial statements have been prepared assuming
the Company will continue as a going concern and do not include adjustments to reflect the possible effects on the recoverability and
classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future capital requirements and the adequacy of available funds will depend on many factors, including those set forth in the section
titled <i>&#8220;Risk Factors&#8212;Risks Related to Conduit&#8217;s Business and Industry.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Cash
Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table set forth our cash flows for the period indicated (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash (used in) provided by:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Operating Activities</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,266</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,151</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Investing Activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(183</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Financing Activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,448</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,898</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Effect of exchange rate
    changes on cash and cash equivalents</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net (decrease) increase
    in cash and cash equivalents</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(252</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Flows Used in Operating Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities during the year ended December 31, 2022 was $2.3 million, resulting primarily from a net loss of $4.9
million, adjusted for non-cash charges of $2.0 million and working capital adjustments of $0.6 million.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 167; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities during the year ended December 31, 2021 was $2.2 million, resulting primarily from a net loss of $3.7
million, adjusted for non-cash charges of $0.1 million and working capital adjustments of $1.4 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Flows Used in Investing Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities for the year ended December 31, 2022 was $0.2 million resulting from the issuance of a loan to a related
party of $0.3 million, partially offset by an option fee received from Cizzle of $0.1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Flows (Used) Provided by Financing Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities during the year ended December 31, 2022 was $2.4 million. resulting from the proceeds from the
sale of shares received for the sale of future revenue of $1.3 million, proceeds from notes payable of $0.2 million and the issuance
of our convertible debt of $0.9 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities during the year ended December 31, 2021 was $1.9 million, resulting from the proceeds from the
sale of shares received for the sale of future revenue of $1.2 million and the issuance of our convertible debt of $0.7 million.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
Obligations and Other Commitments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, we had no non-cancellable commitments for the purchase of clinical materials, contract manufacturing, maintenance
and committed funding which we expect to pay within one year.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
Accounting Policies and Significant Judgments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements,
which we have prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and related disclosures of contingent assets and liabilities at the date of the financial statements as well as the reported
amounts of revenues and expenses during the reporting period. Estimates are based on several factors including the facts and circumstances
available at the time the estimates are made, historical experience, risk of loss, general economic conditions and trends and the assessment
of the probable future outcome. Subjective and significant estimates include, but are not limited to, research and development accruals.
Actual results could differ from those estimates. Estimates and assumptions are reviewed periodically and the effects of changes, if
any, are reflected in the statements of operations in the period that they are determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the accounting policies described below involve a significant degree of judgment and complexity. Accordingly, we believe
these are the most critical to aid in fully understanding and evaluating our financial condition and results of operations. For further
information, refer to Note 1 &#8220;Nature of the Business, Basis of Presentation and Summary of Significant Accounting Policies&#8221;
to our financial statements included elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Accounting
Standards Codification (&#8220;ASC&#8221;) Topic 820, Fair Value Measurements and Disclosures, defines fair value, establishes a framework
for measuring fair value, and expands disclosures about fair value measurements. Fair value is to be determined based on the exchange
price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market
for the asset or liability in an orderly transaction between market participants. In determining fair value, we used various valuation
approaches. A fair value hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable
inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs
are those that market participants would use in pricing the asset or liability based on market data obtained from sources independent
of the Company. </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 168; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Unobservable
inputs reflect the Company&#8217;s assumption about the inputs that market participants would use in pricing the asset or liability developed
based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels, based on the
inputs, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1&#8212;Valuations based on quoted prices for identical instruments in active markets. Since
                                            valuations are based on quoted prices that are readily and regularly available in an active
                                            market, valuation of these instruments does not entail a significant degree of judgment.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2&#8212; Valuations based on observable inputs other than quoted prices included in Level
                                            1, such as quoted prices for either similar instruments in active markets, identical or similar
                                            instruments in markets that are not active, or model-derived valuations whose inputs or significant
                                            value drivers are observable or can be corroborated by observable market data.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3&#8212;Valuations based on inputs that are unobservable. These valuations require significant
                                            judgment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company&#8217;s Level 1 assets consist of cash and cash equivalents in the accompanying balance sheets and the value of accrued expenses
and other current liabilities approximate fair value due to the short-term nature of these assets and liabilities. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the years ended December 31, 2022 and December 31, 2021, the Company has two financial liabilities, a convertible note and liability
for the Cizzle Option (the &#8220;Option&#8221;) that are adjusted to fair value on a recurring basis for which the fair value is determined
based on Level 3 inputs as such inputs are not readily observable. For further information, refer to Notes 2 &#8220;Fair Value&#8221;,
4 &#8220;Liability Related to the Sale of Future Revenue&#8221; and 5 &#8220;Convertible Notes Payable&#8221; to our financial
statements included elsewhere in this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investments
in Equity Securities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Investments
in the equity securities of Cizzle that have a readily determinable fair value are reported at fair value. Changes in fair value between
accounting periods are recorded in other income, net, in the statements of operations and comprehensive loss. Realized gains or losses
upon sale are recorded in other income, net, in the statements of operations and comprehensive loss. We assess the fair value of our
equity securities periodically, a large fluctuation in the fair value of the shares may lead to a material adjustment of our investment
in equity securities. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Option for Convertible Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determination
of the fair value of our convertible notes. The significant assumptions used to estimate the fair value of the convertible notes involved
inherent uncertainties and the application of significant judgment and included the time to maturity and the probability of various possible
settlement outcomes. The sensitivity of these inputs to the fair value of the convertible notes is assessed on a periodic basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
values of the derivative liabilities related to the convertible notes were estimated using a probability-weighted expected return method,
where the values of various instruments were estimated based on an analysis of future values of the business, assuming various future
outcomes. The resulting instruments&#8217; values were based upon the probability-weighted present value of expected future investment
returns, considering each of the possible future outcomes available to us, as well as the economic benefits attributable to each class
of instruments. The expected future investment returns were estimated using a variety of methodologies, including both the market approach
and the income approach, where an observable quoted market does not exist, and were generally classified as Level 3. Such methodologies
included reviewing values ascribed to our most recent financing, comparing the subject instrument with similar instruments of publicly
traded companies in similar lines of business, and reviewing our underlying financial performance and subject instrument, including estimating
discounted cash flows.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 169; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
Accounting Pronouncements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">A
discussion of recent accounting pronouncements is included in Note 1 <i>- Nature of the Business, Basis of Presentation and Summary of
Significant Accounting Policies</i> to our financial statements included elsewhere in this proxy statement/ prospectus.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualitative
and Quantitative Disclosures About Market Risk</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to market risk related to changes in interest rates. Our primary exposure to market risk is interest rate sensitivity, which
is affected by changes in the general level of U.S. interest rates. Due to the low interest rates available on cash investments and the
immaterial amount of cash as of December 31, 2022, we believe an immediate 10% change in interest rates would not have a material effect
on our operating results until maturity, and therefore, we would not expect our operating results or cash flows to be affected to any
significant degree by the effect of a change in market interest rates on our investment portfolio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently exposed to market risk related to changes in foreign currency exchange rates; however, we do contract with vendors that
are located primarily in the United Kingdom and may be subject to fluctuations in foreign currency rates. We may enter into additional
contracts with vendors located outside the United States in the future, which may increase our foreign currency exchange risk. <span style="background-color: white">We
do not believe that foreign currency risk had a material effect on our business, financial condition, or results of operations during
the periods presented.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
do not believe that inflation had a significant impact on our results of operations for any periods presented in our financial statements.
Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher
costs, and our inability or failure to do so could harm our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
Growth Company Status and Smaller Reporting Company Status</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
April 2012, the Jumpstart Our Business Startups Act of 2012, or the&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt; background-color: white">JOBS
Act</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">, was enacted. Section 107
of the JOBS Act provides that an &#8220;emerging growth company&#8221; may take advantage of the extended transition period provided
in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. Therefore, an emerging growth company
can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. New Conduit
has elected to avail itself of this extended transition period and, as a result, New Conduit will not adopt new or revised accounting
standards on the relevant dates on which adoption of such standards is required for other public companies. In addition, as an emerging
growth company, New Conduit may take advantage of certain reduced disclosure and other requirements that are otherwise applicable generally
to public companies.&#160;New Conduit will take advantage of these exemptions until such earlier time that it is no longer an emerging
growth company.&#160;New Conduit would cease to be an emerging growth company on the date that is the earliest of (i) the last day of
the fiscal year following the fifth anniversary of the date of the completion of this offering; (ii) the last day of the fiscal year
in which its total annual gross revenue is equal to or more than $1.235 billion; (iii) the date on which it has issued more than $1.0
billion in nonconvertible debt during the previous three years; or (iv) the date on which it is deemed to be a large accelerated filer
under the rules of the Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, New Conduit will be a smaller reporting company as defined in the Exchange Act. New Conduit may continue to be a smaller reporting
company even after we are no longer an emerging growth company. New Conduit may take advantage of certain of the scaled disclosures available
to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as (i) New Conduit&#8217;s
voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second
fiscal quarter or (ii) New Conduit&#8217;s annual revenue is less than $100.0 million during the most recently completed fiscal year
and its voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of its
second fiscal quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 170; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="md_026"></span><b>BENEFICIAL
OWNERSHIP OF SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the beneficial ownership regarding: (i) the actual beneficial ownership of MURF common
stock as of April 30, 2023; (ii) the actual beneficial ownership of Conduit ordinary shares as of April 30, 2023; and (iii)
expected beneficial ownership of the common stock of New Conduit immediately following the closing of the Business Combination, assuming
that no holder of MURF&#8217;s Public Shares exercises redemption rights as described in this proxy statement/prospectus, by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of MURF&#8217;s current executive officers and directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
    current executive officers and directors as a group;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of Conduit&#8217;s current executive officers and directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit&#8217;s
    current executive officers and directors as a group;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person who will become an executive officer or a director of New Conduit upon consummation of the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of the executive officers and directors of New Conduit as a group after the consummation of the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person known to be the beneficial owner of more than 5% of the outstanding shares of MURF common stock as of April 30, 2023;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person known to be the beneficial owner of more than 5% of Conduit ordinary shares as of April 30, 2023; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person who may become the beneficial owner of more than 5% of outstanding shares of New Conduit common stock immediately following
    the Business Combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Beneficial ownership is determined
according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses
sole or shared voting or investment power over that security. Under those rules, beneficial ownership includes securities that the individual
or entity has the right to acquire, such as through the exercise of warrants or stock options or the vesting of restricted stock units,
within 60 days of the closing of the Business Combination for purposes of the calculations set forth below. Shares subject to
warrants or options that are currently exercisable or exercisable within 60 days of the closing of the Business Combination or
subject to restricted stock units that vest within 60 days of the closing of the Business Combination are considered outstanding
and beneficially owned by the person holding such warrants, options or restricted stock units for the purpose of computing the percentage
ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person.
As of the closing of the Business Combination, New Conduit is not expected to have any options that will be exercisable within 60
days or restricted stock units that vest within 60 days.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
beneficial ownership of shares of MURF common stock prior to the Business Combination is based on 6,247,978 shares of common stock
of MURF (consisting of <span style="background-color: white">2,941,728</span></span> shares of Class A common stock and <span style="background-color: white">3,306,250
</span>shares of Class B common stock) issued and outstanding as of April 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
beneficial ownership of Conduit ordinary shares prior to the Business Combination is based on 2,000 ordinary shares of Conduit issued
and outstanding as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected beneficial ownership of shares of New Conduit common stock after the Business Combination assuming none of the public shares
are redeemed has been determined based upon the following: (i) that no additional public stockholders exercise their Redemption
Rights; (ii) that none of the investors set forth in the table below has purchased or purchases additional shares of common stock (prior
to or after the Business Combination); (iii) that 65,000,000 shares of New Conduit common stock are issued to the former Conduit shareholders
as Merger Consideration including the shares of New Conduit common stock issued upon conversion of the Conduit convertible notes (excluding
shares issued to the Private Placement Investor and shares issuable upon exercise of the warrants issued to the Private Placement Investor);
(iv) that the aggregate unpaid principal amount on Conduit&#8217;s convertible notes is &#163;2.4 million; (v) that the &#163;2.4
million in Conduit&#8217;s convertible notes are converted into $3.1 million U.S. dollars; (vi) that the Conduit shares
to be issued upon conversion of the convertible notes are issued at $8.00 per share (which reflects the 20% discount as required by the
terms of each convertible note); and (vii) that there will be an aggregate of 75,247,978 shares of New Conduit common
stock issued and outstanding after the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Investor is not listed below because the Private Placement Investor has contractually agreed to restrict its ability
to exercise the warrants such that the number of shares of <span style="background-color: white">New Conduit</span> common stock held
by such investor and its affiliates after such exercise does not exceed the beneficial ownership limitation set forth in the warrant
which may not exceed 4.99% of the then issued and outstanding shares of <span style="background-color: white">New Conduit</span> common
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share numbers and ownership percentages set forth herein do not take into account the issuance of any shares of New Conduit common stock
upon completion of the Business Combination under the 2023 Stock Incentive Plan. In addition, the calculations of the expected number
of shares of New Conduit common stock to be issued in the Merger has been determined based upon the number of Conduit shares and convertible
notes of Conduit that were issued and outstanding as of April 30, 2023, after giving effect to the conversion of each of Conduit&#8217;s
convertible notes into Conduit ordinary shares based on the assumptions set forth above. If the facts are different from the assumptions
set forth above, which they are likely to be, the share numbers and ownership percentages upon completion of the Business Combination
will be different.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 171; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as noted by footnote, and subject to community property laws where applicable, based on the information provided to MURF and Conduit,
respectively, the persons and entities named in the table below have sole voting and investment power with respect to all shares shown
as beneficially owned by them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
    the Business Combination (1)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
                                            the Business</span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Combination
                                            (2)</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    and Nature of Beneficial Ownership</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
    Percentage of Outstanding Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    and Nature of Beneficial Ownership</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
    Percentage of Outstanding Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Name
    and Address of Beneficial Owner (3)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
    Directors and Executive Officers Before the Business Combination</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele
    Chiavacci Farley</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(4)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;*
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Feinberg</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(5)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;*
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,814,250
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(6)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,724,250</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(7)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">6.2</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis
    Knuettel II</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(8)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;*
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam
    Sragovicz</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(9)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    directors and executive officers of MURF as a group (5 individuals)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,814,250</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,814,250</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
    Directors and Executive Officers Before the Business Combination</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Regan (10)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,755,326</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(11)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Tapolczay (12)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,003,177
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(13)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    directors and executive officers of Conduit as a group (2 individuals)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,507</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,758,503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Executive Officers After the Business Combination (14)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Bligh</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faith
    L. Charles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele
    Chiavacci Farley</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(15)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;*
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freda
    Lewis-Hall</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,003,177</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(16)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jennifer
    McNealey</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Regan</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,755,326</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(17)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam
    Sragovicz</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(18)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Tapolczay</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,003,177
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(19)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    directors and executive officers of New Conduit as a group (8 individuals)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,791,680
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(20)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Five-Percent
    Holders of MURF Before the Business Combination</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
    Canyon Acquisition Sponsor, LLC (the &#8220;Sponsor&#8221;)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,814,250
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(21)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,724,250
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(22)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Five-Percent
    Holders of Conduit Before the Business Combination</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corvus
    Capital Limited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,755,326</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(23)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">St
    George Street Capital</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">225</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,269,594</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(24)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Five-Percent
    Holders After the Business Combination</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corvus
    Capital Limited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,755,326</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(25)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
    Canyon Acquisition Sponsor, LLC (the &#8220;Sponsor&#8221;)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,814,250
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(26)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,724,250</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(27)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">St
    George Street Capital</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">225</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,269,594</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(28)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; width: 25%; margin-right: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Less than 1%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The percentage of beneficial ownership of MURF before the Business Combination is calculated based on <span style="background-color: white">2,941,728
</span></span>shares Class A common stock and <span style="background-color: white">3,306,250</span> shares Class B common stock
outstanding as of April 30, 2023. Unless otherwise indicated, MURF believes that all persons named in the table have sole voting
and investment power with respect to all shares beneficially owned by them prior to the Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 172; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->167<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The &#8220;Amount and Nature of Beneficial Ownership&#8221; and &#8220;Approximate Percentage of Outstanding Shares&#8221; after the
Business Combination is calculated based on 75,247,978 shares of New Conduit common stock expected to be outstanding immediately
following consummation of the Business Combination whereby all Class B common stock will be converted into Class A common stock, all
of which will be converted into New Conduit common stock. Such expected number of shares outstanding amount: (i) assumes that no additional
Public Stockholders properly elect to redeem their shares of MURF Class A common stock for cash and (ii) includes the 2,700,000 shares
issued in the Private Placement to the Private Placement Investor but excludes shares issuable upon exercise of the warrants issued to
the Private Placement Investor. The amount of beneficial ownership for each individual or entity after the Business Combination does
not include shares issuable upon exercise of the warrants included in the units offered in the initial public offering. Unless otherwise
indicated, MURF believes that all persons named in the table have sole voting and investment power with respect to all of the shares
shown to be beneficially owned by them after giving effect to the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Unless otherwise indicated, the business address of each of the entities and individuals below is c/o Murphy Canyon Acquisition Corp.,
4995 Murphy Canyon Road, Suite 300, San Diego, California 92123.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Reflects 15,000 shares of common stock and 15,000 redeemable warrants underlying 15,000 units (consisting of one share of Class A common
stock and one warrant to purchase one share of Class A common stock) that the Sponsor has agreed to transfer to each of MURF&#8217;s
independent directors immediately after the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Reflects 15,000 shares of common stock and 15,000 redeemable warrants underlying 15,000 units (consisting of one share of Class A common
stock and one warrant to purchase one share of Class A common stock) that the Sponsor has agreed to transfer to each of MURF&#8217;s
independent directors immediately after the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Includes the following securities held by Murphy Canyon Acquisition Sponsor, LLC: (i) 3,306,250 shares of Class B common stock, which
at the time of the Business Combination, are automatically convertible into shares of Class A common stock, which will then automatically
convert into New Conduit common stock; (ii) 754,000 shares of Class A common stock underlying units (each consisting of one share of
Class A common stock and one redeemable warrant); and (iii) 754,000 shares of Class A common stock issuable upon exercise of 754,000
private placement warrants underlying units. Mr. Heilbron is the Managing Member of Murphy Canyon Acquisition Sponsor, LLC. By virtue
of this relationship, Mr. Heilbron may be deemed to share beneficial ownership of the securities held of record by Murphy Canyon Acquisition
Sponsor, LLC. Mr. Heilbron disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Includes the following securities held by Murphy Canyon Acquisition Sponsor, LLC: (i) 3,306,250 shares of New Conduit common stock due
to the conversion of the shares of Class B common stock into shares of Class A common stock and finally into shares of New Conduit common
stock at the time of the Business Combination; (ii) 709,000 shares of New Conduit common stock, which prior to the Business Combination
were part of the MURF units; and (iii) 709,000 shares of New Conduit common stock converted from an equal number of shares of Class A
common stock issuable upon exercise of 709,000 private placement warrants, which prior to the Business Combination were part of the MURF
units. Mr. Heilbron is the Managing Member of Murphy Canyon Acquisition Sponsor, LLC. By virtue of this relationship, Mr. Heilbron may
be deemed to share beneficial ownership of the securities held of record by Murphy Canyon Acquisition Sponsor, LLC. Mr. Heilbron disclaims
any such beneficial ownership except to the extent of his pecuniary interest therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Reflects 15,000 shares of common stock and 15,000 redeemable warrants underlying 15,000 units (consisting of one share of Class A common
stock and one warrant to purchase one share of Class A common stock) that the Sponsor has agreed to transfer to each of MURF&#8217;s
independent directors immediately after the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
It is anticipated that Mr. Sragovicz will serve as New Conduit&#8217;s Chief Financial Officer following the closing of the Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)
Dr. Andrew Regan is currently a director of Conduit (Dr. Regan also undertakes duties typically associated with an executive officer
in connection with his service as a director of Conduit).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)
Assumes that 32,309,305 shares of New Conduit common stock are issued to Corvus Capital Limited and 14,377,641 shares of
New Conduit common stock are issued to Algo Holdings, Inc., in each case as consideration in the Merger for the cancellation of the Conduit
shares held by it and 68,380 shares of New Conduit common stock are issued to Dr. Regan as consideration for the Conduit shares that
will be issued to Dr. Regan upon the conversion of the convertible promissory notes held by him. Dr. Regan is the Chief Executive
Officer of Corvus Capital Limited and Algo Holdings, Inc. is a wholly owned subsidiary of Corvus Capital Limited. By virtue of this relationship,
Dr. Regan may be deemed to share beneficial ownership of the securities held of record by Corvus Capital Limited and Algo Holdings, Inc.
Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein. The business address of Corvus
Capital Limited is Floor 2, Willow House, Cricket Square PO Box 709 Grand Cayman KY1-1107, Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)
David Tapolczay is currently a director of Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)
Assumes that 2,003,177 shares of New Conduit common stock are issued to Mr. Tapolczay as consideration in the Merger for the cancellation
of the Conduit shares held by him.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 173; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->168<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise indicated, the business address
of each of the entities and individuals below is c/o Murphy Canyon Acquisition Corp., 4995 Murphy Canyon Road, Suite 300, San Diego,
California 92123.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 4 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes that 2,003,177 shares of New Conduit
common stock are issued to Intelmed LLC as consideration in the Merger for the cancellation of the Conduit shares held by it. Ms. Lewis-Hall
is the Managing Director of Intelmed LLC. By virtue of this relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership
of the securities held of record by Intelmed LLC. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her
pecuniary interest therein. The business address of Intelmed LLC is 11421 Golden Eagle Court Naples, Florida 34120.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 11 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 9 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 13 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) an aggregate of 50,776,680 shares
of New Conduit common stock and (ii) an aggregate of 15,000 shares of New Conduit common stock underlying warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 6 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 7 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 11 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes that 7,269,594 shares of New Conduit
common stock are issued to St George Street Capital as consideration in the Merger for the cancellation of the Conduit shares held by
it. The business address of St George Street Capital is 10 Queen Street Place London, England EC4R 1BE, United Kingdom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 11 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 6 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 7 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(28)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See footnote 24 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 174; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->169<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_027"></span>CERTAIN
RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Person Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
Code of Ethics requires MURF to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions approved
by the MURF Board (or the appropriate committee of its board) or as disclosed in its public filings with the SEC. Under MURF&#8217;s
code of ethics, conflict of interest situations will include any financial transaction, arrangement or relationship (including any indebtedness
or guarantee of indebtedness) involving the company. MURF&#8217;s conflict of interest policy provides that a committee of independent
members of the MURF Board may, among other things, cause any officer or director who has a direct or indirect interest in a transaction
to recuse him or herself from the consideration of such transaction and, to the extent necessary, the committee may retain appropriately
qualified, non-conflicted personnel to advise the company in connection with such transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, MURF&#8217;s audit committee is responsible for reviewing and approving related party transactions to the extent that it enters
into such transactions. An affirmative vote of a majority of the members of the audit committee present at a meeting at which a quorum
is present will be required in order to approve a related party transaction. A majority of the members of the entire audit committee
will constitute a quorum. Without a meeting, the unanimous written consent of all of the members of the audit committee will be required
to approve a related party transaction. MURF also requires each of its directors and executive officers to complete a directors&#8217;
and officers&#8217; questionnaire that elicits information about related party transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a
conflict of interest on the part of a director, employee or officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURF
Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2021, the Sponsor purchased an aggregate of 4,312,500 shares of the MURF common stock for the aggregate price of $25,000
(the &#8220;Founder Shares&#8221;). The Founder Shares included an aggregate of up to 750,000 shares subject to forfeiture by the Sponsor
to the extent that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the Sponsor would collectively
own 20% of MURF&#8217;s issued and outstanding shares after the initial public offering (assuming the Sponsor did not purchase any Public
Shares in the initial public offering and excluding the Private Shares). As a result of the underwriters&#8217; election to exercise
their over-allotment option, on January 26, 2022, the Sponsor surrendered and forfeited 1,006,250 Founder Shares. Following such forfeiture,
the Sponsor now holds 3,306,250 Founder Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier
to occur of: (A) six months after the completion of our initial business combination, and (B) subsequent to the initial business combination
if we complete a liquidation, merger, stock exchange or other similar transaction that results in all of our public stockholders having
the right to exchange their public shares for cash, securities or other property. Notwithstanding the foregoing, the Sponsor shall have
the right to transfer its ownership in the founder shares at any time to the extent that it determines, in good faith, that such transfer
is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act
of 1940. Also, and notwithstanding the foregoing, if subsequent to our initial business combination the reported last sale price of our
common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and
the like) for any 20 trading days within any 30-trading day period commencing at least 90 days after our initial business combination,
all of the Founder Shares will be released from the lock-up, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Units</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Contemporaneously
with the closing of the initial public offering and the exercise of the overallotment option, the Sponsor purchased an aggregate of 754,000
private units in a private placement at a price of $10.00 per private unit. Each private unit consists of one Private Share and one Private
Warrant. The private units are identical to the units sold in the initial public offering except that the <span style="background-color: white">(a)
the placement units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation
of the Company&#8217;s initial business combination except to permitted transferees and (b) the warrants and rights included as a component
of the placement units, so long as they are held by the Sponsor or its permitted transferees, will be entitled to registration rights,
respectively. Additionally, the warrants underlying the placement units contain a cashless exercise provision and shall be non-redeemable
while held by the initial purchasers thereof or their permitted assignees</span>. The Sponsor has agreed not to transfer, assign or sell
any of the private units and underlying securities (except in connection with the same limited exceptions that the Private Shares may
be transferred as described above) until after the completion of the initial business combination. The Sponsor has agreed to transfer 45,000 placement units (15,000 each) to each of MURF&#8217;s three independent
directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 175; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->170<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021, the Sponsor issued an unsecured promissory note to MURF pursuant to which MURF could borrow up to an aggregate principal
amount of $300,000. The promissory note is non-interest bearing and payable on the earlier of (i) the consummation of the Proposed Public
Offering or (ii) the decision not to execute the Proposed Public Offering. <span style="background-color: white">As of December 31, 2021,
there was $177,057 outstanding under the promissory note. The balance was paid in full on February 10, 2022.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Services Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
entered into an agreement whereby, starting February 2, 2022, through the earlier of MURF&#8217;s consummation of a business combination
or its liquidation, MURF will pay Murphy Canyon Management Group, Inc., an affiliate of MURF&#8217;s sponsor, a total of $10,000 per
month for office space, utilities and secretarial and administrative support. For the period from February 2, 2022, through September
30, 2022, MURF incurred and paid $80,000 for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sponsor
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently
with the execution of the Merger Agreement, MURF entered into a support agreement with the Sponsor pursuant to which the Sponsor has
agreed to, among other things, vote all of the shares of MURF common stock legally and beneficially owned by it in favor of the Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subscription
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with the transactions contemplated by the Merger Agreement, MURF entered into a subscription agreement, subsequently amended
on January 27, 2023, with the Private Placement Investor. Pursuant to the Subscription Agreement, the Private Placement Investor agreed
to purchase 2,700,000 units, with each unit consisting of (i) one share of <span style="background-color: white">Class A</span> common stock and (ii) one warrant to purchase
one share of <span style="background-color: white">Class A</span> common stock, for a purchase price of $10.00 per unit in the Private Placement. The Subscription Agreement contains
registration rights, pursuant to which within fifteen (15) business days after the closing of the Private Placement, MURF will use reasonable
best efforts to file with the SEC a registration statement registering the resale of shares of <span style="background-color: white">MURF</span> common stock included in the
Units and the shares of <span style="background-color: white">Class A</span> common stock issued and issuable upon exercise of the warrants. The closing of the Private Placement
is conditioned on there not being a suspension of the qualification of <span style="background-color: white">MURF</span> common stock for offering or sale or trading in any
jurisdiction, or the initiation or threatening of any legal proceeding, no legal prohibitions to consummate the Business Combination,
and all conditions precedent to the closing of the Business Combination set forth in the Merger Agreement having been satisfied or waived.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white">The
warrant will be exercisable for a period of five years after the completion of the Business Combination and will have an exercise price
of $11.50 per share, subject to adjustment as set forth in the Warrant for stock splits, stock dividends, recapitalizations and similar
customary adjustments. The Private Placement Investor may exercise each warrant on a cashless basis if the shares underlying the warrants
are not then registered pursuant to an effective registration statement. The Private Placement Investor has contractually agreed to restrict
its ability to exercise the warrants such that the number of shares of <span style="background-color: white"><span style="background-color: white">MURF</span></span> common
stock held by the investor and its affiliates after such exercise does not exceed the beneficial ownership limitation set forth in the
warrant which may not exceed 4.99% of the then issued and outstanding shares of <span style="background-color: white"><span style="background-color: white">MURF</span></span>
common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In connection with the amendment
to the Subscription Agreement dated January 27, 2023, the Private Placement Investor agreed to receive and be issued shares of New Conduit
common stock. Upon the closing of the Business Combination, and specifically the filing of the Proposed Charter, MURF&#8217;s Class A
common stock and Class B common stock will be reclassified as a single class of common stock, and MURF&#8217;s company name will change
to &#8220;Conduit Pharmaceuticals Inc.&#8221; also referred to as New Conduit. The underlying terms of the Class A common stock and the
single class of common stock are materially the same as each has or will have the same voting right of one vote per each share, same dividend
rights and same liquidation rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The closing of the Private Placement
will occur immediately prior to consummation of the Business Combination and is conditioned thereon and on other customary closing conditions.
The common stock to be issued pursuant to the Subscription Agreement has not been registered under the Securities Act, and will be issued
in reliance upon the exemption provided under Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Subscription
Agreement will terminate and be void and of no further force and effect, and all rights and obligations of the parties without any further
liability on the part of any party in respect thereof, upon the earlier to occur of: (a) the mutual written agreement of each of the
parties to terminate the Subscription Agreement; (b) such date and time as the Merger Agreement is terminated in accordance with its
terms; (c) if any of the conditions to the closing of the Private Placement are not satisfied or waived on or prior to the closing of
the Private Placement and, as a result thereof, the transactions contemplated by the Subscription Agreement are not consummated at the
closing of the Private Placement or (d) written notice by either party to the other party to terminate the Subscription Agreement if
the transactions contemplated by the Subscription Agreement are not consummated on or prior to February 7, 2024.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Consulting
Agreement with Jack K. Heilbron</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Jack
K. Heilbron, who is currently the Chief Executive Officer, President and Chairman of the Board of Directors of Murphy Canyon Acquisition
Corp., has entered into a Consulting Agreement with Murphy Canyon Acquisition Corp., which is effective upon the closing of the business
combination. The Consulting Agreement provides that Mr. Heilbron will provide advisory and consulting services from time to time to Conduit
Pharmaceuticals Inc., the post-closing combined entity, for one year following the closing of the business combination. Mr. Heilbron
will no longer serve as an officer or director of Conduit Pharmaceuticals Inc., the post-closing combined entity, after the closing of
the business combination. However, pursuant to the terms of the Consulting Agreement, Mr. Heilbron is entitled to rights as an observer
to the Board of Directors of Conduit Pharmaceuticals Inc., the post-closing combined entity. Mr. Heilbron is entitled to be paid $25,000
per calendar quarter for his consulting services and is also entitled to a stock option to purchase the number of shares of the common
stock of Conduit Pharmaceuticals Inc., the post-closing combined entity, determined by dividing (i) $300,000, by (ii) the per share Black-Scholes
valuation as of the grant date, utilizing the same assumptions used in preparation of the financial statements, with the resulting quotient
rounded down to the nearest whole share.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conduit
Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of transactions since January 1, 2020, to which Conduit has been a participant and in which the amount involved
exceeded or will exceed $120,000, and in which any of Conduit&#8217;s directors, executive officers or holders of more than 5% of any
class of Conduit&#8217;s equity interests at the time of such transaction, or any members of their immediate family, had or will have
a direct or indirect material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 176; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->171<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholder
Support Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Concurrently
with the execution of the Merger Agreement, MURF, Conduit, and certain shareholders of Conduit entered into a certain shareholder support
agreement dated November 8, 2022, pursuant to which the Conduit Shareholders agreed to vote all Conduit shares beneficially owned by
them, including any additional shares of Conduit they acquire ownership of or the power to vote, in favor of the Business Combination
and related transactions. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the support agreements,
each Conduit shareholder has also agreed that, prior to the termination of the applicable support agreement, such shareholder will not
transfer or otherwise enter into any agreement or understanding with respect to a transfer relating to any shares of Conduit owned by
such shareholder. The support agreements will terminate automatically without any further required actions or notice upon the earliest
to occur: (a) the effective time of the Business Combination; (b) the termination of the Merger Agreement in accordance with its terms;
and (c) the mutual agreement of Conduit and the shareholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conduit
Shareholder Lockup Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Merger Agreement, as a condition to receiving New Conduit common stock after the closing of the Business Combination in respect of
their Conduit shares, certain Conduit shareholders are required to execute lockup agreements pursuant to which such shareholders must
agree not to sell, transfer or take certain other actions with respect to such shares of New Conduit common stock for a period of 180
days after the closing of the Business Combination, subject to certain customary exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corvus
Capital Limited </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corvus
Capital Limited (&#8220;Corvus&#8221;) is a significant investor in Conduit due to its ownership of 1,000 ordinary shares of Conduit
as of the year ended December 31, 2022. Dr. Andrew Regan, the Chief Executive Officer of Corvus, is a member of Conduit&#8217;s board
of directors. For the year ended December 31, 2021, Conduit incurred $1.6 million (&#163;1.3 million) in advisory fees for funding and
review of a potential acquisition candidates to Corvus. For the nine months ended September 30, 2022, Conduit incurred director&#8217;s
fees payable to the CEO of Corvus of approximately $0.2 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January 2023, under the terms of the 2022 Convertible Loan Note Instrument, Conduit issued convertible notes payable with an aggregate
principal amount of $0.2 million (&#163;0.2 million) to Dr. Regan. The convertible notes payable generally mature three years after
issuance and bear 5% annual interest, only to be paid in the event of a material breach by Conduit of the terms of the 2022 Convertible
Loan Note Instrument or an Event of Default (as defined in the 2022 Convertible Loan Note Instrument). In the event of a Change of Control
(as defined in the 2022 Convertible Loan Note Instrument), the convertible notes payable automatically convert into ordinary shares of
Conduit at a conversion price equal to a 20% discount to the price per share paid for the most senior class of shares in respect of such
Change of Control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>St
George Street Capital</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">St
George Street Capital is a significant investor in Conduit due to its ownership of 225 ordinary shares of Conduit. Dr. David Tapolczay,
the Chief Executive Officer of St George Street Capital is also the Chief Executive Officer of Conduit. Further, Conduit has a Global
Funding Agreement (as defined below) with St George Street Capital. On March 26, 2021, Conduit entered into the Exclusive Funding
Agreement (&#8220;Global Funding Agreement&#8221;) with St George Street Capital. Under the Global Funding Agreement, Conduit
has the exclusive first right, but not the obligation, to provide or procure funding for the performance drug discovery and/or development
project that St George Street Capital wishes to undertake. The Global Funding Agreement entitles Conduit to 100% of the net revenue
on projects that Conduit funds by itself. For additional information regarding the Global Funding Agreement and related agreements,
see the &#8220;<i>Business of Conduit Pharmaceuticals Limited &#8212; Global Funding Agreement &#8212; St George Street</i>&#8221; section
of this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>A.G.P./Alliance
Global Partners</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">A.G.P./Alliance
Global Partners (&#8220;A.G.P.&#8221;) is a financial advisor to both MURF and Conduit in connection with the Business Combination transaction.
Upon the closing of the Business Combination, A.G.P. is entitled to receive (i) a cash fee of $6,500,000, 1,300,000 shares of New Conduit
common stock and warrants to purchase 54,000 shares of New Conduit common stock at an exercise price of $11.00 per share pursuant to
its engagement agreement with Conduit entered into on August 2, 2022 and (ii) $4,628,750 of deferred underwriting fees as a result of
its engagement for MURF&#8217;s initial public offering. There can be no assurance that the fact that A.G.P. acted as the financial advisor
to both parties to the Business Combination did not impact the advice that A.G.P. delivered to either or both parties, or that certain
terms of the Merger were not impacted by the potential conflict of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>New
Conduit&#8217;s Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
noted above, certain of the individuals that will serve as members of the board of directors of New Conduit upon completion of the Business
Combination have relationships with MURF, Conduit and/or one of their respective stockholders. Dr. Freda Lewis-Hall, who will serve as
the Chairman of New Conduit&#8217;s board of directors, is a shareholder of Conduit and will receive shares of New Conduit&#8217;s common
stock in the Business Combination. Dr. David Tapolczay, who will serve as a director of New Conduit and as the Chief Executive Officer
of New Conduit, is currently a stockholder of Conduit and will receive shares of New Conduit&#8217;s common stock in the Business Combination
and he is also a director of Conduit and the Chief Executive Officer of St George Street Capital. Dr. Andrew Regan, who will serve as
a director of New Conduit, is currently a director of Conduit and a shareholder of Conduit and will receive shares of New Conduit&#8217;s
common stock in the Business Combination. James Bligh, who will serve as a director of New Conduit, is an employee of Conduit. Faith
L. Charles, who will serve as a director of New Conduit, is a partner at Thompson Hine LLP, a law firm that provides legal services to
Conduit. Chele Chiavacci Farley, who will serve as a director of New Conduit, is currently a director of MURF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
addition, upon completion of the Business Combination, the executive officers of New Conduit will include Dr. David Tapolczay, as Chief
Executive Officer of New Conduit, and Adam Sragovicz, as Chief Financial Officer of New Conduit. Dr. Tapolczay is currently a director
of Conduit and the Chief Executive Officer of St George Street Capital. Mr. Sragovicz is currently MURF&#8217;s Chief Financial Officer
and a director of MURF.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the consummation of the Business Combination, New Conduit&#8217;s board of directors intends to adopt a policy with respect to the
review, approval and ratification of related party transactions. Under the policy, New Conduit&#8217;s audit committee is responsible
for reviewing and approving related person transactions. In the course of its review and approval of related party transactions, New
Conduit&#8217;s audit committee will consider the relevant facts and circumstances to decide whether to approve such transactions. In
particular, New Conduit&#8217;s policy requires New Conduit&#8217;s audit committee to consider, among other factors it deems appropriate:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    related person&#8217;s relationship to New Conduit and interest in the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    material facts of the proposed transaction, including the proposed aggregate value of the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact on a director&#8217;s or a director nominee&#8217;s independence in the event the related person is a director or director
    nominee or an immediate family member of the director or director nominee;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    benefits to New Conduit of the proposed transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    applicable, the availability of other sources of comparable products or services; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    assessment of whether the proposed transaction is on terms that are comparable to the terms available to an unrelated third party
    or to employees generally.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee may only approve those transactions that are in, or are not inconsistent with, New Conduit&#8217;s best interests and
those of New Conduit&#8217;s shareholders, as the audit committee determines in good faith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under New Conduit&#8217;s code of business conduct and ethics, which will be adopted prior to the consummation of the Business
Combination, New Conduit&#8217;s employees, officers, directors and director nominees will have an affirmative responsibility to disclose
any transaction or relationship that reasonably could be expected to give rise to a conflict of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the transactions described above were entered into prior to the adoption of the New Conduit&#8217;s written related party transactions
policy (which policy will be adopted prior to the consummation of Business Combination), but all were approved by Conduit&#8217;s board
of directors or management considering similar factors to those described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
16(a) Beneficial Ownership Reporting Compliance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires MURF&#8217;s directors, officers and persons owning more than 10% of MURF common stock to file reports
of ownership and changes of ownership with the SEC. Based on its review of the copies of such reports furnished to MURF, or representations
from certain reporting persons that no other reports were required, MURF believes that all applicable filing requirements were complied
with to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>


<!-- Field: Page; Sequence: 177; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->172<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_028"></span>COMPARISON
OF STOCKHOLDERS&#8217; RIGHTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination is consummated, shareholders of Conduit will receive and become holders of shares of new common stock of New
Conduit. Conduit is incorporated under the laws of the Cayman Islands and New Conduit is organized under the laws of Delaware. Differences
in the rights of holders of Conduit shares and holders of New Conduit common stock will arise due to differences between the laws of
their respective jurisdictions and their respective constitutional documents, including their certificates of incorporation, bylaws or
memorandum and articles of association, as applicable. As holders of shares of New Conduit common stock, your rights with respect thereto
will be governed by Delaware law, including the DGCL, as well as the second amended and restated certificate of incorporation of New
Conduit in the form attached to this proxy statement/prospectus as <i>Annex B</i> and the second amended and restated bylaws of New Conduit.
This section summarizes the material differences between the rights of Conduit shareholders and holders of shares of New Conduit common
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary is not a complete statement of the rights of the shareholders or stockholders of either of the two companies or a complete
description of the specific provisions referred to below. The identification of specific differences is not intended to indicate that
other equally significant or more significant differences do not exist. The form of the second amended and restated certificate of incorporation
of New Conduit that will be in effect upon the completion of the Business Combination is attached to this proxy statement/prospectus
as <i>Annex B</i>. We urge you to read the second amended and restated certificate of incorporation in its entirety for a complete description
of the rights and preferences of the post-combination company&#8217;s securities following the business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">For
more information on the charter amendment proposals, see the section entitled &#8220;<i>The Charter A<i>mendment</i>
Proposals</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    Conduit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conduit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
    Documents</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
    the Business Combination, the rights of the stockholders of New Conduit will be governed by the second amended and restated certificate
    of incorporation of New Conduit (the &#8220;New Conduit Charter&#8221;), the second amended and restated bylaws of New Conduit (the
    &#8220;New Conduit Bylaws&#8221;), and Delaware law, including the DGCL.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    rights of the shareholders of Conduit are governed by the memorandum of association and the articles of association of Conduit (the
    &#8220;Conduit M&amp;A&#8221;) and Cayman Islands law, including the Companies Act (as Revised) of the Cayman Islands (the &#8220;Companies
    Act&#8221;).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Number
    of Authorized Shares</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Conduit will have 250,000,000 authorized shares of capital stock, each with a par value of $0.0001 per share, consisting of 250,000,000
    authorized shares of common stock, and 1,000,000 authorized shares of preferred stock.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    authorized share capital of Conduit is GBP40,000 divided into 400,000,000 Ordinary shares of par value GBP0.0001 each.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
    Stock of New Conduit v. Ordinary Shares of Conduit</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Conduit stockholders will have no preemptive or other subscription rights and there will be no sinking fund or redemption provisions
    applicable to the common stock.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
    of ordinary shares have no preemptive or other subscription rights (other than applying for a subscription for consideration by the
    directors of Conduit). There is no sinking fund or redemption provisions applicable to the ordinary shares that Conduit&#8217;s shareholders
    may exercise. The Company may, by its directors, issue redeemable shares, with the consent by a special resolution of members, vary
    the rights attaching to a certain class of shares or purchase all or any of its own shares, including any redeemable shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 178; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->173<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
    Stock</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            New Conduit board of directors will be authorized to issue shares of preferred stock in one
                                            or more series, and to fix voting powers (if any), designations, powers, preferences and
                                            relative, participating, optional, special and other rights for each series and any qualifications,
                                            limitations or restrictions applicable to the shares of each series. The number of authorized
                                            shares of preferred stock may be increased or decreased (but not below the number of shares
                                            thereof then outstanding) without stockholder approval.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    New Conduit board of directors will be able to, subject to limitations prescribed by Delaware law, without stockholder approval,
    issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of
    the common stock and could have anti-takeover effects. The ability of the New Conduit board of directors to issue preferred stock
    without stockholder approval, while providing flexibility in connection with possible acquisitions and other corporate purposes,
    could, among other things, have the effect of delaying, deferring or preventing a change of control of New Conduit or the removal
    of New Conduit&#8217;s management and may adversely affect the market price of New Conduit common stock and the voting and other
    rights of the holders of New Conduit. New Conduit will have no preferred stock outstanding at the date the second amended and restated
    certificate of incorporation becomes effective. Although the Conduit board of directors does not currently intend to issue any shares
    of preferred stock, we cannot assure you that the New Conduit board of directors will not do so in the future.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights,
    Warrants, and Options</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Conduit will have the authority to create and issue rights, warrants, and options entitling the holders thereof to purchase shares
    of any class or series of New Conduit&#8217;s capital stock or other securities of New Conduit, and such rights, warrants and options
    shall be evidenced by or in instrument(s) approved by the New Conduit board of directors. The New Conduit board of directors will
    be empowered to set the exercise price, duration, times for exercise and other terms and conditions of such rights, warrants or options;
    provided, however, that the consideration to be received for any shares of capital stock subject thereto may not be less than the
    par value thereof.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the provisions of the Companies Act and the Conduit M&amp;A about the redemption and purchase
                                            of Conduit&#8217;s own shares, the directors have general and unconditional authority to
                                            allot (with or without confirming rights of renunciation), grant options over or otherwise
                                            deal with any unissued shares of Conduit to such persons, at such times and on such terms
                                            and conditions as they may decide.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Share of Conduit may be issued at a discount except in accordance with the Companies Act.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
    Power</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
    as otherwise required by law or by the second amended and restated certificate of incorporation, the holders of common stock will
    possess all voting power for the election of New Conduit&#8217;s directors and all other matters requiring stockholder action. Holders
    of common stock are entitled to one vote per share.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    holders of ordinary shares are entitled to one vote per share. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
    Elections</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the special rights of the holders of one or more series of preferred stock to elect directors, at each succeeding annual meeting
    of stockholders, a director shall be elected and hold office until the next annual meeting of stockholders. There is no cumulative
    voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election
    of directors can elect all of the directors.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
    may, by resolutions passed by a simple majority of the voting powers of Conduit shareholders as, being entitled to do so, voting
    at a general meeting of Conduit or approved in writing, appoint any person to be a director of Conduit. The board of directors of
    Conduit may also appoint any person to be a director. Each appointment of directors may be to either to fill a vacancy or as an addition
    to the existing directors, subject to any upper limit on the number of directors prescribed pursuant to the Conduit M&amp;A. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to applicable law and the rights, if any, of the holders of any outstanding series of the preferred stock, the holders of the shares
    of the common stock shall be entitled to receive such dividends and other distributions (payable in cash, property or capital stock
    of New Conduit) when, as and if declared thereon by the New Conduit board of directors from time to time out of any assets or funds
    of New Conduit legally available therefor, and shall share equally on a per share basis in such dividends and distributions.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the Companies Act, Conduit may by ordinary resolution declare dividends in accordance
                                            with the respective rights of the members but no dividend shall exceed the amount recommended
                                            by the directors.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    directors may pay interim dividends or declare final dividends in accordance with the respective rights of the members if it appears
    to them that they are justified by the financial position of Conduit and that such dividends may lawfully be paid.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
    may be paid in cash or wholly or partly by the distribution of assets.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 179; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->174<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exclusive
    Forum</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            New Conduit consents in writing to the selection of an alternative forum, the Court of Chancery
                                            of the State of Delaware shall, to the fullest extent permitted by the applicable law, the
                                            Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any
                                            stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding
                                            brought on behalf of New Conduit, (ii) any action asserting a claim of breach of a fiduciary
                                            duty owed by any director, officer or other employee of New Conduit to New Conduit or New
                                            Conduit&#8217;s stockholders, (iii) any action asserting a claim against New Conduit, its
                                            directors, officers or employees arising pursuant to any provision of the DGCL or the second
                                            amended and restated certificate of incorporation or the bylaws, or (iv) any action asserting
                                            a claim against New Conduit, its directors, officers or employees governed by the internal
                                            affairs doctrine and, if brought outside of Delaware, the stockholder bringing the suit will
                                            be deemed to have consented to service of process on such stockholder&#8217;s counsel except
                                            any action (A) as to which the Court of Chancery in the State of Delaware determines that
                                            there is an indispensable party not subject to the jurisdiction of the Court of Chancery
                                            (and the indispensable party does not consent to the personal jurisdiction of the Court of
                                            Chancery within ten days following such determination), (B) which is vested in the exclusive
                                            jurisdiction of a court or forum other than the Court of Chancery, or (C) for which the Court
                                            of Chancery does not have subject matter jurisdiction. Notwithstanding the foregoing sentence
                                            will not apply to suits brought to enforce any liability or duty created by the Exchange
                                            Act or any other claim for which the federal courts have exclusive jurisdiction, and (ii)
                                            to the fullest extent permitted by the applicable law, the federal district courts of the
                                            United States of America for the District of Delaware and the Court of Chancery of the State
                                            of Delaware shall have concurrent jurisdiction for the resolution of any complaint asserting
                                            a cause of action arising under the Securities Act or the rules and regulations promulgated
                                            thereunder.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    any action the subject matter of which is within the scope described above is filed in a court other than a court located within
    the State of Delaware (a &#8220;Foreign Action&#8221;) in the name of any stockholder, such stockholder shall be deemed to have consented
    to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action
    brought in any such court to enforce Section 12.1 of the New Conduit Bylaws immediately above (an &#8220;FSC Enforcement Action&#8221;)
    and (ii) having service of process made upon such stockholder in any such FSC Enforcement Action by service upon such stockholder&#8217;s
    counsel in the Foreign Action as agent for such stockholder.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation,
    Dissolution, and Winding Up</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to applicable law and the rights, if any, of the holders of any outstanding series of the preferred stock, in the event of any voluntary
    or involuntary liquidation, dissolution or winding-up of New Conduit, after payment or provision for payment of the debts and other
    liabilities of New Conduit, the holders of the shares of the common stock shall be entitled to receive all the remaining assets of
    New Conduit available for distribution to its stockholders, ratably in proportion to the number of shares of the common stock held
    by them.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the event of any voluntary or involuntary liquidation, dissolution or winding-up of Conduit,
                                            after payment or provision for payment of the debts and other liabilities of Conduit, Conduit
                                            will distribute any remaining proceeds or assets to holders of ordinary shares ratably in
                                            proportion to the number of shares then held by them.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
    if Conduit is wound up, the members may, subject to the Conduit M&amp;A and any other sanction required by the Companies Act, pass
    a special resolution allowing the liquidator to do either or both of: (a) to divide in specie among the members the whole or any
    part of the assets of Conduit and, for that purpose, to value any assets and to determine how the division shall be carried out as
    between the members or different classes of members; (b) to vest the whole or any part of the assets in trustees for the benefit
    of members and those liable to contribute to the winding up.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>


<!-- Field: Page; Sequence: 180; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->175<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_029"></span>DESCRIPTION
OF NEW CONDUIT SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of the material terms of the share capital of New Conduit following the Transactions includes a summary of specified
provisions of the charter documents of New Conduit that will be in effect upon completion of the Transactions. This description is qualified
by reference to New Conduit&#8217;s charter documents as will be in effect upon consummation of the Transactions, copies of which are
attached to this proxy statement/prospectus and are incorporated in this proxy statement/prospectus by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Business Combination, New Conduit&#8217;s second amended and restated certificate of incorporation will provide for 251,000,000 authorized
shares, consisting of (a) 250,000,000 shares of common stock, $0.0001 par value per share, and (b) 1,000,000 shares of preferred stock,
$0.0001 par value per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the common stock will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the voting power
represented by shares of New Conduit common stock voted for the election of directors can elect all of the directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of New Conduit common stock will not have any conversion, preemptive or other subscription rights and there will be no sinking fund or
redemption provisions applicable to the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s second amended and restated certificate of incorporation will authorize the issuance of 1,000,000 shares of preferred
stock with such designations, rights and preferences as may be determined from time to time by the New Conduit board of directors. The
New Conduit board of directors will be empowered, without stockholder approval, to issue the preferred stock with dividend, liquidation,
conversion, voting or other rights which could adversely affect the voting power or other rights of the holders of New Conduit common
stock. In addition, the preferred stock could be utilized as a method of discouraging, delaying or preventing a change in control of
New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Transactions, New Conduit will have warrants outstanding to purchase an aggregate of 16,733,000 shares of
common stock (assuming no holders of public shares of New Conduit seek to redeem such shares). Each outstanding whole warrant of New
Conduit shall continue to represent the right to purchase one share of common stock upon closing of the Transactions at a price of $11.00
per share, subject to adjustment as discussed below, at any time commencing on the later of 30 days after the consummation of a business
combination and 12 months from the closing of the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle
such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying
the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below
with respect to registration. No warrant will be exercisable and we will not be obligated to issue shares of common stock upon exercise
of a warrant unless the common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under
the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately
preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant
and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. In the event
that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have
paid the full purchase price for the unit solely for the share of common stock underlying such unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants, as well as any warrants underlying additional units issued to the Sponsor or New Conduit&#8217;s officers, directors
or their affiliates in payment of working capital loans, are identical to the warrants underlying the units offered in the initial public
offering except that such warrants will be exercisable for cash or on a cashless basis, at the holder&#8217;s option, and will not be
redeemable by New Conduit, in each case so long as they are still held by the Sponsor or its permitted transferees. The Private Warrants
will become worthless if MURF does not consummate a business combination by February 7, 2023 (or August 7, 2023, at the election of MURF
subject to satisfaction of certain conditions in accordance with its amended and restated certificate of incorporation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 181; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->176<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit may call the warrants for redemption (excluding the Private Warrants and any warrants underlying additional units issued to the
Sponsor, New Conduit&#8217;s officers, directors or their affiliates in payment of working capital loans made to New Conduit), in whole
and not in part, at a price of $0.01 per warrant,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                            not less than 30 days&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr>
                                                                                                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
                                                                                                                                      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, the reported last sale price of the common stock equals or exceeds $18.00 per
                                            share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
                                            and the like) for any 20 trading days within a 30-trading day period commencing once the
                                            warrants become exercisable and ending three business days before we send the notice of redemption
                                            to the warrant holders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by New Conduit, New Conduit may not exercise its redemption right if the issuance of shares of
common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or New
Conduit are unable to effect such registration or qualification. New Conduit will use its best efforts to register or qualify such shares
of common stock under the blue sky laws of the state of residence in those states in which the warrants were offered by New Conduit in
the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
New Conduit calls the warrants for redemption as described above, New Conduit&#8217;s management will have the option to require any
holder that wishes to exercise its warrant to do so on a &#8220;cashless basis.&#8221; In determining whether to require all holders
to exercise their warrants on a &#8220;cashless basis,&#8221; New Conduit&#8217;s management will consider, among other factors, New
Conduit&#8217;s cash position, the number of warrants that are outstanding and the dilutive effect on New Conduit stockholders of issuing
the maximum number of shares of common stock issuable upon the exercise of our warrants. If New Conduit&#8217;s management takes advantage
of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of common
stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied
by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y) the fair
market value. The &#8220;fair market value&#8221; for this purpose shall mean the average reported last sale price of the common stock
for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of
warrants. If New Conduit&#8217;s management takes advantage of this option, the notice of redemption will contain the information necessary
to calculate the number of shares of common stock to be received upon exercise of the warrants, including the &#8220;fair market value&#8221;
in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive
effect of a warrant redemption. New Conduit believes this feature is an attractive option to New Conduit if it does not need the cash
from the exercise of the warrants after its initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of a warrant may notify New Conduit in writing in the event it elects to be subject to a requirement that such holder will not
have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person&#8217;s
affiliates), to the warrant agent&#8217;s actual knowledge, would beneficially own in excess of 4.9% (or such other amount as a holder
may specify) of the shares of common stock outstanding immediately after giving effect to such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the number of outstanding shares of common stock is increased by a stock dividend payable in shares of common stock, or by a split-up
of shares of common stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the
number of shares of common stock issuable on exercise of each whole warrant will be increased in proportion to such increase in the outstanding
shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if New Conduit, at any time while the warrants are outstanding and unexpired, pays a dividend or makes a distribution in cash,
securities or other assets to the holders of common stock on account of such shares of common stock (or other shares of New Conduit&#8217;s
capital stock into which the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends, (c) to
satisfy the redemption rights of the holders of common stock in connection with a proposed initial business combination, (d) to satisfy
the redemption rights of the holders of common stock in connection with a stockholder vote to amend New Conduit&#8217;s amended and restated
certificate of incorporation (i) to modify the substance or timing of New Conduit&#8217;s obligation to allow redemption in connection
with New Conduit&#8217;s initial business combination or certain amendments to New Conduit&#8217;s charter prior thereto or to redeem
100% of New Conduit&#8217;s common stock if New Conduit does not complete its initial business combination within 12 months from the
closing of this offering (or up to 18 months from the closing of the offering at the election of New Conduit subject to satisfaction
of certain conditions or as extended by the New Conduit stockholders in accordance with New Conduit&#8217;s amended and restated certificate
of incorporation) or (ii) with respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination
activity, or (e) in connection with the redemption of our public shares upon New Conduit&#8217;s failure to complete its initial business
combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the
amount of cash and/or the fair market value of any securities or other assets paid on each share of common stock in respect of such event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the number of outstanding shares of New Conduit&#8217;s common stock is decreased by a consolidation, combination, reverse stock split
or reclassification of shares of common stock or other similar event, then, on the effective date of such consolidation, combination,
reverse stock split, reclassification or similar event, the number of shares of common stock issuable on exercise of each warrant will
be decreased in proportion to such decrease in outstanding shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 182; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->177<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case of any reclassification or reorganization of the outstanding shares of common stock (other than those described above or that solely
affects the par value of such shares of common stock), or in the case of any merger or consolidation of us with or into another corporation
(other than a consolidation or merger in which New Conduit is the continuing corporation and that does not result in any reclassification
or reorganization of New Conduit&#8217;s outstanding shares of common stock), or in the case of any sale or conveyance to another corporation
or entity of the assets or other property of New Conduit as an entirety or substantially as an entirety in connection with which New
Conduit is dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the
terms and conditions specified in the warrants and in lieu of the shares of New Conduit&#8217;s common stock immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities
or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following
any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately
prior to such event. However, if less than 70% of the consideration receivable by the holders of common stock in such a transaction is
payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted
in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered
holder of the warrant properly exercises the warrant within 30 days following public disclosure of such transaction, the warrant exercise
price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of
the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary
transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive
the full potential value of the warrants in order to determine and realize the option value component of the warrant. This formula is
to compensate the warrant holder for the loss of the option value portion of the warrant due to the requirement that the warrant holder
exercise the warrant within 30 days of the event. The Black-Scholes model is an accepted pricing model for estimating fair market value
where no quoted market price for an instrument is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants will be issued in registered form under a warrant agreement between Vstock Transfer, LLC, as warrant agent, and New Conduit.
You should review a copy of the warrant agreement, which will be filed as an exhibit to the registration statement of which this proxy
statement/prospectus is a part, for a complete description of the terms and conditions applicable to the warrants. The warrant agreement
provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any mistake,
including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement
set forth in this proxy statement/prospectus, or defective provision, but requires the approval by the holders of at least a majority of the then outstanding
public warrants to make any change that adversely affects the interests of the registered holders of public warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) New Conduit issues additional shares of common stock or equity-linked securities for capital raising purposes in connection
with the closing of the initial business combination at a Newly Issued Price of less than $9.20 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the New Conduit board of directors and, in the case of any such
issuance to New Conduit&#8217;s sponsor or its affiliates, without taking into account any founder shares held by New Conduit&#8217;s
sponsor such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more
than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date
of the consummation of the initial business combination (net of redemptions), and (z) the Market Value is below $9.20 per share, then
the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and
the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be
equal to 180% of the greater of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant
agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full
payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number
of warrants being exercised. The warrant holders do not have the rights or privileges of holders of common stock and any voting rights
until they exercise their warrants and receive shares of common stock. After the issuance of shares of common stock upon exercise of
the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive
a fractional interest in a share, New Conduit will, upon exercise, round down to the nearest whole number of shares of common stock to
be issued to the warrant holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Anti-Takeover Provisions of Delaware Law and New Conduit&#8217;s Proposed Second Amended and Restated Certificate of Incorporation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination and assuming approval of the New Conduit charter amendment proposals, New Conduit will have
certain anti-takeover provisions in place as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 183; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->178<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Special
Meeting of Stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s bylaws will provide that, subject to the rights of the holders of any outstanding series of the preferred stock of New
Conduit and to the requirements of applicable law, special meetings of stockholders, for any purpose or purposes, may be called only
by (i) the chairperson of the board of directors, (ii) the chief executive officer, or (iii) a majority vote of New Conduit&#8217;s board
of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
Notice Requirements for Stockholder Proposals and Director Nominations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s bylaws will provide that, in addition to any other applicable requirements, for a nomination to be made by a stockholder,
such stockholder must have given timely notice thereof in proper written form to the Secretary. To be timely, a stockholder&#8217;s notice
to the Secretary must be received by the Secretary at the principal New Conduit&#8217;s executive offices (i) in the case of an annual
meeting, not later than the close of business on the 90th day nor earlier than the close of business on the 120th day before the anniversary
date of the immediately preceding annual meeting of stockholders; provided, however, that in the event that the annual meeting is more
than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so received no earlier
than the close of business on the 120th day before the meeting and not later than the later of (x) the close of business on the 90th
day before the meeting, or (y) the close of business on the 10th day following the day on which public announcement of the date of the
annual meeting was first made by New Conduit; and (ii) in the case of a special meeting of stockholders called for the purpose of electing
directors, not later than the close of business on the 10th day following the day on which public announcement of the date of the special
meeting is first made by New Conduit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Authorized
but Unissued Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s authorized but unissued common stock and preferred stock will be available for future issuances without stockholder approval
and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee
benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or
discourage an attempt to obtain control of New Conduit by means of a proxy contest, tender offer, merger or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exclusive
Forum Selection</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s second amended and restated certificate of incorporation will require that, to the fullest extent permitted by the applicable
law, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial
owner) to bring (i) any derivative action or proceeding brought on behalf of New Conduit, (ii) any action asserting a claim of breach
of a fiduciary duty owed by any director, officer or other employee of New Conduit to New Conduit or New Conduit&#8217;s stockholders,
(iii) any action asserting a claim against New Conduit, its directors, officers or employees arising pursuant to any provision of the
DGCL or the second amended and restated certificate of incorporation or the bylaws, or (iv) any action asserting a claim against New
Conduit, its directors, officers or employees governed by the internal affairs doctrine and, if brought outside of Delaware, the stockholder
bringing the suit will be deemed to have consented to service of process on such stockholder&#8217;s counsel except any action (A) as
to which the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction
of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten
days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery,
or (C) for which the Court of Chancery does not have subject matter jurisdiction. Notwithstanding the foregoing, (i) the foregoing will
not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal courts
have exclusive jurisdiction and (ii) to the fullest extent permitted by the applicable law, the federal district courts of the United
States of America for the District of Delaware and the Court of Chancery of the State of Delaware shall have concurrent jurisdiction
for the resolution of any complaint asserting a cause of action arising under the Securities Act or the rules and regulations promulgated
thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes
with New Conduit or any of New Conduit&#8217;s directors, officers, other employees or stockholders, which may discourage lawsuits with
respect to such claims. New Conduit cannot be certain that a court will decide that this provision is either applicable or enforceable,
and if a court were to find the choice of forum provision contained in New Conduit&#8217;s second amended and restated certificate of
incorporation to be inapplicable or unenforceable in an action, New Conduit may incur additional costs associated with resolving such
action in other jurisdictions, which could harm New Conduit&#8217;s business, operating results and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitation
on Liability and Indemnification of Directors and Officers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s second amended and restated certificate of incorporation will provide that directors and officers will be indemnified
by New Conduit to the fullest extent authorized by Delaware law as it now exists or may in the future be amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Conduit&#8217;s bylaws will also permit New Conduit to secure insurance on behalf of any officer, director or employee for any liability
arising out of his or her actions, regardless of whether Delaware law would permit indemnification. Upon consummation of the Business
Combination, New Conduit will have purchased a policy of directors&#8217; and officers&#8217; liability insurance that insures New Conduit&#8217;s
directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances and insures New Conduit
against its obligations to indemnify the directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may discourage stockholders from bringing a lawsuit against New Conduit&#8217;s directors for breach of their fiduciary duty.
These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though
such an action, if successful, might otherwise benefit New Conduit and New Conduit stockholders. Furthermore, a stockholder&#8217;s investment
may be adversely affected to the extent New Conduit pays the costs of settlement and damage awards against directors and officers pursuant
to these indemnification provisions. We believe that these provisions, the insurance and the indemnity agreements are necessary to attract
and retain talented and experienced directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to New Conduit&#8217;s directors, officers and controlling
persons pursuant to the foregoing provisions, or otherwise, New Conduit has been advised that, in the opinion of the SEC, such indemnification
is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 184; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->179<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_030"></span>MURF
SECURITIES AND DIVIDENDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Murphy
Canyon Acquisition Corp.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Market
Price of Units, Common Stock and Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF&#8217;s
units, warrants and Class A common stock are traded on the Nasdaq Stock Market LLC under the symbols MURFU, MURFW and MURF, respectively.
The shares of MURF Class A common stock and warrants underlying the units began trading separately on the Nasdaq Global Market on February
3, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2023, there were &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; holders of record of units,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
holders of record of shares of MURF common stock and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
holder of record of warrants. Management believes MURF has in excess of 300 beneficial holders of its securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
has not paid any dividends to its security holders to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transfer
Agent and Warrant Agent</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent for MURF common stock and warrant agent for its warrants upon consummation of the Business Combination will be VStock
Transfer, LLC, 18 Lafayette Place, Woodmere, NY 11598.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conduit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Market
Price of Ordinary Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historical
market price information regarding Conduit is not provided because there is no public market for its securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2023, there were &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; holders of record of Conduit
shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 185; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->180<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_031"></span>OTHER
STOCKHOLDER COMMUNICATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
and interested parties may communicate with the MURF Board, any committee chairperson or the non-management directors as a group by writing
to the board or committee chairperson in care of Murphy Canyon Acquisition Corp., 4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123.
Following the Business Combination, such communications should directed to Jack K. Heilbron, Chief Executive Officer. Each communication
will be forwarded, depending on the subject matter, to the board of directors, the appropriate committee chairperson or all non-management
directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_032"></span>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference LLP will pass upon the validity of the shares of New Conduit common stock to be issued in connection with the Business Combination.
The material U.S. federal income tax consequences of the Business Combination will be passed upon for Conduit by Thompson Hine LLP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_033"></span>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Murphy Canyon Acquisition Corp. as of December 31, 2022 and 2021, and for the year ended December
31, 2022 and the period from October 19, 2021 (inception) through December 31, 2021, included in this proxy statement/prospectus,
have been audited by Marcum LLP, independent registered public accounting firm, as set forth in its report thereon, appearing elsewhere
in this proxy statement/prospectus, and are included in reliance upon such report given on the authority of said firm as experts in auditing
and accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Conduit Pharmaceuticals Limited as of December 31, 2022, and 2021, and for the years then ended included
in this proxy statement/prospectus (which contain an explanatory paragraph relating to the substantial doubt about the abilities of Conduit
Pharmaceuticals Limited to continue as a going concern as described in Note 1 to the financial statements) have been so included in reliance
on the report of Marcum LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing
and accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="md_034"></span>DELIVERY
OF DOCUMENTS TO STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the rules of the SEC, MURF and services that it employs to deliver communications to its stockholders are permitted to deliver to
two or more stockholders sharing the same address a single copy of MURF&#8217;s proxy statement. Upon written or oral request, MURF will
deliver a separate copy of the proxy statement to any stockholder at a shared address to which a single copy of each document was delivered
and who wishes to receive separate copies of such documents. Stockholders receiving multiple copies of such documents may likewise request
that MURF deliver single copies of such documents in the future. Stockholders may notify MURF of their requests by calling or writing
MURF at its principal executive offices at 4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123 or (760) 471-8536. Following the Business
Combination, such requests should be made by calling or writing New Conduit at 4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123,
or (760) 471-8536.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="md_035"></span><b>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURF
files reports, proxy statements and other information with the SEC as required by the Exchange Act. You may access information on MURF
at the SEC web site containing reports, proxy statements and other information at: <i>http://www.sec.gov</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
and statements contained in this proxy statement/prospectus or any annex to this proxy statement/prospectus are qualified in all respects
by reference to the copy of the relevant contract or other annex filed as an exhibit to this proxy statement/prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
information contained in this document relating to MURF has been supplied by MURF, and all such information relating to Conduit has been
supplied by Conduit. Information provided by one another does not constitute any representation, estimate or projection of the other.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you would like additional copies of this document or if you have questions about the Business Combination, you should contact via phone
or in writing:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
K. Heilbron</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92123</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(760)
471-8536</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 186; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->181<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="md_036"></span>INDEX
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audited
    Financial Statements of Conduit Pharmaceuticals Limited:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page(s)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_001">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_002">Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>F-3</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_003">Statements of Operations and Comprehensive Loss</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>F-4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_004">Statements of Changes in Shareholders&#8217; Deficit</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>F-5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_005">Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>F-6</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_006">Notes to Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-7</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audited
    Financial Statements of Murphy Canyon Acquisition Corp.:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sj_022">Report
    of Independent Registered Public Accounting Firm</a> (PCAOB No. 688)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sj_023">Balance
    Sheets as of December 31, 2022 and 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-22</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sj_024">Statements
    of Operations for the year ended December 31, 2022 and for the period from October 19, 2021 (inception) through December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sj_025">Statements
    of Changes in Stockholders&#8217; Equity (Deficit) for the year ended December 31, 2022 and for the period from October 19, 2021
    (inception) through December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sj_026">Statements
    of Cash Flows for the year ended December 31, 2022 and for the period from October 19, 2021 (inception) through December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sj_027">Notes
    to Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-26</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 187; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceutical Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying balance sheets of Conduit Pharmaceuticals Limited (the &#8220;Company&#8221;) as of December 31, 2022 and
2021, the related statements of operations and comprehensive loss, changes in shareholders&#8217; deficit and cash flows for each of
the two years in the period ended December 31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022,
in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Explanatory
Paragraph &#8211; Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described
in Note 1, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds
to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company&#8217;s ability to continue
as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the
United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were
we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an
understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the
Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum <span style="font-variant: small-caps">llp</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<span style="font-variant: small-caps">llp</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif">New
York, NY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 12, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 188; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
31, 2022<br />
<b>CONDUIT PHARMACEUTICALS LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_002"></span>BALANCE
SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share amounts)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Intangible assets &#8211; research and development</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Liabilities and shareholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,308</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">927</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Option liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,404</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,235</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible notes payable, carried at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">749</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,083</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,958</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Notes payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">175</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,081</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,942</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Commitments and Contingencies (Note 8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ordinary shares, par value $0.0001 (&#163;0.0001) per share; 400,000,000 shares authorized; 2,000 and 1,000 shares issued and outstanding as of December 31, 2022 and 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,764</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,877</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">688</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total shareholders&#8217; deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,076</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,942</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and shareholders&#8217; deficit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 189; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
PHARMACEUTICALS LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_003"></span>STATEMENTS
OF OPERATIONS AND COMPREHENSIVE LOSS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share amounts and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Research and development expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">37</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">28</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,890</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Funding expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">74</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">255</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,160</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,173</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss from operation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,160</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,173</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,727</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(484</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,727</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(484</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,887</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,657</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to ordinary shareholders &#8211; basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,887</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,657</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted-average shares outstanding used in calculating net loss per share &#8211; basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Comprehensive loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,887</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,657</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,134</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,578</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br /></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 190; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
PHARMACEUTICALS LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_004"></span>STATEMENTS
OF CHANGES IN SHAREHOLDERS&#8217; DEFICIT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share amounts)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-style: italic">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">other</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-style: italic">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Ordinary shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">comprehensive</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">shareholders&#8217;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-style: italic">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"> deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">   income/(loss)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"> deficit</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-weight: bold">Balance at January 1, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,220</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(144</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,364</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,657</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,657</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance at December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5,877</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(65</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5,942</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Issuance of common shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">753</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">753</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,887</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,887</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Balance at December 31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,764</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">688</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,076</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 191; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
PHARMACEUTICALS LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_005"></span>STATEMENTS
OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net Loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(4,887</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(3,657</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss on sale of equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">129</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in fair value of convertible notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in loan allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">331</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued expenses and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,357</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash flows used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,266</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,151</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loans to related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(331</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash flows used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(183</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of convertible notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">688</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from sale of equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,341</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,210</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Proceeds from related party long-term debt</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">179</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash flows provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,448</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,898</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net change in cash and cash equivalents before effect of exchange rate changes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(253</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Effect of exchange rate changes on cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net decrease in cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, at beginning of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">252</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, ending</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Supplemental schedule of noncash financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">FV of shares received related to the sale of future revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,471</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,286</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 192; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
PHARMACEUTICALS LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_006"></span>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature
                                            of the Business, Basis of Presentation and Summary of Significant Accounting Policies</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals Limited, formerly known as SGS Global Limited (&#8220;Conduit&#8221; or the &#8220;Company&#8221;), was incorporated
in the Cayman Islands as an exempted company in December 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical
assets that have not been, or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products
that meet the unmet medical needs of patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including
uveitis, Hashimoto&#8217;s Thyroiditis, preterm labor and renal transplant rejection. The Company&#8217;s development pipeline also includes
a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2022, the Company entered into a Merger Agreement (the &#8220;Merger Agreement&#8221;) with Conduit Merger Sub, Inc. (&#8220;Merger
Sub&#8221;) and Murphy Canyon Acquisition Corp. (&#8220;MURF&#8221;), a publicly traded blank check special purpose acquisition company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Merger proposed in the Merger Agreement, a wholly owned subsidiary of Murphy will merge with the Company, with the Company
being the surviving company and therefore becoming, upon closing of the Merger Agreement, a wholly owned subsidiary of Murphy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination will be accounted for a reverse recapitalization in accordance with U.S. GAAP. Under the reverse recapitalization
method, MURF will be treated as the acquired company for financial reporting purposes, and the Company, the accounting acquirer, will
be assumed to have issued shares of stock for the net assets of MURF, with no goodwill or other intangible assets recorded. This determination
is primarily based on the following predominant factors: (i) post-closing, the Company&#8217;s shareholders are expected to have a majority
of the voting power of the combined company and ability to elect the members of the combined company&#8217;s Board of Directors (&#8220;Board&#8221;);
(ii) the on-going operations post-merger will comprise those of Conduit; and (iii) all of the senior management of the combined company,
except for the Chief Financial Officer, will be members of the management of the Company. As a result of the Business Combination, MURF
will be renamed &#8220;Conduit Pharmaceuticals Inc.&#8221; The board of directors of each MURF and Conduit have each approved the Business
Combination. The completion of the Business Combination, which is expected to occur in the second quarter of 2023, is subject
to a special resolution of the Company&#8217;s shareholders and approval of MURF&#8217;s stockholders of the respective entities and
the satisfaction or waiver of certain other customary closing conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange Commission. The functional currency
of the Company is the British pound sterling. The accompanying financial statements are reported in United States Dollars, the reporting
currency of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 193; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
and Going Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
its inception, and in line with its growth strategy, the Company has prepared its financial statements assuming it will continue as a
going concern. Since its inception, the Company has incurred net losses and negative cash flows from operations. As of December 31, 2022,
and 2021, the Company had an accumulated deficit of $10.8 million and $5.9 million, respectively. For the years ended December 31, 2022
and 2021, the Company had net losses of $4.9 million and $3.7 million, respectively, and cash used in operating activities of $2.3 million
and $2.2 million, respectively. To date, the Company has not generated sufficient liquidity to fund its operations and has relied on
funding through a combination of debt and equity financing. The Company has determined additional financing will be required to fund
its operations for the next twelve months and the ability of the Company to continue as a going concern is dependent upon obtaining such
additional financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in Note 5 &#8211; Convertible Notes Payable, in the fourth quarter of 2022 the Company approved approximately $3.6
million of Convertible Notes, of which approximately $1.8 million was issued and funded in full through the date of issuance of the financial
statements. Additionally, as further discussed in the preceding section, on November 8, 2022, the Company entered into a definitive Agreement
and Plan of Merger with Merger Sub and MURF, that included a private placement of an aggregate amount of $27 million of MURF&#8217;s
shares of common stock which will be settled upon closing (referred to as the &#8220;PIPE&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has raised and plans on raising further funds as set out above including through the above-mentioned convertible debt as well
as through the transactions contemplated by the Merger Agreement and the related PIPE transaction. There is currently no public market
for the Company&#8217;s ordinary shares. While the Company believes in the viability of its ability to raise additional funds, there
can be no assurances to that effect. These matters raise substantial doubt about the Company&#8217;s ability to continue as a going concern
for a period of twelve months from the issue date of this report. These financial statements have been prepared assuming the Company
will continue as a going concern and do not include adjustments to reflect the possible effects on the recoverability and classification
of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to risks common to companies in the pharmaceutical industry including, but not limited to, uncertainties related to
commercialization of competitor products, regulatory approvals, dependence on key products, dependence on key customers and suppliers,
and protection of intellectual property rights. Clinical assets currently under development will require significant additional research
and development efforts, including extensive preclinical and clinical testing and regulatory approval prior to commercialization. These
efforts will require significant amounts of additional capital, adequate personnel, infrastructure, and extensive compliance and reporting
capabilities. Even if the Company&#8217;s efforts are successful, it is uncertain when, if ever, the Company will realize significant
revenue from product sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on March 11, 2020, the World Health Organization declared the Coronavirus Disease 2019 (&#8220;COVID-19&#8221;) a global pandemic.
The pandemic has been a highly disruptive economic and societal event that remains unpredictable. Its duration and extent continue to
be dependent on various developments, such as the emergence of variants to the virus that may cause additional strains of COVID-19, the
administration and ultimate effectiveness of vaccines, and the eventual timeline to achieve a sufficient level of herd immunity among
the general population. Accordingly, the COVID-19 pandemic may continue to have negative effects on the health of the U.S. and other
economies for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
this crisis has unfolded, the Company has continued to monitor conditions and adapt its operations to meet federal, state, and local
standards. The Company cannot predict the duration or severity of the COVID-19 pandemic or its ultimate impact on the broader economy
or the Company&#8217;s operations and liquidity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the pandemic, all clinical trials in the United Kingdom that were not related to COVID-19 were put on hiatus through a significant
portion of the year ended December 31, 2021. During the year ended December 31, 2022, the hiatus As a result, during the hiatus, the
Company shifted its activities to focus on clinical trials related to COVID-19.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 194; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Significant Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents are primarily maintained with major financial institutions in the United Kingdom and Switzerland. The Company considers
cash equivalents to be short-term, highly liquid investments that (a) are readily convertible into known amounts of cash, (b) are traded
and held for cash management purposes, and (c) have original maturities of three months or less at the time of purchase. The Switzerland
bank accounts holding cash balances are uninsured. The Company has not experienced any losses on this account through the year ended
December 31, <span style="font-weight: normal">2022.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">As
of December 31, 2022 and 2021, the Company did not hold any cash equivalents. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and related disclosures of contingent assets and liabilities at the date of the financial
statements as well as the reported amounts of revenues and expenses during the reporting period. Estimates are based on several factors
including the facts and circumstances available at the time the estimates are made, historical experience, risk of loss, general economic
conditions and trends, and the assessment of the probable future outcome. Subjective and significant estimates include, but are not necessarily
limited to, the inputs used to determine the fair value of convertible notes payable and the amount to reserve for the related party
loan receivable. Actual results could differ materially from such estimates. Estimates and assumptions are reviewed periodically by management
and changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. The effects of changes
are reflected in the financial statements in the period that they are determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Accounting
Standards Codification (&#8220;ASC&#8221;) Topic 820, Fair Value Measurements and Disclosures, defines fair value, establishes a framework
for measuring fair value, and expands disclosures about fair value measurements. Fair value is to be determined based on the exchange
price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market
for the asset or liability in an orderly transaction between market participants. In determining fair value, the Company used various
valuation approaches. A fair value hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable
inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs
are those that market participants would use in pricing the asset or liability based on market data obtained from sources independent
of the Company. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Unobservable
inputs reflect the Company&#8217;s assumption about the inputs that market participants would use in pricing the asset or liability developed
based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels, based on the
inputs, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1&#8212;Valuations based on quoted prices for identical instruments in active markets. Since valuations are based on quoted prices
    that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree
    of judgment.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 195; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2&#8212; Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for either similar
    instruments in active markets, identical or similar instruments in markets that are not active, or model-derived valuations whose
    inputs or significant value drivers are observable or can be corroborated by observable market data.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3&#8212;Valuations based on inputs that are unobservable. These valuations require significant judgment.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company&#8217;s Level 1 assets consist of cash and cash equivalents in the accompanying balance sheets and the value of accrued expenses
and other current liabilities approximate fair value due to the short-term nature of these assets and liabilities. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">As
of December 31, 2022 and 2021, the Company has two financial liabilities, convertible notes that are adjusted to fair value
on a recurring basis as well as an option liability for which the fair value is determined based on Level 3 inputs as such inputs
are not readily observable. See Note 2 and Note 5 for further information on the Company&#8217;s financial liability held at fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development and Funding</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Research
and development expenses consist primarily of costs incurred in connection with the research and development of our product candidates
and programs. Funding expenses consist primarily of costs incurred in connection with the Company providing funding to St George Street
Capital (&#8220;St George Street&#8221;) to carry out its research and development activities. St George Street holds all
licenses to conduct clinical research through third party pharmaceutical companies. The Company expenses research and development costs
and intangible assets acquired that have no alternative future use as incurred. These expenses include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
    incurred under agreements with organizations that support the Company&#8217;s drug discovery and development activities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
    incurred in connection with the preclinical and clinical development of the Company&#8217;s product candidates and programs, including
    under agreements with contract research organizations, or CROs&#894;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    related to contract manufacturing organizations, or CMOs, that are primarily engaged to provide drug substance and product for our
    clinical trials, research and development programs, as well as investigative sites and consultants that conduct the Company&#8217;s
    clinical trials, nonclinical studies and other scientific development services&#894;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs of acquiring and manufacturing nonclinical and clinical trial materials, including manufacturing registration and validation
    batches&#894;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">employee-related
    expenses, including salaries, related benefits and equity-based compensation expense, for employees engaged in research and development
    functions&#894;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    related to compliance with quality and regulatory requirements&#894;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">payments
    made under third-party licensing agreements&#894; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">direct
    and allocated costs related to facilities, information technology, personnel and other overhead.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Advance
payments that we make for goods or services to be received in the future for use in research and development activities are recorded
as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or consumed or the related services are performed,
or until it is no longer expected that the goods will be delivered, or the services rendered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">General
and administrative expenses consist primarily of salaries and related costs for personnel in executive management, finance, corporate
and business development, and administrative functions. General and administrative expenses also include legal fees relating to patent
and corporate matters&#894; professional fees for accounting, auditing, tax, and administrative consulting services&#894; insurance costs&#894;
administrative travel expenses and other operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 196; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company has incurred increased accounting, audit, legal, regulatory, compliance and director and officer insurance costs as well as investor
and public relations expenses associated with being a public company. The Company anticipates that its general and administrative expenses
will increase in the future as it increases its headcount to support the development of its product candidates and programs and with
continued research and development activities.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income
Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">ASC
Topic 740, <i>Income Taxes</i>, sets forth standards for financial presentation and disclosure of income tax liabilities and expense.
Interest and penalties recognized have been classified in the statements of operations and comprehensive loss as income taxes. Deferred
tax assets and liabilities are recognized for future tax consequences attributable to temporary differences between the financial statement
carrying amount of existing assets and liabilities and their respective tax bases and operating losses carried forward. Deferred tax
assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in the statements of operations in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if
necessary, by a valuation allowance for any tax benefits of which future realization is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company is exempt from income tax in the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss per Ordinary Share Attributable to Ordinary Shareholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company calculates net loss per share attributable to ordinary shareholders &#8211; basic and diluted using the two-class method under
ASC Topic 260, <i>Earnings Per Share</i>. Basic net loss per share attributable to ordinary shareholders is computed by dividing the
net loss attributable to ordinary shareholders by the number of weighted-average ordinary shares outstanding for the period. Diluted
net loss attributable to ordinary shareholders is computed by adjusting net loss attributable to ordinary shareholders to reallocate
undistributed earnings based on the potential impact of any dilutive securities. Diluted net loss per share attributable to ordinary
shareholders is computed by dividing the diluted net loss attributable to ordinary shareholders by the number of weighted-average ordinary
shares outstanding for the period including potential dilutive ordinary shares. All potentially dilutive securities have been excluded
from the diluted net loss per share calculations for the years ended December 31, 2022 and 2021, respectively, as the assumed issuance
of all such potentially dilutive shares would have had an anti-dilutive effect. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intangible
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets subject to amortization include a developed patent. The Company qualitatively evaluates intangible assets for impairment annually
or whenever events or changes in circumstances indicate that it is more likely than not the carrying amount of intangible assets may
excess their implied fair values. The company recorded an immaterial amount for the intangible asset and an immaterial amount of amortization
expense for the year ended December 31, 2022. As of December 31, 2022, no indicators of impairment of the intangible asset were identified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
loan made to a related party is stated at the principal amount of $0.3 million outstanding. The Company recorded an allowance in full
of $0.3 million for potential loan losses, resulting in no balance on the face of the balance sheet at December 31, 2022. The loan carries
no interest, and as such, no interest receivable is recorded. The Company has recorded a full reserve against the loan as the related
party did not have the ability to repay the loans as of December 31, 2022. The Company will analyze the reserve periodically to determine
whether an adjustment to the allowance is appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 197; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investments
in Equity Securities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Investments
in equity securities that have a readily determinable fair value are reported at fair value. Changes in fair value between accounting
periods are recorded in other income, net, in the statements of operations and comprehensive loss. Realized gains or losses upon sale
are recorded in other income, net, in the statements of operations and comprehensive loss. The Company did not hold any available for
sale or trading securities at the years ended December 31, 2022 and December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Currency Translation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monetary
assets and liabilities in the functional currency are re-measured into the reporting currency at the rates of exchange prevailing at
the reporting date. Income and expense transactions in the functional currency are re-measured into the reporting currency at the average
exchange rate prevailing during the reporting period. Non-monetary items in functional currency are re-measured into the reporting currency
at the historical exchange rate (i.e., the rate of exchange at the date of the transaction). The gains or losses resulting from foreign
currency translation are included in the statements of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerging
Growth Company Status</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). Under
the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of
the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period
for complying with new or revised accounting standards that have different effective dates for public and private companies until the
earlier of the date that: (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended
transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with
the new or revised accounting pronouncements as of public company effective dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Business Combination (see Note 1) were to be consummated, the surviving company will remain an emerging growth company, as defined
by the Jumpstart Our Business Startups act of 2012, until the earliest of (i) the last day of the combined entity&#8217;s first fiscal
year following the fifth anniversary of the completion of MURF&#8217;s initial public offering, (ii) the last day of the fiscal year
in which the combined entity has total annual gross revenue of at least $1.235 billion, (iii) the last day of the fiscal year in which
the combined entity is deemed to be a large accelerated filer, which means the market value of the combined entity&#8217;s common stock
that is held by non-affiliates exceeds $700.0 million as of the prior December 31<sup>st</sup> or (iv) the date on which the combined
entity has issued more than $1.0 billion in non-convertible debt securities during the prior three year period</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
Adopted Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2021, the Company adopted ASU No. 2020-06, <i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</i> (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 was
issued to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for
certain financial instruments with characteristics of liabilities and equity. For convertible instruments, the FASB decided to reduce
the number of accounting models for convertible debt instruments and convertible preferred stock. In addition to eliminating certain
accounting models, the FASB also decided to enhance information transparency by making targeted improvements to the disclosures for convertible
instruments and earnings-per-share guidance. The adoption of ASU No. 2020-06 did not have a material impact on the Company&#8217;s financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 198; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the FASB issued ASU 2016-02, &#8220;Leases (Topic 842).&#8221; Topic 842 was subsequently amended by ASU 2018-10, &#8220;Codification
Improvements to Topic 842, Leases&#8221; and ASU 2018-11, &#8220;Leases (Topic 842)&#8221;. The amendments in this update increase transparency
and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information
about leasing arrangements. For leases with a term of 12 months or less, the amendments permit lessees to make an accounting policy election
by class of underlying assets not to recognize lease assets and lease liabilities. For finance leases, the amendments in this update
require a lessee to (1) recognize a right-of-use asset and lease liability, initially measured at the present value of the lease payments,
on the balance sheet; (2) recognize interest on the lease liability separately from amortization of the right-of-use asset in the statement
of operations; (3) classify repayments of the principal portion of the lease liability within financing activities and payments of interest
on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases,
the amendments in this update require a lessee to (1) recognize a right-of-use asset and a lease liability, initially measured at the
present value of the lease payments, on the balance sheet; (2) recognize a single lease cost, calculated so that the cost of the lease
is allocated over the lease term on a generally straight-line basis; (3) classify all cash payments within operating activities in the
statement of cash flows. On October 16, 2019, the FASB approved the proposal to delay the effective date for this standard for private
and all other entities. Due to the Company&#8217;s extended transition period election, the amendments are effective for fiscal years
beginning after December 15, 2020. In June 2020, the FASB issued ASU No. 2020-05, Coronavirus Disease 2019 (&#8220;COVID-19&#8221;) in
response to the pandemic which has adversely affected the global economy and caused significant and widespread business and capital market
disruptions. The FASB is committed to supporting and assisting stakeholders during this difficult time. The FASB issued ASU 2020-05 as
a limited deferral of the effective dates of certain ASUs, including ASU 2016-02 (including amendments issued after the issuance of the
original) to provide immediate, near-term relief for certain entities for whom these ASUs are either currently effective or imminently
effective. This update is effective for annual periods beginning January 1, 2022, and interim periods beginning January 1, 2023, with
early adoption permitted. The Company is in the process of evaluating its impact. The Company did not have any lease agreements as of
the years ended December 31, 2022 and 2021 and does not believe the new standard will have a material impact on the financial statements.
The Company adopted the standard on January 1, 2022. The adoption of ASU No. 2016-02 did not have a material impact on the Company&#8217;s
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Pronouncements Not Yet Adopted</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU No. 2019-12, <i>Income Taxes (Topic 740)</i> (&#8220;ASU No. 2019-12&#8221;). ASU No. 2019-12 was
issued to simplify the accounting for income taxes. The amendments in this update remove certain exceptions and add other requirements
to govern the accounting for income taxes. This update is effective for public business entities for fiscal years beginning after December
15, 2020. For all other entities, this update is effective for fiscal years beginning after December 15, 2021, and interim periods within
fiscal years beginning after December 15, 2022. The Company is exempt from tax in the Cayman Islands and therefore does not believe that
the adoption of ASU No. 2019-12 will have a material effect on its financial statements or related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): <i>Measurement of Credit Losses on Financial
Instruments</i>. The ASU adds to US GAAP an impairment model known as the current expected credit loss (CECL) model, which is based on
expected losses rather than incurred losses. The objectives of the CECL model are to: (1) reduce the complexity in US GAAP by decreasing
the number of credit impairment models that entities use to account for debt instruments, (2) eliminate the barrier to timely recognition
of credit losses by using an expected loss model instead of an incurred loss model, (3) require an entity to recognize an allowance of
lifetime expected credit losses, and (4) not require a specific method for entities to use in estimating expected credit losses. This
ASU will be effective for fiscal years beginning after December 15, 2022. An entity should apply the amendment on a prospective basis
at the beginning of the interim period that includes the adoption date. The Company is currently evaluating the new standard to determine
the potential impact on its financial condition, results of operations, cash flows, and financial statement disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 199; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present as of December 31, 2022 and 2021 respectively, the Company&#8217;s liabilities subject to measurement at fair
value on a recurring basis (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value Measurements as of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;&#160;&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left">Convertible notes payable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,835</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,835</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Option liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,404</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,404</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total Liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,239</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,239</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurements as of December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-bottom: 1.5pt">Convertible notes payable</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">&#160;&#160;&#160;-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">749</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">749</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">749</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">749</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents additional information about the convertible notes payable subject to measurement at fair value on a
recurring basis for which the Company used significant unobservable inputs (Level 3) (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Balance, beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">749</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Notes issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">908</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange impact</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(86</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,835</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 200; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
convertible notes payable were valued using the fair value option and are considered Level 3 measured instruments. See Note 5 for additional
information. Due to the embedded derivatives included in the convertible notes payable, the Company elected to use the fair value option.
The fair value was determined based upon a probability-weighted present value approach under three scenarios that consider the provisions
of the convertible notes payable. The following table outlines the range of significant unobservable inputs used in the third-party valuation
of the convertible notes payable as of December 31, 2022 and December 31, 2021, respectively:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assumption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Unobservable input - Change of control</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Probabilities of conversion provisions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 - 90%</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 - 67.5%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Estimated timing of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25
                                            - 1.41 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.75 - 2.41 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Time period to maturity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.41
                                            years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Risk-adjusted discount rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">6.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">2.9</td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
option liability was valued using public market research to determine the probability of success that similar studies in the respiratory
and cardiovascular disease areas and a Black-Scholes pricing model. In reviewing the public market research, the Company determined the
phase transition success rates for trials similar to the Covid Asset from Phase I to Phase II was 52.7%. In applying this rate to the
sale of future revenue consideration realized , the Company determined the underlying Covid Asset value to be $2.8 million. The Company
used the underlying Covid Asset value within a Black-Scholes model to determine the fair value was $1.4 million at December 31, 2022.
In accordance with ASC 815, the fair value of the option will be remeasured at the end of each reporting period, with changes in fair
value recorded to the statement of operations and total comprehensive loss. For the year ended December 31, 2022, the Company recorded
an option liability of $1.4 million on the balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents
additional information about the option liability subject to measurement at fair value on recurring basis for which the Company used
significant unobservable inputs (Level 3) (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, beginning of period</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Option issued</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">1,404</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency exchange impact</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,404</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the inputs to the Black-Scholes model as of December 31, 2022 to determine the fair value of the Covid Asset
option (in thousands where applicable):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold">Black-Scholes Inputs</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assumption</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Underlying asset price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,812</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Strike Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,960</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.68</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Option term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.71 years</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2022 and 2021, there were no transfers between 1evel 1 and Level 2, nor into or out of Level 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accrued
                                            Expenses</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses consisted of the following as of December 31, 2022 and 2021 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued expenses:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Professional service fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,246</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,308</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Payroll</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">921</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,584</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 201; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability
                                            Related to the Sale of Future Royalties</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Indirect
Investment Regarding the Covid Asset</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 3, 2020, the Company entered into an agreement with St George Street for an indirect investment in the AZ Covid Asset. Under
the terms of the agreement, St George Street agreed to pay the Company a royalty of 30% of sales of the Covid Asset should it
reach the commercialization stage and generate revenue in exchange for the Company funding St George Street&#8217;s research and
development efforts. This funding for this agreement differed from other projects under the Funding Agreement as the Company was investing
in the future revenues of the AZ Covid Asset and not funding 100% of the total project. The Company has the right of first of refusal
to fund projects. Should the Company choose not to fund a project as requested by St George Street, St George Street has the right
to seek third party funding at which point the Company will not receive the 30% royalty per the agreement for future revenues generated
from that specific project. St George Street holds all intellectual rights received from third party pharmaceutical companies
and performs all of the research and development and clinical trials necessary to move each asset toward commercialization. As of December
31, 2022, the Company provided $0.3 million in funding to St George Street.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Vela
Technologies PLC</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an Agreement with St George Street to approve funding from Vela Technologies PLC (&#8220;Vela&#8221;) on
October 20, 2020, whereby Vela agreed to provide funding to the Company via a purchase of future royalties an asset related to COVID-19
(the &#8220;Covid Asset&#8221;) totaling 8% of future revenue earned if the Covid Asset is commercialized (the &#8220;Vela Agreement&#8221;).
Total consideration under the Vela Agreement was $2.9 million (&#163;2.35 million), consisting of $1.6 million (&#163;1.25 million)
cash and the issuance of 1.1 billion ordinary shares in Vela, which based on the fair value of stock at the September 10, 2021, was $1.3
million. The Company received the $1.6 million (&#163;1.25) million cash consideration during the year ended December 31, 2020. This
consideration was recorded as deferred revenue in the balance sheet in accordance with ASC 470-10. The shares were received by St
George Street and subject to lock-up agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2021, the Company received the 1.1 billion ordinary shares in Vela from St George Street, upon expiration
of the lock-up agreement, that were issuable as consideration under the agreement. On the date the Company received the shares, Vela&#8217;s
equity securities had a fair value of $1.3 million and were recorded as a liability on the balance sheet. During the year ended December
31, 2021, the Company sold all 1.1 billion of its Vela shares for $1.2 million. The Company recorded a loss on the sale of Vela shares
of $76 thousand to the statement of operations and comprehensive loss. The Company incurred placement fees of $0.3 million in conjunction
with the sale of its investment in the Vela shares, which the Company recorded with the loss on sale of shares as other expense in the
statement of operations and comprehensive loss. During the year ended December 31, 2021, the Company did not pay any net sums to Vela
for the commercialization of the Covid Asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share
Consideration in Cizzle PLC</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 11, 2022, the Company entered into an agreement with Cizzle PLC (&#8220;Cizzle&#8221;) whereby Cizzle agreed to provide funding
to the Company for the Covid Asset for use in the field through a purchase of a 5% of future revenue earned if the Covid Asset is commercialized.
Total consideration under the agreement is specified as $1.4 million (&#163;1.2 million), consisting of the issuance of fair
value of 25.0 million new ordinary shares in Cizzle on the date of the agreement and the fair value of 22.0 million shares to be issued
at the earlier of Cizzle&#8217;s shareholder approval or one year from the date of the agreement. The 22.0 million shares were received
in October 2022. The Company recorded a liability related to deferred revenue of $1.4 million for the consideration received from Cizzle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payments received for the sale of future revenue will be classified as deferred income. Under ASC 470-10-25, a seller of future revenue
should evaluate whether the proceeds received should be accounted for as debt or deferred income. In assessing the factors that created
rebuttable presumption of debt within the guidance, the Company determined that there were factors present to overcome the debt presumption
and deferred income classification to be appropriate. The main factors the Company considered were that the transactions in form were
sales, and not debt transactions. Each agreement does not guarantee a return to each purchaser, the return is based solely on future
performance of the AZ Covid Asset should it reach commercialization, with neither purchaser having an involvement in generating future
cash flows from the AZ Covid Asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 202; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents as of December 31, 2022 the Company&#8217;s liability for the sale of future revenue (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Liability related to the sale of future royalties</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">December 31, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,958</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sale of future royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,439</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign currency exchange impact</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(314</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">December 31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,083</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2022, the Company entered into an agreement with Cizzle whereby the Company granted Cizzle the option, but not the obligation,
to sell its economic interest in the Covid Asset back to the Company. The agreement contained an option period of nine months from the
date of the agreement for Cizzle to notify the Company of its intent to exercise the option to sell its economic interest in the Covid
Asset. Upon closing of the agreement, Cizzle agreed to pay the Company an option fee of $0.1 million (&#163;0.1 million). If Cizzle
does exercise the right to sell its interest in the Covid Asset, consideration payable by the Company to Cizzle is $3.9 million (&#163;3.25)
million through the issuance of new Ordinary Shares in the combined entity post-Merger at the same price per share of the proposed PIPE
investment in the Company by new and existing investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
                                            Notes Payable</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 27, 2021, the Company approved a Master Convertible Loan Note Instrument (the &#8220;2021 Convertible Loan Note Instrument&#8221;),
permitting the Company to issue convertible notes in a maximum aggregate principal amount of up to $1.4 million (&#163;1.0 million).
The convertible notes issuable under the 2021 Convertible Loan Note Instrument mature three years after issuance to the respective noteholders
and bear 5% interest, only to be paid to the noteholders in the event of a material breach by the Company of the terms of the 2021 Convertible
Loan Note Instrument. In the event of a Change of Control (as defined in the 2021 Convertible Loan Note Instrument), the convertible
notes issued under the 2021 Convertible Loan Note Instrument automatically convert into ordinary shares of the Company at a conversion
price equal to a 20% discount to the price per share paid for the most senior class of shares in respect of such Change of Control. The
Company, with consent from the noteholders, may prepay the convertible notes payable issued under the 2021 Convertible Loan Note Instrument
without penalty. The convertible notes payable issued under the 2021 Convertible Loan Note Instrument are general, unsecured obligations
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued $0.3 million (&#163;0.25 million) convertible notes payable to two separate investors on June 11, 2021 and June 12, 2021,
$0.5 million (&#163;0.4 million) on August 26, 2022 and $67 thousand (&#163;50 thousand) on October 6, 2022. As of December 31, 2022,
$1.1 million (&#163;950,000) 2021 Convertible Loan Notes were issued and outstanding. As of December 31, 2022, $67 thousand (&#163;50
thousand) convertible notes were available for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2022, the Company approved a master Convertible Loan Note Instrument (the &#8220;2022 Convertible Loan Note Instrument&#8221;),
permitting the Company to issue convertible notes payable for a maximum aggregate principal amount of up to $3.3 million (&#163;3.0
million). The convertible notes payable issuable under the 2022 Convertible Loan Note Instrument mature three years after issuance to
the respective noteholders and bear 5% interest, only to be paid to the noteholders in the event of a material breach by the Company
of the terms of the 2022 Convertible Loan Note Instrument. In the event of a Change of Control (as defined in the 2022 Convertible Loan
Note Instrument), the convertible notes payable issued under the 2022 Convertible Loan Note Instrument automatically convert into ordinary
shares of the Company at a conversion price equal to a 20% discount to the price per share paid for the most senior class of shares in
respect of such Change of Control. The Company, with consent from the noteholders, may prepay the convertible notes payable issued under
the 2022 Convertible Loan Note Instrument without penalty. The convertible notes payable issued under the 2022 Convertible Loan Note
Instrument are general, unsecured obligations of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 203; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2022, under the terms of the 2022 Convertible Loan Note Instrument, the Company issued convertible notes payable with an
aggregate principal amount of $0.4 million (&#163;0.3 million) to an investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected to fair value the convertible notes payable issued under the 2021 and 2022 Convertible Loan Note Instruments. At the
end of each reporting period, the Company calculates the fair value of the convertible notes payable, and any changes in fair value are
reported in other income, net, in the current period&#8217;s statement of operations and comprehensive loss. There has been no change
in fair value from a change in credit quality. For the year ended December 31, 2022, the Company recorded a loss from the change in fair
value of convertible notes payable of $0.3 million in other income, net, in its statement of operations and comprehensive less. For the
year ended December 31, 2021, the Company recorded a loss from the change in fair value of convertible notes payable of $0.3 million
in other income, net, in its statement of operations and comprehensive loss. See Note 2 for additional information regarding the fair
value measurement of convertible notes payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loans
                                            Payable</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 1, 2022, the Company entered into Loan Agreements (the &#8220;Loans&#8221;) with two lenders, totaling $0.2 million. The Loans mature
two years from the date of the agreement and bear no interest. Each loan was made available to the Company by the lenders in three tranches
of (i) $33 thousand (&#163;30 thousand); (ii) $33 thousand (&#163;30 thousand) and (iii) $28 thousand (&#163;25 thousand), totaling
$0.2 million. The Loans provided for events of default, including, among others, failure to make payment, bankruptcy and non-compliance
with the terms of the Loans. As of December 31, 2022 the Company utilized all three tranches of the first loan and two out of three tranches
of the second loan, with total loans payable at December 31, 2022 of $0.2 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
                                            Shares</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and 2021, the Company has authorized the issuance of up to 400,000,000 ordinary shares, par value &#163;0.0001
per share (the &#8220;Ordinary Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, 2,000 and 1,000 Ordinary Shares (the &#8220;Ordinary Shares&#8221;) were issued and outstanding,
respectively. The Company issued 1,000 ordinary shares during the year ended December 31, 2022. No shares were issued during the year
ended December 31, 2021. As of December 31, 2022 and 2021, no cash dividends have been declared or paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Ordinary Shares are entitled to one vote per share, and to receive dividends, on and if declared by the board of directors and,
upon liquidation or dissolution, are entitled to receive all assets available for distribution, subordinate to the rights, preferences,
and privileges of any outstanding preferred shares (if any) with respect to dividends and in connection with liquidation, winding up
and dissolution of the Company. The holders have no preemptive or other subscription rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
                                            Loss Per Share Attributable to Ordinary Shareholders</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the calculation of basic and diluted net loss per share attributable to holders of the Ordinary Shares (in thousands,
except share amounts and per share data):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Numerator:</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(4,887</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(3,657</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted-average shares outstanding used in calculating net loss per share &#8211; basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to ordinary shareholders &#8211; basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,444</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,657</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 204; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the Company was in a loss position for all periods presented, basic net loss per share attributable to holders of the Ordinary Shares
is the same as diluted net loss per share attributable to holders of the Ordinary Shares for all periods presented as the inclusion of
all potential Ordinary Shares outstanding would have been anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potentially
dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would have been anti-dilutive
were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 80%; text-align: left">Ordinary Shares potentially issuable upon conversion of convertible notes payable</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">1,250,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; width: 80%">Ordinary Shares potentially issuable upon conversion of convertible notes payable</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right; width: 16%">500,000</td><td style="padding-bottom: 1.5pt; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">500,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commitments
                                            and Contingencies</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal
Proceedings</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings or other litigation relating to claims arising in the ordinary course
of business. The Company intends to accrue a liability for such matters when it is probable that future expenditures will be made and
that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and estimated exposure
amount. Legal fees and other costs associated with such proceedings are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
                                            Party Transactions</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corvus
Capital Limited </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corvus
Capital Limited (&#8220;Corvus&#8221;) is a significant investor in the Company through holding 1,000 and 775 Ordinary Shares as of the
years ended December 31, 2022 and December 31, 2021, respectively. On November 4, 2022, the Company issued 1,000 Ordinary Shares to Corvus
Capital Limited. Corvus Capital Limited subsequently transferred 775 Ordinary Shares to other investors. The Chief Executive Officer
of Corvus is a member of Conduit&#8217;s board of directors. For the year ended December 31, 2021, the Company incurred $1.6 million
(&#163;1.3 million) in advisory fees for funding and review of a potential acquisition candidates to Corvus, which are included in general
and administrative expenses in the statement of operations and comprehensive loss, the Company did not incur advisory fees during the
year ended December 31, 2022. As of December 31, 2022 and December 31, 2021, approximately $0.6 million and $0.7 million, respectively,
of the advisory fees were not paid and were recorded to accrued expenses on the balance sheet. For the years ended December 31, 2022
and 2021, the Company incurred director&#8217;s fees payable to the CEO of Corvus of approximately $0.4 million and $0.4 million, respectively.
As of December 31, 2022 and 2021, the Company owed the CEO of Corvus director&#8217;s fees of approximately $0.4 million and $0.4 million,
respectively. These amounts owed to the CEO of Corvus are included in accrued expenses and other current liabilities in the balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January and February 2023, under the terms of the 2022 Convertible Loan Note Instrument, the Company issued convertible notes
payable with an aggregate principal amount of $0.5 million (&#163;0.4 million) to the CEO of Corvus. The convertible notes
payable mature three years after issuance and bear 5% interest, only to be paid in the event of a material breach by the Company of the
terms of the 2022 Convertible Loan Note Instrument. In the event of a Change of Control, the convertible notes payable automatically
convert into ordinary shares of the Company at a conversion price equal to a 20% discount to the price per share paid for the most senior
class of shares in respect of such Change of Control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 205; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>St
George Street Capital</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">St
George Street Capital is a significant investor in the Company through holding 225 Ordinary shares. The Chief Executive Officer of St
George Street Capital is also the Chief Executive Officer of Conduit. Further, the Company has an Exclusive Funding Agreement (as defined
below) with St George Street Capital. For the years ended December 31, 2022 and December 31, 2021, the Company incurred expenses to St
George Street Capital totaling$0.3 million and $0.1 million, respectively. As of the years ended December 31, 2022 and December 31, 2021,
the Company did not owe any amounts to St George Street Capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2021, the Company entered into the Exclusive Funding Agreement (&#8220;Funding Agreement&#8221;) with St George Street Capital.
Under the agreement, the Company has the first exclusive right, but not the obligation, to provide or procure funding for the performance
or research and development projects undertaken by St George Street Capital. The Funding Agreement entitles the Company to 100% of the
net revenue on projects that the Company funds by itself. As of December 31, 2022, the Company has not recognized any net revenue from
the Funding Agreement. See Note 1 for discussion on research and development costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
                                            Expense </b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents other expense, for the years ended December 31, 2022 and 2021 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Loss on Cizzle option</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized foreign currency transaction loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on sale of investment in equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">129</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Placement fees on sale of investment in equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">327</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible notes payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">265</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">73</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,727</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">484</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subsequent
                                            Events</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated all events occurring through May 12, 2023, the date on which the financial statements were available to
be issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements,
except for the ones described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
Loan Note Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 10 &#8211; Related Party Transactions, during January and February 2023, under the terms of the 2022 Convertible
Loan Note Instrument, the Company issued convertible notes payable with an aggregate principal amount of $0.5 million (&#163;0.4
million) to the CEO of Corvus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January and February 2023, under the terms of the 2022 Convertible Loan Note Instrument, the Company issued convertible notes payable
with an aggregate principal amount of $1.3 million (&#163;1.1 million) to non-related third parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
March 2023, the Company issued promissory convertible notes payable with an aggregate principal amount of $0.8 million to a non-related third party. The note matures and is payable in full 18 months from the date of the note. The note carries
20% interest and is payable every six months from the date of the note until the maturity date. The note is subject to conversion into
shares of the Company&#8217;s common stock prior to the consummation of the Business Combination, which shares will then convert
into MURF common stock. The Company notes that this issuance was outside of the terms of the 2022 Convertible Loan Note Instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Vela
Option Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 2023, the Company entered into an agreement with Vela which granted Vela the right, but not the obligation, to sell its 8% royalty
interest in the Covid Asset back to the Company. Vela paid a one-time, non-refundable option fee to the Company of $0.5 million (&#163;0.4
million). Total consideration payable to Vela upon exercise is $4.8 million (&#163;4.0 million) through the issuance of shares of the
Company, following the consummation of the Merger at a price per share equal to the volume-weighted average price per share over the
ten (10) business days prior to the date of the notice of the exercise of the Option. The option is exercisable in whole at any time
from the close of the Merger (the &#8220;Effective Time&#8221;) until the earlier of (i) the date that is six (6) months from the Effective
Time, and (ii) February 7, 2024, the expiration of the term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 206; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_022"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying balance sheets of Murphy Canyon Acquisition Corp. (the &#8220;Company&#8221;) as of December 31, 2022 and
2021, the related statements of operations<b>,</b> stockholders&#8217; equity (deficit) and cash flows for the year ended December 31,
2022 and for the period from October 19, 2021 (inception) through December 31, 2021, and the related notes (collectively referred to
as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the year ended December
31, 2022 and for the period from October 19, 2021 (inception) through December 31, 2021, in conformity with accounting principles generally
accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Explanatory
Paragraph &#8211; Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described
in Note 1 to the financial statements, the Company&#8217;s business plan is dependent on the completion of a business combination which
is less than one year form the date of the issuance of the financial statements. Additionally, the Company has incurred and expects to
continue to incur significant costs in pursuit of its acquisition plans. These conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The financial statements
do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<span style="font-variant: small-caps">llp</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY<br />
March 28, 2023</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 207; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_023"></span>BALANCE
SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_z9qExrfPLBg3" summary="xdx: Statement - Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20221231_zRINcOyARruk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20211231_zwYVfm5koWWi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsAbstract_iB_zqbIhOZ098bl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrentAbstract_i01B_zfnXunmhZrkd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzZ5n_zUb7V0hModM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 62%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">345,777</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,555</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseCurrent_i02I_maACzZ5n_zkk7sqNiLgid" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,862</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,608</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AssetsCurrent_i02TI_mtACzZ5n_maAz1vQ_zx5OdIBNczD4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">646,639</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,163</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AssetsHeldInTrustNoncurrent_i01I_maAz1vQ_zrbXV78CjTmd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments held in
    Trust Account</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,871,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0050">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DeferredCosts_i01I_maAz1vQ_zj4xoum2kCnl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    offering costs</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0052">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredCosts" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,962</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Assets_i01TI_mtAz1vQ_z7U4P1Wbe4tg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Assets</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">137,517,822</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">213,125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND STOCKHOLDERS&#8217;
    EQUITY (DEFICIT)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrentAbstract_i01B_z4bl8Aa8ova" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedLiabilitiesCurrent_i02I_maLCzYTT_znuPu2xJRs38" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accrued expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,113</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,449</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzYTT_zp3wvyRShAv2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income taxes payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,862</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0068">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NotesPayableCurrent_i02I_maLCzYTT_zZSb82U9Fagg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Note
    payable &#8211; Sponsor</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0070">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,057</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzYTT_maLzuev_zsQ1DbYyqsh4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">417,975</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,506</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DeferredCommissionPayableNonCurrent_i01I_maLzuev_zBH5uDFWbdR5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    commission payable</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:DeferredCommissionPayableNonCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,628,750</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0077">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Liabilities_i01TI_mtLzuev_maLASEz9lK_zDAWH1rLJxq1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Liabilities</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,046,725</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,506</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CommitmentsAndContingencies_i01I_maLASEz9lK_zYJFHdrpxaYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Commitments and Contingencies
    (Note 6)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maLASEz9lK_zgeMcgoF1OLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Common stock subject
    to possible redemption at redemption value (<span id="xdx_901_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20221231_ztfWlFOGYN83" title="Shares subject to possible redemption"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,225,000</ix:nonFraction></span> shares at $<span id="xdx_90A_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_c20221231_zTelkzmEvdCa" title="Temporary equity, redemption price"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.34</ix:nonFraction> </span> per share)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,771,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0086">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stockholders&#8217; Equity
    (Deficit)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--PreferredStockValue_i02I_maSEzBsq_z0jN3s4a4ipa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Preferred stock, $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zKVA0GKCpmTd" title="Preferred stock, par value"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231_pdd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_z6AviJsSUlnl" title="Preferred stock, shares authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_c20211231_pdd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span>
    shares authorized; <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_dn_c20221231_zlDPEWwBtP5i" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20221231_znRQPLSMKDKe" title="Preferred stock, shares outstanding"><span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_zQtc0GFytCMl" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zJifSrb2ESae" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0095">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0096">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CommonStockValue_i02I_pp0p0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ztZDkqIPDuzb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z07NMelQrcU9" title="Common stock, par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ztwcRBYPKrN5" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value;
    <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziLDFvBsxBia" title="Common stock, shares authorized"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zhZB3k9Xucq6" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHIaOCqcBvZh" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJw9jqIJuJJh" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">754,000</ix:nonFraction></ix:nonFraction></span></span> (excluding <span id="xdx_90D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zgKjJON4BZz" title="Shares subject to possible redemption"><span id="xdx_90A_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zYxueGrn7trc" title="Shares subject to possible redemption"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,225,000</ix:nonFraction></ix:nonFraction></span></span> subject to possible redemption) and <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_dn_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zAXbWAAIcqyl" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_dn_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJGIl5OaAoK9" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding at December
    31, 2022 and December 31, 2021, respectively</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0115">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CommonStockValue_i02I_pp0p0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_maSEzBsq_z51AoCDyZXOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class B common stock, $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zPcehA0vKbHi" title="Common stock, par value"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value;
    <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z1QZQ0vG5Nmc" title="Common stock, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKgGhZaNK33g" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zRoqSYL6YCT9" title="Common stock, shares outstanding"><span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjrUyprHLqMd" title="Common stock, shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">331</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">331</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CommonStockValue_i02I_maSEzFvD_zM6ifFYHJZ6j" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Common stock value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzBsq_zSFPmDcqMpFi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0159">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,669</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzBsq_zF9HeUok95Nd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,300,492</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtSEzBsq_maLASEz9lK_zb7KXyi1Yfy4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Stockholders&#8217; Equity (Deficit)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,300,086</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,619</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i02TI_pp0p0_mtLASEz9lK_zk8TvHRJ72Ec" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T<b>otal
    Liabilities and Stockholders&#8217; Equity (Deficit)</b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,517,822</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">213,125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>


<!-- Field: Page; Sequence: 208; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_024"></span>STATEMENTS
OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_113_zJ7agqzyAHq3" summary="xdx: Statement - Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20220101__20221231_zJkO7lXZDXJ9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Year<br /> December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20211019__20211231_zptPnRJaTQL3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">FOR
    THE PERIOD FROM OCTOBER 19, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_402_eus-gaap--GeneralAndAdministrativeExpense_msOILztbq_zfqIDiYLp7Ud" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,682</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381</ix:nonFraction></span></td><td style="width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_401_ecustom--AdministrationFeeRelatedParty_msOILztbq_zuoAW8rksyRc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Administration fee
    &#8211; related party</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:AdministrationFeeRelatedParty" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0175">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iNT_di_mtOILztbq_maILFCOzLU7_zjlFBE0al7rf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,202,682</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_40B_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zIWKMofKbaHc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other Income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_403_eus-gaap--InvestmentIncomeInterest_i01_pp0p0_maNIEzZky_ztWPuAFwAaY3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest income &#8211;
    Investments held in Trust Account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,976,183</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0184">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEzZky_maILFCOzLU7_zpqDOJ6Ic7P7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,976,183</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0187">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_mtILFCOzLU7_maNILzWfO_zFCiXfUSw0xe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net income (loss) before
    income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">773,501</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    </tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msNILzWfO_zidr6WPSmhqf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax expense</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,862</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0193">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_mtNILzWfO_zkmrBf5AR0N8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    income (loss)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,639</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    </tr>
  <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z0zti7CpvUFc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class A common stock
    &#8211; weighted average shares outstanding, basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,558,058</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0199">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zreEGYXev1sg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class
    A common stock &#8211; Basic and diluted net income (loss) per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0202">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zLt1TUmzJUnc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class B common stock
    &#8211; weighted average shares outstanding, basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_fKDEpKDIp_z9BERFWUTNNi" title="Class B common stock weighted average shares outstanding, basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember" id="Fact000207" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,875,000</ix:nonFraction></ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td>
    </tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXXNMUI6dT0c" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class
    B common stock &#8211; Basic and diluted net income (loss) per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0F_zxiSApN2Okuk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zMVsWOMrsdoe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000211" xml:lang="en-US">Excludes
    an aggregate of up to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9R4rmUGX3I7" title="Number of option issued for forfeiture" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-02-062022-02-07_us-gaap_OverAllotmentOptionMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">431,250</ix:nonFraction></span> shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised
    in full or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such,
    the Class B common stock is no longer subject to forfeiture (see Notes 5 and 6).</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0D_ztruckNSELO5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zL9bLDcoxrW8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000214" xml:lang="en-US">On
    January 26, 2022, the Sponsor surrendered and forfeited <span id="xdx_902_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zNxtqdOMKVt5" title="Stock surrendered and forfeited during period shares" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2022-01-252022-01-26_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,006,250</ix:nonFraction></span> founder shares for no consideration following which the Sponsor
    holds <span id="xdx_902_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zyA2yNai3ox4" title="Stock issued during period on hold" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="MURFU:StockIssuedDuringPeriodShareOnHold" contextRef="From2022-01-252022-01-26_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 209; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (DEFICIT) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_025"></span>FOR
THE YEAR ENDED DECEMBER 31, 2022 AND FOR THE PERIOD FROM OCTOBER 19, 2021 (INCEPTION) TO DECEMBER 31, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_114_z6rOXb5uTcdi" summary="xdx: Statement - Statements of Changes in Stockholders&apos; Equity (Deficit)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember_zLg52HtypwFk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember_z99o7JvBn7Yb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zx4PNvUJuBY7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zUSm1tUQXuB" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Deficit</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4BA_z2zzRSA8fqc1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Deficit)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Class
    A</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Class
    B</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional
    Paid-in</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders&#8217;
                                            Equity</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Deficit</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Deficit)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43B_c20211019__20211231_eus-gaap--StockholdersEquity_iS_zL63wdFA71r9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance, October 19, 2021 (inception)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20211019__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zVxuR7bjXao8" title="Beginning balance, shares" style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0226">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20211019__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zp1FuUa7RW68" title="Beginning balance, shares" style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0228">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0222">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0223">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zsGjTZwmt3sf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of Class B common stock to Sponsor<sup id="xdx_F41_zHIOqqxIO1Z6">(1) (2)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0230">-</span></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211019__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_fKDEpKDIp_z4rOoYuhcUU7" title="Issuance of Class B common stock to Sponsor, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="Fact000236" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" id="Fact000231" format="ixt:numdotdecimal" decimals="0" unitRef="USD">331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-10-192021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000232" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,669</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0233">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-10-192021-12-31" id="Fact000234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_zS5bgQInkxQ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0239">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0240">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-10-192021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20220101__20221231_eus-gaap--StockholdersEquity_iS_zizKsuKqbgca" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance, December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zkCYys3yvx91" title="Beginning balance, shares" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0250">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0244">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zA8lvC0jiwab" title="Beginning balance, shares" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">331</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,669</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,619</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_zjI9D3xaBJv" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds allocated to Public Warrants, net
    of offering costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0254">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0255">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,917,543</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0257">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,917,543</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z37diYoL0PK7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sale of Private Placement Units, net of offering
    costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zD7oxB2xKEZ1" title="Sale of private placement units, net of offering costs" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">754,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0261">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,520,275</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0263">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,520,350</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_iN_di_zSISTdOWcCXf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement of Class A common stock subject
    to possible redemption upon IPO</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0268">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0269">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,462,487</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,818,567</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,281,054</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_iN_di_zzedhP78KCCk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement of Class A shares to redemption
    value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,876,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,876,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zBZjT5ilKoh9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0280">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0281">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,639</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,639</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLoss_zfMTQvdWFrjb" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income (loss)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0286">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0287">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0288">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,639</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,639</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_43B_c20220101__20221231_eus-gaap--StockholdersEquity_iE_z5xvkSvyCYbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance, December 31,
    2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zq9j5v3AaEpl" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">754,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zEWIKVpwbESh" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0294">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,300,492</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,300,086</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0A_zGnE4RE0TwA6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zKcRLQAawKCd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000301" xml:lang="en-US">Includes
    an aggregate of up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSlF8GRYa24f" title="Number of option issued for forfeiture" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-02-062022-02-07_us-gaap_OverAllotmentOptionMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">431,250</ix:nonFraction></span> shares of Common stock subject to forfeiture if the over-allotment option is not exercised in full
    or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such, the Class
    B common stock is no longer subject to forfeiture (see Notes 5 and 6). </ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F00_z8xIRUCuV3n8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zaRsXskkvTgh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000304" xml:lang="en-US">On
    January 26, 2022, the Sponsor surrendered and forfeited <span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zQctBQNw3rp9" title="Stock surrendered and forfeited during period shares" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2022-01-252022-01-26_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,006,250</ix:nonFraction></span> founder shares for no consideration following which the Sponsor
    holds <span id="xdx_901_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_z89iBBfkzGP3" title="Stock issued during period on hold" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="MURFU:StockIssuedDuringPeriodShareOnHold" contextRef="From2022-01-252022-01-26_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).
    </ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>


<!-- Field: Page; Sequence: 210; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_026"></span>
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_112_zuFncwWB9LFc" summary="xdx: Statement - Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20220101__20221231_z82fXrxe0Znh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Year Ended December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20211019__20211231_z1H1YsN4Kdz4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">FOR
    THE PERIOD FROM OCTOBER 19, 2021 (INCEPTION) THROUGH DECEMBER&#160;31,&#160;2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zcbljTDuhlX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash flows from operating
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_maNCPBUzR84_zpQCrW96iYp6" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Net income
    (loss)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,639</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zgWcGwCVUtXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Adjustments to reconcile
    net income (loss) to net cash used in operating activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--FormationCostsPaidByNotePayableSponsor_i02_maNCPBUzR84_z49GA87kNAij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Formation costs paid
    by note payable &#8211; Sponsor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:FormationCostsPaidByNotePayableSponsor" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,994</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InvestmentIncomeInterest_i02N_di_msNCPBUzR84_zdjjWmVtMFZc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif">Interest earned on investments held in Trust Account</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,976,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0323">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zlfmkJGh17h4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif">Changes in operating
    assets and liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUzR84_zgKAxwZcNHG8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif">Deferred offering costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,962</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_msNCPBUzR84_z7NI20ETUw35" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">245,254</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,608</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_maNCPBUzR84_z0Sg67BY2996" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif">Accrued expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,664</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0335">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzR84_z9tX05kSE7wl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    income taxes payable</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,862</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0338">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzR84_maCCERCzXzA_z8jvgXBctixa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in operating activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,311,310</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,995</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zDB8P5EdAV01" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash flows from investing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsToAcquireInvestments_i01N_di_msNCPBUzpYT_zoLECGvDPqhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    deposited into Trust Account</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,895,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0347">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzpYT_maCCERCzXzA_zDqDLxGPrZCl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in investing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,895,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zSibLildKRU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash flows from financing
    activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PaymentsOfFinancingCosts_i01N_di_msNCPBUz1Xq_zM1TyiNh0yui" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Deferred offering costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,450</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUz1Xq_zCQXL2cv63Ph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Proceeds from note payable
    - Sponsor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0358">-</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUz1Xq_z1xIqCHYA1Uk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Proceeds from issuance
    of Class B common stock to Sponsor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0361">-</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i01_maNCPBUz1Xq_zut87Kd0QMg9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Sale of units in public
    offering</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,250,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0365">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_i01_maNCPBUz1Xq_zgZBLl7obNE7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Sale of private placement
    units</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,540,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--PaymentsOfStockIssuanceCosts_i01N_di_msNCPBUz1Xq_zyqcg3zT9rX" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Payment of offering costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,109,411</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msNCPBUz1Xq_zdbLBPYVwrMb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Repayment
    of note payable - Sponsor</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,057</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUz1Xq_maCCERCzXzA_zali9ykF3i98" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,503,532</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,550</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzXzA_z1vcranB0311" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net change in cash</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">297,222</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,555</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zHxqmmMFC4Sd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash at beginning
    of period</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,555</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zHmfADY6Fz3f" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    at end of period</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">345,777</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,555</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_z2OybHA29WAg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Non-cash financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--DeferredOfferingCostsIncludedInAccruedOfferingCosts_i01_zmw8fNfka0lh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred offering
    costs included in accrued offering costs</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:DeferredOfferingCostsIncludedInAccruedOfferingCosts" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,449</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--PrepaidExpensesPaidByNotePayable_i01_zwrHzJp8cWok" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses
    paid by note payable - Sponsor</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:PrepaidExpensesPaidByNotePayable" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--DeferredOfferingCostsPaidByNotePayable_i01_zcdbmDZjZvzk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred offering
    costs paid by note payable - Sponsor</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:DeferredOfferingCostsPaidByNotePayable" contextRef="From2021-10-192021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,875</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--DeferredUnderwritingCommissionPayable_i01_zXc5bjs7HVHi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred commission
    payable</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:DeferredUnderwritingCommissionPayable" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,628,750</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ClassASharesSubjectToRedemption_i01_z2flfxtyYqUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Class A shares subject to redemption</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">$</p></td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><ix:nonFraction name="MURFU:ClassASharesSubjectToRedemption" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,771,183</ix:nonFraction></p></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">$</p></td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0404">-</span></p></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 211; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEAR ENDED DECEMBER 31, 2022 AND FOR THE PERIOD FROM OCTOBER 19, 2021 (INCEPTION) THROUGH <span style="text-transform: uppercase"><span id="sj_027"></span>DECEMBER
31, 2021</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to financial statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zEJHUe1aB8Db" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212; <span id="xdx_82C_z0Smo3N7JC28">DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on October 19, 2021. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;). The Company is not limited to a particular industry or sector for
purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company
is subject to all of the risks associated with early stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had not commenced any operations. All activity for the period from October 19, 2021 (inception) through
December 31, 2022 relates to the Company&#8217;s formation, the proposed initial public offering (&#8220;Initial Public Offering&#8221;),
which is described below, and searching for an initial Business Combination, as defined below. The Company will not generate any operating revenues until
after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form
of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year
end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering (the &#8220;Registration Statement&#8221;) was declared effective
on February 2, 2022. On February 7, 2022, the Company consummated the Initial Public Offering of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zdwwo7ZGbCh4" title="Stock issued during period shares new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-02-062022-02-07_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,225,000</ix:nonFraction></span> units (&#8220;Units&#8221;), generating gross proceeds
of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zL2WaGa4E2M7" title="Proceeds from isssuance"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-02-062022-02-07_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,250,000</ix:nonFraction></span>, which is described in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zWykxjFP54t7" title="Sale of stock"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">754,000</ix:nonFraction></span>
units (the &#8220;Private Placement Units&#8221;) at a price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zck7Zm2CBKw5" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-02-07_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>
per Private Placement Unit in private placements to Murphy Canyon Acquisition Sponsor LLC (the &#8220;Sponsor&#8221;), with gross
proceeds of $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zWm4NK8UNSpa" title="Gross proceeds from shares issuance"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,540,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on February 7, 2022, an amount of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSVGw2JzzYL3" title="Net proceeds from sale of equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-02-062022-02-07_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,790,000</ix:nonFraction></span> from the net proceeds of the sale of the Units
in the Initial Public Offering and the Private Placement Units was placed in the Trust Account, as defined below. This resulted in an
overfunding of the Trust Account of $<span id="xdx_90B_ecustom--OverfundingOfTheTrustAccount_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z89Qs2fzbYO2" title="Overfunding of the trust account"><ix:nonFraction name="MURFU:OverfundingOfTheTrustAccount" contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,895,000</ix:nonFraction></span>. As such, subsequent to the initial funding of the Trust Account, $<span id="xdx_901_ecustom--OperatingCashAccount_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zmUslQpYtNZe" title="Operating cash account"><ix:nonFraction name="MURFU:OperatingCashAccount" contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> was transferred
to the Company&#8217;s operating cash account and $<span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_c20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7NNEFbLp1od" title="Offering costs"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2022-02-07_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,895,000</ix:nonFraction></span> was used to pay offering costs. The funds held in the Trust Account may
be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as
amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that
holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as
determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account,
as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2022, the Company entered into a definitive Business Combination Agreement (the &#8220;BCA&#8221;) with Conduit Pharmaceuticals
Limited, a Cayman Islands exempted company (&#8220;Conduit&#8221;), and Conduit Merger Sub, Inc., a Cayman Islands exempted company (&#8220;Merger
Sub&#8221;). Merger Sub is a wholly owned subsidiary of the Company. Conduit is a pharmaceutical company led by experienced pharma executives,
established to fund the development of successful deprioritized clinical assets licensed from large pharmaceutical companies through
its exclusive relationships. The BCA was amended in January 2023, see Note 10 for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the consummation of the transactions contemplated by the BCA, Merger Sub will merge with and into Conduit, with Conduit surviving as
a wholly owned subsidiary of the Company (the &#8220;Business Combination&#8221;). The Company is expected to be renamed Conduit Pharmaceuticals
Inc. at the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BCA, at the closing, the Company shall issue and deliver to the shareholders of Conduit an aggregate number of shares of the Company&#8217;s
common stock with an aggregate value equal to $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20221107__20221108__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zXEgmZpeRXyd" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-11-072022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">650,000,000</ix:nonFraction></span>, with each share valued at $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20221108__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zV4CvPhmoVkd" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share. A private placement transaction
shall be conducted by the Company contemporaneously with the Business Combination (the &#8220;PIPE Financing&#8221;), pursuant to which
the Company has entered into subscription agreements providing for aggregate investments in the Company&#8217;s securities of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20221107__20221108__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zjjSm9LoeISg" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-11-072022-11-08_custom_SubscriptionAgreementsMember_custom_ConduitPharmaceuticalsLimitedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 212; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Business Combination or PIPE Financing will occur as planned or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
<span id="xdx_904_eus-gaap--BusinessCombinationControlObtainedDescription_c20220101__20221231_zgytHUl17Jm1" title="Business combination description of transaction"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="us-gaap:BusinessCombinationControlObtainedDescription">The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions
and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of
1940, as amended (the &#8220;Investment Company Act&#8221;). Upon the closing of the Initial Public Offering, management has agreed that
an amount equal to at least $10.00 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants,
will be held in a trust account (&#8220;Trust Account&#8221;), located in the United States and invested only in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended
investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the
distribution of the funds held in the Trust Account, as described below.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide the holders of the outstanding Public Shares (the &#8220;Public Stockholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (net of taxes payable). There will be no redemption
rights upon the completion of a Business Combination with respect to the Company&#8217;s warrants. All of the Public Shares contain a
redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder
vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and
restated certificate of incorporation. In accordance with U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and its guidance
on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a
company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be
issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as
temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Class A common stock is subject to ASC
480-10-S99. If it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in
the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become
redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately
as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We
have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction
to retained earnings, or in absence of retained earnings, additional paid-in capital). The Public Shares are redeemable and will be classified
as such on the balance sheet until such date that a redemption event takes place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority
of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange
rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide
to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation
(the &#8220;Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the (&#8220;SEC&#8221;)
and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction
is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business
or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not
pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor
has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering
in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting,
and if they do vote, irrespective of whether they vote for or against the proposed transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 213; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section 13 of <span id="xdx_903_eus-gaap--RetainedEarningsRestrictions_c20220101__20221231_zFWVJCI5L5E7" title="Retained earnings restrictions"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="us-gaap:RetainedEarningsRestrictions">the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more
than an aggregate of 15% of the Public Shares, without the prior consent of the Company.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares have agreed (a) to waive their redemption rights with respect to the Founder Shares and Public Shares held
by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation
(i) to modify the substance or timing of the Company&#8217;s obligation to allow redemptions in connection with a Business Combination
or to redeem <span id="xdx_907_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20220101__20221231_zq7fVaZW2R2h" title="Debt instrument redemption price percentage"><ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined
below) or (ii) with respect to any other provision relating to stockholders&#8217; rights or pre-business combination activity, unless
the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company has not completed a Business Combination within 12 months from the consummation of our initial public offering (or up to
February 7, 2024 at the election of the Company subject to satisfaction of certain conditions, as amended at the January 2023 Special
Meeting, see Note 10) (&#8220;Business Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account
and not previously released to pay taxes (less up to $<span id="xdx_90C_eus-gaap--InterestExpense_c20220101__20221231_zNDqVrzGlcQe" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> of interest to pay dissolution expenses), divided by the number of then
outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#8217; rights as stockholders (including the
right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of directors, dissolve and liquidate,
subject in each case to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. Our Sponsor has committed to provide additional funds if needed to make such a deposit for the extensions. There
will be no redemption rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if
the Company fails to complete a Business Combination within the Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founders Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails
to complete a Business Combination within the Combination Period. However, if the holders of Founder Shares acquire Public Shares in
or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the
Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to
their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination
within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will
be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value
of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9JF2QNb4Rsf" title="Share issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below <span id="xdx_905_eus-gaap--BusinessCombinationControlObtainedDescription_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zSvn4B3UPk4a" title="Business combination description of transaction"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TransactionAgreementMember" name="us-gaap:BusinessCombinationControlObtainedDescription">(i) $10.00 per Public Share or (ii) such
lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00
per public Share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn
to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account
and except as to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</ix:nonNumeric></span> Moreover, in the event that an
executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability
for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account
due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company&#8217;s independent registered
accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the
Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 214; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management&#8217;s
Plan and Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&#8217;s assessment of going concern considerations in accordance with Accounting Standards Update (&#8220;ASU&#8221;)
2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined
that the Combination Period is less than one year from the date of the issuance of the financial statements. There is no assurance that
the Company&#8217;s plans to consummate a Business Combination will be successful within the Combination Period. Additionally, the Company has incurred and expects to continue to incur
significant costs in pursuit of its acquisition plans. As a result, these factors
raise substantial doubt about the Company&#8217;s ability to continue as a going concern for the next twelve months from the issuance
of these financial statements. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
and Uncertainties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position, results of its operations, and search for a target company, the specific
impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_z1tfUPZXcHU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_82D_zayDyBGeuz2h">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5piLhu7ej1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z2s4oTn5D1p1">Basis
of Presentation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) as contained within the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards
Codification (&#8220;ASC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_84F_ecustom--EmergingGrowthCompanyPolicyTextBlock_zjC1R0hQahwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zvm2ZrWcsrtd">Emerging
Growth Company</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities
Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 215; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_845_eus-gaap--UseOfEstimates_z4nl6qfhdbFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zJelOGGc3Nml">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with US GAAP requires the Company&#8217;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVlny8JIRqsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zhzZ1uWcrlZ8">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zItSu1MAHKQb" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">345,777</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_zAXyIs9fLL0l" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,555</ix:nonFraction></span> in cash as of December 31, 2022 and 2021. The Company did not have any cash equivalents
as of December 31, 2022 or December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:InvestmentsHeldInTrustAccountPolicyTextBlock"><p id="xdx_84E_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zFxKRtwFobx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_ziy9pjH8T3Ul">Investments
Held in Trust Account</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2022 and 2021, the Company had $<span id="xdx_902_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231_zAM9IxI5iFb8" title="Assets held-in-trust, noncurrent"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,871,183</ix:nonFraction></span> and <span id="xdx_906_eus-gaap--AssetsHeldInTrustNoncurrent_iI_dxL_c20211231_zHMaCXASoyL5" title="Assets held-in-trust, noncurrent::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0462">zero, respectively,</span></span> in investments held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock"><p id="xdx_849_ecustom--OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_zudH8q6aDGg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z3gArUAOjrqa">Offering
Costs Associated With a Public Offering</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A
&#8212; &#8220;<i>Expenses of Offering.&#8221;</i> Offering costs of $<span id="xdx_908_ecustom--PublicOfferingCosts_c20220101__20221231_z74ORiIF3Ma7" title="Offering costs"><ix:nonFraction name="MURFU:PublicOfferingCosts" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,738,161</ix:nonFraction></span>
consisting of $<span id="xdx_90E_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220101__20221231_zMxCUY4QWAC9" title="Underwriting fees"><ix:nonFraction name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,645,000</ix:nonFraction></span>
of underwriting fees, $<span id="xdx_904_ecustom--DeferredUnderwritingFee_c20220101__20221231_z28EFCWSEu85" title="Deferred underwriting fee"><ix:nonFraction name="MURFU:DeferredUnderwritingFee" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,628,750</ix:nonFraction></span>
of deferred underwriting fee (which are held in the Trust Account with Wilmington Trust Company acting as trustee),
and $<span id="xdx_906_ecustom--InitialPublicOfferingCost_c20220101__20221231_z8aumYHAK5Sg" title="Initial public offering costs"><ix:nonFraction name="MURFU:InitialPublicOfferingCost" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">464,411</ix:nonFraction></span>
of Initial Public Offering costs. Of these costs, $<span id="xdx_905_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zXUWyMRpGmOc" title="Warrant issuance cost"><ix:nonFraction name="MURFU:WarrantIssuanceCost" contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,358,457</ix:nonFraction></span>
and $<span id="xdx_903_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zYx1IjVJCyKe" title="Warrant issuance cost"><ix:nonFraction name="MURFU:WarrantIssuanceCost" contextRef="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,656</ix:nonFraction></span>
were allocated to Public Warrants (as defined in Note 3) and Private Placement Warrants (as defined in Note 4), respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"><p id="xdx_848_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zoX2Q6Nuuvk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zyBsnjIJzmM">Class
A Common Stock Subject to Possible Redemption</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance enumerated in
ASC 480 &#8220;<i>Distinguishing Liabilities from Equity</i>&#8221;. Common stock subject to mandatory redemption is classified as a
liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature
redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events
not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, common stock is classified as
stockholders&#8217; equity. The shares of the Company&#8217;s Class A common stock feature certain redemption rights that are
considered by the Company to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022, the shares of Class A common stock subject to possible redemption in the amount of $<span id="xdx_903_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20221231_zBT9Z72q0hg5" title="Temporary equity, carrying amount, attributable to parent"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,771,183</ix:nonFraction></span>
are presented as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance
sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zAAtN7Xllgck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Class A common stock subject to possible redemption reflected on the  balance sheet are reconciled
in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z2lr5YRJKgz3" style="display: none">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Gross proceeds from IPO</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220101__20220630_zBcvvUviX5xj"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">132,250,000</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds allocated to Public Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_c20220101__20220630_zWdMy6PlaCT2" title="Proceeds allocated to Public Warrants" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MURFU:ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,276,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--PaymentOfCommonStockIssuanceCosts_c20220101__20220630_zIxPVWPRMts7" title="Class A common stock issuance costs" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MURFU:PaymentOfCommonStockIssuanceCosts" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,360,054</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Remeasurement
    adjustment of carrying value to redemption value</td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_c20220101__20220630_zNpPbOs9GoVf" title="Remeasurement adjustment of carrying value to redemption value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,281,054</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Class A common stock subject to possible redemption, as of March 31, 2022</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220401__20220630_zBfOe0vjE2D6" title="Common stock subject to possible redemption,beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:CommonStockSubjectToPossibleRedemption" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,895,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
    of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220401__20220630_zaW7wQN58XQb" title="Remeasurement adjustment of carrying value to redemption value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,767</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of June 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220701__20220930_zGEnAZuXHCS3" title="Common stock subject to possible redemption,beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:CommonStockSubjectToPossibleRedemption" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,996,767</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220701__20220930_zE0IrPa6a7Hj" title="Remeasurement adjustment of carrying value to redemption value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">609,920</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of September 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20221001__20221231_zWqQDblob9tc" title="Common stock subject to possible redemption, ending" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:CommonStockSubjectToPossibleRedemption" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,606,687</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20221001__20221231_zeBxdaBxnqU4" title="Remeasurement adjustment of carrying value to redemption value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-10-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,164,496</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class A common stock
    subject to possible redemption as of December 31, 2022</span> </td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--CommonStockSubjectToPossibleRedemption_iE_c20221001__20221231_zJaLl4a4Gdd2" title="Common stock subject to possible redemption, ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MURFU:CommonStockSubjectToPossibleRedemption" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,771,183</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_z9qdT5gxpjZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 216; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zn0FzwpBJdvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zYQRHT7aCAC9">Net
Income (Loss) per Common Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding
for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share
as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with
the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence
of future events. As of December 31, 2022, the Company&#8217;s outstanding warrants <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iNI_pid_di_c20221231_zgDwP3Bwqh86" title="Outstanding warrants">(<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,979,000</ix:nonFraction>)</span> have been excluded from diluted net
loss as their inclusion would be anti-dilutive. As a result, diluted net income (loss) per common share is the same as basic net income
(loss) per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdAkAOIxXnUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zfgvdKXe6VI1" style="display: none">SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    Since Inception to</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            A common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            B common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income
    per common share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpJakvAbgL5i" title="Allocation of net loss" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNvmZ3n0yCh" title="Allocation of net loss" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi0MkF0B8cG2" title="Basic and diluted weighted average shares outstanding" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhyfsoULUYjd" title="Basic and diluted weighted average shares outstanding" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,875,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    income per common share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z80ASqkgnzX2" title="Basic and diluted net loss per common share" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzlqgSgwVEad" title="Basic and diluted net loss per common share" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the Year Ended</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    A common stock</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    B common stock </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic
    and diluted net loss per common share</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation
    of net income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zelEscxqJxXj" title="Allocation of net loss" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">315,560</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwAq2pxVG2qj" title="Allocation of net loss" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,079</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted weighted average shares outstanding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjZmhKJzYDsj" title="Basic and diluted weighted average shares outstanding" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,558,058</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWshQ7fU0va" title="Basic and diluted weighted average shares outstanding" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per common share</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziECzwENsQN2" title="Basic and diluted net loss per common share" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMFMgISDwU08" title="Basic and diluted net loss per common share" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zRriBmV9v45d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 217; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zpJvohATqhyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zbSXj7JbaAnb">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zGoKsW9Q3Ku" title="Unrecognized tax benefits"><span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zrOfsYFfHLYk" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> unrecognized tax benefits and <span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zFgAyY9FX99k" title="Income tax penalties and interest accrued"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_zWXhhtgX9265" title="Income tax penalties and interest accrued"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts accrued for interest and penalties as of December 31, 2022
or December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals
or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified the United States and California as its only tax jurisdictions. The Company is subject to income taxation by major
taxing authorities since inception. All tax periods are open to examination by tax authorities. These examinations may include questioning
the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws.
The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next
twelve months. The Company actual tax expense differs from the expected tax expense due to the change in the valuation allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zrB7CsIHY3Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z5P8XqvPQWC5">Concentration
of Credit Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to credit risk consist principally of cash and investments held in the Trust Account.
Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal Depository Insurance Corporation coverage
limit of $<span id="xdx_902_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_c20220101__20221231_z7VwwBJMlLpf" title="Federal deposit insurance corporation premium expense"><ix:nonFraction name="us-gaap:FederalDepositInsuranceCorporationPremiumExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>, and investments held in the Trust Account. As of December 31, 2022 and 2021, the Company had not experienced
losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:InvestmentHeldInTrustAccountPolicyTextBlock"><p id="xdx_84D_ecustom--InvestmentHeldInTrustAccountPolicyTextBlock_z6YuSdd0hoJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zh45SLpsh3hb">Investments
Held in Trust Account</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Investments held in the Trust Account were $<span id="xdx_905_eus-gaap--AssetsHeldInTrust_iI_c20221231_zik71MYja2A3" title="Investments held in trust"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,871,183</ix:nonFraction></span>
at December 31, 2022 and <span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_pn5n6_dc_c20211231_zcEi6YD5K7kg" title="Investments held in trust"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="-5" scale="6" unitRef="USD">zero</ix:nonFraction></span>
as of December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government
securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held
in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s
investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities
and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account
in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using
available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 218; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zc1MdaksWCJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zQyJQZeygsM3">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value Measurements&#8221;
approximates the carrying amounts represented in the balance sheet, partially due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:DerivativesReportingOfDerivativeActivity"><p id="xdx_84D_eus-gaap--DerivativesReportingOfDerivativeActivity_zf24iZVNypg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zQwdV4WDP7A3">Derivative
Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each
reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:WarrantInstrumentsPolicyTextBlock"><p id="xdx_841_ecustom--WarrantInstrumentsPolicyTextBlock_zTPTyDfseDVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z02RYyXYP4i3">Warrant
Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants in accordance with the guidance contained in FASB ASC 815, &#8220;Derivatives and Hedging&#8221;.
Under ASC 815-40 warrants that meet the criteria for equity treatment are recorded in stockholders&#8217; equity (deficit). The warrants are
subject to re-evaluation of the proper classification and accounting treatment at each reporting period. If the warrants no longer
meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the
statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z3cMEn6mP34e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zItt09U2ct97">Recent
Accounting Standards</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on the Company&#8217;s financial statements.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_854_ziDHbBIPRhn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:InitialPublicOfferingTextBlock"><p id="xdx_80F_ecustom--InitialPublicOfferingTextBlock_z80ZLp633gn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_828_zX855hzHCL4g">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zg48gCIVVX8h" title="Sale of stock"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-01-012022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,225,000</ix:nonFraction></span>
Units at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zclg5L1FUhk1" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>
per Unit. Each Unit consists of one share of Class A common stock (&#8220;Public Shares&#8221;) and one redeemable warrant
(&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a
price of $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znwDZBOUSjbi" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember_custom_PublicWarrantMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span>
per share, subject to adjustment (see Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 219; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="MURFU:PrivatePlacementsTextBlock"><p id="xdx_804_ecustom--PrivatePlacementsTextBlock_z1cyrpaelahb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; <span id="xdx_825_zwxhPPINYXK3">PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private sale to the Sponsor of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPxqeLBbTst5" title="Number of shares issued for private sale"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-01-012022-12-31_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">754,000</ix:nonFraction></span>
Private Placement Units at a price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zvOhyfndF422" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-12-31_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>
per Private Placement Unit ($<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwc3XSZSRG7b" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2022-01-012022-12-31_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,540,000</ix:nonFraction></span>).
Each Private Placement Unit is comprised of one Class A share and one warrant (&#8220;Private Placement Warrant&#8221;). Each Private Placement Warrant is exercisable to
purchase one share of Class A common stock at a price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CapitalUnitClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zj7LzwxKwsj7" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31_us-gaap_CapitalUnitClassAMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span>
per share, subject to adjustment (see Note 7). The Company&#8217;s Sponsor has agreed to transfer, but has not yet transferred, <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember_ziqRs6ikHV92" title="Number of units transferred to director"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></span>
Private Placement Units to each of our director nominees. The proceeds from the sale of the Private Placement Units were added to the net
proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within
the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the
redemption of the Public Shares (subject to the requirements of applicable law) and the securities comprising the Private Placement
Units will expire worthless. The Private Placement Units (including the Class A common stock issuable upon exercise of the warrants
included in the Private Placement Units) will not be transferable, assignable or saleable until 30 days after the completion of an
Initial Business Combination, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zGOdRUgIDTyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; <span id="xdx_829_zJdOdhEvuE5c">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Founder
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2021, the Sponsor received <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211114__20211116__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUVTWHcECAtg" title="Number of shares issued to sponsor"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-142021-11-16_custom_SponsorMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,312,500</ix:nonFraction></span> shares of the Company&#8217;s Class B common stock (the &#8220;Founder Shares&#8221;)
for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20211114__20211116__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zudlNC0MqXml" title="Number of shares issued to sponsor, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-142021-11-16_custom_SponsorMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span>. On January 26, 2022, the Sponsor surrendered and forfeited <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_ziO090Co09oh" title="Stock surrendered and forfeited during period shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2022-01-252022-01-26_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,006,250</ix:nonFraction></span> Founder Shares for no consideration, following which
the Sponsor holds <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesOnHold_c20220124__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zThclrPrwyfl" title="Stock issued during period on hold"><ix:nonFraction name="MURFU:StockIssuedDuringPeriodSharesOnHold" contextRef="From2022-01-242022-01-26_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></span> Founder Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until
the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x)
if the last reported sale price of the Class A common stock equals or exceeds $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20211116__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zcxIQBk4QS1h" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-11-16_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></span> per share (as adjusted for stock splits, stock capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar
transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities
or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note &#8212; Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021, the Sponsor issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to
which the Company may borrow up to an aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20211104_zjJXC6lA1z8f" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-11-04" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>.
The Promissory Note is non-interest bearing and payable on the earlier of (i) the consummation of the Initial Public Offering or
(ii) the decision not to execute the Initial Public Offering. As of December 31, 2021, there was $<span id="xdx_902_eus-gaap--NotesPayableCurrent_iI_c20211231_zhA6TFolkO39" title="Notes payable, current"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,057</ix:nonFraction></span>
outstanding under the Promissory Note. The balance was paid in full on February 10, 2022. See Note 10, regarding a new promissory
note issued by the Sponsor to the Company for $<span id="xdx_907_eus-gaap--SponsorFees_pn5n6_c20220209__20220210_zIrjQMU6L2x4" title="Sponsor fees"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2022-02-092022-02-10" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction> </span>million, subsequent to December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
and Administrative Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 60pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the date the Units are first listed on the Nasdaq, the Company has agreed to pay the Sponsor a total of $<span id="xdx_903_eus-gaap--PaymentsForRent_c20220101__20221231_zv2wdPYiTgdk" title="Monthly payment for office space"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span> per month for office
space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company&#8217;s
liquidation, the Company will cease paying these monthly fees. During the year ended December 31, 2022, the Company incurred $<span id="xdx_902_ecustom--AdministrationFeeRelatedParty_c20220101__20221231_z60g1ZIvfWuh" title="Administration fee related party"><ix:nonFraction name="MURFU:AdministrationFeeRelatedParty" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></span>,
of such expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Loans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#8220;Working
Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of
a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $<span id="xdx_903_eus-gaap--DebtConversionOriginalDebtAmount1_c20220101__20221231_z8uO0enqZx14" title="Notes payable converted"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> of the notes may be converted upon completion
of a Business Combination into units at a price of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20221231_z3K5YWU6CyAb" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per unit. Such units would be identical to the Private Placement Units. In
the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay
the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December
31, 2022 and 2021, there were <span id="xdx_90E_ecustom--WorkingCapitalLoan_iI_do_c20221231_zGwWXN7hU398" title="Working capital loans"><span id="xdx_905_ecustom--WorkingCapitalLoan_iI_do_c20211231_zKzO1aepYf23" title="Working capital loans"><ix:nonFraction name="MURFU:WorkingCapitalLoan" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="MURFU:WorkingCapitalLoan" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts outstanding under the Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 220; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znrsQDwRNvqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; <span id="xdx_826_z26ulJyilrw8">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and
any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working
Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement
to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale.
The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company
register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration
statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities
pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required
to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are
released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underwriting
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQgudg26swP1" title="Issuance of Class B common stock to Sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></span> additional Units
to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The option was
fully exercised on <span id="xdx_907_ecustom--OptionExercisedDate_dd_c20220101__20221231_zqdPaiqUPHje" title="Option exercised date"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:datemonthdayyearen" name="MURFU:OptionExercisedDate">February 7, 2022</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were paid a cash underwriting discount of $<span id="xdx_905_ecustom--CashUnderwritingDiscount_c20220101__20221231_z8XuC5VNjcdl" title="Cash underwriting discount"><ix:nonFraction name="MURFU:CashUnderwritingDiscount" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></span> per Unit, or $<span id="xdx_904_ecustom--UnderwritingDiscount_c20220101__20221231_zeKwhIeH74E4" title="Underwriting discount"><ix:nonFraction name="MURFU:UnderwritingDiscount" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,645,000</ix:nonFraction></span>, payable upon the closing of the Initial Public
Offering. In addition, the underwriters are entitled to a deferred fee of $<span id="xdx_900_ecustom--DeferredFeePerShare_iI_c20221231_z2DbQr5CAKFj" title="Deferred fee per share"><ix:nonFraction name="MURFU:DeferredFeePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></span> per Unit, or $<span id="xdx_903_eus-gaap--DeferredOfferingCosts_iI_c20221231_zG7EzTdC73F1" title="Deferred fee"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,628,750</ix:nonFraction></span>. The deferred fee will become
payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the underwriting discount, the Company paid the underwriters $<span id="xdx_90F_ecustom--AdvancePaymentForUnderwriterExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_z6cVoj9RINVc" title="Advance payment for underwriter expenses"><ix:nonFraction name="MURFU:AdvancePaymentForUnderwriterExpenses" contextRef="From2022-01-012022-12-31_custom_UnderwriterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span> as an advance against out-of-pocket accountable expenses
actually anticipated to be incurred by the underwriters, which advance will be returned to the Company to the extent not actually incurred.
The Company agreed to pay or reimburse the underwriters for travel, lodging and other &#8220;road show&#8221; expenses, expenses of the
underwriters&#8217; legal counsel and certain diligence and other fees, which such fees and expenses are capped at an aggregate of $<span id="xdx_905_ecustom--UnderwriterExpenses_c20220101__20221231_zx86g7kjcpC1" title="Underwriter expenses"><ix:nonFraction name="MURFU:UnderwriterExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></span>
(less the $<span id="xdx_90D_ecustom--AdvancePaymentForUnderwriterExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zbsVCVDq5Bhl" title="Advance payment for underwriter expenses"><ix:nonFraction name="MURFU:AdvancePaymentForUnderwriterExpenses" contextRef="From2022-01-012022-12-31_custom_UnderwriterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span> advance previously paid).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z6xxhHJbtBl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_829_z7fSFEqua8Ob">STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_ziQ2EVAZKFMf"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of preferred stock with a par value of $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zduoJI93pcGl" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. As
of December 31, 2022 and December 31, 2021, there were <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zCQffYugdEob" title="Preferred stock shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_z3lnrpOE6P9e" title="Preferred stock shares outstanding"><span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zMi4f0y7cu" title="Preferred stock shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zElXWJHfISz" title="Preferred stock shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
A Common Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJpJMsNlsfi9" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> shares of Class A common stock with a par value of $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zeivWtl2ldkj" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
per share. <span id="xdx_909_eus-gaap--CommonStockVotingRights_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWjp8Od3H5Tc" title="Voting rights"><ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" name="us-gaap:CommonStockVotingRights">Holders of Class A common stock are entitled to one vote for each share.</ix:nonNumeric></span> As of December 31, 2022 and 2021, there
were <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zV6J6dHO1675" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJRdHJKqYue6" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">754,000</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_dc_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zy1bhK43NEYc" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_dc_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8Big6Y9G5rc" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">zero</ix:nonFraction></ix:nonFraction></span></span>, respectively, shares of Class A common stock issued and outstanding (excluding the <span id="xdx_90D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zoSh2ZecVRC3" title="Shares subject to possible redemption"><span id="xdx_902_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zlrXrPLiUdd5" title="Shares subject to possible redemption"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,225,000</ix:nonFraction></ix:nonFraction></span></span> shares subject to
possible redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
B Common Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z6DbX4ROIHNg" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUVdQzMpLku2" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span>
shares of Class B common stock with a par value of $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zLD8W3nhY5j" title="Common stock, par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zYRbC6dW9Sed" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>
per share. Holders of Class B common stock are entitled to one vote for each share. As of each December 31, 2022 and 2021, there were <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzpbd3IsWOi4" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zIkH9tJEDEHi" title="Common stock, shares outstanding"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdSLktfDN2y7" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zD6WVhj4Bws1" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,306,250</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span>
shares of Class B common stock issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 221; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of
our shareholders except as otherwise required by law. In connection with our initial business combination, we may enter into a stockholders
agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance
arrangements that differ from those in effect upon completion of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier
at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock,
or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to
the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common
stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment
with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of
all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all
shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked
securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed
in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest
in the target to us in a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class B common stock will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise
required by law. In connection with our initial business combination, we may enter into a stockholders agreement or other arrangements
with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from
those in effect upon completion of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
</i></b>&#8212; Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation
of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion
of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years
after the completion of a Business Combination or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A
common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from
registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue
any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified
under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination,
the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have
declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the
warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed.
Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities
exchange such that it satisfies the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the
Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221;
in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to
file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 222; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption
of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00</i></b> &#8212; Once the warrants become exercisable,
the Company may redeem the outstanding Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231_zDOANFFXAcZa" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per Public Warrant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    a minimum of 30 days&#8217; prior written notice of redemption, or the 30-day redemption period to each warrant holder; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the last reported sale price of the Class A common stock equals or exceeds $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7jgLlaBqZze" title="Share price per shares"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> per share (as adjusted for stock splits,
    stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on
    the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that
wishes to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise
price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in
the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as
described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally,
in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination
within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive
any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company&#8217;s assets held
outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants and Public Warrants are recorded in stockholders&#8217; equity (deficit) as they qualify for equity treatment
under ASC 815.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key assumptions used to value the Public Warrants, which was determined to be $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember_zAgzSxSNqi48" title="Warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,276,000</ix:nonFraction></span>, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term
    &#8211; <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zpkkryrcOfdk" title="Warrant expected term"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility
    &#8211; <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z1Ikpd7iiOK9" title="Warrant measurement inputs"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">22</ix:nonFraction></span>%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
    &#8211; <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zcf9G3kqPwgb" title="Warrant measurement inputs"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span>%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
    rate &#8211; <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_ztfvl5e36EO4" title="Warrant measurement inputs"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputDiscountRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.76</ix:nonFraction></span>% </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 223; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_80D_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z6COOCJFVTZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; <span id="xdx_828_zYzdnx7j1Op8">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zu2TxWQCc0A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value at December 31,
2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_z2pylKwhXTJe" style="display: none">SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0Mjy4Tf55Eb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsAbstract_iB_zoOkDuDLTXvj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zHZWkQ1kdbY2" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investments held in Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,871,183</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zsLA3m5VVvl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify">As
of December 31, 2021, there were <span id="xdx_90E_eus-gaap--AssetsHeldInTrustNoncurrent_iI_do_c20211231__srt--ProductOrServiceAxis__us-gaap--FinancialServiceMember_zxUuBH1DIxma" title="Investments held in trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31_us-gaap_FinancialServiceMember" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> assets requiring fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_znVqMWBYuS54" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; <span id="xdx_826_zQLcBl1ErrNh">TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zdlxj36gAKF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected tax expense based on the statutory rate is reconciled with actual tax expense as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span id="xdx_8BE_zegrbkaZkNY" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20220101__20221231_ztBO9JiSAqB" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Year
    Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zpiP2iCHC56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">U.S.
    federal statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_zvGp5IACUHr4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">State
    taxes, net of federal benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zZPiAqn7dbB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.36</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zeVDLX67TYl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">Income
    tax provision</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48.46</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zR1W0dW1cfSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The effective tax rate differs
from the statutory tax rate of <span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231_zpZu02cEIZJe" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% for the year ended December 31, 2021, due to the valuation allowance recorded on the Company&#8217;s
net operating losses. The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various
taxing authorities. The Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. The Company
considers California to be a significant state tax jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and
liabilities and the change in valuation are as follows at December 31:</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zXgh0p8Lvp01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zWmmuSHGaLTh" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span> </span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20221231_zjXfeH5w61Pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNetAbstract_iB_z5EO900vwzIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpense_i01I_msDTAGzZX3_zFPjgyXFWaP3" style="vertical-align: bottom; background-color: White">
    <td style="width: 81%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Startup
    costs</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesDeferredExpense" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,627</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_i01TI_maDTANznat_mtDTAGzZX3_zJtetEhhZ59k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,627</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_di_msDTANznat_zykPUm3eeTcg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation Allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,627</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01TI_mtDTANznat_zakgSTSosEUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zDfJCxRrTAc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlDQRPDVQMmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;SCHEDULE
OF CHANGE IN VALUATION</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zjd2Zov0DUK8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_ztbOTcYfa2R4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 81%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_iN_di_zMATFmWpeVA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">374,862</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_zbbOudZnaMzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">211,627</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_zj5vWIJN2Zi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State and
    Local</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zgyPTYBnm8Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_z7DPciRMrj09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_z6zOhjx3JZs2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in
    valuation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,627</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_z9vkKwAn6fkk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income Tax Provision</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,862</ix:nonFraction></td><td style="font-size: 10pt; text-align: left"></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zT9SsyLFliDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In assessing the realization of
the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will
not be realized. The ultimate realization of deferred tax assets is independent upon the generation of future taxable income during the
periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration
of all of the information available, management believes that significant uncertainty exists with respect to future realization of the
deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31,2021, the change in the valuation
allowance was zero.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zkBsJeFKFOT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8212; <span id="xdx_828_zbXALt37NXl5">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements
were issued. Based upon this review, except as disclosed below, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initially,
the Company was required to complete an initial business combination transaction by 12 months from the consummation of  initial
public offering or up to 18 months if the Company extended the period of time to consummate a business combination in accordance
with the Company&#8217;s Certificate of Incorporation. On January 26, 2023, at a special meeting of the Company&#8217;s stockholders
(the &#8220;Special Meeting&#8221;), the Company&#8217;s stockholders approved a proposal to amend the Company&#8217;s certificate of incorporation to allow the Company to extend, at the Company&#8217;s election, the date by
which the Company has to consummate a business combination up to 12 times, each such extension for an additional one month period, from
February 7, 2023, to February 7, 2024. The Company&#8217;s stockholders also approved a related proposal to amend the trust agreement allowing the Company to
deposit into the Trust Account, for each one-month extension, one-third of <span id="xdx_901_ecustom--PercentageOfDepositInTrustAccount_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLxcW2p92Czc" title="Percentage of deposit in trust account"><ix:nonFraction name="MURFU:PercentageOfDepositInTrustAccount" contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction>%</span>
of the funds remaining in the Trust Account following the redemptions made in connection with the approval of the extension proposal
at the Special Meeting. At the Special Meeting the Company&#8217;s stockholders also approved a proposal to amend the Company&#8217;s certificate of incorporation
to expand the methods that the Company may employ to not become subject to the &#8220;penny stock&#8221; rules of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with such proposals, the Company&#8217;s public stockholders had the right to redeem their shares for cash equal to their pro rata share of
the aggregate amount on deposit in the Trust Account as of two days prior to such stockholder vote. The Company&#8217;s public stockholders holding <span id="xdx_908_ecustom--StockIssuedDuringPeriodShareOnHold_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zfthNgs7rAS2" title="Stock issued during period on hold"><ix:nonFraction name="MURFU:StockIssuedDuringPeriodShareOnHold" contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,037,272</ix:nonFraction></span>
shares of Class A common stock (out of a total of <span id="xdx_90C_eus-gaap--SharesIssued_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zEwwQAWHFTDk" title="Stock issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,979,000</ix:nonFraction></span> shares of Class A common stock) exercised their right to redeem such shares
at a redemption price of approximately $<span id="xdx_905_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_uUSDPShares_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zUyf8G0vxfT2" title="Redemption price per share"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.33</ix:nonFraction></span> per share. Approximately $<span id="xdx_90A_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMw9csqjGC88" title="Number of stock redeemed, value"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114</ix:nonFraction></span> million in cash was removed from the Trust Account to pay
such stockholders and, accordingly, after giving effect to such redemptions, the balance in the Trust Account was approximately $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEHOMQih1FSa" title="Investments held in trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23</ix:nonFraction></span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the approval of such proposals, the Company agreed to deposit into the Trust Account one-third of <span id="xdx_907_ecustom--PercentageOfDepositInTrustAccount_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhWKE9AFSg27" title="Percentage of deposit in trust account"><ix:nonFraction name="MURFU:PercentageOfDepositInTrustAccount" contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction>%</span> of the funds then on deposit
in the Trust Account for each month of the extension period, resulting in a monthly contribution of approximately $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxDXFbe0sO56" title="Price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span> per share that
was not redeemed in connection with the Special Meeting, or an aggregate of approximately $<span id="xdx_90C_eus-gaap--DepositAssets_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zboE1G94Dw8a" title="Aggregate of deposit"><ix:nonFraction name="us-gaap:DepositAssets" contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,000</ix:nonFraction></span> per month, and an aggregate of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlgJuuCYuK7f" title="Proceeds from business combination"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">924,000</ix:nonFraction></span>
if the date the Company has to consummate a business combination is extended 12 times, each assuming no interest is earned on the funds in the
Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt">On March 7, 2023, the
Company entered into a $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20230306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znA5Zs4wiA3b"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-03-06_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span>
million promissory note with the Company&#8217;s Sponsor to fund the Trust Account and for the Company&#8217;s operating expenses.
On March 7, 2023 the Company&#8217;s Sponsor advanced $<span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20230307__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJD1SUJo7Pfj" title="Sponsor advanced amount"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-03-072023-03-07_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>
and will provide additional funds as necessary under the promissory note. These loans are non-interest bearing, unsecured and will
be repayable in full upon the earlier of (i) the date on which the Company consummates an initial business combination and (ii) the date that
the Company&#8217;s winding up is effective.</p>

</ix:nonNumeric><p id="xdx_81F_zTFJhTbrpW2l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 224; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 150.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="annex_001"></span>Annex
A-1</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT
AND PLAN OF MERGER</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>by
and among</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURPHY
CANYON ACQUISITION CORP.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDUIT
MERGER SUB, INC.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDUIT
PHARMACEUTICALS LIMITED</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dated
as of November 8, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 225 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">TABLE
OF CONTENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 229.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    I DEFINITIONS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">2</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    1.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Definitions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">2</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    1.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">16</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    II THE MERGER; CLOSING</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">17</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Merger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">17</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">17</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Time</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">18</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational
    Documents of Murphy and the Surviving</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">18</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.5</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">18</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.6</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">18</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.7</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Further Ownership Rights in Company Capital Stock.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">18</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.8</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
    Not Transferable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">19</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    2.9</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taking
    of Necessary Action; Further Action</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">19</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    III ACTIONS PRIOR TO THE MERGER; CONVERSION OF SECURITIES; CONSIDERATION</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">19</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    3.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONVERSION
    OF SECURITIES</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">19</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    3.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of Merger Consideration</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">21</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    3.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withholding
    Rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">21</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    3.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register
    of Members</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">22</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    3.5</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">22</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    3.6</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenter&#8217;s
    Rights</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">23</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">23</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization
    and Qualification</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">24</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational
    Documents.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">24</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">24</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority
    Relative to this Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">25</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.5</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Conflict; Required Filings and Consents</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">26</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.6</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permits;
    Compliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">26</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.7</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">26</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.8</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undisclosed
    Liabilities.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">27</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.9</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Certain Changes or Events</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">28</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.10</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Litigation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">28</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.11</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Benefit Plans</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">28</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.12</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor
    Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">29</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.13</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
    Property; Title to and Sufficiency of Assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">30</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.14</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    Property</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">30</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.15</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">31</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.16</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
    Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">33</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.17</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
    Contracts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">33</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.18</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">35</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.19</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal
    Controls</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-36</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 226; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.20</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    Statement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1-36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.21</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
    Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">36</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.22</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    Approval; Vote Required</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">36</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.23</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">36</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.24</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover
    Laws</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">37</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.25</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International
    Trade Matters; Anti-Bribery Compliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">37</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.26</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    Party Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">38</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.27</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    An Investment Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">38</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.28</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusivity
    of Representations and Warranties</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">38</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    4.29</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Disclosure</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">38</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    V REPRESENTATIONS AND WARRANTIES OF MURPHY AND MERGER SUB</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Organization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">39</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
    and Merger Sub Organizational Documents</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">39</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">40</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority
    Relative to This Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">40</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.5</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Conflict; Required Filings and Consents</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">41</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.6</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">41</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.7</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
    SEC Documents and Financial Statements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">42</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.8</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Certain Changes or Events</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">43</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.9</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Litigation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">43</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.10</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    Approval; Vote Required</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">43</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.11</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Prior Operations of Merger Sub</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">43</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.12</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
    Trust Fund</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">44</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.13</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">44</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.14</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">44</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.15</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">47</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.16</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    Company Act</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">47</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.17</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    Statement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">47</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.18</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">47</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.19</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">47</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.20</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor
    Support Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">47</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.21</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy&#8217;s
    and Merger Sub&#8217;s Investigation and Reliance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">48</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    5.22</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Disclosure</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">48</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    VI CONDUCT OF BUSINESS PENDING THE MERGER</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">48</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    6.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
    of Business by the Company Pending the Merger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">48</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    6.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
    of Business by Murphy Pending the Merger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">51</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    6.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Claims
    Against Trust Account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">51</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    6.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Per Share Merger Consideration</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">52</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    VII ADDITIONAL AGREEMENTS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">52</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation
    of Registration Statement; Special Meeting; Company Requisite Approval</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">52</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
    to Information; Confidentiality; Publicity</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">54</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusivity</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">55</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 227 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreements.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1-57</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.5</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors&#8217;
    and Officers&#8217; Indemnification</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">57</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.6</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Litigation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">57</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.7</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">59</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.8</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Exchange Listing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">60</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.9</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
    Public Filings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">60</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.10</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Efforts
    to Consummate; Antitrust; Regulatory Approvals</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">60</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.11</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trust
    Account</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">62</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.12</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    16 Matters</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">62</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.13</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation
    and Delivery of PCAOB Audited Financial Statements and Interim Financial Statements.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">62</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.14</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
    of Transaction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1-63</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    7.15</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of Certain Events</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">63</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    VIII CONDITIONS TO THE MERGER</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">63</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    8.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
    to the Obligations of Each Party</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">63</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    8.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
    to the Obligations of Murphy and Merger Sub</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">65</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    8.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
    to the Obligations of the Company.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">66</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    8.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frustration
    of Conditions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">67</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    IX TERMINATION, AMENDMENT AND WAIVER</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">67</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    9.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">67</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    9.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of Termination</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">68</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    9.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">68</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    9.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">68</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    9.5</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">68</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    X NON-SURVIVAL OF REPRESENTATIONS AND WARRANTIES</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">69</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    10.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Survival</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">69</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
    XI GENERAL PROVISIONS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">69</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">69</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.2</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">71</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.3</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire
    Agreement; Assignment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">71</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.4</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
    in Interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">71</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.5</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
    Law</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">71</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.6</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WAIVER
    OF JURY TRIAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">72</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.7</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Headings</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">72</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.8</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">72</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.9</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific
    Performance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-<span style="font-size: 10pt">72</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
    11.10</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Legal
    Representation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1-72</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 228 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">MERGER
AGREEMENT AND PLAN OF MERGER</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<b>AGREEMENT AND PLAN OF MERGER</b>, dated as of November 8, 2022 (this &#8220;<span style="text-decoration: underline">Agreement</span>&#8221;), is entered into by and among
(i) Murphy Canyon Acquisition Corp., a Delaware corporation (&#8220;<span style="text-decoration: underline">Murphy</span>&#8221;), (ii) Conduit Merger Sub, Inc., a Cayman Islands
exempted company (&#8220;<span style="text-decoration: underline">Merger Sub</span>&#8221;), and (iii) Conduit Pharmaceuticals Limited, a Cayman Islands exempted company (the
&#8220;<span style="text-decoration: underline">Company</span>&#8221;). Murphy, Merger Sub, and the Company are sometimes referred to individually herein as a &#8220;<span style="text-decoration: underline">Party</span>&#8221;
and, collectively, the &#8220;<span style="text-decoration: underline">Parties</span>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
Murphy is a special purpose acquisition company incorporated in Delaware and formed to acquire one or more operating businesses through
a business combination;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
Merger Sub is a newly formed, wholly owned, direct subsidiary of Murphy and was formed for the sole purpose of the Merger;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
subject to the terms and conditions of this Agreement and in accordance with the Companies Act (Revised) of the Cayman Islands (the &#8220;<span style="text-decoration: underline">Companies
Act</span>&#8221;), at the Effective Time, Merger Sub will merge with and into the Company pursuant to the Merger, with the Company surviving
as the Surviving Corporation;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
in connection with the Merger, the Shareholders will be entitled to receive the Merger Consideration, as described in this Agreement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
the Sponsor, certain of Sponsor&#8217;s Affiliates and Murphy have entered into a Sponsor Support Agreement, dated as of the date hereof
(the &#8220;<span style="text-decoration: underline">Sponsor Support Agreement</span>&#8221;), providing that, among other things, the Principal Shareholders will vote in favor
of this Agreement and the Transactions (including the Merger);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
Murphy and the Principal Shareholders, contemporaneously with the execution and delivery of this Agreement, have entered into the Shareholder
Support Agreement, dated as of the date hereof (the &#8220;<span style="text-decoration: underline">Shareholder Support Agreement</span>&#8221;), providing that, among other
things, the Principal Shareholders will vote in favor of this Agreement and the Transactions (including the Merger);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
at the Closing, Murphy, certain stockholders of Murphy and certain Shareholders will enter into an Amended and Restated Registration
Rights Agreement with Murphy (the &#8220;<span style="text-decoration: underline">Registration Rights Agreement</span>&#8221;), which will, among other things, govern the registration
of certain Company Ordinary Shares for resale and also provide for a lock-up pertaining to certain Company Ordinary Shares owned by such
Shareholders and which shall be effective as of the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
in connection with the Merger, Murphy shall adopt the second amended and restated certificate of incorporation (the &#8220;<span style="text-decoration: underline">Amended
Charter</span>&#8221;) in the form attached hereto as <span style="text-decoration: underline">Exhibit B</span>, to provide for, among other things, an increase in the number of
authorized shares of Murphy Common Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
in connection with the Merger, Murphy shall adopt the amended and restated bylaws (the &#8220;<span style="text-decoration: underline">Amended Bylaws</span>&#8221;) in the form
attached hereto as <span style="text-decoration: underline">Exhibit C</span>;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 229; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
in connection with the transactions contemplated by this Agreement, Murphy will enter into subscription agreements (each, as amended
or modified from time to time, a &#8220;<span style="text-decoration: underline">Subscription Agreement</span>&#8221;), with certain persons providing for aggregate investments
in Murphy Common Stock in a private placement of an amount not less than $27,000,000 and valued in an amount of $10.00 per share (the
&#8220;<span style="text-decoration: underline">PIPE Financing</span>&#8221;);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
the respective boards of directors of each of Murphy, Merger Sub and the Company have each (a) unanimously approved and declared advisable
this Agreement and the Transactions upon the terms and subject to the conditions of this Agreement and in accordance with the DGCL and
the Companies Act, as applicable, and (b) adopted a resolution recommending to their respective stockholders or shareholders, as the
case may be, the approval and adoption of this Agreement and the Transactions;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
the sole shareholder of Merger Sub has approved and declared advisable this Agreement and the Transactions upon the terms and subject
to the conditions of this Agreement and in accordance with the Companies Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
each of the Parties intends that, for United States federal income tax purposes, (a) this Agreement shall be adopted as a &#8220;plan
of reorganization&#8221; within the meaning of Section 368 of the Code and Treasury Regulations Section 1.368-2(g) and (b) the Merger
shall constitute an integrated transaction that qualifies as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the
Internal Revenue Code of 1986, as amended (the &#8220;<span style="text-decoration: underline">Code</span>&#8221;) and the Treasury Regulations to which the Murphy, Merger Sub
and the Company are parties within the meaning of Section 368(b) of the Code (collectively, the &#8220;<span style="text-decoration: underline">Intended Tax Treatment</span>&#8221;);
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>,
all capitalized terms not defined in these Recitals shall have the respective meanings ascribed to them in this Agreement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOW,
THEREFORE</b>, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally
bound hereby, the Parties hereto hereby agree as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
1.1 </b><span style="text-decoration: underline">Certain Definitions</span>. For purposes of this Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Action</span>&#8221;
has the meaning set forth in Section 4.10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Additional
Murphy SEC Documents</span>&#8221; has the meaning set forth in Section 5.7(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Affiliate</span>&#8221;
of a specified Person means a Person who, directly or indirectly through one or more intermediaries, controls, is controlled by, or is
under common control with, such specified Person. For the avoidance of doubt, Merger Sub shall be deemed to be an Affiliate of Murphy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Affiliate
Transaction</span>&#8221; has the meaning set forth in Section 4.26.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 230; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Agreement</span>&#8221;
has the meaning set forth in the preamble of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Amended
Bylaws</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Amended
Charter</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Ancillary
Agreements</span>&#8221; means the Amended Charter, the Amended Bylaws, the Shareholder Support Agreement, the Sponsor Support Agreement,
the Registration Rights Agreement, the Subscription Agreements, and all other agreements, certificates and instruments executed and delivered
by the Parties in connection with the Transactions and specifically contemplated by this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Anti-Corruption
Laws</span>&#8221; means any applicable Laws relating to anti-bribery or anti- corruption (governmental or commercial), including the U.S.
Foreign Corrupt Practices Act of 1977, as amended (the &#8220;<span style="text-decoration: underline">FCPA</span>&#8221;), the U.S. Travel Act, 18 U.S.C. &#167; 1952, and the
U.K. Bribery Act 2010, and any other equivalent or comparable Laws of other countries in which the Company has conducted and/or currently
conducts business, when applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Antitrust
Laws</span>&#8221; has the meaning set forth in Section 7.10(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Applicable
Per Share Merger Consideration</span>&#8221; means, with respect to each holder of Company Ordinary Shares, including Company Ordinary Shares
issued upon the Company Convertible Debt Conversion, such holder&#8217;s pro rata portion of the Closing Payment Shares for each Company
Ordinary Share issued and outstanding as of the Effective Time after giving effect to the Company Convertible Debt Conversion as specified
on <span style="text-decoration: underline">Exhibit A</span> as updated pursuant to <span style="text-decoration: underline">Section 6.4</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Blue
Sky Laws</span>&#8221; has the meaning set forth in Section 4.5(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Books
and Records</span>&#8221; means books and records (whether written, electronic, or otherwise embodied) in which a Person&#8217;s assets,
the business or its transactions are otherwise reflected, other than stock books and minute books.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Business
Data</span>&#8221; means all business information and data, including Personal Information (whether of employees, contractors, consultants,
customers, consumers, or other Persons and whether in electronic or any other form or medium) that is accessed, collected, used, processed,
stored, shared, distributed, transferred, disclosed, destroyed, or disposed of by any of the Business Systems or otherwise in the course
of the conduct of the business of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Business
Day</span>&#8221; means any day on which the principal offices of the SEC in Washington, D.C. are customarily open to accept filings, or,
in the case of determining a date when any payment is due, any day on which banks are not required or authorized to close in New York,
NY.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Business
Systems</span>&#8221; means all Software, computer hardware (whether general or special purpose), electronic data processing, information,
record keeping, communications, telecommunications, networks, interfaces, platforms, servers, peripherals, and computer systems, including
any outsourced systems and processes, that are owned or used or held for use in the conduct of the Company Business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 231; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Claims</span>&#8221;
has the meaning set forth in Section 6.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Closing</span>&#8221;
has the meaning set forth in Section 2.2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Closing
Date</span>&#8221; has the meaning set forth in Section 2.2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Closing
Payment Shares</span>&#8221; means sixty-five million (65,000,000) shares of Murphy Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Code</span>&#8221;
has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Companies
Act</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company</span>&#8221;
has the meaning set forth in the preamble of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Acquisition Proposal</span>&#8221; means any proposal or offer from a Person or a &#8220;group&#8221; (as defined in the Exchange Act) relating
to (a) any direct or indirect acquisition or purchase, in a single transaction or series of related transactions, of (i) any equity ownership
in the Company or any of its controlled Affiliates or (ii) all or a material portion of assets or businesses of the Company or any of
its controlled Affiliates (in the case of each of clause (i) and (ii), whether by merger, consolidation, recapitalization, purchase or
issuance of equity securities, tender offer or otherwise), or (b) any equity or similar investment in the Company or any of its controlled
Affiliates. Notwithstanding the foregoing or anything to the contrary herein, none of this Agreement, the Ancillary Agreements or the
Transactions shall constitute a Company Acquisition Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Affiliate Agreement</span>&#8221; means any Contract between the Company, on the one hand, and a Related Party, on the other hand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Board Recommendation</span>&#8221; has the meaning set forth in Section 7.1(f).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Business</span>&#8221; means acquiring, developing, researching, commercializing, </span><span style="font-family: Times New Roman, Times, Serif">licensing,
sublicensing, out-licensed, in-licensed, distributing, selling, funding, investing in, and the management of pharmaceutical, therapeutic,
biologic and/or medicinal product candidates or devices, including, but not limited to, entering into strategic partnerships, joint ventures,
development, royalty, commercialization, licensing, funding, investment and/or collaboration agreements related thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Capital Stock</span>&#8221; means the Company Ordinary Shares and includes Company Ordinary Shares issued upon the Company Convertible Debt
Conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Convertible Debt</span>&#8221; means, collectively, (i) the convertible notes issued by the Company prior to the date hereof that are listed
on <span style="text-decoration: underline">Schedule 4.3(d)</span> of the Company Disclosure Schedule, and (ii) the convertibles notes that may be issued by the Company following
the date hereof but prior to the Closing Date pursuant to Section 6.1(a), provided that the Company shall promptly provide Murphy with
notice, including all information that is required by Section 4.3(d), after any such issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 232; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
D&amp;O Insurance</span>&#8221; has the meaning set forth in Section 7.5(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Debt</span>&#8221; means the following consolidated obligations of the Company: (a) all indebtedness for borrowed money or in respect of
loans or advances of any kind or for the deferred purchase price of property or services, including &#8220;earn-out&#8221; payments;
(b) all liabilities evidenced by bonds, debentures, promissory notes, mortgages or other debt instruments and debt securities; (c) all
guarantees of the debt of other Persons on assets or properties of such Person, whether or not the obligations secured thereby have been
assumed; (d) contingent reimbursement obligations with respect to letters of credit, bankers&#8217; acceptance or similar facilities
(in each case to the extent drawn); (e) obligations under capitalized leases, (f) any unfunded or underfunded liabilities pursuant to
any pension or nonqualified deferred compensation plan or arrangement and any earned but unpaid compensation (including salary, bonuses
and paid time off) for any period prior to the Closing Date; and (g) guarantees, make-whole agreements, hold harmless agreements or other
similar arrangements with respect to any amounts of a type described in clauses (a) through </span><span style="font-family: Times New Roman, Times, Serif">(f)
above, and with respect to each of the foregoing, any unpaid interest, breakage costs, prepayment or redemption penalties or premiums,
or other unpaid fees or obligations. For the avoidance of doubt, Company Debt shall not include any trade payables or other accounts
payable incurred in the ordinary course of business to suppliers or other service providers. The amount of Company Debt as of the date
hereof is set forth on <span style="text-decoration: underline">Schedule 1.01(b) </span>of the Company Disclosure Schedules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Disclosure Schedules</span>&#8221; has the meaning set forth in the preamble to Article IV.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Employees</span>&#8221; has the meaning set forth in Section 4.11(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
IP</span>&#8221; means, collectively, all Company-Owned IP and Company-Licensed IP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company-Licensed
IP</span>&#8221; means all Intellectual Property rights owned or purported to be owned by a third party and licensed to the Company or to
which the Company otherwise has a right to use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 233; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Material Adverse Effect</span>&#8221; means any event, circumstance, change, effect or occurrence (collectively &#8220;<span style="text-decoration: underline">Effect</span>&#8221;)
that, individually or in the aggregate with all other Effects, (a) has had, or would reasonably be expected to have, a material adverse
effect on the business, financial condition, assets or results of operations of the Company or (b) has a material adverse effect on the
ability of the Company to consummate the Transactions in accordance with the terms of this Agreement; <i>provided, however, </i>that
for purposes of clause (a) above, any Effects directly or indirectly attributable to, resulting from, relating to or arising out of the
following (by themselves or when aggregated with any other, changes or effects) shall not be deemed to be, constitute, or be taken into
account when determining whether there has or may, would or could have occurred a Company Material Adverse Effect: (i) any change or
proposed change in the interpretation of any Law (including any COVID-19 Measures) after the date of this Agreement; (ii) events or conditions
generally affecting the industries or geographic areas or markets in which the Company operates; (iii) any material downturn in general
economic conditions, including material changes in the credit, debt, securities, financial or capital markets (including changes in interest
or exchange rates, prices of any security or market index or commodity or any disruption of such markets); (iv) acts of war, sabotage,
civil unrest, terrorism, cyberterrorism (including ransomware attacks), epidemics, pandemics or disease outbreaks (including COVID-19),
or any escalation or worsening of any of the foregoing; (v) any hurricane, tornado, flood, earthquake, wild fire, natural disaster, or
other acts of God or other force majeure event, including, for the avoidance of doubt, COVID-19 and any COVID-19 Measures, (vi) any actions
taken or not taken by the Company as required by this Agreement or any Ancillary Agreement, (vii) any fact, event, circumstance, change
or effect attributable to the announcement or execution, pendency, negotiation or consummation of the Merger or any of the other Transactions
(including the impact thereof on relationships with customers, suppliers, distributors, licensors, partners, providers, employees or
Governmental Authorities), <i>provided, however,</i> that the exceptions in clauses (vi) or (vii) shall not be deemed to apply to references
to &#8220;Material Adverse Effect&#8221; in the representations and warranties set forth in Section 4.9<span style="text-decoration: underline">(a)</span> and, to the extent
related thereto, the condition in Section 8.2(a), or (viii) any failure to meet any projections, forecasts, guidance, estimates, milestones,
budgets or financial or operating predictions of revenue, earnings, cash flow or cash position (<i>provided, </i>that clause (viii) shall
not prevent or otherwise affect a determination that any event, change, fact or circumstance underlying such failure to meet projections
or forecasts has resulted in, or contributed to, or would reasonably be expected to result in or contribute to, a Company Material Adverse
Effect, and <i>provided, further, </i>that any event, change, fact or circumstance referred to in clauses (i), (ii), (iii), and (v) may
be taken into account in determining if a &#8220;Company Material Adverse Effect&#8221; occurred to the extent it has a disproportionate
impact on the Company as compared to similarly situated companies in the industry in which the Company conducts its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Ordinary Shares</span>&#8221; means the Company&#8217;s ordinary shares, with a par value of GBP0.0001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Organizational Documents</span>&#8221; means the Certificate of Incorporation of the Company, as issued by with the Assistant Registrar
of Companies, Cayman Islands, on December 21, 2018, together with the Memorandum and Articles of Association of the Company, as filed
with the Assistant Registrar of Companies, Cayman Islands, on December 21, 2018, as each may have been amended, supplemented, designated
or modified from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company-Owned
IP</span>&#8221; means all Intellectual Property rights owned or purported to be owned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Permits</span>&#8221; has the meaning set forth in Section 4.6.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 39pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Company
Requisite Approval</span>&#8221; means the affirmative vote of the holders of at least a two- thirds majority of the outstanding shares
of the Company Ordinary Shares, voting together as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Confidential
Information</span>&#8221; means any information, knowledge or data concerning the businesses and affairs of the Company, or any Suppliers
or customers of the Company or Murphy or its subsidiaries (as applicable) that is not already generally available to the public.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Confidentiality
Agreement</span>&#8221; has the meaning set forth in Section 7.2(b). &#8220;<span style="text-decoration: underline">Contribution</span>&#8221; has the meaning set forth in Section
4.14(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 234; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Contributor</span>&#8221;
has the meaning set forth in Section 4.14(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">control</span>&#8221;
(including the terms &#8220;<span style="text-decoration: underline">controlled by</span>&#8221; and &#8220;<span style="text-decoration: underline">under common control with</span>&#8221;) means the possession, directly
or indirectly, or as trustee or executor, of the power to direct or cause the direction of the management and policies of a Person, whether
through the ownership of voting securities, as trustee or executor, by contract or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Copyright
License</span>&#8221; means any license that requires, as a condition of use, modification or distribution of software or other Intellectual
Property subject to such license, that such software or other Intellectual Property subject to such license, or other software or other
Intellectual Property incorporated into, derived from, used or distributed with such software or other Intellectual Property subject
to such license (a) in the case of software, be made available or distributed in a form other than binary (e.g., source code form), (b)
be licensed for the purpose of preparing derivative works, (c) be licensed under terms that allow the Products or portions thereof or
interfaces therefor to be reverse engineered, reverse assembled or disassembled (other than by operation of Law) or (d) be redistributable
at no license fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">COVID-19</span>&#8221;
shall mean SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemics or disease outbreaks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">COVID-19
Measures</span>&#8221; means any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; workforce reduction, social distancing,
shut down, closure, sequester, workplace safety or similar Law promulgated by any Governmental Authority, including the Centers for Disease
Control and Prevention and the World Health Organization, in each case, in connection with or in response to COVID-19, including the
CARES Act and Families First Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">D&amp;O
Indemnified Persons</span>&#8221; has the meaning set forth in Section 7.5(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">D&amp;O
Insurance</span>&#8221; has the meaning set forth in Section 7.5(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">D&amp;O
Tail Insurance</span>&#8221; has the meaning set forth in Section 7.5(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">DGCL</span>&#8221;
means the General Corporation Law of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Dissenting
Shares</span>&#8221; has the meaning set forth in Section 3.6(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Effective
Time</span>&#8221; has the meaning set forth in Section 2.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Environmental
Laws</span>&#8221; means any applicable Law, and any United States federal, state or local or non-United States laws relating to: (a) pollution
(or the cleanup thereof) or the protection of natural resources, endangered or threatened species, human health or safety, or the environment
(including ambient or indoor air, soil, soil gas, surface water, groundwater, sediments, surface or subsurface strata); or (b) concerning
the release, threatened release, presence of, exposure to, contamination of, or any injury or threat of injury to persons or property
relating to, or the management, manufacture, use, containment, storage, recycling, reclamation, reuse, treatment, generation, discharge,
transportation, processing, production, sale, distribution, labeling, disposal or remediation of any Hazardous Substances or materials
containing Hazardous Substances. The term &#8220;<i>Environmental Law</i>&#8221; includes the following (including their implementing
regulations and any state analogs): the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by
the Superfund Amendments and Reauthorization Act of 1986, 42 U.S.C. &#167;&#167; 9601 et seq.; the Solid Waste Disposal Act, as amended
by the Resource Conservation and Recovery Act of 1976, as amended by the Hazardous and Solid Waste Amendments of 1984, 42 U.S.C. &#167;&#167;
6901 et seq.; the Federal Water Pollution Control Act of 1972, as amended by the Clean Water Act of 1977, 33 U.S.C. &#167;&#167; 1251
et seq.; the Toxic Substances Control Act of 1976, as amended, 15 U.S.C. &#167;&#167; 2601 et seq.; the Emergency Planning and Community
Right-to-Know Act of 1986, 42 U.S.C. &#167;&#167; 11001 et seq.; and the Clean Air Act of 1966, as amended by the Clean Air Act Amendments
of 1990, 42 U.S.C. &#167;&#167; 7401 et seq.; the Occupational Safety and Health Act of 1970, as amended, 29 U.S.C. &#167;&#167; 651
et seq; the Safe Drinking Water and Toxic Enforcement Act of 1986, 27 Cal. Code Regs., &#167;&#167; 25249 et seq, and Federal Insecticide,
Fungicide, and Rodenticide Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 235; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Environmental
Claim</span>&#8221; means any action, suit, claim, investigation or other proceeding by any person alleging liability of whatever kind or
nature (including liability or responsibility for the costs of enforcement proceedings, investigations, cleanup, governmental response,
removal or remediation, natural resources assessments and damages, property damages, personal injuries, medical monitoring, penalties,
contribution, indemnification and injunctive relief) arising out of, based on or resulting from: (a) the actual or alleged presence,
generation, use, handling, transportation, storage, treatment, disposal, threatened Release or Release of, or exposure to, any Hazardous
Substances; (b) any actual or alleged non-compliance with any Environmental Law or term or condition of any Environmental Permit; or
(c) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of
the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">ERISA</span>&#8221;
has the meaning set forth in Section 4.11(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Exchange
Act</span>&#8221; means the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Exchange
Ratio</span>&#8221; means the quotient of (a) the Merger Consideration, <span style="text-decoration: underline">divided by</span> (b) the number of shares of Company Capital Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Export
Control Laws</span>&#8221; has the meaning set forth in Section 4.25(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">GAAP</span>&#8221;
has the meaning set forth in Section 4.7(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Governmental
Authority</span>&#8221; has the meaning set forth in Section 4.5(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Hazardous
Substance(s)</span>&#8221; means: (a) any material, substance, chemical, waste, product, derivative, compound, mixture, solid, liquid, mineral
or gas, in each case, whether naturally occurring or man-made, that is hazardous, acutely hazardous, toxic, carcinogenic, mutagenic,
radioactive, a pollutant, a contaminant or is otherwise characterized by words of similar import or regulatory effect or that could give
rise to Liability under Environmental Laws; and (b) any petroleum or petroleum-derived products, radon, radioactive materials or wastes,
natural gas, synthetic gas, asbestos in any form, lead or lead-containing materials, urea formaldehyde foam insulation, polychlorinated
biphenyls and per- and polyfluoroalkyl substances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">HSR
Act</span>&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 236; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Immediate
Family</span>&#8221; means, with respect to any natural person, such person&#8217;s spouse or domestic partner, lineal ancestor or descendant,
or sibling, including any adoptive relationship and relationships through marriage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Intellectual
Property</span>&#8221; means any and all of the following in any jurisdiction throughout the world (a) patents and patent applications,
together with all reissues, continuations, continuations-in-part, divisionals, extensions or reexaminations thereof; (b) trademarks and
service marks, trade dress, trade names, corporate names, any other indicia of source or origin, and all applications, registrations,
and renewals in connection therewith, together with all of the goodwill associated with the foregoing; (c) copyrights and other works
of authorship (whether or not copyrightable), and moral rights, and registrations and applications for registration, renewals and extensions
thereof; (d) trade secrets, know-how and other confidential information, in each instance, that derive independent economic value from
not being generally known to the public and not being readily ascertainable by other Persons; (e) Internet domain names, social media
accounts, websites and content; (f) Software and rights in Software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Intended
Tax Treatment</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Interim
Balance Sheet</span>&#8221; has the meaning set forth in Section 4.7(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Interim
Financial Statements</span>&#8221; has the meaning set forth in Section 4.7(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">International
Trade Control Laws</span>&#8221; has the meaning set forth in Section 4.25(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">International
Trade Laws</span>&#8221; means all applicable laws, regulations, rules and licenses of the United States and other governments, including
but not limited to, the sanctions, embargoes and restrictions administered by the U.S. Department of the Treasury&#8217;s Office of Foreign
Assets Control (&#8220;<span style="text-decoration: underline">OFAC</span>&#8221;) and the Foreign Trade Regulations administered by the U.S. Department of Commerce&#8217;s
Bureau of Census, the anti-boycott regulations administered by the U.S. Department of Commerce and the U.S. Department of the Treasury.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Investment
Company Act</span>&#8221; has the meaning set forth in Section 4.27.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Knowledge</span>&#8221;
or &#8220;<span style="text-decoration: underline">to the Knowledge</span>&#8221; of a Person shall mean (i) in the case of the Company, the actual knowledge of the Persons listed
on <span style="text-decoration: underline">Schedule 1.01(c)</span> of the Company Disclosure Schedules after reasonable inquiry, or (ii) in the case of Murphy, the actual knowledge
of the Persons listed on <span style="text-decoration: underline">Schedule 1.01(c)</span> of the Murphy Disclosure Schedules after reasonable inquiry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Law</span>&#8221;
means any federal, state, local or foreign (including the general principles of common law, civil law and equity) statute, law, ordinance,
regulation, code, executive order, injunction, judgment, decree, constitution, convention, treaty, common law, act, code, edict, determination,
binding interpretation, subpoena, decision, verdict, judgment, award, administrative requirement, decree and the rules and regulations
promulgated thereunder, in each case enacted, promulgated or imposed by any Governmental Authority, and to the extent they have the force
of law, any policies, guidelines and notices of any Governmental Authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 237; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Leased
Real Property</span>&#8221; means the real property leased by the Company as tenant, together with, to the extent leased by the Company,
all buildings and other structures, facilities or Improvements located thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Liabilities</span>&#8221;
means any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise,
whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required
to be recorded or reflected on a balance sheet under GAAP or other applicable accounting standards), including Tax liabilities due or
to become due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Lien</span>&#8221;
means any lien, security interest, mortgage, pledge, adverse claim or other encumbrance of any kind that secures the payment or performance
of an obligation (other than those created under applicable Securities Laws).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Material
Contracts</span>&#8221; has the meaning set forth in Section 4.17(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Merger
Consideration</span>&#8221; means six hundred and fifty million dollars ($650,000,000).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Merger
Sub</span>&#8221; has the meaning set forth in the preamble of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Merger
Sub Ordinary Shares</span>&#8221; has the meaning set forth in Section 5.3(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Merger
Sub Organizational Documents</span>&#8221; means the certificate of incorporation and memorandum and articles of association of Merger Sub,
as amended, modified or supplemented from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy</span>&#8221;
has the meaning set forth in the preamble of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Acquisition Proposal</span>&#8221; means any proposal or offer from a Person or a &#8220;group&#8221; (as defined in the Exchange Act) relating
to (a) any direct or indirect acquisition or purchase, in a single transaction or series of related transactions, of (i) any equity ownership
in Murphy or any of its controlled Affiliates or (ii) all or a material portion of assets or businesses of Murphy or any of its controlled
Affiliates (in the case of each of clause (i) and (ii), whether by merger, consolidation, recapitalization, purchase or issuance of equity
securities, tender offer or otherwise), or (b) any equity or similar investment in Murphy or any of its controlled Affiliates. Notwithstanding
the foregoing or anything to the contrary herein, none of this Agreement, the Ancillary Agreements or the Transactions shall constitute
a Murphy Acquisition Proposal.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Board</span>&#8221; has the meaning set forth in Section 5.10(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Board Recommendation</span>&#8221; has the meaning set forth in Section 7.1(e).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Certificate of Incorporation</span>&#8221; means the Amended and Restated Certificate of Incorporation of Murphy, dated February 2, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Class A Common Stock</span>&#8221; means, at all times prior to the Effective Time, Murphy&#8217;s Class A Common Stock, par value $0.0001
per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 238; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Class B Common Stock</span>&#8221; means, at all times prior to the Effective Time, Murphy&#8217;s Class B Common Stock, par value $0.0001
per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Common Stock</span>&#8221; means, at all times prior to the Effective Time, Murphy Class A Common Stock and Murphy Class B Common Stock,
collectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Disclosure Schedules</span>&#8221; has the meaning set forth in the preamble to Section 4.29.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Financial Statements</span>&#8221; has the meaning set forth in Section 5.7(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Material Adverse Effect</span>&#8221; means any Effect that, individually or in the aggregate with all other Effects, (a) has had, or would
reasonably be expected to have, a material adverse effect on the business, financial condition, assets or results of operations of Murphy
or (b) has a material adverse effect on the ability of Murphy and/or Merger Sub to consummate the Transactions in accordance with the
terms of this Agreement; <i>provided, however,</i> that for purposes of clause (a) above, any Effects directly or indirectly attributable
to, resulting from, relating to or arising out of the following (by themselves or when aggregated with any other, changes or effects)
shall not be deemed to be, constitute, or be taken into account when determining whether there has or may, would or could have occurred
a Murphy Material Adverse Effect: (i) any change or proposed change in the interpretation of any Law (including any COVID-19 Measures)
after the date of this Agreement; (ii) events or conditions generally affecting the industries or geographic areas or markets in which
Murphy operates; (iii) any material downturn in general economic conditions, including material changes in the credit, debt, securities,
financial or capital markets (including changes in interest or exchange rates, prices of any security or market index or commodity or
any disruption of such markets); (iv) acts of war, sabotage, civil unrest, terrorism, cyberterrorism (including ransomware attacks),
epidemics, pandemics or disease outbreaks (including COVID-19), or any escalation or worsening of any of the foregoing; (v) any hurricane,
tornado, flood, earthquake, wild fire, natural disaster, or other acts of God or other force majeure event, including, for the avoidance
of doubt, COVID-19 and any COVID-19 Measures, (vi) any actions taken or not taken by Murphy as required by this Agreement or any Ancillary
Agreement, (vii) any fact, event, circumstance, change or effect attributable to the announcement or execution, pendency, negotiation
or consummation of the Merger or any of the other Transactions (including the impact thereof on relationships with customers, suppliers,
distributors, licensors, partners, providers, employees or Governmental Authorities), <i>provided, however, </i>that the exceptions in
clauses (vi) or (vii) shall not be deemed to apply to references to &#8220;Murphy Material Adverse Effect&#8221; in the representations
and warranties set forth in Section 5.8 and, to the extent related thereto, the condition in Section 8.3(a), or (viii) any failure to
meet any projections, forecasts, guidance, estimates, milestones, budgets or financial or operating predictions of revenue, earnings,
cash flow or cash position (<i>provided, </i>that clause (viii) shall not prevent or otherwise affect a determination that any event,
change, fact or circumstance underlying such failure to meet projections or forecasts has resulted in, or contributed to, or would reasonably
be expected to result in or contribute to, a Murphy Material Adverse Effect, and <i>provided, further, </i>that any event, change, fact
or circumstance referred to in clauses (i), (ii), (iii), and (v) may be taken into account in determining if a &#8220;Murphy Material
Adverse Effect&#8221; occurred to the extent it has a disproportionate impact on Murphy as compared to similarly situated companies in
the industry in which Murphy conducts its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 239; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Organizational Documents</span>&#8221; means the Murphy Certificate of Incorporation and bylaws, in each case as amended, modified or supplemented
from time to time, which will be amended and restated in connection with the Merger as provided herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Preferred Stock</span>&#8221; has the meaning set forth in Section 5.3(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Private Placement Warrants</span>&#8221; has the meaning ascribed to &#8220;Private Warrant&#8221; in the Murphy SEC Reports as of the date
of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Proposals</span>&#8221; has the meaning set forth in Section 7.1(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Public Warrant</span>&#8221; has the meaning ascribed to &#8220;Public Warrant&#8221; in the Murphy SEC Reports as of the date of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
SEC Documents</span>&#8221; has the meaning set forth in Section 5.7(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Units</span>&#8221; means the units of Murphy issued in connection with its initial public offering, which such units are comprised of one
share of Murphy Class A Common Stock and one Murphy Public Warrant, which ceased trading and were separated into their component parts
as of March 28, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Murphy
Warrants</span>&#8221; means, collectively, Murphy Public Warrants and Murphy Private Placement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Nasdaq</span>&#8221;
means the Nasdaq Global Select Market or The Nasdaq Global Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Open
Source License</span>&#8221; means any license meeting the Open Source Definition (as promulgated by the Open Source Initiative) or the
Free Software Definition (as promulgated by the Free Software Foundation), or any substantially similar license, including any license
approved by the Open Source Initiative or any Creative Commons License. For the avoidance of doubt, Open Source Licenses include Copyright
Licenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Outside
Date</span>&#8221; has the meaning set forth in Section 9.1(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Outstanding
Company Transaction Expenses</span>&#8221; has the meaning set forth in Section 3.5(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Outstanding
Murphy Transaction Expenses</span>&#8221; has the meaning set forth in Section 3.5(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Owned
Real Property</span>&#8221; means the land owned by the Company (collectively, the &#8220;<span style="text-decoration: underline">Land</span>&#8221;), together with all buildings
and other structures, facilities, and other improvements located thereon (collectively, the &#8220;<span style="text-decoration: underline">Improvements</span>&#8221;); all right,
title and interest of the Company if any, in and to any and all appurtenances, strips or gores, roads, easements, streets, alleys, drainage
facilities and rights-of-way bounding any of the Land; all utility capacity, utilities, water rights, licenses, permits, entitlements,
and bonds, if any, and all other rights and benefits attributable to the Land; and all rights of ingress and egress thereto; all transferable
consents, authorizations, variances or waivers, licenses, permits and approvals from any Governmental Authority in connection with the
Land or the Improvements held by or granted to the Company any of its respective predecessors in title, and/or the agents thereof with
respect to the Land or the Improvements; all right, title and interest of the Company in and to all site plans, surveys, soil and substratus
studies, and engineering and architectural drawings, plans and specifications, in the possession or control of the Company relating to
the Land or Improvements; all equipment and other personal property owned by the Company located on and/or exclusively used in connection
with the operation of the Land or Improvements; and all written service and maintenance contracts and other written contracts, if any,
relating to the Land or Improvements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 240; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Party</span>&#8221;
and &#8220;<span style="text-decoration: underline">Parties</span>&#8221; have the meaning set forth in the preamble of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">PCAOB
Audited Financial Statements</span>&#8221; has the meaning set forth in Section 4.7(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Permitted
Liens</span>&#8221; means: (a) such imperfections of title, easements, encumbrances, Liens or restrictions that do not materially impair
the current use of the Company&#8217;s assets that are subject thereto; (b) Liens for Taxes not yet due and payable, or being contested
in good faith for which adequate reserves have been set aside according to GAAP; (c) zoning, entitlement, conservation restriction and
other land use and environmental regulations promulgated by Governmental Authorities, (d) non-exclusive licenses, sublicenses or other
rights to Intellectual Property owned by or licensed to the Company granted to any licensee in the ordinary course of business; (e) non-
monetary Liens, encumbrances and restrictions on real property (including easements, covenants, rights of way and similar restrictions
of record) that do not materially interfere with the present uses of such real property; and (f) materialmen&#8217;s, mechanics&#8217;,
carriers&#8217;, workmen&#8217;s, warehousemen&#8217;s, repairmen&#8217;s, landlord&#8217;s, and other similar Liens arising in the ordinary
course of business, or deposits to obtain the release of such Liens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Person</span>&#8221;
means an individual, corporation, partnership, limited partnership, limited liability company, syndicate, person (including a &#8220;person&#8221;
as defined in Section 13(d)(3) of the Exchange Act), trust, association or entity or government, political subdivision, agency or instrumentality
of a government.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Personal
Information</span>&#8221; means (a) information related to an identified or identifiable individual (e.g., name, address telephone number,
email address, financial account number, health information, government-issued identifier), (b) any other data used or intended to be
used or which allows one to identify, contact, or precisely locate an individual, device or household, including any internet protocol
address or other persistent identifier, and (c) any other, similar information or data regulated by Privacy/Data Security Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">PIPE
Financing</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Plan</span>&#8221;
has the meaning set forth in Section 4.11(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Plan
of Merger</span>&#8221; has the meaning set forth in Section 2.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Principal
Shareholders</span>&#8221; means (i) Corvus Capital Limited, (ii) St. George Street Capital Limited, and (iii) Algo Holdings, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Prior
Financial Statements</span>&#8221; has the meaning set forth in Section 4.7(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 241; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Privacy/Data
Security Laws</span>&#8221; means all Laws, self-regulatory standards, third party system and platform requirements, and industry regulations
governing (a) the receipt, collection, use, storage, processing, sharing, security, disclosure, transfer, sale, unauthorized access or
modification, theft, loss, inaccessibility, breach, or transfer of Personal Information, Confidential Information, the Company&#8217;s
Business Systems or Business Data and (b) unfair and deceptive practices, accessibility, advertising communications (e.g., text messages,
emails, calls), PCI-DSS, location tracking and marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Products</span>&#8221;
mean any products or services, developed, manufactured, performed, out- licensed, sold, distributed other otherwise made available by
or on behalf of the Company from which the Company has derived previously, is currently deriving or is scheduled to derive, revenue from
the sale or provision thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Prohibited
Party</span>&#8221; has the meaning set forth in Section 4.25(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Proxy
Statement</span>&#8221; means the proxy statement to be filed by Murphy as part of the Registration Statement with respect to the Special
Meeting for the purpose of soliciting proxies from stockholders of Murphy to approve Murphy Proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Redeeming
Shareholder</span>&#8221; means a stockholder of Murphy who properly demands that Murphy redeem its Class A Common Stock for cash in connection
with the Murphy Proposals and in accordance and in compliance with Murphy Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Registered
Company IP</span>&#8221; means patents, patent applications, registrations and applications for registration of trademarks, service marks,
and trade dress, internet domains, and copyrights owned or licensed by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Registration
Rights Agreement</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Registration
Statement</span>&#8221; has the meaning set forth in Section 7.1(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Related
Party</span>&#8221; means, with respect to the Company, (a) any Affiliate of the Company or any Person who serves as a director, officer,
general partner or managing member of such Affiliate;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any Person who serves as a director, officer, general partner or managing member of the Company; (c) any Person that beneficially owns,
directly or indirectly, at least 5% of the Company Capital Stock or any Affiliate described in clause (i) of such Person; or (d) any
Immediate Family member of any Person described in clause (a), (b) or (c). For purposes of this definition, &#8220;<span style="text-decoration: underline">Affiliate</span>&#8221;
shall not include the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Remedies
Exceptions</span>&#8221; has the meaning set forth in Section 4.4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Representatives</span>&#8221;
has the meaning set forth in Section 7.2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Sanctions
Laws</span>&#8221; has the meaning set forth in Section 4.25(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Securities
Act</span>&#8221; means the Securities Exchange Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 242; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Securities
Laws</span>&#8221; means the securities laws of any state, federal or foreign entity and the rules and regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Shareholder</span>&#8221;
means a holder of Company Ordinary Shares, including holders of shares of Company Ordinary Shares issued upon the Company Convertible
Debt Conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Shareholder
Support Agreement</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Software</span>&#8221;
means all computer software (in object code or source code format), data and databases, and related documentation and materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Special
Meeting</span>&#8221; means a meeting of the holders of Murphy Common Stock to be held for the purpose of approving the Murphy Proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Sponsor</span>&#8221;
means Murphy Canyon Acquisition Sponsor LLC, a Delaware limited liability company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Sponsor
Support Agreement</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Subscription
Agreement</span>&#8221; has the meaning set forth in the recitals of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Subsidiary</span>&#8221;
means, with respect to a Person, any other Person, of which (a) an amount of the voting securities, other voting ownership or voting
partnership interests of which is sufficient to elect at least a majority of its board of directors or other governing body (or, if there
are no such voting interests, fifty percent (50%) or more of the equity interests of which) is owned directly or indirectly by such first
Person or (b) such Persons controls any other Person. For the purposes hereof, the term &#8220;Subsidiary&#8221; shall include all subsidiaries
of such Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Supplier</span>&#8221;
means any Person that supplies inventory or other materials or personal property, components, or other goods or services that are utilized
in or comprise the Products of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Surviving
Corporation</span>&#8221; has the meaning set forth in Section 2.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Surviving
Corporation Organizational Documents</span>&#8221; means the form of certificate of incorporation and articles and memorandum of association
set forth on <span style="text-decoration: underline">Exhibit D</span> to this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Surviving
Provisions</span>&#8221; has the meaning set forth in Section 9.2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Tax</span>&#8221;
and &#8220;<span style="text-decoration: underline">Taxes</span>&#8221; means any U.S. federal, state, local, foreign, and other income, gross income, adjusted gross income or
gross receipts, franchise, estimated, alternative or add-on minimum, sales, use, transfer, value added, excise, stamp, customs, duties,
ad valorem, real property, personal property (tangible and intangible), capital stock, social security, unemployment, payroll, wage,
employment, severance, occupation, registration, communication, mortgage, profits, license, lease, service, goods and services, withholding,
disability, estimated, escheat, premium, turnover, windfall profits or other taxes of any kind whatsoever, together with any interest,
penalties, additions to tax, or additional amounts imposed by any Governmental Authority with respect thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 243; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Tax
Return</span>&#8221; means any return, information return, statement, declaration, claim for refund, estimate, report, or other document
relating to Taxes that is filed or required to be filed with any Governmental Authority, including any schedule or attachment thereto
and including any amendments thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Terminating
Company Breach</span>&#8221; has the meaning set forth in Section 9.1(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Terminating
Murphy Breach</span>&#8221; has the meaning set forth in Section 9.1(e).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Transactions</span>&#8221;
means the transactions contemplated by this Agreement, including the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
and the Ancillary Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Treasury
Regulations</span>&#8221; means the final and temporary United States Treasury regulations issued pursuant to the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Treasury
Shares</span>&#8221; has the meaning set forth in Section 3.1(b)(ii). &#8220;<span style="text-decoration: underline">Trust Account</span>&#8221; has the meaning set forth in Section
5.12.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Trust
Agreement</span>&#8221; means the Investment Management Trust Agreement, dated December 2, 2022, between Murphy and Wilmington Trust Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Trust
Fund</span>&#8221; has the meaning set forth in Section 5.12.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Trustee</span>&#8221;
has the meaning set forth in Section 5.12.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Willful
Breach</span>&#8221; means, with respect to any agreement, a Party&#8217;s knowing and intentional material breach of any of its representations
or warranties as set forth in such agreement, or such Party&#8217;s material breach of any of its covenants or other agreements set forth
in such agreement, which material breach constitutes, or is a consequence of, a purposeful act or failure to act by such Party with the
Knowledge that the taking of such act or failure to take such act would cause a material breach of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Withholding
Agent</span>&#8221; has the meaning set forth in Section 3.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
1.2</b> <span style="text-decoration: underline">Construction</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless
the context of this Agreement otherwise requires, (i) words of any gender include all other genders, (ii) words using the singular or
plural number also include the plural or singular number, respectively, (iii) the terms &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereby,&#8221;
&#8220;hereto&#8221; and derivative or similar words refer to this entire Agreement, (iv) the terms &#8220;Article,&#8221; &#8220;Section,&#8221;
&#8220;Schedule&#8221; and &#8220;Exhibit&#8221; refer to the specified Article, Section, Schedule or Exhibit of or to this Agreement,
(v) the word &#8220;including&#8221;, &#8220;include&#8221; or similar derivations means &#8220;including without limitation,&#8221;
(vi) the word &#8220;or&#8221; shall be disjunctive but not exclusive, (vii) references to agreements and other documents shall be deemed
to include all subsequent amendments and other modifications thereto, (viii) the word &#8220;extent&#8221; in the phrase &#8220;to the
extent&#8221; means the degree to which a subject or other thing extends, and such phrase shall not mean simply &#8220;if&#8221;; and
(ix) references to statutes shall include all regulations promulgated thereunder and references to statutes or regulations shall be construed
as including all statutory and regulatory provisions consolidating, amending or replacing the statute or regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 244; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
phrases &#8220;delivered,&#8221; &#8220;provided to,&#8221; &#8220;furnished to,&#8221; &#8220;made available&#8221; and phrases of similar
import when used herein, unless the context otherwise requires, means that a copy of the information or material referred to has been
(i) provided no later than five days prior to the date of this Agreement to the Party to which such information or material is to be
provided or furnished (A) in the &#8220;virtual data room&#8221; set up by the Company in connection with this Agreement or (B) by delivery
to such Party or its legal counsel via electronic mail or hard copy form, or (ii) with respect to Murphy, filed with the SEC by Murphy
no later than five days prior to the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;When
used herein, &#8220;ordinary course of business&#8221; means an action taken, or omitted to be taken, in the ordinary and usual course
of the Company&#8217;s or Murphy&#8217;s business, as applicable, consistent with past practice (including, for the avoidance of doubt,
recent past practice in light of COVID-19 or COVID-19 Measures).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent and no rule of
strict construction shall be applied against any Party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Whenever
this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days are specified. If any action
is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day, then such action may be deferred
until the next Business Day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All
accounting terms used herein and not expressly defined herein shall have the meanings given to them under GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
MERGER; CLOSING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.1</b> <span style="text-decoration: underline">The Merger</span>. On the terms and subject to the conditions set forth in this Agreement, at the Effective Time, (a) Merger Sub
shall be merged with and into the Company in accordance with the Companies Act, and the separate corporate existence of Merger Sub shall
thereupon cease, (b) the Company shall be the surviving corporation in the Merger (sometimes hereinafter referred to as the &#8220;<span style="text-decoration: underline">Surviving
Corporation</span>&#8221;) and become a wholly owned Subsidiary of Murphy, and the separate corporate existence of the Company with all
of its rights, privileges, immunities, powers and franchises shall continue unaffected by the Merger as provided in the Companies Act,
and (c) the Merger shall have such other effects as provided in the Companies Act and this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.2</b> <span style="text-decoration: underline">Closing</span>. Subject to the terms and conditions of this Agreement, the closing of the Merger (the &#8220;<span style="text-decoration: underline">Closing</span>&#8221;)
shall take place at the offices of Sichenzia Ross Ference LLP, 1185 Avenue of the Americas, 31st Floor, New York, New York 10036 on a
date no later than three (3) Business Days after the satisfaction or waiver of all the conditions set forth in Article VIII that are
required to be satisfied prior to the Closing Date, or at such other place and time as Murphy and the Company may mutually agree upon.
The parties may participate in the Closing via electronic means. The date on which the Closing actually occurs is referred to in this
Agreement as the &#8220;<span style="text-decoration: underline">Closing Date</span>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 245; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.3</b> <span style="text-decoration: underline">Effective Time</span>. Subject to the satisfaction or waiver of all of the conditions set forth in Article VIII of this Agreement,
as soon as practicable following the Closing on the Closing Date the Company, Murphy and Merger Sub will cause a plan of merger relating
to the Merger and other documents required by the Companies Act (collectively, the &#8220;<span style="text-decoration: underline">Plan of Merger</span>&#8221;) to be executed,
acknowledged and filed with the Registrar of Companies of the Cayman Islands in accordance with the relevant provisions of the Companies
Act. The Merger shall become effective at the time when the Plan of Merger has been duly filed with and accepted by the Registrar of
Companies of the Cayman Islands or at such later date and time as may be agreed by the Parties in writing and specified in the Plan of
Merger (such date and time, the &#8220;<span style="text-decoration: underline">Effective Time</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.4 </b><span style="text-decoration: underline">Organizational Documents of Murphy and the Surviving Corporation</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;At
the Closing and immediately prior to the Effective Time, subject to obtaining the affirmative vote of the stockholders of Murphy for
the Murphy Proposals in accordance with the Proxy Statement, Murphy shall cause the Murphy Organizational Documents to be amended and
restated in their entirety to be the Amended Charter and the Amended Bylaws, respectively, until thereafter supplemented or amended in
accordance with their respective terms and the DGCL. Without limiting the generality of the foregoing, as of the Effective Time, Murphy
will change its corporate name to &#8220;Conduit Pharmaceuticals Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;At
the Effective Time, by virtue of the Merger, the Company Organizational Documents, as in effect immediately prior to the Effective Time,
shall be amended and restated in their entirety to read in the forms of the Surviving Corporation Organizational Documents, and as so
amended and restated, will be the certificate of incorporation and articles and memorandum of association of the Surviving Corporation
until thereafter supplemented or amended in accordance with their respective terms and the Companies Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.5</b> <span style="text-decoration: underline">Directors</span>. Immediately after the Closing, the board of directors of the Surviving Corporation and of Murphy each shall
consist of five (5) directors, consisting of (a) one</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
director designated prior to Closing by the Sponsor and reasonably acceptable by the Company and (b) the remaining designated prior to
the Closing by the Company; with at a least three (3) of the five (5) directors who will serve as independent directors satisfying the
independence requirements of the Securities Act and the Nasdaq rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.6</b> <span style="text-decoration: underline">Chief Financial Officer</span>. Immediately after the Closing, the Chief Financial Officer of Murphy, Adam Sragovicz shall be
appointed Chief Financial Officer of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.7</b> <span style="text-decoration: underline">No Further Ownership Rights in Company Capital Stock</span>. At the Effective Time, the register of members of the Company shall
be closed and thereafter there shall be no further registration of transfers of Company Ordinary Shares on the records of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 246; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.8</b> <span style="text-decoration: underline">Rights Not Transferable</span>. The rights of the Shareholders as of immediately prior to the Effective Time are personal to each
such Shareholder and shall not be assignable or otherwise transferable for any reason (except (i) in the case of an entity, by operation
of Law or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
in the case of a natural person, by will or the Laws of descent and distribution). Any attempted transfer of such right by any holder
thereof (otherwise than as permitted by the immediately preceding sentence) shall be null and void.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
2.9</b> <span style="text-decoration: underline">Taking of Necessary Action; Further Action</span>. If, at any time after the Effective Time, any further action is necessary or
desirable to carry out the purposes of this Agreement and to vest the Surviving Corporation with full right, title and interest in, to
and under, and/or possession of, all assets, property, rights, privileges, powers and franchises of Merger Sub and the Company, the officers
and directors of Merger Sub and the Company are fully authorized in the name of their respective corporations or otherwise to take, and
will take, all such lawful and necessary action, so long as such action is not inconsistent with this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACTIONS
PRIOR TO THE MERGER; CONVERSION OF SECURITIES;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSIDERATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
3.1 </b><span style="text-decoration: underline">CONVERSION OF SECURITIES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Company
Convertible Debt</span>. Prior to the Effective Time, all holders of Company Convertible Debt shall have converted their full principal
amount of Company Convertible Debt that is issued and outstanding immediately prior to the Effective Time into a number of shares of
Company Ordinary Shares at the then-effective conversion rate as calculated pursuant to the senior secured convertible promissory note
agreements that govern the terms of the Company Convertible Debt (the &#8220;<span style="text-decoration: underline">Company Convertible Debt Conversion</span>&#8221;). After
the Company Convertible Debt Conversion, the Company Convertible Debt shall no longer be outstanding and shall cease to exist, and each
holder of Company Convertible Debt shall thereafter cease to have any rights with respect to such securities, except for its pro rata
portion of the Closing Payment Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Cancellation
of Company Capital Stock</span>. At the Effective Time, by virtue of the Merger and without any action on the part of Murphy, Merger Sub
or the Company, each Company Ordinary Share issued and outstanding immediately prior to the Effective Time shall be canceled and automatically
converted into the right to receive, without interest, the Applicable Per Share Merger Consideration. For avoidance of any doubt, each
Shareholder will cease to have any rights with respect to his, her or its Company Ordinary Shares, except the right to receive the Applicable
Per Share Merger Consideration. At the Effective Time (and, for the avoidance of doubt, following the Company Convertible Debt Conversion),
by virtue of the Merger and without any action on the part of any holder thereof:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Company
Ordinary Shares</span>. Each Company Ordinary Share (including Company Ordinary Shares issued as a result of the Company Convertible Debt
Conversion) that is issued and outstanding immediately prior to the Effective Time, other than the Dissenting Shares, shall thereupon
be converted into the right to receive, and the holder of such share of Company Stock shall be entitled to receive, the Applicable Per
Share Merger Consideration;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 247; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Company
Treasury Stock</span>. Each Company Ordinary Share held in the treasury of the Company (&#8220;<span style="text-decoration: underline">Treasury Shares</span>&#8221;) immediately
prior to the Effective Time shall be cancelled without any conversion thereof and no payment or distribution shall be made with respect
thereto; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Company
Dissenting Share</span>. Each of the Dissenting Shares issued and outstanding immediately prior to the Effective Time shall be cancelled
and cease to exist in accordance with Section 3.6(a) and shall thereafter represent only the right to receive the applicable payments
set forth in Section 3.6(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Murphy
Class B Common Stock</span>. Each share of Murphy Class B Common Stock shall automatically convert into and become one validly issued, fully
paid and non- assessable share of Murphy Class A Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Merger
Sub Shares</span>. Each ordinary share of Merger Sub issued and outstanding immediately prior to the Effective Time shall no longer be outstanding
and shall thereupon be converted into and become one validly issued, fully paid and non-assessable ordinary share of the Surviving Corporation,
and all such shares shall constitute the only outstanding shares of the Surviving Corporation as of immediately following the Effective
Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Surrender
of Certificates</span>. All securities issued upon the surrender of Company Ordinary Shares in accordance with the terms hereof, shall be
deemed to have been issued in full satisfaction of all rights pertaining to such securities, provided that any restrictions on the sale
and transfer of such Company Ordinary Shares shall also apply to the Closing Payment Shares so issued in exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Lost,
Stolen or Destroyed Certificates</span>. In the event any certificates for Company Ordinary Shares shall have been lost, stolen or destroyed,
Murphy shall cause to be issued in exchange for such lost, stolen or destroyed certificates and for each such share, upon the making
of an affidavit of that fact by the holder thereof; provided, however, that Murphy may, in its discretion and as a condition precedent
to the issuance thereof, require the owner of such lost, stolen or destroyed certificates to deliver a bond in such sum as it may reasonably
direct as indemnity against any claim that may be made against the Company or Murphy with respect to the certificates alleged to have
been lost, stolen or destroyed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Adjustments</span>.
Without limiting the other provisions of this Agreement, if at any time during the period between the date of this Agreement and the
Effective Time, any change in the outstanding securities of the Company or Murphy shall occur (other than the issuance of additional
shares of the Company or Murphy as permitted by this Agreement), including by reason of any reclassification, recapitalization, share
split (including a reverse share split), or combination, exchange, readjustment of shares, or similar transaction, or any share dividend
or distribution paid in shares, the Exchange Ratio and the number of the Closing Payment Shares (as well as the Applicable Per Share
Merger Consideration) payable to the Shareholders pursuant to this Agreement shall be appropriately adjusted to reflect such change;
<i>provided, however,</i> that this sentence shall not be construed to permit Murphy or the Company to take any action with respect to
its securities that is prohibited by the terms of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 248; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
3.2 </b><span style="text-decoration: underline">Payment of Merger Consideration</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon
and subject to the terms and conditions of this Agreement, on the Closing Date, Murphy shall issue to each Shareholder such number of
Closing Payment Shares as set forth opposite such Shareholder&#8217;s name on Exhibit A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
certificates or scrip representing fractional Murphy Class A Common Stock will be issued pursuant to the Merger, and such fractional
share interests will not entitle the owner thereof to vote or to any rights of a shareholder of Murphy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
certificate issued pursuant to the Merger to any Shareholder shall bear the legend set forth below, or a legend substantially equivalent
thereto, together with any other legends that may be required by any securities laws at the time of the issuance of the Closing Payment
Shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;ACT&#8221;),
AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL (I) SUCH OFFER, SALE, TRANSFER, PLEDGE
OR HYPOTHECATION HAS BEEN REGISTERED UNDER THE ACT OR (II) THE ISSUER OF THE SHARES HAS RECEIVED AN OPINION OF COUNSEL IN FORM AND SUBSTANCE
SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE WITH THE ACT.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
3.3</b> <span style="text-decoration: underline">Withholding Rights</span>. Each of Murphy and Merger Sub (each, a &#8220;<span style="text-decoration: underline">Withholding Agent</span>&#8221;) shall be entitled to
deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any Person such amounts as it is required
to deduct and withhold with respect to the making of such payment under applicable Law; provided that prior to making any deduction or
withholding pursuant to this Section 3.3, the Withholding Agent shall use reasonable best efforts to provide the Shareholders with advance
written notice of any such intended deduction or withholding (other than any withholding on amounts properly treated as compensation
to employees for U.S. federal income Tax purposes) at least ten (10) days before the making of such payment, and the Withholding Agent
shall consult with the Company and/or its Shareholders in good faith to determine whether such deduction and withholding is required
under applicable Law and cooperate in good faith with the Shareholders to obtain any available exception from, or reduction in, such
deduction or withholding (including through the request and provision of any statements, forms, or other documents to reduce or eliminate
any such deduction or withholding) pursuant to this Section 3.3 to the extent permitted under applicable Law. To the extent that amounts
are so withheld by the Withholding Agent or any of their respective Affiliates with respect to any Person and are properly remitted to
the applicable Governmental Authority, such withheld amounts shall be treated for all purposes of this Agreement as having been paid
on behalf of such Person in respect of which such deduction and withholding was made. In the case of any such payment payable to employees
of the Company or its Affiliates in connection with the Merger treated as compensation, the parties shall cooperate to pay such amounts
through the Company&#8217;s payroll to facilitate applicable withholding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 249; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
3.4</b> <span style="text-decoration: underline">Register of Members</span>. At the Effective Time, the register of members of the Company shall be closed and there shall be no
further registration of transfers of Company Capital Stock thereafter on the records of the Company. From and after the Effective Time,
the holders of Certificates representing Company Capital Stock outstanding immediately prior to the Effective Time shall cease to have
any rights with respect to such Company Capital Stock, except as otherwise provided in this Agreement or by Law. On or after the Effective
Time, any Certificates presented to Murphy for any reason shall be converted into the Merger Consideration in accordance with the provisions
of Section 3.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
3.5 </b><span style="text-decoration: underline">Payment of Expenses</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
sooner than five nor later than two Business Days prior to the Closing Date, the Company shall provide to Murphy a written report setting
forth a list of all of the following fees and expenses incurred by or on behalf of the Company and/or the Shareholders in connection
with the preparation, negotiation and execution of this Agreement and the consummation of the Transactions (together with written invoices
and wire transfer instructions for the payment thereof), solely to the extent such fees and expenses are incurred and expected to remain
unpaid as of the close of business on the Business Day immediately preceding the Closing Date: (i) the fees and disbursements of outside
counsel to the Company incurred in connection with the Transactions and (ii) the fees and expenses of any other agents, advisors, consultants,
experts, financial advisors and other service providers engaged by the Company in connection with the Transactions (collectively, the
&#8220;<span style="text-decoration: underline">Outstanding Company Transaction Expenses</span>&#8221;). On the Closing Date concurrent with the Closing, Murphy shall pay or
cause to be paid by wire transfer of immediately available funds all such Outstanding Company Transaction Expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
sooner than five nor later than two Business Days prior to the Closing Date, Murphy shall provide to the Company a written report setting
forth a list of all of the following fees and expenses incurred by or on behalf of Murphy and/or Merger Sub in connection with the preparation,
negotiation and execution of this Agreement and the consummation of the Transactions (together with written invoices and wire transfer
instructions for the payment thereof), solely to the extent such fees and expenses are incurred and expected to remain unpaid as of the
close of business on the Business Day immediately preceding the Closing Date: (i) the fees and disbursements of outside counsel to the
Company incurred in connection with the Transactions and (ii) the fees and expenses of any other agents, advisors, consultants, experts,
financial advisors and other service providers engaged by the Company in connection with the Transactions (collectively, the &#8220;<span style="text-decoration: underline">Outstanding
Murphy Transaction Expenses</span>&#8221;). On the Closing Date concurrent with the Closing, Murphy shall pay or cause to be paid by wire
transfer of immediately available funds all such Outstanding Murphy Transaction Expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor the Surviving Corporation shall be liable to any holder of Company Capital Stock for any such Company Capital Stock (or dividends
or distributions with respect thereto) or cash delivered to a public official pursuant to any abandoned property, escheat or similar
Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 250; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
shall not pay or cause to be paid any Outstanding Murphy Transaction Expenses or Outstanding Company Transaction Expenses other than
in accordance with this Section 3.5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
3.6 </b><span style="text-decoration: underline">Dissenter&#8217;s Rights</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding
any provision of this Agreement to the contrary and to the extent available under the Companies Act, shares of Company Capital Stock
that are outstanding immediately prior to the Effective Time and that are held by Shareholders who shall have neither voted in favor
of the Merger nor consented thereto in writing and who shall have demanded properly in writing dissenter&#8217;s rights for such Company
Capital Stock in accordance with the Companies Act and otherwise complied at all times with all of the provisions of the Companies Act
relevant to the exercise and perfection of dissenters&#8217; rights (collectively, the &#8220;<span style="text-decoration: underline">Dissenting Shares</span>&#8221;) shall
not be converted into, and such Shareholders shall have no right to receive, the applicable Merger Consideration in accordance with the
provisions of Section 3.1, unless and until such Shareholder fails to perfect or withdraws or otherwise loses his, her or its dissenter&#8217;s
rights and payment under the Companies Act. Any Shareholder who fails to perfect or who effectively withdraws or otherwise loses his,
her or its dissenter&#8217;s rights as to such shares of Company Capital Stock under the Companies Act shall thereupon be deemed to have
such shares of Company Capital Stock converted into, and to have become exchangeable for, as of the Effective Time, the right to receive
the applicable Merger Consideration in accordance with the provisions of Section 3.1, without any interest thereon, upon surrender of
the Certificate or Certificates that formerly evidenced such shares of Company Capital Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prior
to the Closing, the Company shall give Murphy (i) prompt notice of any demands for dissenter&#8217;s rights received by the Company (which
demands must, for the avoidance of doubt, be received prior to the passing of the Company Requisite Approval in accordance with the Companies
Act) and any withdrawals of such demands, and (ii) the opportunity to participate in all negotiations and proceedings with respect to
demands for dissenter&#8217;s rights under the Companies Act. The Company shall not, except with the prior written consent of Murphy
(which consent shall not be unreasonably withheld, conditioned or delayed), make any payment with respect to any demands for dissenter&#8217;s
rights or offer to settle or settle any such demands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in the disclosure schedules delivered as of the date hereof by the Company to Murphy in connection with this Agreement (the
&#8220;<span style="text-decoration: underline">Company Disclosure Schedules</span>&#8221;), the Company hereby represents and warrants to Murphy that each of the following representations
and warranties is true, correct and complete as of the date of this Agreement (or, if such representations and warranties are made with
respect to a certain date, as of such date). Any disclosure made with respect to a section of this Article IV shall be deemed to qualify
any other section of this Article IV specifically referenced or cross-referenced therein or to the extent that it is readily apparent
that such disclosure is applicable thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 251; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.1 </b><span style="text-decoration: underline">Organization and Qualification</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company is an exempted company duly organized, validly existing and in good standing under the laws of the Cayman Islands and has the
requisite corporate or other organizational power and authority and all necessary governmental approvals to own, lease and operate its
properties and to carry on its business as it is now being conducted. The Company is duly qualified or licensed as a foreign corporation
or other organization to do business, and is in good standing, in each jurisdiction where the character of the properties owned, leased
or operated by it or the nature of its business makes such qualification or licensing necessary, except for such failures to be so qualified
or licensed and in good standing that do not constitute a Company Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as provided in <span style="text-decoration: underline">Schedule 4.1(b)</span> of the Company Disclosure Schedules, the Company does not directly or indirectly own any Subsidiaries.
The Company does not directly or indirectly own any equity or similar interest in, or any interest convertible into or exchangeable or
exercisable for any equity or similar interest in, any other corporation, partnership, joint venture or business association or other
entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.2</b> <span style="text-decoration: underline">Organizational Documents</span>. The Company has prior to the date of this Agreement made available a complete and correct copy
of the Company Organizational Documents. Such Company Organizational Documents are in full force and effect. The Company is not in violation
of any of the provisions of the Company Organizational Documents. The Company has prior to the date of this Agreement made available
a complete and correct copy of the organization documents of its Subsidiary. The organizational documents of such Subsidiary are in full
force and effect. The Company&#8217;s Subsidiary is not in violation of any of the provisions of the Company Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.3 </b><span style="text-decoration: underline">Capitalization</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
authorized share capital of the Company is GBP40,000 made up of 400,000,000 Company Ordinary Shares. As of the date of this Agreement,
(i) 2,000 Company Ordinary Shares are issued and outstanding, (ii) no Company Ordinary Shares are held in the treasury of the Company,
and (iii) other than with respect to the Company Convertible Debt, there are no Ordinary Shares or other equity or voting interests of
the Company reserved for issuance. <span style="text-decoration: underline">Exhibit A</span> sets forth the current capitalization table of the Company, including all of the
Company Ordinary Shares, the holders thereof, and each such holder&#8217;s pro rata percentage of the issued and outstanding Company
Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
aggregate outstanding and unpaid Company Convertible Debt as of the date of this Agreement is set forth on <span style="text-decoration: underline">Exhibit A</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other
than this Agreement, the Ancillary Agreements and the Company Convertible Debt, there are no options, restricted shares, restricted share
units, phantom equity awards, warrants, preemptive rights, calls, convertible securities, conversion rights or other rights, agreements,
arrangements or commitments of any character relating to the issued or unissued shares of the Company or obligating the Company to issue
or sell any shares of, or other equity interests in, the Company. The Company is not a party to, or otherwise bound by, and the Company
has not granted, any equity appreciation rights, participations, phantom equity or similar rights. Other than this Agreement and any
Ancillary Agreements, there are no voting trusts, voting agreements, proxies, shareholder agreements or other agreements with respect
to the voting or transfer of the Company Ordinary Shares, the Company Convertible Debt or any of the equity interests or other securities
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 252; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Schedule
4.3(d)</span> of the Company Disclosure Schedules sets forth, as of the date of this Agreement, the following information with respect to
each instrument evidencing Company Convertible Debt outstanding (i) the name of the holder of such Company Convertible Debt and (ii)
the date on which such Company Convertible Debt was incurred. The Company has made available to Murphy an accurate and complete copy
of each promissory note evidencing Company Convertible Debt. All Company Ordinary Shares subject to issuance pursuant to the Company
Convertible Debt Conversion upon issuance on the terms and conditions specified therein, will be and has been duly authorized, validly
issued, fully paid and nonassessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as contemplated by or as otherwise set forth in this Agreement, there are no outstanding contractual obligations of the Company to repurchase,
redeem or otherwise acquire any shares of the Company or to provide funds to or make any investment (in the form of a loan, capital contribution
or otherwise) in any Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All
outstanding shares of the Company Capital Stock have been issued and granted in compliance with (A) all applicable Securities and other
Laws and (B) all pre-emptive rights and other requirements set forth in applicable contracts to which the Company is a party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Shareholders collectively own directly and beneficially and of record, all of the equity of the Company (which are represented by the
issued and outstanding shares of Company Capital Stock). Except for the Company Capital Stock held by the Shareholders and the Company
Convertible Debt, no shares or other equity or voting interest of the Company, or options, warrants, convertible debt or other rights
to acquire any such shares or other equity or voting interest, of the Company is issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.4</b> <span style="text-decoration: underline">Authority Relative to this Agreement</span>. The Company has all necessary power and authority to execute and deliver this Agreement,
to perform its obligations hereunder and, subject to receiving the Company Requisite Approval, to consummate the Transactions. The execution
and delivery of this Agreement by the Company and the consummation by the Company of the Transactions have been duly and validly authorized
by all necessary corporate action, and no other corporate proceedings on the part of the Company are necessary to authorize this Agreement
or to consummate the Transactions (other than, with respect to the Merger, the Company Requisite Approval, which the written consent
delivered in connection with Section 7.1(f) shall satisfy, and the filing and recordation of appropriate merger documents as required
by the Companies Act). This Agreement has been duly and validly executed and delivered by the Company and, assuming the due authorization,
execution and delivery by each of Murphy and Merger Sub, constitutes a legal, valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&#8217; rights generally, by general equitable principles (the
&#8220;<span style="text-decoration: underline">Remedies Exceptions</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 253; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.5 </b><span style="text-decoration: underline">No Conflict; Required Filings and Consents</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as set forth in <span style="text-decoration: underline">Schedule 4.5(a)</span> of the Company Disclosure Schedules, the execution and delivery of this Agreement by the Company
does not, and the performance of this Agreement by the Company will not, (i) conflict with or violate the Company Organizational Documents
or (iii) result in any breach of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default)
under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of a Lien on
any property or asset of the Company pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise
or other instrument or obligation to which the Company is a party or by which the Company or any of its property or assets is bound or
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
execution and delivery of this Agreement, and the transactions contemplated hereby, by the Company do not, and the performance of this
Agreement by the Company will not, require any consent, approval, authorization or permit of, or filing with or notification to, any
United States federal, state, county or local or non-United States government, foreign government, governmental or quasi-governmental,
regulatory or administrative authority or office, any political or other subdivision thereof, agency, instrumentality, bureau, authority,
body or commission or any court, tribunal, judicial or arbitral body or body exercising, or entitled to exercise, any judicial, quasi-judicial,
legislative, executive, police, regulatory, taxing or other administrative instrumentality (a &#8220;<span style="text-decoration: underline">Governmental Authority</span>&#8221;),
or conflict with or violate any Law, rule, regulation, order, judgment or decree applicable to the Company or by which any of its property
or assets are bound or affected, except for applicable requirements, if any, of the Securities Act, the Exchange Act, state securities
or &#8220;blue sky&#8221; laws (&#8220;<span style="text-decoration: underline">Blue Sky Laws</span>&#8221;) and takeover laws of the Cayman Islands, the pre-merger notification
requirements of the HSR Act, and filing and recordation of appropriate merger documents as required by the Companies Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.6</b> <span style="text-decoration: underline">Permits; Compliance</span>. The Company is in possession of all material franchises, grants, authorizations, licenses, permits,
easements, variances, exceptions, consents, certificates, approvals and orders of any Governmental Authority necessary for the Company
to own, lease and operate its properties or to carry on its business as it is now being conducted (the &#8220;<span style="text-decoration: underline">Company Permits</span>&#8221;),
except where the failure to have such Company Permits does not constitute a Company Material Adverse Effect. To the Company&#8217;s Knowledge,
no suspension or cancellation of any of the Company Permits is pending or threatened in writing. Except (i) with respect to compliance
with Environmental Laws (as to which certain representations and warranties are made pursuant to Section 4.16) and compliance with Laws
related to Taxes (which are the subject of Section 4.15), and (ii) where the failure to be, or to have been, in compliance with such
Laws would not, individually or in the aggregate, reasonably be expected to constitute a Company Material Adverse Effect, the Company
is, and since January 1, 2020, has been, in compliance with all applicable Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.7 </b><span style="text-decoration: underline">Financial Statements</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company has made available to Murphy true and complete, in all material respects, except for the absence of footnotes and subject to
any audit adjustments, copies of the unaudited consolidated balance sheets as of and the related audited consolidated statements of operations
and cash flows of the Company for the periods ended December 31, 2020 and December 31, 2021 (collectively, the &#8220;<span style="text-decoration: underline">Prior Financial
Statements</span>&#8221;). The Prior Financial Statements (including any notes thereto), except for the absence of footnotes and subject
to any audit adjustments, (i) were prepared on an accrual basis in accordance with United States generally accepted accounting principles
(&#8220;<span style="text-decoration: underline">GAAP</span>&#8221;) applied on a consistent basis throughout the periods indicated (except as may be indicated in any notes thereto),
(ii) were derived from the Books and Records of the Company, and (iii) fairly present, in all material respects, the financial position,
results of operations, income (loss), changes in shareholders&#8217; equity, and cash flows of the Company as at the date thereof and
for the period indicated therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 254; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prior
to Closing, the Company will deliver to Murphy a true and complete, in all material respects, except for the absence of footnotes and
subject to any yearend and/or audit adjustments, copy of the consolidated unaudited balance sheet of the Company as of September 30,
2022 (the &#8220;<span style="text-decoration: underline">Interim Balance Sheet</span>&#8221;), and the related unaudited consolidated statements of operations and cash flows
of the Company for the nine-month period then ended (such financial statements, including the Interim Balance Sheet, the &#8220;<span style="text-decoration: underline">Interim
Financial Statements</span>&#8221;). The Interim Financial Statements, except for the absence of footnotes and subject to any yearend and/or
audit adjustments, will be (i) prepared on an accrual basis in accordance with GAAP applied on a consistent basis throughout the periods
indicated, (ii) derived from the Books and Records of the Company, and (iii) fairly present, in all material respects, the financial
position, results of operations, income (loss), changes in shareholders&#8217; equity, and cash flows of the Company as at the date thereof
and for the period indicated therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prior
to Closing, the Company will deliver to Murphy true and complete, in all material respects, copies of the audited consolidated balance
sheets of the Company as of December 31, 2020 and December 31, 2021 and the related audited consolidated statements of operations, cash
flows and shareholders&#8217; equity for the years ended December 31, 2020 and December 31, 2021, together with the auditor&#8217;s reports
thereon, which will comply in all material respects with the applicable accounting requirements and with the rules and regulations of
the SEC, the Exchange Act and the Securities Act for financial statements required to be included in the Registration Statement (collectively,
the &#8220;<span style="text-decoration: underline">PCAOB Audited Financial Statements</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
PCAOB Audited Financial Statements (i) will be prepared from, and will reflect in all material respects, the Books and Records of the
Company, (ii) will present fairly, in all material respects, the consolidated financial position, results of operations, income (loss),
changes in shareholders&#8217; equity, and cash flows of the Company as of the dates and for the periods indicated therein in conformity
with GAAP consistently applied throughout the periods covered thereby, and (iii) when delivered by the Company for inclusion in the Registration
Statement for filing with the SEC in accordance with Section 7.1, will comply in all material respects with the applicable accounting
requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act for financial statements required
to be included in the Registration Statement, in effect as of the respective dates thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.8</b> <span style="text-decoration: underline">Undisclosed Liabilities</span>. The Company has no liabilities, obligations or commitments of any nature whatsoever, asserted
or unasserted, known or unknown, absolute or contingent, accrued or unaccrued, matured or unmatured or otherwise, except (a) those which
are adequately reflected or reserved against in the Interim Balance Sheet as of the date thereof, and (b) those which have been incurred
in the ordinary course of business consistent with past practice since the date of the Interim Balance Sheet and which are not, individually
or in the aggregate, material in amount. Except for the Company Convertible Debt, the Company does not have any Indebtedness for borrowed
money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 255; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.9</b> <span style="text-decoration: underline">Absence of Certain Changes or Events</span>. Since inception, or as expressly contemplated by this Agreement and the Transactions,
(a) there has not been any Company Material Adverse Effect, and (b) the Company has conducted its business in the ordinary course consistent
with past practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.10</b> <span style="text-decoration: underline">Absence of Litigation</span>. Except as set forth on <span style="text-decoration: underline">Schedule 4.10</span> of the Company Disclosure Schedules, there is no cause
of action, litigation, suit, hearing, arbitration or other similar proceeding of any nature, civil, criminal, regulatory, administrative
or otherwise, whether in equity or at law, in contract, in tort or otherwise (an &#8220;<span style="text-decoration: underline">Action</span>&#8221;) pending against or, to
the Knowledge of the Company, threatened in writing against the Company, any directors, or officers thereof, or any property or asset
of the Company. Neither the Company nor any material property or asset of the Company is subject to any continuing order of, consent
decree, settlement agreement or other similar written agreement with any Governmental Authority, or any order, writ, judgment, injunction,
decree, determination or award of any Governmental Authority that would constitute a Company Material Adverse Effect. There is no unsatisfied
judgment or any injunction binding upon the Company which would, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.11 </b><span style="text-decoration: underline">Employee Benefit Plans</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Schedule
4.11(a)</span> of the Company Disclosure Schedules sets forth a true and complete list of each company benefit plan (&#8220;<span style="text-decoration: underline">Plan</span>&#8221;).
For purposes of this Agreement, &#8220;Plan&#8221; means each &#8220;employee benefit plan&#8221; as defined in Section 3(3) of the Employee
Retirement Income Security Act of 1974, as amended (&#8220;<span style="text-decoration: underline">ERISA</span>&#8221;), and any stock purchase, stock option, equity or equity-based
or phantom equity compensation, severance, retirement, employment, individual consulting, retention, change-in-control, fringe benefit,
collective bargaining, bonus, incentive, deferred compensation, employee loan and all other employee benefit plans, agreements, programs,
policies or other arrangements, whether or not subject to ERISA, whether formal or informal, oral or written, in each case, (a) which
are contributed to (or required to be contributed to), sponsored by or maintained by the Company for the benefit of any current or former
employee, officer, director or individual consultant of the Company (the &#8220;<span style="text-decoration: underline">Company Employees</span>&#8221;) or (b) pursuant to which
the Company could have any liability, other than any statutory plan, program or arrangement that is required under applicable Laws and
maintained by any Governmental Authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;With
respect to each Plan, the Company has delivered or made available to Murphy copies, to the extent applicable of each Plan and any current
trust agreement or other funding instrument relating to such plan and the most recent summary plan description, with respect to such
Plan. Each Plan has been established, administered and funded in accordance with its terms, and in compliance in all material respects
with all applicable Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as set forth on <span style="text-decoration: underline">Schedule 4.11(c)</span> of the Company Disclosure Schedules, neither the execution and delivery of this Agreement by
the Company nor the consummation of the Transactions will (whether alone or in connection with any subsequent event(s)) (i) result in
the payment, acceleration, vesting, funding or creation of any compensatory rights of any Company Employee to payments or benefits or
increases in any compensation or benefits (including any loan forgiveness) under any Plan (or under any plan, agreement or arrangement
that would be a Plan if in effect as of the date of this Agreement), (ii) result in severance pay or any increase in severance pay upon
any termination of employment, or (iii) require any contributions or payments to fund any obligations under any Plan, or cause the Company
to transfer or set aside any assets to fund any Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 256; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.12 </b><span style="text-decoration: underline">Labor Matters</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company is not a party to any collective bargaining agreement or other agreement with a labor union or like organization, and to the
Knowledge of the Company, there are no activities or Actions by any individual or group of individuals, including representatives of
any labor organizations or labor unions, to organize any employees of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
of the date hereof, the Company does not have any employees located in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company is, and since January 1, 2020, has been, in compliance in all material respects with all applicable Laws regarding employment
and employment practices, including all laws respecting terms and conditions of employment, health and safety, employee classification,
non-discrimination, wages and hours, immigration, disability rights or benefits, equal opportunity, plant closures and layoffs, affirmative
action, workers&#8217; compensation, labor relations, pay equity, overtime pay, employee leave issues, the proper classification of employees
and independent contractors, the proper classification of exempt and non-exempt employees, and unemployment insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company is not delinquent in any material respect in payments to any of its current or former employees, officers, directors, consultants
or other service providers for any services rendered or amounts required to be reimbursed or otherwise paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
the knowledge of the Company, no employee of the Company at the level of senior vice president or above is in violation of any term of
any employment agreement, nondisclosure agreement, noncompetition agreement, restrictive covenant or other obligation with or to: (i)
the Company; or (ii) a former employer of any such employee relating (A) to the right of any such employee to be employed by the Company
or (B) to the knowledge or use of trade secrets or proprietary information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All
employees of the Company are legally permitted to be employed by the Company in the jurisdiction in which such employees are employed
in their current job capacities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Since
January 1, 2020, the Company has not entered into any settlement agreement related to allegations of sexual harassment or sexual misconduct
by any director, officer or employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 257; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.13 </b><span style="text-decoration: underline">Real Property; Title to and Sufficiency of Assets</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Since
its inception, the Company has not, and as of the date of this Agreement, does not, own or hold any Owned Real Property or lease any
Leased Real Property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company has legal and valid leasehold or subleasehold interests in, all of its material properties and material assets, tangible and
intangible, personal and mixed, used or held for use in its business, free and clear of all encumbrances, liens or other restrictions
other than Permitted Liens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.14 </b><span style="text-decoration: underline">Intellectual Property</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Schedule
4.14(a)</span> of the Company Disclosure Schedules contains a true, correct and complete list of the Registered Company IP (showing in each,
as applicable, the jurisdiction, filing date, date of issuance, expiration date, owner, and registration or application number, and registrar).
Each item on <span style="text-decoration: underline">Schedule 4.14(a)</span> is subsisting, in full force and effect, and has not expired, been cancelled, abandoned or otherwise
terminated and the registered, issued and/or patented items on <span style="text-decoration: underline">Schedule 4.14(a)</span> are valid, subsisting and enforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as provided on <span style="text-decoration: underline">Schedule 4.14(b)</span>, the Company solely and exclusively owns and possesses, free and clear of all Liens (other than
Permitted Liens), all right, title and interest in and to the Company-Owned IP and the Company has the right to use pursuant to a valid
and enforceable written license, all Company-Licensed IP used by it in the Company Business. Except as provided on <span style="text-decoration: underline">Schedule 4.14(b)</span>,
no funding, facilities or personnel of any governmental authority or any university, college, research institute or other educational
institution have been or are being used by the Company to develop or create, in whole or in part, any Company-Owned IP. All documents
and instruments necessary to record the ownership rights (if applicable) of the Company in the registrations, patents and applications
for the Company-Owned IP have been validly executed and filed with the appropriate governmental authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company has taken reasonable actions to maintain, protect and enforce rights in the Company-Owned IP, including the secrecy, confidentiality
and value of its trade secrets and other Confidential Information. To the Knowledge of the Company, the Company has not disclosed any
trade secrets or other Confidential Information that is material to the business of the Company to any other Person other than pursuant
to a written confidentiality agreement under which such other Person agrees to maintain the confidentiality and protect such trade secrets
and Confidential Information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as provided on <span style="text-decoration: underline">Schedule 4.14(d)</span> of the Company Disclosure Schedules, all Persons who have contributed, developed or conceived
(each, a &#8220;<span style="text-decoration: underline">Contributor</span>&#8221;) any Intellectual Property (i) for or on behalf of the Company, or (ii) in the course of and
related to his, her or its relationship with the Company (in each case a &#8220;<span style="text-decoration: underline">Contribution</span>&#8221;) have an obligation to maintain
the confidentiality of the Company&#8217;s proprietary information and have either assigned all rights, title and interest to such Company-Owned
IP to the Company or is a party to a &#8220;work-for- hire&#8221; agreement under which the Company is deemed to be the owner or author
of all property rights therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 258; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company owns, leases, licenses, or otherwise has the legal right to use all Business Systems. In the past year, there has not been a
material failure with respect to any of the Business Systems that has not been remedied. Except for commercially available, &#8220;off-the-
shelf Software or shrink-wrap licenses, the Company does not hold any licenses for any Software, including Open Source Licenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company is in compliance in all material respects with all applicable Privacy/Data Security Laws. Since January 1, 2020, except as set
forth on <span style="text-decoration: underline">Schedule 4.14(f)</span> of the Company Disclosure Schedules, to the Knowledge of the Company, there have been no material incidents
of security breaches or intrusions or unauthorized access, distribution, disclosure, destruction, disposal or use of any of the Business
Systems or Personal Information that are in the possession of and controlled by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.15 </b><span style="text-decoration: underline">Taxes</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company: (i) has duly and timely filed (taking into account any extension of time within which to file) all material Tax Returns required
to be filed by Law by the Company and all such filed Tax Returns are complete and accurate in all material respects; (ii) has timely
paid all material Taxes, whether or not shown as due on such filed Tax Returns, except with respect to current Taxes that are not yet
due and payable or otherwise being contested in good faith and are disclosed in <span style="text-decoration: underline">Schedule 4.15(a)</span> of the Company Disclosure Schedules
or that are described in clause (a)(v) below; (iii) with respect to all material Tax Returns filed by or with respect to them, has not
waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency
which such waiver or extension remains in effect, and no written request for any such waiver or extension is currently pending; (iv)
does not have any deficiency, assessment, claim, audit, examination, investigation, litigation or other proceeding in respect of material
Taxes or material Tax matters pending or proposed or threatened in writing, for a Tax period for which the statute of limitations for
assessments remains open; and (v) has provided adequate reserves in accordance with GAAP in the most recent consolidated financial statements
of the Company, for any material Taxes of the Company that have not been paid, whether or not shown as being due on any Tax Return.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company is not a party to, bound by or has an obligation to any Governmental Authority or other Person under any Tax sharing agreement,
Tax indemnification agreement, Tax allocation agreement or similar contract or arrangement (excluding agreements, contracts, arrangements
or commitments the primary purpose of which do not relate to Taxes).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company has (i) withheld or collected all material Taxes required to have been withheld and paid in connection with amounts paid or owing
to any current or former employee, independent contractor, creditor, shareholder or other third party, and (ii) reported and timely remitted
such amounts required to have been withheld or collected, reported and remitted to the appropriate Governmental Authority. All Tax Returns
required with respect thereto have been properly completed and timely filed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company has not been a member of an affiliated group filing a consolidated, combined or unitary U.S. federal, state, local or foreign
income Tax Return (other than a group of which the Company was the common parent).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 259; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company does not have any material liability for the Taxes of any Person (other than the Company) under Treasury Regulation Section 1.1502-6
(or any similar provision of state, local or foreign Law), as a transferee or successor, by contract (excluding contracts, the primary
purpose of which do not relate to Taxes), or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company (i) does not have any request for a material ruling in respect of Taxes pending between the Company and any Tax authority; and
(ii) has not entered into any closing agreement, private letter ruling technical advice memoranda or similar agreements with any Tax
authority in respect of material Taxes, in each case, that will be in effect after the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company has not in any year for which the applicable statute of limitations remains open distributed stock of another Person, or has
had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section
355 or Section 361 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company has not engaged in or entered into a &#8220;listed transaction&#8221; within the meaning of Treasury Regulation Section 1.6011-4(b)(2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
There are no Tax liens upon any assets of the Company except for Permitted</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Company is not, and has not been a United States real property holding corporation within the meaning of Section 897(c)(2) of the
Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code. The Company has not been a permanent establishment
(within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place of business in a country other than the country
in which it is organized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
unpaid Taxes of the Company (i) did not, as of the date of the Financial Statements, exceed the reserve for Taxes (rather than any reserve
for deferred Taxes established to reflect timing difference between book and Tax income) set forth on the face of the Financial Statements
(rather than in any notes thereto), and (ii) do not exceed that reserve as adjusted for the passage of time through the Effective Time
in accordance with the past custom and practice of Company in filing its Tax Returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
the Knowledge of the Company, the Company does not expect (i) any jurisdiction to assess any additional Taxes for any period for which
Tax Returns have been filed, and (ii) any jurisdiction in which Tax Returns are not filed to require the filing of Tax Returns. To the
Knowledge of the Company, within the last three (3) years, no written claim has been made by any Governmental Authority in a jurisdiction
where the Company does not file a Tax Return that such entity is or may be subject to material Taxes by that jurisdiction in respect
of Taxes that would be the subject of such Tax Return, which claim has not been resolved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company is organized outside the United States and has no operations in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;None
of the shareholders of the Company are &#8220;United States persons&#8221; within the meaning of Section 7701(a)(30) of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 260; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company will not be required to include any item or income, or exclude any item or deduction or loss from, taxable income for any taxable
period (or portion thereof) ending after the Effective Time as a result of any:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;change
in method of accounting for a taxable period (or portion thereof) ending on or prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;use
of an improper method of accounting for a taxable period ending on or prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;ruling
by, or written agreement with, a Governmental Authority (including any &#8220;closing agreement&#8221; as described in Section 7121 of
the Code (or any corresponding provision of state, local, or non-U.S. Tax law)) for a taxable period ending on or prior to the Effective
Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;installment
sale or open transaction disposition made on or prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
prepaid amount received on or prior to the Effective Time;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;intercompany
transaction or excess loss accounts described in the Treasury Regulations promulgated under Section 1502 of the Code (or any corresponding
or similar provision of state, local or foreign income Tax Law) that existed prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
election under Section 965(h) of the Code; or</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
election under Section 108(i) of the Code.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Section 4.15 shall be construed as providing a representation or warranty with respect to any taxable period (or portion thereof)
beginning after the Effective Time or (ii) the existence, amount, expiration date or limitations on (or availability of) any Tax attribute.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.16</b> <span style="text-decoration: underline">Environmental Matters</span>. The Company is currently, and has been, in compliance with all Environmental Laws, and there are
no actions or Environmental Claims pending or threatened in writing against the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.17 </b><span style="text-decoration: underline">Material Contracts</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Schedule
4.17(a)</span> of the Company Disclosure Schedules lists, as of the date of this Agreement, the following types of contracts and agreements
(other than purchase orders) to which the Company is a party (such contracts and agreements as are required to be set forth in <span style="text-decoration: underline">Schedule
4.17(a)</span> of the Company Disclosure Schedules, the &#8220;<span style="text-decoration: underline">Material Contracts</span>&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
each employee collective bargaining Contract;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;each
contract and agreement with consideration paid or payable to the Company of more than $100,000, in the aggregate, over any 12-month period;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 261; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;each
contract and agreement with suppliers to the Company for expenditures paid or payable by the Company of more than $100,000, in the aggregate,
over any 12-month period;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;any
Contract that is a definitive merger, acquisition, purchase and sale or similar agreement entered into in connection with an acquisition
or disposition by the Company since January 1, 2020, involving consideration in excess of $250,000 of any Person or of any business entity
or division or business of any Person (including through merger or consolidation or the purchase of a controlling equity interest in
or substantially all of the assets of such Person or by any other manner), but excluding any Contracts in which the applicable acquisition
or disposition has been consummated and there are no material obligations of the Company ongoing;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
management and employment contracts (excluding at-will contracts for employment that do not contain any severance or change of control
provisions) and all contracts with natural person consultants and natural person independent contractors that cannot be terminated with
less than 30 days&#8217; prior notice and that provide for base salary or compensation in excess of $125,000, in either case to which
the Company is a party;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;any
Contract evidencing or guaranteeing Company Debt or under which the Company has created, incurred, assumed or guaranteed any other Person&#8217;s
indebtedness, has the right to draw upon credit that has been extended for indebtedness, or has granted a Lien on its assets, whether
tangible or intangible, to secure any indebtedness, in each case, in an amount in excess of $50,000;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
partnership agreements, collaboration agreements or other joint venture agreements that are material to the business of the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
contracts and agreements with any Governmental Authority to which the Company is a party, other than any Company Permits and Environmental
Permits;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
contracts and agreements that materially limit, or purport to materially limit, the ability of the Company to compete in any line of
business or with any Person or entity or in any geographic area or during any period of time, excluding customary confidentiality agreements
and agreements that contain customary confidentiality clauses;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;any
Contract that (A) grants to any Person any preferred pricing, &#8220;most favored nation&#8221; or similar rights or (B) grants exclusivity
to any Person in respect of any geographic location, any customer, or any product or service;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;each
Company Affiliate Agreement, excluding those that are employee confidentiality and invention assignment agreements, equity or incentive
equity documents, and employment agreements;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 262; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
contracts or agreements for any Company-Licensed IP that are material to the Company Business, including for Intellectual Property rights
incorporated in or necessary for any Products, and the Business Systems of any other person (excluding both unmodified, commercially
available, &#8220;off-the-shelf&#8221; Software or shrink-wrap licenses and Open Source Licenses);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
contracts relating to registration rights, drag-along, tag along, right of first refusal or put rights or any other agreements with,
among or between Shareholders;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
contracts or agreements providing for revenues to the Company, whether currently, in the future, or since January 1, 2020, in an amount
exceeding $25,000;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;all
leases or master leases of personal property reasonably likely to result in annual payments of $25,000 or more in a 12-month period by
the Company, or for any facility material to the operations of the Company; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;any
commitment to enter into any Contract of the type described in clauses (i) through (xiv) of this Section 4.17(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
Material Contract is a legal, valid and binding obligation of the Company and, to the Knowledge of the Company, the other parties thereto,
and the Company is not in breach or violation of, or default under, any Material Contract nor, to the Knowledge of the Company, has any
Material Contract been canceled by the other party. To the Company&#8217;s Knowledge, no other party is in breach or violation of, or
default under, any Material Contract. The Company has not received any written claim of breach or default under any such Material Contract.
The Company has furnished or made available to Murphy true and complete copies of all Material Contracts in effect as of the date of
this Agreement, including amendments thereto that are material in nature. Each Material Contract sets forth the entire agreement and
understanding between the Company and the other parties thereto. Since January 1, 2020, the Company has not received any notice or request,
in each case, in writing, from or on behalf of any other party to a Material Contract to terminate, cancel or not renew such Material
Contract, or to renegotiate any material term thereof that would reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, or alleging or disputing any breach or default under such Material Contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.18</b> <span style="text-decoration: underline">Insurance</span>. As of the Closing Date, the insurance policies maintained by the Company are in full force and effect and provide
insurance in such amounts and against such risks as the Company reasonably has determined to be prudent, taking into account the industries
in which the Company operates, and as is sufficient to comply with applicable Law. With respect to each such insurance policy and as
of the Closing Date, the Company is not in material breach or default (including any such breach or default with respect to the payment
of premiums or the giving of notice) and no written notice of cancellation, non-renewal, disallowance or reduction in coverage or claim
or termination has been received other than in connection with ordinary renewals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 263; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.19</b> <span style="text-decoration: underline">Internal Controls</span>. As of the Closing Date, except as set forth in the Registration Statement or in any notification from
the Company&#8217;s auditors provided to Murphy, the Company will maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (a) transactions are executed in accordance with management&#8217;s general or specific authorizations; (b)
transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
(c) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (d) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. Since January 1, 2020, the Company has not identified and has not been advised by the Company&#8217;s auditors of any
fraud or allegation of fraud, whether or not material, that involves management or other employees who have a role in the Company&#8217;s
internal controls over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.20</b> <span style="text-decoration: underline">Registration Statement</span>. None of the information relating to the Company supplied by the Company, or by any other Person
acting on behalf of the Company, in writing specifically for inclusion or incorporation by reference in the Registration Statement will,
as of (a) the time the Registration Statement becomes effective under the Securities Act, (b) the date of mailing of the Proxy Statement
to stockholders of Murphy or (c) the time of the Special Meeting (including any adjournment thereof), contain any untrue statement of
a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading; provided, however, notwithstanding the foregoing provisions of this Section 4.20, no representation or
warranty is made by the Company with respect to information or statements made or incorporated by reference in the Registration Statement
that were not supplied by or on behalf of the Company for use therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.21</b> <span style="text-decoration: underline">Support Agreement</span>. The Company will deliver to Murphy a true, correct and complete copy of the Shareholder Support Agreement.
The Shareholder Support Agreement is in full force and effect and has not been withdrawn or terminated, or otherwise amended or modified,
in any respect, and, to the Knowledge of the Company, no withdrawal, termination, amendment or modification is contemplated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.22</b> <span style="text-decoration: underline">Board Approval; Vote Required</span>. The Board of Directors of the Company, by resolutions duly adopted by unanimous vote of
those voting at a meeting duly called and held and not subsequently rescinded or modified in any way, or by unanimous written consent,
has duly</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
determined that this Agreement and the Merger are fair to and in the best interests of the Company and its Shareholders, (b) approved
this Agreement and the Transactions (including the Merger) and declared their advisability, and (c) recommended that the Shareholders
approve and adopt this Agreement and approve the Merger and directed that this Agreement and the Transactions (including the Merger)
be submitted for consideration by the Shareholders. The Company Requisite Approval is the only vote of the holders of any class or series
of capital stock of the Company necessary to adopt this Agreement and approve the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.23</b> <span style="text-decoration: underline">Brokers</span>. Except for those Persons set forth on <span style="text-decoration: underline">Schedule 4.23</span> of the Company Disclosure Schedules, no broker, finder
or investment banker is entitled to any brokerage, finder&#8217;s or other fee or commission in connection with the Transactions based
upon arrangements made by or on behalf of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 264; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.24</b> <span style="text-decoration: underline">Takeover Laws</span>. Assuming the accuracy of the representations set forth in Section 5.3(e), no anti-takeover, &#8220;fair
price&#8221;, &#8220;moratorium&#8221;, &#8220;control share acquisition&#8221;, &#8220;business combination&#8221; or other similar
statute or regulation is applicable to this Agreement or the transactions contemplated hereby. The Company does not have any shareholder
rights plan or &#8220;poison pill&#8221; in effect, including any agreement with a third-party trust or fiduciary entity with respect
thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.25 </b><span style="text-decoration: underline">International Trade Matters; Anti-Bribery Compliance</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company currently is and, since its inception has been, in compliance with applicable Laws related to (i) Anti-Corruption Laws, (ii)
economic sanctions administered, enacted or enforced by U.S. Governmental Authorities (including, but not limited to, OFAC, the U.S.
Department of State and the U.S. Department of Commerce), the United Nations Security Council, the European Union, Her Majesty&#8217;s
Treasure, or any other relevant Governmental Authority (collectively, &#8220;<span style="text-decoration: underline">Sanctions Laws</span>&#8221;), (iii) export controls, including
the U.S. Export Administration Regulations, 15 C.F.R. &#167;&#167; 730, et seq., and any other equivalent or comparable Laws of other
countries in which the company has conducted and/or currently conducts business (collectively, &#8220;<span style="text-decoration: underline">Export Control Laws</span>&#8221;),
(iv) anti-money laundering, including the Money Laundering Control Act of 1986, 18 U.S.C. &#167;&#167; 1956, 1957, and any other equivalent
or comparable Laws of other countries; (v) anti-boycott regulations, as administered by the U.S. Department of Commerce; and (vi) importation
of goods, including Laws administered by the U.S. Customs and Border Protection, Title 19 of the U.S.C. and C.F.R., and any other equivalent
or comparable Laws of other countries in which the Company has conducted and/or currently conducts business (collectively, &#8220;<span style="text-decoration: underline">International
Trade Control Laws</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company, its directors and officers and, to the Knowledge of the Company, the employees or agents of the Company (acting on behalf of
the Company), is not and is not acting under the direction of, on behalf of or for the benefit of a Person that is, (i) the subject of
Sanctions Laws or identified on any sanctions-related lists administered by the U.S. Department of State, the U.S. Department of the
Treasury, including the OFAC specially Designated Nationals List, the U.S. Department of Commerce, including the Bureau of Industry and
Security&#8217;s Denied Persons List and Entity List, Her Majesty&#8217;s Treasury, including the Consolidated List of Financial Sanctions
Targets and the Investment Bank List, or any similar list enforced by any other relevant Governmental Authority, as amended from time
to time, or any Person owned or controlled by any of the foregoing (collectively, &#8220;<span style="text-decoration: underline">Prohibited Party</span>&#8221;); or (ii) located,
organized or resident in a country or territory that is, or whose government is, the target of comprehensive trade sanctions under Sanctions
Laws, including, as of the date of this Agreement, Crimea, Cuba, Iran, North Korea, Sudan and Syria. Neither the Company, nor any director
or officer, nor, to the Knowledge of the Company, any employee or agent of the Company (acting on behalf of the Company) has since the
Company&#8217;s inception, engaged in any transaction involving a Prohibited Party, or any country or territory that was during such
period or is, or whose government was during such period or is, the target of comprehensive trade sanctions under Sanctions Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
the Knowledge of the Company, the Company has not exported (including deemed exportation) or re-exported, directly or indirectly, any
commodity, software, technology, or services in violation of any applicable Export Control Laws or has participated in any transaction
in violation of or connected with any purpose prohibited by Anti-Corruption Laws or any applicable International Trade Control Laws,
including support for international terrorism and nuclear, chemical, or biological weapons proliferation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 265; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Since
its inception, the Company has not received written notice of, nor, to the Knowledge of the Company, none of its officers, employees,
agents or third-party representatives is or has been the subject of, any investigation, inquiry or enforcement proceedings by any Governmental
Authority regarding any offense or alleged offense under Anti-Corruption Laws or International Trade Control Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.26</b> <span style="text-decoration: underline">Related Party Transactions</span>. <span style="text-decoration: underline">Schedule 4.26</span> of the Company Disclosure Schedules sets forth a true, complete and correct
list of the following (each such arrangement of the type required to be set forth thereon, whether or not actually set forth thereon,
an &#8220;<span style="text-decoration: underline">Affiliate Transaction</span>&#8221;): (i) each Contract entered into prior to the date hereof, between the Company, on the
one hand, and any Shareholder or any other current or former Affiliate of the Company on the other hand; and (ii) all Indebtedness (for
monies actually borrowed or lent) owed by any Shareholder or any other current or former Affiliate to the Company. Other than the Affiliate
Transactions, no Shareholder or Affiliate thereof owns any right in or to any of the material Assets or properties belonging to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.27</b> <span style="text-decoration: underline">Not An Investment Company</span>. The Company is not an &#8220;investment company&#8221; within the meaning of the Investment
Company Act of 1940, as amended (the &#8220;<span style="text-decoration: underline">Investment Company Act</span>&#8221;), and the rules and regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.28</b> <span style="text-decoration: underline">Exclusivity of Representations and Warranties</span>. Except as otherwise expressly provided in this Article IV (as modified
by the Company Disclosure Schedules), the Company hereby expressly disclaims and negates, any express or implied representation or warranty
whatsoever (whether at Law or in equity) with respect to the Company and its Affiliates, and any matter relating to any of them, including
their affairs, the condition, value or quality of the assets, liabilities, financial condition or results of operations, or with respect
to the accuracy or completeness of any other information made available to Murphy, its Affiliates or any of their respective Representatives
by, or on behalf of, Company, and any such representations or warranties are expressly disclaimed. Without limiting the generality of
the foregoing, neither the Company nor any other Person on behalf of Company has made or makes, any representation or warranty, whether
express or implied, with respect to any projections, forecasts, estimates or budgets made available to Murphy, its affiliates or any
of their respective Representatives of future revenues, future results of operations (or any component thereof), future cash flows or
future financial condition (or any component thereof) of the Company (including the reasonableness of the assumptions underlying any
of the foregoing), whether or not included in any management presentation or in any other information made available to Murphy, its Affiliates
or any of their respective Representatives or any other Person, and that any such representations or warranties are expressly disclaimed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
4.29 </b><span style="text-decoration: underline">Full Disclosure</span>. No representation or warranty by the Company in this Agreement and no statement contained in the Company
Disclosure Schedules to this Agreement or any certificate or other document furnished or to be furnished to Murphy pursuant to this Agreement,
including all information furnished in writing to Murphy by or on behalf of the Company specifically for inclusion in the Registration
Statement, contains any untrue statement of a material fact, or omits to state a material fact necessary to make the statements contained
therein, in light of the circumstances in which they are made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 266; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPRESENTATIONS
AND WARRANTIES OF MURPHY AND MERGER SUB</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in (a) the disclosure schedules, delivered as of the date hereof, by Murphy and Merger Sub in connection with this Agreement
(the &#8220;<span style="text-decoration: underline">Murphy Disclosure Schedules</span>&#8221;); (<i>provided, however, </i>that any disclosures made with respect to a section
of this Section 4.29 shall be deemed to qualify any other section of this Section 4.29 specifically referenced or cross- referenced)
and (b) the Murphy SEC Reports filed at least five days prior to the date hereof (to the extent the qualifying nature of such disclosure
is readily apparent from the content of such Murphy SEC Reports, but excluding disclosures referred to in &#8220;Forward-Looking Statements&#8221;,
&#8220;Risk Factors&#8221; and any other disclosures therein to the extent they are of a predictive or cautionary nature or related to
forward-looking statements), Murphy and Merger Sub hereby represent and warrant to the Company as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.1 </b><span style="text-decoration: underline">Corporate Organization</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
of Murphy and Merger Sub is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of
its incorporation and has the requisite corporate power and authority and all necessary governmental approvals to own, lease and operate
its properties and to carry on its business as it is now being conducted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Merger
Sub is the only Subsidiary of Murphy. Except for Merger Sub, Murphy does not directly or indirectly own any equity or similar interest
in, or any interest convertible into or exchangeable or exercisable for any equity or similar interest in, any corporation, partnership,
joint venture or business association or other Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.2</b> <span style="text-decoration: underline">Murphy and Merger Sub Organizational Documents</span>. Each of Murphy and Merger Sub has heretofore furnished to the Company complete
and correct copies of the Murphy Organizational Documents and the Merger Sub Organizational Documents. The Murphy Organizational Documents
and the Merger Sub Organizational Documents are in full force and effect. Neither Murphy nor Merger Sub is in violation of any of the
provisions of the Murphy Organizational Documents and the Merger Sub Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 267; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.3 </b><span style="text-decoration: underline">Capitalization</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
authorized capital stock of Murphy consists of (x) 100,000,000 shares of Murphy Class A Common Stock, (y) 10,000,000 shares of Murphy
Class B Common Stock and (z) 1,000,000 shares of preferred stock, par value $0.0001 per share (&#8220;<span style="text-decoration: underline">Murphy Preferred Stock</span>&#8221;).
As of the date of this Agreement (i) 13,979,000 shares of Murphy Class A Common Stock are issued and outstanding, all of which are duly
authorized, validly issued, fully paid and non- assessable and not subject to any preemptive rights, (ii) 3,306,250 shares of Murphy
Class B Common Stock are issued and outstanding, all of which are validly issued, fully paid and non- assessable and not subject to any
preemptive rights, (iii) no shares of Murphy Class A Common Stock or Murphy Class B Common Stock are held in the treasury of Murphy,
and (iv) 13,979,000 Murphy Warrants are issued and outstanding, all of which constitute binding obligations of Murphy under the law of
the jurisdiction governing the Murphy Warrants, and consisting of (A) 13,225,000 Murphy Public Warrants and (B) 754,000 Murphy Private
Placement Warrants, and (v) 13,979,000 shares of Murphy Class A Common Stock are reserved for future issuance pursuant to the Murphy
Warrants. There are no shares of Murphy Preferred Stock issued and outstanding. Each Murphy Public Warrant is exercisable for one share
of Murphy Class A Common Stock at an exercise price of $11.50. Each Murphy Private Placement Warrant is exercisable for one share of
Murphy Class A Common Stock at an exercise price of $11.50.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
of the date of this Agreement, the authorized capital stock of Merger Sub is U.S. $50,000 made up of 50,000 ordinary shares (the &#8220;<span style="text-decoration: underline">Merger
Sub Ordinary Shares</span>&#8221;). As of the date hereof, one Merger Sub Ordinary Share is issued and outstanding. The outstanding Merger
Sub Ordinary Share has been duly authorized, validly issued, fully paid and is non- assessable and is not subject to preemptive rights,
and is held by Murphy free and clear of all Liens, other than transfer restrictions under applicable Securities Laws and the Merger Sub
Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All
of the outstanding Murphy Units, shares of Murphy Common Stock and Murphy Warrants have been issued and granted in compliance with all
applicable Securities Laws and other applicable Laws and were issued free and clear of all Liens other than transfer restrictions under
applicable Securities Laws and the Murphy Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Closing Payment Shares to be delivered by Murphy in the Merger shall be duly and validly issued, fully paid and nonassessable, and each
Closing Payment Share shall be issued free and clear of preemptive rights and all Liens, other than transfer restrictions under applicable
Securities Laws and the Murphy Organizational Documents. The Closing Payment Shares will be issued in compliance with all applicable
securities Laws and other applicable Laws and without contravention of any other Person&#8217;s rights therein or with respect thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
in connection with this Agreement and the Ancillary Agreements, no anti-takeover, &#8220;fair price&#8221;, &#8220;moratorium&#8221;,
&#8220;control share acquisition&#8221;, &#8220;business combination&#8221; or other similar statute or regulation is applicable to this
Agreement or the transactions contemplated hereby. Murphy does not have any shareholder rights plan or &#8220;poison pill&#8221; in effect,
including any agreement with a third-party trust or fiduciary entity with respect thereto. As of the date hereof, neither Murphy nor
Merger Sub own any of the capital stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.4</b> <span style="text-decoration: underline">Authority Relative to This Agreement</span>. Each of Murphy and Merger Sub has all necessary power and authority to execute and
deliver this Agreement, to perform its obligations hereunder and, subject to the approval of the Murphy Proposals, to consummate the
Transactions. The execution and delivery of this Agreement by each of Murphy and Merger Sub and the consummation by each of Murphy and
Merger Sub of the Transactions, have been duly and validly authorized by all necessary action, and no other proceedings on the part of
Murphy or Merger Sub are necessary to authorize this Agreement or to consummate the Transactions (other than with respect to the Murphy
Proposals, the approval of a majority of the then-outstanding shares of Murphy Common Stock). This Agreement has been duly and validly
executed and delivered by Murphy and Merger Sub and, assuming due authorization, execution and delivery by the Company, constitutes a
legal, valid and binding obligation of Murphy and Merger Sub, enforceable against Murphy and Merger Sub in accordance with its terms
subject to the Remedies Exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 268; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.5</b> <span style="text-decoration: underline">No Conflict; Required Filings and Consents</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
execution and delivery of this Agreement by each of Murphy and Merger Sub do not, and the performance of this Agreement by each of Murphy
and Merger Sub will not, (i) conflict with or violate the Murphy Organizational Documents or the Merger Sub Organizational Documents
or (ii) result in any breach of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default)
under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of a Lien on
any property or asset of each of Murphy or Merger Sub pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license,
permit, franchise or other instrument or obligation to which each of Murphy or Merger Sub is a party or by which each of Murphy or Merger
Sub or any of their property or assets is bound or affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
execution and delivery of this Agreement by each of Murphy and Merger Sub do not, and the performance of this Agreement by each of Murphy
and Merger Sub will not, require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental
Authority or conflict with or violate any Law, rule, regulation, order, judgment or decree applicable to each of Murphy or Merger Sub
or by which any of their property or assets is bound or affected, except (i) for applicable requirements, if any, of the Exchange Act,
Blue Sky Laws and state takeover laws, the pre-merger notification requirements of the HSR Act, and filing and recordation of appropriate
merger documents as required by the Companies Act and (ii) where the failure to obtain such consents, approvals, authorizations or permits,
or to make such filings or notifications, would not, individually or in the aggregate, prevent or materially delay consummation of any
of the Transactions or otherwise prevent any of Murphy or Merger Sub from performing its material obligations under this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.6</b> <span style="text-decoration: underline">Compliance</span>. Neither Murphy nor Merger Sub is in breach or violation of, (a) any Law applicable to Murphy or Merger Sub
or by which any material property or asset of Murphy or Merger Sub is bound or affected, or (b) any note, bond, mortgage, indenture,
contract, agreement, lease, license, permit, franchise or other instrument or obligation to which Murphy or Merger Sub is a party or
by which Murphy or Merger Sub or any property or asset of Murphy or Merger Sub is bound, except, in each case, for any such breaches
or violations that do not constitute a Murphy Material Adverse Effect. Each of Murphy and Merger Sub is in possession of all material
franchises, grants, authorizations, licenses, permits, easements, variances, exceptions, consents, certificates, approvals and orders
of any Governmental Authority necessary for Murphy or Merger Sub to own, lease and operate its properties or to carry on its business
as it is now being conducted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 269; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.7</b> <span style="text-decoration: underline">Murphy SEC Documents and Financial Statements</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
has filed all forms, reports, schedules, statements and other documents, including any exhibits thereto, required to be filed or furnished
by Murphy with the SEC since Murphy&#8217;s formation under the Exchange Act or the Securities Act, together with any amendments, restatements
or supplements thereto, and will file all such forms, reports, schedules, statements and other documents required to be filed subsequent
to the date of execution hereof by the Parties (the &#8220;<span style="text-decoration: underline">Additional Murphy SEC Documents</span>&#8221;). Murphy has made available
to the Company copies in the form filed with the SEC of all of the following, except to the extent available in full without redaction
on the SEC&#8217;s website through EDGAR for at least two (2) days prior to the date of this Agreement: (i) Murphy&#8217;s Quarterly
Reports on Form 10-Q for each fiscal quarter of Murphy beginning with the first quarter Murphy was required to file such a form, (ii)
all proxy statements relating to Murphy&#8217;s meetings of shareholders (whether annual or special) held, and all information statements
relating to shareholder consents, since the beginning of the first fiscal quarter referred to in clause (i) above, (iii) its Form 8-Ks
filed since the beginning of the first fiscal quarter referred to in clause (i) above, and (iv) all other forms, reports, registration
statements and other documents (other than preliminary materials if the corresponding definitive materials have been provided to the
Company pursuant to this Section 5.7(a)) filed by Murphy with the SEC since Murphy&#8217;s formation (the forms, reports, registration
statements and other documents referred to in clauses (i), (ii), (iii), and (iv) above, whether or not available through EDGAR, are,
collectively, the &#8220;<span style="text-decoration: underline">Murphy SEC Documents</span>&#8221;). The Murphy SEC Documents were, and the Additional Murphy SEC Documents
will be, prepared in all material respects in accordance with the requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley
Act, as the case may be, and the rules and regulations thereunder. The Murphy SEC Documents did not, and the Additional Murphy SEC Documents
will not, at the time they were or are to be filed, as the case may be, with the SEC (except to the extent that information contained
in any Murphy SEC Document or Additional Murphy SEC Document has been or is revised or superseded by a later filed Murphy SEC Document
or Additional Murphy SEC Document, then on the date of such filing) contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading. As used in this Section 5.7(a), the term &#8220;file&#8221; shall be broadly construed to
include any manner in which a document or information is furnished, supplied or otherwise made available to the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
financial statements and notes contained or incorporated by reference in the Murphy SEC Documents and the Additional Murphy SEC Documents
(collectively, the &#8220;<span style="text-decoration: underline">Murphy Financial Statements</span>&#8221;) are or will be, as the case may be, complete and accurate and fairly
present in all material respects, in conformity with U.S. GAAP applied on a consistent basis in all material respects and Regulation
S-X or Regulation S-K, as applicable, the financial position of Murphy as of the dates thereof and the results of operations of Murphy
for the periods reflected therein. The Murphy Financial Statements are or will, as the case may be (i) prepared from the Books and Records
of Murphy; (ii) prepared on an accrual basis in accordance with U.S. GAAP consistently applied; and they contain and reflect or will
contain and reflect, as the case may be;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
all necessary adjustments and accruals for a fair presentation of Murphy&#8217;s financial condition as of their dates; and (iv) adequate
provisions for all material Liabilities for all material Taxes applicable to Murphy with respect to the periods then ended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as specifically disclosed, reflected or fully reserved against in the Murphy Financial Statements, and except for liabilities and obligations
of a similar nature and in similar amounts incurred in the ordinary course of business since Murphy&#8217;s formation, there are no material
liabilities, debts or obligations (whether accrued, fixed or contingent, liquidated or unliquidated, asserted or unasserted or otherwise)
relating to Murphy. All debts and Liabilities, fixed or contingent, which should be included under U.S. GAAP on a balance sheet are or
will be (as the case may be) included in Murphy Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 270; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.8</b> <span style="text-decoration: underline">Absence of Certain Changes or Events</span>. Since its inception, except as expressly contemplated by this Agreement, there has
not been any Murphy Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.9</b> <span style="text-decoration: underline">Absence of Litigation</span>. As of the date of this Agreement, there is no Action pending or, to the Knowledge of Murphy, threatened
in writing against Murphy, or any property or asset of Murphy, before any Governmental Authority. As of the date hereof, neither Murphy
nor any material property or asset of Murphy is subject to any continuing order of, consent decree, settlement agreement or other similar
written agreement with, or, to the Knowledge of Murphy, continuing investigation by, any Governmental Authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.10 </b><span style="text-decoration: underline">Board Approval; Vote Required</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Board of Directors of Murphy (the &#8220;<span style="text-decoration: underline">Murphy Board</span>&#8221;), by resolutions duly adopted by majority vote of those voting at
a meeting duly called and held and not subsequently rescinded or modified in any way, has duly (i) determined that this Agreement and
the Transactions are fair to and in the best interests of Murphy and its stockholders, (ii) approved this Agreement and the Transactions
(including the Merger) and declared their advisability, (iii) recommended that the stockholders of Murphy approve and adopt this Agreement
and Merger and the other Murphy Proposals, and (iv) directed that this Agreement and the Merger and the other Murphy Proposals be submitted
for consideration by the stockholders of Murphy at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
only vote of the holders of any class or series of capital stock of Murphy necessary to approve the Murphy Proposals is the affirmative
vote of the holders of a majority of the outstanding shares of Murphy Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
board of directors of Merger Sub by resolutions duly adopted by written consent and not subsequently rescinded or modified in any way,
have duly (i) determined that this Agreement and the Merger are fair to and in the best interests of Merger Sub and its sole shareholder,
(ii) approved this Agreement and the Merger and declared their advisability, and (iii) recommended that the sole shareholder of Merger
Sub approve and adopt this Agreement and approve the Merger and directed that this Agreement and the Transactions be submitted for consideration
by the sole shareholder of Merger Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
only vote of the holders of any class or series of capital stock of Merger Sub that is necessary to approve this Agreement, the Merger
and the other Transactions is the affirmative vote of the holders of a majority of the outstanding Merger Sub Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.11</b> <span style="text-decoration: underline">No Prior Operations of Merger Sub</span>. Merger Sub was formed solely for the purpose of engaging in the Transactions and has
not engaged in any business activities or conducted any operations or incurred any obligation or liability and holds no assets, other
than as specifically contemplated by this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 271; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.12</b> <span style="text-decoration: underline">Murphy Trust Fund</span>. As of the date of this Agreement, Murphy has at least $134,895,000, subject to deferred underwriting
fees of $4,628,750 in the trust fund established by Murphy for the benefit of its public shareholders (the &#8220;<span style="text-decoration: underline">Trust Fund</span>&#8221;)
in a United States-based account maintained by Wilmington Trust (the &#8220;<span style="text-decoration: underline">Trustee</span>&#8221;) acting as trustee (the &#8220;<span style="text-decoration: underline">Trust
Account</span>&#8221;), and such monies are invested in &#8220;government securities&#8221; (as such term is defined in the Investment Company
Act) and held in trust by the Trustee pursuant to the Trust Agreement. There are no separate agreements, side letters or other agreements
or understandings (whether written, unwritten, express or implied) that would cause the description of the Trust Agreement in the Murphy
SEC Documents to be inaccurate in any material respect or, to the Parent Parties&#8217; Knowledge, that would entitle any Person to any
portion of the funds in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account are permitted to be released,
except in the circumstances described in the Organizational Documents of Murphy and the Trust Agreement. Murphy has performed all material
obligations required to be performed by it to date under, and is not in material default or delinquent in performance or any other respect
(claimed or actual) in connection with the Trust Agreement, and, to the Knowledge of Murphy, no event has occurred which, with due notice
or lapse of time or both, would constitute such a material default thereunder. As of the date of this Agreement, there are no claims
or proceedings pending with respect to the Trust Account. Since February 2, 2022, Murphy has not released any money from the Trust Account
(other than interest income earned on the funds held in the Trust Account as permitted by the Trust Agreement). Upon the consummation
of the transactions contemplated hereby, Murphy shall have no further obligation under either the Trust Agreement or the Organizational
Documents of Parent to liquidate or distribute any assets held in the Trust Account, and the Trust Agreement shall terminate in accordance
with its terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.13</b> <span style="text-decoration: underline">Employees</span>. Other than any officers as described in the Murphy SEC Reports, Murphy and Merger Sub have never employed any
employees. Other than reimbursement of any out-of-pocket expenses incurred by Murphy&#8217;s officers and directors in connection with
activities on Murphy&#8217;s behalf in an aggregate amount not in excess of the amount of cash held by Murphy outside of the Trust Account,
Murphy and Merger Sub have no unsatisfied material liability with respect to any employee, officer or director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.14</b> <span style="text-decoration: underline">Taxes</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
and Merger Sub (i) have duly and timely filed (taking into account any extension of time within which to file) all material Tax Returns
required by Law to be filed by Murphy or Merger Sub, and all such filed Tax Returns are complete and accurate in all material respects;
(ii) have timely paid all material Taxes, whether or not shown as due on such filed Tax Returns and any other material Taxes that Murphy
and Merger Sub are otherwise obligated to pay, except with respect to current Taxes not yet due and payable or otherwise being contested
in good faith or that are described in clause (a)(v) below; (iii) with respect to all material Tax Returns filed by or with respect to
them, have not waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a Tax assessment
or deficiency which such waiver or extension remains in effect, and no written request for any such waiver or extension is currently
pending; (iv) do not have any deficiency, assessment, claim, audit, examination, investigation, litigation or other proceeding in respect
of a material amount of Taxes or material Tax matters pending or proposed or threatened in writing, for a Tax period for which the statute
of limitations for assessments remains open; and (v) have provided adequate reserves in accordance with GAAP in the most recent consolidated
financial statements of Murphy, for any material Taxes of Murphy and Merger Sub that have not been paid, whether or not shown as being
due on any Tax Return.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 272; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub is a party to, is bound by or has an obligation to any Governmental Authority or other Person under any Tax sharing
agreement, Tax indemnification agreement, Tax allocation agreement or similar contract or arrangement (excluding agreements, contracts,
arrangements or commitments the primary purpose of which do not relate to Taxes).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
of Murphy and Merger Sub has (i) withheld or collected all material Taxes required to have been withheld and paid in connection with
amounts paid or owing to any current or former employee, independent contractor, creditor, shareholder or other third party, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
reported and timely remitted such amounts required to have been withheld or collected, reported and remitted to the appropriate Governmental
Authority. All Forms W-2 or 1099 or other Tax Returns required with respect thereto have been properly completed and timely filed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub has been a member of an affiliated group filing a consolidated, combined or unitary U.S. federal, state, local
or foreign income Tax Return.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub has any material liability for the Taxes of any Person under Treasury Regulation section 1.1502-6 (or any similar
provision of state, local or foreign Law), as a transferee or successor, by contract (excluding contracts the primary purpose of which
do not relate to Taxes), or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub (i) has any request for a material ruling in respect of Taxes pending between Murphy and/or Merger Sub, on the
one hand, and any Tax authority, on the other hand, or (ii) has entered into any closing agreement, private letter ruling technical advice
memoranda or similar agreements with any Tax authority in respect of material Taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub has in any year for which the applicable statute of limitations remains open distributed stock of another Person,
or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part
by Section 355 or Section 361 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub has engaged in or entered into a &#8220;listed transaction&#8221; within the meaning of Treasury Regulation Section
1.6011-4(b)(2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;There
are no Tax liens upon any assets of Murphy or Merger Sub except for Permitted Liens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub has been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code
during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code. Neither Murphy nor Merger Sub has a permanent establishment
(within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place of business in a country other than the country
in which it is organized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 273; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
unpaid Taxes of Murphy and Merger Sub (i) did not, as of the date of the Financial Statements, exceed the reserve for Taxes (rather than
any reserve for deferred Taxes established to reflect timing difference between book and Tax income) set forth on the face of the Financial
Statements (rather than in any notes thereto), and (ii) do not exceed that reserve as adjusted for the passage of time through the Effective
Time in accordance with the past custom and practice of Murphy and Merger Sub in filing its Tax Returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
the Knowledge of Murphy and Merger Sub, Murphy and Merger Sub do not expect (i) any jurisdiction to assess any additional Taxes for any
period for which Tax Returns have been filed, and (ii) any jurisdiction in which Tax Returns are not filed to require the filing of Tax
Returns. To the Knowledge of Murphy and Merger Sub, within the last three (3) years, no written claim has been made by any Governmental
Authority in a jurisdiction where Murphy or Merger Sub does not file a Tax Return that such entity is or may be subject to material Taxes
by that jurisdiction in respect of Taxes that would be the subject of such Tax Return, which claim has not been resolved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither
Murphy nor Merger Sub will be required to include any item or income, or exclude any item or deduction or loss from, taxable income for
any taxable period (or portion thereof) ending after the Effective Time as a result of any:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;change
in method of accounting for a taxable period (or portion thereof) ending on or prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;use
of an improper method of accounting for a taxable period ending on or prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;ruling
by, or written agreement with, a Governmental Authority (including any &#8220;closing agreement&#8221; as described in Section 7121 of
the Code (or any corresponding provision of state, local, or non-U.S. Tax law)) for a taxable period ending on or prior to the Effective
Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;installment
sale or open transaction disposition made on or prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
prepaid amount received on or prior to the Effective Time;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;intercompany
transaction or excess loss accounts described in the Treasury Regulations promulgated under Section 1502 of the Code (or any corresponding
or similar provision of state, local or foreign income Tax Law) that existed prior to the Effective Time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
election under Section 965(h) of the Code; or</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
election under Section 108(i) of the Code.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
of Murphy and the Merger Sub is classified as a domestic C corporation for U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 274; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
Murphy has no Subsidiaries (and has not had any Subsidiary) other than</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Section 5.14 shall be construed as providing a representation or warranty with respect to (i) any taxable period (or portion
thereof) beginning after the Effective Time or (ii) the existence, amount, expiration date or limitations on (or availability of) any
Tax attribute.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.15</b> <span style="text-decoration: underline">Listing</span>. As of the date hereof, the Murphy Units, Murphy Common Stock and Murphy Warrants are listed on the Nasdaq Stock
Market, with trading symbols &#8220;MURFU&#8221;, &#8220;MURF&#8221; and &#8220;MURFW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.16</b> <span style="text-decoration: underline">Investment Company Act</span>. Murphy is not an &#8220;investment company&#8221; within the meaning of the Investment Company
Act and the rules and regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.17</b> <span style="text-decoration: underline">Registration Statement</span>. As of the time the Registration Statement becomes effective under the Securities Act, the Registration
Statement (together with any amendments or supplements thereto) will not contain any untrue statement of a material fact or omit to state
a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;
provided, however, that Murphy makes no representations or warranties as to the information contained in or omitted from the Registration
Statement in reliance upon and in conformity with information furnished in writing to Murphy by or on behalf of the Company specifically
for inclusion in the Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.18</b> <span style="text-decoration: underline">Contracts</span>. Except for those contracts filed (or incorporated by reference) as exhibits to the Murphy SEC Reports, neither
of Murphy or Merger Sub is party to any contract that would be required to be filed (or incorporated by reference) as an exhibit to Murphy&#8217;s
Annual Report on Form 10-K pursuant to Item 601(b)(10) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.19</b> <span style="text-decoration: underline">Brokers</span>. Except as set forth on <span style="text-decoration: underline">Schedule 5.19</span> of the Murphy Disclosure Schedules, no broker, finder or investment
banker is entitled to any brokerage, finder&#8217;s or other fee or commission (including any deferred underwriting commission) in connection
with the Transactions (including the Private Placement) based upon arrangements made by or on behalf of Murphy, Merger Sub or any other
their respective Affiliates, including Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.20</b> <span style="text-decoration: underline">Sponsor Support Agreement</span>. Concurrently with the execution of this Agreement, Murphy has delivered to the Company a true,
correct and complete copy of the Sponsor Support Agreement. The Sponsor Support Agreement is in full force and effect and has not been
withdrawn or terminated, or otherwise amended or modified, in any respect, and no withdrawal, termination, amendment or modification
is contemplated by the Company or Sponsor. The Sponsor Support Agreement is a legal, valid and binding obligation of Murphy and Sponsor
and neither the execution or delivery by any party thereto of, nor the performance of any party&#8217;s obligations under, the Sponsor
Support Agreement violates any provision of, or results in the breach of or default under, or requires any filing, registration or qualification
under, any applicable Law. No event has occurred that, with or without notice, lapse of time or both, would constitute a default or breach
on the part of Murphy or Sponsor under any term or condition of the Sponsor Support Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 275; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.21</b> <span style="text-decoration: underline">Murphy&#8217;s and Merger Sub&#8217;s Investigation and Reliance</span>. Each of Murphy and Merger Sub is a sophisticated purchaser
and has made its own independent investigation, review and analysis regarding the Company and the Transactions, which investigation,
review and analysis were conducted by Murphy and Merger Sub together with expert advisors, including legal counsel that they have engaged
for such purpose. Murphy, Merger Sub and their Representatives have been provided with full and complete access to the Representatives,
properties, offices, plants and other facilities, Books and Records of the Company and other information that they have requested in
connection with their investigation of the Company and the Transactions. Neither of Murphy nor Merger Sub is relying on any statement,
representation or warranty, oral or written, express or implied, made by the Company or any of its Representatives, except as expressly
set forth in Article IV (as modified by the Company Disclosure Schedules). Neither the Company nor any of its respective Shareholders,
Affiliates or Representatives shall have any liability to Murphy, Merger Sub or any of their respective Shareholders, Affiliates or Representatives
resulting from the use of, and Murphy, Merger Sub and their Representatives shall not have relied upon, any information, documents or
materials made available to Murphy or Merger Sub or any of their Representatives, whether orally or in writing, in any confidential information
memoranda, &#8220;data rooms,&#8221; management presentations, due diligence discussions or in any other form in expectation of the Transactions.
Neither the Company nor any of its Shareholders, Affiliates or Representatives is making, directly or indirectly, any representation
or warranty with respect to any estimates, projections or forecasts involving the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
5.22</b> <span style="text-decoration: underline">Full Disclosure</span>. No representation or warranty by Murphy or Merger Sub in this Agreement and no statement contained in
the Murphy Disclosure Schedules to this Agreement or any certificate or other document furnished or to be furnished to the Company pursuant
to this Agreement, including all information furnished in writing to the Company by or on behalf of Murphy or Merger Sub specifically
for inclusion in the Registration Statement, contains any untrue statement of a material fact, or omits to state a material fact necessary
to make the statements contained therein, in light of the circumstances in which they are made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUCT
OF BUSINESS PENDING THE MERGER</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
6.1 </b><span style="text-decoration: underline">Conduct of Business by the Company Pending the Merger</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except
as (i) contemplated by any other provision of this Agreement or any Ancillary Agreement, (ii) set forth in <span style="text-decoration: underline">Schedule 6.1</span> of the
Company Disclosure Schedules, (iii) taken (or omitted to be taken), as reasonably necessary, in response to COVID-19 Measures, (iv) may
be requested or compelled by any Governmental Authority or (v) required by applicable Law (<i>provided, however, </i>that Company shall
provide to the extent practicable reasonable advance notice in writing to Murphy of any action taken as a result of clauses (iii)-(v)),
the Company shall not, between the date of this Agreement and the Effective Time or the earlier termination of this Agreement, directly
or indirectly, do any of the following without the prior written consent of Murphy, which consent shall not be unreasonably withheld,
conditioned or delayed:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;amend
or otherwise change its or any Subsidiary&#8217;s certificate of incorporation or bylaws or equivalent organizational documents;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 276; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;issue,
sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or encumbrance of, any shares
of any class of capital stock or other securities of the Company or of any Subsidiary or any options, warrants, convertible securities
or other rights of any kind to acquire any shares of such capital stock, or any other ownership interest (including any phantom interest),
of the Company or any Subsidiary;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)
fail to maintain its or any Subsidiary&#8217;s existence; or (B) adopt or enter into a plan of complete or partial liquidation, dissolution,
merger, consolidation, restructuring, recapitalization or other reorganization of the Company or any Subsidiary (other than the transactions
contemplated by this Agreement);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;declare,
set aside, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to any Company
Capital Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassify,
combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any Company Capital Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)
acquire (including by merger, consolidation, or acquisition of stock or assets or any other business combination), whether in whole or
in part or via an equity or asset acquisition, any other corporation, limited liability company, partnership, other business organization
or any division thereof; (B) incur or guarantee any indebtedness for borrowed money or issue any debt securities or assume, guarantee
or endorse, or otherwise become responsible for, the obligations of any Person, or make any loans or advances, or intentionally grant
any security interest in any of its assets, other than additional extensions or borrowings as permitted under existing credit facilities
or (C) enter into any new line of business;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;make
any loans, advances or capital contributions to, or investments in, any other Person (including to any of its officers, directors, agents
or consultants), make any material change in its existing borrowing or lending arrangements for or on behalf of such Persons, or enter
into any &#8220;keep well&#8221; or similar agreement to maintain the financial condition of any other Person, except as required under
any indemnification agreement to which the Company is a party as of the date hereof and which has been disclosed in the Company Disclosure
Schedules;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
except to the extent otherwise permitted pursuant to this Section 6.1, ( A) adopt, enter into or materially amend any Plan or any collective
bargaining or similar agreement (including agreements with works councils and trade unions and side letters) to which the Company is
a party or by which it is bound, (B) grant or provide any severance, termination payments, bonus, change of control, retention, or benefits
to any employee of the Company, except in connection with the promotion or hiring (to the extent permitted by clause (C) of this paragraph)
or separation of any employee in the ordinary course of business, (C) hire any employee of the Company or any other individual who is
providing or will provide services to the Company other than any employee with an annual base salary of less than $150,000 or any employee
hired to replace terminated employees in the ordinary course of business, (D) adopt, enter into or materially amend Contracts with any
consultants or natural person independent contractors that involve consideration of more than $150, 000 in the aggregate or (E) take
any action to accelerate the vesting, payment or funding of any cash or equity-based compensation, payment or benefit other than as contemplated
by this Agreement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 277; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160;grant
any material increase in the compensation, incentives or benefits payable or to become payable to any current or former director, officer,
employee or consultant of the Company as of the date of this Agreement, other than (A) increases in the ordinary course of business,
or (B) increases required by the terms of a Plan or applicable Law;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;make
any change in any method of financial accounting or financial accounting principles, policies, procedures or practices, except as required
by a concurrent amendment in GAAP or applicable Law made subsequent to the date hereof, as agreed to by its independent accountants;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;make,
change or revoke any material Tax election, adopt or change any material Tax accounting method or period, file any amendment to a material
Tax Return, enter into any agreement with a Governmental Authority with respect to a material amount of Taxes, settle or compromise any
examination, audit or other Action with a Governmental Authority of or relating to any material United States federal, state, local or
non-United States income Tax liability, consent to any extension or waiver of the statutory period of limitations applicable to any claim
or assessment in respect of Taxes, or enter into any Tax sharing or similar agreement (excluding any commercial contract not primarily
related to Taxes);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;take
any action, or knowingly fail to take any action, which action or failure to act would reasonably be expected to prevent or impede the
Transactions from qualifying for the Intended Tax Treatment;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;enter
into, modify in any material respect or terminate any Contract that is (or would be if entered into prior to the date of this Agreement)
a Material Contract of the type described in Section 4.17(a), other than in the ordinary course of business;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
acquire any fee interest in real property;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;settle
any Action (A) if such settlement would require payment by the Company in an amount greater than $200,000 or (B) to the extent such settlement
is adverse to the Company and involves an Action brought by a Governmental Authority or alleged criminal wrongdoing;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;make
or authorize any payment of, or accrual or commitment for, capital expenditures in excess of $100,000 for any individual capital expenditure
or series of related capital expenditures or $300,000 in the aggregate;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 278; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)
enter into, renew, or materially amend, any Company Affiliate Agreement;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)
make any payment, distribution, loan or other transfer of value to any Related Party, other than (A) payments to employees in the ordinary
course of business, and (B) payments pursuant to Company Affiliate Agreements set forth on <span style="text-decoration: underline">Schedule 4.26</span> of the Company Disclosure
Schedules;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)&#160;&#160;&#160;&#160;&#160;&#160;&#160;fail
to maintain, cancel or materially change coverage under any insurance policy in form and amount equivalent in all material respects to
the insurance coverage currently maintained with respect to the Company and its assets, properties and businesses;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)&#160;&#160;&#160;&#160;&#160;&#160;&#160;permit
any material item of Company IP to lapse or to be abandoned, invalidated, dedicated to the public, or disclaimed, or otherwise become
unenforceable;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;in
all respects not already set forth in this Section 6.1, fail to conduct the Company Business in the ordinary course of business consistent
with past practice; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;enter
into any agreement or otherwise make a binding commitment to do any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
6.2</b> <span style="text-decoration: underline">Conduct of Business by Murphy Pending the Merger</span>. From the date hereof through the Closing Date, Murphy shall remain a
&#8220;blank check company&#8221; as defined under the Securities Act, and without the Company&#8217;s prior written consent (which shall
not be unreasonably withheld, conditioned or delayed) shall not conduct any business operations other than in connection with this Agreement
and ordinary course operations to maintain its status as a Nasdaq- listed special purpose acquisition company pending the completion
of the transactions contemplated hereby. Without limiting the generality of the foregoing, from the date hereof through the Closing Date,
other than in connection with the transactions contemplated by this Agreement, without the Company&#8217;s prior written consent (which
shall not be unreasonably withheld, conditioned or delayed), Murphy shall not amend, waive or otherwise change the Trust Agreement in
any manner adverse to Murphy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
6.3</b> <span style="text-decoration: underline">Claims Against Trust Account</span>. The Company (on its own behalf and on behalf of the Shareholders) agrees that, notwithstanding
any other provision contained in this Agreement, the Company does not now have, and shall not at any time prior to the Effective Time
have, any claim to, or make any claim against, the Trust Fund, regardless of whether such claim arises as a result of, in connection
with or relating in any way to, the business relationship between the Company on the one hand, and Murphy and Merger Sub on the other
hand, this Agreement, or any other agreement or any other matter, and regardless of whether such claim arises based on contract, tort,
equity or any other theory of legal liability (any and all such claims are collectively referred to in this Section 6.3 as the &#8220;<span style="text-decoration: underline">Claims</span>&#8221;).
Notwithstanding any other provision contained in this Agreement, the Company hereby irrevocably waives any Claim it may have, now or
in the future and will not seek recourse against the Trust Fund, any monies held in the Trust Account (or any distributions therefrom
directly or indirectly to Murphy&#8217;s stockholders) for any reason whatsoever in respect thereof. This Section 6.3 shall survive the
termination of this Agreement for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 279; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
6.4</b> <span style="text-decoration: underline">Applicable Per Share Merger Consideration</span>. At least three (3) Business Days prior to the Closing Date, the Company shall
provide Murphy with an updated version of <span style="text-decoration: underline">Exhibit A</span> that sets for the Applicable Per Share Merger Consideration for each holder
of the Company Ordinary Shares, including (a) Company Ordinary Shares issued upon the Company Convertible Debt Conversion and (b) the
conversion of any convertible notes that were issued following the date hereof but prior to the Closing Date pursuant to <span style="text-decoration: underline">Section 6.1(a)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 45.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL
AGREEMENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.1 </b>Preparation of Registration Statement; Special Meeting; Company </span><span style="font-family: Times New Roman, Times, Serif">Requisite
Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
promptly as practicable after the execution of this Agreement, (i) Murphy (with the assistance and cooperation of the Company as reasonably
requested by Murphy) shall use reasonable best efforts to cause to be filed with the SEC a registration statement on Form S-4 (as amended
or supplemented from time to time, and including the Proxy Statement contained therein, the &#8220;<span style="text-decoration: underline">Registration Statement</span>&#8221;)
in connection with the registration under the Securities Act of the Murphy Common Stock to be issued in connection with the Merger. Murphy
shall use reasonable best efforts to (i) cause the Registration Statement when filed with the SEC to comply in all material respects
with all legal requirements applicable thereto, (ii) respond as promptly as reasonably practicable to and resolve all comments received
from the SEC concerning the Registration Statement, and (iii) cause the Registration Statement to be declared effective under the Securities
Act as promptly as practicable and (iv) keep the Registration Statement effective as long as is necessary to consummate the Transactions
unless this Agreement is terminated in accordance with Article IX. The Company shall promptly provide to Murphy such information concerning
the Company (including, for the avoidance of doubt, any Company financial statements) and the Shareholders as is required by the Securities
Laws. As promptly as practicable after the Registration Statement is declared effective under the Securities Act, Murphy will cause the
Proxy Statement to be mailed to stockholders of Murphy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
agrees to include provisions in the Proxy Statement and to take reasonable action related thereto with respect to approval and adoption
of (i) this Agreement, the Merger and the other Transactions, (ii) the Amended Charter, (iii) the issuance of the Murphy Common Stock
in connection with the issuance of the Merger Consideration, including any required approvals under Nasdaq rules, (iv) the election of
directors effective as of the Closing as contemplated by Section 2.5, and (v) any other proposals the Parties deem necessary or advisable
to effectuate the Merger and the other Transactions (collectively, the &#8220;<span style="text-decoration: underline">Murphy Proposals</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 280; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
filing of, or amendment or supplement to the Proxy Statement or the Registration Statement will be made by Murphy without the approval
of the Company, which shall not be unreasonably withheld, conditioned or delayed. Murphy will advise the Company, promptly after it receives
notice thereof, of the time when the Registration Statement has become effective or any supplement or amendment has been filed, of the
issuance of any stop order, of the suspension of the qualification of the Murphy Common Stock to be issued or issuable to the Shareholders
in connection with this Agreement for offering or sale in any jurisdiction, or of any request by the SEC for amendment of the Proxy Statement
or the Registration Statement or comments thereon and responses thereto or requests by the SEC for additional information. Each of Murphy
and the Company shall cooperate and mutually agree upon (such agreement not to be unreasonably withheld, conditioned or delayed), any
response to comments of the SEC or its staff with respect to the Registration Statement and any amendment to the Registration Statement
filed in response thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If Murphy or the Company becomes aware that the Registration Statement,</span> <span style="font-family: Times New Roman, Times, Serif">(i)
as of the Effective Time, contains any untrue statement of a material fact or omits to state a material fact necessary in order to make
the statements, in light of the circumstances under which they were made, not misleading, or, (ii) at any time prior to the Effective
Time, information contained in the Registration Statement shall have become false or misleading in any material respect or that the Registration
Statement is required to be amended in order to comply with applicable Law (including the Securities Laws), then (x) such Party shall
promptly inform the other Parties and (y) Murphy, on the one hand, and the Company, on the other hand, shall cooperate and mutually agree
upon (such agreement not to be unreasonably withheld, conditioned or delayed) an amendment or supplement to the Registration Statement.
Murphy shall use reasonable best efforts to cause the Registration Statement, as so amended or supplemented, to be filed with the SEC
and the Proxy Statement to be disseminated to the holders of shares of Murphy Common Stock, as applicable, in each case pursuant to applicable
Law and subject to the terms and conditions of this Agreement and Murphy Organizational Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
shall use reasonable best efforts to, as promptly as practicable, after the Registration Statement is declared effective by the SEC,
(i) establish the record date for, duly call, give notice of, convene and hold the Special Meeting in accordance with the DGCL, (ii)
cause the Proxy Statement to be disseminated to the stockholders of Murphy and (iii) solicit proxies from the stockholders of Murphy
to vote in favor of each of the Murphy Proposals. Murphy shall, through the Murphy Board, recommend to its stockholders that they approve
each of the Murphy Proposals (the &#8220;<span style="text-decoration: underline">Murphy Board Recommendation</span>&#8221;) and shall include the unqualified Murphy Board Recommendation
in the Proxy Statement. The Murphy Board shall not (and no committee or subgroup thereof shall) change, withdraw, withhold, qualify or
modify, or publicly propose to change, withdraw, withhold, qualify or modify, the Murphy Board Recommendation, except as required by
Law; <i>provided, however, </i>that, the Murphy Board may make a withdrawal of such recommendation or an amendment, qualification or
modification of such recommendation to the extent that (i) after consultation with counsel, the Murphy Board determines that a failure
to make such a change would reasonably be likely to be inconsistent with its fiduciary duties under applicable Law, (ii) Murphy promptly
delivers to the Company a written notice advising the Company that the Murphy Board proposes to take such action and specifying the reasons
therefor, (iii) until 5:00 pm on the third Business day following the date such notice was delivered, if requested by the Company, Murphy
will engage in good faith negotiations to make adjustments to the terms of this Agreement so that the need to make such change in the
Murphy Board Recommendation is obviated and (iv) following such time referred to in clause (iii) above, the Murphy Board determines in
good faith (after consultation with its counsel, and taking into account any modifications to this Agreement proposed by the Company
prior to such time) that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law. Notwithstanding
the foregoing provisions of this Section 7.1(e), if on a date for which the Special Meeting is scheduled, Murphy has not received proxies
representing a sufficient number of shares of Murphy Common Stock to approve, in consultation with the Company, the Murphy Proposals,
whether or not a quorum is present, Murphy shall have the right to make one or more successive postponements or adjournments of the Special
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 281; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
promptly as reasonably practicable, and in any event within 10 Business Days, the Company shall use reasonable best efforts to obtain
and deliver to Murphy a true, complete and correct copy of a written consent (in form and substance reasonably satisfactory to Murphy)
evidencing the Company Requisite Approval that is duly executed by the Shareholders that hold at least the requisite number and class
of issued and outstanding shares of Company Capital Stock required to obtain the Company Requisite Approval. If the Company Requisite
Approval is obtained, then promptly following the receipt of the Company Requisite Approval, the Company will prepare and deliver to
its Shareholders who have not consented the notice required by the Companies Act. Unless this Agreement has been terminated in accordance
with its terms, the Company&#8217;s obligation to solicit written consents from the Shareholders to give the Company Requisite Approval
in accordance with this Section 7.1(f) shall not be limited or otherwise affected by the making, commencement, disclosure, announcement
or submission of any Company Acquisition Proposal. The Company shall, through the Company Board, recommend to the Shareholders that they
adopt this Agreement (the &#8220;<span style="text-decoration: underline">Company Board Recommendation</span>&#8221;). The Company Board shall not (and no committee or subgroup
thereof shall) change, withdraw, withhold, qualify or modify, or publicly propose to change, withdraw, withhold, qualify or modify, the
Company Board Recommendation, except as required by Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.2 </b><span style="text-decoration: underline">Access to Information; Confidentiality; Publicity</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;From
the date of this Agreement until the Effective Time, the Company and Murphy shall (and shall cause their respective subsidiaries, Affiliates
and Representatives to): (i) provide to the other Party (and the other Party&#8217;s officers, directors, employees, accountants, consultants,
legal counsel, agents and other representatives, collectively, &#8220;<span style="text-decoration: underline">Representatives</span>&#8221;) reasonable access at reasonable
times upon prior notice to the officers, employees, agents, properties, offices and other facilities of such Party and its subsidiaries
and to the Books and Records thereof; and (ii) furnish promptly to the other Party such information concerning the business, properties,
contracts, assets, liabilities, personnel and other aspects of such party and its subsidiaries as the other Party or its Representatives
may reasonably request. Notwithstanding the foregoing, neither the Company nor Murphy shall be required to provide access to or disclose
information where the access or disclosure would (i) jeopardize the protection of attorney-client privilege or contravene applicable
Law or (ii) require providing access that such Party reasonably determines, in light of COVID-19 or COVID-19 Measures, would jeopardize
the health and safety of any employee of such Party (it being agreed that the Parties shall use their reasonable best efforts to cause
such information to be provided in a manner that would not result in such jeopardy or contravention).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All
information obtained by the Parties pursuant to this Section 7.2 shall be kept confidential in accordance with the confidentiality agreement,
dated July 29, 2022 (the &#8220;<span style="text-decoration: underline">Confidentiality Agreement</span>&#8221;), between Murphy and the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 282; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
Party hereto shall make any public announcement or issue any public communication regarding this Agreement or the Transactions, or any
matter related to the foregoing, without first obtaining the prior written consent of the Company or Murphy, as applicable (which consent
shall not be unreasonably withheld, conditioned or delayed), except if such announcement or other communication is required by applicable
Law or legal process (including pursuant to the Securities Laws or the rules of any national securities exchange), in which case Murphy
or the Company, as applicable, shall use their reasonable best efforts to coordinate such announcement or communication with the other
Party, prior to announcement or issuance and allow the other Party a reasonable opportunity to comment thereon (which shall be considered
by Murphy or the Company, as applicable, in good faith); <i>provided, however,</i> that, the foregoing shall not prohibit any Party from
communicating with third parties, under confidentiality terms no less restrictive than the Confidentiality Agreement, to the extent necessary
for the purpose of seeking any third party consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.3 </b><span style="text-decoration: underline">Exclusivity</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;From
the date of this Agreement until the earlier of the Closing or the termination of this Agreement in accordance with its terms, the Company
shall not, and shall cause its Representatives not to, directly or indirectly: (i) solicit, initiate, encourage (including by means of
furnishing or disclosing information), facilitate, discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written
or oral) with respect to a Company Acquisition Proposal; (ii) furnish or disclose any non-public information to any Person in connection
with, or that could reasonably be expected to lead to, a Company Acquisition Proposal; (iii) enter into any Contract or other arrangement
or understanding regarding a Company Acquisition Proposal; (iv) prepare or take any steps in connection with a public or private offering
of any equity securities of the Company (or any Affiliate or successor of the Company); or (v) otherwise cooperate in any way with, or
assist or participate in, or knowingly facilitate or encourage any effort or attempt by any Person to do or seek to do any of the foregoing.
The Company shall, and shall cause its Affiliates and Representatives to, immediately cease any and all existing discussions or negotiations
with any Person (other than with Murphy, its stockholders and their Representatives) conducted prior to the date hereof with respect
to, or which is reasonably likely to give rise to or result in, a Company Acquisition Proposal. The Company agrees to (A) notify Murphy
promptly upon receipt of any Company Acquisition Proposal by the Company, and to describe the material terms and conditions of any such
Company Acquisition Proposal in reasonable detail (including the identity of the Persons making such Company Acquisition Proposal) and
(B) keep Murphy reasonably informed on a current basis of any modifications to such offer or information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 283; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;From
the date of this Agreement until the earlier of the Closing or the termination of this Agreement in accordance with its terms, Murphy
and Merger Sub shall not, and shall cause their Representatives not to, directly or indirectly: (i) solicit, initiate, encourage (including
by means of furnishing or disclosing information), facilitate, discuss or negotiate, directly or indirectly, any inquiry, proposal or
offer (written or oral) with respect to a Murphy Acquisition Proposal; (ii) furnish or disclose any non-public information to any Person
in connection with, or that could reasonably be expected to lead to, a Murphy Acquisition Proposal; (iii) enter into any Contract or
other arrangement or understanding regarding a Murphy Acquisition Proposal; (iv) prepare or take any steps in connection with a public
or private offering of any equity securities of Murphy (or any Affiliate or successor of Murphy); or (v) otherwise cooperate in anyway
with, or assist or participate in, or knowingly facilitate or encourage any effort or attempt by any Person to do or seek to do any of
the foregoing. Murphy and Merger Sub shall, and shall cause their Affiliates and Representatives to, immediately cease any and all existing
discussions or negotiations with any Person (other than with the Company, its stockholders and their Representatives) conducted prior
to the date hereof with respect to, or which is reasonably likely to give rise to or result in, a Murphy Acquisition Proposal. Murphy
and Merger Sub agree to (A) notify the Company promptly upon receipt of any Murphy Acquisition Proposal by Murphy (or any Affiliate or
successor of Murphy), and to describe the material terms and conditions of any such Murphy Acquisition Proposal in reasonable detail
(including the identity of the Persons making such Murphy Acquisition Proposal) and (B) keep the Company reasonably informed on a current
basis of any modifications to such offer or information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 284; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.4</b> <span style="text-decoration: underline">Employment Agreements</span>. The Company and Murphy shall cooperate in good faith to negotiate new employment agreements with
the persons listed on <span style="text-decoration: underline">Schedule 7.4</span> of the Company Disclosure Schedule, to be effective on the Closing Date, and subject to the
terms identified thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.5 </b><span style="text-decoration: underline">Directors&#8217; and Officers&#8217; Indemnification</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or former
directors and officers of Murphy, Merger Sub or the Company and each Person who served as a director, officer, member, trustee or fiduciary
of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of Murphy,
Merger Sub or the Company (the &#8220;<span style="text-decoration: underline">D&amp;O Indemnified Persons</span>&#8221;) as provided in their respective organizational documents
or under any indemnification, employment or other similar agreements between any D&amp;O Indemnified Person and Murphy, Merger Sub or
the Company, in each case as in effect on the date of this Agreement, shall survive the Closing and continue in full force and effect
in accordance with their respective terms to the extent permitted by applicable Law. Such rights shall include indemnification against
any costs or expenses (including reasonable attorneys&#8217; fees), judgments, fines, losses, claims, damages, or liabilities, whether
asserted or claimed prior to or after the Effective Time and whether the claim involves the enforcement of the terms of this Section
7.5(a). For a period of six (6) years after the Effective Time, Murphy shall cause the Amended Charter and the Surviving Corporation
Articles of Incorporation to contain provisions no less favorable with respect to exculpation and indemnification of and advancement
of expenses to D&amp;O Indemnified Persons than are set forth as of the date of this Agreement in the Murphy Organizational Documents
and Company Organizational Documents to the extent permitted by applicable Law. The provisions of this Section 7.5 shall survive the
consummation of the Merger and are intended to be for the benefit of, and shall be enforceable by, each of the D&amp;O Indemnified Persons
and their respective heirs and representatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;For
a period of six (6) years after the Effective Time, the Surviving Corporation shall maintain in effect directors&#8217; and officers&#8217;
liability (&#8220;<span style="text-decoration: underline">D&amp;O Insurance</span>&#8221;) covering those persons who are (i) currently covered by the Company&#8217;s and officers&#8217;
liability insurance policy and (ii) at or after the Closing Date on the board of directors of the Surviving Corporation (true, correct
and complete copies of which have been heretofore made available to the Company or its agents and Representatives) (the &#8220;<span style="text-decoration: underline">Company
D&amp;O Insurance</span>&#8221;) on terms no less favorable than the terms of such current insurance coverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 285; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;For
the benefit of Murphy&#8217;s, Merger Sub&#8217;s and the Company&#8217;s directors and officers, Murphy and the Company shall be permitted
prior to the Effective Time to obtain and fully pay the premium for a &#8220;tail&#8221; insurance policy that provides coverage for
up to a six-year period from and after the Effective Time for events occurring prior to the Effective Time (the &#8220;<span style="text-decoration: underline">D&amp;O Tail
Insurance</span>&#8221;) that is substantially equivalent to and in any event not less favorable in the aggregate than Murphy&#8217;s existing
policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, Murphy shall maintain
the D&amp;O Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and Murphy shall timely pay or
caused to be paid all premiums with respect to the D&amp;O Tail Insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding
anything contained in this Agreement to the contrary, this Section 7.5 shall survive the consummation of the Merger indefinitely and
shall be binding, jointly and severally, on Murphy and the Surviving Corporation and all successors and assigns of Murphy and the Surviving
Corporation. In the event that Murphy, the Surviving Corporation or any of their respective successors or assigns consolidates with or
merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or transfers
or conveys all or substantially all of its properties and assets to any Person or effects any division transaction, then, and in each
such case, Murphy and the Surviving Corporation shall ensure that proper provision shall be made so that the successors and assigns of
Murphy or the Surviving Corporation, as the case may be, shall succeed to the obligations set forth in this Section 7.5. The obligations
of Murphy and the Surviving Corporation under this Section 7.5 shall not be terminated or modified in such a manner as to materially
and adversely affect any present and former director or officer of the Company or Murphy, or other Person that may be a director or officer
of the Company or Murphy prior to the Effective Time, to whom this Section 7.5 applies without the consent of the affected Person. The
rights of each Person entitled to indemnification or advancement hereunder shall be in addition to, and not in limitation of, any other
rights such Person may have under the Company Organizational Documents, the Murphy Organizational Documents, or any other indemnification
arrangement, any applicable law, rule or regulation or otherwise. The provisions of this Section 7.5 are expressly intended to benefit,
and are enforceable by, each Person entitled to indemnification or advancement hereunder and their respective successors, heirs and representatives,
each of whom is an intended third-party beneficiary of this Section 7.5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.6</b> <span style="text-decoration: underline">Transaction Litigation</span>. In the event that any Action related to this Agreement, any Ancillary Agreement or the Transactions
is brought, or to the Knowledge of Murphy, threatened in writing, against Murphy or its directors or officers by any of Murphy&#8217;s
stockholders or by a Governmental Authority prior to the Closing, Murphy shall promptly notify the Company of any such Action and keep
the Company reasonably informed with respect to the status thereof. Murphy shall provide the Company the opportunity to participate in
(subject to a customary joint defense agreement), but not control, the defense of any such Action, shall give due consideration to the
Company&#8217;s advice with respect to such litigation and shall provide the Company with a meaningful opportunity to review and give
due consideration to the Company&#8217;s concerns regarding the settlement of any such Action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 286; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.7 </b><span style="text-decoration: underline">Tax Matters</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
of Murphy, Merger Sub and the Company shall use their respective reasonable best efforts to cause the Merger to qualify, and agree not
to, and not to permit or cause any of their Affiliates or subsidiaries to, take any action which to its Knowledge could reasonably be
expected to prevent or impede the Transactions from qualifying for the Intended Tax Treatment. This Agreement is intended to constitute,
and the Parties hereto hereby adopt this Agreement as, a &#8220;plan of reorganization&#8221; within the meaning of Treasury Regulation
Sections 1.368-2(g) and 1.368-3(a). Each of Murphy, Merger Sub and the Company shall report the Transactions in a manner consistent with
the Intended Tax Treatment unless otherwise required pursuant to a &#8220;determination&#8221; within the meaning of Section 1313(a)
of the Code, including attaching the statement described in Treasury Regulations Section 1.368-3(a) on or with its U.S. federal income
Tax Return for the taxable year of the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company, Murphy and Merger Sub hereby adopt this Agreement as a &#8220;plan of reorganization&#8221; within the meaning of Treasury Regulation
Sections 1.368-2(g) and 1.368-3(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
and the Merger Sub will cause the Company to continue the Company&#8217;s historic business or use a significant portion of the Company&#8217;s
historic business assets in a business within the meaning of Section 1.368-1(d) of the Treasury Regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;If,
in connection with the preparation and filing of the Registration Statement/Proxy Statement, if the SEC requires that an opinion of counsel
be provided with respect to the tax treatment of the Transactions, Murphy and the Company shall deliver to counsel for both Parties,
respectively, customary Tax representation letters satisfactory to each counsel, dated and executed as of the date the Registration Statement
shall have been declared effective by the SEC and such other date(s) as determined reasonably necessary by such counsel. Notwithstanding
the foregoing or anything to the contrary herein, neither Sichenzia Ross Ference LLP nor Thompson Hine LLP shall be required to provide
a tax opinion with respect to the Intended Tax Treatment. In addition, as the Company is a non-U.S. corporation without a sufficient
nexus to the United States, including having no U.S. shareholders or operations, notwithstanding anything in this Agreement or any Ancillary
Document to the contrary, the Company and its Affiliates, representatives, and advisors shall not be required to provide a Tax opinion
with respect to the Intended Tax Treatment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
and the Company acknowledge that the Merger is not conditioned on the receipt of a Tax opinion that the Merger qualifies as a reorganization
within the meaning of Section 368(a) of the Code. Any filings with the SEC in connection with the Merger, including the Registration
Statement/Proxy Statement, shall include a statement indicating that the Merger is not conditioned on the receipt of a Tax opinion that
opines that the Merger qualifies as a reorganization within the meaning of Section 368(a) of the Code. The Company is organized outside
the United States and has no operations in the United States. None of the shareholders of the Company are &#8220;United States persons&#8221;
within the meaning of Section 7701(a)(30) of the Code. Thus, even if the Merger were a taxable transaction for U.S. tax purposes, neither
the Company nor any of its shareholders would have any U.S. tax liability resulting from the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
of the Parties shall (and shall cause their respective Affiliates to) cooperate fully, as and to the extent reasonably requested by another
Party, in connection with the filing of any relevant Tax Returns, and any audit, examination or other proceeding with respect to Taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 287; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Murphy
shall be responsible for any sales, use, real property transfer, stamp or other similar transfer Taxes imposed in connection with the
Transactions and the preparation and filing of any Tax Returns required to be filed with respect thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.8</b> <span style="text-decoration: underline">Stock Exchange Listing</span>. Murphy will use reasonable best efforts to cause the Murphy Common Stock issued in connection with
the Transactions to be approved for listing on Nasdaq (and the Company shall reasonably cooperate in connection therewith), subject to
official notice of issuance, in each case, as promptly as reasonably practicable after the date of this Agreement, and in any event prior
to the Effective Time. During the period from the date hereof until the Closing, Murphy shall use reasonable best efforts to keep the
Murphy Common Stock and Murphy Warrants listed for trading on Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.9</b> <span style="text-decoration: underline">Murphy Public Filings</span>. From the date hereof through the Closing, Murphy will use reasonable best efforts to keep current
and timely file all reports required to be filed or furnished with the SEC and otherwise to comply in all material respects with its
reporting obligations under applicable Securities Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.10 </b><span style="text-decoration: underline">Efforts to Consummate; Antitrust; Regulatory Approvals</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon
the terms and subject to the conditions of this Agreement, each of the Parties hereto shall use reasonable best efforts to take, or cause
to be taken, appropriate action, and to do, or cause to be done, such things as are necessary, proper or advisable under applicable Laws
or otherwise to consummate and make effective the Transactions, including using reasonable best efforts to obtain all permits, consents,
approvals, authorizations, qualifications and orders of Governmental Authorities and parties to contracts with the Company necessary
for the consummation of the Transactions and to fulfill the conditions to the Merger. In case, at any time after the Effective Time,
any further action is necessary or desirable to carry out the purposes of this Agreement, the proper officers and directors of each Party
shall use their reasonable best efforts to take all such action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
of the Parties shall keep each other apprised of the status of matters relating to the Transactions, including promptly notifying the
other Parties of any communication it or any of its Affiliates receives from any Governmental Authority relating to the matters that
are the subject of this Agreement and permitting the other Parties to review in advance, and to the extent practicable consult about,
any proposed communication by such Party to any Governmental Authority in connection with the Transactions. No Party shall agree to participate
in any meeting with any Governmental Authority in respect of any filings, investigation or other inquiry unless it consults with the
other Parties in advance and, to the extent permitted by such Governmental Authority, gives the other Parties the opportunity to attend
and participate at such meeting. Subject to the terms of the Confidentiality Agreement, the Parties will coordinate and cooperate fully
with each other in exchanging such information and providing such assistance as the other Parties may reasonably request in connection
with the foregoing. Subject to the terms of the Confidentiality Agreement, the Parties will provide each other with copies of all material
correspondence, filings or communications, including any documents, information and data contained therewith, between them or any of
their Representatives, on the one hand, and any Governmental Authority or members of its staff, on the other hand, with respect to this
Agreement and the Transactions. No Party shall take or cause to be taken any action before any Governmental Authority that is inconsistent
with or intended to delay its action on requests for a consent or the consummation of the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 288; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
the extent required under any Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization
or restraint of trade, including the HSR Act (&#8220;<span style="text-decoration: underline">Antitrust Laws</span>&#8221;), each Party agrees to promptly, but in no event more
than fifteen (15) Business Days after the date of this Agreement, make any required filing or application under Antitrust Laws, as applicable.
The Parties agree to supply as promptly as reasonably practicable any additional information and documentary material that may be requested
pursuant to Antitrust Laws and to take all other actions necessary, proper or advisable to cause the expiration or termination of the
applicable waiting periods or obtain required approvals, as applicable under Antitrust Laws as soon as practicable, including by requesting
early termination of the waiting period provided for under the HSR Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
Party shall, in connection with its efforts to obtain all requisite approvals and authorizations for the Transactions under any Antitrust
Law, use reasonable best efforts to: (i) cooperate in all respects with each other Party or its Affiliates in connection with any filing
or submission and in connection with any investigation or other inquiry, including any proceeding initiated by a private person; (ii)
keep the other Parties reasonably informed of any communication received by such Party or its Representatives from, or given by such
Party or its Representatives to, any Governmental Authority and of any communication received or given in connection with any proceeding
by a private person, in each case regarding any of the Transactions; (iii) permit a Representative of the other Parties and their respective
outside counsel to review any communication given by it to, and consult with each other in advance of any meeting or conference with,
any Governmental Authority or, in connection with any proceeding by a private person, with any other Person, and to the extent permitted
by such Governmental Authority or other Person, give a Representative or Representatives of the other Parties the opportunity to attend
and participate in such meetings and conferences; (iv) in the event a Party&#8217;s Representative is prohibited from participating in
or attending any meetings or conferences, the other Parties shall keep such Party promptly and reasonably apprised with respect thereto;
and (v) use reasonable best efforts to cooperate in the filing of any memoranda, white papers, filings, correspondence or other written
communications explaining or defending the Transactions, articulating any regulatory or competitive argument, and/or responding to requests
or objections made by any Governmental Authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
of Murphy and the Company shall not, and shall cause its respective subsidiaries (as applicable) not to, acquire or agree to acquire,
by merging with or into or consolidating with, or by purchasing a portion of the assets of or equity in, or by any other manner, any
business or any corporation, partnership, association or other business organization or division thereof, or otherwise acquire or agree
to acquire any assets, or take any other action, if the entering into of a definitive agreement relating to, or the consummation of such
acquisition, merger or consolidation, or the taking of any other action, would reasonably be expected to: (i) impose any delay in the
obtaining of, or increase the risk of not obtaining, any authorizations, consents, orders or declarations of any Governmental Authorities
or the expiration or termination of any applicable waiting period; (ii) increase the risk of any Governmental Authority entering an order
prohibiting the consummation of the Transactions; (iii) increase the risk of not being able to remove any such order on appeal or otherwise;
or (iv) delay or prevent the consummation of the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 289; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Parties further covenant and agree, with respect to a threatened or pending preliminary or permanent injunction or other order, decree
or ruling or statute, rule, regulation or executive order that would adversely affect the ability of the Parties to consummate the Transactions,
to use reasonable best efforts to prevent or lift the entry, enactment or promulgation thereof, as the case may be.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Company will pay all filing fees related to Antitrust Laws required by the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.11</b> <span style="text-decoration: underline">Trust Account</span>. Prior to or at the Closing (subject to the satisfaction or waiver of the conditions set forth in Article
VIII), Murphy shall provide notice to the Trustee in accordance with the Trust Agreement and shall deliver any other documents, opinions
or notices required to be delivered to the Trustee pursuant to the Trust Agreements so that the Trustee shall make appropriate arrangements
to cause the funds in the Trust Account to be disbursed in accordance with the Trust Agreement, for the following uses: (a) the redemption
of any shares of Murphy Class A Common Stock held by a Redeeming Shareholder in connection with the Offer;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the payment of the Outstanding Company Transaction Expenses and Outstanding Murphy Transaction Expenses pursuant to <span style="text-decoration: underline">Section 3.5</span>;
and (c) the balance after payment and disbursement of the amounts required under the foregoing clauses (a)-(b), to be disbursed to Murphy,
and thereafter shall cause the Trust Account and the Trust Agreement to terminate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.12</b> <span style="text-decoration: underline">Section 16 Matters</span>. Prior to the Closing, the Murphy Board, or an appropriate committee of &#8220;non-employee directors&#8221;
(as defined in Rule 16b-3 under the Exchange Act) thereof, shall adopt a resolution consistent with the interpretive guidance of the
SEC so that the acquisition of Murphy Common Stock pursuant to this Agreement and the other agreements contemplated hereby, by any Person
owning securities of the Company who is expected to become a director or officer (as defined under Rule 16a-1(f) under the Exchange Act)
of Murphy following the Closing shall be an exempt transaction for purposes of Section 16(b) of the Exchange Act pursuant to Rule 16b-3
thereunder. Murphy shall provide the Company and such individuals with copies of any resolutions proposed to be adopted by the Murphy
Board in connection with the foregoing prior to such adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.13</b> <span style="text-decoration: underline">Preparation and Delivery of PCAOB Audited Financial Statements and Interim Financial Statements</span>. As soon as reasonably
practicable following the date of this Agreement, the Company shall deliver to Murphy the PCAOB Audited Financial Statements and Interim
Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 290; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.14</b> <span style="text-decoration: underline">Support of Transaction</span>. Subject to Section 7.3, without limiting any covenant contained herein, including the obligations
of the Company and Murphy with respect to the notifications, filings and applications described in Section 7.10, which obligations shall
control to the extent of any conflict with the succeeding provisions of this Section 7.14, Murphy and the Company shall each, and shall
each cause their respective Subsidiaries to: (a) use reasonable best efforts to assemble, prepare and file any information (and, as needed,
to supplement such information) as may be reasonably necessary to obtain as promptly as reasonably practicable all governmental and regulatory
consents required to be obtained in connection with the Transactions, (b) use reasonable best efforts to obtain all material consents
and approvals of third parties that any of Murphy, the Company or their respective Affiliates are required to obtain in order to consummate
the Transactions, including any required approvals of parties to Material Contracts with the Company, and (c) take such other action
as may reasonably be necessary or as another party may reasonably request to satisfy the conditions of Article VIII or otherwise to comply
with this Agreement and to consummate the Transactions as soon as practicable. Notwithstanding the foregoing, in no event shall Murphy,
Merger Sub or the Company be obligated to bear (and without the consent of Murphy the Company shall not agree to bear) any material expense
or pay any material fee or grant any material concession, in connection with obtaining any consents, authorizations or approvals pursuant
to the terms of any Contract to which the Company is a party or otherwise in connection with the consummation of the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
7.15 </b><span style="text-decoration: underline">Notice of Certain Events</span>. Each Party shall promptly notify the other Party of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the
transactions contemplated by this Agreement or any Ancillary Agreement, or that the transactions contemplated by this Agreement or the
Ancillary Agreements might give rise to any Action by or on behalf of such Person or result in the creation of any Lien on any Company
capital stock, any share capital or capital stock of Murphy or any of the Company&#8217;s or Murphy&#8217;s assets;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;any
notice or other communication from any Authority in connection with the transactions contemplated by this Agreement or the Ancillary
Agreements;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;any
Actions commenced or, to such Party&#8217;s Knowledge, threatened against, relating to or involving or otherwise affecting the consummation
of the transactions contemplated by this Agreement or the Ancillary Agreements;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
occurrence of any fact or circumstance which constitutes or results, or might reasonably be expected to constitute or result, in a Material
Adverse Change; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
occurrence of any fact or circumstance which results, or might reasonably be expected to result, in any representation or warranty made
hereunder by such Party to be false or misleading in any material respect or to omit or fail to state a material fact.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 51.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDITIONS
TO THE MERGER</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
8.1</b> <span style="text-decoration: underline">Conditions to the Obligations of Each Party</span>. The obligations of the </span><span style="font-family: Times New Roman, Times, Serif">Company,
Murphy and Merger Sub to consummate the Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible)
at or prior to the Closing of the following conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Murphy
Stockholders&#8217; Approval</span>. The Murphy Proposals shall have been approved and adopted by the requisite affirmative vote of the
stockholders of Murphy in accordance with the Proxy Statement, the DGCL, the Murphy Organizational Documents and the rules and regulations
of Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 291; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Company
Requisite Approval</span>. The Company Requisite Approval shall have been obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">No
Order</span>. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law, rule, regulation, judgment,
decree, executive order or award which is then in effect and has the effect of making the Transactions, including the Merger, illegal
or otherwise prohibiting consummation of the Transactions, including the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">No
Litigation</span>. There shall not be pending any Action by any Governmental Entity in any court of competent jurisdiction seeking to prohibit
the consummation of the Merger or any other transaction contemplated by this Agreement or that would otherwise cause a Murphy Material
Adverse Effect or a Company Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Antitrust
Approvals and Waiting Periods</span>. If applicable, all required filings under the HSR Act shall have been completed and any applicable
waiting period (and any extension thereof) applicable to the consummation of the Transactions under the HSR Act shall have expired or
been terminated, and any pre-Closing approvals or clearances reasonably required thereunder shall have been obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Registration
Statement</span>. The Registration Statement shall have been declared effective under the Securities Act. No stop order suspending the effectiveness
of the Registration Statement shall be in effect, and no proceedings for purposes of suspending the effectiveness of the Registration
Statement shall have been initiated or be threatened by the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Stock
Exchange Listing</span>. The shares of Murphy Common Stock to be issued in connection with the Transactions shall have been approved for
listing on Nasdaq as of the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Ancillary
Agreements</span>. The Ancillary Agreements shall have been executed and delivered by all parties thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Minimum
Proceeds</span>. The aggregate cash available to Murphy at the Closing from the Trust Account and its corporate account (after giving effect
to the redemption of any shares of Murphy Class A Common Stock in connection with the Murphy Proposals, but before giving effect to (i)
the payment of the Outstanding Murphy Transaction Expenses, and (ii) the payment of the Outstanding Company Transaction Expenses), shall
equal or exceed twenty-seven million dollars ($27,000,000).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Net
Tangible Assets Test</span>. Upon the Closing, Murphy shall not have redeemed shares of Murphy Class A Common Stock in the Offer in an amount
that would cause Murphy to have less than $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under
the Exchange Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 292; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">PIPE
Financing</span>. The aggregate cash proceeds available to Murphy from the PIPE Financing and the funds remaining in the Trust Account after
redemptions shall be not less than an aggregate of $27,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Lock-Up.
</span>The holders of the Company Capital Stock set forth on <span style="text-decoration: underline">Schedule 8.1(l)</span> shall have entered into lock-up agreements in a form
that is reasonably satisfactory to Murphy and the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Non-Continuing
Directors and Officers</span>. Each of the Company and Murphy shall have delivered resignation letters, in a form that is reasonably satisfactory
to Murphy and the Company, for the directors and officers of each of the Company and Murphy that shall not continue in such positions
following the Closing (it being understood that each of the Company and Murphy shall notify the other party of all such individuals at
least three (3) Business Days prior to the Closing).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
8.2</b> <span style="text-decoration: underline">Conditions to the Obligations of Murphy and Merger Sub</span>. The obligations of Murphy and Merger Sub to consummate the Transactions,
including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Closing of the following additional
conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Representations
and Warranties</span>. The representations and warranties of the Company shall be true and correct in all respects (without giving effect
to any limitation as to &#8220;materiality&#8221; or &#8220;Company Material Adverse Effect&#8221; or any similar limitation contained
herein) on and as of the date of this Agreement and on as of the Closing Date as though made on and as of the Closing Date (except to
the extent that any such representation or warranty expressly is made as of an earlier date, in which case such representation and warranty
shall be so true and correct as of such specified date), except where the failures of any such representations and warranties to be so
true and correct, individually or in the aggregate, have not had a Company Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Agreements
and Covenants</span>. The Company shall have performed or complied in all material respects with all agreements and covenants required by
this Agreement to be performed or complied with by it on or prior to the Effective Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Officer
Certificate</span>. The Company shall have delivered to Murphy a certificate, dated the date of the Closing, signed by an officer of the
Company, certifying as to the satisfaction of the conditions specified in Section 8.2(a), Section 8.2(b) and Section 8.2(e).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Consents</span>.
All approvals, consents and waivers that are listed on <span style="text-decoration: underline">Schedule 8.2(d)</span> of the Company Disclosure Schedules shall have been received,
and executed counterparts thereof shall have been delivered to Murphy at or prior to the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">No
Company Material Adverse Effect</span>. No Company Material Adverse Effect shall have occurred between the date of this Agreement and the
Closing Date that is continuing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 293; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Shareholder
Support Agreement</span>. The Shareholder Support Agreement shall be in full force and effect, and no signatory to the Shareholder Support
Agreement shall have attempted to repudiate or disclaim any of its or his obligations thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Company
Convertible Securities</span>. Murphy shall have received evidence acceptable to Murphy that the Company shall have converted, terminated,
extinguished and cancelled in full the Company Convertible Debt, and any other securities convertible into Company Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Conduit
UK Management Ltd.</span> Conduit UK Management Ltd. will be transferred to the Company and become a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Assignment
of Certain Intellectual Property</span>. Application No. JP 2022- 176753 shall have been assigned to Conduit UK Management Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
8.3</b> <span style="text-decoration: underline">Conditions to the Obligations of the Company</span>. The obligations of the Company to consummate the Transactions, including
the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to Closing of the following additional conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Representations
and Warranties</span>. The representations and warranties of Murphy and Merger Sub shall be true and correct in all respects (without giving
effect to any limitation as to &#8220;materiality&#8221; or &#8220;Murphy Material Adverse Effect&#8221; or any similar limitation contained
herein) on and as of the date of this Agreement and on as of the Closing Date as though made on and as of the Closing Date (except to
the extent that any such representation or warranty expressly is made as of an earlier date, in which case such representation and warranty
shall be so true and correct as of such specified date), except where the failures of any such representations and warranties to be so
true and correct, individually or in the aggregate, have not had a Murphy Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Agreements
and Covenants</span>. Murphy and Merger Sub shall have performed or complied in all material respects with all agreements and covenants
required by this Agreement to be performed or complied with by it on or prior to the Effective Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Officer
Certificate</span>. Murphy shall have delivered to the Company a certificate, dated the date of the Closing, signed by the President of
Murphy, certifying as to the satisfaction of the conditions specified in Section 8.3(a), Section 8.3(b) and Section 8.3(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Material
Adverse Effect</span>. No Murphy Material Adverse Effect shall have occurred between the date of this Agreement and the Closing Date that
is continuing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Equity
Incentive Plan</span>. Murphy, in consultation with, and based on the recommendations of, a compensation consultant, shall have agreed to
a new equity incentive plan for Murphy to be in effect following the Closing Date with customary market terms for comparable public companies
and with an initial share reserve of no more than ten percent (10%) of Murphy&#8217;s fully diluted common stock immediately outstanding
after Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
                                            8.4</b> <span style="text-decoration: underline">Frustration of Conditions</span>. None of the Parties may rely on the failure of any
                                            condition set forth in this Article VIII to be satisfied if such failure was caused by such
                                            Party&#8217;s breach of a covenant or agreement contained herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 294; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 93.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TERMINATION,
AMENDMENT AND WAIVER</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 93.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
9.1</b> <span style="text-decoration: underline">Termination</span>. This Agreement may be terminated and the Merger and the other Transactions may be abandoned at any time prior
to the Effective Time, notwithstanding any requisite approval and adoption of this Agreement and the Transactions by the Shareholders
or Murphy, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
by mutual written consent of Murphy and the Company;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;by
either Murphy or the Company if the Effective Time shall not have occurred prior to May 31, 2023 (the &#8220;<span style="text-decoration: underline">Outside Date</span>&#8221;);
<span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that this Agreement may not be terminated under this Section 9.1(b) by or on behalf of any Party that
either directly or indirectly through its Affiliates is in breach or violation of any representation, warranty, covenant, agreement or
obligation contained herein and such breach or violation is the principal cause of the failure of a condition set forth in Article VIII
on or prior to the Outside Date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;by
either Murphy or the Company if any Governmental Authority in the United States or a foreign government shall have enacted, issued, promulgated,
enforced or entered any permanent injunction, order, decree or ruling which has become final and nonappealable and has the effect of
making consummation of the Transactions, including the Merger, illegal or otherwise preventing or prohibiting consummation of the Transactions
or the Merger;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;by
Murphy upon a breach of any representation, warranty, covenant or agreement on the part of the Company set forth in this Agreement, or
if any representation or warranty of the Company shall have become untrue, in either case such that the conditions set forth in <span style="text-decoration: underline">Sections
</span>8.2(a) or 8.2(b), as applicable, would not be satisfied (&#8220;<span style="text-decoration: underline">Terminating Company Breach</span>&#8221;); <i>provided, however,
</i>that Murphy and Merger Sub are not then in material breach of their representations, warranties, covenants or agreements in this
Agreement; and <i>provided further,</i> that if such Terminating Company Breach is curable by the Company, Murphy may not terminate this
Agreement under this Section 9.1(d) for so long as the Company continues to exercise its reasonable efforts to cure such breach, unless
such breach is not cured within the earlier of (i) 20 Business Days after notice of such breach is provided by Murphy to the Company
and (ii) the Outside Date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 295; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;by
the Company upon a breach of any representation, warranty, covenant or agreement on the part of Murphy or Merger Sub set forth in this
Agreement, or if any representation or warranty of Murphy or Merger Sub shall have become untrue, in either case such that the conditions
set forth in <span style="text-decoration: underline">Sections </span>8.3(a) or 8.3(b), as applicable, would not be satisfied (&#8220;<span style="text-decoration: underline">Terminating Murphy Breach</span>&#8221;);
<i>provided, however, </i>that the Company has not waived such Terminating Murphy Breach and the Company is not then in material breach
of its representations, warranties, covenants or agreements in this Agreement; and <i>provided further,</i> that, if such Terminating
Murphy Breach is curable by Murphy and Merger Sub, the Company may not terminate this Agreement under this Section 9.1(e) for so long
as Murphy and Merger Sub continue to exercise their reasonable efforts to cure such breach, unless such breach is not cured within the
earlier of (i) 20 Business Days after notice of such breach is provided by the Company to Murphy and (ii) the Outside Date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&#160;&#160;&#160;&#160;&#160;&#160;&#160;by Murphy if there is a Company Material Adverse Effect;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;
by the Company if there is a Murphy Material Adverse Effect;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;by
either Murphy or the Company if any of the Murphy Proposals shall fail to receive the requisite vote for approval at the Special Meeting;
or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;by
written notice from Murphy if the Company Requisite Approval is not obtained within 10 Business Days after the date of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
9.2</b> <span style="text-decoration: underline">Effect of Termination</span>. In the event of the termination of this Agreement pursuant to Section 9.1, this Agreement shall
forthwith become void, and there shall be no liability under this Agreement on the part of any Party, except as set forth in this Section
9.2, Article XI, and any corresponding definitions set forth in Article I, or in the case of termination subsequent to a Willful Breach
of this Agreement by a Party. The provisions of Section 6.3 (Claims Against Trust Account), Section 7.2 (Access to Information; Confidentiality;
Publicity), this Section 9.2 (Effect of Termination) and Article XI (General Provisions) (collectively, the &#8220;<span style="text-decoration: underline">Surviving Provisions</span>&#8221;)
and the Confidentiality Agreement, and any other Section or Article of this Agreement referenced in the Surviving Provisions which is
required to survive in order to give appropriate effect to the Surviving Provisions, shall in each case survive any termination of this
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
9.3</b> <span style="text-decoration: underline">Expenses</span>. Except for the Outstanding Company Transaction Expenses and the Outstanding Murphy Transaction Expenses paid
at the Closing, and the expenses paid by the Parties as contemplated in Section 7.10(g), all expenses incurred in connection with this
Agreement and the Transactions shall be paid by the Party incurring such expenses, whether or not the Merger or any other Transactions
are consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
9.4</b> <span style="text-decoration: underline">Amendment</span>. This Agreement may be amended in writing by the Parties hereto at any time prior to the Effective Time. This
Agreement may not be amended except by an instrument in writing signed by each of the Parties hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
9.5</b> <span style="text-decoration: underline">Waiver</span>. At any time prior to the Effective Time, (a) Murphy may (i) extend the time for the performance of any obligation
or other act of the Company, (ii) waive any inaccuracy in the representations and warranties of the Company contained herein or in any
document delivered by the Company pursuant hereto and (iii) waive compliance with any agreement of the Company or any condition to its
own obligations contained herein, and (b) the Company may (i) extend the time for the performance of any obligation or other act of Murphy
or Merger Sub, (ii) waive any inaccuracy in the representations and warranties of Murphy or Merger Sub contained herein or in any document
delivered by Murphy and/or Merger Sub pursuant hereto and (iii) waive compliance with any agreement of Murphy or Merger Sub or any condition
to its own obligations contained herein. Any such extension or waiver shall be valid if set forth in an instrument in writing signed
by the Party or Parties to be bound thereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 296; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
X</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NON-SURVIVAL
OF REPRESENTATIONS AND WARRANTIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
10.1</b> <span style="text-decoration: underline">Non-Survival</span>. All representations and warranties of Murphy, Merger Sub and the Company contained in this Agreement shall
terminate as of the Closing, and no such representation or warranty shall survive the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
XI</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL
PROVISIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.1</b> <span style="text-decoration: underline">Notices</span>. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given
(and shall be deemed to have been duly given upon receipt) by delivery in person, by email or by registered or certified mail (postage
prepaid, return receipt requested) to the respective Parties at the following addresses (or at such other address for a Party as shall
be specified in a notice given in accordance with this Section 11.1):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">If
to Murphy or Merger Sub, at or prior to the Closing:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, California 92123</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Jack K. Heilbron, CEO</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
jheilbron@presidiopt.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31st Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Darrin Ocasio, Esq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
dmocasio@srf.law</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">If
to the Company, at or prior to the Closing</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
Ogier Global (Cayman) Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89
Nexus Way,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Camana
Bay</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand
Cayman, KY1-9009 Cayman Islands</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Dr. Andrew Regan; James Bligh</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<span style="text-decoration: underline">ar@corvus.com</span>; jb@conduitpharma.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 297; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thompson
Hine LLP 335</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Madison
Avenue</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12th
Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10017-4611</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Faith Charles, Todd Mason, and Corby Baumann</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:<span style="text-decoration: underline">faith.charles@thompsonhine.com</span>;<span style="text-decoration: underline">todd.mason@thompsonhine.com</span>;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">corby.baumann@thompsonhine.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">If
to the Surviving Corporation or the Company following the Closing</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, California 92123</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Jack K. Heilbron, CEO</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
jheilbron@presidiopt.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
Ogier Global (Cayman) Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89
Nexus Way, Camana Bay</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand
Cayman, KY1-9009</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Dr. Andrew Regan; James Bligh</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<span style="text-decoration: underline">ar@corvus.com</span>; jb@conduitpharma.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
copies (which shall not constitute notice) to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31st Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Darrin Ocasio, Esq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
dmocasio@srf.law</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thompson
Hine LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335
Madison Avenue</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12th
Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10017-4611</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Faith Charles, Todd Mason, and Corby Baumann</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:<span style="text-decoration: underline">faith.charles@thompsonhine.com</span>;<span style="text-decoration: underline">todd.mason@thompsonhine.com</span>;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">corby.baumann@thompsonhine.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 298; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.2</b> <span style="text-decoration: underline">Severability</span>. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any
rule of Law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect
so long as the economic or legal substance of the Transactions is not affected in any manner materially adverse to any Party. Upon such
determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties hereto shall negotiate
in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a mutually acceptable
manner in order that the Transactions be consummated as originally contemplated to the fullest extent possible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.3 </b><span style="text-decoration: underline">Entire Agreement; Assignment</span>. This Agreement and the Ancillary Agreements constitute the entire agreement among the Parties
with respect to the subject matter hereof and supersede, except as set forth in Section 7.2(b), all prior agreements and undertakings,
both written and oral, among the Parties, or any of them, with respect to the subject matter hereof, except for the Confidentiality Agreement.
This Agreement shall not be assigned (whether pursuant to a merger, by operation of law or otherwise) by any Party without the prior
express written consent of the other Parties hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.4</b> <span style="text-decoration: underline">Parties in Interest</span>. This Agreement shall be binding upon and inure solely to the benefit of each Party hereto, and nothing
in this Agreement, express or implied, is intended to or shall confer upon any other Person any right, benefit or remedy of any nature
whatsoever under or by reason of this Agreement, other than Section 7.5 (which is intended to be for the benefit of the Persons covered
thereby and may be enforced by such Persons).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.5</b> <span style="text-decoration: underline">Governing Law</span>. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware,
without regard to any conflict of law rule or principle that would result in the application of any laws other than the laws of the State
of Delaware. All Actions and proceedings arising out of or relating to this Agreement (whether in contract, tort or otherwise and whether
seeking monetary or equitable relief) shall be heard and determined exclusively in the Delaware Court of Chancery (or, only if the Delaware
Court of Chancery declines to accept jurisdiction over a particular matter, the Delaware Supreme Court or the United States District
Court for the District of Delaware), and any appellate court from any thereof. The Parties hereto hereby (a) irrevocably submit to the
exclusive jurisdiction of the aforesaid courts for themselves and with respect to their respective properties for the purpose of any
Action arising out of or relating to this Agreement brought by any Party, and (b) agree not to commence any Action relating thereto except
in the courts described above in Delaware, other than Actions in any court of competent jurisdiction to enforce any judgment, decree
or award rendered by any such court in Delaware as described herein. Each of the Parties further agrees that notice as provided herein
shall constitute sufficient service of process and the Parties further waive any argument that such service is insufficient. Each of
the Parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or
otherwise, in any Action arising out of or relating to this Agreement or the Transactions, (a) any claim that it is not personally subject
to the jurisdiction of the courts in Delaware as described herein for any reason, (b) that it or its property is exempt or immune from
jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior
to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the Action in any such
court is brought in an inconvenient forum, (ii) the venue of such Action is improper or (iii) this Agreement, or the subject matter hereof,
may not be enforced in or by such courts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 299; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.6 <span style="text-decoration: underline">WAIVER OF JURY TRIAL</span>. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT
IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS
AGREEMENT OR THE TRANSACTIONS. EACH OF THE PARTIES HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THAT FOREGOING
WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS, AS APPLICABLE,
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 11.6.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.7</b> Headings. The descriptive headings contained in this Agreement are included for convenience of reference only and shall not
affect in any way the meaning or interpretation of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.8</b> <span style="text-decoration: underline">Counterparts</span>. This Agreement may be executed and delivered (including by facsimile or portable document format (.pdf)
transmission) in counterparts, and by the different Parties hereto in separate counterparts, each of which when executed shall be deemed
to be an original but all of which taken together shall constitute one and the same agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.9</b> <span style="text-decoration: underline">Specific Performance</span>. The Parties agree that irreparable damage would occur if any provision of this Agreement were not
performed in accordance with the terms hereof, and, accordingly, that the Parties shall, prior to a valid termination of this Agreement,
be entitled to seek an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of
the terms and provisions hereof (including the Parties&#8217; obligation to consummate the Merger) in the Delaware Court of Chancery
(or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, the Delaware Supreme Court or the
United States District Court for the District of Delaware), and any appellate court from any thereof, without proof of actual damages
or otherwise, in addition to any other remedy to which they are entitled at law or in equity as expressly permitted in this Agreement.
Each of the Parties hereby further waives (a) any defense in any action for specific performance that a remedy at law would be adequate
and (b) any requirement under any Law to post security or a bond as a prerequisite to obtaining equitable relief.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
11.10 </b><span style="text-decoration: underline">Legal Representation</span>. The Parties agree that, notwithstanding the fact that Sichenzia Ross Ference LLP may have, prior
to Closing, jointly represented Murphy and/or Merger Sub in connection with this Agreement, the Ancillary Documents and the transactions
contemplated hereby and thereby, and has also represented Murphy and/or its Affiliates in connection with matters other than the transaction
that is the subject of this Agreement, Sichenzia Ross Ference LLP will be permitted in the future, after Closing, to represent Sponsor
or its Affiliates in connection with matters in which such Persons are adverse to Murphy or any of its Affiliates, including any disputes
arising out of, or related to, this Agreement. The Company, who is or has the right to be represented by independent counsel in connection
with the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any
actual or potential conflict of interest that may hereafter arise in connection with Sichenzia Ross Ference LLP&#8217;s future representation
of one or more of Sponsor or their respective Affiliates in which the interests of such Person are adverse to the interests of Murphy,
the Company or any of their respective Affiliates, including any matters that arise out of this Agreement or that are substantially related
to this Agreement or to any prior representation by Sichenzia Ross Ference LLP of Murphy, Merger Sub, or any of their respective Affiliates.
The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, Sponsor and Murphy shall be deemed the clients
of Sichenzia Ross Ference LLP with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents.
All such communications shall remain privileged after the Closing and the privilege and the expectation of client confidence relating
thereto shall belong solely to Sponsor and Murphy, shall be controlled by Sponsor and Murphy and shall not pass to or be claimed by Murphy
post-Closing; provided, further, that nothing contained herein shall be deemed to be a waiver by Murphy or any of its Affiliates (including,
after the Effective Time) of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications
to any third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>signature
Page Follows</i>]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 300; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date first written above by their respective officers
thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MURPHY
    CANYON ACQUISITION CORP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s
    Jack K. Heilbron&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDUIT
    MERGER SUB, INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jack K. Heilbron</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDUIT
    PHARMACEUTICALS LIMITED</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Dr. Andrew Regan</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Andrew Regan</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 301; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">LIST
OF EXHIBITS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
    A</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization
    Table </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
    B</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Amended Charter</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>EXHIBIT
    C</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Amended Bylaws</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
    D</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Surviving Corporation Certificate of Incorporation and Articles and Memorandum of Association</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 302; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="annex_002"></span>Annex
A-2</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">AMENDMENT
TO AGREEMENT AND PLAN OF MERGER</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this &#8220;<span style="text-decoration: underline">Amendment</span>&#8221;), dated as of January 27, 2023 (the &#8220;<span style="text-decoration: underline">Effective
Date</span>&#8221;), is made and entered into by and among Murphy Canyon Acquisition Corp., a Delaware corporation (&#8220;<span style="text-decoration: underline">Murphy</span>&#8221;),
Conduit Merger Sub, Inc., a Cayman Islands exempted company (&#8220;<span style="text-decoration: underline">Merger Sub</span>&#8221;), and Conduit Pharmaceuticals Limited, a
Cayman Islands exempted company (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;). Capitalized terms used herein and not otherwise defined will have
the meanings ascribed to such terms in the Merger Agreement (as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Parties entered into that certain Agreement and Plan of Merger on November 8, 2022 (the &#8220;<span style="text-decoration: underline">Merger Agreement</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Pursuant to Section 9.4 of the Merger Agreement, the Parties may amend the Merger Agreement by an agreement in writing signed by the
Parties at any time prior to the Effective Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Parties desire to amend the Merger Agreement as set forth in this Amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, intending to be legally bound hereby, the Parties agree as follows, as of the Effective
Date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<span style="text-decoration: underline">Amendments to the Merger Agreement</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The definitions of &#8220;<span style="text-decoration: underline">Exchange Ratio</span>&#8221; and &#8220;<span style="text-decoration: underline">Murphy Common Stock</span>&#8221; are amended and restated in their
entirety as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;&#8216;<span style="text-decoration: underline">Exchange
Ratio</span>&#8217; means the quotient of (a) the Merger Consideration, <span style="text-decoration: underline">divided by</span> (b) the number of shares of Company Capital Stock,
<span style="text-decoration: underline">divided by</span> (c) ten dollars ($10).&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;&#8216;<span style="text-decoration: underline">Murphy
Common Stock</span>&#8217; means, at all times prior to the Effective Time, Murphy Class A Common Stock and Murphy Class B Common Stock,
collectively, and at all times as of and from the Effective Time, Murphy&#8217;s common stock, par value $0.0001 per share, as set forth
in Article IV of the Amended Charter.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Section 2.5 is amended and restated in its entirety as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63.35pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Section
2.5 </b><span style="text-decoration: underline">Directors</span>. Immediately after the Closing, the size and composition of the board of directors of each of the Surviving
Corporation and Murphy shall be mutually determined by Murphy and the Company, provided that the board of directors of each of Murphy
and the Surviving Corporation shall consist of no more than nine (9) directors, at least a majority of whom shall be independent directors
satisfying the independence requirements of the Securities Act and the Nasdaq rules.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 303 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Section 3.1(c) is amended and restated in its entirety as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63.35pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;(c)
<span style="text-decoration: underline">Murphy Class A Common Stock and Murphy Class B Common Stock</span>. At the Closing and immediately prior to the Effective Time, in connection
with filing the Amended Charter pursuant to <span style="text-decoration: underline">Section 2.4(a)</span> hereof, each share of Murphy Class B Common Stock shall automatically
convert into and become one validly issued, fully paid and non-assessable share of Murphy Class A Common Stock, and by virtue of the
Merger and without any action on the part of Murphy, Merger Sub or the Company, each share of Murphy Class A Common Stock shall automatically
convert into and become one validly issued, fully paid and non-assessable share of one class of Murphy common stock, par value $0.001.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Section 3.2(b) is hereby amended by deleting the reference to &#8220;Class A&#8221; such that Section 3.2(b) is amended and restated
in its entirety as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63.35pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;(b)
No certificates or scrip representing fractional Murphy Common Stock will be issued pursuant to the Merger, and such fractional share
interests will not entitle the owner thereof to vote or to any rights of a shareholder of Murphy. If a holder would be entitled to receive
a fractional interest in a share of Murphy Common Stock, the amount of shares of Murphy Common Stock will be rounded down to the nearest
whole number of the number of shares of Murphy Common Stock to be issued to such holder.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Section 8.3(e) is hereby amended and restated in its entirety as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 63.35pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;(e)
<span style="text-decoration: underline">Equity Incentive Plan</span>. Murphy, in consultation with, and based on the recommendations of, a compensation consultant, shall have
agreed to a new equity incentive plan for Murphy to be in effect following the Closing Date with customary market terms for comparable
public companies and with an initial share reserve of no more than twelve and one-half percent (12.5%) of Murphy&#8217;s fully diluted
common stock immediately outstanding after Closing.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 304; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Section 7 is hereby amended by inserting the following provision at the end of such section:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Section
7.16</b> Murphy shall, within fifteen (15) Business Days after the Closing, use reasonable best efforts to file with the SEC (at its
sole cost and expense) a registration statement (the &#8220;<span style="text-decoration: underline">Resale Registration Statement</span>&#8221;) registering the resale of 4,060,250
shares of Murphy Common Stock held by the Sponsor or its designees and 754,000 shares of Murphy Common Stock issuable upon exercise of
the Murphy Private Placement Warrants held by the Sponsor or its designees, and Murphy shall use reasonable best efforts to cause such
Resale Registration Statement to become effective within 60 Business Days following the Closing. Murphy agrees that it will use its reasonable
best efforts to cause such Resale Registration Statement or another registration statement (which may be a &#8220;shelf&#8221; registration
statement) to remain effective until the earlier of (i) the date on which the Sponsor or its designees cease to hold the Registrable
Securities covered by such Resale Registration Statement, or (iii) on the first date on which the Sponsor or its designees can sell all
of its Registrable Securities under Rule 144 promulgated under the Securities Act (&#8220;<span style="text-decoration: underline">Rule 144</span>&#8221;) without limitation
as to the manner of sale or the amount of such equity interests that may be sold. If the SEC prevents Murphy from including any or all
of the Registrable Securities proposed to be registered for resale under the Resale Registration Statement due to limitations on the
use of Rule 415 of the Securities Act for the resale of Murphy&#8217;s Registrable Securities by the applicable stockholders or otherwise,
(i) such Resale Registration Statement shall register for resale such number of Murphy registrable securities which is equal to the maximum
number of Murphy registrable securities as is permitted by the SEC and (ii) the number of Murphy registrable securities to be registered
for each selling stockholder named in the Resale Registration Statement shall be reduced pro rata among all such selling stockholders.
&#8220;Registrable Securities&#8221; shall include the shares of Murphy Common Stock referenced in the first sentence of this Section
7.16 and any other equity security of the of Murphy issued or issuable with respect to the Registrable Securities by way of share split,
dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise, but not, for the avoidance of
doubt, any other equity security of Murphy owned or acquired by the Sponsor or its designees. For as long as the Sponsor or its designees
holds the Registrable Securities, Murphy shall (A) make and keep public information available, as those terms are understood and defined
in Rule 144, (B) file in a timely manner all reports and other documents with the SEC required under the Exchange Act, as long as Murphy
remains subject to such requirements, and (C) provide all customary and reasonable cooperation necessary, in each case, to enable Subscriber
or its designees to resell the Registrable Securities pursuant to the Resale Registration Statement or Rule 144 (when Rule 144 becomes
available to the Sponsor or its designees), as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Amended Charter attached as Exhibit B to the Merger Agreement is here by amended and restated in its entirety as set forth in Exhibit
A to this Amendment. All references to the Amended Charter in the Merger Agreement shall refer to the Amended Charter attached hereto
as Exhibit A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<span style="text-decoration: underline">No Further Amendments</span>. Except as expressly modified by this Amendment, the Merger Agreement will remain unmodified and in full
force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<span style="text-decoration: underline">Counterparts</span>. This Agreement may be executed and delivered (including by facsimile or portable document format (.pdf) transmission)
in counterparts, and by the different Parties hereto in separate counterparts, each of which when executed shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<span style="text-decoration: underline">Conflict</span>. To the extent there is a conflict between the terms and provisions of this Amendment and the Merger Agreement, the terms
and provisions of this Amendment will govern as to such conflict.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[SIGNATURES
BEGIN ON FOLLOWING PAGE]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 305; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have caused this Amendment to be executed and delivered as of the Effective Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
    CANYON ACQUISITION CORP.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jack K. Heilbron</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</span><span style="font-family: Times New Roman, Times, Serif">:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
    MERGER SUB, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jack K. Heilbron</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
    PHARMACEUTICALS LIMITED</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Andrew Regan</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Andrew Regan</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:   </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Amendment to Agreement and Plan of Merger]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 306; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form
of Amended Charter</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 307 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="A3_001"></span>Annex
A-3</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">SECOND
AMENDMENT TO AGREEMENT AND PLAN OF MERGER</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this &#8220;<span style="text-decoration: underline">Amendment</span>&#8221;), dated as of May 11, 2023 (the &#8220;<span style="text-decoration: underline">Effective
Date</span>&#8221;), is made and entered into by and among Murphy Canyon Acquisition Corp., a Delaware corporation (&#8220;<span style="text-decoration: underline">Murphy</span>&#8221;),
Conduit Merger Sub, Inc., a Cayman Islands exempted company (&#8220;<span style="text-decoration: underline">Merger Sub</span>&#8221;), and Conduit Pharmaceuticals Limited, a
Cayman Islands exempted company (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;). Capitalized terms used herein and not otherwise defined will have
the meanings ascribed to such terms in the Merger Agreement (as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Parties entered into that certain Agreement and Plan of Merger on November 8, 2022 (the &#8220;<span style="text-decoration: underline">Original Merger Agreement</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
T<span style="background-color: white">he Original Merger Agreement was amended by the Amendment to Agreement and Plan of Merger (the
&#8220;<span style="text-decoration: underline">First Amendment</span>&#8221;) dated as of January 27, 2023 (the Original Merger Agreement as amended by the First Amendment is
referred to herein as the &#8220;<span style="text-decoration: underline">Merger Agreement</span>&#8221;)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Pursuant to Section 9.4 of the Merger Agreement, the Parties may amend the Merger Agreement by an agreement in writing signed by the
Parties at any time prior to the Effective Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
The Parties desire to amend the Merger Agreement as set forth in this Amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, intending to be legally bound hereby, the Parties agree as follows, as of the Effective
Date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<span style="text-decoration: underline">Amendments to the Merger Agreement</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Section 7.7(d) is amended and restated in its entirety as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;(d)
If, in connection with the preparation and filing of the Registration Statement/Proxy Statement, if the SEC requires that an opinion
of counsel be provided with respect to the tax treatment of the Transactions, Murphy and the Company shall deliver to counsel for both
Parties, respectively, customary Tax representation letters satisfactory to each counsel, dated and executed as of the date the Registration
Statement shall have been declared effective by the SEC and such other date(s) as determined reasonably necessary by such counsel.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Section 8.1(j) is amended and restated in its entirety as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;(j)
<span style="text-decoration: underline">Net Tangible Assets Test</span>. Upon the Closing, Murphy (i) shall not have redeemed shares of Murphy Class A Common Stock in the Offer
in an amount that would cause Murphy to have less than $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1)
under the Exchange Act) or (ii) shall otherwise be exempt from the provisions of Rule 419 promulgated under the Securities Act.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Section 9.1(b) is amended and restated in its entirety as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;(b)
by either Murphy or the Company if the Effective Time shall not have occurred prior to February 7, 2024 (the &#8220;<span style="text-decoration: underline">Outside Date</span>&#8221;);
<span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that this Agreement may not be terminated under this <span style="text-decoration: underline">Section 9.1(b)</span> by or on behalf of any Party
that either directly or indirectly through its Affiliates is in breach or violation of any representation, warranty, covenant, agreement
or obligation contained herein and such breach or violation is the principal cause of the failure of a condition set forth in <span style="text-decoration: underline">Article
VIII</span> on or prior to the Outside Date;&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<span style="text-decoration: underline">No Further Amendments</span>. Except as expressly modified by this Amendment, the Merger Agreement will remain unmodified and in full
force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<span style="text-decoration: underline">Counterparts</span>. This Amendment may be executed and delivered (including by facsimile or portable document format (.pdf) transmission)
in counterparts, and by the different Parties hereto in separate counterparts, each of which when executed shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<span style="text-decoration: underline">Conflict</span>. To the extent there is a conflict between the terms and provisions of this Amendment and the Merger Agreement, the terms
and provisions of this Amendment will govern as to such conflict.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[SIGNATURES
BEGIN ON FOLLOWING PAGE]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 308; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have caused this Amendment to be executed and delivered as of the Effective Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
    CANYON ACQUISITION CORP.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jack K. Heilbron</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
    MERGER SUB, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jack K. Heilbron</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
    PHARMACEUTICALS LIMITED</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Andrew Regan</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Andrew Regan</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Second Amendment to Agreement and Plan of Merger]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 309 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="annex_003"></span>Annex
B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECOND
AMENDED AND RESTATED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF INCORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
CANYON ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;&#160;
], 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the &#8220;Corporation&#8221;),
DOES HEREBY CERTIFY AS FOLLOWS:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The present name of the Corporation is &#8220;Murphy Canyon Acquisition Corp&#8221;. The original certificate of incorporation of the
Corporation was filed with the Secretary of State of the State of Delaware on October 19, 2021 (the &#8220;Original Certificate&#8221;).
The Corporation amended and restated the Original Certificate, which was filed with the Secretary of State of the State of Delaware on
February 2, 2022 (&#8220;First Amended and Restated Certificate&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
This Second Amended and Restated Certificate of Incorporation (the &#8220;Second Amended and Restated Certificate&#8221;), which both
restates and amends the provisions of the First Amended and Restated Certificate, was duly adopted in accordance with Sections 228, 242
and 245 of the General Corporation Law of the State of Delaware, as amended from time to time (the &#8220;DGCL&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
This Second Amended and Restated Certificate shall become effective on the date of filing with the Secretary of State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The text of the First Amended and Restated Certificate is hereby restated and amended in its entirety to read as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAME</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
name of the corporation is Conduit Pharmaceuticals Inc. (the &#8220;Corporation&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURPOSE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL. The Corporation
is to have a perpetual existence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTERED
AGENT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
address of the Corporation&#8217;s registered office in the State of Delaware is 1209 Orange Street, Wilmington, Delaware 19801, New
Castle County. The name of the Corporation&#8217;s registered agent at such address is National Registered Agents, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.1 <span style="text-decoration: underline">Authorized Capital Stock</span>. The total number of shares of all classes of capital stock, each with a par value of $0.0001 per
share, which the Corporation is authorized to issue is 251,000,000 shares, consisting of (a) 250,000,000 shares of common stock (the
&#8220;Common Stock&#8221;), and (b) 1,000,000 shares of preferred stock (the &#8220;Preferred Stock&#8221;). Upon the filing and effectiveness
of the Second Amended and Restated Certificate (the &#8220;Effective Time&#8221;), each share of Class A Common Stock, par value $0.0001
per share, of the Corporation issued and outstanding immediately prior to the Effective Time shall, automatically and without any further
action by the Corporation or any stockholder, be reclassified into one fully paid and nonassessable share of Common Stock. The number
of authorized shares of Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the
affirmative vote of the holders of a majority in voting power of the stock of the Corporation with the power to vote thereon irrespective
of the provisions of Section 242(b)(2) of the DGCL or any successor provision thereof, and no vote of the holders of any of the Common
Stock or Preferred Stock voting separately as a class shall be required therefor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 310 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.2 <span style="text-decoration: underline">Preferred Stock</span>. The Board of Directors of the Corporation (the &#8220;Board&#8221;) is hereby expressly authorized to provide
out of the unissued shares of the Preferred Stock for one or more series of Preferred Stock and to establish from time to time the number
of shares to be included in each such series and to fix the voting rights, if any, designations, powers, preferences and relative, participating,
optional, special and other rights, if any, of each such series and any qualifications, limitations and restrictions thereof, as shall
be stated in the resolution or resolutions adopted by the Board providing for the issuance of such series and included in a certificate
of designation (a &#8220;Preferred Stock Designation&#8221;) filed pursuant to the DGCL, and the Board is hereby expressly vested with
the authority to the full extent provided by law, now or hereafter, to adopt any such resolution or resolutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.3 <span style="text-decoration: underline">Common Stock</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<i>Voting</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Except as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), the
holders of the Common Stock shall exclusively possess all voting power with respect to the Corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Except as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), the
holders of shares of Common Stock shall be entitled to one vote for each such share on each matter properly submitted to the stockholders
on which the holders of the Common Stock are entitled to vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Except as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), at any
annual or special meeting of the stockholders of the Corporation, holders of Common Stock, shall have the exclusive right to vote for
the election of directors and on all other matters properly submitted to a vote of the stockholders. Notwithstanding the foregoing, except
as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), holders of
shares of Common Stock shall not be entitled to vote on any amendment to this Second Amended and Restated Certificate (including any
amendment to any Preferred Stock Designation) that relates solely to the terms of one or more outstanding series of Preferred Stock if
the holders of such affected series of Preferred Stock are entitled exclusively, either separately or together with the holders of one
or more other such series, to vote thereon pursuant to this Second Amended and Restated Certificate (including any Preferred Stock Designation)
or the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<i>Dividends</i>. Subject to applicable law and the rights, if any, of the holders of any outstanding series of the Preferred Stock,
the holders of shares of Common Stock shall be entitled to receive such dividends and other distributions (payable in cash, property
or capital stock of the Corporation) when, as and if declared thereon by the Board from time to time out of any assets or funds of the
Corporation legally available therefor and shall share equally on a per share basis in such dividends and distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<i>Liquidation, Dissolution or Winding Up of the Corporation</i>. Subject to applicable law and the rights, if any, of the holders of
any outstanding series of the Preferred Stock, in the event of any voluntary or involuntary liquidation, dissolution or winding up of
the Corporation, after payment or provision for payment of the debts and other liabilities of the Corporation, the holders of shares
of Common Stock shall be entitled to receive all the remaining assets of the Corporation available for distribution to its stockholders,
ratably in proportion to the number of shares of Common Stock held by them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.4 <span style="text-decoration: underline">Rights and Options</span>. The Corporation has the authority to create and issue rights, warrants and options entitling the holders
thereof to acquire from the Corporation any shares of its capital stock of any class or classes, with such rights, warrants and options
to be evidenced by or in instrument(s) approved by the Board. The Board is empowered to set the exercise price, duration, times for exercise
and other terms and conditions of such rights, warrants or options; provided, however, that the consideration to be received for any
shares of capital stock issuable upon exercise thereof may not be less than the par value thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 311; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOARD
OF DIRECTORS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.1 <span style="text-decoration: underline">Board Powers</span>. The business and affairs of the Corporation shall be managed by, or under the direction of, the Board. In addition
to the powers and authority expressly conferred upon the Board by statute, this Second Amended and Restated Certificate or the By-Laws
of the Corporation (&#8220;By-Laws&#8221;), the Board is hereby empowered to exercise all such powers and do all such acts and things
as may be exercised or done by the Corporation, subject, nevertheless, to the provisions of the DGCL, this Second Amended and Restated
Certificate, and any By-Laws adopted by the stockholders; provided, however, that no By-Laws hereafter adopted by the stockholders shall
invalidate any prior act of the Board that would have been valid if such By-Laws had not been adopted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.2 <span style="text-decoration: underline">Number, Election and Term</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The number of directors which shall constitute the entire Board shall be the number of directors as fixed from time to time in accordance
with the By-Laws, a majority of whom shall be independent directors in accordance with The Nasdaq Stock Market LLC&#8217;s requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
A director shall hold office until the annual meeting for the year in which his or her term expires and until his or her successor has
been elected and qualified, subject, however, to such director&#8217;s earlier death, resignation, retirement, disqualification or removal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Unless and except to the extent that the By-Laws shall so require, the election of directors need not be by written ballot. The holders
of shares of Common Stock shall not have cumulative voting rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.3 <span style="text-decoration: underline">Newly Created Directorships and Vacancies</span>. Subject to Section 5.5 hereof, newly created directorships resulting from an increase
in the number of directors and any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal or
other cause may be filled solely and exclusively by a majority vote of the remaining directors then in office, even if less than a quorum,
or by a sole remaining director (and not by stockholders), and any director so chosen shall hold office for the remainder of the term
of the class of directors to which the new directorship was added or in which the vacancy occurred and until his or her successor has
been elected and qualified, subject, however, to such director&#8217;s earlier death, resignation, retirement, disqualification or removal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.4 <span style="text-decoration: underline">Removal</span>. Subject to Sections 5.5 hereof and except as otherwise required by this Second Amended and Restated Certificate,
any or all of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of
a majority of the voting power of all then outstanding shares of capital stock of the Corporation entitled to vote generally in the election
of directors, voting together as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.5 <span style="text-decoration: underline">Preferred Stock - Directors</span>. Notwithstanding any other provision of this Article V, and except as otherwise required by law,
whenever the holders of one or more series of the Preferred Stock shall have the right, voting separately by class or series, to elect
one or more directors, the term of office, the filling of vacancies, the removal from office and other features of such directorships
shall be governed by the terms of such series of the Preferred Stock as set forth in this Second Amended and Restated Certificate (including
any Preferred Stock Designation) and such directors shall not be included in any of the classes created pursuant to this Article V unless
expressly provided by such terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 312; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BYLAWS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
furtherance and not in limitation of the powers conferred upon it by law, the Board shall have the power and is expressly authorized
to adopt, amend, alter or repeal the By-Laws. The affirmative vote of a majority of the Board shall be required to adopt, amend, alter
or repeal the By-Laws. The By-Laws also may be adopted, amended, altered or repealed by the stockholders; provided, however, that in
addition to any vote of the holders of any class or series of capital stock of the Corporation required by law or by this Second Amended
and Restated Certificate (including any Preferred Stock Designation), the affirmative vote of the holders of at least a majority of the
voting power of all then outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors,
voting together as a single class, shall be required for the stockholders to adopt, amend, alter or repeal the By-Laws; and provided
further, however, that no By-Laws hereafter adopted by the stockholders shall invalidate any prior act of the Board that would have been
valid if such By-Laws had not been adopted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MEETINGS
OF STOCKHOLDERS; ACTION BY WRITTEN CONSENT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.1 <span style="text-decoration: underline">Meetings</span>. Subject to the rights, if any, of the holders of any outstanding series of the Preferred Stock, and to the requirements
of applicable law, special meetings of stockholders of the Corporation may be called only by the Chairman of the Board, the Chief Executive
Officer of the Corporation, or the Board pursuant to a resolution adopted by a majority of the Board, and the ability of the stockholders
of the Corporation to call a special meeting is hereby specifically denied. Except as provided in the foregoing sentence, special meetings
of stockholders of the Corporation may not be called by another person or persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.2 <span style="text-decoration: underline">Advance Notice</span>. Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders
before any meeting of the stockholders of the Corporation shall be given in the manner provided in the By-Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.3 <span style="text-decoration: underline">No Action by Written Consent</span>. Any action required or permitted to be taken by the stockholders of the Corporation shall be
taken at an annual or special meeting of stockholders of the Corporation and shall not be taken by any consent in writing by such stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIMITED
LIABILITY; INDEMNIFICATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.1 <span style="text-decoration: underline">Limitation of Director Liability</span>. A director of the Corporation shall not be personally liable to the Corporation or its stockholders
for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof
is not permitted under the DGCL as the same exists or may hereafter be amended unless they violated their duty of loyalty to the Corporation
or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful
stock purchases or unlawful redemptions, or derived improper personal benefit from their actions as directors. Any amendment, modification
or repeal of the foregoing sentence shall not adversely affect any right or protection of a director of the Corporation hereunder in
respect of any act or omission occurring prior to the time of such amendment, modification or repeal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 313; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.2 <span style="text-decoration: underline">Indemnification and Advancement of Expenses</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
To the fullest extent permitted by applicable law, as the same exists or may hereafter be amended, the Corporation shall indemnify and
hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened,
pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#8220;proceeding&#8221;)
by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the Corporation,
is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership,
joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan (an &#8220;indemnitee&#8221;),
whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other
capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without
limitation, attorneys&#8217; fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred
by such indemnitee in connection with such proceeding. The Corporation shall to the fullest extent not prohibited by applicable law pay
the expenses (including attorneys&#8217; fees) incurred by an indemnitee in defending or otherwise participating in any proceeding in
advance of its final disposition; provided, however, that, to the extent required by applicable law, such payment of expenses in advance
of the final disposition of the proceeding shall be made only upon receipt of an undertaking, by or on behalf of the indemnitee, to repay
all amounts so advanced if it shall ultimately be determined that the indemnitee is not entitled to be indemnified under this Section
8.2 or otherwise. The rights to indemnification and advancement of expenses conferred by this Section 8.2 shall be contract rights and
such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit
of his or her heirs, executors and administrators. Notwithstanding the foregoing provisions of this Section 8.2(a), except for proceedings
to enforce rights to indemnification and advancement of expenses, the Corporation shall indemnify and advance expenses to an indemnitee
in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized
by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The rights to indemnification and advancement of expenses conferred on any indemnitee by this Section 8.2 shall not be exclusive of any
other rights that any indemnitee may have or hereafter acquire under law, this Second Amended and Restated Certificate, the By-Laws,
an agreement, vote of stockholders or disinterested directors, or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any repeal or amendment of this Section 8.2 by the stockholders of the Corporation or by changes in law, or the adoption of any other
provision of this Second Amended and Restated Certificate inconsistent with this Section 8.2, shall, unless otherwise required by law,
be prospective only (except to the extent such amendment or change in law permits the Corporation to provide broader indemnification
rights on a retroactive basis than permitted prior thereto), and shall not in any way diminish or adversely affect any right or protection
existing at the time of such repeal or amendment or adoption of such inconsistent provision in respect of any proceeding (regardless
of when such proceeding is first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior
to such repeal or amendment or adoption of such inconsistent provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This Section 8.2 shall not limit the right of the Corporation, to the extent and in the manner authorized or permitted by law, to indemnify
and to advance expenses to persons other than indemnitees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BUSINESS
COMBINATIONS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation will not be subject to Section 203 of the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
X</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATE
OPPORTUNITY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent allowed by law, the doctrine of corporate opportunity, or any other analogous doctrine, shall not apply with respect to the
Corporation or any of its officers or directors, or any of their respective affiliates, in circumstances where the application of any
such doctrine would conflict with any fiduciary duties or contractual obligations they may have as of the date of this Second Amended
and Restated Certificate or in the future, and the Corporation renounces any expectancy that any of the directors or officers of the
Corporation will offer any such corporate opportunity of which he or she may become aware to the Corporation, except, the doctrine of
corporate opportunity shall apply with respect to any of the directors or officers of the Corporation with respect to a corporate opportunity
that was offered to such person solely in his or her capacity as a director or officer of the Corporation and (i) such opportunity is
one the Corporation is legally and contractually permitted to undertake and would otherwise be reasonable for the Corporation to pursue
and (ii) the director or officer is permitted to refer that opportunity to the Corporation without violating any legal obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
XI</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT
OF SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation reserves the right at any time and from time to time to amend, alter, change or repeal any provision contained in this Second
Amended and Restated Certificate (including any Preferred Stock Designation), and other provisions authorized by the laws of the State
of Delaware at the time in force that may be added or inserted, in the manner now or hereafter prescribed by this Second Amended and
Restated Certificate and the DGCL; and, except as set forth in Article VIII, all rights, preferences and privileges of whatever nature
herein conferred upon stockholders, directors or any other persons by and pursuant to this Second Amended and Restated Certificate in
its present form or as hereafter amended are granted subject to the right reserved in this Article XI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 314; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
XII</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXCLUSIVE
FORUM FOR CERTAIN LAWSUITS; CONSENT TO JURISDICTION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
12.1 <span style="text-decoration: underline">Forum</span>. Subject to the last sentence in this Section 12.1, and unless the Corporation consents in writing to the selection
of an alternative forum, to the fullest extent permitted by the applicable law, the Court of Chancery of the State of Delaware shall
be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought
on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other
employee of the Corporation to the Corporation or the Corporation&#8217;s stockholders, (iii) any action asserting a claim against the
Corporation, its directors, officers or employees arising pursuant to any provision of the DGCL or this Second Amended and Restated Certificate
or the By-Laws, or (iv) any action asserting a claim against the Corporation, its directors, officers or employees governed by the internal
affairs doctrine and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of
process on such stockholder&#8217;s counsel except any action (A) as to which the Court of Chancery in the State of Delaware determines
that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent
to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive
jurisdiction of a court or forum other than the Court of Chancery, or (C) for which the Court of Chancery does not have subject matter
jurisdiction. Notwithstanding the foregoing, (i) the provisions of this Section 12.1 will not apply to suits brought to enforce any liability
or duty created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction and (ii) to the fullest
extent permitted by the applicable law, the federal district courts of the United States of America for the District of Delaware and
the Court of Chancery of the State of Delaware shall have concurrent jurisdiction for the resolution of any complaint asserting a cause
of action arising under the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
12.2 <span style="text-decoration: underline">Consent to Jurisdiction</span>. If any action the subject matter of which is within the scope of Section 12.1 immediately above
is filed in a court other than a court located within the State of Delaware (a &#8220;Foreign Action&#8221;) in the name of any stockholder,
such stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts located within the
State of Delaware in connection with any action brought in any such court to enforce Section 12.1 immediately above (an &#8220;FSC Enforcement
Action&#8221;) and (ii) having service of process made upon such stockholder in any such FSC Enforcement Action by service upon such
stockholder&#8217;s counsel in the Foreign Action as agent for such stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
12.3 <span style="text-decoration: underline">Severability</span>. If any provision or provisions of this Article XII shall be held to be invalid, illegal or unenforceable as
applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity,
legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Article XII (including,
without limitation, each portion of any sentence of this Article XII containing any such provision held to be invalid, illegal or unenforceable
that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and
circumstances shall not in any way be affected or impaired thereby. Any person or entity purchasing or otherwise acquiring any interest
in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article XII.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Remainder
of page intentionally left blank]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page Follows]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 315; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused this Second Amended and Restated Certificate to be duly executed and acknowledged in its
name and on its behalf by an authorized officer as of the date first set forth above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Second Amended and Restated Certificate of Incorporation]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 316; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="annex_004"></span>Annex
C</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDUIT
PHARMACEUTICALS INC.<br />
2023 STOCK INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
I.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURPOSE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan&#8217;s purpose is to enhance the Company&#8217;s ability to attract, retain and motivate persons who make (or are expected to make)
important contributions to the Company by providing these individuals with equity ownership opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
II.<br />
DEFINITIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in the Plan, the following words and phrases have the meanings specified below, unless the context clearly indicates otherwise:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 &#8220;<span style="text-decoration: underline">Administrator</span>&#8221;
means the Board or a Committee to the extent that the Board&#8217;s powers or authority under the Plan have been delegated to such Committee.
With reference to the Board&#8217;s or a Committee&#8217;s powers or authority under the Plan that have been delegated to one or more
officers pursuant to Section 4.2, the term &#8220;Administrator&#8221; shall refer to such officer(s) unless and until such delegation
has been revoked.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2 &#8220;<span style="text-decoration: underline">Applicable
Law</span>&#8221; means any applicable law, including without limitation: (a) provisions of the Code, the Securities Act, the Exchange Act
and any rules or regulations thereunder; (b) corporate, securities, tax or other laws, statutes, rules, requirements or regulations,
whether federal, state, local or foreign; and (c) rules of any securities exchange or automated quotation system on which the Shares
are listed, quoted or traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3 &#8220;<span style="text-decoration: underline">Award</span>&#8221;
means an Option, Stock Appreciation Right, Restricted Stock award, Restricted Stock Unit award, Performance Stock Unit award, Dividend
Equivalents award or Other Stock or Cash Based Award granted to a Participant under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4 &#8220;<span style="text-decoration: underline">Award
Agreement</span>&#8221; means an agreement evidencing an Award, which may be written or electronic, that contains such terms and conditions
as the Administrator determines, consistent with and subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 &#8220;<span style="text-decoration: underline">Board</span>&#8221;
means the Board of Directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 317 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6 &#8220;<span style="text-decoration: underline">Cause</span>&#8221;
shall have the meaning ascribed to such term, or term of similar effect, in any offer letter, employment, severance or similar agreement,
including any Award Agreement, between the Participant and the Company or any Subsidiary; provided, that in the absence of an offer letter,
employment, severance or similar agreement containing such definition, Cause means, with respect to a Participant, the occurrence of
any of the following: (a) an act of dishonesty made by the Participant in connection with the Participant&#8217;s responsibilities as
a Service Provider; (b) the Participant&#8217;s conviction of, or plea of <i>nolo contendere</i> to, a felony or any crime involving
fraud, embezzlement or any other act of moral turpitude, or a material violation of federal or state law (or equivalent in any non-U.S.
jurisdiction) by the Participant that the Administrator reasonably determines has had or will have a material detrimental effect on the
Company&#8217;s reputation or business; (c) the Participant&#8217;s gross misconduct; (d) the Participant&#8217;s unauthorized use or
disclosure of any proprietary information or trade secrets of the Company or any other party to whom the Participant owes an obligation
of nondisclosure as a result of the Participant&#8217;s relationship with the Company or any Subsidiary; (e) the Participant&#8217;s
breach of any material obligations under any written agreement or covenant with the Company or any Subsidiary; (f) the Participant&#8217;s
continued substantial failure to perform the Participant&#8217;s duties as a Service Provider (other than as a result of the Participant&#8217;s
physical or mental incapacity) after the Participant has received a written demand for performance that specifically sets forth the factual
basis for the determination that the Participant has not substantially performed the Participant&#8217;s duties and has failed to cure
such non-performance to the Administrator&#8217;s reasonable satisfaction within 30 business days after receiving such notice; (g) the
Participant&#8217;s violation of the Company&#8217;s code of ethics; or (h) the Participant&#8217;s disregard of the policies of the
Company or any Subsidiary so as to cause loss, harm, damage or injury to the property, reputation or employees of the Company or a Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7 &#8220;<span style="text-decoration: underline">Change
in Control</span>&#8221; means any of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
consummation of a transaction or series of transactions (other than an offering of Common Stock to the general public through a registration
statement filed with the Securities and Exchange Commission) whereby any &#8220;person&#8221; or related &#8220;group&#8221; of &#8220;persons&#8221;
(as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act) directly or indirectly acquires beneficial ownership (within
the meaning of Rules 13d-3 and 13d-5 under the Exchange Act) of the Company&#8217;s securities possessing more than 50% of the total
combined voting power of the Company&#8217;s securities outstanding immediately after such acquisition; provided, however, that the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by the Company or any of its Subsidiaries; (ii) any acquisition
by an employee benefit plan maintained by the Company or any of its Subsidiaries, (iii) any acquisition which complies with clauses (c)(i),
(c)(ii) and (c)(iii) of this definition; or (iv) in respect of an Award held by a particular Participant, any acquisition by the Participant
or any group of persons including the Participant (or any entity controlled by the Participant or any group of persons including the
Participant);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Incumbent Directors cease for any reason to constitute a majority of the Board;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 318; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries)
of (x) a merger, consolidation, reorganization, or business combination, (y) a sale or other disposition of all or substantially all
of the Company&#8217;s assets in any single transaction or series of related transactions or (z) the acquisition of assets or stock of
another entity, in each case other than a transaction:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &#160;which results in the Company&#8217;s voting securities outstanding immediately before the transaction
continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that,
as a result of the transaction, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all
of the Company&#8217;s assets or otherwise succeeds to the business of the Company (the Company or such person, the &#8220;Successor
Entity&#8221;)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity&#8217;s outstanding
voting securities immediately after the transaction;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) &#160;after which no person or group beneficially owns voting securities representing 50% or more
of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this
clause (c)(ii) as beneficially owning 50% or more of the combined voting power of the Successor Entity solely as a result of the voting
power held in the Company prior to the consummation of the transaction; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) after
which at least a majority of the members of the board of directors (or the analogous governing body) of the Successor Entity were Board
members at the time of the Board&#8217;s approval of the execution of the initial agreement providing for such transaction; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
completion of a liquidation or dissolution of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, in no event will the transactions contemplated by the Merger Agreement or the transactions occurring in connection therewith
constitute a Change in Control, and if a Change in Control constitutes a payment event with respect to any Award (or any portion of an
Award) that provides for the deferral of compensation that is subject to Section 409A, to the extent required to avoid the imposition
of additional taxes under Section 409A, the transaction or event described in subsection (a), (b), (c) or (d) of this definition with
respect to such Award (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such Award
if such transaction also constitutes a &#8220;change in control event,&#8221; as defined in Treasury Regulation Section 1.409A-3(i)(5).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator shall have full and final authority, which shall be exercised in its sole discretion, to determine conclusively whether
a Change in Control has occurred pursuant to the above definition, the date of such Change in Control and any incidental matters relating
thereto; provided that any exercise of authority in conjunction with a determination of whether a Change in Control is a &#8220;change
in control event&#8221; as defined in Treasury Regulation Section 1.409A-3(i)(5) shall be consistent with such regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8 &#8220;<span style="text-decoration: underline">Code</span>&#8221;
means the U.S. Internal Revenue Code of 1986, as amended, and all regulations, guidance, compliance programs and other interpretative
authority issued thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 319; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9 &#8220;<span style="text-decoration: underline">Committee</span>&#8221;
means one or more committees or subcommittees of the Board, which may include one or more Company directors or executive officers, to
the extent permitted by Applicable Law. To the extent required to comply with the provisions of Rule 16b-3, it is intended that each
member of the Committee will be, at the time the Committee takes any action with respect to an Award that is subject to Rule 16b-3, a
&#8220;non-employee director&#8221; within the meaning of Rule 16b-3; however, a Committee member&#8217;s failure to qualify as a &#8220;non-employee
director&#8221; within the meaning of Rule 16b-3 will not invalidate any Award granted by the Committee that is otherwise validly granted
under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10 &#8220;<span style="text-decoration: underline">Common
Stock</span>&#8221; means the common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11 &#8220;<span style="text-decoration: underline">Company</span>&#8221;
means Conduit Pharmaceuticals Inc., a Delaware corporation, or any successor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12 &#8220;<span style="text-decoration: underline">Consultant</span>&#8221;
means any person, including any adviser, engaged by the Company or a Subsidiary to render services to such entity if the consultant or
adviser: (i) renders bona fide services to the Company or a Subsidiary; (ii) renders services not in connection with the offer or sale
of securities in a capital-raising transaction and does not directly or indirectly promote or maintain a market for the Company&#8217;s
securities; and (iii) is a natural person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13 &#8220;<span style="text-decoration: underline">Designated
Beneficiary</span>&#8221; means, if permitted by the Company, the beneficiary or beneficiaries the Participant designates, in a manner the
Company determines, to receive amounts due or exercise the Participant&#8217;s rights if the Participant dies. Without a Participant&#8217;s
effective designation, &#8220;Designated Beneficiary&#8221; will mean the Participant&#8217;s estate or legal heirs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14 &#8220;<span style="text-decoration: underline">Director</span>&#8221;
means a Board member.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15 &#8220;<span style="text-decoration: underline">Disability</span>&#8221;
means a permanent and total disability under Section 22(e)(3) of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16 &#8220;<span style="text-decoration: underline">Dividend
Equivalents</span>&#8221; means a right granted to a Participant to receive the equivalent value (in cash or Shares) of dividends paid on
a specified number of Shares. Such Dividend Equivalent shall be converted to cash or additional Shares, or a combination of cash and
Shares, by such formula and at such time and subject to such limitations as may be determined by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17 &#8220;<span style="text-decoration: underline">DRO</span>&#8221;
means a &#8220;domestic relations order&#8221; as defined by the Code or Title I of the Employee Retirement Income Security Act of 1974,
as amended, or the rules thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18 &#8220;<span style="text-decoration: underline">Effective
Date</span>&#8221; has the meaning set forth in Section 11.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19 &#8220;<span style="text-decoration: underline">Employee</span>&#8221;
means any employee of the Company or any of its Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20 &#8220;<span style="text-decoration: underline">Equity
Restructuring</span>&#8221; means a nonreciprocal transaction between the Company and its stockholders, such as a stock dividend, stock
split (including a reverse stock split), spin-off or recapitalization through a large, nonrecurring cash dividend, that affects the number
or kind of Shares (or other Company securities) or the share price of Common Stock (or other Company securities) and causes a change
in the per share value of the Common Stock underlying outstanding Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 320; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21 &#8220;<span style="text-decoration: underline">Exchange
Act</span>&#8221; means the U.S. Securities Exchange Act of 1934, as amended, and all regulations, guidance and other interpretative authority
issued thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22 &#8220;<span style="text-decoration: underline">Fair
Market Value</span>&#8221; means, as of any date, the value of a Share determined as follows: (i) if the Common Stock is listed on any established
stock exchange, the value of a Share will be the closing sales price for a Share as quoted on such exchange for such date, or if no sale
occurred on such date, the last day preceding such date during which a sale occurred, as reported in <i>The Wall Street Journal</i> or
another source the Administrator deems reliable; (ii) if the Common Stock is not listed on an established stock exchange but is quoted
on a national market or other quotation system, the value of a Share will be the closing sales price for a Share on such date, or if
no sales occurred on such date, then on the last date preceding such date during which a sale occurred, as reported in <i>The Wall Street
Journal</i> or another source the Administrator deems reliable; or (iii) if the Common Stock is not listed on any established stock exchange
or quoted on a national market or other quotation system, the value established by the Administrator in its sole discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23 &#8220;<span style="text-decoration: underline">Greater
Than 10% Stockholder</span>&#8221; means an individual then owning (within the meaning of Section 424(d) of the Code) more than 10% of the
total combined voting power of all classes of stock of the Company or any parent corporation or subsidiary corporation of the Company,
as determined in accordance with Section 424(e) and (f) of the Code, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24 &#8220;<span style="text-decoration: underline">Incentive
Stock Option</span>&#8221; means an Option that meets the requirements to qualify as an &#8220;incentive stock option&#8221; as defined
in Section 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25 &#8220;<span style="text-decoration: underline">Incumbent
Directors</span>&#8221; means, for any period of 12 consecutive months, individuals who, at the beginning of such period, constitute the
Board together with any new Director(s) (other than a Director designated by a person who shall have entered into an agreement with the
Company to effect a transaction described in clause (a) or (c) of the Change in Control definition) whose election or nomination for
election to the Board was approved by a vote of at least a majority (either by a specific vote or by approval of the proxy statement
of the Company in which such person is named as a nominee for Director without objection to such nomination) of the Directors then still
in office who either were Directors at the beginning of the 12-month period or whose election or nomination for election was previously
so approved. No individual initially elected or nominated as a director of the Company as a result of an actual or threatened election
contest with respect to Directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person
other than the Board shall be an Incumbent Director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26 &#8220;<span style="text-decoration: underline">Merger
Agreement</span>&#8221; means the Agreement and Plan of Merger by and among Murphy Canyon Acquisition Corp. Conduit Merger Sub, Inc. and
Conduit Pharmaceuticals Limited dated as of November 8, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 321; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27 &#8220;<span style="text-decoration: underline">Non-Employee
Director</span>&#8221; means a Director who is not an Employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.28 &#8220;<span style="text-decoration: underline">Nonqualified
Stock Option</span>&#8221; means an Option that is not an Incentive Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29 &#8220;<span style="text-decoration: underline">Option</span>&#8221;
means a right granted under Article VI to purchase a specified number of Shares at a specified price per Share during a specified time
period. An Option may be either an Incentive Stock Option or a Nonqualified Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30 &#8220;<span style="text-decoration: underline">Other
Stock or Cash Based Awards</span>&#8221; means cash awards, awards of Shares, and other awards valued wholly or partially by referring to,
or are otherwise based on, Shares or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31 &#8220;<span style="text-decoration: underline">Overall
Share Limit</span>&#8221; has the meaning set forth in Section 5.1 below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.32 &#8220;<span style="text-decoration: underline">Participant</span>&#8221;
means a Service Provider who has been granted an Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33 &#8220;<span style="text-decoration: underline">Performance
Stock Unit</span>&#8221; means a right granted to a Participant pursuant to Section 8.1 and subject to Section 8.2, to receive Shares, the
payment of which is contingent upon achieving certain performance goals or other performance-based targets established by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.34 &#8220;<span style="text-decoration: underline">Permitted
Transferee</span>&#8221; means, with respect to a Participant, any &#8220;family member&#8221; of the Participant, as defined in the General
Instructions to Form S-8 Registration Statement under the Securities Act (or any successor form thereto), or any other transferee specifically
approved by the Administrator after taking into account Applicable Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35 &#8220;<span style="text-decoration: underline">Plan</span>&#8221;
means this 2023 Stock Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.36 &#8220;<span style="text-decoration: underline">Restricted
Stock</span>&#8221; means Shares awarded to a Participant under Article VII, subject to certain vesting conditions and other restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.37 &#8220;<span style="text-decoration: underline">Restricted
Stock Unit</span>&#8221; means an unfunded, unsecured right granted to a Participant under Article VII to receive, on the applicable settlement
date, one Share or an amount in cash or other consideration determined by the Administrator to be of equal value as of such settlement
date, subject to certain vesting conditions and other restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.38 &#8220;<span style="text-decoration: underline">Rule
16b-3</span>&#8221; means Rule 16b-3 promulgated under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.39 &#8220;<span style="text-decoration: underline">Section
409A</span>&#8221; means Section 409A of the Code and the regulations promulgated thereunder by the United States Treasury Department, as
amended or as may be amended from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40 &#8220;<span style="text-decoration: underline">Securities
Act</span>&#8221; means the Securities Act of 1933, as amended, and all regulations, guidance and other interpretative authority issued
thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 322; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41 &#8220;<span style="text-decoration: underline">Service
Provider</span>&#8221; means an Employee, Consultant or Director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.42 &#8220;<span style="text-decoration: underline">Shares</span>&#8221;
means shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.43 &#8220;<span style="text-decoration: underline">Stock
Appreciation Right</span>&#8221; or &#8220;<span style="text-decoration: underline">SAR</span>&#8221; means a right granted under Article VI to receive a payment equal to the excess
of the Fair Market Value of a specified number of Shares on the date the right is exercised over the exercise price set forth in the
applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.44 &#8220;<span style="text-decoration: underline">Subsidiary</span>&#8221;
means any entity (other than the Company), whether U.S. or non-U.S., in an unbroken chain of entities beginning with the Company if each
of the entities other than the last entity in the unbroken chain beneficially owns, at the time of the determination, securities or interests
representing at least 50% of the total combined voting power of all classes of securities or interests in one of the other entities in
such chain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.45 &#8220;<span style="text-decoration: underline">Substitute
Awards</span>&#8221; means Awards granted or Shares issued by the Company in assumption of, or in substitution or exchange for, awards previously
granted, or the right or obligation to make future awards, in each case by a company or other entity acquired by the Company or any Subsidiary
or with which the Company or any Subsidiary combines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46 &#8220;<span style="text-decoration: underline">Tax-Related
Items</span>&#8221; means any U.S. and non-U.S. federal, state and/or local taxes (including, without limitation, income tax, social insurance
contributions, fringe benefit tax, employment tax, stamp tax and any employer tax liability which has been transferred to a Participant)
for which a Participant is liable in connection with Awards and/or Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.47 &#8220;<span style="text-decoration: underline">Termination
of Service</span>&#8221; means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) As
to a Consultant, the time when the engagement of a Participant as a Consultant to the Company or a Subsidiary is terminated for any reason,
with or without cause, including, without limitation, by resignation, discharge, death or retirement, but excluding terminations where
the Consultant simultaneously commences or remains in employment or service with the Company or any Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) As
to a Non-Employee Director, the time when a Participant who is a Non-Employee Director ceases to be a Director for any reason, including,
without limitation, a termination by resignation, failure to be elected, death or retirement, but excluding terminations where the Participant
simultaneously commences or remains in employment or service with the Company or any Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) As
to an Employee, the time when the employee-employer relationship between a Participant and the Company or any Subsidiary is terminated
for any reason, including, without limitation, a termination by resignation, discharge, death, disability or retirement; but excluding
terminations where the Participant simultaneously commences or remains in employment or service with the Company or any Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 323; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, in its sole discretion, shall determine the effect of all matters and questions relating to any Termination of Service, including,
without limitation, whether a Termination of Service has occurred, whether a Termination of Service resulted from a discharge for Cause
and all questions of whether particular leaves of absence constitute a Termination of Service. For purposes of the Plan, a Participant&#8217;s
employee-employer relationship or consultancy relationship shall be deemed to be terminated in the event that the Subsidiary employing
or contracting with such Participant ceases to remain a Subsidiary following any merger, sale of stock or other corporate transaction
or event (including, without limitation, a spin-off), even though the Participant may subsequently continue to perform services for that
entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
III.<br />
ELIGIBILITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein. No Service Provider shall have
any right to be granted an Award pursuant to the Plan and neither the Company nor the Administrator is obligated to treat Service Providers,
Participants or any other persons uniformly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
IV.<br />
ADMINISTRATION AND DELEGATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.1 Administration</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Plan is administered by the Administrator. The Administrator has authority to determine which Service Providers receive Awards, grant
Awards and set Award terms and conditions, subject to the conditions and limitations in the Plan. The Administrator also has the authority
to take all actions and make all determinations under the Plan, to interpret the Plan and Award Agreements and to adopt, amend and repeal
Plan administrative rules, guidelines and practices as it deems advisable. The Administrator may correct defects and ambiguities, supply
omissions, reconcile inconsistencies in the Plan or any Award and make all other determinations that it deems necessary or appropriate
to administer the Plan and any Awards. The Administrator (and each member thereof) is entitled to, in good faith, rely or act upon any
report or other information furnished to it, him or her by any officer or other employee of the Company or any Subsidiary, the Company&#8217;s
independent certified public accountants, or any executive compensation consultant or other professional retained by the Company to assist
in the administration of the Plan. The Administrator&#8217;s determinations under the Plan are in its sole discretion and will be final,
binding and conclusive on all persons having or claiming any interest in the Plan or any Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 324; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Without
limiting the foregoing, the Administrator has the exclusive power, authority and sole discretion to: (i) designate Participants; (ii)
determine the type or types of Awards to be granted to each Participant; (iii) determine the number of Awards to be granted and the number
of Shares to which an Award will relate; (iv) subject to the limitations in the Plan, determine the terms and conditions of any Award
and related Award Agreement, including, but not limited to, the exercise price, grant price, purchase price, any performance criteria,
any restrictions or limitations on the Award, any schedule for vesting, lapse of forfeiture restrictions or restrictions on the exercisability
of an Award, and accelerations, waivers or amendments thereof; (v) determine whether, to what extent, and under what circumstances an
Award may be settled in, or the exercise price of an Award may be paid in cash, Shares, or other property, or an Award may be canceled,
forfeited, or surrendered; and (vi) make all other decisions and determinations that may be required pursuant to the Plan or as the Administrator
deems necessary or advisable to administer the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.2 Delegation
of Authority</b>. To the extent permitted by Applicable Law, the Board or any Committee may delegate any or all of its powers under the
Plan to one or more Committees or officers of the Company or any of its Subsidiaries; provided, however, that in no event shall an officer
of the Company or any of its Subsidiaries be delegated the authority to grant Awards to, or amend Awards held by, the following individuals:
(a) individuals who are subject to Section 16 of the Exchange Act, or (b) officers of the Company or any of its Subsidiaries or Directors
to whom authority to grant or amend Awards has been delegated hereunder. Any delegation hereunder shall be subject to the restrictions
and limits that the Board or Committee specifies at the time of such delegation or that are otherwise included in the applicable organizational
documents, and the Board or Committee, as applicable, may at any time rescind the authority so delegated or appoint a new delegatee.
At all times, the delegatee appointed under this Section 4.2 shall serve in such capacity at the pleasure of the Board or the Committee,
as applicable, and the Board or the Committee may abolish any committee at any time and re-vest in itself any previously delegated authority.
Further, regardless of any delegation, the Board or a Committee may, in its discretion, exercise any and all rights and duties as the
Administrator under the Plan delegated thereby, except with respect to Awards that are required to be determined in the sole discretion
of the Committee under the rules of any securities exchange or automated quotation system on which the Shares are listed, quoted or traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
V.<br />
STOCK AVAILABLE FOR AWARDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.1 Number
of Shares</b>. Subject to adjustment under Article IX and the terms of this Article V, Awards may be made under the Plan covering up
to the sum of (i) 11,497,622 Shares; and (ii) an increase commencing on January 1, 2024 and continuing annually on each anniversary thereof
through (and including) January 1, 2033, equal to the lesser of (A) 5% of the Shares outstanding on the last day of the immediately preceding
fiscal year and (B) such smaller number of Shares as determined by the Board or the Committee (the &#8220;<span style="text-decoration: underline">Overall Share Limit</span>&#8221;).
Shares issued or delivered under the Plan may consist of authorized but unissued Shares, Shares purchased on the open market or treasury
Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 325; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.2 Share
Recycling</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) If
all or any part of an Award expires, lapses or is terminated, exchanged for or settled in cash, surrendered, repurchased, canceled without
having been fully exercised or forfeited, in any case, in a manner that results in the Company acquiring Shares covered by the Award
at a price not greater than the price (as adjusted to reflect any Equity Restructuring) paid by the Participant for such Shares or not
issuing any Shares covered by the Award, the unused Shares covered by the Award will, as applicable, become or again be available for
Awards under the Plan. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not count against
the Overall Share Limit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Notwithstanding
the foregoing, the following Shares issued or delivered under this Plan shall not again be available for future grants of Awards: (i)
Shares tendered by a Participant or withheld by the Company in payment of the exercise price of an Option; (ii) Shares tendered by the
Participant or withheld by the Company to satisfy any tax withholding obligation with respect to an Award; (iii) Shares that are repurchased
by the Company with Option proceeds; and (iv) Shares subject to a Stock Appreciation Right that are not issued in connection with the
stock settlement of the Stock Appreciation Right on exercise thereof. Notwithstanding the provisions of this Section 5.2(b), no Shares
may again be optioned, granted or awarded pursuant to an Incentive Stock Option if such action would cause such Option to fail to qualify
as an incentive stock option under Section 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.3</b> <b>Incentive
Stock Option Limitations</b>. Notwithstanding anything to the contrary herein, no more than 57,488,110 Shares (as adjusted to reflect
any Equity Restructuring) may be issued pursuant to the exercise of Incentive Stock Options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.4 Substitute
Awards</b>. In connection with an entity&#8217;s merger or consolidation with the Company or any Subsidiary or the Company&#8217;s or
any Subsidiary&#8217;s acquisition of an entity&#8217;s property or stock, the Administrator may grant Awards in substitution for any
options or other stock or stock-based awards granted before such merger or consolidation by such entity or its affiliate. Substitute
Awards may be granted on such terms and conditions as the Administrator deems appropriate, notwithstanding limitations on Awards in the
Plan. Substitute Awards will not count against the Overall Share Limit (nor shall Shares subject to a Substitute Award be added to the
Shares available for Awards under the Plan as provided above), except that Shares acquired by exercise of substitute Incentive Stock
Options will count against the maximum number of Shares that may be issued pursuant to the exercise of Incentive Stock Options under
the Plan. Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary
combines has shares available under a pre-existing plan approved by stockholders and not adopted in contemplation of such acquisition
or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as appropriately adjusted to reflect
the transaction) may be used for Awards under the Plan and shall not reduce the Shares authorized for grant under the Plan (and Shares
subject to such Awards may again become available for Awards under the Plan as provided under Section 5.2 above); provided that Awards
using such available shares shall not be made after the date awards or grants could have been made under the terms of the pre-existing
plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees, Directors or Consultants prior
to such acquisition or combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 326; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.5 Non-Employee
Director Award Limit</b>. Notwithstanding any provision to the contrary in the Plan or in any policy of the Company regarding non-employee
director compensation, the sum of the grant date fair value (determined as of the grant date in accordance with Financial Accounting
Standards Board Accounting Standards Codification Topic 718, or any successor thereto) of all equity-based Awards and the maximum amount
of cash that may become payable to a Service Provider as compensation for services as a Non-Employee Director during any calendar year
shall not exceed $750,000, increased to $1,000,000 in the calendar year of a non-employee Director&#8217;s initial service as a non-employee
Director. The Administrator may make exceptions to this limit for Non-Employee Directors in extraordinary circumstances, as the Administrator
may determine in its discretion, provided that the Non-Employee Director receiving such additional compensation may not participate in
the decision to award such compensation or in other contemporaneous compensation decisions involving Non-Employee Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
VI.<br />
STOCK OPTIONS AND STOCK APPRECIATION RIGHTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.1 General</b>.
The Administrator may grant Options or Stock Appreciation Rights to one or more Service Providers, subject to such terms and conditions
not inconsistent with the Plan as the Administrator shall determine. The Administrator will determine the number of Shares covered by
each Option and Stock Appreciation Right, the exercise price of each Option and Stock Appreciation Right and the conditions and limitations
applicable to the exercise of each Option and Stock Appreciation Right. A Stock Appreciation Right will entitle the Participant (or other
person entitled to exercise the Stock Appreciation Right) to receive from the Company upon exercise of the exercisable portion of the
Stock Appreciation Right an amount determined by multiplying the excess, if any, of the Fair Market Value of one Share on the date of
exercise over the exercise price per Share of the Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation
Right is exercised, subject to any limitations of the Plan or that the Administrator may impose and payable in cash, Shares valued at
Fair Market Value on the date of exercise or a combination of the two as the Administrator may determine or provide in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.2 Exercise
Price</b>. The Administrator will establish each Option&#8217;s and Stock Appreciation Right&#8217;s exercise price and specify the exercise
price in the Award Agreement. Subject to Section 6.6, the exercise price will not be less than 100% of the Fair Market Value on the grant
date of the Option or Stock Appreciation Right. Notwithstanding the foregoing, in the case of an Option or Stock Appreciation Right that
is a Substitute Award, the exercise price per share of the Shares subject to such Option or Stock Appreciation Right, as applicable,
may be less than the Fair Market Value per share on the date of grant; provided that the exercise price of any Substitute Award shall
be determined in accordance with the applicable requirements of Sections 424 and 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 327; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.3 Duration
of Options</b>. Subject to Section 6.6, each Option or Stock Appreciation Right will be exercisable at such times and as specified in
the Award Agreement, provided that the term of an Option or Stock Appreciation Right will not exceed ten years; provided, further, that,
unless otherwise determined by the Administrator or specified in the Award Agreement, (a) no portion of an Option or Stock Appreciation
Right which is unexercisable at a Participant&#8217;s Termination of Service shall thereafter become exercisable and (b) the portion
of an Option or Stock Appreciation Right that is unexercisable at a Participant&#8217;s Termination of Service shall automatically expire
on the date of such Termination of Service. In addition, in no event shall an Option or Stock Appreciation Right granted to an Employee
who is a non-exempt employee for purposes of overtime pay under the U.S. Fair Labor Standards Act of 1938 be exercisable earlier than
six months after its date of grant. Notwithstanding the foregoing, if the Participant, prior to the end of the term of an Option or Stock
Appreciation Right, commits an act of Cause (as determined by the Administrator prior to or after the Participant&#8217;s Termination
of Service), or violates any non-competition, non-solicitation or confidentiality provisions of any employment contract, confidentiality
and nondisclosure agreement or other agreement between the Participant and the Company or any of its Subsidiaries, the right to exercise
the Option or Stock Appreciation Right, as applicable, may be terminated by the Company and the Company may suspend the Participant&#8217;s
right to exercise the Option or Stock Appreciation Right when it reasonably believes that the Participant may have participated in any
such act or violation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.4 Exercise</b>.
Options and Stock Appreciation Rights may be exercised by delivering to the Company (or such other person or entity designated by the
Administrator) a notice of exercise, in a form and manner the Company approves (which may be written, electronic or telephonic and may
contain representations and warranties deemed advisable by the Administrator), signed or authenticated by the person authorized to exercise
the Option or Stock Appreciation Right, together with, as applicable, (a) payment in full of the exercise price for the number of Shares
for which the Option is exercised in a manner specified in Section 6.5 and (b) satisfaction in full of any withholding obligation for
Tax-Related Items in a manner specified in Section 10.5. The Administrator may, in its discretion, limit exercise with respect to fractional
Shares and require that any partial exercise of an Option or Stock Appreciation Right be with respect to a minimum number of Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.5 Payment
Upon Exercise</b>. The Administrator shall determine the methods by which payment of the exercise price of an Option shall be made, including,
without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Cash,
check or wire transfer of immediately available funds;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If
there is a public market for Shares at the time of exercise, unless the Company otherwise determines, (i) delivery (including electronically
or telephonically to the extent permitted by the Company) of a notice that the Participant has placed a market sell order with a broker
acceptable to the Company with respect to Shares then issuable upon exercise of the Option and that the broker has been directed to deliver
promptly to the Company funds sufficient to pay the exercise price, or (ii) the Participant&#8217;s delivery to the Company of a copy
of irrevocable and unconditional instructions to a broker acceptable to the Company to deliver promptly to the Company an amount sufficient
to pay the exercise price by cash, wire transfer of immediately available funds or check; provided that such amount is paid to the Company
at such time as may be required by the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 328; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) To
the extent permitted by the Administrator, delivery (either by actual delivery or attestation) of Shares owned by the Participant valued
at their Fair Market Value on the date of delivery;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) To
the extent permitted by the Administrator, surrendering Shares then issuable upon the Option&#8217;s exercise valued at their Fair Market
Value on the exercise date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Any
other lawful consideration permitted by the Administrator; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) To
the extent permitted by the Administrator, any combination of the above payment forms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.6 Additional
Terms of Incentive Stock Options</b>. The Administrator may grant Incentive Stock Options only to employees of the Company, any of its
present or future parent or subsidiary corporations, as defined in Sections 424(e) or (f) of the Code, respectively. If an Incentive
Stock Option is granted to a Greater Than 10% Stockholder, the exercise price will not be less than 110% of the Fair Market Value on
the Option&#8217;s grant date, and the term of the Option will not exceed five years. All Incentive Stock Options (and Award Agreements
related thereto) will be subject to and construed consistently with Section 422 of the Code. By accepting an Incentive Stock Option,
if requested the Participant agrees to give prompt notice to the Company of dispositions or other transfers (other than in connection
with a Change in Control) of Shares acquired under the Option made within (a) two years from the grant date of the Option or (b) one
year after the transfer of such Shares to the Participant, specifying the date of the disposition or other transfer and the amount the
Participant realized, in cash, other property, assumption of indebtedness or other consideration, in such disposition or other transfer.
Neither the Company nor the Administrator will be liable to a Participant, or any other party, if an Incentive Stock Option fails or
ceases to qualify as an &#8220;incentive stock option&#8221; under Section 422 of the Code. Any Incentive Stock Option or portion thereof
that fails to qualify as an &#8220;incentive stock option&#8221; under Section 422 of the Code for any reason, including becoming exercisable
with respect to Shares having a fair market value exceeding the $100,000 limitation under Treasury Regulation Section 1.422-4, will be
a Nonqualified Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
VII.<br />
RESTRICTED STOCK; RESTRICTED STOCK UNITS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.1 General</b>.
The Administrator may grant Restricted Stock, or the right to purchase Restricted Stock, to any Service Provider, subject to forfeiture
or the Company&#8217;s right to repurchase all or part of the underlying Shares at their issue price or other stated or formula price
from the Participant if conditions the Administrator specifies in the Award Agreement are not satisfied before the end of the applicable
restriction period or periods that the Administrator establishes for such Award. In addition, the Administrator may grant Restricted
Stock Units, which may be subject to vesting and forfeiture conditions during the applicable restriction period or periods, as set forth
in an Award Agreement, to Service Providers. The Administrator shall establish the purchase price, if any, and form of payment for Restricted
Stock and Restricted Stock Units; provided, however, that if a purchase price is charged, such purchase price shall be no less than the
par value, if any, of the Shares to be purchased, unless otherwise permitted by Applicable Law. In all cases, legal consideration shall
be required for each issuance of Restricted Stock and Restricted Stock Units to the extent required by Applicable Law. The Award Agreement
for each Award of Restricted Stock and Restricted Stock Units shall set forth the terms and conditions not inconsistent with the Plan
as the Administrator shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 329; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.2 Restricted
Stock</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Stockholder
Rights</span>. Unless otherwise determined by the Administrator, each Participant holding shares of Restricted Stock will be entitled to
all the rights of a stockholder with respect to such Shares, subject to the restrictions in the Plan and the applicable Award Agreement,
including the right to receive all dividends and other distributions paid or made with respect to the Shares to the extent such dividends
and other distributions have a record date that is on or after the date on which such Participant becomes the record holder of such Shares;
provided, however, that with respect to a share of Restricted Stock subject to restrictions or vesting conditions, except in connection
with a spin-off or other similar event as otherwise permitted under Section 9.2, dividends which are paid to Company stockholders prior
to the removal of restrictions and satisfaction of vesting conditions shall only be paid to the Participant to the extent that the restrictions
are subsequently removed and the vesting conditions are subsequently satisfied and the share of Restricted Stock vests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Stock
Certificates</span>. The Company may require that the Participant deposit in escrow with the Company (or its designee) any stock certificates
issued in respect of shares of Restricted Stock, together with a stock power endorsed in blank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Section
83(b) Election</span>. If a Participant makes an election under Section 83(b) of the Code to be taxed with respect to the Restricted Stock
as of the date of transfer of the Restricted Stock rather than as of the date or dates upon which such Participant would otherwise be
taxable under Section 83(a) of the Code, such Participant shall be required to deliver a copy of such election to the Company promptly
after filing such election with the Internal Revenue Service along with proof of the timely filing thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.3 Restricted
Stock Units</b>. The Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as reasonably practicable
after the Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant&#8217;s election, subject
to compliance with Applicable Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
VIII.<br />
OTHER TYPES OF AWARDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.1 General</b>.
The Administrator may grant Performance Stock Unit awards, Dividend Equivalents or Other Stock or Cash Based Awards, to one or more Service
Providers, in such amounts and subject to such terms and conditions not inconsistent with the Plan as the Administrator shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 330; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.2 Performance
Stock Unit Awards</b>. Each Performance Stock Unit award shall be denominated in a number of Shares or in unit equivalents of Shares
or units of value (including a dollar value of Shares) and may be linked to any one or more of performance or other specific criteria,
including service to the Company or Subsidiaries, determined to be appropriate by the Administrator, in each case on a specified date
or dates or over any period or periods determined by the Administrator. In making such determinations, the Administrator may consider
(among such other factors as it deems relevant in light of the specific type of award) the contributions, responsibilities and other
compensation of the particular Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.3 Dividend
Equivalents</b>. If the Administrator provides, an Award (other than an Option or Stock Appreciation Right) may provide a Participant
with the right to receive Dividend Equivalents. Dividend Equivalents may be paid currently or credited to an account for the Participant,
settled in cash or Shares and subject to the same restrictions on transferability and forfeitability as the Award with respect to which
the Dividend Equivalents are granted and subject to other terms and conditions as set forth in the Award Agreement. Notwithstanding anything
to the contrary herein, Dividend Equivalents with respect to an Award subject to vesting shall either (i) to the extent permitted by
Applicable Law, not be paid or credited or (ii) be accumulated and subject to vesting to the same extent as the related Award. All such
Dividend Equivalents shall be paid at such time as the Administrator shall specify in the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.4 Other
Stock or Cash Based Awards</b>. Other Stock or Cash Based Awards may be granted to Participants, including Awards entitling Participants
to receive cash or Shares to be delivered in the future and annual or other periodic or long-term cash bonus awards (whether based on
specified performance criteria or otherwise), in each case subject to any conditions and limitations in the Plan. Such Other Stock or
Cash Based Awards will also be available as a payment form in the settlement of other Awards, as standalone payments and as payment in
lieu of compensation to which a Participant is otherwise entitled. Other Stock or Cash Based Awards may be paid in Shares, cash or other
property, as the Administrator determines. Subject to the provisions of the Plan, the Administrator will determine the terms and conditions
of each Other Stock or Cash Based Award, including any purchase price, performance goal(s), transfer restrictions, and vesting conditions,
which will be set forth in the applicable Award Agreement. Except in connection with a spin-off or other similar event as otherwise permitted
under Article IX, dividends that are paid prior to vesting of any Other Stock or Cash Based Award shall only be paid to the applicable
Participant to the extent that the vesting conditions are subsequently satisfied and the Other Stock or Cash Based Award vests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 331; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.5</b> <b>Performance
Goals and Criteria</b>. Performance goals or performance criteria established by the Administrator for any Award may be described in
terms of Company-wide objectives or objectives that are related to the performance of a Subsidiary, division, business unit, department,
region or function within the Company or Subsidiary in which the Participant is employed or in terms of the performance of the individual
Participant and may be based on the following criteria: revenues, earnings from operations, operating income, income before taxes, net
income, cash flow, earnings per share, return on total capital, return on invested capital, return on equity, return on assets, total
return to shareholders, earnings before or after interest, taxes, depreciation, amortization or extraordinary or special items, return
on investment, free cash flow, cash conversion cycle, cash flow return on investment (discounted or otherwise), net cash provided by
operations, cash flow in excess of cost of capital, operating margin, profit margin, contribution margin, stock price, new customers,
order intake, cost controls, operating efficiencies, strategic partnerships or transactions (including in-licensing and out-licensing
of intellectual property, milestones related to research development (including, but not limited to, preclinical and clinical studies),
product development and manufacturing, implementation or completion of projects or processes (including, without limitation, clinical
trial initiation, clinical trial enrollment and dates, clinical trial results, regulatory filing submissions, regulatory filing acceptances,
regulatory or advisory committee interactions, regulatory approvals, and product supply), submission to, or approval by, a regulatory
body (including, but not limited to the U.S. Food and Drug Administration) of an applicable filing or a product, market penetration,
geographic business expansion, cost targets, productivity, corporate value and sustainability metrics (including, without limitation,
environmental, social and governance matters), human capital metrics (including, without limitation, employee satisfaction, management
of employment practices, employee benefits, retention and safety), supervision of litigation or labor negotiations, dealings with regulatory
bodies, acquisitions or divestitures, customer satisfaction, strategic business criteria related to a Participant&#8217;s area or areas
of responsibility, or any other criteria established by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
IX.<br />
ADJUSTMENTS FOR CHANGES IN COMMON STOCK<br />
AND CERTAIN OTHER EVENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.1 Equity
Restructuring</b>. In connection with any Equity Restructuring, notwithstanding anything to the contrary in this Article IX, the Administrator
will equitably adjust the terms of the Plan and each outstanding Award as it deems appropriate to reflect the Equity Restructuring, which
may include (a) adjusting the number and type of securities subject to each outstanding Award or with respect to which Awards may be
granted under the Plan (including, but not limited to, adjustments of the limitations in Article V hereof on the maximum number and kind
of shares that may be issued); (b) adjusting the terms and conditions of (including the grant or exercise price), and the performance
goals or other criteria included in, outstanding Awards; and (iii) granting new Awards or making cash payments to Participants. The adjustments
provided under this Section 9.1 will be nondiscretionary and final and binding on all interested parties, including the affected Participant
and the Company; provided that the Administrator will determine whether an adjustment is equitable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 332; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.2 Corporate
Transactions</b>. In the event of any extraordinary dividend or other distribution (whether in the form of cash, Common Stock, other
securities, or other property), reorganization, merger, consolidation, split-up, spin off, combination, amalgamation, repurchase, recapitalization,
liquidation, dissolution, or sale, transfer, exchange or other disposition of all or substantially all of the assets of the Company,
or sale or exchange of Common Stock or other securities of the Company, Change in Control, issuance of warrants or other rights to purchase
Common Stock or other securities of the Company, other similar corporate transaction or event (including the sale, merger or other corporate
transaction involving a Subsidiary), other unusual or nonrecurring transaction or event affecting the Company or its financial statements
or any change in any Applicable Law or accounting principles, the Administrator, on such terms and conditions as it deems appropriate,
either by the terms of the Award or by action taken prior to the occurrence of such transaction or event (except that action to give
effect to a change in Applicable Law or accounting principles may be made within a reasonable period of time after such change), is hereby
authorized to take any one or more of the following actions whenever the Administrator determines that such action is appropriate in
order to (x) prevent dilution or enlargement of the benefits or potential benefits intended by the Company to be made available under
the Plan or with respect to any Award granted or issued under the Plan, (y) to facilitate such transaction or event or (z) give effect
to such changes in Applicable Law or accounting principles:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) To
provide for the cancellation of any such Award in exchange for either an amount of cash or other property with a value equal to the amount
that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of the Participant&#8217;s
rights under the vested portion of such Award, as applicable; provided that, if the amount that could have been obtained upon the exercise
or settlement of the vested portion of such Award or realization of the Participant&#8217;s rights, in any case, is equal to or less
than zero, then the Award may be terminated without payment;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) To
provide that such Award shall vest and, to the extent applicable, be exercisable as to all Shares (or other property) covered thereby,
notwithstanding anything to the contrary in the Plan or the provisions of such Award;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) To
provide that such Award be assumed by the successor or survivor corporation or entity, or a parent or subsidiary thereof, or shall be
substituted for by awards covering the stock of the successor or survivor corporation or entity, or a parent or subsidiary thereof, with
appropriate adjustments as to the number and kind of shares and applicable exercise or purchase price, in all cases, as determined by
the Administrator;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) To
make adjustments in the number and type of shares of Common Stock (or other securities or property) subject to outstanding Awards or
with respect to which Awards may be granted under the Plan (including, but not limited to, adjustments of the limitations in Article
V hereof on the maximum number and kind of shares which may be issued) or in the terms and conditions of (including the grant or exercise
price), and the criteria included in, outstanding Awards;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) To
replace such Award with other rights or property selected by the Administrator; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 333; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) To
provide that the Award will terminate and cannot vest, be exercised or become payable after the applicable event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.3 Change
in Control</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Notwithstanding
any other provision of the Plan, in the event of a Change in Control, unless the Administrator elects to (i) terminate an Award in exchange
for cash, rights or property, pursuant to Section 9.2, or (ii) cause an Award to become fully exercisable and no longer subject to any
forfeiture restrictions prior to the consummation of a Change in Control, pursuant to Section 9.2, (A) such Award (other than any portion
subject to performance-based vesting) shall continue in effect or be assumed or an equivalent Award substituted by the successor corporation
or a parent or subsidiary of the successor corporation and (B) the portion of such Award subject to performance-based vesting shall be
subject to the terms and conditions of the applicable Award Agreement and, in the absence of applicable terms and conditions, the Administrator&#8217;s
discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) In
the event that the successor corporation in a Change in Control refuses to assume or substitute for an Award, the Administrator shall
cause such Award to become fully vested and, if applicable, exercisable immediately prior to the consummation of such transaction, and
with respect to Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at the
greater of: (i) one hundred percent (100%) of target levels, or (ii) the actual level of achievement of all relevant performance goals
against target measured through the date immediately prior to the Change in Control (or as close to such date as administratively practicable),
unless specifically provided otherwise under the applicable Award Agreement or otherwise determined by the Administrator, and all forfeiture
restrictions on such Award to lapse and, to the extent unexercised upon the consummation of such transaction, to terminate in exchange
for cash, rights or other property. The Administrator shall notify the Participant of any Award that becomes exercisable pursuant to
the preceding sentence that such Award shall be fully exercisable for a period of at least 10 days from the date of such notice (or such
shorter period as required to permit a timely closing of the transaction), contingent upon the occurrence of the Change in Control, or
that such Award shall be settled for an amount of cash or securities equal to the in-the-money spread value (if any) of such Award, and
such Award shall terminate upon the consummation of the Change in Control in accordance with the preceding sentence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) For
the purposes of this Section 9.3, an Award shall be considered assumed if, following the Change in Control, the Award confers the right
to purchase or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether stock,
cash, or other securities or property) received in the Change in Control by holders of Common Stock for each Share held on the effective
date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a
majority of the outstanding Shares); provided, however, that if such consideration received in the Change in Control was not solely common
stock of the successor corporation or its parent, the Administrator may, with the consent of the successor corporation, provide for the
consideration to be received upon the exercise of the Award, for each Share subject to an Award, to be solely common stock of the successor
corporation or its parent equal in fair market value to the per-share consideration received by holders of Common Stock in the Change
in Control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 334; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.4 Administrative
Stand Still</b>. In the event of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or
other distribution (other than normal cash dividends) of Company assets to stockholders, or any other extraordinary transaction or change
affecting the Shares or the share price of Common Stock (including any Equity Restructuring or any securities offering or other similar
transaction) or for reasons of administrative convenience or to facilitate compliance with any Applicable Law, the Company may refuse
to permit the exercise or settlement of one or more Awards for such period of time as the Company may determine to be reasonably appropriate
under the circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.5 General</b>.
Except as expressly provided in the Plan or the Administrator&#8217;s action under the Plan, no Participant will have any rights due
to any subdivision or consolidation of Shares of any class, dividend payment, increase or decrease in the number of Shares of any class
or dissolution, liquidation, merger, or consolidation of the Company or other corporation. Except as expressly provided with respect
to an Equity Restructuring under Section 9.1 above or the Administrator&#8217;s action under the Plan, no issuance by the Company of
Shares of any class, or securities convertible into Shares of any class, will affect, and no adjustment will be made regarding, the number
of Shares subject to an Award or the Award&#8217;s grant or exercise price. The existence of the Plan, any Award Agreements and the Awards
granted hereunder will not affect or restrict in any way the Company&#8217;s right or power to make or authorize (i) any adjustment,
recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, (ii) any merger, consolidation,
spin-off, dissolution or liquidation of the Company or sale of Company assets or (iii) any sale or issuance of securities, including
securities with rights superior to those of the Shares or securities convertible into or exchangeable for Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
X.<br />
PROVISIONS APPLICABLE TO AWARDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.1 Transferability</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) No
Award may be sold, assigned, transferred, pledged or otherwise encumbered, either voluntarily or by operation of law, except by will
or the laws of descent and distribution, or, subject to the Administrator&#8217;s consent, pursuant to a DRO, unless and until such Award
has been exercised or the Shares underlying such Award have been issued, and all restrictions applicable to such Shares have lapsed.
During the life of a Participant, Awards will be exercisable only by the Participant, unless it has been disposed of pursuant to a DRO.
After the death of a Participant, any exercisable portion of an Award may, prior to the time when such portion becomes unexercisable
under the Plan or the applicable Award Agreement, be exercised by the Participant&#8217;s personal representative or by any person empowered
to do so under the deceased Participant&#8217;s will or under the then-Applicable Law of descent and distribution. References to a Participant,
to the extent relevant in the context, will include references to a transferee approved by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 335; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Notwithstanding
Section 10.1(a), the Administrator, in its sole discretion, may determine to permit a Participant or a Permitted Transferee of such Participant
to transfer an Award other than an Incentive Stock Option (unless such Incentive Stock Option is intended to become a Nonqualified Stock
Option) to any one or more Permitted Transferees of such Participant, subject to the following terms and conditions: (i) an Award transferred
to a Permitted Transferee shall not be assignable or transferable by the Permitted Transferee other than (A) to another Permitted Transferee
of the applicable Participant or (B) by will or the laws of descent and distribution or, subject to the consent of the Administrator,
pursuant to a domestic relations order; (ii) an Award transferred to a Permitted Transferee shall continue to be subject to all the terms
and conditions of the Award as applicable to the original Participant (other than the ability to further transfer the Award to any Person
other than another Permitted Transferee of the applicable Participant); (iii) the Participant (or transferring Permitted Transferee)
and the receiving Permitted Transferee shall execute any and all documents requested by the Administrator, including, without limitation
documents to (A) confirm the status of the transferee as a Permitted Transferee, (B) satisfy any requirements for an exemption for the
transfer under Applicable Law and (C) evidence the transfer; and (iv) any transfer of an Award to a Permitted Transferee shall be without
consideration, except as required by Applicable Law. In addition, and further notwithstanding Section 10.1(a), the Administrator, in
its sole discretion, may determine to permit a Participant to transfer Incentive Stock Options to a trust that constitutes a Permitted
Transferee if, under Section 671 of the Code and other Applicable Law, the Participant is considered the sole beneficial owner of the
Incentive Stock Option while it is held in the trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Notwithstanding
Section 10.1(a), if permitted by the Administrator, a Participant may, in the manner determined by the Administrator, designate a Designated
Beneficiary. A Designated Beneficiary, legal guardian, legal representative, or other person claiming any rights pursuant to the Plan
is subject to all terms and conditions of the Plan and any Award Agreement applicable to the Participant and any additional restrictions
deemed necessary or appropriate by the Administrator. If the Participant is married or a domestic partner in a domestic partnership qualified
under Applicable Law and resides in a community property state, a designation of a person other than the Participant&#8217;s spouse or
domestic partner, as applicable, as the Participant&#8217;s Designated Beneficiary with respect to more than 50% of the Participant&#8217;s
interest in the Award shall not be effective without the prior written or electronic consent of the Participant&#8217;s spouse or domestic
partner. Subject to the foregoing, a beneficiary designation may be changed or revoked by a Participant at any time; provided that the
change or revocation is delivered in writing to the Administrator prior to the Participant&#8217;s death.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.2 Documentation</b>.
Each Award will be evidenced in an Award Agreement in such form as the Administrator determines in its discretion. Each Award may contain
such terms and conditions as are determined by the Administrator in its sole discretion, to the extent not inconsistent with those set
forth in the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 336; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.3 Discretion</b>.
Except as the Plan otherwise provides, each Award may be made alone or in addition or in relation to any other Award. The terms of each
Award to a Participant need not be identical, and the Administrator need not treat Participants or Awards (or portions thereof) uniformly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.4 Changes
in Participant&#8217;s Status</b>. The Administrator will determine how the disability, death, retirement, authorized leave of absence
or any other change or purported change in a Participant&#8217;s Service Provider status affects an Award and the extent to which, and
the period during which, the Participant, the Participant&#8217;s legal representative, conservator, guardian or Designated Beneficiary
may exercise rights under the Award, if applicable. Except to the extent otherwise required by Applicable Law or expressly authorized
by the Company or by the Company&#8217;s written policy on leaves of absence, no service credit shall be given for vesting purposes for
any period the Participant is on a leave of absence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.5 Withholding</b>.
Each Participant must pay the Company or a Subsidiary, as applicable, or make provision satisfactory to the Administrator for payment
of, any Tax-Related Items required by Applicable Law to be withheld in connection with such Participant&#8217;s Awards and/or Shares
by the date of the event creating the liability for Tax-Related Items. At the Company&#8217;s discretion and subject to any Company insider
trading policy (including black-out periods), any withholding obligation for Tax-Related Items may be satisfied by (i) deducting an amount
sufficient to satisfy such withholding obligation from any payment of any kind otherwise due to a Participant; (ii) accepting a payment
from the Participant in cash, by wire transfer of immediately available funds, or by check made payable to the order of the Company or
a Subsidiary, as applicable; (iii) accepting the delivery of Shares, including Shares delivered by attestation; (iv) retaining Shares
from the Award creating the withholding obligation for Tax-Related Items, valued on the date of delivery, (v) if there is a public market
for Shares at the time the withholding obligation for Tax-Related Items is satisfied, selling Shares issued pursuant to the Award creating
the withholding obligation for Tax-Related Items, either voluntarily by the Participant or mandatorily by the Company; (vi) any other
lawful consideration permitted by the Administrator; or (vii) any combination of the foregoing payment forms. The amount withheld pursuant
to any of the foregoing payment forms shall be determined by the Company and may be up to, but no greater than, the aggregate amount
of such obligations based on the maximum statutory withholding rates in the applicable Participant&#8217;s jurisdiction for all Tax-Related
Items that are applicable to such taxable income. If any tax withholding obligation will be satisfied under clause (v) of the preceding
paragraph, each Participant&#8217;s acceptance of an Award under the Plan will constitute the Participant&#8217;s authorization to the
Company and instruction and authorization to any brokerage firm selected by the Company to effect the sale to complete the transactions
described in clause (v).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.6 Amendment
of Award; Repricing</b>. The Administrator may amend, modify or terminate any outstanding Award, including by substituting another Award
of the same or a different type, changing the exercise or settlement date, and converting an Incentive Stock Option to a Nonqualified
Stock Option. The Participant&#8217;s consent to such action will be required unless (i) the action, taking into account any related
action, does not materially and adversely affect the Participant&#8217;s rights under the Award, or (ii) the change is permitted under
Article IX or pursuant to Section 11.6. In addition, the Administrator shall, without the approval of the stockholders of the Company,
have the authority to (a) amend any outstanding Option or Stock Appreciation Right to reduce its exercise price per Share, or (b) cancel
any Option or Stock Appreciation Right in exchange for cash or another Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 337; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.7 Conditions
on Delivery of Stock</b>. The Company will not be obligated to deliver any Shares under the Plan or remove restrictions from Shares previously
delivered under the Plan until (i) all Award conditions have been met or removed to the Company&#8217;s satisfaction, (ii) as determined
by the Company, all other legal matters regarding the issuance and delivery of such Shares have been satisfied, including, without limitation,
any applicable securities laws and stock exchange or stock market rules and regulations, (iii) any approvals from governmental agencies
that the Company determines are necessary or advisable have been obtained, and (iv) the Participant has executed and delivered to the
Company such representations or agreements as the Administrator deems necessary or appropriate to satisfy Applicable Law. The inability
or impracticability of the Company to obtain or maintain authority from any regulatory body having jurisdiction, which authority is deemed
by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of
any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained,
and shall constitute circumstances in which the Administrator may determine to amend or cancel Awards pertaining to such Shares, with
or without consideration to the Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.8 Acceleration</b>.
The Administrator may at any time provide that any Award will become immediately vested and fully or partially exercisable, free of some
or all restrictions or conditions, or otherwise fully or partially realizable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE
XI.<br />
MISCELLANEOUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.1 No
Right to Employment or Other Status</b>. No person will have any claim or right to be granted an Award, and the grant of an Award will
not be construed as giving a Participant the right to continue employment or any other relationship with the Company or a Subsidiary.
The Company and its Subsidiaries expressly reserve the right at any time to dismiss or otherwise terminate its relationship with a Participant
free from any liability or claim under the Plan or any Award, except as expressly provided in an Award Agreement or other written agreement
between the Participant and the Company or any Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.2 No
Rights as Stockholder; Certificates</b>. Subject to the Award Agreement, no Participant or Designated Beneficiary will have any rights
as a stockholder with respect to any Shares to be distributed under an Award until becoming the record holder of such Shares. Notwithstanding
any other provision of the Plan, unless the Administrator otherwise determines or Applicable Law requires, the Company will not be required
to deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares may be recorded
in the books of the Company (or, as applicable, its transfer agent or stock plan administrator). The Company may place legends on any
share certificate or book entry to reference restrictions applicable to the Shares (including, without limitation, restrictions applicable
to Restricted Stock).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 338; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.3 Effective
Date</b>. The Plan was approved by the Board on [&#9679;], 2023. The Plan will become effective on the date immediately prior to the
date of the closing (the &#8220;<span style="text-decoration: underline">Effective Date</span>&#8221;) of the transactions contemplated by the Merger Agreement, provided that
it is approved by the Company&#8217;s stockholders on or prior to the Effective Date and such approval occurs within 12 months following
the date the Board approved the Plan. If the Plan is not approved by the Company&#8217;s stockholders within the foregoing time frame,
or if the Merger Agreement is terminated prior to the consummation of the transactions contemplated thereby, the Plan will not become
effective. No Award may be granted pursuant to the Plan on or after the tenth (10<sup>th</sup>) anniversary of the Effective Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.4 Amendment
of Plan</b>. The Board may amend, suspend or terminate the Plan at any time and from time to time; provided that (a) no amendment requiring
stockholder approval to comply with Applicable Law shall be effective unless approved by the Board, and (b) no amendment, other than
an increase to the Overall Share Limit or pursuant to Article IX or Section 11.6, may materially and adversely affect any Award outstanding
at the time of such amendment without the affected Participant&#8217;s consent. No Awards may be granted under the Plan during any suspension
period or after Plan termination. Awards outstanding at the time of any Plan suspension or termination will continue to be governed by
the Plan and the Award Agreement, as in effect before such suspension or termination. The Board will obtain stockholder approval of any
Plan amendment to the extent necessary to comply with Applicable Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.5 Provisions
for Foreign Participants</b>. The Administrator may modify Awards granted to Participants who are nationals of a country other than the
United States or employed or residing outside the United States, establish subplans or procedures under the Plan or take any other necessary
or appropriate action to address Applicable Law, including (a) differences in laws, rules, regulations or customs of such jurisdictions
with respect to tax, securities, currency, employee benefit or other matters, (b) listing and other requirements of any non-U.S. securities
exchange, and (c) any necessary local governmental or regulatory exemptions or approvals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.6 Section
409A</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">General</span>.
The Company intends that all Awards be structured to comply with, or be exempt from, Section 409A, such that no adverse tax consequences,
interest, or penalties under Section 409A apply. Notwithstanding anything in the Plan or any Award Agreement to the contrary, the Administrator
may, without a Participant&#8217;s consent, amend this Plan or Awards, adopt policies and procedures, or take any other actions (including
amendments, policies, procedures and retroactive actions) as are necessary or appropriate to preserve the intended tax treatment of Awards,
including any such actions intended to (A) exempt this Plan or any Award from Section 409A, or (B) comply with Section 409A, including
regulations, guidance, compliance programs and other interpretative authority that may be issued after an Award&#8217;s grant date. The
Company makes no representations or warranties as to an Award&#8217;s tax treatment under Section 409A or otherwise. The Company will
have no obligation under this Section 11.6 or otherwise to avoid the taxes, penalties or interest under Section 409A with respect to
any Award and will have no liability to any Participant or any other person if any Award, compensation or other benefits under the Plan
are determined to constitute noncompliant &#8220;nonqualified deferred compensation&#8221; subject to taxes, penalties or interest under
Section 409A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 339; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Separation
from Service</span>. If an Award constitutes &#8220;nonqualified deferred compensation&#8221; under Section 409A, any payment or settlement
of such Award upon a Participant&#8217;s Termination of Service will, to the extent necessary to avoid taxes under Section 409A, be made
only upon the Participant&#8217;s &#8220;separation from service&#8221; (within the meaning of Section 409A), whether such &#8220;separation
from service&#8221; occurs upon or after the Participant&#8217;s Termination of Service. For purposes of this Plan or any Award Agreement
relating to any such payments or benefits, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like
terms means a &#8220;separation from service.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Payments
to Specified Employees</span>. Notwithstanding any contrary provision in the Plan or any Award Agreement, any payment(s) of &#8220;nonqualified
deferred compensation&#8221; required to be made under an Award to a &#8220;specified employee&#8221; (as defined under Section 409A
and as the Administrator determines) due to his or her &#8220;separation from service&#8221; will, to the extent necessary to avoid taxes
under Section 409A(a)(2)(B)(i) of the Code, be delayed for the six-month period immediately following such &#8220;separation from service&#8221;
(or, if earlier, until the specified employee&#8217;s death) and will instead be paid (as set forth in the Award Agreement) on the day
immediately following such six-month period or as soon as administratively practicable thereafter (without interest). Any payments of
&#8220;nonqualified deferred compensation&#8221; under such Award payable more than six months following the Participant&#8217;s &#8220;separation
from service&#8221; will be paid at the time or times the payments are otherwise scheduled to be made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.7 Limitations
on Liability</b>. Notwithstanding any other provisions of the Plan, no individual acting as a director, officer or other employee of
the Company or any Subsidiary will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any
claim, loss, liability, or expense incurred in connection with the Plan or any Award, and such individual will not be personally liable
with respect to the Plan because of any contract or other instrument executed in his or her capacity as an Administrator, director, officer
or other employee of the Company or any Subsidiary. The Company will indemnify and hold harmless each director, officer or other employee
of the Company or any Subsidiary that has been or will be granted or delegated any duty or power relating to the Plan&#8217;s administration
or interpretation, against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of
a claim with the Administrator&#8217;s approval) arising from any act or omission concerning this Plan unless arising from such person&#8217;s
own fraud or bad faith; provided that he or she gives the Company an opportunity, at its own expense, to handle and defend the same before
he or she undertakes to handle and defend it on his or her own behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 340; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.8 Data
Privacy</b>. As a condition for receiving any Award, each Participant explicitly and unambiguously consents to the collection, use and
transfer, in electronic or other form, of personal data as described in this Section 11.8 by and among the Company and its Subsidiaries
and affiliates exclusively for implementing, administering and managing the Participant&#8217;s participation in the Plan. The Company
and its Subsidiaries and affiliates may hold certain personal information about a Participant, including the Participant&#8217;s name,
address and telephone number; birthdate; social security, insurance number or other identification number; salary; nationality; job title(s);
any Shares held in the Company or its Subsidiaries and affiliates; and Award details, to implement, manage and administer the Plan and
Awards (the &#8220;<span style="text-decoration: underline">Data</span>&#8221;). The Company and its Subsidiaries and affiliates may transfer the Data amongst themselves as necessary
to implement, administer and manage a Participant&#8217;s participation in the Plan, and the Company and its Subsidiaries and affiliates
may transfer the Data to third parties assisting the Company with Plan implementation, administration and management. These recipients
may be located in the Participant&#8217;s country, or elsewhere, and the Participant&#8217;s country may have different data privacy
laws and protections than the recipients&#8217; country. By accepting an Award, each Participant authorizes such recipients to receive,
possess, use, retain and transfer the Data, in electronic or other form, to implement, administer and manage the Participant&#8217;s
participation in the Plan, including any required Data transfer to a broker or other third party with whom the Company or the Participant
may elect to deposit any Shares. The Data related to a Participant will be held only as long as necessary to implement, administer, and
manage the Participant&#8217;s participation in the Plan. A Participant may, at any time, view the Data that the Company holds regarding
such Participant, request additional information about the storage and processing of the Data regarding such Participant, recommend any
necessary corrections to the Data regarding the Participant or refuse or withdraw the consents in this Section 11.8 in writing, without
cost, by contacting the local human resources representative. The Company may cancel Participant&#8217;s ability to participate in the
Plan and, in the Administrator&#8217;s sole discretion, the Participant may forfeit any outstanding Awards if the Participant refuses
or withdraws the consents in this Section 11.8. For more information on the consequences of refusing or withdrawing consent, Participants
may contact their local human resources representative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.9 Severability</b>.
If any portion of the Plan or any action taken under it is held illegal or invalid for any reason, the illegality or invalidity will
not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provisions had been
excluded, and the illegal or invalid action will be null and void.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.10 Governing
Documents</b>. If any contradiction occurs between the Plan and any Award Agreement or other written agreement between a Participant
and the Company (or any Subsidiary), the Plan will govern, unless such Award Agreement or other written agreement was approved by the
Administrator and expressly provides that a specific provision of the Plan will not apply.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.11 Governing
Law</b>. The Plan and all Awards will be governed by and interpreted in accordance with the laws of the State of Delaware, without regard
to the conflict of law rules thereof or of any other jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 341; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.12 Clawback
Provisions</b>. All Awards (including the gross amount of any proceeds, gains or other economic benefit the Participant actually or constructively
receives upon receipt or exercise of any Award or the receipt or resale of any Shares underlying the Award) will be subject to recoupment
by the Company to the extent required to comply with Applicable Law or any policy of the Company providing for the reimbursement of incentive
compensation, whether or not such policy was in place at the time of grant of an Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.13 Titles
and Headings</b>. The titles and headings in the Plan are for convenience of reference only and, if any conflict, the Plan&#8217;s text,
rather than such titles or headings, will control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.14 Conformity
to Applicable Law</b>. Participant acknowledges that the Plan is intended to conform to the extent necessary with Applicable Law. Notwithstanding
anything herein to the contrary, the Plan and all Awards will be administered only in a manner intended to conform with Applicable Law.
To the extent Applicable Law permits, the Plan and all Award Agreements will be deemed amended as necessary to conform to Applicable
Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.15 Relationship
to Other Benefits</b>. No payment under the Plan will be taken into account in determining any benefits under any pension, retirement,
savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary, except as expressly provided
in writing in such other plan or an agreement thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.16 Unfunded
Status of Awards</b>. The Plan is intended to be an &#8220;unfunded&#8221; plan for incentive compensation. With respect to any payments
not yet made to a Participant pursuant to an Award, nothing contained in the Plan or Award Agreement shall give the Participant any rights
that are greater than those of a general creditor of the Company or any Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.17 Limitations
Applicable to Section 16 Persons</b>. Notwithstanding any other provision of the Plan, the Plan and any Award granted or awarded to any
individual who is then subject to Section 16 of the Exchange Act shall be subject to any additional limitations set forth in any applicable
exemptive rule under Section 16 of the Exchange Act (including Rule 16b-3 of the Exchange Act and any amendments thereto) that are requirements
for the application of such exemptive rule. To the extent permitted by Applicable Law, the Plan and Awards granted or awarded hereunder
shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.18 Prohibition
on Executive Officer Loans</b>. Notwithstanding any other provision of the Plan to the contrary, no Participant who is a Director or
an &#8220;executive officer&#8221; of the Company within the meaning of Section 13(k) of the Exchange Act shall be permitted to make
payment with respect to any Awards granted under the Plan, or continue any extension of credit with respect to such payment, with a loan
from the Company or a loan arranged by the Company in violation of Section 13(k) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 342 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="annex_005"></span>Annex
D</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="annexd_001.jpg" alt="" style="height: 869px; width: 670px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 343 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="annexd_002.jpg" alt="" style="height: 869px; width: 670px" /><span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 344 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="annexd_003.jpg" alt="" style="height: 869px; width: 670px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 345 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="annexd_004.jpg" alt="" style="height: 869px; width: 670px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 346 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="annexd_005.jpg" alt="" style="height: 869px; width: 670px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 347 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="annexd_006.jpg" alt="" style="height: 869px; width: 670px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 348 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="annexd_007.jpg" alt="" style="height: 869px; width: 670px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 349 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="annexd_008.jpg" alt="" style="height: 869px; width: 670px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 350 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="annexd_009.jpg" alt="" style="height: 869px; width: 670px" /><span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 351 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
20. Indemnification of Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL concerning indemnification of officers, directors, employees and agents is set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Section
145. Indemnification of officers, directors, employees and agents; insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened,
    pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by
    or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the
    corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation,
    partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts
    paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person
    acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation,
    and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful.
    The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or
    its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person
    reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or
    proceeding, had reasonable cause to believe that the person&#8217;s conduct was unlawful.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened,
    pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact
    that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
    as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses
    (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of
    such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the
    best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to
    which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery
    or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability
    but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which
    the Court of Chancery or such other court shall deem proper.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense
    of any action, suit or proceeding referred to in subsections (a) and (b) of this section, or in defense of any claim, issue or matter
    therein, such person shall be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred by
    such person in connection therewith. For indemnification with respect to any act or omission occurring after December 31, 2020, references
    to &#8220;officer&#8221; for purposes of these paragraphs (c)(1) and (2) of this section shall mean only a person who at the time
    of such act or omission is deemed to have consented to service by the delivery of process to the registered agent of the corporation
    pursuant to &#167; 3114(b) of Title 10 (for purposes of this sentence only, treating residents of this State as if they were nonresidents
    to apply &#167; 3114(b) of Title 10 to this sentence).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            corporation may indemnify any other person who is not a present or former director or officer
                                            of the corporation against expenses (including attorneys&#8217; fees) actually and reasonably
                                            incurred by such person to the extent he or she has been successful on the merits or otherwise
                                            in defense of any action, suit or proceeding referred to in subsections (a) and (b) of this
                                            section, or in defense of any claim, issue or matter therein.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 352; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: left; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    indemnification under subsections (a) and (b) of this section (unless ordered by a court) shall be made by the corporation only as
    authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or
    agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a) and
    (b) of this section. Such determination shall be made, with respect to a person who is a director or officer of the corporation at
    the time of such determination, (1) By a majority vote of the directors who are not parties to such action, suit or proceeding, even
    though less than a quorum, or (2) By a committee of such directors designated by majority vote of such directors, even though less
    than a quorum, or (3) If there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion,
    or (4) By the stockholders.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
    (including attorneys&#8217; fees) incurred by an officer or director of the corporation in defending any civil, criminal, administrative
    or investigative action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit
    or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately
    be determined that such person is not entitled to be indemnified by the corporation as authorized in this section. Such expenses
    (including attorneys&#8217; fees) incurred by former directors and officers or other employees and agents of the corporation or by
    persons serving at the request of the corporation as directors, officers, employees or agents of another corporation, partnership,
    joint venture, trust or other enterprise may be so paid upon such terms and conditions, if any, as the corporation deems appropriate.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not
    be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any
    bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#8217;s official
    capacity and as to action in another capacity while holding such office. A right to indemnification or to advancement of expenses
    arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to or
    repeal or elimination of the certificate of incorporation or the bylaws after the occurrence of the act or omission that is the subject
    of the civil, criminal, administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses
    is sought, unless the provision in effect at the time of such act or omission explicitly authorizes such elimination or impairment
    after such action or omission has occurred.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee
    or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of
    another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and
    incurred by such person in any such capacity, or arising out of such person&#8217;s status as such, whether or not the corporation
    would have the power to indemnify such person against such liability under this section. For purposes of this subsection, insurance
    shall include any insurance provided directly or indirectly (including pursuant to any fronting or reinsurance arrangement) by or
    through a captive insurance company organized and licensed in compliance with the laws of any jurisdiction, including any captive
    insurance company licensed under Chapter 69 of Title 18, provided that the terms of any such captive insurance shall:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Exclude from coverage thereunder, and provide that the insurer shall not make any payment for, loss in connection with any claim made
against any person arising out of, based upon or attributable to any (i) personal profit or other financial advantage to which such person
was not legally entitled or (ii) deliberate criminal or deliberate fraudulent act of such person, or a knowing violation of law by such
person, if (in the case of the foregoing paragraph (g)(1)(i) or (ii) of this section) established by a final, nonappealable adjudication
in the underlying proceeding in respect of such claim (which shall not include an action or proceeding initiated by the insurer or the
insured to determine coverage under the policy), unless and only to the extent such person is entitled to be indemnified therefor under
this section;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 353; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Require that any determination to make a payment under such insurance in respect of a claim against a current director or officer (as
defined in paragraph (c)(1) of this section) of the corporation shall be made by a independent claims administrator or in accordance
with the provisions of paragraphs (d)(1) through (4) of this section; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 59.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Require that, prior to any payment under such insurance in connection with any dismissal or compromise of any action, suit or proceeding
brought by or in the right of a corporation as to which notice is required to be given to stockholders, such corporation shall include
in such notice that a payment is proposed to be made under such insurance in connection with such dismissal or compromise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 59.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of paragraph (g)(1) of this section, the conduct of an insured person shall not be imputed to any other insured person. A corporation
that establishes or maintains a captive insurance company that provides insurance pursuant to this section shall not, solely by virtue
thereof, be subject to the provisions of Title 18.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    purposes of this section, references to &#8220;the corporation&#8221; shall include, in addition to the resulting corporation, any
    constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate
    existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that
    any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request
    of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust
    or other enterprise, shall stand in the same position under this section with respect to the resulting or surviving corporation as
    such person would have with respect to such constituent corporation if its separate existence had continued.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    purposes of this section, references to &#8220;other enterprises&#8221; shall include employee benefit plans; references to &#8220;fines&#8221;
    shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to &#8220;serving at
    the request of the corporation&#8221; shall include any service as a director, officer, employee or agent of the corporation which
    imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its
    participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the
    interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed
    to the best interests of the corporation&#8221; as referred to in this section.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when
    authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the
    benefit of the heirs, executors and administrators of such a person.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Court of Chancery is hereby vested with exclusive jurisdiction to hear and determine all actions for advancement of expenses or indemnification
    brought under this section or under any bylaw, agreement, vote of stockholders or disinterested directors, or otherwise. The Court
    of Chancery may summarily determine a corporation&#8217;s obligation to advance expenses (including attorneys&#8217; fees).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment of expenses incurred or paid by a director, officer or controlling person in a successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, we will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to the court of
appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 354; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.2 of MURF&#8217;s certificate of incorporation will provide:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;(a)
To the fullest extent permitted by applicable law, as the same exists or may hereafter be amended, the Corporation shall indemnify and
hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened,
pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#8220;proceeding&#8221;)
by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the Corporation,
is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership,
joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan (an &#8220;indemnitee&#8221;),
whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other
capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without
limitation, attorneys&#8217; fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred
by such indemnitee in connection with such proceeding. The Corporation shall to the fullest extent not prohibited by applicable law pay
the expenses (including attorneys&#8217; fees) incurred by an indemnitee in defending or otherwise participating in any proceeding in
advance of its final disposition; provided, however, that, to the extent required by applicable law, such payment of expenses in advance
of the final disposition of the proceeding shall be made only upon receipt of an undertaking, by or on behalf of the indemnitee, to repay
all amounts so advanced if it shall ultimately be determined that the indemnitee is not entitled to be indemnified under this Section
8.2 or otherwise. The rights to indemnification and advancement of expenses conferred by this Section 8.2 shall be contract rights and
such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit
of his or her heirs, executors and administrators. Notwithstanding the foregoing provisions of this Section 8.2(a), except for proceedings
to enforce rights to indemnification and advancement of expenses, the Corporation shall indemnify and advance expenses to an indemnitee
in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized
by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The rights to indemnification and advancement of expenses conferred on any indemnitee by this Section 8.2 shall not be exclusive of any
other rights that any indemnitee may have or hereafter acquire under law, this Second Amended and Restated Certificate, the By-Laws,
an agreement, vote of stockholders or disinterested directors, or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any repeal or amendment of this Section 8.2 by the stockholders of the Corporation or by changes in law, or the adoption of any other
provision of this Second Amended and Restated Certificate inconsistent with this Section 8.2, shall, unless otherwise required by law,
be prospective only (except to the extent such amendment or change in law permits the Corporation to provide broader indemnification
rights on a retroactive basis than permitted prior thereto), and shall not in any way diminish or adversely affect any right or protection
existing at the time of such repeal or amendment or adoption of such inconsistent provision in respect of any proceeding (regardless
of when such proceeding is first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior
to such repeal or amendment or adoption of such inconsistent provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This Section 8.2 shall not limit the right of the Corporation, to the extent and in the manner authorized or permitted by law, to indemnify
and to advance expenses to persons other than indemnitees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us
pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy
as expressed in the Securities Act and is theretofore unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 355; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
21. Exhibits and Financial Statement Schedules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No. </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex1-1.htm" style="-sec-extract: exhibit">Underwriting Agreement (filed as Exhibit 1.1 to the Current Report on Form 8-K filed February 8, 2022) and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_001">Agreement
    and Plan of Merger Agreement dated as of November 8, 2022, by and among Murphy Canyon Acquisition Corp., Conduit Merger Sub, Inc.
    and Conduit Pharmaceuticals Limited (included as Annex A-1 to this proxy statement/prospectus and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_002">Amendment
    to Agreement and Plan of Merger dated as of January 27, 2023, by and among Murphy Canyon Acquisition Corp., Conduit Merger Sub, Inc.
    and Conduit Pharmaceuticals Limited (included as Annex A-2 to this proxy statement/prospectus and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#A3_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment to Agreement and Plan of Merger dated as of May 11, 2023, by and among Murphy Canyon Acquisition Corp., Conduit Merger Sub, Inc. and Conduit Pharmaceuticals Limited (included as Annex A-3 to this proxy statement/prospectus and incorporated herein by reference)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_003">Form
    of Second Amended and Restated Certificate of Incorporation of New Conduit (included as Annex B to this proxy statement/prospectus
    and incorporated herein by reference) </a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex3-1.htm" style="-sec-extract: exhibit">Certificate
    of Incorporation of Murphy Canyon Acquisition Corp. (filed as Exhibit 3.1 to the Registrant&#8217;s Registration Statement on Form
    S-1 (333-262036) and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex3-1.htm" style="-sec-extract: exhibit">Amended
    and Restated Certificate of Incorporation for Murphy Canyon Acquisition Corp. (filed as Exhibit 3.1 to the Registrant&#8217;s Current
    Report on Form 8-K filed on February 2, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315223003557/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Amended and Restated Certificate of Incorporation Murphy Canyon Acquisition Corp. (filed as Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed on February 3, 2023, and incorporated herein by reference)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex3-5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Amended and Restated Bylaws of Conduit Pharmaceuticals Inc.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex3-3.htm" style="-sec-extract: exhibit">By-Laws
    of Murphy Canyon Acquisition Corp. (filed as Exhibit 3.3 to the Registrant&#8217;s Registration Statement on Form S-1 (333-262036)
    and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex4-1.htm" style="-sec-extract: exhibit">Specimen
    Unit Certificate for Murphy Canyon Acquisition Corp. (filed as Exhibit 4.1 to the Registrant&#8217;s Registration Statement on Form
    S-1 (333-262036) and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex4-2.htm" style="-sec-extract: exhibit">Specimen
    Common Stock Certificate of Murphy Canyon Acquisition Corp. (filed as Exhibit 4.2 to the Registrant&#8217;s Registration Statement
    on Form S-1 (333-262036) and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex4-3.htm" style="-sec-extract: exhibit">Specimen
    Warrant Certificate of Murphy Canyon Acquisition Corp. (filed as Exhibit 4.3 to the Registrant&#8217;s Registration Statement on
    Form S-1 (333-262036) and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex4-1.htm" style="-sec-extract: exhibit">Warrant
    Agreement between Vstock Transfer, LLC and Murphy Canyon Acquisition Corp. (filed as Exhibit 4.1 to the Registrant&#8217;s Current
    Report on Form 8-K filed on February 2, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222032104/ex4-1.htm" style="-sec-extract: exhibit"><span style="background-color: #CCECFF">Form
    of Murphy Canyon Acquisition Corp. Warrant (filed as Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed November
    14, 2022, and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315223002970/ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Amended and Restated Warrant (filed as Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on January 27, 2023, and incorporated herein by reference)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315223009306/ex4-7.htm" style="-sec-extract: exhibit">Description of Registered Securities (filed as Exhibit 4.7 to the Registrant&#8217;s Annual Report on Form 10-K filed on March 28, 2023, and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specimen
    Common Stock Certificate of Conduit Pharmaceuticals Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specimen
    Warrant Certificate of Conduit Pharmaceuticals Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of Sichenzia Ross Ference LLP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">8.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Opinion
    of Thompson Hine LLP regarding tax matters</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 356; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Letter
    Agreement, dated February 2, 2022, among Murphy Canyon Acquisition Corp., Murphy Canyon Acquisition Sponsor, LLC, and each of the
    executive officers and directors of Murphy Canyon Acquisition Corp. (filed as Exhibit 10.1 to the Registrant&#8217;s Current Report
    on Form 8-K filed on February 2, 2022, and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Promissory
    Note, dated November 4, 2021, issued to Murphy Canyon Acquisition Sponsor, LLC, by Murphy Canyon Acquisition Corp. (filed as Exhibit
    10.2 to the Registrant&#8217;s Registration Statement on Form S-1 (333-262036) filed on January 6, 2022, and incorporated
    herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Investment
    Management Trust Agreement, dated February 2, 2022, between Murphy Canyon Acquisition Corp. and Wilmington Trust Company (filed as
    Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on February 2, 2022, and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Registration
    Rights Agreement, dated February 2, 2022, among Murphy Canyon Acquisition Corp. and certain securityholders (filed as Exhibit 10.3
    to the Registrant&#8217;s Current Report on Form 8-K filed on February 2, 2022, and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex10-5.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Securities
    Subscription Agreement, dated November 4, 2021, between Murphy Canyon Acquisition Corp. and Murphy Canyon Acquisition Sponsor, LLC.
    (filed as Exhibit 10.5 to the Registrant&#8217;s Registration Statement on Form S-1 (333-262036) filed on January 6, 2022,
    and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex10-4.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Placement
    Unit Purchase Agreement, dated February 2, 2022, between Murphy Canyon Acquisition Corp. and Murphy Canyon Acquisition Sponsor, LLC
    (filed as Exhibit 10.4 to the Registrant&#8217;s Current Report on Form 8-K filed on February 2, 2022, and incorporated herein by
    reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222000566/ex10-7.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Form
    of Murphy Canyon Acquisition Corp. Indemnity Agreement (filed as Exhibit 10.7 to the Registrant&#8217;s Registration Statement on
    Form S-1 (333-262036) filed on January 6, 2022, and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222003484/ex10-6.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Administrative
    Support Agreement, dated January 31, 2022, by and between Murphy Canyon Acquisition Corp. and Murphy Canyon Management Group, Inc.
    (filed as Exhibit 10.6 to the Registrant&#8217;s Current Report on Form 8-K filed on February 2, 2022, and incorporated herein
    by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222032104/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Form
    of Subscription Agreement between Murphy Canyon Acquisition Corp. and the investors named therein (filed as Exhibit 10.1 to the Registrant&#8217;s
    Current Report on Form 8-K filed on November 14, 2022, and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222032104/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Form
    of Lock-Up Agreement (filed as Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on November 14, 2022, and
    incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222032104/ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Sponsor
    Support Agreement dated as of November 8, 2022, by and among Murphy Canyon Acquisition Corp. and each of the Persons set forth on
    Schedule I attached thereto (filed as Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed on November 14, 2022,
    and incorporated herein by reference)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315222032104/ex10-4.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Shareholder
    Support Agreement dated as of November 8, 2022, by and among Murphy Canyon Acquisition Corp., Conduit Pharmaceuticals Limited and
    each of the Persons set forth on Schedule I attached thereto. (filed as Exhibit 10.4 to the Registrant&#8217;s Current Report on
    Form 8-K filed November 14, 2022, and incorporated herein by reference)</span></a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 357; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315223002970/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Subscription Agreement dated as of January 27, 2023 between Murphy Canyon Acquisition Corp. and the investors named therein&#160;(filed as Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on January 30, 2023, and incorporated herein by reference)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1896212/000149315223006939/ex10-1.htm" style="-sec-extract: exhibit">Note
    Issued March 7, 2023 (filed as Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed March 8, 2023, and
    incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_004">Form
    of Conduit Pharmaceuticals Inc. 2023 Stock Incentive Plan (included as Annex C to this proxy statement/prospectus and incorporated
    herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-17.htm">Form
    of Stock Option Agreement</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17*#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Form of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with David Tapolczay</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18*#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with Adam Sragovicz </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-20.htm">Exclusive Funding Agreement between St George Street Capital and SGS Global Limited, dated March 26, 2021</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.20+</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-21.htm">AZD1656 Project Funding Agreement For Use In Renal Transplant between St George Street Capital Limited and Conduit Pharmaceuticals Limited, dated November 2, 2022</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.21+</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-22.htm">AZD1656 Project Funding Agreement For Use In Preterm Labour between St George Street Capital Limited and Conduit Pharmaceuticals Limited, dated November 2, 2022</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.22+</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-23.htm">AZD1656 Project Funding Agreement For Use In Hashimoto&#8217;s Thyroiditis between St George Street Capital Limited and Conduit Pharmaceuticals Limited, dated November 2, 2022</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.23+</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-24.htm">AZD1656 Project Funding Agreement For Use In Uvetis between St George Street Capital Limited and Conduit Pharmaceuticals Limited, dated November 2, 2022</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10.24+</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-25.htm">AZD5904 Project Funding Agreement between St George Street Capital Limited and Conduit Pharmaceuticals Limited, dated November 2, 2022</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries
    of Conduit Pharmaceuticals Limited </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of Marcum LLP, independent public accounting firm of Murphy Canyon Acquisition Corp.</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-2.htm">Consent of Marcum LLP, independent public accounting firm of Conduit Pharmaceuticals Limited</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Sichenzia Ross Ference LLP (included in Exhibit 5.1 hereto) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Thompson Hine LLP (included in Exhibit 8.1 hereto)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-5.htm">Consent of ValueScope, Inc.</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#poa_001">Power
    of Attorney (included on signature page to the proxy statement/prospectus which forms part of this registration statement)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Consent of Dr. Freda-Lewis Hall (Director nominee)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-2.htm">Consent
    of Dr. David Tapolczay (Director nominee)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-3.htm">Consent
    of James Bligh (Director nominee)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-4.htm">Consent
    of Faith L. Charles (Director nominee)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-5.htm">Consent
    of Chele Chiavacci Farley (Director nominee)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-6.htm">Consent
    of Jennifer I. McNealey (Director nominee)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-7.htm">Consent
    of Andrew Regan (Director nominee)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#annex_005">Opinion
    of ValueScope, Inc. (included as Annex D to this proxy statement/prospectus and incorporated herein by reference)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.9*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Proxy Card </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex107.htm">Filing
    Fee Table</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; width: 25%; margin-right: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
To be filed by amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
Management contract or compensatory plan or arrangement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+
Certain portions of this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(10). The Registrant agrees to
furnish supplementally an unredacted copy of this Exhibit to the SEC upon its request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 358; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
22. Undertakings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
    if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering
    price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
    to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
    be deemed to be the initial bona fide offering thereof.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule
    424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other
    than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of
    the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus
    that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
    statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
    to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the
    registration statement or made in any such document immediately prior to such date of first use.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution
    of the securities, that in a primary offering of securities of the undersigned registrant pursuant to this registration statement,
    regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such
    purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will
    be considered to offer or sell such securities to such purchaser:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 359; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
    as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
    persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
    of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore,
    unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of
    expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,
    suit or proceeding) is asserted by such Director, officer or controlling person in connection with the securities being registered,
    the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
    of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and
    will be governed by the final adjudication of such issue.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration
    statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that
    such reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings
    by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    every prospectus: (1) that is filed pursuant to the immediately preceding paragraph, or (2) that purports to meet the requirements
    of Section 10(a)(3) of the Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part
    of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining
    any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement
    relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona
    fide offering thereof.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    respond to requests for information that is incorporated by reference into the prospectus pursuant to Item 4, 10(b), 11, or 13 of
    this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other
    equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration
    statement through the date of responding to the request.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein,
    that was not the subject of and included in the registration statement when it became effective.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 360; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in San Diego, California, on the 12<sup>th</sup> day of May, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MURPHY
    CANYON ACQUISITION CORP.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jack K. Heilbron</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    K. Heilbron</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="poa_001"></span>KNOW
ALL MEN AND WOMEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Jack K. Heilbron
and <span style="background-color: white">Adam Sragovicz</span>, acting singly, his true and lawful attorney-in-fact, with full power
of substitution and resubstitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments
including post-effective amendments to this proxy statement/prospectus and to file the same, with all exhibits thereto, and other documents
in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact
or his substitute, each acting alone, may lawfully do or cause to be done by virtue thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities
and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 27%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 42%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 24%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><i>/s/
    Jack K. Heilbron</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    Chief Executive Officer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">May
                                            12, 2023</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack K. Heilbron</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><i>/s/
    Adam Sragovicz</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer, Treasurer, and director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">May
                                            12, 2023</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam Sragovicz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><i>/s/
    Chele Chiavacci Farley</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">May
                                            12, 2023</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chele Chiavacci Farley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><i>/s/
    Richard Feinberg</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">May
                                            12, 2023</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Feinberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><i>/s/
    Francis Knuettel</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">May
                                            12, 2023</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis Knuettel II</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 361; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.5
<SEQUENCE>2
<FILENAME>ex3-5.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 3.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED BY LAWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT
PHARMACEUTICALS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(THE
&#8220;CORPORATION&#8221;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Amended and Restated Bylaws of Conduit Pharmaceuticals, Inc. a Delaware corporation (the &#8220;Corporation&#8221;), are effective as
of [&nbsp;&nbsp;&nbsp;&nbsp;], 2023, and hereby amend the restated bylaws of the Corporation in its entirety:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OFFICES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.1. Registered Office</B>. The registered office of the Corporation within the State of Delaware shall be located at either (a) the
principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as
the Corporation&#8217;s registered agent in Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.2. Additional Offices</B>. The Corporation may, in addition to its registered office in the State of Delaware, have such other offices
and places of business, both within and outside the State of Delaware, as the Board of Directors of the Corporation (the &#8220;<B><I>Board</I></B>&#8221;)
may from time to time determine or as the business and affairs of the Corporation may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCKHOLDERS
MEETINGS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.1. Annual Meetings</B>. The annual meeting of stockholders shall be held at such place, either within or without the State of Delaware,
and time and on such date as shall be determined by the Board and stated in the notice of the meeting, provided that the Board may in
its sole discretion determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication
pursuant to <U>Section 9.5(a)</U>. At each annual meeting, the stockholders entitled to vote on such matters shall elect those directors
of the Corporation to fill any term of a directorship that expires on the date of such annual meeting and may transact any other business
as may properly be brought before the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.2. Special Meetings</B>. Subject to the rights of the holders of any outstanding series of the preferred stock of the Corporation (&#8220;<B><I>Preferred
Stock</I></B>&#8221;), and to the requirements of applicable law, special meetings of stockholders, for any purpose or purposes, may
be called only by the Chairman of the Board, the Chief Executive Officer, or the Board pursuant to a resolution adopted by a majority
of the Board, and may not be called by any other person. Special meetings of stockholders shall be held at such place, either within
or without the State of Delaware, and at such time and on such date as shall be determined by the Board and stated in the Corporation&#8217;s
notice of the meeting, provided that the Board may in its sole discretion determine that the meeting shall not be held at any place,
but may instead be held solely by means of remote communication pursuant to <U>Section 9.5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.3. Notices.</B> Written notice of each stockholders meeting stating the place, if any, date, and time of the meeting, and the means
of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting
and the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date
for determining stockholders entitled to notice of the meeting, shall be given in the manner permitted by <U>Section 9.3</U> to each
stockholder entitled to vote thereat as of the record date for determining the stockholders entitled to notice of the meeting, by the
Corporation not less than 10 nor more than 60 days before the date of the meeting unless otherwise required by the General Corporation
Law of the State of Delaware (the &#8220;<B><I>DGCL</I></B>&#8221;). If said notice is for a stockholders meeting other than an annual
meeting, it shall in addition state the purpose or purposes for which the meeting is called, and the business transacted at such meeting
shall be limited to the matters so stated in the Corporation&#8217;s notice of meeting (or any supplement thereto). Any meeting of stockholders
as to which notice has been given may be postponed, and any meeting of stockholders as to which notice has been given may be cancelled,
by the Board upon public announcement (as defined in Section 2.7(c)) given before the date previously scheduled for such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.4. Quorum</B>. Except as otherwise provided by applicable law, the Corporation&#8217;s Certificate of Incorporation, as the same may
be amended or restated from time to time (the &#8220;<B><I>Certificate of Incorporation</I></B>&#8221;) or these By Laws, the presence,
in person or by proxy, at a stockholders meeting of the holders of shares of outstanding capital stock of the Corporation representing
a majority of the voting power of all outstanding shares of capital stock of the Corporation entitled to vote at such meeting shall constitute
a quorum for the transaction of business at such meeting, except that when specified business is to be voted on by a class or series
of stock voting as a class, the holders of shares representing a majority of the voting power of the outstanding shares of such class
or series shall constitute a quorum of such class or series for the transaction of such business. If a quorum shall not be present or
represented by proxy at any meeting of the stockholders of the Corporation, the chairman of the meeting may adjourn the meeting from
time to time in the manner provided in <U>Section 2.6</U> until a quorum shall attend. The stockholders present at a duly convened meeting
may continue to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum.
Shares of its own stock belonging to the Corporation or to another corporation, if a majority of the voting power of the shares entitled
to vote in the election of directors of such other corporation is held, directly or indirectly, by the Corporation, shall neither be
entitled to vote nor be counted for quorum purposes; provided, however, that the foregoing shall not limit the right of the Corporation
or any such other corporation to vote shares held by it in a fiduciary capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.5. Voting of Shares</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Voting Lists</U>. The Secretary of the Corporation (the &#8220;<B><I>Secretary</I></B>&#8221;) shall prepare, or shall cause the officer
or agent who has charge of the stock ledger of the Corporation to prepare and make, at least 10 days before every meeting of stockholders,
a complete list of the stockholders of record entitled to vote at such meeting; provided, however, that if the record date for determining
the stockholders entitled to vote is less than 10 days before the meeting date, the list shall reflect the stockholders entitled to vote
as of the tenth day before the meeting date, arranged in alphabetical order and showing the address and the number and class of shares
registered in the name of each stockholder. Nothing contained in this Section 2.5(a) shall require the Corporation to include electronic
mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for
any purpose germane to the meeting, during ordinary business hours for a period of at least 10 days prior to the meeting: (i) on a reasonably
accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the
meeting, or (ii) during ordinary business hours, at the principal place of business of the Corporation. In the event that the Corporation
determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information
is available only to stockholders of the Corporation. If the meeting is to be held at a place, then the list shall be produced and kept
at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If a meeting
of stockholders is to be held solely by means of remote communication as permitted by Section 9.5(a), the list shall be open to the examination
of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to
access such list shall be provided with the notice of meeting. The stock ledger shall be the only evidence as to who are the stockholders
entitled to examine the list required by this Section 2.5(a) or to vote in person or by proxy at any meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Manner of Voting</U>. At any stockholders meeting, every stockholder entitled to vote may vote in person or by proxy. If authorized
by the Board, the voting by stockholders or proxy holders at any meeting conducted by remote communication may be effected by a ballot
submitted by electronic transmission (as defined in <U>Section 9.3</U>), provided that any such electronic transmission must either set
forth or be submitted with information from which the Corporation can determine that the electronic transmission was authorized by the
stockholder or proxy holder. The Board, in its discretion, or the chairman of the meeting of stockholders, in such person&#8217;s discretion,
may require that any votes cast at such meeting shall be cast by written ballot.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Proxies</U>. Each stockholder entitled to vote at a meeting of stockholders or to express consent or dissent to corporate action in
writing without a meeting may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted
or acted upon after three years from its date, unless the proxy provides for a longer period. Proxies need not be filed with the Secretary
until the meeting is called to order, but shall be filed with the Secretary before being voted. Without limiting the manner in which
a stockholder may authorize another person or persons to act for such stockholder as proxy, either of the following shall constitute
a valid means by which a stockholder may grant such authority. No stockholder shall have cumulative voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A stockholder may execute a writing authorizing another person or persons to act for such stockholder as proxy. Execution may be accomplished
by the stockholder or such stockholder&#8217;s authorized officer, director, employee or agent signing such writing or causing such person&#8217;s
signature to be affixed to such writing by any reasonable means, including, but not limited to, by facsimile signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A stockholder may authorize another person or persons to act for such stockholder as proxy by transmitting or authorizing the transmission
of an electronic transmission to the person who will be the holder of the proxy or to a proxy solicitation firm, proxy support service
organization or like agent duly authorized by the person who will be the holder of the proxy to receive such transmission, provided that
any such electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic
transmission was authorized by the stockholder. Any copy, facsimile telecommunication or other reliable reproduction of the writing or
transmission authorizing another person or persons to act as proxy for a stockholder may be substituted or used in lieu of the original
writing or transmission for any and all purposes for which the original writing or transmission could be used; provided that such copy,
facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or transmission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Required Vote</U>. Subject to the rights of the holders of one or more series of Preferred Stock, voting separately by class or series,
to elect directors pursuant to the terms of one or more series of Preferred Stock, at all meetings of stockholders at which a quorum
is present, the election of directors shall be determined by a plurality of the votes cast by the stockholders present in person or represented
by proxy at the meeting and entitled to vote thereon. All other matters presented to the stockholders at a meeting at which a quorum
is present shall be determined by the vote of a majority of the votes cast by the stockholders present in person or represented by proxy
at the meeting and entitled to vote thereon, unless the matter is one upon which, by applicable law, the Certificate of Incorporation,
these By Laws or applicable stock exchange rules, a different vote is required, in which case such provision shall govern and control
the decision of such matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Inspectors of Election</U>. The Board may, and shall if required by law, in advance of any meeting of stockholders, appoint one or
more persons as inspectors of election, who may be employees of the Corporation or otherwise serve the Corporation in other capacities,
to act at such meeting of stockholders or any adjournment thereof and to make a written report thereof. The Board may appoint one or
more persons as alternate inspectors to replace any inspector who fails to act. If no inspectors of election or alternates are appointed
by the Board, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before discharging
his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to
the best of his or her ability. The inspectors shall ascertain and report the number of outstanding shares and the voting power of each;
determine the number of shares present in person or represented by proxy at the meeting and the validity of proxies and ballots; count
all votes and ballots and report the results; determine and retain for a reasonable period a record of the disposition of any challenges
made to any determination by the inspectors; and certify their determination of the number of shares represented at the meeting and their
count of all votes and ballots. No person who is a candidate for an office at an election may serve as an inspector at such election.
Each report of an inspector shall be in writing and signed by the inspector or by a majority of them if there is more than one inspector
acting at such meeting. If there is more than one inspector, the report of a majority shall be the report of the inspectors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.6. Adjournments</B>. Any meeting of stockholders, annual or special, may be adjourned by the chairman of the meeting, from time to
time, whether or not there is a quorum, to reconvene at the same or some other place. Notice need not be given of any such adjourned
meeting if the date, time, and place, if any, thereof, and the means of remote communication, if any, by which stockholders and proxy
holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment
is taken. At the adjourned meeting the stockholders, or the holders of any class or series of stock entitled to vote separately as a
class, as the case may be, may transact any business that might have been transacted at the original meeting. If the adjournment is for
more than 30 days, notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after
the adjournment a new record date for stockholders entitled to vote is fixed for the adjourned meeting, the Board shall fix a new record
date for notice of such adjourned meeting in accordance with <U>Section 9.2</U>, and shall give notice of the adjourned meeting to each
stockholder of record entitled to vote at such adjourned meeting as of the record date fixed for notice of such adjourned meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.7. Advance Notice for Business</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Annual Meetings of Stockholders</U>. No business may be transacted at an annual meeting of stockholders, other than business that
is either (i) specified in the Corporation&#8217;s notice of meeting (or any supplement thereto) given by or at the direction of the
Board, (ii) otherwise properly brought before the annual meeting by or at the direction of the Board or (iii) otherwise properly brought
before the annual meeting by any stockholder of the Corporation (x) who is a stockholder of record entitled to vote at such annual meeting
on the date of the giving of the notice provided for in this <U>Section 2.7(a)</U> and on the record date for the determination of stockholders
entitled to vote at such annual meeting and (y) who complies with the notice procedures set forth in this <U>Section 2.7(a)</U>. Notwithstanding
anything in this <U>Section 2.7(a)</U> to the contrary, only persons nominated for election as a director to fill any term of a directorship
that expires on the date of the annual meeting pursuant to <U>Section 3.2</U> will be considered for election at such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
In addition to any other applicable requirements, for business (other than nominations) to be properly brought before an annual meeting
by a stockholder, such stockholder must have given timely notice thereof in proper written form to the Secretary and such business must
otherwise be a proper matter for stockholder action. Subject to <U>Section 2.7(a)(iii)</U>, a stockholder&#8217;s notice to the Secretary
with respect to such business, to be timely, must be received by the Secretary at the principal executive offices of the Corporation
not later than the close of business on the 90th day nor earlier than the opening of business on the 120th day before the anniversary
date of the immediately preceding annual meeting of stockholders; provided, however, that in the event that the annual meeting is more
than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so delivered not
earlier than the close of business on the 120th day before the meeting and not later than the later of (x) the close of business on the
90th day before the meeting or (y) the close of business on the 10th day following the day on which public announcement of the date of
the annual meeting is first made by the Corporation. The public announcement of an adjournment or postponement of an annual meeting shall
not commence a new time period (or extend any time period) for the giving of a stockholder&#8217;s notice as described in this Section
2.7(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To be in proper written form, a stockholder&#8217;s notice to the Secretary with respect to any business (other than nominations) must
set forth as to each such matter such stockholder proposes to bring before the annual meeting (A) a brief description of the business
desired to be brought before the annual meeting, the text of the proposal or business (including the text of any resolutions proposed
for consideration and in the event such business includes a proposal to amend these By Laws, the language of the proposed amendment)
and the reasons for conducting such business at the annual meeting, (B) the name and record address of such stockholder and the name
and address of the beneficial owner, if any, on whose behalf the proposal is made, (C) the class or series and number of shares of capital
stock of the Corporation that are owned beneficially and of record by such stockholder and by the beneficial owner, if any, on whose
behalf the proposal is made, (D) a description of all arrangements or understandings between such stockholder and the beneficial owner,
if any, on whose behalf the proposal is made and any other person or persons (including their names) in connection with the proposal
of such business by such stockholder, (E) any material interest of such stockholder and the beneficial owner, if any, on whose behalf
the proposal is made in such business and (F) a representation that such stockholder (or a qualified representative of such stockholder)
intends to appear in person or by proxy at the annual meeting to bring such business before the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The foregoing notice requirements of this <U>Section 2.7(a)</U> shall be deemed satisfied by a stockholder as to any proposal (other
than nominations) if the stockholder has notified the Corporation of such stockholder&#8217;s intention to present such proposal at
an annual meeting in compliance with Rule 14a-8 (or any successor thereof) of the Securities Exchange Act of 1934, as amended (the
&#8220;<B><I>Exchange Act</I></B>&#8221;), and such stockholder has complied with the requirements of such Rule for inclusion of
such proposal in a proxy statement prepared by the Corporation to solicit proxies for such annual meeting. No business shall be
conducted at the annual meeting of stockholders except business brought before the annual meeting in accordance with the procedures
set forth in this <U>Section 2.7(a)</U>, provided, however, that once business has been properly brought before the annual meeting
in accordance with such procedures, nothing in this <U>Section 2.7(a)</U> shall be deemed to preclude discussion by any stockholder
of any such business. If the Board or the chairman of the annual meeting determines that any stockholder proposal was not made in
accordance with the provisions of this <U>Section 2.7(a)</U> or that the information provided in a stockholder&#8217;s notice does
not satisfy the information requirements of this <U>Section 2.7(a)</U>, such proposal shall not be presented for action at the
annual meeting. Notwithstanding the foregoing provisions of this <U>Section 2.7(a)</U>, if the stockholder (or a qualified
representative of the stockholder) does not appear at the annual meeting of stockholders of the Corporation to present the proposed
business, such proposed business shall not be transacted, notwithstanding that proxies in respect of such matter may have been
received by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
In addition to the provisions of this <U>Section 2.7(a)</U>, a stockholder shall also comply with all applicable requirements of the
Exchange Act and the rules and regulations thereunder with respect to the matters set forth herein. Nothing in this <U>Section 2.7(a)
</U>shall be deemed to affect any rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy statement
pursuant to Rule 14a-8 under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Special Meetings of Stockholders</U>. Only such business shall be conducted at a special meeting of stockholders as shall have been
brought before the meeting pursuant to the Corporation&#8217;s notice of meeting. Nominations of persons for election to the Board may
be made at a special meeting of stockholders at which directors are to be elected pursuant to the Corporation&#8217;s notice of meeting
only pursuant to <U>Section 3.2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Public Announcement</U>. For purposes of these By Laws, &#8220;<B><I>public announcement</I></B>&#8221; shall mean disclosure in a
press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly
filed by the Corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d) of the Exchange Act (or any
successor thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.8. Conduct of Meetings</B>. The chairman of each annual and special meeting of stockholders shall be the Chairman of the Board or,
in the absence (or inability or refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director)
or, in the absence (or inability or refusal to act) of the Chief Executive Officer or if the Chief Executive Officer is not a director,
the President (if he or she shall be a director) or, in the absence (or inability or refusal to act) of the President or if the President
is not a director, such other person as shall be appointed by the Board. The date and time of the opening and the closing of the polls
for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting by the chairman of the meeting.
The Board may adopt such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. Except to
the extent inconsistent with these By Laws or such rules and regulations as adopted by the Board, the chairman of any meeting of stockholders
shall have the right and authority to convene and to adjourn the meeting, to prescribe such rules, regulations and procedures and to
do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations
or procedures, whether adopted by the Board or prescribed by the chairman of the meeting, may include, without limitation, the following:
(a) the establishment of an agenda or order of business for the meeting; (b) rules and procedures for maintaining order at the meeting
and the safety of those present; (c) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation,
their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine; (d) restrictions
on entry to the meeting after the time fixed for the commencement thereof; and (e) limitations on the time allotted to questions or comments
by participants. Unless and to the extent determined by the Board or the chairman of the meeting, meetings of stockholders shall not
be required to be held in accordance with the rules of parliamentary procedure. The secretary of each annual and special meeting of stockholders
shall be the Secretary or, in the absence (or inability or refusal to act) of the Secretary, an Assistant Secretary so appointed to act
by the chairman of the meeting. In the absence (or inability or refusal to act) of the Secretary and all Assistant Secretaries, the chairman
of the meeting may appoint any person to act as secretary of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.9. No Action Without a Meeting. </B>No action shall be taken by the stockholders except at an annual or special meeting of stockholders
called and noticed in the manner required by these bylaws. The stockholders may not in any circumstance take action by written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.1. Powers; Number</B>. The business and affairs of the Corporation shall be managed by or under the direction of the Board, which may
exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation
or by these By Laws required to be exercised or done by the stockholders. Directors need not be stockholders or residents of the State
of Delaware. Subject to the Certificate of Incorporation, the Board shall consist of not less than three (3) and not more than nine (9)
directors as fixed from time to time exclusively by the Board pursuant to a resolution adopted by a majority of the Board. Directors
shall be elected at each annual meeting of stockholders, with each director to hold office until the next annual meeting and until his
or her successor shall have been duly elected and qualified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.2. Advance Notice for Nomination of Directors</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the Corporation,
except as may be otherwise provided by the terms of one or more series of Preferred Stock with respect to the rights of holders of one
or more series of Preferred Stock to elect directors. Nominations of persons for election to the Board at any annual meeting of stockholders,
or at any special meeting of stockholders called for the purpose of electing directors as set forth in the Corporation&#8217;s notice
of such special meeting, may be made (i) by or at the direction of the Board or (ii) by any stockholder of the Corporation (x) who is
a stockholder of record entitled to vote in the election of directors on the date of the giving of the notice provided for in this <U>Section
3.2</U> and on the record date for the determination of stockholders entitled to vote at such meeting and (y) who complies with the notice
procedures set forth in this <U>Section 3.2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In addition to any other applicable requirements, for a nomination to be made by a stockholder, such stockholder must have given timely
notice thereof in proper written form to the Secretary. To be timely, a stockholder&#8217;s notice to the Secretary must be received
by the Secretary at the principal executive offices of the Corporation (i) in the case of an annual meeting, not later than the close
of business on the 90th day nor earlier than the close of business on the 120th day before the anniversary date of the immediately preceding
annual meeting of stockholders; provided, however, that in the event that the annual meeting is more than 30 days before or more than
60 days after such anniversary date, notice by the stockholder to be timely must be so received not earlier than the close of business
on the 120th day before the meeting and not later than the later of (x) the close of business on the 90th day before the meeting or (y)
the close of business on the 10th day following the day on which public announcement of the date of the annual meeting was first made
by the Corporation; and (ii) in the case of a special meeting of stockholders called for the purpose of electing directors, not later
than the close of business on the 10th day following the day on which public announcement of the date of the special meeting is first
made by the Corporation. In no event shall the public announcement of an adjournment or postponement of an annual meeting or special
meeting commence a new time period (or extend any time period) for the giving of a stockholder&#8217;s notice as described in this <U>Section
3.2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding anything in paragraph (b) to the contrary, in the event that the number of directors to be elected to the Board at an
annual meeting is greater than the number of directors whose terms expire on the date of the annual meeting and there is no public announcement
by the Corporation naming all of the nominees for the additional directors to be elected or specifying the size of the increased Board
before the close of business on the 90th day prior to the anniversary date of the immediately preceding annual meeting of stockholders,
a stockholder&#8217;s notice required by this <U>Section 3.2</U> shall also be considered timely, but only with respect to nominees for
the additional directorships created by such increase that are to be filled by election at such annual meeting, if it shall be received
by the Secretary at the principal executive offices of the Corporation not later than the close of business on the 10th day following
the date on which such public announcement was first made by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
To be in proper written form, a stockholder&#8217;s notice to the Secretary must set forth (i) as to each person whom the
stockholder proposes to nominate for election as a director (A) the name, age, business address and residence address of the person,
(B) the principal occupation or employment of the person, (C) the class or series and number of shares of capital stock of the
Corporation that are owned beneficially or of record by the person and (D) any other information relating to the person that would
be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies
for election of directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder; and (ii)
as to the stockholder giving the notice (A) the name and record address of such stockholder as they appear on the
Corporation&#8217;s books and the name and address of the beneficial owner, if any, on whose behalf the nomination is made, (B) the
class or series and number of shares of capital stock of the Corporation that are owned beneficially and of record by such
stockholder and the beneficial owner, if any, on whose behalf the nomination is made, (C) a description of all arrangements or
understandings relating to the nomination to be made by such stockholder among such stockholder, the beneficial owner, if any, on
whose behalf the nomination is made, each proposed nominee and any other person or persons (including their names), (D) a
representation that such stockholder (or a qualified representative of such stockholder) intends to appear in person or by proxy at
the meeting to nominate the persons named in its notice and (E) any other information relating to such stockholder and the
beneficial owner, if any, on whose behalf the nomination is made that would be required to be disclosed in a proxy statement or
other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of
the Exchange Act and the rules and regulations promulgated thereunder. Such notice must be accompanied by a written consent of each
proposed nominee to being named as a nominee and to serve as a director if elected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If the Board or the chairman of the meeting of stockholders determines that any nomination was not made in accordance with the provisions
of this <U>Section 3.2</U>, or that the information provided in a stockholder&#8217;s notice does not satisfy the information requirements
of this <U>Section 3.2</U>, then such nomination shall not be considered at the meeting in question. Notwithstanding the foregoing provisions
of this <U>Section 3.2</U>, if the stockholder (or a qualified representative of the stockholder) does not appear at the meeting of stockholders
of the Corporation to present the nomination, such nomination shall be disregarded, notwithstanding that proxies in respect of such nomination
may have been received by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
In addition to the provisions of this <U>Section 3.2</U>, a stockholder shall also comply with all of the applicable requirements of
the Exchange Act and the rules and regulations thereunder with respect to the matters set forth herein. Nothing in this <U>Section 3.2
</U>shall be deemed to affect any rights of the holders of Preferred Stock to elect directors pursuant to the Certificate of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.3. Compensation</B>. Unless otherwise restricted by the Certificate of Incorporation or these By Laws, the Board shall have the authority
to fix the compensation of directors, including for service on a committee of the Board, and may be paid either a fixed sum for attendance
at each meeting of the Board or other compensation as director. The directors may be reimbursed their expenses, if any, of attendance
at each meeting of the Board. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving
compensation therefor. Members of committees of the Board may be allowed like compensation and reimbursement of expenses for service
on the committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BOARD
MEETINGS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.1. Annual Meetings</B>. The Board shall meet as soon as practicable after the adjournment of each annual stockholders meeting at the
place of the annual stockholders meeting unless the Board shall fix another time and place and give notice thereof in the manner required
herein for special meetings of the Board. No notice to the directors shall be necessary to legally convene this meeting, except as provided
in this <U>Section 4.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.2. Regular Meetings</B>. Regularly scheduled, periodic meetings of the Board may be held without notice at such times, dates and places
(within or without the State of Delaware) as shall from time to time be determined by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.3. Special Meetings</B>. Special meetings of the Board (a) may be called by the Chairman of the Board or President and (b) shall be
called by the Chairman of the Board, President or Secretary on the written request of at least a majority of directors then in office,
or the sole director, as the case may be, and shall be held at such time, date and place (within or without the State of Delaware) as
may be determined by the person calling the meeting or, if called upon the request of directors or the sole director, as specified in
such written request. Notice of each special meeting of the Board shall be given, as provided in <U>Section 9.3</U>, to each director
(i) at least 24 hours before the meeting if such notice is oral notice given personally or by telephone or written notice given by hand
delivery or by means of a form of electronic transmission and delivery; (ii) at least two days before the meeting if such notice is sent
by a nationally recognized overnight delivery service; and (iii) at least five days before the meeting if such notice is sent through
the United States mail. If the Secretary shall fail or refuse to give such notice, then the notice may be given by the officer who called
the meeting or the directors who requested the meeting. Any and all business that may be transacted at a regular meeting of the Board
may be transacted at a special meeting. Except as may be otherwise expressly provided by applicable law, the Certificate of Incorporation,
or these By Laws, neither the business to be transacted at, nor the purpose of, any special meeting need be specified in the notice or
waiver of notice of such meeting. A special meeting may be held at any time without notice if all the directors are present or if those
not present waive notice of the meeting in accordance with <U>Section 9.4</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.4. Quorum; Required Vote</B>. A majority of the Board shall constitute a quorum for the transaction of business at any meeting of
the Board, and the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the
Board, except as may be otherwise specifically provided by applicable law, the Certificate of Incorporation or these By Laws. If a
quorum shall not be present at any meeting, a majority of the directors present may adjourn the meeting from time to time, without
notice other than announcement at the meeting, until a quorum is present.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.5. Consent In Lieu of Meeting</B>. Unless otherwise restricted by the Certificate of Incorporation or these By Laws, any action required
or permitted to be taken at any meeting of the Board or any committee thereof may be taken without a meeting if all members of the Board
or committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic
transmission or transmissions (or paper reproductions thereof) are filed with the minutes of proceedings of the Board or committee. Such
filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained
in electronic form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.6. Organization</B>. The chairman of each meeting of the Board shall be the Chairman of the Board or, in the absence (or inability
or refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director) or, in the absence (or
inability or refusal to act) of the Chief Executive Officer or if the Chief Executive Officer is not a director, the President (if he
or she shall be a director) or in the absence (or inability or refusal to act) of the President or if the President is not a director,
a chairman elected from the directors present. The Secretary shall act as secretary of all meetings of the Board. In the absence (or
inability or refusal to act) of the Secretary, an Assistant Secretary shall perform the duties of the Secretary at such meeting. In the
absence (or inability or refusal to act) of the Secretary and all Assistant Secretaries, the chairman of the meeting may appoint any
person to act as secretary of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMITTEES
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.1. Establishment</B>. The Board may by resolution of the Board designate one or more committees, each committee to consist of one or
more of the directors of the Corporation. Each committee shall keep regular minutes of its meetings and report the same to the Board
when required by the resolution designating such committee. The Board shall have the power at any time to fill vacancies in, to change
the membership of, or to dissolve any such committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.2. Available Powers</B>. Any committee established pursuant to <U>Section 5.1</U> hereof, to the extent permitted by applicable law
and by resolution of the Board, shall have and may exercise all of the powers and authority of the Board in the management of the business
and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers that may require it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.3. Alternate Members</B>. The Board may designate one or more directors as alternate members of any committee, who may replace any
absent or disqualified member at any meeting of such committee. In the absence or disqualification of a member of the committee, the
member or members thereof present at any meeting and not disqualified from voting, whether or not he, she or they constitute a quorum,
may unanimously appoint another member of the Board to act at the meeting in place of any such absent or disqualified member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.4. Procedures</B>. Unless the Board otherwise provides, the time, date, place, if any, and notice of meetings of a committee shall
be determined by such committee. At meetings of a committee, a majority of the number of members of the committee (but not including
any alternate member, unless such alternate member has replaced any absent or disqualified member at the time of, or in connection with,
such meeting) shall constitute a quorum for the transaction of business. The act of a majority of the members present at any meeting
at which a quorum is present shall be the act of the committee, except as otherwise specifically provided by applicable law, the Certificate
of Incorporation, these By Laws or the Board. If a quorum is not present at a meeting of a committee, the members present may adjourn
the meeting from time to time, without notice other than an announcement at the meeting, until a quorum is present. Unless the Board
otherwise provides and except as provided in these By Laws, each committee designated by the Board may make, alter, amend and repeal
rules for the conduct of its business. In the absence of such rules each committee shall conduct its business in the same manner as the
Board is authorized to conduct its business pursuant to <U>Article III</U> and <U>Article IV</U> of these By Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.1. Officers</B>. The officers of the Corporation elected by the Board shall be a Chief Executive Officer, a Chief Financial Officer,
a Secretary and such other officers (including, without limitation, a Chairman of the Board, a President, Vice Presidents, Assistant
Secretaries, a Treasurer and Assistant Treasurers) as the Board from time to time may determine. Officers elected by the Board shall
each have such powers and duties as generally pertain to their respective offices, subject to the specific provisions of this <U>Article
VI</U>. Such officers shall also have such powers and duties as from time to time may be conferred by the Board. The Chief Executive
Officer or President may also appoint such other officers (including without limitation one or more Vice Presidents and Controllers)
as may be necessary or desirable for the conduct of the business of the Corporation. Such other officers shall have such powers and duties
and shall hold their offices for such terms as may be provided in these By Laws or as may be prescribed by the Board or, if such officer
has been appointed by the Chief Executive Officer or President, as may be prescribed by the appointing officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Chairman of the Board</U>. The Chairman of the Board shall preside when present at all meetings of the stockholders and the Board.
The Chairman of the Board shall have general supervision and control of the acquisition activities of the Corporation subject to the
ultimate authority of the Board, and shall be responsible for the execution of the policies of the Board with respect to such matters.
In the absence (or inability or refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director)
shall preside when present at all meetings of the stockholders and the Board. The powers and duties of the Chairman of the Board shall
not include supervision or control of the preparation of the financial statements of the Corporation (other than through participation
as a member of the Board). The position of Chairman of the Board and Chief Executive Officer may be held by the same person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Chief Executive Officer</U>. The Chief Executive Officer shall be the chief executive officer of the Corporation, shall have general
supervision of the affairs of the Corporation and general control of all of its business subject to the ultimate authority of the Board,
and shall be responsible for the execution of the policies of the Board with respect to such matters, except to the extent any such powers
and duties have been prescribed to the Chairman of the Board pursuant to <U>Section 6.1(a)</U> above. In the absence (or inability or
refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director) shall preside when present
at all meetings of the stockholders and the Board. The position of Chief Executive Officer and President may be held by the same person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>President</U>. The President shall make recommendations to the Chief Executive Officer on all operational matters that would normally
be reserved for the final executive responsibility of the Chief Executive Officer. In the absence (or inability or refusal to act) of
the Chairman of the Board and Chief Executive Officer, the President (if he or she shall be a director) shall preside when present at
all meetings of the stockholders and the Board. The President shall also perform such duties and have such powers as shall be designated
by the Board. The position of President and Chief Executive Officer may be held by the same person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Vice Presidents</U>. In the absence (or inability or refusal to act) of the President, the Vice President (or in the event there be
more than one Vice President, the Vice Presidents in the order designated by the Board) shall perform the duties and have the powers
of the President. Any one or more of the Vice Presidents may be given an additional designation of rank or function.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Secretary</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Secretary shall attend all meetings of the stockholders, the Board and (as required) committees of the Board and shall record
the proceedings of such meetings in books to be kept for that purpose. The Secretary shall give, or cause to be given, notice of all
meetings of the stockholders and special meetings of the Board and shall perform such other duties as may be prescribed by the
Board, the Chairman of the Board, Chief Executive Officer or President. The Secretary shall have custody of the corporate seal of
the Corporation and the Secretary, or any Assistant Secretary, shall have authority to affix the same to any instrument requiring
it, and when so affixed, it may be attested by his or her signature or by the signature of such Assistant Secretary. The Board may
give general authority to any other officer to affix the seal of the Corporation and to attest the affixing thereof by his or her
signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Secretary shall keep, or cause to be kept, at the principal executive office of the Corporation or at the office of the Corporation&#8217;s
transfer agent or registrar, if one has been appointed, a stock ledger, or duplicate stock ledger, showing the names of the stockholders
and their addresses, the number and classes of shares held by each and, with respect to certificated shares, the number and date of certificates
issued for the same and the number and date of certificates cancelled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Assistant Secretaries</U>. The Assistant Secretary or, if there be more than one, the Assistant Secretaries in the order determined
by the Board shall, in the absence (or inability or refusal to act) of the Secretary, perform the duties and have the powers of the Secretary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Chief Financial Officer</U>. The Chief Financial Officer shall perform all duties commonly incident to that office (including, without
limitation, the care and custody of the funds and securities of the Corporation, which from time to time may come into the Chief Financial
Officer&#8217;s hands and the deposit of the funds of the Corporation in such banks or trust companies as the Board, the Chief Executive
Officer or the President may authorize).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Treasurer</U>. The Treasurer shall, in the absence (or inability or refusal to act) of the Chief Financial Officer, perform the duties
and exercise the powers of the Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.2. Term of Office; Removal; Vacancies</B>. The elected officers of the Corporation shall be appointed by the Board and shall hold office
until their successors are duly elected and qualified by the Board or until their earlier death, resignation, retirement, disqualification,
or removal from office. Any officer may be removed, with or without cause, at any time by the Board. Any officer appointed by the Chief
Executive Officer or President may also be removed, with or without cause, by the Chief Executive Officer or President, as the case may
be, unless the Board otherwise provides. Any vacancy occurring in any elected office of the Corporation may be filled by the Board. Any
vacancy occurring in any office appointed by the Chief Executive Officer or President may be filled by the Chief Executive Officer, or
President, as the case may be, unless the Board then determines that such office shall thereupon be elected by the Board, in which case
the Board shall elect such officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.3. Other Officers</B>. The Board may delegate the power to appoint such other officers and agents, and may also remove such officers
and agents or delegate the power to remove same, as it shall from time to time deem necessary or desirable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.4. Multiple Officeholders; Stockholder and Director Officers</B>. Any number of offices may be held by the same person unless the Certificate
of Incorporation or these By Laws otherwise provide. Officers need not be stockholders or residents of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.1. Certificated and Uncertificated Shares</B>. The shares of the Corporation may be certificated or uncertificated, subject to the
sole discretion of the Board and the requirements of the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.2. Multiple Classes of Stock</B>. If the Corporation shall be authorized to issue more than one class of stock or more than one
series of any class, the Corporation shall (a) cause the powers, designations, preferences and relative, participating, optional or
other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such
preferences and/or rights to be set forth in full or summarized on the face or back of any certificate that the Corporation issues
to represent shares of such class or series of stock or (b) in the case of uncertificated shares, within a reasonable time after the
issuance or transfer of such shares, send to the registered owner thereof a written notice containing the information required to be
set forth on certificates as specified in clause (a) above; provided, however, that, except as otherwise provided by applicable law,
in lieu of the foregoing requirements, there may be set forth on the face or back of such certificate or, in the case of
uncertificated shares, on such written notice a statement that the Corporation will furnish without charge to each stockholder who
so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of
stock or series thereof and the qualifications, limitations or restrictions of such preferences or rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.3. Signatures</B>. Each certificate representing capital stock of the Corporation shall be signed by or in the name of the Corporation
by (a) the Chairman of the Board, the Chief Executive Officer, the President or a Vice President and (b) the Treasurer, an Assistant
Treasurer, the Secretary or an Assistant Secretary of the Corporation. Any or all the signatures on the certificate may be a facsimile.
In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall
have ceased to be such officer, transfer agent or registrar before such certificate is issued, such certificate may be issued by the
Corporation with the same effect as if such person were such officer, transfer agent or registrar on the date of issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.4. Consideration and Payment for Shares</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to applicable law and the Certificate of Incorporation, shares of stock may be issued for such consideration, having in the case
of shares with par value a value not less than the par value thereof, and to such persons, as determined from time to time by the Board.
The consideration may consist of any tangible or intangible property or any benefit to the Corporation including cash, promissory notes,
services performed, contracts for services to be performed or other securities, or any combination thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to applicable law and the Certificate of Incorporation, shares may not be issued until the full amount of the consideration has
been paid, unless upon the face or back of each certificate issued to represent any partly paid shares of capital stock or upon the books
and records of the Corporation in the case of partly paid uncertificated shares, there shall have been set forth the total amount of
the consideration to be paid therefor and the amount paid thereon up to and including the time said certificate representing certificated
shares or said uncertificated shares are issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.5. Lost, Destroyed or Wrongfully Taken Certificates</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If an owner of a certificate representing shares claims that such certificate has been lost, destroyed or wrongfully taken, the Corporation
shall issue a new certificate representing such shares or such shares in uncertificated form if the owner: (i) requests such a new certificate
before the Corporation has notice that the certificate representing such shares has been acquired by a protected purchaser; (ii) if requested
by the Corporation, delivers to the Corporation a bond sufficient to indemnify the Corporation against any claim that may be made against
the Corporation on account of the alleged loss, wrongful taking or destruction of such certificate or the issuance of such new certificate
or uncertificated shares; and (iii) satisfies other reasonable requirements imposed by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If a certificate representing shares has been lost, apparently destroyed or wrongfully taken, and the owner fails to notify the Corporation
of that fact within a reasonable time after the owner has notice of such loss, apparent destruction or wrongful taking and the Corporation
registers a transfer of such shares before receiving notification, the owner shall be precluded from asserting against the Corporation
any claim for registering such transfer or a claim to a new certificate representing such shares or such shares in uncertificated form</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.6. Transfer of Stock</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If a certificate representing shares of the Corporation is presented to the Corporation with an endorsement requesting the registration
of transfer of such shares or an instruction is presented to the Corporation requesting the registration of transfer of uncertificated
shares, the Corporation shall register the transfer as requested if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
in the case of certificated shares, the certificate representing such shares has been surrendered;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
(A) with respect to certificated shares, the endorsement is made by the person specified by the certificate as entitled to such shares;
(B) with respect to uncertificated shares, an instruction is made by the registered owner of such uncertificated shares; or (C) with
respect to certificated shares or uncertificated shares, the endorsement or instruction is made by any other appropriate person or by
an agent who has actual authority to act on behalf of the appropriate person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Corporation has received a guarantee of signature of the person signing such endorsement or instruction or such other reasonable
assurance that the endorsement or instruction is genuine and authorized as the Corporation may request;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the transfer does not violate any restriction on transfer imposed by the Corporation that is enforceable in accordance with <U>Section
7.8(a)</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
such other conditions for such transfer as shall be provided for under applicable law have been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Whenever any transfer of shares shall be made for collateral security and not absolutely, the Corporation shall so record such fact in
the entry of transfer if, when the certificate for such shares is presented to the Corporation for transfer or, if such shares are uncertificated,
when the instruction for registration of transfer thereof is presented to the Corporation, both the transferor and transferee request
the Corporation to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.7. Registered Stockholders</B>. Before due presentment for registration of transfer of a certificate representing shares of the Corporation
or of an instruction requesting registration of transfer of uncertificated shares, the Corporation may treat the registered owner as
the person exclusively entitled to inspect for any proper purpose the stock ledger and the other books and records of the Corporation,
vote such shares, receive dividends or notifications with respect to such shares and otherwise exercise all the rights and powers of
the owner of such shares, except that a person who is the beneficial owner of such shares (if held in a voting trust or by a nominee
on behalf of such person) may, upon providing documentary evidence of beneficial ownership of such shares and satisfying such other conditions
as are provided under applicable law, may also so inspect the books and records of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.8. Effect of the Corporation&#8217;s Restriction on Transfer</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
A written restriction on the transfer or registration of transfer of shares of the Corporation or on the amount of shares of the Corporation
that may be owned by any person or group of persons, if permitted by the DGCL and noted conspicuously on the certificate representing
such shares or, in the case of uncertificated shares, contained in a notice, offering circular or prospectus sent by the Corporation
to the registered owner of such shares within a reasonable time prior to or after the issuance or transfer of such shares, may be enforced
against the holder of such shares or any successor or transferee of the holder including an executor, administrator, trustee, guardian
or other fiduciary entrusted with like responsibility for the person or estate of the holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
A restriction imposed by the Corporation on the transfer or the registration of shares of the Corporation or on the amount of shares
of the Corporation that may be owned by any person or group of persons, even if otherwise lawful, is ineffective against a person without
actual knowledge of such restriction unless: (i) the shares are certificated and such restriction is noted conspicuously on the certificate;
or (ii) the shares are uncertificated and such restriction was contained in a notice, offering circular or prospectus sent by the Corporation
to the registered owner of such shares within a reasonable time prior to or after the issuance or transfer of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.9. Regulations</B>. The Board shall have power and authority to make such additional rules and regulations, subject to any applicable
requirement of law, as the Board may deem necessary and appropriate with respect to the issue, transfer or registration of transfer of
shares of stock or certificates representing shares. The Board may appoint one or more transfer agents or registrars and may require
for the validity thereof that certificates representing shares bear the signature of any transfer agent or registrar so appointed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VIII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.1. Right to Indemnification</B>. To the fullest extent permitted by applicable law, as the same exists or may hereafter be
amended, the Corporation shall indemnify and hold harmless each person who was or is made a party or is threatened to be made a
party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (hereinafter a &#8220;<B><I>proceeding</I></B>&#8221;), by reason of the fact that he or she is or
was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of
the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other
enterprise or nonprofit entity, including service with respect to an employee benefit plan (hereinafter an
&#8220;<B><I>Indemnitee</I></B>&#8221;), whether the basis of such proceeding is alleged action in an official capacity as a
director, officer, employee or agent, or in any other capacity while serving as a director, officer, employee or agent, against all
liability and loss suffered and expenses (including, without limitation, attorneys&#8217; fees, judgments, fines, ERISA excise taxes
and penalties and amounts paid in settlement) reasonably incurred by such Indemnitee in connection with such proceeding; provided,
however, that, except as provided in <U>Section 8.3</U> with respect to proceedings to enforce rights to indemnification, the
Corporation shall indemnify an Indemnitee in connection with a proceeding (or part thereof) initiated by such Indemnitee only if
such proceeding (or part thereof) was authorized by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.2. Right to Advancement of Expenses</B>. In addition to the right to indemnification conferred in <U>Section 8.1</U>, an Indemnitee
shall also have the right to be paid by the Corporation to the fullest extent not prohibited by applicable law the expenses (including,
without limitation, attorneys&#8217; fees) incurred in defending or otherwise participating in any such proceeding in advance of its
final disposition (hereinafter an &#8220;<B><I>advancement of expenses</I></B>&#8221;); provided, however, that, if the DGCL requires,
an advancement of expenses incurred by an Indemnitee in his or her capacity as a director or officer of the Corporation (and not in any
other capacity in which service was or is rendered by such Indemnitee, including, without limitation, service to an employee benefit
plan) shall be made only upon the Corporation&#8217;s receipt of an undertaking (hereinafter an &#8220;<B><I>undertaking</I></B>&#8221;),
by or on behalf of such Indemnitee, to repay all amounts so advanced if it shall ultimately be determined that such Indemnitee is not
entitled to be indemnified under this <U>Article VIII</U> or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.3. Right of Indemnitee to Bring Suit</B>. If a claim under <U>Section 8.1</U> or <U>Section 8.2</U> is not paid in full by the Corporation
within 60 days after a written claim therefor has been received by the Corporation, except in the case of a claim for an advancement
of expenses, in which case the applicable period shall be 20 days, the Indemnitee may at any time thereafter bring suit against the Corporation
to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation
to recover an advancement of expenses pursuant to the terms of an undertaking, the Indemnitee shall also be entitled to be paid the expense
of prosecuting or defending such suit. In (a) any suit brought by the Indemnitee to enforce a right to indemnification hereunder (but
not in a suit brought by an Indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (b) in any suit
brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled
to recover such expenses upon a final judicial decision from which there is no further right to appeal (hereinafter a &#8220;<B><I>final
adjudication</I></B>&#8221;) that, the Indemnitee has not met any applicable standard for indemnification set forth in the DGCL. Neither
the failure of the Corporation (including its directors who are not parties to such action, a committee of such directors, independent
legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the Indemnitee
is proper in the circumstances because the Indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual
determination by the Corporation (including a determination by its directors who are not parties to such action, a committee of such
directors, independent legal counsel, or its stockholders) that the Indemnitee has not met such applicable standard of conduct, shall
create a presumption that the Indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the
Indemnitee, shall be a defense to such suit. In any suit brought by the Indemnitee to enforce a right to indemnification or to an advancement
of expenses hereunder, or by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden
of proving that the Indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this <U>Article VIII </U>or
otherwise shall be on the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.4. Non-Exclusivity of Rights</B>. The rights provided to any Indemnitee pursuant to this <U>Article VIII</U> shall not be exclusive
of any other right, which such Indemnitee may have or hereafter acquire under applicable law, the Certificate of Incorporation, these
By Laws, an agreement, a vote of stockholders or disinterested directors, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.5. Insurance</B>. The Corporation may maintain insurance, at its expense, to protect itself and/or any director, officer, employee
or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability
or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the
DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.6. Indemnification of Other Persons</B>. This <U>Article VIII</U> shall not limit the right of the Corporation to the extent and in
the manner authorized or permitted by law to indemnify and to advance expenses to persons other than Indemnitees. Without limiting the
foregoing, the Corporation may, to the extent authorized from time to time by the Board, grant rights to indemnification and to the advancement
of expenses to any employee or agent of the Corporation and to any other person who is or was serving at the request of the Corporation
as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including
service with respect to an employee benefit plan, to the fullest extent of the provisions of this <U>Article VIII</U> with respect to
the indemnification and advancement of expenses of Indemnitees under this <U>Article VIII</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.7. Amendments</B>. Any repeal or amendment of this <U>Article VIII</U> by the Board or the stockholders of the Corporation or by changes
in applicable law, or the adoption of any other provision of these By Laws inconsistent with this <U>Article VIII</U>, will, to the extent
permitted by applicable law, be prospective only (except to the extent such amendment or change in applicable law permits the Corporation
to provide broader indemnification rights to Indemnitees on a retroactive basis than permitted prior thereto), and will not in any way
diminish or adversely affect any right or protection existing hereunder in respect of any act or omission occurring prior to such repeal
or amendment or adoption of such inconsistent provision; provided however, that amendments or repeals of this <U>Article VIII</U> shall
require the affirmative vote of the stockholders holding at least 66.7% of the voting power of all outstanding shares of capital stock
of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.8. Certain Definitions</B>. For purposes of this <U>Article VIII</U>, (a) references to &#8220;<B><I>other enterprise</I></B>&#8221;
shall include any employee benefit plan; (b) references to &#8220;<B><I>fines</I></B>&#8221; shall include any excise taxes assessed
on a person with respect to an employee benefit plan; (c) references to &#8220;<B><I>serving at the request of the Corporation</I></B>&#8221;
shall include any service that imposes duties on, or involves services by, a person with respect to any employee benefit plan, its participants,
or beneficiaries; and (d) a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the
participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed to the best interest
of the Corporation&#8221; for purposes of Section 145 of the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.9. Contract Rights</B>. The rights provided to Indemnitees pursuant to this <U>Article VIII</U> shall be contract rights and such rights
shall continue as to an Indemnitee who has ceased to be a director, officer, agent or employee and shall inure to the benefit of the
Indemnitee&#8217;s heirs, executors and administrators.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.10. Severability</B>. If any provision or provisions of this <U>Article VIII</U> shall be held to be invalid, illegal or unenforceable
for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this <U>Article VIII</U> shall
not in any way be affected or impaired thereby; and (b) to the fullest extent possible, the provisions of this <U>Article VIII</U> (including,
without limitation, each such portion of this <U>Article VIII</U> containing any such provision held to be invalid, illegal or unenforceable)
shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.1. Place of Meetings</B>. If the place of any meeting of stockholders, the Board or committee of the Board for which notice is required
under these By Laws is not designated in the notice of such meeting, such meeting shall be held at the principal business office of the
Corporation; provided, however, if the Board has, in its sole discretion, determined that a meeting shall not be held at any place, but
instead shall be held by means of remote communication pursuant to <U>Section 9.5</U> hereof, then such meeting shall not be held at
any place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.2. Fixing Record Dates</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment
thereof, the Board may fix a record date, which shall not precede the date upon which the resolution fixing the record date is
adopted by the Board, and which record date shall not be more than 60 nor less than 10 days before the date of such meeting. If the
Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting
unless the Board determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be
the date for making such determination. If no record date is fixed by the Board, the record date for determining stockholders
entitled to notice of and to vote at a meeting of stockholders shall be at the close of business on the business day next preceding
the day on which notice is given, or, if notice is waived, at the close of business on the business day next preceding the day on
which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders
shall apply to any adjournment of the meeting; provided, however, that the Board may fix a new record date for the adjourned
meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same
or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the foregoing provisions of
this <U>Section 9.2(a)</U> at the adjourned meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment
of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the
purpose of any other lawful action, the Board may fix a record date, which record date shall not precede the date upon which the resolution
fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed,
the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board adopts
the resolution relating thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.3. Means of Giving Notice</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Notice to Directors</U>. Whenever under applicable law, the Certificate of Incorporation or these By Laws notice is required to be
given to any director, such notice shall be given either (i) in writing and sent by mail, or by a nationally recognized delivery service,
(ii) by means of facsimile telecommunication or other form of electronic transmission, or (iii) by oral notice given personally or by
telephone. A notice to a director will be deemed given as follows: (i) if given by hand delivery, orally, or by telephone, when actually
received by the director, (ii) if sent through the United States mail, when deposited in the United States mail, with postage and fees
thereon prepaid, addressed to the director at the director&#8217;s address appearing on the records of the Corporation, (iii) if sent
for next day delivery by a nationally recognized overnight delivery service, when deposited with such service, with fees thereon prepaid,
addressed to the director at the director&#8217;s address appearing on the records of the Corporation, (iv) if sent by facsimile telecommunication,
when sent to the facsimile transmission number for such director appearing on the records of the Corporation, (v) if sent by electronic
mail, when sent to the electronic mail address for such director appearing on the records of the Corporation, or (vi) if sent by any
other form of electronic transmission, when sent to the address, location or number (as applicable) for such director appearing on the
records of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Notice to Stockholders</U>. Whenever under applicable law, the Certificate of Incorporation or these By Laws notice is required to
be given to any stockholder, such notice may be given (i) in writing and sent either by hand delivery, through the United States mail,
or by a nationally recognized overnight delivery service for next day delivery, or (ii) by means of a form of electronic transmission
consented to by the stockholder, to the extent permitted by, and subject to the conditions set forth in Section 232 of the DGCL. A notice
to a stockholder shall be deemed given as follows: (i) if given by hand delivery, when actually received by the stockholder, (ii) if
sent through the United States mail, when deposited in the United States mail, with postage and fees thereon prepaid, addressed to the
stockholder at the stockholder&#8217;s address appearing on the stock ledger of the Corporation, (iii) if sent for next day delivery
by a nationally recognized overnight delivery service, when deposited with such service, with fees thereon prepaid, addressed to the
stockholder at the stockholder&#8217;s address appearing on the stock ledger of the Corporation, and (iv) if given by a form of electronic
transmission consented to by the stockholder to whom the notice is given and otherwise meeting the requirements set forth above, (A)
if by facsimile transmission, when directed to a number at which the stockholder has consented to receive notice, (B) if by electronic
mail, when directed to an electronic mail address at which the stockholder has consented to receive notice, (C) if by a posting on an
electronic network together with separate notice to the stockholder of such specified posting, upon the later of (1) such posting and
(2) the giving of such separate notice, and (D) if by any other form of electronic transmission, when directed to the stockholder. A
stockholder may revoke such stockholder&#8217;s consent to receiving notice by means of electronic communication by giving written notice
of such revocation to the Corporation. Any such consent shall be deemed revoked if (1) the Corporation is unable to deliver by electronic
transmission two consecutive notices given by the Corporation in accordance with such consent and (2) such inability becomes known to
the Secretary or an Assistant Secretary or to the Corporation&#8217;s transfer agent, or other person responsible for the giving of notice;
provided, however, the inadvertent failure to treat such inability as a revocation shall not invalidate any meeting or other action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Electronic Transmission</U>. &#8220;<B><I>Electronic transmission</I></B>&#8221; means any form of communication, not directly involving
the physical transmission of paper, that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that
may be directly reproduced in paper form by such a recipient through an automated process, including but not limited to transmission
by telex, facsimile telecommunication, electronic mail, telegram and cablegram.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Notice to Stockholders Sharing Same Address</U>. Without limiting the manner by which notice otherwise may be given effectively by
the Corporation to stockholders, any notice to stockholders given by the Corporation under any provision of the DGCL, the Certificate
of Incorporation or these By Laws shall be effective if given by a single written notice to stockholders who share an address if consented
to by the stockholders at that address to whom such notice is given. A stockholder may revoke such stockholder&#8217;s consent by delivering
written notice of such revocation to the Corporation. Any stockholder who fails to object in writing to the Corporation within 60 days
of having been given written notice by the Corporation of its intention to send such a single written notice shall be deemed to have
consented to receiving such single written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Exceptions to Notice Requirements</U>. Whenever notice is required to be given, under the DGCL, the Certificate of Incorporation or
these By Laws, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and
there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any
action or meeting that shall be taken or held without notice to any such person with whom communication is unlawful shall have the same
force and effect as if such notice had been duly given. In the event that the action taken by the Corporation is such as to require the
filing of a certificate with the Secretary of State of Delaware, the certificate shall state, if such is the fact and if notice is required,
that notice was given to all persons entitled to receive notice except such persons with whom communication is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever
notice is required to be given by the Corporation, under any provision of the DGCL, the Certificate of Incorporation or these By Laws,
to any stockholder to whom (1) notice of two consecutive annual meetings of stockholders and all notices of stockholder meetings or of
the taking of action by written consent of stockholders without a meeting to such stockholder during the period between such two consecutive
annual meetings, or (2) all, and at least two payments (if sent by first-class mail) of dividends or interest on securities during a
12-month period, have been mailed addressed to such stockholder at such stockholder&#8217;s address as shown on the records of the Corporation
and have been returned undeliverable, the giving of such notice to such stockholder shall not be required. Any action or meeting that
shall be taken or held without notice to such stockholder shall have the same force and effect as if such notice had been duly given.
If any such stockholder shall deliver to the Corporation a written notice setting forth such stockholder&#8217;s then current address,
the requirement that notice be given to such stockholder shall be reinstated. In the event that the action taken by the Corporation is
such as to require the filing of a certificate with the Secretary of State of Delaware, the certificate need not state that notice was
not given to persons to whom notice was not required to be given pursuant to Section 230(b) of the DGCL. The exception in subsection
(1) of the first sentence of this paragraph to the requirement that notice be given shall not be applicable to any notice returned as
undeliverable if the notice was given by electronic transmission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.4. Waiver of Notice</B>. Whenever any notice is required to be given under applicable law, the Certificate of Incorporation, or these
By Laws, a written waiver of such notice, signed by the person or persons entitled to said notice, or a waiver by electronic transmission
by the person entitled to said notice, whether before or after the time stated therein, shall be deemed equivalent to such required notice.
All such waivers shall be kept with the books of the Corporation. Attendance at a meeting shall constitute a waiver of notice of such
meeting, except where a person attends for the express purpose of objecting to the transaction of any business on the ground that the
meeting was not lawfully called or convened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.5. Meeting Attendance via Remote Communication Equipment.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stockholder Meetings</U>. If authorized by the Board in its sole discretion, and subject to such guidelines and procedures as the
Board may adopt, stockholders entitled to vote at such meeting and proxy holders not physically present at a meeting of stockholders
may, by means of remote communication:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
participate in a meeting of stockholders; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
be deemed present in person and vote at a meeting of stockholders, whether such meeting is to be held at a designated place or solely
by means of remote communication, provided that (A) the Corporation shall implement reasonable measures to verify that each person deemed
present and permitted to vote at the meeting by means of remote communication is a stockholder or proxy holder, (B) the Corporation shall
implement reasonable measures to provide such stockholders and proxy holders a reasonable opportunity to participate in the meeting and,
if entitled to vote, to vote on matters submitted to the applicable stockholders, including an opportunity to read or hear the proceedings
of the meeting substantially concurrently with such proceedings, and (C) if any stockholder or proxy holder votes or takes other action
at the meeting by means of remote communication, a record of such votes or other action shall be maintained by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Board Meetings</U>. Unless otherwise restricted by applicable law, the Certificate of Incorporation or these By Laws, members of the
Board or any committee thereof may participate in a meeting of the Board or any committee thereof by means of conference telephone or
other communications equipment by means of which all persons participating in the meeting can hear each other. Such participation in
a meeting shall constitute presence in person at the meeting, except where a person participates in the meeting for the express purpose
of objecting to the transaction of any business on the ground that the meeting was not lawfully called or convened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.6. Dividends</B>. The Board may from time to time declare, and the Corporation may pay, dividends (payable in cash, property or shares
of the Corporation&#8217;s capital stock) on the Corporation&#8217;s outstanding shares of capital stock, subject to applicable law and
the Certificate of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.7. Reserves</B>. The Board may set apart out of the funds of the Corporation available for dividends a reserve or reserves for any
proper purpose and may abolish any such reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.8. Contracts and Negotiable Instruments</B>. Except as otherwise provided by applicable law, the Certificate of Incorporation or these
By Laws, any contract, bond, deed, lease, mortgage or other instrument may be executed and delivered in the name and on behalf of the
Corporation by such officer or officers or other employee or employees of the Corporation as the Board may from time to time authorize.
Such authority may be general or confined to specific instances as the Board may determine. The Chairman of the Board, the Chief Executive
Officer, the President, the Chief Financial Officer, the Treasurer or any Vice President may execute and deliver any contract, bond,
deed, lease, mortgage or other instrument in the name and on behalf of the Corporation. Subject to any restrictions imposed by the Board,
the Chairman of the Board, the Chief Executive Officer, the President, the Chief Financial Officer, the Treasurer or any Vice President
may delegate powers to execute and deliver any contract, bond, deed, lease, mortgage or other instrument in the name and on behalf of
the Corporation to other officers or employees of the Corporation under such person&#8217;s supervision and authority, it being understood,
however, that any such delegation of power shall not relieve such officer of responsibility with respect to the exercise of such delegated
power.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.9. Fiscal Year</B>. The fiscal year of the Corporation shall be fixed by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.10. Seal</B>. The Board may adopt a corporate seal, which shall be in such form as the Board determines. The seal may be used by causing
it or a facsimile thereof to be impressed, affixed or otherwise reproduced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.11. Books and Records</B>. The books and records of the Corporation may be kept within or outside the State of Delaware at such place
or places as may from time to time be designated by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.12. Resignation</B>. Any director, committee member or officer may resign by giving notice thereof in writing or by electronic transmission
to the Chairman of the Board, the Chief Executive Officer, the President or the Secretary. The resignation shall take effect at the time
it is delivered unless the resignation specifies a later effective date or an effective date determined upon the happening of an event
or events. Unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.13. Surety Bonds</B>. Such officers, employees and agents of the Corporation (if any) as the Chairman of the Board, Chief
Executive Officer, President or the Board may direct, from time to time, shall be bonded for the faithful performance of their
duties and for the restoration to the Corporation, in case of their death, resignation, retirement, disqualification or removal from
office, of all books, papers, vouchers, money and other property of whatever kind in their possession or under their control
belonging to the Corporation, in such amounts and by such surety companies as the Chairman of the Board, Chief Executive Officer,
President or the Board may determine. The premiums on such bonds shall be paid by the Corporation and the bonds so furnished shall
be in the custody of the Secretary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.14. Securities of Other Corporations</B>. Powers of attorney, proxies, waivers of notice of meeting, consents in writing and other
instruments relating to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the Chairman
of the Board, Chief Executive Officer, President, any Vice President or any officers authorized by the Board. Any such officer, may,
in the name of and on behalf of the Corporation, take all such action as any such officer may deem advisable to vote in person or by
proxy at any meeting of security holders of any corporation in which the Corporation may own securities, or to consent in writing, in
the name of the Corporation as such holder, to any action by such corporation, and at any such meeting or with respect to any such consent
shall possess and may exercise any and all rights and power incident to the ownership of such securities and which, as the owner thereof,
the Corporation might have exercised and possessed. The Board may from time to time confer like powers upon any other person or persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.15. Amendments</B>. The Board shall have the power to adopt, amend, alter or repeal the By Laws. The affirmative vote of a majority
of the Board shall be required to adopt, amend, alter or repeal the By Laws. The By Laws also may be adopted, amended, altered or repealed
by the stockholders; provided, however, that in addition to any vote of the holders of any class or series of capital stock of the Corporation
required by applicable law or the Certificate of Incorporation, the affirmative vote of the holders of at least a majority of the voting
power (except as otherwise provided in Section 8.7) of all outstanding shares of capital stock of the Corporation entitled to vote generally
in the election of directors, voting together as a single class, shall be required for the stockholders to adopt, amend, alter or repeal
the By Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*****</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>3
<FILENAME>ex10-17.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.17</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT
PHARMACEUTICALS INC.<BR>
2023 STOCK INCENTIVE PLAN<BR>
STOCK OPTION GRANT NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
Pharmaceuticals Inc., a Delaware corporation, (the &ldquo;<U>Company</U>&rdquo;), pursuant to its 2023 Stock Incentive Plan, as may be
amended from time to time (the &ldquo;<U>Plan</U>&rdquo;), hereby grants to the individual listed below (&ldquo;<U>Participant</U>&rdquo;),
an option to purchase the number of shares of the Company&rsquo;s Common Stock (the &ldquo;<U>Shares</U>&rdquo;), set forth below (the
&ldquo;<U>Option</U>&rdquo;). This Option is subject to all the terms and conditions set forth herein, as well as in the Plan and the
Stock Option Agreement attached hereto as <U>Exhibit A</U> (the &ldquo;<U>Stock Option Agreement</U>&rdquo;), each of which are incorporated
herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant
Notice and the Stock Option Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%">Participant:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Grant Date:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercise Price per Share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Total Exercise Price:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total Number of Shares Subject to the Option:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Expiration Date:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Vesting Commencement Date:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of Option: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
    Incentive Stock Option </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
    Nonqualified Stock Option</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    Schedule: </FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
his or her signature and the Company&rsquo;s signature below, Participant agrees to be bound by the terms and conditions of the Plan,
the Stock Option Agreement and this Grant Notice. Participant has reviewed the Plan, the Stock Option Agreement and this Grant Notice
in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands
all provisions of the Plan, the Stock Option Agreement and this Grant Notice. Participant hereby agrees to accept as binding, conclusive
and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Stock Option Agreement
or this Grant Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT
    PHARMACEUTICALS INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PARTICIPANT</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A<BR>
TO STOCK OPTION GRANT NOTICE<BR>
<BR>
STOCK OPTION AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Stock Option Grant Notice (the &ldquo;<U>Grant Notice</U>&rdquo;) to which this Stock Option Agreement (this &ldquo;<U>Agreement</U>&rdquo;)
is attached, Conduit Pharmaceuticals Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), has granted to Participant an Option
under the Company&rsquo;s 2023 Stock Incentive Plan, as may be amended from time to time (the &ldquo;<U>Plan</U>&rdquo;), to purchase
the number of Shares indicated in the Grant Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.<BR>
GENERAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1 Defined
Terms</B>. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.2 Incorporation
of Terms of Plan</B>. The Option is subject to the terms and conditions of the Plan which are incorporated herein by reference. In the
event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.<BR>
GRANT OF OPTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1 Grant
of Option</B>. In consideration of Participant&rsquo;s past and/or continued employment with or service to the Company or any Subsidiary
and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the &ldquo;<U>Grant Date</U>&rdquo;),
the Company irrevocably grants to Participant the Option to purchase any part or all of an aggregate of the number of Shares set forth
in the Grant Notice, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article
IX of the Plan. Unless designated as a Nonqualified Stock Option in the Grant Notice, the Option shall be an Incentive Stock Option to
the maximum extent permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2 Exercise
Price</B>. The exercise price of the Shares subject to the Option shall be as set forth in the Grant Notice, without commission or other
charge; provided, however, that the exercise price per share of the Shares subject to the Option shall not be less than 100% of the Fair
Market Value of a Share on the Grant Date. Notwithstanding the foregoing, if this Option is designated as an Incentive Stock Option and
Participant is a Greater Than 10% Stockholder as of the Grant Date, the exercise price per share of the Shares subject to the Option
shall not be less than 110% of the Fair Market Value of a Share on the Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.<BR>
PERIOD OF EXERCISABILITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1 Commencement
of Exercisability</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Subject
to Sections 3.2, 3.3, 5.12 and 5.18 hereof, the Option shall become vested and exercisable in such amounts and at such times as are set
forth in the Grant Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) No
portion of the Option which has not become vested and exercisable at the date of Participant&rsquo;s Termination of Service shall thereafter
become vested and exercisable, except as may be otherwise provided by the Administrator or as set forth in a written agreement between
the Company and Participant. For the avoidance of doubt, employment or service during only a portion of the vesting period shall not
entitle Participant to vest in a pro-rata portion of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Notwithstanding
Section 3.1(a) hereof and the Grant Notice, but subject to Section 3.1(b) hereof, in the event of a Change in Control the Option shall
be treated pursuant to Sections 9.2 and 9.3 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2 Duration
of Exercisability</B>. The installments provided for in the vesting schedule set forth in the Grant Notice are cumulative. Each such
installment which becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant Notice shall remain vested and
exercisable until it becomes unexercisable under Section 3.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3 Expiration
of Option</B>. The Option may not be exercised to any extent by anyone after the first to occur of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Expiration Date set forth in the Grant Notice, which shall in no event be more than ten years from the Grant Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If
this Option is designated as an Incentive Stock Option and Participant, at the time the Option was granted, was a Greater Than 10% Stockholder,
the expiration of five years from the Grant Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
expiration of three months from the date of Participant&rsquo;s Termination of Service, unless such termination occurs by reason of Participant&rsquo;s
death or Disability or Cause;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
expiration of one year from the date of Participant&rsquo;s Termination of Service by reason of Participant&rsquo;s death or Disability;
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Participant&rsquo;s
Termination of Service for Cause (or, following a Termination of Service other than for Cause, upon the Administrator&rsquo;s subsequent
determination that Participant committed any act or omission during his or her employment or service with the Company or a Subsidiary
that constituted Cause).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Participant agrees that the Company and its officers, employees, attorneys and agents do not have any obligation to notify him or her
prior to the expiration of this Option pursuant to this Section 3.3. The Participant further agrees that he or she has the sole responsibility
for monitoring the expiration of this Option and for exercising this Option, if at all, before it expires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4 Special
Tax Consequences</B>. Participant acknowledges that, to the extent that the aggregate Fair Market Value (determined as of the time the
Option is granted) of all Shares with respect to which Incentive Stock Options, including the Option (if applicable), are exercisable
for the first time by Participant in any calendar year exceeds $100,000, the Option and such other options shall be Nonqualified Stock
Options to the extent necessary to comply with the limitations imposed by Section 422(d) of the Code. Participant further acknowledges
that the rule set forth in the preceding sentence shall be applied by taking the Option and other &ldquo;incentive stock options&rdquo;
into account in the order in which they were granted, as determined under Section 422(d) of the Code and the Treasury Regulations thereunder.
Participant also acknowledges that an Incentive Stock Option exercised more than three months after Participant&rsquo;s Termination of
Employment, other than by reason of death or Disability, will be taxed as a Nonqualified Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5 Tax
Withholding</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Participant
acknowledges that, regardless of any action taken by the Company or, if different, the Subsidiary or other affiliate of the Company for
which Participant renders services (the &ldquo;<U>Service Recipient</U>&rdquo;) the ultimate liability for all Tax-Related Items is and
remains Participant&rsquo;s responsibility and may exceed the amount (if any) actually withheld by the Company or the Service Recipient.
Participant further acknowledges that the Company and/or the Service Recipient (i) make no representations or undertakings regarding
the treatment of any Tax-Related Items in connection with any aspect of this Option, including, but not limited to, the grant, vesting
or exercise of this Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends; and (ii)
do not commit to and are under no obligation to structure the terms of the grant or any aspect of this Option to reduce or eliminate
Participant&rsquo;s liability for Tax-Related Items or achieve any particular tax result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Option cannot be exercised until Participant has made such arrangements as the Company may require for the satisfaction of any Tax-Related
Items that may arise in connection with the exercise of the Option or the acquisition of the Shares by Participant. The Company shall
not be required to issue, allot or transfer Shares until Participant has satisfied this obligation. At the time Participant exercises
the Option, in whole or in part, or at the time any other withholding event for Tax-Related Items occurs with respect to the Option,
Participant hereby authorizes the Company and/or Service Recipient, or their respective agents, at their discretion, to satisfy any applicable
withholding obligations for Tax-Related Items by one or a combination of the following methods: (i) withholding from Participant&rsquo;s
salary, wages, or any other amounts payable to Participant, in accordance with Applicable Law; (ii) withholding Shares otherwise issuable
to Participant upon the exercise of the Option, provided that to the extent necessary to qualify for an exemption from application of
Section 16(b) of the Exchange Act, if applicable, such Share withholding procedure will be subject to the express prior approval of the
Board or the Committee; (iii) instructing a broker on Participant&rsquo;s behalf to sell Shares otherwise issuable to Participant upon
exercise of the Option and to submit the proceeds of such sale to the Company; or (iv) any other method determined by the Company to
be in compliance with Applicable Law. Participant agrees to pay the Company or the Service Recipient any amounts of Tax-Related Items
that cannot be satisfied by the means described above in Section 3.5(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Company may withhold or account for Tax-Related Items by considering statutory withholding amounts or other applicable withholding rates,
including maximum rates applicable in Participant&rsquo;s jurisdiction(s). In the event of over-withholding, Participant may receive
a refund of any over-withheld amount in cash and (with no entitlement to the equivalent in Shares) or if not refunded, Participant may
seek a refund from the local tax authorities. In the event of under-withholding, Participant may be required to pay any additional Tax-Related
Items directly to the applicable tax authority or to the Company and/or the Service Recipient. If the obligation for Tax-Related Items
is satisfied by withholding in Shares, for tax purposes, Participant is deemed to have been issued the full number of Shares subject
to the exercised Option, notwithstanding that a number of the Shares is held back solely for the purpose of satisfying the withholding
obligations for Tax-Related Items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.<BR>
EXERCISE OF OPTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1 Person
Eligible to Exercise</B>. Except as provided in Section 5.4 hereof, during the lifetime of Participant, only Participant may exercise
the Option or any portion thereof, unless it has been disposed of pursuant to a DRO. After the death of Participant, any exercisable
portion of the Option may, prior to the time when the Option becomes unexercisable under Section 3.3 hereof, be exercised by the deceased
Participant&rsquo;s personal representative or by any person empowered to do so under the deceased Participant&rsquo;s will or under
the then applicable laws of descent and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2 Partial
Exercise</B>. Any exercisable portion of the Option or the entire Option, if then wholly exercisable, may be exercised in whole or in
part at any time prior to the time when the Option or portion thereof becomes unexercisable under Section 3.3 hereof. However, the Option
shall not be exercisable with respect to fractional Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3 Manner
of Exercise</B>. The Option, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of the Company
(or any third-party administrator or other person or entity designated by the Company; for the avoidance of doubt, delivery shall include
electronic delivery), during regular business hours, of all of the following prior to the time when the Option or such portion thereof
becomes unexercisable under Section 3.3 hereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) An
exercise notice in a form specified by the Administrator, stating that the Option or portion thereof is thereby exercised, such notice
complying with all applicable rules established by the Administrator. The notice shall be signed by Participant or other person then
entitled to exercise the Option or such portion of the Option;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
receipt by the Company of full payment for the Shares with respect to which the Option or portion thereof is exercised, including payment
of any applicable Tax Related Items, which shall be made by deduction from other compensation payable Participant or in such other form
of consideration permitted under Section 4.4 hereof that is acceptable to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Any
other written representations or documents as may be required in the Administrator&rsquo;s sole discretion to evidence compliance with
the Securities Act, the Exchange Act or any other applicable law, rule or regulation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) In
the event the Option or portion thereof shall be exercised pursuant to Section 4.1 hereof by any person or persons other than Participant,
appropriate proof of the right of such person or persons to exercise the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any of the foregoing, the Company shall have the right to specify all conditions of the manner of exercise, which conditions may vary
by country, and which may be subject to change from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.4 Method
of Payment</B>. Payment of the exercise price shall be by any of the following, or a combination thereof, at the election of Participant:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Cash
or check;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) With
the consent of the Administrator, surrender of Shares (including, without limitation, Shares otherwise issuable upon exercise of the
Option) held for such period of time as may be required by the Administrator in order to avoid adverse accounting consequences and having
a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised portion thereof; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Through
the delivery of a notice that Participant has placed a market sell order with a broker with respect to Shares then issuable upon exercise
of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction
of the Option exercise price; provided that payment of such proceeds is then made to the Company at such time as may be required by the
Company, but in any event not later than the settlement of such sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.5 Conditions
to Issuance of Shares</B>. The Shares deliverable upon the exercise of the Option, or any portion thereof, may be either previously authorized
but unissued Shares or issued Shares which have then been reacquired by the Company. Such Shares shall be fully paid and nonassessable.
The Company shall not be required to issue or deliver any Shares purchased upon the exercise of the Option or portion thereof prior to
fulfillment of all of the conditions in Section 10.7 of the Plan and following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
admission of such Shares to listing on all stock exchanges on which such Shares are then listed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
completion of any registration or other qualification of such Shares under any state or federal law or under rulings or regulations of
the Securities and Exchange Commission or of any other governmental regulatory body, which the Administrator shall, in its absolute discretion,
deem necessary or advisable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
obtaining of any approval or other clearance from any state or federal governmental agency which the Administrator shall, in its absolute
discretion, determine to be necessary or advisable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
receipt by the Company of full payment for such Shares, including payment of any applicable Tax Related Items, which may be in one or
more of the forms of consideration permitted under Section 4.4 hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) The
lapse of such reasonable period of time following the exercise of the Option as the Administrator may from time to time establish for
reasons of administrative convenience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.6 Participant&rsquo;s
Representations</B>. If the Shares issuable hereunder have not been registered under the Securities Act or any applicable state laws
on an effective registration statement at the time of exercise, Participant shall, if required by the Company, concurrently with such
exercise, make such written representations as are deemed necessary or appropriate by the Company or its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.7 Rights
as Stockholder</B>. The holder of the Option shall not be, nor have any of the rights or privileges of, a stockholder of the Company,
including, without limitation, voting rights and rights to dividends, in respect of any Shares purchasable upon the exercise of any part
of the Option unless and until such Shares shall have been issued by the Company and held of record by such holder (as evidenced by the
appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment will be made for
a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Article IX of the
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.<BR>
OTHER PROVISIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1 Nature
of Grant</B>. By accepting the Option, Participant acknowledges, understands, and agrees that: (a) the Plan is established voluntarily
by the Company, it is wholly discretionary in nature; (b) the grant of this Option is exceptional, voluntary and occasional and does
not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been
granted in the past; (c) all decisions with respect to future option or other grants, if any, will be at the sole discretion of the Company;
(d) Participant is voluntarily participating in the Plan; (e) this Option and any Shares acquired under the Plan, and the income from
and value of same, are not part of normal or expected compensation for any purposes, including for purposes of calculating any severance,
resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday pay, pension or retirement
or welfare benefits or similar payments; (f) the future value of the Shares underlying this Option is unknown, indeterminable, and cannot
be predicted with certainty; (g) neither the Company nor any Subsidiary shall be liable for any foreign exchange rate fluctuation between
the Participant&rsquo;s local currency and the United States Dollar that may affect the value of Participant&rsquo;s Options or of any
amounts due to or from the Participant pursuant to the exercise of the Participant&rsquo;s Option or the subsequent sale of any Shares
received; and (h) no claim or entitlement to compensation or damages shall arise from forfeiture of this Option resulting from Participant&rsquo;s
Termination of Service (for any reason whatsoever, whether or not later found to be invalid or in breach of Applicable Law in the jurisdiction
where Participant is providing service or the terms of Participant&rsquo;s employment or other service agreement, if any).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2 Administration</B>.
The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation
and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations
and determinations made by the Administrator in good faith shall be final and binding upon Participant, the Company and all other interested
persons. No member of the Committee or the Board shall be personally liable for any action, determination or interpretation made in good
faith with respect to the Plan, this Agreement or the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.3 Whole
Shares</B>. The Option may only be exercised for whole Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.4 Transferability</B>.
The Option shall be subject to the restrictions on transferability set forth in Section 10.1 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.5 Tax
Consultation</B>. Participant understands that Participant may suffer adverse tax consequences as a result of the grant, vesting or exercise
of the Option, or with the purchase or disposition of the Shares subject to the Option. Participant represents that Participant has consulted
with any tax consultants Participant deems advisable in connection with the purchase or disposition of such Shares and that Participant
is not relying on the Company for any tax advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.6 Binding
Agreement</B>. Subject to the limitation on the transferability of the Option contained herein, this Agreement will be binding upon and
inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.7 Adjustments
Upon Specified Events</B>. The Administrator may accelerate the vesting of the Option in such circumstances as it, in its sole discretion,
may determine. In addition, upon the occurrence of certain events relating to the Shares contemplated by Article IX of the Plan (including,
without limitation, an extraordinary cash dividend on such Shares), the Administrator shall make such adjustments the Administrator deems
appropriate in the number of Shares subject to the Option, the exercise price of the Option and the kind of securities that may be issued
upon exercise of the Option. Participant acknowledges that the Option is subject to adjustment, modification and termination in certain
events as provided in this Agreement and Article IX of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.8 Notices</B>.
Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of
the Company at the Company&rsquo;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&rsquo;s
last address reflected on the Company&rsquo;s records. By a notice given pursuant to this Section 5.8, either party may hereafter designate
a different address for notices to be given to that party. Any notice which is required to be given to Participant shall, if Participant
is then deceased, be given to the person entitled to exercise his or her Option pursuant to Section 4.1 hereof by written notice under
this Section 5.8. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested)
and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service
(or similar non-U.S. entity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.9 Titles</B>.
Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.10 Governing
Law; Venue</B>. The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance
of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. Each party hereto agrees
that it must bring any action between the parties hereto arising out of or related to this Agreement in the Court of Chancery of the
State of Delaware (the &ldquo;<U>Court of Chancery</U>&rdquo;) or, to the extent the Court of Chancery does not have subject matter jurisdiction,
the United States District Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such courts
(the &ldquo;<U>Delaware Federal Court</U>&rdquo;) or, to the extent neither the Court of Chancery nor the Delaware Federal Court has
subject matter jurisdiction, the Superior Court of the State of Delaware (the &ldquo;<U>Chosen Courts</U>&rdquo;), and, solely with respect
to any such action (a) irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (b) waives any objection to laying venue
in any such action in the Chosen Courts, (c) waives any objection that the Chosen Courts are an inconvenient forum or do not have jurisdiction
over any party hereto and (d) agrees that service of any process, summons, notice or document pursuant to Section 5.8 above shall be
effective service of process in any action, suit or proceeding in Delaware with respect to any matters to which it has submitted to jurisdiction
as set forth in the immediately preceding sentence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.11 Conformity
to Securities Laws</B>. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with
all provisions of the Securities Act and the Exchange Act and any and all Applicable Law and regulations and rules promulgated by the
Securities and Exchange Commission thereunder, and state securities laws and regulations. Notwithstanding anything herein to the contrary,
the Plan shall be administered, and the Option is granted and may be exercised, only in such a manner as to conform to such Applicable
Law. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform
to such Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.12 Amendment,
Suspension and Termination</B>. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified,
suspended or terminated at any time or from time to time by the Administrator or the Board; provided, however, that, except as may otherwise
be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Option in
any material way without the prior written consent of Participant; provided that the Administrator may modify an Incentive Stock Option
to disqualify such Option from treatment as an &ldquo;incentive stock option&rdquo; under Section 422 of the Code without Participant&rsquo;s
consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.13 Successors
and Assigns</B>. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall
inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section
5.4 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.14 Notification
of Disposition</B>. If this Option is designated as an Incentive Stock Option, Participant shall give prompt notice to the Company of
any disposition or other transfer (other than in connection with a Change in Control) of any Shares acquired under this Agreement if
such disposition or transfer is made (a) within two years from the Grant Date with respect to such Shares or (b) within one year after
the transfer of such Shares to Participant. Such notice shall specify the date of such disposition or other transfer and the amount realized,
in cash, other property, assumption of indebtedness or other consideration, by Participant in such disposition or other transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.15 Limitations
Applicable to Section 16 Persons</B>. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to
Section 16 of the Exchange Act, the Plan, the Option and this Agreement shall be subject to any additional limitations set forth in any
applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements
for the application of such exemptive rule. To the extent permitted by applicable law, this Agreement shall be deemed amended to the
extent necessary to conform to such applicable exemptive rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.16 Not
a Contract of Service Relationship</B>. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue
to serve as an Employee or other service provider of the Company or any of its Subsidiaries or shall interfere with or restrict in any
way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services
of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise by Applicable
Law or in a written agreement between the Company or a Subsidiary and Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.17 Entire
Agreement</B>. The Plan, the Grant Notice and this Agreement constitute the entire agreement of the parties and supersede in their entirety
all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof, provided that the Option
shall be subject to any accelerated vesting or extended post-termination exercise provisions in any written agreement between Participant
and the Company (or any Subsidiary who is the employer of Participant) or a Company plan pursuant to which Participant participates,
in each case, in accordance with the terms therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.18 Section
409A</B>. This Option is not intended to constitute &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section 409A.
However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines
that the Option (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion
(without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the
Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with
retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate either for the Option to
be exempt from the application of Section 409A or to comply with the requirements of Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.19 Limitation
on Participant&rsquo;s Rights</B>. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement
creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust.
Neither the Plan nor any underlying program, in and of itself, has any assets. Participant shall have only the rights of a general unsecured
creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Option, and rights no greater
than the right to receive the Shares as a general unsecured creditor with respect to options, as and when exercised pursuant to the terms
hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.20 Electronic
Delivery and Acceptance</B>. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation
in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate
in the Plan through an on-line or electronic system established and maintained by the company or a third party designated by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.21 Foreign
Asset/Account, Exchange Control and Tax Reporting</B>. The Participant may be subject to foreign asset/account, exchange control and/or
tax reporting requirements as a result of the acquisition, holding and/or transfer of Shares or cash (including dividends and the proceeds
arising from the sale of Shares) derived from the Participant&rsquo;s participation in the Plan in, to and/or from a brokerage/bank account
or legal entity located outside the Participant&rsquo;s country. The applicable laws in the Participant&rsquo;s country may require that
the Participant report such accounts, assets and balances therein, the value thereof and/or the transactions related thereto to the applicable
authorities in such country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of
the Participant&rsquo;s participation in the Plan to the Participant&rsquo;s country through a designated bank or broker within a certain
time after receipt. The Participant acknowledges that it is the Participant&rsquo;s responsibility to be compliant with such regulations
and the Participant is encouraged to consult with the Participant&rsquo;s personal legal advisor for any details.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.22
Appendix</B>. Notwithstanding any provisions in this Agreement, the Participant&rsquo;s Option shall be subject to the special terms
and conditions for the Participant&rsquo;s country set forth in the Appendix attached to this Agreement. Moreover, if the Participant
relocates to one of the countries included therein, the terms and conditions for such country will apply to the Participant to the extent
the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.
The Appendix constitutes part of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPENDIX
TO OPTION AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Appendix includes special terms and conditions that govern the Option granted to the Participant under the Plan if the Participant resides
and/or works in one of the countries listed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained herein is general in nature and may not apply to the Participant&rsquo;s particular situation, and the Participant
is advised to seek appropriate professional advice as to how the relevant laws in the Participant&rsquo;s country may apply to the Participant&rsquo;s
situation. If the Participant is a citizen or resident of a country other than the one in which the Participant is currently working
and/or residing, transfer employment and/or residency to another country after the Grant Date, is a consultant, changes employment status
to a consultant position, or is considered a resident of another country for local law purposes, the Company shall, in its discretion,
determine the extent to which the special terms and conditions contained herein shall be applicable to the Participant. References to
the Participant&rsquo;s employer shall include any entity that engages the Participant&rsquo;s services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Placeholder
for country-specific appendices]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Options: NewSection Last; Value: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>4
<FILENAME>ex10-20.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.20</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPECIFIC
TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE (1) SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS
PRIVATE OR CONFIDENTIAL; OR (2) DISCLOSURE OF SUCH INFORMATION WOULD CONSTITUTE A CLEARLY UNWARRANTED INVASION OF PERSONAL PRIVACY. THESE
REDACTED TERMS HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS [***].</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATED</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26
    <B>March 2021</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)
ST GEORGE STREET CAPITAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)
SGS GLOBAL LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin: 0pt auto; width: 50%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXCLUSIVE
FUNDING AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-transform: uppercase; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin: 0pt auto; width: 50%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
  AGREEMENT is made the</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>day
  of March 2021</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BETWEEN:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>St
                                            George Street Capital</B>, a private company limited by guarantee without share capital incorporated
                                            in England and Wales, company number 10537833 and also a registered charity in England and
                                            Wales (registered charity number 1171470) whose registered office is at Bates Wells Braithwaite,
                                            10 Queen Street Place, London, United Kingdom, EC4R 1BE (&ldquo;<B>Capital</B>&rdquo;); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SGS
                                            Global Limited</B>, a company incorporated in the Cayman Islands, company number OC-346289,
                                            whose registered office at do Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand
                                            Cayman KY1-9009, Cayman Islands (&ldquo;<B>Global</B>&rdquo;),</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
a &ldquo;<B>Party</B>&rsquo; and together, the &ldquo;<B>Parties</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS:</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(A)</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            is a UK registered charity whose objects include the advancement of medical research and
                                            development for public benefit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(B)</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            has and expects to have a number of drug discovery and/or development projects which it will
                                            require funding to support.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(C)</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            and Global entered into a deed of licence dated 28 January 2019 (the &ldquo;<B>Deed of Licence</B>&rdquo;)
                                            pursuant to which Capital agreed to offer all drug discovery and/or development projects
                                            to Global to be licensed exclusively.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(D)</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            and Global wish to terminate the Deed of Licence and Capital wishes to offer Global an exclusive
                                            first right to provide or procure the provision of funding to support Capital&rsquo;s drug
                                            development projects on the terms of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
IT IS HEREBY AGREED</B> as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            this Agreement except where the context requires otherwise, the following words and expressions
                                            shall have the following meanings:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means with respect to a given entity, any person, corporation, partnership or other entity, that Controls, is Controlled by, or is under
common Control with such entity. For the purposes of this Agreement only, Capital and Global shall not be considered to be Affiliates
of each other.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Agreement</B>&rdquo;
means this agreement and each of the Schedules as amended from time to time in accordance with Clause 16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means a day other than a Saturday, Sunday or any public holiday in England and the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercialisation
Agreement</B>&rdquo; means any agreement pursuant to which Capital grants rights to a Third Party to further develop, commercially distribute,
supply, license, commercialise and/or otherwise exploit any Project Results which shall include: (i) any licence granted by Capital under
any such Project Results; (ii) any grant of the right to acquire such a licence; or (iii) any agreement pursuant to which Capital assigns
any of its rights in the Project (including any Project Results) to a Third Party, but which shall exclude any arrangements entered into
with a CRO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercially
Reasonable Efforts</B>&rdquo; means the efforts and resources commonly used by a company with similar resources available as Capital
has available for the Project (or, where applicable, its licensee) for a product at a similar stage in its life cycle, with similar market
potential taking into account efficacy, safety, patent and regulatory exclusivity, anticipated or approved labelling, present and future
market potential, competitive market conditions, pricing and reimbursement issues, and other relevant factors commonly considered in
similar circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Competent
Authority</B>&rdquo; means any local or national agency, court, authority, department, inspectorate, minister, ministry official or public
or statutory person (whether autonomous or not) of, or of any government of, any country having jurisdiction over the Agreement or any
of the Parties (such as the Financial Conduct Authority or any successor entity) or over the development or marketing of medicinal products
(such as the United States Food and Drug Administration or the European Medicines Agency).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential
Information</B>&rdquo; means any information, in tangible or non-tangible form (including oral disclosure) which is not in the public
domain including inventions, know how, research and development plans, information relating to the customers, suppliers, business partners,
clients, finances, business plans and products (in each case actual or prospective) of a Party, the terms of this Agreement, and any
other technical or business information (whether or not marked as confidential), which is obtained by any Party from another (or its
representatives) pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Control</B>&rdquo;
means the possession (directly or indirectly) of fifty per cent (50%) or more of the voting stock or other equity interest of a subject
entity with the power to vote, or the power in fact to control the management decisions of such entity through the ownership of securities
or by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Effective
Date</B>&rdquo; means the date this Agreement is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Executive
Officers</B>&rdquo; means an authorised representative of Capital and an authorised representative of Global or such other authorised
officer of a Party as may be substituted from time to time upon the giving of written notice by that Party to the other Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Expenses</B>&rdquo;
means all costs and expenses incurred from time to time by or on behalf of Capital in relation to the filing, prosecution, drug development,
management and out-licensing of any intellectual property licensed or acquired in relation to or generated in or pursuant to a Project
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            travel and other out-of-pocket expenditure;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            FTE Costs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            cost of insurance incurred in relation to the Project;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            Third Party fees incurred in the negotiation and finalisation, management and enforcement
                                            of an out-licence in respect of the Project;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            Patent Costs directly related to the Project including, without limitation, legal fees;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            consideration payable by Capital to a Third Party in respect of the use of any intellectual
                                            property which is necessary or useful for the research, development or commercialisation
                                            of any intellectual property generated in or pursuant to a Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">courier
                                            charges and Third Party printing costs; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            non-recoverable taxes or charges including Value Added Tax which may be imposed in connection
                                            with any of the foregoing or any Net Revenue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Expert</B>&rdquo;
has the meaning set out in Clause 24.1.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Force
Majeure</B>&rdquo; means in relation to a Party any event or circumstance which is beyond the reasonable control of that Party, which
event or circumstance that Party could not reasonably be expected to have taken into account at the Effective Date and which results
in or causes the failure of that Party to perform any or all of its obligations under this Agreement including act of God, lightning,
fire, storm, flood, earthquake, strike, lockout or other industrial disturbance, war, terrorist act, blockade, revolution, riot, insurrection,
civil commotion, public demonstration, sabotage, act of vandalism, explosion, epidemic or pandemic, provided that lack of funds shall
not be interpreted as a cause beyond the reasonable control of that Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>FTE
Costs</B>&rdquo; means the costs of any full time equivalent employee of Capital engaged in running or managing a Project which costs
shall be calculated based on time spent using an FTE rate which will be agreed from time to time in good faith by the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Initial
Project Cost</B>&rdquo; has the meaning given to it in Clause 3.4.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Joint
Commercialization Committee</B>&rdquo; or &ldquo;<B>JCC</B>&rdquo; means the relevant joint Commercialization committee to be established
by the Parties pursuant to Section 4.1 to oversee and manage the development and execution of a commercialisation strategy for any Project
Results arising from the performance of each respective Project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
Revenue</B>&rdquo; means the amount of all payments (excluding value added tax or other sales tax) and, as applicable, the value of all
non-monetary receipts received from time to time by or on behalf of Capital or its Affiliates in respect of any Commercialisation Agreement,
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">option
                                            fees, licence issue fees or up-front payments, annual licence fees, milestone or other lump
                                            sum payments which are attributable to the grant of the rights in question (whether at the
                                            stage of development, marketing, or otherwise), royalties, success, bonus, maintenance, periodic
                                            (including annual) and all other payments or any other sums Capital or its Affiliates may
                                            receive in respect of a Commercialisation Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            any Commercialisation Agreement is entered into as part of a cross-licensing arrangement,
                                            the value of any Third-Party licence obtained under such arrangements; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            shares, options, or other securities obtained from a Third Party in consideration for the
                                            grant of rights by Capital under a Commercialisation Agreement,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
to the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the transaction giving rise to the payment or receipt is not an arm&rsquo;s length commercial
                                            transaction, the Net Revenue shall be the amount or value that would have been paid or due
                                            if it had been such a transaction;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            a payment to which this definition applies arises from a transaction relating to both (i)
                                            a Project or any Project Results and (ii) other intellectual property (including from a different
                                            Project), then if the Parties cannot agree within a reasonable period the proportion of the
                                            payment which is attributable to the particular Project, the matter shall be referred to
                                            an Expert appointed in accordance with Clause 24.1 for final determination; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the avoidance of doubt, no payment shall be due (i) in respect of payments received by Capital
                                            or its Affiliates that are for the purpose of research and development itself; or (ii) in
                                            respect of payments received in relation to any share capital or other equity-like interest
                                            of Capital or any of its Affiliates except for any portion of such payment which is premium
                                            paid over the fair market value of the relevant shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Patent
Costs</B>&rdquo; means any costs and expenses incurred in filing, prosecuting, maintaining, defending and enforcing any Patents licensed
or acquired as part of or arising from the performance of a Project, including official filing, prosecution, maintenance and renewal
fees, patent attorney, translation, legal and other professional fees and expenses and costs and expenses associated with any opposition
or interference action or inter parties review and all FTE Costs associated therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Patents</B>&rdquo;
means any patent applications, patents, author certificates, inventor certificates, utility models, and all foreign counterparts of them
and includes all divisionals, renewals, continuations, continuations-in-part, extensions, reissues, substitutions, confirmations, registrations,
revalidations and additions of or to them, as well as any supplementary protection certificate, or any like form of protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project</B>&rdquo;
has the meaning given to it in Clause 3.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project
Cost</B>&rdquo; means the Initial Project Cost together with all FTE Costs and all Third Party Service Provider costs incurred by Capital
in relation to a Project and all other payments Capital makes to Third Parties in relation to the Project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project
Funding Agreement</B>&rdquo; has the meaning given to it in Clause 3.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project
Notice</B>&rdquo; has the meaning given to it in Clause 3.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project
Option</B>&rdquo; has the meaning given to it in Clause 3.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project
Results</B>&rdquo; means all data, information, results, inventions and intellectual property rights arising from the performance of
a Project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Term</B>&rdquo;
means the term of this Agreement determined in accordance with Clause 12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
Party</B>&rdquo; means a person other than a Party, or a licensee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
Party Service Provider</B>&rdquo; means any Third Party who provides research, development and/or manufacturing services to Capital in
connection with a Project, including contract research organisations, universities and hospitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Year</B>&rdquo;
means a calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            this Agreement:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unless
                                            the context requires otherwise, all references to a particular Clause, paragraph or Schedule
                                            shall be references to that clause, paragraph or schedule, in or to this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            table of contents and headings are inserted for convenience only and shall be ignored in
                                            construing this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unless
                                            the contrary intention appears, words importing the masculine gender shall include the feminine
                                            and vice versa and words in the singular include the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unless
                                            the contrary intention appears, words denoting persons shall include any individual, partnership,
                                            company, corporation, joint venture, trust association, organisation or other entity, in
                                            each case whether or not having separate legal personality; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                            to the words &ldquo;include&rdquo; or &ldquo;including&rdquo; shall be construed without
                                            limitation to the generality of the preceding words.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LICENCE
                                            TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
effect from the date of this Agreement, and in consideration for the rights granted by the Parties pursuant to this Agreement, the Parties
hereby agree to terminate the Deed of Licence. Each Party hereby irrevocably and unconditionally releases the other Party from all the
obligations, duties, liability, claims and demands under the Deed of Licence, whether actual or contingent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROJECT
                                            FUNDING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Project
                                            Option</U>. Global shall have the exclusive first right (but not the obligation) to provide
                                            to Capital (or procure the provision of) all funding for the performance of a drug discovery
                                            and/or development project that Capital wishes to undertake (each a &ldquo;<B>Project</B>&rdquo;)
                                            in consideration for a share of the Net Revenue in respect of such Project (each a &ldquo;<B>Project
                                            Option</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Project
                                            Notice</U>. Capital shall promptly notify Global in writing of each Project that Capital
                                            wishes to undertake (each a &ldquo;<B>Project Notice</B>&rdquo;), including reasonably detailed
                                            information regarding the scope of such Project and the estimated total amount of funding
                                            required to undertake such Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
                                            of Project Option</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            [***] of receipt of a Project Notice by Global, Global shall notify Capital in writing whether
                                            it wishes to exercise its exclusive right to provide (or procure the provision of) all or
                                            some only of the funding required to perform such Project as set out in the Project Notice.
                                            Such notice exercising the Project Option shall specify the source of funding for the Project
                                            and the amount of the required funding that Global (together with any Third Party) will provide.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall have the right, by providing notice in writing to Global, to object to Global procuring
                                            funding from a Third Party if Capital, acting reasonably, considers that Capital&rsquo;s
                                            association with the Third Party funder proposed by Global (but not the involvement of Global)
                                            is likely to have a material adverse impact on Capital&rsquo;s reputation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Capital objects to the initial Third Party funder proposed by Global in accordance with Clause
                                            3.3.2, Global shall have [***] from the date on which Capital notifies Global that it objects
                                            to the initial Third Party to propose that an alternative Third Party funder that is reasonably
                                            acceptable to Capital provides the funding, Capital may, acting reasonably, object to the
                                            alternative Third Party funder if it considers that Capital&rsquo;s association with the
                                            Third Party funder proposed by Global (but not the involvement of Global) is likely to have
                                            a material adverse impact on Capital&rsquo;s reputation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Capital objects to the initial Third Party funder proposed by Global in accordance with Clause
                                            3.3.2 or to an alternative Third Party funder proposed by Global in accordance with Clause
                                            3.3.3, Global shall be deemed to have not exercised the Project Option and Clause 3.5 shall
                                            apply.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            clarity Global shall have the right to exercise a Project Option in whole or in part and
                                            may provide all or some only of the funding required to perform a Project either itself or
                                            through a Third Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Project
                                            funding terms</U>. In the event that Global exercises its Project Option in respect of a
                                            Project, the Parties shall discuss in good faith the terms of an agreement for the provision
                                            of funding for the Project (each a &ldquo;<B>Project Funding Agreement</B>&rdquo;), including
                                            but not limited to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            total amount of funding required to be provided for performance of the Project including
                                            the FTE Costs, Third Party Service Provider costs and all other Expenses (the &ldquo;<B>Initial
                                            Project Cost</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            payment schedule in respect of the total Project Cost;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            identity of any Third Party providing any funding for performance of the Project;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            extent to which the terms of any agreement between Capital and any Third Party licensor or
                                            assignor of intellectual property rights need to be reflected in the Project Funding Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            share of Net Revenue payable to Global (and/or any Third Party funder where Global has procured
                                            the necessary funding from a Third Party) in consideration for the provision or procurement
                                            of funding for the Project (the &ldquo;<B>Agreed Percentage</B>&rdquo;). The Agreed Percentage
                                            in respect of any Project funded by Global itself shall be 100%. Where Global has exercised
                                            its Project Option to procure the provision of funding from a Third Party, the Agreed Percentage
                                            shall be equal to 100% LESS the total percentage share payable by Capital to the Third Party
                                            funder(s).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Project Funding Agreement shall be in the form (or substantially in the form) of a template agreement which shall be agreed between the
Parties as soon as possible following the Effective Date and added to this Agreement as Schedule 1 and the Parties agree to negotiate
in good faith to finalise and execute each Project Funding Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Alternative
                                            funding sources</U>. In the event that Global does not exercise its Project Option in respect
                                            of a Project within [***] of receipt of a Project Notice or otherwise notifies Capital that
                                            it does not wish to exercise such Project Option Capital shall be free to seek alternative
                                            funding sources from Third Parties itself. In the event that Global assists in the negotiation
                                            and procurement of any such alternative funding sources, the Parties shall discuss and agree
                                            any Agreed Percentage of Net Revenue that will be payable to Global in consideration for
                                            such support.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Additional
                                            funding</U>. If, for any reason, it appears that the Project Cost for a particular Project
                                            in respect of which a Project Funding Agreement has been entered into, will exceed the agreed
                                            Initial Project Cost for such Project, Capital will notify Global in writing as soon as it
                                            becomes aware that an overspend may occur. The Parties shall discuss in good faith the terms
                                            on which any further funding may be provided or procured by Global, provided always that
                                            Global shall have the exclusive first right (but not the obligation) to provide or procure
                                            the provision of such further funding. In the event that Global does not agree to provide
                                            or procure the provision of the further funding to meet the additional Project Cost within
                                            [***] of receipt of a notice pursuant to this Clause 3.6, or otherwise notifies Capital that
                                            it is unable or does not wish to provide or procure the provision of such additional funding,
                                            Capital shall be free to seek alternative funding sources from Third Parties or to directly
                                            provide the funding itself. At the time any such Third Party or direct funding is proposed
                                            to be provided to or by Capital for a Project, the Parties shall negotiate in good faith
                                            and agree upon changes to the Agreed Percentage that reflect the value of the additional
                                            funding provided and provide an appropriate financial return for the provider of that additional
                                            funding. In the event the Parties are unable to agree upon such changes to the Agreed Percentage,
                                            the matter shall be referred to an Expert appointed in accordance with Clause 24.1 for final
                                            determination. The Parties shall also agree in good faith additional changes to the Project
                                            Funding Agreement for the Project including to the JCC provisions of Clause 4 to reflect
                                            the fact that Global is no longer providing all of the funding. In particular Global shall
                                            cease to have any final decision making authority under the JCC for any applicable Project
                                            if Global is providing [***] of the funding required for such Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
                                            of funds</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            will be responsible for the day to day management of all funds provided or procured by Global
                                            for the performance of a Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            undertakes to use any amounts provided by Global or any Third Party procured by Global exclusively
                                            to fund the applicable Project. Capital will not use any such funds for any purpose other
                                            than as described in this Clause 3.7.2.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consequences
                                            of licensing or termination</U>. If a Project is terminated or if Capital enters into a Commercialisation
                                            Agreement in respect of a Project , such that Capital is no longer responsible for funding
                                            the Project, then Capital will within [***] of the date of termination or licensing, complete
                                            a final reconciliation of costs (including all actual and contingent FTE Costs, CRO costs
                                            and all Expenses) regarding the Project and identify any residual amount which was contributed
                                            by Global and/or any Third Party funding source. Any such residual amount will be returned
                                            to a bank account nominated by Global and, if relevant, any such Third Party funding source
                                            for the purpose of receiving such refund within [***] of receipt by Capital of confirmation
                                            from Global (and, if applicable, such Third Party funding source) that it accepts the calculation
                                            provided by Capital. In the event that Global (or, if applicable, such Third Party funding
                                            source) does not accept the final reconciliation proposed by Capital, the Parties agree to
                                            discuss the matter in good faith and thereafter, failing agreement, the final reconciliation
                                            will be referred to an Expert appointed in accordance with Clause 24.1 for final determination.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGEMENT
                                            OF THE PROJECT AND REPORTING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Joint
                                            Commercialisation Committee</U>. Within [***] of the entry into any Project Funding Agreement,
                                            the Parties shall establish a joint commercialisation committee (the &ldquo;<B>JCC</B>&rdquo;)
                                            to oversee and manage the development and execution of a commercialisation strategy for any
                                            Project Results arising from the performance of such Project. In particular, the JCC shall,
                                            in respect of each Project:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discuss
                                            and approve the commercial strategy for commercialisation of Project Results;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discuss,
                                            develop, review and approve proposals for seeking potential licensees or acquirors of Project
                                            Results;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discuss
                                            and review all proposals received from third parties regarding the licensing or acquisition
                                            of any Project Results; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">keep
                                            minutes of all meetings held in connection with a Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>JCC
                                            Membership and Meetings</U>. The JCC for each Project shall be composed of two (2) representatives
                                            of each of Capital and Global and, where applicable, any Third Party funder of the particular
                                            Project. All representatives selected shall each have the appropriate expertise, seniority
                                            and decision-making authority to serve as members of the JCC for such Project. Each of Capital,
                                            Global and any Third Party funder (if applicable) may replace its JCC representatives at
                                            any time upon written notice to the other parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum
                                            and Frequency of Meetings</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to Clause 4.3.2, at least two (2) members of the JCC will constitute a quorum for any meeting,
                                            provided that at least one (1) representative from each of Capital and Global is present.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            funding has been received for a Project from a Third Party and such Third Party has elected
                                            to appoint a representative to attend the JCC, at least three (3) members of the JCC will
                                            constitute a quorum for any meeting, provided at least one (1) representative from each of
                                            Capital, Global and any Third Party funder is present.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JCC shall meet at such regular times as is agreed in any Project Funding Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>JCC
                                            Decision Making</U>. All decisions of the JCC shall be made by unanimous agreement of all
                                            JCC members present at a meeting and no action taken at any meeting of the JCC shall be effective
                                            unless a representative of each of Capital, Global and any Third Party funder (if applicable).
                                            In the event that the JCC is unable to reach agreement on a matter (including due to lack
                                            of a quorum at a meeting) (a &ldquo;<B>JCC Deadlock</B>&rdquo;) within 30 days after the
                                            date of the JCC meeting at which such matter is first scheduled to be voted upon, such JCC
                                            Deadlock shall be referred to the senior representatives of each of Capital, Global and any
                                            Third Party funder (as applicable) identified in the Project Funding Agreement. If the senior
                                            representatives do not reach resolution within thirty (30) days of the referral of a JCC
                                            Deadlock to them, then Global shall have the final decision-making authority with respect
                                            to the JCC Deadlock (unless otherwise set out in the Project Funding Agreement) provided
                                            that (i) such decision shall be consistent with the terms of this Agreement, (ii) Global
                                            shall have no right to amend the terms of this Agreement, (iii) such decision-making authority
                                            shall not apply to day-to-day operational decisions with regard to a Project which decisions
                                            shall be made by Capital and (iv) at all times no decision of the JCC shall, require or cause
                                            Capital to breach any term of an agreement in respect of which Capital has been granted rights
                                            including intellectual property rights from a Third Party in relation to a Project or is
                                            likely to, bring Capital into disrepute.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commercialisation</U>.
                                            Capital shall use its Commercially Reasonable Efforts to seek potential licensees or acquirors
                                            of its rights and enter into a Commercialisation Agreement in relation to each Project in
                                            consultation with the JCC for such Project. Capital shall keep Global reasonably informed
                                            through the JCC with regard to the progress of negotiations with a Third Party in relation
                                            to each proposed Commercialisation Agreement. The approval of the JCC shall be required prior
                                            to Capital signing any heads of terms (or similar document) relating to a Commercialisation
                                            Agreement. Global shall not unreasonably withhold its approval of any Commercialisation Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reporting</U>.
                                            Capital shall provide a report to Global at least once every calendar month (and/or at such
                                            other times as may be agreed in writing between the Parties). Such report shall give a brief
                                            report on the progress of the research and development of the Project, the financial position
                                            of the Project (including a schedule of the Expenses incurred to date), and shall set out
                                            in reasonable detail any activities undertaken by Capital in relation to the commercialisation
                                            of the Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REVENUE
                                            SHARING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall distribute any Net Revenue it receives as follows:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall first pay any Expenses that it has incurred or accrued in relation to the Project that
                                            were not part of the Project Costs; and thereafter; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            remaining Net Revenue shall be shared between the Parties according to the Agreed Percentage.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT
                                            AND STATEMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payments</U>.
                                            Except as otherwise expressly provided in this Agreement, all payments due under this Agreement
                                            shall be made in pounds sterling (GBP) in cleared funds to such bank account as the receiving
                                            Party may notify to the paying Party in writing from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Timing
                                            of Payments</U>. The share of Net Revenue due under Clause 4 shall be payable within ten
                                            (10) Business Days of receipt by or on behalf of Capital of the Net Revenue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exchange
                                            Rate</U>. Where Net Revenue is received in a currency other than pounds sterling (GBP), the
                                            rate of exchange to be used for converting such other currency into pounds sterling (GBP)
                                            shall be the relevant mid-spot rate quoted by the Financial Times on the Business Day prior
                                            to which the Net Revenue is received in cleared funds by Capital.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payment
                                            of Costs</U>. All costs of transmission shall be borne by the payee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payments
                                            other than in Cash</U>. If Net Revenue is received other than in cash:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the non-cash Net Revenue is divisible and transferable (without consent of any party or the
                                            operation of any pre-exemption, right of first refusal or similar process), Capital shall
                                            transfer to Global and/or any Third Party funding source (as applicable) the Agreed Percentage
                                            of the non-cash asset; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the non-cash asset is not divisible and transferable (without consent of any party or the
                                            operation of any pre-exemption, right of first refusal or similar process), Capital shall
                                            use its reasonable efforts to obtain the consent or to exercise any pre-exemption, right
                                            of first refusal or similar process to enable the non-cash asset to be divided or transferred
                                            to Global and/or any Third Party funding source (as applicable) the Agreed Percentage of
                                            the non-cash asset;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the non-cash asset is not divisible and transferable (without consent of any party or the
                                            operation of any pre-exemption, right of first refusal or similar process), and Capital is
                                            unable to obtain the consent or to exercise any pre-exemption, right of first refusal or
                                            similar process to enable the non-cash asset to be divided or transferred to Global and/or
                                            any Third Party funding source (as applicable) Capital shall pay to Global the Agreed Percentage
                                            of the non-cash asset, calculated on, and payable within ten (10) Business Days of, the date
                                            on which Capital receives a cash amount in respect of such non-cash asset unless the Parties
                                            otherwise agree.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>VAT</U>.
                                            All payments under this Agreement are expressed to be exclusive of value added tax (or any
                                            other sale goods tax) howsoever arising, and the paying Party shall pay, in addition to those
                                            payments, on receipt of a tax invoice or invoices from the receiving Party, all value added
                                            tax for which the receiving Party is liable to account in relation to any supply made or
                                            deemed to be made for value added tax purposes pursuant to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Withholding</U>.
                                            If the paying Party is required by law to make any tax deduction or withholding, the paying
                                            Party shall give reasonable assistance to the other Party to claim exemption from or (if
                                            that is not possible) a credit for the deduction or withholding under any applicable double
                                            taxation or similar agreement from time to time in force, and shall promptly give the other
                                            Party proper evidence as to the deduction or withholding and payment over of the tax deducted
                                            or withheld. Any and all expenses incurred by the paying Party in providing such assistance
                                            shall be fully reimbursed by the receiving Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Monthly
                                            Report</U>. After a Commercialisation Agreement has been entered into by Capital with a Third
                                            Party in respect of a Project and for so long as that Commercialisation Agreement exists,
                                            Capital shall send to Global and/or any Third Party funding source (as applicable) a written
                                            statement detailing in respect of that calendar month (including a nil report if appropriate)
                                            within thirty (30) days after the end of each calendar month:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            each Commercialisation Agreement, details of each item of Net Revenue received by Capital
                                            during that calendar month and the Net Revenue payable to Global and/or any Third Party funding
                                            source (as applicable) thereon;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to Clause 6.3, any currency conversions, showing the rates used; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            further information in the possession of Capital or which Capital is reasonably able to obtain
                                            and which is necessary for the calculation of Net Revenue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCOUNTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">keep
                                            and notwithstanding the expiry or termination of this Agreement, maintain and shall use its
                                            Commercially Reasonable Endeavours to procure that each licensee keeps and maintains, for
                                            at least three (3) years, true and accurate accounts and records (including any underlying
                                            documents supporting such accounts and records) in sufficient detail to enable:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount of all sums payable under this Agreement to be determined; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
                                            to confirm that all funds provided by Global or a Third Party funder have been applied by
                                            Capital to Projects in accordance with the terms of this Agreement; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">during
                                            the Term and thereafter until the said period of three (3) years relevant to the accounts
                                            and records has expired, at the reasonable request of Global and (subject to Clause 7.2)
                                            at the expense of Global from time to time, permit or procure permission for a qualified
                                            accountant nominated by Global and reasonably acceptable to Capital to inspect and audit
                                            those accounts and records and, to the extent that they relate to the calculation of those
                                            sums, to take copies of them.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                            following any inspection pursuant to Clause 7.1.2, Global&rsquo;s nominated accountant certifies
                                            that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Net Revenue payments in respect of any Year fall short of the sums which were properly payable
                                            in respect of that Year under this Agreement, Global shall send a copy of the certificate
                                            to Capital and Capital shall (subject to Clause 7.3) within seven (7) days of the date of
                                            receipt of the certificate pay the shortfall to Global and, if the shortfall exceeds [***],
                                            Capital shall also reimburse to Global the reasonable costs and expenses of Global in making
                                            the inspection; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            funds provided by Global or any Third Party funder have been applied other than in accordance
                                            with this Agreement, Global shall send a copy of the certificate to Capital and Capital shall
                                            (subject to Clause 7.3) within seven (7) days of the date of receipt of the certificate pay
                                            to Global an amount equal to the amount which has been dis-applied and, if the amount dis-applied
                                            exceeds [***], Capital shall also reimburse to Global the reasonable costs and expenses of
                                            Global in making the inspection.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            within seven (7) days of the date of receipt by Capital of any certificate produced pursuant
                                            to Clause 7.2 Capital notifies Global in writing that it disputes the certificate, the dispute
                                            shall be referred for resolution by the Expert in accordance with Clause 24.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANTY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                            reliance on warranties not in the Agreement</U>. Each Party acknowledges that, in entering
                                            into this Agreement, it does not do so in reliance on any warranty or other provision except
                                            as expressly provided in this Agreement, and all conditions, warranties, terms and undertakings
                                            implied by statute, common law or otherwise are excluded from this Agreement to the fullest
                                            extent permissible by law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warranties</U>.
                                            Each Party hereby represents and warrants to the other Party that, as of the Effective Date:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            is duly organised and validly existing under the laws of its place of incorporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            has legal power, authority and right to enter into this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            execution and performance by it of its obligations hereunder will not constitute a breach
                                            of, or conflict with, its organisational documents nor any other material agreement or arrangement,
                                            whether written or oral, by which it is bound;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            has full corporate power and authority and has taken all corporate action necessary to enter
                                            into and perform this Agreement, and that this Agreement has been duly authorised, executed,
                                            and delivered by that Party; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            this Agreement is a valid, binding, and legally enforceable obligation of that Party (subject
                                            to applicable laws of bankruptcy and moratorium).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                            Further Representations or Warranties</U>. No director, officer, employee or agent of any
                                            Party or its Affiliates is authorised to make any further representation or warranty to the
                                            other Party which is not contained in this Agreement, and each Party acknowledges that it
                                            has not relied on any such oral or written representations or warranties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INSURANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Capital
                                            to take out insurance</U>. Reasonably prior to commencement of any human being dosed with
                                            any product developed in the performance of a Project, Capital shall put in place and thereafter
                                            maintain comprehensive product liability insurance and general commercial liability insurance
                                            through a reputable insurance company. The cost of any such insurance will be a Project Cost.
                                            At Global&rsquo;s request, Capital shall provide Global with a certificate evidencing the
                                            coverage required hereby, and the amount thereof. Such insurance shall be maintained for
                                            not less than three (3) years following the expiration or termination of this Agreement (or
                                            such longer period as is customary practice) for any reason.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIMITATION
                                            OF LIABILITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exclusion
                                            of liability</U>. Subject to Clause 10.2, no Party nor their respective directors, officers,
                                            employees and agents shall have any liability under or in connection with this Agreement
                                            whether under statute or in tort (including but not limited to negligence), contract or otherwise
                                            in respect of: (i) any consequential or indirect loss; and/or (ii) any loss of goodwill,
                                            opportunity or contract (in each case whether direct or indirect), in either case even if
                                            advised in advance of the possibility of such losses.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                            exclusion of liability for personal injury or death</U>. Nothing in this Agreement shall
                                            be construed as excluding or limiting the liability of any person for: (i) death or personal
                                            injury caused by negligence; (ii) fraud or fraudulent misrepresentation; or (iii) any other
                                            liability which cannot be limited or excluded by law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIALITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality
                                            undertakings</U>. Each Party (the &ldquo;<B>Receiving Party</B>&rdquo;) undertakes with each
                                            other Party (the &ldquo;<B>Disclosing Party</B>&rdquo;) that it shall keep, and it shall
                                            procure that its respective directors, partners, officers, employees and agents (collectively,
                                            &ldquo;<B>Representatives</B>&rdquo;) shall keep, secret and confidential all Confidential
                                            Information of the Disclosing Party and shall not publish or disclose the same or any part
                                            of the same to any person whatsoever other than:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of Capital to: (i) licensees, acquirors or licensors of intellectual property and
                                            Third Party Service Providers, and potential licensees, acquirors and potential Third Party
                                            Service Providers, provided that any such persons have agreed to be bound by a legal obligation
                                            of confidentiality no less restrictive than that set forth in this Clause 11; (ii) investors
                                            in Capital pursuant to its obligations under applicable laws and regulations (in particular
                                            but without limitation those of the Financial Conduct Authority); (iii) Competent Authorities
                                            in the Territory as necessary in communications relating to any products covered by any intellectual
                                            property arising from a Project;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of each Party to potential investors in or acquirors of that Party, provided that
                                            in each case such persons have agreed to be bound by a legal obligation of confidentiality
                                            no less restrictive than that set forth in this Clause 11;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            a Party is exercising its rights pursuant to Clause 14, to potential investors in or acquirors
                                            of that Party&rsquo;s interest in Net Revenue, provided that in each case such persons have
                                            agreed to be bound by a legal obligation of confidentiality no less restrictive than that
                                            set forth in this Clause 11; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of each Party, to its Representatives directly or indirectly concerned in the exercise
                                            of the rights granted under this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representatives
                                            to be bound by confidentiality</U>. Each Party shall ensure that each of its Representatives
                                            to whom any Confidential Information is disclosed shall previously have been informed of
                                            the confidential nature of the Confidential Information and shall have agreed to be bound
                                            by a legal obligation of confidentiality no less restrictive than that set forth in this
                                            Clause 11.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exclusions
                                            from confidentiality undertakings</U>. The provisions of Clauses 11.1 and 11.2 shall not
                                            apply to Confidential Information which:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Receiving Party can demonstrate by reference to written records to have been in its possession
                                            (other than under an obligation of confidence to the Disclosing Party or to a Third Party)
                                            at the date of receipt;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Receiving Party can demonstrate by reference to written records to have been received from
                                            a Third Party which does not have an obligation of confidence to the Disclosing Party;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enters
                                            the public domain otherwise than through a breach of any obligation of confidentiality owed
                                            to the Disclosing Party; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Receiving Party can prove it has independently developed without direct or indirect access
                                            to any of the Disclosing Party&rsquo;s Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Permitted
                                            disclosure</U>. The Receiving Party may disclose Confidential Information to the extent that
                                            such disclosure is:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">necessarily
                                            required of the Receiving Party by order of a Competent Authority or otherwise by applicable
                                            law; provided, that the Receiving Party shall, to the extent practicable, first have given
                                            notice to the Disclosing Party and given the Disclosing Party a reasonable opportunity to
                                            quash any such order or obtain a protective order requiring that the Confidential Information
                                            the subject of such order be held in confidence by such Competent Authority or, if disclosed,
                                            be used only for the purpose for which the order was issued; and provided further that if
                                            such order is not quashed or a protective order is not obtained, the Confidential Information
                                            disclosed in response to such order shall be limited to that information that is legally
                                            required to be disclosed in response to such order;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">required
                                            with regard to the disclosure requirements of (i) a national securities exchange or other
                                            stock market; (ii) a related regulatory body on which the Receiving Party&rsquo;s securities
                                            are or are proposed to be traded; or (ii) in the case of Capital, the UK Charities Commission,
                                            provided it has used reasonable endeavours in the time available to provide notice to the
                                            Disclosing Party of the terms of any such disclosure beforehand.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notification
                                            by Disclosing Party</U>. Insofar as the Receiving Party believes that any of the provisions
                                            of Clause 11.4.1 or 11.4.2 apply to Confidential Information, it shall notify the Disclosing
                                            Party at the earliest opportunity.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Effect
                                            of disclosure</U>. The Receiving Party agrees that the disclosure of the Disclosing Party&rsquo;s
                                            Confidential Information without the express written consent of the Disclosing Party may
                                            cause irreparable harm to the Disclosing Party, and that any breach or threatened breach
                                            of this Agreement by the Receiving Party may entitle the Disclosing Party to injunctive relief,
                                            in addition to any other legal remedies available to it, in any court of competent jurisdiction.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Duration</U>.
                                            The provisions of this Clause 11 shall remain in force for a period of ten (10) years from
                                            the expiry or termination of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
                                            AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term</U>.
                                            This Agreement will become effective on the Effective Date. Subject to the provisions of
                                            this Clause 12, it will remain effective in respect of each Project until the expiry of the
                                            right of a Party to receive a share of the Net Revenue pursuant to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Right
                                            to terminate</U>. Without prejudice to any other rights of the Parties, this Agreement may
                                            be terminated in respect of a Project by notice in writing:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            Capital on the one hand, or by Global on the other hand, forthwith if, in respect of the
                                            other Party, a voluntary arrangement is proposed or approved or an administration order is
                                            made, or a receiver or administrative receiver is appointed of any of the other Party&rsquo;s
                                            assets or undertakings or a winding-up resolution or petition is passed (otherwise than for
                                            the purpose of solvent reconstruction or amalgamation, in particular with respect to any
                                            reorganisation of the structure of that Party) or if any circumstances arise which entitle
                                            a court or a creditor to appoint a receiver, administrative receiver or administrator or
                                            make a winding-up order or similar or equivalent action is taken against or by that other
                                            Party by reason of its insolvency or in consequence of debt;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            Capital in the event of material or persistent breach of this Agreement by Global which is
                                            not capable of remedy and where that breach is capable of remedy, Global fails to remedy
                                            it within [***] after service of written notice from Capital requiring Global to remedy that
                                            breach provided that the parties shall continue to perform this Agreement and to be subject
                                            to the obligations and benefit from the rights set out in this Agreement and this Agreement
                                            shall not be terminated until such breach is confirmed by a final, unappealable decision
                                            of a court of competent authority or otherwise agreed by the parties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            Capital in the event that Capital decides to cease development of a Project provided that
                                            in such event termination shall apply to that Project only and this Agreement shall continue
                                            in full force and effect in respect of any other Projects.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of any doubt Global&rsquo;s rights to receive a share of revenue in accordance with Clause 5 shall continue in full force
and effect notwithstanding termination of this Agreement (or any Project) in accordance with this Clause 12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Provisions
                                            to continue on termination</U>. The termination of this Agreement howsoever arising will
                                            be without prejudice to the rights and duties of any Party accrued prior to termination.
                                            The following Clauses will continue to be enforceable notwithstanding termination: Clauses
                                            3.7, 3.8, 4.5, 5, 6, 7, 9, 10. 11, 14, 15, 18, 19, 20, 21, 23, 24 and 25.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORCE
                                            MAJEURE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Force
                                            Majeure event</U>. If a Party is unable to carry out any of its obligations under this Agreement
                                            due to Force Majeure (the &ldquo;<B>Non-Performing Party</B>&rdquo;) this Agreement shall
                                            remain in effect but the Non-Performing Party&rsquo;s relevant obligations under this Agreement
                                            and the relevant obligations of the other Party (&ldquo;<B>the Innocent Party</B>&rdquo;)
                                            under this Agreement shall be suspended for the duration of the circumstance of Force Majeure
                                            provided that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            suspension of performance is of no greater scope than is required by the Force Majeure;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Non-Performing Party gives the Innocent Party prompt notice describing the circumstance of
                                            Force Majeure, including the nature of the occurrence and its expected duration, and continues
                                            to furnish regular reports during the period of Force Majeure;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Non-Performing Party uses all reasonable efforts to remedy its inability to perform and to
                                            mitigate the effects of the circumstance of Force Majeure; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            soon as practicable after the event which constitutes Force Majeure the Parties shall discuss
                                            how best to continue their operations as far as possible in accordance with this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Right
                                            to terminate</U>. If the Force Majeure continues for [***] or more, the Innocent Party to
                                            this Agreement may give [***] written notice to terminate this Agreement to the Non-Performing
                                            Party and termination shall occur if the Force Majeure is continuing at the end of that [***]
                                            notice period.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rights
                                            to assign</U>. This Agreement shall be binding upon and inure to the benefit of the Parties,
                                            their successors and assigns.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                            as provided in this Clause 14.2, this Agreement shall not be assigned without the prior written
                                            consent of the other Party to the Agreement, such consent not to be unreasonably withheld,
                                            conditioned or delayed. Notwithstanding the foregoing:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            Party shall have the right to assign the right to receive or retain its share of Net Revenue
                                            pursuant to Clause 5.1.2; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            Party may assign this Agreement in its entirety, without any consent of the other Parties
                                            to an Affiliate provided always that on the assignee ceasing to be an Affiliate this Agreement
                                            is assigned back to the assigning Party and failure to assign this Agreement to the assigning
                                            Party shall be a material breach of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>.
                                            All notices shall be in writing and sent by hand, email, or recorded delivery and shall be
                                            deemed to be properly served (i) if sent by hand, when delivered at the relevant address;
                                            (ii) if sent by recorded delivery, three (3) Business Days after posting; (iii) if sent by
                                            email, when transmitted, provided a confirmatory copy is sent by post within twenty four
                                            (24) hours of transmission, and shall be sent to the following addresses or email address
                                            as may be amended by the relevant Party in writing:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
    2a/2b Thrales End Business Centre, Thrales End Lane, Harpenden, AL5 3NS</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    [***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the attention of: [***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
    SGS Global Ltd, do Ogiers, 89 Nexus Way, Camana Bay, Cayman Islands</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    [***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the attention of: [***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VARIATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            variation, modification, amendment, extension or release from any provision of this Agreement
                                            shall be effective unless it is in writing, signed by all Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ENTIRE
                                            AGREEMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party confirms that this Agreement (including all Schedules) represents the entire understanding,
                                            and constitutes the whole agreement, in relation to its subject matter and supersedes any
                                            previous agreement between the Parties with respect thereto.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party confirms that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            entering into this Agreement it has not relied on any representation or warranty or undertaking
                                            which is not contained in this Agreement and it will not have any claim, right or remedy
                                            arising out of any such representation or warranty or undertaking; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
                                            as provided for in this Agreement and without prejudice to any liability for fraudulent misrepresentation
                                            or fraudulent misstatement, each Party agrees that the only rights and remedies available
                                            to it arising out of or in connection with any warranties, statements, promises or representations
                                            will be for breach of contract and irrevocably and unconditionally waives any right it may
                                            have to any claims, rights or remedies which it might otherwise have had in relation to them.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
                                            ASSURANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt; padding-left: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party hereby undertakes to do all such other acts and things, and execute and provide all
                                            such documents at another Party&rsquo;s request and cost as may be necessary or desirable
                                            to give effect to the purposes of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WAIVER</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            relaxation, forbearance, waiver or indulgence by any Party in enforcing any of the terms
                                            or conditions of this Agreement or the granting of time by any Party to another shall prejudice,
                                            affect or restrict the rights and powers of such Party, unless contained in a writing signed
                                            by the Party charged with such waiver. The waiver of any breach of any term or any condition
                                            of this Agreement shall not be construed as a waiver of any subsequent breach of a term or
                                            condition of the same or of a different nature.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEVERABILITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the whole or any part of this Agreement is or becomes or is declared illegal, invalid or
                                            unenforceable in any jurisdiction for any reason (including by reason of the provisions of
                                            any legislation and/or by reason of any court or Competent Authority):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of the illegality, invalidity or unenforceability of the whole of this Agreement
                                            it shall terminate only in relation to the jurisdiction in question; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of the illegality, invalidity or unenforceability of a part of this Agreement that
                                            part shall be severed from this Agreement in the jurisdiction in question and that illegality,
                                            invalidity or unenforceability shall not in any way whatsoever prejudice or affect the remaining
                                            parts of this Agreement which shall continue in full force and effect and in no circumstances
                                            shall sums paid by Capital to Global under this Agreement be repayable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            in the reasonable opinion of any Party any severance under this Clause 20 materially affects
                                            the commercial basis of this Agreement, the Parties shall discuss, in good faith, ways to
                                            eliminate the material effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NO
                                            PARTNERSHIP</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in this Agreement is deemed to constitute a partnership between the Parties nor constitute
                                            any Party as the agent of any other Party for any purpose.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement may be executed in any one or more number of counterpart agreements each of which,
                                            when executed, shall be deemed to form part of and together constitute this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNOUNCEMENTS,
                                            PUBLICATIONS AND USE OF NAMES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                            as provided in Clause 23.2 no Party shall make, or procure or permit the making of, any press
                                            release or other public announcement (including on any website or in any company publication)
                                            in relation to this Agreement without first obtaining the written approval of the other Parties
                                            to any such release or announcement, which shall not unreasonably be withheld, conditioned
                                            or delayed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            Party may make an announcement with respect to this Agreement or any ancillary matter if
                                            required by law or the regulations of any stock exchange to which it is subject, without
                                            the other Parties&rsquo; consent provided it has used reasonable endeavours in the time available
                                            to consult with the other Parties on the terms of any such announcement beforehand.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            Party shall use the name or marks of the other Party, other than as provided in Clause 23.1
                                            and 23.2 without the prior written consent of such Party which shall be at that Party&rsquo;s
                                            sole discretion.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DISPUTE
                                            RESOLUTION AND GOVERNING LAW</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the event that a determination of the Expert is sought under this Agreement:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Parties shall appoint a suitably qualified, mutually agreed independent expert. However,
                                            in the event that the Parties are unable to reach agreement on the identity of such an expert
                                            within fifteen (15) Business Days of any Party seeking in writing to the other to appoint
                                            such expert, each Party shall submit two (2) names to the President for the time being of
                                            the Association of the British Pharmaceutical Industry (or any successor body thereto), who
                                            shall select an individual from the names submitted and the Parties shall appoint such individual
                                            as an expert. The individual appointed pursuant to this Clause 24.1.1 shall be the &ldquo;<B>Expert</B>&rdquo;;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            opinion of that Expert (who shall act as an expert and not as an arbitrator) shall be final
                                            and binding on the Parties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            Party shall make written submissions to the Expert and to the other Parties within twenty
                                            (20) Business Days of the Expert&rsquo;s appointment;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            Party shall have ten (10) Business Days to respond to the other Party&rsquo;s submissions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Parties shall request that the Expert deliver his or her opinion within a further twenty
                                            (20) Business Days; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            costs associated with the appointment of the Expert shall be borne in such proportions as
                                            the Expert may determine to be fair and reasonable in all the circumstances or, if no such
                                            determination is made by the Expert, by the Parties in equal proportions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            shall be a condition precedent to the commencement of any action in court or other tribunal
                                            (save an action for an interim injunction) in respect of any dispute relating to this Agreement
                                            that the Parties have sought to resolve the dispute by a Party notifying the other Party
                                            in writing specifying the nature of the dispute and requesting that the dispute be resolved
                                            by the Executive Officers who shall meet (whether in person or via teleconference) within
                                            twenty-one (21) days of such notice to seek resolution in good faith. If the Executive Officers
                                            are unable to resolve the dispute at such meeting, any Party may pursue any remedy available
                                            to such Party at law or in equity, subject to the terms and conditions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement and any non-contractual obligations arising out of or in connection with this Agreement
                                            shall be governed by, and construed in accordance with, English law. Subject to Clauses 24.1
                                            and 24.2, the courts of England shall have exclusive jurisdiction to determine any disputes
                                            arising out of or in connection with: (i) the creation, validity, effect, interpretation
                                            or performance of, or the legal relationships established by or otherwise arising out of
                                            or in connection with this Agreement; and (ii) any non-contractual obligations arising out
                                            of or in connection with this Agreement. For these purposes each party irrevocably submits
                                            to the jurisdiction of the English courts, waives any objections to the jurisdiction of those
                                            courts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTRACTS
                                            (RIGHTS OF THIRD PARTIES) ACT 1999</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            term of this Agreement is enforceable under the Contracts (Rights of Third Parties) Act 1999
                                            by a person who is not a party to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties hereby execute this Agreement by their duly authorised representatives:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    <B>ST GEORGE STREET CAPITAL</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dave Tapolczay</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave
    Tapolczay</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    <B>SGS GLOBAL LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Andrew Regan</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Regan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROJECT
FUNDING AGREEMENT TEMPLATE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Copy
to be added following agreement of the template after the Effective Date]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>5
<FILENAME>ex10-21.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.21</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED
BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THESE REDACTED TERMS
HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS [***].</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
PROJECT FUNDING AGREEMENT for use in renal<BR>
transplant</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;) is dated 02 November 2022 (the &ldquo;<B>Effective Date</B>&rdquo;) and is between:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>St
                                            George Street Capital Limited</B> (&ldquo;<B>Capital</B>&rdquo;), a private company limited
                                            by guarantee without share capital incorporated in England and Wales, company number 10537833
                                            and also a registered charity in England and Wales (registered charity number 1171470) whose
                                            registered office is at Bates Wells Braithwaite, 10 Queen Street Place, London, United Kingdom,
                                            EC4R 1BE; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conduit
                                            Pharmaceuticals Limited</B> (&ldquo;<B>Conduit</B>&rdquo;), formerly known as SGS Global
                                            Limited, a company incorporated in the Cayman Islands, company number OC-346289, whose registered
                                            office is at c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009,
                                            Cayman Islands,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
a &ldquo;<B>Party</B>&rdquo; and together the &ldquo;<B>Parties</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            is a UK registered charity whose objects include the advancement of medical research and
                                            development for public benefit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Parties entered into an Exclusive Funding Agreement dated 26 March 2021 pursuant to which
                                            Capital gave Conduit an exclusive first right to provide or procure the provision of funding
                                            to support Capital&rsquo;s drug development projects (the &ldquo;<B>Exclusive Funding Agreement</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            accordance with clause 3.4 of the Exclusive Funding Agreement, Conduit wishes to provide
                                            funding to Capital for the development of the Candidate (as defined in this Agreement) AZD1656
                                            for the treatment of Renal Transplant (the &ldquo;<B>Field</B>&rdquo;) on the terms set out
                                            in this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Candidate</B>&rdquo;
                                            means AZD1656 and any co-crystals, salts, prodrugs, esters, amides, active metabolites, solvates,
                                            intermediates, fragments, derivatives (including pegylated versions and any linkers thereof),
                                            analogs and polymorphs of such compound.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercialisation</B>&rdquo;
                                            means any and all activities directed to the preparation for sale of, offering for sale of,
                                            or sale of a product, including activities related to marketing, promoting, distributing,
                                            importing and exporting such product. When used as a verb, &ldquo;<B>to Commercialise</B>&rdquo;
                                            and &ldquo;<B>Commercialising</B>&rdquo; means to engage in Commercialization, and &ldquo;<B>Commercialised</B>&rdquo;
                                            has a corresponding meaning.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercially
                                            Reasonable Efforts</B>&rdquo; means, with respect to the Development or Commercialization
                                            of Product by Capital, that level of efforts and resources that Capital would normally devote
                                            to the Development or Commercialization, as the case may be, of a product owned by it, or
                                            to which it has exclusive rights in relation to, which is of a similar commercial potential
                                            at a similar stage in its lifecycle, in each case taking into account issues of safety and
                                            efficacy, product profile, the proprietary position, the then current competitive environment
                                            for such product and the likely timing of such product&rsquo;s entry into the market, the
                                            pricing and launching strategy for the respective product, the regulatory environment and
                                            status of such product, and other relevant scientific, technical and commercial factors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Competing
                                            Product</B>&rdquo; means any pharmaceutical or biologic product or a program directed at
                                            a pharmaceutical or biologic product that targets the same indication as the Product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential
                                            Information</B>&rdquo; means information in whatever form (including in written, oral, visual
                                            or electronic form or on any magnetic or optical disk or memory and wherever located) relating
                                            to the research, development, data and/or results and product information, inventions, works
                                            of authorship, processes, methodologies, the business, sales targets, sales statistics, market
                                            share statistics, prices, market research reports and surveys, advertising and other promotional
                                            materials, future projects, business development or planning, commercial relationships and
                                            negotiations, customers, products, affairs and finances, and employees of a Party or its
                                            affiliates, and trade secrets including, technology, technical data and know-how relating
                                            to the business of such Party or its affiliates or any of their suppliers, customers, agents,
                                            distributors, shareholders, management or business contacts, whether or not such information
                                            is marked or identified as confidential, including information relating to the existence
                                            and terms of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Develop</B>&rdquo;
                                            means, in relation to a Product, the performance of all preclinical and clinical development
                                            (including, without limitation, toxicology, pharmacology, test method development and stability
                                            testing, process development, formulation development, quality control development, statistical
                                            analysis), clinical trials, and manufacturing and regulatory activities that are required
                                            to obtain regulatory approval of such Product. When used as a verb, &ldquo;<B>to Develop</B>&rdquo;
                                            and &ldquo;<B>Developing</B>&rdquo; means to engage in Development, and &ldquo;<B>Developed</B>&rdquo;
                                            has a corresponding meaning.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Development
                                            Plan</B>&rdquo; means a written plan for the Development of a Product, substantially in the
                                            form attached hereto as Schedule 1 (or subsequently agreed by the parties), and which will
                                            be subject to amendment from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disclosing
                                            Party</B>&rdquo; means a Party to this Agreement which discloses or makes available, directly
                                            or indirectly (for the avoidance of doubt including via a third party or its affiliates on
                                            the Disclosing Party&rsquo;s behalf), any Confidential Information to the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding</B>&rdquo;
                                            has the meaning set out in Section 3.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Budget</B>&rdquo; means the reasonably detailed budget for the Development of the Product
                                            setting out the anticipated costs for the Development of the Product and the expected timing,
                                            as set out in the initial budget in Schedule 2 (or subsequently agreed between the Parties)
                                            and as amended from time to time by approval of the JSC in accordance with Section 8.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Percentage</B>&rdquo; means 100% of the total Funding Requirement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Requirement</B>&rdquo; means the funding required by Capital to obtain, by itself or through
                                            a Third Party, the first regulatory approval and/or first commercial sale for the Product,
                                            or as otherwise agreed by the Parties, as set out in the Budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
                                            Property</B>&rdquo; means ideas, concepts, discoveries, inventions, developments, know-how,
                                            trade secrets, techniques, methodologies, modifications, innovations, improvements, writings,
                                            documentation, electronic code, data, and rights (whether or not protectable under state,
                                            federal or foreign patent, trademark, copyright, or similar laws) or the like, whether or
                                            not written or otherwise fixed in any form or medium, regardless of the media on which contained
                                            and whether or not patentable or copyrightable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>JSC</B>&rdquo;
                                            means the joint steering committee established by the Parties in accordance with Section
                                            8.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
                                            Receipts</B>&rdquo; means the Net Sales and the Sublicensing Revenue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
                                            Sales</B>&rdquo; means any amounts received by Capital or its affiliates related to sales
                                            of a Product other than Sublicensing Revenue and less the following permitted deductions:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            portion of such amounts that is payable to a third party pursuant to a legal or contractual
                                            commitment; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            tax payable by Capital on such amounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Product</B>&rdquo;
                                            means any product containing the Candidate (alone or with other active ingredients) in all
                                            forms, presentations, formulations, and dosage forms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Progress
                                            Report</B>&rdquo; means a written report prepared by Capital setting out in reasonably detail
                                            a summary of the progress made by Capital regarding the Development of the Product as described
                                            in Section 8.3.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project</B>&rdquo;
                                            has the meaning set out in Section 3.2.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Receiving
                                            Party</B>&rdquo; shall mean a Party to this Agreement which receives or obtains, directly
                                            or indirectly (for the avoidance of doubt including via a third party or its affiliates on
                                            behalf of the Disclosing Party), any Confidential Information of the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sublicensing
                                            Revenue</B>&rdquo; shall mean all cash payments, the fair market cash value of any equity
                                            consideration (less any amounts paid for such equity consideration), and forgivable loans
                                            (to the extent actually forgiven) received by Capital or its affiliates in consideration
                                            for and directly attributable to the grant of a sublicense under any of its rights in a Product,
                                            including any royalties, upfront payments, license maintenance fees, milestone payments or
                                            the like less the following permitted deductions:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            portion of such amounts that is payable to a third party pursuant to a legal or contractual
                                            commitment; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            tax payable by Capital on such amounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Term</B>&rdquo;
                                            has the meaning set out in Section 12.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Territory</B>&rdquo;
                                            shall mean worldwide.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
                                            Party</B>&rdquo; means any person other than the Parties and their respective affiliates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            this Agreement:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            references to a particular clause or schedule shall be a reference to that clause or schedule
                                            in or to this Agreement as it may be amended from time to time pursuant to this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            headings are inserted for convenience only and shall be ignored in construing this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            importing the masculine gender shall include the feminine and vice versa and words in the
                                            singular include the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            denoting persons shall include any individual, partnership, company, corporation, joint venture,
                                            trust association, organisation or other entity, in each case whether or not having separate
                                            legal personality;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            words &ldquo;include&rdquo;, &ldquo;included&rdquo; and &ldquo;including&rdquo; are to be
                                            construed without conveying any limitation to the generality of the preceding words;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reference
                                            to any statute or regulation includes any modification or re-enactment of that statute or
                                            regulation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            references to USD, dollars or $ are to United States Dollars</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            reference to notices or consent being sought or given in writing shall require the consent
                                            or notice to be signed by an appropriately authorised person and shall not include consents
                                            or notices conveyed by email; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the event of any inconsistency or conflict between this Agreement and any of the Schedules,
                                            this Agreement shall prevail.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FUNDING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            shall provide to Capital the sums set out in the Funding Budget (the &ldquo;<B>Funding</B>&rdquo;)
                                            in accordance with the budget payment schedule set out in the Funding Budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Funding will be used by Capital solely to support its Development and Commercialisation of
                                            a Product in the Field (the &ldquo;<B>Project</B>&rdquo;). The Funding provided by Conduit
                                            shall be the Funding Percentage of the Funding Requirement unless otherwise agreed between
                                            the Parties pursuant to Section 3.6. For clarity:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Funding is indirect investment in the Product for use in the Field and not a loan, equity
                                            investment, gift or donation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Funding must only be used for the Project; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Parties do not consider the subject matter of this Agreement to constitute a supply of services
                                            in respect of which VAT would be payable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise agreed in writing, Capital shall be responsible for any costs required to achieve
                                            the Purpose which exceed the amount of the Funding and Conduit shall have no obligation to
                                            provide any further amount to Capital in addition to the Funding.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall submit invoices to Conduit in respect of payments to be made in accordance with Schedule
                                            2. Conduit shall endeavour to pay all undisputed invoices within ten (10) days of receipt
                                            of such invoice by Conduit. If Conduit disputes any invoice, the provisions of Section 6
                                            shall apply. Notwithstanding Conduit&rsquo;s right to dispute any invoice in accordance with
                                            Section 6, Conduit reserves the right to refuse to pay any invoice for any amount which was
                                            not incurred in respect of the Purpose and/or which was not included in the Funding Budget.
                                            Conduit shall not be in breach of this Agreement unless undisputed invoices remain outstanding
                                            for a period of more than [***].</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            acknowledges that to ensure that Conduit has the funds required to advance the Funding to
                                            Capital as required pursuant to this Agreement, Conduit may obtain funding from Third Parties
                                            and that accordingly payment of the Funding by Conduit may be dependent on Conduit obtaining
                                            the necessary funding from such Third Parties. Conduit shall not be in breach of this Agreement
                                            if the reason for its failure to advance any of the Funding to Capital is its inability to
                                            obtain funding from Third Parties or the failure of a Third Party to advance amounts that
                                            the Third Party had committed to advance to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            at any time Capital anticipates that the agreed Funding Budget is insufficient to complete
                                            the activities set out in the Funding Budget, Capital shall promptly inform Conduit in writing
                                            and the Parties will discuss in good faith the action to be taken. Conduit shall have the
                                            first right to provide any additional funding required to complete the Development of the
                                            Product as described in the Funding Budget and the first right to provide any further funding
                                            which may be required for Capital to complete any further Development of or the Commercialisation
                                            of the Product provided that such funding may include Conduit obtaining additional funding
                                            from a Third Party to meet such requirements. If Conduit is unable to provide any additional
                                            funding required by Capital, Capital may obtain additional funding from a Third Party and,
                                            as appropriate, the Parties shall agree in good faith any adjustment that should be made
                                            to the Funding Percentage.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
                                            OF FUNDING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Capital (i) ceases to undertake the Project for any reason, or (ii) if this Agreement is
                                            terminated, and at the relevant time Capital has not spent all of the Funding, Capital shall
                                            promptly repay such unspent portion of the Funding to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall only use any equipment purchased using the Funding for the Project in accordance with
                                            this Agreement, or as otherwise permitted in writing by Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall comply with all applicable law, regulatory requirements and ethical guidelines and
                                            principles in conducting the Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            to enable Capital to undertake the Project, Capital needs to enter into any agreements with
                                            any Third Party where the Funding will be used to pay any amounts due to such Third Parties
                                            or where any Intellectual Property generated using the Funding will be provided to such Third
                                            Parties (including license agreements in respect of any Intellectual Property), Conduit shall
                                            have the right to approve any such proposed Third Party agreements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT
                                            OF REVENUE SHARE TO CONDUIT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            consideration for the advance of the Funding by Conduit to Capital, Capital shall pay to
                                            Conduit an amount equal to the Funding Percentage of the Net Receipts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall calculate the Net Receipts at the end of each Calendar Quarter, in the currency that
                                            they are received by. Capital. Capital shall pay to Conduit the Net Receipts with respect
                                            to a given Calendar Quarter within thirty (30) days after the end of such Calendar Quarter
                                            and each such payment once made shall be non-refundable. Each payment shall be accompanied
                                            by a statement setting out the amount of Net Receipts (including such amounts expressed in
                                            local currency) and the calculation of the amount of Net Receipts for such Calendar Quarter,
                                            including details of any deductions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            payments shall be made by Capital to Conduit without setoff, by deposit in the requisite
                                            amount to such bank account as Conduit may from time to time designate by notice to Capital.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT
                                            DISPUTES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            sixty (60) working days of receipt of each invoice received by Conduit in accordance with
                                            Section 3.4, or statement of Net Receipts received by Conduit in accordance with 5.2, Conduit
                                            may serve a written notice on Capital disputing such invoice, whether the activities covered
                                            by the invoice are included in the Funding Budget and/or the calculation of Net Receipts
                                            (a &ldquo;<B>Dispute Notice</B>&rdquo;) and the provisions of Section 6.2 shall apply.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Conduit serves a Dispute Notice in accordance with Section 6.1, the Parties shall, during
                                            the period of thirty (30) days commencing on the date of service of the Dispute Notice, seek
                                            in good faith to reach agreement on the disputed matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall maintain complete and accurate records of, and supporting documentation for, invoices
                                            submitted to Conduit and Capital&rsquo;s calculation of Net Receipts pursuant to this Agreement
                                            and demonstrating that the Development and Commercialisation activities undertaken by Capital
                                            pursuant to the Project are consistent with the Funding Budget. Such records shall be retained
                                            for inspection by Conduit for at least five (5) years following the calendar year to which
                                            such records pertain.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            (or its professional advisers) may during normal business hours and upon fourteen (14) days&rsquo;
                                            written notice to Capital, enter the premises of Capital and have access to the personnel,
                                            books, records and reports of Capital; and inspect, audit and take copies of relevant records,
                                            and other documents as necessary to verify Capitals compliance with the terms and conditions
                                            of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DILIGENCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            thirty (60) days of the Effective Date, Capital shall prepare a Development Plan for the
                                            project and shall submit such Development Plan to the JSC for review in accordance with Section
                                            8.2.1, and to Conduit for approval in accordance with Section 8.2.4. Capital may propose
                                            amendments to the Development Plan from time to time by submitting any amendments to the
                                            JSC for review and to Conduit for approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall use its Commercially Reasonable Efforts to Develop and Commercialise at least one Product
                                            in the Field in each of (i) the United States of America; (ii) each of the major European
                                            countries (being Italy, France, Germany, Spain and the United Kingdom); and (iii) Japan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            fourteen (14) days of the end of each month, Capital shall submit Progress Reports to Conduit
                                            in a form to be agreed between the Parties. Such Progress Reports shall set out, among other
                                            things, the Development activities undertaken by Capital in the preceding month in respect
                                            of all Products, and the Development activities which will be undertaken by Capital in the
                                            succeeding month. Capital shall prepare a Progress Report, in respect of each Product, each
                                            calendar month commencing the first calendar month following the Effective Date until expiry
                                            of the Term, unless otherwise agreed between the Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOVERNANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
                                            Steering Committee</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            thirty (30) days after the Effective Date, the Parties will establish the JSC which will
                                            oversee and manage the Project. Each Party initially will appoint two (2) representatives
                                            to serve as representatives to the JSC (the &ldquo;<B>JSC Representatives</B>&rdquo;). The
                                            initial representatives of Capital will be the CEO of Capital and Capital&rsquo;s senior
                                            clinician working on the Project. Each JSC Representative shall have knowledge and expertise
                                            regarding developing products similar to the Product and sufficient decision-making authority
                                            within the applicable Party to make decisions on behalf of such Party within the scope of
                                            the JSC&rsquo;s decision-making authority. If any such representative is not an employee
                                            of the appointing Party, such representative shall execute a confidentiality agreement in
                                            form and substance acceptable to the other Party (and, for the avoidance of doubt, the appointing
                                            Party shall remain responsible to the other Party for any noncompliance by such representative
                                            with such confidentiality obligations). Each Party may replace its JSC Representatives at
                                            any time upon written notice to the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC chairperson (&ldquo;<B>JSC Chairperson</B>&rdquo;) shall be designated from the Parties&rsquo;
                                            JSC Representatives and shall serve for a term of one (1) year. Capital shall appoint the
                                            first JSC Chairperson and subsequent appointments will rotate on an annual basis between
                                            Capital and Conduit. The JSC Chairperson will be responsible for drafting and circulating
                                            the draft agenda and ensuring minutes are prepared.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
                                            the Effective Date, through the date of completion of successful license deal and/or first
                                            regulatory approval and/or first commercial sale of the Product, the JSC will meet at least
                                            once per calendar quarter (and for clarity, such meetings are intended to be conducted via
                                            teleconference) unless the Parties mutually agree otherwise. Either Party may call a special
                                            meeting of the JSC (by videoconference or teleconference) by providing at least ten (10)
                                            days&rsquo; prior written notice to the other Party, which notice shall include a reasonably
                                            detailed description of the matter, in the event such Party reasonably believes that a significant
                                            matter must be addressed prior to the next scheduled meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC may invite individuals who are not JSC Representatives to participate in JSC meetings;
                                            provided that (a) all JSC Representatives of both Parties consent to such non-member&rsquo;s
                                            participation; and (b) such non-member has executed a confidentiality agreement in form and
                                            substance acceptable to the non-inviting Party (and, for the avoidance of doubt, the inviting
                                            Party shall remain responsible to the non-inviting Party for any noncompliance by such individual
                                            with such confidentiality obligations). For clarity, such non-members will have no voting
                                            rights at the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party will bear its own expenses relating to the meetings and activities of the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JSC
                                            Responsibilities and Decision-Making</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall discuss and review (i) overall strategic direction of the Project; (ii) the Funding
                                            Budget and Development Plan; (iii) material changes in or amendments to the Funding Budget
                                            and Development Plan submitted by Capital or proposed by the JSC; (iv) forecasts of the estimated
                                            timeline for Development activities of the Products; and (v) any other matters the Parties
                                            mutually agree in writing shall be subject to discussion and review by the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall discuss, review and approve (i) any increases or decreases in the Funding Budget,
                                            and (ii) any other matters the Parties mutually agree in writing shall be subject to approval
                                            by the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall have no authority to (i) amend, modify or waive compliance with this Agreement,
                                            or (ii) resolve any dispute concerning the validity, interpretation, construction of, or
                                            breach of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            shall have the sole right to approve any amendments to Funding Budget and the Development
                                            Plan, taking into account any reasonable comments of the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCLUSIVITY
                                            COMMITMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the Term, Capital shall not, either by itself or through a Third Party, conduct human clinical trials of, or sell, offer for sale or
have sold any Competing Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLECTUAL
                                            PROPERTY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party will retain all right, title and interest in and to all Intellectual Property owned
                                            or controlled by such Party as of the Effective Date (&ldquo;<B>Existing Intellectual Property</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            Intellectual Property developed by or on behalf of Capital as a result of Capital undertaking
                                            the Project (&ldquo;<B>Arising Intellectual Property</B>&rdquo;) shall be assigned or sub-licensed
                                            to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall use Commercially Reasonable Efforts to prosecute, protect, defend and maintain the
                                            validity and enforceability of its Existing Intellectual Property and Conduit shall use Commercially
                                            Reasonable Efforts to prosecute, protect, defend and maintain the validity and enforceability
                                            of the Arising Intellectual Property.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIALITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential
                                            Information</B>. Except to the extent expressly authorized by this Agreement or by the Disclosing
                                            Party in writing, during the Term and for years thereafter, the Receiving Party shall maintain
                                            in confidence and shall not disclose to any third party or use for any purpose other than
                                            to exercise its rights or fulfil its obligations pursuant to this Agreement any Confidential
                                            Information of the Disclosing Party. Receiving Party may use the Confidential Information
                                            only to the extent required to perform its activities under this Agreement and for no other
                                            purpose. Receiving Party shall not use the Confidential Information for any purpose or in
                                            any manner that would constitute a violation of applicable laws. Both Parties shall ensure
                                            that all of its officers, employees, consultants, agents, subcontractors, third party vendors,
                                            investigators or contractors who receive or are in possession of any Confidential Information
                                            of the other Party understand and shall be bound by confidentiality provisions at least as
                                            stringent as the confidentiality obligations in this Agreement. Except as expressly set out
                                            in this Agreement the Parties agree that each Party is and shall remain the exclusive owner
                                            of its respective Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exceptions</B>.
                                            The obligations of confidentiality and nonuse set forth in Section 11.1 shall not apply to
                                            any specific portion of information that Receiving Party can demonstrate by competent written
                                            evidence: (a) is in the public domain or comes into the public domain through no fault of
                                            Receiving Party; (b) is furnished to Receiving Party by a third party rightfully in possession
                                            of such information not subject to a duty of confidentiality with respect thereto; (c) is
                                            already known by Receiving Party without restriction at the time of receiving such Confidential
                                            Information as demonstrated by files in existence at such time; or (d) is independently developed
                                            by Receiving Party without access to the Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
                                            Disclosure</B>. Notwithstanding the foregoing in this Section 9, the Receiving Party may
                                            disclose certain Confidential Information to the extent such disclosure is required by applicable
                                            laws or regulation (including the regulatory requirements of a stock exchange), or pursuant
                                            to a valid order of a court or other governmental body having jurisdiction, provided that
                                            the Receiving Party to the extent permitted by applicable laws, provides the Disclosing Party
                                            with reasonable prior written notice of such disclosure and reasonable assistance to the
                                            Disclosing Party&rsquo;s reasonable and lawful actions to avoid and/or minimize the extent
                                            of such disclosure, all at the Disclosing Party&rsquo;s expense. In the event of a limited
                                            disclosure of the Confidential Information as set forth in this Section 11.3, Receiving Party
                                            shall continue to treat such information as Confidential Information for all other purposes
                                            and subject to the other terms and conditions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Publication;
                                            Use of Names</B>. Under no circumstances may either Party use the name of the other Party
                                            or any of its personnel in any publication or any form of advertising without such other
                                            Party&rsquo;s prior written consent such consent not to be unreasonably withheld.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
                                            Party Confidential Information</B>. Neither Party shall disclose to the other Party any confidential
                                            or proprietary information that belongs to any third party unless Disclosing Party first
                                            obtains the consent of such third party and enters into a separate confidentiality agreement
                                            with Receiving Party covering that disclosure. Receiving Party shall not represent to Disclosing
                                            Party as being unrestricted any designs, plans, models, samples, or other writings or products
                                            that Receiving Party knows are covered by valid Intellectual Property protection belonging
                                            to a third party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Return
                                            of Confidential Information</B>. Upon written request and at the expense of the Disclosing
                                            Party, Receiving Party shall promptly return or destroy all documents, notes, and other tangible
                                            materials representing Disclosing Party&rsquo;s Confidential Information and all copies thereof;
                                            provided, however, that Receiving Party may retain a single archival copy of the Confidential
                                            Information for the sole purpose of facilitating compliance with the surviving provisions
                                            of this Agreement. Notwithstanding anything to the contrary in this Agreement, the Receiving
                                            Party shall not be required to destroy any computer files stored securely by the Receiving
                                            Party that are created during automatic system back-up. The Receiving Party shall continue
                                            to be bound by its obligations of confidentiality and non-use under this Agreement as set
                                            forth herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Injunctive
                                            Relief</B>. The Parties expressly acknowledge and agree that any breach or threatened breach
                                            of this Section 9 by Receiving Party may cause immediate and irreparable harm to Disclosing
                                            Party that may not be adequately compensated by damages. Each Party therefore agrees that
                                            in the event of such breach or threatened breach by Receiving Party, and in addition to any
                                            remedies available at law, Disclosing Party shall have the right to secure equitable and
                                            injunctive relief, without bond, in connection with such a breach or threatened breach.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
                                            AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B>.
                                            This Agreement shall commence upon the Effective Date and continue until terminated (the
                                            &ldquo;<B>Term</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                            by Conduit</B>. If at any time Capital ceases the conduct of the Development or Commercialisation
                                            of the Products in accordance with the Development Plan, Conduit shall not be obliged to
                                            make any further advances of the Funding to Capital. Capital shall provide Conduit with a
                                            reasonable explanation of the reason why it has ceased such activities. If Capital does not
                                            resume the Development or Commercialisation activities in accordance with the Development
                                            Plan within [***] of the date of cessation of such activities, Conduit shall have the right
                                            to terminate this Agreement in its entirety or in respect of the relevant Product only with
                                            immediate effect by giving notice in writing to Capital.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                            for Material Breach</B>. Either Party may terminate this Agreement immediately upon written
                                            notice to the other Party if the other Party materially breaches this Agreement, and does
                                            not fully cure the breach to the non-breaching Party&rsquo;s satisfaction within ninety (90)
                                            days after the non-breaching Party gives notice of the breach to the breaching Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
for Insolvency</B>. Either Party may terminate this Agreement upon written notice to the other Party if the other Party makes an assignment
for the benefit of creditors, or commences a case or proceeding under any bankruptcy, reorganization, insolvency, or similar laws, has
a trustee or receiver or similar officer of any court appointed for such Party, or for substantial part of the property of such Party,
or bankruptcy, reorganization, insolvency, or liquidation proceedings are instituted by or against such Party without such proceedings
being dismissed, in each of the foregoing cases for a period of at least sixty (60) days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect
                                            of Termination</B>. If Conduit terminates this Agreement pursuant to Section 12.2, pursuant
                                            to Section 12.3 in the case of Capital&rsquo;s material breach or pursuant to Section 0 in
                                            the case of Capital&rsquo;s insolvency Capital shall grant and hereby grants to Conduit a
                                            nonexclusive, perpetual, irrevocable, worldwide, royalty-free, fully paid-up, sublicensable
                                            (through multiple tiers) licence under any and all of Capital&rsquo;s Existing Intellectual
                                            Property embodied within, necessary or reasonably useful for the exploitation of the Arising
                                            Intellectual Property and the Product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Provisions
                                            to continue on termination</B>. The termination of this Agreement howsoever arising will
                                            be without prejudice to the rights and duties of any Party accrued prior to termination.
                                            The following Clauses will continue to be enforceable notwithstanding termination: Clauses
                                            4.2, 4.4, 5, 6, 7.3, 9, 10, 11, 13.4, 14, 15, 16, 17, 19, 20, 21, 22, 23, 24 and 25.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANTIES
                                            AND INSURANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party warrants as of the Effective Date that (a) it has the full power and authority to enter
                                            into this Agreement, (b) this Agreement has been duly authorized, (c) this Agreement is binding
                                            upon it; and (d) that the terms of this Agreement are not inconsistent with its other contractual
                                            arrangements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            warrants that, as of the Effective Date:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
                                            publicly filed accounts give a true and fair view of its financial position;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            is solvent and has disclosed to Conduit all material information regarding its financial
                                            position;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            has no indebtedness and it covenants that it shall not incur, create, assume, or permit to
                                            exist any indebtedness during the Term without the prior written permission of Conduit; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the best of its knowledge its Development and Commercialisation of a Product in accordance
                                            with the Development Plan will not infringe the intellectual property rights of any Third
                                            Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            to the extent expressly set out in Section 9.1 and 13.2, all warranties, express, statutory
                                            or implied and whether written or oral related to the subject matter of this Agreement are,
                                            to the fullest extent permissible by law, excluded. Without limiting the generality of the
                                            foregoing, the Parties acknowledge that the Candidate is experimental and at a very early
                                            stage of development and as such there is no guarantee the Development of the Candidate will
                                            result in asset that can be Commercialised. Capital shall have no liability to Conduit, in
                                            contract, tort or otherwise, in the event the Development of the Candidate does not result
                                            in asset that can be Commercialised.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall have and maintain, at its sole cost and expense, an adequate liability insurance (including
                                            product liability insurance) to protect against potential liabilities and risk arising out
                                            of activities to be performed under this Agreement, the Products and any agreement related
                                            hereto and upon such terms (including coverages, deductible limits and self-insured retentions)
                                            as are customary in the relevant industry generally. Such liability insurance shall insure
                                            against all types of liability, including personal injury, physical injury or property damage
                                            arising out of Capital&rsquo;s activities. This Section 13.4 shall not create any limitation
                                            on the Parties&rsquo; liability under this Agreement. Capital shall provide a copy of such
                                            insurance policy to Conduit promptly on request from Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORCE
                                            MAJEURE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure of either of the Parties to perform any obligation under this Agreement solely by
                                            reason of force majeure shall not be deemed to be a breach of this Agreement; provided, however,
                                            that the Party so prevented from complying herewith shall continue to take all reasonable
                                            actions within its power to comply as fully as possible herewith.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party shall deliver all notices, consents, and approvals required or permitted under this Agreement in writing in English to the other
Party to the addresses specified below. Each Party may change its address for receipt of notice by giving notice of such change to the
other Party. Notices shall be sent by electronic mail, overnight courier, certified mail, return receipt requested, or by other means
of delivery requiring a written acknowledged receipt. All notices shall be effective upon receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Conduit: Conduit Pharmaceuticals Limited, c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands
If to Capital: Bates Wells Braithwaite, FAO St. George Street Capital, 10 Queen Street Place, London, England, EC4R 1BE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>16.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NO
                                            PARTNERSHIP</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in this Agreement shall create a partnership. Neither Party is an agent or employee of the
                                            other Party and neither Party shall have the authority or power to make any statements, representations
                                            or commitments of any kind, nor to take any action which is binding on the other Party, except
                                            as may be explicitly provided for herein or authorised by the other Party in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>17.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
                                            Party shall sell, transfer, assign, delegate, pledge, or otherwise dispose of, whether voluntarily,
                                            involuntarily, by operation of law or otherwise, this Agreement or any of its rights or duties
                                            hereunder without the written consent of the other Party (such consent not to be unreasonably
                                            withheld, conditioned, or delayed); provided, that (a) a Party may make such an assignment
                                            without the other Party&rsquo;s consent to (i) its affiliate, or (ii) to a successor, whether
                                            in a merger, sale of stock, sale of assets or any other transaction, of the business to which
                                            this Agreement relates, and (b) Conduit may make an assignment of its right to receive Net
                                            Receipts (and related reports) pursuant to Section 3 to an affiliate or a third party without
                                            Capital&rsquo;s consent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>18.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COUNTERPARTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement may be executed in any number of counterparts, each of which when executed and
                                            delivered shall constitute an original of this Agreement, but all the counterparts shall
                                            together constitute the same agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>19.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
                                            ASSURANCES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            of the Parties shall take, or cause to be taken, all actions necessary, proper, or advisable
                                            under applicable laws to give effect to the provisions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>20.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD
                                            PARTY RIGHTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement and no person
                                            other than the Parties shall have any rights under it.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>21.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEVERABILITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any provision of this Agreement (or part of a provision) is found by any court or administrative
                                            body of competent jurisdiction to be invalid, unenforceable or illegal, the other provisions
                                            shall remain in force.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any provision of this Agreement (or part of any provision) is or becomes illegal, invalid
                                            or unenforceable but would be legal, valid and enforceable if some part of it was deleted
                                            or modified, the provision or part-provision in question shall apply with such deletions
                                            or modifications as may be necessary to make the provision legal, valid and enforceable.
                                            In the event of such deletion or modification, the Parties shall negotiate in good faith
                                            and acting reasonably in order to agree the terms of a mutually acceptable alternative provision.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>22.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            as expressly provided for in this Agreement, each of the Parties shall bear their own costs
                                            in relation to the investments and the contributions to be made pursuant to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>23.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VARIATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            variation of or amendment to this Agreement shall be effective unless made in writing and
                                            signed by authorised representatives of both Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>24.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WAIVERS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure or delay of either Party to enforce or to exercise, at any time or for any period
                                            of time, any term of or any right, power or privilege arising pursuant to this Agreement
                                            does not constitute and shall not be construed as a waiver of such term, right, power or
                                            privilege and shall in no way affect either Party&rsquo;s right later to enforce or exercise
                                            it, nor shall any single or partial exercise of any remedy, right, power or privilege preclude
                                            any further exercise of the same or the exercise of any other remedy, right, power or privilege.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>25.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICABLE
                                            LAW</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement (and any dispute or claim relating to it or its subject matter (including non-contractual
                                            claims)) is governed by English law and on acceptance the parties submit to the non-exclusive
                                            jurisdiction of the courts of England.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signatures
Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT IS EXECUTED by the authorized representatives of the Parties as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
    by Dr. David Tapolczay for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    David Tapolczay</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ST
    GEORGE STREET CAPITAL LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
    by Dr. Andrew Regan for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Andrew Regan</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT
    PHARMACEUTICALS LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
Development Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Funding
Budget</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>6
<FILENAME>ex10-22.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.22</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SPECIFIC
TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE
OR CONFIDENTIAL. THESE REDACTED TERMS HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS [***].</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD1656
PROJECT FUNDING AGREEMENT for use in</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRETERM
LABOUR</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;) is dated 02 November 2022 (the &ldquo;<B>Effective Date</B>&rdquo;) and is between:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>St
                                            George Street Capital Limited</B> (&ldquo;<B>Capital</B>&rdquo;), a private company limited
                                            by guarantee without share capital incorporated in England and Wales, company number 10537833
                                            and also a registered charity in England and Wales (registered charity number 1171470) whose
                                            registered office is at Bates Wells Braithwaite, 10 Queen Street Place, London, United Kingdom,
                                            EC4R 1BE; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conduit
                                            Pharmaceuticals Limited</B> (&ldquo;<B>Conduit</B>&rdquo;), formerly known as SGS Global
                                            Limited, a company incorporated in the Cayman Islands, company number OC-346289, whose registered
                                            office is at c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009,
                                            Cayman Islands,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
a &ldquo;<B>Party</B>&rdquo; and together the &ldquo;<B>Parties</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            is a UK registered charity whose objects include the advancement of medical research and
                                            development for public benefit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Parties entered into an Exclusive Funding Agreement dated 26 March 2021 pursuant to which
                                            Capital gave Conduit an exclusive first right to provide or procure the provision of funding
                                            to support Capital&rsquo;s drug development projects (the &ldquo;<B>Exclusive Funding Agreement</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            accordance with clause 3.4 of the Exclusive Funding Agreement, Conduit wishes to provide
                                            funding to Capital for the development of the Candidate (as defined in this Agreement) AZD1656
                                            for the treatment of Preterm Labour (the &ldquo;<B>Field</B>&rdquo;) on the terms set out
                                            in this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Candidate</B>&rdquo;
                                            means AZD1656 and any co-crystals, salts, prodrugs, esters, amides, active metabolites, solvates,
                                            intermediates, fragments, derivatives (including pegylated versions and any linkers thereof),
                                            analogs and polymorphs of such compound.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercialisation</B>&rdquo;
                                            means any and all activities directed to the preparation for sale of, offering for sale of,
                                            or sale of a product, including activities related to marketing, promoting, distributing,
                                            importing and exporting such product. When used as a verb, &ldquo;<B>to Commercialise</B>&rdquo;
                                            and &ldquo;<B>Commercialising</B>&rdquo; means to engage in Commercialization, and &ldquo;<B>Commercialised</B>&rdquo;
                                            has a corresponding meaning.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercially
                                            Reasonable Efforts</B>&rdquo; means, with respect to the Development or Commercialization
                                            of Product by Capital, that level of efforts and resources that Capital would normally devote
                                            to the Development or Commercialization, as the case may be, of a product owned by it, or
                                            to which it has exclusive rights in relation to, which is of a similar commercial potential
                                            at a similar stage in its lifecycle, in each case taking into account issues of safety and
                                            efficacy, product profile, the proprietary position, the then current competitive environment
                                            for such product and the likely timing of such product&rsquo;s entry into the market, the
                                            pricing and launching strategy for the respective product, the regulatory environment and
                                            status of such product, and other relevant scientific, technical and commercial factors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Competing
                                            Product</B>&rdquo; means any pharmaceutical or biologic product or a program directed at
                                            a pharmaceutical or biologic product that targets the same indication as the Product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential
                                            Information</B>&rdquo; means information in whatever form (including in written, oral, visual
                                            or electronic form or on any magnetic or optical disk or memory and wherever located) relating
                                            to the research, development, data and/or results and product information, inventions, works
                                            of authorship, processes, methodologies, the business, sales targets, sales statistics, market
                                            share statistics, prices, market research reports and surveys, advertising and other promotional
                                            materials, future projects, business development or planning, commercial relationships and
                                            negotiations, customers, products, affairs and finances, and employees of a Party or its
                                            affiliates, and trade secrets including, technology, technical data and know-how relating
                                            to the business of such Party or its affiliates or any of their suppliers, customers, agents,
                                            distributors, shareholders, management or business contacts, whether or not such information
                                            is marked or identified as confidential, including information relating to the existence
                                            and terms of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Develop</B>&rdquo;
                                            means, in relation to a Product, the performance of all preclinical and clinical development
                                            (including, without limitation, toxicology, pharmacology, test method development and stability
                                            testing, process development, formulation development, quality control development, statistical
                                            analysis), clinical trials, and manufacturing and regulatory activities that are required
                                            to obtain regulatory approval of such Product. When used as a verb, &ldquo;<B>to Develop</B>&rdquo;
                                            and &ldquo;<B>Developing</B>&rdquo; means to engage in Development, and &ldquo;<B>Developed</B>&rdquo;
                                            has a corresponding meaning.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Development
                                            Plan</B>&rdquo; means a written plan for the Development of a Product, substantially in the
                                            form attached hereto as Schedule 1 (or subsequently agreed by the parties), and which will
                                            be subject to amendment from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disclosing
                                            Party</B>&rdquo; means a Party to this Agreement which discloses or makes available, directly
                                            or indirectly (for the avoidance of doubt including via a third party or its affiliates on
                                            the Disclosing Party&rsquo;s behalf), any Confidential Information to the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding</B>&rdquo;
                                            has the meaning set out in Section 3.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Budget</B>&rdquo; means the reasonably detailed budget for the Development of the Product
                                            setting out the anticipated costs for the Development of the Product and the expected timing,
                                            as set out in the initial budget in Schedule 2 and as amended from time to time by approval
                                            of the JSC in accordance with Section 8.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Percentage</B>&rdquo; means 100% of the total Funding Requirement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Requirement</B>&rdquo; means the funding required by Capital to obtain, by itself or through
                                            a Third Party, the first regulatory approval and/or first commercial sale for the Product,
                                            or as otherwise agreed by the Parties, as set out in the Budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
                                            Property</B>&rdquo; means ideas, concepts, discoveries, inventions, developments, know-how,
                                            trade secrets, techniques, methodologies, modifications, innovations, improvements, writings,
                                            documentation, electronic code, data, and rights (whether or not protectable under state,
                                            federal or foreign patent, trademark, copyright, or similar laws) or the like, whether or
                                            not written or otherwise fixed in any form or medium, regardless of the media on which contained
                                            and whether or not patentable or copyrightable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>JSC</B>&rdquo;
                                            means the joint steering committee established by the Parties in accordance with Section
                                            8.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
                                            Receipts</B>&rdquo; means the Net Sales and the Sublicensing Revenue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
                                            Sales</B>&rdquo; means any amounts received by Capital or its affiliates related to sales
                                            of a Product other than Sublicensing Revenue and less the following permitted deductions:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            portion of such amounts that is payable to a third party pursuant to a legal or contractual
                                            commitment; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            tax payable by Capital on such amounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Product</B>&rdquo;
                                            means any product containing the Candidate (alone or with other active ingredients) in all
                                            forms, presentations, formulations, and dosage forms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Progress
                                            Report</B>&rdquo; means a written report prepared by Capital setting out in reasonably detail
                                            a summary of the progress made by Capital regarding the Development of the Product as described
                                            in Section 8.3.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project</B>&rdquo;
                                            has the meaning set out in Section 3.2.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Receiving
                                            Party</B>&rdquo; shall mean a Party to this Agreement which receives or obtains, directly
                                            or indirectly (for the avoidance of doubt including via a third party or its affiliates on
                                            behalf of the Disclosing Party), any Confidential Information of the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sublicensing
                                            Revenue</B>&rdquo; shall mean all cash payments, the fair market cash value of any equity
                                            consideration (less any amounts paid for such equity consideration), and forgivable loans
                                            (to the extent actually forgiven) received by Capital or its affiliates in consideration
                                            for and directly attributable to the grant of a sublicense under any of its rights in a Product,
                                            including any royalties, upfront payments, license maintenance fees, milestone payments or
                                            the like less the following permitted deductions:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            portion of such amounts that is payable to a third party pursuant to a legal or contractual
                                            commitment; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            tax payable by Capital on such amounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Term</B>&rdquo;
                                            has the meaning set out in Section 12.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Territory</B>&rdquo;
                                            shall mean worldwide.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
                                            Party</B>&rdquo; means any person other than the Parties and their respective affiliates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            this Agreement:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            references to a particular clause or schedule shall be a reference to that clause or schedule
                                            in or to this Agreement as it may be amended from time to time pursuant to this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            headings are inserted for convenience only and shall be ignored in construing this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            importing the masculine gender shall include the feminine and vice versa and words in the
                                            singular include the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            denoting persons shall include any individual, partnership, company, corporation, joint venture,
                                            trust association, organisation or other entity, in each case whether or not having separate
                                            legal personality;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            words &ldquo;include&rdquo;, &ldquo;included&rdquo; and &ldquo;including&rdquo; are to be
                                            construed without conveying any limitation to the generality of the preceding words;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reference
                                            to any statute or regulation includes any modification or re-enactment of that statute or
                                            regulation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            references to USD, dollars or $ are to United States Dollars</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            reference to notices or consent being sought or given in writing shall require the consent
                                            or notice to be signed by an appropriately authorised person and shall not include consents
                                            or notices conveyed by email; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the event of any inconsistency or conflict between this Agreement and any of the Schedules,
                                            this Agreement shall prevail.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FUNDING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            shall provide to Capital the sums set out in the Funding Budget (the &ldquo;<B>Funding</B>&rdquo;)
                                            in accordance with the budget payment schedule set out in the Funding Budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Funding will be used by Capital solely to support its Development and Commercialisation of
                                            a Product in the Field (the &ldquo;<B>Project</B>&rdquo;). The Funding provided by Conduit
                                            shall be the Funding Percentage of the Funding Requirement unless otherwise agreed between
                                            the Parties pursuant to Section 3.6. For clarity:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Funding is indirect investment in the Product for use in the Field and not a loan, equity
                                            investment, gift or donation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Funding must only be used for the Project; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Parties do not consider the subject matter of this Agreement to constitute a supply of services
                                            in respect of which VAT would be payable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise agreed in writing, Capital shall be responsible for any costs required to achieve
                                            the Purpose which exceed the amount of the Funding and Conduit shall have no obligation to
                                            provide any further amount to Capital in addition to the Funding.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall submit invoices to Conduit in respect of payments to be made in accordance with Schedule
                                            2. Conduit shall endeavour to pay all undisputed invoices within ten (10) days of receipt
                                            of such invoice by Conduit. If Conduit disputes any invoice, the provisions of Section 6
                                            shall apply. Notwithstanding Conduit&rsquo;s right to dispute any invoice in accordance with
                                            Section 6, Conduit reserves the right to refuse to pay any invoice for any amount which was
                                            not incurred in respect of the Purpose and/or which was not included in the Funding Budget.
                                            Conduit shall not be in breach of this Agreement unless undisputed invoices remain outstanding
                                            for a period of more than [***].</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            acknowledges that to ensure that Conduit has the funds required to advance the Funding to
                                            Capital as required pursuant to this Agreement, Conduit may obtain funding from Third Parties
                                            and that accordingly payment of the Funding by Conduit may be dependent on Conduit obtaining
                                            the necessary funding from such Third Parties. Conduit shall not be in breach of this Agreement
                                            if the reason for its failure to advance any of the Funding to Capital is its inability to
                                            obtain funding from Third Parties or the failure of a Third Party to advance amounts that
                                            the Third Party had committed to advance to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            at any time Capital anticipates that the agreed Funding Budget is insufficient to complete
                                            the activities set out in the Funding Budget, Capital shall promptly inform Conduit in writing
                                            and the Parties will discuss in good faith the action to be taken. Conduit shall have the
                                            first right to provide any additional funding required to complete the Development of the
                                            Product as described in the Funding Budget and the first right to provide any further funding
                                            which may be required for Capital to complete any further Development of or the Commercialisation
                                            of the Product provided that such funding may include Conduit obtaining additional funding
                                            from a Third Party to meet such requirements. If Conduit is unable to provide any additional
                                            funding required by Capital, Capital may obtain additional funding from a Third Party and,
                                            as appropriate, the Parties shall agree in good faith any adjustment that should be made
                                            to the Funding Percentage.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
                                            OF FUNDING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Capital (i) ceases to undertake the Project for any reason, or (ii) if this Agreement is
                                            terminated, and at the relevant time Capital has not spent all of the Funding, Capital shall
                                            promptly repay such unspent portion of the Funding to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall only use any equipment purchased using the Funding for the Project in accordance with
                                            this Agreement, or as otherwise permitted in writing by Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall comply with all applicable law, regulatory requirements and ethical guidelines and
                                            principles in conducting the Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            to enable Capital to undertake the Project, Capital needs to enter into any agreements with
                                            any Third Party where the Funding will be used to pay any amounts due to such Third Parties
                                            or where any Intellectual Property generated using the Funding will be provided to such Third
                                            Parties (including license agreements in respect of any Intellectual Property), Conduit shall
                                            have the right to approve any such proposed Third Party agreements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT
                                            OF REVENUE SHARE TO CONDUIT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            consideration for the advance of the Funding by Conduit to Capital, Capital shall pay to
                                            Conduit an amount equal to the Funding Percentage of the Net Receipts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall calculate the Net Receipts at the end of each Calendar Quarter, in the currency that
                                            they are received by. Capital. Capital shall pay to Conduit the Net Receipts with respect
                                            to a given Calendar Quarter within thirty (30) days after the end of such Calendar Quarter
                                            and each such payment once made shall be non-refundable. Each payment shall be accompanied
                                            by a statement setting out the amount of Net Receipts (including such amounts expressed in
                                            local currency) and the calculation of the amount of Net Receipts for such Calendar Quarter,
                                            including details of any deductions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            payments shall be made by Capital to Conduit without setoff, by deposit in the requisite
                                            amount to such bank account as Conduit may from time to time designate by notice to Capital.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT
                                            DISPUTES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            sixty (60) working days of receipt of each invoice received by Conduit in accordance with
                                            Section 3.4, or statement of Net Receipts received by Conduit in accordance with 5.2, Conduit
                                            may serve a written notice on Capital disputing such invoice, whether the activities covered
                                            by the invoice are included in the Funding Budget and/or the calculation of Net Receipts
                                            (a &ldquo;<B>Dispute Notice</B>&rdquo;) and the provisions of Section 6.2 shall apply.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Conduit serves a Dispute Notice in accordance with Section 6.1, the Parties shall, during
                                            the period of thirty (30) days commencing on the date of service of the Dispute Notice, seek
                                            in good faith to reach agreement on the disputed matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall maintain complete and accurate records of, and supporting documentation for, invoices
                                            submitted to Conduit and Capital&rsquo;s calculation of Net Receipts pursuant to this Agreement
                                            and demonstrating that the Development and Commercialisation activities undertaken by Capital
                                            pursuant to the Project are consistent with the Funding Budget. Such records shall be retained
                                            for inspection by Conduit for at least five (5) years following the calendar year to which
                                            such records pertain.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            (or its professional advisers) may during normal business hours and upon fourteen (14) days&rsquo;
                                            written notice to Capital, enter the premises of Capital and have access to the personnel,
                                            books, records and reports of Capital; and inspect, audit and take copies of relevant records,
                                            and other documents as necessary to verify Capitals compliance with the terms and conditions
                                            of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DILIGENCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            thirty (60) days of the Effective Date, Capital shall prepare a Development Plan for the
                                            project and shall submit such Development Plan to the JSC for review in accordance with Section
                                            8.2.1, and to Conduit for approval in accordance with Section 8.2.4. Capital may propose
                                            amendments to the Development Plan from time to time by submitting any amendments to the
                                            JSC for review and to Conduit for approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall use its Commercially Reasonable Efforts to Develop and Commercialise at least one Product
                                            in the Field in each of (i) the United States of America; (ii) each of the major European
                                            countries (being Italy, France, Germany, Spain and the United Kingdom); and (iii) Japan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            fourteen (14) days of the end of each month, Capital shall submit Progress Reports to Conduit
                                            in a form to be agreed between the Parties. Such Progress Reports shall set out, among other
                                            things, the Development activities undertaken by Capital in the preceding month in respect
                                            of all Products, and the Development activities which will be undertaken by Capital in the
                                            succeeding month. Capital shall prepare a Progress Report, in respect of each Product, each
                                            calendar month commencing the first calendar month following the Effective Date until expiry
                                            of the Term, unless otherwise agreed between the Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOVERNANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
                                            Steering Committee</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            thirty (30) days after the Effective Date, the Parties will establish the JSC which will
                                            oversee and manage the Project. Each Party initially will appoint two (2) representatives
                                            to serve as representatives to the JSC (the &ldquo;<B>JSC Representatives</B>&rdquo;). The
                                            initial representatives of Capital will be the CEO of Capital and Capital&rsquo;s senior
                                            clinician working on the Project. Each JSC Representative shall have knowledge and expertise
                                            regarding developing products similar to the Product and sufficient decision-making authority
                                            within the applicable Party to make decisions on behalf of such Party within the scope of
                                            the JSC&rsquo;s decision-making authority. If any such representative is not an employee
                                            of the appointing Party, such representative shall execute a confidentiality agreement in
                                            form and substance acceptable to the other Party (and, for the avoidance of doubt, the appointing
                                            Party shall remain responsible to the other Party for any noncompliance by such representative
                                            with such confidentiality obligations). Each Party may replace its JSC Representatives at
                                            any time upon written notice to the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC chairperson (&ldquo;<B>JSC Chairperson</B>&rdquo;) shall be designated from the Parties&rsquo;
                                            JSC Representatives and shall serve for a term of one (1) year. Capital shall appoint the
                                            first JSC Chairperson and subsequent appointments will rotate on an annual basis between
                                            Capital and Conduit. The JSC Chairperson will be responsible for drafting and circulating
                                            the draft agenda and ensuring minutes are prepared.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
                                            the Effective Date, through the date of completion of successful license deal and/or first
                                            regulatory approval and/or first commercial sale of the Product, the JSC will meet at least
                                            once per calendar quarter (and for clarity, such meetings are intended to be conducted via
                                            teleconference) unless the Parties mutually agree otherwise. Either Party may call a special
                                            meeting of the JSC (by videoconference or teleconference) by providing at least ten (10)
                                            days&rsquo; prior written notice to the other Party, which notice shall include a reasonably
                                            detailed description of the matter, in the event such Party reasonably believes that a significant
                                            matter must be addressed prior to the next scheduled meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC may invite individuals who are not JSC Representatives to participate in JSC meetings;
                                            provided that (a) all JSC Representatives of both Parties consent to such non-member&rsquo;s
                                            participation; and (b) such non-member has executed a confidentiality agreement in form and
                                            substance acceptable to the non-inviting Party (and, for the avoidance of doubt, the inviting
                                            Party shall remain responsible to the non-inviting Party for any noncompliance by such individual
                                            with such confidentiality obligations). For clarity, such non-members will have no voting
                                            rights at the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party will bear its own expenses relating to the meetings and activities of the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JSC
                                            Responsibilities and Decision-Making</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall discuss and review (i) overall strategic direction of the Project; (ii) the Funding
                                            Budget and Development Plan; (iii) material changes in or amendments to the Funding Budget
                                            and Development Plan submitted by Capital or proposed by the JSC; (iv) forecasts of the estimated
                                            timeline for Development activities of the Products; and (v) any other matters the Parties
                                            mutually agree in writing shall be subject to discussion and review by the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall discuss, review and approve (i) any increases or decreases in the Funding Budget,
                                            and (ii) any other matters the Parties mutually agree in writing shall be subject to approval
                                            by the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall have no authority to (i) amend, modify or waive compliance with this Agreement,
                                            or (ii) resolve any dispute concerning the validity, interpretation, construction of, or
                                            breach of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            shall have the sole right to approve any amendments to Funding Budget and the Development
                                            Plan, taking into account any reasonable comments of the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCLUSIVITY
                                            COMMITMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the Term, Capital shall not, either by itself or through a Third Party, conduct human clinical trials of, or sell, offer for sale or
have sold any Competing Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLECTUAL
                                            PROPERTY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party will retain all right, title and interest in and to all Intellectual Property owned
                                            or controlled by such Party as of the Effective Date (&ldquo;<B>Existing Intellectual Property</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            Intellectual Property developed by or on behalf of Capital as a result of Capital undertaking
                                            the Project (&ldquo;<B>Arising Intellectual Property</B>&rdquo;) shall be assigned or sub-licensed
                                            to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall use Commercially Reasonable Efforts to prosecute, protect, defend and maintain the
                                            validity and enforceability of its Existing Intellectual Property and Conduit shall use Commercially
                                            Reasonable Efforts to prosecute, protect, defend and maintain the validity and enforceability
                                            of the Arising Intellectual Property.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIALITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential
                                            Information</B>. Except to the extent expressly authorized by this Agreement or by the Disclosing
                                            Party in writing, during the Term and for years thereafter, the Receiving Party shall maintain
                                            in confidence and shall not disclose to any third party or use for any purpose other than
                                            to exercise its rights or fulfil its obligations pursuant to this Agreement any Confidential
                                            Information of the Disclosing Party. Receiving Party may use the Confidential Information
                                            only to the extent required to perform its activities under this Agreement and for no other
                                            purpose. Receiving Party shall not use the Confidential Information for any purpose or in
                                            any manner that would constitute a violation of applicable laws. Both Parties shall ensure
                                            that all of its officers, employees, consultants, agents, subcontractors, third party vendors,
                                            investigators or contractors who receive or are in possession of any Confidential Information
                                            of the other Party understand and shall be bound by confidentiality provisions at least as
                                            stringent as the confidentiality obligations in this Agreement. Except as expressly set out
                                            in this Agreement the Parties agree that each Party is and shall remain the exclusive owner
                                            of its respective Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exceptions</B>.
                                            The obligations of confidentiality and nonuse set forth in Section 11.1 shall not apply to
                                            any specific portion of information that Receiving Party can demonstrate by competent written
                                            evidence: (a) is in the public domain or comes into the public domain through no fault of
                                            Receiving Party; (b) is furnished to Receiving Party by a third party rightfully in possession
                                            of such information not subject to a duty of confidentiality with respect thereto; (c) is
                                            already known by Receiving Party without restriction at the time of receiving such Confidential
                                            Information as demonstrated by files in existence at such time; or (d) is independently developed
                                            by Receiving Party without access to the Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
                                            Disclosure</B>. Notwithstanding the foregoing in this Section 9, the Receiving Party may
                                            disclose certain Confidential Information to the extent such disclosure is required by applicable
                                            laws or regulation (including the regulatory requirements of a stock exchange), or pursuant
                                            to a valid order of a court or other governmental body having jurisdiction, provided that
                                            the Receiving Party to the extent permitted by applicable laws, provides the Disclosing Party
                                            with reasonable prior written notice of such disclosure and reasonable assistance to the
                                            Disclosing Party&rsquo;s reasonable and lawful actions to avoid and/or minimize the extent
                                            of such disclosure, all at the Disclosing Party&rsquo;s expense. In the event of a limited
                                            disclosure of the Confidential Information as set forth in this Section 11.3, Receiving Party
                                            shall continue to treat such information as Confidential Information for all other purposes
                                            and subject to the other terms and conditions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Publication;
                                            Use of Names</B>. Under no circumstances may either Party use the name of the other Party
                                            or any of its personnel in any publication or any form of advertising without such other
                                            Party&rsquo;s prior written consent such consent not to be unreasonably withheld.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
                                            Party Confidential Information</B>. Neither Party shall disclose to the other Party any confidential
                                            or proprietary information that belongs to any third party unless Disclosing Party first
                                            obtains the consent of such third party and enters into a separate confidentiality agreement
                                            with Receiving Party covering that disclosure. Receiving Party shall not represent to Disclosing
                                            Party as being unrestricted any designs, plans, models, samples, or other writings or products
                                            that Receiving Party knows are covered by valid Intellectual Property protection belonging
                                            to a third party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Return
                                            of Confidential Information</B>. Upon written request and at the expense of the Disclosing
                                            Party, Receiving Party shall promptly return or destroy all documents, notes, and other tangible
                                            materials representing Disclosing Party&rsquo;s Confidential Information and all copies thereof;
                                            provided, however, that Receiving Party may retain a single archival copy of the Confidential
                                            Information for the sole purpose of facilitating compliance with the surviving provisions
                                            of this Agreement. Notwithstanding anything to the contrary in this Agreement, the Receiving
                                            Party shall not be required to destroy any computer files stored securely by the Receiving
                                            Party that are created during automatic system back-up. The Receiving Party shall continue
                                            to be bound by its obligations of confidentiality and non-use under this Agreement as set
                                            forth herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Injunctive
                                            Relief</B>. The Parties expressly acknowledge and agree that any breach or threatened breach
                                            of this Section 9 by Receiving Party may cause immediate and irreparable harm to Disclosing
                                            Party that may not be adequately compensated by damages. Each Party therefore agrees that
                                            in the event of such breach or threatened breach by Receiving Party, and in addition to any
                                            remedies available at law, Disclosing Party shall have the right to secure equitable and
                                            injunctive relief, without bond, in connection with such a breach or threatened breach.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
                                            AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B>.
                                            This Agreement shall commence upon the Effective Date and continue until terminated (the
                                            &ldquo;<B>Term</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                            by Conduit</B>. If at any time Capital ceases the conduct of the Development or Commercialisation
                                            of the Products in accordance with the Development Plan, Conduit shall not be obliged to
                                            make any further advances of the Funding to Capital. Capital shall provide Conduit with a
                                            reasonable explanation of the reason why it has ceased such activities. If Capital does not
                                            resume the Development or Commercialisation activities in accordance with the Development
                                            Plan within [***] of the date of cessation of such activities, Conduit shall have the right
                                            to terminate this Agreement in its entirety or in respect of the relevant Product only with
                                            immediate effect by giving notice in writing to Capital.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                            for Material Breach</B>. Either Party may terminate this Agreement immediately upon written
                                            notice to the other Party if the other Party materially breaches this Agreement, and does
                                            not fully cure the breach to the non-breaching Party&rsquo;s satisfaction within ninety (90)
                                            days after the non-breaching Party gives notice of the breach to the breaching Party.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">12.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                            for Insolvency</B>. Either Party may terminate this Agreement upon written notice to the
                                            other Party if the other Party makes an assignment for the benefit of creditors, or commences
                                            a case or proceeding under any bankruptcy, reorganization, insolvency, or similar laws, has
                                            a trustee or receiver or similar officer of any court appointed for such Party, or for substantial
                                            part of the property of such Party, or bankruptcy, reorganization, insolvency, or liquidation
                                            proceedings are instituted by or against such Party without such proceedings being dismissed,
                                            in each of the foregoing cases for a period of at least sixty (60) days.</FONT></TD></TR>
                                                                                                                                                  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect
                                            of Termination</B>. If Conduit terminates this Agreement pursuant to Section 12.2, pursuant
                                            to Section 12.3 in the case of Capital&rsquo;s material breach or pursuant to Section 12.4
                                            in the case of Capital&rsquo;s insolvency Capital shall grant and hereby grants to Conduit
                                            a nonexclusive, perpetual, irrevocable, worldwide, royalty-free, fully paid-up, sublicensable
                                            (through multiple tiers) licence under any and all of Capital&rsquo;s Existing Intellectual
                                            Property embodied within, necessary or reasonably useful for the exploitation of the Arising
                                            Intellectual Property and the Product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Provisions
                                            to continue on termination</B>. The termination of this Agreement howsoever arising will
                                            be without prejudice to the rights and duties of any Party accrued prior to termination.
                                            The following Clauses will continue to be enforceable notwithstanding termination: Clauses
                                            4.2, 4.4, 5, 6, 7.3, 9, 10, 11, 13.4, 14, 15, 16, 17, 19, 20, 21, 22, 23, 24 and 25.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANTIES
                                            AND INSURANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party warrants as of the Effective Date that (a) it has the full power and authority to enter
                                            into this Agreement, (b) this Agreement has been duly authorized, (c) this Agreement is binding
                                            upon it; and (d) that the terms of this Agreement are not inconsistent with its other contractual
                                            arrangements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            warrants that, as of the Effective Date:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
                                            publicly filed accounts give a true and fair view of its financial position;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            is solvent and has disclosed to Conduit all material information regarding its financial
                                            position;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            has no indebtedness and it covenants that it shall not incur, create, assume, or permit to
                                            exist any indebtedness during the Term without the prior written permission of Conduit; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the best of its knowledge its Development and Commercialisation of a Product in accordance
                                            with the Development Plan will not infringe the intellectual property rights of any Third
                                            Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            to the extent expressly set out in Section 9.1 and 13.2, all warranties, express, statutory
                                            or implied and whether written or oral related to the subject matter of this Agreement are,
                                            to the fullest extent permissible by law, excluded. Without limiting the generality of the
                                            foregoing, the Parties acknowledge that the Candidate is experimental and at a very early
                                            stage of development and as such there is no guarantee the Development of the Candidate will
                                            result in asset that can be Commercialised. Capital shall have no liability to Conduit, in
                                            contract, tort or otherwise, in the event the Development of the Candidate does not result
                                            in asset that can be Commercialised.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall have and maintain, at its sole cost and expense, an adequate liability insurance (including
                                            product liability insurance) to protect against potential liabilities and risk arising out
                                            of activities to be performed under this Agreement, the Products and any agreement related
                                            hereto and upon such terms (including coverages, deductible limits and self-insured retentions)
                                            as are customary in the relevant industry generally. Such liability insurance shall insure
                                            against all types of liability, including personal injury, physical injury or property damage
                                            arising out of Capital&rsquo;s activities. This Section 13.4 shall not create any limitation
                                            on the Parties&rsquo; liability under this Agreement. Capital shall provide a copy of such
                                            insurance policy to Conduit promptly on request from Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORCE
                                            MAJEURE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure of either of the Parties to perform any obligation under this Agreement solely by
                                            reason of force majeure shall not be deemed to be a breach of this Agreement; provided, however,
                                            that the Party so prevented from complying herewith shall continue to take all reasonable
                                            actions within its power to comply as fully as possible herewith.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party shall deliver all notices, consents, and approvals required or permitted under this Agreement in writing in English to the other
Party to the addresses specified below. Each Party may change its address for receipt of notice by giving notice of such change to the
other Party. Notices shall be sent by electronic mail, overnight courier, certified mail, return receipt requested, or by other means
of delivery requiring a written acknowledged receipt. All notices shall be effective upon receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Conduit: Conduit Pharmaceuticals Limited, c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands
If to Capital: Bates Wells Braithwaite, FAO St. George Street Capital, 10 Queen Street Place, London, England, EC4R 1BE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>16.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NO
                                            PARTNERSHIP</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in this Agreement shall create a partnership. Neither Party is an agent or employee of the
                                            other Party and neither Party shall have the authority or power to make any statements, representations
                                            or commitments of any kind, nor to take any action which is binding on the other Party, except
                                            as may be explicitly provided for herein or authorised by the other Party in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>17.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
                                            Party shall sell, transfer, assign, delegate, pledge, or otherwise dispose of, whether voluntarily,
                                            involuntarily, by operation of law or otherwise, this Agreement or any of its rights or duties
                                            hereunder without the written consent of the other Party (such consent not to be unreasonably
                                            withheld, conditioned, or delayed); provided, that (a) a Party may make such an assignment
                                            without the other Party&rsquo;s consent to (i) its affiliate, or (ii) to a successor, whether
                                            in a merger, sale of stock, sale of assets or any other transaction, of the business to which
                                            this Agreement relates, and (b) Conduit may make an assignment of its right to receive Net
                                            Receipts (and related reports) pursuant to Section 3 to an affiliate or a third party without
                                            Capital&rsquo;s consent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>18.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COUNTERPARTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement may be executed in any number of counterparts, each of which when executed and
                                            delivered shall constitute an original of this Agreement, but all the counterparts shall
                                            together constitute the same agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>19.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
                                            ASSURANCES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            of the Parties shall take, or cause to be taken, all actions necessary, proper, or advisable
                                            under applicable laws to give effect to the provisions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>20.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD
                                            PARTY RIGHTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement and no person
                                            other than the Parties shall have any rights under it.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>21.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEVERABILITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any provision of this Agreement (or part of a provision) is found by any court or administrative
                                            body of competent jurisdiction to be invalid, unenforceable or illegal, the other provisions
                                            shall remain in force.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any provision of this Agreement (or part of any provision) is or becomes illegal, invalid
                                            or unenforceable but would be legal, valid and enforceable if some part of it was deleted
                                            or modified, the provision or part-provision in question shall apply with such deletions
                                            or modifications as may be necessary to make the provision legal, valid and enforceable.
                                            In the event of such deletion or modification, the Parties shall negotiate in good faith
                                            and acting reasonably in order to agree the terms of a mutually acceptable alternative provision.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>22.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            as expressly provided for in this Agreement, each of the Parties shall bear their own costs
                                            in relation to the investments and the contributions to be made pursuant to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>23.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VARIATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            variation of or amendment to this Agreement shall be effective unless made in writing and
                                            signed by authorised representatives of both Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>24.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WAIVERS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure or delay of either Party to enforce or to exercise, at any time or for any period
                                            of time, any term of or any right, power or privilege arising pursuant to this Agreement
                                            does not constitute and shall not be construed as a waiver of such term, right, power or
                                            privilege and shall in no way affect either Party&rsquo;s right later to enforce or exercise
                                            it, nor shall any single or partial exercise of any remedy, right, power or privilege preclude
                                            any further exercise of the same or the exercise of any other remedy, right, power or privilege.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>25.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICABLE
                                            LAW</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement (and any dispute or claim relating to it or its subject matter (including non-contractual
                                            claims)) is governed by English law and on acceptance the parties submit to the non-exclusive
                                            jurisdiction of the courts of England.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signatures
Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT IS EXECUTED by the authorized representatives of the Parties as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
    by Dr. David Tapolczay for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    David Tapolczay</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ST
    GEORGE STREET CAPITAL LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
    by Dr. Andrew Regan for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Andrew Regan</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT
    PHARMACEUTICALS LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
Development Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Funding
Budget</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.23
<SEQUENCE>7
<FILENAME>ex10-23.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.23</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED
BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THESE REDACTED TERMS
HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS [***].</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">AZD1656 PROJECT FUNDING
AGREEMENT for use in</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">HASHIMOTO&rsquo;S THYROIDITIS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>THIS AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;)
is dated 02 November 2022 (the &ldquo;<B>Effective Date</B>&rdquo;) and is between:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>St George Street Capital Limited</B> (&ldquo;<B>Capital</B>&rdquo;), a private company limited by guarantee without share capital incorporated in England and Wales, company number 10537833 and also a registered charity in England and Wales (registered charity number 1171470) whose registered office is at Bates Wells Braithwaite, 10 Queen Street Place, London, United Kingdom, EC4R 1BE; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conduit Pharmaceuticals Limited</B> (&ldquo;<B>Conduit</B>&rdquo;), formerly known as SGS Global Limited, a company incorporated in the Cayman Islands, company number OC-346289, whose registered office is at c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">each a &ldquo;<B>Party</B>&rdquo; and together the
&ldquo;<B>Parties</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital is a UK registered charity whose objects include the advancement of medical research and development for public benefit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Parties entered into an Exclusive Funding Agreement dated 26 March 2021 pursuant to which Capital gave Conduit an exclusive first right to provide or procure the provision of funding to support Capital&rsquo;s drug development projects (the &ldquo;<B>Exclusive Funding Agreement</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with clause 3.4 of the Exclusive Funding Agreement, Conduit wishes to provide funding to Capital for the development of the Candidate (as defined in this Agreement) AZD1656 for the treatment of Hashimoto&rsquo;s Thyroiditis (the &ldquo;<B>Field</B>&rdquo;) on the terms set out in this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Candidate</B>&rdquo; means AZD1656 and any co-crystals, salts, prodrugs, esters, amides, active metabolites, solvates, intermediates, fragments, derivatives (including pegylated versions and any linkers thereof), analogs and polymorphs of such compound.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercialisation</B>&rdquo; means any and all activities directed to the preparation for sale of, offering for sale of, or sale of a product, including activities related to marketing, promoting, distributing, importing and exporting such product. When used as a verb, &ldquo;<B>to Commercialise</B>&rdquo; and &ldquo;<B>Commercialising</B>&rdquo; means to engage in Commercialization, and &ldquo;<B>Commercialised</B>&rdquo; has a corresponding meaning.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercially Reasonable Efforts</B>&rdquo; means, with respect to the Development or Commercialization of Product by Capital, that level of efforts and resources that Capital would normally devote to the Development or Commercialization, as the case may be, of a product owned by it, or to which it has exclusive rights in relation to, which is of a similar commercial potential at a similar stage in its lifecycle, in each case taking into account issues of safety and efficacy, product profile, the proprietary position, the then current competitive environment for such product and the likely timing of such product&rsquo;s entry into the market, the pricing and launching strategy for the respective product, the regulatory environment and status of such product, and other relevant scientific, technical and commercial factors.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Competing Product</B>&rdquo; means any pharmaceutical or biologic product or a program directed at a pharmaceutical or biologic product that targets the same indication as the Product.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential Information</B>&rdquo; means information in whatever form (including in written, oral, visual or electronic form or on any magnetic or optical disk or memory and wherever located) relating to the research, development, data and/or results and product information, inventions, works of authorship, processes, methodologies, the business, sales targets, sales statistics, market share statistics, prices, market research reports and surveys, advertising and other promotional materials, future projects, business development or planning, commercial relationships and negotiations, customers, products, affairs and finances, and employees of a Party or its affiliates, and trade secrets including, technology, technical data and know-how relating to the business of such Party or its affiliates or any of their suppliers, customers, agents, distributors, shareholders, management or business contacts, whether or not such information is marked or identified as confidential, including information relating to the existence and terms of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Develop</B>&rdquo; means, in relation to a Product, the performance of all preclinical and clinical development (including, without limitation, toxicology, pharmacology, test method development and stability testing, process development, formulation development, quality control development, statistical analysis), clinical trials, and manufacturing and regulatory activities that are required to obtain regulatory approval of such Product. When used as a verb, &ldquo;<B>to Develop</B>&rdquo; and &ldquo;<B>Developing</B>&rdquo; means to engage in Development, and &ldquo;<B>Developed</B>&rdquo; has a corresponding meaning.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Development Plan</B>&rdquo; means a written plan for the Development of a Product, substantially in the form attached hereto as Schedule 1 (or subsequently agreed by the parties), and which will be subject to amendment from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disclosing Party</B>&rdquo; means a Party to this Agreement which discloses or makes available, directly or indirectly (for the avoidance of doubt including via a third party or its affiliates on the Disclosing Party&rsquo;s behalf), any Confidential Information to the other Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding</B>&rdquo; has the meaning set out in Section 3.1.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding Budget</B>&rdquo; means the reasonably detailed budget for the Development of the Product setting out the anticipated costs for the Development of the Product and the expected timing, as set out in the initial budget in Schedule 2 and as amended from time to time by approval of the JSC in accordance with Section 8.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding Percentage</B>&rdquo; means 100% of the total Funding Requirement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding Requirement</B>&rdquo; means the funding required by Capital to obtain, by itself or through a Third Party, the first regulatory approval and/or first commercial sale for the Product, or as otherwise agreed by the Parties, as set out in the Budget.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual Property</B>&rdquo; means ideas, concepts, discoveries, inventions, developments, know-how, trade secrets, techniques, methodologies, modifications, innovations, improvements, writings, documentation, electronic code, data, and rights (whether or not protectable under state, federal or foreign patent, trademark, copyright, or similar laws) or the like, whether or not written or otherwise fixed in any form or medium, regardless of the media on which contained and whether or not patentable or copyrightable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>JSC</B>&rdquo; means the joint steering committee established by the Parties in accordance with Section 8.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net Receipts</B>&rdquo; means the Net Sales and the Sublicensing Revenue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net Sales</B>&rdquo; means any amounts received by Capital or its affiliates related to sales of a Product other than Sublicensing Revenue and less the following permitted deductions:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any portion of such amounts that is payable to a third party pursuant to a legal or contractual commitment; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any tax payable by Capital on such amounts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Product</B>&rdquo; means any product containing the Candidate (alone or with other active ingredients) in all forms, presentations, formulations, and dosage forms.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Progress Report</B>&rdquo; means a written report prepared by Capital setting out in reasonably detail a summary of the progress made by Capital regarding the Development of the Product as described in Section 8.3.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project</B>&rdquo; has the meaning set out in Section 3.2.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Receiving Party</B>&rdquo; shall mean a Party to this Agreement which receives or obtains, directly or indirectly (for the avoidance of doubt including via a third party or its affiliates on behalf of the Disclosing Party), any Confidential Information of the other Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sublicensing Revenue</B>&rdquo; shall mean all cash payments, the fair market cash value of any equity consideration (less any amounts paid for such equity consideration), and forgivable loans (to the extent actually forgiven) received by Capital or its affiliates in consideration for and directly attributable to the grant of a sublicense under any of its rights in a Product, including any royalties, upfront payments, license maintenance fees, milestone payments or the like less the following permitted deductions:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any portion of such amounts that is payable to a third party pursuant to a legal or contractual commitment; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any tax payable by Capital on such amounts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Term</B>&rdquo; has the meaning set out in Section 12.1.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Territory</B>&rdquo; shall mean worldwide.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third Party</B>&rdquo; means any person other than the Parties and their respective affiliates.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In this Agreement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all references to a particular clause or schedule shall be a reference to that clause or schedule in or to this Agreement as it may be amended from time to time pursuant to this Agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the headings are inserted for convenience only and shall be ignored in construing this Agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words importing the masculine gender shall include the feminine and vice versa and words in the singular include the plural and vice versa;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words denoting persons shall include any individual, partnership, company, corporation, joint venture, trust association, organisation or other entity, in each case whether or not having separate legal personality;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the words &ldquo;include&rdquo;, &ldquo;included&rdquo; and &ldquo;including&rdquo; are to be construed without conveying any limitation to the generality of the preceding words;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reference to any statute or regulation includes any modification or re-enactment of that statute or regulation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all references to USD, dollars or $ are to United States Dollars</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any reference to notices or consent being sought or given in writing shall require the consent or notice to be signed by an appropriately authorised person and shall not include consents or notices conveyed by email; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the event of any inconsistency or conflict between this Agreement and any of the Schedules, this Agreement shall prevail.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FUNDING</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit shall provide to Capital the sums set out in the Funding Budget (the &ldquo;<B>Funding</B>&rdquo;) in accordance with the budget payment schedule set out in the Funding Budget.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Funding will be used by Capital solely to support its Development and Commercialisation of a Product in the Field (the &ldquo;<B>Project</B>&rdquo;). The Funding provided by Conduit shall be the Funding Percentage of the Funding Requirement unless otherwise agreed between the Parties pursuant to Section 3.6. For clarity:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Funding is indirect investment in the Product for use in the Field and not a loan, equity investment, gift or donation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Funding must only be used for the Project; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Parties do not consider the subject matter of this Agreement to constitute a supply of services in respect of which VAT would be payable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise agreed in writing, Capital shall be responsible for any costs required to achieve the Purpose which exceed the amount of the Funding and Conduit shall have no obligation to provide any further amount to Capital in addition to the Funding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall submit invoices to Conduit in respect of payments to be made in accordance with Schedule 2. Conduit shall endeavour to pay all undisputed invoices within ten (10) days of receipt of such invoice by Conduit. If Conduit disputes any invoice, the provisions of Section 6 shall apply. Notwithstanding Conduit&rsquo;s right to dispute any invoice in accordance with Section 6, Conduit reserves the right to refuse to pay any invoice for any amount which was not incurred in respect of the Purpose and/or which was not included in the Funding Budget. Conduit shall not be in breach of this Agreement unless undisputed invoices remain outstanding for a period of more than [***].</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital acknowledges that to ensure that Conduit has the funds required to advance the Funding to Capital as required pursuant to this Agreement, Conduit may obtain funding from Third Parties and that accordingly payment of the Funding by Conduit may be dependent on Conduit obtaining the necessary funding from such Third Parties. Conduit shall not be in breach of this Agreement if the reason for its failure to advance any of the Funding to Capital is its inability to obtain funding from Third Parties or the failure of a Third Party to advance amounts that the Third Party had committed to advance to Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If at any time Capital anticipates that the agreed Funding Budget is insufficient to complete the activities set out in the Funding Budget, Capital shall promptly inform Conduit in writing and the Parties will discuss in good faith the action to be taken. Conduit shall have the first right to provide any additional funding required to complete the Development of the Product as described in the Funding Budget and the first right to provide any further funding which may be required for Capital to complete any further Development of or the Commercialisation of the Product provided that such funding may include Conduit obtaining additional funding from a Third Party to meet such requirements. If Conduit is unable to provide any additional funding required by Capital, Capital may obtain additional funding from a Third Party and, as appropriate, the Parties shall agree in good faith any adjustment that should be made to the Funding Percentage.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS OF FUNDING</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If Capital (i) ceases to undertake the Project for any reason, or (ii) if this Agreement is terminated, and at the relevant time Capital has not spent all of the Funding, Capital shall promptly repay such unspent portion of the Funding to Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall only use any equipment purchased using the Funding for the Project in accordance with this Agreement, or as otherwise permitted in writing by Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall comply with all applicable law, regulatory requirements and ethical guidelines and principles in conducting the Project.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to enable Capital to undertake the Project, Capital needs to enter into any agreements with any Third Party where the Funding will be used to pay any amounts due to such Third Parties or where any Intellectual Property generated using the Funding will be provided to such Third Parties (including license agreements in respect of any Intellectual Property), Conduit shall have the right to approve any such proposed Third Party agreements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT OF REVENUE SHARE TO CONDUIT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In consideration for the advance of the Funding by Conduit to Capital, Capital shall pay to Conduit an amount equal to the Funding Percentage of the Net Receipts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall calculate the Net Receipts at the end of each Calendar Quarter, in the currency that they are received by. Capital. Capital shall pay to Conduit the Net Receipts with respect to a given Calendar Quarter within thirty (30) days after the end of such Calendar Quarter and each such payment once made shall be non-refundable. Each payment shall be accompanied by a statement setting out the amount of Net Receipts (including such amounts expressed in local currency) and the calculation of the amount of Net Receipts for such Calendar Quarter, including details of any deductions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All payments shall be made by Capital to Conduit without setoff, by deposit in the requisite amount to such bank account as Conduit may from time to time designate by notice to Capital.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>6.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT DISPUTES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within sixty (60) working days of receipt of each invoice received by Conduit in accordance with Section 3.4, or statement of Net Receipts received by Conduit in accordance with 5.2, Conduit may serve a written notice on Capital disputing such invoice, whether the activities covered by the invoice are included in the Funding Budget and/or the calculation of Net Receipts (a &ldquo;<B>Dispute Notice</B>&rdquo;) and the provisions of Section 6.2 shall apply.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If Conduit serves a Dispute Notice in accordance with Section 6.1, the Parties shall, during the period of thirty (30) days commencing on the date of service of the Dispute Notice, seek in good faith to reach agreement on the disputed matters.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall maintain complete and accurate records of, and supporting documentation for, invoices submitted to Conduit and Capital&rsquo;s calculation of Net Receipts pursuant to this Agreement and demonstrating that the Development and Commercialisation activities undertaken by Capital pursuant to the Project are consistent with the Funding Budget. Such records shall be retained for inspection by Conduit for at least five (5) years following the calendar year to which such records pertain.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit (or its professional advisers) may during normal business hours and upon fourteen (14) days&rsquo; written notice to Capital, enter the premises of Capital and have access to the personnel, books, records and reports of Capital; and inspect, audit and take copies of relevant records, and other documents as necessary to verify Capitals compliance with the terms and conditions of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DILIGENCE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within thirty (60) days of the Effective Date, Capital shall prepare a Development Plan for the project and shall submit such Development Plan to the JSC for review in accordance with Section 8.2.1, and to Conduit for approval in accordance with Section 8.2.4. Capital may propose amendments to the Development Plan from time to time by submitting any amendments to the JSC for review and to Conduit for approval.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall use its Commercially Reasonable Efforts to Develop and Commercialise at least one Product in the Field in each of (i) the United States of America; (ii) each of the major European countries (being Italy, France, Germany, Spain and the United Kingdom); and (iii) Japan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within fourteen (14) days of the end of each month, Capital shall submit Progress Reports to Conduit in a form to be agreed between the Parties. Such Progress Reports shall set out, among other things, the Development activities undertaken by Capital in the preceding month in respect of all Products, and the Development activities which will be undertaken by Capital in the succeeding month. Capital shall prepare a Progress Report, in respect of each Product, each calendar month commencing the first calendar month following the Effective Date until expiry of the Term, unless otherwise agreed between the Parties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>8.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOVERNANCE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Steering Committee</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within thirty (30) days after the Effective Date, the Parties will establish the JSC which will oversee and manage the Project. Each Party initially will appoint two (2) representatives to serve as representatives to the JSC (the &ldquo;<B>JSC Representatives</B>&rdquo;). The initial representatives of Capital will be the CEO of Capital and Capital&rsquo;s senior clinician working on the Project. Each JSC Representative shall have knowledge and expertise regarding developing products similar to the Product and sufficient decision-making authority within the applicable Party to make decisions on behalf of such Party within the scope of the JSC&rsquo;s decision-making authority. If any such representative is not an employee of the appointing Party, such representative shall execute a confidentiality agreement in form and substance acceptable to the other Party (and, for the avoidance of doubt, the appointing Party shall remain responsible to the other Party for any noncompliance by such representative with such confidentiality obligations). Each Party may replace its JSC Representatives at any time upon written notice to the other Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC chairperson (&ldquo;<B>JSC Chairperson</B>&rdquo;) shall be designated from the Parties&rsquo; JSC Representatives and shall serve for a term of one (1) year. Capital shall appoint the first JSC Chairperson and subsequent appointments will rotate on an annual basis between Capital and Conduit. The JSC Chairperson will be responsible for drafting and circulating the draft agenda and ensuring minutes are prepared.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the Effective Date, through the date of completion of successful license deal and/or first regulatory approval and/or first commercial sale of the Product, the JSC will meet at least once per calendar quarter (and for clarity, such meetings are intended to be conducted via teleconference) unless the Parties mutually agree otherwise. Either Party may call a special meeting of the JSC (by videoconference or teleconference) by providing at least ten (10) days&rsquo; prior written notice to the other Party, which notice shall include a reasonably detailed description of the matter, in the event such Party reasonably believes that a significant matter must be addressed prior to the next scheduled meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC may invite individuals who are not JSC Representatives to participate in JSC meetings; provided that (a) all JSC Representatives of both Parties consent to such non-member&rsquo;s participation; and (b) such non-member has executed a confidentiality agreement in form and substance acceptable to the non-inviting Party (and, for the avoidance of doubt, the inviting Party shall remain responsible to the non-inviting Party for any noncompliance by such individual with such confidentiality obligations). For clarity, such non-members will have no voting rights at the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Party will bear its own expenses relating to the meetings and activities of the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JSC Responsibilities and Decision-Making</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC shall discuss and review (i) overall strategic direction of the Project; (ii) the Funding Budget and Development Plan; (iii) material changes in or amendments to the Funding Budget and Development Plan submitted by Capital or proposed by the JSC; (iv) forecasts of the estimated timeline for Development activities of the Products; and (v) any other matters the Parties mutually agree in writing shall be subject to discussion and review by the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC shall discuss, review and approve (i) any increases or decreases in the Funding Budget, and (ii) any other matters the Parties mutually agree in writing shall be subject to approval by the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC shall have no authority to (i) amend, modify or waive compliance with this Agreement, or (ii) resolve any dispute concerning the validity, interpretation, construction of, or breach of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit shall have the sole right to approve any amendments to Funding Budget and the Development Plan, taking into account any reasonable comments of the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>9.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCLUSIVITY COMMITMENT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">During the Term, Capital shall not, either
by itself or through a Third Party, conduct human clinical trials of, or sell, offer for sale or have sold any Competing Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>10.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLECTUAL PROPERTY</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Party will retain all right, title and interest in and to all Intellectual Property owned or controlled by such Party as of the Effective Date (&ldquo;<B>Existing Intellectual Property</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Intellectual Property developed by or on behalf of Capital as a result of Capital undertaking the Project (&ldquo;<B>Arising Intellectual Property</B>&rdquo;) shall be assigned or sub-licensed to Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall use Commercially Reasonable Efforts to prosecute, protect, defend and maintain the validity and enforceability of its Existing Intellectual Property and Conduit shall use Commercially Reasonable Efforts to prosecute, protect, defend and maintain the validity and enforceability of the Arising Intellectual Property.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>11.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIALITY</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential Information</B>. Except to the extent expressly authorized by this Agreement or by the Disclosing Party in writing, during the Term and for years thereafter, the Receiving Party shall maintain in confidence and shall not disclose to any third party or use for any purpose other than to exercise its rights or fulfil its obligations pursuant to this Agreement any Confidential Information of the Disclosing Party. Receiving Party may use the Confidential Information only to the extent required to perform its activities under this Agreement and for no other purpose. Receiving Party shall not use the Confidential Information for any purpose or in any manner that would constitute a violation of applicable laws. Both Parties shall ensure that all of its officers, employees, consultants, agents, subcontractors, third party vendors, investigators or contractors who receive or are in possession of any Confidential Information of the other Party understand and shall be bound by confidentiality provisions at least as stringent as the confidentiality obligations in this Agreement. Except as expressly set out in this Agreement the Parties agree that each Party is and shall remain the exclusive owner of its respective Confidential Information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exceptions</B>. The obligations of confidentiality and nonuse set forth in Section 11.1 shall not apply to any specific portion of information that Receiving Party can demonstrate by competent written evidence: (a) is in the public domain or comes into the public domain through no fault of Receiving Party; (b) is furnished to Receiving Party by a third party rightfully in possession of such information not subject to a duty of confidentiality with respect thereto; (c) is already known by Receiving Party without restriction at the time of receiving such Confidential Information as demonstrated by files in existence at such time; or (d) is independently developed by Receiving Party without access to the Confidential Information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized Disclosure</B>. Notwithstanding the foregoing in this Section 9, the Receiving Party may disclose certain Confidential Information to the extent such disclosure is required by applicable laws or regulation (including the regulatory requirements of a stock exchange), or pursuant to a valid order of a court or other governmental body having jurisdiction, provided that the Receiving Party to the extent permitted by applicable laws, provides the Disclosing Party with reasonable prior written notice of such disclosure and reasonable assistance to the Disclosing Party&rsquo;s reasonable and lawful actions to avoid and/or minimize the extent of such disclosure, all at the Disclosing Party&rsquo;s expense. In the event of a limited disclosure of the Confidential Information as set forth in this Section 11.3, Receiving Party shall continue to treat such information as Confidential Information for all other purposes and subject to the other terms and conditions of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Publication; Use of Names</B>. Under no circumstances may either Party use the name of the other Party or any of its personnel in any publication or any form of advertising without such other Party&rsquo;s prior written consent such consent not to be unreasonably withheld.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third Party Confidential Information</B>. Neither Party shall disclose to the other Party any confidential or proprietary information that belongs to any third party unless Disclosing Party first obtains the consent of such third party and enters into a separate confidentiality agreement with Receiving Party covering that disclosure. Receiving Party shall not represent to Disclosing Party as being unrestricted any designs, plans, models, samples, or other writings or products that Receiving Party knows are covered by valid Intellectual Property protection belonging to a third party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Return of Confidential Information</B>. Upon written request and at the expense of the Disclosing Party, Receiving Party shall promptly return or destroy all documents, notes, and other tangible materials representing Disclosing Party&rsquo;s Confidential Information and all copies thereof; provided, however, that Receiving Party may retain a single archival copy of the Confidential Information for the sole purpose of facilitating compliance with the surviving provisions of this Agreement. Notwithstanding anything to the contrary in this Agreement, the Receiving Party shall not be required to destroy any computer files stored securely by the Receiving Party that are created during automatic system back-up. The Receiving Party shall continue to be bound by its obligations of confidentiality and non-use under this Agreement as set forth herein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Injunctive Relief</B>. The Parties expressly acknowledge and agree that any breach or threatened breach of this Section 9 by Receiving Party may cause immediate and irreparable harm to Disclosing Party that may not be adequately compensated by damages. Each Party therefore agrees that in the event of such breach or threatened breach by Receiving Party, and in addition to any remedies available at law, Disclosing Party shall have the right to secure equitable and injunctive relief, without bond, in connection with such a breach or threatened breach.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>12.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM AND TERMINATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B>. This Agreement shall commence upon the Effective Date and continue until terminated (the &ldquo;<B>Term</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination by Conduit</B>. If at any time Capital ceases the conduct of the Development or Commercialisation of the Products in accordance with the Development Plan, Conduit shall not be obliged to make any further advances of the Funding to Capital. Capital shall provide Conduit with a reasonable explanation of the reason why it has ceased such activities. If Capital does not resume the Development or Commercialisation activities in accordance with the Development Plan within [***] of the date of cessation of such activities, Conduit shall have the right to terminate this Agreement in its entirety or in respect of the relevant Product only with immediate effect by giving notice in writing to Capital.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination for Material Breach</B>. Either Party may terminate this Agreement immediately upon written notice to the other Party if the other Party materially breaches this Agreement, and does not fully cure the breach to the non-breaching Party&rsquo;s satisfaction within ninety (90) days after the non-breaching Party gives notice of the breach to the breaching Party.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>12.4</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination for Insolvency</B>. Either Party may terminate this Agreement upon written notice to the other Party if the other Party makes an assignment for the benefit of creditors, or commences a case or proceeding under any bankruptcy, reorganization, insolvency, or similar laws, has a trustee or receiver or similar officer of any court appointed for such Party, or for substantial part of the property of such Party, or bankruptcy, reorganization, insolvency, or liquidation proceedings are instituted by or against such Party without such proceedings being dismissed, in each of the foregoing cases for a period of at least sixty (60) days.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect of Termination</B>. If Conduit terminates this Agreement pursuant to Section 12.2, pursuant to Section 12.3 in the case of Capital&rsquo;s material breach or pursuant to Section 12.4 in the case of Capital&rsquo;s insolvency Capital shall grant and hereby grants to Conduit a nonexclusive, perpetual, irrevocable, worldwide, royalty-free, fully paid-up, sublicensable (through multiple tiers) licence under any and all of Capital&rsquo;s Existing Intellectual Property embodied within, necessary or reasonably useful for the exploitation of the Arising Intellectual Property and the Product.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Provisions to continue on termination</B>. The termination of this Agreement howsoever arising will be without prejudice to the rights and duties of any Party accrued prior to termination. The following Clauses will continue to be enforceable notwithstanding termination: Clauses 4.2, 4.4, 5, 6, 7.3, 9, 10, 11, 13.4, 14, 15, 16, 17, 19, 20, 21, 22, 23, 24 and 25.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>13.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANTIES AND INSURANCE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Party warrants as of the Effective Date that (a) it has the full power and authority to enter into this Agreement, (b) this Agreement has been duly authorized, (c) this Agreement is binding upon it; and (d) that the terms of this Agreement are not inconsistent with its other contractual arrangements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital warrants that, as of the Effective Date:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its publicly filed accounts give a true and fair view of its financial position;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it is solvent and has disclosed to Conduit all material information regarding its financial position;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it has no indebtedness and it covenants that it shall not incur, create, assume, or permit to exist any indebtedness during the Term without the prior written permission of Conduit; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the best of its knowledge its Development and Commercialisation of a Product in accordance with the Development Plan will not infringe the intellectual property rights of any Third Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except to the extent expressly set out in Section 9.1 and 13.2, all warranties, express, statutory or implied and whether written or oral related to the subject matter of this Agreement are, to the fullest extent permissible by law, excluded. Without limiting the generality of the foregoing, the Parties acknowledge that the Candidate is experimental and at a very early stage of development and as such there is no guarantee the Development of the Candidate will result in asset that can be Commercialised. Capital shall have no liability to Conduit, in contract, tort or otherwise, in the event the Development of the Candidate does not result in asset that can be Commercialised.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall have and maintain, at its sole cost and expense, an adequate liability insurance (including product liability insurance) to protect against potential liabilities and risk arising out of activities to be performed under this Agreement, the Products and any agreement related hereto and upon such terms (including coverages, deductible limits and self-insured retentions) as are customary in the relevant industry generally. Such liability insurance shall insure against all types of liability, including personal injury, physical injury or property damage arising out of Capital&rsquo;s activities. This Section 13.4 shall not create any limitation on the Parties&rsquo; liability under this Agreement. Capital shall provide a copy of such insurance policy to Conduit promptly on request from Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>14.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORCE MAJEURE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The failure of either of the Parties to perform any obligation under this Agreement solely by reason of force majeure shall not be deemed to be a breach of this Agreement; provided, however, that the Party so prevented from complying herewith shall continue to take all reasonable actions within its power to comply as fully as possible herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>15.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Each Party shall deliver all notices, consents,
and approvals required or permitted under this Agreement in writing in English to the other Party to the addresses specified below. Each
Party may change its address for receipt of notice by giving notice of such change to the other Party. Notices shall be sent by electronic
mail, overnight courier, certified mail, return receipt requested, or by other means of delivery requiring a written acknowledged receipt.
All notices shall be effective upon receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">If to Conduit: Conduit Pharmaceuticals Limited,
c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands If to Capital: Bates Wells Braithwaite, FAO
St. George Street Capital, 10 Queen Street Place, London, England, EC4R 1BE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>16.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NO PARTNERSHIP</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing in this Agreement shall create a partnership. Neither Party is an agent or employee of the other Party and neither Party shall have the authority or power to make any statements, representations or commitments of any kind, nor to take any action which is binding on the other Party, except as may be explicitly provided for herein or authorised by the other Party in writing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>17.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither Party shall sell, transfer, assign, delegate, pledge, or otherwise dispose of, whether voluntarily, involuntarily, by operation of law or otherwise, this Agreement or any of its rights or duties hereunder without the written consent of the other Party (such consent not to be unreasonably withheld, conditioned, or delayed); provided, that (a) a Party may make such an assignment without the other Party&rsquo;s consent to (i) its affiliate, or (ii) to a successor, whether in a merger, sale of stock, sale of assets or any other transaction, of the business to which this Agreement relates, and (b) Conduit may make an assignment of its right to receive Net Receipts (and related reports) pursuant to Section 3 to an affiliate or a third party without Capital&rsquo;s consent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>18.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COUNTERPARTS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute an original of this Agreement, but all the counterparts shall together constitute the same agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>19.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER ASSURANCES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the Parties shall take, or cause to be taken, all actions necessary, proper, or advisable under applicable laws to give effect to the provisions of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>20.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD PARTY RIGHTS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement and no person other than the Parties shall have any rights under it.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>21.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEVERABILITY</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any provision of this Agreement (or part of a provision) is found by any court or administrative body of competent jurisdiction to be invalid, unenforceable or illegal, the other provisions shall remain in force.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any provision of this Agreement (or part of any provision) is or becomes illegal, invalid or unenforceable but would be legal, valid and enforceable if some part of it was deleted or modified, the provision or part-provision in question shall apply with such deletions or modifications as may be necessary to make the provision legal, valid and enforceable. In the event of such deletion or modification, the Parties shall negotiate in good faith and acting reasonably in order to agree the terms of a mutually acceptable alternative provision.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>22.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as expressly provided for in this Agreement, each of the Parties shall bear their own costs in relation to the investments and the contributions to be made pursuant to this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>23.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VARIATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No variation of or amendment to this Agreement shall be effective unless made in writing and signed by authorised representatives of both Parties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>24.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WAIVERS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The failure or delay of either Party to enforce or to exercise, at any time or for any period of time, any term of or any right, power or privilege arising pursuant to this Agreement does not constitute and shall not be construed as a waiver of such term, right, power or privilege and shall in no way affect either Party&rsquo;s right later to enforce or exercise it, nor shall any single or partial exercise of any remedy, right, power or privilege preclude any further exercise of the same or the exercise of any other remedy, right, power or privilege.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>25.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICABLE LAW</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement (and any dispute or claim relating to it or its subject matter (including non-contractual claims)) is governed by English law and on acceptance the parties submit to the non-exclusive jurisdiction of the courts of England.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signatures Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">THIS AGREEMENT IS EXECUTED by the authorized representatives of the Parties
as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed by Dr. David Tapolczay for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David Tapolczay</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ST GEORGE STREET CAPITAL LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed by Dr. Andrew Regan for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Andrew Regan</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT PHARMACEUTICALS LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Schedule 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form Development Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Schedule 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Funding Budget</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>8
<FILENAME>ex10-24.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.24</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED
BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THESE REDACTED TERMS
HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS [***].</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">AZD1656 PROJECT FUNDING
AGREEMENT for use in UVETIS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>THIS AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;)
is dated 02 November 2022 (the &ldquo;<B>Effective Date</B>&rdquo;) and is between:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>St George Street Capital Limited</B> (&ldquo;<B>Capital</B>&rdquo;), a private company limited by guarantee without share capital incorporated in England and Wales, company number 10537833 and also a registered charity in England and Wales (registered charity number 1171470) whose registered office is at Bates Wells Braithwaite, 10 Queen Street Place, London, United Kingdom, EC4R 1BE; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conduit Pharmaceuticals Limited</B> (&ldquo;<B>Conduit</B>&rdquo;), formerly known as SGS Global Limited, a company incorporated in the Cayman Islands, company number OC-346289, whose registered office is at c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">each a &ldquo;<B>Party</B>&rdquo; and together the
&ldquo;<B>Parties</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital is a UK registered charity whose objects include the advancement of medical research and development for public benefit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Parties entered into an Exclusive Funding Agreement dated 26 March 2021 pursuant to which Capital gave Conduit an exclusive first right to provide or procure the provision of funding to support Capital&rsquo;s drug development projects (the &ldquo;<B>Exclusive Funding Agreement</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with clause 3.4 of the Exclusive Funding Agreement, Conduit wishes to provide funding to Capital for the development of the Candidate (as defined in this Agreement) AZD1656 for the treatment of Uveitis (the &ldquo;<B>Field</B>&rdquo;) on the terms set out in this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Candidate</B>&rdquo; means AZD1656 and any co-crystals, salts, prodrugs, esters, amides, active metabolites, solvates, intermediates, fragments, derivatives (including pegylated versions and any linkers thereof), analogs and polymorphs of such compound.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercialisation</B>&rdquo; means any and all activities directed to the preparation for sale of, offering for sale of, or sale of a product, including activities related to marketing, promoting, distributing, importing and exporting such product. When used as a verb, &ldquo;<B>to Commercialise</B>&rdquo; and &ldquo;<B>Commercialising</B>&rdquo; means to engage in Commercialization, and &ldquo;<B>Commercialised</B>&rdquo; has a corresponding meaning.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercially Reasonable Efforts</B>&rdquo; means, with respect to the Development or Commercialization of Product by Capital, that level of efforts and resources that Capital would normally devote to the Development or Commercialization, as the case may be, of a product owned by it, or to which it has exclusive rights in relation to, which is of a similar commercial potential at a similar stage in its lifecycle, in each case taking into account issues of safety and efficacy, product profile, the proprietary position, the then current competitive environment for such product and the likely timing of such product&rsquo;s entry into the market, the pricing and launching strategy for the respective product, the regulatory environment and status of such product, and other relevant scientific, technical and commercial factors.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Competing Product</B>&rdquo; means any pharmaceutical or biologic product or a program directed at a pharmaceutical or biologic product that targets the same indication as the Product.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential Information</B>&rdquo; means information in whatever form (including in written, oral, visual or electronic form or on any magnetic or optical disk or memory and wherever located) relating to the research, development, data and/or results and product information, inventions, works of authorship, processes, methodologies, the business, sales targets, sales statistics, market share statistics, prices, market research reports and surveys, advertising and other promotional materials, future projects, business development or planning, commercial relationships and negotiations, customers, products, affairs and finances, and employees of a Party or its affiliates, and trade secrets including, technology, technical data and know-how relating to the business of such Party or its affiliates or any of their suppliers, customers, agents, distributors, shareholders, management or business contacts, whether or not such information is marked or identified as confidential, including information relating to the existence and terms of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Develop</B>&rdquo; means, in relation to a Product, the performance of all preclinical and clinical development (including, without limitation, toxicology, pharmacology, test method development and stability testing, process development, formulation development, quality control development, statistical analysis), clinical trials, and manufacturing and regulatory activities that are required to obtain regulatory approval of such Product. When used as a verb, &ldquo;<B>to Develop</B>&rdquo; and &ldquo;<B>Developing</B>&rdquo; means to engage in Development, and &ldquo;<B>Developed</B>&rdquo; has a corresponding meaning.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Development Plan</B>&rdquo; means a written plan for the Development of a Product, substantially in the form attached hereto as Schedule 1 (or subsequently agreed by the parties), and which will be subject to amendment from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disclosing Party</B>&rdquo; means a Party to this Agreement which discloses or makes available, directly or indirectly (for the avoidance of doubt including via a third party or its affiliates on the Disclosing Party&rsquo;s behalf), any Confidential Information to the other Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding</B>&rdquo; has the meaning set out in Section 3.1.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
    Budget</B>&rdquo; means the reasonably detailed budget for the Development of the Product setting out the anticipated costs for the
    Development of the Product and the expected timing, as set out in the initial budget in Schedule 2 and as amended from time to time
    by approval of the JSC in accordance with Section 8.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding Percentage</B>&rdquo; means 100% of the total Funding Requirement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding Requirement</B>&rdquo; means the funding required by Capital to obtain, by itself or through a Third Party, the first regulatory approval and/or first commercial sale for the Product, or as otherwise agreed by the Parties, as set out in the Budget.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual Property</B>&rdquo; means ideas, concepts, discoveries, inventions, developments, know-how, trade secrets, techniques, methodologies, modifications, innovations, improvements, writings, documentation, electronic code, data, and rights (whether or not protectable under state, federal or foreign patent, trademark, copyright, or similar laws) or the like, whether or not written or otherwise fixed in any form or medium, regardless of the media on which contained and whether or not patentable or copyrightable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>JSC</B>&rdquo; means the joint steering committee established by the Parties in accordance with Section 8.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net Receipts</B>&rdquo; means the Net Sales and the Sublicensing Revenue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net Sales</B>&rdquo; means any amounts received by Capital or its affiliates related to sales of a Product other than Sublicensing Revenue and less the following permitted deductions:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any portion of such amounts that is payable to a third party pursuant to a legal or contractual commitment; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any tax payable by Capital on such amounts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Product</B>&rdquo; means any product containing the Candidate (alone or with other active ingredients) in all forms, presentations, formulations, and dosage forms.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Progress Report</B>&rdquo; means a written report prepared by Capital setting out in reasonably detail a summary of the progress made by Capital regarding the Development of the Product as described in Section 8.3.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project</B>&rdquo; has the meaning set out in Section 3.2.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Receiving Party</B>&rdquo; shall mean a Party to this Agreement which receives or obtains, directly or indirectly (for the avoidance of doubt including via a third party or its affiliates on behalf of the Disclosing Party), any Confidential Information of the other Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sublicensing Revenue</B>&rdquo; shall mean all cash payments, the fair market cash value of any equity consideration (less any amounts paid for such equity consideration), and forgivable loans (to the extent actually forgiven) received by Capital or its affiliates in consideration for and directly attributable to the grant of a sublicense under any of its rights in a Product, including any royalties, upfront payments, license maintenance fees, milestone payments or the like less the following permitted deductions:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any portion of such amounts that is payable to a third party pursuant to a legal or contractual commitment; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any tax payable by Capital on such amounts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Term</B>&rdquo; has the meaning set out in Section 12.1.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Territory</B>&rdquo; shall mean worldwide.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third Party</B>&rdquo; means any person other than the Parties and their respective affiliates.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In this Agreement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all references to a particular clause or schedule shall be a reference to that clause or schedule in or to this Agreement as it may be amended from time to time pursuant to this Agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the headings are inserted for convenience only and shall be ignored in construing this Agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words importing the masculine gender shall include the feminine and vice versa and words in the singular include the plural and vice versa;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words denoting persons shall include any individual, partnership, company, corporation, joint venture, trust association, organisation or other entity, in each case whether or not having separate legal personality;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the words &ldquo;include&rdquo;, &ldquo;included&rdquo; and &ldquo;including&rdquo; are to be construed without conveying any limitation to the generality of the preceding words;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reference to any statute or regulation includes any modification or re-enactment of that statute or regulation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all references to USD, dollars or $ are to United States Dollars</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any reference to notices or consent being sought or given in writing shall require the consent or notice to be signed by an appropriately authorised person and shall not include consents or notices conveyed by email; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the event of any inconsistency or conflict between this Agreement and any of the Schedules, this Agreement shall prevail.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FUNDING</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit shall provide to Capital the sums set out in the Funding Budget (the &ldquo;<B>Funding</B>&rdquo;) in accordance with the budget payment schedule set out in the Funding Budget.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Funding will be used by Capital solely to support its Development and Commercialisation of a Product in the Field (the &ldquo;<B>Project</B>&rdquo;). The Funding provided by Conduit shall be the Funding Percentage of the Funding Requirement unless otherwise agreed between the Parties pursuant to Section 3.6. For clarity:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Funding is indirect investment in the Product for use in the Field and not a loan, equity investment, gift or donation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Funding must only be used for the Project; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Parties do not consider the subject matter of this Agreement to constitute a supply of services in respect of which VAT would be payable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise agreed in writing, Capital shall be responsible for any costs required to achieve the Purpose which exceed the amount of the Funding and Conduit shall have no obligation to provide any further amount to Capital in addition to the Funding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall submit invoices to Conduit in respect of payments to be made in accordance with Schedule 2. Conduit shall endeavour to pay all undisputed invoices within ten (10) days of receipt of such invoice by Conduit. If Conduit disputes any invoice, the provisions of Section 6 shall apply. Notwithstanding Conduit&rsquo;s right to dispute any invoice in accordance with Section 6, Conduit reserves the right to refuse to pay any invoice for any amount which was not incurred in respect of the Purpose and/or which was not included in the Funding Budget. Conduit shall not be in breach of this Agreement unless undisputed invoices remain outstanding for a period of more than [***].</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital acknowledges that to ensure that Conduit has the funds required to advance the Funding to Capital as required pursuant to this Agreement, Conduit may obtain funding from Third Parties and that accordingly payment of the Funding by Conduit may be dependent on Conduit obtaining the necessary funding from such Third Parties. Conduit shall not be in breach of this Agreement if the reason for its failure to advance any of the Funding to Capital is its inability to obtain funding from Third Parties or the failure of a Third Party to advance amounts that the Third Party had committed to advance to Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If at any time Capital anticipates that the agreed Funding Budget is insufficient to complete the activities set out in the Funding Budget, Capital shall promptly inform Conduit in writing and the Parties will discuss in good faith the action to be taken. Conduit shall have the first right to provide any additional funding required to complete the Development of the Product as described in the Funding Budget and the first right to provide any further funding which may be required for Capital to complete any further Development of or the Commercialisation of the Product provided that such funding may include Conduit obtaining additional funding from a Third Party to meet such requirements. If Conduit is unable to provide any additional funding required by Capital, Capital may obtain additional funding from a Third Party and, as appropriate, the Parties shall agree in good faith any adjustment that should be made to the Funding Percentage.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS OF FUNDING</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If Capital (i) ceases to undertake the Project for any reason, or (ii) if this Agreement is terminated, and at the relevant time Capital has not spent all of the Funding, Capital shall promptly repay such unspent portion of the Funding to Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall only use any equipment purchased using the Funding for the Project in accordance with this Agreement, or as otherwise permitted in writing by Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall comply with all applicable law, regulatory requirements and ethical guidelines and principles in conducting the Project.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to enable Capital to undertake the Project, Capital needs to enter into any agreements with any Third Party where the Funding will be used to pay any amounts due to such Third Parties or where any Intellectual Property generated using the Funding will be provided to such Third Parties (including license agreements in respect of any Intellectual Property), Conduit shall have the right to approve any such proposed Third Party agreements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT OF REVENUE SHARE TO CONDUIT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In consideration for the advance of the Funding by Conduit to Capital, Capital shall pay to Conduit an amount equal to the Funding Percentage of the Net Receipts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall calculate the Net Receipts at the end of each Calendar Quarter, in the currency that they are received by. Capital. Capital shall pay to Conduit the Net Receipts with respect to a given Calendar Quarter within thirty (30) days after the end of such Calendar Quarter and each such payment once made shall be non-refundable. Each payment shall be accompanied by a statement setting out the amount of Net Receipts (including such amounts expressed in local currency) and the calculation of the amount of Net Receipts for such Calendar Quarter, including details of any deductions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All payments shall be made by Capital to Conduit without setoff, by deposit in the requisite amount to such bank account as Conduit may from time to time designate by notice to Capital.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>6.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT DISPUTES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within sixty (60) working days of receipt of each invoice received by Conduit in accordance with Section 3.4, or statement of Net Receipts received by Conduit in accordance with 5.2, Conduit may serve a written notice on Capital disputing such invoice, whether the activities covered by the invoice are included in the Funding Budget and/or the calculation of Net Receipts (a &ldquo;<B>Dispute Notice</B>&rdquo;) and the provisions of Section 6.2 shall apply.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If Conduit serves a Dispute Notice in accordance with Section 6.1, the Parties shall, during the period of thirty (30) days commencing on the date of service of the Dispute Notice, seek in good faith to reach agreement on the disputed matters.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall maintain complete and accurate records of, and supporting documentation for, invoices submitted to Conduit and Capital&rsquo;s calculation of Net Receipts pursuant to this Agreement and demonstrating that the Development and Commercialisation activities undertaken by Capital pursuant to the Project are consistent with the Funding Budget. Such records shall be retained for inspection by Conduit for at least five (5) years following the calendar year to which such records pertain.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit (or its professional advisers) may during normal business hours and upon fourteen (14) days&rsquo; written notice to Capital, enter the premises of Capital and have access to the personnel, books, records and reports of Capital; and inspect, audit and take copies of relevant records, and other documents as necessary to verify Capitals compliance with the terms and conditions of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DILIGENCE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within thirty (60) days of the Effective Date, Capital shall prepare a Development Plan for the project and shall submit such Development Plan to the JSC for review in accordance with Section 8.2.1, and to Conduit for approval in accordance with Section 8.2.4. Capital may propose amendments to the Development Plan from time to time by submitting any amendments to the JSC for review and to Conduit for approval.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall use its Commercially Reasonable Efforts to Develop and Commercialise at least one Product in the Field in each of (i) the United States of America; (ii) each of the major European countries (being Italy, France, Germany, Spain and the United Kingdom); and (iii) Japan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within fourteen (14) days of the end of each month, Capital shall submit Progress Reports to Conduit in a form to be agreed between the Parties. Such Progress Reports shall set out, among other things, the Development activities undertaken by Capital in the preceding month in respect of all Products, and the Development activities which will be undertaken by Capital in the succeeding month. Capital shall prepare a Progress Report, in respect of each Product, each calendar month commencing the first calendar month following the Effective Date until expiry of the Term, unless otherwise agreed between the Parties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>8.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOVERNANCE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Steering Committee</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within thirty (30) days after the Effective Date, the Parties will establish the JSC which will oversee and manage the Project. Each Party initially will appoint two (2) representatives to serve as representatives to the JSC (the &ldquo;<B>JSC Representatives</B>&rdquo;). The initial representatives of Capital will be the CEO of Capital and Capital&rsquo;s senior clinician working on the Project. Each JSC Representative shall have knowledge and expertise regarding developing products similar to the Product and sufficient decision-making authority within the applicable Party to make decisions on behalf of such Party within the scope of the JSC&rsquo;s decision-making authority. If any such representative is not an employee of the appointing Party, such representative shall execute a confidentiality agreement in form and substance acceptable to the other Party (and, for the avoidance of doubt, the appointing Party shall remain responsible to the other Party for any noncompliance by such representative with such confidentiality obligations). Each Party may replace its JSC Representatives at any time upon written notice to the other Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC chairperson (&ldquo;<B>JSC Chairperson</B>&rdquo;) shall be designated from the Parties&rsquo; JSC Representatives and shall serve for a term of one (1) year. Capital shall appoint the first JSC Chairperson and subsequent appointments will rotate on an annual basis between Capital and Conduit. The JSC Chairperson will be responsible for drafting and circulating the draft agenda and ensuring minutes are prepared.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the Effective Date, through the date of completion of successful license deal and/or first regulatory approval and/or first commercial sale of the Product, the JSC will meet at least once per calendar quarter (and for clarity, such meetings are intended to be conducted via teleconference) unless the Parties mutually agree otherwise. Either Party may call a special meeting of the JSC (by videoconference or teleconference) by providing at least ten (10) days&rsquo; prior written notice to the other Party, which notice shall include a reasonably detailed description of the matter, in the event such Party reasonably believes that a significant matter must be addressed prior to the next scheduled meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC may invite individuals who are not JSC Representatives to participate in JSC meetings; provided that (a) all JSC Representatives of both Parties consent to such non-member&rsquo;s participation; and (b) such non-member has executed a confidentiality agreement in form and substance acceptable to the non-inviting Party (and, for the avoidance of doubt, the inviting Party shall remain responsible to the non-inviting Party for any noncompliance by such individual with such confidentiality obligations). For clarity, such non-members will have no voting rights at the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Party will bear its own expenses relating to the meetings and activities of the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JSC Responsibilities and Decision-Making</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC shall discuss and review (i) overall strategic direction of the Project; (ii) the Funding Budget and Development Plan; (iii) material changes in or amendments to the Funding Budget and Development Plan submitted by Capital or proposed by the JSC; (iv) forecasts of the estimated timeline for Development activities of the Products; and (v) any other matters the Parties mutually agree in writing shall be subject to discussion and review by the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC shall discuss, review and approve (i) any increases or decreases in the Funding Budget, and (ii) any other matters the Parties mutually agree in writing shall be subject to approval by the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The JSC shall have no authority to (i) amend, modify or waive compliance with this Agreement, or (ii) resolve any dispute concerning the validity, interpretation, construction of, or breach of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit shall have the sole right to approve any amendments to Funding Budget and the Development Plan, taking into account any reasonable comments of the JSC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>9.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCLUSIVITY COMMITMENT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">During the Term, Capital shall not, either
by itself or through a Third Party, conduct human clinical trials of, or sell, offer for sale or have sold any Competing Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>10.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLECTUAL PROPERTY</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Party will retain all right, title and interest in and to all Intellectual Property owned or controlled by such Party as of the Effective Date (&ldquo;<B>Existing Intellectual Property</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Intellectual Property developed by or on behalf of Capital as a result of Capital undertaking the Project (&ldquo;<B>Arising Intellectual Property</B>&rdquo;) shall be assigned or sub-licensed to Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall use Commercially Reasonable Efforts to prosecute, protect, defend and maintain the validity and enforceability of its Existing Intellectual Property and Conduit shall use Commercially Reasonable Efforts to prosecute, protect, defend and maintain the validity and enforceability of the Arising Intellectual Property.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>11.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIALITY</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential Information</B>. Except to the extent expressly authorized by this Agreement or by the Disclosing Party in writing, during the Term and for years thereafter, the Receiving Party shall maintain in confidence and shall not disclose to any third party or use for any purpose other than to exercise its rights or fulfil its obligations pursuant to this Agreement any Confidential Information of the Disclosing Party. Receiving Party may use the Confidential Information only to the extent required to perform its activities under this Agreement and for no other purpose. Receiving Party shall not use the Confidential Information for any purpose or in any manner that would constitute a violation of applicable laws. Both Parties shall ensure that all of its officers, employees, consultants, agents, subcontractors, third party vendors, investigators or contractors who receive or are in possession of any Confidential Information of the other Party understand and shall be bound by confidentiality provisions at least as stringent as the confidentiality obligations in this Agreement. Except as expressly set out in this Agreement the Parties agree that each Party is and shall remain the exclusive owner of its respective Confidential Information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exceptions</B>. The obligations of confidentiality and nonuse set forth in Section 11.1 shall not apply to any specific portion of information that Receiving Party can demonstrate by competent written evidence: (a) is in the public domain or comes into the public domain through no fault of Receiving Party; (b) is furnished to Receiving Party by a third party rightfully in possession of such information not subject to a duty of confidentiality with respect thereto; (c) is already known by Receiving Party without restriction at the time of receiving such Confidential Information as demonstrated by files in existence at such time; or (d) is independently developed by Receiving Party without access to the Confidential Information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized Disclosure</B>. Notwithstanding the foregoing in this Section 9, the Receiving Party may disclose certain Confidential Information to the extent such disclosure is required by applicable laws or regulation (including the regulatory requirements of a stock exchange), or pursuant to a valid order of a court or other governmental body having jurisdiction, provided that the Receiving Party to the extent permitted by applicable laws, provides the Disclosing Party with reasonable prior written notice of such disclosure and reasonable assistance to the Disclosing Party&rsquo;s reasonable and lawful actions to avoid and/or minimize the extent of such disclosure, all at the Disclosing Party&rsquo;s expense. In the event of a limited disclosure of the Confidential Information as set forth in this Section 11.3, Receiving Party shall continue to treat such information as Confidential Information for all other purposes and subject to the other terms and conditions of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Publication; Use of Names</B>. Under no circumstances may either Party use the name of the other Party or any of its personnel in any publication or any form of advertising without such other Party&rsquo;s prior written consent such consent not to be unreasonably withheld.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third Party Confidential Information</B>. Neither Party shall disclose to the other Party any confidential or proprietary information that belongs to any third party unless Disclosing Party first obtains the consent of such third party and enters into a separate confidentiality agreement with Receiving Party covering that disclosure. Receiving Party shall not represent to Disclosing Party as being unrestricted any designs, plans, models, samples, or other writings or products that Receiving Party knows are covered by valid Intellectual Property protection belonging to a third party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Return of Confidential Information</B>. Upon written request and at the expense of the Disclosing Party, Receiving Party shall promptly return or destroy all documents, notes, and other tangible materials representing Disclosing Party&rsquo;s Confidential Information and all copies thereof; provided, however, that Receiving Party may retain a single archival copy of the Confidential Information for the sole purpose of facilitating compliance with the surviving provisions of this Agreement. Notwithstanding anything to the contrary in this Agreement, the Receiving Party shall not be required to destroy any computer files stored securely by the Receiving Party that are created during automatic system back-up. The Receiving Party shall continue to be bound by its obligations of confidentiality and non-use under this Agreement as set forth herein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Injunctive Relief</B>. The Parties expressly acknowledge and agree that any breach or threatened breach of this Section 9 by Receiving Party may cause immediate and irreparable harm to Disclosing Party that may not be adequately compensated by damages. Each Party therefore agrees that in the event of such breach or threatened breach by Receiving Party, and in addition to any remedies available at law, Disclosing Party shall have the right to secure equitable and injunctive relief, without bond, in connection with such a breach or threatened breach.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>12.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM AND TERMINATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B>. This Agreement shall commence upon the Effective Date and continue until terminated (the &ldquo;<B>Term</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination by Conduit</B>. If at any time Capital ceases the conduct of the Development or Commercialisation of the Products in accordance with the Development Plan, Conduit shall not be obliged to make any further advances of the Funding to Capital. Capital shall provide Conduit with a reasonable explanation of the reason why it has ceased such activities. If Capital does not resume the Development or Commercialisation activities in accordance with the Development Plan within [***] of the date of cessation of such activities, Conduit shall have the right to terminate this Agreement in its entirety or in respect of the relevant Product only with immediate effect by giving notice in writing to Capital.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination for Material Breach</B>. Either Party may terminate this Agreement immediately upon written notice to the other Party if the other Party materially breaches this Agreement, and does not fully cure the breach to the non-breaching Party&rsquo;s satisfaction within ninety (90) days after the non-breaching Party gives notice of the breach to the breaching Party.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>12.4</TD>
    <TD STYLE="text-align: justify"><B>Termination for Insolvency</B>. Either
Party may terminate this Agreement upon written notice to the other Party if the other Party makes an assignment for the benefit of creditors,
or commences a case or proceeding under any bankruptcy, reorganization, insolvency, or similar laws, has a trustee or receiver or similar
officer of any court appointed for such Party, or for substantial part of the property of such Party, or bankruptcy, reorganization, insolvency,
or liquidation proceedings are instituted by or against such Party without such proceedings being dismissed, in each of the foregoing
cases for a period of at least sixty (60) days.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect of
    Termination</B>. If Conduit terminates this Agreement pursuant to Section 12.2, pursuant to Section 12.3 in the case of
    Capital&rsquo;s material breach or pursuant to Section 12.4 in the case of Capital&rsquo;s insolvency Capital shall grant and hereby
    grants to Conduit a nonexclusive, perpetual, irrevocable, worldwide, royalty-free, fully paid-up, sublicensable (through multiple
    tiers) licence under any and all of Capital&rsquo;s Existing Intellectual Property embodied within, necessary or reasonably useful
    for the exploitation of the Arising Intellectual Property and the Product.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Provisions to continue on termination</B>. The termination of this Agreement howsoever arising will be without prejudice to the rights and duties of any Party accrued prior to termination. The following Clauses will continue to be enforceable notwithstanding termination: Clauses 4.2, 4.4, 5, 6, 7.3, 9, 10, 11, 13.4, 14, 15, 16, 17, 19, 20, 21, 22, 23, 24 and 25.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>13.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANTIES AND INSURANCE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Party warrants as of the Effective Date that (a) it has the full power and authority to enter into this Agreement, (b) this Agreement has been duly authorized, (c) this Agreement is binding upon it; and (d) that the terms of this Agreement are not inconsistent with its other contractual arrangements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital warrants that, as of the Effective Date:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its publicly filed accounts give a true and fair view of its financial position;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it is solvent and has disclosed to Conduit all material information regarding its financial position;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it has no indebtedness and it covenants that it shall not incur, create, assume, or permit to exist any indebtedness during the Term without the prior written permission of Conduit; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the best of its knowledge its Development and Commercialisation of a Product in accordance with the Development Plan will not infringe the intellectual property rights of any Third Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except to the extent expressly set out in Section 9.1 and 13.2, all warranties, express, statutory or implied and whether written or oral related to the subject matter of this Agreement are, to the fullest extent permissible by law, excluded. Without limiting the generality of the foregoing, the Parties acknowledge that the Candidate is experimental and at a very early stage of development and as such there is no guarantee the Development of the Candidate will result in asset that can be Commercialised. Capital shall have no liability to Conduit, in contract, tort or otherwise, in the event the Development of the Candidate does not result in asset that can be Commercialised.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital shall have and maintain, at its sole cost and expense, an adequate liability insurance (including product liability insurance) to protect against potential liabilities and risk arising out of activities to be performed under this Agreement, the Products and any agreement related hereto and upon such terms (including coverages, deductible limits and self-insured retentions) as are customary in the relevant industry generally. Such liability insurance shall insure against all types of liability, including personal injury, physical injury or property damage arising out of Capital&rsquo;s activities. This Section 13.4 shall not create any limitation on the Parties&rsquo; liability under this Agreement. Capital shall provide a copy of such insurance policy to Conduit promptly on request from Conduit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>14.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORCE MAJEURE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The failure of either of the Parties to perform any obligation under this Agreement solely by reason of force majeure shall not be deemed to be a breach of this Agreement; provided, however, that the Party so prevented from complying herewith shall continue to take all reasonable actions within its power to comply as fully as possible herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>15.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Each Party shall deliver all notices, consents,
and approvals required or permitted under this Agreement in writing in English to the other Party to the addresses specified below. Each
Party may change its address for receipt of notice by giving notice of such change to the other Party. Notices shall be sent by electronic
mail, overnight courier, certified mail, return receipt requested, or by other means of delivery requiring a written acknowledged receipt.
All notices shall be effective upon receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">If to Conduit: Conduit Pharmaceuticals Limited,
c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands If to Capital: Bates Wells Braithwaite, FAO
St. George Street Capital, 10 Queen Street Place, London, England, EC4R 1BE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>16.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NO PARTNERSHIP</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing in this Agreement shall create a partnership. Neither Party is an agent or employee of the other Party and neither Party shall have the authority or power to make any statements, representations or commitments of any kind, nor to take any action which is binding on the other Party, except as may be explicitly provided for herein or authorised by the other Party in writing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>17.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither Party shall sell, transfer, assign, delegate, pledge, or otherwise dispose of, whether voluntarily, involuntarily, by operation of law or otherwise, this Agreement or any of its rights or duties hereunder without the written consent of the other Party (such consent not to be unreasonably withheld, conditioned, or delayed); provided, that (a) a Party may make such an assignment without the other Party&rsquo;s consent to (i) its affiliate, or (ii) to a successor, whether in a merger, sale of stock, sale of assets or any other transaction, of the business to which this Agreement relates, and (b) Conduit may make an assignment of its right to receive Net Receipts (and related reports) pursuant to Section 3 to an affiliate or a third party without Capital&rsquo;s consent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>18.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COUNTERPARTS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute an original of this Agreement, but all the counterparts shall together constitute the same agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>19.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER ASSURANCES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the Parties shall take, or cause to be taken, all actions necessary, proper, or advisable under applicable laws to give effect to the provisions of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>20.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD PARTY RIGHTS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement and no person other than the Parties shall have any rights under it.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>21.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEVERABILITY</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any provision of this Agreement (or part of a provision) is found by any court or administrative body of competent jurisdiction to be invalid, unenforceable or illegal, the other provisions shall remain in force.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any provision of this Agreement (or part of any provision) is or becomes illegal, invalid or unenforceable but would be legal, valid and enforceable if some part of it was deleted or modified, the provision or part-provision in question shall apply with such deletions or modifications as may be necessary to make the provision legal, valid and enforceable. In the event of such deletion or modification, the Parties shall negotiate in good faith and acting reasonably in order to agree the terms of a mutually acceptable alternative provision.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>22.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as expressly provided for in this Agreement, each of the Parties shall bear their own costs in relation to the investments and the contributions to be made pursuant to this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>23.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VARIATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No variation of or amendment to this Agreement shall be effective unless made in writing and signed by authorised representatives of both Parties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>24.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WAIVERS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The failure or delay of either Party to enforce or to exercise, at any time or for any period of time, any term of or any right, power or privilege arising pursuant to this Agreement does not constitute and shall not be construed as a waiver of such term, right, power or privilege and shall in no way affect either Party&rsquo;s right later to enforce or exercise it, nor shall any single or partial exercise of any remedy, right, power or privilege preclude any further exercise of the same or the exercise of any other remedy, right, power or privilege.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>25.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICABLE LAW</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement (and any dispute or claim relating to it or its subject matter (including non-contractual claims)) is governed by English law and on acceptance the parties submit to the non-exclusive jurisdiction of the courts of England.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signatures Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">THIS AGREEMENT IS EXECUTED by the authorized representatives of the Parties
as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed by Dr. David Tapolczay for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David Tapolczay</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ST GEORGE STREET CAPITAL LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed by Dr. Andrew Regan for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Andrew Regan</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT PHARMACEUTICALS LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Schedule 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form Development Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Schedule 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Funding Budget</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>9
<FILENAME>ex10-25.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 10.25</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED
BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THESE REDACTED TERMS
HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS [***].</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZD5904
PROJECT FUNDING AGREEMENT </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;) is dated 2 November 2022 (the &ldquo;<B>Effective Date</B>&rdquo;) and is between:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>St
                                            George Street Capital Limited</B> (&ldquo;<B>Capital</B>&rdquo;), a private company limited
                                            by guarantee without share capital incorporated in England and Wales, company number 10537833
                                            and also a registered charity in England and Wales (registered charity number 1171470) whose
                                            registered office is at Bates Wells Braithwaite, 10 Queen Street Place, London, United Kingdom,
                                            EC4R 1BE; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conduit
                                            Pharmaceuticals Limited</B> (&ldquo;<B>Conduit</B>&rdquo;), formerly known as SGS Global
                                            Limited, a company incorporated in the Cayman Islands, company number OC-346289, whose registered
                                            office is at c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009,
                                            Cayman Islands,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
a &ldquo;<B>Party</B>&rdquo; and together the &ldquo;<B>Parties</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            is a UK registered charity whose objects include the advancement of medical research and
                                            development for public benefit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Parties entered into an Exclusive Funding Agreement dated 26 March 2021 pursuant to which
                                            Capital gave Conduit an exclusive first right to provide or procure the provision of funding
                                            to support Capital&rsquo;s drug development projects (the &ldquo;<B>Exclusive Funding Agreement</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            accordance with clause 3.4 of the Exclusive Funding Agreement, Conduit wishes to provide
                                            funding to Capital for the development of the Candidate (as defined in this Agreement) for the treatment of Idiopathic Male Infertility (the &ldquo;<B>Field</B>&rdquo;) on the terms set out
                                            in this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Candidate</B>&rdquo;
                                            means AZD5904 and any co-crystals, salts, prodrugs, esters, amides, active metabolites, solvates,
                                            intermediates, fragments, derivatives (including pegylated versions and any linkers thereof),
                                            analogs and polymorphs of such compound.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercialisation</B>&rdquo;
                                            means any and all activities directed to the preparation for sale of, offering for sale of,
                                            or sale of a product, including activities related to marketing, promoting, distributing,
                                            importing and exporting such product. When used as a verb, &ldquo;<B>to Commercialise</B>&rdquo;
                                            and &ldquo;<B>Commercialising</B>&rdquo; means to engage in Commercialization, and &ldquo;<B>Commercialised</B>&rdquo;
                                            has a corresponding meaning.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commercially
                                            Reasonable Efforts</B>&rdquo; means, with respect to the Development or Commercialization
                                            of Product by Capital, that level of efforts and resources that Capital would normally devote
                                            to the Development or Commercialization, as the case may be, of a product owned by it, or
                                            to which it has exclusive rights in relation to, which is of a similar commercial potential
                                            at a similar stage in its lifecycle, in each case taking into account issues of safety and
                                            efficacy, product profile, the proprietary position, the then current competitive environment
                                            for such product and the likely timing of such product&rsquo;s entry into the market, the
                                            pricing and launching strategy for the respective product, the regulatory environment and
                                            status of such product, and other relevant scientific, technical and commercial factors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Competing
                                            Product</B>&rdquo; means any pharmaceutical or biologic product or a program directed at
                                            a pharmaceutical or biologic product that targets the same indication as the Product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential
                                            Information</B>&rdquo; means information in whatever form (including in written, oral, visual
                                            or electronic form or on any magnetic or optical disk or memory and wherever located) relating
                                            to the research, development, data and/or results and product information, inventions, works
                                            of authorship, processes, methodologies, the business, sales targets, sales statistics, market
                                            share statistics, prices, market research reports and surveys, advertising and other promotional
                                            materials, future projects, business development or planning, commercial relationships and
                                            negotiations, customers, products, affairs and finances, and employees of a Party or its
                                            affiliates, and trade secrets including, technology, technical data and know-how relating
                                            to the business of such Party or its affiliates or any of their suppliers, customers, agents,
                                            distributors, shareholders, management or business contacts, whether or not such information
                                            is marked or identified as confidential, including information relating to the existence
                                            and terms of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Develop</B>&rdquo;
                                            means, in relation to a Product, the performance of all preclinical and clinical development
                                            (including, without limitation, toxicology, pharmacology, test method development and stability
                                            testing, process development, formulation development, quality control development, statistical
                                            analysis), clinical trials, and manufacturing and regulatory activities that are required
                                            to obtain regulatory approval of such Product. When used as a verb, &ldquo;<B>to Develop</B>&rdquo;
                                            and &ldquo;<B>Developing</B>&rdquo; means to engage in Development, and &ldquo;<B>Developed</B>&rdquo;
                                            has a corresponding meaning.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Development
                                            Plan</B>&rdquo; means a written plan for the Development of a Product, substantially in the
                                            form attached hereto as Schedule 1 (or subsequently agreed between the Parties) and which will
                                            be subject to amendment from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disclosing
                                            Party</B>&rdquo; means a Party to this Agreement which discloses or makes available, directly
                                            or indirectly (for the avoidance of doubt including via a third party or its affiliates on
                                            the Disclosing Party&rsquo;s behalf), any Confidential Information to the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding</B>&rdquo;
                                            has the meaning set out in Section 3.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Budget</B>&rdquo; means the reasonably detailed budget for the Development of the Product
                                            setting out the anticipated costs for the Development of the Product and the expected timing,
                                            as set out in the initial budget in Schedule 2 (or subsequently agreed between the Parties)
                                            and as amended from time to time by approval of the JSC in accordance with Section 8.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Percentage</B>&rdquo; means 100% of the total Funding Requirement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Funding
                                            Requirement</B>&rdquo; means the funding required by Capital to obtain, by itself or through
                                            a Third Party, the first regulatory approval and/or first commercial sale for the Product,
                                            or as otherwise agreed by the Parties, as set out in the Budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
                                            Property</B>&rdquo; means ideas, concepts, discoveries, inventions, developments, know-how,
                                            trade secrets, techniques, methodologies, modifications, innovations, improvements, writings,
                                            documentation, electronic code, data, and rights (whether or not protectable under state,
                                            federal or foreign patent, trademark, copyright, or similar laws) or the like, whether or
                                            not written or otherwise fixed in any form or medium, regardless of the media on which contained
                                            and whether or not patentable or copyrightable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>JSC</B>&rdquo;
                                            means the joint steering committee established by the Parties in accordance with Section
                                            8.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
                                            Receipts</B>&rdquo; means the Net Sales and the Sublicensing Revenue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
                                            Sales</B>&rdquo; means any amounts received by Capital or its affiliates related to sales
                                            of a Product other than Sublicensing Revenue and less the following permitted deductions:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            portion of such amounts that is payable to a third party pursuant to a legal or contractual
                                            commitment; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            tax payable by Capital on such amounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Product</B>&rdquo;
                                            means any product containing the Candidate (alone or with other active ingredients) in all
                                            forms, presentations, formulations, and dosage forms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Progress
                                            Report</B>&rdquo; means a written report prepared by Capital setting out in reasonably detail
                                            a summary of the progress made by Capital regarding the Development of the Product as described
                                            in Section 8.3.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Project</B>&rdquo;
                                            has the meaning set out in Section 3.2.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Receiving
                                            Party</B>&rdquo; shall mean a Party to this Agreement which receives or obtains, directly
                                            or indirectly (for the avoidance of doubt including via a third party or its affiliates on
                                            behalf of the Disclosing Party), any Confidential Information of the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sublicensing
                                            Revenue</B>&rdquo; shall mean all cash payments, the fair market cash value of any equity
                                            consideration (less any amounts paid for such equity consideration), and forgivable loans
                                            (to the extent actually forgiven) received by Capital or its affiliates in consideration
                                            for and directly attributable to the grant of a sublicense under any of its rights in a Product,
                                            including any royalties, upfront payments, license maintenance fees, milestone payments or
                                            the like less the following permitted deductions:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            portion of such amounts that is payable to a third party pursuant to a legal or contractual
                                            commitment; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            tax payable by Capital on such amounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Term</B>&rdquo;
                                            has the meaning set out in Section 12.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Territory</B>&rdquo;
                                            shall mean worldwide.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third
                                            Party</B>&rdquo; means any person other than the Parties and their respective affiliates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            this Agreement:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            references to a particular clause or schedule shall be a reference to that clause or schedule
                                            in or to this Agreement as it may be amended from time to time pursuant to this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            headings are inserted for convenience only and shall be ignored in construing this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            importing the masculine gender shall include the feminine and vice versa and words in the
                                            singular include the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            denoting persons shall include any individual, partnership, company, corporation, joint venture,
                                            trust association, organisation or other entity, in each case whether or not having separate
                                            legal personality;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            words &ldquo;include&rdquo;, &ldquo;included&rdquo; and &ldquo;including&rdquo; are to be
                                            construed without conveying any limitation to the generality of the preceding words;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reference
                                            to any statute or regulation includes any modification or re-enactment of that statute or
                                            regulation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            references to pounds or &pound; are to pounds sterling;</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                    <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">2.1.8</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">all references to USD, dollars or $ are to United States Dollars</TD></TR>
                                                                                                                    </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            reference to notices or consent being sought or given in writing shall require the consent
                                            or notice to be signed by an appropriately authorised person and shall not include consents
                                            or notices conveyed by email; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the event of any inconsistency or conflict between this Agreement and any of the Schedules,
                                            this Agreement shall prevail.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FUNDING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            shall provide to Capital the sums set out in the Funding Budget (the &ldquo;<B>Funding</B>&rdquo;)
                                            in accordance with the budget payment schedule set out in the Funding Budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Funding will be used by Capital solely to support its Development and Commercialisation of
                                            a Product in the Field (the &ldquo;<B>Project</B>&rdquo;). The Funding provided by Conduit
                                            shall be the Funding Percentage of the Funding Requirement unless otherwise agreed between
                                            the Parties pursuant to Section 3.6. For clarity:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Funding is indirect investment in the Product for use in the Field and not a loan, equity
                                            investment, gift or donation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Funding must only be used for the Project; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Parties do not consider the subject matter of this Agreement to constitute a supply of services
                                            in respect of which VAT would be payable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise agreed in writing, Capital shall be responsible for any costs required to achieve
                                            the Purpose which exceed the amount of the Funding and Conduit shall have no obligation to
                                            provide any further amount to Capital in addition to the Funding.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall submit invoices to Conduit in respect of payments to be made in accordance with Schedule
                                            2. Conduit shall endeavour to pay all undisputed invoices within ten (10) days of receipt
                                            of such invoice by Conduit. If Conduit disputes any invoice, the provisions of Section 6
                                            shall apply. Notwithstanding Conduit&rsquo;s right to dispute any invoice in accordance with
                                            Section 6, Conduit reserves the right to refuse to pay any invoice for any amount which was
                                            not incurred in respect of the Purpose and/or which was not included in the Funding Budget.
                                            Conduit shall not be in breach of this Agreement unless undisputed invoices remain outstanding
                                            for a period of more than [***].</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            acknowledges that to ensure that Conduit has the funds required to advance the Funding to
                                            Capital as required pursuant to this Agreement, Conduit may obtain funding from Third Parties
                                            and that accordingly payment of the Funding by Conduit may be dependent on Conduit obtaining
                                            the necessary funding from such Third Parties. Conduit shall not be in breach of this Agreement
                                            if the reason for its failure to advance any of the Funding to Capital is its inability to
                                            obtain funding from Third Parties or the failure of a Third Party to advance amounts that
                                            the Third Party had committed to advance to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            at any time Capital anticipates that the agreed Funding Budget is insufficient to complete
                                            the activities set out in the Funding Budget, Capital shall promptly inform Conduit in writing
                                            and the Parties will discuss in good faith the action to be taken. Conduit shall have the
                                            first right to provide any additional funding required to complete the Development of the
                                            Product as described in the Funding Budget and the first right to provide any further funding
                                            which may be required for Capital to complete any further Development of or the Commercialisation
                                            of the Product provided that such funding may include Conduit obtaining additional funding
                                            from a Third Party to meet such requirements. If Conduit is unable to provide any additional
                                            funding required by Capital, Capital may obtain additional funding from a Third Party and,
                                            as appropriate, the Parties shall agree in good faith any adjustment that should be made
                                            to the Funding Percentage.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
                                            OF FUNDING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Capital (i) ceases to undertake the Project for any reason, or (ii) if this Agreement is
                                            terminated, and at the relevant time Capital has not spent all of the Funding, Capital shall
                                            promptly repay such unspent portion of the Funding to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall only use any equipment purchased using the Funding for the Project in accordance with
                                            this Agreement, or as otherwise permitted in writing by Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall comply with all applicable law, regulatory requirements and ethical guidelines and
                                            principles in conducting the Project.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            to enable Capital to undertake the Project, Capital needs to enter into any agreements with
                                            any Third Party where the Funding will be used to pay any amounts due to such Third Parties
                                            or where any Intellectual Property generated using the Funding will be provided to such Third
                                            Parties (including license agreements in respect of any Intellectual Property), Conduit shall
                                            have the right to approve any such proposed Third Party agreements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT
                                            OF REVENUE SHARE TO CONDUIT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            consideration for the advance of the Funding by Conduit to Capital, Capital shall pay to
                                            Conduit an amount equal to the Funding Percentage of the Net Receipts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall calculate the Net Receipts at the end of each Calendar Quarter, in the currency that
                                            they are received by. Capital. Capital shall pay to Conduit the Net Receipts with respect
                                            to a given Calendar Quarter within thirty (30) days after the end of such Calendar Quarter
                                            and each such payment once made shall be non-refundable. Each payment shall be accompanied
                                            by a statement setting out the amount of Net Receipts (including such amounts expressed in
                                            local currency) and the calculation of the amount of Net Receipts for such Calendar Quarter,
                                            including details of any deductions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            payments shall be made by Capital to Conduit without setoff, by deposit in the requisite
                                            amount to such bank account as Conduit may from time to time designate by notice to Capital.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENT
                                            DISPUTES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            sixty (60) working days of receipt of each invoice received by Conduit in accordance with
                                            Section 3.4, or statement of Net Receipts received by Conduit in accordance with 5.2, Conduit
                                            may serve a written notice on Capital disputing such invoice, whether the activities covered
                                            by the invoice are included in the Funding Budget and/or the calculation of Net Receipts
                                            (a &ldquo;<B>Dispute Notice</B>&rdquo;) and the provisions of Section 6.2 shall apply.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            Conduit serves a Dispute Notice in accordance with Section 6.1, the Parties shall, during
                                            the period of thirty (30) days commencing on the date of service of the Dispute Notice, seek
                                            in good faith to reach agreement on the disputed matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall maintain complete and accurate records of, and supporting documentation for, invoices
                                            submitted to Conduit and Capital&rsquo;s calculation of Net Receipts pursuant to this Agreement
                                            and demonstrating that the Development and Commercialisation activities undertaken by Capital
                                            pursuant to the Project are consistent with the Funding Budget. Such records shall be retained
                                            for inspection by Conduit for at least five (5) years following the calendar year to which
                                            such records pertain.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            (or its professional advisers) may during normal business hours and upon fourteen (14) days&rsquo;
                                            written notice to Capital, enter the premises of Capital and have access to the personnel,
                                            books, records and reports of Capital; and inspect, audit and take copies of relevant records,
                                            and other documents as necessary to verify Capital&rsquo;s compliance with the terms and conditions
                                            of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DILIGENCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            thirty (60) days of the Effective Date, Capital shall prepare a Development Plan for the
                                            project and shall submit such Development Plan to the JSC for review in accordance with Section
                                            8.2.1, and to Conduit for approval in accordance with Section 8.2.4. Capital may propose
                                            amendments to the Development Plan from time to time by submitting any amendments to the
                                            JSC for review and to Conduit for approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall use its Commercially Reasonable Efforts to Develop and Commercialise at least one Product
                                            in the Field in each of (i) the United States of America; (ii) each of the major European
                                            countries (being Italy, France, Germany, Spain and the United Kingdom); and (iii) Japan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            fourteen (14) days of the end of each month, Capital shall submit Progress Reports to Conduit
                                            in a form to be agreed between the Parties. Such Progress Reports shall set out, among other
                                            things, the Development activities undertaken by Capital in the preceding month in respect
                                            of all Products, and the Development activities which will be undertaken by Capital in the
                                            succeeding month. Capital shall prepare a Progress Report, in respect of each Product, each
                                            calendar month commencing the first calendar month following the Effective Date until expiry
                                            of the Term, unless otherwise agreed between the Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOVERNANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
                                            Steering Committee</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            thirty (30) days after the Effective Date, the Parties will establish the JSC which will
                                            oversee and manage the Project. Each Party initially will appoint two (2) representatives
                                            to serve as representatives to the JSC (the &ldquo;<B>JSC Representatives</B>&rdquo;). The
                                            initial representatives of Capital will be the CEO of Capital and Capital&rsquo;s senior
                                            clinician working on the Project. Each JSC Representative shall have knowledge and expertise
                                            regarding developing products similar to the Product and sufficient decision-making authority
                                            within the applicable Party to make decisions on behalf of such Party within the scope of
                                            the JSC&rsquo;s decision-making authority. If any such representative is not an employee
                                            of the appointing Party, such representative shall execute a confidentiality agreement in
                                            form and substance acceptable to the other Party (and, for the avoidance of doubt, the appointing
                                            Party shall remain responsible to the other Party for any noncompliance by such representative
                                            with such confidentiality obligations). Each Party may replace its JSC Representatives at
                                            any time upon written notice to the other Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC chairperson (&ldquo;<B>JSC Chairperson</B>&rdquo;) shall be designated from the Parties&rsquo;
                                            JSC Representatives and shall serve for a term of one (1) year. Capital shall appoint the
                                            first JSC Chairperson and subsequent appointments will rotate on an annual basis between
                                            Capital and Conduit. The JSC Chairperson will be responsible for drafting and circulating
                                            the draft agenda and ensuring minutes are prepared.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
                                            the Effective Date, through the date of completion of successful license deal and/or first
                                            regulatory approval and/or first commercial sale of the Product, the JSC will meet at least
                                            once per calendar quarter (and for clarity, such meetings are intended to be conducted via
                                            teleconference) unless the Parties mutually agree otherwise. Either Party may call a special
                                            meeting of the JSC (by videoconference or teleconference) by providing at least ten (10)
                                            days&rsquo; prior written notice to the other Party, which notice shall include a reasonably
                                            detailed description of the matter, in the event such Party reasonably believes that a significant
                                            matter must be addressed prior to the next scheduled meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC may invite individuals who are not JSC Representatives to participate in JSC meetings;
                                            provided that (a) all JSC Representatives of both Parties consent to such non-member&rsquo;s
                                            participation; and (b) such non-member has executed a confidentiality agreement in form and
                                            substance acceptable to the non-inviting Party (and, for the avoidance of doubt, the inviting
                                            Party shall remain responsible to the non-inviting Party for any noncompliance by such individual
                                            with such confidentiality obligations). For clarity, such non-members will have no voting
                                            rights at the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party will bear its own expenses relating to the meetings and activities of the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JSC
                                            Responsibilities and Decision-Making</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall discuss and review (i) overall strategic direction of the Project; (ii) the Funding
                                            Budget and Development Plan; (iii) material changes in or amendments to the Funding Budget
                                            and Development Plan submitted by Capital or proposed by the JSC; (iv) forecasts of the estimated
                                            timeline for Development activities of the Products; and (v) any other matters the Parties
                                            mutually agree in writing shall be subject to discussion and review by the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall discuss, review and approve (i) any increases or decreases in the Funding Budget,
                                            and (ii) any other matters the Parties mutually agree in writing shall be subject to approval
                                            by the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            JSC shall have no authority to (i) amend, modify or waive compliance with this Agreement,
                                            or (ii) resolve any dispute concerning the validity, interpretation, construction of, or
                                            breach of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduit
                                            shall have the sole right to approve any amendments to Funding Budget and the Development
                                            Plan, taking into account any reasonable comments of the JSC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCLUSIVITY
                                            COMMITMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the Term, Capital shall not, either by itself or through a Third Party, conduct human clinical trials of, or sell, offer for sale or
have sold any Competing Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTELLECTUAL
                                            PROPERTY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party will retain all right, title and interest in and to all Intellectual Property owned
                                            or controlled by such Party as of the Effective Date (&ldquo;<B>Existing Intellectual Property</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            Intellectual Property developed by or on behalf of Capital as a result of Capital undertaking
                                            the Project (&ldquo;<B>Arising Intellectual Property</B>&rdquo;) shall be assigned or sub-licensed
                                            to Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall use Commercially Reasonable Efforts to prosecute, protect, defend and maintain the
                                            validity and enforceability of its Existing Intellectual Property and Conduit shall use Commercially
                                            Reasonable Efforts to prosecute, protect, defend and maintain the validity and enforceability
                                            of the Arising Intellectual Property.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIALITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential
                                            Information</B>. Except to the extent expressly authorized by this Agreement or by the Disclosing
                                            Party in writing, during the Term and for years thereafter, the Receiving Party shall maintain
                                            in confidence and shall not disclose to any third party or use for any purpose other than
                                            to exercise its rights or fulfil its obligations pursuant to this Agreement any Confidential
                                            Information of the Disclosing Party. Receiving Party may use the Confidential Information
                                            only to the extent required to perform its activities under this Agreement and for no other
                                            purpose. Receiving Party shall not use the Confidential Information for any purpose or in
                                            any manner that would constitute a violation of applicable laws. Both Parties shall ensure
                                            that all of its officers, employees, consultants, agents, subcontractors, third party vendors,
                                            investigators or contractors who receive or are in possession of any Confidential Information
                                            of the other Party understand and shall be bound by confidentiality provisions at least as
                                            stringent as the confidentiality obligations in this Agreement. Except as expressly set out
                                            in this Agreement the Parties agree that each Party is and shall remain the exclusive owner
                                            of its respective Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exceptions</B>.
                                            The obligations of confidentiality and nonuse set forth in Section 11.1 shall not apply to
                                            any specific portion of information that Receiving Party can demonstrate by competent written
                                            evidence: (a) is in the public domain or comes into the public domain through no fault of
                                            Receiving Party; (b) is furnished to Receiving Party by a third party rightfully in possession
                                            of such information not subject to a duty of confidentiality with respect thereto; (c) is
                                            already known by Receiving Party without restriction at the time of receiving such Confidential
                                            Information as demonstrated by files in existence at such time; or (d) is independently developed
                                            by Receiving Party without access to the Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
                                            Disclosure</B>. Notwithstanding the foregoing in this Section 9, the Receiving Party may
                                            disclose certain Confidential Information to the extent such disclosure is required by applicable
                                            laws or regulation (including the regulatory requirements of a stock exchange), or pursuant
                                            to a valid order of a court or other governmental body having jurisdiction, provided that
                                            the Receiving Party to the extent permitted by applicable laws, provides the Disclosing Party
                                            with reasonable prior written notice of such disclosure and reasonable assistance to the
                                            Disclosing Party&rsquo;s reasonable and lawful actions to avoid and/or minimize the extent
                                            of such disclosure, all at the Disclosing Party&rsquo;s expense. In the event of a limited
                                            disclosure of the Confidential Information as set forth in this Section 11.3, Receiving Party
                                            shall continue to treat such information as Confidential Information for all other purposes
                                            and subject to the other terms and conditions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Publication;
                                            Use of Names</B>. Under no circumstances may either Party use the name of the other Party
                                            or any of its personnel in any publication or any form of advertising without such other
                                            Party&rsquo;s prior written consent such consent not to be unreasonably withheld.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
                                            Party Confidential Information</B>. Neither Party shall disclose to the other Party any confidential
                                            or proprietary information that belongs to any third party unless Disclosing Party first
                                            obtains the consent of such third party and enters into a separate confidentiality agreement
                                            with Receiving Party covering that disclosure. Receiving Party shall not represent to Disclosing
                                            Party as being unrestricted any designs, plans, models, samples, or other writings or products
                                            that Receiving Party knows are covered by valid Intellectual Property protection belonging
                                            to a third party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Return
                                            of Confidential Information</B>. Upon written request and at the expense of the Disclosing
                                            Party, Receiving Party shall promptly return or destroy all documents, notes, and other tangible
                                            materials representing Disclosing Party&rsquo;s Confidential Information and all copies thereof;
                                            provided, however, that Receiving Party may retain a single archival copy of the Confidential
                                            Information for the sole purpose of facilitating compliance with the surviving provisions
                                            of this Agreement. Notwithstanding anything to the contrary in this Agreement, the Receiving
                                            Party shall not be required to destroy any computer files stored securely by the Receiving
                                            Party that are created during automatic system back-up. The Receiving Party shall continue
                                            to be bound by its obligations of confidentiality and non-use under this Agreement as set
                                            forth herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Injunctive
                                            Relief</B>. The Parties expressly acknowledge and agree that any breach or threatened breach
                                            of this Section 9 by Receiving Party may cause immediate and irreparable harm to Disclosing
                                            Party that may not be adequately compensated by damages. Each Party therefore agrees that
                                            in the event of such breach or threatened breach by Receiving Party, and in addition to any
                                            remedies available at law, Disclosing Party shall have the right to secure equitable and
                                            injunctive relief, without bond, in connection with such a breach or threatened breach.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
                                            AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B>.
                                            This Agreement shall commence upon the Effective Date and continue until terminated (the
                                            &ldquo;<B>Term</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                            by Conduit</B>. If at any time Capital ceases the conduct of the Development or Commercialisation
                                            of the Products in accordance with the Development Plan, Conduit shall not be obliged to
                                            make any further advances of the Funding to Capital. Capital shall provide Conduit with a
                                            reasonable explanation of the reason why it has ceased such activities. If Capital does not
                                            resume the Development or Commercialisation activities in accordance with the Development
                                            Plan within [***] of the date of cessation of such activities, Conduit shall have the right
                                            to terminate this Agreement in its entirety or in respect of the relevant Product only with
                                            immediate effect by giving notice in writing to Capital.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                            for Material Breach</B>. Either Party may terminate this Agreement immediately upon written
                                            notice to the other Party if the other Party materially breaches this Agreement, and does
                                            not fully cure the breach to the non-breaching Party&rsquo;s satisfaction within ninety (90)
                                            days after the non-breaching Party gives notice of the breach to the breaching Party.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">12.4</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><B>Termination
for Insolvency</B>. Either Party may terminate this Agreement upon written notice to the other Party if the other Party makes an assignment
for the benefit of creditors, or commences a case or proceeding under any bankruptcy, reorganization, insolvency, or similar laws, has
a trustee or receiver or similar officer of any court appointed for such Party, or for substantial part of the property of such Party,
or bankruptcy, reorganization, insolvency, or liquidation proceedings are instituted by or against such Party without such proceedings
being dismissed, in each of the foregoing cases for a period of at least sixty (60) days.</TD></TR>
                                                                                                                                                  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect
                                            of Termination</B>. If Conduit terminates this Agreement pursuant to Section 12.2, pursuant
                                            to Section 12.3 in the case of Capital&rsquo;s material breach or pursuant to Section 12.4  in
                                            the case of Capital&rsquo;s insolvency Capital shall grant and hereby grants to Conduit a
                                            nonexclusive, perpetual, irrevocable, worldwide, royalty-free, fully paid-up, sublicensable
                                            (through multiple tiers) licence under any and all of Capital&rsquo;s Existing Intellectual
                                            Property embodied within, necessary or reasonably useful for the exploitation of the Arising
                                            Intellectual Property and the Product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Provisions
                                            to continue on termination</B>. The termination of this Agreement howsoever arising will
                                            be without prejudice to the rights and duties of any Party accrued prior to termination.
                                            The following Clauses will continue to be enforceable notwithstanding termination: Clauses
                                            4.2, 4.4, 5, 6, 7.3, 9, 10, 11, 13.4, 14, 15, 16, 17, 19, 20, 21, 22, 23, 24 and 25.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANTIES
                                            AND INSURANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party warrants as of the Effective Date that (a) it has the full power and authority to enter
                                            into this Agreement, (b) this Agreement has been duly authorized, (c) this Agreement is binding
                                            upon it; and (d) that the terms of this Agreement are not inconsistent with its other contractual
                                            arrangements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            warrants that, as of the Effective Date:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
                                            publicly filed accounts give a true and fair view of its financial position;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            is solvent and has disclosed to Conduit all material information regarding its financial
                                            position;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            has no indebtedness and it covenants that it shall not incur, create, assume, or permit to
                                            exist any indebtedness during the Term without the prior written permission of Conduit; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            the best of its knowledge its Development and Commercialisation of a Product in accordance
                                            with the Development Plan will not infringe the intellectual property rights of any Third
                                            Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            to the extent expressly set out in Section 9.1 and 13.2, all warranties, express, statutory
                                            or implied and whether written or oral related to the subject matter of this Agreement are,
                                            to the fullest extent permissible by law, excluded. Without limiting the generality of the
                                            foregoing, the Parties acknowledge that the Candidate is experimental and at a very early
                                            stage of development and as such there is no guarantee the Development of the Candidate will
                                            result in asset that can be Commercialised. Capital shall have no liability to Conduit, in
                                            contract, tort or otherwise, in the event the Development of the Candidate does not result
                                            in asset that can be Commercialised.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
                                            shall have and maintain, at its sole cost and expense, an adequate liability insurance (including
                                            product liability insurance) to protect against potential liabilities and risk arising out
                                            of activities to be performed under this Agreement, the Products and any agreement related
                                            hereto and upon such terms (including coverages, deductible limits and self-insured retentions)
                                            as are customary in the relevant industry generally. Such liability insurance shall insure
                                            against all types of liability, including personal injury, physical injury or property damage
                                            arising out of Capital&rsquo;s activities. This Section 13.4 shall not create any limitation
                                            on the Parties&rsquo; liability under this Agreement. Capital shall provide a copy of such
                                            insurance policy to Conduit promptly on request from Conduit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORCE
                                            MAJEURE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure of either of the Parties to perform any obligation under this Agreement solely by
                                            reason of force majeure shall not be deemed to be a breach of this Agreement; provided, however,
                                            that the Party so prevented from complying herewith shall continue to take all reasonable
                                            actions within its power to comply as fully as possible herewith.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party shall deliver all notices, consents, and approvals required or permitted under this Agreement in writing in English to the other
Party to the addresses specified below. Each Party may change its address for receipt of notice by giving notice of such change to the
other Party. Notices shall be sent by electronic mail, overnight courier, certified mail, return receipt requested, or by other means
of delivery requiring a written acknowledged receipt. All notices shall be effective upon receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Conduit: Conduit Pharmaceuticals Limited, c/o Ogier (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands
If to Capital: Bates Wells Braithwaite, FAO St. George Street Capital, 10 Queen Street Place, London, England, EC4R 1BE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>16.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NO
                                            PARTNERSHIP</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in this Agreement shall create a partnership. Neither Party is an agent or employee of the
                                            other Party and neither Party shall have the authority or power to make any statements, representations
                                            or commitments of any kind, nor to take any action which is binding on the other Party, except
                                            as may be explicitly provided for herein or authorised by the other Party in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>17.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
                                            Party shall sell, transfer, assign, delegate, pledge, or otherwise dispose of, whether voluntarily,
                                            involuntarily, by operation of law or otherwise, this Agreement or any of its rights or duties
                                            hereunder without the written consent of the other Party (such consent not to be unreasonably
                                            withheld, conditioned, or delayed); provided, that (a) a Party may make such an assignment
                                            without the other Party&rsquo;s consent to (i) its affiliate, or (ii) to a successor, whether
                                            in a merger, sale of stock, sale of assets or any other transaction, of the business to which
                                            this Agreement relates, and (b) Conduit may make an assignment of its right to receive Net
                                            Receipts (and related reports) pursuant to Section 3 to an affiliate or a third party without
                                            Capital&rsquo;s consent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>18.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COUNTERPARTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement may be executed in any number of counterparts, each of which when executed and
                                            delivered shall constitute an original of this Agreement, but all the counterparts shall
                                            together constitute the same agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>19.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
                                            ASSURANCES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            of the Parties shall take, or cause to be taken, all actions necessary, proper, or advisable
                                            under applicable laws to give effect to the provisions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>20.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD
                                            PARTY RIGHTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement and no person
                                            other than the Parties shall have any rights under it.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>21.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEVERABILITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any provision of this Agreement (or part of a provision) is found by any court or administrative
                                            body of competent jurisdiction to be invalid, unenforceable or illegal, the other provisions
                                            shall remain in force.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any provision of this Agreement (or part of any provision) is or becomes illegal, invalid
                                            or unenforceable but would be legal, valid and enforceable if some part of it was deleted
                                            or modified, the provision or part-provision in question shall apply with such deletions
                                            or modifications as may be necessary to make the provision legal, valid and enforceable.
                                            In the event of such deletion or modification, the Parties shall negotiate in good faith
                                            and acting reasonably in order to agree the terms of a mutually acceptable alternative provision.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>22.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                            as expressly provided for in this Agreement, each of the Parties shall bear their own costs
                                            in relation to the investments and the contributions to be made pursuant to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>23.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VARIATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            variation of or amendment to this Agreement shall be effective unless made in writing and
                                            signed by authorised representatives of both Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>24.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WAIVERS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            failure or delay of either Party to enforce or to exercise, at any time or for any period
                                            of time, any term of or any right, power or privilege arising pursuant to this Agreement
                                            does not constitute and shall not be construed as a waiver of such term, right, power or
                                            privilege and shall in no way affect either Party&rsquo;s right later to enforce or exercise
                                            it, nor shall any single or partial exercise of any remedy, right, power or privilege preclude
                                            any further exercise of the same or the exercise of any other remedy, right, power or privilege.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>25.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICABLE
                                            LAW</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement (and any dispute or claim relating to it or its subject matter (including non-contractual
                                            claims)) is governed by English law and on acceptance the parties submit to the non-exclusive
                                            jurisdiction of the courts of England.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signatures
Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT IS EXECUTED by the authorized representatives of the Parties as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
    by Dr. David Tapolczay for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    David Tapolczay</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ST
    GEORGE STREET CAPITAL LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
    by Dr. Andrew Regan for and on behalf of</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Andrew Regan</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDUIT
    PHARMACEUTICALS LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
Development Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Funding
Budget</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Historical
Payments made in relation to Idiopathic Male Infertility Project:</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 50%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07 January 2021:</FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&pound;</TD><TD STYLE="width: 18%; text-align: right">127,000.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28 October 2021:</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&pound;</TD><TD STYLE="text-align: right">58,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31 May 2022:</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&pound;</TD><TD STYLE="text-align: right">20,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21 July 2022:</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&pound;</TD><TD STYLE="text-align: right">15,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>10
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in this Registration Statement of Murphy Canyon Acquisition Corp. on Form S-4 of our report dated March 28,
2023, which includes an explanatory paragraph as to the Company&rsquo;s ability to continue as a going concern, with respect to our audits
of the financial statements and related financial statement schedules of Murphy Canyon Acquisition Corp. as of December 31, 2022 and
2021, and for the year ended December 31, 2022 and for the period from October 19, 2021 (inception) through December 31, 2021, which
report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the
heading &ldquo;Experts&rdquo; in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>11
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in this Registration Statement of Murphy Canyon Acquisition Corp. on Form S-4 of our report dated May 12, 2023,
which includes an explanatory paragraph as to the Company&rsquo;s ability to continue as a going concern, with respect to our audits
of the financial statements of Conduit Pharmaceuticals Ltd. as of December 31, 2022 and 2021, and for the years then ended<B>, </B>which
report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the
heading &ldquo;Experts&rdquo; in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.5
<SEQUENCE>12
<FILENAME>ex23-5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF VALUESCOPE, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92123</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
The Board of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
    Statement / Prospectus of Murphy Canyon Acquisition Corp. (&ldquo;Murphy&rdquo;), which forms part of the Registration Statement
    on Form S-4 of Murphy (the &ldquo;Registration Statement&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
of the Board of Directors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the inclusion of our opinion letter, dated November 4, 2022, to the Board of Directors of Murphy as Annex D to the
Proxy Statement/Prospectus included in the Registration Statement filed with the Securities and Exchange Commission today and the references
to our firm and our opinion, including the quotation or summarization of such opinion, in such Registration Statement. The foregoing
consent applies only to the Registration Statement being filed with the Securities and Exchange Commission today and not to any amendments
or supplements to the Registration Statement, and our opinion is not to be filed with, included in or referred to in whole or in part
in any other registration statement (including any amendments to the above-mentioned Registration Statement), proxy statement or any
other document, except in accordance with our prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
giving our consent, we do not admit that we come within the category of persons whose consent is required under Section <I>7 </I>of the
Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we admit
that we are experts with respect to any part of such Registration Statement within the meaning of the term &ldquo;experts&rdquo; as used
in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    10, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-5_001.jpg" ALT=""></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    ValueScope, Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>13
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
17, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92123</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
to Reference in Registration Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &ldquo;Company&rdquo;) has filed a registration statement on Form S-4, as amended, with the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), as of the date hereof. In connection
therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus included
in such registration statement as a future member of the board of directors of the Company following the effective time of the business
combination described in this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Freda Lewis-Hall</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freda
    Lewis-Hall</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>14
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
17, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92123</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
to Reference in Registration Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &ldquo;Company&rdquo;) has filed a registration statement on Form S-4, as amended, with the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), as of the date hereof. In connection
therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus included
in such registration statement as a future member of the board of directors of the Company following the effective time of the business
combination described in this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Tapolczay</I></FONT></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Tapolczay</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>15
<FILENAME>ex99-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
17, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92123</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
to Reference in Registration Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &ldquo;Company&rdquo;) has filed a registration statement on Form S-4, as amended, with the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), as of the date hereof. In connection
therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus included
in such registration statement as a future member of the board of directors of the Company following the effective time of the business
combination described in this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
    <P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    James Bligh</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Bligh</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>16
<FILENAME>ex99-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">April 17, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Murphy Canyon Acquisition Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4995 Murphy Canyon Road, Suite 300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">San Diego, CA 92123</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consent to Reference in Registration Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Murphy Canyon Acquisition Corp. (the &ldquo;Company&rdquo;)
has filed a registration statement on Form S-4, as amended, with the U.S. Securities and Exchange Commission under the Securities Act
of 1933, as amended (the &ldquo;Securities Act&rdquo;), as of the date hereof. In connection therewith, I hereby consent, pursuant to
Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus included in such registration statement as a
future member of the board of directors of the Company following the effective time of the business combination described in this registration
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
    <P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0"><I>/s/ Faith L. Charles</I></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">Faith L. Charles</P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>17
<FILENAME>ex99-5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
5, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4995
Murphy Canyon Road, Suite 300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92123</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
to Reference in Registration Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &ldquo;Company&rdquo;) has filed a registration statement on Form S-4, as amended, with the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), as of the date hereof. In connection
therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus</FONT>
included in such registration statement as a future member of the board of directors of the Company following the effective time of the
business combination described in this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
    <P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 12pt"><I>/s/ </I></FONT><I><FONT STYLE="font-size: 10pt">Chele
    Chiavacci Farley</FONT></I></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">Chele Chiavacci Farley</P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>18
<FILENAME>ex99-6.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">April 17, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Murphy Canyon Acquisition Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4995 Murphy Canyon Road, Suite 300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">San Diego, CA 92123</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consent to Reference in Registration Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &ldquo;Company&rdquo;) has filed a registration statement on Form S-4, as amended, with the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), as of the date hereof. In connection
therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus</FONT>
included in such registration statement as a future member of the board of directors of the Company following the effective time of the
business combination described in this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
    <P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0"><I>/s/ Jennifer I. McNealey</I></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">Jennifer I. McNealey</P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>19
<FILENAME>ex99-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">April 17, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Murphy Canyon Acquisition Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4995 Murphy Canyon Road, Suite 300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">San Diego, CA 92123</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consent to Reference in Registration Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &ldquo;Company&rdquo;) has filed a registration statement on Form S-4, as amended, with the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), as of the date hereof. In connection
therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus</FONT>
included in such registration statement as a future member of the board of directors of the Company following the effective time of the
business combination described in this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
    <P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0"><I>/s/ Dr. Andrew Regan</I></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">Andrew Regan</P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>20
<FILENAME>ex107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Table </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
S-4 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Murphy
Canyon Acquisition Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Table
1: Newly Registered Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type</B></FONT></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Security<BR> Class Title</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fee<BR> Calculation<BR> Rule</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount<BR> Registered (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed<BR> Maximum<BR> Offering<BR> Price Per Unit</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed Maximum<BR> Aggregate<BR> Offering Price (2)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fee Rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount of<BR> Registration<BR> Fee (3)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; text-align: left">Fees to Be Paid</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center">Equity</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%">Common Stock, par value $0.0001 per share</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">65,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">10.47</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 1%; text-align: left">680,550,000.00</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">0.00011020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right">74,996.61</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">Total Offering Amounts</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">680,550,000.00</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00011020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right">74,996.61</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">Total Fees Previously Paid</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&mdash;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">Total Fee Offsets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&mdash;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">Net Fee Due</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right">74,996.61</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on the maximum number of shares of New Conduit Common Stock, par value $0.0001 per share, estimated to be issuable in connection
    with the business combination (the &ldquo;Business Combination&rdquo;) described in the proxy statement/prospectus forming part of
    this Registration Statement on Form S-4. Such number represents the maximum number of shares of New Conduit Common Stock issuable
    as consideration to the holders of outstanding Conduit ordinary shares (including the ordinary shares issued upon conversion of all
    outstanding convertible debt, which conversion shall have occurred prior to the consummation of the business combination).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for purposes of calculating the registration fee in accordance with Rule 457(f)(1) of the Securities Act of 1933, as amended
    (the &ldquo;Securities Act&rdquo;), based upon the average of the high and low prices of MURF Class A Common Stock as reported on
    the Nasdaq Capital Market on May 9, 2023 (such date being within five business days of the date that this registration statement
    was first filed with the SEC).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    pursuant to Rule 457 under the Securities Act by calculating the product of (i) the proposed maximum aggregate offering price and
    (ii) 0.00011020.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>forms-4_001.jpg
<TEXT>
begin 644 forms-4_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %M 9P# 2(  A$! Q$!_\0
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M1_\ H8KZ0^-'_),K[_KO;_\ HU:Y*R2G&W]:G;0;=.5_ZT/F+[/#_P \8_\
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MM63JG_'RO^X/YFIKI<@\.VY[GJ4?P7\;1Q(AL;4E5 R+M:=_PIKQK_SX6O\
MX%K766GQ1\67=E!<[])3SHUDV_8Y#C(SC/FU-_PLGQ9_SUTG_P  G_\ CM>;
M_:,5I?\  ZGAZ;.-_P"%->-?^?"U_P# M:/^%->-?^?"U_\  M:[+_A9/BS_
M )ZZ3_X!/_\ ':/^%D^+/^>ND_\ @$__ ,=H_M*/?\ ^KTCC?^%->-?^?"U_
M\"UH_P"%->-?^?"U_P# M:[+_A9/BS_GKI/_ (!/_P#':/\ A9/BS_GKI/\
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M_P#C='_"C/&'_/72/_ I_P#XW7M>_P 0?]!2P_\  !O_ ([1O\0?]!2P_P#
M!O\ X[1]<EW_  #ZO3['BG_"C/&'_/72/_ I_P#XW1_PHSQA_P ]=(_\"G_^
M-U[7O\0?]!2P_P# !O\ X[1O\0?]!2P_\ &_^.T?7)=_P#ZO3['BG_"C/&'_
M #UTC_P*?_XW1_PHSQA_SUTC_P "G_\ C=>U[_$'_04L/_ !O_CM&_Q!_P!!
M2P_\ &_^.T?7)=_P#ZO3['B3? KQ@9$;SM(^7/\ R\OW_P"V=._X49XP_P">
MND?^!3__ !NO:]_B#_H*6'_@ W_QVC?X@_Z"EA_X -_\=H^MR[A["GV/%/\
MA1GC#_GKI'_@4_\ \;H_X49XP_YZZ1_X%/\ _&Z]KW^(/^@I8?\ @ W_ ,=H
MW^(/^@I8?^ #?_':/KDN_P" ?5Z?8\4_X49XP_YZZ1_X%/\ _&Z/^%&>,/\
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M#^D3:]<6JV[>5NM5C621AM21,L=PZOG& >.M<7*@CGDC5MRHY4-Z@'&:B7Q
MB.[KK"JTBA'876"RC@ \\BJ_]I6'_/\ 6W_?U?\ &IGKM$"U157^TK#_ )_K
M;_OZO^-']I6'_/\ 6W_?U?\ &L^678"U157^TK#_ )_K;_OZO^-']I6'_/\
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M ($I_C1_;^B_]!?3_P#P)3_&@#1HK._M_1?^@OI__@2G^-']OZ+_ -!?3_\
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M\<KG"DX4'8..<=J3I81=/S*5;&OK^1%_PMSQ'_SXZ+_X#R?_ !RC_A;GB/\
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M?_@&_P#\<H\O5_\ GXTO_P  W_\ CE7J*+^0%'R]7_Y^-+_\ W_^.4>7J_\
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M?CN >F>>*A8;"]_Q+>+QBZ+[O^"=!_PLW3O^A#TS_P "%_\ C-'_  LW3O\
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M8M[:X-M&DMU= 9,%NNYE'JQ. OXD5GSK>WC;WT;2P?6YEWM^B$?K5VUM(K&
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MH.& X*GT(/(/L:L5G)O8I(****D84444 %%%% !1110 4444 %%%% !1110
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M$8([52P=&6TG]Y,L=7CO%?<=I_PD?@3_ *$%O^_Z_P#Q5'_"1^!/^A!;_O\
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MZ+&20H/WA45E\1GO6@9=(,,%Q;1R1332$)YC$!E+8V[5^<YSG]VW XI>T?\
M5Q\IN_V<O_0NM^&H?_7J6W33[)Q--X;FA8'_ %PC6X*^^5+-^E;*LKJ&1@R,
M,JP.01ZBEHYK_P!,+$UI>VU_#YUK.DL><$J>A]#Z'V-3U@:I']C235[8!+FW
M7?+C@3QCEE;U.,X/4'VS6\I#*&'0C(K.2MJBDQ:***D84444 %%%% !1110
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MU.'4)%A>:*-(E#1Y7:J[1D>N!UK9_MSP7_T(C_\ @T?_ !H_MSP7_P!"(_\
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M@0W_ (.9:/[,E_Z!#?\ @YEHY5W_ *^\+G0;6]#^5&UO0_E7/_V9+_T"&_\
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M,D8D6(0L5Y;;M\P?*'[[3BIE@J4;7D]?,N./K3ORQ6GD;O\ ;_PQ_P"A,O\
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M.#@\]*?U.C>W._O)>.KI7Y%]QUG]O_#'_H3+_P#[X3_X[1_;_P ,?^A,O_\
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M%S4__ E/_CU'V2R_Z%S4_P#P)3_X]6[13YG_ $Q6,+[)9?\ 0N:G_P"!*?\
MQZC[)9?]"YJ?_@2G_P >K=HHYG_3"QA?9++_ *%S4_\ P)3_ ./4?9++_H7-
M3_\  E/_ (]6[11S/^F%C"^R67_0N:G_ .!*?_'J/LEE_P!"YJ?_ ($I_P#'
MJW:*.9_TPL87V2R_Z%S4_P#P)3_X]1]DLO\ H7-3_P# E/\ X]6[2,<*3@G
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M3CJKJ5(_ TS)]31]5J?\_6+ZW3_Y]([/_A'O /\ T/DW_?A?_B*/^$>\ _\
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MH71BC)^RQ&:8,<%5! )P?<CBNGB\<2)9-"6O3(R7@+^;U:;'EGK_  X_#M4
M\2Z?/K>J75Y!=_9M0LEMG\HKY@8!,MSP<E#^='/4U]T/9TM/>.8"2LA=5<HO
M5@#@?4U8O]/O--O7L[N%XYT;:5ZY/L1P>O:NFLO%&DZ9HMYIEI;7YCG29 96
M0[MZ@ MV&TCMU_"K5UX\M);Y9TMKV16N&F/G2+NMP83'^Z]#SN^H'UI.I4OI
M'0:I4N76>IQ'E3Y<>5+E/O?*?E^OI3,GU-=1J?BQ+O1[BPMUNE:06Z&>1QOF
M6-6!,F.I.X<<\ 5RU:PE)KWE8QJ1C%VB[BY/J:,GU-)15F8^,GSH>3_K8_\
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MT?5ZW_/UC^LT?^?*.M_X0SPQ_P!%*T;_ +XC_P#CM'_"&>&/^BE:-_WQ'_\
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M_P#X"7%=%O;^\?SHWM_>/YT<R[!9G._VY/\ \_FG_P#@)<4?VY/_ ,_FG_\
M@)<5T6]O[Q_.C>W]X_G1S+L%F<[_ &Y/_P _FG_^ EQ1_;D__/YI_P#X"7%=
M%O;^\?SHWM_>/YT<R[!9G._VY/\ \_FG_P#@)<4?VY/_ ,_FG_\ @)<4Y/'&
MAM%>2RWLEK':0_:':ZB>'=%N*ATW ;@6! QU./44O_";:*&B4W<P,MFMZF8F
MYC894?[Q'1>M+F78=F,_MR?_ )_-/'UM9ZFMKQM0<1?\)#81L3CR[:("0_3S
M&/\ Z#6WO;U8>Q-13P0W49CN(8YD/59%##]:=T*S);'3+:P+O&'>:3_63RL7
MD?ZD]O8<>U7*Y]M^@J+B"1VTY2//MW8MY2Y^^A/( [KTQTQCGH*RDGN6@HHH
MJ1A1110 4444 %%%% !1110 4444 %%%% !1110!\C:=_P @RU_ZXI_(59KJ
MH/!&B16\4<?Q"TAD1 JM]E)R .#Q+4G_  A>C_\ 10-(_P# 4_\ QVO>CF6&
M44G+^OO/FYY;B')M+\3D:U/#FIQ:-K]KJ$R.\<)8E4 ).5('7CJ:VO\ A"]'
M_P"B@:1_X"G_ ..T?\(7H_\ T4#2/_ 4_P#QVB68X62:<OZ^\4<NQ46I);>9
M9M/&UHK6TL]J\4R6K6["VA41Q-O#>9&H*X+ 889']*8_C.UDM9;?[/.D,J7H
MDA4*$9IB#&<=.,>G':H?^$+T?_HH&D?^ I_^.T?\(7H__10-(_\  4__ !VL
M?K>"[_U]YT?5<;V1>U#QMIES9/!%;W?_ ![W$,>]5^02(J@9W$D KR??I7+V
M.I06NA:A8O&[2W,]O(K # $98G/Y\5M?\(7H_P#T4#2/_ 4__':/^$+T?_HH
M&D?^ I_^.U4<;@XJRE_7WDRP>,D[M(T8/'EB-2U.ZN([UUNIV**<,/)*%0A!
M;"X)SW_#K55?&L BAC*W.V 67D@HK"-H5(<A2<<Y_'OBH/\ A"]'_P"B@:1_
MX"G_ ..T?\(7H_\ T4#2/_ 4_P#QVH^M8+N4\-C>R-6#Q9I9_M"]6YOK9R;3
M[K RRE'8L%#,<+C (+'K^%,L/'>EVUQ!.;*YB:-0NR(*5V^=)(4 R.,.!D],
M'BLW_A"]'_Z*!I'_ ("G_P".T?\ "%Z/_P!% TC_ ,!3_P#':7UG!=9#^KXW
M2R1(/&<$=FMO$ER$CMD2-. HE6X\S>.>/EXSU_"N>UZ_CU37KZ_B:9H[B5I%
M\[[P!YVGD].@]A6[_P (7H__ $4#2/\ P%/_ ,=H_P"$+T?_ **!I'_@*?\
MX[6L,=A(.ZD93P6+FK22.1HKKO\ A"]'_P"B@:1_X"G_ ..T?\(7H_\ T4#2
M/_ 4_P#QVM/[3PW\W]?>9?V9B>WXG)Q?Z^'_ *ZQ_P#H8KZAU>TDOM+G@A($
MQ :,MTW*0RY]L@5X=!X+T;[3#GQ]I+#S$.U;8@GYAP#YE>_5YV+Q-.M-2IN]
MCUL#AZE&$HU%NS*L[V._B9T!21#MEA;AXF[JP_KT/458I+S2;2]E69U:.X48
M6>%BD@'IN'4>QR*SIXY+-BK>)(4QVNXXR1^(VUR\T=[V.ZS-*BL;[9_U-6E?
M]^D_^.4?;/\ J:M*_P"_2?\ QRIYX?S(=GV-FBL;[9_U-6E?]^D_^.4?;/\
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M#4BT6VO;/1;2VU&Y^TWD<>V6;<6W'/J>3Q@9/7&:OU5_L_5_^@K;_P#@%_\
M9T?V3>2\7.KS[>ZV\:Q9_'!;\B*-.X:E?5G^T0R:3!A[NZ0H5'_+*-N&=O0
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L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>forms-4_002.jpg
<TEXT>
begin 644 forms-4_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %O 8(# 2(  A$! Q$!_\0
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M)_\ GXN/^_S_ .-'VB?_ )^+C_O\_P#C4=%'LH?RK[D'M:G\S^]_YDGVB?\
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M/,VH25!)R,9*G\JB_MYO^@#KW_@&/_BJ/KM?^;\@^HX?^7\_\SS;_A4FO?\
M04TG_OF7_"C_ (5)KW_04TG_ +YE_P *])_MYO\ H Z]_P" 8_\ BJ/[>;_H
M Z]_X!C_ .*H^NU_YOR#ZCA_Y?S_ ,SS;_A4FO?]!32?^^9?\*/^%2:]_P!!
M32?^^9?\*])_MYO^@#KW_@&/_BJ/[>;_ * .O?\ @&/_ (JCZ[7_ )OR#ZCA
M_P"7\_\ ,\V_X5)KW_04TG_OF7_"C_A4FO?]!32?^^9?\*])_MYO^@#KW_@&
M/_BJ/[>;_H Z]_X!C_XJCZ[7_F_(/J.'_E_/_,\V_P"%2:]_T%-)_P"^9?\
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M^%2:]_T%-)_[YE_PH_X5)KW_ $%-)_[YE_PKTG^WF_Z .O?^ 8_^*H_MYO\
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MO^%2:]_T%-)_[YE_PH_X5)KW_04TG_OF7_"O2?[>;_H Z]_X!C_XJC^WF_Z
M.O?^ 8_^*H^NU_YOR#ZCA_Y?S_S/-O\ A4FO?]!32?\ OF7_  H_X5)KW_04
MTG_OF7_"O2?[>;_H Z]_X!C_ .*H_MYO^@#KW_@&/_BJ/KM?^;\@^HX?^7\_
M\SS;_A4FO?\ 04TG_OF7_"C_ (5)KW_04TG_ +YE_P *])_MYO\ H Z]_P"
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M- $E%1^8_P#SQ?\ ,?XT>8__ #Q?\Q_C0!)14?F/_P \7_,?XT>8_P#SQ?\
M,?XT 245'YC_ //%_P Q_C1YC_\ /%_S'^- $E%1^8__ #Q?\Q_C1YC_ //%
M_P Q_C0!)14?F/\ \\7_ #'^-'F/_P \7_,?XT 245'YC_\ /%_S'^-'F/\
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M6%<^,_#5G<2V]QK=C'+"Q216E&48=0?3%;&^;_GD/^^__K5YBY;^Q?$&>/\
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M %Z6G_H4])XP\S^W/#V\*/WEQT/_ $RI/"V__A*=9V!3_HEIG<?]J>OBI_\
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MF8QEQO&4!]?3\:<.M>>_V7=6>MZ[/'X7DO8)1N,<XC/G.7#+M<$%TSEBK#@
M#VH ] $B$H!(A+C*X8?,/4>M*K*^=K*V#@X.<'T^M>?6OAZ\1D$6E3I/))#)
M;W<D<<8L2LCM* H8F-3N^55SD'!Z5M>$],GL)96;3&T]!:002(2O[^=-V^7Y
M2<@Y'S'D_A0!KV'_ "/=S_V"H?\ T=+7DOQ1_P"2CWG_ %ZV_P#[-7K%GO\
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M?QC/VL]?^N3TL+_ J^@8O_>*/J?2E>)?&;_D;=-_Z\&_]&5[3B;^]'_WR?\
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MEM^3_P "KNP'\=?,\_,?]VE\OS/5OAG_ ,DXT/\ Z]__ &8U+\1?^2=>(/\
MKRD_E5;X:HY^'.AD2L!]GZ #^\?:I?B&CCX=Z^3*Q'V*3@@>GTKC?Q?/]3N7
MPGCG@#_DHVA?]=I?_1,E?1M?./@($_$70P"0?.EY'_7&2OHKRW_Y[/\ D/\
M"N[,?X_R1Y^6?[O\V>$?%G_DH3_]>$'_ *%+7H7PC_Y)[:_]?-S_ .CGKSSX
MK@CX@."Q;_0(.3_O2UZ!\)48_#ZU(D91]IN> !_SV>G6_P!TI^K_ %%0_P!\
MJ>B_0W/'7_(@>(?^P=/_ .@&O#/!'_(_>'_^OL_^BI*]O\<HX\!>("96/_$N
MGXP/[A]J\/\ !()\>^'P#C_2SS_VR>EA?X%7T#%_[Q1]3Z4KQ+XS?\C;IO\
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M7O\ L(W'_HQJ*H1]->$/^1)T#_L&V_\ Z+6MFL;PA_R).@?]@VW_ /1:ULT
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MWG_75'4_!?\ Y%*__P"PE)_Z+CKN=8_Y E__ ->TG_H)K@_@U'O\)WYWNO\
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MIZO_ -]G_&OEC1AG5M)'_40M_P#T>M3@]JG^$K';T_\ $CZKKR7XV_\ ,O\
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M]"-=OX8A4^$]&.7_ ./&#^,_\\UKCR;_ 'O%_P"+_,UQ/\.GZ%+QW_R+\/\
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M;2QY)X !_P"%C:%P?]=+_P"B9*^C*XI? ?A2-PZ>'K%'7HRH01]#FIO^$/\
M#W_0(A_[Z?\ ^*K?$UO;5.>UCGPM#V%/DO<\T^+(/_"P7X/_ !X0?^A2UZ%\
M(P1\/;7(_P"7BY_]'/4DG@3PK*^^7P_92/C&YU+''U)I\?@KPU"NR+1+:-1S
MM3<H_(&G.OS48T[;"AA^6M*K?<T?'0SX!\0X_P"@=/\ ^@&O#/! /_"?>'^#
M_P ?9_\ 14E>QMX,\.2(4?1K=T88*L6((]QFHE\!^$T<.GAZQ5EY#*A!'T.:
M*5?V=.<+?$%;#^TJ0G?X3M:\2^,H)\6Z;Q_RX-_Z,KOO^$/\/?\ 0)A_[[?_
M .*J*7P+X6F8--H%G(P& 9%+$#\344*GLJBG:]C2O2]K3<+VN9OP7X\)7_\
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M_4)G_P#0&K>L_P#CQM?^N*?^@BL@>"O#*Q^4-$M1'C&SYMN/3&<8K=4!0JJ
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M(6SP^_G;C(/S>]=!_;]O_P! _6O_  5S_P#Q-']OV_\ T#]:_P#!7/\ _$T
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M#$ ^I..:?-HMI:/K^IG0&FW[;>&TM8]KW"#:S,<==SGD_P!U/P.U_;]O_P!
M_6O_  5S_P#Q-']OV_\ T#]:_P#!7/\ _$T <<='NC:0"+3+UY&B/V/$+1)8
MW!FWMA6.40+MP3U"D=\5H:UHUUY.J1Q07<\$VJQ7!9D-R6C$0R?+)'F+N&-O
M0=<<5T/]OV__ $#]:_\ !7/_ /$T?V_;_P#0/UK_ ,%<_P#\30!R4.G7CRZ;
M =*OK74;>S4'42CN6D\ME2/?DA$&06SWX[9J6VT6=])N1;:=?V,2R63):LQ0
MR3(P\URH/S#&,GHQ4GGK74?V_;_] _6O_!7/_P#$T?V_;_\ 0/UK_P %<_\
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M /%4?\)%KW_0P:Q_X'R__%5FT57L*7\J^XGZQ6_G?WFE_P )%KW_ $,&L?\
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MED\U9 <RAUV[F!Y!W''(Q4KDO;V:^[U\BW[2U_:O[_3LSDO^$CU[_H8-8_\
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M_P#BJS:*/84OY5]P?6*W\[^\Q;SQ]XOAO9XD\3:L$21E4?:W. #]:*YW4/\
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M\*/K]?O^"#^SL/\ R_BSRG_A6/BW_GVT[_P-_P#L*/\ A6/BW_GVT[_P-_\
ML*]6_P"$BA_Z!6N?^"R7_"C_ (2*'_H%:Y_X+)?\*/K]?O\ @@_L[#_R_BSR
MG_A6/BW_ )]M._\  W_["C_A6/BW_GVT[_P-_P#L*]6_X2*'_H%:Y_X+)?\
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M9XO[I_[Z-$%S!<J6MYHY5!P3&X8 _A4M $7V>+^Z?^^C1]GB_NG_ +Z-2T4
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M5%P%P/\ 5CTKU&:2>&"24B,A%+8YYP*\R^"7_'IKW_7S%_Z+%>G7W_'A<_\
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M?^O67_T$UYU:_P#'GX3_ .OJS_\ 0#7Q^;_[UA/\?Z'N8?\ AU/0]/\ W_\
MTS_6N)UK?_PG<N_;G^S(NG_762N[KAM=_P"1\D_[!<7_ *-DKHS[_D75/E^:
M)PG\:)?\#>;_ &'<[=F/[1N^N?\ GLU6?&GG?\(1KF?+Q]AFZ9_N&H? G_(!
MN?\ L(W?_HYJM>-?^1&UW_KPF_\ 0#7H87_=H?X5_P"DHPG\;]?U.6N,_P!K
MZ!MQG^TDZ_\ 7.2O0?W_ /TS_6O/Y_\ D,:!_P!A)/\ T7)7HM>)PS_N'_;S
M_0Z\=_&^1Y_=[O\ A-M:W8SY5KT_W7K8\#^;_P (U\NS'VR[ZY_Y^)*R+W_D
M=]:_ZY6O_H+UM^!/^18'_7Y=_P#I1)2P/_(WQ/HOT"K_ +M#YD?COS?^$/N]
MVS'F0=,_\]DK&BW?\)CH&W&?-N.O_7%JW?'O_(FWG_76#_T<E8</_(Y>'_\
MKK<?^B6IYC_R-<+\PH_P*AW?[_\ Z9_K7!R[O^$TUW=C.ZVZ?]<A7H-<!/\
M\CKKW^];?^BJUXC_ .1=/UC^9&#_ (R^8_3?-_X4R^-FW^R9_7/W'KH;/_CQ
MM?\ KBG_ *"*P=,_Y(L__8)G_P#0&K>L_P#CQM?^N*?^@BO>A\*]%^2.5[GR
MEXP_Y';7O^PC<?\ HQJ*/&'_ ".VO?\ 81N/_1C450CZ:\(?\B3H'_8-M_\
MT6M;-8WA#_D2= _[!MO_ .BUK9H *Y>QUO5Y=?U.PN$M-RHS6,)5E#A3U\T%
M@PP06& 0>U=15"UT73++4;G4+6RABN[G_72JN"WK],GDXZGK0!FR:IJ\_A'3
M;ZQMTDU&\$.Y8T#*NX9<JK.N< ' +"LBX\97T.G2:I%]GGM+40QRQ/"8Y99'
M4DD?,0@5L#'S9PW/2NGET'2YX?)FLHY(/+2-86SL54)*[1V(R>1S3O[#TD7$
M$_\ 9MKYL$?E1-Y8^1,$;0.F,$C\3ZT 0:+>WL\U]9Z@]O+/:M%^]MT**P=
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M^#7!3-N\::Z0"/FMNHQ_RR%>@UP$_P#R.NO?[UM_Z*K7B/\ Y%T_6/YD8/\
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MGZ([K6_^0!J/_7K+_P"@FO.K7_CS\)_]?5G_ .@&O0=:@C&@ZB0#_P >LO\
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M4_Y$[0_^P?!_Z+6O _'^?^$\\1;B"?.7I_UPCKWCPJ)O^$/T3#)C[!!U4_\
M/-?>N_$_P:7H>=A/X];U.;^,7_(C+_U_0?\ H5<E\&?^1JU3_KQ3_P!&&NJ^
M, D_X0==S*1]N@Z+C^+ZURGP;W?\)5JFP@'["G49_P"6AHI_[I/U05/]]AZ,
M]MKY=\6?\C+XD_Z_KG_T(U]/8F_OQ_\ ?)_QKY@\5Y_X23Q)GK]NN>G^\:K+
M_P"*_1DYE_"7JCZ1\._\BSI7_7G#_P"@"N%^-?\ R+VD?]A$?^B9*[;P\)O^
M$:TK#)C['#U4_P!P>]<-\:!)_P (_I.]E(_M'L,?\L9/>N3#_P 6/JCLQ/\
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MPY_;']JZ9JUO]H>(Q?\ $NG;<%4@]%/K24H_5.6^MQN$OKG-;3E/8J^5+/\
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MK;.J<ZF!J0@KMVT7JB<+)1JILZ/P)_R ;G_L(W?_ *.:K7C7_D1M=_Z\)O\
MT U@>$_$%MIFDS07=GJT<C7MQ*!_9EP<JTK,IX3N"*G\4>)+/4?"NK65K::M
M)<3VDD<:?V7<#<Q4@#)3%=^'36'@GORK\D93?OOU,^?_ )#&@?\ 823_ -%R
M5Z+7EDVIJVI:1,NGZL4M[Y993_9L_P JA'&?N>I%=I_PF.F?\^^K?^"JY_\
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MXP_Y';7O^PC<?^C&HJA'TUX0_P"1)T#_ +!MO_Z+6MFL;PA_R).@?]@VW_\
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MT9/7  ]\D"@ O;Z#3[8W%S(4CW!1M4LS,>  H!))] *EBE2:)9(W#(PR"#7
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MY&:Y72-$6_DOH)8M0M[:.=X)7>3B[5)28U(8$L%4*/,!!Q\N3CA?^%K^"/\
MH-_^2DW_ ,12_P#"V/!'_0;_ /)2;_XB@#LR<DD]37'^)--=;V"X>*]U'[9<
MM%]GA=E"IY1*+UVIMD4/YG!!_6/_ (6OX(_Z#?\ Y*3?_$4O_"V/!'_0;_\
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@157Q+J5I?>*M8N[:7?!/>S2QOM(W*SD@X(R.#10!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>forms-4_003.jpg
<TEXT>
begin 644 forms-4_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %< 6X# 2(  A$! Q$!_\0
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M )[S?]_6_P ://G_ .>\W_?UO\:CHH]G#^5?<@]K4_F?WO\ S)//G_Y[S?\
M?UO\://G_P">\W_?UO\ &HZ*/9P_E7W(/:U/YG][_P R3SY_^>\W_?UO\://
MG_Y[S?\ ?UO\:CHH]G#^5?<@]K4_F?WO_,D\^?\ Y[S?]_6_QK*U^_O;:P1X
M+VYB<R@%DF8'&#QUK1K&\2_\@V/_ *[#^35AB*<%2DTEMV.C"U)NM%.3W[L]
M9T'X40WWAS2[LZ]<QF>SAE*"U0A=R XSGGK6A_PIZ#_H8KK_ ,!(_P#&NS\)
M_P#(F:#_ -@ZW_\ 1:UL$@ DD #J37@+$UE]IGTCPM!Z\B^X\T_X4]!_T,5U
M_P" D?\ C2_\*=A!P?$-W_X")_C7HID2:"4PR;\!ES"P)# =!VW#W[UP>CVN
MI/X8U*&+^U$:*]C:*1O,22X_>#>"KDD8_BVG:?SI_6:W\S%]4H?R+[BK_P *
M>@_Z&*Z_\!(_\:7_ (4Y#_T,-W_X")_C72:_-K%WJ6GMI4#26$%_&)S',8V+
M"3#!EV\Q@<\'!^@KGA;:ANB^T6^N-9^4?[053+O>\P^UDP<E<[>5^7[GH<'U
MFM_,P^J4/Y%]Q'_PIZ#_ *&*Z_\  2/_ !H_X4]!_P!#%=?^ D?^->@V)N(]
M)M3>Y-TMNAGYY+A1N_7-4-/N?$>I:;:W\.FZ4L5S"DR*]])N"L 0#B+KS1]9
MK?S,/JE#^1?<<;_PIZ#_ *&*Z_\  2/_ !H_X4]!_P!#%=?^ D?^-=WY?BC_
M *!^C_\ @?+_ /&:/+\4?] _1_\ P/E_^,T?6:W\S#ZI0_D7W'"?\*>@_P"A
MBNO_  $C_P :/^%/0?\ 0Q77_@)'_C7=^7XH_P"@?H__ ('R_P#QFCR_%'_0
M/T?_ ,#Y?_C-'UFM_,P^J4/Y%]QPG_"GH/\ H8KK_P !(_\ &C_A3T'_ $,5
MU_X"1_XUW?E^*/\ H'Z/_P"!\O\ \9H\OQ1_T#]'_P# ^7_XS1]9K?S,/JE#
M^1?<<)_PIZ#_ *&*Z_\  2/_ !H_X4]!_P!#%=?^ D?^-=WY?BC_ *!^C_\
M@?+_ /&:/+\4?] _1_\ P/E_^,T?6:W\S#ZI0_D7W'"?\*>@_P"ABNO_  $C
M_P :/^%/0?\ 0Q77_@)'_C7=^7XH_P"@?H__ ('R_P#QFCR_%'_0/T?_ ,#Y
M?_C-'UFM_,P^J4/Y%]QPG_"GH/\ H8KK_P !(_\ &C_A3T'_ $,5U_X"1_XU
MW?E^*/\ H'Z/_P"!\O\ \9H\OQ1_T#]'_P# ^7_XS1]9K?S,/JE#^1?<<)_P
MIZ#_ *&*Z_\  2/_ !H_X4]!_P!#%=?^ D?^-=WY?BC_ *!^C_\ @?+_ /&:
M/+\4?] _1_\ P/E_^,T?6:W\S#ZI0_D7W'"?\*>@_P"ABNO_  $C_P :/^%/
M0?\ 0Q77_@)'_C7=^7XH_P"@?H__ ('R_P#QFCR_%'_0/T?_ ,#Y?_C-'UFM
M_,P^J4/Y%]QPG_"GH/\ H8KK_P !(_\ &C_A3T'_ $,5U_X"1_XUW?E^*/\
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M2"*Z??<QVJK*V<Y<)ACGOSGFIO"HE_X0_1,.F/L$'\/_ $S7WH VZ*CVS?\
M/1/^^/\ Z]&V;_GHG_?'_P!>@"2BH]LW_/1/^^/_ *]&V;_GHG_?'_UZ )**
MCVS?\]$_[X_^O1MF_P">B?\ ?'_UZ )**CVS?\]$_P"^/_KT;9O^>B?]\?\
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M ,C&OI[[/$?X!58OX:?^$6"^*K_B/'OC5_R'=$_Z]9__ $..N@^#'_(H7O\
MV$9?_0$KG?C.BIKFB;1C_19__0XZW_@W$C^$;PLN3_:,G_H"4Y_[G'U9,/\
M?I?X4;GQ-_Y)QK?_ %P'_H2UY9\+O^2BV?\ U[7'\EKU#XEPQK\.=;*K@^2/
M_0UKRWX8*&^(EF&&1]FN/Y+2H?[M4^0\1_O5+YGT#7RUXN_Y#_B3_K^NO_0V
MKZ@^SQ?W!7R]XL 77O$8'07UU_Z&U/ ?'+T8LQ_AQ_Q(^HH/^/>/_='\J\G^
M-O\ KO#W_;S_ "CKU2&WB\B/Y!]T?RKRGXU1I'-X?VC&?M/\HZPPG\:/J=&,
M_@3]#9^#'_(H7O\ V$9?_0$KH_'O_)/O$'_8/F_] -<S\&XD?PC>%ER?[1D_
M] 2NB\>01KX \0$+S]@F_P#0#45OXLO7]2Z'\&/HOR/)?A;_ ,E%L_\ KVN/
MY+7T!7S]\+U#_$.S##(^S7'\EKWS[/%_<%=&/_COY'-EW^[1^?YGS1XW_P"1
ML\3?]?4O_H KZ-T/_D :;_UZQ?\ H(KYQ\; #Q9XE Z?:I?_ $ 5]%:)!$=
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M=_R)-G_V$8__ $7)7T)QG8^$_P#D3-!_[!UO_P"BUK8K'\)_\B9H/_8.M_\
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M2R*3_:,O4?["5T7CR*,?#_Q 1&@/V";H/]@U%;^++U_4NA_!CZ+\CR3X6_\
M)1+/_KVN/Y+7O^1ZBOG_ .%ZAOB)9A@"/LUQU^BU[]Y,7_/)/^^171C_ .._
MD<V7?[M'Y_F?,OC?_D;/$W_7U+_Z *^C=#(_L#3>1_QZQ?\ H KYR\; #Q9X
ME &!]JE_] %?1>B0QG0-.)C0_P"BQ?PC^X*>*_A4O06#_BUO4\U^-A!F\/\
M/_/S_*.KWP5(&A:QS_R__P#M&.L_XUHB3>']JJO_ !\]!CM'5[X+1H^AZP61
M3_IXZC_IC'3?^YK_ !"7^_/_  G6^/B/^%?>(.1_QX3?^@&O&OAO_P E'T?_
M +;_ /HEZ]C\>Q1CX?\ B B- ?L$W0?[!KQSX<J&^(VCA@"/W_!_ZXO1A_\
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M?^*7Z&^-_B_)'GTG_(;\1_\ 7[_[0BKJ_"1'_"&Z'R/^0?!_Z+6N3<!=:\1
M  ?;>@_ZX15U7A.&(^#=#)C3/]GP?PC_ )YK1E7^_P"+_P 2#$?P:?H97C$@
MZUX?Y_CN/_1=)X/(&OZ_GTMO_0&I/&"(FM>']JJOSW'08_Y9T>$41]?U_<H;
MBVZC/\#4W_R//^X8O^87YG2ZN1_8U]R/^/>3_P!!->>:7]WPA_UWA_\ 2=Z]
M!U:&(:-?8C3_ (]Y/X1_=->>Z8 R^$ 0"//@Z_\ 7N]5FW^]X3_&_P @P_\
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M\*Z#P]XDM;#PSI5G<V>K)/!9Q12+_9DYVLJ $9">HJ[:ZQ8WES);PW*&5'9
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M(CJF4 0@"/(;*GJ3T'4@%?PWI:ZC'!J$T$L$D4ZRSRRPA7NYTRN_)Y4#&#@
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M ',_;=6_Z%F^_P# FW_^+H^VZM_T+-]_X$V__P 77344 <S]MU;_ *%F^_\
M FW_ /BZ/MNK?]"S??\ @3;_ /Q==-10!S/VW5O^A9OO_ FW_P#BZ/MNK?\
M0LWW_@3;_P#Q==-10!S/VW5O^A9OO_ FW_\ BZ/MNK?]"S??^!-O_P#%UTU%
M ',_;=6_Z%F^_P# FW_^+H^VZM_T+-]_X$V__P 77344 <S]MU;_ *%F^_\
M FW_ /BZ/MNK?]"S??\ @3;_ /Q==-10!S/VW5O^A9OO_ FW_P#BZ/MNK?\
M0LWW_@3;_P#Q==-10!S/VW5O^A9OO_ FW_\ BZ/MNK?]"S??^!-O_P#%UTU%
M ',_;=6_Z%F^_P# FW_^+H^VZM_T+-]_X$V__P 77344 <S]MU;_ *%F^_\
M FW_ /BZ/MNK?]"S??\ @3;_ /Q==-10!S/VW5O^A9OO_ FW_P#BZ/MNK?\
M0LWW_@3;_P#Q==-10!S/VW5O^A9OO_ FW_\ BZ/MNK?]"S??^!-O_P#%UTU%
M ',_;=6_Z%F^_P# FW_^+H^VZM_T+-]_X$V__P 77344 <S]MU;_ *%F^_\
M FW_ /BZ/MNK?]"S??\ @3;_ /Q==-10!S/VW5O^A9OO_ FW_P#BZ/MNK?\
M0LWW_@3;_P#Q==-10!S/VW5O^A9OO_ FW_\ BZ/MNK?]"S??^!-O_P#%UTU%
M ',_;=6_Z%F^_P# FW_^+H^VZM_T+-]_X$V__P 77344 <S]MU;_ *%F^_\
M FW_ /BZ/MNK?]"S??\ @3;_ /Q==-10!S/VW5O^A9OO_ FW_P#BZ/MNK?\
M0LWW_@3;_P#Q==-10!S/VW5O^A9OO_ FW_\ BZ/MNK?]"S??^!-O_P#%UTU%
M ',_;=6_Z%F^_P# FW_^+H^VZM_T+-]_X$V__P 77344 <S]MU;_ *%F^_\
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M>UIDM'&G7&V[($!Q]\D9'TR!D9ZBDL!3?VQO,:J_Y=GO'_"P?"/_ $,6G_\
M?X4?\+!\(_\ 0Q:?_P!_A7@\OA[68(IY9+"94@R93D':!C)X/(&1G'3/-/G\
M,Z];/ DVEW2M</Y<0VYW-C../;GZ4_[/I_S_ )?YB_M*K_S[_/\ R/=?^%@^
M$?\ H8M/_P"_PH_X6#X1_P"ABT__ +_"O!9-!U>&62*2QG5XWCC8''#2?<'O
MGMBKDGA+5X+)+J>+RXWBFDP/F9?*X8,!TZ'\J3P%-?;_ "_S!9C5?_+O\_\
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MFDD,JEBDFX #Y=[YZ=1BN4T/4?['URRU$Q&86THD*;L;L=LU[#_PK7PC_P!
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M@K<?^#27_P"+I/,M,Y_M6XR/^HI+_P#%T?V55_F0?7(=F>K?\(_JO_0SW?\
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M (-)?_BZ026@Z:K<#_N*2_\ Q=']E5?YD'UR'9GJW_"/ZK_T,]W_ . EO_\
M$4?\(_JO_0SW?_@);_\ Q%>5>;:_]!6X_P#!I+_\71YMK_T%;C_P:2__ !='
M]E5?YD'UR'9GJ2Z!JQ=A_P )->8&/^72W_\ B*?_ ,(_JO\ T,]W_P" EO\
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M8[#_ (1W0_\ H#:?_P" J?X5&WA[1!-&/[&T[!!_Y=4_PKD_^%CZA_T+B?\
M@P'_ ,133\1=0+JW_".)\N?^8@/_ (BCZGB/Y&'MZ?\ ,=E_PCNA_P#0&T__
M ,!4_P */^$=T/\ Z VG_P#@*G^%<?\ \+'U#_H7$_\ !@/_ (BC_A8^H?\
M0N)_X,!_\11]3Q'\C#V]/^8ZR7P]H@V8T;3N6 _X]4_PJ3_A'=#_ .@-I_\
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M;?3+*&5,;7CMT5AQV(&:TJB3_7R_A_*I: "N9F_Y'NZ_[!</_HV2NFKF9O\
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M[:>?&?M4'0_\M![>]'U[$?SO^OD'U>E_*<+_ ,*\UG_H-V'_ ( O_P#':/\
MA7FL_P#0;L/_  !?_P".UZ%'<03$B*:-R.2%8&I*?U[$?SO^OD'U>E_*>;O\
M/]93;_Q.K#DX_P"/%_\ X[3O^%>:S_T&[#_P!?\ ^.UZ#-_RS_WQ4M'U[$_S
MO^OD'U>E_*><_P#"O-9_Z#=A_P" +_\ QVFO\/M91=W]M6'4#_CQ?_X[7I%1
MS_ZH_4?S%'U[$_SO^OD'U>E_*>>_\*\UG_H-V'_@"_\ \=H_X5YK/_0;L/\
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MT#3[&*%+&XG ENVD=BL!095<J<L=^T@]PISUQ4-S-XDOTDMFM+RW^TP$LZ;
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M_P" ?_V-&- _Y]+7_P  _P#[&OH&BO0_M27\B.;ZHOYF?/N- Z?9+7_P#_\
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M_P!6OT% #J*** ([?_CWC_W14E1V_P#Q[Q_[HJ2@ J.'H_\ OG^=25'#T?\
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M+CRQ+D*/N' ST]QQUY%7_LMO_P ^T/\ W[7_  H D_X2GP]_T'M+_P# R/\
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JAI'_ 'ZE_P#CE<[XR^)FL^*=&BL;VUT^.)+A9@8(W#9"L.[GCYC0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>forms-4_004.jpg
<TEXT>
begin 644 forms-4_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $Z BT# 2(  A$! Q$!_\0
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MU?3M5@^WZ@7O[R[U1;F,6@)<(%\XG>2%4D+R"<DUZ3_PANE_\_6N?^#V]_\
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MPMS<S74-W()&4 ,6??N5FS@ # /1>@Z;_A#=+_Y^M<_\'M[_ /'J/^$-TO\
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MME#")5(=47)"$E<-@D>U9,OAKXBR0HL[W5S>6K!XIC?CR&58OE0)N!+ESR[
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MULEPAD!]USFKT<D<J[HW5U!*Y4Y&0<$?@0169H.HHHH **** "BBB@ HHHH
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M>1O7=(.<%R01\G!W4".JHHHH *1UW(R\<C'(R/RI:CN&=+:5XEW2*A*KZG'
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M0/, )$SCK@$^G450:ZO;.TAU-+E7MC8H6EN=1DC3:I'+ AE53_SUY8ACGH*
M.V@C\F".+.[8H7/K@5)4<$GG6\<N-N]0V/3(J2@ HHHH *R#I=\NI//'?0"W
M&YX86MR2DC<,68.-R]<# (SU-:]<Q'?6EOXGG\S4V6Z!<W-O+='9%"!\C^66
MVH"<?,!SD\GL 6+70+J*;4Y9+NSC:^//V*R,/!/+/EVWR;>-W'T[5O*H10J@
M!0, #M7G)U.2:WUT7-[;0R1RK)<-)K\L*QJ'($;E5_T4XQC9DOCGJ37;Z%)/
M+H5G)<[O-:($[BQ..V2P#$XQR0#Z@4 :%%%% !67J>F7-[/&UO=QP1L ERKP
MES)'G.%(8;#UY^;@]*U*YOQ'<0P7]KYU]+;38'V*-;AHQ/,6Y4J"!)QCY3G@
MDX[@ VDM93<P7$TR-)$DB'9&5!W%2.I.,!?Q]J=9VQM8-CR>9(S,[OC&23GI
MV'8>P%<[?:MH\WBFRMX==1-0\MF$(U$+&Z88;?*W8=BP)SM)78>1P"[P-=I<
MZ1,$F@N DN&N+?5I-1C=MHSB60 CW4# S[F@#J**** "BBB@"A-K6GV\%_-+
M/MCL/^/DE&^3Y0W Q\W![9].M7E8,H8'((R*P-1T&YNWNA')"([G?YBMGYOE
M'E]NS9)]JRCX.O6\2:E?/*C07=L8MXE1'&55=AVPARHP2"93@]%'8 ZG4[>U
MO+%[6\:589B(SY4KQL<G@;D(89^M,O;^RT*PC>82) N(XXX('E;IP%1 6. #
MT' &>@K!7PC]GEOH=.L]/TV.9D:*_M JW"J&!*;?+P .<?,>3T'6I=4T74[C
MPY:6-K;V*31,2\<-RULG0X97$;D<G)4J0<D$L,[@#;O=6L]/LTNIY',<A C$
M,32O(2,X1$!9C@$X / )Z"I[2ZCO;6.XB654D&0)H7B<?5' 8?B!6(+3Q +*
MVG==-EU&VE8K&)'CADC*XQG82A'T;IVW<06>D:G'K<FJRZ;I,5TZ$O-%<NTD
MI( \IF\H?(N,@\]!\HY- '1SW$5M&'F;:I=4!P3\S$*!Q[D5+6=J5K<:C8&%
M46)Q<1L-[9RJ2!L\>H' ^E<_+X+M[:2UDL=(TF9%$9N;><;$FD&?WI(1MSC.
M02,G/4=: .NBB2"/9&NU<DXSGDG)_4U%?64.HV4MI<&7R91AO*F>)L?[R$,/
MP-2PF5HP9D1),G*HY8=>.2!V]J?0 R*)(8DBB0)&BA551@ #@ 4^BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ JC/J]G;:C#82O*L\P)0^2YCS@G!DQL!P
M"<$@FKU9%S'K$GB&V=;>S?2HUR6:Z991(<@ML\LAL# 'SCJ2<\8 'R^(M,BT
M^.^\Z62WDD:-&AMY)2Q!()"JI.T8)W8QCG..:LM>V5M/;6WF(LETS&)$7.\X
M+$\=![GC)'<BL;6=%U&ZTY(;1;>5Q<RRE)+EH!ABQ!WJC'C(RN,-R"2,@ZOD
M7$PLS(%5K>;+<_? 1ER .F2<X]*!D;>(-.6.]D,DWEV;!)7%M(59B<;8SMQ(
MV?EPFXYXZ\5?@F6X@CF0.%D4,!(A1@#ZJP!!]B,UQQ\)ZD(KZ)9"8S(LD*_V
MM<+YY#$Y) _T?@X_=YSU[5U.E6\]II5M!<OOF1 &)E:3\-[?,V.FX\G&3UH$
M7**** "BBB@"KJ&H0Z;:FXG2Y= 0,6UM)._/^S&K-^.*JP>(-/N9[2*,W0:Z
M3S(F>SF1<<\,S* K<'Y6(;VJ[>)/):2QVSJDS+M5VZ+GO^'6LBZTV^;6[&2V
MM[=;.TCPLC7LN>A&WR-FST&_.X G [$ U)-1M(KW[&\P%P(C,4 )P@(!)].O
M&>O..AI+'4K;48DDMVDPR;]LD3QLHR1\RL 5.0>" >*1K:2>YMYIEC 6!TE0
M,6&6V\ X&1\IYX^E9>G:#-INJPRPNYMA&X??>RN<D\#:V0_&#O8Y!!Q]XT =
M!1110 444R99&@D6%UCE*D([+N"GL2,C/TR* ,ZY\1:9:Q7$CS2NMM-Y$WDV
M\DI1MH8Y"*3@ C+=!W(J:\U>RL'MEN'D'VA@J,D+NHR0 6900@)(&6(%<Y'H
MWBFQLKF&*;2+TW%PC.%\VS_=",*PR?..25 /MDY!(QJZA'KTUS9I;V>G&S23
M=.K7KHQ QMQB$Y .3C*Y(7G!(H T+35;2^8K \FX.R8>%T)*XR0& RO(PW0Y
M&":N5SP\/RV^K0W5HSB/[07D#7LORKCLO(8=1L.% ((Y45T- !1110 5GOKF
MFQVMW<M=+Y-HYCF<*2 P .T<?,>0/ESSQUXK0K/FL99(-40,F;L'9DGC]V%Y
M_$4 3WM_;Z?9M=7!D\I<<11-([$\ !%!9C[ &J\>N:?+,(TED),2R@F!PI#$
M  ,1C=DCY<[AD9 S1?Q7[PYM8K9I8&62 2S,JR'!!#$*=HYX(#?2LBY\,S2V
M8D7_ (_O)(94O988V<MD@%1\G4C>%W=/04 =114<"ND$:2-N=5 9L]3CFI*
M"BBB@ JE%JMG-J<NGH\GVB(9;,+A#TX#D;6(R,@$D9YJ[6(;+4TU1G2*S>UB
M9YH6:9E=W?@JPV$*!D\@G/' H F;Q'IB?;-\LRFTQY@:VE!;)P/+&W]YD\#9
MNR>!S6C!,MQ!',@<+(H8"1&1@#ZJP!!]B,UR]WI.NZG%?B]@LU8RJ]L8-3EC
M+(I.$++$K1<')92YW$]@ .@TJWGM-*MH+E]\R( Q\UI,>V]OF;'3<>3C)ZT
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M$(N,MC:VY20/]W!R1SVK<K.U+^Q3>:>NJ?8#=>;FQ%ULW^9C_EGNYW8_N\T
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M]9AP?-&<#8NS+'.>"O85DW3:NFN6JPWEC]AD)WV[6CF7 '+"3S !SM'W#UH
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M+=@DL\F/,-G+=;% R3Y46&;L.H SD],&/5]?:SU'3;>&9$AGQ)+,;.6X!3(
M'R8$><G]XYVC'0YX8$2:7J%EK$$T$UY+ T[!L^1A(\#AN =G  VY?*IDD;JZ
M6N=T[Q!,]_\ 8[X$2-.Z K8S1@?W0<Y'J/,)"L<8^\!714@"BBB@ JAJRS"U
M2:"U>Z>"19?(1E#28[*6(7/.1D@<=:OUEQW]VJZAY\4)DBG$=O'$3\P*J5W$
M]\G)(' ]<9(!46.]AT>#_B6322VSK/\ 9U>/+Y).Q27QN7(ZD#(X-4+C1=1%
MBEQ U[',(2YM8# 2K[@0$W@KO Q]YBF4'O6O%>WMQX6@OOM%G:W3VRRR331L
MT,9V@L=NX$CK_$/K6:WB'4+.6/[?$ K6J.5BL9FP^1N(89W<9Q&!N! R3N%
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M* ,J_P##.AZK8I9ZCI5I>01[MBW$0D*ENI!;)!/KG--E\-:=--:RL;M&M,B
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M&<YSF./'3<1U6_MO$-W+HTUC::A8PQ2D7$3M&TFXL"9'\NZ5&4C=P?,Z_<H
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M07<EPHM[%[E;B,0F170"W^;.]MS D?[N3D#CO0!KF>)9U@,J"9U+K&6&XJ,
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M&'SY8'#!XYHMI>-AT8;@5S]010 V+44;1XK\F&021*X^S2^:CE@,!'P-P).
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MB:5U4E8U(!8^@R0.?>GUG7>JM:7\-M_9UY*DH($\83RP^"0ARP;)QUQM]2*
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MEG5%U"W6Q65;CR_LA,ID"[2?,WXQCMMR.F<<5!<ZS>WOA;3I+%)[V]OD#DV
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MP^V;KK89!$(S93"9F(S@1;-YXR<A<8!/0$U=N;NSTV*-YF6%)9EC7"GYI';
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MU!+&:203,F_(@<H!@G!<#:I.#@$@G' J2QU*VU&))+=I,,F_;)$\;*,D?,K
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MT2PNSW<=OL)%[/"LCYR>06*9Y^<9?IR<"@#JJ*C@5T@C21MSJH#-GJ<<U)0
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M- %55& H'0 4 .HHHH **** "BBB@ HHHH **** *&K/<QVT+VTXAQ<1"3Y
MQ92X!49X&<]<'C.,'D5M9M[N2ZLFM=8O+-FE5/(A2$I+SN;=OC9ONAOND5:U
M74;+3;3SKX2&'<.([=YB,<[BJ*2 ,9W8P/44AFTZUN[:(L@N+IG,/!9FR-S'
M/.!P.>G0>@H R-3OM4M;'44BEFGN&O$AA^S11AXT95.$$AV[L$X+DC<>>/EK
M:TJX^U:5;2DSEB@#&X""3<.#NV?+G(.=O'IQ5!-1T765U"RGM)&B5-UTE]IT
ML4;KTR?-0*X^7MGI6CISVDNF6LFGJBV31*8%1-BA,#: N!@8QQCB@"U1110
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M0 5SUV/#;>*XQ/JRQ:V\81;1=5DB9UPQ'[D2 -U8_=/K70U3N$FDOH6\HM!
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M\,962YEN"3G=(%!' X^4 >_XU-0 4444 %%%% !1110 4444 %%%% !1110
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MCK4'U+^S5B\*M?[RGV4>(F,NX=1L^SYS[8H\@.ZHKE_[7\6?] '1?_!Q+_\
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M4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \322L#U/,;+PSXQATK49[JXUF_O
M\*V4-QJ+0;8]W[P[8KG#,!TW2\\<YS7$WU_XFTO4M7L]:UO4K'RH]]O&+\F5
M%))78IO%+DC/&9<<#K7T)_P@GA#_ *%30_\ P70__$T?\()X0_Z%30__  70
M_P#Q-,=SR_PYH?CV+2KOS;[4HKV33)(XS=2^9&\Q^XX9KAV5O^V:#U (IO\
MPB'B;4[FW-W!JT5C%=V<@M[K6#)(I53Y\@993@9QCG/4@#->I?\ "">$/^A4
MT/\ \%T/_P 31_P@GA#_ *%30_\ P70__$T[ZW)MI8Y*.PUC0?%GB#4(-(FU
M*/4TB-O<V\L.^'8FWRW$KKQGYL@G.:Y.T\->.[K5-"6Z.NVUJF!K#G6\B=MS
M'=&%E)5<8! V]1@<9KUG_A!/"'_0J:'_ ."Z'_XFC_A!/"'_ $*FA_\ @NA_
M^)J;?U]_^?Y#?]?A_D>47>D>+=!\(W%S-?ZP;EK/9*9-4+L)3<C;M)9@I\O
MR!TZ\U!JFA>/GU+49=%L]=MK9UA^Q)>:SYIC88WDD76 #SU$F?1<UZ]_P@GA
M#_H5-#_\%T/_ ,31_P ()X0_Z%30_P#P70__ !--ZCN>87OASQE!H5DEL-6N
M]1EAG:ZG?5Y2R2Y_=@*MS$BKCN V,?=/?,M?"WCI-#EMVLM176+B\:6:Y;54
M-JT+)AU,0DP6)R.4/.#NXKV+_A!/"'_0J:'_ ."Z'_XFC_A!/"'_ $*FA_\
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M-#_\%T/_ ,31_P ()X0_Z%30_P#P70__ !- %NBJG_"">$/^A4T/_P %T/\
M\31_P@GA#_H5-#_\%T/_ ,30!;HJI_P@GA#_ *%30_\ P70__$T?\()X0_Z%
M30__  70_P#Q- %#Q7IXU3P]/:>5?R[V0[;!XEE.&!X,I"8XY!ZC-<%_9WCM
M;R]U**+6?[4;$%D\LFG^5Y ?($X'1OO$^6.FWG->F?\ "">$/^A4T/\ \%T/
M_P 31_P@GA#_ *%30_\ P70__$T+1W Y'7=!OO',]K8ZO875AHT=N\DR^='Y
MDMP<JH&QV VC+#.021Z5QO@/P1XR\(>,X7M;18- NV9KH3302RJ@WA%=@ =W
M0_)E>1SUKV#_ (03PA_T*FA_^"Z'_P")H_X03PA_T*FA_P#@NA_^)IK1W0/5
M69;HJI_P@GA#_H5-#_\ !=#_ /$T?\()X0_Z%30__!=#_P#$T@+=5-457TNZ
M1K :@&C(-H=F)N/NG>0O/OQ1_P ()X0_Z%30_P#P70__ !-'_"">$/\ H5-#
M_P#!=#_\32:N@1Y9)X9UN\%UJT^@ZQ!XBN8)(2UK-8I;+&RA5A^9W.P #YMN
MX\^P&UK'A6[U#P#INF)I)DU/3)K>.*2X:(N51TWNC[N%(4]=K$#E>U=S_P (
M)X0_Z%30_P#P70__ !-'_"">$/\ H5-#_P#!=#_\35+3\/P$]?Q_%6/%/$'P
MS\2Z1XPGUWP3:/YBS%U>ZG@<LS[BS1JPPJKG;\QW<\9ZU[G#YGD1^=M\W:-^
MWIG'.*K_ /"">$/^A4T/_P %T/\ \31_P@GA#_H5-#_\%T/_ ,326D>4;U=R
MW153_A!/"'_0J:'_ ."Z'_XFC_A!/"'_ $*FA_\ @NA_^)H MT54_P"$$\(?
M]"IH?_@NA_\ B:/^$$\(?]"IH?\ X+H?_B: +=%5/^$$\(?]"IH?_@NA_P#B
M:/\ A!/"'_0J:'_X+H?_ (F@"W153_A!/"'_ $*FA_\ @NA_^)H_X03PA_T*
MFA_^"Z'_ .)H MT54_X03PA_T*FA_P#@NA_^)H_X03PA_P!"IH?_ (+H?_B:
M +=>7:WX9UTZUJ/V?1VO([G5[74H[U)H@8TB493#L#O^4A>WS\D<UZ-_P@GA
M#_H5-#_\%T/_ ,31_P ()X0_Z%30_P#P70__ !-&SO\ UT_R#I;^NO\ F>66
M>@^+-/NYT_LK4);.[U*:\N57^SW 5OFC=/,.[S5;;]XE1MXSQ79^!-,U'3-/
MU$:E;RPR7%_+<(UQ*CS2*V,-)Y9*!NV%XP!Q70?\()X0_P"A4T/_ ,%T/_Q-
M'_"">$/^A4T/_P %T/\ \30M%;^NG^0/7^O7_,MT54_X03PA_P!"IH?_ (+H
M?_B:/^$$\(?]"IH?_@NA_P#B: +=<1XRT?4[C7+/4[+2_P"U8DL+JT:V$L:%
M6D4;6^=@,'&T]\'H:ZS_ (03PA_T*FA_^"Z'_P")H_X03PA_T*FA_P#@NA_^
M)I-7_KY?J-.W]?UV/)=2\'>+]3\.:3ITNEV\L&E+;10Q27PCD9T9?,E^4%2I
M7*C+!@ 3MR<5T7@WPOJ&G^(XKN:WU&TL++3A9V\5[<6\C9+;BJ^2.57'!<[C
MGI7<?\()X0_Z%30__!=#_P#$T?\ "">$/^A4T/\ \%T/_P 357U;[DVTL6ZR
M])_Y'S6O^P98_P#HV[JS_P ()X0_Z%30_P#P70__ !-:&F:#H^B^;_96DV-A
4YV/,^RVZ1;\9QG:!G&3^9I#/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>forms-4_005.jpg
<TEXT>
begin 644 forms-4_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %X @(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(DM[X7-RTDK,[@(RCYFR3UZ9J*[\.:P;+Q/#:/ DFK7(,;ES\D155<GCK@'
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MD5_^%H>+O^@C#_X"I1_PM#Q=_P!!&'_P%2N0HKI^J4/Y4<OUW$?SO^OD=?\
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M1117FGJA7D5]\)KS6M7U+48=?A@CN+V=Q$]D7*YD8D9\P9_*O7:I:7_J)_\
MKYF_]#-7"I.F[P=C.I2A45IJYY%_PIZX_P"AOL?_  !_^VT?\*>G_P"AOL/_
M  !_^VU[%]AM/^?6#_OV*/L-G_SZP?\ ?L5M];K_ ,S,?J>'_D1X[_PIZ?\
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MQ6]]AL_^?6#_ +]BCZW7_F8?4\/_ "(\=_X4]/\ ]#?8?^ /_P!MH_X4]/\
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M6\+*X(R80O()!X^H-6OL-G_SZP?]^Q1];K_S,/J>'_D1X[_PIZ?_ *&^P_\
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M&)SD =0:/K5?^9A]3P_\B.-_X4]/_P!#?8?^ /\ ]MH_X4]/_P!#?8?^ /\
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M9M+1;Q+6Z$$=S@;8X6 &)FD'?LK!![#\* -W[-K/_04M/_ (_P#QRC[-K/\
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M(MCSM +?\M.@!!STP1ZU!;^%-)T^QO8K"XGCN+N"2"2>3+%@V,9P!]WD*!@
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MCCV-.LO^/&W_ .N2_P J )Z*** "J6E_ZB?_ *^9O_0S5VJ6E_ZB?_KYF_\
M0S0!=HJ#[.W_ #\3?F/\*/L[?\_,WYC_  H X_Q%K>J:?XI$5K+(\21P.MHF
M-T^78.%7RR6. .=Z[>O/>.U\8:Q/9VU]/:0P18N?,C1&D+E(U= ,=""6!'?:
M>G0;]YJJV6J)8RQZCM:-I3<@1^4J+C<Q).0!N&>.]*FMZ/)&TBZY&42/S&(E
M7Y5W;<GCCYN/K0!F6'BFYN=%L=4O4%K"+Z2&Y9(V*F,!PK=R 6V<\]>N*JGQ
M#KXL#F!0#;C$IB82B0QM(#MQMP, 8ZY/X5MS:]H\%O).=:5TCMS<GRY%8F,#
M.X #GBFW^MV^GSK&W]HS1^0+B2:%%9(HR2-S=\<$\ \"@#,A\8:EG5)KC2=M
MO8S!2J$M*4W,OW1WX5OH3[$M3Q3KSZI=6!TF".2(Q1AF=B S,BEB!R4^=B.G
MW>O7&M=^(-(LE9I=8^5)EAD*NI$;'.-W' X(^M3Q:G8SQWSQ:A+(MC_KRN"!
M\@?CCGY2.E &%+XOU5+W583IL445I*L:2R%CM&\+O=1SM(.X8QQ^8Z+P_<W-
M[X?L+F[S]HE@5Y,KM^8CGC Q^59]_P"(+33K^*TGENU=XEF9F>)%C1B1EMQ!
MXVG. :NP:CIUU$DL&KK)&_W6612#\P7T_O$#ZG% &K16'::WIMZ9A'JCJ86"
MN'91@E/,ZXP?EYX]#Z5J)%YB*Z74K*PR"".1^5 %BBH/L[?\_,WYC_"C[.W_
M #\S?F/\* )Z*@^SM_S\S?F/\*/L[?\ /S-^8_PH GHJ#[.W_/S-^8_PH^SM
M_P _,WYC_"@">BH/L[?\_,WYC_"C[.W_ #\S?F/\* )Z;(6$;%!N8 X'J:A:
M JI9KJ4 #))*\?I61!KMC<BU,5S>D75S);1$Q8!9,Y).W@?*<$]<C% &;HNN
MZD^G7;GS]1N D9BC>)8F\XKF6(9"C"''7GDC)-9]GKWB!Y-$6?[5YUP=KQ-
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MC7,*A]A9_0;N.,YZC(J&/Q++_9MM>W%G>Q)<&=U7>I,<,:LP=^.-V!P,_>%
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M' ZGTH Z^BH/L[?\_,WYC_"C[.W_ #\S?F/\* )Z*@^SM_S\S?F/\*/L[?\
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MW<MVY!G+%G(3I(, +@X !/%366@Z\D(,U\R%2\JQ&]ED!E"!5W-@$J6W,5&
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M..M;>J:-KMSJ5Q/!,3#O4HBW\D.^+ !BVJI"'()WC+<XX[ &]_:$G_0.O/\
MOE?_ (JC^T)/^@=>?]\K_P#%5S%SHNOQQ6R&ZN+N9FCC<)>R1((T0LV6 )!9
M\#=@D@#D9-.;P_XC:0(=5?B)(S<K=.&*[ K 1XVAL[GWY+9P..: .E_M%_\
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MM_\ ?QO\:/LD7^W_ -_&_P :-]S_ ,\(_P#OZ?\ "C?<_P#/"/\ [^G_  H
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M )Z*** "J6E_ZB?_ *^9O_0S5VLVSE\C3[R;;N\N:=L>N'8T 7O/A_YZQ_\
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MX,TEWN6@N([=I@X$D8'F*&B,?#DY_B=NO);VK*C^'T$)$"ZC;-;R;WE\R(.
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MX?\ GK'_ -]"L'S];_Y\M&_[_P G_P ;H\_6_P#GRT;_ +_R?_&Z -[SX?\
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M&VU%+V,R6JI/&KLA:.56 93@C@]01B@"A]NLO^?VU_[_ *?XT?;K+_G]M?\
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MH^W67_/[:_\ ?]/\:TWN9(T9WMRJJ,DEUP!^=.\Z;_GV;_OM?\: ,K[=9?\
M/[:_]_T_QH^W67_/[:_]_P!/\:U?.F_Y]6_[[7_&CSIO^?5O^^U_QH ROMUE
M_P _MK_W_3_&C[=9?\_MK_W_ $_QK5\Z;_GU;_OM?\:/.F_Y]6_[[7_&@#*^
MW67_ #^VO_?]/\:/MUE_S^VO_?\ 3_&M7SIO^?5O^^U_QH\Z;_GU;_OM?\:
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M1O,2.-D.",98YZ]/2I4\2W5Q;2O;Z58LP.Y6(?;&H1W97^3)D7:H('&7 [4
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MRV\26]Q<1V[S+:7$I'E0WD1A>4'H5!/(_4=P*MWMYI-_93VD]["8IXS&^V4
MX(QP:Q?[+TR2[^TW/B2XN'.SS!)+$ _EL6CX"C&&.>,9/7- &LNN6;R1(NJZ
M:SS.4C E'SL."!SSSQ1'K=I,BO'JFFNC2^2I64$&3^Z.>N.<5B-HNC2W"K)J
MR"QCM8K9;>-T&]4);YCC/WB#\I'09S4UMI.AP*2^L/+-Y;QB9ID5E!0(-NT
M JHP"!W/7- &FNOV;S6\,>I6,CW!D$>PE@=@R_(.!@$'\12C7;5OLNW4;)Q=
MNT<)0E@[*I9AD'L :Q+7P]X>M;&>T_M9I(KB*:.8-+&-PD" G@#&!&,?CG-2
MP:+H%M8):0ZJ8U"S*SQR(K,90 6X'!  QC&/>@#7_M2TN[3/]H:=+!*"GW\A
MN0I'7U8#\1ZTG]J65@GV87^F0+ 5A\L.%$9Q\JXSQQV]*Q[#0O#^GM9LFJEV
MM;A[F/=(F/,888D  ?=^4>@Z<\TNIZ'X>U2%(I=4*()Y)Y DJ8D9V!.[(/H
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M/^U#]E!1A;&9"FY55-QXR<JN,$XY/'- &M<>(;*TAEEFU.P"Q0?:& ;)\O\
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MQ=_WH?\ OD_XU%_:^G?\_P!;_P#?P4?VOIW_ #_6_P#W\% $N+O^]#_WR?\
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M;?4[?4-1;[1-=QI!"EJEPP2-F )8[@">25R>?0=*TY5>*%Y);P+&BEG9D4
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M -\"@">BH/)G_P"?D_\ ? H\F?\ Y^3_ -\"@">BH/)G_P"?D_\ ? H\F?\
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M0!N?:E_YY3?]^S1]J7_GE-_W[-8?V/4/^AAU/_OW;?\ QJC['J'_ $,.I_\
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MELG'';T .\TQ%T[3H;0M<S>6#\[QG)R2?R&< >@%6_M2_P#/*;_OV:PQ:7S
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M )Y3?]^S1]J7_GE-_P!^S6']CU#_ *&'4_\ OW;?_&J/L>H?]##J?_?NV_\
MC5 &Y]J7_GE-_P!^S1]J7_GE-_W[-8?V/4/^AAU/_OW;?_&J/L>H?]##J?\
MW[MO_C5 &Y]J7_GE-_W[-'VI?^>4W_?LUA_8]0_Z&'4_^_=M_P#&J/L>H?\
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MCX+OV\F,1(K",KM ( *F;#8!(!() X%4_P#A9GAK_GXU[_OD?XT?\+,\-?\
M/QKW_?(_QI>PJ_RO[@^L4?YU]Z-K2K:WT2"2'3O#&JP)(V]_]6Y8XP,EI2>
M !Z"K_\ :-S_ - +5O\ OB'_ ..5RW_"S/#7_/QKW_?(_P :/^%F>&O^?C7O
M^^1_C3]A5_E?W,7UBC_,OO1U/]HW/_0"U;_OB'_XY1_:-S_T M6_[XA_^.5R
MW_"S/#7_ #\:]_WR/\:/^%F>&O\ GXU[_OD?XT>PJ_RO[A_6*/\ ,OO1U/\
M:-S_ - +5O\ OB'_ ..4?VC<_P#0"U;_ +XA_P#CE<M_PLSPU_S\:]_WR/\
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MZ 6K?]\0_P#QRC^T;G_H!:M_WQ#_ /'*Y;_A9GAK_GXU[_OD?XT?\+,\-?\
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M\C_&C_A9GAK_ )^->_[Y'^-'L*O\K^X/K%'^9?>CJ?[1N?\ H!:M_P!\0_\
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M*_#W_0=TW_P*3_&C_A*_#W_0=TW_ ,"D_P : ->J>I_\>B_]=X?_ $8M5/\
MA*_#W_0=TW_P*3_&I+B\M;_3([BSN(KB$W$($D3AE.)5SR* -.BBB@ HHHH
MHVW_ "%[_P#W8OY&KU4;;_D+W_\ NQ?R-7J "BBB@ HHHH **1F5$9W8*JC)
M). !63_PE?A[_H.Z;_X%)_C0!KT5D?\ "5^'O^@[IO\ X%)_C1_PE?A[_H.Z
M;_X%)_C0!KT5D?\ "5^'O^@[IO\ X%)_C1_PE?A[_H.Z;_X%)_C0!KT5D?\
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M_KD_\C3K/_CQM_\ KFO\JI'5-/U/3;UK"]M[H)$P<PRA]N0<9Q5VS_X\;?\
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MM^^T9^Z21W[9/YT :F!Z"HKIY(;662"%9954E(RVT,?0GM]:K_:[S_H&2_\
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MSI%YK1QLXC! W$#.,]LUS5EXIN;GPWJ%_P#9(GN;1E3"I(J'<JMG##=\H?D
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MO/H,]>H_.@#G=/AUS3=9C@D-Q?6;2,GFR,1MX4EB,G\,\?>P!D5OZI_J(?\
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M:0J^]3AW^8X&3DC( R,[@#@G/-)J<.MV.L27=D;B]MW97:#<5 Z@*.>F1S@
M<C.>:Z";5M.M[&.]FOK:.UDQLF:4!&STP>AIXU"S:9X1=0F5"JL@<9!;H,>]
M %FBBB@#C/#PUN!-6%ZM^7EXB,@+%),R9QEB" -GS#:AXP!S5>QL->.C0-!/
M>I-!.1%YX=7G!"_-('=MN"'')((.0!D&NQMM2L;SS_LUY!-Y#%9?+D!V'T/I
M4<.LZ7<K$T&H6LBRN4C*R@[F'4#WZ?F* &:)-=3:3"UY;/!,,KM=B6(' )SS
MD^]9&F_\>6J?]AH_^C4KIHY$EC62-PZ. RLIR"#W%<SIO_'EJG_8:/\ Z-2@
M#J**** "BBB@"C;?\A>__P!V+^1J.]\0Z)IMS]GO]8L+6? ;RY[E$;!Z'!.:
MDMO^0O?_ .[%_(UQOQ&NC#-:1VWB#3M*N!%)+)'<2)&\RC !#-&YP"2< 9/0
M>P!V=V0;S3B#D&9O_1;UD>*S<$V,5O%J1=Y#^_M"^V  CYF5?O'L ?EY.>E:
MMQS<:7SG]Z>?7]T]2W>HV6GM$+R[@MS,VR,2N%WGT&>M ',:4-:B_M+>E\)G
MB* SL74W)9\,F20$QLZ8'3C(-5+>QUY[/[1:3:G"4DQ#!=N6=B8UWLQ+=-P?
M&<CGC (-=G;ZC97<D\=O=12O;MLF",#L/(P?3H?RJ&#6M+N5C:#4;619694*
M2J0Q7J!SVH K0S7,_A65[NW:WF^SR*49B3@ @$YYY !YYYK5A_U$?^Z/Y56O
MW271KJ1&#(UN[*P.005/-68?]1'_ +H_E0!S2V5];+KMQ:?;%N+C=#91R3/(
MBL$)$F&8A<N3SP,!:S+*PU]M(BDAN;])XKAO*2?<&D!"Y+AG8J 0XY)!SD 9
M%==:ZQIM[//!;7UO++;C,R)("8QDCD=N0?RIL&M:7=)"\&H6TBS,5B*R AR.
M2!ZT )HDUU-I,+7EL]O, 5V.Q+$#@$YYR?>M"FQR)+&LD;!T<!E93D$'N*=0
M!RFM)JY\7Z=+:B[^QH$W"/=L8;FWYPP XV_>5L\!<')JO]FU>]UJ\4/J-LDJ
MR$RLS>4(R$,:JN>&R&!QAN6R>1737&KZ=:7L-E<7L$5S-@11.X#/DX&!WY%*
M^KZ='// ]];+-;IOE0R#<B^I';J/S'K0!D^&WUA)IK?4H)2H166XD;)/  7'
M3..N.X.>HKHJBAN(+@$PRI(!@DHP/49'Z$'\:EH YWQG'J$NCQIIQN5?SLR-
M;ABP7:V.$96(W;>A'J<@$56U=O$<EAIB6-N^Z*2!KS,^R1B&C)4$*0RX+;B,
M=/J*Z.]OK33K<W%[<Q6\((&^5PHR>V33+G4["S, N;RWA-PVV'S) /,/MZ]1
M^8H YZ.'6].UX;3<7UE)<$$NQ 3=C)ZG@*?89!XSBNLJO%?V<\ACBNH7<.8R
MJN"=P&2/J*L4 07OG?8;C[.&,WE-Y85@"6QQ@G@<^M<7IZZ['X,O[=UU%KUV
M/D2,'$@&U-QPS%ASOXW?-SMQD8[HD*I9B  ,DGM52'5=/N+%[Z&^MY+1,[YE
MD!1<=<GH* .12R\0+I=G<QS7IF5)$:!BP)C#.0>6)!*E0 <L,#G(.>RL)9Y[
M""6Y@\B9T!>/.=IJ)-8TV149+^V97C,JD2CE!U/T&#^1]*N]: "N2B&L0>-K
MF5ENGT\!G9B6*E=B[41,[<AMQR/FZY[9ZVJR:A9R7TEBEU"UW&H9X X+J/4C
MKZ?F* .12VU"^;63#)K%D%8&-)B[&4JS?,I) &[( 52  JYZD5N^'I=3,=S#
MJ=NR21R'$I;(DR3G'L.,8XP<=0:N'6M+!N =0M?]'<)-^]7]VQZ!N>#U_(U;
MCECE#&-U<*Q4E3G!'44 8+_\A[7_ /L'6_\ .>MNS_X\;?\ ZYK_ "K$?_D/
M:_\ ]@ZW_G/6W9_\>-O_ -<U_E0!-1110 52TO\ U$__ %\S?^AFKM4M+_U$
M_P#U\S?^AF@#A+V]%Y\1+2^BOM4@T^*Y&GL_DGR'G4G,:D2# )^4DH1GC/3'
M=?\ ,>/_ %Z_^S5Q\%IX??Q=*C^%];BO([[SA<M',;9I22?-&&V8[YQWKL/^
M8\?^O7_V:@"KXCTF;6+&.& PB2.3>IE:1=IVE<@HP((W?YZC,U3PM?:C<6$_
MV]?-MD\DR,7R5RC>9@$ OE3P<KS[<ZGB#Q#:^';2*>Y1G:5]B(K*I) +'EB!
MP :GNM7AM%L&:&=Q>RI$A100A89!8YP!0!EVWAF6QUE+RQN5M[??^\@4$@H
M !S]#[ 8QT%:^J?ZB'_KYA_]#%4M*\36FJW'D1QR12?-\LN >,8[]3SQVVG.
M,5=U3_40_P#7S#_Z&* +M8#Z3JEMH L["YM1>MF22YF0G,I<,S <\\MC.<?+
MV&*W9&9(G9$+L%)" @;CZ<UCVNOR7.C7.H?V9.AAE:,1&2,[]IP6#;MNT'.2
M3_": ,Z;PB7L[/[.8;2[MXP-\;.06!&.3SZY.,YP>U=-;1RQ6L,<TOFRHBJ\
MF,;V Y..V:P8_&=A(;<^3,JW$"31L^T [N@)SCISGIP>:Z($, 000>010 M9
MWV"<:K=7_F1N[QQPPJV0(T!R_P"))_\ '5]*T:RX]6E?Q ^E-82J%B\[[1YB
M%=N<#(!R,G.,C^$^E &%IW@DVVFW%G<31RKA$@(,AV[0RF0Y8_,58@J/EXZ<
MFMW0]-NM+M)+>XN_M"A_W/&-B8  _K6>WBT0+<M=:9<PK!<+;LP='!8J6/*M
MV&./5@.M;=A?0ZA:BX@.4)('()]LXZ9&#CKS0!9JC?6#WMW8NT@%O;RF9XR/
MOL 0GY$Y^H'I3Q#%+>3F2-7("@;AG'6N8U[7_P"R?%>F:5%I]K)!<>7Y\C Y
M0/)Y:].G/3KD\<=: +=UX8GO_$,=_<3Q+:G#3P)NQ*RJZC.>,;7_ $Z'J)M*
M\/7&E:J;B*\ M7#&2  G))..3ST(.3SG/J:Q]0\23Q>(;G3;#2[.Y"[H85S\
M\DOV<SAO39@;?KWK1\,:S:ZZ)X;BWM8;Z +YEN@R5XP3GH1N# 8SQCUH ZBL
MW7=.DU72);2&14=F1P6R =K!L94@KG'4'(ZBHKQ%@UG21"HC#R2!@O&X>6QY
MJUJ^IQ:/I<U_,C,D6,A2!U( R20 ,GDGH.: ,5_#U^OA:/1XYK1L1E&:3S!G
M=NW ,K!A@,.<DM@YZYIMUX3F,L-Q8WHM[J-$4S!3EVQM9B,X'&#@<=0>M7I?
M%%C#X937727R9(_,CA4 R/P3A><'@$YSC SG%'_"3V8U5]/>.1)%=4#N0%;(
MR3DGH./KD8S0!MT444 <CIWA*[L[/5+5[R(I?1&W+IORJ'S/G )(4_O/NKA1
MCCK1;^#6;2OLUW+%YQFWJT9D81+A00NYB3DH#\V0#TZ"M/1_$L&N?;UM+>7S
M+1MI1F7+'+ #@G:<J>&P1QZU53QC"L$4MW87-LDD\D.XE''R$ ME2<C<2..?
ME8]!0!KZ/:75EIL<%Y<BXF4GYP, #/ _"L73?^/+5/\ L-'_ -&I716MPEW:
MQSIC:Z@XW X]LCC(Z5SNF_\ 'EJG_8:/_HU* .HHHHH **** *-M_P A>_\
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MW^T0-CRV' E4D\CL 361'K>I66O"SU$"2&2X*1M @."V-JGIT!#'J?P!KJZ
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M')/_  +%%% !OTW_ *#DG_@6*-^F_P#0<D_\"Q110 ;]-_Z#DG_@6*-^F_\
M0<D_\"Q110 ;]-_Z#DG_ (%BC?IO_0<D_P# L444 1,VDVL-_/'J"2W$\&QF
@DN Q(4-M Y_VF_.MFT!%E ",'RU_E110!-1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>forms-4_006.jpg
<TEXT>
begin 644 forms-4_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $0 B8# 2(  A$! Q$!_\0
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MN ?NG; #@]."#Z$5N44 %1SQM-;RQ)-) [H566,*60D?>&X$9'7D$>H-244
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M)*<X;;\V1MYSN"\ D9%&CT#8UK6WCL[2&VBSY<,:QKDY. ,"I:**;U$%%%%
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M( HHHH **** "BBB@#$U33)9KB>6V@4E[8YP0OF.&4A3]0N,FJ0_M))3K/\
M8=XSO.3_ &>)8/. ,:IN)\SR^J_W^A]>*ZBB@#D9_#M\EI;>3<7(=+3;)!&8
MO++JH P6&[<>!R=N <@9S71:5]I_LR#[6DL<V#E)65G49.T,5)!8# )!/.>3
MUJY10 4444 %%%% !4-Y))#9S210S32*A*QPE ['T7>0N?J0*FHH X!-*UQ0
M+PV^MM<R&14+7%JLZ.P3;+-L81E04QM3(( W(QZ:NJ:-?)<SW=O)?W"X23[-
M"\*Y;=\RQD[2.['>W4C:1BNJHH BM1,+2$7!!G\M?,(Z;L<_K4M%% !1110
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M.#P>NHHH **** "N/\+_ /(,O/\ L*ZC_P"EDU=A7'^%_P#D&7G_ &%=1_\
M2R:M:>Y$]C:HHHK<S"J>JRV<&E74M_<&WM$B8S2K*T91<<D,I!!]P<U<HI/5
M#1PFF3P76FVEYIVM3SVXU- D4>I&YV*Q4;)'W,S'&3M+$#?T. 0:S-J>EZO?
MRM>Q1VDABDDEEOY0L49<!2R<+$,Y'RGYPK9(-=W10UV_K;_(+]R"RN#>6%O<
MF,QF:)9"A.2N1G%3T453W$%%%%(#)_YJ#I7_ &"K[_T;:44?\U!TK_L%7W_H
MVTHKFG\1K'8ZRL",7M]JU[<?VO<V\%C/Y7V*!(MD@"*WSEXR^3N_A8#&.^2=
M^J%QHFDW>HQ:C<Z7937T(Q%<R6Z-(@YX5B,CJ>GK4%&*OB'79+*VE31M-$\M
MN;IXGU1U"Q<8PWD<MSR, #CDYI]KJNHKJ%Q*5A?3Y+L1HK.WFC,*,".,* 01
MMYSNSD8PVQ>:+I6H1V\=[IEG<I;$- LT"N(B.A4$?+^%63;0$DF&,DOO/RCE
ML8S]<<9I@8FE:KJ^I "ZLK6R9H8[J'[/=F?S$).5;=&FT].F>OM4,.N:C>^%
M=4NKBU33-0MHY%\J-VD,3!,@YDC0'GN RG'!(KH1;6ZKM$$079Y> @QL_N_3
MVJK::'I-A82V%GI=E;64V?,MX;=$C?(P<J!@Y'!I 8_GZAH]VMI)J=UJ@D$;
M[IQ"DD9:0(%^2-5VMD]1GY3SZ9R^.-6,MO:-X?C&H.[++:K-<,8@-H'S"VQU
M)^8XCX!WD'CJ+/0M(TZT:TLM*L;:V9_,:&"W1$+<<E0,9X'/M5<>$O#:VL=J
M/#^E"WCD\Y(A91[%? &X#& W YZ\4P,R_P#%U[;Z])IEEI O#L<1/OFC#RJA
M?9O,/E=L<2,1_=X.(9?&5^(M-6#1DGN[O>985>Y'E;6"X_X]\@\\F18U'&3@
MYK=F\-Z%<W4]U/HNG2W%PNV:5[5&>48QAB1DC''/:A_#6@R65O9R:)IK6MLQ
M>"!K1"D3'DE5QA3]*0&I1110 4444 %%%% !1110 4444 %%%% &!JEU?VE[
M=E+TB)K3=&@C7$)#!2^2"2?F)YXP!QU)J :DTQT<Z]>JRW!'V\16_G,/+5]A
M'E^7_$?X,X'U-=-)!#+N\R*-]R%&W*#E3U!]O:J!\.Z&VE+I1T;3CIRMN%H;
M5/)!SG.S&,Y)/2@#GY-6UI/L]UB[>">Q!!C$'D[\9+8/[S>.3_<Q@=375V-P
M;JS25E*ORK@D'#*2IY'7D'GBG26EM,NV6WB=?+,6&0$;#C*_0X''M2VUM!9V
MT=M:PQP01*$CBB0*J*.@ ' % $M%%% !1110 56U"\&GZ?/=F&>80H6\J"-I
M'?V55!)/TJS10!P5MKFH:M%?/%JE_9M8K)/A[#R/-P ?+(FBR4'3*X;D9.:T
M)]1UJWU:YC,=XT4S1F'<8!$JY&=A&7&<@-O!Y)*]*Z"ZT?3+YXGN].M+AH9?
M.C:6!7*2<?.,CAN!R.>*DNM/LKZ&:&\L[>XBF4)*DT2NLB@Y 8$<@$G@T 2V
M\ZW-M%<("$E0.N>N",U)2 !5"J  !@ =J6@ HHHH **** "N-BU75E>^N+B>
MYB2X646JDP-' $D"%L!-P."&^9F'7(3[M=E5--(TR*ZNKF/3K1+B[&VYE6!0
M\PQC#G&6X]: .7DNM=T[4Q"+J_U&VMI=C2E;9?,+(&"RX53P6&TQ@=]W'-='
MHMY)>:>K3!_.3"N7VY)*A@?EXZ,.!TZ<]:FL]*T[3K:*VLK"UMH(6+1100JB
MH3G)4 8!.3T]34EG96FGVXM[*UAMH0Q81PQA%R3DG XR22: )Z*** "BBB@
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MIKE[B8SR22QQ(2QQDXB1%YQDG&23R36I0 4444 %%%% !1110 4444 %%%%
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MF%I"+@@S^6OF$=-V.?UJ6@ HHHH **** "LZ/7]&FFNX8]7L'EL@6ND6Y0M
M!U+C/R@>^*T:Y)[;5)GU6&&QU.&S:&51!<36^V9V;.Z$HY=21N^^RCE>!R0
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M9R?FR>>M6Z** "BBB@ HHHH **** "BBB@ HHHH IWFF0WK.TC2 O"8<J0,
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M*KYMY I+' VMMP_/!VDX[XH N00I;6\4$>=D:!%SZ 8%2444 %%%% !1110
M5BMX<CDDN2^H7K1RHR0Q'R]MMN()*?)D\@'#EAQC&.*VJS?[=LC)>(BWC_9
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I&J^.;&XM[/4D@@TV[222ZT^>W4,\ML5 ,B*"2$;@>AHKGG\1I'8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>forms-4_007.jpg
<TEXT>
begin 644 forms-4_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %! <\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB3:!*OS=<'I[<UZOJ>CV>L"V6]1I$MIUN$4,0"Z],@=1[&JNM^%M)\0-"]_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0%-RXV?=($F!U&1SZ 'H%%9GA^TO[/1XHM4N6N+TLS2R%MPY8X X' &.U:=
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M3C&4D9O.8R.X<@_=VJRH!D\+]*ZF@ HHHH ***J-#?%V*WD:J3P#!G _[ZH
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M*59-\9:3;+T("G8$'4[NN,C/;>1J'_/[%_X#_P#V5'D:A_S^Q?\ @/\ _94
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MWB$D-K'I[S&]&QBQ$B\(00![=\[A74>1J'_/[%_X#_\ V5'D:A_S^Q?^ _\
M]E0!YPWC/Q.FA1?;8+FSOH6E$[C3"[2OA&BC5-V &#L,YY,9 ()K8\*:[XDO
M_$T\.KPM#82I.]NLEN$/R2[0 1T('4-UR"N1FNO\C4/^?V+_ ,!__LJ58;X.
M"UY&5SR!!C(_[ZH MT5%.DSJ!!*L;9Y+)NR/S%0>1J'_ #^Q?^ __P!E0!S7
MCG7M6T2336TW)CD9O-1;5IGD(*X5<<<@MQD$\8Z&LVU\>:S#::;'?:(TEU,\
M"RN@=5VNL9+#Y>&'F'*_[)YX..W\C4/^?V+_ ,!__LJ/(U#_ )_8O_ ?_P"R
MH YB+QCJIN-'CDT%]NH2NK,KMB)1($&<K][&7(]!^-=G5/R-0_Y_8O\ P'_^
MRH\C4/\ G]B_\!__ +*@"Y155(;T2*7NXV4'E1!C(^NZI)TG<#R)EB/<LF[/
MZB@":N>\6ZO>Z39VQL0/-F:4;BF[E()) H'J60#\ZU?(U#_G]B_\!_\ [*F2
M6=W+M\RZ@?8P9=UMG!'0CYNM ''V'B3Q3IEI8IK6FK=3WDFY#&,,$_=C9\H*
M[\L[#.!M3DYS47ASQ;KEUXS.E:AB6"1YAE;1HECVY( 9L$X  ((_B!R017<>
M1J'_ #^Q?^ __P!E3#:7AD60W4!D4$*QMN0#C(!W=\#\A0!?HJGY&H?\_L7_
M (#_ /V5.CAO5D4R7<;H.JB'&?QW4 6JQ?%E[J&G^&+VYTI=U\H40C9NY+@=
M/H36I.EP^WR)UBQUW1[L_J*A\C4/^?V+_P !_P#[*@#AM&\9>)6E73;O1'N+
MT+,6D;]U\RE]JG *D_(H++P?,4BK,OC_ %(>1)%X:N3#/:RW49<E6*+YA0%=
MO#$("1V\Q>M=AY&H?\_L7_@/_P#94>1J'_/[%_X#_P#V5 '+CQK?1/#%<Z,R
MS23&#Y"[*6$L2<'9TV2LW./N'ZC4\+>(+OQ!#>276ER6'D3>6JN<EAZ'@8([
MUJ>1J'_/[%_X#_\ V5'D:A_S^Q?^ _\ ]E0!<HJM#%=K(#+=1R)W40[3^>35
MF@ HHHH Q]?@NITM?*BN9[=9";B"VF\J1QM.W#;EX#8)&1^F*Q4TK6YI-A-]
M!<$L6NFO=\>S8?+0*#]X-MR=HSACD[L'KWECC95>15+9VACC.!DX_"E1UD17
M1@R,,JRG((]10!Q\MCK,KPW%[;7TL4K++/:VUX%9&(E^4$.O"YB'!YQGFM"W
MLM<\G2OM5QEH)5,HBDY=/+(/F$_>(..G?FM\31, 1(A!8H,,/O#.1]>#^5/H
M Y[PG::O:6]TNJE^9!Y0DDWL<#YF)W-C<>< @>@%=#2*ZL6"L"5.#@]#437=
MLEH;MKB(6P7?YQ<;-OKGIB@":BJUGJ%EJ,1EL;N"YC!P7AD#@'ZBK- !1437
M,"+N::-1N*Y+ <@$D?7 /Y4Y)8Y#A)%8XS@'/&<?S!H ?1110 4444 %%%%
M'&1Z;KC/XA16OHUEE62UE>Y&YB#G:OS$!,8'13C@],U6OM+\2R2:OY;W?ES3
MJT>R<9"AV(V#S!D;2F>8\8Q\V.>UN[VUT^W,]Y<PV\((!DF<(N3TY-0R:QID
M7G>9J-HGD$"7=,H\LGH&YXS[T 8]W;^(II-%\@JD5O)&;U3,0\F!ACD##+R>
M.,G%=+4;SPQB,O+&HD8*A+ ;B>@'J:DH **** .0\3V.O7&MQ2Z/]I&;22/?
MY^V)&(/. P^?IU!'3E<9JI=6/B-]#LK. 7BRQR/(Y\T!V4[O+#-YG8[20&.!
MTSC%=C-J%E;W*6TUW!'.Z%UC>0!BHZD ]A36U33ULTNVOK86TAVI,95V,?0'
M.">#^5 '(SZ?KRV^H(;>_E,]P"CI=!6C)+Y9<2#**"N!\I)QD8%:<]KK,GBK
M3[B+[2+&*,))NE #8WABP#=3E#]TYQU7'.T^KZ;&)2^H6JB%Q'(6F4;&/13S
MP>#Q4SWEM'<QVSW$2W$H)CB+@,X'4@=30!-1110 4444 %<O8V^JVAUDS6]Y
M.DS,T7[]5D9B7.$.\A5QM /RD$\CBNHJ(W, ,H,\8,(S*-X^08SEO3CGF@#C
MXM+U^*RMKF"2[\\!O,M)YLJHWY" [R3U !)R0O49Q790F1H(VE4)(5!=0<@'
M'(SWJ"/4["95:*^MG5UWJ5E4Y7.,CGIGBK5 !1110 4444 <G#::TEKK,<<=
MXGGD&W$MR"RG'S[6W' /8\<GHN,F :;X@MTBNK9[ECEO]#GGSM02912V[DXQ
MGGL1DYKJH]0LIHII8KRW>. D2NL@(C(ZACGC'O21:E8S!3%>6[[E#KME4Y4G
M (YZ$\4 64+%%+ !L<@'.#2T44 %%%% '.:]9ZS/K>FS6#R?98S\ZH^U=V]<
ME_F!(V[N@;GC'-9\5AKJZ%>0&.]\YS$RJUR&9V7;YN&W@JKG. ".,_=SBNLF
MO;6VFAAGN88I9CMB1W 9SZ 'K0][:QP2SO<PK%$2LCEQM0CJ">U '*IIWB6U
M2SN5F>YG\J/[1 \V$W#H <\^I/UY;I78U72_LY6"QW<#DA6 60'(;[I_'MZU
M8H **** *NIQRS:7=10&42O$RH86"N#C^$G@'ZUQD.F^(VTO3$6.^@N8X9%>
M3[5D!2' W R'#\H?XN@&Y<5W<DB11M)(ZHB@LS,<  =R:JPZOIMPT"PZA:R-
M<*7A"3*3(!U*\\]#T]* .5L-/\0Q7&F3SQW!$3N3#Y^Y$C+=&)DW%MN,?>'.
M#BM31[75XO$6H377F"Q?)C\R3<7);*X&XA0J_+P%SWR>:UFU;35FAA;4+42S
M$K$AF7+D$@@#/)R"/J*EBO;6XN)H(;F&2:$XEC1P63Z@=* )Z*** "BBB@#+
MUG18]9-L)99(U@9V_=NR$DH5^\I![Y]ZYV[\"W5S.[#5ML7V-+98UC9<[0F"
M2&Y&4)Q_M$?7KKF]@M)(8Y20TN[9@9^ZI8_H#5?^W-+%FET]]!'"Z[@9'"XZ
M=<]#\P_.@# 7P2ZVLD0U)P\QW3R*A7S&R_. W'#XX]*E/@YH[&>U@O%\N25)
M/*E5VC.TMPP#@D8*]"/N"M=O$.F)=R6K72++& S@D !2<;L],5>M[F"[MTN+
M>5)87&5=#D&@#ESX,E65&CU'&)EE9RC;V8)&I?(8?/\ NSR01ASP>^G9:"UE
MXBO-12X M[B)8Q;A3A2  ",G@#'0 #G\]JB@#DI?"4MM"\]I-OO%M%@3!*;M
ML85><X # -T[4ZX\'S3V94WRM<OY>]Y%=E;:A!X# _>8N/0@5U=% ')3>#9Y
M;_[2=49N)-K.C%T+(Z_*=V /GR>.2HZ5'-X)E:V@AM]1$ AEWH$C;:/WDCYV
M[L$_/WXR,\=NQHH **** "BBB@ HHHH Q_$NCRZYI!M()(8I1(KI)*C-M([C
M:00>?7VZ&LMO"E_$MX+74H4:X(R6A8[N268C?@.02,J%P">.F-S6-9M=#LA=
M78E*-(L:K$FYBQZ#%5;[Q5I6GBY\Z9\V_EAP$/5]VU03@$X4DCMCF@"&[\,F
M\GTJ8WC0?V=(C10PH/+*KVPV2#CC(/3BN@K-N-<LK6>UBD,I-R%92L9(0,0J
MEO[H)('/<UI4 %%%% ',>(?"DNNZDDZ7B6T1MWAE*1GS'!S@9W8*\YZ9'.",
M\,D\+7CZ3!8?:X%$4C3+*%DS&[%L[,.",!N"2?>MBXURSMM9BTI_--Q)"9LK
M&2JJ,\D_@?\ )%0S^)M.@TNSU$M(8+QPD(V[68D$]&QC@'K0!D3^#+B6&Z1-
M2$1EF\Q"B/\ +D.';E_OL)"#C ..GI<7PNZZ]::B+O"P1I&4VMDJ@8*!\V.0
M_.0>G&*E;Q=I2FX4&=V@F\EE2$DDC<21[ (Y/^[[C-Y]9M$O[.TS(6NUW0R!
M"4;@MC=ZX!/_ .L9 -"BBB@ HHHH *P+'PY)IUUJDT-^TQU @L+J)7VD!O3&
M[J!SV7%;]9B:]8L-0+M)$-/&Z<RQE<+@G</4'!_R1D QAX-(M8R+Q8[U7>7S
MT1N&9BP RQ. 2W))//48Q74PHT<,:/(9'50&<C!8XZUC6WBW2KEH51Y0TR[D
M5DZ_,5QZ9R#[<5N4 %%%% !1110!S8\-7#1:FCW< ^W;<[(2 NT?*<%C[9 P
M.. "2:BD\(,R)-'>+#?[WE>>*,@%V?=P,\ 9('?ID\5J1^(+&2WOICYR"Q;;
M,KQ$-TR,#J<]AUY%1P>*-,N+E+=7E6=L#RWC(*MNVE3[@]: -A0510S;B!@G
MUI:** "BBB@#)U73+J_O[&2.:!;6%P\T3QDM(0P9?F!& ",XZ9QGIBJ=YX8\
M_3;JRAEBBCFNOM8 C( 8,K!3M(."5.<$'FM6^U2#3I(%G2;;*P7S$C+(A)"C
M<>V20*J6OB6POM,N-0M?.F@@;:=D9);IR/;!!]N^* ,\^$"D=H]M?&&[@C5#
M<*ARY  R1GT  [\#)-=161;>)=,N[F.WAE=I)41T!0C<' (_0@FM>@ HHHH
MKW]J+W3[BU(C(FC9/WB;EY'<9&1^(KFK7PGJ"6]C;3ZE&T,$;!C'&PD60[L,
MCDD_*&PN[/<G)QCK:R=0\1:?I>HI9732+(T#7#,(R51%SDL>W0_Y(H K:9X:
M_LVWL8!=F:.S:>2)9(P!O=B5)"X'RAF'3OGBK&G:7=V^KW=]=S6\OFC9$(XB
MAC3.=O4@Y.23U)^@IEMXITVZ:U$9F_TCH3&<)EBB[CT&6! ]<5<M]5@N-2GL
M DR3Q+N_>1E0ZYQE2>HSQ0!>HHHH **** *.IZ7%JD4:R2SPO&Q9)('VL,@J
M1GT()%9MYX,T>]64/'(N\18P^0GE@J, Y'(.#ZX'I5_5M7BTA())HV:.1RI*
M<D84L,#N20!^-9J^,+41(T]K<QNRLYB";G159U9F[ #RR3R>O>@"P_A;3G+_
M .N"N "@?Y>.G&.W]:O:5ID&CZ='8VS2&*/)!D;)Y))^G7H.!63)XVTJ'3Y+
MUTN5A1@.8\%E.[#J,\K\C>_'2F0^,X)%5GL;J)7@,J,P!&09>&QTR(B1UZ]J
M .FHKG[GQ9;Q:8;Z*UGDB%S'#EAL#*S;3(N>H'S'L?EJK-X[L;:PDNI[>55^
MT2P1;2&WA2 '/<!MR]CC- '545@6WBRQO(]0^SQRM+8PF612I"L0#E5;H<$8
MJ,^+H7DBC@LKAF:X6)V<;55/GW2 ]P/*<>^/3F@#HZ*Y=/'.G7&GR7=G:WMQ
MLB:78(MAVC;CEB!SN&/_ *U2OXMB6\:W%G*["Y%N-AY)WJA.#C !;GGMQ0!T
M=%4K#5+;4C,+?>3"VR3<N-K<Y4^XQR/<5=H **** "BBB@"AK.DPZWISV,\L
M\43D%C"P!(]#D$$?45G'P7HJF1K>![:1]A\R%^05W8(SD9.]LGOFK7B+5YM$
MTHWD-I]J(=59=Y4*IZL< G ]@?RS5*3Q'=HM](EE:/!;",I+]K(5RXW!?N?>
MVE>%W9+@4 7'\.6326K;YPML%5(Q)\K(I!56]0"H([_G6O6!>>)C::CIUFUA
M(&ND228N2! &8* < C.XXY(^M;] !1110!FW>B6U[K%GJ4TDYDM ?+C#_)D\
M;L=<_0C/?.!4,_AVWGLH[+[3<I:HFSRT<#<#G.3CG()'\L&H-7\3)HVL0VUW
M ([)X6D>[9R &&3M  .3QW(SGC.#42^*S/X6CURVLEE0L_F1"<$JJLP."H.3
MQ]!W.!F@!9/!.D2V]Q WG^5.ZLR[P< %CM&1T^=N3D\]>!C0;0[9[RUN&EN"
M+4YBBW_(#R!QCL"1[\9S@5BKXU>8W*P:<K,DA$6^?:LJ 2$MG;Z1-C&1R.1S
MBZ?%"'7+/3X[5S%/%'(T[$@(9 Q1>A&3L/<?C0!T%%%% !1110 5CMX<LY#>
M^=)<3"]79,)),Y3YODZ9P-Q]^G.!BMBLJPU>6ZU"_LY;3RY+8*Z;9-WFHV[!
M&0!GY>Q('3.0< $+>%M.DL!:2F:0;F<R,PW,[')8\8S^&.3Q6Q#$L$,<*9V(
MH5<G)P!CK7-_\)<R0V<UQITD,-P@)D,FY4?<05) YP 3Q[8'>NECD26-9(V#
M(X#*P.00>AH =1110 4451U'4&L&M,6[2K/<)"S!P!'N_B.>O/84 51X;M-E
MXKSW4GVO_6L\N3@9V@'&?ESD'KZDXILWA;3KBR2VF\Z0)N/F,_SLS-N9B<=2
M<^W)QBJ\'B@RZ=>7;V03R8DFB03 ^8CE@F3CY3E3D<X]340\7F*94O+ P)O:
M)IO,W1[U<J^#MY P3Z^H&: .F50B*J]%&!S2TBL&4,I!!&01WI: "BBB@#.O
M]'BU"_L[N2XN$:U)9(T8;&)Z[@0><9&>H!/K5:U\,6EE:2VUM<7<2R +N609
M55 "@<=% P <Y!.<U/J>J3:?<V<4=LLZSR!"!+A^HR57!W8&6.2  .M9\/B:
M>?2;JZCTTO/$(GC@CEW^8LH!4Y"\'!Y&#TXS0!9F\+:9/96]JZ2>7;H$C(?D
M 'U]3_\ JQ6U7-)XOB$MOY]MY5O.BLER6.P\ MU4'CD=,Y'(%=+0 4444 %8
M^L>&K#7+J":^:=TA5E$(?"'(QDCKGGL1[YQ6C>W#VMC/<10F>2-"RQ*P!<@<
M#)]:YRS\73WGV +8(GVI"&D:1]D<N6 C)V9!)7G<!C/>@"XOA'31/:3NT\DU
ML[2*[L"6=CG<>.H//&!P.M7;#1X]/OKN[6YN9I+HAI!,P8#'3'&0!V&<"L>#
MQ=*9M-2YT]8A>D;&69FR&<JA7Y!G(PQSMP&'7I6G8:TUYJLUFUL(T7S#%()-
MQ?RWV-E<?+\W3DY'I0!K4444 %%%% $-Q:6]W'Y=S!',G(VR*&'((/7V)'XU
M6.AZ2T,4)TVT,46/+0PKA<$D8X]6/YGUJEXCN=4A6RBTI7,LTS*^Q$)"A&/\
M9  R!6.GC._CF>UN=,C%Q#+Y3LCN4D(P-J$*?G)R0IQP.2.X!O1>&=%BLS:?
MV;;20F0RL)(PVYSG+'/4\D?C5I=*T]8RBV-N$.?E$8QSNS_Z&W_?1]:YG4?&
M5YIMBEW+II9I(ED6%2Q')?C.W[V%''J>_>N_CR\6VN+C^R6_T=V5DWG:1N4
MAMO)P3\H[T =<NDZ<BRJMC;!9G\R0"(8=O4^IJ.;0=(N$C2;3+218R2BM"I"
M].G'^R/R'I5Z-_,B20 @,H.",$9]J=0!5CTVQB:=H[2!3<#;,0@^<8Q@^O%.
M6PLT966UA5E.00@XZ_\ Q3?]]'UJQ10!231]-C@>!+"V6)U9&01#!4]1CT]J
M5M)TYL[K&W.3N.8QUR#GZY /X5<HH JV&GV^G12) &_>RM-(S'+.['))/Z?0
M"K5%% !1110 4444 5;_ $ZRU2V-M?VL5S 6#;)5W#(Z&FW.DZ=>0&"XLH)8
MBXD*-&"-X& WU  &:S/&.IW>D:"UW9SQPR+*@+/'O^4GD =,GWP.V02*PU\3
M:O(U[Y[BRB651YC6Q<VJ98#>OJV$XR?O9SVH Z\Z5I[202-90%X&W1,8P2AX
M&0>W0?D*N5RUSKE^+G0\;8Q<!1=0*I\PR'9E0"",+DD\@XY[5U- !115+5YY
MK;1[R>W>..:.)F1Y%+*IQU('.* 'R:;93:A%?R6D+7D*E(YB@WJ#U /^>I]:
MBFT73+C'GV-O(J\A70%0<EL@=,Y)Y]ZX^/Q7J+V-@\5TKW;V4DSPR6N-^ ^&
M!!^8DJ,!>" 2<9%2W'BC54T"QEC:(W4DL@EDV9&Q2VP@ <[RH (P"3QC- '5
M/H6DNDR/IMHRS.))085P[#H3QR>OYGUJ;^S+'[7'=?8X/M$>[9+L&Y<]<'\3
M^9KBSXK\0#3=5F33Y);B(_NXXX-WV<9?(<9!)PJG S]X'.#@;MQK3GQ186%O
M=Q@2*6FMWBQ@?,/OY^]D !1V#$]J .AHHHH **** "JD.F6%M*\L%G!%)))Y
MCLB %FYY.._)_,U;KEH_$&I,VO>=8RVYM4!LDDAR9#M<]03OR5S@8P"!UH Z
M!].LI(!"]I"T04J$*# !.2,?4 U85510J@*H&  , "N(M_$6NK807LJ1S6YW
MJYCCRQ"OC>.@(QM&>!S[5VL,@FACE"LH=0P5Q@C(Z$=C0 ^BBB@ IDD4<H42
M(K[6#+N&<$=#]:?10!231]-C654L+95F9FD C&'+##$^N12_V5I_V9+;[%;^
M0B[%C\L;0,YP!]0#67<:K?VVGZNTAB-Q!,RVP2)L; B-G&<L1N)..N*RU\0:
MS!'#=2JMS8MN DBA(=T63'F8Z#<,8[?,"* .T    & **16WHK8(R,X(P12T
M %%%% %2YTRQN[J"ZN+2&6X@_P!5(Z@LG(/![<@?E4?]B:4()(!IUJ(9"6=!
M$,,3@DD>O _(50US59;+5-,M8+I(Y+B3'DO%E9%R <OGY>#@ <DD=@:R8?$>
MI-H-[</,AFC:,AQ!M,8.WS5"DX)3=C)('KT- '5/IMB\2Q-9P&-%550QC"@'
M( 'H*M5QR>(-:MTL[J\M<VT\4;ND41,D?KD=BQ[9],5V- !1110 R6&.>%X9
MHUDB=2KHXR&!Z@BJ4&A:3;?9_)TZU0VZ&.$B(913U /XG\SZU+J<TMOI=U-
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M9Z=5R>_\@#KJ*YO6K'5KS7--GLA)'#%)B0F7"JH=26 ##.Y=R\ANO0=:Z2@
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MY(8#'3K[UF+HVNVZ0W-J\OF#=_HDUQN5$$F43.>2!C//8C)S0!V=%(FXHN\
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MB#29I&1-0MB1-Y )D #28!VJ>YY'2J9\)6+N[37%W-O!+AY!AG("ES@#YBH
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M%D\I"S!L@,68Y+<#&?;&.>E;D,2P0QQ)G:BA1DY. ,=: 'T444 %%%% &?\
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M&<].<<&GQ^,M.>)F$-XS!055("?,XRVSUVCKTK170-(6X2<:;;><BA5?RQD
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M"KE !5;4+F2ST^XN8K=KB2)"RPH<%R.PJS4<\$-U;R03QI+#(I5T<9# ]B*
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M/]K!KN:* ..36M>MX[*ZN8&FMYH8FDCB@(D0X /!'\39_#' KL:** "BBB@
MKEM=U74++Q-I]M!.XM9H9-\<=J9&# 'YSQR!QP"#['(KJ:* .*LM?U"2XTN*
M:\??)))OW6I"2PJQ ;=M!W$8P %Y!)&,5O:<U]+K.H/)=2/8+L6&-XE7YB-Q
M(( )4!E'.><UKT4 %%%% !1110!B>(M+N]6%E#;3"*-9F:9B7QC8P'"NI/)'
M>L];;Q9;7.FQ1W8FM5E<7+RI&6*!P$SR#@H,Y&3N//'%=)=7MI81B2\NH;>,
MG:&FD" GTR:F5@RAE(*D9!'0T <CJ6DZ[%)<W^G%/[1>.%=Z2,4SN?S"D;MM
M!V[.OO5B:#Q4\.8[P1REP2$2/:%$:\ $'J^[/)/ Q72LZJ5#, 6.%!/4]<#\
MC4%KJ%E?&06EY;W!C.'$,JOM^N#QT- &6XUB+3M-DEAENKJ&X)N$A=%:1-KJ
M#R54]4)'^%8<:>-I==$\L<D5HKD1H)(2 I<9#XZKM';Y@37<TUW5%W.P49 R
M3CDG H YW3T\2OJ:?;962T61FDXB.[[V N!G9]WK\V0<\5TE%("&4,I!!Y!'
M>@!:*** "BBB@ HHHH **** ,#QC9WM]H+1:>EP]P)48)!*(RV#W.Y<KZX(/
M?MBJ']E^))DUG[5<A3<6T8M?LMRPV.I?Y1GIU7+=_P"747-W;V4)FNKB*"($
M O*X503TY-1OJ5A$LS27MLBP$+*6E4",GH&YXS[T 9>K07MSK&FF"TNA%%+N
MDN([@*$ (XV;QN#="2#@9 &36]3#-$JHQD0"0@(2P^8GICUI] !1110!S>I6
M.I2^,=/N;9;@V@A=)G\_;&@.>0H/WN1U# \=,5GZCINO2:'IMA UVT\ +3N)
MAND.&"9<L,X.TGGIR,FNN>[MH[J.U>XB6XD!9(BX#L!U('4BDDO;2* 3R74*
M0EMHD:0!2<XQGUSQ0!Q6HZ1XMG34-\P<S31O%]EN&&T!'& K%< 'RR>>N3ST
MK8EL]6EU^RN-DRQ(J!G%Q\B ;_,!7/S;LI@X[<[<<[+:IIZ>9NOK9?*<1R9F
M4;&/13SP?:IFN;=+B.W>>)9Y 2D9<!F ZX'4T 2T444 %%%% !7+VUGJACUS
M$%[:O<[DMP;E9,'#8D!+G:2<< # VCL3744U9$:1D5U+IC<H/*YZ9H XFWT;
MQ'#90W ED^T+NS:&<E%CW95,ER2?^!'IC-=K"9&@C,RJLI4%U4Y ..0#48O+
M4MM%S"3@G&\= <$_GQ]:GH **** "BBB@# GLM333]7@@>XDDN)F>!VG&578
MF5!S\N2& QTZ^]98TG7K=(KFU><L"W^B3W&X(@DRB$[N2!C//8C)S77F>(+(
MQE0+%GS#N&$P,G/IQS4<=]:2A3'=0.&4.NV0'*DX!'L3QF@"=-Q12X ;'(!R
M :6BB@ HHHH PM;MKVXU33/LUO<F-)-\EQ%<!1& 1P4W#=NZ$X.!G R:I6VG
M:[_8^KVVI!+JYN)6D@>*=@@.Q,#J"J[@>!Z'GGGI9;JW@EBBFGBCDE.(T=P"
MY] #UI@O[,V\EP+N P1$K))Y@VH1U!.< B@#G;C1M6TZX@DTJXGN8XXXT:*Y
MG.&VX YSD\_,?J>O2NJJ!+RUEQY=S"^55AM<'(;[I^A[>M3T %%%% !7-ZM8
MZE+XNTNZM4N#:I&R3-Y^V- <\[002W3J&!XZ8S7257GO[.UE6*XNX(I&5G5)
M) I*KR2 >P[F@#E(M)U^'4-)D:2YFBMDPX:X!R=[%BYW L2A7'!Y'.!6AH=C
MJUOK^HW%Z93;S%BF^0%1\Y*!0&.,*<'('(XR.:V8=3T^X,0AOK:3SBPBV2J=
MY'7;@\X[XJ6.YMYII88IXGEB($B*X)0GID=J ):*** "BBB@#(UW0QKB6T;7
M,MN(6=M\+%7R491@CTW9]#BL&'P/=CSUGU1C%(%"QQLZ(NU"J@ -P%)&.>@Y
MKJ=1U.UTJ#SKIV52&(VH6)VJ6/ ]@:HVWBC3[N_6QA2Z-SG#QM;LIBZ_>STZ
M9^E &?!X8U!?%B:O/J:R6Z<B#:V6.S:"><9&3S[U:?PV_P!HN)X;A(W<W#QX
M4@*\BJJL0"-VW:W_ 'UVKH** .+TWP7?6D$OGZL\DSK(BE7D 2-E<;!\W&&8
M'/7Y13-.\(:M#<-]KU%&CC,?EL-[%PIC;:5+;0 5.. 2>>G%=O10!QFF^#+^
M!_,O=6,S++YB*A=57)CW<;NX1AS_ 'S^/3:/8G3-&LK E";>%8LH" =HQQGF
MKM% !1110 4444 %%%% !1110!B^*-&EUS1S:0- DPD5T>8,0I'<;2,'D^H[
M$<UEW/A*ZN'N7>>T=G6)4&R2,,4).YMCC#98_=P">2/3?U;5[31;-;F\,@1I
M%C41QEV9CT  _&J\OB73X9)HW%UYD97""V?=)G(R@QEAP>GH: *MYX<N;Z?2
M9IM3D+Z=*C@;%*R[>K'(R'/(R#T)KH:S9=>T^*:TC,S-]J57C948J%8@*6(&
M%!) &>YK2H **** .<UCPY<ZGKUO?P7B6BI"T4DL2_OB#G !.5[DYQD<^O&?
M-X*N6T:RTM+V,QVCR.DC(5SO+\;4P/E##'8D<C!KH;K7;&SU-=.D,S7+0F?;
M'"SX49ZX!ZX./_U4Q_$6GQZ5'J3--]F=BI(A8E""0VX8X (.2: ,:3PE=M9Z
MC;K=6Q2[8X5TD(&=VY_OY5SO_APO&,<\6CX;N&\16FJ-=H?)148;3DA-X&!G
M;R'YXXQQUJY/XFTZV6Y:7[2GV<CS ;9\[3GYQQRORMSTX^F;4VK6L%_;V<GF
MA[C_ %;^4VPG!(&[& 2 >/:@"]1110 4444 %<[:>&KBRN=6DCU2=O[2*[I"
MJ"6+ 895@O)&5 R#@**Z*LU-=L&6_9I'C%B-TYDB9<+S\PR.1P>G7'TH PH_
M!!MM/MXK>]"W5N7*3^6%X,A=1A<#C<><9S760JZ0QK))YCJH#/C&XXY..U94
M/B?2YID@$LBS-_RR>)E8-G&T@CAL]O3FMB@ HHHH **** ,*?0"UEJ=K;M!%
M'?3-,?W? )51R.^67)]0:H-X/EV1SPW4<%^&>5Y8T.W<S[L!2> ,D#OP*W1K
M-@;6\N1,3%9R-',VQN& !( QSU'3K5>W\3:7<W"6\<SB9L#RVB8,&W;2I!'!
M!ZCMUH UE!"*&;<P')QC-+110 4444 8VKZ5<ZC?V+H;7[+"X:9)$.]\,"N&
M'0 C..Y [#!S8?"MS%I-U9/+:2"41J!Y;HI$6T(3M8'<=O)!]/3GHKG4+:SG
MMH9Y-LERYCB&TG<0"3TZ< ]:IVOB&PO=/FO;4S3PQ/L/EPLS,>,;1C)SD4 9
M;^$YP+6>#4/+OX8U5[@J6,A&!D@GL ,=S@9-=365:^)-+O)XX(+@O)(J.B[&
M&0PR.W8$$^E:M !1110 5@:GH-Q>^)-/U.&6WC2W1EDW(2[CG"]=N.?3(YP>
M:WZS;O7;&RU.+3Y3,;F2)I@L<+/A1GDX!ZX./_U4 8Q\(21WFE7$-S$#9H/,
M+(V9)-Q9FP#@[F8]0<=1S6G8Z1/;Z]=:E+);@2Q",)"A&?F+9;)(SDGIC.<F
MEA\2Z;/+!&K3AYF*8:!QY;;BN'X^4E@0,]35Z+4+6?4+BQCDW7%NJ/*H!^4-
MG'/3/!X_QH LT444 %%%% %#5=(M=8MQ!=[S&-PPIQD,I4@_@QIMOH6F6EZ+
MNWLH(Y%C6- D2@1@%C\N!P3O.<=:BUS7%T,6LDD!DAE=A+(&QY*A"Q<CN!@9
M] 2>U9@\:1-=26T=INF6P6Z5?,P&D*AC%N(QG#*<Y[GCB@#J:*Y73/&7VZ^%
ME)82).+L6KL@<QJ?+\SEF1=K=!M//.:ZJ@ HHHH **** "BBB@ HHHH ****
M "BBB@#.UO2(M<TQ["::6*-R"QBVY('8A@1C\*HKX4MT\XK?WX>219%DWH7B
M*@@!6*YP%)&#GJ>_-6/$>KSZ)I)O(+47+!U5E9RH5>[' )./8'\@:R[WQFNG
MVNH74]M$T$"*87BGRLCD$A&8J IP-W? (SS@$ T9_"]A<2Z<\AE9=/(\A"5P
M -I4$XS@%0>N?7-;58-_XIM+&YTBWPKR:DZ!?GVA5;HV<<\X&!ZY[5O4 %%%
M% &1J/A^#4]4MK^6ZNHWMT98UB8* 2,;@<9!^AP>,@XJ!O"T#:<=/^V70M&+
M%T&P;RQ)8GY<#.>@ Q@$8/-&J^()].URWL!:1&&:%F$\L^Q=X!(7[I Z=3CV
MS@BF3>(KJ+PXFJ_8$+98O'YK -&I/SI\N2"!D9 X.3@"@![>%;=[:]@>_OG6
M[DWREC&QQ@C;DIRN#@ YQ@8P>:LC0XQJEM??;+HFVC,<<+%60 Y]5SG&!G.<
M <]<X_\ PF%S/'?BUL(FGMG4)'),P\P,[(HR$^\64=,C#=>*V9]0O8M9L;)+
M:W>.=&>5O-;=&%')QMP1DJ.HZ^U &I1110 4444 %9*^'[<27TC7-R[7B[)2
MQ4_)AL+]WD#<>3D\ 9P,58U6_?3;,7"6YG_>QQE=X7:&8+NY],].]9MGXJ@U
M"36DM(?-.F+D /\ -*<-QC^'E2!GKUH 5/!VE)ID=@!+Y:%F#Y4,68Y).!C\
M,8YZ5N0Q+!!'$A)5%"C<<G &.3WKET\82HD+W6G^4KDQR.&;$<@8@J05SP!G
MIW&,]:ZF.1)HDEC8,CJ&5AT(/0T .HHHH **** ,^XT>"YANXFDF5+I]\@5A
M][:J@@XXQM!'O5.;PKI]Q:)!,\[LI9C*6&]F9MS,3C&<D]L#)P!3Y-<>*PU2
MYDLRC6,QB5#*/WGRJ5)(^Z#O'K@?E6>/%SPS*EY8"&/>T33B0LF]'*O@[<D#
M![9[$#.: .H50B*HS@# R<TM(K!U#*05(R".]+0 4444 5[JSBNS 9=W[F3S
M% .,G!'/M@FL>+PC9V^F3V%O>7D$4X56,;(&VJ  OW>@ QZD$Y)K2O\ 4'L;
MBQC%N9$N9O*:3> (_E+9QU/3%9FG^*HM5TG5+^QM_.%D[*D8E ,H"*P)S]W.
M>AY&/PH L7?AFQO8((IVE)@141TVHV!_N@#IQTX[8K9KG)?%7V:[@2[M#!;3
MQHZ7#/E3D MT';./PYP.:Z.@ HHHH *Q]5\/0ZM?VUW)=W4+VZL(Q"RC:Q&-
MP)!((SVX/&0<5L5@:SXE_L75[6WN(%6QDC9Y+IG/RD9PH4 \\=R,]LD8H =!
MX5M(!:A;N[(MP!C<@\S:Q9"V%&2K$D'N>N:M6.@V&G:E<W]M&ZW%RH$I+DAC
MN+%L= 26.<5B6?CA+R33MMHJQ7<ACR)2Q#>:T8 VJ0<8!.2, \9K3TWQ!]NU
MV\TQK<1M!N*D,22%;;ELJ ,]1@GCK@\4 ;=%%% !63+?:TLSK'HL;QAB%<W@
M&X=CC;Q6M2')!P<'UH PY;C5YP!-X<MI  0-]XIZC!ZKW!(J$K?F'R3X5LO*
MY.S[2FWE=IXV?W>/IQ6%;>(O$6DB87ZOJA:]F@B/V8P_+&P 5=H.7?=D9POR
M'FE;QQK*16,$FD9NKGSUE>-)-L)5G5, CD_*,C/\0]10!N6R7UG&L=MX5LH4
M5]X6.Y10&QC/"=<<9JU_:&N_] *+_P #A_\ $UAR:UXA6YT&)82R:G:PR2.+
M<G[.Z8>;=Z;D.U0>C"J&G^/]4N[I9Y](D@LD 61=CGAI( ),[<C:LKY7'53Z
M' !U?]H:[_T HO\ P.'_ ,31_:&N_P#0"B_\#A_\363H?B_4-6UJTLI=#FMH
M9[-;AIG)&TD9Z$#C/R]CGM5:T\4ZYJNKZ=;1:=]B@:\VW+NCL50)(WEG*@*X
M*+DC(^=<'F@#?_M#7?\ H!1?^!P_^)H_M#7?^@%%_P"!P_\ B:Y:\\3:[#K%
MU$DKATO1#]@&FN0L'F*HD\[H=RDG\?\ 9-2)XSUI[9 VCR)NCCQ* Q?=MMV;
M*[, ?OF'_ #T[ '2_P!H:[_T HO_  .'_P 31_:&N_\ 0"B_\#A_\37.MX]U
M!;JUA.AN?.NQ"X'F9A7>J'<2F-XW;B 2, \]Z@O_ !=K]IH/A^>*PN+B[E3[
M5J(BM"V(5(#+C(VD[N.I^4\&@#J?[0UW_H!1?^!P_P#B:/[0UW_H!1?^!P_^
M)KE[OXAZC:W<\2^'I9TBG9!Y.]FD7)V[1LY9L9QU7/(QS3X_'&MR6<-W_8D<
M:/;7$GEN[Y9XVC  ;;@##L>1_ : .E_M#7?^@%%_X'#_ .)K2GEN4LS)#;"6
MXP"(3)M!/<;L?TJ#1M0;5=&M+YX7A:>,.8W4J5/T(!J]0!C?VAKO_0"B_P#
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MM/J/EZ\FFF;56=G/ANV+/G<3>+\V0 <_+SP /P%;U% '/2-J4R!)/#%HZ@
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M5D2,E6/E[VR3U'[SC!'3'O)IZ^)Y?$CM?1LFFQR,8LR)R,.!G;R1]P\C()-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>forms-4_008.jpg
<TEXT>
begin 644 forms-4_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %# 6P# 2(  A$! Q$!_\0
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MFMH68Q*23&"2<"IOL-G_ ,^D'_?M?\*6Q!_L^VX/^I3^0JQ@^AKZR$(\JT_
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M;;O^9( RD(<,00,$ ]QQ3Y_#%S:Q/+<:%+#&@!=Y+0J%!. 22..:ZE/&-O\
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M#9_\^D'_ '[7_"C[#9_\^D'_ '[7_"K)!+$X/)S1@^AKIY(]OP./GEW?W_\
M!*WV&S_Y](/^_:_X4?8;/_GT@_[]K_A5G!]#1@^AHY(]OP#VDN[^_P#X)6^P
MV?\ SZ0?]^U_PH^PV?\ SZ0?]^U_PJS@^AHP?0T<D>WX![27=_?_ ,$K?8;/
M_GT@_P"_:_X4?8;/_GT@_P"_:_X59P?0T8/H:.2/;\ ]I+N_O_X)6^PV?_/I
M!_W[7_"C[#9_\^D'_?M?\*LX/H:,'T-')'M^ >TEW?W_ /!*WV&S_P"?2#_O
MVO\ A1]AL_\ GT@_[]K_ (59P?0T8/H:.2/;\ ]I+N_O_P""5OL-G_SZ0?\
M?M?\*/L-G_SZ0?\ ?M?\*LX/H:,'T-')'M^ >TEW?W_\$K?8;/\ Y](/^_:_
MX5SVOQQP7T:Q(L:F('"* ,Y/I758/H:Y?Q(#_:$?'_+$?S-<F,BE2T78[<#.
M3K*[Z,^AO#OPC\&W_AC2;RXT^X:>XLX99"+V9069 3P&P.3T%:?_  ICP/\
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MQPO_  ICP/\ ] VY_P# ^?\ ^+H_X4QX'_Z!MS_X'S__ !==UY1_YZR?F/\
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M>!_^@;<_^!\__P 77=>4?^>LGYC_  H\H_\ /63\Q_A1S2[AR1['"_\ "F/
M_P#T#;G_ ,#Y_P#XNC_A3'@?_H&W/_@?/_\ %UW7E'_GK)^8_P */*/_ #UD
M_,?X4<TNX<D>QPO_  ICP/\ ] VY_P# ^?\ ^+H_X4QX'_Z!MS_X'S__ !==
MUY1_YZR?F/\ "CRC_P ]9/S'^%'-+N')'L<+_P *8\#_ /0-N?\ P/G_ /BZ
M/^%,>!_^@;<_^!\__P 77=>4?^>LGYC_  H\H_\ /63\Q_A1S2[AR1['"_\
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M\CK9_P#8.3_T9)7OU> _''_D=;/_ +!R?^C)*[A-W=V>R^$/^1*T'_L'6_\
MZ+6MFL;PA_R)6@_]@ZW_ /1:ULT",KQ%I+ZUHTUE')"CO@@SQ>8O'J,@CZ@@
MBL"/P$T-VMTFJEKA'28320[G>50@^=MWS1_(#MX.3G=7:44 <U8>%'LKV"5M
M0\R)9OM4J>3@O/M92P.>%^;[N#T'/6ND(R"#WI:* (_)3_:_[Z-'DI_M?]]&
MI** (_)3_:_[Z-'DI_M?]]&I** (_)3_ &O^^C1Y*?[7_?1J2B@"/R4_VO\
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MSR_\>% $E%1[Y/\ GE_X\*-\G_/+_P >% $E%1[Y/^>7_CPHWR?\\O\ QX4
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M'_D=;/\ [!R?^C)*[AGLOA#_ )$K0?\ L'6__HM:V:QO"'_(E:#_ -@ZW_\
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M)7R64?\ (TQ7K^IZ.(_@4_ZZ'04445]:><<9\4?^1*?_ *^[;_T:M>=^#/\
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M*X!!'(.3U)K=HH RK;PWI=I=07,%NRR0KA/WKE<X(W$$X+X9AN//)YK5HHH
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MH_[YHV2_\]1_WS0!)14>R7_GJ/\ OFC9+_SU'_?- $E%1[)?^>H_[YHV2_\
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M2_\ Q-'_  E^B?\ /S-_X"2__$UN5!/>06TD,<K[6F<1IQ_$02,^F=IZ]^*
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MW*HZEJMKI(MWNRZQS2B$2!"51CT+$?=&>,GC)'K0!1_X2_1/^?F;_P !)?\
MXFC_ (2_1/\ GYF_\!)?_B:W*HZGJD&EQ1-*&>2>010Q)C=(Y!.!G & "23T
M - %'_A+]$_Y^9O_  $E_P#B:/\ A+]$_P"?F;_P$E_^)K8@GBN8(YX)%DBD
M4,CJ<A@>A%.9U1=SL%&0,DXZT 8O_"7Z)_S\S?\ @)+_ /$T?\)?HG_/S-_X
M"2__ !-7-/UBTU*XO+:%RMS9R^5/"^-R'J#P>A'(/]00-"@#RZ#5K1;[4W87
M(66^DD0_8YOF4XP?N^U;?A3Q'IEAX>BM[J2XBE6:=BK6DN<-,[ _=[@@_C75
MR:G91:C%I[W4:W<H+)"6^9@ 3_($_@?2K=>;ALNIX?$5,1%MN>^UM[Z&\ZTI
MP4'T,/\ X2_1/^?F;_P$E_\ B:/^$OT3_GYF_P# 27_XFM+4-2L]*MOM%]<)
M!%G&YOIG^0)]@*LJP90RD%2,@CO7I&!YW\0==L-6\*M:V)N9Y_M,#[$M)2<+
M(I)^[V S7%>%Y39>+])N[FVO8K>&61I)&LYL*#$X&?E]2!^->[RRQP1/+*ZI
M&@+,S'  '4FHK*^MM1MEN;29)H6) 93W!P1[$$$8K&5)2FIOH*PS3]3M-4A:
M:T=G16VDM&R<]>C >M>&?''_ )'6S_[!R?\ HR2O?J\!^./_ ".MG_V#D_\
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MW"'LPZC/!Z<9R,2P\-6VIR_VAJ%O<K$Q8VUI<OEH06#!B1\P.0&"DG8>F.@
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M65@<$9P5X!KL8Q::59P6X=(8441Q!VZX!.,GJ< G\*>B06%G@$1P0IRS-G
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M<4GF*S3JBN$8%592P4MNP> 2,XSC(SUK-TG1++4IXM:A#0PSJ_FVG#*')Q(
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M+UDB07<2/-:Q+^X+\%7"L,AL8&>,X&1D5=U35;;2;=9)RQ=R5CB12SN0"3@
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MA>6Y'*NB@C)P !;S4KWQ5=RVNE3.+:*8@$.H)^7@N,']V3NP<,0P((Y^7J=
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M X6DZ$?%'FZAJL,1M[AG#C80\HV[,!@WW 1N'7#+E2003V5]IEIJ)@:ZA#M
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M_P"2L/\ \1110 ?\+7\;?]!K_P E8?\ XBC_ (6OXV_Z#7_DK#_\1110 ?\
M"U_&W_0:_P#)6'_XBC_A:_C;_H-?^2L/_P 1110 ?\+7\;?]!K_R5A_^(H_X
M6OXV_P"@U_Y*P_\ Q%%% !_PM?QM_P!!K_R5A_\ B*/^%K^-O^@U_P"2L/\
M\1110 ?\+7\;?]!K_P E8?\ XBC_ (6OXV_Z#7_DK#_\1110 ?\ "U_&W_0:
M_P#)6'_XBC_A:_C;_H-?^2L/_P 1110 ?\+7\;?]!K_R5A_^(H_X6OXV_P"@
MU_Y*P_\ Q%%% !_PM?QM_P!!K_R5A_\ B*/^%K^-O^@U_P"2L/\ \1110 ?\
M+7\;?]!K_P E8?\ XBC_ (6OXV_Z#7_DK#_\1110 ?\ "U_&W_0:_P#)6'_X
MBC_A:_C;_H-?^2L/_P 1110 ?\+7\;?]!K_R5A_^(H_X6OXV_P"@U_Y*P_\
MQ%%% !_PM?QM_P!!K_R5A_\ B*/^%K^-O^@U_P"2L/\ \1110 ?\+7\;?]!K
M_P E8?\ XBC_ (6OXV_Z#7_DK#_\1110 ?\ "U_&W_0:_P#)6'_XBC_A:_C;
M_H-?^2L/_P 1110 ?\+7\;?]!K_R5A_^(H_X6OXV_P"@U_Y*P_\ Q%%% !_P
MM?QM_P!!K_R5A_\ B*/^%K^-O^@U_P"2L/\ \1110 ?\+7\;?]!K_P E8?\
MXBC_ (6OXV_Z#7_DK#_\1110 ?\ "U_&W_0:_P#)6'_XBC_A:_C;_H-?^2L/
M_P 1110 ?\+7\;?]!K_R5A_^(H_X6OXV_P"@U_Y*P_\ Q%%% !_PM?QM_P!!
MK_R5A_\ B*/^%K^-O^@U_P"2L/\ \1110 ?\+7\;?]!K_P E8?\ XBC_ (6O
MXV_Z#7_DK#_\1110 ?\ "U_&W_0:_P#)6'_XBN/\5^*]:U[5(KK4KWSYDA$:
0MY2+A0S'&% '4FBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>forms-4_009.jpg
<TEXT>
begin 644 forms-4_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #N @P# 2(  A$! Q$!_\0
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M27P\_P"A>_\ )VX_^.5Z!10!Y_\ \*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\
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ME'_"DOAY_P!"]_Y.W'_QRO0*3(SC(R.<4 <!_P *2^'G_0O?^3MQ_P#'*/\
MA27P\_Z%[_R=N/\ XY7H%% 'G_\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_
M "=N/_CE>@4@()(!!QP?:@#@/^%)?#S_ *%[_P G;C_XY1_PI+X>?]"]_P"3
MMQ_\<KT"B@#S_P#X4E\//^A>_P#)VX_^.4?\*2^'G_0O?^3MQ_\ '*] I%8,
M,J<C)'Y<4 <!_P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\ XY7H%% '
MG_\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE>@4@(8 @@@\@B@#@
M/^%)?#S_ *%[_P G;C_XY1_PI+X>?]"]_P"3MQ_\<KT"B@#S_P#X4E\//^A>
M_P#)VX_^.4?\*2^'G_0O?^3MQ_\ '*] I 0P!!!!Y!% ' ?\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE>@44 >?_\ "DOAY_T+W_D[<?\ QRC_ (4E
M\//^A>_\G;C_ ..5WY(4$D@ <DFEH \__P"%)?#S_H7O_)VX_P#CE'_"DOAY
M_P!"]_Y.W'_QRO0** //_P#A27P\_P"A>_\ )VX_^.4?\*2^'G_0O?\ D[<?
M_'*[]F"C+' R!^?%+0!Y_P#\*2^'G_0O?^3MQ_\ '*^=/B?I=IX7^(NK:1HR
M/:6$'DF.%97;&Z%&/+$D\D]37V77R!\;?^2O:Y_V[_\ HB.@#W_X)?\ )(="
M_P"WC_THDKT"O/\ X)?\DAT+_MX_]*)*] H **** "BBB@ HHHH **** "BB
MB@ HHHH \;\1?$;7-#\:^-=/EN432[:R5-/F9(A]FO&M&FC&206#E)>"&^8(
M.,\T_$7Q*\1:;8^'KF"[Q]F\/VFMZDOEQ_\ $P\V:&(Q9*_NOO.=R_WL8& :
M]$U+X>:+JS^)FO&NW'B%+=;I1( (S"N(VCP,@@X/.X$CIC(K/B^$7A58=02>
M"2[>\LH+(37212/;K%#Y*O$2GR.5 )/J <#&* ,/QCXPU;0?%^H6VL:IJN@:
M))%$FE:E9Z?%<6WF&-V<SED=BV\8"+M.%R< [JCN/B#J5K>>/8'U&2[%CIEM
M-I<]CIS2P)(]J9#)N17"HS;6'F,1CN0#5?6[O0]+FO?"<.H^+MD:6&@36EM)
M;/'<&:!Q&5\X$1DHI5RNP9P<=31]M\):,?$>F+IGB"WO-6>QT"XTP- SP![9
MDMS&Y<I@H",L[$$<@"@#TSPG?7&I^#=#O[R3S+JZT^WFF?:!N=HU+' X&23T
MK3N/]6/]]/\ T(50\-VPL?#6FV2VMW:I:VZ6Z0W;1M*%0; 6,9*$D*#P>_;I
M5^X_U8_WT_\ 0A0!+1110 5%<?ZL?[Z?^A"I:J:E=0V5BUS</LBC9"S8)Q\P
M["FDV[(3=M68^KW>LQ>);"&S68V#^7YQ2 ,O+D-EL<<8[UT=1P31W$$<\3;H
MY%#HV,9!&14E5.5TE:UB8QLV[WN%12_ZR#_?/_H)J6HI?]9!_OG_ -!-062T
M444 %1-_Q]1_[C?S6I:B;_CZC_W&_FM $M%%% !42_\ 'U)_N+_-JEJ)?^/J
M3_<7^;4 2T444 %1+_Q]2?[B_P VJ6HE_P"/J3_<7^;4 2T444 %11?ZR?\
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M_P!$1T >_P#P2_Y)#H7_ &\?^E$E>@5Y_P#!+_DD.A?]O'_I1)7H% !1110
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M_,!D#@:'_"N-8_MCROM-C_9G_"5?\))]HWOYWW?]3Y6W;][C?OZ<[>U>H44
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M@ [3PXUB_A^S?3=+DTNT9"R64EI]F:$DDLICP-IW9Z<'J"0<F_<?ZL?[Z?\
MH0K,\*Z#_P (QX7T[1?ML][]CB$?GSGYFYSP.RC.%7G"@#)QFM.X_P!6/]]/
M_0A0!+1110 5%<?ZL?[Z?^A"I:BN/]6/]]/_ $(4 2T444 94^M>1XDM=(^S
M[O/B,GF[\;?O<8QS]WU[UH2_ZR#_ 'S_ .@FI:KW<\5N(I9Y4BC5^7=@H'RD
M=35.SLDB5=7NRQ145O=6]W&9+:>*9 =I:-PP!],BI:EJVY2=]@J)O^/J/_<;
M^:U+43?\?4?^XW\UH EHHHH *B7_ (^I/]Q?YM4M1+_Q]2?[B_S:@"6BBB@
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MJ,S1Y(^UJ<0OA3M5F5&)S@[<'U2LOQ+J4VC>%=7U2W6-I[*RFN(UD!*ED0L
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M[B2Q8]OEJOXC\#V%UXGOFN/$,<%WXBO;.>UL)+?S(Y39QL6CE3</-B*\D?*
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M$*EJ*X_U8_WT_P#0A4M !7R!\;?^2O:Y_P!N_P#Z(CKZ_KY ^-O_ "5[7/\
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M&GDO"6V;,2-C # @8(Q0!J:/X(\1:?X[M=<ET_=:Q>)=4N61)HRYM[F)$CF
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MXO\ -JEJ)?\ CZD_W%_FU $M%%% !447^LG_ -\?^@BI:BB_UD_^^/\ T$4
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M+J:.6 ONW[958/AMQR-V#QZ#'244 1P00VMO%;V\4<,$2!(XXU"JB@8  '
M'&*>RAAAAD9!_+FEKGU\::$=<O-)>[\J2TB\V2XE4I <>9N42GY2R^5(6&>-
MC]2C[0#H**P]$\7Z'XAN/L^G7<C3_9TNECGMY8&DA8X61!(JETR,;ER.1ZBM
MR@ I&4,,,,C(/Y<UF>(=?L?#.C3ZGJ#2>5$C,(XEWR2E5+%47N=JL3V 4DD
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M4 >(?V#K']L?V7_95]]H_P"%@?VSO^SOY/V/;N\SSL>7T_AW;L\8SQ7M]%%
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MCA(?"2 . "0,D8/.,X-?/GQM_P"2O:Y_V[_^B(Z^OZ^0/C;_ ,E>US_MW_\
M1$= 'O\ \$O^20Z%_P!O'_I1)7H%>?\ P2_Y)#H7_;Q_Z425Z!0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT33M!LWM=-M_)CDE>>1F=I'ED8Y9W=B6=CZDD\ = *^4/C;_ ,E>US_MW_\
M1$= 'O\ \$O^20Z%_P!O'_I1)7H%?/'P\^-7ASPAX&T[0M0LM5ENK4RAWMXH
MV0[I7<8)D!Z,.U=/_P -'>#_ /H&ZY_WXA_^.T >P45X_P#\-'>#_P#H&ZY_
MWXA_^.T?\-'>#_\ H&ZY_P!^(?\ X[0![!17C_\ PT=X/_Z!NN?]^(?_ ([1
M_P -'>#_ /H&ZY_WXA_^.T >P45X_P#\-'>#_P#H&ZY_WXA_^.T?\-'>#_\
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MP45X_P#\-'>#_P#H&ZY_WXA_^.T?\-'>#_\ H&ZY_P!^(?\ X[0![!17C_\
MPT=X/_Z!NN?]^(?_ ([1_P -'>#_ /H&ZY_WXA_^.T >P45X_P#\-'>#_P#H
M&ZY_WXA_^.T?\-'>#_\ H&ZY_P!^(?\ X[0![!17C_\ PT=X/_Z!NN?]^(?_
M ([1_P -'>#_ /H&ZY_WXA_^.T >P45X_P#\-'>#_P#H&ZY_WXA_^.T?\-'>
M#_\ H&ZY_P!^(?\ X[0![!17C_\ PT=X/_Z!NN?]^(?_ ([1_P -'>#_ /H&
MZY_WXA_^.T >P45X_P#\-'>#_P#H&ZY_WXA_^.T?\-'>#_\ H&ZY_P!^(?\
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%O0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>forms-4_010.jpg
<TEXT>
begin 644 forms-4_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &2 P(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPO\ A1_:;_E#^RH_S'RUYB_Y!H\Q?\@U]2_V1IG_ $#K3_OPO^%']D:9_P!
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M_?0KZ<_X170?^@3:_P#?L4?\(KH/_0)M?^_8JO[3_NB_LI?S'S'Y\7_/1/\
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M3_P(E_\ BJ/^%4>"/^@$G_@1+_\ %5V=% '&?\*H\$?] )/_  (E_P#BJ/\
MA5'@C_H!)_X$2_\ Q5=F3@9IJ-OC5\8W &@#CO\ A5'@C_H!)_X$2_\ Q5'_
M  JCP1_T D_\")?_ (JNSHH XS_A5'@C_H!)_P"!$O\ \51_PJCP1_T D_\
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M?_BZ[.B@#C/^%3^"/^@$G_@1+_\ %T?\*G\$?] )/_ B7_XNNQ#Y=EQ]VG4
M<9_PJ?P1_P! )/\ P(E_^+H_X5/X(_Z 2?\ @1+_ /%UV=% '&?\*G\$?] )
M/_ B7_XNC_A4_@C_ * 2?^!$O_Q==G37;8A;&<4 <=_PJ?P1_P! )/\ P(E_
M^+H_X5/X(_Z 2?\ @1+_ /%UV8Y%% '&?\*G\$?] )/_  (E_P#BZ/\ A4_@
MC_H!)_X$2_\ Q==G10!YYKWPO\&VGA[4[F#142:*TED1O/E.&"$@\MZUT_@P
M8\"^'@.@TVV_]%+5CQ-_R*FL?]>,W_H!J#P;_P B-X?_ .P;;?\ HI: -NBB
MB@ HHHH **** .?\(?\ (,OO^PK??^E,E=!7/^$/^09??]A6^_\ 2F2N@H *
M*** "BBB@ HHHH **** .'B\4W\.KQ6=XZ*DM\ZQR!0 T*QL64^X(4YJO!XQ
MO;Z+4H8YTAF)5[1G0+A-^U@,\$CC&?6NUETNPG55EM(7"L7&Y <,05)^I!(_
M&BXTNPNXUCN+.&5%78JN@("\<?H/RH Y"V\47\$\$)^U:@=DXD58%$@*^7@M
MCC^(\C'4<5T_A^]FU'0[:[N,^;(&+9&,?,14]KI6GV2J+6SAA"A@-B <'&?S
MP/RJS##'!$(HD5$7HJC % #8>LO^_P#T%2U%#UE_W_Z"I: ,RSO)IM;U"V=@
M8H5C*#'3.<_RK3J".T@BNIKE$Q+, ';)YQT_G4]:5'%OW>R)BFEJ12?ZV/\
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M?Y"I: "BBB@ KAO"?_)3?'G^]8_^BFKN:X;PG_R4WQY_O6/_ **:@#N:***
M"BBB@ HHHH *XKQ+_P E/\#?34/_ $2M=K7%>)?^2G^!OIJ'_HE: .UHHHH
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MO )'W17EYAFE' *+JIOF[>1T4:$JU^7H=517)_VS??\ /;_QT4?VS??\]O\
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MIJ^R 9)_K8_QJ6HI/];'^-2T@"BBB@!&^Z?I3+?_ (]HO]P?RI[?=/TIEO\
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M'YT?V19?\\1^=7JJW6HV]FX29B"1D8&:XZN%P%&//4A%+NTC6-2M)VBVR/\
MLBR_YXC\ZCCTJS,DH,(P& '/L*/[<LO[[?\ ?)JQ97$=T)98B2I?C(QV%8T8
M996ER4E"3\DBI.O%7E=$L%O%;1[(EVKG.*EHHKUH0C"*C%62.=MMW844450B
M*X_X]W^E2U%<?\>[_2I: "BBB@ HHHH B3_7R?A4M1)_KY/PJ6@ HHHH *CG
M_P!0_P!*DJ.?_4/]* 'CH*6D'04M !1110!E^)O^14UC_KQF_P#0#4'@W_D1
MO#__ &#;;_T4M3^)O^14UC_KQF_] -0>#?\ D1O#_P#V#;;_ -%+0!MT444
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M^PK??^E,E=!7/^$/^09??]A6^_\ 2F2N@H **** "BBB@ J.6>* *994C#'
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M4'MZNOYU?TO4[;5]/CO;1F:&3[I92I_6@">'K+_O_P!!4M10]9?]_P#H*EH
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MK+_O_P!!4M10]9?]_P#H*EH *AM[<0>9AL[W+_3@#^E34V21(D+R.J(.K,<
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MLO@FW74["]^W7&ZS7   &\Y8\D?[Q_\ K5TD_P!P?[PJ6HI_N#_>% $M%%%
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MR*Z+$O'S$_-NS[!3]127>GWLM]?6JZ)*S3W:31WY:((BA@3SNWYP#QMKM**
M/,[C2O&<=Q!]D-SG[,R,3)&(T/S?[62QXP,8]ZB?3?&W]C6\2B_,HF9OOQ;U
MZ8W?/C:>>021Z<\>HT4 >:2:;XTWZF(C=XDC4J[R1C)RN50!CDXW<MM_6NR\
M+0ZE;Z%#'JK2&Y!/^MV[@.P.TD9^AK9HH BAZR_[_P#05+44/67_ '_Z"I:
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M_P"@&H/!O_(C>'_^P;;?^BEJ?Q-_R*FL?]>,W_H!J#P;_P B-X?_ .P;;?\
MHI: -NBBB@ HHHH **** .?\(?\ (,OO^PK??^E,E=!7/^$/^09??]A6^_\
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MPE2A"3=971A6C4DER.QJV$SW.GVT[XWR1*[8Z9(S5BHX(4M[>.&/.R-0JY]
M,5)7))IR=MC9;:B-]T_2F6__ ![1?[@_E3V^Z?I3+?\ X]HO]P?RJ1DE%%%
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M@W_D1O#_ /V#;;_T4M3^)O\ D5-8_P"O&;_T U!X-_Y$;P__ -@VV_\ 12T
M;=%%% !1110 4444 <_X0_Y!=]_V%;__ -*9*TVU>P6W6<W*B-I/+!YY;.,8
M^M9GA#_D%WW_ &%;_P#]*9*PI_!NI/=QMBUE3[0)O,>=U,(#[L*H&&S[XZT
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M0!E^)O\ D5-8_P"O&;_T U!X-_Y$;P__ -@VV_\ 12U/XF_Y%36/^O&;_P!
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M,M_^/:+_ '!_*GM]T_2F6_\ Q[1?[@_E0!)1110 5$O_ !\/]!4M1+_Q\/\
M04 2T444 %1W'^I/U'\ZDJ.X_P!2?J/YT 2#I10.E% !1110!%#UE_WS_(5+
M44/67_?/\A4M !1110 5PWA/_DIOCS_>L?\ T4U=S7#>$_\ DIOCS_>L?_13
M4 =S1110 4444 %%%% !7%>)?^2G^!OIJ'_HE:[6N*\2_P#)3_ WTU#_ -$K
M0!VM%%% "8&[=@9Z9I:** "BBB@ HHHH ***R;_4I;74UMUV[#9S3\_WD*8_
M]"- &M17+#QG;VMBLE[&RRA [@=-I#?-],KC\:ST^(D-_:-<:9")F3AHMX(^
M\@SD>ST =P%4,6"C<>"<<FHY_N#_ 'A7,V?C:VEU2STV:)DGN0Q5F( R'9<
M=_N_RKII_N#_ 'A0!+1110 44CG:C$=AFN;.OW08C:GY5YN.S.A@>7VU]>RN
M;TJ$ZM^7H=+447^MF_WQ_P"@BN>_M^Z_NI^5-77;I68A4^8Y/'MBO._UEP'=
M_=_P3;ZC6\CJ**YV'7+F29$*I@G'2NBKT\#F-#&Q<J-].ZL85:,J32D%%%%>
M@8D5Q_Q[O]*EJ*X_X]W^E2T %%%% !1110!$G^OD_"I:B3_7R?A4M !1110
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MXR(KC_CW?Z5+45Q_Q[O]*EH **** "BBB@")/]?)^%2U$G^OD_"I: "BBB@
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M6N*\2_\ )3_ WTU#_P!$K0!VM%%% !1110 4444 %8^MW5VD]E96<Z6TET[
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MTJS/]P?[PH EHHHH **** "HHO\ 6S?[X_\ 014M11?ZV;_?'_H(H EHHHH
M**** (KC_CW?Z5+45Q_Q[O\ 2I: "BBB@ HHHH B3_7R?A4M1)_KY/PJ6@ H
MHHH R;K4)XM7CME(\MBH/'K6E/\ ZA_I4,FGV\MTMRX;S%((.?2II_\ 4/\
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M<8YSUKL0,#% $<\T=M;R3RG;'&A=CZ #)K B\::=+9_:5M[TIN(P(.=HZO\
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MR0V* /2(9HKB%)H)$EB<95T8,K#U!'6GUE^';2>RT6*&YB\J7?(YCR#L#.S
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MNC_T.?B__P &8_\ B*/^%='_ *'/Q?\ ^#,?_$4 =K17%?\ "NC_ -#GXO\
M_!F/_B*/^%='_H<_%_\ X,Q_\10!VM%<5_PKH_\ 0Y^+_P#P9C_XBC_A71_Z
M'/Q?_P"#,?\ Q% ':T5Q7_"NC_T.?B__ ,&8_P#B*/\ A71_Z'/Q?_X,Q_\
M$4 =K17%?\*Z/_0Y^+__  9C_P"(H_X5T?\ H<_%_P#X,Q_\10!VM%<5_P *
MZ/\ T.?B_P#\&8_^(H_X5T?^AS\7_P#@S'_Q% ':T5Q7_"NC_P!#GXO_ /!F
M/_B*/^%='_H<_%__ (,Q_P#$4 =K17%?\*Z/_0Y^+_\ P9C_ .(H_P"%='_H
M<_%__@S'_P 10!VM%<5_PKH_]#GXO_\ !F/_ (BC_A71_P"AS\7_ /@S'_Q%
M ':T5Q7_  KH_P#0Y^+_ /P9C_XBC_A71_Z'/Q?_ .#,?_$4 =K17%?\*Z/_
M $.?B_\ \&8_^(H_X5T?^AS\7_\ @S'_ ,10!VM%<5_PKH_]#GXO_P#!F/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>forms-4_011.jpg
<TEXT>
begin 644 forms-4_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ G # 2(  A$! Q$!_\0
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MY/\ 5S&_]!'_ *7_ )C^N4]N3\O\CI/^$2\-_P#0O:3_ . 4?^%'_")>&_\
MH7M)_P# */\ PI/"6D:9XET)=0N+'5]/F\QXWMFUV[=D*G'/S@@]\$ UN_\
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M ,(EX;_Z%[2?_ */_"C_ (1+PW_T+VD_^ 4?^%;G_"$:-_?U;_P<7?\ \=K
M\3Z5IGAZ"":*TU*\\UP@A77[Q96Y&XJNXA@JY8Y(Z>]+_5S&_P#01_Z7_F4L
M;3?V/R_R'_\ ")>&_P#H7M)_\ H_\*/^$2\-_P#0O:3_ . 4?^%<V][;1Z9/
M=MH6H,\30@I'XEOBNV0 @ER JX!YW$#CK75^&M"T;Q%X<L=7,6JV_P!JCW^5
M_;EV^WDC&?,&>GI3_P!7,;_T$?\ I?\ F3]>I?R?E_D0?\(EX;_Z%[2?_ */
M_"C_ (1+PW_T+VD_^ 4?^%;G_"$:-_?U;_P<7?\ \=H_X0C1O[^K?^#B[_\
MCM+_ %<QO_01_P"E_P"8_KM+^3\O\C#_ .$2\-_]"]I/_@%'_A1_PB7AO_H7
MM)_\ H_\*9XGTK3/#L$$T5IJ5YYKA!"NOWBRMR-Q5=Q#!5RQR1T]ZPH[FU-H
MTTFBWX*R0*P3Q)?,H67;AB^ JX!).XCIU-'^KF-_Z"/_ $O_ #!XVDMX?E_D
M=!_PB7AO_H7M)_\  */_  JUIGA?P_;ZK9S0Z%ID<L<Z.CI:1AE8,"""!P14
M'A_0],UI;UI+?4HH[>?R8YH=?O)8Y\*"Q4EUX#$KT[5T%EX/TFVOK>>-M3\R
M*577?JMTZY!R,JTA!'L00:TI\/8R$XR=?9I_:[I]Q2QE)IKD_+_(Z&XT+2+N
M:::YTJQFEF79*\ENC&1<8PQ(Y&..>U1OX<T.4()-&TYPA)0-:H=I)#$CCCE5
M/U /:KPN8#.8!/&9AUC#C<.AZ=>X_.I:^T/+*%YH>D:A;BWO=+L;F$/O$<UN
MCKN]<$8S[TMSHNE7EJEK=:99SV\>=D4L"LBYZX!&!5TL%&6( ]32@@C(.10!
MGS:%I%Q"89M*L9(F96*/;H5) P#@CJ!P/:F1^&]"BL_L<>BZ<EK@CR5M4"8/
M7Y<8YR:N_:[;[7]E^T1?:=N_R=XW[?7'7%34 4_[)TT&,C3[3,9RA\E?E."O
M'''!(^A(IJZ)I*7)N5TRR$Y7:91;INQZ9QG')_.KU% &:/#VBK>F]&CZ>+L@
M SBV3>0.@W8SV%22:+I4OG>9IEF_G1>3+N@4^9'DG8W'*Y)X/'-7J* &10QP
M1+%#&D<:C"HB@ #V I]%% !1110 4444 %5KG3K&\D62ZLK>=T&%:6)6*_0D
M59HH R[OPSH%_N^V:)IMQO(+>=:1ON(SC.1VW''U/K4C:#H[>3NTFQ/D(8XL
MVZ?NU)R57C@$@' K0HH P_\ A#/"WEF/_A&M&\LYROV&+!R03QM]5!_ >E:]
MO:V]I%Y5M!%#'G.R- H_(5+10!@:YH>H7^KV&I:;J-K:36L$]NRW-HTZNLC1
M-D;9$((,0[GJ:K?V/XL_Z#VB_P#@GE_^2:ZBB@#A+CP)?W;S/<R^%)FG;=*9
M/#K,9#ZMFXY/ Z^E1?\ "N[C:J[?"&%8,!_PC1X(& ?^/CJ!Q7H%12W5O RK
M+/'&68* S 9)Z#\<'\J .8@T#Q-;0K#!K.A11+]U(]%D51] +FI/['\6?]![
M1?\ P3R__)-=$MW;.CNMQ$40X=@XPI]_2G13PSKNAE21>#E&!'/(Z4 <W_8_
MBS_H/:+_ .">7_Y)K,N/ E_=O,]S+X4F:=MTID\.LQD/JV;CD\#KZ5W=% '!
MQ> ;V#_4MX3C_P!SPX1VQVN/3CZ5H6_A_P 2VEO';VVL:##!&H5(XM$D55'H
M +G %=1-<0VZEII4C4#)+L!QT_J*:MW;/&TB7$3(OWF#@@?4T7$<[_8_BS_H
M/:+_ .">7_Y)H_L?Q9_T'M%_\$\O_P DUTL4T4R[HI4D''*,#3Z!G#7O@?4=
M2F>:_F\+74K@!GG\.LY8#H"3<<XHM? ^I6+%K2?PM;DC:3%X>9,C&,<7'IQ]
M*[FHI[F"V0O/-'$H&278  9QW]R/SH YBW\/^);2WCM[;6-!A@C4*D<>B2*J
M@=  +G %2?V/XL_Z#VB_^">7_P"2:Z..Y@ED:..:-W3EE5@2OU%+%/#.NZ&5
M)%X.48$<\CI0!S?]C^+/^@]HO_@GE_\ DFJ%UX+U6^GDGN[KPQ<32*$>27P^
MSLRCH"3<<CD\>]=O10!P,/P]NK==L'_"(Q+G.$\-E1GIGBXK2M_#_B6TMX[>
MVUC088(U"I''HDBJH'0 "YP!73SW,%LA>>:.)0,DNP  SCO[D?G36OK11*6N
MH (AND)D'R#U/I0!SW]C^+/^@]HO_@GE_P#DFC^Q_%G_ $'M%_\ !/+_ /)-
M=)#/#<+NAE21< Y1@1SR.E24 <1=>"]5OIY)[NZ\,7$TBA'DE\/L[,HZ DW'
M(Y/'O54?#F94V!/!X7CY1X:..#D?\O'J2?QKT&HI[F"V0O/-'$H&278  9QW
M]R/SH Y>V\/^)+.VCM[76-!@@C7:D46B2*JCT %S@"I?['\6?]![1?\ P3R_
M_)-=&ES!+(T<<T;NG+*K E?J*6*XAG ,,T<@(W#8P.1Z\4 <W_8_BS_H/:+_
M .">7_Y)JA=>"]5OIWGN[KPQ<32*$>27P^SLRCH"3<<CD\>]=O10!P4'@"[M
MO]0?"47&W]WX;*\<\<7'N?SK3CT/Q1#$L46MZ&D: *JKHLH"@= !]IKI9[F"
MV0O/-'$H&278  9QW]R/SI%NK=FD5;B(F,9<!Q\H]3Z4 <[_ &/XL_Z#VB_^
M">7_ .2:/['\6?\ 0>T7_P $\O\ \DUT-M?6EX";6Z@G ZF*0-C\JGH XBZ\
M%ZK?3O/=W7ABXFD4(\DOA]G9E'0$FXY')X]ZK+\.[A(S&B^$%0C:5'AH@$9S
MC'VCU)_.O0*9+-'"A>61$4 G+' X&3^E ')6?AGQ!IUN+>QU3P]:P EA'!H<
MB+D\DX%SBK']C^+/^@]HO_@GE_\ DFNAAO;2X!,%S#*%&X[) <#UXIT5S!/_
M *F:.3C/R,#_ "H YS^Q_%G_ $'M%_\ !/+_ /)-4;[P=J^J.'U"[\,W;*I0
M-<>'WD(4]1S<GCVKMJ* ."M_ -Y:,&MF\)PD8P8_#A7&#D=+CU)_.M"V\/>)
M+.!8+75]!@A7[L<6B2*H[\ 7.*ZJ6:.%"\LB(H!.6.!P,G]*:MS X0K-&1(I
M=,,/F4=2/4<C\Z .<_L?Q9_T'M%_\$\O_P DT?V/XL_Z#VB_^">7_P"2:Z."
MZM[D9@GBE&,YC<-QT[5+0!Q=WX1UJ_F2:\OO#=Q*BE4>;0'=E!Y(!-SP*II\
M.[B)"D:^$$4DDA?#1 )((/\ R\>A(^AKT"F231PH6ED1% )RQP.!D_I0!R5E
MX9\0:;:K:V&I^'K6W7)6*#0I$09Y. +G%6/['\6?]![1?_!/+_\ )-=(EQ!)
MY>R:-O,7<F&!W#U'J.1^=)'<P3.Z131NR'#*K E3[^E '.?V/XL_Z#VB_P#@
MGE_^2:IW?A'6K^9)KR^\-W$J*51YM =V4'D@$W/ KM** ."B\ 7D$7E0MX2C
MCWB38GAP@;AT; N.O Y]JT+;P]XDLK9+:UU?08((QA(HM$D55'H +G KJI)H
MX4+2R(B@$Y8X' R?TI$N()/+V31MYB[DPP.X>H]1R/SH YO^Q_%G_0>T7_P3
MR_\ R31_8_BS_H/:+_X)Y?\ Y)KHHKNVF8K%<12,"1A'!.1U_F*FH XN[\(Z
MU?S)->7WANXE12J/-H#NR@]0";G@553X?74<#0)_PB*PLV\QKX;(4MZX^T8S
MP*[ZD9E099@!G')[T <=9>%==TR,QV&H^'+5#@%8-!=!QTX%S5^VTKQ-'=0O
M/K6D20JZF1(]*D1F7/(#&X(!QWP<>AK=BO+:<(8;B*0."4V.#NQUQZXHCN[:
M9ML5Q$[ XPK@G_/(H SK[29;B%XUEB:/S&E5'BS\S C#'=@CEN,#MSZQP^'D
MC>0O)&ZL-H7RL!%SG8.?N?[/^0Z33+M[V:57A0.6'G _O"IVX_ARN!O PWOW
MX:^F:D9&\N\9$)*Y\]V)3D#@CA@,<]SR>@H&.ET%))9&+6X#LI"_9A_#G&<'
MD@< ]L5!J>@F6W80+&[R$B7,*MO''4,0&QC')XSD=*%T2^DE\Z>\<2E024N'
MPK8[#I@%F[<\9[U)?Z-<7.JG4(I$#J@C0%MN%'7Y@NX$[G'!Q]T]10(E;2)Y
M997^T)"DT"1F- Q,;#NIW <=B5R,#Z543PT3N\R6 ?/\V(/]<./]9\WS="1Z
M']7Q:/J NXYGNWVY&]5NI#P#D 9X(!+#GJ,9Z5OT 8\^@1RJQ1XUD8'+M%NR
M>-I.3\V,=\]:2'05A$1$L9D242>88LEN1DD9QN(X+8S]*V:* "BBB@ HHHH
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MR,)"XSE9&  VKU )^;CO0!VM%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %1&V@,YG,$?G,H4R;!N(!R!GT!YHHH EJ
M.."&%Y'BB1&E;?(54 NV ,GU. !^%%% $E%%% $1MH#.9S!'YS*%,FP;B <@
M9] >:EHHH C6"%9WG6)!,ZA6D"C<P&< GJ0,G\ZDHHH *B-M 9FF,$?FNFQG
MV#<R^A/IR>*** ):C6"%9WG6)!,ZA6D"C<P&< GJ0,G\Z** )**** (GMH)9
M5ED@C>1%*J[("0#U /H<5+110!&L$*SO.L48F=0K2!1N8#. 3U(&3^=2444
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B50J@ #@ =J9)!#*\;R1([Q-NC9E!*'&,CT."1^-%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>forms-4_012.jpg
<TEXT>
begin 644 forms-4_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %$ N@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;,$.H^\I_.CE8<\3KZ*HZ/J4>KZ1:ZA%]R>,-QV/<?G5ZI*3N%%%% !1110
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MJI:)F,J+>Z.A\"ZW<^(/"=K?W?\ KSE'8#&XCO6-\5M;.F>%OL4+'[3?N(4
MZXSS_A^-=I8V-MIME%9VD2Q01+M1%["L?6/"-CK>MV.IWDLK-9,&CB!^3((/
M/X@5BI14^;H;.,O9\M]3QS6Y+T^$-*M(O#=[9RZ6WF"[8<'CD_G@_A752ZQ%
MKOB;P+J (W.LH<$]&"\BO4[NUBO;*>TF7=%-&T;CV(P:X<?"C24CA6._OX_)
M9FB*28*%NN#6_MHRW5C'V$DK)W*?C5[?3_B#X9N[<I%/F0SLG&8P.2WL!FI/
MB->VVH:?X<N+.>.>*34XBCHV0PYZ5O:5X"T?3+F6ZD\^]N98S$9KJ0NP4C!
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M@#J:*Y;_ (3&[_Z$[Q!^=I_\?H_X3&[_ .A.\0?G:?\ Q^@#J:*Y;_A,;O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q'@G_D77_["-_\
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MV0/+ '+<\<=>:\]CUKSK-77Q!(FFRSRLDOVE6EC"Q HKOVW,&8*>>@]JV/\
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M>M>=9JZ^()$TV6>5DE^TJTL86(%%=^VY@S!3ST'M6Q_PA'CTC!^)G_E!@_\
MBJ;_ ,(+XZQC_A9*XSG']@6__P 52 JVOB!FU2T9=1EGOX[,2WMAYJY9S$"(
MHX^N_/S'T'4\XK4\%ZE?:A'JHU W!GCO.DL101@HIV+GL#GWY![U5_X0;QYN
MW?\ "RAN]?[ @S_Z%3O^$(\>_P#13/\ R@P?_%55Q6.PKF/ '_(I)_U^WO\
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M_H JC_PA/C[_ **9_P"4&#_XJJ]A\._&NEZ?;V%G\2/*MK:-8HD_L.%MJ@8
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M7XE@*!@ :#!Q_P"/4R;'8USO@+_DGWA[_L'0?^@"J/\ PA/C[_HIG_E!@_\
MBJKV'P[\:Z7I]O86?Q(\JVMHUBB3^PX6VJ!@#)8D\>M(9UVHS06VFW,US=&U
M@2-F><$ QC')R<UP+:S(=/CD_MZ6*R?[5+#*+A7D5E5#%&[<\G+MM/L.U:[>
M!_'CJ5;XE@J>"#H,&#_X]3%\!>.$7:GQ(15SG \/VX&?7[U S,U'7-2M[MGM
M+XO-)92M)''<"8Q2*@)!AQ^[VG///. >M=1X8NC<#48X[U[ZSAN0EO<NX<L#
M&I8;OXL,3S^':LP>!O':LS#XE*&;J1H$&3_X]2KX'\>(H5?B6% Z :# /_9J
M9-CL:YWP%_R3[P]_V#H/_0!5'_A"?'W_ $4S_P H,'_Q55[#X=^-=+T^WL+/
MXD>5;6T:Q1)_8<+;5 P!DL2>/6D,Z[49X+;3;F:YNC:P)&S/." 8QCDY.:X
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MLNS\,Z58Z=-806V(9Y3-+ER6=MV[);J<''X"M>BD4]2K/IUI<W'GSP+(YA:
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M[6T!-/5#51%'RJHYSP.](88FZQH>@Y4=NE/HH&%%%% !7G__  B7Q#_Z*?\
M^4"W_P :] HH \__ .$2^(?_ $4__P H%O\ XT?\(E\0_P#HI_\ Y0+?_&O0
M** //3X/^()=7/Q-4NH(#?\ "/V^0#U[^P_*@>#OB".GQ-4<Y_Y%^WZ^O6MK
M5/%%SIOC"RTE[6%+*>!Y#<32,I=@1\J84J3ST)!.>W>70O$-W?&1;^WAC8V4
M5_'Y+$XCDW84YZL-O7H<]!2NK7_K3_A@ZV,%?"'Q"7.WXG 9.3C0+?D_G2_\
M(E\0_P#HI_\ Y0+?_&N@\/:[>:G.8;V""-WM(;V+R6) 23=A3GJPV]>ASTKH
M*IIK<2:>QY__ ,(E\0_^BG_^4"W_ ,::/!WQ 4,!\35 8Y;'A^WY/YUZ"3@$
M@9]JXBU\:ZE<^'M=OCI]I'>Z;O;[&\[AT4 G]X"@YX.",AN<''-+K;^MTOU*
MM=I=W8K_ /"(_$/.?^%G_P#E M_\::/!OQ 7&WXF*,'=QX?M^OKUKJYM4NX]
M=L+,6T7V6Y@=S+O._>H!VA<=.>N:S] \27-YIM[<:FB0W5M$)WLQ;2PR1*03
M@^9][D$;EX.#2;23?;]!+6UNMOQ,5?"'Q!0$+\30 3GCP_;]?SI?^$2^(?\
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MQYX]NM0Y)*_I^(UJ[?UH<P?!OC\OO/Q,4O\ WO\ A'[?/\Z%\&_$!0 OQ,4
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MST%7O"GB.Y\0VMU))%"KQ;"NT.G++G!#<D#^^.&ZBG<5U>QAKX0^(* A?B:
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M 2%'4^U<;I7BW4M4\/WM\\>F64]I<2)+'-)(3$BLPPZE5.XXQUP>OM2NE?R
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MGCTRRGM+B1)8YI)"8D5F&'4JIW'&.N#U]J3:5_("E_PA_P 02X?_ (6:-X!
M;_A'[?(![=?84@\'?$ =/B8HP<\>'[?KZ]:V;KQ%JEH]A))9VH%S;F5[1I2)
MHML1=F9C\H4-A#_O#GM3O#GB:ZUK1]0NS;HTML?W:QQNAD/EAP#&WS Y./\
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MB:E>W<MW:ZA' MS;E&W0$[&5UR.O.1R/?&>,X&O0":>J//\ _A$OB'_T4_\
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M_KXK0K@_#^N^$M&EO97\7>&0;IU8PVEU%%$I P6P9&^8]S[#TR=S_A._!_\
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MWH=];>?W]!*]]?+_ ()W&EZK%J]N;B"&=(<CRWF3;YBD9#*,YQSW -7J\_\
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M (JC_A._!_\ T->A_P#@QA_^*H*)I?%.EPZM=:<\DWFVD)FN)!"QBB &XAG
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MS,AP<G<2<]<5*O;S#[7E?\-/^"=II6L0:LDIBBGADA8!XITV.,@%3CT(.?\
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M_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\
M\31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@
M_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30_
M_!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$
MUT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_
M /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^
MA4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %
MT/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_
MP@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z
M%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#
M_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%%
M '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /""
M>#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/
M_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\
M\31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@
M_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30_
M_!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$
MUT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_
M /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^
MA4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %
MT/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_
MP@G@_P#Z%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z
M%30__!=#_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#
M_P#$UT%% '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%%
M '/_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$UT%% '/_ /""
M>#_^A4T/_P %T/\ \36Y!!#:V\5O;Q1PP1($CCC4*J*!@  <  <8J2B@ HHH
MH **** "BBB@ HHHH **** "BBB@#%\7Q3S^#]7BMHWDG>U=41 26..@QS6)
MI^EZ[I=_Y$-TT=LT,MT+6! T*N!&JQ;W!(!^9B!MZG&,5VM%*V_G_DU_P1-7
M:?\ 6_\ 2/.TU7Q"^Q&O-46Q=HOM-Y_9RB:WD*2%XT3RL,H81#<5;&X\GJ(=
M'U/Q#IVAV>GI;WAN1]D\B-[-@/+*#S S;<+\P.<D$9[<5Z511+56V_K^OZU"
MVEOZ_K^M-CAM%N-1N-?TR:XU?6Y(GMI!-#-8K%$)OD)C/[D$ 9;!SGC&X\@T
M;/2=;MO[4U:V+6LWVRZ5 J.\DX:?"LRM\NU5''!X[@=?1Z*?]?C?_@"MHU_6
MUO\ @G"7TWB%+^XL4OM2=@QA0"TCVR0>3DS&01X$F_(P"!P!MYS5#3-,O]'O
M]%MX9]1M;)%M_/:"TC'FNT<I(DVQ8QNP"<#&<DY.:]*HI)6=Q2CS=0HHHIEA
M1110 4444 %%%% !7G7C1+F[B\1Q++=B:.&#RH[<,VZ+:[8(4@A6<,"1_=&<
M@8KT6F^6GF>9L7S,;=V.<>F:EJ[7]=O\@>UCS62+5GU_2Y6LKJWF6&W40GS9
MF7[V[;-RH49&\,26QU!QG3\)NUC,_F6^H1PO:6\4XEAD):\^?S#TR3C;EAP>
M.:[FBJ[D\NMSS.W$]M/<RV:2"(WUD;1A!- I9I2LBE)<LS^63N;H1C@%37IE
M-:-'9&=%9D.Y21DJ<8R/3@G\Z=1TL.VMPKE?B'#//X.NTMWN@^,XMU9MX )V
MMM(8*?4>V<C(KJJ*35QGG\PNC?Z#-'83QZA$(A/;E)Y) N#D?:&)3;_>SDG&
M,YQ5OPVVIQZCJ@UZPNXVOC%NWGS8]S!@47;D! ,#/Y\FNUHHMK?U_$FWZ?A?
M_,YOPEI,-@E_=PV9LX[J<^5;[=NV-/E4D>K<MSSA@.U=)113&D%>=>-$N;N+
MQ'$LMV)HX8/*CMPS;HMKM@A2"%9PP)']T9R!BO1:;Y:>9YFQ?,QMW8YQZ9J6
MKM?UV_R&]K'GP6=M8T6<V5U!/$BB]@$=Q)*B^4V1YYRKI]WY1R6'7=Q5OP])
M-9+JL=O%*$N' LF2TFBC\SRV)&V3)!^7ER=I) ZYKN**;5[^=_Q%U3[6_ \U
MT9KRVM[)6C87(OK7$[02P/-(RD3HP=B7*H"2W3_OFO2CTIK1HSJ[(I9.5)'(
M^E.JF[BC&W4\UT33[^:U\7VL\6IM'(Q>.ZDFECED;8#LV;N".!E, @XZ8 V-
M?U*Q30H;"ZL[J\NXXH28E@F=8V96VM)L!X&UCCDY XR1794F "2 ,GJ:CETM
MY)?=_7]/4KK?U_$\Y@AU/^WX09;BX4Q0PVDTUE-O6(PX>;>2%1@^XE6&X\#N
M*O\ A=+JWCO87$MO;W(2"V>.&8@S!'+RX< KG"DDX&1C)/)[BBFU>]^M_P ?
MZ_KI*C:WE;\#D?!%O=PM?%XO+LR(EB^651)( =\F) &YRN>.N>3UKKJ**8TK
M;$<^?L\F-X.TXV#+=.WO7E.G:=</X8F@O_M:1Q:I+(DMU9W-T+L_O1AX0VY.
M2#D$ MCO7K5%*VMRK_U\FCS:%]>;6XKF73Q'=-#$MK:M;2,MNIA^8B7.Q"'W
M @C)X'<5H>$;J[L+">&6SEFGD";93:30M-<>6Q=)"Y;IL'[S(4EL=:[FBGW\
MR+:W.1\%)J\=WK?]KVMS%-+<1REYG#*S&)-P3!("@C Q_/-==113;*(Y\_9Y
M,;P=IQL&6Z=O>O)+.SU4>&GMFAN]BZK*QNKM)YEE'[WF2 ,6Z[>A W$'M@^O
MT5#6X^AYMIT-XEU9/>6NJ"^0VYC>02.5M1 !*K,!C.\/D<,6*G'2M7PO?PQV
MM]-9V5Y";F;%O826\R;"$)&YG7 +;22V=H) R3R>THJGJV^_]?UYZDV.1\%)
MJ\=WK?\ :]K<Q32W$<I>9PRLQB3<$P2 H(P,?SS77444VQD<^?L\F-X.TXV#
M+=.WO7ENE%K'PG?0ZGIFHW@;4)%MY95N'\QRS_/)&"Q4+U.."<8YKU:BIMOY
MAT.%DT*.[O=/FLH)7NK:Q\]]0EB:.2:3RS'$IW '.<L1U&U<]:L>$Y%M+B6.
M."^BLYD@B59H)0?M.US*26'' 7+="W?-=E13ZM_UJ3R[>1B^&;1[&SO('^T$
M"]F*-.S,S*6R#EN2*VJ**%M8HCGS]GDQO!VG&P9;IV]Z\MTHM8^$[Z'4],U&
M\#:A(MO+*MP_F.6?YY(P6*A>IQP3C'->K44K;^8=#SB]DB:^LX+2+5Y+NWL=
MQO/L\Z/=MY)58P2NU,YW$MC# <$YQ9\*>;::+J5K=&Y4SL5CF@LIU0'R06VQ
ML-P((.>?F;IR<#OJ*&KW\[_B)*UK=+?@<OX)A-KI]S:I;QK;Q2 1SI:R6PGR
MHR=CDG(/&<X-=1115-WW%%65B"^#&PN C2JWE-@P@%P<?P@]_2O,-.MK@>";
MFTO+:X69;R?[-/<075SYQ!/S^6&+1MGID]03R<FO5J*AQO?S_P [E=O(\V-G
MJ=Q>K&%U*TU25L-<LKN(K8VF/O#Y3B7^$8)89QWJWI)U*'0M;BM;>6W>Y5TT
MU8TEVF40G+#S "H+#JP )SC.<GOJ*IZ_U_7]7[BBN6WE;\/Z^[0YGPC&D?V\
MVL%S#I[-&8DN$=#OV#S" _(YQGU.[WKIJ**!15E8@O@QL+@(TJMY38,(!<''
M\(/?TKSK0]/OY/ ]U!-!J"20:B7AD\^;?<@2\L49BRCKE<X)&>>2?3**5M6_
M3\'<;5U;U_%6.=OH+RV\327UE!/<R-ILH6-Y2(C(&3:HS\JD\\]>OI6?X/?4
M;>35+;5[>^BFN+W,<DOS!B8$9L%<A5!#8YQV!R*[*BA*W]>=P:Z^=_PL8?A.
MVEL]&D@E$X*7MUM\]F9BGG/M.6Y.1@Y[UN4453=Q]0KC?B1!<SZ%:BU^V,ZW
MD+&*W#XD^=?E8H0R]<@^H^E=E14M7&G8\ZN8;N#7[BZM[*>YO;BW820BVE66
MT MQPERQV,-R@=,EG)SP:?X;;4;+P[JUO LIOI@PLW2UEBA,H@SPL@RGS#DD
MX+$]#D#T*BAJZ:[Z"6C3[6_"W^1RW@@3)I]Q$\)"*ZD3M;2P-*Q0;MRR$L2#
MP6SS]0:ZFBBJ;N3%65@HHHI%!1110 4444 %%%% !1110 4444 %%%96M:I-
M8&RM[6.-[J]G\F(RL0BX1G+'')P%/ ZGTZT :M%<?%X_TRW>TM;VZ@GNYFVL
MUKA%7+E =LC!SR#PH8C![<U+<>/],LUE>[M;RWC&_P F27RE6<K*L1"G?Q\[
M*,OM'.<XS0'6QU=%<[9>,;+44@>TM+J5)(7F=P8@D2JS*2S%\'YEQE2P.00<
M<TS1/%T&OZBL=H@2W$,K2;W1V5U:/HT;LA&'SP3_ #H\A-I'2T5S'A?Q7_;T
MMRDPMX]LNR (QRXP2>#U&-I#CA@W%5XO'MBVIZQ;.$=+)E6$02*TDS;Q&R[2
M1M/F$*,X!R#FDG>W]?UN%_\ (Z^BN/7QR8%N3>:/?AHI)2T<2Q%H8DV L_[S
M!.7'W"<]A5B7QI!$ \EC=Q&-Y(IK9T0RJZA" "KE>0X/4]>U%U:XN9'445R<
M_CFVMI&,UE=1B,.LL+^6'C=70<OYGE@8<'.['OGBI(_&1:>[C;1+\B&>*WB,
M;PMYSO&KA1^\P#ANI.WWZX$[[#33.HHKDK[QY;VVHR:=;Z9=75['+&AABGMR
M2&=5/_+3Y2"PX;;G/IDB>S\9V<KS03QRK<I=FW6,*H+#S)$##YCD 1N2?]DD
M#H*?2X7.FHK!\.>+M,\4?:/[/+D0A&R61@RMG:1L9L9P?E;##N!FMZFTUN,*
M***0!17,ZAXDN[+QI8:+]E@2TN86<7,\C+O<$ *F%(R,]"03GMWFT#7+K4K_
M %&RN4A$MIL.422/.[=QM<!B!M^^!@YXZ&A._P"/X ]/Z[G045@>']<N=2U#
M4;*Z2(26FP[HXY(_O;N-L@!(&W[X&TYXZ&M^CS **** "BN9U#Q)=V7C2PT7
M[+ EI<PLXN9Y&7>X( 5,*1D9Z$@G/;O+H6NW>I7NI65PD/GVFP@HDD8.[=QA
MQN(&W[X&#GCH:2=]?7\ >CMZ?B=#16%X=UJXU66_@N5B$EK(J[DC>/((S]Q_
MFXZ;NA[5NT_,5PHHHH&%%<S=>);NW\;V^A&UMXK>:!GCGN)65IG&.(\*0<9Y
M&<]^.-T^@Z]+?_VBM]Y*&R<;I%C>(;2,\K)A@!_>Z'MT-*ZM?U_#05];&_16
M!X:\1'Q!+J1\E(HK>95@^;+/&R*P9AV)R>.PQGG-;]5:PPHHHI %%<S=>);N
MW\;V^A&UMXK>:!GCGN)65IG&.(\*0<9Y&<]^.-TV@ZY=:D-2CGCC::S8 >7'
M)'NRN<;'&[VW=#VI<RM?U?W!UL=!16#X6UFZU>SD-_Y<=XFUGMQ;2P-$&&0&
M63D\YY'!P:WJIJPDT]@HHHI#"BN9NO$MW;^-[?0C:V\5O- SQSW$K*TSC'$>
M%(.,\C.>_'&Z31O$,MW%JIO5CS8'+-'$\>1MW?<DPW&,;NA[5/,DKOS?W;AU
MM_6IT5%8/A?7I-=M9)9U2*7"2"#R9(VC1QE<[P-W0_,!@XK>JVFM&)-/5!11
M12&%%<S=>);NW\;V^A&UMXK>:!GCGN)65IG&.(\*0<9Y&<]^.-T^@ZU=ZK_:
M,$JP"XM7"JXBDC!)&1E'PV!Z]#VI7O\ UVT%>SL;]%8?A^_U2]GU&/4/LCI;
M2B%);9&57;&7&&8YQD#/KD=JW*8PHHHH **YFZ\2W=OXWM]"-K;Q6\T#/'/<
M2LK3.,<1X4@XSR,Y[\<;IM#UZXU!=32Y2'S+)ARJ/"&RN<%9,,,=-W0]NAJ>
M96OZO[MPZV.@HKF_"/B.?Q#;W#SQQ(8]A!163[RYQM;DX_O#Y6ZBNDJ["33U
M04444AA17,7GBF:R\:PZ-<06UO8R6[2BYN)60R$ $[/EVG'<$@]^.-S-/\8B
M\TW7M1>V58-.S)"BO\\D7E"0%A_"3D\=N,\YH6JNOZUL"5W;^M3JJ*R-$U*]
MNY;NUU".!;FW*-N@)V,KKD=><CD>^,\9P->@2:>J"BBB@845RT_BR2T\8S:3
M>PVUG8QVYF6XN)65I<+N8I\NT@8.1NR,$],9M^'/$$FO1:C)]G6(VUQY<<>_
M+%#&CJ6]"0W3MT[4EJKK^M;";L[?UM<WJ*R_#^I7.JZ8UQ=PQ0SK<30LD3EE
M'ER,G!(&?N^@K4IC"BBB@ HKEI_%DEIXQFTF]AMK.QCMS,MQ<2LK2X7<Q3Y=
MI P<C=D8)Z8S:\/>()M>@U-UMXXGMKCRX8V?DJ8T=2^,X)W<CMT[4EJKK^M;
M"O9V_K:YOT5D:#J5UJ*7HNE@;[/<&%9[?/ERX )QG^ZQ*GGJI^@UZ8PHHHH
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M_P"$M^(?_1,/_*_;_P"%>@44[W"UCS__ (2WXA_]$P_\K]O_ (4?\);\0_\
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M(H8@Q,?E_P ('1>GH>1SS7K%%*RM8#R[1M2\<:%9_9;+X97/D#&U)O$\4H0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1-'+=^1#=0V7DP K<HZL;C#>:?GY/\&2."<\UUE<_P#\(]JG_0YZY_WYLO\
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M[\V7_P CTQI6V.@KDOB)!<7'AG;;-=AUF5BENKD2 ?PN4(8#W!Z@9R.*N_\
M"/:I_P!#GKG_ 'YLO_D>C_A'M4_Z'/7/^_-E_P#(])JXS E'B"Z\0: UYHUU
M%8J1$\2W(E0!K=_,,ASDD-A<GTZDM5_1+2RT6SU"[:PN+6"_F=(K:"!RRQ(K
M '"C(+!6;)P?F4=<"M#_ (1[5/\ H<]<_P"_-E_\CT?\(]JG_0YZY_WYLO\
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MT46/*!;:KY*<@Y)."QXYXK1_X1[5/^ASUS_OS9?_ "/1_P (]JG_ $.>N?\
M?FR_^1Z?]?C<BWZ?@K$GA.VEL]&D@E$X*7MUM\]F9BGG/M.6Y.1@Y[UN5S__
M  CVJ?\ 0YZY_P!^;+_Y'H_X1[5/^ASUS_OS9?\ R/3;N5U.@KC?B1!<SZ%:
MBU^V,ZWD+&*W#XD^=?E8H0R]<@^H^E:7_"/:I_T.>N?]^;+_ .1Z/^$>U3_H
M<]<_[\V7_P CU+5QIV&VUI/_ ,)+;7,D=U&)M,995:9G2)]T>%!Z9^]SU/6H
M=%>ZTGP]-;QVUS/=F[O!:QS%R9,22,FYVS@$ 89CSFK'_"/:I_T.>N?]^;+_
M .1Z/^$>U3_H<]<_[\V7_P CT^_]=6_U)BK+^NUBIX(358O[935;>ZCD-Z'#
MW#*=Y:*/=MP2-H;.,<#IV-=77/\ _"/:I_T.>N?]^;+_ .1ZW((VAMXHGFDG
M=$"M+(%#.0/O': ,GKP /0"FP2L24444AA1110 4444 %%%% !1110 4444
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M0J."1C:OS8Y]:DTWQ'JB:'KVIZK'9S1Z:9!&UF&19O+3+XW$]&RN?4'BB_\
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MSQCBO?**+ >(:5\1_$NCPR1VWPF\1,TS^9-+///))*V ,LS0DG@ >@QQ5_\
MX6_XP_Z)-KGYS?\ QBO8** /&KKXJ^*;VUEM;CX1ZX\,JE77?,,@^X@S638^
M,M8T_1QI=O\ ![7EM_M"7+'S)MSR*ZN&9O(R>57\!BO>Z*/,#Q-/B7XF2\O+
MM?A)KPN+Q%260239VJ"% _<<8R3QW)JNOC[75L[.S_X4]KAM+6(Q);L\QC92
M ,.OD8?IGG//->Z446 \0TOXBZ]HJW"Z=\&]8MUGD\V01B4 G&/^>' ]JO\
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MT2;7/SF_^,5[!10!X_\ \+?\8?\ 1)M<_.;_ .,5D:[XYUOQ(ENNI_!_7I1
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>forms-4_013.jpg
<TEXT>
begin 644 forms-4_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (= C0# 2(  A$! Q$!_\0
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M_$4?\+LU;_H6[7_P-/\ \17F]%']GT//[P_M.OY?<>D?\+LU;_H6[7_P-/\
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MID>3[BLA!;Z>M*]G=1PF5[:98P=I=D(&?3-5]0H?TQ?VCB/+[CT'_A=FK?\
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M3U>H R_^$;T+_H#:?_X#)_A1_P (WH7_ $!M/_\  9/\*U** ,O_ (1O0O\
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M;T+_ * VG_\ @,G^%6K[4;+3(5FOKJ*WC9MH:5@H)]/K5#_A+/#_ /T&+/\
M[^"@"7_A&]"_Z VG_P#@,G^%'_"-Z%_T!M/_ / 9/\*B_P"$L\/_ /08L_\
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M#)_A1_PC>A?] ;3_ /P&3_"HO^$L\/\ _08L_P#OX*/^$L\/_P#08L_^_@H
ME_X1O0O^@-I__@,G^%'_  C>A?\ 0&T__P !D_PJ+_A+/#__ $&+/_OX*/\
MA+/#_P#T&+/_ +^"@"7_ (1O0O\ H#:?_P" R?X4?\(WH7_0&T__ ,!D_P *
MB_X2SP__ -!BS_[^"C_A+/#_ /T&+/\ [^"@"7_A&]"_Z VG_P#@,G^%'_"-
MZ%_T!M/_ / 9/\*B_P"$L\/_ /08L_\ OX*/^$L\/_\ 08L_^_@H E_X1O0O
M^@-I_P#X#)_A1_PC>A?] ;3_ /P&3_"HO^$L\/\ _08L_P#OX*/^$L\/_P#0
M8L_^_@H E_X1O0O^@-I__@,G^%'_  C>A?\ 0&T__P !D_PJ+_A+/#__ $&+
M/_OX*/\ A+/#_P#T&+/_ +^"@"7_ (1O0O\ H#:?_P" R?X4?\(WH7_0&T__
M ,!D_P *B_X2SP__ -!BS_[^"C_A+/#_ /T&+/\ [^"@"7_A&]"_Z VG_P#@
M,G^%'_"-Z%_T!M/_ / 9/\*B_P"$L\/_ /08L_\ OX*/^$L\/_\ 08L_^_@H
M E_X1O0O^@-I_P#X#)_A1_PC>A?] ;3_ /P&3_"HO^$L\/\ _08L_P#OX*/^
M$L\/_P#08L_^_@H E_X1O0O^@-I__@,G^%'_  C>A?\ 0&T__P !D_PJ+_A+
M/#__ $&+/_OX*/\ A+/#_P#T&+/_ +^"@"7_ (1O0O\ H#:?_P" R?X4?\(W
MH7_0&T__ ,!D_P *B_X2SP__ -!BS_[^"C_A+/#_ /T&+/\ [^"@"7_A&]"_
MZ VG_P#@,G^%'_"-Z%_T!M/_ / 9/\*B_P"$L\/_ /08L_\ OX*/^$L\/_\
M08L_^_@H E_X1O0O^@-I_P#X#)_A1_PC>A?] ;3_ /P&3_"HO^$L\/\ _08L
M_P#OX*/^$L\/_P#08L_^_@H E_X1O0O^@-I__@,G^%'_  C>A?\ 0&T__P !
MD_PJ+_A+/#__ $&+/_OX*/\ A+/#_P#T&+/_ +^"@"7_ (1O0O\ H#:?_P"
MR?X4?\(WH7_0&T__ ,!D_P *B_X2SP__ -!BS_[^"C_A+/#_ /T&+/\ [^"@
M"7_A&]"_Z VG_P#@,G^%07OAO0Q87)&C:>"(FP?LR>A]JTK+4+/4H#/97,5Q
M$&*EXVR,CM2WW_(/N?\ KD_\C0!/X8 7PII    LXL ?[@HI?#/_ "*ND_\
M7G%_Z"** */B;_D)^'_^OUO_ $4]7JH^)O\ D)^'_P#K];_T4]7J "LW4];M
M=*E5+G< 8))RP[!,9'N3N&*TJY;Q:\+7FEV]Q/I]JC.[K<WD8?:Z@8502!DY
M)_"@#7T?5FU2*;S;.2TG@<))#(P8C*AAR..A%0:]H!UQ85_M"ZMD216=(F&U
MP#[C@^]/T%5-O/+_ &C:W[RR[GFMT503@#!P3S@"G:OX@TW0S +^XV/.X5$
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M-?RH\J/_ )YK^5/HH 9Y4?\ SS7\J/*C_P">:_E3Z* &>5'_ ,\U_*CRH_\
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MW_L(-_Z+2KU]_P @^Y_ZY/\ R- %CPS_ ,BKI/\ UYQ?^@BBCPS_ ,BKI/\
MUYQ?^@BB@"CXF_Y"?A__ *_6_P#13U>JCXF_Y"?A_P#Z_6_]%/5Z@ KGO$LQ
M-U867FV5LL^\_:KN%9 I4#Y5#<;CGOV!KH:Y#7KQ;J26S>740BRDE1HYG0C
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MLE_Y[?\ CM&R7_GM_P".U+10!%LE_P">W_CM&R7_ )[?^.U+10!%LE_Y[?\
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MU_#UE>6K:C->6T%LUU<^:D,+[U4;%4\X')()J76/#UAKAA-XLA,3JWR2,H8
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MX,)OUW6OF8?Z-#T./XGKV*G^XKY?FSQ*?_(PE\_R1[16#XV_Y$;7?^O&;_T
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M!\;?\B-KO_7C-_Z :V?-?_GB_P"E87C61CX'UT>4P_T&;GC^Z:\A'M,^;O\
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M_J>#_P!<EKH?@PQ77M;PA;_1H.G^\]>Q4_W%?+\V>'2_Y&$OG^2/::Q/&/\
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M/_ ?Z5]*>!_^1%T+_KQB_P#017KYGM'YGBY5O/Y?J;]>-?&K_D.:'_U[3_\
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MU]_R#[G_ *Y/_(U1T;_C_P!=_P"P@W_HM*O7W_(/N?\ KD_\C7VQY98\,_\
M(JZ3_P!><7_H(HH\,_\ (JZ3_P!><7_H(HH H^)O^0GX?_Z_6_\ 13U>JCXF
M_P"0GX?_ .OUO_13U>H **** "N:\7Z'?:[;6]O;BS:$3(S^>A+)@\LI!].U
M=+4-Q=V]HJ-<3)$'8(I=L9)Z"@#,N=&F?3](M4G,K6-Q#(\DI^9P@()^IJMX
MATF\U=9[2.QL/+F0*+R1OWL7N!MSD=N:W9+B&(QB25%,K;4!;&X^@]:9-?6E
MO/'!-<Q1RR?<1F +?2@#G7\/:AN?3U> Z;)?+>-*6/F##!RFW&.6'7/0UU55
MS?6@NQ:&YB%P1GRMPW?E5B@#"UY0VL>&@>G]I?\ M&2M'QI!&/ ^ND Y^PS=
MS_<-9^N?\AGPU_V$O_:,E:GC;_D1M=_Z\)O_ $ T SYI_P"6/_ ?Z5]'^!X8
MV\"Z&2O)LHNY_NBOG#_EC_P'^E?2?@;_ )$30O\ KQB_]!%>QF>T/F>)E6\_
ME^IN?9X_[I_,UXY\:(U36=%VC'[B;O\ [25[/7C?QJ_Y#.B?]<)OYI7#A/X\
M3T,;_N\_0Y?X?*&^(>C ]-TO_HIJ^B/L\?\ =/YFOGCX>?\ )1-%_P!Z7_T4
MU?1=:YA_'?HC'+?]W7JR/R(_[I_,U\KW0QJ%Z!_S]3?^C&KZLKY4NO\ D(WW
M_7U-_P"C&K3+?XC]/U,LU_A1]?T/9/@Y$C^#[HL,G[?+W/HM>A_9X_[I_,UY
M_P#!K_D3KK_L(2_R6O1*X:_\67JST*'\*/HOR/._C#$B>"HRHP?MT/<^]>+V
MXS?V0/\ S]0_^C%KVOXR?\B1'_U_0_S->*6W_'_9?]?</_HQ:]/!_P"[S^?Y
M'E8[_>J?R_,^J/(C_NG\S1]GC_NG\S4E%>.>V?/'Q)4)\1=4"C \N#_T6*W_
M (,(KZ[K6X9_T:'O_M/6#\3/^2CZI_US@_\ 18KH/@M_R'=:_P"O:'_T)Z]B
MI_N*^7YL\2G_ ,C"7S_)'L7V>/\ NG\S6#XUAC'@?72 <_89NY_NFNBK!\;?
M\B-KO_7C-_Z :\A'M,^:O^6/_ ?Z5](>"(8SX&T,D'/V&+N?[HKYO_Y8_P#
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M1]GC_NG\S4E%>.>X?.OQ%4+\1=8 Z?N?_12UT/P817U[6]PS_HT'?_:>N?\
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M&;O_ +!K/US_ )#/AK_L)?\ M&2M3QM_R(VN_P#7A-_Z : 9\T_\L?\ @/\
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MH'VZ'H?K7B]OG[?98Z_:H?\ T8M>U_&3_D2(_P#K^A_F:\4MO^/^R_Z^X?\
MT8M>G@_]WG\_R/*QW^]4_E^9]49F_N)^=&9O[B?]]5)17CGMGSQ\2=W_  L7
M5-P .R#I_P!<Q6_\&"XUW6M@!_T:'J?]IZP?B9_R4?5/^N<'_HL5T'P6_P"0
M[K7_ %[0_P#H3U[%3_<5\OS9XE/_ )&$OG^2/8LS?W$_[ZK!\:F7_A!]=RJX
M^PS=_P#9-=%6#XV_Y$;7?^O&;_T UY"/:9\U?\L?^ _TKZ0\$&7_ (0;0\*N
M/L,7?_9%?-__ "Q_X#_2OI3P/_R(NA?]>,7_ *"*]?,]H_,\7*MY_+]3;S-_
M<3_OJO'/C07.N:'O '^C3]#_ +4=>SUXU\:O^0YH?_7M/_Z%'7#A/X\3T,;_
M +O/T_R.8^'F[_A8FC;0"=TW7_KDU?1&9O[B?]]5\\_#K_DHVB_[TW_HIJ^B
MJUS#^._1&.6_[NO5D>9O[B?G7RO=?\A"^SU^US?^C&KZLKY4NO\ D(WW_7W-
M_P"C&K3+?XC]/U,LU_A1]?T/9_@\9!X*DVJI'VZ;J?I7H&9O[B?]]5P7P<_Y
M$F3_ *_IOZ5Z#7#6_B2]7^9Z-#^%'T7Y'G?QA,A\$Q[E4#[=#T/N:\7ML_;[
M+'7[5#_Z,6O;/C'_ ,B1'_U_0_S->)VO_(0LO^OJ'_T8M>G@O]WG\_R/(QW^
M\T_E^9]49F_N)^=&9O[B?]]5)17CGN'SI\1-W_"Q=8W  _N>G_7):Z+X,%QK
MVM[ #_HT'4_[3US_ ,1O^2C:S_VQ_P#12UT7P5_Y#^M_]>T'_H3U[%3_ '%?
M+\V>'2_Y&$OG^2/8\S?W$_[ZK$\8&7_A#=9RJX^QR=_]DUOUB>,?^1,UG_KS
ME_\ 037C/9GN(YI?^/0?]<_Z5O\ @PR_\(7HV%7'V./O_LU@+_QZ#_KG_2NC
M\%_\B5HO_7G'_P"@BOB>%-ZWR_4]7,-HFSF;^XG_ 'U7%^)2Y\8Z?O '^@3=
M#_MQUW%<5XG_ .1QT[_KPF_]#CKZ'.O^1?5]/U1Q87^-$HIN_P"$HT': 3Y\
MG7_KDU=_F;^XG_?5<%%_R-6@_P#7>3_T4]>@UQ\-_P"X+U?YFN._C/Y$1,V#
M\B?G7FV@?\@A<]?.F_\ 1KUZ:>AKS/0?^02O_7:;_P!&O7+Q5_NT/\7Z,TR_
M^(_0Z#P,9!8:GM52/[2EZGV6NIS-_<3_ +ZKF? G_(/U/_L)2_R6NJKZ'!?[
MM3_PK\D<57^)+U9R7C@R&PTW<J@?VC#T/UKG]>S_ &2V.OFQ?^C%KH_'7_(/
MTW_L(P_UKG-=_P"04W_76+_T8M?)YY_R,Z'R_P#2CT<)_ G\_P CTG,W]Q/S
MHS-_<3_OJI**^W/*/.US_P )%K^X '[6O3_KDE7?"Y<>+=5V '_0[?J?]J2J
M?_,R:_\ ]?B_^BDJ]X4_Y&W5O^O.W_\ 0I:^'P7_ "/JG_;WY(]6K_ND?D=C
MF;^XG_?58/C0R_\ "&:ME5Q]G;O715@^-O\ D2]6_P"O=J^VG\+/+6YSD_\
MQXR?]<S_ "KI?"IE_P"$1T?"KC['%W_V17-3_P#'C)_US/\ *NI\*?\ (H:/
M_P!><7_H(KXOA3_E[\OU/3S'[/S,O1<_;M=W  _V@W3_ *YI5^^_Y!]S_P!<
MG_D:HZ-_R$-=_P"P@W_HM*O7W_(/N?\ KD_\C7VQY98\,_\ (JZ3_P!><7_H
M(HH\,_\ (JZ3_P!><7_H(HH H^)O^0GX?_Z_6_\ 13U>JCXF_P"0GX?_ .OU
MO_13U>H **** "BBB@#DO$WB*_TS7M-L8/L]O!.P)N+G.QR0WR9'3&!^8J34
M-:N;?Q"]M)J$-E:(D15G@+"0MG/S9P.PJSXC\.2Z^]O&U^\5JKYEA"*0PVL#
M@D<'YJDU+1;R_M7TY+V.+3)(EB>,Q;I-H&" V>_KB@"A)KNHJ\NHAX?[.BU
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MQ5G_ $%--_\  1O_ (JKQ=6-6KS1V,L'1E1I<D]]3K*^5+K_ )"-]_U]3?\
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M=_Z\9O\ T U1_P"*L_Z"FF_^ C?_ !55-4T[Q/JVE7>G3ZMIZQ7,31.5M6R
MPP<?-7GGIG@?_+'_ (#_ $KZ4\#_ /(BZ%_UXQ?^@BO+_P#A3]_MV_V[!C&/
M^/<_XUW&E:=XGTG2;33H-6T]HK:)8D+6K9( P,_-7H8W$0K<O)T/,P&&J4.;
MGZG;UXU\:O\ D.:'_P!>T_\ Z%'7<_\ %6?]!33?_ 1O_BJYGQ1X(UOQ7=6M
MQ>ZS9H]LCH@CMB 0Q!.?F_V17-AYJ%6,I;(Z\33E4I2A'=G#_#K_ )*-HO\
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ML(=6T]HK>-8U+6K9( QS\U?-9%EM?!.HZUO>M:SOW.[%UX5>7EZ';5Q7B?\
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M$;_XJO7PU-TZ,(2W22^Y(YYM2DVAWCK_ )!^F_\ 81A_K7.:[_R"F_ZZQ?\
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M?^O.+_T$44 4?$W_ "$_#_\ U^M_Z*>KU4?$W_(3\/\ _7ZW_HIZO4 %%%%
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M\WU(%7]&OKS[9=:3J+))=VRK(LZ# FB8D*V.QR""* -FBBJUYJ-EIX0WEU%
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M]U#:S7"6]V7D6%<L 8W&<?4BJ_\ ;K?] C4_^_'_ ->@#7HK(_MUO^@1J?\
MWX_^O1_;K?\ 0(U/_OQ_]>@#7HK(_MUO^@1J?_?C_P"O1_;K?] C4_\ OQ_]
M>@#7HK(_MUO^@1J?_?C_ .O1_;K?] C4_P#OQ_\ 7H UZ*R/[=;_ *!&I_\
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MNM_T"-3_ ._'_P!>@#7JAINCV.DM<-:0[7N)6ED8G))))//IDGBJ_P#;K?\
M0(U/_OQ_]>C^W6_Z!&I_]^/_ *] &O161_;K?] C4_\ OQ_]>C^W6_Z!&I_]
M^/\ Z] %K5-+M=8LOLEZA>'>KE0<9*G(JW'&D4:QQJ$11A548 %97]NM_P!
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MG6NE6,=G9Q".&,8 [GW)[FK59']NM_T"-3_[\?\ UZ/[=;_H$:G_ -^/_KT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO^@WJ/\ W_-']LZU_P!!O4?^_P":/[.K>0?VI1\SZEHKY:_MG6O^@WJ/_?\
M-']LZU_T&]1_[_FC^SJWD']J4?,^I:*^6O[9UK_H-ZC_ -_S1_;.M?\ 0;U'
M_O\ FC^SJWD']J4?,^I:*^6O[9UK_H-ZC_W_ #1_;.M?]!O4?^_YH_LZMY!_
M:E'S/J6BOEK^V=:_Z#>H_P#?\T?VSK7_ $&]1_[_ )H_LZMY!_:E'S/J6BOE
MK^V=:_Z#>H_]_P T?VSK7_0;U'_O^:/[.K>0?VI1\SZEHKY:_MG6O^@WJ/\
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MBO*);?8D[(  -_\ %TXJI5:D9*+?7MTT(C1I3BY173OUU/(:***[SS@HHHH
M**** "HY_P#CWE_W#_*I*CG_ ./>7_</\J3V8X[H^F/!?_(CZ%_UX0_^@"BC
MP7_R(^A?]>$/_H HKY ^V.2^,.FWVJ:;HEOI]O\ :+@WQQ'N"Y_=MW->9_\
M"$>+_P#H!-_W_2O<O$W_ "$_#_\ U^M_Z*>KU=-+$U*2Y8,Y:V$I5I<TUJ?/
M_P#PA'B__H!-_P!_TH_X0CQ?_P! )O\ O^E?0%%:_7Z_?\#'^SL/V_$^?_\
MA"/%_P#T F_[_I1_PA'B_P#Z 3?]_P!*^@*BGN8+95:>9(@[!%+MC)/04?7Z
M_?\  /[.P_;\3P3_ (0CQ?\ ] )O^_Z4?\(1XO\ ^@$W_?\ 2O=Y]0LK61([
MB[@B=_NJ\@!/TJ:6:*")I9I$CC499W. /QH^OU^_X!_9V'[?B>!?\(1XO_Z
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M^E?0%%'U^OW_  #^SL/V_$^?_P#A"/%__0";_O\ I1_PA'B__H!-_P!_TKZ
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M_P#/EIG_ '_?_"NHHH Y?R_%/_/EIG_?]_\ "CR_%/\ SY:9_P!_W_PKJ**
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M?PG^X*T_/7T?_ODT 2T5%YZ^C_\ ?)H\]?1_^^30!+147GKZ/_WR://7T?\
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MH_\ WR://7T?_ODT 2T5%YZ^C_\ ?)H\]?1_^^30!+147GKZ/_WR://7T?\
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M6=I!86<-I;)LAB4*B^@J#6?^0%J/_7K+_P"@&KU4=9_Y 6H_]>LO_H!H O\
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MDC/EMYA!X .1MVC% &UH^HC5M(M[T)Y9E7YDSG:P."/S!HUG_D!:C_UZR_\
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MOY5E^)88AX6U4B-?^/27M_LFOMF>4<E;_P#(*B_ZX+_Z#74^#2/^$+T7D?\
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M4.@HH'045XY[9\T>,?\ D>M?_P"OQO\ T%:]$^"7_(.US_K[3_T6M>=^,?\
MD>M?_P"OQO\ T%:]$^"7_(.US_K[3_T6M>QB/]SA\OU/$PW^^S^?Z'J=<+\7
M?^2?W'_7S;_^C%KNJX7XN_\ )/[C_KYM_P#T8M>72^./JOS/7J_PY>C_ "9X
M4G_'Q!_UWC_]#%?5]?*"?\?$'_7>/_T,5]7UZ&9?Q(^GZGF95_#EZ_H%?-WC
MO_DH6O?]?"?^BDKZ1KYN\=_\E"U[_KX3_P!%)6>7_P ;Y,US/^!\T=S\$O\
M5Z__ -=8?_037K%>3_!+_5Z__P!=8?\ T$UZQ7/BOXTO4Z<)_ AZ'&?%7_DG
M6I?[T7_HQ:^?KC_4M^'\Z^@?BK_R3K4O]Z+_ -&+7S]<?ZEOP_G7H8#^#/\
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M]]5GB_X\C7!?[O#T_P SG/B-_P DZU[_ *]&KYQNO^/2;_KFW\J^B_B(9?\
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M_P @BX_ZX-_Z#77^'3-_PC.DX1,?8X?XO]@5\9PI\-;U7ZGIYAO$UZX/5O\
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MS_K[3_T6M>QB/]SA\OU/$PW^^S^?Z'J=<+\7?^2?W'_7S;_^C%KNJX7XN_\
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MK_\ 7O;?^U*F\/\ _(]'_L&-_P"C5J'4/^1YU?\ Z][;_P!J5-X?_P"1Z/\
MV#&_]&K7Q%/_ )*"7S_])1ZLO]S7]=3N:P_&?_(EZS_UZ2?RK<K#\9_\B7K/
M_7I)_*OMI;,\M;G*WG_((N/^N#?^@UV?AS_D6-)_Z\H?_0!7&7G_ ""+C_K@
MW_H-=GX<_P"18TG_ *\H?_0!7QG"GPUO5?J>GF&\33K@]6_Y'B^_Z\H/_0I*
M[RN#U;_D>+[_ *\H/_0I*]CB#_D7U/E^:.;!_P 9#M$_Y'B'_KPE_P#0TKNJ
MX71/^1XA_P"O"7_T-*[JGD/_ "+Z?S_-BQ?\:1C^+/\ D4-9_P"O*7_T UR:
M_P#(+'_7#_V6NL\6?\BAK/\ UY2_^@&N37_D%C_KA_[+7B\5?\N?G^AU9?\
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MO_0111X9_P"15TG_ *\XO_0110!1\3?\A/P__P!?K?\ HIZO51\3?\A/P_\
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M\E&U'_KC!_Z!7/@/XZ^9TYC_ +N_D;OP7<)K>MYS_P >\'09_B>O8O/3T?\
M[Y->/_!7_D-ZY_U[P?\ H4E>RUGB_P"/(UP7^[P]/\SE/B),K?#S70 W_'HW
M537SI=?\>DW_ %S;^5?1WQ&_Y)UKW_7HU?.-U_QZ3?\ 7-OY5W9=\$_ZZ,\_
M,_CI_P!=4?4NDSH-&L1A_P#CWC_A/]T5<\]/1_\ ODU!I'_(%L?^O>/_ -!%
M7*\<]L\_OF#^-]7(S_Q[VW48[25+H3A/'))S_P @QN@S_P M5J/4/^1YU?\
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MP!(F?L4O\0_N&N362/\ LL?O%_U']X?W:\3BK_ES\_T.K+_M'7>$O^1/T?\
MZ\XO_016S6'X2FB'A#1P9$S]CB_B']T5L>?%_P ]4_[Z%?:+8\LXC6/^1ZN_
M^P?!_P"AR4:-_P CU:?]>$__ *''3-8EC/CJ[/F)C[!!_$/[\E&CRQCQS:'S
M$Q]@G_B']^.OB?\ FH/Z_E/4_P"8/^NYWU97B;_D5M6_Z])?_036CY\7_/5/
M^^A67XEFB/A?50)4S]DE_B']TU]LSRSDK?\ Y!47_7!?_0:ZGP;_ ,B5HO\
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M0GX?_P"OUO\ T4]7JH^)O^0GX?\ ^OUO_13U>H **** "BBB@ HHHH ****
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M 5!=V<%[&D=PF]$D60+GC<IR,^O-3T4 <A-OD\4ZKI<.G)<+=BWDF,Z?N40
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KTX*ZE3C3FZ$?]=:ZFB@"KIMF-.TNTL@YD%O"D6\C&[: ,X_"BK5% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>forms-4_014.jpg
<TEXT>
begin 644 forms-4_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '? ?8# 2(  A$! Q$!_\0
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M_P !H_\ "N=HH^J4/Y0^NXC^=G1?\+ \9?\ 0P/_ . T?^%'_"P/&7_0P/\
M^ T?^%<[11]4H?RA]=Q'\[.B_P"%@>,O^A@?_P !H_\ "C_A8'C+_H8'_P#
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MDUFUEO?-6*>"-&)A)[D]\>U-4<,W;E_,EU\6E?F_(7_A8'C+_H8'_P# :/\
MPH_X6!XR_P"A@?\ \!H_\*UK7P2MIJ6C73W,=]I]Q?+;R Q-&<^F&Y(/K6-)
MI]J_CUM.\O;:'4/)V*<83?C _"DJ6&DW:/2XY5L7%*\MW8?_ ,+ \9?]# __
M (#1_P"%'_"P/&7_ $,#_P#@-'_A71^*O"6FV6EWDT&G3:?<17:P6@>;>+L$
M]0#R*R[SX?75E!(\E_"7MVC%TOEL!"'(&0QX;&><5,8822ORV+G/&1;7-?\
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M7_"P/&7_ $,#_P#@-'_A1_PL#QE_T,#_ /@-'_A7.T4?5*'\H?7<1_.SHO\
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M4_X4]=_]#!%_X"__ &5>EA\;2ITHQE>Z/*Q. K5*LIQM9^9YU17HO_"GKO\
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M5 8Y+DF12G3YSUJ8^.E/B:SU8::%BAL_LC6XDZK@C@_0UI_\*>N_^A@B_P#
M7_[*C_A3UW_T,$7_ ("__94?6<+YB^JXSR.?;Q1!;Z3)I^G6+6\?V]+R(O)O
MV;1T/K5JY\7:;)KMOK<.A[+\3B:<M,61^,$ =L]:UO\ A3UW_P!#!%_X"_\
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M_P# 7_[*C^T*/G]P?V97\OO/.J*]%_X4]=_]#!%_X"__ &5'_"GKO_H8(O\
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MSZ/_ -_W_P : +>T^AHVGT-5/^$,T+_GT?\ [_O_ (T?\(9H7_/H_P#W_?\
MQH M[3Z&C:?0U4_X0S0O^?1_^_[_ .-'_"&:%_SZ/_W_ '_QH M[3Z&C:?0U
M4_X0S0O^?1_^_P"_^-'_  AFA?\ /H__ '_?_&@"WM/H:-I]#53_ (0S0O\
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M(2/&\N%S_H3?^A"O<_,D_P">1_,5X=\(O^1XE_Z\6_\ 0A7NM7COX\OZZ&>
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M?*7_ "Z+_NC^E?6-M_QZP_[B_P J]7,OBCZ'D95\,_47S)/^>1_,5YMX?_Y
M5K_NG_T(UZ;7F>@?\@.U^A_]"-?GG%?^[T_\7Z'U&7_&_0ZKP4[CP;I>(R?W
M/K[FM[S)/^>1_,5B>"?^1+TK_KC_ %-;]?5T_@7HOR1Y[W/.X<G5]:R,?Z<_
M\A6UX)9AIM_A"W_$PF[^XK%B_P"0QK7_ %_/_(5N^!O^09?_ /80G_F*^2RK
M_D;XGY_FCT<1_NT#H_,D_P">1_,5PVI$GQGJ.5Q_H\/]:[VN$U/_ )'34?\
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M\B/T/YFKQW\>7]=#/ ?[O'^NIP?QB_Y$A/\ K]B_K7EO@?\ Y'W0_P#KX/\
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MUKR_P02/'FAX&?\ 2#_Z":Z<-_NM3^NARXK_ 'RG_75GTE7,?$7_ ))[K?\
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M?)_SR/YBOGWXE$GXA:ED8_=P_P#H-88#^.OF=&9?[N_5'<_!7_D!:K_U^_\
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MR?$[N?">L9C(_P!"F[_[!KRCV#YC_P"71?\ =']*^L;;_CUA_P!Q?Y5\G?\
M+FO^Z/Z5]6VSR?98?W1^XO<>E>KF7Q1]#R,J^&?J6:\ST#_D!VOT/_H1KTC?
M)_SR/YBO-O#_ /R K7_=/_H1K\\XK_W>G_B_0^HR_P"-^AUW@G_D2]*_ZX_U
M-;]<[X*=QX,TO$9(\GKGW-;V^3_GD?S%?5T_@7HOR1Y[W//XO^0QK7_7\_\
M(5N^!O\ D&7_ /V$)_YBL*'G5]:R,?Z>_P#(5M>"&8:9?X3/_$PF[^XKY+*O
M^1OB?G^:/1Q'^[0.JKA-3_Y'34?^O>'_ -FKM]\G_/(_F*X;4B3XSU'(Q_H\
M/]:]+B'_ )%\_E^9A@_XR+OA+_D8=8_ZYP?R-=A7&^%2P\0ZQM7=^[@[^QKK
MM\G_ #R/YBNO*/\ <*7^%?J9XG^++U.1\5?\C/I7_7O-_P"RU!HW_(ZV_P#U
MY2?^A+4OB@L?$^E;EV_Z/-W]UJ#2"1XTML+G_0I/_0EKPJO_ "/X>G_MK.N/
M^YOU_4[NN4\;?>T7_K]'_H#5T^^3_GD?S%<KXT9BVB[DV_Z;Z_[#5]%F/^Z5
M?\+_ ".*C_$CZF7_ ,S#H?\ U]'_ - ->A5YX<CQ!H>!G_2C_P"@&N_WR?\
M/(_F*\KAK_<%ZO\ 0Z,=_&^1A>./^12O/JG_ *&*Y76O^/)/^OF'_P!#%=-X
MV9SX3O,QD#*<Y_VQ7,ZW_P >*?\ 7Q#_ .ABN+//]_POK_[<C7"?P:G]=#L_
M%?\ R*NI_P#7!J(?^/>+_KFO\A3/%3/_ ,(MJ8\LX\AN<T^'_CWB_P!Q?Y"O
ML#S2E;?\CFW_ &#A_P"C**+;_D<V_P"P</\ T910 RP_Y#VO?]?$?_HL5IUF
M6'_(>U[_ *^(_P#T6*TZ "BBB@ IKHDB%)$5T88*L,@TZJFJ:C!I&FS7USN\
MJ(9(49))X _.@">""*U@6""-8XD&U408 %1RV%G.D:2VL,B1',:L@(7Z50M-
M9N;[1X+ZWTJX+S=(695P/7.<8JM_PE44EK!-:V4\Y>!KB1 0#$BG!)SU.0>G
MI0!M&SM6NENC;Q&X48$I4;@/K4U82>)[>6X7RK>5[(RI ;H$;1(P! QU[@9]
M:W: ,NR_Y*!+_P!@M?\ T8:XSXU_Z_0OK-_):[.R_P"2@2_]@M?_ $8:XSXU
M_P"NT+ZS?R6NG"_QX^IRXS^!/T,;X1?\CQ+_ ->+?^A"O=:\*^$7_(\2_P#7
MDW_H0KW6KQW\>7]=#/ ?[O'^NIY_\8O^1(3_ *_8OZUY;X'_ .1]T/\ Z^#_
M .@FO4OC%_R)"?\ 7[%_6O+? _\ R/NA_P#7P?\ T$UTX;_=:G]=#EQ7^^4_
MZZL^DJYCXB_\D]UO_KV/\Q73US'Q%_Y)[K?_ %['^8KS(_$CUI?"SY[M/^0A
M8_\ 7S#_ .ABOJNOE2T_Y"%C_P!?,/\ Z&*^JZ]+,OXB]/U/+RK^%+U_0@OO
M^/"Y_P"N3?R-?)P_X\#_ -<S7UC??\>%S_UR;^1KY.'_ !X'_KF:>6[S]!9I
M\,/4^I?#O_(LZ5_UZ1?^@"M.LSP[_P BSI7_ %Z1?^@"M.O*/7/EW6_^1DU?
M_K^F_P#0C7N7PN_Y)WI?T?\ ]#:O#=;_ .1DU?\ Z_IO_0C7N7PN_P"2=Z7]
M'_\ 0VKU<9_N]/\ KH>/@O\ >:O]=3L*^>OB9_R4/4O^N</_ *#7T+7SU\3/
M^2AZE_USA_\ 0:PP'\=?,Z,R_P!W?JCN/@K_ ,@+5?\ K]_]D6O3:\R^"O\
MR M5_P"OW_V1:]-K#$?Q9>K.G#?P8>B/%/C-_P C1IG_ %YO_P"ABI?@M_R'
M=9_Z]HO_ $)JB^,W_(T:9_UYO_Z&*E^"W_(=UG_KVB_]":NY_P"X_/\ 4\Y?
M\C#Y?H>S5YA\:_\ D#Z/_P!?A_\ 1;5Z?7E_QJ_Y ^C_ /7X?_1;5PX;^-'U
M/0Q7\"?HSC?A?_R42P_ZX3?^@U]!5\^_"_\ Y*)8?]<)O_0:^@JWQ_\ '?R.
M?+O]W7S.)^+'_)/KW_KK#_Z,%>,^&/\ D<=#_P"O^+^=>S?%C_DGU[_UUA_]
M&"O&?#'_ "..A_\ 7_%_.M\)_NU3^NASXS_>J7]=3Z<K)\4?\BGK'_7E-_Z
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M3'D)[_G63XGA0>$]8//_ !Y3=_\ 8-;59/BC_D4]8_Z\IO\ T UY1[!\O_\
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MK;_]>4G_ *$M>%5_Y'\/3_VUG7'_ '-^OZG:^0GH?SKE?&D:HVBXS_Q^^O\
ML-775RGC;[VB_P#7Z/\ T!J^BS'_ '2K_A?Y'%1_B1]3'(!\0:'G_GZ/_H!K
MO_(3T/YUP/\ S,.A_P#7T?\ T UZ%7E<-?[@O5_H=&._C?(YOQM$J^$[PC/5
M._\ MBN8UL9L4'_3S#_Z&*ZKQQ_R*5Y]4_\ 0Q7*ZU_QY)_U\P_^ABN+//\
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M4]9U0:9IMS/'LDN(H]XBW<XSU(ZX'6L.:W.HZE;IJ7EQWTL6=.U.T8E3CYB
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M)+=W=F=+TM586TEA<1S ;+=E9>'_ +P SCUS746.FVFFQ,EI;QQ;L%]@^\:
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MT?\ "-W7_0=O?R6N@HH Y_\ X1NZ_P"@[>_DM'_"-W7_ $';W\EKH** .?\
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M%_\ SWL?^_%'_"U?%_\ SWL?^_%'U&O_ "A_:&'_ )OP9[_17@'_  M7Q?\
M\]['_OQ1_P +5\7_ //>Q_[\4?4:_P#*']H8?^;\&>_T5X!_PM7Q?_SWL?\
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M_P H?VAA_P";\&>_T5X!_P +5\7_ //>Q_[\4?\ "U?%_P#SWL?^_%'U&O\
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MOK^*=&D"A4 ;[H ["KOBOQ!IFE:OX@CM(IGU*\6.%W+ Q@  Y%0JM:Z36O\
MPW_!-'2H6;3T]?)_\ Y6]\%ZK8:=+=R^43#&LLT*MEXU;H2*8/"&I'58M.S%
MY\EI]K7YN-F,_G6WKOC:WU?3KDQS7L%S<0B)X %\O. #SUQ4]OXUT5;JUU*6
MTNOMZ6'V)PI&P#:1N%-3K\MVM273P_-9/30R'\'F#1=*U-KN!S>/S!OP2-P
M"^_KZ4EQX0N;C7=5@MUAM+6RD"R/-+\J9Z#=W-.3Q!I<OA_1[:XBN!>Z9*6C
M*8V.I8,<U<E\6:5J%SKUO?P7(L-2G6=&B(WH5]:+UE?^NO\ D'+0=OE^7X:G
M(S64D6HM9*R2R"3RPT9RK'V-=3XJ\)6>DZ?#-I\TDLD,PMKP,>%D*@C'M61H
M]_I>F^*HK]H9GL()"\<9P6./NY_&MN3QY_:EAJEGJMK'LN2)(6@0 B0-D%O7
MBKFZO-%Q6BW,Z:I<DE)ZO8SKKP-JUI<P6K&!KF>0)'"LF6((SNQV%0:AX3OM
M.:U,DMN\-Q*85G1_D5QU!/:M&?QE&OCV+Q#;P.T2(J&-SS@+M.*NR^,=-_M2
MQF<WE[9Q3M+)!<*H5<C P!U(S4\U=6NNA?)AW>SZ_P!,YS6?#5YHMK;W<DD,
MUM.Q5)86R-PZBL:NO\3^*;/5]#@TZW%PS0W+2^9, ,J1TP.E<A6])S<??W.>
MLH*?N/0****U,0HHHH **** "BBB@#O_ (.?\CAJ?_7@O_HRBCX.?\CAJ?\
MUX+_ .C**^9QG\>1]9@?]WB6O$?@34?$?C;7+RTO;:&,21J5E0DY\L>E4?\
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M>1?\*DUO_H*V/_?MO\:/^%2:W_T%;'_OVW^->N^?#_SVC_[[%'GP_P#/:/\
M[[%'URO_ #!]2P_\IY&/A-KH! U:R /4>6W/ZTG_  J36_\ H*V/_?MO\:]=
M\^'_ )[1_P#?8H\^'_GM'_WV*/KE?^8?U+#_ ,IY%_PJ36_^@K8_]^V_QH_X
M5)K?_05L?^_;?XUZ[Y\/_/:/_OL4>?#_ ,]H_P#OL4?7*_\ ,+ZEA_Y3R+_A
M4FM_]!6Q_P"_;?XT?\*DUO\ Z"MC_P!^V_QKUWSX?^>T?_?8H\^'_GM'_P!]
MBCZY7_F#ZEA_Y3R+_A4NN?\ 05L?^_;?XTK?";76.6U:R)/<QM_C7KGGP_\
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MQ_W^;_&C[*O_ #TN/^_S?XUI_9-7^9?B3]=AV9ZHGA?0O-D']FV^!C^&I/\
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M_-_C1_9-7^9?B'UV'9GK'_"+:%_T#+;_ +YH_P"$6T+_ *!EM_WS7D_V5?\
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M_C4<T9MO*FBFN%D$\6#YS?WU'K4SRNI&+DY+3U''&0;2L>N?\(KH7_0,M_\
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MJQA!C.<G'4^]:Z_>'UH \PLM=URQN=4@LK](8%U"?:AA5L?-ZFKG_"4>)_\
MH*Q?^ RTS3?"NL:I-JEU9SV:PMJ,X E#;N&QVJ]_P@OB'_GYT[\GKVJ4L![-
M<ZUMKN<$UB.9\NWR*G_"4>)_^@K%_P" RT?\)1XG_P"@K%_X#+5O_A!?$/\
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M :=%9VLZNFC6:7#1&7S)!&H#!1D@G)8\ <58T^\74=.M[Q(W1)T#A7&",^M
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MQH^I8C^1A[>E_,>@T5Y]_P +$U#_ * <?_@5_P#8T?\ "Q-0_P"@''_X%?\
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M4444 %1P]'_WS4E1P]'_ -\T 24444 %1I_KI?P_E4E1I_KI?P_E0!)1110
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M]=+^'\J )**** "N:O?^1WC_ .P<W_HP5TM<U>_\CO'_ -@YO_1@H T****
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MY(@TL6,;3].WTKE-C1HHHH CD_UL7U/\JDJ.3_6Q?4_RJ2@ HHHH CF^X/\
M>'\ZDJ.;[@_WA_.I* "BBB@!DW^I?Z&G+]T?2FS?ZE_H:<OW1]* %HHHH #T
MJ.#_ %"?2I#TJ.#_ %"?2@"2BBB@ J.'H_\ OFI*CAZ/_OF@"2BBB@ J-/\
M72_A_*I*C3_72_A_*@"2BBB@ KFKW_D=X_\ L'-_Z,%=+7-7O_([Q_\ 8.;_
M -&"@#0HHHH S[;_ )'-O^P</_1E%%M_R.;?]@X?^C** &6'_(>U[_KXC_\
M18K3K,L/^0]KW_7Q'_Z+%:>* "BBB@ HHHH **** "BBB@ HHHH ***,&@ H
MHHH **** "BBB@ I5^\/K24J_>'UH Q_!]C:3Z??O-:PR.=1N/F>,$_?KH?[
M+T__ )\;;_OTO^%87@V>&/3;]7E13_:-SP6 _CKH_M5O_P ]XO\ OL4 0_V7
MI_\ SXVW_?I?\*/[+T__ )\;;_OTO^%3?:K?_GO%_P!]BC[5;_\ />+_ +[%
M %5-,T_SI/\ 0;;M_P LE_PJ3^R]/_Y\;;_OTO\ A3DNK?SI/W\7;^,5,DT4
MN?+D1\==K T 116-I!()(;6&-Q_$D8!JQ110!'_R\_\  /ZU)4?_ "\C_<_K
M4E !1110!')_K8OJ?Y5)4<G^MB^I_E4E !1110!'-]P?[P_G4E1S?<'^\/YU
M)0 4444 ,F_U+_0TY?NCZ4V;_4O]#3E^Z/I0 M%%%  >E1P?ZA/I4AZ5'!_J
M$^E $E%%% !4</1_]\U)4</1_P#?- $E%%% !4:?ZZ7\/Y5)4:?ZZ7\/Y4 2
M4444 %<U>_\ ([Q_]@YO_1@KI:YJ]_Y'>/\ [!S?^C!0!H4444 9]M_R.;?]
M@X?^C**+;_D<V_[!P_\ 1E% #+#_ )#VO?\ 7Q'_ .BQ69<PP:IXMN[+4IG$
M$%M&]M!YIC5]Q.Y^",D8 ]JT[#_D/:]_U\1_^BQ5F]TVQU$(+VTAN-GW?,0'
M'TH Y^YU^2UUNTM+.7S;,7<=E*C1C"L1GAR<DCCM4<&M:Q/:V<K7-K$;Z]>V
MC;RLK"JEOF.3RQ QBNB&DZ<+H7(L;<3C&)/+&X8Z<T^33[.:U-K):PO;D[O+
M*#;G.<X]<T <1:ZS=:=#),WE74JW%\Q9<X)7&,<]/6M237-3L7E22>VO%AAA
MNY9(H]H6)FPZ\$\@<@^@KHXM/LH%58K2% N[:%0#&[K^?>DM],L;6&6&WLX(
MHI<^8BH '^OK0!S%WXHNFT^2YM9E1G$UQ;(L(;=;IP&8DC )[^]2?\)'?Q3Q
M7-UMCM)[<26\<<882MY>XJ6SE6SGMTKH9=)TZ>.&.6QMW2 ;8E:,80>@]!2I
MI=A'="Z2S@6=1M$@09 QC^5 &+%JM_#IVF7D]Y;3_;KB%6"1A5B1P<C.>>W)
MJDVNA_$9N)YD6VLFO(]R<C:H0Y/J>:Z0:-IBP30+86XBF.Z1!&,,?4BI(],L
M(DV1V4"KAA@1C&&Z_GWH Y)?$^K&6>U1HFE\ZV6.2:(+A9<YRH)Z8R*T_%;7
M2:%;V<<GG7UQ.D:?-Y22L/F(8@_*I /2MB#2=.M5"P6-O& 0WRQ@<CH?PJ:Z
MM+:^@,%W!'/$3DI(N1F@#"\&:K#>:?\ 8$DEEGL<)<M)_!(228_?;TSZ8KG]
M,GN$UJ"7RYX2U[=$W#7!9+A4S^Y"9P#TQ]*[NVL+.S;=:VL,)VA<QH%R!T%+
M]CM=JK]GBVK)YJC:.'_O#W]Z .1L-?\ $>H6#7,%K&1- )8RX5?+;=RH^;YN
M,]<<BI8]?OKRXM[6UU*WC)M9II);BW"MOC8 KMS@8[\UT7]BZ7^^_P")?;CS
M_P#6X0?/SGG\:JR^&M-FOH)GM83!# T*VYC&T98'/UXH P?^$DOI+>6\MX88
M[B6&RP'R0#*S _AW%6M2U^\T[48;>.Z6X,-Q#;70-N%4M(?7.0<$' !KI6LK
M5B2UM$<[<_(/X?N_EVJ.32[":[^URV<#W''[UD!;CIS[4 <UI^J:J-+M%DU"
M*2>\U&2V\^2(8@56;MGD\8&:?::SK&HZC%IL%Q:QN/M"R7/E;@YC90"HSWSS
M71-I6GO'/&UE 4N&WRJ4&';U/O3X[*W@1!;P11-&A2,J@^0'L/;.* ,?0]<N
M=7O1"R(GV6#%Z,<K/NP%'M@$_B*Z%?O#ZUG:3I8TR*X+2^=<W4QGN)M@7>YX
MZ#H  !6BOWA]: /'/L%K/J>K22VT;N=0FRS+D_>I_P#95A_SYP_]\5V/A[P=
MH^L1:C>7D4[3/J-P"4G=1PV.@.*V/^%=>'?^>-S_ .!4G^->U2S"C"FHN%[+
MR.">%G*3:E^9YM_95A_SYP_]\4?V58?\^</_ 'Q7I/\ PKKP[_SQN?\ P*D_
MQH_X5UX=_P">-S_X%2?XUK_:='^3\B/JE3^;\SS;^RK#_GRA_P"^*Z/X?6\-
MMXPN5@B6-6L,D*, G>*Z-?AYX>,CCR;K QC_ $J3_&M/1O">D:#=R75C#(LT
MB>6SR2L_RYSCD^M<V)QU*K2<(PL_D:TL/.$U)LYWQUXOO-!UJRM(B\-H(&NK
MF:-59RH=5V@,<=\G'-8L?C[7='O#%X@@<1I<[I&CC7(C93M0<XQWSUP*],O-
M,L-1:)KVS@N#"V^,RQAMA]1GI27&DZ?=JZW%E;RAY%D8/&#EQT8^XKR3M)D<
M23(Z_=:/(^E35%TN1_N?UJ6@ HHHH CD_P!;%]3_ "J2HY/];%]3_*I* "BB
MB@".;[@_WA_.I*CF^X/]X?SJ2@ HHHH 9-_J7^AIR_='TILW^I?Z&G+]T?2@
M!:***  ]*C@_U"?2I#TJ.#_4)]* )**** "HX>C_ .^:DJ.'H_\ OF@"2BBB
M@ J-/]=+^'\JDJ-/]=+^'\J )**** "N:O?^1WC_ .P<W_HP5TM<U>_\CO'_
M -@YO_1@H T**** ,^V_Y'-O^P</_1E%%M_R.;?]@X?^C** &6'_ "'M>_Z^
M(_\ T6*TZS+#_D/:]_U\1_\ HL5IT %%%% !1110 4444 %%%% !117-WVM7
M5CXSM[61T&EO !)E>4D8G:V?3Y2* .DHKBK+QA<1+?SWP1EDNTCL8ON (RDC
M<WT&<^]7HO%TEVJ"RTMY9#!).X:4(JA&VD D<Y[>M '3T5SUIXBGN[^YVVL2
MV$=G%<K*\H5OG!.#V'3%5H?$TFHWME#$HA9;X03A'WJZF,L,'% '545A7FN/
M8>*%LI(;B:W:S\T+!"7(;?C)QVQ6-;>.Q%IT+W$)FN"CSR@_(PC$A4 +CEN.
MGM0!VU%8=WXEBM=6M+,QQO'<ND899?G1G&1E,<#\:R++Q#JTMA'&8T?.ERW3
MW)?#A@Q P,<]* .SI5^\/K6!H.M7-Y]DM;ZT,,\MDERC^8&WC@'('0Y/3WK?
M7[P^M &?X*_Y!E__ -A*Y_\ 0ZZ2O%K?4=6M[S58[75KFWA&H3XCC"X'S>XJ
MS_:^O_\ 0?O?R3_XFO1AEU><5)6L_,Y98JG%M,]@HKQN77O$%L$E&NW3XE0%
M65,$%@"#Q[UZQJEY)8:9<7<4*S/$N[8T@C&.^6/ '>N:OAYT)*,^IK3JQJ*\
M2PG^NE_#^525YW;_ !3LO-LFN=/E@BNT=VD\P,%VD@%<?>!*]1ZBNTT75H-:
MTN&]@:,AQ\ZHX?8W=21W%<YJ:%%%% $?_+R/]S^M25'_ ,O(_P!S^M24 %%%
M% $<G^MB^I_E4E1R?ZV+ZG^524 %%%% $<WW!_O#^=25'-]P?[P_G4E !111
M0 R;_4O]#3E^Z/I39O\ 4O\ 0TY?NCZ4 +1110 'I4<'^H3Z5(>E1P?ZA/I0
M!)1110 5'#T?_?-25'#T?_?- $E%%% !4:?ZZ7\/Y5)4:?ZZ7\/Y4 24444
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MVPLGWXV.2K>O/-;%% %.#2[:WN+>>,-O@M_LR9;^#(/Y\"KJ_>'UI*4'!!H
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M)]*YS[5XJ]=&_P"^9?\ &D2X\5(@4'1N/]F7_&@#J**YC[5XJ]=&_P"^9?\
M&C[5XJ]=&_[YE_QH Z>HX>C_ .^:YS[5XJ]=&_[YE_QI%N/%2YYT;DY^[+_C
M0!U%%<Q]J\5>NC?]\R_XT?:O%7KHW_?,O^- '3U&G^NE_#^5<Y]J\5>NC?\
M?,O^-(+CQ4&9LZ-\W^S+_C0!U%%<Q]J\5>NC?]\R_P"-'VKQ5ZZ-_P!\R_XT
M =/7-7O_ ".\?_8.;_T8*;]J\5>NC?\ ?,O^-1VMKJLNMG4=3DL_EM_(1+96
M'5LY.X^U &M1110!GVW_ ".;?]@X?^C**+;_ )'-O^P</_1E% #+#_D/:]_U
M\1_^BQ6G698?\A[7O^OB/_T6*TZ "BBB@ HHHH **** "BBB@ HHHH ****
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MGF2*XBE8S094D;ESC:,8]JS(;R_T>Z"/%']FM9&;RS,2K2*@W 'N>IQZM[4
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M^OB/_P!%BM.J-QH.J+JEY=Z?JD,,=TRNT<ML),$+C@Y'I2?V1XB_Z#=I_P"
M(_\ BJ +]%4/[(\1?]!NT_\  $?_ !5']D>(O^@W:?\ @"/_ (J@"_15#^R/
M$7_0;M/_  !'_P 51_9'B+_H-VG_ ( C_P"*H OT50_LCQ%_T&[3_P  1_\
M%4?V1XB_Z#=I_P" (_\ BJ +]%4/[(\1?]!NT_\  $?_ !5']D>(O^@W:?\
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M(\1?]!NT_P# $?\ Q5 %^H)[.UNF1KBVAF9/NF2,,5^F:K_V1XB_Z#=I_P"
M(_\ BJ/[(\1?]!NT_P# $?\ Q5 %QHHW+%HT8LNTY4'*^GT]J6...&-8XD6-
M%&%51@#Z"J7]D>(O^@W:?^ (_P#BJ/[(\1?]!NT_\ 1_\50!?INQ/,\S:N_&
MW=CG'IFJ7]D>(O\ H-VG_@"/_BJ/[(\1?]!NT_\  $?_ !5 %J*UMX'D>&WB
MC:0Y=D0 L??'6C[-;[HV\B+=%Q&=@RGT]*J_V1XB_P"@W:?^ (_^*H_LCQ%_
MT&[3_P  1_\ %4 7Z:41F5BJEE^Z2.5^GI5+^R/$7_0;M/\ P!'_ ,51_9'B
M+_H-VG_@"/\ XJ@"Q'9VL,[3Q6L*3/\ >D6,!C]33GM;>10KP1,H;> R @-Z
M_7WJK_9'B+_H-VG_ ( C_P"*H_LCQ%_T&[3_ , 1_P#%4 7ZK7&GV5XX>ZL[
M>=P,!I8E8@>F2*A_LCQ%_P!!NT_\ 1_\51_9'B+_ *#=I_X C_XJ@"R;2U,L
M<IMH3)$-L;^6,H/0'M3I+>"5762&-UD^^&4$-]?6JG]D>(O^@W:?^ (_^*H_
MLCQ%_P!!NT_\ 1_\50!> "J%4  #  ' J*XM+:[0)=6\,Z Y"RH& /KS5;^R
M/$7_ $&[3_P!'_Q5']D>(O\ H-VG_@"/_BJ )!I>G#R\6%K^[^Y^Y7Y?IQQ5
MEHXV)+1JQ*[22H.1Z?2J7]D>(O\ H-VG_@"/_BJ/[(\1?]!NT_\  $?_ !5
M%R**.&-8XHTCC4854& /PHFABN(FBFB26-NJ.H(/X&J?]D>(O^@W:?\ @"/_
M (JC^R/$7_0;M/\ P!'_ ,50!/\ 8+(VPMC9V_D Y\KREVY]<8Q4WEIE#L7Y
M.%^4?+]/2J7]D>(O^@W:?^ (_P#BJ/[(\1?]!NT_\ 1_\50!<B@A@4K#%'&I
M.XA% !/KQ3F570HZAE88*D9!%4?[(\1?]!NT_P# $?\ Q5']D>(O^@W:?^ (
M_P#BJ )5TVP6!H%L;80L<M&(EVD^XQ4RV\"1)$D,:QH<JBH %^@JI_9'B+_H
M-VG_ ( C_P"*H_LCQ%_T&[3_ , 1_P#%4 6T@ACD>2.)$>0Y=E4 L?<]ZDJA
M_9'B+_H-VG_@"/\ XJC^R/$7_0;M/_ $?_%4 72B,Q8HI8C:21R1Z?2HX[2V
MAA,,5M#'$W)1$ 4_456_LCQ%_P!!NT_\ 1_\51_9'B+_ *#=I_X C_XJ@"V(
M(1-YPBC$NW;YFT;L>F?2I*H?V1XB_P"@W:?^ (_^*H_LCQ%_T&[3_P  1_\
M%4 761'8,RJQ7."1DC/6HH+.UM0XM[6&$/\ >\N,+N^N*K_V1XB_Z#=I_P"
M(_\ BJ/[(\1?]!NT_P# $?\ Q5 %K[-!NC;R(MT7$9V#*?3TJ6J']D>(O^@W
M:?\ @"/_ (JC^R/$7_0;M/\ P!'_ ,50 EM_R.;?]@X?^C**L:7HE];:K)J&
4H:A'<R& 0(L< C &[.>IS10!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>forms-4_015.jpg
<TEXT>
begin 644 forms-4_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "9 G # 2(  A$! Q$!_\0
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M'VI17Q-%87DUG->16D\EK 0)IDC)2,GIN;H,^]-:SN4>9&MIE> ;I5*$&,9
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MAU.YMFW037<LD; $94N2#@].*SZ^C?\ A07A7_G_ -9_[_1?_&Z/^%!>%?\
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MS::UM)Y@ATZW@D^4C#JF&'/H:]S_ .%!>%?^?_6?^_T7_P ;H_X4%X5_Y_\
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M!>%?^?\ UG_O]%_\;JHXNC%)*_W"E1FVV?.5%?1O_"@O"O\ S_ZS_P!_HO\
MXW1_PH+PK_S_ .L_]_HO_C=/ZY2_I"]A,^<J*^C?^%!>%?\ G_UG_O\ 1?\
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M/[D7Y'_&C^V;C^Y%^1_QH]M .=&W16)_;-Q_<B_(_P"-']LW']R+\C_C1[:
M<Z-NBL3^V;C^Y%^1_P :/[9N/[D7Y'_&CVT YT;=%8G]LW']R+\C_C1_;-Q_
M<B_(_P"-'MH!SHVZ*Q/[9N/[D7Y'_&C^V;C^Y%^1_P :/;0#G1MT5B?VS<?W
M(OR/^-']LW']R+\C_C1[: <Z-NBL3^V;C^Y%^1_QH_MFX_N1?D?\:/;0#G1M
MT5B?VS<?W(OR/^-']LW']R+\C_C1[: <Z-NBL3^V;C^Y%^1_QH_MFX_N1?D?
M\:/;0#G1MT5B?VS<?W(OR/\ C1_;-Q_<B_(_XT>V@'.C;HK$_MFX_N1?D?\
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MBMS^QK?^_+^8_P */[&M_P"_+^8_PI>QF/D9AT5N?V-;_P!^7\Q_A1_8UO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#\#?\ [&MXUX6]YZ_/_(SE3=]%_7WG4?#O_D7Y_P#KZ;_T!*ZZL+P9I/\
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MUM[2&<)/*Q4E@GWBHW$98YV@$]L=M&Y\.^-;LYFL(CEQ(X7[.HD8="X&-_\
MP+/4^M.?0/&TD_G-IUN6\ORB-EMM91C *]#C QD<8XJ545K<Z^_T_P"#Z7'R
M/^5_<9(L8/)N;86MB=2+NRPM)+D1E%93&0VT\;C\Q)/'7I4>IZ7%::>JVZV\
MCQQQ2SOYCF5-ZCMPFW+ <9;U(SBM<^'/&A,Q-A$7F)+R?Z/OY&" _P!Y1CC
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; 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>annexd_001.jpg
<TEXT>
begin 644 annexd_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ_8)+?\ U9? R22K ');)QD<=!7K7@+0;'P_X;2#3=9N-6LY7,L-Q-/YHV$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-_+\;?YE15W;U7W?\,=917FOPQ\4:_?:EK?AWQ5=I<:O8&.59%C1,QNH.,*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?FKUP^!?"!))\*Z&2?\ J'Q?_$U>M/#^C6%V+NSTBPMKD1B(30VR(X0  +N
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M* !5M)[]K?>VW^8DK;=T_N5D>4? ;4KRVT[5_"6J1M#?:3<$B%NJ*QY&>X#
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M_2M.TB P:;86ME"3GR[:%8US]% %*NF6":D^I)8VRW[IY;W0B42LO]TMC)'
MXS322LNGO?\ DRL)W=WZ?@[GS#KC7_A?4;'X?W_F2PV6M0WFGSGH8&)&/S(_
M'=7U16??:#H^J7,-SJ&DV-W<0_ZJ6XMTD:/G/RD@D<\\5H4TWR6>_P#P$OT!
MI<UUM_P6_P!0HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3^&5Y<W_ ,-]#NKRYFN;B2WR\TSEW<[CR2>36-X[^).L>#=3DAM_!=]J=A'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@DCE@8+(C>Q((Y'!XK(U'X5:'J7@C3_"<UWJ*V%C)YD4B2()2?F^\2F/XCT
MJ8W2UZ./W1=_^!]Q?VD^GO7]6K?CN97QMO=-@^%MS:WDD7VF?RA:QL1O+A@<
MJ.O SS7&^-UFT_P;\+VU!BA@G@,SR<;,*AY^@'Z5VV@_ SP9H-_'>^5>7\L3
M!XQ>RAE4CI\JJH/XYKM/$7AK2?%6DOIFL6HN+9B& R0R,.A4CD&J^'WEJ^9/
M[NA%KI1>R37WGGGQ_N[<_#B&(3QE[B\B,*ALF0 $DCU&*S/B(C1^)?A:C@JR
MSH"#V.8JZ'0_@5X-T/5([\)>WTD;!XX[R5612.APJKG\<]*Z?Q%X*TWQ-K&C
M:G>S74<VD3>= L+J%8Y4_-E22/E'0BG!*+3_ +R?W*P2N[_X6OO.9^/'_)*K
M_P#Z[P_^ABNW\.?\BQI/_7G#_P"@"JWBWPM8^,O#\NC:C+<16TKJ[-;LJOE3
MD8+ CMZ5JV5I'86%O9Q%C'!$L2ECR0HP,^_%3'12\VORL-J\D^R?YW/%OVD
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M+X&ELV_E[UT_NT"%U)-[I+YZ:K]?4]1\)_\ (GZ+_P!>,/\ Z *\ATQ$U/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^BZP86EAM;@D^: "<#*J02 <?+7.W/QUUZSO+>SNOAKJ4%U<G$$$L\BO*?\
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MY@FV-@@#8N/7J:7XC?%B+P#J5I81Z2=2FFB,T@%QY7E+NVJ3\C9R<^G2O*]
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MX\_C55'R*2ZQU_&Q,'S<LNC_ ,KH]<TSXL^!=8O4L[/Q!"9Y" BRQ20AB3@
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MS7I7@GQKIOCK0AJ6GAHV5MD\#_>B?T/J/0U!\.-O_"LO#^[&W[ F<^F*\T^
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M-=GJ6J6&CV,E[J5Y#:6L?WI9G"J/Q/>OG?Q#XP7QKIGP]U!R/ML&I""\4=I
M8^?HPYKK?BU"-<^(_@OPY>NPTNXE,DL8. YW8Q^0Q_P*JLTE'JY-?*R?Y$N2
M^+HHW^=VCMM)^*?@G6]06QL=?@>Y8[522.2+<?0%U )^AK9O/%&CV'B"RT*Z
MO/*U*]4M;PF)\2 9SAL;<\'@FO//BSX#\+6GPXO[VRT:QL+JR5)(9K:%8V)W
M 8) ^;(/?-8OBJ2]F^%W@KQS\S:CI#0RRO\ Q/&V%;/U(7\S0FNO1I/Y]?OW
M&^;IU3MZKH>N^(/$^C^%K2&YUF\^S132B&,^6[EG/0 *">WI6+K/Q3\&>'M4
METS5-9^SWD.TO$;69MN0".50CH17(>))XO'/Q<\)Z3 QDL+"W_M6<?PG=@IG
MWX7_ +ZKD/$M]]@^.WB"7_A#?^$JS;QK]C\GS-GR1_/C8_TZ=^M)7ND^O-^&
MGYW'=--KHE^/_ L>TCX@^%SX5;Q,-4_XDZR>4;G[/+][.,;=N[J?2M70]>TS
MQ+I46J:1="YLY20D@1ER0<'A@".?:O(_'EPMU\ 99QX:'AS?=1DZ;Y7E^6?-
M SC8O7&>G>G^#=;'@.R\9Z3<C;#I\8U2S7& 4E4$*/\ @6T?C3;2Y[]-ON3?
MYZ$Z^ZN_^;2/2-/\=^&M5\23^'K+4Q-JD!<20"&0!2OWOF*[3CV-9-]\7_ F
MFZA<6-WKOEW-O(T4J?9)SM93@C(3!Y]*\R^&VC2:-\5M%%R#]LO=$>]N2W4R
M2,S<_A@?A6'8:C]@\<^,Q_PK[_A+/,U"3G[/YGV;YW_Z9OC/X=*3NK)[V=_5
M.W^92::DUM=6]&KGT1'XLT*;P[-K\.IPS:7 C/+<19<*%ZY !.1Z8S7/V?QB
M\!ZA>P6=KKOF7$\BQ1I]DG&YF. ,E,#D]Z\P\%P6T?P2\=2Q3QB>82M-9(K+
M]D^4X0[@.?\ "E^&6J*UOX?L7^% N%+JO]OFTR/O?ZW=Y/;UW=NM5%7G;II^
M*[[&;E:-_7\/+<]7UOXI>#/#NK3:7JNL_9[V''F1?99GQD CE4(Z$=ZW]%U[
M2O$5@+W2+Z&\MB=N^)LX/H1U!]C7@'B77_#?AWXZ^(;KQ/I']J6;V\<:0_9H
MYMK[(R#AR . >>O-=A\#-,N$_P"$@UZ.Q;3]'U2X#V%JQZ("W(]N0/PI4_>C
M=]K_ (VL:5/=E9=U^5[_ "/8*\@G^,5U=?%6Q\-:1;6DFDR7(MI+J1&+NP^\
M4(8# /'0UH_&7QNWAO1[71[:Z%G=ZL3&;ME8BWA& [_*"2><<#/6O)KK7_!N
ME>/O!;Z)J7F:+I,:BYN#;R*=^YBS%2H8DY!X!J8.\T^E[?AK\EMZ^@JEU!I;
MVO\ E^+_ "/J>D=BJ,P4L0,A1U/MS45I=0WUG!=VS[X)T62-L$;E(R#@\]*F
MJFGL--/5'CEU\1/B9?-=7FA^!(HM-M7=9/MS'S6"G!P-ZY/!^Z&_&NF\,_%'
M3=<^'UYXIN8&MA8!A=0*VXA@ 0%/&<Y&/K5?XF>/#HUN/#>B1&]\2:DOE0V\
M?)B##&]OZ#\>@KCO$?@F3P/^SUJ&GNXDO9IHI[MDR0&+IP/8  9J.9JG)^B3
M\[Z_)?F.UYQ7WKRZ#Q\8O'$>G+XHG\(6H\*-(%$@D/FXSC.=WKWV8]Z] \2>
M.;BP\)Z?K7A[1+G6CJ)00)%P$WC@OC)'ITZ]2*Y.[\C_ (9A7=MV?V4F/][<
M,?\ CU=!\(IQ;?"+2)[R18HHXI&9Y" %0.W)/IBM))+GC?X6M?+6_P"1G&3?
M++^:_P#P#EO^%J^-?#.KV$?CKPO:66GW[A(YK5_F3U)^=P<9'!VGK77^.?&'
MB+0[RRTWPUX8FU6[O$9DG8_N$QV.#]#R5&._IPUY]H^-7CBT^QQM%X2T6;<U
MTPP;E^,A?KC'L.3U KV/6-8T_P /Z3/J6I7"6]I;KEG;] !W)Z 5+?N*4M-?
MPZ7_ *_,I7YVHZZ?B>;>&OB?XCB\:V_A3QOH5OIU]=KNMY+9\J<YP"-S YP1
MD-U[5ZQ7B_@[3=1^(OQ"7XA:E:FSTFT'EZ9"_P!^4#.&/MR3GUX'2O:*K7E7
M,K/^K?.PE\3MM_5_E<****104444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MP?Q8\$ZEX[\,6VFZ7/:0S172S%KIV5=H5A_"K'/([4[QA\/E\5_#^UT1WA34
MK.&/[-<'.U)54 \XSM.,=/?'%=U14\JLUW=_F.^J?96/+O$'@;Q;XF^%=MX<
MU"\TQM8@F0FY\V0QR(F<$G9G=CV[=:M>#]"^*&FZU;'Q'XCTN\T>.,HUO;Q@
M.?EPN#Y*G@X[UZ/15IZM]_\ *Q'*N51[?YW.$\"^"M2\,>)?%.I7L]I)#JUW
MY\"PNQ95W.?FRH /S#H372^)O#UEXJ\/7>C7X/D7*8W+U1AR&'N#@UK45+2<
M5%[))?<7=J3EU;N>+1?#GXHV%A_8.G^-[-=#"^4I:,B94QT'R$CZ!ZZ7_A6*
M:9\*;_PAH]PC75TA+7-SE0\A(R3@$@8& .:]$HH:YDT^N_<2T::Z'F6J?#&[
MOO 6@V,%W;VOB71(T^RWL9.P.O4$[<[3]/PKI]:T?6=?^'E[I%VUE'J]W9M
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M%"Q:=XP\8VLNCHX9HK-/GDQTS^[3/U);UKT_4O#=E>^#[CPXB".T>T-K&O\
M<&W"G\.#6S11)*47%[,%I)2['FGPK^'6J>#)M1O==O+6[O[A(H(GMW9@D2#
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M\5:&VFPR()8(857,0(RJXMQCC@<BO6:**;=T"5@HHHI#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "N5\':/?Z5J/B>6]@\I+W57N+<[U;?&44 \$XY!X.#7544+1W^7
MY?Y ]5;^NO\ F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTC2C*S3*< %U0CN,#)'4UB?#.XMK3Q[J.DZ/I6N:-I#:>DZZ=JR.K))YA!=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW-GX9L]+,$-MH]]#.5D8C]U&I7"X!RW(ZXKI;P71LYA9-"ET4/E-.I9 W;<
M02/H14]%#UOYZ_>))*UNFAYOJ'AWXA^*;5M)\07GABVTJ5U:5].BG>=@K X7
MS#M7..O45Z.JA$"C. ,<TM%'2P6UN%%%% PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOP*;\5-UY:>']#9V6UU75H;>YQQNC&6*_C@5WL,,5M D$,:QQ1J%1%& H'0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"N=/M1/ QZ9$@8 #/Y"O0Z*A*WH4]3A/%-CK&K6/A[Q/IVEL-4TN;[2VFS,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 44C,$4LQ 4#))["O"O'?QX,-PUAX1\MPIP]_*F03Z
M(I_F?R[UI3IRJ.T1-I;GNU%?'OBM?'$5M9ZGXBN=1:#48Q+"\DY*$'D# .%.
M.=O'!KD,\Y[UU1P=U?F(<_(^\:*^&+75-0L2#:7]U;D=#%,RX_(UV&C?&'QK
MHRK&-5-Y$O\ !>H)?_'OO?K1+!RZ,/:(^MZ*\B\,?'S0=1CCAUV&33;HX#2*
MI>$GUR.1^(_&O6;>XANK=)[>5)89!N21&#*P]017).G*#M)%II[$E%%%0,**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#QOX]>,9M*TJV\/6-P8[B^4R7)0X80] /HQS^"GU
MKAO@Y\.6\2ZHNMZI;YT>U;Y%<<7$H_AQW4=3^7K6UXP\)WWQ ^.E[IJ%DLK&
M* 7,_P#SSC**V![DL<?GVKW?2]+LM%TV'3M.MDM[2$;8XT' [G\<\YKM=14Z
M2C'=F=KN[&ZKH^GZWIDNFZC:QW%I*NUHW7@>A'H1V(Z5\N?$;X7:AX)NC<VP
MEO-'?E;G9S$2<;7QT/3GH:^L:@O;*VU&RFL[R!)[:92DD4@RK ]C6-&M*F_(
MJ4;GPI17JOQ-^$5QX79]5T1)KK2#EY5."UKST/<KSU[8Y]:\JKUH3C-7B8M6
M"NF\(^.M;\&7Z3Z=<LUOG]Y:2L3%(#URN>#[CFN9HJG%25F(^O? GQ+T;QO;
M)'&ZVNJ8)DL7;+<=U.!N'ZUVM?)/P90/\5]%!Z#SC^4+FOK:O(Q%-4YV1O%W
M04445SE!1110 45C^)?$NG^$](.J:H95M5=8RT49<@GIQZ5G>%/B#X?\9W%Q
M!H]Q*\MNH=TEB*':3C(SU_\ KU7)*W-;05SJ:**Y'Q3\2O#?@_4H]/U:XF6X
M>(2A8H2^%)(&<?0T1BY.R'>QUU%9VA:U:>(M&M]5L/,-K< F,R)M) )&<?A6
M9XP\;Z1X(L[:YU4S%;B0QQK"FYB0,D]>G3\Z%%M\J6H7.DHK@/#GQ@\,>)M<
MM](L_M<=S<;O+,T8520"<9SUXKOZ)1E%VDA)W"BN<\6>-]%\%Q6LFLR3(MRS
M+'Y<9?)7&<X^HI_A3QEH_C.TGNM'DE>*"01N9(RASC/>CDE;FMH%^AT%%%8?
MBGQ;I7@[3(M0U>25+>280*8XRYW%6;H/9322;=D,W**Y;PI\0= \9W%Q!H\L
M[O;H'D\R(I@$X'6NIH<7%V8!17GLWQH\'6^HR6$EQ=^?',86 MCC<#CK]:[C
M4]0M])TNZU&Z+"WM8FFD*C)"J,G _"J<)+="NBU17FO_  O;P1_S\WG_ ("M
M1_PO;P1_S\WG_@*U5[&I_*PYD>E45F:!KUCXET6#5M-9VM)]VPNNT\$@\?4&
MN7\1_%[PCX;GDMI+U[RZC.'AM%WE3Z%N%S[9J5"3=DM0NCNZ*\OT[X]>#KV8
M1W'VZQ!_CGAR/_'"QKTBQO;;4K&"]LY1+;3H)(I%Z,IY!HE"4?B0)IEBBJ&K
MZWIF@V)O=5OH;2W!QOE;&3Z =2?85YWJ'Q]\(6DYCMTU"]4''F0PA5_\?(/Z
M41IRE\*!M(]3HK@] ^,/A#Q!<PVL5[+;74S*D<-S$5+,3@ $9&<X[]Z[RE*,
MHNTD"=PHK@/$/QD\(>'YGM_MDE_<(VUX[--^T]QN.%_6LBQ_: \)75RL4]OJ
M-FC'!EEB4J/KM8G]*M4:C5T@YD>K452TK5].UNQ6]TN\AN[9N!)$V1GT/H?8
MTNJZG;:-I5UJ5X66VM8FED*KDA0,G K.SO89<HKS7_A>W@C_ )^;S_P%:K^F
M?&+P1JDPA75_L\C'"BYB:,'_ ($1@?B:MTJBZ,7,CNZ*16#*&4@@C(([UPNM
M?%[PGH&L7.E7\]TMU;-LD"6Y8 XSU_&IC&4M(H&['=T5YK_PO;P1_P _-Y_X
M"M6YX6^)7ASQCJ<NGZ1-</<1PF=A)"4&T,JGD^["J=*:5V@NCKJ***S&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME-X<TL^)(_$"VRIJ20M 95XWH<<-ZXQP:U:NM4]I+F%%61YS\<+ 7GPRO9<
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M>/-7UR>W\4:!'I]BMLSI*L97,FY0%R6/8L?PJ946E>Z^\.8]#HHHK$H****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*VUY;S,.HBE5B/R-("S13(Y8YDWQ2*Z]-RG(IHN8&C\P31E,[=P<8STQGUH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP(]<UN:E/H/B#Q5JD=EX#;7[RV?[/=WDPC2(.HQM5G.,CH< 5T%AX=\6074
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MI%YH7A^UTR^U1]3FMUV"Y>/867L",GH.,YK7HJY59S5I,226P4445F,****
M"BBB@ HHHH **** "BBB@ HHHH **** "JTFGV<NH0W[VT37<*,D<Q7YE5NH
M!]#BK-% !1110 4444 %%%% !1110 4444 %5[NPM+]8EN[>.=8I5FC$BYVN
MIRK#W!JQ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>annexd_002.jpg
<TEXT>
begin 644 annexd_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 '6OB_QWH8\.
M^-]6TQ4V113EH1@X\MOF7'X$#\*^T*\6^/WA%K[2[;Q)9P;IK3]U=%>OE'[K
M$>Q_]"]JZL+/EG9]2)JZ/G:NR^'OQ!OO NKB13+/IDI_TBT#X#<?>&> P_7I
M7&T5ZDHJ2LS%.Q]RZ1JUEKFEP:CI\Z36TZ!E96!QD=#CH1W%7:^2_AA\1IO
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1@P!'4<=ZDHG4G/XF"26QQ'Q ^&]IX_>P:ZU">T^QB0+Y2!MV[;US_NUQ?\
MPSEI7_0?O?\ ORM>UT4XUJD59,'%,\BT?X!Z9I&M6.I)K=W(]I.DRHT2@,5(
M.#^5;_COX5Z=XYU2#4YM1N[.[AA$"F(*5*AF8<'G.6/>N^J"[O;33X#/>W4-
MM"#@R32!%'XFCVU1RO?47*CR ? :XV^4WC;4#;]XQ"<?^C,?I7:>"OAGH7@C
M?-9J]S?/D-=W&"X']U<<*/U]ZZZ"XANH$GMYHYH7&5DC8,K#V(ZU)1*M.2LV
M-12"O-/%'P2\.^(=0:_M99M*N7Y?[,H\MF_O;3T/T(KTNBHC.4'>+!I,\67X
M ,?DE\8WSPC^ 08_]G/\J]%\$^#+/P/HKZ;9W,]PLDIE>2;&2Q '&!P.*Z![
MB&*6.*2:-))21&C, 7QR<#O4E7*K.2M)@DD8_B3PQI7BO2GT[5K82Q-RK#AX
MV_O*>QKS+_A0*6SG^R_%VHV<9_A\O)_-67^5>PK/"\TD*RHTL8!= P+*#TR.
MV:DI1JS@K)@TF>5Z%\"]#T[4DO\ 5;ZYUB1.1'<*!&3ZL.2?IG%>I(BQHJ(H
M5%&%51@ >@IU%*4Y3^)@DD<3XZ^'%IXYO=-N;G4)[4V.[:L:!MV2#SG_ ':[
M:BBDY-I)]!V"LWQ#H\?B#P_?:1+*T4=W"8FD49*@]Q6E123L[H#Q=?V=]-48
M7Q%?@>@B7_&E_P"&>=/_ .ADU#_OVO\ C7L]%;?6*G<GE12T?3ETC1+#3$D:
M5;.VCMQ(PY8(H7)]SBKM%%8/4H**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *Y7QSX#TOQQI+6UVBQ7B#_ $>\5,O$?3W4]Q7544XR<7= ?%OBSP9K/@W4
M?LFJVQ5&)\F=>8Y@.ZG\N#R*Y^ON'6]!TOQ'IS6&KV4=U;$YVN.5/J".0?<5
M\Z>.?@EJ_A]9M0T4MJ6GJ2QC5?WT2YX^7^(#U'/M7J4<2I:2T9C*%MCRFO7O
MA-\6&\/R)H>OSR/I382WF//V4YZ'OLY_"O(W1XW9)%9'4X*L,$&FUT3A&<;,
ME.Q]X1R)+&LD;JZ, 593D$>H-.KYV^#OQ3&EO%X;UZX8V<C!;.X<Y$)/\#'^
MZ>Q[?3I]$]:\>K3=.5F;IW"N1^*-L;OX9:_&!G;;&3_O@AOZ5UU9^O6/]J>'
MM2L-N[[3:R18]=RD?UJ(.TDP>Q\7:#IDFLZ_I^F1@E[JX2+CW(!K[?1=B*H[
M#%?//P*\"R76K-XHOXV6WLV,=JK*1YDF,%Q[*,CZGVKZ(KJQ<U*5ET)@M K&
M\72R0>"]=EB=HY$TZX9'4X*D1L00>QK9K#\9_P#(B^(/^P;<_P#HIJY8_$BV
M<K\)]5NETZ?P_JMW+<:C;*EW$\SEFDMYE#J<GDX)(/IQ6+XTU>]U3QWI\NFZ
ME/%IVD:G9V,Z12%5FFEDRZG!Y"JH!SW-.U>9/!UKX2\=B-WA33(["^CCZNK1
M!HS^##'XBB?0VT;P+X:DN.;_ %'Q#9W]XYZF623<0?H,#\*ZDES<W?\ X-_Z
M\R.ECM];\8?V;K"Z/IND7FL:EY0FDAMBJK"A. 79B N><#VIVA^,[;6HM2B^
MPW=MJFFC-UILB@RKQE=N#AMW;FN$OK$6GQ6UR/4_%%_H@U**&>SFAE6..=5!
M4H688RIZ#W-27L-EX/T;Q/XET'Q*^LZT;>&.:66:.8Q N%#D*.PR>?[M1[.-
MDNNG<=V=%<_$6YTPP7&L>$]5T_3IIEA%W*\;;"QP"Z!B5%7]7\:O:>()=#TK
M0[W5[^"%9IU@=(TB5LXRSD<GT%>9?$!8(?!$+2^-;W7+ZXEA8Q131F$C<"7,
M:CY5'8D]2*[_ ,4:/H=WK$U[:>(X]"\2)$JM<1W*JQ0<@21L<,O3MV'-#A%6
M=N_?_AQ79>O/&O\ 9FAV6HZEHM]9O=7R60MI2F]6;.&R"05XK0\4>);?PMIT
M%[<02S)-=1VP6,C(+G //:O+-:\07^M?#*QU+598ISIOB&-);R!,1SQH2/-
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M[*%FOMN/.B9=R,5'\6.,?3O4WA[QGX:TOP'H[W>NZ>A@TZ 21K<*T@(C4$;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;RWO[=H)7U&YF520<HSDJ>/45U$\$5S \$\22Q2*5='4%6!Z@@]:DHIRE=W
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<8Q"O?'<5-/?F>_Y+_-ESVLMOS_X"_%GI5%%% PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **@@O;2YFGAM[F&66W8),D<@9HF(R P'0XYP:GH **** "BJ%GKF
MD:C=RVECJMC=7,/^MA@N$=T_WE!R/QJ_0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAHENWD8&#&Q+9R.1SUZU-XET%?#7PCT?3FOTU+3['48'N[A8]JO!YV3\H)&
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M[ ?H*V)/"^C2^'9- >S!TN0$- )'&06W'YL[AS[UKT4=+!UOU&HBQQJBC"J
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M^$H9(M#TN&S$GWV4EG?V+,2Q'MFMRBBJ;;W$E8****0PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQWJYH$B>%?'7B'19F6.PO$_MBUR>!GB8?@P#?C2NK7Z:_>M_PU&[IV]/N?\
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M/\_[';I!YNS;OVC&<9./SK3HIWW_ *V%8****0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .*\+_$%?$/BO5=!FTQK)[-Y
M%MY3-O%RL;E'(&T;2#CC)ZUT?B#68?#V@7NK3J72UB,FP'!<]E'N3@?C7DT:
MMI5E+XMA#;M(\37@N=O>VDD"R?E\I_"NV\4NNO\ B?0/#D;![<O_ &G>8&08
MHR/+!]F<C_ODU*?-"/?2_P!R=_NO]PF[2EVUM]]K??;[S2\$^*)?%WA_^TI]
M..GRK/) ]N9O,*LAP?FP._M71UY9X-FEM_A-XEF@D>*6.XU%D=&*LI!8@@CH
M:[?P?/-<^"=$N+B626:2QA=Y)&+,S%!DDGDFJO=7\D_O5Q*_7N_P9N45YEHF
MJ:A+\%-9OY+^Z>\CCOREPTS&1=KR;<-G(Q@8],5?\):%K&K6VC^)-;\1ZKYY
MA25-/MIA';;2HP)!C,A[DD]?:A:NWI^*N-NWX_@['?45Y9I6F:WXOUKQ1:7/
MBC5K#3++5'CA33YO+F)VJ<>802$'&%&.IK7\)7&JZ+XPU#PCJ6J7&JP16D=[
M9W=S@S!"Q4H[#[Q!&<THNZ7FK_A<&[7\G;]#9\%Z_=>(])N[N\CA22&_N+91
M"I *QN5!.2><#FNCKQSP3X6U/Q'IFK>=XEU72]/CU>[$$.E2B!V;S#EG?!)Y
MX &!Q6[X;36=0T[Q=X3N]:NYKG3I?(M-2W[)PKQAD)9><@]^]*_NI];)_A&_
MSUN"W^;7XNWY'HU%<-I/C-T^%LVNW_\ Q_Z=!)#=H<Y^T1_*1SW+8_.MOP79
MZA9>$M/35;J:YU"2/SKB2:1G.]_F*@GH!G '08J[:M=K?C_P-1)Z+SO^&_XZ
M#_$_BG3O"FG+=WWFR/*_EV]M F^6>0]%1>YKG%\:^,1()I?AM?+8$_ZQ-1A:
M8#U\GKGVS4>HHM[\==)ANE#16>CRW%L&Y'F,^UB/<"O0J4=E)]?T=OT94MW'
MT_%7$4Y4$@J2.AZBEKC?B#>Z=;:?;IJ7C&?P[ Q8N;5E6>=<=%."PQZJ.XKD
M_AUXHM)_'4NB:+XKU+Q#I$EBT^_4@QE@E5P,;V12P(;\*(^\VD*7NJYZ]17E
M6DZ9KOB_7O%5I<>*=6L-*L]3:.)+";9,3M4X\P@E4'&%&.IK2\+1ZI:^(/$?
M@Z^UN^O[:"VBEM+R>3_2(UD# @N,$D$9!J4[J_=77W7&W9_.QZ'17$>#/$4T
M'@R^77+AGO\ 0&EM[Z20DL_EC*N2>3N7!SWK!BUGQ#IGP\TV<W<G]O\ B6_5
M87N',BV@F)*[58X 5!PO3-4][+7;YWV_S^0KZ:^?X;_UYH]5HKS+6?"FN^%=
M&N_$.E^,]>OKZSC-Q+;:A,);><+RRB/ V9&<8/%/\8ZYJU_9>"+G0+Y[&75;
MQ 6Y*['B8G<O&[&<@'C(%'IW2^_;\@;MJ^S?W?\ #GI5%>5>)-%UCP-;6_B.
MR\8:[?NMW"EU:ZA.LL$J.X4A4"@)U[5ZK0M5?^NX7UL4M8U2#1-&O-4NB?(M
M86E?'4@#.!6=X/\ $R^+/#\>I?9&LYQ(\4]J[[FA=3@J3@9['IWKD_BMXET?
M3IM"T76+P6UC>70N+QC&SYAB^8+A03\S[1TZ9JIX/\;^&[_XG:C9Z!J"W-IJ
M\"W) A>/9<(-K<.!]Y #QW4TH>\W\_P_SU7R";Y;?UOI^&_S/5:*\ZU'^UO&
MOC?5-"MM<O=(T?2(XA.^GN(YYYG&X 28.U0,=.M6]6:Z^'/@#4[F+5M0U:X5
M@+634Y1*ZNY"J"V!D!CFB_N\WW>>MOQ'UM]_EU.ZHKSAO!?B/2]*EUB+QOK5
MQK20&5XKB16LW8+DJ(<?*.,9!SWJA<ZQJ?\ PSS;ZH-0NAJ#6L3&Z$S"4DR@
M$[\YZ<=:?==K?B["3NUYW_!7/5JS-?U.ZTC1Y;VSTN?4YT9 +: X=@6 )'!Z
M Y_"DUJ62+PM?S1R.DJV<C*ZMA@0A.0?6N#U35=1C^ ^FZBE_=+?/;V9:Y69
MA*Q9T#$MG)SDY]<T=;=FOQ=@3ND^]_P5ST\'(!QCVI3TKSOXB75]#>Z7'<ZI
MJND^&Y(G-[?:6I\V.08V!G"L43&>0/K6MX'L+>VLY[G3_&%]XATZ8#RFN[A9
MVB89S\X .3GH>F*5[IOM?^O+R"^W]?UYFGIOB!IO#DVL:O83:0D'FM+%<<LB
M(3\W R00,]._>M&XNRFERWMM"]T1"98XDX:7C( SW->/WXO=;^ >I75UK&H^
M;!+=,Q$V3,JS, CE@25 [ CIZ5V&E>&Y/#/@_4KN+Q!KM_)-IQ=?[0O?-$!$
M9(\O@;>OZ"IF[0D^R7_I-_Z_X8J/Q*/=O\)6.NTF]FU'2+2\N;*6RFGB61[:
M7[T1(Y4^XJY7F;^)-6M/A7X6%G=%M9UE;:TBNISYA1W7+2'=]X@ GGO2:SX4
MUWPKHUWXATOQGKU]?6<9N);;4)A+;SA>641X&S(SC!XK6I:,I7T2=OZ]"(7<
M5;5L]-HKS?QOKVJW7ASPC?Z!=-:7.I:A;A3D[=LD;'#C(W 9S@^E4?%6@ZUX
M+TB3Q39^,]>O;JUDC:XMKV97MYD+JK 1A0$Z]O\ Z]*S3L]-;?/3_,:=TG'6
MZO\ G_D>K5SWBGQ?8>%HK9)HI[N_NV*6EC:INEG;V'8#N3TK?1M\:MZ@&N L
M46\^.>JR7(W/8Z3"MJ&_A#L2Q'\JG[2CZ_@KAS+EYO3\2>U\8^+S>PB_^'5[
M;V4L@03Q:C#,Z@G +1C! QR>>*[JBO/-1_M3QKXTU30K?7+[1])TB.)9VTYQ
M'//,XW#Y\$JH&.G7-.^R0]M6>AT5Y[IAU7P;XWTWP_<ZS>ZOI6JPRFWEOV$D
M\,L8R07 &X$'OZ56N8]=U_XD^(-!M]<O-/TN.VMI97MG_>IE6&V(G(3=U+ 9
M^44M[6ZW_#<5[7OTM^.QZ717FWB^#6-!A\':1HNMWWGRZB;=[N]F,KR*8WR9
M.@<CJ 1C(%5?$6BZUX"TU_%%AXMUO4?LLB/>6>I3++%-&6 8(H V'G(QZ4U9
M^E[?E_F%WM;6U_S_ ,CU.BFQ2"6))%Z.H89]Z=0"=U=!1110,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*D$'D''2NI\):)KLOB+4/%7B6&"TOKJ!+:WL8)/,%O"IW89APS$GMQ6SX?\
M#O\ 85WK4_VKS_[3OFO-OE[?+RJC;U.?N]>/I6Y4Q5DNZ27X:@U=OUO_ )'*
M^ ='O]$T2]M]0@\F634KF=%WJV4>0E3P3U';K1X:T>_T_P 6^++ZZ@\NVO[F
M&2V?>I\Q5B"DX!R.?7%=55+5K:^O-*N+?3=0_L^\=<177DK+Y1]=C<'\:-K/
MLK?DOT#E6WG?\W^IYAK6B2W'Q47PY T;:3J4L6LWT0.=C19!!'H[",_537KE
M<QX5\(-H%U>ZEJ&JSZOK-[M$][-&(_E7HB(.%7O@5T]-+EBH_P!?TE9!O)R_
MK^F]3D/&?A;4-4NM/US0+J*VU[3"WD&8$QS(WWHWQS@^O:J4'B/XBRSI;2^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M# C/)JGJ6C:+H?Q3\,+X:MK:ROIC,+^VLE5%-N$ZNB\#YL8.*(ZVOUO^%_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !112,2J$@9(&<>M)NRN M%
M>4>&]'U+XB:6^OZCXPU[3Y7N)8UL=*NA;QVP5B C *2QP >?6N[@D7PEX7>;
M7-9GO(K16>:]GB^?;GC*H.< @<"GLKO3^O\ @AN[+^K?\,;E%1?:8OLGVK?^
MYV>9NP?NXSG'7I7-Z_J^G:K\/;G5K77I]-L)X!(FIP1/OC7</F"X#>W3/-#T
M_KY M;>9U-%<'XM^)FC>#[_1K"ZU"(O.ZFZ9T9VC@V$[R%Y!+;<<=SQ72:?X
MJT/5/#O]OVNHQ'2L,3=2@Q* IP<[P".11T;Z(2>WF;%%<OH?Q&\(^)-2;3M)
MUN"XNUSB(HZ%L==I8 -^&:ZB@=PHKC=5\%:KKNHW$][XSUJSM2^;:VTF1;41
MKCHS8)<]?T]*J^"-5U&VN_$VCZIJ,FI6^B3*(K^4#>R,FXJY'5E]:5U9MZ:7
M^2!^7H=Y17ENA:'KWCK24\3W?BW6M,DNV:6QM+"58X(8LX3>F#YAP 3D]ZT;
M#QU=P?#+5-9U%8Y-4TAIK6< 862>-MJG'8,2I_&ANR=]UT_KK=I M6DMGI_7
MW,]!HKS!_"/BJWT%O$*^--8?7U@^TM:NZFR+ ;C'Y., =LY]Z[KPUK*>(?#6
MG:NB[!=P+*5_NDCD?@<U5MUU7]?H2I)V:V>W]?,U:***104444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-=%DC9&&58
M$$>U)[: <?J_PZT^[U&;5]'OKW0M6E.Y[FPDVK*>?]9&?E?KZ ^]<Q?:_?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ;%P-JC=T]%%:-WX$\06%A-JMIX[U^;6HHS+LGE5K21@,[?)VX .,<&MB_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.\.Z_=6.J)J"2&VO+>/R9@4&3YD62,$?Q+@9[5V"7]G+>RV4=W ]W"H>2!9
M713T)7J :O1V:\_Z^0M=5Z?U\RQ1112*"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>0:Y/1?"EYJ_PGUG0;F&2SN;JZNS$+B,I@F4LC$$9P>#GTKTVBKF^>4I=_\
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MO\K'G'_":^(=2TN71T\$:W;ZT]N8VEGB5;-'*X+>=GYASG !)Z57A\'WVM_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6MC&T=G;0V\;.TC+#&$!9CDL0.Y/4U2U'PUH.KSB;4]$TV]E P'N;5)& ^K
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M ".0^+7_ "(<G_7[:_\ HY*E^(EM);:=8^)K52;G0K@7+!>KP'Y95_[Y.?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45YVVN^*?&FKZA:>%;NUTG2+&5K:35)[?
MSY)91]X1H<+@=,FMWPYI7B[3+Z1=<\2VVLV3(=K?8%MY5?(Q]P[=N,^]$=5<
M3=CIZ*S;[Q#HFEW*6^H:QI]I/)]R*XN4C9OH"03U%7)[RVM;-[NXN(8K9%WM
M-(X5%7U+'@#WH\Q^1-169<^(]#L[N.TNM9TZ"YE ,<,MTBNX/3"DY-6Y[ZSM
MIK>&XNH(I;AMD"22!6E;&<*#U./2@"Q14-U=VUC:R75Y<16]O&-SRS.$11ZD
MG@5'=:E86%E]MO+VVM[7 /GS2JB8/0[B<47 M454T_5-/U:W^T:;?VMY!G'F
M6TRR+GZJ2*9/K.E6JW+7&I6<*VI N#).JB$D9 ?)^7(YYH>FX+4O454L=5T[
M5+4W6GW]K>6XS^]MYED7CKRI(KS6U\0^+;[1-+>'4&6[UO6F%JWV>,^38*6)
MXVX/RKU.3R*.O+Z?B[?\'T3$VDK_ -:*_P#7FT>JT45FW_B'1=*N([?4=8T^
MSGD^Y'<7*1LWT#$$T#-*BHVGA6W-PTJ" +O,A8;0N,YSTQCO5.37=(BFM(9-
M5L4EO #;(UP@:<'IL&?F_"CR T**BN;F&SMI+BXE2*&-2SN[8"CW-<_X7\<:
M)XKL8)+/4+(7DRL_V);I'F502,E1R.,'IQFE??R!Z'2T5P'@/Q1:6O@B"Z\0
MZ[!%))>7*+-J%V%+ 2N  7/. .GM7=P3PW,*302I+$XRKQL&5AZ@CK5?U^"?
MZBZV]?P;7Z$E%9UWK^C6%['97FKV%O=R?<@FN41V^BDY-:-+S&%%</JWC%['
MQEJ%MYVS3-%TE[V^4("9)&(V+D\C !/&,YJM_P )MJ&D_#O1M3O(#?Z[JY1+
M6U4! \DA+*IP.%5<9/MZTD[JZ_J[:7WV8-V=OZV3_5'H-%>?IH'Q,N52[F\;
M6%G.0&-C#I*20@_W?,8[\>]3^)KO5;+4? \,UZ5GGU%8[S[*S1QS?NF)&,\K
MD9P:?5+SL2Y63?E<[FBL19K[_A-'A.JV)L/L(8:?Q]H$F_'F>NS''IFKFI:Y
MI.C*C:IJEE8ASA#=7"1;C[;B,T=$RNMB_147VF#[+]I\^/[.$W^;O&S;C.<]
M,8[U0N?$V@V9MQ=:WIL!N5#0>;=QKYH/0KD_,.1T]:/(/,U**I:EJMGI6DSZ
MG=3QI:PQ&4N6 ! &>#[URD_Q#TZ_\ WFKZ5J%DVJ+I_GBTAN4FDAD8 *K*.>
M&('(Z]J3=D_(:W7F=Q17!:7?>)I?%>BZ-<ZDS"UTG[5J["&,>9,YVH/N\8(8
M_+CIS6CX/UR_N;_6M!UB43:EI5Q@3;0OGP/\T;X  SC@X&,BJMK;U_!V_P"#
MZ$*5U?T_%7_KS.LHK%\5^)+3PGX=NM7NRA$*Y2)I GFOT"@^Y]C5K2M=TG7(
MF?2]3LKT1X\S[+<)+L)Z [2<4EK>Q3T-"BLR3Q'H46HC3I-:TY+XG MFND$N
M?]W.?TK3HZ7#R"BH);VU@GC@FN88YI%9TC>0!F5?O$ \D#(SZ9JMI^NZ/JTD
MD>FZK8WLD7^L6VN$D*?4*3B@#0HJ"2]M(KE;:2ZA2=HVE6)I &*+C+ =<#(R
M?>HK#5M-U6*273M0M+R.)BDCV\RR!&'4$J3@^U %RBLRT\1Z'?WKV5GK.G7-
MTA(:"&Z1W7'7*@Y%6_MUF+\6!NH/MAC\T6_F#S-F<;MO7&>,T 6**@NKZTLO
M*^UW4$'G2"*+S9 N]ST49ZD^@K+T6:^DU?6TNM5LKR&.Y46\%N1OM5V#*28Z
M,3SSG@_@!?U^'^8/0VZ*SKCQ!HMKJ":?<:O80WKXVVTERBR-GT4G)KG_ (>W
MMW>V^OF[N9IS%K=U%&99"VQ PPHST ["A:_UYV!Z?UZ_Y'8T5G2>(-%AU)=-
MEU>P2_;[MJUR@E/T3.?TK1H\P"BJU]J%EIELUS?WEO:0+UEGE$:C\2<4W3]4
MT_5K;[1IM];7D&<>;;3+(N?JI(H MT5GW.O:/9V\L]UJUC!##)Y4LDMRBJC_
M -UB3@'D<'GFK%E?6>HVRW-C=075N_W98) ZGZ$<4;@6***S!XCT(ZD=-&M:
M=]O!P;7[4GFY]-F<_I1Y!YFG145S=6]G;O<74\4$*?>DE<*J]N2>*I2^(=%@
MU)=-EUC3X[]ONVSW*"4_1<Y_2CR TJ*Q/%,U]!I"/I^JV6F3?:809[T@(5+C
M<G/\3#@>Y[=:TY;^S@N%MYKN".=HVD6-Y &*+C<P!YP,C)[9H_K]0+%%9^G:
M]H^KO(FF:M87KQ_?6VN4D*_7:3BJDLU\/&=O"NJV2V)LG9M/;'VAWW#$@[[0
M.#VS1U2 VZ*HZEK6E:-&DFJ:G9V*.<*UU.L08^@+$9JS;75O>VZ7%K/%/"XR
MLD3AE8>Q'!H EHK,N/$>A6EJ+JYUK3H;<NT8FDND5"ZG!7).,@@@BKUM<V]Y
M;I<6L\4\+C*21.&5A[$<&@"6BL?Q3KT7AGPU?:O,N\6\>43^^YX5?Q) K&G\
M23^#_ EOJ?B:\CN=08(74E807=A\BX'1<]<$X&32NM?E^(/3\?P.QHKAO'/B
M6TN_AKKM]X>UN":2WB ^T:?=!C&VX?Q(>#BNAC\1Z+;R6UC=:U817[QJ1;RW
M2+*V1_=)R::UO_72XF[?UV-BBBLZUU_1KZ^>QM-7L+B\C^_;Q7*/(OU4'(H\
MAFC11TKRN;Q]J<^BWEY9W($FI:XNEZ0OE*?+0$*S\CGHYYSVH6KM_6Z7Z_@Q
M-V5W_6C?Y(]4HKBO$?B369O$</A7PNEO_:7DBXN[RZ4M':Q9P/E'WF/85GW5
MC\2/#=I+J:>);3Q(D*[Y+";34MF91U".A^]CU]*7,K7>W]?AYCZV6YZ+165I
M?B+3=4\-VNO+<)#8W$2R^9,P0)GC#$\ @\?6GR^(=%@U)=-EUC3X[]ONVSW*
M"4_1<Y_2J:L[=1)IJYI45B^*YKV#P_-)I^JV6EW(>/;=7N/*4%P"#GC)&0/<
MBM.2\MK>2&&>YACFFSY:,X4R8&3M!ZX'/%(9/16;9>(-%U*[DM+#6-/NKF/.
M^&"Y1W7'7(!R*K7<U\OC#3H8]5LHK)[:4RV#D>?,P*[73OM7G/U[]CMYA?<V
MZ*J:AJFG:1;_ &C4K^ULH,X\RYF6-<_5B!3[*_L]2MEN;&[@NH&^[+!('4_0
MCB@"Q16?<Z]H]G;RSW6K6,$,,GE2R2W**J/_ '6). >1P>>:=_:]A+I$NIVM
MY;W%I'&TGG0R!T( R>1Q4N247+L-*[L7J*\OTG6O%UW;^#;2XU!EO]3EEOKX
M_9XP4M%Y"8VX'WD&?O<]:Z/P]K=^OB_6O#6K3^?- %O+*<HJF2W<XVD* ,JP
M(SCGBKMK;U_"U_S_  9',M_3\;V_+\5W.MHHK,'B/0FU+^S5UK3C?YQ]E%TG
MFY]-F<_I2\BO,TZ*AN[RUL+9[F\N8;:W09>69PBJ/<G@57TW6M*UE&?2]3LK
MY5.&:UN%E ^NTF@"]1168/$>A'4CIHUK3OMX.#:_:D\W/ILSG]*/(/,TZ*Y_
MQMXA7PQX0U/4Q-#'<10,8!*P&Z3'R@ ]>2.*POAY96SQG5(O&]]X@N98%^UP
MO?I-##(V#\J+_JSU&,T1U;\A-VMYG>T5SOB3QEI?AB^TJUO[FVB:_G\LM-.L
M8B0*29#GMD =N6ZUC^.-=6;0-%OM$U4/!-K-K$9[*XRLBF3#+N4X([$4+6UN
M]OQM^HWIOVO^#?Z'=45FQ^(M$EU(Z;'K&GO?@X-JMTAE!_W,Y_2M%W6-&=V"
MJHR6)P *.EP\A:*S]/UW2-7DDCTW5;&]>+_6+;7"2%/J%)Q6A0 45G7VOZ-I
MEU':W^KV%I<2_P"KBGN4C=_H"<GK7/>#[ZZNO%7C**>ZFFA@OXT@1Y"RQJ8E
M.%!Z#//%"U=O7\+?YB;M_7K_ )'945F77B/0[*^6QN]9TZ"\;&VWEND60_12
M<U!XJ\2VGA3P[=:O=%"(4S'&T@3S6Z!0?<^QI75KCMK8VJ*S]*UW2=<B9]+U
M.RO1'CS/LMPDNPGH#M)Q2?\ "0:,-3_LPZO8?V@>/LOVE/-_[XSG]*?6PDTU
M<T:**XI]4EM_BW<V]Q?/%I\>B+,8Y)BL2MYQ&_!. <<9I7UMZ_@KCZ7_ *WL
M=K15#3=;TG64=]+U2ROE0X8VMPDH4^^TG%2:AJFG:1;_ &C4K^ULH,X\RYF6
M-<_5B!3>FX;ENBH;2\MK^V2YL[B&XMY!E)87#JP]01P:IW'B'1;6S%Y<:QI\
M-J9#&)I+E%3>#@KN)QD$$$4>0;FE15:\U&QT^T-W>WEO;6PY,TTJH@_X$3BB
MQU"RU.U6ZT^\M[NW;[LMO*LB'\02* +-%9^I:]H^C%!JFK6-B7^Y]JN$BW?3
M<1FK:W,#6WVE9XS!MW>:'&W'KGIBCI<"6BO)- U&W\:^++V\G\=W5I+;ZB\-
MAI-C?QQ)+%'CEH^3(&P3GTSBO6Z%K%/N'5KL%%-=TC1GD9511EF8X %4-/\
M$&BZM/)!INKV%Y-']^.VN4D9?J%)Q0!HT51U+6])T9$?5-3LK%7.%:ZN$B#'
MVW$9JQ:WEM?VZW%G<PW$#C*R0N'5OH1Q0!-1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?+8E>CKR=I! (Y-9$'@GQ;&Z6\GQ&OWTU, 0BPA68J.QFZ_CBM9-.I)]W?\
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M^_SVZVU_[=_IZ=1)M.+?F_QO^MC$O]0N=4_9VLKJ\D,L[?9U:1NK[;A5!/X
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MI71T=+_UV#K8**YRTU^[G^(6HZ T<(M+:PAN4<*=Y9V8$$YQC@=JZ.A:I/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "H;N!KFTF@2XEMVD0J)H<;TSW7<",CW!J:BDU?0#R/X8>$2TM[J
MK>)/$)-KK%TAM?MO[B;:^-TB;?F)ZGIDUHP6FJ?$75]8F?Q'JND:1I]XUE;0
M:5,(9)'3AW=\$D$G@=.*L^&K/Q9X7U^]TH:#!>Z+>ZC+=C4TO5C,"R'<0T9&
MYB/:D?3O%?@S6=5N/#NCV^NZ7J=P;HVK7BVTMO,WWR&8%64XSZTH[1OV_'W?
M^#;H*SN[;W_"[_X'F6?"UYJNC>,KWPAJFI3:G"MHM[8W=P!YVS=M9'(X8@]_
M>M7Q_9/?>!]71+Z[L]EK+(6MF56<!"=I)!^4]\8/O5#PMH6LR^);WQ7XCBM[
M:_N+=;6WLH)/,%O"#N(+_P 3$]<<5TVLV!U30[_3U<(UU;R0AC_#N4C/ZTJJ
M;IVZV_S_ $L52:4[]+_Y7_4XSX<>&/[)\+6.I_V[K=Y]JTV/_1;R[\R"'*@_
MNTP-N.@YZ5S7P]\'ZIXC\ Z?/=^*M9TVV7>MK;Z3,+<*H=OF=L$N2<^@Z5U_
M@<^*[33(]!USP]#:P6-H(8M0BODD6X*@*,1@;EX[DUH?#S2;[0O NF:;J4'D
M7<*N)(]ZMC+L1RI(Z$=ZVG9SDUMI;[V9QNH13WOK]Q@>'_%FH:7X#\1W6KSF
M_NO#]S<6_G, IN!& 5+8[G(!K@!XTT*XL5U:X^*VMQ>(/+\P6\5O*+-),9V&
M'RL, 3C)/O7I>C>$;B?2/&&EZO"88-7U&X>)E=6)B=0 XP3CIT//%4[#4/B1
MH%G;Z.WA2SUD0((H]3CU-(%91PI>-ANS@ G'X5EJ]7O9??;7RO?^MT7:VBVN
M_P#@?+<ZKP;KDGB7P?I6L31K'+=0!Y%7H&Z''MD5PGQ.\.OJ/C'PFS:YK%NM
MW?F%4MIUC%O^[)W1X7(8XZDGJ:].T]KQ]/MVU".&.\,8,R0L616QR 3R17-^
M+M%U#5/$/A.ZL[?S8;#4#-<MO5?+381G!()Y/;-7*SJ)^?\ F0KJFUY#-<M[
M;P]X,AL+KQG>Z9&CA3J=W,DEQ*,DE=S#D\]0,@"N!\*^*],M_'VC:9X<\;ZS
MX@L[XRQW=OJI=S&0A971W1<<C&!78^._#^L76OZ)X@TK2[763IHE233;F58Q
M)O ^96;*AACO50Z=XRU_Q9X9UO5-)MM,L["XDWV,=TL\B!HF'F,XP#S@!5!Z
MY-*GK*[[Z_<_S\AS5HM+MIZ_UW-;1;V[E^*/B>SDNIGMH;6T:*%I"4C+!\E5
MZ G SBN8\*:5K_C.QU!M1\4ZO8Z?:ZE<PP+I]QLFDQ*3EY""=H^Z%&.!77Z3
MH]_;?$;Q%JLT&VRN[:UC@EWJ=[(&W# .1C(ZBCP#H]_HFB7MOJ$'DRR:E<SH
MN]6RCR$J>">H[=:4.E^WX\S_ !L$KWT[_P#MJ_4Y_6TU[4OBJ-!T_7;O3].;
M1TEN'B.YQB1AE-V0KG@%L$X%%G9:GX*\?:)IB^(M6U;3-72=7CU2<3/%(BA@
MRO@'';%= FCWX^*<VLF#_B7MI"VPFWK_ *P2EMN,YZ'KC%'B#1[^^\<>%-1M
MX-]I8/<FYDWJ-F^/"\$Y.3Z9IPTY?G?_ ,F_X Y*_-Z*WW(X'Q;XZTJ[\9ZG
MHNL^,=1\.:?I^R-$TQ'$UQ(1N9C(J-M R!COS6O\-/&":KK&K:%I^NSZ]8VM
MND]I?7<;+,,D@QR%E!;!P=V.]:6H:5XG\,>*=2UOPSIUOK%GJFQ[K3I+D6\B
MS*-N]'8;<$=0?2M[P[J/B?4%N9M<T&VTE0H\BW6]%Q(S<YW,HV@=,8]:F"]S
M7L[^O];6"6_ST]/ZWN>;:2AUB]$7B#Q_XCT3Q47(:P:=;>W!R<>7&5VR+Z8)
M)KI/B!/J%I<:3;WFL:OIWAXPN+[4M,3$HE&-I=E4E%/S$D#%0>(9O&OB>PNM
M$NOAU8+#.K1I>7.KQ2Q1GLX4('XZC !K?N[CQ3X:T72K'2?#Z^(GAMTBGE;4
M4MFW*,9PZG(./7-'V5ZKYZ?>O\[!]I_/Y?H_\A? UA;V]I-<Z?XPOO$6G3!1
M$UW<+<-$1G/S@ Y.>AZ8KK:X'PEH^K6OB#5O$^K:39Z#%<VRH=/MYQ+EE))E
MD90%W8XX[5M^!M;U+Q'X7@U?4H((&NG=X$A5E_<[B$)R3R0,_CTJ[W^[_@"6
MGW_I?^O^"<G\:-(>]T&RN?[5U&!%OK>+[/!(JQDM)C>?EW;AGCG P.*E\86>
MH>"OAYMTO6]7OKL:C;LD^H7ADD;=*HV%P!\AZ8]S6[\1-%U#7?#MO:Z;;^?.
ME_;S,N]5PBN"QRQ X%/^(.CW^N>&H[33H//G%[;2E=ZK\J2JS'+$#@ U$596
M_O+[O=_X(3O>_P#=?W^\5(M*N_"EGJ/BG6/$6JZG=0V4DDUJ\P2T4@;OW<0'
MR], DDXK(TGPAKWB72;77]2\;:]::C=Q"=(+"98[:$-\RKY>#OP",DGFO0M3
ML(=5TN[T^X!,-U"T+XZ[6&#_ #K@-.E^(OAC3H-!@\-V.LQ6Z>3;ZF-06%0@
MX7S(R-Q(&,[:.K_#\;_/;<JVB_'\+?KL.L_$FJZA\+?$KWLQCUC24N[26X@S
M&6DC4XD7'0D8/'>J,7AGQ%JW@RW\17/C36K;5A8BXBAM952U7Y,@,F"7]R3R
M36S:^#;[3/AIK>E;TO-9U..YFG9,*LD\JGA=QX'0 FM^RT^ZA\"0::\6+M=.
M$!CW#A_+QC.<=>^<4JEU&36]E]]G>WS"%KQ72[^ZZM?Y'$:/H/B'QKX3L_$>
MH^,=8L+Z>W\Z"WTR00V\?'R[EP2^< G)[D5U_P /]8O-?\"Z5J5^RM=RQ$2N
MHP&96*YQ[XI_@W3+S2O 6DZ9>P^5>06:Q21[@VU@.F02#^!J+X>:3?:%X%TS
M3=2@\B[A5Q)'O5L9=B.5)'0CO6TK*<DMM+?>S.-^6+>^OY$OC2ZMK;03]J\2
M_P#"/QM(H-VI3>1W5=V>3Z@9KS/PKXKTRW\?:-IGASQOK/B"SOC+'=V^JEW,
M9"%E='=%QR,8%=CX[\/ZQ=:_HGB#2M+M=9.FB5)--N95C$F\#YE9LJ&&.]5#
MIWC+7_%GAG6]4TFVTRSL+B3?8QW2SR(&B8>8SC /. %4'KDUG3^*[[Z^FOY^
M1<_A:\M/7^NYZ)<1&>WEB662%G4J)(\;DR.HR",CW!KR+P)X0+>./$UPWB3Q
M"3I^J+E!> )=?(&_?*%PWIQCCBO8:Y+PCHNH:7XB\675Y;^5!?WZS6S;U;S$
M" 9P"2.1WQ1'2=_)_I_P0GK&WFOU*7A>_O+@^./.NYY?LVI3)!OD+>4HB4@+
MD_*,\X%<]X.\,Z]XP\$Z5JFK^-=>M9G@'D)I]P(@%&0&D)!:1CC)R:ZGP[H6
MI6!\8?:;;9_:&H2S6OSJ?,0QJ >#QR#UQ6AX"TN\T7P)HVFZA#Y-W;VX26/<
M&VMSQD$@_@:(K37M'[];_,3OS?.7Z6*'P\UB_P!0\*7']LWBS76GW=Q9R7;
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MXJ\3V<&FM#;&ULM.BG$QC#$%V=QP2< <5G#:-NVOW.WXVM8NIO+UT_\ )?\
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M/E\/WWARTT.RN,1W=_\ V@MP7CS\WEHH!!./XO6O1K6WCM+2&VA&(H46-!Z
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M*3Q!;?&35+S0+:WOI(M)@\ZQFE\KSU+OC:^"%8$=QCDUJ:7I?BCQ)XPL-?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&E5#<O=-(9I>!O,*KPHSD#<3GK74^(@%\+:J   +.4 #_<-9WP\'_%N?#O\
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M_P!>1*;:=][/3Y_UZE_6M5U?2['PLNLVFCW&HW6JQ6\YBC=XHR0YWQ;B"&
MY/J:L>)/$^JPZY#X<\,V-K=ZQ) ;B62\D9(+:/. S[>6R>P]*Q_%NLV&OV?@
MK4],F,]G/KL)CD,;)N #CHP![>E.UZ];P9\1I/$M_;W$FB7]@MM/<P1M)]E>
M-BP+JH)VD'J*77WM-7^2LOO_ *U#_#KHOS=_P_K0N:7XH\2:;XALM$\8V&G1
MR:AN%I>Z8[F%G49*,K_,#CH>^*AU'Q=XFE\;:IX8T'2K&>:W@BFCN;N1DBB#
M Y,F,EN<8"@=^:SY==M?B/XL\._\(ZL]QI>E71O;K4'MWCCR%*JBEP"223G
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MV0S.D!?]X4[YQZ5QVOV/P[U+0WN_"%AJ.J:I#+$\^H2M<X@4.N3(9"%)QP
M?TK65O:M+9-+\OPUWN1%OV2OO9_K^.FQZYXP\8:IH'B'0M+TO3(]0DU19E6-
MFV$.H4J=V<*O))X)P.*H#Q/XTT#6]-A\5V&B/INI70M8IM,DEW0.V=H</][.
M,<8JSXA /Q2\%?\ 7&]_] 6G?$O_ %'AG_L/VG\S4P^SYNWRO8IZI_X;_.S?
MZ&%XHN?&S?%C3;?1AH2;;&=[5;QYF4H60.S[0"&X& ,C&>:],T[[=_9UO_:?
MV?[=Y8\_[-N\K?CG;NYQGIFN!\9ZO;>%OB-H?B#5A-%I(L9[:2Z2%I%C=F4J
M&V@D9Q7?:??VVJZ=;W]G(9+:X021.4*EE/0X8 C\11#X/F_S8W\>OE^1YGXH
MN?&S?%C3;?1AH2;;&=[5;QYF4H60.S[0"&X& ,C&>:Z76_$^KZ-:Z/I<=C:7
M_BC45($$4C);J5&9)"Q&X(/S.:R/&>KVWA;XC:'X@U831:2+&>VDNDA:18W9
ME*AMH)&<4OB6_,.N^&?'EA;W-_H\<$L-QY$+&1(I0"LH0C=@$<C&:F-N1)[7
M=_O?W7T"5^9VWLK?<OOMJ2IXH\8>&[ZR7QE8:.^GWLZVZWFDO)B"1N%WK)S@
MGC(KT&O*/$/BO3?B7;V7A_PH9[_S+R&6[NOLTD<5M'&P<DLZCYN  !ZUZO5J
M]M>_X:?K]XOM67;\?^&.?\2W'BQ&@@\,6&ER-("9+G49W6.(C&!L0;FSSR#Q
M6?X4\2:W>:WJ/A_Q)964&J644<_FV#LT,T;D@$!OF&".]<1XSO=''C[4;;XA
M7>IP:!Y,7]FQ1&86TV1\^[RN2V1W["K7PST[2M/^(>M?V%I%SINE3:;#);I<
M%]THWL#)AR6 )& #CIG'-33U^=_Z\O3_ (<=33[U_7GN>IZG_P @J\_ZX/\
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M;_4****!A1110 45 ;VT6^6R-U"+MD,BP&0>84!P6"]<9[U/0 4444 %%%%
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MJ2.X/44 3T444 %%%% !1110 4444 %%%% !14%U>VEBB/=W4-NLCK&C2R!
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MM)9W,-Q&KM&S0R!P&4X*DCN#U% $]%%% !1110 4444 %%%% !1110 4444
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MJWMI8HK?^SH[9BC8R?D;D @=C1#75];_ (7_ ,M?7[U*ZT6ZM^G^?X&GKWQ
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MP[LBR.D+RS26R/U$)D8I^E:VLY1[?YM?\$S4KJ,N_P#E?_@,V/'7_(@>(/\
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M*E7:BNK_ ,F_QL%_B?:_YI?J=GX<\<Z;XCO)+ 6FHZ9J,:>8;+4[8P3%,XW
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M1F^'(D8ZBVI#2H7;@_9'_>!^G.(LCZBE=M:;M)KYZ/\ 1^@[\K][9-W^Z_\
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M< &^8XZX[?E5O6)XK7XS>'3/(L:S:9<Q1ES@,^Y#M'OCM3CJDN\G_P"D_P#
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M0.MRO?65OJ5A<6-W'YEM<1M%*FXC<I&",CD<>E<Q??"WP3J-]'>W7AZV>=
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M/.ZAB07<Y8\DXR>W2KM%"T5D#U=V%%%% !1110 4444 %%%% !1110 4444
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MUW2(=3LMYMYPQC+@ D D9X)]*Q/AYK%_KOA)+[4I_/N3<W$9?8J_*LK*HPH
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M9R0&''2O7IX5N+>2%R0LB%"1UP1BJ6@Z+;>'="L](M'E>WM(Q'&TQ!<@>I
M_2DEJ_.WYL'T^?Z')_\ "M5;X=7_ (;FU-Y;Z_D-S<7[(,O<%@VXK_=R ,>E
M4-1\+_$/Q'X?O=$UG5]!M[1X#&CZ?%*))R!\HD+Y"*2!G:#W KTRBAJ]_/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-.U)-9\>%(9K:2[NE-I-(A57/D !E)'(![CTKNJ*AQNK>5OP2_0KK?SO^?\
MF>&^'=-M;/25T6Z^%=Y>>(RI6:^O[..2VDE/60W#D\<YX'M6[;^&-8G^ /\
M8*V;+JB0L!;N-A9EF+8&<=0./J*]5HJG=W\[?@[K025FGVO^)P-QKMWXK^'_
M (AME\-ZWI]W'821"*]M=AF<H1B+!)?GV[BH=7\/ZM<^"O"M[IEMOU?1/(N5
MM)OD,N(]KQDG[K8)Z]Q7HE%#WNO)_-7_ ,P459)[:KY.W^1Y?KOB+7/&VC77
MAK3/"&N:=/>+Y%S=ZE (8($/#E6R=_&0,>U:_B;2+B/4/ T%G;SSPV&H*)'2
M,L(T6%EW,1T'3D^M=S10M+/S3^[_ (<3C>]^UOO_ .&..^)UE=:AX+D@LK::
MYF-W;-Y<,9=L"9"3@<X !-=C110M+^?^5AM:W_K>YY%XEL!8_$;4-5\1>#M2
M\3:;-#$NG&TMA=+;8'SJ8B0!D\Y-:/@;2+JT^(&K:A_PC*:#I]UI\/V>"*%4
M P[9W[!M$G<@$X!%>F441]VWE?\ '^MPDN;\/P/(]?T#6O\ A*K[PS96%R^@
M^(+J&]N+M$)CMP/]>A/0%MBX!Z[C6U\4-(NKRQT5HM*N-5TBRNO,O]-M3\\T
M87Y<*"-V#_#WKT*BE:T4NWZ;?<M!]6^_Z[_>>+RZ9'JVJ^'+W0/AW-H=G9ZG
M"]Q<7%@EO<,.1@*F6V#J68@=*[>YLKMOB_87HM9C:+H\L;3B,^6',JD*6Z9Q
MVKL:*I:-?/\ %6)MOYV7W.YY]IFE:N;OXAK;136MQ>S_ .@SR(45F\@ ,I(Y
M ;N*X[1-,LUT%=#'PJNW\0F I-?:E91M;F7',AG8DD9.<*,^E>Y45'+I;R2^
MZ_\ F5MKYM_?;_(\GO-#U>7]GZQTB"QG&J"*W00-$V]6$RGE<9 '4\=*T+_Q
MIXCFTR718_ ^MC7)(3#YIC7[$&(QO\[=C;WZ UZ1153]_FOL]_NL**Y4K=/\
M[GFVM^&+S2_ 'A31;:&:\EL-0LO-,,9? 5\NW X4<\^E+XX\-LGBVT\4_P#"
M-P^(K,6IM+RQ:%)9% .Y9(U?@D9((ZUZ110VV[];M_>K HI*W2UOQN>>^$IM
M$OM<C?3?AI<Z&8U8F^O-*AM&0XQA<?,<YQQ[UWUPLCVTJPMME*$(WH<<&I**
M)+F5AK1W/#?#FFP:;9'2M6^%]]JOB5F;SK^ZM(YK:=RQ(<SN2%'/85UO@<WW
M@_X8(NH:'?W%Q!<W >RL;?<Y!E;E$8KE<<CU&,5Z+11K9KO;\/(5M5_7XGDF
MFQ_VOXTTS4?#/@S6?#C1SEM3N;RV%G'/#@Y4QAB)&)P<XXKULC(Q111I;E"V
MK9Y?I&H:K\-HKO1;KPQK&JZ=]JDFL;K2+<3Y1V+;77(*D$GGI6UX+TW5KC7M
M:\5:S9M83:EY<-O9.X9XH8P<%\<;B23CM7;44+3?>UOR_1;@U?[[_K^;.(^'
MMA>65]XN:ZM)X%GUN:6$RQE1(A"X9<]1[BNLU2[N+'3+BZM;*2]FB7<MM&P5
MI/8$\9JW12>R2Z)+[E8?5ON[GFNH^.]0UW2KO2;/X?\ B8WES"T.+ZS6&W!8
M8),A;! SZ<U'K?@*_'P]\-V<5M:ZIJ&@M'*UI< -%= *0\?S<=#QGT%>G446
M^_3\-OS8K:Z^?X[GE.G7.@7FHV]K;_!V\MKKS5#S7&C00PQ<@%A+WQU&!SCB
MK7C6\U+3_BGX9N],L#?R16-T9+9&"O)'E VS/&X<'!QG%>F5SE]H%W=>/M(U
MY)(1:V=I/!(C,=Y9RN"!C&.#GD4^L?7]&*2]U_UU1R=[?ZO\1-7T>R@\-:OI
M.DV5ZE[>7.JPB!V,?*HBY.<GO5K7[K4?"_Q(;Q"- U35M.N]-2T)TR'SI(I%
M<MRF1P0>M>BT4;6MY_BK/\!VO>_]6=_S/-_&WA^6\UO1_%B>&X];ABMF@N]+
MN(4>4(V&#*K9&]3G(]S3O"T^AW^NVYTWX7W6CF/<S7][I,-H8C@XVXRQ)Z<>
MM>C441T]/\P:N<=X9LKNW\?^,KF:VFC@N);4PRO&0L@$6#M)X.#QQ1I=E=1_
M%;7[Q[:9;673[5(YVC(1V!?(#="1D9%=C10M+>2L#5[^;O\ E_D<='978^,,
M]\;:;[(=$2(3^6?++^<3MW=,XYQ7.V>H:[X3\8^+-0E\,ZIJ.CWEXAC:PAWS
M!EC4;@A(WH<XR"<%37J=%)*UK=$U][N#2;U\OP5CS_P[;ZIXF\:W/BG4=)NM
M)L([#[#9VUX L\@9MSNZ#.WL,5RNGZ/8^"89-(UWX:2:\D<K_9=2T_2HKMIH
MB<CS,X*L,XY]*]JHHM;;T_&_YL?K_6EOR.%EM$N?A=KD>F^%FT5KFUN!'I\=
MNB2.2A )2/\ B/IR>E=+X8AEM_"ND0S1O'+'9Q*Z.I#*0@R"#T-:M%5W\[?@
M*VWE?\;?Y%74KFXL]-N+FTLVO;B)"R6R.%,I'\()X!KB)/B-J-Q%):6WP^\4
M-?E2H2XM5CMRWH92V-OOCFO0:*EJ]T]BK]CS2/P%JMO\)['1HY8O[:L9EOH1
MN^03+(9!&#V')7-0:WKVO^.-'E\+VGA'6=,N+O;#>W=_$$MX(\_.4?)\S@$#
M [UZE13>K;>SUM]W^2OZ$VMMOW];O\VSFM1UX:!K'AWP[:6/VE[\M&#YNSR8
MHU&7(P<]ACCZUTM4VTNR?5H]5: &]CA:!)23\J$@D =.2!SUXJY1=M:[Z@E;
M1;:'C][XNNM1\4/<:WX+\7SZ?82_Z#:6VE%XG<'_ %TA+#<?[HQ@=>37<Z-K
MZ>,[#4;270=<TJ/R_*;^U+/R/,#@@[.3G'?ZBNGHI<JY>5Z_UO\ U^B']KF1
MY=I'B+Q#X.T6'PQ=>$-9U.^LT,%I=V<0:VG0<(SR9_=\8R".,59B_MKX=?#2
M,0Z5<ZMKES.\DL=E"TP265BS,0O)5>GN<#(SFO2**'=WN]7N_P"N_422379'
MDWA[QG#H5O*S>"/'=UJ%RWF7E[+H_P \[_\ ??"CH%' %;/CSQ5J]I:6%GI>
MA^('2_C$ES=6%@9I;:,]5 S@2'IR>.O->@44-7T_KT_K_,$K?U^)YWX:\9V5
MDMCHFG^!/&%C;EQ&);C2]J*6/+R/O)ZG)8UZ)115-W!*VQP7PR)L?^$DT&4!
M9[#5IGQGK'+\Z'\B?RJGIM_J7A/QSKMK<^&]7O+;6+])[:]L8!+$@**I\PY&
MS!'>NS/AZT'B<:_%)/%=M;_9YE1ALG0'*[P1U4YP01U[UK5,=.5]E;\E^B_$
M&MUYW7X_YLX[PS97=OX_\97,UM-'!<2VIAE>,A9 (L':3P<'CBA[*Z/QBBOO
MLLWV,:(T1G\L^7O\[.W=TSCG%=C136EO)6_!K]1O6_G_ ,#_ "/&_P"P[3P;
MJFJ0:Q\/6\1V-S=O<VE_8Z;%=S .=QCD5OF&TYP>E=]X+%F^G3SV7A(^&XI)
M!MADMHX))1@89D3IUQ@\UTU%$=%;Y":N[A1110,\BN?">J-\2CHZVLW_  CE
MQJ":X\PC/E!U4@Q$],EP&Q73?%+2]2U;PO!%I]I->PQWD4M[90OM>Y@!.Y!Z
M]N/:NWHJ;>ZH]OZ_))>B#[3EW_K];^IX;J^FVVMZ3;#PU\,KG2/LMY;O-<WF
MFI!/M$BY$87+MZDG P#7H/BNRN[GQKX,N(+6:6&WNIVFD2,LL0,1 +$< $\<
MUV-%6G:WK?\ "Q/+OZ6/-M1N]4\&?$'5]8/A[5=6TO5H( 'TN$32121@KADR
M#@CG--T=]>UCXL6VN7NA7>FZ8=)EAMQ.,N#YBG]YC(1CGA<YP*]+HI1]VWE_
MP?\ ,<M;^?\ P/\ (\7:PCTGQ?KDOB?P#J?B2ZO+QGLKV&S6[B$!QL0[CB/'
MT]?2NF^&NCWVEWOBC[7HT>DI<WD<L%M"F(E0QC 4@!3CH=O&<UZ%122M&WE;
M^O,)*[OYW/-_AS?ZEH447@_4O#>KQ302SD:@L :T9"[.#YF>ISC&*CTSPK=Z
MSX*\9:+<PRVDE_JEV\#3Q%0<L"CC/520.17IE%#5]][6_%._X(=[.Z[W_/\
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M8-7?R_/_ (9!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^0D$$?SJCX%N9KOP#H5S=3R3326,3R2RN69B5&22>2?>A=?*WXW_ ,@[>?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"X\!>)]626RUWQ_<WNDS<2VL.F0V[2+G[ID7G&.#@<UWT4200I%&NU$4*H]
M.!5W;6N_]?+[B+6>@^O,(?#NE:_\9O$1U:UBO([:SM6CMIQOC+$,-Q0\$@<<
MCC<:]/KB=5\ 7%WXFOO$>F>(;K2]4GCCBBEAB5T154@JZ,2'!.#VQCK4[23M
MW_(IZQ:]/S,YM)T_PK\6M$CT.VAL8=6M+A+NVMT"1MY8#(^T< \D9 K/U;4-
M-\0>(+^XT3X:Q^*+F"3[-<7MVT,4)9."J-+G)' X [UU7ASP7<:9K#ZYKFNW
M&N:PT7D)<20K"D4><D)&O"YXR>]9H^'NL:?J-VWA[QG=Z5IEY.UQ-9"SCF(=
MCEBCORF?H:+/1/S_ !>WI;^K"ZMKR_!;^M_ZN9GPOM;FZ\-^+-):U.C$:C/#
M':QS"7[&6C7*JPX."<\5GVVCZ-X4TVWL?&'@*P%M!MC.NV4"3(Q!XDD.!+'G
MN3D>]=UX:\&)X6LM8MK#49S_ &A.UPDTB[Y(G*!2Q+$ASN!;D <XQ6-<> O$
M^K)+9:[X_N;W29N);6'3(;=I%S]TR+SC'!P.:?VDUV7X?C_2"VCOW?X_@8_Q
M%N+[4?'6A:1;>'U\0V2V<EY_9[W:6\<K9"AB6X8*/X?]JH]$T?Q''X\TC4K3
MX>V_A>S3?%?M::A Z31E> T:8Y# $$ FNX\1^#;;78K&2WNY],U#3O\ CSO;
M;&^($8*D'AE('(-5]"\->)K+4X[O7/&MSJT<0.RW2QBM8SD8^;9DMCM1#1_-
M_C?]-/\ @"DFUKV7]??K_P $PM)T73?%?Q%\57>O64&H'3I8K.T@ND$B11F,
M,2$.1DD]:BT_0-.T#XXPQ:7$EM;SZ-+*;6+B.-O,4$JO1<X' P.*WM=\$7EW
MKDFN>'O$-QH6ISQK%<NENEQ%.J]"T;<;@.,TW1? 4FE^*XO$EYKESJ6H&T>V
MN))XPOF992"H4A448/R@=^M*GIR]+)K\'^;U'+[76_\ FORL=G5+6;J6QT2_
MNX5W2P6\DB#U(4D5=I&574JP!4C!!Z$4IIN+2*BTFFSSGP+X*\-:IX(T_4M3
MTBRU*_U* 7%U=W<*R2.[\GYCR,9QQCI5;PHS6OA#QKHD<S366DW%S;6C,Q;9
M'Y>X)D_W<D5H#X>:SIA:U\,^-+S2-(=RYL39QS^6"<D1NW*#KCKC-;^F>$++
M1_"=QH-E++BXCD$MS,=\DDC@[I&Z9))SVHJ^]&?*K75DOZTTV0H>ZXWZ.]_Z
M[_H<MX!\ ^&+KX?:3/J&C6=]=7=FDDMQ=1"60Y7@!FR5 & ,8Q@5I?";<G@6
M.V+LT=K=W-O%N.2$25@H_ 5TOA[2/[!\.:=I'G^?]CMT@\W9MW[1C.,G'YU6
M\*>'?^$8T=[#[5]IW7,UQO\ +V8\QRV,9/3.,UK-KVDFMG_G_D9QB^6-]U_D
M;E<IX^U71[+1HK#5M+FU8ZA,L4&G0)N:=P=P[C & 2375USGB[PG_P )/#92
M6^HS:;J-A,9K2\B4.8V(P<J>&!]*RET-4>77L%W9^*O"EROPYM?"R?VK'&E[
M;W4!>56# HR1@'D<\YQC%>Z5P*_#S4KV\TV_U_Q9=:K?:?=I<0L;5((E"GD"
M-"!DCC<2<=A7?5:^&WF_T(^U?R7ZA7EOA[POI>O?$+QE<ZO;1WT5M?(L-K<*
M'A5FA7<^P\%L #)Z5ZE6'HGAW^QM8UW4/M7G?VK<K/Y?E[?*P@7&<G=TSGBI
M7Q7\G^G_  1RNU9=U^O_  #A/B3]J;Q+X8\.V'AV/5]/$4LYTD7"6L4IC "@
MD_+A0<[<55TW1O$@\::)J%C\.;;PO##*4O9K34;=EE@8$%6C0+G!P0<$\5Z#
MXI\)VWB>&U9KJXL;^RD\VTO;8@20MT/7@@CJ#UK/T7PQXIM-3ANM:\<W.J00
MDE;:.PBME;@CYRN2PZ'MTIPT>O=O^ORU%-77RM_7YE'0)$\*^.O$.BS,L=A>
M)_;%KD\#/$P_!@&_&L:PMWNOA=XP\3W*;;G78+BY /580A6)?^^1G\:ZGQSX
M&7QG!:!-2DTZ>W+HTT<0<O#(NV2/DC&1CGMBMG5-#BO_  K=:# XMH9K1K5'
M";O+4KM!QD9QZ9%9N+=-KK:R]/\ AK+Y&D7:HGTO?^OQ?S/-?&5W?#X>^"M+
MM+%KY-1>VAGM!.(/M""+=Y9D/"AB!^6*H7>A^)9KC39='^%5GX>O+2YCD6^M
M-3MMP0$;U95"[P5R.2:]*U#P98ZKX/M/#][+(1:QQ"*ZA^22.2, +(O7!X]Z
MS+'PAXMBOH3?_$*\NK")PPMTT^&%W /"M*,DC'!X&:VNO:-_WK_UU^7GZF"B
M_9I/^6W]=/\ ABL]S%X7^*6J3SOY=GJNE?:R2>/,M^'_ /'"OY5SWA"*?P[K
MVA:W>Y0^*HY_MC-QB8L980?^ %EKM/'/@=/&D-@G]H-8O;2L7=8MYDB==KQ]
M1@,._P"E6O%WA1/$WAQ=+@NSI\T,D<MM<I'O,+(>"%R,\9'7O6:O%76ZT^6O
M^:_\!-&N9VZ/7YZ+]+_,R_ALGVVSUGQ$_+:QJ,LL9/\ SQ0^7'^&%S^-=O6?
MH>DPZ%H5CI4#%HK2!858C!; QG\>M:%6TEHMEI]W]?B*-[7>[U^\X7XH2R2:
M3I&D^:\5KJNJ0V=VZ'!\ILDKGMG 'XU5\:>!/"]CX)U&[T_2;'3+RPMFN+:\
MMH1%+&Z#<IWKR>1WS77^(O#]CXGT6;2]05_*DPRO&VUXW!RK*>Q!KDW^'>MZ
MD!9:_P".+[4]%!&;(6D<+2*#D+)*OS,..>F:SLVFEH[WO]WY6_$N]FF]5V^?
MZF)X^M[36_AOX>UK4-.M9-0GEL \TD*LX5V4LNXC.TY/'3FO4=.TO3](MOLV
MF6%K90%BWE6T*QKD]\* ,UD^*?"R>(]$M],CN19I!<PSJ1%O&(V!"XR,9QC/
M:NAK2ZO*VEW?Y6,XQ:Y;]%;YW"O-_'FE6FM?$;P987Y)M95N_,BW%1, JG8<
M=0<<COBO2*\V\?Z0NM_$'PA9FYN+5S'=O%<6[[7B=50JP['GL>#4_:CZ_HRW
M\,O3_(B\>>'-%\,6^DZ_H6FVFF:C;:C;QJUG"L7FH[A61@H 8$'OZ5JR'_B^
M$/\ V &_]'BFVGP_U*YUFSU#Q3XKN==2QE\ZTMOLD=M&C]F8)]\CL>*T/%/@
MV?7-3L]8TK6Y]&UBTC:*.ZCB656C8@E71N&''K36EGYOY75OSU$U>_HE]SO^
M6A0\8NO_  L#P(F1N-W<$#V\DUEZMH.G:_\ '!(-4B2XMXM$646LO*2L)6 +
M+T8#.<'(K2M/AW=GQ%I'B#5_$UUJFIV$C$O) L<;(4*[$C4@)R<D\DXJUKW@
M)M8\5#Q%;:W=:;J$5JMO;26Z ^60S$E@20ZD-C:1VZTEIR^3E^*T!ZW]%^#,
M?6]$TOPIX\\)WV@V5OITE]=/974-K&(XYHRA;)5<#(('.*TM"_Y*[XM_Z\[+
M^3U-H?@>]M]=AUOQ'XCGU[4+9&2U+6R6\4 ;AB$7C<1QFM:P\._8O%^K:]]J
MW_VA##%Y'EX\ORP>=V><Y]!BG'2U_P"]^-K+\_O$];_]N_@]?Z\CS.34;K2_
MAGXXGLY7AF?7;B'S4.#&'E52P/; )YKO](^'OA+2[.R6WT'3S+;['2Y:!6F+
M#!#%\;B<\]:73O!5I;:-K>E7\OVVUU:[GN9%V>7M$ASMZGIZ\?2LW3O!/B;3
M;FVAC\?WTFCV[+MM);*)I2JD':TWWB.,=.G%*&EEY1U](I6^_4<M;O\ Q:>K
M_P M!557^-MRK %6T! 0>X\YJS_#NJQ>!]/\4:+>L5@T0M>6FXYW6TF60#Z-
ME:ZU?#NWQQ)XD^U??L%LOL_E],.6W;L^^,8_&N*\=Z7:^(OB3X>TFVE)N#&S
MZHD;#!M$=757[C+@8^I]:E)VC'O=?BW?Y;_,<K7<GTL_P2M\]CI_AWI$^D^#
M[9KS/V^^9KV[+=?,D.XC\ 0/PKJJ ,# Z45HVF]"8II:G$>/M3T8S:=HE[X>
MF\0W\SFXM]/B0$ *""[EB%"\D<YKCM%BO+/XL^'VE\#VOA/S[:Y1DM+J&5;E
M0H/*Q@ 8..3US[5WOBGP=<:WJEGK&DZW-HVL6D;0I<I"LRM&Q!*LC<'I533?
M -S!XBTWQ!JOB*ZU35+02(\DL*QHR,N-J(I"H ><\D^M3#1ION_R:7_!O_D.
MI=II?UL_^&L5] D3PKXZ\0Z+,RQV%XG]L6N3P,\3#\& ;\:I^%M0L]+\'ZWX
MYUT%(]8F:Z< ;F\C[D2 >I&./]JMSQSX&7QG!:!-2DTZ>W+HTT<0<O#(NV2/
MDC&1CGMBM36_"^GZYX4E\.S!XK-XEB0Q'#1[<;2/H0*FSY/.UOE?_*R^0_MK
MM>_S_P"'N_F>,^*;(#P5?2Z=\(X=-L8X#)'J<US!%<P8Y#[>9#CTW<UW?B^1
MYM/\!2R,6=]6M&9CW)C;)I+GX;ZYJ^E76EZ]XYO-0L7B*0PK9QP;6Q\K2,IW
M28.#@D9(YKH]5\*?VG:>'X/MOE_V1=0W.[RMWF^6I7;U^7.>O-:+?YI_F19_
M@U\V96K_ /)8_#7_ &#;S^:5@:MJ&F^(/$%_<:)\-8_%%S!)]FN+V[:&*$LG
M!5&ESDC@< =Z[N\\._:O&6F^(/M6W[%;30>1Y>=_F;>=V>,;>F#UKG!\/=8T
M_4;MO#WC.[TK3+R=KB:R%G',0['+%'?E,_0U"6R?G^+_ "L5U;]/P7^91^$O
MG1:/XEM)=/&FK;ZI*J6"S"5;;**2@8<$9)Z55^%?@KPWJ'@"ROM1TJRU*ZN?
M,WRW<2S% '8!%W9V@#L,5V7A7P=!X4@U6"VNY9X[^Y-QF;)=2453N8D[B2"V
M>.O2N<T[X9:SX>TR*Q\.>-[O3HSS<HUE'.DCGJR!SF,GV)%5U^27W;A;3YME
M?PU&-.T+Q[H5N['3]-FF2T5B3Y:-#N* GL"36/KM[>P_!7P;8V5LUS_:)M+6
M:!9A#YR%<F/>>%W8 S[UZ)I/@ZUT;PM>:-;W,TDEZ)6N+R?YY)99!AG;IGZ>
MU,/@BQN? =IX5U"5YXK>".);B,>6X= -LB\G:01GJ:36FNOP_.U[_P!,%]WQ
M?*^VWZ'FFIZ!XDN+>U_L7X2V>A:A:S1RP7]IJML'3:1D':%+@C(.3WKW%<E%
MW##8Y'O7#6O@WQ=%<QI<_$2]GT^-@1 NGPI*R@]&E')XX)Q7=55]!6U^05YA
M#X=TK7_C-XB.K6L5Y';6=JT=M.-\98AAN*'@D#CD<;C7I]<3JO@"XN_$U]XC
MTSQ#=:7JD\<<44L,2NB*JD%71B0X)P>V,=:G:2=N_P"13UBUZ?F9S:3I_A7X
MM:)'H=M#8PZM:7"7=K;H$C;RP&1]HX!Y(X%7_ A_XJ7QN/\ J+C_ -%)5OPY
MX+N-,UA]<UO7;C7-8:+R$N)(5A2*/.2$C7A<\9/>JFJ>!-4_X2"\UCPSXKN-
M#EORIO(OLD=S'(RC 8*^-IQWIK2WHU][37Y$M7N_-?@FG^?X"::P;XU:Z <D
M:1; ^WSO7./X9B\,3:BVO^"+7Q%83W$MP=5@BCGN41B3AXW^;Y0<90G@=,UU
MWAKP*/#OB.^UIM6N;^XOK9(KAKD L[JQ._(. ,8 4  8JK>^$O&=W>3;/B)/
M#82L?]'728-ZJ?X1)U^AQFILTDEO;Y;M^OS7_ &MVWWO^"1F^-Y-+F^%VEOH
MOE_V8;RQ^S>6" $\Y<#GG\Z7Q]H]MKWQ%\&Z?>[FM'6[::,,5$JA4.TXZ@D#
M([UNW_@2UG\&6/AFRNGMK>SEAD21T\QF\MPYSR.20>??I6AJ7AW^T/%>BZY]
MJ\O^S4G7R?+SYGF*!][/&,>AS5Z<U_[U_P#R6WYDJ]O^W;?C_D<;XT\,Z)X?
MU#PKJFBZ59Z==KK,$!DM(5BWQOD,K;0,_C6;XSEU+5/BF-/3PG'XFM=/T])H
M[&>\C@C1W8@R$."'X 7IQ7HGB;P[_P )%'IB_:OL_P!AU"*]SY>_?LS\O48S
MGKS]*I^)_!HUR_MM6T_4[C2-:M4:.&]@57RA_@=&X=<\X-1VOT;_ !2_4MJ^
MW9?@_P#(Y+PCI'B&U\?QZ@O@B'POI,MJ\5Y%;W\,L4KCE&V)C!'(R!WIEQX8
M'A[5-6NM9\%6OB>PO+F2Y_M"**.:ZA5N=C1N,D+V*'H.E=AX=\/>(=.OFN]<
M\7W&LG842$6<=M$,XY*IG)X/.>]4M1\+>,[O4)GMOB%-:V,CDBV&DP,Z*?X1
M)P?H<9^M-K:W9_G?^K"2W_KI;^KE/6-!LO%G@71O^$6CLYM.M9TN8;&X#)!<
M(N08G&,CDGJ.".:3PS)X<M_$\%K/X,C\,^(#$_DA;>,1S+_%Y<L?ROCWP<=J
MV1X2O--\)VNB>&]?GTJ2W);[6]O'<M*226+AQ@Y))XQ571O!6J1:W:ZOXD\4
M7&N75F'%HOV2.VBBW#!;:F=S8R,Y[U2MS.VW_ Z?\$37NKO_ ,'K_P  [.H+
MV\@T^QGO+J01V\$;22.>BJ!DG\JGJMJ%C!JFFW-A=*6M[F)HI%!QE6&#_.HE
M>SY=RXVNK['C5XEIK.DWE[HGP?BO+"\628ZA>SP6\K;LGS%W9?'<8(JUJLDU
MY^S78&29_->WM5\S/S#]\H!S[<5T-E\.-:@M%TBZ\<7]QX>2/REL%M8XY#'C
M 1IQ\Q&..,<>E:4W@,2_#BV\(#4=H@6)1=>1G.R0/]S=WQCK565FEM>/X/[M
MNQ*OS)OI?\5_F9OB3X=^%;;P!J:QZ)9_:(;*25;PQ SF15+;S)]XG(SUK-\1
MW5QJ?PU\&V-Q.XBUF>RMKV0-M+1LNYAG/\6,?C7H^K:?_:FAWNF^;Y7VFW>#
MS-N[;N4C.,C/7IFL>Y\%V=_X&M?#%[/*Z6\$4:7,/[MU>,#;(O7!R,]Z7>_>
M+^Z]_P! 2T7>S7WI6_$Y?XC>!?#-C\.]6N=/TBRT^YM+9GBGM8A$YQU5F&"P
M(X(.<YKO]$_Y &G?]>L7_H(KB+WX;Z[K6E7>EZ]XZO-0LI(RL$0LHX=K?PM(
MRG=)@X.,C)'-=_8VWV.PMK7?O\F)8]V,9P ,X_"FMGYM?DQ6U7DG^:)Z\P\<
MZ!HUS\3/!K3Z382F]GN!=%[9&\_;$-N_(^;';.<5Z?6!K/AG^U_$N@:Q]K\K
M^R9)7\KR]WF[TVXSD;<=>AH7Q1?G^C_X!7V6O(P/$]I;6/C/P#:VEO%;V\5U
M<+'%"@1$'DMP .!6?<>'=.\0?&W41JMNMU;6^DV[BVE^:-WWL 67HV.<9]:[
M+6?#O]K:]H6J?:O*_LJ:27R_+W>;O0KC.1MQG/0T6_AW[/XTOO$7VK=]JLX[
M7[/Y>-NQB=V[/.<],41W3?\ >_%*Q,U?;^[^#=SDWT/3/#GQ@T$Z+8P:?'?V
M%TES%:QB-)-FTJ2HXSD]<54UW4-+UWQ-?-I'P[7Q5?V9%I<75RT4<"E>2@:7
M()&>P[]:[>^\._;?%^DZ]]JV?V?#/%Y'EY\SS .=V>,;?0YKGIOA_J]GK%]=
M>&_&%SH]IJ$YN+JT^Q1W +G&XHS\IG\?TJ5?1/S_ #T^5KCZMKR_+7Y[&9\*
M1/"/%UI+I:Z0L5_E=-2994MBT8)"LO!!Z\<5#\*_ _AZ]\!65_JFDVFHW5SO
M)DO(A,44.P"KNSM 'ICJ:Z_POX-A\+R:N8;Z>Y&I2K,S3_,X;9M8EL_,2<GH
M,9Q5WPEX?_X1;PQ9Z-]J^T_9@P\[R]F[+$],G'7UJEY]DONO<6OXM_AH<+X6
MN9?#G@/QO'IX(CTB^O5LH^OEA5# #/8$UI^#/ /A:;P;IMS>:/9:C=WENMQ/
M>74*RRR2.-S'>PR.3V-=%H/AB/1DUJ.6X%U'JE]+=LACVA X *=3GIUX^E<[
M!\/->TH"RT'QU?:?HH)VV3V<4[QJ3]U)6Y4#MP<41WUWM'7T6OXZ_(;7;:[_
M !V_7[RQJP"_&+PR , :;=@ ?5*Q==U#2]=\37S:1\.U\57]F1:7%U<M%' I
M7DH&ER"1GL._6NUN/#9N/%VEZ\;PYL+66W,)CSYF_;\V[/&-O3!ZU@3?#_5[
M/6+ZZ\-^,+G1[34)S<75I]BCN 7.-Q1GY3/X_I4I;)^?XO\ *PEU?I^6IF?"
MD3PCQ=:2Z6ND+%?Y734F65+8M&"0K+P0>O'%;GPF_P"29:-_N/\ ^C&J[X7\
M&P^%Y-7,-]/<C4I5F9I_F<-LVL2V?F).3T&,XJ[X2\/_ /"+>&+/1OM7VG[,
M&'G>7LW98GIDXZ^M4OTBONN%OS;^]&U11104%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !167H6J76K6
M4T]YI<^G2)<20K%,<EU5L!QP.&'(_KUK4H **AN[F.RLY[J7/EPQM(V/0#)K
MD/!^M>,?$+V^KWUGHUMX?O(C+!'&\C7:@CY2Q^X<^WK0M78'HKG:T444 %%%
M% !1110!1TK1[#1+:2WT^#R8I)GG==[-EW.6/)/4]NE7J*K:A?VNE:?/?WLH
MAMK=#))(03M4>PY/X4 D6:*IZE>2V6D75[;6DEY+%"TD=O'PTI R%'N:?I]S
M)>:=;7,UL]K+-$KO!)]Z,D9*GW'2@5RS1110,**** "BBB@ HHKG-?\ $%WI
M7B;PWIL$<+0ZG/+%,SJ2RA8RPVX( .1W!HZI=PZ-G1T444 %%5;'4;34XI9;
M.82I%,\#L 1AT.UASZ$&JND:G=:C/J,=SI<]BMK=&")Y3D7"  B1>.AS^E']
M?U]X&I1110 4444 %%5;O4;2PEM8KF81O=S>1 N"=[X+8X]E/7TJU0 4444
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M(V 70,<>XK+\2^)M-\*:5]OU)WVLXCBBB7=),YZ(B]R:;TW)B^971L45Y_\
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MX?.!V,1$3M;'(! (SVS46I6GC;QS);Z1J_A^VT+1X[A);N;[>MR]RJ-N"H%
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MLAY>0@D@9P%&  *Z3X?W>J1WGB'0-3U&743I%VD<-U,!YCQN@8!B.I&>M7?
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M?<@+-_:*3M<D$$(@& @)'5CTHDES.W\WX77X;^84F[1<NR^_J>G67_'C;_\
M7)?Y5PNOHM[\9O"UM<C=!;V5S<PJW0R\#./4"N\MD:.TA1AAE101[XKF/&OA
M6\US[!JFBW<=GKNER&2TED7*.",-&_?:U$G::EV?^:_6XH)NGR];+]/\K'65
MPGB:ZU37?&=MX0TW5)]*MULS>WUU;8\XH6V*B$_=.<G/6HX_$?Q(+"V?P#:"
M3.#>?VQ'Y7U"8WX]NM6_$VAZY#XDL_%?AV*WN;^&V-K=6,\GEK<1$[@%?HK
M]">.:32NF]O^!I\KEW=FEO\ \%?C:YDRVVJ_#S7-%*^(=4UC1]2NQ93Q:I*)
MI(G<'8ZN #C(QCWI==&O:K\6/[#T_7+K3=/?2%FN&A.67$K#]V#E58\ M@G
MJ6/3?%7C/7-)NO$>C6^AZ9I=Q]J6U%XMS+/,!A264!0HR3ZUM)H]^/BG-K)@
M_P")>VD+;";>O^L$I;;C.>AZXQ32U7-_>^ZVE_G<G^;E\OOOK;Y'/V=EJ?@K
MQ]HFF+XBU;5M,U=)U>/5)Q,\4B*&#*^ <=L5)J*:IXV\<ZIHD&NZAI&D:1'$
M)CIKB.:>9QN_UF"0H&..];GB#1[^^\<>%-1MX-]I8/<FYDWJ-F^/"\$Y.3Z9
MK+U?3/$WA[Q?>^(?#6FP:O;ZE%&EYI\ER+=Q(G"NCM\O0\@^E).]N;^]^EOU
M_ IJU^7R_6_Z&39Z3J.B?&#0;*[U:YU2T73;DVT]YAIU&5W*[@#=T!!QGDUT
M?A2]NKGQKXS@GN9I8;>[@6&-Y"RQ P@D*#P 3SQ69IVE^+=2^(>D^)-9T^WL
MK6.RG@^R0W"RFW)VD;FXW,W/W1@;1SS1>V7BWPOXQU?5M!T*#7;'5_*>2#[:
MMM)#(B[<Y<8*D >]"NK7_O?B]"&KMV[Q_)W-..]NS\89[$W,WV0:(DH@\P^6
M'\XC=MZ9QQFLW3OMVM7_ (^L)-7U"W2*\1(7AE&Z%?)5BJ;@P4$YS@=SWJ3P
MYHOB@_$6Z\1Z];6L,5SIH@2*WEWK 1)D(2<%CC))  YQ6EX<T._L]>\7SW</
ME0:E=H]L^]6WIY04G .1R#UQ42BW"W7EE]]]"K^]?S7W6.<^#_A?[+X7T?7/
M[>UR;S;9A]@FO-UJF6(^6/''3U[UZA7GO@1/%7ABRB\.ZOH4 TK3XY-NL17R
ME9%!++^ZQN!Y[XZ5O^!M;U+Q'X7@U?4H((&NG=X$A5E_<[B$)R3R0,_CTK:3
MYGIM_7_!)BN56>_]?H:VL3+!H]Y(^HIIP$+?Z9)MVP''#G=QP>>:\*U/Q;HV
MB3QWFA?$W7-6UE9X@]G<LTEK.I8;@!Y81>#U!XQBO5OB)X<O?$_A4V6GB![B
M.XBN!!<'$<X1LE&]C7*:[9>._%OA>32CX5LM!MXGCD,0OHYWGVN&VH%PJ#C.
M2>V,<U$?BOYK[M+_ *Z%3^&WD_OU-3XBW=]%?:8ESJ>JZ3X;DCD-[?:6I\V.
M08V!G"DHF,\@?6M;P-86]O:37.G^,+[Q%ITP41-=W"W#1$9S\X .3GH>F*M^
M(M5\2:6+?^P_#":TK#$G_$Q2V:,_1E((_'\*QO!FAZPGB;4_$6I:1::$M[ D
M/]G6TXE+,I),CLH"[L''':G#JO7^O\K"E>R?I_7^=S;\<6]]<^"M573+F:VO
MD@,L$D,C(P9/F R"#SC'XURWB76[[Q)X4\,V6B7L]I>:_LD-Q;2%)(HUCWN0
M1R.0%_&O2&4,I4C((P17F_@'PAK&C^(KJ35H%2PTU);72")%8M%)*SEL \<;
M%YYXJ;7;C\_NO_P/N*;:2:WV^^WY:D6I>)[[5OA;HPLKF:#5]5GATXO%(5DC
ME#XE(8<@@(YS5/Q_XSLK#Q3!X8U#Q/>:!IT5FLT]U:(SW$[,<*BN%8I@ DMC
M)S5[3?!>KVWQ-::2W3_A&K>XFU&U?S%/^D2HJE=N<C!WG)&.:U?$>BZ]I_BI
M/%?AF"WO9VMOLM[I\\OE>>@)92CD85@21SQS3;O:3ZN[\M++\;_@2DU>*Z:+
M[[_E9?><OX!\96+>-HO#VC^*;_Q'I=S;/*)-15_/MI%YQO95+*1GMQBNC\"_
M\?\ XX_[#,O_ *+2M3P[JWB[4[YCK7ABWT6R5#P=06YE=^,8V  #KUYXJ+PI
MHNH:9=^*GN[?RUOM3DGMCO4[T** >#QR#P<&E-/E?^%_FAK?YK\F0?";_DF6
MC?[C_P#HQJW_ !)<16WA^[DEUA='79C[<VW]U[C=P3V%9OP\TF^T+P+IFFZE
M!Y%W"KB2/>K8R[$<J2.A'>J?Q%\.ZEKMAID^EV]M>3Z;>K=FQN6VQW( (VDG
M@'GC/%55U?W?H$=/Q_-GF\?BW2-(\1Z5_P ([\1-;UR[GU"*WN[*_9Y(9(W;
M:Q0F,*N"<C!/M77^/[FY3Q+;P:OKFLZ'X9:V!6]TK*?Z1NY660*Q08QCH#SS
M4.KV'CCQ7;:4L_AVTT2TL-1MYS9K>I/)*JN,D,NU555R<<DXQ76>)-8\4:==
M)'HOA"/6K9T^:3^TX[<J>X*NO(]\_A2?PJ_=_DNWX;Z_<"W=NWZ^?]6^\?X-
ML$LM*=K;Q/=Z_93,&@N+F99F5<=/,4?-^-6/&&NGPSX1U/6%17DM82T:,>"Y
MX4'VR16)X#T#4]-O=9U74=.M-(_M.2.1-,M)!(L)5<%F8 *78GG;QQ70^)=#
MB\2>&]0T>9S&EW"8]X&=A[''L<&BI?E\QT[7UVN<GI7@76+E;/5]4\;^(#J3
M;)98;>X6.UYY*"+;C&,C.?>L/Q[XXL$\9R^'-3\4WGAW3;:V2266PC8SW$C\
MA0ZJQ0 8/3G-;VFZI\1; 6NDW7A.QNUBVQMJL>IJD;*.-WE$;\X'3U-3:[H_
MB#1_%DOBCPS:6^HM=6ZP7VG33"$R;,['1R, \XYXIRM=6^'7\M//_@DQORZ_
M%9?GKY?\ Y[X=^,K2Y\8R>'=+\2WGB+2WM#<17%^CB>"16 *%F52X(.<XXI_
MA[3=?\92Z]#>>)M5T_3+/5KF&'[!/LGD(?.#(02J*, */>NR\.:IXKU.[D?7
M/#EMHMJL>$3[<MS*SYZY4!0N,^]1>!M'O]'@UM;^#R3<ZO<7,/SJVZ-V!5N"
M<9]#S3ZZ]OU_R#IIW_1W.-\1>$7U'XM:7:MXE\0VXETR9UDMKP1O$%9!M5@O
M0]3G))[UU?BE;31O"EE97GC.ZT:*,K&U]+*C7-PH4@C<PSN/!+ 9XJOXOTWQ
M#;>+-*\3^'],AU5[6VEM9K)[E8&97*D,KMQQCO6?XET?Q)=:WH/BRW\.6FHW
M5K:/%/H\]V@,3N0=R2,-I(Y&<5"^!+S=_O;7];:ZCVDWY*WW)?UZ:&!X*\4Z
M>OQ T_2?#WC/5_$.G7D,QN8]4+N\+J 597=%.#R,"NVT:]NY?BAXHM)+J9[:
M&TM&BA:0E(R0^2J] 3@9Q6;;:;XOUGQQH'B'6--M=/M;1)XS917 F>'>GWG?
M@,20!A0<8ZULZ5H]_;?$7Q%JLT&VRO+:VC@EWJ=[(&W# .1C(ZBJULK]I?\
M _X!/>W]W_@G&^#]"UWQKX=:[U7QAKMI!'=3QVZ:=<>4Y"R,,R2$%F[@#@
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M[+JW5U<;@W\;$'()'((/6C2\K;:6^]_\ G7W;[]?N1T]%%%(T"BBB@ HHHH
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M@G.<\C'!K5HZ7#K8**** .0\4^$-6\3WIA?Q3<6>@RQJEQIL%J@:7KG]]G<
M> 1BNJMK:&SM8;6WC$<,*".-%Z*H& *S]'\06FMW.IP6T<R-IUT;28R* &<
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MM4=+AY!16+'XMT.7Q3)X:COU;6(X_,>V$;_*N >6QMZ$<9S6U1TN'6P4444
M%%%% !165)X@M(_%,'AXQS?:YK5KM7"CRPBL%()SG.3Z5JT=+AY!1110 444
M4 %%(2%!)( '))KC+_XM>!--OC9W/B*W\X'!\J.250<XP612H_.E=7L'2YVE
M%5M/U"SU6PAOK"YCN;69=T<L;95A5FGL"=PHHHH **** "BBB@ HHK.UC7=-
MT"WAGU.Y\B.>9+>+",Y>1ONJ H)YH T:*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H) &3T%%-D
M3S(G3.-P(S2E>SL"//8O%'C7Q/)/=^$-/T2/2(IGBCN-5EEW76TX+(L?W1D$
M<]:WO"OBF77K34(;VR^PZMIDIAO+;?O4-C*LK=U(Y%<;X8\9:9\.M%7PQXL^
MTV%S92R1V\IMI)([N,L65D95/.#R#6SX(@N[_4_$_BF>TFL[?5GC6TAG39(8
MHTVAV7J-W7FE)VB^5W5F[^=E_P '3I;R$_B5][[>5W^EG?\ I9^A>+?B#XN\
M/VNJ:'I.A6\?*ROJ$DH\]@2#Y2IG:O&,L>M='H/C:*_\.:EJ.K6_]G7.D/)'
MJ,&[>(V09)4]P1R*X7X>_$C1?#/@/3['Q$+JPD7?]F?[-)(ERI=B"C(",]00
M<<BM/1]!U+Q/X/\ &EW):R6$GB.5WM()QM=4"!4+#MNQTIU+I2Y>WXZ?\'3R
M^\7Q*_?\-?\ ):ET>(_B+<V*Z]:Z%HBZ08_/%C+<2?;'CQD$,!Y8)&#@UH:[
MX_CL?!NC^)M/@\^UOKB!#&R$OL<X( !'S#IZ9KR^PL?@]:6=O9^)= O--UY4
M"3V4GVUF>0<$H5)!!(.*[CQ7:Z=:> _"L&E6DMIIXU:Q,$$P;>BF3.&#$G//
M>J:Z+:Z5_GKKU_KT)N[7>]G^7;U.K\/7'B^ZOII]=M-)L].>,&WM[>222X1L
M])&.$Z?W:QM4U+XEPRW5Y9:1X=33[<N1;SW,K7$R+GE64!%R.QZ5UFNO?QZ!
MJ#Z6N[4%MI#;#&<R;3M_7%>$6</@+7=(6#5+;7->\:- ?,M+EKH2I,1R.JHJ
M9]3@#%92;UMT7^?3KY_TS1+:_5_Y?<=MX\\1ZGK'P<&M:-#;16]];(US]HD;
M?&CE5*H N&.2022./6MG[9XMT[P1KE[XFA\/SO!9O);162RM&X"$D2A^H/'
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M![UD^#].\,VWQ3T>[\(Z1<VFDSV-R!=3&4+<L-O*"4EL $<X .?:E3U?K?\
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M#XM2SN+NPLXYK6\2W0O)$DF,2!1U (YQ4K2"3VN[_P!>>G_ *G?F;6]E^O\
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M@>:C!E!]CC'XU,K6UVTOZ75_PN4K]-^GK9V_&QH^'_#NF>&=(ATW3+6.&&-
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M8Y%&GZ!::;K>JZK#),T^IM&TRNP*J47:-H R./4FM6BA:?UWW';^O38XB_\
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MH5KX:T*VTBRDFDM[<$(TQ!<Y)/)  [^E,TCPY9:,NIK"TLJZE=274ZS$$;G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)=6E][L/HWZ_@KG>T5X]X[\"Z=X2T/\ X2/PY<7MEK\=S"AOWNY)6FWNJ'S
MY(/7/3M4GC?P!I7AOPK=^*-.GOT\1602?^TGO)'DE8,,A@6VX/H *$^_>WWV
M_P PU;LMSUVBN1\:ZIHD'A>&+7K^\M4O"@1;!G6>9N#M4)\Q![^U>::.^CZ+
MX[\.#POX:\3^'X[N[:"Z.HQ2);W2%"1C>[9;(!'2FM9<OR_K^KDN7N<WE<]Y
MKE?'FL7^BZ=I<NGS^2\^JVUO(=BMNC=\,.0<9'?K7-ZWI$NO?&)].>]N+>P?
M18WNTMY#&\RB5L)N'(!)YQSQCO3?'6C:-X.\%:/::; +/3K?6K:8KO9]OSY8
MY8DFDG\,GW7_ *59_D5+JEV?_I+:/4**\Z\+S1?$'69=?U$LL6F7#16>DR*5
M:W<?\M95/5R.G8#WS7*^)M6L_$'CG6[#7_#WBC6]+TYTM[>TTB%V@#;0S-)M
M=26R1CV%%WHNKU^7]/\ X.XKK5_+Y_U_6Q[?6?I6L6FLK=M:%F6UN7M78@8+
MIC=CGIDX_"O.OAVL\^HZUH<>C>)-.\+O;*;:'5HY(7A8Y5TCDW9"XP1\V1S4
M'PP\ ^&3+>ZT=-)U&QUBZBMYS<2DHJ/A1C=@\=R"::^+RM?\;?U]XF]/.]OP
MN>N4444%!17G?Q&O?"=S>6FE:X-7U&Y$;2#2-*,K-,IP 75".XP,D=36)\,[
MBVM/'NHZ3H^E:YHVD-IZ3KIVK(ZLDGF$%T#,QVD'UZYHC[S^_P##^O,4GRK[
MOQ/7Z*\CT'P;8>+O$/C!==DNKG38=7=8[!;AXHMY527;806/W<9.!CWK8\$6
M"^&?''B'PU8S3G2(+>WNK:":5I/(+[@RJ3SCY:47=)OJK_A<&[7\G;]#T2N5
M\/ZQ?WWC;Q7I]S/OM;"2W6VCV*-@:/<W(&3D^N:Y'PSX0TOXBVUSXF\4+=7L
M\MY,MI$;F2-+6-'*J$"L,'Y<DGO6A\.M/DTKQGXTL9+N:Z$,ULL<L[;I"GEY
M4,W<@8&3R<4X[Z]F_P#TG\=0D]-.Z7XO_(](HHKS7QGIUQJWQ1\.:?#?3V<4
M]A=+<26[;9&B#(2JM_#D@#(YQFEU2[_Y-_H#=DW_ %T_S/2J*\R\8VME\-O
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MF J\$$+DY;!["L'PV8=(\8Z.OA#P?XOT6QN)C%J46H6LGV9HR.'RS-M8''/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[!6!POF':N<=>HKTBBDM[CZ6..\7>&=:OM3TC6_#=Y9PZII@DC2._5FAE1P
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M_++;3/G$<R$,C<<CD=NV:A\%>'KOP_HTHU.:&XU6\N)+J]FASM:1CT7/. ,
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MBN,U>Z^(S:C.=%TWP]'80L=GVZXE:6X7U78 $SSUSU%/L?'MM+\.7\6WMLT
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M?4DT;7OT5_QL%[VMW_2YUE%>;:KXF^(?ARSDUS6-)\/MHT14SVUK<2FYB0D
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MV-[*4F/=QM*[/F[Y S7!6FM^&#K5@/AA?:@UW)=QBYTZWAG%F82WSLZR*%3
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M0M[^37WV_P AM75O._Y_YGE6B^*+#X:2ZMHWBK[190/?RW-G??9Y)8KA)6W
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M@#ONZX]\5W%G>6VH6<-Y9S)/;3('CE0Y5E/0BGTN*^MB>BBB@84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R
M4,87"??*G;]:?12DKIH%H<!\()[8>!TLP\8U"VN)EOX]PWK-YC9+#KSQR:9X
MTNK>W\<^"=2O)8_[)6:=/.+?NUF=!Y9)Z>N#6QKOPV\'^)-0^WZKH<$]T3EI
M5=XR_P#O;"-W3OFMF70=)GT1=&FT^WDTU4$:VSIN0*.@P?2FVW:756]-K?\
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MM06^M_#L G5MR^9+)(H.<\(S%?TI135O))?=Y#MOZM_>=A!,MQ;Q3*"%D0.
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M:$E-^0R9Z[6!!'X&D\/>$]"\*V$EEHNGI:V\IW2)N9]Y]RQ)-39N'+V_SO\
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MFSUI_B3P1X;\7&$Z[I<=V\/^K?>R,H]-R$''MTI[<OE?\0:O>_E^#N8^K_\
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M4NJ_SO\ J<]XJ=8_A-X7D=@J)<::S,>@&Y.37>^(-!M/$VC/87,DJ(S++'-
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M234KK0(GNI)/,=A-*JLV<DE0P4Y/7CFNNM;2WL;2*UM((X+>)0D<4:A54#H
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M\[?G_D=[14%I>6M_;)<V=S#<V[C*2PN'5A[$<&JM]K^C:9=1VM_J]A:7$O\
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M\C/>E>^W>WXK_,/Z_/\ R.[HK+/B+1(K]-.EUG3TOVP!;-=()2?]W.?TK4)
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MLE^+_2WW#>[MWO\ @OUO]YC?8-;TSX"Z]9:[:O:SPV]P(8'N%F,</5%WJ3G
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M9$GR6^9 K!F).XD@G/'7I61:> /$.E&.RTGQY?6VBQGY+.2SBFD1<_=69OF
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MI\GV&U: 0QOL\PH 0<D9&2?KWK;GLO.TF2Q\S&^ P[]N<97&<4ZJ;C.V[_\
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MN"0. <U?\.Z%K.EK<R:QXGN=8N9E"AFMHX(XL9Y5%XSR,Y)Z5,5:%GV:]?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#@9? .NZ?=W3^%O&EQHUI=3O<26DMA%=*KL<DH7P5!
M.3CGK6QX;\'C1+^YU6^U2ZU?5[F-8I;NY"KA!SM1%&%7/.*Z:BA:;":N%%%%
M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH BN+:"\@>"Y@CGA?AHY4#*WU!X-2]*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#&\5Z#_PD_AB_P!%^T_9OM<>SSO+W[.0<[<C/3UK
M6AC\F".+.=BA<^N!3Z*%H 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !7@_Q\TK2+>'1K+3=)T^#4]3O2SS0VR)+)VY8#)RSC.:]XKP[QD/\
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MP1X# Y(P.P(R0,YQS6[XX,WQ$^,MEX*::1-'T]1+=(C8WG;N8_7!51Z9-/\
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M>X5-P[(<;<^VX ?\"JK\++V?PI\'[SQ*NGSZC-=7IF>" '>R[@A(X.<?,?\
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MOU)KSGX"1G5-2\5^)9"Q>[N]BEO0DN?YBM97]N[?93_2/^9E&WL;O[37ZO\
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MC+Q\TBA1C\6KR3Q]\*]9\)^ )[B7QM?:CI]HT873GB=(AE@ 0#*0,9STJ_\
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M5/$GQD\(^&G&^&/$LR,-RD,V2"._RI^M2H-J,'O*5_DO^ BW-*3FMHQ_%_\
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M?D/_ (ZIK@O@I'?:U\2;5M0Y_L+3WA0$<J Q4 ^X+M^57&/+-4ND;/[HZ_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!-]%^2*'A;X=^,O$?AG3M9D^)VN6IO(A+Y&^9]H/3YO.&>/:K_Q)U35QX_\
M!GA72M7U"W9]INF@G=#*I8#+8//",>?6MCPG\+M?\/:OI]W=?$#5;ZRM?^8>
MPD2-@%P%_P!:1@<<8[5SVF9\2?M-W]RRLT.CVY13U (4+_Z$[5=TZL4MKM_<
MB=?9R;WM;[V3?'+7==AU30M#\/7]Y:74R2SO]EN&B9P!P#M(ST:MWPQXXEO/
M@=+X@GG=KVRLY8Y97.6:5 0"3W)^4_C6- @\1?M+W3M'O@T:QV9)X#%?\9#^
M5>:Z_J,_@VS\:> \L!=7T<EJ%7JA;<1^*[/RKG5W3Y>LKM?^!6_(U?\ $3Z1
MLG]U_P ['N'P>EU%_AM:ZAK.H75U/<O).9;N9I&5,X'+$\87/XUX]XJ\=>)=
M7UZ?Q/IVL7]GX>@U*.Q@AM[B1$E !8L0I .0,G_> KN?B/K3^#OA9H_A'31(
MVIZA;1VJQH,N$P ^ .<DG;^)KS'Q%J&K6OPNT_PW<^!]3TJWL[A9I-1N4<+)
M(0P/#1@ G/\ >/3'-;2DO:N2VBTE]ZO^"^]D05Z:B_M)M_<[?B_P/I7QKK+:
M-X#U?58F*R16;M$P."&(PI!^I%>1_!/Q3K__  E4NC>(=1OKP:A9+=VC75PT
MN .>"Q.,@G_OFMCXOZNTGP=TBWC^:756MD !Z_*'_F!^=9WQ#TT^ [WP'XFM
MH]D6F+'8W(49^4#_  \RDO=J2;VOR_@_UL2VY4XVWMS?E_P3>TS5]4UK]H+4
M[2+4;P:3I5IM>V65A"SX Y7."<L>2/X:S=5\5>*?B)XVO?#'@W4!I>EV&5N]
M14?,QR0<'J.<@ 8)P3FE^#2RZM_PFGBA-S3:A=.D#,, @;F'_H2_E5;]G*:W
M73M>MI'1=1^TJSQL<.5 QG'IG-*$;\L9=(W^;?Z7*E*W-*/65ODE^MCK/"?@
M7Q=X;\0Q7%]X[O-8TO8QE@N0VYGZ*!O9\#OD$'CWK#^%FLZMXE^(WBW49]2O
MI=+MY&BM[:2=FA3+G&U<[0<+V'>O1O$FN6^G>%-:U"&>.5K*WD+"-P2KA> <
M=#TKROX1WEOX-^#NJ>*+[=^]GDEPQP9"N%4#ZMD?C0IV<I/:,?S?]6'*.BBM
MV_R5R;XN>*=9O?$$'A3PS?W-I/:V\E]?3VLC(RJJ%@F5(/3MZE:Z_P"#^KW6
ML_#33KJ^NIKFY#2))-.Y=V(<]6))/&*\3\)Z]XDLEU_7)? VK:Q<:[&X^W)'
M((T1LYV_NV!'X]% KM?A'KHTSX'Z[='DZ>]PP'3G8"/U-)7A3G?>R?SN]/R0
M/WIQMM>WRMO]]V7_ (5ZUJWB;XC>+;^XU*]ETVWD,5O:O<,T29<X*J3@<)V'
M>O8Z\D_9ZTW[+X!GOF.6O;MVZ=E 7^>:];K24>5*'9+\B8OF<I=V_P#+]#R/
MX[^(-2TO3-$TW1[^ZLKR^NS^\MIFC<J!C&5(.,L/RKG6OO%OPO\ B!H.F:AX
MINM>L-595D2ZW%ERP4XW,Q&"000>>>*A^*\&I^*OC/HV@Z-+#%>VENLD4DQ^
M1'R9,MP>RKV-=?X;^%FL2>+(/%/C?74U;4K8#R(84Q$A&<'.%Z9S@*.:BCTD
M]FW?S6UOO0ZO6*[+[WK<B\>^.-?O?&5OX$\&.D6HR -=WI ;R!C) R"!A>2>
MO( YKF/%-KX[^$\=CKY\:76N6TDXBN+:[+E<D$X 9FX.#R,$<5:^'4L</Q^\
M7)J3QI>R&40!^"PW@X7_ (#C\*G^.FK)KUQHW@G272YU*>[$DL<9W&/@A0V.
MGWB?H*F-U&#C\4K?GMZ)%NSE-2^&/^6_WG1?%KQ;-8_"F/4M,NI[2XU%H!!+
M!(4=0WSG##D< CBJGBO5]5\+_ *VFDU"[.K36\$9NFG;S@[D,3OSNR!D=:P/
MC!:F6_\  O@J$%D+H'"=P-L8./INK3^-J_VC?^#O"L*;A=WH8J#_  KA/Y,?
MRJFE)-1^U.R]%_3(4G'E<OLQN_5C_@?XBUFXFUOP[XAO+JZO[1DG1[F5I&V,
M,$;F.<?=/_ JE^'VIZQXH\<^.+S^UKO[!$[6EFCR.T439(#*F0,@*#QCK6-X
M_N_^%=?%NR\2QKLL=1L'MY=JY^95VCI_VS/X5T?P#TYK;X?-?RAO.U&[DF9F
M[@?*#^AIJU2\GV:^=[?DA.\+1[M/Y6N_Q/.O$.B>+]%^(&C^$K?XC:W=SZ@%
M9Y3--&(021G'FG=P">HKVSP/X2U3PK;W::KXIOM>DG=2CW1?]T #P SMUS[5
MYUHG_%2?M,:K>';)!I,#(A(^Z0H3_P!"9J]QH@_W<7WO]U]/R')7J-=K??;7
M\SS?XI_$"^\,"PT3P_$LVOZFVV$$;O*4G ;;W)/ SQP?2N.\0^%?B/X4\.S>
M*W\?7=S>6RB6XLB6\D#(! RVTX]-@[TOB26.W_:>T>74GCCM_)3R7D.%^XX7
MD]]^:ZCXX>)[32_ ]QHZ31OJ6I[88[<'+[,@LV/3 P/<UG=JFIKXFW^=K?YF
MFCJ<CV27XJ]S6TWQR=3^$$OBQU$<Z6,KR*AP!*@(./3D?K7F7@+P=XS\;^%X
M];;XDZY8"25T6+S9I<A3C.?-7OGMVK1\7VDO@O\ 9RLM&G79=W1CCD7N&9C(
MP_(8JYX-^$WB.TT_1KO_ (3_ %6VM L5P^F1"1$ .&,?$H SDC.W\*VLG4F^
METOU9BFU3CWU?JMD>M:%IT^DZ'9Z?<W\U_/!$$DNIB2\K=V.23^IKS#2]7U:
M+]H[4])FU*]DTY[4O%:O.YB0[$.0A.!R#T'>O7Z\"\>ZW#X.^.HUR0( -'9U
M!_CDV.JC\2%%0YVJ*3_O?D:<O[MQ7E^:-OQ;K.K^+/BUIOA#0M2O+*RL!YVI
MS6<[1D]"5)4CM@#W;VI-'UC5=<_:&U&SAU*_&D:7 0ULL[^2S!0O*YP3N8GG
MTK1^#N@2Z1X6O/%&K9;4]8+7<KOU$?)'Y\G\16#\"LWEQXN\67&[-S<'!8YX
M^9VY_$4U^[=I?93;]7I^'Z$2?.FUU:2]%K^)2U,^)?'GQGUK0]*\5:IHUC8Q
M %K::0H"H4'Y%=1DL3W[5M:]X9\1^!OAKXEO)?&VK:K=ND1AF>62-K<!QNVD
MR,02#VQTKB?AU\.=,^*$NO:[K-QJ$"M?,8OLKHN2V6;)9&SC(Z8KTSQ?X5L/
M"?P-UC1=->9K>"!G#S,&=B7#')  _2LY)PHZZ.R_%IFL6I5?*_Y:?,SYO&=[
MHGP#TW43=SSZS?VXM[>5Y"TC2N2-V3R2!D_@*@^&'BZ\T_X1:QKVNW]U>2V5
MQ+\]U,TCDA5VH"Q/\1Q^-<O\/XF\=:YX9L#\^D^&+ 32_P!UKACD#WQQ_P!\
MFN7T:2[US2+3P#9R9DO]<DFN=ISLB4*,GT'WC_P&M9)N<XK>6WDN:U_S?W&,
M6E"+>T=_N;M^2^9[5\%XM<NO"TVNZ]J5[=S:G,9(8[B=G6*,$XVJ3A<G/3MB
MO2J@LK.#3[&WLK:,1P01K'&@' 4# J>G)IO38J"=M=PHHHJ2@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".>(SV\D0E>(
MNI421XW+D=1D$9_"N;\&> ](\#6]W'IKW4\EW)YDUQ=NKR.>PR%'')/3N:ZB
MBA:.Z!ZZ,Y74O &E:IXXL/%LUQ>)J%D@2-(W01,!N^\"I)^\>XJ+QE\-?#GC
MDQRZK;RI=1KL2ZMGV2!>N.001]0<9-=?12LK)=AWUN<3X+^%GAWP+>27NEF\
MENI(S$9;F8,=I(.,* .P[5)XR^%_AKQQ,ESJ<$T-XJA!=6KA)"N>AR"#^([U
MV5%.7O6OT$M-CPGX:>$9_ WQ/U+3K[P_=W-N^18:S]F=T1>H!<#:N1P3Q@C'
M0UZUXJ\(Z-XRTL:?K-L98E;?&Z-M>-O536Y10]8J,M;"2M)M=3SKPU\$_"'A
MK48[^.*[OKB)MT37TBN$/8A551GZ@UN>-? >E^.[>SM]5N+R**TE,J+;.J[B
M1CYMRG],=:ZFBFW>WD"5KVZG+^+_  !HGC;3;:RU5;A5ML^1);R;&3( [@@]
M!U!K+\)?"'PKX.U!=0LHKFZO4SY<]Y(',>?[H "@^^,UWE%):-M=0:323Z'*
M6?P_TJR\>W?C%;B]DU&Y0HT<CH8E! 'R@*#T7U/>I/&O@;3?'>GVUCJES>PP
M03><!:NJ[FP1SN5N.3Z5T]%*VB7;8?5ON59;"*32GTY6>*%H3 #'@,J[=O'&
M,X]JQ?!7@C2_ FDRZ=I<MS+%+,9G>Y96<D@#JJ@8X]*Z2BGU;[BLK)=C@?%G
MP>\*>+]2;4;N.ZM+V0@RS6<@0R8_O!E89]\9XK5\(?#WPYX)1_[(LR+B10LE
MS,V^5AZ9Z >P %=311'W59#>NYS)\#:6_CT>,7FNWU%8/(2-G7RE7&,@;<YY
M/?O5?QQ\.=%\?I9C59+N%[0MY<EJZJQ#8R#N5N.!7744K*R78.K?<JZ9I\&D
MZ7:Z=;;O(M8EACW==JC S[\5!KFA:;XCTF;3-6M4N;28?,C<8/8@CD$>HK1H
MIR][<(^[HCRRR^ '@VRU);P2:I,$<.L,EPNQ2#D?=4-[<FN\\1^&-(\6:4=-
MUFT6XM\AEY*LC#H58<@UKT4/5<KV!:/F6YYAI'P$\%:5?"ZDCOK_ &MN6*\F
M5HP?HJKGZ'-=?XM\(:?XQ\/_ -B7TUS;VF]'_P!$95;Y>@Y4C'X=JZ"BAZJS
MV!:.ZW.8U7P'H^K^"(O"=P;A=/ACCCC>-E$J[,8.2",\<\=S6=JWPMT?6O"&
MF>&KS4=5-EIS!HG66/S&P" &.S! ![ 5W%%#U;;ZN_S0)6M;H16T"6MK#;Q#
M$<2!%!] ,"N;U7X?Z)K/C.P\4W?VEK^Q4+$@DQ$=I)4D8SD$GH1[YKJ:*.O-
MU%9<O+T"N4T#P!I7A[Q3JOB*VN+V:^U(L91.Z%5RVXA0%!';J3TKJZ*%H[C>
MJLRAK6E0Z[HE[I5Q++%#=PM#(\) <*PP<$@C/X5CZ+X$T?0_!DWA6 W$VGS+
M(LC3LID8/UY"@?3CM73T4K*S7?<+[/L<WX0\%:?X,T.71[*YO+JSD=GV7C(^
MW<,$#:HX/H:Y&]^ '@F\U(W:+J%JA;<;:"<"(\Y[J6 ]@1[8KU*BF]7S/<$K
M*R,O0?#NE>&=+33='LTM;9>=J\ECZL3R3[FL'2?AIHNCZ3KVGP7%](NN%S=2
MRR(7&X$':0H ^\>H-=E10];M]= 6EK=-3C-&^&6AZ%X/U'PU8S7JVVH!A<7#
M.AF(88X.W'3@<=S6WX7\-V/A+P_;:+IQE:V@W8:9@78DDDD@ =3Z5L44[O5]
M_P!-A67]>9RGB3X?:5XJ\0:;JVJ7%[)_9Y#0VBN@@)SG+*5R<X&>>PK:U[1;
M;Q%H5YH]XTB6]W$8G:(@, >XR",_A6C14V7+R]!]>;J8WA7PU9^$?#]OHMA-
M<2VT!8HUPRE_F))R5 '4^E9OB/X?Z3XH\1Z5K=_/>"?3&#0Q1.HC8AMWS J2
M>0.A'2NKHJFVY*3W%96Y>@5RGACX?Z5X4US5=7LKB]FNM3<O,;AT8+EBQVX4
M8Y/?/05U=%):.XWJK,YGP_X&TSPYXAU?6[6>[FO-5??,9W4A>2<* HP.>^>@
MK-\3_"KP_P"+/$UMK]_+?1W< 0;8)$"2;#D;@5)]N".*[BBA:6MTV\@>M[]=
MSD[CX?:3>^.H?%MW<7MQ>VZA8()'0P18&!M7;G/)/7J:O^+O"EAXTT"31]2E
MN(K=W5R]NRJX*G(P6!'Z5NT4K*W+T_IAUOU.,U'X9Z-JMIX>M;JZU!H="V_9
MU$B#S,;<>9\G/W1TQWK9\5^%]/\ &/A^;1M2,RV\K*V^%@'4J<@@D$?I6U13
M?O:/O?Y@M-5Z?U]Y@^$/"6G^"M!72-,DN)(%D:3?<,K.2W7)4 ?I7+^)/@EX
M0\2ZI)J,B7EC<3,7E-E*JK(QZDJRL ?IBO1J*'J[O<%HK(XN'X7^'[7P3>>%
M+1[VWL+QP\TB3 RL<CNP('W1VJ+4?A7HNI>#],\+R7VIQZ98-O58I4#3'D_O
M#LYZGH!7<T4/5W?E^&WW"2MMY_CN5K>PMK738]/@C$=M'$(411PJ@8 _*N)L
M/A'H6F^$M4\-V]]JGV+4I%DF<RQ^8I&.%.S !P.H-=_10]6V^O\ G?\ ,:T2
M2Z?\,>11?LZ>#XY4D^WZT^U@=K318..Q_==*]<1%C144 *HP .PI:*=W:PK*
M]SE+/X?Z59>/;OQBMQ>R:C<H4:.1T,2@@#Y0%!Z+ZGO75T44EHDNP^K9Q/C'
MX5>&/&UT+S489X+W:%-S:2!'8#H#D$'ZXS4O@_X8^&/!,IN-,M9)+PKM-U<O
MODQZ#@!?P KL:*(^[L#][<Y34/A_I6I^.K+Q=<7%Z;ZS0)%"'3R>,XR-N?XB
M>M2ZEX&TS5O&FG>*;J>[-YIZ;((5=1%WY(VYS\WKV%=-10M+6Z?J#UO?J<SX
MV\"Z3X\TR"QU5[F)()?-CDMF57!P01EE(P<^G:M3P_H=KX;T&ST>R:1K:TC\
MM&E(+$=<D@ 9Y]*TJ*%HFEU!ZV;Z'*^%_ &E>$]8U75;.XO)[O4WWSM<NC8.
MXL0NU1@9/OT%=5111T2[!U;[G,>,/ .@>.+:.+6+9S+$"(KB%MDD>>N#T(]B
M"*Q?"_P9\(^%;]+^""YO;N)MT4M[('\L^H50JY]R,UZ#11'W=4#]Y69RWC7P
M'I?CNWL[?5;B\BBM)3*BVSJNXD8^;<I_3'6NGC18HUC0850% ]A3J*%HK('J
M[A7$^,/A;H/C;6K35-5FOEEMD$8C@D54=0Q;# J3W/0BNVHHZI]@Z-%*_P!,
M@O\ 1;C2BSP6\T#6^82 R*5V_+D$ X]JP=!\ :5X=\'7?AFQN+W[)="023.Z
M&4;Q@D$*!TZ<5U=%)I.]^NX+2UNFQX__ ,,X^#_^@EKG_?\ A_\ C5>B77A3
M3KOP:WA8F6/3S:BUS&5#A  ,@XQGCTK<HIO5<KV#K?J<QX*\":1X$TR>QTIK
MB19Y/,DEN65G8XP!E5 P/IW-9WA/X5>'_!^OW&M6,M[/>3JRYNG1@FXY.T*H
MQZ=^*[BBG?7FZ["LK6Z;A1112&%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !11534['^TM,N;+[5<VOGQE//M9-DL>>ZMV/O28%NBO&?$?@Z
M[TCQ)X:TZW\<>,FAU2YDAG:35B64*A8;<* #GU!K=\2>%O\ A&OAIXK_ .)]
MKFJ^?8M_R%;SS_+P#]W@8SGGZ"ANT7+^NG^8+67+_77_ "/2:*X.W^)W@O1[
M;3]+OM?MX[L6\2L@5W"':.&9054_4BMOQ=<VS>"[ZY_MN32[9H0XU&V4R-&I
M(PRA>3GV]:J2MMWM^-B8/F2[M7.AHK%UCQ/HOA?28;S6M4CMX&4!))<[I#C/
M"@9)[X J+PWXV\.>+O-_L+5([MHAET",C*.F2K ''X4MVTN@[Z)OJ;]%%>>Z
ME>:WXQ\87WA_2-4ETC2=+55O[RW4>?-*XR(T)'R@#DD<TNMD/1*[/0J*\TU3
MPQXB\&:;-K6@>*]9U0V@,T]AK$XN%N(P,LJMM!0XZ8KLH_%&EGPQ:>()Y_)L
M+F.)U<J6QYA 4' /=@*>C_KOM]XKV>ILT5R+_%#P3'K)TEO$-J+P-L(PVP-T
MQYF-F?QJYXOEACL=.:77)])5M0@"RP(7\XEN(CCLW3)X]:%K9KJ#=K^1T5%9
M.J>)]%T2Z2VU/4(;21X7G7S<JNQ2 QW8QU8<9R<\5G:!\1/"?BB^:RT?6H;B
MZ )\HH\;,!UVAP-WX9H6NPWIN=/17.S21#X@VL1UNX24Z>[#2@C>7(-X_>EN
MF1TQUY^M,\1?$#PKX4N%M]:UF&VN& /DA6D< ]"50$@>YI7T7F'5HZ6BJ&D:
MUINOZ>M_I5[#=VK$@21-D9'8^A]C6#J'Q.\&:7;">\UV&-3*\07RY&?<C%6^
M0*6P"",XQ[TWH[,%KJCK:*S]&US2_$.G)?Z1>Q7=JQP)(ST/H1U!]C6A3:MN
M)-/5!17.:!-!_;?B3&NS7WEW2^9;S(RK8_NP=BD\$'[V1QSZYK/'Q9\"-J?]
MGCQ';&XW;<A'\LG_ *Z;=GZTEK9+=C[OL=G10#D9'2N&^*YQX.B)Z?VE9_\
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M5>'/"^E^%K.2WTZ.3=,_F3SS2&269O5V/)-2:!H%KX<LIK2SDF>.:YEN6,S
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MYBE2>%)8SN1U#*?4'D5P7QD2"3X?O'=$"W:]M1*2<?+YJY_2N_5510J@*JC
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M;,9(&.A)KIM;\.V6O6EG:W#2Q16ES%=1B A?FC.5!R#\OM0DKW?5Q?W/\_\
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M]@8MG&,YR?7\*-0\/VFI:YI6K323+<:89#"J, K;UVG<",GCI@BE'3D\K_\
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M( J[4)! ]<C.:N>"G>7P-H+NQ9FL(22>_P @K3U"PBU+2KK3YF=8;F%H79"
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M:(?'MA;:GXO\"6UY$LT+7LKLCC(8K%N&1WY J;XI6T(T31[D1()K;5[3R7
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M *TM_F*^MOZZ_P"04444#"BBN5LM8OY?B?JFCO/FP@TV">.+8ORNSL"<XR>
M.,XHZV]?PU$W97_K4ZJBBB@84452U?5+;1-'O-4O"PM[6)I9-O4@#.!GO2;L
M-*[LB[152:XGETA[FPB5[AX#)!'*<!F*Y4-Z<XI-)DOYM(M)-5@B@U!HE-Q%
M$VY4?'(!YXS[FGU:[$III-=2Y1110,**** "BBL_6M8M-!TJ74;TL(8RJD*
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M"/;%5_"_A;4+.?6-2\0W5I<ZAJX1;B*SB*0(JJ5"KGENIY/-96?))1TW^_\
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M3()X;J".>WE26&10Z21L&5E/0@C@B@#.UK0+379-.>ZDF0Z?=I>1>4P&YU!
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M=K ,,C(['F@"S114;7$"7$=N\T:S2@M'&6 9P,9('4XR,_6@"2BBB@ HHHH
M**** "BBB@ HK#\/^(O[=N]:@^R^1_9E\UGN\S=YF%4[N@Q][IS]:W*.B8!1
M110 44R::*WA>::1(HHU+.[L%50.223T%5[^^6RTBYU!%$RPP-, &P' 7/7G
MKZTG)13;Z#2;=D6Z*S/#VK?V]X<T[5O(\C[9;I/Y6_=LW#.,X&?RK3JI)Q=F
M2FFKH****0PHHJ.>9;>WDF8,5C4N0HR2 ,\"DVDKL$KDE%9^AZQ;^(-$L]6M
M$F2WNHQ(BS+M< ^HYK0JFFG9B3OJ@HHHI#"BBB@ HHHH ***0D*"20 .230
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M?>WZM??;4I:<WK^B?YF_;^(=<\4?"C6[F+5+.&_LFN8);VVA\V.X2-3\T?S
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MX/2NW\+3VMOH5[?V'@J?1(\[DLTM8H9[D!<@[%( /. &-9K^'OT_'3_@Z?\
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M=<^$NJZ%<0/:7<U]<RPK<QE?F$Y="01]TX'X&MZS]^:7]>]9_A?]#*EM!O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5GZW_ &Q_9,W]@_8?[2X\K[?O
M\GJ,[MGS=,].]:%%)ZC6AR?A+PQJ.G:A?ZYX@O+>[UR_"I(ULI6&&->D:9YQ
MDDY/)KK***?D2E8****!A1110 4444 %%%% '.>,O#]WXAL=.@M)(4:VU&WN
MW,K$ I&V2!@'GTKHZ**%HK?U_6@=;G.>)= N]9U;PY=V\D*QZ9?_ &F82,06
M78RX7 .3DCKBNCHHH6BM_7]:"MK?^OZU"BBB@85SGC+P_=^(;'3H+22%&MM1
MM[MS*Q *1MD@8!Y]*Z.BCJGV_0.E@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#E/!.M7NJVNN2ZE<B06FK7-O&Q54"1(>!P!T'<\UK7'B
M?P_:16\MSKFF0QW*AH'DNXU$H/=23\P^E<EX&_Y 'C#_ +#%]5#X9>!/#=W\
M.]*N]2TBSU"ZN[?=)->1"5P,D!5+9V@#@ 8I1NTO)1?WH3=I6\Y?@>GHZ2QK
M)&ZNC#*LIR"/4&G5PGPG3[-X7OK%&8V]EJMU;0*Q)V1K)PO/I7:7LS6]A<3H
MNYXXF=1ZD#-$I)1YNEK_ (7'&[=O.WXV*E_XAT32KA+?4=8T^SFD^Y'<7*1L
MWT#$$U=:Y@2V^TM/&L&W=YI<!<>N>F*\W^'7@_P_K7@RUUO6-+L]5U+50US=
M7-Y"LSEB3P"P.T#I@>E6?%FGVNJ^./"OA6[B']B>1/<M:#A)6C"A%([@9)Q3
M:::B]_PVO^GS)4DUS=/^#;^NQVFFZ]H^L[_[+U6QOMGWOLMPDNWZ[2<58EU"
MR@G,$UW!',(S*8WD 8(#@M@GIGC/2O./'WA[1O"UEIWB'0=.M-,U&UOX$4V<
M0A\Y'<*T;!0 P(/?TJ3Q+H5EX@^,>D6FI1>?:)I,LKP,3LE(D& P_B&2#@\9
M I)W:2[M?A<;=KW[7_&QW>FZ[I&L[_[+U6QOMGW_ ++<)+M^NTG%32ZE86\T
MD,U[;1RQ1B61'E4,B$X#$$\+D8STKS[7?#VD>'?B!X.O=%TZUTZ6XNI;:<6D
M2Q+)&8R<,JX!Y'6FZMX?L/$/QN6'4X1<6D&BI*;9SF.1O-8#<O1@,DX/&::U
MM;K?\%<+VO?I;\78[[3=;TG64=]+U2ROE0X8VMPDH4^^TG%2W^I6&E6QN=1O
M;:S@!P9;B58U!^K$"O/]1T'2O#GQ3\)S:+I]MIWVU+J"X2UB$:2*J!AE5P,@
M]ZP=;DU36/BGK:?\(3#XI@TR*&&""YO8H8[<.NYFV2 ABQ[XXVTKWM;K?\/^
M'0]KW\OQ_P"&9[#9WUIJ-JEU8W4%U;O]V6"0.C?0C@U5U'Q!HNCR)'J>KV%B
M\G*+<W*1%OH&(S7 >!M+\0Z9XMU2]D\()X;T:XLP39PWT4\;7"GAE5,;25..
M!CBCX<>%M"\1>%_^$BUO3+35-4U2:66XFO85F*'>5"+N!V@  8%/KIVO^+7Z
M"OW[V_"YUWB+QGI'AQ=-:ZN[8+?W*0H[W"HJJ<YD)/&T8^G3FF:UK O_  ]'
M>^'O$6DP*;J)/MDDR/"PW@,@;D;B. .N3VZUS/C_ ,.:(-2\%1?V18LG]J16
MA#6ZMF$1OB,Y'*^QXJS\1]-L-*\"06NG65M9VXU.T816\2QH"9ER<* *4=?_
M  *WXQ_S_I$R;2?^&_X2_P OZ9WEU=VUC;/<W=Q%;P1C+RRN$51ZDG@5!IVL
MZ7K$32:7J5G?1J<,UK.LH!]RI-<1KEC:^)OBS9Z+K$2W&FV6F&]BM)!F.69G
MV;F'\6!V/K5;Q5HFE^$?$?A;5] L;;3KFXU)+&>*TC$2W$3@Y#*HP<8!SBG'
M6U^KM^+7YHJ3M>W37\+_ )'H<NI6%O-)#->VT<L48ED1Y5#(A. Q!/"Y&,]*
MBTW6])UE'?2]4LKY4.&-K<)*%/OM)Q7 ZMX?L/$/QN6'4X1<6D&BI*;9SF.1
MO-8#<O1@,DX/&:?J.@Z5X<^*?A.;1=/MM.^VI=07"6L0C2150,,JN!D'O1'6
MU^M_U_R"6E[=/^!_F>E57AOK2XNI[6"Z@EN+<@31)(&>+(R-P'(R/6K%<'=2
M)X?^+8NY&V6FLZ6PD8G@2VYW9_[X8_E2;2>OG^"O^C&]KKR_.WZG90ZE87%]
M/8PWMM)=VX!F@253)&#TW*#D9]Z@OM0A:&_M+34K2'4(;<R$22*3!D':[KU"
MYYR?2O+?#/G:3KNA>+;C('B>XN(KDD8P)#OML_0)C_@5;&@K_:.B>.?$AY_M
M&6XBA;_IC"AC7!]"0QJ)MJ#;W2=_)JVGX_F$7>:2[JWIKK^#_ WKSQ9%X8\"
M6>K:QJ%G?7!BB4S02JL=R[$#<AZ;><Y Z<U3\<^);2[^&NNWWA[6X)I+>(#[
M1I]T&,;;A_$AX.*Y'7M-L;OX#^';FYLK::>**Q2.62)69%9XPP!(R 1P?6NG
M^(FBZ7HWPJ\0Q:5IMG81R0AG6U@6(,=PY(4#)K2KI*?E*WY?U_P!4G=P]/U:
M.HC\1Z+;R6UC=:U817[QJ1;RW2+*V1_=)R:V*X"Z^''A1? ]Q"^B6<MQ]B9V
MO'B#3M)LSO\ ,/S9SSUK;^']U->_#[0+BXD,DSV499VZDXJGO)=OUO\ Y$0?
MNQ\U^27^9TE9DGB/0HM1&G2:UIR7Q.!;-=()<_[N<_I67\1-3N](^'VM7UB[
M)<QVY".O5,D#</IG-9]E\,_!K^&(;230K&7S+<;[MX@9F)7E_,^]G//6L[[O
MHO\ *YIV7?\ X'^9V%W>6NGVKW5[<PVUNF-\LSA$7)P,D\#FI))8XH6FDD1(
ME4LSLV% '.2?2O&I]0N;_P#9UO&NKAKA[=S;+.QR9$CN JMGOP!7I^ONJ>#=
M3=F 46$A)/\ US-%1\L9273_ "N."O*,7UO^#L7CJFGBRAO#?6WV6<J(I_.7
M9(6.%VMG!R2,8ZYIL>KZ9-J3Z;%J-H]_&N][59U,JKZE,Y Y]*\KUQ'E^ /A
MR..5HI&_L]5D7JA+IR/<5Z/HGA/0O#H5M-TRVAN-FQ[H1@S2Y.3OD^\V3R<F
MM91M*2[.WX&:E=+S5_QL;59VH>(-%TB6.+4M7L+*23[B7-RD9;Z!B,UH$@ D
MG '4UY#<W>F^)+Z^U/P]\+(O$23RE9=1O9(8%F*_+F,R9)'&. .E9-ZV1IT/
M69+NVBM&NY+B)+94\QIF<! N,[BW3&.]4;GQ)H5E-##=ZUIT$LX!B26Z16D!
MZ%03SG(Z>M>:>%VE_P"%"^(8983!Y"ZA$MN9-_DJ-WR!NX'(S6YX6^'GA>?P
M-I_V[1K.]NKJS1YKJYB$DS,R#D.?F&.@P1C%.3M=]%9_>KDIW2\[_@['H0(9
M0000>016;%XCT.?43IT.M:=)? X-LETAD'_ 0<UPW@_7;'1_@G:WFMM+-:1)
M);%%&YY%\QHU0#N2,"N)\86DL/@^YN++X30:-;0!)8M4:Z@CN("&&&* ;SSQ
MC/-4])VZ:?C;Y;,:NUYZ_A=>NZ/4?&E[=VNO^#X[>YFACN-5\N98Y"HD7RW.
MU@.HR!P:ZFUOK.],PM+J"X,$ABE$4@?RW'56QT(]#7$^,F9]9\ NQRS:HI)]
M3Y+U)"G_  C7Q5F3[NG^(H/-'.%6ZB'S?BR<_P# 326FC[R_"W_!,^:_O+M'
M\;_YH[(WUF+\6!NH/MAC\T6_F#S-F<;MO7&>,U2C\3:!+J!L(]<TU[T'!MUN
MXS(#Z;<YKB] TR3Q?'XOUQ;F2 ZOOT^PG /[N",% R^Q8L:RK33M#\,V]E9^
M+O %A:)"\<:ZU90)-"S@C:[L )(\G^\",]Z4=6K];?C_ $OFRY.R=NE_P_X-
M_N/0[N:^7QAIT,>JV45D]M*9;!R//F8%=KIWVKSGZ]^UG4?$.B:/*D6IZQI]
ME(XRB7-RD9;Z!B,US&K$'XQ^&B.G]FW?\TK%O_##:+K^KZEJ7@RT\4V%].;C
M[2J1RW=NN -GER?> QQM.?:DGHK^?X/^M].@7U?R_%'J$4L<\2RQ2+)&PRK(
M<@_0T^L7PG/HEQX:M'\.QI%IGS".-4*>6=QW*5/((.<BMJK:LPB[JYR.N:UJ
M&C>//#\3W'_$FU-9+5XBBX2X W(V[&>0",9Q[5<\=:]+X;\':AJ-L1]L""*U
M&,YF<[4X[\D56^(VD2ZKX+O&M ?M]EB]M&'598SN&/J 1^-<W/JT7C[Q-X/L
MX3OLH[8:U=J.FX?+&I_X'N_*H2YER>?X/7\+-?<#?*^;R_%:?C=?B=]8R2Z=
MH%L^LWR-/%"OVFYFVQJ7Q\Q. % S3M-UO2=91WTO5+*^5#AC:W"2A3[[2<5R
M_C[4]&,VG:)>^'IO$-_,YN+?3XD! "@@NY8A0O)'.:X[18KRS^+/A]I? ]KX
M3\^VN49+2ZAE6Y4*#RL8 &#CD]<^U4GS2];_ *_\-H)^Y'T_K_@G;Z+>W<OQ
M1\3VDEU,]K#:VC10M(2D98/DJO0$X&<5U5I>VM_"9K.YAN(@Q0O#('4,#@C(
M[@\$5QNA?\E=\6_]>=E_)Z7X4G_BD)_^PE>?^CFHCK%>E_\ R9H<G:3]?_;4
MSL8+VTN9IX;>YAEEMV"3)'(&:)B,@,!T..<&JMWK^C6%['97FKV%O=R?<@FN
M41V^BDY-<3H%X]GJGQ)O+<;Y(+KS$ &<LMN./S%<3X;T_5+_ ,+P7$WPDLM<
MDOH_.EU2XU6W\VX+<E_F4LG7H",5*;>ODG]]_P#(/\VON_X<];\;^(Y?"WA6
MXU.V@2:Y#)%"CGY-[L%4MCL"<FL2'0/B/'*MVWCBQF8D%K)])181Z@.&W_C4
MWA'P[?7GPUCT#QC9,7(>%X)9EE81;CL^=2<D#&#G/ K)U6W\4?#?3)-4LM;;
M6]!M #-8:BH,\46<$QS#EB!CAAVJM(R=WVL^GS^?J&LEIY_TOZ1Z1/<0VENT
M]S-'#$@R\DC!54>I)Z55TW7-(UD.=+U6QO@GWC:W"2[?KM)Q7"^(8K7Q=\1O
M#ND:@C2Z/_9TFI"V?[D\F0%W#O@'./>NHET72/"^EZIJ.AZ/965R+5V/V6W6
M/?M!*@@  \U+?+%REY_AI^C''WFE'R_$OWOB+1--NTM+[6-/M;E\;(9[I$=L
M],*3DUH&1!%YI=1'C=NSQCUSZ5YUX%\%>&M4\$:?J6IZ19:E?ZE +BZN[N%9
M)'=^3\QY&,XXQTH\!LUKH7BO1(YFFLM)O9[:T9F+;(]FX)D_W<D4ZEX*2>Z3
M?EI_7S%%\UFMF[??_P ,=E/XFT"U2V>XUS385NE#6YDNXU$P/0ID_,/I6HK*
MZAE8,K#((.017E_PT\#^&=0^'.DW6H:39ZC<W5OF2>[B65QR0%5CDJ . !C&
M*PVU.^\/?"SQEI^F32&/3-3>QLGW_-%$[(,!CTV[R >U5/W6X]5_FE^J%!\R
M3Z/_ (/^3/7$\0:+)J9TR/5[![\=;5;E#*/^ 9S^E:->$W?AK6;CPX=.L/@Y
M9V=P(AY&HQ:Q;>?&X^[)O #$@\_>YKV?1/MPT+3QJ:[;\6\8N!N!Q)M&[D<'
MG/2BV@7NUYG/?$^]NM/\!WEQ97,UM.LT $L,A1@#*@/(YY!(K</B+1(K]-.E
MUG3TOVP!;-=()2?]W.?TKF?C AE^&FHQJQ0M) H8=1F9.:K>(_AYX5M? .IK
M%HEF+F"RDE6\\H&X\Q5+;S)]XG(SUK/FY8RD]D_T+Y>:44MW?\ST%W2-&>1E
M5%&69C@ 50T_Q!HNK3R0:;J]A>31_?CMKE)&7ZA2<5Q>H:]I@^&?A^'7=.GU
MF?5;>W2.PA7<]S(%5O48 (R2?UKD+V"[L_%7A2Y7X<VOA9/[5CC2]M[J O*K
M!@49(P#R.><XQBM;6J.#[V_K_(SYOW?-Y7_K\3V?4M8TS1XEEU34K.QC8X5[
MJ=8@3Z L14MG?6>HVRW-C=074#?=E@D#J?H1Q7!^*_"]TWBYO$)\.6/B>S>U
M2!K&Y9/,MRI)+1"0%#G/(X/'%;7@>?PY+97J^']+.E.EQ_IEB\'DO#+@<,@X
M' &,<>E3'5:[_P!?U=%-V9U59ESXDT*SM5NKK6M.@MV=HUEEND5"ZDAE!)QD
M$$$=L5IUY5\.?!^A:KIVKW^JZ9:ZC-)JUVB?;(A*(D$A^5 V0O.3QW-)7;:\
MK_C8&[6\W^EST:[US2;"R2]O-4LK:UD^Y/-<(B-]&)P:LVMU;WMLES:3Q7$$
M@RDL3AU8>H(X->5_#SP1H%S=>)/MVG07\-EJLUI9P7B>=';1 AMJ*V0,ENPK
M7^'\5IH.I>-;&#%OIECJ DCBS\D*F)6; [#VIW6[[7^6F_W@[IV\[?G_ )'8
MWGB+0].NTM+[6=/M;E\!(9[I$=L],*3DUH@@J&!!!&017B\K66OV]WJ&@_"&
M+5;.]:25M0OIH+=Y=Q.73?EL$Y(P1VIR:C>1_LZZ6$GDB>Y,5F\H;YHXVFV'
MG_=XS2UMYZ?B[>H-I/RU_!7/1=5\2:3<:7JUMI^M64FH06DK&*WND,L9"GG
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M[NXY8^:0D:ECSP,!1^%8?PP6YMO&WBNTET"/P^ICMICID-PDR1L0P+ H HR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.[^^T<QF-;5;2.%RN, /*OS..F>F<5Z)10U>]^H+1)+H<A=>!_M/@32_#/\
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M0_$^I7<<NA^,'T:(+M>$Z=#<JQ]06P0?QQ6WINF6.CZ?%8:=:QVUK$,)%&,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9@IY:.,Y+C@D=,\4FTMQV.WHK"M/%VE7/@U/%+2-#IIMS<,9!\R =00.^1C
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M_F:$GK?I;]?\A.6JMUO^AUU%%%!04444 %%%% !1110 4444 %%%% !1110
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M=)=OTW XJ[%#'!$L4,:1QJ,*B*  /8"G'N][6_!+\D)KHNKO^+?YLX7X5_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\=2*W]3N[VT@0V.G-?3.VT+YJQJG!.YF/('&. 3STKF_B/\ \@O1O^PU9_\
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MZMDSNF@G5T7'7+ X%<EXVEU&7Q;X5L+6SM[J"26>=HKJ=H8GDC3*!F"/TR6
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M2S<0+>7;0()&DVLX*QOE@ !T& QYYI)W4?._X7_R$]&_*WXV_P SJ;W6H/\
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MGVMO+<RQHZPW%PT2<@$Y<(QXS_=Y]JQ_B(0WPW\0$=#82G_QVMO2/^0+8?\
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MX&^RR6]T9T<J,E&)1"K8R<8(.#S7G&FPW(TCPU>23>=;S>+)IS+MPKJS2!6
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M*7Y6# ?NT5<9'IGWZ5T%%"T5OZ[_ )AY_P!=AI0&(QY8 C;D'G\ZYU_"4MQ
M]K=^)=;NK&0%7MI'@4,I_A+I$),?\#S[UTE%%@,34?"]E?)I_P!GEGTZ?3N+
M2>SV!HE(VE0'5E*D8&"#TJ*;PHCZBNI0:OJ-KJ!@2WN+F'R=URBDD;U:,KG)
M/*JIYKH**!66QSUEX+TBQM=8ME2::#5SNNTFDW;CL"DYZY/4Y)Y-20^%[?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% &1H6B'1SJ$LMP+BXO;IKB239
MMX/"KC)X &*UZ**;;>XDK!1112&%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>annexd_003.jpg
<TEXT>
begin 644 annexd_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWC>2".Y$9\]5QN*M&[+GD<$@\]*+:??^ &W167I&O66LZ!'K,'F16S(S,LP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P/-/CT^RB+F.SMT+QB)RL0&Y!G"GCD#)P/<U#5XV\FOO'?6_FOPM_D<]X#
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M^-$=&O5/\@>S]'^H[2OW/Q2\1++A&N+&TDB!/WU7S Q'K@XS]16)#<175_\
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M\?4UTUK96EC:K:VEK#;VZ#:L,481%'H .*6VM;>RM4MK2"*""-=J11($51Z
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M_P O\OS)M_E^?^?Y',6FIZCK]SKSS:U)HMKI=ZUL%MHX3(550=\C2JXPV[(
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M>WR_'^OQ&]/Z['I-%<3:QW.L^.O$^FW=]>#3K=+5HX8+F2$JS(2<,A#*/EZ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9W !7S;:TCC?!ZC*@&M:BD,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;XD$=N))I$PJY:3.%Z<GZ5PWQ#TC3-&^%/B"#2].M+&%H=[1VL*Q*6W*,D*
M,\"H?&,,>L>(_!WAR^RVE7IEGN8LX6<Q1AD1O49.<=\4+71=U^5_T'YOS_-?
MYG9Z;KVC:PSKI>K6%\T?WQ:W*2E?KM)Q5F6\M8+B.WEN88YI%9TC>0!F5<;B
M!U(&1GTS7G'Q#\-Z)X8\.)XBT/3+/2]3TZYA>&2SA$)D!D56C;:!N#!B,'-3
M>.M(M]>^(7@NQO0S6LB7C31!B!(H1#L;'520,CO0E>UN]OPN&U[]K_C8[BPU
M[1]5GE@T[5K"\FB_UD=O<I(R?4*3CH:EU#5=.TBW^T:E?VME#G'F7,RQKGTR
MQ KS[QEX:T3P_J/A75-%TJRTZ[76H+<R6D"Q;XY-P96V@9R/6KWB[PO<W/BF
M'7QH-CXCM%M1;/IUVRAHCN),D6\%"2#R#CH.:71,=OZ_ [:RO[/4K9;FPNX+
MJ!ONRP2!U/T(.*L5RG@FX\.RQ7\6AZ/_ &/<12@7MBUL('C?'&5'RD$="N0:
MZNFR4%9J^(M$;4_[,76=/-_G'V472>;GK]S.?THU_6+#0="N]2U1BMG"F9,#
M);/ 4#N22!^->*>*[+'@V^ET[X10:=91V_FQZG+<V\-S;XY#[!ER1Z;LFIOJ
M58]WNKNVL+9[F\N(K>",9>69PBJ/4D\"J^FZSI>LQM)I>I6=\BG#-:SK* ?0
ME2:Y+Q1X=O?$>E>'K^*TL]4:Q GETV^;;%=;H\<G! 8=1D$<FG^$9?#<>O3V
MMOX57PYKH@R]N;:./S(LC+(T>4=<XY!S56U:?F3>Z31W%06E]::A;BXLKJ"Y
M@)*B2&0.N0<$9''!!%3UY4FI2^$].\=Z3"S">&Y\_3U/.3=#Y /^VI:I[V_K
M;_,I(],L=1L=3@::PO+>[B5RAD@E610PZC(/4>E.M;ZTODD>TNH+A(Y&B=H9
M X5UX*G'0CN*\RT)H/AG+KFC2'%K'I2:I 3_ !NB>7-CW+*A^K53UN'4?#GP
M3TFR@BDEO=1N($NE601-(9WWR*7/W=Q.W=VS5-=O+[V[?H_P$M?Q^ZU_Z^9Z
MA:Z]H][?R6-IJUC<7D?W[>*Y1Y$^J@Y%8'BB\NK?QKX-@AN9HH;BZN%FC20J
ML@$+$!@." >>:\\U30/$=QIBPZ/\(;+1=0A97MM0M=5M1+"RD')( +>A!/.:
M[GQ09#XU\!&48D^TW&\>A^SMFG%:KU_1AT?HRW8WET_Q7UBS:YF:UCTNVD2
MN2BL7<%@O0$X'/M775Q6G?\ )9-<_P"P1:_^C)*[6E]E?UU8NK_KHBGJ.KZ;
MH\(FU/4+2RB)P'N9EC4GTRQ%36MW;7ULES9W$5Q!(,I+"X=6'J".#7G/B2_T
MO6?$MY#IO@!?%6IZ>JV\\UQY4<$9Y;9OER-PR3P.XYJ#X8PW/]I^,].DTE=
M'G0L-/AG65;9GBY*LN!S@' Z=*2U3]+C>C1W[^)-"BU+^SI-:TY+[./LS72"
M7/7[N<_I6I7CUOH.D^$M*2R\7^!+&ZM(!MDUZTMTGWC/^LE! E0]R1N'/7%>
MO0M&\$;PE3$R@H5Z%<<8IVT%U,GQ/->P:5&]AJEEILWVF$&:\QL*EP&3G^)A
MD#W/;K5;7_&>D>'-6TO3]0N[6!KYW!>>X6,0HJ%MQSZD!1TZUF?%+_D4H/\
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M=_-J<]N!>Q+*((HVVHBJP(7CGCUH^)T;Z7H.@:!HNDI-9WFH+ ^G0RK;)-&
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MQ"WEU")+,2B06PVD^6&'! )/-*_NM]E<I*\U'N['IUUXCT.RG@@N]9TZ":<
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M0"1S71ZUX7_MC2-*L/MGD_8+JVN=_E;O,\H@XQD8SCKSCWKH:*+@9/B?1/\
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M$G7R?+SYGF*!][/&,>AS[5MT4[A;<Q/$GA[_ (2%-+7[5]G^PZA#>_ZO?O\
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M,EACKC&:[*BE?6X6TL8B^'MOC>3Q)]J^_IZV7V?R^F'+[MV??&,?C1XF\/\
M_"16MC!]J^S_ &6^@O,^7OW>6V[;U&,^O;TK;HH[>7_#C[_UTL<_XF\*0>(C
M:7,=Y<:?J=DQ:TOK;&^/(PP(/#*>X-5- \.>)K'4%NM<\:7&KQH#LMTL(K9#
MD8^;;DM[<BNKHH6@/4Q=%\/_ -D:OKE_]J\W^U+E;C9Y>WRL(J8SDY^[G/'6
MDB\/^5XUN?$7VK/G6*6?V?R_N[79MV[/^UC&/QK;HH[ <1J/@34HM5O-0\*^
M*;G07OI/-NH?LJ74+OW<(_W6/&2#SBM34/",6M>%H]&UC4+F[GC82+J VQS)
M*#E9%VC"D=L#I71T4=+!UN<58>$_%L.H1O?_ ! N[NPC<,+9-.@B=@#PK2#)
M(QP< 9]J[6BBG<#$\1>'O[?ETA_M7D?V=J$=[CR]WF;0PV]1C.[KS]*)?#_F
M>-;?Q%]JQY-B]G]G\OKN=6W;L_[.,8_&MNBDM/Z[Z!_7ZF+K/A_^U]8T._\
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M_:QC'XUMT4=@"L6W\/\ D>,K[Q!]JW?:K.*U\CR\;=C,=V[/.=W3':MJBCS
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MQW&H:G=6>JZ7:0Z9/<PWCNLUS&?EM@JY!;ZGCM_2K?V^V_M+^S_-'VORO/\
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M36/BC -QIMU.L*"3'S!+=D"LO7!7([UT?C6?6W\;^%M+TC5)+%;Z.[6XD W
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M?^&M1\1_\(YXITW[7_:6KZ/<36UG<3* TW[L/'O[$_,![UB>%[:TU748)/\
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M/8JS;LM_\SL**\UTKPCKOB32K/7]2\:Z]::C=1+<)!83+':PAOF5?+VD/@$
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MZ7_KI_F.S;LOZW_R.]HKY[NO&^A65G)J]A\5-;O-?2/>+:>WD^QSN!G9Y/E
M*#C&<\9SFN_\6:SJ.H>&O#VH07.I:=HU\@EU.YTR/?<0(T>5VX4D+D\L!D<5
M36E_D);GHM%<7X$L;*-);O2?&VI>(;!UVE+R[2Y,;\'.X ,IQ_"?6NTH:L).
MX4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!YQI7A'5K?XD7,T]NJ^'8+J74K1_,4[[B5%4C;U&W
M]X<G^]3=;\':M=?$6":UMU;P_>SV][J#&51MF@#;1MSD[OW?3^[S7I-%-.UO
M+^O\ON0/6_G_ %_G][.7\1Z1?7_BWPI?6T&^VL+F=[E]ZC8K1%0<$Y/)QQFL
MKQ#9>)](\<?\)+H&C0ZU%<6*V4UH;M;=T*N6#AF&".<8ZUWM%+:WS_$'KO\
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MD<]W=0+*'N8XFA)D7]T3N)R_W<@8 )R>U)=/ZW'UM_6AZ!<W-O9V[W%U/%!
M@R\DKA54>Y/ J4$$9'(K@M;UN]G^&^M7WB[P>MLD(^;3FU!91.F5P?,0?+R?
M3/%;?B#Q/%X=L+!8=/GO;V^<0V=E;D R-MSC<>%  Y)H_K\ .BHKS7_A87C&
M'7M/TB\^'@M9[XGRF?6HBI"\L<A",@<XZ^U=3XCUW6=+>*#1?"]UK-PZ[B5N
M(X(DYZ%W/7VQ1TN'6QT-%<KX?\8SZS%JEM<:%=66M:8%,^FM+&Q8LI*[),A6
M!P1DX%<WX$\6^,-7O[M+OPL[6#ZG/'+>MJ49^RA3CRQ'R6VX X.#DFG;6PF[
M*YZ1#=6]Q)-'#/%)) VR54<$QM@'# =#@@X/K4U<KX=O=-.N^+/(T^.R>VO%
M%W<>:6\\^4IWD$?+@<8'IGO62GQ!UW40+[0O M_J&B'.V]:[BA>102"T<3?,
MP/4<C-(?<] HKF)/&]C)X!N_%EA$]Q#;V[RFWD/EN&3[R-P=I!!!X-8LOQ$U
MR:T35=+\"ZA>Z(8_-:\-U'%(R8R62$_,PQTZ9H>FX+78]!HKF[OQIIUOX/M?
M$D,4]S;W8B%M#&H\R1Y" J<G .3@\\55T3Q-XHO-4CM=9\#W.EV\I(6Z34(;
MA5P"?G"X*]AWY-.SO85]+G7445'/*8;>241O(44MLC&6; Z#WI;#)**\^NOB
M'KNE9OM9\"WUCH090UZ;V&22,$@;GA4Y R>>36SXJ\:0^%KG2(I+&>\&I2/%
M&+?E]X7*A5QSN.!U &<F@#J**X.+Q]J]EJMI;^)/!UUH]E>W"V]M>?;(KA=[
M?=$BI]S/'<\UL^*?%B^'FL[2UTZ?5-6OBPM;&!@I?:,EF8\*HXR?>CS U=1U
M>QTEK-;V?RC>7"VT'R,V^1@2%X!QT/)XJ]7DGB+Q)J>HZIX1L==\.7.B7QUN
M&6-6G2XBD4!@<2)QN&1P0.O&:]7GD>*WDDCA:9U4LL2D N0. "2!D^YQ3^S?
MU_0.MOZZF!KOCWPOX:U&#3]7U>&VNYL;(=C.W)P"=H.T'U.*W8+NVN7E2"XB
ME>%@DJHX)C; .&'8X(.#ZUY/X*UKQ)/X^\2N?!N4N=1CBO+A]0B#6:", *1S
MOX^;"G')%=EH-_8#6/%[6FEK;3VMVOVF42EC=-Y*L&P1\O'&!GU[TMHW?:X=
M;+O8ZRBO.+#XE:YKVCVNI^'? UYJ-NZ SN][' J-_$J;QF3!R,@ 9%=?X9\1
MVOBC0H]4M89H0S-')!,NV2)U)#*P]013::OY"N;%%>?W_P 0/$6G)+J%QX U
M&/0X5+RW3WD(F1!U;R 2?UK7\3>.++PUI.DZHT$EU9ZA<1PJT62P#H65@H!+
M'@#''7K2*MK8ZFBO/Y_B'K.ESQW&N^";W3=%DD2,7YO(I6C+$!3)$O*#)YY.
M*Z/Q/XIM?#%G;R2V]Q=W5W,(+2TMEW23R'L,\  <DGI1TN+K8W:AM[JWO(S)
M;3Q3H&9"T3A@&!P1D=P1@BN>\.:]XEU.]D@USP?)HT03?'-_:$5PK<_=.W!!
MY_G2>!;JPNM$O)-.TQ;")=1ND:)92^]Q(0SY(&-QYQVZ4[?U\P.HJEJ>KV.C
MQ02W\_DI/.EO&=C-ND<X4< XR>_2N,O_ (@>(M.274+CP!J,>APJ7ENGO(1,
MB#JWD D_K4OQ"N8KSP_X=NH&W0S:S82(WJI<$&A*[7JE]X;77K^!W=%%<GKO
MB;Q)9:A):Z)X)N]52+&^XDO8K:-L@'Y"Q);KCH.<TAV.LHKEK3QM!?>"=1\1
M0V,R/8)/Y]E.P5TDB!W(2,@=.O/6L9/B)KFH6$&J:)X%O[_2GC$CW+7<<+$8
MR?+C;YG YQP,XXZT/01Z%165H^OVNN^&K?7+&.:2">$RI$%'F<9RN,XW9!'7
MK7)W7Q#UW2LWVL^!;ZQT(,H:]-[#))&"0-SPJ<@9//)IVUY>H=+G:7VKV.FW
M-C;W<_ERWTWD6Z[&.]]I;' XX!Y.!5VN)\;,&\1>"&!R#JY(/_;&2MG1/$?]
MJZUK6DSVGV6[TR95V^9O\V)URD@X&,\C'.,=:$KK[_PM_F+K]WXW_P C=HKE
M[CQI;VVN:W9O;DV6BV2W5Y=A\E6(+",)CD[1G.>XXK-LO&GBF[N8)6^']['I
M4Y4I=#4(&D"MC#&+.1^=):C>FYW5%<[XD\5?V'/;6%CIEQJNKW:LT%E;LJ_*
MO5W=N$7) R>YZ55T#QE=7VKKHNOZ#/H6JR1--!"\Z3QSH#\VR1."1D9'7FA:
M[ ]#K**X:^\<:W-J5Y;>&?!T^M0V,[6]S<M?16RB0 $JH;);&?:NMTJ]FU#3
M8;JXL9[&60'=;3E2Z'..=I(]Z%JK@]'8F:ZMTNDM6GB6XD4ND)<!V48R0.I
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M!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEIDE?F5?7/?UKMM0TRPU:V-MJ-C;7D!.3%<1+(OY,"*-/TS3])MQ;Z=8VUG
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M>^,4+789N451U'6+#27LX[V<QO>3BWMU",Y>0@D#"@]@>3P.YJ]0 45R^O\
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M(&.A)%5/WG)=WO\ U^ 0]WE?;_.Y@7,TVH:3\+XM;^:UNI$:Z68X$DH@)C#
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M\-M/EA@C66[,DD[A1F0[V')[\ "NJT[0+73+_5KR&29I-4F$TP=@0K! GRX
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MM37?AYIFM:K)JD&H:OH]_,%6>XTF\,#3@= _!!QZXS5S0?!6D>'-4GU#3_M
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M6NK6OG+&XDB=6*21..C*PP0?I4[._P#6I6ZL:]<%IZQ77QHUHWRH\]KIMO\
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M !1110 4444 %%%>?RW?BKQ/XMU:UT77[?1]/T>:.!U^Q+</<N5#MN+$;5Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=JJ,D  <"LX^!;^/X02^#HKBW:[\EHDE=FV',A8$G;GIUXZUW4*&."-#C*J
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MA+>^!KZ:V&;NP*7\&%R=\3!_U (_&N<\<HWCTZ-H^GS$1/82:PS(>C!,0?\
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MV'A*.QN#;7,FL01I,!DINC<$@>H!-4]=\)_$'QAX<O-*US5M!M4908X].CE
MG8$%1([Y*KD9(5:ZKQ+X>N]8'A[[/) O]FZE#=S>8Q&Y$5@0N <GGOCZT)+K
MW7W6&WIIV92/@S1?#.A:]=Z?#,;V[LI!<W5Q<22R380X)+$\_3%<YX6^&NB>
M(_!>AZGKSWM]J3V<3Q7)O)$-N-HVB-58*N !VY(R:]#\1?\ (LZK_P!><O\
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M5_P.V\5&=/!^LFTXG%C-Y6.,-L.*H?#D6Z_#CP\+8#R_L,73^]M^;\<YKIB
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MSCFE,AA62,DH">=HQP*W?".@76@0ZNEU)"YO-4GO(_*).$<@@'('/K_.C2-
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MK/T+3H-7OO'^G7*AH+K4/*<>S6T8K'^'3:EKFN!M7B8'PM VEJS?\M;C.&D
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M7%NJQ%3O>.3LHR,-Z9XS65JWB;X@>';:37-5T?06T2(JTUM:W$K74*$@%BQ
M1L>@%.\96MG9^#O"MMI]N]O91ZMIZPPR;MR)O& =V3D#UYK9^)W_ "3/Q#_U
MYM3=E=KO_E_F$5>R?5?YF%\2;[Q,+[PQ'H0TQ;>YU"+RVNY),O+M9E#JHX3
MSD'.<<5NVF@:SJMSHNH^*9M.^VZ9)-*(-.1_)9V&U&RYSE5W<8ZGVK(\>RM8
M:1X4UAX)I+/3-0AN+MH4+F.+RV!<@<X&1FNPT#Q#I?B?2UU/1[DW-F[%%D,3
MIDC@\, ?TII6O;HV3>]F^J7_  2AIGA"TL?#^IZ7<.+K^TYIYKN1DV^8TI.>
M,GH, ?2J'PPOI[SP-:P73F2XT^66PD<G)8Q.4!_("NODD6*-I'8*B@LQ/8"O
M,O!FO6WAGX;OKUY!<RPZCJDTL$," R/YTQ"8!('/!Y/2E'=KR7YV0Y='YO\
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M4D7:ZI(&7T/F-D53\23R>%?B#;^*[FVN)M'GTXV-U+!&TAM2K[U=E&3M/()
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MQZH)!:76E/(51T7<4</SDC/(J;7/^2M^$_\ KSOOY1T>+O\ D?/ W_7W<_\
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M7/B++9G69]!T4:2\7F_8$N)/MH0C/WB/++8YV\>F:O?"5@WPOT1AG!C<C/\
MUT:J%G\5-%N+!=,2VU#_ (2(0!&TC[%+YHDQC!.W:!G^(D#'-:'PG5T^&.BI
M(NUU20,OH?,;(JOYK;:?F_O,VW[M]]?R1VE%%%24%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% %'6;>6[T/4+:!=\LMM(B+D#+%2 ,FJ7@^PN=*\&:+I][%Y5U;64
M44J;@VU@H!&02#SZ5MT4+2_]?UN 4444 %%%% '$^,&\8ZM+<^'M&T>&WT^[
MB$<FM2WB_NU88<+$/FW8R <XKJ]+TZWTC2K33K1-MO:Q+%&/8#%6Z*%HK ]6
M0W=I!?V<]I=1K+!.ACD1AD,I&"#6?X;T>;0-#M]+EOFO4MLI#*Z;6$0/R*W)
MR0,#/&<=*UJ* "BBB@ HHHH **** "BD9E12S,%4#)). !4=K=6][:QW-I/%
M<6\J[HY8G#HX]01P10!+1110 4444 %5=2GN[73+F>PLOMMW'&6BMO-$?FMV
M7<>%SZFK5% '$>'=)U[5?%+>*O$]A#ITT-N;6PTZ.<3F!2<N[.."S8 X[5TM
MUH=I>:[8:O/O:XL$D2!<C8I? +8QG=@8!ST)K2HIWVMT#N%%%%( HHHH ***
M* "BBB@ HHHH \_U.S\5>'_&6IZ]H^A6WB"'48X8Q&UZMM-;; 05!<$%"><#
MG)I]AIOB;Q)XHTG7-?TFST2#2_-:*VCN1<SR.ZE,,Z@*%P2<#/:N]HH6EO+_
M (/^8/7Y_P!?H%%%% !1110 4444 %%%% !1110!E^(M*FUS0KK3(;UK+[2O
MER3(FYA&3\P7D8)&1GMG.#4,_A;3)[;1[4QLEKI,J36T"$;-R*57<".<9SVY
M K:HH6@!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <O\0](OM=\%W>GZ;!Y
M]U))"RQ[U7(656/+$#H#73C@"EHHZ6!A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %5=2TVTU?3+G3K^+SK2YC,<L>XKN4]1D$$?A5JBC<#Q3Q/\*_!>G>+
M/"=E:Z-Y=O?W4L=RGVJ8^8JQ%@,E\CD=L5WMIH'A;X8:'JNJZ7IDEM;K%YUR
ML4KRLX0'&/,8C/)[BJ?C3_D>O G_ %_3_P#HDUH_$G_DFOB/_KPE_P#0:+M0
MNN[_ #0[)R2?E^HZQ\=:?JNN0Z;IMAJMY$Y96U"&T)M(F49*M*2!GC'&>>*K
MZU\0K/1]2EL8]#\0ZG) <3OIVFO(D1P#RQP#P>V:W-!@AL?#6G001B.&*TC"
MHHP  HK@-+U/QCXXT5]?L_%>G^&]-\V0)$EBES(J*2O[UI&P#QG@=Q3EHVET
M_P R8ZQ3[_Y'9_\ "8Z1)X-F\56\DMQIL4+S-Y:8?"YW#:V,$$$8.*PKKXL:
M+!B>#2]>O=- W2:G::>SVL8[DOD9 [D BN3T5_-_9\\2R&Z%V7-^WV@($$N7
M;Y]HX&>N.V:]1TVWA@\(6EO'&JPK8H@0#@#8.*4M$WVM^5QQU:7>_P"=A+SQ
M1I%EX=37I;L-ITB(\4D:%C)OQM"J!DDY QBLG1/B!;:SJD>GR>'_ !'IDDQ(
MBDU'36BCDP"3A@2!P.^.M9/@O0K7Q'\&M#T^[>:-3"DD<L+;7B=')5E/J"!5
ML:MXA\*ZYI.FZU?VFL66I7'V:&X6+R+J-\$@N@)5UP,$@+CKBJ:2FU]Q*=XW
M-CQ)XOM?#<D4+:;JVHW4J[UM]-LFG?;G&<\*/Q-2>&?%NG>*8;@V<=W;W-JP
M2YM+R Q30,1D!E/MZ9KFKG5_$_BCQ7K>AZ#J]CHD&E&..2=[87-Q(S*&W*C$
M*%[<Y[UF_#O[9_PGWC**ZU^/7+N*&UC>]2W2$%@'^7:AQQTS4QV=^S9;\O)'
M0:G\3-*LM1GL;'2M<UN6V<QW+:38F=(''\+-D#/TSTJAXL^(\FC7_AZ.RT?6
MKF.^D$LRP:>S.\9C8B-=V 7S@D Y !SBIOA#-;CP+'9[T&H6MQ.E_'D;UF\Q
MLEN^3QU[5+XTGB7Q5X&F,J"(ZE( ^X8.87 Y]Z=K-+T_(3>[[7#6]8TO6?#>
MBZCJNGZY81RZK;B&WDC$$Z2B3">8I/W">3SG!!%=!XB\3Z;X8M(IK]Y6>9_+
M@M[>(R2S/C.U%')/Z5@_$S_D%Z'_ -AVR_\ 1E0:W-%9?&'P_<Z@RI:S:=/;
MVLDG"BX+*2,] 2HXH6NBTU?Y)@]-?+]30T/XAZ9K.IQZ9<6&K:-?S!C!;ZM9
MFW:8#KL.2#],YX/%3:WX]T;0-:.D7@NFO3;K/%%!"96GW,5VHJY8M\I)XP!W
MK(^)<T,D_ABP@(;5GUFWEMD5AO55),C8_NA<Y^M/6".3XZ/*R O'H"[">V9S
MFA:V^?X*X/2_HOSL7_#WQ TWQ!JATI]/U;2=1\LRI:ZI:&!Y$&,LO)!'/KFN
MLKA_%"@?$WP.V/FW7HS[>2.*[BCHGZ_@#T=O0Y/7?'UIHFH26,>B>(-5N(L>
M<--TYY5CR 1EC@=".A-7K;QAI-[X2N/$EJ\LUC;Q222*(]L@\O.Y=K8PPP>#
M7'Z?J7C#QO:WFIZ=XFT_P[IT%U+"B)9+<RA4)4F4NP5<]>!TQ63X4D,OP<\;
MR-?+?LUQJ!-VL803G9]\*. #UP/6I;M!OK:_]?>4DG.*[NQU$WQ8T58X[BST
MK7M1L2H:6]LM/:2"'H3N?(''?;G&#75VVNZ9=:"FN17D?]FM#YXN&^50F,DG
M/2J?A"WB@\#:+#&@6,:?"-H'J@S7F<<4TG[-<B0!BJ&1I%7KY2W)+C_OD&KF
MK.4>W^=B(>\HR[_Y7.H?XI:->VL__$LURWTZ2%A%JMQI[):/D8!\SL#GJ0!6
MK\,O^29^'O\ KR2KFJZGHQ\"W5\]Q;MI+V+$.&!1D*' '8^F*I_#'_DF?A[_
M *\DHVYEZ?J+?E?K^2(O'VLZE:KI.AZ),(-3UJY^SI<$9\B-1ND<#N0.GUJD
MOP<\(N8Y[R'4+S45 _XF$^H3><6'\60P /X4WXBM_8^M^%O%<J.UEI=U)'>,
MHSY<<J;=Y'H#C-=S;WUI=V:WEO<PRVSKO69'!0KUSGIBI7PW\W_P"WNEY?YW
M,G5-:TKP7HEK]ON+AHUVV\"X:>>=\8  &69CBLS1OB+IFJZE#IUUINLZ+=W!
M(MX]7LC!YY'9#D@GVSFJ/B>XM[3XG^$+Z^=%L&AN889G/R+.P7;ST!*@@4?%
M26&32-)L8F5M5GU2V-DBD;PRR LP'H%W9/O36K3?5V_&W_!)>B:717_!O_@&
MWKGC;2/#VK1Z9??:3=36YGACAA,C38;;L15^9FYS@#H"<\5DVGQ6T"1I8=0M
MM6TB]10R66HV31SS@G \M!G>2>,#G\*+R*.3XV:6[H&:/1)V0G^$^:HS^1/Y
MTGB"WAE^+WA!Y(U9DM+UE)'(("#/ZG\Z25[7ZW_7_(<M+^5OT_S+F@_$+3=;
MUD:1+INL:3?NC20PZK9F SJ.I3DYQ^!JQK7CO1]!UAM)NUNWOOLZW$4-O"97
MG#,R[8U7YF;Y23Q@#O6=XN5?^$_\"MM&X7=R <<X\AJI3WEA:_'R&.[DC2>?
M0A';%R!EO.8E1[D _D::5[?/\!O2[]'][-OP[X]TSQ#J#::UEJ>E:D$,BV>J
M6I@D=!U91D@C\<U+XC\9VGAVY2T_LO6=3NV02>1IEB\[!"2,D\*.A[YK&\7S
MV\_Q#\%V5LZOJ4-U+/(J'YHX/*8,6] 3CKUQ5=]5\5>+?$.N:;HFM6.@VFE3
MBW:5K47-Q(V Q;:Q"JO.!U[TMTK>?X6_S%LW?R_&_P#D=5X:\4Z=XILYI[%;
MF&2WD\JXMKJ$Q30/@':RGH>>V16!)\5-'9)5L-,UO5+J&:2&:UT^R,TD11RN
MYL':H)&1DY((XK*^%K3GQ5XT6ZUJ/6ITN+=)+Z.%8A(PC(/RKP,=./2M;X60
M1Q:!JDB( \NLWK.0.6(E(_D!3M?[D_Q%?\[?@7X/B!H]WX2OO$5K%>S06!(N
MK80[9X67&Y61B.0#D\] >M="NH6K:8-1$R_9##Y_FYXV8SG/IBN.\*V\4_C'
MQ];2HK0RW<"NA'#!K=<_G7+27-U;^$9?AT)&.HMJ(TF)SU^QO^\$G3G$65^H
MI;K3=VM\]']V_H/1;[)N_P#7X>MCU'0=9A\0Z':ZM;P3PP72>9&LX ?;G@D
MD<CD<]#6E5)9=/T>"RLFGM[5#MM[:-W";R!PJ@]3@=!Z5=INU]-A*]M0HHHI
M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHD_<DY9&0#?NXZ]/UJ;Z7?:Y36MO.QZ;5'6M5@T+1;S5;E)7@M(FED6%=SD
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M_%V%-JS?K847=+T/2:*X;QCXCUJTU#PM#X=:!SJTLD96<9C*F/<K$@9POWL
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MW^H^$OB#KK3^'-7U"RUJ>"2WNM.@$JQE4",).1L /.3VKT>BFM&OZW$U>_\
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MJ:Z^BFG:WE_G<.K??_*QQ7BJQN[CX@^";F"UGEM[::Z,\J1EEB!BP-Q'"Y/
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M^)UG=:A\.]5M;*VFN;AQ'LBA0N[8D4G ')X%==13;N_G?\4_T"/NV\E;\_\
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M85 #@=23G@=:HVWQ-O)+J;19_"6H1>*(U#KI:3(ZNA_C\_A G0$GN< &A:[
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MN1CS@Y7&>:Q$^(FN:A80:IHG@6_O]*>,2/<M=QPL1C)\N-OF<#G' SCCK0]
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M8Z5:-=ZC>6]G;*0&FN)5C0$\#+,0*RX?&OA2XF2&'Q/HLDLC!41+^(LQ/
M;DUA?%OR/^$''VKR_L_]H6GF^;C9M\Y<[L\8QUS3K)?A6]_;K8+X-:\,B^0(
M!:F3?GY=N.<YZ8HCJ#T.XHKD=>\:75GJ\FB^'] N-=U2&-99XHYT@B@5N@>1
MN Q&2!BI_#GC!M7U&;2-4TFXT;6H8A,UG.ZR!XR<;D=>&&>.U"UV!Z'3T5PU
MS\0;EM8U;1=(\.W&J:M83^6((IUC0IL5O,>1@ @)8@#DG!]\=C837-QI]O->
M6HM;EXU:6W$@D\IB.5W#AL'C(HMI<.MBQ117&ZQX[ET_Q3=>'+'0KG4M22TC
MN;>.&55$@8L#N9@%C5<+R2<[N!0!V5%<AX?\:W5_K0T/7] N-"U9XC-#%).D
M\<R \[)%X)'&1[UJ:/X@_M77==TS[+Y7]E31Q>9YF[S=\8?.,#;C..IIV%<V
MZ*Q%\0[O&\GAO[+]S3UO?M'F=<N4V[<>V<Y_"L&Y^(-RVL:MHND>';C5-6L)
M_+$$4ZQH4V*WF/(P 0$L0!R3@^^$,[FBN.UGQU)H%QH5I?Z)<-?:K!(PM;:0
M2NDRA3Y0. &^\?FR ,9J"R\>:G!J]K8^*/"ESH<=[+Y-I<_:X[F-W/16*?<)
MQP.:=M; ]%<[BBN7\1>+Y-*U*/1](T>XUK69(C.+2&18ECCSC=)(W"@G@=<U
M%H'C2XOM871->T*XT+5Y(C-##),LT<R@\[)%X)'!(XZTEKL#T.MHKB=3\;:R
M=6O+#PSX2GUO[#((;J9KZ*U1'*AMJ[\EC@C/ K:'B6.U\*R:[K-E<:4D*LTM
MO/M:1<'  VD@DG&,=<BCI<=M;&Y17 -\0M9L3]OUGP3?Z=H!QF_:ZBDDC!P
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M+25;R.87 *\MM493L<'^][4TM7?I_7]=Q-Z*W7^OZ[';4444AA1110 4444
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MSM=/MEMK*VAMH%R5BAC"*,G)P!QU)-5*5Y2EW_S;_4B*M!1[?Y6)ZXGXF?\
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M/GO$QMN);5&D7'3#$9%6+[3;'5+0VNH65M=VQP3#<1+(AQTX((JW)N7-UO\
MY_YDJ*2Y>G_#?Y'->*)/!NL6-A<ZIK]E9D[I-/U"'4E@D7LS12!N1TSU'3-9
MW@_Q'-/XKO-"B\0P>(]-AM!<KJ$80O V['ER/'\C$C)! !X.:ZZX\.Z)>6$-
MC<Z/I\]G  (K>6V1HX\=-JD8'X58L-,L-*MA;:=8VUG;@DB*WB6-0?HH I+2
M_P#7]?(;U17T37]+\1V!OM(O$NK82-$9%!&&4X(P0#6E4%I8VFGP>196L%M#
MN+>7#&$7<3DG [D\U/2 **** .(^*T4<W@R.*5%DC?4;-61QD,#,F01W%;=O
MX,\+6EQ'<6WAK1H9XF#QR1V,2LC#H00N0:U;JSM;Z$0W=M#<1!E<),@<!@<@
MX/<$9!J>A:+^NP/5_P!=SSC3-9T_PG\0O$]KK]U#IXU.6*\L[FZ<1QS((PC*
M'.!E2.A]:?;:E9^*?BS87NB3QW=EI6GS1W5Y VZ)GD*[8PPX8C:6XKNM0TRP
MU:V-MJ-C;7D!.3%<1+(OY,"*?9V-IIULMM8VL%M;IPL4$815^@'%"TM?I_P5
M^H-7O;K_ ,#_ "./\%HH\8^.7"C<=2B!/? @3_$UV]00V=K;33S06T,4MPP>
M9XT"F1@,98CJ< #)J>CHEY"ZL*\TN/$.F:!\:]0.JSI:07.DV\:W4QVQHP=R
M%9CPN1G&2/NUZ77%Q:2UU\3M<DO=/,VG7&DV\6Z:'=#(0\F5R1@G!&1[T+XO
MO_(;V^[\S+O=:TWQ7\4/#4.A74-^NE+<7-Y<VSAXXU=-BKO'!)/;VHTGQ!I/
MAWXC^,+76M1M=.>[DM[FW:[E6)94\H*2&; ."#Q7>Z?I6G:1;_9]-L+6RASG
MR[:%8USZX4 5'J6B:3K*HNJ:797RH<H+JW24*?;<#BGM:WG^-O\ ('KOY?A?
M_-G":#KMCX@^-%_<Z;*+BTBT58EN$'[N4B;)*-T8 G&1QD&M/P6BCQCXY<*-
MQU*($]\"!/\ $UU\5A9PSK/%:01RI'Y*R)& P3.=H./NYYQTI8;.UMIIYH+:
M&*6X8/,\:!3(P&,L1U. !DT+2WHU^-Q--_>OP5CS[Q[J]IH?Q%\%ZA?96UC6
M\$LNTD1!D0;SCH 2,GMFH_''B71O$L>C^']"U&UU/4+K4K>4"SE640I&X=W8
MJ2%  _6MOQ!87%S\1_"=PMI++:0Q7JSR",LB;D4 ,>@SSC/6NBT_0](TF263
M3=*L;)Y3F1K:W2,O]2H&:([*_1M_B.6K=NR_)G%2ZG9^%/BOJEUKEPEG9ZO9
M0"TNYR%B#1;@T9<\*>0>>M,O]8T_Q9\2?#,.@7,%^NE&:ZO+NV??'$C(45-Z
M\$L3TSVKO[RQM-1MFMKZU@NK=_O13QAU;Z@\4VPTRPTJV%MIUC;6< .1%;Q+
M&OY* *(Z6OT_X/\ F#UOY_\  _R.(\0Q^$HM<NKRW\:V_AW7.!<&'4(E\P@8
M'FPN2K$#'4 ].:Q-;O-5\;_!F[N&#7$UO>9,U@I0W4,,HS+$#G!*@D>XKT>]
M\+^']3N_M=_H6F75SP/.GM(Y'_,C-:B(L:!$4*JC 4#  J5M;^M[AU_KM8\3
M;2O FJ:06N?BYX@EM;B/Y[>XU^/<RGJK1LN?P(KO?$MAX2&F:9:ZWK,6FR6\
M>+"\>_6UN$PH4LCY&>,9XQTR*V_^$9T#^T?[1_L/3?MV<_:?LD?F9QC.[&>G
M%6-1T?3-8B6+5-.L[Z-3E4NH%E /J P--[: M[G&^#O$4]QXLO-!A\00^)-.
MBM!<)?QA"\#%MOE2/'\CDC)! !X.:[^JMAIEAI5L+;3K*VL[<'(BMXEC4'Z*
M *M4V(P?&VG7.K^"-:T^S&ZYN+.1(U!^\Q7@?CTK$T+XC^$4\*VDMSK5C92V
M]NL<UG/*L<T3J,,GEGYL@C' KN:S9_#VBW.H+J%QH^GRWJ?=N9+9&D'T8C/<
MTNZ[C['G-A:W$'P+\27%Q ]N+Z.^O(87!!CBD+,HQVXY_&O0?"G_ ")^B_\
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M'B[0_%_PF\27.A7WVN&&(1R-Y3Q[6RIQAU':ME_BAX*T^]BTJZ\0VJ784*P
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M**\C0X<*"K)]58!AT[CF@#9HHKSJYUS2_#WQ3UZ_U>^AL[5=(M09)3C)WR<
M=2?8<T=0Z'HM%8'AOQMX<\7"7^PM5BNVB^^FUD=1Z[6 ./?&*3Q'XX\->$RB
MZYJ\%I(X#+%AGD(Z9V*"V.#SC'%#TW!:['045BV7B[0=2\/S:[9:E'<Z; C/
M++$K,4 &3E0-P('.,9]JT[.\M[^R@O+642V\\:R1R#HRD9!_*FU8">BLBW\4
M:)<Z-/JZ:C$NG0.\<ES+F- 5.UN6 R,\9'![51\/_$'PIXHO9++1M9AN;E,D
MQ%6C8@=2H8#</IFEY ]-SI:*** "BJ.FZQ8:O]K%C.9#:7#6TX*,A21<97#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=?Z_K8#6HHJM)?VL6H06#S 74Z/)%'@Y95QN/X;A^= %FBBB@ HHHH ****
M"BBJT>H6LVH3V$<P:ZMT226, _*K[MISTYVM^5 %FBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **KPW]M<7MS9Q2AI[;;YR 'Y-PROMR!52'4[J
M3Q'=:8^F3QVL-O',E\3^[E9B04''48!Z]^W&0#3HHHH **** "BBB@ HHHH
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MD6P?=+1;2Y(&,@4WV\E;\1>?F_T+?AR\NK[X=>(I+NYFN)%N=1C5I7+D*K.
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M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*D$@]<4_P'8?"JX\20W7@VPN)+Z!7(N56[\N+(P03(=N2#TYZTH:[^?Z_P#
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M=^G2LW0]5^(5UX3TF\T31]$CTZ.SCVPZA/)]IN%51RNP;4W8.,D]1GTK1O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45!:WEK?1M):7,-Q&KM&S1.' 93@J2.X/
M!%3T <OJ&D7T_P 2-%U:.#=8VUC<PRR[U&UW*;1C.3G!Z"NHJ*YN;>RMI+FZ
MGB@MXE+22RN%5 .I)/ %/1UD171@R,,JRG((]11TM_7<.MQU%%% !1110 45
M1O\ 6])TN:&+4-3LK26<XB2XN%C,A]%!(S^%7@<C(Z4 %%%% !1110 4444
M%%%01WEK+=S6D=S"]S"%:6%9 7C#?=++U .#C/7% $]%%% &;8:'::=JNIZE
M%O:ZU%T>9W(. BA55>.%&"<<\DUI444 %%%% !1110 45!<7MK9F$7-S# 9Y
M!%$)9 OF.>BKGJ3@\"IZ "BBB@ HHHH **** "BBB@ HHHH **"<#)Z51L=;
MTG5)YH-/U.RNY8#B:.WN$D:,]/F )Q^- %ZBBB@ HHHH **** "BBB@ HHHH
M ***@N;RULD1[NYA@6218D,L@4,[' 49ZDGH* )Z*** "BBB@ HHHH ****
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MUR\R[?YV_P"&"G[SC?J[6_K\3?F^+&BK''<6>E:]J-B5#2WMEI[200]"=SY
MX[[<XP:Z.3Q3HT7AA?$;7@.EM$LJS*I)8-P %QG)) QC.:C\(6\4'@;188T"
MQC3X1M ]4&:Y3P%H=IXA^#MGI5YYBP2/+AHFVO&5G8JRGL00"/I525G**Z?Y
MM$0=XQEW_P KFQI'Q#M=5U6*P?P]XDT\S-MAGOM-:.*0^S G'XXJS9G2_P#A
M9&J+%]M_M3^SH#-N8>1Y>]]NT9SNSG/;ICO65+J?B+P=J6EVVK:E:ZUIM_=+
M:1RM$(+N-F/RDA?ED [D!3WJ?3O^2R:Y_P!@BU_]&24ENK>?Y#=TG\OS.8\(
M>.++0-(O[*/3-8U:\75KQI(-*LS.T2F9L%SD!<XZ9S[5Z'H7B72_%.E2WFG2
MNT:,T4T4B&.2)QU5E/(-<K\)KRPDTW7;6"2/[9%K-VUP@/S<R':Q'IC S[5)
MX5EAO/B!XWN[!E>Q/V:)I(VRCSK&V_'N 5!J7\/_ &[?\$-;M^?ZLHW3Z9)^
MS_J#Z/\ ;/L!TZ?ROMK!I<9;.X@D=<_A6UJ)TL?\(3]O^V_:#<(+/[.P"^9Y
M#?ZS)^[C/3G..V:Y;3_^39[C_L&W'_H3UM^(?^/GX=?]?Z?^D[UI;WK>:_)D
MO;Y2_,9XC^(\^B>.[72(=#UV^MEMI7F2RT\NTKY7:4SC<J\Y(.,L.M=+H_BR
MTUC59-,^QWUC>I:17GDWL0C8QR>@#$Y4\,#T/K6/J4B1_&30P[JI?2;E4R<;
MCOC.![X%.\:Q'2-:T/Q;$"%LYOLE\0.MM*0N3_NOM;\ZF.ROUO\ FU^=BI;N
MW1+\K_YF_=>(+2V\26.@^7-+>7<4DX\L*5BC3&6?)! )( P#S6E/,+>WDF97
M98U+%8T+L<#. HY)]A7&>#E&M^)_$'BI@#&\O]FV1Z_N820Q'LTA;\A7;TNB
M_K^M+!U?]>IXGH&KZ/XC^(FNR:MX*U;499[V*WM[BZTL2)91J@ #[_\ 5<Y;
MIG!%>@:]\0-,T/4FTR&PU;5]0B56FM=)LS.\*GH7Y &?3.?:J7@7_D:O'/\
MV%5_]%+47P[FBAU?Q=I]RRKJHUB6>1&/SM$P'EM[KMX%-:I+RN#W;\['1^'/
M%6F>*+>9[!IDFMV"7%K<Q&*:!B,X=#R/Y5CW/Q,TB(3QVUAJ^H7L-Q+ ]E86
MAFF'EMM+D X"YZ$D9]*IZ9+%>?&O5IM/97@@TB*&]>,@KY_F$H#_ +07-/\
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M'!MO;F-(II=['<J9VC&<#&3T%9-WX#\+WWB.'Q!<:1"VJPN)%N%9E)8="0"
MQ&!R0:Z.BEY@%9&N>&-&\2&S.KV"77V.83P;F8;''?@C(]CD'TK7HH 0J&4J
MP!!&"#WKC)?A+X$FU(W[^'+7SR=Q =Q'G_KF&V?I7:44=;AY%"[T73[Z73Y;
MBV#-I\OFVN&*B-MI7. 0#P2,'(JU<6\5W;2VTZ[XI4*.N2,J1@C(J6BAZZ,%
MIL9%QX8T>Z\,KX<FL]VDK$D(M_-<?(N-HW [N,#O5C5-&T_6M+;3=0M_.M&*
MDQ[V7.TAEY!!X('>K]%.[W I:II&G:WI[V&J6<-W:O@F*9=PR.A]C[UE>&_
MGAGPC+-+H6E):23#:[^8\C$>F78G''2NBHI; <D/AAX*&M_VQ_PCUK]MW[\Y
M;9N]?+SLS^%;UKHFFV>F2Z;#:(+*9I&DA;+JQD8L^<YX)8\=.:OT4=+= ZW.
M<T7P%X8\/1ZA'I6E);)J"[+D+*YWKSP,L=HY/3%:UOI&GVNC1:/':H=/CA$"
MP29=?+ P%.[.1CUJ[11OH!R6F_#'P7I&K?VG9>'[:.[#;U<L[JASG*JQ*J?H
M!BN@OM(L=2N;&XNX/,EL9O/MVWL-C[2N>#SP3P<BKM% %+5M(L=<L#9:C!YU
MN720IO9?F5@RG*D'@@&KM%% &;KGA_2O$NFMI^L6,5W:L<['R,'U!&"#SU!S
M5.W\&>'[31;/1X-/"6%G<+<P1"5_DD5MP;.[)YYY)%;U%"TV J:IIEGK.F7&
MG7\/G6EPACECW%=RGMD$$?@:6ZTVROM.;3[NUBGLW38T,J[E*^A!JU10!R.D
M_"_P7H>J+J6GZ#!%=JVY)&D>38<YRH9B%/T KH!I%B-;;61!_P 3!K<6QFWM
M_JPV[;C..ISG&:O447"Q#=VEM?VDMI>01SV\JE9(I5#*P/8@]:Y73OA7X(TK
M55U*S\/P)=*^]&:1W5&SD%59BH((XP..U=A10M'=!TL9>N^'-'\36/V/6=/A
MO(,DA9!RIQC*L.5/N"*J^'/!?AWPDCKH>E0VAD&'<%G=AUP68EL>V:WJ*%IL
M#U*#:+I[:\FMFW_XF*6YM5FWMQ&6W%=N<=>^,TR7P_I4WB"#7I+-&U2"$P1W
M!)RJ'DC&<=SSC/)]:TJ* "J4&D6-MJUWJD,&V]O$1)Y=['>J9VC!.!C)Z"KM
M% %'3=(L='6Y6P@\D7-P]S-\[-ND<Y9N2<9]!Q1;:18V>JWNIP0;+R^""XDW
ML=^P87@G P#V J]10 5SDG@/PQ+XGC\2-I$0U>-MXN%=URW]XJ#M)YZD9KHZ
M*.MPZ6*6GZ18Z7+>RV<'E/>SFXN#O9M\A !/).. .!@40Z38P:O<ZK'!MO;F
M-(II=['<J9VC&<#&3T%7:* .2G^&'@JYUO\ MB;P_:O>E]Y;+;&;U,>=A//<
M5T-CI-CIMO-;VENL<,TKS2)DD,SG+'GU)Z=*N44=+!UN<[H?@7PSX:U2XU+1
MM)BL[JX79(\;OC;G. I.%&0.@%="0&4@]",&EHHW5@\REI.DV.AZ7#INFP>1
M:0 B./>S;<DD\L2>I/>J'B+P=X?\60I'KFEPWFSA';*NHSG =2& X[&MRBAZ
M[@M#D?\ A%K+P7X4U;_A"]'A@U V[M$HR[22 $J"S$EN2< FO+T7X,W;)_;=
MM?3>()@&NH98;Q)WF(RV40!02?3 YKWZBCK=ATT.%\#:*][X%FT[7K&XDT^>
MYE-K::F2\J6Q;,:OGD$=0#R.*N:=\+_!>DV]S!9:##&MRNV5FDD=R,@X#,Q9
M1D#H1TKKJ*=];BMI8HW>D6-]?V%[<P;[BP=GMGWL/+++M)P#@\''.:NNBR(R
M.H96&"I&012T4O(9R5G\,/!5AJYU2V\/6L=WG(.6**?54)VJ?< 4NM>#(;[1
M]$T.Q6.WTBRNXIIH69F+11Y94!.<Y;;G)Z9KK**:=K %9VN:#IGB329=+U>U
M%S9RE2\9=ER0<CE2".1ZUHT4@*=QI5C=:/)I,UNK6$D/V=H<D QXQMXYZ4FD
M:38Z%I5OIFF6XM[.W7;%$&)VC.>I))Y/>KM% 6.2UGX8>#-?U$W^I:#!)=,<
MM(CO%O/JP1@&/US726&GVFEV,5E86T5M:PC;'%$NU5'L*LT4+160/5W"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH Y?P)J]]K.B7=QJ$_G2QZC=0*VQ5PB2E5' '0#KUKJ*\?\
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M6:6ST2)F,TCL1^]*LIV #@9ZDT> 9FL/&D5AH/AOQ1I'AV:U<SV^KVTBQ13
M@JT;,S8SR",\\4HZ_P!?UV%+3^OZ[GKM%>#ZCJNG>*O$6MMXE\+>+=>M;6^>
MULX=,@D:UA6/Y<_(ZYD)R3GL171^$+S47\,^+K&;3M<M-)MX6;31K4+),J-&
MVY,G.X*PXY. 12O[KEY7+M[W+YV/5:*\H\*?#/1/$?@C1-0\0->ZA?O9QO%,
MUY(GV<%1M$:JP48 7L<D9-=/\,KN[NO!,"WMS)<S6T\]KYTIR[K'(RJ6/<X
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MQ[UT]%5)\U[]582TV[W.)\&Z%XN\/PIHVHWFCW6AVMN8;66&.1;IL?=W@_(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M11'3^N]_\PEK_78*\IT#5M=\&2Z^]]X5U>_TZ\U>YGMGTZ 22KE\?-&2IVG
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M2]X=U+6=3MYY=8T!M&=9-L,;7:3M(F/O'9POTR:%J#T-FBBB@ HHHH ****
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M@A7.V.) JC)R< <=235.'P_HMOJ,FH0Z181WT@(>Y2V02,#URP&31/WKKO\
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MZ$'@TEIMW_2P]_NM^-SS3QGXHT36M>\(6>DW]MJ,D>M0RR26D@E2(88#<RY
M))X&<G!]*H>-M,M8OBDEYK7B'6- T^^T](;>_L+L6R>:C,3'(^"!P<C..]>G
MVV@:-9VT=O:Z380012B:.**V1520=&  P&]^M6[NSM;^V>VO+:&X@<8>*9 Z
ML/0@\&C:WS_%)"W>O9?@[GG?A/0_"B>+X+W3_'>I>(=3@MY D5SJJ782-L!C
M\JY'.._I47A[Q3HVA_$+QI9ZM>0:>9KV.2*>Z<1QR8A0%0YP,C@XS_%7H.FZ
M)I.C(R:7IEE8HYRRVMNL0)]]H'H*Y70=!CO->\91ZQI*3V=SJ,<D2WEN&CE
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 55U+3K35]-N=.O
MHO-M+F,QRQ[BNY3U&001^%6J* &0Q)!!'#$NV.-0JC.< # JKJVD6.NZ=)I^
MI0>?:R%6:/>RY*L&'*D'J!5VBCS!:!THHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MK"\1>,_#OA1%;6]6@M&<96,Y:1AG&0B@L1^%-\/>-O#?BO(T35[>[=1N,0RD
M@&<9V, V/?%"UV!Z;F_1110 4444 %%5[V^M--LY;R^N8K:VB&YY97"JH]R:
MY.T^+7@2]OS90^([83 E<R(\:$YQP[*%/YT+5V#I<[2BD!#*&4@@C(([TM !
M15>^O;;3;">^O)1%;6\9DED(.%4#)/%.M+J"^LX;NVD$MO.BR1NO1E(R#^5
M$U%%4M1U?3]):T6^N4@-Y.MM!N!^>1LX48^AH NT444 %%%% !1110 45EZ#
MKUKXALIKNTCF2.*YEMF$H .Z-BI(P3QD<5J4 %%%% !1110 4444 %%%% !1
M110 4444 %%%96GZ_:ZEK>JZ5#',L^F-&LS. %8NNX;2#D\=<@4 :M%%9>F:
M]:ZMJ.JV,$<RRZ9.L$QD  9B@;*X)R,$=<4 :E%%% !1110 4444 %%%4]5U
M*'1](O-3N%=H;2%YY%C +%5!)QD@9X]:3=M6-)MV1<HJMI]['J6FVM]"KK%<
MQ+,@< , P!&<=^:LU333LR4TU=!1112&%%%% !1110 445EVFO6MYXAU'1(X
MYA<V$<4DK,!L(DSMVG.<_*<Y H U**** "BBLO2->M=:N-3AMHYD;3KMK28R
M  ,X4-E<$Y&&'7'TH U***I7>KV%A?V-C=7*QW5\S);1D',A4;B!]!ZT 7:*
M** "BBB@ HK+U_7K7P[IRWUW',\33Q0 0@$[I'"@\D<9/-:E !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+K5WK>H>'O$MC9V^JV<23B6QD9H9XW) 90WS+@C&#4/@L?\ %7>.#_U$H_\
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M1.+.\GD^URKC/!4;$)'0$G'>L:#_ )(EXR_Z^-2_]&M7IED,>&;8#_GS7_T
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MUMT+S36<T<:CNQ0@#\ZX;POKFE>+O $G@VUN)H=9AT?[+<V\UO)&8&V;.25
MZ]@<U-VE*V__  Y=D^6^U_\ (LVOB#XAZ];0ZSHNCZ#!I$R^9#;W\\OVJ:/L
MV5&Q-PP0#G%=5X5\1Q>*-#34$MWMI5=X;BWD.6AE0X921UP>]<9HGQ,T;P_H
M>GZ)XACOK#7+6!;=K$V<KM,R#:#&54JP;''-;GPXTR^LM#OK[4;9K6XU74)M
M0^S. &A5R-JL!WP 3]:NRN[;='\_\ON,[O2^C[?U_3.QHHHJ2@HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:<&,OD9 "L V< \8S7 RIXS\<:/8:9<^$;30K,203C4&ODD**C*W[J-5W*Q
MXSC'0UU'BKQ#=V^N:=X?TC1K?4M5N(WNE-W*(XH$3C>3@DG)Q@#/-)JVG6X)
MW=^EB[X<\=^&/%LDD6AZO%=2QC+1;6C?''.UP"1R.0,4WQ'X^\+>$YT@UO6(
M;:=QD1!&D?'8E4!(''4UQ$/_  E2_%[PP?%']@"=[:[$9TGS=S)M&1)YG;.,
M8]ZLSSZ_X<^(^OMH/A^W\1/J$<-S,!=K;2VHV[ K,XP0=I( YZT=OG^ ^_E;
M\3K/#GQ!\+^+;V2TT/4FNYHD\QP+:5 JYQRS*!^&<U%J?Q+\&Z/JPTN^U^UB
MO-VUD 9PA]&9057\2*HZ!H^M:'X<\2W]U%;V^HZA)->165H^Y+=O+PJ@XY8E
M<D@=37(^"+7XA3>!; :1'X(ETVYAW'[2+EI)2?O>;C@OG.?>D_+HE^(=/F>R
MQ2QS1)+$ZO&X#*ZG(8'H0:=7,^ ="U+PUX/M-)U66WDN8&DYMF9HU4N2JJ6
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M8B\UK4(;. G"E\DN?15&2Q]@*P/BE:V+?#?5I+A$1K6#S+5P #'*"-FWT.[
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MN)4ABDP2K._W1D=CZ]*\SUFZ\=ZEX,O;N+1O">F:'/9/+);7DLLDOEE2V<H
M@.,?C46M6T>I?!OP3:W0\R*XN--CD#'.Y3@$?E347L][I?>'FMM?P5SL;?XH
M^";K6!I4/B*U:[+;%&&",>P$A&PGGL:V]<\0Z1X:T\WVLW\-G;@X#2'ECC.%
M Y8^P!-<]\3["T_X5=K,0MX@EO;>9"H0 1LI!4KZ8]JLZYX>O-:M]$U/3KR&
M#5=-_>P&YB,L3[D 8. 0?Q!R*73YAU+7AOQSX:\7-(FAZK%=R1#+Q[&1P..=
MK@''(YQBJVN?$GP?X;U#[!JNN00W0.&B1'E9#Q][8#MZCKBFZ/XBNSXA;1_$
M&CPV&K&W::&XMI?.AN(E(#;6(#+@D?*1[U@V/B#QCXJM9=5\):-X>L]-GD=5
MN-6DD,ERJG;N*QCCD'[Q/ H?D"\ST&QO[/4K&*]L;F*XM95W)-$P96'L:YD_
M%'P4-:32!X@MWO7<1JL:.Z%O3>%*Y[=:X32Y[VW_ &??$+P&(7"37BG[(2(U
M4RD/Y?<* 6Q[5ZMH%AIUGX=L+73X(5LE@0Q*@&TC (/N>^:=M;]-/Q5Q=/O_
M  =CDM:^+GAK0?&/]C7VI0QVT5NYN)5BDE*3[@%C^0''&\GCTZ5MW-_:7?B7
MPW/#KMQ"MU!-+!9)$VR]4HIW,<?+M!!&<'FLYS_Q>^+_ +%]O_1XH\1?\E4\
M&?\ 7*^_] 6B/V;];_\ MW^0Y:<UNW^1M>(_&7A[PE$CZYJL-GYG*(07=AG&
M0B@L1[XJ?0/$VB^*+(W>BZC#>0J0&,9(9">S*<%3]17,>%$AN?B5XRN+L*^H
MP300PE^6CM_+!&WT!8L3CO274<-I\;-,-BJI+=Z7.;]4&-RJR^6S8[YR,FDN
ME^O^3?Z ]+^7_ _S-?5/B'X3T6*X?4=:A@\B=K>1"KE_,7&0% W-C<.0".>M
M:6@^)-'\3V'VW1=0AO( <,T>05/7#*<%3[$5RGP_TZU'BCQKJ/D(;MM8:'S2
MOS! BD 'TRQJ?08(K7XM^*4@18UELK29U48#.?,!;ZX YIQZ7ZJ_X)A+2_DS
MN:***0!7):K\3?!FB:I_9M_K]O'=AMK(JO($/3#,H(7\2,5OZS)<1:'J$EJ"
M;A+:1HL?W@IQ^M<Y\,K:P_X5MH[6R1.MQ;![AN&,DI^^6/<[LYS0M;^7]?H#
MT2.G74K)]+_M..YCDLO*,PGC.]2@&<C'7CTK%/C_ ,+#4].TT:O$]YJ*HUM#
M&CNS!@"I. =F00?FQ7*>$UB@\+>.[.R_Y!EM?7D=H ,*J^7EE7_9#%NE=#\,
MM.M=/^'>B&WB57N+2*:9_P")W9022>_I] !36NO33\0=UIZK[CKJ***0'GFI
M?&'POI'B^?2+[4X8[:W@_>3)%)*?/WX,?R ] .>.IZTFK:SING?%73]4O;V&
MVL?[ E?SIFVK@S)CKZYZ5>M3_P 7JU(?]0.#_P!'/575=.M;_P"-NC-=0)+]
MFT>::,.N0K^8J@_7#&B/V>^OY2!_:_K^4W/#GC_PMXLN'M]$UB*ZG0;C$4>-
M\>H5P"1SU%6O$7B[0/"=ND^N:G#9J_W%;+._KM106/4=!6#XP@B3QWX(NT15
MN#>30F0##%#"Q*D^F0.*YF;_ (2^Y^+WB-]!7P\UQ;06Z1?VP)2Z0E<YBV=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-A;_ &:P,+0A8SR P()R<Y8Y)R<\U8T?2X-$T:RTNV:1X+.%((VD(+%5&!G
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M>:#]JOYH+R-TGN+BX,LS;UVLVYL\X]L>U:VGV4>FZ;:V,+.T5M$L*%R"Q"@
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M8****0RKJ.GVNK:;<Z?>Q"6UN8S%+&3C<I&#7-Z;\/[+3='U32O[9UR[L[^
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M /2M:BB_0'KJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !/\%=+FLYYI=2EAB:?RY_*DN$5\.H?^%F4'GU-5O!FD^ K'Q'"-+L-3T'7
M&9K&]FGC:?@@\.Q24#)/RD^M5;WFA7]U,]2HKS3X@W7@_4=4&FZO:ZWKEW;Q
M MI.E><X )R&=4*KN[\G.!57X67T<6M>)=-LK'6-/TFU2WFMK#5E82V^Y6W!
M0S$A3M!'-2M4WZ_@4U8]5JAJ&KVNFW6GVUP6\V_G^SP*HSEMK,2?;"G]*\V\
M+^#-)^(NAIXG\6"YU*YOI9)((FNI$CM(PY54148 <*,GN:?X[\$Z#>^(O!=I
M>6T]Q#).UHZRW<IW1K"S ?>X.0"6&">Y-.SND]Q::VZ7/0M:FU>"&U.CVD%S
M(UU&LZS/M"PD_.PYY('0?H>E:=><>,-"TWPWX4\/:7I-M]GLH==LRD6]GQF7
M)Y8D]2>]6_%:2>(O'&E^$IKFXM],>REOKM;>1HVN &"+&6'.W))('7BC?;O^
MB8>;[?K8[RBO+=5\,:?\-;O1]5\+^?96TNH16E[8FY>2*=)3MW;7)PX.""/2
MI=;T4^(/C*UA/>74.GG0T>YBMY3$9P)F"J67#!<G)P1G%%K[>?X*X;7O_6MC
MTVBO,+?PUI_@+XB^';7PX)[33]62YCNK,W#R1LR(&5P&)PW&,^E>GT=+AUL%
M%>8P:#9_$CQ-XB?Q$]Q<Z9IEY]AM=/6=XHE*J"TC!2"S$G@FK_BFW7P7X&M=
M'\.O+9+>7T-C#*9&D:W$KX)5F)(P,@9/'%);+SM;YCMK;M^AW]%>:ZO\+-#T
MG2+W5M#EOK'7H(6F34?MTK.[J-W[S<Q5@2!D8JIXIU&]\1^#_ =]!<O97>H:
ME:LTT6-T9>-PQ7.?4XII7T7=+[Q>;\_PU/5:*\B\:>!K#PG:6FM>%KF]TS6)
M;^"WEN_M4DQF$C;#O$A8'KGIUIWC3P/I/A#1CXIT9[V'7+:X@+7LEY+(\X,B
MJRR!F(((/H.E"U^^WY?Y@_TO^?\ D>MT5Y_\2+>XO=2\'6UM>2V<DVJ[#/"<
M.JF%]VT]B5R,]LUD^+/!.E>!=$N/%?ADW=CJ=DZ3S,;R21;M=P#+('8@Y!/X
MT+S[V_+_ ##=V7];_P"1ZM17#^/M1\-2V5EIVO2ZE*]SF6/3M-:4RW*[3E66
M/DKSW(&:Y#P'-8:=\1[;3M T+Q#H.F7-C,\UCJR.B/(K+AXPSMSR03GTH2N[
M";LKGL]%>66_AR/Q3\1?&5CJ=Q<'1XY+9I+.&9HA.[0@?.RD$J .F>2>>E1^
M/;N'0;CPWX1L=/UI]%,,DDUKHBN]P\<> J9W!MF3ECG/2ET7G_P?\BGHWY?\
M#_,]7HKQ+PRT.D>+]'C\(^#_ !?HMA<3&/48M0M9?LS(5X?+.VU@0.>.*Z.[
MT6V^('C_ %S3M=:XET;1HX(H[%)GCCEDD7>9'VD$D< <T[;6\_P_X<F^]_+\
M3HM0U>^@^)&BZ3'/ML;FQN9I8MBG<Z%-ISC(QD]#745Y?9>&X/#/Q=T.SL)[
MC^S3IER;>UFE:06Y!0,%9B6VGY>">,''6O3)X4N()(9-VR12C;'*G!&."""#
M[CFC[*MY_F'VG?R_(J:;K%KJLVH16I8FQN3:RD@8+A58XYZ#<!]0:OUY%\/?
MA]X8DUK7-3?36>]TW79H[69KF4E NTKGYL-R3RV2>]:;Z):_$/QAXAMM?>>;
M2=)ECM8-/2=XHV8H':1]I!8Y( YXQ1VMVO\ @O\ ,;T;OWL>E45YWI%@O@GX
MAV7A[3)YSHFIV4LL=I-,THMI(BO*%B2%*MT]17HE'2XNM@HKQKQ/)X#U[6KJ
MYET3Q1XJN(Y2C-IBW$L5JP !"$.J#D#IGFI;#4+G4/V?->:YDNW:&*\@C-Y_
MKE168*LG^T!P?I4W]ULJWO)'L%%>9Q_"W1=4\/6^I:M-?W6O&T60:D;R17B?
M;D;%!VJ >@Q561M1UKX/^'_$X=YM8TA8[]7ZM*$RL@/KN3=^-4U9M/I_G8E/
MFM;K_E<]6HK@/&E]'XET_P /:#8S Q^()DED(//V1!YCG\1M7_@5=\B+&BHB
MA548 '0"BS6X7VL+5/5=3MM&TF[U.\8K;VL32R%1DX SQ[UY=XH\/Z;+XIU&
M[\=:+JNJ:6\BM87EK)-)#:1[!E6CB8,AR"=VT@Y'-7/&6C^'[SX*WK:==3W]
MA;6[W%I*;V23+9R,G=\P!/1LXQTJ?LW+27-8].AE6:&.500KJ&&>N",T^N&L
M/!?A_P )^#M7FT33_LLEYI[&<^=(^_$;$?>8XZGI6?X#\%:?J/A_PYXBUMI]
M0U2*VAEM7DG<1VR[1M5$!V] ,D@DGFK:5VNW_!_R,TWRI]_^!_F>DTV218HV
MD=@J*"S$]@*\F\:3^!];UVYCOM)\1>*+JV81R6FEK/+%;,!SPK*@/KR3S2>#
M8XO$/P]\4:7?1ZJ+"TO)X[>WOY9([B*,1JZQR$-G@D\$D8ZYK-OW'+LKFEO>
M2^1Z?I&J6^MZ1::G:;_L]U$)8]XP=IZ9J[7F?PR\(^'M \'Z=XGL].\O4Y],
M#3S>=(V_(#-\I8J,D#H*X33[S2/$UC%K/B7P;XZUC59RTR7EI;R^3#DY40;9
M  H &#CJ*TFK2<>Q"=U?N?0]%>3K?^*KKX+7+O!K,.H0S&(F6(Q7K6HD&6P?
MX_+SR.I!Q7%WFA_#+Q/+IUMX-L;W4-5DO(C= _:MOE%OWAF9S@<9Y4@YI6]Z
MR\OQ_K\POI?U_#^OR/>=0FU>/5=+CL+2"6PD=Q?2R/AXE"Y4J,\Y;CO_ %K3
MK@_$5G;Z?XP^']G:1+#;P7%Q'%&O15%NP %4;O28?B!X_P!<TO6IKB31='C@
MB33XYFB2:21=Y=]I!.. .:+7V\_PM_F/;5^7XW/2J*R/#OAG2O"NGM8:/ \%
MJ7+B-IGD"D]@6)('?'N:;XJU'2],\.7<VL7\ME9NGE--"[+("W "%?FW>F.:
M3TV!&S7+:UJ]]:>/_#&F03[+.]CNFN(]BG>412O)&1@D]"*\EO7\/Z+J%CJ/
MA?PSXNTN^.H0*^J744RV]RC2 ,)#(YR&R?X1DUZ9XB_Y*IX,_P"N5]_Z M-+
M5/S_ $8F]'Z?JCJ(M7M9M=N-'0L;JW@2XDX^4*Y8*,^ORFK]>0K\.?"NM_%;
MQ#!J>FR72):6UPOF7<V1(Y?<<[\_PCCH,<8H\?:O'=>-U\.ZAI'B'4]$M;!9
M9+/1(G8RNY('FE64[ J\#/))I=%W?_!_R*>[\O\ @?YGKU%>1> 9FL/&D5AH
M/AOQ1I'AV:U<SV^KVTBQ13 @JT;,S8SR",\\5/HGA.U\7:UXN@UR6XN-)AUB
M0)8),\2,Y1"6<H06QQ@9P.:=NW;];$W_ *]3U:BO,_%&AB\^(WA71[6ZN+&Q
M73;F.46TA1VA4QXC#=0"0N2#G ZU!>^$M*\ ^*O#-YX96XL4O]0^QWEN+F22
M.=61CE@Y/((X-"5[>?\ F#=D_+_(]3HKS[XB7GA2YN;?2=;75]1N1$THTC2S
M,S3*<#+K&1W&!N(ZFN?^'3V:^,]5T+2]*U[1M$ETQ9?[/U3S(G1]Y4M'ERR@
M@]0<Y'M26OX_@-Z?A^)ZEINL6NJS:A%:EB;&Y-K*2!@N%5CCGH-P'U!IEC-J
M\FL:G'>VEO%I\;1_89HWR\H*_/N';!X%>:?#WX?>&)-:US4WTUGO=-UV:.UF
M:YE)0+M*Y^;#<D\MDGO6M8Z3!KWBGXD:5<9\J[%M$Q'49@ZCW'6CI?RO^"_S
M';5I][?BST>BO.].\7W%C\)9[ZZ0G5]-5M.DBSDM=(?+4?\  B5/XUSWB,S>
M#_#_ (1\(K#K%Q'=B2;41HZ%KJ<J SA<$'#._P QSG IM:V7E^.OY:B6VOG^
M'_!T/9:*\,T5K?1_$^C-X-\&>,M&BFNUBU&.^M9?LTD+<%FW.V&4X(/'&:Z#
MQIH%M>>*[B[\6:-JNL^'FBC%I]ADD9+-P#O+Q1L&.<_> /'%)]&'<]3JO?WL
M&FZ?<WUT^R"WB:61O15&3_*L3P3#H$/AV,>&KQ[G3&<F/?.\OE\ ;/G.Y<8^
MZ>E4_BAIEKJ7P[UK[4LC"WM)9XPDSH-ZH<$A2-P]CD>U*?NIV'!7:3-N]U)G
M\*W&J6A:-C9-<1%@,K\FX9'(STJ#P??W.J^#-%U"]E\VZN;**65]H7<Q4$G
M  Y]*YC0_!?A_P ->!+V^TC3_LUS>Z3FX?SI'W_NR>C,0.2>F*R/"/PQT+7_
M  -H=]KQO+Z^:SC>&8W<B?9E*C:(U5@JX 7L<D9-7)6<EVM^I$7>$7W_ ,D>
MLT5PO@;6?(^&QNM<U%O+L9+BWEO)G.[9'(R!B>N< <]:\P\0GPI;:5=ZQX?\
M/^-7U1(O-@\1%+C9N'(9W=Q\N."=O2I=D[?UJ4DSWK4]7M=):R6Y+;KRY6UA
M5<9+MD_E@$GZ5?KRKXA>'],\13^"KC5())VO;V&WG7[1(J&-HW8@*& !)QR
M#[UZ%H/A_2_#&E)IFCVOV:S1F98_,9\$G)Y8D_K3M:]^[7W"O>UNR?WFG17
M?%**YGA\,06EW):3RZY#&)X\;D#(X)&0><$U@^-/ UAX3M+36O"US>Z9K$M_
M!;RW?VJ28S"1MAWB0L#USTZTEK]]OR_S&]/NO^?^1Z[17DGC3P/I/A#1CXIT
M9[V'7+:X@+7LEY+(\X,BJRR!F(((/H.E=?X[U'0+?2(+/7;R]B6[D B@L&D$
MTY')4"/YB/7MTH>U_D'6QUE%>&^&9=+T?XB>'[;PUX;\3>'K6]::*[AU2*1(
M+@",LI4.[98%1^%=SX=7_A'/B!K>@GY;/4A_:MD.P8D+.O\ WUM;_@5.VWS_
M  $]/P_$[FL'QMJ-WI'@C6M1L9?*N[:TDDBDVAMK <'!!!_&L7P,O]LZWK_B
MUR'2[N/L=DW7%O"2N0?1GW'\JO\ Q)_Y)KXC_P"O"7_T&IEI&Y<?BL=!ITKS
MZ7:32MNDDA1F.,9)4$U9KS:S^%.AZEHMG?:A-?RZZUJA&IK>RK)$Y7/R*&VJ
M 3P,8Q69>>--7C^#%C?-+<2:G<70TUY[1-TS$2LC/&/[Y53CW(JY[OU_-V(A
MK%/^MKGKE%?/MU]ATV-M1\)^"/B!8^(E976\N+29UG((RLP,C!E(SGBO?X7:
M2"-W4JS*"5/8XZ4K:7"^H^BN$^(=[X7E%MI.NG5+R9U:1-+TPRF2X7I\RQD9
M'89(&37+?#V:RM/B%+I&C:+K^BZ//ICROI^L(Z@R+(HWQAF8X(8@\TH^]MY_
M@-Z:GLE%<#X(NH_#5GK_ (=O&V1:#,\T+,>MHX,B'\/F7\*K>&Y;/3/A_JGB
M;Q%>2Z?_ &Y))>3S!RLD2/\ +$JE>=P3;C'.31Y^2_'^G]P[:V\[?U^'WGH]
M9FH3:O'JNEQV%I!+82.XOI9'P\2A<J5&><MQW_K7A6MR>'='5=7\,^&O&%CJ
M:7$++K5Q'.()@77<)&=^5/3E1DXKU+Q;SX[\"G_I[N?_ $0U4E>WK;\&R;[K
MRN74U>^/Q2FT8S_\2]='6Y$.Q?\ 6&4KNSC/08QG%=37$1_\ENN/^P G_H\U
MR/B>3P'KVM75S+HGBCQ5<1RE&;3%N)8K5@ "$(=4'('3/-3?1?UU8WN_E^2/
M1_&VHW>D>"-:U&QE\J[MK222*3:&VL!P<$$'\:U=.E>?2[2:5MTDD*,QQC)*
M@FO*+"_N=0_9\UYKF2[=H8KR",WG^N5%9@JR?[0'!^E:]G\*=#U+1;.^U":_
MEUUK5"-36]E62)RN?D4-M4 G@8QBF]+_ "_*XMVOG^9TGQ U6]T3P)J^I:=-
MY-W;P[HI-H;:=P'1@0?Q%=# Q>WC9CEF0$G\*\JU'5[S6OV>;^ZU"02W:0/!
M++_ST:.79N_';FK?Q*UZ>S;PWHJ0:Q-:WY>2[CT="UU)'&H.Q<$$ EAD@YP#
M0U:Z\U^5RK;7\_P:/3J*\,T5K?1_$^C-X-\&>,M&BFNUBU&.^M9?LTD+<%FW
M.V&4X(/'&:]SHMI<F^MBA%J]K-KMQHZ%C=6\"7$G'RA7+!1GU^4U?KR%?ASX
M5UOXK>(8-3TV2Z1+2VN%\R[FR)'+[CG?G^$<=!CC%;.I:9#XV\?:CX>U26X_
ML32;.%C913/$MQ))DY<J06 "X SU-):I=V4]WV7_  #T6BO-8=&@^'OC;0+/
M0I)XM&U<RVTVGR3M*D<BJ761-Y)'<'GO7I5/I="ZV//_ !+XZU/0?B#8:5]F
MM7T1XH6O)BK>;$99&C4@[L;=P7/'>N_9E12S$!0,DGL*\ZU[18O$/C[7-)EX
M%SX<C16_NOYSE6_ @'\*BF\37>K_  OLK:-C'K>HRC1W53EHY@2DK?@JNWY4
ME=QTW_S;7X-?<-VYO+_@)_D7/ _CG4_%/B?5K2YMK2+3HX5N+!H@WF/$TCHK
M.2<<A,C '!%=_7GWANRATWXKZQ8VR[8+?1K.*-?15+ ?RJU\.O\ 6^+?^Q@N
M?Y)5:.UNWZV)UU;[_FKG;T5Q.A$'XL^+?:TL?Y25S7A?P?9^+SXC7Q!)<76F
MPZW=I!8I.\48;?N+ML(+')XSP,>]2E>WI?\ &Q3TOZV_"YZW17FOB#15U7XJ
M:7I7VJYMK#^Q9//BMI3&94610$W#Y@,D9P0>,=ZANO#6G_#CQ%X=N?#/VBTL
MM1OQ8WEB;AY(I ZG#X<G# J.1VII7MY_YM?H2]+^6OX7.HTG5[ZY^(?B+2YI
M]UE9VUJ\$6Q1L9P^XY R<X'4UU%>6R^&+?Q/\6?$UMJ,]S_9JV5IYUK#,T2S
MDAP-Y4AB -W&<'/M5K0]"M?!?Q+@T316GAT>_P!,DG:RDF>1(Y$=1N7<21D,
M<\T+5+T_S_R'+1O^NW^9Z117">#'7PWJ_B#PO.XCMK.0ZA9%L "VE)) ]E<.
M/Q%2_#B%[VRU+Q1<#]_KEVT\9(Y6W7Y(E_[Y&?\ @5"U^Z_]?C]P/3[[?U\K
M?>=M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** .;\0>'[O5O$GAK48)(5ATNYDEF61B&8-&5&W (
M)R>Y%6_%ND7&O>$=5TFU>)+B\MGAC:4D*"1@9(!./PK9HI6TM_7]:#OK<K65
MLUOIMO:R$%HX5C8KTR!@XKS_ $7PIX[\,VZZ%H^K:%_822.8KFXMY6NXE9BV
M H(1B,]2?\*])HJF[MON):1Y3@K;P)?V?PTUKPNMY%/<WC7/DW$S'!$C$J7(
M7KSS@?2NRM[5XM'BM&*F1+<1$CID+C\JMT4GJFGU_P K M'?^M[G(Z)H?B'P
M[\.K#1].FTLZQ:1;-]P)'MV.2?X=K=^O;T-9]MX=\9:WK.F7GBV\T**WTRX^
MTPQ:3%*6D?:5&YY#\HYZ <UWU%.^O,*VEC@+SPSXOTCQ1JFK>$[W16AU9TDN
M8-5CD_=NJA<H8^N1V-7_  OX4U/1O$VLZOJ>IQW\FIPP!V";-KIO!"IC 3!7
M')/7-=A126GY#9YY#X8\:^%WEL_".HZ)-I$LSRQV^K12AK7<<E4:/[RY)/.,
M5I^)O#>N:OIVBW5EJ%G'K^E2BX626)OL\SE"K @'<JG/;)%=A10'6YQNJ:#X
MCU_P[I$.J2Z4NJ6VI07=P;4R+"4CDW87<"Q./7 SZ5;\4>&+S5+^PUG1;]+'
M6K ,L4DJ%XI8VQNCD4$$@X!R.0:Z>BC_ (</Z_4X*V\+^*M>U73[OQI?:3]F
MTZ?[1!8Z5')LDE ^5W:3GC)X'M6VF@72_$67Q"9(?LCZ6MF$R?,WB0OG&,8P
M?7\*Z*BG?^O4-_Z^9SNLZ!=:CXN\.:M#)"MOIC7!F5R0S>9'M&T 8//7)%=%
M112Z6!]SA]2\,^)M+UV_U?P=?Z:AU%E>ZL=4C<PF0#'F*R?,"0!D=#5^[\-Z
MCXE\'-IGB6[MEU%W$JW&G*RK!(I#(4W')VD=^OM74T4=+!UN>=W?A_XBZU:2
MZ+JNMZ%%I,J>5-=V=O(+N5. PVL=BDC(R,XK:UOPF]U:^&;/2_(AMM'OX)RD
MC$?NHU9<+@')Y'7'UKJJ*=_\P\OZU.>\8Z%=>(=+M+6TDA1X;^WN6,I(!6.0
M,0, \X'%)XXT&Z\2^%+G2K*2&.>62)E:8D+A9%8Y(!/13VKHJ*2T^^_Y?Y!_
M7Y_YGGGQ.L9M0OO!]K;W;V=PVK9BN$4,8W$3E3@]1D#([C--O/"WC;Q1)'I_
MBC5-%CT..99)(],AE$MV%.0K[R0H) )QFNQU70;75[W2[NXDF633;G[3"(R
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M:W4[BBO/&TSXFQVQU<^*-->X$?F'1_[- @SC.P2[M_X^M/UOQU/)\)8_%VE
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MX:LKJ#Q]XRN9K::."XEM3#*\9"R 0X.TG@X/!Q7844KVV\_QM_D-Z_A^%_\
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MIYWX4FT*_P!;A?3OAC=Z,T62;Z\TF&T,1P<;2#N)/3CUI/%^N:5?W<ND:O\
M#KQ%J^QBD=Q%IJ21GL&24/E?KP17HM%#U!:'.>!;/5K'PE:P:UYHN@SE4FE\
MV2.,L2B,_P#$P7 )KHSTHHIR=Q)6/.- T'4KGX-ZGHS6LD%]<K?)'%<(8SEY
M)-N0>@.1S[UL^!O$%UJ5A'I=YX=UC2[FPMXXY9+VW"0R,!M(C?/S],YQTKKJ
M*+[_ "_!6&]=?7\7<*\7MK"'2?$&KQ^)OAYJ7B+4[N^DDM[]+-+J%X6/[M2S
MG$>!QC'%>T44NMPZ6/-/!?A:[/ASQAH^I:9%I:ZC>3".&!,1)')"@&S@ @9Q
MD#&0:=H7BS7]$TVR\.W_ (*UN?5+:(6ZW%K&C6DH4;5<S%@%! R01D5Z313;
M_3\ _K[SRO2?"6L:K\)=7T6^A%MJTM]<3)O4JAE$V]2,CE"1P<=#6@?&GB#4
M]/FTB/P1K=MK3VYC:6XC5;-'*X+>=N^8#.< $FO1**3U371_Y6&G9W_K>YY5
M=Z1J1^ .GZ8-/NFOTAM0UL(6,H(F0G*XSP 3TKU,H'B*-T9<&G44Y/FO?K_E
M8E*UK=/\[GB]CH^G^";=](USX:R:ZL<S_9=2T_2H;MIHB<KYF<,K#..?2N_T
MN\M]'\)2W]EX-N]/3>7_ ++L[:)9WZ#=L5@N<=LYP/PKJ:*6MK#TO<\CM_\
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M21V*$ E(\C<>..3TKH_#,4EOX5TB&:-XY8[*%71U(92$ ((/0UJ44[[_ "_
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M.%''"L!^E2W;4:U.OHKQ?X7_  Q\'ZOX*TK6;[2/-U N[F;[3,O*RL%X#@<
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MRPKM1_,>-@.>,HP..3Q2>V@+S*6@ZO>ZQ?:SX5\10V4UU:PKYLUF3Y4\4NX
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M!Y,4DSSLN]FR[MN8\D]2>G2JO^27XW$]7\_TL7:***D84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9
MESXCT.RM5NKK6=.@MVD:)99;I%0NI(902<9!!!';!K0AFBN(5FAD22)QE71@
M0P]010 ^BLV]\0:+IUY'9WVL:?:W4F-D,]RB.V>F%)R:L7[R#2[E[>XB@D\E
MC'/+RB'!PQ]AUI-V5QI7=BU163I5^(/#FG7&JZK93RR11*]Y'(JPSR-@ H>
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M9=0ET^.\MWO8E#R6ZRJ9$4]"5SD ^M(99HJ 7UHU\UBMU";M(Q*UN)!Y@0G
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MJ:*'4=5L;.6;B-+BX2-G^@8C/X5:N+JWM;5[JXN(H;>-=[S2.%15]23P![T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-U/J-C%)++"K,R,"60DC.TD\CI7HVG:7I^D6WV;3+"ULH-Q;RK:%8UR>IPH
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M01Z5;K+L/82@<'WQ3F[R;7_ W)@K12?E^1UVE26,VD6<FF&,V#0H;<Q_=\O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ***CN+B&TMY+BYFCA@B4O))(P544=22> *
M)**9#-%<01SP2)+%(H9)$8,K \@@CJ*AL]0LM0$ILKRWN1#(8I3#*K[''56P
M>"/0\T 6:*K_ &^S_M V'VN#[:(_-^S^8/,V9QNV]<9XSTJQ0 4444 %%%%
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M=RD9!P0"./6@"S1110 452U;5['0M.DU#4I_(M8RJM)L9L%F"CA03U(J[UH
M**I:GJ]CH\4$M_/Y*3SI;QG8S;I'.%' .,GOTJ[0 4444 %%%% !114-O=6]
MY&9+:>*= S(6B<, P.",CN",$4 34444 %%%% !1110 4444 %%%% !1110
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MEBT&Y\ W&IW"Q6]G>>7<7,APB,8&7+,>@)[FFMU?NOR?]?,+_DSM=#O-2O\
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M9:AJAM-&;4+2RN-1)56C@M0I>3<1C&X@8YR>>F:R_B$!_P *Z\1?]@Z;_P!
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MH_S1IZ7XXU?^W++2_$OA.XT1[]F2TF%Y'<QNX4L58IC:<#CUI;G_ )+5I_\
MV IO_1R5PAMM(A\?^%/[+\9ZSXD;^T"9C<7XNK>',;XP5&U6/.!GH#7=W/\
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M.!T((Z=JPM('_%WO$O\ V#K/^<E<SKM[<^$;SQ%X;L21+K[I-I(S]V29A',
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH KO8V<E]'?/:P-=Q(4CG,8,B*>H#=0#Z4MW9VNH6LEK>VT-S;R
M##Q3('1A[@\&IZ* $551%1%"JHP !@ 5FZAX<T/5KA+C4M&TZ\F3[LES:I(R
M_0L"16G10 U$2) D:JB*,!5& *5T61"CJ&5A@J1D$4M% &7;>&M!LX;B&UT3
M38(KE=LZ16D:K*/1@!\P^M79[&TNO(^T6L$WD2"2'S(PWEN.C+GH1GJ*GHH
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M6X88K>%88(DBB085$4*H'L!3Z* "H8;2VMI9Y(+>**2=]\S(@4R-@#+$=3@
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MR/(N.F&(R*N7-K;WEK):W4$4]O(I1XI4#(R^A!X(J6B@!J(L:*B*%11A548
M'H*=110!!#9VMM-/-!;0Q2W#!YGC0*9& QEB.IP ,FH%T72DU0ZHNF60U C:
M;L0+YI'IOQG]:O44 9 \*^'1?_;QH.E_;-V[[1]CC\S/KNQG-:]%% %:^TZR
MU2V:VU"SM[NW;K%<1+(I_ @BHM-T72M&C>/2],L[%'.66U@6(,?4A0,U>HH
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M=K?VS6U[;0W,#$%HIHPZD@Y&0>." :?/;PW,#P7$,<L+C#1R*&5AZ$'K4E%
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MQ9H>K:V?"L4>FSEVDTXW F:-E*LF7!!!STXZ4TM=?/\  3>FG8Z_Q'XQ\/\
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M4XYP2*\YLL)\&/'-M;D_V?;7-_%8^@A!X"^P)8"O3?"NF6FD^&-/M;.)8XQ
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MPD=I)-+M]0:.T<L23E!S@YZ @5O:9X4TW2- N]%LEDBLKEIF*+@>7YF<A<#
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M7:=P(R>.F"*U:*.WE_7ZL#&B\,V4/BZX\2K+=&]GM5M6C,O[H(#D$+CK^/\
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M&%D8L5&T# &X@>@ K=HHZ6#K<YWPOX0@\*B=+?5]8O89 JI#?W9F2!1G"QC
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN+^%O_ "*$O_81O/\
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M3;J]DY2WA>5N<<*"?Z5P&G?"G0=2TRTU/59M0N]=F@61]4^W2K*KL,Y3#!0
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MP[9%'  R<=0:]2^&-[JUWX7E35[;4X6M[N2&V.IPF.X> 8*%P>IP<$]\4TM
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M%8Z5;9\FTA6)2>IP,9/N>M8>G^ -.L_$9UVYU#5M4O%=WMQJ%T98[7=G(B7
M"CG'? %=736D;=P>K]!LB"2-D/1@0:XKP7X?\6>%WBT:YO-(NO#EJKK;R*DB
MW9!.5#?P8&3SS7;T4EHP>JL<]X.T&Z\/:3=6EW)"\DM]<7*F(DC;)(6 .0.<
M'FFZ)X?N=.\1>);^Y>![?59XI(D0DL%6((0P(QU';/%='11_E;\O\@_SO^?^
M9YW;^&?'/A6-M/\ "6HZ'<Z1YC/!!JZ3![92<[%:,_,N2<9Z5VVD1:E#IL::
MO=07-[R9)+>(QIUX 4DG@8[U>HIW J:K:O?:/>VD1423P/$I8\ LI S[<UY[
MH^E?%C1]&LM)@E\&"WM84@21OM32;5& >@!./8"O3:*0=+')Z!X(AT[P_JFG
MZK='4KG6)))=0G*;!(SC!"C^$ <"LBVT'XCZ3:Q:-INNZ'-I<2>7%>WEO*;N
M-.BC .QB!@9.,UZ'10!Q-Y\.H'^'?_"+6E])'*KK.+R10Q></YA=AWRW;TK)
MUGPK\0?%GAV^TG7-6T*VB>/]TNFQR@SN.5$C/G:N0"0HR:],HIWUO_7]: M-
MCFM7\/7=_K_A>_BD@6+2I97G#L0S!HB@V\<\GOBM?6=)MM=T6\TJ\!-O=Q-$
M^.H!'4>XZU>HI/56?]7!:6MT//K70OB+';C19]=T0Z2L?DB_2WD^VE,8^Z3Y
M8;'&>?7!KH?!&@3^%_!^GZ-<R1R2VJLI>,D@@N2.H'8CM7044[O7S%9:>1A^
M,/#B^+/"M]HK7!MS<*-DH7=M96#*2.XR!D5R6H^&/B%XDT"_T76M7T*VM9(#
M'&^G12B2<X^42%\A%) SM!XR!BO2:*15]O(Y77/#-[J=KX8BAE@5M*OH+F?>
MQ 940@A<#D\\9Q5GQQH5UXE\'W^D64D,=Q<! C3$A!AU8Y(!/0>E=#13;O\
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MK@G\3>,?$=S=MX-L=%33K6=[?[7JTDO^D.IPVQ8QP >,D\XI=;#Z7._HKD]
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M*1D'\JX_[9XMT[P7KU[XGA\/S206;R6\5DLK1N A)$HDZ@\<#MFK5YXL71?
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M5-M2KZ'CFD6[VO[.&KV\D!MWB@OD:$MN\LB5QMSWQTS7J-D,>&;8#_GS7_T
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MJ#\P*]*]0HI=;ATLSS3P[J[:[\8;S4([.ZM[)M$5+9[F(QM,HFY<*>0,D@9
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MU68*"<9[UZ#13<FW?K>_X6)2LK>5CSKQ9J]AK]GX)U/39C/9SZ] T4AC9-P
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MWPQ\-:#=^%8=1N=$TV:^^VW)^TR6J-+D3N =Q&>*])HH6EW_ %N#U5CG_'
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M<_LL_P#,7.G.+/'KOZX]\8KHM9\2V.AQ6-Q=B4V=W,L0NXPIBB+?=+G.0I.
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MKJ;39)K16_LUMUH@9@D1Q@'8#M) Z9!QVQ3?O)KN3'2WD<!\-8+S1-;N-/\
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M(L=1N+&XNX/,EL9O/MVWL-C[2N>#SP3US5VETMYO]!VUOY+]0HHHI#"BBB@
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MI_@?_A%KZ7[=:NLJ2ML\O>'=FZ9.,;NN>V:J;3E*VSM^?^1-/2,;[K_+_/\
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M&BI:1J%5YEWJ,#@-W'?O3OB3;Q>&O GV+P[I-O;+J%_#;RP62I;"0.P##<
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MV%/+LU$(4,'W;=N,$Y/(]:ZCQ9X6/B6ULS;ZE-INH6$WGVEW$@?RWVE>5/#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M YP ":P_B-ILLGB;1M4U#P_>^(= MH9%EL;-/-9)B1MD,61OXR/;K2W5O/\
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MF\_@*JV-]JOPYN-3L)_#>K:OI5Q>R75E<Z3 )G7S"69'3((P<\]#D4[6T?\
M3O\ Y!>^J_K^G^1N^%-=U:36=3\-^(#;R:G8(DR75NNQ+F%\X;:2=I!!!'2N
M:\.7'C_QIH9NH/$EKHT45S-"DRZ>EQ+<;789()"J!P.!GY<YYK>\)V&JW_B?
M5?%FK6,FG?:X([2TLI6!D2)"26?' )8].U3?#2SNK#P7%!>6TUO,+JY8QS1E
M&P9G(.#S@@@T6[[V7WW?Z6#T[_I_F2>!M;U75+74[+6_(;4=+O6M)9K=2J3
M ,K@'ID,.*ZNN/\ "-K=V6L>,9IK2=%FU0RP[T*^:OE(,J3U&01FMGPSK%YK
MNA0W]_H]QI-Q(S!K2X.77!(!Z#KUZ"C>S\D+9OU9KT444AA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6RNIX3=WE\4#FW@!VC8#P68\#/2NVK@)I4TKXWQR79"1:MI @MI&Z-+'(6*
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ME<UX%^)>A^-(;>U@O$.L_9O/N;5(9%$?0, S#!P2!P374ZQ_R [_ /Z]I/\
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M#.#P2>M.>CLN@HZJ[ZF]X]O+:_\ A5KMW9SQSV\VG2/'+&P96!7J"*Z/2/\
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M8W'S5 8^Y _2E#=-]4W^#&]I>7^:.B\1^._#'A.1(M;U>&UE<96(*TCX]=J
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MN054HNT;0!D<=<DUJT4[@>??$+3+36/%7@W3[Z+S;:>ZN5=<D'_4D@@CD$$
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M:U$<*W4RB65$4#A>"QZ=!WK#^$V@_P!E^&)=1DMW@EU6=KE(I"2T,'2*/GG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1$"!MCD*@G)/.!S7+:'X4U_7-+LO$=]XUUNWU6ZA%PEO;2*MG%N&Y4,)4A@
M<$DY-4_">O7'AGX0ZWK5W'$]W:WEX[HN0C2^:1@=\;C3?N\W-T_S$O>MR]7^
MAZM17SY+XVT)+,ZM'\5=:D\0+%O6W-O(+)I,9V>3Y6-N>,YSWS7<>(_$^KWW
MA+P7JVD/]FO-3OK<&/>?+/F1OE6 ^\H/./846?XV^\%_G^!Z717%R>'M;\/Z
M'K=_I^NZMK&MSVI,*7LJM$L@!QY48 5<^GL*YWPI:V&I:K#-:_$3Q(VL(RO=
M:7J$ZJ>Q9?L[H-H[97H#P:$KNP/17/5J**YGQWKMWH7AY6TXQC4+VYBLK5I!
ME4DD;:&([X&3CVI =-67XDUN+PYX<O\ 6)HS(EI"TGE@X+$=!GW.!7%ZEX,U
M_1--N];TSQMKUUJMO$9C!>RK):S%?F*>5M 4'&.#QFJ'Q+D/BCX,C7X[Z]M8
MWM8K@VL+J(Y2[)P^5+$#M@C\:&M-/+\2HJ\D=EX6G\8W+2S>);?1H+>1 ]O'
M8/(TB9_AD+<$XQRO?-=+6!X3\._\([IK1?VQJ^I^<5DWZG=><R<?=4X&![5O
MU4M]#..JN<9IWC];WXA7_A6;36MU@++!>&;<L[JJ.R[=HVD*X/4]*ZK4+Z#3
M-.N;^Y8)!;Q-+(Q[*HR:\GU6UF2?Q;KUFK->:'KT5\@7JT8@C$J_BA;\A75^
M+[N/Q#;Z#H-G('BUN5)IB.?]$0"1S]&^5?\ @5*UXI+?3\=;_=?[BMI.^W^7
M3\OO+?@/QC-XSTV\NKC26TR6VN?(,+3^:3\BL"3M&.&Z5U=>>_#W]VWCC9\N
MW7;G&.,?(M;'PUN[F_\ AUHEU>7$MQ<26^7EF<N['<>23R:;L]5V3^\'H[/N
M_P +'545P_@V_O+K1O%,EQ=SS/!JU['$TDA8QJOW54GH!V Z5D^!-'USQ-X:
MT#7=:\3:M%Y<<;PVEG<;$E5>\[$%I"V,GD#!Q[TDK_A^(/3\5]QZ=17F26>N
M>)O'OBS23XBU'3M(M7MR!92!9MS1#Y4=@=B\9.T9)/6K^@G5/"WC>+PQ=ZQ>
M:OIU[9O<VDU\P>>)D8!E9P!N!# Y-):V\_Z_0):7\O\ @?YFYX8UZZUJ]\00
MW,<*+IVI/:0F,$%D"*V6R3DY8],?2NBKR70?#NI>(O$'C*$>(-1TK34UA_ET
MQQ%-))L3),A!(4 +P,9R<UM^%X]3MM<\1^#[[6;Z_M[>WBEM+V:3%S&DH8$%
MQ@D@KD-UHW2[VO\ @-[OM<[^BN*\'>(98?!EX-<G9K[06EMKZ20G+>6,AR3R
M=R;3GOFKOP_74I/"<&H:M/-)>ZB[7C++(S")7.410?N@+MX''6G;?^M]A>O]
M6.HKCM8\=M;ZQ/HOA_1+O7M5MU!GC@=8HH">BO*W"D^G-=@Q(1B!D@<"N"^#
M\:OX&^WLH^V7U[<SW38Y:3S6'/T  I)7;\O^&&]%?^NYL>'/$&OZG=R6NN>$
MKG1G5"ZR?:XKB)AQQN7&&YZ8[5TU%>,^*M:\,0:O<2WWQ8UJWO5D<PV^G29@
MAP>$=(HV#8X!W')P?>DV"1[-17E]SXFU34/V?WU_[4\>IFRW?:(3L8LK[=PQ
MC&<=O6I[_P '>()M&DUR3QOKD6LI;&98H)%2S5@I;;Y.WD=LDDTY>[>_3_*X
MH^]:W7_ACTFBO-M3UW5)/ WA?QLD\T?V;R;C48(G81RP2 +(2HX.W.X9Z8-:
MWC>_NKI]"T'2KJ2&?5[M2\T$A1TMHQOD8,O(R,+G_:JG%IV\[?U\M?D)/2_E
M?^OZZG9T5Y]J"ZGXS\8ZKH-OK=_I&DZ1'$L[:>X2>>:0;A^\()50 .G7)I=,
M.J>#O&NF^'KG6;W5]*U6"4VTM^0\\,L8W$&0 ;@5/?IBDM;>?_!_R&]/EO\
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M1LF[IU'/MFN[HH>NG0%IJ>?#P%J/_"N=*TA;Z%-:TN5;NUF&YHHY58L$YY*
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MXFTR6(:'X536HG7YV_M)+9D//&'7!'3G/?I7.Z)X3UBZB\3W=[96OA]];M1
MEC:3>:(7VL#*[* I<[A]WTZUZ+14VT:[E7:::_JQY=H-KXZL- C\*P^%=+TV
M.*W\AM76]5XVXP7$*J&+'KR1SG)K1A\%7]W\*-)T&5TL]7L$AEA=L.L<\;;E
MS@G(/0X]:] HJFV[OJ_T)22_KN<=H^M>.;C5(;/5?"%I:6RG]_J$>IJZ,/5(
M]N[GWJA?6?BKP_X[U/6-%T.#6;+5T@613>K;O;M&"N3N!W#!SQS7H%%%]4Q]
M&CE8](OQ\49=9:WQ8-HZVPEWK_K!*6*XSGH>N,5AVUGXQ\#-=V.AZ#;^(-)F
MN7N+9?MR6TMMO)9E;>,,,DX(YYKT:BE_7XW#^OPL<EX0\/ZG9ZAJVOZ\T']K
M:HR!H;=BT=O$@(1 3U/))..IJ7X?:1?:'X2CL=1@\FY6YN'*;U;Y6E=E.5)'
M((-=113O_D']?H<QX5TF^TW6/%$]W!Y<5]J7GV[;U.]/+1<\'CD'@X-=/112
M[(.MSEY](OG^)]GK"P9L(])EMVEWKQ(9%8#&<] ><8K,US5?&-S<7.ECX=VF
MH:?(3&MQ-J\7E.IX#-&R;NG4<^V:[NBC=)#OK<P?!>B77AWPCI^E7LR2W$"$
M,8R2BY8D*N>=J@X&>PK>/2BBG)\VY*5CROX0^#]=\+ZEXGFUFQ^S1WMPKVY\
MY'W@%R3\K''WAUQUJ[\9-#\2>)O#%MHWAZQ-R)K@/=-YT<85%Y ^9AGD@\9^
M[7H]%)ZI)]+?@4G9M][_ (GG%K\#O 4=C#%<:*99UC59)?M<X+-CEL!\#GGI
M6=\+?"GB?PE;>(]"U&Q(TR1WDL)_.C;S"<KT#$C("GD#O7K%%#UOYJPEI;R/
M,/@OX2USPEX5U*RURQ^RW$UT9(T\U'RNQ1G*L1U!JK\(? FJZ%H'B#3?$^F+
M#%J$H C:5)!)&5(/W&..M>LT4V[MM]58%HK>=SR_X:^'/%/@C7=3T"XM&N/#
M#2-+8WGGQDQGK@KNW<C@\=1GH<UZA111>Z5PMJSBO&>F:\GB#1/$F@6$.I3Z
M<LT4MC).(6E20*,JYX!&WO1KFCZ[K=IH7B"TM;?3_$6FLTOV*>?S(RKC;)$S
MJ.XQ\P'45VM%):(.IYM?V?C+QY%%I.M>'K;0-($\<MVQOUN9+A4;<$0( %!(
M&2:]) P,#H***=]+!UN4M8L#JFB7^GAPANK>2$,?X=RD9_6N2\(#Q9!HA\/Z
MSX>@M8;*Q^SPW\5\DBW+*NT8CQE<CG)-=U14M737?^OU'?;R.>\"Z9>:-X&T
M;3K^'R;NVMECECW!MK#MD$@_@:R= \)SR>$O$.BZQ"T":E?WC#:ZL?*D8[6&
M"<'!S@\^M=O152?,VWU)BN5*W0\[L=0^(VA6MMH[^%+/61 HB74X]32!&4<*
MSQLI;. "<9]J[VR:Z>Q@:^CBCNB@,J1,616QR 2 2/>IZ*&[[A:VPV0NL3M&
M@=PI*J3@$]AGM7F7B$^-?%^GW.AW?P_L+6.8,B:A<ZM',D)[2*JIOR.HZ'I7
MI]%3;N5?L<AJV@ZC+K_@R:)3<Q:7)+]KG9E! ,)0,03DY;TSUJQXZTF^UG1[
M*"P@\Z6/4K6=UWJN$20,QY(Z =.M=/157_._XW)MI;RM^:_4\^\6:)KMOXWL
MO%6D:-:ZZL-D;0V,UPL+1L7W>8C."H/8]\"G:=IGBO4?'FE>(]9L+:RMH[*>
M#[)#.)6MRQ0C>_&XM@_=&!MZ\UW]%):?+_@_YC>IRWA_2+ZQ\:^*]0N(-EK?
MR6S6TF]3O"1;6X!R,'UQ4/BG0M7.NZ?XF\.BWDU*SB>WEM;A]B7,+$$KNP=K
M @$'I77T4=O+^OU#OY_\#_(Y30-9\8ZGJ"KJWA*WT:R4'>[ZFEP[<<;0BXZ]
M<FGZ3I%];?$/Q%JDT&VRO+:U2"7>IWL@?<, Y&,CJ*ZBBG?J'D<Q=Z3?2_$O
M3-72#-C#IL\$DN]?E=G0@8SGH#SC%8KZ?XJ\&ZOJMQX=T>WUW3-2N3=_96O%
MMI;>9A\Y#,"K*< ^HKT&BE_7WNX_Z^XXWPQH6L2>)+WQ5XBBM[:_N+=+6WLK
M>3S!;0@[B&?C<Q8\X&.*-#\,W/E>,;35(#';:OJ$SQD.IWQ/&J[N#QT/!P:[
M*BAZJWE82;6OG?[CSG2)OB)H-G:^'AX=L-0CMT$,6L'41''L'"EXMI<D #.*
MF\.^"+QOAQJGAG7G(FN[BY+3KCYM[EED !.,\-@UZ!13;O>_7_.X+2UNAY]:
MZM\2-,B@TR7PC9:F\:B/^TX]52&-\<!FC*[@>Y _"M/Q5I.JZNGA9X[:-YK3
M5(+J\$<@"QJJMN(+8) )^OM77447UO\ ,5M++M8KWTMU#8S265LES<JI,<+R
M^6'/H6P<?7!KS?4[7QCXVDM+6_\ !=IH7V>YBG74Y=2CN)(@K@D1A%SN(!')
M YKU"BDM'<;U5@K \8^'9/$WA][*WN1;7D4L=S:S$9"2HP921W&1@_6M^B@#
MSB_N?B/KMA<:%)X;L-,^T1>3-J_]HB6,*>&9(@ ^<$XS6AXO\*7$GPGN/#&A
MP&>:.VB@@C+JI8(R]2Q Z GK7;T4[_UZ#3LT^Q' I2WC5AAE0 C\*DHHI/4E
M*RL<QX?T6YMM5\5/?VX%MJ-\)(<L")(_)1"< \<@C!Q6'\//"&K:%J=_-K)W
M16:G3])^<-BT#EP3@G!.5'.#\@KT.BFG;[K#>OWW.0\&:%?Z9-XI_M"#R4O]
M7FN(#O5M\3*H#<$XZ'@X-8/A^/Q_X2TZ'PS:^&;'4;6W+I;:HVI+$@0L2N^/
M:7)'?'_UZ]-HI?Y)?<-N[O\ ,XCP/X=UC1/#>MV>J[)+VYOKF=9$("RAP,,!
MD[03G@\BM;P+IEYHW@;1M.OX?)N[:V6.6/<&VL.V02#^!KH:*=_T_ FWZ_B>
M46\_B2P^)GC.]T&PM]4C#6J3V$MQY#,?)!5DD(*YZ@@CTYK?\.Z3XBU3Q:?%
M/B:T@TUH;4VMEIT4XF,08@NSN!@DX XXQ6[I7A[^S/$>NZO]J\W^U7A;RO+V
M^5Y:;>N?FSUZ"MNA:)>G^8Y:M_UV_P CE_"&D7VEW_B:6\@\I+W5GN+<[U;?
M&40 \$XY!X.#2Z=I-]!\1M;U62#;97-E;10R[U.YD+[AC.1C(ZBNGJO?0W%Q
M87$-I=?9;EXV6*X\L/Y3$<-M/!P><'K2O;7LK?A8>_S/,?'&DSS>.[71K)E%
MMXG1!J* \JENP9GQC^)/DSGTKU5$6-%1%"JHP .@%<KX:\'7&DZI-K.M:W-K
M>LRQ>0+F2%85BCSG:D:\+DXSZXKJZ>T4OZ_I(G=W_K^O\@KSLZ-XJ\$ZG?S^
M%[&VUG1KV8W!TR6Y%O+!*Q&[RW(V[3UP?P]_1**76X_(Y72KSQ3K]I?V^M^'
MXM!CD@:.(K?K<R;B,;OD  '/KGBN7\,V?CG0-%A\+VWA32[9(8_*_MH7RF)_
M^FAA"[V;DG!(R>XKU*BC]0/-?^$1UF+X&R^&!;^;JH@>)8Q(@WGS20<YVC(Y
MZUWEW;RRZ%/;(N96MFC"Y'+%<8S]:O442]Y-/K_E8(^[:W3_ #N<UX7T*2'X
M=Z;H6KVP5Q8+;7,)(8#Y<,,C(-<G\,+*\O=5OM1U"03KHZ'1+*7.[S$C8EY,
M^I^0'_=-=AXGT77-96WCTCQ-)HL0W"Y$5HDK3*<=&8Y0CGD>OM5_0-#L_#FB
M6VE6*L((%QN<Y9V)RS,>Y)))^M5S7DY/K_5_N_,5K)17]>7Y?<<OJVD^(M \
M57OB/PU8V^JQZA%&E[ITMP('+IPKHY!7H<$'THT?2/$&N^++/Q-XEL+?2UL(
M)(K+3HK@3NK/P[NX 7H  !7=45*T_K^NXWK_ %_78Y?PQI%]IWB+Q5=74'EP
M7U\DULV]3O01*I. <CD$<XHM](OD^)][K#08L)=*BMTEWKS()&8C&<]".<8K
MJ**.WEI^%A-;^?\ PX5R7C[1=0UJUT--/M_.:VUBVNIAO5=L:$EFY(SCT'-=
M;10M&GV*N<OXYTB^UBPTJ*P@\YX-6M;B0;U7;&CY8\D9P.W6MG6M*@US0[[2
MKDL(;N!X7*]0&&,BK]%#5UR_U_6@7U3['G5G>?$C1K&#1%\-Z?J30Q^5'J_]
MHK%&0.%9XBN_. ,@4Z^\$7]G\(M2\/6A%_JMTKRRL"$$LSN&8C<0 /3)[5Z'
M13O?5[_\&XEI:W0P/%6FW>I>!-5TVTB\R[GL)(8X]P&YRA &2<#GWJ0V%U_P
M@_\ 9WE?Z7_9OD>7N'W_ "]N,YQU[]*VZ*F2YDT^O_!_S"/NM-=/^!_D8G@^
MPN=*\&:+I][%Y5U;6444J;@VU@H!&02#SZ5M,-RD9QD8S2T54WS-M]1)65CR
MOPOIWC;P=;-H%GX5TZ\0S2,-;-^L:N&8D-)'M+LPXZ>W/>NJ^'VAZEX?\/3V
M6JE7NC?7$ID7 $@=RP< $XSG..HKJJ*+C>K_ !"BBBD 4444 %%%% !1110
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M8Y&230]$V^U_Q&E=I+>]CNJ*\YMO$?Q$US2+36]&T70H+"2%9?L]]/)]HG&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***ANKA;2UEN&1W6-2Q5!DD#TH FHJIIN
MHP:I9+=6^X(Q(PX ((]<5%:ZQ;WFIW%C$DI>#[[D#;Z8SG/Z=J/(#0HK&OO$
MUCI^H?8IEF,GR[F5057/KS6I<3K;6TL[@E(T+D+U( S1TN'6Q+15/3-2AU6S
M%U LBH6*X< 'CZ$U'J&L6^G75M;S)*SW#;4* $#D#G)]Z/(#0HJIJ6H1:79/
M=3J[1J0"$ )Y..Y%5KO7;6STJ#4)(YC#-C:J@;AD9YY]J -2BL"S\7:??7D5
MK%#<AY&V@LJX_P#0JN7>N6]K<M;)!=74R %TMHMY3/K0!IT56LKV.^@,L:2Q
M@':RRH58'Z50?Q':^8R6UM>7@0X9[:'>H/UH V**J1:C;R:?]M9FBA ))E4J
M1@XZ50_X2:VQYGV._P#L_7[1]G/EX]<]<?A0!M456>_MUTY[Y&\V!4,F4YR!
MZ5F+XGMMBR2V5_! V,32083GIR": -RBJ&H:M!I]O#,R2S+,P2,0 ,6)&1CF
MH[76?M5RD/\ 9FHP[OXYH-JCZG- &G1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIT444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>annexd_004.jpg
<TEXT>
begin 644 annexd_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWC>2".Y$9\]5QN*M&[+GD<$@\]*+:??^ &W167I&O66LZ!'K,'F16S(S,LP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P/-/CT^RB+F.SMT+QB)RL0&Y!G"GCD#)P/<U#5XV\FOO'?6_FOPM_D<]X#
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M^-$=&O5/\@>S]'^H[2OW/Q2\1++A&N+&TDB!/WU7S Q'K@XS]16)#<175_\
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M\?4UTUK96EC:K:VEK#;VZ#:L,481%'H .*6VM;>RM4MK2"*""-=J11($51Z
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M_P O\OS)M_E^?^?Y',6FIZCK]SKSS:U)HMKI=ZUL%MHX3(550=\C2JXPV[(
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M>WR_'^OQ&]/Z['I-%<3:QW.L^.O$^FW=]>#3K=+5HX8+F2$JS(2<,A#*/EZ
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M\Z0S20R!@(RTK9<[@6&&8_=XQS1'?[_R![?UW.XHHHI %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^'EIK5AX*L;/7X7AOH2Z;))EE98PQV NI(.%P,^U=)--';P23S.$BC4N['H
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M/&5.T-&@'(8 @@$\UH^']$TSQ;XQ\5:GK]C#J$MG??8+:&\C$D<$2HI^5#D
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MA]KAA;3+[QSJ-WH'E^4+(VT:2LF,;7G'S,,9!Q@D=Z[^BAZ[CN<S;>";#_A
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M</=WUSC?*0,*,#A5 Z 5OT4EH-Z[F#X:\-?\(]/K4GVO[1_:>H27V/+V>7N
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M[D9,9R,?>SGFMJBCMY?U^H;G(>(_!E_J6O1:[H7B*;1-3$'V:606R7"2Q9+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGB34IM'\,:IJ=NJ--:6DL\:R E2RJ2,X(../6I=$O9-2T'3[Z9466YMHYG"
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MP)0G('(!![^M;<+F2"-SC+*"<?2O)+SQ--XK^ &LW]Q,D\T:R6[3HA03;)
M^T_=W#!Q[UU'BK5-2-WX>\-:1>&QNM6+-)>*H9H88T#/M!XW'( /:G;=>:_*
MX732?K^#2.VHKS#6=+U;X<6">(++Q1K>JV<,\8OK35IQ<!HF8*2AP"A&X'BM
M'QI<:U)XV\*Z9H^J26"7T=TL[J-P"!4.X*>"XYP2#C/2BU[6]/PN'>_J=]17
MF6I:;JOP]GL=7MO$^LZK837L5O>VFJSB?Y9&VAHSM&T@D<#@U<\2-K5]\3=/
MT73M8N-/L[C2I)+EH<%@%D'*!LJ'.0-Q!P":6]K?UI</Z_&QZ#17D\^E>)?#
MOC+2_#6E^+M4N+#6(9GEGU)UN+BV\O!)C8@#)! P00,DXJ]#I^J>"O'.@6D7
MB35]5T[6&FBGAU6<3-&ZH75D; P.,8II7MY@^OD>E45X]XU\<Z9)XTOO#^K^
M+;_P[IUC%'DZ=&WGW,K#<?WBHQ15&T8XSDU>^&WC&VU#Q/?>'M/\0W7B#3(K
M1;FWO+R-EGC(;:T;LRJ7ZJ0<=Z4?>V"7N[GJ=%>3^%]%UWQGI^I/J7BW6K*S
M@U2ZBMDTZX\J5@LC<O(0S$#. HP  *W/!S:M.OB;PSJ&M7=Q)IMRL$&H@()_
M+>,,N2006&>I!S1T^5_R_P P_P [?G_D=G97]KJ,4DEI,)4CE>%F /#H2K#\
M""*LUY1\*?")CLTUD^(O$#F&^ND^Q/>YMI,2.NYDV\D_>)SUYKU>FUHOZ[!U
M845YY<Q:IXY\5:UIL>NZAH^CZ0\=N?[,D6.:>8J'),F"54 @8'7FIM&?5?#'
MC2#PO>:O=ZKI]_9R3V=S>$-<1/&0&1G &X8(.2*2U^?]?H#T^7]?J3ZWXA\3
MW7BB?0/"5II)FLX(Y[NXU1Y @WD[44)SG"YSTKLX3*8(S.$$VT;PGW0V.<>U
M>/:'X->Y^+'B9'\4>(U:S%G*9([Q8S<94G;+M0!E&,  #@FO9*:^%>?_  0E
M\37]="LVH6J:E'IS3 7<D33)%@Y**0"?3JP_.L>]UZZMO'FDZ$D<)M;RSGGD
M<@[PR%  #G&/F.>*X;6O"4FL?&1H'\3>(+42:0UPKV=VL+1CSL>6I"?<[X.3
MD<FKGBC3M2?XC>$]-TS4YK>0:;<Q2WL@$DPC'EY8$\%S@<D=R<41UY7WO_[=
M_D$M+KT_0].K,?4[I?$L6F#3)VM'M6G-^#^[5PP'EGW(.>O_ -;AY=,U/P+X
MGT!K?Q-K.JV&J7GV.YMM5G$^"49E9&P-N"O0=:W+B\NE^+MC9"YF%HVC32M
M)#L+B5 &*],X)&:$KM?/\$#Z_P!=3KZ*\?O&^W^)KZW\5^-/$'AR\6ZD6PAM
MYQ:VDD.1L*N5*R$C&06SG(Q7JVFV\MIIMO!->R7LB( US(%#2>YV@#\J2U5P
M>CL0Z[J?]BZ!J&J>3YWV.WDG\O=MW[5)QG!QG'7%<3:>-_'M]9P7=M\,]\$\
M:R1M_;T W*1D'!7/0UT_CG_D0?$/_8.G_P#19KC?#WBGQ[#X<TN*W^&_GP):
M1+'-_;D">8H08;:1D9'.*%K?Y?J-[+Y_H>FV[RR6T3S1>3*R O%N#;&QR,CK
MCIFI*XWQW?6$&E6XU7Q;/X:B<,T@M9$$THQRJ'!;CU49Z5ROPZ\46ESXWET3
M1?%>H^(=(:P:XWZD&,T$JN 1O9%+ AOPQ37O-HG9)GI.FZG=7VH:I;SZ9/:1
MV<XBAFD/RW*E0V]>.@)QWZ?4#3KCO"][=7'B+QI%-<S2QV]^B0H\A81+Y*'"
M@]!DD\5SG@/2M<\7>%](U?6/$^KP1PMF&WLKC9YP1R,S.06?=CID#&._-"UM
MZ+\1OJ_-H]4HKS6YMM<\0?$OQ!HT/B"^T[28K2VDD^R.!*&8,,1LV1'GDD@9
MR!5G08-4\+?$"/P[)KNH:OIEYI[W41U*02S0R(X!^? )!#=.U):V\_\ @_Y
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M[X9?Q!X'71GF-K=+%$T4HY\J:/#*?<!A72T4?U]P=4<%!KOQ(1TLIO!5A)*
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M/J*ZZBEZ>OX6#^OO/-K^S\9>/(HM)UKP];:!I GCENV-^MS)<*C;@B!  H)
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MY;@6\D4YQN:-R"N&ZD'\*BN=-\7^.S;6GB#2K70-#259;JT6\%S/=;2"J;E
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M<G+O_G<E*R2"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_B76-#GM/LUSI_ENA\S<)X7'#C@8Y!!'/2B/Q']H\:3^'K>UWBVM%N+FY\S
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MSC@@CD$<&A:JX/0WJ*\ZLOB3K&N6+3>'/!=UJ4D4SQ7&Z]C@BC96(PKN/G.
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MC5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.6NNFL[6XN()YK:&6:W):&1XPS1DC!*D\@D<<475G:WL:QW=M#<(KK(JRH'
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M1'E9.GWMBG;U'7%&V@+4ZJBLMO$FBIH0UQM4M1I9&X79D'EGG'7Z\8K*\/\
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M0J.K'L/Q.!2;LKC2N[(TZ*\YLO!OB'Q/8PZGXB\7:YI]U.OFK9:/<"VBMU8
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M@9&$B_*%*@D'(7.,<UT6I:]I>C26T>I7T=L;@/Y;2Y"G8NYB6Z# &><4>O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)=/NFBF#<DDOR6))).<Y-4]#^'NG:/J46HW&J:UK%Y!G[/+JUZ9_(R,'8,
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MM^TM(F/D;! 90I.3P!DU+H]AXFUSQK8^(M:T2WT&.QMI8! EXMQ+<%]OWF4
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M *M_IMAJML;;4;*VO(#R8KB)9%/X,"*CTW1-)T9&32],LK%'.66UMUB!/OM
M]!5ZB@ HHKE_'.KWVCV&E2V$_DO/JUK;R'8K;HW?##D'&1WZT+5I =11110
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M>ZN@N+G69;1XI[^YN'D>4$9/!.U>0. !CI7'^!_AMHOB;X?Z)>^)#=ZC<M;
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M6?$_@[QOK5[-,\D$]E!*;>W3<0JP[9%'  R<=0:]<\)>%[W2;G4=6UN_CO\
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M%O*NZ.6)@RL/4$=:FH **** "BBB@!&4,I4]",5F^'M"M?#6A6ND6<DTEO;
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MMO#UE'"T$=FUW?RNI)0$[8U4@@ DAB<@\"J'CJ/=H^G>*K)2\^C3+>K\I#/
M1B5<8SRA)QZJ*3X>1OJ-OJ?BJ<-YFMW)DAW#!6V3Y(1CMD M_P "H7GTO?\
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M9SCWI+K\OS8WLO5_D4/"5]<^&OA;XEUZPM1%9_:;J^TJWN$(40<%/EX(4X)
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M\K9F*32VESGT82?S%<#X$O\ QK<>$S;>&-/T>.&WO;E7NM6EDQ*3*Y(1(QG
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M\MH7\P,R+NRA[@@C%5OA3_R(D/\ U^7?_H]Z9X/FCMM7\=3S9\J/52[[5+'
M@C)P!DGZ"AJUUY?CI_F/K\[?B_\ (J:3KGQ%UFWM-9M+#PN^D72++';"ZF-P
M$([R8V9'T]JZWQ!/K\-D@\/65E<7DC;2U[.T<<0P?F(4$MSC@8KRC4O$/@MY
M[B7X?7VH0>)R^Z.RTZUN$BN),X(EB91'CU. 1Z\5K_$&_C@\4::GBZZU&R\*
M-8EI&LC((WNMV"DK1_-MVG@4WJM-/^&OOU_S$M_Z_(Z'0O$?B>#Q/'X>\566
MEBZN;9[FUN=,DD\IPA 9&5QN!^8'/2N<T&[^(=UX\\1B >&UCBNK>.[29YW*
M)Y8($1 &?E)^\!\Q]*SO!VF>&K7XH:3>>$='N;32;C3[C%U-YH6Y8%#E!*=V
M ".< '/?%;EKXFTWP?\ $CQ):Z\T]H=7N+>2PD^SR.EQ^[5"%*@\AN.::6J[
MV?YHE[/Y?DSITU5S\3Y=(^R6FQ=(6X^T"/\ ?$F4KMW9^[WQCK63<>)O%NOZ
MC?0>#+'1Q9V$YMI;W5I)-LTB_?5%C&>#@9)QUJ:/_DMUQ_V $_\ 1YK$T?Q1
M8?#:35='\5?:+*!M0FN;.^^SR2Q7"2L7 #(IPPY!!]*E;*_;]7^A3W=O+\O\
MSJ_"WB>[U6[U#2-8L$L=9T[89XXI-\4B,,JZ-P<'!X/(KFM'\6^/?%FE-<Z#
MI6AV_DW$L,EQJ,DH24JY&(T3)Z;<DGKGBK_A(SZ_XUUCQ:MI/;:;+:Q65G]H
MB,;SJI+-)M/(&3@9ZU/\*?\ D1(?^OR[_P#1[T[7W[+\W^@>G?\ 3_,TO!OB
M2Z\0V-ZFHV*V6I:?=-:74,;[TW@ Y4^A!!KH9O\ 4R?[I_E7'>!_^1@\:_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% !1110 5FZ;HEII5[J5Y!O:XU&<3SO(022%"A1Q]T <#ZUI44
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MMZQXWTC0M5ETV]^T_:EMTG1(HC(TVYF4(BKEF;*GC'3G/6M+0=8_MW2H[_\
MLW4-.WLP^SZA#Y4PP<9*Y. >U<K]FAE^.C321JTD.@*8V(^Z3,P)'X5WE)?"
MGW_S8/>R_K1!7-ZQXWTC0M5ETV]^T_:EMTG1(HC(TVYF4(BKEF;*GC'3G/6N
MDK@_LT,OQT::2-6DAT!3&Q'W29F!(_"A:NWK^0]$F_ZW1MP^,+$>%F\0:E:W
M^D6JD@PZC;F.8'. -@)))/0#DUGZ7\2-+U#5(K"ZTS6M)>X?R[675+%H([EN
MP1B3R1T!P3FLCXO)=?8_#L\.H_V;!#JT;2WQ@$RVY*L$=D;@@,1UZ9%0:AX%
M\5:M;VJZQ\28[JQ6XBG5#H\,8=E8,N'5@1T[4XZN[VO;\B972T[7_,V;G_DM
M6G_]@*;_ -')5_Q%XWM/#UZ+(:1K>J7>P2-#IE@TQ13G!)X7MZYJA<_\EJT_
M_L!3?^CDK-BU7Q9XSU/6X=&UVQ\/V.EWC6FXV8N;AV3JS!F"JI[<=J7V5;S_
M #93W;]/R.BL_'.EZCX:NM:LH-0F6U8Q36B6CFYCD&,H8P,YY'M[UC?#SX@7
M/BJSM(;S0]:BGDB>5K^6R"6C?,<!9 >>, <<X-9_PQ:9W\:^?JR:O,+_ &O?
M)"L0F81 $A5X'3''I6U\*Y%F^%>BB%U9EMV3@YPP9N#3VN_)/[[D]EYM?=8?
MJ?Q)TNPU&:RM=,UO5VMY#'=2Z98--';L.H=N!D=\9QBNAT[7M,U71$UFSO(W
MT]D,GG$[0H'WMV>A&#D'IBO(_AYHGB^]\.-!IWQ!&FR6UQ-'<Z>=(AF>"7>2
MVYF.XY)SD^M;.H^%;[0/A!XKLH]8&KW=RTUU+-%;B+EMID78K$#@,>/7I2>D
M7\OT_#6Y=KRLN]OS_KYFPGQ5T6Y+LNFZZFF$';J[Z>XLR.F?,Z@>Y %6/A-_
MR3'1<$$;'Y!_Z:-6M!J>BGP0E\MQ;_V1]BSOW#8(]G3TZ<8K'^$6T_"W0]OW
M?*?'T\QJJUG)=K?FS.]U%][_ )([:BBBI*"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY:^>3N(#N(\_]<PVS]*[2BCK</(H7VB:=J(L1=6P<6,ZW%L Q41NH(4X!&<
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MK#09OXX&MUEWMQ&2&(QG'4#G&:PM9^&W@_Q!JHU34]#@GO,@M('=-Y&/O!2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX1,;3@D<"E'7^OZ[!+3^O3_,[ZY\0:+96K75UJ]A!;K(83++<HJ!P<%<DXW
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M_*@;(7G)XZDT]]NUR;VT?>WX7/3HIHKB%9H9$DB<95T8$,/4$5RGPTO+J_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS/\ A7VL:E(L'B;QG>:OI*2*ZV(LXK<2;3D"1TY<<#TSBN^HHOK<.EA  H
M  X %<GXA\#C7?$=MKD>K76GWMI;&&VDM@-T;%LECG(8$9!4CO76T4O,/(XO
M1_ ^H1ZW;:QXF\37&O7=GN^R*;5+:*$L,%MB=6QD9)[U9\0^#)=2U8:UHNM7
M&B:SY0@>YBB65)4!R!)&W#8YP>*ZNBA@<_X;T36M+:676_$]QK4SJ%&ZUCMX
MT&>H1._N2:V[FVAO+6:UN(UD@F0QR(W1E(P1^52T4/71@M-C@;3P%X@TIXK/
M2?'=_;:)$<)92V<4TBKG[BS-\P X X. *V/$G@\:U?6VJZ?J=QI&M6L;1PWL
M"*^4/\#HW#KGG!KIJ* V.0T3P5=6VL0ZSXB\07&O:E;HR6SO D$4 ;J5C3C<
M1QDFM2Q\/_8O%NKZ[]JW_P!H0P1>3Y>/+\L-SNSSG=Z#&*VZ*=P,6X\/^?XR
MLO$'VK;]FLY;7R/+SNWLK;MV>,;>F.]8^K^"M2F\3RZ[H'B:?1KBZ2..]C%K
M'<).J?=P'^Z<'&>:[*BDM+>0=SEO$7@YM6U*'6-*U>XT;6XHC"+R&-9!(G7;
M)&W#@'GM4WAS0M=TR>2?7/%5QK4C+L5/LD=O&@SG.U.K>Y-='10M >IB>&O#
MW_".Q:DGVK[1]MU":]SY>S9YASMZG./7CZ4NA^'_ .Q=0UJ[^U>=_:=Y]JV^
M7M\OY%7;G)S]W.>.M;5%'_#?E_D'_#_U]YB:5X>_LSQ'KNK_ &KS?[5>%O*\
MO;Y7EIMZY^;/7H*\[\'>%M8O-+U._P##_BFYT2>?5KL7"?9DN8I-LK ,$?[K
M8P,@] .*]?JEI>D6.C6TEOI\'DQ23/.R[V;+NVYCR3U)Z=*%^EOQ!_K^AF>%
M?"EOX7M;H"[N+Z]O93/=WEP07F?IVX  X '2LV/X>VK> Y/"UW?2R(T[SK<P
MKY;HYE,BD#)Y4D?7%=E10_Z^6P'G5]\-M;UW1[K3?$?C>[U*%TQ B64=ND;_
M ,+.$.9,'!P2!FNA\4>$SXAL;!;?4YM.U#3Y1-:7D2!]C[2O*'A@0>E=)11T
ML!R]SX0DUGPFFC^(M6FU&\1_-748H5MY$D!RCH%X4KT_G5*P\)^+8=0C>_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!AS^,_"
MUK<26]QXET:&>-BCQR7\2LK#@@@MD'VK9BECFC62)UD1AE64Y!_&O-O _ACP
M_JZ^);G5-#TR\G&NWB^;<VD<C!0PXW,"<58^',%I8^(_%]GHS#^P(+J+[,J/
MNB24IF54.>@...U->?:_Y?Y@]+V[V_/_ "/1**X27Q]K%[,\WAOP;>:QI44C
M(]]]KB@#[3@F)&YD'!],XK5?QSI0\&?\)/$EQ+;$A! $Q+YI?9Y94]&W'')Q
M2Z7#K8Z:BN/TCQ1XJNM5BM]5\"7.G6DK86Z74(9]ONZK@J/SINL>.Y=/\4W7
MARQT*YU+4DM([FWCAE51(&+ [F8!8U7"\DG.[@4 =E17(>'_ !K=7^M#0]?T
M"XT+5GB,T,4DZ3QS(#SLD7@D<9'O3-7\:ZBNJW6F>&?#-QKUQ9L%NW%U';0Q
M,1G9O?[S 8R .,]: .RHK"\-^*+?Q#:W1:VFL+VRD\J\L[G&^!L9Y(X*D<AA
MP17.I\0M9U5C<^&?!=WJVD*Y3[<U[%;^9@X+1HW+CK@\9HZV [^H+R\MM.LY
MKR\GC@MH5+R2R-M50.Y->>^,_%?BC3O%WARQTGP[/<K,TLGE&^CA%TPB.4SD
MX"[LG<!DJ,>M9_Q-UKQ#-X'L(KGPF\3W=U;_ &J(WT3I&?-XB)!RV["\XP W
M)XHZ?.WXV_K_ ((=?E?\+_U_P&=YX;\8Z!XNCN'T+4%O%MV"RD1NFTGI]X#/
MU%;M<=)XMU72_#EOJ&L>&1IUU+?PV0LQ?)+A'8*'WHN.,GY<=JW?$FL?\(]X
M:U'6/(^T?8X&F\K?LW[1G&<''Y&F]-?Z_K4%J3:CJ]CI+6:WL_E&\N%MH/D9
MM\C D+P#CH>3Q2RZO8P:Q;:3)/MOKF)YHHMC'<B8W'.,#&1U-<?XXN/M4?@F
MXV[?-UNU?;G.,HYQ4^KEA\7?#Q4 M_9EY@$XR=T=%N_=K[E<3>EUV3^]V.VH
MK#\)^(U\3Z,;QK;[)<Q3R6]S;&3>8948@KNP,]CG'>D\.>(_^$BEU5H;7R[.
MSO&M(IS)GSR@&]@,# #9'4YQ1;^OZ]1_U_7W&[17/>*/$[Z ;*UL],GU35+]
MG2UM(I%CWE5W,6=N% &.>>O2F>&]>U_4[B6WUSPG<:*ZKO5_MD=Q&XR!C<G1
MNO&.W6DM0>ATE%8GAGQ!_P )':7L_P!E^S_9;Z>SV^9OW>6VW=T&,^G;UHTK
MQ#_:?B/7=(^R^5_93PKYOF;O-\Q-W3'RXZ=31_P_Y?YH/Z_K[B]I>KV.LVTE
MQI\_G11S/ S;&7#HVUAR!T(Z]*NUY!X.\4:S9Z5J=CX?\+7.MSPZO=F=_M4=
MM%'F5B%#O]YL8. .AZUW_AGQ7!XCL[MOL=Q8WUC(8;NRN0 \+XR.1P01R".M
M'2_E?\$'6WG^K.@HKSFP^)>L:[H]OJ7A[P3>:C"0?M+&\CA6-A]Y4+C,I&.P
M [9J2W^)=_KU@EUX2\(7^KA?EN?.N([187[QY?.YAQG QSUH ]!9@JEF("@9
M))X%1V]Q!=V\=Q;31S02*&22-@RL#W!'!%8>A>)K3Q1X7GU%+66,)YL-S:3X
M#1NF0R-C_/-</K'B>\TOX/:/>>&-!EMK>YCA51%=J!:*TB@+N8AF+9QD#C))
MH_X'X_U_6@KZ??\ @>LT5Y_K/BSQ;:^ M8U*Z\(2:=?0QN(T3489@B;"3,6!
M'"G^$9)J[X.\1:]=:+]H\2:!_9-G;V:2K>R:BD_G@+DL0HRO SSZT=_(?;S.
MSHKS\_$/6I(AJEKX%U*;P]L,AOC<Q+,8_P"^MN?F(Q@]0<=JZ'4_&&E:;X43
MQ'ODN+*5$:W6!=SSE\;%4>I)QB@-W8U=2U&TTC3;G4;Z7RK2VC,DLFTMM4=3
M@ D_A4\,J3P1S1-NCD4,IQC((R*\H\:>,-=E\":['KO@V\TBSN+1XH+H7<=P
M-S A1(J?-'G@=QD\XKT[2/\ D"V'_7O'_P"@BFEHW_6PF]47****0PHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPPT;: ,I(3@=_,:CX6J!X1F( !.I7A.._P"_>NOM+.UL+5+6SMH;:WCX2*%
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M' 5C@T[,KED;U%(K!@"""#T(I:1(4444 %%%% !1110 4444 %%%% !1110
M444ULXXZT +F@<]Z\XBU/6->\=R0V5R\5E9L0X"@@X(%>CBFP%HHHI %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQZ"M^@ HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <+X]\!W'
MBR_TVXL[F*WVYMK_ 'D@RVC,K,BX!^;*C&<=3S73ZYHL.M^&[[16<PPW5NUO
MN0<H", @>U:=%*WN\O0=];GG$'AKX@76D/X>U+6=$@TD6_V87-C!(+J1 NT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !16?JVLVFC6RRW+,
M6=@D<4:[GD8] H')_I5>--9O[@M,5TZT ^6.,AYG/JQY51[#=GVH M7^KZ?I
MJ%KNZCC/92<L?8#K61=^-+.SM1=R6.HBV+(@D-LRY+=  >3U'3^E3KINA^&$
MNM8F"I(1F:[G;<Y[=3T^@JKI-E>ZYJ$6NZQ%Y,<1W:=9AO\ 5JRC+R#N_I_=
M_6D!U%%&<#)KEM?\?:-H,C0-(UU=+]Z&WP2OU). >1QUI@=3167H%_?ZEI2W
MFHV*V+R'='%YFX^60""W P>O':JLVL76I?:+;P^D4LD9\MKR8Y@C?N..6(]!
MQV)% &I?ZE::; 9;J94'0#JS'L .I)]*S)9]:U6-!8(NG6[C)N+A=TF.HQ'V
M]/F((]*M6FB6\%\-0G=[J_$?E^?+_".X4=%'/U]2:NW5U!96SW%S*D4*#+.Y
MP!0!0CT_3M(,NHSN#-M_>7=PV6QC'7H![#%<\UM/X\N8I;E/+\-(0Z0NI62Z
M<9Y/HN>WM2Q6MSXYD%S>,T&@*^8;7;AYRI^5V/89SQ]*[-$6.-40850 !Z"D
M JJ%4*H  & !VI:**8!1110 4444 %%(6 ZD#ZUF7FOV5K=BS0M<WAP3! -S
M(I_B;LJ^YP* -2L+6O%%GI5S'8Q*UWJ<O^JM(N6/H6_NCW-<T_B37?$VKR:7
MH$UO"(&_TF[0>9'$.FT,>K^V.W7@UU.B>&-/T.2:X@$DUY/_ *VZG;?*XSG&
M>PSV'%("?1Y-6EAEDU:""!V?]W%$VXHN!U/<YS6E113 **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4'N;;09SI&BVIU'7)8_-D\V3G']^60]!GHH_ 4@*VI7-W;VL4_B!GGN9I?\
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M#ZC@8.Y^GZ%>:OJZ:YK^ $!^RZ:?F2$'&&;/!?K]">IXQUE "*JHH55"J!@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'MT'>H/"7AJ:YL(WO;>6QLO,9VLV^_=M@?O)FSDYY^7@>V*[]$6-%1%"JHP
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MD\[@=NT9X^AY[NL(^%;-O$\VN23W+RRHBF R8BRN,-M'4\#KQWZUNT %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E:WK
MD6D6Y"H;B]=28+6/EY,>@]*J>*O%=EX6T_SI_P!Y._$<(/)]S[5R.@:)K/B;
M49-8U226SCE7;N7*R.AZQK_<3(R>YR*5P+MBNI74[1VMRD^M3?\ 'SJ&S?%9
M*.3&F?XN<<>H-=GI>E6^E6PBA!:0\RS/R\K=V8]S4]I9V]C;);VT2Q1(,!5&
M*R/%$>O7%DEMH?E1O,2LL[2;6B'8KZGK^E,#G?''BZZ#?V%X<W3ZA*K>;) 0
MS1 $94>Y&>>WUJSX-\"1Z.JW^I$7%^_S!6Y$1/)^K>_UQU-:GA7P?8^&(&:,
MF>]E'[ZY<?,W? ]!DFNCI6 ***P/$.O7>FS6UCIFGM>ZC<AF1/NHBKU9F[=0
M*8%C7=>BT: *D;7-]("8+6/EY/4_0>M4= T&[2Y.KZY<?:=2E'RH.$MT)R$4
M="0<C=UZ^M3:%X<_LZYDU&_N&O=5E&'N'_@'=4]%]JWZ "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJEJ]Y/I^ESW5M9R7DT8
M&R",X+DD#],Y_"@"/5M;L=%BB>^F$8E?:N2!]3SV Y/]3Q6!=ZEK'B6<V>A%
MK*P!'FZC(ARXQRL:G!]LU'9>$KC6KU-7\5LLTX&(K%#^YA&[(^I.!GZ5V8 4
M8 P/04@,O2?#NFZ- J6\&^3.6GE^>1SUR6/-:M%%, HHK(\1:E=Z9I@ELK22
MXF>18\HN[R@>KD>@_P * )]3UFRTH(+F7]](#Y4* L\F.P KF1'/J]S!?>)V
M^R6I8_9-*'S%RO.]\<L> <=!^-)IEIJ5Q?27EM:,+IT\M]2U!?F"]A&F>G4\
M_E72:=HD%C(+B622[O=NPW4YR^.N!Z#V%(#.AMK[7HE\Y)M*TU68"U7"RS+T
M^8C[JGK@<^I[5173K?7-=EB1571=+8(D,7"33\E]V/O!?E&/7/I6UXEU<Z1I
M)>+F[N)$MK9?65SM4_09R?85SAU./P];V_AKP[!_:&HH"6!;(C).6>4^I8D_
M7/I0P.@N+C1_#EL)IOLUG$25'R@$]\#')Z=JYB8>(O'$IBA\_0]'1CF4\37*
M],8_A&"?TZUI:9X+DEOEU3Q->#5+Y5 C0H%BA_W5_+\J[#I0D!FZ3H6G:);B
M*PM8XN/F<+\S>Y-:5%%,!" P((!!X(-1_9H/*>+R4$;@AE"@ @^M2T4 0V]I
M;VD8CMH(XD QA% I\D22KMD177.<,,T^B@ P,YQS1110 5$EK!'/).D*++)C
M>X7!;'J:EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *ANA<&TF%H4%P4/EF3[H;MGVJ:B@
M#A-#\#7<VHRZKXNG@U"_W 0K$S-$BC.."HYYKNP,# Z444 %%%% !1110 4F
M!NW8&>F:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH PO$_A]]?M[-8KEK:6VN5E$B
MGG;T8#WQT]ZGT3PYIOA])A8PE9)VW32NVYY#ZDFM:B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP!6OH?B#5K^RO)-8\-7.CW-LF\QR7$<T<G4_*Z]>G/'>E?2X=;'145YIIGQ
M\<:SIEOJ-A\-?.M+E!)%)_;L*[E/?!4$?B*]!T^XNKC3+>XO[/[%<O&&FM_-
M$GE-CE=PX./4535MQ7N6J*Y?P=XU@\7MJ(CM'M3:RXC#ON\Z%L[)1P,!L'CG
MIUKJ*0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML<=3P.:EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2,H=2K#((P12T4 <AH-P-&EU>QE/%OF9,]P/\K5KPE"8M+N-1G/SW#M
M(S'^Z,_US5?Q+H=_=:@+G3XMXEB\N;YE7H?<_3\JU=1LKF+PU]@L(O,E\M8L
M!@O'<\GZ_G2N[7Z[!UM\SDU-MJ-AK%[<7$*7,K[H4>0!L#G 'TX_"NFM;W[?
MX-DF)RXMG1_J%(_^O4=AX2TU;"$7EINN=O[P^:W7\#BJ^E:3J-C9ZM8O ?(E
M5_L[;U.3@CUXR,=?2F]F@6Z9:\&?\B^O_71JI^*O^0WHW_73_P!F6H=,B\4:
M59BU@TVW9 Q;+NI//T<5HZOI%[JUC9W *0ZC  Q7/RYXR,\]Q3;U3$MFB7Q?
M_P BY/\ [R?^A"L?7/\ D2--^L?_ *":ENK+Q)K<:6E[%;VT 8%W4@EL?0G^
ME7_$.D3W.A6]E81>88G7 + ?*%([XJ7L4MT-TG6[ZXDMK631KB&(J%\]MVT
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M+A92F\+D#/<U):WVJRW*)<:/Y$1^])]I5MOX#K3O<6QIT444AA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
;%%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>annexd_005.jpg
<TEXT>
begin 644 annexd_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWC>2".Y$9\]5QN*M&[+GD<$@\]*+:??^ &W167I&O66LZ!'K,'F16S(S,LP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P/-/CT^RB+F.SMT+QB)RL0&Y!G"GCD#)P/<U#5XV\FOO'?6_FOPM_D<]X#
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M^-$=&O5/\@>S]'^H[2OW/Q2\1++A&N+&TDB!/WU7S Q'K@XS]16)#<175_\
M$R2%M\?DHH8="1;D'![\@C\*[S4=&TO6$1-4TVSODC.Y%NH%E"GU&X'!J4:?
M9!9E%G;@3H(Y1Y2_O% P%;CD8)&#425XV\FBD[2OYI_<<EINA6VL>$O#$BW\
M^GZI;:?&UK<VSJ)%!C7<-K AE.!D$$=.AK"\1:MJ5YX#\6Z;J<MO=3:9-%"+
MVW38LV2C<KD[6&<$ XKT*\T#1M1LX;.]TFPN;6  10SVR.D>!@;5(P...*E&
MDZ:--&FC3[06  46HA7RL#D#9C'Z5I*5Y.7G?\4S.*M%+M_DT<OJ*%/BOX=F
M;A'TRZC4GNVZ,X^N,G'L:39))\5-7CB;;(VA0A6]"99,&NJU#2M.U:V^S:E8
M6M[!D'RKF%9%SZX8$4^'3[*WG$\%I;Q2B)81(D85O+7HF0/NCL.E3NK/S_$I
M:?A^%CE?!=Y;:7\-+07\R0'3K8PWOF''E.F0P;/O^>1ZUS.E6=S9:7\,8+U6
M$PNY7V.,%%,,K*I'8@$#\*])GT/2+K4(]0N-*L9KV/A+F2W1I%^C$9%69K2V
MN)H)9[>*66!B\+N@8QL002I/0X)&1ZU7-[W,_P"M_P#,5M+>OXG+>)/^2@>#
M?]^[_P#1-6O'^DW.M^!M5L;-"]RT0DB0?QLC!POX[<?C6_):6TUQ#<2V\3SP
M9,4C("T>1@[3U&1P<5-4]+?UNG^A2^*_]=?\S-T36;+6]'AU"SF5HF3YP>#&
MP^\K#JI!R"#TQ6% &MOBG<SW$@\B_P!+B2S8GABCL74'U^93CN/I6S?^%O#V
MJ7/VG4-!TN[N,8\VXLXY&Q]2":N7FF6&H6?V.]L;:YM< >1-$KIQT^4C%.^M
MR4M+'*0YO/B=J]U:RA[:UTF.UN"O(\XNSA2?4+R1VW#UJQ\,P%^&FA  #_1<
M\?4UTUK96EC:K:VEK#;VZ#:L,481%'H .*6VM;>RM4MK2"*""-=J11($51Z
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M_P O\OS)M_E^?^?Y',6FIZCK]SKSS:U)HMKI=ZUL%MHX3(550=\C2JXPV[(
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M>WR_'^OQ&]/Z['I-%<3:QW.L^.O$^FW=]>#3K=+5HX8+F2$JS(2<,A#*/EZ
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M+X3^'M#U'X@>.+:^T?3[F"VNBL$4]LCK$/-D&%!&%& !QZ"G%)M/HU?\;?\
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M*96P?8XHA=J*[N0Y:2D^RB>H:/\ $CP?KUW/:Z=KUM+- K,ZN&C^49R07 #
M $Y&>*-(^(_A#7M6.EZ;KMO/>@D"/#+O/^R6 #=/X2:\A^)/@[0H?B_X2T^U
MTVVM+._,:W$%M$(T?$F#PN!R.#5KXI:!I7A[XA^!IM&T^VT]I;I5<6L2Q!ML
MD>"0N.?F/-.%I<OF[$RTNNRN=EX]O;NW^(GA&&'Q9_94,DV'L=DI^U?,!CY%
M*G.=OSD 9R*3QK\7=.\+>+M*T:.XM7B,I_M24J\AMD[ !/XO;!QZ<U@?%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;K2@/)O[5=A8A2.5#9QST#=NM=[10];^>H+1)=OZ_0\S\-?"+^S/$5MKVO\
MB;4?$%_:9^S-<Y"Q^GWF8G')Z@>U>F444[]!6ZA1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17-
MS;V5M)<W4\4%O$I:265PJH!U))X J6HKFVM[VVDMKJ"*>WE4K)%*@97!Z@@\
M$4 8G_"=^#_^AKT/_P &,/\ \54P\7>'7TR]U&#6K&YM+&/S+F2UF$_E+SR0
MF3V/Y5P_BWPCX:MO&?@N"#P]I,4-Q>3+-''91JLH$1(# +@C//-;7C;0M'T3
MX:^)_P"RM*L; 2V$GF?9;=(M^%.,[0,XR?SI-VCS?UT_S&E[R7]=?\CM894G
M@CFB;='(H93C&01D4VYN;>SMWN+J>*"!!EY)7"JH]R>!7G=MX]UV/1;.]TSP
M-J%]HL=LC/>FZCBD90HRR0GYF'ITS6QXHU[2-0^%MWKDEB-3TN:U6?[,[F/S
M%)& 2,E2#^HJY*S=N_ZDPUMYG8@@C(Y%%<QX@\4R:(-.L-,T:;5-4OHV:VLX
MI5B7:@&XL[<*!D#OUZ5-X;US7-4>:+6_"\^BS1@,I-U'<1N#V#)W]L4@OHCH
M:PY_&?A6UN)+>X\2Z-#-$Q22.2_B5D8<$$%L@UN5X]X6_P"$ ^T^(_\ A)?^
M$:^W_P!N7>/[2\CS=F[C[_..M+J5TO\ UU/5]/U.PU:U%UIM];7EN25\VVE6
M1,CJ,J2,U:K$L)]%L/#<MWX:M+6YL$#R1PZ.L965AU";2%+9&.M<Z/'^MV%]
M;_\ "0^"[O2M,N9TMXKW[;%/M9SA?,1>4!X[G%/K9$]+L[A[JWCN(K>2>)9Y
M03'&S@,X'7 ZG%2URVLW5A%X^\,VT^F)/>S1W1M[PR$&W"HNX!<?-N!QUXJM
MJ?CR2T\1:AX?L=$N-1U2WCBD@@AE5?-#J22S-@1JN ,DG[PXI=/O_ ?7[OQ.
MRHKB]5\=W/A^UT)M8T">*\U1Y(FL[><3O%(%RJ @8<L<#.0!GKQ5>+Q]J]EJ
MMI;^)/!UUH]E>W"V]M>?;(KA=[?=$BI]S/'<\TTKNR%?2YWE%<[XD\5?V'/;
M6%CIEQJNKW:LT%E;LJ_*O5W=N$7) R>YZ55T#QE=7VKKHNOZ#/H6JR1--!"\
MZ3QSH#\VR1."1D9'7FDM=AO0ZRBN&OO'&MS:E>6WAGP=/K4-C.UO<W+7T5LH
MD !*J&R6QGVK4U'Q<=+\-6NJ7>CWT=W=3+;PZ=\GFM*Q(5<YVCIG.>E'2X=;
M'2T5R>@^)/$]]J2VNM^";C28G!*7"7\5R@P"?FVX*]@.#UKK*+ 1SSPVT+33
MRI%$HRSR,%4#W)JCIOB'1=9=TTO6-/OF3[RVMRDI7Z[2<5Q+Z=#X\^(^K6VL
M*;C1M $445DQ/E2SNNYG<?Q8!  -:7B'X;^';K299-*TNSTG4X%,MI>6$*P/
M%(!D'* 9'J#2O9<S':[Y4=M17"6WQ %O\)['QA>0><3%%]H16V_,7$;L.#T.
M3C\*CN_B#K=FK:C+X&U(>'E7S&OOM,7G!/[YM_O 8YY(..U4U9M=B5JD^YW5
MQ=6]JJ-<3Q0AW$:&1PNYCP%&>I/85+7(^+=5TF70]#OIK"/5+6ZU&T^S$RE
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M]\RQV^FP[6F>0C.WKC@9R<X&*Q[7Q[JMG>VT/BOPE<Z%!=RK!!="\CNHM[=
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M4"(O?@#@4[VT\DON)W^]O\#QG4=)T^V^)?B&/7_%VM^&Q?-'<V<MIJ M(+A
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MN_TU7],$M5V7_#&%X4U.+QWXS;Q+",Z?IMBEM;9'_+>4!Y>?51M7\Z]%KG?
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MI5'S*7=JW]?<./Q+M>_XO_,X[7-.N-0^ WAQH#=;+2*RN9_L9Q,(E W%#_>
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M]B*+ 6**Y(_$[P5_;7]C_P#"0VGVPMLQ\VS=Z>9C9G\:K_"G_D1(?^OR[_\
M1[TUJF_ZW!Z':T45RVN_$CPAX:OQ8ZMKD$%UWB5'E9/][8#MZCKBD!U-%9A\
M1:,-";7/[2MCI:IO-T) 8\9QU^O&/6N5\$_%70/%TD5@MZJZO*\Q6U6"48C5
MFVDL1MSL )YZ_E32N[ W97.]HKROPQXS\.^$K+Q VN:K#:&37[PHA#.[#<.0
MJ@L1[XKT+1-?TKQ)IRW^CWT5Y:L<;XST/H0>0?8C-+=77E^*0/1V]32HKE=8
M^)/@[0=4&FZEKUM#>;MK1A6?8>.'*@A.O\1%;EWK&GV6BR:Q-=)_9\</GM.F
M779C.X;<Y&/2CI<.MB]16 OC?PV_B.'P]'JL4NJS E;>)6<C"[CN(!"G'."1
M6_0 45P/B'XL>'?#?B^#1K[4(8XEAD:[D6-Y#%)E=B80'D@L3QV'3-=-<>*M
M#M/#\.O7.I0P:9/&LD4\N4WAAD8!&<D=L9]J.G-T';6QL45@>&_&OASQ<LIT
M+58KMHOOH%9'4>NU@#CWQBC4_&OAS1DOFU'58;86,BQSB0-D.R[PH&,L2O/R
MYH>FXEKL;]%8G_"7:"+'3[U]1CCMM0C:6VEE5D5T5=S$E@-N%Y^;%4=(^)'@
M_7KN>VT[7K:2:!69U<-'\JYR07 #  $Y&1B@#J:*Y;2/B1X0UW5SI6FZ[;SW
MN2%CVLH<C^ZS !OP)J]XB\7Z!X3MTFUS4X;-9/N*P+._KA5!8]1T%&VH>1MT
M5C>'?%>A>++5[G0]1BO(XR ^T%63.<;E8 CH>HK9IM6"X4444@"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'&N()(8O^)OYQECB\L%?+V=$)+$^]=]X2\&:7X,M+FWTU[F07$HD9[F0.P
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M0>M6/#?A6W\-K,4U+5=1GF $EQJ5XT[D#. ,\#KV [4E\-O*PGJ_G<P?A)!
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M + "?^CS5S6_ &G:SKBZS'J.KZ7?%52:33+PP>>J]%?@Y'TP:UET"U3Q0WB
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!D3>%/#ES??;I] TJ6[W!OM#V<;2;AT.XC.:UE4*H50 H& !VI:* "BBB
M@ HHHH **** "BBB@ HHJAJ^KVNB62W=X6\MIHX%"C)+NX11^9H OT5G:[-J
ML&B74NB6T-SJ2KF"&=MJ.<C@G([9[BKZ%C&I< /@;@#D T .HHHH 1E5U*LH
M92,$$9!%4]-T?2]&B:+2]-L[&-SN9+6!8@3ZD*!5VB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX7NY)].,IPDD\DA@( &S#G<F,#Y35[Q5J.EZ9X<NYM8OY;*S=/*::%V60%N
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M@"1D9S6GX;B\6AI9?%%UI#$J!'!ID4@53GJ6<Y/'; HAHOZ_IA/5DWB[5Y=
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MGA]YPVL-9%@XB*'&=OS;-V,XKAM'\*_#SQ%XZT5_!VDSWFF0>:^H2.+@0(0
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MHHH **** "BBB@ HJM=:E8V,UO#=WMO;RW#[($EE5&E;T4$\GV%6: "BBB@
MHHJ.>>&U@DGN)4AAC4L\DC!54#J23P!0!)15)M8TQ-+_ +4;4;1=.VA_M9G4
M1;2< [\XQGWJ>TN[:_M8[JSN(;BWE&Z.6%PZ./4$<&@":BBB@ HHHH **JQ:
ME8SWTUC#>VTEY  9K=)5,D8/0LH.1GWJU0 4444 %%%% !1110 4444 %%!(
M R3@52T[6-,UB.232]2L[Y(VVNUK.LH4^A*DX- %VBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#P_X)?\C_X\_P"OH_\ HV2O4?'#6R>!==:\MVN+
M9;&4R0K)Y9=0IR V#@^^#7C_ ,)=<TG1?'OCAM5U2RL%ENR(S=7"1!\2R9QN
M(SUKTWQ?K6E:U\-O$TFE:G97Z1Z?,KM:SK*%.P\$J3BIG_"7^%%1_BOU.=\!
MZ_8:!\#CKFFZ7,MM:)-*+6:Z#NY#D',@0#GV7BJ5Q\> VCP:GIOA'4[ZV5%:
M^G7<L-JQZIYFPAB/?:.:S/#7_)K>H?\ 7O<_^C#6IX/AC'[-%P @P^G7C-[G
M,G/Z5I4T<WVL335^6/=O\R2]^.MM)I:WWA_POJVKQ1H'O) C1QVO!RK.%89'
M7TP>M=/;>+=)\:?#+4]9AMI7LVM)TGM7?8X*H=R;AG&1W]ZYCX/PQ?\ "D+@
M>6O[S[5OX^]P1S^ K%^$?_)"O$_UN_\ T0M345HS797^\=-WE!]W8TO 7B6R
M\.?!2?5]%T'49$BN)0+<2_:)"W]]V5% 0<9.W@#O5'X1_$3Q/J*6FFWV@:IJ
M5O<W<ADUIY)&CBSSMY0@ =,;AC-6?A6C2? #5D0%F9+P #N=E2_ 7Q#HUOX&
MATJ?5+.+4&O9 EJ\RB5]V,;5)R?PJ_\ EY+T7]?U^1DOX<?5_K_7_!.F\9?$
M74/#>L#2M,\':MK=SY:REK=2(]IST*JYSD=P*G\#_$JR\9K?6YTZ[T_5+ 9N
M;&898=OEX!/(Q@@'/:O.V\577BKXC:_I.O\ C.Y\+Z3ITC);Q6UREH\A5BO^
ML/7CDCG.1CI3/@U]G/Q:\4&TO;N^MC;DQ75XY>69=ZX=F(&<]<XY&*B&OS39
MI4]WY-(K0_%KQ._Q.U.XM/#.M7UNEMY*:+F1'@ *GS'C"MAOP_B S71?%N]T
MN=/!-UK>B7<D]Q.'6%+OR3 3Y99'!C;<,D9^Z?EZC-9OA[5]-T/]HGQ9+JU]
M;6,4D)5)+F58U)_=D#+$#H*L?'2XANY_!%S;RI+!+>%XY$.5928R"#W%..U/
MS:_-BEO4]'^1Z%XY^(.E^!+2W-W%-=7ETVVVM( "\F._L.0/QZ5SF@?&1+S7
M;;1_$GAO4/#MU=D"V-UDI(3P,EE4C)XZ$>]<]\4Y$T;XR^#]=U/*Z4BJAD89
M5&5V)/X;E/X51^-&MZ3XKU7PKIGAZ^M=1U W1(>TE678&*@ LIXY&<>U*&K5
M^KMZ?UN.>EUV5_Z_(]%\;?$VR\#>(-*L-1LW>UO8W=[E'.8MO0! IW9.!U'6
ML"U^-ZIXBM=.USPGJFC6MXX6VNKK*ELD ,4*C Y&2"V*ROBS$LGQ8^'\<@#*
M9T# ]_WJ5)^T(J^3X6;:-POF ..<?+3A]EOK*WXI"D][=%?\&>U5P/C;XI67
MA/58=%L],N]9UN90RV5KV!Z9(!.2,G !Z=J[U?NCZ5X3'?VGA?\ :5U2[UZ>
M.TM[VU_T:XG;:@RJ '<> /D89-)*\E'U_!%?9<CM_!GQ4M/$^L/H6HZ3=Z'K
M:*7^QW6?F'7@D*<XYP5'MFJ^N_%ZS\/>-;[PW=:1=32PPH]NUJ3))<R,%(C"
M!>.IYSVKC=4U"S\4?M'Z#-X?N(KR*T@7[1<6[!TPN\GYAP>& S[XJ[%&DG[5
M4Y=02EGN7/8^2!G]30O><>E[_@)^ZI=;6_%HZ'PG\7DUWQ0OAS6?#M[H6I2@
MF&.X8G=QG!RJE20#C@CCK7IE>)^,E _:2\)$  FV7)]>9:]LIK6*?K^#!JTF
MO3\3YKMO!&F^._CGXKTW5)[N&&(R3*UJZJQ8,@YW*PQR>U:VH#5?@EXOT>.W
MUB[O_#&H-Y36]V^XQ $ X[ @,"" ,]".*=X3U?3=&_:"\7SZIJ%I8PLDB+)=
M3+$I;>AP"Q SP:C^)NLVOQ)\9^'?"_AJ9=06"8R7,\/S1KDKD[NA 4$DCCD#
MK13T5-+K:_XW_ )[U+]/\E;\3I/BU-HT?C+P2-1TRXNYI+K$,D5V(E3YX_O+
ML;<,D'@J>.O-='XZ^)=MX-OK32[?2[K5M8NUWPV=MP2,XY(!/.#@ 'I7&?&D
M;?'/P_'I>8_\B15L_$[0/"FMZU:/>>*HO#OB.UA#VUR\PC^3<<=2N>0V"&!%
M)? O5_H.WO:]D:OAOXD7NM6FIM?^#-;TZZT^#SVMC$7:7KA4!"L6..FW'O7F
MWA#XL>*YO%.NS+X9U;68;FY11;QR2%=.4%AMVA&"G'7[N2IKIOA1XVU_4O%F
MJ^%]6U*UUJ"RB,D6IVV"K8(&-PP&!W=>N0>36+\']?TC0O%/C:'5]3M+!Y+W
M*"ZF6/?AY,@;B,GD<"KBO?OY7_%?U^1#ORM>?Z?U^IW_ (L^*%AX-\666CZG
M:E;6XM'N7O!+RF-V%";>22N.HY-8UWXWB\9?#7Q5>:AX;O;33;>#]VDLQCDN
M4(SN!V$+V_O"L7XC00W?Q[\%13QK+$T<9*L,@XD<C^5>A?%#_DF/B+_KS>L7
M_";?G^:-%_$27D_P9Y]</8R?LN3/IUI+:VIA^6*682N#]HP26"J"2<GH.M4?
M#7Q;;PMX T2&W\+:GJ-C:PB.[U!5:.&)MW*JQ0AB,]R!GO4T/_)J#_\ 7%O_
M $IHT;QIX8A_9ZETZ74K1+Y;":V-DTB^:TC;@"$ZD$D'-:U':51KR)@KJ"?]
M[]#O];^)5CI_PW7QGIMJ;^U?8%A:7RFRS;2"<-@@YSQVJ_<>,?(^&W_"7_8-
MW^@+>?9/.QU4';OV^_7'X5XNEC>1_LKS&2*3#W8F0$'B/SEY^G!-;^H>-_#G
M_#/<=@FK6CW[:9':?9%E4S"3 4Y3J ,$YQC%*IHIVW37XH4->6_6_P"#.IE^
M)\\WPG'C"VT*Z::82(EO 3,(2I8;W; P@VY)QW ]ZYOX0?$#Q+J5OIND7_A_
M5;ZVFDE+Z]-+(Z#[S8)*$<$;?O?X5-X.5G_9DO%4$L;&]P!_O25<^!OB'1D\
M :=I+ZI9KJ7G2J+1IE$IRQ883.2,<YQ5V2J37H#?N1?J-\(2Z,?CSXJBMM,N
M(M06$F2Y>[#QMRF=L>P%<D@\L>G&*O>(_C%%I_B"XT/P[X=O_$5_:G%P+7(6
M/'4956)(. >,>]87@K_DXWQA_P!>[?SBK.^$VLZ7X3\9^,M.\0WUOIUY)=;E
MDNY1&' 9\_,QQ_$#[YK..L8K^[?\6.6CD_-+\#TSP+\0],\<PW"003V6H6AQ
M<V5P/GC/3(/<9R.@/J!7+M\;HC?ZOI=MX:O[W5K*Z>""SLRTIG5209"0GR#(
MZ88\CK6%\.9HM;^/7BG6M*(DTORF4S)]UF)0#'KDJQJQ\'(T/Q,\?R%1O6Z9
M0W< RR9_D*:7-;I>-_Q!Z)];-(['P!\3[7QO>7FFS:9<:5JUH-TMI,V[C.#@
MX!R#C((&,UWE>)>$U"_M,^*0  /LK'C_ +8UZWXAU";2?#FIZC;P^=-:VLDR
M1_WF520/TI2:4%/NK_F"3<W'S/.=6^,FIV-]=+:_#_6[FPM'9+B[<,@3:2&/
MRHRX&,YW"NQTKQQI^N>!9_%.FQR20PP2R&"0[&#("2A(SCIUYZUXMI6M1^*O
M!>H:UXF^(VIP:F1*D.DV%XD&[CY5\H#+[B<<#IQFN@^%/_) ]?\ I>?^BA2E
M=0E?=*_]=!JSG'LW8O1?'<W^B17FC^#]3U&Y4%KV* L8K4 G&Z41G.0 ?N@8
M/7BNZ\%^.]+\:^''UBT5[9(69+B.8C,1 R>1P1@YS7(? 2*-?A8[!!F2ZF+\
M?>X Y_ 5RWP=MI[OX7>-K:T!\^4RI$%X.XQ$#&*J?N\WDKBA[RB^[M^?^1T<
M/QR@U+4KI-/\+:M=Z+ 2LVIP(S^6/[Q0+PN.>6SCM5/]G(@^'-<*G(-^,'U^
M057^"OC'PQH_P[GLM2U2RL;J&>5Y8KB54:0$#!4'EN!C STJU^SJR/X?UYXQ
MA&O\J/;:,4TK2:\OU0F[Q7^+;Y,[7XL?\DM\0?\ 7M_[,*B^$'_)*M!_ZXM_
MZ&U7/B797&H?#?7K:UC,DS6C%449+8P2![X%<?\ "/QYX9M?AMI]G?ZW865U
M9!XY8KF=8V^\2" Q&[((Z9J8?;^7ZA)?"_7]#*^&?_)=_''UE_\ 1HK:U?XT
M21:[>Z7X;\(ZEKYL7,=U+ 6"HP.. J.<9!&3CIWK$^#I.L_$[QGXCM58Z=-(
MZ12D8#EI-PQ^ S^(JAXDTK1-)U;5?$O@CXA6FDZGOD>ZTZ>Y4"60$[E"GGKG
M"E6&3QBDM(PO_*5:\YV[_P"1ZK!X^T]? S>*]3M;O3+1=P:&Y0"4D-MP #U)
M&!G'X5Q47QU:-XKS4O!>L66@S,!'J; LI!Z'&P+CKT8^V:Y?Q=K^L^._V?[?
M6+NW FM]0 N&B0A9$7*[\=N6&>V0:S[?PSIVM^%[?[;\;-MG+"A?3[N0GR\8
M^0QM/_"1Z=N*IZ2?E;\K^HE;E7G?\[>A])V]Q#=VT5S;R+)#*@>-U/#*1D$5
M+61X5T^/2O">DV$5U]KBM[6-$GV;/,4*,-M).,CMFM>G))2:0HNZ384445(P
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[MK!T'"L#CIQ@US,_C6]\1W=W-9?$#0?"]G;W#PPV]PD,L\P0X+2"1QM!(.
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M=<$CD-VXI/A-_P DQT7_ ''_ /1C4[;_ "_$E[+U?Y':4444AA1110 4444
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M]_\ .Y,59)=O\K'DMO<:!-<)9-\&+M+[@/NT:V%NI[_OB=I'O7K*J%0*JA5
MP .@I:*+Z!8*X^.RNA\8)[XVTWV0Z(D0G\L^67\XG;NZ9QSBNPHI+1W&]K?U
MO<R?%%KJ%]X6U6UTJ4Q:A-:R);N&VX<J<<]OK7DMEIEC<>&Y-"L?A3<1:X+4
MQR7NIV,?DK)MP9!.Q+/SR-HR:]PHI-7OYC3M;R/,=6TK49/@/IVG)873WR6M
MDK6RPL9%*O'N!7&>,'/IBMW7;*ZF^)'A&ZBMIGMX(KP33+&2D99%"[CT&>V>
MM=C15N5Y.7G?\&OU)MI;RM^-_P!#E/B5:7-_\.M:M;.WEN+B2#"10H7=CN'
M Y-;=[&[^'KB)48R&T90@&23LZ8]:T**AJ\7'O\ Y6*3LT^W_ _R/+KCPC?:
MQ\(?#-LNGQR:EI:6]T+"^CPLK(N&B<,.,@D<]ZBLI_#UW?1V2?!N[AN]P5WF
MT6W2!#G!/FDX('J.M>K45;E>3EW=R;:)'*^,->MM,B2RO?"6L:[:3K\PL;!+
MJ,=?E92P/Z8YZUC> [:\L)=:O[70M2TK0)(TDLM*N2/-\P;BY2,L1&&RHVD@
M9]*]#HJ5I<;Z'CWB&\3Q7,XT?X?>)+#Q*I_T;59[-;01,#C<TP?YEZ\<@BO7
MH1(L$8E8-(% 8CH3CFGT4UHK ]7<*X#4;36O!_BZ_P!?TG2YM7TG5%5K^SMV
M'GPRHN!)&I(# @ %1SFN_HI=;H/)GFVI>)O$/C/3)M'T'PKK.E_:P8+B_P!8
M@6W6WC889E7<2[8X&.YJ3XD:9'I'P=FTNP(5+5;6&$OVVRH 37HM<[XXT&Z\
M2^%+G2K*2&.>62)E:8D+A9%8Y(!/13VH[+S7YK\AIZW]?R9S6H^-/$D^G2Z+
M;^!]9&N2PF+SFC7[$K$8+^<&P5[XP#VXI=:\-7>F>!/">BVT4MW)8:C8^:88
MRV KC>_'11R<]A7HHX %+33L[^:?W$_\'\58Y'4[.ZD^*F@WB6TS6L6GW223
M!"41BT> 6Z G!P/:D\;6=U=ZIX2>VMIIE@UE)9FCC+"-/+<;FQT&2.3ZUU]%
M):6\O\[@U>_G_E8Y"XL[IOB[8WHMIC:+HTT33B,[ YE0A2W3. 3BL.QOM5^'
M-QJ=A/X;U;5]*N+V2ZLKG28!,Z^82S(Z9!&#GGH<BO2Z*-OZ\[C>O]>5CBO"
M=AJM_P"*-5\6:M8R:=]K@CM+2SE8&1(D))9\< ECT[5/\.K.ZL= O8[NVFMY
M&U2\D594*$JTK$, >Q'(-==13O;;M;\;BM_G^%CC?#D%Q8>+?&U[=6\T-M)<
MPR12R(5615@ )4G@@$$<5K^$=?E\3^&;369; V0N@72$R^8=F2%.<#J!GIWK
M5N[6&^LY[2X0O!/&T<BABN5(P1D<CCTI;:WAL[6*VMXUCAA01QHO15 P!^5)
M;6]!_P";):XOXB6NHFVT35-.T^;4#I6I)=S6T',KQA64[!W/S=.]=I11YAY,
M\]\4WMWXL\!V]S::'J]M(=3MC]DN[4I.%6926* DA< G/H,UT7CFWGN_ >O6
MUM#)-/+83)'%&I9G8H<  <DUT%%*2NFN_P#DAQ=I*7;_ #N><^*/"UUJGAKP
MQ?0Z5!J-UHZQO)IMVBXG0QA73#<!AP1GN*K:-/X>OM8M[>T^$EY8SI*I:ZNM
M&@@CAP?OB3/.#R-O->GT5=_>;\[D)6BEV5@HHHJ2CS2WN]4^'>K:S"_AO5=7
MTC4+U[VVGTJ(3R1M)]]'CR",$$@].:T/$=OJ_B70='\0:9I4]MJFF7@O(M.O
MML<DJ#*LAP2%9E.1SP<9KNZ*%LO*WX ]_7]3S+7/$.M^-='N_#6F>$=<TZ:\
M7[/<WFIP+#!"AX<JVX^9QD#'J*U]<TF>+Q/X%2UMYY;:PFF6254++&OD%06(
MX&3@<]Z[:BFG;\_S7ZA_PQR/Q$L[J]T.PCM+::X==5M)&6)"Y"K*I+$#L!R3
M5;Q78ZIIGBW3?%VEZ;)J:P6TEG>6D+ 2F)B&#(#PQ!'3OFNWHI;;?UI8/^&_
M&YS?A_Q1+XE6Z_XIW6]+CC3AM4MA"9&]%7<2?K7,Z)X<U&^^!!T%K>2VU":R
MFC6&X0QL'+L0"#TSQ^=>E44/9KO^FHT[-/M_PQYM%XQ\0:AHKZ+;^"-<M]8^
MS>2TMU$J6B-MP6$N?F ZX R:O^&[NY\+_"G13=Z'JEY-#:I'-96MN&G7@YRC
M%3^'7GI7=44V[W\_^#_F2DE;R/*M!A.I>-K#4_#GA#5_#=NK/_:DE[;BTCN4
MVG:OE!CN;<0=V..>:Z'0=,N#XV\;M<VTT=K>-;+%*\9"RCR=K;2>#@\'%=I1
M2TM;R:^\>OY?@>8:%KFM> M(@\-:EX3UK4_LA:&SO-*@6:*:+/RE_F'EGD Y
M]#6CHFB:M'X>\5:IJ=L8M3UOS9A9HV]HE$>R-..K8'./6N^HI2]Y.^[5AK1J
MW1W,#P/;SVG@/0;>YADAGBL(4DBD4JR,$&00>0:H?#BSNK'PM)#=VTUO*;^[
M<),A1MIF8@X/8@@@UUU%7*5Y.7?_ #N2E9)=@KDO'>C:E?VNF:GHT23ZCI%X
MMY%;NVT3K@JR;NQ()P?45UM%3YC/,M<\0ZWXUT>[\-:9X1US3IKQ?L]S>:G
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MNP%G<,P=W=1G;T  KEX-$L?!4EW8:S\.7\06S7,DMGJ&GZ7%=R-&[%@L@/S
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MUN8UEB?:5W*1D'! (X]:LUQ?AK6K/P_\)-$U.^9A!#IL'RHNYG8JH55'=B2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT2+EGBC7"*!ZD<X[UZ3XM_Y'OP+_ -?=S_Z(:NCM?#>A6-M-;6FBZ=;V\_\
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M]-P.*5];C;O?UO\ G_F>>W.DZ)I7P8\5#0M8N=7M;B.XFDN[B=9F>0J WS@
M'IUYYSS7H%@BKX6MD4 *+)0![;!5I]/LI+!K![.W:S9"C6YB4QE?0KC&/:IU
MC18A$J*(PNT(!P!Z8]*):IKO_E82T:?;_-,\>2TGN?V=](>"%Y_LH@NI(4&2
M\<<VY@!] 3^%=/XA^(/A2]\&:@;/6+*^FNK.1(;*"4//(S(0%\L?,#ZY''>N
MVM;2VL;6.UL[>*WMXQA(H4"(H] !P*IP>'M%M;R:\M]'T^&ZF!$LT=LBO(#U
M#,!D_C1/WN9=_P#*P0]VS[?YW/,M<TZXU#X#>'&@-ULM(K*YG^QG$PB4#<4/
M]X [A]*IS:)X$U33=ES\6]>N;:X4!K:;7HW+@] 8RN?P(KV>WMX+2VCMK:&.
M&")0D<4:A511T  X K/C\,Z!%J!U"/0]-2])R;E;2,29_P![&:J4KS<N[N)7
M44NQR/BN>W\.>.?"NMZ@Y328H)[%[E_NP.X78S'' .TC/2L[X@>*]"U<^';'
M2K^UU*8:W:2.UG*)E@4/C+,N0N2< $\YKT^>"&Z@>"XBCFA<8>.10RL/0@]:
MHVWAW1+.U%K:Z/I\%N)%F\J*U14WJ<AL 8W @$'J*479J_1W_&X]MNUOPL:5
M<MXRM_"US':+X@U:#2[E"SV=U]N%K/&<88QL2/49'(Z9%=35+4='TS6(EBU3
M3K.^C4Y5+J!90#Z@,#4L:.+\)>(;BZ\47WA^#Q##XCT^.S$Z:A&$+P,6VB-W
MC^1R1D@@ \'-4_AYXGT3PWX67P]KNIV>EZIIDLL4\-Y,L)?+LP==Q&X$$'(K
MT.PTRPTJV%MIUE;6=N#D16\2QJ#]% %0ZCH.CZN\;ZGI-C>O']QKFW20K]-P
M.*J_]?,7]?A8X[P-*-6U_P 8>(K13_95_/%':R8($WE1[6D&>H)XSWQ7(OIU
MQJ'[/>B- ;K9:7*7,_V,XF$2S-N*'^\ =P^E>VK&B1B-$54 P% P /3%16EG
M:V%JEK9VT-M;Q\)%"@1%[\ <"ETLO+\'<+]7Y_BK'C<VB>!-4TW9<_%O7KFV
MN% :VFUZ-RX/0&,KG\"*[+Q1&(O&W@*-22J7-PH)ZD"W:NEC\,Z!%J!U"/0]
M-2])R;E;2,29_P![&:NS6=K<7$$\UM#+-;DM#(\89HR1@E2>02..*I.UO7_/
M_,7?T.'\5WD/@SQ?;>*IB4T^\M7LKXYP Z R0L??AT_X$*U?A[IMQ8^%8[N^
M7&HZG(^H7>1@AY#NV_\  5VK^%<_KMQJ'Q!U"'PW'X=U6QTF"]634;S48!$D
MR1MD+%R=X8@<]A]:]*    & *4?A_K;?\QRW_K?;\@K@OAM_Q_>-/^Q@G_\
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M 0S1V\EWO&6<2N.,$8PM1_#>.SB^(NO#3]9U36;3[!!LOM1G,S2_.^=CX&Y
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ME>S+*1YJ)#L,@![,0:[R_P! T;5+B*?4-)L+N:+F.2XMDD9/H2"1T%7FAB>
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M!]#[&N8^&! \-Z@3P/[7O?\ T<U.V]^G^8K[':T5R0^)_@HZT-('B*T-X6V
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MWF,68'  Q\Q'TKFO^%2Z)O\ ).J^(#I6,?V2=2?[)CTV=<>V:3U3CWM^5O\
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MT.STFT:1[>TC$4;2D%B!ZD #]*J^[[V_7_,FVB7;_@&A1114C"BBB@ HHHH
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M/ER9!5D;'(# XSVKG-4M_&_CFT;0M4\/6V@:7)(OVRY_M!;EYHP<E8U0#;G
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M[4#SR-[X5&((7.22<9XXK0OK/Q5X?\=ZGK&BZ'!K-EJZ0+(IO5MWMVC!7)W
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M'L.:L:?\/)#\-[[P[J=XAO\ 49)+J>>$'9'.S;P5!_A! ^N*J7VG_P .]?\
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M.,9 '2KGC+_D;_!'_81E_P#1#TSXB?\ 'UX0_P"P_;_^@O2CT];!+KZ7_/\
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M;Q'>Z??V6C:)90WFLWJO)&D\ACBAC7&Z1R 3C) P.3FJ'Q._Y%_3O^PQ9?\
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M1110 4444 %%%% !1110 4444 %%%% !1110 45!<WEK9(CW=S# LDBQ(99
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIY&HP>3+QWVY/![5S5];Q3?&W27DC5FAT6=XR1]UO-49'X$_G7=5*^%-]?\
M-C>]O3\BMJ.HVFDZ?/?W\Z06L"%Y97Z*!7&Q_%?1O/4W>DZ_8:>Y"IJ=YIS1
MVK9( ^?J <]2 *=\5AM\*6L\JEK*WU*UFO1M)'DK(-Q('8<$_2M7QCJ6D1^
M=5NKV>%]/ELI #O&)=RD*%/<DXQ2O9.7;I\OZL4E=J/?_.Q?UOQ#8:!9VUW>
MNPM[BXCMUD3!52YX8DD?+ZFJ>@^+[;Q'J$\%EIFK);1H'CO[FT,5O."?^6;-
MRWY5Q.NV4S?"KP79:I&6E-[IL<\<G)Z@$'\.*]6    & .@%6XV;\FU^1FG=
M)]U?\3(\5Z*GB+PKJ>DMC-S RH?[KXRI_ @&JG@;7&UWP5IU_<';<K%Y5T&X
M*2I\K@^G(-='7C7B*^N?"FH>+_#UFI$NO>5<:8%X_>3D12X^A^;\:E7U2Z[>
MO_#/\"]-&^GY/_ACJOAV!JDVO>+9!DZK>LENW7_1HOD3'U(8_C23_%?1[:4O
M)H_B)=-'WM4.ER"V4>I8X;'_  'O6MJEU%X!^'<LUK;B9-)L@L<><!BH &3]
M>37!>+X?&#^ ;[6=6\=Z;:6<]BQ:QM--1HIMR\(LCL6RV<9'UHDTMMEI_7KO
M\PBN;?=_U^&GW'5_$>1)M%T"6-@T;ZW8LK#H09!@UT9U^U'BE?#WES?:S9F\
MWX'E[-^S&<YSGVQ[UP_B'_DG?@G_ *_M+_FM:=S-';_&^S$SK']HT)XX=QQO
M83 E1ZG'.*OELW'SE^"_X!"ES04O)?G_ ,$Z;4=>M=,U?2=-FCF:;4Y'CA9
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ML6NI7FI6;*ILK*V,TLH9 ^Y%4_= (!+8&:N^&?&>F>*&G@MXKRSOK8 SV-_
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MUTDCV]I$TTBQ %B ,G ) S^-9?@;P_\ \(QX5M]+&I)J(CDD?[2D0C5MSEB
MH) P21P:A^)/_)-?$?\ UX2_^@T3TV_K8(J[LQUCXZT_5=<ATW3;#5;R)RRM
MJ$-H3:1,HR5:4D#/&.,\\57UCXBZ9I>HS6%MIFM:Q/;MMN1I5BTZVYQG#MP
M<=@2:W?#]M#9^&]-M[>-8XH[6-451@ ;17DW@71O%M[::E;:?X^72KBWU"X%
MUIYTB&9XW,A.XLYW$,""#[X[4Y*TG%=/\[$Q=XJ7>WY7/2V\8:;-X5?7]/2[
MO[?! CM+9Y)=XX*E ,@@]<XQWKS[X/W&D:E9VT\WA*]35R);N77+G3U$<KLY
MSLG)R3AL8XZ&NP\(>&I_#>EZTMUKB:O<WES)<S3);K %<H 1M5B >,]NO2L+
MP=#=W'[/L<-B&-W)IMPL(7J6)?&/>DWR\TEV7ZC2NXQ[M_H:D_Q5T6*X<P:;
MKMYIT9(EU2UTYWM(]I(;+]2!CJ 170ZGXHTS2]$MM9>4S6%Q)#''-"001*P5
M6R2!MY!)]*\W\&Z%XLU7P9ITNE?$N.*P%LL?V<:) WD8&#&Q+9R.0<U9\2>'
M(M#^#FG:#)?)J4,=_;1F<($616N0<8!.!SCKVJN6SY?-?B[$WTOZ_D=IHWC2
MSU[4Y;:PTW5FM4B,J:E):%+68 @81V(W'GC P0#S6=;?$[2-06P_LS3=9U%[
MO9O2SL_,^RAC@&9@=J>O4G'/2NQ=%CMF1%"JJ8  P ,5Q7P@MH;?X9:48HU4
MR^9(Y ^\QD;D_D*2M=^5OS93V]?\C1\0>.M.T"^_L]++5-5U ()'M-+M#/)&
MIZ,W0*/J<UH^'O$NG>)K)[BQ:5'B?RY[>XC,<T#]=KH>0:\STS3/$MWX^\76
MNG>-%T.Z:^$QM6TR*X::(H-D@9SG&!C X&/>NJ\->$M4T74=?U"^\3IK.IW\
M$:,5LTMRA16"DA&([^@Z5*?NW?:XVO>LN]A]U\3](BU*6TL],US4XK>0Q7%Y
MIVGM-!"PZAF'7'? -0?#.]MM2G\67MG,D]M/K3O'(AR&4Q1U-\*+FS_X5OIL
M44B+):HT=VA(#1RACOW^ASD\U3^%<]E=-XNGTXJUH^O3-&R?=/RIDCV)S5I6
M;7E^J_I"O>-_/_/^F=Y>W:V-E-=/'-*L2EBD$32.WLJJ"2?85P'@7XD7/B.<
M6MUX?UY7FNIU2\:Q"VT2*S;59\\$ !3Q][BO1JXCX62(_A*X174O'J5XK@'E
M3YS'!_ U*W=^WZ@]EZ_H3ZQ\1M,TO4IM/M-+UK6KFW;;<+I-D9Q <9P[9 !]
M@36UX?\ $>F>)[!KS3)S(B.8I8W0I)$XZJZGE3]:YCX4S0IX>O\ 3Y75=4MM
M1N?MT9X?>TC$,0><%2,&D\(S0WGQ*\97>G$/8'[-%)(A!1[A5._&.X!4'WII
M=/*_Y?Y@^OD[?BU_P3OJX_6/B-IFEZE-I]II>M:U<V[;;A=)LC.(#C.';( /
ML":[ ]*X+X4S0IX>O]/E=5U2VU&Y^W1GA][2,0Q!YP5(P:2U?]=PV1TV@^)=
M+\2::]]ID[2)&[1RQNA22)QU5E/*GZU@VWQ.TC4%L/[,TW6=1>[V;TL[/S/L
MH8X!F8':GKU)QSTJGX7FAO/B)XUN].(>P*V\4DB$%'N%1M^,=P"H/O5CX06T
M-O\ #+2C%&JF7S)'('WF,C<G\A36NODG][?^0/33SM^"9W-<YXE\:Z;X8F@M
M9H+Z_P!0G4O%8Z?;F:=U!P6VCH/<D5T=<%ILD=M\:-<2]=%GNM.MC8[^"T:E
MMZKZ_-@D4EJ[#V39HZ5\0]&U;5;+24@U"VU*Z#DV=Y;&&6$*N[+JQS@] 1D$
M@^E;&FZ]:ZIJVK:;!',LVF2I%,S@!6+('&W!)(P>X%<?KMU92_&SPG;Q/&U[
M%:79F"D%E4J-H/XAJM>$IXX_B-XXM7<+.UQ;3+&3@LGD@;@.XR,4UK9^OX-$
MNZ;^7XIG2KK]JWBE_#PCF^UI9B\+X'E["Y3&<YSD>GXUD:]\0-,T/4GTR&PU
M;5]0C56FM=*LS.\*GH7Y &?3.?:LK3]1M;[XYZC':SI*;;1$BE*-D*_F[L?7
M!%/^'<T4.K^+M/N65=5&L2SR(Q^=HF \MO==O I)72]+_C8;=F_5+\+G0:'X
MOTKQ!875S9_:5EL^+FTE@9;B$XSM:/&[/IC.>V:Y/PM\3;C6-=O[&;P[XA>)
MM2:W@G73\0VR!5&)6R"ISEB""1N%6],EBO/C7JTVGLKP0:1%#>O&05\_S"4!
M_P!H+FIOAS(ANO%\6X>8NOW!9<\@$+@X]Z<=[^5_QL#V:\U^1>U[Q_INB:B^
MG0Z?JVKW\05IK;2K,SM"IZ%SP!GTSGVK6T#Q%IOB73VO-.E<JCF.6*5"DD+C
MJKJ>5(KRWP[I/BB\\3^*[73_ !PNBW2ZK)++9-I<5PS(V"D@9SDJ5P/08KJ=
M$\):KHEMXJN)_$BZSJNI0C+):+;F.18V5<JK$9/'ITJ;VAS/M<IKWN5=[$TO
MQ2T87TD-IIFNW]G"Y2;4;+3WEMHRN=V7')QCJ 14?PLN8+S2]?NK:5)8)M<N
MI(Y$.0RD@@@_2K?PSO+ _#31C!+$J6]JL=P,@>7(OWPWH<YZUG_".6UN-#UN
M:Q*FTDUN[:$KT*$C&/;%:6Y9279?JC-NZ3\_T?\ 3._DQY3[L[=ISCK7%^']
M=T/0?A9;ZS:+J+:/;Q,ZBX*O/M\P@YYQU)[]*[.;_4R?[I_E7CJ#/[,4H_Z<
MW_\ 1QJ.]O+\RTKM+S?Y'4W7Q8T2U<RKIFO7&EJ,OJT&G.UHH[G?W'N 1S7;
MVUS#>6L5U;R+)!,@>-UZ,I&016;>6\4?A"XMTC40K8,@0#@+Y>,5G_#GGX;^
M'?\ KPB_]!%59:KM_P '_(E.Z3[_ / _S.GHHHJ1A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW4SJ$_AVV-P6W':[HA.<\H&"G\JZ#4M TO5M'&D7EHKV"[,0*Q0#805QM((
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MTV.[3RF/.,-A78GDLVT'D]3CFNLHHZ6'?6Y7L+*'3M/MK&V7;!;Q+%&OHJC
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M8Y8.3R"O!K<M?^2TZE_V X/_ $<]):V^?X#;M^'XNQVU%<1XB/\ Q=7P8/\
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M=0T:29H1=PF,2 9V'J#COR!7'3>&?B#K.B76@ZQK&AV^G/;F 3:?#)Y\PP0
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MZ^E:T3^9$CXQN4''I7F7B#7I?$W[/]WK$\:1S7-EF14^[N#@''MD<5Z5;?\
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M'=D@C.W\*DH]'HKS]O&FH7OPLUS6$5++6M,2>"=8\.L<\7!(# Y!X(!]:O\
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M&R;^?R!7;LO3YG:T5XY#XPUG5;2/6T^)/A72W>/S8]$D$+J!U5)9"X<-C .
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MK(P09!!Y!JA\.+.ZL?"TD-W;36\IO[MPDR%&VF9B#@]B""#7745<I7DY=_\
M.Y*5DEV*.M:9'K.AW^ERMM2[MW@9@,XW*1G]:X/2?%FO>&=)L] U/P7KEYJ%
MK$+>.XT^%9+:8+\JL9-PV9 &<CBO2J*D9YDWAG5K+X1^)XKN!I=9U87-Y+;6
M^9"LDG2-<?>(  X[UZ%I:-'I%DCJ5=8$#*PP0=HX-6Z*=_T_!6%;KZ_CJ%><
MF;5/ 'B+6[@:!J.KZ-JMP+Q'TN(2S0RE0KJT>02#@$$?C7HU%+K=#Z6.$\.P
M:MXA\:OXLU#3+G2K*"R^QV-I=X$S[F#/(ZC.SH!@G/%4_#]]J/A;Q7K&D7GA
MS5[B'5-6>[MK^T@$ENJ2!?\ 6-D;,8YKT>BFG9Z?UK?\P>J?];''^&K*Z@\?
M>,KF:VFC@N);4PRO&0L@$.#M)X.#P<4-977_  N&.^^S3?9!H9B\_P L^7O\
MX';NZ9QSCK7844+2WE_DU^H=_/\ X'^1Y#=:%:>$M>UB35? )\2:=?W;7=M=
MV>GQ74\1?EHW5OFP#D@].:Z[PU'8S:'J,^F^#G\.K,A58I+2."6?Y3@E$Y&,
MXP>>37845-O=Y?*P[^]S?,YGX=VMQ9?#S0K:[@EM[B*T19(I4*.A]"#R#734
M45<GS-LF*LK'D.M6*:=\0-7U#Q)X*U+Q-;7?E#39K6U6\2! N&0HQ 3YLG/?
M-:W@+2;K3/&'B2^G\/PZ%875M:O;P0QJJ(H\P$,5 3?W8#.,CFO2*IZMIT>K
MZ/>Z;*[I'=P/"S)]X!@02/?FI3<5IVL5HWKU/#4M_"MSK6HZGJ_P\UW6[F6^
MDEAO=)LFDLY8L_(5VNJMQU)!R<\UW/B'4;/Q9\(=8C\.6=PQ2+[,+!;9EEA=
M2N8S&!D$#L*6RTKXGZ3:VVE65_X4FL+:-88[FX@G6?8 !DHIVY ]\&NF\*^'
M9/#UE="ZOFOK^]N&NKNX*; \A 'RK_"H   ]J:LE9;*UODUT^0KOFYNO]=38
MBCW6:1N",QA2#]*\=L='T_P3;OI&N?#6375CF?[+J6GZ5#=M-$3E?,SAE89Q
MSZ5[112ZW!:*QQ$GARU\1_#C4M)M- 3PXM\C[+9H8XRKC&UW6/@9*CWP*Y6U
MDTFRB@T_5?@W/+JBJ$>2RT:WEMG;IN$N0 #C//3->PT4=0Z6.%\4Z=/-:>#$
ML=)>".WU:VDDMK>+*VJ!&SG8,!5SC/2KGQ$L[J]T.PCM+::X==5M)&6)"Y"K
M*I+$#L!R37744[_G?\O\A6_*WY_YG(?$ZSNK_P !WMM96TUS.TL!6*&,NQ F
M0G '/ !-9_C[PU->ZKHWB"'1+;7$L \-SILZ(QEB?'S('XW*1G'?)KOZ*7^=
M_P +#_X;\;GF_AF?0-0URW&G_"V\TF2-MQOKS1X+00\'!4YW$\8^7UK:L;.Z
M3XKZQ>-;3+:R:7;1I.4(1F#N2H;H2,CCWKKJ*=_U_$5OT_ Y#6+.ZE^)_AB[
MCMIGMH;2\6698R40L$VAFZ G!QGKBL>YO=1\)?$76;^3P[J^IV&L1VPAFTR
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M66_U&!1$;S3M'@N(;C' <N<;2>IW=*[NYU6#P[X2M'3P=J!MY!AM+TRTCE:
M$YPR*P'4\[<]?QKJZ*;;>XDDMCS#P?:O/XS34M!\+ZGX:T4P2+?07L0MEN)>
M-A2 ,<$<_, ..*]/HHHOI876YY=XWT759?&7V;3K*XDL?$=M%:7\\49*0".0
M%F=AP-T;,HS4_P 2M-U:RGL]5\.6%Q<7,UI-I,L=M&6*I(N8W..BJPZ]LUZ5
M12Z)?UZ?<VOF5?6_]>OX+[C@O&V@RV_PH&B:9:S7#VZVL210H78A)$R<#D\
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MDF"$HC%H\ MT!.#@>U==112Z6#K<**** "BBB@ HHHH **** "BBB@ HHHH
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M*5-L1$22!CYL@8P?K5/5/'T]IXGU#PYIWAZZU/4[>&.6*.&54616!)+NV%C
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/!0 /L:GCU.:K?#(8TC6@/\ H.7O_HPUV-K:V]E:QVUI!%;V\2[8XHD"(@]
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MX=L;/3?#>FV6G3O/90VR)!+(06=,#:20!V]A5V[B:>RGA1MK21LH/H2,5,
M  , =!11/WKWZBC[MCS7X?>,/#NB^";/1]6U6RTS4=,5K:ZM;N=8G5U)R0&(
M+ ]01GK4OPQNX]0B\87D,+Q13ZU-(BNA4E3&A#8/(R.?QKM;K0='OKV.]O-)
ML;B[BQY<\ULCR)]&(R*M0V=M;O.T-O#$T[^9,40*9&P!EL=3@ 9/I3;YKM[M
M6_(%HK+:_P#G_F>=>#(M"N/@IID/B.6UBTV1&5WN9A$H;S6VD.2,-G&"#G-1
M6&OQ:/XGT?3-"\8IXDL;^<PR64DZ74ULNTMY@E3G:, $/GCO7H?]CZ8-,_LS
M^SK3[!@K]E\A?*P>HV8QW/:H]-T#1M&+G2M)L+$R??-K;)%N^NT#-._O7$UI
M;U_,XC2]:TWPG\0_%-KK]Y!IYU*6*\L[BZ81QS1B,*5#G RI&,9[U;^(6KZ=
MK/PH\07.EWUO>P+%L,MO('3<&7(R.#U%=EJ&EZ?JUO\ 9]2L+6]@SGR[F%9%
MS]&!%-&C:6NF'3%TVS&GD;3:B!?*(]-F,?I4K9)]+?@RD[2N<1XINX] \9>%
M/$6H9328[>:SFN",K;O(%V,WH#M(S5?QUXATCQ19Z;X?T#4K34]2NM0MY%%G
M,)?(1'#M(Q4G: !W]:])>&*2$PR1H\1&"C*""/3%4]-T/2-&#C2]*L;$/RXM
M;=(MWUV@9IIZ^CO^-_S)MI;RM^%CF_%T'A*74X)M3\1PZ'K44?[FYCU%+:<1
MDYP0QPZ$@\,".M4/#6L:AXDT[Q/HJZM!J\=JGD6NKP1A5F+QGY6V_*67C)7@
MY'%=CJ6@:-K+(VJ:187Q3[ANK9)=OTW XJW:VEM8VR6UG;Q6\$8PD4*!%4>@
M X%3:\6GU*O9IKH>%^%=+\.GP_;6^J?$KQ)H6HVJ^1<Z=+KB6P@=>"J(P^[Z
M8SQBNEUG0;"S^#8B\.75SJ^GVUTE]YCN)'G19P\G(49Z-V[5Z%J'AS0]6N$N
M-2T;3KR9/NR7-JDC+]"P)%:*1I&@2-%5%& JC %4Y/?KI^#N39;=/Z7ZG"^(
M?B#X4O?!FH&SUBROIKJSD2&R@E#SR,R$!?+'S ^N1QWK9^'_ /R3OP[_ -@Z
M#_T 5HP>'M%M;R:\M]'T^&ZF!$LT=LBO(#U#,!D_C5ZWMX+2WCM[:&.&")0D
M<4:A511T  X H35GYV_7_,>NB[?\ DKRO2?^2/>,/^NVJ?\ H;UZI51-+T^.
MSFLTL;9;6<N98%A4)(6^]N7&#G)SGK4M737=?J5%VE%]G<H>%$5/!6BHH 4:
M?" !_P!<Q6'\)?\ DFVF_P#72?\ ]'/79Q0Q00I##&D<2*%1$4!5 X  '05'
M:6=KI]LMM96T-M N2L4,811DY. ..I)JY2O*4N_^;?ZF<5:"CV_RL3T445)0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%9ESXCT.RM5NKK6=.@MVD:)99;I%0NI(902<9!!!';!J_%
M/%/"LT,J21,-RNC J1Z@B@"2BLZ7Q!HL$%K-+J]A'%=D+;N]R@68GH$.?F_"
MIM0U33])M_M&I7UK909QYMS,L:Y^K$"@"W14%G?6FHVRW-C=07-N_*RP2!U;
MZ$<46M]:7HE-I=07 BD,4GE2!]CCJIQT(]* )Z*H-KFD),T+ZI9+*DRV[(;A
M 1*W*H1G[Q[#J:N3316T$D\\J10QJ7>1V"JJCDDD]!1Y@/HK*U?7;33/#%WK
MHECFM8;9KA'C8,L@QD8(X.>,?6J_AR[O(?#NDCQ!?Q-JMXFY@^R,LY!<HJC&
M=J\<<X7)IVW W:*IVFK:;J%Q<6]EJ%I<SVQ GCAF5VB)Z!@#E>AZ^E12:_HT
M6IKIDFK6":@_W;5KE!*WT3.>Q[4@-&BFNZ1(SR,J(HR68X %8/\ PG7A ''_
M  E6AY_[",7_ ,50!T%%8AN;M_%ULD6K6/\ 9SV+/]AR#/(^X8E7N4P<9Z9/
MOQ9O_$.B:5<);ZCK&GV<\GW([BY2-F^@8@F@#2HK!\3^+--\+Z5#?W<\.R:>
M.&,-,$#;V +9/8 EC["KMMX@T6]L);^UUC3Y[.)MLEQ%<HT:'C@L#@'D?F*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RWX=^$M U73]7OM4T
MZUU*=M6O$7[9&LPA42GY4#9"\Y/'4FM#P9:PZ'XN\7^'M/\ DTNW\BY@@!)6
M!I48NJ^@RH./>L+P=X6UB\TO4[_P_P"*;G1)Y]6NQ<)]F2YBDVRL P1_NMC
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M;2:?3E,TEO;I&TG[O/S$ $\^M.T?P/8Z5X1OO#1EDFL+MY\YR&5)2?ER222
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MF0>"?%ENZ6T7Q&OQI: *L+:? T^T#@><1DGWQ4K??L'0I>-=-.LZWX!L=5#
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M+M6 Q:MI4$X4^S'!_/-:?AKPY#X;T^:!+JXO)[B=KFYNK@@O+(V,DX  X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC<[-KQL1G ()&16-JEOXW\<VC:%JGAZVT#2Y)%^V7/\ :"W+S1@Y*QJ@&W.
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MX$H9@PQ&S9$>>22!G(%=#K6D7UWX_P##&IP0;[.RCNEN)-ZC8710O!.3D@]
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MR_+7RW)7X7?YZ?@9OA#7I_#GP,N-:ECC-U;-=OY?\/FF=P!]-QK0MO!/B%+
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MPLP ;*.4/0D8RI[T :E%%<OXB\=V'A[4H]-&GZMJE^T8E:VTNT,[QQDX#MR
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M+:Q65G]HB,;SJI+-)M/(&3@9ZU/\*?\ D1(?^OR[_P#1[T[7W[+\W^@>G?\
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MQ+I&8E*DY).2#G!.1G':MKX3?\DQT7_<?_T8U'?T7ZAV]7^1VE%%%2,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H/2BB@#E_A]I%]
MH?A*.QU&#R;E;FX<IO5OE:5V4Y4D<@@UU%%%-NX!1112 **** "BBB@ K-TW
M1+32KW4KR#>UQJ,XGG>0@DD*%"CC[H X'UK2HH **** "BBB@ HHHH ****
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MM;6/[\LSA5'IR:Y7XGV%I_PJ[68A;Q!+>V\R%0@ C92"I7TQ[5G^)PEWXN\
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M?X=TB?4]3N4M[:%<EG/4]@/4GTKE_!?Q+T/QI916L%XAUG[(9[FU2&11'T#
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MR0>G!Z9I=--]/QO_ )#\_7\+?YF_X>^(GA/Q3>-9Z-K,-Q<@9\ID>-F'?:'
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MZFJE_P##+2;K4)KNRU37-'%Q(9;F#2[]H(IV/4LN".?;'4UVM%(#/T31-/\
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MD#H*]&JYKEE8F+NKA1114#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI]W.UP;/5HY<6[L<MY;1G."><$<9-;'A?PK/HIU._P!2OEO]9U1P]U<+'Y:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BO%O#5Y/X0\1:KK\LSMH6
MIZW<V=\K'Y;:42D12CT4YVG\#7<>.B#?^$".1_;D7_HN2A:I/O;\0>C:[7_
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M'(&,;XSM;'0X(X/K3YYX;6WDN+B5(88E+R22,%5%')))X KC? '_ "%/&?\
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MCU>R,'GD=D.2"?;.:N:[XXT?PYJT6F:@;D7,UN9X5BB,AEPP78JKEBW.< =
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M3<Z:L2S"2WPQ920,C)'K5/3O&MEJ^O#3-/T_5;B'#9U)+4BS#+U7S21DY&.
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MW'N 1S7;VUS#>6L5U;R+)!,@>-UZ,I&011;2X7):*** "BBB@ HHHH ****
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M[U%X.LO#I\9Z7<_#FTU&'20LIU.X8SK;3+M(10)?O.'].F#2AJK>ORO?[O\
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M$@.RTO!_9=^<<#<=T+GZ/E<_[0H^'L9U)=7\5RIA]9NBT&>HMH_DC'XX+?\
M JQ_'GB/3O%<%WX#T99+[5KB=+>Z7[,^RS0,"TC,0%X XP3SBO1K"RATW3[:
MQMU"P6\2Q1J.RJ,#^5$?AO\ =Z;O_+[QRWM]_P MOZ\D5?$7_(LZK_UYR_\
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M/BI!%<^&;"*:-9$;5[,%6&<@R@']":ZF^T33M1%B+JV#BQG6XM@&*B-U!"G
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M,,?4&NMU3PB=1M-*EMM6N++5M-A\NVU"%%;(*@-N1LAE. <>W6J7_"I/ ?\
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M[U+>PQR?&W2W= S1Z).R$C[I\U1G\B:T_#WP^\*>%;EKG1M&AMK@@CSBSR.
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M!SR>3UKUFSTBQL+^^O;:#R[B_=9+E]['>RKM!P3@< #C%<_K/PP\&:_J)O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+GTRI(J#4?$.BZ/*D6IZQI]C))RB7-RD1;Z!B,T :5%5Y;ZT@M1=374$=N2
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M5O5LC<PB[:,RK 9!O* X+!>N,D#-1:CJVFZ/ )]3U"TLH2<"2YF6-2?3+$4
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MV_=_E_F/T[?K_D<OXHT32_"7B/PMJV@6-MIUQ<:FEA/%:1B);B&0'(95&#C
M.<5Z77&Z/X(O8]8MM7\3>([C7KVSW?9 UNEO#"2,%A&G!;'&2:[*GTMZBZW/
M,/"GA?2M<\3>+KO5[.'4$AUB2."WND$D49*(68(>-QX&?:J7CE[Z[^(^FZ+:
M^%8O$%C8Z;]ICTU[J.WB#E]F\AQM<*!@+CC=7H.@>'_[#NM9G^U>?_:5\UYC
MR]OEY55V]3G[O7CKTJOXF\))K\]I?VNH7&EZO9AA;7UN Q4-U5E/#J>.#2VY
M?*WY?YE=9>?^:.*\,Z1XB@^(%AJ,/@*#PMIK020WXM;^"2.88S&3&F,$,.H!
M/S58O_#']C:]J^I:EX-M/%-C?7!N1<K''+=VXP!Y?ER?>48XVG/M74>'O#WB
M/3[W[3KGC&XU@*I5(5LHK:,9[D+DD_C575/#/C&[U26:P\?RV-B[9%K_ &5!
M(4&>BR'!Z="03]:'T_K^OD)=?D8'C:;1KGX(W#>'BMMII>$1")3'Y)^T+N&#
M@J0V>.QK:U;X<^$6\+W40T:RCE2W9UO1&//#@$B0R_>+9YR3S65X[\.V>@?!
MV\TF%Y9XO/B:629LO*SW"EV8C'))/3%6KGX=:S>P?V7-XYU)O#K*$:P-M'YS
M)_<-Q]XC''()(HDKJ27??Y?>-.W+?S_,Q[W4+KQ#X#\ V.HSOY.MW$,6H,#@
MS($9MI/7YBHS6GX\\&^'=)\%7^JZ5I5CI>HZ;%]IM;NTA6*173D#<HR<].<]
M:ZG6?".EZSX;BT.1'M[>W"&U>!MKV[)]QD/8BN?_ .%?:QJ4BP>)O&=YJ^DI
M(KK8BSBMQ)M.0)'3EQP/3.*J3NW;36_Y?D3%62OKI_F4/&5G'XEU3X?P7RN(
MKR61YXU8KN'D;F0X['H1W!-+XY\*Z#H5MHFJZ/I%EIU[;:M:JDUI L3%7<*R
MMM W @]Z[#5O#HU/7=!U(7(A&DRR2"(1Y\S?&4QG(VXSGH:=XG\/_P#"1Z?;
M6GVK[/Y-Y!=;O+WY\MPVW&1UQC/:A-737>_XK] MI9]K?.S_ . <]XS\+W-_
MXBL=<31;'Q!;V]NT#Z7>,HQE@?,CW@INXQAL9XY%7?!4_AQY-1AT?0_[#OXR
MGVZQ>V6!UZ[3A?E*GG!4D&K?B31?$>IS1/H7BQ]%"KAX_P"SXKE7Z\_/@@_C
MCCI2>&O"LNB7-WJ.HZO<:MJ]XB1SW<L:QC:F=JHB\*,DGOUJ5LUZCE_D<+9?
M\F\Z[_N:A_Z.DKI=+^'/A&Y\)6L-SHUE=23VJF6]DB5IY&902_F_>SGG(-6K
M?P,(?A[?>%#J.X70N ;GR<;?-=F^[NYQNQUYQVK.;X>:W!;KI>F^.M1L]!">
M7]B^S1R2JG]U)S\RCL.I'K0];KO;\K#?Q7]?S.9N;VXO_P!GE'N9VG>*>. 3
M,<EUCN@BD^^%%=?XM_Y'OP+_ -?=S_Z(:K^J^";2\\#)X5L)OL5K&(EC<IYA
M 1U?D9&2<=<]\U=U;P]_:FNZ%J?VKRO[*EDE\OR]WF[XRF,Y&W&<]#5W7-?S
M_2WYD]/D_P 7<PK2&*X^+NOPS1I+%)HULKHZAE92\@((/45F?#KPUH/VWQ)<
M?V)IOG6FO3I;R?9$W0JH7 0XRH'8"NQM_#_D>,K[Q!]JW?:K.*U\CR\;=C,=
MV[/.=W3':L>'P3J6G>*9]3T?Q//9:=>77VJ]TUK2.597XW;7;E <<XJ8]/2W
MXW&]GZW_  *'AV]A\%W?B?1+QO+L+#=JMH3T%M)EF4#_ &7##CU%:GPYTZ>T
M\++?WJLM_JTSZA<ANJM(<JOX+M'X5S_Q&TVW\0>,/#6BV\I%[.7%\L9'_'B-
MK.'[@%E4#\:],50BA5 "@8 ':A?#?Y?=_2^X);V^?W_TW\SSOXNZ3IMUH-E>
M7&GVDUR-1M(1-)"K.(S*,KN(SM.3D=.:=X]T^RTS0=(T#3;6#3=-U;5X;6[2
MSC6$&-LEA\N,;MH!/I73>*_#G_"3Z5#9?:OLWEW<-SO\O?GRW#;<9'7&,U9\
M0Z!8^)M&FTR_#^5(0RO&VUXW!RKJ>Q!YI+1?._RT'U^7^9R/C/P+X8L?!6I7
MFGZ18Z9>6%LUQ;7EK"L4L<B#<IWJ,GD=ZS_&,EQK_A3P')-+);SW^HVAE>,[
M67?$V[!['D\UIO\ #W6M2S9>(/&]]J>BY&;$6D4#2*#D+)*OS...>F:Z+7O#
M2:T=%$=P+9-,OH[Q5$>X.$!&SJ,=>O/3I35NO=,GT[/_ (!:T?PYHOA]&72-
M*L[+<H5V@A56<#IN8#+?CFJ/C35])TGP[*-8M9;R"[86JV<2;WN7?@1J,CD_
M6NAK"\5^&(/%6EQ6LEU-:3V\Z7-M<P8W0RKT8 \'J>*3UW*1Y'XDMKFT33+J
MW^&%KX=A@U*V,.J1W5N)ES(HPT<8W'.<8)/K79>+]$M->^*GABSOU,EH+&ZD
MEAW$+* 4PK =5S@X/!Q4T_PZU?5[6-/$?C*ZU2:"XCGMMMFEO%&48-DHA^<D
M C).!NZ9KI[OP_\ :O&&G:_]JV_8K::W\CR\[_,*G.[/&-O3!ZU2Z7[O\O\
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M\+VOAO3[BWAGGN;BZD::ZN[AMTD\A_B;M[ #@4/5.W:UON_KY^HGO\[W^_\
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M'Y)RP.0O^[CGZ]NX!IT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPOJD^M^%=*U2Y6-)[RTCGD6,$*&903C))QSZT[;^7]?H'1/N:U%%%( HHHH
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M^'("KL\=G(JSSCC[IVLXQS]T<YKG_AGXGM[WQ;J&BZ3XGO\ Q!H\=DMQ'/J
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M(UO6=2>^BBGLKUFEMYD9P'V?NPB8!R"I[8%=/<_#[6_^%?6>GQI827EMJO\
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M='>PTN\@FNRJY\N,QE=Y [*6!JG\4?&GAO4?AWJ=GIVJ6>IW-Q&NR&SF69E
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M-N 4W)@##9)Z]L<=:I^%?^2C>.O^NMG_ .B:-1D2;XM^&I8G5XWTN[964Y#
MF/!![BCPK_R4;QU_UUL__1-'3Y2_-">S_P"W?U$\-:JR?#QK[PQX95I%N)EB
MTQ;P('(F96/F.,#/+8Q[56L_'/BQO$FFZ1J?@,6)O6/[P:Q%,8XU^\Y55S@9
M'IR0.]0^!]<L?#GPJ?5=1E$=O!<W9)) +'SWPHSW)XJ[X4UWP_)=/?WOB319
M]>U-E4PQ7\3F)?X($ 8YQGG'WF)/I3^U]WY(<MGZO\V;/B37=9TN2*#1?"]U
MK4[KN)6XCMXD&>A=SU]L56\/^,9]9BU2VN-"NK+6M,"F?36EC8L64E=DF0K
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MGB/0K/5['?\ 9[J/>H<89>Q!]P<C\*K^%$5/!6BHH 4:?" !_P!<Q6'\)?\
MDFVF_P#72?\ ]'/5R24I1[?YM$1=X1EW_P KG;4445!04444 %%%% !1110
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M4$*0PQI'$BA41% 50.  !T%1VEG:Z?;+;65M#;0+DK%#&$49.3@#CJ2:GHH
MS!X=T-=2.I#1M/%^3G[4+5/-ST^_C/ZU<6SM4O'O%MH5NI$$;SA '91DA2W4
M@9/'O4]% &=>:!HVH7D=Y>Z187-U%CRYYK9'=,=,,1D5:CL[6&2>2*VA1[@@
MS,L8!D(& 6/?@ <]JGHH R;?PMX>M+[[=;:#I<-YN+?:([.-9,GJ=P&<U?FL
M[6XN()YK:&6:W):&1XPS1DC!*D\@D<<5/10!7O+&TU&V:VOK6"ZMW^]%/&'5
MOJ#Q3;#3+#2K86VG6-M9P Y$5O$L:_DH JU10!!%96L%S/<PVT,<]P09I4C
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MZ?:BW%O8VL(ME*0>7"J^4IQD+@?*#@<#TJW10!!%96L%S/<PVT,<]P09I4C
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M@N8"03%/&'4D'(.#QP0#4]% !56_TVQU6U-MJ-E;WEN3DQ7$2R(?P8$5:HH
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MHSC.1[UD_$C2_P"V?$W@W3_MU[8^;=W ^T6,WE3)B$GY6P<=,?0FMG0/ O\
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MDMON]X2N,>PK6\&>);G6=#NCJ\<<&IZ9/):7ZQY*;TYWKWP00?QKIV8(I9B
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M\1\?K7&^"+7XA3>!; :1'X(ETVYAW'[2+EI)2?O>;C@OG.?>M)JTFET_X/\
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MNXKJTESLEB;*G!P?UKEI]"\0Z!KNIZOX=&GW\&HRB>YL;PF*3>%"_NY0",'
M^5ACKS6WX6UJUUW1OM-K9O9&*:2">U=5!AE5L.IV\'GN.N:2U7F-[FU1110
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MK3HHW!:;#(8EAACB4DJBA1GK@#%9V@Z#:^'K*:TM))GCEN9;EC*03ND8L0,
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MZ5\/;!/%'A@75C=P7<)ND^UR2)=H\@5ED#L<GYB0?6A+OWM^*7ZD]/E?\_\
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M+F.ZTV::57NI>61T"XPWR@ G@8'/2MCQ186VE:EX T^RB\JUMM3$42;BVU1
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M?>/K5WQ+X9T[P/I&CZUX?M#;0:#=&66)79RUM*=LPRQ)[AO^ T*WXV_+_/\
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M\-O+\CL,YAQ(%" GY?EZ5['X$O=6U#P3IEQKD$\&I&,K.MQ$8Y"58@,RGH2
M#^-/EW\B;K2QT=%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG-9%_P"'OB%XHM7TGQ%>>&;;2I64ROIT,SSL%8'"^8=JYQUY(KT>BB^J?]:
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MF12!%.>26<Y/'; KG+;PQXU\,S2V/A74M$?1)9WE2+4X9?,M YR5380&&22
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MZ?HOQ&T5;?2K/6- N])@ C2ZO()?M2QCH,*=C$# R:] HI+3\/P!Z_UW./\
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M[%9N^%R<#\:LT4[]Q!1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .'O_ (O^!-,U"XL+S7?+N;>1
MHI4^R3G:RG!&0F#SZ5TGA_Q'I7BG2QJ6C77VJT+E!)Y;)\PZC# ']*\R\+?$
MCPGX4N?$>G:UJWV6[.N7<GE_9Y7^4MP<JI'8UZ+:>)(=?\,MK'A?R]2#AA;B
M0M KL#@@EER .>W:A?#?R0/XK>;-RJ5QJ^GVFJ6>F3W*)>WH<V\1!S($&6QV
MX!KBF\2^-_#^HV#^*-/T)]+O[Q+17TV67S;=G.%+[QAAG XQ6WK.JO:^//#6
MFBTM)%O([HF:2/,L6Q5/R-GC.>>.::6P/9G3T5P-QXO\1WGBK7?#FA:98S7=
MBT1CN+MG2&*-HPV9"N2S%B0 H' YZ<R^(/%?B#PX/#-K)IUG?ZGJ;O!/%:ED
M3S0F1L9C\JYZD@G&>*7;S_K]!M6=OZ_K4[FBO/)?$WC?P[J-C)XGT[0WTF]N
MTM1)ILLIDMF<X4OO&&&<#C%;WB;Q'>Z??V6C:)90WFLWJO)&D\ACBAC7&Z1R
M 3C) P.3FCH(Z6BN)TGQ)XDT_7[+1?&%GIBS:B'^QW>EO(8F9!DHRO\ ,#C)
M!Z&JLWB/QIKFL:G;>%;7P_%;:9<FUF.JRRF61@ <A8Q\J\\9SGK0!Z!17):Y
MXGU70/"MG>7FFVHU:YN([40_:3Y$;NQ 9I-O"XYZ=\4N@3>/UU)8_$=KX=DL
MG!_?:;+,&C.#C*R#YLG'0C%.P=+G65B>(?%_A_PK"LFMZK!9[QE$8EG<>H10
M6/X"MNO/?AQ90ZO/JWB^]C6?4KR^FAAE<9,,$;%%1,_='&3CK26K#97.@\/>
M._#'BIS'HNLV]U, 3Y/,<F!U.Q@&Q[XKHJX3XIZ7!_PBLWB&!%AU?1L7=K=*
M,.NTC*D]U89!'2K7BSQC=:!I&@W]I8_:SJ5W% 8!]]A(C$!3D '(7D\8S3WV
M[V^_8+:_C]VYV-4KO5["PO[&QNKE8[J^9DMHR#F0J-Q ^@]:XB_\3>.O#2MJ
M_B#2=$DT)67SET^>5KBV0D#<Q8!7QGG %;>O:Q]F\4>$[:.VM)X[^>8>=+'N
M>("$L#&<_*3T)YX-"5V@[G4T5PFK>+?$*^.;OPOHFEVES,+&.YBGN':..'+,
M&,A&21PN HSUYJ30O$OB:W\51>'/%MCIB7%U;O<6MWIDCF)PA&Y"K_,",YST
MI+7^OZ[ ]/Z_KN=5!J]A=:M=Z7#<J][9JCSP@'*!\E3Z<X[5=KE],U<R^/O$
M6GO:VD4=G;6LGVA(\2R;@Y(=L\@8XXXR:Q+?Q-XX\3I_:?A73=#BT7S&6%]4
MEE\VZ53C>H080'!QNSV-';^NX/3^O(]#HKFO#OBI]<T2_FELS9ZEISR07=J[
M;A'*HSP1]Y2,$'WKE]$\5?$/Q;X<L=7T32=!M8I(\R'49)09V'#&-4SM7((&
MXDFC^OO ]-HK \'>(W\4: M]-:?8[J.:2WN;??O\N5&*L >XXK?IM6 *X_6_
MBCX-\.:M-I>JZS]GO8<>9%]EF?&0".50CH1WKL*K:C_R#+O_ *XO_P"@FHD[
M)LJ*N[''6GQB\!7U[!:6VO;YYY%CC3['.-S,< 9*8')KIM,UZUU;4=5L8(YE
METR=8)C(  S% V5P3D8(ZXK"^%'_ "2WP_\ ]>O_ +,:YC3-0\2CQMXVL/#.
MGV,EP;Z*5[O49&6",>2@"X0%F8X/3 'K6C5I./K^G^9FG>*EZ?J>L45R'A3Q
M)K-WK-_X?\2V5G;ZM9Q).)+)V:">)R0&4-\PP1C!JG<^)/%NO7U[%X-LM&%G
M8W#6TEYJLLF)I%^^J)&,X!XR3S@U)1W=5=2U*TTC3+G4;^7R;2VC,DLFTMM4
M=3@ D_A61X4\1RZ];WL-[9BRU33YS;7ENK[U#8!#*W=2"".]5_B3_P DU\1_
M]>$O_H-*6BN..KL9'_"[?AX?^9A_\DKC_P"-UWT<BRQK(ARK ,#Z@UYSIGQF
M\ 1:=9V[Z_B5840K]CGX8 #'W*ZOQ%<>)DB@C\,V6FS2R!B\^H3ND<6,8^50
M6;.3T(QBKDK$Q=S=JEI^KV&JR7D=C<K,]G.;>X"@CRY  2IS]1TKF_#'B/7I
MO$-WX<\3V=A%J4%LMVD^GN[0RQLQ7@/\RD$8YZU+X<UJ2[?Q6WV2S@:PU&6)
M3#'M,NV-3NDY^9N<9XX J7HF_*XUKIYV.LHKSSPQXJ\9>+].TG4]/TW2;33I
M!']LFO&DWR_\]/(1>@!R 7/./3DON/%WBF^\7:]X;T'2M/EFL#$R7=Y(Z0QJ
M\8;Y]N69BV<  <#DTVFG;^M 6JN>@45QOACQ+KTOB.Y\->*+*PAU.*V%W%/I
M[L89HRQ4X#_,I!P.:@O?$GBG6=5O[+P;9:08=.F\BXO=5EDV/*!ED1(QGY<C
M))QU%(#N:*XW3?&\QT77I-6T[R-5T%6-Y:P/O5QLWJT;>C#UY%4])U;XBZB;
M34Q8^%I-(N0LBPPW4QG5&QSOQL) ]!3MK_74-D=]17&>(O$?B#_A)E\-^&+;
M2OM_V07;SZI*ZQ["Q7"J@W,>#D]LBMKPY+XCDM)%\2VNG0W2-A7T^5VCD&.N
M&&5^AS26JN#TT-FN2UOXG>#/#UZ;+4M>@CN5)#1QH\Q0CLVQ3M//>I/B/K%Q
MH7P_U>_M'*7*Q".)QU5G8("/INS5_P +>'+#PQH-M86,"IA 9I,?/,^/F=CW
M).:%K=C>EO,MZ1K>EZ]9B\TF_M[VWS@O"X8 ^A]#[&K]>>:C;6_AGXM:%<:=
M&L$>OQ3V][%'PLCQJ'23'3=U&?0U8U#Q7XEF\8ZMX:T'3+&:>V@AFCNKMV2&
M(.#GS-N2QSC 4#C.3Q1O:WG^&XK-;^7XG=U2LM7L-1N[ZUM+E99[&417* $&
M-R P'/7@]JYG0/$VO1^(E\.>+;&Q@U":!KBUN=/D9H+A5.&4!_F5@".O6KGA
MK5&OO$'BFV-I:0BSODC$D,>UYLQ(=TAS\S<XSZ 4_P#(5SIZ9+*D,3RR,%1%
M+,Q[ =37FVC^+?'OBS2FN=!TK0[?R;B6&2XU&24)*5<C$:)D]-N23USQ70^&
M?%%WKFB:HVH6$=IJ>F326UU K^9&75<@@]U((J7\+?E<I+6WG8Z#3-3L]9TR
MWU'3YQ/:7"!XI " P^AY'XU;KA]-\8Q:=\*M,\0SV$*/-;QB&QLD\M&D<[4C
M0<[03CZ53N]?^(VB6LVLZMHN@S:5"OF36EE<2_:HD'+'<PV,0,G QFJDK2:[
M$QU2MU/1**Y#Q9XT;1/"VFZ]IEN+V&\N;=%CQ\TD<G]WD?-C&,\5CZMXF^('
MAVVDUS5='T%M$B*M-;6MQ*UU"A(!8L0$;'H!1;6WR'TNCT>BFQR++$DB'*N
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ME+F;;W?_  ;B2LDD34445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVYG Y.PY(./3.?:NMIV **X[6/B1I>F:G/IUGIFM:W=6S;;E-(LC.(#Z.<@
M^V36O=>*M+T_PW'KM\\UK:2*I59HF$I+?=79UW'TZTNEPZV-JBN*T_XFZ5=Z
MC#9WVEZYHQN)!%;3:K8F"*=CG 5LD9/OCJ*U?$7C/1_"U[96VJR2QF\21HF1
M-P)3;\N!\Q8[@  #F@#H**XW2_B3IFHZU#I5UI6MZ3<7+%;5M4L6@2X(R<(<
MGL.^.HK6\2>+=+\+10&^,\MS<DK;6=K$99YV R0B#K]3@<]:/,%J[&VS*BEF
M8*H&22< "H[6ZM[VUCN;2>*XMY5W1RQ.'1QZ@C@BN<TOQ5'XETK4L:/K.F20
M1-NCU2S,#$%3@KR01P:Q_"6O6OAOX.^']1O(YI(5MX(ML(!;+L$'4@8RP[T[
M;_+\1-_K^!Z!15/5=2AT?2+S4[A9&AM(7GD6, L54$G&2!GCUK-O_%VEZ;X>
ML]:N?M AO%C-O#'$9)I6==RHJ+G+8_E2&;U%<MX>\<V^OWYL6T+7]+G*ET&I
MZ>T(<#KALD?F13O#+:6?$'BD6/VW[2+Y/MGVA@4\SREQY>#PNW'7G/MBG85S
MIZ*XB[^*.DPWLD-EI.O:K!"YCFO=.T]I8(B#ALOD9QWP#TK=3Q5I4_A.7Q+:
M3FZTZ.W>X+0CYB%!)&#C#<$8..:72_0JSO;J;5%<'-\6-%6..XL]*U[4;$J&
MEO;+3VD@AZ$[GR!QWVYQ@UT<GBG1HO#"^(VO =+:)95F522P;@ +C.22!C&<
MT-6$M39HKC](^(=KJNJQ6#^'O$FGF9ML,]]IK1Q2'V8$X_'%=A0 45Q-Q\3]
M(1KJ&ST[6=3O+6XDMYK33[,SRQE&VEFP<*I(XR03Z4T?%;P_/8I-IUOJNIW9
M)#Z=8V327,)!P?,3^#!]2,X.,T#M9V.XHK$\,^*M.\5V,MQ8K<1202>5<6UU
M$8YH'QG:ZGH:QM3^)>GZ;?S6ZZ'XBO8K=V2XN[33':"$J<-ECC('/(!Z4/30
M2UV.THKGY_&6DPV>BWRM+-8ZQ,D-O<QJ-BLP)7?D@KG&.G7BKGB'7K3PUHTN
MIWJRO%&541P@%Y&8A5502 221WIM6_K^NX;FI12(Q9%8J5)&=IZCVKC+SXFZ
M/;7=]906.KZAJ%G<-!)96%H9I3C'SX!P%YX+$9P>.*7D'F=I16#X8\7:;XKA
MN#9)=6]S:N$N;2\A,4T#$9 93_3-9NL?$;3-+U*;3[32]:UJYMVVW"Z39&<0
M'&<.V0 ?8$T/30%J=A16!8>,=)U30+C6-/-U=16[%);>&V=KA'!P4,0&X-[8
M]^E<U\/OB+<^*(K>WN]"UQ)9GF;[<]D%M H=BJ^8#U PO3J*=M; ]%<]"DD2
M&)Y975(T!9G8X"@=23V%-M[B"[MX[BVFCF@E4/'+&P974]""."*H^(O^19U7
M_KSE_P#0#7GGA7XCZ;I?@O0K6/2==U&."QACN;K3[!I8(&"#<&?@''.=N<8/
M>DNOR_7_ "';1'JM%9UEKVEZAH2:W;7L3Z:\1F^T$X4*.I.>F,'.>F*Y6/XK
MZ(TZ-)IVN0:8Y 35Y].=+-LX .\\@'/4@"G;6W472YW=%(K!E#*001D$=ZRS
MK]J/%*^'O+F^UFS-YOP/+V;]F,YSG/MCWI=;!YFK167J.O6NF:OI.FS1S--J
M<CQPL@!52B%SNR00,#L#7$ZC\3IK#Q[=:4GA[Q#?6EO: F.STTL[2%R-^&P=
MF!@,."<T?U]P,]*J".\M9;N:TCN87N80K2PK("\8;[I9>H!P<9ZXKG-3GTN3
MQKX7:Y34$U&6&Y:T52%C4;%+B5<YS@C&,\YJGH?_ "5CQ;_UYV/\I*=OU_ .
MGW?B=M17&>%]3TO3/A^]_H]GK%Y9P33E;<H)KIV\U@P4 \_-G'/3WJI;_%2W
MEU.QL)_"/BVS>]G6")[O31&FX^I+] ,DXSP#1:[L@>F_]6.^HKG/$?C33?#=
MQ'9O;W^H:C*GF)8Z;;&>8H#@M@< >Y(]JF\-^+=.\3QSBU2ZMKNV(%Q97L)A
MGA)&1N0^OJ,BDM=@>FYNU!%>VL]S/;0W,,D]N0)HDD!:,D9&X#D9'(S7*:I\
M2-+L-7ETVTTS6M7FMWV73:78M.ENWH[9'/L,UG^ =3L]9\:^,]0L)A+;S26A
M5L$$$0X((/(((((/((HCK_7H#T_ [VYN;>RMI+FZGB@MXE+22RN%5 .I)/ %
M/1UD171@R,,JRG((]17,?$C_ ))KXB_Z\)?_ $&L2V^*.D6.GV@&EZ[<V$4"
M"75+;3W>TCP,'+]P,=0"*%U#L>B45A7/BW3+:71/FDEMM9?R[6[BVF+<5W*&
M).1N'3 //I5CQ#X@M/#>F"]NTFE#S1P1PP &221V"JJ@D#//KV-.S_0#5HH'
M(!QCVKD-:^(5GH^I2V,>A^(=3D@.)WT[37D2(X!Y8X!X/;-(#KZ*S]$UNP\1
M:1!JFF3>=:S [6*E2"#@@@\@@@BN;^(WC*?PEIEJUI97]Q<7%S$FZWM3(JH7
M&X9QMW,,JHSDDT/1V8+4ZZ[N[:PM9+J\N(K>WC&7EF<(BCU)/ J4$, 000>0
M17FWC+Q#_P )%\(?$=W_ &1JVE^7'Y?E:I;>1(W*G<!DY7G&?8U;?XK:+9Q1
MO_9>O3Z:B#?JL&G.UHN."=_<>X!'-.V_]=+AV9W]%<IXWN]&G\"RW>H27<NE
MRF!P]@X$C R+L*DD<9(S[9J[KGB[2?#=W:6VI221?:8I94D"[EQ'MRO')8[A
M@ ')I>H;[&]2,RHI9F"J!DDG  K!TCQ9;:II=[J5QI^IZ3:VC'>^J6WV?<H&
M2Z@G.W'<XKG7^*6C7MK/_P 2S7+?3I(6$6JW&GLEH^1@'S.P.>I %*3:3&E<
M[RUNK>]M8[FTGBN+>5=T<L3AT<>H(X(J6N3^&7_),_#W_7DE7_$/BW2O"\UB
MFJ221+>,ZQNJ[AN5=V,#DD]  "2>*N:Y96)B[JYNT5QFF_$K2KW5X=-N],UO
M2);A_+M9-4L6@CN&YX1B3SQT..M;7B+Q+:^&[:.6>UO[N68E8K>QM6GDD(&<
M #@?B14O17'Y&S17->&O&^G>);N>Q2TU+3M1@02O9:E;&"4(3@-CD$?0U6O_
M (BZ/87=]9"UU*[U"TG,'V*SMO.FE(17+(JG[H#@9;'- '745YOXD^)<^E:U
MX>MK?0-?=+L--<V\>G$RLOE$B-0>"P+ MM/R[<$]JZ2S\9VES>:/:7&G:GI\
MVK12/ E[ (RK)U1QNR'QR!W%.P-V.DHK*UOQ!::$;!+B.:6:^NDM8(H0"S.W
M?D@8 !)/H*MZC?)IMA->20W,RQ#)CMH6ED;MA54$FETN'6Q%/K>DVVHQZ=/J
MEE%?2_ZNVDN$65_HI.35^O&?AE?:1KNK7-Q?>#M1EU6YU&XN!J]UIRM'#M8[
M$\TDE&4 +@=Q79ZI\2]+L-2GL;+2M<UF2V<QW+Z58M.D##'RLV0,\]LT=%YA
MU=NAV=%9.D>)=+UW1GU73IS-;IN$@VE71E^\K*<%6'H:PK+XEZ3JDFG)I>G:
MQJ!O!$7:UM-Z6F\ CSGSM4@') )Q3L[V"^ESLZ**X[5_B+8Z5J,MFFA^(M0$
M#%;B>QTUY(H2.N6.,CZ9Z4K@=C16!/XQTB+P:WBJ*62XTL1"7=$OS%<XZ-CD
M'J#Z5A77Q8T2U<RKIFO7&EJ,OJT&G.UHH[G?W'N 1S1UL'2YWE%8EYXJTZRG
MT5&\V2#6)/+MKJ, Q!BNY0Q)!&X=, \U-XA\06GAO3!>W:32AYHX(X8 #))(
M[!5502!GGU[&G;_(#5HH'(!QCVKB;CXH:/&US#9Z=K.IWEK<26\UII]F9Y8R
MC;2S8.%4D<9()]*0>9VU%8OASQ3IGBBQDN=/:56A?RY[>>,QRPOC.UU/0_I4
MWAW7K7Q-HD&K64<T<$Q<*LP 8;6*G(!(Z@]Z=@\S4HK*TKQ!::Q+JD=O',IT
MVZ:UF\Q0-SA0Q*X)R,,.N*Y^V^)VD:@MA_9FFZSJ+W>S>EG9^9]E#' ,S [4
M]>I..>E):Z ]#M:*Y35OB#I&D:K>:4]OJ%SJ5LB.MI9VYFEG# GY%4YP,<DX
M R.>:G\->-],\37$UG%;W]AJ,"AY;#4;<P3JA. VTY!'T)H6NP/3<Z2BN3U[
MX@:9H>I/ID-AJVKZA&JM-:Z59F=X5/0OR ,^F<^U:/ASQ5IGB>WF>Q::.:W8
M)<6MS$8IH&(SAT/(_E0M=0>FYMT5PT_Q2TQ+MH[/1/$6HVB.4?4+'36DMU(.
M&^;()QCD@'VS70ZIXHTK1]$AU:]FDCMY]@A01,9)&?[JJ@&XL?3%'2X=;&Q1
M7):'\0=-UG4X]-GTW6-'O9@3;PZM9FW,X')V')!QZ9S[5UM.P!165XBU^U\,
MZ.^J7L<SVT;HCF( E=S!=QR1P"1FJWBSQ;IW@[1EU/4$N)HFD$:1VR!W8D$\
M D#  )//04AVZ&]16/K?B2RT+0AJ\Z33P.T:QI;@,\C2,%4*"0#RP[UGI)I8
M^)<PQ?#5AI"LPW P>3YIQA0<[\^W2CK_ %VN+I?^M['45!'>6LMW-:1W,+W,
M(5I85D!>,-]TLO4 X.,]<5YUIGQ1FNO%NJZ>?#?B2XM8YX88##IIQ!E?F:7=
MADR3GD?=&:9)XFL?#?Q2\4-<Q7=S<3VEF(+2R@:::8A7)VJ/3CDX'(YH6MO,
M._D>GT5S/AGQQIOB:[GL8[74=.U&!!))9:E;&"8(3@-C)!'T--\0^/--T"__
M +.6RU/5=1""1[/2[0SR(AZ,W0 ?4YH>@+4ZBBL'PWXNTSQ0DZV?VB"[MB!<
MV5Y"8IX"1D;D/\QD>]6M"UZU\06]U/:1S(MM=RVCB4 $O&VTD8)XST_E3L!J
M45AIXILI+[6[1+>]>71_+\\1P^89-Z;@(U7+,<>PKE? OQ(N?$<XM;KP_KRO
M-=3JEXUB%MHD5FVJSYX( "GC[W%):Z('H>C455U&^33=/FO)(;B98ER8[:%I
M9&]E50237"_#[XBW/BB*WM[O0M<269YF^W/9!;0*'8JOF ]0,+TZBA:Z('HK
ML[VUO+6^C:2TN8;B-7:-FB<. RG!4D=P>"*GKR/PAXXL=!T?4+*/3M6U:]75
MKQI+;2K-IWB4S-@OT"Y]SGVKT3PWXGTWQ5IK7NG-*!'(8IH9HRDD,@ZHZGH1
M1NKKR_)!_7YFQ17$7GQ1T>WNY([;3-<U&UA<I/?V.GM+;1%3ALOWQWV@UU]A
M?VNIV$%]93I/:SH'CE0Y#*>]"U5P>CL6**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYY1!;R2D$A%+$
M#J<#-244GMH"/*].U#QEXP\-IXFB\8Z;X<TUP\BQ0V"7!C0'&)'D; 88[ =:
MSM$?S/V:M4?S?.W6]Z?,V[=_[Q^<=L^E=P/AAX*&M_VQ_P (]:_;=^_.6V;O
M7R\[,_A6P?#6D'0KK1/L8_LZZ\PS0B1AN\QBS\YR,ECT/':GIRM=[?F-/5#=
M-MX8/"%I;QQJL*V*($ X V#BO+Y59OV<M(=@S6\7V>2Y &<PK."_X8'Y"O8T
MMXH[9;9%Q$J",+D_=QC&?I533]&T[2M&BTBSM533XHS&L#$N-IZ@[B2>IZTY
M.\G)>7X.Y$5913Z7_%6,CQ?J.DCX>:K=W%Q ^G2V,@1@P*R H=H7U)XQ3_A_
M_P D[\._]@Z#_P! %5+'X8>"M-U*34+3P_;1W+@C=N=E7/!VJ3M7ZJ!72Z?8
M6VE:=;:?91>5:VT:Q1)N+;5 P!DDD\>M"M9^=OU_S*Z)=O\ @''^+)$B^)'@
M5I&"J9;Q06.!DP\#ZFF_$J".YD\)12H'C;7[?*GH>'-=-K_AO1_%&G_8=:L(
MKRW#;@KY!4^H8$$'Z&H(/!^@VVF:9IT-@$M-,G%Q9QB5_P!W(,X;.<M]X]<]
M:(NUK]'?\;@]=NUOP?\ F8OQ;4-\,M7R,[?*(]CYJ5B?$V'4&\2>#9K;61HT
M(FFC%^]NLZ13,@"95B%Y&X GIFO1-6TFQUW3)M-U*#S[2;'F1[V7."".5(/4
M#O3[_3+'5;!['4+2&ZM9!AHID#*?P-):???\+#O^37WV. D\"^)KO5-'NM<^
M(27T%E>QW44!TF&$NZ]@RMGD$COUZ5Z2>E<GHGPR\&^'=174-+T.&&[4Y25I
M))"A]5WL=O7M764WM8GK<X'X3RPIX>OK*1XQJD&I7/VZ//S[S(Q#,.N",8-'
MCVXA@\0>"]1NI$_LJ'4F$TIY1':-EC8GH/F[^M:_B#X=^$_%-V+O6-%AN+D<
M&97>)V],E""?QK7_ +#TO^Q1HQL+=M-$?E"U9 4V^F#2OL^JM^&@WU\[_B<K
M\6[BT_X5[>6SLKW5VT<=C&K#?),779L]2#SQVJ+7[<2_$OP&+E0\D<-XYS_?
M$:\UJZ)\-_!_AW4CJ&EZ';PW><K*S/(4//W=Q.WJ>F*W+G2+&[U6RU.>#?>6
M0=;>3>PV!P W .#D =0::TMZW_!K]0>JMY6_%?Y'*_$E1L\+-CYE\06F#Z<M
M4%[+#:?&^QDU!XTCN-&:*Q:0@ RB7+JN?XBI'X5V.I:18ZN+47T'FBUN$NH?
MG9=LB?=;@C.,]#Q4>N>'])\26!L=8L(;RW)R%D'*G&,J1RIYZ@@TD[?>_P 5
M8;L]/+];D^H.IT^\0,-X@8E<\@8->479V?LYZ/*<[(DLY'/HHF0D_@*]#\/^
M"?#GA:VN;?1=,2UCN1B;$CNSCG@LQ)[GOWJ];:%I=IH*:'%9QG3$B\@6TF9%
M*?W3NR3^-/;;R_!W)WW\_P 58Q/B%JUC:?#;6KF6ZB$4]C(D+;QB1G4A0OKD
MD=*9;>'H/$7@/P]%)<7%K<6UO;W%M=6[ /#((P PR"#P2"",$&DL/A9X(TV>
MXFM?#]NLDZLCLSN^ P(.W<QV<$CY<5JZKX0T'7-#@T74M.2XT^W"B*)G8%-H
MP,,#N!QQG.:71_+\+CUNOG^-C%L=:U[0_%.G>'M>NK'4TU".0VUY;Q^3,&1<
MGS(LD8(_B4@9XQ5'1([B74?B/':DBX>ZVQ8_O&V7'ZUT'ASP'X7\)2O-HFCP
MVLS@AI2S2/@XR SDD#@< XK6LM(L=.N[ZZM8/+GOI1-<MO8[W"A0<$X'  XQ
M1))IKR:^^P)V=_-/[KG-_#*]L)/AOHXMY(T%K;"*Y7.#%*OWPP/0YR>:Y32G
MCN/A]\1KNS'_ !++BYOGLV!RKKY>&9?]DL&KL-6^&?@W7-4_M+4-!MY;O=N9
MU9TWGU8*0&Z=P:WI-'T^317T?[)&FG/";<V\?R*(R,%1MQCCTHF^;F?5C@U%
MKLFF4/"%O%!X&T6&- L8T^$;0/5!FN4\!:':>(?@[9Z5>>8L$CRX:)MKQE9V
M*LI[$$ CZ5Z%:VL-E9PVENFR"&-8XTR3M4# &3STK*_X1#03X:/AUM.1]).<
MVSNS#EBQ.2<YW'/7CM53=Y2:Z_YMDP5HQ3Z?Y6.>EU/Q%X.U+2[;5M2M=:TV
M_NEM(Y6B$%W&S'Y20ORR =R I[UWE<IH/PU\'^&;X7VDZ'##=#[LKR/*R=1\
MI=CMZGIBNKI= ZG"_#.&-(O%$BH \GB"[WMW.& %+X$MX8_$WC>5(U61]6"L
MP') B0_S8G\:ZO3=(L='6Y6P@\D7-P]S-\[-ND<Y9N2<9]!Q2V.DV.FW%[/:
M0>7+?3>?<-O8[WP%SR>. .!@4+]+?E_D-ZW];_G_ )G&Z%<+I_C?XAW?EEA"
M;:4JO5L09_/BLBWO/&?B3PHGBB3QMIGA_3I86F\FWT]+A43T=Y&^\ .< <DU
MZ1:Z/866HW]_;V^RZORAN7WL?,*KM7@G P..,5S]O\,/!5KK7]KP^'K5;P-O
M!RQ16]1&3L!X["IM=6\K?F.^K?G_ )?Y'.>$M#'B3X"6.G*^)Y+=WMY<8V2K
M(S(WM\P%+:ZP?'^K^$[)T^2SB.IZG&W&R:,F)8R/7S Y_P" UU.JZ]X9^'6D
MVL%W*UG;2.ZVT4<<DI=R2Q48!ZD]\#FLWX:Z+);6VK>(+JQ-E=Z[>-=?9V3:
MT463Y88=F()8^[5HG>3ETW^>W]>B(M:*77]'O_7FSN:X;X?PQKK?C68(!(^M
MNK-CD@1I@?J?SKN:I:?I%CI<M[+9P>4][.;BX.]FWR$ $\DXX X&!4+1W\OU
M7^13VM_74Y;2%"_%WQ-M&"VGV9/N<R"H/A3-"GAZ_P!/E=5U2VU&Y^W1GA][
M2,0Q!YP5(P:["'2;&#5[G58X-M[<QI%-+O8[E3.T8S@8R>@K&\0_#WPIXJN5
MN=9T6&XN!@>:K/&Y Z LA!/XT+1)>5OQ;!Z_??\ "QC>$YH;SXD>,[O3B'L"
M+:*21""CW"H=^,=P"H/O4_PCD1_AS8JK M'+<*X!Y4^<_!]#S76:9I5AHUA'
M8Z;9PVEK'G;%"@51GK^-9%KX#\+V/B4^(K72(8=5.XF>-F RWWCLSMR<GG&>
M::TTZ62^Z[_4'JOG?\+&CXB_Y%G5?^O.7_T US_PRO\ 39?ACHDEM/"(8+-4
MF(8 1NH^?=Z<Y/-=;<6\5W;2VTZ[XI4*.N2,J1@C(KE;[X6^"=2N+>XNO#]L
M\L"JJ%6=,A0 -P5@'X 'S9I+KYV_7_,'T_KL<!+#<WGP/\52Z:&%I/J=Q/;%
M!N!MO/!8J.XP&..];)\)^*_$/AI@?BE!<:1>6^UBNAVX1HV&,9#<<?E7I\%K
M;VMI':6\$<5O&@1(D4!54<8 Z8KD9?A+X$FU(W[^'+7SR=Q =Q'G_KF&V?I1
MIMTT_!6'=[]=?Q=SIM%LO[-T+3['[1]I^SV\<7GXQYFU0-V,G&<9ZFN3N9H[
M?XWV8F=8_M&A/'#N.-["8$J/4XYQ7<(BQQJB*%10 J@8  [5D>(O">A>++5+
M;7--BO(T.4+$JR>NUE(89P.AYIMMRYO7\;BBDH\O]=/\CE_%FIVC_%+P1IB3
M(UVDUS,\:MDHIA8 D=L\X^AJS;R(GQMOXV=0\FA0[%)Y;$SYQ6MI?@/PQHGV
M/^S='AMFLY3+"R,VX.5*DLQ.6^4D?-FG^)/!/ASQ=Y)UW2XKMH?]6^]D=1Z;
ME(./;.*%I;Y_B#U_#\&8_B+_ )*IX,_ZY7W_ * M+H?_ "5CQ;_UYV/\I*Z5
MM!TQ[[3KPVH^T:=&T=HP=@(U8!2,9P> .N:?!I%C;:M=ZI#!MO;Q$2>7>QWJ
MF=HP3@8R>@HV5O\ %^(;_A^!R/PTN[>P^&_VNZE6*WAN;QY)'. JB>0DFM70
M+.XU;4#XFU.)HY)$*:?;2#!MH#_$0>DC\$^@P.QS9F\&Z!/X:D\.R6!.E2N9
M'@$\@RQ?>?F#;OO<]?TK#M/@[X"L;V"[MM!V3P2+)&_VR<[64Y!P7P>11?6[
M\OR5PEUMY_GH<U<:?X@N?B_XBM]/\7+H%Q<06\D"/I\=P;F$+CY2YXVMNR!Z
MUTWAKPAJVE^,+C6M9\6IK-[)9"V\L6$=L50/N!.QN<'/;OUKH/$/A/0?%=LM
MOK>F0WB)]POE73_=92&'X&H_#G@WP]X2CD30]+BL_-X=PS.[#K@LQ)(_&E'1
M6^02U?\ 7E_D8'PIEA3PW?6<CH-2M]2NOMR'A@YE8AB.O*XP:@\!7-E=^/O'
MDU@\;P&[MP6C(*EQ&0V,?[0-;>N_#KPEXDU%=0U;1(+B[7&90S(7QC&[:1NZ
M=\UKZ9H&E:--/+IME':M.L:2"+(4A!M4!>@P.. *:?5]K?E_D$M=N]_S_P S
M'^)/_)-?$?\ UX2_^@U/X?U31F\!6-]#<6ZZ5'8IN<L B*$ (/ICH16QJ.G6
MNK:=<:??1>;:W"&.6/<5W*>HR""/PKF[SX7^"K_5AJ=SX>M7NLY)!948^K(#
MM8^Y!J>C7?\ R?\ F'5/M_P#E_#V@7&N? VWMH5:*Z4R7FFENL;+*SPX]!C
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MX?DL\Z7$J(D'FOP$(*_-G=P0.]6;C1["ZU6RU.:#=>60=;>3>PV!P W .#D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*2L$EJFLP+URQ4HX'U95_.J/A"W;P'K5M:Z@^U-7TG[9<.QP#=Q$M*?J5?\
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MDNY88E1[B3[TI P6/N>M4W=B2LBS1114C"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&<GC&,"DM0>B.GHKE]5\>Z1I&HWNG317LU]:B/;;6T!EDN"ZE@(U4Y. ISG
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M"@\D@<\52U_7K7P[IRWUW',\33Q0 0@$[I'"@\D<9/-<[XN_Y'SP-_U]W/\
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MZ9KEE9S6LBP:C>V#16LI92%Q)VSV+ 5TOP__ .2=^'?^P=!_Z *:6C?I^O\
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MHQ9% QON8#A1]2) /PJLEDOPYNO"M],<6[V,FGZ@_K+@S*Q/^^)!_P "KO\
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M4N!/M<EXUWD ,"0>.2*W-&\&ZW:>,[36M=\:)J]Q;VTD,<']G1VS%'QGE&Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGH16M:S:N^O:A#=6D":4B1&TG1\O(Q!WAAGC'&./S["VOZ_@#T_#\33HHHH
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M7\.7>GQ*(TO+V";[2$' RJG:Q QSD9I/=_+\M=?ZN);+Y_\  T.L\-7=]?\
MAC3+K4X'@OY;:-KB)T*%9"HW J>1SVK4KD-;OM;BU[PMHME>8FG=I]1F2%</
M#&HW<,#M#,RCCD9ZUU]5+5W]1+30X[X@7_AV.QM=.UZZOQ]ID)BL].:7SKG
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MUM'M +,^UUS(2>_;%=+\.=1OK9]>METG7[+0K6-)M/BUF!TE3Y3OC5B3N4$
MCDD9K5U+PQXCTS7;[6/!U_IT;Z@5>[L=31S"T@&/,5D.Y3CJ.AQ6YX>@\2?9
MISXHN=,FFDP%AT^)UCC'.>7)+9X]*E7Y;+>WXE.W-\_P.'\*>!-*\9:#9>*O
M$C7E[K%\#<I.+R6/[*"3M6((P"@#'XUI?"RVN+(^*[:ZNGNIHM;D0SR8W2 1
MI@MCOC&?>DL?#'CCPR/[*\.:IHDFA"1FA_M&&4SVJ,<[5V$*X&3C.*V/ _A6
M[\*QZS'=WHO&OM0:[68_>;<B@[A@ '<&X&1C'-6FM;:*WZK^O,GI9ZN_^?\
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M-)H6@W6F>)/$FHSR0M#J=Q%+"J$EE"Q!#NR  <CL31LK>7XVC_P1/]?PN_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA)J1OM4U3473RA>:I=&>5(^NQ3@ #/M74U3TG4H=8TBTU*W61(;J%9D65=K
M,,C([&KE4[IV9*L]4%%%%(84444 %%1S3PVZ!YY4B4LJ!G8*"S' '/<D@ >]
M24 %%9JZY;-XE?0O+N/M2VHNB_E_N]A;;C=ZY[5I4 %%%1QSPS/*D4J.T3;)
M%5@2C8!P?0X(./<4 24444 %%%% !116+X7\0?\ "2:;<7?V7[/Y-Y/:[/,W
MY\MRN[.!UQG':@#:HHHH **Q_%6N_P#",^&+_6?LWVG[)'O\G?LW\@8S@XZ^
ME:T3^9$CXQN4''I0 ZBBB@ HHHH **** "BBLW7M;MO#VD2ZE=QSR0QLBLL$
M>]_F8*,#ZD4 :5%1R3PPJAEE2,.P1=[ ;F/0#/<^E$T\5O'YD\J1)D#<[!1D
MG &3ZD@4 24444 %%%% !114<<\4Q<12I(8V*/M8':WH?0\CB@"2BBB@ HK$
M\6^(?^$7\.3ZM]E^T^4\:^5YFS.]U3K@]-V>G:ML'(!H **** "BBB@ HHHH
M **** "BBL27Q!Y?C6W\._9<^=8O>?:/,Z;75=NW'^UG.?PHZV VZ*** "BB
MB@ HHHH **Q-1\0_V?XJT71/LOF?VFD[>=YF/+\M0?NXYSGU&/>MNCI<.M@H
MHHH **** "BBB@ HHHH ***CAGBN84F@E26)QE71@RL/4$=: )**Q/$WB#_A
M';6QG^R_:/M5]!9X\S9M\QMN[H<X]._K6W1TN 4444 %%%% !1110 5EZ9H-
MKI.HZK?023-+J<ZSS"0@A6"!<+@# P!US6I10 445B6/B#[;XMU?0OLNS^SX
M8)?.\S/F>8&XVXXQM]3G-'D'F;=%%8FH^(?[/\5:+HGV7S/[32=O.\S'E^6H
M/W<<YSZC'O1UL'2YMT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M4%Y9V^H64]G=PI-;3H8Y8W&0RD8(-3T4-7 X)?A38Q2*D/B?Q9#8K@+81ZLP
M@"_W0,;L?C77:/HVGZ!I<.FZ9;+;VL6=J D\GDDD\DD]2:OT4[A8****0!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'S=_G(C;?,Z#&2#QSTZUSWC>#7$\:^%]5T;2WOQ8)=/<1@[0R,$7:&/ <Y)
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MB,D<\UITY*S:%%W29Y=X-\7^,M3U[58IO"DDEC_:SPRW#ZG%_H*JJJ4"<[L
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M2X9GA>\-_# 69&*OLC;E@"#CIFN@U/Q1!HWAV#5;ZSNHY9]B1V(4-.\K](@
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MO-C!P!WZUO?";7M(F\$:/HZ:E:_VI!"R2V1E43(58YRF=W'TJW\+E5?#NHD
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M86J6MG;0VUO'PD4*!$7OP!P*FHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RS28?'?BF[UNY
ML_'?]FVUKJEQ:16W]D0385&X^8X/0]ZZ7P;KVKWNH:SH>OK;-J6E21@W%LI6
M.>.1=R-M).#@'(KA] F^(%NOBF;PQ#X>FLDUF\;R[WSO/=PW(7:0OIC)KJO
M*PGPQ>^*!=O?:KJ8,]Y(\0C*2(NWR0@^Z$P1@DGOWH32C=[)+\E_P1R5Y6ZW
M_7_ACK+W7M'TVZBM;_5K&UN)CB**>Y1'?Z G)ZCI5BXOK2T:!;FZ@A:X<1PB
M20*9'/(5<]3QT%>%>%[?5]4\.QZC<?">Q\0S:ANFEU2ZU.W\R<L3R ZED Z
M C&*ZBV\,^()?A$]EJ-FUIK&F7#7>FQ27"SM$(WWQ+O4G/&4^GI3>B][I_3^
MX2U:2Z_TOO/4+FY@L[:2YNIXX((E+22RN%5 .I)/ %17.IV%E8_;KJ^MH+3
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** ,3PUX>_X1V+4D^U?:/MNH37N?+V;/,.=O4YQZ\?2H=(\+KHGB/5=0L[K
M;8ZD1++8F/A9_P"*16SQN'48ZC.:Z&BC_AOZ^X/^'.!?X?ZSIDTR^$O&-QHE
MC-*TK63V,5U&C,<GR]^"@SDXYZUV&D6$^G:;':W6H7&H3+DO<W 4,Y)ST4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4454TR]_M&PCNO+\O>2-N[
M.,$CK^% %NBFR.(HGD;.%4L<>U8B>*;9XA,;#44@//G-!\@'KD&@#=HID,T=
MQ"DT3AXW&58="*?0 4444 %%%% !145Q<16MN\\S;8T&2:CL+V/4;*.ZB5U1
M\X#C!X./Z4 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*1,>=N.<C&*T!I,MOH-Y;JWG7=PKM(W3>[#WZ"M#3HG@TVUAD7;(D2JPSG!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_C1X=T=-,LP[P>7=/D2'?G(R<=\=,4D-FS1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54TRR_LZP
MCM?,\S82=VW&<DGI^-6Z* "BBB@ HHHH Q3HUY!))_9^K/;0NY?RFA60 GK@
MGH*NZ?IR6"RGS9)II6W22R'ECV_"KM% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>annexd_006.jpg
<TEXT>
begin 644 annexd_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWC>2".Y$9\]5QN*M&[+GD<$@\]*+:??^ &W167I&O66LZ!'K,'F16S(S,LP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P/-/CT^RB+F.SMT+QB)RL0&Y!G"GCD#)P/<U#5XV\FOO'?6_FOPM_D<]X#
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M^-$=&O5/\@>S]'^H[2OW/Q2\1++A&N+&TDB!/WU7S Q'K@XS]16)#<175_\
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M\?4UTUK96EC:K:VEK#;VZ#:L,481%'H .*6VM;>RM4MK2"*""-=J11($51Z
M#@4G\+7E_F_U&]?Z\DOT.)^&FI6,7PY662>...TDN/M!8@>7^]=LGZ@YI_@K
M4K3P_P"!]!AU:<6;ZA.Z6<4H.3YCL\:>WRD=:L>$?"-M!X8TV'7M&LI-0M))
M60SQ1RM%F5F!5N<<$'@UU<]I;7)B,]O%*87$D1D0-L8<!EST/)Y%5U^X7_!_
M4DD_U;?0UYC\.O"OA>]^'5C?:EHFE23,)6ENI;9/,&)&^8R8R" .N>,5ZAU&
M#6$O@GPHDPF3PQHJRJVX.+"(,#USG;UJ>Y72W];'"PSZG>>"/#VIWT\DMG9:
MXLS32$L9+-9&6.1CW !1MQ[#<:Z?QRWVP^'["SF7[;-JL$\04Y/EQG<[\?P[
M<C/3D#O77%%*;"HV8QMQQCTJG8:+I6E/*^G:996;S'=(UO L9<^IV@9IWU^=
M_P O\OS)M_E^?^?Y',6FIZCK]SKSS:U)HMKI=ZUL%MHX3(550=\C2JXPV[(
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M>WR_'^OQ&]/Z['I-%<3:QW.L^.O$^FW=]>#3K=+5HX8+F2$JS(2<,A#*/EZ
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M\BSMH;>+<6\N% BY)R3@=R22:9?Z;8:K:FVU&RMKRW)!,5Q$LB$CV8$5:HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOBS[-;O;$MH^R7]]P_/"F,YQU9@1MXZUYO?:5JN@_&?P@NH6'AS3[B65"(]
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M2!1'6R?57_!"F[7MT=OQ/<:***0PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI-^=SB?!OP^_X1+Q)X@U?^U/M?\ :\QE\K[/Y?E?.S8SN.[[V.@Z4O@7X?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*BD9@BEF("@9)/:N"_X6!K6HM]J\.>"KS5M'#E?MQO(H/, ."T:-RXX..F:
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M:\2RH57YWSP%"_WB>,>M<Y+\0M>TY&U#6? FH6.AKAFO%NXI9(U)'S/"OS*
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M%HIM3NY$)!!*F5B.#R.M-+?^NHGI;^NAW5%%%(84444 %%%% !1110 4444
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MZ*>,.K?4'BFV&F6&E6PMM.L;:S@!R(K>)8U_)0!3CI:_3_@_Y@];^?\ P/\
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MAO( <,T>05/7#*<%3[$4+78'H:M%<KKWQ(\(>&;[[#JVN0077\42(\K)_O!
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M.#@_K0M5= ]"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR23G J8[:]FBW_D8/PBMX#X%CO3&IU"\N)Y+^0CYWF\Q@0WTX&*G\8JJ>+?
MRJ JC490 . /W#T[4?AGI5YJ4]_8:IK>B27+^9<II-\8$G;^\RX(S[C'4UI:
MSX+TO6]"L]*N9+V,615K6ZAN&6XA=1@.).3NP>ISFG?52[6%W7>_XF7\3/\
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M7D'@GEB/>I/BY% G@U+Y$4:E:WENU@ZK\XE\Q0 O?D9KJ=:\.:9XATI=.U*
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MFT-M.X#HP(/XBNA@8O;QLQRS("3^%'2X$E%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#PY8_;;BUMY=/N_M/V=RCR1AHSL##E03MR1@X%=]8P-:Z?;6[D%XHE1BO3(
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M=M;3S&4VKHP4JI8DA""."3R*MZEX8\1Z9KM]K'@Z_P!.C?4"K7=CJ:.86D
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MO$UKX@\5WFD_:+*&2&WM]*BD"$/C+.[G)Z=,8[U5US.VVO\ 7_ Z$Z\JOO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LN
MXT&UN?$EEKKR3"ZLX)((T!&PJY4DD8SGY1CFM2B@ HHHH **** "BBB@ HHH
MH **** ,NTT&UL_$.HZW'),;F_CBCE5B-@$>=NT8SGYCG)-:E%% !1110 44
M44 %%%% !1110 4444 4]5TV'6-(O-,N&=8;N%X)&C(#!6!!QD$9Y]*?I]E'
MINFVMC"SM%;1+"A<@L0H &<=^*LT4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1156#4K&ZN[BTM[VVFN;8@3PQRJSQ9Z;
ME!RN?>@"U1110 4444 %%%% !15+3M8TO5UE;3-2L[T1-MD-M.LFP^AVDX-7
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBJ][?6>FVCW5_=P6MLF-TT\@
M1%SQR3P* +%%-1TEC62-E=& *LIR"/4&G4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+B1H@%8\L"3D;>02W&.15J-IN/F_P_4B[=-2\D_Z\CWBBBBH+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9/A_Q#:>)
M+.XN;..=$M[J6U83* 2\;;21@GC/2C4_$%II.K:3IT\<S3:I*\4+1J"JE5+'
M=D@@8'8&N:^%7_( U;_L-WO_ *,-+XT_Y'KP)_U_3_\ HDT+>/G;\5<2V?E?
M\&SNJ*\_US6?%,OQ)_X1K0[FU@@ETM;EI[B'S!;GS&4L%&"S'Y0 6 [TFFWO
MBOPWXSTO0]?UN#7+35HYC#<BR6VDBDC4-M(4X*D9]\TTKV\_^#_D-Z?U_7<Z
M>W\0>?XROO#_ -EV_9;.*Z\_S,[M[,-NW'&-O7/>MJN*T_\ Y+'KG_8(M?\
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MX4L58IC:<#CUJ;6_&6J6^M7&C^'/#$^N7EHJ/='[7';1Q!P2HW/U.!G 'XT
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M\Z3Q3A>H61.-P'."*$K@=?117(Z]XTNK/5Y-%\/Z!<:[JD,:RSQ1SI!% K=
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M.0P & 1Z]:4='?S"6JMY',72@_&O3B1DC0YB/;]\E.\9#_BL/ Y[_P!HR_\
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M'K'BQ #!Y%O8VW?;A!)(/^^G /\ NUWUM:V]G:QVMK!%!;QKM2*) J*/0 <
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M:1W%T^E172S2X +&X9CD$]ST_"NU^'6AWFB:/?&ZL8]-2\O9+F#3HW#"UC8
M!,CC/!) X&:I+1K\>_Z^9+U=_P"O\B'XHV\[^%K>\BBDFCT_4+>]N(HUW,T2
M."W'? Y_"M?3_&_A;59+:*Q\0:;<3W) BACN5,C$C.-F=P_$5OUFV_AW1+34
M&U"VT;3X;U_O7$=JBR-]6 S4KL]AO4XG0-;TWPGXP\4Z;X@O8-/DO;[[?:SW
M<BQQSQ,BC"N< E2",=:ETK4;7Q/\6WU31I$N=.T[2VM)[V(YCDE=PP16'#8
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MJ.6P6(Z9/4U>T?2K;0]&L]+LU*V]I$L29ZX QD^YZT[[OT7Y?Y!+5_-O\_\
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MSC"LRA6.>F"<T=;!TN==17GFI?&'POI'B^?2+[4X8[:W@_>3)%)*?/WX,?R
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MK(WFB:C%>0J=K%,AD/HRD C\15'Q%\0/"OA2=;?6M9AMIV (A"M(X!Z$J@)
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M4;_6-/TS2)-5N[E$L8T#M.H+KM.,$;<Y'(Z5S]W\4?!-CJW]EW/B&U2ZSM(
M9D4^C.!M4\=S1UL'2YUU%0RW=O#:-=RSQ);*GF-,S@(%QG=GIC'>O/?$'Q'\
M(>(/"_B'2]+URWGO?[/N%6+:R;R$;[A8 /T_A)I2=DRHKF:7<](HKB&DBB\"
M>%#+K4^E O8JLD*%C,2%Q$<= W0GIZTWQ=\3]"\)>(=-TN]OH4\UV-Z=CR-!
M'L)7A 2"6*]CQGZU<E:3CYM?<9Q?-%2\KG<T5R-UK>F:W_PB^I6'B&>VM;J\
M/D+%"X%]\CCRV! VC@G+#'R^N#6OX@\4:)X6M%NM;U*&SB;A-Y)9_7:HR6_
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M]8EBCGB>*5%>-U*LK#(8'J#7#_\ "JM+BF LM=\2V%CG/]G6FJ.EO@]0%QD
M^@(J;7NGU'>UK=#I_#5A>:7X9TRPU"9)KRVMDBFD1BP9E !() )Z=Q7(>-+:
MQN_BAX%BU!(WCS=LB2#*F0(I7CZ\CW%=];6\=I:PVT6[RXD"+N8L< 8&2>37
M >.=(LM<^(7A'3[^+S()(KT\,596"H0RL.58$ @BK;O43\_T9*5H->7^1/\
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M=-IIAGEC\N<\E$8@2=!P0,_X]:O65Y;ZC8V][:R>9;W$:RQ/@C<K#(.#ST-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%#&NYMH/ 8Y ![5R7C7PKJ/AO0K,P>)=6U2QDU.T%Q#JTPG9?WJ[6C? *\@
M@Y&">]=IXRT+5+ZYTG6]!,!U;2I6>.&X8JD\;KM="1T)&"#ZBN:UZW\>^,M+
MMX;GPY;Z-%;7UO.\!U!+B6X"R*3@C"JH&6Y))*X YHANO7\+H<MGZ?C9_P#
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MY+40Q/(2L0,.3M!X&3R<5SMGJVI-\"]9U!M0NC?1I?%+DS-YB[97"X;.1@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW6YW[I1O<&3#DLH)& #CIG'-5M?\1?#FXU.[DTK4=1T_Q02=ITNTN8II9!R
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M=U&2C*XW*<=#WQ3-0\7:^_C#5?#.B:9:7%W!##+!-<LR11*RG<TI&2>=H"J
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M902;#PS\\L>Y[UB^$]3;6?BKKM^MG<6UM)IEM]G-Q&8WE0._S[3R 3G&0#@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC0/'?W-H8K><$_\ +-FY;\JV[RZAL;*>[N&988(VDD*J6(4#)P "3]!4H
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M,3GK]C?]X).G.(LK]17?ZSX0AOXM.DTV^GTF_P!,C,=E<VZJP12 "C(PPRG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]0;H7^8$K&.V,%NO3KRE]XTO/$&J:C'8^/=#\*V=E<M;1K<I#+<3LG#,RR.
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MWC12&Z?+R2< ]ZPO$?C*YO?$^H:%8>+M'\+Q:>$6:[O1&\TLC#=B-)&"[0,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /+-<\-:G<?%RV2*SF?0[][?4+R<*
M?+66W#A5)Z9)\OCVKH/B58WTF@6VJZ5;S7&I:3=I=00P(6>0?<=0!R?E8_E7
M9T4G\*CV_K_@#O[UV<QX:\-BS^'5GH-V"KR61CN?7?("7_'+&O/M-LM/\*Z?
M!HWB#X5RZK>6X\I=0TW1X;J.Y4<!V8X*L1C.[OFO:**IN\F^Y*VL9?AV*&'0
M[<0:*FC(<M]A5$7RLD]0GRY/7CUK#\<Z7J4LVBZ]I%H+V]T>Z,IM=P5IHG4H
MZJ3QNP01]*["BD][H:T5CR7QAK^N>-?"5Q8Z5X/UVT59H7N'U&V$3%5D4[8T
M!9G/O@  'FNJ\3V5U<>,_!D\-M-)#;W-PTTB1DK$#"P!8C@9/'-=A133M]]_
MPL'^5CSS49-3\%>-=5UN'0K_ %?2=7CB:4:;&))X)HQL_P!7D%E(QR#QBHK&
MXUO7OB;HVMSZ#>Z=I2Z?<11"Z3$H8E"3(%R$SP "<_*:](HH6EO+_@_Y@];^
M?_ _R"N1^'5G=6.@7L=W;36\C:I>2*LJ%"5:5B& /8CD&NNHI+2_]=;@]3B-
M%T>>X\1>/(;NVFBM=0EB2.1XR%D4VX5BI/#8.1Q63HGB/6_!FC6?AO4_"&MZ
MA<V:BWM[O3(%E@G1>$9FW#R^,9STYKTVBA=O3\/^'#_._P!YQ?A+P_JEOX>U
MJXU5$AU36YY;J2 /N$&Y=J)D=< #)JK\.-6OX-+L?"VI>&]8L+K3;41R74T
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M-#*5"NK1Y!(. 01^-6_#L&K>(?&K^+-0TRYTJR@LOL=C:7>!,^Y@SR.HSLZ
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MU.:Z3XA:;-/X1MK/3[268Q7UF5B@C+%469,G [ #\ *[*BA.R2[/\MAO6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !17CFI>/O%_C+Q;?^'?A^MI;0V!*
MW&I7(##<#CC(8 9! ^4D]>*ZKP3!\1;349[?QA>:7>V2Q;H[FV3#NY/3@*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\H4<#K6K<_#_ .T?%.U\;?VGM\B#R?L?V?.[Y67._=Q][^[VHC9.-^G-_P
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M[4KG48W66]O/G8,R;<@$YQWP6_&HEK!I=K%*RJ)O:]SSSX*>"O#NK?#JZO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKC4X;:.9&TZ[:TF,@ #.%#97!.1AAUQ]*/Z_0#4HHHH **** "BBB@ HHHH
M**** "BLOQ#KUKX:T675;V.:2")D5EA +99@HP"0.K#O6H.1F@ HHIDTJP02
M3,"5C4L0.N ,TF[*[!:CZ*S]"UBW\0Z%9:O:)*EO=Q"6-90 X!]0"1G\:T*I
MIIV8D[ZH****0PHHHH ***R](UZUUJXU.&VCF1M.NVM)C(  SA0V5P3D88=<
M?2@#4HHHH **** "BN3U_P")GA#PQJC:9K&K_9KQ5#F/[-*^ >G*H1^M7?#/
MC;P]XQ%R=!U#[6+;;YO[F2/;NSC[ZC/0]*%KL#TW-^BBJ6HZOI^DM:+?7*0&
M\G6V@W _/(V<*,?0T 7:*** "BBB@ HHHH **** "BB@D 9/ H **XR^^+'@
M73M0^PW'B*V\_=M/EH\B YQ@NJE1SZGBNJL-0LM5LH[S3[J&ZMI!E)87#*WX
MBC=7#9V+-%%% !15+3=7T_6%N&T^Y2<6T[VTVT'Y)%^\ISZ5=H **KWU[;:;
M83WUY*(K:WC,DLA!PJ@9)XIUI=07UG#=VT@EMYT62-UZ,I&0?RH FHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK%\0>+O#_ (6B636]
M5M[/<"51R2[ >B#+'\!1<#:HKG?#GCOPQXMD>/0]7ANI4!+1;6C< 8YVN <<
MCG&*Z*G:P!1112 **** "BLOP_KUKXDTE=2LXYHX6DDC"S !LHY0]"1C*GO6
MI0 453U75;'1-,GU'4KA;>T@&Z25@2%&<=!SU(JVC*Z*ZD%6&01W% "T444
M%%%% !15*XU?3[35+/3)[E$O;T.;>(@YD"#+8[< U!::]:WGB'4=$CCF%S81
MQ22LP&PB3.W:<YS\ISD"@#4HK+T'7K7Q#937=I',D<5S+;,)0 =T;%21@GC(
MXK4H **R],UZUU;4=5L8(YEETR=8)C(  S% V5P3D8(ZXK4H **** "BBB@
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M.,4F]VM]-/E?\]/ZN.W1[:Z_.WY&GK7C;R_A_;>*-&2.1;E[<(MPI("R2*C
M@$<C)[]1WK=\2:E-H_AC5-3MUC::TM)9XUD!*EE4D9P0<<>M>?WOA;5=+^!4
M&E"V:?4;7R[N6WB&22)A*R*!U(&1QZ4>)?B;HGB+P9K6G>'TOK_4I+.2.2V6
MSD0V^5.XR,RA5VC/?DC S14T4E'^M/\ .X4_BC?;_@_Y&AXWO9-2^&FD7TRH
MLMS=:=,X0$*"TL9.,]N:VO%?B;4=.U"PT30;&"\UJ_5WC%PY2&&->LDA')&2
M!@<FN=\3_P#)(O#W_733/_0XZN^+ISX9\<Z7XMN;>XETI;*6QO)(8VD-ME@Z
MR%1SMX() JYI*36RYG^7_#&=-MQ3Z\J_/_AS"\1WWBI=5\(V/BBPTT2/K<,D
M5WI<CF$D!@499,,IP<@\@X/2O7*\E\0^,M.\7:EX2;04N+NPAUN%YKYK=XHE
M;# ("X!8G)Z XQSUKUJI^S\W^A7VODOS9PWQ>D$/PTU*5@Q5)(&(49)Q,G2J
MUWKOQ%LK9]:;0M$;28X_->P6YD-Z$ R?FQY>['.!GTS5SXM)-)\.;]+:/S)V
MEMQ&G]YO.3 _.L_4?BKHS:;-ID-MJ+>(Y("BZ0;*42B0C&"=NW&>X)&.:F[4
M7;>_Z%M+W;[?\$WM4\:6]MX9T[5=.MVOI]5:./3[;=L,KN,@$_P@#))[8K(/
MB7QEX=NK>X\6Z?HK:3=7"6XETN60R6S.<*9 XPPR0"5QZUA>)O \Z_#/PM:7
MFG/JB:*\4E_8P.P>6/80X3:02RYR,'G%96DZ=\$[S6+:UTK2[N;4Q*N+=$OM
M\3!@,MDX !QG)P*TLN=I=_P_J^IGKR)^7XZ_\#0]QKGO&/B.7PUH\5S;VT=Q
M<W%S':PB:7RXU=S@,[8.%%=#6+XJU'0M,T&:7Q&JMI;_ "2A[9YUP?[RJK<<
M=<8K-EK<S= F\?KJ2Q^([7P[)9.#^^TV68-&<'&5D'S9..A&*H:AXK\2S>,=
M6\-:#IEC-/;00S1W5V[)#$'!SYFW)8YQ@*!QG)XKGO"VKZ/-XMTV'X?7VIW6
MD.SKJ-K(DQM+= I*LAE&4;=M&U3@CMQ5J;Q/;>%OBQXENM2AN!IKV=H)KN&%
MI1 P5R-X4%@I&[G&./>JZJ_F+H_D;^@>)M>C\1+X<\6V-C!J$T#7%K<Z?(S0
M7"J<,H#_ #*P!'7K4-[XD\4ZSJM_9>#;+2##ITWD7%[JLLFQY0,LB)&,_+D9
M)..HK/TS6(?'OQ$TK6-%BG?1=(MIP;Z2%HTGEEPNQ-P!. I)-<=J/AKP-H'B
M;7&^(.D7&RZO7N;/5 ;DQ2I)SY9\H\,ISU'-)]+Z;_GI^ +K;R_X)ZAX?\7-
M>VFKQZW;1Z?J.C-B_1)-\>W;O$B-W4KSSR*Q;#Q!\0_$4$&L:-I&@VFCS?/%
M!J,TOVF6//#90;5W#! .<>]0^&O#O@_4?!WB"V\$V=Q:6^I6[0-<2B<+*2C!
M2OFG) W=1ZTSP_\ $S0]#T73M"U];W3M;M8$MGLGLI7:1D&W*%%(8''!S5=?
M/3_@_H'33S_X'ZG2WVJ20_$/1=,-I:/]HL+F0W#1YE0J4^5&SPISR,<X%<-!
M)X^D^+FL&RC\-I<+96XE6=YW18-S;=I !+YW9R,=*ZO4V#_%WPVPS@Z9=GG_
M 'HZ9I7_ "6?Q#_V"[7_ -">E'=/_$)[-?X32L]4:7XD:II9M+15ATZWF^T+
M'B9]SN-K-GE1C(&.,FL8^)_&/B6[O#X-T_1H].M+AK?[9J\DN+AU.&\M8QP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<OI.D7UM\0_$6J30;;*\MK5()=ZG>R!]PP#D8R.HKJ**%H[A
MTL%%%% !1110 4444 %%%% !1110 5FZ]>ZGI^DR7&CZ1_:MXK*%M/M*P;@3
MR=[<# YK2HH Y#P?H>JIJ>I>)?$44,.K:B$C6VB?>MK GW8]W<Y))(XS77T4
M4P"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <OX8TB^T[Q%
MXJNKJ#RX+Z^2:V;>IWH(E4G .1R".<5U%%%'9 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-D+
M")R@RP!P/>DW97 Y?7OB1X0\,WWV'5M<@@NOXHD1Y63_ '@@.WKWQ6U/KNE6
MVC+K%QJ%O%IS()!<R.%0J>A!/KV]:Y+X16\!\"QWIC4ZA>7$\E_(1\[S>8P(
M;Z<#%)XRCAF\=^";"]1#I;37#^6P'EM,L8\H$=.,G ]:JVJCU_X%PTU?17_
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M8."0.":SO!D26WA_QO:PJ$@AU:]6*-1A47:#@#L,DUO_  Y.?AMX=_Z\(O\
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M%=(L]37Q]X>C4?V,]^\,2J/EC9XP9 O88?GCH:;5KKJM?R_ST!-.SZ7M^?\
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M/U2*ZO[9#)-'$K,J $ _/C;P2!C.:RY?BOX%@U0Z;)XCM1<!MI(5S&#_ -=
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M,:S9Z[H45[96SVL>YXWMW4*T4BL5=2!QPP/2DM4-[^1L4444 %%%% !1110
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M..*GIIV]=0>NAB>(_"FF>*((5OEFCGMV+6]U;2F*:!B,$HXZ?3I5+P]X(M]
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M>!7/5M5R?^_#U26J?G8F3T?HSN**XO2?^2N^)/\ L'6?\Y*35?\ DL'AP?\
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MH9&B(# $8."01G\*4M58<=&FSA+31?B+'H=II>F:[HW]EO;*B7MS!(;R%"O
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MTB:$&XC+PW$1Y\N0 YQGD$<BG^'HO'+7OF^)KK05ME4@0:9%*2Y[$M(>,<\
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M3LT^QDG2YSX0_LG?']H^P?9MV3MW>7MSG&<9]JPW\$->_#O2O#UW=""_T^&
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MQ9IM_P"&O!6M^'[N.[5[^]O+464<L'.]64-^])^F0<'->N44[^]S ]4UWO\
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MW!6Z$C(SCIFNOHIIVV\_Q%O^'X!7&Z;97<?Q:UV]>UF6TETVV2.<QD([!FR
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M>VX!GL;Z PSQ ]"5/;W&167>?$W1[:[OK*"QU?4-0L[AH)+*PM#-*<8^? .
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M0U-:M+^MKAW]+G;45YKJ/Q.FL/'MUI2>'O$-]:6]H"8[/32SM(7(WX;!V8&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5'/*(+>24@D(I8@=3@9J2BD]M 1Y7IVH>,O&'AM/$T7C'3?#FFN'D6*&P2
MX,: XQ(\C8##'8#K6'9K/<_LTW+02&<>9+)*ZKM,D0N27.!TRH)Q7H8^&'@H
M:W_;'_"/6OVW?OSEMF[U\O.S/X5T.GZ58Z79-9V=NL5NTDDACR6!9V+-USU)
M/'2JV3MY?@[COJK_ -:-?J)IU[87.DVMS8SP-9/&ODO&PV8Z #''M7*6\B)\
M;;^-G4/)H4.Q2>6Q,^<59@^%W@JUUI-7@\/V\=ZCB1&1G"*PZ$)NV _A6AXD
M\$^'/%WDG7=+BNVA_P!6^]D=1Z;E(./;.*+ZW]?Q)MIR^GX&3JO_ "6#PY_V
M#+S_ -"CJOX4FAMOB7XRL[ME34;B6"> /PTMN(P 5SU (8''>NL&A::NHV5^
M+8"YLH&M[=P[82-L97&<'[HZCM53Q%X.\/\ BR%(]<TN&\V<([95U&<X#J0P
M''8T;6MY_BPWO?R_!'.W4L-U\;-,%@RO+:Z7.-09"#M5F7RU;WR"<5+\/X8U
MUOQK,$ D?6W5FQR0(TP/U/YUT>@>&=%\+V1M-%TZ&SA8@L(P2SD=V8Y+'ZFK
M.GZ18Z7+>RV<'E/>SFXN#O9M\A !/).. .!@4*R^Y_B[C>M_E^"L<MHZJOQ=
M\38&-VGV9;W.9!4-QH.M^#+.YNO#>KVS:7$7G.EZFG[M 2681S+ADZG 8, ?
M2NOBTBQ@U>YU6.#;>W,:132[V.Y4SM&,X&-QZ"N7/PB\!MJ)OV\.P&<MO(,L
MA0G_ '-VW\,5.MDEV_5CTNV_ZT1TF@ZM'KWA^PU:*)HDO($F$;]5W#.*Y:YF
MCM_C?9B9UC^T:$\<.XXWL)@2H]3CG%=Q'&D4:QQHJ1H JJHP% Z "LCQ%X3T
M+Q9:I;:YIL5Y&ARA8E63UVLI##.!T/-4W[UUY_CH)?#9_P!;?Y'+^+-3M'^*
M7@C3$F1KM)KF9XU;)13"P!([9YQ]#3)[RPM?CY#'=R1I//H0CMBY RWG,2H]
MR ?R-=%I?@/PQHGV/^S='AMFLY3+"R,VX.5*DLQ.6^4D?-FN<U+1M.U[XN7>
MGZK9Q7=I)H$9:*49&1.V"/0CU'-"T:2_O?D-NZ=^R_,L>+Y[>?XA^"[*V=7U
M*&ZEGD5#\T<'E,&+>@)QUZXH\$316_C/QI8W3*NIR:B+@*W#/;F-0A&>H&".
M.E;OASP1X;\)>8=#TF&T>3AY-S.Y'IN8DX]LXIWB/P5X<\6*@US2H;MHQA)"
M61U'H'4AL>V:%IMY_C;_ "$]?P_"_P#F<_'-#=_&]FT\A_LNC&+4'C8%0QD!
MC5O]K 8_2I?A_#&NM^-9@@$CZVZLV.2!&F!^I_.NFT+P[I'AFP^Q:-I\-G;Y
MR5C'+'&,L3RQ]R2:FT_2+'2Y;V6S@\I[V<W%P=[-OD( )Y)QP!P,"A67W6^]
MW!Z_A^"L<MHZA?B]XFP,;M/LR?<YD%='XCTE-=\-:EI3]+JV>('T)'!_ X-3
M0Z38P:O<ZK'!MO;F-(II=['<J9VC&<#&3T%7:EJ\5'R_S&G:7-_73_(\H\.7
M0\>7WAZ&[7?'I.E.]ZK=/M,F8-I'J DI_&JFBSS:O<>%/!]WEYM$OIVO-W=;
M7B(_COC/X5Z;HWAO2/#\M])I=DMN]].;BY(=FWN>IY)QU/ P*+7PUH]EX@O-
M>M[)8]3O45+BX#,2ZC&!@G Z#H!G%7S>]?Y_/?\ -_=8FVEEZ+TV_(YE8(Y/
MCH\K("\>@+L)[9G.:?XH4#XF^!VQ\VZ]&?;R1Q75#2+$:VVLB#_B8-;BV,V]
MO]6&W;<9QU.<XS1=:18WNIV.HW$&^[L"YMI-[#9O&UN <'(]<TD[<OE_]M_F
M-Z\WFOT7^1S&G_\ )8]<_P"P1:_^C)*K?">6%/#U]92/&-4@U*Y^W1Y^?>9&
M(9AUP1C!KL8](L8M9GU=(,7T\*P22[V^9%)*C&<#!)YQFL7Q!\._"?BF[%WK
M&BPW%R.#,KO$[>F2A!/XTD[:>5OQ;#>_K?\ "QE^.XX+S7?! 8)+$=9##N"1
M$Y'ZBI?BN ? SG'*WMH0?0^>E=#_ ,(UHXBTN);)$CTN3S+)$9E$+;2O !YX
M)X.15C5M(L=<L#9:C!YUN720IO9?F5@RG*D'@@&FM+>M_P 5_D)J]_2WX/\
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M\\N\2V?B#3O%?A&+7?&L.JM-K$3QZ>FG1P&/&<N&4EBHSCGUKL+G_DM6G_\
M8"F_]')5_2OAYX3T2".'3M%A@"3I<!@[E]Z'*DN26(&3P3CVK:;2+%]:CUAH
M,W\<#6ZR[VXC)#$8SCJ!SC-4G:WS_%6%W]%^=RZ>E<+\)+>*'P/YD<:J\U]=
M/(P'+'SG&3^  KNJI:3I%CH=@+'3H/)ME=W";V;YF8LQRQ)Y))J5I?\ KK<;
MV_KL>6W&G^(+GXO^(K?3_%RZ!<7$%O) CZ?'<&YA"X^4N>-K;L@>M=+X;\':
MKIOB^YUC6_%B:U=RV/V4Q?8([<A-VX$[&.>XZ=^M=#XA\)Z#XKMEM];TR&\1
M/N%\JZ?[K*0P_ U%X>\%^'?"D,L6B:5#:"88D8,SLX]"S$DCGIFA:*WE8):N
M_P#73_(YRZTG7/ .D7%UH6K6]SHMFC2_V7J:X\M 22L<XP1[!@W;FF>)=7M[
MN_\ A[K3_P"CVMQ>^9F4XV>9 VT$^N3BKT?PA\!1:A]M7PY;F;<6VM)(T>3_
M -,RVS'MC%=/JNB:9KFF-IVIV,-U9MC]U(O QT(]"/44T[6?6X/6_P SC_BS
MJ-I;^'].LI)T%S=:I:"*+/S-ME5B<>F!UJSXN_Y'SP-_U]W/_HAJLZ?\,?!F
ME6LEO9:%#&DCI(S&1V?*L&7YRQ8 %0<9QQ707FD6-_?V-]<P;[FP=GMGWL-C
M,NTG .#P<<YH6EO6_P"%@_RM^)REO(B?&V_C9U#R:%#L4GEL3/G%:.L^%;NX
MUDZYH>L2:7JC1+#+NA$T%PBDE0Z'!R,G!4@\]ZL>)/!/ASQ=Y)UW2XKMH?\
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M %U"/O;%BBO.OAYX[UOQAX!U+6YK"UDU&WDEC@MK8,BRE45E'S,W))QUK?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKM)<K"=*\[S2OE'(??\ P].G>G'5V![:'HNI>+-!T>6\CU'4X;5K.))9_-R
MJN2%P<88DJ>!D\4VU\7:!=^&U\11ZG$FD-G%U,#$O#;>C@'J,=.:YF#3+2]^
M.&H75S$LLEII-NT(;D(Q>0;@/7&0#VR?6J7Q/_M>?Q5X.L],736WSSR(FJ;S
M;/,J#8&"\YP6*^]+HO/_ (/^0=7Y?Y+_ #.J\.^/O"WBRXDM]$UB&ZGC&3$5
M:-\>H5P"1[BNDKS"X\-_$76?$&AWVL'PG$FFWBSF6P-PLQ3D.@+ C!!/'':O
M3Z?2XNH5E:]XET7PQ9"[UK48;.$Y"F0_,Y')"J,EC[ &M6N*\1>(M3D\4)X>
M\/:/97FJ0VWVM[F_DV0VRL2JG@%F)(Y QP*E]D5ZFQX<\9>'O%L4DFAZI#>>
M7]] &1U]RK ,![XJOXB^('A7PI.MOK6LPVT[ $0A6D< ]"50$@>YKCO#_P#P
MD2?&A1XD_L07KZ*Y_P")3YF&02KCS-_.>N/:MCX80021>(=1E13JLVL7,=U(
MW+@*V$3/H%Q@55KVMVO^-A/3?^M+G76VN:9>:*NLPWT)TUHS*+EFVIL'4DG&
M!]:Q-'^)7A#7]9_LG2]:BN;X[ML:Q2 -CKM8J%;UX)XYK,^*,4;Z5H-C,@&F
M7.M6T5ZO13&23AO8L%KND@AC2-$B15C&$ 4 +QCCTXH7?I_7^8/2RZF#XC\=
M^&/"<B1:WJ\-K*XRL05I'QZ[4!('!Y(Q6KIFKZ?K.FQZAIMY%=6D@)66)MP.
M.OX^U>3>'/\ A.Y_$OBR[T)?"YE_M62*9M4$_P!H55P(U^3C9MQC\:ZSP1X;
M\0Z)=>(;S76TA/[2D29(-+,@B1PI5SAP,$X4]3DYJ?LW\KC?Q67>Q:OOBEX)
MTZ"TFNM?@1;M \0$<C,5/0E0I*CC^("M'5O&.B:5X6?Q"^HV[V!0M#*CAA,V
M#A5QU)QC%<Y\&;33X_AI9/:Q1%YWE-RP R[[V!#>O&!]*S-'6&#P[\2[2QVC
M3H;BY$"I]Q&, +JOH V>.U%3W5)=E?\ +_,<5>272]OQ?^1TO@?XB:)XTM88
M+2]2354M4FNX$@D18V. P!88(#''!-2ZG\2_!NCZL-+OM?M8KS=M9 &<(?1F
M4%5_$BDT*6>+X3Z?+: M<)HJ-$!W<0C'ZUPG@BU^(4W@6P&D1^")=-N8=Q^T
MBY:24G[WFXX+YSGWK2HK3DET_P W]VWF9QUBF^O^1[ ]Y:QV1O7N(EM53S#,
M7&P)C.[=TQCO7GWB#XC^$/$'A?Q#I>EZY;SWO]GW"K%M9-Y"-]PL 'Z?PDUD
M:QH6I>'/A)I.AZU-;/'_ &K!%>&W=S$MNT^=H+ ':,@<]J[#XCZ=ILOPRUN&
MY@@%O!9.\(V#$;*OR%?0YQC%95$N63Z?\!?YFM-VG'O_ ,'_ (!L>%/^1/T7
M_KQ@_P#0!6O61X4_Y$_1?^O&#_T 5KUM5^.7J_S9A2_AQ]%^11O=8L=/O;&S
MNIS'/?R&*V78Q#L%+$9 P. >I%0:IXDTC1M0TZPU"\6"ZU&0Q6L95B9&XXX!
MQU')P.:P?B;;LOA5-7B7,^C74.H)CKA&&\?BA:N<U^P?QEJ7B75+$^8=)LHH
M-.8'C[0"+AB/RB'YUFK;OIOZ:&MNBZ[>M['I%_K%AIES8V]W/Y<U]-Y%L@1F
M+O@G' .. 3DX%8VFZC8V%]XGNKGQ#)/!;7*M/'<*42P'EJ=@)X(/WN..?7.<
M'2=3B\:>/=&U&')M-.T<7?L)KCY0#[A5;\ZT/!?_ "-OCC_L)Q_^B$IV:];/
M\TO\R;_I^3?^15\'_%KP[XIO5TX7RKJ<UQ,EO;K!+\T:EBK%BNW)09ZUE>&/
M&?AWPE9>(&US58;0R:_>%$(9W8;AR%4%B/?%;_PM/_%(2_\ 82O/_1[U2^&.
MFVD5SXKU%84^USZ[=(\NT;MJMPN?3DG\:%^G_P B-[?/_P"2.PT37]*\2:<M
M_H]]%>6K'&^,]#Z$'D'V(S6E7"^%(8[7XE^-X(%$<)-G+L487>T9W-CU..:[
MJCHGW#9M?U_6I'//%;023SR+'#&I=W<X"J!DDGTK@/#_ ,8/#.M:[<Z4VHQK
M.]]]FL$2"4^>F% 8M@KRV['(XQ7H=<1\.C^^\7?]C!<_R2B.[OV_5 _AT[_Y
MF59^)=&\+^.?'-YK6H0V<!FM I<DESY'15&2Q^@KLO#OBW0?%EJ]QH>I17D<
M9PX4%63ZJP##IW%<OX8TVTD^+?C749(4>ZB-I%'(R@E%,0)P>V<#\JL)#';_
M !PD,*A/M&@[YMHQO99L GU('&:([13[?HV$MY-=_P#(V/$?COPQX3D2+6]7
MAM97&5B"M(^/7:@) X/)&*UM+U;3];T^._TR[BN[63[DL39!]1['VKR7PY_P
MG<_B7Q9=Z$OA<R_VK)%,VJ"?[0JK@1K\G&S;C'XUU_@+PWXAT34-=O-=;2$_
MM*:.9(-+,@B1PI5SAP,$X4]3DYHCJKOM<):.R[V.WI'8(C.QPJC)/M2U%=?\
M>DW_ %S;^51)V38TKM(@TK5;+6]+M]2TZ;SK2X7?%)M*[ATZ, 1^(J.QUO3M
M2@O)[2X\R.SFD@G.QALD3[PY'./4<5SOPI96^%^@D$'%N0?J&;-9W@":.X\.
M>+)HF#1OK%\58="*J?N\UNBN3#5*_5V_/_(TKWXJ^"-.BM)+KQ! HNHUEB"Q
MR.VUAD%E524S_M8KJ;&_M-3L8KVQN8KBUE7='+$P96'L17'_  FTNRLOACHP
M@MXU^TV_FSG:,R,V<EO7T^E<[I+36'P@\91Z<#&;6[U)+=8^/+4,>% Z8&:<
M_=YEV_SL$/>Y?,ZT_$[P5_;7]C_\)#:?;"VS'S;-WIYF-F?QJK\+72+P!')(
MRHB75V69C@ "=\DFM7P]I>CCP#86,-O;OI<EBFY-H*.I0$D^N>I->51O);_L
MW!-.D00->M$9)"0GDFZ(.['.TC@^Q--KE<EUT7_DUAI\T4_ZVN>EV/Q-\&:E
MK0TBS\06LMX3M50&".?17(VL>>@)K>O]8L-+FM(KVY6!KMVCAW X9@I<Y/0?
M*I.3CI7FFL>&_B5K_AJ319HO B6,D86,P"Y!BQ]UDX(!'4'%:7CO2Q?R^!--
MU3$X;4D2Y )VR$0ON!]02#G/4&DELO.PK]?*YTVE>.?#.MKJ+Z=J\$T6G &Z
MFPRQQ@YYWL I'!Y!-4M,^*/@K6=672[#7H);MFV(AC= [9QA690K'/3!.:U_
M$/A^W\0>&KO1'<V\,\816C4?N\$$8'3 ('%<X=:USPW+86_BK3+"ZT]IXX(M
M4L#@1R,0J;X6Y7).,JQ ]J%J[?U_7E^(WM<@UKXN>&M!\9?V-?:E#';16[FX
ME6*24I/N 6/Y <<;R>/3I74:CXKT+2-%AUC4-3@MK"= \4LN09 5W#:N-Q..
M< 9K!<_\7OB_[%]O_1XJ7Q-XBOE\2VGAS0]'M-0U8VYO?-O9-D-LF=H;(!).
M>,#FE]E=W_F_\AM>\^VGZ&GX;\;>&_%WFC0]5BNWBY>/:R.H]=K ''OC%1:I
MX_\ "VBK=G4=8AMS:3>1,C*VX/M#8"@9;A@<J".:XS2QXF7XR:4?$PT(7;Z7
M<!3I/FY9-R?ZSS.>O3\:U_!FFVA^(7CC4VA1KL7L4*RE<E4\E3@'MDG]*=KV
M]'^#L3>WX?BCJ?#_ (IT3Q59M=Z)J,5Y$AP^S(9#_M*0"/Q%4/$'Q!\*>%KQ
M+36=9AMKEL'R@K2, >A8(#M'UQ67IT$5M\:=9$,:QB?1X)90HQO?S'&X^IQQ
MFF_#&*&2#Q!?2JIU.;6+E+IR/G&U\(I/7 7&![T;ZKM?\;!M=>=OPN)X5O;7
M4?B;XHO+*XCN+::RL6CEB8,K#$G((K8\.7MK#8:U<G7;C4H;>_N#+)-&P^S;
M>6B QDA>Q'7M6!X/L["R^*_C>+3TCC0I9O(D8P%D*N6X]^OXU%X7_P"1/\<_
M]A34?Y5,G:%UTC?\67:\K/NE^!LWWQ4\$:;);)=>(+=7N462,*CN0K $%MJG
M9D$'YL5TL>IV$NF#4TO(&L#'YHN1(/+V8SNW=,5S7PVTJQM/AIHD,-M$([BR
MCDF&P?O&=<L6]<Y/6N2TS2EU#X%ZOIRW45I##/=['FSY:)'.S!6Q_#A<'':K
MFN5R7;_.W]=R8>];S_R.@E^-/P]AE>)O$2ED)4E+6=A^!"$$>XKM-/O[;5-/
M@OK1V>WG0/&S(R$J>APP!'XBO,94\9^.-'L-,N?"-IH5F)()QJ#7R2%%1E;]
MU&J[E8@<9QCH:]7HM9:BO?8*X[QU\0=+\$I8I=74*W-S<1!HV#,4@+?/)M7G
M@!L>_K78UQ'Q).(?#&?^A@M/YM4K=+S171^C_(RO''B72/%7PHO]1T6[^U6@
MN8(S)Y;I\PFCR,, >XK=D^*/@F#5QI,GB&U%WNV$ ,4#>AD V \=S57XOQ+/
M\,]2B;[KR0*?H9D%:7BC2-/A^&^K:=':0K:0Z=*(X@@"KM0D$#U! -)R48N7
M1/\ 0%'FE&/5_P"9OWE]::?927MY<Q06L2[WFD<*JCU)-<YHWQ*\'>(-4_LW
M3-=@FO,E5C*.F\_[)8 -T[9K)/B5](^'7A9!IXU74-4@MK:WMY7"I)(8PV78
M@X P3TKF_&!\:BZ\.2>((?#$%D-;M1;I8M,;F,E_NAF 7IG.*TY;5.7SL0G>
M-^MKG3^(?BQX=\-^+X-&OM0ACB6&1KN18WD,4F5V)A >2"Q/'8=,UVNGW]MJ
MNG6VH64OFVMS&LL3[2NY2,@X(!''K7)WY_XO)HO_ &![G_T9'7:U"^%7\_S*
M?Q?=^05QGC;XC:/X+NM.M;R[A6:YG3SD*L[10<[I-J\]L#W['%=G7$^/CC5O
M!F?^@Y'_ .BY*.J7F#V;\C-\:>(=*\3?#RVU32+K[19-JEHHE\MDY$Z \, ?
MTK:'Q1\$MK7]DCQ#:F\+;,8;9N]/,QLS^-4OB[;1WG@;[+,,Q37]I&X]09E!
MJ[\0-,LE^%VN6BVD*V\%A(T480!4*J2I [8(HNE%OI?]$"5Y)>7ZLZ>[O+;3
M[.6[O+B*WMHEW22RL%51ZDFN?T/XB^$O$FI/IVDZW!<7:Y_=%70MC.=NX -T
M_AS7'^/Y=2G\*>"8;5K-C=7EL)/[0+?9Y'\LE!+MY(+ ?B!3]7\-?$OQ +"+
M4/\ A#88[.ZBN(YK3[2LL>Q@?D+ @9''TJK6DT^]O^"3S7BFNUST#4/$>CZ3
M<O;ZA?PVTB6YNF\TE5$08*6W'CJ0,9SS4.D>+="UW0Y=:T_4$?38BP>YD5HE
M7;][.\#@>O2N9U?3K74?C5HXNXEE2#2)9D1N5WB50"1WQG(]\&H_C"U\?#ND
MV]G]EV7&K6\<WVS=Y!7)*B7;SL+!<U*V7G_G8NVOIK^%S;T?XD>$-?U4Z9IF
MNV\]X"0(RK)O(_N%@ W3^$FNIKRC7O#/Q.\1Z;#8W@\%PQPS1S0RVWVE9(61
M@04)! Z8Z=*]67.T9ZXYI]">HM<_K<D2>)/#JOK4]D[S2A+.-"4O3Y9)5B.!
MM^]S_.N@KB?%W_(^>!O^ONY_]$-0OB7]=Q]'Z&GXC\>>&/"4L<6MZO#:S2#*
MQ!6D?'/)5 2!P>2,5I:)KVE^(].6_P!(O8KNU8X\R,]#@'!!Y!Y'!YK U'P_
MKFG^)KOQ%X<DL)Y;R...ZLKX,H?8"%,<JY*'!Z$$'VK1\*Z[%K=K>*=.;3;Z
MTN##>VC%6V2X!R&7A@000W>DM4#WT-^HKBXBM+:6YG;9%$A=VP3A0,DX%2UF
M^(O^19U7_KSE_P#0#4S?+%M%15Y)&#??%3P1ILELEUX@MU>Y19(PJ.Y"L 06
MVJ=F00?FQ74VM[:WME'>VMQ%-:R)O29'!1E]0?2N6^&VE6-I\--$AAMHA'<6
M4<DPV#]XSKEBWKG)ZUPV^:S_ &?]6BM"\<4=Y/ =AP4@^U%6 ]!L)_"M)1M*
M4>W^=B(ZI/\ K:_Z'<+\5O S:K_9H\26AN,[<X;R\_\ 73&S]:[ $$ @Y!Z$
M5CRZ7HK>$VL#;VW]C_9<; H\L1[>H[=.<UC_  KFN+CX9Z(]R79A"51GZF,,
M0A_[Y I6W7;_ (/^07V??_ASL:***0PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH P/$G@_2_%-QIDVHB
M7?IUP)XO+8#?C!V-D'*D@$CCH*V+VRMM1L9[*[A6:VGC,<L;=&4C!%3T4=+!
MUN<):?"C1;?,,^IZ[?:<!MCTV\OVDM8AVQ'CG'8-FMJ?P=IUQX5L/#K370L[
M$P&)PR^8?)(*Y.W'.T9X'X5T-%.["QA>)_"6F^*[:".]:Y@GMG,EM=6DQBF@
M8C&58?UR*Q[7X8:-!<65W<W^KZC?V=PD\5[?WAFE&TDA,D8"G/( &<#GBNUH
MI+38'KHSE_$G@33?$>H1:D;W4],U*./ROMFEW1@E:/.=A."",^U+HW@32-"U
M>+5;9[N2_6!X);BYF\V2X#%26D9N21L&.0!D\5T]%"TV!Z[G)ZI\/].U'Q'_
M &[!J.KZ9>.4^T?V=>&%+H+C:)!@Y&!CC'%;$.@VL'B6ZUY9)C=7-M';.A(V
M!4)((&,Y^8]ZU**%H#UW./UGX<Z9JFI3:A::EK.BW5P0UQ)I-Z8//([N,$$^
M^,ULZ#X:TOPWIKV.F0-&DCM)+([EY)7/5F8\L?K6O11TL'F9GA[0K7PUH5KI
M%G)-);VP(1IB"YR2>2 !W]*;HN@6NA-J+6LDSF_O'O)?-(.'?&0N ...^3[U
MJT4[ZW#R_K^M0ILD:31/%(@>-U*LK#((/4&G44@.$M?A1HEK-L74M=?2\\:0
M^H,;,#T\OJ1[$D<UM)X/LH/":>';.]U&RM8]WES6EQY,T>6+<,H' )Z8Q@<Y
MKH:*.E@ZW./T;X=:?I>IP:A=ZOKFM7-NQ:W;5KXSB!B,$JN ,X/4@TNL^ $U
MC5)+[_A*O%5B).6M[+5&CA_!2#CZ#%=?10!SDO@C1F\'7'A>%)K?3YU(D:.3
M,I);<6+-G+$]SFN5\>W&G7GB;3/#FM:J=#TZ.V^VP:FLPAE,ZMM"QRGY4(4D
MGJ3N[5Z;56_TVPU6V-MJ-E;7D!Y,5Q$LBG\&!%#N-6M8\DCFM-&\0:/'X6^(
M.L>(KVYO(XYK&?4$OHS 3^\8X'R8'.<UZC::#:V?B'4=;CDF-S?QQ1RJQ&P"
M/.W:,9S\QSDFIM-T32=&1DTO3+*Q1SEEM;=8@3[[0/05>IWT),N;0K6;Q+;:
M\TDPNK>V>V1 1L*N022,9S\H[TFGZ!:Z;K>JZK#),T^IM&TRN054HNT;0!D<
M=<DUJT4AF7;Z%:VWB.^UQ))C=7D$4$B,1L"INQ@8SGYCGFD70+5?%+^(1)-]
MK>S%F4R/+V!R^<8SG)]?PK5HH Y'7/AYI>L:G+J=OJ&KZ-?SX$]QI-X8&F &
M!O&"#]<9XK1TSPK9Z7H5UI2W>H7*W2L)KB[N6FF<LNTG<W0X[ 8SVK=HHMI;
MH.^MREH^EP:)HMEI=LTCP6D*01M(06*J,#. !GCTJKI'ANQT;19M)B\V>UFD
MFDD$Y!+>:Q9AP!Q\Q'TK7HIMWNWU$M-CD] \ 67APW*66KZXUI-"8([26_9H
MK93_ ,\AU4^AR2*H+\+-/DG)U'Q%XGU2T+;C8W^J-) W.0"H ) ]"?KFN[HI
M7UN BJ%4*H  & !VI:** .?\3^#M-\5"VDN9KRTO+0DVU[8SF&>'/7:WH?<5
M0TWX<Z1IVH6&I-=:E>ZE92&1;V^N?.FD!1DV,S#[N&)PN.0#77T4+38'J9<.
M@VL'B6ZUY9)C=7-M';.A(V!4)((&,Y^8]Z77O#^F^)=.^PZI;^;"'$B%6*O&
MXZ,K#E2/45IT4=+!UN<?HWP]MM)U**]E\0^)-2,+;HH=0U)I(D/^Z  ?QS78
M444 %<OXD\":;XCU"+4C>ZGIFI1Q^5]LTNZ,$K1YSL)P01GVKJ** .8T;P)I
M&A:O%JML]W)?K \$MQ<S>;)<!BI+2,W)(V#'( R>*KZU\.M+U;5)M3M=0U?1
M;Z?'VB?2+PVYGQTWC!!^N,UU]%#U QF\+:7/X8/AZ]26^L&0H_VN4R2/SG)<
M\[L\YZBLK1?A_:Z)JL=ZFO\ B*[2'/DVEYJ+201<$<)CG .!DFNNHIWUN'2Q
MRFO?#_3-<U%M2BO=4TC49%"RW>E79@>51T#<$'ZXS6AH?AVW\.:=/##>:A>R
M2_-)<7]TT\CD#')/3Z  5MT$ C!&14M:-(=];L\?\!_#_3]:\ Z5?1:KK6DS
M3HQN?[+O3 MQAV&77!!.!C. :]*TGPUI.B:"-%L;14L-K*T9);?N^\6)Y)/<
MUH6EG:V%JEK9VT-M;Q\)%"@1%[\ <"IJJ33OV%UN<OX9\#V?A2ZE>PU369;5
MD\N*QNKPR6\"YS\B$<?4DU0O/A?I<MY+<:;K.OZ(DSF26WTK4&AB=CU)7! _
M#'6NWHI 9'_"-:6WAMM GA>YT]HS&Z7$K2,X)R26)SG/.<US2?"C1C%-;WFK
M:_J%FZ%([.]U!I88,@@%$(QD9XW;L8!KO**'J"TV*VGV4>FZ;:V,+.T5M$L*
M%R"Q"@ 9QWXJS113;;=V)))61!>VD.H6%Q9W"[H;B-HI!ZJPP?YUF>%_#%CX
M3T--)L9+B:)79VEN7#22,QR2Q  /ITZ 5M44AG/>%O!FE^$/M_\ 9S7#_;9O
M-?SW#;!V1< 809.!SUZU=TS0;72=1U6^@DF:74YUGF$A!56"!<+@# P!US6I
M11_PP'*6'@#3M*\2-K&GZEJ]JCRM-)IT5X1:/(V<L8\<GG/7' XK6T/0+70(
M[Y+629Q>7DEY)YI!P[G) P!QZ?SK5HH6BL&YE6.@6MAK^J:S%),;C4A$)E8C
M8OEJ57:,9'!YR36K110 5RC^ -.7Q0=>M-1U>PEDF$]Q:VEX8[>Y<=Y$QSTY
MY&:ZNBC9W#I8RM/T"UTW6]5U6&29I]3:-IE<@JI1=HV@#(XZY)H.@6I\4KXA
M\R;[6+,V>S(\O9OWYQC.<^^/:M6B@._G_7Z'*:]\/],US46U**]U32-1D4++
M=Z5=F!Y5'0-P0?KC-:?A[P[;^'+22&&\U"]DE8-)<7]TT\CD#')/3Z  5L44
M+38'KN%'6BB@#A3\*M&6]EDM=5U^RLIG:273;347CMG9LELJ.1G/0$5O:'X4
MTSP[IEYIVFH\5I=323&/(Q&7 !"X' &.,YK<HHZ6#K<S]"T>W\/:%9:1:/*]
MO:1"*-I2"Y ]2 !G\*AT;P]9:)9WEK TLL5W<S7,HG(;YI#EAP!\OM6M10W>
M[?425MCAHOA5HL%SB'4M=CTPDDZ0FHN+,Y.2-G7'MG%;VE>%-*TGPV^@10^=
MIKF7=#, 1MD8L5P !M&X@>V*VZ*.EA^9P<7PJTV"55A\0^*(]/7A=.357%NJ
MX^Z!]['?[U=/J?A^TU6[TFXF>9&TNX^T0"-A@MM*X;(.1ACTQ6K13NPL5-2L
M%U/3IK-[BZMUE&/-M9C%(O.<JPY%<KIWPSTZTOH+J_UOQ#K1MY%EABU74#-'
M&XZ,%  )'OFNUHI+1W0/56.:\3>"-/\ $]U;7LEYJ6G:A;J8X[S3;DPRA#R5
MS@@C\*@UKX?Z;K8L96U#5K/4+*$01ZC9WACN63C(9\'=G&3D=SZUUE%'D!RV
MC^ =(T75;75(9KZXU&")XGN[NX,LLX;;GS&89.-O & ,GCFM73-!M=)U'5;Z
M"29I=3G6>82$$*P0+A< 8& .N:U**=PL9<>@VL?BB?Q ))OM<UHEHR$C8$5B
MP(&,YR3W_"L36/AUIFJZM+JEMJ6LZ/=SD&Y?2KTP?:,=-XP0?J,&NOHI <_H
M'@S2/#.H7EYIBS(]W''','??N*%CO)/S%CN.22<X%2V'A:QT[3=5L89;AHM3
MGGN)B[*65I?O!<#@>F<_C6W10]59^@+34I:/I<&B:+9:7;-(\%I"D$;2$%BJ
MC S@ 9X]*XCQ7;VG@KP.NF0DMINH:@8;RYNUWK;QSNS2.=H' S@9Z9&<UZ)3
M9(TEC:.1%=&&"K#((^E$FV[OK_PXUH>)WUIX6T327N=-^+NN2W-O'_HUO'K4
M=R&<#Y5\E1\PS@8KUSP_/?W7AS39]4C\J_DMHWN$QC;(5&X8[<]JCL?"WA[2
M[G[3I^@Z7:7&,>;;V<<;8^H -:U.^A-M0K*\1>'=/\4:2^FZDDAB++(CQ.4>
M-U.596'0BM6BD-.QRO\ P@EI)X3F\/7FL:S?033+*US>70EG!5E8 ,5P%RHX
MQZUT&HV$6IZ7=:?,SK%<PO"Y0@,%8$'&>_-6J*'JK/\ KH"T::Z?\.<WJ'@C
M2-3\+V.@W/V@P6"QBUN$DV3Q,BX5U8 8;'MCVK,@^%^D*(9+W4M9U2[@GCGA
MN]1O//EB*.&"KD84$C!P,D=Z[>BG=WYNHK:6.<\3^"]/\4R6MQ/=:A87UKN$
M%[I]P89D#8W -@\''I6UI]F-/T^WLQ/<7 AC">=<2;Y'P.K,>I/K5FBDM%8?
MF%8_B7PSI_BK2Q8ZAYRA)!+#-!(4EAD'1T;L1FMBB@+V.8_X0BTD\-1:'=ZK
MJ][''<I<_:;NY$L[,CAP"Q7&W( QCI6SK&EP:WHM[I5R\B07D+0R-&0&"L,'
M!((S^%7J*'KHP6CNC*O?#FF:EX<&A7\'VFQ$2Q;9#SA0 #D8PPP#D8YKG[#X
M:V=CJ$=R_B/Q/>0Q.'CL[K5':!"#D?* "0.F"3QUS7:T4[N]Q6TMT,N30;63
MQ1#X@,DWVN*T:T5 1L*,P8DC&<Y [_A5C5=*L=;TR?3M2MTN+2==LD;]"/Z'
MWJY12Z6*OK<XBS^&5C:7J2MXB\3W%K&P9+&?57:!<'(&T8) ]"37;T447$%9
M>HZ#:ZGJ^DZE-),LVF2/)"J$!6+H4.[()(P>Q%:E%'F!RFO^!EU[43>#Q-XF
MTUB #%IVI-%&<#&=I! _#%:V@>'=/\-6+VNGI)B20RS2S2&229SU9V/)/ K5
MHH6FB!Z[A4%[:I?6-Q:2EA'/&T3%3R PP<>_-3T4FDU9C3L[HI:/I<&B:+9:
M7;-(\%I"D$;2$%BJC S@ 9X]*J:3X:T_2-$FTA ]Q:3R322+<8;=YC%F!P ,
M?,1]*V**IN[;?42TV."_X5+HF_R3JOB Z5C']DG4G^R8]-G7'MFNY@@AM;>.
MWMXDBAB4(D:#"JHX  ]*DHI7TL'6X4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-=MD;/C.T$TF[*X
M#J;(2L3D=0I(KROPSX-TCXBZ''XH\5+<ZA=WLLDD$9NY4CM$#E52-58 <*,G
MN:V_!-Q=66I^)_"]Q>3WD.DRQM:S3OOD$4J;@C-U.T@CGG&*))V:>]K_ -?>
M/KIM?^OR-3X>:M?:YX$TS4M2G\^[G1S))L5=V'8#A0!T [5LZS<2VFAZA<P-
MLEBMI'1L X8*2#@UY5\/OASHGB;P!IEYXA%S?R'>;=#=21I;J'8 (J$#/<DY
M))K<T">[@\->,M!NKN6\31WF@MYYFW2&)H=ZJQ[D;L9HK;2MO:_X(</B7:]O
MQ9M:9JWB&]^'NAZG8PP7VJ7,-J\_GD1JRMM\QN, $ DX'Y'I76UY/J7_ "0[
MPM_O:9_Z,CJS\3Y;"/7-)'BI[U/![0R+<?9S((S<9&P2^7\VW&<>]:U=)R2[
MM&<=4O3]3T^BO$O OA7P;J'Q%&K^%=)GET.UM \=U.)EC6ZWX'E^806XSG.0
M"!C%:7C2?P/K>NW,=]I/B+Q1=6S".2TTM9Y8K9@.>%94!]>2>:S>EO,I=3UN
MJ&C:Q:Z[IPO[(L8&DDC4L ,['*$C!Z$J<>U<#\- FO\ A/7M)O$U5=/@U&2W
MA@OI7BN8HMJ,(V96W#!)'7IQ5;X/>"/#MMX>T[Q)%IVW5\SI]H\Z0\>8Z?=W
M;?N@#I56U=^R?WB>WSL>B:--J\R7G]KVEO;LEU(ML(7W;X ?D8^A/<5I5Y?H
M6KRZ#X'\=:K H::TU6_EC##(W C&?;-6-.^%.@ZEIEIJ>JS:A=Z[- LCZI]N
ME65789RF&"@ DX&.E3TOY+\5<;WMYO\ !GI%%>17^KW^I? C7_M]P9[ZP>:R
M>XXS(8I0H?ZD8_&M+4?A;HMQH,NJW<^H3>(4M#(-5-[*)5D"DY4!MJC.> ,8
MH;LF^B_RO^0TKV75_H['I=5[^]@TW3[F^NGV06\32R-Z*HR?Y5E>"M0N-5\$
M:)?W;[[B>SB>1_[S%1DUF_%#3+74OAWK7VI9&%O:2SQA)G0;U0X)"D;A['(]
MJ*B<+KL%.TFO,ZBSNDOK&WNX@PCGC610W4!AD9]^:GKSW0O#N@^ / UWXAT7
M3/)O&TH7$Q,TC^85CW]&8@<^F*J:)\,M#U_1-/US7I+Z_P!<NH$N&OS>RJT;
M.-V(PK *%SP,54E:32Z?\'_(B#O%-]?^!_F>FT5QWPXU*]O=#OK+4+EKJYTK
M4)M/-RY!:54(VL2.IP1GZ5TFK:7:ZSIDUA>K(UO*/G6.9XB<'/WD(/ZU,M%=
M?UU*6]F<7X5N_%/BN]7Q$OB""UT3[5+%'I<=DK^9&CLFYI2=P8XSQQTKT&O)
M_@OX/T&U\-6WB*&QVZJ[7$+7'G.<H)64#:6V]%';M71?"7_DF^F_]=)__1SU
M373LE^(-6;?FU]USMJ*X#PB03X]Q_P!!>?\ ]$I65\.O!&GZQX1\.:WKS3ZA
M>011262M.ZQ6JI]P*BD G@$D@Y/MQ22O]R?W@]-/7\#U2BO*K?PO;^*OB5XS
MMM5N+I])C>U+6,4[1)*[0CERA#$ #IG'-7O#.D6_@_XF7'AW2'GCT:XTH7BV
MDDS2+#()=I*;B2 0>?>A*]O-7!Z7MT_X'^9VFFS:O+J&J)J-K!#:1SA;&2-\
MM+'M!)89X.[([?3N=.N!\.1W,VM_$**SE$5T]ZJPR'HCFW3:?P.*Y'2O#W@^
MQNK,>*]-UG1_$I94;5+F\GV7$N,$I.KE.?0X/;%"ULO) ^K\V>AZUJ]]:>/_
M  QID$^RSO8[IKB/8IWE$4KR1D8)/0BNIKS;Q[ILFK_$+P98QWD]JDJ7@EDM
MWVR&/8A90W49Z9'//%4]8\(:3X!UGP_JWAI+BREN]6AM+Q/M4DB7"2;@=X=C
MD@\@T1U27=M?B$MW;LG^#/5:**\Z^(6B2:EK-E/JNEZCK'AE+=DGL=/E8.DV
MX$2,BLID&!T&2/0U(ST6BN#\)OX3T7PSJU[X3EG:VMHV>6SEFE8V[HK';Y<A
MW(3SGUKS6PGT?7M/M]7U_P '>/\ 5-:F3SAJ5K;R[(RW(\C;(%"#C'':F]Q=
M+GT-17D^H:AK-W^S]?W&LPW<&I1P,A^UPF*5@LF$9E/0D $UT-I\-]&NH7U#
M5A/J&LW=H\,]Y-.YXD4AE1,[549(  XIM-7\O\K@NGG_ )V.WK,UJ;5X(;4Z
M/:07,C74:SK,^T+"3\[#GD@=!^AZ5QV@>*)-$^&%])J(+7_A\26,RYYDDC^6
M/_OH%/SK+U+0Y- ^'GA6TN"6O'UNSN+MSU::27<^?Q./PII>]IM=?C_P!=-=
M]?P3_4]8HKSWQ-;MXL^(=MX3NKJXBT>#3C?7<$$IC-T6?8J,PP=HY. ><UHQ
M^']$^&WAG6]1T"Q>!8[9[@PM/)(I9%)& S'&>^/05#=H\S*M>7*M_P#,[&BO
MGFT_L?5-.@U/5O!_Q#OO$$L7F?VO#;R_([#.8<2!0@)^7Y>E=O-%XI\2?"[0
MY+RTU WBS*=4LE<VEQ<PJ64@$XP3\K8R,_C5--)^7]?UH)-/8]/HKS;P%IW@
M6RUIU\/6U_I&J+$6FTR\DGC<J?XC'(Q#8Z;ER!ZUZ30T(**\T^(-UX/U'5!I
MNKVNMZY=V\0+:3I7G. "<AG5"J[N_)S@52^&36]WJ?BC0(++6].T1(H#!8:F
MTD4]N'5@P4[BRJ=H(P<TH^]<;T->"[\4^*O%&J'2O$%OI6E:1>BT, LEG:Z9
M55GW,Q^4<X&VNRL-7M=1O=1M+<LTFGS""8D<;RBO@?@P_&O+OAQX"\-/K_B/
M4&T]S=Z=K4\%K-]IEW1H%''WN3\QY.3SUI_@WX=>%;GQ9XCNY],>2XTW6!]E
MD>ZF)3"(XS\_S'<2?FS3CT7E?\O\QRT;];'KM%>&Z[JUAXD\6Z[;^(O#7BO7
M=/L+G[+:VVE02-;1[0"S/M=<R$GOVQ75?#"[OOMNL:>NEZ]8Z%"(GT^/6H&2
M2/((>-68G<H(!')QFDM5?RN*6CL>D45Y)X#\%Z?XI\-0WGB%I[Z*"]G%G:F=
MTB@"S/\ -M4C<Q.>3GC KUNG;^OD@ZV_K=A17G>NV/\ PF?Q$D\-:A<W":)8
M:>MS/:02M']JDD8J Y4@E0!T!ZFK]SH^E?#/P3KM[X=LV@$5N\ZPO-)*H<*<
M8W$D#/6IO:/,QVO+E1VM%>;Z=\*=!U+3+34]5FU"[UV:!9'U3[=*LJNPSE,,
M% !)P,=*R[[6-0U'X$Z]]NN#-?6#S6;W/&9#%*%#_7&/QJFK775?YV%'WK6Z
M_P"5SURBO*/%/P^TRR\'WOB;[3?MXFM+(W*ZJ;R3S#(J[CA=VT*>1M   -.N
M_AUIFI^#/^$AU.YOKCQ+_9_VH:G]KD5HY-F\;%!"JH/0 =*3]U-OIO\ \#[@
MC[UDNO\ P/\ ,]5HKRWQ7J%[J/P$M-0>?%]/;V4IFQ_RT,D9W?GS5W5/A9HP
ML+C58;G44\11PM(NK&]E\TR $Y(W;<9_A  QQ3FN3FOT8+WDK;O_ #L;OCG5
M[[1[#2I;"?R7GU:UMY#L5MT;OAAR#C([]:ZBO+=:U:?7?AQX,U2Y \^YU/3Y
M),="V\9/YT?$O7&_X2C2_#T]CKM[ILEM)=7=MHD;---R%56*D$1]2<'KBAKE
M]WK=K\$"U2?E^IZE5"TU>UOM4U#3X"S36!C6<\8!==P ]\8_.O)O"3IIGC/2
M[7PMX3\6Z-H]SYD>HPZE;2BW'RY2169VVMD8SD9S5GPU\.O"U]X^\4R7>FR3
MR:=?0-;/)=S,R$Q*Y))?+?-S\V:$M5VU_"W^8F[+[OU_R/35FU?_ (25X#:6
M_P#8WV4,MQO_ 'GG[L%=OIMYS6E7$1_\ENN/^P G_H\UB:1X6TWXE/JFL>*1
M<7T2:A-;6EG]IDCBMXXF* A5(^8\DD^M):I>GZM#>C?R_*YZE17!^$A-H'C3
M6/"2W<]SIT-K%>V8N)#(\"L2K1[CR1D9&:YKP-X TCQ9X4^T^)#=:C$+RY6V
MMFN9(XH%$KCA489).XY.3SBC?;M?\;!Z][?A<]AHKA_APL]D/$.BO=3W-MI>
MIM!:M<2%W6,HK!2QZXW&NSN9OL]I-/C/EHSX'? S1)I*_3?]02;=B6BO*_#/
M@72/'7A^S\3^*?M.HZG? W"/]KE1;4$_*D2JP"@ #\16MX0ADO[?Q)X1U:ZN
M;VWTR[$$<[3LLK0LH=5:1"&R,XSGFFTU=/?^O\Q76_3_ (?_ "&Z!=^*O%>L
M3ZQ;Z_;V&B6U_);+IR6*R&=(VVEFE)RI)!QCCI7H%>3_  A\$^'K6TDUZ'3]
MNIP7UW;QS^=(=L8=E VEMIXXSC->K.@DC9&SA@0<$@_F.11M%6[?H@WD[_UJ
MRE8:O:ZC>ZC:6Y8R6$P@F)'&\H'P/P85B^']7OK[QKXKT^XGWVMA);+;1[%&
MP/%N;D#)R?7-<7X-^'7A6Y\6>([N?3'DN--U@?99'NIB4PB.,_/\QW$GYLU-
M;>%+7Q3\3?&D.JS7+Z8C6H>SBG:))G,(Y<H0Q '09QS0NGI_D-[/R:_,]7K,
MTV;5Y=0U1-1M8(;2.<+8R1OEI8]H)+#/!W9';Z=SQGAG28/!_P 2[CPYI#31
MZ-<:4+Q;229I%AD$NT[-Q) (.3[U8\.1W,VM_$**SE$5T]ZJPR'HCFW3:?P.
M*72Z[-_<PZV?=?B=]17B>E>'O!]C=68\5Z;K.C^)2RHVJ7-Y/LN)<8)2=7*<
M^AP>V*]L'2FUH*^H45YM\4]>GL[S0=%2#6)K6_DEDNX]'0M=21QJ#L7!! )8
M9(.< URNBM;Z/XGT9O!O@SQEHT4UVL6HQWUK+]FDA;@LVYVPRG!!XXS1'WF.
M6B_$]SHKS+6]%/B#XRM83WEU#IYT-'N8K>4Q&<"9@JEEPP7)R<$9Q3;?PUI_
M@+XB^';7PX)[33]62YCNK,W#R1LR(&5P&)PW&,^E"5[>?_!_R!Z7MT_X'^9Z
M?17C7C>7PT/'=]%\2'O1HYAB;25!G^SD@'S#^ZYWY/?L1[5=^%/A?0K#5==U
M[2]+EM].:4)IMU=>8KM#L!? ?^#=T)&3Z\4HZJX2TT/6**\.UQ_ >MWUQJ,&
M@^,/$EPTCLFHZ>EQ(ENV>/+8NJ@ ], CY:VX=2U[4O@#:7MM->RW[0J)I8#F
MX,*R[7*GJ7V \]:.E_3\0?Q6]?P/5J*^<[S0_AEXGETZV\&V-[J&JR7D1N@?
MM6WRBW[PS,YP.,\J0<UVGC_48=/UO1/"4>F:W/HB633366A1LTLBJ0B(<$$1
MCG.#Z4= 1ZQ17C'A&1-+\::7;>%?"?BS1M(N?,34(=3M9!;_ '<I(I9FVMD8
M[9!K3M_#%MXJ^(WC2TU>:XETF-[4FQCG>)))&A'S.4()P ,#./:G;MY_A;_,
M.]_+\3U2BO(=+\#VC^-]:\)-?:A_PBUM:PW*:6+IPN^3*[=X._9A3\N[&3[5
ML>%=(M_"/Q*O_#ND--%H\FEI>):/*TBQ2>85)4L20".M"5[>?]?H)Z7\O^!_
MFCT:BO!]1U73O%7B+6V\2^%O%NO6MK?/:V<.F02-:PK'\N?D=<R$Y)SV(KK/
MA_>:B^F>)+&;3M<M-)MP&TT:U"R3*C(=R9.=P5AQR< BIO[KEY7*:]ZWG8],
MJ*XN(K2VEN)F"Q1(7=CV &2:\F\#_#;1?$WP_P!$O?$AN]1N6M@8-UU(BVR=
M%5%1@!@ <D$DU-86G]L?![Q!I^K7%U>+IDU]!%*]PZNXBW;-Y4C=CT/!P.*=
M3W5+NA0]YQ\]#TW2]0AU;2;34;=76&ZA2:,. &"L 1G'?FK=<'\,O!?A_0O#
M^FZQING^1?WVGPFXE\Z1M^Y58\,Q YYX KO*N:49-$Q=U<****@HYWPCK]UK
MT.KO=QPH;/4[BSC\H$91" "<D\^O\JP/"MWXI\5WJ^(E\006NB?:I8H]+CLE
M?S(T=DW-*3N#'&>..E,\%Z7:ZSH?BJPO5D:WEUZ[WK',\1.'!^\A!_6LSX+>
M#]!M?#EKXBAL=NJNUQ"UQYSG*"5E VEMO11V[4X[W\E^-AR6C]6OS/5ZH:7J
M]KK"W36A9EMKE[5V.,%TX;'MGC\*M75M'>6DMM-O\J5"C[)&1L$8.&4@@^X(
M->5?#'P#X9$U[K?]FDZC9:Q=Q6\YN)2457*J,;L'CN0326KU_K43T7]=CLO#
M&KWVH^(O%5K=3^9!8WR0VR[%&Q#$K$9 R>23SFNHKR?3/!]GXK\;^-DUF6YF
MTQ+Z("QCG:*-W\E,L^P@M@8P,XZUJ^$--B\*_$'5O#6FRSC1_P"SX;V"VEE:
M00.796"%B2 <9QFFM4O3]!/2_K^IZ'17@5QJ>E^+-4U6Z\4>$O&&O1QWTL-H
MFG02-:01QDJ-NUUR_!+$^M>@?"^\U.:PU2UO++6K:QMKK&G_ -L0LEQY)4':
M2?O;3D Y/&*4=5?Y_P!?>#T=OD=[10>E>/>!O &D>+/"GVGQ(;K48A>7*VUL
MUS)'% HE<<*C#))W')R><4+5O^NH^ESV&BO-?#.I7'ACPSXT@^T3WD.@7,WV
M3[0Y=@@B614+=2 3BN#M/['U33H-3U;P?\0[[Q!+%YG]KPV\OR.PSF'$@4("
M?E^7I1_P/Q';OZ?<?0U%>1ZSXK\0VOPET%[^WU2#5]2N8[*Y$%N5O-N6W%$.
M,2,J<=.6R*YJ5K/2)(]0\&^!_'FG:VLZ.\]S:3-'<KN^=9@7;((+=!UJK>];
MSM^7^8NE_P"NO^1] URWC/5[[29_#BV4_E"\UB&VG^16WQLK$KR#CH.1S61X
ML@;Q/XWTKPG<SW$.E/92WUY%#(T9N,,$6,L,';R20#6'XC\%:;X3U;P@=":X
MM;!];A66R:=Y8BV&(==Y)4]0<$9SSTI1W5^_ZA+1.W;]#URN4\<:SJ>GPZ5I
MVC30P:CJUX+6.XF3>L(VEF?;_$0%X!XR:ZNO*_B7X1T35_&'A1[^UDG-]?-!
M.&N90I01$X"AL+RHY7!.*G=I>8]DV=]X>L-8T[33!K>M#5[K>2+D6JV_R]@5
M4D<<\UK5YSX@TV&QNO"O@+2))],TF[:9YC;S.)/*B&\QJY)(W%N><XK.\2^$
M-*^&VCCQ-X46XT^:TGB:Y@%U(\=U&SA65E=B"<-P1CFJW?KI^2_,FSVZ[_G_
M )'J]%>=>.+:YU+Q_P"$+*VO)K-;F&\2:6$[9!'M0L%/8G&,]LY%=9X=\*Z-
MX5MYX-'M&@2XD\V8M,\C.^,;B7)-);78WY>7XFS1110 4444 %%%% !1110
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M:0#'F*R'<IQU'0XK=\.Q>)D@F?Q-=:9)</C9%IT3K'&!G/S.26SQZ5MT4=+
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MF2X&DWY@29SCYF7!&>.HQ6KX=\':7X:DFN+8W5U?3J%FOKV=IIY .Q8]!GG
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MD7;Q/<6ENL4C1$E"1Z$@''X5G:%X3GLO#FN:3?S1$:E=W<H: D[8YB<=0/F
M/T]ZZRBG+WKWZBC[MK=#CO!VD^,-$MAI6K7FC7&F6EL(+*:WCD$[%<!3("=H
M  Z#\ZVO#-OKMKH4,7B.]M[W4PS>9-;IM0C)V\8';'85KT4VVW=BMV"BBBD,
MYSPEH%UH,&KI=20N;W4[B\C\IB<)(00#D#GUZ_6F^ O#UWX6\)6^DWTD$D\<
MLKEH&)7#R,PY(!Z$=JZ6BC_@+[@_SN%<-HOASQ7X<\1W,=A>Z1/X<O+V2\E6
MX20741<Y94V_*1GN:[FBA:.X/56.>\/Z#=:3KGB.^GDA:+4[Q)X1&22JB-5P
MV0,'(/3-)!H-U'\0KOQ 9(?LDVFQVBH"=X=9&8DC&,8([_A7144=O+_AA6W.
M!G\+^+/#^I7]SX,O])-I?SFXEL-6CDV12-]]HVC.>3@[2,=:ZCP_%KT5BQ\0
MW5C/>.V[;8Q,D48P/E&XDMSGDX^E:U%"T5AO5W#M7/>"=!NO#?AJ/3;R2&29
M9YY"T))7#RLXZ@'.&':NAHH6@',:-X8DM;CQ0-0\B:UUB[:58T))\LQJA#9
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M\+!_E8\I\3>,-*^(-@GA?PP;J]N[B[A%T_V22-+1$D#,TA=1@_*0!ZUM>/\
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M>W7<5C +N2<!5!(R22 .>]#5@6NQI45'!(9H(Y3&\9=0VQ\;ER.AP2,_C4E
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MDY( QG-9VD?$.UU758K!_#WB33S,VV&>^TUHXI#[,"<?CBBVM@OI<["BBB@
MHHK+T#7;7Q%IK7UI',D2SRP$3 !MT;E#T)XR#B@#4HK+TS7K75=1U6R@CF67
M3)U@F+@ ,Q0/E<$Y&".N*YAOBMH\EL)=.TG7=5<,RS0Z=8F9K<JQ'[P@[5Z9
MQG."#CF@#NZ*RM!\1:9XDTO^T=-N-\ 9D<.I1HV7JK*>5(]ZYH?%;19+MA;:
M;KEWIR,5DU6VT]WM$()!RXYP,=0"*.M@Z7.SM;RUOHVDM+F&XC5VC9HG#@,I
MP5)'<'@BIZX7X6W,,GA&]NHY%D@;5+V173Y@RF5B",=>*:_Q8T:&8/<:1XAM
M]-) _M6;3'2UYZ'<?F SQ]VG;5+T_&PO/U_4[RBN&^(7CB7PM#I:6=CJ%U+=
MW<*EK6T,JF,MED5B-I=@" N<\YXZUM:=XMM+OP[<:Y?V6HZ+:VY;S5U6W\F1
M0,?-MR>#GCUI=+CZI=S?HKB;/XGZ1<7\5O<Z9KFG6T[A(+^_L&AMI6/W0'/3
M/;(%:GB3QG8>&IH;5[34=0OYD,D=EIMJ9YF0'!; P !GN10!T5%8?AOQ1;^)
M8)GBT_5+"6$@26^HVC02+G..O!Z=B:W*;5@N%%%%( HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \\^$U
MY82:;KMK!)&+N'6;MKA 1NYD.UB/3&!GVIWA.>"^\?\ CB\T]Q)8$V\321G*
M-.L;;\>I&5!K*\*>!O#7B[P]=OKFDQ7<D6K7H23<T;@><W&Y"#CD\9Q7I&EZ
M/IVBZ<FGZ99PVEHF<11+M'/4^Y]Z'M\K?>D'?U_5G*?""VAM_AEI1BC53+YD
MCD#[S&1N3^0KEX=.\0W7Q2\5VNG>,5T&ZE>&9('TZ.X-Q#Y8"LI<YP"""!WK
MU32=)L=#TN'3=-@\BT@!$<>]FVY))Y8D]2>]4/$7@[P_XLA2/7-+AO-G".V5
M=1G. ZD,!QV-.3O+F_KI_D'1I_UJ_P#,QO"GA/4]'\4:CJVK^*DUJ]N;:.!U
M%DEN4522I(1B#U/:J/PFO+"33==M8)(Q=PZS=M<("-W,AVL1Z8P,^U=1X=\(
M:!X2@DAT/3(K-9,>8REF9\9QEF))QD]37">%/ WAKQ=X>NWUS28KN2+5KT))
MN:-P/.;C<A!QR>,XH6[MV_436WK^A:T?6+>U\4_$/7[%?M.GVL4)8Q-\LL\4
M3%P#TSC:":I3S^,M:\&_\)-=>.-,T73YK4SFWMM-29 A&0IDD;.['''>O2],
MT;3=&TU=.TZQ@MK-00(8T 7GKGUS[U@67PP\%:=J_P#:MKX?M8[O.5;+,BGU
M5"=JGW %2U=6\K?GT^92>M_/_+_(X^X&?V8T'_4*3_T(5ZA:I#IVBPK#$%AM
M[<;8T&,!5Z"JTGAG2)?#9\//9YTKR_*^S^8X^3.<;L[OUK550B!%&% P![5<
MW?FMU?Z$Q5DEV_S/+-.U#QEXP\-IXFB\8Z;X<TUP\BQ0V"7!C0'&)'D; 88[
M =:RM)?S/V:-2?S?.W17;>9MV[_WS?-CMGKBN\'PP\%#6_[8_P"$>M?MN_?G
M+;-WKY>=F?PK>M=$TVSTR738;1!93-(TD+9=6,C%GSG/!+'CIS4_9:76WX.Y
M2>JOW*-](DW@.YDB=71M-<JRG((\LUP&K#;\$/"<\BEK*W;3IKT;21Y*E=Q(
M'8<$_2NYT7P%X8\/1ZA'I6E);)J"[+D+*YWKSP,L=HY/3%:]II=E8Z3#I4%N
MHL881 D+Y<; ,!3NSGCUJF]6UW3^YMDQ5HJ+\_Q5C'\8ZEI$?@'5;J]GA?3Y
M;*0 [QB7<I"A3W).,5Q>JV<Q\%?#6TU.,F8:E8B5).N1&W!KJ;/X6^"=/U8:
MG;>'K5+H,&4DLR*1@@JA)4'CL*Z'4=(L=6:S:]@\TV=PMS!\[+LD4$!N",]3
MP>*2LG?S3^Z_^8WM;R?XJQR_Q;4-\,M7R,[?*(]CYJ5VD?\ JD^@JIJVDV.N
MZ9-INI0>?:38\R/>RYP01RI!Z@=ZN    =!26S7G^E@>MOZZBUPGQ'_Y"/@O
M_L/P_P#H#UW=4-2T;3]7DLI+ZW\UK*X6YMSO9=D@! ;@C/4\'(IK1I]F)ZQ:
M[IG(^-98[+Q[X*OK]E334GN(FD<X1)WCQ&2>@_B I/BY-"W@U+)&5M2NKRW6
MPC5AO,OF*05'L :[34--LM6L9++4+6&ZM9!AXID#*?P-8.@?#KPEX8O3>Z1H
MD%O='I*SO(R_[I<G;^&*4=+7Z._XI_H-]UVM^?\ F97B>VBN/BCX'$Z*_EI>
M2 $9PP1<&N]JC<Z18W>JV6ISP;[RR#K;R;V&P. &X!P<@#J#5ZGTMZ_BPZ_)
M?@%<5\6O^28ZR>P6,GZ>8E=K4-W:6]_:2VEW#'/;S*4DBD7<K*>H(I>G]:I_
MH.+L[G+?$1+B^^%NM#3CYDDED67R_FW)P6QCK\N:Y>P\->*]>\*QO;_%&&72
M;FVV8&AV^T1E<%2=W&!Q[5W7ASP;X?\ "2W2Z'IR6@NF#3 2.^XC./O$X')X
M''-95U\*/ M[J9U"?P[;&X+;CM=T0G.>4#!3^5#2U\Q*Z2\O^!_D.'@B.7PS
MH-I!K$\5_H\*K9ZG;JN?N[22C;E*L.H.?K2:-KNM6GBP>&->DL;R:2U:ZM[R
MS4QDJI4$21DG:?FX(.#6GKO@OP[XET^VL-6TN*XMK88@0,T?E#@84J00, ?E
M2^'/!GAWPE'(NAZ5#:&3AW!9W8=<%V)8CVS57O)M^?\ 7D*VB2,/X<R(;KQ?
M%N'F+K]P67/(!"X./>GZ'_R5CQ;_ ->=C_*2M.[\!^%[[Q'#X@N-(A;587$B
MW"LRDL.A(! 8C Y(-:L&D6-MJUWJD,&V]O$1)Y=['>J9VC!.!C)Z"I6R]+?@
ME^A3=[^;O^-SE?A-%''X%5D0*9+VZ9R/XCYSC/Y ?E3?A=;PPZ7KSQQJC2:[
M>%B!UP^!^@KK=)TBQT.P%CIT'DVRN[A-[-\S,68Y8D\DDT:9I%CHT,\5A!Y*
M3SO<2#>S;I'.6/)/4]NE.^OR2_+_ "$]?O;_ #_S//M*M[F70_B7!IZD74FH
M72PA!@ES N,>^:Z7P%J.F3?#S1YK2:%;:"SC23Y@!$RJ P;T((.<UN:?I%CI
M<M[+9P>4][.;BX.]FWR$ $\DXX X&!7/ZC\,/!6JZK_:=YX?MI+LMN9E+(KG
M.<LJD*Q^H-+I;R7X*PWJ[^;_ !M_D<CH1$GPD\;W, (TZXGU&6Q]#"0<$>Q.
M[%=]X0MXH/ VBPQH%C&GPC:!ZH,UHSZ58W&D2:3);(+"2$P- GR+Y9&-HVXP
M,>E36MK#96<-I;IL@AC6.-,D[5 P!D\]*'LTO+\%86NC]7]]CSGP7H</B+X(
MQZ/+\JSK<)&W_/-A,Y1A]" ?PJK!JTWC>3PEH5RO[Z!FO-80\8:W;9M(_P!J
M7GZ+777^K>%OAGH%K#=2G3]/,C) @268EV)<C@,>3D\\5E_#K27:ZUWQ7<V#
M64^N77F102)M=(%&$+#LS<L?K5)WDWTT^]:+^O)!+;UO]SO?^O,[/^T++^T#
MI_VNW^VB/S?LWF#S-F<;MN<XSQGI5FN>TOP[+:^,-;\074D;R7BQ06RIG]W"
MB]#D=2Y8]^U=#4]$'4#TK@OA3-"GAZ_T^5U75+;4;G[=&>'WM(Q#$'G!4C!K
MO:YGQ#\/?"GBJY6YUG18;BX&!YJL\;D#H"R$$_C0M'_7>X;JQC^$9H;SXE>,
MKO3B'L#]FBDD0@H]PJG?C'< J#[U/\+)$?PG<(KJ7CU.\5U!Y4^<QP?P-=7I
MFE6&C6$=CIMG#:6L>=L4*!5&>OXUD)X#\+Q>)QXDCTB&/5@2WVA&9?F((+%0
M=I)R><9IK33I:WXW!ZZ^=_PL9/P_AC76_&LP0"1];=6;') C3 _4_G2Z6I'Q
M9\4>6 ';3;,_4_O #75Z?I%CI<M[+9P>4][.;BX.]FWR$ $\DXX X&!1#I-C
M!J]SJL<&V]N8TBFEWL=RIG:,9P,9/04NR\K?A8;Z^M_QN>/_  \T3Q?>^'&@
MT[X@C39+:XFCN=/.D0S/!+O);<S'<<DYR?6NE'AN7PS\+/%MM/K*:M-<1WES
M).D"P@.\?S#:K$#D$\8Z]*W]?^''A'Q/>?;-7T2&>Y[RH[Q,W^\4(W?CFM2#
MPUHUKX?DT*VT^*'3)8VC>WBRH*L,-R#G)SUSFE*[BUU:M_7W#BTIJ72]R#P9
M;0VG@C0X8(U2,6,)"J.Y0$G\S6Y4-I:PV-G!:6R;(((UCC7).U0, 9//05-5
MS?-)LS@G&*3$8[5+>@S7EVEZGXQ\<:*^OV?BO3_#>F^;($B2Q2YD5%)7]ZTC
M8!XSP.XKU*N2G^&'@JYUO^V)O#]J]Z7WELML9O4QYV$\]Q4=2^AP.DK=7G[/
MGB+[+<?;)GFO&,Z)M\Y?-)9@HZ97)P/6O5]!O=-N?#EA<Z=- ; P((FC8;0,
M  >V.F*L:?I=EI<$L-E L,4LKS.H)(+N<L>>F3VZ5SG_  J[P5_;2ZN/#]LM
MXC^8K(SJ@;UV [,]^E5?7RT_!6)MI]_XNY6MY$3XVW\;.H>30H=BD\MB9\XI
M?$7_ "53P9_UROO_ $!:V/$G@GPYXN\DZ[I<5VT/^K?>R.H]-RD''MG%7FT'
M3'OM.O#:C[1IT;1VC!V C5@%(QG!X ZYHCI:_3_@_P"8WUMU_P"!_D<;?ZC!
MX&\>:I>W3LFF:Q8M=^PN(%^8 >K)@^^VH;;2[C3_ (+ZY<WP(U'4K*YO[O/4
M22(3C\!@?A79Z]X9T;Q1;P6^M6*7<4$HFC5F8;7'?@C/7H>#5Z]L;;4=/N+"
MZB\RUN(FBECR5W(1@C(P1QZ5+5X-==OEO_7HBHNTU+I>_P _Z_$\Y\3.L7PJ
M\+22,%1+C3&9B< #<G)KLO%VACQ)X5O=.1@LTD>^WD_N2K\R,/HP%7)]#TRZ
MT,:+<644VG")8?L\OS+M7&!SSQ@<]:YEYO!/PCTE($0Z;;7DS&.-%FG:63 X
M!^8YQ@<D"JG)-R\W=&<$XJ*[*QBVNL'Q_J_A.R=/DLXCJ>IQMQLFC)B6,CU\
MP.?^ UZA7#?#719+:VU;Q!=6)LKO7;QKK[.R;6BBR?+##LQ!+'W:NYIR[?/Y
MO_+8:_X"]$%<!H$L-M\7_%<-Z\:7ES!:O9AR-SP!"&"Y[!LYQ7?UB^(O".@>
M++=(=<TR&\5/N,V5=/7#*0PZ#H:E:.X]U8Q?BHDMQ\-]92US(8U1ID0Y/EAU
M9QQ_LY_"MN75M%/A-M2:YMCHYM2WF;AL,>WI^7&*?H/AG1O#&FG3M&L([6U9
MBS1@EMQ/!)+$DG'J:Q?^%5^!QJW]I_\ ".6GVG.[&6\O/_7/.S]*35TX]'_E
M8=]GV_SN<,]I*?@!H-M?Q-MDN[4>7)U\IKD;0?\ @)%=E\7(T?X7ZPC("NV+
M@C_IJE=3J>CV&LV2V=_;^; LB2J@9EPR,&4_*1T(%+JVDV.NZ9-INI0>?:38
M\R/>RYP01RI!Z@=ZMN[^=_R_R%'1I^7ZO_,Y[XA11I\+-=B5%$::<X5<<#"\
M5A?$6:VMOA_X>GO=OV6._L'FW#(V @G/X5Z!J.FVFK:7<:;?0^;:7$9BECW%
M=RG@C(((_ UR'Q(@CBT+0;=$ B76K&,*>1MW@8YZ\4EOZM"2T]$_R+7Q'U#3
M4^&FL27$\+0W-F\<&&!\UV&$"^ISC&*Y#QE:ZO'-\/&.L_V,T:-#)?RVZSK%
M<-$H7<K';DX89/3-=E9?#'P5I^LC5K7P]:QW@;<K98HAXP50G:IXZ@"NCU#3
M;+5K&2RU"UANK608>*9 RG\#2VU\[_FOU'_D_P ;?Y' 2>!?$UWJFCW6N?$)
M+Z"RO8[J* Z3#"7=>P96SR"1WZ]*TH_^2W7'_8 3_P!'FK>B?#+P;X=U%=0T
MO0X8;M3E)6DDD*'U7>QV]>U;PTBQ&MMK(@_XF#6XMC-O;_5AMVW&<=3G.,TT
M[6^?XJPGU^7X.YY_ID-W<:)\2X;$,;N34+I80O4L8$QCWK,\&Z%XLU7P9ITN
ME?$N.*P%LL?V<:) WD8&#&Q+9R.0<UZII^D6.ERWLMG!Y3WLYN+@[V;?(0 3
MR3C@#@8%<[JGPM\$ZSJ9U&^\/V[W3-N9D=XPYSG+*K ,?J.:7EY)?<K%-W^]
MO[[?Y'+>(=!'ACX3Z-ITE^NH6%AJ5N]W<+'M5X//R?E#$ #([GI74_$:^TU?
MAEK<US/";::R=8FW AV*_)M]3G&,5TD>EV$.EC2X[.!; 1^4+;8/+V8QMV],
M5S=C\+?!.G7-Q<VOA^W26=61V+NV P(.T%B$X)'RXHG>2:[_ .27Z!%\K3[?
MYW-CPI_R)^B_]>,'_H K7J&TM8;&S@M+9-D$$:QQKDG:H& ,GGH*FJIOFDVC
M.$>6*3Z'GGQ8N+.TMO"]QJ!5;2+7K=I6?HH ?D^PZU>^*5W8_P#"M=56:2-S
M=0B.U4')DE8C9L]3G!XKJ-1TC3]7^SB_M4N!;R^=$KYP&VE<D=#PQ&#D<U@Z
M;\,_!ND:O_:MCH%M%>!MROEF5#ZJI)53] *E;6?>_P"7^1HWJFNW^?\ F9OB
MZ";2;/P_XJPWVC1V1;T@9+6T@"2Y]<'#?\!-2^%\:_XXU[Q*0&M[;&E6+9SD
M(=TK#ZN0/^ U%X[\:Z9;V]_X5M(Y-0\0W=N8H=/2V=P?,& S-C;M&<GGI72>
M$]!C\,>%=-T:+!^RPA78?Q/U8_B2:I.]Y>MOGO\ UYDM62C]_P MOZ\C9HHH
MJ1GD]E!=W/PW^(4-BK-<OJ6HA%3J?8>^,TSP[H'BO6O"%G-IWQ/A.F26JH(U
MT.W(C7;@H3NZCH<^E>FZ;H]AHZ7*V$'E"YN'N9AO9MTC\LW).,^@XKG+_P"%
M7@?4]3.HW7AZW:Y+;V*.\:L<YR45@IYZY'/>E;H^R_!6'UOYO\7<PO$>@)H7
MPJTBVBU<276C3V\EC=B(;)9@^U R[L;3NQUXZ]JOVWASQGKNK:7=>+KW1(K7
M3;D744&DQREI9 I W-(> ,] .:C^(7V?3;+1M.NK.5/!QWQZF+. MY<:I^[4
MA065,]2O(P.17 RV7PYO(2/AI9ZC+XD#J+:>R-VH@8G[TC2?*$QG.>H!JT[R
MOY_Y*]OQ):M%+R_SZ_UN>BZQK7B+6/&UWX6T#4+'21:6B3S7<\'GRL7SCRT)
M"X&.2<\XK$\')?P?&/4[;4_$L>O7<.CJKSI:I!Y7[W/EE4)&1G/K\U=GX@\"
M>&_%OD2:_I4-W/$H42AWC;Z;D()&2>#Q5W2_"^B:++%+IFG0VC10&W3RLJ A
M;<1CH3GG)Y]Z4=-_/]0EJM/+]# \ ?\ (4\9_P#8=D_]%QUVU4M/TBQTN6]E
MLX/*>]G-Q<'>S;Y" ">2<< <# J[1T7HOR&]VRMJ/_(,N_\ KB__ *":XWX1
MW^FR_"W2#:S0JEM"5N "!Y;@DMN]/7GUKLM1_P"09=_]<7_]!->:^#_AWX2\
M2^!/#>H:OHL%Q=K9QYE#.A;'3=M(W= .<TEU^7YL'T^?Y(K:1)'<_#?XAWEH
M<Z;<W5_):,/NLGEX++[%@U>@>#+:&T\$:'#!&J1BQA(4#N4!)_,U>?1M.?1'
MT86D::<\)@-O$-B^61@J-N,<'M5BTM8;&S@M+9-D$$:QQKDG:H& ,GGH*>EF
MEY?@K [O7U_&QQ'PQGACC\0Z=,RKJL.L7,EU&W#D,V4?!YP5Q@^U,T.2.\^+
M'BFXTQE>V2QMX+B1#E&N06/4=PI -;GB+P#X6\5S+/K6CPW,Z@ 2AFC<@= 6
M0@D<]":UM)T?3="L$L=*LH;2U0Y$<2X&>Y/J?<TNFO:WX6_KS!^7>_XW.0^$
M,UN/ L=GO0:A:W$Z7\>1O6;S&R6[Y/'7M63\18[^7QWX2GLM?318I([B*'4&
MMDN(UE8+A<,=H+*" :ZK7?AOX0\2W_V_5M#@GNNK2J[QL_3[VPC=T'7-:]SX
M?TB\T5-&N=.MI=-1%1;9T!10O3 [8[4V[M/K_P "P=UW_P [G&1^"/$DGB'1
MK_7O'R:BEA<^?#;G2HH"[;2" RMGH?>MK4O"NH1:U<ZUX<UG^SKRZVFZM[B$
M36UP57:"5R&4XP,J>W0T:#\-?!_AF_%_I.B1070^[*\CRLG!'REV.W@GI3==
M^&/@[Q)J;ZEJVBI/>. 'E6:2,MC@9V, >/6D^E@76Y!I=Q'\1?"FHZ=K$"P3
M6]TUI<-93ED$L9#"2)\>N",]",&J\NI^(O!VI:7;:MJ5KK6FW]TMI'*T0@NX
MV8_*2%^60#N0%/>NDD\*:#+X=;0&TJV&DL,&U1=J=<YX[YYSUSS69H/PU\'^
M&;X7VDZ'##=#[LKR/*R=1\I=CMZGIBFFN;R%T.C6_LWOWL$NX&O(T$CVXD!D
M53T8KG('O5BN>T3P[)I_B77];NI(Y+C4I8UC"9_=PQH JG(ZYW$_45T-+HA]
M0KAOA;<P?\(O?0>:@EM=3O%G0L,QGSF/S#MP<UW-<IJWPT\&ZYJW]J:CH-O-
M>%MS2!G0.?5E4@-^(-"T?]=[@]C+^'E_;:GXA\;7=G*LL#ZHJK(AR&VQ*I(/
M<9!IGP?O;"7P?<002Q?:(+^Y^TH"-RL96()_X#CGVKLM-T/3-&>Z?3K..V-R
MRM*(\A254*N%Z#"@# Q7FW@SP%X7\6^"K6?7-(BNIX[JZ59=[QO@3R8!9""1
MST/%->79+\0>U_/]"33C)J:?$^XT-]\%PQCMGB/RO.L&'*^^['-=9X%U#2W^
M'.CSVL\(LX;*-)#N $950&#>A!SG-;VFZ98Z/81V.G6D-K:QC"11*%4?A7.S
M_#'P5<ZU_:\WAZU:\W;RWS!&;U,8.PGGJ11TMTLOPO\ YAOKYO\ &W^1Q_A7
MQ-#X9^#>J:]I]NL\,5_<M;1GY5(:;:F?0#<#]*J^/[7Q=%X#U#4M8\=Z?':S
MVV#I]KIL?ES%APB2,Q?G/4?6O58/#^DVVF76FQV,?V*Z>22:!\NKF0DOD'/!
M)/'2L*P^%O@G3'NGM- @1KJ-HI"TCN=K A@NYCLR"1\N*3U_#\$O\AIV?S?X
MLR?&KI%X;\&2R,%C35[ LS'  P>34OQACN7\$1R6]P;>**_MY;B<1>;Y48<9
M<KT8*=IP>.*[#4-#TS5='.DW]E%<V!0(89!D8'3GKD8Z]:K:'X4T/PWI$FE:
M5I\<%C(S,\+,T@<D8.=Y)/  IR=[^M_R_P B8Z)+RM_7WG":IX(\5^(- D@U
M#XH0W.E7* L?[%@5&7(((8,,<@<@UUVL>%);Z[M-4TW5YM-UBU@^SBY6-9$E
MCSDK)&WWAD9X(([&J4/PF\"0:F-0C\.6PN VX NYC!]HRVS]*T/$G@/PSXNE
MAEUS2DNY85VH_F/&P'/&48'')XI/;0:\ROX8\0ZE=ZSJ>@:TEF^H:<D<AN;(
MGRI4?=C*G)1AMY&3[5T=E?V>I6PN+"[@NH"2HE@D#KD'!&0<9!K)L?"VG>'?
M#]WI_AFPM;%Y(F$?7#/M(4NW+'ZG)J;PKH,7ACPOI^C1$,+6(*SC^-SRS?B2
M33T$;%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%9VI>(-%T>2./5-7L+%Y/N+=7*1%OH&(S5W
MSX?(\_S4\G&[S-PVX]<^E'F!)16?INO:-K#.NEZM87S1_?%K<I*5^NTG%69;
MRU@N([>6YACFD5G2-Y &95QN('4@9&?3- $]%9]AKVCZK/+!IVK6%Y-%_K([
M>Y21D^H4G'0UQWQ'\116U]HGA\>(DT5=1G<7EVDZ1R0PJA/#-]PL< -^5';S
M&>@T5A>'H++1O#<;+K]QJ=B 95U"_NUF+*>YD& 1Z&M'3M7TW6(&FTS4;2^B
M4[2]M,LJ@^F5)IM:DERBJ<VK:;;1W4D^H6D26A N&>95$.1D;R3\O!!Y[5)%
M?V<]BM]%=P26;+O6X20&,KZALXQ[TAEBBJ.FZSI6LQO)I>IV=]&AVLUK.LH4
M^A*DXI\VJ:?;O.D]];1-;QB697F53$ASAFR> <'D^AH MT52T[5],UB%IM,U
M&TOHE.UGMIUE4'TRI-+J.K:;H\ GU/4+2RA)P)+F98U)],L11L&Y<HJ"TO;6
M_MDN;.YAN;=QE989 ZL/8C@U6M=>T>]OY+&TU:QN+R/[]O%<H\B?50<BCR T
M**K7VH66F6K76H7EO:6Z_>EN)5C0?4D@4W3]4T_5K?[1IM_:WD.<>9;3+(OY
MJ2* +=%%% !116=<>(-%M+,7ESJ]A#:F0Q":2Y14W@X*[B<9!!!'J* -&BJU
MYJ%EI]HUW>WEO;6R\F::4(@_X$3BEL;^SU.U6ZL+N"[MV^[+!()$/T(.* +%
M%9]SKNCV5O+<76JV,$$4GE222W"*J/\ W22<!N1QUYJU:W=M?6R7-G<17$$@
MRDL+AU8>H(X- $U%9UQX@T6TLQ>7.KV$-J9#$)I+E%3>#@KN)QD$$$>HJLD]
MXWC%XAJMBUA]A#K8#'GA]Y_>^NPCCTS0!M45G7'B#1K.U>ZN=7L(+=)#$TLM
MRBHK@X*DDX# \8ZU:M[VUO+1;NVN89[9UW+-%(&0CU##C% $]%<QH7CWP_KM
MW<6D.J6"7*7<EM% ;I#)-M_B5,YP><8SP,UT]'F 445'//#:P//<2QPPH,O)
M(P55'J2>E $E%4=-UK2M91WTO4[*^1#AFM9UE"GT.TG%3O>VL=P8)+F%)A&9
M3&T@#! <%L=<9[]* )Z*J:?JFGZM;&XTV^MKV ,4,MM,LB[AU&5)&:MT %%%
M9M[XAT33;N.TO]8T^UN9,;(9[E$=L],*3DT :5%12W,$%LUS-/'' J[FE=P%
M ]23QBJVFZUI6LH[Z7J=E?(APS6LZRA3Z':3B@"]15>6^LX)FAENH(Y5C,I1
MY &" X+8_NY[]*ATW6M*UF-Y-+U.SOD0X9K6=90I]"5)Q0!>HJ"UOK2^1WL[
MJ&X6.1HG:&0.%<<%3CH1W% OK1KYK%;J$W:1B5K<2#S A. Q7KC/&: )Z***
M "BLV_\ $.B:5<);ZCK&GV<\GW([BY2-F^@8@FM!9$>,2*ZLA&0P.01]: '4
M5GV6O:/J5W+:6.K6-U<P_P"LA@N$=T^J@Y'XU:DN[:*XCMY+B))Y%9DC9P&<
M+C<0.I R,^F: )J*S+?Q%H=W*L5MK.G32-*852.Z1B9 ,E  ?O <XZU=N[NV
ML+62ZO+B*WMXQEY9G"(H]23P* )J*Q8[B[?Q@T8U:Q>P-@KK8*09P^__ %OK
ML(X],U;U+6])T9$?5-4LK%7.$-U<)$&/MN(S0!?HJ**ZMY[87,,\4D#+N$J.
M"I'KD<8JKI^N:1J[RIINJ65Z\1Q(MM<)(4^NTG% %^BJ6I:QIFCPK-JFHVEC
M$QVJ]U.L2D^@+$5-:7MKJ%LES97,-S XRLL,@=6^A'% $]%%% !116?/KVC6
MNHIIUQJUA#?2?<MI+E%D;Z*3DT :%%<?\/KVZO;?Q ;JYFG,6MW449ED+;$#
M#"C/0#L*WIO$.B6VHKIT^L:?%?-]VVDN460_12<T=O/_ "N'?R-*BBLS_A(]
M#_M/^S/[:T[[?G'V7[4GFYQG&S.>GM0!IT5!%>VLUU/:Q7,,EQ!M\Z)9 7CW
M#*[AU&1TSUH-Y:K>K9&YA%VT9E6 R#>4!P6"]<9(&: )Z*I7&L:7:1W,ESJ5
MG"EJ0MPTDZJ(B1D!B3\N00>?6D76M*?3#J::G9M8 ;C="=3$!Z[\X_6@"]15
M73]3L-6MA<Z;?6UY 3CS;:59%SZ94D4S4M9TO1HDEU34K.QC<[5:ZG6(,?0%
MB* +M%1I<0RVXN(YHWA*[A(K J1ZYZ8K.N?$V@6<-M-=:YIL$5RH:!Y;N-1*
M#T*DGYA]* -6BJUU?VMEI\M_<7$<=K&AD:5F 4+C.<UC^%_&>C>*K"UELK^R
M-Y- )GLH[I))8AQD,H.1C(SQ0'F=#1110 454GU33[4W N+^UB-M&)9Q),J^
M4ASAFR?E!P>3Z&C3]5T[5[?[1IM_:WL.<>9;3+(N?3*DB@"W15*?6=+MH;F:
MXU*SBBM7V7#R3JJQ-@'#$GY3@@X/J*F2]M)+);U+J%K1D$BSK(#&5/(8-TQ[
MT 3T50TW7-(UD.=+U6QO@G#&UN$EV_7:3BK%W>VNGVSW-[<PVUN@R\LT@15'
MN3P*-@)Z*X?Q%KT5YJO@^71M62>TN=5,4KV=R&CE41.=K%3AAD#@]Q78I>6L
MEY+9I<PM=1*KR0JX+HIS@E>H!P<?2G;3^O+_ #%?6Q/14#WEK'>1V;W,*W4J
MEXX2X#NHQDA>I R,GWJ/4-4T_2;?[1J5]:V4&<>;<S+&N?JQ I#+=%86K^+M
M(TOPK=>(%O;:ZLX8F=&AG4K*P'"JPR,D\4MOXCTW7-'NY-%UO39+B.W+L\=P
MDJV[%3@O@\ $=_0T/1-]AI7MYFY16=H4MQ+X?L);R]MKVX:W1I;JV(\J5L<L
MI'&#U%):>(=$U"]>RLM8T^YNX\AX(;E'=<=<J#D4VK.Q*=U<TJ*AFN[:WEAB
MGN(HI)V*1*[A3(P!)"@]3@$X'854M?$&BW]])8V>KV%Q=QYWP0W*/(N.N5!R
M*0S1HHHH ***S8O$6B3:DVFQ:QI\E\O#6RW*&4?5<Y[^E &E145S=6]G#YUU
M/%!%N"[Y7"KDG &3W)( ^M0#5M-;4SIBZA:'4 F\VHF7S0OKLSG'OB@"Y111
M0 45C6,UZWBG58I=4LI[1(H3#91X\ZW)#;B_?#<8SZ'\9KGQ%H=G:"[NM9T^
M"V,C1":6Z14+J2"NXG&0001[4 :=%0Q7EM/:+=PW$,ELR[Q,C@H5]=PXQ7/>
M'/'N@>)&:*VU.Q6Z-Q+#%:_:T,LBHQ <+G."!NZ=*.M@Z7.GHJAJ6MZ3HRHV
MJ:I96*N<(;JX2(,?;<1FK9N(1;FX,T8@"[S+N&W;C.<],>]'F!)15"37-(AF
MM(9=4LDEO #:HUP@:<'IL&?FZCI3I]9TNVAN9KC4K.**U?9</).JK$V <,2?
ME."#@^HH NT57&H61L!?B[@-FR"07 D'EE3T;=G&/>H=-UK2M91WTO4[*^1#
MAFM9UE"GT.TG% %ZBJM_J5CI5J;G4;VWL[<'!EN)5C0?BQ JA:>+_#.H74=K
M9>(M(N;B0X2&&]C=V/H &R: -FBL_4M>T?1B@U35K&QW_<^U7"1;OIN(S3]0
MU:RTW2)]4N+B);2&(RF3>-I &>#2;LKC2N[%VBL'PSXNTCQ1I]M-97]D]U);
MI/+:0W22R09 R& Y&"<<@5<O?$&BZ=>1V=]K&GVMU)C9#/<HCMGIA2<FJ::=
MF2G?5&E13'FCCA:9Y$6)5W,[, H7KDGTJC<>(-%M&MEN=7L(3=+NMQ)<HOFK
MURN3\P^E(9HT5%;75O>VT=S:SQ3V\JAHY8G#*X]01P13;>]M+N2>.VNH9I+=
M_+F6.0,8VQG:P'0X/0T 3T444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %-D8I&[ 9(!./6G44GL!YC\.O#
M&A^(_"R^(M;TNSU/5-4FEFN)KV%9BIWLH1=P.T  # JWXQL+6\\1^#O"4L2I
MH<[322VR?*DGDH#'&<?PY.<>U3S> =7L+RX?PKXPNM$M+F9IYK-K..ZC#MR3
M'OY3)R<<\FMG6/",.N:+8V=WJ%V+ZQ99+?4HR%G251C?TQSW&,&JNM';MI\A
M]7KO?7^ON.4^(?AO1/#'AQ/$6AZ99Z7J>G7,+PR6<(A,@,BJT;;0-P8,1@YJ
M;QUI%OKWQ"\%V-Z&:UD2\::(,0)%"(=C8ZJ2!D=ZO6W@+5;R^MIO%7BVYUVW
MM)EG@M!:1VT>]?NEPGW\=1GBM_4?#W]H>*M%UO[5Y?\ 9B3KY/EY\SS% ^]G
MC&/0Y]J%TOWO^'^8GUMVM^*_0X[QEX:T3P_J/A75-%TJRTZ[76H+<R6D"Q;X
MY-P96V@9R/6D\;Z!HUS\3/!K3Z182F]FN1=&2V1O/VP_+OR/FQCC.<5V7B3P
M]_PD*:6OVK[/]AU"&]_U>_?Y9/R]1C.>O/TIFL>&O[6\2Z!K'VORO[)>9_*\
MO=YOF)MQG(VXZ]#1'I?N_NM_F/37T_$X/QXEQ_PF6@>'=-\*PZSIMO9272Z2
M+B.UA9@P4$[AM(4'[N/XL]J30M(\1Q^.])U"U^'UOX6LD$D5^UIJ%NZ3QE3M
M#1H!R& ((!/-=WXF\*0>(C:7,=Y<:?J=DQ:TOK;&^/(PP(/#*>X-5- \.>)K
M'4%NM<\:7&KQH#LMTL(K9#D8^;;DM[<BB#MOYBEKL<YI?AS3M>^*7C!]6MX[
MVVMI+4QVLZAXM[0C+E3P3@8&>F35?XBK<KXB\,>'--\.1:MIPBFN#I"W"6L4
MIC"A02?E(7).W'\J[O2O#W]F>(]=U?[5YO\ :KPMY7E[?*\M-O7/S9Z]!3/$
M_A6V\2Q6KM<W%E?V4GFVE[;$"2%NAQG@@C@@\&ETCY6_4;U<O/\ X!Y]IFC^
M(QXTT74++X<6WAB&&5DO9K34;=EE@8$%6C0+G!P0<$\5J7'AW3M?^-.H_P!J
M6ZW5M;Z3;N+:7YHG<NX#,O1L#.,^M;NA^&O%%GJ4=SK?CBXU6&,Y6VCT^&V5
MN"/G*Y+=CU'2M2W\/^1XROO$'VK=]JLXK7R/+QMV,QW;L\YW=,=JI=/G^)#6
M_P CDVT/3/#GQ=T(Z+8V^GI?V%TES%:QB-)-FPJ2HXR"3SBH_#^B:9XM\8^*
MM3U^QAU"6SOOL%M#>1B2.")44_*AR 6))S77WWA_[;XMTG7?M6S^SX9XO(\O
M/F>9MYW9XQM]#G-9.M>"+R;6;C6?#?B*YT'4+H*MT5@2XAFVC 8QOQNQQD&I
M3M:_G^?]?>4^OR_!:F7\28AX<\ )IWA_3HX8KR^BMC;6I6!661_F4-T3=]W/
M;=7):IH'B.XTQ8='^$-EHNH0LKVVH6NJVHEA92#DD %O0@GG->H'PK_:/A.7
M0_$>HRZNTW,MTT:PMNSD%0O"X(R/3WK'M_!GBV&=(I/B+?R::F (?[/@$Q4=
MC-C)^N*:T?S_ ,OF#>BT_K\A/&/AF^U74-(U@:18ZVME Z3Z3>N%5RVT[T+
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M*=5Z%XWX+ 9 -"TM\_Q?]?>#UO\ +\#.^(OAK0K+X7:U%;:-80QP0O/"B6Z
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M:%J=CJ^HZKIMMJ,\FK7:)]LB$RQ()3\J*V0O.2<=<UW%CX?^Q>+=7UW[5O\
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MJ<^]0U>#7=?B5>TT^S_ S/"NFZ;H7PWM=8TS2;*#4#HR2O-#;HDDK"(-\S
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M^SS-F/,<)G.#TSG'>@#:HHHH ***C,\*W"VYE03.I=8RPW,HP"0.N!D<^XH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK]W^8.SO;M^C*7C;QA-8:[:>'+'6M,T6>>W:YGU'42NV&/.U0BL0&<G/!.,
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M-LVJ3:1;M9W5L&"R3PLJ@LA.!N!4'!ZT=-=K_H_^ AMN^G;]5_7R*T]YXO\
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M37>JW%N"(T0!3((A\NYF/ Z"N<\1VGBK2]6\(6FN:O;ZU:R:W"R7BVHMI8W
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M0;KQ!9:=#:20HUMJ5O=N920"D;[B!@'G'3^==%111TL 4444 %%%% !1110
M45%-=6]L8A//%$97$<8=PN]CT49ZGVJ6@#G4T"Z7XBR^(3)#]D?2ULPF3YF\
M2%\XQC&#Z_A7145$+JW-T;43Q?:0GF&'>-X7.-V.N,]Z.E@ZW_KL2T45%'=6
M\T\T,4\3RPD"5%<%D)&1N';(]: ):YZUT&Z@\?:CKS20FUN;&&V1 3O#(S$D
MC&,?,.]=#11UN'D%%%% !115/5=5LM$TNXU+49O)M+==TLFTMM&<=%!)_ 4
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M,$<]* -.BFHZR(KHP9&&593D$>HIU !1110 445#;W5O>1F2VGBG0,R%HG#
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M/:BW$XA=MC8R 5)YP0<^O2O-K/4-.\1>'(=7U[XH:K#J4J%CIFDWJ6S(Y/\
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M/:22K*-C9VLKKPPXK/\ #:C_ (6IXU; W>78C..<>6U/T_\ Y+)KG_8(M?\
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MEK/=VXEF,\:(3YH(B()W'<0!G& #UKTI3E02,$CIZ5P_Q6_Y%6S_ .PK9_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM[2W7[L5O$(T'T &*LT4=+ <%X&\,6=UX)M[7Q!H4$TD=W<NL6H6@8KF9R"
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MY!J>B@!&574JRAE(P01D$5GV&@:-I4\L^G:386<TO,DEO;)&S_4J 3U-:-%
M$$UG:W%Q!/-;0RS6Y+0R/&&:,D8)4GD$CCBIZ** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN@>&/%SZV=*5K\2W*0:87\F,F(AL!P",D ]^]2W:#EY7_"XTKS4?.QT3>/\
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M$&PA2KL,;P<_>(SFICVZZ_/K^7Y%2[]#9\1?$#PKX4G6WUK68;:=@"(0K2.
M>A*H"0/<UJ0:_I-QH2ZW'?P?V8T?FBZ=MJ;?4DXQ7)?#"""2+Q#J,J*=5FUB
MYCNI&Y<!6PB9] N,"E^(Z0--X4LKI572I]9C2Y0\(_RL45ATP7 X-"Z+O;\0
M?7RO^!HZ1\3/!NO:G_9NG:];RW9;:L;*\>\^BE@ W3L36[J6M:=I#VJ:A=I;
MFZ=DB+YVDJI<Y/0?*I.3@<5S7Q2M;%OAOJTEPB(UK!YEJX !CE!&S;Z'=@<5
MC^.(X+]?A\FM(A274X3.DG0OY3'!_P"!8XIK73S2^\3=M?)O[CHM(^)/@_7M
M5.F:;KMO->;MJQE63>?1"P ;I_"36QK?B#2?#=@;[6+^&SMP<!I6Y8XSA0.6
M/L 37*_%N"T7X?75PR(MW:R1/8N%&])@Z[=GOVX[5A>*3XENOBUI46D+HS7$
M.D&6W76!)Y>\OB1D"<[P OX9I;[?UI<K;5_UJE^IWOASQCX?\6PR2Z%JD5X(
MO]8H#(Z^Y5@& ]\5N5YQIGAOQS<>/=-\0:\WAJ*.UAEAE.EF<23(PX#;QA@&
M (Y&.:]'IO9$]1LDBQ1/(YPB*68^@%<C>?%/P38?8_M/B"W0WD:RP@([':V"
M"P"_)G/\6*Z?4?\ D&7?_7%__037'_"S2K&W^%6D0I;1[+JU\R<%0?,9LYW>
MO7'TJ>C?;_@_Y#[>?_ +^L?$GP=H/V?^T=>MD-PBR1B,-*2C#(;" X!]36R^
MO:6N@OK@O8WTQ(3.;F/+KL R2-N2?PKCO@YI5E9_#FV:&VC5KF6=ICM&7Q(R
MC/J, "L;2XDA^"'BVWA0+%%)J:1HO15#O@#VIS]U/R5_R_S&E>27G;\_\CU:
M"YBN;2.ZB?=#(@D1L$94C(..O2J%KXCTB\T :[%?1C2RA?[3+F-0H)!)W $<
M@]:BT:>)/!EA.SJ(ET^-R^> /+!S7%^#M!C\4_ [3=,:X:#S4+QRJH;8RS%E
M)4\$9 R.]5)6E)+I_FU^A$'>,6^O^2?YG0Z/\3?!NOZH--TW789KQCM6,QNF
M\^BEE ;\":R-2^,/A?2/%\^D7VIPQVUO!^\F2*24^?OP8_D!Z <\=3UJXFNZ
MUH=_IUGXKTJQEMYYUM[;5-/8[%D;A \3_,F>F5+#/I2VI_XO5J0_Z@<'_HYZ
M26J^?X(;=D[^7YG9PRI/!'-$VZ.10RG&,@C(I]%%(9Y=HGC#0/"5]XNEUW4X
MK,2Z[+Y:L&9W_=Q@D*H+$<]<5W^A^(-)\2Z>+_1K^&\MB<%XSRIQG# \J>>A
M -<?\/K:Q_X2SQQ=*D9O_P"UBCM@;A'L4J/89+5)I\<=G\8]<BT^-4CFTB&>
MZ2, *9][!2?]HK^=">BOV_)!+=M=_P!;&MKGQ&\(^'-173]5URW@NR<&(*TA
M3I][:#MZC[V*Z*UN[>^M(KJTGCGMY5#QRQL&5@>A!'6O&?A\GQ#G\,-<Z.O@
M]X[FXF:Y:^%P;AI=[;A+MXR.GTQ7??#SP[J_AG0;FSUA[ RR7LMQ''8%S#$C
MX.Q0P! #;N/>FEIJ#WT.NK/U+7=+T>6WCU&]CMC<!S&9<A2$7<V6Z# &>2*T
M*X'QW8VVH^-/ UO=Q++#]NF<HXR"5B+#(^H%+=I=_P#@AT;-72/B1X/UZ[GM
MM.UZVDF@5F=7#1_*N<D%P P !.1D8HTCXD>$-=U<Z5INNV\][DA8]K*'(_NL
MP ;\":Q?B;I%AJ>I>#4N[:.4'6HXSN4<IL9BOT)49'M5CXEVT L?#DPB598-
M<LQ$X&"@+X('H,4XZV];?EK^(GU7E?\ /_(ZC7/$.D>&K#[;K.H06=OG :5N
M6.,X4#EC@= ":I^&_&WAOQ=YHT/58KMXN7CVLCJ/7:P!Q[XQ69XF\17R^);3
MPYH>CVFH:L;<WOFWLFR&V3.T-D DG/&!S7-:6/$R_&32CXF&A"[?2[@*=)\W
M+)N3_6>9SUZ?C2CJ]>M_U_R'+1?U_74[;Q'XZ\,^$GC37-6AM99!E8MK2.1Z
M[4!(''7&*Y[1]5L-;^+KZAIEW%=6DN@+LEB;*G$YR/J/2IO \44WC#QK>7*(
M=234A!N/+) (U\L#T!Y-5]-M+&T^.^JFSCCCDFT6.2X"#&7\W&3[D 4X[J_5
M-_@$]FEW7YHZ#Q%X_P#"OA2X6WUK68;:=L$0A6D< ]"50$@>YK:T_4;+5K&*
M^T^ZBN;64926)@RM^->0^$?^$^GO/$5WH8\*L[ZM<)<-J7GFY!5L!6*<;0H&
MT>E=K\/_  YKN@#67ULZ4K7]W]I2#3"_DQDJ V X!&2 >_>E'5:]K_E_F*6C
MLN]CLZY_Q;)%%::<9=:GTH'4;=5DA0L9B6XB..@;H3T]:Z"N)^)G_(+T/_L.
MV7_HRFOB7JOS'T?H_P F;^J>*-$T6Y:WU/4H;218#<'SB5'EA@N=W3J0,9SS
MTJEX=\?^%O%EP]OHNL0W,Z DQ%'C<@=2%< D>XK#U73K6_\ C;HS74"2_9M'
MFFC#KD*_F*H/UPQJ?QA!$GCOP1=JBK<&]FA,@'S%#"Q*D^F0.*(ZVOU_X/\
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MT%U?ZWXAUHV\BRPQ:KJ!FCC<=&"@ $CWS7:T47UN'2P4C*'4JP!4C!![TM%
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M'%=912 XZP^&^D65W8WTU[JNH:A9SB:.]O[HS3'AAL)(P$^;HH&<#/2K6N>
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M6NQZ8S%CI":@RV9SR1L'.">V<5T6E>%M+TCP])H4,'F:=(TI:&4 KMD8L5P
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MES& G3:N.#^/TQDYVJ**/(?F%8$?@_2XO&LOBM1+_:$EOY!7</+'3YP,9W8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'37$4\\T@W?ZS!*J !P.N:I66E:CHOQ=T.RN]6N-3M%TRY-M/>8:=>4#*[@
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MGR:A]E>ZNY#*\B&)\M)T#D?>&>,@4+5+S8/1OR7Z'HE%>3^)=)\1>"I],O\
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MR_4;V7S_ $.CHKE/'VMZAI&CV=MI$B1:GJE[%8VTTB[A$7SE\=\ '\<4S1/
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MK< Y&#ZXKJ:I:M;7MYI=Q;Z=J']GWCKB*Z\E9?*/KL;@_C3O;;S_ !#??R_
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MH+;20(S;MD@<'=@DX*]A6WKFEZQJUYX/NVLXQ+9WPN+Y8Y05A'E.IP3@L-Q
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M1110 4444 %%%% !1110 4444 %%%0W1N5M)C9I$]R$/E+,Y5"V. Q ) SZ
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ML[^RN&M;RVW;A'*N,[6[J000?>MZ@"*XN(K2VEN9VV11(7=L$X4#).!7"?\
M"[?AY_T,/_DE<?\ QNNN\1?\BSJO_7G+_P"@&O-_!_Q>\"Z5X,T73[W7/*NK
M:RBBE3[).VU@H!&0A!Y]*2W?R_4;V3/4[&]M]1L+>^M)/,MKB-98GP1N5AD'
M!Y'![U/6)K%]K4FDV\_A>TLKN:YP5DO9FBCC0KD.0 6;MP,'FL30?$?B:#Q1
M'X=\666EK<W-L]S;76F2.8F"$!E*O\P(W YZ55M;$WTN=3:ZOI]]J-[I]M<I
M)=V)07,0!S&6&5S]1Z5=KEM$U=[KQ?XKLC:6D0L7MPLL4>V27=%N_>'/S8Z#
MI@5A>&O%OC+QCI6G7^E:;I%M:[@MY<7K2CS"&(<0HN3QZL<9R/>DM;?+\1O2
M_P#7F>C45P>H>+?$LOC35?#.A:78SS6]O#-'<W<C)%$&!SYFW)8YQ@*!QGFK
M'AWQ+XB'B=O#?BNQT^*^>U-W;W.FR.894#;6&'^8$9%"U_K^NP/3^OZ[G:45
MQ6I^(_$NIZS?:7X.LM+<Z>RQW5[JDCB(2$;O+54&XD C)SCFK?AWQ5=WAU73
M]:L4MM9TE5:YCMG+QRHREE>,GG!P>#R"*+Z7^?R"VMCJJ*\XTKQ%\0]?L[?7
M-*T_PPVD7*^9%:R74WVG;Z%P-@;U&..E:OB7Q'KT.OVGAWP[:Z9_:=Q:M=&;
M4Y76%55@"JA!N=NO3&.#3::T [*BL/PW+XG>":/Q/:Z7'.A'ERZ=*[1R YS\
MKC*XX[G-;E# *YKQ#\0?"GA6<6^LZU!;SG'[E5:1QGH2J D#CJ16IK^H'2?#
MNI:BHRUK:R3 >ZJ3_2N=^&>B6^G^#['4G02:GJ<2WEY=. 9)7D&[EO09P![4
MEK?R&]$C<T'Q1H?B>V-QHNIV]ZB@%A&WS)GIN4X*_B*UZ\\\=6UOH/B7PWXH
MLHUAO)=1CT^Z,?R^?#+D8;'WL$ C-:/B?Q7JVD>+=)T/2],BOI-1MIG0.Y0(
MZ%<%F[( 6SP3G&*>ZT]/U_(3TW_KI^9V54AJ^GG6FT87*?VBL N3!@Y\LG;N
M].O%<=;>)_%NA:SI]GXRL-(-IJ,_V>"]TJ23;%*1\J.LG/.#R*UTU5S\3Y=(
M^R6FQ=(6X^T"/]\292NW=G[O?&.M"6WS_! ]+_UUL=/17G<7BWQCK>K:[I7A
M_2]*$FFWK0?;+^218=F 57:F69_O9/ '%;'A'Q+JVI:EJ>B>(+&VM=7TX1L[
M6DA:&9'!VNF[D=#P:2U_,'H;^FZOI^L+<-I]RDXMIWMIMH/R2+]Y3GTJ[7'>
M&_$L)T;Q'J5]!:6=OIVI7:2-;1;=R1GEV&3ESW/>LVWUWXD:I;1:QIVAZ#%I
MDJ>;%975Q+]KD0\@[@-BDC!P>E'_  /Q0=?F_P #T.BN*OO'F_X877BW3;8"
M6&(DVUR"=DBOM=&P1T.>]4+OQ!\1?L!UVTT/0TTI(?/^PW%Q)]L=,9Z@;%;&
M..<>IH>E[] 6IZ)15#1=5AUS0['5;=2L5W DRJW4!AG!J_3::=F).ZN@HJKJ
M4M[!IT\FG6L=U>*O[J&27RU8^[8.!^%<.WB7QOX?U&P?Q1I^A/I=_>):*^FR
MR^;;LYPI?>,,,X'&*2U=AO:YZ%17&>(O$?B#_A)E\-^&+;2OM_V07;SZI*ZQ
M["Q7"J@W,>#D]LBMKPY+XCDM)%\2VNG0W2-A7T^5VCD&.N&&5^AS0M5<'IH;
M-%%8?C#5-0T3PGJ.J:9%#+=6D7G".92RLJG+< @YVY[TF[;C2N[(W**X_P 6
M^+;O3O#&GW>@0V]UJ6J/&EE%."4;<N\D[2#PH/?KBDU?QG)#\/+3Q#ID<,MW
M?+ EK%*#L,LK*N" 0>"3W[55G^-B4T[>>IV-%<AK?B/7&UC_ (1[PS9V-SJT
M=NMQ=7%[(R6]N&.%R%RS%B#@#H!UI?#OB36&UV3PYXHL[.#5A;_:HIK!V:"X
MCW;3MW?,I!QD'US26HSKJ*** "LNTUZUO/$.HZ)'',+FPCBDE9@-A$F=NTYS
MGY3G(%<K+XG\7^(-4OH?!]AHXL-/N#;2W>JR28GD7[XC6,9 !XR:J>"=1NKW
MXC^+Y=2LOL%W#;6<<\6\.H*B3YE;NI&""0#STHCKKY-_D#V?R_,])HKSZ'Q)
MXX\1QC5/"^F:(FBEV\DZE-*)KM <;D"#" X.-V>QK;T[QK8W?@J?Q)=126D=
MJL@NX&^9HI(R0Z<=>1@>N11TN'6QTU%>>2^(?B'#9G7I-!T4:.D7GO8"YD-Z
M(\9/S8\O=CG'X9J]XE\=MI>@^']8TJT^W0:M=PQ+%C#NLB,5"\@!LA>N1UIV
M?Z M3M:*\UU?QAXW\)-%J/B'1=)N-(GF6$1:5-(UQ"S?=#%P%;)P.,5)J7BG
MQUX<\O5]<TG1!H32QQRPVD\KW5N'8*&9B C8)Z =Z$K@]#T:BCJ**0!17)^,
M/%EWX;U+0[:UL!>G4998?)7AV<)E #G &[&2<X&:2/7->T#0-5UGQDFE1PVX
M\R"+3&D9MO\ =8OC+$D 8 %'2X=;'6T5YU=>(_B%I=G)KVHZ'H@T:*/SIK*"
MYD-Y%'C+'<1Y;$#)P,>F:Z^\U*]G\/QW_A^UAOIYT1X$GF\I"K8.XG!Z YQB
MBV@&M17!67B/QEH_B'2]/\6V6BO;ZI*T$%QI4DO[J0*6 =9.N0#R*DUCQ'XI
MO/%%YH'A2VT9)K&*.6>;5I9 '#@X")&,D#'+9QVH_K[@.YHKFO\ A(-1T+PA
M>:OXMMK2WGLP2ZV,K2)*.,;=P!!8G !]N:P3K7Q-CMSJ[Z#H)T\1^:=.6YE^
MV!<9QOQY9;VQ[4/0.AZ'17&:_P".TL_AJ/&&E1+-$RPR)'*ISM:158$ CY@"
M1UZBLW4_$7Q%L+"77_[#T-=(AB,\EB]S(;P1@9/S >6&QSCGH1S0]+WZ M4K
M=3T6BLO^U)[WPU'JFCVJ74UQ;I-;PRR^6&W $9;!QP?2N1;Q+XW\/ZC8/XHT
M_0GTN_O$M%?399?-MV<X4OO&&&<#C%.SYN7J*^ET==<:]:VWB2RT)XYC=7D$
MD\;@#8%0J""<YS\PQQ6I7F_C*^O['XH^&CIEBM[?36%W%#&\FQ 24)9VP<*
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M#+GO@@TVFK^1-]GW-FBBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M453=R4C-\1?\BSJO_7G+_P"@&L[X?_\ )._#O_8.@_\ 0!71T4EI?SM^%_\
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MK5MD[F-X5 '@S1@/^?"'_P!%BL+X2_\ )-]-_P"ND_\ Z.>NVHJI2O*4N_\
MFW^I$5:"CV_RL%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPEX8O3>Z1HD%O='I*SO(R_[I<G;^&*VKG2+&[U6RU.>#?>60=;>3>PV!P W
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MAB[\.RZQ+?>($UF[O[E9II%ME@V.%"\JK$9( ]*L^(O /A;Q9,L^M:/#<SJ
M!*&:-\#H"R$$CGH36CH7A[2?#6GBQT:PBL[;.XI&#\QP!DD\DX Y)S2CHOE;
M\O\ ():OYW_K[SF_BRC-X!N'*LUO'<V\ETJC.85E4O\ ACFM'Q?J.DCX>:K=
MW%Q ^G2V,@1@P*R H=H7U)XQ71RQ1S1/%*BR1N"K(PR&!Z@CO7*6/PP\%:;J
M4FH6GA^VCN7!&[<[*N>#M4G:OU4"I:O%Q[_Y6*3M)2[?YW.>A\27V@?#'P3;
MZ8MJM[JD=M9Q379/E0DQYW,!R>G ]:Q?&=EXCTW4/#BZ]XW@U 7&M6K1Z9'I
ML<.") =RN"6VKTYZYYKU&X\*Z'=^'(O#]SIT4VEQ1K%';R$MM51A<,3G('?.
M?>LW3/AOX0T:V,%AHD,*F:.8MYCL^]&#+\Y8M@$ XSCVK9R3J.?G?\2$K1MY
M?YE'7Y$B^+7A#S'5=]K>HNXXRV$X'O4GBKQ!K2^*],\,:%-8V=S>027#WEXA
MD"JI VH@(W-DYY/2MSQ#X6T3Q79+9ZYI\=Y"C;D#$JRGU#*01^!JE??#_P *
MZGH5GHMYHT,MA9KMMT+N&B'LX.[G'///>L^B7]:CZW.%@MM8L/C'X:L]:\71
MZ]<K;W3B-;&.W:W!0==A.=V._P#=KU^L#2?!7AS0A9C3-*AM3:,S0LA;(++M
M8L<Y8D<?-FM^G?1+U_,5M6_0X;X<R(;KQ?%N'F+K]P67/(!"X./>F^%8(_\
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MK<7LA@,0RLFU$$I7'7.&Z=:[:^^%G@G4H;6.ZT"!Q:H(XBLCJVT= S*P+?\
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M;_:UY#:X\W;Y7F*6W=#NQCIQ714VK"3N%%%%(84444 %%%% !116+XI\0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M57XH:7?ZEHVG&WL)]2L;>^2;4-/@?#W,(!RH'&[!P=O?%*3O;SM^*01Z_/\
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MGTKD[KQKJ?AV-M:F^(OAS7XD93-I%ND,;!"0&\EU<LS#J V<XKH_$%O/\2/
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MW$EHRI%$A=V/H .2:CHWUO\ HB]&TO7\SF=6D^(=OH,OBQ=>L+=(+8W;:(+
M,FP#<4:8G>6QW  R.U=M]NO-3\*Q7^FO;VUU<VJ31-=*6CC+ 'Y@",X!]:I^
M);:>?X=:I:PP227#Z7)&L2(2[,8R H Y)SVKE/%>C:G=_#SPO$NF7-];69MI
M-3TR,E)9XECY3;QD@X.WOBJE;5>:_4B-WROK9_H43XIUGP]KVGK<>/M%\1I=
MW\=I<:=%!#%+;[VVY38Y8[21G=VKL;;6-0L_B/=Z)J%QYEE?6BW6FY55V%/E
MECR!ENJMSZFO/[[38=:&C7'AWX;S:+#9ZI:R7%Q=:<EO<%1( 0BKEBHSEF)
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MN-4M%TBW%U!:8,ZC?(59%)&[&"",YY&*MV$VK>-O&VDZQ+H6H:/H^D+*\?\
M:*"*>>9UV8\O)PH&>>^:4>GX_C_P+ ^M_E^'],GN[_Q1XLU[5=.\.:O!HEAI
M<JV\MX]F+F6:;:&955B%"@$#/7-6?#NLZ[9^)Y_"GB.XMKRZ%H+NSU"&'RA/
M&#M8.F<!@>>#C![5G&;5/ 'B+6[@:!J.KZ-JMP+Q'TN(2S0RE0KJT>02#@$$
M?C5OP[!JWB'QJ_BS4-,N=*LH++['8VEW@3/N8,\CJ,[.@&"<\41Z>FOK;_/\
M!RZ_A^'Z7.=\.Z/XPN_'OB=D\:+ +:\MQ<HFEQLMPOEJP4;F)C 4[>"?6M'Q
M'XRN;WQ/J&A6'B[1_"\6GA%FN[T1O-+(PW8C21@NT# ).>34L=_J/A+X@ZZT
M_AS5]0LM:G@DM[K3H!*L95 C"3D; #SD]JH:WH,/A_QAJVL:AX*7Q-I6IE)@
M]O91W-S:R@!2NQN2IX/'3FI6T>UOQ_KY ]Y=[_A_7S-OP+XMN-4U74= O=7T
M[69[&*.:/4]/*[)T;(^95)"N".0#CD5C^'+CQ_XTT,W4'B2UT:**YFA29=/2
MXEN-KL,D$A5 X' S\N<\UT?@DZ9<&ZNM-\#R^'$*A1)<6,5K)-R<C8GS8&._
MJ,4OPTL[JP\%Q07EM-;S"ZN6,<T91L&9R#@\X((-7;5W[+\_\A=/G^A#X8U;
MQ#K>BZUIUW=6EOKFFW;69O$MR\38"L'\O<.2K=,XS^58'PBTSQ*VAV&IW/BH
MSZ6[W!;3381@EC(X+>;G=][+?CBNE\'V5U;:WXO>XMIH4N-4\R%I$*B1?*0;
ME)ZC((R/2LCX=WVHZ'##X/U+PYJ\4UO+.1J"P!K-D+LX/F9ZG.,8S2CO?JTO
M^".2TMV;-SP1J]_K%OKC7T_FM;:O<VT)V*NV-" J\ 9QZGFN.\1ZYXF\/K=:
MC<?$?PXMY;1-,-#^RQ*LN ?E#,_FY../<5>LM&UV3P)XVLK*&XM=1NM3O7M=
MX,1=6(P5)[,,@'I[US3Z78:CX4N]$T;X4W-IJJVC1M>:E81JD;;2"R3'+R-D
M<;1R2.G6I;=KKHE^2_IE*U[/:[_,['QO>C4_"?A>_";!<ZMI\VWTW.#C]:N:
MM_R5_P ._P#8,O/_ $*.J.NZ;?3> _"%O%97+SP7FG--$L3%HPI7<6&,@#OG
MI6KJ=G=2?%30;Q+:9K6+3[I))@A*(Q:/ += 3@X'M6K24K+^9_D9)MTTWO9?
MFA_@O6;^[?6-'UFX$VIZ5>-&TFU5,L+?-$^U0 ,J<=/X32^#-7U#Q!-K6J3S
M$Z8UZUOIT6Q0!''\K/D#)W,&ZD].*YWXD/?>'=5@UK2$)N=7@.C.JG!\ULF!
M^O\ "2W3L:[O0-(AT#0+#2K<?N[6%8P?4@<G\3D_C4+57^7SZ_A;[V7+>WS^
M7_#W^XR/&?B#4-(CTW3]&AAEU;5;G[/;&?/EQ@ LSMCD@ =*3P_HWB[3]2:;
M6O%L6KVCH?W TU+<QMVVLI.1UZ^@J#QSI.I3SZ+KVCVJWE]HURTWV4N$,T;J
M5=5)X#8P1GTJ?P_XRFU_43:'PMX@TU44F2?4;40Q@]@IW'=GGI_6E'\=?N_K
M\0E^'Z_U8XGPG:>+-5E\46NBZQ;:)9Q:[=$W1M!<RRN6!("L0JJ!CGDG/;%=
M?X*UC69]1UKP_K\\-U?Z3)$/MD,7EB>.1=RL5Z!N#D#BCX?65U96_B 75M-
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M)Y=W;0[XWVAL'<.Q!%<Y>VWQ'?2VU^+Q)I]JZ6YG&C#3P\1 &[8TQ._..,@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%-DD6*)Y'.$12S'T JMIFIV>LZ9;ZC83>=:7*"2*3:5
MW*>^" 1^(H MT444 %%%% !1110 4444 %%%% !1110 4444 %%(S!5+,0%
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M>&O$^J^(K+5_&-YI3)IK,]G9Z8DGE^81CS'+\D@$@#IWKN:**.E@ZW"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ[F&!@=:[_P[HT7A_P .Z?I,/*6D"Q[L8W$#EOQ.3^-<O\1_^0CX+_[#\/\
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M5OJP&3T'>M!E5U*LH92,$$9!%+10!G6&@:-I4\L^G:386<TO,DEO;)&S_4J
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M6CZK-%-J.E6-Y+#S&]Q;I(R?0L#C\*M16=M!/+/#;PQS2A1)(B ,X487)'7
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M2],LK%'.66UMUB!/OM ]!4\-G:VTT\T%M#%+<,'F>- ID8#&6(ZG  R:GHH
M@%G:K>M>BVA%VT8B:<1C>4!R%+=<9).*K:EH6D:R$&J:58WP3[HNK=)=OTW
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MX>T6TCNH[;1]/A2[!%RL=LBB8'.=X ^;J>OK5^**."%(88TCBC4*B(H"J!P
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MMO/_ (-_S^XE/2_D_P /Z7WGHBLKHKHP96&00<@BJFHZMINCP"?4]0M+*$G
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M=@6JN>^ A@"""#R".]+7&?#+3];TOPQ+9:W8/8>7=R?9+5[E9S%;G!1-ZDY
MR0,]A79T-68D02WEK!<1V\MS#'-(K.D;R ,RKC<0.I R,^F:K6&O:/JL\L&G
M:M87DT7^LCM[E)&3ZA2<=#7$>/-'MM=^(O@RPO S6CK>--$&($JA$.UL=5)
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M)#INKV%Y+%_K$MKE)&3ZA2<=*YWQ/K&E6_A/3;76=-GUB34Q%'%80QAWN)
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M#'))-3>.?^1!\0_]@Z?_ -%FN>\*_#_PI=^!],-YHUC?375E&\UW/$LDSLR
MD^8<L/;!X[4EL_E^HWT^?Z'H%9T&OZ-<ZD^FP:M82WZ??MH[E&E7ZJ#D=1VK
MRB?6=3L_@9<Q6L\L\L5^VEQ2^9M=H?M'ECYST)7Y=W:JFI>'=>N-$-GI?P=L
MM*O8P#;:A;ZO;":%QRK[@ S<^IYHTOY?YI/]1?GK^#M^A[G6-=37J^+M/BCU
M2RBLFMIC+8OCSYF!7:Z=]J\Y^HZYXT;$W!T^V-VNVY,2^:,@X? W=..N:Y+5
M?^2P>'/^P9>?^A1T[>];U_)BO[M_ZZ'4SZMIUK]I^T:A:Q?95#7'F3*OE \@
MMD_*#@]?2ET_5=.U>W^T:;?VM[#G'F6TRR+GTRI(KSZ+PWIFO_&'Q&^JVL=Y
M#;6=H4MYQOB+,&^8H>"0 0,],FK-KHNG>'?C#:1:/9P6$%]I$K7$%L@CC=DD
M3:VT< _,>E$=;7Z_\'_(;TOY?\#_ #.VU+6=+T:)9=4U*SL8W.U7NIUB#'T!
M8BE_M;3?L<5Y_:%I]EF95BG\Y=CECA0K9P22>,=:\_\ "6@Z5XLUOQ/K6OZ?
M;ZC=QZI+8Q1WD0E6"&+ 555L@9R23[U>\?:=9:3X1TNST^UAM;6/6+,K%"@1
M%S."< <#DFA=+];?C;_,'UMTO^%_\CN;FYM[*VDN;J>*"WB4M)+*X54 ZDD\
M 4U[VUB$!DN84%PP2'=(!YK$9 7U. 3QZ5SGQ*8+\-?$18@#[#(/S%<[X\MF
MO?#_ ()M5GD@\[5+6,R1-AE!B8'!['&>:2U^]+[P_P F_N.^BUO2IY[J"'4[
M*2:T&ZYC2X4M"/5P#E1]:237-(AFM(9=4LDEO #:HUP@:<'IL&?FZCI61=>'
M-%\/^%M772-*L[+=92*[00JK. AQN8#+?CFL?X;^$]&C\(Z%J]Q8V]WJDEK%
M-]MN(U>5#L&T(Q&5"C  &.E-:_*WZ_Y"=[??^AV.I:SI>C1)+JFI6=C&YVJU
MU.L08^@+$5:BFBGB26&1)(W&5=&!##U!'6O$+5]6UOQ1XDU&3X<VOBDQZC):
M1SWE_ @@CCP%C6.0''][(Z[JZ7P7:^(?#VE>*I[OP_\ V+9;3=:=IZW<=PL3
M;#O"E3P"P!Q@#GBIO:+D^URFO>Y5WL=[/KVC6NHIIUQJUA#?2?<MI+E%D;Z*
M3DUS_P /KVZO;?Q ;JYFG,6MW449ED+;$##"C/0#L*R? W@?PSJ7@;3K[4M'
ML=1OM1MQ<W5W<PK)*\D@W,=Y&1U[$8Q4WPDMEL]$UNU25Y4AUNZC61W+LP!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8OA?P__
M ,(WIMQ:?:OM'G7D]UO\O9CS'+;<9/3.,]Z3PYX>_L!]7;[5Y_\ :&H27O\
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MG'7UJC9^"K:+2O$6FWEPUS;:W=SW$@5/+,:R  J#DYQCKQ]*ZBBAZWOU_K]
M6FW];_YL\^@^'6M263:3JGC>_OM"\KR4LEM8X7*8P%>9?F88Z],ULS>";:[^
M'UOX2NKN5HX;:*$7,0V.&CP5<#G'*@XYKJ**;;:!:&'X9TK6])M)8M;\1-K<
MK,#%(UFEOY:@=,+G=]33O%/A_P#X272$L/M7V;;<PW&_R]^?+</C&1UQC/:M
MJBB^MQ6TL8OBWP__ ,)3X8O-&^U?9OM(4>=Y>_;A@W3(ST]:E\1:+_;_ (8U
M#1OM'D?;+=H/.V;MF1C.,C/TS6K12Z6*N<OXA\&_VWIFEQV^J3Z?J6ED/:7T
M*!BCA-IRAX8$=1^M9:_#W4;RZTV^U_Q7=:K?Z?=I<0N;9((E"GE1&A R1QN)
M..PZUWE%.^M_F396M\CA?BS+"G@X1I(4U5[N'^RPA'F?:=XVE0?J<^V:Z;PW
MHT7A[PY8:3%R+:%49O[S=6;\3D_C5*V\"^&;3Q+-XBBTF+^UIF+M<N[.0QZE
M0Q(4_0"NAI+16[C>K]#/US3/[:T#4-+\[R?MEO)!YFW=LW*1G&1G&>F:XY/A
MWK>GVD.F:+XYU"PT=$V-:&UCF<#N(Y6^9!UQUQVKT&B@=^A@Q^#M%C\'?\(L
M;8OI9A,3*S?,V3DL3_>SSGUK @\$^++=TMHOB-?C2T 586T^!I]H' \XC)/O
MBN]HIWUN+I815VJ%R3@8R>IK&N_#_P!J\8:=K_VK;]BMIK?R/+SO\PJ<[L\8
MV],'K6U12ZW#I8Q+'P_]B\6ZOKOVK?\ VA#!%Y/EX\ORPW.[/.=WH,8I;CP_
MY_C*R\0?:MOV:SEM?(\O.[>RMNW9XQMZ8[UM44=O+_@_Y@];_P!=O\CB]6\#
M:@=8NM5\,>)KG0;J]*M=H+9+F&5@,;O+?[K8QR#VJ]>^$3K'@YM!UK5KJ]F8
MAS?JJQ2"0-N5E"C"X.,#T%=-11TL.^MSSF]^&^N:YI-WIGB'QS>:C:R1E88T
MLHX K?PM)M.9,'!QD D<UTFK>%O[4M] B^V>5_9-Y#=9\K=YOEJ5V]1MSGKS
M7144[B_K[RMJ-I]OTR[L]_E_:(7BWXSMW C.._6JWA_2O["\.Z=I/G>?]CMT
M@\W9MW[5 SC)QTZ9-:5%(#C-6\#WS:O=:MX9\27&@WEX5-VJVR7$,Q QN\M^
MC8[@UM:!I&H:;92QZOKD^LW$QR\LL*1*!C&%1!@#\ZV:*.E@>KN<#!\/=9TN
M7[)H7C6^T[0RS-]@%I%*T8))*QRL,H.>!@XK=\(>%(/"&GW=C;7#S0SW<ERO
MF9W(&Q\I))+'CKWS70T4)V!ZF/XJT+_A)O#%_HWVG[-]KCV>=LW[.0<XR,]/
M6H==\-_VW_8O^E^3_9E]%>?ZO=YFP$;>HQG/7GZ5O44+3\PW_KN8OBWP_P#\
M)3X8O-&^U?9OM(4>=Y>_;A@W3(ST]:V5&U0OH,4M% '*^*O"-UKFH66K:3KD
MVC:M9H\4=RD"S*T;D;E9&X/3CFI[CPQ<WE]X:O;S53/<Z.SO+(;<*;IFC*$X
M! 3KG@'TKHZ*%IL!B^)_#_\ PD>GVUI]J^S^3>076[R]^?+<-MQD=<8SVJMX
MF\))K\]I?VNH7&EZO9AA;7UN Q4-U5E/#J>.#71T4 <OX>\/>(]/O?M.N>,;
MC6 JE4A6RBMHQGN0N23^-=1110!PUSX#U6UU2YN?#'BVYT2VO)C/=6GV..X0
MN<;F3?\ <)Y)Z\UI>%O!L7A?4=6NX[^XNVU)HI)&N.7WJI#,6SSN)S@  =!7
M3T4+38'KN<)<^ =6L;RYE\)>+KC0K>ZE:>:T:RCNH@[=2@?&S)Y(%=)9:/=0
M:!+IUYJUQJ%Q*CJ]W.BALL,<*H  'I6O12MIRCOK<PM&\,6^F^"[;PS=NM];
M16OV65FCVB5<8/RY./SKG8? ?B;3Q'9Z5\0+ZUT>,;4M9+"&:5$_NK,W/ X&
M0<5W]%4W=W9*5E8Y_7?#+:WI>F637\BM8W=O=&:1-[2F(@X.",%L=?TJUXGT
M3_A(_#.H:-]H^S_;(3%YVS?LSWQD9_.M:BD]?Z_KL-:6.=UW1->O;*TAT/Q.
M^C20+M=A8Q7"RC '(?D'CL>_>H/#GA&[TO59-9UK7KC6M6>#[.)WA2"../=N
MPD:<#)QDY.<5U-%.^MPMI8X>]\!ZG;:A=W?A/Q5<:"+R4S7-O]DCN86D/5E5
M\;2>,X-=+H6FWFEZ?Y-_J]QJMRS%WN)D5,DXX55 "KQT]ZTZ*2T5@>KN9VNZ
M)8^(]&N-*U&,O;3C#;3AE(.0P/8@@$&N/D^'FNW\9T[6/'>H7VA$!6LA:Q12
M2*,?*\R_,P/(/ SFO0:*%H!SWBGPK%XB\*G08)UL8@T)1EBWA%C=6 "Y']W'
M6NA P ***=Q604444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !114-U
M<+:6LMPR.ZQJ6*H,D@>E $U%5--U&#5+);JWW!&)&' !!'KBHK76+>\U.XL8
MDE+P??<@;?3&<Y_3M1Y :%%8U]XFL=/U#[%,LQD^7<RJ"JY]>:U+B=;:VEG<
M$I&A<A>I &:.EPZV):*IZ9J4.JV8NH%D5"Q7#@ \?0FH]0UBWTZZMK>9)6>X
M;:A0 @<@<Y/O1Y :%%5-2U"+2[)[J=7:-2 0@!/)QW(JM=Z[:V>E0:A)',89
ML;54#<,C///M0!J45@6?B[3[Z\BM8H;D/(VT%E7'_H57+O7+>UN6MD@NKJ9
M"Z6T6\IGUH TZ*K65['?0&6-)8P#M994*L#]*H/XCM?,9+:VO+P(<,]M#O4'
MZT ;%%5(M1MY-/\ MK,T4(!),JE2,''2J'_"36V/,^QW_P!GZ_:/LY\O'KGK
MC\* -JBJSW]NNG/?(WFP*ADRG.0/2LQ?$]ML626ROX(&QB:2#"<].030!N45
M0U#5H-/MX9F2699F"1B !BQ(R,<U':ZS]JN4A_LS48=W\<T&U1]3F@#3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME7_$.D3W.A6]E81>88G7 + ?*%([XJ7L4MT-TG6[ZXDMK631KB&(J%\]MVT
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M+A92F\+D#/<U):WVJRW*)<:/Y$1^])]I5MOX#K3O<6QIT444AA1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JFF67
M]G6$=KYGF;"3NVXSDD]/QJW10 4444 %%%% &*=&O())/[/U9[:%W+^4T*R
M$]<$]!5W3].2P64^;)--*VZ260\L>WX5=HH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>annexd_007.jpg
<TEXT>
begin 644 annexd_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWC>2".Y$9\]5QN*M&[+GD<$@\]*+:??^ &W167I&O66LZ!'K,'F16S(S,LP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P/-/CT^RB+F.SMT+QB)RL0&Y!G"GCD#)P/<U#5XV\FOO'?6_FOPM_D<]X#
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M^-$=&O5/\@>S]'^H[2OW/Q2\1++A&N+&TDB!/WU7S Q'K@XS]16)#<175_\
M$R2%M\?DHH8="1;D'![\@C\*[S4=&TO6$1-4TVSODC.Y%NH%E"GU&X'!J4:?
M9!9E%G;@3H(Y1Y2_O% P%;CD8)&#425XV\FBD[2OYI_<<EINA6VL>$O#$BW\
M^GZI;:?&UK<VSJ)%!C7<-K AE.!D$$=.AK"\1:MJ5YX#\6Z;J<MO=3:9-%"+
MVW38LV2C<KD[6&<$ XKT*\T#1M1LX;.]TFPN;6  10SVR.D>!@;5(P...*E&
MDZ:--&FC3[06  46HA7RL#D#9C'Z5I*5Y.7G?\4S.*M%+M_DT<OJ*%/BOX=F
M;A'TRZC4GNVZ,X^N,G'L:39))\5-7CB;;(VA0A6]"99,&NJU#2M.U:V^S:E8
M6M[!D'RKF%9%SZX8$4^'3[*WG$\%I;Q2B)81(D85O+7HF0/NCL.E3NK/S_$I
M:?A^%CE?!=Y;:7\-+07\R0'3K8PWOF''E.F0P;/O^>1ZUS.E6=S9:7\,8+U6
M$PNY7V.,%%,,K*I'8@$#\*])GT/2+K4(]0N-*L9KV/A+F2W1I%^C$9%69K2V
MN)H)9[>*66!B\+N@8QL002I/0X)&1ZU7-[W,_P"M_P#,5M+>OXG+>)/^2@>#
M?]^[_P#1-6O'^DW.M^!M5L;-"]RT0DB0?QLC!POX[<?C6_):6TUQ#<2V\3SP
M9,4C("T>1@[3U&1P<5-4]+?UNG^A2^*_]=?\S-T36;+6]'AU"SF5HF3YP>#&
MP^\K#JI!R"#TQ6% &MOBG<SW$@\B_P!+B2S8GABCL74'U^93CN/I6S?^%O#V
MJ7/VG4-!TN[N,8\VXLXY&Q]2":N7FF6&H6?V.]L;:YM< >1-$KIQT^4C%.^M
MR4M+'*0YO/B=J]U:RA[:UTF.UN"O(\XNSA2?4+R1VW#UJQ\,P%^&FA  #_1<
M\?4UTUK96EC:K:VEK#;VZ#:L,481%'H .*6VM;>RM4MK2"*""-=J11($51Z
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M_P O\OS)M_E^?^?Y',6FIZCK]SKSS:U)HMKI=ZUL%MHX3(550=\C2JXPV[(
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M>WR_'^OQ&]/Z['I-%<3:QW.L^.O$^FW=]>#3K=+5HX8+F2$JS(2<,A#*/EZ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 444V1BL;,!D@$@>M)NRN!0U'7]&TB6./4]6L+*27_5K<W*1E_H
M&(S5]9$:,2*ZF,C(8'C'KFO-?AYX9T+Q)X67Q#K>E66IZIJ<LLUQ->0+*RG>
MRA%W9VA0 ,#TJQX*C72=:\9^'+1C_9FGRQR6L>XD0>;&6:,9Z 'G'O3=TG?=
M*_Y?YCW>FU[?C;]#OK2[MK^UCNK.XBN+>0926%PZ,/4$<&F1:C8SPSS0WEO)
M%;LR3.DJE8V7[P8@\$=P>E<O\*CGX8:!C_GW_P#9C6-X58/X.\<LI!!U/4<$
M?2BI[O-Y*XH>];S=OS_R.[DUS2(9K2&75+));P VJ-<(&G!Z;!GYNHZ5?K@?
MAOX3T:/PCH6KW%C;W>J26L4WVVXC5Y4.P;0C$94*,  8Z5WU5./*VB8MM7*<
MVK:;;1W4D^H6D26A N&>95$.1D;R3\O!!Y[5)%?V<]BM]%=P26;+O6X20&,K
MZALXQ[UYSI?AS3M>^*7C!]6MX[VVMI+4QVLZAXM[0C+E3P3@8&>F35?XBK<K
MXB\,>'--\.1:MIPBFN#I"W"6L4IC"A02?E(7).W'\JGHO/\ X/\ D6]&_+_@
M?YGI&FZSI6LQO)I>IV=]&AVLUK.LH4^A*DXJ2_U*QTJU-SJ-[;V=N#@RW$JQ
MH/Q8@5Y5IFC^(QXTT74++X<6WAB&&5DO9K34;=EE@8$%6C0+G!P0<$\5KVVD
MZ?XM^*?B(Z[:Q7T6CQ6\%G:W*AXD$B;V?8>"2>,^U.U]O/\ #_AQ7WOY?B=]
M8:E8ZI;"YT^]M[NW/26WE613^()%5XO$6B3:DVFQ:QI\E\O#6RW*&4?5<Y[^
ME<GX\L[7PSX N[;0K:#2HKVZAAE:SC6,(LCJCL , ';QFK&J?#;P>OAJXMH=
M#L+1HH&,=W'"JS1LHR'\P?-D'G.:EM).71?Y7!*[4>K_ ,['8SW5O:B,W$\4
M(D<1IYCA=SGHHSU)]*J0:[H]SJ,FG0:K8RWT?W[:.X1I5^J@Y'Y5Y?K-U=>)
M/@_X0FO9Y5N+R^L4EF1BKDE]I8$8()ZYJW\2_!?A_3/!BW>D:7:Z7?6]U;K#
M>640BF3=(J$[UP3PQZFK<6G;SM^7^8D[J_E?\_\ (]%&O:,VJ'3%U:P.H#K:
M"Y3S?^^,Y_2K<UU;VS0K//%$TS^7$'<*7;!.U<]3@$X'I7FGQ#\$^&]'^'5_
M>:=H]I:WUBB307D406<.K [C)]XGUR:N?$VT&IV'A.UDED1;C6K=)&C8JV"C
M[@",$9&1^-)*_P!]OO'YOLW]QVEKKND7M]+8VFJV,]W%_K((KA'D3ZJ#D41:
M]HT^IMIL.K6$E^GWK5+E#*OU0'/?TKSOXC^"M L-"TV?2--M])O%U*VA2ZT^
M,02A9'",-RX)X)ZT_P"(G@_P]H7@HZAI&CV5C?6-S;O!<V\*I*#YJCEP,MP3
MU)H6MO6WY?Y@_P!+_G_D>G2RQP1-+-(L<:C+.YP /<FJFFZSI6LQO)I>IV=]
M&AVLUK.LH4^A*DXKSOXFW&H7?BKPWHUOH0UVVDCFNI-->Z2W2=DVA=S-P0N2
M=O?\*I:9H_B,>--%U"R^'%MX8AAE9+V:TU&W998&!!5HT"YP<$'!/%*.HF[(
M]3GU;3K7[3]HU"UB^RJ&N/,F5?*!Y!;)^4'!Z^E+I^JZ=J]O]HTV_M;V'./,
MMIED7/IE217GT7AO3-?^,/B-]5M8[R&VL[0I;SC?$68-\Q0\$@ @9Z9-6;71
M=.\._&&TBT>S@L(+[2)6N(+9!'&[)(FUMHX!^8]*<=;7Z_\ !_R&]+^7_ _S
M.VU+6=+T:))=4U*SL8W.U6NIUB#'T!8BN9MM2FN/BW);Q7KRZ>VA),D:2EHB
MQF(W@9QG'&:R?#^AZ7XJ\7^*]2U[3[?4)K6_^PV\5W&LJPQ(BD;5.0,EB<TF
M@Z)8:#\:=0MM,C6"UDT5)1;(?DB)FY"KT4'&<#C)-$=U?JF_P"6B:7E^:.[U
M+7-)T94;5-4LK%7.%-U<)$&/MN(S4[7UHEB;TW,/V4)O,V\;-OKGIBO,]7O]
M-\0:Y?W&B_#:/Q1<P2_9;B]NS#%$63@JC2YR0<#@#O1\-[&*]\+^*-+U31+>
MWMH=4F TN5DN([?Y$;8#C:0&.1BI^RWV5QVU2\['8>%O&^B>*[."2SU"R^UR
MJS_8EN4>9%!(R5'(XP>G&:M^&9KV;3IVO]4LM1E%W,JRVF-JH'.U#C^)1P?<
M=^M<Q\)=#TBW\!Z)J<.E6,>H26Q#W26Z"5LL<Y<#)Z#O7.+J5UI7P:\1W-G*
MT,S:M=1>:O6,/<[&8>X#&K:LVEY?FE^I,7=+U_1_Y'J(\1:(=3.F#6=/-^#@
MVOVI/-S_ +F<_I5RYN[:R@,UU<101 A2\KA5R3@#)]20/QKDI/AEX,'AYK%=
M"L$ @VBZ$*B8''W_ #/O9[YS7&ZGJ%YK?[.$-S=3NUTXAB,^3N;;<*@?/7)
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M63RW*EE\ALKD<X(R#[&D^(7A/P_H?ARUU72-&L=/O[*_M6AGM8%B<9E52"5
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M#U.ZU6REGN],GTZ1+B6$13')958@..!PP&1_7K6)X&L+6"WEN=-\8ZAXAL)
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MCOQ!X0U#P['X2T_083:M$)5ODE$V!]R-% ";L8RQ& >^*]3HH>O]=MAI[/\
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MB!T![UT]%+_._P"7^1:=G?\ K^M3G_&>FW>K>!-8TVQA\V[N+-XHH]P7<Q&
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MG1;C1-9$7GK;2RK*DJ9P3'(O#8XR.#S0M=@>FYU5%8NA^(/[:U#6K3[+Y/\
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M?'UC8O&&F&E_;8[JUE;DE5BR60L3_ 1]*]46RM4NY;M;:%;F50DDPC =U&<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-O\ :A#L;_5[MN[.,=>,9S3LP+U%4KS5[&PO[&QN9]ES?NR6R;&.]E7<1D#
MX&><55U'Q1HFD7%Q!J&HPVKV\"W,OFY4+&S%0<]#D@C Y]J0[&O16;H.OZ9X
MFTJ/4](N3<V<C,JR>6R9(.#PP!Z^U<MXG^*?A_PMXILM(OK^%%*NUXX1Y&@^
M4%%P@)!8GT/ ]Z'H[,72Z.[HKSGQ)KFF7GB#P%K<5Y&--DFN9A<29C79Y#?,
M=V"/QK<T;XD^#_$&JG3-,UR">\R56,JZ;R,_=+ !NAZ$T[??K^ /N=515#6-
M;TS0+!K[5KZ&SME.#)*V,GT'<GV'-9_AOQKX<\7+*="U6*[:+[Z!61U'KM8
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M%?48)H(82_+1V_E@C;Z L6)QWJSI?PVL-(U&"XMM=\1&UMV#0Z=)J3-;1XZ
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M 4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU17$Z;\7/ VKZE;Z=8ZYYMW<R".*/[).NYCT&2@ _&NVHL*_0****!A1110
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MA\,>(K3Q9X>M=:L(YX[:Y#%%G4!QABIR 2.H]:2UOY#->BBB@ HHHH ****
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M4H5 )!X&WH:]&^&/C"X\;>"X=4O(HX[M9'AF$8PK,N.0.V016#\.?^2 P_\
M7E=?^A25!^SU_P DV?\ Z_I?Y+6C5ISCVM^9%_=B^[:_ WOC!J-QI7PSU2ZM
M?)\P&)<30),A!D4$%'!4\'N*P=:\>ZGX7^">AZ[;P0S7]U#!&&,06.,LI);:
MN !Q@ 8'(K3^./\ R2?5?]^'_P!&K5!->L= ^"7AV?5-#EU?3I;2&*YACC#[
M$\LG>0>,# ZD8SUK+[,O5?D:]8Z=ROX%NOB9J-Y8:C=>)- UC1+D@S_9PK/
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M(_'>K^*H-7T[Q D?]I:3*L<DJ(%W@[@<@<9!4],#GI6+^SC_ ,B?JW_80/\
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M=%.1@]<CFO4_A[%X6F\.>(=0\+^&K_1[>2W*>9>.Y-P-C$%0S,,#/4'O4?\
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MX_M=.GO["UB$5VD RT8&X$GVVN>>F1R>:-/=3V=K_<-WYIVZ-V^\2V\:>.O
MGBW2M(\=7%CJ5EJC[8[NU0*8SD#LJY )&05[]>,5?^(7CCQ/X?\ B;H.CZ(8
MYX;V  V4JJ%DD9F4$OM+ #@\'M7)ZQK,OQJ\:^'5T'2K^'2M-E,ES=7,84+\
MREAE21T48&<G/2KGQ9O+K3_C3X3O+*T>\N(($D6W3[T@$CY ]\9Q3_DYN[^Z
MPOYN7M^-R\WC'X@>!O&^E67C.[TZ_P!-U>78AM$ $'S ?*=JG@LOWLY'>M3X
ME_$?4](\2V?A/0+G3["]N(_,FU'49%2* '..6X!XSR#V&#FN/U_7)/C!X_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S+PGXTU@^,=1T[
M7YDDTZ[O[FWTJ<(%V/$Y!A8@#DK@@G).#SZ=1XLU6]TR\\.1V<WEK>:K';SC
M:IWQE')'(XY Y'-<QHWAR'Q1X0\1Z<\C0S?V[>2VUPOWH9EDRCCZ'],U4E\0
MSZW!X4M]218=:T[Q!%;:A".T@CDPP_V6&&!]Z<=>5>GS6G]/Y#EO)^OZ_P!?
M>>HW5U;V5L]S=SQ001C<\LKA%4>I)X%0:=K&F:Q"TVF:C:7T2G!>VG64 ^F5
M)KBM;LK7Q+\6+/1=8A6YTVRTLWT5K*,QRS-)LW,O1MHZ ^M5O%&B:7X2\1^%
MM6T"QMM.N+C4TL)XK2,1+<0R Y#*HP<8!SBB*O:_7_@K]!2TO;I_E<]+I&94
M4LS!5 R23@ 4M<)\04&I:OX6\/W);^S=2OG^UH#@2K'&76,]\$@9'M2ZI+J'
M=G5:?K^C:M-)#INKV%Y+%_K$MKE)&3ZA2<=#5N6[MH)HH9KB*.6;/EH[@,^!
MDX'? Y-><_$/PIH&@>#[C7M&TVQTG4]+*7%M<VD*PMN# ;25 W!@2,'/6I?'
MEE!K?B+P+:WNY8+FYF\Z,.5WCR22AQV/0CN"136MK=[?A<-M?)O[CM[#7M'U
M2XEM]/U:QNYH3B6.WN$D9/\ > )(Z'K5:ZFO5\7:?%'JEE%9-;3&6Q?'GS,"
MNUT[[5YS]1USQQ7Q!\,Z'X;T&W\0:'I5EINIZ?>0-#+:0K$7#2*C(VT#<"&/
M!K9U3GXO^'/^P9>?^A1T+5K^NC8F[7]/U2.FN-;TFTAN)KG5+*&*V<1SO)<(
MHB8@':Q)^4X(.#ZBIK'4++4[5;JPO+>[MV^[+;R"1#]"#BO.?#WA;2-;^('C
M2\U>RAOUAOHXX8+E!)$A,*%F"'Y=QX&<9XJ[X<TNRT#XLZWI^E6T=G97&EP7
M3V\*[8Q)YCKD*.!P.U"UM?JK_A<&]_)V_0ZG09KV6YU<7FJ65\J7K+ EMC-N
MFU<1R8_C')YYY'X3W7B'1+*_2PN]8T^WO'QLMY;E$D;/3"DY-<-I%_/I>D_$
MF_M1FXMM1N98^,_,L"$5<\)^ ?"MWX-TZ>]T:QU"YO;9)[B[N85DEE=UW,V\
MY8<D]#Q2Z7\E^**>C^;_  M_F=U<75O9VLEU<SQ06\:[WEE<*BKZDG@"J5SX
MAT2SO8K.ZUC3X+J4 QP2W**[YZ84G)KS"WGE_P"%+^---:=YX-+EO;&VE=BQ
M,2?=&3UQG'X5TMC\.O"LG@V**[T6SNKB6S#2WD\0>=W*9+>8?F!SZ'BAZ)RZ
M*WXJXENH]=?P=CO*#TKD_AE<2W7PUT"6>1I)/LJJ68Y) ) _0"NL/2G-<K:%
M%W5S%\,3W<F@K+J6JV.HS"27==69'E%0[8''&5& ?<'ZU/8^(]#U.Z>UL-9T
MZ[N$^_%!=)(Z_4 Y%>?>'-"N/$OP9GTJUG2*::[N"IDSL?;<LVQ\<[6Q@X[&
MK6DKX>TO6]-M]:\!VGA_4VEV6=Y;P1O!))T 69 ""1T#@?C1;6WI^2'+2_S_
M #9Z544EU;PSQ02SQ)--GRHV<!GP,G:.^!SQ4M>>_$/3TU7Q5X,L)9)$AGN[
MA9?+8J63R267(Y (&#[&EU2[_P#!#HV=M8ZMINIO.EAJ%I=O;MLF6"99#&WH
MV#P>#P:C37M&EU-M,CU:P?4%^]:K<H91]4SG]*Y#Q[;VW@SX::S+X:TZUTZ6
M14C)M(EA/S,$W$@#D GD]*XJ\\-ZS/X>;3[#X-V5C<B,"WU"+6+;SXI!]V3>
M &)!P?O<T#M^)[=/=VULT*W%Q%$TS^7$)'"F1\$[5SU. >!Z54@\0:+=:B^G
M6^KV$U\GWK:.Y1I%^J@Y'6N!\>65YJ7AKP38ZLTD-Y/JEI'=F.3#!C&P<!E/
MU&0:3XC^#_#NB^!;C4])T6PL+[3Y(9K>YMH%CD5A(HY8#)X/?-5:SU[V_+7\
M1+6UMVK_ )_Y'ILLL<$32S2+'&HRSN< #W)KAO&OB:TN_":77A_6X9BNI6D3
MRV%V&P&F0%24/<'D=P:B\<01ZWXK\(>'K\;]+O))[BYB+869HD!1#SR,G./:
MLWXD>#] TO1]/U#2]-M--N(]3M4/V.)81,IE7Y6"X#=CSTQ2CNF^Z_-">SMV
MO^#/3;JZM[*V>YNYXH((QN>65PBJ/4D\"HM/U33]7M_M&FW]K>P9QYEM,LBY
M],J2*\P\>SZCJ/Q+L-*B\,)XDM+33C=KI\UW'!&9&<KYC;\A\ 8QCC=FG>&=
M(\10?$"PU&'P%!X6TUH)(;\6M_!)',,9C)C3&"&'4 GYJ(Z_UZ_Y#EH>F3:M
MIMM'=23ZA:1):$"X9YE40Y&1O)/R\$'GM4D5_9SV*WT5W!)9LN];A) 8ROJ&
MSC'O7G.E^'-.U[XI>,'U:WCO;:VDM3':SJ'BWM",N5/!.!@9Z9-5_B*MROB+
MPQX<TWPY%JVG"*:X.D+<):Q2F,*%!)^4A<D[<?RI=%Y_\'_(;T;\O^!_F>D:
M;K.E:S&\FEZG9WT:':S6LZRA3Z$J3BG:CJVFZ/ )]3U"TLH2<"2YF6-2?3+$
M5Y9IFC^(QXTT74++X<6WAB&&5DO9K34;=EE@8$%6C0+G!P0<$\5L:5HNF^*O
MB%XJN]>LK?4#ITL5G:072"1(8S&&)"'(RQ/7VIVOMY_A;_,F]M_+\;_Y&H=5
MDN?BKIT-K?M+ITVBRS!(IMT3MYJ /@'!.">:[.O,]/T'3M ^-\46EQ);6\VB
MRRFUB.(XV\U 2J=%S@<# XKTRC3E5O/\V-[_ '?D07E[:Z?;/<WMS#;6Z#+2
MS2!%4>Y/ J/3]5T[5[?[1IM_:WL.<>9;3+(N?3*DBN.\;:GI%UJ]MHC>%7\3
MZM%$;J.TVIY<*GY0SLYVJ"1CH:YSP8EW:?%HQR^$+?PLMQI#L]I;744J3;9%
M ?$8 4C)'2E'5_?^ /1'IM_XAT32KA+?4=8T^SGD^Y'<7*1LWT#$$UH(ZR('
M1@RL,AE.017EMQX870-3U6ZUGP5:>)K&[N9+K^T(HHYKJ)6.=C1R<D+R 4)X
M XKT#PW/I%SX=LI="$8TMH_]'6-2H5?3!Y&#D8H6JN#T=C0N+B&TMY+BXE2*
M&-2SN[8"CU)KG_"WC?1/%=G!)9ZA9?:Y59_L2W*/,B@D9*CD<8/3C-:^KV-G
MJ6E7%K?6D%U;LA+13QAT)'(R#QP1FN*^%.B:3:_#_1M5@TFR347M3ONDMT$K
M\G@OC)Z#O23W;Z?\$'TMU_X!V.HZ_HVD2QQZGJUA922_ZM;FY2,O] Q&:OHZ
MR('1@RL,AE.017FOP\\,Z%XD\++XAUO2K+4]4U.66:XFO(%E93O90B[L[0H
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M9#,<O@C&X^O6I2O))^?Y#;M%OT_,[Y;BQ\/:)!_:.K*MO"BH;R_G52_;+.<
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MW7'7*@Y%<;X]TZQTO0=)T'3+2#3=.U?5X+6\6SB6$-&V=P^7'+;0N?2G>,_
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MHVEW$=OJ&KV%I/+_ *N.XN4C9_H"03UJ\TT20&=I46%5WF0L H7&<Y]*\Y\
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MVTL%<UI7A:ZT;P[?:99:P\-S<74UREXENI,1DD+XVMN!QG'/7VKI:*0S@X/
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MX?BK@^_K^#.XHKR2?QK>^([N[FLOB!H/A>SM[AX8;>X2&6>8(<%I!(XV@D'
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MV:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=P![X[BNWHIR]Z]^O^5@C[MFNG^=S@/!M]<ZMX9'A+5/#FLZ;-:Z<+6>XN8
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M%27=AK/PY?Q!;-<R2V>H:?I<5W(T;L6"R _,"N2,],8KT7P@EH-(>6S\,?\
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MDD4BE61@@R"#R#6_13OO\OPO_F!Q.@6-Y#J_CIY;6=$N;L- S1D"4>0HRO\
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MW4GQ(\(W,-M,]M;Q7@EF6,E(\HH7<W09QQGK78T44=+!UOZ?@%%%% !1110
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M_K^O^ 4UJUV_K^O^"=M17,ZGXM?1-!T^ZU/2IUU6^98HM*MI%FD:4C)0-P"
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M1L;:\@)SY5Q$LB_DP(I?9L'6YP?AGQ"\/C*WT"Q\41^)]-FM9)C-NCDFLRF
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD(\U'W+@\_*3C\:O1RN_Y5]]Q/2-E_-^%F87P2NK_3?$'BOPQ/>RW5CI<NV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M('+$2D?R J/PTCGQ9\08X/ED:YAV8_O&W7G\Z5[+Y7_!/]1[OYV_%_Y%B_\
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M/3)!/I6WX:\6:9XILIKBQ\^)[=_+N;>ZB,4L#XSM=3T/TR*P/AE!'''XIE5
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MVVJZQ.P)>STZR:6>'!P?,7C9R#U(SVS1\+(8X_#^J.B!6EUF]9R/XCYI&3^
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M8UBW2R9Y+F33-2CW0AF.YMDJD-'DY/.X9/2DVEK_ %_5AJ^QU]C>1:A807D
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M28V:D-*<VS ]"#][';.VMKQ!XRTCPS>V5KJ;RQM>)(T+(F[<4V_( /F+'<,
M YKF]137OAOHC7MKJL&J:!9*,V5^H2XCB'&V.9>&(XP&7)Z9IGB_4-/M_B3X
M"N[YTBAD%T(VEP KLB!<YZ')Q]3323:2[_HV'=OM?\C7TCXCZ7J>KQ:7=:;K
M.CW4Y(MAJMD8!<$?W#DC/L<&M/Q'XMT[PRL*7*7=U>7&[[/964!FGFQUVJ.W
MN<#FN?\ BC<6[V.B6".K:G/JUJUG&I^?*R LP] %SD^]8?B2SUF;XR^78^)U
MT"6ZTI$M97L4N!/M<EXUWD ,"0>.2*2UM\_P5P>GW?K8[?PWXST[Q+--:QV]
M_I^H0J'DL-1MS!.J$X#;3U4^H)JEK?Q%TO2-4ETRVT_5]9OH,?:(-)LS.8,C
M(WG( ^F<U1T;P;K=IXSM-:UWQHFKW%O;20QP?V=';,4?&>4;D @=0:3X82P1
MQ>(;&5HUU:/6+E[N,GYR&;*,1UVE<8/M3W^[];?\$6WW_I_2+?B+4]'U3P]H
M>H:A!JL$$VIVQ@C5?*E67?A1(K$87/4=?2N7^)_B&U;Q9X<T:\T#5]3LHKIY
MKBVAL6=;HK'\JH#@2X+9(' QS72?$EUDTG0V1@R_V[9#(.1_K:B\8?\ )2_
M/_7>[_\ 1-"5VO7]"K:/T?Y@J^'(K_P:\6CWVD23S3265G' MNL3F(EQ-&#Q
MP.V>?QK8\2>-]+\-745E)#?:AJ4J>9'8:=;F>=DS@MM' 'N2.AQ6;XN_Y'SP
M-_U]W/\ Z(:JV@2PVWQ?\5PWKQI>7,%J]F'(W/ $(8+GL&SG%"UM\_PL)JVO
MI^-SI-$\2P:UH\VI-I^IZ<D!82PZA:F*5<#)^7G/'IFN?'Q6T=+I%NM(\065
MB[JB:E=::\=LQ) 'S'D9)[@5K>./$[^%O"MWJ=M'#/<1O'"BROA$=V"@OCD
M9R:\X^)=GXLL_ ][>:WX[LFMKA%4:9;Z9&J3$D?*DA8O[Y_I0M9>6B^^PTKZ
M=3M_&_/B/P3_ -A<_P#HF2HC(8OC1=R!&D*>'E;8GWFQ,W ]Z/%__(9\!_\
M84'_ *(>GQ_\ENN/^P G_H\T)=/\7Y(B]TWY1_,Z3P_KMGXDT2VU:Q\P03@X
M24 .A!(*L 3@@@@C--T3Q!:>(!?/91S>5:73VIE< +*Z?>*8)) /&3CD&N"O
M-8;X?7?BNP1<I=1_VEI4>,!I9&$;QC_MH5./1Z[CPCH:^'/"NG:7D&2&(><X
M_CD/+M^+$FC?7T^__@6_(IZ:?U;_ (-U^)M4444@"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?<7WPKU'Q4@/V^?46U^'/W@L;_(N?^N2X_&G&VC>RW^^W_!^0-/5+=[?=?\
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M+%%,""K1LS-C/((SSQ5C3?"T'BOQEXSMM7GN)-'BOT/V&*9HEED:%,LY4@D
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MV[\-Q6*-EQI\,S2RCTRYPO;IFF^(?#.NKXA_X2/PI?6,&I/;BVN;?4$9H+A
M<J24^96&3R.M=E10!P5EX3\37/C'1?$NO:GI\L]G'-%):V:,D,:NN!LW99CG
MJ6(X P*Z33K;Q!'XBU6;4+^VFTB3R_L%O''B2+ ^?<<<Y/N?PZ5LT4[_ ->H
MK?UZ!1112&<A\1?"=[XN\.QVNF7,5KJ$$ZRPS2DA5X*MT!ZJS=JZ.TTVWM-&
MATM44VT4 MPF."H7;C\JN446T:[AU3['%_#OP9<^#[*_CO;B&>>XG C>(D[8
M$4)$I) Y '/;FFZOX7\067B&[U_P??V$-S?(BWEEJ4;M!,R\+("AW*P7CCKQ
M7;44VVW<.Y@^&XO%2K-+XGNM*>1@!'#IL3A(\9R2SG+9X[#'-;U%%# X6?P/
M>3?$M==%Q;C1BT=U+;9;S&ND1HU;&-NW:P/7.5%-\7^!;SQ!XITW4;2YMXK,
MB./4XY,[IHXY5E0* ""<@CG'!KO**$[6MT!ZW\SG?%^@W7B"RTZ&TDA1K;4K
M>[?S20"D;[B!@'G'3^=+>Z#=7/CS2==22$6MG9SP2(2=Y9RA! QC'RG/-=#1
M26G]>5@>O]>=SG=%T"ZTWQ9XDU6:2%H-3>!H50DLH2/:=P(P.>F":Z*BBCI8
M.MSSG3?"WCKPW)-IF@ZGH)T26XDF26\@E:YAWL6( 4A6P3U)%;'A?POJGA?0
M=6LX+^"YO;B]ENH+BZ4L"7QS(%V\Y!X7\ZZZBCI;Y?U]P/5W^?\ 7WGG5SX=
M\?>)UBL/$]YX;MM,6:.=SI<4S3.48,%!D.%SCJ,FMWQ$/'@OE/AE_#AM"OS+
MJ:3B0-[%#@C\!^-=110!R.@>$;JVLM<;7+N"YOM<.;L6D9CA0>7LVH"23QW/
M)K'TKPY\1-+L(= CUS0QH\$8@BOOLTAO%C P,+GR\@< G/KS7HU% '#Z/X)O
M=*^%E[X3^TPR7,D-U%%,6.T^8SE"QVYSAAG ZYQFNAL]+GM_"$&D.\9N([%;
M8L"=NX)MSG&<9]JUZ*)>\FGU_P K G9I]C%\+Z/<:)X.TS2+EXGN+6T2!VC)
M*%@,<$@''X5AZ9X#S\+X?".L3(9%C(,UJQ.Q]Y=64D Y!P>G:NVHIR=VV^O_
M  X+1)+H<%!8_%*%TLSJWAB6T0!?MTEM-]H8 =3&&V9S[UWB@A0&.X@<G&,T
MM%%PL87C'P\WBGPQ=:5'=?99I"DD4VW<$=&#*2.XR!6#?Z%XR\0^ ]8T;79M
M#&H7*".V>R\U8\<$ERP)SQV%=W126G]?UV'?5/L5+JU>;1YK12HD>W:($],E
M<?E7&77@._N?A]X?T9+Z"WU;16@GAFVF2$RQC&"" 2IR?0UWU%'G_6@EI9?U
MV/-]2\*^.O%%A%%X@U31(/LUU#<16^FI*(Y=CJ29'?)Z;L #KC)K=\9>'-6U
M6ZTG5M!N[2#5=*E=X5O$9H90Z[65MO(X[BNKHH HZ.-5&E0?VV;,ZC@^=]B#
M"'.>-N[GICK61XV\,W'B;2[5+*\2UO[&[CO;621-Z>8F<!AW!R:Z6BAZNX+0
M\WU+PKXZ\46$47B#5-$@^S74-Q%;Z:DHCEV.I)D=\GINP .N,FNFUW0;K4_$
MWAO4H9(5ATR>:297)#,'C*#;@$$Y/<BNBHIIV_/] _X8YZUT&Z@\?:CKS20F
MUN;&&V1 3O#(S$DC&,?,.]=#112Z6#K<Y[P_H-UI.N>([Z>2%HM3O$GA$9)*
MJ(U7#9 P<@],U!XH\,7FJ7]AK.BWZ6&M6 98I)4+Q2QMC='(H()' .1R#744
M4=O(._F<IH$7CU]063Q)=>'H[1 ?W.F13%I"1QEI#\N#Z YJEK'AGQ+8>([O
M7?!U[ID<M^J+>V>IHYA=E&%D5D^8-CC'0UW%% 'F.D6&K6OQDM;C7+Z&ZU"X
MT.4NMM&4@B E3"H"2V.2<DY.>U7I?#/C+0M>U.Z\)W^B/8:G<_:IK?5(I<PR
M$ ,4,9^;.,X.*ZR30;63Q1#X@,DWVN*T:T5 1L*,P8DC&<Y [_A6I3OHOG^=
MP?7Y?D<9X2\(ZIH7B?6]8U/4X[^35(X-SJNPJZ;@0%Q@( 5 Y)X.:ET;PM?:
M=H/B2QFEMVEU.\N[B$HS%564?*&R.#ZXS^-==12>JL^UOD-/6_G<R?"^ESZ)
MX5TK2[EHWGL[2."1HR2I95 .,@'''I7-7OACQ/HNL:AJ/@R_TM8]1E$US8:I
M'(8EEQAI$:,Y!.!D=*[NBG)N4N9[B6BL8FB6NO2:=.GBBXTZXGG^7RK&)EB1
M2,%<N26SZG%<MIWAOQ[X=BCT;1-7T.30X\K!-?02M<VZ$G"@*0KXXP217HE%
M+K<.ECE_ WA>Y\)Z9?V=S=B[,]_+=+-GYF5\<MP &R#G'%=1VHHH>HDK'"6W
M@O4H?A9J7A=I[4WUTMT$D#MY8\R1F7)VYZ,,\?G6EKWA.;6-$TN.WOOL.K:6
MR2VEVJ;U215VD%3]Y2,@BNIHH_X'X:#ZW]?QW.6\/Q^._P"T2?$EQX?-DJD*
MNG1S>9(>Q8N<#Z#UK);PQXO\-W5W_P (;?Z.^GW<[7!LM727%N['+>6T9S@G
MG!'&37?T4 <S/I&OZGX(U33-6O+"75+VWEB5K>-HX8]R8"\[F(![]?:M?1;&
M73M T^PF9&EM[:.%RA)4E5 .,]N*OT4/6Z[AV.0\.Z!KWAOX?Q:393Z:=7A:
M1D>82/ =TC-@XVMT./8^M9J>'?&WB#4=.?Q7>:!!96%VEVD>DQ2F25US@%I#
M\HSCIUY%>@T4[ZW!Z_UW.,USPQKD'B&;Q%X2O[*WO[F%8;JUOXV:WN-OW6)0
M[E8 D9&<UI^'(O%H,LOB>ZTAF*@1P:9%($4YZEG.3],"N@HI+16!ZG!7UE\3
MKZ2XLFNO",>G3!HS,L%PTP0C&=A8J3[$XKK-!TF/0= L-)BE>6.S@2%9'ZMM
M&,FM&BA:*P/5W.:\;>&;CQ-I=JEE>):W]C=QWMK)(F]/,3. P[@Y-<YJ7A7Q
MUXHL(HO$&J:)!]FNH;B*WTU)1'+L=23([Y/3=@ =<9->D44+3\_Z^X'KH<]>
MZ#=7/CS2==22$6MG9SP2(2=Y9RA! QC'RG/-)XGT&ZUJ^\/SVTD*+IVI+=S"
M0D%D",N%P#DY8=<?6NBHH[>7_#B:O?S.0\2>&=8EUZ'Q'X8OK2VU:.W-M+%>
MQLT%S'G< VWY@0>A'K6;%X2\5:CXH\/^(=?U/37GTZ27=:6*.D*(\97*ELLS
M$[>I  !Q7H-%"T_K^NXWJ%>;^/K"[U#XA>#HM/OC97J)>20S[ ZA@B'#+W4C
M((R#SUKTBLJ]T"UOO$&F:S+),+G3EE6%5(V,)  VX8R>G&"*%NG_ %LQWT?]
M=CE%\+^,/$6JV+^+]1T==-L+A;F.TTJ.0?:'7E#(9#P ><#(K2\2>%]4GUR#
MQ'X:O[>SUB* V\D=W&7@NH\Y"N%.1AN0PYY-==10(YGP[%XV-VTOB>ZT,0A2
MJ6^EQ2\GC#%Y#GUX ].:E\/Z#=:3KGB.^GDA:+4[Q)X1&22JB-5PV0,'(/3-
M=#13N*QSU[H-U<^/-)UU)(1:V=G/!(A)WEG*$$#&,?*<\TFLZ!=:CXN\.:M#
M)"MOIC7!F5R0S>9'M&T 8//7)%=%126EO+_@_P"8^_F<]XCT&ZU?5O#MW;R0
MK'IM\;F82$@LOELN%P#DY8=<4DV@W4GQ"M?$ DA^R1:;):,A)WEVD5@0,8Q@
M'O\ A7144+3\?Q X9/#OBO1_%]]?:'>Z1)I.J727%Y#?1R>;$0JJWEE.#D#^
M+I5K65^(W]J2#0Y/"ITX_<-ZEP)E^NTE3^GTKKZ*.B78.[,'PCX=D\-:*UI/
M="ZN9KB6ZGD2/RT+R-N(5<G"CTJ[K^D1Z_X>U#2)9&CCO('A+KU7<,9K1HHE
MJK,%IJ><0>&OB!=:0_A[4M9T2#21;_9A<V,$@NI$"[0#N^1"1U(!QVK0N_!V
MH3_#C1O#J36HN[$V9D<LWEGR64M@[<\[3C@?A7;T57,]_1_<*RM;I_FK#)8D
MGA>&50T<BE64]"#P17GUKX<\?>%X$TOPSJ6A7>D1D^0NKQS>= F>$!C.& YQ
MG':O1**D93TN*_ATV&/4[F*YO0#YLL,?EHQSV7)P,<=:K^)--FUCPQJFF6[(
MLUW:2P1M(2%#,I S@$XY]*U**4ES*S'%N+370X_6/"E]J'@72M#BEMUNK1[-
MI'=F"'R60M@XSSM../RK9\4Z7/K?A35M*MGC2>\M9(8VD)"AF4@9(!./PK7H
MIR]Z]^I,5RVMT*FEVKV.D65I*5,D$"1L5Z$JH!Q[<5G>,=&N/$/@_5=(M'B2
MXN[=HHVE)" GU(!./PK<HHE[U[]1Q]U)+H8VHZ FK>#YM NI-BSV?V9Y$YVG
M;C(]>>:Y2'P_\1;G3FT/4=<T2/3/)\@WMK;R?:Y$QCD$[%)'<9QZ5Z)10];W
MZ@M$DNAP5QX(U*7X2VGA-)[7[=#' C2%F\H[)%8X.W/0>E;?B+0;K5]5\.W5
MO)"J:;??:9A(2"R^6RX7 .3EAUQ7144^9WOYW%96M\@KF=>\.W>J>+_#&K02
M0+;Z5).\ZNQ#,'CVC: "#SUR17344EHTQG->*O#%QK4^GZGI=^+#6=-=FMIV
M3>C*PP\;KD94@#W&*Q8_#'B[Q'>V3>,[[1UL+*X6X6STF.3$[KRID:0YP#S@
M#FN_HH6@/4YZ]T&ZN?'FDZZDD(M;.SG@D0D[RSE""!C&/E.>:L>*/#T/B?0I
MM-EF>W<LLD,\?WHI%(96'T(K9HHZ6_KN'6_]=CCM'M_B)'JD,6KW_AV;3(S\
M\UO#*MS,!Z@G8I/7C-0:EX8\1Z9KM]K'@Z_TZ-]0*O=V.IHYA:0#'F*R'<IQ
MU'0XKN** ,3PY%XE2"63Q-=:9)<.1LBTZ)UCC SGYG)+9X]*VZ**'J"/.=-\
M+>.O#<DVF:#J>@G1);B29);R"5KF'>Q8@!2%;!/4D5<TWP/?:;X(\2:$;Y+F
MXU.2Y>*XF)!)E3&9,+P<YS@&NZHI6TM\OZ^X=_>4NSO\RAHMC+IV@:?83,C2
MV]M'"Y0DJ2J@'&>W%<UH_@8K\,V\):Q)&QD657DMR2%+2,ZLI8#D9!Z=17:4
M54GS-M]?\[BC[J273_*QY\F@_$6YM)-%U'7=$_LMH3"U];V\@O)%QCH3L4D9
MY&<>E=-X/T:?P]X0TO2+IXWGM+=8G:(DJ2/3(!_2MNBBXK!1112&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%(2%!)Z#F@!:1F5$9V.%49)]!7D*^-K[Q,\FH6GQ$\/^&K1)G6WLITAEFE
M13@-+YC@IG!("CH:W-/\0ZIXT^'.H3V.HV=CJ-J\UM<7,$7VB*38#EHOF'#
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M+W7/!-KJNGM;6EY>6:3H;E2T<1903D @D#)[U335[]!)WM;J;M8FH^(?[/\
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M.P!9L9P,]3@'CVJ2O,OB-9>(+SQ7X3CT[Q FG1S7;K#MLEE,4@B<ESN;#\9
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M;$%#@C)YR:2U$W97/4Z**XWQYKFM:/=>'8=$$3SW^H?9GCF V,#&Q!8XR I
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF6B3B$ #"E-PX[< CCM72T4WJA+1GFG@BSD?Q;+J6B^&]2\.:!);,MQ:7J"
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M3O7<TUI&W]>7YMC>LOZ_KL@HHHI %%%% !1110 4444 %%%% !1110 4444
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M98@*9(EY09//)Q6UXI\8P^%KO28);&>[_M&1XHQ;\OO"Y50N.=QP.2 .IXH
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M+BR0J07C*!0^#TW$$_C7:WOA_1=2NX[N^TBPNKF(@QS3VR.Z'V8C(Z"M  *
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M6EI:+:6UK##;*NU88XPJ >@4<8J-=+T];".P6QMA9Q;?+MQ"OEIM.5PN,#!
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M0@XJS0 44V21(HVDD=411DLQP /K5'3=>T?66D72]6L;XQ_?%K<I+M^NTG%
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M2W?RYECD#&-L9VL!T.#T- $]%%% !1110 4444 %%%% !1110 4444 %%%%
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MM;V%%?;N7#!D;AE/&1[5D#X=:C>WVE:CKOBRZU2_TZ[2XB9K9(8@H)RHC0@
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M)(DSDB.->%SQD\GBE'2WE^._YW7W>@Y:W\_PV_*S^_U.=\27^EZSXEO(=-\
M+XJU/3U6WGFN/*C@C/+;-\N1N&2>!W'-5OAI+=6%_P"-8GT1-%\B6*9=+BF6
M5(6,63M*X7YL X'3I6Y>^!-6BUV]U+PWXMN-&CU"437EM]CCN%=\ ;D+_<)
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M\44=V@ECC&Q"2J-D G(R<9X%>B:38_V9H]E8>9YOV6!(=^W;NVJ!G'..E4-
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M%O\ 8[CVN(@6C/XKN7\!3K/PAXMAO$%U\0KVXTY&!%NNGP)*P!X#2X)/'!.
M36WXL\._\)/H;6"7;65RDJ3V]TB!S#*C!E8 XSTZ>]5>UG_6NG]>A-KZ?UW_
M *]3#\-+_;OCO7_$CC,%I_Q*;(YXPAW2L/JYQ_P&N3@U"ZTWX 7\UG(T4SW5
MQ#YJG!C#W3(S9[8#'FO3O#6A0^&_#MGI$,AE%NF&E88,CDY9R/4DD_C6?I/@
MRTLO!D_AF^E^VVL[3^8VSR\B1V;&,G!&[KGMFAV2:WT7SL[O[]?O*3UOY_I9
M?=H9M[\./"5MX5FM[;1[.VEAMB8[Z.,+.C!<A_-'S9SSG-<M<ZC>Z=^SGI+6
M&_SY[>WM\HX0[7<*PW'[N02,]LUT4/P^UPPMIE]XYU&[T#R_*%D;:-)63&-K
MSCYF&,@XP2.];ECX.L8O <'A/4&^VVB6PMW?;L+@=& R<$<$<]10];^=OS$M
M+>5_R/+]2\.Z]<:(;/2_@[9:5>Q@&VU"WU>V$T+CE7W !FY]3S74>-],.M:U
MX"L-5# S3R_:XT?&[$&70E>H."#CJ":O0>"?%ENZ6T7Q&OQI: *L+:? T^T#
M@><1DGWQ70ZKX=_M/7-!U+[68_[)EDDV%-QFWQE,9R,=<]#3TNO6_P"#%;?T
ML<?XY\*Z#H5MHFJZ/I%EIU[;:M:JDUI L3%7<*RMM W @]ZM>*+*#Q'\3M$T
M#5$,VE0V,M^;9O\ 5SRAE5=P_B"@DX]ZZCQ/X?\ ^$CT^VM/M7V?R;R"ZW>7
MOSY;AMN,CKC&>U0>)_"D7B%K2[AOKG3=4LBS6M];8+)N'S*5/#*<#(/I4I]^
M_P"G^>HW^GZ_Y"RZ/I/A?2M3U#1-&LK.X6U=B+2W2/>54E00H&>:\D\.V&JW
M_ABWN)_A'9:W)?1>=+JESJMOYMP7Y+Y92R=>F>*]9\.:'KVG&X;7_%$FN&1=
MJ*;*.W1!_NIU)]2:PA\/];TIC!X5\:7.CZ87+BRDL8KI8\G)$;/@J.O'/6BV
MNH7T-?X>6FM6'@JQL]?A>&^A+ILDF65EC#'8"ZD@X7 S[5U%4]+LY=/TV&UG
MO9[Z5 =UQ/C?(<YR< #\A5RJD[NXEL<3H?\ R5CQ;_UYV/\ *2L'X9^#- U'
MPN^HZII5IJ-S/>7(#7D2S>6@F<!4# A1P3QW)KN;'P]]B\6:OKOVK?\ VA#!
M%Y/EX\ORPW.[/.=WH,8H\*>'_P#A&-!33/M7VG;-++YGE[/OR,^,9/3=CKVI
M*UODE^+*EK]_Z6.?^&UI%I=QXJTFT7R[&SU=UMX<\1*T:,5'MDFN[K%T/P__
M &+J&M7?VKSO[3O/M6WR]OE_(J[<Y.?NYSQUK:HOHO1?D+J_4X?QQJ>C3:A8
MZ%<>&I/$FIE3=PV*HA6-1E=[ER%49..<_2N6\+Q7EG\6K 2^"[;PH+C39P\%
MK=12I<!60@D1@ $$^F3FNT\2^#+K5M:@UW1=>GT36(H#;&=($G22(MNVLC<'
MG.#4>D^!9[+Q)9>(=0UZZU/4X;>2":6:-460-MP$1<+& 03@ D[N3Q1#1W?G
M^O\ P EJK+R_0P?#WA;2-;^('C2\U>RAOUAOHXX8+E!)$A,*%F"'Y=QX&<9X
MJYX>TFPT+XKZYINF6L5K87.EP7,EM$NV/S-[KD+T' [5U.B^'_[(U?7+_P"U
M>;_:ERMQL\O;Y6$5,9R<_=SGCK21>'_*\:W/B+[5GSK%+/[/Y?W=KLV[=G_:
MQC'XTET7E;\/\Q/KZ_J<KX=U2+P3I_B?1KUBMOH9:\M,_P 5K)ED ^C;D_*M
MWX?:1/I/A"V-X#_:%ZS7MV6'/FRG<0?ID#\*YGQSI=KXB^)'A[2K>4F<QL^J
M(A&#:(ZNJOWYD Q]37IW2FOAOU>GW?YZ?<-[V^?W_P!/[PHHHI %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M91U*L/4&O.-*B\=>";*/0+#PY:Z_IL+LMI>+J"VS1Q$Y D5@<D9ZKV%0MW^
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MH5G+KEK#:ZF\8-Q#"VY$;T!R?YGZFM&I:L[#3N%%%%(84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 8OA?P__ ,(WIMQ:?:OM'G7D]UO\O9CS'+;<
M9/3.,]ZVJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N0NO!NH:GXNM]6U3Q%+<Z997'VFRTM;5(UBD"X!:0<O
MC)//K77T4+1W!ZJP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSQ*51GQR0"3@9KFK'6]1D\=>)]/9S-;6-I;2VUN%48=E<MSC)R5'4FEL_O\
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MHW!+$@G^*M/QQXOETC4]/T*SU33=)N;V-YI-0U%@(X(UP/E!(#.2> 3C@T=
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MB=S$#KP 37#P^-=1\2QC5K;XC>'/#MN78V^F3)#+(R _+YS.X*DXZ*!@&EY
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MFND^+->\,Z39Z!J?@O7+S4+6(6\=QI\*R6TP7Y58R;ALR ,Y'%2VGAO5-/\
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M5E;^(!=6TT!EUNZEC$L97>A8889Z@]C4>CZ9<-X_\:/<6TR6EY%:)'*T9"R
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MN^[E3ZX[$T+4#9MKVUO1*;6YAG$4ABD,4@;8XZJ<=".XJ>N(^&O_ !Z^)/\
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MUU]12"*>&73[IK6>.<*&#  Y&">"",55\,^,=-\5R:BFGI<*;&<PN9D"^9U
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MO3'2&0DX&&!) /7) KLZ5AW"BLCQ#XBM/#EDEQ<V][<M*_EQ065LTTDC8)P
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M!*T><;@,D$9]Z%KL#T.IHKE_$/CS3= O_P"SELM3U740@D>STNT,\B(>C-T
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MU0/31F]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7UVU:!,C=@-\QQUQCC\17HE<IIOPU\'Z1;^18:)#"OG1S[O,=GWHP9?G+%L
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M6LSZND&+Z>%8))=[?,BDE1C.!@D\XS1/I%C<ZO::K-!NO;1'C@EWL-BOC<,
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M,LTJ,?G,3!?+;'7;MX%1>'[FQNOC/XH:R>-RFGVR3M&01Y@+9Y'?&T5O>(O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4GZJ2*BU+7-)T94;5-4LK%7.%-U<)$&/MN(S2 OT5''<02VXN(YHW@*[A(K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M];U+QEJ376D/\.K*\L928UN;C5XFB*GHS(4W?AC/IZUT_A/2+G0?"FF:5=W
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M\4Z%JYUS3O$WAX6\FI6<3V\MK</L2YA8@E=V#M8$9!Z5+V5]K_I_F-=>]O\
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M)U;3M2<.%(LY""S<GDK@XQD_-TI*]K+JW^EG]_ZE.SWZ?YN_X?H<M<127?\
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M'XE\/VMK*WPCM)[V%!Y^IQZA;"XG/5I,%=^X]<$YSQ3=KW?E^6OEZ@MOF_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K$U'P]_:'BK1=;^U>
M7_9B3KY/EY\SS% ^]GC&/0Y]JVZ*.MPZ6"BBB@ HHHH **** "BBB@ HHHH
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MV[ZL$K!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** //[?XC:CJ\<\7A_PI<:I>VUS+!<H+M(8H=DA49D<#+$#=M
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MV2!TX9&7^\#QCOQCK7/O\1-9M8SJ=_X&U*U\/!0[7S7,32HA_C> ?, .IY)
M[5B:CX5T]_@[KMEX4U:\UI+BX-V]P\ZS23.K(T@5PH!)"^_-9D6F^!]4T8/<
M?%OQ$()XL2VMUKZ!L$<HT;+GV(Q3>[MY?E]XULOG_78]&\4>-[3PQ!H]RUM)
M>6^ISB%&MSN;E"RE5 .XL0!CCKG-9)^(.LZ=?V__  D/@N\TK2[F=8(K[[9%
M/M9CA?,1.4!^IJ'Q#96MG/\ #JRMG>:U@U!$B>0Y9E6!]I/ YX!Z5>^*P_XH
M63_K]M/_ $>E.R3^=OE=+]2+NWRO^#?Z';4445)1A^(]:U328X4TGP[=:S<S
M;MJ131PQIC'WW<_+G/'!Z&J/ACQ?<ZSJ=UH^KZ'/HNL6T2SM;23I,KQL2 R.
MO!Y'/'%<SXIUN2[\>W/A_4_%S^%])ALDEC>*1()+MF)#$3./EVXQ@<\^U4/
M,-C%\5=0&FZ[JNN6G]D@+?:A<>?O82\K')@!E'MD9S3AK^/X!/1?=^/_  YU
M&H^/-1EU:\TWPKX7N-?EL9!%=S?:H[:&-\9*!WSN8<9 '&:T]1\71Z)X4AUG
M6=/N;2XE*QKIZ$2S-*QPL:XX8FN7\$^(='\+OK>@:_J-KIFH1:G/<?Z9((1/
M'(^Y'5FP&R../2K/CO4;6:R\,^*;:5;S1M/U-;BXFMQYBB/:R&08ZA2>U);+
MSM^/]6![OROIZ?U<V-!\1>)]1U46^J^"IM*LW!:.Z;4(ING0,B\J3^-5+[QS
MJLU]<P>%_"=SKD-I*8;BZ^UQVT0<?>5"_+D=#@=:W+#Q?X;U:YBM=.U[3;NY
MF!*0P7*.Y &3\H.1QZUX]X>T71[-M1TS7_'_ (@\.ZG;7DQ>U75UM(75G++)
M&&&"&!R<'KFCK;^MPZ7_ *V/6]-\6VNK>&;S5[:"5)+,2K<6D_R212QC+1MU
MP??GKFN<MOB+KFK:=::GH7@:^U#3I8P\LYO(X2#QN$:-\TF#D9P,D<>M.T#2
M=#TSP-XC?0M=NM:BN1/)/=W%RL[-+Y6#\Z@9X ]?K5?P'X^\+V?P]TF&_P!9
ML["XL[...:VN91'*"JCD(>6!&", YS0[:^5OUN'1>K_0T-=\;RW'PRNO$?AZ
MQN+AF@DR&98FM"H(9G#$'*D=%R2?SJSX*U[Q!?Z2C^(/#YTJVAM(W2\DU&.X
M^T?+RQ &5XYY]:Y;2;>XN?@SXMO4MI4356O[RUB*D,8GSMX]P,_C6_9ZGIOB
M[X:3:5H>JV=S?2:/Y7E13J7C8Q[1N7.5YXY%$M%)VUTT^7Z,%9N*;TN]?FOT
M(O\ A8>M72?VCI7@?4;[0,%OMWVF*.1T&?FCA/S,#U'(S707/C'1[;P>/%'G
M-+IS1+)&8UR\A8X50O\ >).,>M>3^&]/\+S^'K5;[XG^)-(NX8A%<:?/KJ6Y
MMW489 C*"%!''MBNCU[1K#2?A1I!T*XN-1TG2[Z"^,A(D>6!9=SG(49 R3P.
M@JFDM+]5K\_N\_\ @ G=[=]/E]^^@>)_&>O2>#M;_MKP5?:7IUQ92QQ7GVJ.
M<J64A3)&OS("2!WQGGUKO?"G_(GZ+_UXP?\ H KD?&WCOPM?> =7AL=9LK^X
MN[*1(;6VE$DK%D/5!EACJ<C@ YKKO"G_ ")^B_\ 7C!_Z *%L_E^3$WK'Y_H
M:]8=OXB\SQI>>');41/#:1W<,WF9\Y68JWRXXVD#N>O:MRN!\>WL?AGQ!H'B
MR4[;>#SK*Z/^Q(A9?_'T'YU%TGK_ %_3*M=:&CIOCF+4?'E]X:6Q9([=6$=Z
M9<K-(@0R(%QP5\Q>_K5H>(TO=?US118K);Z;:(\\QE^\[ACY>W''RC.<]^E<
M5-IMQX>\#^'_ !-*NR^L[\:E?]ODN"1,#] X_P"^*W/!"F[\*ZWK[\OK-S<7
M2M_TR&4C'TVJ#^-$U:+OND[^O]7^X$TY*W5JWIU_3[S%UGQ+<Z7\$+/4/#6B
M2VD,]FH00W0Q8JQ SN8AF//! SGDXK7U'5=?U3X=>)VU[PW_ &*R:?*(A]NC
MN?-!C;)R@^7''7UKG[I&?]F6#8I;;I\+D 9P ZDG\ ":ZS7]?T?7OASXA?2=
M4L[X)IDID%O,KE,QMC< <J>#U]*JLM)_UT'1UE3?];F'HGC?7D\*Z3+HW@B^
MU+3(;.-9+MKJ.!F"J QCB;YG'!QTSCCUKL(O&.D2>#%\5-,T>FF#SB6'S#MM
MQ_>SQCUJ7PHBIX*T5% "C3X0 /\ KF*\RM+*YN_V?[4VEN]PUK=FZ:!!DR)'
M=%F '?@'CVJJGQR3[[^LK/\ S,J:]R+7W?*Z_P CIG^(/B"UB;4K_P  ZE;:
M$J^8;O[7$\R)_>: ?, .2>3TKH-;\5V^EZ%8:M:Q+>V][<V\,9638"LK!0^<
M'IG./Y5E:E\2O!\GAF>ZAUNQNFFMR([-)5::1F& GE@[LD\8Q7-ZM87>@?!+
MP^NH1N'TV:RGNEP28D656;(Z_*#^E2M]>Z_%ZE>G9_EI^)Z-XDUC_A'O#6HZ
MQY'VC[' TWE;]F_:,XS@X_(UR7Q$\4:WIOAO2[C1M+FE:\N+;?*ERD83<ZD1
MY)W9;[N<8 )SZ54^(OCOPU=?#W5[;3M8L]0NKJU9(X+.997P1RQ522H R23C
M&*L>/95M_ASH]U*2L%O=V$TKXR$0.F2?:DO/NAW[=F=7X;U+6M3L9)=<T#^Q
M;A9-J0?;$N=ZX'S;D&!SD8]JV:I:9K.EZU T^E:C:7T2MM9[:99 IQG!*DX/
MM5VFQ(\T^,NH:E!X=M[*UT1[RUGN[<2S&>-$)\T$1$$[CN( SC !ZULGQ=JN
MFZ3IEQK'A@:;=7NIQ:>+47R2[$?I)N1<'O\ +Q]:@^*W_(JV?_85L_\ T:M)
M\4Y5L]%T?4I<BUL-9M;BX< G9&&(+''89%*/G_,OT&]7\G^IT7BK7?\ A&?#
M%_K/V;[3]DCW^3OV;^0,9P<=?2J/B?QE;>%H])FN[=WAOYC"3&260^6SC:H!
M+DD!0..37)?%'QQX=O/A[J=EIFK6>HW5U&%6*SE$S*NX%F;;G: .YQ6OXQ17
MUCP&'4,/[5!P?40N13BK_>E^ 2=E?R?Z%H^*/$YT75;Z3P7<6S01AK.-[^$O
M.""2S#.(]N 2,D\\"L[X<^(?%.LZ!9+K'AYX;-K 2)JKZ@DIN6P,$Q@;ER"3
MSTQ7;ZLC2:/?(BEF:WD  ZD[37'_  T\0:/?> ]'TVVU.TDU""P59;19E\Y"
MHPV4SN&#[5+VEZ?YC[>O^1S'@#Q;KD'P_P!,M?#OA"ZUG[,'2>9KJ.UC#;V.
M$+\N1D9P,>]>B:!XLL==\/2ZN4DLDMFDCNXKG"M;O']\-].M9/PD14^&&C;0
M!E9"<>OF-7/V&FW.K>#/B1IUDN;FXU2]2-1QN8HO'X]/QJJCMS>E_P O\PBD
MW\[?C+_(U3\0]:DB&J6O@74IO#VPR&^-S$LQC_OK;GYB,8/4'':MO7/&EAI'
MA.V\21[;G3YY( )-^P".1@-_0] <X]L<5YCHMCX1O= MWNOBIXET^01!)[&Y
MUY(7A8##)Y;*#@'(KI/%.FZ;IWPDTBPTRX>[TU+NR6"65@QDC,ZD$D  ]?2G
M;6WFOS^XB[M?R?Y'5Z#XBUC6]2?S/#%Q8:.T7F07US<('E.1@>2,LN1D\D=.
ME=)112*,/Q1XB/AJULKM[,SVLUY%;7$@DV_9U<[1(1@Y ) QQUIWBKQ"GA?P
M[<:JUNUR\95(K=6VF:1F"JH.#C)([&K'B#1X/$'AZ_TFX'[N[A://H2.#^!P
M?PKS;0=5E\;ZMX:T>ZR9- 5KG5ESQ]IB)BC!^K!G^F*(J[M_5NOY?B#T5_ZO
MT^^_X'::[XNFTJ:UTZQT:?5-<N83,+"WE51&HX+/(V JYX!QSZ4SP[XON-3U
M-M'UO1)]$U@1>>MM),LR2QYP621>&QQD<$9KB?&VF6L7Q22\UKQ#K&@:??:>
MD-O?V%V+9/-1F)CD?! X.1G'>M;PGH?A1/%\%[I_CO4O$.IP6\@2*YU5+L)&
MV Q^5<CG'?THCKJ_/]?^!N*5UIZ?I_P30E^(5Y<7VJ:9HGAJXU75+"Z:!X$N
M4BC" ##M(X 7.3A>3\IJ[/>VS>//#\5YHR+JLVG3R+<>?N-L!LWQ@ 8;)/WN
M.G'6JO@!5&K^-& &XZY("?7$:?XT[5?^2P>'/^P9>?\ H4=$?L^?_P BPEIS
M>7^:.2CU[Q.?B_J<]MX):YFCL((1'+J,$;P1%V/F9^8?,<_*#GY1FNZLKFP/
MQ)U2UCTQ([]--@>2]$A)D0NX";<8&""<]\^PK.TK_DL_B'_L%VO_ *$]2:?_
M ,ECUS_L$6O_ *,DHCM'T?ZA+>3\U^A'>>/=3NM1N[3PGX4N->6RE,%S<F\C
MM8ED'559\[R.^!70W&LWMOX<CU(Z%>RWCJI.GPLC2JQ.,$DA>.YS7%> /$>C
M>&=*O/#VO:I::;J=E>SF1;V58?-5Y&99%+8# @CI5CQSXLD1_#<6GZ[%I>D:
MM*_G:RH5E157*JK-\HW'/S'TI=$EUM_7Y_\ #E=7Y7_ O:7XXU?^W++2_$OA
M.XT1[]F2TF%Y'<QNX4L58IC:<#CUK'UOQ=XNMOB:-.TKPM-?0PZ>[K;-J44
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M;7=AHNG6MR^=TT%JB.V>>6 S5P65J+XWPMH?M9C\HS^6/,*9SMW=<9YQ4]%
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M%03WP37,0?\ "97'Q0\63: /#C7$$D,7_$W\XRQQ>6"OE[.B$EB?>EO:WG^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '"W?QC\!65Y/:7&O;)X)&CD7['.=K*<$9"8/(K
MJ=&U[2O$-C]LTB_@O;?."\+9VGK@CJ#[&O ?AT?"(\<^-3XK_L7R_M;^1_:?
ME=?-DW;-_?IT]JU_@BL+?$+Q?+HJL- R1#C.S_6'9C/^SNQ[&G'5*_57%+2]
MNCL>\45X)HOC[XC>)KO6]!T)8;B^@OI/^)A<)&B6L )55  P6R#R0WX]NE\9
M^.O$?AV/P[X6TY+>[\6:C#&)II -B-]TL ,#E@W;  /%+=)KK:WS5QO1M=KW
M^1ZM17B;>,O'WP[\0:7;>.;FPU33-2DV"YM4"M"<@'HB=,@X(.1G!JY\3OB#
MX@TOQE8>%="OM/T@W,*RMJ5_C8I).!E@0!\N,D'KVH[6ZZ!WOZGL%%<9X%3Q
MS#'=)XNOM,OHPJFUN;-1F3).<D!1@<?PCZUYOX1\7?%#QOI^JV6CWVG1SVES
MDZC=QJI"GI&JK&5)X)R1WHZV\K@MK^=CWNBO,/A?\0=3UR'6M+\3+$NJ:*Q$
M\T:A1(HR&) XR"IZ8'(XKB5^)OC#Q=<W5_HWB;PUX=T^"4K#::C<1)-.HP03
MO5C^(VCG';-#W^5_D'_#'T+17FG@SXIC6?A[JNOZM;QI=:1O%TEN<K)@94KR
M>O3KUKF=#UCXO^.+%?$>C7^CZ?ISR$0V4L8_>!6P>2C'VSN7IQBG;6W]:[!?
M2_\ 6A[3>7]GIT(FOKN"UB+! \\@12QX R>Y]*BU?5+;1-'N]4O"PMK2)II"
MBY.T#)P*\,^.<GBE;OPW:37EDMG+*AA$2L&-RH4%W!!&T%N ,]\UW2IXVT+X
M;^)KCQ5J]CJ&H1VTLEK)!"A1%$9X93&H//8@U#?NM]OZ_KR&OB2[V_K^NIUG
MA7Q/8>,- @UG35G6VF+*%G0*ZD'!! )'Y$UM5XGI.N^)F_9Z36]&NXK74K1Y
M)#]GLX40Q+(0P$838,+SP >*WKOXC3#X&CQ9#.BZD]L(@VT<7&=A.W&.N6QC
M%7.T>;RM^),;NWG?\#TZBO&M1^(WB#PA\+-%O]4E2^\1:P2T1N(TB2)3R"P4
M*. 5_$\G K!'Q-\7^$KRSO=:\3^&O$6GW$P2:VTZXB>6W4\DC8JGCU.X<8[Y
MHM[W+YV^87TO\_D?0=<GK_Q,\(>&-4;3-8U?[->*H<Q_9I7P#TY5"/UKJD=9
M(U=#E6 (/L:^>/&U[H.G_M$Q7/B5('TE+5?.%Q;F9.8F"Y0 YYQVJ?M*/K^1
M7V6SV7PWX]\,^+I;F/0]2^UO;('E'D21[0>A^=1GIVIO@_QWH_CB*^DTD7(6
MSF\J3SX]N[T9<$\'!ZX/J!5/P1JW@35OMTO@R#3T:(*MRUK8&V.#G:#E%ST/
MK7'?"#Q#J.I>'_%MQ<-;++;W#O&8+2*'YMK'<0B@,<@<G)IMI7OT5Q6NEYNW
MX'L=%>">$?%?Q5\>^%V;1;S3;>2SD99]0N44/<-]X(J",J, @=.<CFNU^$/C
MK4_&>C7\>M1QKJ.G3"*1T7:'!'!(Z Y!SCBJY=6OG\A7V?R/1J*\7\7:S\1K
M'5KQE\8^$]&MHG<VUK/-&DD\8/'#JQSC ZCDUTWP]\>7OC+X>WNK7,4<&H6G
MFQ.T2_(S*@8, <^HX]JB_NN7;4JWO*/<]"HKP3PCXK^*OCWPNS:+>:;;R6<C
M+/J%RBA[AOO!%01E1@$#ISD<UV/PH^(&H>*O#VIOKR1I>Z5)LGE1-H=<$Y(Z
M C:V<<535KWZ:_(F^WGI\STJN>\8^,M+\#Z,NJ:JMP\+RK"J6Z!G9CD]R!T!
M/)[5Y;I?BKXG?$J6^U#PE>:=HVDVTQBC6X0,\O ."2C\XQTVCGO6O\5]4U_1
MOA+8S:@UA)JKW,276;2.:$G#' 216'! YQV[5,M%=^7XEQ2<K>OX'JUG=17U
ME!=P$F&>-9$)&"589'';K4U<AK-YXD/@.QN_#\VG)J3Q0M))? +&%91N(P0
M<D'H1[5Y=8_$GQ?X:\4:3::SXF\/^);+4)EB?^S98W:#) SE%7!^8'D$'!Z5
M=O?<%WL9I^XI>5SUCQ1X\TOPEJVCZ;?P7DDVJR^5 T"*54[E7YLL"!EAT![U
MU%>*?&O_ )'OP!_U^'_T9%7M=):POYO]"I:2MY(PX_&&@R^*Y/#"7^=9C7>U
MMY+\#:&SNV[>A'>MRO#M/_Y.JU#_ *]?_:"5<U[QUXS@^,-]X4T+[-<K-;HM
MK%<JJQV[E%=I&8#<P W<9[_A26JCW=_P&U:4NRM^*7^9[+7*^-/B'H/@."!]
M7>=Y;C)BM[>/<[@8R>2  ,CJ17!>'_&/CKP]\3K+PAXQNK/45OTWQSV\879D
M'&"%7(RI!!&?>N5^+5MXHF^+FAH;O3XY9I$726121$/,P#+N4Y.[D_>'M19M
MQMU#:]^A[AX.\8Z=XWT4ZKID-W% )3$5N8PK;AC/0D$<CH:Z&O*?$_C3Q)\/
M/ VFP:K+::KXKOIGB22-<1'YN&P%3. 5&,#DUAZIXH^*7P\2UUKQ3<:;JFE7
M$RQRV\" /!G)QE47!ZC.6'%-VOIMM\Q6=O/]#W*BO*?B?\0]0\,IX3U/1YV:
MPOI3)/"L:,9XL(0H+ D$ACTQUK9\'S?$"YN[_4_%(M;.PEMRUI80[2T+9S\Q
MQDG'^U^ I=&WTO\ @';SM^)WM%> ^#_%_P 4_'?AZYCT>\TZ&>SE/G:C=(H:
M7/*QH@C*@@ Y)'<<BI?"?CKXF^/=,N=+TC^R[._L#BZU.X7&[/ 4(%90W#9.
M,>PIV_S^0?\ #'O-%>8?"/QSK?B9]9TCQ$(GU'2I0C31H%W\LIR!QD%3T ZU
MF>,]5^(EIKEVL'C#PKH=DCM]ECNIHXY)TX(R)%?D=.HZTGI;SU!:W\CV*J]O
M?V=W-<0VUW!-+;-LG2.0,T3=<, ?E/L:\Z^'OCGQ!X[\!:E<01V$6O6LA@CD
MD#"!S@$,0,D<$]/2O-_A/;_$#5M1U6]T;7;*WM_[05]36X0%IV))8KF-L<9[
MK32]_E\KB;M'F\[?F>WWWCO1]/\ &]EX2F^TG4KR/S$98\QKUP"<YR=IZ ^^
M*Z:O)?$6N7UO^T)X=TN,V_V62TRVZUB:09$F0)"N]0=HX! XJ/Q+XW\7:]X_
MN?!G@9K.TELX]US?7*AMI&,XR&  R%^Z223TQ26L5W=_P8VK-]E;\3UZBO)_
M!WCKQ-8>.V\#^-OLL]^\>^VO;9=HEX+<@ #! .#@<C%9VH^.?'$GQ:UOPEH1
MM+@%$%K]K55CM!L5F<E5W-U/!)Y(^E':W6_X!WOT_4]IHKQOPGXR\:Z1\3H_
M!7C*YM+][F(R17,$87'REA@A5RORL.5SGO7LE.VB?<76P4444AA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P! 6F? +_C[\8_]?Z_S>O::*J_O<WE;\O\ (35U;SO^?^9X?\)1*WCWXC"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>%["1X(9[:6$SR?O'+.#ND;D;B2<GI^%:^E6']F:-9:?YGF?9K=(?,VXW;5
MSCMTIRU4OE^7^8)[6\_TL>2?98-1_9N>2_@ANI;.UG6WDFC#M%LD9%*D]"%
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M3&<C;C.>AK;I]-.[)MMZ+]0HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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M!IT444 %%%% !1110 4444 %%1^?%YX@\U/.*[Q'N&[;G&<=<9[U)0 4444
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M0ULNH3^+C+IRW]V)M/.G1CS6\QP6\W.X9;YL=NE-TR#Q/J/C?QM8Z%J-MI,
MOHGDOY+<7$FXPIA$0D+VR2<]1Q6EX'O]1\/WLOA74/#FKAVOKF:/48H ]H8W
M=G!:3/!YQC&>E;'A*SNK;Q1XQFGMIHHKC4(WA>1"HD40H,J3U&01D4+6S\O_
M )$)=?7_ .2(/">J:_;>)]2\+^(KV#4I[:VCN[>_B@$)EC8E2'0< @CM4'B^
M778;]G'Q T;PQ8Y @6:UB>23CG<97 ZYQM'2KMM972_%S4+TVTPM'T:&)9S&
M=A<2N2H;IG!!Q7!Z9I\&DZCJ%IXB^'&HZ_K=S=RR#439QW,$R%CL_>2'$8
M&,<?C2WMZ?JT/:_K^B9NP>(M;\4?"G6[J'4[*"_LFNH);RVA\V.=(P?FC^;C
M<,?-SCTK2^&6E>(+/P_IMUJ7B;^T+";3X?L]E]@CB^SY52/G4Y; XYZ]:I^#
M?#>IV_@/Q/H]S816%U=W5X(H(UVQ*)$&W8<#*#.,@8XK1^'NMWLNEVGA^_\
M#FL:;=:;9I%+/=0 6\C* N(W#?-GKP*I;NW9?EJ+>*]7^>AV]>?7FK^*M2\=
MZWX;T>\M[2&&WMY1>S0"3[*&5L[4XWLQQC<<#!^E>@UR&C6=U%\3O$]W);3)
M;36MFL4S1D)(5#[@K="1D9QTS4I7?R?Z#Z?=^9F^(_$NH^%K71- G\0:?_:]
M\',NL:E&D$*(G+-L!"[CD +GZUFZ)XPO-+\2Z9I5YXUT?Q9;:G*T(EM%BBGM
MI-N5RL;$%#@C)YR:U?B!X:FO=7T?Q!#HEMKJ6 DAN=-G1&,L3X^9-_&Y2,X[
MY-5?#,^@:AKEN-/^%MYI,D;;C?7FCP6@AX."ISN)XQ\OK3CJ[L4E9:%C5-4\
M5WWQ#U#PWHM[;V=L-.AN/M<T E-LQ9P=J<;F;C[QP-O3FGZ7J7B;PYXLT_0/
M$FJ6^L6VIQR&TOTM1;R+*@W%'125P5Z$>E9FI:KJ6B_&#5+VSTFXU2T72+<7
M4%I@SJ-\A5D4D;L8((SGD8JW83:MXV\;:3K$NA:AH^CZ0LKQ_P!HH(IYYG79
MCR\G"@9Y[YHCT_'\?^!8'UO\OP_I@^K>+=:\9^)/#VDW]O8P6;PLM]-;+*8%
M>(':B<;F+9.6) 'KVF\4>)[_ ,,6^AZ"^N:>FK7J-YVKZDBPPHJ ;GV @;B2
M %SBK_AJRNH/'WC*YFMIHX+B6U,,KQD+(!#@[2>#@\'%4?B!X:FO=7T?Q!#H
MEMKJ6 DAN=-G1&,L3X^9-_&Y2,X[Y-+I'Y7_ !_X!3U<K?+\/^"96B>,+S2_
M$NF:5>>-='\66VIRM");18HI[:3;E<K&Q!0X(R><FK&H:KXCUSQEJ6B67BZS
M\,O9R*MO;/8I/->(5!\P>8P!&21\H[<T_P ,SZ!J&N6XT_X6WFDR1MN-]>:/
M!:"'@X*G.XGC'R^M3^,==TN>[DTC5_A]X@UJ-#^[FATQ)XCGNK[\K^AIOI\_
MZ_X<2Z_(U=9U[4/!G@.;4]:GM;W4(<('B3R8Y'9]J9!)VCD9.>QKA[OQGJ^B
M6TFN/\1_#&L>4H>71(%A0%>-PBD#ERV,XR#FM9?!^MZU\*)]'OD,5Z+DW%C;
MWT@F,<:R;HHI6R=W VGKP?:J$%SH9=+*X^"UVNHX <1Z-;&WW8R<3$A<>_X4
M:\S[Z?E]WJ'1?/\ /[_0Z3QIXFUBQC\+R^'A$\FJ7JQ>5,!L=7B8C<<$@ X8
MXP>,5F:O/XY\&_9];U#Q+9ZQISW44-S8_P!G+!Y22.%S&ZDL2"1]ZMKQ787$
MNL>##:64AAM=2W2"&,E8$\EQS@85<D#TI_Q+L[J_\&206=M-<3&[M6\N&,NV
M!,A)P.<  FFK73\_PNO^"3K9W[?C9G/>/K'Q%>?$/PK!IWB--.2=K@VVVQ64
MPLL7S,VYL/D$@<#&>]>A:/:W]EI5O;ZGJ/\ :-X@(EN_(6'S#D\[%X'&!QZ5
MRGCR/4;+7/#7B*STJ[U.#2Y9_M-O9J'FVR1[0RKD;L'M75Z/J1U?2H+\V-Y8
M^<"?L][&(YDYQ\R@G'KUI1^&WF_S*E\2?D5O%=[<:;X1UB^M)/+N;>REEB?:
M#M94)!P>#R.]<]X9/C#7UTG7KS6(+#39(ED.F1V:N\ZE>&>4GY23SA1P#BMW
MQE!-=>"=<M[>)YII;"9(XXU+,[%"  !R34_AF*2#PKI$,T;QRQV4*NCJ0RD(
M 00>AHCU?I^H/9+U_0\^U7QG=ZUKNIV-CXXT3PK::=<&V#W2Q2W%Q(H^<[9&
M 5,G .,D@UT7@'Q;-X@.J:==WEC?W>ERJAOK!@8;E'7*N,$@'J",D9%<I=:%
M:>$M>UB35? )\2:=?W;7=M=V>GQ74\1?EHW5OFP#D@].:Z?1[9+WPKK!\/\
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MM )(IE==P8HK@%A@@@$#/TK O[&+3/'6M7?B7P+J7B4WLZG3[JWM%O(XX0H
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M$T%O#%>R%(YV9&>*W_>>7)*5!R57!;&:ZWPW#+!X3TF&:-XY4LHE='4AE(0
M@@]#7*>"Y[OPQ\*[1[O1-4N)XGFWV5O;YGP97.=C%<\'/J<\9JIV4I+HO\V9
MPNXQ;W_X!9\+6GBE[J"_D\=V'B#29<EUCT^./ P<;'C8]\=<]*[>O)]+3^V/
M&6FZCX:\&ZSX<*7!;4[F\MA9QSPE3E3&&_>,6(.<<'O7K%)[(?4R_$']IG2G
M_LF^L[&XW#-Q=QET1>YQD<^F3BN T#Q5J=CXQTK1[CQMI'BRVU(RHSVL44<U
MLZIN&1&Q!4X(YYS5SXEZ;<7&L:%J%UH=WKV@VGF_:]/M!O<N0 C^7D;\<\>]
M9%EIGV[QMX6UC2/ AT#3()YEF>2R2"X8F%L%T0':@(QECR6'%%/66O\ 6XY;
M$E[I/BZ_^+NHP6/C%-.==,CE1TTQ) L1E8"/:['D$9+=_05ZO"KI!&LLGF2*
MH#/MQN..3CM7G_B"ZU'PO\1F\0C0-4U;3KO34M#_ &9")I8Y%D9N4R."#UKT
M"&0S01RF-XRZAMD@PRY'0^])? OZZL'\3_KHBOJGVW^S+C^SIK>&[V?NY+E2
MT:'U8 @D8SWKRX^*=9\/:]IZW'C[1?$:7=_':7&G100Q2V^]MN4V.6.TD9W=
MJZ/XH:7?ZEHVG&WL)]2L;>^2;4-/@?#W,(!RH'&[!P=O?%<;?:;#K0T:X\._
M#>;18;/5+62XN+K3DM[@J) "$5<L5&<LQ(&!WIPUDO4);?+_ #/:ZYOQ]JUY
MH7@;5M4T^3R[JVB#QL5#8.X=B"*Z2N.^*O/PPUX @?Z/U/\ O"I>W]=T5%7>
MIG7-E\2)K7^V[?Q%IT$GE>:-%.GAHCQG8TV=Y/;( &1TKH-,UVY\2^!K?6=*
M:WM+FZMPZ&Z4M'$W1MP!!(!!].E<U+XX\10Z8NDKX(UJ76V@V)-'&ILF;& _
MG;N%XS@@'M5#7O!^IZ;\-O#>D)9S:M;Z=<1RZI8VSX:YC^8LJCC< QSM[XJG
MU72ZM][OYD1OH^O_  %\MR$^*=9\/:]IZW'C[1?$:7=_':7&G100Q2V^]MN4
MV.6.TD9W=JZ/Q%KGB*+Q]9:!HC0 7FG/+NN$#) RR &0XPS?+D!<X)(KC;[3
M8=:&C7'AWX;S:+#9ZI:R7%Q=:<EO<%1( 0BKEBHSEF) P.]=Y<6=TWQ=L;T6
MTQM%T::)IQ&=@<RH0I;IG )Q32VOY_D-];=OU.7^(.E^*K'X=^7=>+5NY?MD
M0FF_LU(VD#2H$4!6PH4\G@[NF17230^)?#/@;7KK4O$O]K7\-K+/;7'V".#R
M2J$@;5R&Y&>:L?$;2K_6/!5W;:9!]HNTDAG2'< 9/+D5RH)[D*:I7FN7'B[X
M?>(A%X>UK3[C['-"EO?VGER2L8S]Q026&>*S;?)*V_\ P$5!+GC?;_@AJOBO
M4[#P7X?ELHHKK7=9$$%OYWRQ^:Z;F=\8X !.!5W0=%\8V.JBXUGQ=#J=FX.^
MT73$@V'MM=3D@>]9&K:%JTW@SPI?:;:>9JNB?9[D6<I\LR@1[7CR?NM@GKW%
M:^A>-+C7-4%BWA/Q#IVT'S;B_M5BA4@'A6W'?DC' ]ZUE;GE;N_N,8WY(W[+
M[Q_@;5[[6=.U26_G\YX-5NK>,[%7;&CX4< =!WZTGA_5[Z^\:^*]/N)]]K82
M6RVT>Q1L#Q;FY R<GUS7,Z3J^J^!;_5M*N_"FN:E#=ZE-=V=WID"S1LLA#8<
M[AL()QS_ $K1\!VVM?\ "5>+-1UG37L6OI;>2%"=P"",@+NZ%@,;L9 -3'6S
M\OQM'_@ERTNO/\+O]+$_PSW?\(QJ.PJ'_M:^V[NF?.;K7+^(?$/B7PS'<ZG<
M?$7P[<7=NGFMH/V:*,..ZJV\RY(Z>]6XM#U^?X3^(M.L(+BVU.?4+MXHWS$\
MB&<MA2<?>7(!]^M8&I:98:MX0U#2O#_PINK#4([9@;K4-.CCV$#GRY/F>1S@
M@8[D'BEY]DOR1273NW^;.[\9>)]7TU/"\NC1+)+J=V(C;O@*^Z)BH9L$J V"
M2.< UM>'=-\164EU+KWB"+4S-M,4,-DL"6_7< 02S Y'WCVK$UVPO)KCP&8K
M2=Q:WJ-<%8R?*'D,,MQ\HR0.>]=S5NRO;N_NT(3;2OV05YO%?^,_$7B;Q/H^
MF:O;Z7::?=HL=\]HL\BAHU;RU0X'7)+-D_-@=*](KR?3=?U+P]XW\:W":%?Z
MMIKWT88::@DGBD$*?\LR064@CD'C!XJ%OKV?Z%.]M.Z_4Z+PUK.NV/B>Y\+>
M);JWOKA+07EKJ$,/E>?'NVL'0<!@<=.,&LVPN/&GCJ!M9T?Q%;:!I33.MG$-
M/6YDG16V[Y"Y^7)!P%[&K7AR#5?$GC2Y\5:EI-SI5BEC]ALK6[ 6=U9@SNZC
M.WH !6=HFJZM\.=-_P"$=O?"VM:I;6\KBQO-*@$ZR1,Q8!QN!0C..>.*?:^]
MOU?XVL'IM_P/\SH_"7B+4-2_MC2M92!-8TB413/;Y$<JLNY)%!Y&1V]17-2>
M,=<A^!L/B<7/FZME"9/+0;_WX4C&,#*\=/UK>\':3JBW>O\ B'6+8VEYK$JE
M+/>':&*-=J!B.-QY)QZURQT?5/\ AGZUTW^S;S[>K1YM?(;S1BY#'Y,9Z<].
ME.W?^[^>H*WRN_R_SV-/6(?B-8:3<>(QXDTY#;0-</HRZ<#%@ DIYQ;>3COQ
MDCM4'Q)O-3UKX9V&J:=J"V%O=&UDEB^S^8[^8\>W#%@ %)R1@YQCBNY\3PRW
M'A#6((8WDEDL9D2-%)9F*$  #J:Y'5]$U2^^"VG:?:6;OJ,%K9R?97^1RT91
MF3GHWRD8/>ITZ[)K\]0ULN[3_+0ZKPUIFN:9:S1Z[XA_MJ9WW1R_8DMO+7'W
M<(2#SSFMNL/PSXC?Q):2SOHFKZ48F"&/4[?R6<XR2HR<CWXK<IL2//K+Q+J\
MO@KQGJ#W>;K3;N^CM)/+3]VL8^08Q@X]\Y[U6L(?B-XBT&QUR'Q+8Z4TMNLR
M:>NGK,L@*@CS)&.06[[0,9]J2PTO4$\ >/+9K&Z6>ZO=1:"(PL&E##Y2HQE@
M>V.M=MX;AE@\)Z3#-&\<J642NCJ0RD( 00>AI?9;ZV7Y%-ZV\Y?FBKX)U^;Q
M/X/T_5KB)8KB9")D3[H=6*MCVR#6W.LK02+!(L<Q4A'=-P5L<$C(R/;(KE/A
MA9W6G^ +"VO;::VG5YBT4T91AF5R,@\]"#77U4[7$M/Z\V>2> -)\63ZYK=V
MWC$"U@UR5+NU&F1D714+DAR2R C P,XQ79:!K%_>^-?%>GW$^^UL)+9;:/8H
MV!XMS<@9.3ZYK!\/WVH^%O%>L:1>>'-7N(=4U9[NVO[2 26ZI(%_UC9&S&.:
MU_#5E=0>/?&5S-;31P7$EJ897C(64"'!VD\'!X.*2V7I^-D$E9OU7W79SOAZ
MX\?>,]!^V6_B.UT9(;F:))!IZ7$ESM=AELX5!T& "?ESGG%+H.H>/_&VFW C
MU>Q\/OI]U)9RW$-F+EKJ1#AF"N0$7IZG(/3I71?#2SNK#P7%!>6TUO,+JY8Q
MS1E&P9G(.#S@@@T?#RSNK+2]72[MIK=I-9O)466,H61I,AAGJ".A[T6UMY+[
M] EOIW?W:D/A7Q5?-X<UR;Q&8FNM"N)H+F:!<+,L:AMX7L2#TKD8?&&LZK:1
MZVGQ)\*Z6[Q^;'HD@A=0.JI+(7#AL8!P!@]JZ70_#\U_:>.].OH)[>'4M1G6
M-WC*[T>)%WKGJ,YY'I7+Z=!IWA^QMM(U_P"$LM_J,"B(WFG:/!<0W&. Y<XV
MD]3NZ4M]>ME^6OD/1:+N_P#@'I?A'Q"GBKPII^M)%Y7VJ/+1ALA6!(8 ]QD&
MMNN0O->C\*^&]&%GX=2UEO[N.U@TM&2$1-(23G8"!@9)P*Z^JE:[:)6VIQWQ
M5./AAKYQG_1^G_ A68^G_$AK!-8M_$>GPR+ )%T4Z>&B/&0C3%M^>V0 ,CI6
MW\1[&ZU/X>ZS964#SW,T(2.-%+$G<.PK$E\;>(K:P&CGP/K<NN>3Y:RQ1H;)
MGQC=YV[ 7C." >U1K:5M^GW%=K[:_FB6_P#&EW?>%?"6M:8YM?[4U.UAG0JK
M?(Q(=.1ZC&1@\5M?$#5;W1/ FKZEITWDW=O#NBDVAMIW =&!!_$5S.I>#]5T
MKX9^'[#3X1?ZCHMU;WKP*X7SF5BSJI/^\<?2L_QGXCU[QGX(U/3=&\&Z]:NT
M8,[ZC;"$[002L:@EI&.,<"K=KV7?\/=_#<(?9;[?J_QM8O\ Q2AUNZM/#?V#
M6DL8IM3M8R!:"1A*22LA);!"D [<<GO7;>'K#5]-TTP:UK?]L7?F%OM/V1+?
MY>,+M4XXYY]ZP/'VGZC<^'-)N=.L9+R?3-0MKU[:/ >1$^\%SWYZ5O\ AW7#
MX@TTWITG4],^<IY.I0"&4XQSMR>.?TH6S2[O]">D6^QK4445(PHHHH ****
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M=\0^._#'A6YAMM:U>&UGFP4BVL[8/0D*#@<'DX% '144U'61%=3E6&0?:G4
M%%%% !7/>']!NM)USQ'?3R0M%J=XD\(C))51&JX;(&#D'IFNAHH0!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% %2ZTRSO+RSN[B 23V;L]
MNQ)^1BI4G'0G!(Y]:MT44 %%%1375O;&(3SQ1&5Q'&'<+O8]%&>I]J ):***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-6U_QAXBM%/]E7\\4=K)@@3>5'M:09Z@GC/?%)Z)V[7O]W]?+U$]_G:WW_\
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MWC2ZL]7DT7P_H%QKNJ0QK+/%'.D$4"MT#R-P&(R0,56\1?\ )5/!?_7*^_\
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M+G3GUM+5(F!/^K5E^Z>HQGK4]?3_ #'TN>UZ#KEGXCT:#4[$OY,N04D7:\;
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M<5=\,Z!X2_X2^PO;/Q_J?B#4K5)&@@N-6CNU567:QPJY'&.XZ"B-GJ_/]?\
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M42*C[0S2.  6 )"@$_SK7U[Q;-I,]KIMAHT^JZY<PF9;&"55$:C@L\C<*N>
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M/'! -3T53=W<E*RL03V=K<R027%M#*]N_F0M)&&,;8QN4GH<$C(]:+NSM;^
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M19&#MP/ER..*N44 95[X7\/ZG=_:[_0M,NKG@>=/:1R/^9&:U$18T"(H55&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M +#]O_Z"]<CXY/CN7X?ZFUYI?A33M%%KN>U,DLD\?IL( 3=G&/>NB\7$M8>
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M$CPAX9OOL.K:Y!!=?Q1(CRLG^\$!V]>^*HZ,6'Q5\8%!EA966![[9*B^$5O
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MQ7<D0R\>QD<#CG:X!QR.<8JAJGAV\UK3O#^IZ=>0P:IIJ"6 W41EB?=& P<
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MAL_,Y1""[L,XR$4%B/?%6]$U_2O$>G+J&CWT5Y:MQOC/0^A!Y4^Q ->8P?\
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M23LPPQ=CR21Q69H/P^TWP^;J*#4-7NM/GA, TZ\O#+;1(>H1"./3DGBNLHH
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MNK!UN8'A+PAIW@W3)+'3I+F999/,>6ZD#R,<!0,@#@   >@JMXA\!Z9X@O\
M^T1=ZEI>I;!&U[I=T8)70?PL1D$?45U%%#UU8+0Q/#GAFW\-P2I'?ZG?S3$&
M6XU&[:>1L9QR>!U[ 5/X?T&U\-Z2NFV<DTD*R22!IB"V7<N>@ QECVK4HIW
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MJK]U^*N*6B=O/\&:Z:_=-\19?#QCA^R)I:W@?!\S>9"F,YQC ]/QKHJXB/\
MY+=<?]@!/_1YKMZ7V5_75C?Q/Y?D@HKS:&TU/XB:IK$K^(]5TC2-/O6LK:#2
MIEADD>/AW>3!)!)P%Z<5H^&+S5-&\87OA'4]1FU.%+-+VQN[A1YWE[MC(Y
M8@XYZ\TEK^?Z_D#T.XHKS#2=-U7XD0W6MW?BC6-+T\W4L5A:Z1<"#$:,4W.V
MTEB2"?05I^);K6+*3PWX0TO5IDOM19Q-J<RJ\JQ1+N=@,8WG(&<8%&NG=_\
M#AU?E^AWE%<QX<\'R>';V2X_X2?7]321-IAU.[$R@Y^\OR@CO^?M4'PXO+J^
M\+237=S-<2B_NT#S.7;:)F &3V   %/^OQL!UU%<AX2O+JY\3^,89[F:6*WU
M"-(4>0L(U\E#A0>@R2<"N:\':5KGC'08KS5/$^KVEM;W<R01V%QY;S!96YED
M(+,/X0HP,"DM?N3^\3T^^QZI117GVH#4_&GC+5="M];OM(TK28XEG;3G6.>>
M:0;Q^\()55 ' ZYHZV0^EV>@T5Y_IAU3P=XUTWP]<ZS>ZOI6JP2FVEOR'GAE
MC&X@R #<"I[],532#7?$GCSQ7HJZ]?:=I-L]NS/:28F!:$?)&S B,9!8D#.<
M=.:/3S_ .]_+\3TRJUU?VME+;1W$PC>ZE\F%2"=[X+8'X*3^%)IMC_9NF6]E
M]JN;KR$">?=2>9+)CNS=S7G?Q(\/OJWB_P ) ZYJ]HEQ=O"%LYUB\G$3-O0A
M<ACC&23P2!C-'5) MFV=9XOUZZ\/V6G36D<+M<ZE;VCB4$@)(^TD8(YQT_E7
M15YCX^TFZT3P+HVGV6I7E]=1ZS:^3=:G+YTC.9"1O/&0"?R%1^*?#NM^%=$O
M/%-IXUUVZU"S432V]U*C6LJ@C<HB"@+D>G2FK6^?Z+_,;6UNWZL]2HKG_$M]
M OACS[C7QH"2A#]LRF5S@E1O!&2..F:\P\/>*M*L_'&BV'AOQWK.OQ7MPT%[
M:ZH7E"KL8AT=D7&"!P,YS0E>7*2W[O,>S-J%JFI1Z<TP%W)$TR18.2BD GTZ
ML/SJS7DNM>$I-8^,C0/XF\06HDTAKA7L[M86C'G8\M2$^YWP<G(Y->J6EO\
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M3Q#J'BGQ)#;VM]=P);6]E!)Y@MH5.[#/T9BQYQQQ6QH'A_\ L.ZUF?[5Y_\
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M<VCEFDTRYE"+-N0+D,<J&4C@GUJM+8^,O$>M^&]3U+1K72;33K[S'L4NUGD
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MCS5*EV(XZ9[5ZE11_7XW_,7]?H<7X,\/:MHOA_7+34S'+>7=]<3K)'A5E\P
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M44 %%%% !1110 4444 %%%% !1110 4455U)[N+2[N2Q6-KM87:%9%)4N <
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MM*V#E5!WDCD=  .375Z_XDU:UO[+0-$LK2[U^YMS/(9Y62WMT& 7; +$%C@
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M'3&:[8:_>#XA1^'FC@^S'2C>,X!W^9Y@3 .<;<>V?>A*Z3[_ /!_R!Z-^7_
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MW>N6O@\_V2+-8I)XHYY)Y&##=(@4*H7!!)Y)(XZ9H>EO.WXV_P P[^5_PO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$C !QTSCFNC^&O\ QZ^)/^P_>?\ H0KMZ*=_RM^-R;?G?\+'%?%(9\(P@_\
M03L__1Z5V%U#]IM)H-Q7S(V3([9&*EHJ6KQ<7U_RL/JG_6]SYUT[0?AAX<L5
MTSQ]HUQ8:U S1O,QNVCNP#Q)&8R5P01QQ@UZEIK>"O#WP[DDCT^:T\-2,YDA
MNK6>4D$X)9&#/M..XQCFNXHJF[H+*]SQ[P]K&A2>*=+A^'-]J5Q9/.5U&R\N
M8V<,)4G</-'[MLXP%(!Z8K3O/$=AX#^).O7OB'S[73M5@MFMKP6[R1EXU960
ME0<-WQZ5Z=11?:WG^/\ PP=_E^!YCI.N_P#"0_&2UOK:TN8M-_L25+:>XB,1
MN/WJ%F56PVWD#) S6OX6Y^(OCK_KK:?^B:[>BC2UO)K[V#U_#\#S+X8>)M-L
M+"W\%WK3VWB"WEN-]I);2#*^8[;@VW;@@]<UDZ_XB^'-QJ=W)I6HZCI_B@D[
M3I=I<Q32R#D!TV!),_[0/'>O8Z*3U'?5F9X=FU*X\-Z;-K$0BU)[9&N4QC;(
M1SQVY[5YS\0KVPA\:QP^,KO4[7PFUB/)^S&5899RQ#+*8OF/RXP/K7K-%$M9
M7$M%8\9\"Z9H%C\5(+CPOHUS8Z1<:1,8IYS*/M+"2/+*LA+!0"HR0,UJ:;XD
ML/AKJNO6'B?[3:6EYJ,E]9W_ -G>2*99<$IE 2&!!X/:O4J*;>UO3\;AZ^7Y
M6/._'6KV>O\ P]L]1L3(UK-J=IY;2Q-&6 N%&=K '![9'2N@^(/_ "3KQ%_V
M#I__ $ UTE%3)7BXKK_DAQ=I*7;_ #N><>*_^1&\'_\ 81TS^:UC_$+PWH2>
M/$U[Q;I%Q?Z!/9"%KB RG['(A)RXC(.PJ>O."*]?HJI.[OYM_>3%6BH]E8\M
M^'UC\,)=?^V>"K"X:ZBB8-=!;KRT!P"I,IVYY''6JOBZ>\\,^(M7T;3HWSXN
MC06;(IQ'<DB*4\?[!#_@:]<HH=G;L-:7L>?^/?!HN_AO;:-IUD;J+37@D%DK
ME#<1Q\,@(YR5S^-<+;:?\#[FX2SCT:__ +3; -ALOO.5O0C../KBO>J*$]6W
MUU#HDNAP/C#?X=\4>'_% LYY],LH9K.[$"&1X$<+MDVCD@%<'ZU@>+?&^F>+
MK?05\/+<7UG%K=HUS>&W>.*+]X %!<#+$D<#/'6O7:*(NS3?1W_&X>G:WX6"
MO,WU^S^'GC3Q#-XA6>WTO5I8[JVOU@>6,,$"-&VT$@Y (XZ&O3**76Z#I8\R
MTG7%\0_&*TU"TM;A--;1)5MKB>(QFXQ*A9E5L-MY&"0,\U';^+=+\ ^+_$]O
MXE:XL8=0O5N[.Y-M))',IC52H* \@KTKU&BG>UK>:^]W!Z[^7X'G'A+5)-:^
M*NO7_P!BN;6VDTRV%M]IC,;R1AW^?:>0"=V ><"M#X:@?9O$O_8?O/\ T(5V
M]%"=ONM^-P>OWW_"QQ-S_P EJT__ + 4W_HY*3PJ!_PLCQR>_FV?_HFNWHH3
MM;T?XNX/7\/P.(?_ )+='_V+[?\ H\5Y[JUWX.T_QQXACUGQ/KGAIC=AA9Z7
M-,L5R"@+2OL5AEB2"!MQCUR:]VF0R0R(KE&92 PZJ2.M>9Z(_CSP=I4&A6_@
MJTU>.#(&H0:K' )LD_.Z.N[<>IZ]:E=%V_5W&W^GX(ZSP1<^&9_#,$7A.XAF
MTR'*CRV)96/)W[OF#'.3GGFJ/Q1MKFY\!7?V6VEN)(9H)S%$NYBJ2JS8'?@&
MIO!V@ZGIUWK.KZS]DCO]6G21[:SR8X51=JC<0"S'J3BNKJI;WZZ?H_T)75/S
M_K\3SKQ%XOT3QA\*O%%SHEVUS%#92)*6A>/:Q7./F S^&:[.R&/#-L!_SYK_
M .@"M*BDU=-=_P#)K]1K1I]O\U_D>-+X>G\1_L_:%!;VC7C6WE736BN5-PB.
M=R CG)4G'O65;:?\#[FX2SCT:_\ [3; -ALOO.5O0C../KBO>J*=_>;%;W4N
MPV-%CB2-!A54 #T KS+7->3P[\9C>W-K<2V!T-4N)8(C(8!YS$.57+%<C!(!
MQD5Z?7+)I%\/BE-K)@_XE[:.ML)MZ_ZP2EMN,YZ'.<8I*_,GZ_D/11:]/S1S
M0\16GQ$\9>'CX=2>YTO2IWN[K4&@>./=L*K&NX EB6YKGO$_AOPCI?CO6M1\
M>:1<3:;J!2>TU.,SF.([0K1.(CP<@$$CG->WT4=K>?X_\,'KY?A_PYY[\-['
MP"LU[>^"+"XC1HU22Z=;@1R#)X4RGD@@YP*N?"G_ )$2'_K\N_\ T>]=M13O
MO_76XNGS_2QQ%DN_XP:\F<;M'MA_X_)6!X9\8Z7\.M#C\,>+#<V%S92R1V\I
MM9)([N,L65D9%(Z, 0>0:]6HI+33^MV_U'_7X6_0X'P;8W>K:AXI\0W%K/90
M:TZ16L4Z;)/*CC*!V7J-Q).#SBLGPGXZTGP;H-EX5\2+=V.L6(-LD LY9/M0
M!.UXRBD,&&/QKU2BG^6B^[^F&^KW_K_)'G_POFN+F3Q9<75H]I++K4DA@DQN
M0&.,KNP3S@C/O6C\1]+O=1\-0S:? ]S<Z?>P7RVZ'F81MDJ/4XS@>HKKZ*&]
MK=+?A;_(=]6WUO\ B<=H_P 3_"^N:I#I5G<7?]IR'#6DEE*CPGOO)7:,?7O6
M'!KUK\./$GB)?$2W%OI>I7GVZUU!87EC)955HVV@E6!'&>H->FT4O-"Z6//?
M#]XWC#XA_P#"3V-O/'HEGIQM+>XGA,9NG=@Q9 V#L  Y(ZFL7Q=/>>&?$6KZ
M-IT;Y\71H+-D4XCN21%*>/\ 8(?\#7KE%&FBZ?GW'=ZOK_EL>?\ CWP:+OX;
MVVC:=9&ZBTUX)!9*Y0W$<?#(".<E<_C7"VVG_ ^YN$LX]&O_ .TVP#8;+[SE
M;T(SCCZXKWJBFGJV^NHNB2Z'#:]&D?Q0\$QHN%2"]"CT C2K7Q-T"X\2>!KR
MQM(/M$RO'.MN6*^<$8,4R.F0"![XKKZ*3U5OZWN"T=_ZVL>!067P/D=+670[
M^'5& W::R7QG5L9*X!QG\:[WQC;OH>J>%?$=M87,^GZ1YEO<0P(9)(H9$"AP
MO4[<#/4XKT"BG?M_7]7%9=3R'QGX\TCQ=H%K#X<^T:A FIVC7-T+:2.. "5<
M99P,L25&!G@YKUZBBCI8.MSS#4?$*>&?B[JM_?6MRVE'2;=+B[AA:46YWR%2
MRKD[2 W(!Q@5+;:Y;?$'QWH-[H*W$VCZ.)IY[]X'CC>1TV+&FX D\DGBO2J*
M$[6\O^#_ )C?6W7_ ('^1YQX\OI/!6O1^+;:!Y([RT?3[A$4G,H!:W8@#^]E
M,_[0KJ?!FB/X?\)V%A,Q:Z"&6Y<]6F<[G/\ WT37.2V'BCQCX@L%UW1(='T/
M3+K[3Y?VQ;B2\D7/E_=X51G<0><@5Z#0M(_UMO\ FV$M9?UOM^1Q/CZVO+>]
M\/\ B.TM)KQ-'NWDN+> %I#$Z%&95_B*YSCZU@>*/&^E^/= NO"_A3[3J&HW
MS+;R_P"B2(EHI;YGD9U & #[YKU6BDNSVW_+_(=];K?_ (?_ #.!\?>9HS>%
MM9^S7%S9Z3>[KKR(R[I&T3)OVCG R,USWC3Q[I7BS0;.#PX+F_MUU.U:YNQ;
M21Q0@2K@%G RQ)48&>N:]?HIIZW?>_XI_H2UI9=K?G_F<1XC /Q4\%_]<K[_
M -%K7;T44NEO4;WOZ!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)$4FHZ:T4<F 2<,"0.!WQUJSXB\;Z=X>NUL?LFI:GJ+)YOV+3+4SRA,XW$#
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MJS@\N:_E$URV]CO? &<$X' '3%1P:!IEM'J4<-MM34I&ENQYC'S&90K'D\<
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M#2*"TC#.<%V)8CZFN=\7V5KJ/Q'\(V5[;QW%M-!?))%*H97&Q."#36C27?\
M1_H'1M]OU0OQ1N+=['1+!'5M3GU:U:SC4_/E9 68>@"YR?>K&J_\E@\.?]@R
M\_\ 0HZOZ!\//"?AB^>]T?18+>Z;/[TLTC+GKM+$[?PQ6S+I%C/K%MJTD&Z^
MMHGABEWL-J/C<,9P<X'44+2WJW^%A/7^O.YR/A6"/_A9_CFXV#S=]FF[OCR<
MXIY4#XX(0,%O#YS[XG&*ZJTTBQL=2OM0MX-EU?E&N9-['>47:O!.!@>F*#I%
MB=<&LF#_ (F M_LHFWM_J]V[;C..O.<9H3MR^2_1_P"8WKS>?_ _R.*\,QW$
MMO\ $*.U)%P^J7"Q8_O&%,?K6E\,KVPD^&^CBWDC06ML(KE<X,4J_?# ]#G)
MYKI-/TBQTN6]ELX/*>]G-Q<'>S;Y" ">2<< <# K U;X9^#=<U3^TM0T&WEN
M]VYG5G3>?5@I ;IW!I7Z>2_ ;U=_-_B<?I3QW'P^^(UW9C_B67%S?/9L#E77
MR\,R_P"R6#5W_A"WB@\#:+#&@6,:?"-H'J@S5^31]/DT5]'^R1IISPFW-O'\
MBB,C!4;<8X]*L6MK#96<-I;IL@AC6.-,D[5 P!D\]*'\+2\OP30F[M/U_&W^
M1Q/PNNK:P^%EA<74\5O;0F<O+*X1$43/U)X KN8I8YHDEB=9(W4,CH<A@>A!
M[BN5UOP3;W7@Q?"^DA+/3WG0S*SLQ\KS-\@4G)R>>OK75HBQQK&@"JH  '8"
MJ;O=_P!;('OIY_FSB?$FOZY/XTM?"6@W%E83RV37DM[=QF4[=VT+&F0"V>>>
MU<YI,&JV7QGTRSUCQ9'K]U'IMP2%LH[<VX)7@A"<YQGGICWKO_$?@[P_XMAB
MCUW3(KP19\MBS(ZYZX92"!P.,T:3X.\/:$;0Z7I<-JUHKI"8R<@/C=DY^8G:
MO+9/%3'1W?G^H2U5E_6Q@>%8(_\ A9_CFXV#S=]FF[OCR<XIY4#XX(0,%O#Y
MS[XG&*ZJTTBQL=2OM0MX-EU?E&N9-['>47:O!.!@>F*#I%B=<&LF#_B8"W^R
MB;>W^KW;MN,XZ\YQFFG;E\E^C_S!Z\WG_P #_(Y#X=2Q1:KXOL;B11JBZS+-
M*C'YS$P7RVQUV[>!47A^YL;KXS^*&LGC<II]LD[1D$>8"V>1WQM%;WB+P#X6
M\63I/K>CPW4Z  2AFC? Z LA!(YZ&K^F>&=&T6Y^T:9I\5I)Y"V_[K*KY:DL
M!MZ=6)SC)S0NC?16_"P2UO;J[_C<U:XCX62(_A.X174O'J=XKJ#RI\YC@_@:
M[>N<3P'X7B\3CQ)'I$,>K EOM",R_,006*@[23D\XS26_P#7J#V,?X901QQ^
M*950"237[O>W<X( I?#JD?$WQR(\!F2R(_WO*;FNLTW2+'1UN5L(/)%S</<S
M?.S;I'.6;DG&?0<46VD6-GJM[J<$&R\O@@N)-['?L&%X)P, ]@*/\K?@E^@[
M[^;O^-SR#X>:)XOO?#C0:=\01ILEM<31W.GG2(9G@EWDMN9CN.2<Y/K7HG@3
MPW+X9TJ\MI]935IKB]DN9)T@6$!WQN&U6('()XQUZ4:_\./"/B>\^V:OHD,]
MSWE1WB9O]XH1N_'-;FDZ1I^AZ?'8:79Q6EK'DK%$N ">I^M-/03U?]>?^9=H
MHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%9FNS:O!IZ/HEK!<W7GQJT<[[5\LL Y
MSD<A<G^AZ5IT %%%4(M7M9M=N-'0L;JW@2XDX^4*Y8*,^ORF@"_16:LVK_\
M"2O ;2W_ +&^RAEN-_[SS]V"NWTV\YK2H **** "BBB@ HHHH **** "BBB@
M HHHH **Y>?5[Y/B?9Z.L^+"329;AHMB\R"15!SC/0GC.*ZBCHG_ %V#K8**
M** "BBB@ HHHH ***H:MK%KHT-O+=%L7%S%:QA "2\C!1U/3G)]@: +]%%%
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M(LC,^2KKQ\A'<$$'%0:?X9\5:OKVGZIXROM),>FNTMK9:5')Y;2$8$CM)SD
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M6X&2/Q^II+9+R_5AU;\_T1LT444AA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5GZWI7]M:3-I_V^^L/-Q_I%A-Y4R8(/RM@XSC'T)K0HH&G
M8Q/#7A73O"MI-#9&XFEN'\RXNKJ4R33OC&YV/4_I6W111>XK6"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFZ=/;P7VH6EK+<ML@CGF5&E;@84$_,>1P/6KE !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%5[/4++4$D>RNX+E8I#%(89 X1QU4X/!'<58H
M**** "BBB@ HHHH **A6ZMWNGM5GB:XC4.\(<%U4YP2.H!P>?:IJ "BBB@ H
MHJ%KJW2Z2U:>);B12Z0EP'91C) ZD#(Y]Z )J*** "BBB@ HHHH **** "BB
MB@ HIDTT5O!)--(L<4:EG=S@*!R23Z5A>'O''ASQ7=75MHFII>2VO,H6-U &
M<9!8 $<=1FC</,Z"BBB@ HHHH **** "BBB@ HHHH **** "BBHK:ZM[R$36
ML\4\1) >)PRD@X(R/0@B@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHJC::O8WVI7VGV\^^ZL"BW,>QAL+KN7DC!R/3-7J "BBB@ HJ*"ZM[H.;>>*
M81N8W,;AMK#JIQT(]*EH **** "BBHKBX@M+>2XN9HX8(U+/)(P55 ZDD\ 4
M 2T51U'6=/TF"WGO;@1Q7$T=O$P4L&=SA1\H/4]^E*VKV*:U'H[3XOY(&N%B
MV-S&"%)SC'4CC.: +M%%% !1110 4444 %%%% !1110 4444 %%%% !1145M
M=6]Y")K6>*>(D@/$X920<$9'H010!+1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?Z\OOW,K6?$']D:QH=A]E\W^U+EH-_F;?*VHSYQ@Y^[C'%'BGQ!_PC6D)?\
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M (*U&TT_5K'4[R_MFM[:SMIA++(\@VJ-BG<.3WQBHOI=:OM]WYEV5TGHN_\
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M[)LN:#X@T;3/#_B;5DTS^S[6PU*Z^TB)S(9G4C=)R!@MQQT'K2V'B_Q5<W\
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MI:MI>A^%;K5-0TZZ,$B+<I#%M &&:1P "<G"@$_+[UWM<1X 4#5O&;8Y.N2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:UZ** &R11S1M'*BNC##*PR"/<52TW0](T8.-+TJQL0_+BUMTBW?7:!FK]%
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M]1TK3M7@$&I:?:WL(.?+N85D7/T8$4NGZ5IVD6_V?3;"ULH<Y\NVA6-<^N%
M%6Z* *T6G6,$4T45E;QQSNTDR)$H$CMU9ACDGN3533_#.@:1<&XTW1--LIB,
M&2VM(XV(],J :U** "JUWIUC?M UY96]RUO()83-$KF-QT9<C@^XJS10!6OM
M/LM4M&M=0L[>[MF(+0W$0D0D'(R"".M/N+2VNK1[2XMXIK:1=CPR(&1E]"IX
M(]JFHH KSV%G<PQ0SVD$L4+J\221AE1E^Z5!'!'8CI2FSM6O5O3;0F[6,Q+.
M8QO"$Y*ANN,@'%3T4 %06]G:VCS/;6T,+3R&68QQA3(^,;FQU. .3Z5/10!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1137=8T9W("J,DGL*
M *%]X@T72[F.WU#5["TGE_U<5Q<I&S_0$@GJ*MSW=M:VCW=Q<10VT:[WFD<*
MBKZECP![UY+/<6/B-[G4_#_PFAUVWNW<OJ%])!;F;MO0R98@\\\=!2:5)+)^
MS9J2RAD,=I>1*A??Y:K(X"[N^ ,9]J/LMOI;\1VU2/3[GQ#HEG>Q6=UK&GP7
M4H!C@EN45WSTPI.36E7!V/PZ\*R>#8HKO1;.ZN);,-+>3Q!YW<IDMYA^8'/H
M>*T/AE<2W7PUT"6>1I)/LJJ68Y) ) _0"J:LVNW_  ?\B$[I/O\ \#_,ZRBB
ML'QMJ5SI'@?6]0LR5N;>SD>)@,[6V\'\.M1)V5RTKNQ=DU_1HM373)-6L$U!
M_NVK7*"5OHF<]CVJU<7UI:201W-U!#)</Y<*R2!3(W7:H/4^PKP^ST+5+CPQ
M':CX.65R\]N#_:+:Q;&>1F&?-\PC<"2=W6O1+;0;C5_AA::;XL9H+^*V5IIS
M*"\$J<K*'!QN& <YJFN5._3^OZN2G=KS.KN[ZSL$C>\NH+99)!$AFD"!G/11
MGJ3V%-O]2L-*MC<ZC>VUG .#+<2K&H_%B!7F?@#4I_'&N+J&NRHT^C1*MC;[
M&03AAC[9M8#(8#"XX'/K6EXNU'2=3\1G3+?P7_PE6L:?#EDD$:PVX?!"N\GR
M@D#/0]*&K6_K3^ON]1K\OS_K[SN['4++4[5;JPO+>[MV^[+;R"1#]"#BJMSX
MCT.RM5NKK6=.@MVD:)99;I%0NI(902<9!!!';!KSWX<)<VOQ"\0V\WAN+PVL
MEE;S'3H+A)8]VYQO&P!1D<8 [5)\//"&A:IINK7^K:;:ZE-)JUXB?;(A*(4$
MK?*@;(49R3C&2:+?E?\ &PK]^]OPN>AWFM:5I]FEY>ZG9VUJ^-L\TZHC?1B<
M&K-O<P7ELES:SQ3P2+N26)PRL/4$<$5Y;\/?!.@7-QXC%]IT%_#9:O/:6<%X
M@FCMH@0VU%;(7)8]!6U\.[.#2M6\8:59)Y5C;:F#! #\L6Z)&(4=AD]*73Y7
M_+_,;T^^QOZ!J$L/AK[9K6MZ;>%)9/,O;=U6$+YA"C/0$#"GW%79O$&BVVHI
MI\^KZ?%?/C;;27*+(WT4G)KRH9_X9TUG!P=]US_V\M757GPY\*#P9<PR:)9R
MW!LV9KR2(-<,^W)<R'YMV><YHD[)R>RM^5QVUMW;_.QW9( ))P!U)K.L_$.B
M:A>R65EK&GW-W'G?!#<H[KCKE0<BN.M?$&GVGP=T6?7X9M06_LH;;[+&N^2Z
M=UP$ R,D_6N)\26US:)IEU;_  PM?#L,&I6QAU2.ZMQ,N9%&&CC&XYSC!)]:
MIQM/E\[$7]SF\KGJ^O\ C/2/#FK:78:A=VL#7SN"\]PL8A14+;CGU("CIUIV
MIZFUW#HUUHVO:9%:SWJ*\DDBNMU'\V8XCT+DCC'H:YCQEH.CWOQ,\(-=:38S
MFZ:Z%P9;9&\X+"-H?(^;';/2K/CBRM=.'@RTLK:&VMH]?@"0PQA$4;7/"C@4
MHZVOW_4J6E[=K_@SMKV_L]-M6NK^[@M;=/O2SR!$'U)XIMAJ=AJML+G3KZVO
M("<"6WE61?S4D5PTFFV7BKXKZK:ZY:QWEII-E ;2UN%#Q;I-Q>3:>"?E YJ.
M_P!(T[PE\2?#,V@VT%@NJF:UO+2V41QRJJ%U?8.,J1UQWHCK:_7_ (/^0/2_
ME_P/\SNY]6TZU^T_:-0M8OLJAKCS)E7R@>06R?E!P>OI2Z?JNG:O;_:--O[6
M]ASCS+:99%SZ94D5Y]%X;TS7_C#XC?5;6.\AMK.T*6\XWQ%F#?,4/!( (&>F
M35FUT73O#OQAM(M'LX+""^TB5KB"V01QNR2)M;:. ?F/2B.MK]?^#_D#TOY?
M\#_,]#HHHI %9]QKNCVEH]W<ZK8PVR2&)YI+A%17!P5+$X!!XQUK0KRWP+X4
MTC6;OQ)?:Q90:B4UN[B@BNXQ+'"N_)*JP(!)/)Z\"A:O^NX]+7_KJ>E7%_9V
M=D;VYNX(+4+N,\L@5 /7<3C%,L=4T_4[/[787UK=VW/[Z"99$XZ_,#BO+/&,
MFHZA\3UTV'PE%XEL].TY)8K":[C@BC9V(,A5P0_"A1QQ^-6_".D^(+;QZE\/
M \/A?29;1XKN*WOX98I7!!1O+3&".1D#O0M?Q_7_ "Z$O3\/T_S/3;2\M;^U
MCNK.YAN;>0926%PZ,/8C@UC^(=2+:#JJZ3KFFV5_:@*]Q<R*8[9C@_O!SMR/
M4=Q7->&K^'P:_BK1+LJEII1;4K4?].T@+X'^ZX8?E6+J&F367P'UR^O4VZAJ
MR-J%UGLTC@A?P7:/PI[Z^GXM?\'[O,I+6WG_ %^GWGK!F2&U$L\T:JJ@O(2%
M7ZY["JVFZUI6LQO)I>IV=]&AVLUK.LH4^A*DXKS?XBSZA=^(?"VBV^A#7;62
M"6ZDTU[I+=)V0*%W,W!"Y)V]_P *K:9H_B,>--%U"R^'%MX8AAE9+V:TU&W9
M98&!!5HT"YP<$'!/%"U?WD7M'Y(]8M+VTOXFEL[J&XC5VC9X9 X# X*DCN#U
M%-LM1L=265K&]M[I8I#%(8)5<(XZJ<'@CTKSI-4/@R[\>VHR-F-4LEZ[FF7;
M@?\ ;5>GO4/A>)/AQJ5SIEV^VWN='74F<G :XB7;.?J1L-+I=]OQM?\ 1EVU
MLN_^7^:/3;:^M+TS"UNH)S#(8I?*D#>6XZJV.A'H>:GKD_AO82V7@>QEN!_I
M5^7OIR1@[Y6+\_0$#\*ZRG)6=F2G?5!6:_B+1(]2&FR:QIZWY.!:M=()3_P#
M.?TK+^(>IW>C_#_6KZQ=DN8K8['7JA) W#Z9S^%4;3X:>#7\.16<FA6$N^ !
MKIX5,S$CE_,^]G/.<U/=]O\ ARNWF=?<W-O9V[W%U/%!"GWI)7"JO;DG@5 =
M7TU=373#J-H-09=ZVIF7S2OJ$SG'X5Y5)J%U?_LZ:B]S<M<2P1RVZW#')D6.
M;:K9/7@"O0?#WA+1=&B@NX+"W?4BF9;^2,-<2LP^8F0C=SZ9Q56U?;_-7)=U
M^/X.QT%%%%(92U+6=+T:)9=4U*SL8W.U7NIUB#'T!8BI[>\MKNU6ZMKB&:W=
M=RRQN&0CU!'&*\Y\):#I7BS6_$^M:_I]OJ-W'JDMC%'>1"58(8L!556R!G))
M/O5KQQIUG;6?AKPO:0)9:/J.J+!<PVZB-6CPSF/C& S#G%"Z=W;\0>C?E?\
M [&Q\0:+J=U):V&KV%W<1G#Q07*2.GU .1TJW-=VUO+#%-<11R3L4B1W ,C
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M^(J&PD?6/'OB#Q %WP:);G3K, Y#2XWS'ZYVK^!I7TOZW^7]+[QVUMZ6^?\
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MQ#HFH7LEE9:QI]S=QYWP0W*.ZXZY4'(JW+>6L%Q';RW,,<TBLZ1O( S*N-Q
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MB0YPS9/ .#R?0TW3M7TS6(6FTS4;2^B4[6>VG650?3*DUP-QX=T[7_C3J/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#@9!Q6_K/AAM7BT)&U"0-I5[%=F21-[3E%(P<$8)SG/Z5T%%.[%8Q?$_A_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4454TR]_M&PCNO+\O>2-N[.,$CK^% %NBFR.(HGD;.%4L<>U8B>*;9XA
M,;#44@//G-!\@'KD&@#=HID,T=Q"DT3AXW&58="*?0 4444 %%%% !15"_U>
MVT^1(F66:=QE884WN1ZXJ>RN_MMOYOD3P<D;)TVM^5 %BBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&
M4.I5AD$8(I:* .0T&X&C2ZO8RGBWS,F>X'^5JUX2A,6EW&HSGY[AVD9C_=&?
MZYJOXET._NM0%SI\6\2Q>7-\RKT/N?I^5:NHV5S%X:^P6$7F2^6L6 P7CN>3
M]?SI7=K]=@ZV^9R:FVU&PUB]N+B%+F5]T*/( V!S@#Z<?A736M[]O\&R3$Y<
M6SH_U"D?_7J.P\)::MA"+RTW7.W]X?-;K^!Q5?2M)U&QL]6L7@/D2J_V=MZG
M)P1Z\9&.OI3>S0+=,M>#/^1?7_KHU4_%7_(;T;_KI_[,M0Z9%XHTJS%K!IMN
MR!BV7=2>?HXK1U?2+W5K&SN 4AU& !BN?ESQD9Y[BFWJF);-$OB__D7)_P#>
M3_T(5CZY_P B1IOUC_\ 034MU9>)-;C2TO8K>V@# NZD$MCZ$_TJ_P"(=(GN
M="M[*PB\PQ.N 6 ^4*1WQ4O8I;H;I.MWUQ);6LFC7$,14+Y[;MH '7[O]:L/
M'>Z5J%U<P6IN[6X8.ZHV)$8#!P#U%5].G\2+/;PW6GVR6RX5W# L !_OG^57
M)[S689W2/28[B/)V2+<!..V0>]4][DK8@U358[GPS>7-HS @>6P(VLA) (([
M'FM33X([;3X(85 14&,?3K5&STJ1[6^%_L\R]8F1(SP@Q@8]_>H('UW38EM3
M81WZ1C:DJ3B,[1TR#WI#'^(/WL^F6KC,,UT-X]0.<&MO QC'%9=W97&J:9&)
M@MM>(XEC*G<$8'CGOQ4'VSQ!M\K^RH/,Z>?]H&S/KMZT>0>90B BTSQ%;)Q#
M$S[!V7*Y(%+%KUC+H,=C!YES=&W$7DI$QYVXYR,8K0&DRV^@WENK>==W"NTC
M=-[L/?H*T-.B>#3;6&1=LB1*K#.<$"BVEGY!?6_J<_JD,]CI.B1!/-GBN(QL
MW8W, >,_I6O9WNIS7*I<Z1]GB(.9/M*OC\!46OVUW/'9O:6_GO!<+*4WA<@9
M[FI+6^U66Y1+C1_(B/WI/M*MM_ =:=[BV-.BBBD,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*J:99?V=81VOF>9L).[;C.23T_&K=% !1110 4444 8IT:\@DD_L_5GMH7<O
MY30K( 3UP3T%7=/TY+!93YLDTTK;I)9#RQ[?A5VB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>annexd_008.jpg
<TEXT>
begin 644 annexd_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWC>2".Y$9\]5QN*M&[+GD<$@\]*+:??^ &W167I&O66LZ!'K,'F16S(S,LP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P/-/CT^RB+F.SMT+QB)RL0&Y!G"GCD#)P/<U#5XV\FOO'?6_FOPM_D<]X#
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M^-$=&O5/\@>S]'^H[2OW/Q2\1++A&N+&TDB!/WU7S Q'K@XS]16)#<175_\
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M\?4UTUK96EC:K:VEK#;VZ#:L,481%'H .*6VM;>RM4MK2"*""-=J11($51Z
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M_P O\OS)M_E^?^?Y',6FIZCK]SKSS:U)HMKI=ZUL%MHX3(550=\C2JXPV[(
M XQR:X^S(D^$&BDEW#:_'DRJ Q_TT_>&!@^HP*]6GT/2;K48]1N-+LI;Z+B.
MYDMT:1/HQ&14ATO3VMUMVL+4P++YPC,*[1)NW;\8QNW<YZYYHB[?A^#O^(WK
M^/XIHYKXCH_]@6-UG_1[/5+6YN3C@1+(-S'V'!/TJ#XB7=L;/P]&)$=YM:LW
MC"G.5$@RWTY S[CUKMF4.I5@"I&"".#6=;>'=$LD=+71M/@1Y%E=8K5%#.IR
M&.!R0>0>M$7:WK?\O\@>OW-?G_F3ZK!-<Z1>P6S[)Y('2-O1BI /YUR_AW4+
M.Q^%5H]U*D*6>GB"Y5\ QR(NUD(_O;@1BNSJA)H6D2ZFFIR:58O?H,+=-;H9
M5^CXR.I[U+5TUW_X/^8T[6?;^OT//K>SN]/T3X8VE\&%S%=(KJW5?]'D^4_0
M<?A7J%0S6EM<R0R3V\4KP/YD+.@8QM@C<I/0X)&1ZU-5RE?[V_O)2M;T_P _
M\SB?AJZQ^']6=V"JNLWI+$X 'FFJMH5UOQ5XC\1VC;]-CTP:?!./NSNI9W9#
MW4$@9'!.?2NE;P=X7>[-VWAO1VN2_F&8V,1<OG.[=MSG/.:V#%&8O**+Y>W;
MLQQCTQZ5#5XV\K?A8I.S^=_QN>66@#>#OA:" ?\ 2[8\_P#7!ZZ#XB6\[GP]
M=K>SV5I:ZFKW-Q"JLT09&57^=67 9@"2"!G-=6NEZ>L-K"MC;"*T(:V00KMA
M(& 4&/EP"1QZU:95="CJ&5A@@C((JY2O*_G<E*RMY6_/_,YE/"JMKFF:G>^)
M-4OY[/S&MHY_LRH=R[6.(XE+<'UJI\-R+3PS<6%RX6]LKZY6Z5L!E)E9PQ'H
M58,#Z&N@T_P[HFD3O/INC:?93.,/);6J1LWU*@9I=0\/Z+JT\<^I:187DT7^
MKDN;9)&3Z%@2*2=OZ\[C9SNGJ8_B]K3,0!-I-LT?^T \@./7&1^8J3PBKV7B
M'Q7:7;@7,FH_:T#<%H&C0*P]0-I7ZK70W^C:7JOD_P!HZ;9WGDMNB^T0+)L/
MJNX'!^E&HZ-I6L(B:GIEG?+&=R+<P+*%/J-P.*$[?E^-P[GE^M*;CP?\0-0C
M<26%YJ$?V<CE7V")'8>H+ C/^S7IVJV-AJ6BS66I!?L<R!'R^S&<8P>QSC!]
M<59GL;2YLS9SVL$MJ0 89(PR$#H-IXI\T$-S \$\4<L+C:T;J&5AZ$'K2Z6]
M/P5@ZW]?Q9R%K/J_AWQ3IFB3ZJ=8L;]9=AN$47-ML7.YF7 =/X<E0<D<FNSK
M/TW0M(T4.-*TJQL1)]_[+;I%N^NT#-:%/H(****0PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHH[4 9FB^(-*\16\\^E7B7*03-!+A2
MI1UZ@@@&IXM5LI]6N=+CFW7MM&DLL>TC:KY"G.,'.T]#VKRKPWYGAK0[3Q=;
MJS6IN;BVU>)1UA%Q($FQZQD\G^Z3Z5TUO?16GQ"\5:AD/##H]K-E3G<H\X\4
M]$KOM^B?ZA9WMY_K8[NBN'TK3[S6/!]MX@FU?4(]7N;3[4DD5RZPQ%AN5?)S
MY;*,X^923ZYYJOHWB6ZO-8\,:Q)+(EAX@T\PO 7)CBN4&\%0>FX>8/?:*?*T
M^5[_ /#_ .30KZ77]?U>YZ!17F^J>*KRRM_%OB.*:4VUD\>F6,66>/S00'DV
M#J=\F/7"8I)]3:PFTZYT1O%=[?-=11WD=W8WOE31,=KMB1!'%C.[Y-O3'2DE
M>WR_'^OQ&]/Z['I-%<3:QW.L^.O$^FW=]>#3K=+5HX8+F2$JS(2<,A#*/EZ
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M]%7:O_ :4=[_ -:_U?[@>W]?UY'24444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,L\4=N%W&5W 4#USTQ7G7P]\(>']9\&6FMZQI=GJNIZH&N;JZO(5F<NQ/ +
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ME;?-#G$B,B!=P*GW/%..K\KV!W2\]_S_ ,CV>H+N]M=/MGN;VYAMK=!EY9I
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M""VK,.I24EU'O@@T_BE]_P"5R=HW_KL30>'_ (AP7:73^.;*Y4OE[.31T2(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&G:CIFF^3JFL2ZM=EBSW,D*1=AP$7@#C]:U**2T5AO5W"BBB@ HHHH ****
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MNV&J75W>:M!/IDUI'92B.&:0Y6Y78&WKQT!.._3KU Y5?'&IM\'7\7F"T_M
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MSJ.H>&O#VH07.I:=HU\@EU.YTR/?<0(T>5VX4D+D\L!D<4-:7^0+<]%HKB_
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M=01U%4/&MWK8\;>&-,T:_:T-]'=I*_WE4!4._9T9@,[<]S26OWV_"X[?E?\
M&QWU%<]IFB#PSH]_YWB/4[GS-TK7FJ7*R>1QU7("JHZXQBO']>\6Z+H0GO\
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M'&&P2<$5Z312_K]?U#^OT.7U&#7=:^'^K6U[I]O!JEU:3QQVL$^]064A07(
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M>]?3X'U&*&*\9<RQPN616] 2!GZXJS13NWN39= HHHI#"BBB@ HHHH ****
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M%T/Q!_;6H:U:?9?)_LR\^R[O,W>9\BMNQ@8^]C'/2D!M45BV_B#S_&5]X?\
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MA?Q3;^)M+GNOLTUC/:S/;W=K<8#P2+U!QQC!!SZ4_-?UL#T=O-_J;U%<$WQ
MUF]/VS0?!5]JFBJQ!OOM44)D4'!:*-OF<<''3-==HFLV7B#1[;5-/D+VUPNY
M21@CL01V((((]J72X%^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO"L,,:1Q(,*B* %'H *H2>'M$EU(:E)H^GO?KTNFMD,H_P"!XSW/>AZW7?\
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ML;06EI9V]O; 8$,,2H@'IM Q4EK:V]E:QVUI!%;V\2[8XHD"(@] !P!3OO\
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M_9Z)?%WDGM4OHIK>27^+? Q.&)'.S:>O>NV\)ZM<Z[X4TS5;RW%O<74"R/&
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M8$BM%$2) D:JB*,!5& *KFO?S)L.HHHJ1A1110 4444 %%%% !1110 4444
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M$# '&3Q6I1V^7Y(7?Y_FSAWT3Q%X9U/5+_P]%8:G9ZA.UU/8W3&&82$ '9*
M00<=&''K65XPUFSUWX3B^LK=K6/[?;QO;NH5HG6Y574@<<,#TK;U3X>1ZIJD
MMZ?%7BNU25MS6MKJK)#UY 4@D#V!'MBM1_!NA/X3;PR;+&ELNTQ[SNSG=NW9
MSNW<Y]:2T7I;\&O\AO5^M_Q5AOC+Q!%X<\//=/8F_DGD2UAM,@":20[54D\
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MI]M?_%[PI]KB67[/8W<R!AD!P4 ./;)JQ9_#*QM+U)6\1>)[BUC8,EC/JKM
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M45V&[8JH-Q&.^0,G\^]KC]:^'6FZOK,NK6^IZSI%Y.%%R^E7I@^T;>!O&#G
M],5/4?0P?AY_:R_$/Q@FM_V6+_R[1IETO?Y.XJ_/S\[L8S5WX5:9:0:=K&HK
M$IN[C5KM7E/+;5E;"@]AU./4FNBT#P;I'AJ_NKS3$ECDNHHXY@[[]Y0L=Y)^
M8N=YR23G JWH.@VOAZRFM+229XY;F6Y8RD$[I&+$# '&3Q5W_*WXDO7[_P!#
MSG5?^$JN?C)J8T)=!:XMM/@\@:QYI*QL3N:+9T^;AC["MGPWX<\8Q^/'\0^(
M&\/Q))9&VD32C,#*=P96<.,$CD9SWKH?$G@[3/$SPSW#W=I?6X(@OK&<PSQ
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MI)>7_!$N=%TZ#P#/I4=G"+);!D\G8-N-GIZ]\UPVK.TG[-EL[L68Z=:Y)/\
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M5WMM'C>P23D*6D82,H/\7"C([4GC..&W\>>"[NU55U.6]D@<H/FDMS&2^[U
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!EZ#H-KX>LIK2TD
MF>.6YEN6,I!.Z1BQ P!QD\5J444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7?G.[8&VYSSG'6I]?^'_ (5\47\5]K.C0W5U& !+N9"0.@;:1N'L<UTM%+R
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M'''#$D42*D: *J*,!0.@ [4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *JZE>_V;IES>_9;FZ\B,OY%K'OE
MDQV5>Y]JM44 ><3_ !AM+:>""?P9XRBFN&*PQR:6%:4@9(4%\DXYXK37X@^9
MX9UK6?\ A&M<LO[,@\[R=5MOLOG\$X0Y;TY..,BH?&G_ "/7@3_K^G_]$FM'
MXD_\DU\1_P#7A+_Z#2;M&_K^@TO>2_KK_D='9W'VJR@N-NWS8U?;G.,C.*FK
MS2WL/B)>>'[35K7Q'8:=MM%DCTG^SUE1@%!"O*3NR1U*@8[5HW/Q!^S_  OL
M?%300I<WJ1)''*^V)9G.WYF[(#DD^@JY*S?D_P!="(.Z7G_EJ=U17CEUXUU/
MP[&VM3?$7PYK\2,IFTBW2&-@A(#>2ZN69AU ;.<5[#'(LL22+]UU##Z&E;2X
M[CJYSQ7XRM?"1L$FTW4]0FOI&CA@TZ 2R$J-Q^4L#T],UT=>=?$C5/[&\3>#
M=0^PWM]Y5W<'[/8P^;,^82/E7(SUS] :GJE_74I=36T/Q]_;>K0V'_")>*K#
MS<_Z1?Z;Y4*8!/S-N.,XP/>NOKD] \=?V]JBV/\ PBOB?3MRLWVC4=/\F(8[
M%MQY/:L_Q?+KL-^SCX@:-X8L<@0+-:Q/))QSN,K@=<XVCI3?02UN=K>726-C
M<7<BNT<$;2,$7<Q &3@=SQ46DZE#K&D6FI6ZR)#=0K,BRKM8!AD9'8UR7A?Q
M9?:WX!U749I[62^L&N8/M5H 8I3&"5D4$D8(P?2J>I^+-8L/A'HGB&.5IM1F
M%DTVV-,S;V3>H&,#<"1P!C/&*=OT_$.E_7\#T6BN4TZS\6P276JZUKMNT36K
ME-+MK-0EN_4'S22SX QR #GI7+^&F^(GC+PEINKIXGM-&,D(*HNG).UQCC>Y
M8@+DC.%' -(#U.BN+\/^,YY/ -_KFN11K=:4]Q%=BW!VNT)()7/K@5R \7ZW
M<V:ZX/B3X4MI3%YRZ%B%HSQD1M*7W[NQ('4=*'H"/8Z*\[UOQS>7'@OP_J^F
MSP:5#K#JD]_=1^;'8@J3DC(!^8;03QZUL^%;#Q-;3>=J?BVTU_3I8RT<B6*0
M.&XQ@HQ4KC/OS3L[M/H*ZLFNIU=%>6V.I>*_%>KWRV?C2PT2YM+F2+^Q3IR2
MR;48A6<NP;##!RHQ@\5Z58K=)80+?212W8C F>)2J,^.2 2<#-);7&][%BHK
MJZ@LK66ZNIDAMXE+R22-A54=234M<%\4%^VQ>&]%E.+/4]8AANES@/& 7VGZ
ME11NTEU#17;Z!_PM?3)9%>RT#Q/?V#?\Q"UTIV@QW.202!UX%=9H>O:9XCTQ
M-1TFZ2YMG)&Y0058=58'D$>AJ^B)%&L<:JB* %51@ #L*X/1T32_C+KFGVJ>
M7;W^FPW\J+PHF#E"V/4C&?7%-;V]?P$]%<[ZBO,=)O/'/BY]:@LM=MM'M[#5
M+BVCNS8I<2RA6X4*<*JJ"!GDFM_PCK>L/JVJ>&_$+P3ZEIRQRI=P)L6YA<'#
M%?X6!!! X]*73Y7_ %&]'^!NZ#KEMXATI=1M(YXX6D>,+/'L;*,5/'U!K2KS
MFU\4:S)\&]5U][S.IVZWACG\I/EV2.J_+C:< #M2?9OB/JFCPZ[!XDL-.=K<
M3II(T]94;C(5Y2=V3WV@8[4/2[[6_*X[:V]?P=CMM=UFW\/:)=:K=QS206R[
MG6!-[D9 X'XU?1Q)&KC.& (R,&N#U+QA?W/P7?Q59,MI?O9+,I50P1\@' 8$
M$9SUJ_XEU_5HKS1M!T+R%U74U:0W-PA:.WB0 NY4$9.2 !TYIM-77G;\+DIW
M29U]%><SWGB_P--976NZ_;Z_I-S=);3N;%;66V+G:K#8<,N<9SSS5WQIKOB&
MP\6^&])T%K?=J:W*2"X7**552)#@;CM&XX!&>E':P^_WG<T5YO/<^,_!^M:1
M+J_B*VUS3-2ODLI(_P"SUMWMV?.TH5)R,]=V:](HZ7#K8***Y?QB=86WC:P\
M3Z;X>M I,]Y=P+(X.1C;O8(!USFI;&CJ**X#P%XGO]0US5-"O==T[Q MG#%/
M#J=BJ*) Y8%7"$J&!';L:S+'4O%?BO5[Y;/QI8:)<VES)%_8ITY)9-J,0K.7
M8-AA@Y48P>*JVOXB/4J*XCQEKFM:!H6D1F_LK.XNYEM[S5I("T%J2A._83@9
M8 #<<#/-7/"MAXFMIO.U/Q;::_ITL9:.1+%('#<8P48J5QGWYH2W!G5T5R_@
M;5[[6=.U26_G\YX-5NK>,[%7;&CX4< =!WZTGA_5[Z^\:^*]/N)]]K826RVT
M>Q1L#Q;FY R<GUS26OW7_+_,//SM^+7Z'4T5Y?H=UX\\8V%\UKXAM]&BM-1N
M+>.X^P)<27 60@ @X55 PO0DE<DTFAZCX_\ %\&H6*ZM8:)+I5V]G/?168N&
MNI%/54<A47!&>O)[4?\ #_+3_,/^&_K[CU&BN,\'^(=3>RUVT\1RPS7FAW#1
M2W4";!.@0.'V]C@\@<5R$'C+5=?MX]9A^(_AG0D?+PZ1*L,AVY^59G9PRL1U
MV@8S0P/8J*\]E\?WMW\+(O$]A!!'<O(L,S,#+%;_ +S9)+\O+(O+?2K?A:T\
M4O=07\GCNP\0:3+DNL>GQQX&#C8\;'OCKGI3MJT*^AV]%%%(845Q_C-]:C9'
MM?&.E>&M/"#=<7-LDDC/D\9D8(%Z=LYS5?X>>)KW6I-8TV^U.QU:33)HT34K
M(*([E'3()"D@,""#CBA:W!Z%E/'&_P $ZSXC_L[']FR7*?9_/_UGDL5SNV\9
MQZ''O74V=Q]JLH+C;M\V-7VYSC(SBO*(/^2)>,O^OC4O_1K5ZCI'_(%L/^O>
M/_T$4UM]WXJXNOW_ (.Q<HHKC?'FOZOH=SX>31XUFFOK\VS0/@+)F-]NYB"5
M 8 DCG I=4AG945QQN=;\'Z#K.N^)M=35HXH?.CMH+);=82,Y53DELD@98\8
MKC9?%^MQ69US_A9/A1YDB\XZ$@A\MN,^6)=^_=VSZ]J- L>QT5Q.L^-;EO">
MAWNAV\;:CKSQ1627&2D9==Q9\=0H!K!\4S_$+P5X3U#5G\26FL@)@@Z>EN]J
M6( =""0X!/1AT[T[.]GWM\_Z8+6UNIZI17*:_K-_9:YX1M[>?9%J%V\=RNQ3
MYBB%F Y''(!XQ3_'NKWVB^'8KK3Y_)G:^MH2VQ6^1Y55A@@CD$BBWYV_%+]1
M7TOY7_-_H:NH:Y;:;JNEZ=-'.TVHN\<+1Q[D4JNX[CVX%:=<OXCU>^L/%OA2
MQMI]EM?W,Z7*;%.]5B+ 9(R.1GC%8^IZSXHNOB'?^&M%N+>"'[!!<"ZGA#K:
MY9PS!1@NS?* "<#!/L4M5]_X#>GX?B>@45Y]XA\1:IX.TG1M'N]?L)]:U"5T
M.K:C$EO!&B_,SLBD#(!50,\FLG3/&5[HFOZ79WGCG1?%EKJ5R+5A:I#%/;.P
M^5@L;$,F1@YYY%-*[L@>BNSU>L34?$/]G^*M%T3[+YG]II.WG>9CR_+4'[N.
M<Y]1CWK!UW5/$6L^+9?#'AK4(-*%I;)<7FH26XG=2Y.Q$0G;R 22:Q/*\0V7
MQ5\)66O7MOJ6R"[:"_BA\AI,H RO&"0", Y!P<].*(ZM>?\ P?\ ():)_P!=
MO\SU2BBBD!B:5XA_M/Q'KND?9?+_ +*>%?-\S=YOF)NZ8&W'3J:L:'KEMK]E
M+=6L<\:17$MNPG3:=T;%20/3(KF_"O\ R4?QS_UUL_\ T3573_&UW8_#W6O$
M&IL;R:SOKJ&% H3=ME*1I\H^@SUHZ7\E^=@^U;S_ $N>@T5PVEZ/\09;NTU+
M4O%MG'&Y5Y]*ATQ#&JGJJREM^??U]JS_ !1XRN)O%-WX=L/%.D>&ELHD>XOK
M\1O([OR$B1V"D!>I.?O"AZ: M=>AZ317 >"/%UQ?>(+SPW>ZWINO2P6RW4.I
MZ?L E0G:RNJDJK@X/!Z$5G:/?>.O%TVN6]EKMKI%M8:I/;1WALEN)9 K<*%.
M%"J,#)R3GVIV_P _T#H>H45QG@W6M;EO]=T'7IH+S4-(>/;=01>4+A'3<I*]
M W!SCBN=T#4/&/B\'4+/QQIMA=1L1-H7]F(YMR"1LD+-Y@/'7C..*77\0]3U
M6BN+\;>+9_#D.DZ?'>Z=::CJ3E/ME\VRW@5%R[G)&>P SR2*YS3/&5[HFOZ7
M9WGCG1?%EKJ5R+5A:I#%/;.P^5@L;$,F1@YYY%-*[L@>BN_4]7HKS;6=7\0:
MKXVOM LO%=GX8^S",VRRV23RWP9<EE\P@$ Y&%R>.:[C1(-6MM,2+6KV"]O%
M)!G@A\H..V5R<'UQQ26JN#T=C1HHHH **Y3QEX@U/3KG2=&T*.W;5]6F9(I+
MD$QPQH-SR$#K@8P/4U)X=T?Q5I=Y+)KOBR/6;5H^(_[.2W:-O4%#R,9Z^U"[
M@]#IZ*\@7QM?>)GDU"T^(GA_PU:),ZV]E.D,LTJ*<!I?,<%,X) 4=#70:;XV
MN]9^&.MZQ%);)J>FQW,+36I$D+2QJ2)$SD%3P1G/7O0](M]BE&\E'SL=_4<<
M\,SRI%*CM$VR158$HV <'T."#CW%</H \:^(K;3=<EURVTRSE@#KIZV"RF4%
M/E:1RP(.?FVKCCC/>L#P!I/BR?7-;NV\8@6L&N2I=VHTR,BZ*A<D.260$8&!
MG&*KE]YQ?]:V(O[O,CTFQURVU#6-3TR*.X6?3FC69I(\(V]=PVGOQUKGO^$U
MU2]\23:?HGA>?4=/M+G[+>:B;N.%8GXW;4;E]N><8Z4_3-4UC4_%'C'2X[^.
M(636ZV320!UA+Q;B2 5+<\\FN3^%6D^)/MFIWDOBK?80ZQ=I<V7]GQC[3(#@
MOYF=R9.#@<#&*45=J_:XY:)^MOPN>E:-KEMKB7CVT=P@M+J2UD\Z/9ET."1Z
MCT-:5</H7BRXB\.>*=7U>9IX]*U&\1 J*I$4?W5& ,^F3S572['XB:U#9ZU/
MXHLM+CG"R_V3%IJRHJ'D*TK-NW8/..,TEK^'XH'I?Y_@>A45S?B\ZPME&VG>
M(M.T&W 8W%[=P"1EZ8VAF"#OG/M7/>"?$^I7?B._\.W/B33/$0BLUNH-3LXT
M7!+%2DBQL5R.#@8X^M"U!Z:GH*3Q2221QRHSQ$"158$H2,@$=N"#4E>2>#]&
M\7W'BWQ%,/&8CBM]647<*Z7&1=8C0X!+$QC;A>"<8SUJ_P"(_&5S>^)]0T*P
M\7:/X7BT\(LUW>B-YI9&&[$:2,%V@8!)SR:.B\PZOR/3**X#P9XPNK^\U;1+
MG4]/UVZT^W6XAU#3V4)<J<C#*I(5P1R <<BLKP[>^,?%D"ZK8^.],AGZS:)_
M9B,+9NACD8MY@(_#GVIVU%<]4HI%W;1N(+8Y('&:6D,**Y/Q9KNJV^J:7X?T
M 0)JFI>8_P!HN$+QV\* ;G*@C<>0 />L6>\\7^!IK*ZUW7[?7])N;I+:=S8K
M:RVQ<[58;#AESC.>>:%J#T.G\5>)CX<MK5;?3YM2U&]F\BSLXG"&5\$G+'A5
M ')[5<T&^U/4=+6XU?1SI-X6(:U-PL^T=CO7@YKSKXA:=XBNOB/X32R\1QV*
MSRW LRE@LAMB(OF9MS8D)&1T&,UZ;IEO>6NF6\%_??;KN- LMSY0B\UO[VT<
M+]!0OAN$M&D6Z**Y'Q3K>K_VYI_AGP\\$&HWD4EQ+=W$?F+;0I@%@N1N8D@
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M2S\F0QD++MC8,%)X.#P<5RGBC5+3Q.TUO'\-_% UU5*6E^UDEN8I!]T_:0_
M!YZD'\:]<HI6V78J^K?]=/\ (\X\5^%=3OK#PQJMSIMKKVH:2FV^L9E1ENE=
M )"N\8W @,,U'X?F\/ZAK5M'9?"F\TV6.0,;R\T:"V6$CG<K9R2"/X>>E>ET
M4[ZW)MI8X/QEK^F_:7TG5_ .OZY N&26WTQ+F$Y'56W94]N@-5-(U+4? WPX
MU'4]3L+D1PW+-I^G7%SOF2)F58XF?YN<GWP"!7H]5+_3+/5(HHKV 3)%,DZ*
M20 Z'*GCK@\X/%):?/\ S_,;)[=Y)+:)YHQ%*R O&&W;3CD9P,X]:DHHH8D<
M9XUTO4QJVA^)='LOM]UI,DBRV8D"--#(NUMI/&X8!P>M6_#_ (MD\374MJ?"
M^OZ9"L9+S:G:B!2>!M7YB6[\XQQ7444=+/;_ #&^YXO8Z/I_@FW?2-<^&LFN
MK',_V74M/TJ&[::(G*^9G#*PSCGTKL9[..;X7ZW%IGA=M&:YM+CR]/CMT21V
M*$ E(\C<>..3TKMZ*3UBTRD[24EZF7X9BD@\*Z1#-&\<L=E"KHZD,I" $$'H
M:XSP_?:CX6\5ZQI%YX<U>XAU35GN[:_M(!);JD@7_6-D;,8YKT>BK<KR<N_^
M=S.*M#E]/P./\-65U!X^\97,UM-'!<2VIAE>,A9 (<':3P<'@XJ/X;V-W8V&
MO+=VL]NTNMW<L8FC*%T+###/4'L:[2BDG;[K?C<;5W?SO^%CSK1/#5SJGA#Q
MEH]W#-:'4=3O?*::,KE7(VN,CE<\Y'6G:3XUUK3+6ST75?!.OOJ4*+"T]G"L
MMJ^WC?YNX  XS@C(KT.BDM/P_!6&]?Q_$\H\7V M?B#)K&O>$=1\2Z2]I'%9
M):6XNA;2 DN&B) YX^;\*M>#M'N(/B-<ZK%X530-,N-*$<,,<*(<B4',@0;5
M<YZ9)P!7IM%$=/Q_$4M?P_ \YTZ_U'PKXWUNTN?#FKWEMK&H)<6U[8P"6) 4
M1#YAR-F".]9^MZ!#X?\ &.K:QJ'@I?$VE:F4F#V]E'<W-K* %*[&Y*G@\=.:
M]6HH[>6@^_F<;X-DTV1+R]TWP)/X?01@ S6,-M-<=<KL4YX(_BP.17)>)M0@
M\4M-%8?#KQ-;^(P"MIJ<MDEKY,@Z,;@/]T'W(/XUZ_10]P6A!9)<1V%NETX>
MY6)1*Z]&?')'XU/113;N[B2LK'%^,-.U6V\0Z-XIT>R.H2Z>LD%S9(P5Y89,
M9*$\;E(!P>M8VIZAJOQ'6STBU\-:SI&G+=Q3WUUJT @.R-@X1%R2Q) YZ"O3
M:*2T^7_#_F-Z_P!?(XKQ58W=Q\0?!-S!:SRV]M-=&>5(RRQ Q8&XCA<G@9KM
M:**.EO7\1MW85Q/BJPU33O%>F^+=*T]M2^SV\EG>6D1 E:)B&#)D@$@CIWS7
M;44=;H7D>:7=]JWQ%O=*LX/#NKZ/I-I>QWEY<:K"('?RSN6-$R2<G'/3BKFK
MIJGA+QO>^);31;O5]-U*UCBNXK$![B&2/.U@A(W@@XX.>*[^BC;;^KAZ_P!=
M3D6F?X@^#=7LI-(U/1TNH7@C&I0B*0DC[VP$D 'UK*TGQKK6F6MGHNJ^"=??
M4H46%I[.%9;5]O&_S=P !QG!&17H=%/J+H>?>(9=3\,?$ >)H=#U#5M-N=.6
MSF33HQ)-"ZR%E.S(+ [NW3%5([G7?$7Q(\,ZS)X>O].TB"&Y13=H!*&9!S(J
MY$8. !DY)SQ7IE%):6\O^#_F#5[^?_ _R/+]2U74M%^,&J7MGI-QJEHND6XN
MH+3!G4;Y"K(I(W8P01G/(Q5NPFU;QMXVTG6)="U#1]'TA97C_M%!%//,Z[,>
M7DX4#//?-=):Z#=0>/M1UYI(3:W-C#;(@)WAD9B21C&/F'>NAIK1+R_X/^8/
M=^?^2/&GL8])\6ZW)XG\!:EXDNKV]9[*]ALTNXA <;$.\@1[?<>OI72?#O1[
MW2I_% NM&BTI+F\66"V@0")4,2X"D *2.AV\;LUZ#14_9MY6*>KOYW.2^&-G
M=6'P[TBUO+::VN(T</%,A1U^=CR#R*S?#OA^>^T?QOIE]!/;)J6J78C:2,KN
M1T4!USU'N..*[^BG+WKWZJWY?Y G;;O?\_\ ,\VT7Q=K?AS3+'P_JO@O7KF_
MM8EMUN-/A6:VF"_*K^86&W(&2".*U_B%&]MHEKXE@0BZT.9;W;QEHL;94Z]T
M)_$"NRKAO$/ASQ5XIU.73;^]TJW\*-*CM';+(;N=%P?+<GY0"1U7M3;<GY]_
MZ^?J))+T[$O@B-M+\&77B#4@5NM2:75;K<>55AE5YZ;4"C\*W?"VLS^(?#-A
MJ]Q8_8GO(A*(/-\S:I^[\V!U&#T[U=O=.M-1TR;3KJ$/:3Q&&2,,5RA&",C!
M''I5B*-(8DBC4+&BA54= !T%#:U_#^ON%KUWZCJ***0PHHHH **** "BBB@
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MO_HYJ=M_3]1-_G^AVM%%%(84444 %%%% !1110 4444 %%%% !1110 4444
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M*I!Z<$<5ZW:*J64"J %$:@ =ABB[M+:_M9+6\MXKBWD&'BF0.C#T(/!J4 *
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MGD9''%4=0\,Z!JUP+C4M#TV\G P)+FTCD;'IE@32Z)>OXEW_ *^\\_N]<O\
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ML8HVB,113&1M*$<8],>E5+#1=*TJWEM].TRRLX93F2.W@6-7/3)"@ TWK?\
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ME^!Y[\)DMT\0>+OLFH:CJ-J9K8PWFHN7EG7RS\VX@;EZX..@%;OPP_Y%R_\
M^PO>_P#HYJZ^.UMX9I)HH(DED"AW5 &<+]T$]\9X]*2UL[6QC:.TMH;>-G:1
MEB0("S')8@=R>2:=_P DOQ)M^=_P)Z***104444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=CU_# ]JLZ#H-KX>LIK2TDF>.6YEN6,I!.Z1BQ P!QD\4UIIY6_&Y+U=_/\
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MUQO7H_F#!W>XJ5LO)E=7YK]#C[CPW\1=9\0:'?:P?"<2:;>+.9; W"S%.0Z
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M%XGM85"00Z]<K%&HPJ+\IP!V&2:Z?P]H5KX:T*UTBSDFDM[8$(TQ!<Y)/)
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M#48Y-T+^9!/#(8Y87_O(PY!K,T#P);Z%J"WTFO>(=5F0$1_VGJ#3+'D8.%
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MC&<_*,<UJ4?92]?S%;6_I^04444AA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D3>%/#ES??;I] TJ6[
MW!OM#V<;2;AT.XC.:UE4*H50 H& !VI:* "BBB@ HK-U[4KK2=(EO+/3)]2F
M1D MH#AV!8 D?0'/X5I#D=,4 %%%% !1110 4444 %%<[XJU^ZT.;0DMHX7&
MH:I%9R^:"=J,&)*X(YX'7/TKHJ.EPZV"BLOQ)K<7ASPY?ZQ-&9$M(6D\L'!8
MCH,^YP*SO"T_C&Y:6;Q+;Z-!;R('MX[!Y&D3/\,A;@G&.5[YH6H/0Z6BBB@
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M.N#<V\@3>J_*LJLQRQ X )J+Q;H&JW.IZ7X@\/O!_:NF[T\BX8K'<0OC<A8
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MV&'RL,H)QDG)ZYKN]1\1ZUKGPTT+6K$W=JMXT3:E+IT7F30PD$.T:D$_> Z
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MW^7LQYCEMN,GIG&>];5%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %5-5>]BTF\DTY8FO4A=
MH%F!*%P. 0"#C/O5NBDU=:#3LS&\)ZZOB;PKIVL!51[F$-(B]$D'#K^# BJ>
MF>(+S5/'.L:7"D']EZ7%$DDNP^8UP_S%0<XP%QQC.3UKG]"U&'P;K/B_1[I@
MEE:J=9M03_RRD!,@'T<'_OJM'X?6W]E>"#K&JR+%<ZDSZI>R2' 0O\W.>@5=
MH_"JNG>72WY_Y6?X$V:]WK?\O\[K\3M*Y?Q[J]]HOAV*ZT^?R9VOK:$ML5OD
M>5588((Y!(KRG7?^$*O8;O5=,\/^-=4OS&[P:];)<,L3<D$.S@!1U^[C!KKO
M$-]<:G\'?#U]=/ON+B739)'_ +S&2,DT15[/S7XM!+1/T?X)GJ%%<3KG_)6_
M"?\ UYWW\HZ3XB'_ $KPA_V'[?\ ]!>DM;>;M^-AOKY*_P"%SMZ*\G^(VMB?
MQI:>'+S3=?U'2$L3=7-IHD;-).S,542;64^6 #T/)(JIX)E_LWQO8V?AOPOX
MKT?0;F&5;V#5;:00(X&Y'1F9MI)R#R,Y%./O?U_78):'2S^)O%WB#4]1M_!U
MEHR6NG7)M9KK5I)<2RJ/F")&,@#(Y)YKJ/#TVO36+_\ "0V=E;7B/M!LIFDC
MD&!\PW %><\'-<]>^%M?T;5[W5?!^HVB+>R>?=:7J$9,,DG +HZ_,C$#W!-.
MM?'<EQX6\0WESIS66KZ'')]JLW<.%<(64JPZJ1T-3>T;^0[7E9=7H=K17F7A
M_P"&6AZ[HNG:[XB:\U/6[F%+EKU[R5&C9AN 0*P"A<\#%7/$=K_PE/C^V\)7
M5Q<1:-;Z:;VY@@E:,W19_+5&9<'8!DD \YJG%I\O7_(E--<W0]!HKR^]\/V7
MPUUOP]=>&S<6EA?Z@MA>6#7#R12"0'#@.20P('(/2I-:T4>(/C%)I]S=W,6G
M-H:/<P02F,SXF8*K,N&"\DG!&:+7M;S_  5Q[7O_ %K8],HKS+_A'K/X=^,/
M#R^'3/;:;JMP]I=6#3O)&6V%ED7>20P*\_6N:UW5K#Q)XMUVW\1>&O%>NZ?8
M7/V6UMM*@D:VCV@%F?:ZYD)/?MBEZ>?X6_S#U\OQO_D>Y45YQ\,+N^^VZQIZ
MZ7KUCH4/E/I\>M0,DD>00\:LQ.Y00".3C->CTVK"05F0S:N?$=U!-:P+HZV\
M;07 ?]XTI)WJ1GH!M[=^_;3KBM/_ .2QZY_V"+7_ -&24EO]_P"0WM]WYG:T
M5XDWAWP[9WLDWQ$TS5EU43L4U[[1.UN07)0J\;8BQD<, !ZU[+8I#%I]M';R
MF:%8E$<C2;RZ@<$MWR._>A;7!Z.Q8HHK-\1?\BSJO_7G+_Z :F3Y8MCBKM(T
MJ*\H\*?#/1/$?@C1-0\0->ZA?O9QO%,UY(GV<%1M$:JP48 7L<D9-+9^)M5T
MGX(W5Z+MY]0M9I+&&YF.YN)S$KL>Y (/X5I*-FX]5_G;\R8N]GW_ ,KGJU4-
M:U>UT'1KK5+TL+>VC+OL +'V&<<D\5Q3?"'P^MHUW'/J2Z_Y61JYOY?/,F/O
M'YMOX8Z5SOB:=?&7P!AUK55>2]AC7+)*R(T@F$;,54A6S@D9!QGC%*WZ?B[%
M1U:[/_*Y[*IW*".XS2U@>%O!N@>$+>9-"L/LBW.UI1YTDFX@<??8XZGI6_0R
M8NZ"BBO&O$\G@/7M:NKF71/%'BJXCE*,VF+<2Q6K  $(0ZH.0.F>:F^I1[+1
M7E&@7]SJ'P(UQKF2[=H8+Z!#>?ZY47>%63_: X/TJ?1OA?HNO>%-+U'79+Z^
MU>2SCD6\:\D5H"5! C52%4+QCCMDYIO2[[6_%7$MEYW_  /4**Y+X9ZA=ZG\
M/=*N+Z=I[@*\32N<L^QV0$GN<**ZVG)6=@7F%%174XMK2:<C(BC9\>N!FOGW
M3[S2/$UC%K/B7P;XZUC59RTR7EI;R^3#DY40;9  H &#CJ*F^H^A]#T5Y3]M
MU>]^ NNG68+^*ZAMKF)#J$)CG>(9V,X/\6W&3W(JU'\+=%U3P];ZEJTU_=:\
M;19!J1O)%>)]N1L4':H!Z#%.6EWV_P KB6MEW_SL>F45Y/--J&J_"#P[XK+/
M<:MHXCO]V?FE5"5D!/NF[\:V_&]U'XDM= \.V;EXM=F2:9D/2T3$CG\?E7\:
MIQUMYV_X/W7^X2=U?RO_ %^'WG5K-J__  DKP&TM_P"QOLH9;C?^\\_=@KM]
M-O.:TJX>!53XUS(H 5?#Z  =AYYKG/"_@^S\7GQ&OB"2XNM-AUN[2"Q2=XHP
MV_<7;806.3QG@8]Z2UMZ7_&PWI>_E^5SUNBO.]8TV/Q9X\;PK>RSQZ#IVFI/
M):03-%]I=V*@.5()0*O3/4U7?0K7X<^*?#J^'GGM]*U2Z:RN=/>X>6/<5++(
MH<DJ00<X/>A:V\]OQ_R$W:_E_P #_,],HKS#4/#Z>)/B_JME>75RFF#2+=KB
MV@E:+[0=\@4,RX;:,MP",U)IGAZR\#?$S2=-T W%MI>J65PTUDT[R1AX]I#J
M&)(/.#S0M;>?_!_R!NU_+_@?YGI=%>5V_ABV\5?$;QI::O-<2Z3&]J38QSO$
MDDC0CYG*$$X &!G'M572_ ]H_C?6O"37VH?\(M;6L-RFEBZ<+ODRNW>#OV84
M_+NQD^U):V\U<IZ-^1Z]17G/A72+?PC\2K_P[I#31:/)I:7B6CRM(L4GF%25
M+$D CK7&ZCJNG>*O$6MMXE\+>+=>M;6^>ULX=,@D:UA6/Y<_(ZYD)R3GL11V
MM_6MA=[]/^'/>**\S^']YJ+Z9XDL9M.URTTFW ;31K4+),J,AW)DYW!6'')P
M"*S? _PVT7Q-\/\ 1+WQ(;O4;EK8&#==2(MLG15148 8 ')!)--K]/Q_X85_
MU_ ]9N+B*TMI;B9@L42%W8]@!DFH=+U"'5M)M-1MU=8;J%)HPX 8*P!&<=^:
M\RL+3^V/@]X@T_5KBZO%TR:^@BE>X=7<1;MF\J1NQZ'@X'%;/PW\(>&_#?AF
MPUZRLEM;NZTV)[NX:=R&!4,Q(9BHYYX HTU?33\5<;OI;NU]QW]<U\0-5O=$
M\":OJ6G3>3=V\.Z*3:&VG<!T8$'\17ENN?\ "#:K+=:G9Z!XSUV[;S&BUBR2
MX=8&R2-C,Z@*#TP",5T>KW]SJG[.37MY*TMS+I<9DD;JQR!D^]):J_I^+14;
M<R1ZA Q>WC9CEF0$G\*DJ*V_X]8?]Q?Y5+3>YG'X4%%<O\0];NO#_@;4K^Q8
M)=A5BA<C.QG8(&_#=G\*SM*^%/AJQNK35)DO+O6H2LCZC->RF25QU+#=M(/3
M&.G%):^A3T]3N:*\WN]*M_B!X\US2];DN)-&T>.")+".=XDFDD7>7?:06QP!
MSZT6.F1> OB!HVC:/+<+HNL03K]AEG:58)8@&#)N)(!!((S32O;S_P"#_D#T
MO;I_P/\ ,](HKRC3?"5IXK\:^-8=9FN9M*COXP+".=XHWD,*99]A!;@+@9Q6
MIX0TR+PK\0M6\-Z;+<#1SI\-Y#:RS-(L#EV4A"Q) .,]:%K;S5_U$W:_D['H
M=%>*WGA_0;?5KNX^(FE:M)=FYD>WUQ9YWMEB+9C ,;?N=H(X90."<UU'C2.V
MBT/P;'9W#7%JNMV(BF:7S2Z\X._^+([T+6WG;\1O=KU_ ]"KE_%6KWVFZWX6
MM[2?RXK[43!<+L4[T\IVQR..0.1@U6^*I ^&&O9_Y]Q_Z$*K>+_^0SX#_P"P
MH/\ T0]$=6O5?DV$M(OT?Z'5OK%JFOQ:+EC=R6SW0  P$5E7GGJ2W'T-7Z\D
MUGP%X;U[XRM;ZI82744VD&Z=7NIO]9YVW((?(&#C:,#VK?\ &\GA2RTO3M U
M5]1:/;BWTS37F:6X15V[6"'<RX]3U[TOLI]7_F_\AM>];H=Y17C'@.:PT[XC
MVVG:!H7B'0=,N;&9YK'5D=$>167#QAG;GD@G/I6E;^%[?Q5\2O&=MJMQ=/I,
M;VI:QBG:))7:$<N4(8@ =,XYIVVMY_@+O?I;\3U6J%IJ]K?:IJ&GP%FFL#&L
MYXP"Z[@![XQ^=</X:T>W\(?$NY\.:2]Q'HUSI(NUM'G=UAD$NTE"Q)&0<GGK
M6/X:^'7A:^\?>*9+O39)Y-.OH&MGDNYF9"8E<DDOEOFY^;-"U:[6?YV$]%YZ
M?CJ>OT444AA17#^.)KG4?$'AWPM%=SV=MJ<DTMW+;N4D:.)0WEJPZ;B1G'.!
M6!XE\(:5\-M''B;PHMQI\UI/$US +J1X[J-G"LK*[$$X;@C'-"UMYZ?I^;!]
MEO\ U_D>KT5YQXNL;C5_B9X<L8;V>SAN-.NA<O VV1HMT9*JW\)) &1SC./6
MNP\/>&-'\*V4MGHUH;:"64S2 RO(6<@ DER3V'>FEI?^M["OKH:]%%(S*B%F
M8*JC)). !2&+17AVN/X#UN^N-1@T'QAXDN&D=DU'3TN)$MVSQY;%U4 'I@$?
M+6C?:A=:I^S8MW>S/-<-;QJTDARS;9PH)/<X S32NON_%V']I+U_ ]@HK*UX
M@>%-3)X'V*7_ - -<%<:E>V/P5\,6^GW#VUSJ,=C8+<1_>B$FT%@>QQG!]:5
MM[>7XB6J3]?P5SNO%=[<:;X1UB^M)/+N;>REEB?:#M94)!P>#R.]4X=0UV?P
MKH-YI]O!>7=R+9KLS,$ C8 R.,8&1G('Z=JX[Q3\,="T+P9K>H:(U[9ZDME*
M\MS]KDD-R IW"16)5@PSVZG(JQXA_P"2=^"?^O[2_P":U45?[U^HGT]'^AWT
MVKVL&N6ND,6-W<PR3H . B%02?Q88_&K]>4^)O WAW7OB]81:I8R7,=UILTT
MJO=2\NCH%QAOE !/ P.>E:OBBU$=_P"%/ VG3SZ?IET)/-:WE99/(@0$1*_4
M9R 3G.!4K5+N_P#@_P"13M=]D>@T5Y1XE\(:5\-M''B;PHMQI\UI/$US +J1
MX[J-G"LK*[$$X;@C'-:'BZQN-7^)GARQAO9[.&XTZZ%R\#;9&BW1DJK?PDD
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M;\-V&CQS-.MI$(_-88+'N<=N>W:M6BA:*P/5W"JFJVKWVCWMI$5$D\#Q*6/
M+*0,^W-6Z*32:LQIV=T9/A?2Y]$\*:5I=RT;SVEI'!(T9)4LJ@'&0#CCTK.\
M+^&)-*\+7.C:IY$ZW$]R[B,DJ8Y9&;'('.&YKIZ*J3YFV^O_  XEI:W0\[M/
M#WQ"T"VBT;1-9T.?2(ALAN-0@E-U!'V4!3M?:.A.*ZGPIX<A\+Z&E@D[W,S2
M-/<7,@ ::5SEG('3)[>F*VZ*+L5@HHHI#"BBB@ HHHH **** "BBB@ HHHH
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M+\R<J"".W%7_  1KUWJ/A^=-9E4ZIID\EK?/@+ED/#X&  RX;CCFEY^5Q_\
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M7*+-%N7< V>,KG!JI+EO?H*/O-)=3NJ*\Q5_B)JGABW\36^OV%@?L8N5TK[
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M!K%OK5OJ%K+/;WBVBV\B/&5W*RJ=N,-UZT+6WG_P?\@;M?R_X'^9W2SPM</
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M;L]0O(C;S7-[$J6L*MP["4,0^ 3@#K^E=9XOT&Z\066G0VDD*-;:E;W;F4D
MI&^X@8!YQT_G714WK>_5_H@7NVMT7ZLX3Q%X=U'3?^$8U;1+;[?<Z I@>UWA
M6G@9 C;2>-PP" :R]:U/5OB/8KX>LO#&MZ5:33QF^O-5@%N$B5@Q"#)+D[0.
M.*]/HHN[W?>_SO?\Q6LK+32QR&HV5RWQ2T"[CMIFM8=.ND>8(2B,3'@%N@)P
M<#VH\;6=U=ZIX2>VMIIE@UE)9FCC+"-/+<;FQT&2.3ZUU]%"Z>7^=PMOY_Y6
M.,\9Z_8VK_V7J?@K6]>M9%W;K33DNHL^ARV01[@>U9GA;3-2@\)>)4_LV]L-
M-N5<Z5IMT^^:%#%@K@$[06Z)GBO1J*EJ\6NY5]4^QY=J^CZS<?!30-.L;*7^
MU8Q8 0R1L#&RNF=XQE0,<Y' !JQK'B_Q#J^EW>@6?@G6X-8N83 TUQ&@LXBP
MP6$P8A@,YX&37I-%5)\S=^KN*/NV:W7_  YP'B3P_<V/@WPMI%E#-=G3]0L%
M<Q1EB$C8!G..@&,D]JT=3L[J3XJ:#>);3-:Q:?=)),$)1&+1X!;H"<' ]JZZ
MBGS-N[[M_>K"MI;RM^-SD?"5G=6WBCQC-/;3117&H1O"\B%5D40H,J3U&01D
M5C^![_4?#][+X5U#PYJX=KZYFCU&* /:&-W9P6DSP><8QGI7HU5[[[9]@N/[
M/\C[;Y;>1]HSY>_'R[L<XSC..:F]ONL.U]/.YY;XULKVT\5RZ#IX86_C'RTE
M93CRFC($S=<_-%QP.HKU:"".UMXK>% D42!$4=  , 5R/AWPUKK>(3XC\67E
MA/J20&VM;?3T<06Z$Y8@O\Q9L#D]*[*GM%+^O+[D)ZN_]>9Q7BJQN[CX@^";
MF"UGEM[::Z,\J1EEB!BP-Q'"Y/ S2^,-.U6V\0Z-XIT>R.H2Z>LD%S9(P5Y8
M9,9*$\;E(!P>M=I12V2MTO\ B4W??M8\RU/4-5^(ZV>D6OAK6=(TY;N*>^NM
M6@$!V1L'"(N26)('/05O7%G=-\7;&]%M,;1=&FB:<1G8',J$*6Z9P"<5U]%-
M.VW]:6%_7XW"O*?%]@+7XA2:OKWA+4?$VDO:1Q626=N+H6T@)+YB) YX.[\*
M]6HI=;CZ6/,O!VCW$'Q&N=5B\*IH&F7&E".&&.%$.1*#F0(-JN<],DX K?\
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M($&U7.>F2< 5O>"+.ZM-2\6/<VTT*SZS)+"9(RHD3RT&Y<]1D'D>E=?13O\
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M9Z55\3W-WXH\,:#>6NBZK;M_;5K(]M=6Q6:-%EY9E!.T8&<GM7H%%"=OOO\
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M_F3;;R"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M U8M[:"SMT@MH8X(4&$CB0*JCT ' I+2U^BM^%OR&];VZ_YW..^%RJOAW42
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M),<BAU)4J2",C@\C\:\Y\=ZI_P (;XMMO$:J2M]IL]B5_OSI^\A'U)W"O2@
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M>)HIHTDC889'4$$>X-4]-T+2-&#C2]*L;$/]X6MND6[Z[0,U/2WK^(6ZKR_
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MP!_N"M6>WAN;>2WGACE@D4H\<BAE93P00>"/:EBBC@A2&&-(XHU"HB* J@<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6KY;.SZ?U^A-U:YZ?16=)K^C1:FNF2:M8)J#_=M6N4$K?1,Y['M6@2%4LQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^E5/$OA :W?6VK:?J=QI&M6J-'#>P(KY0_P.C<.N><&EMR^2_2WYC>KEYO\
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MU[KUU;>/-)T)(X3:WEG//(Y!WAD*  '.,?,<\4=;!TN=#1110 4444 %%%%
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M*\D,BDJ'QU8$$9[URO@V^\8Z1IFJ3:/H=OKUE/J]V4A^VK:RV["5@>7!5E.
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M'Q!TB^USPF]EIT'G7!N;>0)O5?E6568Y8@< $T1TL_/\+Q_X(2Z^GXVE_P
MJ>+]0U2Z\0:/X6TF^;3Y+]);BYO(U5I(X8\9" \!F+ 9[5BZEIVJ_#@66K6W
MB76=6TUKN*"^MM6G%P0DC!-Z-M!4@D<=#70^+= U6ZU/2O$&@/ =5TTNGD7+
M%8[B%\!T+ ':> 0:Q;BR\7^.IK*TU[0;?0-(M[I+FX3[<MU+<E#N51L "KG&
M<\\41Z>NOI?_ "_$);/TT];/]?P,_P 3>%7UCXNV$3>(]>M!/IL\JM972PF$
M*Z#8A"\*<Y.<DD#GBO3=/L_[/TZVL_M%Q<^1&L?G7+[Y),#&YF[D]S7(^+=/
M\0VOBG2_$WA_3(=5>VMI;6:R>Y$#,KLI#*[<<;><UUVGS75QI]O->VHM+IXP
MTMN)1)Y;$<KN  ;'K0OAM_6XW\7]=C-\7ZZ?#/A+4]85%=[6 O&C' 9^B@^V
M2*YS2O VKSM9ZOJOC7Q VI';+-!;W"QVGJ4$6W&,9&>O>NJ\2:)%XD\.:AH\
M[E$NX6CW@9*'LV/8X-<MINJ?$.R>UTJ\\*6-TD>V-]6BU-4C91_%Y17?G Z>
MI]*4=_/0);?>&KOJ7BSQK>^&K36;O2=.TZUCENY;!E6>623.U0Y!V  9XY.:
MALH]6\$>+]'TB76[_6-&U821(VHN))[>95+C]X "RL,C!'&*NZYI&OZ1XKE\
M3^&K6#46N;9;>]TZ:<0F39DHZ.00#R1@\5#INE>)/$GBG3M?\2Z=;Z1;:8DA
MM-/CN1<2-*XVEW=0%P%Z >M.'3\?Q_X%@EU_#\/^#<HW-MKGB#XE^(-&A\07
MVG:3%:6TDGV1P)0S!AB-FR(\\DD#.0*LZ#!JGA;X@1^'9-=U#5],O-/>ZB.I
M2"6:&1' /SX!((;IVK9TG2+ZV^(?B+5)H-ME>6UJD$N]3O9 ^X8!R,9'44MW
MI-]+\2],U=(,V,.FSP22[U^5V="!C.>@/.,41TY?37\?^ $NO]=O^"<\;74O
MB!XDUR(^(M4TG2-)N19Q1:5,(9)90H+L[X)Q\V-OM4?ARQU'3/C%>V>H:C)J
M*QZ(GV>YF4"5HS-T<C 8@YY &1BKEU8^*_"7B+5;_P /:-!KNG:K*MQ):F\6
MVE@FVA68,P*E2 /?-2>']'\3-\1+CQ%KEO;017.F"W2&WE\Q;<B3(0L<%CC)
M)"@<XHAT]'?UM_F$^ORMZ71=^'EY=7NEZN]W<S7#1ZS>1(TLA<JBR8"C/0 =
M!VIOAR_N9/'?C2&>ZFDM[:2U\F-Y"5B!ARVT'@9/)Q6/9V_C7P=J6IV>E>'+
M;6],OK^2\AG_ +06W:#S""P<,#D Y^[GBM'P3H.O:=K_ (FO]?6W+ZG)!*C6
M[9CX0@H,G/R\#) SUI+:Z[?C9?\ !$]+KS_"[,;0](U?XC:;_P )'?\ BK6]
M,MKB60V-GI-P+=8X@Q4;SM)=CMSSZTWXB^&YKF[\&V\GB'65W:A':EX9DC;=
MY;DS A<B0XZYP!T%6=-MO&O@2!M&TGPY:Z_I*S.]G*NH+;20(S;MD@<'=@DX
M*]A6MXOTKQ!JVBZ)J%C:6K:QIEW'?/9&;"2$*P:-7(_VN"<4]-&MKH;OJNNO
M_ .AT'1O[!TI+#^TM1U':S-]HU&?SI3D]"V!P.U7YYEM[>6=_N1H7;Z 9JAH
M%[JNH:6MQK.CC2;PL0;472W&T#H=Z@#GTK1DC66)XW&5=2I'L:4KV=MPC8\S
MT/0M8\>:1;^)=1\6:YIINR9K6STNX6&*&,GY PVGS#@ G/J16CHFMZM)X>\5
M:7J=T9=3T3S81>(NQI4,>^.3CHV#SCN*IZ9#XY\$62:#IOA^UU_38G9;.[_M
M!;9X8B<A958?,1GJO4"M31?"VI6'ASQ!+?O%/KFM>;-.L)Q&K%-J1J3V P,F
ME/X9<NUOQ_SWN./Q*^]_P_JQG^"]%UG7]'T#Q%K/B355D6"*6.RM9_+A==HQ
MYW&Z0MC<<GOBO1:Q/!]A<Z5X,T73[V+RKJVLHHI4W!MK!0",@D'GTK;K2I;F
M:6UV1!:*YPWQ#N]8@O\ PM;Z+?&TGN]3\AW.2NPQ/DLN<-CJ >,@5D>(=&UG
MP'ITOBBQ\6:WJ0MI$DO;/4IEEBFB+ ,$ 4>61G(QZ8J]\3XK^:_\(+I<T4-\
M-6W0M*"4+")SAL<X.,'ZU6U>V\<^-X1H&I>'[30]*>5/MMW_ &@MPT\:MDK&
MJ@%<X'+=C4QZ>OX:?\$I[Z[6_P RYXROM:;QGX6T_1;][3^T(;I97/S*BA4.
M_9T9@,XST)I^KK=?#WP;?W%IJVI:MJ%U<1QP2:K<"79+(P08   4$YV@5I:Q
MHU[<>/?"^HV]ONL;"*Z6>3>HV;T4+P3DYP>@-7O%_A[_ (2CPU<Z6MP;>9RL
MD$P&?+E1@R''<9 S2T2^?X77Z!JW\E]]G^IR]UX%U^PLIM5L_'6O3ZS'$9/+
MN)4:TD<#.WR=N%!QC@\5%?>)KNXT+PAXXCFGALC(B:E:QNWEE)1L+%>AV/@@
MGL34L]_\2]0LI-%;PUIUI-)%Y3ZP-1#P\C!=8@N_/)P#W%='%X1L8O 8\)DE
M[06?V4L>">/O?7/-.]M?2WXW_#\1)7LO6_X6_$SO&%[=W>O>'O#FG7<UO+=W
M'VJZD@<JRVT7+#<.1N8JOXFG:1?7+?$OQ3;2W,S6MO:6;QPM(2D9(?<5'09P
M,^N*I> -"\00WMWK'BN%(]2$$6GVX659,PQCE\CIO8EL=>!6II>CWUO\0O$>
MISP;;&\MK6.&3>IWE ^X8!R,9'446MHNS_2WZ?B/>]_+\]?Z[',>'])U?X@6
M"^)[SQ9K>FQSS2-8V>F3+#'%$K%5W@J?,)VY.?7%3>!+B[TFX\=W&KSI<7%I
M>[Y9D78)%2!2&QT!*@$]LYI=+MO&W@B-M#TOP]:ZYI(G=K.Y_M!;=K>-FW;9
M%8$M@D\KV%:/@_PUJ]K+XJ'B(12'5KH2;X2-C(T04JHSD!>5YP3C..:3V?+V
M_'0>E_>[_AK^ECS6#QUH&M6\>JZQ\3M;TS5GRZV5A#(MM;'/",@B(DQQDD\U
MZU\//$DWBOP58ZK<E&G<O'(\:E5<HQ7< >F<9QVS7/Z:WCWP;I\&A6OAJV\0
MV5L/+MKU-22V81#[HD1UZ@<9'I7>:6^H2Z;"^J0007K F6*"0NBG/ #$#/&.
MU5I9VV)UOKN7****D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 8OA?P_P#\(WIMQ:?:OM'G7D]UO\O9
MCS'+;<9/3.,]ZVJ** "BBB@ HHJDVKV":TFCM<J-0> W"P8.3&#@MGIU- %V
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK-\0:W;>&]!N]8O$E>WM4W
MNL(!<C(' ) [^M:".)(U<9PP!&: '4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 450UO5[?0=#O=6NDE>WLX6FD6(
ML0!DX!(&?QJU;3K=6L-P@(25 ZANN",\T 2T5ER:]:Q^*(?#YCF^URVC7:N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<\:;"9K"X-T)5E/55V[8T3..20 ,9JJCO)\OR\]_O)AMK_PW^1W?BS7D\3?
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MH?F+>V<3[P65-X*-W5A@C-4-)U;XBZB;34Q8^%I-(N0LBPPW4QG5&QSOQL)
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M_P#L%1?^BQ5?X5_\DOT#_KV_]F-:U%:4TNG^;_R,XO2/G_D2:?X\M+CX>?\
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M";=P4$X.".E+3W;^7Y,'=\UOZU1IP:_KFG>*-&TC7XM/V:E9OB:S5]HNDY9
M6/W2G(XSP:MZOX@N[?QAHF@:?%"[W0DN+QY%+>5 @QD8(PQ8@ G(Z\50\5+%
MXJ\#P:YH;&>:T9-3T]]C(7:,YQA@"-R[EZ=ZK> )QXFU/5_&A#>3>LMI8!AC
M%O'U..O,A?KZ"J6^O3?]/QT^0GM==?Z?X:G>45BZ'XGLM?OM6M+2*Z232[G[
M-,9HMJLV,Y4YY'Y?D16U4C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM-0OGDMM&U.XMDN+F3+"%,,-S'K@'K[5<K7?EK^06?3O;\7_ )'=45X#KO\
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M$,952%QDEF"@#/<DBO"+3^Q]4TZ#4]6\'_$.^\02Q>9_:\-O+\CL,YAQ(%"
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MEVM\M6B8WE%/O?\ (]DHK@/&E]'XET_P]H-C,#'X@F260@\_9$'F.?Q&U?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M \"HQ+*$CVG<" !SZ$U@6WACQSX<O+NU\-ZEH<FCW5U)<@:C#*9K;>V6";"
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M>F11)!"D,:A8T4*JCL!P!7,^'/ >G>'-0DU(WVJ:IJ+IY0O-4NC/*D?78IP
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDB)X" @DD%B.6.0*.EV):M)=3M**\;NO&.M:;9R:ZWQ(\*W\D4?FOH4(A",
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M"\NX^U+:BZ+^7^[V%MN-WKGM6E7*PZM?_P#"T)-%:Y+6":.ER(RB\R^:5+9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ=C'Y*R;<&03L2S\\C:,FO<**35U;R2^Y6'?6_G<\NU?1]9G^"F@:=8V4O\
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MH-RYZC(/(]*Z^BDG;[K?C<;UO\OP5CA-?@U7PYXV/BO3]*N-5L;FR%K?6UH
M9XRA+*Z*2-_4@CKTJK'-JOCWQ+HEXVA:EH^CZ3.UVQU.,133R[2JJL8)( R2
M2>M>BT4EI;R_K]0>M_,Y&QL[I/BOK%XUM,MK)I=M&DY0A&8.Y*ANA(R./>DU
MBSNI?B?X8NX[:9[:&TO%EF6,E$+!-H9N@)P<9ZXKKZ*%I;R_X/\ F)J]_/\
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M'%=?10NGEI^?^8WK?SM^%O\ (Y"XL[IOB[8WHMIC:+HTT33B,[ YE0A2W3.
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M=%X%L]6L?"5K!K7FBZ#.52:7S9(XRQ*(S_Q,%P":Z.BDM%8;U84444 %%%%
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MMU*I>.$N [J,9(7J0,C)]ZP/$GCG3/#=Y%8/;:AJ.I2IYJ6.FVQGFV9QN(&
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M5D'\2@Y##Z&FZSX^TC1-7N=)GAOI]0B@2:.VM8/-DN Y8 1JIR2-O.< 9'-
M'4T5S'ASQUIGB2]DT];74=-U*-/-:QU.V,$VS.-P'((^AI/$'CK3M OO[/2R
MU35=0""1[32[0SR1J>C-T"CZG-#T ZBBLCP]XET[Q-9/<6+2H\3^7/;W$9CF
M@?KM=#R#6O0U8+W"BN3U[X@:9H>I/ID-AJVKZA&JM-:Z59F=X5/0OR ,^F<^
MU7M#\8:5X@L+JYLOM(EL_P#CYLY8&6XA.,[3'C.3VQG/;-'2X/1V-"_UO2=+
MFABU#4[*TEG.(DN+A8S(?102,_A5X'(R.E>)Z!J^C^(_B)KLFK>"M6U&6>]B
MM[>XNM+$B64:H  ^_P#U7.6Z9P17MG2G]E/N*^K045C>(O$MKX;MHY9[6_NY
M9B5BM[&U:>20@9P .!^)%4_#7C?3O$MW/8I::EIVHP()7LM2MC!*$)P&QR"/
MH:2UV&]-SI:*XN\^)NCVUW?64%CJ^H:A9W#0265A:&:4XQ\^ <!>>"Q&<'CB
MM#0_&VF^(--O[FRM[Y;FP!^TZ?/!Y=S&VW(4H3C)[<X]Z.EPZV.DHK/T/6;3
MQ#HEIJUB6-M=1B1 ^ R^H."<$'(/N*BT#Q!:^([2>[LHYA;Q7$ENLD@4"4H<
M%DP3E<Y )QTZ4VFG8.ES5HJM?W]KI>GW%_>S+#:VZ&261NBJ.IKD['XEV5[J
M,-L?#WB:V@G<)#>W&ENL#DG"X;D@'.<D"DM79!TN=K164=?M1XI7P]Y<WVLV
M9O-^!Y>S?LQG.<Y]L>]+J.O6NF:OI.FS1S--J<CQPL@!52B%SNR00,#L#1V\
M_P"OT U*BN;FWLK:2YNIXH+>)2TDLKA50#J23P!6!XD\;Z7X:NHK*2&^U#4I
M4\R.PTZW,\[)G!;:. /<D=#BL3Q/K\?B+X2^)+M-.U+3REG-&\&HVQAE4A<_
M=.>,$<BDWHVAI:I,[U'61%=&#(PRK*<@CU%.KSN#XI:/8:9:;-+UV\L(H$$V
MI6FGL]K'@ -F3C('<@$5WME>V^HV,%[:2K-;3QB2*1>C*1D&K:LW8A.Z5R>B
MBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "JNIH\FDWB1_?:!POUVFK5%3)730T[-,XSX8R1R?"K0S$00M
MGM..S D']0:XU!G]F*4?].;_ /HXUW7A+1;[P[>:OI+0;M&>X:ZL9PZ_*)#E
MXBN<C#9(.,8/7-:0\*:(/#!\-BR_XE!0H;?S7^Z6W8W9W=?>M)/F;?>WYW8H
M^[9=F_R'7EO%'X0N+=(U$*V#($ X"^7C%>:ZD/\ BQGA.:8!K&&2PDO0PR/)
M#+NS[=,UZY);Q2VK6SKF)D,97)Y4C&,_2J]GI%A8Z/%I$%L@T^*$0+ ^779C
M&T[LDC'K2OJWYI_<VQ)627K^*L3Q7-O+!%-#-$\,H'ENK J^>F#WKC?"W_)1
M?'7_ %UM/_1-7-,^&?@[1M:75]/T.&"^4DI(LCD(?55+;5_ 5O6FD6-CJ5]J
M%O!LNK\HUS)O8[RB[5X)P,#TQ2T_!_C8?2WH<E\)KF ?#NWC:5 ]K/<1SJ6&
M8F$KG#>G!!YK-\$W@UG2?'USI4HD\_5+D6\B'(8^4H4CVS70:A\,?!>JZP=5
MO/#]M)>,VYFW,JNW7+("%8_4'-;VFZ+IVCFZ.GVJ6XNI?.E5"<%]H7('0<*!
M@8'%#]Y._56_+_(J]G==[_BW^ISOPSO+ _#31C!+$J6]JL=P,@>7(OWPWH<Y
MZUC?#26UN/"'B::Q*FTDU6]:$KT*'ICVQ6]??#+P7J6L_P!K7?A^UDO"VYFR
MP5SZL@.UCSU(-;MEHNG:=!=06=LL,5W*\TR*QPSL,,>O'3H,"B;YN9]6B4K6
M2V3N>574,=Q^S]X;AE4-'))8JRGN#,H(KOOB$BGX<>(DVC:-.FP/3"'%7CX6
MT4Z#:Z&;/_B6VK1M##YK_*48,OS9R<$#J:OZA86NJZ=<Z?>Q>;:W,;12Q[BN
MY2,$9!!'X4ZCYE*W5_HA4_=<6^G^;//_ !=#(? /AG4+6[%OJEG+:/8ETW))
M,ZA K@D?*=QR>W6KMCX<\7ZOKVF:EXNO=&2+2Y6F@MM)CDQ(Y4J"[2'(P">
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M75HYPZE2<, >JD8.17;R2(R31JZEU7YE!Y&1QD5@^(? ?A?Q7()=:T:"YF
M\X%HY,#H"Z$$CGIFI_#O@_0/"EM+;Z'IL=G'-CS-K,S/C.,LQ)/4]Z)/F3ON
M"2CL8_PF_P"28Z+_ +C_ /HQJK_$9;G79-+\':?>"UN=3D,\T_EB3RH(OF)*
MDC(+;!@\'FF-\%/AZS%CX?Y)R?\ 3;C_ ..5TND>$]$T&:*73;+R9(K86D9,
MKOMB#%@HW$]R3GJ:;=W=_P!?T[!M>WG^+_R;//O$WA3QQ8Z;'KESXU_M@Z+*
M+^.S&DQ6Y?9]X!T.1E"PQ@YK=\6W\/BFW\-Z'92A[?7)5N9BIS_HL8$C?F=B
M_B:[R1%EC:-U#(P*L#W!K'TGPGHFASP3:?9F*2"V^R1%II'V1;MVT;F..3]>
M@Z 4)]^]_P"OG;[@?EZ?U^)IW#6JQK!<M"$E_=B.4C#\?=P>OTKS'QCH>F^
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M3P9_UROO_0%KMZHW.D6-WJMEJ<\&^\L@ZV\F]AL#@!N <'( Z@TEHT_ZV?\
MF#V:_KH<II,H@^*7C&4@D)8V3$#J<+(:Q-.U#QEXP\-IXFB\8Z;X<TUP\BQ0
MV"7!C0'&)'D; 88[ =:]&@TBQMM6N]4A@VWMXB)/)O8[U3.T8)P,9/05@#X8
M>"AK?]L?\(]:_;=^_.6V;O7R\[,_A1T2\O\ /_,;>M_ZV1P^B/YG[-6J/YOG
M;K>]/F;=N_\ >/SCMGTKT/P_JFC-X"L;Z&XMUTJ.Q3<Y8!$4( 0?3'0BKO\
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M;T_2(<;;6%8R1_$V/F;\3D_C7"V=U8?$GX@Z3K>FP22Z-H<4CK?20-&)YWP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$N+>SF&Z)Y)'8,[*>&P !S6OXBL[+P;X'\07_AW3;33YUM'E'V6!8QN"G#$
M <5/XE\'G6K^WU;3=5N='UJVC:**\@57#(>=DB-PZYYP:FT30-3MM/N[;Q'K
MSZ^;E=C>9:1P($P05")Z@\Y)J&KPLO/\RT[2N_(R-#^'/A"3PK9QSZ'87DD]
MNKRW<T*O-*S*"S^8?FR2<\&N:M[NXG^ WB6WGN'N!8K>V<4[MDO'&Q"G/?C
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M,!1@@!0 !BE'3?LQ2\O(YWX<^&M!%]XCN/[$TWS[37ITMI?LJ;H54+M"'&5
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MX=U\^%_$NCW^G/X>M[QW&G6ZW:7'V573#!64] W(''7BL^TT_0_#,-E:^+/
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M*HD#8QL5<+&HPW !SNZU)KO@JYO-:DUOP_K]SH6JS1K%/)'"L\4ZKT+QOP6
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MH"\J,K HR1@'D<\YQBNNU'3;/Q3\7'T_6H5NK#2],2XM[.8;HGED=@SLIX;
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M550NK[!QE2.N.];_ (B\'-JVI1:QI6K7&C:W%$81>0QK('CZ[9(VX< \BHM
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M<E6"X!Z#K74#PU,_B31]:N-2,TVGV4EK(#"%,[/MR_!POW>@'?M4VO\ A_\
MMR[T6?[5Y']F7RWFWR]WF85EV]1C[W7GITH6EO7]7^A+U3]/T//?&<NI:G\4
M1I\?A.+Q-:V&G)-'8SWD<$:.[$&0AP0YP O3C\:M>$=)\06WCU+X>!X?"^DR
MVCQ7<5O?PRQ2N""C>6F,$<C('>NM\2^#QK=];:KI^IW&D:U:HT<-[ JOE#_
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MHH ***YWPQKUUK5[X@AN8X473M2>TA,8(+($5LMDG)RQZ8^E"U#I<Z*BBB@
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MBK#GT((H LT5SW@[7KKQ#I-U=W<<*217UQ;*(@0-L<A4$Y)YP.:Z&@ HHHH
M***:[I%&TDC!44%F8G  '>@!U%< ?B'JNK;Y?"'@Z\UNS1RGVR6ZCM(I,=3&
M7R7&>,X%=3X?U6^U;3S-J.BW.DW*/L>WG='R< Y5E.&7G&>.E%@-:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BCM7/>"=>NO$GAJ/4KR
M.&.9IYXRL((7"2L@ZDG.%'>A:@=#1110 4444 %%%% !1110 4444 %%%% !
M1110 445F:IJ=U87NF06^F3WD=W<>3-+&>+9=I.]N.F0!VZ_0$ TZI7FD6-_
M?V-]<P;[FP=GMGWL-C,NTG .#P<<YJ[10 4444 %%%% !1110 4444 %%%%
M!39(UEB>-QE'4JP]0:AM+^VOO/\ LTHD\B5H), _*ZXR/PS5BC<# \-^"?#G
MA$2_V%I<5HTW^L?>SNP]-SDG'MG%;]0W<K06<\R@%HXV8 ],@9K*\':Q<>(?
M!^E:O=I$EQ=VZRR+$"$!/H"2<?C3U?R%L;=%%%(84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN O;K[U5UOQ?J&H_!./Q):%[;4&,!80N4Q()U1U!ZX)!'T-6FU'XF-:'2/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,Y^4T0WB_/\ S_KYA/9KR_K^O(])NI9(+266&W>XE1"R0HRAI"!PH+$ $^Y
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M:YI6A?%?Q9'J^HVNGFZALW@-U,L0E 1E.TL0#SQ0OCMZ_H&\'\BMJ&NS:/\
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M(1Z@@BJ/P^4+\.O#H P/[.A/_C@KBM+UJ^\._!C6-4TR,/=6][=E,IN" W+
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MED;:1-*,P,IW!E9PXP2.1G/>I?AC%#)!X@OI54ZG-K%RETY'SC:^$4GK@+C
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M 3S@5Q&N>#3X0TJ_USP?JUSI!M(GN6T]Y/-LI0OS,/+;[F<$94C&:3Q#JO\
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MP,9]SZUL^*/#E]J6HZ;K.CW=M!JNFB00K=Q&2&57 RK8(*]!AAR/>ET3[_\
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MS5+JWDF9]2N?M,PD((5MH7"X P,*.N:36= M=<DTU[F29#I]XEY%Y1 W.H(
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MTI!8@>I  _2M"BG=@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5;6W]>?W"Z7?]?\ #GJ&H:O:Z;=:?;7!;S;^?[/ JC.6VLQ)]L*?TJ_7EGQ
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M(S@D$KD9Q28+S.QHKSOX?Z?X'LM3G'AJ*^TV^6+_ $C3+N2>-U!(^8Q2DY/
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MBO+]/\.:?\2M4UV_\3?:+NTL]1DL;.P%Q)'%"L7!?:I&78D\GM6AX8B?PO\
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M\,3^+=&MM/M[O[(8[V*X:8'YE5#G*\'YNF,\5@ZAX;^('B""31-8UG0X]$E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK4XM(\._V;;*TC6C74K7,B+DY#A0@)'8BH_'.IQ:U\-]*U2!66*[O+"=5;J
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MNBBN=\:Z[>>&O#C:M:112K;SQ&Y61"V(2X#D8(Y .<\].E '145Q7C_QA?\
MANSL1HMK!>7UR9)C'*&(\B-"\C *1SC 'N:N>(_%$UEI6C3:0()KC5[N""V\
MU2R;7^9FP"#P@)ZTTK_?;^OZ[@]/NN;@U?3SK3:,+E/[16 7)@P<^63MW>G7
MBKM<M_:TQ^)<^DI9V9VZ.MRLY0B4MYI787Y^3OC'6N/\)W/Q"NO%OB!E/AS[
M,FJHE\LC3LZ*(TXA( !^3'W@/FSVH6MOZZV!Z7^7Y7/1-/U^UU+6]5TJ&.99
M],:-9F< *Q==PVD')XZY K5KRBVU#Q#'\3/&ECX;T^SFNY&M9&N;^5D@A A
M&0H+,2>PQT/-=-X8\2Z[+XAN?#?BBSL8=4BMA=Q3:>[F&>(MM. WS @X'-"U
M2] >C?\ 78[&BN%O?$WBG6M8U"P\&6.DF'3I1!<7VJR2>6TN,M&BQC.1D9).
M.U:'ACQ/?ZAJE[H6O6$5EK5E&DK"WD+PSQMP)$)Y R""#R*2U!Z'545SW@S7
M;KQ%H3WUW'"DJW=Q !""%VQR,@ZD\X S4&F:_JNJ7_BFS@@LVFTRY6"T#LR*
M^8U;]XPW=V/0=.U'^5_R_P P_P"&_/\ R.HHKRSX8W'CJ[B\^\?07T=[^Z-P
M5\[[3O\ ,?.W^'&_IG^'WKU.G;8.K0445S<.OW<?C^X\/WL<"VTMFMU82*"&
M?!VRJV202"5(P!P>]+K8.ESI**YJX\0W1\>PZ#:) ;2"R:[U"9P2T>3B-5((
M )PQ.0>!6'#XD\<>(XQJGA?3-$312[>2=2FE$UV@.-R!!A <'&[/8T?U^@?U
M^IZ#17&R>.'N/AIJ/B>SM1#=V<,V^UN/F$<T9(9&P1D9'4$9%/T+6/%NO7UE
MJ*Z?IEEX=F0L5N'D:\D4K\K!1\J G!P23CWXIVU_KU%?2YT.FZQI^KI<M872
M3K;3O;S%<_)(OWE.?2L"P^(.FZIKITVQTW6)X%=XVU-+,_8PZ9W#S,]L'MBJ
M>D:QJ^I>'_$4FDV.DQ7UMJES;QAP\4;!3]]]H8LYZGIGVK%^#C>*O^$/L'O?
M[&.A?9Y&M_*\W[47WG[^?DQ][I[4EU?9)_>OZ_(;[>;7W?U^IZ/I6K6.N:;#
MJ.FW*W%I,"8Y5! ;!(/7GJ#5RN$T3QG!9?">W\3WME!"!&Q%I8Q[%9S(55$7
M)P2<?G4VDW?Q'N=1MKC4=.\.VNES$&2V2:9KJ%2.[8V,1Z"FUK85]/Z[G:T5
MS'B*?QL;T0>&;+1! $#-=:G/(0QYRH2,9&..2:K:!XEUW6=)U>W?3K&#Q#ID
M_P!FDB:=OL[MM#!PP4L%(.<8)J;Z-C.PJEINKZ?K"W#:?<I.+:=[:;:#\DB_
M>4Y]*\[^$]QXUN](L[F^?0WT262X=V3SOM9<R.3U^3&_/X>]=!X;\2PG1O$>
MI7T%I9V^G:E=I(UM%MW)&>789.7/<]ZIZ7OVO^7^8>7G;\_\CL:*\\M]=^)&
MJ6T6L:=H>@Q:9*GFQ65U<2_:Y$/(.X#8I(P<'I6G/XW%S\,KWQ7IL 2:"VED
M^SW()\N5,AD;!&<$$<$4GI>_0%K:W4["BO.F\0_$6_TV+7-+T/0X]-:$3BSO
M)Y/M<JXSP5&Q"1T!)QWKL?#FM1>(_#FGZQ!&8X[R%90C')4GJ,]\'(IV>OD*
MZT\S4HHHI#"BN0UJX^(3ZE*F@6'AZ.QB/RR:C/*SSC .0$ "<Y')-5U\<75Q
M\,=2\31V,=OJ%C'.)+:1C(BRQ$J1D8R,CVHOI<+:V.WHKSIO$/Q%O]-BUS2]
M#T./36A$XL[R>3[7*N,\%1L0D= 2<=ZVW\=64?P\B\7M!)Y,MNDB6X.7:1B%
M$8/KN.,TVK7OT$G>UNIT=[=)8V-Q=RAC'!&TK!1R0HR<>_%0Z/JD&MZ-9:I;
M+(D%Y"D\:R !@K#(S@D9Y]:X#5M7^(5MX=U*_P!9T;13I;VDA>VLIY#=P*5.
M2=PV/M[@$>U=3\/_ /DG?AW_ +!T'_H H2T?R_4?;Y_H='113)94@A>:5@L<
M:EF8] !R32;MJ ^BO/+7Q'X]\1P1ZOX<TK0H=&D):%=2FE^T7$8/##8-J;@.
M,YZBM.P\4:GXC\'W=WI%C;6VLV\CVUQ:WTK!()4X8%D4EAW' SGM2>B;[#2N
M[$FG?$#3]7\0?V7I^F:Q<0^8\1U)+,_8PZYW+YF?;'3%'_"P-.E\2G1+/3=8
MOC'/]GGO;6S+VT$G]UY,\8XSP<5R/PI?QP/ EF\4?AZ73C;N;-7DF28R>8?]
M80"N/O\ 09Z>].^$LGB[[)/+>-H8T7[==M<,GF_:/-WMN(S\NW=Z\XJ[6=GT
M7]>G_#$WNKKJ_P"OZ]3UBBO/H?$GCCQ'&-4\+Z9HB:*7;R3J4THFNT!QN0(,
M(#@XW9[&K\GCA[CX::CXGL[40W=G#-OM;CYA'-&2&1L$9&1U!&14]+L?6QV5
M%<?H>L>+==O;/45T_3++P[,A8K</(UY(NWY651\J G'!)./?BLBP\2^/?$J'
M5/#]CX;32A,\8M[V>;[2VQBIR5&U"<=#G%-JSLP3NKGH]%16K3O:0O<QK%<,
M@,D:-N"MCD ]QGO4M)@%%5-5NGL='O;N(*9(('E4,."54D9]N*X'3/$OQ$\2
MZ%8ZSHNCZ#;VLL*NT>H32^;.<#)0)P@)SC<3Q@FE<#TFBN6TCQM:WO@)O%-]
M UG'!'(;F'.XQO&2K*#WY'%8RZU\3+BV75[?0=!73VC\U=.EN9?MC+C(&\#8
M&Z<8]J;T=F"U/0J*R_#FNVOB;0+/5[,.L-RF[8_WD(.&4^X((_"M2FU9V8)W
M"BJNI/=Q:7=R6*QM=K"[0K(I*EP#@$ @D9]Q7*/XXE/PNM_$\,,+7]Q!&L4!
M!V&Y=@@3&<XWGUS@4OZ^\#M:*XZT\9S#X;7?B*^BA2^L8IEN84!"">,E2H!.
M<%@._0U?EO?%#>%=/GLM/T^XUF>-#.DLK0P0DKDGHS$ X&.O/6AZ7_K<%K_7
M8Z*BN&T;Q'XJLO%-GH'BVSTCS+^*66UNM+>39F, LC+)SG!SGI2:AXNU]_&&
MJ^&=$TRTN+N"&&6":Y9DBB5E.YI2,D\[0%4 G)],T?U]P?U]YW5%</KWBO7?
M"VG^'?[2L[.\U"_NC;7,-@K[68HY01;CD98*"6XQGI6SH$GBUS>2^(;?1XD(
M4VD%C)(SKUR)'8 $].5'K3MU WZ*\XU7Q%\1="LKC7=0T?P\=(ME\R:SAN96
MND0=3O("$CKTK6\8>,;O0(O#\VG6 OAJET(/(Z.VZ-F7:<@+\VW).<#-+_A@
M.QHKSJ\\3^.?#5Q;WWB/3-"?19[F.!_[/GE,UMO8*K,7 # $@' %1?$6Z\6)
MXH\+V^B#24BDO&,)NY)#OE$3_P"L51P@4G&"23CI1V^X._WGI5%<5<:_XET%
MO#G_  D$6E-'?736E])8K)MB=L^25+'@' !R.IXK1\6>(+O2'TBQTV*&74=3
MO4MXQ,I940?-(Y (/"@]^I%.WYV#_ASI****0!17.>*_$TVA"PL]/LA?:OJ,
MQAM+9I/+4X&6=FP<*HY-8)\3^,_#,MM/XQT_19-+N)T@:ZTF27-L7.%+K)U&
M2!D'BA:@]%<]!HKC?$_B_4=%\5:7HVGZ:E_)J-M,T4>2I\U63!9^BH%+$G!/
M QZ';\/?\)$;*4^)1I8NS*?+&F^84$>!C)?DMG/3CI32NK@^QKT444@"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#R7XDKJ&A>(WN]*1B_B6R_L@[?X;C</+<_\  &?G_9KM[^PO-!^'
MD]AX>0F]LM/,5H% )+JF!@'J<_K71T4K>[R_U_6K^\=_>3_K^M$?/)M?A_K^
MAR1?9-;U_P 8BU(>*Z>Z\V*;;SO)(C50V3UQ]:Z[4O\ DAWA;_>TS_T9'7K%
M%6I?FG]Q+5U;U_%6//\ QU>CP]XP\-^)KN"=M*M([F"[FAB:3R/,5=KL%&=O
MRG)K$\1>,[#Q=JGA(Z#'=76G1:U"\U\UN\40;Y@J N 6/7H.,>]>MT5,=+>3
MN$E>]NJM^AY+\2/#6CR>-;+Q!XFTBXU+0&LC;3O 92;1U8LLC",ABI!(/7%/
M\!V'PJN/$D-UX-L+B2^@5R+E5N_+BR,$$R';D@].>M>KT41T'+4X>_\ BSX-
MTV^GT[5;VYL[J-VC:">QF)?DC(PI!!QP>]8WA;09]6T+QLMI93Z5I6M.ZZ=;
MSQ^45S'M:39_"&;G''%>HT4K:-/JK#O9IKH[GF7A_P")FAZ'HNG:%KZWNG:W
M:P);/9/92NTC(-N4**0P..#FKGB*Y?POX_M?%MQ;7,VC7&G&RNI8(FD-J0^]
M791D[3D@D#BO0:*IR;?-U_S)227+T/+[[Q!9?$K6O#UKX:$]U86&H)?WE^UL
M\<48C!P@+@$L2>@[4NN:\GAWXS&]N;6XEL#H:I<2P1&0P#SF(<JN6*Y&"0#C
M(KT^N632+X?%*;63!_Q+VT=;83;U_P!8)2VW&<]#G.,4+=)>?XH?1W\OS_IG
M-#Q%:?$3QEX>/AU)[G2]*G>[NM0:!XX]VPJL:[@"6);FN9UWPUX,T;QEKMWX
M_P!(N7M+ZX^TV>J*UPT>U@,Q-Y1^4ANF1R#7NE%+M;S_ !_X8/\ @?A?_,X+
MX;V'@>)+Z\\%6%Q#!*$62XD6X"38SC;YIYQSG KO:**;=Q)!7%:>/^+R:V>_
M]D6O_HR2NUHI+1W]1O56.)US_DK?A/\ Z\[[^4=<1K]UX<F\9ZU:?$FYU40M
M.JZ79C[0+:6':""HA'S/N/.>^*]MHH[?/\6'?Y?@>6_"G3[/2M;\61V&E7&E
MZ>7MI;:WN"QD\LHWS$,2PS@G!Y&<<=*R-=\1_#Z:\O9_#6H:E8^*FW%(]+L[
MB.2>89(5XB@1^<YW#/7FO::*'K;^F"TOZE+1Y+V71;&34HQ'?/ C7"+T60J-
MP_/-7:**;=W<25E8P/'/_(@^(?\ L'3_ /HLU/X4 _X0[10.!]@@_P#0!6Q1
M2Z-=_P#@_P"8WT\K_I_D?/<?AOX=^&;B]LOB%I%Q!>BZD:#4";IHKN)F+*08
MS@,!P1CM7HN@6'A>S^'FM/X3L+BTT^>*9_WRS#S3Y>-ZB4[MI&/:N_HI-7@X
M^5AW][F\[GD^I?\ )#O"W^]IG_HR.I/B=X:TZZ\4:3KNO:1<:IH45N]M=);M
M)NMV+;DEVQD,1U!Q7JE%7-\TG+SO^%B4K*WE;\;GD?@BP^$MUXFM9_"%A<3:
MA 699T6[V0_*?O&0[>1D#-:#Z_9_#SQIXAF\0K/;Z7JTL=U;7ZP/+&&"!&C;
M:"0<@$<=#7IE%*_8+=SS+2=<7Q#\8K34+2UN$TUM$E6VN)XC&;C$J%F56PVW
MD8) SS7IM%%%]$ET_P [CZW"N"\5M/X>\<Z7XL>TN+G3%LY+&\-NC2-;AF#+
M)L&25R,'%=[12ZW0=+'ENK>)[#XE76CZ5X6\^]MHM1BN[V^-L\<4"1'=MW.!
MER<  >M;EU_R6K3_ /L!3?\ HY*[:BFG:UO/\58-_P"O.YQ?C+_D;_!'_81E
M_P#1#UVE%%+I8'O<*XKXI?\ (I0?]A.S_P#1Z5VM%"W3]/S![-'GOCK4X/#?
MC;PSXBU))DTFWBNH+BYCB:186<)MW!03@X(Z5V^EZG9ZSIEOJ5A*9;2X0/%(
M49-RGOA@"/Q%6Z*%M8'O<*H:WID6LZ%?Z9,,QW4#PG_@0(J_12:NK#3L[GEG
MPWEF\5W37^HH6&DZ>FCD..LW_+<_H@_.J7@F*YNO&=CX>N@[)X0CN4W,.&+M
MM@/_ 'ZS7L%%7S:W_J^NOWMDVTM_5NWW)'$1_P#);KC_ + "?^CS65H_B;3?
M"OCSQ%I.MM/:7.JZFDMAFWD9;A6C1?E95(X(P<]*],HI+2WW?C<;UO\ +\%8
MXCPJ!_PLCQR>_FV?_HFA_P#DMT?_ &+[?^CQ7;T4+2WDOT:_4'U\_P#@?Y'E
M^G^(K+X:ZIKUCXF^T6MC=ZC)?6=^+>26*02X)0E 2&!!X-:'AB63Q1\0;WQ;
M;VT\.D)IZ6%I)/$8VN27WLX!YVC@ GK7H%%):?=;\+?D#UO;K_P_YGD_A?QO
MH_@F&\\.>(C=V6HIJ-PT$?V.63[2CR%E:,HISG=BM?X;7=Q?ZUXQN[FSFLWF
MU)'6"88=4,2[=P[$K@X[9KT&BA>?:WY?Y ]?OO\ G_F>9_#WQ-IFE3S>#]1:
M>UUTZA=.EM);R?O$:1W#A@NW:1W)KTRBBCH@ZL*XOXB1-86NF^*H$)FT.Y$T
MFU<EK=ODE'';:=W_  &NTHH\T'J<+X%LVU?2=8\13J8YO$,SR1DC#);@;(A_
MWR-W_ J\OT[0?AAX<L5TSQ]HUQ8:U S1O,QNVCNP#Q)&8R5P01QQ@U]%44:7
MT]/N#U/--2L="L?@AKJ>'+&XLM->TG=(KA9%?.""<2'< <=Z[[1QC1+ #_GV
MC_\ 015VBG??^NEA6V.#^'__ ""O%?\ V'+[^8I_PH_Y)-HW_7"3_P!#:NYH
MI/9KR2^X?6_FW]YY!IFD7NL? #3(M.B,UY;NMU'"#CS3'.7V_B ?QKJ])^*?
MAC5]0M],BEO8]5E*JUC+8RK)$3C[YV[0!GDYQ7:453=V_P"NEA6_KYM_J>&Z
MG=>&KGQ1K5I\3)]5:<WI33;'_2/L\D''EF-8>&8YY)/4UTWPET^WTV7Q3;6>
MESZ9:"^1H+6=B71#$I4G))R0<X)R,X[5Z914K16\K?UYCEJ[^=SS+X7^)=-L
M+"V\%WK3VWB"WEN-UI);R#*^8[;@VW;M(/7-,T+2)=>\#^.M*@8+-=ZK?Q1E
MC@;B1C/MFO4**'JG?JK?E_D.^M_._P"?^9YOIOQ6T33=+M-,UB#4+/7X81&^
MF?8I7D=U&/D(7:P)!P<U2?2;[2_@9XD;4H?L]W?1W=[)!WB\PE@I]P,5ZK11
M+6[>[_SN))*UME_E8S;(8\,VP'_/FO\ Z *P?A7_ ,DPT#_KV_\ 9C7844V[
MMOO_ )M_J2E9)=O\DOT"D;.T[?O8XI:*3*/ +*3P?JQ>U^(:ZUJ'BQIY,Z:X
MNB =Q"B%8\)MV@<Y]:V=(M39?L_^)K4VC6GE&^3[,S;C$ Q^4G)SCIG)KV:B
MCHUW_P" ._O7\_\ ,S;(8\,VP'_/FO\ Z *\VL=*O=6_9^TB/3X3/=VZ174<
M _Y:F.7>5^I /XUZW13;NVUUM^#N2E9)/I_E8\TU3XH:+K?A_4M-T>&^NM;D
MM)$.G-9R(\3%2#YC, J@=SFNH^'_ /R3OP[_ -@Z#_T 5T=%%]'Y_P#!_P Q
M]O(*J:I9_P!H:3>60;9]H@>+=Z;E(S^M6Z*EJZLQIV=T>7>'/B%I'A'P]I_A
MWQ.MWIVL640M1;_9)9/M&WY5:)E4A@W'?O6QX%LKY=(U[6+^U>SDUF\EO([:
M1=KQQ%0J;AV8A<D>]=S13DW*[>[$M+6V1Q/PB_Y)9H?_ %R?_P!&-5?X90_:
M?!&HP;BOF:C?)D=LRL*[ZBG+WFV^N@HKE279GSKIV@_##PY8KIGC[1KBPUJ!
MFC>9C=M'=@'B2,QDK@@CCC!KO]2L="L?@AKJ>'+&XLM->TG=(KA9%?.""<2'
M< <=Z]+HI/5-#5DTREI&!HEAZ"VC_P#017E.O^(OAS<:G=R:5J.HZ?XH).TZ
M7:7,4TL@Y =-@23/^T#QWKV.BB7O2N$?=BD9GAV;4KCPWILVL1"+4GMD:Y3&
M-LA'/';GM6G113;N[B2LK&;XB_Y%G5?^O.7_ - -9OP_X^'?AW_L'0?^@"ND
MHI+9^=OU_P QOH>5:-HL_B'X-:WI5J0+BXNKT19. 6$[$ GW(Q6A!\6]"MK&
M*RO;?4H?$"Q8;2/L,K3-(!R%(7:1D'!STKT6BCRZ:?@K#\_7\7<Y;X=Z/>Z)
MX+M+;4D$=[*\ES-$,8C:1R^WCTSBNIHHIMW8@KQ_1;>63QT?!11OL>E:K-K#
M<?*8F >%?^_DC'_@%>P44EH[_P!>7X@]5;^OZL>.>(;::#QU/X.5&-GXAU"V
MU(87(")DW ].3$A_X%6K\2[V.U\0:0NOWFIV?A(P2&YEL3(JF?("K*8QN"X/
M ]:].HHZ)=O^&_(=]6SP_P ,Z7X5@^)GAN_\&Z/=6VERQ7*/>R^<$N'\O(""
M4[L 9Y  .>^*[K0O^2M>+?\ KTL?Y25VU%5?;Y_B3;?SM^!Q7C@9\1^"<_\
M07/_ *)DK0^($VL6_@;59=!$IU%8@8_)7+A=PW%1_>"YQ72T5/2W]=/\BD[2
MO_77_,^<]=L_AUK/AC4I-"L]7UOQ'!:EI)[A[HO;E1R\K.0@Q@\<Y(P!7I7B
M$9N?AUG_ )_T_P#2=Z]"HJD[???\_P#,EJZ^5OR_R.)^*W_(BR_]?EI_Z/2H
M?B-=#2+[POKMQ%,VGZ=?L]W+%&7\E&B9=Q YP":[RBI6FW>_X6'O]UCEK_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*XF3XGZ1Y9%EIVL:E=K+)&]G86?G2QA)#&6;!VJI*G&3DCM6KXA\8Z=X<,$,
M\%]>7UPA>&PL+<S3NHZG:.@'J2!1TN'6QT-%8'AOQ?IWB;SHH(;RRO;< SV-
M_ 89XP>A*GL?4$UEWOQ+TBUN;VSM[#5]1O[.X:"6ST^T,\HQCY\ X"\\$D9P
M>.* W.SHK"\->+=,\56\SV/GQ3V[!+FTNHC%- Q&<.IZ?49'O6.OQ.TB>.W_
M +/TW6=2GE<J]O8V?FO  Y3=(0=JC*GOG'.*=M;"OI<[6BN?\1^,-.\--#!/
M#>WM].I>&QL+<SSR*.I"CH/<D"E\-^+].\3>?%!#>65[;@&>QOX##/&#T)4]
MCZ@FDM1O0WZ*X:?XI:8EVT=GHGB+4;1'*/J%CIK26ZD'#?-D$XQR0#[9KH]1
M\2:9I6A)K-[.T-I(J%,QMO<M]U0F-Q8YZ8S1TN'6QK45R&C?$33=5U2/3KC3
M-9TBXG)%M_:MD8%N".<(<D$XYP<&K&M^/=&T#6CI%X+IKTVZSQ100F5I]S%=
MJ*N6+?*2>, =Z W.GHKD_#WQ TWQ!JATI]/U;2=1\LRI:ZI:&!Y$&,LO)!'/
MKFL'4?B=-8>/;K2D\/>(;ZTM[0$QV>FEG:0N1OPV#LP,!AP3FCJEW ]*HK#U
MSQ3:Z#I]O<SV6I7$MR/W5I:6C33,<9V[1P#]2*J>'O'6F^(9[FT6SU/3]0MH
MO.DL=0M&BF\O. P7G(^A-'?R Z>BO--!^*%QJ/B74K"3PWXCE@%^EO;R1Z:0
MENNU03,205Y);D9"D5TFE-I?_"P/$*V_VW^TA;VINO,8&';AMFP9R#USGVQW
MII; ]+G3T5Q^L?$;3-+U*;3[32]:UJYMVVW"Z39&<0'&<.V0 ?8$ULZ#XETO
MQ)IKWVF3M(D;M'+&Z%)(G'564\J?K2Z7#K8UZ*X%?BWHUU8PW6EZ1K^K;AF6
M/3K S&WZ\2$':#QT!)Y%=7H&OZ=XFTF/4]+F,MNY*_,A5E8'!5@>00:=@>FA
MIT5#>74-C93W=PS+#!&TDA52Q"@9.  2?H*XV'XI:2VH107>C^(-/MII%BAO
M[W3FBMY&8X4!CR,Y[@4EJ[('HKG<45SOB3QG8>&IH;5[34=0OYD,D=EIMJ9Y
MF0'!; P !GN14WAOQ1;^)8)GBT_5+"6$@26^HVC02+G..O!Z=B:%KL#TW-RB
MN>\;>(SX6\*WNIQVUS<31Q-Y2P0-(%;:2&? PJC')/%4_!GC)_$E@/M.C:U8
M/#;1R27.HV8@BF)')0YP1WZ#@T+6_D#TMYG6T5P<GQ8T;S6>VTGQ!>::N=VJ
M6VFN]JN,Y._J0,=0"*[2PO[75+""^L9TGM9T#QRH<A@:.EP\BQ17,>-VTM;'
M2SJOVWR_[5MA#]D8 ^:7^3=DCY,]>_I6%XC^(\^B>.[72(=#UV^MEMI7F2RT
M\NTKY7:4SC<J\Y(.,L.M"_K[KCM_7SL>B45S.J>-[#2-+T^ZN;'5&NK^/?;Z
M9%:%[MN 2#&.A&1G)P#WJ7PWXNM_$KS1+I6L:;<0@,T.IV30-@]".H/YT[:V
M$=#137=8XV=L[5!)P,\5PK_%C1H9@]QI'B&WTTD#^U9M,=+7GH=Q^8#/'W:6
M[L'F=Y169K?B#3/#VDMJ>I72PVH( 8 L78]%4#EB?05D^'_&\7B#4FLAX?\
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MM.-D[^OZ_<#U5OZZ?>87@:1/^$F\;1;U\P:L&*9Y ,*8./3@TNA_\E9\6_\
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ME*2.01G. "2%&>P I-737<:=FGV_X GA;5-(F\#Z;>VEQ;KIT=H@+;@%C"J
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M,5;=V_5O[S-*R7HE]QC_  GEA3P]?64CQC5(-2N?MT>?GWF1B&8=<$8P:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 45D^'_$-IXDL[BYLXYT2WNI;5A,H!+QMM)&">,]*-3\06FDZMI.G
M3QS--JDKQ0M&H*J54L=V2"!@=@:.WF!K4444 %%8MOX@\_QE?>'_ ++M^RV<
M5UY_F9W;V8;=N.,;>N>];5'F 4444 %%%% !1110 45'+/% $,TJ1AV"+O8#
M<QZ >Y]*R?%/B#_A&M(2_P#LOVG=<PV^SS-F/,<)G.#TSG'>@#:HHHH ****
M "BBB@ HHK-T;7+;7$O'MH[A!:74EK)YT>S+H<$CU'H: -*BBB@ HHHH ***
MCDGABDBCDE1'E;;&K, 7."<#U. 3] : )**** "BH_/B\\0>:GG%=XCW#=MS
MC..N,]ZDH **** "BL1?$.[QO)X;^R_<T];W[1YG7+E-NW'MG.?PK;HZ7#K8
M**** "BBB@ HHHH ***X[6?&FI6_B";1O#_AF?6[FU1'O&6ZCMTA#Y*C+_>;
M SBCK8/,[&BN1\0>,=0T_5H=&T/PY-K6JFW%S-"MTD"01DX!9VXR2#@>QKJ+
M266>SAEG@-O*Z!GA+!C&2.5)'!QTXHZ7 FHHHH **C>>*.6.)Y4624D1HS %
M\#)P._%24 %%8MOX@\_QE?>'_LNW[+9Q77G^9G=O9AMVXXQMZY[UM4>8!111
M0 4444 %%8MOX@\_QE?>'_LNW[+9Q77G^9G=O9AMVXXQMZY[UM4>8!1110 4
M444 %%%% !1110 4444 %%%% !16)8^(/MOBW5]"^R[/[/A@E\[S,^9Y@;C;
MCC&WU.<UMT>8>0445'-/%;Q^9/*D29 W.P49)P!D^I(% $E%%% !1110 45B
M>)O$'_".VMC/]E^T?:KZ"SQYFS;YC;=W0YQZ=_6MNCI< HHJ-9XGFDA25&EC
M +H&!9<],CMG!H DHHHH **** "BBB@ HK,AURVG\1W6AK'.+JVMX[AW*?NR
MKD@ -Z_*?\YK3H **** "BBHYIX;= \\J1*65 SL%!9C@#GN20 />@"2BL7Q
M3X@_X1K2$O\ [+]IW7,-OL\S9CS'"9S@],YQWK:H **** "BBB@ HHHH ***
M* "BBB@ HKF)O&EL? M_XHM+2>2&UCF803CRF<QL5([XR5//-=#9W'VJR@N-
MNWS8U?;G.,C.*+ 345C^*M=_X1GPQ?ZS]F^T_9(]_D[]F_D#&<''7TK6B?S(
MD?&-R@X]* '4444 %%%!.!DT %%<;H?C35/$.K+]@\+SGP^TCQKJ\EW&NXJ2
M"PB^\5)& :2U\:ZIJOB*2TT?PO/>:1!=&UN-4:[CB5'4X8K&?F< \9'O0M;
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MT:3E"$9@\A*ANA(R./>N)@T2Q\%27=AK/PY?Q!;-<R2V>H:?I<5W(T;L6"R
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M30QJ=[W!8(=Q&1M^0G!_BK=^(6FW&H>#[E[&)Y;ZR>.]MDC4LS21,' 4#G)
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MY!(_&L#6(?B-8:3<>(QXDTY#;0-</HRZ<#%@ DIYQ;>3COQDCM6U\3K.ZO\
MP'>VUE;37,[2P%8H8R[$"9"< <\ $UL>)X9;CPAK$$,;R2R6,R)&BDLS%"
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MK$!G)SP3C -8WB/6-<\90Z*=/\*ZS8V-KJ]K-<MJ-OY<K 2#[L8+':,[BQP
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M3?;\3T^O-XK_ ,9^(O$WB?1],U>WTNTT^[18[Y[19Y%#1JWEJAP.N26;)^;
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MI1114%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 452OM7L=
M-N;&WNY_+EOIO(MUV,=[[2V.!QP#R<"KM !1110 4444 %%%% !15&YU>QM-
M5LM,GGV7EZ':WCV,=X0 MR!@8!'4BKU !141NK<78M#/$+ED,@AWC>5!P6V]
M<9(&:EH **** "BBB@ HJB-7L3K;:,)_^)@MN+DP[&_U9;;NSC'48QG-7J "
MBBB@ HHJ&XNK>SC$ES/%!&65 TKA06)P!D]R2 !0!,1D8JIINFV>D:?%8V$(
MAMH@0B DXR<GD\DY).35NB@ HHHH **** "BBB@ HHJEI>KV.LVTEQI\_G11
MS/ S;&7#HVUAR!T(Z]* +M%%% !1110 4444 %%%% !17.:OX]\+Z%K,&D:E
MJ\4.H3E52 ([D$XQNV@A<Y'7%='1TN'6P4444 %%%% !1110 4444 %%<XWC
MWPNOB=/#G]KQ-JSML%NB.WS?W2P&T'CH3FNCHZ7#K8***BN+B*TMI;F=MD42
M%W;!.% R3@4-VU8;DM%5M/O[;5=.MM0LI?-M;F-98GVE=RD9!P0"./6K--JV
MC ****0!115&YU>QM-5LM,GGV7EZ':WCV,=X0 MR!@8!'4B@"]1110 4444
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M+NU?6"4E@D$B-B*3H1P<$?I5CXK#_BA9/^OVT_\ 1Z4ETOW_ %BOU$^OI_\
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MAM[^PNQ;)YJ,Q,<CX('!R,X[TOY5W_RN-K5^7^9VWAWQ?<:GJ;:/K>B3Z)K
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M#;HF>0KMC##AB-I;BJ_A+7M*\*:UXFT;Q!J-MIUY)JDM[$]Y((EGADP596;
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M$[P5%I-U#?B">Y,MS;,)(D+0G";QQN."<9SQ6UIW_)9-<_[!%K_Z,DJELO\
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M&=4TJQOC']S[5;I+M^FX'%68[&TAN#<16L"3F,1&18P&V DA<]< D\>]3T4
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M.?M+6D9DSZ[L9K4HH X'QU!>QZYI]]<Z%=:]X=BMY$N-.M465O-+*5<Q$@2
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M[ON3;H%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 444R61887E<X5%+'Z"DW;4#E]8^)?@W0-2_L[4M>
MMXKL-M:-5>38?1B@(7KWQ6W/KNF6^A/KCWD;:8D)G-S'F1=F,[AMR3^%<%9Z
MYXU\4:8=5\-:+X:L-*N]S!M6DD:2X3D;F6(8&<'@D]:R-&9F_9KU3<8SBVO1
M^Z)V >8_W<_P^GM3U46WNK?BQI7:ML=M?_%'P3IFI+I]WXAMDN6Q\H5V5<_W
MF *K^)&*W;K7M+LWTY9[M!_:4@BM&4%EE8KN # $#('&2,UG:5HFG6O@*WTN
M.SA^QFQ"M$4&U\IR2.Y-<?HVC3>(?@-I4$#'[?!;+<6;GJLT3%D_ECZ&G*T6
M[]/RNU^A,6Y)>?\ DO\ ,]%U;5K'0],FU'49Q!:0@%Y"I;&3@8 !).2. *N(
MP=%=<X89&00?R->:WFKQ>/KKP?IT S;SJ-7OT!X18N%0_P#;7C'^R:]+H:MO
M_5O^"%[G.^(_'?ACPG(D6MZO#:RN,K$%:1\>NU 2!P>2,5J:?K6FZKI2ZGI]
M[%<V3*6$T3;A@=?Q'IUKR?PY_P )W/XE\67>A+X7,O\ :LD4S:H)_M"JN!&O
MR<;-N,?C73>$_#?B'1$\47FNMI"?VEB9(-+,@B1PA5SAP,$X4]3DYJ6[0<O*
MY=O>MYV+][\5?!&G16DEUX@@474:RQ!8Y';:PR"RJI*9_P!K%;5QXGT6VT:#
M6)-0B;3IW1([F,&1"7;:O*@X&>,G@=ZY[X3:7967PQT806\:_:;?S9SM&9&;
M.2WKZ?2LKPAH-MK7P[\1^'RJI;/J=];P@+Q%B0[=H[8."/I5R7*VNW^9$7=)
M]_\ )GHUY=V]A93WEU*L5O!&9))&Z*H&2?RKGI=2LM0\1>&KJWUVY@CNX)I8
M+(0N$O5**=S9'R[001G!YKC[K6[GQ5X'T#PY(^-4U.Y^P:BO\2+ ?]()';.T
M#_@8K?UZ-(?B?X)BC4+&D%ZJJ.@ C3 H2][Y_H_^ #?NOT_5+_,VM3\:^'-&
M2^;4=5AMA8R+'.) V0[+O"@8RQ*\_+FK#>*-$C\/1:_+J,,.ES()([B;,88'
MIPP!R?3&:Y3PSIMK/\6O&>H2Q*]Q UJD+,,^7NA&XCT)P.?:I?%"0W7Q1\(V
MFH!7LO)NIH8Y/N/<*%V\'@D*6(J4KV\_^#_D-V3?E_P/\S7\/?$'PIXJN6MM
M&UF&YN "?)9'C<@=2%< D?2K^J>*-$T6Y:WU/4H;218#<'SB5'EA@N=W3J0,
M9SSTKF/BI'#%I&DW\2J-5@U2V%DZCYRQD 90>N"N[(INJZ=:W_QMT9KJ!)?L
MVCS31AUR%?S%4'ZX8TUK:WG^5PV^Z_XV-SP[X_\ "WBRX>WT76(;F= 28BCQ
MN0.I"N 2/<5;U3Q9H.B3W$.IZG#:/! MQ()<C",Q4$'&"201@9/M7/\ C"")
M/'?@B[5%6X-[-"9 /F*&%B5)],@<5!)I]K=_'=;B>%9)+70E>$L =C&9AD>^
M,_G0M;6\_P  VO?R_%V-C3OB-X/U73+G4;37[0VMKCSGE)B*9.!E7 /)X''-
M3>&_'?AGQ=)+'H>K174L0R\>QXW ]=K@$CGJ.*Y[5]'T^[^-NA7,]I$\J:7/
M+N*@Y974*3ZX#'%6?$$,<?Q<\(3H@662WO4=QP64(I /J 30M;>=_P +_P"0
MGI?R_P"!_F=!XB\7:!X3MTGUS4X;-7^XK99W]=J*"QZCH*FT'Q'H_B>P^W:+
M?Q7EOG:6CR"I]&4X*GV(%>:S?\)?<_%[Q&^@KX>:XMH+=(O[8$I=(2N<Q;.@
M+%L^^*W_  IX;\6VGC>^U_Q V@QI=V:P/%I)E D=6RKL'')P6&<^E*.JNQRT
M=D:>H_$SP;I5LMQ>ZY#$K2O$%\MV?<C%6^0*6P"",XQ[UIP>+- NO#SZ]#JU
ML^EQC+W(?"K['N#R.#SS7,?"G3;2WTO6;Z.!!=76L7?FR[?F(64@#/H,=/>I
MO!4$5IXP\=6UNBQ0B_AD$:#"AFA4L<>YYI/;Y7_!?YA?\[?B_P#(9X)^*N@>
M+I(K!;U5U>5YBMJL$HQ&K-M)8C;G8 3SU_*M/7/B3X/\-ZA]@U77((;H'#1(
MCRLAX^]L!V]1UQ5+X3,!\-=/8G@/<9_[_/698^(/&/BJUEU7PEHWAZSTV>1U
M6XU:20R7*J=NXK&..0?O$\"JEH[+^M@MO?O;\SHO%=_::G\--;O;&YBN;6;3
M9VCEB8,K#8W0BM'PI_R)^B_]>,'_ * *\Y\,>9_PHCQ&LOD;U&H@BVSY0Y?(
M3/\ #GI[5Z-X4_Y$_1?^O&#_ - %.UK_ "_)B?3Y_FBQK&MZ9H%@U]JU]#9V
MRG!DE;&3Z#N3[#FLOPYX]\+^+)GAT36(;J9 28BK1O@8R0K@$CD<@8K%UI8K
MKXP^'[;4%1[:/3KB:U20Y4W&Y02 >"P3.*3XEQ00S^&-0A4+JT>LV\5LZK\[
M*Q(D7/7;MR3]*4=;7ZZ?C8;Z^2O^%SI]1\4:)I%Q<0:AJ,-J]O MS+YN5"QL
MQ4'/0Y((P.?:I=!U_3/$VE1ZGI%R;FSD9E63RV3)!P>& /7VKCY]-M;_ ..B
M2W42R_9=#26)6&0'\Y@&QZ@$X^M>A4ELF^O^;![V7]:%#6-;TS0+!K[5KZ&S
MME.#)*V,GT'<GV'-9_AOQKX<\7+*="U6*[:+[Z!61U'KM8 X]\8KC/'7]O7'
MQ1\/6VCKI#2I8SS6ZZOYAA,FX!BH3G>%QCV)JS:>'/'M]XVT;7-=;PQ%'8&1
M9&TTSB65'4C:=XP1G!QD41UW\PEIL=5XC\;>&_"0C_MS5H;1Y!E8R&=R/78H
M+8]\8JYI?B'2-:T4:Q87T4NG%2WV@Y10!USNQC'?/2N4\#PQ7'C/QI?74:G4
MTU$6X9N62W$:^6!Z \GWJ3XJ;8_"=M"^(["?4[6.^(.T>2T@WY]B<9^M"V7=
MV_$?5^5_P+=E\4O!&H:L-,MO$-J]T6VJ"KJC'. %<@*3SV/-0?$S_D%Z'_V'
M;+_T96EXRT[29O 6JVU[#"MA'9R,!L&(\*2I4=B#C&*Y#5I[JY^&7@>>]W&Y
M>_TQI"W4G<.3[U4=UY-?G_P!=/5/\CT'6_$&D^&[ WVL7\-G;@X#2MRQQG"@
M<L?8 FJ/ASQQX:\6EUT/5H;N2,9:+:R.!Z[6 ./?&*PKQ(KKXVV,.H*KQ6^C
MM-8K)RHE,F'90?X@N/PIOQ!CB@\1^#;ZV11JIU=(%95^9X65O,!/7;C!I15[
M7Z_YM?H$M+VZ?Y7.A\1^-?#GA)8SKFJPVC2<I&0SNP]0J@G'OBJ.@?$KPEXH
MU-=.T;56NKLJ7V"UF4 #J260 ?B:Y_79-9T'XGS7^AZ-;Z_<ZAIZ![0W*V\M
MLD;$;@[ J%8MTZDCVK;\%Z/K,&JZWKNLVEOITVJM$RZ?;R^8(MBXW,P #.<\
MD<<"E'5782TT7D:/A26&2'53%K<^J!-2G5FG0K]G((S",]57UZ50/Q1\%#6D
MT@>(+=[UW$:K&CNA;TWA2N>W6N,:>YM_A9\0Y+0L)1JM\,J<$*64,?\ ODFO
M3M L-.L_#MA:Z?!"MDL"&)4 VD8!!]SWS37?T_%7!Z-KS?X,C\0>*M"\*VRW
M&MZG!9H^=@<DL^.NU1EFQD=!WIOAWQ=H/BRV>?0]3BO$C.'"@JZ=<95@&&<'
MJ.:PM=\0ZO=>*Y-!\-:-876HV5NLTM[J,I2*W\S[H 4%FSC)QCI6'X2_M]?C
M#J2^(O['%^VC(SC2?,\LCS?E+[^=W7\,4HZ_C^ 2T7W?B;O@#_D*>,_^P[)_
MZ+CKJM3U2RT>R:\OYQ#;JZ(7*DX+,%7H#W(%<KX _P"0IXS_ .P[)_Z+CIGQ
M?B6;X::E$^=KR0*<>AF04^D?2/Z#TYG?S+P^)?@TZ[_8H\06IOM^S8-VS=G&
MWS,;,YXQFDNOB;X+LM:_LBX\06J7N[85PQ16Z89P-JGCH35+XD:78Q?"35[-
M+6);>VL\PQA !&5QM(]"*D\0Z186GP?U&PAM8EMH=)<I'M& 5CR#]<C.?6I;
MLF^P17,TN_\ P/\ ,ZV\OK33[*2]O+F*"UB7>\TCA54>I)KG-&^)7@[Q!JG]
MFZ9KL$UYDJL91TWG_9+ !NG;-9UUXC.C> _#42:<-4OM3BM[6VMI'"H\AC!R
M[$' &">E<MXP/C477AR3Q!#X8@LAK=J+=+%IC<QDO]T,P"],YQ5\O[SE\[$)
M\T%+K:_X'3^(?BQX=\-^+X-&OM0ACB6&1KN18WD,4F5V)A >2"Q/'8=,TGB+
MXL^'-"ET/_B8PM!J!6:1S&[-';E"5?:!N!)V@ CN>.*M7Y_XO)HO_8'N?_1D
M='C,X\7^!_\ L)2_^B'J8[1\W^K+>[\E^AN6/BS0M0\.#Q#;ZE$-)(8_:I08
ME&#M.=X!'(Q5/P_\0?"GBB]DLM&UF&YN4R3$5:-B!U*A@-P^F:YKXK'4Y-0\
M)6FGC3SYVHL=NI%OLS2JA,8<+R><X]P*@O\ PW\2-=U#2)=4/A"&/3[V*Y6:
MR-RLRJI^95+ C!&1CO3C9ORO83T7X_G_ )'=:CXHT32+BX@U#48;5[>!;F7S
M<J%C9BH.>AR01@<^U5K?QOX;N?#7_"1)JL2:3N*BYF5H@2#C # $G/MS7.SZ
M;:W_ ,=$ENHEE^RZ&DL2L,@/YS -CU )Q]:Z+Q9X<D\0V=G]FNUM;VQNEN[:
M22+S(]Z@C#KD9!!/<$=:7V4^_P#FQNU[?UM<A\._$+PIXKNFM=%UB*YN%!;R
MC&\;$#J0'4$CZ5TU<?IWB'4[?Q%9:1XHT>UM[ZZ1Q:7]E)YD,Q499?F =#CG
M!R/>NBUF2XBT/4)+4$W"6TC18_O!3C]:4GRQY@BFY<I@:K\3?!FB:I_9M_K]
MO'=AMK(JO($/3#,H(7\2,5T:ZE9/I?\ :<=S')9>49A/&=ZE ,Y&.O'I7,?#
M*VL/^%;:.ULD3K<6P>X;AC)*?OECW.[.<U@^$UB@\+>.[.R_Y!EM?7D=H ,*
MJ^7EE7_9#%NE.I[BDNJ5PA[S3Z-V.K/C_P +#4].TT:O$]YJ*HUM#&CNS!@"
MI. =F00?FQ72'I7(_#+3K73_ (=Z(;>)5>XM(IIG_B=V4$DGOZ?0 5UQZ551
M<K:[7(BVU<Y3P_J^G:7X*?4[KQ!/J5E!+,9+^XB<-_K2-I7&<*?EZ=O2F7?Q
M1\$V.K?V7<^(;5+K.T@!F13Z,X&U3QW-<-C/[.FLCU>Z_P#2EJ]&N=%TZ#P#
M/I4=G"+);!D\G8-N-GIZ]\U,G9.7:W_I-S2WO6[M_G8K>.?&UAX-\,2ZE)<6
MYN)$/V.)SD3/QC ') R"<=JM>&O&OA_Q=;W$VBZ@+E+; G8Q/&$)!(^^H]#7
M"ZL[2?LV6SNQ9CIUKDD_[:5T?Q5GNX/A;JSV;;7:)$9@3Q&SJ')QSC:3GVJI
M+EYEV=B8^]R^9:M_B?X*NM:&DP>(;1[PL%4#=L8GH!)C83SV-=!?ZM8Z6UJM
M[<+";J800[@2&<@G&0..%/)P*\RO?#WQ'UKPHVB>1X"&ESV_EQB%;D!%(^5D
MX(!'4'%7?'&DRR^'O ^DZM()Y?[5M(+ID8D2'RV#\G!(//YT6Z>:0DUOY-G6
M:9XY\-:S+J,>FZK'='3D\RZ:)'*(O/(;&&Z'[I/2J-]\4O!.G3VT-UX@MTDN
M462,!';"L 5+84[,@@_-BMK78HX/">I10QK'&EE*JH@P%&P\ 5A?#.QTU/AA
MHD=M! 8)K-6F 4$.Y'S[O4YSUJ>_E;]?\A]O._Z'176N:99Z*=9FO(_[.""3
M[0F74J<8(VYR.1TJC#XT\.W/B;_A';?5(IM5"EC!$K/M Y.6 V@CT)S7F0VK
M\#/%\%NW^@P7UU%9;?NB$2C 4^F<XKUO1=.M=)T:UL[*%8H8XQ@*.IQR3ZDG
MDGO3[OII^*N)WV]?P=C)U_XA>$_"]XMGK&M06]RV/W05I&7/3<$!V_CBK&K^
M+]%TCPN_B"34+=K$QEH95<,)FP2%7'4G'2O,_ X^(-Q8:E=Z*OA)O/U"X^U-
MJ'V@W/F!R"LA3C@8P/3%=#I?AW6O#GP\\71ZTVG"2[6ZNHX=.+^3$&BY50X!
M R"<<]:B5U!ORO\ U_F:15YJ/G;\;&SX'^(FB>-+6&"TO4DU5+5)KN!()$6-
MC@, 6&" QQP32WWQ2\$:;JO]FW7B&U6Z#;&"J[JC9P0SJ"JD$<Y(Q4_AO4(-
M*^%^E:C<9\BUTB*:3:,G:L0)Q^5<G/J'CG6_"\VH:=HOA73=%N[=YVAU&622
M1XV!.YO+ 4$CGG-:5?=E*W3_ (/^7F9T_>2OU_K^MCJ?&_CG3O"/A9]5-U;/
M--'FQC+;A.QQ@C')7D$D=JAA\;>'?%OA76I]'UZ2**UMF^T7D5O*K6V5)W@,
MH)(P3QZ5R%ZQ;]F:V+$G_0+?DG_IHM=]XU_Y)YKW_8,G_P#19J:BY5/R_P B
MZ?O.'G_F7+34;+3O"UI?WFJJ]G':QLU]<GR_,&T?.V<8)ZX]ZR]$^)/@_P 1
MZC_9^EZY!-=YPL3(\9<\_=W@;NAZ9KEM4$<]E\,K.^"G3)I(_.1S\CR+;YB#
M#H?F['N*V?BW;V@^'MY=2*JW5HT<EC(J_.DP==FSN"3QQVJYJTG?NU^-OUV,
MZ>L8^B?X?\ ZG4]>TO1I;>/4KV.U-QO,9ER%.Q=S9;H, 9Y(K&T?XD^#]?U4
MZ9IFNV\UYDJL95TWG_9+ !NG8FL;QK8PZKXI\ V^H0)*C7<LDD;C(++"6&1]
M0*M?$ZWA_L?1K@1J)K?6+/R7 Y3,H!P>V0<5*6JOWM^*7ZC;TT[7_/\ R-[Q
M%XOT#PG;I-KFIPV:R?<5@6=_7"J"QZCH*=X=\5Z%XLM7N=#U&*\CC(#[059,
MYQN5@".AZBL[Q!X=U.7Q!:^(]!N;-=2@MVMF@OHRT4L9;=C<OS(V?X@#[@U+
MX:\0/J6I:AINHZ2-,UFU5'N(U<2)*C9".K@#<#@]0"*4=1OR'>-_%UEX,\-7
M.IW4T2SA&%K%(?\ 72X^50!R>>OM69:^.= \9>%-:_L:_%U+;V+FX40R1A"R
M-C[ZC/(/3/2K7Q._Y)GXA_Z\VK1U+GP/=D?] Y__ $6:B?\ #G?^M&7'XXV_
MK5''>&OB/X0\.^#?#>G:KKD$%V=/@!B"O(4^1?O;00O4=<5Z+;7MK>64=[;7
M$4MK(GF),C JR^H/I7+?#;2K&T^&FB0PVT0CN+*.28;!^\9URQ;USD]:X222
MZL_V>]8BL&*"*ZN(!R<1P_:2K#CH I/3M6]7XY=[_F[&<%=1_KI<[ZW^)_@J
MZUH:3!XAM'O"P50-VQB>@$F-A//8UOW^L6&ES6D5[<K UV[1P[@<,P4N<GH/
ME4G)QTKS.]\/?$?6O"C:)Y'@(:7/;^7&(5N0$4CY63@@$=0<5=\7Z,UQ;_#[
M2-99;EQ?QQ715B5E*P-NY."5)!SGJ#S4VZ>=OS"^E_+_ ".QT'QAH'BBXO(=
M%U%+UK,J)S&C;5SG&&( ;H>A-9TWQ/\ !5OK(TF7Q%:"[+;,#<4#>AD V \=
MS5KQS)<6/P]UQ].!CFBL)?*\K@IA3TQTP*X/2-)^(5YX)M=.L;?P%)HUQ:*J
M*5N3O1EZG'!;N3ZU-][=/^"/MYGK%W>VMA927EW<106L2[WFD<*BKZDGBN:T
MCXF>#=>U/^S=.UZWENRVU8V5X]Y]%+ !NG8FN5UK2KG2?#/@'0-?GBGMUU&&
MWOF5R8I-JL8U)8#*Y"]?2NB^*5K8M\-]6DN$1&M8/,M7  ,<H(V;?0[L#BF[
M*[W5[?E_GL$;NRZ_\/\ Y&3\7?%^FZ-I-MH\NK-:7%[<PK<"!CYJ6I;]XPV\
MC@$>OI6Y\/+'PA;Z ]UX+4C3;F4EF+3'<Z\$XEY'\JQO'[S2^&_!TER")VUG
M3VD![,>OZUZ/32Y4_5K[K W=1?E<****D HHHH **** "BBB@ HHHH ****
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M*:TM))GCEN9;EC*03ND8L0, <9/%&G:#:Z9JVK:C#),TVIRI+,KD%5*H$&W
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MQBS X &/F(^E;%%4W=MOJ"TV.#3X5:9#,%M=?\3VM@O TZ#576W ] /O ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KW]];Z9
MI]Q?7;E+:WC:65PA8JH&2< $GCT%6*9-$D\$D,JAHY%*LI[@C!I.]M!JU]1E
MG=V^H64%Y:RB6WGC62*0=&4C(/Y5676M/?79-%2<MJ$< N'B$;$+&3@$MC:,
MD'C.?:N6^&UPUAI&H>&KJ3]_H%R]OECU@/SQ-_WR<?A3?ATK:K)KGBV13_Q.
M+PBV)Z_9HODC^F<,?QJ]+Z;6O]^W]>3)U2UWO;_/^O-'=5EZ_KUKX=TY;Z[C
MF>)IXH (0"=TCA0>2.,GFN4U;5_B38K=:G%I'AW^S;96D:T:ZE:YD1<G(<*$
M!([$5'XYU.+6OAOI6J0*RQ7=Y83JK=0&E0X_6E'6WJOQ82T3]'^"9Z'17.ZC
MKUU9^.=#T2..$VU_;W,LKL#O!C"[=ISC'S'.0:/%6OW6AS:$EM'"XU#5(K.7
MS03M1@Q)7!'/ ZY^E):V\_\ AA]_+_*YT5%<MXE\2:E:ZK;:!X>LK:[UFYA:
M?-U*4AMX@<;WP"3EB  .3S531/$GB"U\0VWA_P 76>G1WEY$\MG=:9(YAEV8
MW(5?YE8 @^AH6H/0O>(?B#X4\*W*VVLZS#;W! /DJKRN >A*H"0/K6GH?B'2
M/$EA]MT:_AO+?.TO&?NG ."#R#@C@\UP>GZI;_#SQ)KY\26ES%;:G?-=0:RL
M!DB*-M BD902A4\#/%=[;ZEI"Z/+J]I<6K6!1KA[B J48 <MD=3@?I1=<MV-
MKWK+_AS2HKSNP\0?$/Q%!!K&C:1H-IH\WSQ0:C-+]IECSPV4&U=PP0#G'O6Q
MXD\3:G9ZI9Z!H%C;WFN74+3G[1(4@MXQQYCX&2-Q  ')IM-".LHKA;#Q/XGT
MC6]/TOQE8:6JZE(8K6^TJ1S$) ,B-UD^8$@'!Z4_6_%NNV_C@^&-&TRUNYY=
M/6ZBEG<QI$=[*S2,,DK@+@*,DGKZ+T_JP+KY';T5P^E>)O$VG>(;+1/&-CIB
M/J ?['>Z8[F)G49,;*_(.,D'O3]3\1^)=3UF^TOP=9:6YT]ECNKW5)'$0D(W
M>6JH-Q(!&3G'- ':T5S/A7Q)>:I=:AI&LV<5IK6FE/M"0.7BD5QE70GG!P>#
MR,5TU.P&7)KUK'XHA\/F.;[7+:-=JX V!%8*03G.<D=OQK4KS7Q/?:E9?%[2
MAI.GI>WL^CS11I))Y<:?O5)9VP2% '8$DD"KVF^)/%NE^)M.T?Q?9:04U,NM
MK=Z4\FU75=VQUDYY /(XH6J7S_-A+1_<=Y17/>))_%PDBA\,66DMN7<]SJ4S
MA%.?N[$&3QWS5/PIXEU6_O=6T?Q!8VUOJVEB-Y&LG9X9D<$JR;N1T(P:7<#K
M:*\WTOQ+\0/$EI%K6B6'AH:1*3LMKFYF-R0"1@LHV*WM@XKT6(R-"C2H$D*@
MLH.0#W&>].P=;#Z*J:K=/8Z/>W<04R00/*H8<$JI(S[<5P.F>)?B)XET*QUG
M1='T&WM985=H]0FE\V<X&2@3A 3G&XGC!-3<#TFBN2T_QY:3?#U_%=];O:K"
MCB>W#;F61&*% >^6&!]:R3K7Q-CMSJ[Z#H)T\1^:=.6YE^V!<9QOQY9;VQ[4
MWIN'0]#HKS/XA>([[5?A&^L^'A;?8KV!3,]P[+(B,RKM50""<D@Y(Q[UUOA;
M_A+/L\W_  E/]B[_ )?L_P#9?FXQCG?YG?ITIVWOT%?1/N;]%%>>1^*_&&MZ
MGKNE^'M,TE9=,O6@-WJ#R+"4P"JA4RS/UR> ..M+K8?F>AT5YKI_C3QIK4]_
MH5CH6F0:_ICA+VXNIW^QC(RI0*"[;ADXXP,9-;O@_P 2ZMJ>H:KHOB"RMK;5
M],,9D:T9FAF1P2K)NY'0\&FE<#K:*X[5[GXB-J,IT33O#J6$3';]NN)6EG7U
M&P (3SUSVJQI?C:VN_ #>*KV!K6.&*1KB$-N*/&2K*#WY7 I7TN.VMCJ&8*I
M8] ,UF^'M=M?$NA6NKV<<T=O<@E%F #C!(Y )';UKCX=<^(LMF=9GT'11I+Q
M>;]@2XD^VA",_>(\LMCG;QZ9J'P/K]MX=^"6FZM<([QQ1-LB7[TCM*P5![DD
M"G;>_2WYDWVMUO\ D>DT5YW=^)/'VA6TFN:WHVB'1(E#SVUG<2-=P)QEB6 1
M]O)(&*]!AF2X@CFB;='(H=3Z@C(HL%Q]%!S@XY->=ZMKWQ(TFTN=:GT?PZ-*
MM8VFELUNI6N=BC)P^T)G'/3M4W*2;V/1**KV%Y'J.G6U[""(KB)94SUPP!'\
MZ34+Q=/TVZO61Y%MXGE*(,LP4$X'OQ3E[M[]!1]ZUNI9HKSO2=<^(NLV]IK-
MI8>%WTBZ198[874QN A'>3&S(^GM6IXL\6:GH7B+0]*T[38[Z75$G58R^PAT
M"E26Z! "Q/!/'%-IIVZ@M=CL**X!?$WC#P]J=FOB^PT9M-OKA;:.ZTJ23_1W
M;A1()!R">,C&*U/$7B358]:C\/>&;*TNM7>W-S+)>2,D%M'G:K-M!9B3G 'H
M:0'5T5Q^@>)-=CU]?#OBNSL8=1F@:YMKC3G9H)U4@,N'^96&1UZU1G\4>+?$
M&IZA;^#-/TE;/3YS;RWVK22;)I%^^L:QC/RG R3B@#L=3U>PT>."34+E8$GG
M2WB+ G=(YPJ\>M5O$7B.P\,:9]NOS*RLZQ10P1F22:1NB(HZDUA>(M7U/3/#
MNB3:G8:9)?SZG:P3Q[6EBC+28W)G!W#J">AKG_B7)XJ/BWPK'I<>CK%]O)M&
MNI)26F\IO]8%484#=T))XZ46V7G8.E_*YV&D^--.U););FUU#2;J]E>&WM-3
MMC#,[(NX\<C&.<Y_6NCKBKK5-7LM6\'6>LVFD2ZA>SSI<2P1NRQ%8V8&$L<K
MD8!SGO2ZYXHUV?Q'-X<\)6%C/?6T*S7=WJ$C+;V^[[J$)\S,0">,8IOR\_P!
M>?\ 6YVE%9'AUO$+:>P\2QZ:E\KD Z<SF)E['Y^0>V/;WK7H8!17!WGBCQ3K
M>M:AIW@RPTHPZ;*(;B_U623RWEQEHT6/DD9&235_4O$VJ>'?#%G-JMA;7&OW
M<RVL%G92GRYIF)QAF&0N!N)/04NEP>CL=;17G=UXE\=^&86U7Q-I>AS:,K#S
MO[+EE\^V0G&Y@XP^,C.,=ZUO&/BZZ\.G06T^R6_&IW@MO*!PS;D8KM.0!\P7
M).>,\4 ==17FFI^,O&WA*XMI_$>BZ3=V%[.+:W32)I#-'(P.Q7\S ;)P,C'<
M^U3WGBCQQX>O+2]\0Z5HAT6YN8[9EL)I6GMC(0JLQ8!6&3@X'>FE<'H>B45R
M7C#Q5J'A[4]"M-/TY;^34YI(!$6VG<$RIW9PHS]XX/&<"LJ7Q/XS\-7=O<>+
M-.T5]'N;A(#/I<LF^U+G"F02#YAD@$C%):@]#KKC7K6V\266A/',;J\@DGC<
M ; J%003G.?F&.*GM=7T^^U&]T^VN4DN[$H+F( YC+#*Y^H]*Y?5?^2O^'/^
MP9>?^A1U>T'57O/&?BFP:TM(ELI+<++%'MDEW1;OWAS\V.@Z8%-:I?/\&)]?
ME^)T]%<5JMY\1Q>SRZ5I?AU+"%VVQW=S*T\Z \%2H"H2.QSC-0ZE\0)(OA5'
MXSL[-0[+$S6\F6QF0(ZC!&2/FP?I26U_ZU*MK8[NBO.M3\1?$6PL)=?_ +#T
M-=(AB,\EB]S(;P1@9/S >6&QSCGH1S6_K7C.VTKPC:Z[!;27;WPB6RM4(#3R
M2XV+GMUY/H#182U.FHKD=$F^(3ZM&VN6GAR/3),EDLY9C/%QD9+#:WH<8]:J
M7OB3Q3K.JW]EX-LM(,.G3>1<7NJRR;'E RR(D8S\N1DDXZB@#N:*YOPIXDN-
M:.H6&IV:6>L:9*(KN&-]\9W#<KHW=6'KR*Z2FT 45PFI>(_%FI>)=2T;PI;:
M'&VF&,7$FK2R9D+KN&Q(QG'/4GKFK.N^(O$/A_X>7FLW]EI\6K6VT>5&[2PM
MEU7/\)Y!/':DM?Z^0[:V.RHJEJ=Y)9Z)>7L84R0V[RJ&'!(4D9]JY34/&MY8
M?"FS\6O#;FYD@MII8PC;!YC('P,YZ,<<GMUH_P"!^(EK:W7_ (<[BBN(.J>/
MKFVO=2@TS1K6R^R/+9VL[22732#E!)@J@!'4 Y![UM:9XGL[[P5#XE9U2V:T
M^TR<\)A<LOX$$?A0]$V^G]?H"U:2ZF[17#1>,]5@\':->W>FPRZ[K+A;.PB8
MQK\V67<S$X"H,L?R%1Q>)?%^@:A9+XPL=&.GW]RMK%<:5)*3!(WW!(KCD$\9
M'2G9WM_5^PKZ7_KU.]HKF]#U^\N_$^NZ%J44,<]BZ2VS1*5$MLX^5CDG+ A@
M<8'M1IOB"[U3QMJ^EP1PC3-,BC224J=[W#_,5!SC 7&1C.3UI+6WWC>ESI**
M*XK5_$WB&^U^\T+P?8Z=+<6*H;R\U*1U@B9N1&%0;F;;SZ#(H [6BN0\/>)M
M7?7G\.>)["UM=6%O]IAFLI&>WN8P<,5W#<I!['UK-;Q?XHU/Q!KV@Z!IFGR7
M6GW(1;J\9T@CC,:L-^W+.Y8MPN!@<^Y;L!Z#15>P^V?V?;_VB8#>^6OG_9P?
M+WX^;;NYQGIGFI)VD2WD:&,22JI*(6VACC@9[?6AZ M22BO.-5\2_$'PY:RZ
MYK&D^'VT6$J9K>TN)3<Q(2 6W,-C8SG %:_C#Q;?^'[_ $"WTW3EOVU2:2$1
M$[6+;,KALX49ZD@\9H_X8#L**\\E\3>-_#NHV,GB?3M#?2;V[2U$FFRRF2V9
MSA2^\889P.,5UGB&?7X;)!X>LK*YNY'VEKV=HXXA@_,0H);G' Q1TN'6QKUE
MVFO6MYXAU'1(XYA<V$<4DK,!L(DSMVG.<_*<Y KG=!\1^)H/%$?AWQ99:6MS
M<VSW-M=:9(YB8(0&4J_S C<#GI5!9=0@\?>.IM)2&34(].LW@29249PLA (!
M!YZ=:-M7M9_@-:Z==/Q/1:*PM*\46FH>"H?$KGRK<VAN)0?X"H.]?P((_"N8
M;QKXB/AWPZ8]/TY=:U]G-NMRSQ6\"X++OZLS;=O QDYQBFTTVOZ_K02U5ST2
MJ5KJ^GWVHWNGVURDEW8E!<Q ',9897/U'I61X;E\9_:)8O%%KHGE[=T=QIDL
MF,Y'RE)!GU.<U7TG6VD\5>+K=[.V1-.,!$D$6)9LQ;OG.?F(Z#IQ2>F_9L-_
MO1UE%><:5XB^(>OV=OKFE:?X8;2+E?,BM9+J;[3M]"X&P-ZC''2O1E)*@L &
MQR <X-.S6X7%HK-U_6K7P[H5YJ]Z3Y%K&78+U8] H]R<#\:XXZU\38[<ZN^@
MZ"=/$?FG3EN9?M@7&<;\>66]L>U*X['?75U!96DUU<R+%!"ADD=NBJ!DDUSO
MAGQM:^*;J2.TTC6K> 1^9%=WED8H;A<]8V)YZ@]!Q7.^/]<O=<^$-SJV@+:&
MPO+)GN&NG99$C.,A54$%NHY( ]ZZ+P0/$XT9!XC_ +'V^5%]D_LWS?N;?X]_
M?IT]Z:6KOT);T5NIT]%-<N(V,84O@[0QP">V3VKRCPG<_$*Z\6^(&4^'/LR:
MJB7RR-.SHHC3B$@ 'Y,?> ^;/:DM78;T5ST33]?M=2UO5=*ACF6?3&C69G "
ML77<-I!R>.N0*U:\HMM0\0Q_$SQI8^&]/LYKN1K61KF_E9((0(0!D*"S$GL,
M=#S73>&/$NNR^(;GPWXHL[&'5(K87<4VGNYAGB+;3@-\P(.!S36J7H#T;_KL
M=C17#7OB3Q3K.JW]EX-LM(,.G3>1<7NJRR;'E RR(D8S\N1DDXZBM7PIXDN-
M:.H6&IV:6>L:9*(KN&-]\9W#<KHW=6'KR*2U!Z'2445P-[XC\8:OX@U33?"=
MMH,2:7*L,[ZM+*7D8J&RJ1CA>>IZT>0'?45R'B#Q%KN@?#NZUJ\LK&+5K<+F
M!7:6'F0+G/RGD'/M71:G>26>B7E[&%,D-N\JAAP2%)&?:B3LFWT_RN-)MI=_
M^&(/$.O6OAK19=5O8YI((F166$ MEF"C ) ZL.]:@Y&:\P\;:Q+JOP*CUF[1
M5EN8;.XE2%3@$R1L0H)_+)J[=Z[\1;*V?6FT+1&TF./S7L%N9#>A ,GYL>7N
MQS@9],TVN6Z?1V_ 6]FNO^9VNIZO8:/'!)J%RL"3SI;Q%@3ND<X5>/6KM<;X
MB\3POX:T#5K&VM;NWU#4+-4%U%O"K(P^8#/#CL>QJSXE\2:E:ZK;:!X>LK:[
MUFYA:?-U*4AMX@<;WP"3EB  .3S0TUZWL"UU\OU.IHKB]$\2>(+7Q#;>'_%U
MGIT=Y>1/+9W6F2.89=F-R%7^96 (/H:BU+Q/XEU37K_1O!UAIKMIQ5;N^U21
MQ")",^6JH-Q(!&3VI =S17E_Q!O?&EO\.T-Q#HT5V]Q'%=O#-*4P955=@*Y(
M8]<D$#CDUVOAK_A*/LLW_"4_V/\ :-_[K^R_-V;<?Q>9SG/I32W\A-[&W111
M2&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'DOQ)74-"\1O=Z4C%_$ME_9!V_P -QN'EN?\ @#/S_LUV
M]_87F@_#R>P\/(3>V6GF*T"@$EU3 P#U.?UKHZ*5O=Y?Z_K5_>._O)_U_6B/
MGDVOP_U_0Y(OLFMZ_P",1:D/%=/=>;%-MYWDD1JH;)ZX^M==J7_)#O"W^]IG
M_HR.O6**M2_-/[B6KJWK^*L>?^.KT>'O&'AOQ-=P3MI5I'<P7<T,32>1YBKM
M=@HSM^4Y-8GB+QG8>+M4\)'08[JZTZ+6H7FOFMWBB#?,%0%P"QZ]!QCWKUNB
MICI;R=PDKWMU5OT/)?B1X:T>3QK9>(/$VD7&I: UD;:=X#*3:.K%ED81D,5(
M)!ZXI_@.P^%5QXDANO!MA<27T"N1<JMWY<61@@F0[<D'ISUKU>BB.@Y:G#W_
M ,6?!NFWT^G:K>W-G=1NT;03V,Q+\D9&%((..#WK&\+:#/JVA>-EM+*?2M*U
MIW73K>>/RBN8]K2;/X0S<XXXKU&BE;1I]58=[--='<\R\/\ Q,T/0]%T[0M?
M6]T[6[6!+9[)[*5VD9!MRA12&!QP<U<\17+^%_']KXMN+:YFT:XTXV5U+!$T
MAM2'WJ[*,G:<D$@<5Z#15.3;YNO^9*22Y>AY??>(++XE:UX>M?#0GNK"PU!+
M^\OVMGCBC$8.$!< EB3T':EUS7D\._&8WMS:W$M@=#5+B6"(R& ><Q#E5RQ7
M(P2 <9%>GURR:1?#XI3:R8/^)>VCK;";>O\ K!*6VXSGH<YQBA;I+S_%#Z._
ME^?],YH>(K3XB>,O#Q\.I/<Z7I4[W=UJ#0/''NV%5C7< 2Q+<US.N^&O!FC>
M,M=N_'^D7+VE]<?:;/5%:X:/:P&8F\H_*0W3(Y!KW2BEVMY_C_PP?\#\+_YG
M!?#>P\#Q)?7G@JPN(8)0BR7$BW 2;&<;?-/..<X%=[113;N)(XFZ_P"2U:?_
M -@*;_T<E.\9?\C?X(_[",O_ *(>NTHH3M;R_P W_F-ZW\T>+^*;S06\<ZO:
M_$>ZU.+2SY2Z5;IYXM9DV@L<0_>?=Z^U:'POT_3M*\8^*%TK2+G2],>VM);>
M&X+EW3]X-Y#$L,D'@\^PKUBBE'W5\K ]3Q;7?$?P^FO+V?PUJ&I6/BIMQ2/2
M[.XCDGF&2%>(H$?G.=PSUYKUS1Y+V71;&34HQ'?/ C7"+T60J-P_/-7:*:T5
M@>KN9OB+_D6=5_Z\Y?\ T UF_#_CX=^'?^P=!_Z *Z2BDMGYV_7_ #!]#R33
M]$N_$'P9U6PL &NSJ%U+"A.-[)=%POX[<?C6NWQ=T(V9M%M]2_X2 Q?\@?[#
M+YWF8^[]W;C/?.,5Z)10]5;I_P "P^M^NOXNYY9?>%]3TSX 2:*;=IM1CMQ+
M)!$-QW&42,H ZX&1QZ5V?A7QEHGBZVE;1[F28VVU9U>"2,QL1]T[@ 3P>F:Z
M"BJ;NW?K_P ,+HOZWU"N)\ ?\A3QG_V'9/\ T7'7;45*T?\ 7E_D'2W]=3B?
M"'_(]^.O^ORV_P#1"TS23(/BEXQ,(!E^PV6P'UVR8KN:*.GRL'?S=_Q/G[33
MX*UFW2V\;Q:YJWC(L_FZ=+]JWK)G[L83"*I&.<XP*Z;PUX>NM6^ -YH<%OY%
MVWVJ-("^=KK.Y"%L\\C&:];HIWT:[V_ :=FGV/.[/XJ:+<6"Z8EMJ'_"1" (
MVD?8I?-$F,8)V[0,_P 1(&.:P;/P[>>(?V>+'3H+;SKJ/]\;4L5\W9,6:/(Z
M9 ('OBO8J*3UOYV_!W)2M;LO\K'@4%E\#Y'2UET._AU1@-VFLE\9U;&2N <9
M_&O=[6&*WLX(($,<4<:HB'.54# '/M4U%.^@6U,+QI+JL'@S5I=##G4EMF,'
MEC+9_P!D=SC./>O$]0L_AYKOAR\73K36M>\5QVC!FN7NO-AD"G+2,Q$8"G)Q
MW/ !KZ)HJ;;EIVL9'A3_ )$_1?\ KQ@_] %:5S-';6LL\V?*C0N^U2QP!DX
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MNPDG/'/.*=K@=A17.:YXWTCP]JL>FWWVG[5+;F>%(83(TV&V[$5?F9N<X Z
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MSJ+6MU=>2A(AM86E=CVX';U)X%)NRNQI7=C3J"UO+6^C:2TN8;B-7:-FB<.
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M1^%)H;;XE^,K.[94U&XE@G@#\-+;B, %<]0"&!QWKL-)TFQT/2X=-TV#R+2
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MG6EPNV6/<5W#.>JD$?@:'JDGW_5,<7:2?I^"9SWC6&*/X5:U"B*(TTJ157'
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M*/7=,BO!"3Y;%F1ESU 92#CVS5E/#NE1W.F7"6@672XFALR'8")&4*1C.#P
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MC >A*D$CGH>*WT18T5$&%48 ]!0MDNW_  ?\P>[?]=#B[G_DM6G_ /8"F_\
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M*$[NHZ'/I4NOZ5!X8\.> K6\O8[S2=-U.);B[90L9&U@CL,D!0Q'<]JZ6_\
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MA$0(_6I?'"C_ (27P0V!D:N0#_VQ>NHNM(L;W4['4;B#?=V!<VTF]ALWC:W
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MCI<&+169KLVKP:>CZ):P7-UY\:M'.^U?++ .<Y'(7)_H>E:= !1110 4444
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M?E\,^$;[5+=$>YC"I"LGW?,=@JY]LL#2>&-,\2:?Y[^(/$<>K>:%:-$L4MQ
M>X!4_,.F,\\4+4'H=#1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <1\-?^/7Q)_V'[S_ -"%0?$C
M!U;P4L1Q=G78BF.NP*V_\,51LM ^).@7FK)HDGA1[&\U":\0WIN#*-[9P=H
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M9<NS6B_K^F$=&K[W.%\#_#;1?$WP_P!$O?$AN]1N6M@8-UU(BVR=%5%1@!@
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M/LTJ0QF-(F#A@L:G)VXSR6))_31\,:#=:+>^()KF2%UU'4GNX1&22J%%7#9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWT88::@DGBD$*?\ +,D%E((Y!XP>*V_#,6K>(?&T_BS4-*N=)LHK+[%8VUV
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M]X:TR33/"D\AEEBA.FV@53:J_4D*"N%[XX]P.:Z>JEN["5[*X4445(PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#GO#^@W6DZYXCOIY(6BU.\2>$1DDJHC5<-D#!R#TS70T44 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%0W5PMI:RW#([
MK&I8J@R2!Z4 3454TW48-4LENK?<$8D8< $$>N*BM=8M[S4[BQB24O!]]R!M
M],9SG].U'D!H45C7WB:QT_4/L4RS&3Y=S*H*KGUYK4N)UMK:6=P2D:%R%ZD
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH **** "BBB@ HHHH *J:99?V=81VOF>9L).[;C.23T_&K=% !1110 4444
M8IT:\@DD_L_5GMH7<OY30K( 3UP3T%7=/TY+!93YLDTTK;I)9#RQ[?A5VB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>annexd_009.jpg
<TEXT>
begin 644 annexd_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <7!7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWC>2".Y$9\]5QN*M&[+GD<$@\]*+:??^ &W167I&O66LZ!'K,'F16S(S,LP
M:/:2&# $@$$$'GM4VCZI'K6CVFIPPS0Q748E1)U <*>A(!.,CGKWI6 O45RM
MMJ.H>*-1U*+3K]M.TVQG-J;B"-'FFF7!?;O#(JC.WE22<],<[%G;W>EV<YNM
M1O-4V_,IDBB$F/0"-5!_*CI<.MC2HK!MO%*/J=M87^E:AI<UWN%J;ORBLQ R
M5!CD?!P,X;!/;H::WBVWDU+4M-LM/OKZ_P!/D5)H(!&#AE5@P9W50,-W()(.
M <4 =!17.MXSTU-.AO7BND1KY;"9&C :VE8[<2#/ R0,C/W@1D<UHZKK-OI,
MEC'+'+++?7*VT,<0!)8@DDY(X !)]AWIV T:*P9?%,1N)X['3-0U&.VD,5S/
M:I'LB88R/G=2Y&>0@;D$=>*=>^+M(LM)L-4>9WLKZ9(8I(TS\S9QD'GJ,8QG
M/&*0&Y16'#XE0ZI!87NF7^GO<L5M9+D1E)R 6(4H[%3@$X8*?UK<H **X1O%
MM^/B (MZ_P#".B<:43L&?MA3S-V[&<=(\=,FNKU36+;21 LJRS7%PY2WMX5W
M23, 20,D <#J2 .YHZ)]PZV-"BL8^(H[;2;K4M6T^\TJ*W(!6Z\MV?.,;1$[
M@Y)P!G.>U4[CQG;V"VIU/2M2L&O+F.VMEG2,F5G8 $%'8#KG#$-@'CBG:[L!
MTM%9MKK=M=Z]?Z/&DHN+&.*21F V$2;L8.<_PG.0*IW/B&RG7Q#9_P"F1-I4
M.;B2+"MAHRX,9SU ]<<U+=E?YC2N[&]17.0>([2UT;1EMXM0O[B]M5DMK?*&
MXE0*I+.S,J @$9)8#)J+7-;0>#[^^U&TUG28X2JNL31+<#YA@HRNR]_7IFJ:
ML[?UO8E.Z3.HHKBM7\6:I8^/=.T:VT6^N;:2TEF;R7M\SD; "N^1<!<G.2"2
M> 1S6O;7]O+XTN+/S-06[&G13/;R.IMT4NP! !/[S(()Z8 YI+7\?P'_ ,#\
M3>HKG7\7V^R6XMM-U&[TZ$N);ZWC1HU*DAL*6$CX(/**PJ?4/%6F::-*:1WE
MCU1]EJ\"[PYV%QWR<@8&,\D4 ]#;HK&L_$27&JKIEWIU[IUW(C20)=",B95Q
MN*M&[#C(X)!]JLZ[K%OH&AWNK7>3#:Q&1@O5L= /<G _&AZ*X)7=C0HKFK?3
M?$.I645U>>(;G3;F1-WV:P@@:*//(4F6-V8CH2"H..@J]?:U'I<EO8^5<ZCJ
M4D9=;>V5!(ZK@%SN*HHR>Y'H*'IN&^QKT5EZ;KMOJ/VJ/R9[:[M,?:+6X4"2
M/(R.A*L#S@J2.#SQ531O%4&OVUE=:;I]]-:7*;FN,1JD!QG:^7R3V^0-@]<4
M ;]%<O;>.+:_TM-3T_2=4O+++":6%(_W&TX;*EP6(P>$#?GQ70V5[;:C8P7M
MI*LUM.@DCD7HRD9!H GHI')",1U KSWP>^N:[X-M=>O?%]_#-)YCNOD6@@4*
M[#D>3NQ@<_,#[BE??R'8]#HKF-#\4M)X&L]>UZ,6DDB@.J(W[QBVU2B\GY^"
M!U^85<M_$D;W\%G?:;?:;+<L5MC=B,K.0,X!C=@#@$X;!X/'!JFM;$W-NBLG
M4M9N+&X\J#0M3OU"[GDMA"%4?]M)%)/LH)XJO/XPTB#P]::YYKM874L<2R!<
M%"[;?F!QC!Z]Q@\4AF]16/)XB@M;"[U#4+.[L;*W *S3JG[X'IL16+YS@890
M22.*YGQ7XENOLNCH+34](EN-7M8T\YD7SD,@W#,;MP0?NM@D \<&FE=I!TO_
M %H=]10>!DUS9\96I@:]AT[49])0,7U**-#" I()"[O,8<?>5".^<4@.DHKA
M_'.N7D,F@6-A:W\]KJ=V$DEL)XXVDC\MFV(YD4J3@'<". ?F!Q75:1;+::7!
M&L=Y$"-QCO;EIY4)Y(9R[YQ_O$>E.VEP+U%<#X5_MWQ)::A>S^*=2MVBU*YM
MXX88+7RPB2$*/FA+'CK\V:U].UVX-WK&BZNR?;;"$3B:U&SSH'!VN 2=K J0
M1G&0#WP)>U_*_P"%PZV\[?C8Z>BN4L?%6E:=X7\.W4DU_);:DL<4$UUAYB3&
M7!E(/+$+CC.216I)X@CM=/EO-0L;NQ191%$DP1GG+$!=BQLQY)P <'U JFK-
MH%M<UZ*Q;#Q''=ZDNG7>GWNF7KQF6*&[$9,J# )5HW=3C(R,Y&>E1R^*%:XG
MBTW2=1U1;>0Q3RV@B"1N,97,DB;B,\[=V"".O%(#>HKB8?%VK2?$'4-&&@ZA
M):VUM"P$;VW!9V'FDF0':0!@#)X/RBMR\\1QPW\UC9:?>ZG=6X4W$=H(QY(8
M9&YI'1<XYP"3@@XP:.B8=;&U16'/XLTR#P]/K9,QM8'\N9-FV2-MX0AE;&""
M>?;GFG/XEMH+2ZO[FUNK?38(Q(MY($*3 \#8H8OGIC*C.1C- &U1638:Q<WE
MYY$V@ZG9(5++/<&$HV/]R1F!/N!6M0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P/-/CT^RB+F.SMT+QB)RL0&Y!G"GCD#)P/<U#5XV\FOO'?6_FOPM_D<]X#
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M^-$=&O5/\@>S]'^H[2OW/Q2\1++A&N+&TDB!/WU7S Q'K@XS]16)#<175_\
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M\?4UTUK96EC:K:VEK#;VZ#:L,481%'H .*6VM;>RM4MK2"*""-=J11($51Z
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M_P O\OS)M_E^?^?Y',6FIZCK]SKSS:U)HMKI=ZUL%MHX3(550=\C2JXPV[(
M XQR:X^S(D^$&BDEW#:_'DRJ Q_TT_>&!@^HP*]6GT/2;K48]1N-+LI;Z+B.
MYDMT:1/HQ&14ATO3VMUMVL+4P++YPC,*[1)NW;\8QNW<YZYYHB[?A^#O^(WK
M^/XIHYKXCH_]@6-UG_1[/5+6YN3C@1+(-S'V'!/TJ#XB7=L;/P]&)$=YM:LW
MC"G.5$@RWTY S[CUKMF4.I5@"I&"".#6=;>'=$LD=+71M/@1Y%E=8K5%#.IR
M&.!R0>0>M$7:WK?\O\@>OW-?G_F3ZK!-<Z1>P6S[)Y('2-O1BI /YUR_AW4+
M.Q^%5H]U*D*6>GB"Y5\ QR(NUD(_O;@1BNSJA)H6D2ZFFIR:58O?H,+=-;H9
M5^CXR.I[U+5TUW_X/^8T[6?;^OT//K>SN]/T3X8VE\&%S%=(KJW5?]'D^4_0
M<?A7J%0S6EM<R0R3V\4KP/YD+.@8QM@C<I/0X)&1ZU-5RE?[V_O)2M;T_P _
M\SB?AJZQ^']6=V"JNLWI+$X 'FFJMH5UOQ5XC\1VC;]-CTP:?!./NSNI9W9#
MW4$@9'!.?2NE;P=X7>[-VWAO1VN2_F&8V,1<OG.[=MSG/.:V#%&8O**+Y>W;
MLQQCTQZ5#5XV\K?A8I.S^=_QN>66@#>#OA:" ?\ 2[8\_P#7!ZZ#XB6\[GP]
M=K>SV5I:ZFKW-Q"JLT09&57^=67 9@"2"!G-=6NEZ>L-K"MC;"*T(:V00KMA
M(& 4&/EP"1QZU:95="CJ&5A@@C((JY2O*_G<E*RMY6_/_,YE/"JMKFF:G>^)
M-4OY[/S&MHY_LRH=R[6.(XE+<'UJI\-R+3PS<6%RX6]LKZY6Z5L!E)E9PQ'H
M58,#Z&N@T_P[HFD3O/INC:?93.,/);6J1LWU*@9I=0\/Z+JT\<^I:187DT7^
MKDN;9)&3Z%@2*2=OZ\[C9SNGJ8_B]K3,0!-I-LT?^T \@./7&1^8J3PBKV7B
M'Q7:7;@7,FH_:T#<%H&C0*P]0-I7ZK70W^C:7JOD_P!HZ;9WGDMNB^T0+)L/
MJNX'!^E&HZ-I6L(B:GIEG?+&=R+<P+*%/J-P.*$[?E^-P[GE^M*;CP?\0-0C
M<26%YJ$?V<CE7V")'8>H+ C/^S7IVJV-AJ6BS66I!?L<R!'R^S&<8P>QSC!]
M<59GL;2YLS9SVL$MJ0 89(PR$#H-IXI\T$-S \$\4<L+C:T;J&5AZ$'K2Z6]
M/P5@ZW]?Q9R%K/J_AWQ3IFB3ZJ=8L;]9=AN$47-ML7.YF7 =/X<E0<D<FNSK
M/TW0M(T4.-*TJQL1)]_[+;I%N^NT#-:%/H(****0PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHH[4 9FB^(-*\16\\^E7B7*03-!+A2
MI1UZ@@@&IXM5LI]6N=+CFW7MM&DLL>TC:KY"G.,'.T]#VKRKPWYGAK0[3Q=;
MJS6IN;BVU>)1UA%Q($FQZQD\G^Z3Z5TUO?16GQ"\5:AD/##H]K-E3G<H\X\4
M]$KOM^B?ZA9WMY_K8[NBN'TK3[S6/!]MX@FU?4(]7N;3[4DD5RZPQ%AN5?)S
MY;*,X^923ZYYJOHWB6ZO-8\,:Q)+(EAX@T\PO 7)CBN4&\%0>FX>8/?:*?*T
M^5[_ /#_ .30KZ77]?U>YZ!17F^J>*KRRM_%OB.*:4VUD\>F6,66>/S00'DV
M#J=\F/7"8I)]3:PFTZYT1O%=[?-=11WD=W8WOE31,=KMB1!'%C.[Y-O3'2DE
M>WR_'^OQ&]/Z['I-%<3:QW.L^.O$^FW=]>#3K=+5HX8+F2$JS(2<,A#*/EZ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M L>XC@$X')]S6+\2?^2:^(_^O"7_ -!I2=E<<5=V-F;7M&M]0CT^;5K".]E
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MJN7W^7SL3?W.;RO_ %]QZOK_ (STCPYJVEV&H7=K U\[@O/<+&(45"VXY]2
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M:R1NKHPRK*<@CV->&:4VKZUJ>MZK-\-+/Q0\FH30K=WFH0+Y:1MM6-8Y =N
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MAUA8XD^56'MUHZ+^OZ[>HOZ_K\SLK;QEX7O;F.VM?$FCSSRL%CBBOHF9R>@
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M(V]<]#6-J?@75?\ A(;S6/#7BNXT22_*M>Q&SCN4E91@,H?[IQ]:[>BC^OO
MY?PUX+C\.:WJ6J+J-S>3:C%$L[W/+M(F[+DYQR& V@ #;3;3P9]E\':QX?\
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M_P"15M;?UV_,]#HKS?5O%=[JWP,N?$=N[V=^UIN+0L4,<JOM;!Z@9!_"DO\
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M7=WK/A[P]IUU+!)>W/VFYE@D*,MM%AF&X$$;B57\35<NMO.W]?+4F^E_*_\
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M2XEF"N,MN&%55!)QR21TJ;QU-=:KXGL;/3-"@\3KIJ,]]I4TB1QHT@_=NSR
MH6 #87D_-GWKTFN-UGP3J,VMW6L^&_$]QH=[>!!=C[+'<Q2[!A3L?HV,#(/;
MI1?9?,?]?B5/#7B6[T_4[+0-5\#CPREX7%E]FN(9H795+,I\L#:< D<<U$^G
M^*_!NKZI/X=T>WUW2]2N3=_9&O%MI;>5A\Y#,"K*2 ?6M/1?!5U;ZO;:QXA\
M0W6NZE:JRV[/"D$,.[@LL:<;L<9)/>NOIOOU)7;H8_AZ\UV^M))]=TFWTN4L
M/+MHKKSV48YW, !G/I6)X^T+7-9G\/2Z$T,=Q87YNFDF/R*!&V PSDAB0IQD
MC.>U=G12ZICZ6/-=6M_&_C:W.@:GX=M-$TMY4^V7G]H+<&>-6!*QJH!7.!RW
M8UN>*_#^J3ZCI.O>'F@_M33-\8M[ABL=Q"X 9"PR5/ (/J*ZZBCT Y'0];\:
M:EJ4<>J>#[?1[)3^]FDU1+AF&#C8J+ZXZD=:Q?BHMYIITO6M'9%U29GTI4)P
M95G! QQR58*_X&O2*XW3_!.H-XCAUGQ%XDGUEK-W:QM_LJ6\4!;C)5?OL <
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M"3DCTR17>Q.9(4D9&C+*"4;JN>Q]Z5@ZV'T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%0W5PMI:RW#([K&I8J@R2!Z4 3454TW48-4LENK?<$8D8< $$
M>N*BM=8M[S4[BQB24O!]]R!M],9SG].U'D!H45C7WB:QT_4/L4RS&3Y=S*H*
MKGUYK4N)UMK:6=P2D:%R%ZD 9HZ7#K8EHJGIFI0ZK9BZ@614+%<. #Q]":CU
M#6+?3KJVMYDE9[AMJ% "!R!SD^]'D!H454U+4(M+LGNIU=HU(!" $\G'<BJU
MWKMK9Z5!J$D<QAFQM50-PR,\\^U &I16!9^+M/OKR*UBAN0\C;065<?^A5<N
M]<M[6Y:V2"ZNID +I;1;RF?6@#3HJM97L=] 98TEC .UEE0JP/TJ@_B.U\QD
MMK:\O APSVT.]0?K0!L454BU&WDT_P"VLS10@$DRJ5(P<=*H?\)-;8\S['?_
M &?K]H^SGR\>N>N/PH VJ*K/?VZZ<]\C>; J&3*<Y ]*S%\3VVQ9);*_@@;&
M)I(,)STY!- &Y15#4-6@T^WAF9)9EF8)&( &+$C(QS4=KK/VJY2'^S-1AW?Q
MS0;5'U.: -.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3TQ5=(]5TJXN5M;%+VWFE:53YPC92>H.>M6](L[B!KJZN]BW%TX=DC.50 8
M]S26PV:=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !533++^SK".U\SS-A)W;<9R2>GXU;HH ****
M "BBB@#%.C7D$DG]GZL]M"[E_*:%9 ">N">@J[I^G)8+*?-DFFE;=)+(>6/;
M\*NT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
; 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>ex23-5_001.jpg
<TEXT>
begin 644 ex23-5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  X 2P# 2(  A$! Q$!_\0
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MV^UWUW,SR2W$Y3S'9W9LL0"0*[/_ #_A2$@=2!GIDXI<CU]OQ]*P72VOFO(
MHI,@\]L Y[8/OT_P[]:,C)'<8R.>_3_]?;O3 6BBB@ HHHH /U_S[U^<_BBV
M>P_X*B_#._2-_+UW]C[X@Z8[JC;'N;'XC:#>0QN4!!98H9&5I2JHI8*P).?T
M8K\Z_P!IC5KOX??MF?L2^/<O'HGB_4?B1\%]?N!#^YA7Q%X:FUK0FFN@<H7U
MK3XH(X64(?-:<2AXA$^E*"G)Q=U^[J25K+WHQNE9IWNU:RUML!^B@ '3C_\
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MR6LJ)I_B+Q)IGF:?:22*OV2*:&18]AK\CO\ @F=\#O#OQT_;PT;_ (67HO\
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M=XJSO*S6NBLE'NPC[M2G4W5-R;@_AGS0E"TO*+ES+1ZI'\U'P]_;^^,/Q+^
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MXRJ.[;2Y==$VE>35F][-M:[Z'U?^S?\ LW_%S]E'_@G#-X.^ NGV3_M0>(/
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MZ*::<K+F2::YDKI-VU2T[7$?D!_P1>\-7Z?L[_%;XG>*/#&K>'/''QA_:/\
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MX5URS:_T;Q-H^J^']5M5=8FETS6M/N-,U"-96!\HR6ES/&LB@E6D'!KHJ/\
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<#U%%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>46
<FILENAME>murfu-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaiO6bP9z5Z8iekhvWB3bVk6jyApebl0RyCQAIh2kd0A -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:MURFU="http://bloomberg.com/20221231" elementFormDefault="qualified" targetNamespace="http://bloomberg.com/20221231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://bloomberg.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/StatementsOfOperationsParenthetical" id="StatementsOfOperationsParenthetical">
	  <link:definition>00000005 - Statement - Statements of Operations (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit" id="StatementsOfChangesInStockholdersEquityDeficit">
	  <link:definition>00000006 - Statement - Statements of Changes in Stockholders' Equity (Deficit)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical" id="StatementsOfChangesInStockholdersEquityDeficitParenthetical">
	  <link:definition>00000007 - Statement - Statements of Changes in Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000008 - Statement - Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" id="DescriptionOfOrganizationBusinessOperationsAndGoingConcern">
	  <link:definition>00000009 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/InitialPublicOffering" id="InitialPublicOffering">
	  <link:definition>00000011 - Disclosure - INITIAL PUBLIC OFFERING</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/PrivatePlacements" id="PrivatePlacements">
	  <link:definition>00000012 - Disclosure - PRIVATE PLACEMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000013 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/StockholdersEquityDeficit" id="StockholdersEquityDeficit">
	  <link:definition>00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/FairValueMeasurements" id="FairValueMeasurements">
	  <link:definition>00000016 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/Taxes" id="Taxes">
	  <link:definition>00000017 - Disclosure - TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000018 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
	  <link:definition>00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/TaxesTables" id="TaxesTables">
	  <link:definition>00000022 - Disclosure - TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" id="DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative">
	  <link:definition>00000023 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" id="ScheduleOfCommonStockSubjectToPossibleRedemptionDetails">
	  <link:definition>00000024 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" id="ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails">
	  <link:definition>00000025 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative" id="InitialPublicOfferingDetailsNarrative">
	  <link:definition>00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/PrivatePlacementsDetailsNarrative" id="PrivatePlacementsDetailsNarrative">
	  <link:definition>00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000030 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative" id="StockholdersEquityDeficitDetailsNarrative">
	  <link:definition>00000031 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" id="ScheduleOfFairValueOfAssetsAndLiabilitiesDetails">
	  <link:definition>00000032 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative" id="FairValueMeasurementsDetailsNarrative">
	  <link:definition>00000033 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="ScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
	  <link:definition>00000034 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
	  <link:definition>00000035 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/ScheduleOfChangeInValuationDetails" id="ScheduleOfChangeInValuationDetails">
	  <link:definition>00000036 - Disclosure -  SCHEDULE OF CHANGE IN VALUATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/TaxesDetailsNarrative" id="TaxesDetailsNarrative">
	  <link:definition>00000037 - Disclosure - TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://bloomberg.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000038 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="murfu-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="murfu-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="murfu-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="murfu-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="MURFU_SponsorMember" name="SponsorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_BusinessCombinationAgreementMember" name="BusinessCombinationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_ConduitPharmaceuticalsLimitedMember" name="ConduitPharmaceuticalsLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_SubscriptionAgreementsMember" name="SubscriptionAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_TransactionAgreementMember" name="TransactionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PublicWarrantsMember" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PrivatePlacementWarrantsMember" name="PrivatePlacementWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PublicWarrantMember" name="PublicWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_UnderwriterMember" name="UnderwriterMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember" name="PrivatePlacementWarrantsAndPublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DeferredCommissionPayableNonCurrent" name="DeferredCommissionPayableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_AdministrationFeeRelatedParty" name="AdministrationFeeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_StockIssuedDuringPeriodShareOnHold" name="StockIssuedDuringPeriodShareOnHold" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" name="AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_FormationCostsPaidByNotePayableSponsor" name="FormationCostsPaidByNotePayableSponsor" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts" name="DeferredOfferingCostsIncludedInAccruedOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PrepaidExpensesPaidByNotePayable" name="PrepaidExpensesPaidByNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DeferredOfferingCostsPaidByNotePayable" name="DeferredOfferingCostsPaidByNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DeferredUnderwritingCommissionPayable" name="DeferredUnderwritingCommissionPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_ClassASharesSubjectToRedemption" name="ClassASharesSubjectToRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DisclosureInitialPublicOfferingAbstract" name="DisclosureInitialPublicOfferingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_InitialPublicOfferingTextBlock" name="InitialPublicOfferingTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DisclosurePrivatePlacementsAbstract" name="DisclosurePrivatePlacementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PrivatePlacementsTextBlock" name="PrivatePlacementsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock" name="InvestmentsHeldInTrustAccountPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" name="OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock" name="InvestmentHeldInTrustAccountPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_WarrantInstrumentsPolicyTextBlock" name="WarrantInstrumentsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" name="ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_OverfundingOfTheTrustAccount" name="OverfundingOfTheTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_OperatingCashAccount" name="OperatingCashAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" name="ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PaymentOfCommonStockIssuanceCosts" name="PaymentOfCommonStockIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" name="TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_CommonStockSubjectToPossibleRedemption" name="CommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PublicOfferingCosts" name="PublicOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DeferredUnderwritingFee" name="DeferredUnderwritingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_InitialPublicOfferingCost" name="InitialPublicOfferingCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_WarrantIssuanceCost" name="WarrantIssuanceCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_StockIssuedDuringPeriodSharesOnHold" name="StockIssuedDuringPeriodSharesOnHold" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_WorkingCapitalLoan" name="WorkingCapitalLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_OptionExercisedDate" name="OptionExercisedDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_CashUnderwritingDiscount" name="CashUnderwritingDiscount" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_UnderwritingDiscount" name="UnderwritingDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_DeferredFeePerShare" name="DeferredFeePerShare" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_AdvancePaymentForUnderwriterExpenses" name="AdvancePaymentForUnderwriterExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_UnderwriterExpenses" name="UnderwriterExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_PercentageOfDepositInTrustAccount" name="PercentageOfDepositInTrustAccount" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member" name="RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_ClassCommonStockParValue0.0001PerShareMember" name="ClassCommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" name="UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MURFU_IncreaseDecreaseInAccruedFormationAndOfferingCosts" name="IncreaseDecreaseInAccruedFormationAndOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>47
<FILENAME>murfu-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bloomberg.com/role/Cover" xlink:href="murfu-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/BalanceSheets" xlink:href="murfu-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/BalanceSheetsParenthetical" xlink:href="murfu-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfOperations" xlink:href="murfu-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfOperationsParenthetical" xlink:href="murfu-20221231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:href="murfu-20221231.xsd#StatementsOfChangesInStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:href="murfu-20221231.xsd#StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfCashFlows" xlink:href="murfu-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:href="murfu-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/InitialPublicOffering" xlink:href="murfu-20221231.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/PrivatePlacements" xlink:href="murfu-20221231.xsd#PrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/RelatedPartyTransactions" xlink:href="murfu-20221231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/CommitmentsAndContingencies" xlink:href="murfu-20221231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StockholdersEquityDeficit" xlink:href="murfu-20221231.xsd#StockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurements" xlink:href="murfu-20221231.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/Taxes" xlink:href="murfu-20221231.xsd#Taxes" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SubsequentEvents" xlink:href="murfu-20221231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurementsTables" xlink:href="murfu-20221231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/TaxesTables" xlink:href="murfu-20221231.xsd#TaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:href="murfu-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:href="murfu-20221231.xsd#ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:href="murfu-20221231.xsd#ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="murfu-20221231.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/PrivatePlacementsDetailsNarrative" xlink:href="murfu-20221231.xsd#PrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="murfu-20221231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="murfu-20221231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative" xlink:href="murfu-20221231.xsd#StockholdersEquityDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:href="murfu-20221231.xsd#ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="murfu-20221231.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="murfu-20221231.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="murfu-20221231.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfChangeInValuationDetails" xlink:href="murfu-20221231.xsd#ScheduleOfChangeInValuationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/TaxesDetailsNarrative" xlink:href="murfu-20221231.xsd#TaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SubsequentEventsDetailsNarrative" xlink:href="murfu-20221231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaapDeferredCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredCommissionPayableNonCurrent" xlink:label="loc_MURFUDeferredCommissionPayableNonCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_MURFUDeferredCommissionPayableNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdministrationFeeRelatedParty" xlink:label="loc_MURFUAdministrationFeeRelatedParty" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_MURFUAdministrationFeeRelatedParty" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:title="00000006 - Statement - Statements of Changes in Stockholders&apos; Equity (Deficit)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:title="00000007 - Statement - Statements of Changes in Stockholders&apos; Equity (Deficit) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_FormationCostsPaidByNotePayableSponsor" xlink:label="loc_MURFUFormationCostsPaidByNotePayableSponsor" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_MURFUFormationCostsPaidByNotePayableSponsor" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:title="00000009 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/PrivatePlacements" xlink:title="00000012 - Disclosure - PRIVATE PLACEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StockholdersEquityDeficit" xlink:title="00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurements" xlink:title="00000016 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/Taxes" xlink:title="00000017 - Disclosure - TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurementsTables" xlink:title="00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/TaxesTables" xlink:title="00000022 - Disclosure - TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:title="00000024 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/PrivatePlacementsDetailsNarrative" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000030 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative" xlink:title="00000031 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:title="00000032 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000033 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000034 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfChangeInValuationDetails" xlink:title="00000036 - Disclosure -  SCHEDULE OF CHANGE IN VALUATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/TaxesDetailsNarrative" xlink:title="00000037 - Disclosure - TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000038 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>48
<FILENAME>murfu-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bloomberg.com/role/Cover" xlink:href="murfu-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/BalanceSheets" xlink:href="murfu-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/BalanceSheetsParenthetical" xlink:href="murfu-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfOperations" xlink:href="murfu-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfOperationsParenthetical" xlink:href="murfu-20221231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:href="murfu-20221231.xsd#StatementsOfChangesInStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:href="murfu-20221231.xsd#StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfCashFlows" xlink:href="murfu-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:href="murfu-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/InitialPublicOffering" xlink:href="murfu-20221231.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/PrivatePlacements" xlink:href="murfu-20221231.xsd#PrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/RelatedPartyTransactions" xlink:href="murfu-20221231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/CommitmentsAndContingencies" xlink:href="murfu-20221231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StockholdersEquityDeficit" xlink:href="murfu-20221231.xsd#StockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurements" xlink:href="murfu-20221231.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/Taxes" xlink:href="murfu-20221231.xsd#Taxes" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SubsequentEvents" xlink:href="murfu-20221231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurementsTables" xlink:href="murfu-20221231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/TaxesTables" xlink:href="murfu-20221231.xsd#TaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:href="murfu-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:href="murfu-20221231.xsd#ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:href="murfu-20221231.xsd#ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="murfu-20221231.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/PrivatePlacementsDetailsNarrative" xlink:href="murfu-20221231.xsd#PrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="murfu-20221231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="murfu-20221231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative" xlink:href="murfu-20221231.xsd#StockholdersEquityDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:href="murfu-20221231.xsd#ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="murfu-20221231.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="murfu-20221231.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="murfu-20221231.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfChangeInValuationDetails" xlink:href="murfu-20221231.xsd#ScheduleOfChangeInValuationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/TaxesDetailsNarrative" xlink:href="murfu-20221231.xsd#TaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SubsequentEventsDetailsNarrative" xlink:href="murfu-20221231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaapDeferredCosts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapDeferredCosts_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapNotesPayableCurrent_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredCommissionPayableNonCurrent" xlink:label="loc_MURFUDeferredCommissionPayableNonCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_MURFUDeferredCommissionPayableNonCurrent_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommitmentsAndContingencies_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockValue_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="24" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdministrationFeeRelatedParty" xlink:label="loc_MURFUAdministrationFeeRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUAdministrationFeeRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_70" xlink:to="loc_us-gaapInvestmentIncomeInterest_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_70" xlink:to="loc_us-gaapNonoperatingIncomeExpense_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_70" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SponsorMember" xlink:label="loc_MURFUSponsorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MURFUSponsorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodShareOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodShareOnHold_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodShareOnHold_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:title="00000006 - Statement - Statements of Changes in Stockholders&apos; Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" xlink:label="loc_MURFUAdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUAdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_60" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:title="00000007 - Statement - Statements of Changes in Stockholders&apos; Equity (Deficit) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SponsorMember" xlink:label="loc_MURFUSponsorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MURFUSponsorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodShareOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodShareOnHold_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodShareOnHold_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:title="00000009 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/PrivatePlacements" xlink:title="00000012 - Disclosure - PRIVATE PLACEMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StockholdersEquityDeficit" xlink:title="00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurements" xlink:title="00000016 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/Taxes" xlink:title="00000017 - Disclosure - TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurementsTables" xlink:title="00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/TaxesTables" xlink:title="00000022 - Disclosure - TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_BusinessCombinationAgreementMember" xlink:label="loc_MURFUBusinessCombinationAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_MURFUBusinessCombinationAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SubscriptionAgreementsMember" xlink:label="loc_MURFUSubscriptionAgreementsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_MURFUSubscriptionAgreementsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_TransactionAgreementMember" xlink:label="loc_MURFUTransactionAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_MURFUTransactionAgreementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ConduitPharmaceuticalsLimitedMember" xlink:label="loc_MURFUConduitPharmaceuticalsLimitedMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_MURFUConduitPharmaceuticalsLimitedMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OverfundingOfTheTrustAccount" xlink:label="loc_MURFUOverfundingOfTheTrustAccount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_MURFUOverfundingOfTheTrustAccount_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OperatingCashAccount" xlink:label="loc_MURFUOperatingCashAccount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_MURFUOperatingCashAccount_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationControlObtainedDescription" xlink:label="loc_us-gaapBusinessCombinationControlObtainedDescription_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationControlObtainedDescription_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsRestrictions" xlink:label="loc_us-gaapRetainedEarningsRestrictions_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRetainedEarningsRestrictions_100" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage_100" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense_100" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:title="00000024 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicWarrantsMember" xlink:label="loc_MURFUPublicWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPublicWarrantsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementWarrantsMember" xlink:label="loc_MURFUPrivatePlacementWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPrivatePlacementWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicOfferingCosts" xlink:label="loc_MURFUPublicOfferingCosts_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUPublicOfferingCosts_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:label="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredUnderwritingFee" xlink:label="loc_MURFUDeferredUnderwritingFee_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUDeferredUnderwritingFee_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InitialPublicOfferingCost" xlink:label="loc_MURFUInitialPublicOfferingCost_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUInitialPublicOfferingCost_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WarrantIssuanceCost" xlink:label="loc_MURFUWarrantIssuanceCost_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUWarrantIssuanceCost_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:label="loc_us-gaapFederalDepositInsuranceCorporationPremiumExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFederalDepositInsuranceCorporationPremiumExpense_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="loc_us-gaapAssetsHeldInTrust_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsHeldInTrust_60" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicWarrantMember" xlink:label="loc_MURFUPublicWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPublicWarrantMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/PrivatePlacementsDetailsNarrative" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalUnitClassAMember" xlink:label="loc_us-gaapCapitalUnitClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCapitalUnitClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SponsorMember" xlink:label="loc_MURFUSponsorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MURFUSponsorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodSharesOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodSharesOnHold_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodSharesOnHold_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapNotesPayableCurrent_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="loc_us-gaapSponsorFees_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapSponsorFees_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapPaymentsForRent_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdministrationFeeRelatedParty" xlink:label="loc_MURFUAdministrationFeeRelatedParty_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_MURFUAdministrationFeeRelatedParty_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WorkingCapitalLoan" xlink:label="loc_MURFUWorkingCapitalLoan_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_MURFUWorkingCapitalLoan_100" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000030 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwriterMember" xlink:label="loc_MURFUUnderwriterMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_MURFUUnderwriterMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OptionExercisedDate" xlink:label="loc_MURFUOptionExercisedDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUOptionExercisedDate_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_CashUnderwritingDiscount" xlink:label="loc_MURFUCashUnderwritingDiscount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUCashUnderwritingDiscount_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwritingDiscount" xlink:label="loc_MURFUUnderwritingDiscount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUUnderwritingDiscount_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredFeePerShare" xlink:label="loc_MURFUDeferredFeePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUDeferredFeePerShare_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdvancePaymentForUnderwriterExpenses" xlink:label="loc_MURFUAdvancePaymentForUnderwriterExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUAdvancePaymentForUnderwriterExpenses_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwriterExpenses" xlink:label="loc_MURFUUnderwriterExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUUnderwriterExpenses_50" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative" xlink:title="00000031 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember" xlink:label="loc_MURFUPrivatePlacementWarrantsAndPublicWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPrivatePlacementWarrantsAndPublicWarrantsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharePrice_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_140" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_140" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_140" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:title="00000032 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsAbstract_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_20" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000033 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember" xlink:label="loc_us-gaapFinancialServiceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapFinancialServiceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000034 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfChangeInValuationDetails" xlink:title="00000036 - Disclosure -  SCHEDULE OF CHANGE IN VALUATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/TaxesDetailsNarrative" xlink:title="00000037 - Disclosure - TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000038 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PercentageOfDepositInTrustAccount" xlink:label="loc_MURFUPercentageOfDepositInTrustAccount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_MURFUPercentageOfDepositInTrustAccount_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodShareOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodShareOnHold_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodShareOnHold_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssued_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaapDepositAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDepositAssets_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_70" xlink:type="arc" order="10" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>49
<FILENAME>murfu-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SponsorMember" xlink:label="MURFU_SponsorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_SponsorMember" xlink:to="MURFU_SponsorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_BusinessCombinationAgreementMember" xlink:label="MURFU_BusinessCombinationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_BusinessCombinationAgreementMember" xlink:to="MURFU_BusinessCombinationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_BusinessCombinationAgreementMember_lbl" xml:lang="en-US">Business Combination Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ConduitPharmaceuticalsLimitedMember" xlink:label="MURFU_ConduitPharmaceuticalsLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ConduitPharmaceuticalsLimitedMember" xlink:to="MURFU_ConduitPharmaceuticalsLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_ConduitPharmaceuticalsLimitedMember_lbl" xml:lang="en-US">Conduit Pharmaceuticals Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SubscriptionAgreementsMember" xlink:label="MURFU_SubscriptionAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_SubscriptionAgreementsMember" xlink:to="MURFU_SubscriptionAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_SubscriptionAgreementsMember_lbl" xml:lang="en-US">Subscription Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_TransactionAgreementMember" xlink:label="MURFU_TransactionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_TransactionAgreementMember" xlink:to="MURFU_TransactionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_TransactionAgreementMember_lbl" xml:lang="en-US">Transaction Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicWarrantsMember" xlink:label="MURFU_PublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PublicWarrantsMember" xlink:to="MURFU_PublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementWarrantsMember" xlink:label="MURFU_PrivatePlacementWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrivatePlacementWarrantsMember" xlink:to="MURFU_PrivatePlacementWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US">Private Placement Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicWarrantMember" xlink:label="MURFU_PublicWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PublicWarrantMember" xlink:to="MURFU_PublicWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PublicWarrantMember_lbl" xml:lang="en-US">Public Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalUnitClassAMember" xlink:label="us-gaap_CapitalUnitClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalUnitClassAMember" xlink:to="us-gaap_CapitalUnitClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalUnitClassAMember_lbl" xml:lang="en-US">Capital Unit, Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwriterMember" xlink:label="MURFU_UnderwriterMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_UnderwriterMember" xlink:to="MURFU_UnderwriterMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_UnderwriterMember_lbl" xml:lang="en-US">Underwriter [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember" xlink:label="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember" xlink:to="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember_lbl" xml:lang="en-US">Private Placement Warrants And Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember" xlink:label="us-gaap_FinancialServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialServiceMember" xlink:to="us-gaap_FinancialServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialServiceMember_lbl" xml:lang="en-US">Financial Service [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Investments held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Note payable &#8211; Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredCommissionPayableNonCurrent" xlink:label="MURFU_DeferredCommissionPayableNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredCommissionPayableNonCurrent" xlink:to="MURFU_DeferredCommissionPayableNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DeferredCommissionPayableNonCurrent_lbl" xml:lang="en-US">Deferred commission payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Common stock subject to possible redemption at redemption value (13,225,000 shares at $10.34 per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity (Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity (Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity (Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_lbl" xml:lang="en-US">Shares subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US">Temporary equity, redemption price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdministrationFeeRelatedParty" xlink:label="MURFU_AdministrationFeeRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdministrationFeeRelatedParty" xlink:to="MURFU_AdministrationFeeRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_AdministrationFeeRelatedParty_lbl" xml:lang="en-US">Administration fee &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Total expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income &#8211; Investments held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Net income (loss) before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Class B common stock weighted average shares outstanding, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Class B common stock &#8211; Basic and diluted net income (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of option issued for forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Stock surrendered and forfeited during period shares</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodShareOnHold" xlink:label="MURFU_StockIssuedDuringPeriodShareOnHold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_StockIssuedDuringPeriodShareOnHold" xlink:to="MURFU_StockIssuedDuringPeriodShareOnHold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_StockIssuedDuringPeriodShareOnHold_lbl" xml:lang="en-US">Stock issued during period on hold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Sale of Private Placement Units, net of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Sale of private placement units, net of offering costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Proceeds allocated to Public Warrants, net of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" xlink:label="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" xlink:to="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_lbl" xml:lang="en-US">Remeasurement of Class A common stock subject to possible redemption upon IPO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Remeasurement of Class A shares to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_FormationCostsPaidByNotePayableSponsor" xlink:label="MURFU_FormationCostsPaidByNotePayableSponsor" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_FormationCostsPaidByNotePayableSponsor" xlink:to="MURFU_FormationCostsPaidByNotePayableSponsor_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_FormationCostsPaidByNotePayableSponsor_lbl" xml:lang="en-US">Formation costs paid by note payable &#8211; Sponsor</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeInterest_2_lbl" xml:lang="en-US">Interest earned on investments held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Accrued income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Cash deposited into Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from note payable - Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of Class B common stock to Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Sale of units in public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Sale of private placement units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payment of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of note payable - Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:label="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:to="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs included in accrued offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrepaidExpensesPaidByNotePayable" xlink:label="MURFU_PrepaidExpensesPaidByNotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrepaidExpensesPaidByNotePayable" xlink:to="MURFU_PrepaidExpensesPaidByNotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PrepaidExpensesPaidByNotePayable_lbl" xml:lang="en-US">Prepaid expenses paid by note payable - Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredOfferingCostsPaidByNotePayable" xlink:label="MURFU_DeferredOfferingCostsPaidByNotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredOfferingCostsPaidByNotePayable" xlink:to="MURFU_DeferredOfferingCostsPaidByNotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DeferredOfferingCostsPaidByNotePayable_lbl" xml:lang="en-US">Deferred offering costs paid by note payable - Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredUnderwritingCommissionPayable" xlink:label="MURFU_DeferredUnderwritingCommissionPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredUnderwritingCommissionPayable" xlink:to="MURFU_DeferredUnderwritingCommissionPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MURFU_DeferredUnderwritingCommissionPayable_lbl" xml:lang="en-US">Deferred commission payable</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ClassASharesSubjectToRedemption" xlink:label="MURFU_ClassASharesSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ClassASharesSubjectToRedemption" xlink:to="MURFU_ClassASharesSubjectToRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_ClassASharesSubjectToRedemption_lbl" xml:lang="en-US">Class A shares subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DisclosureInitialPublicOfferingAbstract" xlink:label="MURFU_DisclosureInitialPublicOfferingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DisclosureInitialPublicOfferingAbstract" xlink:to="MURFU_DisclosureInitialPublicOfferingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DisclosureInitialPublicOfferingAbstract_lbl" xml:lang="en-US">Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InitialPublicOfferingTextBlock" xlink:label="MURFU_InitialPublicOfferingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InitialPublicOfferingTextBlock" xlink:to="MURFU_InitialPublicOfferingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_InitialPublicOfferingTextBlock_lbl" xml:lang="en-US">INITIAL PUBLIC OFFERING</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DisclosurePrivatePlacementsAbstract" xlink:label="MURFU_DisclosurePrivatePlacementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DisclosurePrivatePlacementsAbstract" xlink:to="MURFU_DisclosurePrivatePlacementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DisclosurePrivatePlacementsAbstract_lbl" xml:lang="en-US">Private Placements</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementsTextBlock" xlink:label="MURFU_PrivatePlacementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrivatePlacementsTextBlock" xlink:to="MURFU_PrivatePlacementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PrivatePlacementsTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_EmergingGrowthCompanyPolicyTextBlock" xlink:label="MURFU_EmergingGrowthCompanyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_EmergingGrowthCompanyPolicyTextBlock" xlink:to="MURFU_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:label="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:to="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock_lbl" xml:lang="en-US">Investments Held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" xlink:label="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" xlink:to="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_lbl" xml:lang="en-US">Offering Costs Associated With a Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xml:lang="en-US">Class A Common Stock Subject to Possible Redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income (Loss) per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InvestmentHeldInTrustAccountPolicyTextBlock" xlink:label="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock" xlink:to="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock_lbl" xml:lang="en-US">Investments Held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesReportingOfDerivativeActivity" xlink:label="us-gaap_DerivativesReportingOfDerivativeActivity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesReportingOfDerivativeActivity" xlink:to="us-gaap_DerivativesReportingOfDerivativeActivity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesReportingOfDerivativeActivity_lbl" xml:lang="en-US">Derivative Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WarrantInstrumentsPolicyTextBlock" xlink:label="MURFU_WarrantInstrumentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_WarrantInstrumentsPolicyTextBlock" xlink:to="MURFU_WarrantInstrumentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_WarrantInstrumentsPolicyTextBlock_lbl" xml:lang="en-US">Warrant Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" xlink:label="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" xlink:to="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CHANGE IN VALUATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock issued during period shares new issues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xml:lang="en-US">Proceeds from isssuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Gross proceeds from shares issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Net proceeds from sale of equity</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OverfundingOfTheTrustAccount" xlink:label="MURFU_OverfundingOfTheTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OverfundingOfTheTrustAccount" xlink:to="MURFU_OverfundingOfTheTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_OverfundingOfTheTrustAccount_lbl" xml:lang="en-US">Overfunding of the trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OperatingCashAccount" xlink:label="MURFU_OperatingCashAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OperatingCashAccount" xlink:to="MURFU_OperatingCashAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_OperatingCashAccount_lbl" xml:lang="en-US">Operating cash account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share issued price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationControlObtainedDescription" xlink:label="us-gaap_BusinessCombinationControlObtainedDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationControlObtainedDescription" xlink:to="us-gaap_BusinessCombinationControlObtainedDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationControlObtainedDescription_lbl" xml:lang="en-US">Business combination description of transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsRestrictions" xlink:label="us-gaap_RetainedEarningsRestrictions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsRestrictions" xlink:to="us-gaap_RetainedEarningsRestrictions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsRestrictions_lbl" xml:lang="en-US">Retained earnings restrictions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">Debt instrument redemption price percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_3_lbl" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" xlink:label="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" xlink:to="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_lbl" xml:lang="en-US">Proceeds allocated to Public Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PaymentOfCommonStockIssuanceCosts" xlink:label="MURFU_PaymentOfCommonStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PaymentOfCommonStockIssuanceCosts" xlink:to="MURFU_PaymentOfCommonStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PaymentOfCommonStockIssuanceCosts_lbl" xml:lang="en-US">Class A common stock issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" xlink:label="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" xlink:to="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_lbl" xml:lang="en-US">Remeasurement adjustment of carrying value to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_CommonStockSubjectToPossibleRedemption" xlink:label="MURFU_CommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_CommonStockSubjectToPossibleRedemption" xlink:to="MURFU_CommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="MURFU_CommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Common stock subject to possible redemption, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US">Remeasurement adjustment of carrying value to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_CommonStockSubjectToPossibleRedemption" xlink:to="MURFU_CommonStockSubjectToPossibleRedemption_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="MURFU_CommonStockSubjectToPossibleRedemption_2_lbl" xml:lang="en-US">Common stock subject to possible redemption, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Allocation of net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic and diluted net loss per common share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xml:lang="en-US">Assets held-in-trust, noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicOfferingCosts" xlink:label="MURFU_PublicOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PublicOfferingCosts" xlink:to="MURFU_PublicOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MURFU_PublicOfferingCosts_lbl" xml:lang="en-US">Offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl" xml:lang="en-US">Underwriting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredUnderwritingFee" xlink:label="MURFU_DeferredUnderwritingFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredUnderwritingFee" xlink:to="MURFU_DeferredUnderwritingFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DeferredUnderwritingFee_lbl" xml:lang="en-US">Deferred underwriting fee</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InitialPublicOfferingCost" xlink:label="MURFU_InitialPublicOfferingCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InitialPublicOfferingCost" xlink:to="MURFU_InitialPublicOfferingCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_InitialPublicOfferingCost_lbl" xml:lang="en-US">Initial public offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WarrantIssuanceCost" xlink:label="MURFU_WarrantIssuanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_WarrantIssuanceCost" xlink:to="MURFU_WarrantIssuanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_WarrantIssuanceCost_lbl" xml:lang="en-US">Warrant issuance cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xml:lang="en-US">Temporary equity, carrying amount, attributable to parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Outstanding warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Income tax penalties and interest accrued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:label="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:to="us-gaap_FederalDepositInsuranceCorporationPremiumExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalDepositInsuranceCorporationPremiumExpense_lbl" xml:lang="en-US">Federal deposit insurance corporation premium expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xml:lang="en-US">Investments held in trust</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Shares issued price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Number of shares issued for private sale</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xml:lang="en-US">Proceeds from issuance of private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Number of units transferred to director</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Number of shares issued to sponsor, value</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodSharesOnHold" xlink:label="MURFU_StockIssuedDuringPeriodSharesOnHold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_StockIssuedDuringPeriodSharesOnHold" xlink:to="MURFU_StockIssuedDuringPeriodSharesOnHold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MURFU_StockIssuedDuringPeriodSharesOnHold_lbl" xml:lang="en-US">Stock issued during period on hold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayableCurrent_2_lbl" xml:lang="en-US">Notes payable, current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="us-gaap_SponsorFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SponsorFees_lbl" xml:lang="en-US">Sponsor fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Monthly payment for office space</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdministrationFeeRelatedParty" xlink:to="MURFU_AdministrationFeeRelatedParty_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MURFU_AdministrationFeeRelatedParty_2_lbl" xml:lang="en-US">Administration fee related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US">Notes payable converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WorkingCapitalLoan" xlink:label="MURFU_WorkingCapitalLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_WorkingCapitalLoan" xlink:to="MURFU_WorkingCapitalLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_WorkingCapitalLoan_lbl" xml:lang="en-US">Working capital loans</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OptionExercisedDate" xlink:label="MURFU_OptionExercisedDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OptionExercisedDate" xlink:to="MURFU_OptionExercisedDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_OptionExercisedDate_lbl" xml:lang="en-US">Option exercised date</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_CashUnderwritingDiscount" xlink:label="MURFU_CashUnderwritingDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_CashUnderwritingDiscount" xlink:to="MURFU_CashUnderwritingDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_CashUnderwritingDiscount_lbl" xml:lang="en-US">Cash underwriting discount</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwritingDiscount" xlink:label="MURFU_UnderwritingDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_UnderwritingDiscount" xlink:to="MURFU_UnderwritingDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_UnderwritingDiscount_lbl" xml:lang="en-US">Underwriting discount</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredFeePerShare" xlink:label="MURFU_DeferredFeePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredFeePerShare" xlink:to="MURFU_DeferredFeePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DeferredFeePerShare_lbl" xml:lang="en-US">Deferred fee per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredOfferingCosts_2_lbl" xml:lang="en-US">Deferred fee</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdvancePaymentForUnderwriterExpenses" xlink:label="MURFU_AdvancePaymentForUnderwriterExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdvancePaymentForUnderwriterExpenses" xlink:to="MURFU_AdvancePaymentForUnderwriterExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_AdvancePaymentForUnderwriterExpenses_lbl" xml:lang="en-US">Advance payment for underwriter expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwriterExpenses" xlink:label="MURFU_UnderwriterExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_UnderwriterExpenses" xlink:to="MURFU_UnderwriterExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_UnderwriterExpenses_lbl" xml:lang="en-US">Underwriter expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_2_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_2_lbl" xml:lang="en-US">Preferred stock shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_2_lbl" xml:lang="en-US">Preferred stock shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Voting rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price per shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrant expected term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrant measurement inputs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_2_lbl" xml:lang="en-US">Assets:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_3_lbl" xml:lang="en-US">Investments held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">U.S. federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes, net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpense_lbl" xml:lang="en-US">Startup costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">State and Local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Change in valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Provision</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PercentageOfDepositInTrustAccount" xlink:label="MURFU_PercentageOfDepositInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PercentageOfDepositInTrustAccount" xlink:to="MURFU_PercentageOfDepositInTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PercentageOfDepositInTrustAccount_lbl" xml:lang="en-US">Percentage of deposit in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Stock issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_2_lbl" xml:lang="en-US">Redemption price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_2_lbl" xml:lang="en-US">Number of stock redeemed, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_3_lbl" xml:lang="en-US">Price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="us-gaap_DepositAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositAssets_lbl" xml:lang="en-US">Aggregate of deposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_2_lbl" xml:lang="en-US">Proceeds from business combination</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Sponsor advanced amount</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member" xlink:label="MURFU_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member" xlink:to="MURFU_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member_doc" xml:lang="en-US">Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ClassCommonStockParValue0.0001PerShareMember" xlink:label="MURFU_ClassCommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ClassCommonStockParValue0.0001PerShareMember" xlink:to="MURFU_ClassCommonStockParValue0.0001PerShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_ClassCommonStockParValue0.0001PerShareMember_doc" xml:lang="en-US">Class A Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" xlink:label="MURFU_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember" xlink:to="MURFU_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember_doc" xml:lang="en-US">Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredCommissionPayableNonCurrent" xlink:to="MURFU_DeferredCommissionPayableNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_DeferredCommissionPayableNonCurrent_doc" xml:lang="en-US">Deferred Commission Payable Non Current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdministrationFeeRelatedParty" xlink:to="MURFU_AdministrationFeeRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_AdministrationFeeRelatedParty_doc" xml:lang="en-US">Administration fee related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_SponsorMember" xlink:to="MURFU_SponsorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_SponsorMember_doc" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_StockIssuedDuringPeriodShareOnHold" xlink:to="MURFU_StockIssuedDuringPeriodShareOnHold_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_StockIssuedDuringPeriodShareOnHold_doc" xml:lang="en-US">Stock issued during period shares on hold.</link:label>
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_IncreaseDecreaseInAccruedFormationAndOfferingCosts" xlink:label="MURFU_IncreaseDecreaseInAccruedFormationAndOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_IncreaseDecreaseInAccruedFormationAndOfferingCosts" xlink:to="MURFU_IncreaseDecreaseInAccruedFormationAndOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_IncreaseDecreaseInAccruedFormationAndOfferingCosts_doc" xml:lang="en-US">Increase (Decrease) in accrued formation and offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredUnderwritingCommissionPayable" xlink:to="MURFU_DeferredUnderwritingCommissionPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_DeferredUnderwritingCommissionPayable_doc" xml:lang="en-US">Deferred underwriting commission payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_FormationCostsPaidByNotePayableSponsor" xlink:to="MURFU_FormationCostsPaidByNotePayableSponsor_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_FormationCostsPaidByNotePayableSponsor_doc" xml:lang="en-US">Formation costs paid by note payable sponsor.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:to="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts_doc" xml:lang="en-US">Deferred offering costs included in accrued offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrepaidExpensesPaidByNotePayable" xlink:to="MURFU_PrepaidExpensesPaidByNotePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PrepaidExpensesPaidByNotePayable_doc" xml:lang="en-US">Prepaid expenses paid by note payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredOfferingCostsPaidByNotePayable" xlink:to="MURFU_DeferredOfferingCostsPaidByNotePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_DeferredOfferingCostsPaidByNotePayable_doc" xml:lang="en-US">Deferred offering costs paid by note payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" xlink:to="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_doc" xml:lang="en-US">Remeasurement of Class A common stock subject to possible redemption upon IPO.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OverfundingOfTheTrustAccount" xlink:to="MURFU_OverfundingOfTheTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_OverfundingOfTheTrustAccount_doc" xml:lang="en-US">Overfunding of the trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OperatingCashAccount" xlink:to="MURFU_OperatingCashAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_OperatingCashAccount_doc" xml:lang="en-US">Operating cash account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_TransactionAgreementMember" xlink:to="MURFU_TransactionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_TransactionAgreementMember_doc" xml:lang="en-US">Transaction Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_BusinessCombinationAgreementMember" xlink:to="MURFU_BusinessCombinationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_BusinessCombinationAgreementMember_doc" xml:lang="en-US">Business Combination Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ConduitPharmaceuticalsLimitedMember" xlink:to="MURFU_ConduitPharmaceuticalsLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_ConduitPharmaceuticalsLimitedMember_doc" xml:lang="en-US">Conduit Pharmaceuticals Limited [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_SubscriptionAgreementsMember" xlink:to="MURFU_SubscriptionAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_SubscriptionAgreementsMember_doc" xml:lang="en-US">Subscription Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_EmergingGrowthCompanyPolicyTextBlock" xlink:to="MURFU_EmergingGrowthCompanyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_EmergingGrowthCompanyPolicyTextBlock_doc" xml:lang="en-US">Emerging Growth Company [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:to="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock_doc" xml:lang="en-US">Investments Held In Trust Account [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" xlink:to="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_doc" xml:lang="en-US">Offering Costs Associated With Public Offering [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PublicOfferingCosts" xlink:to="MURFU_PublicOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PublicOfferingCosts_doc" xml:lang="en-US">Public offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredUnderwritingFee" xlink:to="MURFU_DeferredUnderwritingFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_DeferredUnderwritingFee_doc" xml:lang="en-US">Deferred underwriting fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InitialPublicOfferingCost" xlink:to="MURFU_InitialPublicOfferingCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_InitialPublicOfferingCost_doc" xml:lang="en-US">Initial public offering cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_WarrantIssuanceCost" xlink:to="MURFU_WarrantIssuanceCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_WarrantIssuanceCost_doc" xml:lang="en-US">Warrant issuance cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PublicWarrantsMember" xlink:to="MURFU_PublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PublicWarrantsMember_doc" xml:lang="en-US">Public Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrivatePlacementWarrantsMember" xlink:to="MURFU_PrivatePlacementWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PrivatePlacementWarrantsMember_doc" xml:lang="en-US">Private Placement Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" xlink:to="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_doc" xml:lang="en-US">Schedule Of Common Stock Subject To Possible Redemption [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" xlink:to="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_doc" xml:lang="en-US">Proceeds allocated to public warrants, net of offering cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PaymentOfCommonStockIssuanceCosts" xlink:to="MURFU_PaymentOfCommonStockIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PaymentOfCommonStockIssuanceCosts_doc" xml:lang="en-US">Common stock issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" xlink:to="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_doc" xml:lang="en-US">Temporary equity accretion to original redemption value adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_CommonStockSubjectToPossibleRedemption" xlink:to="MURFU_CommonStockSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_CommonStockSubjectToPossibleRedemption_doc" xml:lang="en-US">Common stock subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock" xlink:to="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock_doc" xml:lang="en-US">Investment Held In Trust Account [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_WarrantInstrumentsPolicyTextBlock" xlink:to="MURFU_WarrantInstrumentsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_WarrantInstrumentsPolicyTextBlock_doc" xml:lang="en-US">Warrant Instruments [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InitialPublicOfferingTextBlock" xlink:to="MURFU_InitialPublicOfferingTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_InitialPublicOfferingTextBlock_doc" xml:lang="en-US">Warrant Instruments [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PublicWarrantMember" xlink:to="MURFU_PublicWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PublicWarrantMember_doc" xml:lang="en-US">Public Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrivatePlacementsTextBlock" xlink:to="MURFU_PrivatePlacementsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PrivatePlacementsTextBlock_doc" xml:lang="en-US">Private Placements [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_StockIssuedDuringPeriodSharesOnHold" xlink:to="MURFU_StockIssuedDuringPeriodSharesOnHold_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_StockIssuedDuringPeriodSharesOnHold_doc" xml:lang="en-US">Stock issued during period shares on hold.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_WorkingCapitalLoan" xlink:to="MURFU_WorkingCapitalLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_WorkingCapitalLoan_doc" xml:lang="en-US">Working capital loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_OptionExercisedDate" xlink:to="MURFU_OptionExercisedDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_OptionExercisedDate_doc" xml:lang="en-US">Option exercised date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_CashUnderwritingDiscount" xlink:to="MURFU_CashUnderwritingDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_CashUnderwritingDiscount_doc" xml:lang="en-US">Cash underwriting discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_UnderwritingDiscount" xlink:to="MURFU_UnderwritingDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_UnderwritingDiscount_doc" xml:lang="en-US">Underwriting discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredFeePerShare" xlink:to="MURFU_DeferredFeePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_DeferredFeePerShare_doc" xml:lang="en-US">Deferred fee per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdvancePaymentForUnderwriterExpenses" xlink:to="MURFU_AdvancePaymentForUnderwriterExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_AdvancePaymentForUnderwriterExpenses_doc" xml:lang="en-US">Advance payment for underwriter expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_UnderwriterMember" xlink:to="MURFU_UnderwriterMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_UnderwriterMember_doc" xml:lang="en-US">Underwriter [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_UnderwriterExpenses" xlink:to="MURFU_UnderwriterExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_UnderwriterExpenses_doc" xml:lang="en-US">Underwriter expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember" xlink:to="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember_doc" xml:lang="en-US">Private Placement Warrants And Public Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PercentageOfDepositInTrustAccount" xlink:to="MURFU_PercentageOfDepositInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MURFU_PercentageOfDepositInTrustAccount_doc" xml:lang="en-US">Percentage of deposit in trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" xlink:to="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo_3_lbl" xml:lang="en-US">AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_2_lbl" xml:lang="en-US">Payments of Financing Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_DeferredUnderwritingCommissionPayable" xlink:to="MURFU_DeferredUnderwritingCommissionPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_DeferredUnderwritingCommissionPayable_3_lbl" xml:lang="en-US">DeferredUnderwritingCommissionPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock" xlink:to="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_InvestmentHeldInTrustAccountPolicyTextBlock_3_lbl" xml:lang="en-US">InvestmentHeldInTrustAccountPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_CommonStockSubjectToPossibleRedemption" xlink:to="MURFU_CommonStockSubjectToPossibleRedemption_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_CommonStockSubjectToPossibleRedemption_4_lbl" xml:lang="en-US">CommonStockSubjectToPossibleRedemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_2_lbl" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_PublicOfferingCosts" xlink:to="MURFU_PublicOfferingCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_PublicOfferingCosts_3_lbl" xml:lang="en-US">PublicOfferingCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MURFU_StockIssuedDuringPeriodSharesOnHold" xlink:to="MURFU_StockIssuedDuringPeriodSharesOnHold_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MURFU_StockIssuedDuringPeriodSharesOnHold_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodSharesOnHold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>50
<FILENAME>murfu-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bloomberg.com/role/Cover" xlink:href="murfu-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/BalanceSheets" xlink:href="murfu-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/BalanceSheetsParenthetical" xlink:href="murfu-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfOperations" xlink:href="murfu-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfOperationsParenthetical" xlink:href="murfu-20221231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:href="murfu-20221231.xsd#StatementsOfChangesInStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:href="murfu-20221231.xsd#StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StatementsOfCashFlows" xlink:href="murfu-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:href="murfu-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/InitialPublicOffering" xlink:href="murfu-20221231.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/PrivatePlacements" xlink:href="murfu-20221231.xsd#PrivatePlacements" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/RelatedPartyTransactions" xlink:href="murfu-20221231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/CommitmentsAndContingencies" xlink:href="murfu-20221231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StockholdersEquityDeficit" xlink:href="murfu-20221231.xsd#StockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurements" xlink:href="murfu-20221231.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/Taxes" xlink:href="murfu-20221231.xsd#Taxes" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SubsequentEvents" xlink:href="murfu-20221231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurementsTables" xlink:href="murfu-20221231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/TaxesTables" xlink:href="murfu-20221231.xsd#TaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:href="murfu-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:href="murfu-20221231.xsd#ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:href="murfu-20221231.xsd#ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="murfu-20221231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="murfu-20221231.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/PrivatePlacementsDetailsNarrative" xlink:href="murfu-20221231.xsd#PrivatePlacementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="murfu-20221231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="murfu-20221231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative" xlink:href="murfu-20221231.xsd#StockholdersEquityDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:href="murfu-20221231.xsd#ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="murfu-20221231.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="murfu-20221231.xsd#ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="murfu-20221231.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/ScheduleOfChangeInValuationDetails" xlink:href="murfu-20221231.xsd#ScheduleOfChangeInValuationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/TaxesDetailsNarrative" xlink:href="murfu-20221231.xsd#TaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://bloomberg.com/role/SubsequentEventsDetailsNarrative" xlink:href="murfu-20221231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaapDeferredCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapDeferredCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredCommissionPayableNonCurrent" xlink:label="loc_MURFUDeferredCommissionPayableNonCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_MURFUDeferredCommissionPayableNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdministrationFeeRelatedParty" xlink:label="loc_MURFUAdministrationFeeRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUAdministrationFeeRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SponsorMember" xlink:label="loc_MURFUSponsorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MURFUSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodShareOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodShareOnHold" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodShareOnHold" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit" xlink:title="00000006 - Statement - Statements of Changes in Stockholders&apos; Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" xlink:label="loc_MURFUAdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUAdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical" xlink:title="00000007 - Statement - Statements of Changes in Stockholders&apos; Equity (Deficit) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SponsorMember" xlink:label="loc_MURFUSponsorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MURFUSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodShareOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodShareOnHold" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodShareOnHold" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_FormationCostsPaidByNotePayableSponsor" xlink:label="loc_MURFUFormationCostsPaidByNotePayableSponsor" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_MURFUFormationCostsPaidByNotePayableSponsor" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:label="loc_MURFUDeferredOfferingCostsIncludedInAccruedOfferingCosts" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_MURFUDeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrepaidExpensesPaidByNotePayable" xlink:label="loc_MURFUPrepaidExpensesPaidByNotePayable" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_MURFUPrepaidExpensesPaidByNotePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredOfferingCostsPaidByNotePayable" xlink:label="loc_MURFUDeferredOfferingCostsPaidByNotePayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_MURFUDeferredOfferingCostsPaidByNotePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredUnderwritingCommissionPayable" xlink:label="loc_MURFUDeferredUnderwritingCommissionPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_MURFUDeferredUnderwritingCommissionPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ClassASharesSubjectToRedemption" xlink:label="loc_MURFUClassASharesSubjectToRedemption" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_MURFUClassASharesSubjectToRedemption" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:title="00000009 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - INITIAL PUBLIC OFFERING">
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_MURFUDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InitialPublicOfferingTextBlock" xlink:label="loc_MURFUInitialPublicOfferingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MURFUDisclosureInitialPublicOfferingAbstract" xlink:to="loc_MURFUInitialPublicOfferingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/PrivatePlacements" xlink:title="00000012 - Disclosure - PRIVATE PLACEMENTS">
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DisclosurePrivatePlacementsAbstract" xlink:label="loc_MURFUDisclosurePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementsTextBlock" xlink:label="loc_MURFUPrivatePlacementsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MURFUDisclosurePrivatePlacementsAbstract" xlink:to="loc_MURFUPrivatePlacementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StockholdersEquityDeficit" xlink:title="00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurements" xlink:title="00000016 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/Taxes" xlink:title="00000017 - Disclosure - TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_MURFUEmergingGrowthCompanyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUEmergingGrowthCompanyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:label="loc_MURFUInvestmentsHeldInTrustAccountPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUInvestmentsHeldInTrustAccountPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" xlink:label="loc_MURFUOfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUOfferingCostsAssociatedWithPublicOfferingPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InvestmentHeldInTrustAccountPolicyTextBlock" xlink:label="loc_MURFUInvestmentHeldInTrustAccountPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUInvestmentHeldInTrustAccountPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesReportingOfDerivativeActivity" xlink:label="loc_us-gaapDerivativesReportingOfDerivativeActivity" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesReportingOfDerivativeActivity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WarrantInstrumentsPolicyTextBlock" xlink:label="loc_MURFUWarrantInstrumentsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUWarrantInstrumentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" xlink:label="loc_MURFUScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurementsTables" xlink:title="00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/TaxesTables" xlink:title="00000022 - Disclosure - TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_BusinessCombinationAgreementMember" xlink:label="loc_MURFUBusinessCombinationAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_MURFUBusinessCombinationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SubscriptionAgreementsMember" xlink:label="loc_MURFUSubscriptionAgreementsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_MURFUSubscriptionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_TransactionAgreementMember" xlink:label="loc_MURFUTransactionAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_MURFUTransactionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ConduitPharmaceuticalsLimitedMember" xlink:label="loc_MURFUConduitPharmaceuticalsLimitedMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_MURFUConduitPharmaceuticalsLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OverfundingOfTheTrustAccount" xlink:label="loc_MURFUOverfundingOfTheTrustAccount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_MURFUOverfundingOfTheTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OperatingCashAccount" xlink:label="loc_MURFUOperatingCashAccount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_MURFUOperatingCashAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationControlObtainedDescription" xlink:label="loc_us-gaapBusinessCombinationControlObtainedDescription" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationControlObtainedDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsRestrictions" xlink:label="loc_us-gaapRetainedEarningsRestrictions" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRetainedEarningsRestrictions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails" xlink:title="00000024 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" xlink:label="loc_MURFUProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUProceedsAllocatedToPublicWarrantsNetOfOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PaymentOfCommonStockIssuanceCosts" xlink:label="loc_MURFUPaymentOfCommonStockIssuanceCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUPaymentOfCommonStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment" xlink:label="loc_MURFUTemporaryEquityAccretionToOriginalRedemptionValueAdjustment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUTemporaryEquityAccretionToOriginalRedemptionValueAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_CommonStockSubjectToPossibleRedemption" xlink:label="loc_MURFUCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUCommonStockSubjectToPossibleRedemption" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_CommonStockSubjectToPossibleRedemption" xlink:label="loc_MURFUCommonStockSubjectToPossibleRedemption_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_MURFUCommonStockSubjectToPossibleRedemption_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicWarrantsMember" xlink:label="loc_MURFUPublicWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementWarrantsMember" xlink:label="loc_MURFUPrivatePlacementWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicOfferingCosts" xlink:label="loc_MURFUPublicOfferingCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUPublicOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:label="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredUnderwritingFee" xlink:label="loc_MURFUDeferredUnderwritingFee" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUDeferredUnderwritingFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_InitialPublicOfferingCost" xlink:label="loc_MURFUInitialPublicOfferingCost" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUInitialPublicOfferingCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WarrantIssuanceCost" xlink:label="loc_MURFUWarrantIssuanceCost" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_MURFUWarrantIssuanceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalDepositInsuranceCorporationPremiumExpense" xlink:label="loc_us-gaapFederalDepositInsuranceCorporationPremiumExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFederalDepositInsuranceCorporationPremiumExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="loc_us-gaapAssetsHeldInTrust" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsHeldInTrust" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_MURFUDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MURFUDisclosureInitialPublicOfferingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PublicWarrantMember" xlink:label="loc_MURFUPublicWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPublicWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/PrivatePlacementsDetailsNarrative" xlink:title="00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DisclosurePrivatePlacementsAbstract" xlink:label="loc_MURFUDisclosurePrivatePlacementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MURFUDisclosurePrivatePlacementsAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalUnitClassAMember" xlink:label="loc_us-gaapCapitalUnitClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCapitalUnitClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_SponsorMember" xlink:label="loc_MURFUSponsorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MURFUSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodSharesOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodSharesOnHold" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodSharesOnHold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="loc_us-gaapSponsorFees" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapSponsorFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdministrationFeeRelatedParty" xlink:label="loc_MURFUAdministrationFeeRelatedParty" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_MURFUAdministrationFeeRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_WorkingCapitalLoan" xlink:label="loc_MURFUWorkingCapitalLoan" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_MURFUWorkingCapitalLoan" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000030 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwriterMember" xlink:label="loc_MURFUUnderwriterMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_MURFUUnderwriterMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_OptionExercisedDate" xlink:label="loc_MURFUOptionExercisedDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUOptionExercisedDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_CashUnderwritingDiscount" xlink:label="loc_MURFUCashUnderwritingDiscount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUCashUnderwritingDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwritingDiscount" xlink:label="loc_MURFUUnderwritingDiscount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUUnderwritingDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_DeferredFeePerShare" xlink:label="loc_MURFUDeferredFeePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUDeferredFeePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_AdvancePaymentForUnderwriterExpenses" xlink:label="loc_MURFUAdvancePaymentForUnderwriterExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUAdvancePaymentForUnderwriterExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_UnderwriterExpenses" xlink:label="loc_MURFUUnderwriterExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_MURFUUnderwriterExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative" xlink:title="00000031 - Disclosure - STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember" xlink:label="loc_MURFUPrivatePlacementWarrantsAndPublicWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_MURFUPrivatePlacementWarrantsAndPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails" xlink:title="00000032 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000033 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember" xlink:label="loc_us-gaapFinancialServiceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapFinancialServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000034 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/ScheduleOfChangeInValuationDetails" xlink:title="00000036 - Disclosure -  SCHEDULE OF CHANGE IN VALUATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/TaxesDetailsNarrative" xlink:title="00000037 - Disclosure - TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://bloomberg.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000038 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_PercentageOfDepositInTrustAccount" xlink:label="loc_MURFUPercentageOfDepositInTrustAccount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_MURFUPercentageOfDepositInTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="murfu-20221231.xsd#MURFU_StockIssuedDuringPeriodShareOnHold" xlink:label="loc_MURFUStockIssuedDuringPeriodShareOnHold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_MURFUStockIssuedDuringPeriodShareOnHold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaapDepositAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDepositAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399904896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MURPHY
CANYON ACQUISITION CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001896212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-3272543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4995
Murphy Canyon Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">471-8536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4995 Murphy Canyon Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">471-8536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Jack
K. Heilbron<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782400584672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 345,777<span></span>
</td>
<td class="nump">$ 48,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">300,862<span></span>
</td>
<td class="nump">55,608<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">646,639<span></span>
</td>
<td class="nump">104,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">136,871,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">108,962<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">137,517,822<span></span>
</td>
<td class="nump">213,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">43,113<span></span>
</td>
<td class="nump">15,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">374,862<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Note payable &#8211; Sponsor</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">177,057<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">417,975<span></span>
</td>
<td class="nump">192,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DeferredCommissionPayableNonCurrent', window );">Deferred commission payable</a></td>
<td class="nump">4,628,750<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">5,046,725<span></span>
</td>
<td class="nump">192,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Common stock subject to possible redemption at redemption value (13,225,000 shares at $10.34 per share)</a></td>
<td class="nump">136,771,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">24,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(4,300,492)<span></span>
</td>
<td class="num">(4,381)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity (Deficit)</a></td>
<td class="num">(4,300,086)<span></span>
</td>
<td class="nump">20,619<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity (Deficit)</a></td>
<td class="nump">137,517,822<span></span>
</td>
<td class="nump">213,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">75<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DeferredCommissionPayableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Commission Payable Non Current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DeferredCommissionPayableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399740064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares', window );">Shares subject to possible redemption</a></td>
<td class="nump">13,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price</a></td>
<td class="nump">$ 10.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares', window );">Shares subject to possible redemption</a></td>
<td class="nump">13,225,000<span></span>
</td>
<td class="nump">13,225,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">754,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">754,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">3,306,250<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">3,306,250<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399621488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 4,381<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,092,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_AdministrationFeeRelatedParty', window );">Administration fee &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total expenses</a></td>
<td class="nump">4,381<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,202,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income &#8211; Investments held in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,976,183<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,976,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net income (loss) before income taxes</a></td>
<td class="num">(4,381)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">773,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(374,862)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (4,381)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 398,639<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Class B common stock weighted average shares outstanding, basic and diluted</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,558,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Class B common stock &#8211; Basic and diluted net income (loss) per share</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Class B common stock weighted average shares outstanding, basic and diluted</a></td>
<td class="nump">2,875,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Class B common stock &#8211; Basic and diluted net income (loss) per share</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes
    an aggregate of up to <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9R4rmUGX3I7" title="Number of option issued for forfeiture">431,250</span> shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised
    in full or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such,
    the Class B common stock is no longer subject to forfeiture (see Notes 5 and 6).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On
    January 26, 2022, the Sponsor surrendered and forfeited <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zNxtqdOMKVt5" title="Stock surrendered and forfeited during period shares">1,006,250</span> founder shares for no consideration following which the Sponsor
    holds <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zyA2yNai3ox4" title="Stock issued during period on hold">3,306,250</span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_AdministrationFeeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Administration fee related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_AdministrationFeeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399647616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Operations (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Feb. 07, 2022</div></th>
<th class="th"><div>Jan. 26, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=MURFU_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Stock surrendered and forfeited during period shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,006,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_StockIssuedDuringPeriodShareOnHold', window );">Stock issued during period on hold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of option issued for forfeiture</a></td>
<td class="nump">431,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_StockIssuedDuringPeriodShareOnHold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares on hold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_StockIssuedDuringPeriodShareOnHold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=MURFU_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=MURFU_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782395748720">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Statements of Changes in Stockholders' Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Common Class A [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Common Class B [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Oct. 18, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Oct. 18, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of Private Placement Units, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">24,669<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of private placement units, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,381)<span></span>
</td>
<td class="num">(4,381)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="nump">24,669<span></span>
</td>
<td class="num">(4,381)<span></span>
</td>
<td class="nump">20,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of Private Placement Units, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 75<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,520,275<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,520,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of private placement units, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">398,639<span></span>
</td>
<td class="nump">398,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Proceeds allocated to Public Warrants, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">21,917,543<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">21,917,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo', window );">Remeasurement of Class A common stock subject to possible redemption upon IPO</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(29,462,487)<span></span>
</td>
<td class="num">(2,818,567)<span></span>
</td>
<td class="num">(32,281,054)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Remeasurement of Class A shares to redemption value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,876,183)<span></span>
</td>
<td class="num">(1,876,183)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">754,000<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (4,300,492)<span></span>
</td>
<td class="num">$ (4,300,086)<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    an aggregate of up to <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSlF8GRYa24f" title="Number of option issued for forfeiture">431,250</span> shares of Common stock subject to forfeiture if the over-allotment option is not exercised in full
    or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such, the Class
    B common stock is no longer subject to forfeiture (see Notes 5 and 6).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On
    January 26, 2022, the Sponsor surrendered and forfeited <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zQctBQNw3rp9" title="Stock surrendered and forfeited during period shares">1,006,250</span> founder shares for no consideration following which the Sponsor
    holds <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_z89iBBfkzGP3" title="Stock issued during period on hold">3,306,250</span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement of Class A common stock subject to possible redemption upon IPO.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782477116752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Changes in Stockholders' Equity (Deficit) (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Feb. 07, 2022</div></th>
<th class="th"><div>Jan. 26, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=MURFU_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Stock surrendered and forfeited during period shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,006,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_StockIssuedDuringPeriodShareOnHold', window );">Stock issued during period on hold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of option issued for forfeiture</a></td>
<td class="nump">431,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_StockIssuedDuringPeriodShareOnHold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares on hold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_StockIssuedDuringPeriodShareOnHold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=MURFU_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=MURFU_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399628448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (4,381)<span></span>
</td>
<td class="nump">$ 398,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_FormationCostsPaidByNotePayableSponsor', window );">Formation costs paid by note payable &#8211; Sponsor</a></td>
<td class="nump">3,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned on investments held in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,976,183)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">108,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(5,608)<span></span>
</td>
<td class="num">(245,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">27,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Accrued income taxes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">374,862<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(5,995)<span></span>
</td>
<td class="num">(1,311,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Cash deposited into Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(134,895,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(134,895,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred offering costs</a></td>
<td class="num">(45,450)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from note payable - Sponsor</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of Class B common stock to Sponsor</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Sale of units in public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">132,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Sale of private placement units</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,540,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(3,109,411)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of note payable - Sponsor</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(177,057)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">54,550<span></span>
</td>
<td class="nump">136,503,532<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="nump">48,555<span></span>
</td>
<td class="nump">297,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at beginning of period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">48,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at end of period</a></td>
<td class="nump">48,555<span></span>
</td>
<td class="nump">345,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts', window );">Deferred offering costs included in accrued offering costs</a></td>
<td class="nump">15,449<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_PrepaidExpensesPaidByNotePayable', window );">Prepaid expenses paid by note payable - Sponsor</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DeferredOfferingCostsPaidByNotePayable', window );">Deferred offering costs paid by note payable - Sponsor</a></td>
<td class="nump">47,875<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DeferredUnderwritingCommissionPayable', window );">Deferred commission payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,628,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_ClassASharesSubjectToRedemption', window );">Class A shares subject to redemption</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 136,771,183<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_ClassASharesSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_ClassASharesSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs included in accrued offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DeferredOfferingCostsPaidByNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs paid by note payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DeferredOfferingCostsPaidByNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DeferredUnderwritingCommissionPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting commission payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DeferredUnderwritingCommissionPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_FormationCostsPaidByNotePayableSponsor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Formation costs paid by note payable sponsor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_FormationCostsPaidByNotePayableSponsor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_PrepaidExpensesPaidByNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses paid by note payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_PrepaidExpensesPaidByNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399892176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zEJHUe1aB8Db" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212; <span id="xdx_82C_z0Smo3N7JC28">DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Murphy
Canyon Acquisition Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on October 19, 2021. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;). The Company is not limited to a particular industry or sector for
purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company
is subject to all of the risks associated with early stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had not commenced any operations. All activity for the period from October 19, 2021 (inception) through
December 31, 2022 relates to the Company&#8217;s formation, the proposed initial public offering (&#8220;Initial Public Offering&#8221;),
which is described below, and searching for an initial Business Combination, as defined below. The Company will not generate any operating revenues until
after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form
of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year
end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering (the &#8220;Registration Statement&#8221;) was declared effective
on February 2, 2022. On February 7, 2022, the Company consummated the Initial Public Offering of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zdwwo7ZGbCh4" title="Stock issued during period shares new issues">13,225,000</span> units (&#8220;Units&#8221;), generating gross proceeds
of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zL2WaGa4E2M7" title="Proceeds from isssuance">132,250,000</span>, which is described in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zWykxjFP54t7" title="Sale of stock">754,000</span>
units (the &#8220;Private Placement Units&#8221;) at a price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zck7Zm2CBKw5" title="Sale of stock price per share">10.00</span>
per Private Placement Unit in private placements to Murphy Canyon Acquisition Sponsor LLC (the &#8220;Sponsor&#8221;), with gross
proceeds of $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zWm4NK8UNSpa" title="Gross proceeds from shares issuance">7,540,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on February 7, 2022, an amount of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSVGw2JzzYL3" title="Net proceeds from sale of equity">139,790,000</span> from the net proceeds of the sale of the Units
in the Initial Public Offering and the Private Placement Units was placed in the Trust Account, as defined below. This resulted in an
overfunding of the Trust Account of $<span id="xdx_90B_ecustom--OverfundingOfTheTrustAccount_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z89Qs2fzbYO2" title="Overfunding of the trust account">4,895,000</span>. As such, subsequent to the initial funding of the Trust Account, $<span id="xdx_901_ecustom--OperatingCashAccount_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zmUslQpYtNZe" title="Operating cash account">2,000,000</span> was transferred
to the Company&#8217;s operating cash account and $<span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_c20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7NNEFbLp1od" title="Offering costs">2,895,000</span> was used to pay offering costs. The funds held in the Trust Account may
be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as
amended (the &#8220;Investment Company Act&#8221;), with a maturity of 185 days or less or in any open-ended investment company that
holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as
determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account,
as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2022, the Company entered into a definitive Business Combination Agreement (the &#8220;BCA&#8221;) with Conduit Pharmaceuticals
Limited, a Cayman Islands exempted company (&#8220;Conduit&#8221;), and Conduit Merger Sub, Inc., a Cayman Islands exempted company (&#8220;Merger
Sub&#8221;). Merger Sub is a wholly owned subsidiary of the Company. Conduit is a pharmaceutical company led by experienced pharma executives,
established to fund the development of successful deprioritized clinical assets licensed from large pharmaceutical companies through
its exclusive relationships. The BCA was amended in January 2023, see Note 10 for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the consummation of the transactions contemplated by the BCA, Merger Sub will merge with and into Conduit, with Conduit surviving as
a wholly owned subsidiary of the Company (the &#8220;Business Combination&#8221;). The Company is expected to be renamed Conduit Pharmaceuticals
Inc. at the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BCA, at the closing, the Company shall issue and deliver to the shareholders of Conduit an aggregate number of shares of the Company&#8217;s
common stock with an aggregate value equal to $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20221107__20221108__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zXEgmZpeRXyd" title="Shares issued">650,000,000</span>, with each share valued at $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20221108__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zV4CvPhmoVkd" title="Share price">10.00</span> per share. A private placement transaction
shall be conducted by the Company contemporaneously with the Business Combination (the &#8220;PIPE Financing&#8221;), pursuant to which
the Company has entered into subscription agreements providing for aggregate investments in the Company&#8217;s securities of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20221107__20221108__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zjjSm9LoeISg" title="Shares issued">27,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Business Combination or PIPE Financing will occur as planned or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
<span id="xdx_904_eus-gaap--BusinessCombinationControlObtainedDescription_c20220101__20221231_zgytHUl17Jm1" title="Business combination description of transaction">The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions
and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of
1940, as amended (the &#8220;Investment Company Act&#8221;). Upon the closing of the Initial Public Offering, management has agreed that
an amount equal to at least $10.00 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants,
will be held in a trust account (&#8220;Trust Account&#8221;), located in the United States and invested only in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended
investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the
distribution of the funds held in the Trust Account, as described below.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide the holders of the outstanding Public Shares (the &#8220;Public Stockholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (net of taxes payable). There will be no redemption
rights upon the completion of a Business Combination with respect to the Company&#8217;s warrants. All of the Public Shares contain a
redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder
vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and
restated certificate of incorporation. In accordance with U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and its guidance
on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a
company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be
issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as
temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Class A common stock is subject to ASC
480-10-S99. If it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in
the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become
redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately
as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We
have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction
to retained earnings, or in absence of retained earnings, additional paid-in capital). The Public Shares are redeemable and will be classified
as such on the balance sheet until such date that a redemption event takes place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority
of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange
rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide
to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation
(the &#8220;Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the (&#8220;SEC&#8221;)
and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction
is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business
or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not
pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor
has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering
in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting,
and if they do vote, irrespective of whether they vote for or against the proposed transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section 13 of <span id="xdx_903_eus-gaap--RetainedEarningsRestrictions_c20220101__20221231_zFWVJCI5L5E7" title="Retained earnings restrictions">the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more
than an aggregate of 15% of the Public Shares, without the prior consent of the Company.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares have agreed (a) to waive their redemption rights with respect to the Founder Shares and Public Shares held
by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation
(i) to modify the substance or timing of the Company&#8217;s obligation to allow redemptions in connection with a Business Combination
or to redeem <span id="xdx_907_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20220101__20221231_zq7fVaZW2R2h" title="Debt instrument redemption price percentage">100%</span> of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined
below) or (ii) with respect to any other provision relating to stockholders&#8217; rights or pre-business combination activity, unless
the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company has not completed a Business Combination within 12 months from the consummation of our initial public offering (or up to
February 7, 2024 at the election of the Company subject to satisfaction of certain conditions, as amended at the January 2023 Special
Meeting, see Note 10) (&#8220;Business Combination Period&#8221;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account
and not previously released to pay taxes (less up to $<span id="xdx_90C_eus-gaap--InterestExpense_c20220101__20221231_zNDqVrzGlcQe" title="Interest expense">100,000</span> of interest to pay dissolution expenses), divided by the number of then
outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#8217; rights as stockholders (including the
right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of directors, dissolve and liquidate,
subject in each case to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. Our Sponsor has committed to provide additional funds if needed to make such a deposit for the extensions. There
will be no redemption rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if
the Company fails to complete a Business Combination within the Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founders Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails
to complete a Business Combination within the Combination Period. However, if the holders of Founder Shares acquire Public Shares in
or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the
Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to
their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination
within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will
be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value
of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9JF2QNb4Rsf" title="Share issued price per share">10.00</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below <span id="xdx_905_eus-gaap--BusinessCombinationControlObtainedDescription_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zSvn4B3UPk4a" title="Business combination description of transaction">(i) $10.00 per Public Share or (ii) such
lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00
per public Share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn
to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account
and except as to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span> Moreover, in the event that an
executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability
for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account
due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company&#8217;s independent registered
accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the
Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management&#8217;s
Plan and Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&#8217;s assessment of going concern considerations in accordance with Accounting Standards Update (&#8220;ASU&#8221;)
2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined
that the Combination Period is less than one year from the date of the issuance of the financial statements. There is no assurance that
the Company&#8217;s plans to consummate a Business Combination will be successful within the Combination Period. Additionally, the Company has incurred and expects to continue to incur
significant costs in pursuit of its acquisition plans. As a result, these factors
raise substantial doubt about the Company&#8217;s ability to continue as a going concern for the next twelve months from the issuance
of these financial statements. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
and Uncertainties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position, results of its operations, and search for a target company, the specific
impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782398900368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_z1tfUPZXcHU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_82D_zayDyBGeuz2h">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5piLhu7ej1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z2s4oTn5D1p1">Basis
of Presentation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) as contained within the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards
Codification (&#8220;ASC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_ecustom--EmergingGrowthCompanyPolicyTextBlock_zjC1R0hQahwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zvm2ZrWcsrtd">Emerging
Growth Company</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities
Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_845_eus-gaap--UseOfEstimates_z4nl6qfhdbFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zJelOGGc3Nml">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with US GAAP requires the Company&#8217;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVlny8JIRqsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zhzZ1uWcrlZ8">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zItSu1MAHKQb" title="Cash and cash equivalents">345,777</span> and $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_zAXyIs9fLL0l" title="Cash and cash equivalents">48,555</span> in cash as of December 31, 2022 and 2021. The Company did not have any cash equivalents
as of December 31, 2022 or December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zFxKRtwFobx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_ziy9pjH8T3Ul">Investments
Held in Trust Account</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2022 and 2021, the Company had $<span id="xdx_902_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231_zAM9IxI5iFb8" title="Assets held-in-trust, noncurrent">136,871,183</span> and <span id="xdx_906_eus-gaap--AssetsHeldInTrustNoncurrent_iI_dxL_c20211231_zHMaCXASoyL5" title="Assets held-in-trust, noncurrent::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0462">zero, respectively,</span></span> in investments held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_ecustom--OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_zudH8q6aDGg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z3gArUAOjrqa">Offering
Costs Associated With a Public Offering</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A
&#8212; &#8220;<i>Expenses of Offering.&#8221;</i> Offering costs of $<span id="xdx_908_ecustom--PublicOfferingCosts_c20220101__20221231_z74ORiIF3Ma7" title="Offering costs">7,738,161</span>
consisting of $<span id="xdx_90E_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220101__20221231_zMxCUY4QWAC9" title="Underwriting fees">2,645,000</span>
of underwriting fees, $<span id="xdx_904_ecustom--DeferredUnderwritingFee_c20220101__20221231_z28EFCWSEu85" title="Deferred underwriting fee">4,628,750</span>
of deferred underwriting fee (which are held in the Trust Account with Wilmington Trust Company acting as trustee),
and $<span id="xdx_906_ecustom--InitialPublicOfferingCost_c20220101__20221231_z8aumYHAK5Sg" title="Initial public offering costs">464,411</span>
of Initial Public Offering costs. Of these costs, $<span id="xdx_905_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zXUWyMRpGmOc" title="Warrant issuance cost">1,358,457</span>
and $<span id="xdx_903_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zYx1IjVJCyKe" title="Warrant issuance cost">19,656</span>
were allocated to Public Warrants (as defined in Note 3) and Private Placement Warrants (as defined in Note 4), respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zoX2Q6Nuuvk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zyBsnjIJzmM">Class
A Common Stock Subject to Possible Redemption</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance enumerated in
ASC 480 &#8220;<i>Distinguishing Liabilities from Equity</i>&#8221;. Common stock subject to mandatory redemption is classified as a
liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature
redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events
not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, common stock is classified as
stockholders&#8217; equity. The shares of the Company&#8217;s Class A common stock feature certain redemption rights that are
considered by the Company to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022, the shares of Class A common stock subject to possible redemption in the amount of $<span id="xdx_903_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20221231_zBT9Z72q0hg5" title="Temporary equity, carrying amount, attributable to parent">136,771,183</span>
are presented as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance
sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zAAtN7Xllgck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Class A common stock subject to possible redemption reflected on the  balance sheet are reconciled
in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z2lr5YRJKgz3" style="display: none">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Gross proceeds from IPO</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220101__20220630_zBcvvUviX5xj">132,250,000</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds allocated to Public Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_c20220101__20220630_zWdMy6PlaCT2" style="text-align: right" title="Proceeds allocated to Public Warrants"><span style="font-family: Times New Roman, Times, Serif">(23,276,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--PaymentOfCommonStockIssuanceCosts_c20220101__20220630_zIxPVWPRMts7" style="text-align: right" title="Class A common stock issuance costs"><span style="font-family: Times New Roman, Times, Serif">(6,360,054</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Remeasurement
    adjustment of carrying value to redemption value</td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_c20220101__20220630_zNpPbOs9GoVf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">32,281,054</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Class A common stock subject to possible redemption, as of March 31, 2022</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220401__20220630_zBfOe0vjE2D6" style="text-align: right" title="Common stock subject to possible redemption,beginning"><span style="font-family: Times New Roman, Times, Serif">134,895,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
    of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220401__20220630_zaW7wQN58XQb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">101,767</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of June 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220701__20220930_zGEnAZuXHCS3" style="text-align: right" title="Common stock subject to possible redemption,beginning"><span style="font-family: Times New Roman, Times, Serif">134,996,767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220701__20220930_zE0IrPa6a7Hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">609,920</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of September 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20221001__20221231_zWqQDblob9tc" style="text-align: right" title="Common stock subject to possible redemption, ending"><span style="font-family: Times New Roman, Times, Serif">135,606,687</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20221001__20221231_zeBxdaBxnqU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">1,164,496</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class A common stock
    subject to possible redemption as of December 31, 2022</span> </td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--CommonStockSubjectToPossibleRedemption_iE_c20221001__20221231_zJaLl4a4Gdd2" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, ending"><span style="font-family: Times New Roman, Times, Serif">136,771,183</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_z9qdT5gxpjZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zn0FzwpBJdvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zYQRHT7aCAC9">Net
Income (Loss) per Common Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding
for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share
as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with
the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence
of future events. As of December 31, 2022, the Company&#8217;s outstanding warrants <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iNI_pid_di_c20221231_zgDwP3Bwqh86" title="Outstanding warrants">(13,979,000)</span> have been excluded from diluted net
loss as their inclusion would be anti-dilutive. As a result, diluted net income (loss) per common share is the same as basic net income
(loss) per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdAkAOIxXnUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zfgvdKXe6VI1" style="display: none">SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    Since Inception to</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            A common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            B common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income
    per common share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpJakvAbgL5i" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNvmZ3n0yCh" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif">(4,381</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi0MkF0B8cG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhyfsoULUYjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif">2,875,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    income per common share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z80ASqkgnzX2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzlqgSgwVEad" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif">(0.00</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the Year Ended</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    A common stock</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    B common stock </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic
    and diluted net loss per common share</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation
    of net income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zelEscxqJxXj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,560</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwAq2pxVG2qj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,079</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted weighted average shares outstanding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjZmhKJzYDsj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,558,058</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWshQ7fU0va" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,306,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per common share</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziECzwENsQN2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;0.03
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMFMgISDwU08" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;0.03
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zRriBmV9v45d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zpJvohATqhyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zbSXj7JbaAnb">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zGoKsW9Q3Ku" title="Unrecognized tax benefits"><span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zrOfsYFfHLYk" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zFgAyY9FX99k" title="Income tax penalties and interest accrued"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_zWXhhtgX9265" title="Income tax penalties and interest accrued">no</span></span> amounts accrued for interest and penalties as of December 31, 2022
or December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals
or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified the United States and California as its only tax jurisdictions. The Company is subject to income taxation by major
taxing authorities since inception. All tax periods are open to examination by tax authorities. These examinations may include questioning
the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws.
The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next
twelve months. The Company actual tax expense differs from the expected tax expense due to the change in the valuation allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zrB7CsIHY3Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z5P8XqvPQWC5">Concentration
of Credit Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to credit risk consist principally of cash and investments held in the Trust Account.
Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal Depository Insurance Corporation coverage
limit of $<span id="xdx_902_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_c20220101__20221231_z7VwwBJMlLpf" title="Federal deposit insurance corporation premium expense">250,000</span>, and investments held in the Trust Account. As of December 31, 2022 and 2021, the Company had not experienced
losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--InvestmentHeldInTrustAccountPolicyTextBlock_z6YuSdd0hoJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zh45SLpsh3hb">Investments
Held in Trust Account</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Investments held in the Trust Account were $<span id="xdx_905_eus-gaap--AssetsHeldInTrust_iI_c20221231_zik71MYja2A3" title="Investments held in trust">136,871,183</span>
at December 31, 2022 and <span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_pn5n6_dc_c20211231_zcEi6YD5K7kg" title="Investments held in trust">zero</span>
as of December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government
securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held
in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s
investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities
and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account
in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using
available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zc1MdaksWCJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zQyJQZeygsM3">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value Measurements&#8221;
approximates the carrying amounts represented in the balance sheet, partially due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--DerivativesReportingOfDerivativeActivity_zf24iZVNypg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zQwdV4WDP7A3">Derivative
Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each
reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_ecustom--WarrantInstrumentsPolicyTextBlock_zTPTyDfseDVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z02RYyXYP4i3">Warrant
Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants in accordance with the guidance contained in FASB ASC 815, &#8220;Derivatives and Hedging&#8221;.
Under ASC 815-40 warrants that meet the criteria for equity treatment are recorded in stockholders&#8217; equity (deficit). The warrants are
subject to re-evaluation of the proper classification and accounting treatment at each reporting period. If the warrants no longer
meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the
statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z3cMEn6mP34e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zItt09U2ct97">Recent
Accounting Standards</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on the Company&#8217;s financial statements.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<p id="xdx_854_ziDHbBIPRhn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782475741744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DisclosureInitialPublicOfferingAbstract', window );"><strong>Initial Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_InitialPublicOfferingTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p id="xdx_80F_ecustom--InitialPublicOfferingTextBlock_z80ZLp633gn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_828_zX855hzHCL4g">INITIAL PUBLIC OFFERING</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zg48gCIVVX8h" title="Sale of stock">13,225,000</span>
Units at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zclg5L1FUhk1" title="Sale of stock price per share">10.00</span>
per Unit. Each Unit consists of one share of Class A common stock (&#8220;Public Shares&#8221;) and one redeemable warrant
(&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a
price of $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znwDZBOUSjbi" title="Shares issued price per share">11.50</span>
per share, subject to adjustment (see Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DisclosureInitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DisclosureInitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Instruments [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782475792688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DisclosurePrivatePlacementsAbstract', window );"><strong>Private Placements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_PrivatePlacementsTextBlock', window );">PRIVATE PLACEMENTS</a></td>
<td class="text"><p id="xdx_804_ecustom--PrivatePlacementsTextBlock_z1cyrpaelahb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; <span id="xdx_825_zwxhPPINYXK3">PRIVATE PLACEMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private sale to the Sponsor of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPxqeLBbTst5" title="Number of shares issued for private sale">754,000</span>
Private Placement Units at a price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zvOhyfndF422" title="Sale of stock price per share">10.00</span>
per Private Placement Unit ($<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwc3XSZSRG7b" title="Proceeds from issuance of private placement">7,540,000</span>).
Each Private Placement Unit is comprised of one Class A share and one warrant (&#8220;Private Placement Warrant&#8221;). Each Private Placement Warrant is exercisable to
purchase one share of Class A common stock at a price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CapitalUnitClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zj7LzwxKwsj7" title="Exercise price of warrants">11.50</span>
per share, subject to adjustment (see Note 7). The Company&#8217;s Sponsor has agreed to transfer, but has not yet transferred, <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember_ziqRs6ikHV92" title="Number of units transferred to director">15,000</span>
Private Placement Units to each of our director nominees. The proceeds from the sale of the Private Placement Units were added to the net
proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within
the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the
redemption of the Public Shares (subject to the requirements of applicable law) and the securities comprising the Private Placement
Units will expire worthless. The Private Placement Units (including the Class A common stock issuable upon exercise of the warrants
included in the Private Placement Units) will not be transferable, assignable or saleable until 30 days after the completion of an
Initial Business Combination, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DisclosurePrivatePlacementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DisclosurePrivatePlacementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_PrivatePlacementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private Placements [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_PrivatePlacementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782403698976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zGOdRUgIDTyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; <span id="xdx_829_zJdOdhEvuE5c">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Founder
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2021, the Sponsor received <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211114__20211116__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUVTWHcECAtg" title="Number of shares issued to sponsor">4,312,500</span> shares of the Company&#8217;s Class B common stock (the &#8220;Founder Shares&#8221;)
for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20211114__20211116__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zudlNC0MqXml" title="Number of shares issued to sponsor, value">25,000</span>. On January 26, 2022, the Sponsor surrendered and forfeited <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_ziO090Co09oh" title="Stock surrendered and forfeited during period shares">1,006,250</span> Founder Shares for no consideration, following which
the Sponsor holds <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesOnHold_c20220124__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zThclrPrwyfl" title="Stock issued during period on hold">3,306,250</span> Founder Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until
the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x)
if the last reported sale price of the Class A common stock equals or exceeds $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20211116__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zcxIQBk4QS1h" title="Sale of stock price per share">12.00</span> per share (as adjusted for stock splits, stock capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar
transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities
or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note &#8212; Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021, the Sponsor issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to
which the Company may borrow up to an aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20211104_zjJXC6lA1z8f" title="Principal amount">300,000</span>.
The Promissory Note is non-interest bearing and payable on the earlier of (i) the consummation of the Initial Public Offering or
(ii) the decision not to execute the Initial Public Offering. As of December 31, 2021, there was $<span id="xdx_902_eus-gaap--NotesPayableCurrent_iI_c20211231_zhA6TFolkO39" title="Notes payable, current">177,057</span>
outstanding under the Promissory Note. The balance was paid in full on February 10, 2022. See Note 10, regarding a new promissory
note issued by the Sponsor to the Company for $<span id="xdx_907_eus-gaap--SponsorFees_pn5n6_c20220209__20220210_zIrjQMU6L2x4" title="Sponsor fees">1.5 </span>million, subsequent to December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
and Administrative Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 60pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the date the Units are first listed on the Nasdaq, the Company has agreed to pay the Sponsor a total of $<span id="xdx_903_eus-gaap--PaymentsForRent_c20220101__20221231_zv2wdPYiTgdk" title="Monthly payment for office space">10,000</span> per month for office
space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company&#8217;s
liquidation, the Company will cease paying these monthly fees. During the year ended December 31, 2022, the Company incurred $<span id="xdx_902_ecustom--AdministrationFeeRelatedParty_c20220101__20221231_z60g1ZIvfWuh" title="Administration fee related party">110,000</span>,
of such expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Loans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#8220;Working
Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of
a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $<span id="xdx_903_eus-gaap--DebtConversionOriginalDebtAmount1_c20220101__20221231_z8uO0enqZx14" title="Notes payable converted">1,500,000</span> of the notes may be converted upon completion
of a Business Combination into units at a price of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20221231_z3K5YWU6CyAb" title="Conversion price">10.00</span> per unit. Such units would be identical to the Private Placement Units. In
the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay
the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December
31, 2022 and 2021, there were <span id="xdx_90E_ecustom--WorkingCapitalLoan_iI_do_c20221231_zGwWXN7hU398" title="Working capital loans"><span id="xdx_905_ecustom--WorkingCapitalLoan_iI_do_c20211231_zKzO1aepYf23" title="Working capital loans">no</span></span> amounts outstanding under the Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399698944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znrsQDwRNvqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; <span id="xdx_826_z26ulJyilrw8">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and
any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working
Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement
to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale.
The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company
register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration
statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities
pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required
to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are
released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underwriting
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQgudg26swP1" title="Issuance of Class B common stock to Sponsor, shares">1,725,000</span> additional Units
to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The option was
fully exercised on <span id="xdx_907_ecustom--OptionExercisedDate_dd_c20220101__20221231_zqdPaiqUPHje" title="Option exercised date">February 7, 2022</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were paid a cash underwriting discount of $<span id="xdx_905_ecustom--CashUnderwritingDiscount_c20220101__20221231_z8XuC5VNjcdl" title="Cash underwriting discount">0.20</span> per Unit, or $<span id="xdx_904_ecustom--UnderwritingDiscount_c20220101__20221231_zeKwhIeH74E4" title="Underwriting discount">2,645,000</span>, payable upon the closing of the Initial Public
Offering. In addition, the underwriters are entitled to a deferred fee of $<span id="xdx_900_ecustom--DeferredFeePerShare_iI_c20221231_z2DbQr5CAKFj" title="Deferred fee per share">0.35</span> per Unit, or $<span id="xdx_903_eus-gaap--DeferredOfferingCosts_iI_c20221231_zG7EzTdC73F1" title="Deferred fee">4,628,750</span>. The deferred fee will become
payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the underwriting discount, the Company paid the underwriters $<span id="xdx_90F_ecustom--AdvancePaymentForUnderwriterExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_z6cVoj9RINVc" title="Advance payment for underwriter expenses">50,000</span> as an advance against out-of-pocket accountable expenses
actually anticipated to be incurred by the underwriters, which advance will be returned to the Company to the extent not actually incurred.
The Company agreed to pay or reimburse the underwriters for travel, lodging and other &#8220;road show&#8221; expenses, expenses of the
underwriters&#8217; legal counsel and certain diligence and other fees, which such fees and expenses are capped at an aggregate of $<span id="xdx_905_ecustom--UnderwriterExpenses_c20220101__20221231_zx86g7kjcpC1" title="Underwriter expenses">150,000</span>
(less the $<span id="xdx_90D_ecustom--AdvancePaymentForUnderwriterExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zbsVCVDq5Bhl" title="Advance payment for underwriter expenses">50,000</span> advance previously paid).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782489360976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (DEFICIT)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY (DEFICIT)</a></td>
<td class="text"><p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z6xxhHJbtBl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_829_z7fSFEqua8Ob">STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_ziQ2EVAZKFMf">1,000,000</span> shares of preferred stock with a par value of $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zduoJI93pcGl" title="Preferred stock, par value">0.0001</span> per share. As
of December 31, 2022 and December 31, 2021, there were <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zCQffYugdEob" title="Preferred stock shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_z3lnrpOE6P9e" title="Preferred stock shares outstanding"><span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zMi4f0y7cu" title="Preferred stock shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zElXWJHfISz" title="Preferred stock shares outstanding">no</span></span></span></span> shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
A Common Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJpJMsNlsfi9" title="Common stock, shares authorized">100,000,000</span> shares of Class A common stock with a par value of $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zeivWtl2ldkj" title="Common stock, par value">0.0001</span>
per share. <span id="xdx_909_eus-gaap--CommonStockVotingRights_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWjp8Od3H5Tc" title="Voting rights">Holders of Class A common stock are entitled to one vote for each share.</span> As of December 31, 2022 and 2021, there
were <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zV6J6dHO1675" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJRdHJKqYue6" title="Common stock, shares outstanding">754,000</span></span> and <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_dc_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zy1bhK43NEYc" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_dc_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8Big6Y9G5rc" title="Common stock, shares outstanding">zero</span></span>, respectively, shares of Class A common stock issued and outstanding (excluding the <span id="xdx_90D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zoSh2ZecVRC3" title="Shares subject to possible redemption"><span id="xdx_902_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zlrXrPLiUdd5" title="Shares subject to possible redemption">13,225,000</span></span> shares subject to
possible redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
B Common Stock</i></b> &#8212; The Company is authorized to issue <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z6DbX4ROIHNg" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUVdQzMpLku2" title="Common stock, shares authorized">10,000,000</span></span>
shares of Class B common stock with a par value of $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zLD8W3nhY5j" title="Common stock, par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zYRbC6dW9Sed" title="Common stock, par value">0.0001</span></span>
per share. Holders of Class B common stock are entitled to one vote for each share. As of each December 31, 2022 and 2021, there were <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzpbd3IsWOi4" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zIkH9tJEDEHi" title="Common stock, shares outstanding"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdSLktfDN2y7" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zD6WVhj4Bws1" title="Common stock, shares outstanding">3,306,250</span></span></span></span>
shares of Class B common stock issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of
our shareholders except as otherwise required by law. In connection with our initial business combination, we may enter into a stockholders
agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance
arrangements that differ from those in effect upon completion of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier
at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock,
or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to
the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common
stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment
with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of
all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all
shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked
securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed
in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest
in the target to us in a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class B common stock will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise
required by law. In connection with our initial business combination, we may enter into a stockholders agreement or other arrangements
with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from
those in effect upon completion of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
</i></b>&#8212; Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation
of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion
of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years
after the completion of a Business Combination or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A
common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from
registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue
any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified
under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination,
the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have
declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the
warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed.
Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities
exchange such that it satisfies the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the
Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221;
in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to
file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption
of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00</i></b> &#8212; Once the warrants become exercisable,
the Company may redeem the outstanding Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231_zDOANFFXAcZa" title="Warrant exercise price">0.01</span> per Public Warrant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    a minimum of 30 days&#8217; prior written notice of redemption, or the 30-day redemption period to each warrant holder; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the last reported sale price of the Class A common stock equals or exceeds $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7jgLlaBqZze" title="Share price per shares">18.00</span> per share (as adjusted for stock splits,
    stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on
    the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that
wishes to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise
price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in
the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as
described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally,
in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination
within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive
any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company&#8217;s assets held
outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants and Public Warrants are recorded in stockholders&#8217; equity (deficit) as they qualify for equity treatment
under ASC 815.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key assumptions used to value the Public Warrants, which was determined to be $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember_zAgzSxSNqi48" title="Warrants">23,276,000</span>, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term
    &#8211; <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zpkkryrcOfdk" title="Warrant expected term">5</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility
    &#8211; <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z1Ikpd7iiOK9" title="Warrant measurement inputs">22</span>%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
    &#8211; <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zcf9G3kqPwgb" title="Warrant measurement inputs">0</span>%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
    rate &#8211; <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_ztfvl5e36EO4" title="Warrant measurement inputs">1.76</span>% </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782404018128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z6COOCJFVTZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; <span id="xdx_828_zYzdnx7j1Op8">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zu2TxWQCc0A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value at December 31,
2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_z2pylKwhXTJe" style="display: none">SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0Mjy4Tf55Eb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsAbstract_iB_zoOkDuDLTXvj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zHZWkQ1kdbY2" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investments held in Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">136,871,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zsLA3m5VVvl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify">As
of December 31, 2021, there were <span id="xdx_90E_eus-gaap--AssetsHeldInTrustNoncurrent_iI_do_c20211231__srt--ProductOrServiceAxis__us-gaap--FinancialServiceMember_zxUuBH1DIxma" title="Investments held in trust account">no</span> assets requiring fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782402803888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_znVqMWBYuS54" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; <span id="xdx_826_zQLcBl1ErrNh">TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zdlxj36gAKF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected tax expense based on the statutory rate is reconciled with actual tax expense as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span id="xdx_8BE_zegrbkaZkNY" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20220101__20221231_ztBO9JiSAqB" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Year
    Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zpiP2iCHC56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">U.S.
    federal statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_zvGp5IACUHr4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">State
    taxes, net of federal benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zZPiAqn7dbB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27.36</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zeVDLX67TYl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">Income
    tax provision</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48.46</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p id="xdx_8A6_zR1W0dW1cfSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The effective tax rate differs
from the statutory tax rate of <span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231_zpZu02cEIZJe" title="Effective income tax rate">21</span>% for the year ended December 31, 2021, due to the valuation allowance recorded on the Company&#8217;s
net operating losses. The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various
taxing authorities. The Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. The Company
considers California to be a significant state tax jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and
liabilities and the change in valuation are as follows at December 31:</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zXgh0p8Lvp01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zWmmuSHGaLTh" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span> </span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20221231_zjXfeH5w61Pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNetAbstract_iB_z5EO900vwzIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpense_i01I_msDTAGzZX3_zFPjgyXFWaP3" style="vertical-align: bottom; background-color: White">
    <td style="width: 81%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Startup
    costs</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">211,627</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_i01TI_maDTANznat_mtDTAGzZX3_zJtetEhhZ59k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">211,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"/></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_di_msDTANznat_zykPUm3eeTcg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation Allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(211,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01TI_mtDTANznat_zakgSTSosEUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zDfJCxRrTAc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlDQRPDVQMmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;SCHEDULE
OF CHANGE IN VALUATION</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zjd2Zov0DUK8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_ztbOTcYfa2R4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 81%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_iN_di_zMATFmWpeVA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">374,862<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_zbbOudZnaMzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(211,627</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_zj5vWIJN2Zi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State and
    Local</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zgyPTYBnm8Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_z7DPciRMrj09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_z6zOhjx3JZs2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in
    valuation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">211,627</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_z9vkKwAn6fkk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income Tax Provision</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">374,862</td><td style="font-size: 10pt; text-align: left"/></tr>
  </table>

<p id="xdx_8A7_zT9SsyLFliDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In assessing the realization of
the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will
not be realized. The ultimate realization of deferred tax assets is independent upon the generation of future taxable income during the
periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration
of all of the information available, management believes that significant uncertainty exists with respect to future realization of the
deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31,2021, the change in the valuation
allowance was zero.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782475806832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zkBsJeFKFOT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8212; <span id="xdx_828_zbXALt37NXl5">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements
were issued. Based upon this review, except as disclosed below, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initially,
the Company was required to complete an initial business combination transaction by 12 months from the consummation of  initial
public offering or up to 18 months if the Company extended the period of time to consummate a business combination in accordance
with the Company&#8217;s Certificate of Incorporation. On January 26, 2023, at a special meeting of the Company&#8217;s stockholders
(the &#8220;Special Meeting&#8221;), the Company&#8217;s stockholders approved a proposal to amend the Company&#8217;s certificate of incorporation to allow the Company to extend, at the Company&#8217;s election, the date by
which the Company has to consummate a business combination up to 12 times, each such extension for an additional one month period, from
February 7, 2023, to February 7, 2024. The Company&#8217;s stockholders also approved a related proposal to amend the trust agreement allowing the Company to
deposit into the Trust Account, for each one-month extension, one-third of <span id="xdx_901_ecustom--PercentageOfDepositInTrustAccount_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLxcW2p92Czc" title="Percentage of deposit in trust account">1%</span>
of the funds remaining in the Trust Account following the redemptions made in connection with the approval of the extension proposal
at the Special Meeting. At the Special Meeting the Company&#8217;s stockholders also approved a proposal to amend the Company&#8217;s certificate of incorporation
to expand the methods that the Company may employ to not become subject to the &#8220;penny stock&#8221; rules of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with such proposals, the Company&#8217;s public stockholders had the right to redeem their shares for cash equal to their pro rata share of
the aggregate amount on deposit in the Trust Account as of two days prior to such stockholder vote. The Company&#8217;s public stockholders holding <span id="xdx_908_ecustom--StockIssuedDuringPeriodShareOnHold_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zfthNgs7rAS2" title="Stock issued during period on hold">11,037,272</span>
shares of Class A common stock (out of a total of <span id="xdx_90C_eus-gaap--SharesIssued_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zEwwQAWHFTDk" title="Stock issued">13,979,000</span> shares of Class A common stock) exercised their right to redeem such shares
at a redemption price of approximately $<span id="xdx_905_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_uUSDPShares_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zUyf8G0vxfT2" title="Redemption price per share">10.33</span> per share. Approximately $<span id="xdx_90A_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMw9csqjGC88" title="Number of stock redeemed, value">114</span> million in cash was removed from the Trust Account to pay
such stockholders and, accordingly, after giving effect to such redemptions, the balance in the Trust Account was approximately $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEHOMQih1FSa" title="Investments held in trust account">23</span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the approval of such proposals, the Company agreed to deposit into the Trust Account one-third of <span id="xdx_907_ecustom--PercentageOfDepositInTrustAccount_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhWKE9AFSg27" title="Percentage of deposit in trust account">1%</span> of the funds then on deposit
in the Trust Account for each month of the extension period, resulting in a monthly contribution of approximately $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxDXFbe0sO56" title="Price per share">0.035</span> per share that
was not redeemed in connection with the Special Meeting, or an aggregate of approximately $<span id="xdx_90C_eus-gaap--DepositAssets_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zboE1G94Dw8a" title="Aggregate of deposit">77,000</span> per month, and an aggregate of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlgJuuCYuK7f" title="Proceeds from business combination">924,000</span>
if the date the Company has to consummate a business combination is extended 12 times, each assuming no interest is earned on the funds in the
Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt">On March 7, 2023, the
Company entered into a $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20230306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znA5Zs4wiA3b">1.5</span>
million promissory note with the Company&#8217;s Sponsor to fund the Trust Account and for the Company&#8217;s operating expenses.
On March 7, 2023 the Company&#8217;s Sponsor advanced $<span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20230307__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJD1SUJo7Pfj" title="Sponsor advanced amount">300,000</span>
and will provide additional funds as necessary under the promissory note. These loans are non-interest bearing, unsecured and will
be repayable in full upon the earlier of (i) the date on which the Company consummates an initial business combination and (ii) the date that
the Company&#8217;s winding up is effective.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782394520304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5piLhu7ej1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z2s4oTn5D1p1">Basis
of Presentation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) as contained within the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards
Codification (&#8220;ASC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p id="xdx_84F_ecustom--EmergingGrowthCompanyPolicyTextBlock_zjC1R0hQahwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zvm2ZrWcsrtd">Emerging
Growth Company</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities
Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_845_eus-gaap--UseOfEstimates_z4nl6qfhdbFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zJelOGGc3Nml">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with US GAAP requires the Company&#8217;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVlny8JIRqsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zhzZ1uWcrlZ8">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zItSu1MAHKQb" title="Cash and cash equivalents">345,777</span> and $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_zAXyIs9fLL0l" title="Cash and cash equivalents">48,555</span> in cash as of December 31, 2022 and 2021. The Company did not have any cash equivalents
as of December 31, 2022 or December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock', window );">Investments Held in Trust Account</a></td>
<td class="text"><p id="xdx_84E_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zFxKRtwFobx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_ziy9pjH8T3Ul">Investments
Held in Trust Account</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2022 and 2021, the Company had $<span id="xdx_902_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231_zAM9IxI5iFb8" title="Assets held-in-trust, noncurrent">136,871,183</span> and <span id="xdx_906_eus-gaap--AssetsHeldInTrustNoncurrent_iI_dxL_c20211231_zHMaCXASoyL5" title="Assets held-in-trust, noncurrent::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0462">zero, respectively,</span></span> in investments held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock', window );">Offering Costs Associated With a Public Offering</a></td>
<td class="text"><p id="xdx_849_ecustom--OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_zudH8q6aDGg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z3gArUAOjrqa">Offering
Costs Associated With a Public Offering</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A
&#8212; &#8220;<i>Expenses of Offering.&#8221;</i> Offering costs of $<span id="xdx_908_ecustom--PublicOfferingCosts_c20220101__20221231_z74ORiIF3Ma7" title="Offering costs">7,738,161</span>
consisting of $<span id="xdx_90E_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220101__20221231_zMxCUY4QWAC9" title="Underwriting fees">2,645,000</span>
of underwriting fees, $<span id="xdx_904_ecustom--DeferredUnderwritingFee_c20220101__20221231_z28EFCWSEu85" title="Deferred underwriting fee">4,628,750</span>
of deferred underwriting fee (which are held in the Trust Account with Wilmington Trust Company acting as trustee),
and $<span id="xdx_906_ecustom--InitialPublicOfferingCost_c20220101__20221231_z8aumYHAK5Sg" title="Initial public offering costs">464,411</span>
of Initial Public Offering costs. Of these costs, $<span id="xdx_905_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zXUWyMRpGmOc" title="Warrant issuance cost">1,358,457</span>
and $<span id="xdx_903_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zYx1IjVJCyKe" title="Warrant issuance cost">19,656</span>
were allocated to Public Warrants (as defined in Note 3) and Private Placement Warrants (as defined in Note 4), respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text"><p id="xdx_848_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zoX2Q6Nuuvk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zyBsnjIJzmM">Class
A Common Stock Subject to Possible Redemption</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance enumerated in
ASC 480 &#8220;<i>Distinguishing Liabilities from Equity</i>&#8221;. Common stock subject to mandatory redemption is classified as a
liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature
redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events
not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, common stock is classified as
stockholders&#8217; equity. The shares of the Company&#8217;s Class A common stock feature certain redemption rights that are
considered by the Company to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022, the shares of Class A common stock subject to possible redemption in the amount of $<span id="xdx_903_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20221231_zBT9Z72q0hg5" title="Temporary equity, carrying amount, attributable to parent">136,771,183</span>
are presented as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance
sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zAAtN7Xllgck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Class A common stock subject to possible redemption reflected on the  balance sheet are reconciled
in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z2lr5YRJKgz3" style="display: none">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Gross proceeds from IPO</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220101__20220630_zBcvvUviX5xj">132,250,000</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds allocated to Public Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_c20220101__20220630_zWdMy6PlaCT2" style="text-align: right" title="Proceeds allocated to Public Warrants"><span style="font-family: Times New Roman, Times, Serif">(23,276,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--PaymentOfCommonStockIssuanceCosts_c20220101__20220630_zIxPVWPRMts7" style="text-align: right" title="Class A common stock issuance costs"><span style="font-family: Times New Roman, Times, Serif">(6,360,054</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Remeasurement
    adjustment of carrying value to redemption value</td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_c20220101__20220630_zNpPbOs9GoVf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">32,281,054</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Class A common stock subject to possible redemption, as of March 31, 2022</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220401__20220630_zBfOe0vjE2D6" style="text-align: right" title="Common stock subject to possible redemption,beginning"><span style="font-family: Times New Roman, Times, Serif">134,895,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
    of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220401__20220630_zaW7wQN58XQb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">101,767</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of June 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220701__20220930_zGEnAZuXHCS3" style="text-align: right" title="Common stock subject to possible redemption,beginning"><span style="font-family: Times New Roman, Times, Serif">134,996,767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220701__20220930_zE0IrPa6a7Hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">609,920</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of September 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20221001__20221231_zWqQDblob9tc" style="text-align: right" title="Common stock subject to possible redemption, ending"><span style="font-family: Times New Roman, Times, Serif">135,606,687</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20221001__20221231_zeBxdaBxnqU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">1,164,496</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class A common stock
    subject to possible redemption as of December 31, 2022</span> </td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--CommonStockSubjectToPossibleRedemption_iE_c20221001__20221231_zJaLl4a4Gdd2" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, ending"><span style="font-family: Times New Roman, Times, Serif">136,771,183</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_z9qdT5gxpjZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) per Common Share</a></td>
<td class="text"><p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zn0FzwpBJdvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zYQRHT7aCAC9">Net
Income (Loss) per Common Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income (loss)
per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding
for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share
as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with
the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence
of future events. As of December 31, 2022, the Company&#8217;s outstanding warrants <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iNI_pid_di_c20221231_zgDwP3Bwqh86" title="Outstanding warrants">(13,979,000)</span> have been excluded from diluted net
loss as their inclusion would be anti-dilutive. As a result, diluted net income (loss) per common share is the same as basic net income
(loss) per common share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdAkAOIxXnUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zfgvdKXe6VI1" style="display: none">SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    Since Inception to</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            A common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            B common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income
    per common share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpJakvAbgL5i" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNvmZ3n0yCh" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif">(4,381</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi0MkF0B8cG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhyfsoULUYjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif">2,875,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    income per common share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z80ASqkgnzX2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzlqgSgwVEad" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif">(0.00</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the Year Ended</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    A common stock</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    B common stock </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic
    and diluted net loss per common share</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation
    of net income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zelEscxqJxXj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,560</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwAq2pxVG2qj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,079</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted weighted average shares outstanding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjZmhKJzYDsj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,558,058</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWshQ7fU0va" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,306,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per common share</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziECzwENsQN2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;0.03
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMFMgISDwU08" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;0.03
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zRriBmV9v45d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zpJvohATqhyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zbSXj7JbaAnb">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zGoKsW9Q3Ku" title="Unrecognized tax benefits"><span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zrOfsYFfHLYk" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zFgAyY9FX99k" title="Income tax penalties and interest accrued"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_zWXhhtgX9265" title="Income tax penalties and interest accrued">no</span></span> amounts accrued for interest and penalties as of December 31, 2022
or December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals
or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified the United States and California as its only tax jurisdictions. The Company is subject to income taxation by major
taxing authorities since inception. All tax periods are open to examination by tax authorities. These examinations may include questioning
the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws.
The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next
twelve months. The Company actual tax expense differs from the expected tax expense due to the change in the valuation allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zrB7CsIHY3Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z5P8XqvPQWC5">Concentration
of Credit Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to credit risk consist principally of cash and investments held in the Trust Account.
Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal Depository Insurance Corporation coverage
limit of $<span id="xdx_902_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_c20220101__20221231_z7VwwBJMlLpf" title="Federal deposit insurance corporation premium expense">250,000</span>, and investments held in the Trust Account. As of December 31, 2022 and 2021, the Company had not experienced
losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_InvestmentHeldInTrustAccountPolicyTextBlock', window );">Investments Held in Trust Account</a></td>
<td class="text"><p id="xdx_84D_ecustom--InvestmentHeldInTrustAccountPolicyTextBlock_z6YuSdd0hoJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zh45SLpsh3hb">Investments
Held in Trust Account</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Investments held in the Trust Account were $<span id="xdx_905_eus-gaap--AssetsHeldInTrust_iI_c20221231_zik71MYja2A3" title="Investments held in trust">136,871,183</span>
at December 31, 2022 and <span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_pn5n6_dc_c20211231_zcEi6YD5K7kg" title="Investments held in trust">zero</span>
as of December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government
securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held
in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s
investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities
and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account
in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using
available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zc1MdaksWCJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zQyJQZeygsM3">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value Measurements&#8221;
approximates the carrying amounts represented in the balance sheet, partially due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesReportingOfDerivativeActivity', window );">Derivative Financial Instruments</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--DerivativesReportingOfDerivativeActivity_zf24iZVNypg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zQwdV4WDP7A3">Derivative
Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each
reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_WarrantInstrumentsPolicyTextBlock', window );">Warrant Instruments</a></td>
<td class="text"><p id="xdx_841_ecustom--WarrantInstrumentsPolicyTextBlock_zTPTyDfseDVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z02RYyXYP4i3">Warrant
Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants in accordance with the guidance contained in FASB ASC 815, &#8220;Derivatives and Hedging&#8221;.
Under ASC 815-40 warrants that meet the criteria for equity treatment are recorded in stockholders&#8217; equity (deficit). The warrants are
subject to re-evaluation of the proper classification and accounting treatment at each reporting period. If the warrants no longer
meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the
statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z3cMEn6mP34e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zItt09U2ct97">Recent
Accounting Standards</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on the Company&#8217;s financial statements.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_InvestmentHeldInTrustAccountPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Held In Trust Account [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_InvestmentHeldInTrustAccountPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments Held In Trust Account [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering Costs Associated With Public Offering [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_WarrantInstrumentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Instruments [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_WarrantInstrumentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesReportingOfDerivativeActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesReportingOfDerivativeActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782475716320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock', window );">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zAAtN7Xllgck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Class A common stock subject to possible redemption reflected on the  balance sheet are reconciled
in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z2lr5YRJKgz3" style="display: none">SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Gross proceeds from IPO</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220101__20220630_zBcvvUviX5xj">132,250,000</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Less:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proceeds allocated to Public Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_c20220101__20220630_zWdMy6PlaCT2" style="text-align: right" title="Proceeds allocated to Public Warrants"><span style="font-family: Times New Roman, Times, Serif">(23,276,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--PaymentOfCommonStockIssuanceCosts_c20220101__20220630_zIxPVWPRMts7" style="text-align: right" title="Class A common stock issuance costs"><span style="font-family: Times New Roman, Times, Serif">(6,360,054</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Remeasurement
    adjustment of carrying value to redemption value</td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_c20220101__20220630_zNpPbOs9GoVf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">32,281,054</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Class A common stock subject to possible redemption, as of March 31, 2022</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220401__20220630_zBfOe0vjE2D6" style="text-align: right" title="Common stock subject to possible redemption,beginning"><span style="font-family: Times New Roman, Times, Serif">134,895,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
    of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220401__20220630_zaW7wQN58XQb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">101,767</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of June 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220701__20220930_zGEnAZuXHCS3" style="text-align: right" title="Common stock subject to possible redemption,beginning"><span style="font-family: Times New Roman, Times, Serif">134,996,767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220701__20220930_zE0IrPa6a7Hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">609,920</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Class A common stock subject to possible
    redemption as of September 30, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20221001__20221231_zWqQDblob9tc" style="text-align: right" title="Common stock subject to possible redemption, ending"><span style="font-family: Times New Roman, Times, Serif">135,606,687</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Plus:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remeasurement adjustment
of carrying value to redemption value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20221001__20221231_zeBxdaBxnqU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"><span style="font-family: Times New Roman, Times, Serif">1,164,496</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Class A common stock
    subject to possible redemption as of December 31, 2022</span> </td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--CommonStockSubjectToPossibleRedemption_iE_c20221001__20221231_zJaLl4a4Gdd2" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, ending"><span style="font-family: Times New Roman, Times, Serif">136,771,183</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdAkAOIxXnUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zfgvdKXe6VI1" style="display: none">SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Period
    Since Inception to</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            A common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class
                                            B common</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">stock</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income
    per common share</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allocation
    of net loss</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpJakvAbgL5i" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNvmZ3n0yCh" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif">(4,381</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares
    outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi0MkF0B8cG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhyfsoULUYjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif">2,875,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net
    income per common share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z80ASqkgnzX2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzlqgSgwVEad" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif">(0.00</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the Year Ended</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    A common stock</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
    B common stock </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basic
    and diluted net loss per common share</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation
    of net income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zelEscxqJxXj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,560</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwAq2pxVG2qj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,079</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted weighted average shares outstanding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjZmhKJzYDsj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,558,058</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWshQ7fU0va" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,306,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per common share</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziECzwENsQN2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;0.03
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMFMgISDwU08" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;0.03
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Common Stock Subject To Possible Redemption [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782544396160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zu2TxWQCc0A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value at December 31,
2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_z2pylKwhXTJe" style="display: none">SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_496_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0Mjy4Tf55Eb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsAbstract_iB_zoOkDuDLTXvj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zHZWkQ1kdbY2" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investments held in Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">136,871,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399797248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zdlxj36gAKF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected tax expense based on the statutory rate is reconciled with actual tax expense as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span id="xdx_8BE_zegrbkaZkNY" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20220101__20221231_ztBO9JiSAqB" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Year
    Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zpiP2iCHC56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">U.S.
    federal statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_zvGp5IACUHr4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">State
    taxes, net of federal benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zZPiAqn7dbB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27.36</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zeVDLX67TYl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif">Income
    tax provision</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48.46</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zXgh0p8Lvp01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zWmmuSHGaLTh" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span> </span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20221231_zjXfeH5w61Pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNetAbstract_iB_z5EO900vwzIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpense_i01I_msDTAGzZX3_zFPjgyXFWaP3" style="vertical-align: bottom; background-color: White">
    <td style="width: 81%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Startup
    costs</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">211,627</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_i01TI_maDTANznat_mtDTAGzZX3_zJtetEhhZ59k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">211,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"/></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_di_msDTANznat_zykPUm3eeTcg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation Allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(211,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01TI_mtDTANznat_zakgSTSosEUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF CHANGE IN VALUATION</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlDQRPDVQMmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;SCHEDULE
OF CHANGE IN VALUATION</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zjd2Zov0DUK8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_ztbOTcYfa2R4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 81%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_iN_di_zMATFmWpeVA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">374,862<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_zbbOudZnaMzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(211,627</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_zj5vWIJN2Zi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State and
    Local</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zgyPTYBnm8Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_z7DPciRMrj09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_z6zOhjx3JZs2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in
    valuation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">211,627</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_z9vkKwAn6fkk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income Tax Provision</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">374,862</td><td style="font-size: 10pt; text-align: left"/></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782394494000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 08, 2022</div></th>
<th class="th"><div>Feb. 07, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from isssuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 132,250,000<span></span>
</td>
<td class="nump">$ 132,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,628,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationControlObtainedDescription', window );">Business combination description of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions
and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of
1940, as amended (the &#8220;Investment Company Act&#8221;). Upon the closing of the Initial Public Offering, management has agreed that
an amount equal to at least $10.00 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants,
will be held in a trust account (&#8220;Trust Account&#8221;), located in the United States and invested only in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended
investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the
distribution of the funds held in the Trust Account, as described below.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsRestrictions', window );">Retained earnings restrictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more
than an aggregate of 15% of the Public Shares, without the prior consent of the Company.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument redemption price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=MURFU_BusinessCombinationAgreementMember', window );">Business Combination Agreement [Member] | Conduit Pharmaceuticals Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued</a></td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=MURFU_SubscriptionAgreementsMember', window );">Subscription Agreements [Member] | Conduit Pharmaceuticals Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued</a></td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=MURFU_TransactionAgreementMember', window );">Transaction Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationControlObtainedDescription', window );">Business combination description of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) $10.00 per Public Share or (ii) such
lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00
per public Share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn
to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account
and except as to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period shares new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from isssuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,225,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds from shares issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_OverfundingOfTheTrustAccount', window );">Overfunding of the trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_OperatingCashAccount', window );">Operating cash account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_OperatingCashAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating cash account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_OperatingCashAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_OverfundingOfTheTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Overfunding of the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_OverfundingOfTheTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationControlObtainedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents a description of how the entity obtained control of the acquired entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationControlObtainedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsRestrictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Terms of any restriction upon retained earnings. This may include restrictions that arise from: (1) the aggregate preferences of the preferred shares exceeding the par or stated value of such shares upon liquidation; (2) dividend restrictions - for example, restrictions on the payment of dividends, indicating the source, the pertinent provision, and the amount of retained earnings or net income restricted or free of restrictions; (3) other appropriations; (4) any restrictions on distributions to shareholders; (5) retained earnings appropriated for loss contingencies; and (6) the amount of consolidated earnings which represents undistributed earnings of 50 percent or less owned by persons accounted for by the equity method, (7) state laws that govern circumstances under which corporations may acquire its own stock and on the availability of retained earnings for payment of dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21332-112643<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsRestrictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=MURFU_BusinessCombinationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=MURFU_BusinessCombinationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=MURFU_ConduitPharmaceuticalsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=MURFU_ConduitPharmaceuticalsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=MURFU_SubscriptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=MURFU_SubscriptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=MURFU_TransactionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=MURFU_TransactionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399884592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Issuance Initial Public Offering</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,250,000<span></span>
</td>
<td class="nump">$ 132,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts', window );">Proceeds allocated to Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,276,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_PaymentOfCommonStockIssuanceCosts', window );">Class A common stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,360,054)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment', window );">Remeasurement adjustment of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,281,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_CommonStockSubjectToPossibleRedemption', window );">Common stock subject to possible redemption, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,606,687<span></span>
</td>
<td class="nump">$ 134,996,767<span></span>
</td>
<td class="nump">$ 134,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Remeasurement adjustment of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,164,496<span></span>
</td>
<td class="nump">609,920<span></span>
</td>
<td class="nump">101,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_CommonStockSubjectToPossibleRedemption', window );">Common stock subject to possible redemption, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136,771,183<span></span>
</td>
<td class="nump">$ 135,606,687<span></span>
</td>
<td class="nump">$ 134,996,767<span></span>
</td>
<td class="nump">$ 134,996,767<span></span>
</td>
<td class="nump">$ 136,771,183<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_CommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_CommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_PaymentOfCommonStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_PaymentOfCommonStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds allocated to public warrants, net of offering cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity accretion to original redemption value adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782395762736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Allocation of net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 315,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,558,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net loss per common share</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Allocation of net loss</a></td>
<td class="num">$ (4,381)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 83,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="nump">2,875,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net loss per common share</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes
    an aggregate of up to <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9R4rmUGX3I7" title="Number of option issued for forfeiture">431,250</span> shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised
    in full or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such,
    the Class B common stock is no longer subject to forfeiture (see Notes 5 and 6).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On
    January 26, 2022, the Sponsor surrendered and forfeited <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zNxtqdOMKVt5" title="Stock surrendered and forfeited during period shares">1,006,250</span> founder shares for no consideration following which the Sponsor
    holds <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zyA2yNai3ox4" title="Stock issued during period on hold">3,306,250</span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782400510512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 345,777<span></span>
</td>
<td class="nump">$ 48,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held-in-trust, noncurrent</a></td>
<td class="nump">136,871,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_PublicOfferingCosts', window );">Offering costs</a></td>
<td class="nump">7,738,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees', window );">Underwriting fees</a></td>
<td class="nump">2,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="nump">4,628,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_InitialPublicOfferingCost', window );">Initial public offering costs</a></td>
<td class="nump">464,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, carrying amount, attributable to parent</a></td>
<td class="nump">$ 136,771,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding warrants</a></td>
<td class="num">(13,979,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Income tax penalties and interest accrued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalDepositInsuranceCorporationPremiumExpense', window );">Federal deposit insurance corporation premium expense</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Investments held in trust</a></td>
<td class="nump">136,871,183<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=MURFU_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_WarrantIssuanceCost', window );">Warrant issuance cost</a></td>
<td class="nump">1,358,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_WarrantIssuanceCost', window );">Warrant issuance cost</a></td>
<td class="nump">$ 19,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_InitialPublicOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial public offering cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_InitialPublicOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_PublicOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_PublicOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_WarrantIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant issuance cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_WarrantIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense related to distribution, servicing and underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalDepositInsuranceCorporationPremiumExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalDepositInsuranceCorporationPremiumExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=MURFU_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=MURFU_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782395747184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 16, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="nump">13,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Class A [Member] | Public Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=MURFU_PublicWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=MURFU_PublicWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782399831216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 07, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 7,540,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of units transferred to director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued for private sale</a></td>
<td class="nump">754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,540,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Capital Unit, Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CapitalUnitClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CapitalUnitClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782395284544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2022</div></th>
<th class="th"><div>Jan. 26, 2022</div></th>
<th class="th"><div>Jan. 26, 2022</div></th>
<th class="th"><div>Nov. 16, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 04, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued to sponsor, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 7,520,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,057<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SponsorFees', window );">Sponsor fees</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Monthly payment for office space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_AdministrationFeeRelatedParty', window );">Administration fee related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Notes payable converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_WorkingCapitalLoan', window );">Working capital loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=MURFU_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Stock surrendered and forfeited during period shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,006,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_StockIssuedDuringPeriodSharesOnHold', window );">Stock issued during period on hold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=MURFU_SponsorMember', window );">Sponsor [Member] | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of private placement units, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued to sponsor, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    an aggregate of up to <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSlF8GRYa24f" title="Number of option issued for forfeiture">431,250</span> shares of Common stock subject to forfeiture if the over-allotment option is not exercised in full
    or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such, the Class
    B common stock is no longer subject to forfeiture (see Notes 5 and 6).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On
    January 26, 2022, the Sponsor surrendered and forfeited <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zQctBQNw3rp9" title="Stock surrendered and forfeited during period shares">1,006,250</span> founder shares for no consideration following which the Sponsor
    holds <span class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_z89iBBfkzGP3" title="Stock issued during period on hold">3,306,250</span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_AdministrationFeeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Administration fee related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_AdministrationFeeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_StockIssuedDuringPeriodSharesOnHold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares on hold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_StockIssuedDuringPeriodSharesOnHold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SponsorFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SponsorFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=MURFU_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=MURFU_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782398896960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_OptionExercisedDate', window );">Option exercised date</a></td>
<td class="text">Feb.  07,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_CashUnderwritingDiscount', window );">Cash underwriting discount | $ / shares</a></td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_UnderwritingDiscount', window );">Underwriting discount</a></td>
<td class="nump">$ 2,645,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_DeferredFeePerShare', window );">Deferred fee per share | $ / shares</a></td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred fee</a></td>
<td class="nump">$ 4,628,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_UnderwriterExpenses', window );">Underwriter expenses</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of private placement units, net of offering costs | shares</a></td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=MURFU_UnderwriterMember', window );">Underwriter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_AdvancePaymentForUnderwriterExpenses', window );">Advance payment for underwriter expenses</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_AdvancePaymentForUnderwriterExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance payment for underwriter expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_AdvancePaymentForUnderwriterExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_CashUnderwritingDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash underwriting discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_CashUnderwritingDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_DeferredFeePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred fee per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_DeferredFeePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_OptionExercisedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option exercised date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_OptionExercisedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_UnderwriterExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriter expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_UnderwriterExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_UnderwritingDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_UnderwritingDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=MURFU_UnderwriterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=MURFU_UnderwriterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782402134784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares', window );">Shares subject to possible redemption</a></td>
<td class="nump">13,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per shares | $ / shares</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember', window );">Private Placement Warrants And Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants | $</a></td>
<td class="nump">$ 23,276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember', window );">Private Placement Warrants And Public Warrants [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant expected term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember', window );">Private Placement Warrants And Public Warrants [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant measurement inputs</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember', window );">Private Placement Warrants And Public Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant measurement inputs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember', window );">Private Placement Warrants And Public Warrants [Member] | Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant measurement inputs</a></td>
<td class="nump">1.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Voting rights</a></td>
<td class="text">Holders of Class A common stock are entitled to one vote for each share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">754,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">754,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares', window );">Shares subject to possible redemption</a></td>
<td class="nump">13,225,000<span></span>
</td>
<td class="nump">13,225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">3,306,250<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">3,306,250<span></span>
</td>
<td class="nump">3,306,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782398329664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">$ 136,871,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">$ 136,871,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782396016512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in trust account</a></td>
<td class="nump">$ 136,871,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_FinancialServiceMember', window );">Financial Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_FinancialServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_FinancialServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782403613360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">27.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="nump">48.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782398986000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpense', window );">Startup costs</a></td>
<td class="nump">$ 211,627<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">211,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation Allowance</a></td>
<td class="num">(211,627)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782398831376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CHANGE IN VALUATION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 374,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211,627)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Change in valuation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Provision</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 374,862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782404290240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782395506784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 07, 2023</div></th>
<th class="th"><div>Jan. 26, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 06, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 04, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Redemption price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Number of stock redeemed, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,876,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136,871,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_PercentageOfDepositInTrustAccount', window );">Percentage of deposit in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Number of stock redeemed, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Aggregate of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Proceeds from business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 924,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Sponsor advanced amount</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_PercentageOfDepositInTrustAccount', window );">Percentage of deposit in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MURFU_StockIssuedDuringPeriodShareOnHold', window );">Stock issued during period on hold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,037,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,979,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Redemption price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_PercentageOfDepositInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of deposit in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_PercentageOfDepositInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MURFU_StockIssuedDuringPeriodShareOnHold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares on hold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MURFU_StockIssuedDuringPeriodShareOnHold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MURFU_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>forms-4_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:MURFU="http://bloomberg.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="murfu-20221231.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-10-192021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-10-192021-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-10-192021-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-02-062022-02-07_us-gaap_OverAllotmentOptionMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-06</startDate>
            <endDate>2022-02-07</endDate>
        </period>
    </context>
    <context id="From2022-01-252022-01-26_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MURFU:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-25</startDate>
            <endDate>2022-01-26</endDate>
        </period>
    </context>
    <context id="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-18</instant>
        </period>
    </context>
    <context id="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-18</instant>
        </period>
    </context>
    <context id="AsOf2021-10-18_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-18</instant>
        </period>
    </context>
    <context id="AsOf2021-10-18_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-18</instant>
        </period>
    </context>
    <context id="AsOf2021-10-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <instant>2021-10-18</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-10-192021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-10-192021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-02-062022-02-07_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-06</startDate>
            <endDate>2022-02-07</endDate>
        </period>
    </context>
    <context id="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-06</startDate>
            <endDate>2022-02-07</endDate>
        </period>
    </context>
    <context id="AsOf2022-02-07_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-07</instant>
        </period>
    </context>
    <context id="From2022-11-072022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">MURFU:ConduitPharmaceuticalsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-07</startDate>
            <endDate>2022-11-08</endDate>
        </period>
    </context>
    <context id="AsOf2022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">MURFU:ConduitPharmaceuticalsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-08</instant>
        </period>
    </context>
    <context id="From2022-11-072022-11-08_custom_SubscriptionAgreementsMember_custom_ConduitPharmaceuticalsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">MURFU:ConduitPharmaceuticalsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-07</startDate>
            <endDate>2022-11-08</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TransactionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MURFU:TransactionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="From2022-10-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassAMember_custom_PublicWarrantMember_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CapitalUnitClassAMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CapitalUnitClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-11-142021-11-16_custom_SponsorMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MURFU:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-14</startDate>
            <endDate>2021-11-16</endDate>
        </period>
    </context>
    <context id="From2022-01-242022-01-26_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MURFU:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-24</startDate>
            <endDate>2022-01-26</endDate>
        </period>
    </context>
    <context id="AsOf2021-11-16_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-16</instant>
        </period>
    </context>
    <context id="AsOf2021-11-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <instant>2021-11-04</instant>
        </period>
    </context>
    <context id="From2022-02-092022-02-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-10</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UnderwriterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MURFU:UnderwriterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MURFU:PrivatePlacementWarrantsAndPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FinancialServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-252023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-25</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="From2023-01-252023-01-26_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-25</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-26_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="AsOf2023-03-06_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-06</instant>
        </period>
    </context>
    <context id="From2023-03-072023-03-07_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001896212</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-07</startDate>
            <endDate>2023-03-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-12-31">0001896212</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-12-31">false</dei:AmendmentFlag>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0052"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0068"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0070"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:DeferredCommissionPayableNonCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0082"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0086"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0095"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0096"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0159"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:AdministrationFeeRelatedParty
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0184"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0199"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0202"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-10-18_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0222"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-10-18_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0223"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0226"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-10-18_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0228"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-10-192021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0233"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0239"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-10-192021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0240"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0244"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0250"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0263"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0323"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0347"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-10-18"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:DeferredOfferingCostsIncludedInAccruedOfferingCosts
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:PrepaidExpensesPaidByNotePayable
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:DeferredOfferingCostsPaidByNotePayable
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:DeferredUnderwritingCommissionPayable
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <MURFU:ClassASharesSubjectToRedemption
      contextRef="From2021-10-192021-12-31"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0515"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0519"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0728"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0740"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0742"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-12-31">S-4</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-12-31">MURPHY CANYON ACQUISITION CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-12-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-12-31">87-3272543</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-12-31">4995 Murphy Canyon Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-12-31">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-12-31">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-12-31">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-12-31">92123</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-12-31">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-12-31">471-8536</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">Jack K. Heilbron</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">4995 Murphy Canyon Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">92123</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-012022-12-31_dei_BusinessContactMember">471-8536</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-12-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-01-01to2022-12-31">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">345777</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">48555</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">300862</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">55608</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">646639</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">104163</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">136871183</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:DeferredCosts contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">108962</us-gaap:DeferredCosts>
    <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">137517822</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">213125</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">43113</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15449</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">374862</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">177057</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">417975</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">192506</us-gaap:LiabilitiesCurrent>
    <MURFU:DeferredCommissionPayableNonCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">4628750</MURFU:DeferredCommissionPayableNonCurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">5046725</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">192506</us-gaap:Liabilities>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">13225000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">10.34</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">136771183</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">13225000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">13225000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">75</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">331</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">331</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24669</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-4300492</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-4381</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-4300086</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">20619</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">137517822</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">213125</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1092682</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">4381</us-gaap:GeneralAndAdministrativeExpense>
    <MURFU:AdministrationFeeRelatedParty
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">110000</MURFU:AdministrationFeeRelatedParty>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-1202682</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">-4381</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1976183</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1976183</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">773501</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">-4381</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">374862</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">398639</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">-4381</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">12558058</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">2875000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000207"
      unitRef="Shares">2875000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-02-062022-02-07_us-gaap_OverAllotmentOptionMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">431250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2022-01-252022-01-26_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1006250</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <MURFU:StockIssuedDuringPeriodShareOnHold
      contextRef="From2022-01-252022-01-26_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">3306250</MURFU:StockIssuedDuringPeriodShareOnHold>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000236"
      unitRef="Shares">3306250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="0"
      id="Fact000231"
      unitRef="USD">331</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-10-192021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000232"
      unitRef="USD">24669</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      id="Fact000234"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-10-192021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-4381</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">-4381</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">331</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">24669</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-4381</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">20619</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">21917543</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">21917543</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">75</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">7520275</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">7520350</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">29462487</MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo>
    <MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">2818567</MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo>
    <MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">32281054</MURFU:AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">1876183</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1876183</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">398639</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">398639</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">398639</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">398639</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">75</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">331</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-4300492</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-4300086</us-gaap:StockholdersEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-02-062022-02-07_us-gaap_OverAllotmentOptionMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">431250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2022-01-252022-01-26_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1006250</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <MURFU:StockIssuedDuringPeriodShareOnHold
      contextRef="From2022-01-252022-01-26_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">3306250</MURFU:StockIssuedDuringPeriodShareOnHold>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">398639</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">-4381</us-gaap:NetIncomeLoss>
    <MURFU:FormationCostsPaidByNotePayableSponsor
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">3994</MURFU:FormationCostsPaidByNotePayableSponsor>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1976183</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">108962</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">245254</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">5608</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">27664</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">374862</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-1311310</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">-5995</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">134895000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-134895000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">45450</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">75000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">132250000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">7540000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">3109411</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">177057</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">136503532</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">54550</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">297222</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">48555</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">48555</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">345777</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">48555</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <MURFU:DeferredOfferingCostsIncludedInAccruedOfferingCosts
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">15449</MURFU:DeferredOfferingCostsIncludedInAccruedOfferingCosts>
    <MURFU:PrepaidExpensesPaidByNotePayable
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">50000</MURFU:PrepaidExpensesPaidByNotePayable>
    <MURFU:DeferredOfferingCostsPaidByNotePayable
      contextRef="From2021-10-192021-12-31"
      decimals="0"
      unitRef="USD">47875</MURFU:DeferredOfferingCostsPaidByNotePayable>
    <MURFU:DeferredUnderwritingCommissionPayable
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">4628750</MURFU:DeferredUnderwritingCommissionPayable>
    <MURFU:ClassASharesSubjectToRedemption
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">136771183</MURFU:ClassASharesSubjectToRedemption>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zEJHUe1aB8Db" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2014; &lt;span id="xdx_82C_z0Smo3N7JC28"&gt;DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Murphy
Canyon Acquisition Corp. (the &#x201c;Company&#x201d;) was incorporated in Delaware on October 19, 2021. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company is not limited to a particular industry or sector for
purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company
is subject to all of the risks associated with early stage and emerging growth companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Company had not commenced any operations. All activity for the period from October 19, 2021 (inception) through
December 31, 2022 relates to the Company&#x2019;s formation, the proposed initial public offering (&#x201c;Initial Public Offering&#x201d;),
which is described below, and searching for an initial Business Combination, as defined below. The Company will not generate any operating revenues until
after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form
of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year
end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s Initial Public Offering (the &#x201c;Registration Statement&#x201d;) was declared effective
on February 2, 2022. On February 7, 2022, the Company consummated the Initial Public Offering of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zdwwo7ZGbCh4" title="Stock issued during period shares new issues"&gt;13,225,000&lt;/span&gt; units (&#x201c;Units&#x201d;), generating gross proceeds
of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zL2WaGa4E2M7" title="Proceeds from isssuance"&gt;132,250,000&lt;/span&gt;, which is described in Note 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zWykxjFP54t7" title="Sale of stock"&gt;754,000&lt;/span&gt;
units (the &#x201c;Private Placement Units&#x201d;) at a price of $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zck7Zm2CBKw5" title="Sale of stock price per share"&gt;10.00&lt;/span&gt;
per Private Placement Unit in private placements to Murphy Canyon Acquisition Sponsor LLC (the &#x201c;Sponsor&#x201d;), with gross
proceeds of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zWm4NK8UNSpa" title="Gross proceeds from shares issuance"&gt;7,540,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on February 7, 2022, an amount of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSVGw2JzzYL3" title="Net proceeds from sale of equity"&gt;139,790,000&lt;/span&gt; from the net proceeds of the sale of the Units
in the Initial Public Offering and the Private Placement Units was placed in the Trust Account, as defined below. This resulted in an
overfunding of the Trust Account of $&lt;span id="xdx_90B_ecustom--OverfundingOfTheTrustAccount_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z89Qs2fzbYO2" title="Overfunding of the trust account"&gt;4,895,000&lt;/span&gt;. As such, subsequent to the initial funding of the Trust Account, $&lt;span id="xdx_901_ecustom--OperatingCashAccount_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zmUslQpYtNZe" title="Operating cash account"&gt;2,000,000&lt;/span&gt; was transferred
to the Company&#x2019;s operating cash account and $&lt;span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_c20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7NNEFbLp1od" title="Offering costs"&gt;2,895,000&lt;/span&gt; was used to pay offering costs. The funds held in the Trust Account may
be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as
amended (the &#x201c;Investment Company Act&#x201d;), with a maturity of 185 days or less or in any open-ended investment company that
holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as
determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account,
as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 8, 2022, the Company entered into a definitive Business Combination Agreement (the &#x201c;BCA&#x201d;) with Conduit Pharmaceuticals
Limited, a Cayman Islands exempted company (&#x201c;Conduit&#x201d;), and Conduit Merger Sub, Inc., a Cayman Islands exempted company (&#x201c;Merger
Sub&#x201d;). Merger Sub is a wholly owned subsidiary of the Company. Conduit is a pharmaceutical company led by experienced pharma executives,
established to fund the development of successful deprioritized clinical assets licensed from large pharmaceutical companies through
its exclusive relationships. The BCA was amended in January 2023, see Note 10 for additional information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the consummation of the transactions contemplated by the BCA, Merger Sub will merge with and into Conduit, with Conduit surviving as
a wholly owned subsidiary of the Company (the &#x201c;Business Combination&#x201d;). The Company is expected to be renamed Conduit Pharmaceuticals
Inc. at the closing of the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the BCA, at the closing, the Company shall issue and deliver to the shareholders of Conduit an aggregate number of shares of the Company&#x2019;s
common stock with an aggregate value equal to $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20221107__20221108__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zXEgmZpeRXyd" title="Shares issued"&gt;650,000,000&lt;/span&gt;, with each share valued at $&lt;span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20221108__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zV4CvPhmoVkd" title="Share price"&gt;10.00&lt;/span&gt; per share. A private placement transaction
shall be conducted by the Company contemporaneously with the Business Combination (the &#x201c;PIPE Financing&#x201d;), pursuant to which
the Company has entered into subscription agreements providing for aggregate investments in the Company&#x2019;s securities of $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20221107__20221108__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--ConduitPharmaceuticalsLimitedMember_zjjSm9LoeISg" title="Shares issued"&gt;27,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
can be no assurance that the Business Combination or PIPE Financing will occur as planned or at all.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
&lt;span id="xdx_904_eus-gaap--BusinessCombinationControlObtainedDescription_c20220101__20221231_zgytHUl17Jm1" title="Business combination description of transaction"&gt;The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions
and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of
1940, as amended (the &#x201c;Investment Company Act&#x201d;). Upon the closing of the Initial Public Offering, management has agreed that
an amount equal to at least $10.00 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants,
will be held in a trust account (&#x201c;Trust Account&#x201d;), located in the United States and invested only in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended
investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the
distribution of the funds held in the Trust Account, as described below.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide the holders of the outstanding Public Shares (the &#x201c;Public Stockholders&#x201d;) with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (net of taxes payable). There will be no redemption
rights upon the completion of a Business Combination with respect to the Company&#x2019;s warrants. All of the Public Shares contain a
redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder
vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and
restated certificate of incorporation. In accordance with U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and its guidance
on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a
company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be
issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as
temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Class A common stock is subject to ASC
480-10-S99. If it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in
the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become
redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately
as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We
have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction
to retained earnings, or in absence of retained earnings, additional paid-in capital). The Public Shares are redeemable and will be classified
as such on the balance sheet until such date that a redemption event takes place.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority
of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange
rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide
to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation
(the &#x201c;Certificate of Incorporation&#x201d;), conduct the redemptions pursuant to the tender offer rules of the (&#x201c;SEC&#x201d;)
and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction
is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business
or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not
pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor
has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering
in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting,
and if they do vote, irrespective of whether they vote for or against the proposed transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section 13 of &lt;span id="xdx_903_eus-gaap--RetainedEarningsRestrictions_c20220101__20221231_zFWVJCI5L5E7" title="Retained earnings restrictions"&gt;the Securities
Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to more
than an aggregate of 15% of the Public Shares, without the prior consent of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares have agreed (a) to waive their redemption rights with respect to the Founder Shares and Public Shares held
by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation
(i) to modify the substance or timing of the Company&#x2019;s obligation to allow redemptions in connection with a Business Combination
or to redeem &lt;span id="xdx_907_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20220101__20221231_zq7fVaZW2R2h" title="Debt instrument redemption price percentage"&gt;100%&lt;/span&gt; of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined
below) or (ii) with respect to any other provision relating to stockholders&#x2019; rights or pre-business combination activity, unless
the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company has not completed a Business Combination within 12 months from the consummation of our initial public offering (or up to
February 7, 2024 at the election of the Company subject to satisfaction of certain conditions, as amended at the January 2023 Special
Meeting, see Note 10) (&#x201c;Business Combination Period&#x201d;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account
and not previously released to pay taxes (less up to $&lt;span id="xdx_90C_eus-gaap--InterestExpense_c20220101__20221231_zNDqVrzGlcQe" title="Interest expense"&gt;100,000&lt;/span&gt; of interest to pay dissolution expenses), divided by the number of then
outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#x2019; rights as stockholders (including the
right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Company&#x2019;s remaining stockholders and the Company&#x2019;s board of directors, dissolve and liquidate,
subject in each case to the Company&#x2019;s obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. Our Sponsor has committed to provide additional funds if needed to make such a deposit for the extensions. There
will be no redemption rights or liquidating distributions with respect to the Company&#x2019;s warrants, which will expire worthless if
the Company fails to complete a Business Combination within the Combination Period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founders Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails
to complete a Business Combination within the Combination Period. However, if the holders of Founder Shares acquire Public Shares in
or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the
Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to
their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination
within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will
be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value
of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9JF2QNb4Rsf" title="Share issued price per share"&gt;10.00&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below &lt;span id="xdx_905_eus-gaap--BusinessCombinationControlObtainedDescription_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zSvn4B3UPk4a" title="Business combination description of transaction"&gt;(i) $10.00 per Public Share or (ii) such
lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00
per public Share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn
to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account
and except as to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;/span&gt; Moreover, in the event that an
executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability
for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account
due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company&#x2019;s independent registered
accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the
Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Management&#x2019;s
Plan and Going Concern&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Company&#x2019;s assessment of going concern considerations in accordance with Accounting Standards Update (&#x201c;ASU&#x201d;)
2014-15, &#x201c;Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern,&#x201d; management has determined
that the Combination Period is less than one year from the date of the issuance of the financial statements. There is no assurance that
the Company&#x2019;s plans to consummate a Business Combination will be successful within the Combination Period. Additionally, the Company has incurred and expects to continue to incur
significant costs in pursuit of its acquisition plans. As a result, these factors
raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for the next twelve months from the issuance
of these financial statements. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Risks
and Uncertainties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#x2019;s financial position, results of its operations, and search for a target company, the specific
impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-02-062022-02-07_us-gaap_IPOMember"
      decimals="INF"
      unitRef="Shares">13225000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-02-062022-02-07_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">132250000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-02-07_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">7540000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-02-062022-02-07_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">139790000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <MURFU:OverfundingOfTheTrustAccount
      contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">4895000</MURFU:OverfundingOfTheTrustAccount>
    <MURFU:OperatingCashAccount
      contextRef="From2022-02-062022-02-07_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">2000000</MURFU:OperatingCashAccount>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2022-02-07_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">2895000</us-gaap:DeferredOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-11-072022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember"
      decimals="0"
      unitRef="USD">650000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-11-08_custom_BusinessCombinationAgreementMember_custom_ConduitPharmaceuticalsLimitedMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-11-072022-11-08_custom_SubscriptionAgreementsMember_custom_ConduitPharmaceuticalsLimitedMember"
      decimals="0"
      unitRef="USD">27000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:BusinessCombinationControlObtainedDescription contextRef="From2022-01-01to2022-12-31">The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions
and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of
1940, as amended (the &#x201c;Investment Company Act&#x201d;). Upon the closing of the Initial Public Offering, management has agreed that
an amount equal to at least $10.00 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants,
will be held in a trust account (&#x201c;Trust Account&#x201d;), located in the United States and invested only in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended
investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the
distribution of the funds held in the Trust Account, as described below.</us-gaap:BusinessCombinationControlObtainedDescription>
    <us-gaap:RetainedEarningsRestrictions contextRef="From2022-01-01to2022-12-31">the Securities
Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to more
than an aggregate of 15% of the Public Shares, without the prior consent of the Company.</us-gaap:RetainedEarningsRestrictions>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:InterestExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">100000</us-gaap:InterestExpense>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:BusinessCombinationControlObtainedDescription contextRef="From2022-01-012022-12-31_custom_TransactionAgreementMember">(i) $10.00 per Public Share or (ii) such
lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00
per public Share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn
to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account
and except as to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).</us-gaap:BusinessCombinationControlObtainedDescription>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_z1tfUPZXcHU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2014; &lt;span id="xdx_82D_zayDyBGeuz2h"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5piLhu7ej1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_z2s4oTn5D1p1"&gt;Basis
of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (&#x201c;GAAP&#x201d;) as contained within the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards
Codification (&#x201c;ASC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--EmergingGrowthCompanyPolicyTextBlock_zjC1R0hQahwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zvm2ZrWcsrtd"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities
Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--UseOfEstimates_z4nl6qfhdbFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zJelOGGc3Nml"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with US GAAP requires the Company&#x2019;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVlny8JIRqsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zhzZ1uWcrlZ8"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $&lt;span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zItSu1MAHKQb" title="Cash and cash equivalents"&gt;345,777&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_zAXyIs9fLL0l" title="Cash and cash equivalents"&gt;48,555&lt;/span&gt; in cash as of December 31, 2022 and 2021. The Company did not have any cash equivalents
as of December 31, 2022 or December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zFxKRtwFobx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_ziy9pjH8T3Ul"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2022 and 2021, the Company had $&lt;span id="xdx_902_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231_zAM9IxI5iFb8" title="Assets held-in-trust, noncurrent"&gt;136,871,183&lt;/span&gt; and &lt;span id="xdx_906_eus-gaap--AssetsHeldInTrustNoncurrent_iI_dxL_c20211231_zHMaCXASoyL5" title="Assets held-in-trust, noncurrent::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0462"&gt;zero, respectively,&lt;/span&gt;&lt;/span&gt; in investments held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_zudH8q6aDGg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_z3gArUAOjrqa"&gt;Offering
Costs Associated With a Public Offering&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A
&#x2014; &#x201c;&lt;i&gt;Expenses of Offering.&#x201d;&lt;/i&gt; Offering costs of $&lt;span id="xdx_908_ecustom--PublicOfferingCosts_c20220101__20221231_z74ORiIF3Ma7" title="Offering costs"&gt;7,738,161&lt;/span&gt;
consisting of $&lt;span id="xdx_90E_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220101__20221231_zMxCUY4QWAC9" title="Underwriting fees"&gt;2,645,000&lt;/span&gt;
of underwriting fees, $&lt;span id="xdx_904_ecustom--DeferredUnderwritingFee_c20220101__20221231_z28EFCWSEu85" title="Deferred underwriting fee"&gt;4,628,750&lt;/span&gt;
of deferred underwriting fee (which are held in the Trust Account with Wilmington Trust Company acting as trustee),
and $&lt;span id="xdx_906_ecustom--InitialPublicOfferingCost_c20220101__20221231_z8aumYHAK5Sg" title="Initial public offering costs"&gt;464,411&lt;/span&gt;
of Initial Public Offering costs. Of these costs, $&lt;span id="xdx_905_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zXUWyMRpGmOc" title="Warrant issuance cost"&gt;1,358,457&lt;/span&gt;
and $&lt;span id="xdx_903_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zYx1IjVJCyKe" title="Warrant issuance cost"&gt;19,656&lt;/span&gt;
were allocated to Public Warrants (as defined in Note 3) and Private Placement Warrants (as defined in Note 4), respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zoX2Q6Nuuvk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zyBsnjIJzmM"&gt;Class
A Common Stock Subject to Possible Redemption&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance enumerated in
ASC 480 &#x201c;&lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;&#x201d;. Common stock subject to mandatory redemption is classified as a
liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature
redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events
not solely within the Company&#x2019;s control) are classified as temporary equity. At all other times, common stock is classified as
stockholders&#x2019; equity. The shares of the Company&#x2019;s Class A common stock feature certain redemption rights that are
considered by the Company to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022, the shares of Class A common stock subject to possible redemption in the amount of $&lt;span id="xdx_903_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20221231_zBT9Z72q0hg5" title="Temporary equity, carrying amount, attributable to parent"&gt;136,771,183&lt;/span&gt;
are presented as temporary equity, outside of the stockholders&#x2019; equity (deficit) section of the Company&#x2019;s balance
sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zAAtN7Xllgck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Class A common stock subject to possible redemption reflected on the  balance sheet are reconciled
in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_z2lr5YRJKgz3" style="display: none"&gt;SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross proceeds from IPO&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220101__20220630_zBcvvUviX5xj"&gt;132,250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds allocated to Public Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_c20220101__20220630_zWdMy6PlaCT2" style="text-align: right" title="Proceeds allocated to Public Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(23,276,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PaymentOfCommonStockIssuanceCosts_c20220101__20220630_zIxPVWPRMts7" style="text-align: right" title="Class A common stock issuance costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,360,054&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Remeasurement
    adjustment of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_c20220101__20220630_zNpPbOs9GoVf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;32,281,054&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Class A common stock subject to possible redemption, as of March 31, 2022&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220401__20220630_zBfOe0vjE2D6" style="text-align: right" title="Common stock subject to possible redemption,beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;134,895,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220401__20220630_zaW7wQN58XQb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;101,767&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock subject to possible
    redemption as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220701__20220930_zGEnAZuXHCS3" style="text-align: right" title="Common stock subject to possible redemption,beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;134,996,767&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220701__20220930_zE0IrPa6a7Hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;609,920&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock subject to possible
    redemption as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20221001__20221231_zWqQDblob9tc" style="text-align: right" title="Common stock subject to possible redemption, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,606,687&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20221001__20221231_zeBxdaBxnqU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,164,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock
    subject to possible redemption as of December 31, 2022&lt;/span&gt; &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--CommonStockSubjectToPossibleRedemption_iE_c20221001__20221231_zJaLl4a4Gdd2" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;136,771,183&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z9qdT5gxpjZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zn0FzwpBJdvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zYQRHT7aCAC9"&gt;Net
Income (Loss) per Common Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income (loss)
per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding
for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share
as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with
the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence
of future events. As of December 31, 2022, the Company&#x2019;s outstanding warrants &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iNI_pid_di_c20221231_zgDwP3Bwqh86" title="Outstanding warrants"&gt;(13,979,000)&lt;/span&gt; have been excluded from diluted net
loss as their inclusion would be anti-dilutive. As a result, diluted net income (loss) per common share is the same as basic net income
(loss) per common share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdAkAOIxXnUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zfgvdKXe6VI1" style="display: none"&gt;SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Period
    Since Inception to&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class
                                            A common&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class
                                            B common&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpJakvAbgL5i" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0511"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNvmZ3n0yCh" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,381&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi0MkF0B8cG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0515"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhyfsoULUYjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z80ASqkgnzX2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0519"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzlqgSgwVEad" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class
    A common stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class
    B common stock &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Basic
    and diluted net loss per common share&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 62%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation
    of net income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zelEscxqJxXj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwAq2pxVG2qj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,079&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjZmhKJzYDsj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,558,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWshQ7fU0va" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,306,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net loss per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziECzwENsQN2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;0.03
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMFMgISDwU08" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;0.03
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zRriBmV9v45d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zpJvohATqhyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zbSXj7JbaAnb"&gt;Income
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zGoKsW9Q3Ku" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zrOfsYFfHLYk" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zFgAyY9FX99k" title="Income tax penalties and interest accrued"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_zWXhhtgX9265" title="Income tax penalties and interest accrued"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2022
or December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals
or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has identified the United States and California as its only tax jurisdictions. The Company is subject to income taxation by major
taxing authorities since inception. All tax periods are open to examination by tax authorities. These examinations may include questioning
the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws.
The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next
twelve months. The Company actual tax expense differs from the expected tax expense due to the change in the valuation allowance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zrB7CsIHY3Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_z5P8XqvPQWC5"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to credit risk consist principally of cash and investments held in the Trust Account.
Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal Depository Insurance Corporation coverage
limit of $&lt;span id="xdx_902_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_c20220101__20221231_z7VwwBJMlLpf" title="Federal deposit insurance corporation premium expense"&gt;250,000&lt;/span&gt;, and investments held in the Trust Account. As of December 31, 2022 and 2021, the Company had not experienced
losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--InvestmentHeldInTrustAccountPolicyTextBlock_z6YuSdd0hoJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zh45SLpsh3hb"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Investments held in the Trust Account were $&lt;span id="xdx_905_eus-gaap--AssetsHeldInTrust_iI_c20221231_zik71MYja2A3" title="Investments held in trust"&gt;136,871,183&lt;/span&gt;
at December 31, 2022 and &lt;span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_pn5n6_dc_c20211231_zcEi6YD5K7kg" title="Investments held in trust"&gt;zero&lt;/span&gt;
as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government
securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held
in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s
investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities
and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account
in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using
available market information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zc1MdaksWCJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zQyJQZeygsM3"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;Fair Value Measurements&#x201d;
approximates the carrying amounts represented in the balance sheet, partially due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--DerivativesReportingOfDerivativeActivity_zf24iZVNypg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zQwdV4WDP7A3"&gt;Derivative
Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each
reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--WarrantInstrumentsPolicyTextBlock_zTPTyDfseDVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_z02RYyXYP4i3"&gt;Warrant
Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants in accordance with the guidance contained in FASB ASC 815, &#x201c;Derivatives and Hedging&#x201d;.
Under ASC 815-40 warrants that meet the criteria for equity treatment are recorded in stockholders&#x2019; equity (deficit). The warrants are
subject to re-evaluation of the proper classification and accounting treatment at each reporting period. If the warrants no longer
meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the
statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z3cMEn6mP34e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zItt09U2ct97"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;p id="xdx_854_ziDHbBIPRhn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5piLhu7ej1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_z2s4oTn5D1p1"&gt;Basis
of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (&#x201c;GAAP&#x201d;) as contained within the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards
Codification (&#x201c;ASC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <MURFU:EmergingGrowthCompanyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84F_ecustom--EmergingGrowthCompanyPolicyTextBlock_zjC1R0hQahwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zvm2ZrWcsrtd"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities
Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</MURFU:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_845_eus-gaap--UseOfEstimates_z4nl6qfhdbFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zJelOGGc3Nml"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with US GAAP requires the Company&#x2019;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVlny8JIRqsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zhzZ1uWcrlZ8"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $&lt;span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zItSu1MAHKQb" title="Cash and cash equivalents"&gt;345,777&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_zAXyIs9fLL0l" title="Cash and cash equivalents"&gt;48,555&lt;/span&gt; in cash as of December 31, 2022 and 2021. The Company did not have any cash equivalents
as of December 31, 2022 or December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">345777</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">48555</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <MURFU:InvestmentsHeldInTrustAccountPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84E_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zFxKRtwFobx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_ziy9pjH8T3Ul"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2022 and 2021, the Company had $&lt;span id="xdx_902_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231_zAM9IxI5iFb8" title="Assets held-in-trust, noncurrent"&gt;136,871,183&lt;/span&gt; and &lt;span id="xdx_906_eus-gaap--AssetsHeldInTrustNoncurrent_iI_dxL_c20211231_zHMaCXASoyL5" title="Assets held-in-trust, noncurrent::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0462"&gt;zero, respectively,&lt;/span&gt;&lt;/span&gt; in investments held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MURFU:InvestmentsHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">136871183</us-gaap:AssetsHeldInTrustNoncurrent>
    <MURFU:OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_849_ecustom--OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock_zudH8q6aDGg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_z3gArUAOjrqa"&gt;Offering
Costs Associated With a Public Offering&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A
&#x2014; &#x201c;&lt;i&gt;Expenses of Offering.&#x201d;&lt;/i&gt; Offering costs of $&lt;span id="xdx_908_ecustom--PublicOfferingCosts_c20220101__20221231_z74ORiIF3Ma7" title="Offering costs"&gt;7,738,161&lt;/span&gt;
consisting of $&lt;span id="xdx_90E_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220101__20221231_zMxCUY4QWAC9" title="Underwriting fees"&gt;2,645,000&lt;/span&gt;
of underwriting fees, $&lt;span id="xdx_904_ecustom--DeferredUnderwritingFee_c20220101__20221231_z28EFCWSEu85" title="Deferred underwriting fee"&gt;4,628,750&lt;/span&gt;
of deferred underwriting fee (which are held in the Trust Account with Wilmington Trust Company acting as trustee),
and $&lt;span id="xdx_906_ecustom--InitialPublicOfferingCost_c20220101__20221231_z8aumYHAK5Sg" title="Initial public offering costs"&gt;464,411&lt;/span&gt;
of Initial Public Offering costs. Of these costs, $&lt;span id="xdx_905_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zXUWyMRpGmOc" title="Warrant issuance cost"&gt;1,358,457&lt;/span&gt;
and $&lt;span id="xdx_903_ecustom--WarrantIssuanceCost_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zYx1IjVJCyKe" title="Warrant issuance cost"&gt;19,656&lt;/span&gt;
were allocated to Public Warrants (as defined in Note 3) and Private Placement Warrants (as defined in Note 4), respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MURFU:OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock>
    <MURFU:PublicOfferingCosts
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">7738161</MURFU:PublicOfferingCosts>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">2645000</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <MURFU:DeferredUnderwritingFee
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">4628750</MURFU:DeferredUnderwritingFee>
    <MURFU:InitialPublicOfferingCost
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">464411</MURFU:InitialPublicOfferingCost>
    <MURFU:WarrantIssuanceCost
      contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">1358457</MURFU:WarrantIssuanceCost>
    <MURFU:WarrantIssuanceCost
      contextRef="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">19656</MURFU:WarrantIssuanceCost>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_848_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zoX2Q6Nuuvk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zyBsnjIJzmM"&gt;Class
A Common Stock Subject to Possible Redemption&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance enumerated in
ASC 480 &#x201c;&lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;&#x201d;. Common stock subject to mandatory redemption is classified as a
liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature
redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events
not solely within the Company&#x2019;s control) are classified as temporary equity. At all other times, common stock is classified as
stockholders&#x2019; equity. The shares of the Company&#x2019;s Class A common stock feature certain redemption rights that are
considered by the Company to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022, the shares of Class A common stock subject to possible redemption in the amount of $&lt;span id="xdx_903_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20221231_zBT9Z72q0hg5" title="Temporary equity, carrying amount, attributable to parent"&gt;136,771,183&lt;/span&gt;
are presented as temporary equity, outside of the stockholders&#x2019; equity (deficit) section of the Company&#x2019;s balance
sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zAAtN7Xllgck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Class A common stock subject to possible redemption reflected on the  balance sheet are reconciled
in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_z2lr5YRJKgz3" style="display: none"&gt;SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross proceeds from IPO&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220101__20220630_zBcvvUviX5xj"&gt;132,250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds allocated to Public Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_c20220101__20220630_zWdMy6PlaCT2" style="text-align: right" title="Proceeds allocated to Public Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(23,276,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PaymentOfCommonStockIssuanceCosts_c20220101__20220630_zIxPVWPRMts7" style="text-align: right" title="Class A common stock issuance costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,360,054&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Remeasurement
    adjustment of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_c20220101__20220630_zNpPbOs9GoVf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;32,281,054&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Class A common stock subject to possible redemption, as of March 31, 2022&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220401__20220630_zBfOe0vjE2D6" style="text-align: right" title="Common stock subject to possible redemption,beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;134,895,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220401__20220630_zaW7wQN58XQb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;101,767&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock subject to possible
    redemption as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220701__20220930_zGEnAZuXHCS3" style="text-align: right" title="Common stock subject to possible redemption,beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;134,996,767&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220701__20220930_zE0IrPa6a7Hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;609,920&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock subject to possible
    redemption as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20221001__20221231_zWqQDblob9tc" style="text-align: right" title="Common stock subject to possible redemption, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,606,687&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20221001__20221231_zeBxdaBxnqU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,164,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock
    subject to possible redemption as of December 31, 2022&lt;/span&gt; &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--CommonStockSubjectToPossibleRedemption_iE_c20221001__20221231_zJaLl4a4Gdd2" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;136,771,183&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z9qdT5gxpjZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">136771183</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89B_ecustom--ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock_zAAtN7Xllgck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Class A common stock subject to possible redemption reflected on the  balance sheet are reconciled
in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_z2lr5YRJKgz3" style="display: none"&gt;SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross proceeds from IPO&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220101__20220630_zBcvvUviX5xj"&gt;132,250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds allocated to Public Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts_c20220101__20220630_zWdMy6PlaCT2" style="text-align: right" title="Proceeds allocated to Public Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(23,276,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PaymentOfCommonStockIssuanceCosts_c20220101__20220630_zIxPVWPRMts7" style="text-align: right" title="Class A common stock issuance costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,360,054&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Remeasurement
    adjustment of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TemporaryEquityAccretionToOriginalRedemptionValueAdjustment_c20220101__20220630_zNpPbOs9GoVf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;32,281,054&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Class A common stock subject to possible redemption, as of March 31, 2022&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220401__20220630_zBfOe0vjE2D6" style="text-align: right" title="Common stock subject to possible redemption,beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;134,895,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220401__20220630_zaW7wQN58XQb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;101,767&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock subject to possible
    redemption as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20220701__20220930_zGEnAZuXHCS3" style="text-align: right" title="Common stock subject to possible redemption,beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;134,996,767&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20220701__20220930_zE0IrPa6a7Hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;609,920&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock subject to possible
    redemption as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CommonStockSubjectToPossibleRedemption_iS_c20221001__20221231_zWqQDblob9tc" style="text-align: right" title="Common stock subject to possible redemption, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,606,687&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement adjustment
of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_c20221001__20221231_zeBxdaBxnqU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remeasurement adjustment of carrying value to redemption value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,164,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class A common stock
    subject to possible redemption as of December 31, 2022&lt;/span&gt; &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--CommonStockSubjectToPossibleRedemption_iE_c20221001__20221231_zJaLl4a4Gdd2" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;136,771,183&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">132250000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <MURFU:ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">-23276000</MURFU:ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts>
    <MURFU:PaymentOfCommonStockIssuanceCosts
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">-6360054</MURFU:PaymentOfCommonStockIssuanceCosts>
    <MURFU:TemporaryEquityAccretionToOriginalRedemptionValueAdjustment
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">32281054</MURFU:TemporaryEquityAccretionToOriginalRedemptionValueAdjustment>
    <MURFU:CommonStockSubjectToPossibleRedemption contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">134895000</MURFU:CommonStockSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">101767</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <MURFU:CommonStockSubjectToPossibleRedemption contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">134996767</MURFU:CommonStockSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">609920</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <MURFU:CommonStockSubjectToPossibleRedemption contextRef="AsOf2022-09-30" decimals="0" unitRef="USD">135606687</MURFU:CommonStockSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-10-012022-12-31"
      decimals="0"
      unitRef="USD">1164496</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <MURFU:CommonStockSubjectToPossibleRedemption contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">136771183</MURFU:CommonStockSubjectToPossibleRedemption>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zn0FzwpBJdvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zYQRHT7aCAC9"&gt;Net
Income (Loss) per Common Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income (loss)
per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding
for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share
as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with
the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence
of future events. As of December 31, 2022, the Company&#x2019;s outstanding warrants &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iNI_pid_di_c20221231_zgDwP3Bwqh86" title="Outstanding warrants"&gt;(13,979,000)&lt;/span&gt; have been excluded from diluted net
loss as their inclusion would be anti-dilutive. As a result, diluted net income (loss) per common share is the same as basic net income
(loss) per common share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdAkAOIxXnUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zfgvdKXe6VI1" style="display: none"&gt;SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Period
    Since Inception to&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class
                                            A common&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class
                                            B common&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpJakvAbgL5i" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0511"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNvmZ3n0yCh" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,381&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi0MkF0B8cG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0515"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhyfsoULUYjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z80ASqkgnzX2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0519"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzlqgSgwVEad" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class
    A common stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class
    B common stock &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Basic
    and diluted net loss per common share&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 62%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation
    of net income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zelEscxqJxXj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwAq2pxVG2qj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,079&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjZmhKJzYDsj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,558,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWshQ7fU0va" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,306,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net loss per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziECzwENsQN2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;0.03
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMFMgISDwU08" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;0.03
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zRriBmV9v45d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">13979000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdAkAOIxXnUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zfgvdKXe6VI1" style="display: none"&gt;SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Period
    Since Inception to&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class
                                            A common&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Class
                                            B common&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpJakvAbgL5i" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0511"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ProfitLoss_pp0p0_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNvmZ3n0yCh" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,381&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi0MkF0B8cG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0515"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhyfsoULUYjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z80ASqkgnzX2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0519"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20211019__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzlqgSgwVEad" style="border-bottom: Black 1.5pt solid; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class
    A common stock&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class
    B common stock &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Basic
    and diluted net loss per common share&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 62%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation
    of net income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zelEscxqJxXj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwAq2pxVG2qj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: right" title="Allocation of net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,079&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjZmhKJzYDsj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,558,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWshQ7fU0va" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,306,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net loss per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ziECzwENsQN2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;0.03
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMFMgISDwU08" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Basic and diluted net loss per common share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;0.03
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">-4381</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">2875000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-10-192021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">315560</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">83079</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">12558058</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zpJvohATqhyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zbSXj7JbaAnb"&gt;Income
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zGoKsW9Q3Ku" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zrOfsYFfHLYk" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zFgAyY9FX99k" title="Income tax penalties and interest accrued"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_zWXhhtgX9265" title="Income tax penalties and interest accrued"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2022
or December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals
or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has identified the United States and California as its only tax jurisdictions. The Company is subject to income taxation by major
taxing authorities since inception. All tax periods are open to examination by tax authorities. These examinations may include questioning
the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws.
The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next
twelve months. The Company actual tax expense differs from the expected tax expense due to the change in the valuation allowance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zrB7CsIHY3Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_z5P8XqvPQWC5"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to credit risk consist principally of cash and investments held in the Trust Account.
Cash is maintained in accounts with financial institutions, which, at times may exceed the Federal Depository Insurance Corporation coverage
limit of $&lt;span id="xdx_902_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_c20220101__20221231_z7VwwBJMlLpf" title="Federal deposit insurance corporation premium expense"&gt;250,000&lt;/span&gt;, and investments held in the Trust Account. As of December 31, 2022 and 2021, the Company had not experienced
losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FederalDepositInsuranceCorporationPremiumExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">250000</us-gaap:FederalDepositInsuranceCorporationPremiumExpense>
    <MURFU:InvestmentHeldInTrustAccountPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84D_ecustom--InvestmentHeldInTrustAccountPolicyTextBlock_z6YuSdd0hoJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zh45SLpsh3hb"&gt;Investments
Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Investments held in the Trust Account were $&lt;span id="xdx_905_eus-gaap--AssetsHeldInTrust_iI_c20221231_zik71MYja2A3" title="Investments held in trust"&gt;136,871,183&lt;/span&gt;
at December 31, 2022 and &lt;span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_pn5n6_dc_c20211231_zcEi6YD5K7kg" title="Investments held in trust"&gt;zero&lt;/span&gt;
as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government
securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held
in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s
investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities
and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period.
Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account
in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using
available market information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</MURFU:InvestmentHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrust contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">136871183</us-gaap:AssetsHeldInTrust>
    <us-gaap:AssetsHeldInTrust contextRef="AsOf2021-12-31" decimals="-5" unitRef="USD">0</us-gaap:AssetsHeldInTrust>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zc1MdaksWCJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zQyJQZeygsM3"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;Fair Value Measurements&#x201d;
approximates the carrying amounts represented in the balance sheet, partially due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesReportingOfDerivativeActivity contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84D_eus-gaap--DerivativesReportingOfDerivativeActivity_zf24iZVNypg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zQwdV4WDP7A3"&gt;Derivative
Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each
reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesReportingOfDerivativeActivity>
    <MURFU:WarrantInstrumentsPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_841_ecustom--WarrantInstrumentsPolicyTextBlock_zTPTyDfseDVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_z02RYyXYP4i3"&gt;Warrant
Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants in accordance with the guidance contained in FASB ASC 815, &#x201c;Derivatives and Hedging&#x201d;.
Under ASC 815-40 warrants that meet the criteria for equity treatment are recorded in stockholders&#x2019; equity (deficit). The warrants are
subject to re-evaluation of the proper classification and accounting treatment at each reporting period. If the warrants no longer
meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the
statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 48.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MURFU:WarrantInstrumentsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z3cMEn6mP34e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zItt09U2ct97"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <MURFU:InitialPublicOfferingTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80F_ecustom--InitialPublicOfferingTextBlock_z80ZLp633gn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2014; &lt;span id="xdx_828_zX855hzHCL4g"&gt;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Initial Public Offering, the Company sold &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zg48gCIVVX8h" title="Sale of stock"&gt;13,225,000&lt;/span&gt;
Units at a price of $&lt;span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zclg5L1FUhk1" title="Sale of stock price per share"&gt;10.00&lt;/span&gt;
per Unit. Each Unit consists of one share of Class A common stock (&#x201c;Public Shares&#x201d;) and one redeemable warrant
(&#x201c;Public Warrant&#x201d;). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a
price of $&lt;span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znwDZBOUSjbi" title="Shares issued price per share"&gt;11.50&lt;/span&gt;
per share, subject to adjustment (see Note 7).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</MURFU:InitialPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-01-012022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="Shares">13225000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember_custom_PublicWarrantMember_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SharesIssuedPricePerShare>
    <MURFU:PrivatePlacementsTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_804_ecustom--PrivatePlacementsTextBlock_z1cyrpaelahb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 &#x2014; &lt;span id="xdx_825_zwxhPPINYXK3"&gt;PRIVATE PLACEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private sale to the Sponsor of &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPxqeLBbTst5" title="Number of shares issued for private sale"&gt;754,000&lt;/span&gt;
Private Placement Units at a price of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zvOhyfndF422" title="Sale of stock price per share"&gt;10.00&lt;/span&gt;
per Private Placement Unit ($&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwc3XSZSRG7b" title="Proceeds from issuance of private placement"&gt;7,540,000&lt;/span&gt;).
Each Private Placement Unit is comprised of one Class A share and one warrant (&#x201c;Private Placement Warrant&#x201d;). Each Private Placement Warrant is exercisable to
purchase one share of Class A common stock at a price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CapitalUnitClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zj7LzwxKwsj7" title="Exercise price of warrants"&gt;11.50&lt;/span&gt;
per share, subject to adjustment (see Note 7). The Company&#x2019;s Sponsor has agreed to transfer, but has not yet transferred, &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember_ziqRs6ikHV92" title="Number of units transferred to director"&gt;15,000&lt;/span&gt;
Private Placement Units to each of our director nominees. The proceeds from the sale of the Private Placement Units were added to the net
proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within
the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the
redemption of the Public Shares (subject to the requirements of applicable law) and the securities comprising the Private Placement
Units will expire worthless. The Private Placement Units (including the Class A common stock issuable upon exercise of the warrants
included in the Private Placement Units) will not be transferable, assignable or saleable until 30 days after the completion of an
Initial Business Combination, subject to certain exceptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MURFU:PrivatePlacementsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-01-012022-12-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2022-01-012022-12-31_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">7540000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31_us-gaap_CapitalUnitClassAMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_srt_DirectorMember"
      decimals="INF"
      unitRef="Shares">15000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zGOdRUgIDTyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 &#x2014; &lt;span id="xdx_829_zJdOdhEvuE5c"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Founder
Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 16, 2021, the Sponsor received &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211114__20211116__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUVTWHcECAtg" title="Number of shares issued to sponsor"&gt;4,312,500&lt;/span&gt; shares of the Company&#x2019;s Class B common stock (the &#x201c;Founder Shares&#x201d;)
for $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20211114__20211116__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zudlNC0MqXml" title="Number of shares issued to sponsor, value"&gt;25,000&lt;/span&gt;. On January 26, 2022, the Sponsor surrendered and forfeited &lt;span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_ziO090Co09oh" title="Stock surrendered and forfeited during period shares"&gt;1,006,250&lt;/span&gt; Founder Shares for no consideration, following which
the Sponsor holds &lt;span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesOnHold_c20220124__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zThclrPrwyfl" title="Stock issued during period on hold"&gt;3,306,250&lt;/span&gt; Founder Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until
the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x)
if the last reported sale price of the Class A common stock equals or exceeds $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20211116__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zcxIQBk4QS1h" title="Sale of stock price per share"&gt;12.00&lt;/span&gt; per share (as adjusted for stock splits, stock capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar
transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities
or other property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
Note &#x2014; Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 4, 2021, the Sponsor issued an unsecured promissory note to the Company (the &#x201c;Promissory Note&#x201d;), pursuant to
which the Company may borrow up to an aggregate principal amount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20211104_zjJXC6lA1z8f" title="Principal amount"&gt;300,000&lt;/span&gt;.
The Promissory Note is non-interest bearing and payable on the earlier of (i) the consummation of the Initial Public Offering or
(ii) the decision not to execute the Initial Public Offering. As of December 31, 2021, there was $&lt;span id="xdx_902_eus-gaap--NotesPayableCurrent_iI_c20211231_zhA6TFolkO39" title="Notes payable, current"&gt;177,057&lt;/span&gt;
outstanding under the Promissory Note. The balance was paid in full on February 10, 2022. See Note 10, regarding a new promissory
note issued by the Sponsor to the Company for $&lt;span id="xdx_907_eus-gaap--SponsorFees_pn5n6_c20220209__20220210_zIrjQMU6L2x4" title="Sponsor fees"&gt;1.5 &lt;/span&gt;million, subsequent to December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;General
and Administrative Services&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 60pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
on the date the Units are first listed on the Nasdaq, the Company has agreed to pay the Sponsor a total of $&lt;span id="xdx_903_eus-gaap--PaymentsForRent_c20220101__20221231_zv2wdPYiTgdk" title="Monthly payment for office space"&gt;10,000&lt;/span&gt; per month for office
space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company&#x2019;s
liquidation, the Company will cease paying these monthly fees. During the year ended December 31, 2022, the Company incurred $&lt;span id="xdx_902_ecustom--AdministrationFeeRelatedParty_c20220101__20221231_z60g1ZIvfWuh" title="Administration fee related party"&gt;110,000&lt;/span&gt;,
of such expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Related
Party Loans&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working
Capital Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of
a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $&lt;span id="xdx_903_eus-gaap--DebtConversionOriginalDebtAmount1_c20220101__20221231_z8uO0enqZx14" title="Notes payable converted"&gt;1,500,000&lt;/span&gt; of the notes may be converted upon completion
of a Business Combination into units at a price of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20221231_z3K5YWU6CyAb" title="Conversion price"&gt;10.00&lt;/span&gt; per unit. Such units would be identical to the Private Placement Units. In
the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay
the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December
31, 2022 and 2021, there were &lt;span id="xdx_90E_ecustom--WorkingCapitalLoan_iI_do_c20221231_zGwWXN7hU398" title="Working capital loans"&gt;&lt;span id="xdx_905_ecustom--WorkingCapitalLoan_iI_do_c20211231_zKzO1aepYf23" title="Working capital loans"&gt;no&lt;/span&gt;&lt;/span&gt; amounts outstanding under the Working Capital Loans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-11-142021-11-16_custom_SponsorMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">4312500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-11-142021-11-16_custom_SponsorMember_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2022-01-252022-01-26_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1006250</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <MURFU:StockIssuedDuringPeriodSharesOnHold
      contextRef="From2022-01-242022-01-26_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">3306250</MURFU:StockIssuedDuringPeriodSharesOnHold>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2021-11-16_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2021-11-04" decimals="0" unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">177057</us-gaap:NotesPayableCurrent>
    <us-gaap:SponsorFees
      contextRef="From2022-02-092022-02-10"
      decimals="-5"
      unitRef="USD">1500000</us-gaap:SponsorFees>
    <us-gaap:PaymentsForRent
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">10000</us-gaap:PaymentsForRent>
    <MURFU:AdministrationFeeRelatedParty
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">110000</MURFU:AdministrationFeeRelatedParty>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <MURFU:WorkingCapitalLoan contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</MURFU:WorkingCapitalLoan>
    <MURFU:WorkingCapitalLoan contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</MURFU:WorkingCapitalLoan>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znrsQDwRNvqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2014; &lt;span id="xdx_826_z26ulJyilrw8"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Registration
Rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and
any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working
Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement
to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale.
The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company
register such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration
statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities
pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required
to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are
released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Underwriting
Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zQgudg26swP1" title="Issuance of Class B common stock to Sponsor, shares"&gt;1,725,000&lt;/span&gt; additional Units
to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The option was
fully exercised on &lt;span id="xdx_907_ecustom--OptionExercisedDate_dd_c20220101__20221231_zqdPaiqUPHje" title="Option exercised date"&gt;February 7, 2022&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters were paid a cash underwriting discount of $&lt;span id="xdx_905_ecustom--CashUnderwritingDiscount_c20220101__20221231_z8XuC5VNjcdl" title="Cash underwriting discount"&gt;0.20&lt;/span&gt; per Unit, or $&lt;span id="xdx_904_ecustom--UnderwritingDiscount_c20220101__20221231_zeKwhIeH74E4" title="Underwriting discount"&gt;2,645,000&lt;/span&gt;, payable upon the closing of the Initial Public
Offering. In addition, the underwriters are entitled to a deferred fee of $&lt;span id="xdx_900_ecustom--DeferredFeePerShare_iI_c20221231_z2DbQr5CAKFj" title="Deferred fee per share"&gt;0.35&lt;/span&gt; per Unit, or $&lt;span id="xdx_903_eus-gaap--DeferredOfferingCosts_iI_c20221231_zG7EzTdC73F1" title="Deferred fee"&gt;4,628,750&lt;/span&gt;. The deferred fee will become
payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination,
subject to the terms of the underwriting agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the underwriting discount, the Company paid the underwriters $&lt;span id="xdx_90F_ecustom--AdvancePaymentForUnderwriterExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_z6cVoj9RINVc" title="Advance payment for underwriter expenses"&gt;50,000&lt;/span&gt; as an advance against out-of-pocket accountable expenses
actually anticipated to be incurred by the underwriters, which advance will be returned to the Company to the extent not actually incurred.
The Company agreed to pay or reimburse the underwriters for travel, lodging and other &#x201c;road show&#x201d; expenses, expenses of the
underwriters&#x2019; legal counsel and certain diligence and other fees, which such fees and expenses are capped at an aggregate of $&lt;span id="xdx_905_ecustom--UnderwriterExpenses_c20220101__20221231_zx86g7kjcpC1" title="Underwriter expenses"&gt;150,000&lt;/span&gt;
(less the $&lt;span id="xdx_90D_ecustom--AdvancePaymentForUnderwriterExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember_zbsVCVDq5Bhl" title="Advance payment for underwriter expenses"&gt;50,000&lt;/span&gt; advance previously paid).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <MURFU:OptionExercisedDate contextRef="From2022-01-01to2022-12-31">2022-02-07</MURFU:OptionExercisedDate>
    <MURFU:CashUnderwritingDiscount
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.20</MURFU:CashUnderwritingDiscount>
    <MURFU:UnderwritingDiscount
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">2645000</MURFU:UnderwritingDiscount>
    <MURFU:DeferredFeePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.35</MURFU:DeferredFeePerShare>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">4628750</us-gaap:DeferredOfferingCosts>
    <MURFU:AdvancePaymentForUnderwriterExpenses
      contextRef="From2022-01-012022-12-31_custom_UnderwriterMember"
      decimals="0"
      unitRef="USD">50000</MURFU:AdvancePaymentForUnderwriterExpenses>
    <MURFU:UnderwriterExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">150000</MURFU:UnderwriterExpenses>
    <MURFU:AdvancePaymentForUnderwriterExpenses
      contextRef="From2022-01-012022-12-31_custom_UnderwriterMember"
      decimals="0"
      unitRef="USD">50000</MURFU:AdvancePaymentForUnderwriterExpenses>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z6xxhHJbtBl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 &#x2014; &lt;span id="xdx_829_z7fSFEqua8Ob"&gt;STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_ziQ2EVAZKFMf"&gt;1,000,000&lt;/span&gt; shares of preferred stock with a par value of $&lt;span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zduoJI93pcGl" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share. As
of December 31, 2022 and December 31, 2021, there were &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zCQffYugdEob" title="Preferred stock shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_z3lnrpOE6P9e" title="Preferred stock shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zMi4f0y7cu" title="Preferred stock shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zElXWJHfISz" title="Preferred stock shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of preferred stock issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Class
A Common Stock&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJpJMsNlsfi9" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt; shares of Class A common stock with a par value of $&lt;span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zeivWtl2ldkj" title="Common stock, par value"&gt;0.0001&lt;/span&gt;
per share. &lt;span id="xdx_909_eus-gaap--CommonStockVotingRights_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWjp8Od3H5Tc" title="Voting rights"&gt;Holders of Class A common stock are entitled to one vote for each share.&lt;/span&gt; As of December 31, 2022 and 2021, there
were &lt;span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zV6J6dHO1675" title="Common stock, shares issued"&gt;&lt;span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJRdHJKqYue6" title="Common stock, shares outstanding"&gt;754,000&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_dc_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zy1bhK43NEYc" title="Common stock, shares issued"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_dc_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8Big6Y9G5rc" title="Common stock, shares outstanding"&gt;zero&lt;/span&gt;&lt;/span&gt;, respectively, shares of Class A common stock issued and outstanding (excluding the &lt;span id="xdx_90D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zoSh2ZecVRC3" title="Shares subject to possible redemption"&gt;&lt;span id="xdx_902_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zlrXrPLiUdd5" title="Shares subject to possible redemption"&gt;13,225,000&lt;/span&gt;&lt;/span&gt; shares subject to
possible redemption).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Class
B Common Stock&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z6DbX4ROIHNg" title="Common stock, shares authorized"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUVdQzMpLku2" title="Common stock, shares authorized"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;
shares of Class B common stock with a par value of $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zLD8W3nhY5j" title="Common stock, par value"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zYRbC6dW9Sed" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;
per share. Holders of Class B common stock are entitled to one vote for each share. As of each December 31, 2022 and 2021, there were &lt;span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzpbd3IsWOi4" title="Common stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zIkH9tJEDEHi" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdSLktfDN2y7" title="Common stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zD6WVhj4Bws1" title="Common stock, shares outstanding"&gt;3,306,250&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
shares of Class B common stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of
our shareholders except as otherwise required by law. In connection with our initial business combination, we may enter into a stockholders
agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance
arrangements that differ from those in effect upon completion of this offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier
at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock,
or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to
the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common
stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment
with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of
all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all
shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked
securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed
in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest
in the target to us in a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class B common stock will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise
required by law. In connection with our initial business combination, we may enter into a stockholders agreement or other arrangements
with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from
those in effect upon completion of this offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants
&lt;/i&gt;&lt;/b&gt;&#x2014; Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation
of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion
of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years
after the completion of a Business Combination or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A
common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from
registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue
any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified
under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination,
the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have
declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the
warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed.
Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities
exchange such that it satisfies the definition of a &#x201c;covered security&#x201d; under Section 18(b)(1) of the Securities Act, the
Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless basis&#x201d;
in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to
file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Redemption
of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00&lt;/i&gt;&lt;/b&gt; &#x2014; Once the warrants become exercisable,
the Company may redeem the outstanding Public Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
    whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
    a price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231_zDOANFFXAcZa" title="Warrant exercise price"&gt;0.01&lt;/span&gt; per Public Warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
    a minimum of 30 days&#x2019; prior written notice of redemption, or the 30-day redemption period to each warrant holder; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
    and only if, the last reported sale price of the Class A common stock equals or exceeds $&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7jgLlaBqZze" title="Share price per shares"&gt;18.00&lt;/span&gt; per share (as adjusted for stock splits,
    stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on
    the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that
wishes to exercise the Public Warrants to do so on a &#x201c;cashless basis,&#x201d; as described in the warrant agreement. The exercise
price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in
the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as
described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally,
in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination
within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive
any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company&#x2019;s assets held
outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Placement Warrants and Public Warrants are recorded in stockholders&#x2019; equity (deficit) as they qualify for equity treatment
under ASC 815.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions used to value the Public Warrants, which was determined to be $&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember_zAgzSxSNqi48" title="Warrants"&gt;23,276,000&lt;/span&gt;, were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Term
    &#x2013; &lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zpkkryrcOfdk" title="Warrant expected term"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Volatility
    &#x2013; &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z1Ikpd7iiOK9" title="Warrant measurement inputs"&gt;22&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividends
    &#x2013; &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zcf9G3kqPwgb" title="Warrant measurement inputs"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discount
    rate &#x2013; &lt;span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsAndPublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_ztfvl5e36EO4" title="Warrant measurement inputs"&gt;1.76&lt;/span&gt;% &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember">Holders of Class A common stock are entitled to one vote for each share.</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">754000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">13225000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">13225000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">3306250</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharePrice
      contextRef="AsOf2022-12-31_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="USDPShares">18.00</us-gaap:SharePrice>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember"
      decimals="0"
      unitRef="USD">23276000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      unitRef="Pure">22</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsAndPublicWarrantsMember_us-gaap_MeasurementInputDiscountRateMember"
      decimals="INF"
      unitRef="Pure">1.76</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80D_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z6COOCJFVTZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2014; &lt;span id="xdx_828_zYzdnx7j1Op8"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zu2TxWQCc0A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets and liabilities that are measured at fair value at December 31,
2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_z2pylKwhXTJe" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0Mjy4Tf55Eb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AssetsAbstract_iB_zoOkDuDLTXvj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zHZWkQ1kdbY2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;136,871,183&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zsLA3m5VVvl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify"&gt;As
of December 31, 2021, there were &lt;span id="xdx_90E_eus-gaap--AssetsHeldInTrustNoncurrent_iI_do_c20211231__srt--ProductOrServiceAxis__us-gaap--FinancialServiceMember_zxUuBH1DIxma" title="Investments held in trust account"&gt;no&lt;/span&gt; assets requiring fair value measurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zu2TxWQCc0A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets and liabilities that are measured at fair value at December 31,
2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_z2pylKwhXTJe" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0Mjy4Tf55Eb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AssetsAbstract_iB_zoOkDuDLTXvj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_zHZWkQ1kdbY2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;136,871,183&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      unitRef="USD">136871183</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2021-12-31_us-gaap_FinancialServiceMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_znVqMWBYuS54" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2014; &lt;span id="xdx_826_zQLcBl1ErrNh"&gt;TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zdlxj36gAKF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
expected tax expense based on the statutory rate is reconciled with actual tax expense as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BE_zegrbkaZkNY" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220101__20221231_ztBO9JiSAqB" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Year
    Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zpiP2iCHC56" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_zvGp5IACUHr4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State
    taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zZPiAqn7dbB8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zeVDLX67TYl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zR1W0dW1cfSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;The effective tax rate differs
from the statutory tax rate of &lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231_zpZu02cEIZJe" title="Effective income tax rate"&gt;21&lt;/span&gt;% for the year ended December 31, 2021, due to the valuation allowance recorded on the Company&#x2019;s
net operating losses. The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various
taxing authorities. The Company&#x2019;s tax returns since inception remain open to examination by the taxing authorities. The Company
considers California to be a significant state tax jurisdiction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred tax assets and
liabilities and the change in valuation are as follows at December 31:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zXgh0p8Lvp01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zWmmuSHGaLTh" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20221231_zjXfeH5w61Pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsNetAbstract_iB_z5EO900vwzIk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpense_i01I_msDTAGzZX3_zFPjgyXFWaP3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 81%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Startup
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_i01TI_maDTANznat_mtDTAGzZX3_zJtetEhhZ59k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_di_msDTANznat_zykPUm3eeTcg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation Allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01TI_mtDTANznat_zakgSTSosEUj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zDfJCxRrTAc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlDQRPDVQMmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;SCHEDULE
OF CHANGE IN VALUATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20221231_zjd2Zov0DUK8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_ztbOTcYfa2R4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 81%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_iN_di_zMATFmWpeVA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;374,862&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_zbbOudZnaMzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(211,627&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_zj5vWIJN2Zi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;State and
    Local&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zgyPTYBnm8Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_z7DPciRMrj09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_z6zOhjx3JZs2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change in
    valuation&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_z9vkKwAn6fkk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Income Tax Provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;374,862&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"/&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zT9SsyLFliDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;In assessing the realization of
the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will
not be realized. The ultimate realization of deferred tax assets is independent upon the generation of future taxable income during the
periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration
of all of the information available, management believes that significant uncertainty exists with respect to future realization of the
deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31,2021, the change in the valuation
allowance was zero.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zdlxj36gAKF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
expected tax expense based on the statutory rate is reconciled with actual tax expense as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BE_zegrbkaZkNY" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF EFFECTIVE INCOME TAX RATE RECONCILIATION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220101__20221231_ztBO9JiSAqB" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For the Year
    Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zpiP2iCHC56" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 81%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_zvGp5IACUHr4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State
    taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zZPiAqn7dbB8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zeVDLX67TYl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.2736</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.4846</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zXgh0p8Lvp01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zWmmuSHGaLTh" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20221231_zjXfeH5w61Pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsNetAbstract_iB_z5EO900vwzIk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpense_i01I_msDTAGzZX3_zFPjgyXFWaP3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 81%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Startup
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_i01TI_maDTANznat_mtDTAGzZX3_zJtetEhhZ59k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_di_msDTANznat_zykPUm3eeTcg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation Allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01TI_mtDTANznat_zakgSTSosEUj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpense contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">211627</us-gaap:DeferredTaxLiabilitiesDeferredExpense>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">211627</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">211627</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlDQRPDVQMmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;SCHEDULE
OF CHANGE IN VALUATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20221231_zjd2Zov0DUK8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_ztbOTcYfa2R4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 81%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_iN_di_zMATFmWpeVA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;374,862&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_zbbOudZnaMzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(211,627&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_zj5vWIJN2Zi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;State and
    Local&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zgyPTYBnm8Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_z7DPciRMrj09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_z6zOhjx3JZs2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change in
    valuation&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;211,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_z9vkKwAn6fkk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Income Tax Provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;374,862&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"/&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-374862</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-211627</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">211627</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">374862</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zkBsJeFKFOT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2014; &lt;span id="xdx_828_zbXALt37NXl5"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements
were issued. Based upon this review, except as disclosed below, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initially,
the Company was required to complete an initial business combination transaction by 12 months from the consummation of  initial
public offering or up to 18 months if the Company extended the period of time to consummate a business combination in accordance
with the Company&#x2019;s Certificate of Incorporation. On January 26, 2023, at a special meeting of the Company&#x2019;s stockholders
(the &#x201c;Special Meeting&#x201d;), the Company&#x2019;s stockholders approved a proposal to amend the Company&#x2019;s certificate of incorporation to allow the Company to extend, at the Company&#x2019;s election, the date by
which the Company has to consummate a business combination up to 12 times, each such extension for an additional one month period, from
February 7, 2023, to February 7, 2024. The Company&#x2019;s stockholders also approved a related proposal to amend the trust agreement allowing the Company to
deposit into the Trust Account, for each one-month extension, one-third of &lt;span id="xdx_901_ecustom--PercentageOfDepositInTrustAccount_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLxcW2p92Czc" title="Percentage of deposit in trust account"&gt;1%&lt;/span&gt;
of the funds remaining in the Trust Account following the redemptions made in connection with the approval of the extension proposal
at the Special Meeting. At the Special Meeting the Company&#x2019;s stockholders also approved a proposal to amend the Company&#x2019;s certificate of incorporation
to expand the methods that the Company may employ to not become subject to the &#x201c;penny stock&#x201d; rules of the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with such proposals, the Company&#x2019;s public stockholders had the right to redeem their shares for cash equal to their pro rata share of
the aggregate amount on deposit in the Trust Account as of two days prior to such stockholder vote. The Company&#x2019;s public stockholders holding &lt;span id="xdx_908_ecustom--StockIssuedDuringPeriodShareOnHold_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zfthNgs7rAS2" title="Stock issued during period on hold"&gt;11,037,272&lt;/span&gt;
shares of Class A common stock (out of a total of &lt;span id="xdx_90C_eus-gaap--SharesIssued_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zEwwQAWHFTDk" title="Stock issued"&gt;13,979,000&lt;/span&gt; shares of Class A common stock) exercised their right to redeem such shares
at a redemption price of approximately $&lt;span id="xdx_905_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_uUSDPShares_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zUyf8G0vxfT2" title="Redemption price per share"&gt;10.33&lt;/span&gt; per share. Approximately $&lt;span id="xdx_90A_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMw9csqjGC88" title="Number of stock redeemed, value"&gt;114&lt;/span&gt; million in cash was removed from the Trust Account to pay
such stockholders and, accordingly, after giving effect to such redemptions, the balance in the Trust Account was approximately $&lt;span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEHOMQih1FSa" title="Investments held in trust account"&gt;23&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the approval of such proposals, the Company agreed to deposit into the Trust Account one-third of &lt;span id="xdx_907_ecustom--PercentageOfDepositInTrustAccount_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhWKE9AFSg27" title="Percentage of deposit in trust account"&gt;1%&lt;/span&gt; of the funds then on deposit
in the Trust Account for each month of the extension period, resulting in a monthly contribution of approximately $&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_uUSDPShares_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxDXFbe0sO56" title="Price per share"&gt;0.035&lt;/span&gt; per share that
was not redeemed in connection with the Special Meeting, or an aggregate of approximately $&lt;span id="xdx_90C_eus-gaap--DepositAssets_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zboE1G94Dw8a" title="Aggregate of deposit"&gt;77,000&lt;/span&gt; per month, and an aggregate of $&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230125__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlgJuuCYuK7f" title="Proceeds from business combination"&gt;924,000&lt;/span&gt;
if the date the Company has to consummate a business combination is extended 12 times, each assuming no interest is earned on the funds in the
Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"&gt;On March 7, 2023, the
Company entered into a $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20230306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znA5Zs4wiA3b"&gt;1.5&lt;/span&gt;
million promissory note with the Company&#x2019;s Sponsor to fund the Trust Account and for the Company&#x2019;s operating expenses.
On March 7, 2023 the Company&#x2019;s Sponsor advanced $&lt;span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20230307__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJD1SUJo7Pfj" title="Sponsor advanced amount"&gt;300,000&lt;/span&gt;
and will provide additional funds as necessary under the promissory note. These loans are non-interest bearing, unsecured and will
be repayable in full upon the earlier of (i) the date on which the Company consummates an initial business combination and (ii) the date that
the Company&#x2019;s winding up is effective.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <MURFU:PercentageOfDepositInTrustAccount
      contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Pure">0.01</MURFU:PercentageOfDepositInTrustAccount>
    <MURFU:StockIssuedDuringPeriodShareOnHold
      contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">11037272</MURFU:StockIssuedDuringPeriodShareOnHold>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">13979000</us-gaap:SharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">10.33</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">114</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">23</us-gaap:AssetsHeldInTrustNoncurrent>
    <MURFU:PercentageOfDepositInTrustAccount
      contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.01</MURFU:PercentageOfDepositInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="USDPShares">0.035</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DepositAssets
      contextRef="AsOf2023-01-26_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">77000</us-gaap:DepositAssets>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-01-252023-01-26_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">924000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-03-06_us-gaap_SubsequentEventMember"
      decimals="-5"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-03-072023-03-07_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">300000</us-gaap:ProceedsFromNotesPayable>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000207"
          xlink:label="Fact000207"
          xlink:type="locator"/>
        <link:footnote id="Footnote000211" xlink:label="Footnote000211" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes
    an aggregate of up to <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9R4rmUGX3I7"
  title="Number of option issued for forfeiture">431,250</xhtml:span> shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised
    in full or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such,
    the Class B common stock is no longer subject to forfeiture (see Notes 5 and 6).</link:footnote>
        <link:footnote id="Footnote000214" xlink:label="Footnote000214" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    January 26, 2022, the Sponsor surrendered and forfeited <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_902_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zNxtqdOMKVt5"
  title="Stock surrendered and forfeited during period shares">1,006,250</xhtml:span> founder shares for no consideration following which the Sponsor
    holds <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_902_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zyA2yNai3ox4"
  title="Stock issued during period on hold">3,306,250</xhtml:span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000207"
          xlink:to="Footnote000214"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000207"
          xlink:to="Footnote000211"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0230"
          xlink:label="xdx2ixbrl0230"
          xlink:type="locator"/>
        <link:footnote id="Footnote000301" xlink:label="Footnote000301" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    an aggregate of up to <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220206__20220207__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSlF8GRYa24f"
  title="Number of option issued for forfeiture">431,250</xhtml:span> shares of Common stock subject to forfeiture if the over-allotment option is not exercised in full
    or in part by the underwriters. The underwriters exercised the over-allotment option in full on February 7, 2022. As such, the Class
    B common stock is no longer subject to forfeiture (see Notes 5 and 6). </link:footnote>
        <link:footnote id="Footnote000304" xlink:label="Footnote000304" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    January 26, 2022, the Sponsor surrendered and forfeited <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_zQctBQNw3rp9"
  title="Stock surrendered and forfeited during period shares">1,006,250</xhtml:span> founder shares for no consideration following which the Sponsor
    holds <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFN0b2NraG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_901_ecustom--StockIssuedDuringPeriodShareOnHold_c20220125__20220126__srt--TitleOfIndividualAxis__custom--SponsorMember_z89iBBfkzGP3"
  title="Stock issued during period on hold">3,306,250</xhtml:span> founder shares. All share amounts have been retroactively restated to reflect this surrender (see Note 5).
    </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0230"
          xlink:to="Footnote000301"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0230"
          xlink:to="Footnote000304"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000231"
          xlink:label="Fact000231"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000231"
          xlink:to="Footnote000301"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000231"
          xlink:to="Footnote000304"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000232"
          xlink:label="Fact000232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000232"
          xlink:to="Footnote000301"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000232"
          xlink:to="Footnote000304"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0233"
          xlink:label="xdx2ixbrl0233"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0233"
          xlink:to="Footnote000301"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0233"
          xlink:to="Footnote000304"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000234"
          xlink:label="Fact000234"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000234"
          xlink:to="Footnote000301"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000234"
          xlink:to="Footnote000304"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000236"
          xlink:label="Fact000236"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000236"
          xlink:to="Footnote000301"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000236"
          xlink:to="Footnote000304"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M (^A* ?@^YD0:O=03E#?\ W_ U!+ P04    " !,BJQ6F2)@IN "   )"@
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M50K6J0IVI6 ?*%A="DZEX!PHF%Z'@ELIN*<.VJL4O(*L<G8+:J:(H_$5)4^
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M5=NDKE&C;0_3'ARX!*O&IK9)6FD_?M= 4*I2U$A]"?XZQ_><:U\GW$IUIW,
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M$\F_X4-=KOF%[UE9U^6*_UQ"BZ:B!_#[O 1;]1]H@?;_ /#V?P!02P,$%
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MPE_"!YLEZ;-Z2')@&;^$$@[Q$"*#;P0% H60T^0!U@G 9!GW]!A^1,.?+PJ
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M6ME GF,+M=++4-)1N[>@$8PF!')V^HEBOW4=&_W-<.N ^B!!7M6E\IP*"MZ
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MM>6LE&?)<^DHZ;H \3D 4IX.WE#*2,LT.V9O9I!?P!LXH3(5%'SCO!J0-BL
MFOSUJM$O76N:118<H#J$QU:[D%;:-(@%OE/S][D4(2CDM/ OQVL;KU"S>32@
M9AOGT]C0VCVD&I*Z!S=D\P)5H)&<(>& P;FY]#T![WN1T!]FJIN-\[48H=8-
M3CCQ#BAE8]6CJ7MS3+S]Q3R82 V:?,AVJJDPLJ1-!)(97<-D:Q'R2BBC-I0R
M,2:F54[BG??+3\?CP^/WBO=X*,\;2K()FB^2X$V;V.V:#3MK=#;M98,G[]=.
M'[9.=T?*]0DNPW[$XNI>GKM3$5JH,\U8.8K7WVJRVO1X#C+K/K*I2*>O$T"
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MTE 2*^9E(]!*O+JG5K%<W>#4BATHS4QW>1GOI&S(J[.AD*]D,",DV<G*X-<
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M(((;7;C,PF618KINH$_8%@"C%N!YM-/B!28]V!]T(0JC:(>]_47 ^][>_K:
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MF.("H=JFL.2BTYOL"#S'E0&7A&@7?:1L('@JW7JL45%6&.M4 C!1RGZ&(SU
M-A*]LU\43QJG1I8R:\/MXAFW=W-V*B-/E;&IA4,,.9N(G>Z;BH"744-]':6:
M>B0D4D])%F#CP?&*($NYA+RQC]9]OMG,GL2O(==YYMH9F<J' ZND0Z=-J$!N
M&.LYA&--J@4R $'5XJ2_H<K85)59<#G>WAD0$, A6:E092A.*?7RW13Q-4SP
M?!.XP0198@*&MA%T)^DEU_<_QP'KF^/HH*MURE&?YBB%C"&K4L_3RWXRGIR:
M&C]N-T>&_**[;<03\YX<TQ#8[2Q.F5II[OXYO4-(Z#B5DB)#^9Y2Y0JYQ1#5
M/M(4)0WM5*HQ5^I0J23? @W[9QRE5;.UY->#LTCP=['8#U[OCP[V!P=M^-9)
MGP]#*5E0[G/!&KAXILS;ZX+NF24VP6V-Q!%J)[5P=31TG& /M)JO\5S4FSH_
M6:"ZEXPVIN/6B*-]>;#_W0X;"$OIQ!"R=XWR36CL7+Z32U._A#,DY1RA)2%S
MU3;LRI? 'E^;W"UWKIASV<FO2*%R/J\"18E1U6#P81EX-+4/7G&_T*%'0)3L
MZA#B1Z ^#%*+FN+V*Y5BDG)K-3P^)]30YMWT6KN/NR8]N=V_1M>I2B>^&;SN
M]?O9MR^^.SG][@R^R@"&*I1U4@+.FTOKS](,Z3-)+77@DV_H7F^0!HDR,#P#
MVF?A)'?49YYK[SA#+[ZPU!@36?LHQR8#N5J034?]EUC9&2'[M&'6X0O)-DL#
ML,](Y94=XSPC$PQ.%_3 $N$1#WEH/BFCG829R9"=?*&2RU3K,L$^$S=CWF+1
M!B&ES$A!0DM5(?3++G37<<PM>BK)WG4M#J<<2@GB-/ *H-'4[1FL!6"V 4!&
M7L4]4J=Z4[/"-D=@TOW6"IRAGF\4^Q[9V-65+L("I6U2"$GO!A'EN52NL'H$
M5[>TC'DS6<O0YF\<Z.(5&)L5"(NK/\>6:16G$3<-G5&7JYYH\@6$E;=,NZ:E
M7@OCZG#$_4C:,PN0X?Q(!_6O:*4WU:7P=Z^9Z"RO+!-7H6W1S*C %70.K]N#
M.Y)TQ91<4,+&I:8S%W$I6,5*$#&:"+M,[P7'J)!S[0&6/V1;'XR=R#H]@_8F
M@=1PXG0&#7,Z)"^PI<U7)]9LY;P1??68;[6P2]3)S'%[G\"V;;J0^KR8FRR8
MH9,\R0,]<9&N-ZMEGG5[/]ZQB]OU$B'HLH7[]G@.VZ(U07]-Q%KFQ:.GVM&T
M9;';B^M3+W<;"&SS5%!IJ 8OQVYAC 1U8JJJ!,E["Z>A4A9TM9H_6\E;7R/.
M"CTB'RGH)HF:DR!X\Y@4ZOV&H!Q";/+CLA7'.5E2!=6HF*F5[Q@3B1Y-EH-S
M@QD9W<_1;4!,@35SGNC#JCZ)Q@4W%G3=LMR.LD"CW"HN0/"<[>$D@>+X2.1V
M6\DB,$]:Q#?;)7WO!69K2_*FY Z=TO#/-8$1B?&YR^W/[PX<;&X6>ERR-7!!
M]^:E+:+AJD[L4UM9:'] -,91:HO .-WG"8_>)=PC!]J_N+L2KP?'0;<'K$&<
MFD#:CIH?S@\<DYNM69''V_8%$R=*#RI]6((,^T8,C_+AZ0E]W9<*\3WF9*PX
MZ/8XO?[%T,&@@H9I<#A,H^\B8;DTV.^,.<9-QC=([?B@=WHBMGTC?-CYVIZ9
MC7Z<0.T=1(1O\-/;]/N'B_"U_VIZ^/'$C]).-+Q4J3&6]GNGQWNA0+</WLSY
M1P CX[V9\<>IDO Z3<#XV!C?/M &Z5<AY_\%4$L#!!0    ( $R*K%:13^!A
M%@,  )(&   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;)5546_B.!!^
MYU>,LJ=]JAH2V!910 HEU2+1;E5H[^%T#R89B+6.G;,=V-ZOO[$#N9S4(MV+
MX[%GOOEF/#.9')7^:0I$"[]*(<TT**RMQF%HL@)+9JY5A9)N=DJ7S)*H]Z&I
M-++<&Y4BC/O]F[!D7 :SB3][UK.)JJW@$I\UF+HLF7Z?HU#':1 %YX,7OB^L
M.PAGDXKM<8WVM7K6)(4M2LY+E(8K"1IWTR")QO.AT_<*;QR/IK,'%\E6J9].
M6.;3H.\(H<#,.@1&GP/>HQ .B&C\=<(,6I?.L+L_HS_XV"F6+3-XK\3O/+?%
M-!@%D...U<*^J.-W/,7SS>%E2AB_PK'1'0P#R&IC57DR)@8EE\V7_3KEH6,P
MZG]B$)\,8L^[<>19+IAELXE61]!.F]#<QH?JK8D<E^Y1UE;3+2<[.WM(EB_P
MEJQ>4WA,D_7K2_J8/FW6D] 2N%,)LQ/0O &*/P&*8GA4TA8&4IEC_E^ D%BU
MU.(SM7E\$7&!V34,HBN(^W%\ 6_0ACKP>(//0F5<PQL3-<*"FTPH4VLT\$>R
M-593=?SY4= -Y/!C2-<Q8U.Q#*<!M81!?<!@]O5+=-._NT!XV!(>7D+_/V]S
M$>ACFD\_-FEO!%^_C.(HOH-/G,&FP-Y."6I>+O=@V58@>!!I#7#9C 7?7UOJ
M>; %PKTJ*R;?/?+MG0%F#)(RDSD(SK9<<,LI\;9@%IA&*)&YI\B!Y)U[I(-_
M))*H!+#<HG9ET'-E<.51N,QYQJS'P*Y)P5$SG17OH';^SATW]+BL:FNZ_*"V
M1.5O\FL5-;)%3?V%-)ZRHH,YAO7]]W3QNDKAQT,W2R0EZW5**4J>%K!:)O/E
M:KE9INO> DVF>>7=KO" HHVC=R[G7N)S,NXMY0&-+7TV"Q0N-MAHZGM(LDS5
MTD($OT$TN+D:W497T6@ B>E1<-W,.$1:*31*YM$M4L%']1=VYD2)>N^GH0'O
MIQD9[6D[<)-FSORKWDSK1Z;W7!H0N"/3_O7MMP!T,P$;P:K*3YVMLC3#_+:@
MGP9JIT#W.Z7L67 .VM_0[!]02P,$%     @ 3(JL5CZA&Y*2!0  ?0P  !D
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MTO/N?.@(UB\.LQ[BJH-(7X!(4OB@E2LMW*@<\UV (=FS,2I=&W65'D1\B]D
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M:/P&6B\T!:__\0=LAOWI?U!+ P04    " !,BJQ66-[&"7D5   /00  &0
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M(()#=O@SI ,QP+Z!QW^Z(FJ_BJC]'U3^=-X[^=S>->W>OJW*)WTEF(W0R4Z
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M*FLRVY7T&ITU;N#8'K.;]0"-+HU"MQB%CS.4-I&H<BQMZK?K"3IAL$WB%?-
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M BJT-I%KWSVP1V?NGH3$7PFM_4RN]<NR3A9I/V4PW/ ;QV?G'3$VTFI]4K2
M"JW-8A.D&=J#-'?UCW!#KN96[DBC-</-&(;;=8K'(ZW6)T4+J-#:W#7!FN'_
M^UT#.\#.G&W&+-SN\48:>"%%"ZC02L[Z:Q\Z2H6<F4]2X2D(&$3E-X_JI_5G
MKZ[,QY[Z3?'RFUE?N)S%F6*)F(+HX.@4%)7E9ZC*&YTOS&>3)KG6>6HNYX)'
M0F(!>#_-<[VZP0KJCX%=_A=02P,$%     @ 3(JL5D8:ATEE!   918  !D
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MI:.@ )8XC?@#V;Z'<D#MC,\G$<O_T;:(M2T%^2GC)"[!H@=QF!1'_+5\$'L
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M^H0I _E^2:G83]0&[;^'R3]02P,$%     @ 3(JL5N_O(@2)!   !A$  !D
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M\!>G6]@ U6[3_=EFC/I&ID[%U#$RW4&ZY )W\R);J<<C3%U"/&HLEO(\PZS
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M];0ZY)\51UM[VWSSA>"*B3FF49+ #$V=DP!)Q.;0O;E1?%F<6R=<X2FXN%P
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M0A8^^C&2M2DR-4&.3RD5JX8*4%6[O?]02P,$%     @ 3(JL5M4J#%86!
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M>?6@9[4A65$^!7C/I&19^7))24RY/D"]/V=,/FWH!C:/VX[^!U!+ P04
M" !,BJQ6&RI^MH #  !^"P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6RU5MMNVS@0_96!MEBT0&I=?$W6%N#8Z:Z!V@GJI'TH]H&61A812=22M)T"
M^_$E*5E6$%DMBN9%(B7..8?#F>&,#XP_BAA1PE.:9&)BQ5+F5[8M@AA3(CHL
MQTS]B1A/B513OK5%SI&$QBA-;,]Q!G9*:&;Y8_/MCOMCMI,)S?".@]BE*>'?
MKC%AAXGE6L</G^@VEOJ#[8]SLL4URH?\CJN97:&$-,5,4)8!QVAB3=VK:[>O
M#<R*SQ0/HC8&O94-8X]ZL@@GEJ,588*!U!!$O?8XPR312$K'?R6H57%JP_KX
MB/[!;%YM9D,$SECRA88RGE@C"T*,R"Z1G]CA'RPW9 0&+!'F"8=B[:!G0; 3
MDJ6EL5*0TJQXDZ?2$36#GG/&P"L-/*.[(#(JYT02?\S9 ;A>K=#TP&S56"MQ
M--.GLI9<_:7*3OJSV^5R<;^\6=VO8;J:P^QV=;]8_7VSFBUNUO!VCI+01,"*
M<$ZT_]Z-;:EHM;$=E!37!85WAL+U8,DR&0NXR4(,GP/82F\EVCN*OO9:$><8
M=*#K7H#G>!X\K.?P]LT[> ,VB)AP%.6KA:E;N:=KF+IGF-:[C: A5?%Z 6N2
M(+ (UI(%C_#UHUH*"XFI^+?))P5NKQE7Y]J5R$F $TLEDT"^1\O_\P]WX/S5
MHKI7J>ZUH?NWN8EX?$(>4($AA$1BD\AVF ^XZ0 XPPLPCFX1UJ^$]5L19T3$
ML%-1P ^<2IIM(:0B8+M,PO^U\VN26@ /#; N-7O?Z2A)^P8U@TK-H%7-0Y.0
M)NX"IE_C]@:]ON,XS?S#BG_8RC_'"#E7QQ,A0HZ\V/T//3%L\$2WWRQE5$D9
M_;24)L[1"P_T!MYHV#_C@<N*]O+G3D!M'I_432.:MWSY@M[5[C_#[CJGXN>T
M)\H>^?MIDC"I+AH)9=Y\76*Z0=Z8UNV OYC7;JU:NZ]4CTK@WRS<.PGW6CU]
M%)MSNE?%"/)$<1FG[S(JQ05DJ@-1_UFD E'G8\"$%"H7SN=!R3BH1\70.Y^6
M[JGHNZW5^5E8M@;#:Q1Y]U3EW=YK!4-KX?]5X:=;P&V_!J;AGF2!"@+RS82
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M[8>J'P9[ &MM#SLSD*W4']_Q)38#9A:O3O.!8/!YSL \LL>OS.R%LL]\0XA
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M.+5''5) =O5!:0$H+82BJ5*TX:6E3R_[9E9Z7&\=0*-+4)IO=22A8S4>JGV
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MJV[TKS8$W9;WF2^I$#0KGVX(C@DK=I#OKR@5KQM%@^;G%O/_ %!+ P04
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !,BJQ67#P!8>\#  "Q&0  #P
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M6./Y[Z0Z#-^ZZ?AQ^=A$"><CSA9NQG>_4$L#!!0    ( $R*K%9CUHH4FP$
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M<' N>&UL4$L! A0#%     @ 3(JL5G+^FX[N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 3(JL5IE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !,BJQ6AO3GGL $  !^%   &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 3(JL5JE7_ABB
M!0  9!H  !@              ("! PT  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( $R*K%9:.;E0B@,  /(/   8              "
M@=L2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !,BJQ6
MS&4JVJX$  #M$P  &               @(&;%@  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ 3(JL5IDB8*;@ @  "0H  !@
M     ("!?QL  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M $R*K%:'92ZJI@4  %D?   8              " @94>  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " !,BJQ6IVI.\KD"   B"   &
M            @(%Q)   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ 3(JL5B)Z2U%9!@  B1\  !@              ("!8"<  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( $R*K%8-FPN%5!4   U
M   8              " @>\M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " !,BJQ6'B;GIE,4   A.   &0              @(%Y0P
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( $R*K%:>OI)[
M0@(  "$%   9              " @0-8  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ 3(JL5M>8X!9N @  7 4  !D
M ("!?%H  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !,
MBJQ632>*?]P$  !T"@  &0              @($A70  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( $R*K%9D="CY# 4  .<+   9
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M970Q."YX;6Q02P$"% ,4    " !,BJQ66-[&"7D5   /00  &0
M    @(&=@0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M $R*K%;ED(-!]P0  .P,   9              " @4V7  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ 3(JL5H%-"^0$ P  9@8  !D
M             ("!>YP  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " !,BJQ6[L"QGJD#  #9"   &0              @(&VGP  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( $R*K%;?5P&7L@L
M !A,   9              " @9:C  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ 3(JL5D8:ATEE!   918  !D              ("!
M?Z\  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !,BJQ6
MBR^R=9T#  !)#   &0              @($;M   >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( $R*K%;O[R($B00   81   9
M      " @>^W  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ 3(JL5H"(SDOX @  ^0H  !D              ("!K[P  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !,BJQ6U2H,5A8$  "8%0
M&0              @('>OP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( $R*K%9VA*N5) <  'H[   9              " @2O$  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 3(JL5ALJ?K:
M P  ?@L  !D              ("!ALL  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " !,BJQ6I\UZTD &  #W)@  &0
M@($]SP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( $R*
MK%9WU)2+A0(  .L'   9              " @;35  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ 3(JL5MRO%5A( @   @8  !D
M         ("!<-@  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " !,BJQ6"DA2Y>4"   P"   &0              @('OV@  >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( $R*K%;_N[[P5 (  +L%
M   9              " @0O>  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ 3(JL5A!7=KC5 @  ]PD  !D              ("!EN
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !,BJQ6[(X-
MA48"  ".!0  &0              @(&BXP  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( $R*K%80&H!KX@4  'HQ   9
M  " @1_F  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
M3(JL5N3_;VX\ P  \A,   T              ( !..P  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " !,BJQ6EXJ[',     3 @  "P              @ &?
M[P  7W)E;',O+G)E;'-02P$"% ,4    " !,BJQ67#P!8>\#  "Q&0  #P
M            @ &(\   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 3(JL
M5K>]PDN! 0  *1<  !H              ( !I/0  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ 3(JL5F/6BA2; 0  E!<  !,
M         ( !7?8  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     "X +@!Y
)#   *?@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>81</ContextCount>
  <ElementCount>186</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>29</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/BalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/StatementsOfOperations</Role>
      <ShortName>Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/StatementsOfOperationsParenthetical</Role>
      <ShortName>Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Statements of Changes in Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit</Role>
      <ShortName>Statements of Changes in Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Statements of Changes in Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Statements of Changes in Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INITIAL PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/InitialPublicOffering</Role>
      <ShortName>INITIAL PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - PRIVATE PLACEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/PrivatePlacements</Role>
      <ShortName>PRIVATE PLACEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - STOCKHOLDERS??? EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/StockholdersEquityDeficit</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/Taxes</Role>
      <ShortName>TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://bloomberg.com/role/FairValueMeasurements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/TaxesTables</Role>
      <ShortName>TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://bloomberg.com/role/Taxes</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails</Role>
      <ShortName>SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails</Role>
      <ShortName>SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative</Role>
      <ShortName>INITIAL PUBLIC OFFERING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/InitialPublicOffering</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/PrivatePlacementsDetailsNarrative</Role>
      <ShortName>PRIVATE PLACEMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/PrivatePlacements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/RelatedPartyTransactions</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - STOCKHOLDERS??? EQUITY (DEFICIT) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (DEFICIT) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure -  SCHEDULE OF CHANGE IN VALUATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/ScheduleOfChangeInValuationDetails</Role>
      <ShortName>SCHEDULE OF CHANGE IN VALUATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/TaxesDetailsNarrative</Role>
      <ShortName>TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/TaxesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="forms-4.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bloomberg.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://bloomberg.com/role/SubsequentEvents</ParentRole>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-4" original="forms-4.htm">forms-4.htm</File>
    <File>ex10-17.htm</File>
    <File>ex10-20.htm</File>
    <File>ex10-21.htm</File>
    <File>ex10-22.htm</File>
    <File>ex10-23.htm</File>
    <File>ex10-24.htm</File>
    <File>ex10-25.htm</File>
    <File>ex107.htm</File>
    <File>ex23-1.htm</File>
    <File>ex23-2.htm</File>
    <File>ex23-5.htm</File>
    <File>ex3-5.htm</File>
    <File>ex99-1.htm</File>
    <File>ex99-2.htm</File>
    <File>ex99-3.htm</File>
    <File>ex99-4.htm</File>
    <File>ex99-5.htm</File>
    <File>ex99-6.htm</File>
    <File>ex99-7.htm</File>
    <File>murfu-20221231.xsd</File>
    <File>murfu-20221231_cal.xml</File>
    <File>murfu-20221231_def.xml</File>
    <File>murfu-20221231_lab.xml</File>
    <File>murfu-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>annexd_001.jpg</File>
    <File>annexd_002.jpg</File>
    <File>annexd_003.jpg</File>
    <File>annexd_004.jpg</File>
    <File>annexd_005.jpg</File>
    <File>annexd_006.jpg</File>
    <File>annexd_007.jpg</File>
    <File>annexd_008.jpg</File>
    <File>annexd_009.jpg</File>
    <File>forms-4_001.jpg</File>
    <File>forms-4_002.jpg</File>
    <File>forms-4_003.jpg</File>
    <File>forms-4_004.jpg</File>
    <File>forms-4_005.jpg</File>
    <File>forms-4_006.jpg</File>
    <File>forms-4_007.jpg</File>
    <File>forms-4_008.jpg</File>
    <File>forms-4_009.jpg</File>
    <File>forms-4_010.jpg</File>
    <File>forms-4_011.jpg</File>
    <File>forms-4_012.jpg</File>
    <File>forms-4_013.jpg</File>
    <File>forms-4_014.jpg</File>
    <File>forms-4_015.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="330">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "forms-4.htm": {
   "axisCustom": 0,
   "axisStandard": 11,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 330,
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 81,
   "dts": {
    "calculationLink": {
     "local": [
      "murfu-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "murfu-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "forms-4.htm"
     ]
    },
    "labelLink": {
     "local": [
      "murfu-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "murfu-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "murfu-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 324,
   "entityCount": 1,
   "hidden": {
    "http://bloomberg.com/20221231": 9,
    "http://fasb.org/us-gaap/2022": 58,
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 69
   },
   "keyCustom": 37,
   "keyStandard": 149,
   "memberCustom": 10,
   "memberStandard": 19,
   "nsprefix": "MURFU",
   "nsuri": "http://bloomberg.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://bloomberg.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - INITIAL PUBLIC OFFERING",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://bloomberg.com/role/InitialPublicOffering",
     "shortName": "INITIAL PUBLIC OFFERING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:PrivatePlacementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - PRIVATE PLACEMENTS",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://bloomberg.com/role/PrivatePlacements",
     "shortName": "PRIVATE PLACEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:PrivatePlacementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - RELATED PARTY TRANSACTIONS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://bloomberg.com/role/RelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://bloomberg.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://bloomberg.com/role/StockholdersEquityDeficit",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://bloomberg.com/role/FairValueMeasurements",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - TAXES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://bloomberg.com/role/Taxes",
     "shortName": "TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://bloomberg.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "19",
     "role": "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://bloomberg.com/role/BalanceSheets",
     "shortName": "Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://bloomberg.com/role/FairValueMeasurementsTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - TAXES (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://bloomberg.com/role/TaxesTables",
     "shortName": "TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock",
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
     "shortName": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationControlObtainedDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock",
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails",
     "shortName": "SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "MURFU:ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock",
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-012022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "MURFU:ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-012022-12-31_us-gaap_CommonClassAMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
     "shortName": "SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-012022-12-31_us-gaap_CommonClassAMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "MURFU:OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "lang": null,
      "name": "MURFU:PublicOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-11-16_us-gaap_CommonClassAMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
     "shortName": "INITIAL PUBLIC OFFERING (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "MURFU:InitialPublicOfferingTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_CommonClassAMember_custom_PublicWarrantMember_us-gaap_IPOMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
     "shortName": "PRIVATE PLACEMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "MURFU:PrivatePlacementsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-012022-12-31_srt_DirectorMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-10-192021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-02-092022-02-10",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:SponsorFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://bloomberg.com/role/BalanceSheetsParenthetical",
     "shortName": "Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:OptionExercisedDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "MURFU:OptionExercisedDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_WarrantMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails",
     "shortName": "SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative",
     "shortName": "FAIR VALUE MEASUREMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_FinancialServiceMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxLiabilitiesDeferredExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxLiabilitiesDeferredExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure -  SCHEDULE OF CHANGE IN VALUATION (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails",
     "shortName": "SCHEDULE OF CHANGE IN VALUATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - TAXES (Details Narrative)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://bloomberg.com/role/TaxesDetailsNarrative",
     "shortName": "TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityRedemptionPricePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://bloomberg.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2023-01-252023-01-26_us-gaap_SubsequentEventMember",
      "decimals": "INF",
      "lang": null,
      "name": "MURFU:PercentageOfDepositInTrustAccount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-10-192021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://bloomberg.com/role/StatementsOfOperations",
     "shortName": "Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-10-192021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-252022-01-26_custom_SponsorMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRedeemedOrCalledDuringPeriodShares",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Statements of Operations (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://bloomberg.com/role/StatementsOfOperationsParenthetical",
     "shortName": "Statements of Operations (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Statements of Changes in Stockholders' Equity (Deficit)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
     "shortName": "Statements of Changes in Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-10-192021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-252022-01-26_custom_SponsorMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRedeemedOrCalledDuringPeriodShares",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - Statements of Changes in Stockholders' Equity (Deficit) (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
     "shortName": "Statements of Changes in Stockholders' Equity (Deficit) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-10-192021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000008 - Statement - Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://bloomberg.com/role/StatementsOfCashFlows",
     "shortName": "Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2021-10-192021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "MURFU:FormationCostsPaidByNotePayableSponsor",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern",
     "shortName": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-4.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 29,
   "tag": {
    "MURFU_AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remeasurement of Class A common stock subject to possible redemption upon IPO.",
        "label": "AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo",
        "negatedLabel": "Remeasurement of Class A common stock subject to possible redemption upon IPO"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockRemeasurementOfClassCommonStockSubjectToPossibleRedemptionUponIpo",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_AdministrationFeeRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Administration fee related party.",
        "label": "Administration fee \u2013 related party",
        "verboseLabel": "Administration fee related party"
       }
      }
     },
     "localname": "AdministrationFeeRelatedParty",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_AdvancePaymentForUnderwriterExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance payment for underwriter expenses.",
        "label": "Advance payment for underwriter expenses"
       }
      }
     },
     "localname": "AdvancePaymentForUnderwriterExpenses",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_BusinessCombinationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Agreement [Member]",
        "label": "Business Combination Agreement [Member]"
       }
      }
     },
     "localname": "BusinessCombinationAgreementMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_CashUnderwritingDiscount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash underwriting discount.",
        "label": "Cash underwriting discount"
       }
      }
     },
     "localname": "CashUnderwritingDiscount",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "MURFU_ClassASharesSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A shares subject to redemption"
       }
      }
     },
     "localname": "ClassASharesSubjectToRedemption",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_CommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock subject to possible redemption.",
        "label": "CommonStockSubjectToPossibleRedemption",
        "periodEndLabel": "Common stock subject to possible redemption, ending",
        "periodStartLabel": "Common stock subject to possible redemption, ending"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemption",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_ConduitPharmaceuticalsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conduit Pharmaceuticals Limited [Member]",
        "label": "Conduit Pharmaceuticals Limited [Member]"
       }
      }
     },
     "localname": "ConduitPharmaceuticalsLimitedMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_DeferredCommissionPayableNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Commission Payable Non Current.",
        "label": "Deferred commission payable"
       }
      }
     },
     "localname": "DeferredCommissionPayableNonCurrent",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_DeferredFeePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred fee per share.",
        "label": "Deferred fee per share"
       }
      }
     },
     "localname": "DeferredFeePerShare",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "MURFU_DeferredOfferingCostsIncludedInAccruedOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering costs included in accrued offering costs.",
        "label": "Deferred offering costs included in accrued offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInAccruedOfferingCosts",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_DeferredOfferingCostsPaidByNotePayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering costs paid by note payable.",
        "label": "Deferred offering costs paid by note payable - Sponsor"
       }
      }
     },
     "localname": "DeferredOfferingCostsPaidByNotePayable",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_DeferredUnderwritingCommissionPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred underwriting commission payable.",
        "label": "DeferredUnderwritingCommissionPayable",
        "verboseLabel": "Deferred commission payable"
       }
      }
     },
     "localname": "DeferredUnderwritingCommissionPayable",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_DeferredUnderwritingFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred underwriting fee.",
        "label": "Deferred underwriting fee"
       }
      }
     },
     "localname": "DeferredUnderwritingFee",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_DisclosureInitialPublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering"
       }
      }
     },
     "localname": "DisclosureInitialPublicOfferingAbstract",
     "nsuri": "http://bloomberg.com/20221231",
     "xbrltype": "stringItemType"
    },
    "MURFU_DisclosurePrivatePlacementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placements"
       }
      }
     },
     "localname": "DisclosurePrivatePlacementsAbstract",
     "nsuri": "http://bloomberg.com/20221231",
     "xbrltype": "stringItemType"
    },
    "MURFU_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Growth Company [Policy Text Block]",
        "label": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_FormationCostsPaidByNotePayableSponsor": {
     "auth_ref": [],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Formation costs paid by note payable sponsor.",
        "label": "Formation costs paid by note payable \u2013 Sponsor"
       }
      }
     },
     "localname": "FormationCostsPaidByNotePayableSponsor",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_InitialPublicOfferingCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial public offering cost.",
        "label": "Initial public offering costs"
       }
      }
     },
     "localname": "InitialPublicOfferingCost",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_InitialPublicOfferingTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Instruments [Policy Text Block]",
        "label": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "InitialPublicOfferingTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/InitialPublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_InvestmentHeldInTrustAccountPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Held In Trust Account [Policy Text Block]",
        "label": "InvestmentHeldInTrustAccountPolicyTextBlock",
        "verboseLabel": "Investments Held in Trust Account"
       }
      }
     },
     "localname": "InvestmentHeldInTrustAccountPolicyTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_InvestmentsHeldInTrustAccountPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments Held In Trust Account [Policy Text Block]",
        "label": "Investments Held in Trust Account"
       }
      }
     },
     "localname": "InvestmentsHeldInTrustAccountPolicyTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering Costs Associated With Public Offering [Policy Text Block]",
        "label": "Offering Costs Associated With a Public Offering"
       }
      }
     },
     "localname": "OfferingCostsAssociatedWithPublicOfferingPolicyTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_OperatingCashAccount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating cash account.",
        "label": "Operating cash account"
       }
      }
     },
     "localname": "OperatingCashAccount",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_OptionExercisedDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option exercised date.",
        "label": "Option exercised date"
       }
      }
     },
     "localname": "OptionExercisedDate",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "MURFU_OverfundingOfTheTrustAccount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Overfunding of the trust account.",
        "label": "Overfunding of the trust account"
       }
      }
     },
     "localname": "OverfundingOfTheTrustAccount",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_PaymentOfCommonStockIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issuance costs.",
        "label": "Class A common stock issuance costs"
       }
      }
     },
     "localname": "PaymentOfCommonStockIssuanceCosts",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_PercentageOfDepositInTrustAccount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of deposit in trust account.",
        "label": "Percentage of deposit in trust account"
       }
      }
     },
     "localname": "PercentageOfDepositInTrustAccount",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "MURFU_PrepaidExpensesPaidByNotePayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses paid by note payable.",
        "label": "Prepaid expenses paid by note payable - Sponsor"
       }
      }
     },
     "localname": "PrepaidExpensesPaidByNotePayable",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_PrivatePlacementWarrantsAndPublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placement Warrants And Public Warrants [Member]",
        "label": "Private Placement Warrants And Public Warrants [Member]"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsAndPublicWarrantsMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placement Warrants [Member]",
        "label": "Private Placement Warrants [Member]"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_PrivatePlacementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placements [Text Block]",
        "label": "PRIVATE PLACEMENTS"
       }
      }
     },
     "localname": "PrivatePlacementsTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/PrivatePlacements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds allocated to public warrants, net of offering cost.",
        "label": "Proceeds allocated to Public Warrants"
       }
      }
     },
     "localname": "ProceedsAllocatedToPublicWarrantsNetOfOfferingCosts",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_PublicOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering costs.",
        "label": "PublicOfferingCosts",
        "verboseLabel": "Offering costs"
       }
      }
     },
     "localname": "PublicOfferingCosts",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_PublicWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Warrant [Member]",
        "label": "Public Warrant [Member]"
       }
      }
     },
     "localname": "PublicWarrantMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Warrants [Member]",
        "label": "Public Warrants [Member]"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Common Stock Subject To Possible Redemption [Table Text Block]",
        "label": "SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION"
       }
      }
     },
     "localname": "ScheduleOfCommonStockSubjectToPossibleRedemptionTableTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor [Member]",
        "label": "Sponsor [Member]"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_StockIssuedDuringPeriodShareOnHold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares on hold.",
        "label": "Stock issued during period on hold"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodShareOnHold",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "MURFU_StockIssuedDuringPeriodSharesOnHold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares on hold.",
        "label": "StockIssuedDuringPeriodSharesOnHold",
        "verboseLabel": "Stock issued during period on hold"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOnHold",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "MURFU_SubscriptionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription Agreements [Member]",
        "label": "Subscription Agreements [Member]"
       }
      }
     },
     "localname": "SubscriptionAgreementsMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_TemporaryEquityAccretionToOriginalRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity accretion to original redemption value adjustment.",
        "label": "Remeasurement adjustment of carrying value to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToOriginalRedemptionValueAdjustment",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_TransactionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction Agreement [Member]",
        "label": "Transaction Agreement [Member]"
       }
      }
     },
     "localname": "TransactionAgreementMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_UnderwriterExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriter expenses.",
        "label": "Underwriter expenses"
       }
      }
     },
     "localname": "UnderwriterExpenses",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_UnderwriterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriter [Member]",
        "label": "Underwriter [Member]"
       }
      }
     },
     "localname": "UnderwriterMember",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "MURFU_UnderwritingDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting discount.",
        "label": "Underwriting discount"
       }
      }
     },
     "localname": "UnderwritingDiscount",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_WarrantInstrumentsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Instruments [Policy Text Block]",
        "label": "Warrant Instruments"
       }
      }
     },
     "localname": "WarrantInstrumentsPolicyTextBlock",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "MURFU_WarrantIssuanceCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issuance cost.",
        "label": "Warrant issuance cost"
       }
      }
     },
     "localname": "WarrantIssuanceCost",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "MURFU_WorkingCapitalLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital loan.",
        "label": "Working capital loans"
       }
      }
     },
     "localname": "WorkingCapitalLoan",
     "nsuri": "http://bloomberg.com/20221231",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r325",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://bloomberg.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r172",
      "r283",
      "r304",
      "r313",
      "r349",
      "r350",
      "r354",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r172",
      "r283",
      "r304",
      "r313",
      "r349",
      "r350",
      "r354",
      "r374"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r346",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r90",
      "r101"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r5",
      "r312"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r341",
      "r342",
      "r343",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r46",
      "r54",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Proceeds allocated to Public Warrants, net of offering costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income (loss) to net cash used in operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r89",
      "r100",
      "r112",
      "r130",
      "r166",
      "r168",
      "r170",
      "r173",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r246",
      "r250",
      "r261",
      "r312",
      "r352",
      "r353",
      "r372"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS",
        "verboseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r109",
      "r117",
      "r130",
      "r173",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r246",
      "r250",
      "r261",
      "r312",
      "r352",
      "r353",
      "r372"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrust": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.",
        "label": "Investments held in trust"
       }
      }
     },
     "localname": "AssetsHeldInTrust",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Investments held in Trust Account",
        "terseLabel": "Investments held in trust account",
        "verboseLabel": "Assets held-in-trust, noncurrent"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative",
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r244",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r71",
      "r72",
      "r244",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationControlObtainedDescription": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a description of how the entity obtained control of the acquired entity.",
        "label": "Business combination description of transaction"
       }
      }
     },
     "localname": "BusinessCombinationControlObtainedDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalUnitClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A of capital units, which are a type of ownership interest in a corporation.",
        "label": "Capital Unit, Class A [Member]"
       }
      }
     },
     "localname": "CapitalUnitClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r33",
      "r111",
      "r295"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r28",
      "r33",
      "r37"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash at end of period",
        "periodStartLabel": "Cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r28",
      "r83"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r130",
      "r148",
      "r149",
      "r151",
      "r153",
      "r156",
      "r157",
      "r173",
      "r179",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r191",
      "r192",
      "r195",
      "r199",
      "r206",
      "r261",
      "r294",
      "r334",
      "r338",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperations",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Exercise price of warrants",
        "verboseLabel": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "negatedLabel": "Outstanding warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r14",
      "r92",
      "r104"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies (Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r45",
      "r177",
      "r178",
      "r293",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StatementsOfOperations",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperations",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r341",
      "r342",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r312"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Voting rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r98",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r340",
      "r361",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "negatedLabel": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r340",
      "r361",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "auth_ref": [
      "r35",
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Notes payable converted"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r47",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r84",
      "r86",
      "r188",
      "r270",
      "r301",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Principal amount",
        "verboseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt instrument redemption price percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCosts": {
     "auth_ref": [
      "r88",
      "r99",
      "r335"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.",
        "label": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r340",
      "r362",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Offering costs",
        "verboseLabel": "Deferred fee"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r340",
      "r362",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "negatedLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r228"
     ],
     "calculation": {
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpense": {
     "auth_ref": [
      "r68",
      "r360"
     ],
     "calculation": {
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs.",
        "label": "Startup costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Aggregate of deposit"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesReportingOfDerivativeActivity": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.",
        "label": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesReportingOfDerivativeActivity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r125",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r147",
      "r148",
      "r151",
      "r152",
      "r153",
      "r154",
      "r254",
      "r255",
      "r284",
      "r286",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Class B common stock \u2013 Basic and diluted net income (loss) per share",
        "verboseLabel": "Basic and diluted net loss per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Net Income (Loss) per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income tax provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r132",
      "r223",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "U.S. federal statutory rate",
        "verboseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
      "http://bloomberg.com/role/TaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r357",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r357",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r54",
      "r107",
      "r121",
      "r122",
      "r123",
      "r134",
      "r135",
      "r136",
      "r138",
      "r144",
      "r146",
      "r155",
      "r174",
      "r208",
      "r216",
      "r217",
      "r218",
      "r234",
      "r235",
      "r253",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r271",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative",
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to distribution, servicing and underwriting fees.",
        "label": "Underwriting fees"
       }
      }
     },
     "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r256",
      "r257",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r78",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r190",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r257",
      "r280",
      "r281",
      "r282",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r190",
      "r209",
      "r214",
      "r257",
      "r280",
      "r305",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r190",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r280",
      "r281",
      "r282",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r80",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalDepositInsuranceCorporationPremiumExpense": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.",
        "label": "Federal deposit insurance corporation premium expense"
       }
      }
     },
     "localname": "FederalDepositInsuranceCorporationPremiumExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r131",
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Federal"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialServiceMember": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial assistance, including, but not limited to, management and maintenance of depositor account, credit card, merchant discount, trust, investment and insurance.",
        "label": "Financial Service [Member]"
       }
      }
     },
     "localname": "FinancialServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r17",
      "r87",
      "r93",
      "r106",
      "r166",
      "r167",
      "r169",
      "r171",
      "r285",
      "r300"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Net income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r224",
      "r226",
      "r231",
      "r236",
      "r239",
      "r241",
      "r242",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/Taxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income tax penalties and interest accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r145",
      "r146",
      "r165",
      "r222",
      "r237",
      "r240",
      "r287"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Provision",
        "negatedLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails",
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.",
        "label": "Change in valuation"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r120",
      "r220",
      "r221",
      "r226",
      "r227",
      "r230",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Accrued income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "verboseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r85",
      "r96",
      "r124",
      "r164",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r21",
      "r163"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Interest income \u2013 Investments held in Trust Account",
        "negatedLabel": "Interest earned on investments held in Trust Account"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows",
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r11",
      "r130",
      "r173",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r247",
      "r250",
      "r251",
      "r261",
      "r299",
      "r352",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r91",
      "r103",
      "r312",
      "r339",
      "r347",
      "r370"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r110",
      "r130",
      "r173",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r247",
      "r250",
      "r251",
      "r261",
      "r312",
      "r352",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r28",
      "r30",
      "r32"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r18",
      "r32",
      "r94",
      "r105",
      "r108",
      "r118",
      "r119",
      "r123",
      "r130",
      "r137",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r150",
      "r166",
      "r167",
      "r169",
      "r171",
      "r173",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r255",
      "r261",
      "r300",
      "r352"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Note payable \u2013 Sponsor",
        "verboseLabel": "Notes payable, current"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r166",
      "r167",
      "r169",
      "r171",
      "r300"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "negatedTotalLabel": "Total expenses"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Monthly payment for office space"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payment of offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Cash deposited into Trust Account"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized",
        "verboseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r3",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued",
        "verboseLabel": "Preferred stock shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred stock shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r3",
      "r312"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r116",
      "r175",
      "r176",
      "r296"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Sale of units in public offering",
        "terseLabel": "Proceeds from Issuance Initial Public Offering",
        "verboseLabel": "Proceeds from isssuance"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails",
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from issuance of Class B common stock to Sponsor"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Sale of private placement units",
        "verboseLabel": "Proceeds from issuance of private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Net proceeds from sale of equity"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Sponsor advanced amount"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from note payable - Sponsor"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r108",
      "r118",
      "r119",
      "r126",
      "r130",
      "r137",
      "r145",
      "r146",
      "r166",
      "r167",
      "r169",
      "r171",
      "r173",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r245",
      "r248",
      "r249",
      "r255",
      "r261",
      "r285",
      "r300",
      "r310",
      "r311",
      "r336",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Allocation of net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://bloomberg.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Repayment of note payable - Sponsor"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r61",
      "r102",
      "r291",
      "r292",
      "r312"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r107",
      "r134",
      "r135",
      "r136",
      "r138",
      "r144",
      "r146",
      "r174",
      "r216",
      "r217",
      "r218",
      "r234",
      "r235",
      "r253",
      "r288",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsRestrictions": {
     "auth_ref": [
      "r16",
      "r52",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terms of any restriction upon retained earnings. This may include restrictions that arise from: (1) the aggregate preferences of the preferred shares exceeding the par or stated value of such shares upon liquidation; (2) dividend restrictions - for example, restrictions on the payment of dividends, indicating the source, the pertinent provision, and the amount of retained earnings or net income restricted or free of restrictions; (3) other appropriations; (4) any restrictions on distributions to shareholders; (5) retained earnings appropriated for loss contingencies; and (6) the amount of consolidated earnings which represents undistributed earnings of 50 percent or less owned by persons accounted for by the equity method, (7) state laws that govern circumstances under which corporations may acquire its own stock and on the availability of retained earnings for payment of dividends.",
        "label": "Retained earnings restrictions"
       }
      }
     },
     "localname": "RetainedEarningsRestrictions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Gross proceeds from shares issuance"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of stock",
        "verboseLabel": "Number of shares issued for private sale"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of stock price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "SCHEDULE OF CHANGE IN VALUATION"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/TaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r64",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/TaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "SCHEDULE OF BASIC AND DILUTED NET INCOME LOSS PER COMMON SHARE"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/TaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r49",
      "r51",
      "r53",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r113",
      "r114",
      "r115",
      "r156",
      "r191",
      "r192",
      "r193",
      "r195",
      "r199",
      "r204",
      "r206",
      "r303",
      "r334",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Number of option issued for forfeiture"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share price per shares"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Stock issued"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Share issued price per share",
        "terseLabel": "Price per share",
        "verboseLabel": "Shares issued price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.",
        "label": "Class A Common Stock Subject to Possible Redemption"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date.",
        "label": "Shares subject to possible redemption"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r38",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SponsorFees": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.",
        "label": "Sponsor fees"
       }
      }
     },
     "localname": "SponsorFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r340",
      "r356",
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State and Local"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfChangeInValuationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r130",
      "r148",
      "r149",
      "r151",
      "r153",
      "r156",
      "r157",
      "r173",
      "r179",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r191",
      "r192",
      "r195",
      "r199",
      "r206",
      "r261",
      "r294",
      "r334",
      "r338",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperations",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r15",
      "r54",
      "r107",
      "r121",
      "r122",
      "r123",
      "r134",
      "r135",
      "r136",
      "r138",
      "r144",
      "r146",
      "r155",
      "r174",
      "r208",
      "r216",
      "r217",
      "r218",
      "r234",
      "r235",
      "r253",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r271",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative",
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperations",
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r155",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/FairValueMeasurementsDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperations",
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r54",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Sale of private placement units, net of offering costs",
        "terseLabel": "Number of units transferred to director",
        "verboseLabel": "Stock issued during period shares new issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r15",
      "r54",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Shares issued",
        "verboseLabel": "Proceeds from business combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r54",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Sale of Private Placement Units, net of offering costs",
        "verboseLabel": "Number of shares issued to sponsor, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock surrendered and forfeited during period shares"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Number of stock redeemed, value",
        "negatedLabel": "Remeasurement of Class A shares to redemption value"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r44",
      "r312",
      "r339",
      "r347",
      "r370"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r63",
      "r129",
      "r192",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r208",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "STOCKHOLDERS\u2019 EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r268",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r268",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r268",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r268",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r277",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://bloomberg.com/role/InitialPublicOfferingDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfChangesInStockholdersEquityDeficitParenthetical",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://bloomberg.com/role/PrivatePlacementsDetailsNarrative",
      "http://bloomberg.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "verboseLabel": "Remeasurement adjustment of carrying value to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfCommonStockSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r179",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187"
     ],
     "calculation": {
      "http://bloomberg.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Common stock subject to possible redemption at redemption value (13,225,000 shares at $10.34 per share)",
        "verboseLabel": "Temporary equity, carrying amount, attributable to parent"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheets",
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r1",
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary equity, redemption price",
        "verboseLabel": "Redemption price per share"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/BalanceSheetsParenthetical",
      "http://bloomberg.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r219",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r158",
      "r159",
      "r161",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Warrant measurement inputs"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrant expected term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/StockholdersEquityDeficitDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r147",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Class B common stock weighted average shares outstanding, basic and diluted",
        "verboseLabel": "Basic and diluted weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://bloomberg.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareDetails",
      "http://bloomberg.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r314": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r315": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r316": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r317": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r318": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r319": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r321": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r322": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r323": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r324": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r325": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r326": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r327": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r328": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r329": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r331": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r332": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r333": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21332-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0001493152-23-016741-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-016741-xbrl.zip
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ML 0&C'/XV\RB?5E]?QWC=,,-9J3;6.@R7TU5[+WQA27Z*/8RG72*:.B\JL&
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M;B5Z$% QK"_P/2 #*6]D_QE2VVE_S.:\U"2HO#=YF7Q%YC'>YZ>':5K/YB0
M4M+0\*OPS'-M4YA[FS.Z!8F*3N]]XR0B$WFIWC87G^71V/!:Z[+WOC=7VR\=
M?IUTPUC#%+W:0&RZO9\.^3=]_Q4525+^#B_M$N> D$K0:?#S_IE#RLWAI@A[
MRRNF>X:L?<+>S>=RGNLHN9#6CE DRVF; T8/F1[AUBJS:3GO;'"5MX$:M'\I
M)\S12L3A=3\TV?5'0C_< $L ("E8&],L N.I[)*8W@\]OR$\>7PEK#O!^="Y
MGJ'^94J.&(P^WNOX)8G0=AI9J4I!FNQPR/9ZV]_HIQ4=2Z)Q29VKTA//AXNO
M&]$48;*EI8N0.YM_%%=ML#;ZU5@(9$.;*JV.:B-'8>OU&PU5256VZ1-U1[B3
MHDJI%]5H;L'<TJ(:OLPBUCLI?U-5D#-I#&@<(0WGS28 T#171(4C/@TX!@+@
M95Z,(*5 7@S@OQZ_6K7+AW]@02^G<VLN[>:[)_W9WXX@_+GEY5>52V636UAT
M6KB-8U8YD/1E0>+LLK(=+;)(?=<- H!9R1<T<-8XJDHN#?GDFP'M,6NU=Z,4
MI)0<Y&W(;(Q\@6OYJ8@959I,;QF!U#2FM%7.VM7DM?X-,DUU"^*0AI&F!6D*
MJMO4._ZVVLEMWQSY/#] K]G7P5272+;C]W-L16E;1'3C,.6E_[)\X3'GUT^;
M.TX!2JHR9Q:XOZ*^)[CK"B&[1MV_*A6C:MJ"/FTJW[$F:Y_(GW0+F;S;E#1E
M>8(PRV/:GG*L]&EGQG#@>$*H:V;QPZ?7$>1P"!RY],B6>^U87$B]I-.>@X8,
M1DO#M*$XZB.-??JA(!5,,8X_A"W8XE)U3\G1*0BJ-'+YPRNK?'?;E !@" KT
M6QEAGZ#BDPFVT?_<!VKRNTG,_,X/^(&T3=!:T8< D.B?P$&HQM3R6M]21\)I
M[.MUM/#<2WUEDE&R\:V=E0E1&PL$0(*)#Q+*8@HF[IEI8/E38VTE;YK_+"EH
M.!JP%MI)W'0QZ1LSI6V2.Z-OK48Z(%@IQ@FB 8L;CWN?SXGX);L[** BU7\/
M &FMY'HY/I6NQ%/K3HL>(\HT@P429+0315Z7ON[<?[?)44FM[K<E4UZ]J&_9
MG[YJH>S8*8XL%VCH3X-*+:2O6]&E/?&8Y68>:!?.G X1S9)"M*<@$;G?='/E
MOHB2S,@&'_CM*5RVAU=2:TQN@P9>)[:F6(&P+F/:>:W)DZN!YLN/&6-:.<JV
M&(Y^FAZ\I1P\44JZH_*M"MIO#=0C&_Y1X<MU+N-:V&!B=GJ3E,GV,&LIN'0!
M) ?ZVI36_IP X/Z9UP3ZQ"Y) 'QD[.$WO21=J)947_=?-ED>4X M9Z=J]G+<
M[?A9QT$.@SB<$P +!Z4M^ZQ!<7O[M0>7^"5!4:OTP*!]CS:Y/?@@6QO]NK4D
MMJD"K&;4'JEW ZY7;*&8MZ,C-4#YC3CW\-..Q]3,9BC0KP+<ON,]!>0(SK,H
MX#*M$F.>YQO<*NC/+P;2/@U>]Q94L1K=B,' $V']Y07;S8RGQJ6!KX\LFY7,
M1\<9F-A\DS(V@8;4"2JTFD6[L:NN(^XS2(_[]6>9O[=T'X[B[E)SAD]\,0]H
MH]\_PG]=SA"UJ@JF4/=0X<)^E&;3[IX)?R%';.WS:",X6\/7*[[8#W[")C3;
M*\Y" '23(N9.0'L$0 .HT10(51KJ?ZPP.G.\'1,8?'J^#,^\?3G38 1)FM$W
M#>'%B+"SH..7.X 6,[>?AK%=^E7W3X_*#W(ZTB>A"8"!G@&&,Z2;Q/'P@B"]
M0[U_:T]=I%%-7< 1+*+<]6=518[7=01">W,8ZT19^_V6[T\"F?TJ1IS*]DXG
MJ]\4OEK+ZYTC]E6<55N!?ZIGEYR0H2@/U-H'2>-B,Q5&F>^0W;]XKZF[)&CE
M>>1=AU=SF5AW=%3WG^V!Q)1B;IP>3A][%0W?U)9^O>C?[I(F].R<,9?]A",N
M1+0/8<-L#O85O0^7;G^9X>&Q_NE%_ >)GVNKV7EEHSO*UMT;QJ#ZS8)Q2U0\
MSHPQ#">A4LU;W>SCG2#\_I*R:@#@2,HVIC91CJ7NCUYU8PFLKW93V8$A*@]$
MV74V9-FQ',,SR3.G6W*%T*F=DKQ&2.SL689CCZCQ0?=!H/:7PWJ=FY%REK]_
M(**X8[YIIUJ6#'R;.Q"HTD.DKH\0 #W!=W8.-UPSHT4/CUZL+XVN#O*GF"XK
M85.N*PK#9%8("=S%]UXG7\K+!,UG*56/N62)F4Y01DKJ\TFD8^SV :+T&]ED
MV-P*<(M^I$+0O>#B[8GNPZH?$RV]O@D %8/PE 'SSFHLJMRFCW>ZH6?D.;*;
M7UAFI!8E5*1XR-7O,4I&I\SV=:9L]V(GT(A^#*O:;ZX7?VQ;ZJQ[:52O3?F#
M-+KM-KYM]T?1I+D$7T8SN7 X-AK# KJQZ&Q\>D&740N+51RX[_7%;;@! (@S
MS9K.1'3$CI2!DQ<>S0:)ESC)G?E?2BX>/!B5'UTSD!J3Y_H2O-]1?L?ZH.)X
M1S@>G9.H^<DGRU5C2AI1N&/^ZFLRM^I7=E54>!T8IQ3C%P;TQ,OFO$I;T'[H
M[)ORE;/5^2RX('R0HO:U'6GI[I-9]]ESLA;0,ESJ9UZ, ).^.AW@OS*O3(RW
M_9QE:O,EAN+BE!\SR8C291CH2!0[>@<-%XXHCT4=HZ(HX>UZ-+4TI:@;;&NK
MDPHRXI]0#G]KQYC!+'Q<VB,NM$XYQZ-VK:'[AZ'8V5\60=)_*X,@XG%)!Z/Y
M#WAZ1XON]ODFWUK<9+_:FL:S.)G/QE?@3+S/WES,OIT;GQWR_)@J0IX"KV8C
MH;"V#NE@Q&L3 +_Q(FD5"XDZ'8<@O#9:7N]3<U" 7C2><?MOR3W88H40Z:7H
MW4IH(@%PJ$-]%=)SY5J%80RKA=.ZLL@6!RHO>FU+^?\5$<LU^U6\,92L.:1X
MSP#;TRW++O.7 /CE(UCUIN'(V&KF3]F\]?=?20G! GX>LR&N>$%\7 E,TGA>
M77P,]R?G/F20?;ICCPYR3'[$0;K5P>"(9OMX(1Y]G.G&5CD8N6SZI;E(][&*
MUB;4RQI>MF7<W!%Y("T<S6=AMH\?'6,FZEYEOADFA37T%J>&@2$]OC#Z@A3E
MRE8-'G]31L[-4@#ET?9SEX-\*]_K>J#A<ORNC@#_)*0']VT37K,,05@.9W>X
MIY^+O@D*BM%F\^I6W,UU5;((^W57D6UH#O<D9ZA-NVN9>A)W+Z\^M6C$1X1*
MZH7Y>FHF/_/Z*TJ/;7/%T=AB<-3SS!?3;@8;$[91\03 D]MK]W:$-A:2OP>8
M777=KC)A?H?"+@;7E]OZ%6F6/O8GGG\6.O-^U9:T6&8-0K=1WX M7M%1TQ?R
M3GKP)_Z/;0-Q<@#$&T__HZ-F+*P/E;.Q4P3<W-M ^ 9+U?CM6AUT($09>V%"
MVXJ57[.G)=;C>Z7M*6]4*-Q*&2^M2CB]O, -N!8S3IMOBF**+G42$>YY#89/
MS-<XZUA#Q2Y#28+?*ZS6>;#S1H)#[N,>QNP]_&*S8"]GZ;828EH%U<*2K;0)
MO]0>L+C<CV^R;?EF_C DICPGEZ^%FA:LJHLQV(X-%/W#K=ML4:+>(K2>_D/!
M<&"23IT'=;75D4R'X@4)BF<"$XW&>CCN@:.>)+5VW,%&COJ_^Y9 PSS$D:),
MRL_QI"X)J7<N!R(E &:O&S@%U\4@AY5*_@'%)\ZPAN^E]\.>K8>&_8[?>\:=
MU(7\)<,18<Y>N!*OVNUEM2-L:\?_C2Z:BTSKO!TCF(A4!I3&3\SF)RXQ0K <
M'A!GE>R3*_.&U:943/V93CC";:1R+2FX"")@WM\+$F.Z7[+;.2;3CUUZ.XEC
M1;?5W1)XG4TL-=C_1X@]Y$-(ZH*3*C&0^0=\('#=VF:8EC3.>HCY54*.4%DX
M=J-%[Q[850MCG'SQMMI%3/1K)#&/Y,.M5PF/R[#!Z^4;>@=;ZE5?K =ESK+]
M,?B#19Q\Y .@PX$XU\.2=]\ -Y.5-82ED%S2(;Q8\P3R7Z,?PN<VA+:\54.M
MJ?Z>/$-U6\.U6$D3E :-DIYMO2]KPGE--$/N@85U,++5^2Y^-5::LDER63>Z
M=^@37N'F#9Z=:SX1[!*HO>Y]<Q8K:%HZL.:7HX[_W3_J#>A-7"R+WI5_#P'P
M@[P2":<PQ0[W'&[!XAKN63S?V9O9*SLW3 KK3%A.+7=P9HN(:/NN'O?^:;6@
MW2#Y0RE4WPMO@R/7PY^PUI2]G$VOO@YGP( V&OV$.+@4K5<U;G!=BY1AH+$@
M$8N!$,&ZYLE*4T4+LR*YA!7$7>(%>7YFZ!,,](,WE*W'@:'4PY]\_K=]XEY5
MF19W^[J[?%7N*RZAA ]O8EQ3E5"!> K,_1/7NDIL-C^F>?D(3Z-Z8\'I<,#-
M_S1*V\3C4.,\3I";](/'W*PH1E,+F^Z <"K$^'WR7E+3O30@B80]K.#I>8VA
M\8@[@WK^#SQ)#Y,>?OW)6+<&"W<,K=1OO*BY5>]@O$A$C!)DVISXM)4>XHJK
MRH$WF5@.UU5>%Y*=P(;5]&BW_7= N1^Z$ZQF66)08TZ*K^D  !F;;F!":CI"
M_%. #'R R+] S0]4O/N2MV)\2:B45J#[,_U7NW7B:Z/JX B5KL7\ E=NMF3@
ME3S<Z#P5O^:_E$@E\LINN\R Q 91%V+[CK?%"YO#@E4@*F259D9=Q\."JYP<
MG49J6GP7#1#-XC%M9OF&.]:#XAFS1SAJMAD?<;IM"!M.VPNA++GPLM5"^NA-
MSH]$>_O/<J7\G.^ECJM2$%2?F] #GW#Z'B7J/J4N8P^:$V2$UR0CE9XIX]]=
M2<RT7(J3.->SR[5C[+V6ZJ[VN)BY_6P$ '3V@*:Q(:6+*47(!^]*X5Z6HLKB
M16L+B,L#B_)G2\!(?FSW_F]WK=W%F2#H_*'/NNMDL#)[9+)?CIQV\:Y]!QTX
M/=1>CW(.R]$7S]7G)M/7_RU@[_T-*2E!E<XU/-W26]EIZ18;QC\=K3.MALP?
MDWZ'/1P*/Y_]F1,10 &^"58H;G=3=CA*L^/R'UIH>.]K-^6]Y3*3B][5F I2
MS=NJ%%TTS@!6CX#6%2/?/GJT^/S[)L]W(G,X?&-ONDTL$Q?WW8;;:K*CLB!]
M$\L.PI3WS<BVRZ.74R&;@\6FSQK.DCISLQ)"'A%Q>I-V8%YQ4+;Z%%GC7L_D
M31IOL"E9L7M[+$88FTW9H\GNXY:NA&>D"8";SAE^\3+4]"*SACMR)=P@A2\%
MV@.W;X2I;.WH\'\"4A>!8VTF9)HV6AHZ)N!!DA:259C/ONVOUCP6V'3457UG
MCSK&CNKRK-1' OTMUJ'#QJ,9K03 J@TN.=@./P_9FBY180>KOIH$&B$A-+MI
MW11M&MMIR\H[:VHMG.M:_2'6RN50C&;D'LX"L9O%@-=:K6]<:/OQ^K[;ZYZ;
M88J)S[\5"X@=C!TZ=&OI6:5(J-!>IS61Z\+^*A"RUU^!N\[IR<Y(U0M,RKG)
M]13EZLJU,9"YYISA.? RUK&J$17N0*8@D<-%"EHG$5SG\,8[B@:%?JE$4'=9
M0P>SA:\Z[Z##7"_6@@#@25<C *!J.%@3Z(.4.FB%3==Y[5F>CL:3@[T;);#O
MR:X3QU2W9GO:V>K&17F^[5?F2^3_>>PIJ<<#4+HP^<Z_M[^RWD@SZ%\Q)&??
M?]1/W]88QS%3I@=/L3+J8(V1J)/O.\@B &YU&"1V1879,&!W#:H==)@/CF@3
MN%6EOB?,=8W]C3FEH-(8,*IC-/?9;UMOXB%S6S>[FS3EH$6?Z8P09>CI/L1Z
MCHZX'0^^ 6?+SZV'4TJ(3J7LN(B3@N6TT2HQWFV"5>P,7X;&WB.ROJ[X KR)
M?^1K>QYK\6[:[OJ)5=:/26/7V7#+ NBG 9:8KA+ER5A_>^97*=Z!6BMHZNH+
M8]54I"@%\BR2!QL>"*JP'/FZ9SWTJ)R8-OY/F,P8CR].5\*Z>#4GBD4U$=]W
M5>X53#UW=@YQ\+8\Z/=JLKC,JPD21#MV9]-,YT_MJZ\O+6I***^5+9N=$!EI
MA#05:B^Y7+%"(&NX;FAK10LO%B_\>Q6ON$WKG'[A%^V=F>_H'YPEME;,_D;Q
M.RW6/N#X&&J&+HZJ#!)%9+*Q_PDY6'[(W-*2;98XM5$.[NBZWK#O*D6O"ZZ\
MA!F$^\L%R5(1(B:E+Y@1;\[71-M/E>?J-K&0GD7>BI1#' 11(4JG_Z@[1N#'
MC?^R''9\XF"."@6^;)9RXCMY(2CQU>H<3/FL?RFJ2-EUDK,M+%A1:?T])_AC
M5^+9LU&(D(EEZY4J])"Z;GBJ6MW?)"Q$>F!5CQGRNB<W$_S-WKY9+O!,Z/#.
M2#CS!<8Z6<9*H4YC\E:NBP^)WD-8=/H(Q6Z-PD"[X+%>8U75[)MU>MU@"YVZ
MCK#NU9>UD8>K5SJM*4*#_)=ENGJ(5Z@@,T2;Y/Z^..YQH?EBD5R/\I[3;E)2
M*C]WS*UW^B][_%V]7,1^-$5:>,J1Z?<\8&^Z;_R"71I=.;5-TA'M[5SH%9&@
MA/WV]1*P.#[3%2SFKO\*=>*F]-PT4W]*]-V,X^&J'*V([<)EO@>SRM3E_I-A
M[5K7MB>'RQ/S#UE<HXVE+;]35G/Z_*"0-@[8;5:#J]EG5,9:C3&E,9%T,_,\
MD60V4> F+BE>=F5YF^4!(CG-=W:5&78+4]A\Y:QW7X!?Q)]-V8DBW:G SW0\
M:TZH9)!GA<A:#X+I5CA1V,/Q(]ST>M\L(K4J>X2"-:8\-9MNI$[O*3E[S3A5
M.7:IB*M(3FRTN'&=O4@F"_K&U0P(FKNYVL',]JC2MFIKTUCQY?0[W0+%^:M<
MX,&WRV]CN@%&,HYO#'4L_^:5[IC79^8O5/:7EIB;=H_\U/*1["ULD^RE1+LX
M046+:BQ^5SU(GD[Y8Y;4]:1Q=&5)(N&XM5]'W0'2K8<XHJKHL9H$EM<+NA,
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M1YPDTLX[Z6^=0IP#K=3YO_J79+XD3CFZE_-CHS9$:$LQ/5J%';X=H-,  SF
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M_?@P?M&=)^ZSTBP%N@=1'[ZJ1ZD:W:I_'Y:=6Z+'S1 8I=/X#D)!F4UMXW*
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M#_:A&M:G8 O_%)VD53!O.I<C5-91G\!T#?!.GGDT1,P3M8,#+SKY;G31RKU
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M(D%U;\63:X#M:TE0>P46V!XHBFQY;.K=T9TP[;!G11(U/S81:O<XXJ.SW(=
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M2[]C<;0T]T'^OK>;SL2R>:37[0'H95Z<ZJ*;A>YRF6,?_&.&BDFNM6Q^;97
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MMI.P/4LZT2($]1B/A:_\'I*>FB"/>C2]XATW,;DS@@=CS=&=+5RC./*E\8#
M'7+84XX0@LNQ^W(&BMA FE9OX?8+:*R_%ET\S)(^[&$6GY8LNW9QS_EEMN][
MO6B+20SJ+# +7@8EX2Y"F:$&D/"!AAV$KC)[^_\$4R[^A_HA\F)6D5/HM_VJ
M7DQA/<==B#)WLI%59:>WX))%\**6QOHU0#/UU&$COI][^]7[Z,PES]_'S&YC
M-;6L! [I%3''UP!J\V'/,U_?3R'D.ZL5EAF,;MD!?O>V[(M;BDYI4EOLI%=8
M";<"Q<=R_B#FE[FBK$0^SPB5?NT825 %:VS C-%N'?@7$Q\0M=)7ALX<4$W_
MCF?OG[];S.SVD5QOIHC*$$0>X\)=6RBQ#K^\A3IT*ZN3]O<7W@"TTTKCB $Q
M_L6P^UIN58'#\R3)>N)*E^KL_)"JLM;#%HB7Y[_>N_U-?V<0P6]KG8PAZFBF
M[)1BR<H9.(W6$FM73N+S4S$T:FTE3Y%D@@3Z3LY7YI@ ?<DG8[WH+YD[N6E)
M@@RL0V NJ@0!?"I16N8B%R&C!8U,@]#@XTO0+?@7.60 =S8:QO(I+MQ0A2?H
M97"W]W)-S?_I;&*C?.IY*-R\,\D(JI2!3@L1@=_=A$H9QJ31T2*I:JI(ZXPY
M_P#BJ,G>^QH_!E_*8Y^>O1'7_==Q48^=NN?G/1Z<#&.>L 50CM-LN[\Y\=J6
M6Q?(6M)B547/IM_-<#HUH^>PGU()M*Y_7\DC"7+30E\#PMP/*+"F@A0S/YR?
M<:CJ'">5#I6JLRW>FCTMZ^?UG;_RHC*J;62R"\'3VV<3P)N;QNQ:/)O>Q*11
M\3T-^BRVI(CK*P/38DU[NBU8TU00MO51*&/CCU!;X_[,&%H"S^/_'*3D11GS
MZ.HII+HG9*^<UN3C1/F(1Q3PRSWPP1?]"R38=2E62H=4:VG  $A*\O[YA_%[
MO7GO%Q-4 GI%JY4I#?M/"7/7S7ZPT*/7(L)DY)UR'=J5G)PI&/1(*WDX*P&W
M?8Z+Y>C0<C^6&/>,-EYG'WS,%\_B@L442,QPXH)XV=SBU/?,^:GW#P811O_M
MFFZ$U"R0.:*&\FUE9Y,=QWV.2H?R#:MZUMI#B/[Z)K]E$<"*+QW0[QP"I6+7
MBV@ZO_XVFG\[\3SW3OA+L.FQU--/-8=3)0?K+B_\V=''@41I[2HKNGXD G+C
MZS5%ZR68D2_=$ON4IKONL0(SK\;X19K8VE&37%'/!Y.#I-.;E W/CJX!X=P#
M%T<R.UVLA/Y\R\T?G4RWM510^YYS?&;:/R5;F2*,>N[4\?U$1P0=4Q*8JE/$
M?QK@;"4IYW(Z5(_[(1OQ!V"LJ<R54S4%,O;TX1K>Q2SQE125L^I.=O3O[M)Z
M_R&17#GS0#I:4KIGZ8$H-&6[MNN"#%"[[K<P4,;#0GD7]Q[?'?M?#C:-=R;J
M+O!-86[I"R''>WZ=C6+-'J)CY@[/3 DB$1Q4BN?!>CK:G<:JRLSZNY2&'S_C
MQ='<:2MS4J@>@^S#1V5K1PFHQB(> K<&LS@@3QN<^)CRSHY@L4-:^K=J&#^)
MV0\.6Y0:S_Y/R46O\HLHVC3H&]]]U]1K %F-A Q/,18TV)PTH)]5SN7#3/9U
M-33EL<MS VNV45?T@%(]FIJ%X@AD/?[+95EMCJ"T+=HFJ7X5HK&[F8LG6H+.
M,H-VL =GF3JQ<G3VV5)^=Q'[M<1:,1\E\(/L HH]YKT!1/G&Z/BV:P"IM[2^
MN<:@\W[%0[EWT"2^1X?//<,,Z<^Z??YS1NF_1-(KUQD.6B%DWA'FL(G]@Q/W
M^J:$ ?8N$<5;<D'=VO(,4\U8LU\+6&$M= W4-*AR?.VA,GMO-O!!TP'S]YZ_
MOK?,FZD%/4Q\ AG)MP^0N"%@%PO1&,SH&<N^9@FPB80@%>D95_3,QK-/[T7K
M"G/)Y_5NOCDQ(&G.N)*("KVZA$#>^^-NDM,NDYR49"WW]S4.Y1')K-,K;1\/
MAHY.K%C<5@-^B?VWA7 6$858:Y5Q&=FK4(?"]G2KF.Z1!PF+)W/9ZK)]98Y/
MCM<VF4&(PTMP4" Q=*)E;FU!\Y'3@!U7Z_-X4%-]? E#+4:_W;0B>L^=F5&[
MCG5ZQY>S^9M:\>-8E;O4"3H$Z%M;%K'*S&EVX'KIEHJ7$E9Q\_,2[&\JNW_1
MJ+Z_"ZAXVGR5C>,)"'#U$<@MB^1)R7>I[HJI[.O9O]J9M,^;F/LWWIE\<IDG
M^9=IL91Z]2UC^[7T^=F"3\(07_OO*JXX"LH8>=:BA=L:)VLN,GK\' _E?SP3
MJR:,4^'A3#!(A)RJ56CD9$P47)#P6<QI&[_%!OS:QI/%MP?;58VM\.HZO;W+
MJ.W[Y]/JR:"K/'I(CO(:\#.UX1H 7KH&K!CN4NM.M*R8\K&X%>-HT>L5OS8O
ME+M.B^LN]-021#YWTX=F9DV_I-1N-7I^E0EC(Y9'F6ZP'L\+XD4MX,HDTW-$
MFF11+ZC5&5:_O,F50USP_E0W,2'\_^EZ 0K*Y9[86L';WA]F],86:](=G%.I
MH&I_FS0J\;3ZV42^RQO8(@Q=1ZI1(SQ*AN.]B%]LQL>:9/+P5=:3^)BXH&!3
MUAH[W%<Q^=/[.E>W=D*1'I;TV!!*<JQTE^[6!6UR(/OS=SG.1[H*]S1!5MF9
M_K#$[*=6GBBS>=3>GPV;E-/J0+_LRX 562)-=%?%UXJ#P.&"=\4BG\\_70/\
M;56H'QJ("$;.4V($2EA^Y %9'6 )M&_Q@T(VMY('V)AE=^*P$P5MN?Y,M>-.
M5>]KTN>IA_6H'PQ*+[440QOW2LG1>?:$3GT,1;732=1@NB2XW]7!4+G8MS6G
MY/']AHS&+Z FR[*X]+/ELV#W/94 N0/S!^_:GD09B%5GE5(0][[V.,@T-K$N
MGG+T_>Q(*YXP:]*8:K+B8GRG0O1(%A()>_+3>Z:[TCNY8V'FH;EE;UW)J?W:
ME%*+RMN0AMZUS]XE.\!R;\M3+P1^G&Q2'B45<N[2HL1)7G-?<=6.""UWDIZV
M?PY+RY]+@3.FJYL6"F98>&J<75%:9BP?!/V$B^DL:UH_EYBM[!W=P#<2SEP@
MU0,J''R=P[BA;CZ/QJUCU) /0MGW9+M'U'=0]5=$2VFA&:VGGE6;GL(_2D?S
M&KT-_O[M)['B%J<((/>)"!<H! 6UB(YGZ_,WQ^PQD8$;-9*(5H97#'4/GPA4
M(C&5S_UGJS:O ?V;)X/"R\/!'M&(ZFH, ;</,7%5%^?C2 D W1OAO?3:?RV8
MA0I=7GB55>:X8-MTV)EM.;T&_K9!]#3/4W9GPPL!DU\>)MX,I$9OA&7@J6*Z
MJRQ*'W35_SZ/.Y&TVI_J,3UC_=K"-#:SU%WFXU?P=G8[%66EZ,/5*/*S^(1"
M1552U@%Q]F%M^@H/7+_O/Z:[W[+GFYY.U#E,[ TQU!)6G<"/>V\/55ZE&_3>
MX4E5D#?5B0Q\TH(&A91[9$GQ^3A_2!(QK#>RZ7A.]%A-]@K(MT0;EMNQR$QJ
M$*U1J:6\%[=3"U7DL_TJZ6^#.7CC_Z]9)1F"KP'F_X:4D2XMD*L)J' ])'EC
M8N\:<"MS#M()BEJ8&@4>8<6U&D?G!:4#2A+67F2N#'YD/1OT-0[Q!Q9@=UXR
MI&8SB!E-RU">Y8"5MF7)%=$K(!R?(.5^]\(?;K>MJ".=(%N=2/\/IX5X+OSG
M<^_+^OE+, 8UD5>LP4P%VK?AGN60VU\(&-9'RO@L0<BW)U%&9<5<M7N]^M0J
M/)]"7$B>YE$$J)6P<&*<(Y9()9Q/9@ZJ%$6RWSFMR?SX9/=(04?1XD[)W"9>
M#(8YK0XH=I@\(XX&Y?6X?H[D(([;_<G)F@$"'3"<ZA"]VY*_'\BZ19>>'Y;]
MT^AY%1>"E%?]F].'.W="\:*9(%[+\OC5 ^PUX$=>5J%S>D4Z]!Q/<!]GAP6[
MRKAT5>PGJ1#G[KK%)+G(AY0#P=0P^J4Y4R=!P\G 83\*F5[\@/ *VX/^7\S$
M!^^(VA8H-KTN(-&#Z[&%[QC-#5-G!QWC5X,&@WZP\BZZ'Y>#.Z$+[[%[RR3@
M)?)KP)<2,4S%% XB;-?'.AP;/UZH?66OC6MQO :$@'_SYUU*!XK)CFMA(B).
MS $[=8VE=S3)WLSI?+]_WS5TG;!'M)*Z<IA*DRR:T_E7XLCJ<UEBCM_E]P8Z
M?.WB6QB["K<MF#(ZGFN]2)@R^QVV9&L=WJ8@N=-_A@-6CXDT.3U4JQG;#24%
MODWE[1#3!NP[HJH=K@&FX!]/H"#(NHZ/L-FTCA# 5&*Z55;H+K KD-G?!0%3
M7HX.X.D4\Q0;F7]BYE"6Z_XW*WAV+\&'R:O+3ZSP&L!6,GSQW]8C5OR B2[1
M^^N@M9<OVH@G:@)>JN^ERQS8HL*^^6$2]PD_YCO4G:I;KN^!$_6T\E+W\&FR
M:<N"L2>"Q-O9C+5_0L9>(?9QD3&;G<5K*L9DSP.MD:+3VZ;YX?'67/OY/N3Y
MI6!?D\RG\9UG%5DXI15"3/D/]-F;SW(S=_/88+HH!>N-S8[TG4#^EZ+#7_&D
MZ+6=/V/[7$*:CR0HO*Q9$WIP]XH'N5C*M?Q+(:N:2=A&WH4-S[@9=6SA8A;H
MC1DC<R!1@W6MGMIJM.LQ(>)V8'@=2$8W=\H[9.!E(^RPEF^"'T02B6&C'V)D
M=&M;3#\:CI:[@ZXM[(B^G.%GZ&[?[M-3^U@79OW!ZU:(PGD5I?^D8%1><\:2
M5PC,[4@L-T]$J/\:T(FIHZD^>0P6?@FL4$D^/[D\8US?FI#V+8\HQX9V7LB'
ME3UNF 3)#5*/?;66,VNPDP7<(]G;>MLXW"5_U]O/(.WUA"BD>EZI!J8R^7$F
M@7CM3=P7X\?+ZLN8X:YADJWG+Y+:VQ<NC5QQ/)[W[!;"K@$M)0D8_K,I.6GO
M$$NL$GCIZ2 ,>"K/\W?Z4/5HQ?I*RFM'W6)+#K80#LGJ<1\'YEC&XTA9QN38
ML.^PAK#7HCK8Y-)LW89+&;B?1/=<4R-$8V+D9$^XL]' M"#17>#3&B=G,/UG
MQ;:E( [(O[##\HX?V4IOQ\+ PK3@02\%2ED[MQN\(S'5[)J=M84GG^P)VH79
MY<W&_MG"Q.H-N@;I&1+P7@."G5ACQ<8VX%HMJPL;OZ0N2^#G-?%JXSBOI3+C
MSF2L[X#^0\<$.BJ%QPF$?&<M'YJT96-M%OPMT=P9O]^]G=MI,1^$Q5(7G:H/
M3>J'"#TD@F@<"8:C1-+%NYRHWX6>#LP].'#6]!!2^SN+?\0:9C7E*/\>,QS3
M@^,[P&K*#+[4#AQ>#\C8 %]\Q XOC24W5OE-+TQ(@W^H%^1-(HV.'3=&'V"K
M7V9T5 /1VRZ#^:TQA[/*:??HRA4(5GVM18>G<1_0++_\"+/*F];?Z;!W,00D
MN39\7R3[UKIZ5O$<_8YV%$>%053J/,JVXM.RB1HXU?FV1+$H>0VX9QENFE,+
MC]BU7%*HU]N&SZR/<QR R^963T_F9LH,##><TP/Y6KJ=C6*OP)3\P\:3^"?>
MPAV--2B+DM*K[%,FG\2 5+MN!8Z4EU(/YJ''YGX:&)J@YC'!7[ Z'F=LAH3<
M%P^B*620=YHE>B$B4 H;OM-YH7J:GS'3PZ!T:K^.NN1@6^J]$^2S,^C)>D=D
MX,N_42G4(JZKYHK5H)[2RK$GY_9LO+,"[HG^6:X7ZAH06^J@/Y>2YO&?77\Y
MIOAZ>;!='AX8HYX.4^7:O/37:>PHS:('T4V4L#?A=P"8D<GX;DM&:/BQGSD+
M:M-D;KNSVWGZ;;2WRAUX/PE/IHOP)"Q]QQ+MG+)R0-@26>23+I#,$)T1"F+/
MNOQ>3?/T47*"]]T"BB.=_#TL\-#,]^)>/H+![-]9I"W_>_=M7]4/O_]25]YY
MK*J_-ZCLX$%^DDGG.=Q",FH3^T=EC8-M\6BLH-AA5V1\@D72 _-PV?;(W,(^
MD""*7VQBSN;2C54T)).)?">Y[?(7G&$+)HQ1U4+*L5IX%ZS?K:.]%8:X-_/U
M_:U;.O1#*G*UELMV\12QSC+B.:] _NI%@BGD,/_OH60@T*8\2TC]P0,LM\X=
M_+!I>/8^9W.Z?6&33=^MZ,([4X"[CI+IA3R;R4<M<*[S.&2F\3RLD9+U$<R5
M);.%%]).F]L>RZ;+EG!>/R2<-=]\:CW??*<S6[+^#SH;4N;M]ZIA,B[GC4*B
MRT/OQ18AU4+M9K5R[8/>?VW:RGS&$VS++3\_^^(:$&^LB(YR=4)'JV4?*D?Q
M+B?^6&4C5-CKD_M>QIFT$8NGK3V<O 8D9MHL/(.G7P/0%&9XVHI8?^&2*=65
M"E*4B</9/I5DF>6ZCEZ@%Q$]$W-AF0=>$A/QM49Z@%^\P^)1AF$33,4F*W[_
M(7,<Y<BA@36\D-SG-#[60J+FDLF)[DN-"51TG(PQ;>5Q8'W/G]63V\WQ;_^S
MT)YR2WC;-*7=#&56;C)S#/#B^4G#?QFE-V[9D7\-J/B;'^B96PZ)7)]GP$*6
M)6! T)(.XZ;1A<<):A^:-'U8*-G*X78G\T'"G)]QJ7$T5EH+$<B.>VGYU32E
MJ'K,B2BMX.4U(/"-<+C<;#+$@DCC-*K,QUBH&E]V]">M<P]Z D[Y5VGRWOQ7
M;POT7^A6&^XM6CM_!4YFYM#X[C1AD&;LK^G6M+&]$6M[J5OOGC8FHF,-8]EQ
M:?Y@GAI1NA2_BR22UC-\0RDQ-![C?M9#,Z>KWU^*] )_/R@.2(D7P! %P\R6
M06&>\TP(09'N2;8?) U'-B]Z(S.I/.T\99L\2BPH1UIX'1HG*C&L7X^;!EDD
M^D6;8>\ESUWJY32R*:21N:-&V65GUP"^!_T-!G[@K*&'K2WW$+ 7RY;4V\;5
M*'6*,J^-UC]-M(:S&^O]091_I1Z:"T;"9&V7*RC--Y&+YW1/8@<F'GU^Y!<:
M:HHPJ,DTL.CC.J/SS%N;:,KFI^N 1(G1LDY)@6-WD4JD:T_L>W_H,Q/UJET0
ME:?A::(<(/= N,>YLQSFYH_YW=Q2*!]S<"Y2W;T+6&^FBF)8UY)K.J,:+6AD
ML2WV?]'4@J8-M2:<:ZZ(=%<;WX56)O^1.B'8&QH_QO$53M8$V%EB??SRS&N_
M^3;/92@<,,58'1%WN]4P>6UUN2/TTV!Y$'-EFH&/C4S_HIR(-(3<6U!SM((S
M7#-:K4[ZI?K+SSH$07X7AJR1@;0MF+20<G<G*3/O<MLD<:/ZCP;M?WBX%&6;
M^<IS(B\OO]"Q5\FH#"_!NU1&<]!7R)CC'7-Z]OM?:EZ^X]%J.!S]VNU;ZV5J
M'$S7'GBK900FS/D![YU)6I)D[%_ZHODK$< 3P+#'FV-QZ' R2U6M4]?S#0M<
M5 TK/2:U]U<J5 47![T^ZO(0^L6)IKYK >AQG,(Z+&;IM^:^_9.]CG)ZZI<L
M^C5.Q>$^4XS$4X $Z4BV8OE%E)<7J/YS"=<5V#13L -.N"WWH G#!#TR[6W,
MPC1\4=C5*'KF,JT;.OP)*;Q,&=$B>PT(BRW"YK:G3Z98G?:.L=D-R(T4$[-U
M]DM:3.Q2&^0#S7*@_9,,T^47>'&9TZ,.^'U1U@C!_%GO5)0@E<AE[%[3HX0>
M2%/# PW,++^G*7/^7ER8M</O^8"JTT>&W/4]%]UWDDVI#2W!\E@K,Y @(OR0
MMKXJFYI-)+'JMJ]-C#$-NK#--#X8)NA:X)ALJB62IO5<[.^_DO^[;?;G1BBJ
MJ?$)/V/ ,<Y9O P6?V\BD'#;>OG>CA3_.H0V\;1W?Q V)M5XO_4/X E1BR2S
MJT4HAG0)9R%17>,-8N@PJ$S^6]-D.#3>UK;IFD!928/2U9C?CG<*W9/TDK%8
M68)TZE _,_6*D;$&"L3%T>=4ZV2_=A_>'Y?7,YMLEM=#SZ4<A.[+2'SEJ/%3
M C)< UR<VB$=H68BNISY='35A'G?FE@<T!5+DT6+?;6,<YZ'D_OX)?80'JCG
M^T2V5GI;2\7S>_T8HHX%EFM >S<"I[ND!=3X<VGC<%]X#6)O2'#_@RU3A>/I
MO2=03\A[C;[RC71@(!DF_M]=I_D3*%6>Y5;>YU+%F*W''[48?-@MV8K?,\1
MVTL.'NZ@^/=J]V"TF)D>8%%N4ZB(6EO0&^K0D9,>QQ-3WAVP-)Z6I@::;.G7
MT"4?6@%?<C+S+I#D-]:.T+ID36F #4[+WIVU3IRO#T9O+%O$+SMYZ:&'OXH
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MH<$],@P5I?Y/1HZS&(X,1[E:JI!E2P[)NI>?8O:WQ?TOOQ<1Q*D\D>3,S![
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MO>;\E;WT#AI[T=A-T+AP0.^8QEP/UOV)"3XPM>Y6>%/+;YUO^BSHU;.CM:/
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M"NPB,4]66BAV92GMK=],P X=S39&1=H/[Q5' @HC3R6Z/<LTQY@;-5>D:*8
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MM)W\X>Z?V)I0C"8O=D?G>X5N)5T\,$S;X<RFV<)XS>/;2=HRH3G$'Q8GHB[
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M>_RK3$'(%G.0>[U2&")-4XW>38XFXDJ\;:A^9^=A0@#A%GZF4*9 /+<C&<0
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M?QK!(2(F)B4A920C8Q1[P/I [/]TN>L$4!$1,N#[X>)P >Y1X>!2X=SU C@
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M0%G4USO(%/,ETQ=T2+>(Z<AUHP";GJ,JK* ,,_+=O7K)N"H?"5UECU1:767
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M.GW]R<ISB,B^=DN<0ML/+9K2,VXZUY@?#H-W  HD]^IH3'VICT^!KZB-#!_
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M,M2CE8T]1 :G/3,!XOO:N93/.#?8(V(VA/B_Q #^,R(@F.$(%;:O;U3B$7^
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MI"M4YOE]&(+VOLDZFV:THK(*W>&R0A?> 2+\)__Z3-LIX-'\'2 ^4(&N84;
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M&%/FK7W8'SU&*[BC^LK 5]8[?C.ZIKFV(7VLQ(I+K><AH5(=VJBDT(W?="=
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M"_6U[;_CI2)V+I2#7,MG;"PW+(8JTJ*(?Q-F=(UL_1V.)>)#.4$636;RYDO
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MN+US)V]]HY@=_*-#A;"E^HG]("X?+_31?$#72/("-X5,<<T-X%F"M/^T$?J
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M 9HE_=X-EWW@T]J4?L7?JL:\C&U=Q&_<%[+[IIUS6E<^C#5&&1DY_SGA%QA
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M_BZKD+?MU1"8%!^:?&9JD[I,SBA#)4FFT=M/$Q$(W\ Z7X2>MVH&R; GJ;A
M&2=P:C"?H8V_+8\F?DWJS(3N59]X_26R6:Q.2@JRH'@>4>C<9+XBYVX8V7ZY
MUO(EWS[E\8C.&4]],MJ 0X'BA0'A2HQ/;G7#SF60'['_#<!(N@1"%9C;E;+
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MO8^/7TN+2;<JQDK? %Z-R-/.SVP_1XGOP)6U7\Z\V.A/3(D?(C'SYLKW5'B
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M90$L'-YKC#UBV[3Z;E<Q[(:X5C;2UN;!#7<H!H@X"[HS B][GW /7?&=.\*
MOZ=-]=_:3PK+^4F3X:$%84=(L*]VML?RXZA<.N$*8N(*UB_FT71Y^8,20K=<
MXT;[*6$/;TAZ#.35G.#"ZJ$;)7XWF!9M3+Q^(RK(_F( ]:I,V!W%!AZW*UUC
M*6@L"9( RKP2WMVWQCHQO<,D)Y&--KGE_WBUN:W\A.0?0O:P.CFNOWYA<,R+
M33=%GH(<D,DCS1]\ABJ9F<(D/<0$&+'M?^MB2<G?WADR\%/(N$NNM:\[ _(7
MC&;3U$Q1TR$$>UV.HWXB3= &56H"(0M>0>^'7/[AS3<*;SM'+OX9E%#VD8U^
MQ<@5S]D8]7F=RXEDVY_UW<94LWQ$<CE$)HAB*0F^!NDT/B)Q.C'CR>]N,\TN
M6B(V/@&[.S:RHIU^GN,$]- T"S,[>.+$5[]C3'\*V3R?#2-A>FF6 PW>ZV&K
MBCAIV!"[ 5#.;[<\QBSD$\:52EL?]0LW/AA@%LYU^H=P]?P1=%^^=9W<[IJI
M>P=94W5(RB<K9;-L#M:L ?]<P!_K!RM]9W[V@6OU@+M,L@0OAYE(\(G4/!0,
MXOC2\<#TQ5FMGT<\=\QH8I)/.\9$V^=$;/.';JWC >3O8IS?6>W.!=1]V?Y$
MYMIK;JOU_C["G7T=?#7_F$69JJUKSN:[G.0IW))LUAR%O0%T&8F8:K$R4"-_
MVOCTF  BB>UE6=DER[HBRFI/<8YX1>=QC.1&9:,"8T[+E>"B-3/72]NCX936
MH:'Y>9$85V.O:22LO=G6I#:Q'50#SW-@@/N#Y1,!F:-9*6JO0YZI6?K=*B;#
MY-JTJ_FNT\5^C*'L\=\B^ +NU91GM)Y:EDY-P_@[4\\XZU"R18%G%]ZG/(J2
MA$82CCDF/H_!@PH@K!N>LP:<RE,U(2A:5[9J-Y=\CU/AF4#/L';2[LE;,&@>
MCET\I:MM]<?32])7Q^PLIWPS>HV)W'1T=Y3N_)#<RUH5=$#:R87G&F>%"A1B
MYH3;EH'\3+D^:YI\2:,38;H/[I#(D8/?*AMI>=<NI5TK IO*L2A<K-!8@%SQ
M/(ZD<?1NQN]MX7:W(L)MJP^O2U\\K(B*LMHQU_DBJ^8*-[E.WFA'=B6)9:@G
ML%RY,JO_>7?AF/73=9INXG_5S61N:6F-K#.B699A:73F\)E:]S=!AZ#1<VT"
M708V=P2I\S N/NA&AR= MFNC1><CHC+X%M82-_2T_4S"!;O2-4V-'&9E('=>
M51^-JT2SLL%RWQUV:F&ZAG9TL-YYR 64EJ-+Q!4ZE50:M^M+'&_N20ND:TJX
M*L=;^35>+&(T;VW4J]'3&LQBK"/\$70(?ZS;".:-?^U_SA]JP^TA]ZU,M_MU
M95:[KIV7 JE3SK3\@%7"N5Y%;*^)^%(/[P>3^M6[K&GGTOQF'O]61OA] ,>A
MKH9O@W"F!I[,QZM-]*J@*;14MM_U/A,-./M3F?#S6X&\&^#M*+<17+T#MK.&
M^GZR44=_UQ2IT L&K*9MVA47'1Q;[LDDWNT9-U<8;)TXO@$\L /!A[_BGA?:
M)[<X%>6(,FC:<OE^?,.%/%P]^<1^W6F_:2%>/W7ZLL+YGD^X-B>'-!H_H4;Z
M@'+>L=M+O9M@H0'Y9.'(N='Y@$=I5,-#([ [?>M2ON92K4/ 7Q*&:&YNS2S-
MNWWB8^K@O@Z/82:Z/N.MY%M/HD71O:PU =J8C7*SV/9Z?B'P>(Z)<%=30C8X
M-]%B0T5-*/E(<]]0M*7VV/F@]H+=M,A>.A''B-D+L3_7\KUO[)N,IA=^/*TT
M:V9M12R?M*W_%O3*R/'<^]'SZJ:D5I8,M4[@4]W)IJ>$H,"\Z=_=OK2U-6]:
MINN#:>J)RYWD2KY.GJ <G35JV)FQ-NYY@<E'\^OU3>.Z]\Z^,SQZ5N]URKWT
MCOF<G]]JO_$"=FZ*&;E5Z@M:@><W )'0P\ "6!ZV]O5A4&J!5E%^,R+9NZ8&
M*\+X,XPL^!I-LG5@G#95 L=VZV(&SFY#_ZXH2@[TQ#90B5)(UY>)*D3];6*R
M)&O$*>B)FJ:O#%[BWK]N&U/Q/WA[SZ HONA;=!0%)4K.0;)$R3F)))$L<4@*
M2'(8<H91D)P$!"0K44E#FB$,,)*3Y# RY" YQP&&X?+[W_?J?GH?W_W0U55=
M=;K.Z5U[G;5V[^[5A56&M]6%\'1=Z:1U[YVGR9"!W++7LA[CH_0).#><L7R+
MGTY=<WG:M\%?$G0Q_0'^C]:TG\Z9'O:Q1OAX&_Z[<&"Y!: V?BYLG4N3X8_X
M+2=]OO*R=LHJ_G-8'B-0N7>B2-1P*&(]WSS-DLUZCDP0']+H5"2>#I8>&P8:
M-;7 :3Q&2$G?]-#%T.4PK<:>-?,=')R(2/@?_^>H>9*=,=5"M'+C^";N!7):
M'&25XHL;BM>2I^2+8.M-;M(CX"C6*= H]R_OE<3QMHZ[G2;(Z<'\!=E:[SFF
MK7%XB=[W_0B@D]BD>M-ML0 ,55HGL<8%X5C7/!;(:A'P(YOXDD9X%F^5Q*,%
MVA31<K[HKQ1%9_2K[ @&WA*X=FTU%S*[J1^K-0X]2WHP/^O\):1@CRO2^S,3
MO:1FA?)(,)XY^G,J5OM0Z)=MEF)YP3Q)GOX4J*5R_!<IX;&6Y4>Q7HL#IV(0
MP\'E+4 SQ A7$=!_=!"=D'3NB&7+VD0%0X4A7Y%V9/%N)PUVX-"T"0Q/Y[&_
M3?N5;[)X@?GRB_<>HPB*H:0/J<!38YO0W6S0S*-./HV?4&F,%^27DX':THUV
M9V"+D8K F@L1P%7]Q>[29>:V5_R[5O98;0W/O+)%E%TB)LC!SP$,C4,X?Q?=
M\3/LX8JO.A5XWJF@LNLBR*'="(EF$;]31JOU+9'3TNM.?5I*ONWPFJ55^?]0
MR;/<_+QA*6.3^0:,F3O2$=.I.01]&0M6/>RP<@'ZVH<;3GA'NT7\"1BH2QV
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MHV )SR0>57$T.%>^CGP^;&\\K,SYM@DKHKN%8XUK.-M88U0"X@@*QBQ+8UI
MX&60GG9-5H]K4D/OLVAESW\3;G^G1/K?_1U6%]&#'1F?P<-_NK+PCLZJADW^
M>S+/U3F0FTA92*$\.R)>5?'W6FC#0"W@)/CE](>/R&EY<DCIYH/X1=BDIQ9#
MSMNBB% 'EI8<4]45,,V,OZLNK-')L37O7"UV>'H2/RB*@TWX@UV*<RMU5Y:C
MBIK'E6E,B[FWFWKIDG8<Q9=,ML>_5*5R.EFY_0EU@_(M?F,\5I"T.ZR"MX#(
MW%VNMJ83"9[)53 'Z2);TL&3HH=TT@?CGZOV_KF[#=QM1UX3=[EC>+10S%WI
M5^H/[$ QG,PH9?A(H5?A$:STO,PG35'T  ^+!=HC>T4.6M]C<TMG=&[J9T1-
M8P_F6/011Z2A+/F+*2L\7U]'5;6 /6A7KH89,#I8:5DN5_=\>MU,2-^J2.0E
M]4"8O?N]=_A[WYGP3,^2&+:K7<4V<2R']>BIO3*.^5M B0:82:Y'>>$6X']]
M[]45SR(6>N':> N CNYN5D#)7#+0\"S'26_7!.Y_EH6S0^Q(91D3:\(3%!KF
MDE6=VMA?$KM FQ5 P5MH.+S?;JR\K:7PD).RV^N!5SN?-G$L/6=".#_>:)AL
M[(HBNR8Z82,JF(^1W.6BJ1EPL\G.. ]A>6B"B5E1"'K1=GB3'E4PZ,&$JJE:
M:TY\^.UCE[),W["H%J.[R- K2%S#9<+6L:D<R,BL>NQMF-4+"!=/KN"J''V#
MY@:A- &]PI7Q]O$(RPY#N#^KUN39#7-]YO)T99ZV<2,PA=Q&ACC\03*Z7@C'
MX1IH1GO5\ FZ6T\Q0')BU76L7J%,?)CXQFM$WLAB:P/<#OF6C46:)*D65+=H
MK,39D)G-:I\''%2!.<DM+"P^VN?VC= O 60X3ZD32OPWC*RL)W3^LR4>M6_S
M8L[IV9?[5ASL^-;^ND+=G<Q2'^:+/VXJY\+[TZV[O2['@HJ66_(X/G,6P>3(
M7*>%X/\*L[<SFO@3:ML&Y^6^5CR0\%C?8!3+;\T304FH7W3G,4X(+8S? KH8
MC"L'[(+%%GH2F^CI#3VEJ[1?'W+7N=)^!KFY5:!GM?. \ZJN-<[[0 \32R@;
M#4]."#\?*T85LOS>OQ=' =UEQCDT)-_\6MM@T1Q>%#L<?G;6 %T&#Q^LQ;0E
MS#:L+&YF#.45VOW\N^V[LJK7VH#X?)JR8)RLM_*8^GT+LA/.((M] US$[[R_
MV:OG/<E5 [!H0;0I%X<:=N8C1DUPL-6@/HG,4S )QG?5>E+0V&*3JP/8C;__
MHCZA9]<KWL#'8>,&TO[@+-0&A<6K*6A*(O;OO?8]WWDU*8Y(X+"H5PNH*+6]
M5!T;0T59'B7KN[;Q'G'EE0KFQ2S%#1D_[;F.$6:')]3>NR2R;[#T9EJ/^CY=
M:J7FF6XM'78+:&=(BEZIR9(1H  K#O@2;G$J[[]0]YB MIJ.!8-^^<<>]^CP
M=-)2;$[8#4_^:]9,(Q7U?7I9!%BSM[4WF%Z<+FC+P-7+R1:RU+P5@BDFIJ[C
M'ID$L/]=Y!-A8UIE5EF5J0(:'RT4WC3Y%?G;=5PPG)YSF>SKP;CJ#43HT<RX
M$^^EP&F>*!_SL\684,YT1ID/8)1&)"T<L=3-Z_B;TYYZC;E3!K]D;QLA=2&H
M]"0P9"MD]_3A$7[L8;?H#D.0FOBB8TSW '4 I+%4OJ%ZO1)MC;;I&I^95_5@
M:%+WMR?%PPM[S-R^S1\]CF.1^'B85C>(-[,9IAU3K;M5]<W]MQVCBE# 1K'L
M[UR\E;WS7%8:BW_YLVD$:GEBL)&5(LK3\FN3,ZS2B$V3'_4\= N#G-!K/9<;
MX"V[0,'1H,\7J)0*D^FC3,[D9KY/*2Y +:NO::<"^KKX.@$;6 &])X,$Y[G0
MSIM7(#+P-Z&$.6TY;K%&E8LDJ,78$6LL9S/&2[%A>?:9A'05B#DMY4W<@%5"
M!JB+-8/I4VJ6D9N(Y]Z-ZU^/^J(,S_.,U5L D:O%:19W=GFWUT]UNGJ/PN1>
M2T7)G""&+?X110IKEQ-_#9WZED.T\_23F9YI5-B^C.*XYC\X[P E*M_B5';<
MX)\O#KE$3N_E8C3I8R6G^<EQ\HP(R&L.%\@0$W !CM)PY)%1?WCR^XD*P1<U
M=U9J[\$0E]G.+(?Q_; =4\V<(+HUZE^'.T9YUQT>%HN4-S]*-*=I@4E<J](C
M*\\A#-&(TG^7SC@';?4,"$9I;3@L!*@#0X9UK.K71QZOWNBTI/+U\UR7Z>HM
MF_)W"26=CW2%$'43BS$/-WZH^!8?ND(W9Q\DEJ[T$6K4>$0[@W6V6UZLW;\V
M+FJPAF0F(.A($![#7BAQ#;/2J<5CY)JV;ZH5-7+P1(JW0B&HR^9O5GJ4X[F-
MW+7AR2X".]1FV@?T?>XU0;=2>S;"(I2P$KZ,.<W.WID1I ARVOOKEADGFM;^
M6__^6HTTKO@68/,;NG,@1\@?/QGL$?2?*:_%CB+[**->.K +GCXFE.Z;8+8D
M;6\I<E ?ZJ.^L<(-*VZ8]<G'VZ9A(+<EN6R.U8BG #@_M;Y#/QZJJ]DK'(QZ
M>,1@6D \O0ZXA2T,<(>/!L?/KMEJ6M_K5>U?@9KF8HTF*W<%L(*_-*VU_<]^
M<MV,9[QG9$KX[L,#4X1$9TUGBIO*'H2!O>=IS&E$@E')FF/I;,]2N/[AZT&I
M-*SD]RXAWZ1 @1:W@,Q-<9,'"]PT"Q*PP[/NDKX#08L@(%**7</H1*.!Z<DC
MF1'Q9F0,I*Y%HV#SBT5(R8ZAH^#U4!C=%X><0Z]A ).C@I/%[ B.[!+/%YG<
MJD8=MS+OW"*W+&ADJD;"58G0C VDZ1V\6BDQ_*?S-6T^SB*]M7!S%@*3<&5D
M7O3;,WU,$YH=?2KQ;OAJQ  .S&;\*?0=C!"@(# ZY8A=QG(='JC+BC-D1'\0
M/,MUN1)1F!K"OK-K^BCW1O+%IU%;4]-B)P:-R*5F!L5,DH+7/>8<<.4?LW1+
MWLRR[GSH?\T9+XS6ZQ)[*JDW_/+)@U5*.J[2?RPQJ\^^2,+7;FB)'F(XG1LE
M55>$P5:@3!88"V:6Y3TN1+AASHL24DL'(J&IWC]: +O$5F=(YT/4ML\;T_R&
M+@5'G5:XXM-#J_6TXGG=:HV0\[X2]!_WMG?"O$J45K18SC:;A%O ,F-C_7'+
MK!+,8NXRD])V&>4FS=^^[4G"BIJ'KI$4WP0G;/,3Z!_QS,B;%_L'$MG46UKW
M<AXC,^M5*" TS[U2E/&2*M]98R[>-$VZ508_6Y9+")23>2U%RWTLYQ2>6!8_
MLZ"A&FN*:R6X"=GP4O-:8#@"(6,$A1_5-]:VU7A1_X\\@(O*NJLPA?%G3(1R
M[U@_'7_7=KCQ:?^,O*]1.(B)O.=W3IE8?)\&,[Y,Z73[^$;1F%DHU9$$,O;4
M*X2D9;I6@[]=H7Z)(%)-VD&Z<@!DIC7']["UWG6C!OA3!\V6_)V"3$0_!Y\?
M17]@V,^N2MG/\?#EPV]YOTT39P+.4><02@>!7S]=2(BW52X_V'=YL/XND\(^
M&K<86)QN%N[BW&.\!5BXW +P9G@K\LDQL;T=5YSHRLLOW?2$-5V(/ T>PC*Y
M%%?:ET<:L3[,)G0^9'B6SLW!,S.^%T>:;^PX@FT=O+"8'RZ[D:>FCF_5/&1+
M$\]8]P9;.3I9:!M1CC5\#2EQ1?!8;@XY5>2"6T[05!()YE^PZ@K_/-66J:24
MI$F_8(=ECJB<".-S_$<]CVPU9?ZWN4-S;.<A,AJYS%G7VG@M/(,;#)'(6Q0+
M/1"L07SO"9$+'"OVC[LVZLK:3SZWX;]^MF(C]6=^_4!G_KGD:JF1EMP>^A:0
M>J-O@T5*7#%,HWQ1R?7I#>2ZL?^(7BY_M'57UW#W9R^I(E,^$DHH\N<PG7X[
MGM4S/(Y;TWH@2F]A_B!;FW@U_8/'Z/O2B6#@"B+AU:,S,H#5S%_=99,MGT?O
M[1\<CM#]4Y>1SS&RP+'&OM;YSW'<5_;([X/;T/?&N+VG\IVD1RU"'@BPI6.K
MCF5\!MP J]T<)D@[-,4Q]KECC[NS+^_M?;920AGZ.;W ]1;ZE5L O8O%>275
M G4*D*.L7G3XJ@BRR4?]YKNNGRTQMO1!38'B6<;(4</9+8"88OS@ZFYY**S,
MUB\_$-<?^-C<RPMR@'V,)8UR((5L_-)*296I5O/$&B9NA=')NS[RBM_U?=[I
M*ZV<)[,JEF]]5ZL"L/R2J[U7L+V]/Z'4AQ'3#8ZN_*H2RW<R5W1G4@,A=]2W
MRA2KM=DRU3N5^X]ZQ$E1"(8Z#1KL Y4V--4Z)FX/+(%2Z*D<G:_.V9L2E%;>
M-T$WS]$942U$ 3^!S>_]@OXNO0&OO%D0XY:A!QCAVHXL3V/Y&3L6.&%'UA$T
MOURI1O'?)VIRT_D7&46:L'R?'I*L>#S'S[W1K<A2VT+C9W&>\7!,^LE@ $.;
M5U*S;B!*[H@/=PO8S=+]5&+96CG<$ BO=(\BH3(3^!=R*(*9FE6*S".NJZ8)
M[PST'J#%!\;YI)BLIEA]^H"3X#NPSH;8^"^<;_MH[K#S%^*;T!.7LL5:K,,2
M[+0/N:/LG%W?"A3/@#Z(7ZL-]BV$\WQG2G%EG^V]JDS;J[ 6.$P8C@#[\48R
MU@0P_P&.S),:,8I-9 5*.=QQ-TI?4\< -<\%WB,8,@(&$NT)>E:E<_7JW3&I
MO:,.PL"(*5T0Q4'W$]C=/)3T&9;@9W[8Z3QDFR @.12<4K^)[_GJ/N4$TW@S
M[ JB&?+!Y]0TK_^(TC)]1D)'ZG=SQ/IG.XKL$9AZBN@J5PKER?/3K:P]\1"+
M$>NQ/1_MQ\3I#08Q'.^>NP>1_TU,,Z&>:,@,C.4M$B6*F]76B!!R^Q&Q 1&B
M3E$N4<=M;_PZI^J=W&6GY=;>L:=IO%9Q?A,@0\]X>>G/=F+IEJ,7K2BPC1+]
M.'WUL,47/A#XN)@QMPWASA>'(>NBE15#6UK]#4!=+4U*2)D&RQ/^KG ]/G8O
M>^XNO?-*=G8$NW=I==/AAFK0.T9N..QXM66;3H"@2]7Y^O6QQTOO&0.XC5,,
M< .IJ1CC@6/A&%G["YQDXDJ_UJ3X/#-TCS"'^6BX%&\;$;5J_;F-IT:1F(5;
M.$[,\;SEBJ2I%P43 GOT__>C(G _MA>J)'QVXQ)WN'T%&BZ4S,?_X2QXBB<&
MY!P85U<P5^G;EKV:&C@:B;((Z8[J^E7<:FFSN!D7XI<\DBG078,A%EZV3OIQ
M!Q=@P^E=W.#:+<!A_B8#DHD8NL1SZ\&7766:FE4+V;N44^I*XYR%H[!38TUJ
M;V<Q<7LLXFV'!S.^-^G#<M#Z@,SYUNC9!B8[9B]+=+!FV^1[9.UHL*!7F8ND
MJ>?L$,4\IP%[(8AXO!% T_Y4F2>IIU@.O3@-Y[^ZT5,N:-P#]^H5[$P'"I]S
M#:W_"'CO]C1RII.2S9:00AEP+\7RB_26P29.=I+5$CZ&U5G.3L#?/_&;89KG
M^F/T1-0TT!:_U\75"@G=[@!Q^7H?[=!0[!AM;BF"ER(<4P03C@LI[@T_#R"(
M7X>:IF_+GJ*E>A2,!>K+<PUQ&UH-9H*V3[VB@M-]+PTTF/(M-H,55EUW;B#7
M!#:'NU<L)8>92^J-VM'KRNZ^S4OVCLDO0];RSQ"W@*=2[P_^:TC,3: .7\ZG
MN 5TJ-R4$D_GV[5,0%FF_>6',+U\OY?<?X>K)ZWH[4&?N%H$TS3"Q]<T&7;^
MC&0^HW<@2I0\&@XZ_>$*UL;6WP)$%D]J6M6H]/^O5!)[@_EO 8_(T/(:MX#'
MPE@.&S!NMKGW/"-Y?7>^=W&#V56UW8\A.)_B# AY-)"P_+7&R!V^EFW?+-B;
M@>7@1X&I9_66D(3SEEH>'LNY#,Y%[PXXT\G%Y%B*4IJX81]V0>([#O :6!CZ
MP?\Q5+6'C@$/M7%D/[5-]J86CY!8,M4A[+T5!=:.*X>+*)^;5ZC7DQ501T?@
MC FKC-4@_Z]W>/?)P*]2.QD^3<D;K0I3;SW)/%T/DQ:T?$;D)_!J-O8J_DL3
M]?RV!4U2Q2YN<KP"# ]9A &+$*'9G[JM8NF68MY%BB=*T+U1 ]S;?<@OV3 ]
MC:5 +F\R!T,A/>?7,\MPB\C\%5:2WHJ=6P"5CYG/,_V:"?'R2;C3W"U@\"EA
MV&[@O=Z3\K%G-C-A:K;M$87W67_>'.T<6)>S1M5K^G#\4BO<V@J=RRZ&JSR[
M!7Q:5:K419OD7 4Y'[QUF=;+G>ZA%LG)R:D20665UITT+.T3;FNU96!-YP0K
M[*ZYZ0HO-;Z4->X=HW*P,D<FX<N+A!!;5XO*O,Q?6U[:)'^D4@5>]P;8#B(8
M/SU@X9^8>O'3& !X#M@SOT#C)_R:U_"!%)E9S:GAJLSW4C3T?G!P%)-<#UW\
MU[]%AR;\[[4Q[>$PCL3(^JCXK%9V=N@7A[KYJWT;@;?505(&NZYC+G0?]D E
M66:"/V*U^IRMGCS[\NFC66(C'M/DY(>4W93KR/3*"U".<#==<9+6N(1#Q 9\
M'*8)%BI4FPLN[GO?&^RH%&%\E)\D+PQ92E"?T)NJ\.%O?3%3N5>Q5TRAS=&(
M+GR'[4R=(S8M>/*(+3[<'-[&/"8 MCZ?T)C8VU],SV-\H\6X_=M^\GA>NC4?
M2X2S8:^:, 1",5Z?CEJ_7OEU(,EFK)CF@//.1YI:(W_H5:#Z91>^DEF?V1EG
MS83>F9)2.'5^_+W&Q+)TQ\4K$4U24XN'8O$!(+?8Q6C3/$R^4?5XJ*"_VXYA
M&[RN@2$$?=D@6N&<8H0GH Q]4;&GUWDE5'_45EYD9E.O'#TT5?M*GZ5QCI3/
MISD$V0^=+*G*PC7HG<J046,UQB"UZ^-8A2!26.7"C\AI='O7HABQVWO+"#P9
M&8G<E5;R%IE#21+F.?GT<I?$P=&&G,^K1]RM1#JCIPETS\=/RQF?+/I;S!:9
M7^WAC1K'(?BM[I[1 >A'TZ=H[F>%I$7AR>VK8?=*[=O.,'*S)Z0-H9#8FF[_
M&&K<,W\.SW X?X?8WUV+C)7I3)^R8,66Q#%'WTBS*F;!84[>1'KX+: >P!G"
M7YTR,.[Z4Z@8%K'/1OPTK?#A*DD[.C#^HEO/<&H5+(=[A@L'[LP(MT,GCP@F
MY!^7.95H0^-"GZ:,^]\" D >T*?OR(R=8M=N1*R$XW CRZU^[;)S!T_'Q)>Y
M*NIJTX\;>J@Y/Y 2T/$L(%27(62YJGL;+R9(]KW.DVHUUAWIAG<=BUVTF+S4
MQP9B-SN)*T0?75";WJT1,A1X]JY! [V(FK/?PO$=XJ#^ J=#8+W61E[[X[TJ
M&D,J.\X]'F8-BU4<K6OS:P:KX1C%8E?2LN9B]$VBN?%[SH&NMX_[5\<1(7+*
M8_5^?A/B<40TD);IZ7YR<-6HF*XL=PKZ^Q1IAKW/0SK:]_/RHTJ+/1 +ZE2D
M#[AG:<)U EOASO+HB#1UV=QGA P3K@^?$%Z9+&W"/S:.<8Q5GZNJ^$O2RQH!
M/,R=4WR*R8!BPE\KOD^!N\\(#FS8'_\2Z-9SO]?C6C]9K\-C_L;*2+NV[8V,
M@8];2H3B[*=N8-@"HQD%D;]=)">=V:I^6>%?0@,3V!5_Z.-0389->.LM@!'G
M2'GXBSI8[M>7[S33X,>*R%;Q/+Z&PSC7!!^EN*>'N);DS\X_)NTBU:W+.!.&
MF2 MBFEHBQF+OSUC,[.J8$8YS4'BM_?>RP@H[^L9O8&QDCC)MJR ]%Y.@!WP
M[NV##-7QMG^/@5I2L!0VW[GL#Z9O 7'@L^=M+)C("YN)LX<(1)0^D+\.3%K\
M((AB[T5XX[T>%6GIU43^FI]+88Q.AG3LF@4J$9J3?#]/ =Z_^+YQV84=V5Q)
M=;,^6-!*)KHIF_65)NTC3.K%3UT!3<IZ+U!."LVI.8(JU4_^+/I*\*X*!!%G
M+1PE13%V9?%U@D1GMVDFN*:^[I)R9)*J2.\&$/R=ALZHG7^#7U7"ZGLT?S=&
ML=B_7$T^(=68?%,^$R"'0ZZW+3E+8J>0>L?2X&B+Q-P*C)=:X\0!"%R9;56O
MRM52SDZY[BE:%#N-^2YV.-C%>K:Y^,?DU((TX>%7$_TM27*T&EN6-,7,?8[P
M+^W*OS^<Y,%<ML<7KJ:U@0C_*L$U1OO8-Z2)"H_D&1@N+$V#<#9KT@@MK3L1
MASR1+UV1S*M8()F"2I!HZXU7IOUH:IDH/OX'%V6/"/DK;1E/>:#EL'P+>#CO
M&J@-Z?@S+9']K2K%%:@%^[FOJMD2_]U0 Z*+1572O7,*3F6@@^_]?0/J+5'@
ME^WL#*1)<W<3WZ/4J<MM[@>[)-=@W^"]R2U:S(:$%GE>QRIJA?044QEH5D.Y
MHG!/%C'F>2*W@,_EUP203- :Q"5 IC=%K.$/5BSVK*RW]3 _\DRN 8$\Q*7Y
M>&(6Q<\-$'!\?+/XO&? !21T%7S,JAT82I"WA9)EP)J.5[80<$'_HA?>3ZU.
M1%\+S9$)?$%R8Z^\3+%*E5MM%$<9L?6+3ZS;2_N#@LYWS/?G[1+],P&_O3ZE
M<=!!E2=.*^4T/[:7_+68>:$;C' RD1@94Z;*2DPMV3Z,]E%0'#]G\Z18ITY6
MN7HN?@YK02T<8( O0$&+@X?(C9!0C<?%VY)MO)AF=$D<N^46VNW;=-W"2R^F
M%$3D(\9"6^*C'<NA*BAX!;S'CZ0*UF@9Y0K;-\O0KFG1EHHPB*;O$[IDPBE.
M[4ZGFS2'U +-@:J@^\0"^CWDIIL$]\OTEO<H=@RLU%<U)OZU_6^C<I73=V*O
M9H7R#\&A"RI5T*LQB\5?_T*I])'X6!<:[2;*820_UW[PAE6.V!I>8Z(>\\Z$
M/%L<:[CX2S7"@AZF>[BE2LI2LV]"MI*^ZXP%/?Y_M.&&ZH_?)F5SA&=ET;UK
MB'AZQQAX)_G8>0F_>P-(P[)VCK'4$: V2)P\JD,6E[QL!>ZZ$FK].>N,2BK3
M#F)<>,5NOI+ZT-R\FE36#IV_;/5NT!*#7"$:DL'.VNS.>FM-!J>^G14H;1RA
M9PHN0;1JJX[[I*E-B2/XEZ)XA2K'K4IGW:5_+4_L5FZ<+-<W)((%U-8Y;27;
M^RP_Y1;R)'XM+/Z/,S5LRO OS%O=X4HZ?]B4TGBHI!-Y[Z"%LY_H8-(RJ;&I
MDB&)'VS(B86YJ?8(OP[JXMG-=7,=O6H6PT_2'-+UX%-* $]B2<01SYTD3D/:
M_.:$TB!F3_1.92W6%=F=,P*1G7LN/=WT^_8-7.2!;8_D-%!T57FQAJ8F?$+#
M&^1V1U+M@\O14*[IW>].2_>UI;X*;/ZV+4V[J,N3-3&-W'6K4"1PN;^/WQ"P
M)RQ$@?^ +OFBMHI,]]$*(E->YL?@SP1U'4;=H"5/(8LIXG#<P_B+RL<_8E?H
MG^:)IS^C*B_\Z6#KSQ8^:2 Q1.^7@97^=9VH4'@+(+ED.N@<N>2Q9KX%5 <K
M73VJ2B]H@(<-H^5<G>S"'GWE]'CYPYCJ+D* 7Z[F@UFZ5OV? ]XE]_A?X%ZP
M/+D;LFMS]2!M$#-\=='>)C!)JQ,1<V1<U@FJ#AF<>BK%^KH\_!9P#VK<6 =#
M.%FLH^FS'C^HH7\BDM![+T.!C"=Y1Z>QIAZ1_M@-9)NE[7?R-("#^)U;]M>\
MJ#F35_Q0/XAZBNOALPNKC(5L9QQ/+B9<*^H%$@,NGDV:MUB\5%TD9\KO6IO*
MI]I.#R3H!I-NRQ9W6)@-OO7X(.0@9V=.Q \8&G670_EYV#G[B5-:HMO%X0=M
MM"G/>[A[1(M.I?=Y6ZOK)O>RT+AQHG+?ZS$]NF2]2?+8<L1BY>SU*9>:2[.Y
M<..)#95_N<8T%KPT*,A]Q7@+X#<ZX<J:ZDHNW?_[4$BZOU]ZQ [X*':1J<3S
M>^TF?_A69H*/R15-DC/QDUEGD^?=8)YL0@VWV!HDA^=':?D\C4IS&I,PS"*1
M4^BTW7$\SNR$T%'.SZ<GH)M(._@60&WK<O$?@75?I*UZ6!KI/9L>\\_,)\B<
MV F1^3'X"X%7M^D1,JGEC@OJJ*/TIG;/B%K5YROW*@6+*5[MK[J$A2?W[S]T
MQ:K7(MK&3[WK85G+A=."G#ZQHO_T%;69O/&:*C'!"@6S+H(_VPNWCFRD%IJT
M[<WUICX.O4H2MPB2NF*OFDP%SIXYDJV4\]2/A;+.6/&*JI;-]++)8P<9\:YB
MIS#U=]N$Z97:+:#0I'DGFU^[\W$S/-*+.,PLOB;R>,[;842U?\W S]'UIT5K
MY5Z]E.1!PM'K3V/5GJ)D!%GPV:D+Y$K^)J\0,( _%++N&:I8D]DBY5HY\\MU
MC^)-6[2PB3%KBUXWD;$>OB5/; NPPK_I41#7RXGZ]=Z'M.O)GR[LDC DYD=)
M,3"@2;;R*%:JW-J%]CDH\LCV_C#[#+WSXR6HI=UX@_RS[VK+$**M*W%.<M 3
M4UO%DSPS'&>6P?Q@J9YI(99VH=]E0.3ZAF8Q:>G#-$^\N.D1;?B9%3LWD> 4
M@M/^E&0*HL_O%INID2GNE)L[C->A1'[*,V9;C9(@ K&:U:B _5PA?!T#VX ^
M 66V,[KR4+ZC"@-_/%.4O+ ?"")8NH_]JY>5##?U\FA',RJFC;E8LX[Y9)A,
MB8<H7J;N9Y?;?X5.N$N\G]"MJ:Z_YLI-:VV%BZQU4A38T6WBRQJ_.M:YXS70
MG?77%!$I,RSD*Y-C^_*, 7ZW "(I\^DS&5 ,C:1?_S^M'ET,N>X4'N<&$^&^
M_,NR\6!)XGNLX.B36X E T(;3+Q) W&Z%HHJ:3]/>Z:4YLQP6188^?OR4_^.
MR=K$;HED#U#.3[*"8='[57 *_CU=1:-$Z9+ZZXEK*,Z^$=ZF$W)^"^#X@H'=
M MB9\L^N7>_BG5*,B0%QP7/M5ER-N3=>--(*T);_#C4WQ5W*W (^HLS]'%Q_
M*MNVPB/7*=I;F@I)FPC8EHZ^*$OT^*.Z9+O"#CH9:*-\S ^J"HXS])WNSW0Q
MV=9\R7L5/D&=5[Z\<&'#B2Q=LTKU2Y^NN[Y;_K>\1PY'M-$2![1A+ O+W9%Y
M2^ZV<>5XF\-:6'[AWRP<8UCA$AM_/YO)2N^A5P/GOCZM:6]/TN9JF]/9GK.=
MGU:==*+%65@.SR*30;BR<>IXU@/R21P/=_XO)PO%NKIKHU<U;3,7H5-N*7M7
M;@34($^$ABOPJ!5WC<P409BF7R"774.FI?,)YGJK,"/=;1P3/7OL_LNP2/='
MP*@$W0W+,SSI$9A3,(>:7J2LXBB^R0N/G74)7X].JN<5(B]C*.(?&-]3/NW6
M<'9T+4475Z;52TYO7;!'W&>_6")]2*1#:]^VOK@MY5=^ &D7'ET-92+66YF#
MC(:N7@KZ23R$I15G?D.C.^]EJ0JTO7D;W*M@7C.9;V0T-B;4+]S$J5AY\6&U
MC6-A\":<-,KI3T/SOXZ_/49EA5X<H8\8:H3:2( Z15JE2728IDHL5%#PWV2X
MZD?IAY)V8%W^,8=:6-XVT2_0CY05DH774#IA%G72B4E[GVX]H\'"_5M \8T?
M$:+T!@)DD?JYW2";WPDE<T%YU-=B@DRB7<8*:/C74A+_[O2HFA::^:,ZKHK.
MI\\9<+E>'EY=^IWNE4^7\IM)-0!G]V&5NP)[#+[P^C!*]W6M/QX1)V:'YM4R
MBNME%OY>JM6M0;,*C+KP9D]M/9(R#GC@OX_]Y7I6@3LGM<B![;7C&><)O;33
M:ZC=Y\-(9)&_D<618@QT6[+99]7%<T'](N51NG]1NXG)![S$;R,NJ1U9W>F(
M(TB75);7)1PY ]],_7GYOE/27.^(^"AYTQ4Q6:_ 8?Y(0D>H!Z,Q0%3NG0&>
M<)>N<GT]40K'0,LMN;XFF^5R+_ 6DU-'?SE(,XJW)W;G>UL8&T)I$X%4SAN>
MMX#$Q"R!J9P"";"<%B9UY>;.J.H=6M%O51MF<1SP?PYSZIX*?+V=0Q:+P"-H
M@@^1SI"KP/F"46W:"97&QTZ%1%$R#RO81=2IE>&Z7*ZJ9C4B3^G,<P[(&9__
M0H6]4M71%2Q?IPHB]AR@TMRB(UY6I^7T^;T4:$#M:E/P7^><9+/0!19XHZ=X
M^&++T)\ F&099#_!:MP*#/=<YD [<*1SWD/7SEK6';;B,FDC6EQ9FD >/LPU
M8\7-VKV/NN[;^<BAG#:(-;L#8YT#O4U2T!IO7=+'Z^2_5/"1SR1J\<=3Z'%.
M@>3N&'622/;K,>^=9V:VK; R]:Z0-X0<A=8FES-<5X^A/E";;N0)EM1-Z5+P
M@O7\GMX-DZO<[^;]U)*=!;YQ\!D_4.>%E:]I[$* B=07:2N$BI)D2/EH1-KW
M-JD.-"OL&[90*5V^(W-X?MXCS\-X7UR'^T _3K]I?+>D->K&^$_ZYCC/6'0?
M]EFO=J $9L[S3F3Q7/ SY<47XP3\VU7:7?F?DY62F4-(L08%_N!.UL/$G>:T
MO(PRYY1!JL.%5]49@^FDB)K&)U[)ULG,:46FJ=8:KH16KZD=,NWNK1&-BOFP
MV:]*  U&O4'6FFN3]=E$J*1]B:%:3=--,R9#4RUA_E!!7.'_T^\L;?/XE01(
MNY>%O=Y0O/S<;,^^_3Y$B+V2;>2=_TBPR6)'MS'F[?+2]WOG^OY763LT=.ED
M3]^IT,RWF1DTL'P[+;%  \W0O:[.8.K6%M4/'B\^D1-\Q_NDXURPFS$/.>$>
M0B"5>A;7/)!$F+&S"LBHY\4M0-W40_\_15I87%PON<.9P%]A\)EXK]\NL>A"
M0H&K0+M6>U\K-%P;8HJ!WP*,(C 9#H'I:*7H^FO3Y@S55EI#8(_H\4L54[2"
ML@R6_\7@BFG8007%GKQVR<MX1$O3OJ$,;?Q2X1,OC*FQV0E&KS/#-/]#XYW:
MD9A6#1@W[QE)'MWG$!<4WT*>79!4NGDJBDV"*K"J2[< 6L1E,Q,)G[9[7-,[
M2K;'3_=I$]O.3%>$8[QM*# >\@K?MTT"2W[]M.RHUG!\_K4WBM@J-K4>0,;=
M*M87U7<L7W3LNW=\GM!XVOO:6/"_TD(,BXZ85G5M@.(U$,CIT%:L/"31VLP#
MZ98+V=2]KMP##X66/EOA_8HU/%1VIRLR_4RY31Y0*1QC<ZPC?T<WK$4A?)MK
MM?59^XQ-H!]!W_ >O7=J]^_T^9\"S-M@%5AC*R8$"K1H%[B@F.FKZ::@<>3T
M!GCJ."HMPW8P]0-A]1.G6$J1>FB,-07\T '6/5WC#!9L+:B &VK2^#CH$P9
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M^:KX"G7#6&412<E]:].U72H;$[WS>Q[2/=/%(\9!_@;%!^"_CC#]VRS5:(1
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M7(H56^+)1N>3 61RS*;_[5'.L 8/>9;?U)*0^#24..F)D-GW=T]9SBO./6>
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M)!6,@Z-AUN]]'7R?T1*8=KRG'K0N7KE& "Q5^-UPK AZJEYPE3CAN,GK=IK
MMC]BR_%AYVH>VV^Z[B1CM0RF,M\Z];N=DI^_B3PR$UW[<<C'1]-N<"_]_9^M
MCR2/ZZZY8N*"&P'P[B$!,-:7M/2-[0.&^RH"1@ </](ATT78$0"%QDW2XEN(
MX\RT !9TH+I1XY0'U._G_(31>,'KG)T1TV<T:1^;U[]2R# .:E'[('N@_/N?
MZW8I/7P*??(S]3(TSOPU[[,KAC'<)%LPS>G>7 O0PC3;Q(Z9Q,1?K$VMT;*R
M8)V7(@LGY-@WSF@S"H2EH,M,^31H.YX-:TX/#HX;*?L?+@KPWI#5*E.D.F+)
MA@"P&-4&1^8&$/NB;T^H6?X=<=KCF]>FE>S^S(XX(V+?.RZMNZ87Q;KP0-.)
M;MW-)/%?T]2_.*/>C 2YA>^.EV,#6RE_8._M;75K94]TU[SILVF$9P.%)71G
MZ(53)%BJ>S^::M8N=:,U!.3#O5')>>KU=*@ -XU3D>"5V@0>M)"T<W\1#[(?
MK)6:U0(T.[;\++X'1![M+Q0VXT9J=3&"7T3E'SJ:<H?QUTG,O#W$G8LZV/S*
M1+K^23B*4^&>;X;>=O[@S&]F65_?@"!]Q551N,Q1>T-9.9#,=5X2*<<H4'L*
MH9H=M"N?^;0ZVPEV8QZXL^Q47<F1H\OKOM2[5NJ_]#=')_'4WG#K=75C>_Q0
M-L@MMF*9.+MU.6'XK6C\R<+%[U('KBL/?+WTO:=YW_[-X^C_;9 ;=4C)XJ/R
M+&>V'O@*#9::CWQI,WMZ2%4<XA<W!RK+BY;BVL1R(A2YP-LMX/_/)HJ&J*W.
M;+5&7/M+PZO''3:L5@JNQH+F=FU:__?:,!KFHVX0F*NWI[J;U-%2E?-=6;14
MHA9 MUO$Z$'![X%$I<?A*LJWC%D_4TYJ$V_\N_*"]_9ZMW\K$(3FE4;4OJW*
M!#6VM@VYTQF0)(3K#<B<T4.WGFZ[^I7_YX<!VNK$^WK,NT^KV3+>'9%\HY:8
M@\.$^QS]_O6SJP'_A6]*<]G3_#S+G!#U8RI#?$L# :"=%_V47D=)$>0/"F12
M_>?,/L==)A$A$J+DQ5*.1EDE@-:_&:S]+Z'HZ>_P/O+,6WNF(JXZ7YU=8<3G
MGO!D=E?Q_Y*L$-X9]2_IN[E-X:J[ ]2O$V^,)0J)$PT,K&=D_YL2+/\ E<.@
MCI9NR9<I=^&O6/I;[_S[<%U2.CT^2 )@N/M09[QS>IUWR9GUFAU@!*/W]A8/
M%Q%M<68?YHO](E-4.R290Y$T4SI*]VU:[O+C_LTVZS]>4D7F #4SZ.;&Y]K-
MF):H2L^3%U>0U/&P:IBFYYF($&?"F]R$L4^&)+DW/1\"_K,CWG7PW*UTYH>Q
MP[.WZ(L:N:QB5^Z-?Q5Z&3K([M[[?RH:?5IX WRL+M7[^:PR;*SV%;LK@^:]
M1.G02>V;Q_\=Y]CKO$U^$=85>%@,GD[.2GH7)ZZ'S2HT<32BI66TA$.''%<%
MS%2KA0O(KJ:=/N44^1GVY:-WN54/=ACG<$EF,^8W#_/M,X>]P,VY)-+QA>Z(
M.]P-K"3JSS&Q+U%H6T2\ZWRM;VQB=Z7,1X=LD68X'#,:XLD[:(T?-"G6DH#O
M3=LIKB;Z^2U..$['GC6TEQ$ !UWMA[N!LO+E-:<I&$&U2=&G?((>;6"EC-4&
M,Q;3@8Y:\;R&-Z/5O0[8B#X_E;!]IUU/E71&#*>]";7K^V_G"FPOK!O? =R-
MV>B*X9#;7(E"#?F>OBY\'(9,*."+-SRRX0[S7)^>8 L7W:1(;.(P??[/E=82
MIX=&%D+?S55N0GH%&P/8:$6(/IY>0+,K\]0HL[FFG#*H74EP1PQ<\3^V GGZ
M4C"\ZI.>C2+EL8)FXVM-G*:#I2;T5"OQ>U1:+KXWRGWV[A1C()]>5Y<OZWT4
MDGW\7EZ;8DD+&_-C#JOP54ATXWF@G%$QG3^P'(YCZ_^MV]S6S(OW"V(M\HXZ
M&1*D"#"?J 2_+=2,Y7/K)?V@RN7.LZ2CPGD X9G[+?=H,V.MK%F_.0A:X$A>
MB&Z8<B:E$(HKE&3'^U8$?CCL&UU._0RVB1-+4LN08'SU:8V.F7A+64EK^3PW
MLY?U?LVGE/I'95$AS\ZG'\2VYBAMJC$IR4$K>PD RT_B%1D;23CYPBW'? ?@
M01V7SNG^+G@GA?^(HO9<SJJ?801W:4VC>80.BG7V];>^%5Y9XBCF7D=E8FS*
M4"CMEM8A<7_T9L)W5HDB%0* JWT9W_&, ,B/53DXI4=:8.HZ5;Y=3/"*2;(_
M7@PJ2G89M]0@ %:FF>O 4T%/YPX0,2*CM$KNIYS-\*9ZUS2QM*_?BL(B!TB+
M+QB'IX,>_]ED+$ %F')'BDHZ#]!1%#L,\[SJD!=F)H^0^5#N(/T>VXGV(H9E
MV@_'K0L:9QB6+K,QVQ]NGV;S3;1*%MWEO$ME7#B45\IQ!N5XQRK<#R6;>])B
M<;4;%-Q</+\0 BD= P$?\%EA_<6CCB/W*JU]<@8.G=.C)4C2;\LI%'PTB]:Z
M[].!S7F5(NBAX3?0;\,*^C+SXH96RGG,6W)R7]GFZ&49L35PL!PWI.Y+WMI5
MZXE"GJ76<)VK,)*EUC*^4)V9 *" <D9-_=[\$J[W%>*M5O0U\Q 88W9';)7F
M&A[=Y=0_@!7G;D+(ZG:5[^ZQC[VK(Z\!/K#19YN?2<BQPAHZ06CK@**,^ZJ8
M6^$Y'+<T-/<U[7?-N '[(PIR!?=6]A39 #A>F6C3G_/^JI6W[[*^25KC9HFX
MW4;19YH=ET-QHEX^%,FFE3'<]769:D^O3K"4FQ[*TVXD";:##\KWYXJTK=*?
M :&(Q1ID9*M9H8_E^,]]O93$Z3W/3Q_,'[[4K_H@>=EH^7>W]YT*QDSYTN/!
MW*;I55AA=X7K%EV&OY(SA_A<-W5V8 ?,7[\FO97B #6A'U.'0(F]UP]JY7"%
MJ&VV\Y> P_VJ.:0#\F3C,Y)%A[@# [>#7@!+T.?C#6E&N&OLO5L65UV.LC<U
M1\5N)BO2"J^^'G_!&0PPN)FH>@/:C<^3/U,YA*GW!W%.UMF-'<]Q["0L."*5
MYP3 PJLO 8.<Y,6__2:':HZ934'INZ"8\78NAXS4:G"1^:;47I+H!$V]LV9/
M5QH)0Q=S]GQC>3LG9B1SJ66@@A&I,UG_3&_8C$7LSZC8KV4W9H!<<;WO?I03
M3K'8I[SK^?:\2*B!;[U/@8:L"';QQ2)SHRU7=,QR=A-T_V$G%!6@49O3E6;(
MAD*BW+EZVPMB5WQ?-+QRT6L4,Z,GGD7'CI^ ]HRNB<G]OXC7^#,PUEJK&T'-
M+Z-:*18/7AJEG-%BNSAKJ34>)Q<2SUJ!^;L-2RU?=Q=E-A.(#*C=%HY^P_JS
M:V+DFY-SX0 )D?OO1.%-/:Q1MU]O:GV)3VB/44/2%GQ,Y6YTGYCQHU@A!:;V
M#Y+<228$ "E_;HQ/T1*'CDCSR6_O?L[;BT'%1\73\T80R/FM8T06XK;+]KS0
M1( TV-[E1UO&X:ZWV>9IPYI9U',A!<4)AGYNAGV- V2LQS[5J&B!%_(B*/=>
M1&*_+ORY9HDFL;/DP-GM1C"5*4@(9_?7%NUY@$LS->4J&#?AZL@!96%@AP"G
MKSXKTWOQBW,?)OI.34=:EHU/_,NO-_[HA4LIZ0]/_PR>,WV]PQ+[ &DT30"$
M$0!#0&";VK92,WP3#_E47!F@,.&AH7H\X'%E9H2(?:7A7&B2CJ*1O7\(N+"3
MFRK,PY:K(X]]ZWE)OA;<2O6Q>9G8LR6DDWS(V-K=[6<4M8?30[=HR/=MYUF2
MZ:K:UC@+/)L;J])5&/FH#R/YT>N9S7)0O_;INNMDUW+1KZ<KP<N&WZ%E"M:V
MRL0\%<IO^JW&:S\Z)J5=9PMX<7Q.=[K3\L<.QS]'948OZ.21Y:]=[].3I&'[
MSE;=/":!@SA8Q?5N'P\H/OJ"(C')P="TKXE!X5 LQ6:"#Q"S-**@MR6<H(?C
M#WG:3K.ARNQ8-MWRC6@R4544N(BC5#R8'_H9JQ<P4?O.4PY$L7++F<M!C;?X
M'+4P7>26LLS@?5TX^&86N7@TOZ#Y;^OI"A>#"I;[Y_&'N\3[+J,OG[N;(W#\
M4(IA*H@="/'79OD2>"F)[X]9EKY87J"'F=[W+\7?\6F^__ )$ ZTTG:O4_,&
MD%Q*EF=XA^/T8%@U;C@V_V;&Z].6>['D"XY]1K=4Y_I(;N>=M5BDH2L12U?&
MA6/R\ITS>(H3=P02IU>(!:LW3%:NRK_/MD=3JX24(_*IWIS[KQA)!?%M5,_V
M"7A @R:T4J8X)O=$UM2-^#NZ65T#>VVP")4OFEC/)8U'L%3\'4^F.P$'C29I
M7L(QV7?.1,=P.DK@<"DL^P-^5>(-Y6=#<RUSW.#4G#7*UHH&YZ!*7+2E'&9V
MGJYM#.HLLJNY"8,E#8NE?E# '*H]DN>5[%=PC\GF+?TMFK.[RP]&U(JR2+O3
M7,KEDR0][?_8),,ZU8?]J1\F0\0'*PDU"'6O[F"(:LXX-J6J<3@#[57SF$\'
MJ5Z=20(C+;G3NK(?M"$:X,VIVS]MPW[ A?@TXEA&GI=)K6#4EX ,9$%]#BX>
MSG;JM+_S!^5*[=E5A<C5F+]_BLG.4E+!O,*KID7*;X\A"O4P9<.0 W=M1M\C
MD^,ICJ%SN "1DW4E0TE;/O<F-E_=4B>^<BT2B%Z+O*_!FH1FJ*L?\30^1HK]
M(+]L7EZ@F369-W.D=9TW^94T\_;3<@JY0?+QXQJ/-J 2Y+:9(Z7Y#!F7,YU@
MXTW]^P-RWS:C>[#*B=S=+8\'-N\/B:0.7+U^HOSLPK"A-MD?D@D\>#L)RQ<@
M %8A6-(_&"0NDI6= *@*(  NB& JRM?8SF&>:7Q)@]NBO0%>%\6-J*ER<,[C
M"?4"<DCLQR MEBO/'\@H7K/M\VM^3:R/NU^Z*10@/N[B#&,WH^=+L.7J,/Y9
M0LKT._3[6JVI>_LT+AV\<[V,OW*1]5=/4V1$6_9X=%/DG'['Y;[X3@"<E*>&
MHAN^<$VJRZ7#_AJ_[7P_)7!\&C<UN!DA$W/QE3>T,60+&"R>^'<_?+A>I3'V
ML_^IZ56^=,B9MF3_#UC(41?K4PQ)>(%93K37&:/LK(07(W]S_B,"P/YY_QI/
M,]R9!O$P9QN<\&R.:QLKAE#'X>W*B1,2QFOKA[VU#O:^7807RZ?<^)I_SR0K
MGLA A3-'T5!D&U+CD)HZ#\Y:Z4HX_]:' PACD5DXT[BSW7GJ;#)M!VV5DN>@
MT^"W#8="#V)^+@@()R1-B!3FU^Q;]5ZVCM83 ,3>*MC8(L?F"E//OO2*33JZ
MFU_ NV8<-V8I_Y*_X6:)(]."^1  2@>G=1Y?IEI $RZUO0\?G,?*K?'0T&BB
M9ZDGZ/?-A\\^M:J7J!:U-V$>\[:\ 3]JC!8;?Q3QRU-2&P8CU]*4]9_^%O),
M3JIU)+C5]-X.-];]Q>TLV/@)CJ;K5.,BR$L0ZX\FSZS<ZE<-E#<<]Z1F2.'W
M5']%/!!:+LA)B47*RO<R?0&S;)FZ'NQ'"3I!H<OZT1-O^9;.Q#;O.#U_^9QH
MPQ5DU*M&TK- W,@FMMT["D^6*!@O4,*.HNG_3DIOIA;J9[^Y=13-4?Z% *!;
MI HHK3S "^*)FM!L= [MC/7PQ!.7PL9F]/Q/%#7?T7.&1]H0<PJ_RJ51YLUV
MCM;$#E-'J0_YC+[A0WH-S]_J2<P2<5(>B_;Y]"$-DY9O9Y[*4PD$NX@T1(^O
MJ8LTFC#+63YG#J:/+9Y<IJDLQ@I:7 -[P^I*GR51U8IQ@_ _F]5FM;PPIEM,
MG*X4K\8C0>7;D*[K\L9^KAMSJ;!?P*F.50B"*V[!"KU+4%HK@=$C,R,9NI3F
M-3PYS<3DFI+ES<6Q=7-,JE6M;0V35&M7BO )PS]M,PU"1D,,G2R'KK(@ID[:
MW_$LV+WM(:#,0B]#@'O=ZV*VMQG=F%@8E+N/3'PGB-,",.O@3%/X*]7!M48B
MH/6=). %DU9I'X\!*GKK'QO/ODY(U"EB+6W+*XCY&F&@I0?Y;A7E%SF^*/[F
M5"]M?;-7.+:#2I'ME38V%$V>_F,KYZ_;GZWFAKP'JERP%'L[G^1C_@'BHV&;
M3?Q]I!4F.Z4"-"^AH0L22;%JD'(RW/FY'=ZI/,A,_/NX&$MK_ -3'.NT9V&D
M&_CZ+4VC77!?RYT]A14#E_%#2!AB9$<0A$,P$0!I:+V#TS9;--N7,[I42\>P
M,=IG5MG"S%6-WU8M*'A\V;+\+'RG,SVMW3'+^I?,":T)&V.%G2_)V7YMN"W<
M-,H;8[&BNW+IWE7# Q,EG8GJ*K%O<;I\^+G357](@^\O4I-#/)#/CB.N:=\$
M<M!0Y[!(4;0I=5K.4\OWV^'TB5THJ=$Z^RY#G]OWQ3@>K7O7<Z2,05YYUA$
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M-^^$I)B1!<.5J$ZTOP51_K>YV1G9GQ(Z53P/[G!+CG+4NR%H72IH @2=A?O
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M6VO]RON^>Z^]E@!!AJ*M&&/VIYF59^AU!61;L;-E:<TNUS0/YQO1R^/Y=W.
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MS9U&;TJ:4K)SNLGGA<^\$Q7G_HWJ"#R3QC%]-'& WS _$(I]0^3"%;.P<&L
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MF,B1PQKY.F! )4?94U[F;VI>NIT!%LHV2-94O"R=$:@3V0=[9RI] OJ9[,H
M[@G/6XH;HRD7(4+PLX5W4Q4E8%M'NFF7JY->)='.E[O:?[_;;%9#\PA%!%,.
M@\K/YH%_P;7*0HU!+_>2V Q=*B3@N#=]2Y$P\ZAM+!L:>O#:_@Z0GP(KRLSV
M#V(/*CC=64F^ ^#? >0:\UI.UZ1BW4K-=_^8[3:%5R(&\K^9[5X']-IPN]4.
ME;%_>TJ/,U959DY\@&%PIMM%9M3SO9K_,Z?!V5AGF?37G6Y(74/R1J=?9\BE
M7S57HWS1\,/\4@$%G&E-/I8QL#./Z(1OXT11>MP3IH): %\Q20GT8VZ=I*]Y
M9S/,"075M+N%KU-@0K>S#;/.C--J&U$HJ;^Q4<0SN+][N9WE!P\2H0$NCY<6
MFJ&A5;MG^M]-(.UZ?]"$Q?N$@I-./GSRX&VFHR3.&T*<)=34<B/A@.""N'X[
M<CND[=4\^B? H9;]T-8:&./&;<-8VO=H0><LR?3+O0#RV'$"CDB B\R='7.7
M]]+4\TL=S.U8-:<X;1PVR7YKO<RQM<?=HI$9.!/RZ4BA?Q'>KVV.;V)BW,RH
MS%GQ.E6XVF+UQ\;5]XT3__4H8W9?<^0=0"I43=QW 74'8&[+:^$>[FY[\0=B
MC1K-+-]M8[*N/6]T*>)3>^/6^$:/K?',@B]#OU'AQ?M@8_?/O,JCBO!6W9H&
M<V/BO"@4^+GR*I>_64M#J@)*(ZI"2RVL9B;+ &8 >/2!OV3#>TR(:-^JB7Y*
MWI<GHO((C,7=+]I2+>:5"\2#.M\3H*J*U5]W@$.<SFN=:]:NI>>FR)2?)<Z3
MYN9.)X;]3&9"&U$6KV4TJ4N?Y$+ZZ4H'YX_SZM<J5'Q41^\ P7M>9M>*$1J-
M*0(12C^_K^<"X#^,T,5Z->A'33F-OD*\X1/<+S?K?9<_N@>^Z]RJ&$9FOY^J
M,8Z^83]>1SU8$*#[N*PTJ73CNUQP:"O:B>=96E9@OPG?A YKY39I0$^\,:/Y
M'4:%6[6K:C1:TV_^NXR^>_C->'-ZEBL %TD^H<^,;,8JQT>T[T] ?_X*$D_9
MUH+?5RV#2M8_==/+AMR;]>Z)@FYL4D:_=QL2LBV-=2?S5=O/KZBTH,UJ%^*_
M@(,M&JN'0$1;G(0:0L:M>,Q>0F&-U(NYWXM&5$]/W^IQY_I+F,97O2DG,U:D
M:0%ETK_H])^3RA:@RLT?D18D5@H*_G;Y_L:M[80I2Y5!<$F*J!/P"XB("MK?
MDB%*@IO[$YCK*/=&)?"7,MDA75=U@[>8M+#'OAHZ%G9;UN<=1-<RY74KIZ3Z
MW,O#,4]AA.7@K^[[="4I \"9I%)AT,+R2M@=X-7Y?QL<:8+L81-F0JL_I?](
M>%@[(BH)T96*XRY6"6"+&5#!,^;@[YYV=O/* Q(Q&[HC EV_(7_ZE@7K9HZX
M62;6VN4N'A4YI!A2OQ@6TWH,P G.T#YT&;D=@69].36&\MSS_PV_$?+M96'Z
M9U."()[NM"0GV8<?N6I:^38=66/U768?N0^?,V>=#T,HG(E$UDR+,G,<@EZ-
M"PZ74:7Y<QG2_9^+7Z[_9/4I1KJ2;_"DK'UO&V;L+%QOM'F10''J84NK]<%5
M.%[ F\!D>W-PO:%D]O]-&9S2 1%C85[FD5CVJ#N 6B("1%3^^R?W%F?YCF$D
MZ$J,T>M-TX]P*1%U@EO \_].U]:$I]QJ8[+/;PU>%XLDMPMAH<4_%R?,I!'2
M>(Y8KO2>RK7'W)6<S+-'B<L])A)NKU92K)Z%&&1K]P'].X1A.>CT7BFJVBQ'
MP06*^L11L4V>C<AGB9^SO#<^9LZL.&,?8_/]1%SB5F+C9?/:O/H_5[YJ#>U?
MUTWM"[(I97'AICI-^OW^^<9"C+5$$/E>]I,6$88(B<<6L<6!41<(O'H551?[
M V.6U75:[V(ZW5MI4N5YO7.,-(QX_O]RI,3_IB8#B*$/CV+#'6-"UL=@N$_G
MT=*:$P63=C\+54%Z8CY&1V),PC$G_,J=N\98,F1-%D/X]=KUY>%\7:%(MJ_[
M<ZL_UCBZ_FRT3W;9"E)2K@*:'Y<U8[#VCQ$D1.@_7?6A*I1-\F/A6LHVL6EB
M#^?#7X>@3BR>S]9)4.:80CR4FVM:$BD3G6^BDWFK&#GC#'"_B75N-;UEKYSL
MF%G"0N'+'GX,$2Z>]S0C#;NYZA^H!RFX7_A./=XOO(S$;5_@XB!$/!U$DT$#
MF96?N[B#M99XYK3+ZV^A[@U4O$QE.=\UBY5G@3E[_[X#($;U=<9K1ZP11_GY
MYBN&8V6F"X,,&54_<A_^"8Y3!_1+I.UX[OO43'%Q%7"8O=02!HY_RZ'536._
M/+U]"(IJRL:$5$KOA]X!=MZT9'?X@>-A+3CY),1[:9PIE+R/ =-K22-U@QNO
MU%_:L^#3>E::99$WU"=2LG!^_9@ Q[,J=7C+51_A"91DFMCT]U?J<:OIH63T
M^P:X97]==EJ_U7EVA8U@O0,\F3%&S-P!PK>FEXWWKXA&>F\8AQ<IB!HJ+]T!
M_84?IP-X4"0]00RM$T*9YC+U-9"G#M<!6I&LC %YLE>/"H(S<RX?M/)'4;=B
M[G,BO*8^%2-^,ZIAA&P]*K1%0"Q3EHQ56D/6W \Z^//(7[F*B4G8DX_O>;/_
M<M1/"XC1Y;:$&$9\?$F:/0N;4%?]*7B]@GJASP6;'#X2/7[H2,\SCE #&C9/
M5'BF*^$)5R^P1+O.==!T7BG2_RPY S\X0/M[( (=U[Z9*(L++%2]DAL8+2 C
M8&8\VP/6YD7ZP]O-3]M77%5FZS70UF,Y4T'L!@5^ 6_;PRL^K7^,]O? 6W%D
M)'[\T?LY&BY3R1JC-3D-<0\DW=;M[9Q>_TX@2EN9 CGN(S':<<C=;V!)Z:=!
MM!.A@P-4>2(E-'R+VG)FVVWB5CY$SK*H+41RW@$$Z#/]/$R_)$1:01;R2[7C
M_;Q>"*9M[MY"?\S&;1.MMI- ZKL.Z6,]?/.7(.[_3(P'2IF65C-*P*L=@^<P
M,.X.I1DU<M*Q/E&.I6O-T4>VIX)>P7(:-X-T_CXT5ZXQ\C;N\SQA-C5-*(V+
MR!!G4[N#H:I<EBL[WB_"[SI7ST8L_T&@:ZSAAWF3GESZ[UHF+:\LDG2B+"64
MLR@W1#\1?UEKI8CZ#KM\?4F"93@6XR%#>QB@"#['Q7-MEC?E_S!2_O?!C<^0
M?!2 %QP<;&KX;L+7!4>K6>G\Q1Y[JTOS'2 Y]-ZS8MO"RR]1\##2LSO X[VW
M=*/Q6P*=^!5)!'5XVU8U4%]W#;/D\66(OQ9<@L@WS]DOAM_<3!;5.M(B3JHL
MS?TB*S0. U>5?U-)KT>HZ.E.31^]9IQ)?2F/BDD3F@E=N$UCMJCFC/O!\2&]
M@>#E3>L^TT+W'8!,,%KTS%3 ='QKBDF#&[@P\%K$K?@=+W$?HX4-/%]3;>_H
M^GC[UGQ F:6\'1&GPD/H),6 )-QIHYQFCM !5)LM%:V>_+%="B<Q\Z=UFVWR
MEV]09:,X>I^XH9"G+Q-FW\]"W"TD].*XX;5U!LHG['G/1<H(T48*=>;W-J_D
M SDNPIOX->WQN/,OLPSD+KH'A;,2?""7CLH%V.&6\V?IUJJX#N=QMM+Z10&2
M=\C:^ B,T&TTKC*G2^7VR*OAO\>72_&E(^Y&BN%2KW8H-!VH@VISA6,?L1,M
MSI[0-*R/ =C$'],7P LF_IM%U*R>:/M3B/#E.R1W88ZJ%^VIQNO!**N>#>7,
MPE$"B=/@LQ$7M+Y*MARR*+G0I 4L65CN.C!!IE,=0TN&TX\P.M.$3B'GN*ZQ
M+)2SD5!+-_M7KU@C\ZQ:WUF&QH^VG"HBZWOH>#Y$=T>6[VCN?.O?Z/>E:PE'
M*AX47%E6)60%^E:JY"6GM%F+/E]516.?J:[N5'#%;G^?8*DX_+TEVY%4+RG9
M!+?VL&>99ZE3T5&ZZ&-47G_M=J4[SY:XI2;5O@D>8#ZJ@6N<-F[#S0#3W$%T
M.]0<Y@L+>]<"<A("#_EE;>.K\![H;%S\:JK\@O%=@TF)>MUJOP\]N.0=(V]+
M2_RZR;&:Q-S 6N0*V(]).VOB2'<Q6?:YVL4J9>D.#V^"4]JW1CWTQKF/,<Z(
M6SOV5Q3S[B:<0W]]JA+>T2CP^GDD G^@&YT%^O-4BS0V]D4HN8H[@Q-1?\-L
MZ/R?"ON3D^_J#NXRD)PM\9AC%[(_SG@9GR\R)FDU"1"Z+KVW!K =:MH<9 V;
MGYI+MG)K@_7J%[ DP]"&66K0;#+B:\T28+Y?LN8Q>563@D/?(LD/=H(B/^J-
MU\B5N!8UH<+VJ$H)<7"QL4F_IT+RBQ'.F-@&HDG7?.:2K?N4:VYSL6]HU.?A
MF-M^_J[9_&LU^LL@R3^&#\:\Z?$_6Y2,1?OX0O?1>@JY(-3;K:VU><+X1T79
M[!S5+2+XMG)[C1P:ZZ'7^E[R&ARU62OPJ[CKQ4%D7W@6-7(F/);V\.W\^^<C
MEB']I:*'@[LZM: '1W> OC:&6:M$4E#QZZZ_Y?W^5"]P:JP)BL68FMYRI+<T
M9MT!X%>1+/E#;M=#&$7L]'>'1(C^C6CV4OITPW.VRWF5[,D:"3K$H(1 GF3!
MI:J'AV1/JO9 PH$&WZB2[D%>TQ-V+OQS'S$H'=H(2NDP.Q_8.E?+[OOBD%>:
M_U>B>PM#>I% KX43/34ZK')!*K+<V8C:H?ISTN*_3J8E]0Q;E2JVQ@TR(C_)
M%XFJU]AFW.FU #4$D9:IG/P,AL?+%E3B2"K9\G&%69#L?<>#Q^8_K.GD=:*[
MS#BG6U1S]K&,,X*SZ>H_APWG\@L>Q=*P<QASCJHO-P#L6O&CG!6AXK?WB&ZT
MPIP )^B1*6V_P$4;[&[3/+PV>:P/?_V8X*S$<P50C&%Z6Q<+,X5-S[=,FI@J
MXP49L<3&^#HOO"18C#ID*[1UAIKV!VI+7-^3RN0HQ>+N,K33UJC0H_IZ7K6+
M1,!J,H&E="P(4MP%EV*<$KRHGWY8456L4D\!S]+3_XM+U AMZLB(VMTI.E]4
M?KWC&U>+X&% U\O[T_GHC(-FQ<@,\J;ROW/^+7]T2G?R;A697R%6J:89ACNN
M-:'XS=@XPZP1 7(G(1U>DWYL_L]X95'V]]+\2M\(V*W^J(K]%(C3)T]-&5;;
M&*#($"EA&&CK5M))*.,,LJ3AI$"TH1ZVV5EW#%9,1E%DSZ[,S D%CGJH(6^7
MLN-J1]R57PG7(XU[R8!TJWTTXN%\<0J\:I1^#Z?O ,\\#P-MOA@9&XQ\VC$X
MYCPH>,87X^H/5Y0G5/6%=MX!A(G,L%"D].!#U_N86XF6X"M7M07[%YA G(Q+
M7332$@EKEE7)30(R-;2O]'WD"17=:KVL,Y#U$4=GJL?/-#Q8N)OB\N"N7^<2
M2W05:!@MD'YVT3PD2\:02WVX#42M<#/CF<+G3,2W.G>^&'?Q>[-T+<GMA$&R
M3I>G/K<:XM%=RX+(FJ0%B/C'"=M)VY];<5/Z<28+%&(<L0RZHQ!)8/4X8O;5
ME*[7<+-S^EKO3Y@57U]^]6=E";^TR;RPO-_SS8UAZUP4VSUFQ#."T8J1W-RK
M?'V3B<^>[[UC90B3J]BA]"ON7H ]>/S*N+%<ZF_%@2S^/+XR(".(?&)"N6#*
M] [P;B_;.FE&@L<_ $OF4%B/J]BH["(B$-#Q_N/!>E+2"KE]/_5#>&2 X#7H
M^[=^OH80TRD^PB\)!F=XVX"+BKBHHN/+E6W/.\![E2B59;TKP\KI=0E]1*SW
M=H\1-%)"P->2HM@1=^&E%Y[UTX0J@E\!'?%.9;8(Z>=+D'I%%.M7(=7']G\,
M\_U5!6W"A;SZ!YLY_VIH];C%/#EV*%59@9\O@DRV!=4>'*NAP%_/#0O"<J:7
M\<,T(VT?TT\UD :/Y0J*1!R-]=B@2'Z2_*/\(&PKPB#@F^3M%F--?P<(\_34
M-C(>QM*<T\S^3Q?3DF^'M>C>HW9X_NJ(G,J)$'O 332=GLC)I(EE)K64;\?J
M#,RC.^L5BB"4Z^Q6]E@=I&,FYP;LH1?U+LB]J,0[>TFU;YKY@HO,%(9V"GL]
M A7'<O23KH$)T<$8??!:/*&9XV#)Z]P_*2M:BKR#](<=(=F\C-MG)6=C3R )
M&/LB=+K9]$%Q%HUC3LKR#!735V'AKYV#+AZ)/=X=%4=1%"DGMV#L)_?+>BSL
M#O#4W?Q?TH[4&Y1T5(5MZ('VO_>:,N+P(3VN!NN7VS'/]3!$W'\\5@^E]LTS
M1DH663/?6.O,O=S4?P)8M6KB8#,"^O&,8'/.?;!UJF=BV?00*R@EQ&97^)+0
M9<SC:2P["[FNZU_]T%,+MV.3VSM A!33WH6[@W[3T=>T]V6;JOX/6T).E*Z?
MZ61^3DA(N"?[0,;]H&*&-?.'(X'Y#N,[(@ES9CN)!2D\'.#X3=-F S_2Y=]>
M\8_0I[W>PKN53FDL^+-[[.MU4XF:M.DF9*8K7%.B &O1K=:W48'@;6CV6>2F
M7GURF]$=X.<8^CNDFS>;4"HL+F!FA@(\\L'^C!E5?C]_"-BX'GXL(;^F.OQ8
M2#S=L^[9[D1U-S4[:UG 7W>_K.0Y3=GQXM).N=58%>D(,T8D*FOJT"\&[BZ+
M6!C6!)(UQRW&M:PR]#43.HN]&D=46Q7IU!E$$L2$]6_J.Q2L99CXB?,T&I^0
MZ3E>8[GO!]+KN(Q'@FQ:Z'K;,KBE2-R7]B]R#A$-+&6D)R91*26*Z%62-80Z
MH^U4=7""EEZWK#@RTZG8VT&ISYYP5!Z++)(ILS31'G]-[9,!W6NBEZFR5I3/
M8S5?4TG]LI8(?(1QEN[.HH$?GI?= 4B=X6D>>Y?"94[?YGKVP=2E+&0&1]9)
M*[3ZMO)J[94?ZX:OQT\S->31R6N$XC &[19D ;7M9(W6B#/>H7#W3H5W:'P0
M4-TY5GVA;YD>N9SJ.5AL9%!S>25OS?24Y5TB/[^,A'5NQ6B4L\9^(/6MS+U%
M,V?,%UOBF.+<ET);33Q?,/Z(=+=<A^NZT-OP:K&XK;7'1(LJ?]4?A)!^'=,V
M2Y4'.KNUEKLVZ8?PU(Q%^,'#1S:T%\V$5I(D8GS)MAW=*2LE5AF<]FJ,J3R/
M2>8,/@Q,+BPH$GYG*>7(H;6O)\^5)S(56EX)^0V[QK[-4(]?E6U_NM)EU%-5
M]4V%7M5=26M2H(Q[58R*H%A3QWI<BMGDGU1DB7,3ZX7AER[XN QC2X);7,2&
MEF)0H/,$6YYJVN4^5H\A^[RL,6)UB6*]NXUD\BRZ.'*[YK/"(>EK9?J? &RR
M>>\R96K/8VL?R\ +(G/U]-$_3?]:'BA0&?J7$1-Y?M=5;A1O[7V15UXG<:)!
M"!GK?6Z\@.[^.*&M'.+U$U93LKGDKK,I5Y.)[^K*(1TIK"^"947:UB:O&YK2
M-,Y3=84_VB=EYO"+XU7,K50LAZEV7Z155!;L:0_RCQ0IG725=  IM(J]95@L
M+IA2=?>A8UB 4/ZIGN@5!KBN\7S9: ']1VM"6Z$NTU[XVL0]HHG#/4_V#N!I
M3X K].>^8CA1SM=FM2/VT9^\RI3FG]G'M(B0TGLK$8B.,<8ESVHJYAAK)R,Q
M4N*@]ZIKQJTX7.1*)X(#A:_'K(SD^L16GV1W-SU<3JB$)&+7E(RXU ]9ORCT
M5)?$L!-]XW47MVMZR[8/W;\>Y_I/\KO1OT&V?V7H]<:R(6NW,M)"C&C$0.<L
M'D\3CA8?L9\^((:JQ'] %D<R]/F!(VL/U8=\$75ICT&'FHELH=8.,;0IVV*<
MBI^>'.WD.H)Y9N\ 6_T\_M"]%63_XU(TN-=;BK\%WL+C7^#K%^/V>K.M*/%9
MFT&'#?OTZIDH#')&6(N.9/UJI"0U-&_U[P#O>)F%4YTOQN)ZJTF%[;Y$GQ/
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M"DPH:;T)%K>5!*T @KXDEDS<DR]7!==S=/3B#<XJ>E<BE=I7/@S+@3=CB1F
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M0([CGCZ]?DUB.=*@)6D8%#_ZOJ6.5+=PF/[KL.WF'K[2,'EL@\MD^=GG_AX
MI_S2P0C<I^T>P:L'66:^R:V'E(VKL-#X4]3_K$Y,HXNE(JY]W5AZ#C#=CKLT
M^-Q5D95P7:,_6@E"U15.?0-QI='/?M!D[>K#7DD[M^WL.D/;4<>,15/.4* J
M"<2V3WNSHTV!R!@C]<";(^JL!I3R:^0F4_LG2,]/$M"@;HPL ".M6E$+HD5
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M!FCF6"BH'">3^\%7\TEV5,QL!E2G/V8-I-;#O/[WA'TA8&)2]J<N =O<OI<
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M6/CKS6 >U*A$/[]UG27<4:1KB$U6F*.8;9AB?MMY+"_NS0<^Y?>J5'FC5*@
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M=]V)UYFX;!$N&V8*%_7=UO1.-<IU P=8K(S ?%' ;4@78,66K[AT:N"BX!)
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M^0^+YR)2IMM&M*MK!7Q1MC[L].'*C?&R(\I))L;9=\.Z+P&L7M07BO/+YX_
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M@L-C@SNL->+)';,X"8.;%("41%B/%ZJ'*%V7%B1XV.VK'#[5[#$-<RVCF_L
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M5X:,9KX)".(,;/%)W),D,@EJ@M"P;N 9R?"\E:-I/[#/6RW/9O+XU%Q_"^!
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M4>(G2%5N+&]62Q./,7=!K-+_Y[77OB.[A-[253+KWA$%D:VU$>,"C0Y7>UW
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M28#N^.MQX__["Q=$N>!T5MZCDI)FP?S\KF*,+U,-QX5 0)W</\>_!OJ6C4R
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M3*UM2[GVXB&P;F.@E]VU]-ZRE6 UW=RZ1J6B&G:+B/6;V72,J%!,0$8$^X0
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M2CF6TS*,FO[7R9#^ZC]/26WSGZ?<.-)";\=C9=:FDNL%=/GJZ)9?52863E4
M/ YCM[P3I"?6UQT^"]F'<^3.]4Z_]S7[NL#$$<#V5?_BBS)1+TK0,5D7F,#J
M\9*[[SL,Z1KLD?FT6N"_3UMN 4_NSC^Q7'J9L^GY,D@'K='^2[1<5ME9\.)#
M!ZFVQ#L&P"PYRS#HZ/3"< F +*D5A//8\:AH%FYN)/T8=I<63SXBO.@X;_9)
M0(05C5>YT.B\7<C9&9I:_[A4.I.VN-@,.D)<DIV>W +"<0YE>XQ;6<7#=C2H
M_IBEH8WY&A7N Y57"X2$@;;QYX7:,Z<HWKW!N>-UVXN)2\.CR@\H=ANN2"+
MHR*T3.9FEA)LHIVB*G6=Y)L%GXQ<W8+*1B3?A0D) $*>P>P@6:D0I6>^)XWJ
M&8UMO05@U/+K$SX4-KYJK'OR?NJ^RI9":*,D3:A+CS<6,7HZ%=>NOVPYBD6
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MM"9)3O%_<F]YHGZG9''>K2SE[5!-4C[&M4]Q;%XM;$"N0K:J<R5*8$O8G@A
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M<$8>)6VP5>-5;NK<O/7UPFW+7*EDF?Y9H^OF5SSD;&))BRE/>/3JX0,G"[K
MPW]E2]R'+*QJ0W;Z/R/[UZ4D!SA2U#E+T>?AX%7H<^]Y*<X4"OZ4@^_A'UIH
MY0#T=W$WC"6PM7.4ODM2:-6/^A0'4%:3Z\)@QY=CYB\OB%CS1G[4H6$YGP(&
M%;W\2@T;P9\7[6:/ZKCU-FO#C,*$EY?@W,5V\+1VT] 4-JS"V47=I[A5BVPD
M\55>C*Q&):@PFC8@L6BBTYCYH_Z][,#, [1PO,>N,O65L?3"&I:N=!'C9C33
MJO"\<ODORATY0_?LY>:_+YN% F,B#7YRBL.<A>@^]9:I;<2O:;$V2E#&B:">
M>OL+#M3>T,>7IWUZYE!J*#P]#[EZ012JL(_%G>1-!3$4[BVQP<:K;3*-!<2S
M_./_<"9D%#Z0/KBH1+&M]F84[WW9,PI(KX.:SZ>X;$Q7D^+4Y::L ,%'Y@G4
M5PL:G)5V9CNT&1;/:Y"YZI'3V92*C'QDD98,'#92*S;)*GD_3)V:ERI^=G$,
MRY>,UP_^>UBN/"<>)B)YQ@ESS'>Z@2SXXMK$)>/NO.^5^4B^W%9.Q?X<TT)3
MBM]IU@F^9Q/N62.[PCL?Z+4"Z6YZ+HO+@X*4O9[I=.66+X,3KE(RWYODP-:Q
MAF:M;7C0$2X@QJ%TES&R]7SN,&886L>G5*I>5@?BE";[-L#:/8UXC"'2/"*L
M9JT4(P,!IVB%[Y(XPYXP[1X'G[NGU!722%E^Z76MR',TJFCIZ>09/'-ET7A^
MP(U>\&%MNPB(G0-;F#TM1(-A5S^*,VXH0G)_V. O67J5:YWMFG#\2'O%UF,2
MZOU59W[(<HH?4=U8#;$!A[X72)AZ(%;9;Y/"Q6"H*QR[IK<J_IV*N."(/)9]
M,AI/T]R@I]'R8)VI9AD*F=*NA[ !&1CSHC^<@:#/UAR^,P$;K]^0,)'2SAF1
M??%\$6C=F/>YN3UMC450Z.&N$=I\/\.HIH?9MRXJ9:HBZ&!>:ZC>E4ARWR)+
M7\!;CK/S'#PO)SBX=.#YKJ[+->:8TA/X@D$A@<]2M>$6D+'MHF1W< @_VPTF
M7;1\VU2'IIE)^M%1LLJO ?M)2'QOOIXY^]Z^49!$0<_J,MGNW!O9XB(2UM#6
M5QLX+DX8]\]VZ,4M( )GK:/.T1S:<>>J*X?U7L.FJT];!C:^VTZZDG4_$P'8
M\_Z/R^XKX=.,M;!9-.Z8:64K!L^=)U4N52*<)W)RR3X16'MTW7_TZ@E%O)?>
M7@ASW;3/,+MAKOK,^EM_5@*5>\;-*)EP_%PY8F@LMZG+'ANZCVM-*/K*+4;,
M8-I(>[H>JCI$(3>3X6OE_]C;<.6C5/FI$)XCCG5:L]36U12U\D*#_\0_2=Y8
M_,+FY*5'8F,??55Z+&W6@XH#.\< @M+H]3:@.J>'/^3Y1BX8+]HKY4YA)R\G
M3#"^(Z/FTS[>_A;!&M8FX_W<]WETZFUD(T;4H<X\(&P[*"0"A]"+B%X5_^SF
M/O2HM*JOY"6MRW,Q0M#+U!3Q1QZHS/*U(2 ;GA^A'.LXC6C6_*2;EUBG&]#8
MWE?0_8?[R_H 6Y]JU9(!9B^5\<'8G2[22A'B"VHQ'[?=R_M+MP!D^9K1>3OM
MV*E#TV2(X'[MPF^Z*X'6@"G(TVSRM* TYL0(FIU"Q;C>$)*)PB/E0I))4KTF
M%>$!TGD5D[?'=THE(_00 ]%HHA-G),P NTL#";(=E[\Q0 -*?SI]YI-[I*",
M"007.;LO#Z^14^S5=JA'B@DH%[_AH/CR ^ G=P+RS66KKSMB+:Q2Y>C=PTD6
MI#%$=;"/B,<[R&9O9$X7Q$7&EYV2&+?J*<08JK<CQ0KF1&A9C96M.\+CM[F0
MZ (M\CGUM6^RKVVS4.YSL((?[S>_VI.JTX]XRH$-8X% 4"F6[<3F</L6@(=-
M'O*+[C"UC!&[5T[2!@1.-1#/70";7[S=DQ'>H#BC<>M:HH*A_]'QL9P7!XN-
MX".E(\=S#3N>>/JQ:"F"IG1KZUZ=042P,OFF&/#KA@G^HDQ@H/MKT6XZ*8[C
M5WB(XI=JZ,WT^.;,SHG!YK2I#+W*;HJF#GS2>\='RPJFR(*LF8L]-N39179I
M%);@_:JYXH$H2L]$O/AM7ZF&G\4,<S;V<R+Y5"YLFBI,J[18@!H,)DCNP<AH
MM+8@Q0ZIG0TG0>IE_4_JH^QX.'S'T441@^E2'WQV019TZ)Z,3_7IDY7/F])I
MOV\)>'&>+_1Q93]2&!6#*9,HV\TM(T=U0">(L^.QKB.C2)0LJ*@D#^+C[UPN
MHIEJTD^I[".%+TQ$,WQ'/,63!\0:>MU+O--0K_1ZQ#1)]RU FYKJ$OE#1YV/
M;,\+]P3MFKPFP#O7N<K9 !(G<Q++SM5/_T=X3X5%$LO'.[F:F.0F!YV>R:_8
M,SJO*SJR<*8+":JHW[;BL.(Y#'MP5C43"U;U$,VL^8-)^EVQQM=X$+KZ[(@V
MO;_EK5-F>"1]8!7Q*,*T9G69>#>7L:$I<79A4<-7R=S<XH]]YDIX4DZ2A0SI
MPZ6"3Y65$N6_)3KOK$?6M8S9$6N&_1^32GXQSL2%C0UL(P?>)"!VMZI5N&@)
MXX"CV&^QD<_9)&Y0V\S"RU_,/CC,WA:K5F;A9W%U9T.7BSI!707<SI(>.XM/
MJ-C$DLR?\/O^I2<48V=@^4Q$3[-H.E]<7"0^GLY#"F9,WWM%SU#N^,-057A-
MX?YN"'N;AF*5#YF$WIOCR//OGE99]E[UR5]4IR#EK6(KPT)=Y++GHQ!(L#L@
M]^K*2_3XWABM7%L47WY!9$E7P(&=4P!!27*Y,_+\^-W$GE?ER0-Z&L.'U 0=
M]'=^^4T 0:4%3UXW'\<R.'/<A8&$G/]9C=6K7J_4?8PAE-KWF":FRB6_M2%]
M;HLC_8%^47)COQT[/H69!)97CDI>];PZ1J$6L4-U<X>QMGTE(XWGPY"[\=O6
M-]'K@XLH<38ES7P^7, BK=::>A_[@WN'4-HFWKJ)&J-:4$\)LG2>PQ7;:U<:
MPIO#4^@EGU"_NY><^S+;RBA4F<P"=496V4(OT4[Y"S$NVL9K4O6&\<,O( F?
MX):PC>MZ_&./$0"6+R"6-\OMA%+=1/"3D?B1^3S019HH5I][+["<_EF-+/L*
M2N)WYH<&4^^,EP]L3UA!Y7C]"P1X3QX! /?,":C3,Q/V/$RCNUAX3XR;IJ!B
MYEYO ^$G@OF3;O%W]^<Y>&__GZH>B)'HDW<UZ4VKD\< -:2RFL,N_.'K_\-+
MP1V+[<!!X7L'7C.YI!,"K?2R?,^ /B7^+@Q4OY8Z4A;U'WGZL=-\S",^-?P(
M!*- EE.5@S2Q,Q?:(DI$^/<_AXF\[/6*?WBX4S)]YX*9#RI6H.PFZ,7<SY#S
M"+(O6G5:S%F<G[^\-S=^Q,0Z>U[Y+836<7T@Y5IO!@9LY$IT=(4QC<JK-4A:
M521'XL<SDR8OM<3R+%NXMF![[%PMHN76\@AWE_A 1LVYYR,'XW&@)>/130W:
M@-5? >L34>C(HB\[ZAZA90OM"1)YI)-_6-5!3I9+PFP22W+"YF34Z5D!$48+
M6UCUE1RA;OB+): 8*JKP(77B+4"S\87FSX"JU:G QX[HY8_>"-(%#7]J)'PN
M?I 2A'KM)?NO$ -AC9B]9_Z<6D"<">G%.]EUGA["/N73O_%MT;*/6K?PQ2R^
M?^]X_'9J=NJ;.8)*'!<,.:<>N0BKFW]&R/2P"3]%.!LM,_/?^/M/C#^PPO_'
MO).:JG(R XL2'^EC%46:W_#_:5H>.A:[N+*J*D!6;J3/Y]7J,T&%=L7-K;XE
MKP9><E^^:R+((LIM"]BJ=%ZZT^8S%AD=?RYXV^2&$.GY/YJ&O-:$+XI*"Z&\
MLP5YH,OE+3Z!=M6,/5;&VB.A'I0%4[D@=#/Z+=Q/L')+6(/$S2/-8S)Q(<EY
M%RNQ(L#7%?"I.65ACS&]E-??);A\X?O6@YLQ=P!;I#?0SC&C.J!A#+H0P^[?
M;27#O<'C6D2:RQO ?E"4<59Q"WCAC%J^FL<F@KKE[T]@%<O(U,SW3"V*?ZD@
MF\W'/QKI_$UZDE16$<**SJF.MFHR/H3Q[5:Y<S9-"<8?-]S#2^W8"[BK66EI
MF4S3"T/H@\@[D_]P7JTVQ4D ]9MX\K'91NH X!'N:_K_7 9_7BT(%".JMEDJ
M@R0FSN1T7=Y.ZLUX@UH^DG5G:NQ&C,A7OE"4QZ",;-":V;E4[>C=YBD.>+L1
M'1V5&0.79\?]^6^L?J=],.^O^G]!&3]\FBR8)%<G"VMU>SEBWCR072$-\<DJ
MP1B]FVSEHHN*=X&4%'%2PB6M]]2Y? $LU_= ^GH!2S=OTJ"NT53%V)>3IPFO
MEP)=(-WV,W_3\B>+IDR@J2R$?VR3K/];',0^*,8DGLLI5HF1R>@ER,+:)UW?
M47T8\4T1(;Y*/)L<5T)Z%-MDCF%YZ")1U?:P]FD?T&[A[PS=UI<R:2/3^"N/
M&G=X9/%6=UM?KC*!^%J#FU\CZ6R9<6<C6]OM+^.OC32464 TB.J._]'A^'_Y
M](BJ,X"[BFU5"QM+=0N8?7LWXE7%N#XF!EFN(ZZ)^VX!!89IMP ^W -<$?QR
M_FXO>U-!JUM''OEI$BW&>-'ORZ(S!<E09$,#^#M[+ 'EKU7M^!2(I]<,/(@&
M(A]1Y-?>L: %<<E?'!0(NA!<$Z9W_[[GD:V]F.J)"ATZFH*":@_=AD.B"Y%\
M*R[6MP#C"!#X$KON4K$ 4CKF1270$U@ 1N2TQ 8Q1JM+R6NAY,9^698I5X?F
M[3%F-_460*97H"_L#SNX&5:LILG)]^!+U!C0.M^15".B;NH@S=Z'P5^"-_H)
M9&"8LI6Y"0X\ ^( &6U#0W6AA7*)L9>;J-/T2=PB>40[>Q[5)2C5&.P$O&SL
M5]@71XVZM/'5'T4>U 2BESLO]*)K9S@1M<M;*OI]/)(<Y;NCSBX*/4*M9HM!
M6==IH[H%C?U8/*>"W3G8R*>3ZIAJ%U:J<K,%V129Y"[F%"+)'4*^Z'%O-OR_
M>[3JU;N9(Q%KNCLEQP<'+G"1>(</O^,_/&"1E*MY/6.(:S>_!2@\A=N%[F_/
M'Y_(N>X;U]?/\(LVD3!5K+*_^4D(4$SGRLT.Q\Q$^JO&8^E^["-H18EA,E*"
M-FVP)O_I*CO UP=P>K>OI+ET@ OH,JW0)ZS4J@P+X57@O@QEIPP8^,#NY5NZ
ME$)7XVK9#9P8SW5&X"+.%]>2A!)%0 4A^D:1?J[F?*J8N%6,K-@J@LHO8.ZL
M)/: 19>'DBF,G?]AM._0?:)5<](EIN@>-MH@H%W9PF*H77%.A883Z3#E2/<+
MIL$O:G@0AD.4057Z?FB'$>QP8OGSWE>C3,< FNJ/(=SS.W-,6H^2RYQJ-<_=
M9/H_/Y-DRO#@<(#(3M'BF&LPR6O5%!IK6O7FQDX9>=9U-52M.OD&!-F13]*?
M-U_IM$&W,3(A[P,M<):)I=J9/9>8TKOZ<0OX'+!+XOET%K%/6@QQ8-B1=J"!
M%FE5#LL7B(& ?L\2=Z"IKZ_C?ZV\S\I]Y+5[>K8J*Y9?'=TNO#2KZ.4A]FU<
M!YJRIL3^NL2RD?Y8_[':@.2P$X8.IX#UN 6\_QYZ:JJ_-(ZX %T7=8$0^@B\
MUH)6\.I%%Y2MQ^+^9+7L6U<8Y>^>>@V?9ZJNX;. GY](SSBR<\&@+DJPAQ]>
M3Z9%EH^'3W#QXN*<T_';ZXW.,&W;,W99 ^!BV\7;.VR\3'!&0A$*QW+RL9=Y
MVG48-ZB?$_1T/]CTHG="Y:?-%[-6E,*]3]\OA7/)?U3GRTH5FOJ%OJJ;_ "E
MG.$N9(BD_V4H"^=(\1_5TYR3N05TA'PZ,:_>ZRVF(5NX!=C7Y:XSM9;]/=H/
MS[P3-!(,E=K1<C145FLM#^8LG8-Q&F]'\@J4<:",IXT! #QDLEX+W#HW_43.
MM/6DZR*7[\BUVJ,2Y/>1A(QR7COEK^A&C0GI+I.+]015&E>VS5S&[[&V&_CG
M(+8*<[-ETUV(-7&)TU\[1Q.EGQFZ3.PE7L;+1*TTJ]>!4CX[]3?-V707AD>C
MVVJ^O<QE3! 768^4EYK2@S<"/B>A$]=_14)0S8O531"L%JAR]ZP"&!PPJN*R
M=;#'P/D*T*'/^\C_%N!HLP-6:<WJQA&ASUN.HK6B]6I2MF3:I)VVC)HS,@RU
M&[N"?MSWHV<^+:X6N<NB <18:1$(![?<\L$]GQ$ZO070^6GVSH0*SN&V' _T
MK'/V:FCQ.&P]9:R;?QX?,N]0"%:O")!H9+K(_Q5\'L[XX!%FC<*3)E%-1I%A
M?]CH2.CC:=)]^;0U<C+H<-KA>?;C!388\$F3.AN8B+1/SFLNVZ?V!'QDB!U(
MA2W;A8YBDTP*6JO77!O[>J2-HAUJD4*B P*Y>P?SR@F93FC?GPW$3Z53(W9-
MY"E])EI=BA57M1Y@X"H3KL"^LM_E<_T"N .#W_8NE<1].C,Q@<M(-\S[H46Y
MG[%\'S&U@DQ=<Z:F9F*PKKWS<N:A^%Z@#;O\]Z*KY]/%%RWDA2&(CTU+XQ9R
MZXC[NTN48[> 57;T9@\J'<'RA]MMZ4#=U.6@+*AC(P(I)Z.?*X$F3%M%/%S$
M%&KFWL@JVU*&HKA:DS?2(DBC"!I6K@#<6HC X/,[AS#=(C!J7M#$QKB7R<%*
M%R40@#N>%GJ(#R+TR;5?06GG"1,A8/XEB5?R<>N(1^0D&' WCBWQ /6C63I>
M]WG;!#6'36 #Z G%1.:,&4)H_ZI)T&);(FW4O\JH+[,'%U?JY+E[<BDD7^'B
M]G06VBP1]&*#V1:R;[8$+P)6!UD'2QVZ"OQC4TXXF%A28OI38-CIRARFOLU\
ME'BZS.(X)Q'12E,XY_2+1$YZV;3A6]5Y,$+>>/,S9THH:9[/+:#8!*<,_&F>
MATN9DWL=>U)-,DS7S6)O'JK#7^.404:3F_HL#0QA.YXQD#-+S F[&/9LYYRN
MQ"JNY[AV6:(O8L7:A#2]X?#ZB:>^8>)C?R9<?)[7JLA%T@4(5EMFW(VJE0,^
MJ.70]DTHB'79Y,JPQJD2.F]*:P=K"C2R)B0ID;#)_7Z'CB/M+)4G>](ST:P)
M:QHRG8<?2N983*6>^AEOFK/_;[R]5U!3;]CV&Z2)-!$!Z2A-I4F7CB!=>N\H
M("6$T#M$04!Z$U"JTA&2B!)"1Z2#]-XA="*04 .$\/%_9[ZC/;-GG^SW($=K
M)C/K>:[[NJ_?FK6>.R- 98TD;)9M@I/J)A5D".W7^HWYL[*_V14('NPL*2I>
M59=VP"Y$NL$3^J?QH*MP%%A?;A[3@/YDJ$9*RK %H8.'\?L&NY4"H\PG/%^"
MN,8DB@4D^KV(_%7D$JG2)J;X.^02@/H<N[)Z*:7 '*G4N1"]QH#JY.KTX ],
MRG][W,BG8:XIS81K0,?%T?W"IY=M]-/;<.Z1,-;7J(.[N';_66&8WXQ_H,4_
MQE540K I[_QKTI3%;CTR!;1C.R/E:B%;4&R'F;B>WT>AO7WHUQRSC%Z1>K%*
M^;6-4B:_W%TXSH85@<]O4QT5R,00:B#A:V"&G3/Q \2/]$50\4RQ@^N9-)?3
M^L5F R<53E4'EP#R18'O"TW^.UQZ59?&^H5;QV*TOT*Y^EF$37KH5&P'5%%7
MH#M"HB9]'_B-:FJ [5?=SIW@8(/!A??O,_JZGA_ WUX#C@M[##+&]78B1/ I
MFD7Q1_;,.],LR"Y.&C?,LK[+_5,F'6_>)E!:$=6'[TC,^CLQF6XW?YVV<^D+
MX@#=:X"MTM_C[P)_FQV!SICYW^+6.+NQS<D3RFV4H^>PQ'P)ES@?2BN\ZOVP
MC3EM0):LA](<!SU&HY.2DXY; +K750+[E:K^\FO3K=M#7K7C37@ED78;SU/%
MZ*)Z:JU"55S"-^ @JP88^EMBODN>))L5Q1-RM8'_KMN&2<-;]9%6-\N 4TYU
M)SK.OT-D&7="")QCEWV;HVWZ/1<0[_'M7VCQTJW3P=*67[P3<:#UUCT,;7U/
M1F2XDO8$G'<<T8"7P5SV6$$K.%V1DP=4ELQ$">]H%.(&?<#@DKK"T^TP=BP;
MKK!_(:?#6MM^L/O%-< 2Z1D*VC$J+>^+>"(&A38OKPQ_JX _F_ $H^P!.*3Q
M^SVXF=JOB7N:IPSTL/%Z#G4V$8Z3+ZB&K>SNZ0)A];<(#*(+\>-.T--K !8#
M(4V#'.0TA2[ F^S]V^3@;;T%()'UPJWRE>$W1?5F\S"\_?M/5?.N(>#/M(9;
M>EZT5YCR(]AN^JP2.C0BJA4J@M8A?%/SBI 01T<(CS3SGC8E6%/V;C8V X.I
MP$][$M4?^)'DY868\7^4?U(6)H'\B26/)CF])3?SI@EQJ=/'\-?GF<J=)L[<
MU!<<GXH.@/\6VU@C7O,#YXO:5B&].WCOZMVZ;!;AN&\+'6X5[F?4]Q9U'F3T
MJJG\;:>E"G&4-]M\[USE=N& G/+W_KX8P[-(Z1SE<\IZ?^5-\S**,ZI6R!JE
M_Z'KI"0#5BJXXP?U%7[ HUQ!'-C72V!S:0E)SBZ=W6ZT;<TM[UB?LR[K+5ZP
M=K]P2M='N76L-"TB<1![T0&4SL!1@VOJUW1EXG3=X-V@GB[%IP4K.&[M<<@O
MA]1.204K<[JAWZE+5OQ_-5K\(P3%X5$G&<!">8O!C;7+>1H!N=4?2$[J9D6A
MFHVK>,7"I9Y!W)9$>E.$&1Y,4#Y&YM^T>,@78(<X#O;"FRE>L+:^)(7#Y,)O
MJ$_8MS"SVYS-7P$=41-F6S7P-4C5;-+!8-QJKCDM4DR:J#O\ETU +J98>5(B
M05??+(MP8%O_WCG\U5+_3X$?P[W$(, ]+U&U@W"I_ZA895YOJW343F\.<5J)
M$>@$5@QYB@@:[?9M*3@?]AGT+"2:?FYE=,TICP&="%D!+Z'>U5,O*G+[&%#A
M7UCOLW\G?QVOI\4O'#^\/GD-X-+;$X;=_&G-SHFJ=7W6^(L)88?P#%40S\<9
M<JK[J5[ H1*L(JSM5NV@NEPY2^FNJJMPX\]??1L'PS"98:A.==C340D(M;OY
MQ4ODU,5$0+JX?6X#^]9#O9?QG55DV^I/S!H3\;5M_=> =5FC3>\;>)&#?)G%
M21LT3H8Q%;LS_3Q'FDMY#PCFJNR_^9KQ[@:6/<U3%R!]XCCP-<#^(O!0<BK,
MG"OLV;3O-4">G/!!P+W.*+/M"[P+\D4"86A[<P-,!/73&L5?E#O7@%G&K+,[
M9]K9$;Y[ARM;OB+R:3UL5T^.T&99%R<%B?.#BQ-BK]X1O:LP83LBC/2,3'.O
M%9[8W;X&_)A$$MY-)J @Q+A06UQ'>4?E3)\O^U*^Q)' HLY U6.;UZT&1/)4
M-"$F DM+H/";FYG&L].  W/[E%KR2RY.OR[3"?E1:CH >6N 3;.6%HWWYAU-
MN5:<HB8X,L>F(@J+9EQ/@> RJR[03]+W#ZCJNAXH6QS^=FF07//"!79(&='B
M+*P\:X P,!=ZV%?\Q4/!@)_:20C98P?1'-M@2#D<+XVG0S== V)&SK1I]60G
MS 98K%1J-)V2#%4:0%TQSV4.3BII%Y6T>8L<$.J>[Q5KO$L%<_9*6Z!GGU>Z
MB/=MOR6/YQ5411'8!?2:K:2<K_(16<8Q]Q92PVGG=$'V>,%187D9X:I@J6]*
M'QE'^B550[G2G"B;-@![Q#(K-)]*A4W63\VN 6/&+.9A58&0]IGCBQZL\TGW
MEU7J-Q=#^L*;2T.6;\*_[CD;O6A?.4+;*):C%,S 47.DG>8^:A5HLJE16,;!
MP]1W0[2.B4>[[K0,8<(CM2*D:*N8C]-U.7D!/O)()6#:8.^=0,'_1,.\M_PH
MOJ]+*V!\4];(R'L\',(*^;+=RM&8<]D18KLX<% 0:E&2]H-L\RG%<S9_Z-/#
M/0CA94KL->"4;KSMF&49!U/&O89M$8)HKVZ;94I\RB&\;6,@0-[GL]9W*58J
MH??EG@H,-0<7+[D'-/*DS]B[YU")(D]C\E^+)EOZ% ,=Q+*)"S]QG/"_.QXF
M>;K[+.CU@5!"SX;MSKB-/FM[P27;OHKO6>R*>RAL&J\$%ZVTY5]:3CE9#Y!]
M^PM8I5^A!FS.I<P "CQ[(,Q@L580%2#G0^UJGHJ7QX6OQOFW^!IEZ+HTC_OW
M%2,R8<Z\M_:XE:18TX,],HQV"ABBN@JDL*5U<&]OOA2&"\X?:N(O?_:.E%G>
M !V B@H5#6V>_._==M8 SZO_WFQ/0TN8Y]?E@U92/H;(9]$%LZC#/1H=NVE4
M=._^Y4GW[8^Q_U,]!\?SV#-ZPOIHG5?1KT%W=Q7'180COCU38F'(-3O"*Y6>
M106TX-LX=ZYZ O_G?(/F7]J3UNUSY,D2HRGBVHWI0 EY3\ON[=^<!S7WETFD
M\0(XQ. =@MFCI6X%6\O+#5'IZ2TCR(JI?/_@N3VFI14=:QT\CT403EN/)EWA
M[/4M$_(/,6;=0:1_W$.Z^N6'W7/+J+TV/G\E$);(6P7RFG38I3CW:"EPW"C2
ME(]IF5.GJ#%SRU[N1P:V[TE<GEM5*;HPC>L7%$;69S3J^N-OC$I\V^JI7#"'
MM6M)VAVYKV^-GIFDC54$91#4PJT)S1O7@!%J78T^QDL&VG"XN%[\H0AMF/0H
M7A5SIC.)J 1[GKS]8<G5=&D3#VJU3U7_KI((D/-1U^6XB^$H7$LA<6N<3O 4
M\==5#XJ+?]N81EI/\OV?*9<+X)ZFC()[29Y-QHW'D&/'1S[V[RC>>,!"R!Y#
M>Q"Y%5V8</*9[41N?ZUXA] Z3-5#BYF('^9%WA(<T78-N)W?FN)?M<U"GN0T
MR9TR&-7Y*N/?@LS"_A#9LGUV*76I@-\X]AH0NV_49!="(!]%#(2]G#RH%2&S
M=6?Q(*B-Z=RISF7XP6)JW'%+EMZB0*2E91+4S/V-=^&T"J:M.*W0=!\BY+C4
M#YU7ZF\XX,3+CH8)K?3!Y66%/0#U[VS^"#NERT6+/3[/[&,F)Z&+ZF)T0R^*
M-)00;"F,&AOW("U*G:=J,LKZI4+!@9U[/A:()$IEH*W[YI]=&6'AU5$#1.?W
MSW>:[ZJL;_P(O=..F8W5Q"8GM][%0!*.K5GC$JT^6457%[YU[5T]_#MOP>;[
MNXONK'!H>3I5VG6YCV-9C:$G3'L2[C=,I4:3[S6%M(I>EWKB5?SY0U)DQS)S
M%__&E0W<'ETY,VKS-@6#_#/'5P[Z/C=ORZY'WP!;;\Y<<DP.C)S7A^O]:;ZT
MF?0(TUFC#J"E"P)W6>T7OO8]M;8&\5&P+"E\]729V]5)AP@:+%5R[?@N/H:+
MXH#^$4B6S;P<LS;'KYUQ?(4<"&*>M/6[V]6=&R\ R7KB)HJL.$Y]+&U4;;AY
MIY#"Y9^NZJ_BC6H>%5N>#)JD<23IOM/L3Z'PS(S+>?N(#\OZ<@B<_;Z"!) Q
M"44V:E+3; U&/ .\-J@;+?!-]YU'W!3X8I@BIKL!FV!2-W%\+EPDZQ08E+[O
M<0X5N.7;]OQWMRS-'Z0BETV0]F.)*UH+PD3#0W'&C#*)ZJ.OK,K^*A1L#D[)
M^E/?E+P5X?CE\XC2\+)&D4/[S1 &YYT,M-BN;)&[6:JJ&UM_G9CZN9OC'(6@
MF%>@4\!%H*(MYA UU(%2W0GA2()OA[RZ +XZ96F4I16UH<;&O%6@(-FL\QO&
MG>,*;T)U"B'C#M^YN70&Q"L+JC$HTKI59FBGLRH28\49)T];[*[X$+BH0M"1
M<"T#-M#_0]>"Z+ZG%@-H>GB<I@TQK8?[!^UW2_?^9HO-+>B[\V7^'*KI-=52
M& ) V4#\3(TWC?U>J5\A!.?[LRC^J<[_QE@/^<WI/P09S.3B!CP&H7!'EV-W
M5R>3)5'L"R@A[X=M+'4??X85@0*3]6TU%QI@??5"I-"HP?J]U+/.?T1(X6=M
M4EY$\F\:+Y[P.H,%POX[OHX/?HX_N09(^1:0CP@W2ZZ6C(-Y8K2B.\?VH^-L
MY!,[*LB?<R/$E3$3%P'?4&XB5A2@$V"'A.N']+O=WU6=:((4Q&TE[\^U7D$/
MQ_&IUX"A:X "Y.]1OER'HB)F_4G1=DAW+%\L\R,*^-=,&&@D(YI(T[SGC:X]
MYN =Y!>>'QH$,6]@^N$N;:SI3+[EG,&&!) -Z;.9@]7X8#GA?@P(73]"F_$P
MJ#8E;LY$U"W+JBU6N/J1O;#<P S?I>:+W_V5,YU4X4"73@+;!&*121-A7<&Q
M.W8QMQGL1$H2*47Z$<!&/^-W!BN+KVI9#KUJ[Z^S]G@1))R4]Z?OFTY1;+_;
MQ$^RO?I;%)PJ L,(6AJ\*E:WRDV1JQG359<I4*5]X6?<_(_A_9_S6/<M]I#X
MX_@G0ON*6<\/F()<K%HGCI/ '8%97KLY#ND2R5>6WS+9 .WQ^-_8N4JTW0.L
MV3>I:!2ESN(CSGL[HUIL-<T^K#*J:UZ<-U41<B704I39)G<-L"OZ>:4$5QTN
MPF0G2(K<VY:]!GR4U)4L&R_SF0IXO'.+6[U?.VM / ,) S!#]Z0[S@(B9*<E
M^W@^S"VW@^]K5@=&/?#8?] M\Z!=<G34I'9^&+M\2&D/$>EPS&L:$2['194#
MT3R/QN:Z@2XJ/<$NSESO$QVCEFI.1*B"RK6QU(2:E?F])^9&SJ%-0H8\A_C?
MHIL"&KT\CMRE@7XF<U-('8)LS=EY!#G=Z@$%,,M.JK S9Z@<%"PY^0Z9Z:"2
MP$K>:V)<^(EF?3T=J-$1P=XTNA^FP=N9*K8;$K6HNE$C9U)409WZS(?VU;2N
M&C4?='VZ;Y>G3>ZJ1V$E_ ZZPXYV_#AA]F$Z:M%"3D5+-8L_4EGA2H"R%WP+
M!^D\:_R4.VTT49(UZ]$G<KE7D7 $(';!<""63:F!:C^P9!F*7RI_\R$^4P^D
MW^9:OZO!%=7[*.YR^FA\H_0:\!"JI%30MAE\FE*.-\&<1@,=/0MHT\>&N+[_
M9(W._ 0)2LGVW@]YVP2A0'=T$IA^3,FG/(0Y#J@U>9F11!+MB]%*#M)&,]*\
M"K3CP]INI*W,ZG^O^0 _\P(\Y[3:J_: ULX_$*S^JBGT53FM,XK(Q.\6[*S)
M:6ZJ1NY[H]@S4@N'J 7S_#F<?0\'H_IXV)/OKK]<N]5='2<=/PVX5OLB[K ]
M(\GS/(6K%17-+13G8U)B:&/^>4:,!X#]!78&!_=&;5N=8D<"#)[?*L9(QWKB
MQ;\M6-KUD:3WA2K\?E;##6QPD"'.\X?EQ(>#-\"I4,)K&W""O#3<%G@1^#%,
M//@U8ZD+5=8F^PN;#D'/%S)/CFZ)VF;>A_[B3.M;#H)83$J"*7;-?6;BCAMX
MLHY5;$T3U,W/'"*],Q:2GPXG25#"Z788Z[)\5-+5PL$^W6^Y&)(Z[CZC?<YF
MKJ&F=-2&*MP6N &_:\!@'C*^62CX^_(,T(KWP@(80)3UA%<%J\,:OKU X]WM
M(VL2<E]1*5Q/)DPC>!7WKYC\V4Z:MI61!K,;[4#4,,/4J,H(2[VYS)H([2(N
MID<O<DS3$(I@#46*U0!*0.ED1%MCC;*/=PO!(^&"O@7/;ZQ)9[5\W*,D1B:I
M\][^EX\V//$]7_F?DR.TUD T6YT%U!.UH=+1PL)%,TFB#XEZY5,I]G:LCXV0
MYP3[=4H-WT2L_8<36VT0K>G(@1#7E$3XDM'B-U=>JF^6UFS)46F66W\*GDU)
MYE.:8VG*2\\;05NYIW(D_A_XIDA_GK^-^#P$8(:K%N6,+M_8FZA/E77_,G>>
M[JV]B$<#*'H>):=P48\_GHIOL0\]UAYTT\)7-1*;E0)1K.RRE%H/U>LF0/L+
M_9VWTNHT'Y 7:F]O?W,#BQRU;4I#;U:Q?SFM;[> J26AJZZ5%X.OPRPJ/IQP
M^/+%L3&VIC\JUJZ'8]+8 H/\*-BLX8^B)=]EO+NP5 3=R"I*'GDU\*?5>-.,
M.%EV&JPF8#6U<W%\3+W4-ID,Z3# U;PZ"BHZT [T(C%PJWFNB<W+'PIDPQY7
M*S!U% ABIC]ZIO\YT\SM" S\:?<*^82K,2%XX"GH7%]A,/"3,=I/P.VM3\&M
M"7^0BU;SI+]<%(^T^4]$9+![JVV]!_^+C#SZC Q;V_L&XA^F\**H!'VFA:"4
M/X$Y^OFA8#8FJ;GO6K\H\L1JP[8*,J5C;RQ^%C=D3X>6+6U9/Y-2<LE\J,KR
M4G5=T-WW<$T^(QV(*/ID6K=S<0WHB*NZ@=]IQSP,,G;_6.?@KKXOCW!C<M&T
MU\>9] I3=58N!TS(VP3V6[OS/7-UC8<J(+ 05Z0$R0%5]*^T1,>TI4;9)U"A
M=2C.@J4%OW@-,!XV_D,0QRR>+$3034B8C7GNLZS,NZ?I-,[F;33_XEPB65]9
M8RA=.:#8M>.8\I^_TC%,OM U1'WJKZH],'T8L_#:_ >S/ WP1U%T^<8A(9WL
MID_^:1C8N[6/[IE3;TY7$?+8XX]\^59N0,;FKFBBEV\O+#E>MGR><.?J1545
MQ'XJ1CH^3 Z,RB<#B07;W?K[4TT>$L)\?\,F_#;,DU(D_O78&,B\@]/9ACBD
M[H@UAJ.)8K9PK&GNL95<TJX#KJ/C &5/9;,SJIUFB_\Y_^J\T_<A55(/=]I\
MG3LG:5#(0<>%1+%Q#FN2V2%*IVKVV]!46HK:\'-B@,M8H_9C*[M%"!P]2E$U
MW[M6FT)Z?T1>K<1][W[=!>+D[S6@P3$S6;7;A^Q!A)+54-V8(K^;05>9I3N!
MK?%'7%C]@8A#[MY#<N*GY8YW14_@*D7I9GBFQ2+6:X!2CV\>5CIV_R8MD-BX
MT?K2[XK<^53O8!AVTB&PXD+L11X/_Q:DMM=,ZUOD?JCF'1C!%[KCV&>>;J1#
METI#ILRIO;O]K>0\&X*^.+9][SJ^=P6Q%T_"!:XJZ/RY *U.>4+W$0*5!LT_
M[IF_>51$]8/\N5WX8(")H<GBV3TM#U\.00RB&ZE86+ECOJ8_53O]MBX_(T3L
M1X<Z>E'W#3RZV1ZE@^9>D[MB]KN4F5KU./Z\WKG?##O-R",>(@VAOI]56/B7
MI>%O4%1'=@X\H5FTZ@4/);A41WP(UBE.KEOL"H@:KF08'U6C5 .C#5MLKP%P
MM"&SZA,S0.4#KC.X;$H[01A3,MZS C77"1=VHTHH=]]YJ./C8ST0=-X=RG+L
M_L3:.C;M[\Y-]J[<;DS*3MP8%R9%/6C.EV%W?,D5*89/#]E"^)XN<>+22BQ[
MBG9R]F.EOMP+]K9;>O&D*4F6Z%V *#$Q7PM+/,LK&C$P<7CV:N99M$3?Y+ZP
MT+JJMX_F$6^$Y3Q@C>>4K!$(E'DXLOKS39E)G44<>6)TSX:Y:Y'.%XF;$LIL
MX^.I'K=5NG&I+YTS051]F)_S?UBJM_F2V<M"WUCPO$<*P)3YR=FC#0H[ENG\
M06)K+R<1+=02.P]=<_;'*$@G?B<Z[)_3*_22S[4PQO,TP".^,0P _6Y [3D0
M?FO)+NSYZ#$M4@WTW2T!S"/]N'3-LJB;AH;">'C+DN7L0^O#&]DBK<P:JERE
M1C/)),:+/P7O/S/_&S@TV=MW1V#B\7?/0Y]P6P)DC*0ZLY&M)TY>)KB:/U:M
M.57DU/,;]<22(UT#G>9#+QI]!:RIO.5J2PC:?KQ9=35WX#9"X+D3\MGNG4UF
M1Q^*/OW/=/'_*DHNSY</2-+-#I$+IC5,UX#9U*07T.1O&RD2\S%TX!ZY%S+=
MX<$P5L,Q C_PKJU;MGD$7:Q>@UG<5@QES.>'#WK5>7W_Z8:PW\_1_6^VK/N.
MJ_&8W_9Q$L> ;MR2YMYK3=/E*E* $\'4ZY#ZOG'&9E/XRW3MWJ-)#%^%XOU=
M#L:C?X1%GR,QK9;F;ZU&:_R>(9QZB+F%V3ZI.*'TS'L*-1_O!?791)@&Q!MI
M&WJ'0_J74Z>2E.R[EH^>EV $%L-$?V 0)_U=@4"2%\*@PS\RJ1NV/D1<='N6
M(;$QA$>X*/664<E\EQ?Q_1962HK]S"1'&"_.P/YW>2ZN\BX,.Q+&V<WSX6H,
M_3?K&%"S,I!O_;OQ;6)V);#2[<^2A;!I8-'@7;:5-:ZC\RFREE61CQ'/,'M3
MF3#W.>I:YQ=)$ML;'*&)#$?L1P@?,97XDSM/D 'SNP='MV$FZ3O?AM U08T"
M<B\Q'=L%;X1GLXTM->6I&$0+Y$XX,UUPX(X(+OM[ RA]^B4W>(4D?)8;.?[(
M/XX^ *6C]+>GW"YOVEF-M^4: %7I[U=0ZET5E)=$#1)W!8Z[,36^;&0L#3T=
M^'QP3U_QT<P2M\!AWEKB5$^L'V4+MQV6]ZHSM=8J?T[_=E*<L^$#HQN_7P\8
M]/,SJ-7IL]XH/^=RW[_Q(/2!C%*<X7PA8#>0_N_#4 DF YTA(Z>'&0].',C7
M=#$*B8VT[\<.#%&GVUH52QDW,,*Y]1I'1?LGOQ*O-(XHO)MD;CSA#ZR/JDXH
M&PC,E?0G)M%(\3C9U?7/?*)H:1V(@UB%]X(MA0<N\)*70RZ_I4.&BE=9;35L
M/O<%!EGY&[.49].S%:TJ$]C\MW)V*HJ@<Q<4_" ]VDX[TN8I^4#'J@YOSQSK
MVVVU#C[SF\]J@D[?/0N67T_^U':WF3H<U?"/;UP8M+=N&FK=(?JZ=;8_B_*=
MS[((\UJ&[2+#$TO>V>4+0AT9;/[@6RQ*G\H*E]*14MS'/5\Q,Z++M!0]$IFH
M^.'.UM>?N#)V(;[),-%3T]_256#1^M?H'_E?_D.*G-$%0:@#NXS,]Q!$2?:%
MY$F>VLN,W]@GCK\%2Z@N?<T?5WXRR="OU)HM2]2GV3YCT8@\OF)910%S@;S(
M@,3TZ,@UKE0:I3LI[5;LP['RS&6N9^DJ9XPU]P,^I']8+Z  G!U#+YZNG^>"
MX7C.HX=J/-F.PRNX4%^E#LJV._:V7>R=XSI/A\EL3;XDQJ4J#WND0(TGPD2P
MM)T1G/^IV?X%LC:(RO4BS"B.GRNL2.7\=LG[_*]GMUK$XK/@H><1%"(C36B(
M?==B7D';*F62O?+8&T2KM9"]MNB-!]&'5,<W:7(G5C(S#*'M[F&O 0E^YC73
M_KIDBXYIO/%"LC(J?_M_IX@N\]#0WI%=RSG>?7+2EG_C-0_5'E? IL[9VN+Q
M KY0K7)W*U/<^ E4,JZNWFDIL?I9+WI1[VEK GFGEN1S>_MFS+J9:+J=@M23
M+QLKF%>QE$.T##.&*B,!=[JPYK&OL7I14E\$ASV[LC1=$IV+TO1,8T?BYXHR
MS)F[W1B7Z=8FH*C) [R<\!<Z#J<I3+\P'_$$9YK6:86_"&50AL[T :*0;'EG
MM.ZK*>R?OX0OI2:9?)?3^:>UBH/X?=>RR_C>WY@K9#PI8CPHYT@W*UB93K6\
M$WW?A@T_?"05A-[1Q2A&^Z_"R7<NU/ZE]GE[5K-_X_DV0-_.Q4'('!G5.#DC
M3>;NM&/%B@4AY'56=0:%/$MJ&0,9+W+:LGH?_' PSEL_KO OI KZ+D*O@0+3
MV.T0&V7U"8D(G=Q>/V1U&UI_<D2CA6J:>\(+#(YH*RL.^14SVLR+NMT,!J/"
MP2:UC7DS?2!!J>T^-DMG9[JH= WJ]!Z%YU5F$0RMR-QNO</Y-&A?XSS5,M>A
M2AC>>[@L"-8:SY-ATR(XW;=/J0&1(.PEIE"Z&6]'T(_55F4G;=4BDIE9'FEG
M&49%*C_'/RV,]*.$4V^+62QI4?9/^PY1"6KO!5,2];*M'-FR,^CI]O7=U/_0
M>D5)^MXU@.J^H=JCR/_'\-G_/WYKDJ'PCX,50WZVTAVC,RH]+O,P7C=/ILD
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MU&^W [;:]#*5IK<-1T=M]#MIF9=QGOV_7;/JSK*1:IN'&R0IO[JCUQV(V-8
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M:#$*=C+HW18J:(L]8D"JW??C-"C3E0C :$E4,SZ?:!+]!^@K']5:FB/:X.#
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MGE&>&Q4_'A7U](($H._I/ 8K;.,R=;(J5N$3UN_.:74DP'K!%1QXI:LMI^D
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M+?_]0X4=,T6<'1$NR+!-&AFJ./=P0>S7^%3$L#+>QK1YKVJ#B="3"]T>SO
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M9.4%*M&'>5GQJH%X\6*T1'2^C$?X<7/L?_-^G1<8\G^ZN(=7O9<*_W(PL]/
M[WE!9=KCW#^^S%GSG@R<L%X! KOP9(P$S'MD2U"9N.UXH,AS<F]YI4\2?[J*
M+?:&S3)3'+'2JI^)EZRTNQ\,I#V"@?'0B>HW_N6Y71(3(C;:R[SW@"-[%@_5
M*TBJ*\,K/U)7F_H;+_X9&=H%40?I_)RNLZ(%]Q1ML KDOP5[.LL2#/< *I<X
M=+M$*_H]9WQ2 UWYD),I;?7RY%6$C,8!G^JQ0(O:L?(?A!NQ6<QQK\\[N:V&
M>J8P25+4R''[)+_BUY9MLKJVJ&;,KK,[AAI2GLGX]TB[=H8]V&\SS@V:Z$,4
M^(?HC[ (P TW)%]M]!X0+'UXM ONX?N%_IT_A&HUVS+RG\.;2B[AL0@=6P^)
M2OL1$>Z47R_(]>(/;SCO'M_MQV^M7&H*U;.4,^#5TQ#(7T/8:2TRWG_?4=XI
M*RPBS!BU'(OP(:FQ,_ 5BL-.TN=]FI6J0_W6KZN@LN$T($+16?>F$YCA$<MM
MKQ;K2V"W)0^>T[!Z^H2SYD!D+(<=O*GS+8LC($9(8WB?SG G_J<LO5>(Q3?I
M\Y<-KIUA6<\G-/^Y(FE?2XX(-T<G+5;'/<+B5 6&BI,I2+Q=^7G+L'8/H(31
M>Q^F4*Q&W@')^O?WL-\0XC'P?=!I:.WL8576=<"8!-MO"2#E)P.BELFK(UQ]
M(GU\H$D4@:]IY/EV,XLRU]Y\;41GKHO9]44+O-D,TL..HU5VHL9V\&*FWV;8
MSYGT)5K+)#I8^3SYHL&'=XOJPT*@:4,D_68XP.]@.HL%917F:Q!?V5PHZVY&
MK< 6/VTE3%CPCO%?KD\C-!LQ=8<[Q^=Q<LN#L01W_R-3"_5G>;+7PZ4G2.R>
M)<R?]4K_"$.V1U"4R%F[JS!T,JKLFUF#3/LWV<:59YW&L@/WSWPNZAH8_,=Y
M[XI:#$JFJ@#111T%^8JMB506CI]UU_E4>/68NR]%Q0&^.8J($VK^<BADO+@-
M35?E16*LL-=&\'H,5H(AKZ8P[+"[Y(M<\=S<A7@R9)>\6%W\^'9:2G?+9V,Z
M=,#JC5+5[.6G*3<Q,P_7YV_%@>F$\HIP?..M%KM[0 @C[G0#2XF1I_?B(I_#
MMP1QVSZ1 ;FOQ5G-]'.?73/%=Z7^O1K$+KXR5OL7@<TX;.8@^@W2VF'1/G63
M><DF!TQ"6G:<@V*4$>T7&=D$#:'-:>3T%VCH5>#R1G2ZGU<7H@5"CI&F];CS
M[KD'Y$1LVV,H/%]V5<(78"@6(_F)3Y\3WL/_!%%QNIN321KJ G'>+P#[<)0;
MA:=?<KM\QP44U*N-KB1*3X$DYVXG^CT7NEN*4DMWTABC[-<Z9C9=@>7CGYUP
M %E8-&896(8.-3:5NRO/?!E E>A1+DO=:<)P\S1?]RW2F@[[4M88IQ'OT,ZU
M=J8>2B;3V8J7;5 \Y_(-"N%>V4=/I&3UX;JPHZ<[\0M%Z?D]X N?0!<Z/&?,
M5YQ'>@E K%B<^+%/ZA-%-_< X^"T+17NDMWR7S.W[+[P1?AV6$/RE #-A.8:
MZP\5L"/5X=&7H"?T#II$;FZ##^(E\GV!\/NX1]L;E4)E#I@,+XBJQL86H[8*
M7 YMT.%0UO\ME'98CH@-D^2I\?'4U:N. 2JI)*9$Z,S3O<]J"QX_(;) N\@<
MZT!7]Y7J[P'A#YFE17N)VFMK]XV/K8X:,0<;KB);[5)*$_5+>&K*1&\'Z92U
M!DB[FV@DE,XEMYI;_W_U.S[9>@I=V]QVUC[SJT)?7='/A=>_=HT-[:"8($+8
MOI,MT^_9#L&R,.&;8H^B=Q.8]M60 X>*HIF?<2EA[\AS.&S#TN26,ZV*A\RS
MS6L31$ (^=<U]0$N=(J[NY,5>VD660U%AC8M/R3="O_:)TOT>/ 4R>#XXX;O
M9:=W8A(QLD$:-A<ZM\"[SUP*, X$$;M"4P1F76VZ(E^?"\S<93T@34WQ5?8-
M@TQ9&G<[Y)]GLR]7U8"9#W_RB O8Q[*(5UL11YF&W68[B)C(=A]#B+J,X 0=
MG&<*<.<T4O^@8?CDNC,H<R VL3;V&.WR5YEY_*P$1"L3YJB_%)9KR?;@A>4W
M(V=SUR<OY,>5RY11#_QM-</R!SZ**?8/S:M[@"9&OF4,9XA^A9A?(7QF[D;T
M19((S1,LIDP[F^M7F85R'A29U3%BS<L(-\YA1H6;OBWVJN)/0Q/BC]=BB6UU
M14/C"_IL7)Q#16@84%H9<<\S7J^Z/JK;](V1F#3AKP N8T!W!YOB;+E5/S$X
M0)N/25[(C9,,-R6<*(VPB>]ER? A3PSXR<Y1YCBV7X6\%QS%$$BW_YH=5?5Y
MTC6=@>!SF,K4UQ.N%S@*C!?VY@E>W]0T?6:,>/Y><X>7[M$F9YHRM"_GW!P6
MZ)AM,:I]<!1A/8Z8Q-P#A%281D!W7B\-VD#[ET)5YUNCWE)77)=,%UAJ=_0V
M'3CQ4FMOC[N!<\.T)=]2MW'9NGK<@A6J:=?M7I*@?PLT-?*!P>>F4%"OT_1Y
MKQW[%Q1)2$.T.X/#/4 QU$B>4E<?UD*F2\WY_/O\GSVBSZX--P*7K3&?+NT&
M[@9[<8M]2 )]?7Q*1]UMO$<21]B_<G_5#!",/>4PZ"1V':AH>YLR]Y-*?:;0
M[\/V-'_8BX#'<*FGF[Y*%392S]TD^&"B;Y7\0&!?;@&Z.ON]Y%U&Y\#?)*FQ
M].XCWDU86J^I 5^Q/O)'8Y2G D86)IZ:,'2 Y\!#)CHN66+'G!WDJ,+1<C"A
M\VAEO#R;O3S-_&M.!534QER:KV+=L45Q()A'8(Q17Z#][]MHP165*-;N^! E
M_)6C[%WC,3]3F]+Y$0L_,$-/_5"C8H%A.8F384/LWTZ<W1HC!;N<#T%[@A&:
MD_W(^O.GP]U5MWC/V2 K*;O%MV13=?+@[B<OF^M16GS,G@L&#8-981NVK<<@
M65^^F7":A4W2 ]_IRK2;CU,-+[YQ(V^[S'@7@;<'@HHYWSW%46IX+[/+=RE%
M#U,%TTMEMN$JL;P2!\U=.,X%C#D>1?> BWW,^WO RZ_-7N#_YY]C_+'03[>>
MXU>Q:WZX=G1BY0N633Y#/=P4NMBVS"R<?C>Z?(\[JLR.8V'NWG.1^7.5FLN;
M/^S,&)JAC_&,?FR[BUWKYGN&_:7%BT"^;)P]FZ]<C[S3M[0PWYWX%<J YQVI
MA%((/>.I#;#8?;= )V\5$I_NR-FJEZ *C)&TGV!@6/&XOIMMYI(TUO[GG^UW
M8&:S*M3KY_CLB:A$-?,]8$ZATGA;HPD5$XZ0PET@OX VZYVY[=Z4%S&;Q:Z"
M[@%)WG*WHMPA$O> "(>Y_GC0!R/#S85+126FUV.?LX(%NG?Y]'UET8E6"#L"
M#Q"=?*/U:EL"92R23P3#\(>LC&^AM#3J2[WQ;-U9:P!*TM[AN*UE>7]V(*#K
MBJ6@&<65L4P_<39D5WK /OFH(7.I44A^S3TQ%.>=B B.2UIIH5W:81)BP830
M,PC1IV'7Q)H&OY@A5/O1^['&/# #)=,#]HS\V\(>R9DP95BMW*\!S>$>U+H.
M*B"]F@$3>]+!C,ELF&0G3>L39$(37<3B=YL'A"]&-$$#T+N E%O YJ<W"M?W
M "GT*ZH?2-/V8YYN N /$L*Y ?H(G]) &:8DG6FS.0SM#L3'KKRKS)KR$Y]%
MR6NE]:@ 0A>>999JBUN[^DC8M19/&:\!MYO\DC?-OQ_%#LLRPDP\]-^:]YE^
M9.%,-3SN@*(.'KF!AK:462.(7?[R4=R]D1, LZ8L;8B!]U:6W9]]AE(>?\X)
MB<?^KL!,FK9Z_B^O!MVWM@^12193<KU:;4Q0?:ZJKT2S@V]P]C2W?*?%LO/K
MK&C#+Z'D86>S)&>^/0F2IB(,&]L4YNG=A[E8#DSC/8 E&IW-3S:TEOZ$!JCK
M]PV?*UX/K*VIW"C5"A4I_4BJ=#RSY?H8,:YK*@5+_2E0L[8"\ 3^=6F[?A5+
M5'_PA#?9A@FOA' C3GB'0\_Z ML09"YS#R#'A5+V@I"8"D%DTZAH5M,(@7P'
M^$@'SR,@X29S]$O/)[SN%>PF)L']GC'H+^'*K9*EG0LJ>&9,OA/N3>NC+;C*
M@2"8V@&KJ_]\Q#C7ALX;PPE&=";<<GM=9',*=M(U%'9Z3OI !%<.'H\2Y'"U
MZTJH'BI26"$&U=Q0<P:A Z=O7_)WX6[IP4H=I)9PUILJ@[L9*<9OM6T;X<OI
M1!O62BI7A*G[#8$/")8(6R8?;^,P94N.+"Z$M!6[AC=G>UUR*@D(.M"W=S[P
M;]2ZZN264<!@WR-Q#D3V,[1>\+$J033MX8J9V4?H$S,6ZG[3&,D?VE7/;=[]
MD:3?=1E,F9 ID:/Y545V$%(]/[#_W3MM/GV-_?OV--$IVGEAE-V)@#62,6"1
M"'I6F7PD.P4NG-IH:B"$N^8!52JT/G9]"@(P,^)3BU!XS$CQ8_;/KU*;;MHZ
M5/PN=D\8((0[!M^93I'LF""[5!31K4[GD[/(F>XA4#&>A>S VX+X<T3K!RP<
MTCCO8,/E^%4F@AW1X>N.E'R8G0_O+P\%OR8)Z0_N,9G?2^HN$_8Z*0).><K\
M.H$!\3U 8_18=\=SQM<IO7#+P&)E\L_,T*E)Q_"[.2^Z(X"8QZL2:9<;GII1
M%^O%=9J[W<HMDI!E_,;9@(8\U'G94N@R\?9KNFEYU3_^08VLJ(YHGC#S<<9A
M!FYI66E6ISB@TU5=D\N1]O(2""UV-$TQG>C'<^4N(D4A2X_A1'LFO+:@XGV'
MX_$L04K][5R/'!ZLQ8YT<)_2G$EV*V+/P55%].14K35KQ??:A;(!="!>JVNS
M2L\HO,V/U'U(<Y#YT&GFT[P8\TQ='VX&8BV4@NQ"H>0*XK\1E!\B-Z&7(+3
M=4KY: >K7(!4^"T#<8JXSF6MX2+KET^%R2]-1>R)"PCC))R,([7 _#Y$'S!_
MK_=(>+>ZX,I6RS S7B0[8!7ELU58WA"P_R"M_#/AH]"Y-\4R?FL^.Y0K)C5Q
M \X;"6!91FYL1J!'@&P?13^:1/[8 EE4#"KV/'=-_RF CYDISGQ%DR7$K8H8
M]7CV#X?VO+4=3Z5CYN#<!ED78$DM(ZK8/TBB+::XV-'WLK9-%G7ZU_]-"Y7!
M:"11SQ^ 5]D1>9RH>2X.AM_.IV/VUN,>$'CY=(G*YQY@LGV9FD6#^F"P8_QB
M2D#"F<M^#THF,!WN4/W#79T:I,/,& :=;-8(<*OR]/F((IJBG):[JINNZ[J1
MJ"$$[NQOWGGH!O!C*- V:]7#-38&FOU4ETYBFPMSUIQ*?5_T&'%J:5<B!<;H
M&X+A,%\R>+<R95\"*S8OZ=P6L]G\4SO]W=H&### *(2+9>L(?83Q+\XM*WN9
M]YU"'L 0XH@1_)+G&0O#<'X8>D[N%X2.R?K8!\C.1][N-Y=Y%Z580&Q2:!WR
M':"4'OBU>O/Q37X*+'MOQ)8$6C"='$D65DS[U_/KOBS,,P)C9.A!Z<D/A_85
MGO> Y&?;3DQ'DD>#-?5+"KW^[U [Q[R>0RJHP]]K2]]"N[@)K8G?L_1[FL8L
M=WXZ:^=1KIUP;?434H7J<2*GS#4>J4Z<BV>75GI@*#R" AH[&^X!:XP--Y9W
M5T/V2_N;VU:[2GW%RD ,45M/Y1WXCN.*GCL48W4P5RZ5OG48BKI*=S^Z6S^-
M^7<&.:(<8:A,1UWO>9 N])0":5C-0J2_?<67:!: !_SER[\'F!I99YMAJ[;P
MTN2228ULO;?:%J%A/1-W+ZVJE^#3G+@'U((K\IJKYTLW/@D1\JBV;9A5&91*
M.+3VW UVGZPHP)6//(2/H@R2"JL"&>'ZZ_J'AZ!)ZDNBL7#M&#Q_K')CGF/&
MA_1H)XM^?*.FL7UZ4N'&:(?S9PG>8-F3(?KI"ZFGM^1%"VJ/*P.?<J[B628K
M^#XBQJZCQ&9V?=DH+K,&(N_1>6,%V9TP_A#VFCK)7'*X@!1-JW-[A-:# *^
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MFYL4A_[#!,%'=Q2]UMXA/6/=1V0+Z0,6=3&3(VN1PURTAR0)^<(TZ_&S+4/
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MYCW@+\I0!94P9)AP+25JI+FN#3UU(' VV=(<F,MAH6@OW4DY]GW4%MPCZAH
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MS=G%^O=%#3^GE6NU%%&!NXD_O23:HYD^)>QPC5( <5^$,:D)/K%H.ZP7&X^
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M :WK;J%H:WB"=JTP9 M?C\\SYYDCV,1<.(Y8:JXVG-26@0JJLIF'B29FCD?
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M'-'$KKGRUV,6@ND[4@>+2@I+W+Q<BCNHM)^VS:Z_FDL9=!E<O/L%,&.<8OX
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M[E<*W+'=?KV+,:Q3(8_)'P0"S-,-D ^VV![78?&^P;@G[*1;HNAFHWC00H>
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M/EC/NCT$'/7*RQ7A5+3]@'3>=$/OJJ*K$LUK@WCB?R1X_<WWB5)W;:#=2::
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M1KL#GR.7B^UC:W(93NG>X_P*M'/UY07^E&G'Z6!_ZU#X1-!RI_L&<.>$]76
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MS;$4#%!39X5\'_%_Y.&%B6D6*N.K:4P<D'E8N89('8Q)XF)?4H"\1M*,SMP
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M%AH06GMR!C]#1(G'46U?F(>43:.G"YL*9K\55OM$QAP6&!-<+)Z4 Q^A<3>
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MKWKT4W[+^/.E.GBTS=JO]F*\MILLN$N)<$<V8>M4D2-HWQA>VNS,8+7)^(,
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M[L0E1^%MV8FINEIRSB-Y./3G,<-MUNEMIJ[_!_@$]34;Z25=-ZR#C-U"0CH
MZISU.1 HAR\3C:%D^'(+?6<B6"7?_*I@U_JP0H2Z6&TC^C?@6$$,).[SY;^^
MXOV?'T8A>/_1VF_>[A!!*<VQQ?$3N=$A<<G>A+Z99 (>@1692N]*<NSW&\#7
MN-,(S'I\G76(3LS'[P3#T;UNYT^Y$DON;> $P:OD.L(_4E1QNT@Q9/-(+04!
M[N4-X%W5R*Z@TZ?CL_O+I-::(.*Y+WU]!"W>6>UQ48&L&.X0'T@)>CMQWLST
ME_'><DP* ^!A34AF2Q.J!.\YH533RC#77F&H-9V',/5BG(6J2CATL%'@:!*L
M-N"C#W\.*GJ:W@ D2]SLWY6@^X^@&2%)?C^NH1XIY^G@/YIQD?+0Y04ZT=^:
M(.L/%\6>7 3'!KJFVN'1>$%'K'IG(RJJMD0"Y+/FO9=[*>X6%-YFR65!]#?[
MH2W,EZ@]%/S0GV+" T5>R9NYH=!K@*['J[IDD2CRX?S:4LG6*HH@I4 ?#U>;
MCX@H25,+@.@@N>_I@8FQ6M&S2Q&M@Z=2O#)0<23G?/.CYZ$!2_428(K-JBW#
ME 87JAEU DEBP.\WL;-NH_4':*)WEQ0=6=7W+<Y0FO1$U6N#T(-X\PP;=P1<
M\@S"W%W374WXG>SO@T%R8D8\I/-:O!+/I43I_WCIK197@D\BMP:A7-#,-.BH
MI(2>C]?+'@IV>9L0;7K)?0.H;%Z1=R,*)0J1?UK@[>)^F?4(D;2A6?35UM+H
M^VX&R(6%.I._$+<5>!>GI#*^,95-? "^]^6R%$20B \HFQ2G"#=_A.E"H6MC
MJ!X\)YK[-5W@<2&6H+YD_J'$9,:[_S0)Q%QOU5 ])NC")<;A_HG[L_(*<WJ@
M@?:\_?-JU\,1QZTJNK5OSKF(S$HWJET[14%<Y5(5Y@"HD5UEG7"XCA[_PT9
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MRSCO5 9S=&GJ+6 TTT #/:=C0A%&Y[Q.!$^7>$R9B9V+VR[,A>E$Y\&\L#K
M!#OS,BW+BHO"V7Z,,5-5M)QT5!<R"YZ "5#14P=Y"[Q+7*8^VTHZU3;?<),R
M-M9PX7Y(1>>4PU#IM;+X0P08CN1*&:4WSH\+BJXEZ[V</BRP%B7C.^R/O=_%
M3RF7$<0V75>>^72-//7Z[";@K918<@%?PS5B!4$+MNG4(*:(P#V;EK%9!2NN
MOY!/ H'XAQ@O +$AS]DM"E5%]XT#@K&2^?90I+%CA(65U\9/^*#MNX 7[ FA
M[?N2/:!."-F:/D::-6]EA&:[)3*E6:A3M,Z^0Q,@,3] C'K ?E$YT@VEJ48-
MK'VL_PV;.'+:!$D_J#2@:L07LFC DX.OI>O8"VAFEW Y&10MSJJ*/RN".1T"
M?RD+K@KYOP#? HP,AV_H.E.$2P,\MI"=\A>CV*1%&#!(W-^IH^QUUY>'A6_W
MQ1UQ]3VV\@009=!*KHR_6-MX]BZ%V&;/(C=)(L+C^P]"B;4$;<BK&?($E%9W
MS>&3_46=$,J+; &ZLQ(<,S=-"S!F$>%+$:N=JG0+(+'#V=!XD"WL@N0I#Q:P
M@QK>#/1) U0JV-@_F)E"R/NV\.ZVEYB O+D6V=;]*)\;W-M&9C]\O5M >-LC
M#>5EIAW72LZI+^F?#-V_^+^]!<265)(LYWLA9[HR]"<E<1T3BX\)7',$/U T
M\2TEFUH,BJKG?\5M[]T"DCC?+8FP:&VV7"]"0X='UH;*[&K -MW./)?I'LO*
M_UR.UP5N/L;UY*&>0=W0'+WB\H]$?YJ)#"H=GY;9^9 ANN^<R"T ?*UWA&3Z
M< RAM"IZ1MK86'IOC9OXX1IZSCQIY>:E+$\'TC.E])Z"?0(SJ5LCT=F0HG3Q
M@'J>YYD=\.K$:E*UJ;=E9DQ6OHJC&\Y5I(P&K7K65^Y]=Q3)$L1FF"A+1A^_
M^28K0,*F8R\?[?,L;07X&'S7/0Y"V[+ %P0TM0J/',I_7AK@RR1D7Y:VT: )
MH 3U"V[J:-8$R+FX+E%#2\/K/^W# H:!"D0S[,$FC/K0,JP1)L9JU4%9#:J)
M.DP-!K&T/RED7[>8X29(Z*7O+RUR6CC>+U_:"Q"[(O;QU718&,<FPUM2<9+2
M]C/95*B.<-YB(%$"W74>R2V@EFV@%,(WE='!:!,#E_86'\KMY_UK,O+Q#P.V
M XJA,9F47\V]*2CG/3X@C[':%&#!7X9N[ET:/$&/C^]UF@LG?:SN4*@RK&_M
M91:D)\,L<UF5AF,N$=? _I2I+:>-C5N .$9X5 [/;G.IG6I7R$TLSYNS_-]Z
MT''<)-MPJT[ST;T=Z#\<P=@KBL7(<=EYBTT.EQO5RK 6>X@&7[H?TC_LX\+:
MWZN]B]W'VHK6MG</P/_@_P[0#$+>H"W]R5 .AR7)XM*0,DOY;AYG1"HPI[*P
MS1F3MJH^0H-5:_P](0):<-(8Y203K4@7]JZQ=.S7^TH:V-QKL:?-[UWLA6VY
M!9A;\5*G.HW\$L%1V?L_:\ D\"6L\EIHP^U._[@^:6E*F"(A< GL!02Z3"!;
M$!'9LE/EHF441!@-[?H]K&-RH-R;S+4JAN7,S&7B%:SDJO2-R7GH;\2D.U,,
M.:A,EV*63V$AB.ESFY7N\)+F5%Z1!DOC@6IQ0^$.DXRB0W3FO??J=:07/2!U
MMR;N7UY8IHEC(5ADQFX%IL#K,D/_%D"*8S<Q58#(/3,?=+74SR8B_T*L-=3X
M:@ \3-@NERS?I<4"BE@UX<?'R"9=6V\H9!_<Q9-PVBYQ&=&+3\\\4\+T\WY?
M@W /'_$1I1-3Y-5:)4^GS(M7SO[CN">,43U)?8F\;2<Q72%(.MGS &/UQ<Q/
MYU,W@U^@,#JY%O[60X75"N'>)=)7O%@U&1>/<N6M4E/D_.%QSV&[L "'C//C
MR'TY+LR 81OYL\;">0T[EQ).UG?Q?7JC;?0KX1R!BE^PWC,<DZ_<CPAW*E.E
M"@[&A3O9_O81+0Q+W3$_7GE ]'G ;#8;2CQT;KU!Z2'G[*6"WL=;P&Q$L4&F
MI&\_U\ZDSQNO ]JE;1^EI "O'"Q#E.ZDXR$?_Y-QY*9J83P\-#*%X8O;//%&
M&^.>5 'T3Q:P*[VM*,!;D'J0>D%S7*B4#Z#3&_>3$89&&-6/M]T)%$L%(::H
M\\@''+HIE@14KUE^ [ @MEX71##")HJ,H2:5.E_L$._/?.]?ERM*1>6_I:H>
M=08C5V\**_97L7/7B.'U)7*L0H4=\'Y]P.-=@\;TK%&A00 \;;W]PV/2ZFM8
MC28/3X</41S$-Y<[T@(3Y6'GPM,4.RRPJ+.<$$;\1WG";HUFQY]\POU ?&4S
M?.5&,6=HZKM^8UJ@T"&#,][>15G_YD0A1A7MIE(]*OK"463!6(]J9W\NDD?
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MV^O\.?)I18[E? QZ#T_:R.QX%A/!5SRRK+?AOL <D,;_#;!T_P&LXN$<3KW
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M<8W2A#>,/KWAG.>VVC&7KL7_./ !37\"/FI:I 3K5O,ISL6VPZOX53PDL0X
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M%:?J0]K]BF2EE'G.U*W9=4AI[/KD2?<5(.D&L).45FM+6Z?)7J*"$1WU\#?
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MCO=EG-!FAK;,N)_(#EOKEE=6CL1+=P)*3=]91N^1$F4D6>=]/I[B]I4M\=H
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M[#^AGDW\8;0G46X#;]=>/XR+PI:;M./.2;IA(-MN?R;8==V1,M&R2+X&@R!
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M@/W.-ZO=Y^$*^D>+:+J5[Z%]XU$&'N.S(9H^K,QF2-Z6YT)OC9I00*97^#4
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M1[HEE498?X";7+KBI&-^ED&0(V\$EI4@(8Z")+>#UX&13.$/3[0>=CF@-:U
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M)R=?(EV4V'#Q'J5L)&]0$C*GX_R#TLW?-<];'C!NAZCR^#'U.? LRJI7:M\
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M1,H>,=6>,\0&*:(;#3=(80V0!/?;!OG)B1/8OQ/586C1Z#FU)"*P(C-WA54
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M'4]<79^?V+6'(TD4MH@H39NIE+5:S/OF727^[>SOQ0D7OT_P&8I M3$_N*9
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ML^>]OK_QV$FU^ S0-POAQC*<WVY]&9PQ3IA ) PKV2^+NO/[O<JQ*>.P6"@
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M6HY_!BA^.?TR5<SDH_K,=I*<<"8]*5J=OTDPA7M65VH/']\ Q$%]<S4=JS<
MXMD%R5/E.02X.<)_]9.+^^2W9KJ&N#!=K"^\6JJC% ?J27T!+K?NX^V%-PQL
MDD%-B;D"Q&FAXW0?OVT3N""?LG02"NZ,(BO8-AJ&F#?]:6ZO?.AU\##NUVMR
M@79.&4X& 4NAB-=3?-.32W/:\O/ (*:XUZ_N/@_!WO:^^.;;V>8%.T"D77"!
MRB#7;?CFOZRH:&$%TY)= DT32C(VV VIXTROW=1$/]F_(OW+6-/$@'0K]!FP
M4QP;=T[@B>TQ83[/^*IY#FE<<):+?E6G.5?)W 88[5; ?C3/0E96XP8,,"/G
M>?0S^Q+SBA8"#L$OJ40,_)EH0C7T4]-E6&,:UI0IL_68^6-X,(W6O%.EC?0H
MWWP'S=)/%;RV\: C6U9JV1W#ZK3S-GQ:\\FUB%+-8L;FT75P#YX+?56''L1+
M!J-=17N'/=Q.NLO-HB:2*OZFJ+PT<O>\=UK:\PTWWJOT!"L26;)K<NE3'3[Y
ML5S;I4%":Z*"IM"=<<M#J'=-TJ][<ONB=3R[-$CFQV\5CV:(V^E@-8="T#>2
M$4\JZQSCY?\E]9BZ&E\ICP(O=_GFYEOQN3> F@B]& 5C6-&R4PB='JU3,W-<
M>E[P9D/%HT<?E"R+;<-%1E/A7V\58!!Q$&&\U;^I=$2WH_0XAB# SC+/Q:Q)
M]G7(G%9*,%2.O9TY8X"=Q1;K6A8#6V6)[#5Y/SUG;=8H(!1#M%"O5MO-S4.#
M+,5\GN,];V'905"(>(LSUTFCLHRDXB(9?ZYMRH[)7)20!%M?+F/A93HQ>3'#
MOY91RS\RY")C\%9H*U,]S&'3W<@R)[$J6BL6R99T_^:-#R8R]\44=_,C$,U%
MN(% UYHAB.(T\Y,GB\ "U5R%A0B!,>1Z*!%W3,:!17[/#> !."6?<C>K,[G2
M,G:P9++@@>;#DN<^WH,R:[(50?+7\(H@@Q:4) 7]EFY]MJ99-=(C':"9(\MD
M;)/BNY[S/DVY8?MH#W*"OZ/4^6TI X2J6%K6P.Q<B/6[[SP0R_'F9#X1)5?N
M!3'A]'21#WK/LY1P]>6MGKJHVQX=0UVODR?4;W6(ZYL$B^W0:(N_7 &(:797
M44729T@I4YX* MO\70\?-1FG""05%0RMA T6",*/\7_F9X)N #QO,$?Q;CR8
MNP4UX#HUD<:R'Q'[P+!FM:@DK; I!5-.!5#-PI^:'TJ\4(,Y&XZ<5GHN6VXF
MFL:2BXA]=[F8;07EU>Q<PZX\@0G(NZS1VC.65:8LL3(P_-<*>U'!>,#6/F5V
ML?G\3L!6]]\:'XTD%10]L\2#^1%U(OS8LQS;K5)G0XA5;@:Z:<KU\M8$L&1Y
MJRQO0+\<2MB$W'8,R(MU8''..AFX4RR>GR++R-87M<M LF<A1Q^])L]F+"*9
MS]!3,?M=R:YPIX*R)T'JARPG!TAK#,L7'NRSBJ#:M6"/I2LY3W3/J'/BK+)Q
MNP?]"/K,RE$*5G^);1IK^<8;"U7OE0LA.JD1/5!Q+P!@JG\<#C&N!"+SG>8#
M$:W+?IX^]9U(4/ -8!7Q(*4#6WT4Y6.E)L_![AA"5U_? G9$;G"EHWUUF3)M
MW])YY;QUB)G#+"= FI3)H*%OA,YT#%670K7O+E*LDK8PN>M9?Z)<04E?1SJM
M+!H:A9GA I:XZUK: K.UK]BD!%L^>/T8> 0?D<I9.:U9_CDU-[]M"C]GOY^O
MDBB?,BK\/B(PB8%SWP"@L')7,HO ?JW,IKRR<P.@!.)0M:O79EM!DJ*Q^%=T
MG;4V6#*MCOA?C9>>3E&TK&N>]!2;MQ1WM^)\#NR"K%Q7K_2HYZ#.2^!W$@'A
MH_4C;CR+8<P0+B)B5G9=:(V?Y0_0PR6>+)(/"JHEN#BM:O9*#WLAI,+3!>OG
MRS+](88Y**<UB@!DGZ'.-)ZM&GQ^_-4>+"PK4CA><*>>:G6YVG!66;'3ZN+J
M\H)6]\ ?<G( 7YRJJURM5 SY-6G6=&"_;!S<U>U%]_U#V@#V,8^#4EHW+M$$
M*Y7,N[B^3-LNZ^1UJSW9<=25VAPP]K!!.3,USF/!*(]CH@F%0<2L3>R+-LH+
M_O$H^K,T'/W.,]*#F/_7[>3P?T/?IM1<;[5"0IXC7%H?G&__;"BPXL_ >E6V
MN^V#.J&%XUL).J_G9ZHG;P#*Z>FH8U;AAKD;P,;)'L[--X0'FU= TD,AWGOI
MZ>\G+>QX</];;O>B'^=BCBVM^+1]<;8.[L.<?5$Y(MH5W1:H!K:2FNL79Z4-
M9:1Z=@SZ8+1.-!9HHEM2O*N'L>EI)BU;E%P7?K<)C#(;S+8BL_-(CF.]-*TP
M:>(^TE%O@R^HL%Q YL\<^!GB79=7R_"\GZC21T8FMHJ_OBU#P>@J5O6_W0!^
MBI9UPMT=IHL_:;KWT;F/CBT\)HY;P]1*MD[6**\JW@ ^T5'GLF_BP(EA79]L
MVQUR3AZ38&O?%^=.Y<-^SA.DK:.<)/X&AB@B*(+-1W!]9Y^:/NTL<4])D$&^
M+%A;O^2QVXG_^(7_HB'?N0LC&B-)5OMP&1IPT1O@%_TH9L*M8+HJ^4$EW>-5
MTC?J;/(FH#B)&T!#D&JJ&:J=MQR7K0'60-=KR\,:8YV(>"]4-%BQ0Y76%),B
M[W")7I7JJT:_)=KBA7BHBP69!E.K/MZ=\=I)<;^CH^AS!$,N9[R8#E94UB8$
MJ_>4XU"]UD)8I?A2Y_,YN_1\[YB,>@NA24['Z;_..<1CFL*IH\Y0;6,L!3SF
M[%\OQ5Q2: '!CH<'1X4?7DZJ]590AGUXP?8-]K_D(=6F^-__85>:JGY.G#H6
MFH\X##O0UCUA*?48$U#;41\-D4)L:G?6CI_5Q=OXK2FSZOE5."YQ-?]NC!(I
MAC<G[I-Y7G!13HZ9Q7]-\HCQZZF0%%!P6'M162P8D@KD*;T5!'^D</>-/R".
MU7?49,)'T71U;@$7LO>S=:S,X;S%[GO;9#72SG$1[NJ1_#W48]0)1[EL\>_L
M:OL"$NI*-=]#BN$I#R%?;M,D,;@S"MW]Y[6G(K5=(0.+>+_?7B='.*L;0)?\
MD/1?UXTTJC"XW^OS42@!@19]@',CR]7=0DM'NHD*HT9<25W1S]=:*R$GI-QE
M'7[YU-[7ID88D0J'P@:R'6X6.@X;F=OT;P)I6SCB_4.*2O_L=E(B)ANIPJ5]
MY>)\1UOWWDPE2U'+'J]OK'N%,K -[ACZ^:*T85;MF27->K5GNP%4"0HZ%3O6
M]),^.FP/%Q:M@9SAV&AZO16>L+AU3]FJ:KL0+IS]S[5>+VA"CP&\&22WIL4,
MC;YM<Z>]A4A$@ZG?"4%C<"P:26#3MC7NT+ZB8=9)8W_+3?1C+>^),C6NK)>=
M?^*P7?S=2K7;U)N.N/E1CT#:ZJHG"^*DKZAQM]<XKITKK&0](<'*5#TMG]FF
M_<^=+*>QD3$^@8Y! LJ107!7ZP.;XTUB<%%OKYO,(&#U1[=,G\/N!;L<1O4'
MZDR4Q@(<8*&5[]) & =ZD;MT/6 1X%E3[OMC%*+4W#'Q%</6G$:[:&6^7*C*
MTKPL;2MT?ZN.DUIQ5!VM" 9B#W.6&*;PO-5.A;LJVO.CNC0/W_0STO_IRMV*
M(S<6OE[>A/F@5L%_HZ4AL/JK,WP@,^$)EBK*M=VIT)' \51FNFH+<AK.;NER
MGT;09E/>"/[KWM"CDFD?8;]N=MJ\-<,9TU[FZK[)5W;9JLW/CZG+/PE<?5U/
MS9G.BLCU5!* >J(%G9;&EG5;HK=H4J)T1[_"G^L^V4IL)!NGAGK83+V&S='[
M/;.VJ,H1U&2Q%5"L%Q,_,BQ,'%WN:$$,;^$>ULQWGH-@HG]SS@O 6.X74ULH
M4"^2N6QV35RG!.8@I)_&6E_\]6B,J-_Y* 9O%T@5VJ@3V+-;S7L]4ZX!8DRV
M52C@80VP]7P24;:F1[T78#P670;EMFZ:.7S_M!'E\<3BI]E;>'8*(_G6QU%3
M+#)9.9+  H5HUGFG;XX1?CW.>A7N3_=C_"M?HE4M2_ E/FPJ4'GXY5@]@AHO
M_LX#+=NN_JX"."^:ZU%"H: 2^BQTR?)#!@_YFF1@OY+0C-!;3#4J<L)>KOIW
MW M.(CNJ!W3D&KS/97@2H%6(_U<U,XV]&^T%\5F1!YKQ_XC5[51-5XG[KF)F
M[O>,[:['T%EI*PA<VP;$-S_,K4&>PTHZ U,6^M (*IQAKT5I!5JCMB9]:+-9
MPX66I\E'35G48$WF:BGOK()NJ39P15!^6'Y8QD>VFBMI88G_\'-2R9_P 9?D
M>9D#0]P8:4T[30UPOH]G2M-&3)W5V3PWAA5 PH.B0(\RZ+=@3#\IC+*?&$SM
MJ^A5[+BO:S^)ZK\[1N8*6:V ^!#H_MX 7G=47<->LH#HP,S\T:?9YOC (EP>
MRU6WDV(Q]:N'S;UA)Z+IO4GWNA</#*!%K[&*%WV+<FS*?9IE#%-;*8NINII!
MG\D_?HYXSU@W,-K_;+*A9(I[I@E$:;W-0;GY>W__3,8:C49W"Q\R>CZE$YLG
M,1AYOF.E'@?2GU#P*L)E4=#? (SK(B;!YFM3:R?V+_>+J3.96 T))E>(8;V=
ME/F+E'V$(HPHR!2=?0,@[RYTY =.%<[4ZK<? /6-(QX:$7OM#[)$<Y/EF.C&
MKK$L"O9>6F?XKUEQ]Z7/Y932\!;V/$1.V@BFQ4<]]HC+\W3>BFMT.AO"*Z/_
M*$A>ES9/U%MNHS!E6>]36<-=RGVX98HQB_WAL)JYFEQ,S8F6M^MH<&#Q*T?.
ME22C,_XXCSU=ADU48-ME",@/#\CH*46:$.!7XUHUIET!?82FTMV4W0=_Q^]6
M^D"8_E0V2P0]7B%?\=NS,O9W2Z[<72)&S)QF(^Z#LSY+6\2A?#,"['YDLMG*
M]N3VV),.2*1>=(+B4=O2]6#$]@W L!Q#J(,%KT'H=B[$CYJ^IRRZ%OTI>NMX
M(<UINWZYV0*B6H)>]9MD?6S&4C0G0IS*+8$#7N>W?Z2_K7&7RGE2SLC4S4]7
ML<(2#"'0UM([RR$S><- VA">9ZD_;M][SM)*3\S4[_X?'W/!@I5LMPCRPT[5
MZZXFAZKF18^U&C]% ,ZY"PH%P3> )U>'?&=3;5=5TMT6A&IWR47Q7H-NR?-8
M=^Z4W=M_&KB>[\X'LOK<JFMT:O=;DY? TD5&59VZ*MG;-WR7"QC?5",%#*Z'
MD@Y@+I'P2(FV,#2"]?H;TK&ZUHV+1@.;5%^;\C"-Y]T'A7^>G17E@[CM] 8*
M?(.)@)=K.UH( COD[J20%@W-F<=21-XFSM)<&CVRN]B#Y2U'.=>DHV!^>NDW
M@ _+M_92=BRD$YJJ[1??9TT99@&_%+CV>/:WS.F]5V<ZJ^I&7_MN]OET8P5_
MID\QXC=^UY%Q,0[&EXBV2]M\G#:!1^#%*YT)K-C^[!J@9/Q89;"@P)P6 %LS
M64;L3@)([G]1E4U<ND/O>VG=@@D!YQKPT$CV1<3?/C^AZ8*)QSDPR>YD29[Z
MQG<>!,'9,X)K;@#:_KD<40H^T! &IR7!21O'S9;T/U_<JS2<;K4'Q7D-CA]7
M+U/M$(288YWESEO<,-HT_6FN]M^2GG$F+J6V#++ZDDC&KK')!=9&6OATYA=T
M%,6V:2HW'!22O]5_TD#.V4\B.\ &_BVH6Q\"*^0"J5R%5*T2A-7+X3VYYONB
MDQ.T=\7#[IZGR3TD<9_/MV1.U)T,>E$&%30.!O<NS]-HE^8_4OZN#ED/V=]*
M4Y;61TTVXWU*%L$A=Y'>\P^I?#Q<AFD?Q(].DU\AE3)KK7!A/YES/^6Q($_G
M*\%WHV*'76,%][EIJ#5#U,L\S/1P/K1+RT4$Q.IHQ@#9P0W@#NM6V.DXAW/G
MG0DW[QL [>PV$CM;.#\GD@>_:PP V/K*,O6'Z'<I[H4,H&\G!PGE]S&7M ;7
M3XU$.!;)J&>"AM<4B5R"Q8%Y=YKSQKLLZ)I&Q%XHF#SC2=8J,6=\/,AY3.$Q
M!_DDZC/^J;4FW(-XSFHTV$M(T(L)]$77BO1V\-1''/-2P\5FQMF1.8'AFKS"
M]>X-H)ICS^;)5K_<9JX-7^LR;9!@L)#'W]H"%:Y[79[Z/)2VP@F91]8M);LT
MSJTZ>47W'@F6&]B1E),3$9HVI"[D%&@&[& 8Z_7=F ++>4?DD<MH0J'U%\D]
M$_UB*7KL@$MZ>5TY_3; [,=5$>M;;W2\T,$Q 7XGL/((=?EG#:]>#;Z,C.7&
ME$6X">_; T%-UKOB?9M_[VD:W_OT842#/T]06Z,.RYY8XDP"Q-X'TWYC"+6K
MU_;\8J!K[$DE4P6B?O4-YS"@WN?+K#I6;>-GWPQO/H<ZK3W6%BQDA:RL 3:;
MO1'4XVA7;GW8/@7HM7%4%;B\ZU&*P8LQ:MI@I98J.Y@='[P!L0:91$J F#M1
M)GCEE85--P50U7P051U6>NYU5I$Z\1!GM-A5R9L>-ZFX4'6MQ<DU[.L'FK6X
M,&"HH@*P,;YH?K:&:XTS,WIAA,0:P-<"CN<VA,S> '2GU')](9/R;Y&%=T],
M'PC(OG;X.*YU.G_%,^V=G<T$U8YBYCLG_Z$\UE3IO;G6<?I/5\)&QO*^W;=J
MNAI7FDSLI6+<^8T+G>I-SZ(KZ3H1]CZ;FESSAO5LRK.&JEMU-B'*G>=R\WNI
M*)QN;;. *[4S6O29"=C?(I0>R4,*Q$LMBR2]K<MAWF ]BMT\2A3$3>@SL,>G
M]#E?J"VK(/V"E$?<5HDCM,\'K CK"1&JGZAINK=?E"7?)O^6V=O\H6<E7H4F
M[CY+##AC%;%]L3='>'<D<80%GH$F)8.<JD [XC@/%X?C\,U:NL8;P*-FW*Q9
MVCJK-VL"6+XO:SGJ .]3Z!CPL'F[-;SX@-M2O>71$U/:MYX:3$2>1/Q9O<@F
M';]^YMH(_D9,3>V[4O/="1WYY9Z-$3WN1T\U[\L.L_K03>ZFFWH&F6*NT<#7
MR#JG"TV>/:;'<5IOZ;=)N[LJM,$7,)]( 8C;\ U 2[9M\16:*ARO6KJ= I:2
M.P&_5(&WY(T @].F;YE5V1Z^:9$Y#(QIAX<\PY3%G )=P2 X2N+ >K4ZBE[
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MT]LK#G0S%M9SRS_M&UHBT)Q]9#V</N24]P8/J6Z;LA3 AJRPD&O_61A_"<X
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M]L5SS G'])W8RLL\V86+%:G+9_T6)H^//84];L[UAKSYVDL:E5-R"_,*5_Z
MG6W"%MM:@<1+V50VDO2/JU1\L9U7I=GOWMG(0(R#AAVFM8,)3Y?AZG<GCI68
M,5(?N[*<:=YK)%#9H!!FI3L7>:=7@#;$_FR&S00:1&R)F!DX]FW8UKP[JME?
M*!@_JP)_^8U$9/$)7Y%<L(V]GH5"&*)V3PS(4F(T+5PUK10KCGZ:3&.9H<TM
M5Y(Q$8%/73:/S<^B,=K$7@'LAQ27\KZ4<E\!7CN4Y,^I6RZCPA\ZEVU]5.-Y
M==M5N5G99LUZX$+]\EKY!1KL]3=".;;\-T!>Y9N3#RO^F3N<,)RZ^O?RUKWQ
M/'\J)6:S?#XZ:L155Q_(),31'VP5]S2I(KV82F^'O[U1H@"30GP8N.ST/=ED
M-67D;!23P@QO274&)EP!7B2_:[K!"+]HXC<?(U(:FVX_4*>$_S83W%$;*RVM
M4.4#U">PG%K%ME<[+#S4#!!"H;1[4Y%87,M:P4(%)L4G*21C6'!W%U%EJL;U
M7>M95CQ*V31#^T^!F87Q5%CTW#C#LC&ISJ]<LB:4,A-&.\_;*0K.<U"&A)S<
M-W.7XS&;CK\"*+A2<P7(O(<NZ&==ECR,;@0NHCA#D(&#B/ ?KB3Q%3>..QX2
MBE2!? M8M 4AB0A819JUL"F</<:G=^<LL]&J)G&-XZ+E^U29WM35J?7[DU##
M6N@J4#3]=)$\7UZ4AG)>4GA?*\L0%F4TSE]3%VM=$/%%N$""P_Y##+#!HY5%
MMDX>R[ABCT)XR=-FOJG%3N3@/5]&OCW[[E),=SBT4J>1H7A'BD[5:*$<=^EI
MZ3A:@=!*4%N*SDV:H%8Q_KEX8\]^HA=R!?@P CZ^,./3'^6=S!M_W-6<>G//
MWOAY9UH<@)5&BW='IRE_^US\SQ[,'/[);^3R .2:D/1?05FV/BFX<51);+?:
MM8LQ^8WWAQ>/).\KR@JIB(XV6G5XVZ[LDYERA$XVTQDVVP5W(68%;)58K)FX
M2;83T]S+8@VPEZ%A 1("TFE<RZ,4](_%A]Q8H]?_L*3DW$APA@S*[3HB"?1_
MFXD&!+.8B__G:AQO5O'6]!OV@#PHR)K29=UTH*(LH/15&8G.L'LYI9\>-FU:
M*!-<X(\0^EVK:?3=GJOX-I-^:Z_<EJQAD;T),N)Q9256F/#8IR:3,<8@M5^-
M<^Z(5)C74/+OUA:>]]A@&]KJ*YZ9LG*M*5%*5<W5XV"#]6X,>8G7164;IX?"
M:\DRF5;FJ2O ]P",F<4'E@7C^IK@O3TIR_6X^")+%,D-U24CZ'V&]9GN>?[J
ME%>Q'1C+FI];<;,\?UD>M/YY<C/JJR3=(+FB/#?>HGSJC><<%&2N">+$)/)T
MQ07A2(ZRFBU\\Q*O70WB4GVBNO&:I?ZZ$T8PB=KTU33:LD5T(D6V"2KWBG.*
M>([IWVV8C>R4<K743WSY6/6#A*T3>;>B5N[N9V<0"C'G3_BTJ$VU]9XAXK3S
M15Y3G_!\^(/U%?F?TZHKAGYZ2V17@"5NQ.3O_Z)1^K$2J+W3G_]^^.N_!0;L
M^S1GQ1[%00EWHB=!82ENK-X\A0 F0EWFIC#BTNFUM6/[@GN+<CS()"L]?*"R
M8>VU\ 45\F:ZE$PI^>!GP(_[!*(SE?EX:V<H+)3&"!S+OBWW-WM4Q[\L>0N5
MLD^]/NA[D/18M4^5E7X1395M=YZ^$,QIB%>T+A:;O:DZOCZQ2]CZU_TV-6PV
M-S'--D(+LSNZ$'VR-78^#@+[70&H>HKV:?I915Y6UO<P1U5)M9+,3E#(=)KP
M5G"KYH.8_8_*YX&@W!^QA;J@$';: W8$-D=CU.-#Y(7YT)L$(.BO4H]S1<4,
M:]3W5?H>V</;#A94R% !@I8MV'\QS$^L+&YY8B50X9G3CSTR <A]EPQ&DH@2
MWR&%R87)U$2OODQ<"P[/'JU,I_L$-8[895%Y(J9ETM[9,O?0\"G#?OZRJ(')
MX80 [&#O$U!?B?N=U8V;,9H,6[$^AR7;<Q*=)D-9_K\)SV,[RS<8;<>%S1DM
MX^/ \L8I4MV 14J<17NW/EYXA<5;,*!;<*TE&BP[PHED43_LH+Q+FN' "K\C
MU'<%0)LW_$A:SYF;PI%GTM@9Z"E1S",*% 46&1. N09Q[,&*LAO<!7#[0,:;
M=SD/[Y;+89$=*'+4(EAA=UHL?7=B B:+-A0AX[6Q8@U5>-ZC&"@2L0'' ;>%
M__5JWNHH[<L?L9D[4F7*[!_R3ZY.6'.-U7?JFCD2#5K725$E&A)B->H/&&*?
M-_U!3'ZQ>!_SD'>>/_=%$?GEL.NSV([(AM3]4!_ZB;E.Y$.:Z1)U@2&SV=5#
M]=5)\$8'E P(40'Z@MF'YHW FJK^K)]L#<CCB$[S0][;AO(/H7]%L*>7/L)'
M+Y,/S3-3:;W6_/?/N,NR(YX(_/\Q 6RC6H'\6@Q.@1A:OARU5#OQU<^M@0\)
M"TO=[URVN_V+T<''"GB51I&"S06["^VI)6KO&7&G'C^KE2.XSQ,3\&KS[O>)
MN4LHVX ".=Z+2-T@,P-%^.?L&HZ9.QZ>@(]89'S25M M>8X/[K9M*=,!-:%F
M(<X<V'*/:"%OO?9YT8:1ZG]Y]B9=I2MU'WA6P_H/@\I9<?!TK[8_V]..Z:S3
MP>/,&6GZNX@G:K3<WP*U/[/4;H+RLY.J_WC4=1CAR?5JQW>%_0R72Z(AQNH;
M0.!E@HQ=LN+(+[U]ZB%18"7>:_  @0PC3L3R=NT046NXV26D(ZI&)+8;^:1@
MYGS68+9CDB!S65%JYW4%<#B$5I:9K-BF- SVT7>[BN.&O+/\9) ]--=.Q"*@
M[4LS:NVX(WFN01[?K< \FQU<L(+?$R_'!]QF+UE:V%6@V?3IF6XLW\G_>69N
MOB\QH-7D*KY2KF0\_PC[H3ZCK'X^$FYJ!^N-_.O[\[.Q[H<[G++@#DN$1[4N
M$K==R[H?<BSHI)ELCVNA,P7I]F;1L1CMKKSS^?Z.>%:J'L"!F?;?[<R@.PB>
M#+?UX-<23#7N\6#T7/UY>CF0EG$):LK.!(;&]X.(%/Y>'?7^0=L2.@[2?N%R
MS;ET#VD*N7V%E=+28IZ1H^Y@8"W?ET?%8JE3MSL;8E;G4WEB'[$^UQ94(\D7
MS<!-Z:@"SQ8V"LX>O815'1.N (-I"^$$S@S.VNIQ00_R:&'#REG!<GCKYZSZ
MDJ=+X^?,J%%9"C_88$WYLA.-*0B=['W!";)"1M! !+C?D5M&P7:?9-G_$?,?
M$,/N+;"J+VLC_"]N55XHI(Q1 CUW+E88"783?C*7!<MF5$87ADF7/\8X^/OG
MUL_"D64JLQZ;(-<(AN3#_PH,7WP74.>7-^NTV?""?J#\Z1FAWR>TP $KVES@
M7P/=F)^]W?JQ8A,CZB71,JRGX7Y/*5N6M'<D'2GB8_O%QXJ=GK^THO_X0C3*
M9^QX_WY//IY7@:++V=A@!#ZPDY;0&HA'%?$QP3%/'+8*T"Z"@HZI4 ONI-36
M$S242I#PV,.+GT?\X U21ZB;@OU>+9/D*DD4K( O$->DU%:?_PV.KT \%:;C
M,=3Z&']V3Z1[PBGM8!RV6UCLN(L<5S>9W/R0T3\T:E5Q)-),0GE9UVW(U*6/
MG8R^ MP]#:G>Y=CEL+M@):=*K;(A>'6_4Y">R$XQ^*^Q=B%/@B82=TZ_7PI'
M\)/M.'$9@\NX1?I9W*VY20WORK.!L#/10JB>Z1_,#_08JR]XM%X4G!JX'0%N
MW]$XEGYJ;&ISOYEJE =KB==_9%?=X;1Z2^7L!]27#U\UY _Z=04(=BN;-U+/
M ['+M#2/#-B((8!J2ZZUK53/"$/2MODNYN'*%.:G&/(W"9NN#\WO7&A_>]ER
M_PI@MWM!5J-@?RC:TF>MX.7%-(-QV3?SI],7GP'CO&@B@'=;7R1Q<T8Q'\T(
MAS(/Q77WJ!TTX9*_CHI>?@-SV3\0X2E^&V#->FZ8-:)G[1N;%Z/T#LLJ;1$H
M9G$?:(Z,]W$4U^@UZJS< *Q53J%,HRX,E?.,H#9V-3Y>J>O^,-+0@9GHF0_W
M5V3=2ZKU?/(S+4:,!,^)? ^I.AKTL,<0C;USX_<R:D@=ON1-XJ=XH_L9WV,(
MRU7"S<S;/GOQ;OGXR)Z'/C_N__S&T"=)SX$W;F?]&S1$1B*V>:QSK=<G,[%M
M&Y=>EV\I+#L4II$!')F[ 88GRL.U,VM[1\[!+N/@[;0CT_VNT02(X]#TM"YL
M%CTB]*N*I3-W,8X*G%=E'F2ZGKZH<-_>Y+*[P3:W&Y:V-RK7(5,WVYGPZO/K
M#;[?=+#UD5U?HD7Z]Y1GIUZ(EG+MSH:"S2 -+*(YLL!4+"MP2HEN,ROB@?P)
M"V?:T:!K IZD$_9'/(/[8&TH)T_T=L(HFSB+)>_=1\9H/E97&?3OD0]S:P.G
MI'#V#Y_,(%],(1V:Z.2-CW\0L%G@F?="BY-,5;?X<5MINEZ'_(O&\3583\_A
M/V.U?PPM_YZKO;?][18TEL4)V]DL0N(P,L#S'>^3BJ7478[V>L,0@HQ+8;@0
M@D["\*"W75FW6]W*RQ0\%^6)N>4#8/E "6%<74^.@*(74S;YH18R8:^LGZDH
M,G*B'R^B;LQ I+?U,OAS7!W7+GOM3BXS'J@;A?)Q,L@>')?51S#$K/B4B/XX
MT XJ$VO211F->M15@S^/B@<+Z=+_,A'G3+)RI-(HRL??7J>BMF_FG/!3]BAV
M2 Y\X_TXV%)%Q13\1I<>(+N1X ^JR?X._P-K7F<+#0WH6MX%FE\87 %V[WZ*
M[#T\6#O[>-0@NR$?1#_$$5K?G5DXUQ(J:^N5NX5.1'1.6EC&.#/% /MM+GYM
M5)01(PQF^A736KXWTM_YOF!XN,_;$*OSR\:I^GXMN!8\F/FSXN^F]'(%>FD/
MF=N@N&3!/&=W;BGE8OTXRE"3_9U:=&82&V2]Z68$%-M>@3*%N+U/:3_8>H]/
M?!]Q(MIPH;EF;[2:^=.2U"W*GS\3&CI-+,M&=\E+U4^XS[5E#)'?A9/62G54
M6B4-298K9L<@R>TM4P^$@Q;174E=\-WNE"+[LXO':V42*G?;= M"]+[%^3_!
MK@>7VX^:RK<L_Q)#B8D_8WFR.W+GHFC\ K;U)'OF+#A6@8-*+/TYHCS$S]X[
MUYYR;3"\*@8J0)O [;EVQ]2C&^2KA5U+"6[D=BLP9C+U=OTK,":^Q1O_36#'
M-P&4G:_)K$7;Q=DGG?0IX_?X.\&V+@^#9^*Z6L>RH:T9E.A\[.UH\> 5F4&N
M2<RLNEP1(F;14>[ME]F>#&VF5;1_'IY;;4SVD7!(G[J;K73+M+EG_Q#J-#VV
M2"&%OB)OR]-'*,4I?PM[)IZ\5?GDE&&Z^1=/(AZ&-!DLDOCWJTTRSW]D XNG
M[3+02/94H!9>&LUAH2$3>)1@;>I,VI/90S_?P11R=_F%;#"=T*F432O&?^M8
MM\Y A2_23^X*0*8=:CL:,'%B(;8"E>A?B(Z!CW&7S7J4U-=D7A9ES6\U.R6=
MI'H%#<PT.*YQ2_:BS'^5C'^HS8?Y0Y<BM/)A_QTK=X&E? V866JB;%\PA*%T
M1O3E_Q8J/^!YD3^J01M(E0]E+FRA$N.?&12_1N<#Z\D2_X*YO$X!L.[='T]7
M[PY_2Y"<5>_Y9(:C-T2GPO>/N). *?D+W"D'E$'+Z2IG-B.R-N>R+,Z3&V]#
M%FDQY!]C!R9BR?&F$ ]AWDR=VG$$_QDITBNQN"C^ZS1 ?^D5VRUW.EV3+WIH
MYU*%>__IJG3Q==2NA?U1.6_]PMI.S\^UFA6^?)<,7)TR.Q3M[+#.$2HK<\TI
M!%B#?PF*.#+.T]234M6_$)M2-"2"CLU3SL<;\//O4VN+]4QS3>;3R +%SRS[
M[QI*20U)'YA1T)7"D$G-)M XCY9THFV&D9_D9"D8K<XN-4X5JN.'^*-I-*K#
M<2I[<&19N$@2,?,'*Y[IM/AHB:4 E,H6R[XH_OQ6Y'U79Q55^8EQ'2T,S/]-
M$@R4M=&"+</U-TBY-P%[#$^G^54L&3*M8R0^10$.RP=6QEU@,_)W*^JP; 7!
M'F3F$/ABS./:*&]'-L ,UZ%GG(H/;&LS"P._M",#6@8CL$Z1V7710@%<YJB"
M[M:PA]K!CZWOY&A(R3J_XZ_/CA!B4.$+?]GDI(<,=]>F;HY\06/<E>9UHX?U
MP:7,,3?<!@]M0]8P#T\B]A_,@F"PU\-*W,"\1A?N!^_&W[UPEAKTJ'Y?S8)6
M<;ZSM%=1@)%P6D(QS6U)>ZSNNHBE3*VDW;9,/OS7O.Z] [)H#[B'Q.9@EF7^
MEJV,VQAG[I((4<Y>QV; :/68S<5,F2Y!'=BW(-2*\SHCH!1BKX$C3Z0&BXXN
M?PE_E(:<,A^2B;U>C14-AT%ETLOU%)H=@H48(OLX^UF0W=Z>DFKMD(E<6EIT
MD]LP6E%9+*_Q^^AXQX%V*'2)=PR\0YPX<>+=8X$3S0EGCBR.+Z17F':!/W1>
M#_L[?MJ>9R/.C%?+H!#>"O^\,AW^7=-6P.L&M_B8.I18D;\UN,A(V]*;IA_L
MPA1C-)/SE)&K5$?C;XD[1?IYAC_55S^M@FRC+8L'3G#W[RRZTYIW;9)H+TI$
M79\_O\-J:"V41#\4>*XUFV#:];@.F;0F97_#+#<1XS-Q_L1A.REP9(ZU_!N!
MZ3K]/*('W!RTB\QF>_,UB[BH$\*RJ)W)-G,FR[8"6,RN?>I),9K+>@+&]4ED
M485:W%)*INJ8OD%9HJ3AF$:=7U@/]3\#;7T#F*X@E$6MN2GS_1$7)*^VKLU;
MPE:JA^W< $X'>R=;_@G.-M*/9VGK:*L7J-&UJ,ER>9FZ5F?76-GZ1-G4"DO_
M:EN?P+8HV<A=B$FQ#T"_WJUI8XK\6/-=]'F4JUM_!J2L/:)D>Q#]R;4$N.X"
M*PCQL_8NZA>+C5VKK(RO%(16?HS[C7JU<:?@M:*8JA%V\"1VR8R_(X"M=OQ-
MBDD$2PE^]1-7D25/I4R9^%ZWC,?-IML1FII^+7=<FJ!EF/8;B%<;WV+>@7X=
M.'UGZ4RP/ZWQR3TW*"F0D8.OJO',U'X*XG9N/>AR/]9U6*P>7ES$^Q9J%]M+
MU]0MIZ8;ZHR5^:UZUAA]_A=X3\#N%>DJ30_?VFG9M__!GV02.'I<@.?'XQW_
MH\:FTL/R%LHJ>Y="0%U>S#PI:R:'PA4]K@DOHF[?(&[U3#9$/ 7B"%XLZ//=
M:Y!T;6;":D"<@.,(Q:+9^<%"99JA4]D&M=3*U0W6$!([  7"MWV>G9UQ3 A,
ML3!-BDXT<_K/!3+6S%H=HTQF2Z'4>*#* 3C0:#L9"JJ)47Q6 -L* 42MJ<F1
MY>^/C:WY!B?A< 0!YWF247AY\R-(HEF5&V\2R!EKM,)"6HXH8Q(99P $>$S@
M8Y4.Y/.\6.LYHCA4PH30W[>&9TLXW@-).7KHD?E;R=+RF?0AZ2 V1*D2&9TE
M0+]>($''3*%\>_6Q;\WY-8"C!];]))9NY%"\7M$=SY\48U-[TE!7&_U>NK!5
M7WG),+%'#D0C?$W8<;<*0@AN7OGVC\*!3[]\KA,)=-5G.]/9E.KRH:#SJ-WY
M.+=9WP!Q9)/1/A <A!->V>HDS$O-*PUY\=__F#C#QL^MB56!7U;9%N%3K[_N
M:K*05768<0^(U5%EKI/7BY4VQA<-4F9SY+>W3,2Z,U?#4L(\M'0U)V(PESE5
MB%JOSO<]AR$?9(66R19=GX-*LR.D>>3AU^NUH\GV;7T&&U4W$N88+8L2G8*G
MZ4JG\/Q1!R:QGC./C!%(G/+PJD L#GZ<\2YW[$4_5XI=8U?;$%#(;<A5%+;S
M)*\/WK_F%.>?)]1 Z#/1#SVQB;0M\&ZV_?=;S6^P=@[Q:DBT1Z-SA$!O_VG1
M!@L_7G!$Q%L;<]BFU,HP+%HM1N%0#I@G!<(^N[B%(SK#9__MK J1/><(A6W\
M&TKQ78&_WGYU2,BR ENJ&XM$PR7/PG#=DOMFAL''(DLM][?.G]=>O*H*4U[?
M^=? =I 8.X38+(!V"@3^WSLF_G]VD0B_GA!"@)X6-(YNC.5JAC\RRI<2*IZB
ME&1]O@HU1Q296^=B8%&9]_P,(:>G6AZDYV$1GK\BN^E3[0R&5&0L\T0UL*%A
MLJI+Z0I&XW[@LFF,[G1NA;+E\XB[A[\+K=I>>/[E2X.E;@7\56@R?;B^L(AZ
MG]TX/=,C_8/C5F*GVTZ*/O5/^HBOY1*_UOBIQ\K("B0"":IY6[K;U) %D]K)
M!!+^+A<N1.H?TZ0'*VNLEIP;35+-YC8G%FO07H8:,XNSF2,Y]HA#4+JEWK6/
MH\[!*.DT/!Q--3OELJ$1W_K!6N/J*GENZ+LBM8[ JM2Y. G$#;)]'TI0Z3)F
M?-1&ZDI!S\&5= Y-:D_=<-$L/YNJ*'=(,5%)0XK[F)[_R(>L/'_EW&;\57@8
M>P.U- -W,$S#I^BU!"T9A'I3X :\=.4SV*V2@FHVM/Y]='5+S#0=GY=L0*M&
M-XKDV]4'F;!L[B48*KPH_AH:,!35:NOH"\N')<:FMY 3OZMHJ&OV70'"T=O3
MT4.)V686QEMC#H8/"I_:DW7\[65DY2A_-Q$@+DPC\^AU'YG>N*]A!J1 HP$;
MVB'\8!"\+.AXN#NL@91(L<X-6[VO\H$B:.H#E+K1_IIS<!E!!<UETQJ8-ZG1
M;]Y80RR527??D\UV?DMS^5O43"SRQZQM0Q,)S'*\$5@X2P^S?/QR-/-"Q[S4
MI*P2Q>7TC-D_3+OJ,Y9O7#(J#<XN/7Z3^Q$%WGZVWJ!E*-UV,^MHB^?+O^YG
M\BC2.HM4OS;MP31LY_W/J5L;T XBQ[LKP",+Z/;YD=SGB%[L1.*47<6;Z?'S
M]@1SF;^_C']1*=9!G. @T5NZ Z\+F7A.LC;)YLB5(:KALHI+VU).0H;+ZS7G
M??Q-C9ZE)F/.0^,B/4Q**-9,);.0*OCV=&R'&8E^=<(>5<U=GO&-L64:;3J!
M.L]H9]^5W[U,>5"OU+&#(T+W<5(3E$JX]]B''T4@L\QO^M<R(NM?LEV3=1<V
M2MQY]R'C>V!67.SK6SZW] QHO.[Q!P\CO(^CH=TF 05> B/&DN/@@=%D?I)\
MC<">KTQ&EK]+RT.9:^"417(U+;XN_)@:S9(9>&=>8Y) VXKI\;U[K%0F/\8N
MRL^V\ JU+,@%IWZ++O^-@A'SU_,OQE]:A$S'1M@TQ6F6.#C6:#L/<@%?HQ!,
M>L//DJ?OB V8X?>5AI>(DR/RC[=]FHNC2D\D#M3 92HJ:_HBWSB8VNY$,)3-
M9_JJ$Q^BB8"%E,S%W7,[?W+3C0C<1=,],)F@97!W5E&/K3 L=U?EOKHI-8JD
M+""IQ>EY;4V$!R,-I[/<"U'3.UWQ/I/-3&92HS+=DTM&YLJSQ5VF-U7]/+HD
M/'@:T>L\8Y&@*D*9#QO]FOS3843F+7OAY51M)A :;5"I@F9 5Y7,# 1/&-UM
M_YH.Z?(T%VFL">UHV_/3O,ZS8U?I]2T-)^[ZLD5O^=^V$5K3$F<43I:YV8VJ
M[<W\8X($_QS[#-:#YJIE<ID5 2_/\R(OD;C@I)&YAZQ1'PT]LLSGMEH>X 9O
MGV.6(8[Q'FRR VN!66=6T>IR)!\7W6\7SW@O8!\W6/0MA$_KF'M;+[.$BT$9
M(=F:OQ941[E FJ!/CZ@;.O/R_-SYO/HS'8ZF_,!9&$_U8HP%':Y!T&5L@*$F
M3J,F3F3U4=0;I6_#"=Z%NJ-$PXM]IPY=^-G,8<L9Q^L1TX6OC4H2$7ZT^:"'
M]R)E#^*%VH(%<HLX/>\P%4 V+%([Y"G'Q32M#>JB7[]BB5^7N65Z81515'#'
M:?M\XAY5ZCFQ@24E4:SIQQ'GK9SH-)(Q3IM*62:X*3ZR;=J@W#/^<=?L376&
M!Z]O^M_@(2+^:BU"'QAMHID+#VH0;J7D-MZ/:N--AE1F^LXDSQ2WXERE)Z4A
M%83'6/X.O0[7FD1S 8,2]Y&SP%F1Q[DS0SM/>.Y[=/%/GQX2@/1[*V $(5$N
M(N+LT(G=SH>DHVA3@1K1Y' QI"W?H:O.S#3\A_(!X[C**YXH]JDR]+)A].]1
MCVA^I5JT]7#IWA(HLF23Z\5;.N?"GP;3ZJC!&!&MS13X-2@I-;?$;OIXT"\W
MTQS4I-BO@/E5A_TLB_ Q'3K"K >82&Y-QR4O_M*HR#AG19,933FWSBO  UGC
MW$QJ!Q//>(>3'?FN)\;(ETIKJE]VS',77;5-Q$;GG/ F5X"?%K['R&4??_K5
M>L^D9?M&LV*\8..GHBN E4D;VW#C;#X^M)?Z+-=9DL]3M'4+*$^OI=TQK]",
M;3R?.($7I,L)?TQ\GS@ >V%:I(MG8K4)AC>>G$$[GCNB#Q?.SW*&[<KO3S9Z
M9V^;/Y[8]5A@Q<RS5U?4@4 @K:=6JHFV%-R]%=<L<//"4!-[VJ,.+8#$B);(
M5]GF? ;ZOS8:<-6B?CWE_.KLFZ[H-UC2X_[!-6@*;AAL8MKL>9:1;KKQ7>RB
MY8%2B=RL<U;5^$95;)_NBS!GLK^RU[KIV6JCW%*35Q=,KB!"F&!;9FP^7Y!Y
M"Q%5G#Q<]%=9).D15B0-5W)MQ^7'7YI]L7@A-C59]F:0>=? +RI.YJ9WB7J1
MF.#HI8Z0H3J\_%QTV"[_K5K@:\J[>J@E<_7%<BH0\276.B:G%-)OCKCC.I.?
M[K8FHO]90FV5P37@MR6]3$T#W?%_#<=-<1C^(3^YY295#2Q'N!#"-ZC0S.ZA
MA/BRS0T3YZ_T<S&$;Z: @_Q@E\_UB)XNL*/P ^^ C\B(>1V;!$N9^_(&C#==
M$OPW70T/*Z$^]<-B9YCF?=%-$_[!\D:78G."./:2F+X&W&8^_C/]9LV+1^C?
M?;R<,UV<?%)5-H1Y6VWBT[CU06@8CNSVVV&SN=N!KU6M9@Z/>MMV(TH<QK8*
M<'C_U2+>1#,/8@M'[<Z3_[-(&5P! F4M"T&PAQ$"[N"WVU[,GVVUFC.X8N57
M'RL%WC9ZSBW)5/CN8/VPI?_<&F'O>C:%T^#OE14!@TH6@$B"@ 6MXC+],[2T
M]?$VX_WGQLH-G(RGIA%3^' W+W:D)656*8A9(L3\MJB%_:M0XU-G'N=2'9<%
MQFU805XC<;_QQSYTZ[(G9\2T);#T4]68-0S5E9+!.;;&V2$VU_[.LMM5MO6V
MS^E6Q!&4%I3!6M/<F &-]!G%. Q-8J<JQ$?BWHU;1=^KD795L5<O;%#87I6\
MZ#V]Q]\O5DX'DE"X_1+L,^^I9> M\ \F(1+.V/<[*';)<65X<B> ;()YB+B\
MWS4].YVWEM,5MN=7 N&1#8D0([$G_<B:&'4^EK0RN$8TY'VAB\P\F]HM+&-1
M/T@M:/^'F+D"X*\ 8[\36*JE4-/<9VH;=5\"/)"+#7*O^]M-?!R0>J88&M4-
M4_6741N^A"Y%.< 08%/DW31B>B&60*$H]S#]"D!Q!6"CP/#+F/\2/.;_RS-!
MJW&32W[ZPN7&SH+$G8-RZMH#Q_AL3+(>!+JL@BS%@'WIO!@,HPZ! U&M\@MS
MP>9UC/+M/SQ2A'&%JV>?5WTOZ3<"1!+-ZO#12Y?<:A/K8UD-E742E)GB]!KI
M;=K]+7]X6*TF@-&B'[!\$7ZR)_-/)CTTV71/=[S$ITN7_1ATE1ZUSD2YTV7O
M.TDX=;?Q@<[8TTW76Y;)F_@[YUG&/L8PA.IE&.7;ZAJ_[C8"MP%88Q8G'X99
M3<AJKY3CE040D4V\[:-_'??Y*C]6]9I%%/,O[C*2KE<(5\MI=EP!J/WH[860
MOL5;@RXR;\Z#R/C"._DX>P&SN>PKW&SV'8;L@U> S+. &WS6_.X6:T1;^(BR
M\_5=PM7]=F"]#P<(5"@8N\OC^;9$=B6*7E)().A452IW+D)CPT796Z%#@18X
M#VEY/U*=28MAYQRY?@WN3)W[-A%:>.O9OKR0NW+/0'(RI@<6D8UF!9K+8#WM
M4;"P)34\:H9W]K->M=2=S_=M[]U6?WE>XF%X$;9NYCN%>\;_#3M07QXJZR+Q
MO1P'@IOT@81K_IG./QA31=14RE UC;-.2H161WMUZX*V_)>;/O=H5T_L?4)J
MR4.%]$)0@X](=YE:=;ZI7'BVK#@-^#K-+_C488X-*1:W!PW?'0A5+,GIZ:3H
M,;SO<K/W?LX.>G/&8AJ32XUN^H@7U4#[V6:I>A=#<@RK$34-OSACVE?ZO6OZ
M9OL?W?H)O6M^^Q:Y8?YDR\HG\P7_%O*,<F7O]=]BVLR0L0_#<$3_+K?Z*'>X
MK;]<N[;LD 35_,>D]R)C9?;N'<5XB>YSI] ]C]0Y"XV)3S]F^@/:U9>211+(
MOTK<I()J<%]#/ 'Z-^;=-<1CKP!B;L.%Y<__HQRBPH%YXC6DLN<4V#.4.[8:
MJ]> !Q^<Z0QY"I.F4:J7G)--^/&O%#8*>Y6:.YQ[X%)GI[7\VC;"A[_VH;[5
M/E#,EIY!.?40?JI/$RVP"H/LWXR]8'D3-4WY6P?V;BBP9R63TP-"\MHK3HF+
MN5O.X@:P*T"$WZ?E0<%&Y4+[:;D\S*?2M<[5:LU#[C_R)O=I6U=A4RT@.'^/
M^;W13^-.>37B:'7A=!F1VB>1(8E5$G[QXZ,FA\U7@-6%38HM_FM?^(UHZZ'L
MW=(IIZH4]/[-9, C!V8Z\@=7 ,4Q'C*1+YEI209^K#$B,51-'_!>)2WAQU<
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M73PP2"UUH,%H_M;ZN9??FJ 6%?#QOF_\F-B& 5%JV*/!>L(C,WQZ_E>)O)E
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MO-$P:3"4;;S"T,MT.("\CZQ12N$B^'"Z2%3_HL$OV7-PR-O#@!'JL[(R:AQ
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MU!QLSJ629M#7]>_<DMN#MA&)BE1$#YW>=!AUMY)RC/KUZ\P8Z%".IS;!E]@
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M6"BI6X-36#L:'?Q:@4<R4?P= [-,FG:L'SH7P5S977J>5A!":=GC>7\%L&G
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MP2^4_85DPMXV.U6B2!5;O_B/,(XI ;57"<7X+4E<GT,IPFDF)!+E<UF#2PD
M ,DG\1,#TYJU0$=>.U".]OMN(@L*J[4E$LDDAXW+ FZ!VAL.-Y8&2YK6['7+
MV"9,W#(]_+&::&VEK2O[>7GEOUX6QXC/^;C'$<._T1,57P3N $F6RX=7IV8;
MCFZ"I';?'4B+%?*VT0OUSP^T9W#C_EOF=MB'0%I2:KR0WQ5QR>)**%0H=?T
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M?;L9+#,71"J2X?]I0K$I:P3EZ?N$5ZG[K;XY"66]MHN/##<_=#%U480:.=\
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M1D#B]_E7IA2"E!.A$D#FE0" &P,E?#7!4_L N^"__W ("_03NP$(%S7CLF\
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M0.T8/'JLOQHB12-VYY7JX[]+QWX:^5;4V%AES&V5^O=TQ!AR$W"#1F/O#S=
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M"S=G/"KJ=A\N)O6)+]*-T%'HBNR28.?IED'8ABV1'\%L@9)N0S!*7#2<)5H
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M72SN2O-(3JRE\0D;+QIWR6E!*$!%EPP><]K; H/4[GG>^P!X)OK3_I-X&'*
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M"JC$DQ^M,]R-YD,\XM_9K/#M?.X<(9(A $1%AY^L:VAS.Y;?OVCNK>J 6%M
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M!KM8VB=6U527%DOJ$),"8D=4>GNAS.NB"$B:,/'W,#^^*!(GYRA>%9_B/YT
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M.QPZRW2C!S7/@ AAQ;(<X@SS9.G*)DPOH'R"+87W&R1__V[)W!I8R0-A]S-
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M'B)@X]IW(COK&,*<>L'G<D.IYZE3(T&&9Y\?Q)X!!D"@9WG2'@Y(PK"/TI1
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MLGRQPAXLZM2-SXJV)0OV6U;@7MHU4Q^JC$?*<X*4.2F!3C'CE.AP*4\1*ED
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MRK7)=;=+D8.7H2\BU9[\A\P?L=@=D3^V:[4/ZN\V%\8NC<*OF^<NU2_E!EC
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MK!F56R$804(TS6%F$\OA,X5'IU(Y@KI!2<@*P0R"R*@9-YG(:J=^V+'4 ^"
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MI9<9ZK6B8=/\P,3;4TKC(E]PKE1Q_>?:<T/H]\PF AGP2/?"G91(R.+YSC\
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MUW <E[IS<2TP R&PUGFQ=> FS<USS]KDBX3P%U>U=H?/KC:I,I@FZ^1B8X\
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M9K&O#4)$0V%?2<U.S=_,Y8W*</V$ -5'&Q3?Z\49[*I;V-B$JI7*W_1.Z4&
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ME#7&Q!0_V'$KC 85Y>?G('67EROWF5NDYFB6Y#]=W3^KR%]58"AV8T("!L/
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ME)$2ZQC*ZT"YC2O9<R2)*SN//*:F.-8_0$ZUHO&, FSQE@QL7Z4NK4R2TDT
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M^].3M"F["8MB9\DB_?: I,ZXNA"0<YFI9@#(BPK2I.PUQAMIR+RS*%,4K($
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M\(?HP+*+FF/1N!K%K@%KURD'WFI]%*CQ;);<>2+EFZH_;N'5E*K&GF9&CXX
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M$ZI']CK?C-<U?9PT>1FBKK)7LZ+,J,!P_O;_\/:607%]WYIP$PB$8 &">^A
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M[N71\0#:IV.2C[OB8%B=A)$;*]6HE(B7[N P7G*LK);]^5CHBFRH,//;Z/(
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MK7R5T42B/[;#BEG-,ZH)76F<OT$W,O^MN*9=3:I2@YV$=++,@J5OY3KS?+X
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M6DFZQG41US)XQHIF)X\_N&WLUQHDS=O.^9CMBS/]0?AO^RVU>C:-!OGR'ET
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MO$+WGCTXUK=">'\=I&"#X"0*?%02IJ@BP<$)S&:F,4J\7>@6/Z(%J!F8/KE
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MSVYSM,,?_8C,BKSHA(GH6/[((WCO-7O1<:K!U"V=N1,(XEU]/"2;'JJ,\R;
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M[:=,#KL:4NX^IXZ\J_WPARSZ\SI6Z787R/17U\@YK3Z(MWHHX&.ZW<%J(LB
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M/%.4'.D+(I)9U15O^E!52X0C XGVECIS;A6NL!26&,;E2?=^#>8?$8O]A$0
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M@"8>-H*F[;&C4W9+97OJK"\!<A2L'2?7/2<$,4ETQXQ&*TMW_,Y[RI\H^AI
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M2NL[+;1:!QZTX4QR>/]!]G6D>Z'#^9L/492L1L59\OLV\7U,$<JT]L:_"!3
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MP>%\UD57'MOX7M\4^R7N#KX/W;$V[UT29OYNRM+EPJ[*8V06M_^JR]_Q;C0
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MB;.A):2J%N%( HW84M?A%&:^%ZSV,QPI#8G?E77#,+1*)8]#N4+,=PG,NQ\
M!7_2EI@03*8]9P^ 3V87FEG.I8$QA8'0Y.]DH[_05%L*1WI(EW1M$ED3B]-)
M9Z,H#6V(3CD-9S=E1%IFDV(^-"-CP7[1[U+MC6JV%X@=@XL4)Z2T:XGDKIAR
M?>M4$:[WR2'/_JN5P>(L'.GZN@&:#9]7G >?[#_N(!+]BGBVNUY<^N':25M'
M=ZD7D\ZX:<#4F5%$Q"SQ*[6TT=&=N.:31^8C8X7?UWA(^-YG:'BB^LAZ;@74
M3AR>-4'41SJ!]OI';X@ZMP ^VJDD+3H86G17TEIO>FI[]F3 #P!3# U4F=:-
MUGFMZ!9GU?VK66B80.J+\(WO#B<JZ!8)<5%S4[#^11ZGDT)H2_*G.!*L^(TP
M,1+>;HO;4%-\A2V'\"W*&,"+2K,7CTS6$S!RME?L7>(G."*1F$ 7O @%5ZB3
M^+%YXBNC@0.$P7G@!%9J=7OG;>XI'1*LCM@Q,=HQYC1%2#HX>QP*G>EE22G]
MK$AA>AK0,*(3F$TWM?;/GST IOY-0O[+8-[T:C\-"-=T'-7D-5BZD*L<Y-LP
MU#6>]O-OWN.XY*==("U5:M -M'LV;PZN9QV@)C7DZ!O<+#9X%^O* )PE?;<E
MHUVFX-E";RQKW _2#6F/7IL]<&EZC8^Z+6TSAWWESQH<"BSRLIDN_A.]0.<U
MV58SK6F$OIAL3),QLF.KZ\*>'''$X2JD,_$W1V+T3GOQ*P?E0.0N@:5)-<@,
M?5$H8DF67$J>!SP8*MTUW$.WI[MH+&*"0C>H/X1KYA6OY 0+:D$:/T%W:)NY
MJ-*.(P$?JD/[!;^%VC\ 'F_+PQZ7J9#Y:Y7[[SN4:PF7VV7CFQ[KC- H K(@
M*6A"%F.4?SKE'V:>MCZ9>VP8,N61@)8&S:^V^% ?37%A/BWDA%K"S0*3+NH*
M3,.41<P6Z6PI*2,DQSF.@2L@GMIO<8'^[VM2U,+3^XZPI(C>0/2O[HTM::G.
MU<_:]M?YE^J\@C'[8;#;HH/K]D\I ]Z5S9;=4Q%2FRY_Y)VLV4K=;Q.A*>3Q
M4KQPN\2K.N*WWGYF7IGO@-7V\M/??7@7K/S0I 6' KV'$O/6<HQ6C?N$JWD'
MT%.B7G?G:%%47;>3)=LZ9<"R]1*[.CV>Z["#9TE-/"@ K["NCO5" W,>9_?L
M>4O;Q$]7)!L__7W&<?(=@ V5++RR\'1\P9QZRYD _CU$NV""SO+MOLMIZ[18
MY5$ R[]([_?RCE#8&.GO_8P5S;9\K,X?5K%Y3*@+@ I]HA\XO[#<+W[@\]'M
MS1">/JW:>VZO2=8KGBR:@JO7I#JG 4]RTY!+;?I>(?2SE@LKNO$J]>K7=TOJ
M3A&Z5T%V5Z6.J[YB])CRWR;.#)1:$%+7U["W%*X=N7(Z\DRD ZG8K4Q2- C-
M.2FY=M?X9C"],B+ +T>KFS=5[KQT$!;^OB5KKUQO%(T@;72O"T.#Z6V.ED10
MNW?Q#YJ]M6^ZE&/,]ZTCS 53664' 4H)M>UFF;96-#^'P.V*'<?-N(OKYQXH
M* N7T@9LOP!DQCHG1!^'XO^HWQXUY&*\,.3IUB_VM8:)H_.,@&&SP+C-MMK(
MKWS[)V0]7L#,Z-#8J<%DK=_WC9F23@6%VPBV%JFG\BS9[^%\(:JR#-;Z]HR%
MD>OJX-FW9#0T+A1.=%QU_V%P/4A]4TMSBWD'::>5$+T<!@=/T8;KQ0. ?\*
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MT(.GS;4\FQW05/@>Q5Z$'@>S#KNMM[0\9@3'K"(-8<FKX90AJL@WBD_>XP,
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M8B338+M/"EC>W0?Z(N38L3"(8VJMU^7P7KSNS9SL+H[EH\9$/  .&/.:6^O
M\5_T>(#Z_Z :PJ,6RCA'XY_J]&%8!2T2_8H)8IB_QP54=2D+KA^,4G9Z$8G&
MO.DYEZF>--BL#T0FJR;+?S0)K&]W.J96%D]L(R9\D6!C4W\D-BV<\&C=.DFR
M-ZX5_*)FS#"6E2?K1<NS$K/N02M ;_Q,"3@G3L<*$$?<E8^7,0+.LL'<V*JG
M?:1:ZZB"S-I<"]1%3<Y#COU=)IP-?YA)[\^J ZC+K4 \IA]+IQKCIA:N3OB4
M,M:EU:XE==T[AVU'=1M\18#?>BEWXX9G4<Q(6?-%S:PR1^B%F4W5L-Z\_P/
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MJ08';9.6:!23G_*0Z(;5[%5%+6]#R@LE1).;:J\WY:8/>(+6>$2GM2MB+E0
M2-D9'[D\8+TI(DYSILS$F!?6H:B3;-"0:52@HGH1C,XEE>+DFD[QN5RL;PPS
M8:_^2C8&13A[ G?\ZT*A9Q?HT4%;$$!;(_+L4>\CD@/DO(4,^/P1U'W75,+=
M8/<Z. Y7PA_>3QTR^/A$\BZ"TS2^8&>"02J#6*^?"T*!![4GACL!-A:WA/Z8
MRPGS]53O#?AJ'XU*<K0PZ?R5J<<Z3J.;%?8<R>$-]&-+Q=UR;1S\''X])3D!
MC"F#IJ.5--3;VEZA^Y3.;<$&%PSH>EYTDGM7R:00Q#C3G?U\>K]"V87^=5E+
M^DE9$!L%TK;HXY)-P2U_A7'UQ_G;<TD)S@QPM:%]@ T\J=23%E+"Q,<<#?!!
M.]*BJ-7JW2 1XJ/D)G,W8X?1B6:H*T;($<FC$-1:% ?VQAT, 0Y3>W'G=<^1
M&P-FQ&<_EY>$[9WI-,PN2P*-5I/%V^#?<@-W2 _@,I RY$?-Y'=SKHP=D)!4
MI<!;H@5ZZTE:WLX>YF>W7%\64"Q(4>7%J,S@.OB0?X<C ^X60;% 1#4RQ?2M
MSHB0*K=F'778^)$'!=TG*E$#?"CM_U '!<R"(,YY'H9Y2**BE:ZO>[5I];B_
M<S67I?POB=R -$-XW3V+@2RE,'\A;\02&3R(3@XF-:<OPN:IV%0^.4!O:9;X
M[4"DFZXQ>VY.-5_<Q;;-F@/]-"6>\!4FI92>++&?Y%N$X(#TP!K<'!C!T-V0
M.R E=_4DVM4*J[@J.+T'_6/QQ0- ,O<FZEY\A^+>#_42@>87PIPZNJ*2K?V5
M4G-S?(K&(F5T*G NB'_>F;$-85947P[?7W))^0D7==;?\CP<DTUT17KVP5 T
M^>K))\&.NFW>/_8=?"?%]:;<, $>TH(&S=)/E^22_O#89 W]W,U,]2^AD<S]
M_ J3KF"J4C(8=N_"YM,=FFK'O^67,;\MFV0)57PC:_-%J1BGJ\@I-R 7=_8L
M%8NZU]U4X&571[YOCT>/X.3>*XOUG5*O:XEGX*B>*D=^5?[6A4^O;:U$^#)*
M#>R'E3%STPS)-W O<\#ZCG?26L YC>_YS@M4MG?RI -TI0OXY=W\"PM@TL[4
MNQR.HPWP P ]00M+@>SK!E':FT02A<"7X8R;SZ4^J]!]=8H;.5.L&^3HQ+$0
MBKDGXLWQQ-^Y3O&84]-:OW#O"]J7N3H,H3O+S]SRZ49-*"=)CI$9).9PUI#P
MT=CEVJ2J,J<99A;@7+:YLK3.>^>%OE'-'>/I3J\0XI>D*ZG%HH^2F'7)5PWN
M?P"(H"Z^+MW+5OH%;G+#1:JE"#Q)9A-AM4-$QC_5(KF?;-(0O#6H L'(VLT*
MGJ5_X<#K5"$EP@#4Y/S&/%Q:)Z&C\7>!C9)(WI^<I];29P3_&*,]_D:#JR?:
MD_.7FW=#=FCUO(L-I7*3('L,K7P %'9Y=^/.-M]I16?K?=*OC_=WLA8HZXO%
M8> V]&5.TUU!*FA!SV"EA<Q+K$OO'*/2?V0&9,7R-)^,4"<)$.P87Y/Q@^"V
MD$_<)Z2=7-CD# W8 ,J1$$[S_B6OGF>NWX.[S+>GN6<O?Y^X_EC[!3^7M%7Y
MP&ATT: OGA7F<N?6*G:B,YXOB!A.MBPS02K-OVXBEA=;H/K#S%XQOM&>:.#1
M@):P0XL'\BN"S_<^  B<O0R?!_/N_3(V-5DG>"6/.S6T!@V3W/0:5O18@N63
MS0IEMLV'\!ZGKJZ,H!)=Z2"THW9H/\U9E+\+AL<%P=L"@@_Y"OXD5A]THO8V
MKG8#O=UE2:>DGG/(7OP!/0"*Y]JU"*9#O;<F18)U9#E1ZO;K6_R)C:3449*>
M\#SP 53FY>RI4)<:O<C<EMO1<\R/G^5IL1BHF'-M#QX ; \ 0#J(3^]/.<I.
M&O'>;BND6]KY 7!M:4PNP9N'&68W5]STR8CG(UM:O?/PM);9GZIW]S)-6C@.
M,O1ML*N).\=--/5 G_]%W%O&M?U]:Z)IL>)67%NL+>[NQ0L4BB8$*%H(P26X
M%7<HT-)BQ250"B$XI5@I;J'%78L$#1!@^ON?.>>>F3MSYLW]S'VQWGT_.WNO
MO>19>S_9BRN=B_Y[(6\4<X"IOGBEKBU7$2UEF_IC#0O*E)%2[:-T<.C ;4GO
M];A;V671SS-'?T5'L/!"@G!CW0 /SXV=SRSL8W?V;.;MA^KM"]\QYY8WJ2I(
M#X9'F18D5=81[?CTGO*[6EBZ,@O8,W*BMAF5/MQX\529RV+UKFP>5YGR41K!
M.#F!#HYXW-M95$/CVT\*V0'6?.0.].RG!U)P'MX!Q.(=()S21$L!A=7.(8]U
M=9535DB"OT'OS/Z<BT-IVE/U>E#(^G$L2^(>5^.++K;D;,E)+K?+=OM1+7*A
M"LN=J=GC=?:UUT>%E3SI>,(4PDPU#+\M!S&).-TJHI-3W%7 ^K[91]'+@]3L
M#*P%E"G..W+@2N#V(M6T8"VG41S_)T]_!_:PHJET)1JZ6"Q+,:R@B__42\T?
MFE^_"/QID\><R%*CF/;CO#I7<24Y#>J/ARJI@ 3\:3PF9&=L/]&K$SJ@N^=U
MAE]2\^:X W7;H<;CY"7XZAV:];W8'2 L0""W,B(^R0;Y;!Z*;\Q'7GKO<6L^
MP]_**DAN&EI3@-1Y4%ULQZ1D=E1<8:5")AP_@JE]Z(41D2I12Y><<ID>CU;%
M$;G_X+14\GLP&>@MG4QRLU=I$2]WAD+!X9OWV_=9W87'/AGK+!GN^%T)[E"3
M>_2>6U5DP'6]%+NM<(9A9O/MY^\GZ)BS?FZ)%U7NH)!_(:ZW0TLXU[5$BMAX
MC$54J+ 16PW]C"D<%C(*1M0CFYQLDB=V><M[.,ES1#,)V-$ZW)$0GOA'Z'OI
M;HC>-ZCXL*0HAD@J==%/X4M'E9YZ%HO0FVVJ!O\@.&9^L^TUKM9:)RZX\MD\
MT^]"D7LG#X7JGNF7*JWF_J=;V_'= )J:J@HGT\D!D<%2O<GO%&'5O40LOPDX
M<$]['V_35JUFHQ_\_;'V]_5/TS;^D%E)]7EE[&&,^G6"[@ /I2&AV<LC5BOI
MJF*6[.WO>)V_0NB>^NX/AL'?&@9$$2<2Z9/WD^;WCE+/[NQ6O#DWF9S_3/)L
MGJJ[8)FJB;M!O#,FQZ&N8K "M,O8D12L,.ZAD &#SKK+N-&SWWCDR:"0,6VB
MI3"'$9U@&6E1T<N,4;%H+8?00]D\K>+&2] 1$DL1#)U>0G=B<=YC5,N ()@"
MJ+Q +6_W:J,T57 (D_G.[LJ:*'_EE!+H?"O2&$XKQ8$R*W86JFKAY,%!<LYH
MK=S@SW0':.\T>NIR\G*FX[^/^.TG$  0SI*O?'M%O,/H&"<@9I^S9C UE$W,
MG/Z$U2/Q<92<M;M,?E_T?N6^VR V!M+JOX0.W?3V^;C*\DS>KSLG.?L)GBM\
M42"02DHQO*OREFKL53?KPTEO._:/9BJM]RX^'?>C;2#.<;T02G5]=7^)#[YR
M'F[+PX^W!/CW\PX-56^VP\-XR?WX0I?%@8N;8%.EH\,(5V+QZ8XO+H<$7G@5
M)_<4>I];Y0:0QV"92F%NQM,^3-Q-3@CIH('G-0RVEQ\:"P"O_429O0:*D4>6
MV= U4 J-^@R;6YX@?Y& 7(G42PL!$?JHEWH!1#50UQNKFCO $>Y$O<YX /3J
MDWYLYPIW$^:G[5A?] SME;9\RQZKTTOBW'T*_=4?+_5+>4U5C[:20/UCL(0>
M@NZTQT MZ).)Q*Y-W(A69+*[!C,Z9R=(:X54L)<89Y'I8V"KRT?(G'2BZ'?-
MKMGN2^;XVI4EO#E,P'[-2'V-<S:>-J&XSOE'FT_N!,1S-:(#FZ4RH)]W@+\5
MYI"GZ>7<Z1V H[16L7$2*M A[6R:\3U=%U(T=\DWF!N5>ZQ1N 8/P+/O+ICM
M6@7!_>W>+UC,:;AL:_ZB(60/3]S:E-\&RE[=J@14!80XBE=U,RO28\4]J)[I
M>+SV9ZXIPIOVI<&]Z!(GG8D-TJC&Q!@ACI*3BMTF[6CKG8'5U?>"7)^41WH
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M,I48P5Y+09?7@J?K4_#4T(=K%R^*YNM23LK%JKPQT.J=.&\,HF/<W-5._J
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M="*$WU%>*G%[A"FOMBOLZ:.P/LN#@_QN6JRLG2<T^XT+)2,S*@R<7.J >9D
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M#GQ+=74ZQ7U3!WP :^;&$@E?K: /:%_C9:I>BPP+U4^+@Q,J":[UT8K+>W<
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MY /6^@R76SFCU.NN@A+_CAQE%^[R7.Y^6(AU&C^8T@YO=#4AR_G(+3=CNT4
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MJBDC-Z$P\Z(<VJX(D8OAEY9B%"/V='%H>CU6[Z-&FUB6O>/6+3[P:J61VW]
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MS[,=-"819F#-9W$VA&W6Y=F;P:[*3&7*O9V<N==, 9ZV$03G,0N6*:,ZOZP
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M:NY#:]Z7=J92L!>BL0A2 6[Z!P0S5I"%'HE:GR;3;"62;.+*[ 5(W0,Y6S
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M"C$0 8M?/D#+M8SN9<YK#"!U0KX.G5=H8M[OXEX,R?2L/Z(@O+EY'('0E_/
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M@,]%^:?Q>0+:/%ZS/W[#;LM(33B3X$O3U1F4Q0U<N8$]]T5Z"%SQR/)A %5
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M9E"QE?_%9@X7E "X8A(=DP(;T>OJ(;8_<(:'DI[2%80P=WD($F?X^+C7<9"
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M]>Y :2>-58[%D+U]F3D!#<*]5J[0?/,=,6;NWZ=2ZM;PWTX # 7G^3@>\]Z
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M+^>L\3RWJQUQ+K 7.Y^2]>%X$VN@T#/]%"?9(MK'.JM3_,6]-UV2O$LZ06_
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M,+XNC4O;_0&<T!K,6S)0+#9!BR,%!R.H:'L-C>T\R[_9N'Q1RW%1QU[\M-
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MW:T@*$J;I?DL7SR(3?H-.._7#D='5H7&VG'X@_@<6$:8[*9_]WM"/$4U(.%
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M?;-H^H'!<%](M'4UK/:V3W#DS&KX,T.4=\NOCWAWEYUT45>P]A#3LX]W$H\
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MV-NGW7^4PNDM@X;V3:-J-*8J7-)9R]MZS2%NS\;6?XHUEXRM?$?3\Z4U,#8
MH;X;@U314D!-R3R<7]USS4+>'.";&P<3GT":0<@&"?>'VJJ=-I[3DP5OBS:6
ME"XD-%$M;0)DC/#)$BD.RF6RB#8]L2!Z0751MH*;J- Z^_'&LKLL$WTX.G21
MZV( 0BON_0MMR0G?)(/BA+6@=H*F.'&_Z:%P_802-;?.SW$/4O7:Z\85P$CL
MI0N6VDZEJXY3I$,&]D*@=D#3'A/^1N37AQ3G@H5^\RL.;)O?I.XXG0O+"FYG
M@&=P;ZF<9;#H;MA)<0)II':+\CIAPH>2:#W<N'=.^!_GY607/'W]9V^R&'+
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M'!1L>![>'I 9)L,*]WQ)FF8%<$7W.NF!0W*D$YAO"AP +"ROT*2X6P'NM7K
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M.KDXPC\_<-PBLI%)UEN/[Y6[$MGLX@?,4-@/Z7,, 5R35!D@J%?R?0IZG<O
MI@MZ%>JIX*O@[&\OT7=-\!3P-PWY5Z*4BCW*P$T^O:VMQ[E@B,"P;8!(T2<P
M*(;X=;)X3%:=4TO[1DC(RELD<[ 9&9FI>5OR;&>G<IS"@,S1.9IQ=JBW/&;5
MVJ&JFQ:] OR<9?D1P+G@1$6;BW56 !O:NB&>*V5X;XT S^(E"V!KEV"L0,2W
MSV5O_HXYGD0TF@BL"S.F;_C&5QKUUY^ JEM:(=TX5:3RX7X8.G?*E>^1S,WE
M^T[RF)'K7C!K=^,>6(\;DFY<]MCS]DNZ[H?;2+>_+OQZ NOVI%)A3.U5;5/%
M4W40\9S&FC3Y1"NSI*^NZS_6SH^,[E-Z,LV-JL M(FO-L ]*1= *(9-^#,WJ
M*G(]Q_,,@ ,FYG&+%OJD53GW*V@6+?'^M!&PX$I/<+JN;A;60;D>[QD8DQ\G
M4RZAWI?%7-.8I6(/L":C,&ZT%]P^,8N1)<ZHED_0_VSAQ"<W[6"8.4HR9@*=
M5ZT[]8&'$XE%1MK4Q?Z=Z$E-T(O[7H+IF)'A6J'W_Q[-VC6M@87CJGF-F>Z]
MB5:'YE_QXB5S*U;Z3"1$$3K_'# WI@2?Y3#B]CAG)>'Y;W*4'1F[&/O)9,O.
M6H07!9!ELL2X8.TLT#LH#0P<CKXT$C4Z9*T@W=QX?I$V5I6WUT;>..LJ(>@:
MG:_R(X(WF"2P-@:@I?R9V$X*J%>'2O?POJ8P+@YR?2.N:NWH6)@:K_7VN]R;
M\<':7?3&BP*L7$VC]F!Q4ZYV#Y\B:T-QA&35%Y+BV@2='[:V1T^+'4JBKHUL
M*T)$SZ8$WP$=*P4RLG1F'@$V,0AB;XN\FEUG/%[ YMQWL0\<&5-WIO:_4%X:
M,_FU6=B9XDIP72%:SGBER(;</D4&<@:Z0*/+RAZ(N_[4D:L$>@<<$1P4'YIL
MV1*#0X7;)6"?]I$J:LTB1G0"*T_3B+EN,[RBC<P(FM)]X],S=G5&Q5< L?[T
M[IMWEEO\I)-R6=OSN1;%7_N3N,[=T44]R9/D=ND:*H%.2EMQ^>Q>YX=J8T=N
M)%?GH@>L>7$#3&VU(<?8RG8Y,3MK/"%D<5B)]L ZSPSW_@\JA[<2O+,5E<=K
MM7 M=!7Q 'Z,#)P$Q\$*H0U]04$$65@*8)\B0^O#GT= ,B\M\ GA6*>_V@G_
MDO6F%86OG8W0-[TV62)A-&.0?5U\:U=\6CCUX'?JQQ&K<KCX@+5K/G&-VUPM
MN"DR3EYB>P(3H/S45-44<+!\7FW%B!<=&!@@+![ ,3[=F\C2^:8.C+=XZR54
MZP"5LM+>]MO3EXJV[O2"G-YV&M*D08I;6GCZ;>S!3PP2;W;Z,P:@5F;YSIY6
MX\?=__"\[4SG;YM?Z-WKZKR&5NZ^F[A9F,L),=3$!U-EEV=AR&ZS,4(/70R;
M9?D+6H>$HW$A*;D.!]"D7[.YK:XN>R2K3Q-WZ*]9U5 (.N/G4YE- ;>6?%4D
M]57JICK%@M4-[EA-2>N=TS^>H=]]X5LYPP-W.&MK3FILP*/M!^FKAY9QO;Q&
M/VQHD['GV?7'F5J/"Y\O@SH[M<GR/XAMCRR>W ?#<BY_WEMU0P4HJV+\NE/(
M\Y=\]#6122^$T@+]C)01;N1"M1.: U2KCM@$]0]S^W.+JX +EI2N>/G==7D;
ME.E9_\01H>.4#'O%?M@3P+6;5CL]ZFMD.*X-^;-TC'7":MQ-:T@3#K]W?5ZF
M[&>,R\Z1V( L,T#Y*35G*S7X@'2D(1=E[OAOF=P)](\ K =J/!I[*P(S7V>/
M+BI?0ZU],(_/W?\,-JG\+&+GU?/TF>M3>['URLW]=P7,N?J_!X^54K$;DH6E
MZJ4&>S2$3;/<+K>#P")-E[BN7! @E0HM002!UN\,:GN-M+QC+/5Z/I8NF5KZ
M1ZG*>&&L,\I6009'^*M$[)M>;&.9O;]C,1'K7.)>92LK1BS!WF^=80C0QXE1
MJ#U#?533_3K-74KGP#A5Q%0U,N6J/92[\F*4^1BB,#C"MY]0+<_I%),;2=#0
M+S+.4*1.7%G8#[%UY=?+].9!"D74C3)W'+316%0ED\59CY8PAN@N.8B7VU'W
MLT3IY<T*?-%NT-2IHVS_#4YQ3Q<?K^DZ^SLF!,'8E&C2PZ+MR?SV"%"JGW/Q
MPS U!:N^2/9*=*>2=^#MXG^*1R<^_P3ATH;_?MDQC&30G/UK/N/-MG9[9*G&
MP&O4VN.60W@=P+&=$2/3T:>(,:^S?D* > K89,1LA,K66'"0+<#ULQ*[8@E=
M1!',CTY@KU*B!15:N1]V$Y._!I1=E(W%9=HTD9U6:%^Q0AM ;Y<0J4CI,6&O
M.;U*?'XN+["4HL6HFSQWF,I%W790X=,XGE,XM3[7%P(K^[-GZ)(64B@5;_-&
M!RS(][GF.14K2RF).PQZ$NNM UN&LN^,]T@2-4ZJCIP"6[H.Q$K^A&O65ZEI
MQ.'Q\O0;7I@20M.X\>7 % M+I@=DL=N(!9"Y=P%.8H+T*RPM3\VG&,YQA:<<
MV$T:V45O&BL8FZQ^0 J%%$_8G0CY1*47-$9\R6=R+UZVM5B+D:X8ROS.FM=H
M3P"-[=$EVYF6.X7,5?[&]$"<<5@U4A-7,85==!1@:<L[K] @C4SH)KE.DH>\
M5-+9&$,.QIR$>MEQD@8&&.(#3XQ&0WM@SB:31ZY2>"B*<TVX"Z:[UY^U3_8;
MGU;XF/$4I-'IOTO01/2?]H?!O+5S>W\9]O*_3<U/>#-OTW.@]-7LX 4L J+_
MHL(.]G>=SUB=F/ 9FH<1>X :%LM*887I!LEL<$H@U^Y,;<\,3%=)#B0>\JYG
M*(>Z@R8H$*6%*NO30*GM*H6 7AZ'Y#-T1=H/AV(G:33L.G8< ,94N<_A:UCJ
M\@Z.T%N]ZED(\$YY[1!&,W2U#CFJE%P@Z3JQ;V+\=)NZV;A3[ZV]T7MZ;H P
MW)\^2*M#FMF8HS_GKK6HX5G_Y)AXHOB3HBFFTKR@+FUE?)MR.+@^<.O;*L,S
MV5,\41IU$L^6Q!X3QIE+:NTN0=&34"X7E4U8-Z?U=&&/%BL.'J.:$$[,"VKH
MJ-L# ])\[SH.[/DMR;'<AJ]OJM\2O=Q,P[%-T8[0N<_CYLE^]A=X]6>/ +Z"
MO$93/%3;IO;,HN+<A?*%ZF?Y75AM(N<@IT>G13S4UC&^\TWY;7:8T)2-:%]D
M'NK+KL[,Q<*<8#27%NL0L2[>E#":\C @W_&?%7I3WG^N<+76+0ZW<FM,5?!'
M?YO4V:G)G.U4V-L[[*YPXF4/OHYQ-:BL^'S:'G3L.@!A>K=D[%,A9A48VU)B
MFL*0VW$H35U',B*S"5)IQ[(VO*^K;?N63;5J5?WS;X*(.48M9!YK-:NQ_#TJ
MO,*:E, ZC<7?_N2B.$KI&NA.Q:G Z]VPN.,@TH\NO D#>)((*I.R9BD*O]<:
M\0&4JYB2@?4D<4V)_\&>I&*TF\PT%7#P@KJ3O!_F=(:Z-DI1;6AK/17,M\QI
M;19=I?RYHJ/5PM<A^95ZC%?ZZ(.>\K5<3/VY&(Q/NV;.9=A'H<M>=&H;(UZY
MMF);XE2: 4EBUR"%>2CH2XL2R3MP'^EZ89N_3N8L]CI8A_I/ H#F(OOTMX#7
M2]W='AK<EBD7/5>9$H$EK9_7!&@) MN8ZBPL)$ZZB1'T7$C5S".2(51^'Q)J
MKCME2ZG6T.JC^O5,'CZR/<$UBQU%=7R@A$XUYU,<*V ET"R&3X12V)4/>;"G
MGSH\BE]BD'SYZE9R77BS<E^K[D]QT:ZKO$=QN+?!QC!W.*FA6_QZ:F4.2"33
M#"++^GQ\Y/O@H##V!&:G6"S)GJ'WO)"H:^U\?;9Y4X( &'+7R?*CQZDY%#>P
M3QY;Q\%3C-0JK[&=$%5UX37 W\KWH6%.('43;%[C/_>N1'B5 ?ZB<5/\GA7]
MR974\5%=AUHS%I.7F7@0,D/]C_LVG(>\JC2./Y*@PL(#?0I><Z'!XG*/@)>"
M(? C:]MC(@.ZAGKNEFYZ'JW&CO&/%]3@/[A-'!F3=Y\0O?5P=\QT/A!XGA?4
M]>7SB9LYK6 O'=KY5T7QS3JS8206:)HE9M/D5'XG/5^9_3UW]%_>:M+/OTP$
MMA6>EI0X&<9]J.%I[::7UAH=?!\=/7++9;^<L"#(LS+4'#9 3H5S'M%LI![9
MON5]*G3OL_0(V N!M0KU2"%HV.8NU*O_^2U$HIVWC/QK^Y)\V[!)?BER551G
MZK=N?XY5O(Y:6LRK8D)BI6R"_/#N4R1=(U=\\D?VZV;=COIO#<;\7A5O<!,<
MWKCNU4[<O74M;Y ^86N.0!#@07%Z$I9<^CVE72[T@/G0+HC-^QDNNHGC:9WI
M[7=&8'M&LYZ?6&B#K_2PQ*IY.;)07S<J26V2!8NU3C=] L L;K,@3<7=$2=B
M^>@_6%M4%S0_III_2Y",RP<<K.R)P+/8@NS,G2E#$-V_,EP8I@HKI+H0;;&8
M21L<>W^_3,%L+\4JZX32C)0&%/ZI2??YB.FZWW'2$@P3S,!:T$I5<HG/G\\C
M-@P6>#*[\%N\W,?8_#JP:0+EG0VSH_Y"Q+&X(VWUCNIM )G$@ET=<3P3:U$W
M;N5BE6&>6VZ[.G6G7/F..9R^-B;I)0E:F>Z<6#L,Y.)KF[]S]Q ^:#95>_PZ
MQD(:\%F786/9R>O%I9[JOC\'Y;SLLX)I;E_4;G+RJL15-FSL<0VEST!+QLO&
M'^CJ:NHU+%+'S1(  "?EM5<==<CC,DLO"'[$'9-SKHP[>^?SB9:8 ^#1A,A'
MXL&U;PGS9JTD"\N:1OWA+6"L$ $(;Y\76P5>3B)Y$!;7%/-R25F,BMUA?)1S
MO\H*]4Q=IMJ*AVLT6JVE@6 WI7'!$;WY"74&]S1S<(D$;AIKWO=7_^.C/)O0
M)K0;8;FHD%1Z8 E59U -'$O).(<SQ(C>3MEU?]A%+P"I>IP&]M;/[5FD@:)5
M-;%TF58CYJ9\Z5%:4AA_A@2:61I C#+?$D(:P,_0?BM(?EG8)(?1AHJZ/F2N
MR]T76L_!A?3<R;XM#P#)$V0[U<36(I8BNV^ ;04W4:+R0>[CUQ5:"QBPR\]\
M?]R+YF*XJ^](PM4KT^^,QX&UOYN>RI=O V;UP5NI9N=1[)*6+T7<C#S755U3
M_ A;F-S7P9;U<YS'%ED+06X\0Q3K?TJ[/.1VQJ!]'-7U=?!J.,A+GSZ 9.S/
MAO0O7B<'+&IE 35:_+WZFZBTH/],/?6,9AL8I]1Q.8R6^/[^L.(1L&W6KR)9
M=G?L49EHNUI3GRXPD$$)$K8,4:*TZ67_C?C7V8&5V+DIP!QM"2X_0%@?KA+_
M%7\/*5:)-)9<_#L1DB33^3G* #F#)ZHGL^G#>XR-2\W?^K:2'R0RV#957I^;
M!@QZ_K+C*\96L=^'35<Q8[Y>49VQE/63H&M/U[L#0F[[BX9RK:7$A]_"8N'4
M#BU(G5&/1JY'P'S*^(!1?82)Z?SECIMG=2FJ<[U:FA$,#[)PV1&UC_@AU%.)
M;H$>SOUBX&1KW@ S\QFEP6X(6R5D_2QY._]Y!YU=MRM@S>)3]8+AN//SD;F)
M04?[YL&DS>?Y2^_<$@<&UC:21SV$;AX!/[DJF^X)!U";#PI2&(^ /T9/,$KE
M^(&L3[4AZV5LF6N1*[>B\+G*BEM<_6,<:7&N^?/GEC>!L,B;?L_+U+]'=@4!
M*I%67Q.6[P8,W^.8VYH[)4ZLQ<<?JKA;VOC97LTG3RQ);^(3#U#K>Q) ^9N]
M'P&$U_]\L3)1ZG*G>= V[&6I?L^4,%=AX-9+DK%?*68,MIA2[%O.,0])Q6O/
MT761Z>:)%4HO'P'UCO/:17MI:E%1:2:I7[_$. W;V%4]\[GRWV/W\A(#*:8>
MP7*#B^.&>6+>%2GV"0F*9J -7A3[#5]^-#V5THZ?PKHS/B%Z>CW1\7^#!FV8
M\RZ98L9(M42?4D/# Z+#:7'=Z9&2,RSLVA(68+;U!49-7<P9J*<^V*Y01YGY
M$]JR@@.V*YW%YJ&&>MZ^GF&0:'!?ZE>!OU('%1;^AN\? :YA W>LAJ"IU>B^
MR_95E/Z&P.QI9EN5EU<QZF"^&S%H?A5/<B=/(]-_\ME)QBQ6>N5R$D5IU(PD
M"P;6<<Q$?3RB]XAG^Y2J,Q1.3"/]F0\U.UR)C?*\N3Z"IY&F.KK&>?^#,;@/
M[)\3ILWJO,K]!,CYC(9(F#0(G(TTPH_9,:;LS2)&,JTQ?*A.AG(58L>C)3TK
MRY:)#_#ZUGQ@DZ<4_)]&@B1F<?*4_!,N5N=28;Z,D]ZJZSVGQX&E"P>>1?G.
MKV2H,[JT:1AU>06[W()?J:E:W<ECF*)87R<([$E=8%7 U29<?-YN^? I5U6#
M)?_5PY6&?=S\TVJ<S<'0"8'9\M>U1"_->/O(^S;SN3QIU.G3W."P7D:$S6!E
M2U8$:P%?S+S45@E*_:&ULOV"_#!Z-K@O<X-:>_VRQ>XW*@3)!<OD"SO:&FQZ
M<Q0='7M].&\RA0"5V!7 PX_?XM GQ9%)KT+9#OC\,UQ[&18,E;U(#A%=\YIL
M2KM6G2[:,Y@':!T#>:*@W7^KYTJ0$WONLWLU]AO&P$VR4/IHV;XT^:%?,1V\
M  Y\@SF_>G%(A15B-[KPM#4X]D?]Q.(X=7G*JR'RP9V&P=TH[D+/2 -#B;_N
ME3;8QGW!1,[D7+\\OR]+"U/I0!1E)R_=HR\EV/LN-QX!NO."^V_5B]8<%6W^
M/7!M/$W:26-_V@C4[EOA(!4M*OZ%\"#-TKG*9XO?H6W9-O)OY(O#5^/(0VGD
M0(GH,?D\W-3;3U::7_P],LLLCD 0ITZ:@TD WW3&9EDJ,-6P;--45,1 +S!(
MW286NUZ:4?$$&24F. @/,J:5/2C[C/[V@ST"L*E(@]T=BX5Z0,/"XK>17O^8
M(N@D;[%=Z!P/;.) K7PFIRV&]65(.;U$G:Q5ORN[1"\JK!&S;%;I"(,87Q.;
M1;J:NKH$#^!1;OBN'^^WZ&>IE.1+/:[" (L;'7UQJ3S$ 7X):)^48*5-;JG?
M-I+!LD(?)RVD K85=P)[(F55R$*[)434IO"_I(Q0 OV?I-0>7$.F^?Y_(66T
MX!D']5N74:83%QOE85.PKI?&*&G7L^"U=SA.VNV%CDV9%:D;F>R[*J?775ZM
MH@^N+U+@-T:Z;';*CP!]*NJ>F 83:-E.2\9_^IUP9\>+_R]4&J/\BT#%/:U2
M6K.7RR"YJ>/:<S#U0[;KE4,B1_("P]JZ/E74-8E[MRA64/LZ]^_6&N1#\0;N
MAUE&*[J&V?QF'5WC<H>R^#ZQF(!68OU>KI_)>J744QZR(A@E;RPVL>@N1^6*
M]@P5HJC GCK187ZM5R"72/=YJS<%K<MBII>/@'?VJ:83.]ZDO\1--Y,[EEQ9
M_85W[V6UO07S'TB+HT'H[BE?^&(<M^O<WBT@%E7%)T!RQ' <&LNG]2?'^1IV
MX  8S./@T+<K;HI D!^S+.Y^J/I^!B$W[B_MV,_Z 03NFUWXVCT"P@?V'P%G
M!@+CMQB&3[@>Y!CGAU$JU\X)C(KUT(C-WPGYI@5-OV"8U9UZF>?&6<V\'ACG
ML5M2Z0@2^]3BU?M$M0(9RC$"K*]OWJH\40UYHF%MR)Q4GL=<6F1@2D_U:QE4
MGJM>LH3'YG8!WW0XN7>IZK&B4/,OAJKTOMXS>=L\[SM-%;)SL'-DA_^SBC#Z
M !/:7VF]YTO+:AIJ0@WX[&<IZX?L!#GL7^G.F7X)&%OA4&T6#]O0B;7CB<XQ
M)]\D ;:VD"9/+B[*4;U[G\L0(?"J)#\'X/!<[.3LCOOARR,@$/7G;)F=)67-
M+_Q+.'8S]4?VDD&IEL2<BN[.%<9) 7L\?5@(S-*1D523?U*1MZ;GV7=W5A$3
M'WE[Q +B3Y=9;7W("OW(-GT4_;%Y@H-8@K* R?#[*9>%W:Q^E>JZM,W4@H!E
MPL*3<P*1 \^IISE)0B[=+^^,>R8%EH5Z/(T\DQ/=X+I.1&7TI6_HUJ((<*T^
MD;KI-OE4+QJ Y"#/=FTU^@@5U-0 &\6Y_]#B-S(9;=J(9UVJ>>T@60)7MM[%
MY[T.JZ\J"Y'R1R?A%9^.(Z86550[MGCIP)XWS;Y)!R0F8WWCZD'=7VV>UW[<
M'I(CE^=44^XX5M=6$Q6Z]S-$GP7=/%1XD!;:\/L19'?F^DU<4G^AMF#=W\:P
MC/-;'>B_OSPQ;"?EW_8Q[1:%[>26@A$ZY35RSE[%*MO#MA8:)->?UYW>J>=6
M*ME0"K:K7-5^7Z$GGUOK$^^5=?HDI,&'*')1)L@OL3 +*.=]43C)M7JZ&G<#
M7[VY&V?^?7H=R%4WRA;:,VIJT!BRSU)7FPZ*V>*/'/CW+/%PO\^C$E0^*M6=
M1I,HIEZTAW#-&+\NJ*]3^G/_P=_0Y:0P_-"A@J73.K^/1L0;MU\K[/71%@MJ
M'J(A9VD#X3^7@>!H+;WSR.)_9?&9)YFAM .=.6%R=?BN?8"F[.9<!-M$DO_
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MVO<Z)U*_9W Z"&,(\O9*/^..8>K[.>C2?$-QM>)._&3W^=\;A@NZ.Z<\Y[H
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MG_PZ^0/G]Q6M=X5G%]:\T=53.3Q'0?Q;>5)EEOV32YM8:X+LYUJT%U59.NY
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M7N2J4;8D+>-V#U]_.>FSRO:83'!\  S4!-.NA#T 9, /@#-WO>U8N8WW<P^
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M<G/"=HNH&5\)[ZH5*D0-=GBMU3XSV6W2[F-%J9)4_L8S$8XI8WSN+W"D&^B
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MI]$:!VPDPV-JB>K*=F2I8"[\7J*9B'>AK.UI-$)"![J? ;]X5/9@TC-F$@^
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M"6J%\_A,4.:+]E3GU?24K"(>6>,(2GK2W1*D"_7=FZR0/.6\.VLX?9+W O+
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M-@9< Z$.L4MR&!F^S;U$G\F6;*%%RGT:4..X-+L2UW1IZOS,?7KI7J:'2EZ
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M>-JGB>;&YZT\NGWBML[Y,&QT1,O'[.2W@WE1HO%MX)<W^4U\TA=K-8K,:]<
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M[<^4K/V&KZDC0Z.GM^AMF7K@B/?*Q6RDZUMH@(;Q-$%JK8[%;!?B32&&].;
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M:QR^+.N,#9609/S"P'Q2-%++0Z5>.N>)V1Q(JA=%KY66^5#5YM8JY:ET1F6
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M2N/KT-/Y!?#KU_&=KWWO%[IN3;,GH47:B$[==#01#&9E?+;/TKWS4[,V-C8
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M$+2D[9FQCBV-$5A0((V"$:% 6+TJG_Q4U>KB69]H=OX"D]>?GD(6Z\12D2X
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MG_G1I0Y7[)!6ML&Y6SI'?2Y:R[,S[Y'ZDD"GRB%ONW-HHPW5L=2V@T7?7=I
MG [C8%)$!%^E+YBF^V@'A>(R3:"V4J[<2WM@+I>Q;O*TP5Y(LR&>;<CNLT"?
MED).9:GBZAOAKMT6:G0O>S^N7S&,34)Z6D.WQ)XJK2K3(B."8CY(^Z@.LTJM
M58$EG:L8U8X7\Y<C0K-MCIM/U'KI'V?X_<D5+QGE9C04)/K^%@$NNAETY-64
M]@1*-BK82L7]M]@RJHKC,:+L57C;+-B#9$/K<[%QT CG-3_=+(W#H7=81X@
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M,H_P-(#[UQG8 E,OC[04&WTL*]0Y1Y/B^K !8SY)V11:IO\BE^N2.M#T\@5
M-[M?28WI!56%&Q%C6:3KWA)!Z)KKV[[U\V/*2UM*30OD5/K)3?.WRX,Q[/F
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M_@<RS$_F'I6Q_C[Z<9NR0,SEM6L(MDC!%[$_;$R]'?33?IK_J-D&E-SZD;+
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M8J3;(UVC$'9IM$*?I/@K=:9K 84JO_Y*/4(2]WRW<#$^]5<WZ@)]E#+?][&
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M(]VC#-)LCZ*G?G)V&G*.9R^:CT1;3Z*O$SCMO*+@8#YK6F7ADAO1RGXBJDQ
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MI('<^C.QB-9V=]J"AOCTC':2!=AF=(Z; /4."T70YPOT9$N@Z)+RU8W>[=W
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M=/F*^NDC?IV,90^+2&KBDV\51E0!:.TCV&I*EH-;CX!%2&)RJ^ _=4_"!X^
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M,6Q,FO)I"L29]3G PW)& WLL[DU>=7-UZZ]A<R>\(:D0L@#)@SIJHN@E6CR
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M;S%(B=!+G3G<<3=_+O+G0]:4E-D-3U01K2&E?)RU"MO+BP\QHHE_[BJ+'WJ
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MQ@^O4V7;,Q"D;2F1589YZX;&.8XI;$$F-?E;V!S?6] 0Q&6P;3'2QKCNC^W
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MY <^ M;)QSY_NM-:<!YF:S%/J#KI&PW[?K$<T5P<.N7X[C(]=*$D7J1F)*Y
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M02+[^PQ,-<L+BU7%]C[%7%\!HBW'W">&4AN)CEJ(N*,N.F(G*$0MAMZ[V[J
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M=L%&_E=,33*W+W&*TY\_)>2/6[*H0%%5G:K]=P$>(CLCQZX]2NK7 RU&2\^
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MJ6  H,Q;ZVT;/'6/(Z:NMKQ/@*#?+"U^:P(%?(,:\SK^%FP_\>C^#. SJYV
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MB/<G*RTNE5P=#N+J#+VLA>1A#=%DB7JFJ N_^A+WO8K9F$!V1EU,1]7$_QF
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MM/IMYTU7>Z>1[<(KMCM^S'+.QXP6._.:H,@$:SCC"R@!S6H1M->8'B^"U.S
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MNVAQO7__$6++UW#KZ*5+4B-)_SJ).QWM4VX!RL::%N5]"Y8[<G=CRR#W^K1
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M-N>*T(3CSO,!(#S+64TP[P$B(O&& J$HRK!6HZK]"TKYKY"&J=^)E?DP#*N
MJJ:$Y+4&[C+T)Z^ BQ5+;2"_><U$+K%<#@,$DRUQZP6J7%#ZQXMG6YLBJ67W
M1K@V_WR5R;>R,1]- CR'0,D'3I%]S<EO3>%9Y*7V&T_X=DD_=D3+1W+S20[\
MF&C1S+OVXKC?EZ^\?,_5QZH?)/G2NZ+SG81WWL?.70YGG&H[AISY)'")U\D#
M0"S>..^//R-#-&,88B"\VN3X'=O/ E!8!MW=<@V;91'1V[2^YM9FHE /!T-L
M M'"\F&J3XF-A,*(])='RZS'M**F[ULUY36;VY)_0+]O.[IT!X,+G6F\NK-P
M=*=Y164-'5X? ].Q$\^UH6]KR_^,Z>&3 =0[!]Z64LGQH.7+E:O5>5?&4IV8
MA'G&&=.18<\1-6%'@@FNN(BWA9O47A;(GF+;M[*_H.OQ: U1FXI;U7+O,%P>
M?D3O8*'2Y[(_8=1F&EF]0?-R12UQLUW^KY#9D7G>&IJS[H?\[)<Z?[X?%9X"
M6WOJ&6+4Z)(GGA]KOYTJVW;@"U5>,5L/9/3>U4&)7N1:5IB:= EARN9"#9\8
M8\52<[@Q_A1Z$9@';?U:/;ZQ1M0V^D-'LT23Q72QC\^SM<I9.,[YJ?K 1]"8
M^V]W)WRT15]B#&]<KAO(VRUF2=/Y0/T!X'$AO@L,+'P D!XS%@!2ZR8<:.#O
MW,6%2O49@QWED<PZ_.'7>]7H<HIVCCL/T*FH/U[5"CJC*]VQQC_AY>B0L%3G
M,P4EXGYUV3907C6Y]I4H^@%P&/4 V%>H-IB/8"";&5P/B+*X TR7'YV*3M]6
M:8J.#K4\ +)B3;@'/8I3^1>7WB4]Q1."&5,-_NO:'#@$9H>O!W"KS81!.6#\
MHO,1 Z)WO4<C5UO?FF#YL@#,)YGY0ULMTMAGVAU76;**?JS*EBXL=%)O1HHG
M@LRUUW, >_=\R*1E=,**'2?4B]L!TVR0SO/@I<M)V0O<,2TM;8D];K]N7;.%
M1]$%W"BMVFV!3GUA_)JZ<?F7)8EW X]!:SH!%_%A?",  >ZYQP7!S1MNP>OT
M.$$>TJ/6G3"Q?+!XEI>;?:T&^T3+S\M. %&GD9*YXKI%6#I'I!RC35HVRXUY
MKO/<>E?SP1N-+_<OHF( FW0)ZJ)N:E/'_IK(.OW)K994/X34-9R6]I>I>\9Z
MLB")7S9@O!"D.Z1[<EME3:#[2/'!OEGDNR:[4=MS<A2+FA_O#0NKKCR)^574
M,_\EQU\X[R*K#C6F?T^)9&A*S;[N CWO_48X)*@[6[U]!TY;E4;<@8&!\/ H
M&4WK#4VZM96"I):_?Y:6>H793J#/HV0UW4!^*-VM 2^*Y T_4T^,V)2^D7$)
M^OYS6HQ;HDWU3<= 9C2!]<"BW+RSS_Y.1+OV8=3Q/F_U(9KL$IIVE?"AK3?U
MO>PR%\&P2I%QXF69F"3&'^&0U>(J:3CV R#<L@8R#3DL1UW\PHT:U[+U/\S$
M3.D%"YJ[^A)B.P<29&A-M;/MB\G1(R\C;F4_^6%W-D-F+1-9?Z4H&BF,+7Z*
M(=U3%CT6E/<PNX!QCX@2$15'RO$?-!BE&7$5$;"L5/'^3LF[45QC>C_2Z)#/
MV\DJ<B?>,R?W%)U6L)^.F[VF,<M31>/'GK45(^.GYH&OCK6+DZYAZO, Z'H
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MKN];(LO+Z<ZK0CQPXB'T/@6AL.6%'OL(W%5JZD@V2ZJK<%]-5<7F5M18>.4
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MB6!P$]M62)* K,WI/?3/U-Q @87YDFT#Z9KY6Y8&:,P@3RC=JZ D[V(3H&*
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M;D-D;O*E*2@2+I@1\_;[+X,_2SY4;/BGYJE[M2I_-U]U!A.Y:.6%6R7=-S\
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M5F+;,PZX\=&'&JAGAP:"L44%]D]PHVQ+C7XQ)6#I:262!^")@\WWW8IRF_#
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M"_Z>MRA50T(+^0G$]KL4+?I3GW")7_G>Y/)R-D"59M,"2Z8/>P6]$QMY)_
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MY#;M^YMB41)'M3)OV\@7MC]8?DOI?%GG7[="TIR*(H*9<TOF#Q8="_\6A.>
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ML!,^YD"T$4NV(;!92]>&\*M-?G>3EF<*PCFDG8,](O[,Q\X;D*W6:72/-3.
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M^P&"=$+7V(H]0*)<SN$]L:46,,SW&D/4E5XLD<V%7APN*! C3!QFD6&R>?J
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M%D"S8W:>XU*L!8:>,_E4K)H:T2=0QY:Z$6I2I>\>R"EN8@8&N]B<YL_!TI"
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M]GP7AR/O"AI\%AX?)A'$UHQHC%,*="B9)WSP8*F\E,Z'_ZO2TT8KNJV4]%M
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M=<PE%9A&%G%3\.0Q)FK*^TT>B,NZ^$>-&#. R ]YNL51BYDH_V)CTG4E1SE
M;>-_&2?)]C9.##C%4PV^6L8&.T_@:F\!8L/P^)ALVDDY9=^"_I*N_"5N1' <
M@_D^ XE8_3.]DT0B;<+ K8:9%VT4 6]G*L_\MS[L&[]!$*IKBWKWM[.HGS-/
M1P2/8 T4Q-G.Z.]64F1*$R(QOKN:4N K]XQKNE&^+?%/PU_392X_5ID)*X<Q
MG))0:]F)#-M#S'QGMA#E+>"=4Q40;A4H42T3#RS'ZVT544<I,ON ?]O164RM
MP!/:[:+)CA]/R%+3]A)EVD3U3"'CV&*"&.LC:;CK?S7'&>N%[#21A/BOI(?O
M=BEP3@<HEYIAU%3');>K24T1@D9&@%9):@.E^D\4%L%)FAZP38PL15E;*LK#
M*UOD:/\B8GT&AO!WF.!@2%SU(@B4LO8E2NA@V&@X), :CLH!N8Q(_<K*!DYH
M$";<]+&FM8E=D.%VXLW*=0,%1BBH,BH S%IYDRD<UMV0YK&X]-*=H5]W8;/0
M?5D<=O1M$]F:=0L \MP"QD8,4JVX<->1^R=U*UYO_R?:14J\[]#^PS8QD/_3
MT2V@AX)LUVQ_^-M<#%AV.3"]@Y)8)_N[+GTMR?%\5=\JS99G5X",8BO:^R:&
M3K'_F9IWT'(I$\;C$&>OG8:"4?QNY4 CINM*E!VHG%P_+Z<XW/P.G-(UP=UK
M<J' Y+U&&R99.J;'&'\MF>L6+8\8^_9)#<6?<F2?X1C$[K/ZUE&OHGM/M[S
MS5 N68JH5OV&+U"&?K_U!9B#P*2[)YZ@.HQ^":4&[)U<C1FM53_'?LTQWKQ*
MO[OD+2 LX-G'VJOIFH?P_1!VDG$IHI]\G[[*#T% 5[$I,!N:\QQ/FJ'RO&<"
M_S"8HRO9C^*Q/!-+/E&'RJPT#H%F2"$F_9.A/KZ_)-U2<]0/\\:;K")PS#,>
M>.6MM1X%X.LV>#[C.^A340/"]H\/^@$7AQHR,'^KXUO \Y2XP9:X:(N9%[<
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M3)S]?>%=F88W_;D_[<CL&[TYTP3RO++E/9&NH:);K,F3S;?P&!G<FAEX[6'
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M+#)YVF>B%&Y%*0)9=X7T$Q7;HBTS_1G2?U)9[68_'9+2 (0BN",'Q:DMIYB
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M%\D:)RJ_,AS>9)I(NO:/QR:TN]G=:"0'.IX0]P*+QAUKVQI@RB\72_R9 WL
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MF(/C>J,DF)-9&6_PKKS)5Z0\H(&W(ZH0@ZTNT7M,Y#>11@&!^Q56# PES!$
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MM_9L09WW;C4Y=*^5_[8VR7=R*;=LIQQ*<=C=ZS QH<*M\W.%B71DW&AUKJ:
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M<_KFM<<98R5B]HW\NQ:%&(-4J:2I3Z'Q[K%S-]BB$>][>J!.&-.!Q@I!.&:
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MF&0M/<.DVOS0E&!R5[FYS$85#I#[6?VJPSC0>/]N8;5%VD&T*%;D#>5(FU<
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M&Q6CW76T%6,^,<IR:T$,>PDD:48=J^(QR%/&<<@Z*K*7>%#+C P,&H_7LI2
M[7A]L,HB&R D[*J+8MD44<TB)_ _YPL*%!S9@_UTJ)I4^9E)6T^")Q4A.?K6
MJ17Q^;J@V3IX;6G^S#?6SYH++"Q@9$>:Z[+?;V$A7>($/(;(&C&*!=*FO*=U
M_N:I*@,ACL<P?$?/K=A#AWV%<,3=$Y\P);_>1.UWCXE+898-J7!;W1F5HK%#
M1B+OELD>/;2$585EW/VFEV&%/[V;\HGCZA+0P[K4,LIC2@$.1K(V%TU^["%?
MZ+ARD[]@9EM ' 'E^[BOK)O*SR2+;,G\-L8?;PZ/U&2,B]6<QF;?G>)SEMHL
M$9T<#LKQ+'ZZ?9HI17PLH[#LLK@CB!,M*YQL85D]I-JUAPWC*E4W:# QU-7)
M(4 ]DLQHWCBP%'=<Q9=8^H/Z4QZPQO!5\X1<]RB)54,ES'17FDO*XJBK&9^?
MASF-X?*'?00?(2_&(5S\2'U]&U\:<<-EGQB$EA\CW@=<6/)WV)&OB<?]DNR:
M"7ST325N<WL&H#Z9.<CN.W17CNT>B4CFPG6C!S.,.LC5WT0J,@PP.P!1/0AB
M@M'IIC2.2W1D)EE3ZOK&9!A^\)1B6[N$VWL"@2AW9.?Q$9GXXY?ZHLIJTP<F
M4P5/T\UQJ"TQG[[1_(S#TWF%(4A_*1ZF[+1Z3QFPSIY'7$#24!WRJ>X;7)SS
MT_T&IJ$W!\4*%9?+G+J"Y:+QR>=_[%.UPZ<7&U=@49_,GWRM!<VH:6=NHJ"@
MX!!81\O^->OJI[9FS?.HU7-F[?F?-:Y^"(G>]=B NNL&\7D,1@G\.+X&&;E6
MU;&8A&XH:&0 K#CM5YC,!"^W9QKO,PBZJA=!-2!J3+L'<2];-XK@NU'U.NQ7
M>*VZ&NPGVC3!BIC#MT;+*;=?=]JH1Q_B+9+O1DB'\!?;*3JXW\7F(P4C!\_M
MQYQF)J&E58"$^EP*]I*UVW$HX OTS?[-\MV.2W1C![7/@!@AQ8J\UUG6J1^K
M6YNI(6H,!D#J+B2:E=-O[]PJ<4%45*?/@)!C5T.^6:7DM2U;4'>^ OX@Z=<T
M[+) +]5AO)G9_6< \"'\HBUA;,GS7&*R1?5MA%_)'%S$O<,C>6V7#BG:A'%X
M&9#Y.]W%D%:H+VJG/2%<\_L&WA[+<&+'$W7336])IU,.*/$C_*/Z=\@$GSK=
MY_LL%+_UA4O>7:9H,F;:,&D23=5 8';^;\+ERS+@*>^C701!4.)$#5A$*M?F
M=:6E93GHFM]I0^350E[3>L7?GK[ESRAW!M*3@5AX0MW 6E@L=5+!9G;)!E>+
M@>)D9>OB+V[,>MOUDK:R\G5V4Y*)AYW 7K:8W:S.- M%WC&9LM[:U5L^ 9T!
M/P[=<^NM?'BG6VL^U(P2*G+?.@$="Q HAP:7 B@KWAK$\+HT'R_1C(H<D.CT
M;Y$=LY^Z:Z.* SBRZT8NZZ3LO,\ 3$\<^0+(DL^CS-C :49Y\QIX3C2>,?7X
M(@#'^C>UC"'=IYKJA1S#[##-=)RT']CUZZGUY/S^L94-:86)AIK#0CDNT%T^
MQP5%MU)=2:*6X'=+^J&:7_M06/ ]!6A6[J+:C,Q7C[%WX,OQ#[9.9;KMQ20.
MN3K0H^_R%%YASNWD=(Q!Z0$O/TTC[G:?S+U9_OEOL6Q-*VR*#;(UL$>>YD&J
M:_I-J'XL[J7FW_$>#?KRGMW-!QW\.?P-3PI320L%T8(2%SI-O*J!?7R1[HW5
MVL:=43RV>Y-_3H%?A:U<.)V\FD1.DC>[9"]5DNSJ=BC,3VM4?:K6AX3W74"M
M_7J0 QU^/OI;\U ME!=*\J+*JXKTE[=/?,#"^+N)[;QE&W<RRYSFMM]UL#J2
MH<F!JB)1,3.G_RPR@RY%2_J+B/K%Y"7-!.4U#*)V?9!>0-03XTVD;=VW9>F\
M;@?4)&@',!;E:VL6: 7BV4]90C_)*L)XJB\9_:$N:F!9I[XA[FQBT5UF22]<
MG@\'"24A4V@LZ7#[GX,:M!OP_H9ZRQV>W)9G/11=:C-#_%:Y@;U"C6U9L>M+
M>>MCNI;,E4(#_A3V3[@$ :78E9.11YFGF:)PUUU%I=\JECB1SK)<=00+18I6
M-HU:%.1DL$=F!ICY/9,Q2RIKQ?W7$D48N!R%%84%+[+KR62A0)FYO29!_<IA
M]_898"15NVG>DF@\GC,UJYBB]4OA^KX.ZARL=??6!3$!D__3OVN@\"!P$ML;
M_AE_9\99GN&WWFT>VNJ/BL_AQBWZ(MN\W39-1Y5^)_H=D;20.S^U/7+AR(=3
MO,888G+LB*/C.22QK1+HK*'X:S/UUBS9.Y;,>LM*Z[NDA;IDH=K8Z2'Q_3?!
MJY23>]D;_KPV>WM+ _-']MM1Z'3DF;H&M,67]"<LW6YL6%TU[7:NQJ%U>L0Y
M8![G]@!0J3Y0,=^",D<AN!&%8*FIU;X#T?4,(+9S!7]YXU2DL_OEEHU^2_ +
MB,_><@<A:[XO76D;H&?@WS93)RQL_&JG?D;=2'?OZC7?KV#+5*SOKI^]OSFR
M\'<L\8^+:%NA)'N'I< WM0*JV 9$^K(3('D)/;A*W&IMH;[\X$)C2;2@@F[4
M#EPA>E@,?9JS1E(/#BYMXW%H$U6"PXHH@7K$IZIX%<A<1)."*WZ=SC8[FK+D
M4ECSK7^NGUA SICU79J^OK%"^3[<L.,98-V/C2]-F]N%@?3&_!D@"OSL!MVE
MES/SLG23&R.V,@_,=J._(MJ\8P\5D5^I) -Y8;$V+:Z&/0,:F7]9.+0'EO Z
MX"FO!83#>6,$%!6Z\-FSN.*P/UH= D_0GP$_"K[,I.W>%-P=:7W=KVO[6W/&
M<8J*8GEL9.[F=+Z?HXZF_M9:/K8?X3Q.5137F+ST"8"!ZJ_J?UE16<(&:;<G
MF>4JF4]3C>37'QD[KXR(XKN$W#,*OJY-6C;'+8DBZH#"9]36 '/J[M2JU0RZ
M+A5?B5]3IB>$5,23>AAOVHCK3^0I.DEC?DR2O(E0P;@MR4\[F_WGS5J4N#FS
M2G54A.^7R#5^+S83UYE<NZ9L"6.!O)'F*9F?S'5O*GL\,$*[B[@*KN )=TT!
M.5#$D3!]>=\)INY\FO'1N)2S+1-E5)J^6#1#2_L\!7Z?JPYKA0TRA^PFO8V5
MU9IT]42YR\P!66((X!L,596(_31C&>)AH^MRNCF6GV+SI]:_T>M'23"N+<RQ
MWQ6Q5!H;SZ8(!P0CB<S$1UPH<G?_YCS5*JJ<ZRQ6L/*[PK+^&QBR*)^B_#4$
M 57T6Z6S?TM/Q5^KQCX#^BZ$%1#Z]Q:--8WA6XL]6CH6..6BD2O3"@%XUBG>
M(;M7\)XLWCTK-YB'W,3[:<EA9R,Q6/VXR&MP/NC5VPS+@.)V$ =,E41N,W&[
MAS/F3."RZ";E;V+EGB1=S[O:OA2SU7=/QII[@S>(E<U:N86;%HRT,54'<?9Y
M?]8P 2Z8?@9DQ,'7]I:F9.P9H_#H(L?Z5CT$=_)$Y2]*$VY"I%/4P7RB1NW'
ML\=ZT %2V6GNK(F6]6[^UU1T-^JK[RHV(8+'QSS/ #ZYN;(772_^Q$6D3X]&
MBJ&?C/P\N59KGH0ID L/DGR\NN:0*&$6>B6Y)&9^DZ@QR^*Q<W@;\".EU=9-
MMD X7VZ4CIDV)MD\$%5UTNV07,?*\+W6K]_63S>UC?*?'MT3H]8>C,HJ/$/:
M,ZFGN.XLGP%I3F[$CHS6>=C%2WF, L=19:>XG=Z,X2("F;1C%X.B[]4G*TP]
M+6I"/UB@26O%U@4U<)AQN'S0VU]:CFWCM(<=!ORU3,[.V1)<RI%MLRE<, ;,
M%+N!%,7.SR>T8F%QU5=ZY]^8;S/>_S:M5&>)WD!N9A:#1KE$S<E -NK"Q]!G
M+2OLT&&LW_8*JX0A,+%:!=M3FW)60$#$D46XVPACC.XF9)5%7U0(B]SV&0#K
M]4%-13=OC'TE(*OQQS1AQ/N?L Z8?8A86N05I5.>=8W5 YE.UNJ3]YNN:=0W
MR&,&M!"F^_-J?FE]!H0.R.&46-CY=U" UJFM\1WHAB[GX\1J>V\B.E/Y(QXL
M5Q"+KS_73A8E/QX6\#FQ?I"#,])SJ"!MX-064#\D[\?? QB?XGG8P.</KS)'
M-V]J2J=J,][+?+6<YF41)EDXU&[*,,/V0S)C]K$M\T&X-L RWZU\LZ3_VLF"
MJR*+UK+=H8>3M#;LT'4WTU:$V.-WVH/,=5-N?- ,)OE%I*E/8T6?>&P44;0[
MHZ<)T=V]^@6'YS"\"7M1NK&Q@@.DG]"WX6]-8&LW!;^3)^9'=V^^4(\K@E?S
M"%^%="2_]AZI,G5Y]Q6E_J2O#*5""4G]S\8WX.?,Z8+BOX[@.GYJ:'L*MNV[
M) 2)?_%!D64:!ML@OVM7WV:D#9O=O&G&+35J"Q954WYE765C6RA?-L=P[UIK
M^QT_ZP;M[[ I]2SJYJ,BF#1O^9W,@#]*@5[)]#G9!*/_(#M9K*.QDL!7Y*2@
M+?!2.EZJ^O6K>7G:Q1^264.:K!3]UU_[^NG/=:F8:V S8F0W"BI3=H<5E51@
M03U0CK9?17^KLXRC3]S%Q.],D-_:;@#C#4OFS\*]NR\UR,H%>WPI8V5V(#8K
M70U^ _S\F#-F)MY'LFTU/[Z7>AWZ%_=7XPMYG]HT@73%AP8>73JF)Y6=T3LM
M@D7Z<VDE:V&08?P%:LYI\F\ -=G!YCK;N*D6X4H#Z_!1A1MARP*C'J2Z*;9+
M'U,>=D'M!<"7[:GS3WM/$CZN*5HGHX3XH_B*?+[%\W^L_O3#A5=<NB7-RT!-
M:2/)9&$%"$1=?S)&LA2Y-Q\N,*2] JNG#G_O;C3PP T(86Q(U6S&^XWQV,[^
MDS(.7># 5KF'^"H3Z\:I8N'&0:EVLE#?_V4^%NF"8W,<H!^P_38BUV':_QV*
MWU:*CW^1XF-K7JP** L^0PT'/AGZ3V0Z/)ZF/R79[!W!.^:/'-AIZX,Y4Y*M
MT$M%Y44P3Y%7#_4"</S"EU<6(9].UD2EW:+-!7R=WO^,1=2,ZAWP.F#M-\V&
M^[YW*M;5LQ&*^Q%T[#IX"TQRWA(M8D5F7_%""1;D@==?/G(H/0-F+^*6E69@
M4"/&E,]3!Y7F4N$^H!F)-K7\M2K7>.J; .VI8]CE-"MM0_ )7(K<L/ ^F,C?
MTF CMJN2= 0^=-)P DMMG<D4H2,.*A>MTCW8A,6BG$#XB2P&Y!K_B!>7/P,B
MQ,C&I*\CC\2K>);%)HTRV KNF>W#--C'(DA5A)$F0FO/ZO=-A<]N%XX<'J1R
M0=H8#L7[9'[I9WY]1^QJ? [99AA0%+<$Y#PT+5+L(IJH,T0\-GM0R5Z]WF@P
M5$31W,.%8?8J5%66=^I3KS"9H. ;+T"."%*W-S!\>X+=5]B2/92.3%_V*:ZJ
M1*5L-Z2OO:^;H;1A*:XG<=O<-#B=@F!,ZVU0L?SKT,-*MPQ;I1;'_.%B_29H
MLV_7"UQER4MH2=M4_]/ND^9Z2=;-EW>.COX]#\\ A+EL0,K:@;#1X.R9J)K#
M*^LZ>!3H?._.5WLTMF["(+=O69KQ+<PVI.7&955R9?"'Q3CK9@.?W; 7O60%
MZ=5&X[<'1,V(B[X14F/J\>I3D),3G3S+7)?NW)G2>'\1>-;A1GSCDX?\]3,@
MZ,E*6II0C415FA#P_S!( \8W9$OW:\19:SW-%K9RV& ;@LVD7^T&Z9<JAW-/
M1!X]5&3&Q)[V?O2+Y/*4"6L-&"U=>W_"D>E$.6=;'52E8?67"QXSFVSO/X=\
M&@?S-,B8U 69J,AJ:O;R]L1'W"U][\'%O)G8EIW$2B%6T^EVK=K8B)P_T7!;
MSZQ='E=L;JY6JZY25JA)49XTK<V\\ME5H9PE6/>-$.S_@WQ&)#K<XN%>C?C<
MG)N$*3"J(O-209JQ8EW/SNLJZV1?MRK,-6<]5K)%*'JS(!C>!8G\6\6VX],H
M90$4KK0PW, \XW"()Q?+60*/(KX!B0OL-:N8X<)ZD=Z!=9'COE,"8PK^6Y=:
MB5&HX[48TG2Y [OE24IT!0^+3XF>%Y1L0+@XI%XMZ+2&$8+JX:JV[ZC'0GK'
MGN56"!IT\"I9L-$FCQ8=VBL=4C8A!  NH)A,V3AJR^T!5B?+D;#XPY?+".Y%
MQ:U;@3/?U1ASC^'XXM%:AUTMZOE4WN2L+:^L+_5ROL,-B[42(\*N9=]5)Y9G
M4H%9E6LN9.+!AZPBV+XL?OP(J*&E/+552H-PC6M_.WG3=ITM%74$?#4,-GA,
ML<?O#4S9Q*(#DWWJCP%[]0YUD@))Z#TJGJ*HFN.VN<$K:;@W$N 'AF+!YMHH
MU-"!UX-F&AL<&X<T*W$^6H9M(2+ZV+N$67@.&Y/J *G'+,"/XH,O/<JS1(NJ
M2D?7;^$ZYZ.1368V3TPGEM&C(E26"YM605?]Y*P,2=_O@I&VHZIP WD5%M7@
MVUU/[$TSAZS;! C=1XBP*PXWK+_F.*&WB+9I?YBVY^FIYV[KY34?SJC=_9S=
M%\/\%0HJ',%APQSKWZ>M_L?G@J,$GO*\MX?O#]VP8M]KUV"S54+_F.4TE;U;
MG3IM+VX173W&V[W^;[R]YSN;_QLWGI;25M':FY96*T;M%12UJBB*VFU1(_;>
MBJ)B%45K[U&24"(VM7?LF$'LG9BQ?S[?^W[\>WC_ ]=UYGV>KW5<Y_M(LRT:
M9.%2=D>GY/Z4D@,#RI6>*ZNS#O*"[];FY_4F]JON\:.^:P#"IWDZ!>A2V3>S
M\HE6,#W]<G8MMBK>.Z@7#T5];QK/DNK@O4*M7,[!!NH]@Z8[!0D3<S2>1-^;
M<<^*Z.!>Q=[F'09,]#/Y!XX[5SVL_9J74WI72VS+'J5-C+CW@<QH48UW=@;T
M?S<%6[G!P2FVU)XFU2Z#"V)? 3.F>C1\8J0EK28$4OV*AMJ45C/^FB'H;H'M
M:A7X^6XNQ=P;TL[^3%5:N->B7^D>\3PA\,"XIJZF(5P5<^;]LYQO]LD. UL6
MU/UF"MJ:D$!%V^6-^*F]P>[7QG@T632VW/[&I3KA\*#'7JXG=-< *[!U!GW?
M%U)0<&(HJF3#5(9&QBDPU\AHCL*MM8X"F<,UM)GY+,40>4MGBJLREOI^])'5
MRJ!@SR$L%O("&=">%,NM@WN6PU;J4TPP:#]A(D8.<M5_-^IR>Q 737^34SSB
M&#D.(&@<*NP3;KV^QJ\O1E&GT?G$"RTQ_X+H_DL)/:)LVF:EI]F8^E^R3#CT
M!>?HEDX ?(=]VO=;RN3^L8_?5V;?]"56[S/](YIWE 9ND E_RA)U+#/4K2WP
M>99B?>-K]8YS+B_!OO)/FNCS(I8O,&^_?^!L0LB!H8/.YMGF\=23&K\?9-*E
MU,W1=Q@X[@!N039M<FPH3?NUR+W]KAY-(KC.#:9E9XHU_+($OJ!>KCGIIOOB
M#_,T<"?'01"/1O".F?5Q:@LH2X#-(+D@\-AG,(!$9LL1(K?8#*^1O@G8UB17
M@/$R@36G!X36/>7176O;M;\W!=UGC#7NLUX%[?OM@\U; RDC6MWLH.3;:&"Q
M"5\;XZGSS*O/QG*"7'3K@NF?ZXR>&Q&- :G?W+S3^OO1G/F.F=-Q:2O&( 79
MNS_J9'(QM36D/T=#&O_=7R:+&1XI.W[B?F!U'"0PH7&.M,9URC&M!2V:;S$%
M%KACV/%)F*1",Q/1_F.%P1??O20=$N1>9.5T>%5I7P9F'TG.WR.\H;RG4J+D
MX,&+Q\REP>>I!O-S2ZTBI2-YC$$>&QWOJG#$8DVR:>W-3E[!OU<A+>UB'=)_
M\GJ900FEHZPHT<GA&T13Q'B]]-=:-':BZK#;<7.Q"K+B3K/ULW^50+?NDGF7
M,X22I/)0CMP[%Z43NV:,[^@L?6 -=&#+(O^+)/9?<36NV)0R,+UINHQ"A6@0
MY37 ;FN:KN08#CSGL7VZ?]&(<23T6D@RNZ0?BB*56!U)!"(OY*X!]]BR'&R/
MX96GXC],'?=/UOJ<9USBT0PHNXAV#$U$NX:M!^M*9U;)9 58?<O>*0[TDB-:
M*',!+:\$<#&R#O8@&8>*RM$0,I?,,COZIE\[Z$PS3$8[/<_RB9#@PF<F30\K
M20='89W(C;RS-&^RE^'.:HBV#&*\?B?A'JFR+B&>,$Y)20AJK_/,=13-8M0H
MG?F3%#N__<@X.'.[KX\M,V.K)#=AB*WHGMQ7#S^-S_M[;8$OZX:A3D7B]/I9
M%I!%]73'Y^:[U(0#HT :G(D9[9@HN!A!%M56(N*JBF9I.M)AC++.:%\# *3N
M;S[_WWR:DQ&"KAXUBF%'=\QM#N#<=?,KVUV_5JJ7N M=,@^-"4'=^*23[[(W
M%>J[&)VRF8EM?Y%&6J?O;L2.(Y38T>OLZ$U+[\2V9+/G(\Q:C4+9%'_;0'S5
MJI9F>D/'3VY8@!L[Z7$7<PW WIF;^^;(8/PL@UBSA8TVGY'+(O2K\(XIE.8_
M0E1?O 8(=U9?/3G7!Z715Y[+I:#=2AWGLHY=H@-%ZE 1-T1Y%$-Q#=@Q,S@V
M[=.J[)M;W55^:\W)[B>Y6EV<ATPY.@M?>XR5(S'?-#HTV@W#OJC2>"M_;&M)
MU^.<T)'00N,H=&_+U/(Y_A^3^HMDI7=,"@!^EYZ6A2]92JR\E'Z_ Q\/\?IK
MY&D4FD?LYS].6G* ,X<F><A\!Z&?7P,H/:#J8F8<^,;CHMSE+^U&2D2JV<N\
M"?#^I5C?+_5GSXVD0\<_M*(;1%*'AU][W9X2Z5O?HWWM%_J-V'Y3$ V7D=+?
MH7EWRTR[R-OMW3@(O*2^0V]>.^Q!TQS+R:-0V?7$Y[DSOIDXUEGY;@_<X(^^
MD5)LAE> !Y@T1>8P%YR,Z?(+NT]QKV7A5N=SX_F^B^"=2Y]?F?0XKV/RG=62
M8KL4IJ9*WS^)F,%@6;WUXJA6?I^64@P][AIPP>GKT%$TW32\9J;ET=PW%2?8
MY]"I]79)9LL.XD4;J]O.1IZB,QZ.S-TR8'I6N7Q*Z4:CSO/F=S>5\JR8Y+\%
MB#FEMYBIL)X#V' ")MIHV;',UU_!JT9ES:7"A*M=XD[L\'BO8V0O#EM[7$9P
MZZ2ORT_<" 0E:E8&)A>]"7'(S);\=W'P 2.(.VH.OR+?.GXY(-HG!3I .;<T
MC$B']+L$HQ"^2KKC[J5\3NHUHQX,_EOJ83.\?I!=1I0>1US+2'7R%5)1"Z.1
M+GTA,['+FS?Z&3^81QF!X8BQ.+:9?O<MX)_DZ==.4HYT+UC:.UQX?+&W-D@"
M5Z7_2#F2\N>D]YN "?WMENA5I)X"AQZ#'L/MY)+Z1%9>%[K AWA[\>_\38_-
M9FV[6Z(\1A?4/A"UV#JK+84XWX/*41->@]%BJ3')16X%8+I/R9CC69)6I)X[
M2&J-E'2D[LT+<ANW*]9AT48IZ:R=/:H^:,_+^_G3*H[QP9F0C$$?KF/:C$5S
M$KM,VL:'\EB?79 <@PM)"E^^3YP+ZFROX95D2PNL$^(UL3C2R1W>(//?4IA1
M0D#I#KO#V+-&5$JE]2\W9,F@S(T0:28MW'5O9IXC?#-O*.^V] -3/R1SXJKW
M1Y-G>CD<,O3</$9=)>B'C*-;YC-< OA@VGQZDY[)#/Z%P=C<^&N'HH>^;EO)
M4JBVMU\;AG-T+W 4YMVY].%^@0[M7\BT8.8ROYI<C ?-NRK28@,YK--]>2RG
MK=O_J&U*\/]0&^>#NZ#_2VVNJ:01-^&EF&^B=DD]QDR$U*KN@Y)]!">[V&SR
M\?)[*72(P+.)&\(B)T#6Y,?X0Z##'ZBPC-71)(+-S!6=\C>E M:TPH*J_+GY
M([ RRJ:FA:O&A3&?'*:Z>>C#_C&R91X%<[<->%X)%X'9I,<$JI[<1OQ 0%YP
M:<<EK9K_#EYF(W$S"_V/HTF:%[\C,L0U*D*L*B&M^YB5VUTUM)%_'SZ(MF9
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MXMU8E;3,ES6M4<TT)Y%]A:EX65N2)^1)RHY"DX/T^SM5&L!S:K4(K?. HVM
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M\.*6W<Z!S#,(;H"^BTDL$1O A&[#2$Z %"ER/*O1^JE_N[>#"52<56 D*;N
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M.*(^^EE.H4ES,O*.2N\ZX=0<^=_'8@$1.<Z$(02*<=,HW66SB3Q"Y2_CP;,
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MV:A#1L/<R=7V0 ).G_X8MT5)3%\^4R\!@#)J)FN)2E RI4&J*>_25*H2]4.
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MR#OOU<BG"4 %F'%[>L-A]O9B&_!EUP1,O= .F2F-.T;P?0]G<)]:JKMMY?(
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M(MO"4)<IJOOVSS">AV=>8TX[J/U1);[QQS_Q+Q)LX#RL62T9+ &$#,I3&W@
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M\&N@%%0]"<$WHVH[4:H&K*J7S==,EY525E95F#+BWQQ%<O(M[+HA3090_F!
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MC2@.TAD^_9PQ<&P3KG'-?GP'_"]M9BKD3:4Q8N1]1Q.<X ):*-DYTUTADEC
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M2''I0;94.+LX7LDI[8]G/4R/\Y?N'18&194Y%C$^\@>985?NL;O'?TMV.'S
M_I]]1/)$.&\9HC0EP\I/.4^=Z F,5M^[8C!_=ALF]%!7[MUA2G. "%RVP#:/
MZ/9#^T<PMX^->)@1<0XH3IG!<DJS7120&92_.7;A$J#M+O$^8Y=O%8ZWQLY/
MN<BKIL9F'W^.IM'W_36,"+!+N*FYQQ8'&K&F;:R0F_E>L=C/L*?6)?Y2U E#
MTRC1[7S1+^4;BO[!18=W!EHIV@ZGJ>ON\S@*_Z70J5Z@UVYL;GA*O4UE@8^$
M[29&,JZ;\/\\P^VP6!2&7D_C/9@M)C4$OOIL<&_3UI+S9]"]3<%MP'U'(NF=
MZ4FS4+J:JT#S3V6N.A9T^[[_/(#&!7R$II)+47G>.Q:5,B_?(1!#E'"MOYY-
MJM7"80/:D@^C.O^#H$;VBU=;>GIGOZ/2IMH1Z"QT:+SWNIW%8RS#@)H/@+.S
MH+MRA%#?-.SJFG_P!FV?6M?]4P(_,233[]S]%*7_.5+@&G!6.'?]S[:%U]!X
MT#EE!"F)Q)Q=G;\J_#(RO/>:1/NX_XFVN^N?\UY4J8FI-9T42&G]4BQHT#;+
MNO,90$JS6;;E?Q[K/=%#&(2?I=VE-#CM3N2?RJZ;K?]'5ZG@$@4I?[A9XI,O
M;?A.#PXB7G/<@6](\OL2JHWSAEH'11?2B@*HM;VNL:M)J,7GIX:3^U>;!'XW
M#Q$)-QGI*%4FK<G7BF\YA@=>&5H3OD"#2\?FQ4](,)TK=/^;W_&@F"*8\WH3
M_X RH[2LPM21])*MX:OJ+H.(3RHXO1$@?@]MKJG<))<04$*M^>:G6/?+>_ZP
MG3:U")W2+,/*DBZ+M/F0]+QFYIT^[114=?2<=H6T/4Y%D4_&E'B'7E@3#TVQ
M"5OU!=2BPJM>"-I7%)\.'_$-P?D,6/"0?B1C]EE\-90+6>V_$YKY-:.\US^G
M0#Z,&/XS_3["G[9)DKFIIR9_5ZKEJ?U%WNQ+DYW0[JC,UN[F/6T,#V@:N;+.
M;SI=*.C6?BU#IU*FV"D%H?J%]E%^SDR=@!L8+[R?II)WX.Z@[E?$P4*AG?/\
M[E-K1<^?88$A01 (M:F-;J2BVNMJF!58#6QF:KQ8^:'DX>'1:P<AG'V2SOJ+
MVF0><W/W?7-05+J9:^LB*L&!NZH\E6'4GU2K"-D%#X,^,K'S<C-1?'MWHF1Y
M<AN[=8Y&1T74HVUHS<F#&\U?/$Z\?;O!U,-P>2B0Z\3G)_-:)9$RE)=FP>M5
M>PJ[V?"<ZN]S,RA:QTND1!/(Y"5E7 KH5$CSI0]#S2^0CB^?\F_^,QX\2(@6
MN3F>(*VRH_:HYF_"M^L+HW<>&&DV7 E50DCT"01XBB1%V\!_H02(N\'[VZ]!
MZYS& ]99]$'IH]_B221[U] <0]$1'AMG ^8M2U[VI6 UCR/[HNXF' I5'+$8
MZLC?X-.MY@CH.M?I5A(Y@;-AD4QET0Q2+S%0(Z/[.F7U+K?CJ8SN(I5$BOQ@
M51>G^O-.VQ5EZXNGG#_M9D9$2X8.K6Q&#UTI>MIQE19PT;?*A"MQ*@BSD^]>
M"Y[\1UFD%2^2';>I,XA)L^"#V0-2;_D-+O^ ?K/02F)BTR[J[I [T6A/.C+[
MV(;)YI+&)='*)O3\88JQ3TPZZJ0I6$-S7L+<'X:=[E1GJNQ?SCR3))'&WXN#
MW[5P#R6MJ/ +[,_QGBK<.J=9'MJM2!70":19[QRI&?R8):<\,BI#[6Y69E7B
ML&):N^SU#QNH&A+J[8HUG)\"\*W,?"*]N"FY6X4TTG!330YUS])\![%HZ+3B
M["45))@3)>,<&=MF"\=YDWL!Y_*\JR>#N.S"QQ-7R5/\1E$]Q*SU-:*;5JL>
M0W4N_K3$%L!)P+\I?BQ889BAL]HG*2;O>@1$ "2HESS+#^YMZXB&*AV@OK,5
MXR4+V&SH"VAH^9]*#1WT^U?5ZYL;6M 9./PR!=$/"K#46+UN?1]D39G7#2^F
M,0XI48VI?2A'!ET)_4)UZVTC]M6#G;FT65"? 57ZYNT!"780;\K\&($;!%?%
MBI^Y9AO4>47'=U^9+6.?@\T?8*/5(0YL,;Z65!UH9ZEC4*ZTOP^^CN6%>#NF
M9=R3HI.$B!1%"R8Q&>YHA57RHF^KGX>TAY"&%C"E/_74E)'YPJGZ#4)(,P.=
M+:?VE$^_*EI1%];0@+^S?I%RVD^PA#SP/P/2[+;/[Z]45F,&[KFZBU@*\5(_
MT5R'Q?RW#<0KZ=%KO3@! @9RV)]"+/YKP*7-EO*V_!K@QM:^-/V$_Q>\RKUY
M(3WZY;KV3=TS(#U@*72MYQDP.V=0JR<XY[4X7SR_I-%$RN^"[_3&G*N%NMF
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MNDV41E11RRG^=M^][^'@\8L7E^V*@2C]=V(LU40R!.5GL-\0<L$4P2N2P%L
M M%5<]6(#9#*UX_->.'>3^'%1^D.E.J9E2UWF4<2?TN\1Y.$Z*, !*IXGHI
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MOZKG^[[F R0+?O&]E+ZQ@O*+9)J+C1#%"4)):(:/A3^!'=8:@:)4=A4E:X1
M,OY1F4[]/^6.0$_4N6GVU/T)M+63S7?"Y%/N27P?O!;_?K[1-S,O#+\846L$
M[P\%@/OS0?FF[8I9]NM-P*CI,J8G0:O^E!$0G&?X0B9")*[ARX\$W%.*-?<C
M]TFO=MIP4(%B4&;]1]CEI>J8Q!P>S902.4JRQKY\4CCH4^U1SB_MCRZ";PBR
M#1/C_U3HK?"E]NTSS;0' "_,=\<#-B<WX:&%528&_?// .+//;=$+W0W>VX*
M\<BD!<PWUA()U94=&7=52D $<KP,/AM+)'ZO2Z;.\URBQF/G>@;4W+U>O3^Q
M\7NGUBA-T.E>T<BV9'G+IJ_=]C9/Y3O**M-3AE0NCL\FI6 J,J?ECF*$D5R"
MJSMCS<Z1^S"H9%Z RI15:]&U(,TV2R?7[JN2+%8?\K8;&AK@.(=QQMD*_N&)
MGDCMM@U"-)N2^I.ASD)FV#,M\(D8FGFI_R#]2\UU[QF@DW(QG(W70#:(R[^=
M^ZECL2QJ&0\#%PM9L4>@-K0&P:@:04?@<$M9$^FH+=VRG,QMJ!-6R\35UW>D
MU04WE<^/YCRQ@FI3Q3<]05L#XY9M?H_^*E0?UL2Z**+>WVA#2)$Z;#H8+'3*
MPDPMUPU%&A::6#*1>R,P-='<DSZGRJT'\/16@$*SUR+(D?%D=PV^O"A2(E!R
M0JDDCKVSNVMQT6I-W5X&H&UC%O6),PSS>BA@1*4/SOI9H(>8$]_/Q?GLM-ZY
MUFF/=QKS12C@[WJP>W\TY9P"O;_83P2.S/C%#Z(/I#(8*SNSS27T[:%&=+0D
MN2E2PW-"!Q[%%OR*AMN34Z)/FZ)C)CFN4#&* <'\P\V=XEL=H?BF3<M0[TGM
MK0I9EHJ0>2>=),!VH/>POP0T,[5@Y:"%\CMT[N-I^7K36K\<AL%;,NPP7MZB
MFI#&Q:RU9P#IUW9I/83)7B,;0Q.B!58<3BJ8,SYGIT>.L__K57<K2L[>@[0G
M+!'CF!(O<1O(Y3,IB)EQP]/"A-VVZFY$DL5MX(.W=CUB?,TN$"LP:: /IVF?
M%CRYC:>236WZ+ N. MBQNM.H^>NGHD<UQ:- S!Z4NV::L*]NOTW@2ANHBL"^
MAK?ZJV6NCS#="'*T9.1OC <_/ />-[:D/E$&<49Y*PT7N@,NGZ8Q^R72QBZ'
MBZ]E#+DU/LTW>4@3XB=-AYUOZOR\*$E*JHPY.;CL&E1T&Q[N55L^!!]TTCB0
M)4CP0 XI2_Y 6PH@FZE6P;Z#Z<.%ZJ=;R*OF(B&(JM"+BD:'$Q<N02YSLT6K
M5"SYQ\(06])E\G7*U$;>$R61JE"2S?2'=E]BTQXB.CIY?U?/;36/?@Q![ G5
M2&)CI_.64RX&JUTG @JY]/1>"D'NY$\P9\_A9BD&:*-J,)HXE8,% 3-L3=7-
MW'7#!N!,/DKCJ2L1Z%YFYO?MX\5>4V4NOGK2ZNE/1Q!OM(Y8\TS=>(CN&V76
M"O$.?0E/8_L-^MF=BY9!&JM!@Q;AU!'!A/L(<P4+UKL$-ZF/>)XYC%5_.X*N
MGP&20\SVR[<&#_]U6,O$1WRLD6+SJW<&^+G7T*>1]\!<]RFLXB=>!77E$J0-
M_EM2W=K$\RO3@)M!('YA!^[Q"$:%>&7^* >"_-S(I%:1J6 .@T$SM+D'1;^L
M4_=RA_8TQ3]<M]\\++[9>C:F]M%I!BPFXR+T-P= ?&JJ>@MV7Y&8ATO\YMM>
MZ$,"KROL5(>&[,?//U6BYU'&WM64"@V^U&^YN9OBIX4^>O2JR%!<]Q[>E'>3
M.Y"2&CSQM+4T@46!)GDTXT5OR%#9KBFL1KI\*/$B0=O'[! NINR=S#U@)G^*
M^B%Y'0K /7V();[ ^$"MO*DZ7;2G,W LZ 7UX"FM*$GBN__FC8/'0LQW!XK,
M?%_B,$GM&I-QPMW-6/.-0#$)7APM,HS^U7FQE;:D*O]"OG:0O1/;0B#V@9#[
MFR?>SFVJQYR*QL:5>U_0OM3-48!M)*C$40QR0O1Q[LBS^@H3XVTU 0L9P,("
MKZW&XVH[)(MKMX72I:'V(.Y=-G/+7!-:-*O50D8?RL6(<3X/TW]59(6FS >E
M:!8$Z,(\#W(ZH9<:U+,50K\F*8M,V+%*PD0 .Q<U.T.4"OGX \% ]:0YDL88
M]2^*!#(D/H7TX4<8:&7=%R&YP=NRVR.9IT[A[WNF-MG?;O^U6_^>NM'41(71
M),E]K)&=:]D6M>WQ&0VK-S+A;@^<]<4Z\_RA6I>FA/36?#]T]"J92&DN"'>V
M.#7^G6)IIF5 /O_;&\K!_/YVTZ7/5A>3:Z[N9<SMP.U5/#FDQEVKO2WJ!$^3
M9LC%[:Z?)B)@6F_Q1H2GUN*?[DKN><Z,3/&[5U,B?V5ZST#* G\XO'T?I;>R
MAX54QT+[_O,NS&YF F#Q'CH$R]1?DNN]/)AV&DZ1>MT>;Z!=)D-'HWR28")
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MY@+2*;/*)5#DLPI#%K%A?"WB4-/991JT07O%WF6P<,=D\&BIUL4G'L^RS5_
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M>@Y%:L)KSM0\R]_Y%37,;'QF<!Y@URZ2AJF)RSSW,CS$K&"K:Y)X<UMOJ>\
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M!RG$]R&")#!XG>DX8HL:J=GB!1K*-7DU>89XGK+F'SA"1\<4J4HG4K>^=._
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MS)T\AN#>FGI/2<ZZQP*F+2C0S$65(Q6.+4NY#;#J$O7DQ:#TES\'Z7"Y87Z
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MGLCC>EU!YM&**R-'+P;:P9!6RK6BFTLEOI@..L_0ORT=,::M2!\ )!'ARJ#
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M*AG;5#-X.G_PG) &/-W=34Y.Z'A^"8W?U8B;?MH9!% C(K<0D?)SW#72"98
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MK?Y3\5;@JJ]6 15M;N0T1@V:,S2)$(ABF<& )KOM2*F04BMZME0].$RNI<I
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M.*$QLAGG =4/V)0+KLH;AIH8A'%9J,00??&KR-<*$',M"<\F>A7Y*A)#60Y
M!OSTX)RM/&LJDZ8G93P4WZKV.1LL);4"I#%UV+/P"(G!G-UM7 %+=/8?E6'U
M]P"MC]&1&5G\L8X=!XB\PX,? H3/.@ZW/;X*@=B6S8?$K\UG(9) 30-GM5I
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MM-^6>#9>%[CIR?$.8W"[JWM Z)TE5$KJ&N]8>=O/8%5ZS=9A(U0C3W7*@57
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M'M@\Y#&],!RD#>Z//2-V\>FM$0I=E7HRX/?A!K?F$].I<*8CS8I)=6_2="B
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M_ \GU53]_OC;8Y%IZR"!T-;ULG+[*%LO[[IG\](Q8/!-V,CB-Z44=:=&J12
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M]_5.]=M>3*^->W!FI3F(RCQ;F*#N(V ]9>_:W9(2@D5BQ8FP$*?8]$IRS'A
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M8R,JV1XFU/SSCD-,"A1@\[KHVJP+$_^)ZW*9:GFW^@826/=]-W*-W(N*GR]
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MQ5;-KKGJ!=LH!)<N2E(TP7A)0#J?<XO6I-%G("_E^Q7U*(/RP3B%R/03<VT
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M"PKIE6^H=7_)/.BBQ.;SO9]=X@U[_A45_51S6YWUE]U#J#]/7_!C /5'"Q<
M3KD0?1U,NHB%PR)I[6CUM@6J[[JE_)UEG04 >)"DAOMQEP8X8*94#0G9$CV>
M4T^AN@?H6$7DE*EK3?)^%3E\A_-NHL83%#9U*T?C$]F%,0A-7]7JXQ(3S!$]
MG)_:LS<<1J:?R RRS.H1(6DA\MM^GB('^&X0<E5/%9@C8%QO$.$06O8NP@E$
M]?GW[3T &O:'XO?0+$<\]R);9*G&+&O\</)P<G9@@ &)=&Z4%);B8TS*\&)K
ME=9U<"XTH_@>\';"X1%M_(<-NC;0&>7WTW?P"9@@2*/J.H[6IHWEIS!R#+MV
M^YI9AT' %REP_3@@C2R54N_]][[,T4CJWGF>+0LFY"A(H)^JOPM\F)._A?+P
MQ^;F*VK*]>'UI/YDY[0MZA08)M486A_'@=W:FEI<I2[8W"%\)?/&\:#0C^)=
MX*"%6)*;"S&(;@UE$27"I%\0:QDK3_[D ]8!KF0#HM5I\,VDX<WO.0NM(%("
M ?I& !3;'_ @%_<5EYF9D1W2S<1D**&3:A"4_7C+P6._AFR!IQ36TU\206)3
MV@;@_!_MW?<WG-&[*/!!$"%$HO?HP6C1.U$C@HA>HH08-7KO)7H-HD2)Z&9$
M&:(3PRC1&;WW,A@]H]V<<]=MZ]ZU[EGKKG6^W^]=\\/G'WCWN_?[//MY]WYZ
MII*\I%^3E"Z;'P3F%9C9H9OLLVX!<H$#Q7F93_&I;(9QT3<$N]YP0[G[Y:4%
MN@JE5  BP#/;_W;4J/)JP6ZH_YB;>=-^1WD;:=&EJG\%"WJ NDC \QZRQ5&H
MW9Q<H1RT<DAT\ZQH'!,X[A'H.=]NW"?HHPO^:/=Y-K 07*;Q\EVU(84X%)H<
MGL(GML3) DAX6;J,^IE0?UA5=T@,"C74-6_0FT[N8E 7V"XO+!/"R@XJ>.%'
MY_LIRIGQAMIP4<S&-E\^P2V. F<B>3Q_QZ0M>V7 ^;$9W*WHA8O%2LGO>*[Y
M5ZEF]0*]P MBO[@<?26\^*!5VFEA$E)%X/*G+W5%2:K9/_^L6W3E;.'0!;(W
M%<"QD\@K'8!"<[KU-?4QB[C;R9S:9^BKR2S.XO]UA]WME@F5&[W2:-70UFC3
M\ME&TN!1'_=62 1#24C.^]/*TD(47RPO_#S\N:V18-*BHFN8]%C.=67'ID#<
M>R*&&6E;',\KF!YB]M.Y=:6KV2Z;Z$TNT>.P.$K6%?EAWS+[[W9-X!]!I*94
M.?4K'TI^]]'X6O=0)ZZ+;]N[CO6/:P;+6]L_K.,>$[.Z7WA$]_84RVA LW8\
M_]',G,H#K,1D'YGU,X[Y$[U_&RIN$CV46>9WLR[S0[;NZQG266/>/P0X4N?T
M3<G7>^SJ?!276>3J%XE=]7G'8[2&+7_6S_#D -KSI*E[<#*L:O!EA?I(KIB3
MC:!IOUP,@K3-D$",2OO0, F4M115G'DM9]2EN7 52VMX="!.G38UP1"<&)BS
MO]W&,"XEZ[B^<]Y)=?,GYR#EQ7PM@^8Q?;719RS<HC1P.#:ANG=^%-U^-'8<
M&K584@J!%-1 TS=7Y>D$GGFYC6 A&C],"N>1\:45_$+0O(\-*YLG4KUM,S$-
M6M9(' L6\EAZ8KSS!F[E%.]5/H_-!(W%K4T@=/N%SBJR6-%O3:%7[WX,/,_/
M)\5&.1)07Y7-'[N^=H/GE\S4QZZX-KW.NY=AE,I^$8.U^?H.@%2%73=RA*Z3
MO$P^C=<T):V'?@0"(]5^5*=%'FH<QU%0W3X";+4R 4V\0Q&TA_MS5.];6W4'
M7CA@&7R2;TT@EPG?&M'U,V5Y.^&H?2T?./!4,AX<2U6H/8P;,@_'SY4[!S?;
M&_N)41 :,(>241FLRI7+!.O2?X!).(4FT^Y$I5@J\O=$K'\.R>%*/!G[0@ET
M<.2Q>F;O2,;ENZ_U_$QZ[^NDE+:+2X!,XDKIXPN=\$3I>60,5@Y=@R=#&*I;
MWJ-H[Y8[3;F VQ:M(+/B>"\S=\-M3)F.J6.;X K&$-H4+_NZ;JS2HJ8ZA*D^
M0N$;G[GLFX!A(:SX8F\]S@5GCTS:-Q,FUK.>2V2./?YU3+ATQ"ZYS^>GE/X)
MJIC_&,)=@OQZLS!SD>=A>W)49NPHQ\1(RZA7*?.F@S"1'W'-=X!@I,GO-J+)
M:ZO2.X"M=];:?OINOO&L4</OX 17S1>YK6[[8I!"Y2,H)..YF29/!CKV>$J?
MPXU8(.)V>Z_C##P+J/I@95\R!VS]3MKU(.Z>4D>YQ&)]TTLE,OZ *JV?DHY@
M\O-,DC(II/9"=3='E/#TJ22;=32$CUT2"+;:V'"VV);,S5W]\5FC>*$23&,G
MP]&"52_P!ZB5("?;$59"5TV]OCZ&_:LRD!XD#';ZT#+I=)3\XIY?C$L>%_EN
M0)_4U4>N =N++.0\I<0LG/X[T2!#'JV3/BN1T/<CF%M('''+Y(*H$D4M=&,?
MZ5<J$A3$'+)1)CX;=JE?,D6WV=A.[=WJN$DC'3&F8+S1VGHOKR94F0QWO=D5
MH),\ERN'![UM9\VH^F[+[<SV&Q!0[$-RX#!U4\E@#%@)DN@[NLV9RG)(1[_-
MX)\9@LWOUJXA*3](?<;_EG?(L(#O&_;+C"9K\Y=H:T-ZS\#O#_8B5Q>.(5=]
MV>+B6QO+?I;-ITKQY*0*Y7$ /  9EEF7)G0<^'AVC"U!". RV=IW$#!H]*U6
M>-!U7'Y\=G<]W>JX^X'K<;NU]GR*W#4HN&FQ 90_35A1L_X\JC!!("-Y6$E[
M/JM_K$76S:.B*LICK/@.8-/K2-J@9-<VLWM;LI?H,>H>.S>7AFA1T#Z\C[<X
MPM=G(XU?P8"\).8NSL>.X>X[\VNGO2S1L:<UIJZL+/S<T^42;8Q_^/QF53HC
M$0SPK>E-&"K=_?W)/MCU[3(=X^O[LO$2+9]@;3B3/(ZX0U_8&UN:DG@0Y]XQ
M9'+/XQNWDO#4P*8J\JA";QG&6CM7XX6Y+IH7)=.K4@#LY=[7:CUJ6]3H-S\9
M4@U]AZ-.$TE^L4X<?@MC2E-PW<=_0^:JTNHVLI/+-U77JZ,ST1/'C\,6]7LP
MSM4D-:RSEP$*+?'641W_:D-1X>(I<S8)/V2SVC4X>?5@U&S/C"D8FL.A5ITN
MNS _A-4H3J_H7WZC)OMR<NPT5H-YTJ(^SKGC\:OYOF>W)Z)O--Z5-T6WFLI8
ME?  O2DOU,6?$ES A;#4C5&X]3'5RMH0/@BM=6OE>^?DQ.-W.M=H?3:0#_E%
M="ZJ!6FE'_*2T#@0"-3L#[QZ[TRU*_XGD8X(^*E+O[7]=@(E4B2\,;[>(J#:
MB1?T2?KEU4=^ESA]'] '1ROL3I S'2EGA^H$)V/P=SR#!A3N1C.X&PF.MH+/
M, M*)%[DQ=T!.NSIKB6@GR.;ISP&RF2C-YHW(E7HL';F$,T2ST)^O;!FB%VS
M=Y15:9M@S=(3I=0[Z3>[ORR.GSJT[(FD7MOV.=B[?ZDWV*(ITLAZP<=3&F,N
M:,D#X9]3T>G8@P="F__'?H<K37Q>+'1GHQ:$='?D#R5"C EE\ 9@=>CBY_JB
M#DT#R+#"\KU5U(^.FXU[;'YZ\4X]#QX[F?-\'K/X[TEM@#,,;19<WI#!?9XI
M%CDC [*6#JUJM53!C[HV?+_DD&**-](P0-],^G&9H>BDHV/GP$V.QG<XSGV0
MYL@@3^)0BX5Y;%*T;U=0TA>]6F8R?9D!2VJA3&6/?M_A7U^3\=-9RS@"9_NA
MPXX,_=BIDJQEG6)RV_7@B>K6Y)=C^S?!@G6:Q#MMC% #AWS:\^"3]D&>3Y/9
M96"C9S6JR<ICJKM1P;7/Z0#X;VRQ)A,K+D/I!5<)J0I2#K5_#J<Y$C\?/Q2_
M);^0!=NT-0:L4B].=<73S$18I^IXL+UPAUE=1DFCW])XM+9%_8(KX^M,$B);
MVQL#>@1R4EDN6&J(?3_0VV)SW_"*-GXR0L6O.SVU!-9-NXY$;E&9V*BPG&US
MFT"@Y=^3RB')EMO8$C_\4G-;K-Y[WP%" LD5YMX<G:7M08>J&"K*UZMMIX:\
MIT;U^#TYESVWROJ^'7;/5M;R2(A&.O.*$G]HM ZAS'$7YT DT>-E?)^Q/;=W
MM'[0DP\8O'X=8/ W'IILM$ZX;P;Z:A5/5BM)AXM3QMYR98!JJWU?/6O$%H&H
M>CJ+T*MN*6;I\9)9%NM%+N7HEDK1EUW&+"X&4>PV",8WQT<T'EM1BW<AKV#N
MUYP_*;ZA J:BKJ>ON3]L*<=7'QZ<T''#=>D-XK;H JD'-59:291KVYLR/>Z?
M:9C4.]GXD"^*X%,!/GR0;FVM4)8FE!^M.[<>1UK4-\1_S1[ ?X#/>B'U8(T$
MEAT[\^$=X?8[^X9PNM]=#^1P4D>PID+=N@&^UN0;-"2PX4=VAS[T;?'T-[]J
M[H_-<59CJ[(-,#KA5Q>]BS+CJ>5?L&L"MA;%39%V;;Z*RQ;\Z+,P-Y%8;/N3
M :SD*L."\KB)0]0W,22Z!+E(*6@-/N'BR@G)6<-G27))D+87O?*"9_E[EKD5
MR/N>/+,<I2\B7HMP<AFG;Z?AQ<_7-@&WF E.\NBIQPX &93758@8[$M/+6&0
MP#!412XUPGK"JJ6V+1VG=-I$N.67(-9'@7J-QOY(O"^T$_\$U:__;.1IX+UD
M$,4Z%VWLU!MS:&)&*D/86+EW1;>G&<7X]<X=P$<21<=T'# ,=97 BZZ\S-9.
M-9AD31\2UW?:Z._=]NUIGW\5E[O%G-;1;-F4-H&D!_=K@C7N (P2D8,H0\[U
MGLQ;7A=XJ?#,CJ]N6YH#<SA%T@G/\$#_PDRBF\ZLX=ST'%MKG3J9*C^Y,C=+
M-^G>%(6:8\$?[19896U=MM'3Z:JR/;0.SE<4/!82%F3A[>:.#B]?=$AZ-/CH
MGK5*(_56 Z+R4K0C>7NW 9U,27EX@NNDJ'@<"#X\@^L8Y9(?!21&,MG$91Y:
M,[8UNIR(^I/(I]@7%IG_30M)'NU-^3H@$!(VN5--\;TVBE>E,:V&V0U:ST*L
M3*>^C>8_2(8.G@9_ 5IMK)_)RN^]=7^(A^1]704Q"2AY\]F_5$S=G>,IF3LK
M7?R"+WIBEO*3;"WD_83S <V%[F>+ \9+? ]-I?/_6O[]#^^07*3NH$TN]!"N
M9AI4M$QQRXVL)./BUYS8TL;&U:.6T8?%I-'O[-9#SJ3.<5)O-,E#O,KL&=AR
M9K:5*BNQ&)P*F>E^PKEI<A@=)CS-'O]$5.GHHXQYQD.B*K5N-TF;679?XP6F
MS023F1.1R*L2M7)T-3G%8Q>UT*X/&?D$^M"=]5D-VHTJ\?]]-HFD=OJ^-E_8
M:NI25C\D6_7S'G(R0%3R[P / 'DZ"(>Z_-#-=TNJ)&D/L(?9)0'<F:3#%?.=
M :N>5VQE5N<:G/[=_2>MJ $&++C\Y1@H/2NM^S0C'1''^U6J80**^R?TG+38
MUT/J5G<,-,M*(4@8_3[EX,*IRT-\8 V"GW].%CP4.7ME%NV_GOUR7/<+H>ZO
M <'3/U%7Y;[+;KM^NN3CX+-!3X-D77=38"BKP,=4S;Z Z:O.0.U$$[3>5+2'
MVW<0V^KFP:IB??T[0Q.DSBEUWSGY$/UK61+CN4O[KA]!MG:<!.;&S(*O#3=D
MBJ)E3=!:'=N\O$)!Q,8$Q5?".8IIC)SW+CK@'"5VF^P,S"A8,:?_#8F*LOAG
ME'#_:8]LN'G>.!@$RB5,,=Z8E-+P%E;?T&)1"+'\=#-YW<ZU+Z&51-WT.J+$
M-GV5F]!@=6WS8_MSOU2CM]JO[C'Q,P7++X=IWV21/%L]UE)>CM3*QR8!JRL!
M7CB#G$%4";/W5^4$PK6>'2NF0&9(3=UR^ =E8@#\SW/<_BV7UV:K)!UFW7G
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M(PW!7/+W0]&7X(3A/U5GG=B\R]-3)_2,7)_[,&!N &+LB^*)RX.?#HW^PB/
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MIN2*%WI$L<?MX1!9@.FA/AK/OINKOJ8]:([KVTW=91>1!A:S_SLAP/JZ-H]
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M5*Y46NI%JV=;L1>-Z_ZK.:Z_0XO,A24SL/EH@RO,F1[,#P2+=H$V'E0P-7Q
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MC7K@/#<;E$1V;#&=1.1$U@63GM^\K.059J7R^2TB0E_GP:/G$9"-\P/!<_V
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MK%DEO-36TFUK-HAJ"W'2<B;\840&D[U<L+R;IA14REHAMURHGBXR$?2EKN2
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M;3P"$"Q&@N/>B@^%-W['<80+B"BD+:W;ZK( 4NZII2=LVW@W5XNO>J]QG+5
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M\/)7Y!UH@^9YW&YZF%I_[%L3^%'#M6<WE;QB2/;'1TC)XH2Y-K7EZ(BD;8*
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M+SF&E2<!GQ\ :1\9KXD> /#TXV,:GC=LBL^CX"1$@,NA8GW,KUEP_0/@W].
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MNF[6A6[GU39TN@QOGP:U-QUB['\<281,I".[NJ_%8G6VZ94UC$FN=-O=0W.
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M@/CC[R![D/73Z!DXK?\7H:]1C_FV/35P/559%]+2?W/Q=>U[6A>HP?Z*W/[
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M&XNKXF@UZ!FJZT(<X:71/">#Y>^1+V;*RUS?DG=B3XKWE7" ^"9,,F:F?+S
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M-V@@L3'*J\0IZRL\H:2XZ@#FATW[6?C++&ZNLA\54UZP7;&CFUHH;U(7Y &
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M/@ FQ\WH0Q%W(MT^ME53A[?%7I2?#6N5=TH%Z VS=0VOE0(%#_','30U9CQ
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M$ST 3$T> *JVDRUVB'"PS1_W/0^.?]I,GI?')"FW 947 U^)QZO@")4KV7T
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MR;1U>/];=WG[GR@P0YO18FL<BX-'1X)TI^-,*DS^-2Z-/S<S<#HV817)R =
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MK#4Z^@_L_5=45$T4-@BW@J"2<PY*E*CD#()D 4%R5$&A:9L@J<E)<@8!18*
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M<2%FO4-6I5\4?RZ95_X>O92XX%^)"T?Q4DV/T3W>BA=C=!CAZ"O10I ^+GM
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MPE%$@%^F]U!G50$WD/^NFG7;)\'6BD6BC'.?VH0%2V@]=<+D3U)K%*_]L\E
M]BWU=Z*GU2WX2XDB]WHWHGM0G-B-KP+K6)J-R#)8S,,77*A,L;4@3F^F6"?Z
M*G:W8Q\#F^GEFX_BUX'6$;_'+.\X7!MJ#DGO,)8A2V6?RJUK'\Q_]^1-66S
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M!+%).8&/C[%DD)^V%T:>S(!N6L(KG9;NBSE3H_"IR6-J&H\VCL3YNM\XG5L
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M1_]5@.'ISE[&6@"QH\SD#7T5O/X0/0N$,J<(%0MSV+H^2=QX<:^.*J5/L>-
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MNRNGO<R41<OT#QFC70%7=XG%<?+O7GY=B6\I\#*TT(Y(U#=5X,:^8F6.1KT
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M?'NI^3!T:+645@[P6U@A-;U\SI&-W..AGR1;A(<%"S?15(H^<O(=!6<?DYV
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M"_6X8[[ZO I<QG; 'C.HZTC;'7T=]O.)XABK$#'E,*. ;#.==Q4*B4#U(Z5
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M=<?/P\'E._LCCF[I*9 >?G&FV%YB)=TOS85*9.^I_EN(*7IS*]A*_\2P6_\
M.!ND+EA,FD6TUHIH?59"5'H^@>$%"(W2SG4B%P8>521 V[JL[T2 W:B^@0A_
MQD*'2WM28Y/YBCH>^1"LZT=J ^L@3W7#V6^'50\>8 XETWI(KO_3]&7\JDU
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M\T[9N_HN#PZ#0'ZP%!:(_<OQFMFQ)2W?](Y%$P*#PW_CG\GV1[TLH,.ER4'
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M]N6 )2 I;EUN,V.4QUW<V0[/8=OYTZ<1W%.,?G"NV]#0J&?<EZW$UCB[M^W
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MJ;9>F]T7;ICH)UI\6?61IT7=Q4Y&1M$#22?R4%%E+4A^>:A-WL(5;(/<1/J
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MO@E<$0BEFA$ELH.,N\UN $>?<<]S;LWTI"3!J30X?G'#,3'4V<]]/?4)B2.
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M7,=H*<H)DF';.HEP)=69M(O0'7ZQ"[KXEL9Z3UH;2^252##'5X]0IL9F&\^
MX1TD%DYNWACS@QH?'=;G/-Q^6161'IS4&;E>%GC"*>45233Y9J(-??*BD./I
MU7,?;O*P$^I\3*PM]JXG\V%T*U,A9,BZ!8U/\\1D(SF<ZJ?IJID5JXCMP *X
M(NF7R:KESL/\_S57.T)N2!SDV-@>A0Z<CI)AH>=&.483B 09F"3LR:,F;=96
M<:'$RN\*R\M'_HQ5'.20QCZ;IQ/PW6LAO0D1F-_=UJ8V)ZW/ZE2HAU9YBN:K
MLNQGTMU#E(2]KF6+$,%?*$9>#0M1'F!8AKW,W$:>QXB[X.:O-R3=; P<\QDW
M $U),^"%V'#\I=,"7LM)PVX6DO?[O-<R)L8^?LO&O)MUHJ4W=B D!ZB0W[V=
MR^KZ^B)E (474*<;C1)9SI-,?RPIS^/MD?K;0465K=?T*',(:]9#"V$_^SL7
M)<TL/!(ZHXHS=&AY= /H]S +X;E%UXW_84<@QS5[IE]?"%N&[03=7O[@]-X[
M!KF@&\!\9@ A?BAX0I%<8J]FXO)ZZ):$29!;%Z]?=HQ>_OV^C'F-9DBRB'T@
MJ<&3U[V'-KD7I+.:0MTGJ4^Z#>5R+)X;E/LT$5<]QNJF$GF/@D+:H:ZB@PQQ
M7T'/%;5;OK]6G[=S QB",ER-:W,^?XM](MGI-$O934EA7OUE=9\9U6T9#I7^
MDC2GY4N TO[SKOH>=_(31]#KUNRS#;:E'$5Y$S1T"?=XJE65_BNAWAT%+_/%
MTL\)@DI(34!2)^LUI(*#^C#((#N$/D'#6H2KJ2/A[4]_):>&^KOO#7OLF09X
M-EE-@@/ZU6JQ=%6E,<)NPG!DW%>N)@NZD]8['H_F"?H#IK Q0N9.>,89]OM%
M]9,^ M6BLP]%[1.&WEB%CQ!K.K786DO:9E\DV-AF"$#PJU9PK%VV$G=RGYZ:
MB.:_!8G:#2E#N52&4-G^75-),$V0VKC+!O)00H_RBO[NR8?Z9)2Z/VOPH!W1
MN_"1N\_Z\C@G<(9'F#FC"5&]X9R=AM@?C%_%GV]1DA%<"Q5C(V\ /+L]MAB*
M6^ZK(BGN]A0\>JH>;Y1N8UO)8(LVF)08EM-30NXC+PNK?.E[,?=)1??J?0U^
M\LP(V_"B0\+++,02A;WM2Y?F855FS*_3,XB2SHGB5U/UF=B$6/KPK"GF1]D?
MP0?>@P@]Y5?FBYC?Q&\.29\3O'^@RJM- KB<>15>&L30BJQ:&8//E9]I;VH^
MUVC[(TQ)=I4\1K";)UCU:?8DU.]LZN,A$:[F!-_,UM"(NK89[=OLMC3]<G>]
M9^:^%T%:HG-26R94<_,>@)4@_94\>L)1>2[TG^$-X)>:]RW[9!ONN%(.S4A$
M)^$VV4#01$JL]63>+<Z_?P,H'/8]S?[5>@,8SL(+!81H'R_1+D 6V@6=,+,"
M8ZDB'P]=&G^\_#WXD[!^GY#\:Q,A-],F-+L/V=R07P5Y@ ()@'T\/ 3A]-6F
M_%^^"[H/#[S,73L&5"H]G1$)$D*3:J")J_@2=.AI9P>]4^$)#Q.W7DN-:8_(
MH(J1AS"$/GV04CO<BQ?1VW/<L_[@P-BMA_4)40A7K"N'[<DU\6+-Y*DZ#UHZ
MJ56QW'P0E22O'LR'V1=Y#G7Y\47DR\C#=G0T4^<J70L*3+VX?8ZQE(I[3[Y1
M'U##XZ00+?,]R:-9BY,V,?6)K&P%!VW'FNUDQ][3_QI+9/V\ <0M,D]6MQH6
M[39CTCPJ' V!;8@)(#P']K=A+=OEW5,VU5[1!.1ID\]%2(,T/)\&DJ&/W(/;
M,EIL)T@5<.SY!0 '[#ZHIB?6G! FI@8P[Z>\.%8F,@_B;49+5N&I:IMR#,+J
MA;<: Q]=Z"^*L[4FAD//NB=RVVE,-Y.P#*B8R"#IE9J]-J#YE>*>M!\OZDIB
M-/'/FF>9EIH\LJC]IU3Y2NP9F%2=HL@- /)02+HCGA'1DSG0S\\XV&N'>WP+
M'"@X+G$M_[47M+@!/*SAAV>K7[T?*02ME$#U]RU.KU>F[OYY&Q_4=7_$XWDS
M__H%5_MD8_[&$+T--SHK!<4FIH]VS8K'7!;!B!AN[16_HU(<YI-1K:(0/Y/_
M^AWVBT-Q</I8%?1U_?6W_JMU+@T6=8>#W+5$GSNM#=VOCH"0H5_0_ COG'H7
M'YILYMQH#Y8,EA42J&<_9[K**IM_C?KM^J9/E]Z:UP/P->NGB5E\:)KB-</&
M:S #MM 83=SV;8OY0S[O3+XGM5L-T\2]U:>5Y%>>(^L)[DV,K%?#,$ACCZ54
MRS='C^TLO\OD0@=N[=IZ+>:1'$^_ISR:X@NJBH+@NRG8RE;WT!U>#GSL"\FW
M-P"&R.Y\#/FM%8\5%K7_/L2_9,'F@T\T@+8TV'Y--/V74FQ#MR9(S\C^;MM,
M)D]^<X;3F^H?GEZ1 S"1P)Z (5#2R@V U,+"RMFC4U24OR,MB]3'3BWBH9N=
M.X0MRA1]CHO",=T&\H$;P*E5Y@!VM]N&K1%]/?)S581KXUR]%9%D=,SW.4''
MF#.&FG7_;62>/YU\<:CR1/?.[7<?^"ZRH?EJ9]?R6-$:7W.9:QNO7AN;RTLP
M4!_,^AY<?(I,C-R%#C2BQ9);M12'EZ+W6N6@KH@_6</TWQ7Z5OZXO+[N0CQ+
M)ABU-\&SF0=)N7X +A']M?(?O*_5,N>SOISVZ4_IW69V8I!R3]XC+$BJT=MN
M"GQZ2/OX\893 _*IE<+7< *IP3RE(\X4>[UML/ZNBN5B_UN4,JWSK-27PFZZ
MJ,\S"!V-YJ)S(F"WZ*]^K_!T&4X @:1T#"^ZJ0W2J@_ZSN(9E;[Z,LN&A?N!
MD6J^<>Z,WDACB>K1DEX.ZOF##J<XC=]Z'XX!UPF"C_\&!+S)-=6/D 2RY-.K
M@Y>'KHVNNOD6]1&DB,SO#:GV;^+667[X_UY+/M,)' ZX =BH@1=>'K0"*W0*
M(.IFTX_Z<T!./'5KH53&*3/U(1R0 *3Z469"T=N:FD? G*&L#9UB=Z8$:>-!
MV +H98+EV.'ISSCS@V6(1<R;SD0\8O-2K(=%G]BQ898C:6)3MZW.T*51^4.Z
MMFBF)MUXFKZ!+$FIY./_?HTA\8!9MR5E+$>Y5V_6#)X=C8R6O&+LH=UAZ/C7
M6/ TW#VYJ/SM?*4 YW0;N+=YOR.9,EK"57SFP-_[K#G>8KXOC>V6)#\9% IK
M>B"NL[NM*F:+XD^0 %6RR'_&R1>] "O]\R+5P/QL6"%R_LNKB=+AJ@1!CR%^
MJT_;?B*:LCJWG+-INJA3.Q4V'OVN-J_6O ]8Y8*:ZB@K#^GWW0 FR>= /_X[
MF$-.M.JA7.5[I"SY$UV\>X)5E/\>>O=[T<HE?OYGF^J13ADP43_-;!O'7)*-
MT=4P]][BNU+KC\OW:IH=SGMMSVF?"%WOCX4I<4&&NON[RQ5'LHM?G?M91JJ@
M^UO>FB3Y 71IYF=&OMX >#.L;@"U&C7XQ'3H=J@REJB]X1AW]DPXR'K5EGJT
MRM*1V32-97OVXPS,OTR'ZU<7<-WD]1#]W-0:A:908!>>=PKA?Z8G9/6C$3$C
M44XM>K<^*UYE]Z?ULP&2/$JN\B!)PKU%WO_.'3?Q'P6.-G&9'"RA/^UO  6S
MQ:Y@(?Q]?/%0I37'SE@>!SJXK:8[,(5ZA[YAIG9NR*.910;S>.Z9 . =[H_'
M&5\%&PCEXKMI%DRB*@=)&9;SG!_"=#:-2*\.B>RG./=-P'4[J(+(6FIK":J'
MIWMJO\LL#GJ/,*#G4OH:6% ''UV&"^9V;(]2&3O6*#%,08?/./P.]OL"-QD+
MK%W;\].O-6?:S4+S+YCE;@#)$Z,K9>CH3)IA6F%Q'L_RD9DTDW! RN<[6C8%
M]3[*U$$:M;79MOCN,:1V-+="EIC7HU;J\(P3@O7H?IG-[ZPSFO7?Y[%^RT26
M[X\,?5A4)@7ZZ/)6S&M8/5HXH@(8$I377LS< /8XE/$)$J^#*HRL.;;=(S8\
M$G;QOA(2<UL(/=%)@T@EO3^/Q1VJ&>\H?[6L%M)"LY7&M-Y?1GN1]TS8]H(<
MB-P%/BR.)[_2OM"DT/-%>"453?R32ER>BP?7;9;VMHM,*VBAR$E5)D[[<O2:
M-(!#F]Y1AFGFQ*19#OQ^+P%/+4,>HD41?K ==G:T2-+7]DH'FE>\=6E0IE5/
MS77R$]%[?>3JRW4W #J_9,KKYX6WJ>:^#NC65$J-;G?R(<>E[(Z9ON2E%;@F
MX]K%-)06TM_C)^VZ/,=&)[%KL;BT'P!/OP$4R>5*]2:Z$ZSRG,3/'I7&'4CV
M3WE?O^@Q!S&[1,A7^F0$4'4+;"U,Q]1(#D!">Z'@[MNH08FMFC?WE_92+!YO
M3#>O+O1S,*JJ"''3YKPT'8W(VC5#:\4JF/'F8K+,AL@1G_RH+SQU6%4VU$I3
M[]LGGH3KN);,X%PZ@%NR/F?_W>W7<S,>5P"N*M.;:TG%E6Q3"4M3TDT/7[V@
MQK20UW&MI3^\HR,SV!N@Z*'\('3M>0R^X_:9TT"DJ]YVZ=D/DI8+O,O)Y[-]
MN\V5AK8R)WI+:\1TV_#.&^*X.]Q*[SK)F]43,42Y:\:M)/ZH(4KBN250>>%@
M$7!;1Z3BKW_)>L0W3J7#;'DMMS.&*)&2-JP3"@CT%I- !N1ZE!WTSA-<3-?$
MX"7'#A4D085Q;K2&$_"U*Y^JK/28&+LH%UP3OR)@4.E3LSSX_07XF -T'II_
M&@O_ZH42K0<[5<V:0ZQ/$XHL[!L8C%G"/OIEL(@KY4UO9:+DLF.#Z$_F=8\N
MKPPB>];/M=Z76L[SF-$X$.G2"J2PEP)2;(1F5\09N<7++!XD+7N3L$Y[-^,[
M_N25TI9#\GN:2]I""R%RW7J^D_&P!4PY=^SSCPY#)JI-J?<&]RT90KBG6J67
M-Z9P.B#G2VA3G.OIIEW&P#""CI0LJ2>Y3?G!!NSL2CF&G1=- TER<X7OOSC?
MGVD."U^/:Q2,3HJ_8Q+.>D?.Y!:SS(?^<EH.=+7M]ACVQ\AO@;_%%3I"EY\O
MIWX/4TA<Y<X3-/O5;G9\>!WT.Y3V8FY4[U[U?\WT9GFK9D=@!5O/G QJOD@6
M9_9T.,>1"/L]^=M#EDOV 1%DL:HYKB!2LCO[OJDM^GAC@5XA:$*+_]R?0^II
M(MH<VMBKR& Z?BCQE8;E:C@$11PG,6DOV.K6#3Z4%C @X.:7*8&DZ&2H8T.7
M]P4_4(J4%)>JK7D+LQ)>3O,&BDE>[(@=AV9]G&V,:^>$^,[J>9F,G]*/<PE.
M BWG7R -OG/2"ZMH]G][N!0GO<C'L,B8HL9L-S>_0^WOZL?SQ=^W7L#'\-<;
M!\Y-&51CR/^J]?D.@C&MG5!X7*5 J^-0XDPU;PT7L.IGR.K\29A+ECA5Z;,U
M)G^Z\P7F@V)SZ ZAO8UP<W^M0<:O1/;WX7T^R4YL=<R1_-SS>9\E,Y7C<*"5
M FA*/'R!:NO'R[3_@[>S"HJSB?K\)%AP)[A;@B6XDT!P"R3H( D^3 :"NP<;
M' (D:'!W'P8+'H+[#.X28"#(X,O[?KM5NQ?[[=9N[5Z<RZ?KZ>[3IW^GY=^M
MH#HUFP8BI(+L<3@@GFC!>UJ.GE!N32Z(]TR3ZIE(.K[4:7/B/)5*VI;PKX&H
MS(J,EWTRXI5F_]FZX+/^M=F.U:(;AM?(5.W=/6\FJ+1IF=T=[X2P)H\&]$Y3
M;<E6T?99PU@E378M "A-/DFI-=O3_G(<KE@(NN.K'D^;?/^MR]&M0)7K,!]A
MR%.>D;%R\GRD](>O.6JN7U/P+]/%E*OG]9W\'<%#E-D(N.)78SOW7=X;A.QO
M="@0]UR8B3E"T_P:H<+L^!^ED'Q_D@1K'5[]N7[5;>L &.CSVFIT"R!%ES(H
M:* .TR&YF?[_W.[3]N"-LL>++Z\IID-FW&(+Z4E;EANC#=:HHM8(#36I$GFY
M&A)W64!4SVC&BB$_$C*<>M77B<E]I9LGA2^EM3GWP<6]O1G#MD[-&./)TV)L
M3I/,4U6AWAVS=TR_FX[E%/)0"^U<GIQQ/><P$Y<<1A.8:^7X )'+R7\L@;68
M>:P0FN8G&:5,7.BVH\I)\QL-O*&B-ZM1I4*!(X%873*2-JU,1/OQGDFOZV?X
M?C0'X^<OTYIP&R S'K]B=XD^V[%'<-"ZZBBJ_'_9$/]/[1DN7L&W0!SVK"E
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M>K6ZR!HI9.OKL0"/L9M<%^FT)VAW=L_+',]+?'?ER8.1\AL$*Y]_?/C@9/
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MXV>+_ '8GCQ],(T3,Z6F94C]5^0H/KU$DDOCDQ$%)VBEN4_JR/)L@MB%XV;
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M8T[J"#-7:IJM9ITTD^%4O^+)>QF5^PF3>Z#/+ E=F,&\?'P/^!82=+8[G*)
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MD=,/GHY@A)%<%]PJ[,A560/.O!4A4*@W,Q-(WUQ/#/@?R^-:L,%=E]MRM8
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MOT3@8,I0^(P*".RF+3\#?O3)OEP$;HH.L1]_TYXK@6_OUNU7CNUO'??EE,*
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M^L!O#(>)+5/-D38PKZ7Y-=!4N*=XCF=NG_@P;1Q4.S8<^AZ,E4F? =/4V\^
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M$2R=8!.NZCK!-K[?OZEJ=R9$,+10$]VX^F513('+C8^LO[K61+-=HW\OV@(
MY 46O;XU/"IU-5WV_K2[: ^N-] ^^$H!EEK1K2>46D_R[4"S]U7EW>43(VQK
M.#E\BD:,N+9(8L_-D540+/;^WN&S8A(Y$MDF3D4/\M&WWP63=(-."W+>_*W/
M1E:MPT'/D%6X[E%<\>L<+U@WXMD76@FP<U7K&!%IMXTVH?@9S/HC># !0_0G
M8\G->:<!=GW)FF2AS;@-V+64+?^P*"=@")/NK>Q\5#"41@K4-.,C_%A4:2V4
M A_VG^<:8/R7'K6P_B%JP[S2B]S(O^L9L)#BQ?H,L#T3K^5(/G=(:1[^5W.X
MQWG==#Y5(,J>G?D,P!>MV#2//H6&U+$!/)PU)NK2187.J+[!&-(FB<-3J>IK
MJI&W4*@O31 \=]''L3Q&U+@X53_9S.N23^MVV2>7!2D_J0V;A,+%PQ[+KRKW
MNY=IG@$_(F"]N!#?[ /HN+'5T$KS$'C!*\IJ%EH@@W!X(XF@LW&FVNS-+IGG
M!"GMVSG$TF%AB'!EK4[N5"T]F6SI%CG,/L002DV*R-'$7&1*S:Y=MH>4QRD0
MWQO8OCU*[-4ZQ"9'ZO^*\8YPQ"2RR^M;^VE8MT,IO,\3&Y+Y1\FS]R;RD\/O
M/ZMQ2,BB7* _XR*""!"5I#UDC-S0]C1'F&WR'XN%(.EM_0842EO'ZB-^Q?%V
M[^X8#GT&6$NC&*NFQ'(,88\>G&<N!Y,65KB>/RCL/,FQ@7-MVFANVD$X\9:H
MT:U/\9P-4&@4O?T +5A8CJR+>L;DGS'QR;['=N\;.$ZRSN39RD''?-]]]F*9
M3X9/RWF?UT&EB/CVS>!0-XWMPA5($.P3RR'\XM4.Y]<IO,Q;S4T\F#1,B,<J
MK<68LA5(*BA,%GP3!"=] Y"@[HO"LES<GXU7Q,<D$EJ?3)(+5?[?H$3)";@W
MT#DG>&U!TLJZIFD M/';@,SYG.7]?3FN;4'EC7?/+#Q]T?I)T)=])J"GS$9-
MA>B>L_/AW,"/_&1#C&)J*Y"]DH.I(;/2WKX2@X,U.BHQ + * !Q\D#,=\LX8
MZQZB.125^_>6T<94X5(C@>>+=CVIR7<4)RXN+E$;$7<KJ]6J4/CP$]D4F\ON
MAOP:APU!=S?WCP'3& GS@=V,6=7_![UE;>L%+JPJ--R=G7@-MC?G' QKX,GN
M<OB/5]\7'1L] X#/@ X1G?,NK^$G:K!8U^I24G1_%*:O%)O9PEB$Y+7%,L!,
MLO-^<=8$407U_^:!?J_LMO(, ,%]\RTH%3;KC^30,RY*5D_X(\J'W9)-\(X1
MD^9(!,M*&!:I6CA9CF0/CD9HS6M5AW]RD;TF,KGN6$9&TX<7D"@4^CL%]\<F
M*T1U2RT69%NR$<YMW-,NZ8=^;.]]J)<_P-C><[.R5O_\JMM!L:SZRQXN3(UJ
M>O.6XJ<?DVU]BA@1]&31G5Q1),V%!'^$\G=<L7\<*AE*E#FTU=7@.@A",8:G
M\)*8[MH=KQ^GK/ST!@7#SK3;#OV/&&,&Z5(GJE?\X1:SA3-'$,S=0[$Q9X9_
M4?WN:%B ?SF K\S4MR-?>%;&[A["1-W.GMJYT3N>2$Y.3YDB,G8,OMV+&F)^
MNZ?W#,#(H[.B8<<5<:]T4N U O6),30YA,&6/P*![=7_KE/&>^O[2W%F8B2\
MMMV.;J\JCU11;7666;+U)D14Q3+!WD*J_F9@NM1OE@"?\L5"B<Y>&_AL$'L1
MS KF(XC C$;7:-0&)BNY9'VX.L&4?;!'CMJ*64Y^@#Q!*/;WS#UP^KK)>?M^
M%C6?C(^[#*@SU4Y-G@G_4)#*O.?S'?]>1/HJ<>TZ^$&TPH-Q3'?FHHQ*57V&
MN-*^LO*/OE%F>#]61Q)R(1IGQ/Z#<-Y>FE'+R@+UNP:8O66O10)*""'9FCHZ
MV9A(5M)H4=>AR9=&CQ;!=981)OEDG?@#L0&B>TS*O^$KORBS/CFF^?HI^)O,
M2OD\O.CY_>&P->U?7@X/#&YJ@V<]:%!6Z]'-?K7P (6-5<<;K6R2N@7,=K3'
MW*U!N,V+6-?;2&#X)C'U[NMK,D ,;H6]A]R_3QY2;(H4H!*KB*N#);]KANDD
M-7=.)D<&A3$J+^TQ0@^_A1YRU-%X5_IJ.;Y)AI]K\4G!++A_7H6+9EU!UT!/
M7[RAD]</]LY^PD&S_\1Q>#U%1"U!!77-^%FCJ)'VUUH<9X']&IYE!#Y<)U]/
MSO4J0[X&2-8986A]P1%[!J1>UZX(EJ69A/(2YJS8B'V85?U)VT1M;#S"=B47
M!;[%96I3&#%[!OQKG1T6G[?J@Z>.NWF:6-RS&OL-FSO .9L7"ATU8-'N^V=/
MOZ?FKWC]R&W=#=J[1JC/KF235[LGZLJ=+.9ZI"GO K#-/%*ZX&S'/54XOF5R
M4]OWVA4+AI[U_<N.ZJ0:MS2<5+63S4O"JI!)EP5?L<'WQ!4M9@)Q_F\">TP]
M:O]IW@1MJTZ[++U4CL[4T&/6D4"R]IM5-!W9M<".LD05GQ78\*_6!?^7AI;?
M?J*U=M/5O.&0C7D/-H,7QP[6/X[C_\Q(HG ,D)6CAJ!WT[RQ)L<-8W,%T\C]
M+[R]9UA3W[LM&@0ITA3I7:E*57H'^=%$FDH-1:6&$) 2"%U0JG0$I(/T$I 2
M.H1>I3<)/33IA!H@A.M_[WU/N?L^^]X/YYP/8WU:SURSO'.^8\PUUII5DX=[
ME?MF3/N<)MFIAIH\R@ND?!7@XH:CUHUCK)OVS;N%Q6T&)8=D=Z>2\^3?0Q=O
M/V7[RML7 #%68;> 5;ZQ]%?7QG/U.K1M]BG( \W**!OH?$SKMI#0;F!/8,?#
M&7QV/G*%5:0;=,:RS.Z0)L_.9G7?K _$LP::L"AH<9-^E_L=25D;2'UMNJ__
MQTPC? VSE%ALAE.L/T(DD#U&@G5>+$[ !C-S\Y1E* B([GC_*R_2?NY6G]B4
M&XI6>E/U829EYO<RNSKC?9BM0D=I$TF8O(YUL=!,XYIVM*4XB6V3B9I3&!>'
MY$+R^?KKT.R(U[-'LDV80V*1;I*:*6.5Q"Z#;7NC9H)#(\],O8SY&(8-Q:Z3
MRO?E5N380/R#5DGTY+Z5PTDE7]/RQE[?]XVZ-;Y"UZQ3H>6B'6K;&X]G<#_1
MORJ:^OX U&?V*A/WQMS2XALI=Z#@)SJ-17UB0&D@)8XO3V.5C=RXH:J^>9H;
M$>E2MZ!>^93MLX,ZUU/:=X!G$\T0]<G]*]O%K%N R/[]%B FLSF(J2\  >RZ
M,CYG"//8YQLYP?<YQWDW2QZB<NR9I+<G>=-VCV]4X RCI]*!=[&!&AAML-EY
M:Y&9H\^7IHSS6\!V7/D/TC5(<20+YSL*S*Y1RQ,P=1B>&XQGGR1)*6#1%$F8
MTQMP$: WNB='W"Y=9I82)$%Z!AS6Z&SC:QCC:7/E67@Q(_?=QN]=@\9U.6R
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M\[J6=!=8N&D5YLN4C-^(CA0MXI*+=7Z*GZ\_R\GNNL [I1O@IS%%T5"+>\O
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M(+.W.\FX94\%1&[-%R?J>F@1D.**IM13;X& ->LGG;E?_)Q7\^![=^\6\!#
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M%$Y.*;P6EM"[*G0F(/"EI3I9)<E4_X@QT"-8Y6JJ"C[Z**4/117$[9/U&<,
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M<T9\44[""*N[NV;^WRPAT\/?JM385YJ_EP!LXDC63'4L!2<X:*07V3FPQK<
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M!.Y1OA7("\^;?$S]1 1JWU O-UW?:P"0?QBCLK(R8;;[-^+Z__(JEMW=6\
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M)_7WT8\M1Q:1;U5<T;> !TNP,HNCS9!"DV&O#^.,!\)S$XQY#EUV+QH%>R(
M_*Q4/NXBX?+&:&HJ:@K40)'I\HY/>LO#'D?3A\-D\57?<659^<&N64^6Z CQ
M]!HQ>H&2H[> ?R:P2+S&*&'@[.(H/MQ1RT^@%?DZZ_@8^>=U2O>2U-%!GC5?
MQ.D^Y6GZ?"V"!E0]:%-G+_WZNI?1GC#*Z"*B1<.W:'G. <7S32IM>*<E/O^8
M$1TJT;O-^DGWN7+[^F:QG^XM(#[P[^5G3PH^QFP+SP<#ZS9AU!,K=E%JO26Y
M:L[GLUK.$\[U'^83+*KBNJ$DM$T"%S<BEV%6*;O6OEH8O@CQFX A-4Q(UO<:
MQT?X/J^"EE!>&R;^OT,N*CU DEM: XOM3=NL*IF'&<UV88"@%-X9Z]*A)\GJ
M -:0*+^R4:81GQF.8$%%FD58VDP@J8FY3K&R:;('L#4.5W3(1+6DKCQLB@EH
M/1I';'^8.JSXRP+NJUWGNEN[N%..^ #8'E*)3<K0+JL(%^E4P+(-Q^0%[+V]
M"U'19IMH.0-JE%X\2_-]IOSYSK6L3(QVCL[:V52RT@,4UE.;C^0"Y51#'+6R
M)L!Y6>TZ%F7DG%VA2M*E>2CORQH-X9)W=BY/16G62R5/]$9Z)N0\;.\X+><@
M=[R27Q*:?(_U]R]9!%&--$671SRKK5?.+WOTS9;%<QRA2[K?(]ZZB80C"91"
M;P$S6Q7&!!C*0,39,CG,R,C5MF112PC]I"^=]0GRO>*7-8GE69:U13Z#U-K
M^P[GRXY3XL!$T;H_]A$I3N%%U[^W3TO&Q9=F\<@7R:/CF:]-3 O"J[0UZ<>$
M.P!13O/;]84"X4?,PA%H)!W6:)Y+KSJ9I4SS)/[>K^94DAP*,L*EI(!GL']^
MUH,01%-5(QD>EVUC+$SST0TC"CNS01Z+*@>([(<[,['VON6_HI(3_+&<T9Z]
M\#_=-O'SXF?- 7IX0"VB5:FRH7_"SWAMF6Y;R7%,O)5J057^YY!B 7>NW=,]
M)<^(!.)G0^R-Z":7>]@LB,^D?BB^VV2GR:F7O/G=]93D\_*BII^<D2LMY!AJ
MM:/*$,K*\.CA8/*A1,A'2'Z"W"=;]^/J.X2$#?<_PBK2VZL6K99@Z=V3<Z/V
MQ/"/H3,L7^8>14J?DW 5+P[T\!TA]7J'\%2?+B[Q#(%'I(*X]U#0D16>YKN@
MT_N&2.)X2&YX.1<-7;N^F_3%KI87FCH<^4YVOS LM_!;W.4MX'U#0^)^S/=1
M?4D!:U;WV#?FIX''3J\#9_-N 7_6+(L"^T*= W>'D:>$:GK0E]I%E^:NQB O
M)#[).@-#'<F5TFYFUPJVA;BR[9T[55EJM+[5>NP>%9OJ'N=[G](2HQ'AXC%_
MS<;P3U7DA5F;,2P!=$^-%GR1[T8@/4!(F&ANN(6+JR0/G-61N@6H%[A@X45'
M%S$>2'J%@IZ1[W5N)DLL'B#F!3%B4TF*A$9&Z;*TESH>S3CDK_"ZB0"K8C-L
M=H\//;QH#CO2I26)BKH%V =?:R7HQ ]J#,94NX]0<Z$*9N4M*E#8/9BU^@2\
MDC==#UB<GZ;*_(]7=8UFEY(PH)T\(ZUGND7O/>;IKL9$B]#6TKQ:<8^7KQ\D
M2SI',V:_.8.B41I ;38?18VUF,RZ!?PFNP7D#7-7@B_Q5IMO0'PN(J.X4! [
M#T8G-K*\EIIA#O3HC'3=5[M5:/UX0)F<2^ DPV:KP,NP&U:$?VD<A%QNO06,
M2XR9P6(F+KJO0C]3&!.C._DWLE[G#;'@=SYG'+2/ZO4F;_O= @".HP<X9_ L
M#UKIH>//W8]8KRY)R7J?[CB65.Z6^ 1RAY-:L7TFIZQ/[CU0Q%;3_BY,"LV:
MQ8VL;_"GN@7H 4$'[R(*K@7C:T2%2\GNJ<@'3;T],Z:*Z6D5Z5[BFD1<LSWL
MI6?V<-LAZ"DX2.6J%=YY;I#4NR']QQ>-*(?.EV6S.5ZQ])$B:FKKLZ3TO9+=
M+@=&GAU'N9KGIVU4=KO08J$M\HD+(#.+2<N%'6IG3%_#$\-H[4\F";JND[3[
M5MWT :38U&+'IIT%X+993#:1JV4Y-3>8VVE.'45&=,"(+O% 9N.HIRSV_[69
ML>,"W2US80?)TFB0(5IJLKQ9/[<\IP409EAORJ!_5LA;H>5&Z<!MK&.U0TP5
M>V9<;#WSLJJT$$:G?F.>[U6<=PF#1G7=RW&J'!$!0G^\ZB1G!0HIGV] #HI"
M?C 0?1,T-"%&$2]I;BE.5ZWJ*ZW:P-8O3IQN :<Z9)" T1,63^001G91ZEKU
M^OGR]=MY?^2[$_Q0\^#RLO.!ZUE)$8AF23WT&7=I_@]Z%.-:4-:R64*C7OC)
MSCF>I"WQGVO-YKM2$L6_ANA7-VEO 6!GUS>\TGG4AAB1;@XJLZ$*,+->V+S:
MEY*TI0GT&W<:&@+(+TE)L0P"H*4T!C(;4N[QM4S@D>_Y/';_%>%A _3#G8Q/
M5,KKF)D6K^X9*RI$(+FCE"5CU=19IC/IYR%?L46[!>'GQ^)?'G'> 0"V?E:^
MP?PF@@DHG;+6_>4&['"!@IV4?N.Z-KVCIXX!_'\3NSZ8^3PIIRYL\[$.V[?C
M]*]0._*&9 (@TY^[GF;[O0BJK"+EZMJF9B]R?(I,I/0LR:8T4=9'404P(7H6
MERAD??,;>>IHQ-']]?<^=)@.>CVL.]JIOJ3J+A01;UC4?Z^Z-E!R@9W$_4U3
M??:V*PIUJ32*)ZO,@\7V&%D^J1F3!]KG>Z=@M(7@,\G'3K_>T:N;RHQ0N4^D
M,Z"45L'8KWM95JC *B%<I3A-^L5 U">57O_=R*.1E%4315Z8\RV@HTEANBY%
MT)C_HOJR0YACJ)^41^XGL3> , M;<?@W.R<,5 3^?CS[=^W0,@3/3_QC%7CM
M,7T4&SX:+O^$N,2+>7ZA&';X&!!$6_RRH8,[*,[GO,)2B6/7F)UELC+G9]6U
M47T@3]MW8:8?D=*AZ-@G ]QQC>V];L], P09TJ@:RV!>.L9J&%]UB"G)@Y>:
MVI\G"2]@@17@GQAQ_(.CK2_[>_):M(&_^TON<"=7/J?,N3O2(^?[#C.L#:IP
MT<,JK1N-ILSB2<[6M5<'_)Q%+$4>HOZH+^3:-$SRI(3V=WZ+LY_:DK#2FCU?
MQHYH"4+&Q9L_N4/HN3-(Z:JWE,0\2<8(S)>#)8 LV?2J+BM#-Z^ONWC_+][>
M*BC.)XH7'"20H,'=+00+[I8$#Q#<(4BP"1!\T,$AN 0(!'<GN+M#@. PN#O,
MH ,,P_*_57MKM[;J;NW#WH?O]6LYIW_2IZM[3;T!NR$YMS'>\LN/7:I:K]&=
MV.NZ3:7\1AA;G,UO*6WO(/%3S2'4U5?=%&P'[%UM"G>Y;-7C_H4F;,;PJ(IE
M"% HA9;,C_&05/\T='9P@X%F9_!O7'&#-PLHMG"+[D7[+2%"JG.6'B;J-[5D
M-]_TBJ0_K8>P?Y1IJ+2;:2'RIOE3V,N_9:3O\T$T*$,"]R9@LSV:CYD%*EZ4
MY/V)98D11K:6L1@^?L!)03-"A"QTMZ)UKZ8 [E>OKYQ6><K-(LS+0$^ZTF=I
M*=I-T@*C]3-=[[Z=MLVV(_M2M-= D6:Q(M&;?>HPP3&(4/T*/=:#-N:[;T;1
MJ!O,;T1(--5)SCOT;O,P*;XG!- #\'RP?AWSM%TAJW1::;NV\4G7X?Y/ )FF
M&;?=+@=-.P8"HH:H;Z.;=:$41XH2UG4L,.$8A'C)XLB6G_@'/]:;4ZZ/Z=]J
MT[C2)H@[86$4W=LDEOU=%Z(@-&0GVQ-@VJ,4R08>[BH&+UJ,/0$4N#1U@?/K
M' 5JQ[O_O3*< !SP9YUU.WW?]_'?MR_M\]5S:[S?=QG"!(^90USD%<FIT[=]
M%?RV"N=\F2RWHG %%.]7^.0\"X?W"&6^:*1\XLN@#AX6D>3P')C)QH'OJ\ <
MQCOZ6S675"R]F'GKPY8Y::S>BB[WH ?J9S' 4C*W3E5Z57,*!U9#Q%9X!"^-
MVC4XS -DC%'[=ZXPR?<KWSC1F<VZ3O/,7$G:-Y]'#M%A7U^ _]O8LB997*"!
MZ2&5PIX)Q_0)\/"N%+Q[EY<+8PR-&S0#C-\ K1;J^$]C]$Y<+X;0*):.3?!_
ML,$TO=[!+<94$E:(6 ;SQ2N<X^4Q^JE^2]R25Y8[P:_#'P>0.CNT?!U3"T/>
MR5W]'!W*N&@C$78U'ZV-[&JEO;I&=QH5/D#*C!8C?(6OQ)VP0'&&[?/NN&C]
M*;J?[5,T%*1_6S()\,OO!&@+_VWFB*:,4UC82UP>U"K,_,E3M/8WPB*B.EV7
MY<NTZZ6P!6@#:Q=):9>N^WO[\9NMM^1$6N%X<0]+Z\KYZINUC9%PEI^$[U"&
M/FVG3__KVJ&",2%[A<WN&=[:%!@ACQ&C06U-Z=P@IWY_'I@VI7RI3;&=KK=
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MGS7WXV1W==G)>T/CVD8^Y#NOE@P3[DF?KQ#HD#9M2H$VSKVO"IS\Q/$.:^A
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M@,><<ERU5!?X*D'].\HR^547'/;:5QLLWXZTW[-_07-#$@*=].>OQE%[JAN
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M[L-?A)D 5$P(=7::S_O3NC%0WN03("-6/;OQ"AAI@!3H*'NVM\C!X3L)KYL
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MFV:"Z5_(A:_,4S!E8'V6NH_!YT <6P*.TA**]/A&?F6JC1C6^K\<&M]T__;
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M]C5@C4->#=!W=/*WL0U+:TWV:F.ET)_;,=VT[ZPSCA@I4^ *VVQ>;\G%&G1
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M/E<5T:ZMK47 ]$*G;+9#B"%HKD+2_''CXWF"YRUR+0"?EJQU%\RUH!)?;B3
M[#E)E/P$ :1DS?257>J73/*1<Q=KXLOR%V63.^Q42N%8-U+H/[<!5@V+VBHU
M4ZX#T<*/M,)CJSC._U0N5OV<X81/V_"D.W*-G=UUT50=<C3*544K)(W!78HG
MU>-HZY]Z__,)L/(8EK)7ZWV4@<1LN[S=CEJ;LHA_R%5F&E^'<^&S-_L6,<8X
M#5? W)R> 'T.=4^ RF?^.V>&WNH!HNR_N\ T:3D=#NS;I 35-:1G +I7G?$S
M.!UH<8/VN/2=]J#2<(DUL[^,:+"I93)T$4[>HYV^SCL.:_:',.W[BWS%V;S_
M7Y6X[975Q]A<Z\&6-<']/K.#76U+@\W2@+?Q3JU4."^2;ON7M2KKJA"Q?VKK
MHK,3!0CJ]<VB8N1I$KGUHAOC[W$96-73AK;%5D#*2@FKW7$N(*=GLS+F%+WS
M ?K]A3B4(\'I6XUS6]@17P&+?58FE/P3F6O\?Q$!=J=VV"922,LOAN[-=-7^
M!$"W,_SF,?V5MM;G6S<9#_,7UX5? 8L2X11[6G//#V6K92CFB[\0H*-(KY/U
MJ)C#C+)XG(\?/7@@U9J'C[JB[6=M2ZQ(_#"+F.VU'Z3"LAN"5A3L=?(RCR.?
M8@OY=I->4AH+SRT,;/W,_LAM3GD"&%XWROJ?HT -@!D  *R@*-VBPP3!A!U4
MR\2^A%MTH CO_<Q.N3K>9D%XJ#_I-9DR1?.BFC2W, $VP6V _XN_[AM)V:0[
MH)V)>Y4D-;6D>L"/"1  K&R@3%  %]_T:#16(1J"_V1VR[#7@#]501+? E9.
M%+9YV85\,[HO6O)BM-?H@SU63B5[IU?:SF],TBKL&QY_KYNOLC^[[%%QK2)U
M,3'JVA;"Z9*,YD9A(!>Z+*_1'&-SLZJQGQ$=MW:$<_H>(!@U)!V>#VNWK=4T
M*J[\)>AUL@^(O"[W4;^>A=X],8%WF#2S71Q)9_[QM,";KZ6KHD(D>?;(4H.]
MI7>QIH@PN027O'3W1SE+]>_?& F7,[W*EL.TNDA*UNXH(XCL(DL'> M[MKDX
M3=FKIAV6T%V]3;]!J5\I&_ .<E/JUH:LAG?%?7/.JQG^HZBSL8&<*KZ.;!4G
M05KLBL-S.MR$ 6B_4P5:_^7(,=X4)8>[X.XU[T?:H*KA'0]^#U.R^X^N-PP>
MJL*S;RSH8GE)]N0=^6/;Z\%AJ6\CCWT%1VR77\JE,<$Z1Q=V_^7K0<8;M5OF
M=1OI&[?3I;:9Y*-08!;4-M57-]X+&WQ76GQCIXP"+]!]*]@W:+G_!, 395CS
M&:ZUNV7D6;A*I%ZS>@)X_J9LH9HXM-P$=[5,^"Q//0&"I/Y"R\!J!LOIG)\E
MGVWY>XOZ>-? 3RC+E*&3GS'I,KFF\_2NRV*O=6X?O?W2_DTZ'K,5ELOZO8N<
ML75W,C3LB:_Z4 ?(+-A7GW#=5S5L!U+N?)@:"Z#A[G1H&]8<UOP NY? ]O\N
M.[LP$*LSJAXXK4%*LCS[;$!D #>-W_7Q9[F([,G%4LW)6Y7J#OG"KB]P795%
M\SBR1M-\S)%I&:>3EC8!PY[+TB5JJ'W3?,1-$-=V ID(UG9=2?,;9'[PRLYA
M@DZ=9VX]#KL9!#,NCS4V43H(90//:2I";%GOKW_==Q%-)H-/X1O.4][0KQ)(
MO=#+M[=OTFSXE',_73E0<G5_\RYZ1=NJEZ='>#(NE:P\"G9C17#9^I0N*?JQ
M-R^0)<;V?G.G<Y8OXIO7489?>+0LPGL3'[S?GRV<><),23R'M:=61V'SM/@S
MNQ[1MG6SD6EA%GM_R(.*,Q?<"YM)&BN<UAG$RU,;.S1?7/6]Z'Q#SX068H+!
M%2/&FC/UE=)3HI.B<))/# _KF!M;@7K<B^RN30%WQ VC]H!754#9/JD2&K-\
MR*120B.=44S@*(S#C!KU$;AHW]_59#JTS7X2^GSEVCS7RX;4,VZ>NB^NOE 4
MVQ+L9[NNC+6N5YMFA(A>9P@J+8F[33V 9KSID1E;'7>=$8U40"'H:4IS4'R;
MQ'CQMLG*Q,C3H]7;^+'$=?E33>;.@M% !-,BZW>>P+HH9"M9<8)J[:7=<O+-
MLR;HTM6_5/)L"M'0<%*6W%%O836AEO>0+$(8!&)X6/7W[8+Z&3:\?\57FXQ\
MWS:^]"5,39\#],MCE2$]9(YGY-6O0,UK_B6)5Y[K.LBQV482Y]8D0Y\! OD,
M3/9WF.F$ 5@'K'63O&42AE4^U&I#E B][IU\R7Z%G:_0>;O!8\1=V8W]7E^U
MAS*HQ718_8-3"S%3J"J#8E5$(LS@0MG< B)W,D#'UNJ-OIAPK+74095%Z0IW
MQ1G=2:A^);Y[]M'Z] WT7NSDKCV3N-X^@U(N=&XE2'1MF"' .V!($747R)ZK
MWPRCJ1RQ>A2D6+1<6I!3^,R5[H::;A5?#1\^K5R"G\/779*0\;'7*HUXUS>A
MOSDQ9UIO'G4&[::$#WNZ594H\8DY OF&LE!@[S]1]\QI*BX4&T6][!&D=CDT
MR?#)G=DC31+PT/!*F.FUK 4=\'-IY:Y0T6!1;978/Y*-BFI:L;N5"5/V)C-Y
M!)'C%U>VF;:.&0*WKV? IATG0A7XUR+ZX_<V#4OUZVA3'%-]94D$!3U?VK Q
MAGL7 N2=ELO<X9$,LVJ5Z4KF9F$/I4[ZS50G\J'WC!8@?"7(Z :9EP!//4W:
MSX088:N&%XP5-)IOK5W"KM7=K+Y2[5XBN1DO[49-NM4HW@53W[5M4&V<[>OX
MOD N+'LNG?9@JF1I@6NJ'Z:=R%YQWP8M[IL;7H-6G@ O]V0T)LY9O<K/ZO-T
M/0<RQ2_'4%V/4W=*2T&N^\RE!V5K\-H(]QXB)>*/W@#FY";WJ_\PH[$^5X__
MJ$B($PY0M>#POF>?K&W5J70)(MN@]0Y;M2#H^F473P\XW1<HW<#3CU!XE-2M
MS5B1P+&E>9UL,GX>7@9[)X.1). H[E"G<DA^25R6MTLBS =-NO6E4=%2.:L^
MMAI .)CWB2GNCA4A:N\J)M(,F&:? %DWZ7)Q1,?E]TJA Y%A\1+,^,=IGV*G
MZI=1;#+9)^Y)"VH3D-3L[&OA'Z;\9[Z+ #E7<SZK*6**9JH;7J2)T7>W/]Y>
MSN%SK#U,*2<O]?BP'&*BK3@"UHF']R5P1,DK]MX\ ;1&S.)W8PP_>$1Z79A%
MH=*6VY&"&9O_!N(4TZWE9?"I4+1'QWJ'! K,C_5.D8\N3F'91N&;W7S>@J2&
M AEC#&S7VY7 <#>I]D2NJHM*J1#""0"8Z0@U"N0,KTZ-4+0SC:6(UH (N,H7
MME%MT5QV#2&_7[)$L42AZ/D]FB8&PX>1%AZFR%V!!Q?PIE%LNY=Y\FIHR&9#
M[<R+6CQ'&:K@8^,,EU2/@'NN7,]08Q_U,?K:B3P<"OW%UIN&51ZH]<S'LAFQ
MY+C8D_[GZ[%=W,4HC*D/2Y='CI+$-'&.#?Z=M+2+7]@JVVQYZ"^^2/><K2&H
M!12J1J<VO]"=R@YV+ R>U3C$#1G4OR4_I]($Y\P8VB7/_>"_<S@.PDX1J#I[
M]HPTR)$3:P>=XOP0W/9^Q&/IP?@)0/DHG_:_+Q38"^.G71H[>%CUW73SW*T;
M#[9TX*,;[IO.G5Q[3X)1P9ALFL ).;56SP-6$W4<F]-K=U64@[:Q#1P*%(:H
MH/G8P?08->_QL>&AY>"ZY,XL^T<I+S#1UY=U<(4)Z5J<0,#*^^0H7?^.S*^4
MUQZ/C?1/@!%95ZW_X6-'I.IXF6LT_[QZ560_K#9*GL@G$J392LZ8<#WJ!SQ^
M F#>=R;&&[?T^<?9_9_YH;ZHN,>#/\&+)DMB]IB"]*4RE+^GI]]1"C/=+7<Q
ML3MQ,=)53V(EVEV=X%I";<)!$&%SCXB+^FPA8F0._X.K-7(1+6. 7&JA,(K+
ML8VDSOY X'B%YN"^&+WPK"1J?:ZH1&EY^J)*8&P;*&LUN,;^:EG36!ADK@ZY
M:3ZL6<CN_PI1\Z'HN([S<C-?];2JJ4]=TBXT?.UI])O%2D-._C/>\UP8/.N>
M<RE9>(\%LQ$&.:)4Y/BDG)*8RFPH2=W^L%8R$1B7[CI(2EI;:T7@XH*#X86F
MB66!O26T4Y*9NW+"_,R;A;*DQ(?5NAZ1R4P7Y>!EZ0C)F4AH+80^:*M/'CZ.
MYB_/+;6E>R6-LT5FJ131!["/FC@G-W,@RXM*RL/6L/WQ=V\M]V??W3U;&.3Y
M11D)IF/N6Z>:_K2Z#W(>ZUJ=AE&"I%=-"1:DP!M'*OB-]0SN+N,0DFG,G*HR
M62MCSTB9RF9ERD%K=7BC[Q=XZNXKN6&5=T)")7 !]RGW"C<W)R*2'42F@1$+
M\P7C"3K-IPU56:UQ6#2/?DC^.!^E\LZ/E2;H/C/F.(NJ(G^..9BQ:M +3-E!
MEBKK]9%(6@%'2I1#:KN "&,SE24IHV0WM9.=/Z5PSO1#@;T8=)\E>#?Q3;+F
M)'21!D6\H-#00%H-+9F'S4X]7Q_"CSOPXZ/[U4OC^;PNZ.@@3K"S(B6&+LVO
M&%Q%272BF'T*4O<7Q=R*@@#=KUD5.W/0,9G\O4O2^*['*O9R+3GU0BVGL0!>
MF^*Q/7Y.548>$V /FV:$A7RBU(>W*.%O0WH9Q 0+H8OV2E/F7KQ-:D,W+U=3
MI]Q^O#MG4NP"F&07VU'D9^7./^1H-<.J@P7/'*STIR5TZ?3874K2*B),J)6I
M/PP6&.W"M>+0[G[_"*:96EFM2@@^EIZ<OYUM&:&!;-O*RKJX@2U!3(,+2"GP
MJZ/XOQOXZ]\&\MO/*]N_:<K<(RLC%NW.V, F,T%$TG =2Q*.:F#ORWRZ1+JA
MU)S>+T.Q,)-KR!<1^5Q#WAKPV@H+>)$+MF$U%HD3'?/'4S(!%9_12L+1CZZ+
MUO_E%6YY10S*K VDLZ0_INOL 9A+^^X5?P/M4-7KIJ [%8JMM?&[)#)/ )2W
M?&'KE/-I()^V7; ;F^:"7<@;_0T61O5W0Y34<I*"XC_8#<\PLZU-9:T-KX-E
M6YKCNX?U*NL0L2(KH9LTLCU&A4+$#GM'<]VS1PY']/ @KN0DO>?%8HJB+U![
M4R%Y!7:W5E78JOEV_,FC[^:&0<+]OVXM%<M=.O3@VM=7W;KC1H.,)*>&X9^]
ML/0#P][:B.)DJC$_ <+PDD5>L'Z_MO5R\U^I*VBL3UTS=W/.5\SEF"$41'V;
M#@#DK!%O3B:EY33E_1GA31W,5?O\O<C"EO/C>B%#80%(ZQC<O;Q%?5]Q;7H?
MTPP9BNVD8&M(LZW:N\3_VN(]Z:#1+UZ4_ICX5?$5\YPBM2:110T50!S:V.I&
MG)6_/R=>/<:17**_3/9X#:M7=']P3X#4@/QLO:U(X!IJG[YWO4^D [/WZ'QQ
M91@Y^Z<HO]KQP^5/=Q\EOOS55,U-\)_9=(?Y:?)U/D,_'SG8A+9:W63IZ^:$
M(Z"B<R2#'U%Z*F D&Q(*1-B\@9"7T\<8U&PRU.%<DXM([0?V=0%49:T-[&_Y
M\]S8RT(K/KDYD;Z20>\7*9A C=,]*B\[*,O<.O+\%<15OYG8SO+O,$' F^PB
MV[GNE%+I<=O4Z+QS)4>3.;<?J']=J7P$15:C;NH\3=FVW,%-F1FTDM"?9,!!
MH"OPN/_*$9\A>%^[K]#@KY'=.!R.#5NG7(9^?WZY+@*W)NOQ!E3)?AR_4)70
M@]_)I?G;^V X;0%5JCG\N',AP9I(O,B<_C@[[^XL<\;T;*.%7-GFP/!!@*VF
MSF8S-&C"6-4-S7TC@,D+(*W82B[JK("Z,.E28;-?C,NY-X6J(7&ZYZ ]^ 1H
MYLD:"SCC9<YE9$GZ#*"*]]'UBPWG-5;;4P;BFK0?K?&$0;!_Q(WOH?3N2E+P
M?N1>G)?BU1AT(G(>S'I'W6K=VC>';X2GQI*7U))CIZ<U-V-W2:I'X,3(:933
MX"<I1(22(ZO3,G' 6V+N4K@,-&C%PX&_*K7/*GG)7#51Z@;\Y%)@,F_<ZJT,
M9NDM0*)! #!91\.FQR+\=G:'4V.'I=-'5I_XY#G[0\U0$$+IW)(,D_JYA.'.
MET;97!F\+$NO4@/Y0E4PY?,W#5*L\4WN"0E+&2T5B6U_^=;*@8.F_M*[U%/<
M9[9L?,KLW"NB/@X53IO,'"B8HL[<F/7$<6L^ R7^%)[<SQVL8B@C2T(R!1>*
M^]'8),T$Z6B\<F'NC[5UU"'$D6C362?)IK)O2BPN66T)F2!QVYUW:2YPOUPS
MG%N:GUNA"4C4CH;\/'_SAY*"#C[8+"R"!BDP'*)E\/&[4[Q>U,,<2H8J,6[>
M9ME#J8>N!^?"?"]W?/OJ:%@5%84"N(S#@8-]I2'4H&R&#9D;F$HO)VDFA!;C
M]0MKIUQD32^"LB.3R!T^05?=5)_*ZFD9E\QU[$C>*N9>OGZM$XNV.\6O2THX
MXUE[UZFAM,ZS:%HVUMWJ3/S#:<))>NI1\KQJ8M2@-O/U*!_V='7U%.]=6MTI
MS7,'S46G:18\6>/4O:79WP;;D#<I]W7!=5J'0>[EWNG/',68GQFR9-26Y2\M
MJ5O;%QJJNX%CA<G^$V_O&=5D$/7[1D#!0A'I76E*%:1746DB3:0&B$H-H=?0
M!:1W$)".= BA0^A%FO022#2A5P&!T",E''S//>][[EKWGGOONFN=#_,I63-/
M9O:>_?M/]K.GV !:AW0-2<3/U#XG2?XDD_S\KK+U+WSXJVEAR_^C[\.._^P;
MF'HRQ1R*2-UBV+#%*,<6WH@2DGS*ZBPJZFNI0W)D$)!=^?NLYT>+-<S"9_(*
M4$&'OOU0NW+*Q<!AST%H-4<64FJ=-'?1G"I-S(!EQ'2Y2\F3 [25GZ,;(WU2
M-3WNS/T(>_7I!TE,07"W3\(S5+'UG:*OG_(LDZ T@'H#J_B((WFMS1U[\6R9
MW26%"QTSKKA.'0IETZ@3%*1LYV-SF$:$Q-])@4]MOF&&SENB,C;P?WT["1H<
MV\>./-HI$*VXI=26)R5 7RGZ?%2Y= OC& _(U9L6%/C&2Z21GBK.BQ10!ICF
M-^5&^(Q? &%P#97IED&GM=E?X].,.BRB.9_9S<-:5/9O1=/E9]AGM >#$!H&
MS4I/K@"?;!2+9 -!_"&$CG.F=[HZXFOEYMR9IM^%"E\^>F[J9$5Z,_B8P])M
M3^WV[U+>MH:&)+)=H0]1&N$'2\8L3Q)KLLLI]3YID19Q(5#.8^]3=\G6[Z>_
M<>"X1\5"-V!J$W.4=Y=&GUS2=,HC84-C1J JF$6ZH>F_[YNIU^*@>@H>.U;@
MZV #6!QVX>LOV/]X$V"2#S/:HC/)+I\S,@?.81%SJ;=?101\9M&#.PDZ?7MF
M8MKC0F7] M?D,4M!]F.7C",*D!-5F7;BVC TX$7<4(9UIGO^1I6QQ^T@B^40
M4RTGO3)'W!LS";3SY'=WY [C!S5\2U56X9 RW2 AGY/1::!\5I+?I$V*C[IK
MI@AJ1GM$+$4)NFXQK'6TW"G]%C9]<QS@28O!S&%!0.[1[%Y#*K5_?C(37LH9
MHJIQ%L"WA%I ?9XV\"RX)HM7-0-E6RBZMQH$N*/C6]$KP/->ZZJ*B/W(^S,)
M,6&D'/&F$\2E%9M^2OG=-RNFMD[N]WF^P+;.YAE'_J;:6+_@:\QV\;ILA\-1
M< L7\(-7'QHCXD6G[8>].]+E8D[RR,OY<Z\ G_>N]Y$C\=^!>)'P*T 4O+\I
M5) P@52I=IA;I[OA>;91_)CH-5]<9L6FR8@33UK9KP65<(AXQ?9CO=^ODZ,\
M"V#@%CDB?VV=^MK/6;>%K(VF<]_4T-C?'.*/D:E(4Z1U_^W@A+F&6CKC8&6)
MW]EMTS=P%+>[Y= V6AC>2Z?W6S0&'E> ZYV8#[HX[1&K, 966/6B?\(L.2%"
M@E9<]G\!];-8_+&SQZ4!R<R,E[9(^)SR2D!ED8*!>%PL%2Z\?38AFQU+FVUU
M/5DITXV-3.VA,[VFZO?H'^_F7CL#L*6UL:;1-[,U KX88_5_#F(=_Q7$/.NP
M6K6E"NEO;7.-D()OUW;%^:4,IH.<I[3*'W)9.@W^=97>: "8Y9?_M/-D@E<W
M(ZL<J@0'NU+G]1/5S\H>Y4VW*>7_'HLLAS#Y1ZN)1GNX)M*=.7**V=^Z?K)B
M:(@R*N?55(._PN4*H 4S6UBD]%MKRD7CLKT@5@><BT&Q8T@)9@%3.4Z7^UF$
M+S>^_7^]T/K_9R/-> GK6]2FAGZ?\A-,QK(Z3LI:QM:6GC61$FX"V<B#A6]?
MR&BJ&B8/IZHMO)VV^C!V^O=GKO-3Q3N9_>8D#?NAJ#0YM,K"']?U]S6[YZ^X
MPFSC.0$I>CD^[I4A^E,['MEL>QJM;QT<O]E:WG'V3(Q[ OFQT[' ?1E /#GH
MN7!V$7#8?QP-%1>FF)_=5"3]YJ#@Z\U-F&C-F9_W^,$[ E@[^] 2-8>R2=U8
MK JSR<:HFQWUVS@6_DT\-''VDT$5UCKPOMMOOSP)7?-^8ME8\WU-Y%.5Z,6(
M"+H88K#1#;+%*:0M5>V0=[Z7*-EAT_+Z*P _]7+)[BAAW#/A%VRM:A8UPZ!]
M%?L"TPU-%?<]+WBO .9>"T,R3KTJ1'O=6VJ#Z,6NX[_F]1>&2YS+DC5M=3.\
M4PUF\ND[3@^5_5O#&$01]TIBXF0,GN(]2N<7P"9QK<O#\+=7 *U6C8AT>!)#
M<+!KOA@'$?1O)&^<S/1 T9DB:DFH<:M3@R% /E=W.H#[)U@7^D%.'0PN86Y
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M1]XO<U/P2;)IK,K4?;$$F%3,D&AKQ!@R.1&9X17O?B[X3&E*C%P"12ZI.=,
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MOVQMMZ\ (.05X'>RB2)UX&H&/I[0QGT%F !W\$Y6';/30;5.4)2B\]^WC(5
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M ?(21#7OS_D0Z$%%!$OYAAW\]MG/DA5A<H6Z?;V>_5RJ[=1(#XCKD/VNP0.
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M&=_,)LFC<P!7U/OJCAF^RGAG^:-A38<>%=;+Q-XZY46"1\1M@G'Q@UE?W82
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M]A2#<_W;;*6=F%Q3Q0^,%/4;1O#CT*H^0NH03T0C,62*]+D$V5#GZH?BO"C
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M'< ^S;R!:Q7YXNHI$$):Q<HL@0-!3@HYA+#.80I;VQ4:Q"J57F?7P7*&87-
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M&-&&K=H@IYI6GBAC5_4IX"XBN,U?[!P\7_QH8=- MK-]0=1 >UZTX%"?9LD
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M.-:V3GK/&E1O),X+1&XZ3^)M-[-M^!'"@%W)YL93V0@/(:_QN$,K)\FM;=M
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M3\:]6;-64(5=\$?C-RB<!V\N U_6S\L^\M[S]LA'HQ;R(QK*WJV=O^RY23L
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MEODV'+5&+P\$MB%M:?Q3C4H;%%?$/3"P0NEQ9*._8KGJ:%RJ2>>J#PE:H,R
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MTC-/ZSCH!(/=7.;M1G:/#0K8V1C\K0R2?!.<5W>V%T40Q;/T7;R8X,D&7@N
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M8.F R'5^>_WTNCO!SUA\;,Y1>@:;@NKE:,NY9;G](W%G^M\F9[*2,7W/9LM
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MG<KO0=0/CQ1&,4^Z,Q$;'91EE#TJ'KH&Q7M;E^GO^#Q3JK+)-IQE=7MT(7E
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M;UOPN'N,\:/?5&9\^8E78?(>T?=YJ$=4>WYGF[G\S,W[P,"Q(99&[/AV?Y:
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M?R*T5FNIM9B=98\M@>7 TB=P:@-7QGFU9+-U7\6#(=]:/\W 'A<H6+*>@[>
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M\XGQL'6=O6 JK2;6/A4]Y>ZM(6Z>%*SBZ"WYPUMN[(/Y<6"QA(4I<;9T]PE
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M6DJL?H5RG\ +]Y=*K\3G-VBTN=2/8 &^7J_3%DNK/T^ +Y/^%=OQ=6@_915
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M)M^=OEN7<K[M9UZGU879'S;RKP%#Q!%46V$ 7+"U,MZKOD7-YIF7@3:P]5=
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M+W ]#H9<W\6*/@CIP*FR_,7Z48Q9$4KX084F9;V$79.H:X1>VPJ^S</<0TE
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MF/XH.!BHI1!I$C:83ND.;LOA2RZK+E^U9ONM=I+[*#7B>"@6#'+UOW@&F+:
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M5MOIJ:]T T#;F-7\4'4\_6-#VUBQVU-WB:+R-"B.+Z2 ) IG9S_4-00HJK4
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M' 56&O[7AD:5>I#NA)_N5L[>DAD<U^MR'2=6W;?I(Z@)*#N;.A# >QK9(L;
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M&$SNX4X*5+ ZU6/#Z,NRS2CV4>X?E^M*OU*3LPV%Z>',H5NZ)P'$4B&ME27
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M';!!Z?Z^C/+7S(IT4X5J8\U"5<V9(\']OY; I(]ZD6(DOE7V6[__MJW+8?Q
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MR#J8X&LK#H8!LVNF4M!"NZ3:/P-XY/$E;24TH'W$/^F'\]XAF N!=KX]Z?<
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M)C,3-?,WFF./ZH:^3R+:XV"TZ^DSI"%2G\QB@ER4E.L0$F_C<QUIKP#V0\Y
MY_3>-S4.()&^(FH\T%IF=D-1PPHSU&!8N)O,9'S*251T+)HJCJ95[>&E.G'N
MQ/BDXVCW]2I.@*UV*9&G4[1,8](_U"9\?FK84CKWNUX#7\VWIZF^?Q3^25""
M>;P7;)1GQR/'AJ)P=,CLE/I>8TGF(/JLQ]<^P['BQ%G5<0'[(GIY^4= GTF-
MIQTXSU0:NU7^3'2;?T^##F&U34Z8>QW_I@XFBDD4\N!LHR:RVA1G@38HLJ2!
MPS5 3"I%.;_@4$>.+%8XD0NI;XAN BG1DY)K*\.-QV28^G<X<0F;2D.YL>-X
M^&I.*&M\NKLJ9_# H<'RM312+4JOD%.G=OHAQ1'L<XXS:V;!J5[;^:2OG<U[
MJ%'#@$.U3<41D1GK"<@1Y/5J7P+%<SH;?&=XK$2TQ$7B3^YT1Q>_/Y^^WA5P
M2%1G2$I,DK#[X!,23.Z>L,9IM69&FA)<IP6V!]LP*CM"R&J=MSCX5"AH;6);
M[RWO:VA=5T%DR9C:@SZ"<@$-EZ:<&(Z[@]'\)/>[V. ]>L-2XND;8W?@^0Z3
MB.6N$]LJK"K]V]# A]=S)LQXI$(IHJ](=S<3H)>7$<!F*JE?Z]M6$0K-DF?L
MI2"RHV=70[#9[NV\$/6H&-(2INUO [80?5J2RU'"I[>62 ((_LD*>/9..,SU
MZO4 0A>1>Q_] Z]3=P8>J\ESY]"<9U,[7+MRB"^G+ORWP?=H7I74[1)ZUE"+
MC("_G"1D/A6^*'%*1"0?.KGF(VY]PSO""\QW_LEW>&& +2T/FIQ1HN6V(0Y>
M(Z*Q1@+"!GM'FT> SEOI%;BH$"0U\?NY #'JF(G)-D^1:8_^[.]-(.,$?A:Y
M!G>AZQDO20O]B761Y()9SB53!6CF<P9-;9@!%^=S!& >OF4 <R=CU*U!;E^H
M?*VN>A?,-#3%4>U'AT(.9 2P1X[.TC^.Y?6*57TG6)I&J$!(N#07&.FKXV@/
MMG)*J+@N74T[FA7OWE;<:62ZF_C/Z_6YW_.8E?DT9\>TJFQO[AB"+<J'.]+@
MCE]06>E4GD62/Y^MMB3<G*S;3B]<\SF?$LW.5J5[1OL-)+X4X\D!>30_SX1<
M.+Q3SV9:C'R]VRK#DM@E\KE]?^?-CO3T,W:/Z/J_NXH*&GGO[+;M( FFYIRJ
M_Q::5=DC_J;R'M=%++.F?C](=6<V9! ]V_6TR[^)*?X'%/?;?R&R],1BX' J
M#P,[ C.:1D0^1/I^4/9/X^+*6P<]>8H!,A!450?15L*9'JK>^L2T3^,VO-=O
M&.IE,6<X(B7)D@G?3>EH%7)BS/FH7SV\]:NKFZKS7G;TO8!; L@-8*W0XIVW
M]Z43,E^/)K9_<AGS<=8UX]NB0)^TU@PG[7TX]]'S>>J;>WBY #11*SZL/QA^
M GU55A&[LN$U'\0)?%1::2 G$:L%T#>42 Z-CYHJ*L:DE3?"9(P-;)K6/*F0
M\[7*7SJ6S!\TGTOG"G@%#BXNXY\ ,_&665,>[!5J4:GF._E3/W5>VK65X<(.
M\:53F)A9*-[6_MCUM$+N>1RZJH/1;\TQ%V;9XM\AIR'BOVD>95+24#:\!=IH
MWB:I\;@H;6*+(>\/1A:[%:W3>AR8F3M5\,N3INB7JKE<YQI67DH7<H[@/I%&
M+ZZ7>P2ID5RU,,*V!32+KV"<J;P?Z8 JOQ6V^;%H$J48=0KE;@X:XY79_FRR
M(I4P;6!CAUIG)BU!K+WUT1=1.2X.+OIY'>A,\>FX!$N<O:]CGBEG3_SP=<83
M+&UA0\#2F1B ," L7<C$K 5.\5IAMQ(Q?8^X<YN8#;E0RYDSZ6!)6:N3XQC-
MB0F>,IE^[Q V/J@T2_?ED'Y2C :V<+V[1RI87MRQ\%\[R?1[<WT1EE3_=;>B
ML/W1%<>%H!5Z.]RKN$=0NO96>U*BYT'WR$#58^6^C.,_BT7 C+Y5\!]-(M\>
M11WJNH)1_3"6/MW3*&_ W*,';ZWQ>HTAPTL'-"VG'BT&#;MM=:U7 .*?V*JG
M&0?9(T\0IOZB\PV<^]^,)0[[:&274V=95\:F?6=<4X3'L-*"&AQJ Z'53A+8
M 5RD;SR0B8>Z3$ 'E72/0';A1P[6:KZ 4?KM@[!SRO52U02040MS0'7LO0?X
M,B/IB[)D1EZ9&K2>LZYTTVH$;;6AG$'R P/A"CQ9A4U"C,K]O^"Y3MI=>5[?
MI@S+@!=K=H.QA/B_PY0VCPZ+4JX NB6#&(W>3%^8/?0>*8ZRT$&6ELV0Y$GZ
M(NS61J*91$4N2U6&TP/PZ[)NXLB-F;EMV^+NA[NN+F1NU<O5.25[RJ;R\^^D
M# @_45,TD?7\U.Z ,GL*.4=3M$6]@5>@MV"R+9=,E#-E8S]W( @2_>K2JK"5
MF79=(]M[Z$..8 .HE'S&I/'[[F2+9D8]]G<:G-]X8$0$GE2H(&*.8<,[\\R\
MK;0L L/0U[NHMPP#4(RA:/1LF[#2@NG.EQS1V%PB?%:@XNY!LXE,@7W^ADD=
MBN%#PR0.WHB+B="]3270S'L+C^M12NYNKIU__!6 \>X58.S;:M:DY<1<A$;R
M](-;]*2ZWH)$XTM?DMRE#D68VXXJ$TRY=S"9]13T+Z!+KL5R/]R2JW8&JR3E
MKW_(U3;)&LMXOC?RD..\LW4W6IJ.Q5"M7[='8'?_&B5'2IFR=39X5I2)]P+3
M">19=T17?GWAW,4MSZV??<#A$B_KEPIWAW%N7F"MA MM[/"31 J[FG*V-B%_
M;Y4E5G6]M#V6<$3>=?%=N#YD43Q;$;G.('^D[69AQ=FZOLO5/*JCP7<GKR[[
MPWZK2Q=5/6/*!--;D;5$SZ W3[.Z(,#P\,,I[ZV&$2WFT@B\=J$&QHBF;;#J
M4^_CNG=:,Q;^*XY.$A6?,QNYAH](U+A5&V-7[-"JA]WW0<!MMAJ<VGO'S$1Z
MPN584=)":7DFACW'1R.(8J;3A/5Z5E.O? CTLH-DUO(YP]3#/$F0.-YF\E3-
MZF1U<=CYZ[J<C>J)^MWYW<LX%YN$T::G')4JRTV4U!,G\F>:_ 0O$(;[5;H#
MXX<2_Y0CJ/_O$) 26=@Y5;8>CMNR=+B IHMLOZG[+-627*<)W^P83!^4>E+-
M]>[(7*%W$Q*9]:)T_.]3X^N4INB\5XF@VQ!*7'/(O&0\OPB^9)JW7+@LR]$0
M/%5K?\; B1HLQ]@>"Y@KH3JXNN>"@L7%5C$>#(HAYQZ?F3&CZ? \]:JG;B[4
M0K%N W* >TEWZQ29^<@-W2)W<0'LNWWO1,C4G<C=XPC5Q!C8,GI%HSL[<Z5^
M?+[>4M\M6Y0E$BW.5RQ<-\&VHS&*]T-A;&A;<A:WBA=0)OS.H@RDI#>1Y_3J
M=<T&KK;=URKR^K)D$O/1.G>" X<F=$O.'ZGK*F @"K\"?-W&?KH<6;T".%J*
MK$C5U5L8&,+T4FO&(NMXH4A/?-JA/V>$[[W-+O8K\)R"I =W[N^5=?.YU4BM
M>JK?B^]E#3]O"\MTOV3>2YZ-RS6?%FD]MK1!OA%BPB7TG0CUV?1XENOB_[V;
M&PS\Q3WY%;D/KCRB;]TZCOITXHR'$WUKW<&5MHD"B9WZ8];57^T6HY^X^_%7
MP>TX489J+)HJZ%0"90OQ3?/?U'A::F4?M8:LL"G'ONO:S&-42V_"Q;L:\?=I
MDA?-'X!&%@/+_>^;.>#XXR(X A\K$['Z,0:CX)V;IN7:1P3IK8Z7MX=?#__<
M^66P^#G91XW^S:;1VV[F<N[3A6]<LU:]=Z0W5M^]H7^274 &5APM$M:P_T8A
M_5V'+Y\'/_H1NM+9+;@-X:Y-)+M01V4R.&F,:*":!NM)A#)B;*[OID^(YN5R
MXN?F2]8K0 A,H[+\PG!2:K-K&W?F*[ B#JGL6D^RKX/H:"Z6])P.-:,7>W@8
MO40>#,$@*Y13,UG6S^F;0(RN0O'6$J/)86A8SJD'&</8<A")%32<.6B):Z[.
M84 /PK MN9%J\[%B5^/C+S;:6<IA3G"!URLC5*=4Q;>D< O-P7O$RX=?)F5#
MW^CD;D1W>2\5U/P6I-J?Z+*AK,'KE\I<@76^KF'@*=J!&YMTL&*\'F[XO?:S
M;TEAJ^Q'\,8;5-GB5!=388!R6/N\6"_8L*5:IB![JN=W\2(CVGK#[+5AD)B.
M0&KE.WZ)@U@?T QUM1',7!U&ZC!631OKO'-4D&QA(]1U_#XF[&X'NT\*T=@^
M$UGB/_ZOY!LW;MRX<>/&C1LW;MRX<>/&C1O_4SR,!:'EV(2%F!D;W39MVVAI
M[EM./#F?\YJ^& -'ZN=1*BT!Q!QC-#1%)3#O_&FCUMB/P3M5^+ <H:3+Y+Q]
M? 5D>_V>2&1JGA_2[N^N_6T[;0.WS1XG,\V*T<'>^0]HDN@Z%7QA]TI$"9!&
M2WTX?<2Y;9CD8;IUI0O>TIJ&<AZ8]APQ@JWMXI5N@2@$4(CC)Z7Z2 7T9WQQ
M,@DQ,8^;T2P:R >$ %(T)6,,BHZF3*5YR!145OA[T%_2H/3TJZE.@.&,KWR_
MS'/G+!3!U,_8ER%II46RASQ5GD6FD]/84GD$0A!@#LR8U9,IQ\M5!)7619[C
M\SGRO6(N+$T'$:WKL[9ZU-MP8K$_YI^'^3IXYLF: ,8SOBCF377E_L9^R@BY
MI1K_,B8X,O[Y)278V3O5IN%"UK+<+^G,ZZC/["TU'E81Y'N!&$HY8^P)U.[Z
ML,KF [(^39FR[@+&_Z(0%1".MA)?[WP<\(S["T,8AC 51OH]]GL9OTHK0,!:
M24D\;PN1BC7+DIU(1$DV1#J(YITG]1,F_]<6=__K&&@(GEPH-4L6/^V>59FJ
M$6OB*%Z0HUW+Z5SD3E'JI5%C\@4]],J96*1B)%-DDSKK(>HD*I)/(YO\*[J'
MN?4O84V69_0@9N+<_O_LKJ<(A]-@:OJ$(&A"U;R?3VV&G3.K(\QU#@*6B(*C
MUN5H'?X);\[_HG^>#Z*__0IIPHT?W0\E1#\IMOEK<4[HL6_@)0CC]9**]B,\
MK_>M;[@C?=2)DG^14T.$N^0%1LYL?0]&V?:CYX#G4&9U_0Q4E&GG]B"LOLGJ
MP:>G"26O^"TD4[3&#K(]P4?C$E,KKDX0+".9]?'B(G55_(E"%!M98"_@''YJ
MJ 'V/;X"$'8)B,.=UZX VEG^1QN2Y'<<"ZR(:\MGW' GX3W0AL VP\'R9*7V
M/E")%WD,3\/$E$]2TOW-=B6)<SU?81+W;@O2*T",G_]FIH$LC7\G3.D*4)1Z
M(3@L86O!/5C85L@ J6&SGO#4]3X7PS!;JM2-%#IOXZD@Z #656=N[4K>VW_A
MOEB;"JLM7@'.'G!= ;QE#]F-SE=_13# 1F5_WQ[&@2P>C2ZIJ8UCMM)(2:JC
MU6S6M X++MD'N:KZ,3\+'QZ0:E82!)PIQ,S1/+5.6(/&8>;,5"'@QV@XJ:+"
MV5:- P!QT3!:*.59#4I'N!'DUV K7VWGC<?0D3+A#QOX2?A3\AWOSC@>=SE7
M&KHT?@7XU_O'FZ4<&(=YJAS^O<W1-?%P^O92A?R._DD5KS69GD'D:LNSCZ*H
MQL ?7SG [(]N$?_TQFC($&^5G[*'RBG*H_PD1ABE>92Q]0\NI+I''[] [0;3
MT9V<Y+'Y>6I$0#1"/-?I)F.S%H7*W3NEUTG]W\GZRGQR6N+O<7\6I2W>A*DE
MM6$"F<_$M^?G*#TF@7A%<J+RI^\'+J7\TF=UWB.<X[W@(1?*33T.+).I\1E8
M9K$C#GBOOD=3"B=5OR"R^[8<J$9;9_,DF!G%8M<S@+OO_1<5B\=2$LJZG# .
M6!_L#<6LFD_SEJ.'?+^>K/$^UXR8'X)8Q7ATQO!\[761RY@T/B,X:LCOVXCN
ML\E:B[E]8(]<%"CS>,9/A+J,+[;WS>]QS7?+\DMY>,_VXF6]+)X.^'C,K>/U
M<<*E;Y-+Z8?9!VSV5?E &-88JO-$V/\AQTG6Q<N*N49$KN][&TTD=Q9_QC_C
M-+]_ &E>KA;+?3S<><-E"-CHL#"5S+^3<&[C"G!^/QV!KW!P*95['?>07P6)
M@U+RN4WIII/06' \JCB&25U5:F^(9L@L4Q7,P]TM2$%4SU,4 0'FH,$P">=X
M*M(J(J8+W6UF),A%-'GA77I5S05C:+<*?-]V%5_Z H0(RX2QE(')(HL1/G&T
MQK'S<9&"Q(](0?55=O __>U:X["U]5:AO?@H]U74B UA@6_>N%F?/7,YOXH;
MQ0=)@#XJ;HA9C 6K.C/-TN;[*7;'H!9Y8I389,5N'2D>8AHF5,.%>:95F]#2
MXND39V9F5K]84KY/JXO7'$TNWR?[TJ\I<=.@JC)<-4H_P%K8D5Y;R5 R8%I\
MM;( N60VM".\OC79Z]4(BF(/\M0EWA#+7Y/)(=DX/NY_7^#GL[%X^*I<D-=;
M:P,P%6A>#GT4P>3^BKC0H0B[;!!XV&G>0;BT!6 _F4*-SD&=(@3_]G>:L\'$
M%[RE_":;<060S>8*:UC&AQWY_R8>8FRNYJ74^,B5>E1\*>SEJ:PA^%VRZ<>,
MS(OPMZZ"\#EF 56RS\+_\):F_S_0Z*F77O9^C1S[?B!*Z0EI=U5=/QVI_H\G
M 9]Z;2Q:E>OX;>%Q?\W'_42:Z%L^\RE!1>OGKD9\N3VQCMF0037V'U&PYJ*!
M?X&ZX<:-&S=NW/C7PGHU\6]02P,$%     @ 3(JL5F3[8*">Q@0 OS %  X
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M$=L^NC##BJK=74Y!27K#:),9@8L_KT?D:9?X*6I1:!KF&)%[T9[]'UWU"6!
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M^B/P(7+19:[:(M>I7ES/"@4YXI)]&%EQRG:]NGG"E@MD!E# ON[;HT9#FV9
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MT0FX7U65,D^T"9Y>NFPP0+TPJQ(SLU;!,,(U0I3YH2ENT>&JE :[S30T!1^
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M]^+XV!DU/<?W/MPP)Q Q^EGER/7!7Y?<8/X)8#H=33%LI?ZW.N(8MH?";S[
MFLP7S_<"M?^+S A D#JU8F\!4H$#26#<;4S!2@5R;F$]',6SU4B>152L<[X!
MX76(J?]Q6=^!UKQU$D6J[*/NS#>;6\%[A5 A#\V\ *9P0FKBC5EOK3+D&N,T
M'++1-(JO2X'.AE.I][7B$2PY>9\5B#X@_<O_-.C2ZVHOC"DZ:>8-PN)X@596
M+Y,4]1F_(O\4%\(CCE[70#;V\#>:28%MLZ>_V5YA-Q3I-V=T*':N/.<-;/TF
M*H&4<OPM%U%&<[K#9)_K$:D^KMMYS0=\ GR.>84B?#[PZ*)Y3N0I*U2/C"S>
MX[51F:Q]FG&"KK]'+JY //+[<WR'2CB2Q8\H.]I704CHR+GD^RS9RX%#AAYB
MR&O$I]-+K1(_'Q]A=/UIZ4>T?0>MV]O@>>D(PF^@$T[(']KW+[D9&GY*!. J
MAPUV).QM4WK/;#T/*-WFZ._'[6R;#,OWJR04<61!7>_RCDTYE<5#>5>C7BF%
M":BFTY\8)ZW#+%NG#/:Y.>*U,>G7J]!%/TX*-BMPG_\=08&_UDQH#\])7?2P
M>ZTK_.AD&52X@)T+"$QJIW09]9II';^*]CL>P-&VI9TL.S:OE[;ZL^F=I/Z)
MF"6'MQ&=S&>#K#PGPOVQ1<4OX.JQV73?67J>O#RZU%IX@5S?6+YHH%K-QEU<
MAN$7B];^?FQ:B%&Q25;:182$;,Y^!NV8+7CSGO)UW*KA\KM2!H'/YC]%,1=E
MF9&C O^I6D3,-I[/'\7L:SVM"',U+&B8<J'B.M\*0+.)%-ET0E?7>V5PJ84\
M:G9ZU=KYP-]-?E20G!_9FZ3B<H8"P(\J*B9H0WFQ<1P<8]-0*:S8L;3J:6K#
M6Y&^]>*5GQ0H*]XQ\Z,.2Z$O!SH231CBXQ/@9<A(J^_G7&NM7 $OAP2M)"9(
MV+Q$*,7HF9!O&'%K,5#X[C$:<Z47:%Z\:)0_W"C/;J08$\:FPO+]N65L6\NP
MR<I)?MN(/+VTG: R[0JRTFB=V:BLC56WBL?R5LD G?,=K0SU_6[C# &<.Z=T
M58U)Z*)'< O>/T@K3%7H0=SL[M(JP654B:\.CT*EN^89']C'6+*$16F(@(\<
MLQ+B.(F_)\L*4MZ;LIDJ\^/=F"?W]W$N_5JSHH;:R];,N-2!!*;'7&RH^(CG
M4,OS&:."J7XM%C%+.G46"XZ/RXU19_\?D'G_E^&6=XT\VL2X0G>&%Y8WG=DM
M'+?T4  3^+YH2 I0(?N$3X^K"!@=P6NV^R;%4C?M0V$.%DIV%!S:UP:#A>*-
M"/.*OP)8V=N9Z[;K8\,,*._"0J@RC:9@D/CK,X.15YA*L:+MG3\0[0>=3X 0
M^_UDYSVQWC $=^X/EP/5HH(7CJ3VG.::WZ,U*&*<$S*0UJ8]W6NW'+QKYUN'
MIB<0"FBYGL[F@ODSF?X@\D$F\)Q:AU ?+B8_*R5UE.,J<:SW&=K*Y/O'Z5BY
M&2Y(3KO6'7& XBTH.\!3NV/S 9;E/B):UDQ.V$H"I0"Z&C9_*(@J.E_*DRF^
M4/_@^2TX*F9^N\K%,)KM7LX49Y^:<X+3I2L=G*SZ*\?DNXI#I?@?P,XW%$_/
M]AX-+4[0@^LWH=:KB9VL98]PD,X,S>'!O"O%[Z'BPNXMLD1%/KV3\S8RRI/V
MHY1,Y1DP],<.@9+ :Y()3UV2R2)".3@Z3I#L6A &(W77+)-WX3)-A)/P]?+Q
M'^+M/^0&@E5R;T.H(@LLHWL4MVRQ7V7 R\/D3S?%%,'%IND&-Q^:FPDX.XU)
M0Y<#0CIZ?J"C3X1 GP#@]NM+=GC-^:/X,++&Y,EV)4@.WLTQEF<+$PQ?VO#Z
M2UFT0UQ: *QUPZ&KGSFYPE\#U*J\^'Y#_0EXMQVM^WX<&HQ:7F%I[AUD$4%1
M%Z\NTTZG1]U[5?ZU9V%5!1Z-FYJE0$3N?NT3ZP^T#PE]O2)1@"&B:-OZW@([
MXQ?72M9]>C.1IO+_ 7/$?QHP.&V/;,W..8ZR:R,=[;F(,.J9&=?<&>.!R7>@
MT%)K$)2"W6;029;7Z&T5'<-\(+%U!*!W"H)A.79\""E:FRPW&3X"[832%N K
M <P<D-K;RBQ 9AX.WW@]-#<<@=?^O,>T]]1NYA*B/RL>JH?=!#Y<-?C*BALL
M8X.D.VM^P@UZY:9R([5"5U9$3(\TPTGDLK!_SE.57&?F[]TIM,Y?+F(9LO!G
M<BT01SL?A "T&UAK%NWKXJN4\XN!Y%\K,3M+@#/)XZQ+Q:XO!K+N MJFDLA=
M8Y*M.5WNV;U573<5[ E[@D\!F-4*="%$FC*H__(O__(OS]!(?WND@Q=OT!#!
M0SMESP03(0:@P2+#4H^P_N:@@+?O-99/C L[\6@.I&BGH?ZX'O$K*-.0Z@M5
M0$<=#K1*S(+2241TE]?$>&WP"4 Q!]_HH3D-V1,R^![K =LY4G\]2&U^Q,#'
MW%KQ[DHCU!3OZKG,D]?^D%!PQEX8*>IJZ' JPK*36'-2%W/@?>M'=.?T2)]Q
MO+AZNN]&CA[I(DTD"?LVNPJT895H#-P2L[7SN T8E9\46.;O(<>MK##]EO1Z
MQ2W7/!/2N=EPV+[@]R6+VO=E!0\<Y>#ZA+1 \:26M;?&) O^F5[U;++G.(I,
M)16%6GH6TW$Z?T48@:\RKW*=V$H2^][^AQ21JMJ[?;6OI.N35D(W:O1BAS^M
MM@!1E6L/2SO$G+,Q/J+F!4"OQ)$\^NII,JT1G=#WRH:%%$ZM.MT>HYVM+_>D
M6.#I&V]FS.Z-2'2K)-Q&>@>Y)D26!I<",'9FH*W?Q-D-:3#@;@,+C$$S[*V<
M#+(A"AB*J$P0GR/XK]EFIH6=/.XN?_2:UH=0P0/3(YQ'T^0+T'(::#6ZL;J'
M/V5URE6<BKY'=5GQF$)5[Q%1+:)-G99RIA%-37 Z$WD*&[A0G>0 <WVI"V=(
MP4BDEOFTXXQK6. Y^B[W3&Y_0Z<6;F->W(@EOA6A"N60^2JEQYAI-GR; C15
M:#ZZ2?"KL!&^H:[,1KP[=0_G?NS,M_FKYJ).PJSTH_X)8.5!T> V;'WPR#SN
MP_V5ZZI9D4)$[V=C/\>FFS89)QSS;#7&CVS,1W0=S* U+G"@)G3'/JV\,B$8
M_1O$S$RES(:K(5AY1M%V]P2(S#K=^0&I W-S<X"F\R<K /.\(E]X_#XFM*-$
MQ5S6ZAH?/@&&O,7==1\XW%>HSF9#)?09E')L\(W?955&XE#^)NV?6Z-T$NUA
MX\9'O#W-#"GO+J\$R]L[>?*42)2WGJ"@5&Q$P/S(X*G*]6="V7FJ:P?^./!X
M%KR4I#,4%6T'+P#O%/4MY>9LDH?0:K?73&'Y/KG]=Q<- B,5)[^)N[\JY&\8
MTU@\7Y/MI+D==..Y)-L\!M2 ;FKW?57R]Q?\:LV2%RPWA=TJ;BQ#.K%OJ'L7
MP"KT"A0J#"7T04-##@"J_@IF..^Z/1'\RX')X_+$I!JDR24%@_X/M:!MS5JV
M\0]2-M%+XMRSF>/MV777D_GTGVH"FN\^;6QR]MU1(L''-<]+*^C:C>=3SA"Z
MIQP-69,)74FA:^E9/V%\_@<%0GY0O&YN,N[O/J]<G6V\L<7R.PZK4(*&5 !5
M,<X!SGL3=<,?VZ6((M=>+^9.'";MN4#J#<?)PPV,LUN> "9Z&V2](F4V4&/#
M:].()X!F;03L?,S3;9:PAUQY3/WUUA<^$8#C%":;XH JM)6$:'GK]7B**1HW
MEVNSF>D20F;*5;7=[MSXVX62<#(!9X![Y9QC+R:ZZ;M+Z0CRE=SUU;"&C.)\
M(]^,:SSNP>0O+4M]6:=M,=^O2V@P7*+Y9M>/(XL,]V9^KBP9P&Q^KVG':_Q^
MV$9FSCI0.:MX5!%Z[J)M6R^M-0T5+"<1W?(K\?85B%=1IY?2Y#XJV?HV0AG<
M$X0+1Q)=*EDR:U:4@4A4S3:S@ID$>]2DDQ,'QE/@P[$HM+AZ)S3U:<K*ZQ=-
MSNN/T6<&]EB[R>2FX9 B ;Z2\445\C\HAO5:/@FCIC"$32$\'68H7['[2!#9
MF>2U7>K2\4WKMA*;\?C#D'1DKH477OZG)T"B^VT"CO:J?=P,W!N&%R*AZS"S
MP%6-,]P1Y).D$]U'I:P+B+LLMS)J:8C=L O[UL)Q+]BX2+@@U>_OVWG1\7O$
M<?HW06T,=/MF0:<T"V%U&K1/0DTY><R4B!$K$PV3R_]Q.]V8H42EX$K-\@1(
M2#WM??",W1(D4!G@'GY\&7W$M)FYXA7=&PFA4',"D>]HQE#L<D8O%=-7E;P5
MJW02>JPO43G#ZZB">YV8QFKCY!NH;:HY_566:Y%IHW!:]7!"HIS]!>^5AYPQ
M'U&8YZW^P4GL3KD]RTV\(-9>!#*D$>8T9$:*42=G^5!,'PFDDG(<#?VMCR%>
MP/+\P7^U]LED;-O7?Z0[W_/\"6!HM'=%$_Z(-6&W!FV>/<I-<=55T'9O,\/@
M^(3_!X4FE5)7 W6Z>3C'N%W"R5 YZ&TB*;$E@RAZ :\)2PO&Z:9I]>3J$\#"
M0/ >^/5PA30P=:CGF*:(JC+M2]&;;$_[>]9PNL3.2AY^Y+ZH)6*&O1AI\N)R
M;:[]U7#>FWJ?)X#\9%BW_XMTW7OA1T)5#8C=8B/.EM5CPX;5HZ0Q5W[IWH)4
MQEUHKC<J.,><_]T:MZ3H3<6?R]67\$G]4\[F_+#.$]QA*V< K[59%]=O:O<3
M?@N:+[R+5*5C@J9AU$QGW.WI>/(-'D=0L.C-[Z\_^1K*M[0Y\J*.&*A\17+>
M]=_H/((W7RZ7C]XAU'?DX7_65@E6L:BXC8,,"T24\Y3"TRXZ3C3KSA8%A7_X
MT7E\[*AE!Y4=\"PNX>/%%YV+H&>S!<3!9_]X"!M7C3?9Y.^:L)P2QX15T,3/
MW V@*OS\J<MLC\X0%=3)#%6"G2![!,N>;1?"#J3Q]EI8)^W.S^>7WS)ZA**Y
M%1_SMANE47[Y509>-/:OV'NQW["7?=C U9H'C^D]:I!$O*ZY73!Y,S(9M1:3
MM1:#)YBZ4?%ZT8.A8Y:\ZXPL73F&5-Y\Z.<EV:%8PB&.I0_[&5HP# ]+H@'W
M5X.6@JAAI""RM;(,8Y!8<._G2^)!O_&:"Y4U7RD+K2^A#^^_NPWPH#Q*CR2J
M"5Q22;I?L.]-^EB?"67B-EH5[=Z!R@88(WJ4D[F:E3Y]X9/4\R.>\.&#1[O#
M^J]P7AM7JTIZJW]Y$R-%W":N D@(PD./%T71M5QO+/5>Q0:Z"Y57H"15_F*?
MI%#PN G\;6T*L8_@/E3V%MF(LXCSU'**G'W8DDX$6I2(N,R>\C>O%<YJ=%W6
M2S'"Y5A<62UGUJ-=YILBP;O[6NI^'S"W1@=6W279/W;^4Z.TO]@+J,FQ]Q$=
M??F#73C^*T )QMXM10KW5YB58H7/[<^0U ZC#H6RE)OK$WW567*K4?H\VFP$
M][3'C;R7\<A5F<C5@ZS2A8=*U^41,5#_YN@\*XYHKI@V/>4R,%FFBBE='[Z:
MGHUJ,B;NC92N(61/8RKH5YKW^TIZ.\6R%T7'$#4KR]S5BMY=N&RJ6BY/U0SN
M-'QG(JQSH:2-J>OLWR9;(0T7?@(PT<#0'_QH'BB8+'QH3ENBR^&]/<(&->D@
M'U!YQ-MDWI<$[A)_Q#7(;I6L581R6AM^O^L?1.A(5G0^LHY+:'^=]7J32[RI
M['#/1X9W_TZ&X8RX&TY]?>P?WL(9Y$_B#^RF0*3X/?^6P]PC$P;OC9^<\]0L
M_VG5" [SAF[4Y2+CN>V&SCSF:>E]>P!ZC3*Q<"?-+6>&Y!.@//8)D/LM4E?-
M-?)+4ES\$6.LTMGK6 3GNLH,CHU^T();^[D<) 9I]UT6(ZY8G(&74&.^1VB[
M/202SLT92P&S7;LCF*(Q'_8H[ "]5CW3C6JR](>QLX,4K\7!)<F.X2]>C*:Q
M6_AC4,\5/U(I4(>?[72+O4F\;V8?L.+)OB4(E./="QIB[3;IO])%<(D"O5W<
M)-DTPOWP(C4:6I*-0L6]#4-K?C79@;=C2HC*MY\  <$&&31GZN&P4J'&<4'2
M"GKYL/F???X+6D@T/RJ(X-+KOA3&9[%1=E"0V )\T9@HG.L+(?VQ)Y];!O]Y
MS'3N__! B)0,F9\O7"X5>C2^>";9$\&2QY,3P0+X?QSDL%.-SE:X//3!^]/C
MU+W5-:3%*O':GWO@=KXRO==]I5=VHC&")3?'.!@\RM(*?U/8=6/0$@8#:[R-
M.!M<:@?^-&1F9 \E)1M%$;2%"Z^#DH.:M(NL[WP1\8;&AF7L(#;"/C\MO3[#
M;<8@+USHJJ;<C=M+[\4TC6 _&O\.)I@&OO438"'3YG'V]^"6;^;@>8N;K97C
M\DWEF$LY_W74AP6TH#*^ D20I)^\R:1>"\-I4ABLCW-MYK!EFJHIPU9UNP%D
M:R[-2H;X=D!Q"+ZA6W5?>0*$[X!/A59NM*"^\MWDT.-(6WG9 O6M+O_#,,Z.
MC1@B2O?RQ1XIU D)4(Y2@37F&8:>8--8F@ SZ48-;P^.2Q8 0(7*B:?]Q;R@
M, '8BB([=637I 9K5C4-&@XV7-2HUW2<.W;;"&SK?;?;!%K#&B5:65@%9C!/
M";#7,9S7+NS8E*MLLK..2K6&N%U^N"*?_!A\JM1)X?_2NI9\>KO"L^Q E^#6
MR7B99GW43$5T#3M)4ES'I/'46CS=:4/W=#1<$ _7V)C7)M"F+C<AWH'X5U2&
M5]R12;8"GB'2()R]XY6'^L@6%W3QX>OQ5F)^7=,7#>2<S7ATYB UVP,#P=@?
M M[I[%IA(Y!ZM7@N!]\?DC\DMBO&Y6<=#&P]YN"80[D:R3T+G7!?0Z>]IC7W
M@T8K$^>JQDP"#_))7;@_\W?;-^2N%<F4CB*Q0W,$P2Y](XX'*PT-+%ZE/ ;B
MN10=*7@(!FJ2R4M3R$/AH:.GGWMRM3_CCIVZV-T4M>#I*.(-]:OFL9;Y:PW(
MX<--\C9HH;WE6-'+'.Q"I,GM[1#;:$.Z0C3FOTYZ6I.9\U!X)&T>.7C1U)QZ
MRRSNY#@[4]]*X\,3W-,0DE0**C4"DD.S%JFF7M8=C2@!BOL8UX+$9KT5\'3=
M"&ZTX[9Y?"AJP_3&H&&S)W97DE(;H_4-36A6C3T\]9SG2#%B5X*5)3Y2CQ/P
M] */P?N/@_?8]-Q5OIGBCT\ \1O'FP>\=T=%A>ZY1W<1B[=IVJ.=3P"(ST?H
M6>UUQBH]'O.AO]7(26+R/SM;&Q<@",=U>_A[!+-[MF_UH?\W%I\3]J%%:+#O
M4M3E57E$1"IP</(19T!]-+5XL#;XXG3QD0"O]@DP&#;7,KOY!*B.7A3V^X.P
MYL;UP!Q5@ONTX$^](4_,UB?4Y;WU[JRT^R/"(.F\*#@S_FGYQ*\Q'&CC(N$G
M'40>$OR0J@0/!N_=J1\^A&.Y,&^3Z6KOS-KO&)LTG]Y"[3&!*8*%/P0IL*+%
MT2AV%_GX41FX@UZ..+<3+XRKYC]G*__I; ?WX2B!H<W"<TI :?!-%ZP.AYU_
M5M[Y;G]Q[-]'A_*;PC5+K0VVMAX3-X9-58+.AN(7NIL*-(Q <8I26;.%X_(S
M;<Y^F*<ZJ6O&^'L-SL/<?^B2] MHFZ(\^GL!9D@1,S,"WCC^*G435^*N==5U
MQE6*RP\8SQ$7O%"A*7]3BUK0&^O?$=U<O6R3ZW%O,'E9P.SZ>TD6Y9ROO+3O
M>0B]*#]HET(>;WI9T%R0%"^1@#^Y-"0;+R=F!0"@F[$7YJ2 D'6E0*?NP8O=
M?I)GH_/0U ?JQX6KH==)3L26.(P!H8"HXK8-AD*#JU& CU#E*=OR$M8\E$K]
M] F09_*>QS!M#3O-XMQ)10I:F^NA)'_ZF%]D36X<.W\,1;_@RKLP1O3TBW;R
M(B=)\AJZ,'_+:V0DO,E;31]A;F_%:UTG/&/^(>A_I/$\RM@,69ZWC&[=FHH+
M\=<=W\_MBFG!7Z\_ 1!T!C&-[@^%UZ-'^EV+?L\[]#@<_S'-ZSUC,%%"S3+X
M'+W\X=C1A ;N_Q"R\6#?+;W@YW^=Q7"XHKC*SH&WLN0\.::Y'AOV!#B-\5@T
M.:.YSER0AOZNG7\<K1X8M+M?C#E1#VHT8#$P6"9ND;EJ3:W?-F&$2Y+DPEY>
MC>)Y/$]]G;4W2L*<-O%55L4=53]5VB4V%FHE7IX>J)T*Z&K).DH>9[O)UC?5
M2?/?M%&%.GEG:ME4YH3D5*&7E\&:L)[/Z1$?K&3<^#CY;/QE,%"KU3FBC$1D
M9*/QQ-LE]SDI\)X ?YO\P?#">XW1QRD4W]2^Q2W+P.?_\O+"//J6#;1GLO\I
MZ+U:6J>I0 3XEW_YE_][^:0K+'2M,V&TK$%$<L8*9$KL*$&:BO=XD5]4#@*?
M@/)J&H)8C[:TJA38T'31BVA/%0!?_#O<UYX =^27T@C29[OH_M39O4+ERW>C
M&6Q060^IC!VJCY_Y+/VKZ5S.XEHZT>&1\S0V%-QDM59'>WJ=0"3\.H%CO->2
MO"SKK3+VB[6HBV&0QZ+<^*5&: OSX\!$F2U*#:%GIF6M<NVZ.C\$>X/Y(F\Y
M=_C!Y0G FW_"].#Z!&" AG[*P-@.KU6B#_T894$0IU9?7UM=ZQU9# M"(?-D
M<BC)7<I ]5RNC76=NS047^9O6PBYCJ2JXE])+8+%_6(99&3>_KPW*5@)B_96
MGI(B63Z(UXO64$V9MKKGKX\=TE)$8F!2EBXJC:]V.[E+P %MN]$&\8D2Z?+"
M\(CZ<W#$.M^/%TP+JN[.@\M@B5^,B]!@(TLL9,BM)HG"H5?#SI\\<V80W%*1
M F9\":Y4779X9OVKBT1!=PS99:_/>K_GQN4F=(O1B\63&7[X@:_T15CG;,]$
M>,T4KBM]&NW?]>S.!*9'W-"EVU;[>^GTQ_JS1O_A2=)1:U7W!U?V_%&CJA;(
M%)CPN&,?JQ3(7_6-$3<Z.#B4DEI!KXS!USS/PT0\$Q<(]/_*>VT#8E0DN!'6
M;L>*BE>YF^%*WH@VO7<:5#WC_GXLH-3Z554E9-.=MS&$0SO"'-BV,9-QW)>1
M+$[G:F<7793!#?E^@2W><UK?<^C:XST%'62:#H3G<F9-XELC*^NK/0%^NY,B
M)B2:ZWI-G%-&DF'$6]W7Q07?,LCKIEU5L0H"UU1_1? $8(LKKZ&.J+]..$\Q
M;BVOH3$]J%S6-'*KWZ@=<S5F>%\W;F?5/ 4V^10TW17#9-S:2 E0&O)SDJ'P
MW<<1[C4H.9CQT@CW87;,$;SGTQ_AVJB/402DEWT\3L-%%RT$V;+O.=?EU+<2
MP"LOO?L$FOG?U<T(_MD FE<'SO 4B:PRU&+4;T@\L-'@PELV/DXM*LU<JERJ
MF2GL@"$)'/T<GNT6<1ZVCG'M9'E0BK']HO*7",\*4R-5YK"F5ZXE>PY#I\WK
MK:$OAJ*TKQ67_J)0N@S;VDAQ^C*_F[0T)C_WU=#Z3%630D: &,Z/J'X%=4#J
M[\_-[P3')$5L2XC"\/#W=2MLRCWD-A3IL/(ZKME_+Z)@$];1U4N80UTN)0%@
MWZ*Y/;>>G0]-M9! KT%'MI[<,T;,K^FE>PU-;T#\FI#F'Y2O:_Y8?/ K4?.\
M"8&PTU#MBV5&^"B J'-:;9(F-:!UQJ?MV*!:.CS4WT$J])D;F9A[&:03%-TM
MY)6U$U!)YE<TE3WTJC^JA'OVZU (CM(BA*!WBV=/@#!YZ'+<WB==3I@TA:&'
MTZI"?=*$S0]7E>\L=%OM%AQU1CY=/U^343EGL//XR$Q##N;\UYE.7;=C"XS>
M_^WVO:XK)U:EY$XI'C([%<M0$Q>?2]WS_[/8/-WD3F#8+Z$JD?5[PPHI#;>.
M2IW-8 N:6HJ!\%U/!5YV99Q_.XYN7O\9;$?\V@$K-M5!Y*#;:@4AVZ!!L+]"
M/=$D[%IBG<2$V4LT2"[&A[9TO,;FY!BC<J!:N K'72V$N0MB"^O<$*I1\G<S
M_A3JUZ9\16%&R4.%BR$B!1WV,.\1)A\I=LVUOJ.\XZH$$8[,3+RO9NA108J;
M#24[Z$5+7R]MEM+ ]P"#()O525A3AL6(B=5O]JSJYQBW#K@\DOPKZ:WL@5/C
M1G@(#AP;37NHAW.[;DI-#&7%8O3F!\\ 2I)HBF3*YPBPWVOAK)J18)5JM*3,
M-XN1YX1T6L3U!1Q'AXG01KGG+2?8NLWT/!#ON+420)?-5:%3EW@O5JU)"!6I
M]3/.17@<A#&F6X \3OR!\2('QOZA5_<:KW:%%IKC^^+4\8ZW2%W,E"T_[V/0
MIV?D+4WG_+UZ A#XF^V3<Q :A'->L;=6"3Q^766*B$\SVV$T+SK07V$Y&S(A
MGX6D\\Q!VYK-[-X0'I%4)NMUQ@7_U&\[4K&Q<1VSUQ@Z^%8F:=4E/>^U'9[7
M;<W%//WFV4(-JP>BB:JEY=,<>'M-H*I=U QGQ"&WD#$$A6OI(5*&6U/$ I>2
M H?*%TD>%N3BG/IHYIYK@]A05ZJOVS.PWGO>?-4#8 "?W%G4WXT*4MJ;X:_Z
M'I/=PNX\[U;Q3LPG"MFT=JWQ!0(-2<U)G*3%W&;:)W9<%8C[;/Q$0<S=S)TU
M"YPSN44J7VN%SA;KJ#]S#,B3=.1$(==EP+OIY@YVR\7ESZ!'([4DD3!IW*5O
M8M$=_ NE1DQ='T.V@OJ:[)#3S//?%&[T<THH%'GX];ZMFW)5]8#%8] EZ@[C
MYL4_C[ E:]CQ?J>P0*I$XN%E>(DQ0Z=;\EU/@F!+H0N,Y;+14\>37$N=0,^,
M&DUE%\U&J+-7+,\@'5H8CF!WS%;R9@F=V%SN=:3H\V+_=?_]>@2X:(AY9W14
M5"YO>#8(E&*5HJH9MX-2R:D*UM?&++==O/RJ15I#3&1&U773P]I $UUAYUH'
M,26 NVW(3MD19$P;K'/1IW%SD"AL.%!N4+%RNE%,.E?FU)\0VC2,)#-^^-;R
MNF&FT'7IW9*2/2'V)==.10V;-)9')4*6\R'Z.E$JL12XA3J<-L&1*H]=REZ!
M78B>:4V2=2EFP!XP^4B_+W;4!'J>2C"-K/G*AHGGA8'8.G"G5M^PD3FDFL V
M>JB/+.P^7?KC8^_8)7NTLZ[>]PE9HGYLAVP1U$T[HC1*;$)'&4]_XYB2B&V$
M(*QGYKC<95A)-5-Y!J1ID3)@I2^EN+M[T%DN2T;5;6D$O]!NF.8"-?&NLZ?;
M+8R8HTZO+C+4RFQ0) H_G(NB%PH@32]87PLO)%YGVDO=E[Z(=*;NH< JW]J,
MHHQ]/[U_41'6D&)#+7"6OR\K6>\)UEZK4ZMZ>T RHT.=%=S7)QGM3@Z>7DY*
M%>Q.RGR3[9!E6Q/S-JI5>L4)<'4@/\Z\B:4S<?*HJ.IQTW$ <SG=N6Y2*Q6W
M)=F-616^446"4(N]2MD]&)#"V6_8&HFH-((#:2<+4K;7KS0]*3SC_ZC0]D8O
M448E( 0AC](S@B\W$SH><1IF7/KROV7 5Q3LRC^M_4ZL_^FZ$Z,@!+; <W.'
MZ$H6>+2,ZIX.;U?:H)1<V]#60=)LXUD_6.;:U4DAKLK KWL-DL-IU%(53YN[
M[BS;-*"F@RYQC"@!>O1Q#<:%M#\!?3D+<[H3.R %)?&F#RJ,C@(C)>]ZOK_8
MQ V(1].H?]$TV-["?9946&%=J;:NPECY..-A6>>KSGU)K*W-\BI]#MEQP4&5
M4LN@$6>WW(NJH,+<M]@4>'UQTO"7I9;W\//?AF,3Y?:^RV&3"K::,YSMA#/V
MGJ04G7#7,FM^R=(\ K&NB!Q\OG/I@5Q&W,T[7=WU6%(C&['TF=C2W83=AFZ(
MJKA!/]]0!1DCFI()J55P+UK*-+>,EU#F5>6TII%)X8:O&I2BE!L+;K!A8B,J
M45K\.$L%88'W*UB-;%-:(/6"01XV74F/C)5)W]8R9K87/J).Y[=U_506*^Y%
M#\)@",)A*JF3Q"EA%S:= 3>)9R_OSP8I!LT+\_7P#:FT(2_%HSHO6$4@=)V+
M.TFRUR@:V5^FL2US96,/9660;9"R\?9OPD)*_TH2CXQ$;"$48+<"X'>2-,KC
MQX+@K\I1L DR$J88B0V7>&',EVNNPPI9'A.P>SWC5R9CY0*<)LI18YV,@P+.
M+!*'<1Z,#LH;8"SCP%T7_.?8%(.N)&/?5]B.4WO4\,Q5I!<RFNV@9Y="NW9-
MSW5\#)\ )DG2 ^\L1V,%O1OKPT)]Z-S!>HM#8\.>UW7@L:HTX5\4?WB<Q)U8
M=INEAT#63X#R'\??RBIPX4&C70URUB0V;"^&*?\.-5J$*HA8?)X+5CM3;V@A
M.YV^KCHEFQE'_MUYM,2';D1C^HXZ-=RFLD+!X;4TOFM=[N-$<%O#KT>:E]NI
MZ\[D0Q_)EFIVMAE()7XZ+M1<V9,:ZL'=U6?*<E[7S-Z0G+V5/[RU-,MNH/XS
M(ITHSFNTQU+62FA#<QKK8:,Y(Q$+\8U!2QU8K?8;3[-"IXDK&\7WF%CL3#&)
M*UI>3$#+EG"HU^F/=.*W $B9]_#V."M;:2@X>TG_$ 3+'TWN4Y.FOJL*Y>9;
M4(VL6U"!,P:3[PQ*N#.#G6=H" 6;W96KIR6DU[R'%2?T.C58FV/PHQ&JI(Y_
M')SX UY2?D#/&=<34XJ$-!MV$MJLK\S,X#\!@(8A"]>'F;Y&;@S$(_X=[6?8
ME3CO%MO(?S40:/ 8^Y8SI2>0+='>]];ZP*+3@YW'OI4[W?0\-XO?P0@%6Z9F
M: ,O&.)0,<K>B*K=WH.KCNNEK?:J:X6E:9H!.N.#YYR_.*!LF#=%5Z?=QKR#
M%=0<YO=/3\*=/](0L7FU2KH\OU^U1TTSQB6XK$ZDSQPC.H&1A3,F$=OVA4^F
MO=2$[$SW^C)91S?%Y<ZDPK+V2(?_KU-V&'9YDU@:M5(^4WG;I1@;*UD0ZU?:
M_\+;6T9%U8;_PD,(*(UT"T@/*-W=2$NG@!(CW3D@T@T""M(= Q)#=X<TS,C0
M(1TSE(#$B\]9ZWQZUSGGTW^M^3Y[W_OZU;VO^]KL5"R7U;CWY%C0LB9$N^A:
MY;BI,H'AT> INT0W :Y2_%@"@=B'$/'][774G_!CB4=_C+-%W<^WW\*UQ50?
MV"=*$[*8'#;H,:!,&/L @-XRL$+S'3*$X;BM0K5V*K8QBNMI?Y+0]. UC:"T
MJ]=E!WI7UH.(G3Z04TF#^YO6O/;X^/X(^>_]6&N:6BP/ ,(. :C#^7U7]=I*
M9+F.\<UVZ5ULGB-U:>I.4,**ZFW'HL^1KMMW6CLZ-[/+Q$U)]7[A1MYBWP\;
MYN1N?X]T3;_$:Q]-#D=N)]G]G@!,0E_^A[+!F(T+:9I]I[)E8U_+7CCUF?'(
M;W.MR^:C?.5!-2XIGU>;C 22#C-7=X1A4#ION%IS0/;K2TN'6>$,[I<JJREH
MV,]\\%R5_?_-(3NLX'"&K&=2OL]A__T]F80_9(:(3R[ABA;U%HKO/*N)/!IL
M83YNB/BU=(Q]PF[>QV"R70IS.H$R8"P[^J,7W^?-2-!4/Q52Z#5Z7,05E4UL
MREN.8DA7==<6Q<P# *YU)N[/E0H/M/&QJQ@K\@7+-,.]1'1L<T1V5)A"A&5.
MI=&B1C"P"AI0/YO$A.I.=U,1!YEOZ+T&TP0*@:?I-"S:\AP]:"'[8F]7U1,0
MOP[MJ^UT4%_(@Y]$]L,N!P^.B!5@EV.LLUS#,F_Q$T0_VI&N7FD A_H:41Z+
M1XH-_-"F;\-N/8G>8L?7'HF]Y946=YA0:&LVS;+ID!M9>VI__>C3!"%7JNZ#
MT+F-XFJQ QUHQD G$<4-"QCAXPTG413.4:UG$N0I#.T2'?3=T]G/D<J9[;^)
MC!0X(31W],]N?SU&ZCI:5L>%KNKSD=N*EJ#H.Y+=$>%_C];9F1N-F#9+C+BU
M\ZD Z>[ZKX2Z%3CN82/(*;+9$HS.XJIB>WH&E43&#>=NW2KI+,XTD4.?CP4'
M?[B1+0V>BAM-#V,[9DQLH%%UGZB&+NJ8N83>VE3YUIF>-%W9.[Q"J$SQ"Y[^
MO'?,T<[3-L3XGM-".>YXU6?0-2T!!(-+'4X"/$AY>L@59$(XQ$>L12AW^8*>
M<$CI>XM4V]DZDY"I2@)&*OPU(3;5#J[[)A_O@XK6OF[]&FO##.L#^(<A6A@B
M;TZBH4[H\UXUA)+%/V8W?:$4<R3>K>+*+P%+18E9F;]OT3:6W0DC;][71 :^
M\*JZ^RJFQ6^N#*)T.G0-OW;GXP]-]&^L0AS=.Y%DSX!N9G9JIXVHL6.YO58)
MU2N_I(P ,U6.-UIZH6U#?_J"Q. 2P2\.=!4$U2W1]_5\ ]XEK=)\3;=A^ -;
MNNVWP2X3.=*K_S$I4^9\ JP"VK:V-T<@5EYGI-OA1$FJ2CS[D MVJMB#_;G4
MC7:J9C:V=KM54U)T?P"0@;>^@E8O3AX ]<_H8+FPS?BB::C-1@W!O@_3HA;\
MO*UE>#AFY524\AZ0:G*Q$PQ$)H96M1/[^?@5[IGX)?QJ]WDEDS1:]V3TZ#T@
M?4+DQ #2;BP=$4SKZZ$'+TQ1+26?,I>(TT_U_3V)F2*6O)*3>1U<=*[5\AB7
M!Y,WG'0O3<>RM?KJ=F\$7EU/6RPOLUX#MHZC;$NI)#('M:+$[@Y!97O!Z'/.
MYT+F![[.&PF&6B?<V-N,2&5FT2+^*?9JYYU! VEDJ)EOO9:\#XBL?HG[?7N=
M]X5>#T(6DQ[?6A6%:YJ".7>^BN$HW$H<I^:B^-.!BX>_A5&:GU#S\XWV^1)Y
M*5C1:FP3GYX!AS<&[Q !ZJ_+U[]>E7B">[?A.P3Q2+F5@S=L.<D;(UGS;?*K
MJ6K(CSELXU49^'N[^$+XM-@H'[T0><7N.357-@H[EFGZ\"-+77W&V]:YW+':
MIB8O2Y$C8,I/U\K0[W,6M"CL*"\N^+^#=6Z%1.$S[P+(?CI]PGIJ1K24\QH1
MBZV>+4DVL!\L/+>HTUJ'[ JO%MRN3QUMS3UR6Y1+C/MB$'C\;E"&UA\V%'FK
M9U?SR+/!;V&Z"\/3%J9FC^9\GT_>>U 4TU61CH?NH[,^D->P%N94U#R[<U:0
M8!>:9<-#1P,BD-E5MD@;-+F5AT&!K1$9:T%*)WT[+)9W)2QI<W;;*C3;5OX)
MLH+"O:"O-1(O/+PPR&.<-(\56(C4OADE$#)#!)KN6Z/W7 [REW4422/^)^9-
MN78*/ "2#[IS+^ZD[Z,%"U',]ZHU45T'O99W6*T<AQ >NT]^1^_20=Y O!0E
MJ@(6JS2V)+<ATH,L4,"B [ Z+R; [VU5LEIH6L\^C@2Q:HU/!OS\ ?"B],3R
MYN#^/0VF/A):QXZFF!(BV?CL[/D#@+57^I#N4<JXX# !H\]J,<RX#8RT:'N)
M:I5WJ24/@/?__>P08+NCA4NMEX&0#K=ZRJ'UM\M;JP'!!%L][J?7X!1E\8TL
M,*[9K[VQ#7P3?)[?I!W9\,7P*M1WP* 0BW]<@O*;F FD3U1I,^K]=AAAU L4
M:S997K/Z52]%:*S3:9'OO3*+[2> !"W<ILP>85&#+EONT.A3^V)TR -]N"(H
M#",FI>_-CQE(>&/V>R<[9P(% Q2W(^&T#"E;Y3LG$B!]VK8E_BW'^KA6SXA/
MF2]8K:TEH TR:V8\Q-S(YLK73^);HU$&Y#[ZR$ADO"CO@O/RL^L@L;NF:O<F
M2XH#3Q=<Y[SIHK;']^1M:E_*E8?"[$D><B79CSMY$DS+7NY,YL/)H]2_Y#&R
M%[,5WYA,F'C+<9>Q^1C$X^_RW@QNW)J;]GU=I>04JJ1WY9^BOJP<H]%0FC^J
M@5BU- 53<VP2Q%]@A^D?-6BPCJ[0!&CPC.)8I8['B$"F#81WMK6QT+9.)35$
MVL0[UX'Z&389B??J7D-W(8^/13E3 E A"*9^A>$&9\&\V7@L"NK#)VEEG<*]
M" ;HU]M"Z72)WF\3R\MN.6Z*'=F0PI^7L*G>V>'W7X<H]9@W:;+H- %;-]H-
M?R%72_1-U\'/AEY45C0-,N"3H'&5K! ?>M#12S&@A)'&#X"R+? -C]K!R@1,
M??B$'D'>&JVF_%K&G'2345B; $L92D'NW>2"N[0HSR_+EH6K2FE#LTF3(4GP
M=,M_JJ$I]<Z9M08L>&-TZD+CD%X;J*L^#NH7&PPM7778P^^X"__5J"5(%9V@
MW(,1EOS=!^+R=#>85(NB)Z#TZD0715#ZI#V4J65>]Y#%*63HMUF"V^I,!\GQ
M!.Q^X:@&F-\<.DC/D23VXYP1Z=B95> @QL?GX/\^+49T# AI[:?\>X0QI9N0
M"Z^Y3C!Y %C";2:A#A(<)>:6EKOTTO73O+'MJ8CB<SW3$5Z42VAT'XGH0L/%
MB4D-./\JJ]M$*'_S*:2AG$??+GJK]2^7,@\!-1LWCLB6Q]29.<V585_=ZEVG
M!H9ZP'A/YQ3,[1N?&-VO"<>C^V^E^XVK'^8^.M4PLDGI]ZLSW;_!*;[\2.?L
M&DR%PNW;Y I"'QH@OLK5R(2IQBT6IH#XO@(DDM>-A +BMCNHRQT02M\*>Z?V
M,KV*X][X\)G*U')(-6MS'NG-J9SQXH(:I3#GO*1Q?6.V)46#X<"57"_7Q1<Y
M5#3>&#D8'"Q$&M)#])RS$EI%39_;A8-<*AS]&U^PSLARF@XD=RJ_'P80#K$8
MYJTZP,2*:QOGN(^.UYQKS13J.&YQF+Z5.E [)S^-?#,+X2Y@>PG,-YK++0A5
M#[ L[B*\LA5?6*9EZP=5NA"JKU5&)R-@DWKF?XEJWQ(U T-W1:75PC9X8SWQ
M WI)=L6$RNT>_[9RR,7)Q8%OM"<6H^53:@/@Z<@YY % N6"V?+!"E(+K4)*
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ML!@+9:PZ,RD<?N7^JM\.HGS-VV-4<GSR6"PDO,\<;H(SULV%QE1;4@ZT8HB
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M;#8UI28UY,T+5$)FQ/!JY"1#^B0G[;_1L[K\D0]M0XX[[@>_F!$ 15G-U6Q
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M6R--1$0:@JOO22CW^W]HB"@M;[STEC^2[0ZL]0 HT+"_57T I( VI&^0&0\
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M>J:NK='KF(%/+MW^XDTPM&G]!-WAYLD#X#+6<K^U.H]H,,._>"%'96J3LP-
MZ_\!*A"/!5=LGMMN3+%S4CJJWB8ADFO1;C9#&R3UFH1%5&<>9]XJ4[AT!&-1
M]'&!"*\,$.*F+)I-Y#W'-!%\:L'7-DO'$QYF)5]J99%_-P2S,V[#@-4NA0V
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M^CMLYLU1V3)TJ5<.QY"3 C?DU:O"ZF!H4:;'EXS<[2XY)@BN?W"I8+XL6<U
M#1D+<14(F%8T4?&*:O(K;I O+9QNS0V%M=&GVS9MV*NQLT_!X.@D?X2U\Y-
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MK!\I\WT3*&^*J0\7A5><P@C916VC\_637U!YA9&K;GEC>&2OU@_=G,+05*(
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M@(K2Y+H) 5NQ4#[<5[%_EP1\7:2 3VE(UPQ\M08.ML:';)_!#E3]"@W?=$H
MV,$%?N.]N!L (BDR,C-$J/9+75L&BZ72EI9X6$V'K1;07?5P(3?;6]GMR,Y#
MQZ Y]?IN6UE$PV$4:T94)<;<W%3-LT+=/M#^+#-58,J@V8-2=Y22A.>KL[QA
M]N8@B^1<1TOSMV!:F3:0/[F;&)TTG?LZ>;['!/,A6+A#%+'L:S9=&V1;[L@S
MK9.S3VVRK3?\W?3QA:5&6D$F'\!XQX$)A&:THLZZ=\6[[6Q'QS>Z A3-M6;N
M.<4*B&3^0U>06Z!_"'3]G;*,F1L>QD +=0.(>MM((G18B\WBG989\?R;;-%O
MF^C+;BVW9L\PW O+5BZR#UQ;)?#;!,TD+$$= ZNT(6R?XE[WM^>UTZKBAUMV
M(E8IJ.@</=0X%N>M(*/-TKX.$J_3 ]A]V9,UW9UY>E<19DXT0Q56F-="-#W^
M+J_RRE)4MQL39X'V^>[!#G&PPT <*]28/B/#HGNT$4'%#GWE5/#Z-H.9]2]D
M_N3:9_4IV%2?<%F,XNWT%N_.8NV"6?S@^"JF65>F!_H\\2A*]3LF":%"(Q,]
M-C">5VIY'0GKL4_EGZD,FQ+3)Q,7GOMM5$LU7T",?:+,_+TE7X?Q6%?&!S8]
M:BM=$T]?F0'\P)U(JAC;7.%GW1]@UQ[\U4_^!O BX?1.M:]U1=$GR&/ ,4/R
M@4%BT9<!"&HNXE3!Q76S/P38U=P!*PMUF76Q%B!L>+Q>Z'J1:):JVRB[[:83
M<G@,@XMT1\%O  1_&W1)%S#M$+07ZWHS$^MS^?Y0(5K[&)9?]X3^D@@GBCT*
M'0M(:&R0]DE>6/Q\*TX3)8D/RIGQC[Z*DCO(0(0/HQ^TIC)9:.H'MCRU22W7
M U,DB[TK*PUIG-3[#AH.>8Q[<*TKEMF7[%>$R(S9\Q:,RYB"34V6U,?:Q=B_
M^8KWKE@<@#_H[CGQK.#Y%#>*JU^)3V/2IB5)8W:_3-@:N,^C!O1SV6Y)E6 .
M>V1D5S=7AJE#F'53KBXLKO38.Y2R_9E?RS.UBEQ0$R#4(#E5-#Z/PHK7:B-4
M$;J,JW\FRM7QS186MK=ZR;RMC\5$CQEE.:"0>X5)9?],1I^0'MP :E91SY54
M^K*A_=4&%MUHF061?:%3%J&W>X3]*0-W!WJ"*S4L8A3S9[_ HXM10TF'0??=
MO#VDTQ[D9YZE3 BD5$<'QX?&C*]\P#>PQ%CW7XK4E3LIDW=/P90T]*0&$JO8
M(^]G,CO2%,D1K-E8,WR!)Y%;_7'*;#OK#*8X: YD?3I(\DN- /0S 6^3!9@:
M,)6X*ASL@@M8NE\5TA9\ _A;DJ3H1HGQ&3_3[N)QS/Z^4^@C4!M<Z-/,W<IO
MA'RK'I_(#%!RAB*2HAH2-'O;V$ ;RP,<^R4=+UR+[R%]C8#P;_VU:._-<(@,
MS(JNMKCENW,MR5#9<]9'$CWNTP2\+'],*I3[$34[^<3.20 3C&LOMD\YG]O9
M.<O ?96&@)$SBEXX_5+J-C/I[B"A=+=C9@7K"[G5FB*_SQQ"V&9K7 Y$),XN
MS=V\N=]T^T6]#8W KRTQ1+]HONY&Q?7+K,YG9^3ER*7M7<9S/N^@;'_GIU15
MC/J#YO\&Q3QC>R:3@]/=ZWDP]HG#]SAWLXS>KUFK9:Z#MW);NI;6W-),4;RA
M.((@GCR9= C^S-?Q%)>LZ>71%-#=KV.F%O>B$15<F@IL,M1YLFNDG6Y8SO;!
MH;T^//FA"I-#$KP@JHMUTJL]M1ZRX^,^X#Z"M;UXIUR<"R[Z\P/6%MS8GFS)
MG\Y<^_P],4,<XIIHMY\1XB6=^B3!I<)LN?5C\EV-JVAFXEPOG+?KTJK410K#
MP>X\3L/9SU,+Q9E6[9?QB_1 RNB[;_[.!D+;)K?RX.*[%GOH[[N#D\HL#@&X
MF++=[)/,N<N_,Z3N<QMG1@[S@WL:#.]?MJZ]Z>0\@+'MRE6+4&L3H!O>W=OZ
MI4&"K0IM0)WW"]]9$&9["O.2.XF._.DJ17)?YJ7F_&.#QK/$#XBR;CCF>L#K
MG_83'676%2LKV/MH[XPO[\[!\B^[IL=&DB%&Z@HF*3-K\=<"ES)]'$R6*%AZ
MQ>Z[U>5="8@FS^KU]Z<.VB\?)QA&O%3P.*U6N %0JL&A']I.PUZ</Y)*GSEG
MD@"P.EHPUR?+VYR=#-@X!.CV"T+O.AI#1.H+\R3,9'^96_;<:VLV?NG>_F)H
M,9\4O\FQTVU5MVOB@#*NJ=NG8#8Z<P RHT)B:=7$.*N/V>8YC7P1= ,0'%.^
M\K^$16SV6A"-]R)N,U;.R^:Y5-K=RISMY]7<+(1'BUI \GBOZD]8O#+1OF.X
M'%\6TE9HSK0_\LTB=K4&!WTVG/D$DQ;L="FUT?E%)!M]H6_5X\+?X<U+_)?O
M31W+NG[Z\GXW-/-BAZ8I<[%Y ML@8#52A9F##T6>BKMX^KN)S$N9L<EALT2L
M%XS"<A-E7NW__(FH"5*9QE+95HPK2C&<Y03508L=,]_ILI4#@P8%M(?7*/IX
M5]K(QD3-)CMD;$LQ,E</I1O48PP,3%GNXB66JQ)WN3O+J*,.8VHZ=)P15 PK
MCBH.WR.U7/9/RHM)U)!"!YM\9<^M.XWF'C4MW-(%)4]7^[#K!C!WZCGAS0%^
M@09'-S:A12,ZS&HA"ZM*U;GR-K127P6Y1@I2YB3H4CW_Q.YT$%;M2$-T8YZV
MV;6[%&\C)Z8-3$-37^60.AQYMA!9R@'O"+XX[^/DF_1.4--#V>(RZG8D8FK>
M2FFMBPNU]&DEL/SDP^<M\6*]7]/Y($_>KQ#YHB4?FOFK+B8#J"\&%M%^>YEK
M*'@DV=R,_.>+9I&2+IX6^] ?B"!1U+$66B2TS"_',O7RT*+K@_EU@^4(FVKW
M!AFS,=Z3S=#8*8P.^=FE2"OA6)^Y+F>S5](C /D':AEVCS18X72'#'*5<H S
MH=#IDCV;W=_D05>8<6OSDQ?TA/>LV%^E"GK^6&%J1>5G0>T]?41&SX^6A>8O
MLJS8FP%$/^6&&'S!/I->5W.G&W;34Y?MN*3+(_E8N"+=#8!W(DEE[QXQ+@9R
ML)N-.HRJ.4FBP>3HM:0211FV)3HP2M]/-Q8K\WG<\W,_.[U[&!>>,3(;4J:$
M)"-+ "-\H][>Z\H>9SFY*FGU8WN;0.TP;.0&'P;8>,8CLV&M4T%\:Z+$.]11
MF=K3KLQ9MK$(X_1B=R*C&-&6-6N&D'/5ME;T1EI-<7*<F8+<6@JIPHC<$Q+F
M066#?"<5-C\[9/^"1:6IY?WJZX0EWZ;O6CG3H\_7Q XH=;AL1;NGD"M6<]8_
MW:SZ+D6^6)=CK/J41:8.$[_<Z:KPIA]Q>Y? 30Z4D/OYM@#.(K7B-_0\TP13
M!&]GZ&QM# .1=3?D.$HKIH2S_&%^)^&1*C?PH 1NQ>%7V,O?H5KID!R<O<,6
M77TR\U%39$C_>>*%DLPKO#D6J>F5+1FPLN*4]TPJC;.]O2+M/3Y_>WY5?.:A
M7YYC^MLAAT<W  F+TV:WV9 HML!;H_=#^2%J;#/2&#$@>DI5MV(6EP5,]+:Q
MSJ#4Y4ZD "$[[RH<TEU7];<I5WS%..]MU:F_%OH ^46Z=$@K9O>3=X-ED(H!
MYE>@V@:K[5!1:D@NW%Y(71X% AD?Q[>8XZ=E<'B<E@<]5?0_^ZO, J5D>](M
ML:,MFRQ3IQ:F@H>9.0'?%E]=C+1@U8E5!5>X;D3#*OF$2M0ID0N/M#U4'KYD
MYH+_\&G4.P#QLNR OVO[#8#$:$\FH";K5K*P[F1NR/A)[=JTV,:T<D?9 _AW
MSSW"+9.LU\PJ&KAH%G<#/DA88=YS-73FJO-$K9/<N:,M.V0P_!6C*(6^LZL%
MI7*"C,<0I0KC1D7>ODJVT KU>>\;%*VU\UAV_YFO;[#+M9/L(F@?NON$P\QR
MUK6+U>\%OUMQ<_?<RM24V4^,7U^-Q<>S-WB;*[<4B.1D^-UX?^:KL(AU=Q^I
M",7>Z-0!\_WO?_AR3W;'I'4)M -1A\]0IP-KS3.26Y\=1+G9/ACT$[$3X?/R
M?AE4W==W^(9]8F$L-2>J*']IX[]TYC[*EQ-&I,91]2?7?JHAO?6OZ^$!KEO"
MZ )\6GMJG8QRZZN]NX2I[_?UW$ZZ/YCSE>K[SW,#VD]//0H*-A1B5*2=2R?-
M[ ?<F+H>-8W_Q*4:&/1U"4YBK8*#OZQLTSK*ETR96ZH%L^>_??JPRM]65@X?
MTV;<E??9 N*W:@XK\8/ <&1^A>I\?N*1RRW6S!>18CK/7$<FK\_4E58KL>.B
M?<H44\H\6QZ8H@&09[G%R@@P6</UK]8^M9R1UJP)7F]\_D83EL[#V[8"4]![
MSI2VHE8\P@894SA,5G_H2C(VL\^=Z#_XD 0KBE0AEX3E4\U(FDIFE?KK+QK%
M6L#:$Y\-3A9DO=,&G%0?DOE9ZA MOLP_.M]?:"H1R#[:M1NP&V0P"GR82,B'
M:G=QZ3BY 827YU\>0ONLIA:@NN]1Q'V=7 .6@&D1K,Y9M7:TAQN=A5;*XF<?
MP,,BO/SUW'SG:HS]_5^.D*XLI9DY[9*=Z?D>H0.+4>>PSW6["7^JW0@<P):L
M*)^"8DMM\DS&7ST+M,_8ZQ1I\0ZWC215*'?:I))BC 5S#-MGW Y$]M99;),"
MWN?TX"=K<MM5OAA;=(9F8JE7@P]QT,@AL+J]@]A.TR5#+N3OC PD6X.P_W?-
MC,\I/OX%U>=J5AW3/Z"7A;$"Y/R%L8#_/T%0!*G:V(J^G]%V]%SDZUHJR6^:
M;U7IP)3XS;_,&XW\G^_$_L\@;]<A@DWTRR<VLZ>QY6 0B49OI/$X??:9QT.L
M<],@'__U.3+Z4PMI#FNMCFD1%AA;BR4IJP0^X2O50566S:F"LGG-TNVF)K'Z
M!N-)(7[SL'Y^@#T'IDKR/W$5Y=_X-_X;&(PIG@WN'""F5LX6G'/>$*"&'M8/
MY.=\9*\)WKHS^]_'-0/H!4RRT\+6Y9%^?2>-]#Q%P^Z#OBV?M'"PP_]!9Z+:
MP&#[T@6EV>LEQJ;AA&E=[J?FZ&'%NX Z=2F.^PDV">F3[Q_^>D=R2I3WGW+"
M\_]SN,=]1U<5I#72RA*L(:"P^%@Y>&J_430!)P+K;I"*&]&E,%')9&BL<EDA
M50@(([WPI57=C[6/]1*\ 82>9UO6P\?>7 9S.F*K<@1;\8EDA]< 9=R<[B0\
MQ1B=KR98);1O3- CA,*GDPM.6P>[5I?H19"W]8]?W[AG;@!LBGJE?DT47+U=
M[!U1AIW9:%MK!\13=@:]%AO[#;[$]YXZCL/#L%7E<[;ZCS--X*LVDQ,5]B#-
M9I1E6M&.VQO7_486(S)2'^;DFOT_"[X>B[&;KEURJJ^K'HMBA:L6''RIFCCT
M_>8)PJ]Z[L;7R,'K$V>CT >37A/X?I!1[(B+?']P[U#2MN:@&[.?FP7&P]J^
MQ,DX,]-@Z2FZAR T7XQ^\UTBN$;, Q97XM-X7GWT^]/RO))D]^AM86;&[&JA
M+.,82X)L"O;)&1=( *+BO(H^@W(3-P!(JS 74B[3M&$:"X+K@/IZ3WLA$QXM
M16F[K?2A/]?M:V5K>)%$.<'V14$J&0<(9Y/JSR9\;>I"K]+>VOO@$?,Z\J:<
M.S9;DDY[I]DTK[+QW@Y44"3)?6L%-T7R>[G)@5Z5L>9C2K5NF:?E,@=EL#E<
M1S?=;,=K](.1GA#@E->RQA\RT-9Z*JA/1#&YZ"KGQ5Z^?&)#%QDF5#3>>E8D
MK>\<YF-<F>0"'-IL,R; 5KTG?C$:D)C>B[5HCD4BRMZ[;*IG\&49S4:J44G)
MSQ5AU><.@T37A'6-IZTIO._P)PDF1WP202C5%_06GI6N8^<0L8T;A1V)G$AD
MPFF3FQV*J)DSEF0YF-OVAQ*ZWLU2^=JK2Q3SOHF+8BCZ!*30_K?CPR=@+,]3
M%H/CD>O?9:>(CCCC]H;9+B90U0Z41@IT[;/#GL=#-DMCK^*]II<+(.4+'71N
MFO[8O-?._5(;-_H)C;O2DW( _5J-+KS&+%;?   8%>0$C1,LP"ZI' ,US/]3
M7-*X&V/CE1S6;_.Q!W>XNH\QO %0KD_F(#83>.NF180/:1;'LT%U/"J'<@LY
M>.;Y_G9G506$06I%,GW[3%JL)05GR<>&\Q<CF\'G;JVY2/9-ABC4;T;,-!)%
M2>J+C\/!TJ9*\PHFWC"A<![8^<8:K!W(Y=UM0,Q%-E+1F$/$S3(:?S[E#0^K
M[%]#Y^(=6JB$8J$EF)U?_D)%V0L'\TU+"R_$T 4[LHI7/K4B&,$:1V7Z=K1R
M&H+CR>*+&<8]1N?AIX&]Z]0L27R*R)6OV/M>LUVB?B-FTQI>F2M5//&"]5HD
MO+N-24@#ANE@T7>;)=B\[MK1/TG(6/.F(GM;N,N3*Y/&5C_KNGIA$<P,<M2.
M]"@>'<^ZA>/"@NK1\QU-TG3;;>F9EU>F.3Y$6FMKG"0]/YEK!-<,'6\ I"J)
M-@LRUXU@Y<6_)2@B'LPQ,C5FDGU?;^;0X)F2*$P&2T=_N5A<C<ECBND2<,I6
M;O4N=;0D@'E;.RS:93&DR]^YFZ[YSWK[5A -LEIF*%MRKDE<A^";2J92QP_7
MA+K\9=736F[49JS9X+33^8HP)C08OM[X*2Z0C*V_P:7SRA8=;TVPN6O&53](
M$/*P[UG?OG:XS*H*]##P<@JT['C6LK$WV_X?>R&A\YLXQ2"=&X#5+C8A4/6>
M*G"-4KN6Z3H?BASJ7SW%=?^<<T1;]_/U02F]09]6;?NWSQQ(9!4*XI,^#V/Y
M<QKHCJR2ISJU10]5QO*I:J_;^[,S8T* D&<]DGDO"!J'[J6\P,.*L]PF.=9+
M2%^_L4P^?52_AJ[(\#[AM#B.<+%E<WOBKR4>O),+$<1%:?O;:X)DN]Z1M5CG
M7K[IR^>(QV)+HV*/!R4Z7H%-46YF#07P\6;X(35URO8#P[:$HV<_?AR,RZT=
MLALM3+I;".-TT0P7Q<67[=#,-=,X9-[L8N-*P9J2TZ&Z\4,W),')[H\GW9&7
MVUA[M/1<KYAC'<6#LW.CF62EK@)._#-X]')X6CQ@::,CR2 W2+)1ONP][I[)
MJN.8F'#1B/RS/RI[X1.M>"\4YCR1"ESD?M,ZJ&M<<RU?9-!CF*.WL^ OWOD6
M_*1/[]W[Z@A"I$3A.KYS7:ONWA=!W:/;073(JQL _0[='R=EVEE)T"?K8^U6
MXM?F[^5L#=(*#LYV7Z T^[DPSQL[H3JXD2NNLZ<KX*RSI$=C%WF>"45N2Z=*
MSHD8"Z0NM2XR[M;?[@1TUG0[NY%F<#Q;BEQS&1I71BFTCFLIC=E@!><::BF#
MGJ 'FIK+S1PGI!8E[0[T:)OF@3]'7MEO$%5 ;@ /;@ T"L77>EMM,OVZ^VXQ
M ;7AW=^QM=\T)LZZ&UR/Q9L3<C24SRNV3>6C!D'!*OV7$U$W@&^BKH=[>?HP
M-@G;P.\:NK^8U@&!V>O*[$X9V7/[I B=)X.Z$C!G_Z!F#F:B>)M =N.H,*3&
M=7&0^=[G[V9-T]NCAH6UPYN,0WRN;@\2.&20 ^D]K=]G%*4J%W8]Q+0:?B:/
M <<*VI2-N!.+J66WLV=1X(%/6#V$7)!2Q188\J"RTN)5WH@K #\\79^-'<FA
M,"=>HL9R7=&HKZ=MIK.&_')4Q'*MHZ!G9+50\)P; !GA6[K0I]I^P=JR6@F-
MN '\?-#JG^D<(GT#>%2.YAJ(LR+'P#MDO(N7QG7*LP6$8U*U;>06F>-%#1);
MRX,$T3["G@.\?6U#48<-'!HO=3I\GQ:(67-3&SU+Q1LB\("UW  8=MI"XJY
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M\" %1(,1["0GL$FOT>;MU]A'N<3ZS%2#7U#G[SN$X:;D;2();B[B/X]C'(&
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M$K>2PJ4=AVV_YS7#$G4C=R*:CH()O0SU-M@</(R[216)[<N#V[@HS2YZXO"
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MLL[L&10?D\YNVR\[Q00C((L3ES< E=:\X)56%]L:QX6G*4ML<:<IA5Y)_.T
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ML]'V^+03&5\EZ#X*ZNO),26/G'=(X6I_[H2_5?YR:W X>-&].S\NOD[]CZR
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M+G$@=9N+N9KQXRGR<M4CG9H24BKJ ?C*,S2)\[[P BW3#K\[MN,R!(9,ZJ^
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MT62RG3L7;5_.#\U5D[R=Z7,EZ-??N5D)IP@"T/:QQ/@:4WD<URT[_^<.C^X
MX9>DV87GZB;C\%=LE9F^5TF, B\IN!MCFL3I--+O/1 O]!.?A"^-E37S%IT[
MZE<UC</>NABK JYXDML9. C7..'XJ*:MEXN'X#UJQ$7=62:DX%Q+:U*:O/5;
ME51F,=/.E.ZF.YUZ!I_AVWY0T#3C)>/D;!;C>=AEKS'W5'OC#OU<@K>52JY"
M34Q_[S[0@Y9X_7/:L>%+*3??P/:Z#9V3-M-S,=!R=\#3QK%;8GG,MGA!2T,M
MY!/;P\&:!&X:5E+GB1N>2AQ(<,Y+7C^8=D'E4]4/2F%-@^_9 (!DVE1.Q-5
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ME-HCPNRB.E3B\ZX^9ZK@^<BAU4I'WJ ! M)PID:4[WFI0ER7LU<HW#G_7=&
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MD.4M&64>M94*]YNA2+:(>SEQLH0 ;0])]Y0?CJ?^TG\7QDAZFDN]4D0&MIP
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MN, Z$PYX-._<L;9-W"OII$JL1XUE"TD*?VM53/#5<R*H'T&.(!??O-.;*#1
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MMF. O/)WD[^">:U,E^GN8:EY^V:)4>>.B63SZLZ>518.R9'+C$V'19NOI6@
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MW=I% I9_CVHU%:TP75I>)G=R=K85UI+$P7%GV1+@)O=_-570X<,+U?""]:H
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M$ ?TG;$!<G)3<LE@T!_,?KMEV,4@T'S5LXLA\AX0M&_5U.^I>G3#5UY>+J,
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M@:@*%7"2 WUQ2[FIRBMUDO&?_K8IE)4,CY,;<)KPX]:2,_>A3'APW;GSG'?
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M,,CPJ(D+,W)2^@'HS '5CLD,U+7;F? EYJ.@I'D%C4D9=QUQ6V"&QQBUPB_
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ME/^LWZ5A#RK*V-S\YX_:\?&5E2/.LD_&)3K\EVFOK[VOG6+CS[:/W4#IS<;
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MT#JT1<QRG49\:(UOQ&E%1Q#_\1^WH"<,B>Z/F51LS0H/ZG4TH[SXVRW*K8A
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M&M3-Y[8&#>X!9'9ULQZ5!C-/F@L]++L+EFD^G+]A@1RN"937O@G0Y?RTS1B
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M4B+4##L9OM[%T%&;9")_@KE"S.%&]7<QIQ$>1XW^.JDZ5<;IZF'2.*EFA+#
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M TQLUYZ-J!I.UH_%R":E/A1;,3\0??7TLUE$V0"]S8,4KR;IR[X/&O>A;=W
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MY\]ISF?6F#XG-;2.VK0XP93XO 11;I"YO^,K&@/^U*$F.E^^AA<*KUW*7/G
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MO!K^YVWML/)%TZ4;]W'L I,;>H^RO3G%\3)<>? 285Z$WG3O0>;C+2^6"?Y
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MJ:7)?SE8C6#,I0B(8P]6 I9*_\%[^?V),I7MT;?'BV]]=Y1RWU8REDP 3^X
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M<5+Y+^A5!"9[[OM_^9GV2Y>X-FGF/-W7^+"PLY2IK^L9RKH@5GS>9S6'QF<
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M7NI&.@QQCF7$8^43'?B:BZ 2W,EA?@ DE:Z.76_X/0!^ @5@$+.)&J.5R0=
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M,MEM6(57#7I-$:6_0%.0*/LT#F-@G7J7H^C./] YXZFII)^L!>H5/+R@5B;
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MZ&"7C+I7*CEEZ2SI=<,]EL6/[YM($W!-Q+B^IU/%7?!QX-::8Y>(,C<;<JY
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MNJ?AEXF4*BWHKNQ$JN"+SB^J92A/S6H[\)%ML+NK^_TTKQ,N.IJZIU4QXGX
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MWO3.>EK=7T@!J*+#4:2=-9*C6!R^([X*F;FS^HXJ[1DJ1,UL]#;0D\3W-EO
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M12>I8Z!+?SQ,8>WQ4UN'@OJ<4AN#^%0+%2/-OYTGC/O#0X]<#R!V'Z&WMO>
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MV2@M FU3B'*$B0HV=$SQ4VG]4:$3F!OCEOH"P@H4'Z*?:C;T;:&C(PM=[WB
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M>P !2E9G FWF#+4SYE"S/%%Y8?^9_-DBF=1ZD"A-)NW%\4R)'V=KI=T8Q?P
M\^<K_L5TUG@F9\TOT'CUQ^4Y/=F$B,NO>8E\XIQ 2<'P+W^.>LKQN9GC^QO!
M!"BNGG;.FMG^EH(^K\^SQX\<]1.GG' QOH7$7(R^+BK/ZOC@-MN,3L_+^P,)
M[ZV@TL@7:54QPVY-D@^0=<%"9F]B8IR5FZVO1,*69;LNB@O\WH&P&SA(9W#E
M@Q7J$[B7RO2.V(2%Q5V-&_*L?:S"S\XJ)^Q_UM2IOW/FY/%7VM=HVJX\7PT+
M($*R7+5/NPE9-CL:Z"W#K"2@56$; WX3BQK  (Z[G^WMX%R3G[\/LNF<"/V(
MD=@A^T,EO.F6=E^_OL,7"TRL)<$5WKO2!7L[D08\;6Q0G)*I)P@"K'&EQ;R_
MHQBGZ8E?7R^2HT_:_P#-_6,7[.*M^7@GNZZ I55SH:ZF_+,Y=\K0EF(_[UD!
MO]=O8,65GK.'S<6_G6FE7\X(P6ZMD9%O)#8G*^;FWB_2//S#<1'E S#^"T@'
M05U3N=77137S@^>.CT3)K@2N,S<HR\-FY2</S_3.O!RT;D2$_$(;DCG;C;EK
MCT;EQ>VRJU"@M2R1;=CV;,_%'OO^X*'1(D80KC6[S!?%*V?M#Z>GWBU?Q5=T
M%]%'UEX!UQ,]73ZD:6GO07D+H'XH7Q 6MQ1FL$_RG,ZMV2H*]&Z:KU2<\[J+
MK;K:>F6%U?+J"0&7\%#G1G;;*8AT>RI_-8/WJ_?G-'/2#W)*G_ZW75'Q?^S_
MV/^Q_SGSYDQ&CH[>#,2NERXS''ZX+5'YV"H(ZOK2IPNL-'.F;[5L/HXPYK\'
M?"7NB2P%6]VVN'=W;7FOZ ABNF9!]_84_I6*F/R::''>=__VT>/DZF)<K<'I
M>U!5Y@83/PLA2$:KN?&#G&LV-[(^?LV?V61_0L(P)>QQF'E*U5_B?:_\!="W
ME-&X*.0D\O?=LMSY/:#GUG91GNTEZHBQ^*8(&_/T[AZP8YSX"0:B<^J&EN^>
MEEULXR;Q*,B_#]"ADWYD&N7T;O,:SW;BR.&#(5=W/+6MA BB]KJP"+N,=\#M
M;VB]O/8"F0:2EQ8]T.:A>UI7GN7^)9 BBLV=\&\"WG;D3<8]P$A&XJ(O"CC:
M3N]U#$*&![IS.-KAZ_/3>+/$X=N9#E:GR%DP\ HR9[H_<!N, Y&+MG6OBE:%
M_'N I2TA4W'(L/7)#\0BB+TC$IY]KLXAT";YS$0EBY_T@^;;W*ANI%.TVRJ.
M=8_6%'H[LD!/4TB*\W YD)DH7=SG"6 YM\16ET+@6FYZ)+9AP3$O*)N2-YZ[
M<]#P)AOXO--GM*W"RQAX_&Q/<AX2HKAO>K(@]DM,8&:8"^9KU89?D>"FT33Y
M/SK)?^1O^SPI->[$;[=M45\;,<PZGB1UR+MTQF# 9V1 Z/FN>AJJ^2[XB S"
M_PW0^2PQ 8\*;8UY^T_;)$N#&5G=/3LFM!492+R(KP+5KNC<9ES$; @)H6.]
MY2H&H,IVSXJ'$#>:U%)L?]JC+)/X 6OHE?=:8PQ>FHWTLW+F*+M>'W T'XV_
MF:J'G4W7>C\5Y1?M\%_\T(^3ZG^45C\^@/^+4%(M%BM%HSRU(](4PPVVB62/
M*=QQP[1 _F,2NVOMY8'(6HW#C.]'!D)Y<T-MN'[<;(OBQ+:[=:"BJO%C1]@3
M\V#<%%DB/&UFJ\4HYBOM.845#[EF8"1*?X-.=H#^F0-(*VSF==]P3_V\OBX
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M^3(MSGM/6]P;VI;2#I=V@WN"_\:O!]0)A@=@V!FT-6J)ETVV@L+D;TMPP"3
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MNPV65R++X^Y8YI*<8-73?YR&M9'+OYR& U;=Y'OOP=I7^'[(;NGWQ?]7JV%
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M>I(ERL6KGS*T"GS8AE-N,6*S&QO "'#^%X9U1-^$F8?A]R5:D?.;G"C[U@#
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M2WGO- :ZTY2P%@.R!!OO/.%,DQ49:GJ_H4K\ATRVA[<]A^AV)4+;8&7=#N*
M=TSZBH!S5G42[,9R\>Z'I1G/WA?"P'+70UF1TW@/B #^#)7EV/B],NJ]L5 G
M126+%0\)TT@BVZ\!4?(N*RTU/)U[-_;+T%1;_[(>="=$.A5PH)+A7M=88&Q3
M6M;MASNES_^RT6HA#5M3N0][MDH@(,*8&'Z1=9C!HQ^YC3I>I.E]3A#;K%>D
M<[&:*5HV%LFK<*T3;,Z'46!XH#-A7"'/FZ!&.U>I?YR 8ZXT\4)>KX_X,8"'
M:F,JDM(_"_XW>'*X.'A=FAYEWN7"HH^H("@KYZMZ;,O(T/QP/]@)O/I-5A6%
M!V+VWJ%I7N0S>8%)R6Q+A&)W4C.;"+I[P-?C !)4]<E;$[R? 3"+2*L9K'N
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MCW2??PW5#[2':-V]NZ6\:S&]!XP_!OTOHQ0<=#=22M'S(3QK_1/^\K3+9OW
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MQ[:07*6I-12XU'9BX6W=M[W)\'6<1^73+,22LH!)%XVHE'?W !F-[>_F,_>
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MT1L%>15]@3 _QS%&)&/WK;0^DC#)CZ(4:LNO%NT84'WR <\Y['.*(;':$_Y
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ME2GA;J4G\]E,>3G8X7RX"LNU]K"Z]G7VC/X[IFK^Z)U4!T&WJ[OVW[H&Y_>
ML'L 4]/CE<@6W3)@F<'!Y24-*PR=/%S(&CE@K;1H:_4]O9B%SCPV:9=\\QZ
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M?H*G(@_(M]&%:XKZ[/&MO>O6S=Q<9#&[V7,EAL:Y&V,;+U@0,&"# O;E\)Q
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M(SB5GM@V)SDP$YH3R<6BXRJ$Z!9/>.0*69\[C'TA.I6PI]V4 AI-ST 3"=?
M8K)$2(_&]"8Q/6(MLL$TEF^OMUC0:\\PSCQV[0)TX34_@\I-S!?W;XZB149_
M\&.E!GY2R]K<MNJAVBP;L$-Y]2R91Q1E(A973<TU\ZT[.[)+<N2ER&6P?+J[
MQW'8JVZ#S*.6%W;_G@>]])>?.=_UEVR=B*2/?F;VQJO.>-A)NLN*8Q0O+N[L
M(.Q=QXSE":QW60Y+^I@]OXQB]M ,H\>&O[M.O!MW-)#1NH.[WE\!/B[6OX #
M*E?Y:Y&D3EJG:I'"04=EX(J'U]0UI@[TF+6(:9Z3Y?1V4TMYN%GNF5TT4+1,
MIP'QLR0G YG4\?(V?+\T0@/(=_JG;=<XIIST->?A8?X$@DX)JD6 [UOO58":
M0*6/GU$?2X1"*@X>V!:J3PG^>,AH%'U-<L5Y3R&GE&PZ4U' S1S^D1+P$L#5
MU:_>I)0VQ8P\V,?EB.9OEZ$KP+C-%N2*557=Y&.Z=@Y &S><=L>M%AO(89VW
M3B$/T_6F)E-4YU2]S.Z.P_?]E+E;5K#AMB!)-M^4  UPV?JZM&9DW$/-)=7'
MY+]E07D=(5'T_Z 8[A]TC(Q';^Y5+OX;<7'U]9?>N<K_^:C2DW%C-%3VF[WE
MUSQ+4G_])AZSL UCULN$M+8B(U3\>6P1$F\MFV]K_R/Q((=J :9+7!WORM7F
MGO&<3F-686?3:VFZPA5OOYX;O61/I,Q <>L RQLU16 ^(VT@67:^MZ:? #XX
M4^-NFJC<=/4W-;KFXC8'G?QUL)R6[P%GJ8#OU3[G?_@YX<0S=1./>!%D!-V.
M=RDQ,G[.6]*4H"!%UJW+R&$+P \[JZY]N7S0V$KZVCOA<NU*]^6:Y<(>]/G(
M\B"VO2=9K;+HLM>7ID__Z8?9D6;+,[5]9;?GP<KOY"$5.WQ7PH'#] PC2>+B
MX*($A=L'"R0_2>M,#6 EUJ*M;[&E3.L;'I-@I/_J69,>([<AT"PW 3<1C7W2
M:91;O]?K1;,]$I3KZ:7ZB!Z<E4*;0L)*HXN+Z@C<4A!>V"SS,<&O[P9O(;7&
M.^'&A\D6*M6?\Q]IC)IW?N(&QO-Q5FJ\N2#"FCMYR\A_J:"Z)6YTKTA#JF@6
MRL'GQRA]966Z]BYXN,,$5A NJJ'O)NU^,DS@/!44)-&<WJ>7H)&LNAY0:#OA
M(RZE.F2T+RU'WD$6RT"X:C#I?=CF$/<N6>65K'9SRLI.:F(Q6%MQVL!)W_G0
MY"K4G:86#V4G(_HDFS]L<A2G4O0)>,3WT28H/6LB8LB#W:C%(EBAS4CY.>GH
M:H_8QC0+1;73,;NOHO(]&^?CGY=L&0CO))SP4_/M6C&W4Y__>9E9I(L;53B)
M>TI7'3*5Y?[DN1(/CC R%]H%Y*+:^?!SR_;1/,0-.1)NUO@Z/^R[UE2H;38*
MS338'W:R_^R/N-(^Z5VLQ(,1&H_9>&#?%OU[EN@6<[A;6-U7G* _$$@UYT&G
MV&<\Y937L%!%-B/D' [/%#V@#7;%DI>@C>EO/LF-@QX<DKQ'8I46\69:W7GQ
M@$J+8G&TL\<,3\=0@]@ -[-895QYW\I7-4[].0QM"R*3>&O+(R\&2LR@_;TJ
MC/7?>,*[)21DD$\EP^.=I,&.M#X\6N2BKNU7QRU6=:G&CI&I_1H:R\NJCOE(
MK%_FO0^"2.G&RX?77=.Z;T/=LZO=RXK&1W33\&?HL9R=)6%YTT_*6S$D5;%+
MH;\F?/+00)I4W9B5P<-=Q[0\]A$78H%=*L'\5%<*B\.J___9*I2K9IGH>ZAG
MW(9'?IL=1EFMV,R=.A*C/ST9;,06&1&1S"7%5^-H+<:*KH++N5A]&!:S)U(=
M>/5N05K(\E<W5KGKU$K$*&G_NT< US,ORA'L&,]=NHF4^@LZ7]B[^?-L4=MM
M$%2"7MP0P%U,V+*:\IR2+J3"3 A6TRZ5/Q0 HA7@,3/N?M.=W*A&IK:1X.Q=
MXX7@^SN>&.-/(9/VH[V5(K7J%?8+NDSB0EY?S@FUG6!OX?2#A?7(NU=>YRV[
M[OJYZH@@*I3=T=KF0&9@U(W,>*^\S<S?C(!RMW!!'.PQ0?GA 3,D1=2=PB,
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M+/Q9DTP$#T5?#@N2$"F$<AK0,W+W&IQ:4W K&=ZF(A2=>?4(>,7"<J (4^C
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M,G*U!RW+"^91'@?F>+;U^TUUXZQ$@CR\C.2CK[2#5>D,O&K .DBY: \-WT>
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M,YU&[:]?I?,_4J'7:#3/SC$ZW&6YD"(3B;*Y)2!1KH"J_7>]:SBLI],?5<R
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M.]%!AYM\B%:I3G,9I<]F.MAH56,.K@PL71*XYMXWJCKYI7G05!K322*VSTG
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M+1%KX!!;]]MR'5+>-2-27GDZ9YZ9W=+ U=G;< >/?[ UGZX8Q_/C&'.\VD<
MG"II7_WE=$MTBJH_(JYF^F^P!$M<POU!3.CHAG]">OVNU\E^'-:A2 IJHCHN
MK5M\<M/L5IG-<FCJ[!% N=P96>&MW^^Y0"&T=P/\X>3R\KEE"J>E?'[OA92S
MT!SBE[_-YCC+P!)FE2SMK4H^NIUGO)L[7U&"."#-)=U9L#^-DFICN\,W!G10
MZ_<@1@:I/W3JJ9WCEICK:"]K;V#"."WG++?;'^"P<1N7I?#^J?[04W=BU3?I
M5/M''KEB..K$7/\I*WMQ.8X0*+-?&N%O47PG.;5Y,A2+-QX^_JT>Z,0%35$]
MVN0U-*0B38A#PTX"SY=5.#0%WJ9:IG5N1IZP=:P>-2'D2$V,-&RPJH75P2^1
M_Y(&B!WP1^<<6;/H74P'2-_?,%TWC'0RF2TJ;1K D6EKI6"X:!V]UI^XRI<-
MZ4SINA1C@2:? NPR0MS'T8<0113T%-,U]NZQ\<P6I&<_@$L&:O2&>HH&G)@J
MJE2UU@51G>9#R&:9H%KY*@'*W:"39&^=1X"F4J-G8D#;YK<TS:W/CP!T]";;
M<KM-S;$S+?1]'>^=_FJ$7ZQ7C(S@N#TS4.>U:[?PELW4H?E$RVK@05^J]Z01
M!)7J5A%EY&'*/Q:09ZR./Z6@_?PZUV5'!FFVK*P[G\]'\M HW097R0:5@#MY
M(K5F'(7;L%.6U,'@T(&[^O@(J>C/J:FAKD)+>=.0VVS]#=EJ"QNJ]&T+?Y8X
M#XL=B>XK\5J#@M1YXQ&!EA66PJ[L2>%81'ILF2U!">B7'84D"G(Z\9VWR) E
MU?'5/WV[8-^L!>^?'QM1&/F-Z;#DIE3')BU+(4EY8V+2XS;ZM -W7<>K@$.4
M5*A>4\:UP?5HOZ@<@8@IOO'Q\T4[R9+REW72-W'Q;E&DDD<@:AW2+&? L[/#
MS/-)AK6A?._47C.FCH3/Q8NCSDVZ0R1J6]',2U4]"N*3ON?4G!V-QT&]O8U=
M//0>B/$O0^8-)YJE)6/6#;EF(05)@R/-7Q2R7F$W%<N9=CAAW2FE]F=<7A'D
MK^\=.,B,$0EW6:6(6F/.*S"I<B1)QIQS<RX[R0VPW1 $/ (J12>%4DV@J*>Z
MAM\4F>(7SZ/>"E[.5CA<$[_"Y*XK=\8E5IN0_ *%"%SSF/$] FK5&?ZR><Z]
MSVX\NW-X4%C_BZ(U?03<I6O0/'1?R=T(2AYR%F2\Z:H^HG-TD2-U%)%RPNU>
M(/ C:S![T_JUD?''9B/K,5>"PMYP+=]\52##/J'1OAG^[/$%[B(4U\*M?!@F
M]87>+JSYM[RU! : 9,)[((!(F6AZ?>(1D'']#*IW'6A#M'EOT=T(<@)M"E)X
M'?-MB<Z^5MI/42FJ=%D,,WS 6E"@7IDRL\MX( YE39G8?Z"B5U2U8&;7]X_"
M6K$DF9"H!1:$%_?L>X=/1DG3P]BU(II:0[U#2O2H \(A!TZR!EAG7SR(*C8K
M7Q*93I3GHHS7:%9>!34("#T" H"F4-)9:%=-.LG"$Z,8Y_!L1M\)?4:R(Z'9
M0?HGDS]L<''CV0V):HUY\>]C^OZBR6_0^Y[7P+K%.O%SE=HB>XV"VTT/^4:'
MCVR\G#93O?%2$XHL$GBX9P2H4:+'.F%:)]5-49_:.])WS8#E;)#O%DGU.-BL
M[I0RF/;>8)6%;:3&3HS(@9\4;O0A\0P/CZ'T3!2-BZ!:2$O#$"V:&L_@FCD,
M\0C 3= R?@28P\R[G7H_8??143"LI#YY9Q'=$_,[;]3F0Y]^[@TZ+$_[S?W!
M=66@^9;PX=7ZD]H)I:!L'@&L?7V/@(NM-&.XP%UJ@-A#J]93=<AIL^/.JF6_
M?03\X#+BEND:/LWF>9/;'X0CK5&TE,3/+X(+)]=$^RS!2+*K.K1I4EP=V1-5
M$#IK."7@?@^V-72_QCQ3VW9G\DRA),DB]*G-LRU_!(2@> @>"!!'/I,QU?;_
MSB?1C V,.SJ^^8Z715").;Y91&%[:@*[1(J1X >U]+J'?^8W(CR0@NQ'@-2#
M^1:N2FY:E]R9N$ T,32\-N(B,A3$>[ZJ(Q7;&(W[';&XT8*1]3(.]C'/.U(=
M*9O>FI/HZFB_&L,;P?$NN0<>+%<,F@:Z\]@_LR0RX>CU-T9I[KRUK[IQ+/1P
MX,[)NPX/N5-Z<72 /]O7]>>!IV/!@;^]60"A[0'ZNR5=V3M,(TW73H_O+/DE
M9?6Z%L7BY_\(V* 78(AXH$-9(RY'$>3)+IB[K<EY<SBMMC4(:]XBR@D,M![*
M0[,,N*$T"[P6TTZR*U+X8#2 6?"*F"O!X<Q!.UV!:^096D)H6R;GO,HP?7V;
M].W04D)N]1VG@V&UE6@#KQ@1)+BH<>/7_2Y@QQ7=&'"6@&A)?+'_"'@Y%,5;
M)"LV?U&M*/8(>",Y=_:?EX0\+60*$L<H?9=-4P:CUCEW4QN5QL:NU+<IAC2:
MS1FCADWL&#R?@C?K6&@S^^<MD$,)D!:(C%)OHQ'FM[]OKO2I0TW%WVU=V\5>
M->^K'FB*=CZM^@:&$>MMD!%=_'%T596_=JEWH$&-T?'[&+4O[K&ORS3;?DH'
MFJ<K2[U%DM745>[?>$#$T" M>E0E'NABKFV_OM)FH0LE22[4<ZK.H[%R8K W
MG#O@SRI%[$N9_G.LL6S-5'O.>RHQ,@)PWR#XQ&D.6W]0F+VYSOS8CVI[ $YB
M!,%6)Q^B[ [+BB"@1X"I4B&0K#01U9[YY_@^&?ST?+(6P>2VJE%:#^W'7=\\
MEK459];,3X+&-,S^^X_T&4U X"1\*-K_30Z+\4\'*9V.6X^:/$:?+PZ_\PN_
M!*=] @(2TN02/489B/S9V^8@L.1#UIP5E=,WT\?H[EM8@(U+\?]*1NW,>GC7
ML)/G[3H2B+9Y&S$-77^!2@'[_)V%[)4:#X6R,(6S)MJZ8DLIT&9V(YT2A(_)
M^_(X(E.V+T=$VH M':+'I-H(>?2_W:/$0 "M5ZU9099I9A<P:$[N]WKN=19V
M;*DL%7(B ['\TR_:O;@^??!4U0*$UV@@.?S!K2D4![U.6FF33VI@*>/K3P7U
MV+;G'LUFX.TF[P*]/D!P,V;TR"[^ZTFCBPHNH+I/4-]7J-:X\4E=_\HC8,1N
M]A'P#U/L(>&M]/\*RYYSNIJC6T\I%7^ "GR.@.1>\W2R/@)^>>2>I;0O[9_U
MZ,ERP386VG5K4!X1>=>SPG^V#=@5T=:6R2+,69->;(H/^5[Y+=)O#R+6)-X)
M\+Z+9;Y05$&[XYEP-TZD1^FJ0:;X[O!LRH!VH4Q!6-6T7!RW]G%M#2MS-;'U
M]PI79_?X73TP6;K</M%H. B>\3;<O[F]0'-M2]0';T+39[NI,N/$.J1L#[=B
MW6[<KNFF>'W)*G2*@9L(POE>%3,!2VV(%::MSW?T5GI6%\F>O=$5(YEVV3F[
MM+@O2HY<-HGU2J:;SN4ZQ9B4X>$8>J"?TDI@1A+$G,?&*_7!1'F(6KZ./T0R
M$WM)#BHY</MN;,1<4G/["OSG1S]]_9U' ,9=(A\JP.*DUS3H,.?%KV9P6<$G
MF()C.P0;4"Z8W;+ELI"/U(J2I5:K7>$;S/<K]4[&B9V</:SYW&*]B_7Q-0>C
MA:?")M1W@%3&GJUX4@ FUW1A'NJ\8J?G)607-37):Z;W)YO8PV$ 6V41C=%K
MW!A)$7NN1>G/C52>B/:$$2E9,;\UHD@$DTW(?A)"67>0Q] W/8ETR(,\!'3Y
M"(B4/AOH.L4_(;@/__<(.#?^^ B(7C\5V%N_I*Q_!$R/FA:3:1P$23WPW'U-
M2VNO?G)\/_KO#)\,H<=3Q3>M?KK$]8/9ZUN]6$0']@#(QL7K,XAT(:/<,7PK
MFG7I30B0%;U],TO?2_GMK./5':]8S7V7<8Y^K7>E!BK-P2;/^\-D8+U9']_J
M^I^B!![;3>>M= ^&U]T  J.U5@:D+^01<(NF\927*6UV7*5.0Z>_O&Z[:++,
MX[JVG$Z ]U^MGF9(\-[[U.IDHKS$>Y'IM6$$I&NQ*#U4J]6;2LI$X/X<W%8K
MNU#EK[LI\\ZV-2(:/P.^Z-C_!"F(L:OI0JN/VL!ARF#-H[F,-VT/?@\81^L6
M2CV_Q"+;<=FK*QV-V_+9RP.]AVVNA^\H,$YJ(I7F"V 0=1F]YQP1-,U?ZX8D
M@^%:[X)5]R:-3"W4FA;.C:NY_Q:I^Y7%Z5!&Z2WY!CO[N>@S14AYLX22XI#:
M$9&IH >_PA2==3IYZ$1XS"(?.I'GVLI,X:3:\IC_TX.L3QVII?IZY!)/P&2>
MGSE'U;IQMJI]CXES0,V?K@+'),%5 9ML"A74?V,>#1GJG+7R5,T:$M9A4F-V
MF3?48IR>@6_9:YM\;.H_9'EO3/!O7,QPSNS8^KRAX4SV-^4&U7>Z\H.Y++<9
MB+3R9H!4'PQL<:FAKCMG*+U>!THO\5&TH8FB!'CL ]\"]FRKS/&]2S61,I!Z
MP]@HFZ9/&:(9VI2E(5'#^)&E^S('Z.8QO@H)6K] OMOE+J2G2B*-V58[:C@J
MW.H;A^_?;KFE/!?/W\75;2FHEY9"F H-4/N9@5+:N"5B#+844]YL5K3F*-0$
MO4?EEX"N4H'WT0BI6%6J=#^4\) HDHQ5U&!CPZ(,*[*P 6]B+6:H"RGZ\S/<
M&DE_E:M)6 6'4_'&QQ'BT$/5-9'5Z;6U>$):LQ?&4<Y_YE+F8E^-SOO/J&BJ
MB#_SFVUL))NO<8?HTU7>*=?-0*GL9Y60Y'F,7YI(%O=J6=\GPWA=DL\GW\8.
MR,HVUJ$\!**%/[:T4Q"^AJ;@6GNH]- 4;3XGO5C=B_FYYYJR,.2@[-)J'LN,
M%(L4T6K<#62<_1PZ]B/G<O;?MA6G%V7"D1;V+!59D.(<)$ (?IE=5G2F4-CW
MF3::#8ZE'&L[>&?#%^=^/%->:78OM_$(2$IOK)N>-F$-(CMWDM%82ZU=!!TI
MEI3ZE I[5J< KF^"W>:">?*0%#'GM;A+?U;W7;\?.I82\HZ&1KU-?SDDYX6[
M+*/,N+)<T&S[P+7["%@B7%[=,[H(KSKE=;:C:'4;<.(1%0T>2LZZ0F_+Y)M#
M_R$\;=Q[IL$,)'[9T 8@]4WQU3T8E14X..EU-R4/X/C0V9BK'7Y4V 2Q5MND
MDM5I0EM,PI_R<U.O/Y(3FA$^U-></QP?_!$$]GLN]2Y]EC<V]UTY<S6,IO1@
MC?IDYZNN/C5O)QVTY:=MG1_:LV-^SY"_[*Y#M'[:Q?YJ,Q=X*KBXJP)&TS8M
M#NGK2PLJF-D=9/4J 0G<U=7)4CP-]06_H.L4(%F:#FCCW%:* &2 MYS1=/2V
MH\5,@M?K)0#?3@L?%>ZO["2]5[3?ZJO,D8Y5"-X2+J1:R<M*NQ(O@M+,NEG'
M\"2A$A$C[2QPGI^CQG[E_*N>BB?+/XC96?$F7*#RDS2M.1)Y().#W1JOOAQ>
MC<")_6T'!H,9XD7T'3WHK2PR5%W@2< SAQX!X;7YU_!'0 -T\E_#(^"U6ZEX
MPU#-0_/5(&=C(YM49?8\660MJD'CY#"[_2PVMIQ_@L^A*E](W=DEBSFAW6O#
M;UX&=_!R"=ZB,NUQ*.GG'3>.GU_:[K@K54;UTF=7XC+/1EO9IS:\DWT%3'UX
M'[=&A\3M7THU[I'<0T7\02_KKT[ZL,.K\"R^MU6&"]*%,J!G,@YJ? 2 </UT
M/;9?O3KLLU\42O+=D5T\UER'K3Y\7A_>VZTAZN2Q/36*AMSSF,Y32K%.@R[9
MK9NX^P-/PJ"!1RY9&V$)H%/_CU-L#3$!S# ]&!W,K:?XC_",HB#P&!N-@ YG
MLI$+;47;4)8.R?X3$<]J9V2?\'EE>C@E'Q@-.^;AVE5V<_/_.+WP=R GM79?
M5+O.4(2&3J*H41$'[^Q$E7(?C52&[CO?Q^E5;4/L_E8+;SUSHF6-RVI)*>L6
M BP<J_=J %JW'DKQ[9;R3E[;2EHO<E^]CK+%-#R^P_2<&04"12]9^<W.E<W_
MI#MF1:O4;YZ<5F1.JD,1R*@>,KNWE#7=1S;V5G1H.V#!/^FCVU"=#/=#5XTA
MRDFI=;ZVZ:>?QXK>*]P6#K0/Q()JC/A^4_,AX+IB9>"S"%N6;X/(C/?+##09
M+/D]+'+Q:O(<S@4QFQ>)44O6&>4:I4L@WP6HF^.R(X5:O5 4OE"D?3#!+_9@
MJ1<\N.^0GJE5ME[4C3DP"B+C=,.\A-6QW8/YEP:K;<MDH]X4".7)J!WR)C,&
M6-IV:[8.LDIQ^4W,.-3PK > *1UPQ%5T_&G/K:NI'=KFD[*T396)\U+W^=9+
M"W\;L$5^#RV#44Y[H1(R/C'2(Y=B622]N-Q<%LH::U-B!#G]]X=R17[CY4XY
M5<^ ERPETO$GHIF?>H2_^HC/!.@&\L&)L:6,"_X=5&)K5%DS3)\P>$$VN!]$
M[-Z&IP+F,14RGE]:4Z*;:[4*TZ!KP\]?#DE>IQKD^>RO6ZP!5_-7 PN9@J:-
M.WI>$WS_^NQ7SR#EISA:-_7B&_R)RWT';9/JC$3(H:X^]->L^[W1!0?\^!.$
M?0FCR?,/*RO SR6+GJ>B](LCJ;9)!!3Y8A(X5UR7J(3$+V7%)NG,+FF/)NJ6
MKNN6IO]3)%1;T""<2PC*7/B:.9\V PTKE,O<*)EJP6NF_]XS$<#SL_%)^,W-
ME<@BHA$\;5PFS';O]ZH<U#BHUE3%)ZD&N9:-/? SI'QYQCT8HF<-O"\/WFH1
M>$?<S*Q-D=#E9!HN*6XY]7WZU]W]N4>B)DPW5SUUL),"_&V.1#N=)AWRD<E"
MNTX]6E]BXOF@T 2(S_[VOWU3C+ZFGO_A*9N/RI:[]$P0)!ETKK%NG,1H50TD
MK%N&G\+4,_PLSITE)Z+>(Y$())F0B^@0]#[.7%>',-\8H-=XJ1A4V<CY"Y0!
M+-W4VGCN'@&U[2#3Y2V/;_K9WKF#8+@<IJU6D:%=$_J6415OXZ"U0;1)A%/;
MMN!=G@UKC@S8"(; *UJXU%VSS=Q.S\CH'9"#.#QC,ZGY\(OO2FL5.\>[LK&:
M/Z&_M"!@?J(S9A2)WP&"5U.;:EY8>1=R%XC+"["\?E&1EX3#FG!1$F=(%I/&
M:@/:EZE0X2/5%T-HT>P%4K?&_%9U@N*]_7#&\FNV>NRLW@:S,0%PQ>HNGN<I
M^9:'0 6I7%-;J%6A;A-4W.=HH$%?ZOC)^S(N14'F]82;R0D*6G!TEI"*()NI
M2ZX4_8Z8JKUJ\ACJ7))<-.7W@NB)0A'Q HI3B 7'DO7/K,F,F<S%\LFAD:Q)
MHF<I 3RY3C&MM&(C=*L14)O283C+?$T5M9081PFK],9-$C:=[>E3/#-YON8B
M!L.=G"/4\>Q!CCTJO^PI#4^=";[[,.9L6&3NB3P"B/<ZJ6<WNN8LN<#"R)[M
M. ?%>ZIH%MQ]VSUGD=T:JD!NVU'_9-.]S,/X;PG$?)IGFM[5EJS!KW:2LRX8
M7^QYK!.".FEGPR^+)51_+(C/$[;]WBFHJ%$G.02J1QI3IP$ZH&*#_29]EW4,
MF9_.L+^3B*\VU0@-@G],/3#NM4Z4TO^4_5EE>]6 [@"?KQIOR<+7[$O!EQ'*
MM:O\OS=D$IZ9%S#OP?C3=>#W?_#V5E%Q14VW:!,(;L$=$B! T. N(;A+\$:"
MTS36N 8($-P")!#</4 W[B[!O?'&(;@U?O-]_QGW/IU[G\Y]6&][CU&[JM9<
MLVK/-8HVK&V[<NE/ZCS/GPG%SS\4&"RI-\6,:?$QU^]FKGJ1:,%EWG^2OP@,
M25V:>- \ TC=#:IHNHH.&]+=K2(]5( BJU,2!>$C5PR6)6C:1WO9JV(.8P?Y
M6=Y@\%9C8\KK<&9NIB2>3W(T24KKV(60:GO/=!Q0LFDO?]]7M>L$MT+,049:
MR!+I[A,3,KG((9!P[JA@"C8JRAY-F5_?.L-!1>VSD _&?@C.6JKY%7=9 -=H
MIM$&F]GXNFL/B+/Q\S(E*N8F3@;K823(T,I)UHJS/0/>!$8_ TQY@O9>P YV
MFJSF+855TM\!![FXP8Y_WNSL4.">8^81#9+_@4SJ2RAUK>M>=?EKMC9,3W??
MI$$X!$]!"4-,,2ZD'T3>%C<@<PLD\TEA.VE5^[_5$<+<,#R)W(:4>&F*<[[C
ME\KS)_\9+LJV?Q.4?4L+(TW*>@UU)AG9V(FS.R%:=$K,E%;2S"RV&%/"J$8M
M*6P_>UD8WE*T-THSM>I 9RE? _CP!K>N7;%S"Y]O*+\A^^H.I5R.1!.-;+Z^
M(4\'!,%%L.%J4Q3@U0Q\$MY3<-69)SA=2>%X4/W3]<GCOEM)&.!$,B3)OA<M
M>#GML0BMR;QK-8)D"*"6<L_3K;\:I6TC1R1X704%KTP:BC9$NF>2?P2:'N\%
MQ%[?:A#R4JH$3 2[&60M5$EJQ)"YK"P9C:R?4,A)C("#F:8_X197#^/$G(W2
M.M)R^0J0AE8C:^=[YN;&)<)+/5S="O.@-5#[0D=+1IS.?@7M=]RXR&GULX\-
M9!/P S+RZT[^.:/8FG KG5^"(F@TGOQ.U-2I-ZD-SKS&)CU\,J^C+&B"8YQC
MCAS=A1E##W7FB=<);K&]QY]Z:H/V&@_K\_,NS1(DX-ALR<J_99C^8!G,U*!6
M 49=\A%CL1*9L-7L M#=+Z)^.D,.#MQ2<&)F+8\PKE@8"T4._G54;WR?K]KX
MU\(S@8)1CV(%U#%5V9W7*!P\KN'K_\X&78[6@&*']+;*\(SB@_E2*0*_E[F"
M$[0M]4.O&5"78M;/U.$+HB8')54*QLB((KN[7\W@]LP*D-!ORR/"?4%Y"+J\
M_$4"QK3(#JQ5 @'FZ[UV,[&?4FHF/]\-L?OCUOT,6'$7#U4"E6'DULBY^F;W
MCKX;T<KJ'U">%V@"_QIP@ZM%9C*X/G LHDJI7E;&JO0UFR;F&1VD%2&$C^NC
MO=%PIX?_\)+(HQ\M'"VUT7+1.CIIF51'/ 04@YJ_35M/7X'?/,ZTZL%AN0T^
MWSW8AO#BJP)*TT]Z<?"HM9/50Y7G8-&#GC\14XXQ3^K_,11=P7$WG>Z+!U0/
M+9!G*CZ<Z>SE +SB;_[&W,'*9HJQ\-+OF.0D0#_$$*[0*P;4_Q35]2"!4!/_
MLV21=:]FATBXYV&AC_O'%''V(;_SHE@!>5$C$P)+9J_L*P/L:8:(QCG05 '@
MR2;9B2Q>?%94[:B1:8%#H+[6K&-.G'6::J;YCT8 'PE!2I<(!6,5^P_G*+AX
M:C=03&G>0Q]WA%_4(_)GY7 -?2O#D>G/?D@(OD@._G'4\(2_7)%WLLK3Y+23
M4"=E8D^I?&Q:66V6;KSO3D0?F$REG@SNU.15S$B:_*E^>N6(,$1F),[E_<P+
MUL-_%*4.U@IKCRV -H4C!#QCTUGP4=FZM!5<O-\45Y%O@/_P>LM?'XB0*5+K
MMB4")<V'K3]C#IBR59]9RH>;WU I? -?3DD_S6:HNL-V<Y<#S?D&5HK!VI</
MCMQ29C,GK%74"/(XYE.HJ)'AP@&Y]LI*=V$E&+?,DC-5[K-@FCDFSJ^++-&Y
MN4S$DDH'_C(H[=HH+AKD9#P*U%L;2I0>&&U@"<V2L'=OO"M<7LMKS)"*O)/K
M>]"[$;5I*C96WV#HZ/AM!RZTO)&&3$O4OG3P3N[WI*-*I]:'SGC@W"8,T:9F
M.-C^3* AZ^P$V#:1H$QJ&012G\EU1)K_1$Q?J6!9,"@YE\#YB;@@<:UTF9&5
MPV #+A(M.8;_/T0CXA<; MM?TYU:0&B)T8T>&?6-TO+'5F(&\:KFMO#,#9'U
M]K-G0!PW_PV1 ;$SL1+E,/\AM?- *:4FB+T["_UT/KI5PO-N)YET.=%A/I=I
M>;*1#N+:A"F\=?9+O\#>5S(S;W^H>#_5!6[TUI5$!0J9N<_VI5MC#]C'"#*;
M_57<C6,'?J*TEV>=56VWBI.^_V/EI+'%GA:A?H8WW\=-"M]??0]$/] /MPJ^
MW#O&ZY4TP!XVV06$8-(>SO)GOAV0G=J8=E\0CU9$>370EN&DQ)+*=,72IGE&
M'MHJA1C4EH"HA%_88AZE>%".H9;B8M#&BHB-9-SM/\E,%C\Z/ /^])\6?[V2
MH.^CBJLL1Y8*E"]EV*U[D"DY:>DF%7S]3* #+WEXV_H[66T>;)[TW@N_SG,>
M$W/E3P3HU7X,[KV^UL8:IAT=48BBNP0ONT RG26;C6V_:^IGI7X-'1.6,'&\
MC6IR;]^CJ]&W[$UO9JL_*#7ENXCO;+H1N@YM"N<Z'2U=$1O[/H55TALTP,XT
M>B4"^P*GB^%]6);$_K7C)*HFJ-/"<*PRG?%-3E!7QVDRT'M3==+]ME)U9W5)
M32GA-26V56)="XWK:ANWZB1TA5H-**9>$P(?E7E!,?%RMRH <F) 9H8K3EK\
M[TOA]>WTL+@3$;T17K8K71:';)>7*OIZYPV[TSO:OFOC#QV#F\?H03;\]%?8
M&H^8^B5&!:*>T=@]A ;@H_Z%"4L4_9RR*6];Q;0>VYYQVTSVD?/V\1WA6[Y?
M3F,G<[!/'QCD*#1Y,& F*[>5LT]?^PR9EQ[&.:9A!)3>/3WV"+M6RR(D1,WE
MG$-S@;DK%J6?R8<:)5P,9:X6FG8A91.K]+ FYJX/W@$O==R,7EC6^R):NDY[
MNF2-GQ:> 5]]YX]:;G8YZ[RJTS)_/K#[SG^<=KP<<E\ $QJJ3O$GU ,-!ONR
M1<;1:C:+!:2L"^?60IN4#JJ7\P/>J*V+_7SCX0X6&*[]%2)>9X)>(?A >/KK
MG W$[CE=U$:M1*><LJQ(&X'VR-XTZ?]R(YY H42AT%[),3WD;Q,.>^;A."J'
M9YR&JEY;49JU94%/H8Q37C_%1RR<[?Y.'I+C,>^K,F>]>?>GG<7W>E'1%P^?
M8H(H#HP^!J+,.E7;AEW>.A8 3BC2W!)R-=S4WYN8EMN^/]7O,593Y[6A2OF6
MPG282.T"*JU#&J]G2NE1939$5&KO\5@SU;U)#,'.99;9_%T5H37%X6%3!UH0
MG[9U:>#Q_]O"I"GMA#FNTX5(JO6ZT#CNN(T]<F9!EM-T],'P3D?T!\?66.,M
M=PH]$Y\!91HY9>GUR995^\GVS=_I @H6+AA71WX1*KR3.<#P;00 4":TC05V
M[PSHZI^:HTU8>H-N,9'<3SVGSX ] N"*Y@P4+*6?-*QR&"10446VLWQBO<B
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MK(;RFX<A,M\"B@O J!?]7&%_!TQ-0_N]*/V[CZ.:KX0IY-AM(.NG1+.^R#,
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M73U!G6HJ&_Z@)^'Y5F5ID)^CO1[GKZW7*^P$Y0E2ZP+D<0^@(N.E-:3>E(@
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MU2ZN==#@A.(U0MKJDP1%E1M&FT&5W\?3O^E!D1Z/3@>*6XTSA;&66-DK/52
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MKH_ >Z$H0!!%N+ROSXI#_]> E-(-\W4HKAL&PSRPPEO;^+!%34=M=F?:(]I
M<HQ+3R"1.5Z$G0E\$R[OS1#77RI[FM&9X&"I&=^3VKTNN([3%$-O-^+XR"[;
MFX5Z.AY=& Z$**LT60!+GBS[.R']6L$#+%$:8/36X2>*,_Q"KXH#7W1HJG.)
M_1!-^,Y@]CO=@(7A7]\M&A*3CX"T*8]9A8Y<'%SKS5^2\@R8\)LPT*QHK*B&
M:D[K,S?6"%;VGRA_PVI\WEC0F_ =O59IX @L?EMT6A5*'B[.7;PW2=@]QU"Q
MB5P^'T4FJ4F@.6K)D823:,D!_H\O/<]"!!ZY0I+PE9II=]_6?;2'6R+9'3JC
M@-=XQ.#%P\RY:\N?9<'-><GO/L',I-E%AW#!WV/-II46_I./9R"WI)2[(Q92
M&^,1 R[&AM0=BIU$PRFA!'1K$R<&#P8KVVE^% G2;(MJN[N*\ZYBASGR9+FG
M6C&_[XG)!R2_W 4&_!7.2/3FX2P1 ]^2Y8#R7N1I]J(*3#QEQ#U"RQPNJ(&Z
MGA>4>_QZY!$YM9.M0M1<':ZE"U^L@1^>CFPXBIL2S%_M@1349R]7/J-GJ,Z
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M=BFFU*=^4U^S3,'4%/;VU4]5, ,N(0W9@(EMAS(@*ZJT^" ]L-+1B7_I$+2
M2L*[I%K+M3%CK419[OXO%#:KR(B/TTZ;T(XY_GOCG^]K*8^U:.NFL=75 /9:
M6BH0-+)1"/_9P(NJG93EEZ@SR?WOZC,J[8V&Q?9],U/.7_<(5!RRZNQY)D<!
MVN3T4^_&L-(IG7+B/L4,:VVAA*"&+#P=^UV6N*^ E.<L??C;U,?^;Z.9E?H
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M_KF$T;AZ-O>7=+O.J0AF[)[=)?-NTS+Z;M<$"-3XE':"4Q<//?E.[&$;80^
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MU/ZYZ+!ODOOZ ,!$AJR#Z39 R8M]S$MTSB9JE!WBOK6#0E^%5H_"Y(R'<4I
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ME\JJZWPECUV41#"95DK7X!_YWAH6EJM9E].6Q.@TOU"G_NF13>PIE:2%TES
M"Q+<\\H50'RV>#Y#WU_O$##YB?(JJ=");C>C.>(YHPYA,G[V>\Q/N==+H$+3
M!7[@50(1,JA'5%9!.KAD%W\82^A3Z\]0<28%S!(M+SE6A';Y-I!X'>FG<:X6
ME9][*\\U56F"[_!!3T' N':4T5T2WGA]0FPX<R8C7GTH-E&A563:F+/PXWV=
M#CY/Z(@V]J8^ U.#]Z(S.@']B-[MUO?>Z/J"5\<?_@# U++UJ3Z^N46G>'FG
MS;76FKYSC<FIZ+?J%_#(OISP7N>3^C'W]3#S-.\[RZI]9_MGC=UJJ3([_-S2
MO>WHG49990-D?%. 2DU$8PZ;MFE+:5?;0CX)8](/]ZA6CB\L7M/Z<N)S,&:F
MWBIG.:INA$ $WV?#FQOWF#"@'/Q=+/M'3Z&I1LZZ;G#?QOX/_JN3OTPOR:LW
MA'N>'1&4R]B.D,N @TQ&U@;!-DF%;#A/=*%BO"B%^"N5"M#P !,G0N!+\9'A
MK4]G.*SBB Q6-4'7H/[2(1M;<E532&*$X:9\*_B9+3(=6&6"5 F2+QHKUF3P
M@+2]W.T8D/S* JM2W-+@?.)<=)Z:L] <+6,M<C.G0CE40-]W\527->J-K<:1
M,.Y(1=/BKP> D*S8:?<S_44?>5+EP$*0IOH\B]3@1*667\6J:2C;2XS7H4\O
M3NUDB$);ITAAH$K-A8ZGCM5.-[<+59FK?.DQ3OS%<3W U"0-0RSRT.>JTGMM
M.E2PHP"=&)$-:L<V&UBFHBM'S@FDB6#HV=,P%GE0J)2/9)66O3X4956&_ "?
MZ[OMC,BRK^P7.2E38/MVOY5$PZ=$D%W;L^-33.W/N5^S3CXK.'<EJ]VQMWX\
M)"?I7'E//$"%9I[]T)J,[V+,/]Y,3P3U77?/_R&!F<L[4SGN#?GK->#CR1B?
MK3AK@[GP^>2E-4<J>%!A;7#=LTW]4/4I90U@S76YN8@4\1-0F'Y;.U2$W\?U
M =#8\+UHPJW8.I<3JS!<EAB+=(KUAPQCX#:8]H#.HL)G1*1=_SW[8+(F_RGT
MZ>@H/EWV^_?VL7>&W9\;UDR"+<T1<K5VT!=.2A*NOS+Z9=X,X=+7#NVQ9Q/
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M2DP"CC7G KNGS:G%_J+X%Y9#3$^A5=<Z^"O(X'R[!=MDX?J:T01!=Z\A]^Y
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M+=-=O<QDFT.@P)O&G(OG*/G-U=XY;S#-1M!KA-0*<H9O?=7$OUBD;,U6J<H
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M/T-][/7>AK\GTL\FG>0-GW$)8@O,-^U<'-0A.[S #=6Q]JIA%\3'B-#A_\J
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M-#F[!_>C^GX'@"VA0SA?1"<L7UU\F.D0]8&8_<3#X(S'3<$*WO?JW8\G\C!
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MF$2'[['E;V*]9Z'K1JCN<8[;E<L' -N/MC1U?HXT>K^65)(ZI=B"(A;W_%H
M^:E"C=CYW^BTJMQ8*]X(SZEB?ILK"335B[W_RCV<QK;3M(K1VSLJ>KBP+T_4
MN/9L5LM9I6W>U?5:N=H\M2'30,/LQ:YON:1+PBM=9%[I$;=+)UC5SL&"?;YA
M+7!(3(HSTJVQ\J_Y(U.3[-19XYZPT!>%"+LO <B'G4YDN.%0!$$S5+S-[-80
M\GY$H&K/)[@@PB!U,>)MV%2C'1)#8:'#;FGG./D1^"3;^X0=/+B&$)"8S+%'
M[90T:=S<D^RVAX#+TM<E%^RZ6L/ZT.2MBT\;OO9[^-RTG'PGDKLH"#&+C\2$
M )%> X9=''-TIS!)JV1N$_P8_T4R19[[':LCWB&4[/>#&]>RP\P'0,)?W+6F
M#;OX<%-9"2D2J-I-4^\G(.G9V;R>"+#OO^=4GA,9VY]N7($X\68U)0>VQZ3F
M9)KG,^<H3 $"[AWB-P0O\("EX$NI6\0&#KBOXPZ[^ & 1XUB_0OEY6'-60^
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M^J[/;_B40>!G;P?LV\K*XM#VU$U29NP,8HL2BQ;WA*=O=%*GOK].!D'*Q#(
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M_T-G)S*^15LT8-$E]]G*5SL^TF,2CX'P(Y-V*H'+Z/M5LQS>8*R<?I%]1\,
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M*_,?KBZ7F%'G^M2C@64A'=_3R.&J$V( ZQT<M: 2N<I<G04%*2<O7QTCV[N
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MCI:/L8\E/,"ND 5SF3%]^I><HSNO6^Q<DM%W_.PXKASJ)B.=3Q3O0O3,4:E
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M!\N^"W_Y0K D:9''\4S0-NT<^Z%M?0M3^+>)\%VGN8>U[Y:^OXMSBT/.#VL
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M1LNT]%HCX4_'U+,T<]N_-+0+[^L3'W9ZKA+[%^W,Z)$<BR6C^VX)2^A_](T
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MT7(F?AY$:2Y0C\>I@XVZ)Z8AR4'NTO<\HC:Y8_I=.)2C: UR(S[%(3FI!4#
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M0"%BRSBIJ7GI9+A8_6$B?,O")Y0)]=:_X70;^,UPCSDDZGG!__G.Y-0DP[5
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M4%$7GCAYB92W2<,:6M&!U88&G1Q_"><5:WH)26P8G0!4*?I#JSJ'T::4Y_<
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M,L;)^UF#T3H2:&G] 1'I*\.B0O/LL(]K:AC5C+G*FT<MP#*TA]!,,3IF;22
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M\%/;G_/[:;5&1L9V V G+<5'3\K3V/C3/K_M.#:>[5$TF%6 H9B:MG?>99L
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MIQN+O&>O&8="SC?8DO/4?;D9/:,!:^]>,)-]U5#I6!C?:E5M0>UMFQX?]<3
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M\VW[L\._6)5!]J;'_EX,H>:KJBQO;M)WHO""8].P;Q7':71B#%BO(.&OK8>
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M4 0^WX$@$\&B75-,\F+=V?MZ%7+EXAMYP5@ MC_K*ZP'@/A161C:)O*7QX]
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MG@QL7E%01>2D=M>U8<]4)J/&%!(LVBW-NIC'__E]8G"D:V^5,1-2N[Z5/GX
ML#\ *O=_>LF$T[9E.^.?& 8=UJKA_S&R:#49.-0VCL7]_OP;UJIUEKHMNJAO
MP@-D.%E[-54!!>D8O^>"G(FY+(001#LWES 3.IL>]<A0[(A?!1T*\E#I5,T@
MU+4*6N&(_&$N!V[BC=K,G[(<' Q<\J9AUCUC&/G?W6,)1C6+8W!L5"\O[NAP
M<Z'#%_)P2<\R.?C\G$=JEX@XM\B9)V4JR#YVC>98V7#^"K^? :;:OLY$M6*+
M:IBHY2,9@^\%/G%F57-,.>FG^9R3ZK<9U(%;H(M.E'%=@]U0\\BDZV7Q!G7I
M[#FJEZ!C&0B D3*+B[W%!;7K LZ!U&OC\1X?E8!FS\]@CWO(OP!*W;/=%6_[
M66I3GP@V9\A636/[>#DYFE@>Y*"!-,^KES,5"3_\RWZ7#3GB_INJ4<4/'$CI
MDF<.\=D478JN1]+ V_'1D4>&=2<,P4WYM#-U61ARI9W4^AD"9'H'_]3X:+@Z
M!RHLM ?N?OQ]VF,E\P718R< NAKL8#R_?0!T_XN4*-C_Q\#3W\/P=?1MB?JJ
MF8J/=,F6T!7J\UD@S&=AVY%Z.RG##<Y'8Y?V(>M9S30OM\6,/2\OG)95X!M6
M2U35Z9/=>*>5GZ5-V3UQ> ^ +BYGQZ:1;XFMS9QS$4\R&JE)O[<=BVU@&3P:
MP\5=$':+A(5'".^+;$WC9Q>ZVQRXNY-IP(41/QCRXK/)U.8#@ 76 SK5EZ1Y
M )A6MI]CEXGKW^6<&$;-=K]_ &@BWM#D1WYJNX@VU@[M*L&,;3BTJP]OWRSU
M>'O?"(+M$"B%P#;ST-OW3?,/@)TT[7G8PDH:I\FC69$IB5K-ID*/Z36V/4>K
M%]:*QW0)+>PE!$!K5Q5JL.+Q,%EB52I6NMI>Q/7<,P7I&A'51H_07_Y=B!;@
MHK#DP!1EJ>!*0KM6[ HG@H$\LWE@:"G#U[_P_,E2U;5L+H3*L*67 2P<H7)+
M5.X1VO>;89DYPD&P]N"R[^5K<A+0#Z:S@@FV&2ZO>1B(N:YRL+WIZ)[^L(5_
M70:M J]T6$><PE\T)Z*606_=LXH=0=1TBG\#!G=--7OAF@:1-]TI!EF,WOO.
MI=W,UHTQ9%NRU.6BK G[C:$XN,"C6XD\A;4' /'N]0?)@GP"QK\63I@IMQJ:
M&Z;M/;!_>&B^^^Y'HNV0: QGLEY7[E]0W,W+L-LL>C3YLG0+HU*:<T>L2A:'
M-Q4*%GZGD@V^8.4LXWTT,)<4/YAZB$":C<'HLLXK(%OP:3G_,GS3_55Y/^9O
M_"$,Q[=C[)DGQ)I_1TRZEE\T*$%$/K0Z>PPUMQ0D"@2^$U]]/GB0-HH.6V_%
M-3_V[0O)W3,0KRLI):]'U-7^L(+T!BRZ)=6^PMK<*" PA$F8'#X  A\ A?I-
MGK ?DQ[I?2GWU#./INSO5H-XL#-U,"[O:+I;;H483W.%(O\8 Q_:76?65<+S
MSZP@SD2FY0(AY/%E$7$M;H[M']*V+@;<;C\<<W]=0XGRB4GG"M)47,:F7MSV
MK&S&B9[T1_JH%Z"GNJ_]8G+4/>GCN$)N7!QYUDCI*U1$"9K=?^,H4U\42WJ7
MFW;^]) WF*T=%+P)OVBP3!L5P^YFQ_JNI?4I8J,(#CH9N:A(VLC&MA,//EDP
M5A*:_FJJNJ!-D]MU:-$QULH1"^5&Z!U#1C)_4[E5>P1B)'8S)] ]N2;MW/3[
MIF1S?9^77/%(NVO^+^B0\MU4TD5PV]/6*1=C2^7>&W,%+D4C_T)EY#<:R8P,
M0[5U&3(3M-OL$@JU?GJXITT$S_R%HY)-TS$( #QAS0*4:T;)RQ BXO)!UT)<
M!.N%&94E:!/]EFDA'@G5ND0C!ZC+KD\C)#H2H^TO/:\B_KE@/4C"CXK ]106
M=H&F0X%B+EZ4 7>77QVW7!.FCEK4?%OJ=R:OP'&CU&SJP?3W6F]6/54C(?$0
MV#>=_.[S8>8B_;M#HK>)"J+A4%ZY)2[^M71;AG7:1<UD^EQ6$9'SQHC!OEYC
MW7%_<(5K,U@LFLH09A^[A!GMH+=R-;#)F#'#%W9=#JR,;@'[O4B;HX&\CU]D
M[X](>4ECY+(:-#!P2"2WRD1FDT4SR><C4V%7E^968.'KM%7P=Y@T7C)D!NDF
M@D'M4MS"Y<04(=0>7FT;DB(Q\=1D2*_8IT-/=&#S^8!4OV"E)0JY!$M\?61=
M6.+'=T\_ PVG'=F]^1*T6G:@JV# O.);^NI#)#&! IW/J*CH;MI\=M_U>W-"
M$'G?EZS>&9^&C0\#AR8V<="K>I^&B\K7QQ6I:U-K-V!?W77#"$$>Q1F?J$QQ
M,R>>8.(6BO>?KGSYL_C-? ^CUO9) NO'C<S-][Q,^0?=B29_$XXP?UWK#L$,
MHQF58*Q=2H3Q[=<MX-LA+QX N-,.)2=,?>+O.GF0W1$OZQLR/X:J"(6'&L>2
M"Y/_'6/0>-L'A@%/.H\/1F/ );9??<MT A5/(?EGQE^T&B(\Z 9YHH]%QS0R
M8A/ X K3W7&/L'5$:#/]UWY)H&O[_,\5SE-,BL^C3SK[&;CR3UYRW>H?&_S!
MM7?OL:XZG<VL,X?ED7F)_+E73*Z,A$)JB>0-3Z3#4?24Y:HL9FS=0YEQ@QV?
M-3 V,V;?^KR;M==<N,C&6ME%/>F#HO9>LT;3/_8([0*QGIOKY;=&4[P(S;"K
M!"#KX8D:17=!8T]Y^%JZ]8TLAE)#Q8O:2@R[-#EP=E06<\KLNDS6\@8HSOGU
M'IR.%X;!:5!Y2&?"F+W.1+ZPHP7$@UM/0Z'I5IF9%02_G1*_*C^1W:Q:-3"/
MV3!3-#-?43T1"2T:=S@2\8U.SV^,_)S'YEZT9&^Y&BM;8;+.G@ %PSTT+H\,
M9FJ7R);QN;.U?V4/)>)\;":HFPJ!-' P):ODVS 2I_8T?:CR49YQ'9[C.(-#
M.&;SFG36-/RT&NFM)S,,VD7N_/*;%S;C#"O(-OJ;6@_^='D8=E&)+Q74CA B
M0T\E;(8KETF/!GWHHT\&*K84>.A>B;(^(RGP+.H>>[Z317=<C?8VF_Y[WJK[
M(<6H*/34*KC-[+OX(8LC<U""BL/PCJNX852JR7@EG\L![Z'ZNU%YPFO+D)<_
MV*B'$GOXY#.VL?ST>WW89EQO0IIC-[K**))'?[H*]15=[LQ%N&?']^%L=3YQ
MSIJ'MP-4A:!DZ)H>@TA8=>7AI]C9#\_83Y/ RF^GG_=YKQ>@M1\ +S-7[D*@
M,N=@79.503_8%-L!5&;J6DEA/<;51VBM[,!J]6QV!O/[U<&B *XIO6OY 5.O
M>%9C61^/CXBXC0"+P%[-8BZ4I7#.[T1W/E;*KKX7](^=]NK.^P'PMZOI.PO3
M_(02([FGG"%#0WX=M/X?$;R]HGBCPL>S;&GIM^3;-8)6N[[E+Z'@,42O0\BW
MM9:<Q<&@A(4$,\J =2Y-4IL@W1H5?^Q$-4\J^RKE(B(ZXM\D%!N,Y!,N:NK"
MZGQFCP6#A,0N15>%_%)F@0O\[%\$$6WU:3F>&-:%$#*"^Y;TN-)D1I*I5!/^
M_.THE->*"O?WY]*C1CV<IP+]E?))BAF5?ZY]FAX P%AD<BKL[+X]WZP%'5:Y
M&WX=F[?*\V[A71P1VX;YNRG%]F6;)P.8[5)B\ < *;KFAI9'FD=&/5U_6NAE
MU^@L#24_^\RBFH1C6;3SF'GR9AM?G&+#L>_!.#J]?-\K(R4_BD[B_+1 =' %
M"WR:0\.3\9%8W>L+ C>4UT<HKRC\@LM7+(756RVUE;*Z;PWG S3>.6A4RK-P
M-IN?P_WT<8N.0B\.O'4;4E9,CS/[(O>:9^[G&7H<!'!$.!3W^R1<RZ/B&/>N
MZE/QUT!XIOMN*5.";\WI!@[R>-L]E-K9CK^^[7]9Y@'J>:ZR/N@C9;MNU*)6
M))2NP4=E,6C7$8)WJG0J_3=1%#<2?GS6<\T1>LO=QHATE9#BTYMB2WF]UO+C
M$U_J%^+F\$4\YDWM>Q \J.@"M6VQ-D8.1"=I-C2$XA]4\%C:.,!YJ>SCE65"
MFKT#186&;%?(+BJ?[1ROH*&=5%[QFZ94K;'+HG/6G-$; J3]+YQ&U%=M%>&5
MZ.[_A.9VI(3Q&]GTH;C_ YH5/JP*FJ&TPN,X!N^<]K>$*/<WV^E")D$B_^C,
M*4]XVB-=@GRQ6R['Z"NQ+J?\&6F>K7W;N#TSO<S;J"0SDKRRZ*"-VKE<2S,I
M; FQ>MHXC/=5A7H;;FTC'C*;L-8>+AX2C $N@YA?&N5U2GQ_F="Q;XHX;S*
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MYFV%3>*6VFB_6A[Z2/>$Z=+EFB.DJ''*@4)]Y+S>EMRQ"A#O'S,)$</RQU&
MH#5[P.N^U,M"]?.\G[/4O-,MV,\(BWLHE@*R^D6/]-L82XNZ*XE# "1_T1JX
M34__2*J5#JZ2/-MW?_;:$@F1W!>]#O)IB+-A+*<A85H2*D=R+QIFML+@>"&+
MNO?P.SLW/_H3IEM6G3TX466JM;7';(*&Y5B6%M%?'!R ?6R1:.D]YTFT.47+
M9$Y*GW=>\<!Q7]UMVW&C/D&L.SVQ,F;)>H6'[GL0,=I$<S+(P>,E(WCC:,#3
M[=8HR;2H!Z*SH'BB&7A!T+'R)?34F:LTY72Z1\XBMEN,XQ<%#QMKY:90*70F
M)>?DLLRZ9*%S'8:W9%/G[EQ.B<P&QZZ)U+E%8/C^/I8X!8-ZEKEI"2^;?%/2
MG4KWK@+2EH>6DE7T]T9'NOCDDO9-LWN8GN_XL8[#6Z1^[KEY9145+\O^ZK<6
M&-+BCOQ[4)N9@RUEMU7O"UW+CKSTFJU\V5EHOONEEW=S7;306.3@RSU#=^/Y
M3S!XMW(7-B:[,*8YNY)2&!NWX3TO% 5AZ5FF;QB'0D5\XQ%=IO+\F&SO(SKL
MG0,YU6%]M#$IU=<B8;<BTHW%\F3JCKE[$C;KBJR\9M=)M<?8GSSR3*<DC==E
M"&S-F=KJIAT@%X)M628J6&50PH^'W$..;^/YLYR!;=Q!79KE;+U'$6OC0@/K
M3^M)[?@7?EN,REI:A)ENA^*VO7;1G!:OM>DL6]HS?SY=(=1./%+4HC508ZPI
M(#Z$81GB,L#I2=._9@H+E]0LL<TF:GDK$^I"\[F^^89:/_9$_Z/.D '#;W>R
M%7<W_D 5. -!CXC72HB/_G_6BT 5+-I\TF"U GX'29)41PZL2HJ$4M6Z%<Q;
M#M?77-C-MC6JZ('WA#\X4&65HS+A+@^ CG86;Y/9(VLT% [R:.[<MX^/2]>
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MN@]C^Q=EXO, >*<.ZDNK!HMX@4)ON:3KI2(4FIT]&<J=:GA7<]K4Z$D76EV
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M\?T(:OJPUBW_D^(EOYCP5@:9U+,LZV1;!+P87-OP?<)ZYEN&S;>WS^0Y/0N
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M/ZD&>1&^Q;(BET.F%R$HZ8A=9YWDFHCFA5]'*\D;%$J7[.+"648$Z'D2[5M
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MF%.29@&KTY!VEU3WOK##:ZJ7*[K=KK/ 9WI)VNQ7&[,;D92<EKBQKKWZQ[<
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MC.U#_+B/'FQLE;> 8';.ZH3]JUWCBYA5[8->?U[;E<8@U.E9M^T$>?10NPO
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M6;CM&295>Z]^9<=0O=VT4T23B.C3HY)WS,L5IDZ?^6-2L3T.R\(3&N]W <0
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M8.-%<!,/[Y)X<RY!U1P?8&02,@,H9WRI*;F:NZNY2#+AU+@3PHTP&R]]]JW
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MYITU:]8SL_YGUN_3=:TK.<YS[V/O?:T\S#^L 9Y_D%>2!Z"AH0%,'S^ AT7
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M6"L#BX$'D7#H":-*:8SHL4KKU-&*4 +VT7NK,:U>!(3Z]TY\!\/99!3P[ST
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M"WA*="=DRV+;'3G2?_]JFFG6)&@KV:LRK7,?>UI W.S O</0!$L>SC'[#*!
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MTN(!&W.4]#]+Q1FK+!'TI'"C>G)>&RE;Z:7'JBI=(2$-U]F'CJ_NPHW+-Q\
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M*&J<=J7E/MT*P+2-$MYTQE+5)=8_UT ?,T6BVKKN^'JH#HM2"J/ZDI5<3S
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M;"I';SO*J\;8)/]Z^M![XHE\9&Q(^9+NXO)^@GZ/T*(]DTX204<M$U$2SEL
MQ9X1ZO/&()R5"^J< :]+!]%.)^Z3Q;/D/EG/LE0GD)<_51OJP,J:8=:Y<)F'
MG.LX*GT=:K%_(6W.L4\MW-?B-9JR/B)F?%FX@34#V6BIJTN8[K,5#8ORD>7=
M4L-8,[4J4M&YC(1Q(-[@>;JH(#?UZS(8T];V<!V3JS^8XY"\\-<@9S[L.RW=
M;7X K#T XAWD;]O6P*E[5/8UA;8\S6G&Q59^5+05LS45N6JY[*KLRG<?^CY
MA41C#ELRZX5YESY4Y]SJ!AIK%5G?,]'Q3[CAO@DC6Z$(I=1[\[5V&K1@&1CX
M5)\?-X/FN:,::16H8.^>Z[(8P50)[_$CBR-M)G.'L=,QOV"]\ L+4MJ0G#[T
M>_P9A)=.)CY7_FQ^9J6Z^\F=.VHML":8! LLR4+S,DA.)ZI;GQF>"*RVI?)-
M&>HRX!JD5)AQR;I/&K@\'9WKD@0TU8U#<B;S6AI#*?5'!:(9^_=CV_$ [B=I
MU66^@DCO2QL$G):@<R(O,-K#J;.<WR[_Y6W'F06=2UKRI*H1^97ABR;U_0?
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M0.?I/=.07&6() ]&KH5CM!#WL[6LV@= >!8A\B)D+;\$2"61%(.*&6GJ<''
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M1_!!=(&9[D_OL35.Z[4&A-'9IK]+46T67%JN=:QO5QOA= ""K1N?E_RD\7L
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M<(FX$KCP0)*E.4P%^>2R7'-J!K23MC$8BSW&5>/;0!VJM.9!,WGHL-_#M?P
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M0%'4M/9=:\MU*57Z$N69^MCO7ZC6_*@3PE%7#I)I;]^9+$\ZG%/K*;PTS+*
M[E6MI=_:>9N$%DPG=@G.^3,TRC<GB5]%:+W_)O02$[ NTZNJ1FLSFHZ@)=?S
M4'FC.W6<*GD*7RHH]&]2ZK&\W.F"T;$@3_7@=YDKU.%'DF/.BJ%K+\>2+W>
MM]XXG<@KY&%VA-VA@S@Q5BAJ5ON&K\^!/$D(RS%6]](\.N,M%FW)<MO!]6W7
MYY@8-OW6X#[1XE"44O/:!-=%-H]T0:?J;/0:X /,OYY)8&8."Z'QY1*V5AP7
MFD ]O[KL_OK^2].@Y"!X-MH! 7[375[*,IQF!-?[:-9H;?CNU:=%>BPLC.=>
M?>JZQO@G3+9T@.K9X\TGEC!S]^ZGW?&;D@KVG^?4C'E*5%A3BR^;.ARK]:I0
MGGFUM-TZGIP*)10IIX7ES=K'#FWWA&L2_ Z6;85M:_YL2LBN'OW99C<*@2N2
MI?K8^Q'9IXNVK\3( _B"L =VEF9;DRILJ+*[_9P'N DO5%-!>/*T4:'UO@UB
MU4TA[;U.(U:VOSK6XZ@N=3[';=8FLTUL'P04>G2#,66EJ/+7RYO2WX3Z,YX8
MLJMLY_SU_N$%R, +?P#@E]4N*HEP)8 WV_#?)SJDE-O>KF[D+H]56<\V1@+G
MJ*#?A";]AH#<ZA8.>8F)^J1KC8+QI<N7VLLF:W?))7..S^@UTW7JSBHI>S^F
M1R9K*(WR]7BW!7*ARM4P]I)7&!145"F&G<.2+.PP7SH/*K+9BXP(41O?/?6!
M]V[.S2;//3<8<\/07'KQ2_[T*5"1\J7,YII+C^".>O7OK!7<\B%/U@;0=P7.
M,@B']RNV;<G.!JD()VAKF'F50M/PA,-Z,PMX)^OP-V%1KU22BS]O;7IWVD5U
MF=Y7>63/#PV]PP= =D+GU[Y;-"+PFA;[LK]_&CA5^_!.;![%$76@+!3(;9\;
M6)PX&&+Y_77\]:$A2ISNZ5=@HG%;N$#)S@QG)2C?NCE*UVD;'I3*^-'EC$[>
M1X<7AKR$(<C#+.M %^Y4YC96]:MO%^@1F&?:OAP/ !;J/A/4[-@#X/T4$'(C
MU:5VQGIMY.4O]-@+?M';AR?ZXLZZ84YSQYP#?34VAU>^'"9UKM?$!P#H?E8I
M3"X73')FSM?48NO]W$RL=;8=X@1OKD!7_[YY )R[)NWK*]P&VDD=K$C=86CZ
M^9M<*VZ=@-=,KM6=ZWNGMX(1,R/-?\?HLNE":R@V?X0G-2-PUS+08_F,,KVR
M(.LWA,]]0;I08;+M67Q\2\%3%YJ8G;?4*?EH"8Z>H^PZW:W@[U(AMVW\'O#_
MV"<+VJ8K7,LU74I6%A<6@X.YNLNI"'O"23M,K!]3^_ZUIX;1B\Y%5?*)_VJ/
MDUJZ7=Q:CKR$W@8@#K43JQY"(GSO2>K=VO##M9JZ!NF3G'BAFD,1C,1>Q4/5
M.>B_WR X+H+?]-U3'-NYX7*ISMC;O>$Z.EPL^/7A]\M;F1[1R>NI3S!R,IU/
MANU*ZLR\6(;!0;S":T$<8YM3G.)L)P8R4;)UD8.KNK#ZV-/)97?Y%?U0)4$"
M-(SX+-$9DNE"9%;F1@LKF9FXD*1_5G%&>NXIV@, I*RQY[;SM]AAYHG^PI7?
MZ&,G[6T9FV]>VCZE:VRPW%WY:0"CG#&45EYF7^(UJ.K/,6."LD$]6RR;]:9U
M 1Y1RO%KIES:/ILSB6<YEU;<#?F*3K9T/](*,!X U'E>+N9+OW.OH18'R8W)
M<<BY3BIF;2ZP8+DGQ,]V)UQR>I1*.[K?_\@@>!_S-71QZ,3A-GN-X^_9#00\
MX\\&T;5ME"QUXJ?R+S?WXA=7IFWI5!Q8W 8DB'J4OUW5-UPR-.APPZLQ^*6W
MH83._SXZH-WY&<V9L8!+GF>R 400Q+2NDAUVS&6?_]U$;]^](^B)4#E[R K.
MYG.ERDD4>)WNLMC2/X<K.YQ!T"7[VC.<+/J>HP&,)JL#0XV_:4/=>8B1M]3&
MGG*(<.<JEWZN=:P-$ N<#MF7[A_1;IFK]1/<YS"XT^^=19B'YV5M$:WN/AO8
M%]5ARA.S67ES(A19YQ#9R5<X[S&6<O9!808IM2;0[FF\JC,C+D:7[X3,ZNOF
MLZ$N2OG<.'UX.S!$W$]0^)T@X E/I,D6N,VAW>&Q@&:=.+DY .WGR/EZ\+!Y
M)Q77/_LI(7)$6],:T_;"U&NI@KE14+XW:3K3K"YQG<UUIT,&4Y*  T'OY7*X
M8>=O[)<^(9GY8<.8 BL%P0%.ESI^Z\?/K!OY/QEUF-E?QW\< C.;5;)\I>?A
M)6K*_HC(A#U:Q!-$T^^K>[Q==I&=T-D5Y:@(#0ISC6/F:%)U!>8$SR<%%82/
M#7Q_,(+^!DOM 9 W\CXST;)3?%*Y(9^UIK#'"V3%6O@U18?IK>Q4B9="6:7S
M:@AKX6,CSIMODU:8%-G025W^+9SG8DG>-ATI].W<1XIPCZH@6?"O:&WRQ/#?
ML^XJP6V9B?[!  ( !4 G:T^E_$ _"U8V@IP<ZR%DS>7G\/ JD6[5EU_4%HB5
M=E\C[!,I3ZC-\ %G1B..2;D? %LNBYO-=:$CE9M9+'6?5RRY!4-08Q^U"4.:
M'?(\*T>?<:)PWT '*QX 7PQ^>,7+,+$H,$7397QM:,.X!']2(SR >X0W"^''
MIG!UI U]S/(\VHCXL%G"Q(36*]W>ZUEZ3V+=*) =P _2E^#MI=Z&LAKTP.22
M0E6=URS.48?R*1[P(13M!0J<.V_B&2PW>60.FQ;PP57:>@#HD/8,RH^=8P1Y
M1UJ%?VU0PS<9,2O1GU_"=;=VX%8\S1->_YD1[7-F;"71$Q>^LJ.)? !T6KLM
M^L"<KT/.OQND-CF\8]4-'A-W)4G[F#!P(VBCS/Z#!V[\OCIE=:NL?XW;9PW/
M"E[\I^[:X(S+5Q&E6_4R=&6 ^QC4?!."$TWS*O-B\P_E3H JEDWD7#<5U]UY
MLJ!W2TC/DM<JAM"K4V[1+9G^2MQ>N*MW2U4 )ZL7&655OIXXC%W/-W1PTR6(
ME["ZX#)D78IPUY\&.N,:0]6GUO:[#6IM]3AZ.*5J*;)(+V&S5=K _T*/'7K>
M3 ](>6R!.]K&SZ]M&]]'G_+FO1KX*@S0+ \\F>8YH.-"%H>]^0W7^E,SYD+F
M6//S.R^3=W3&1BN[!Y#Q6G"T266N%F26Z=JBWWF5?X.8W6+A0,%5V8=6]'L\
M\ M2WA8.#XZ0<#$0K/N?:#UFX:CHU^8-!'WHN1J>IY.X7.Y>LK=Q<;%A)W+
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M9#67#\@V%QB;,5;8"1.PQ0AI?6O[]X*!FB&V+R3?^Q^D!A@Y0BQ[@]C/6A+
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M5*1SM1R YF?MJ[< '9B]JPSSL.<"*[(:!O;L]A'I>]Q38L%)]KWSX;=>2/J
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MTTCCV)?47=TK'.P3C)\-S?96/0_4G:I;S%Q5[9P</SW%V$=[SY2.5YWX(:3
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MGI[N6J4WRFFO'Z:9-%D1*((J"A(7+#?<=D)V0$R&-<NH/0Y+&(8U8H]ZG5T
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M]#$=Y<V4#\O3P_,S7//KZ\K^FY%)CM:^C)8_LW3@[9<Y\_Z7AO,RBT;S[?U
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M<.V=P\GC8&%6)NS3 5%FB:ZSYIL?E+4S\[< !X&Z+G(I(MY?%]&C!ML/7;#
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MI HV.N_T$RML/DA>M/UMZ*MX<FC+M/>_#A\!V3W?+^.SK?F3>QORH0%]'H^
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MP+\BY&7&+P3+<^+;/(ZQMM@> 2SA@>QIV%)&B\'A=]Q%"Z#Y6? -9*JG[Z;
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M!!XZVFT]JNB+-FUST:C(\3(E" 4>O=D. [WI_NQD=4M [FAG&$M09>EN,F:
MB<W,O[GY]QVQ.KVJ&4>J%5MQ;OA#Y[I"JV- E$E/G*CPNTI\>/]S;A*K972*
M-X;/Y.FCN0WR=2LI5\;#'P$G7/R/ )N7!_87GK5'H]PSX9:\!^TMLAK-4P>V
MG >V=I9SSMX'"0.5D9?:"W*2[2N6*=I&\CV4[V(<';$R"[IL+I'LPZUV6FRV
M/5)CTK$X[=N(Z /PN'XC05L>].^G*,T)#N61E/#!JN^V270KR'9@Z]00-'TM
M/?B.?>TO^]N;!V*-LIG(5QM6XFKJ#K[1>NG2[5>9.P<]$SM'.^5")^\:\HRA
M >T&"[HQ$?R*9=_(B+[QS6T(#+M_B>JMX[4/%2<\P2IR&?E@Z.\Y'*\WV&A/
M+^%2@=8(_#E9MUR^0M@PI:[%%V'_^1\;Y:U.:]#HG I>;"V/%[:35S!?^FH;
M)<JY9^C]/YA>&8*SU4^?1KYL&K"^3/Y_]CV0C-FD"2-[0^SE<HL[;*=5*H?+
MJ!R^&;4S]X(VMS='5%>7R:S$V6J_GXNIL':'KW;ZEZ4ZQG\AM\0NV HL:S]?
M0&2%;<#L0Y?PQOE4#Q:E3>HB#_BG972CW^P&66"\OXF1!Z%-C^L?E^Z.[^D(
M.QM^W;MA2ECDYUX*0S-+^6+FL"=OX)9=/+O+_JVN^EKN=!62<4U1U]\>W8P>
M&1S7 S#.JN8C?&DMK/VO%LZ951L]WS)V[%1$_Q&=VRX ,_C'F?XE4 0Y79C+
M7VA9&&J;L&L[O/39]_NPI/;F]P&+[7PQ*X,#*AH:DH \U&178V^+8Y8U(D?7
M(+"1+$$P/DGK&=KU29T0G9E0D4=?=SJVE7#&I"N[!X)J9-Z J^26D%I([:/K
MPUOFPRUL;5FUYNGS>7R*BU^_:B@],J(7WAFYI7R):.C?<"G!;0L3?UXYU59U
M]$/:)E$?(8G7GS^>@E\$/;+:_[+K7);5P$D#/59&?ON96+70;L?$PI[U%32,
M&;0%<)+$%O4QF$#._*J1($.,.&>:>)61FPS%-.='X8>O$V2<9X)]Z#STYK/J
MQVAMDB-*&@GB3'WND_G R]5#/TB49#*53-T=*"I]E47DD>S3H872[H3AS8KN
ME+46=7"[A%4&8$H!ZPP,UTAJQXU7-QUL0B;*EX$:NJ6\U0@2L2I=6/A4J?A>
M\0I0>>>['K%QLCO1&"'?XT$:D]558D.90CK].@.:FTC7_^*(2I<JM$\0G=>E
M37+?+F^$Q&^UC0IJW[-D]>]"KVR)PUBL)#)[!@QP/ [7,OA?HI+5_X"%V+#^
M)U@(<U$ET8<MA1;T?">B%A\.DGZ8B,:YDU4[P>ZF?0$U.&'G2_U&!4[H./6O
M"4?;T:,3D9\A%N/] INBX2/I@.I<SJBC_J[]&F(-.6+/JZJTV@P-8,53['];
M<S'V5"_(I<Q+?%U#?ZH,A_&WHB7!42T5-"WRAIJ'6S2C16%C#PN3!#]O$,8]
M[Y*C:[;6Z%O<F!EBZH1Z"3^-/@G(_2XFHYIQ,ITPY4\'6$%+?)8,) L"+W&,
MA:XK/_W7_[=C56;93?ORQ_M5<'?-M.L?2!D(>_#%!!=VYA??0UI#'?E >X@K
M;6@K<W-5?>0: LQ*&JGWAZ>B.\6?V>!!PE>,X/+_]69U=<?2<SA?.8ZUP=S)
M\J^O;0UU^A6(X*07E8\ T]\;GJ_E'<3LPM9$:=>Q$SNJEJ&Q6]Q\$6>[9XL,
MEK9E53A3[8;K#)$I7IBV<ZBQKL;@D$WD?4(A26\^T8<!O$_#Q.@!B>AV4H<I
MD[6U)M.)=X%>G/?V]L-+60W*ED^DWBQ1Z&-IXW'8+/ =,5[4_)<PFQB#TQA5
MZAGU:F<:07BYT1A?,7$93";5\?%Y>P?-][6\&Y.,FUEX5K/F:NYV@*C1&N94
M.4=^TTEHFN?/,Z#C1C?U3VUJ^9KWU,[PF8Q]6J(?-!E[ <IPV+Z5O0#$JK/Z
M0-1A4^KY#"JD"%;J->OJ+:\MJY&N.UGJDEVDZF5/XRO%A#"0VCP4(SA*F28(
M/&'M>&" RZ7G@AW&W*!ZR0+A;1AW37"[%6!2[G_]RKJR3@]O4+]6.7&-<<7,
M#(*6-L+_Q -UU!_^2;H]".;,7*1^T$;B'^5;K+VKJH">\BEQF7.;^C)@;IQU
MH"<+3!$@9O>LBG234R-C<O\>RMVP>NK![>I3_0EMMQO.2Y31UP1^-JM[V)Y'
MV%$<><KTGWSP::3&7PZRVC=754J5)4DJ1 4KC)>]"=!H"YO:BE14&XK.U<0,
MM0N@H%&VL/)YU4R_IJSXI+-!_IX5"J^(H4/K0O/U^(N$G__!9NV51[.>:+A9
M*0OUM=]HWR"<WR$ED(<VJ7\C4#VV;Q9=^T[H/Z%2^Y[AWX6"O6A;JR^/\.T3
M^!+^4/L/NP])>J"<#W++U#ZS*A+W+^,1X^-<>YUA9X0H!9@J2J6WZ;*P;952
M8'DV3>41L'C<=W/@<=WVSHMUPN[H\("=L;$I39!]3>-4B1Y3&[V0X3P[][_'
M5"S/"&H?VLI^PG6?/0(H6X%]]')+;S0&%40@3*:HEW\DU(V44'$*8:S/WS6_
MS+V#,#8D40BPY%TR.5 Y--_-9N>V3V55G'.2[P 9(R^-Z#4BMUC?S3LRRVE)
M#]P. ^@!ISRLXGUK]@%\[%;6I-YTL 1D:E$&E[QXV ;$;$Q2F<86:*DOJPUW
M%:$!]BHMRAU1@?0>[JH%M8$IR3W(XZAF]K6A4/9SY:]4A>L4_U$],/.)Z>LS
MP160P@EU/8_R\!\2F0/NP/PB:9O+&(;JY^AXK$?SD>)?W>IPX_H^Y5N<4'7<
M!$6)E]J7(ZA8G3#*WW#_9A+$U,/:QJ9V1O@*A[&B=WGS([=__6R;-<C1A1#>
M=,_V[XFYU6,#43U ^I.ZH#L&^H>%J<R:[U@Z/!0+449AN&;+Y)F[]>QN CM%
ME.*PO/T;%X^@>$^2Q>+SV \QZ1^% PZ^E^!+KP7[GS?IV7'R[= K_L)0IP[?
M!I,P9!5^X<DQ#W>4'I][DHUE696JOUS05GM/ %.0OY_4XYS*XT<=H\J@?8;3
MV'ZMS%;&/'IL:\WJ):+V; F_,'S?!MRO\:=Q_QN'V))-;#O_;^A$_/_\?4Z0
M#2*+'R4AKKQYX47/[,K23D*/ 3Q//<S@_#!\<#%&B<K^+%P>5&."KV>MZ_F'
MOY0A@K'328"GF^M#0 =3J;G5\,@MW][?<$O2F>PKF0/T89^F]-7SR[(\VD!*
M1M@0CBN[FQCWG\J)UVH6U4(;$0$IK^<%2T/N2'*E5O;;<#].]N0;AOX^8*'
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MOCKOH<U?SRBNF>#LIKV/7%BB^NM9K&& .!TU(T82<7VJ>)!_6W4@3KE+ZIY
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MZO#,S]<QU$MW2!M/9]GA<715S9&G$LQ^B9]7J /Z1,_%SYGL3)A\^NZ";FY
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M&[$P;S@B9,V""NXA*G.)(LI+!&418=+=RWVXIZ34W#_3F5I_YT@0JR+5?4N
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MO!IXEA&GG\;PL%LQBWE.N4M;A+LURJJ'[QO/-3>,]DTU'&2LP*E6J_  1?U
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MA4P--8%BE-^F)BFM "CR\[ZLSE_OO7-7.9<T[#J:G$G8AA$7V]0:1GUW?V4
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ML@-HM Q^B1Q_&T\_5XO71Y4^".?*GA^#ARX0IXMBZ;LEV(GGI[4#>[C4P;H
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M$-HV8T-;F;B)=NJS:/;R&3WZ>@A]JX-$8X^HS/:K(P/^*:<&+%(=%3A3>Z/
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MF[G.\AD\+!^U2JP4>@0L)Q@U8!H+OUV+?7;@K4GG[A]0<WU)"YGVHESP)H^
MQ5& PR8'791<2PU-ZPT.9TQ&B(?L <M,3+43+BYKBWD']'2UB,[L&V^?M2B3
MO_-<7/2:E-TTVG4L;]&*=!?N>;=K*/KQ"VP</*:R*IQIONC_$-V1>Y6*[C;N
M[/UZHL1].X?N0-?PGY5"L6^)FVKMB:JG _DL@\9^.X4P23LGVS8W,[^NFC&/
M]M2,O]4.T@.JKTY_ 5<4?@@:R;G$E>H#QSGKX[_Y^T8''3V[&7=$1@VTVH0Y
MP#>NC%6<7917#59ZK;,]T%C8"/:^21Z5]!VO"P6$MW*D$/?=@"MA"BM]1,V:
MS<)YF*+C5ANJ9#F#HU1.ZY]IJNARZSQ%M-XF<>5>K>DQA!H7 %V\GR0:GU;K
M7M/H'7QN;DHBH!C4&GE8;V"7KI9_9,JNJCNU.L(66^3UJ@LM/<GP?",N]QBO
M<+UJ==,ORY$I;(.$?8(JS6.PXI+?MS";!]-[$!G"H06.ZVG4K:PJCS%YH_-9
MF 6[:B]1NBT:.])G%,<L+G[(DP4H<4<8N]2"QKG/RR8YC'DAD-C1&1!,OWBE
M?E[7M+U)?YC]:HY&%<2IKCP73$4^J0WE43P0JX^.5X"EFQ&"C]6FN+L:9D:U
MY]T!P0J0&3CNA7Q)@?#[@B-7 U/N[(V '_XX]8WN?LHT938)&O?3/;]YOFP$
M9KH?1^ZYC?/W-_E+G;M79\'DID[3D9\<C#Y%;A?_R%UFM!$=Q. 1H?Q3]-27
MT*Y)!%Y- /?@(^ W,CMM^XSX<.--O4\4>3(]Z\5^4W/TD #!(BAOE]JC80='
M%=M!2!SR,T86[L"< %B)[4Y>3^3!YQWTJF3 1&II3%T_6'Z>E_B4/G]]))L(
M;U!QR>"'Q$<K?#@0T\GYL>+6&AX$)7%\V0K1:6_J'KED,H<QF#3? QN3<U2Y
M[X)5#Q^\R'V58'3\O8N&UAUW:Q+IT3N4]__@DL0+=RKV!O_BGS1LJ3R^:>6X
MLR<9D*@_$E8!8<OF9O43Z^]&OP4D!BAOA59*$SL)'B/5'&:55' 43MXD?)SH
M6R,AO'_GRUTA'.-KL/VW)75O^BHE?5L=L:XXR,1[PIQT65Q0E?T(*.[ZC8R
M@FH.#U$!(6)5[R!=2'WZ5T8!C8\ ((Z/EOL>#P^\SWZ)/]Y[7VKIS#@EZ1'
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MG,@HK>EK=0);[[ \C IT$CN/0:QYWS)=$Z0F4QVE\36='WLJ,F>'1O?<)EP
M-(ZF-W>2W^I5S9E79V.47W=?'KBE$KS,^(UWW"V'V,1JQDU('K=KM?$#XVY
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MG&XE')GCG,%V>!SVF=*-#L]!4]&3![*) ?94G/HZS0'Y2:*:\\;(8S3BY>E
M! M"[ Y[K!9IL)7%Q]X,%\#2,!F<_F2H1!=)GV?P,WGR+XN>A9SXL;,7J9,
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M0-6&+JJE=D"0LNRW"XK1[;=,T;*\Y]#:.STCN]"'HJ"-'K\-%6':T%O*W]B
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M>9NN5>:91I6PHL*1\1R_?-E4BUC^CB\%9&H5L3*?1$2LC9\E?MOME_;8]NJ
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MIU-M[<>\?9,H"?&HQ^:C_]!.3L$HD%4@@Y A?R>]<_\(&Z>_'X*'2F)._A2
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M 9GQWYKJ-DY93^?'UHC@.7T[VI3CBO@6>EW EF-F^5!G1RFZ[:\:(SSY*<W
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MFY5R<-VSEBB)FJ=,]]5[]=TVZR]7?)D(N^]1'W6],<H51*3)@Z!ZS39X'GC
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MYK[P\3*LB^!Y<J\#F'+!]![PK:8W/:ZVN"VR/6E>5>?F#W/,E]8OG>\%6FD
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M\#\4:"/V#JR7EZ<1[!LQ.URI+2V3N<'BKD&89.G58]$3<_0_($D,V0J=0_N
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M3$2LR2VX25@RQ0/:87K98X08BO*CY: -&5_^6UE2L'4@B-_W%3>Y2(J<:B9
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M=56G]8#*-\7\OUS?:)S/5X=#DX:.Z=B14>+?XM>ZMT/ZJ(,[CC2DS_LQNO'
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M-/,N-2;I=PRX4>V:XM]'>$QS")!MJU9^RLMF8-OY1/Q/IXF>N8B]HX2;PU&
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MK)^3/G 'X*?SO1CW#J,CV3G^3 I%7 [6T@]TZ;YAI!C6RF_RF46VTU7&"^Y
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MC11%5B\!*-LTL+95U;Y6IEHZY3+;6_^K")Y*#_NDE%MB#*)4>!L9$]*CRM#
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MTWVJ^_0YG].G^_3HGS9@EN_^7QGB'(ZJ!%>(=GV1$4LK'_&F'OFQPR\1TC<
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MQV=)XKREELVY_PMEJ \L*$K"O@$B@ZS$1E&4,$KA@:3]\W2$D4XJ./E9D ;
M6%Q39W*J7>XKJ(LQZ.VC:A#U\4)C;1K8LU#KGP8>T6]8 Y9AKL:.(BCKZ<0]
M=;1@A]N>T8Q>UH*-KCS1YMNT4%,;(;<V@Q$RA5:$! 2UMV2--H\[.,WQW-*8
M*0A\9?VIR#(YK8#5/)Y@MN[(=>>LLK-R6.4GD'MHNGYJ/TCTR'UN0AT>,S[Q
M:OIMRN;4[04NW+QOLU&W[!O9BA!Z;&=T-31O0":@,:(S_VCWD,,#F)_VD/UN
M2MD\('>+54&SV+N3!>NPW9HS7E^Q>[(GO]3WAKD]4RK:^*E7'1W4*%?/XXH[
M\DQ)U^XHXCP*K9!#CP/14K9V9]!IA=Z-G^QB97UW5]/V- /"?YD?*+/9]>@=
MU/,'HC>/42J803L:?#J:(RVXV9CX,0:\06XTZ0E8#3"EC<JEGSRS5C(PGMVW
MGRDFS+8EW&Z/TTFZ_R6!SN(NN1SOF4J$3RXC-@;G:SVZ5ZVQ]FKV,":K<F=&
M %Q$9*I)492KM+L2@5>Y =Q9SO)P/:]M^&M?EB#'YPX_/1<\4J=E)P)<%PZN
M(9?D>Q>$O$U/7Z19'KHKFO"0#?-59M+ER+KG+>A]Z)KJ0X@S$LJ;*Z[IIBTY
M2DN.-_OUYE=UX7?XG/ !3WL#')@,3R](T0O_H,KKG-#8@J8E'2UWZ[6>]*F,
M9[ \#HIJB>%+XWNY3L[CSLZQBE47C6IG%_E2T=18M6?.MOS]S3'3ID4Z;[1$
M"D\\U.8H=1C]CS<\8ZUKR^<B@,9J90*[<%S_YUK?KR_CRK8>;3WDO0(0C6E4
M4C);]J]1+%N-.UZ0&4UN=LPE\Q@SP[D*ST;< .+?!--)VCVT* &*"*2_BHBS
M5-!!A;PC#ITN=K?%,9C% CMFVF70"_%L2L^-I#;@O]>:S8.(6BBO?SR[N!8T
MZ.6BB>IEOJJ>\4,P@\L^YSJU*&2WAK'&.F=OY0.H[%_51ER67GR$VU8>R-5&
M==[%$NI71_4@%E/[9T"#5]1>/C[^%#\W?N<2V?N&3A-/90P@J1,JUPY)7$T&
M8V\G[$O>T:DL+'Q-HQ(5FKSH80Y#V>VQ.1YKHF"LP&VDX_>&VC=S'HL53'(/
MI4,,?62W4JTSN%@#$^^ZL#5DAK?M/!UC)XMCRAZJ:(LF 2LZ%XP'FBY)YX["
MAV-?9>XYUXYQU,8%R13B HVP->6%KF8!X-]S]G!7X?L6\,%':H)@XON)5@5K
M\V><FFA@9!IS)$-?>GJF1QM0&=2\&C<T;OX3?$G[02S.HTUJ!9?:NX)-*DGO
M<ONC\MOG#@0V>[BRD7I\QC(><'):07B$30&=(.V0N\QLMK5.+-9VUA_ZU7S,
M3'K+U\)-)@.Z1O$CTZ40!#Y!L%=>\U,^+O1U6>_J8T7AD@9ZM1!AR&J*7*0$
MJUC)4S6:?(:35QE<+$!BDUGWQKS;5M#,@8--W5K,G<($4%E:@J^DI^?S8Z+G
M4.*8/44EU"'=SD67*T+1P:/JMG$YQ;PZF&7"DYDW;Z!\EXOY*&VN6"B]ZVYI
MX[?D8^'(5&)Y@=U*?K)M+=[ 7U?65X3VCZV+VXHRRLE>J 4![P<L4TB54Y]X
MG0B[EUP:-!J"QO6**@5(G)=:TU05TCP2$.)O[=5&KRO!;:RM$N\ZG5:;GS[(
MN.IU V"DC=>\UE YC_/.!)'BAFL^>&JDNM'")_@>E:\"#?<N,KLBV\T]"D9#
M3&L?2B<O#O(\[K:OO;!F&:X,X< ^QP7VF2.'9]UK:T2KUV)0-<]$#K[F7+(
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M^H3-IYB+N,#+EV=KDNG[P50W *J!5CU$HJ*<R^ ?"8,%OJK Z+O^=4PN P$
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M,5$%A6P[I%C\(#7N!1RPUV7[5G223)Y-,$!!SQ ^M0QND_X> UBDY>([;=/
M\3ZFI"9Q?V(RKK/:U1L [5Z :4;TM+F8KD^9G;8'1[(];RC:Z#@N!?"N5O$H
M]ZQZ%2A^HH&5CB^UZUU?6K 6^FL:I><XOY.38:7\Y@BZA[NZ^TUMU]3SF]:!
M_LZP%C9F2#YKK<0O;T[08.L++KX9O'6-:\E^0U-Z@&EWV.,W$R/L&PKC -X\
MJ]-Y!\M":/9;3IUO9Z3M:SJQ@[;DWQ.??<-NU'25_-AORH@M$Z[7I).[I6[O
MJ1%0^]H0#ONP/) 777-F/GLJ>L<U(+LIU5:=%V'U@6+J4R& ,S^.](VF[%KF
M\$P#QAS5_7VVNEVW:A<) O;?/FNJEFU^P&N?-=D4]I5>=AL$Z<MD:O'W*H3&
M:C.5U[B.C/)5C0=]*4JB%5?Z/20'B!QT&VW^?@1+*/G>@&A@#R;6@K?J9GW\
MX[FDZVEX8,H.H&@9\)JX-[>'L-.] 23EK@@K@0F^TJ(0D51T9ZH37(+24K(R
MF@NPSO/4FRCFE-?QY% S#B)2[7,#N*,)\9(T6G2+E$N7><)K)S ^1UPV1$8V
ME7_DFU';B]83[%OFK(?/\-='6KONO\T;%A_8,!C:^J!J>Y;F\7K-CAZ:V"O?
M5%RTX.H;$+SC+Y2"<4ZZ%4<5MT89VDW1HB+32/='V>#,(</.X%>65;"?$:[D
MBBFOTN#U6Y&D5 ->9R_-: L&EG=EOD/L==W<.J.X<!3S=VQDJI.B+IH\1<EX
MB7+"MY;G"Q^QE_+BAM?Q26AH3TV'9"SJ2 ?LV',#H#^?G/NMUP&;(]<%#WC]
MVI+M5QG,?%10@X,,3>%3@R%>U#,"$F!SET7IJ4#G>VDIB6LW@%!8TG+U%0S3
MM0G$KOS+V3GJ4A!_',QF988W_5MS)O(>8DE_O7\J.ZXT]A:Z8C9CGZ?QJR$V
MV36XRN9SR&R#6*2D\<%(:=AO%M:S:COJ7?GE8OOCO5:*;<2#\ZI;1R(R(F1C
M:2P<6XEN16NBM"N[1SO(R$1)(S>DZ2!2^./E\?K0DZ'?ZZ1DK)A_Z]7#K,C?
M838]KS:CJW#$.AE]F7XQC6-&8*!C^_=99X9!(<O>=Y>JSXEX':9J<3]N ):I
M \KWZB9%EW^Y/5T22O W-2Q;..=B_3"^>,J_9^JC"V/';4XV")OTSB%),WAC
MST?S,+=;_(O(^!Q>$;N_)[6NJ[ZV5N_(&PQAFA&NOK#XK>Z=.MRAF=%Q[WZ/
MG-R@O0M0= 5;?ZW:9KO497H#()G"'D8M])Z?]%T-5%8H'OM'ZFFLC;V5W6X&
M//E#9,FET-%:WXS]UM222:0,)S'^]%5P\X'Y2)-\^-])^M&<^"GOZ Q%^X=V
MX0:P+?I\SNA,]=RN"!_+A,C0._(R_"XCP:X^69!F+\X9^K.&\O9.-D!"N]9V
M2>U(\(=9G<W/].E^J%.$XP/>)S'F[[<]%I2>U'XZ/:1WM94PN ?U>QEN3O\[
M5C"+N?6N7.^!F<9K>,NX6W%3!OK:;A!)]JDQ7G[NQ]2<X*>Q;)F'3N$!M%]6
M/O3E/LT/36B?Y*[?@%VWX7\5E\KDW0! A)=Z+T#(KGYJ7;7Z.7?O:\F=IA,#
M7N$O#)M);^[/OW):$XY#P03P!F ?%(QR6]HL<Z!<@=II3J:UM554LNP8/W(@
MEAP>YSW(6.O\U4[]2-1T=IG*8J)4E<3ST.[+[.*W <^G=[98B@;EU<_K7A>K
MOR;+QKK-P>FI=]L<-$>YM,;)W!LT]_&U%W5G,)6AK?9@#\].GK 5,X14#FVO
MWCN*Y1T8_Y4&GC'=L,K0P5V>>%S/%0G41*D0N07T=WVJ:5=W):%5:D>8?!V,
M0 7U$_L:>(VY0%,MCC2RO#@"^#\ZS&&6E/U5&M;@;Y4C@/Y<JP3&B'RH^/FA
M_I'*>7]\33)39RBL_MWZ"=/*^I-Q"T#QL"*&9?75W@CF&@:DF/XBLW$-^SPF
MVM/YH'T:<S::QP[2KM:[DS6L:5?'\W1(C721D770$,3SK*VC\3JW4:$A#5-;
ME'!VT=U/!=GL>J(ZU'-172V]AU:*J&*CRN6:WGHZ\ #X;A?PXAD+S>N%]FP?
MS@D/PQT"_1Q&F6+7ECV=6\$T1:%!?3E\3)0G[=U!]^(=Q5R)L5?5KIZ8XL[C
MU^?^\+T+YG^M:-U.)^MD0U8=N&SO91W[(!'R\9S2L2Q9I4-),$CM.=8&R7F:
MH8)-A\8:T@^,3-HM596QG+YE#S&66RO=,(1&]5KE$%(+@#L0$JNYN&%) 0]"
MC4$J:*#/FX2K:*H*![,\\BTJ^]Q82][[U>IA]L3UUPQ2#4SCJ_?*G859C4MM
M7<UIV,')X"WFU97;C8.Q09J>!(&C^R!.F[?TN"<V*+JN@(+W\^.R@P"*/>_8
M/^FX#'26:XT3R#I05R:!*>F?N*0_,;6JV51K-4\BJFMC\#)K2H:_MPW=,O7K
M C*HO47-F!HO3:T]G_*U.H*KP:*:G7!<!%I)'RK]>]G::I J:^;P,??[;CF6
MH5V!1_L=W"MOKT/4.U8J\./.ZE-2=I\R78XX#V,:.\27T9;4\;EI[[_Q>I ^
M:1N?LLEIV9IKQ(M5[C8?B816 K,J,2RAG)MC\9+Z$<F?:61H5'FFZJN$@UQ7
M=?TF3R&T"Z KK2_+XZHA35/619P+'+(*W[1[."L=>FW99JK 9TL&9B[<5G,6
M[74+J1M]%5D.\=I[H2L)>B\[F<'5N/D0A2BD^2'.#E]];;.IR(/*"1S@(I^2
MTK,;"#BKF@ \+<EY_Y!=D^@K+U-R@KBVTEX5SJ_"33XOLAAHMH:1:3*OG]?V
M:!#-VF@Q[*,A&GBR$NH].L;>C93.@=&F^H'?U8URK2Y8^ [Q<G?/P2*\.YR?
M8P]:2\:45T0*_'U<[Z6(S!/7B:V'O:?E6D,V9.D8-ZU@M6+ FEUX4E]),]]P
MZ4J/ LO1&JM>4'F[_:(:I?L+R#-/V)>KS,ERM_%>?93Z/6.6_SW<_/\MB&)1
ML'^S:S(EBU;!E1@NG_4+:WS'YQ..ID7'TW&)Y::R_XYGK-=%VMG+W$)$X+.-
M!G2Z7B66-L$EH[K6K^+?)(D0N9*)QJ5.5/N<&C;XD55\^W_!&/P'_\%_\#\7
M1&M==Z2JS4V.NN+!AV<*H\W@ YT>CI.&V+LGO"R&^F0 []/JA:[XW+MU0$.@
MMA_C0)[G7+6[@PGO3W*2 >+@95HA38C5AC(Y;.@&L#9Q=:5R):T#Z?FCX!_R
M!+I[H)5<&K8S)\/#1ZQS.5CR7J#8A_%ZY@9P/\!+Y9 K=G7B$X'[:,8DYXGV
M6NZ2GR[$B\62T>L#E)=N\$V@4V?@T43<J0I+D$8FT.K"(J/W;ID63QU%;;/H
M,N4#I'C?L8:';<3JM@/\NKC=E.,QC]H[3".45=F(_X1WVOL&<"E?K4;H@)V'
M&3<N<GNO;!'4(.D2Q_#-A!EH[8\5FG:R(O:LT627\Q'PPW_\,^AKEA9#!_Q9
M%1^O!ABAN&.7&8_2\R7_R+F#1:V5;9B3/XK;.V\\L> N\>I!-R=RWM'$,*#"
M*_<)XT_Y,[82EPY'UVI9E^"G7W&S&[ ?/[!VYR$K&(BB^S&!L"(F[<Q9W\8=
M;QPT)G.>99N9@A"R C)>&VC/$AYL6]'&D(:7M\^=!,<MLT>9'C^G.LH^6#K.
M%7LEU"FXS1;UL1%"OV"]2UNZD_+IZT\MKN=:&T3N>4_WPFV8$TY'E1S.X[ ;
M"06W)D!\A<S1 Z9-7RQN*<2%]ONI,%6#,<KTH+H%U7L"&YK' Z&:5_W[@M(8
M@RS$B:3.F5RP"H_RWQE#A%793KZ PU5<XAT=(/3?PM^3T:9SQ!TSR_:4^R0F
MY))/A8S3'ZP92CSL%"JDW@B_QO2_#]8TVK$(",ERYM[O$:\BCY:<=V??X!A.
M\0OV)-O0QMX ].LA\^-_I(\V-^>.-A7\?=F[^;?OA9AZ7?BO'!.^JJULG/PZ
MTV.WG6Z\IN=TT&L^V2\V'D'I0W?O["6ILM0JY9V'85_)1\T_FUE/E)41?$?B
ML$M)MG:-',39H8E1L ]^K8C4K<:OT^(:!E3S &),ZIBCW2*TM(_[#J1=.Q@=
M+Z$W=7 _R%6Z]5T@K\(GRHZ$C3>:[Y)U K07WD+Z#"\*:]NZ5@.Z/G7>W\YD
M#D/T%6YAF.#DL1)LJ5MR)!5_O.7&Q<)M-/_&>W')T(C3?_=$;IVOV;;X2[S_
M]B)IU=U>V9B60NP"-E"$C;0^?].^"_LE"COEKUX)-2[ F99^V$O+?,NC1'/L
M<35[7#:N6_C-;C'Q9Q%*=+_N"-%OJU%0H1MB?[W/\*+P-J!4@T;7@0=0UCT&
MPI6NR7QLYR_OS/'@F]U8U'Q7-Z_!/:K\L?[QQ+='+0:DS@0VP0'KD(OY+.YL
M4]INHG<B>&-17]B[Z\J+92?%L1;P2N3^%K8LH2Z&@+D!,,FYK.,Q.*YJ%(S9
MI5-L6N\\UF]+H_3=IQ'3-8B&R?2E.9_'T6#/>7I&O?Y%M%3UJ#6[@?#+*?&S
MMT1U\*5/-28HS;0; &760-Z\!6'X\@8P>SVV;#^@ (/=.PQM\CU<HV5;5M1!
MT"U=NJQ35=0/:9$UO5=YXNIEM>0 ZS-8:@WF["*>:F<](GY^M%0UM4/_DS><
MRZ=]I^G%Q//W6CP)?0C5D)^9/J."C*\9DE1[R$C;0:AV.NL@OZ.&I_<3GM8\
MK]5W-,$/USK.P-99_6X -G8W %4IAKD\\=W:RS3:^/Y3V ;!>1Q&<RK*!CUY
MWCY['Q=5-3\*DHM^D.+O:/Y C2KOJ;U70F0')8HLX<S@+@YD1EB&-0!=Q>].
M%WYP?,DPQ,+*;J#H''-"&\'&G]B82&.GB8+=M=S)=+"Y]!-\0L#6&:6;;*1>
M>$Q&G=4Z86L_8(*(5\$Z X+A/EZ*QKI>[\W=SW\_ WA]4!FH*=HP#K%+]'S3
MDFD+"]6Q2U"^&_6\?N;W<D:;D\7^')]$G/24A3N2;+:E^I 9_P)[$09&!]NB
M#93?KC!6"72:<S6/ S ISVH5KW,EA47LR%?<4G[W"._92BI[)T>^?5;F&Q9
ME3UC\DD3HZ'2>.[O-!_2OT4$]TN77E.Z@ QVR&DN&QX2S+_Q'[3XW@ 4.&\
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MP0OG=Y-Z%.F +_BT#NZ14?BS I)DMZK]X7TK['M87.E+K/G'95D?W=5:OE'
M2S?M;E82FGLI[Z$[MI7WM$D$J-R8) TKBKYQ4&#S6/6XHU1<,+26,]EJKQ6?
MD&!^)"87R2GWA043%3ON\DUV3?YVVZ4^JP-989W[#,BV+Y0?U.'"@\LG0*R9
M(-V(-Q&:P@T*WV1[]F5W8G9/$V.NO%<H$?W(S,] \C"+-\;SV=ZFIV3A$R_/
MJE>X]C)#$E?US(YWT70<32F:=YS(QIR,&9\=9B.R\4+3(D*=Q*!4'1;*WP>;
MT08701U?!EM,#!<V\E+LL"L>.@(C7.Y]750$R<$: U#!'LA?N=[?$RWG$"D5
M<?>X0NL^EHC;.W,00K<3PGA=J*A7L7MQB])BOWLGW5> B5'3"^B\?P,0@F&K
MTOQJS,X--0(8XLQH$ITA?G^,]O0\Z+7LX2<.BQ*-^.9N%1L&*^0L/3!O/0Y]
MJ =?"GEW\->#V/7:RG8&<LK55!\RZ@HQ>U34E^V:@YZJO-Q"5D,GT.91BI0;
M@Q430AF>(J>-3<^.&<<EA@&TY:P] Z )G\\.X>?%DU:\K\21D*2R@;6-$7$8
M0.7)EL\?&+T-X==5MM6C<H=2MPCF_7J[LB<FHW9I,CSXP=SPNLTB'W:?KE7;
M1<0.I._<@#1("WN8\#'ZZ\03X(NVY;D-::W*;.<P5>[G'LF9E8%_A61S*JB>
M7QGU #U*&DKY<I=.0D:5A20=_ZQ&]\<RX"@GL9_2CAZ::C/I[BPF_[)I[+NE
MN2OQ.MUC6=FM!>1WO$S1SE47Y@':H<Q*W5/8J"2:SW"D]L\W=K+FX7X%X-?6
M4AQ#X*.5#+0?G)M94<P91<E-#VQ<9+I8Z&^LURCQEZ:GN2=&G#R3),?('ZXL
M"/4;E#FVV(D.ID8^2!UI"6<UBFMZ]3UT7.YA69 V+B17*$,G56<6?#H&TA?F
MRW8G'5SG"D^.)$ZB_35G%XJ'H&EQ!NO8J-C3/9[*KR3%UV6L/@!I=@[[T%RQ
MA1@>)^09N4M-P-(](ZW7_R-2[?\?!)D@"@)PM:6?DPK6_X$^UF[45AR>\S.N
M\),(:C;4% I(U<<B/IQV4>P%#%0Z**VG[G[WKZ\Z*'YUX'3YS/#9*-=7A)$Z
MI4'KRGTYL$IW@&W66N4-@%G- XJ,.'62X_$SN<LM^HQ9I5L^=3F%&^!J&/0L
M:P#D$>##ZG",?+BW'MH@2NP>0&NU6U8$\B>>(S@KH5=(MFVEZG2!3C-##L,Q
M+@OODAD0()A:<C?Z&YX/"_N12SO#;%@?LWEP1GZ\U9XDE\C#_=BPZ&C ?P^(
MN2<L]>QL,KOCKU,][= <-%,6R0SLGQ$J.BZ*YWSQ(FA)U69K2VG0;?I(- JC
M:(+:ZV"ZTBYJ:C6L^?64YJGJ:I(F1&>V,-7<;%NAX7!FZPW6*8<VE/8C$ZBH
M-,NI\812-*MABU_!(S=80!)R>P?)'[;PHVD:J!2K+J2AS?FR.56AA8(TQ"%!
ML*@P:^YBKSD]':[V^:\;^=  H85J0*C4MY9VZC-.F';2OH2?L1IVC;0L\:PZ
MATO&SA^DLX^6I%G2B;RE^A9)PIG_>(LL;'YPKN-1#%?-:H.9!FU4.T\)SNM'
M-&H4)KW98Z;^<+M2HC+%@@,@-HRQF8@B4.*L>VWY8X'3*X8G*">7@A0?ES5>
MA\0,C]7<KV>U+PIS5F1D#'?<HT2+<;2Z4T&@<F@%^2';'\/G*8,\Y=&J3T(,
M[W&C.+6K((Q!;-B\6"G^&7>'UOJVI(-T70%&Q>G=GK3(X&[2#M(8LX4AA<O/
MMDS8D.C5);FJ!FL#/DZXUGY_KMKN3UB&3CE*Y99K"$W';$W#Y2%?JLD_ND^;
M?>R_,JF(W+,/&JP!E17F+!T("EILG,)NN0;PQY[9,5@;0"]:DQXZ)L\,M-S'
MYS_F*?4$%6?RY9(_>/-\J%B;\[V&P.FK!5UO;NOLP; @ZA(H[<OF;U-;;9D"
MFR>?E^3KB3_((BL'&2=MNN%F]=8M#_@T- 1G;HGUZZK+!2Z$33MD8^W"3@]O
M;4^Y!CA>F*CR#KQ!B%0M?"+&F6HH&R$+CA)[5VBAFRP(\R8/Q6>?#NS!*?FG
MXW=X?H<)EA=&';I3ZB4(]JQ0X,56LU+]2E45+XIU8BM;B%O#9Z@ 1;ND((,!
M6\HIO%>1R)>*AAUZ'3YMX=^"E50)Y"3>O-XU,3%<;7]%X.^UY:K#UD9AO,$*
M/Z7GNB-<M43Z4K1Y >+:IU4KU%!:76P-O,JM26)96[F2/TM^?-=4?Q/RSVT2
MJKI=/9][)FT=_6 A__%RK&9/*_R3M47F\JYT\L^4!;6G%F\=AGD=>/A_A5HO
M,V%I8E<Q!J8=4R1'-P!7\88D"=$,IBFM.P 2VL]8[9K"&%UU1YF:K1QHUFKI
M1T6#<NTR7<:E^)]5MF;?DPVU!LN?C/2J/), TD:T4Q="U=2RM*9?)V-JR"6N
M"RZ^:!N6*K40YP/,M=4IU=]^D_'S]:\N[:XEL0*)E@6G;SK*+3A+%N0_#R:5
MX>Y+!IJ'MW.70GG4P8(OTS=U?;^4C/4*/N7G<"0:9/QE]-SW%UM;FUB[*2I+
ME!D7L*8^P]><@/0LSEP*:T;V1)*3^'"E]2_C2;'JF*5V-.6H!WU%N^%+QD?=
MQ$)W^/DY,#SEM7J%\1^VI&KOXB"H\R@7*?*(B##T\A)/Q.+[%HI;X0ED <<W
M@# K*JO$F,8; %N_XQPRZ$2;*3=!CBA/2/.7O<>NIMLY6%=S6NJS,:>)?GUG
M-'L WPSE8[.=)!8.-CB'ZST0ATM9S-.*(@#M:ST%&?YFI1:SWDKFOLY[DT'
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MURK/-MIQ1-J(3@S++"EF*G %^9'XB2V.09@_9Y!S;2A;+DH? #@7U[Z509;
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MU@$%T#=#W<R>[.LY3;FU.I;8O4P2'7-XIX2]Q(#CFR-6)9__#5F5$>AT UQ
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M];MR_QIL\7 =9VXBX_8:?\)YX@0U1&./B*SDR9O4U\FB1U !+45F*V.%=@\
MHG;%\J,OB<N*Q86).3U)'_Z:56'IY\\HOVL+S![M;))LO%9&X=YR0*1';^ '
MOI=SD"V28X$Q\A?K_!'FV0,Z--+S?[QV5GV[, YAL.D1P;-%]<0!VE3K+Q$
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M=X=P5^=<LN.GV."DIS7CBEW5-TDAWHB*X\+.-JI6R.W.SM76J^EC)8#V'UD
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MK" <9<%..M1QYJ:4DLE;0SN?KT7T >#%!@D=+ BC<S/!=R7_/:,C8H6R_)9
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M!:<(]VX$-QU$M,+G^_$=)7]]\C:/P8C/-LA"2,[&YT9N5ZXJBYTNW$OYJ3X
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MDIZ\;!)@&&+;98=U*/3E$)R>?"M(=)/BH%-@)UJO:R-JYNFO8?SSV^<!T)>
MA\XY1V9T1A%<2VTK>Z5WK;Y6.AD2[*KJ]^>^<_@B@[,'6E_!U;Z?7EB?PUP9
M\W;VFN%N53)X\A<CNHHY>=IUMO4G>_C!JD2,MT4&S2=)%Z6>E+DS/-80SG38
M+1U8)(3]=#",HC$;)/;)Z5=031J.NI/+@.M"2V7&*MZC+#2%R0^08BDR!%$_
MR5RX.7L^>&OX $AR]W\ F$ > !<N>L5=&^'SQT@A"4)-?UZ]>J5XNM)$RX]Q
ML04%3F/?B2V&L/0J(84&AZUN&0%%N+D@%CV;Z]JM<ASZ,MQ2BO1-+2POUX%[
MY:OCGVE?B5C!?#,_?*SP1*^*H+LW!KYW:Y#1 /J%2T-)9?^-#GM#-7_;)\;<
M\ZGRJG2D $NV'P'BEJ%S^H8&]XRGE1$;0*7&&<%%>X1KVINDJ?C,GTE#5:Y
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MC6/Y'<G3%S1:%VM90S> *?U#)AUF-%4>N AO=R P(Z =UI(.H8R.X)9UX'7
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M7%<7ZSA_I_%S9%LQ9_U&Y%#]@?0GAWN(*8NU="+3QZPDR;M2=*$CQ0)K7"\
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M"'%.:L-8__<-F:#V!73:;ECQ56G?=5^R=F"KJ$]ZB_CW(8U9!Z5[!MZU\!L
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MX%>E_=<#VE.]AT=K?I$D\\/,W3G#2(, _^L8FM/@[!+9/3J;#?_AK] 'XX&
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MYCP;76LJPX8O\[.&NCBL=5>PG.8&'ULUE :K\_^3>'UR;7$#2!WRI6ZS9FG
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MAE4+T\Y@':J@>:?8E[ ]3>;K<>,"K3/:OCR_V,9&C]?YKPE4T.!9*6LXT2,
M5=(,VA>VW2(Z@=Q#NEY"$$_\.*VE_>QC?1PR=C<^C?T2520IL=AD,K6F/[ ?
M^IR2D%HN'//3YS4+M8DZK$Y[92EA(QB%A_7HPQL7;M6[>&M,&21M[P\GO=ES
M5KY5#.^^^F'>3_=DLUB5S]]D3TNR:?""/QPYJ>NF$!#I;NV)XZH4QBGI;V7"
M=4_8M%_)$!-%LY^4%QKO1\LO1$ \!U]<;X)*3<S?3AB2B;]LYF5F)L$PE]GA
M8*5.3$_BZ'%_MBS&%U/?1_:8=[M$]WUH>:MG!UA<CE67:ATZNVQ=K-@(N\ 4
M+,#.DP)];*D:ET3OH*U):"PM!]['F,5LK20_<I]>)O(A0L'B%!E^8)RRZ%G?
M9Q(G3UGDHO70_J24OZK$["#?>Q3<C_D;FVW:%] -I__C55>:=F#%__M5%^L-
M(.(&4"MR;'X]N0)[;R.\MB#JDQIFCYFPW?-:+WS!@#AI71(("(0?R2ZP^8*>
MC9!$2 FS:5>/5SQ 0=Z9PQ^8I<9CG($TRF]4]XR: I3SBO ZO\9R]__X)HR-
MZ\DX%P[ZL-.FLO2=Q[0^V"<6BY5YWW@#N'\KR>B (&;ER5-8U8*J7[9H\)YP
M+613+-MZ/LFF8YY.-SA Y]+JV;+.Y'8[A?.6&W.1:TF?KY>B&]A&/7CO\':R
MFA6"6U?<K5G&%-5).BCN:7 1J&(A4C\2V Z<843Q V+?>V/$0IB] -EIS>_J
M8=2^ 1W^07MHKV'F66<"HY)G-:]!&A*S8;T"!^6YZ?Z\^J L_2+KC?D'D] ]
M!%<XK6\2?IGR[ Q.)-;3(YTMG-\KV\9.,#()I4A-6>R.AJPB+FEJ4UY]%>K(
M57613EP-9Z<A4YQ2IVZ?<WC9F,9!W57;X!TE.2PQ#<\PD$_A_:4-XM/0S^ET
M!%_?J1W#\Y3[^J-.5:D*QJOZ'Z8X-DV2?]"Q[Y&3ZQER8CUCW6WE4%E,SMY[
M>*G2?E&9B85%M#!EMUWX8(Z=%3#IZ8_F TJ_?TZ4$+^C=W1$Z?U[F9!A4+W(
M6O-2V:PKQ8!'5QR\(^LB_MQ5L7H8FA)YDOFX_5)"HVH</RRQC=J@3JUEJREB
MZ79-"BW L0YAVC3_^'_N.IWL^+1"MII8WQ]"K$?*^V8="9;.R,?H#^.C%],^
M0UOQU$<2BIK[1W^2LR@F&/LUJRK3T(/S;#T\M(-LC^G8!KC$SGK7FR&!*C>
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MH]O5^#\'4#Q(;Y.+UGRCN$"?KVQ?&[@@>/[ 'OA9T4M.=KTVV-U)Z1D*\BR
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ML\B2>KFSWB'_*?SAP/I8%*<OTA>OP\4F94$^I7..=6Y&7?X0N2V*["LOPZU
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MBS\F@4G!M!GQ#4#:W:,N3_/;^!5T:,&L?*&LQV9&PL"<.>K%-MUS>;T1F1>
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M_09*YA\:,?5%LLX]9%+='K&'?HLD^UQHY"6@*XA]\O":2^M;]:C@FN=TK]H
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MH277"T?I*70/ZAAX^V)5(@TCH>;&UE\_0U;^K$.J6UJ?,7>)EJF+P'>@-1[
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MD;U:&_Y.,699RDXO]#CE]UJ(G]Y>;,?%$R.%K>/Q2X!*@0SPPON?F=!$7%-
M!5'BE+WVOK:.=A1.#J([9ATAED,S"Y$0=<8F:; )_Q0^F1T9R"*TK3LF1LI:
M>)1M^AC+5^2._-AB'.7?<0)NB* ^JE+!4!PJLFZF([%>#8(D?X_%<ZVND<7
MQZS -(E8Q3#U.JO7]T03TYV%0T?D)U__?O:WBV#PCL6YJ60K+6>*2^ XUVUM
MSU((Q/;UVA=_&WNQQ8HEXHU#"Y^EJX?Q8DE,%&?V@@Q)M+<\J,>L5'Y6\I'
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MS:FF4%N%%.U84S?#[K8**BN["N^9QWR'5O68X0\;&]3XDZ?R8;N@+) )*CA
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MNEKV'AO$,R:ZMF&UN+G#8Z-T1@^;[8!QNN,?]_X/]MXJJLWP>Q<,#L4*Q;U
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M8(QZ9-[?DIZLS8G):@H>O;?6A_)3C1#C,07T\"BS%GJ>&>D%'W3\B=0F!.
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M*.\ UO]]MY#XO[);1);W,"G278N[4O)HNUK[,E7FX\UZ4>->=HE_5[Z'3/)
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M2:-I_J/8W>,GV()N@AI@OJTN\?QT%O0<M#%.7B?>:E'8M(&?XO&'*-/WRQ]
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MQWP[S^3H?<XUXU'Z7&PRQ_RZ-N-#O[+1!!GBVX:\R?J3HB:O:I^>[F;F1-G
M%-G2_%C-Z5 13I--CWV9*3_0N#YP9?""IPH:;.\MWBLQ[Z+#7_<^DR->],62
M2R?KE[\,OZLBVZ71!+'7>*5OE)D_ L\K(@@WXX4^C&&1* TQ/9J>:EU9D^_H
M)049S$(](%[#RRM_E2V-0!_QBFTT;9IB:OK]X6)MMY:\GUK4T\=6OAU=+LM.
MGMT!&'_Z:$'K,[5.%87I;;^#YP$9.UR.N^3MO$553] T38'0O\]]O+6C%VY2
MM%\V')BF*2<\58JO/"=P6'TH57*MO1%,"UY6;#JQ_Y V-@62NGRS\J8$4F K
M-6@%&+1LUN0\ZWM28>(=W!53+OD3A);W@YT&$_@<],ZQR$)Q, N'=2NM_D=5
MD%2'U-#%$$ 78'753=@,%1<;X,K5!X=V RGJ&_$> F_@KVWK&:F_#;U>7-+#
MS=*X,D M03$$_F<W>HYYK=#N(!%T90):1A'/9WA[ZN:7C8BJ.ZZUZVD*W6,3
MWM/J+?>L\\,O1WF!?7-=_S^LK[!^Q_7$X?L$][/(HO/ <ZQ@$+C?(3*3TU\S
MY>5-/_VNS/P$@^[G(@=C]G&MFM"Q'TQ_7'+T]4K/%;:K#-0F#<PKR(U_KG=@
M=VS:HL=O@@5O(_GUT+::LQY5C)C@ 6!0MOA->Q:NMWZWR'#NIS%YPG<[#?C@
M'[OYEEY+_!A>@M^6\#O HQWH(Y]0O9CFY; B'V_-&8[J^HPA;T]W.FRY#;GR
MAT)8QXD:Z\TKL/8G)^')UW[JT7+\@?Z0S7+0"BAGD$OZM=NP\A\W)2[Y/K_[
MO;.B95&\[58]*H"H?L:Z??XI(LXPLKL6\)[RVJJ&BRW:=;K4@IQZZ%H O8ZA
MF>^5E+S2N9G[QC]Q!]"H4X7R*&>Q\@D1<N"WI\F57IE\O68X26E:TS;W%&]A
MK47,_DBDV,[_]88ER- 5,^D_<KN$7"=;[+@XOP,0W 1\)_\(Q,^M&%]?H5P!
M#MGAM[3QSW;AEJ?8],R0A) '@<<]1A6[VPD3C[4P<:M'6NOH=XKV+0T)LW8O
MR0B.*32.$[(:Y7D/'G ?%(,#N]J.EW<2'"Q8)Z]53LI[C=L?G9POP])"WL)D
M?S+5'Y8]0'X?#7&/)>--/Q'L\Y$C7BN'/@ 'L<[APYU^)?11\?X='=-8^_K0
M36.5X0H?YCV[8 _M-)[T#2J&7;N%WAXKGPQ$<51_[;.3S':G+'WZL NT?8;C
M2 \?J6+^X?-[S1)V+'8@>^!C59,BXIQ@XD\W).M5@_O@;)\'.&7PRQ B-5(F
M-[Z:V>H=3'!XM*T_J35/N.\?>DA8Q5(_6;6-EE-\L/E;88BLX5)@H/6Q&OG-
M"=%5VE4##"D8G'TU#>U-]\_HF$/>T&\&,[6R!L)W_5[?IEK-YVLGM"YH_&[*
M8[,'N+G6DTEW59)U7ZY)%'J29=N?7+Y),GI'>$*T]9A12IK=Y@=!.^K*!O9U
M]]:;"0'TJOXQ:1-CJQRN3T6NQ-OMV4(LKW>175_?41_ZZ^>1&L:9@Y+#AH:#
M1XU<_)A*O_T)U[W<PZH#4ZGL'5$T"7D%/5I3%>_E%GVS[9 :R VIL0G1Z.RQ
M5OO5N&O8LL0=H'+T#I C[M]&S6]QZ]33OJPC.AAL;_F'*S7[@B+I#J"D-801
M2-6SWYBIL4)"7+IIY+,I(8I9O$O<Y4G;D$OCZX[!+Q6)A\=_[@#?3H]#CL7*
M92':/:CB4 '/.#H]T2-)B5*VER%87D'ZV)I\6 <9\Y 3K65MO8BLIPW?O$:H
M%]'-6=_9]57][:BR:L#-U7,Q"F,[\;=C':=Z@HJ''%RW(<G))X;S1W.W<G6D
M]>-N-DM[C1J*</],JLT_Z= RY-;M<ZVA)Y,KOQ7<3EAC([L99>\ I#[E+V;F
M;#VFNB_0I90N5!ON NJ 4-&Y9L48AO*#8/RS&\W#HEI)VIJ.GSMT'G0!SBR-
M.^@JI[PBD\3Y0$7L_%_#!Y#@1YT*@BI^8H(XR^,05\^U X=\\(^\,=&/?Y>_
MF7<^V@\$X_2)[ODMYZ[IV/>T4T >J<7IQY+7RY<IS0M\+W#YMICS[,\GN:1C
M2ST#X\)C=]\5-/ORL6!R!TZ?@O@=8/!RE?SJ6O%*A.>BF;N@/DXP/=A7SR28
MHZ?^#O!'!JYRVQ9\$?KJX@YPZDFK>+YQ!Z@W;BN#&4RG_COT= ?X_N3^&Q=.
MD']8GFTH_I%F);P#S-?> :2=!&$=IT Y@CN N>T=8+*[K1OF>ND;D&XMZ'?K
M-/#E&GHR5UJVAU)#% #;EOH37.Q\'MI](YN.E\F@9B(';@2 -_:">'<OVFE.
MMC^4!C95&E2V[O;_J$F(#G417:J9:H_**Q2( R]"VN8ND.>76:3HSWJW@[48
M_Z*(E0O-%-+EEA<JBH7^F?/7OO>8>K/PY]6,4?(63;;QRO*3?!T/S<#OZ.R?
M([<O;BQON^_7J 2T[Q3$_$7'W017_?:[2..INK\KT.D=X+&X)U3V-GC;)[C;
M@-?G<ETHY(-PHRN]?/KW5%:X:Q9>V[1'>AM(#<T:6GD^3K/X1CC&'J'9Q('Y
MG/W%>8@/:W6[/3^OT,/"^+:%:NG7]2^?E<,;>_&(N'59WH]$<@P),%5F'+PN
MUDRW.P!9 #";]%H9[@,%3GD^;6]K9WG>]5!ZLU+7-*"X4LUG-)!>5?;OL,4_
MD*=4T;3^!^3K6=QW@*3TDX$;W[@M<</92J@"38#E;(!!<)'YTJY,A;KH AN4
M+[&8@!/@36*5$.]3Y9.7V*RU)(B).? _1Z[ZZ(6/'O<&1T_XS*WH--=.'%K]
M)$$2U0\_KP:XA[KUGN@"+LN#6.\OD8,FO_&] QPFF" F7V6F(;5OV?V*@QJN
MR1_-=VSNGI%?W;OJYY.J]WDPD\M7_I9H;\;9!BH#5;;_'0_V_9?]E_V7_=]D
MO"-B7P.\U]/;G+;'!X)_ILPU%_85&*_\?*B#,&C\$TNT>GEV8'X19E?FF*:7
M!#^P-6XV?@>N>Y^R ;5&Z$J=YT)<_&09ZHT]XZ+$S'7WM2&*)M4MC9]OWAI?
M/N,HGL'6*+OZ.%^Z'LC.[:G-S?_6K/6OM.O.F_A\Q[B.D9F-N1 )AS)W)Q2D
MWMM0KP3X(N4C<81O\@MI>L8A14%<%G\#EO+BE_?BE^NTYT4,JOU>\!(P]&Q\
M],,X%98;;*QV_@RBM0\"D5IT[Z\+<$80?_'6*R%@KQR7DZB6NZ0<(.$6.=7H
M>JU>RE4(T%0UFD8$2II^*)H69]3>_7(D"!$9SKFRTRSQ9'VXVRQ72E-<X7@A
MHCG\9'3X!6B7+GH"/YF:%<7V5Q$EMWN=X?Q;DK3Q?%PKOP@3J3IG/JT])_9W
M6Z^U ?GLF67EE*L2PZM_;<9?@VZT!K00DC(Q1VV9C5(BBUHU.=>F'[1M2\R<
MO$;<BY=!2PO(I93EUPEZZT146.]@A:X5CEX)BT/NI6;=*07\/9HR)5$)\71)
MIYL/?<]+^3R)^75GG2L$^7\=+?P:@;(ED$^$P0!UJC:[1A::KA7$H\;#YQQM
M=N&0FG2'BTJ.)-9>:;FKN&Y0]B,'&J]J<W-PVGN:2QRA$?Y%I\3@9LVN:VX<
M8UBIOZA"DJMXX0R%<'@:;R1;?R0!B;^59XG',^<G)S<?D:D-\TA2YQC^V1J6
M5_!8,XT-@I(<4@9>B>E>F:>Y?A?&P/YL=V\6E2[28=E*F2WEP?(D\P70"(G1
MHBI54HU&\N*SA!#.<(+23BZ<ZARBDHH#RX<.R,LITY_[%[2TKCL!#Q?S!QL/
MD@G8*RR=:(!VY>9.M"D7*0>7A8W)MLKGG!^4?&D<RM*"2HOWY^X #M/0(^CC
M,;D1QQ35ZYD$XUU 'FRL"8W_V<YIW@38]I'FX/''$?YA'@("/#==29PN9@<<
M-5B^.]S1V,]OGQ:8F4&C$X.D'"NG'W\I+%5.DYJ"O!ARMW<G[6L->\8GP&SJ
M%RHEAB5.G1FX3DJKW12[HC][R,^5>O/&A/89H^($)=$^SW?DA8LVE&G>1?W)
M".2#A1)),7UWV&6L]'H(GX'^DOF"*6K(T]N5NJW5UGU$].,+EH(L/*V*2MAN
M5W*$,@$;# #D+G&NA!_"L[9_^>2$"C=M)7?SQ!GJ88<\S2MU;!Y+K>B=VO-+
MSCQS<AD%RPQCG3W1+*EL5<DSLRP,7ZXI7EA6D "-N'WBL"^BRD@#3.7E9ZTS
M@GT%N-*D<F*T6Q.%7K]F2M1<)??+]5R7)QOV86N9\]A]FH%#XK;$7A]RAB+:
MD6:6=\#1A0VA6:/XY<37#D9MCJ:'D5'-I2[MMK;A!#-9SZXDHSQB@BBOWA7;
M^NR6314BAK5LQY46])C)+;4D[S\Z"J5P^%0:(WX>(P\=ZD1(:CQ1/"'9.2N1
MTQ0_E)A3&WA5._VSRMJ,Y9@NF3A@LC(XIIGLS OG'2P4M*#A3+,,*K'-S'>D
MD8C'YVY<[/3L'!PZ2GA=?^2M/L>B.BT.8IR+N[%J:-1\$.B5! -,_&<D0&[*
MZ1S]1BCHJVV:JKW&4N>[U_WK!(;X:H&BK^MOW#5F"U+D)5_7M/G$<H+ '^.+
M9YY)Y1"?O2+W!S-WA6I_-;2F_](_!>C"ZGKOV>]_5G(H;B[["@&&*]S.G2Z9
MEJ8LVR5@,:LI<XAA.</&:NZQ5+JD";8N_V&^J.:"5G9+E E4DF;FF=TZ+\IT
MNI2<UP>!BOGY3G%5KY(Z<XAVR_R\JHKV3[[5CZI-7;"Y6*#L$I2O2L6IQZ/$
M0+S&S<VSAVQ(,Y*G9LX&^E)2O(FNC2R$!TH,8J^,+X7,%PK[ZB='2<+<_LU;
M8,F))7W5-E\?*+'/"[H!]L^MVT;E96U1K.P2#>W+&&SBAU/A)"1,U7&@62(%
M"CQ^G&=*'W=U(4 %(F&WV^Y7^OB9U".C]\DY.= GZ_A%VRP?/PN*<-/166!*
MR/PS:0BE-  [>)G:=Z?U#O"QFW#^=0T-J<VO]T0L_NWH3^J!(:Y[27\(62)F
MJ?$RCXKRWR,E3/07%VH>VX4J[;NXN*@S*U.I^CO*SUQ4+_WK!2"WFZAD(1<=
MT^DF(O,NA"NO+F?^#)RI>?9#'$P$G3Y>4'>+X;EYQ12;CW"8P%*E'@C00G/X
MN'?'SEU]I#%!BJI"26I%MN5_X4@15,XN!C]0\A(SR?IA=@=XY^.FG8FSCN/$
M#AZDKO($8W[96&80Q-"18'>N"I;2];N;+Z8VQ"_RMR+U!V35IO@@;"0&KDTA
M!Q\2DA;82W/?9,'&IQ%+K*:^M"]GWT.!BN>AJ#7.9^<H79Z^HYNL]/?SDI<N
MP(6JY11?;.ZK1%<-.Q@//*+8NFR!.%/F G6ZF$$$V3*CRBY+Y.&-@6K61ZR#
M,PV'Z> 9ZK)#+C!V&RQ4;_:7U;"P?>X?Q&>OP<S/1XP0H'+B$?\6K[^U"X.<
M*F=LZ[DSB#8NM1>!1J]J:TRD5#Q=$O 5%J)&&;&"8-WS@O9)>M._Q#+!NO6:
MT,>D8H<52?V@KQ-G?$OXO,#3BWF]!O_TA:\0^(1=89H2+'\Q"P^@I_IJ^MQ<
MU@3Y5RT]&.Q/YKH->EDK$"A2 -N1>^+KZ;X>1]<C_WVJ#UJB%E\0:ZI61"6E
M[T>2Z/)L 11LKOC=Y+[^GC_/G3=0I8J@,J;YX"_G)[XT5E6Q=QG*^&VH&>E)
MT4?9U%VSBIT?EO5U1]YI=C[J3/;9:NBQV71.F@N)\(@'; IGVH$K8]/C/(=4
MAE?VS2S\S)SLMV&60WXL(5#IK17.PX(/F/7&X(ARFLJ&J^MVB;993\VCCZEI
M3BL<H(549KGD+<(]# ,-_ _.Y)NS-%[Q:]4\]5)2"1U;/="I"S]P#[?X%BOC
M-MEK>WMY;.F70#&,T.A8DS?\]=&0W - "JS(,U#<4WR:+-]!'-_\P.F=I5A5
MR<L=%DR)0(!FKMF"JKLGW'$"]+W/)@54\-J-C-!0EVA07I[[7JGR ^%[,N:U
M;_89,I,+*%T2%]]P.JT\U\"'*\N9"'%.:"7V;KC)O:>_5WV9"=POQI#QJ'IM
MWK/JYCDQC" K(_]6LVI"W?0#71WE]6Q*H(]1#Q+8MO#8U.@9H\:C4></RI=B
M!"!&,6.29;;JV6O%4KV<@RN0#@E)T R2B,_XN#Y^ZJ$&P%;NBF%JVBY^]R)Q
MR5S9E2L^AK_W!>&FK)I9\$]Y=01VTWW:,GU^PVB<IN&Q9-%]:MHQ]P0QK#%T
M_D!7A@')OU3_2)5DGD*=[^=IPB)^ $EFSGGGYOJ') .S.>!M3*FY]G^$ZHUJ
M[[]^KWOG@$WCF/\^X.1_DGGHU;4A9O@-]X>W&=.]Z36MXV4D)V))[S'VSMPG
M[GE-!XBX#:R+; V (%/V*%6ROAJZCQJAN3Z?=9 $VP<V;R\K(M]4\-A]LWU0
MS-G$A5%B+=D.D=RM=#>=[;L#1*ZWG=P!HCQ*#"KS]!HT>32)!;_BL#FKK8L
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M^7S*%?! $.EEYX&>\=F6;VVX/:0T *^W$')WN_IWXR%Y-Y@SNF^#[VG_\D<
M@;M.7=A\EQ+>#:"V&D@*U-'58>-Z--1,E"#"AV?W%H_;!@K^-1[ ?I6RS!@@
MC#V0^AOFTSJQANK[8;+IA)SPKI!&&5>/4,S/X11GNE)LG05_5@$UM7G&^+[
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M62YL7K%$M!MR<7ML--X J'R$+O1G4BQ' U04PTL8[E;_%FPT5Q=XFX"GCN2
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M:K<KT]WL[[!_W\Q"$\R;R?:WD85:03T'QO=OZ"M"0AFA;Z+>>$76:I2T?_^
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M+?2A-X NNG.VT/,-:%K-CE1FZ8[&K\ZHCTZ!'T/J$P#FJQ4XQS\[E.P^?S;
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M Y'\2O>W$W+XMM]^J_6G=9@M9C?[FW#1$R0Z=:(1H  #;IG9I;M!%,<_)&\
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M!@",!5);;BL*M>&:BCJLD303F1[]Z^HZ(MRD5$D?X\"5:U0)BU=W_9KYM@G
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M ?LRQ/+"=*)&TWGS"$INM(,0JS3^X(#3;V<E#*J&LD\=5#2#5UL45P.QM=1
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M,FEK#[XUG+DIMUOVPGS<R(V[H>(-&*/\O(5MHR?66&9^X"\Z;Z.WP_NY<GZ
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M:;:7MY88-3DDU1:R8MX@5\):7;..@[+0G*9QA9<:8()IP4OUPJZ'[=P6_V)
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M;&ON$>(1QEVJ% MXGRM]/!#VT)2)12]UL20(N3:\X^7VLXG:.M&CRI0R&!6
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MW&.-RZD>>PY%08TJJF1)]3Z;-P5S,##&IW$N 0G=H41%-#XVCNB)\)7C>8)
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MSFD(R0V__%T<M:WO%J.,XU2U\[4Z&7#L6;XB>+8;=M**6XJPN6U+R_<J!0K
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M'UM"K>NW@CE]8F6\D((21K[IH@#80/<1SG3TX,&-C-G "/-]YPQ'S-;CPGH
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M8;C<?QE;560BIED?:&U"I;/-*QR)2:B$*=I/CM!6M75D%%,/[!JNLF,_]LJ
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M?:("^.!*0.DJ+.PZR*?=3?&)B,A]C:7>F5/,AG&^".6DQK#8H"OS5Y9K@%^
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MG+$WI[$S2:M+_^CO\!X!IIXR-TRE*,^[%'77AVZ*SAN!]]H[CP#'  H<\%6
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MB.:<Z'30XK60U<N?![7*[FB_( N?+!=>\P(W.+C@9K$^F^77_3T1/8$X?FH
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M_J>O:&*Q=L"^]^Z8-Z;XKYU^*E)[3[A#'5',E\4B%I_0=A*/<Q>FO)I#N!=
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M2@<#61'B \,)'Y@._&T.>6^6#)VWEB)TC=93BK->K<*_KM)M:)S(A;N!]75
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MG[AB07ZR%.+6W?XJP',5Q7DG4VGG:]^/OQ1P-Z?!3VW8G#@H-*&'S!T LC+
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MFK/O-V'C"U\[3Q55K([ST%4@CEN]*&%XI;I\7X9C)$_<=*'K6)$:;[H=U;I
M)#:519!+W"6W[*4J9\Y"W5$VKQ%\)Z7Y#?S02Y-@=#VIC-D:RUGQN>Q1AJ0U
MU-C;2S[N=EK41*>U(2@RF-D^B2.YBVX=\6;AK&$']?D1L(X*W'87U'VY.4%I
MZAW8*\Z3;EE2<7%H*ZH<S-'_%K]A=[]\B$M9DFC"L*>DM\))PCO%O?#GT-WW
MF9A0'4EWLP=#Z2 \BK+U2V&;_P_7R_QW$ \4J_J2[OYD6NT#178U8,*!8;//
M0/)'0$<2WR,@Z(.DO(,@4#RW:SC&_EZ^U-!.'C^!F-\1IX05) /GN!9G+P'[
M?)4(3+IK[3H*E$'*[*(N(A%>0$DX[T/ \B-@/ZQHIF.[&IQ[C5OW")A*T@4K
M/%M"W,L=(;_B$/\?+^&T[PU4"I%N7U.G_B77UF\*HBY\AH+_+3@\.0J=>VZ4
MO,98AVG_(V#79[P H:OH(.S 3^N@T*H$PJ)4%M:.?/O='/-D*>8&,\9-7YH5
M+GD$G^B>3\MP.XS,;]4V_=MY#-2[?K$AG*#&X_K:I\]WARRP\UYFH[<#FKX!
MT\B&:USHU==-U[8TU?%Q;*Z0W/F_HR*HUP#@4 ]U0EWRH[RFN^L;).>N&J6!
MWB.](N+W7B_V;VL35[I*E?!':$1E8VE/,'\/4AV[?;"EW.I?>W'L+U\L)SHE
M.,)N%G=J8_#2#53H'!S$(FO2> B>>E58VY!V=1O[GUP,V\Y?:1\!26U;3K<;
MYH^ /"'NCOLTP[4[@-(CH""CI?D_>3F_!NZ2W$#WG+K7MKW#(^]%-NAY!WSG
M"[;&F#8=1-ZS2Q674&<-$,/(\UV(U[?1G]'M-J^%S4NCZ9_Q^A-_<:'AYU!Q
M/W)F3K" %W\8PJ1;U_VEI2K.B5GG)0H-PT"QC\FCNF\Z;L7*$Q +8:T23EMW
MV6[]!@ICI^$^8)JB;74^BJ1BN>=,8K >',ESSL57ORX#.H9X)RD_K=V?^J3U
MM!"%3?Q1]UO/Q(\7>VGAU];P1I*$/_W'>H-\YY@N?"VZ%AKN68.T[NW?[=_D
M',J8-JT>X3#N/S76I_ZX??^7>;Y-)\H+U?'BX,$7Z -'G3LH]><(M*<.^RDT
MILYMQKG#=F5>A9JU16*(2L9<&#/$N>O?RZ]G&ZK6,1H9R;[5%\4*9R0]5>3,
MRT^>8_G+!/.2/"2*]B6OB]'1K;_](<VH5PE3^FMIFR$KAO?FA)EQ?:_(TDY<
MZC3R3OK0$_;#3&+1+&G7)HR/5H7GH=77FOSHXX<.D^O[4^(;AQV4#E/=YC3#
M#>4_'9E8EKG/<*L*GC"Z0S7[?B(NRQK4X*E+EM_\"5G1F='+TZ7!?TOO:Y ^
M$*0KPOU('6R",/*,H8:8'(V%R99P,_,1!Y6PT4\ :,X\HM7FX+HA=2.<*M#
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M$TSQ[]KGOM(@P[M>4Z1]F(1@ON=\05#%^>P+0U10ZZVN2M&]#GSN80[R\RS
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MN3O(FMS_<TY;JB1P2!3YQ&6FL%S4-Y-D8*(Y18TT),'LUEOG&<OJ&C\[BZ)
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M09K>]TR,=;2O;;OXOCOPN!.UNRA93J7=,[K]7^R]95"<790NV@0"(;B[)$"
M8('@&I+@P0EN"=J0AN"-2X([!$AP]\9I7()+< N-NT,WVD#37+XY\^.>J3,S
M]U:=,S_NG;=J_7EEU[;UK.?9M=^]:(SGBI%^,#H90F#R):+<2<&>MK2X$].V
M>*Y;7'R7BI9T/K!PT3/SRR.%Z]8^;M0."VMF:,Q,$;X2%DDWZ5&,T-,\L4[,
M1R7UD-:.QY^D3.[\J9S8P]0=N=D#=O7.J"O(UG3S*#I"<8(K-O7KHVD5H)E+
M,=3%GS].>VCENYC<N:"?PV5"6G4_UK<]QRLA-U<94L0Q=OS'I4L,??KSQ$["
MYS3L9I.EB>KCK:<ON :4@I_PD'.L+<N? _C\ZL9H3?[J^ZC!N9N_Q_=3.DPP
MOGU4]D.C-<LEMJ0BKWN9$'X2;&$U(9CF_;:;X'G0Y*O1KR;AGZ4+FU:HY@WW
M94A0+%;>C@R]=>-FK/'*.4E]/:O?5&TG31ZFW@V._(KC#!Y"?GWIT%4%RPVD
MYFLX4[ZA?;9E^?BG%Z!I\*J,MA*53$3H_U?@[![P-J9REXE(DGTM<J=MXER?
MYSA-IHU[4F"G8K+G",5O)+!'^?J $E87Y] .#5^+,#D4SMOXVO?5)7!:HZZA
MS#_X^P6Z]=A9FB)(!FF %FO\*[ET"6QIETQ?S]0ABGGRYK<C4?KMNE/$/D0P
MDHY!^5:CX9O5S+5\4Z(WPQ:5'5P-&Z>00UPN? Z[QOP>$![0<,N1YNU?MM3B
M\#JF=8<F1\+YFF_B'O!SN779'RXSL-[ZFJ$'>@\@SJMG-98N^5IM<=M'WG]@
M:(9?^845Z9@7Z<DB:__E>9/Q:N_+.WCGN=C@=K.JC&+UY%9;\B@1YXF-"!6.
MM_#U$T"F4C_@ZRLN3%VDS>J2BPYZ\A]*[W#E8*/KNNRKSXG1[(&==./)U^FH
MYR^"3/?[@5CTD49&>UC+K!LXN?A<?B'\.#?<+?! >/6%/-#$#1%$F+95?8$6
MM#XLMHS%K_4V)\ZO!?4FT(.TP#'<!F$$*H*%Y;'\HD6L<K6]/4%2NG#R7LT3
M"_V-#XGU;SII),]S4#Q\?+\%7QQ/7:! : 4R>/,^K'O-*KAW&F&T\-:&C[N"
MA.3]V'0FH&*;TR*5-9G=@,4-/R;T6>"N[#%7TBR*S-%MM1?>GD ZINXY_J?\
ML'_H3&2 /#T]T^MF3C>LNJ\Z^VDI .#^J*1EZ1Y@Q.R]MW-=&XYXT5&AOJ%B
MAFLK0JE+-FPYE["\U&<EX0'"H[5\-+^3.3,*?&4'-:,Y'Y:RZ(T_N-+<:\ *
MKHE97 C2"R).WZ'9*90ZZ$ P?6N56?_[.=9DZGDKB<WPYS\Q30<A6D_H"5_+
M)ZZ>$-G*C^]Y&0M#;"OB?@X.$$7/BUV'PUJAZA3\$TO7Z!R>CRD7U8%K^BSW
M@."LC;3H;R,KUFDM&X.CG%MOD*O?\2GAUV/M[-05I5.*U=73E?5X8&$3LQ_V
MOT2JES7=*[%6S;T^?\O7S_CZST[_GWC^->$-#3=M"] -T8-1IU3@0LJ@7RSJ
M]\'(SCT $Q7S;FVZ6JX4V=ZW+D>;>R P\I+_^L\'JN$O;@L-@9I@O^V^@PV9
M"-K!#>=4WQJUB3B%GW@V\2MT<H[@R$YI2H3EGG1#7K>;.  K)U6D<Q?O&5:,
M%VU'(=A&?L+!;Z(0B#!4VN3I.*XIVRKAQE[.T$_?8!?DC3[717&3SE[NGR 7
M9RI8UBS#T&2-<FY\C$7@BNS3HE&+;TC:HX-T=0RD*1]9+*E"_CO&<ES'.A8!
M5 ^Q?K&$DICDAF#R@V0NEHKR#]%0H/?C3-+ 99T[OFIP"0(4P/?C$2+]SR6Q
M+6M8[DXXFRIJ52>Y7=V:C)Y(QKM\O7KM<[B0[Y+LH-3GBT-N!*04]H(<%V'1
M\?$%X86+5*]4?0*S8P(N'\6>-JRF[$J<;#_4\90H-)4]\L1'=!RX0BR?QE;?
M,[&XMZ,88A-DL@G=MFC<3-^\F<L%DW4[(VV46Z%9!JJ&]I'SO)89S/IO//K6
MZO4#!]BCW/;D.^ ;7=+LK;?6E;GOI,8\-9=?.%Y%D+0@1AR XO)9.7N(OT!W
M)T/#_H3J]XV S*(#52FL"_^YK.L4V_^2%,W_-].U;A&NQ,Z,S37\[>*VTP>A
M/ZGWJ>D4&U5XYNR?LV?H"M"4TXC4JT\S:9P8KVYN".1EW=AZNA44=8,J#.";
M,"@3KKP'X')U@GCN =7M0S0.(NBSL:6@%E_AL]3)_R!IRM;.S$GBNF]F3.UZ
ME^H+HY#(SV?,\3KT&U*X&Z(5N3$/ MOD&R3H?_KD90BDW'!W?&'8U8B*BM^P
MC_B1RL!O!>VI]"QSVT=W_W+>IZY[BW 9=K@;;SB(8#2_[.>S#&A>>@SNP%'F
M>H"@;6&.!6T*0!I[E?"-X#Z H\)T3*\]9=VT+%_RNOJ;6A!X_6\'5VVC1;KE
MY@.[,9%C($-W0##_327^?VZE=JD^M- DCR(3WEW>'%M+QC^O[);(4YMK:=T]
M%#)V&3D2WR,_^;[(Q3-#^BA9".S\8HW=BD7?/)815SQRK7SBPU=7A7B1XP;B
MV<!N]-9S:TQ=EU\>:I'^K#2P4:]:CGQZI8GH\?HNXH[8U1/X[5(,$SXZ'2$\
M^@YX)3NT([/(8*_7YT<[[59;L$\KM-4&+2M0FUJX*\%[]T*G1*^?F?Z"X65:
M<\L2[!Y0N7Q!JNMNQ+5P?IL<FF*@E+N;^0J.:J>"CT6XOFB>3L#[=?&D0,5[
MX.^KW\L[/*AW@8MSP'43<9#%^FA&$<_A);36]C2MLK9)(8'_)2HPE"LQ*G[T
M]8&6ZIHZC?U<JM0](,Q-E8UURG&CR4A*7(R24D-MF_O:^@LC#L#%!!]&,)U%
M#/%YPQIZ& ^L,10@]4@!4@1B4O=AG""U=2?1_LE!^W=4V\YH ?ARXIIC*'P/
M)E0T#_*OA[#.;[_>BMI+3&:]O("HA^DMTPI?-INV">=QC?Y![-W8*ULU 8C?
M<?LD[31A"I5M2&$?]!C2NPLGO$V ;+5N_E&DLXC7C\'8P8P81O"%2+Y9?OFM
M!TW5.I6H:?3.BJ<]/^93@M1"X&-I<]FQN8B,F2S_<7L%MX4+T16,D4]%/@K0
MJ3H"O!Y#PE\N%J]'+,I8<B4CAD.C7E>/L9)E*==T$/IP05"Z"'S:S#2V2;:"
M^J[K%!=+Q:TK^I,Q>(PXOE/$7MW84V1XZZ<B<(K)]&%18\2LO2<(HIG T0!B
M&1Y5<294(5EXE&($/XD H4SXPB2Y//-#6QIB8/LKVDI//^$1#VFGH_[^+FU+
M-ZM$87@TI*!(F#6R:+<_4G^$WP!DCIK*35BZ8(X]13-"L>21D;N)&JFPR;$C
M 06*5B?^-V]+F/@W$WSM*T+?M)F%\:W3L 8L"/^ 6I%GH,WCJD7[A%=OMJN+
MX!T1*)D2LT7P W=1$DXY2PO_XF:[R8D??043CMI)_%87Y59RY+<2O;(K,KML
MEG(=N48B'+AA8M&EXB$UFD%0K@?]O/Z.I;-<N<X[EM72TKII#!M)]@%AG52J
MLB[<U%%O8GH$*D=/(GJ?D$+5B*.J64]=3/J#6_D]\I=7#FA[3\WL#4,F!*L5
M:D0G%(9I.0<[!S<O2EH9LI? WDK-=2T)5 E&!Y%)_*3R\ZS<& /TJV?J<PT'
MZ+?G)S?^OT;! K.GW6@R)OR_9FH64SLD>V-.S^(Z6;\+5*A+Z&1RI4RV2JW>
MTI7QK[>)&$R@E TTZU72!B^-5:)($\M^[(RO7O9Z"2=EVXE;-ZUGR%G7CY9P
M.QONN'SA(E9/=UITQ2ER,D;G9:/D$#P9H]&09;#IBE(3'5MR'^ZR\Z]#^B.L
MF&O1'!'7FWE_/72%A.V<2NU$J/(9U]TC&5(?DYE#O@I>[&372/?&^A#=R",<
MG\!W FO0J 9 U*9>P3OJ$.IU+>7<8*ST= Q]X6:":4;I:;?M!#)[%PN"&F9V
ML*4U:WR4Q3;#[E3:"2JXDF_I.AU?&K>^"AE]#WB2F>%;; BV\WU]5+LW8=).
MTQ/\BCYAOTB,F21=MS!^;8$)$Z56-7E.)+Z@,EUWO94Z4NC)0BH_&$H7SKQ6
M/=N</,X;VZ.#(/I%-(^=_.72\CH-M73=QQ_EO0-+OI)M;D)L)U;DQT4:28BM
MQN-*#(N]?4+=)ZV=:1N)]/- ^:\2FH"V;LPN1"OIQU8S+$Q2%[2F?&3755KD
M=!+5)WM.%3!V$DB2WIF?C=HQ8>GWKV?A@ENZU2F+0$4\@R&C*SHX1Y01%KH?
MF1/D9S?QSWN_]*_YTX*]]:?'@D_.1:;<)/I:D]PX"@0Z3Z(7A(FIG>+3W2%9
M.$C3V^X4K\4Y6$"[K_R6@^2Z<+4$X$O%JSSFU4?@?L'<MMF6RG[U/?Y!F)X)
MT]J=*S]5GYX2/$+U[5OYAJ<90G$;+^ B23%21@3G%2U=-ZQ^]/"^K/S^;Y>V
M'TT";D]FTA"?U3>,.2?:%Q"%]HIL2P4+3RXB&]^L.5S^G#IC$I;2;9,OO3)^
M8,J5HR?'+V9]VJ@.[@&/!L[,R':'*WU,)@^MFQM#IG?/A+H6!BR &LH=+]8&
ML%;32=(_YS3#9[/@&SVF#$WPL2P;FV*S2+IALJ^G<KP7HCYBHN8ZSA*Z.V$H
M]O)]:?Y:!&%\J:R55%+:.^KDU\\'_ER_/.@?4/@JBT.!G;6616%W<YE5"AZZ
M5>+?JYB$S0,U![?JOILK'K&+ =(Q+@H(>,XZEONE'/>0?S=;/Y4;V?M)S;A&
M.\HBA&OS]B9ZZ=V]!-4F!*-:YK=A0TJ[Y#;TM#-(D).+X[KWD8C:.$JI$&P+
MXZYZ5[[0'/:"(*BZEO):.<XI,WM.M@)L8?RMYS4XLDOO4O?JZE6YB&X#HM9H
M$71;KLPPU$DJ\#IU"KYHRD/ W<[1/$F=]$A4<"#_:9&4BMC@!O0Q\82_V13N
M_O#R\WM O,W'ASX4\S_'-'5<NP>$TBJ$26+DVS5/S\T95E<I,;?<&D> VM]H
MR)>^C<[F<U <'/'R*[.[@DD=Y<N]3^Q$<%IT<N?CW[KH2$KD&P,9":;JO$/#
M*WC*$Y9@ LJ4>$&RS/1^% 3>-= ;(P2G0T=%?Q92H;/9/T:2I-!>FJ>Q;4:(
M,Y>'?,3M^1, *V^O%I4H($&6]6+$E1%SMK4R&&%FWYSHZ9[I([#\H4=X8-,2
M7]UXE<AK$6X:[K(VAKV7*K71<T59=>C^/>'[9B8NX.J\PH\I](J*"9^WE=W7
M@]QEA+NF'&XUH_1S*)WX]0++@:$22@E4M%.YYLQ<IX=NN <$>!:%J0?SU)6U
M672CF1!E^^%4:3AA$<9?%L7PCX^EC;^J+2<M^*A,"#X(6F F:?-T3@*05XA.
MQ9-J+%XC_Q>W< B [.[09AEB)TV-#%Y7?70/D)NM]WT*FU7$=VK/(,]5&I76
M?.;S7>O-Z#AX@!IR0@;6/3.$MV=9V7A20 N*5!Z/M%84;)Q]WJ5V@WD6Y*XT
M^_/FZ74,W@,ZQ2II?MO #WY3-JN'<)^ /DV[D0?._LXT"J"V^F,4+C%4@2-U
M$)-4?A[.,BU)M^K/"(3!1F/.%F$?)A8K3C*L'R\P!RWA&)[?9A$<9++#TPS
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MO$9?/ VCW@;SFGBZPDDOW]77%^0.V$<4AO< S>I)".V)9FM#+50+4]7I95]
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M0/58X*33NU,L[#4'MY<5&NY3QK8O;[,E"_=__!3_L3))(?A8!Z/.X%4_M-O
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ML]NGP)4;XK(4F5/#!V%PBZ'ZX%H)=;=F8OY[K)6!_L%^MD=E0?YA7L&S!65
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M:;7^R+*P2+QAC\.A:(&?](@+%ZW>T0X-Z]1FGA)(/XRN"V>R5"GY\8=-<\1
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MHQC6/3/,WOBP5J=7!)^CCA7OI"@$-#JE3?-ELH0PTV]M8C8_Y1;@;2F=Z[A
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MG$;,4@\ZG1@$]E'?O#\M%@#EQ]'"#6!7W1KY.?+62XU5QVQ\P#[70E3U):_
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MN\QS<UG]->L_&S8!&88N%+NMG%FP]PZ>R  $?HFQ33/U@=!0D(NG3ND(D&V
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MEQ&8S_]QRUR'^!J$48]AMDBPGK7X\OU='4-MX4[I#0:Z?OZLK9>60Q5^KD$
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M,8]+R-FFRCZ3:IMQK&/2ZBS3[\_L-B-*<G*&=("4/W:GU6ZP4,/Q<OJAF?/
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M?S KT%/?XZ;AAGM0?O;AIW)HJ[U\_\#G=$4(J:W4/]-;J%Z =9QN@[;@"&C
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M]P:&_ZF9.3=S<<[43-7,J>_=];MZ=^W::^_W6<^SGN:>5@&OOL@JR )04%
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MP<J^FX_;4/;-YPPI^Z(<!N*H&,_K I/WJ@;@^KQB]SS5J5Q8)5P99F,I4(C
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M3$3MF,N)W"[DR1.F& & 5'4%J'I'-K?C!8)*YE^K#8MW!N>9/0Q2!DBL:D$
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MD A!L( @SQB5-- *L>[0U\6;_N!YO^$Y:U-?!=?!491G"B6)-7?XG*,I^P&
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M9&O'&"KT]2_GVWD4?&7N= ?H<M(=/KQVQL;NX%)4L^DY.A\MM1U4R3-_NF!
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M9XT?(_=D.-SB,SPZF:N]%QE0FUEL%:=> _^TP_GF5];[=P?+1.M7^SVRW'9
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M2_$EA&/K+8<CQGD_$RQBQUC]V?3F\*?KKE!UC=QW$PN<G7S4<Y62W$RX>Q@
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M/-V4YLB(><&M#YHKRC=U-*:S+GRY/BTG(*^:^A)\_XNKFIKR L%W[#?Y%P"
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M&GO!:W;LXW=!]QL=S\3CH%DBZ%K;.;?[=X=;:\,3K]UF!@Y!UZF'+6&%33Y
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MX)AXUKBGR&U[*:_LB2QV'1LX/EF\\%&%>E.'-#_M\R/NZ/<DH-HX+]%F)^)
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MC@Q9W"'M63;6).LQ0!_CC(874Q=]6V&T5*DL)?^B:]]=E]E,PSLY<VVWT$2
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M$0NF$[,EO$]:+].YZ>A;#N].^9:9C]11KIZVMVB>@?_$]MHRZ9L\QY,$7%Y
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M+'!@^^O$_NVO0<.P)95O4Z?$L8T[GZ@$UUT&^"8\2];D7IBR1??B@GIU*HJ
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MRITNQ:68GXV2%L/:?1E#KDK#S7+7_[+*M7E<V])FOB$1^965*&7'4/UN1/8
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M1HH&EU_,AW@E@A]6&M9_=%0<C)NO[Z2"K,X.59K"&$A(@*LV"C>I>)W/_
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M'X?^.W#1@]T;P)4H5JK8;O6.O0/<\%;\0*GA1G?#H2X(<5SQDS?D3$/U[2-
M/9K:61!S.4+DBP''NFU%B/\&8R-R9'M/1L;FN/:7CRM4=+HD?_PJA EAP<PT
M0P2SIL*<]A6"''A#0AMY#G 3]2QP8@+[POJYSHN_T$=Y%;<J;N!R]&&CKI*G
M^K1\304M"47P="MTP7IN*,*4#U+^^/O?X"U5)*U4P%WTJ8-%;5?%?_0:T8A3
MA!).*]G(_?J"STE/M-+J$BBX&S&?/<^SL?9\">E]7#Y>4VZ;]/SC"SZEJU2S
M-$<,[*5RGJ&=9ENJ(>Q2JQ<(Z@=I<>PGMWPO<8LZFTD@L7G837U%W? (F#1J
MIG3H@:9<P"P:U#]'%AJQ;8EK ,AF7Z):4$2I?/*S<4M_-F\0K^R3S"A3N,JP
M9:2&ZE)$@SXHZNQM?OC!]=^74!J?#J6G/''6L*E/ZJ"<AN^\3CAV9?#T*!(A
M'>UQO.Z22-=%L'+U(32Z/+BR]/))8A7639HQ P 9ZU2@?,-G<[[J#[2$RE<-
M-<26W*)M 2.[I./.?OY8'!?8AO(&TW4V><GVO#WO@E2_0W;89QH)X@<^$4C/
M)(T\ NH? ;P:\ZECWT*V+ZD)0+<5H764/-W>XHG7PE\&"V?=%,G4#,''844"
M!%$WJ$Q_QI$^?\LZ7MZ;I:Q=Z7:<0]Y83E_?B(1U2$B(5$5 K^K.#I7G+I/=
M0'XJ>M,<3%CLQA_;./UR'5 ]N\8Q"EADI,[L8S=*[UK:N!BBE!ISHTQ..[RD
M![R8=M@]TN(^.[Z3EZWXPE2> <;HIA2>7NHZ7Y%]QGJM,\_&&_#-JK<LEVD&
MH$E%*C^3C0PB3B65"U9-/H9+?2\WT5YWORFM/GOX =IH8W!=$F*,(XI31/TD
M];4E20Q .D(U:Z./6Q[K56+0^4?D0$?"YK>"%-:2](8C!JG:/*^BT;Y[P_;#
M)X^:CO1' ,G#%Y(>;!',=O*]8Q"%A<$2:P-N1#*#0[ONM=#@3C;BY4"?RO.
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M8'] E./6I.5&X]2#.EU_J1(<>Y"2UU#89\12IPATT8<=E,5<;CVGB1$+H%J
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MM]2V-Z!)^9D+@3T##E#Q5GL)/IWM_H#<"XDF4<-NH87.AS7CLZ<ISJ5IZWB
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ML9^RW@U+J)'O#A+!+,JP,IY\%N?]WIR2BF+NQ?HX0Q/W5PG2DOX8JT7EA-#
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MBS%_=]O"!)PZHA_Q>L,),:EWSSJKNG*>'P20M\KB%!?UNT79@IS:+1?G2,3
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MO"*]%_FTC<]EVKK4&R'Z5WM\H,R$IO=/OKCKXL8KY);M1I$!Z>Q*H@$ZFH&
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M%IGJFA.G-<2ETMQ$67V@L@8Z7;LF/(TQ7=F<4Q?>Z5[G%?(H(BZN!+( =WG
M2)&&D)Y*-3JJ0M:Z0F,]AI=/[,_@;1)%>DU>[B:W\E"+!Z'HQML4>,1ZT%Y
MSJH/.?D0NO4 SY+6=IEYHH[6B6K19*F#U7(O+O<'TTGFC9[4:@[IOIX_"QQY
M-!+U=H3X:?GT_@OUX;=&)#W*BM751A "'-'KT7K<HN*?!2@EU@0$EV#WNP2=
M( [%OL<>JR%:>HE>,O(H,"+&3^XUZ@>$&ZPOM\A=V"LWS2(;J$)*M1"VFFDN
M97</B,18NOJN@V4__$9Y0->\ZI Q0DN[<=LI\K35-(J='D&!2B.O(#%_Q>$L
M$P^556?VZV9XZU2=2I:&QHQ#W8U[8\2GB;D/1J5]75R)Y)UT@<Y]Y54$RVA$
M3SQ?F?E&FP#U]5!>@!4+GM6N>4*,=R"TZR'&)_6DM*+EENH<F!K$F)S3#62?
M<R>AK%I^+>RGFT:</\*R2T_]<0^P:?R 6O@3Z.#R,PX1#[@JUS^1-%VU+:^L
M7_)?,1UW<$B<]Q3F!O)6N]9_L1>U'!;,]LZU(Y0M1NE%02-X*W17-#*T)AVM
M3GD.UYW"]3K9>;QT "Z^.D,X-]J3;O6-4^>N!<L4+RO4_HS4>4C,A*2?544:
M>$96MK.@U7A:%>BC1W@[:CF_UM":,?]+@PFSLEJX40WY.*0Y>@.+##L#P)<'
MC:,\,.E/,4..)R Z_M%/[;2A=;84NWE-C&0'/O#+[9RU'$))(CN1!"5GWJ5N
M?[.%#S^>!&\ZF"D"&*1L3K$K\UH/5[Q@G08I/R3?5RP<7.OFNC5 9693I@UM
M&4-%/^BDLN ^U-!"2Z;=XO 8-B0\O/+H?*5F@;?GN/ MEA74^R4Q4?PS4=:D
M'H:@?4\R/7X07\4:/]Z^WAW;=*K^#:NC:+J$',PLNFE>1XEZA/I:ER_5'$5J
M$#YBD--#86#D&I9Z\XI7R%).MD\W.</CD,&YU_:"4G:TI-)@1:\](.JJ64(C
MXVE=224);TQWN+S67*_/HUYG^?JR%0.O>T 7C07I86T;9*^29;;8^Z-6:T)"
ML,8'3E[0SCT %Q.Q,GB'^R]+C7SGNJATO>4DTB<B_-QPP5?B6[&L\V733Y(,
M*Y[5(W410><K",YRYL1YFTKW,AW**N>G5])GV#1OO>BF<.J>'>^F_B<'CMV"
MRN?G+./I>K <#.,I[LS_./01>0^Z_Z+QF'P5U9"T%B?*M6X88[.9L)(9;/$U
MU\<<6U++"[M[IODHO,K1-\"R9*C(Z ?%W2"#SL A?E6@(FZV<Z^=8SXXZ%S"
M@'O C_>A9*)%JX]H0[NGF[FR!BJ;78R47.LC>19^ESRC>T)?FPW,1\)B'':0
ME56^59%ARS'.SHX>E_L?E+;PCS_Y6)B5[OF>TV<=MBSLW++4YK5N*(>L,T:5
M@X2V4$+9<4\&HO(F2-7T9P8E2[RIPONIAM\8>J2WYUNB*'9D)RL_-G@VQ+@7
MDT2W*/O5(#H&W5^,E.8-7_K> TQG^C+*C.W=O^MQXU25V)F2\+DMZ%_:&ABG
M9Q0^+QYJC-_ZG"@@7#+R&+R6OE_JI@JV___D;, '.+?SUK0TH7*"=X*G;;_!
M6M.*$D4'>=YUO^-1 %A#'E(*]*B2WY_Q8'KZMXI4=X,6C_/'L+1^.@ NZXR"
M'+=OPUUS0/Q)Q3V@$KYM/2]_L+;+;/&-J4Z'0X'I< ]J<-82@+MR(/.XSIBW
M?$I(@I]OBY<_;[Y\=_.?0\7H:U;7 Y-2.6U/T-4]0"*)W"+5\;1ZL^&*YO',
M,XL5'+[QF\";.N#_P-M;/[7UA>^BH6@I;L6A2''7XI3BQ8N4$*1 D1 H[E!*
ML>!0H,7=@P9W*=+BP9U <0O6((7#9\[]X<[<N3/GE_/]"];:>SW[D3WK?5\K
MYY*NDZA%U0Z_7Z7O\,LI%;HQ<XORHW>I\+=D].P\73<M<,8)X5-]+IZ?$&J)
MJ28]89\?MTX^*#8WJ6Z/8%+YTF[P%K$^Y<GP&M%O023&$ QL:4M5+,V0/+;\
M\8PAIST!*0C I-Y$58/SXYJ8-!E=UE?(]:;N<)'^=!U"$'[VUG8?&&SBL(]Y
MD77=UI^ :(8JKVA?X-2]SXO+RF,NH3%K&QAI,I0!>F;KFAA#OU/,@[ O"4:<
MOEP$SJ%XUBKDLMS*B[[WKP.$U7LJF2*\FJ@LB$5YP,WL3<W022JUHM=Q$1.A
M0V((/74'U\Z(;'LYVN;I.T)D%M45%XSV :#720JO39$&C<T!+AF(_.=DK?_]
M*%Q<<O!;Z[FN\E2;5OE+&Q2+=75.VATL$MLRH.UGEWZEP6GQ!\V#>\<T:)#6
M.9-_^C?,:26 O?2W\RXE?%1X]M5C@O+Z1H C['JV<S,GM'YKG#/@4&8O]WSZ
M3B+_.QMP5^ #U6]7 3I\!>KUN"!+7'KCDDDM6>>7\-H_]URS'J/.^R"YVXVF
MJ&H7%G:^XSD=9?R5'_R8=Z%Y8SXG4VW!3X&.C=GD"+[+%H+T;Y\XFS_<QIUX
M':L"LK<;[0OA1G0SRSSIJ*X(?AGU/#8O\DK:K*Q>\_<:UXMU>4.$ARJ*-W.:
MRIBJF$S]6J9+O^'3 9A(BR,6@$OM4N'LGU97_D.,'/,O56AYE1EM6!DZIY^$
MO;&H]"M46O03<A9K;)I7JI8M>;&-EJMD.H=U2(8+"='L2_;YD=/7FEU1/%P%
MHBZ<RB?7I#ONXQE0D]Q5I-D'EYYZ%L-*?:)-4.:PDN'BZ/G\1GC]MW@QJ[=9
M8[@J[/$,%<:]4MBS(415:?JOM\_?99_)<R9_=</#978_N#O(+YKT8T>_^&WT
M+]C@M]-%EGH0]H&4O\/?US=O.I\Z6;D(-6G\^=0\/,0<;S:79_K_^3PF\J,<
MTT_NC1C^';M8_%P^*RC<MS@=*]"\'V^[G[C%&:_SY=L^7LMT&G!'&YU 15=,
MYXPG O0*33*NX>CLU?UA$]XD)68:3FV</\STC W+>EJ-*W<G:)-OE;!_+NXC
M#;)*ANBX1C_EZO"&+%9M8'-)9^M,+@E#8LVGR!;V*&;W":/C#EM/B?[JIR!E
MB,B2(N5ZNFW,MY@Z3M!@[KC3954OE+P!]L_!TF]M:JUL\$ZAKK4CNB]_=M%A
MQ/1/99VO7NK\Y\S:007I[)1Y/67^U/^H8#7/7!T))+5"$>O.!"BO'ZGVWSB=
M]J>[PAN>@R$AYV61"3@ZKW[ZK5!X-M^8G =C[CT7#Y*9.7D ;-#$OT8<5S+?
MRI"^*<=AJ.^R7&0[5N  0*N1679O9X^+$">==#[I5V<L^JM''A>ZL(6D=?DA
M*?J=N'\\TYQY!S;L10L#BF6.032G5*FM5XGE8.]5C4%OAJ\\[LSR1T_ZO"W5
MQF4NMFONF!S/T:-B?+B]-SGA< .LZ$#LP]<+SNR;5FJ8]*3C(X!-Z,4-U]JJ
M&V7'JL&(:):%X2G?/:P(A#8PF\YKFRYNJV]#,+\OL$T([\OJL\+:S-DSE<-L
MG.W:X$9]+*C<J_XP-[4TC$_>C$6:\-S[=;>UES!&U0U44Z=U+>T:T_CVY/H!
M\&/H3JJ^M79"P+JM,7U594: S3 %GPS&0]+-V.]&*-%M9&SDALY= 6H!,LR:
M4P7$A3L_D#3;CNNZ3KN"PB@0=[#KX(0;X-A_K;LS5<(*M%PK?(Y7SU;M(0W/
M:FK;!MZIA6/KO\LN>$7O9\Q0O.!P3XE8GVQ7/*T"&9TM^VJ6.K3*2.@MEZY+
M"_48L=*LK(D=4>@_ -@ZUQ\ $;=CCL]VX0*X["M=7X^/"G1-]J0"2&ETR=S/
MN/!UW##&94<?'5ZPD\]OK>D L?45N[XP_F>.WA*IO6.O-KC=B@77VC_TTV^&
MKG9\@#K<SE'":_24*<)]+O_%F-K%-51TD:&?ZZ.X.K*T<SQ=[)L2!_%TL6Q-
M0AB?RB2.;P ? $1P_Q6!?D:.[,W7T2I-;?Z^D"-+!5;E>17A7"ZK.Z ;AJR6
M'R6%JK(+#U;#W3A?A/JT:B\QY0*#W"YH7"[W0^BPB[#"E)!^14QFW/<#\_BB
M M7"]ZQEQB8DPC4]N/;K,ZU<:YI^0?B]C4V7=Z#>%B;JA140^)XD:771P;II
MAB!9U-Y$I=,@=D15,0E'!^8YK0\LEBBW[T<%A3X GLI_;9"EEHRMRN..ZWMA
MXE9X:X-_GO%>-(,S%W%I$>K^NYS[JR\O'.P+R6IU)ML"$(F,OYVKF7R-X\K(
M/2E0/''!H*HTM1GW5Z4Y;I]/2".7"U[17QB0^^C;8Z!_9(*1_W3Z+8@]H\$Z
M^ >F-@ZT&16Q1AA/N'&POFZE<92\]7[9 :T) .>;H9-[%K/C/Z+8?TX#28O9
MF%_A)F'(=G!V=DG?\]Q%,-#>MWWO%*N?[I>CGX5WR&DI7F3DR336"I+)0&A4
MEK(+[21/S!X T(91]P$_V4(INZ^>;=(FGL\<G"WTFLX*N>NX>E6>6L^GK@,(
M_2HYK;^(2OXJQ672")1>>*25!T#W"P&O5:,[^?7,""CO<94,>'UAHS'=!')<
M1>M )OR;6K &.W+]B<]VZL#8GAS/P?-8B/#B<-&22O*W%S2A+=QT>:RL\7X'
MI7G20?)1.A9]IY(6D4$T&>]:)QLJ EF6WD.$5<D=YO!C.,*Z"9N"Z<(Q:"I/
MB$<W_BF9-L;]WM#:SN!UPY%(2Q>E^OV4_MAH3!TKF%B69VJW$(Y;MG,S?I7S
M-<#5%ZD)(OMKA!#C,<EOC==19$-ITKPP>:EHJ60=][T\<04<Q(J.W<BRO9,M
M=5A\2PIB^5<G6(]C0]]:]9H(0/.*0\:X:/+UU*K%:? (.^SN ; >G/"(8(Q!
MM..O?6(FGU_;8(>"+TB@ 4$US3-FDO4CCM#0GI^6)FCM!\![M%75[CA!:EJR
MH['!TK\\_(!>-U2VZHHD_0WMQ0WGWIGFL3=1TWG7AG4X0L:W7,L37&SAP]IO
M]/?0\.4W!9AC1$Q-AA<>@Y]=@[5/?!_*OE-L.D#1=WT+)9Y6IDR3^ $>AT3.
MOJ,+>A>D43.HC>S0@#)],G680-Y1>%14_#B&KV&,;LR0'IT?>Z!A-LG9QHYW
M\YLRJ*E"=*"MIZT+$L,3(HH#<MXWZ:]-60T+I[8KE8WUHC#H^N,R@-P[ESS"
MF=I?0TK$"+ W9$%V-.5?*M$\XY^?%]3WD92A-^9"QNHC^H_$VH,)[W3%9O13
MTXYL4K>Y<%?D'8B[<;,+F08ZW*!&"U[<-TW_/!X K&,RQAL@[9N^/EK86 :X
MVI%6 ])9^T,O=0\$2*A"Q79_[A-CBM@^O<^# 55M3XO/M5)?8=+]'J5]9OLU
MSIO'CNV+?$1VRIZ'06?3RT63]3O;ZKTNAT .XU.BKBJ%9IO4M;>:W[55#2$+
M!DNY8@9JTPU,F &2TYZRVKU;JH2_Q7-*S,Q.?K!\-(Q[&9R1F1/P!-M/]ET7
M@O=2+1]ZA2&L+*P-50=(T9=M5A%+RNB;!CP QL_I.)I\V1JCMF.4>9@%J"%+
MVJ]HNL=D'34X\Z+H[6(].MXZ+C)%>?@+-*TX"*O5+40]$9T8:@,ZR#A3X^+"
M@*</@&@;E-AT8TGOS?T/_ '-T;+%2(ILG)GK*.>[37IC/64&WJL'@%#G3O3\
M[DWP%\B:VIP<[7!5I;O\@B>?O$;X47%D9O6/3.&:L5<750/^DMMH"]C/8A\0
M_&,+O/GL GTTR>;%J<#..K3LLYD\U>;')?L!P26MKN[W(X@&JB;#4Z@DZD)?
MN_"Z*JY0..$SB>(N..;TWU7!A@OE :WR3H28?Z2GUOOCH^HC9C)@N=KS?]8V
M3@.OJE7S8;_.W$[NO46@\%>!\ICQIS,ITXQRJ)21680J=G]C,8VY,)7"BYY%
M'5S<4&C\1D?L2FQX>Y-7_1*\=66Y-JJ $_2,0'!<UY_VB+,PJ_,@2(+.V/L_
MA(_!=0C-]K-)4*GQW@2S$7K3)P'%Z<(MQJS@F#ACF2W/$@<YL5GX;Z#L<\-3
M[<Z;;YPU\*M/E8W53;'WSNL R3&\H6JE_"3$Z1UE^.5=,/DO&0M+OB#FX4KP
M*NET@&9A1Z'K>_:BYE:JJ2>:X9$)KS:W[[CG0N'^D7*L9ONU/H:BA,*;&J1]
M!)_RZ:,41T)P9MRS?W  C(LGWWC<!9-J/C*/S(YVUW0 SV:@\]1.7WK'G\;:
M4O:?#4<Q3TP2*-[(60TM?)&>#6K*5=IX %#O+P[DK1>AQ%/*OGV7[?CF+2%>
M]YFB:F"K;!V%2+]TY#SZDWM[G>D2:H.PT?R](M&=C [$LL04BQ%'F'G^.C3(
MQKOG)5)V,W\YS8S2U**,Z*LF!Z)CGC2F9S:J@[>&I(2:B?\J_F6^%SNXT/V+
MG8>=9*9JY9RFS?CG@QY/M4J F^JFP:2R^/$Q6V6E:Y @H@'H0K*[RC5Y&)?'
MGUVGZ&X30_DG_*U-GHRS/D;/@<EB=E[YG2I0EF6NSW0LL81OV6 -Y#B!1S0T
M+_G&+*D_X=7N8SXIA%\']]U;^SWF4E8HRC!V9;"?"6NY!RS3>(4 T?Q1>\Q_
M/T.:XYYSA*0?V>?'I5[>J:S,&Y,C*P@-M%'F&<@5'AV(YN'5V?M5TS<**?D?
MJ(5M/JNQE@3,0909G,.V?(M6KF HJK\:]:%]K9WQA8OF@[Z^KN6]S-YG8W]B
MR=DR,]T1T):*XK(- ;I5="I"N6WF8D5C5K(*68MQ_"))YLCR:^QZ:!R13]4]
M5'SIIOEQGR!MY>+@2#G"F</"*3%9!OX\'U;:;RQ<3UE/G+ 2,"XK81P#K;,_
MP';Y^YU/Y];TPZBHLL<H4V>N4%VCRP!<FAX:RET/@WW^B!R?<)!.'Q,);E3>
MQ"4A4*L%D3IF@R@@TWI6&?;M<(B7Z'A%R)"U92Y &<7:)S62S=B%@$>^:%&6
ML,?*^X$KS+VE\O_(1/%C7G,10,MO$YK?!Y_*#YW]TS2<AEO$T!8=92>[EIOR
M)SKSY\)[LE2N\>NX6+T$%6G&62F=>R' @57Q*<\H#SXEU<F+L)3-^TE%BO.1
M@WI&<VT*@O,UL2G370E=GUN]N70U+=AHC/C0YZR-Q.])*D+QW[VKPM,G!?Y;
MD]A[YUX-55(;KXYR;N*(NL,N\TG:O[K,_G5%)]H6J>!:2W2&Y1\X6%WDD4-T
MX;_"'4SQ#$;+Q\7O0F7"EZO \DZ(_TG"DR0IAG;G43]"2OF/JT9<^R<[[DEH
M:SM/J],3M8;VQO1%I.@GU-LPAB OF="ARC4B=)#_$=/ C>T%^=++HG)0Y*+:
MKV-598PY6=7F3>C);HF W]_]_XPI!Z1M[?P!(#(*MW@.#J)'\ ;(EZ,%S%NZ
M&J(@LYLZ81\;OPO\JMZFHG/#46.%SJ'#Z);L4SO90_!:)[:!*^VV^0,+!M4>
M'*@G;=P;[4H;XY0^)09I6ET=4[ [SJD"N-?O%VU9SW%_NP7I/F4P;A!?SLD)
M/MC99TNZ.-1<CUS2/+6=BQ1C-CK0=_ $P@93C&@,=XJG\>7Q5TX;Z^4C T2L
M*I9-_D6=L)!%RJR)..:TG5MZ4LM*SRRM2"'T$"\157G$#C(J-*P$QIPJ>$,]
M]'Z&D05J']0*=&OSPPP9  S8A+!@XH-CJ@[O?2DH9Z'@_\B5IN97=\$5%JMF
M@QOR>&8'J8WUHN2@ABVOVC3S?-EK@=#$;"FCV7KD_(4L[<#^@7:K_^VVR='%
MO!=\_ 7-TAP]P=8.)H5'\Q$L#@K=@ 3XER^L+BDANYZ:[>J"?M4H>@BPMD;[
M>Q 98 O[T,"(*="+ L_V;XRR;SQ'M]*3?KT .IL-97P*<8WS]F3#B+,GG=$S
MXRN)%[,7:Y,F)D.K["B'W[NP3!T<)2ZSRCW%OY7;D-RLWC.^4T+>'DD;TXJ'
M;5Q?=N@J\-M$.9.M2F[ROB,[64[P 5SD$E5!>R8]#Y9@W-LGYI.V$]G3Y-SC
M4AH9"L.VGI+,@=CN)4C&!C:E=PVG_$42$8TTA*B6J(]"#X! R/B(BJ!?:-PT
MQBZ%L1"2F&[>/ILXM']28/'B.IM 6(BI+?'SRD3R9_<8]QA7D[0U4L\.8?%'
M 7I6VK=QB9&.7GGS\9U\_P3Q=V*S;&QIL*4L/O1\+?*><Q;>!B*_??8V_5CZ
M]T'P6M'4ZSK;)CQ%CD]K,60JRXR!/-HZU/NF=N')>G/M8K*I>6)3BTM[-2#5
M3^?2@<N2O3'G<\5<'EU#TKY9@93#NW)L*-FKPL;6M2_.HM\SR=*>!E/^(G@2
M!&GFF2<B-CW@K,&F,"8.W.PP0M[O+_5VDC?/)8T9$/X<;H];?,&\7SJ>M>4A
M2>&+L:SWW]QSPZ;((^=?B\OO5Q?4/K35M0#4GVVR2JY_>87U"9PS><^R+\<.
MKVF>".!R]:>/J? 5 17JF29]ZA8A&'KG]CKNOMV@L9$H3?JF<+$#"M;;/9(3
MV JIHN*+';$,XY <U)<<<SQRE9 _,X4_ &XQM!X !4EA%9IS9TY2$O^<XQ:A
MFY[!M/L\Y2L.V32GHP,=KA][G)=!JA""MRI>+L'MW=;,1"*S<#@QE>F!U_-Z
M+1>Y',^26LT#S<\2W=W.1SU8;GC[7![-0" #MI*KIXL===*V3VY,7:Z#&2>O
M-F#X6!V ?UY1'17$"N'7 FN@@[U]\_%&AKWY\^CY47'>>#6C,>X7%:8YD<$-
M<DSO'>]?G([(@4:/:J$C%E$XM,IG6^>4KFO2_A>R6J(9=_*DXFF;:,90-35#
MM@O,ERW!9#Z-)QK3&Y,7$/Q L%$JINN51Q;SFQCQE9&3[IW<GCTC.(.UT4QE
M57CMQE(LU?:+4/JTI\)R[G]!4IOTIU+33<>-T/UD47B6Z:#9U,8T?.'N5KU'
M:+@VS>LI;CC@$K<!5/5\(Z4'CE8O-N,E6Z;.3>D7_ PZ/?8J97NBX^S(%<1\
MX&>#6@:OXK4C/!S8U<)0'>%&KT<H-0?:2X>WMI"P:O\4\JG[KK 'P-#)/D]T
MA;^A2G,VIU)S+$'<<W?&)S&7'#55N(/W+U&,R4@!XO>[K?1SB:-NZBQGDD:[
MD4M_W[,EX*ZRA\OIOJHPW2X_0X.5VU 285,\99Y@GY_1YE%RXR^2G[Z\H';R
M'.PD9*O^.^^BT_K?7P.&4<H(")*5(^8D0%JV)&G2M&BF??6C<B^987-WCU'W
MOE_<MS0YUK-V6[N->;Z G:29X^.7Y^*1) P5 T2:]'$%>45+X_?$U[C! @>7
M$O959!9,X.?U,JMTIY#MVB)E5M:UP"I.S"/)EVS.-O1,;Y&M6;AF]2C&6)R2
M#Q;#:<R%T0V;EI]^]=5BD=B;5H1.SD_EYW9T-"$J[3K:4CXT?A%AJY-0UA76
M^M1U6A.@Q*NDWWB*4\3_U6#DN04XRLYFP!M/#G6T)IG+^ZA=H_MRPK6-I[S9
MO'46C>]YGWB EB2XF-W4)%GELLIEF7[2%K=4#/#)2$C9"[,*[]<OY[NP%L\'
MH0P6XF0=EH#X^W./+%X%[&=D15&&7<,G[N@\*PXQLKW:H8O\JLJ\ZA]D!;D(
M]NTKB0E]JI;ZI91'#Y:TK/@RJ['_= Q(*.S]?J**91F:H[$#"WIQ8)JZHJ1Y
M*E?@O7&>)'"/(-/8%SEG(SP7E%5E3I>:ES([O.@P'WS?F+2IDS,&?96- XEI
M]H!4OL+,8_ S7#QGPO8)Y^/9^-B Y+22$.SS#?1(3+(6%O@^@J/&YGID='S/
MYEC[GM!QJ<?[+R,]J>]X*=WWR2MK]E3,<\J3Y+A7/^713-"WSZ_O"2ZDH-O;
MJV,KQ_PE4#P2VZV4WO)X-Q_*GN4 U9F7];2-$>N__^DH&@J+73>KT21XVB-=
ML@;-^R0?F1_<JOP Z#WH< -BE.VYF_(^ &P31\P_).%AQ:0P/P"XC2P;O*1)
M%&GHH3RI*/D8R!VK2X',K/ HX1URP8@@3:FF+DQ7[H/:LSBI[;KX?@8[[:ZF
M!\#7B![O=*,T=ZD>RK]++#E@H=[KR,Q<>0/M.:_7G6G2/YQA&^G4MMF<?S(3
MR40^3Y$(OXY#TZ/TYP20/!5X < -$V=X?TM+-M*SL5F84KS_C3JS]?80=<_-
MC);%0'H=6,+/(KR=1ZY%+,JP+6%5%4SO]+N94R!I$,OK1+-D#4UPN%N%^?.>
M9PX61&NQGWK/V%'7=9;%IMH<2:<8X]L6&M"'<)'7F#D=:$/RK(@C(=Y]'!HF
MS,9A8WD,/<WKR7]5?T]X7EX5% 1V;?0U_7B4/L8H%*X^2H;6=BQB QA=H7Y7
MZ^OQUX'"J'_SDWZ?1Y'_.I&*U&QU9+M2]=Y</D+I-&RV;@.SO?B8QU[AU;H(
MF:8K@F$//KO>(.7'DX0(<'"M\/'7;VN<<!Z E:A9-D^MFLS,OL7\.XQOC/OJ
M6 I_$&V-=*$$IVN%S 3(#%OS"C#/9.BJ$\":UWU-EJ7C=*CS%^>U+J5O_2O\
MAT92$3^E<&SXR,,Q0GIH&'JH68JKI1'MAK9Y/E*;1C431L\H9FV_'(LV<UB*
M4/B>&6?[+G5C=E'.HC,L(OK,Z=IGV6-&&E'':BDUMA\^E1/+JF.BBJ8> +/#
M]P4K2S<KU1-S^2U:U@//I3[5U<(G=J8];]N"Y6^E5FWUR/X*\%AR;VU*[DRE
M]74*-$]?BD]>=I %DIN0^AY V'X+:S)^>L]F3D=O\TG%82FWNFBL',J3C7K9
M5KGGIHP3O>$/<_0&]</ZO5#,XZ^/_6X_)(R%0[?;>9"#**RF68G%=S=&L))O
MS\7=U>H@!,*55>W"F8R!Y6MA[8H/@*?\<7./.+T57_J1N[#M\@ P^B.22=0\
MQC5/6,Z3WH32^KFURO(%H9:$#&39L%0KR%(R(X,N_(8\^]N6C#BM F^D0=O?
M5YDL9FGVQ5X]+<Q:,H0H,^4(#>E125@R);A/^.F;WEM>&%\S;&=4S!\\<YLE
MO^Y=W#@JOJ;Q&HH@: _)](OCOO1]'A:@56XB'U4IRD0( GM'58'4.<F+VO6^
M; *&[JC6,P&!*-!<F(R1C#K#H814P.+'$BMFZ-FOCP36'X3QK/JX&(C]J,KO
MU>_Q&&.KI1D8*'ODXR]C7_NRG7:%.C=D"7.9<G1*) (K4B1?LCO;,/AN)H)P
M(I 9LL&O<_0;H":KR^W>5/6Q=4K<@5M6\Y-3&Q GYVF]%>"HS,1/&1U>MJ=Z
M9E2O550VEEAGFV/)D41%2!_1WUG$O4W/C9*O/YSM'4]QPJ(&UHO"]S3^=M/'
M>%:D.Q<X97.@/B/@9(NQ94WGV5SAM[-"MJJC86^)I&X1#B75.1LNYT0YKO-Z
MYE;K3%3H<:.H^[D-HZ0IS3;8W$FY:N2077^0^3-+$G+6N'\\#:?5D=8H^8CU
MZ5E,"*N(JFR;^"8!].?[I]UC> =07F)WQ[B4B(UXTD?RT8+X>U-6IS@0+J?.
MGEUGM%\J?4%W+TK8$.EHA Y*I>85H97TFA'P!8'B6YG/7U-82?G[TM@CAQA#
M7^;KI$IP<Y_5. 3)GG8V5/_.VVMM-Y;ZJI :)^HF*+6!@F_.SZF:@T_73&:.
M.ID4YCJI@73/&(0^-C0#Y]>.?%ZK+Q9PZIB[SS:(6C XFK,%BD/H>O^2[Z5A
MR,T$\TV]22##L(2J['EE?E' 9(%_<[H.KD;3T:QI9C50]N^;OYK.>=>&N./;
M ,?Z'A:>517?FGE-#*"'%4ZR1B2',&-FN\(##(DCPU;:%I8=;E*2O[;5M@R@
MHV@,$A_/'J_,]-N%Q&ZU;"A2'%;1X_X P#L)K?+4C-9L@50IMJNQQ!20"![C
M;#/C=-,['RA7]_\>=9Y5/MWYZDFHJM?DSG!4B6"O6VR6Y)R2)U@F#QMG<%5@
M#%-VOR=#:?CD#_Q9'8#(W8RYN_C:"6'G)P!<$_L(&(G]=KD:+/%Y$F;;]9!@
M60T@A*[[;WHF2::Z._NA^*]ES.]]-ET&>T,55*NBC9VG[&M11["72Q""L:MD
MAKAJ*F]6QD]NS>-B$E.;ZHUI[B7Y[9=R+.#TL*^TQ5'KP-M_7)MDLK]!@\](
M8W+XQ:\SB5R[QR0/3+W-Y>#1O:VJ41 8(X3_RJ<@6S4PUK'*Z]@J- OV6268
MMD(VJLN@.K\VP!!)W2ZTL91EN"%!R#@#Q884.U"'&>+BTK"YAYI.B,9C040_
MO-+XL@MKYAIDE:2Y02;\:I+JB"VNL"W6D?O]>^+(A7% NA< 3! 4Q-M7-J]B
M[;<X,Y2A>0"857==8%=DOT"E#&25QSY7FC@6&[5\P^'#\N-%' 4'H#VV-WD,
MA\A5]<V_8,"!BT[__FZ5<=^J<)K!#%!YU@,82_[^/T;CK>#6^-$C--0N+CFT
M?F[HZ<)@$?OQ1.UT,+Q*[*"-)?\H[!=0B915VKMKU3D38PT&:)#6X*$EM-:5
MH[E'M$TX;W2^8X?/;ZG;+A,)4I.4S+W:,SMDE)V%B&E*RJBO'\ 8QVXV(+"J
MGX?&F/Z!DRS57-FROB40)P9^SZG]*T$PU>+;Y*/.EJAM*%^,-XNUZYB@4.+T
MS"*RP>*:EY'^ 5!CNW,?QN %;^4XN(ZN,,])T%/^-+<J.;L]7<W7+K*^=UGJ
M9 ?VSTCMA"Z\^?S$4,FF4>1(-6%L&WK>Q8BN-Z\]99.8I:4\ZA@=B4RZ3B,=
MF%U(-'9X4:?I@>V&X^8*X@^M!#>U0F;&6C9*INR^YO"O2@\=I]MBOL+^A#%.
M+>I]1K3Z\1_ESIP%R>4*C\3B>(A+I0?S+]J+U3ZVQ"\*RZ=E0S0R9_;H*&1@
ML&KG!-^%%B,8WM(90T-U+&GD'BZGQK9E1\,6VTR](^IU^_F"EN>'''<+0N;E
MXGB4J*_H[X1[DQJH9TOB?"9+GAG.1\GNRM*[P(KWH/Y5]M/ U=BB<>X^2E0;
M]%/EX+/M<G=J#DR9]72OV9ZI'6]ERBBD!3G0QW$*-VD5>;R_KX<-RZH+91OS
M)T@ 8";I /0QG?\/\C&9SR(3$;A1ZETJ^8JFOPM; E_+2)):9:Y*18Q[<V82
M -]=N]OSG9%J1 .#M7Y=*L3NM93, 9?)NH3#I_>"@OTEF,V#LMR!W@;W/R?$
M" V&SSL'7=CNS8_:KLHDQXA$XIH++V9B^>UL[/7,_7)(Q49?]Q(:O#GE^W?_
M#17%^*=J,RQR0">-+F ,5W+=CMZSJDEU[LASC1!XD"HTRD;>:ZOV)5XDYH]K
MIO,0:[4IQ/3OKH9WTX\*9=_+N7Y9;XW1J_IUX $#GG!XAT3-,)ME@H0,MQN.
MCDRZ77R 'E*6IU^. 3XIJE[-DKW5J+SU"39)6GM6I\Y,W*Y)$)!+,'4HTM7<
MVM3P#AR%_"H=.3&TX2VTSCFN[X^?V@QQ-_0-$,M?06?T[E%.MS:T?_A9_2;'
M+F'X:[(?@;C4YAI.0[L6LB=W'%RRX-!$6U7M\U\+^H5W*>:5A\LL%S1R\*O;
M[MW=*@E55,=A^L_&1*0+D9F]1%-&YY#I!O^+[R%)^6_6Q5_U4*0/QML@VHU=
M-]ID\0_TIXUFI3-\UA,XDUTMO46LK/5"SLG<VXJ8I:5XXD__QKI47YX<\@7W
M-=$R%I]F1.I5D2%?)9 0+3R/B3GCWHF\4ZQR2.,"Y_MH'[S_ENN5?"2TU%O
M9NV?TS'XUIM"%L/1(T53<^;0,\.!7_3Z;K?@Q_K'^=\1*HM]"5*D<T6V/@8_
M.?H=_+'',N1^E,VKU8(61O:WQ;FI27[_)^@T/S\&"#X $MT> />]?[MN7I4M
M!>M,:]T'YRU.*E.$_U^_V;- T>Z<NYZ@(/=MGTO,TU)F<&,NZD*>"/U>1A:V
MWVCZL:Q8BU>"9/5M32K[0FC5H3,!WBO&!O  ;6Q#260 $W([03-/ <'6Q"G!
M]L$&@TWRGC[&;K5-5E5ALL'7.LU@BE? )OY8=K1.S7C7A-[PY*4 Q_ 9XM?
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MFSZGK:>L(NX7SISV])-[M1?'PW)K.^YC,M8R7D$XIY#+/J?&AFG1:[MO%[&
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M^-F>=S;#W"4/2$2_KB.S=?57S?6O,Y%*J,GG[M"EJ0[A4D=3JL3*1^>38AU
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ME6QVH,?9[DZ/Q^KE_0*:D\!E*?%$6(5K"8A_8[9O7PDR^-E*%.TJUEE2UN?
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MH8PO"M Z_=A002B@,P?[T\[7H%N1ZX[ 'WE2>T.>3M6*B7"OS&_6(;\S.'T
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MM37$RLL-FFQG_VZVUY^2(K%#<:UQ%7&>38_VL?#!&4.02E6N)0(M.I][13&
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M0WA99L6KW2*[@NN]>:8?54@N>K#SCFW4"6HI8*CYB>][^5A?#'F/(I%;"PF
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M47CF%G,[E6ZL#=\TAMU8W0& LL!EWS(\0 E&=1DLT.41X3]%'YI1RNYON.2
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M3C%,Y5\'XWLTE (%.$Q,-E$J<0W'2UV6=EWT3)=5OISD#L@HJ93V>=YN*9+
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MBC>)#Q3SS2;=9701B>'EA-_RH><[T-FV3BT4HGFF3V?TB*>U _]QHW1^]0G
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MR0ZPSBRUE7M5/DSN2:%SPIQ+70"!RHD8QBKP'*1;C@09QTE-ZSYFDQ__C,S
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MZIQ)Q/)<@?1\;"4C!M]P7,S/:M8!I\TIW],V19QVKCJ0P24ZVF<"%VV0/^C
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M&W+WINJIAA9?SRZ$M(:,"3U?I,,<1/5@BP/XIHHI\X\Q*":%Y62!J"TTZ!X
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M:;+%O./0"+^BR@CC&Q9V:\<IFJ=,NW-YSCD2.&NYR\MC62W][IC/]-YG\O>
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M,*=4I7ZE_%C=,+6CPM//E61[XM27QM73P_@SSQK(,UR[->8Q3A^W#J.)\[-
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M=W/ \C0T/C;FMRP>OD5<!JX.N:HAUQJ2E<96@]BKXCPCGR4I+IJ<)Q@Q8HU
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M0;_6>XODU0<9O!O'YNDSZ ,D&2?_\2Q*3;M%5,$JPUHIM5YR/['^5/:#/3D
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M6/.3]%IW3#]Y7,LR.77S8(,E(N/T.N7*K6:<7]1P6^@'6WB/KM?7P"2% 9(
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MNP%M=?O=V<:5JFU^SNR0G<Z!+B6=!H"9T8Q9+=UH\G-5##<Z6CB/&C8/VUF
M7K"N8]'BD-I/Y*>T+IH&MR&D4:3$OO)-XRR=LZFU^0H%T9!:PN^T[#1:K":Y
M3$M/R2432*1T0Y>"X02WC+:+3*I0Q87(6B$)Z^.1I $C/$>O6>>?&!Y$/BS]
M<.L6]07JF+-1X>(O<(0L+3.S\QX.]'$ EF^':7"9Y-E:*=-:^KI@_5QSU4<P
MDZ-36TMLO>,C1$PX+"<$5ANHO7U=>#F4/ 5M!E^NTC)B#7F+4/$HM.JD#X"_
M=]*'GD/M8)?^MPQ\]N//0A@B!CN=R38'$[ S;1*4G^:L;+6X3+>!(BOKJ.IU
M6!6*%)_S^Y"/,PN. /0T%0GEO3,53UDH5B:?F0A==$Q3\Z[U7%0-)^4G.14\
MF742'/%N7EG"8Y(<U)?L7IZ$G:7Q^7%%*(5Z[.&7#U,*,,.G-)75\(RRO<QS
M?5\?81[;7LO"<A=LCV(31DH4!&8_Q]>LX.O."O;W ,VZLFDF0>YJ?)!7[6$C
MQG6A><_ @YVN=)N6 8_E%_K8$DVL*$7_,/+%ATFK5P -_8M7I?;YTM03!H$6
MA3TH-OX7[![)&^P/G'AXC*NF*F]?TM6I74(%]D]%W&C(#L-T7K[@6OZTFM<G
M@>,)TZ@H'.73ZQ9 D;$O 7T$K3^R#?YA;'..V>2</BI"F,EUXREO@GYOG.80
M7G[71'-D-Z\RW(@L:9">2S$),KZJ['RH)-#_Q=("SE^X$D^VG;%_7KV\>R,I
M-OFH=2&N*,[<#M#[K2+<)=.=B82G(3^!-ILQNJL4IP:<L?LN::5OACJ+HL(Y
M,!,SK/H%O6WDIBF/ZXIL(IYDEIUTWTBB +J:$]>P<H(M;=@38RPVF';S\N-?
M'(OS[ I$3H\;&XA,AUA,%!'3I7]JL LBB]GCU<[Y[&QB'5S0F[M%3?].JZ5Z
MYF="1?Q4?8PE,I:2CRIPYX#JHP[<9Y_Y?/QIONHR^&OU,K760[_&<C<M.Q%K
MX;V#F!S";=>M;,KQNN;4V,VZNC@">J&WJ3J 559&YVU];[W 7@PKXI8>:2I!
M?N 326A4+?4FJ;84)_"$*'BBY- DA4K+=P@QC3G@*(2.GG3F^ZH!07NNL"VS
MF1XYKATYZ[3]4.>8_>&AQ:L+:-;KG^?)&$D(OL$[Y"BA,Z568D,8SHO/XL/Z
MEC?J[MI:WKF&4C]RCEK\>:,(?J#?-$E7-.LNU*TG4&.7^MV,,))(3BLH4LXU
M)%7%Y'TMW5+B&3HU>P0^[!3=S;.]K@^]"4F2B-I +>HV1QI$?^)Z0AMSQHGA
M&;<MD$T5CWWY2Z\)U-EJTPGY$N<3W>FY-L+#[#L^IY;0ZK6)O6VB%&W!GY5K
M=TXA)%Q_/M:Q3L#]M@2/;K_;+#^\#'@]IB^W?,LIM>SW<+=3EKQN'&09IKIB
MIR;,GB)58$W+CCT:-S6FJ2AZ\$"HO%074$K+>D&UF7I+AQX)M7"0Z_CG5\,"
MKY@CA?*"7_M?,_=T8S"#2<[9*5M?M;"_3=7) /4O(25;TXAZ5WN$Q[CB)KL#
M)6N]<^]O>6S&$Z/4<QAU/-4/*B&.AHC$B2?.5SI-7-Y%S7> S@=CQ7\V6UAR
MU?/ ;!JC<&R<<06L*!!OJE*_1(\\^Z=K7<Y #'$)V%6GH6E*X%-3U")+M=TK
MH:Y.A];OQ(D7<=K.,\HBBYKO#_:C9O4W/\HWF4747(;TD\ZPJ!F]2)>U1C_Q
M7:7M(86M*(>X$4(?,)GP%X0.;93*K/EK<N*O/2:1WYR^FE94Y"@^VW1NA<!X
M&-,B, )E&I4**#EBL[F973)YA[6X U$P_X_A5PT?$\/67FPFZ[BU$X&CM:8K
MW&&T2W;C:L4'HJF&EHY/E,V#V5YB?CN/>@QYG'ZHPRL=,=P2^P#^JSF=H:(.
M'8H1[0O(6DG\EJ0D&/_-LV#2C:%\A''+>][E%5\%W\'G%-JLM3X:Q[$8BW6)
M?JHQ3660P*7<1A?R%G(DU[?I9O)@5QUM$REB4!":.[GX,/1#T@"Y3+$3&W;V
MMV>IO:^:ZM%(6*5TPG>C034PF^)]X@EDQEBPO.@5&1U3!O$]/&M/'RX*=&LG
MLT(3)+'4R*;6FPOY#J%>7?4(QK"8=53#? 51?C3ZDR(L#\VV@<P_N#(V.K7C
M7I,/Q@A'C&4&.0E)ZGDJ,@4W!A<87L:>1A>@B1>S^-9V=,A[.%7R<9UCJGGG
M+U:W-8X\XIU7#O&V#17GNBZH4W<I8\DX")A# IPO=1<H#W@8LT-7)/9:)"KM
MQ$[>*!5Z>G+9$DA9?,MTQ]X W,CLRBD<]499C#JV",(6MU_:YO^<,1JQ88QV
M43#);0!]-?=[.=L\P.U0V *]IOQN6'DAO:E^--*%+]R D7*NV'*VK3:*MFJ!
M(Y+W8VD9Y#N9HIQ[O'KSRFLO!3Y 0K ["&00<Z$9<Y$&WP?[6#>E7.-D>!KS
M2^LO;ILB[8!N=(]HEV-)A,JP>L=S%"E#4E)BEA[;IK:QC8*$HX<Z"$L&7G(N
M?IQ\<8&#?:GWLDC?5[6VN;ZV:<I7QKVP0UMFSFB OT A9EWA#\%V3D]S%)>A
M8*M.G)CQ40\"+\(:31,"VX,>'ICK.T)!J]:(AKD+_:]2*0'LEC;"MJ:TR$(T
MD3\;VNHLI><'#C$N%![RI<HH3$X0M\W:(D#(N=M#^SZ6*C=E5FX>[JI.2RO[
M22?4&6:A-/!CDG3>V#=\"0Q.\+9.8GJX(Q>AY\\J]/I<M>[//A665&=%3-=]
M[<7QQ/#DY\<MWE-)_28I!(0611W[@/FEV3/<0LH&CN;I4DC_TG&K7"__=2LV
MO02T!P@OD<S8JQ,O?D.K \'H@Z[JS" ]&1*5WD\^TPZ*3'PWMK((Z4Z3HYRN
M>W7K<O)V6L3AX12=0IR,I(1\5B#NF[@K[D:Z)[I-K9Z=%]Y%>2OIRTE4ZOPG
M^Q3AGPD%4OM#?TI(F$]3C6NJ2_E_.A,?H;AT[=("9TS?M\WF":U;*=W:5&)5
MQFYV*X3-\S[6*3]@)_-S!^_>KFNF@Z2F67U"G@8!MN2]<>*Y2*UB[^5-)I_[
MN.3(/7"ZM@GU?;/X8J)%K7+'X^.\(E"DI1Y9TD]I5)^XOLG1B,<1L1]H.,L?
MZ%YT6=N543'^:M0>A/VJ1-6*@'FB@2QPY!V%"17EX?7MTSM X"7CKBV-,HH;
M'/X[?"]83=3G/E5N'3'WA43F9-^ AID1;9JVRK-OU)G6]%I_I^;-197]\V=;
M US&/1]+N24974V&*%-3C_&@=P!HT#]\YMKM3YML9L303+A493_KMNA>B!Q:
M)G\Q,+B@[P3$Q0BL"E ,@D#WW9E*N(13=7;Z;=2[^12)#_M/EFWPL*'>Q)1\
M6#L5KM--Q%,C<:=9SNPAAC,S(S@1JHL& V2!_]2+C29ZKA^%P=".W%;XO4")
M5B4@D'9@H-K!)F+T=Y>AS% WB)62^C$L#"'RE1\_W?*5;!H.9X[$,7WC66W4
M!Y)NM^(<)(Z).=D--A0UQ69;,3]R6!\/>]'R"B5=/]%2(\9J&?\U.VNW/O^[
M9^MUI.V$":E$6F<[F8@?]^8;I B4A$E6Y=VSC1X"V0FA55J'I:<VC8"+;J!8
M4,;%"CP\3(#_C9A'_6B9B4(JV1 MKHEK3(!RO:('Y<>V5-R\39I;QLMP%#'S
M7T6D>^PCAN=YMEW(%V\Y<X(#_M:4$/1X!/?(GT']]#K2IA<ICP[2*.L[_$0W
MANW2T^NK0F+GP/V<C):D'<V/N-XO!?\-!4VCQ>\ 5)>>IDW3;H>/P=;''7QO
MA^GX?DL&283ISY=*/#]Y('I>ZCY"9"]Y_KU@H15#+<LV\4V=:JK%*H]$B<FC
MNE^)\5/F:65EE GO?9A?_6>^<:/Y#YWR?'%IND_=[/HJ$Q'GSJ0[HC%1<:KZ
MFS[U!X2JSB5BZIR3C\T\D/$IPGY'&?# ]5"1LHF(![O'GT&6Y^CWM9:)7ZJN
M6^KS>L='6[_2V!KZH-=<V+_/<AYA%- VX:"Z+%?=46@^^ [@UO3%)5@J3EME
M)*L\@>"1$+!X"B/C"8%=FMX^9]6O*[7RZJPF^I7/)8H>X6SC*<S/\,#< >0E
M#FFW]$R?C._S.;"',C/\]4D52L+27R.2_RF][*S3HK>2I:PYR2O2^O":4,;^
MEPF;&+XIW0_'ZCX\5DOLQ+[*LBBSZ2V\+&.P1H_AV7ED"3CXXSBUNM"M5$K=
MQ+AB2,GP!N^5M:\%=H $3#$_RG.\HQ[Q:--7)]<$F&RKX<#.)7RCQ=/O.ZZT
M]N%GZ$_I8\G5W?O\:YKWXW61%3C:@)?89^@VK@P.<KFK"[^-ICH6#--. /R*
MPG3F2NLI%]X!;.\ UD9W "##QY(OS) 9;'P$I+8YT\]^X?^!Q9Q*.]5*6\FP
M%/98>E.C%MQ)R\IE)8CA:'ZRGJ[%^^&M%>$EHLNRDT[)^+ 6=9^"MLQS,XOZ
MABI5G#4+QVULW\8><9:LC\&=9H_YZ\*/S@LKMA+LGB[M==P'.>YD!(TMGF=?
M2%P!=MS4UNE'_[/#Z>N;-W7P)HA97I?)I=2'G)6>V)7)C$F3/]]?LJ6">*]X
M"ZL\-K.*&4D[*G>SZ5M!9#/@>/G41>*WTJ^]&/=TI1JDRJEPPDS+G/PD]704
M/R:#O@^CZE.O&"$1TH(5$% \V;TKD=,ZMKBM730E(R"7@*3F^JP!!1EE"SU?
M"9H8WRL.M"(RNM;ZS_YI7T&/ZT5TG^L$&VUE7%1*[F+Q?USS*^,[#9^"09T>
M]-*NPKMVC^.'S(-Z&WL=?3R@AER&/-A3\]Q%Y?87LS+[!8IODG^BGUO\Y"T@
M^NNJNU4P;O_;;F:!3I9F?'-,^GFAG2<?PXB='2.YL&4*;QE6C[SXZGAMB\!*
MI#",T'AKMCA1<E[#Y8"-O33.@*ZZCW&EL3([JE36>F[W#D#R;]3=K$'J^VJ4
M+W^L3MWF=8Y*Q)>PU0]!']UQ_+[B2IG9;KWG*3TJ#G]RU!:62B U_WM<^()&
M"$!O9[R>&3C!B2CB<8SB[_Z4'_6<Z-_6U/V?-MB+45"+\RJ#VE0=<GELN7:2
MG_6O>8WJ>LX7:.@CI[*R9B45]LP;=1@UN&-%6F61ON:?F<E&T(QUXZ0[<4Q7
M]94NNX<.)R!)XUV4E-<=(*6S/>WJSZDASX@T'6HW':/&&0;S52@"1[8-..9.
M[HGRRSM4)#T5U'%4H-WA#HTK1+53[5P,VJRJ$9-OC&^HM%>_STSJA].&VO#_
MJNK$XQ8,[I;"*]W1UJ-:50>:'FV&UI5'VP2MZOCL KU2:"Q=4\6MZ/H_:/CG
MUXHDHO$Z1?5DV;YW>=!GP6N\IND_3(1PL='RK??1-K)BQTZVPW8/B354\AON
M &3@HHN!T0I?R2HF96,IZ'JCED48:]ZB$G:2/!OV)%+D;"FF!8]2LA*.8@ ]
MMGL&1C7K5AD9\$W-V;IQJ7PBH'N8E;5W(_NY+<VTG6W<MI*FVWLS8A_CG+?5
M1)3ZRYU0+2QA_ME:1.DK=O&KN(?R'^0Y&LNBW5=9",#)2L&&:-RVYJ*=Z6>3
MR9_JQXWZM&M2_JBPQ;FJ D$O'*=EJ'-;FM08&*(;J6;%V>QHGQY\!O3_/ !7
MDG9++L+%8M(ZZ_W9:X]^*\T\"]KQ44ROG$^BH_ B/%ZV=-] 0">ZZ)5#SCBG
MX$"_5^?XEF#^//CCI >6U,8IPPK2SA\Y;26HTUKRGQ6O<GUIX3!',?A(/ L[
M5W-7*00]__IN(#>;E,W#^7I:W50'-:1U_7<Y.[KLG>PTY*7=2=6*] Q1A///
MG_VG5'EE1ABEL8I*D7^>UZC[NP*BRU"GM>L0'PA,U4YS]EUFI%BL2])TT?CQ
M5,P#H7.=E0JO-++],#OHSGB $-.<+4YF/F8:QI(-GIRD\6?]*Q CO(^]U]PV
MYR#2F[-A89.J;>$H,7S0R,1#T^7/U<!,>W0.*WAOKO[VME^5J^*=5M5\2W <
MR4MDLLX=(.G7RLC?AZ:0+<W1Y-8<C[8UXK\(DW8C)NKOE4;V36&E5CBN!4U?
M4 0QD7"#J#!<#><@N6%NS,=N<0NB4E9=KFY:QA?BK*L-,N5?Q]QES'2G?,T_
M(\9ZD)[1N,G] /<0VI3&#]H(]FR-5>.T3C^:[HEMH452>J%9AN9NH,;>GT@[
ML::K;'/V^)S-'OS]\6),I=Q)]>Y7/9[E)7*U4K#TPLY!>8G=/D=;/IC!*B*A
M%SLP =M?A#/@C%A/_ZC+NZV<C:8]Y8 U(A^6C,VR  /8K/_J[]_(@D.0RQHH
M& 4+B9$AM"U'M+!D<6C-8*9KA0@6]%[_J RP=EZ>07Q>7+(-="[?VE1MX7UM
M^#TTQW;/$X8GLFGVN.Z0S,17^2C# !PG195M%&BM]<M2M$OQY*7C%Q65OBW!
MC"WW++TN>M Y3>B>P*?FZ</$69.WJ*4O=HR?0 D]Q73L 33B!6T,9Z#K.T"0
M!(]<RO!BU$GZH;39LEU%)7S!?\ELW-$Q:=93E ?(5^T*U_\B;C7\,MNKO.WI
MM+0B37Q%'3%9[H.3]UZ>QJR6@:GR1.&TUE<N#S9Q$I6+SPJ[=V_<I#)X>#K/
MZ>NSBJ[HA^$W,,\6Q*S_0.H=X/E6LUZ<C'UX]'!EO7-]%HI/2@&!%=N]/O]
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M#:CF?@=@@_^K9KUK_DP&"_I;--4+<^H@-ONT).Z!4 +=E(A/I)\E'C;> :C
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M%.HIBUO>GFOZ@8+"=7B>\0(3Z_"%*U7S(EN6KCM&K^]ZP6P<_-4#MH+:'*?
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M RKK- ?*>9I?06_M4G^RO)B;4!:#W-N8P(RBNUJ+>J^>SJV3IK6WK7$H]""
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MN&/' ZM!X>Y.G=II]3$TE0O1FY\\_&C(HJE3:&B<1[Y(;P#95M -;Y)_/3>
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MVQG 0D5':00!E7#E%SJ!/E?%N;QOA#E((>?"JQO?P143 NE<A-97B._9+[W
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MXS>.&VNCP>3A=D<0B#*\18[_^OUB01[WY_Q-PNZLT-F:"P+"="E*&P19ZOK
MG5J102^CY(Y24>T\+V5A;(BZO:2=H\+KEH-,%N76*A!.N>2D%_.GO&4=S7R
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MM&L^$^GJ=3I)# N.]TMT8MJH<U.]Q\1<%Q&FP9T$K=SNH63:DT4BH<32ZS#
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MIGD9VEQ'89;&2I6T9Q4FUE;AS.%]E+0R; 3VMLGI.=8(/C$;3[G@<%@K!)+
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MB/Z4:#21][]X>\NHMKHH;# M%"@NQ;U86PH4=R]6"A0H&J24HB&X!+<"Q:U
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M ,P\<4O/4?<J%DJ44YCH03J#<"?W-K#"_@I55]90J]T"/WF8-:_:00+N?!C
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MA-WA 2#7;W.<1X3_\A'A(VQ2;VQ]Z:%O[I&QVV'5=9^OOWYH$4&;Y*>\D3C
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M>BW.W5BEYB>[ UE8[3>W'TK^?!%H<W)]Z %&-MQ/\L</)F&2SV]_7,NB*L1
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MY&T]7"LQB4FEO]WS")YI*P'^KZ:7^0&N\4Y:O.3QH6K&EVA<CF=!6J7ZS-D
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MT4H1:[@8+WZ%9W8]AN@0^*J#HN^>(:=$LETWQ[**?(T(7%M&UD[$RGV%=[J
M]T&M,JWWJ6(8/V#AG@S'S&)?%^DYU/%P4SMJY7#L@W4J+9LG8N!IS*NUK-B2
M#A*]!T!2S_\Z)66!M])J,Y *N&=N=WQ7'0FV* >:"/_H4(_D_.B2W&RAI^?J
M,B(VX'X=GN@OVQ]+K1]'M""R(/IFC/><WG043#.IZ>R#7SQSM[KUTN$ >:ZB
M;>:/EAU46V\HLINH9'PNK6QP>O[DZ^AQ?Q %7$Y6D!P@)C8B_$=X%-/7=QV7
M[U8,,F9(X*TI?C=%;D+.EB%* _D5IZS\QI?LP_6SUAQP 693><9/J] 8XSOT
M3V1;S/$N(/9G]8T8$V0?O_6,]5S;W-X5KZ[1B39=Z'RY;\Q1W>9=:F>I'F(T
MT1!P3'[(3^OPE:OM4>YW_<'8:LCJA[F"".UC<&.R+?UE$[E]N3C;79@2ZIP-
M:M@PPU> 2:O8/\)Y;3.;%R+N53.^?VAH*4Z#[1:C=]&5NYW/>XW\)P]@F:9:
MO<RD0G>$F%#=^;,.S1EOA7W7R.)PU8NLB&XQUE;]W- CQP/A(U*,FW9KS@90
M/1Z.&)-,Y0'SO7K$GD09RK?V:J&RR-SD]NWQ124A?164I[HPQW1?1/ KXHWF
M?U".HN_#-I[60(4#\17BR^#MK?Z#>WK\A*$15\V2-#:,WL*BGN;"F+T[3\84
MQ%E@>->BFPRCEO9<._=F_#...P1PC &]%U5?7Z7=&]/Y&0!YW9T5!WEV1+:/
MF&\*O2412??<N#\\G.&T8W=0-:.:2I\TM$DB,3%0+X.X(VZ%VXX/TZA_H$JD
MJYXV$QUL)XA+N?KF&H_.W4I7_+8UPVN,6G1'6!T4-8%V7IS,L[T:$M_%OIC0
M2SF80=\YW7F'+==L\\T,_!(:D:(N =&=WW=4[I_P-&B\,M/LU/FNHY5&%T0A
M'%$,43%%<Z;8U.R;"2]"A>G+4M=9:M,MX5]%QRNW#UB/\;"3)WQPBBV(RXN7
M]RX!/WCS;;\,F5;AR4XV\TB8?PN@FSV X4F)6E8I.8;0",N75>&3.I>H#B\G
M\&>WE!]A MCVKNZQM3; QI?KS)'%K<VV<"B[R=*8F]./,35F-6IF]P3YC9Q.
M8C0.-+^G:AF#-&F<1\R]3S0:K4,H(UV?#<1G$6]E9=2NX,^]#J "M2H(F*%\
M,K2DMO&4DC;,5'7Z/Q$#IHH]4QM/AO+['%"1^DN6W(F7C9NTU]/210O7_A<+
MJ_PJ'DCS">,' -N4</PS^\O Q]!V1>P#XDIVSXD=Y0&!>]?RO3@2<::O4391
M9\RD$-^^Q8#7$8/&_:WP+ 5OGB*/&XJUV&%6K."X1R,RYT(Y% O(M;#<"*6T
M6PU+0T7D5?G@4BASIJ0/X7EUS9"$U4[=FJFE1FW$9%MSH^U&O+/IQ%Z2''-D
M1<Y!]0.@X $00HIX>1&8/H0*8$03,E$WHRTQ4T;Q1DT-HH'6X4I %H5#_BM)
M;T9E-:[\RDXA]%R&:/"9Y$Z[A@38(E^E_22FRTI?XW =(/F-X5%<2:M_H&9K
MQS%G80ERH/,0+*'*%N],ZT8+^)+E<5D%UNW-2'D A KA_=V.FS6=3GUZ<+N:
M(2M, 6+;E'V)'1.EB:A.,_=LNL.N^7*]=)]ZIR41,>1#%5:VM P)W""&5VM)
M_W99-K2/9!MB=_AE2<M?%A.S]>EBP"N -]FD!1.]?L>E-E\\N]Y6WR+*&^I)
M^8YQM'1[]1<YL2A=BT4-Y +U(6X!U:.?^@;W,7!Q/NDM=Q9Y666;V!96O$];
MF1WU[*WJM(?MVK(EV-*-L/Y(&_Z[9#IF:Q<WKZ35?.KDL]?"ZD+9SO:LL-9C
M3&[?D=.&O\W'VGF^@"$W<,4D5\^+\:K8X*8G/L1P%>/C[QE#@\K!MQH;!-J<
M"8OX%UX@ F6IO][V"OZ3&'%QAHR_[:9%YO89\>$<#:$3ZCQZO+S$YZ:)7YVU
MV&V2Q&B%,S?^Y5*?P%@>*>T\NS<H@"$\Y@+LWGCXR'D]Y8<E2N>_]YE%<W>T
M\8W#-W'K9J4D[>P"-[FAQ-B/F+;>Y=JV?&AF$7SLY34:L]/\3U5C"@:U& <*
M;67XYJ44BZ=LV.MCWTNJ8U<88$L6).%QQ852-FPPLO5';G0(#BS(,,/F2S1D
M_\[:N2Y7"+>'-5'%*=.K;84X"^!V&,["IBCW9:1FVE6J?@&-@"I64LQ?PEVX
M@:DOE"\W71R86]^(G.]4R%*N9C\ F%'RZNOU)W<$$M2W*;E4#X#%XOB3I#;[
M[;/LY]?(#>9O<+4\I)4WV#Y!O4/S0NXF_-'PH(JVJ1)??8?LN--&X.);%W/2
M&O<V$,A]7LK.;1WI7SV9ZOIJ2FSSB>:"2US GUWA*3\AM'3'4;0'$;4:6OH!
M\$T(\C=U0_R<=-"V:$7QI;7>ZS?R>T/OIA?=<\EL[V6:T3+QZRAS4H[Y*L\-
MKE9U;W 4N9J^L_+LH,ND_4IP(2;EGD5C0]IQ90'O4*C'L18XT@Y,Y%P+BR-(
M>LH>AM4T%W'U]6)V>/OTKG"#X(>?[F;@O^ TI-;A@589/%Z8WB2ZJ4\WK=^B
MG-1T=5;RD!&6F,Q>7WZ%)\SX'O%4GT=7N^ZK],]HBZNY5UE6=4EY"1(?Z5:*
M-WG4JF$1& \K;\N7_-")P1J*MQ_/K!4RNPAM9A=J$#T;LG@0^G>ULV?-M_*!
M(/(! 7\8\ &P^GK?%5?3I?OVE4'?I=\#P%R[*_KHOFNX9DV21THH#2$;!]<B
M-?S^ZGAEN;A'1:R'R_:+&+/[)M3[?"C^5G:#&SD6Z[5!W)!_9<#'" W_7L^B
M.K<FV#J('+,4F\1Q,9T,+8:$ZJ%A3!SS?M)VZ^M$L 0U0@.0B_#2YS>F"4\0
MS>PV7,*4\-P8/_Q%?0FF4*<-HN? B)RE)R?&8^#VU"_@3<(6+FRW"='6+J?%
MVZ^-GO>P!X  ,SZFRP#-W+<<8/I\ST-:72L)Z,L]Q6W1^DB1[3N+1:U+S*-$
M/;^7((MR^]H)$)JB/[:*C7O9SN?K?FF=U8UD'D+2R@>KI_JP][)?QU;0U-SV
M(M'>[X>#SJGK9@RW>A/@? 00M0&7-*?!(-35_X'T!&%K;M,2Y3&W/5?8G,12
M_93LJ\DA"]D(5D8Q^FYUT4F$Z_CNGU<&RM^+-__ % %!.2P+,!(2>G>1Q0Q+
M;]59*M:O]6&?<_N"G(G<J40F2B#4VK[FY*8H;7IO*WA'AE7BO()+)"G1[YA#
ME XDW@BMGPMAG;ZE9X+;[IVJWY4S8#.M%=9HY<N&64&\^B3@.:$;-BUU\+I,
M@U5V"=.BX,(F3I[FY2!1_JW-J)'5I1'><3AZ\&XZL0 #ZF=B/]9/KU[!S +A
M<\8C5B&2XB%R,A\,QDTH6,6>1#.I2;_T$R_ 1 RMD-<NPIVH[:_]YZ93PQDY
ME4(X &N",>1;F^SDN&(  ]"ZO\21YC%G2LGRP/9RCP6#@$HS8S7I8P%B$IES
MZB"ARF6*;A_ES+*^K15@3[WA)0["54N/G;E[89YG0M*O\\*&'B&[J/@#CE[(
M+_6C3NO/"%61*79@;Q(@"TM2^MY?)7?9P^*[2.2QZ8\_.JEAUK=1TN1=4^0[
M +LX\8_SPI*4RGWQ!)=F$C+I9A99!.'</UT'3X7#]42\!#4D*W$,^),%U>C]
MBD)ON6A+@:A <AZ_#IE G%]FJE%D</;Y5#&3S2-O*Z_X8G5,KK\L1R#/V+3=
MK/F45C=TD\?7H.UX,?2<B'AKR73?)ZR6ECV/7+D_'! [*IC%+/^Q73<?)4,P
M8X76RXWQ0"$S[9Z#HD%+B0<["OM5!6_RN,P*BSV8>&>$I0TQ5@<'"RH-\WDM
MK;_6L)7T"94W! 1\B.W-O_EH7+2MF:IKS'XZ/=PANW(YTIMDU_'^C"OG.]O:
ML1C8B[X5)5\8N?COXRHN'YI>SM]RH)-LLJERJ7ABMI]\TB-ZI/\]\F?8L&7,
ME^0>%DOA55L?K0O.9.+<N_S ,F^K> 3?SJFU0U* =?>D8/"!(9/(C'!F8OY^
M*R-,U*M5:3KW;](HV^G<X/!'\34F7[2NR7Z.0')?JJAG  ,L5"]I3W]GT'<@
M08EX@S:T^I%8SZ;8E.),$F*LZ\H0N-2YNN.AE[@12RY+AK'4GN$0H_Y0SQWH
MT5I^BX<#_U-NOS_ 9>,V[NAGZ>5U[$G_;7#9\91.]?T);[2WQM4GN(?.+P3$
MIMME;ZR*,]')SB$A^N*75#M U._VR^EB2[4ULAL18TZ1L5W(?!P[Y'P-,Y=X
M  PA\Q3:W+)(TD]COBQ,]<N2V$MLAZ?+I#N!O64R_=+"![<;AUP!;!9<0=[#
M4Y0:R^:=]^:S;3=?4[+3-+IJU-DF6=&.\468-'5SXEO%!7A;6ZPRMV\;CWR&
MX9=8).@9YYO*$%>1C#-FLL"1C\<V=ZZ=#X"?5'7G0#YZ3/WJNQNMB -W=1#1
M.\1ZU<"^B9I 84QV'WY%97*<VB!WR0(L&M7%C+'4#2&Z\-1>YNG/G'/@C:(.
M<765_T,D?.&T?*_@*^EYIXT;<>18@DG<N#%RM$Y:P6XX^6SW5/52>: Q+I2K
M6F+FMYDIWP"2GM7MOW;M=L:/6'^9O OB-TOO81/.KOB%J>SK%)KS."+Y4POR
M;"UZ4W11@@871:GV/ I]@S# 165HT*N@]8;Z?_BI0Q%((%(FG:,>B1QGIQH:
MU\<?=S:-'W?%P>%_)W%RQ74E4'S15;/];VGF<KT:+Z1ATY_14=*VF0WLNVBD
MU@"#[8JY"SLGZ502+1VVMIY,T527KG=%%J#!)5T%C177$RF9KS_LD[_]G&3[
M1;<O!'>\Z,TDCL_<5"FFIJ>ULUPVPMW7WTM]KEIC=8D.#2YN2HF85'SS:E05
M=Z%5@_.R?S%#>GFPL,AH;W% :PD<,+\;<[ Y[@'P.)O@< 3*K,:?.Z<-E/H3
M&P\Z4=Y*S;+-'@H%U]A2V>O35^(2>#QCRX-D1K"5?)Q_ %!@1DJ.X]*\UGW+
M)@9;/"BS4\9*WBJ-C*5(S^&L79;1]\N2<_'9YF#5ARBVZ%^86M"1^HITMPU?
MH,Y*F",,1%:)SR:H1B_X#OP%UIV@A^RZVYE!V\,L;K!#MCTM?ZO_=I'5-=KO
M1&;1PD):6+__7,-\8G+XT$QYMU<+EVGOCL79ZL%7WEN?;O3913)R^S5T#5-N
M52KVZ)1S?1;T?]KIOA9011\?GGQ*>BI&,!N%G/:HH5NQKT/LKY VSAY0RX#W
M]^U>^&%=LA&T)<=WQ."/^\L.F!'-GP/CB?]<7!^FEYMD=M7#-Y#J3H(D6>&?
M]+ZO,6NKU(Q=WX:69/[CXV,"&9KV>:% FA6,BNZ<]=PZ4*BCKJU9>]?;MU%
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M?:O_+0@6U(<Q1J&W0'34.V6B,F2M3:W.#K%WN]Z@2=Y3V^@_F:DYQ%T"6).
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M+W_FKE^$N(N5_*^V^/P^V;GS9=X8]^-CT-5HO)T_? ?-.*VJ7\B,X/\@8TT
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MH[;^":%T#\?4_F"#<4XM7^F$K3+1/IG?E<;_IT4*.]F* ]?UOX?9IR(M@I>
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MM@]P!\+:".:F$@2S/5E"#1<7IS CE=<,1E^\&^([S[HP)B [>PA$M]^7V K
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M6.[7A9\-.Z5*22N'/#CXSI&/HD0&DH],B$1\VRN.J/V4G<MRL!<M6/AZ-JP
MZW'*&U+O=>8E^>AK*D8&SW;](IG8*W=ZAF] /52W+FYN7TL=3:]:Z(3(] BV
MN-P'-'SNQMY!J0$\@OOIGGW82E16@!'7<.=T1FX7Y?_!WE/;:E+#>8@SFH^0
MJ<X\_,I1=P_N"#\]S5/1U\@M092BD:$K3ZJZ"_@L:R!FABN,_-\C;J*X,JV
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M[G7^VP<EL!GS8'.R;O>7Q>\^^Z_(.;9 2'Q7ZK!/YMF L.&/^C$D<_\=4Z4
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M@T%MV7$)\8+JSY?L8-@+4M.#7(,#T=+N30IH6FR ;980E>;UVZ"??V^#>I\
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M:3#RR)6N"?47*?=Q?Y>\F+8U?86);G=#4)6([F6&D3+DQC%]4-3H33.G?T'
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MZ+"TM8%R(_G!]2Q6T]>6CMO+*SVM&8%[<FK>$II<H&1%V(J#:>6:*$LNY<J
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MO-)5@<&HP9'TE*Z+(?PWJC6.GVH0%G9Q-OJEFC79EV%5$+ ,?=B[V>V^=GF
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M 0VD+V0UJ#0J00F %\J"GU%T>,=;P1VW#VD-V:KQ+U>P_A.?>("7[E*FX=X
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MX9-^F+9.KU/*#D_%.9'W3.5&5B?06Q'#Q;2%C9_,"31BPRBIK[=Q&-HHGXL
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M,9%\D,%WNR3U&&G[<^;O].S02G^ ?))SP]V]@(**UJ7//@IWQ#!4J)AJ8RW
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M#P3"OJMBW5<V;AR;XW%R\J=B>N/7C@/\L32Z7(&M;Y!2)(7HB0M@Z&AF,62
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MZQ8GDHTU=?5ZD:MFW0M<;N%L@Y*CW^/ND%PS(CDB(B:H,">KZ5U\%^+@H(2
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M!LHC$(>)PPO4:1X8O 7;,FQ$^;@ZB1;6OA2HE=0>O!=Z;2\HIX0&D#*=N5A
M#$%LI/2X(:'W#_1'\E/OLW8?LUG2/C*38-__(922$CU"3"J?)\+:)7P*G]>,
M-G4:-4T#5VGMO,CRIX>7YJ/WYSE ZSU/I:W\GV(;GQ3IRHABW1QI9)M'[J_
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ML6D_'+:#^A@JDGLG=0QD*F:]>0)(4)1ZESXX@A _!PF\73D,!XL''_/]6-*
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M'KUU<VCNDQKK=Z>?FJIAKA_MF,(I=-9SC=?@)]IJS[@_P#<0=P;S[]534);
M_0SL8IAIS(WD[R\Y2O?2D2]\O"$OT4^16;7>TW3M@(]4[5]HS%U]5MR.K#E*
M\.LSYX=N7TA'M-&%UGB8</BQ;F<>5F\WC^JA=#0XUF^$2M@D")B'/T,Q@3$B
MM7_Q;N*;ZZT.F[1.-9.^]OLW__%QXO^-CV-FKRO/\9#DBT)J_+S_]/\U?^;_
M&8KJVE-+TQ>JL6FR@-CKAIQ\()D/JLX0.I=^<WSW2;JP#(&MV31=V*_L#4UJ
MF*GYEPEP!9Q/J0.EZ1&EYK-G2"G2\"(U'Y+5'1NE9I>^9CH.WJ]$K@)Q*0J\
M?).@<+B_K]!PV+E3Y,"JG<G\3B.3X=)Z:1K;D#J"T2(-,.JX#7 %-<*SY\4#
M,S;,WIW)D10W%3O.?5SW%.+C':?M9W+3 M>LHOH"E[*KP_PJ'"BU34&4,C=J
MF[:XH)NT7'N,L$YOL6J.P34.N'KV]@.=V@Q23.B$F6W'< *IR;5&XNJJW*.V
M2HZ3.OP1&E!ZY$G96-8VYPRIX1KEV%M6J6-6U$ICLFW))7/0]Q49Z,:T.#+@
M,S9ZR+E\[2* %F\6:DDJB;-Q77R3<3T3N10$U=6"IS>Z?*[TQM>;OVK=:+__
M<']";R4134F43Q*!2ITDT ,1]0^H7#I:3']DN@A83/SL]X7KM$9ZB:3OW+F-
M"?.?P+#;A,A LWYF8EP'J@=04D1XUFQ%T'5@<Z;[RTJHJ)#UUI<G0$R0VC._
M#V8\)A@7SSZL[T7\]S=NH0[E+?=IX\7%M;YM[04>;&P0AVM^KOVX@  U>P*_
M1EG5 _Z05[-XA[A,%%)*.*QLI5*J0FC,5%'4W) S>FA##*:HLOO(=#B#3W.0
MF5->==0FG7)39RSTF.VR\_TS)SF&/S4'GG2>;AMZR"89W#;##0Q_K0MMQ+;U
MX8*4+C*VFYZ\29ANI7Z]HMMOANPS=O3U7S^R>0*X/P'8_^+C:0!!]U*8YR?R
MUT6> @U-)>_I,O/7.5I<I0LZI9VO^8/:@M)\A'.? ,Q3+D\ R^7$!\Q#]XSQ
MOVS.= :WM&%N%<HE"(?%8XV9:F>CPOA/]8T<:2^]=Z-0%"'6]H\B"V^A$$%G
M(H1Q -[1E5C#LU1VHRY&5TG_"':TV::II!HT?E@-0V@H/ZY0HO\,<#3>UF%O
MQ8DJML9YCLV.)?70]+2X*=49+M,'*D*T&\,IH_?_?F[O)OOR[B-7<!5 <S]'
M( MK%EH&5>WN>P(LEH VS*,?+18CY<J.,RAE!D^-)7"9]_7FN05C75Y6<9;A
MT7ZLE_ O*Z2WN4O =9>F@Q<OW#0(2CU3ZW0CD$'@_>O)U&%^U,E1LE!%"MKK
M,)<M7 %9Q$*9<"6_L9Q+T?)0LYM_;:&S*TG612M@F\D.K.I7=;C&COBY^;V!
MHSU SKW6Q<W'Q7%+:<L@\5,U?$A92@!6(EY6<WR*>\YS7"!R];,24_J-=P2,
MAN]-9\S:0FD'$9$=#I4]1QQNR_&Z],*8_1S,&/D6_O'?#</=K,2$?'$C/SER
M@:C)X,M.@+S3@<6EOK_)$\ \769,98_^"9#R=IOG#C'??072OI=Y)M]BDAMH
MS2/,$7$_8-P5NZE&TT##H&\2#3'P]V*C',*N9D#+7G)NS[)\X79H4 BO;OS\
MD+[&>-%\\\$+NOZ)ZR$O]=:FVMJZUB7"L48KSJY3"WY2Z7RQK]CV+2UT[:P/
M:$'Q*F2.Z5[_K)$V;7O]E8/P,SP#O3I=J&_JJT+9,G BV;WIPX74ED;/[1"O
M:73UH?(U)-YQWLYJH39-]V8+"_/ZZ8N/ME/\BHX!)]0 ?E_:M-*RE0F[XE6S
M]TXLF>3&'R(#5T_0/?<Q* ZS#+*]W?2#:!$U2JUIPH-Y2[<92C[+_K=QY?\T
MJX(VWG5*QL51_F N+'D62SU/ +Z2F@?_)\#([@X<TN8OF3A8[MQITZA<V$3D
M.BL,2/04/Y-P2^S+M=LFYY;$X(EA:;Y$(U!ENAE2&Q))?%.X&C*YRRA:C:KT
M7KC=^0(1-UP"TK%0Z4JOC/Y$%SM2^/@"*'3.#S5?D$3')#QN*^Y<096Y['MG
MO!$@\#IHW?UTHBEC^9DJ1)X P9']W<_33W=I@2 \2/6.U$KLNZ$LDJ9I:^]J
M_^#\RT0E<HRSO<L.G(<RG>4AQ2'Q#EY=Z%'SOL [ME_@P.M_COG;$_;$TOA:
M,$RM(MSBW*NF:$ 9I(&L,PW,\!<(-^76YA0CYQYY[O%@!H.@-%&Q"3=QKJ8,
MC,$:O.K4+8C=@ NGP3O5V.7UQO>O?:RQ$@!F ZZR+(VB,.U+KX<@B#S'D/@9
MY(ZFNG0;;',$3:>EN/AVM_['AF#U(W3&N$!,<]D@4)6:,.>E^YW4PU!QB;R'
M1ZDI<*[KO8FZ;IOE=D7**RE0/!PGD"C6M*VC&0[ICO28?-D;J1GMWX>.\1,[
MI4IV6!-?'03J,;Y>CT+R\SA3LMD8[88X6;U+7JG@TV(/FQ9FMZZ@;A;__^M"
M&X%&&E2%A=T$,PVE7YTI,BW_A$??6.1;NAAT?._(91G7X*#R!%.Y',8$$*/D
MEMJ+2R==2O\H^K,DF.N_;%+TN:M==L(H96P1U.)4W!1^9HGSYD?ARVW<?K"4
M@M\V1$,>(.?V&>3+0*8_/<F0I$KWDQR<(,X[]4Z"MM% >UH0_#FY48VA#U&Z
M(J(_RKU>LN%B+*B))MR4OB@\"K9S)ND@C&/2S)/7.@!LZ,E?/,9D_IB'*OTR
MD[UT"J_#U$#B4SR %&(D^T<JVL"A1LHV3?KC0.XG #\*4=2ZR]NZEMY1%NE6
M(=;&9M+0:3F")LS=*$_<$)?X=E]KF@ICUA?QZ;'%P"9G.ZL2(QAL1-G;,D2+
M/*>HC%P(MR;BBH,*"($(FHFOK05=U\H[1-4%=0!ZD2#M&$"H*H=1=5Y;.HRL
M)9@WPC:.+$X$M^&:XCRAP73)>"TJ?*%!(*J(:'AOB,HZ(4Y@.F'XOS3H=\]5
M>:CJ-\X[0LZY_H1^:HFV>:=8BZ:;OMATHS^S;-Q+3/ AWSJ&":M,"D"-HCTC
M2U(Z5^54?7IVQ@G9:VUBZA5,YI#\< T;^.QV*G^6;5VN2.UUX_E/F2J:T"[:
ME",A#H6:\%C?/N]%O>7%32RH3#C?N?#P8JU[K35AB53A[A?%"8?*<^A;8XL7
M?4[@_*Q>^G1&3JN.9AH*M^FX''E5)J"@!G%9#55H51P_.6U>PE:V/$ V73CY
M3RQQ8XCC0*!F,V$(^4=KI[7OP^1EJ<ISUC&S3'.GI!(";0MH[&@8Y&,X_AU$
MHM>5WS317HS-6U!M@O%AOP.U<L=IK3[N.YVU3(D6F' 8G5FV9L(HN+G^^?!W
M6#;X1>#-^E!04^M>:6*D6-"=0-STI+DNF$NWK*6V1ZV]P)\R1I((A//T9=J'
M71+4-83*-R9(=N#?NNCK+KJ1C.):M?>B3=ZS%-RFORQ/B:B9I_FF)*&%,Q_<
M'[ODN)2JN3;:FU)@>^1[H7IL3-JLGSVDY#!"V6;DJ0F*>(>2!RG#/\BCZ.(!
M .[$=ZRH(H^$IZ_O-9X?.HW[(.1#P _)]?MSB@>'U=5LR$.]B?GR>S=4 F.V
M0KRBL.0D[XU@!U]60$D;9]3($06Y925.*-N\)CJX.;)!58+B!.P>((TM$7>[
M"#=A&.96P-M%Q4@TGC:<^43(SAK'/1W\!:-$ZOG]:,+IZ8NDM;"EY4%G9_(^
M>2PT>=I@O)>:3X"O=K*/,\]/_US@:M9#Z4GR[8\A@7:*PT&'&<7O/B_EW4#.
M/DXW_S3E);EY9\9"TB+S,<*>6X8BTRM2D(M6/^/CC/LQ&]6Y5&.%@L9\&6U)
MZ;P[1,(@6*X<>-/\*RR7>X\DV>W*4MZT(/A-0WW3KR95D(0W>$/N:PSQJXKG
M]L-2!7&8O&%M;(I X8PP0M,*7]NOI/9@:2T_R'M%7]_8F.+#=9H?OA_$;QO_
MX@<5^<J ARC YDZ+)*V*3&"E'XSCMD)@F\:(4D1OZ<28&M(S\=S^7P)Q+A8@
MZQ%GIXT/1!2UE>:JU 8W(2U PPB4X7?XZ.W?K6+62"+(9T63K+2( 873*!H%
MB<<7JE?XQ]<">1>/SPTMG>]<9/C>]Q;?C::.,SZGU9+?P6ZVX5!PL[0SO-*P
MFL]QNCS.<L>_91@CLUD>P&__J25D(U,PA8VX<.@(JR[G%?TUR81W[("VMS&5
M*BY//V5)T:6"]JK@L=7..P,4O65Z!3&:-E0S>>+@/7^,S:4.L<WBB']6\]6[
M?N.+ZA% /"7:_A"$WCJ^=Z#42P^ROQ.#@P\[&6XJ!DZJ=&DNJ7UEJ!>03/:?
MBT\ Z'6>^V-W=:%-/'-\81K)3 2%H0WA&8<PM-^7)+YA<3&3.]O96>;N3T'C
M!Z-G/V_Y*%0N3T__'X*6<?^'H/3_)X*2">LW%[SQ .-LL:'5WM9&_-DNQ+EB
MK#W6F9$E,%LR/B*= ON!<2?:XR1U%&@,_<)Z*VY@I,EV: 3&A_J\[YU9?N*X
MF!14.8^LY.'ALR0?.3P0 _0H!-68P>I2ZF;\H]>OAH@.(=-CW8I#BCIK-5JR
M!._M0&#!OW)@'.T57I\<02P;2[YTQO(>5.80.X=FB"]7/AF8/+J4,'X7941[
MU25%G=V7]45"<0'0>(S!(?-SVN6;,<A"VQCQ77S/5G&D1EU3W3TQJ2?<&+RT
MHTA4Y><2!T8E'R:O%-3:0?.\N3 V470&XWSI)?J:P#K/7I 0C-)#/&XB84+^
M43A]>GG **N(E=#K=<H7B11EYM*"8"HFK0DJ17:.0AS^7R.,*WI<(N]G!2VW
M56>K'-]?;BVN,JQ>P]"?OR(*ZA)LU(=F>_D=5(M-:8\5NR#+!OT(I6?DIF!K
M<O%TT^^GO:T]TU\K("..M;^UZWY^KV2B<4X,(.24*_ /3WR5FF?R]T5G3HH7
MKU/RVS:21&LDT_V> %%MCZG4.30+@IVO55OO/_<?);TR]]&EX]+B5S;-2IV+
M,RC6>C>S_DNJBL3\9FA*N]'/Y-B0&[)^+B]I-=.5=^$P2(QB#AN:G9S@/ 5;
MABZ0.?026VDIYFD-L3=&A!0"=<:ELXO^&$WP\"L[.R;7/Z@$:^@8"VKMH>@Z
M7YEQZ'GG:LUQGM.^;F-N";%A#3#X(HIDOR9&>;%D7+R]]K:!PX/AU9H+.=Z8
M&)9).2I+HB_MY*))B]/.<T=9Z1N6V/>ZX_X+;=;$0W>!DD@1HQAHSG$*@:S!
M97^6S675/QH0<L;>\C+$RWR<N_KIXEQJN&S4(T:X/%!;LY.'U2@/(,F@BW!_
MU8A:IIA_6.ZKKC8&4V":NO\SX: E2_+8:W<##[I1DO[#>-DULYLH8.O6[&5J
MEZ4]80UT<7DY</-+5:J5F<*<=X*"$:U<,BY1Y3G3A1X%AP;07^9KP'0#,DWJ
M?LEIC@Z[AW1&QHMR(5S^?OTF85A\?.,.VLZ@"]%(=^H+]@5B%/W^Y^@J_W=T
MEY M0^BEYDOIV<G%/I27V0W"%Z&&BCA69$P[67C\_],N]*&3BXO*.\U-$639
MR-',YUYVM'8CG-] 23W4Y(XM9B[SD)_CS-!D!+83L'Y+5$-,'1N4/1,HI &7
M<O3,'*K\*^2LEPR7I([M._5^(,;$_/4UA)+UA<1_6S0+_Q];-!/6GDN["CF%
M6(:2VEI3:X5K&^XF8% PI03\5_@,\&8GUOBIS.<9]P/I^6(GR4I="T':_ MI
MJ]'C8P/;NL;6>I#8:7[Z0H;U.WC$NZYP#?*;9[C%6J3T2,BP;VKSR.[,KDO1
MI_).%T2[[M%\27;GD5#NL-@6G]:YVT[P7_VBE&[H8^KE\37_E&2J_R2"<?H&
M%&!S/GSC9']V 319_ATN0Z+E3E6GSM:&9Z?Y+?(>R?JZ>*AL(Y;X7WS0GY/%
MF/FJVLK>+OIM]! %S7L._"\.Z3_S[&$"$D!?^?#HH XP.(5KW2S/ML$^#Q"L
M\&JD E0,'"VAX7._U_O%K@F+TOV@>TW%%T=]-?A,*^RKA^ED-Q:?.FJ;6AMZ
M:#_,<)1@:'R+T_6\$\ZP(^G0AX&S")?YO(E823Y\E$,K0]T59;+QS>R4!^CF
MJLZ=Q>UM#<&<&^@3@OA)G(44OD"21R@DZ704<HN!,/GNI:ME;!-6MUQN&$F\
MVW$X0*^-]<6KD]-/[9EG$O;:>Y:5G./D^/06;11M2?PN.3_*(E)+L2FJ(G(=
MN%@X/X>-6G"_&^8T<@E+A4HY[!*C4)GT/8.VG;TU+WAI-XW*\\ZZA"-CH9%#
MY@6L%U3@_>YF__3CX*>9*MT/U;P";\@QLQ*^^-*I'+/FAXI9H-B3&=-&"L)2
M&([:TGYG-.?CO6O/"L=X2 ZYA>K)$R^WD*2JU\9J9F@F3*[R?-9,,>548?*@
M07&T"3G\D.D1![U8'[=S^I?$9EA-^99? 5\3$A<<4#%!'%P95&+HT#2TK%7;
MU!&<];V:P8A,1@%-!WR5+3S#-;NLT1#.5;_#^:4BJH[7<\._E=K%@#4/IW(=
M&Q&DTWYO]AA>8F9Z(7EXRIC\+(4%C*-B*='DL2IX >0 [?^7Q7G_'[RHN_+A
M5'W&>EE>!FWS?(I,-5@\Z;M+R3'"!&R.Z&AVY!!<OT%CN@C.E+_&\_GUX8][
MR/2@?[HOAB](QOW9Y[CHYQKCY3_I>+E4FE6.^8 K.:SD3L2S?%,-837(MP8R
M%$)\^=RA4%*8/ZWLHN2LOC"+FWQ]Z40_G97BYW6+7IEYB:[U?>MII,Q6_.M!
M?86_'^8_=82K+[(EC010**$%,I0Y=!,@60KD!3,3ZG%H/YXZ'FB-W\;&!>>1
MBJZ( 1)\%UDBD&+;Y$COQS=P5.] II219:5,K>\4ZAMCD]26R2.3?C,7=[#A
M1Z)N:C-.EY]/@%/7!,3M@!]QV0W%JCHTB./Q3=U]MT[--%*N")&A078GA!1)
M']CHL$L3G22GU?T['0RB,D*D;9SC'UDLP7+:G7'7/!L<:IC[#P91L*%='+0+
M^N-;T*C"V61=Y4)%J3X%@$6#DV71-B)F82J<8*FY/UO<.XWV>0)YF$2YF 83
M'O9;)Q4%G2M.[QKO, ]+K^N"RJ%+ZS '4KZUI95!%Q##N?(GR['^>4)3Y#IA
M!Z.3X+F <:1G<?-);973Y'T""CL9.R;Y.(KA(\ 0<BU#:608+#@B)'#CH759
M^+TWV> 72KLVDGH.[/A( _S']Z%@Z]AO@HU.P.H/0",/ & U/IX=?=CVY9%H
M_$> '[=&'#MH<&>V6(EE\HY!U:<P0EGR4/UTF_U5SRV&D]MH=;<%7#UR$R34
MMGC-ZKCEW-K]-O=A@<(6^=+MD4H&[HYTD/E3^P28 9ON53X!,/6FAM0^VJOF
M-0XVY6(D"24*IL5'K\PX'O[],OQ'^Y!D%;=2S-/B0N;WE0P^HO #7"^Y8T:(
MO.:-3F.,#3^=@C8*750%+3TB;%,#V_QM27U5/]CUC[2F?G*P%#8:AOW=5JVD
MR.84^?#V,!P_BJH?SI2N /LP&]<SYH6N_V4;+4'!;:T884W,+[>%?:BG7BI<
MZYJAKC@IW$6H?!S<TO.OU'GL"1 ?O7QWV9)#TMDX'\B,*+@<VY*(!595&8O]
MEW$BUU<0'EK$5G\O)6MK2PZA%\?+YO!+562/@*7KN[!4PS7\^E]UB)IM[X:K
M!$$VVTLF:Q0;]MV6?\>(A?.8?5JT;[FWR(;G;!R^APE?(H>N7+MS=\#>;D.4
M^+&<^^TS/(/SI*=U!GR25NH"2$O/JF($9,-V(:A>,9H+=\AS'W=W_['-VNY8
M#5$I>.$OM !#]Q@K4!GQ(21[-AF(0Z%&[HR"YJ^PGN7E(.N'#*H7B9R*S66G
M<UGSS3:[R\AJP2:S)\!F?+ <("S)EU!WSJ VP$&-QNZ_8^?^P=J6N)2\??(C
M?(H)MR"LO986A%V!U*BG%::NW9$USCNZ^QVLB(5@Q%(9FRA7_CO9ZX&IW'W]
MA=+QXUO3V/OFQ^;:^96C&^%,2/H/R7L>GO>-'7[DYZ]0G&1[>AC+29*W>*)H
M22Z*QY9!QK^%H3@HA&@^U*C3:;)*M'MU'?*"=EOK898XDH/-G:Z=/:QY=-./
M>E)[(37VCTSS0NMX0N%_YK&$5N//#O[4<4];I\D-R5+S)U^5'^36;(P=04NW
MW-L4ZDM!,'??B#0?DM6B']B<=HR,93?2"S_]F-X/&^O:&>=0&,^ZMCD4DI\!
MV'Y@'F#=_YVBN7P"8!TG@=H<9Q4M[P(&._N75V&BIH.\0YMIFVUAR5"AQ(HG
MP*CEQ?Y#&(_,%>OA\IH%5('CON;N*%Y-9]B<? ;W8+[1FRMS=%$LK=\)9[SE
M)?FX?P>RM1PIL76*,9@^)1U9/NB=G"6JJ3=7S5^%BK-Q30WEV8P7GM6(#12:
MMPFG/6($$KORAVI]E,VB7>I!5O2]I^D>)K/7?-,R[3718.W'^0?M+LLEDW'V
MP>!@_4#,HUD#0;?G1:24-' Y=I2<QSDYC")[I'S"D=*(*-V(734%>CXR-/J5
M6%;P]I+G!"LI]$-K(3)DWJ'X.-Y.^]HY"]4]'$3/:G+"R[*B* ? = GZ'<A
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M%'/63F%?A6:<?U(%-MX_NE?QT,_[A=*VY6/VA[NPZKOU H3V6Y**<EWV#9\
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MGM6*KC99>4+&>N6?O\!*#O76O=%QT+W<H7B3>I'TPSJL?=0,&XG37*W<? >
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M7Z18B7" @?.!S#[]LF[*[>ZMU0:9QEQ!XY;7J9[ENV*L*1D-=JC/$]5V0>F
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M&MZ>%LW'_LR.XJ79,#T)IC8YZTMLO"O/):ZE;, K6PPG,K*@7B'(K5A9R)$
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M<<3\\]([?-6<^+E/=?AEHA\Y;Q%&/.K0_>J*G^EU;<2)2;L13"1;":C;U[3
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M%."%5BD#T]:4./@2F]J6;?3:>;@(H-:4?DL'_RF,!;*DE,C']8YU\R[1;/_
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ME[!/Y(TUH$KN#O J._OT\$NM=^M>\I WBGXB<,$329P-0<DL[#?%7K=Z^9Y
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MY$/!"_/J)L8_,6/747)/_@L^=X!+ONE;:IQ;\GUJ4OP_;'> \4>?]#0*+.X
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M=0.M'#\/BXPJ2_EL-]M/*XH<'K+6UMJ@X^\4\_7O.C<?+D]H<R.[OK82'7K
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MPJR\XF93*E&)F-U,$CFV>E'L0/<4K*<<$Z1>CC8;XCT7SW[U':\X3HB/=2*
MZ_E&3OE: \T(0CVVZ*Y_P:OMF09ZCB<!8]C])"_%SBAB:O=Y_;,C1%(ZX4'*
M'WN)BQHL7LN<2TTHS. 9\]KWO[0C09@S[=RRI+LYR=%$7>_=+W(Q\%\_Y1][
M\AB(2_,^_(7[+VIH;A&R+M&(.SP+,1\#*NYLA@K#]ZD35(4WRR-4";\QD[$&
MK0.ED$L)I+I+-V^GUA6S-!KGA3N"B\M;9VIS[(JQ;+>#PO 8Y,88=@+P#I_7
M6J.4LOD^%0[.SS1/Y+3\\GC*]C?[+9D<+OVQ$I%XO4]H'(P+;ZMEYAQ^_:BX
M;);G[")MF<]TLL!]Q<4N0/+%D@G2Y1!9"[)J[VR-6U[FS\JTQ8N35I5Z\IFD
MET0>-T71;854&%]#?PVG(=120LM1NLBO3#,!_\E.LQ:)_3+=-$O7;(7=NB10
M\17OB3@]5]780SY)I_<HN_:*-K?G4NBS%=_(0[WS-:5%@D4-IH]LL. #-8:Y
MGF+T^=&L] &V,G.Q=3?JN6HH],RS*>_K?16GI;*D24W>$]4N.>^E<&W @-MJ
MYI'Z5_G%LSCN@GDIZXJ= .>,N0W1'KLN$[@]RCBK/;7ED O(,!*4A[E<>KR=
M>'9$NC3V 23,(*J3* 6UK(;3L'/FN0 V2,^$D'4/>9P9M^YZQV9W(1%57#%B
M^_6?%IU_-:PM'6PR[MXY[U$<]X@(_-YX.GT\D@!>H0S^RFW0 .(#X5&+Z$_1
MV$1+BW*>7["G+5@$,!!2CCD6DH"7F'2R-"$/O_##"4%P"8A]=,)B='39 _ 0
MJF=UW'Q4.Y [AES3N&-09*NEI$JY$5F/OZD62W0Y R^#D_.TR;ODP0[N)24Z
MR[4C<F-YR4]1%^OJWA_'Q$Q$63'S-C[J=RJLYQ(3K^!C/XBZWCW (K7.JT-!
M*K5XE& )@(O;;?>@M=^EI!%TH:2_I6>ILBZB1$\VPJ_^%*?2 58CS@]4Z@*<
M#1[%/2_#4*30_O\#</&/ZV$T7B ]N_5W:<XVJ#(+\0]LS+;'E),.\Q+(D6$-
M-3IB2MZ/PA.%&,U\[QE&8#JJBU]-$DA&Q!@\D6;YY;M4$L+@S*L@QM>ZKT^_
M']G\['"Q')-6W9VI<;RCF9;2L0%YUTG0C6:Q^8;3$G_]UF?>.STG\V,EW+P(
ME'-TYRO>0(R6-(#>V+4OMZUCS?/.C]5EDE:../7AXTR.+H8INZ_4R1]?G8S<
MD4W2_8D%4M\#8,-*KQ.'I>,P+@%1-_LEQ]OA4J)K0*!=P%N]9.:!L;;\T;/%
MP3QWJ/"(70')E)1Q,&*G>4F NX^J@R]SW-!4UI>662"EUQTJ-'_E$YI#E'-I
M7EU9-DEX-.SLXHAKR!RA%H4/2=@,NCV0DZFE/JF6(3,>(OYX,[K^SK^AOD )
M,U/&,Z&P%\-4*7H-R3$0X/=M^H"EJ067#4C?."PP>#*RF.9@RJ'2.'6 G92/
MF^Y4?T@>*#H^;IADD#[&.E4+/H$@5O:(S7O.&K<DFI,ZW%'INE$#0^I%&IZ5
MO<[JOY7=+S[K^G)E ;'X)W!-KO7EB_PD#;ZA2O8#MA/(#3J,V5L,0IO66][3
M6GCXB#*3+OKNF_+VK"62#U%]6#""%G?&>NC[L:1<U1!0WA"^.][^>".ZQO=B
MYQ]JGO]#S>\ EP^:8KLY.M.A9J%;9'-7]X#>>P"0:%U^_H;6UM-[K<OL#[@U
M?L*K2T/6)RQM')CM-C:[^L*"N-S";UNW?0&\\LBQQ>CC-,B%]U7%H0&5N\.)
MD@^57G]JFC['@C"4Z9,9IO.K%4BTA6#FLGSFRT_W@+8.U[6XO4,PG&Y)''R=
MJ\+^W>MDG)CFN3Z4@5]9\81NZ<&WDD^ZW. C$E\&BVBX(GA\,ULN4Y:426=8
MX@.K1S'F/F*=B)T?&7%C>01Y^1MB^)UA_]9RFO#4]RJ,O,.?.E><!=_BX-7/
M05@3@6/?ML6UQU\6%E%.$3X;='2NC9%%6,PC?O_JZIF+6H+0CKS)6Q>"-G>'
MQC7R7CA"3]M^H(OET+FK/B._VL]LX6/T.J[/.(;AZ#^S4CD4DA0%QN0R[J;O
MYE,M ZM_[XF2N'9\XW4N6QZP036WXN("%X3S$5I8:,^A9=4%K]9Z&-.Y:U?J
M;("++I%T4YRZ>M ]@+1#=N"87QCI:SXKY13$5F3V>S<I\]FAX\\OG=LL7ZI(
M*^18+3EDYB;1'B"UA76#IKG.-XP]OD2)[-OJ8LB;A!^%+'@J'#U2IZ;#':NR
M!'XYRS!"<Y6H-=!;5@Y/X+.D.%H5L8M?!C,W;$4[:49C%?8IL&8P'X$23P(P
M U00\D&M@8,C";QN=;1_==M[KG?7'KQ%_;%,"ZW:Z4QU?HI32U/A#^C_(G:V
M.K,3>J(79/S/X:*R/]2@LYVX:\'F9A$FW3,LZ;H?,V96!5EX6OLLRG"&<;4=
MC0B?#</U.N98(IR1B&=:O!>2<X)@BSP"JS.*+/4+R)K%/POPX^MW%+^>^ 7<
M [0RYKS5G96VD=,%3($J@_RX>91 G-+CSJGEH%>HNN4\A=^4D#A5DO!DMRHX
M*FF5$G>YY4;A^+*_@*O-.-]6,0JQ:N'_=9(N1>+1J+QLHK-]NV9AZ>[N^TK#
M 4>[;#@%%Z52P-F1PIP_[)\IY>KF"+VX<4?21\]$X)4,>G1$)FG9)B J%"2F
MG8P8THED9&[K/5MSK)GQRF4@5H_6@%J<@)BQE!DOG-M8"PS29PO.<GQ2+<MR
MFRQQ/[OR/MT+S<\-2DR L*X7K;J_7=I8R?H;FM)N_.]Z[I<[213;9.2-^,7/
MYT6!;?7/6CXM-I(")2T$4R>FYSNW$1K)<4Y!PMO[!>+@ OSX&$JO5J_1=4.M
M+Y5XF_&HQ#\7#1]FO> @LWYCAI?SW+F&2HR<^AZ0D(Q?NROX-]1E\,4^ZZ*!
MIXOU?PS+4A<3(L+&ASY;$7WRJDY*.FJ_?614PR<["ZE'FYFJZT#FA7[I.O/I
MAP.?3*365K-:;5O%K/C9%N !&ZND^!"$:D=&LV>$]CPKVM T<<*A5)FW5=<M
MFYIJHC]'QRZJ;U0?0@O=;F"](%36D4D)2]Z2<L*5LJ8A$Y=ZA\0=,!*-/$@L
MB*]4L'TL_IZ&M>W<1IPGI&RJL^_L>9 \+=H7P2R[PR![%^8HJF_83!Q!C5^1
MSO-]IS7YASCHNCZ"X2H.R98D7N)7KNBWI/;]VZA%0#@W[L =[O%*9 -O_9D&
MB&>KG>9S69(\[02 -9+V % V!S4=SL\)[EE]O.;\1B6W]\H963[4OCL-8P:U
M8B=PA<F?C2CDC* U*^](6C*%K)IR[K:,A8$T8:-JEO ZHPZT\6H\TOA:<WV@
MI<Y+<XOY>RFC*AO&$RWI(>]&17I^5IUG97:/OC[OU98 <,$[/!X4B(6;C7%E
MTS(>G7T/8.XBOAOXIP](NFXJ$#U6'.VM>Z7QHT)3E &51QST9*]9^MF(01Q>
MP^IIVN,9!']7EE.,1V6X8 2\7!?%] G,1 4;<:W?;313IAVWSLY(7R H(\TC
MNIFM=.VZXQKJ"CF:WS #'D]>+,YGS><D#F=__>-Z+;S!U0!^@9&1&D6KB<NX
MI*@]Y7UK*O7.?2W1Z_>BJ;(#+Z+C.S9F!;(U34!S>.R<.:[QZXWT<3VD_/=N
M>U0J_7SFXTU8Y9>]#R8883_Z&GN/)KA6HH-8BOPT<:,5H"Q-AC+7O(8K4-[!
MQKV '(>Q[I6%18ZOIT!40TQA?P%ISWQIF!9;>_WH[S5U06Q:F;"\G--0)ABZ
MG0]C[VEFXWJ7C*0A\IO7M:F(+.^'@4^JM/&G!:7[9@.^]JZA]J#R1?Y)5X'/
M:9S4'M\+BN(V:V6HT!RO RO!4\Q*[8DE*>"D;<='-+Q;D@*/F7BYG-M4ZPBT
M**7T%F2)^?A@PC-K[8R>8Y=D"H])T[0PMPX#%TK_QIZ$[6?1ZA1VG7U=D'@7
MN97I];-&I?+[<^ +M8[9JAVBD(SX!T,9W4UQW%+,=I=8INSHS<QE=6HZBEM%
M]V4UF%]O"7[N>B2H-A; =DES#WB\&2DE'6P-'!96$>8NA"@7%OJGQM@PN"F]
ML'^PI8?OH_;[+M/4PF'2'L].-IRU=7I9SS#9FZ7DCX_Z0S@[J .&XPF'1E?'
MZU&2 5;%6'?"E:+10HZ)C[W$P7!_H6;M>(>QSP"O7F1<[L%530BVM.MVZ.#&
M';^#2&8W9AK,<-VP_M!YAN8GX<2KKR.8W0#V<M0M6#1@.YRE-=$J81\C[MLH
MZZN-D*)W/XDCNY] 02X@I! >*2^ 3% 5V :("#L8"OL1$::LMM, CF=00@PC
M#HD%C&D[KWV6!RR1W 7$4N0+0O.9YSVK'+Z7PNCL;F$4N=^;?M&K6;?'&Y!W
M?^CH.6TL2CFFR-/-7->OS:D55Z45=.>E?"M''*5;B H=*T8VQPW<8H'\(9ZS
MP8Z_79"@(R0;N"-*'+FEFZ;X[%#OS2RI27-T_PK6;K+710X6WH(.6)<J=1%I
MH8"].&(C#]P<TH" A(MC$95QL.VUS<UKI783484)?QF$ROMG JJK04N3 6?)
M @)O74U:?R3<KB'WW[EXU>#_XMG-TDO5LM)6LLCPK=:9HK_ESH<&4:Y./@IN
M,FV$ AOY7TX*76^DE%F0_<9JP9%\_M7#:,41<IE*T\$*^:X,\OZJL>KH2ND7
MLL@D8&N<2,L?%C(#%TF2C=+5E,9K4#A>CJ>.#A*MW"59=Z[EI@6B<YD$0S@X
M4/54$WL#"*U!!@YCJ$6:*9U"G++Q+K/=X&DW0'$1@\5-=;V>&UJEK[,0.FWW
M<9]OW[?G?,O-:'':,.C]\>U$T8_,)GLH'#;&\807GQ,HC<$E5H;.$A+06HO'
MPW,V/,_U=TXU<'VG^SHQ^3!R(J3YMP-,)+?!0#BIQIIPLXG^RZ9)PE6RPB$W
M]T#!H^.>3UO^8 U&.L,\$FN>&1DB 4QQ5B)< ")FU_%L =6Z8B[LVC^L>-[Y
M)LAYQDQE+H>!RC<A]=+XETXJFOSO@O?;7)7&8 ?I]T6_;MR$VW]VM2:D#%J*
M[>&*_3(MG^8S__4M< 5Z(L9$\1.[<D@6;\D!]-20QJ4X2E63U(6&=UD+D()'
MN;#_S-#+$0TRP8<TI_\ G';8 ];WXWQJRNQAFQ&_]S+=EF#=^(H"A[0,Q(V7
MM0V$:/(!&=),0R\0)XCUB[/O*:,2\&%*64_ZG--I8EZ(D(2IJ?\\?AXDT/4M
M?:T[";21B%WW+6[3,X*BYG( <VJ;(Z?O.'?$?<V58>E/,CK3Q-Q,.A<SP_OD
M>+SG()/0E+'N>+*O?:OZMKS*3N1DZ7!QHG:W\^J;+J;7(:&7>L4?]JS;; :P
M^Q]_)5(LRP^?@#0TNR/E$@57Z7MSX8S[ZB6^XBN8"A2A^$(J,\)X7JUC)FZJ
MKPO'T]_=D?=1R.)["2=2*LB9AAVJ\[.WUX DH)HSJU#G9R=(YA@%^L!86)@%
M07KZ2)>HVDPM6(-W10-:?.*$7+#2.02!O?<&T]$YU=WVJO4]6P]%S:?:M /_
M^K#B$(Q]M2)LDCTY@!CF>&;[)-9>CGJ0Z(PK<QM$'8_'TI#F&S[M.XR( !+/
M'-M8H7@&XK7,'LM*^0TX*!'Z:?G7J4 3_T\R?]:<'S,A='Z2QM-GIL8Z4\Y;
M72)N@JIMGU5\^'B_REF>XV3>K/"-MDEW6?\MS98O_+-BDBELW9RCGNTL3W/[
M4U/-PH>FSCSF> _7[/CU/&QTNIA,G:8GT#O_678IAD#MRQ-1@-;KA1+SG1R?
MRI*QTB58J?V)TC,[DL]TRG(B*7*K7M5\X X&+:U _&L5%V=Z;#L;[1]RNWW%
MW4L+J[5L+=VA\6V]8ZOFY*9[.=+S;:C'?$7?NY+VGA.E$[ M!>+H33*GKC2H
M366^TDJBVCN@&"MZ(:<I2BK&2MQ?OU-(T$FWMJ3H3<BG$$77+*YJI,KZ/%@_
MD*$K\-T]@,Q/=&"9-^[Y^3^F[+&,,965]:3VOY4L=7/=-KH&-W2_;H)ZF"JG
MLX?Z[*C1+]4+T[U<2 _"9Y.%#XP50(5M  :=I3S<C6"NX<T[0=;E^Q*7B=!W
MF6-L!L[W@*9G$!NB5A>=-GK,J;/ZK_> ?AAC=8EBJ;E]BHG]<9%*<8J5$J 7
M%A".Z^;Y-DCR^.$-W>1MCOG4RG&PM8]O.'U3CP/")E0QD\)C=D]Z]N_>@T(Q
M^?JTE:2<UVO"(GXYOV0%);FQZ.+NV5]8\ W7:6'2@<4>7\HX+KRQ+C/87?!=
MT/OF[[FBQM[F?.#;JEVTFD<$H/_P:8;GC5&Z@0%_* ^^R\F1BR76-YH)B?0)
MP9>[&W5H PW7K2-T@?(: W!('W+'T@SM]&F7'C>J&U@T$,F@.!05T=.8\*6T
M'I;4?[]V].BV4!-%F=E6S]L*&\SN\((8>U3:0/OY :O$FADU"#X VG@HG>=J
M/IEP? ] %F6W@EG$\XE,?$?#L/$X.OIL"<>4:%(-$J_QY8,!@%6UE_:#OV68
M.(=0UH K=XCYAFC7S=%M\+9@L"^"*?KB KKD\,W1B*.0LOOGET']U"B+4L>&
MG[R"4U6LOG5UMOT0_:=C"T+2'S3XWMIETOJ^9 ]?HT@KGEK=L%JMQBTX-U9&
M&Z[FXVJKWTK*1_):BBMG&K+]#B1AB,%=]-234CS>[P_A[C9><E11S\TP#=<1
M2FUDC+8DN!.2':1>Y?MTH^K[M:7.\NN(/<-%NE@4PEB?_;% <02OOQDQE^I(
MG9=(5N;"1>.2X:*"NROS#W7\:"7&HB1"':B49.D.3,'>R"<?NSF>4S]*N#<H
M@6&DFM57:K9=)+$2':H6_7JF+A,V 7CESLE!*RZ5IKI1 %[J:1A4Z5&DT*71
M4:0 _#?^&_^-_X]A*,.$(JR,Y3GD=5K/)UO>,]8C?X[5Z0Q.#?>;5!.6)3&R
MEVA)K]2B_R52S3V$KU3T-4-WQ$>%V<(')VG9PO'?2QBTW#&?WE@'/YB&[\AK
M4)Z^66AV/OQ/U%+K.EW =I>SSM9_+H<J\Z#D2'YQ*3&$\UY@>C*&!1:JC:&T
M8F37GLZ0W0,.>NR7/ F[)P5MI$8>YZV>3;@OAXE4_<=Q,$U>SAYP$_61EJ0U
M[/+9S._^TP<_B_N LP%/ 3,E<<\!_Q-)JFMQ*J5I;Y4S6H9K>ZG%.#!G5\G/
M<,)8_WVY]!1Q.LCHX#_D&W-)"/=,6*\77"[[7SOJ!\U)#E&=!737?(O0^4LD
MHZU)FT:'.S)O^[BN7<)$XO=_'D[3BK0=SLGHB6&?[I1=RS[OR'VKW&G=GK3$
M0IQ6RG>9BRE66A<Q?F!7KSS(R#\K=&O$0*=PO &;_^H\-#Y5-R.7HJ2)8>LB
MH"+&.-P>KVI=,$%K&P;_L4.[QD,SK+*I2D_OA4C*>N3PSWX&+M&"YYM)'!E4
MJJJDI2^PCP7<)%&Z#X1^@*,C)E$9E]%W/R$'+>ZF_G<VOJXV=#[K"<[[!>?-
MRE_^=ZL)RGA7!+'LL/XRTS7ORO<_0][;?[.7NKXXPY/X(?6!\W.,%A0ZBH#_
M1^BQ)<?(P!%+YB^O>2</T!99$Z>"6_X?6__YZ.RV,$3YBS\VQ5M/+<K.$*N3
M,M4444EL6@Z U54:-D#U?P_]![_<0:;C)-COR0MS</#7*WPI_UR1OXD07X6\
M -_S?]A]%,<E7,"1HZ+[UMX2T(Z#G24M(&G[7X/V7VAB60!5HACFHQHG>.OJ
MUEM].:^_UZL 1!M^A$XX:OZO#2!56P5T7L12U629;PD.**@>!/A0%4 < $B+
M&_I_C;:6*L!_?-E_H2VVT]XI"#\4$:^NNA$U+_Y%7NPD>]SI;1)Z[,VD\-2?
MQ>"O/_ 3.X)^SUULBXU.//]&KF-PQ[40ND9[/'37=.$*ODV3OM.\S?V+2=LW
M8JXV'WLSFHI*_$$D_1QC]E^2Y<5HA0 Z)B[1ZQIO!B6^WT;TGQ82@Y.?[IV8
M#G?$I>'C=:-TE3#*FE'UU5_1<>H:3/VGR_8DIG3&B3KUZ[$ZLVMQPR&V %3J
MT<OYWK.V/]/_IK@21\R$!5GQE^>>C&NMG&*X#.XI_A=%CY^7I'YY1L6<@N-7
MA%W2>+9"]MO!C(:165Z(2N;-CR#TA<37;7&FC[4]^'XU1BB&WAS7)R;VL%?3
M_BV0)M/A7\_%AC\P"6S07U8Z.S'P>G_6463^O])Y52O2_ 0PUW,@&G@/*"7D
M2Y3="#CFN W5N@>4:-C"3?:9B,Y!9H^EI*L=GX*0Z\MPC?)A]DSVE,W4]5$Q
MW!1E2SVG-_JHR@2A?(\CI<[ILT0VJT"_AO#:2[)VY)B<9F^IM!8K-*F>K[D'
MBZ,D[2ATZ![01VTR'_2&;[ 0K026S#5@SE(WSBQ ,+TP+N3__$TG?#Q$&\-"
M<L8>TLU]O))PUD5L/K^Z !*VVWJQ&,_6DL8)U(:KO DOLUT1+F7(F$+W2:-:
M<@^B7ZE\NC,\^?EW$+D$%=NF\$O[L1<:(T/8%@6S!R&7CR8R@&R62U0X"#%:
M*8)IIJ;M>P \M)?+Z-2?;YK4_AYP8G ^>8UE= _8&>/.+AR&= ,[.G)^(G B
MU@(E Z.CZ (_11ENX;D9R0,3BU+< !/<M8W?V\WCKH;6X:];OMO[3)=MXBE9
MG) 5MY,)B%W6LQ.2C?3IFOYVE"4R'Z3ZY<G:$A!56#[D"U0Z,. )N^FM5YE\
M_2'+\>+6?(?WKJ=$ I^8:8^ZA[CYER:,6WU)7S4#^0?Y..WQZ#";"9D:TODW
M;B,E7]0'U+N;BZM:61*O)5>-U(^9R](BPHJZ_D]VX!_IDW-16\U@R1IGT?Y+
MB<CH"%YPV4JG?<O%U(C4P,>.#]^TW7_GH4R,6U%,,;5\0:*KP;[R<Y;MB8?>
M=#\5OR<6+4H-N=%=MF'2]$ES90VY:NU#OA0.7-X#3'\ED^P_/;],K#P^+XSC
MN7F1JDB?.:-ADSX69,#0)]5/C0_%+.SO #V"&X*A0?F>.I!9WHP8:A+X7\D%
M3+HL5I?]/'>3[83S6QG.7+6Y(,+Z_99!'#*CW6KOQ^N-2RG*K0QBU=T,!@X2
M(:E^67I9(B)\7L::C1U9XYG+A*5/-#7%Q_#3P]S?,$2#?G8+H+"W8BUM<;((
MWCBT9\S C!XW;=:0J/J.2+Z3E](7KH8D2]&^E^D)1DAJ! POQO+6:N:U;#Z;
M'+?T9DW#N./MATCYECKH7[3;5):^2M^34$0L*[H@P9JM7&,=C<QY3#HF=VT(
M!M?A=NF5*/ DWGZ.UT+\16#N+TWL*#SMXTUC]U.Q49ISBHPKU] !+;0H8]:"
M*SH4346.>!4P41Z\QBF4'\SC['*.]TG2:;#V.X4/&9DQ >".GJCM%Z,L9-XK
M.>I)3F;E+:1JJ HNEGNP[[H5<JM6/S?*F%VG16_O.Q^@',T+[GC<3#EU5%*@
M;N>?@7AK):GLL^&^7(.NN#@:*L"$M(&GS@/MB2J=0L9\'73=:@32AC!8>3'$
MSVAK]+JR3D.H]5B6%X)[Z"0SFC?1T46[^F;LH62[IR/VM 7.#%ZKC4[TWVO;
M>%5HM]O.ZD*I_1:NF5[-L(%S)N;W#;Q5.'J"O\F5^PJVC>Y($)RH/-P4?-)W
M53H !J-E+S!^G"96JCM^H+T*$&=O*Z3P,]I_>[P0Q5<\4S3K O9.W("Z3+M+
MT/2WOV\E$ -*#VFI^S=T&-]%>O^5[5&G]2D0[)[R#I8R19^^0KTKOX49JV)_
M5:"8'YJ@G%+:]HA(V,[35T" / =U_*Y^RDT_!? );6=Y]^.HT%H!1MVC7+.8
M>=U4*=-+M=;VD1^6EZ%K;)L)NUR9[>W31>%B;B'H=*G5$Y%34^RA?&B0:6,7
M%91.<;HBMI(T_^-XU<O,W;Q'[AK<L+O0E(Z'>-:1KY=27PMV'-!VN&.YFV_N
M:<N9WU*PI6Q='FNGQ\9*H'R_D#<72N+7H?<==4-JK$DN#UU>)M0@</#MZK.(
M=J>E"WGI%AH'"6&QASR-CC@T&^;(O!I;[VI1F6T22GWA1D'D(0=,-AJ&2@E[
M-@1)S_> ZS9:9KTO<W9+L]4Z>?P^D010/LD+F-&$=1<FK1R'8L K0]&RQ[+D
M-D=Z/;D(O<*2/XLT!T6-:2=_7W*NM(6_*DO-V.!?IQW2GKI1K9E<ZZ$T;\^]
MKI/4[HR;)_GHRQ/J+J,MN+OGP!25XK 0_0Y%U&'I:1WJ-P6/J=<NQ8I[(0B^
MX#5)-IE+QAKR+[,/8<M9U^SD]<YM0WQ2;MYZ*:_[\1M1(/WZ<JZ>AGGE_IU<
M_@%R+D3K7*!3D"/>^PPRSW/'O.O[36:^4%.#_Y%BGHM&WTWOP.W7KG57&HWW
M]3 _CQ$CJ)#A-L0Q^YSA5?UORXDYO%HY6PXI\@1,DXEF#ZEW?M_M&#%05!D(
M>2ZA@.9?.7]J+5XLFLFM=-),_O!,-2X0/H9SQ!W<:-_110SZU-@Y\SD9460J
M @X-G^FOYJ7A[4<H[%R8'\M<FU!E[2&O;A> QST)O*LHZ\IHUT[],G2)Y$Z9
MGZO3*WM6S0@V5I7?]7@[?E)/ST!*"$<-@3W$,J;4],LC>H6:;UB1-UJ4@WXO
M-<BN#52]5J(6).A>U88L^9<KV/UP3^ E6L];3Y)8\'?G#(<99G*R/X_\Y/ZQ
M[5B"($4@>+2<[Q,0Q6B]5I-,@\[!\X[G8]IU&<?4*JO/C 3!Z8=_=8QC!5Y>
ME([,RP [T9%K!D)'I!5YZ<)]$&Z+[U\,/_S-AH@P,:>(T4P&3*(($7[UMD]E
M!X[(#/PRM*Y$:J1S8'A?Z%WL(VY^+B3)4\Z@82#= ;WCGA@+*&_SVYGE][[8
M:3B?8X'P-FJ@KW3U;ND?\[/0^>(E?[KO1NCPR?YXE_;-O*MV )-.1_-C6KHV
M=B$+C!',/"M]TC)TZ;N93N.R70BCQ(S4.]>JB?F3$5<"?@V'/E4"+">/-AKQ
MZB G/BEEZ[4Z!RU"A\L<5H$Q]N*23GD7XP2E7U1'N5BV+H%QD]$:&NJ#R]1S
M0EH F8CWSJ'7?VT:U0.CQEUP= 1>$FW&;-1SCB 6>LYO662C-0<OV[7B&^YX
M]UX8H(>$MDT%Q'6@KU4?#5I; &$'_EA6D%!YXSL!E/5P?&#Y#HGC4Y?\0%]\
M=9'**J0!0K&7[6T*?A,CCGO?USOF]MD@/A1MYTLAPC=ZT/JS6;#LGY38\B3%
MU-S/HZL1\[GKYL1C_O7VC%SFA$-U X1-QLOV623#)Y\^T APWW3,;@,7$<5!
M_*82=[+'3ZXU;E>B;\@:HH/>^UHBZB05NE!1Z8@J;[X7RIXVC<J@SKB.;[MT
M)&_#W *V&DS-_6J&NI_->=T#B/:U[0)",KC@8UY.\UN&6_"V,#UF;%K&OQ5^
MNLY/[@'&D6='4:(!@HIIK@U"7YP)E''I5"1CI<7.JWXM5ZX2D^ZG%1+MY;2D
MUIC$CY;/%).K4I3+>7N-BOWU+,B;LR^_N0>HAY28.F]>K9P!C[<O?@1]Z((L
M,"X'5GF]>M<.>1DOX?^'0'O;?B-<0)FVX76#U/'Q_#E3G*C$YEVB9Z6A1AF/
MWOX+["BV"?KZ=R8;^6T<-/7I_<NLH>0*58OX3$UPN+FZ/4&4Z9U?PFKWBQ>"
MJ4D!WJ4E9N8UU'JWLJQOT<EU*VC/WLOV^ARXRZJ?3U#1(8XBE@?>!IGLT]YY
M%G3B^[)%OP2_=$T%9TP3F81V-WZ+1VK^0Y#TI!NKI+EFE,3$WCV@U[=E7@]J
M,C'3J_?<DG?P<4H>QB2 W)B1(\HX&<^11(%NC"=3\)E2G+H@!3, ]XTV7/MS
MYCW@F/!9^N</%_> \ 0-QV%J';3QJXX9Y])@+5.[#TU)3G_=P?&M3>MY7.%^
MM8D:G?ZK/Q^?7Q^1PASG1394O3]X;4(XJ4(LZ:I94XA1/A37D\1[IWZX_:(!
MWO5(<P7UP%1;V</QUF3'8=7KNO" 2TJ<_P-9IRR;*YOU[;CN^>GY?"]+9/XF
MM,;@+-=_O:TE#@%L%]>6*-164O2_!\1WOI= 9]^(6B*D.08JZ+P+UK5G102M
M8V&IP&]Z8K2L9Z/U%Q-_>&J=D9:L9:2U#EHE":%JI\F4?OY"*T\7_3+7^W70
M6:\?Y.*06=U@NQ62*AC]*K03;_7CY*,*O:V3A3L,G1[>CMU[ %;3ZCV :FG1
M+\J5P-0O7AV%53&U9.R0R8*K!--]J\1,FJ*$-UHK^\1NF3L+H15GX-<'O)9>
M:NQZ"P5R^W0;L"@9?.DUSPK7"FF>18/.XKM>&N>+KIW=,>+3FC>;VD_!5+:!
MSRE#G'PG-;FTGA@LP='7PQ!!V"0%-3F<ALWO1VV18OC; B)B^G=\<7=:9VQ(
MZZ602C;7$G3[-F(+G.(W+&DX\V-I(TV:2T0_ING#B]H1%_&_3>DY.X<--SJ(
M7X%OH9V2-7TE!KL>=9V09!M>MASGXNQW!I%/,#"E/?6%X-RM=R!'2(.C $R]
M L[J^654V>)7"ETQ$!CW4]"A ("B@K@)$2KK3S<;?_1++A]DRZ%5B_2V.WF,
M"PB7?9KAR'H=(GK7;2V]L>!]:3!SO-Q<;^A7XOK$+RTP$)[JP(L4QGMVTCU-
M(VD@X8&).4EO,?^NH'2=CWROFV7F;,EH13U":]:,;99QVM:M5;>QA)Z//NU7
M^FC-,D.$'HHXT7PH)RK;L]Q0WOI"DDZ]\W&A)XX_@Y*/%R;6=ES;:KQDC8;Z
M4+*GLQ"W3!/KMVP@%ZL6"&=S4B?%G_$S,O@ZI#T$<-/1,+:X>?.F'%V_CA"-
M0H*"3%K2A//[XJRA.C\HWQ(9JCM_V+@B[,(.L,EV]7>L,.X+#;[8;YWB@<AH
MQ_]R/7*FYYO29UAW13)P#X4PH83K4P._&AF,N&./BW!NO2Z1ZS!\ _3E-DW*
M"O&6%E@^@YD:_AUE.KAT/\B4M3')8W*:ZF;*O1F<*[\,4<YWP&]8#/HPQW-&
MBZQ==GZV^#-0RLPUI7B%[@VS(%E@GEO ?$%\*"(8=SBSFP%%U(#3C%/LS'.Q
M$&_7<@(<5MJT-L^B<2$VZK&T]2JD/(\?;LEVMII!EJK^($GH6\P@G$I-'>EB
M;[3UYAN\!Q"8CC@+PA7L_;Z/-Z;%&+!/_9HBCT@X'R*]EETX#>U]'-RP__<5
M*G=?Y[MT0X)7 Z']&LY^?*Y5FE)0@2 0"Q_:XIE3N:I%Z?"T5@*9.%]L7:=5
MUEZK?\'RCG<NW6U-5?L/%KV[R=QM@I%M4G--#QF:6A?%V96O6>CM:@=)'<'3
MQK(V^,CX6"IU<LWXP>/7+#$9H][-WC%IL.-GACLZ2EII?WQ)"K; YAMA=GN\
MO_S9._XLU&^SU*RJ> V^0H/^CCWG%.1;H2!K"-8Z&'SOM$3@P>_Z@A3MB32K
MZ&A)'*0:8242-%- .+\DI@!/&P1)H(1[8GJY[:M_6F5VOXXHI0N[!W@Q>1"O
MFS5:99'^-BZ'1K<9?%;;GRZD3T5#=W@K<QWX]R]E:82-I7&VEH=5O>(]06=3
M?Y?5HH.<7X>-JQZZ]ZW.5V15^^4.%'!#SYC('-P<J6 YJA?&9\U4)SQ5HA1>
MNOK8 :2[;\_%FY>($5&E]<9VHCF9:5ZC+'E&50*9!!LT?;T>$I2XLB^J>6SF
MI)S7-8 &Z2]GO8*!*H966DA64@VIB0[^S8V4(JN-\U\/HY)\IW$/>#00ZGA\
MG:IEBLJ8KT2 U%4;406):X[!$HJ1VYT&907^_)FPM!<8.'*3K'GS/1]O+-EK
M9!K*5_;TGN;!M)7O9KY9\YLH]::XE46^#\?#I9QT"""$1$GIU*[LF6$SLD&%
M.8=FW\!^*WJ[N[( !"A<U-)'@14:WF:D$>K=C=V!?-AC:ZT<\K2GM8B63#?Y
M"1UQFGN XWRY>98&$IT(S]U&TWO)",\&J=/,U74#_3P'6C9_PW?3605&1XE_
M;@NV<FE*/*?!::E ;9[? _J0RH,MS@02&45^?XJ>J23$K*FSB&.K;-@VUGMJ
M0IVDZ#ZTB\;(T*C7J;N,I^P9N:023K4ERW++^.OU ;;KN2M1C 4+YKC-CLY\
M V3V'I/D%%#FCZ+;?MM6AK3,MG$U]I596Q^#U.X!\QN^+2ND*^K.(7QD]A?U
MF5ONI8124J\P.BQ?:]ZL)X3A*/J$T,_U0#J%*_:6S3-=06D?"I=X!!15 ^EZ
MHNN?O;5D 5OCX:A*2EC.-P5A.TL7A@G1.5:Q/LA=B>&SC"??23K#B9FAASWU
M9:#TNQ8E_03O21(#-&0@1_/3E.T;]8QTY.//+XM54M;3P2ZKI'DGCM3:/>B/
M:]*.KQNS#!I1C_8%FCM!PE^:KUF_C#JQ2$X!5''3DTK:&0)^[+G&FI&UQ\%L
M6\*Y^X1^TG+26FEW),L7_-G71%GGSTW&!3$(44'5*;MND@5+J QF^U>I@$5C
MF#DZNULK6V\+[@IC$T$+"9UL"$*&YE 2N*.13TT SS*I10O2:?RQ;J0JC]C(
MKX(,*/K;WH#FFPK']I"8"/>"BQ-2CLS6O>(OO &%N4G<LB,^^OI9C%0B\U!-
MYOG5S#<4UIW@)W]M1N0$Q(4G_-:U[(("<1IKT4;W@,%VFN^DQO __;R$G=>Q
M-B_2,$9'9&8AZG-W'YO^AM112U$C\E]J48^MP7O(=PLX(FL3%_4O5)\*O' K
M9[#\T#.(=Z09=3IT)SPK3'LF'; B/^/DLCS#?OUD<<QCU.T /OJD;=6R@"LK
M\BP["V':W>BX1GE\E\Z;P>,^W+)+GGE*LJ4=X="(&\F:QUD-OE5^B_;WK;;W
M9:2=%S:50%RHUW#GLV/G/E)H+8M/A6 5!#RMG+GMH;L'I'3 ?Y[< _CO<+/>
MRI))F;3/R/&Q0)J4TU:>B<L1*83YFX2+C?5-"J=UBW2C!,>JC()>'=\#HNK(
M;(T#.6=H;3(H5H6Z+<.S^YB?[SB&]E-=S8TDW>A4.SXU:7FQ8FQTFT^WU0]8
MMW]_DL6@@K7NMM46R,"D=:S1L?MT>\!0>"[)]IJWO')7>PD\39YQ*ABE1SLB
M\[E0_<(\^(]67<<=E7*1'_X0'Z*'N&MVQ494;X',2/.BH9V6@7A%X78>B_2\
MEB^^Y:H3QIY_6UC#E@"J@BOM7[P'"F;K6UJUO*C$=1$?,=H+XJ0$!SP/U")*
M?"3.:G/-E$'OO-N6(8:UOC]D&Z0$;294Z-_Q^JG4T=;<">F@VI.SIQ+')!%<
M>11KG"TK?&5^=0]@4;KP.;U5@T"N+L.E@%*PBGHIQ:^3'BF&5&!UZQ66)S$O
M&<,VTA>:M7N:T8E%OQ?W&Q".A&^-AVVR5"4<AFAU?F)])OO;*S81O.=LVA#"
MC!:;K-RY2LJJ^FVFZ.V(T^"ZD<V:$#4L$/)F=)+27!=5&"/<);#_"MI)7@_;
MNR3Y\OHRE<NHW\ "DML:A2G>2RM6=E0'N0=\O Q(--J[]KZ^!XP>GB5J$MHJ
M?9]%-FTL]:<S2\N]S].71MQZZD>_G>F47+L(!VF].:5?,F$_@\0"%J]#8]L
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M]1@E+>Z3S_U4(\0334[A$M:-%BMSJO>4<P>P XW:8M6'[*KB_4ES6I@OYNW
MYIA<K!9JY=6./X,V3)IT;CF-9+H&3W_[R&ENBFTMF)S8R]5X^$M7?L68F;H
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MU=]]$#E\5UQ<+'J5//RI_ZRJ[9]+CVO8I+<3T]N[[I\FNC_@D$EU8&7<;4E
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MYU'Q]!<]L!86VY)-FJ(FX,*2LBU/.=4S93"U.8QIUUE)6KP2KT?_BD_]L4,
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MC+^W1 %UH^:(<2.0VJW*D2J;JK3G4^^2UB0GQ/8@?,X$FB\BY2%H1/SP[>$
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MK XK&0./-0ZK0O>%+QTL28R'STKVOL6BDX*6)+^Z).!1%]4QHGW@O-=8'7>
M@IP:OV<H>L;. ]@F#:; _KL=B9W;//2[RO-G?2S[ROH.N/VK\6KJ()^ ^CM
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M%  FDFWA?-1RYGG4,AY1:!-IV/1 Y5UB_X 4XSN=K5FE](+.L7OT%<6\]1(
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MTNU2NV4I)/P!NWDF)!XK#$1_4J6%[M;+ED5L;B9Y*?379']&W$"__*BST[Z
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M9W<_,E'R?GG-?M?+J@GT65$JL8M38JWP4XK2W:;SJ60D."D(/W3[T#MB'M4
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M4'X#V(=F"Z6+=#\", T.F)43N[4##^N'\7K0O:@ <P1T(_K(X41R&0+7OLF
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MXCX>76X"2UK6#I84VK.6$G;T3-B)_6_S=>]' (%^N-GD/Y^CP6#9*)6T'QL
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MYE@9^JHI8NO3AV?ZPKAH_9(6SOJ_-*E&/>([.1%B.8FW$).)!:'%1P!QRQG
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M]"U\OY 'AL0"T9)2!V7>X$TR_P0NL^<OK$!B[_@@'7>\#]:8)RM='4C6BYW
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M^7$$-HC>+]\R_Y\N!4YT+Y5]8NR^A>/B\CZG%.%J6N+\.P?!8EQH16=L';'
M'UKWRH\Y<6Z+8\B&:[P#>.(ZY(S_R989\?8(X_GFJ7#-!%R^-,:*$NL0^[Q&
M+-;K>*!_KJ$:=KHLTIW @.=JY-75_0BPK:MKG;)HKX7?2@R0#O&\_)3%PL=X
MXJT=&E%I8C3N0D"^J]T@\M<V$7&41<2O(BAJ\2VL@]C!Z;D8V>Y732.)4C_
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M7OO\EL8?7 GUO5^)$HVZW)>7AG[FBK'$EJ-MNDWI2!1X]$Y<O6N9 9_?JW^
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MW4A:P^X=WO0]4=JL& =*]ZCR5M'-)P!%[[57;(XG5QY506::G>7OXE >/=0
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MB(TG"];K4P4R]R<Q$)U&^)DT#<@-T%]A3B4#XRIB;MF#FY$UN;I-B2ZC7EM
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MG=[\"&6U2<HVZDOCK>E@59M:61A!.+#\[YIF6OF2@)8\-6?O.P/RAZ\B3X"
MR,695DR8KY%AL'[[U)L$M<#$J0W^-QR-7<;Y&/V87VUC$?;0 A_%3 *,_3)F
MA-Z5V#-46[H"%;9,6W:-I4QD5*/WWD):_NB=G"\]F]U@A2 8] 0P.IHYD*+6
M&7X"8%VFKJYX@UV;EK_^HBVM>JSP1WO)GC>'X0*$2^^MJ3R@S=;)Q@K& #2^
M E"KB3=1R!GIIXI_)0"G+XFIE(0/'1\!SH[P/%G2/^R*#ZG%!<H.,,>XSEG_
M'S>:EK"Q+/!K!A6+"I)C,UCN;][U5EJ9,14I:$4>DJ"'$@,J55-@3:AKI%Q
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M_IM8[1N2E:)Z&30_C*@VOOXG@#)(['R./4KX?0QN69,"#0I&@;CM;M8S8HZ
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M%]E?X ']#IW.T5M0EO:VY/7YR_E!,>O5A_79RPNVWDP.!%FW+:$C1FYSM#O
M8'E0J6!TMED4W<D1NOA>4LYS+]4_\+(#90$9J/6Q=L9%Z?O7NE37[=K^*2ZL
M(7F3/RCC[Q1H;*N:POH</>P%:EJG+.9F=G::@V0#;^$D5$[7>RQ%G[NKX6=1
M4)#_EUD)/<_<W ,GB7JX-:_B1>T;_=I!)PSL#7R/9TKUGU<Y4E&5#KL]=7?=
M6W_-:<_M2H>YM+0&M&1:JN^18,*4Y94Z*:I9CL_RNJ3<:Y7/7K6Y;0BS/]D.
M,9T&QXQT?Y Q/U]T:,1DX1#;++!OD[MV.W9XY(3+Q6VDD?LHP6">EJ4?O>V9
MTTX@0]>)GAHZ9OB]K]PM&GPT(1Y1 Y1&/PJ;&ANF:?_J'4$;XO-LHWEDHZOW
M[!69\%LUYV/JJ*J(/$"71Z)O8BT:@PRFB<BP&9KVL<>(KXM;56%1HVJ//3J3
M55,#NM6X-8KOR"*UEZGRXF70@@.<1#%"ZEN,GA-OGJ,B\/Q]K+H&O#\+/G<F
M/^O#O;>H!RR6M?8VL3=4*%)47EW63Q<1H8_['->[A@$_;4-X=7.J]0-_G]8M
M%B8:'AH:T+S8PCL/P-XP=IZJ![5R;U9X:TR?WEO[YC^D*6>=O-(^4!WZH_C^
MG\&2LL?0AK?&.@G2W;!YWN7LE8?%>3?GYS$*SA&Q(-%0[9424;:+%T+714NW
M9S=Z]X\;9_;K5?]HI+*^@PJLYY9\?QEJ5-39$BLVUL^B_F=KB18:B"#0:WZV
MC4 H^QTIMAN)2<C@6+\;%A5\-:N[X;EQ]3%2ZW>?EM/^C_;N*ZBIO]L;> 0%
MZ:!([U7I)?0NAF*D2>\*2H30(?0F2I..TJ5)+P&!A&AHTCLH)4B'T 0$$GKG
M^)R9=YZ+]_:=]W_.,UY\[O;%;V;-[/U=>^\U:T'(?VV6ANW""^4K.P(WP1/%
M0+%*1/M:3;,<Z+A"B>!5)74J=U65B ?0EL)XA%R\X))>9)4K7$H[96_7XFU5
M8ME0X(,44U8PQ8R6DGC"1V.R9H$%+'&BU)"H90I6AUDSX79*N]P\3Y8VO;_O
MM)JS.[$RLJ#$+$B[OK&A'CT1I 0K;C=2FK'L%RE2BUM5^TFRD===,JDH#F_#
M,C:!E@3/!0//,TR8*RU/IN [TI<87LK59R2,C$,RT%/HI=GCH_VQLZ_O[4M
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MACOYRQ?A?8_*QZWUY9#NUZ4,H&58UHR_%7RR(;J%K,G/56CL3$BBR*,P#O,
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M^\NDXLL<=,*_?7+=B[W'$$;FW0E6@@FGG5YHZYZ<; IY*7*M-@\SE3\#*FC
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M_!4SNXO<**7N9K%HVIKH_1(PU1ME"2KMIHY,2F#TRD&+1%)GCN/5I>],0,[
M3KA@HU< *B90#*Y$2Q^[:DEJ@L[7U  6I=,_2;:#UX? ^O#*QB8NI\135YRI
MYW9U-$LAY[N8?BX26%^1(HX_"VY=W_NXNF[0[[S$498BP55^XBZIY..A/,C0
M*41\I6(X@_1/TB[QN_A!#%6#Q.>BL=,#50&XIWAU\:_$-;U$[@%G(BKJ-V
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MZ/H6P$AT<PNH$/"M<MQJHJPRAR1UZ.P:)70P#<F@DC\_K%,SP=?5<LEO]@"
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M1KEL7/B+]:3O,3.KS:^6NK*%[E8.;#E6#"QPOZ+\U_*[?QFJ'X;=Z$*E7=5
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M3AG^<M C8)X5"K^+$&[:N$54MP""64=Q5FKHE;GZ]5*MJ>VOL(U1OGB6"[9
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M^HTGE0)?G\NW?*MYU"@IV4L_XM@/0QK<'/T!L[VJ<WU?;MQ#4OWB2:=(M[>
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MQ;0JB 4_T "=6]97.N+<>B6AUAR'N_E\Y-MC);X>>4&Q0\\L_/!3H+G"&7'
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MT:9!$H?63790)YH]J6A7;Z!)&E7*5!H3*WS*0LN__\AZ\:7:A?'<;A)5$75
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M(Q#:7:E<OH\YJ2%VUMC2MYCT4K$CU%,H4IT 8D.,XXI*_&(NXM1\&],,0-3
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M*M?"CK,>F0@"^J]CZ_(TF%++7_-E0+:(VLTL&BWI^WV=L[ 6FN9W, "^VS
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MLZ!.-9-BVVF-L8_)@75>)D+\]R+$K6ZM:R%\:W>.]M0/7%1X.#C$N^3Q(3>
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MMW&W[L/=VON][M;=#E'?@._U9'Y^C?+X]=OC?WZ/?_GI\N<WW_]_4$L#!!0
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MUF;*.<2*RU/BDZLQ>%Q]%(1XW5V60!N9W3XZ_N/^O<.SZ/ TPI#3JS\9U4+
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M9C$[6D]*&[!?BL;6%2^2)6Z'HW0W__K#T=WDH]O]L\O9,>\8>YQG(U5,V-S
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M<'##M(R%QXD8T_(@3CE$@I_3/[!6OI(D-9'6E\GW6<3XC<-E:H:Y7< C$-:
MD *4UU0&DU=:1"X=6/L2YWY^ UGR<$M#Q.WM#!*#Y5FI$P@8D$IT:THJX,,H
MB= 5S W6WEN*QFV+ 3,E!%$ '5,5BI6=ABO X$K0**  JK&-E)DTRZX.**D,
ME!(J1N]<@=D>;H>6^3I.SFS,%P)POZ9SW7N)>O^22E'8CLDS4H5Y$;1:$-M$
ML2G6==PA2FN=URH3&4%U0)$2NJ=O"K>VG^M V7X^F4IB53+?>7>-T4BF,UG
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M]05X9WE,G$3X[SJS%$/@G^(8J<<$J282_8HX33V)DHGY)&_T2-DSRVXT"7F
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M'SRQS''8#B0.S3B=!B)ZX(E0_FT9<&66A=,82L6#L:WI842C&CZ@ 7-NC0?
MS3!AU%&LBKB>8+U1[-LX@Q]6PJ]A5(KJ<C4]+LIX38M$&<#YP0YQ^E,Q0Y,W
MQ'."L%^;C.Z\A/;U6;6XLWTE0:I,08HT[IGI#S-CJ8G'VCV#NA'<WD/;S@5A
MH"04?-OFH*[()Q-9Q-041I1JB5SJM2K^6&(DJHSKLJ1*Q/,\ITXVU1C3$]AM
MQS/9(5.E#4U\D.U1PW(NR)8@6]87*][=D%CQT;$G@J=_<G8T.#G][?!]""V'
MH[1V-;T!X9BCG !J*^CJ^4ARTTJF*=37GE,FBW*LIDMKY3-.I^L?^$=VM5G
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MHIZW3+E4"_>> H\/]J,I@9-Z&7AM$$C#=6[SI19FC],*-[?QSB':_<7$1,Z
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MGACP_#&JYG!#L2\V#/+B%TS >/'+MM,J(GV<#?L7YQ?]X?%P\.YL9=)?':G
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M$9G2@C.F#%QJA,46"+ -W$@*!#\58+MT8$RG8L%!7YBT*#U9%B=7\:90"^7
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M//IZI*R&)R/<%G=@I(GAT 2Y18BTUH'@N2,$,"M*(S_@D>FR3F/H& *-E+3
M7XF<2R)\;&]@/^,9>G,Y'"D#8:XU-GANK8]D=6N1737BTPS:T__!*^=^U<2
M,:8\%BJMN*3(7@,GY;>Y#8W]HNEW*A,C1;7#OC?EDZ<=&;^MG1IUQ&J^L6S-
MU6E(XW\V[D.G(C%=9LH.5=1:99!*02K=NE3:^CKF@6].24D<I(2G-E(A@Y-0
M<ZI59!DUK=U&G>PVBNSJ:CR&']1NX-D\E;ZX*#0$HHLK8BHWIJUU'59@"\WF
MV*=/48]<UZPT+JY-1%*36T)Y/Z!5QY4FG*I)#FHP\#N3>B=BZQ["E!CQ069=
MX4#N*F]__%@5NFPL']=A97U2L 66,[LJ@CT";B[LY"&QH/ ,"YCP/.@*B=1Q
MH4;763CUQMTP<^MJ,]/V!.\@<\N(_GK!*!SKI$QG\>YPG4TP,FLE)<O;B'?S
M%^J\*B[E1Y7!'@Y.V5;KK6@I:T[3\Z*@4%X1NC,IS2R*)@%+M]P+"LU%VQ)N
M_?WRG$GW,C99<@W1.DKDFGN\9C%PK3R+F."N.J64O18U&Z<'LK,.,?/*D2ES
M2(N.<6H#3NB'\@:'6)\A=Q]5DYLKJ9Z&2JI0214JJ;Y6U?E3I_)D5RJI3MZ=
MG0ZPH<>EGRAX]S(*15B!RN[:0'VR_4G$O@:JU1KWU'X42V 8%!>D/NMH:[DY
M@W4(B+UFB/$)/X/?J95@B?+T4I;8X#P#73+A-O?&*"YD*A?D,W7MYZF)!^DY
MU7Z MMEVT'7L5^^\!39V"XD1,%+PJXR'<AI =_V!P2<66,X=L9RMSU+^C*0%
M2E&N-%O%:-2R"V%>%3%0.1BXE;8HZ);:.HG,GQT:[\9BD,>Y%51S9$UEV4KI
M<O,) LD'DK]MDM_Z%,G/('GR'RXYQ\BFQ\")H)<L%5<]B[69%\N68XW4 @G$
M"H<732J52.R(0&_["GB5Q6J>2FUZGJ!ST3(9PU0"40>BOG6BWOKD0U_3@5(K
MB'"=\,!:RZ'1R#,I$\V_Q$('E1F$7V$%L-Y A.,#7(?V%<CN=@)'J[3<26ZS
M$?.DDEQ?WLU#\,;\X['QV0-889K"ZBM8-VP$*!(P-\89+]>J-G:63:3#G=)F
MU29[-:1Z!&Q69C9#G?>ZG8%W[:SW>^V(FV=K*A.>:R)6%#Q8\#;1 C&6D./9
MM.(2]3P#/P[\^(LZ3)_NBL/T_/CWM_VSH;>W]*+_:__L?3^Z?'U\T8^&[R+T
MO+X?#(/[--#<G>E 3W? ?>J9HV"K."F]H?9-V&RYZ_,KFQS"E6P;X9]%:)^*
M$,><G@^6$^MC-V/(G,DRNN "BR!D \'?/L%_S<Y+V'SLV6SRP%Q2LO$+F5$]
M!R4LGX@47HHB^J\*M%M9]&R2%Q7#( CQ1FF[2^J!0$52"TH(.K#\Y& M8VDX
M4'?.Y)$QUH!_EQ8#Z-Y=95W6!7H]J/1[CVUEEQB7IO;=;!+9 =V?^R<6TEZS
M36&3W)$34Y5;77^;Y=D#K'2"H;#&/>H+Y_M-N^V8.^4IZ6E[(=@\]9HQ&,^R
M) <3)ERVJW!;^^]8:C1_:YO*CW,X%4T.:,]F>#DZR^S]VJ_S!^W%=6)9U\P)
M!=K:@_%,&&N6ELA2J%1;<Q.LW(KR.X/X">+G]L7/UCO2C[WCT[9ZMV93Q-H<
MN$2'Q]OF=\"!\O&XA]]*Y#S7JL[\)A<[O/9,O6PJ^8D[C$3V@=@EOBETJXJ(
M$DXI?H_:*/Z;2&S*@7(3YI/5S3JLV+J'?.#FY,UG(7DS)&^&Y,VO54Y]ZE2>
M?=6^R-/!Y?G[8?\R.!X#@=V9(OAL^QV/OY&=[.F&4!_1IGX&-O557GP@\ZJ-
MFE)['RR*A^,H<.OX;@5<Y/'!$TJ?:BS?KCGYYT:/GAX<]3:#SD:%DV!-P #'
M7"U$DS$:)A:P&PV9$3QJ0[L&?K&-Z#O%DG$.=WP#'P ^QNX[.FENQB^QF"=K
M#'1W#_UFL2<<Y/)3 RQS1AOB IC7GH%K8&\.CEI8-E\WGPZ6^E_!H+?>4>R=
M6&\3)AAE241M\EL+N573V^&:FLI>E%3%1J@;#;+0BAL601[ RB3W)'.E! WS
M!E?4.@C;L^_!Q_*#-^2H6]F-6%,HF>HLCWH"%E^)P5"#8S"PF]MG-UOO&/R,
MN!2"D5'YMU.JGR"SJ3#Q#)4PX#HHX+G6QC15(>TQCRLDQ3J:W:M!SCPG0F"$
M!CNFB4XG5@6K4>]NT'1N0$SR#PLE<H;PR1BGIZ0[$Z#[=!,91P^L4QLSQ]WJ
MZ;UM+:DI8D#UL.Y'6C9MISH0=]$EXPWP 3IPLGC<OAHJ@1YE%.[#A3HJ.=5Y
ME5$JA887H+!'>T_WHZ7$MNOC/$WS*YNY&-NP$'Z(BR(("=^[XJP)TPUA+8'G
M!YY_ZSQ_ZQ.P-S)Y]PQV&9AN8ZDUHWV(!,PXT)WVR2)FO1$,X6(&GXTP\1BA
M+*<Y<"-B>]6<V'U5E)+@5Y^P=FBXM">(3-OL=A.=..>;[4PY4UAK"CR_@45*
M.%48)!5.S[!(;LV>R=0SY#S*\P^Z5S,6?'HA4="Y@U(;#,L%01Q6B9%3E,$>
MYW,EC3O%%**:Q_GBI6"* [D6K(35&"9KT/!@K0N\%+58T2R\5;L+(9;)\E*P
M;H6@77PSU+NENH'3!D[[1<,9W^]*..-T\&;PJG]VT@^AB4 L=Z:6?/]UAB:L
MH^F9@^2.$JP_'J.] 5+^E)##NDB#<HZFD&@99N>IJ%.KO<$<V+Q",]=%R2>;
M8V4,HW'\X_*$ABOD0L$F7>^H\YO,#]B#D$UNQR@F6XO*H4P[C&M\@OCK)P<M
MD#=3-.6;N0,&6XW_W[6!>:M7,G9&2VO1<[^0Y>IC_&;1V>(;]B3H)X'EWCK+
MW?I@PV=X_ZC%9ZD=5U:ZC"X(L8=J=8$#DQ$$]&8H?\7S)1OO3Y[5 )S>WOZF
MRRB\L*#=B#.$'[S/%+H'+TN"P84/CF%XN#D_,:10@_&-"8Y_ $/H5UB,*KSK
M<ZJL+*@0=B21>0U@6Y>]Z&6!++87O0*+"O@9G,2< #--'-3,[I_PBR2?[;.9
M"!.#F?U#S$7P3P6N=/M<:>MC$ILH@JM>)4O6;G',#(::=K5!HZL!^YE@ 00P
ML;GE7!MYRI"^(T*P9BSI=F]T-^!J'.TK(YMY,7AV#[.@,6Z*CAUO[3B;Z-YJ
M".(3P0;+5>>82,/(Q[AQ3AF_MS<(%V08O.[5_.^:29E^/!9,X88I>H< L$==
MO:"5TJ7:+N@<2:^#8$"7R2RG1Z\\Q86-9_"^.M'Q!G>[\YUV0*1MW\ 6E2K%
M"AY5>#;5-D0R!/G4L[V'5IH,KKNZ]U RW9P^_WU(GP_I\R%]_FO5G#YU*C_L
MBK_YU;M?^Q=GQ\'A'*CE+NV,'[;?X?R/7/GF^%R"C5%P6TWN6B6_;@(*%OJ?
MIIR-;_D=4N#VT^#G!'W6@#QTXSXK_9^D+L4H57I:AV :8]/3<H*[I"4G/<)*
M49=TH3T9[($1YE0&=BTY2&D.8CY'SA.55WFT=[2/^2+8)9?R(1>^*9!8&\V5
M*+K[(#?0M(=_-#4:^-9%^]MNH<9!-/2UK<T:5^;@9-Y8@YYZ-O7?=9-RNCF;
M\!"5>WH\XA3F$2N1U95*)MN[?2RKRW=;?-6]/1GIXR,F"RK? %@A)Z(P4!3D
MY, _Y\8#$FD%Y,*IC&[O*<Z3K=NP)3*F*ID',T%K$54YS0M5>MKX-3:*=%%P
MFPY3F(-DA]*X82,)FS&NT5(,VF7S%!WG<\S8]R\1@(VOS_?:U5%SJQJSL7VA
ML-D5@O+#"<O9/,V7TO-<+! )TR#!5>'R>FL',[W%/\J8.F5C.M18H:S%^(4+
M'>F-F4+^03[N$79SCCD?;5[:/EXX2<[EXNW?P_99#?+7(E>)Q?Y*\FI4]CK+
M\H?Q7)KEFC;3Z.["5.%KYF.;-&1YYJ20C=8>FO]UY:=TMSL'SCT1E(ZVWV*P
M&*:&(5,1<U!J#7N+?$&/ZGZ*E+6XFF[8V9 OX1 [#&I@4 ,W40.W/A#MK6X@
MA<=3H0K.VXWVVKK-2?-1JP"UKF6HP6$2DX?2*(H;I2.OY3A-.A!I:,0R*;F6
MFE=F,MH[Y'J';B"BUA W:S;:V8%:SI"ONK1/MS#8R/+SDLKQ,H)VS#($=1P)
M#;+6N/XW[$M. 7_N7X$:Y<K$K$;HRAK<I:0 E9YS@)(H5@77[FQ2DTA/ CF-
MH116Y[!+.T6 5%9A3@ &?$S@)PE,/##QK67B6Q^W?PF,U)]"5TWV(J\FTU:1
ML*DP--5[%,;5>ERE-=9\(IG=(+(!\4!O8\TV ZF3)-VG<826TI8B+=*Z6KD.
M =?.!&1HU++7IC9Y6B>H1 -S;**__V8@1-+_B3?&8#>JVF#!L3#(;Y ?0$4U
M@/XC:9N.P.N%$KZ-TE*)VK=$2$>Y;R/#KCME5B%V?VJ,H"9H#(JY<NP$5,UC
MDFG82 UWT!-J@Q=H=YQ\&6!E8.."O)DAM8+NS'FT-!T.2)#83+.2<D0>[?O-
MPBE3PLXNV(#A4P9!SWB6S!=8L-ONT<(TMP-KS].89V!+F9@NWG,779,KV6O$
M5[D@6-#&A&_&A.N1*DD^(JQ1A;,!IJ#&P$Y]/>(\)MP&V%M,=DD2@R+*VV3V
M)0/.$^EX*I,*YVX.-8C;(&ZW5MQN?1GG1C83M[!?J!*E1:* .U98!7@US4F"
MH&MMG2E#O6SP_-5<T$_Y84;X>-I*3=\9Y#U[8I^RP]8-"WP-KNVTECE8NRX=
M0% $6)[)V4@6UJOHBW)JUP1<U&3?CO:[SZ9.H,8)F'S""U@[]KR!#*[U N)$
MZ,AJ9^6?= ;:']V%*W#-I&[V"#:W[6Z\@2]75*/F (V52\[]+(\6N?^N4$^A
M&G =[FJ074%V;:WL>KKMLJOOG3)K@U#D,!*,19!?912>R[#$OY#L([(<JK&,
M")6F3BYN#(G[1\(W9[#^$#)80P9K$""[FW&W]6$>8+I^7/_":IXJ9>Z-S/S4
M)@Z\I<2!D($7*&E;5;&C[<_ V\B-P.9AHG1<:0MZ1"7V6'>+F7$4]40</#E1
M,7RQ,/@"C>,<T[%,%:X#0><WE0;2> 5>X"=31SN#*13HMX^G(IM(ZD6+ANH*
M/D$; \\?>&D%WZ !)W3*UF#HN@FMP6Z&_<3)+O;1@I:QT&53NPBGC0OP]"9@
MV@JV+2>3_)H:NW8$0QOGQV*?3'AV8QM@5-?K[^D;;H<(%*?1$""VC</#)A%T
M!AR"N4W*!*S-A6HVZ?ZIZX'-[PR;WWK5Z_/9?,^%4;&MM9'?(\=068S1)60L
M!69VFA=K(>@W0+4C,7$C9_)D-C;,NQ':?F!&@1EM,S/:^DR1SV!&UHE?9XLC
M-1,70HVN%\WR!/$M,4(O,*ED%=_2A:7T9$7P5.)$A=1YBC47V%K2(-;'F+M1
M9+9"'WB+2B@8@5D9Q1S!DU$#[E$0JRPJJP]C+Q-/+E0TL#5?&F,S\*3 DS;B
M25L?3M\(Z\7A2508DZ>20X6-CB'7 -FMMN3IPJ%X!D=27&#)=33 ;_*F2V;F
MI/U(@S12WN\H2. :?R%.PO-=P4GH_^ODS?O+P:^#X>^>V>_OWKX=#+%%X3T'
M6+CCQ=WF.DY-RZ,&"ZE=D)'EB//$>:U@!*I22RR0+.IL91$-IZI(;.JG2;V-
MIA6,;JI2L6<R>B*U4?HB>$8*?XS'\%#J@$Z9Q: ,DCP!69(0^SX!#99S8(VS
M[F"'-SHPY&UCR(>/=H4C#\Z&<"/Z)\/WQV\\]:.+=^?]B^'O]YPA!S*[2RL'
M"&GK@WV?E7?%_9\H69=L'+ X5)E*T]NDE(74W&>58;;Q>P-X.TUEC*Y9%%\(
MI;#$O"W?D!9F=\)BBCQ-.7+FE#6(:V#?W:+0_D>E28:NG5$+^^+K9A!! /\E
MG&'KXT/'OO@WZTG;@)TPC0+1MM!$ZKI@3050NDI+]VT+]+I1H:]M<>?0_'&A
M])\B^29")#060L'L41VO1@],?:%O_+U&#@[,)#"3VV<F6Q_?^<R^ G^BI\"\
MR#45Y/3PSY+:JB5RC&#?#,AE>I-Z(RC8N(T!"X !8RDH_7")O K3SF_6)5S4
M@VO6Y)L#^9D;<-.:-@)/NI&QWD>6=W->_?.05Q_RZ@,R]-<JDC_I8#O<%0?;
MR;NSEX/3_MEP</QF$+QE@6;N4HW= 7!:) FGZ-C7/D9F(##+!V_7 :B-6-EM
MT\UAYIB1+3]BQ;O&M$5.:/J/30QW,WO0'#6YAZ=*QVFN-RSK;K(B>[9=LPUY
M119@AANP8ZA+$K N%Y-?R%BJ15/MS9JM53.].^388NY8.C!IB#Z0\/JHT)P@
M&"FL-J<Q87*H2MM"\WE58"*]R0DMI[Y-NV $^1%U<M/*S-1X(^A/E8Y5RC6F
M394Y#J@KD9DS;!T0!^INX:Y8';LY9X,ON7("".6 VT%PNL[0[M-\T8?29>=^
M%J#%JH(AA4"H$;H!;DNWA=#J?O!ERO)-&A>9DUU=<W-//K7RU5M2>(.TXL^!
M3V1\N\KH*J_2A//W5,F(L N5I_6Y.>BZJ;C2!]$+%[S"@,DB_IRG3<H8/?!C
M8X#FB! L"^!<%@-7<UIAE99P/>$% M[AO[H:D=L<CBO'[[O4M !;$=_TI=T%
M5J5,$"U+UVYY?C[!B!1T9+3?C$D5P?9K;AE/F]2AE,^XKN,55%JZBXBDD3AL
M923!C()/D(5V020(BX2!CVN(*.%9YJ)+9*1TZSDE_0:D"LZ(;V5M6L% ("-6
M&ICF7QLT0VR1H9L@SWGQ=)>D@TWNXE0:O ^F_SBM-!WD5>9+O^:>FHY9^)#K
M3OP^>@N"9GG7FN761ULH(HE4CSR!U$,_ D,P59>K$$9B!Y4(J#K+,Y23R$S0
M<4@=_&RG9U3 '7F*L@N%O[^$)%@_$$@1=LHS3%XY@I@X3E>0QR*+$CFC5'@,
MU1)KQCPGY%H&6\]O*G+!^N2/A"BEZMJC>07[%$=)3JR-!-:,*I.,HM/^W.9S
M@=XR%AR?\O76MA;Z$P%*P6S&59$I/65-JKL;L'K1DLVDBH(6FB[; M2;#1OL
MI>8T\*S=.B@P ]BSW;T_5"UA>QZ2-5#FL)H85^-Y25*P))(E]56@'H[=Y>-0
M(.QP-!"E?#T-TE()=(2S*^J?T(IN1]46VKV#I!^ VL]E:Q*=_&R?& Q%G,I/
M5 *2F/N5R+DDT9$Z@4_OBK+K=D,0RJG5QX, #0+TRPG0K8\P8GB_=ICXD9RQ
MK,$*8[_,65XBR9'54+=@S0LYR;F:@G5J*S:?KW>'@#'NB>-J_1PQYCS *-<:
MLFV#G%A14B\!&5%MHX^6C@GJ-QVT5Y&W&21D''>/P6KMEC@8R6; NI)$@ F4
MQQ_09B"0A7U*;[;>$F^GC." 942A*GY^C.V=*9^$C+T)0DQD.#X"U><@6Z:"
M#N./JE Z81'2:P--^J>4=,^X?1!S633P#AW+OQY:K_7E;(" Z-3PK,4?MJ+>
MN1D,HE#_#%-;#,8D+V0CJJG74+?Q<8> $6'Y",PM8E9,\3@1GM+":<]4IF9
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MDK*T=7TI:,)TP5D-[-4=,BJMJ 839D:JH6]@L'4'.<W-.)L1 \JZQNIC:)U
MZ[+B#$P# Z!]S].Y8+>HAK/']#]3L &Z=5Z4>G\MT/)C;DC<G!)M%JZH2,BH
MJ-L,^$VEFP9F+L9]5&4_D1;_.*3%A[3X+Z'5!^5Q*VVM'W;%UCIY]_YLV+]
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M(PLMN6$1Y &L3')/:JZ4H&%>XXI:!V%S]AWXF'_RAAQU*[L1:PHE4Y7E44W
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M39U C1,P^8(7L'+L>0,97.L%Q(G0D57.RC_I#+0_VH0K<,6D;O8(UK=M,][
M-TNJ47V QLHEYWXFH[GTWQ7J*50!KL-=#;(KR*ZME5W/MUUV=;U39FT0BAQ&
M3&,1R*N,PG,9EOCG7/N(+(>J+2-"I:F2BVM#XN&1\,T9K#^&#-:0P1H$R.YF
MW&U]F >8KA_7[UO-4Z2:>R,S/[6) Q\H<2!DX 5*VE95[&C[,_#6<B-H\S 1
M*BZ5!3VB$GNLN\7,.(IZ(@X>'XL8OI@;?(':<8[I6*8*UX&@\YM*#6F\!"_P
MDZFCG<(4<O3;QQ.6C3GUHD5#=0F?H(F!YP^\M(1O4(,3.F5K,'35A-9@-\-^
MXF3G^VA!\YBIHJY=A-/&!7AZ$S!M!=N6DTE^38U=,X*AC/-COD\FO'9C&V!4
MU^OOZ1MNA@B$3J,A0&P;AX=-(N@,. 1SFX0)6)L+56_2PU/7 YO?&3:_]:K7
M[=E\QX51L:VUD=\CQQ!9C-$E9"PY9G::%RLAZ-= M2,Q<2-G\F0V-LR[%MI^
M8$:!&6TS,]KZ3)%;,"/KQ*^RQ9&:B0NA1M>)IC)!?$N,T#-,*EG&MW1A*3U9
M$3R5.%'.E4RQY@);2QK$^AAS-_+,5N@#;Q$)!2,P*R.?(7@R:L ="F(5>6GU
M8>QEXLF%\AJVYKXQ-@-/"CQI+9ZT]>'TM;!>')Y$A3$RY3I46.L8? 60W7)+
MGC8<BF=P),4%%KJ.!OB-K+MD9D[:#S=((\7#CH($KO$7XB2\W!6<A.X_3]Y_
MO.S]VAO\[IG]?O[A0V^ +0H?.,#"AA=WE^LX-2V/:BRD9D%&)A'G2>>U@A$H
M"L6Q0#*OLI59-)B(/+&IGR;U-IJ4,+JI2L6>R>B)5$;IB^ 9*?PQ&L%#J0,Z
M91:#,DCR!&1)0NS[!#18G0-KG'4'.[S1@2%O&T,^?+(K'+EW-H ;T3T9?#Q^
M[ZD?]<\ONOW![P^<(0<RVZ25 X2T]<&^6^5=Z?Y/E*Q+-@Y8'*)(N>EM4O"<
M*]UG5<-LX_=Z\'::\AA=LRB^$$IA@7E;OB$MS.Z$Q>0R377DS"EK8-? OKM%
MH=W/0I$,73FC!O;%U\T@@@#^2SC#UL>'CGWQ;U:3M@$[T30*1-M $ZGJ@A45
M0*DR+=RW+=#K6H6^ML6=0_/'N5!_BN3K"!%36 @%LT=UO!P^,O6%OO'W"CDX
M,)/ 3.Z>F6Q]?.>6?07^1$^!62X5%>1T\,^"VJHE?(1@WQJ0R_0F]490L'$;
M Q8  \:<4?KA GD5IIW?K$NXJ ?7K,DW!_*6&W#3FM8"3[J1L3Y$EG=S7OW+
MD%<?\NH#,O37*I*_Z& [W!4'V\GYV9O>:?=LT#M^WPO>LD SFU1C=P"<%DG"
M*3KVM8^1&3#,\L';=0!J(U9VVW1SF#EF9///6/&N,&U1)S3]UR:&NYD]:(Z:
MW,-3H>)4JC7+NNNLR(YMUVQ#7I$%F-$-V#'4Q0E85Q>3]WG,Q;RN]M::K54S
MO3ODV&+NF#LP:8@^D.CU4:$Y03!26&U&8\+D4)6VA>:S,L=$>I,36DQ\FW;!
M"/PSZN2FE9FI\4;0GS(=B537F-95YCB@*EEFSK!Q0#I0=P=WQ>K8]3D;?,FE
M$T H!]P.@M-UAG:?YHL^E"Y:]S,'+5;D&E((A!JA&^"VM%L(+>^'ODR97*=Q
MD3G9Y377]^1+*U^^);DW2"O^'/A$IF]7$5W),DUT_IXH-"+L7,BT.C<'73=E
M5^H@>NV"5Q@P6<2?\[1)-48/_-@8H!(1@GD.G,MBX"J=5EBF!5Q/>(& =_BO
M*H?D-H?CDOA]EYKF8"OBF[ZT.\>JE#&B9:G*+:^?3S B.1T9[;?&I(I@^Y5N
M&4^;U**46US7T1(J+=U%1-)('+8RY-%0PB?(0ML@$H1%HH&/*X@HYEGFH@ID
MI'3K=4KZ#4@5.B.^D;5I!0.!C%AI8)I_K=$,L4&&;H*\SHNGN\0=;'(7I]+@
M?6CZC]-2T4%>9;[T:^ZIZ9B%#[GNQ!^BMR!HEIO6++<^VD(12:1ZY FD'OH1
M&(*INER%,!);J$1 U9G,4$XB,T''(77PLYV>40%WY"G*+A3^_A*28/U ($78
M*<\P>>$(8N(X;4$>LRQ*^)12X3%42ZP9\YR0:QEL/;^I\+G6)U\1HI2H:H]F
M)>Q3'"626!L)K"E5)AE%I_FYS><"O67$='S*UUO;6.A/!"@%LQF5>2;41&M2
M[=V U;.&;"95%+30=-$4H-YLV& OU:>!9^W608$9H#W;[?M#U1*VYR%9 X6$
MU<2X&L]+DH(ED2RHKP+U<&PO'X<"88>C@2C5U],@+15 1SB[O/H)K>AN5&VF
MW#M(^@&H_;ILC:.37]LG!D,1I_(3E8 DYGXE?,9)=*1.X-.[HNRZW6"$<FKU
M\2! @P"]/P&Z]1%&#.]7#A,_DC.6-5AAVB]S)@LD.;(:JA:L,N=CJ:LIM$YM
MQ>;+U>X0,,8]<5RMGR/&G <8Y5I#MFF0$RM*JB4@(ZIL].'",4']IH/V*O(V
M@X2,X^YIL%J[)0Y&LAFPJB1A8 +)^!/:# 2RL$_IS=9;XNV483I@&5&H2C\_
MQO;.E$]"QMX8(28R'!^!ZB7(E@FCP_BCS(5*M CI-($F_5-*VF?</(@9SVMX
MAY;E7PVM5OIRUD! =&IX5N(/6U'OW P-HE#]#%-;#,:D7LA:5%.MH6KCXPX!
M(\+R$9B;Q5HQQ>-$>$H+IST5F9@"S3H[N9Y.4R^T0ZX1HR]<.TV#$W< I.6
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MZ0QP%YUD;%/<I::'P=4;)-%=2:)=J$6Y6#.S'YAEE:V "0UMR83IJ,Z;RY4
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M%4.C[Q$\AJ\%NM2KH4.0O&U5AX H> :*2*,71X<0;]L!</BN()7 ;S(4J1'
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M,Y\5=%%8"E_(2-+5.Q;$1! 3]VND'>V*D=;]YT7W[#+$!0.Q;%*GVH%6@.L
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M_/K\]'<T6!^_&WQX_\O_!U!+ P04    " !,BJQ6WU);#I@_  ",# ( "P
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M(]OS]*,*C; PNI@3'3HWXKPRHK%H1R -0#K@5=8K&M:D)N> %N:9*C_\&TY
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M0M8U'0K<L';C)Q .,"H#1/CX^*2ENGVDNI-'.T5VP<LBFL@&IS>[U4RT&N/
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M^4F;)EU.93XZ:VG)M;2Y;[1Y6S.1TUUH)M*_&/:NKZY[PRXV%&G[B>PON1T
M06W5&N[7^Q^U[I>[;+*B6KY=[TN,"05CF6%81K,;A2"4PH(@X[D_&3I?+4X
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M*N(@IJ'RZC#]B(I1]&IQ8\O%^\;%M_E>?M@%W\MY_VW_=>_BK-<Z7?:7T@Z
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M>:]6CI)RYXQ.:1MO+5):".%2.<0*>)6M?+K;\FFKS6@\-X0Q2 3G<Z<W"7G
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M';Q!^C"OT4"7X??K=F_W5?WV@&PX(+?J:2)7)A(VDCT?B9CBX?,"E8+6ZH.
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MMK:D+0JNKW^OB6LNQ$P:[?D]>19 >208H!E+"$WB7OI((=9QD(B9;#)[C=O
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MI8ZXH0.,CM7>:5:^ D(*GTFP8#+L.Q&S?8U-R<J/E'FAW08S]CF^?V%ZBUF
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M'-$==?&.0Y<;9]^D?8NO'L+F-.S3,)/BXX.A!*J$U<QH<_V]>]:P=[SDY:1
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M43/?=[6].94OD@LN7I@+97+PF=YM4&*JBQQ1'714'ALBYT)GZQ?$6<?8B\8
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M- Y^DB91H<IC,)VKB#1*A\V+<8]BNH1_:X%_&0<WV,?OUO6Q.&@"%N0>C#2
M*=7QXNWKYFL3VG:1TC<:V1YX1&3[9%%S.Q^M(HW17D(T-Y#WB&F!E6JGM5:
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MY\%-6L011RY5SB77<Y66 .K5ENCZ,'CMUP68:FTL*Y2FT@;!!EB)3;&<76;
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M,$]F>*YBWJ^)<+)> -I'4MY*Z!KL-9=1&:PT0&QX8H,M#:]&Q,LQ4E 4"Y/
M0R"VY9QFH#P=2UL8;4>D_&%L\2?:MI.[RA"WBM_GVR!^WUQ?#M[U+@,PR!GU
MHA7".TQS>TA5FX>]J.6J&#D'YA.9>]S_A&U4_#(Q38E-=H=#_>J8A$6Z241S
MQ8!D!FJLUJT:AJ,*:P/E;(*N:]LV;1^1MQ+U3TG4XT?;(%$'[_J7IQ3_^CVX
M[+]]UZJUNTQS>TA5&T\'/#&%2SK8OW2EDV79) C9@Z +8N_H^?/G7B8?"DF3
M^U*M/*/N:R9GW/K+)B)ID-JFG,"5;++T;?.H=X^2;Y6>1]L@/:]ZO_8NNZ_[
M[_N#W[=3;K9D=IO /-JLP.QS7-WI?@VEM_L8NQ>,VR[**P\PTCZR;2Q+/'C2
M/Z<J43K'>,\<>UU&"_8A3&=4"@0/DBD=J= VP!MB[3OUJ.Z T/3Q,[&<.,90
M5-SQ8B:>JLJ2-Y-8P85N"[JU%;@[R0D;A?CY4D[PKR5>P/Q1"30.LSJ2-52-
MOU7I&OU<-VD18TIM8"[F2[F3?7FE&@4:!G438P<DQ!Z2L<PY[W>:1I3AVJF:
M<8%9[8/R&^ /2G?%OYEQ6.LIFS[2L#8!AP<.349.F3)38DW;;)[JQ.N>YS#H
M-W71M//6I^TTJ%F)'*<Y1?S@><9I2OA@V!,*,Z-#2G#V@KF4PQ-QYI'M4.J!
M,HI@6B#>!O4SQ=0@KIZ(X8*$Q9=[KE:J[)I4N56-VXJ>E[U_7/3.KEIGXBY3
MVA[2TF:=B2ZQL01TJ20T-O13ERL=D$,IJ%> RH+T)J%*>,T=XV)AM3:&+)K#
M><(YFK9) "&'*#CA+-+[$"OG(EE)XVC]B[M-\+>*UJV *_^U>]EO>PCO.*GM
M(3%M.*\>E-E,N?1%M'%!;$53V23,&HN^DAASZ4@,>H5XA)4!J^;4<B_1W$^'
MGS.4!;R<B972WU1>MBE&FY&86X'-\%NW_VOOLM5%=YC0]I"4-AZ&<:@,)FO:
M@V=P9<;&+Q!P/8_\A/AO!+/D=;<V723)WR)M:T7\I</7(*ZL$<DV\M(QM48$
MXZ/F*I8>@,]J);3$J:OD*T55N ?ZC?H$4<_,&\%M,D<E5%)GW2K<<-C3-87;
M%YC!C&%X?W-<JC)G2V,Z=%;;,+M; >+U8464<>A@714\)_M.T?^#D%+N8N.Y
MRA"R8K%NH7#\$(1BI7FW/XQ+NW)-Q:I3L*?VUHE:S7_7Q,NMY]A6X$QT+R[>
M]T_HU;WO_M8>9[M+;WM(4=N4++MOX?.P"JK@PI,P%FIJO",(,INBGQZ=+IBZ
M6@6W]7#TL'.WW^*'1M$'%$X8$Y@%&P86K /+IG#R-+'.:@1V(^>[]=X40P/)
M;CN#NV:7U:B;D> 4LR/SPF 8;+\\_C,+J$X;4FLHH)3^S_^\@F]$#@J+#MY0
ME[]_O7K8_SH8,"LGM0_FS;.NXN=)6_'S5ZSX60'^\?6QBO8P'>\JZ+Z][/6P
MVCB #[U_]$ZN![U36_E>-D1K<E%X?N3[]U8UEOHZF#=KU#2?7.OD_,435JAY
M)=7?>F R0:T^,Y\B17^]$^O*^91.LT/8];F*@H&8I7'X'S XV)ZB8V0HP6H
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MYS-*]'H1O!<Z;\7)%XN3;P$18U_=P]?GI[^CMOKPW>##^Y__/U!+ P04
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MO/NZ=]$_/X*5ZI]WC_IPA8OH[+SW.WPU>G\>';\_?=4[Z9[VX3)[^(V+;C4
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MK"M0W.I04WHF<K<5;AUI"V<QG,6UKKEYI$4.VQ,3GL^C<@H[%'MCPTU>_HH
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M-E9";'SH>04) 7M=%@8:J$!OMV0"!IZQ$&,FDA([JZ.#D<$GQV**3*F3*7P
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M3),.-:/[.WPCD9-=[2W"P&!DO[$I"V&J()76+Y4V/C6QBB&X&%RRQ]JMD9G
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MGXD"5H$];SZ#*Z. .!!Z9%6P\@N#@?9+-Q$*7#*HZR."]6Z[F6C@JP73J'Z
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MOYW_??.5/Z N3.N5:2U)A-*EEU%SM"R>^PH65YCXRH>/&$#/#(&O-LEL5GW
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M'LGK[OOSUUVX*HBC?G1\=-;K'[V-WO;>]4 >M5W8K]C2-_Q 3T0.TD_F&_T
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M_?V7[T_^Q-36_3?]=V]__?]02P,$%     @ 3(JL5D 73U1!!P  I#D   D
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M561@OU6;&>D2T\1=_[Y@+>8.9[W1;ZTBO *AZ9&4AD6,7X$LD-QB)D;JO2\
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M@<>2L!+>?6=Q/.J\_I5E\+-+_>O,_P!02P,$%     @ 3(JL5D<(CH^- P
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MAJ32@(H:<2P5_I>C/:BFE74C2.YRQ;<"Z"@IJ4-VB%#%70L@FH;F$(B>,"-
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M8SQZO[ II1RPIPM[*?V."DG8\$/Q7[9O>NM!J6SU!O7RXQ$;O2SW0V!8T]6
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MQ-Q'G2G(F!4;HXHF"!?"6'QB2AT':C.D5 T-]:*)!OPE?I#?SY",)B<L6;O
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M5XY,F)/]W64@]%1DF#(^Q4UHQ?7BO :VC(B6K:RBG:11Q=NX:Z'L(H6%W?9
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M1\UX%.AF0T30[?=Z]?A'N(_M*_B%.;H:PQ#A0HR++:(VS#D$@G,:%*5H,VW
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M\YO03W=_)0#702XJ6FID.H9-P]C_L(:OT1K,3='<$,LKH[E9?@%02P,$%
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M'6H->*TC"B=Q<).)P5@D*?J=R-SZ$R*B(&0Q#8" W&5:54P#&A=")K!JGC4
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M_MBK&(:)'VO6C68"PZMJ?=/7K%DVM;A_/&>F4C%ZIFUZ(&#QJW/.&]S2?&[
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M8.JKY!0XVICQFUW-Y=[8*202Z*%GSP'PW8R9AZ+'4W"+[UX%/>YJOI.BKLZ
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M;IMW'!>@Z1,NXW0AL! 2E_A*BO*( A.CQP_2FY^A52^C.=7:Y@7$* CIJ=E
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M*X<*\8_SJ>$E8,V@G<-FXZ!Y:@**IP8GH$$P -,9[#H/-A9U"]I 1B8B0>F
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M22.2Q#&*+'$3K@M,1*GR"$GXYH2K\"<OI$:#RZ:YK<JBL=Y5-%9YA%TL(\,
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MP0X:9AB#;O)$VH-\3@ S*X^.H") LE#TC$=G/'H9J6/[8.UY=([XH,H5E?=
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M/Q8*[.:2U2HP; .^K%_6V/75Y@;VLE3MHEK?KMEV:8>=XEIJ30"V\KW)3FN
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M(&_#LP%0(@3QV>'SH;$V-RIGM?_<5F =N.(JK)-^%L/!4JH7U\U;('4%[01
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M/G=[Z#(4!U<47? ^4EM=V5^T%_A83P,M4MGD/2SR+4_L)]%J%YX7)8/,L&P
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M[D?#1M(V1M\*N6@-!/HD[TRJ+ZJP7)Y5PJ)=4:TJDZRT1Q#S:.<A<_T OY/
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M34&I*XI9R"F!",_V*U(\G?_228OF28MV^"^%%K&:9D25/,!T::5,6&E3P(+
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MG<C[X O3.!JA,5NN)#M:.[9J_%&UR-SZK!L?M5-LJ0K,%,12A?T%CF)C,2C
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MG(DWP2G7L'L>#4'R$WO<->_15)J5V17*J&-EF+ J(<62Z,D!6+<<AM@7FX@
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MM[CAC>(&YT\\+OK X-5^UW[9"O'0;EH[MFHLK2U2D1OXR,Y8A 23@#%9Q%9
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MJ-(N)XDX0.2GCF_-5Y['?A3K.)$*(]:CQ I2JI@*)ISS0$LYF*D#+:5DJPB
M0MS.6%Z![<*MT/4H,3%+/!$.DX()I\!X\;&J<6O]4>CJ0HI@C:39JKJT+.]K
M(3S+SF6I;7C-MLVGBX0=S:=DEZV2[8U<HB;N_SQ_[KSS9>"]=#X!2[T""OZ5
MX<0?(/3XE?,/!)^$OSK/G^M&'L^_T@L:@?D/<D13]4L@QE^=0>\(%IA$@>\M
MT7U,[ZZE[-0[QHCV.4^ %OVW@C*K$NRY=KM18RFEDDM]^Y>(J";CLNZT-DYO
MV2OG\V(.[S^+Q<@?OW(^B)GD;?T0X08.!O:W?M)?PU_E/3WZ=OS\$VQTU9['
M4GQ]/I((6_?2F=.9V>S2FBTN;*>^.6MWP=X\W%5FRJ;>L,YB?+P68XN<N_KU
ML5,Q1P 0S$>])UP3,@W$5T8A$18@"UATW!@5V6FHSLGKKFSSKFQ;G+S;E(G<
MXI(:O(?*.E:-7%[;E4"'IN IJ6)>U6'EJ@QW@ .=9X3E5*AXU84M>]Q1&4M,
M<9GYEO5(^305\4R,949\G#COPW%/^TO7^.P)5R2(Q&[+WM=5MQ2:5J6W"H!1
MPVO4#IBK[B-=\&Q&D=P\Y/DI^4^='&V#''W4IH^J77J/-:\D/&=*GI5J\1,;
M.RSI#)[NHC;OHK;%X/D\C9*:*K5@8EQ/51=?ZLA &3JQ]*2<*8C*RC%AZJ;C
MMU0IZ2V"N/PH6Q3H>"W/5XE+X=J><V8F=%<-%_WNIF(%\KAJ?V[>%F6:$<SF
M;39$3?A65I8&Q[%+CW#A>->H:0AV:Z7EL[R4>K3@NN4W&8_]1$7H:?TS;D>/
M_<LIB'$*G'LR\*_X6/QXS:$6(5,W_5-*GA"/QE&H=J,0>Z^HZ03S]#8]]WG?
M?J>7'B@B7R7F[T!\_CG'@OXJ:?(9&8\]P<0M9I&NS9Q(AML%MJ=9'@K02OLK
M6H1LZK/L[JBK2Z.G,$+MEKH7$VZ\1F%4O'7&L-("%$'AP9--8?6]9F54.KOI
M4=M-3\;!H?BNRA@[LXB[,D*>CRH)L!OT$:H@#-W$O@@Z1Z?)%_:[L"^_&YX1
MCZ5T4^_;GVD$IN3%K>U5KB>I<1MML/Y9%J3^''DPFONLGO-^_+I.S8KF??..
MO%*(YKDHNJS*8OX=0T;);P*;\K"]J7Y@NZI#KK@W7#R,R6 %@U\(,?-N"MC!
MN8@1YIUIK=OF5UP8-4#0Q.JEER-][/L8ZIEPT_-G=W36[!XS#7MX&.6>OEA>
M^DE*XW&6]HCZ1):WQ7RH;A>;S0$]YU,@T2[4Z(=<3^8JX'[3=,D;9M68J=*J
M$N?4(X6+U;!2#!>GUP7KIX(&@NT0.""!':MR-@3\+]S40AL>YQ]J4K$Z7H^_
M[C1D4S1D9]*VP:2-ZLJ $-OCYB!0DFNX]+.%\Z\,9[R U]O9J]UM;-YM;$M@
M_C:5"-0 8NX?AB S#F<JI$VPG%2;.\6!D/GPDR(H&*YR#8Y436,E7@7U0$04
ML0I>=J+BH6*EFRS8>)4-)FUKAW%X>GJTN_-[%L^G"^=<A NP,/^(A ??R'PP
M9@_Z_>ZD&G%2%^A O?'E9>3"004^>(>A+YS3X6!XT!U1(X[H#%M54,^\W-WY
M;^Q1^!][6/OYVX_=.37BG-YBZRB<T3^GZG#^:PY>N>_YT3SM@9O='5,CCJDU
MAL+65AS%+UNPW.:1-CSHG1P5^LV:0UMW+[Y_Q6]Z[WJ[._^#0=S_*V9SG)O0
M<ZG2N@6[T&#2MN=&O-C=^8*![@N"C'*=X3#TG'=!%,7-/:&G)37@D[L[?T7Q
M5]?Y\!>&ROI'S3V:)W5Y/DVC4((YNO>BW]]WAOV3YP>#H]/N<!IQ.-I7P'S=
M?WF3KXA5T X7X5'8&_=3W$C0P%@808@;C&YJ!XT+:&,4:Z;:08(R]:)QAK'C
MQ)D0'I&!*+MX>XYECV;&U_)8 P7LJ^%(]/"HW9U\>M07K' D;(QS6.L[.&3G
M=\RGO\\ILB<\5:7_,=;]*1L%_MBY4(E\3NQC8;3DL1.)E%_MLF65K][=T976
M)JMO!MJHLDI.:U,M<ZGD^ 9T%U.1?/2RWW?FO1E8=&\%UA:$=%PNPL;Q?#%G
M+[V.G+WAOC/2782>6"0.HQ/L[E1@@QC<:&S_"PPLS$C"6>3 R,4L F/UZI/*
M*[.M#4&D99]_$.LM6.39?=P&=W=GKDL52N'^)U)6VD!9^!B%UC^(W79W/JM[
MY3J__7;>G<6#G,4 _)_?Q$0L9)I*YU,@QK([B0<YB2]1Y,U 9X(81C<'#.D7
MW4D\R$EL;=N!8OZ_=72?I6GXDM_5[6)+UO;VN7*NT+[^KRO29]I*;(F3U0#2
M'K5!EV_Q#2!R)QV(W'9!Y(8=B%RK0.26N:"]@N%NU_+S2#W,]_[CAYGWO_W^
MH=&S%W_^_OO9'W_M[GQ\YWS^]:WSZ8^/__]?SL7GL\]O?W_[X?-/\.^+3V_/
M/_]Y42BN;/5^-$[HWWE$\_/43W9WJ),Y7CA3_W(:<)]^0C$L:F[)(WX4YMMD
M[*@7 178<ZS&Q^K6C_+  @8=3AQ_-H_B5(3I[@[/*N@YGQ&0*D7PABS$WJY4
MXV?AB*DH08 IQJQ2D\\DMPF)0D]_*1;FEF;.5L^]IP%<JE"51N72BC$F&4L3
MY,SGYY8?NC3B7J2I&$^Q^#9Q"B='9^MABQ&]^26O- "2P(KG<;C.V?,!/#6.
MLLLI_%W7M]$VW7 0U!2^3 U\!ZD,Y"7LBUD-'<1E!/H@3)9ZV?FW&ER"B$3@
MLQ#-53SA4%KH9ZOVM>>\IY=38#G'3( G>(A^$6PRT7:#,''5FC$LW%-QX:=T
MN1LGSK:LNS[C9.-/ DP8A@Q9Q7KWJ: Z-V6[YHE/P\[Q!G>G^&A$TRMG!#[G
M)6BUT$,')HI?8A=O"GJ/"_!W=U0%_MGX7YFO$DWG43S794[.]C8?=5+Q<2N)
M&P4B_+J[ \H< 8MX!BEJ?R ,=;BD>>L?QVDT O4S.*6<W8!FTCMO9""N,1FI
M/TSV%!A"RFXARP;6'B4TD$#22'L>4S C=>:"Q3'W4U#:*MLAO_%,&!=>@ WK
M(M\J5^4A-8:,"W9,%%^*T/^WT#F["-X(?J /FR;B/)TXMD!)29]C]S'.G\-<
MJ_Z43-0QM*'JK+NEMU[Q1S#QWLE1G*%S<$+L/'3U)&2#,>OX*9IFP'G G'/.
MKT? OS$-_IB 0^"(RTO,*:?$VX,#=S@\<OO]/MB2?EJ 54"+.@<14QX#69S7
M,5S!.%%)]-T=M%5A/X(H)0,VFC/C@Z'Z;-#O82*=7 <_93L8[G.2\' TZ9FN
M-T/F-187/!L<#&$/'=BL@"S6"Q\A&$0HHRP)%KE]:X,_ 27:KZG<@8K]8B_&
MO\+]F&.&C%<P<4Z.#O-MR>>#P%=Q7"WC'(B9PCW +8.''9_B5W9WEA_(3]$R
MP%/(4T["SW-6V.X5FUT^$!^D!^Q^>?,='(2+!TBG@%-NU705ZT"JJ72=2QE*
M%(IP%,LG1<C(WWS</#B%9R>]HT-S1D_I.CXU ;3&3'BG:XFXY@6;396T67,5
M43LOB[.">%*WBYCVX-0].>W3A52!#^F$,ET2(HD(I)$"?.F4H[J*CCR44;X-
MUV LT+\\_8PT1L1$!7>"LHP&-"4@E_@S"#D"EW&2T50C0T?A:[2>0_?%*4G=
MGG.6.$DVGKH8.TDHGFW0RC7)ZGE.U>-<Y]D0'T1;@Q3K5%4LET99 4%S?;/'
M(ID:DG /X#&*)GI,EO#WYV*1[]4X2M*DY[S]-I;S= E2! NWX)^I(T4<LOV%
MY"+UB1GBFZ*?6-P0BFA@G1N!GE.5$KTZ2PP!""8J, 2S1S,]LSG^!D09+]N\
M6'W<\Y,D"C*.2WS#<0XRV7=+Q%# 9/ET[&%/AAC#<L7/PO\C]#S6<XDX\)$"
M.*(]L:\4$V'"J#HM7((^SRH#S]W=V1OQ%XL5;VC6%@OES%SW/-I6H3^*V/(4
MB$/8EQF-' -B+(Q/?$UN.9,>W3O;QX_/(@]$"]\L8,^4QIVBA0RF*C,D/BH"
MZBZ%GMB%JNC:7D0%<842O'7; BS+I%+@$HGGJD9X#RT"=B1E5<9V>RSQ-[$%
M@XO9$4VHNOL:3FF"4/@*'58C^%0>%$),%DUQH&8PA.T)TVF2LT<9B+)RF4N"
M,%;\/'BA'\B4@3C7,\;@O/W(8X$"4IK ?8P1 T==R5&H^0L44!@924/KXSK*
M@:'2:2PEOYS?FC!L)ISY/]7E3N"9R42,C9FE#P7HX(K4I!Q\]235)>)&Z OK
M'H"4/T(AKE&D*E_M,CINA;##J'*B=@:#C;"2PA(+X+\54WH+'UYW!?;Q57N^
MO[^,G 07DATVFNF;T(: J&"YBEMET:"M-H6X&^&7Y/-U'$_C*Z[\=.&26-X;
M5PF%2F9F\"8?)Q_K,76&JVVW8*5_N1E3K_4P%"_O[MS(S,[=\S+ZY3<RLW/7
MO(R*9A-F=NKR,C+!>9&%WQ=8V%[S[@Y8[G!6Q!F!N.Z,]4>]XJ+9MUE$304
M*J'14109E&(,G8&9Z>4VW@>1>.)?SM^":(09/A%_E2E[KVP[+&:C*$A,;@BI
M^]/5W0'6#\W/\'W6S[^87RA![%^!^]ES/F:QLO*16BP%\;1,0@++?L8!^QEP
M%Y01=/-:UST7U@FW?OB"GZK#<&C1(T T> (SC#V^T,X-R1%U4<D,+N?&^"/:
M?S(N>T$H5 /7@QA!QWYP0(X]J81-'D9;M[NCOSX<F$"-<8O6/T#M23XI")_4
M[_6/CH_I4>H7G;!YU"NFW!\639(_K9I:EE@%#(2Q/Q<44AQG>(/1;D"N\I,-
M8_Z("^2LA04";7L!#]*(-&>,1,.F%,7QP&Z83PD7-*/;">\^.>X_/SP9/']Q
M='#<Q=*?PHJW602^*B$Y>JV"Q9PKO;LWZ>-K[+D5+ZR=1=3A]-V=WWX[=^W,
M7.#/? QL!+X8@5Q)%SK%Y^JB&1TZ5W*&,POJ@;F74"%J IPNCA5 :0VI<P,:
M&?SU>Z3.]L1-B]F$S28F<_/_W=WA;DQ7><F$$8U6EFLG;)R1#"4P@$\]H-$U
MAB?9S$M,Y1)Z=5RO5LJ1';K]X[X[/.J7@)(+-MCNSAYZL7Z2JL"8SA_EWUEI
M;!ZX!_WCT@OXP[\4/KROBK\P/^8G24:0CJI?%<-D43C.XAC6$RS J%L99RLY
M[3U@8S!CU:O-$\@IAYW)<$<*29_CHQ]-SBY+J1@0UURY.?90%',84\S"H]&;
M[SF&P)U/*@1_H=I[X6/7,@@H:1\NUNT^)]SC/%(O<-34C/P0EW-AXHJ%!?ZV
M,@*B:QF+M%*)'+<D)X9:O-,Y)KMY-!56ZLB0JHL<2;:>98(5LAZX'H4)1_RR
MXL(Y5JXRA/F>@1 +(PXD<: ;R\7!H$HEIQX6=HS( T:,_1''P(G35<7@=12G
MTX!BFOX$'UBY%UAC254/>5BB=Z]M3"VW"UJPUL99?7=0K4;^-7@$V:@K6GM4
M[+LF&VW&):OH"AP^@W(Y>GNV6ZUV/8W IGC.-@4FR7S/%PR_P %Y55B61 $J
MSY7U99G*'^0UTWEA-N:U_+#GY$LBRZ50[99'V\"$-OGP<[& E3CODP"4 ":
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M3(%/?V4P3YJU1>)32_$*>X4,#8HIE 2Z].Q[SNR>:VYZ.MW:PD:-Q/CK98Q
MHQA C>*7&$-)Y0^O:7X<K97\/;@5*"/PZ<XDCF;Z+NF!P_"Z/S)8\.'@%'\\
MRX)+VAF:ZJ7 8.0X \,!H5K/QAK(MN>\8R!8-59!QBA%SK!/7#NO.*@LP4?
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M!7%+%J\-4^4J)JD+!XA/U#L@\X7"=:$*HC$**Z 17QK!<5T*.TKZ1L(6H/B
M_Q"O<K8715--!@F$/R-A/09&\XT];:42N:T!MX=AE0K'L%%#]JUMJ&V82\/#
M^;?[=A9I+[9!>&-IO/?]5)R%Y#: M]K#3G=L<S=W#TU#MPX<6#J,2_M4SX7
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M#T9ET1]\1)+-LYBIXD5N0^WD_(2_7[R^2%;D9E3LPG#/:).^DYCY"'GA!,W
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MF>**!\)1^6_2MP(5(K!J0J[F2\,KSP,X.7VR08%[6V:%#*T)$'BPRS-:62U
M)?]J4ZYRT"-H>0/K669U4V7S5CEI>(?I ;)BXE1A2I&1R?-D,/F-IP-2-YG3
MI9'I.N&7U%Q>'?#9^:4K0ZE;78B>&<U2-$O1+)V6<#QDL_3R+KJW._M,NJP!
M&&C?R"!#PW#;K?1+40C1[+2U=L"H=B^X+;, @]DQB8GIB?U!IW9JHDJ-PO$H
M5>K[3L#9PJ?5JUFS3Y<*58W-/I>MU%=ORBJ/'N.GEN"HWJ)P/$KU]M)2<TST
M&2?P>,RX%;$L #Y#C\'@[(4R53B""G"1<HEM,G@;X";'V/*4(L.RYK'?>&-L
M>XPOC4KID54T:>UE=ITM48J<N(Y"\/W*S0;)!Z;TH!O./%59 ZZ5';X43!6D
MB[60E2)CWU8%KK.3QLUK4S?34^"\G0)VR,7>+4"/LM0R!0DN;"9\OOT%1R,3
MC4PT,J<J' _9R# #R10U]GI+:A,EP9NB#GB[F':CKV.3F[2JTH(]Y]0;E!L0
M.N8P1?@.8#Q!SS$1IK1,B]HCH:E'7YEL,V^KFKL$P2.59MSMOY>L1&E6I"G1
M+"^2U^UB/75@39#B9*2:T\Q9L<J9VL B9RRR6DE6]4[[5\2=/VHPH]J/:C^J
M_5,5CH>L]B^7Z430RM=5>E5>9XM_"SNE]^7%6U?^PY<N+6SY#Z7 )MR*,V<"
MH/YZOYBV''MY,CUX:M=RTZ$SW,M/99?A2 VX668#K([T3B/+"[3L++P"K\F,
M*#J<3 3 KFAOC\)3^ SZ00LR;2GK+)J;AZM1HKF)PO$HS<WD*".DC.^8&T?3
MJY\HYB<; _>9QYY@7@6TU;-)*-%T4ER9Z7-,-VF&.JI-U*!!OCZ46&--+@50
MH78@ ['* 6(:8$M/92(PA6-KQN/0!]J4!" E>3!+87C[ OU#34[KN8JO#$V'
ME(H\75UT7UG 7.3>T)P>W^W#N-WANT7]$HW/7N,3)>316Z [L(2-$GX))];O
MDR_>XY5,'0/8JWJ7I9&T$S=+KM L21:B2=\]6Y&E(K-15E=IX>!^_G[Q^B)1
M_1E44Z8M1C-U-O!QC+H\U;4HKPIT_P/U0G@-:AGKXEM;IN&LH!#)8)V.X#UI
MMU.#)6'\%7.E!BIS>(IVF7:D+ SM.LE%M<-CVWL7?A_IE?+VFDUJL.\"Z%$Q
M)[P']<AWR173R8]NU,1MH5WU&"$L$+J< T8\9!(>*D:E$/UX;'M??X>/;B?<
M>_;\Z^T]:Z$1OKU;R'V_B>2^^./]D?M^&<E]'PVYKTC%X^1]O?]G^\-<+Y8M
M__=_;);_[XLOOJ$/Y5%?_O+;/RY_^^G9?__RRW^]^MM?SL]>O[E\\^>?__RW
M-Z]/A>7W,;_LC\7XBH#W_$PY(+4N6<-;4NN=%8#+3WVSQT&J7FY-:;*F;>A:
MRK=+O[])J^6SO 0)Y97_76U9=^$T6<?L_$QO;'V2VI #D_&\?I[>U!?)R[W7
MLY2]LV3>-ASAPU=E[$MV&&?A=RMS15?!!<*87VH$P9#K^5ECTHW_<[\C"'D#
M#TWC1F/#'RD #.\A76%=;O%">,M7]4QZA20I44)Q P/S"H_K5]@@"R7( 8QW
M .-A&]=WX4/QZW.$C_1>_BFY??2]DV5:I'4P%HO4"Z9[23+$8V<G70$*&->:
MO[O(JD6[T>FQV?F9AS/%S7F"*]_Q?]9UN]GJ[;#[^]^\@)/>D(5S8@+/=)%M
MZ1LS*Q?Z%PP#HR(1_.G\3/^F@COV$\P/#S\G=[G_(2; -B/WE=?6_U11)08K
MV:2[_E<W:+[M?X@9XL%G%+: ;G3XN8Z)#?X@Q$+#C_F%#]8FM-O];R.D&GR&
M+]K/>*J03@]H9&DSR*VO64H8*! *"2'@_I<LQY!E-YW7[%.5%EY*7KV+)S<F
M+41X4W\!V^/0N\,M&N!V-G'%.11- =UCWJ4859SU3U*D_OYHU-^1YCO2?-]O
MY0:EE'8J5K0U?H'![K^A6#Y\_,G;>ULH_) TFYC9"]RVP"'3H41NLI9)1?48
M1P8:0<0:Q3:*[5T7RG[0Q.HJ1Q3C(9_U)X-8<JQR^KGG?1^U>]G+,V3LW6>;
M;5FA)J%M;)L6("&-H#F%1AA_QV>:#-C9JM)%\M?RABY8S10Y1&&G-'K58HMJ
M4(XO9!VV>]K-40I/:[J@R\O(.H)DNJZ666BYZ/8N!)FJ*G,)8)F]&H@<9269
M@$7*2"%IM4LHS+MJD0Y51T1@5FX-3M#U1K&5C4E8W^,VM+6.(XN3(8Q8?.VC
M?CRY,'XK^JTU&" :R59("5C4%WJ\555NM*(5[/+2U(LJFZ-W;[Z33(BG#'/E
MI4,17Y <V)0 5+3PR,55'<.I&$[%<.J!N@3-U$:X)MO8UC4&@E*FO3=56M3I
M(H96I^"C/KS.J2@<,8#Y$-JJ:#=SG?F@X!J%Q52Z?.!U_MK.\VR1O [:09/K
MDJ&"+-\.5)N#"5W<M:<'[:AE+6,6OT,QR)BW DBT-%)9B2HSJLRH,D]5.#XK
ME5DN9().RGJH!7,X.DMLBZ0K,X<%9 E6I6WQ*KOF&-J$S?]W4IS:,_"SJ:[H
MAI>6CB!JRZ@MH[8\5>'XK+2E;V\!OSO:<-*Z+@&C8Y:6-,6H TB?C#5-1VT6
MM5G49J<J')^5-BO;9J%-HG#\WA;EC> 3M(7\.\\:I=Y3[A!'H\>TZ :Y[[I/
MC>X]RLG>W['NY^"6W0?)S95E;I<E3AT12AWS268;89<N2< %E;!A]$A?F%8W
M?50I^L(GIB"B]8C"$:T'_A> 56Y0SDZU3I]GS,4Q@$X(1@!@3Q+1BMW9 #N9
M.;'?[U;4G:@VH]J,:O-4A>.S4INDD;SB]+/OT%QA=F%N"K/*&@>BXG(*8_6I
MF30X34>B!PH]\W+@PKO92+O/3%:V*=N"9\$7:;U.TNLTR[D)QJM>.-Z^PC79
M];?5.1G MWU+(79+U.%1AT<=?JK"\9!U^)U0N?K,1M;]=/J9W&%I.W6=E^3?
M%E?IE5E&5195651EIRH<#UF5O1>]6N"8FG<4E#<&D3J<4(P[2P^Z,C=SF_R0
MNEG!>'L4SG=GV813J7W_?5IHSKIF  98F*+&GBCSJ.U9U62PP!,&2XT)@5,X
M9%$#1^&(&KC_O\KD&;,6ES:7RLI-,&0936%NFANP"%\"8N1_3&$6*2N^UTWR
M%P#W&?H7?3<6BCZU#$<%%X4C*KB!;^==3(\]L\?!ZWJ;Y9PK3-;=PY_%M7L/
MBONH)*.2C$KR5(7C(2O)R64AA0LQ76(6A[0P2ZZJ\J99)QAL!\25Q9>3L'>3
M5F]-DY1;3.*WA1335W[J.RJZJ.BBHCM5X7C(BNZ^O,$-Q:R<0[3>H'+T*E*\
MPOF5].="6 T]?))6OP70L+@N\^N)NG=IYHT=UL3M:$6JA(LK32N6UO]DG_/0
M#Q"ZK]+KLD)]?&+#)UA3Y(8,DU*V%6:MN",7+J^6WZ,RC\H\*O-3%8Z'K,PG
M>ZVD#1>H=8^0K%>F-FE%RI(9&"60YPRF]UVC(HN*+"JR4Q6.AZS([L,KG7&2
ML*Y9:7$Q>1GH+D?9VA@9_.3Z-W^0 4@NZK:HVZ)N.U7A^&QU6[? G%7+9]NT
MHO"U-M5UMN V<P!71OWUR44TZJ\H'%%_[?'-.D.'#/=6E8U92 81W"YY;@0_
M%W,S)&"[J,^B/HOZ[%2%(^JS,DF;!CQ>BK0AX]1ICN#3-C8;&32Y-H7FW%S,
M6=0I0TSX^'0JKM&27F *QV^=;:.NC+KR_73E<8#G(Z)QPE(PG?[[O67@-@UX
M9T;R3]OJ8OGP_*P<ZJB+LB@WV0),"U4K!(1"A8#19#=: DVE)6)Z@*6A7]#:
MN"J;3L;Y,<F/O_S?5S\]^_)[=[%1X1ZE-'&<[KHG'UE$^^P+=UV.O= ALNIO
M(UDU_GA_9-7/(UGUAR6K/HW#^4F(0D[;4SM)JI"^>-[7(F-8PZQ,U]9P7[5I
MY8'T%KLY)NB5"XK"'S(:,>\<8X^8ISE9X7C("NU.*!](+V^W.<D)+#FHZQ&K
M*! JAR@>_</B?&AC*)(S-L")6BUJM:C53E4X'K)62XO=-(WF<BYAGF79"H-F
M"<1GS&"&"1DX:ZXG*DBZT'?2:F.6R;JDQ\IYZ&C:6I[T8)R+JQ+_IANO<C!Y
MVF'WW]JZSF3._>]O*_(>S=.H4:-&C1KU5(7C(6O4*U,Z/3BQN0I$PASGFL)4
MI$6="G6<[M$3_-2B&?56%(Y'J;?>HPZ7;;;H/,!\89Z!7]S1;Q0VJ@TI-];9
M%0"" SH0A8/;2G/IM&4PC]*,KK9MA<$<4Y_"E8[+*M:PY!-Y E(&0X$A+QT3
MX-S@T<D?\(.H7Z-^C?KU1(7C(>M71D6?2$Q!VJFL*+Q&.U=N0*RT9&1U ](+
M[MB"!F[P)Q1:GM/[RO[X&]S(E_+3/_PN^^,%_^G+,<]QO#/A/2J)O3)]^!E>
M_.^3K[_#1R-;K1]F!6"=?I\\>_[U]I[EY&#[PX=\YB^.>>#[+Q7^?V5[?I8R
M%D(+62$A*<J&\S1YNC 0IM;T(0-K8/)7-VFU?):7)?-.UV16!4#!(B746Y.^
MI1\ O-HQ#"QA]_G?68VVZ7<[_\O?T7_3CQ9-6U]\3J_@\Q.ZRYR"WOT2I%X@
MDGZF,IGX8-F\E4X'=+$6.\O\,W,5$60*Z?.MJ6JX;5(N@?++F&F"1Y#<X/C<
MK--\E9#@GY^9=]O*U#7)Z;]:VHA51C<6FJ&L8M59&?(*YSL68#TF:;4+%TRA
M-WIIZ8=<N%F9JC(,Z,'7R6JKB2^2/[];F&UCF=MHFU&V5OR1Y?D9W:5?"@I(
M\02(9, -QPJ_2=\:.KI).<^53H_'1]LM'[G;#JWPA*PPT"#D>/7Y6=GG8TY7
MC1J6(X\Q=B.X<)>X#[]OBY".1&X<S_ZC?N(_<2\9V9PDX%U)KJJ4#WYCQ0FU
MS:)NJG9!'ZW+&_[3-0632;UF%L0YSF+-QYX_5C#;,>8:Y;5)<V9\K!IX6"F)
MZI*GKNT?$0HNK[,:H:9^+7'?JL.O+>FLPG%*3*X.EK\!UD#J"VJ#(D9 FO?^
M^+>T7J;_.C^SG_(9 ?O-\I]E6Q6=)<V />Z?-[V!H69,\N%18G7"!X@\P7I!
M^M*IL9[;=WX6^'WJ]CE7$7K%Y+6Y@>IUZNO $0<@4I^FPJFHWWETN'BL/^43
M^Q[<6[IPOXM=N/?;A?M5[,+]L%VX'_$PB50\7$6Q_UFRY?_^C\WR_WWQQ;?0
M%+*:>WO(/\S_^-NKU_]%=N?RQS>__/;Z#[^;__$4=.-#?YVG8.G(IW@=\.>=
MGZF[LB!79=7FY!)0;%1G-B/EJ?RXCJFY*_*,RBO#81K#W*1YKOR  3KM$<[(
M+)FK=[DTBXS+".3'"-%@J6ZB]RN=)Y6I"VE=2D286X!4F( 5D3R_OF-U6PHC
M.PDI_YQ]GGM582@7G9_]9G(.5DE(^FATCA083O0K^AO)V2XY%6WW 7;EL;]R
M4FZ#"05/O0=]L#5\GFSTJ5"%I/A"-,)9IXK)F@4,!#UV*U%R%,E1&#@@MX+"
M008K6]!U$+XF5WF[0!8G!7,+ZI.XO*9>;Z#+\HQ6@%5J]1)YM*22BNLJ2=NF
MS#:;MC#HT3,IH%]]\;6]-EF3T6W_FM;K;%,VI1/R-^M=569+_C.B6(.J:)*G
M<\Z_(56%VFI#-ZH1_38SOR9.C+%VK9/+__GIRV]>?*/E5RT3TV-6F.2HZ@RN
M;%:LLSF SK#@=4LO+?EYATTUI'6S)9X<*OS\;)W6HJE=L1GY-7*:&W)LLG*;
MDJY>D/SP-5?P6J7/<-_*7GS_Q=>JO^/9?30&Z@UZ%PZ B=J3'78A(.L4S!D)
M +/I84,'[5B-48[B:U.TQN9?9):8Y"W+ 1:3T6[0$\!+@?ZX1^4A:6Y:B'+3
M]1^QIU8NR$J=GX4KM"EESNKD=4EZA&YCNIH.+XS^WSATB!ZIBF;B#W'JA?>!
M7 CA"BF4=,&I<%Q#-^&"5 Z<,.,OA(?O_(?;B4-@L?V%\-OPKR!-BG8S-U V
MYV?.,>TV#SOW]?>?T\$YH;G34VZC.,FIT\Z28I/%W9K8 @M0I1D<KJ5TVI(R
M"5O%%JCM29%24/:A"1N$L[$C-W:,Q8ZQ4Q6.STJ9-70]3LMMMKFQ,>=>7ZFI
M,JYY>O:3.7FJ]##9BOY>-'2EFEPBN$T3^];0DIML2JEHNA9@B\&#6J)K#1 /
M._37ZG:.K@3$>O3-=JLN-+GDG"^<W!\LO0P.J1;]')6X@%%S1\T=-?>I"L=#
MUMQ:FIBFJ*R:S&K7-69;T_Y>9$A,OVY88[XLRR6KS9^J]BJY7&Y(H3-R(S3^
M$^T(>?G3I3: /)VH+TG",WKLM$)3F:$MZJ0IKDRQ</P%M& @3GJ7.8SERZIO
M:R9.&IM=R<B592WM-H7DYNN6:0JEM>;6E.L^\W<7OM?#Z8]H3J(YB>;D5(7C
M(9N3Z5D-25=H_V!?!4K5FTO=2Q(CG^B6_/4N(3=\6V8 W7(,-K!):%,NKB:&
M)&50:._=\HA$KMH_,F8C=FDJ=84W8BT9E8H!)Z+2CDH[*NU3%8Z'K+3O"P!Q
M:39E(<#L5IL"K;U&'4M]7*LBF6+L@._NU=YL.M1QG:XP+,-=Y"MDB!:[8S1X
M=)E/^8!%[1N%XU%JW^EH%I6Y!EW&PLR29:O)%%:HZ%I2\ C?A82^5R74J!/S
M;DM?P6^Y?711%H7.W*#G]4Y9H$/Z5'6I-K(R>1'R,&AI ,UDY"KZU <G:M4H
M'%&KXG]-QA7)RBQ,MF6$(-*,IJZ19=BDU5O#H]PVBULGJZK<'.G.3G2H8\A_
M,B<@JL<H'(]2/::+=6:N)^=(H><L&R7]F!OGT99AQ,E3R(A98HJZK:1?U??9
M.D=Q3Y/#U,3QFF<+PB7- F@V&>(:^*AZ.Q!FAB 5TMHA4U]W3M9J+522T &"
MQLB4SG&YASM7_J*_?:(Z(QJ4*!R/TJ#<N9W9-KW)9)FI10W?K,F[=MUXJK1K
M(4,N6B24.SE:;MKH=59,6PY:-7+<_GT3Q1B5@3U">N6J+)<3E]'00_#(,'9A
MK)L%#ZE#*;.$(I%L*?,^W@H&>T !S74&&S1M%7Z/L10R(@B$C$[-,$Z;FME&
MUFDI"_&\@Q\C^0_@)MONL_C+S[_:?I]HCZ(]BO;H5(7C(=NC=&H?>-%D14LN
M<S _HW5$TG^KC/YS:37:GB' 8%Y2R%OMG-Y$PV@;!6/)\H&?GZA<HW \2N5Z
M7PTC?MA<9H%<3[2YPTAW-K'+CKO5+UY?L*[. ,)4I-(;GN\D7V*S*"NZL2L!
MS,@LY.)P+]'+#DA8!09B;NY%V5*T,ID@"M>C)51 FD#7B\,,2G,><J^D7)LS
MQD7J*K:"4!15_:<^S5'51^%XE*K^?1JZY^0[KW=U1CH=D-%;4EN2&D<#=[H#
M7X"V!,Y-8589DB?']>Y-=.ZGY6\"U1]";TA7^;5@?^=J+JZG[H[2QT@UF=&!
MN%P0%7A4X%&!GZIP/&0%?E^^.J=\=^)T%BUYZF5;)]NRIK7;A,6>4FC4;5&W
M1=UVJL+Q^>HVA/W@5!"PNEJO$NH\ SKH/*O7XH\"!ABX>T5C<I NM#Q&#@@^
M^GJ57:WOD(7@N/^N_2$QT7L:9R@JV"@<4<'>0<&FUV6V[/0# FFI:"0?NS)*
M+%-U=.[4:1E5T%FQ0OV.?5+2H&D6:51/XGQ$Y1F%(RK/@?+T2M)#$[,;J-C$
M(?KGT%GTQ;1GY,->&=<)/+5&!O3RQ@*YU^Z#15ITJW?:_#! -S(7(_KU#Q^=
MS/6+B^_ZR+/[V%R_NOCVQ7L0NGY:4/,[/*9=X"%"KN\C(1?^>'^$7%]'0JX'
M3,CUT91)I$R@)WZU.C\+$ ?;PC'PZ@B0-D@PC*L6%-,YB),<@/Y&R7H%0!8=
MS K9QS0G:"\O\YF0DS09SX%N .)7>>QLQTIP?K9@;BD_21\BT9(=S--=K3TE
MBPJ<)DM&F=4<#GT:F/9RS@W;(^0*/2O>;XDY/[/D"7^^-@5*EJ/7P)/*/5#+
M#/D."F %,)^G;N:!7AS=O)&6G(OSL\O%@I0&Z1%TS;B.?=J]DD&YD*[:E6V7
M<(%!=(-[.]J*ND7--Q,Z8F&O:-95V5ZM%=@EW\?WP$S!AP@?2M?C&9!F1#[0
MQ\(D(T1)O_K>W/.S)3!'PZ;<E2>"W9MH54H@/L!*P@.E0X=EQT>^J+-K,V,M
M\0RD<NV&Q\+IVRVI@@I'[6+8K1#V# O *!_"59HQ2U"Z) > Y)_]:(^AM%VG
MU28E$UQ>90MA4,HXD8'#4*5;TS;X'$J&3P6<$U/3WB_2EH*%ML G!2C,ZW59
M-<_XC.1E<?6,Z9(L)@A=3WCNYN4R Y3VKFX,DB-@<N&P =?"PR^$<^P='5'H
M+QQIX6AI1%4RG9[V<@2(?!=)I#%Z9+I$:(Q84\/RH15R40)]QL:(0$"7UIZT
MIO,S=O1(_D@JZXX!"*:;1EM 8=!L(XZB-9!\D1728PNFL3VL9!*ZUF+E'<M.
M\NL:7WOUBJZ5+G<?DY*,2S][*9>P-OM4.&1:40_C_KJA5>E(6+"9Y9:T$[VK
M\[.,F8Z\JG"@0.!<<E>:#=Y,N(QMMJ7@OS"Z"QC0"TVYSPR4;-'U'AT.-5K(
M[21J3W[^]9>G\I(^").:_<?Y&;L_9=-1M<QLI^UIN'5GUR2#S#MMJ3>1EFDL
MLY;VY,+U8I7I=;V^H9G.Y^U$1Y-,GI]Q(X5LQ3P3%8\?B.[%E5N4&TUM3 '/
M5)0UVL] ^0Z?#\8!,G-#_B:]SU6(RLW.UYACMS=-(\(RPOAG17_$,#(S?.A,
M,DL7C\M(U&DE_!JY ^>X*5=-#<96_OF2-\Q$9^RQV$-QQEZ1E(.?,H-/W^9,
M:4N'8YDM!!$=/I0*8LWJKC] 11^!8H.3(^#BD$A&>C&';'0P,4Y(:XBFV6SS
M<D?N5V%NO.SC])K%NL"9VT6"Q<=VL%0$SL]:F&ZR].26Y,F&WGA:9/6&Z;,,
M^[1D._)TXWF=;9( LJDN $R-Z%>K7&&;R.^'VU$Q!6_&@-/D*52+=>B^L!2K
M52;'VQMS9OG+R4+CU]X/(<$64T=[:/ G=3\Z.-2!C/=9 2D*)Z?@.JO:VOZ4
M20L1"\/&&-H)SAJT%3=G#P-R&(T@JT''BG3XIA861,YJT";ITUE:2COY[;'^
M]BQ7;0'=$U,R<) &5W>+L.&+Y][1% ISF<D0.KTJ'K?IN"KVFOK =9E?F^5%
M\C/943BG,[>8&T[A@%OR_*PR6[P_Z!P5%E8I*5U\50IAN.O3QHM2'Q ZAFPU
M?#YQ2SUG$'ZR@4Z#A04ID/LY+FA_ST:\6=OD!@C#<1G76]G!;:3W5I*EQDZP
MXX!;8).@(G410E$Y.HTJ0ET;?3ZG_@1N(<^=<TD^6V9N:"'@P\7TJNWCMT!G
M;0$2==K>5P4Y?8WBY]#M<$"%Y$-P;_#Q"1OTY\\O'GM>]H/14'L/>MX)7H!Y
MT73".D@H!R?OMK89I'->R81+G$BQ0YOES,%LPPV2V7ZR,=KJQV:KS\_>FEUB
M<F/55#\2E?#L:H>@1@4JZ\'8THU2[>IA&$:?E&A,>JQL@8 X97Z@"L2]:3(G
M"[#T3.42J 49@80K93XP;8N-H6 (WBU=M#!F60_R@,Y:#K(:&(C2Q9'RU45P
M'<,F]X9Y":DQ[(^'*>+-U;STUW&;OT*/=7[&N#+K]!I6H2;W71"#?4P^B!4[
MY071#C8&=:EWQ,U+?C^[3JYG?S?#Q?F9+7$$ 6Y7[>CEV16RKYL[SW1/9[UT
MPD$V:%T?;&-'STE,>WZV"MFB@LV[2%XB-'^7@M)PI@9W_STMB^&ZO"FP:MYI
M&]-W;#^R)IR?)1<6N0.2?#J>"RNSZG"I1T=?W+$[TA9Y]A8Y,G9X%P:I@R&.
M*;\$6T>3/P<3?)VTPK(TDE@82RB(R] M&PT84K@6QC2)F0#DL9<U&WJA@>1H
MA4S;5T).<_4WH0C*9:W9G_,S?6KQ\$1R>38[J-%AER6#4RN9.E[0MJQ9!*W7
MS&F4Y)##/&K^MF$)8B\^B,V%#-SGP:FR.11%8<(O#\;!XM%),9.<9.Q7,X.7
M*QX>+L5U##IOK=1+ QI+'Y/[?:$]+-N*[GW"[ES,S]S%G7N_2MFM5;%9-_6S
M-#B#8K6@(G&C6:]RY@K]^SA@CRF;':  &<UQ2MI8JOI;5C -5\HX+!U--8U2
M^$7W]+'I@%L."/>.?(!#X1KGR[;AC#H7K6"3D%TX/PL*S7_BYJ\C$J.2(;(2
MZQHITMX#!$X<[7'O5$D?AC=N>B+%<>Y="&NF][GF@VB/H18P. G"B2U)KG#"
M*\@;V1.)Q]Z05>8:4I \1D*G;@:M,+(0?DB8Z[[BX-P*URD<KLN\>[H][CHO
M<7C ;U.)DL"AQ[I.R2=!"@>MM_58:CME):8&&/U+W+S4P[-$&JM<D(^0V(P7
MM_(BFX/<"[WNTOV)#;<@E,$O-'H)]1I\_E+*^':S>GNDDE(/?3?V=YP7C^\Q
MV0A]84>1!+WK5OS^)GW;8^8FCZRD(*H2@NV@B\"2?Y.7^;>2>ZR.03QC-WEN
MD#JC/9"8A(.SVGE*JZPB\5 )T[_1VN #71NZ4M#+H"YV-[W+*4A=&Z?!]NU3
M!ZKM0)/4YZ0S'XR5.*+M^:LO8MOS_;8]OXAMSP^X[3EJE(_D=X9Y]J BYZMP
M9%%+VW?83QP$-FJT@XI^,DCIO"W*&V38QJ\U.S\3^H"9S7M<\1K8Z9AQLE/;
M?\A!8X<6W<:FJ.@4N2 M*'6Z3AN]!-R8N0EL+GU>+]9FV2*1AENS>T#1X5C7
MTHQ-KPZ96O1P^(^N&=D5YAC'SS90NH=UH'J:)WSYT^5,2ESTNIM6TY*_<6DL
M^5.95LOSLR=TJ5>__>FI3\[M8:\,JK3DO6F'6U[R"PDAO1DVT%1X#/\'9+F4
M3<C!"L[X$>JV1@Z'W@P+Q<Q5\#;EDETO*< B@58!5Y!"#]S\MN@Z<"9G+$'6
MDT4:NBS"Q_G]YW0BQW70)!OS'KO2M;LG/'SJEOJ>;^!>9U$[2XJCJ;Q0VZX[
MD9H,R6))K$&KE+FI["P+M\144!#<E8'>"".: \'^H'F<B1:J3IECXDI0:=F6
M/%X")0<5?)-)UX@'\%Y3N <:A:Q^2RL+BX;S'?=FBMW@)A.V1]7$5;#FURW)
MZKJ-E&V??&(\P@E$X7B4.ANYA<GJVF5="ZT=PKWKI6J5UZ#O"VJ.*\A3WBL(
M*ZA\#-V=_-@%JNW UUIN*:J)>%:?_)A$'1J%XU'JT#HO;\Q$)Z];MT":H-:N
MB7\:[DA95*04765'TA[\G_K=JCOS;?,B4_G)W&3T2"(%/5 ]]2VM+U#LS%3L
MVHK=3+R+Y*?3)G@&>BY?27-2N:&W1(Z]A?G:4S3)AD53_<O$#4DWIE,T#-NR
MPAQ8KQ]=<D-NYY:E#$O5VJR=3PR):F/>^@;O:+FBY8J6ZU2%XR%;+LG]3TZ2
MN&8332??E@!>2H_NO]JT0D=@8>HPPPVZFP6KTJD<R1U;!!/RXR__]]5/S[[\
M/L%D@-ED"PMQ*_>RGT:%&A5J5*BG*AP/6J%:S3C1X6.X)MMNIT$ ,!&T@U_&
M.+EQJ-_.97ND4*)<5NE-KW5KHO_+_:] 6##=:0&G807" %1F11 \V&[8&04"
M379%ZM[-$]Z-=;[39\:-[!U%+H7#J,:C&H]J_%2%XS-5X[YK^M5O?^JV2UMD
M'>EJ6<!IYNP/:6R#P?">9J^SQD05%U5<5'&G*AP/6L7=(?07.),6R5ZI[B&*
MM_IN-LA)^^\:_\U9F'3^5XM\0#.9U[9<T<4QLFKSL=J7WTL\1.T9M6?4GJ<J
M' ]9>Y*>XP[DQ?1>MY)'[HNK\=1I5[\& ;!.:_.\.N!-T!8,B"ET'YMF72XG
M+X0L0(9NO:@EHY:,6O)4A>,A:TG5<Y.=S%30OM!LFZ<W]<R.07"Y76!OW5C$
MMLSA3$9?[U,+:M1B43@>I1:[8Y'<MKAR:0=@2)BLNZJ,HI(523!2@%FJD7XK
M(1%)%:Z)O+^F7)3YQ*5P)89^BY981DKX42^:_&8!NWZIKM)"\0CJ/8C7/_[V
M"_VIN[Z)34T9&M<8@I>+."%!HWW0LHJ*_%.?U:C(HW \2D7NDI-WJ(FC\C[:
M+3M2M(DJ[%-+:51A43@>I0IS*%U3E1A%S"D3JBGQ2">'R)BI94U_C9HK:JZH
MN4Y5.!ZRYM)P>)K6FN\\'@LC=#/WBL%]\)^(21,W .3^Z)O+]X28C$0]91T,
M(B,]ENXZK<4Y]LG*("VIR"D;0:3A()JTKN4ORX!T5UUGB[LD1RV9*--VNQ3"
MAJE%H_Z.^COJ[U,5CJB_C];?A]&WIJT"[?$!'M?8'2UPJ.KX0*>#GV8,CBM4
M\%-=<;C=PBH@"+K<"#I,)KBZ_YKL3,XM5C7=.[TR] ^S:*M,P:@K [;DM\9L
M)P_>HGF*<8AQ'4L9:!L-8B+C4VN,:$ZB<#Q*<Z)(C)/U%2G+%:EF!H]&7<L"
M;34>;":SL,U.FV8><S&JM$\MM5&E1>%XE"KM3AYRP-: 4:%MA3'/?E')5?ZC
M\HK**RJO4Q6.AZR\PG'N:1ILF3:I,,)OMV75C)'%1+45U5946Z<J' ];;=VI
MI8?AH\$Z0%&CQ3"U+*N9XZ"62A'=%)S5^T&.O'=&UXV:+FJZJ.E.5#@>LJ9[
M#TB*#?J%%)0"U6OT?G/VS $-+=TX=[IJ4#>WT).V&7S#G)66]C8K+*O*=%?Q
M8D1#_D%IB3XBX\?%=WW:AG'6CV?/O[KX]L7VGF7NL^4>NK6R-RC6"2_-"H,(
M(=MR;9IYNGA;*^U.-H1IK3-::UK9*IOG::!5@*/2M_#VH&8MD\\6C,[IPK2-
MP,I*@:PQBW6!,AD8?Y9MK?0Y('C5PR.\V-IJM\EJ8=#$V>%+F[3*,\ %RSHO
MDE=R.Z:([?)!*]F2I_O6?:N3=$[+D>E?L$/RB(K0%H:86Z,L[%Q^%&ZE ?3Z
M%/9U\\XL6E13A:%ZWM89NU+;',C&%B$^WSGB4?N-64 #C=JG$B^A*Y'3^*!4
ME-UB!GN=7*F5?'LN?.9F&0D03_&)CR% _#(2(.*/]T> ^$TD0(P$B ]=H]SG
MPRD5?<AX.&<6)[5= D6TE]>:6Y7(3.^>"3=R'UJ^I;=2'='X>9&\$>8_6++S
M,\NZ%WQ[7C(B'(-\DC=.MQ-##RJMRG!SOMITMT#%! DY /GO'G=)R?MR<H#8
MAR 1\@_(WD^?2YC7&?XLM=@B]-O,4Q&/;9B8944-)7.?D1NU:(9$U[.AN^$=
M&UKUE2D,>WP@5"Y:,_B^=S$<E;EU&:Q_13Y!1L),;_]QRO7)'=J/%SEXODUA
MTW8]:IYYG3$64[![AG2D[+HR1?N!4R_]?TY@38=X6^[,/&Y]*M/P_%0Z3CU+
ME$A]UD7SF5E.M[JMKDU&II",]"S SOU7FUK:NZ8J\UFWKX].9CHWW 9()X<\
MHO2JVQ)H'V:FFT"O[ZV1=9 ZH6ACWLHYI!-*D0!3U_'_2PLA_LU) $?'YT>U
MMV7=/)/KD=I!%SL?:7CJ^X()Z2KT+ZDRCMR$@P<Z^36FT3VT![I%&Z\O#S*@
M6JWX]XO7%^=GK ]&64WQ%^8.#!%$D$K!!!1%9_K=G0@ _]/3MF="8[L%T6FC
M3ZF;,!2/0? 4+I$L1I/E[L(2(9JZ2_7.I^(G[-JE6!;>E"?8T.=?_/"WGR[Y
M7U_^\'26_$D;->ODOS-R(VL3_N3\[$F:Z*_^]-_!KUP;Z[CE6F5Y!TR?WD-G
M+RA8+=]W0_"UP6OJ[8Z->FVLJ[O%:V+KBAG;P&#;]8X^%0E'(#7,L .D57MK
M.KED>=*LZ*@"^TRD-VY$CBW_Y.7__/3E-R^^8;FB?[_X_HNO9Z'0_DZ@JOMF
M/E@#>2.D.NU#D81N2APZ.ZY27)'4;NFO;N_"1C:IM2)%8 F021\N#5V"SC=L
M)Y8BIY>NP@W",TD?0+]X3</N".?P,B13-EU0QQ5?)CR_EDR'7B%=:\F9!DN
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M9=L,%NKX>)E1 0_5&BPT33HB[9D%0.<A3V>$U>6FK-[R-],M>2YYAU&'Z6T
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MDE8KE-L6*?Q/EO?I1U^*$%]^[$+!NN54(K&GQW&6<#X"($7T5"#D6.C\ ]I
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MR.+UBD(*^@YJV'6RIX8MJ2_Z%_WWF"PSA72@-D;J=1/4Q>7P'EH]<#BFNYF
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MUY(NN2365'Y+M1%9VZ&X(-?!A+V",!3V>=?TI9S+ERBHD7^(IBZR&ASKL*N
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M@RUQ%V S+Y*('/S(SJWC6WM?F69^42]RHQBTC'BREY/[(GF)(OF[%*Z;3W>
M/[6_DM=-\A=3XF*OFPJI;EI$W0HYI\W-V]^[W,?HD@97LBU:)/RT>X,_NZMI
M;=Y?Z1)\G?]C"K-(D<#V3!49N]@PB(NU=<[] TD@T"OG=?O9G]1/M=9F,_.H
M7?2;I_J>N^O9.3\[KFEGUNO:V7O%A)E)S=7.,6Q:S.6#6:,>/_)H2N@6+IJ
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MH<,(&TM'-5VRC+ZO?Y@PS'%_Q$3CG$PJ1E+K828?%97-OEO0Z%1^<!]B0*W
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M@CR@.<2H4/7O!!$J#//"HP^7$GYFXP#R4[DVH>[W(N%RK;FSZ9,$F+Y (U%
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M1USK&8[USBW)["B<?HE*2IKG'T*&!68G-I3Q'/$^.D8]Q]E^\C +K2&H6P$
MD?@)5]F/=843E7M\ALZAJG&IDS"UG-B-GIKI0W%O?1@\Y$%IL8^*/;JW.^U4
M,CAL?%6#,/%;>?'Q:<5(N00\ET#7IH!00[?U<$1?3YUF\VGQJ)\X!"1848V[
M+EH)+;C\67,78Y634ZM]IV$[^_8=5/89D-G9O&+(]MS=W5VMY!8[0*]R^M=6
M^GS9T+0^DQ,O339@O6[@L+"'6;"1?;NGIZ4=C47\>_HWGP ][?O:23E6S):3
M!;^JFQTD%)Q$_!MZHDI+NDF()^&#WW7^T300*VC['[[SO"T>]1._C,$8MH;:
MYV'[<KZN=Q$OC'W29BT%M67>3,"C%9V\E&8M'$E'VKZ6?8$XIN$HB(\3WU!#
M;GQ;+,E3*%TNYW2-72@G#V^H@2>BF&@?&$66;'$)>'M[V#>2J>F)L2KS8DM[
MFWT!.I,T$FP$V"@AI/^E9JF "SH\#>;K$2XZ8.SFK*K#TR&]B#)?)!%XQ7E)
MF8N?PYA_PJGJHJ\0NQ)1E9>#7TCG '5:T_1#AS.7"*E>%\X'M)&I(*=GSM?>
MJXCQ9-)_S)D+'UZ^:PS)J(\D'+VE=;[V2<(0FVHZ?7 RAQ> ;/F+:F_GD!ZO
M$V8]TRN@[>R^*^"VJ,N0%TW3 $?=!!_ MW3#-XA"A>X@N#*3(7K$V6+9^EP
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MALN09=J)-D=@XI=P: =+FJ+<>:* K]F*1)%KD3 5WR)O/3J?9YT]&PTF='U
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M81B'6)/7M=*5VMT,EVML(+K*OM>>G[KOT*X_U1>(G9!@>;A]J2X%\@6-8@N
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MT&F>7G< MK!')!^JC)Y+ ?=MCQ-=U1$I#*:%@E<C,!&ZY$VQB[/AWNYX(N,
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MKJ]^Z@7H ?2T'+G[YIV[6S@^Z=L+[@7["<ESCF[XI/CL\N*>WHXX.1Q!1!^
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M;DEO\I5%>C'MW,)XK8OA6H[-?]*'Q?A;7?ODI;=C+!V'2OZF@;9-]I+%O07
M&\>B$R [>K+GSYX]]RSZXV^8BHE,S)$2Q\*73+6K*RW[F'E*A!^8645W6NQ6
M1L.=9]>+(#53#WO]YY>2ZONN7J^??D]AQIOLGZ!E>=TUSG79WP$:V7K:SQ:M
MGMFKAF(*&6YX^,^?A13<]$CHF-_VY36CC'.!\K&64_BK)@0YJR!#>O7RQ4_?
MALN:)(1GE$/-&Y'/ ' 78&UA0=@*$$*H8=F9!0DD&0JB8 K1!BLE>5W>XC9"
MUA86FX2<GA 5615-BG*RG/;-4]D.K!OP GVS2R'J2]"7FG?0K##_26-Z)H9#
MGAM9AGAYOX!])\>ZKIPI\ B/'7K,Z.U/[+,54XAP2"YRR<B/%UWG>-?PD8&P
M&Y^/(87XW%3:#N Y!U0#\4 :2)( %3M=^XSTS4( B'*59O$PNTS:B/?$20Z1
M,^&L3@#VCJ>8\U1 )6J?S).-G:9!5TKX'O/ !&#\G<O?2%=G>OBB6(W^QM7>
M%QB&4W<0C/G9@E\TG[EJB>+:]@VF*]ARM27<L,F/O3#]H$C2!>&V^)5#4EUH
M :0A]!XK'8L<1DI69-9 B=LE35]X RR9 ]4/09*H-I=7O96M*&JWAHFQJ)3J
M\RK[>]&^&2\(# MYF3[Q4,*N/(Q0H8FI??E#31$/R#/,KO%8K9)2M*ZY=:&W
M<E(R/&\G9'OE.#AN>BXOK.T1:^5)YMI#MC(U,$*X.FS$#%CG:'_DP&WE0/%-
MK7)NTJJ-Z9X)/S":$]_G%4]>N61BCWJ>MS4J;TC"VJ4?>LGIC51.SUA5'/95
M(&8R1JJ) 4W"$X+!AR9I'N'JIG"WC%2G![E&]I'!R'13"->MD4"%I,MFP^7X
MY3Y+JM-RS8+>)8L6:FV*ERP.G5UG7ARYO+%#\1H[L[H'1I[ZQANQ1(,S88[6
MSO&)3P$Q_VD&,3\LB/D/,XAY!C%_[!;E X.8<3R-)5&%NIM)U@UJ!6Y9XTEG
M]#M2CN5JTZZL]XZ/<'BMR(66]'<6+*F5ZF$8F1\C6).C3O*9ZZ($F"RXM(J^
M$D<M'K]S8N>Q;<=#:]7*S9B0]M@:3E<O+^A[%^]XT0;&I,F^YB>!\@!+4YM8
MR3F5<JHF)#OI>88%WW"&772D+7-NBC>X<Z$()H]O@43BZ=)8&;G)\8O=M-XQ
M94(ZT5\QQ#,8)4T*O<""9S*XPBOS4.JE[S^3R -#\'AZZ\R>,.'__2DMW>G-
M>IJG("Z"=1I.GZ#$ASAAMGX'[OOH6;S+,T]X(;_SWD/T/-[EBCKX7_@V1I-/
M?@Z&]9Z#FEP]#S/2R77S]1^_^OH#COTA!TMV"8-+6[W-:8W@E5,N\= .B-+D
M$=D-E1UR%DOQC-?>IS(T71+S@O@U-_1':7WZ)>LHY6IT6,(O-+NH7%>*O]^,
M?,&(513^+;E&ZRKN'O!<QCGR?FL&S37))6=C=@86XXR'-ANSV9@='ZQRVF5*
MJ9UG42'05^]0;CP0^<;H:VB9I.+(ILV2K$@);B&D?IYX_D883)GK/;/,JI[D
MNW*>7A>U"=9PD^HPF<4[8'E]371A>%DB_[A@$. MYA'&MO4-A!J-ML)**]4N
M'@>7>[4N]@W^.1O;W]ZBG?'09F,[&]N3/,<1(@$ EIR)G!.NJ'M46:?6GE94
M8)A^K437%W_"G^[/=3U]_@57 QYO7OKABR8_X4@\*6>[L'2%GIX ;=NQQ54;
MCEZRPBM8[VZ04(V]Q$R2BW]\Y\K\#N=W4 L$BKVM2Z<XPU79,_B%EF>_Y47J
MD6"V2Q]B  (&\4G@%$G HQQ54Q2&;MT !=C -Z%HJ+J\")3'<0#KHMWU )!S
M'-4SD 67#B?X(ASNBY!X%RS37,IYQ/GPG_KF>-%#D2Y!G09:M,@9*B!U!QWD
MCB&;RST(O'4G0?SY-@]X(B;.;U"#88^3G=8<FD5!3  *Q&CW'Z]'V51A26(U
MH_Y/^X0&NRG6/2UUVJ7K7BCJ+R_$;6YI^Y1Y$^Z@O=UF%-.[73\8[_:Z43UH
M 3'1SP#UB,H8LHD3$FY@K;1UT&L!UX)B<WJ)MNCZW*C=CVY[E;VH]HI08X$
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M5, K!,W1W:XNA-V3X0GII>+HM(@KQ+ZJ;_-.2&Y;W,9_CL&6XVI.E* 95G6
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M<S/F&.%V;\J$.]%?$@M!LJG1)ID=-6#4V^:W_43EU2]R69O^(_YVYRCMR>M
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MSM.8Z1M-2>80M-K'&5^EDNK14$EULY54SX=*JJ&2ZK9KE)OW>Y0,Q3"&M=I
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MW1JD.<_6B'23$"ZY<QO7RR3OTZK6PD'1Q*XAA3<8B4*MY0J9,?%53ZM4?4;
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MB5J4?D3H<"34TDGP\L5Q<$\X\5!6@<P$;AS:,4 : .9@2@NAL0;F^7[K%8[
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M_()IH[%J-&SE0\&X>6>K,8;TA0)9101S^T$F):#>%'4\Z$,S'ME4CX=+>?S
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MF,JU&EQ.M3K9D4C8=;H]W:&;7C/)3XM1D>D)C4<F15ND3IM, 091-\'1>2Y
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M6\J(-\R+:K/Q&R<<RG<B,!Y9/EHR71-CR\HRR4C9C"T3_I%;,T^C]JT9R:+
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M)U6M&?@I%3.&RU=.FQ%N0D*X:.I!$A%2)>7RC:V95DUYGE*436EMB#FR;'E
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MKJ(Y 2S$3D+49%SB"F^_1ZEY6S#PF7TL P]>12LI%&H\.-K=F0L)CU#3NBN
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M4M;):H8$4);93$@77  @'%")8_ZU8CXD_LS":'W4J)>Q2GG%]20,OVV6.+9
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M8BT,RQ5M[;+5'W%AMK>6.ZS@K7)X;C0D[?@G+4"A=XX'<'CKDEY^>*_+?G+
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M-D(@@ R^]HI_8PU?GY8NOL$R;=5,_IPAXRJ]^]+C;"\+5DR.J%^3X/^\7'Q
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M&H!7LDG?+(A!'S;Y;P3_6WJ9DS:7;)2B\>"TLX#&A?!MLW%0GB41O"&9JJS
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M,8E:H[-9U2NX@Y*C0%><1H2,"]Y!6_GE3.)2H/3U@_OKG/MHCT9(R5#\@<U
M$!RNR T_@2N-D'L,X"L7_!08M<\NP8:7VO=\B4]/6]NT>6!?#R-K>I'AD#HN
M6:@![2NB!ANRUPL8AZF=<@/Z*KPJU^PN4G:X2%(*EDJ3SD=-6;68S0;KN>76
ML\O\OAU&4^+33S.9^,/5063;*7$[(RL2Q-=NM$&\MJ-A/VSU?CCI<OFB5-59
M01;4<R7B5M.V17NWF\K\Q8UX:8=.E-0(@;%=4NI:=@X/I8-]D1 !OH-%@G-$
MP ?]8.BI>T)XQ2H!<1A71,P[U-Y,OG>=E&>FEHYZZA;7S"ZC]=L?+Z* 0D8-
M"P34MA7.LL7T;XVMJ)D-7&6W&NBQ GZS!0OK>WTCMXSG3E'C3:YFS1G352A"
M*XEN.VHI*8/YQ8(ZDJH^,DY-I"](I0?),L% XDUQ&)Q9'(N0SS@MQ\T<JW)C
MXR<9T8U)B0$#'!1,WSLJ_+(8&S.QC+8M[C9A88&A-F/'E>98M]CXXT!TRA@C
M^KQ<Y^!ED0-9=CA'E%:FN(!+0\1CEBYSA;1^ICQ/<1XE.FHE:\TK$PGRP> E
MB1L5!H=TZW"BX$BD/]GA2!R'8+7BW<3JO4I2F)JT'*/?R,@3IWM2/1S#1)[D
M0"&V5;OS-H]T.(1N^HW<FD/(3_S@&&UP$G*(]1--V8Q06K93-G[/:Q"E"N+C
MH)@>M,-=N"7&V&1\E=FB)U>EAQ2".\[Y""CR,(,U,K,DF\9L7K&"@@$Z/#EE
M<.#2'U%$8I6MJ*H4K;*C(*/CB$DUX>-]IKZ"0 P.G'-D[ ](,E1ODD^*30YQ
M/;^).XL.##PS,5/" UGR21$E9S#]JNXY9_%8"7,"H>J)%=W#"R/7E[@<]CO"
M@N5>R;03%5X'%R\[.%=FXKTR#>_NSN?S\/:=P[Y(TW7)--U_?$69IKOW25[@
M2]G1*TFA/QJDT*]7"OWN((7^9:70OYVMN?T\_U?S&3LZMJL0W5M&C/_EVR\I
M&DWSAFIS$S/GQD7-E&KA817-J5;EY"+V>RNHRC "!4^M1G9+B.$QQ+\T]-PL
M,[]AW6#SJL$7&]DWM*R>SDQ&W 7).7B':?0B*3,#+F#264]=M*N#A":+19$R
M4:I*$'=TS-KH30NBN0HOSY=WMK9)L>5VGT[;I:6S3JNS+>?HE\T<416F  NK
MRM1F>IQ: BI+=X2<3M33AAH;Y^FDH23J&06CKNRG6I3*I&7;SR0FCF80P\%N
MLI<-M8\BUCFB<5\H8;')_RJ6+G%JHW31 4$D:%KA?E,D*.H@[>X8+%9SD+L>
M!N\_NW1B%5.0RY"W,M)%,0F58N6$O4D?*X_]+3R"=)(6"!&!<!8.F?<8H,:[
M.R_S\2&24B<-1YD]^IB)IJU]BDB"#\CK]/!W::6K<<7">.RMV&C]ZJ%Y7>5R
MX:9>>\W#W9V;UT+3$6S=?@VS3N:C]$*HE!DQ8@KJHH<P&C,^DV)<EVEN.D2J
MM))I&R\IMO>25[&/0RGU2T2.9I-7\-[^G*6XO%'(&9,.4LM/&6"NS7'*$QYH
MQ228>:HOC+1^=EBY0P9T7Z5$]5%<[;_<W0D=.,:<KM2(]6KAEZK;IK7=Y>D<
M0HB6SEME"(A,-0HP(FN!KIPI\].%-AUTM39QY;2G[<],_8BLMT3]*/5C+JCG
MCUYIL I:PLD>G:K==E<V$NM6[$_1RO&W]35O?)]ME\?R-60WWP6BC%9[DQ?_
M(*-YP^OJ!/MH=G?&26FF3=:B2!9/:9[4M2E[VEF<I$/6E53&K/=\D:45ZJ%G
M)IEPNW(<51 0DH^"I*5@QN9T2NSN"*!5(48E?(4L6NQW/4^5HV \+HT@GR83
M,#(:RS3YW-3:*YH;22Y[?$,1&(H+YGFF$\8SR+L['8OLJPB3=?9AU9\B%>JK
M?-8]2J%@2'NE0GV@9@3!X[CG9@K\HD?;_N7KI)HD?]L?VE,KF?P%9UL>C T\
MPG3JA!^H-C!-TI*YT*^LC.Z=>AWU^IGR6YS+*YJ8,2PD_(N*L'/RQ'\#5N"5
MW\6R:%C/%1[)64IBIE5=-F-+HDZ_E$:8%V_>2?.+_PXKXQ[RH-Z^=7.AT-$B
M-"F,:JHJ]?M\T(+PSL/5,DW8)U-#YJ(R;^U)I0LK5#7'>A#:S!*<TSGN:M5#
M%"\7*X5EBJ(XGW*W857=L -RXLB?=W=.N!:+B^D]G##48#HX(3>_RU>IR4JB
MD]^:P,$DKL!V>=+\3A9IC7S?XF#VJ%/\>G+R]C#Z(^>$"8:.IIX5E"A-[(+P
M.AZ)1;S&]<%,0%X_)0&H8:/K6:+N"@[,):5*0PV<&!>)^BN<@)J"O4BJ(.@K
MM('>C262VR#P+84W!(_5IF?T,E6=?# *L!9UTBSCF#E#>:^<2#/^*LJT7I+?
M[7-YN$XO0:6/:# ZG<3]*LP3SRDQ)# (H5ZGY ^]G,;FJROJP-Y[M-_#-@X'
M^_K+^ZW>KG%J!=.O3)UK-/@TB=#7],[K,#JQ+.O9$MR<#C6Z+D,K]TK\-(0:
MS/D0\H1^5SV]=#7U14^OJL-OA)SX/C:$UKU;'KJHXE8RE" 45@LU&)L(L0E5
MAOAV6'!H%::(WFS5%>T25B46OY]@9&B6X;9!^ RX[((MTN]CT[35F;7<<[G!
M+$UEG"\);XCC")3QH\,UZ>QX=BV[W[760W E2/N?P@U+K$C!M*LZYGGD1716
M%!/ZN 6P@EN;Y&<$/.++[NZ@]UE.S%<ZT6_I87'MV8,SB"_AI8$%^YWCT.&X
MOOGC&B+EOO-:'&M?!C$4MI@:3"[0-J-="9M9WZ^OY&S),<XQ>FW)J6,R.#^K
M)&M !9=:L&)64C$W8Q@;)G<1#3^=&LSIUN8*E<YA07WY+<T>U.[.OPM1,3V1
M=SUL[6W8VKXL_*5I+G4HZ)VR2P!^&07)X*-Q=H8OX_4".K]4?UDC(Z?GG^[N
MM*@(@LY['[],MY ^E[DA5=^6E[=RUSL8[\CSS(PC$8=88'>'6AN9E9PI'(Z.
MCG%8Z'&T? 2E)4H^L$8Q&D !_[:>P%M.=@J% 66S%E24!8]Q8N!536QU7)I;
M$$M#YBXM6]^F^]0B;EM@CV7BN <Z,.2KEGY@6X(Y=]++5"/_B*1^5/IARTMB
M>97ZPN\:>!+WCY\0Z4V3G=&S;'(M4Y\Z%HJ3<2T;9DB/;-U</L$(8/,^+E+>
M=8H,6!?LA/I?+U??!")H[RZDR2QIX]AKYK))W&A/41=Y?VH[).8:&0C.]@-#
M$.@=4RCKY;$I&PES1:LS+-VMFPNX%^]_>ZYHHS<G[YY%?[P^>?WR]S=_G+[Z
MG^C=\Z=O?O_]^>MGI]'[WT[>P_\\9_MZ^O[-T__^[<VK9\_?G4;_?O/^>4_5
M #]\\O;MNS?_/GD5O7E!?__EC].7KY^?GD9PW5]>OCYY__+-ZP@^\O;-Z<FK
MP\&=63%L1NI?WZCEZL0JBQGZ'Z-F 6<I$A'1FN#[I)/_]8_YY/\='1]96 $O
MEN?O?GW^+CKY]=WSY[ XWG_YUW;=\_^V-O$+A-<D/<4>20YRC0\;G(GT@G_8
M$O<-_)(^0%L<5<8H.19]QSJ5LO5_3M=$NF_E./GYA_1?AVHA3ALB@['#MF!%
MFP*DX[ DKY?/+:TM76'$NSMP_OW=P,N82BZL-(1,'!MWX$IS.KZAU3/'HWJQ
M=-2">'K7=3*><=HN>)/TKB>8^:*)_\C^'$3@L+-.\AP\0O#F#HYEY<4;?/G@
M+J*)Z6OXH#;XXCU%#M*T4ZJ3?URZ5.4/6MMO*I06S8(37!H@P1<NDS-M@4PF
M_:C'-.=^?5@:I<$L.I_^\Z+T'C9[$PO?RV%2%&$P8Z>H6NL!?1L[]U.:UQX/
MS6O7V[QV;VA>V\KFM2W:DK=T+F\@&'P-D1_)=#ZFCN2[4K6EW4,=6IASZ1KR
MT9*EK><%\G01;Y=\YK09^>7&V+/?]H#$(P,.6RRNTCTX^>$=YKV'!\66A]';
MIJP:09JP$H_-CE]V5'2/;F_0&+/N[I#[PW4L1F;!9>U4_ YPN&]YGIYK(9+=
M)C@>NXQH_8T(KO1'534X_;!]_@).U6QY@&HDD]T=F!HV&,A#X<=L2X64DO)2
M8'I!NI8M!K88P[[E@_&6SD77LVTZZZ[2=:\[T&J@JF^CLKLK508H$0H7A&\R
M-27LP+:^@4'7F&BXTX_1;^ OHCEXD4[K9?0[W!*=LV?$?UE%>W<>/CB25.[1
M_F'T)RY1)H;5M.G*H7"1F]EM81"UZ(/%';B"#[:@.C[N"DEJ[X6T?O)381*G
M#KVN.(]_/4D'IP22G)A1K6R8WM>\QU6,F;HC[-NY:G9NWQ;2Y;9B9A&>&0IK
M/-3\^%$77A+(4_A/-\1']-N>"_>",,0*Z@36O-&K"X>XP3 *ZB#1]/DHJ=*J
M749@V&@;0T-*!MT2A0\!"1[[[P*@<4N@_7;;\GB_!%>.Y<TF#3B[";E#*!X@
M$Y<#$&E1V$0'1,27/01\SLAV2E5;CHJE6U2UT/ WWJ9FABRZ(EA_O.1@L+=N
M+FOK]4@F,ZXM#"VH@N6:'X'E@9D'0K+#6V?^W7#CDD5?6!_"TN;8.@(#8V65
MM'E!-5.RZM"POX=Q5U-=FE/+-L3)E#$\T()<,D65.9=J6)<W7/9_RJ^$0?W/
M"9*!'@!^<=WI,^30M\%Z7($L@+T$Q*0RZ3Z?J$00A;3:2:V\OUSN3TN/N6N2
MM'&2X4:7IM/2-F][H5*KEN?5FS$:69';)2_M[D_1S^F_GKI+R0G]]/+)8MHW
MEK0O#$K'I[Y::XB6 ],Q@I*QY4FF'<>,[\^XQLWM-J%KJZ*@MO<%MK."CT 8
M!:N9= K?Q:3S[XR7L&8XL,WNP=)!L#[-^FVL]=MK7=\IHI<6B/#.B#Q':KX>
M9K+UBN[=.WSTX&NP,-W.]4:VM9,W0D0V<@AZ_DP9OE[RAR[LV^T@LUW'?2PI
M+W:0D-7PK/J1I%2*\BS)!4+-]/926V)NHY]84\7_%!B,23%N" Q.OX;?AU!L
M_.GY/H8FLZ+4:Q,?<<V0ZOZ$@?#_96R]/&U0O U<+R]L1S]//2_R ^[5QV9T
MOO$YC&:!/16U9M.P^S2AC#G\$G[;!VKGWZ5T#S@YE*9C=T>)F.#QXJP^PJS@
M-,E9O<8R,<-Y=D8?"'^/WSO3)_(1KFY@+,72&*L'@ V:]#V\=Y:,BE+;;/F'
M\-/28,O90JDZR 4FAA*;1\0&"-2LHVP;(]#HV_#(L"N3FD$:KBW2-?"7\+LZ
M^<ACQD=F\O.T+ @C Y_TQD"/S+6^*36"_B[==PQ5=-./?-,R9_X%)&^AS^*3
MP?Q#PL,,'OU'?#83D^'9R;]MB$$@2G1I\(=2Z2)QL"3Y.?ZB+#XH]^DT)64@
MU4Q&$0_^(,WZ@T%Q07C:%_S3<SMB6=TD@F3;G2E?#*OK8(2G( 85;D7M[N#W
MZ271JJ7X>!FUENY'?HAT_+O.!\8PY;["H?2-Z%?PM7P<9W#RGPM$<OW^_XG-
M/4X4GO:T 0]$5G)3#BBE[9O+-9I]&ST'A8$K'@&6O@5=V/ TB!;%!98CO^XA
M@#TVO)\^XQ#H&GYZ2%;J;)IB(& GH8:C>S3 )N?-N-;RI^M,OW:_^6:+#QOV
M^,->,O<.]61@J2;J:>P >>U!H8>+-?[.P,/98I6,Q<6W(%P] 1S*^#+;A \3
M$SBV(PR&):P-TI3A#H?@O,!G=!4[?:7#8%^X&L)5[^FC6?9H6<JPIF0YJ)5,
MORLK>0D X\D P+A> ,;] 8 Q #"^2<<%T[C@0^>H^7E3*87A#6WN6EHZ$Z]"
MHN]1TYQ$YF2J#F6?=5'D@VG S><) MD<IE]8MAG;WCPFGL=F"C:NIN0KYT.7
M0>JTN'*=6BB&.FYE5A4<OI)S[36CKGH$7FTV\)U146,\IFZPPB>>B>%*[BE9
M@6\#EPL&79HS<,9*>2[6C<)$^0NDP3H]N,^N=YAF;6>-V7_MD=Y8^YCQ38Y8
MF4/[]:JT]AI];#CAF 8#_B9+CH$/E'VR"3\(6EMNWN'@I3;H4< I\2-[QD)Y
M6+4*@]+CP[7QJ5Y96GSX.;@^'>G^JR2K/0^SVKWSX?M:8 /<1H!==$A2BD5&
MX,4J7IHJ"% <M0<]'WDT<(,X:G)J'W1M=/9EHJ@5I:O")CF^U>Z.#]<.06,:
M@G"?$]X_CG*3,FM!#1Y\R>Q;BL7B3:VUF1"/+A-H+W/! 6B/'^[KBQ)'2HNN
M$C('6A%[%GA"/_8;J9H<G!@4,QMEWIXV$[X^"U&#OY\L^6F 24S-9/_';\,0
M?]-B >LU #Y/0>#Z7\0-<[T3GY\E%B$CP-D#IK]E,ER'G'0,V$X'AT[10 B'
MQ%N7F,K$/_DD*ZMR-9^G(K#V66VMPL!U#N,;6I$$-,0&J"R+HP6<?&<&V9<K
MI!0"PQY'9Z1GCPLK'Q,ZD^6C)*-G^%S JV!:!2X$2Z]]H90]H]:5J%Q MZ!%
M;X%N(I]5T5\DG:@0-67D<9DKK]Y%Q7>Y@(\^%HII/1\E:5K%/G0RN*+>I4S/
M9K4=TX>472>AXVJ-FM%O/%KQ7V)[:[H:XJ*)]M314'O83_S< DP!V&+[^_W8
MK^9UK,.PC8=MK /82_9)U(XYSU(*<"XY4XC,W7 %"SZU-]J'@*A8R ZU^?F$
M"61Q+VJ3&[JK&![!OE3A;MK@L-NK(FOX+TH.A]X@9@;E,[BNN6630JHN99_;
M?28H1*S;"=&>%C044^1YY)1^QKQX4GN<G*W0<'_83,-FT@$(_3">BD@DET[@
MCW,,F&CA+VGQD:R([\SAZJ_+=,3+?W='U3<P.$^J6:R(;5O$][W 8?4-JT\'
M4!KR?N"JL3(VPN)99-C$!2:/%Q[+8DS >)&7L6A*B",JX\PGQ1;BJJB<1D:+
M#B5Q^&_#JAM6G>] J&?KN:4DWMI[D!,)J27\I*C4.NE*ONF[OWU\/OO8JV2$
M8Y/Z!PVO4.DQ*:/S-,$:- :U;#+ITOZ=8^\>7E <(VQKGN*1[W3TI'[-:@6Y
MBA"TQA=Z':6U]M1)A1\U!3Q =)=(!ID(YYL$0PK#00$FDD9P8^9Q19: 45&6
MGN8]T6E5#7\:/]N*/F".$*C'WF7))9L4967B,'L@G3V8A4?2"U&L%S8DIUI#
MKX="#)BTO#TZT?!G64'JO"6R[6-,5L7\$FJ&4K!T%L5NY'7Q4)<NBL$\LM/P
MX7<?1YY'YO+L*"$$EQ5N"WTP1.&( .56#M3)#8&IP_:P9"PP//SNWG@_\%-A
M"#DL=R2&P+'H^QR,W&#D= #ADH_M@B>])\DT$%A%W+B*(%.T&10#4R$ Q[<Y
MO*."-L[B$DTK^/H9LR@S5TV3U9B0V(_=GK1<,)H>%/(1W1%VX]")GQGN%J3,
MQID <M#PX+^YB*S;+ 6/F'=Y:P-)2\0'8Q;1A<DR9;-!CE:PIN 5.P2.'VIR
M%L@AIQS]F]@=_UGY8GBV!,([7LVG+ZP:W) K#!Z ,A&X);&(\S FB2.:[(47
M\T4LN;L3Y(.GW&[==;"@J$)2G"8SMCFD??'!U RF1@?@EK@[K-WYMB(+$4?@
MANWN4!HF]O=FX=BAX##F*@+NE5XLN3HM3@(@&B4EBE]R_WG/5O83D?I#L'14
M2KXHR@_HM36PM3-1N"-P=)-;("K&R&"%""R]OW:?4JU"N:;H-R,D'(W)H;(9
M8F+ FI IW-U!^8"2L\N^NB0$V#3,F.4N8S65E*DBS#FFE\2)(6-G=3S%VMFG
MYW)+UC9U:^J6Y71>J&LX2S&+%>V)/2#?IEY3RO7R3?0> EA ,"*IH%NR *2H
MJKB_7!V;F#R@F::B>R83.N!."A4][8A[N. 'LBBH6JO/O3+E>3IVELY>T#IU
M+/)G;RJD(_!OCC<802R*I0!A__!H<X^9;4&'9B\P4U1#:;AE4%\URA4HJ'7%
M8R'OUGLL$\ED7KJ%+#!5Q[_TSV/\"@R@09)R.>7Q;%H8*A3;+Q>"($#'X+S(
MSDU7.8TXPL+YRTP\S@3P: VW)O@]]TP;;#)3*F<Y05HQ=RH; +\Y;81<8LKO
MA51@I1A8+P_P=7 7#/C>$K]YWU;CX;OL5TN;#B?><.+I %R(:)U7.%40]F'-
M6;@"K41=14ZLM<Z:.64$F42XGI@Q+7"11L>U7Y1S2K^R=QVKQQU[)M'WLP,N
M 8OWFFAIO?]<]K8&9DIT8JLL4A08)*FNN"]9KU>VE:68PE2'#!H,??M,7RPR
M:=_-DHN^K7?-@NPW*V+^"?CUQT<#?OUZ\>L/!OSZ5N+7/V5KMD3&!_S9]X<_
ML_DEEU:B ]M*X+D4CJ<PYLO9L0B72H]!^#-.%QG><@'F<TR(:0@BQF;2E)Q7
M$]8)_$5/VH=4O.!LUO/<:>/"T%"JKWOPP<*9&.87)'-DV1/7Y7V(ZM\!E>&V
M*?6L.7=>II4,^+C!JVWM&)=:P*+K>='.T=;)1RO#'%L0S>Z.?*OS66\'Z<ZC
MW&A:3&*"]', :+<"H7""*Y0&PM(\;J=O74*'X]GH#+O<I:$?=BZ#]DCY+VSL
M\"[/;::TC[!UE$ 0=28^]!S3'U19QMC]8S*WM'Q),^&$ WO*B=>+L'H82'U>
M,HS>2YS;H?R14_V.)+TJU0N+N:$@CK)BS.IAV/P;?A3AL1 SX).RQ;_8XM+Y
M-EXIRI$*6<5*N$Y#2F3\6KB;=Y[:YFMGD30@R9)TK@7*JE(3IL_8/<Y.TGUW
M!\>)2,+5Z3FB + X0>J@*#713DD(PMD[?5#;F5#P;?>CP:8--DT'T,HQT9K\
MD%,Y"7OB!4;8^10E;?'\U_0G?A(+(Y2C IM3-!DVQ=@^#]+2=M14"]3IY9@]
MG2]@-W>A>J@F);H&2USMJO-'Q6B2P8*M4JM8\["FAS5MZRW6IL;1O)C U:US
MJ\>)M<6E2RZS ;96E#O0JF@/3P1:SK"&TVE(*1X0M*US.O?]<U7OL1\DDUKI
M(QQ*.W\TK/)AE=O^(:_W8&I,@,%!CBA'[S0LFF'1R #$@>>Z4,/&1<]T1U&#
MX%*L?\Y,PM#\I!REMD/9==Z(<TI!OI&B$X.OL%2&L5)ZGH*7/@9G%&P:%6%5
MUQ>#(_BA=#Z?FP#+%F !/<!?C4%_3 VY:D-CLIM%60<7X,R\@%QXTAP+B5_"
M6T?K7J.E*T_G5+KDP.>,-,O%/-^Y>V3+E9C"9Z,OH4/=N1/6N2=(NDX^D4]8
M+*7!BF[$#M2H+)JS&<M1!!%2Y 5()78]&]0FTN<9791%?C9!^?EADP^;/,CL
M^8UY#/?4(N]4 +OCLN&@&6/(M&8M,4*,*OX-/78$;S4L)TM).^[%NW,LFV%:
M6*26(@IZOLT(AU)Z]#0B[;T-?/+./;ZXY;>RE?%AE0^KO,_++TUN+N(^7$?<
M2H:-3'UA3.[T(8C.,>1K'%;9L,HZ51(QGW'8VT7H89?J9*51SAV2%@R)X>#7
M@P76P1 H?HWX$"]!.(5X J*N&WE76/BR4AY^3Q9^M&;=4X\;LN[,$"E\!?3K
M 'X=-M!E VAW(J-WD8]-UC+64A]![B74WV2X) /8+)\PUQ4IF8- 'U5N0T_=
M8[H0*J-VJL?B%]WE[,VDXI@M[2AA2_AU$=K&@0_O=;=(G)T:QK\ZZJMA&PS;
M0 ? 0. 6)*XV<P^!YE&5]I!T[^X(!46-JAF+RF'BHF0$ZXX9E""V3*@OSQ")
MTH1H8JQB/9.RDI]$UCR!,4_ZN\B:W""3V=A@86M8R,-";MMS;.MIQG5G\=K>
MR2O@LQD=7=6V2KU(JMJB1(B7=UAYP\KK!'RMF"ZP7^RP1Z-4)1%=;@.^.+']
M>$QX5YHSS)X=?I< VEM*H=?/94KTDY](Y^E]IMOK,Q /#L#/;\J.MFEHF7D_
M$XH'8N^DG9)6 35M9,E;X0QO4=.&NK5MKM<5G+3!Q5U[W*GC/S@96T)11W_H
MZ92221\95<C=@/MV\&@'OR+<#T5MG'QHD4^1T:GFQB7+Z-SFQ(:E'Q/ZV'+P
M>E\DG&$"=JW,S?)@G*74#UIB1=00$G02P1^23*N1TL JHQ&.$:J6"(C*]--,
M#TMY6,K^4FY)1&&@WU26924'AQ=6I_!?>EQ06&S3O\92TL-UJ3!^X=@F6LTI
M,F5W<,."1_$HJ!@:+.5[C_*RTY3,]!C2JIV15N44CR1"\'+AF_[C<B>H */-
MTI9AR&.==VF5H3FNISGN>&B.PU]>7W/<PZ$Y[IMICAN"KB'H^A(G<TL.Y*PH
M)HB;QS"EL >S<4(.5 CF@,M5<F-)^ALKE5[DOCQT@$(>0I_!7UP+!VW*<ZR;
MJD Y^(X-&"6;%FCS;TD):HKN(G[>MFIB"B'D7N!BJ#*>:1@?^X*4^ $/=\DK
MNL7#L)*\"\N\XS'82"SE"CU11X:(R!1^LC?1ZBXU3T55^O%@:1)OR"H\Z(]<
M?^:8(Z4*3=5CVG#Z==8>M%-V567Z*'>XNLO8.G0LNL3MR_GD%$Z:A5Q\N_=K
M>+_A(Q+15RL JE<8&>K2M7Q$3OA'B-[@SY;CK5-RIV8(802JO"K]@O29TH\1
M/DCIV0E&N+O3'2*!!JG_!^:(&L"E-!!SAT]IZN(;-5)7/\%7S,^[^]6OU6]$
M:(37=[DO:12W<9B$_8XV^,?VN>=PSEN+*H!YA[V/$F1GJT1Z542;/)M0.@,S
M6G++TB:C6"M^Q81L*Q'H0;.3NALM3V.ST5SBEFSGSO%W^.VYZ#8_T:W=Y+?$
M%ID$FW$WV7B$][1&P+%#X^YN2([.)IU'V%/FJ3&*F[:Z%7=C@[1)I+*="_@;
M,0E#W/\%W 1542=2S4OV%I$M^^?S[LY3DK\Z">J>S%PLVE4DY8Y2B7GT.JDF
MR=\1\HEDZP[IC@HH]P+BK#1<"&[']55JQ[FRN*A $UDMDZ)#ISFO(_U&O?PA
M%?%9&^4J>\1//&" F8$;S&PY&194%_3A7H%<8D@M\[2:*<:;0 ?/GW+4;W%D
M5,V=+[+E:D Y?3NE&U$Y"I>VK[,@/.:.'\:3=D")QF'Y#\O?=^$N]<I('KFU
M'<AT*Q &4>#<B5S/5$DC*4T$)AOL<X)=UXPG%XF/M*)UV5FH)"#J:VPS7H&P
ME5[R:<@P#^OZD@$$R89P12O!..9#QH9[A#Z(R[ H4R+A#50L=+4S=A<6K069
MUR6,7+G4Q-Q/TFJ$B/-)F"IV-M\R[0[K>%C'G[&.F>0/>RE5\=*N96I>;REC
MD8\3N-=^R^8*H9+(?#1SN(O'D$4N-7P5U7EI&9^*7W[\$!M"95T__RB==8BE
MU!O1<?$.&SB/'XX.[G'2G0Z!H>=B6/;^ -K=/:V57T554>3,XFJIWJ1_!QT)
MY)/P"U?K:5DG)B/B1;@REZ^01Q)C1TM$:S'%E:6#X\*3B!X] S\'=:FC>\=Q
M=/?H[A&Y+?"'8ZZ*-?FEU_2X9(E1*9T+[V,U-(E<7[O#=0[[YQ$MTU2B+I4I
MN3SU\?,/HW_=NMG>WI?T<_JO7TV.O*W,OL$O[.<?TG]]M1?1VD'W[AT^>G!K
M]] 7;AGZ*1HEXP]G)4HR(8"P*']$VL_:2 >6C0T]8+S8]+1RJF\H?;0@5F!P
M>,XL\05&IW&TE^ZSCP0V%WUSJ8:V2+Y)O([;0Y*:'*N*J;<VEO:.THPQ]T'+
M(,0;LW0D".1@3AQ*>W?Y"8;,8][=Z6^.X09JM#PN4%[5W$)7TT= F5+42UJN
MJ]"VJZWM3*YE^VT-^KQ[E_;9CK3#9L6-.AECN4_X#N!&>A^K943R0\EYDF9*
MD<QG>QU8Z;UDBLV=9^FY>W)*IXS:QN#[TDMN/9S=G>#I4#9P9CRJ*\K<61ZL
MX+$P[52%A,B,C4%V.8,-R'?N/D+Z*?Q_G!&\H!6CHV70]XABGB0\4;C]+($E
MX"[^0*Y]C'%I;N!"X)^36JL V?? G9H8IB7MCU[)=;^7/#@^.-X[V]\[WK=J
M-;Z[S[IB- 2_O5]#"8O5L=TF]-;IVO>/GY"Z69.=):%X66<!G^,"IJ>,FG"D
M\N7 BCAWZBM#YAFX[[B1S8E?T"X:A?S0M>!B'>@27P0M#N,G^:&L@D_B-^56
M) +K8)3^P.@Y/H,+3Z+WR:+(QO\A,?=)=#))YM%IF9S!0QG_A_MQ)-L,NVV6
MFFGTPOJ.;QB*(60ZBM)0D 4#R?;2C_N2EI9T-#?;5=Y3_0T>Q<'IN*CK@W<%
M>+)%=)+7*6<U7LZIA,+#/D$N$KC\\9-'#UG'8$X56,:0.8&W%0@._W50=MO@
MPZ0*$*Q.&-OAMW!RW7(GJ667?6<IVL2Y'?RJ+5V=Y#YYE2(?Z!DFW5<?P<C"
MY?H.2:< ?E--E<RUS]NRK <:DJ-0(<FR>+BN*RRM&^F(_VIK:AN[,VX<];(:
MWG$]EY,TUY;BJ_ P%UBU0Z_+63II,E(&(?C[1*51LE2KR^1^B?RWM^57R\&N
MK#=S[,'2LZ59P(_Q>*^M\*X 0H1DU7I1WI#9SP6WP@CDO$2'9?4->Q)>FT"[
M;N ?/Q_GS%*PQ[H[S*WGMCV[](OV*^N:+>\.S9;7VVSY:&BV_++-EE]APPS'
M[.7GXK4=L-\=(CHO-CNJ6(U(CG3N2<)L$>8;53( )8/IJ(Q^;_X_>^_:W#:2
M)(I^9P3_ ]:G^USI!J0F*=F2VYZ.H"6Z6[NV[)7DF3/WRPF0A"1TDP ; &5K
M?_W-1U6A\" )2J0(D#41,R-+0"$K*S,KWQE.[A^MS_*^[(H^_SUR#.5OS>)+
MR>C*AHD-$R]6NY=A8TXI0AY6S7JIG)KKK5SV>>+8C<0C+*JI$I59.5D<% /.
M -N3+ =%JK5@$@DIT*>-9#"2P4B&YV5C+7G11TB97G2O D1JP)#GHX6"\;K)
MR)$%#'#AP[\&NM?L9:H?C6@PHL&(AI=0&O*A1FN%D<;E8'E*6-(J%Y5\4IUX
M<3ZHD4U&-AG9M,*$*M'R:3D6+1P3(5!@K0ZW,OMB&= HP<")(D DE]])^?KM
MOZS/CN]P18?U*:;$!1RIBPH8NUNP3!8K1P$WH'(]'F#CR"&EY8)E1W-QEY1C
MRA1464U%J6M%@<Y\QN]*)1__[R'P0JET7Y,FD4J32-L Z4B7RFFK?NI$3<]S
M(TD213'-]2=,Z$4,#O6LK6;"A-&.C'947^U(U1HM=[\OEX7!#0++Y6$LJXR5
MS:%8O_%D!($1!'46!$]HK;<H&RK=!?,9&5"&>PWW&N[=6.H%*-43K'*8E7NQ
M(7>EX5G#LW7FV2>IWDFR!=OE93,M"C,LTDD3RP&29%BLV6%G>-_PON%]_$_.
MCW^H'/=48GOKAF$R=UK>VC0>G>=+K\Z]KWU =-(7\S,*XR.I$LB%$8KE@$$T
MF(A!%>7J^_YO_W*PMXQQZV_8K7]QVVPD0RB*&@_:JO-],K;C$<QY3,SBL71"
M;4#37O1_6^  &#M#ZCQ [1RHR2(^02TL4%)PEL>,SEM#\6GV)R8U^*D1U!%[
M'%6L238GZKN^>^O%JI4$?SO[V?PTXT/KC^ [&$:AG6H.ENH+X?X0[71%";AH
MRT"-*(8I70S+S_Q!$$X";E9ARR H@RL*TTGM2KJPSNQ: *L5=2U(D<C,0'>J
M[\;<7@14YKY4,P)+QKZ17OP G3U\=J:J?=/"]X::63BFZ5(%J*AX?#KR3)][
M8N)!H3B)2<;%L)IM]:<QL10V?:$^//Z\--AT*Q0G$LFSD1FE;JPT8Z4]"<P^
M+?7;DN81,N5X2@80)DF(E/=L@YUWEMK]#AHOAF\-WZZ1;Y?D6!Z2Z-W*N=A%
MU@THT<7135#$T?3 J03%]LR2.0T1W?G9:*E-4\ENM9SY"+/C1^Q'$4D8!#_.
M"?31=L%N\TK5 "B7@V/NEJP]L&U&4_)#PYFE&]1F,L,DL:SL=)]=]\-2?=^F
M^9<X F#@1*J#O^B1-]":FR[S&=R_T,\XD"9L(LY[\X3%2&9J2-_&\6_T$^
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M Q:ME:62%:4TX6C%ON9WL/H[:^_#OK1GRPVJ20UC63JU>2U#;9;4A_4Y.YS
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M'B!418%T;HB6T<C11S%18H[>V,#6=JW2;2V<ER4= )VCTW0O2(%9<>#><#K
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M_S7-3E[>WR'1D(P=3&A*0X1^/$27#./A-LF^;=K+Q1Q57W4F%YJ@M5 1Q)$
MRVF"-H]]*+X7))=\)U*=(? +Q#U)K+(R/S<?9[' I7$4@J%PVIX;?\?QF'+D
MXJWCA18WYFPV'K"HXRGR4I=>MT(=*IA=HZ8P%EX -(V<!N$NN  T$961-X6"
M(OCNSQ46[*W4I05&-NX"DA L6P&.D1QYRXMJ3?@3"R#5CM^(D;E[66H?FL4_
M=Z(2$GQVW!-;_2\,\0HGQFWFP+MH0A$'J-$LA7)&UL]%BP7NTI8WY@K)TVPV
M9DI<SO;!IHVPDIIA+L2O:J>C=&Y*8)ME!5 N<J%:3FQ?**EGB<=#ZX+"9PE@
MB$D>DHU"D$=DB LC/69;23],.<VOWVRP_'6B9(P:K(2I>XQ?+URL-(L![ DD
M2A)G]$1Q9+/!^%ZH_RY<<%EMV$C2JNT%Y/*99C;3&.29DN(<-;1+8-3_UC6T
M&^?'P<?01?>1+C*,J[:*>[FXG>-)7%X#?\*%D+T.(MW+DAZD-DO$T[!(U6--
MW!/#U*CL>3&%J4_E #SMF]&AC?L>NCA7NB^'E$E1UY^.1FZL-QJ,Q"8I;P"-
M>($H8"D9P2J*75VY//2#YD)=J3@\>593@7B2O1W,L4UIR.+7O].-Z&LKD*M!
M)7E<4Y?9S)+(DZHR/W2U4>5Z$T^:])1%+OE3,HI9,MA/OP8.K7]E.H*2^7[O
MA4.!15N] 2CVW >5]"OS?FT>^XFW(5,%CI+G,?8QT+<%APJ&$-ZLZ&5V8I&5
M3*#1S)1DU*6XM_3")[PT_8*!=_KUR#<^SZ='-V$F^7WQ1[SQV!UB_VD:Q1<+
MFBFD1R]*?/>'^7FLS!X4BUB-260]PR+:#BGXE(X))Z9CPFH[)G1,QX1*=DRH
M$$O6="_O^[_]\>73>0_3L[Y\Q$2H\V\7-];U']TK2H7J6;W+LR_?KKJ_]\XQ
MLVI.[A;\];QWT[OZ?''9HR0HS.*Z^'AQED^QXA2MSS*=Z\.W:WCG^AH>^OSA
MXI(2M>QFX^+R[-.W<\R0PH=Z'S]B4IA(JM)3LNQ4BI6M$JPPE^H+O'JEDK1,
MSE0E]P)JZ)?O(M^4@T?G7J1&YL[S"1>I>L::J^)>N(2>Y\!&-AGOH"/;G/ ,
MYSGSB"D=@CJEXV1*#"]@/-(?EDQR5NT,8TXR=Q_)G)@XWM *IIS2I7T["1"H
M'L34+I%;;L9)/V(:[1T&MU[,:<@RCYM[>RV$*Z\\BZ'16B6K#):CCTXDR#AY
MHX^MO&<9=#GC*['G1&)CVJ"#E96Z/LNHT\];M^6R(QB&.EW,H0;I_A,#Q//D
ML,WZ?DWW<H/1QO(I,#@!P=;<X++GQ_ 9EP$Q^YWKX]='C^Q!(88B;S9PHC;I
MW>D'#YRQY1*3YU=3TB$#4L:YG.VE6ES=D+AG[EV'K&'!Q(++,OY.:Z7N3L&.
MAFDJMQ<X]@M?^8J:C2MW$H0Q][0<6A_ 4I].R&TE7#E&W:GB7GZ7(L=&A39I
M6 0JP\!UAU$F^RLKM3PLAH4;?R#29N/[F;S/?8L*KE%8.)7 ATV4T \Y<1Z)
MFD JQONL"F0_G[VDBP.#+'8YLH<PP,+40%]Z\=1>98X'R/>LOK6L!,]V.B%9
M[B7\@AFZ&KOTF5V^)^S"'D5*W7Y93:K(,[XTHQNQ7=6]O.__=O-'3Z@[!:5I
M*?_'>>_Z[.KB0^_<ZG[X\L\>^5DNO]S \S>]R_/$TW)S<?/M!OZ,CI&OGWKP
M([_Y51;#=3]]RJ]^U?O4O;FX_+W9$!5T1?X5=([@W]#[@RZ6[N6Y=7YQ_?4+
MU;[!TI>]?REW$+SW&5ZYOOER]E^'UH?>6??;-9:DG5_\\^+\&VST[.+J[-OG
MZYLN ?"Y^V]8Z^/'WI5M];IG?V#E'VR1'4U6O@K0TOXL5*QKW;<$._J]>Z4\
M0;(J[N+3Q<V_I0_IZMLG1.S%]=FWZVN%6($ ;?UF W>*O]3* _%;[%^Z+GAE
MGIO*DJM)/ *TI="([BWKT\7O?Y!+Z_K;V1^%6-" 3.-8?C=3'9DJ-L1G/GZY
MZEW\?FE<8)6ICDN5#3[C:C&E@2]Z9JE$ (/[%\2]]]N\W(/#%S. :GH6+U!3
MR7X5]T'U\7 *DZ[3S=-0K\?F#C0C,^LRT;H^:!,-$XV=?*-SJ_IT!\N<_)=K
M,5CVL^O&(B4(BR#9(+D7>0U"7=>E\17F(U"6BAJ 1[DCF<QA'":6C$ NY;'.
M-!GY?N^**4\IK&1282.10X-/I=%,6  -3.8YM3KI>E-1Y_"$I;7^*LIN3'NP
M4T:6 "1!O<1J*H5$_O)WD4;[250R%/N9%Z8.D65W:/U+(%%O)])L)!NE&@A<
M*SD__1A&P&28'2.2B.( Z_/]Z;B?[11(I#-@DY;G)&FHD%- ,E@#RSP]MX1?
MU(?#XJ>_^V[1V]E4,G@.U_E.K77B:!_^A*5<#SSN<S224"JFE,!/8TR<X4JE
M?@#V/Z<JL'6OLH(2]''1:KH[2W[[B>%>0!OSR'8/U*%[1 Y--TN:/+LI5\>^
M](KJ<(3(2X-[)W)E2;.UYU&;5$%[T;2/>XT] @Q]N6% MG?@PP>*(A649Y;!
MO VK>OL"]92CI!(098Z4I?7VD<O*WM,%\E%.C\&U"&SLDNIY*=BIU:0;80TR
M@^_^/?4> (TL.QT5$)D5<,E\G(XQ0DAQ:@W*9/?'9,2%Y-0']G:*7V$^VH[[
MZBDI5:<FI6JU*55')J7*I%1MK3HLLP'H*I:Z!R5Q9_);$[&K$ISMM/8,RN%?
ME *+TGTP"*9^3)G&@3^2J@)HEU.Z"W)*@C18;0ON2[C^HV"^LD*Z>^C.5#Z\
M^-#JIJ ;.X\%3]MT'0XY49TRD\742%IHZ(5P&6$C._VWL+SL+A(*%TC2,#9*
MCUSS?-7:(ZT-44-Q/[E)J3P4BY:PXLGQL6] <L=FJT,ID>,[" 923I0F5O@-
M*Z2$9#H4JC%'^.703(IG^VI&)H/*A4M:+%K6,.7/@5\8J,X/LHI]UI!.25=2
MZP.M'O4@HI[ &H-IPV;07+T'=!S "ROU$U@7NYQP-5I*7]041>LA()LI0X4\
MU+N<]JKGGG-W"U$&F%4MT]KA>(J0.H"Q.Y$D$+J$(PI V8@T*IP@Y?&T];,*
M22VS+TFTS]Z8T*0+]&?XK=2+':M(:Z2RCV)K.J'D6TN4"*":*W3\=%%UGL2>
MLBF 1+?963M=_HNS31E]==GI)X74R')!F'M]#"0"97]W & .0/+$ (:??LT:
M.77-Q'H UH-1"P:+;\!10-&G,U;F!!ESQ2*);P/@)33Z5._,5'I44I24QR=+
M?SJD'&:*+*DTN>LM@8IU?T)'HOPC3113#8 &^DG$H=*\Y2(JHT#I1X"F@Y*6
M2T:09 V9Q #/,#9M3!BO!$;1]_DO"S^;,Y]$1EVZ7VN)PA'XRG?W :^#6/1<
MXEK7(5:IL._) 5$,!Q3=<T,4V?J*7&!HUHZ=D;8!U:UF!KR<_43O -\'(3:)
MC1+_D_;! 1PZN1'T^AT<M"5O J2_9*(';"(QG(%[;[$!0Y3<V9Q"1]?@7 HX
ME"20OOLS#1"(PS!5(%?PXZ@\3/@UEP>E4[_FF^_;;'?6="]8G.G3N)ABC19G
MTB0*+3SA%[)^UA]4[.51=P$2%0OZ2+Z?R>3(YG#,]3$^)X]5.!:[TC,&<&3K
MV#"[4-PS*/U!.7'8(DA:CN1%JLSZ5?=@P4V VL)PF+1,*A"- ([H<)+N<(7L
MF0 2<0(/EN=[.''*XC)&'^=8S5S:FKVRU#^)B8,H@HN:]%QQ\\UW;'JQX?,-
MQ]E^IY;D3_.ZFSC<INE.%LPO"N7(O&J9DYA)9LZV6$])IXP_/VE],A!=B^\D
M"5'_$]$)<$Q>BT5=HD@9YT>Q:)D+Y?-6P (YE(02F@U!F587;7G4<G0H59.6
M?(QB!';E 5IAQ2]XLQ7A3/.1VR#D,TE+\2@02'>I'9S[0^1)PGWZZ#KLDX>]
M>*CF"\4/G@-\B0AE?L7!*!!M8C^Z_7"*P]].;*O3ZG14?F:SH1%&JE-,8 78
M[Q0;X 6A/"  Y@"!@5=]#TT&7%/VKL,.>B)T**8V8&<"4-G$%,T<KB5F064,
M8T(MJ(&I!]A'(I4"YP<W[0NI%2&.\@2T(@1:Q!3U!%/V4;V]Z+G/&D\#[:2X
M*-NQ(6/HEY<;Z/5@]Y::)Y%\$HCRGFL*XW0#.DOUGZ/<9=D@0>\RQZ2N24=J
M*^>)SRVG&J5%4D8"9)RJI9>3W)^18 )A"V!$.PR,3]5@A+D_G4B>4LY#-YZ&
M/B.5.;=4I=MV$'5]E3IIY5#J5!DSQVARFR:V DVNN.%15*2)9W4VD@F)B$C;
MW"SON-I-Y_U#ZQJD7[.1E@=Y54D$,8:SG71W(6N"*!GL0J?LK":=8Q>,Z"&[
MP#GRA7"6$3I<DJN<H>+;& .CL%FV*%BVFDYO5J\3SH8+0'B*BF!LA*S5"A<5
M"&?J@^<W!00Q[ ^\R0CUUG-5ZZPI1J2SD[=7<^VEW.B)VA2J3L=Y(I">=-5#
M-:FL5I?@,/'!RCR;OZ<>W(9NKLV>YO Y;#92Y=ZBPYX8;,T#M8K0E*<N\JD@
MH:+F$,5B\@' Y,Z\WO1KLMG(AR'VD K8EXY%/__CAL$^KFMGJ"(/,ZUL%SFN
M2*^Y#8.QJG-"LI"5K"1X:84\-.GY!XD?BVM1E_)F+<Z8$P,K9B;-23?O=@C1
M;;H0L P,[3>5Q87351-G:8H>F-M!KLK0%9*Q'-61\#@& ?IJS+=T% QS4E/E
MD8E1]M0QF8TSI%S@H?2([AFV,\&9S!^1;5Y3X00A/R(%>4;&Z#'>1*?/V W(
MVF)N.+ #4/B=(YOUCIV_7)5;H*H5LPER4MN/V 300^:1!\='UJA<IMF0EH-L
MP#J%"Q'-YAEYNY0VD/]HWJ+'\YF$G%.=&2V-@H:1]2B:J"GO,Y[ '*P5?G>N
MW!=W T#"7?+1(R&-;TOS,"6$(\>JVUQCSWX!06X8F1\XTT@T6N7SLIPIW/,4
M]9*9(;#RP23P_#@'L$0KR=,\7H<>9MU$]VK6?>9V"+WH+Y1]9(%FUTX? ,<C
M63 +%2&:$)KB^QR2*8$802I,OM;:W"TX()6//>\043%!,L]&6.8(!4 _=0?4
MRV>Y/:50?"0)E/&Y6'@7NXX:ZI B#OHV)Q+1Y4VAO]E48LS##9N'G":F52);
MBPJ1C7VX:6I+:=<\6B(KU N2^X+T/6(K60JRB\1)W@32C,V%?9=XE()F@;%F
MSZ[ME'*<;O*23GPIACWG($Q,!<J=3*2:IY?4)\T !%8PF8/@XN"D$)+Y+@&V
M[+Q;H&#@!.,?"#%>E][$@S,^E%RB-QK &P]%X"/EYHBYND+GR*;GH&-R1)+R
M=AKR_87674B;<G[ >_AM)"?,7F(VY?H3-/9174I^3P$%@D_.)J:4113_=$?$
M+(A%_A5B1.MHJV&RH'?"GFKBSLN(+Z::W^+SP]#Y[N]OLVA?4"[PUI0+K+9<
MX-B4"]2^7&"%8THV)PU8T/.=*\6BL#J=).6=C:1#JTMQ*+8T*&_/B8KDJK#%
M!W 54NMNY>XJ]'#I=Z]4HWF>B ?<,P([*C=M@[X@1_/!O74[]8<R]"6\7$X6
MU*1\=E87';I# %UXQ=UZ(ZVA-]C$(28_6X.1XXU)8Q ?5;V,Y%4L+CQ9_"@,
MG:%^D6_S15)]Q?E]_[?<( 33_\#T/ZC+6;Q,FTNP9T)G@&U=N,EBN5K_(%^]
M?#NG[63:N32[9P)Y)6<T34BZ(=#'YT]&?F;#!&QJ5M Q0;J4,_$>KO])3*ZB
MIJ%9+,O(BI/#86%2;#9.^N34X;E]>;3))1C&L546FY[XKH;):X"+@\RWXQ/1
ML 4]ZR1P 'QN-$<Z2J1'AYJ-):>Q^,-E/OB4)&L9=." E7*<2A>[LM[)<-4\
MRKJ35==6J-<AZ4"BB$;&4%545I5G8,5$ALCHI/($5HI)N8:D !:N'D0D9(F
M,))*?Q=&.9<\:4NABKD=(K2^5[-(F5YRNI&YM#=-<=UF(RMF,]=1N2%?09AE
M28L*F-D9*TPL,:%*Y#2KB8_A'+5.."!_W0YL%U-..5<+^UATKTOYK:><,+JO
M!][-N=@(4@1KGFOFE72I%'N\%$+%E[.^CWA([R_Y]BH/XNV;D[?)292"9Y4
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M_:59?^K2.TVY4V>Z75^)]K?A\A\HU_YW:8"9:E_X($0;X-5#+ES1Z^Y?_$3
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MIU)U^SP-)_>/UIGC/P98X/OWU!,AKK,@G!QB%>TY\.EW3-#1&I79BD&_WCO
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M&US?86PDH>Y\&I(6\I^.CU,2Z+CDR 2:EF!K/;%Q-+QJ/4^)C&=LJU'Z[*<
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M1&?8=B=H;^4'Z^T"UBI);X9C=X)C*XDY0WL[07M&R=LNHC-L6\%\Y4T3?.4
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M8)!BW;S<,UX7)""\GA)C#H5$S#L21B9Z0G 4.[UCH# <>MY;N8Z]>T+)CB^
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M$8<IG .8;_DXFK*0"^(X0@KF?U$S(=H0*@(#!,<_YY_ETS@J[DAJ;2C[6[^
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M!A.OGP5@]T;A7WXURY$'>LLEIH"#Z7'P14V'?O6KS8<[H_B!KZ5'SE@$E:"
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M7__3W_6I^"LZL76D3IH_5X?\F'(_:7;/HE6DNR#_3F7;R$@VIA)8 Q+&%8?
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M=G:HXVMXR,<2(671-[WBFL!P0]&"V@%R@I.F+Y7)1($5HF&9B5)#.H11-,C
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M!+? =X[TRFT4"%-H*^'W+AT@?L&!T^%;2]"J+X$\O#M8! OW&_-7C(8=<-4
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M>4 5,OT#=:\X'*CD\O2X&2A60,&?277Y:K7Y9?")ZQ /RY*I"6IG:-X3A=?
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MI:V]]NNLFR-0A?:!JN2-X%L8?M?-B2I5>1\'^3^FJ]QG/[WI6V;+YF!I55N
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MK\#W3.6 528#PR-MZ#**E&/%!>?=0T=%CHWV"E"SHF%509JYSA98Z83<./A
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M,M:'6$H031_".F92RVM5=  5(L^X@%[-MN5%(_C]^CDNV+85>;VNQ5FO3VR
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M[! !) + >$G3[S&]47+@JM;X(J*O(KBC 72W30GQ2_2%?HR*-LI@'X+W,13
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MC3\MZZCO:&#05#$R"#(%_ESX/E6Z^C=:KRJF#-R1&?+*3LIAUPRDO3VI,6\
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M'=X:UM*RP&WDX7>6AQ_,B>*2PE+@0A-LTD8H?E>AR%K* K2+X<?E/>-\8CS
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M0&Z/K)G"%X8O*NY/G.A?<OM@()#&K3CM)C;3LEI LDQ7% /N).^*Q!VP)VQ
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MO,MCW1RK6SO6.R0L?9 Z2K>-RF$C!7=AK-KWJ-BP'YSD=6ZBR$RTQW/10S.
MVRI 4.(=@15^;''<9# ,R\D6H)"IR9.R 4H3UT:2K-NU&,($ '10R"$!A<ZL
MI@SC:JG-(*NYB>K?0RO[-U?^KJYQ5A3T0@$8OE(=O'HRVH^L;K_X]-+PFVG0
M:S:AL0/&B-Y7GRK@J,,3TWY?L6-V!X\?[$5(M&NJ^;5_*HQP638SC@?40>?
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M3TWQ8-B0SUK,;>I'L?LK5 ++/<$YKO-*]@J.TD[RXD+@^592==@P1;!.XL+
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M[0R!"Z>W_$X76D>)6M!E>TKVE/5'V8NQ^R</XN/2Z8@&B[ 3F5 J\R_*QA?
M2B/#EZVPQX\<.#=?>30\=:)=T=\B%*+]9WM;@VU[8E_^?/AKNE8J2A==F*%@
M':VKX<$W0NA4<%\V$VX68/Y"[ZQR+T&@B@=2NVU_P2K;IS-4)W#/117I2'%3
ME'^15('LLFWXXT&4E1VU%&AJ9X9*X$]&1'IX[NVU]SI?O:%YN8!ALI/\<9I/
M3$1QJ1V;SFUE$\+?TE6'(LJ,B_Z+]1X>ZV?D]\&>8^LAR4K</+OB/;.$KZ^%
M08W $++ MM<+QRW]X8Q.#YNBM:G.T$NEVXP_T7\ZPDVM7[0^M DH$CG:SFV$
M FB&!(L-B3F?FWS$80.D !>FK#D!(SKM0IQ),H,0MT^]%6&SDC8J0RIII.D!
MM:;11F96&82V9F%@"C/.%VA2.E$44F]\%65RTF1(.QIO/5_8U"-/2B^=GQAZ
M$@!/("+D8NGW@L=!#3 3+&(VR&VI-S" UF?H))$S(;GILK"1H[,%WI38@>,J
M:T;DT_/W1LU0 \6H?:,AT9*,<_IKGC%.1(U8="X(2>P>RS[7]+A)9M/$D8NC
M@QL":<W(>-F:+1@_+ "[PE\Y[U8Q,0:_G3/;>=#T>L*16QB@9[3LJ$O#R>*Z
M'Q=8T&-AER..>[+H3).XP& A:A:O'\<ZV&LXS:M1 D@LK,68D^U2+*\'N BS
MC'J$I7Y=5L&VHJTYF"W]%^"J2?&[J< [Q>M )OA%G;O.<_+N3(7XU1ES3(=0
MS_E<;3BH0%"M<YI4C;BBG1[-HLGR:00:%\Z.3A<-N[)?.,S!& -H/ V(P')S
M#_,-=L6)FY:UP )DN,F%U #)Y>3N:!>@%%C!BW"Z.\F1H*\+THJMVL 10,(!
M)A5#.CA?1U[?-='%K0VFR@?'Z!EV$^ 6K/!!'&Z<P B"+0? $0>DQG8^_:/6
MSM-/M"/B6.K*V;;P $QO86GJAA%,M/M*"ZX<Y+J^6K= 5I<WN&M./ IQQNTR
MA6^/*LC&.3=JMS4"GRK?,AT]?H'-79Q[:>(Z(4/'^"RO\S?PK'%>39U'$,9=
MVVVF;4=HE(_"@QJ*59<N6G\]^[WE N%^6 %?5*G^=%.I?LV5ZON;2O6[4ZF^
M<3.N4M-^C;.X4F M)!T+S/5^KV6OL_ /G!1;2,'E8-!>$I57[0!K')8#>TBY
M3;C.X3)G'KN!]!#GRK-*$(,D0I_RDPIS4I+*DAI5Q(J+>94-Q2WHU%+.8N.8
M,SPT@ 0V56U6F/MQXV=+_UI"1\96Q2M'L,X"9Y],C4D>@B!+J&#4BD,'"T/6
M2FS\<)9 3 3$+:"ZC0U]".\>H^G.+?\(QLL1_&4^9>@_.F385IF?+7;1<C\M
M@X8Q3<M,/HSA>!0[&]YA\59O62WIUPN*9^AMC2(^^+"W. _+$@YDTI5"=88P
MF(P+=3$(A>WOPI2/._>U;'=;D@D:D=.7+7QYN6>;.2,IQ!68!/TC4<.M\SMH
MJ^-P'5@+9[98,1DUF@_ +EI4=CSF#"9!ZYGJ:LGSN(Y 2R)2'P+SMQ!G3GQ!
M=]X1<KM09]Y%TQ8.FQRKY2?GM.SP6#1F8+EJ KBP2[AG_=Y6"Z2,9V ]A-H[
MMQ.S39\K>VH>S\C>'BD&7;"1IT7@%R]:OWFMI*8<)5%18$N;[%KF)G)U@S\O
MY2AKPR=;IR^K/RF:A!4@? YPRP7V2M9 1R[0=CAE/L>6\DK@>1J=='X 4)X@
M[7,DR#PH:B2J%C*1 9BE)$5TR6A9_#L=:D8;=ULEGIN-KSXKN 7 E9LHOX%=
M(BUC'S,(QXK0J=9B6/)<EV!0L>H+&-AS"P?\MBS,8DU<9XFL!0/E%;_0NE-?
MK#^X"/WNG(MG]2BD+I4S<70@:2#.-?3']V-EJ._'R=7%A&.:,;%IH27)(,VA
M-,"$%$6P2O3;^CH1AZ(MKBSY26=\H>COE.TKY'H4HT.>TH:@IC*.L \IHM[S
M2#AQ%MJZ^O;6X$75W#?I18&(CKO?)72TA$<>(+)LU===I0];%$'(AJ]&NCR2
M$5Q* <PSPI7M,'HY"S-'VFEB3J#2AVI<>",N$*RJ0-;-+DKW*&<"-U\%M2OV
M$3K2?J\]U,5!E0(3,C"GV63\E4/T1I[LH W,J=%YB07%.?/XF_,8Q_!?S>AD
M*DP10#LM(4X5=VA4@F\X)\M[W*9F%-32L<8FH[D#MA'FGBMV[!Z4A.3F9<FI
M60<T[*H[7;84A2&"%59IS+_[B;0O[L@H,MDX.ROUM\V<L\A:MS?)/YG)Q4Z7
M@FYMDBKHY#+Z6;K,UN6(OT2E18#2JUZ@(BA(:ON,>)"@CH129[9:L/]"<NRV
M5;L@4G\83;:8\1,5I>45?#^5 :-E) 7)X'D9&!Z+BB_:R"3:QP$B[R.#LZT!
MXX6$(]!]KS/CZ+FEVCG'E:%A*6S_HNSC.@]"BDJB9642(GM8Q?\&IY&6UT>^
M OG_ZUV$RS1'?8'CH!SEG9Z#/UFRI4.&OJ;ED,JP=G5-^E@KQ3B;.2FSL/'*
MKXW;QJ!\3P3WK)R+4V^7)^@;[BC#<WC3'1TD6-+ 1$I#;4J7:6J- NE<#;BM
MPCGU>[;X;7N!H=96,+LNWMHB;^=U&UQ/]4  31?*<9OMI5^'#AV@*0OO):7M
M9HC3TA?O:"TGUKK%!+%0RA0<Q^#E7!TS".I5-Z4=MV4N OO0(=^3[R#>V>K]
MU@4EEQ+O2A@8I?Z^H7CO#+E*C=PR07\=,:&K2G:@"EPF)G1ER?[DL9?L49WI
MXD"+D5@>*\I65VB!Y/J40 LM[JO50?)EV@!5T]>O#A;1'M=I@W;GV)74P9()
MAP$MV7ZW,<)='G_+KC6[ OY8!07K&+MF<82&C4]*,"-?WJ-NX6!%\(2''>!-
M=@3ZU4/2VLKP@4M[+EQ(8%AQ%3U'L,DCDFHJ/JCRDATPAY&_6!LX2GEGQ,DN
M7+_GVPNJT+WI7,"DM7Y=&8POG!="7VLG=C]4ZWTR$W[S'8-2<1W)!XW4\?XO
M7O=!6 D'8>/I&<+V[SA?V*KFK\-2<A['%"<^"XN\7>F] ,6BB;<+$[EEF\3(
MS>T*:6D%$"$:-O-UUWU&T/]R$]M$Q7>[IUM?A9*Q7+*T60B+@6AA4(F^B!/D
MV!;"C>=%<4::M4 "ZA,T:8Z9R)/^[ML =L,> !5%O(LD[ K?HL:]6I], -/4
MKN7WO0 !#V?HT&;)D]T'(^E&9D.4V<"4E4(-#5?P^4 K^C0J-:0;.&!VI 9-
MKF%X-%@$,*<]EW=T/;R]9-)\Q2TB86)=WJ'T*&';5;^W]UB>3L8L5\OI6RPG
M17&Q MXDJ[3!H=6<G^KO@JK<Q8[ZL-36HU*U7P(#)"@RCA/@;7J3@"NW"Q1:
M+?$J5%OQ-5<+,J3AEB5KS:;U+1_%'&1L%'H,=A%P65$@IUMGCNTMDD_W0Q7<
M)[46DB2096*98+Y&@ZSKJ]IHE$BC.-CL+]0HRC81PPNV)8NF:,1*;0KZV;B9
M)%O.%X3?U+AL3#[EGCW=%T[WN'YA&I*C@A$YSVO%HAK)=GF*%E;GU;"9VGIR
M^1$-VON&3?&I*,\9K1/ &"$8C]5R>T\?19UN5G)E\T;6TR?DZQAY+PBRB"O&
M[^#"\,_)A<F0KG?BRZW)DD5,N3#>9",93&7(Q^)G<.]&"U<P6ZI*'-!H\N4X
MH[?O#)/@N![4T^2K0$_[O6M#/4V^#HQF27G#U=%HVO415P*CH;V]1M33JX+9
M+(*>:I3UFE!/DZ\'/66%=QVHI\G7@9ZV FDK4$_Q0][E%X _C1%/DZ\&/&V-
MXPL13Y,O!3P-T]XL4O*Z'=)E=26N\E),))R3$J4BZW;H]@E2?%<+L'W%'%D
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MP=S?W=U+$'::X#\?D\6(O^X]?_Y(_@I@QCJ""J4[2!\_3^-CY6>#5X?K]>>
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M>-XFP6L2:LN8YRE$MJT%Q':4CX6K $!2I,:!VL24P[Q(\GN!*&[J-HNI&E(
MEFJ<'./D4<#6Q7# MC9'L(]GM I2)>3.KEVQ.EJR7&FS1::OQOY5"A*'GNUW
M3IF:>(R.(2UXH_ V30'1+-1I&9]#@:Y20IJK\%BW)8FKZR'K8II,2/ H'=G'
M9DR/"J)WKNSG("S[<1DW/@'R2SK@?P!VG Z(I!^Q;B[C)EQ/_5X<&'QOBJ*^
MF)QER(?:(.2;%P=<:*B1:\X)%O/*T!X5IF'(2Q\(_T[10'+Y[I]?>S/!"&U>
M6FQ<VL0C;F<\8LF&76]8(EE6^IDQ15$A$0< <-/-%VIQ7_[PAE,9$^>4:_9
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M"][@$4'KCM%[YLH8$_@$)[:@H1KDKOTXBD'.W)99PU;4R@0[&G[JJX5FVH=
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M!2VX2EXU %Y)CM#L5W^?$,3>?0] W%S%[6ML.CI-*\,%R6?("Y-(8$T]-+/
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M RS$,V5.>N/JLJTF2FWY<ZD5Z1-7?3[XR_W:RWO XS;$V*:Z<N,QW>D9?E0
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M/_PS^R&.B\:%-=D/B"[X,C$.2"$A."9-+OB#H/*S(F3M$.OD0%M8$V8&+)I
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M%WX$$YW$3X@F.0ZLH10).V]R+[?QJ#[C!B43*=LH.G[:%=D63=LOF2BW")R
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MPG.>I^?9-'F;+LM\\B?H-#J/60L%F>V#K@<TR/^F:WA:+K07B9U5.L*.\5)
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M &6S[BO*@?"K$FAWN2@CR%6>H>COW-&/-"':N47*:H2MD1&\D(*5+OG,D#9
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MJR[9C'7WG'-JZ]^/Q<5GN#2XU3-[2-0J<NP%/V;>\>N3X!EX;O6V7I-%Y;*
MG#)%,[@HNN+5A2^C3;2LEF>;,"(SDRV,E-YO\;(,UC/3D()DPW*9YG=)J2+/
M2N"I<@U[1*JG^$/[/<^@MKU%+]"F\*5 4VE:&.2R%7C+<#(B&E/4]J3*SDK:
MRUK ^,W*T)=@()#>BW49N.WP9KDZ24QL16U1>CU&^R<U$_TK/:;': !1.>M)
M[H3(S?/!XETVH![V3@_IG0SXW8>@Y7V8PQ</O'X9CK6G&^#B-0,7CS; Q;L"
M7+R32N6:X26**,DF9$/D><;A??$0HEKAZX>;W(%5OE%HTS7OXC^S'W[.RS$<
MYQ<:Q3_VU#9L5N]_OV9N6W_XSX+ENNT;_J6PQQZY,.00=<F:T-K<TJ/)^C9S
M&S=D1[3!XW[R #:S>D B'NM?"RG194PE)7[!VGC.*@E9F7TO3&TVIEE6U4W@
M#K*BJTY(PZ*-7#=;@CS%BO&4J+A$H1LB'I:.LK!S7&S#!(K3JF4&=*9)6EGX
M,<ZFT%/9J<EZW>FU5,;3R#?<91RQG7.'9N2!0)J37\(^)\^Z9I3!?8:\WXXC
MQ.YXYQS-U+UFT?!)3]\49!0%GR.ON(F;D^"'RTZ4Q"?,^_=5GD,8 !X;P]9\
M1'#@L/1"%$I9?^GXM;X-H_C'/5'MP=*-+=N^Y?O)4^L8OI<:R']CTS0R@S_^
M!0,&\]_,T U&\B</^.!H^?YS[P09[7=FX$\??_?TND9^PX/5.+P,$+=26^OU
MTTT[C.+IL/=T:X3R+LGA1O0^+'I(Y."BTQ18LI&\.["9]T+R?#+5)X*BG"H'
M)7ZNR&*J]<_)<TGQ;G3C7=CT>R&A'BA PKB1NCNPD7=-Z@#?6).Z*U ON\-2
MJ)'UFW/I[R@_U:>$*#Y?+Y++(@D603-L6F-=Y!>(*&2%5>M"5+C+H 4%A+-E
MO8U"H/;F )H @ID;:N*XYN**F%A@-@JDZ;Y7K07'?& 0U$0"3K<*NTLGN=:%
M87N+H8*3%J7./H0W6X^+3!2X%Z(M\6!&@8?+@Q5L2-J]K2SRB/2M/Q*INU08
MNYOZH1ACT:4S EXBHS6K>WO$[%.,.])'U9X1[(H(TT!(?[2^%EAP1A3'85-[
MC<%&8ACF@ZA1K>[:=3>#N'6G[4NJE,/K#7IRH[WM+4\!YC$V)9?CH8>"@6VE
M)E=AN9? L6)*]5X]PA!^)\#]&7TDT.O1%;C&SR-9=U16KILQH*VVMVZ2*> ^
MK?V-9R=X-ZPN%I<.'35#L6HUC$$G+RE$YS)%\'!PUFRM$BLN3E>4NF#^M5C*
M"$]JI384"+LT-6BBVZ\'$8S*W]/S-,M]SUGAC\P$TWO%E_0%Z=3]N^4R)\RT
M1)WT *<D:H%#HZ=>P3$75"&3:!AY8/]3:4?\SM/HB@7063 H*(\#EZ5A/KTF
M$Y+7:+A Z ,RB;)QU)"@_:\D&ML"$->EY" ZP[@? GJ?#ML?#DAYKF(3HZ]?
M_3)\_7D<+-UG;54(KOD#*.0NX\5XM40G<LOV@?Q9+\WMK7E;3?..G7I)J=]N
M\@*6_/L4](P!47TI3-J?P@^,5-KM#"4@+YSD(+L7]W .-<WIM$Q7'P']'ZH8
MOJ(<@+:L5P\@NR$-SWB< P4"K184#E8'!(Y?;BEG]9*AA*Q3(&"5#=+2C4WW
M:+."4U-Q-P2PM,C771UJU9)0JH:V2=P\?+:*RM.JK'ZGU9CH,U4W;LDBL: U
M/!,G"=RE_+$1NC$&6E+ N*ME::52IOAE\,)%7'=$*[16:NB\Y')WI$/U'"+J
M:SLKBRH9]:9\3]H4CJ)N'*WCO*732/)Z,HM(</2)62W >L%80!^'>HJ1[X)#
MW@HH<]C7$2!'&/](^2N$MMN%HJ"ZH5\J/DUK4ON8\E$R+?G>*;2E)[.'6^%)
M>D:GTR?XY0!CG![/@L^?:15K[[#RCJP7*$FQ&"BT>$*;2^'6S85C+*()(FGJ
MUBB99%U6H\3^-0M,+"MR]I1%KL:9]*W,[/#A4)23C)42-+,$%3YT KA\PZJ
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M-#X2PF2D&5M@8/VK0B=??)IMUT"SIF]$2 .?4;M)VO"!<!:>[!54:X$)LO]
M6TL:I3%TA4>N<:E=_AS\1==[P^M]JV;R.TZJ'+HA41^MM2&LL_<D,@\>[SU,
MINDJIC?M<59K6)7<HJ4!5*L2LCR#+ ."P3$1;718K"*?P^2FRV\MA*9=7O&
M?Y5J]<*=E4V6&I6W]--R@M7LI"37_!)&XTADI"S8R]G>@E@7W'>8M((@\*S;
M)#U\^!"R,HN'K;/3:%(ZF]&A@W\]LNX]K"PYBZR<IZH*S5W2[/':F];0IK \
MQ3^+EX%7:.!J,>)S64$F3![GG/:1M;/@#T.1U_<FX>@:0KFYI,NB\#/#W-%*
MM)IR9,US4G>J^<'VN=8B=U@(#:-K9 3H30F-4W.#2TG1(4_?6>"HTQ*)+W?Q
M[(.3.W.+%O:8=:P]&RAJBW#XT#(>I5TB:-(@'Z6[:)%.0Y4YXYQ:V/ *FRY'
M$2A8G&-/7*D!ZLNGO[9_,B@.16YO\43"B'U?;6LXRVF\Y9+^+&'03QR"%*FO
M[9Y'J@^(AU\SI>:6C,*_2#P!:-!%T9Y@BZQIG%]=Q4543HE74V[J(6$+P<4;
MT+T#7]]<++=J)J=DRG4%-FXKS\&U;N(L*E:0]LA2J$ ?L\C]$)-"VCFI3K6.
M6$!RK9'&=N==9=$QDD_#K]_(.X.)K)%"?_S3'&4,C"=(E<.697"!ILGU56-E
M5!0#G*+!DJ.DS?+2]W+*Y546Z,3DVB7'.D<AV,DWE=%N^\"GOEOI).AJP\DY
MX^4,,P3I_MJR=K*7M5[P^@1<]']_R =]?9V\L9H+MRM)SC?[>QAH3@>;9"*;
MQ4]ZM/ZD,!Y[U!DPG):=B)[&#2CB]SP*[U&ZU_A=1Q\QZOA5VUO1$S>:Y%;-
MA $_7,)N-U0DL.O.&5MVS'NFIS-@HJ>XAODAP'D%=PY66RN=);6?=:AVFG9M
M&=8IE>/;/ZH,"B5:]H[U4JT\!9V2GEN>CW>8\!=OAJ@K"&A-W"4S>N #.@S;
M6XSW[@V7_OK0EX;U7Y6NO<,Z-]'PJ]4H=MX2-;"Z]AD FW[96%<!H,O)A:(L
M=KQ9CCX<Y)OO+--LJLSS%2GT4JP/7V>V-N7[(*[W[."1.1C.%NH=1-*PCW2C
MN4SL:[;(%(M5QK_BC-<">A:0+<3(T=QBUC7=1$3@D$"FP2(FYKY^'(<-G2R*
MK  V^,%3\SU144%^#GD8#W"2')V,_?6_K54DVJ6IS[_N.KF-V/V'==-!O4M%
M7+9 "0C)4-ZO0HTDJ)N&9$>Q-ELRLKGHO>T2_1\J^!R%R<A0/:IWW 6$$CF6
MK+_B1]+GI!Y%O5@:985(XVK$6)"L:=GA)S57HUV@/"*TNI0"64V[0R73:R=Y
MFBU&Y',M^'I*)]H=N1*7CZ<V\>QW4T>?KQ"XA.5,5\*,OIHN!)"J\^!C6=%R
M35?XG81=$E? )[,U_%=;R$,[7^(L*Q]Y^3JYO7D.8/697J4V7AG\0,!7@:4D
M27S5NH+>/G%6A!16 N=?OF%_NRC;?,J_'W/4$ME\BZ7V/ P?=8KB->E8>G<$
MF8"J\4$#"W(/E$/O#@"&@5L;%L#M+18K(&V@H@Y5#1FWB>"5/T+HM BZ7[29
MY^MA"IE*YT]ZC]82EQBZ[VM=2BG9Z. U^K*+-<;FD.WMZ*KGR%U_O!O5>:MF
M\N7F,%C![L^*:M!P+"^C'R"+FIPT;O Z@N2E5O2^,R9K4BOVR??.3(^C%5DI
MYHB>JJY'NQM$EJMH;6A\EOFP)8-#@TI;BW=Q%'L]NZ%VC\6V^H"7$.#R'?ZL
M>-,0]])XF92$Q E#88 44%JL+;2A&VE-S\@TN4-JAWLX83VDME1T\[H2*,HD
M+TF+5G2].JXK* 9Z2=_E-@SWYT0C17RP=[ W$,#OI_3[[,(I">Z4A=? ZT.Y
M3&F>E3P#M\;._M-NXA"2-1#;M50>6D^"FOB3!T=^)0+/T1#EOA*@ZD<-7/.S
M:P^Z:JXT41K"Z63NIBTIC/W=P\</TH=7?<5"@%-73ZIL#(,B9'HYBBY7;11&
MEU.W7#)8+?=Q:D/?]KT1O_!79F%EN3'A_A+)G-:XUJ!@/-G:J-,2*V8#Q-@O
MWWI+D?/F]-?NZ.#CUFY[Z_+%ZZ<@HK7K+=N#[*$L9W_]UEGF!B<NV]29_8=7
M7-;G04;O7G,B/?E+U%Z*/_ZK/>V9M],><./<&2G^D$8?6K&'P"]\9$K,O><4
MZI7BY*<1FF'9!FYOF?1?D?:1E)&K5?*&=DQA"<%\M -I?4J#J-;KPA)#E_A&
MMD(S35F%C*3UM*R72!*- 5S(G,]9F914[BR5Z#_ZF.><=94D,TKRF)C E^8H
M('\DX ;9RT5*]W2E\PWIU+I=T$6P"C4Z7,!;:8$I1] $PJ]Z8NF!KI 2':)1
MHE^9:-,:7<XI7+YL_=Q@IJ4VS&LTA@?(!6YB# D\/\_YIKIZM[G\H(Y>[0M\
MN'%?EB,7CD)U!M+X@=$R94R)@5G7:()K?HM\F>.&-/_WJ_#7;^$+0VA;+N,1
M]BJ937@C<,M8Z-3*RL/$1-JR"A=+5GVF?O%WTD2Y5O^"CM4/!S3.;_&/-V$W
M:DE]JT#4VE+QG]D/EF0#[19I_9=D&VA^]^7O;UZ0M5!.WLW+')V+/7CQU3(K
M]  QSOET4B[)'3@I)KOA,^=H?.PN&!ZEU%T_2N_<HLS+LQ5]?$H+4*TTF[<K
MB,<[M=R?4T9N7R,8 ;GZ=@#'7*#Q//AD-P-AO=W[]]'D9)\%B1N7Z-K9[T&S
M.GQ^L3UIT$*K$D)]R=6D@@,T+TZLA@O2(*@1 394:G(:EZ-U?<MT)@"!:M%G
M% <<Z!OJNSN4.Y-J17>5]$;W2%'[Q[-RYYG\/7G][.VWOY\>''S[W:,G3PZ3
MG>0U1R^WMWY"NHY6<^_@V[VGWQ[L'1T\9**C3K/P3HWO^L.SXC/(SA=#;&_:
M0'0&O+=[[4&0ZR/+O<YQO:[+*N,0WFWE7/X:=N%95<Z+$"W B*:WG(#]:]B6
M7]MENSD87W)<IVDU*;-IN5%07W9<S[-T3,[B1 9SP7&YN:/E*\XV^_(%QW7B
M*XED.,LV7Y0%PF.S;%SQL;G-_12^ABWZ#1'V24E>D6U2W;BT*><.S++HOO+@
MM^/37Q[><+L!BRK<R<3;H,_RH<K\_4UE_C57YC_>5.;?PLK\9.]VA\FN>X3_
M'/_P,JW>H8S# L_)35"Q?W6K&G6Z'H[>WU17ZUNYTH.--#YGPH$1WV<2A1UW
M]B/3_?"%Z343Y2(:RYQ.4M:KI$V)*\ZXYH\)V^G @++ (ZR4\3.M\8I>I7\$
MN5* 1^?%\G3)%&/.Z80KJ-*$*0DXGUBU7"?B&8KHH8MRZL"[>,HD2(LTSX&K
M%1K]:6^>T5LJYUGW)2T;X\$>:&+KS?]*%\OOGUO)F#!$<?B;JT^7TAB 5HRV
M,3/XPCD] 86^DW29-:! 91@J<RDI!3>CBVD>,P>\JP>9Y Q<2+F8)9"\,3\5
MKW*^&LFFC'3=)24<)H546U*3^ !$EC)#XLZ\!)Y8)X(IEVTUT?+9"[K^=ER-
MFR6KY\C"*HB,*Z8'BJAYG9 -SL8MIP64AM)="[_^%S\@]^RH^\/E6Z777,(]
MT1+WK)A4C)%DD#?]_Z)5L'"E94Z'N_M_QR>_.7ST9/> #I-4ZZ&'.V<U"H .
MN$7WBDZ2\GL)!R-)Q@Q>/8JYRPL@/MQBR2 Q+96DJ4[=(IL 9R;CF'HQ]8VR
M!8Y2MPM0=B^=_#9C7-H!G^%X/G3BTWSUI_/SQ9OQA8/=IW_7!E%D@O)8=SG9
MO2^I[ONPX_='=LUD$')G@0W/M,4'JHAF*$\H8NH_X:_P!;UDPBF' UT)%P"=
MU>T8'4UBN6CFN\DOY07]IB(-+9>BO'&AW+(JC-M;>"F^@NE597&FM#2!+B!?
M21MHKD[MG(36ZJ'HZ/EF7VU1N-S0D@;*[5Y4'3:+E-:+SE%J/>;PD+$#E@F=
M4)Q'NJ5<LZ%S69;+-D^-Q[^EZ[C,ZX8OG*2O&.X+K]Y?'K9XBBS</0]]3>#%
M^[U60SE;G"5U-<%CJD6]<_1_]O8/=_^U//L;V4+-__Z;=TOG#KGM?R2'CY[N
M[C_"P-1E//SN:/<[>E3R[:VVI#=CNQ7"_AE6+PI,O&ESMV/!B3ANH[)[\ C1
MH_4@&I_(@0A:_.YX<1 6T?^.PR*=U]^Z=;O>2[L?0[VY[6;;:0,4_&PB\:'(
M],$F,GW-D>GO-I'I363ZBX^P&T-]W8VF;8*H7\([Q8VC-*;D/65HA!('0 9;
MJ?C.$-JHQ8CD$71AGRTX:QQ4]9RBJ+8I%]9%+?4!C44VG>;<)Q"-#-&X>N$J
M?I+_QF[RD@OWNP.0(O=TN33W$]4='$85*@)I4-JCZ^>Z+9352F\E&;L?)%@<
MD#RIE>;CG(,R".Y,M8C#/%(F?-.RE739>[\\A&M3-\'$VS43 SU/<MI_%22K
M8>8XRSQ%:&\MK!"':"9MQ4VY)%2SF_PQ1P@'95M)7C))!A-)&+X\:Y2P2,6"
MZZC;8BJU0M);HKS8869*;B293>1IW'^))M6B U);P9[$4%TQ[<0FLXG;$9(W
MWV,67!L0;'T<K<>".3(XR%]6M9:G<?R2WLV1%%8$6=2_ET-&G50"<V9.,XRE
MM@A5GBVXP"I*@/CZ1NXN9PTD,!U?5(GP/P_I#/'7PG?$8-P4FM5E1=U63,E9
M5F=TZ"5JKQLF[>_L2/);*I<MQFU5.U^(9JV<Y(D<7-)>>9;4R5 *A\]KYPG\
MB_D;H\;&W%8"68?NSMR'HW!_#O7+\IP%F#;N(JVFHSA) (-U M8RM+^F*Z>7
M'3C</9"LP/[N(7K,7)T42&B 4WF"T> PE[7$3KEML\]*1I>05R;&>B(1^X-K
MB]AO I;7&; \NBI@>?3=T^5[[Z$\VCM8ON=8Y;BZ@8CEE]G*#WGHAQL/_9H]
M]"<;#WWCH7_Q$9*'_JJM$ H-#OAU/OQ$,2.OU2+\QU"9Y5?C_:\;2'T3ZDL5
M0?X!;UQ\G'RE75X_4"^[UAQM8&='$5^")S*YA"R[V](6W2JS]S%_B?)\"+FG
M0U>Y'A]';*!Q!VF?6>Z5TD9=K.O!!H+* ZJ8"P3]9^0&X!'IDL,*F%#:&9%G
MWZC<+&>ZDWFO"2>0 +T6L;V^=IV&X)VVF.R2P'N\&2*)VR*%-Y)/LCO[(RS/
MF[8R'PU9F7KW/3XX@I%I-N?^HT.U,F^+8KPCU]D_LQ^._P=ZB'7(<=N4V6+1
M%BYY+@6D]>XFX/PY'?6P ]M;6L-;"U5.+7S'XZI,I_#3VR64LO_,(/L6P+TA
M^#PNT",[3W2'E8#)R7-GRA;+<*-RNF)="MYR,G?<^Q2!H%&2!OGP+V8&QH][
M$8UWD?X+/*2(6-7) Y*^;->QB$D <.Z8.NA=-BW<BI9IG(.KK!K1=0CHUO96
MWA9GM?97>)<5#X'F2IF7:^U9Z52Z6O$'1D @,O!P9*1BW'K!&0;V7.-H]4/@
M;<]<S;^J5W7C%MJT)JOKUG5?M+TUSDN T6CI"V6FE\^-DD5;3[!H;H4-EX0!
MO?(\K=%XHM)G/^30?2J=='L=KYF>GJT!#K<\V4L:<I.$"GE])Y2',ER00-$U
MC!J.*95SKDJ&0Y.E$U\G3J/-FXPV.<&@M?2OFKMVD398*]J6>:6T<[[F7UBF
MBEF>+A;"5SPN+USN)7<W5BA!4KDQ"+ASD6'(:#$X]#3-TK,"P6$&6_/?.91L
M#,E,R"_/,.I;[B"WB33>JIF<-'23U G.SR)M @#X>('@<-JY8]YH RZ[:\BH
MK<N)]KHR5/[Q\9OGQQZ3+WJMEM X_>^CT%7$WE"K_2P13\X#0"FM2:*'E3"S
M*B<72,R^>?+8(Y]3CFD:V4S%<J>-C,CL+TH2VP:1^J@M!=HR"Z94VAL"\^F/
MMY9!!,\A/4^S7'JWV/<DN#ZD:*V3#+HS -M)QY*;U3?93N<,2I[%EN^WT^.3
MYZ=^_1!KU>L%M'KH=95RV<%;MNZC8<@1S!9 H8I[4Z\62[+]:N[? G6Q$![W
M:>FY_CNG-!SDK#@O<ZA3E';(8EU+AN .A */-J' :PX%/MV$ F]E*'!S27Z\
ME2^Q'[XITV1./BRI41\Y.8N:V*;6Q/9[4MT9#9#OFTX?VIB:&7='*ST;I\RY
M 0.=Y#5K6M+Q)XTV9KD0 Y'^VBB-+1N8^Z.]O3V?V)44.FF=.9N=R0DK]).3
M\&3\3+=@7(,F5.;2%;0JZL@:K5*TP.5!7. "QWTK113<"L2/A(V%-\^.GY\<
M YN"9K\G$@$*LZ)%\J.<ES57WG&RDH?L>7.U:11SS',3&=H@G[QG0 K?A>7"
MT3D!P0+*"Q6:0W?U'\[L<3$[+&('CV?LL,X<G=,M<DQ\RH/RZ7UN<"S7N%C[
MF +K"7R1@0$)X#>S-A<[FM\,:CE>MV# TVV-VA7<]^N6@84--996)V?DDAB6
M8ED":I&A,E%,(18W4B0D0;(F#!-0S,]830!6?&W-S'W&6(V@9V<]0//7#P?Z
M6*A_K_1NI6<F!0J[ *$:F -/.A/H!A>K<2 \1T?92>O;?T7Q31X+"7*\H(OT
M/2WIGS* 4- 8C075I.NCOB>FR.T?=N=)_*ZIFY12W/L/Z=: M <J&ME%W]Y2
MU^ ? ]S@;P,W.&NBGRN2/=^E1;_HE^B.K=3]N>M^+(%6NGK[S%GYY:UW5-9W
MU+L5B(D,^D=P,@R"QHX+<&I18(OK!K@OCKQ[-_GE+3-6#[J'TXH<N@(W[%NQ
M^>+T3%GXH(2/R7" /^& 4/B"4Z>H<PV@O*\A.[^.1R.!JMU+9CTT3%%\I %U
M7*3CQN54R--KA%7T.IW3"*N9;P>EP^8PE787*D)Y<!;W094/R_#F9;4H&:7V
MNF,A#(^7$:2:^^+65%S+'N62_',GJ/!$Q2/=6UE3Q7ZCX$M77%],-Q*YGBCL
MQ-5)KNB\G*P:!"7%/$%3;ED9K#TB7K,L9R9SQJYIE8H$Y3QO.SU[$S^Z53,)
MP5!O;6@T5,XJ;R)L1P"RTYRY[L.A,)DR*;PHJWS*A!(LYIR/2P[^SA%4LO0D
M?XE'_EXP4/NTD6[C%=KU /[LJMIX_/T0]A_M'.S1^<'$&&&:9^^<M+DH)Y-6
M3B09E87@L;5',OW,1D[(N_H@KY\+X^/P%F86]IV#HNK][2T] 57&UEDY=G76
M(43F7W<?* T1!G2'1WM/73"H>4HUG1.W)'TB?85_>=O32S[&V]D3V%SHDF0Q
M6P_\:T0'63N/>F&Z5-0:>Q^!C0)?-6UC\<..DDSR<I+&#@/W5;9#39[0NQ%W
M8N(M9I>C$Y*TUB15^=YB6(<L$[)K>,'>[B/^#7[FS3!=-JCML"L&?L[09H><
M(!*/C6JY53-AF@R#IH= +7QF'&R)4=8F><@-Y>E$.RLQF$$I7\AW*ED<WY.M
M&O$*6$LP,T'B1F!39#:XN5<Z8?#V-",G%9SF6:TM1][+T\W/T3_#/Y,6Z$$?
M7#5" W&0!< ' EP$]"LH (@ECAV2/$V&?K^BX_!X?G7-I#H6Y65-M$N:T=J[
MK2W=2*D]6'%P/2B964VIM!\+.AER*M34VSFE0\'N-?WN%YT#.Z*D8\T$?'OZ
MB]F Z/?&?5W$#JCG<*?;)9;BX#L^G2$(@ _05RWO":55BJ>+TWRT?\G'Y>W^
M6P".H*':Q9I++7%M35<Q 02O@FVU3WB=%+XQTDB(('K?RLPD&900&F1'NK:W
M<I=.-?7+TQFWI+@+44W")4$/0;>Z4"&@]\ [S@]W,3PD:64U9JO;U7%6<()>
M.Z7/3?KY7*[TN;BHD\&S>@*6)7K@F)3KGV4N=Z]F+)#3143)-Y3AK?"1@4Z"
M(#DNY.;2:\7+'<?-)#I1I33L5'(O&=F^)%&>SNGX)*2- ,0"G\? 94+OF8%=
M0QY(WQH%0>%,DILU]&T4=F 5N55A;Y,&#Z2-UNX?7C U::;A[M>KDM[+P3G]
M%*XA38996(OE+-Y.-%2M:E=(;;7O$L8&L]^HHG?1[3]B-/_!7N=$"#8KS6D=
MBK27R**ATSD^TY:$"Q*2O&_"RZ4\LQ[GUFDHU@Y\B7*P"6H(/0L_4L&:H6#J
MV1/[!)] >Y*1@3<F2^*+@;YNY:W[5V=REQ?OF.X3IET#S1FNHL)=D! +%]HH
M2LBNXRUZ(NV=[' <0HT:>MA8S0R]I'O.OGE\>+"]9;EI33%K2SJIKE%B(J'?
M,J7U[/CG-R%9.TN.=A^3:<K(&K2.E*-[\&C3J_=V"9SE<Y#9L$KAG)N5_TN;
M^=%O0]096*TNN#6^BU]+UH,_]KJ3 :E'7=1KG/JIG%I632DM>@<B\!PH.? )
M'"8;1$<FC;Q;52!WEC44L()O ;#0_$?T)AC.:Y&Z"/]CS^^>,[8 AK[9B1YQ
MCW!0=*%M($#*;HFVZ"XTCLSYJL(ZS]'!SY:4;D(=\ZSOY>T<P49MYNSWD\^F
M"9>/6(:>(65K,7;B[&+!!_2*8K+BS)&P>B%;%'1*N?3=WV59OJ5_#:\,3WWF
M+FA(A3N3NSJVFA!R[ 8>FGD'K3Z .='W7W<>9*-5_L-*[$YEOO3LE>I^.L?X
M%=)C-":[DFALU<J$J)^8F\R92(]I S2$)!775CRM7>3AB$H_3M92)$1(3C+[
MW51I6#F,WOVBQF[B"'E;MSQ"J?5V#+<D;35EIJ#*,<(H$!;L)L\UT-74>K+I
ME?-L>5F_,-]+#D8S_-B,&VHGQZ]/XN/K]6>_F"#29^8R1^=A=J5ZZIZ3.VN5
MW2WK]3:E)W^73L0WE%R\MGW>@.R'9Z+;)_";P=Q?2 ^)Q1(C\(MV,:;;%_DF
M4KAI*1&3#@0S N(+1#KV7<'#K'1H[/^?.U1P"60AY^ 9^A%'F3H R*] B5L&
M8_=TUUID2P2>)Q>BWCU3:(_!/H#$3#A]2B\CCZF8%JZ&^T0S].!70X;XEN4(
M2DG42*,7_ILAXX+((1(CFGWH?*7[-M_9F_&U*.'B)447R)#DH5FNR'DZ<QSU
M>$>/V@%X;>E*NK'H7?H$#J'TTA^:]CG:V]D'O E ISV9/?(3M$DCO>L*S!+L
ML0B^&F>.P;)P_]JNCLB9I)O*=VJN$WYMA7O/V[Y7P?J-)<<FKC?XI&QS=,9&
M01U]D-:L[B4JMK>^V=_]SB.4<761/W@8;U-,DBQ\#G ^X5AB,1[O/O[[*/@&
M^4I>AZWYYF#WD7\R>1?TX"><LNJ@?M(X#H?W X],TL_T?VWMIW3!<\%XZ!QS
M'FG&E1_+>2I<,(C;T E/)58JAH,:QP*"-K,FL,1@ OM[RC2A<O]3BSQ_2E;)
M[TP@B)7XKON13G+OGH!]/H0[?K3!'5\O[OAH;X,[_@IPQ_?)SCFUG(L%Y''%
MR9WM<G?.5D%LPW Y"*BK]#YLTHH\/%R/OF3+0*\2ZS!E3Y<=0S(L;6+)\J&W
M\*4>7H-(AW]3DG(F!MF!'>12(Y=,$I0Z(7_="=R4+FGZLR0<JG2)^UA=NFX\
M:8+\)KTWJYL4MQ>^*$^,LS4_9N"2E18F7$H3,,P1[KIMM"#>^A*$3B$HADGS
MBW151X5!5K/DUXA3L,E9B1)"./'((:^T6\$]D+W[<XJ^WN"N/]VG:@,++9T/
MO2QS5-M%CTTOB[<DRA%W9<C%O^XRX#V,^SZV',%>S-Z;G:0G2CF<Z V1];/*
MYE2MXT D_VLJYIZ8B;=_V!\=='F#:N[MK;<5"1TDKTE>I%E.]\A7C_'VP_X,
M$7>_#TW8AYGL@Z ?-0.Q7@S#K *5^Q>?PE1K_)/H,6NADK,J90S4U 5LLG[-
MT,R:8*$+O>+2644@##X?* ;<L0%?+##I6HI(SF@Y=":[R?&$9-" 5Y$/^9MK
M$'Y@!?:*OW(Z3Q$"EQ!.7*[O@PP>+9UFK%FYP'=@?'$@Y^T:*G0RKTK2J/:]
M"(FCF$^)ZF]O&68F"E8HG:==#1+OD)"% ,41)5FG)T90GL/[!WL'^R.9U<$1
M3RH@U&JNXLJ :1F8U.[VUMI2RKJ]KDI4#+/J%2+5<++Y[;;6HSZ"Y5"C/C0?
M)^1#TW3563T!N47K#70Y<"<[=<H5 NOCO'/'\(YJCRM F$+7,:!7O%*0*UJ*
M]JQ\G0EI8<GKSS'JR.N>3O6%!ILD=30(/8OL-0'=<4V'^2WT?:8=2L[2K!A%
MIVJZJO-LF:'162J@-S@<$Y#T5AS!Q<K23ZL(7L@ <UA'A<+GT"M*D2&"0#FG
MXRW!8$^LHM4E@':&.I0U!'8M ,"TF4>*,UI>.K<T6H%_G:RM*1T9:#-E;.'!
M<1] '"CRU4JMN+,I;0[09QKV[7='LL62! 1.Q=J)[M86KWDLGV+X!ZM ; HV
M!@;E/* YZ;WA#=X722=9GDGAQUJE%E\K9>X4M(N;>\*%$8K@#:^A59)7TY5W
MA>>5>H;OL-ZUPIPO<<,NTXN[R:_<M/6R+@1R@MW[95[R+3X([ZRO5KVB<4-\
M YK'@S6Y\4[V[];5WR=S0\&OKS YBE&ZP8?XTZ2FX7*HDQNYD@++W:3%CV7.
M#4?O>I[]3OH0U]\^ZB/]N]<5UT]L;_V*QK@WEUN_Q6O_62X0O\[<@#A*;9\Q
M95(RSI@BM$S&Z3ASH3B"'+B*? 0PL262P4@.OZ/C[MZQH4&7CEH"B;XAD1<@
M]AKJ4>EC9,=#M?![K+@.ACS) 9>!=3Y NG\)Y3-2CQ"Q'I2U<,\"+G.H?32)
M!KSV=F;8\,Y08#KH5,AN;XF9I)84GF.Q:;&LH/'8*:N4?&R0\HG;(G3>+@GZ
M.I!!M5=D\FDM.H[.8_$?=1M\1MX[.O^]*WY<-Z__Q*>V>Q\GO\COHHYR5[NH
M(:IGZYXU*P9&X$MK>7YO34[(PP*_GAQ@*6:1SN&/K#D.QM9=C<H75VHY(SV;
M*0:3P# 8.8L"BGC&&3S99"WJ1P22*TW8:N%6!I)$CN8ZLL+*WON3RBJQN&XP
MFW%:H4K9H+<%.]C;?RH#8\_7=P#J/ZOC<\*?[CJJ*"(<""7\ 8A$\HM(\*NH
M>8>,659)3E3TPO$*"(26,7[2IEWX%CNOE.*.WC">_/T#8 1[D1PX7M0WKUXR
M*0OW'Y(\/%0?9KF]=8[$\C19*Z+\9G\WD*=)W^9]B>K4';IAZ!8-DGQS$'6:
M9LS!X9X1E1AD@3M0& 3^0"#PAWMD9G5/>A3,L6K9VAJ:,.(8KAQ'1FH) \O7
M.&/CR"!K8#NE<.\& T21X6:55Q,N&8O[WN!4>*?3RD!5VB!W75WJ55V^BL0D
MUV8XW,/%ND1U94&P%=+C*:;?(9=6I HST.90$[7'-P[:QD&[Z7R1D,G*XSL2
M2X=5NX%&":1!]ZCK%:V,^4?O'WLKE%R-/"[.QB*E!Z52=^NM$-(P*_1O,A-E
M(_Z?:=A  I!2Y,SYND$DW"ET&AA(P)'P,=)U!T<[1T_(B43^ -QA) @7>+H4
M3I) 33G"RP]A]%VXO,R[5_P>2Y_63.+&!+*E], !/GPE&70"9XQ9CR/C+ZAP
MT T;.:;,B;'M1:K$"#4M8IH5@CGL2AY7_PKM!-T2  6 '$TO/S]]&@W@#M(E
M*2NG5T1!%-]GKYZ[?.EEOS, /)<?6EF@\4*!A>@*)M9,0+$.FOG1U13X3\<K
M?81<=GR/\DW#X0%&079+5KM[CV$)G9RWJ<7\YVMSX^S?!V=?&>6?>TKYDX ,
M]32_1KSKB?H@!+^B))A_\U4QSM\$\O]3]+S? W:4+:O(#M]T>PM^<'*>5;1[
M1;H AO;XS>G.L_+_V3GHYC!8%R( ",K*MA'2]ZP2.'R]*J85IT+*B@QH>=[!
MR+L&XH!YO'OT*9^JR319Z9])+@.PX\%J,7:,6GI4,A8KLH'A1#JQ%SH@E!B
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MZ.S!VY:3FQ6*RP)',W0F$X?0@I/#5Y5V-BSUJ2EG#@Z':0_QUERV%-R=J9P
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M8F7QW,>UHBF9$8<O;S*[-Q.G_VX3I[_F./W!)DY_*^/TMS(R?)/!^!<ML#=
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M'8(K8D>F3?^0$GC$@'LQ -:D9Y53H*>2[OM O^*X?1AX70UK<D"#!1*)69.
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MN!:P?Y8N,^ /I/ZVQ][3UHJ96*'_AU1%M^=._K&LW$[H3S&ZHM'FSQ*.E$'
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M)[E+*V/MCB 4_#<-+!MX:;U91Y1P9W)CSUK%Q]8C=^!/HIE#%LF+=Q^WMUX
M\\Q"(>3-B(%%B8\8\30PC(%HJ(^JI$4A%UH<T0= !*'S6271%MQW,W1QDQQS
M-S,AV)->S)^A-FI#ZVBO3")8"%^O8D\@_0^?V,:@0KX;:():4]\VG,KIPGUO
M* 0-2TH^*$:T")Y,XJ;G&9D\'D_%:K9NS\[0&2M-X%&RSXAF*&2 X OL\->&
M72 A*6/SX7N?5;%=P.IQ5Y.4?>1)Q3$ C=CRXE7.Q,M/]_+IL4$DX\RS.E!S
M1ZD;GEC(0J+5UV3>5NZ>Z?T/@.$?[6W \-<,AG^T </?:C#\]9[#6W"IWQGW
M'BUBPO5GB2:.R" 91UJ;$=5M(87S=&<LT#[:1XCYW@VISF69%4W=SXCW>ZS
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MRM9 &\Y2W2F%\M 7N5NAHX#Y-U8!*XS$U__YU_C85DRJGU=6V4[WO5TU[GB
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M%FVC3.(S04B%F*4DVV<A[6->?BDO8CAZW0.-@/YT\A9R_]%FV5^3H*P\=EE
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M=!6GF'RJ?NT,;1C.(N-D";FD-T0FDMDS"[$X+E7>U:@/\3J9AFSVPM\M#V2
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M$S>@;D21B+G<$,65C/S JA LB9*+S0HW]PL-OH8H@\?M6)A08BD'ITVY<+?
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M0G9+2:M_YZNN5Y;L_@E\G=?]62A97)S \7?2!%OBLSO1J;[A(#_$P^I5)T!
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MT*U-VUQ$H-D(0M3=)+HE#IDUWF:KXKCN0-=N;^:R$EFVQ87>D-MB 1^O6L'
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M8)A8:G]WQ^>7SPR_$01,3G!9ZV7Y[9?!O W:7H.K8NO$ 1KJ\*W3E-$6#2-
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M%+' M"GT(#%*TI+7(+?J D$9U5)_.3AX%4N:;'H >+V[DWK6.^:)WQ#9.AZ
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MD86$D9]$51;I?'W^SCZXY2[]CY#^6[J#\NJ7?M6;IK@8QF<1*/32DH-:<4B
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MK4.WO6MF-%A?]D9K%UBFNT\E,@6B<'^!%1$/.F0*[U;RUF$*PGS5G5#I[D\
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M++B MQZTD:^+K-'EFT;DXZ*X3A#!>5P'<4F#C]*$%%OT<2=I 6<["^8KU9[
M6#,P$R@R1/4FZEUY$-/0&#@JYEXN8'U1$>$/JC4PVU.@LI-7^TT*A#0N,[I7
MH2B"*,Z]3(SA+Z#3]T!,(&2\__J_9X-^_X6G(D?>:V6=1#\K2@W*$.86>N,H
M :('FH/Y!86,.09$-TCOM]S.;F>A)1+>A[C$'XDX%S?P:GDS(@R'IE_FYB4_
MPM_Y3(R*,G^"(.2 *^DDB6Q ]=ZJU Y+^3_/GGEO(A&'/WD?@ROQ @;XJQ3
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MMS,4<00_S97_\3I2^PHG'Z%J;K:Y>8U$WADSK2%ZSDF;SP*FKY2/5A!A4;P
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M(<@."7:F/IE7)K>!@1;LKRVS6O5F,V:O=N#!1*;&RT\(+R:5@QAQ,^:70H*
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M4_-&505?*M%%;OCF\SH]Y4%GL"0)^$Y)9)/HBC".Z)TL<UF@Z0!=AB&U6"I
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M=C:=SLI"UYC#3@JJ<@6BK-8]P+KEZX>E:?M<9(*JR%&;MD33/5Y4N[\(+,"
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M-F:<@NW'X2C.@:^0\LS'SNH$/0;Z1#SWK3 G"Q"*BV/@/ FF1@6H>L! $Z&
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M3L1(<\9'Q&\E\N(XBK'^@\O9J #W]06B,.+<JILQDILA:#-\O3Q[=5X>%67
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M]RXCKQ<::*KA@!8#EHTA2O9SR=X2&*:T@JR5X*K:PDK"NMR[;6*YFR?!M0_
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MF.\ 3',"? *K>G[%:-F[=Q^QM4 <W*!O8<K<2%>5,E*E+MI#Y4O/ZV(B8J*
MX#H8C2*8)TSN?O?CUK-$=K16%>!1./\6""\$@5:N$_\NT5(U/JR<X4H93Y4K
M$G5(!-MF'@M$0ZREVVGD+142PNM\'@93[S(+KH!N1W^;Y[TW6E-N?IRYD7[S
M,GHD+KT6YH=5M7JBU==5,<*:IR\!8.^X*!OA)-DB7]*:HS<?4S"%(JP=QL/^
MB.#!89G)A E7FOGT/+)A31\QPUU7Y*^*9N:OJ "338P>;L)W36?4\!FI9+Z0
MN4C(2)Q(XW.*RK5L^8/%XS9PMG)N2\BC2CV!"5/P:YHG&I2A].@@P!(IC3@3
MA,"G,#[2*T]%-8_C"1$6GWH[TW'U]3(P/TK+C/'%T=<BLX/,,-P,:?DR:-*+
M5G%]UHR$B)-6:X8AQ36!Y 8C"5LVBK)1.<6Z 5:$J%4=B*^;B2#/"!X,34HL
M%);2>B2$V*B,@ZQY,^5YRIS8?*4-E\!Y./%J.Q:<.-%-X6$#Y)PG-\NPBO6G
M[;IYS=S$5"K:E8GURL5[K[M2N+BTP/$[*BVTRAA7?T%#P>-WJE#1%#G>>\(/
MONU%V-)9/C\Y?;ZN:3ZPDD*L&R=7Y8WZ]ML^&[SZ=4^#;M<IC52+!U5V@$IA
M6T*A+27)ED[KL?5D1RR//ZU-9%@ZX9,5)H7KJF"P*R@;IHJV\AO3KQ@!DW2E
MHN-AVS8MQ\/:>"J.A\EH.'4AJ5>$4.ZY<;HE*2+#"2O2'XH9%IQ@#+^2#B^M
M2=O2C:H.\<QR,N(TY-@RV[T./635\N#03<.H$=P-V(II.7;9QE-Q[)*14CCS
MRS9$;]']')%MQ;0<1VKCJ>PL1\(>##@W@R'$<>C@.HABW3MD+!WC>5IF(Z%Z
M"R&B+OJ)@5N%)5FNF<YV>($^-4>$VS MQ[':>"H[R[&"1'*L/!=YKB"Q="1Q
MB?:$AB,&2BG!FM*T,#'>8F(5J'G)_?ACF'>9:."X293):"E/@ZL65.Y9;BK%
M>\T$+3$TUQ<X/#I#;,*[8X?/MJ+4]W%0HNN18NRG287[*DI=3-*\UKA($U64
M,!BR2MM/9%=[56.Q)&V!0T\:;AD1/?@M2Y)2;00G7^7)UB>N@?BI%OTJ34-O
MC!F1KN:\]6NJ)1)22DES<G)(-&+UU$A0'>-6<L"O1KEJHJ)ZYU$2#/K4*CW*
M;LFZJ:3 -].OYH"^SESTK10<G$S=QY976S5CGURJ,J4$>YD(H_L 8WUM#-<!
MT[HJB2I>FM5BNW@1,Q'D:0*L%K$ARCCDIM.8YL,E.5?T%NHKG#(BQ,-6T#P]
M/6WC'3F/8UG%6V/&H<"&<4-50L)%5)6:M@KMTX6PZ+Z)P%4?O.494]V.S$+:
MX^NF<\SN<>N:\MSVN5@=E I>AQ1"H84,<QLFE4=]PQ-5::=2GJBA#'<CUPE/
M-"F4.;7]<U?AZ?)9+U6U>O\$86E?FM;@'S18Q2>!4+EXHA>8:TZUN"Z?]>D(
MK'9FDJN\_L(=HZG'K,Y4K"2N6T5;.O\?12='OPB?!$_9]/+H,]8#%4S7._*.
MHQ@E*9)&3BS!H)M04B9-AIPYY@M=6GWY^J+GO0QR[JEI99#JGE&SB!^FC$WY
M&D1>3A#%@H0LU\21?)[!4F&S \DHJ6&:*NO+-/6J99((3U+I=5)C$_-3J*>,
MG8Y )I&X%DK]!A9IH6'+ON+R$8DA+:3=!\^%"JP])7ST1^)RW+MBG<#T-#IC
MM:;9]">OG,%&CH)<++E==S49.75-1M;<9&3@FHRTNLG(P][0QQ5RC\I?$"Z-
MWA.%__QN&O[OP>#L.Z5V7'SX[>/YI[>7']YW.Q_>>)>?/US\^]</[UZ]_G0I
M!9[WZ>TOOWZ^?#Q M=:?[#-"IZ(U5&^W_8'BJ@>K>?X>P#<A^W@VHYOG=D=N
M?VDCDTH5,6-F@EP6=L\R4UN<P-PJ^@U[Q>R*6HT?2BZW#'0&LM,,*FD<W)@N
MHL$<B^C?YG& E4'X>CL.C][B["I(8,U-([P"&_ &.SUZKR($)D%F#EJ-3%Z2
M_4;A=PVKEDNB0G'SK?WNRC)IDP)R5$B8NM"\$7:LN,'N<];<%)R\A3;PGQ*>
M#R-I&LL"S.I/\,"*J"@EX%>8CDK9$+.2< H/H=+&A5!\,&:OR34TG/,\LFYG
M*D!-A;>54ZXZ0C$1\T-!GJ=@PO C06[I;#WO/&^F@&5;Y'OSM,S4IE<+NA J
M!LNNE0E^A0AMLBNI.D/<N'I>[:M?+M[1Q&X$;C_[5G.!GC4/9#N!(S/"&8&&
MA?:N+&Q*G515CAOR4B\HBF DU>4[L,AP'O^(?CY/$O'%>XF 9J8!R"U34R=2
MK=SM=C[CVR04FNR#"-3.2]49R<N(S9!X<WN"*G7?=H@22N))/0R#(])IG$SX
MYL")::^I.FL"D6$4)%!5\,+0MN+%AIAJS6PXH\#"2L'?*# EZ?6[23F*EY U
MFEDOZG;8BU7Q[.%=PHO** TY<<1,H581+#/,GT$7J3%ZI>93/VQ?"[E KC'E
M01"@AE@!&J5@>=.$"6,XGE?02-$SAZ:\_9D]=IC2V.)+E!<\*6(::BU?R9#J
MJ"D6B,Z0,G"Y[9'59GTE  /*S5V=G1%^?Y6?];P_A%=BX3^P= 9>"^YF<+?R
MWHA]%WB2( KFLN6(ID6+0K0C6;4+1[<+D0:?A4K-H\;7UJJ9^N8F+B=&)0*?
MB;S6L[VQZ;EC>YO$]K[[^0UI-BF%>0THJKHG$V[=3F1*'(Y3$8(8!E# ITKD
M:H!!@X3ZF?&=:(QS^%L-@W>CV_FHQJ*K(J$4MY]^MJ46F2FU(1'I;F?:O6_.
MZM>DYN,Z>O[#FL,7I/GBBJ6PJ=CZWY9H),]?+X[V[-OW8+#6+5@AY6N=!&#.
M\:$='Z;C??U('S1[#VXFONF?WQU^Q:5_\!T!IOV!_08!F](\\5?*GEYH']"R
M9,<'S]Y[HU0BGN+M8%@UPZ!F"-@:;).!?P^]4:;R-1ON^B5[%FZY_;D4V0K<
MV/\ZDYR&YXDTO.,E/6)>@>/=Y<'HK8G/4I?C9RA]X1B3]"8+9BU-BGUP\OVL
M029NL5DML+-LD20MMUC5$Z:].4L\9?; "[2BOOCMOX+I[,6Y!MHF$.VJK[.!
M6BZT!8VA:6P4\4F =2Q"';NNC6%?!?TP3PA&4&]?D@*[;6QNW7 N:[QN+;Y=
MCY[WWWK-X7V)U<E:%IV7Q23-* )!W80?7WEHRXZUO43DP<5.W8BR$F<'Q]Q^
M 'L&!(9BC,M]))O+R& )M93C%GJ8PFCP0KX_Z,$8?=,VP/=DXKKLFF"]259@
M-+ZN$II!\=._?7XS[7ZM!0+:PT6W16FI[[^F#4NSB'+OEY<?C_C "&==9<P>
M'1A*^[#8%LL0$SPO:0F)S2D!3TV^+:96IP0L]L/FJ"A.^-+*=- 7]+IG;M]E
MO2F=4Q%V@MFLHB)4W"5&7TBP]$&(Z8Q!QC-5V5T.3:S4BH!1"H5VK\##>93\
M24U]2OB64GM#&HR;R\F0:KVFW%0[&.7 "?JUT\"O?-K:@J@WK[PO >RELJ86
MJ[/@,.>J V)0_3E^I,I*V%7!O@Z>2*7OBJ3.?=7'B:+GJQ%5 SW5%VAW-6PL
ME%2 >W/=-HO#ZNS#P.[.<U\V0JPV4,E+0;,24WH_O\\WZ?*X? SX#:GK".8)
M!)C<EJ=QJ7PWLB^-#UI2-C?N3W79*').#ADJ2).Y\?6.PMB24G4*PVQW KJ:
M*Y#G]";14S,>'OS!PMP?KCRY$K=MBK.L$*!Y\+#B72GP9RX%?LTI\(<N!;Y=
M*? ;<4^W)OS?4KUYJ1WR4;EE+%/$61>MM2XJ^1L;TUA&>Z96_<<VA!L:?>A2
M:^/HPG1,TMZ6>APQ1S!-[CD1G;D)*\,5DJV$)9=?O.N4:QG3&VJ &XU1 =OW
M,=<0]C&0S37X:[^28DB@'_>9!>,>8(M$[H\1S0)\M^]Q.7L0^UH7Q0G*<DI6
M.%%I)V<P+X%S]$%3Q#15G?6*';OO,Z$8^W3SDZS'YT6F"P\6U'=S)-9$6"%/
M2H74:L[R?E-9?MZH_E.BZPA1(@19'*%0?^RIQO"4"LQ=U/5D>-#[381,: ZC
M J&5!;9!0<'%W>[A ]M4U\U9JIFA.,[F7.L&2;Y9"]!\:55^PT3MHUG\']E*
MR+X*6/TL\106*D]N(P)Y^YB!U<F8;$_);!9N-_<5)N23( 1ADPM$+^*\;B1I
MFTDM/BV#_B:CP9BK"TVL^242Q*6(GA7!GP)3'F06N;S/%I1@#6"C:5\UTZZM
MF:=QZXZA/X@Q":\CLG['L?BB<&0:VHC/TISZ+7G!Z*\RRB-3),4[HBO)T.Y&
M6#'%$FG=U;Y!!=KO0%:T&01CS1N.:X,SGQ-KYA[9%%/+<'V(=$U'* OR.8B6
M%%D:UUV_J6JP-,6E:C=/$UJ)!?B!:T&6UT@'<+_^%(7I';ZT$$TEI]0)KBD=
MICE)J[>8L64YI"JD;7%)3_;T#KF>XM;$*GDPM]4#<(UA+D\&1&?/.X^1G*XF
M,A-F*5&&J>!2#]-TD(L^#+FB_+1%Q*+P ?JDYN54$X.=RV6M@VI=O@K#P6?#
MU,M374E6%C"0+3$>P*GZ=/FQ7ZD%K\^UGA9UAW;/:ZLIT)8H86L#F)MC!+;%
M^EWJ(_A$7%_*PS^"+ NH9!A9\H>9;*KI/ :M9!-/F;+$0)5DU3&V'YI>!6,
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M18@;@*)0!"IFP1=FJOT)<W*.\]HCDXF&,TC(>3-+N6JB GQ)TE1E9)AYXN)
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MU3K6 @T+X&NR38'$8PP2-CYMO)&&?&^LF)1F4E-WKD Y]O%1=;W33!9#RKI
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M$/)M4/,W#J-4>"Z^P3KIJ#T,Q3G#T1".%LPATX Y9QQ<]U!\J,O@9;,+BX9
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MBT!N>DIMFP!<W%.JJFD\&P2ZYY.)O\DO<BPF4EE@:A"D-L2?+&I0Q8475+>
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M%&=KLC,DZ,%TO(PHVJ&S'^9/0EV%#T=Y/^>2 ^J').<=><:Q5&S(%5"3P!^
M_<UU9B3YA@0--S?I5->Z'P]I,6P<E"]M?K)CA87]$UZ[1$C.%RRR"8;<68%Y
M1G_I]S$Q[#"5%^NS PXL5>9?<$,F^.LQV,#P$!-(>:-_Z%X7?8;OK!VU"!@2
MA#HM7!K]3I"@FM1!$G $7P;AE^:EHI])>$@63$2X[4QU84N)9'OH^1F6(;.L
MOL2>%.3T@ 2:9I-+9D$E 4#/:1R ;3<PL9J^W1I>1:)J6%Q9O8Z9TTDPQ6QM
MI=K1 L"885H?$S3U/V"X4622'\O1ZQ3,I1"+D_QK4/@Z"H "/TN1+J5(>VH$
M1W4.M4*]=PH&%NG[?+J8I0[.SO&<T=P@>8=#0"Y!PY+*Q(,XL23?=V2(44T*
M>6N(&M>#B@(@13]20YT9\G2)JRPO_$,%Q<00\8N0E*7Z+PYY!%:K4!,X&!0N
MH^2C%VV?M)]AG55I1:YLHU'-L&.D22^7,#_P+'2&S@1.GF;W<-<-5SY 49<+
MN$18*PM2+!H&- )-5AM-KK6"9D99ID3F77;EI-G9H5#5Q-/JQ+N$L>&DS(A,
M!DL8B'2*91\L+0CM@,8DY=Z-K*M/+("#'>]0+OEB4X;>.V.-X Z>P<I-PQP7
MZ1NW/-0[%V'1!$:V46]M(##B9O#SI<36;[1]+>1T28NW@OM>89&Z@>"Y-?TF
MB+E/4"F&T0V'CA-N6F \,HE56S:(1A(]R=/KHDG\21*)$U,\6\0 @"<P :.%
ML@QN((L-)8&CZ4/LACM,D,TX;Z!1Q3? I N6_ 5T!,DJT5H5Z\OCT42:,>E&
MG;EC+(T=>=!!7OQV/:PFJ"SN_LWPLY^X)-.5A0"&CW"$V8H([(YY#J.G">K=
M.ZO_9IU5NW0"IT!"LJ2Z1G^!'-#1)K*^P&JA4:BQ"JEUEDK3B:2Y8\^I$26#
M^)(YE^ @8=_F81 /LREWB=!DB*7A8+TKOP^-4]LJ@M)6>J5UG\FJ\3828]LE
MQN<KQ51XIN*EX+OD !_$^V#"CKYV;*HBP&4_BB0$A[?EC@9Q(<+=;;=H0&X%
M#HDL')0I*;;]&XD*3X>@)L%7-0FN(F:F<\+U<#EU#Q0]T.KCW"'LDX=9XLLK
MP<(Y?@934F+$%'1PQYL2F:FEL=,IVQP1:[[L+5_*Z[T%KPM^C6G715BX(,38
M(',::>ZF B>0K9D4D\!](?4MTM*$X<U6BN#H1OZ4DKL@;D?)DO4Q<7J-S4M4
M42 [.]?U_E*Z?Z:)\.;VMB-!62TVG3 M/A,M;LWHQ,V)3'=32A1P^TUV8Q'_
MAW:-/^% -Z>!D*@0,^:C1GX]4?EU%B;1V(_A$"2EHXCR1FOGP,DV+0Q5R@6S
M0=X%/#Y5F1^A<$,PQ(0IOBA_D&?%S(?%W8O@PA_R1@J8)3 HI.L<70OYK2"!
M\6G1+ @=H^?B]*2C.^#E%@/)B<SM%N"<&#K42 BY>Q*;@B@L#-D/?%UCPC=V
M\@&9IHE$KB3RL"F)7'-)Y,NF)+(IB5Q\3^7IS#@>Q?#*; ;R%Y',-=.+#SIS
M#&?2>X+1__PT'?V__8/]GW0\\OV73V_;+= 77SZ=?3X[O?"./[SQWIS]>?;F
M],.;B[4&+NNU8D\A2/T^BV=7\W;KQ _GH/R/+8X4S(9XUFWBSH^=0V#RNG;+
M,%MBUA]^=<* W L#R/U+&'N:=,$VNA\H16U0+^,]SC&2G6###>^X@,3&1&OL
MCVP+@0]^,O+_*^="F _?O3MQ?)5D/AU$D\3#5W[IT/_S%[T!_ZNC6S$&UVHB
M812';@F_LF D\  S7GK99*X#*C0=\#TN$5TD'2 2-?-C+CC+C_SW233P)WKH
M\-E;-8@SJE@[Z'C]_7Z_<;;K<UE92/W14"]LK^@Y3@CQR'/?QO_MM%L@%@XD
MJL#HD^]YGDL@H:D5QRS$.G68;_E_=3><PI +<KLDKQ]J6/E16?;!]WX(/J2T
M<J#P+FLE"E4%(4&%.9]WL+_O8.O=#4+-8CG'&]50'V'*JN%-@)B%<-0HAZU4
M#NS=XWU$%"$U\^:B$=E52O#:*S@W5Q,[*8%YUUS(^AQ@OI"Z2TZ[=7RI<W?B
M.WKTE^:B;N-%_4RM+65ON>$1Y:VJ-7^N,1)]CU#%QG];AH7)$6MJS-F?Y'2"
MRYCOP]1[X;WSQ_Y<I:GR/B('9L?[*XI&4T6LP/_&Q@,O7S2"HCX7"(EY.6G8
MR(''%M>E^-^Y-%EL:"NV6%K_$8 LQE(M9)-QFQ\&U.C,E^:Q"&G$8)G3.9G,
M,.%= J'+552FXC&,=$Y>GJI%>^,BU?'L-]&SK;_)6Q\]>XP(VWWB;P9JS%&M
M!BF40PH=-4BA]2*%7NPW2*$&*;0Y\O1Z29T[HG]Z!OUS_OF/TT_MUL7G\Y/_
M\\?YNS>GG[R3\_?OOWPX.SG^?';^H0$ /3F+QR7;E])O:?>$G>#]F,"^B(#&
MJ%,6<D6C:81'\:C?D%:\H\DA""-=(#F7YG%1N#>U22('>X^ML2_C*)MAL2)2
M!1-46I#1PHT>+W@XLLU))UC&/WF+X$\=[_#ERZ/"MSY%/HS] FP1A7DI^$]8
MV#>!NHPZWLFQ][+?ZQ]TD=[,Y1NM"IP)P-HN$Y6I2#MRGBM#Q_^%NOK_=+T_
M5# 9Q/C#$R)X/S7\PU(KW/5._>(3D:^ XW-PL;$X _EZ1VJFI UJ**P_+D^+
MH=VJ8ID7MI(X H]5NA-6[R!RAN1WT"E7VY@;6N/[?:M#]L@BO6]$^KO3WX_?
MM5OOCS]_/OVT7OG]H OPHXKG8'BEPK\#O]WZA+V6WX)H1L/UW;N/4D:.Z"V*
M\.--OH;AC9P6\Q8SD&,1R;?9<QH,YOIX6S%?)>\$339%YF;,XG_I7G0-QQ'6
MNT^5E_K?F#^+S>UDI<0#SDCW.L2 ET,>^ODJFLY0'OV!]&BP!DWXJR;7\X[R
MZ<#(I]/_^_'TT^=&,&V;8*(,I>6M(=H+TT]GB2&&!A\1D@T5]0 ]Z#$4E)*9
M\!\][CRN.<CFRD>*(@R1ZY^T6[G?"#%?$(VX%OD<C!)\<.\E?:E'M)Z*^I4C
M"1W1RY5>W].,S;K>C:F3OLWMY'Z!?Q.>-D,.3*H\YAJ\;!0(^]M['ROL439U
MJ-@.+3.T=F-UB3S-2+&L">J'2*)(7$#C()YV<%42#O*G6*A'D?Y8S>"?'*E#
M4Q%,-5@-:K@\2=0-_AF9DI:.EOLE$I&#G6*L)@%5V$HO[>&5?A\W]1"E(EPB
MK%42!(W@>*5 4"&%72!+0&8[O<G,K9'03_JF:^7\$;FO_*'**!25>$26Q%W-
MJVYZYY:K3H7IH5QX?5Q7.>3>CB;C"J5[)Q[0"?@KX*+,T9GU+V-_AH<<B0;1
MEXNTNX24&"E.;Q1E@]3S!TA.0H??U F[4>M%TX4'XMN#,%/BU5))+](LJAAY
M9,%72X9Q,!"*-&S6U3,EP!5KO.M9*9-$E;>7V*B8JY'N+LI?1P@Q;>I=Y- 6
M7/X:7^HZFUV'QNQZ<_KN[,_33_]NM\[?>F_.3[Z\/_WP^<+[?.XYP;_&*MLV
M6?VQP,0A_*HN#0"%[/":"N-S8G@RF;.)P9X@6[#E<2&:I>&A+OD+&A4Y:@3]
M6^S?GMY$IOM3[E?HF!J.:G]*C3"0:P#Y3N#OF$&)9G,-=C<4"P7A+SQ/NKD8
M44_YS#E/+25HKDPSK$?EFUHE\P:R'O,/UHSCN9X@1$J*#O7(C-:07)>&37PV
MHPC$,#[NAB0_C0!U&8'VKN"W07*EN!L(MZ_*#4Z4#O-$RY.2;JX]JOP.5W*:
M3=)@-EG\2R%7_:J(ED;6B'IDI;Q0>HGL3*J?DR.**XQGZG,3N/&<GVD8?>1]
MR#M&#:(H6AG;8"\?2Z:<LGW:RCW9X"OWC.(2L?OS9_N[WN'SWMZ+HX-G7:\Z
MK%O@!A/#6,8O$5VG65YY.GFRGWN/6&BZ\V-N "6UT[-Y)7MDE"PHX+_^./UT
MVF[]^_P+[.H'[^W9AS?>^_-/I][9A[?GG]Y35JW1LENF9;F,8AR@:F6C&[Y<
MT"#"*$6\A2X,T,1401FC%2W]42HY[+O>OZ.,1*I/_&*Y!\'_Q^.0AHSXO!LU
M .E-VH-<(.89OML ?5BR?P:OK])T]NLOO]S<W'03->Q>1M>(:&N\^6T_NV=V
MJ]D.<0Y$CKY[F;,MO)Y^&*IO[,'>_GVT$_^;P6R1Q9:<QLE$EZ<GQ&I+/<@H
MNR'&JVN@@;>KKK'(@=BT?.X@($UN:0AX'2G>0&[_53#0W+BW#JLYT-M^H(_1
MNG<%6/D4&S/<#?R8TE2.K63(*R\A7&).H$@&'%&A37.!W/8A138V9(>T#]+-
M0SWGTCEP;^1*0'9#/L6YAC-ID&8I=ST!^8U]^\)4K%$P0H,IT4I3GZG_J%P'
M&GI6<ZBW_5"?C=NM.>A^)CE&IRW?N$![9OGCC=4!8P]_1T%#<EB8+-6$,ZN1
M*_@3\6OH]H!TO0Y\;W8%!Y1\D"#4KLVO-=F))V[*KG]Z"#MJMQS<T9.=*7K;
M[=:M[O:3G?N%#SJH$$9XLI.ER$B[I4,C3W:>]ZHA>-;4$*RYAJ#7U!#4N(:@
M:M-7N+N-!7&G^L9\J/.9"76>?7AS^G_;K<_G&.(\_G!R=OS.N_A\_/F4\HI-
MV<"=7:[-5ZL6!FQECBMCBC+HSI/*B:"%HNHG$A*.0%K]!16BZR<M<JRX6O5Y
M:[XOQPP,X^&\-?B.B[M@:'[-W1X0L?>>G-F-_>Z:_=7"'=!ZX EN:GFFI6$M
M-ZQ67XB-2W34Q#O);O&,K7W[X/+#,F"13SA" 1#%OWKQY6"GOW_8Z1^\Z/2/
MCG9KLL7_]+VK6(W_YZ?_-?Y_^_N]GUY_,L"J,P=)]<DBJ3XRDNK8(JG>!O'T
MG[_XZ[JWFST&;_?Z#[[W?UV!;*OEAO=_>OV;/R%<[,654LC!O"7[*(-\NW?0
MW.'<EAY@G:.K<L^Y#2O%1I&-.9K.8G6E0NK\_2Y*MG#/#YN[N[]_6-SH$TJF
M$V:)&)8$IZ2[]+TA#M)T^W;[J+GAN8T_*FV\GUQY;R?1S19>Y6?-5=[??_;3
M:X3'$SJRRG/:\+:^W7M>V 6):7U7Z.*IQ2D6C+F)*>2?)[,UNTW.X)H=.;V]
M2V(%FW5.-Q=A$%>U\5/O'E]:4HVYSOC2@TJP'UM')O_Y?_O]O@Y.\.#N$Z'P
M=CZ>')__YGV(NMZS%R]VM^(DO-WK]QHQ4'DD#DSX@D?',8RE)==;8R7#UC?1
M*F>_<RZO$0-.@..6,OK\,=!?_/Y*^FTZ3 >-'*D\5T>5Y\J-ISAU7SJ><@JV
M13KW=B2NLKO>P\>C>'(G\+ 19_;8/:L^=B::TXBSVP_342/.*L_5<PDG\=@>
M)Z:TUHU^5KW1:XA2U1?3"!KFG"YK\BN^ZH)K'QJ@XT*@X]N]>T$='PSH:,ZH
M<_+LV9AM&D#X4%BKAX"(;1CO)U (F<.GTX_GGSX3>0@B_SZ>PO]\^.Q].OW]
M[.+SZ:?3-]['+[^].SOQCD].SK]\^'SVX7?O[=FG]YLH==ZVC=K ^?J,5!M8
M ^RD.,D&^DTSOKXQ9+O1>.NFMX!V20/DMFX^6WK*0!Z<SX*0*H>%':K:B%K_
M'6^VI'K8?RFA(=0,A$39-1Q&4W@#=>P>")0IX3#@"I1M._@,=.C[^Z].^$'T
MK]ZKW=NBB-14I-?1Q=H^/BK/%1?E03?#'.AF$B4PSZ$-+R05<(T1AQ7XY^@2
MCHU+2'P[T9CE(-(.,96<<-6(#UCM+@H'G3OPD#+/.VC$Z>[I7)X>,\>13R1U
M>I6JB-OTDG7;K;/0B[(8ID]WI[.0Z\V30E]O[ ?Q9-[11?*&8E=7RQ<?,8LD
MGR-%P+)KA=TJ<&86)YYDD]3TX"UL%?ZI>KV]NR]WOT-D?L.(BJ(Q7$2<& X-
MG?#_(+W&I0J14'C"%!BS5%=U*^]+2*>5Y Z-^WBJL ?7VHN?MU3VK%GRGUHF
M1=##ADJ1;F;OE?=[))W-D.>PL?(V8^4A$6=.N%=*$4L8"?)DQG1E29)-F>5*
MV&*TB"#2[5LH*[O><<+T;>,,;Z&AKZ0[S/R5G=P3KWPF<;L, Q#6R-AQ$\5?
MZ9'^+$B18I.D.+B4(.*X-_@P(\'J_@CU@6+I$RK%K8EC'YG+G$+X<1:.$N*Z
MFX)V8\DU@/5W1%<"^^ +F:Z5:ET/%C,AGAQ^6"(/OXT*U%&&1$;'U*!SE_03
M]J=B"=^;E@F6R XN4\(LGM@64!A/$B4M&Y@N!;1R5$482J.OWOQ1A+H+-X>(
M0IFB982'D3^G S#% BH1^1P7)>J(+"72=DTKD.'H<>W2>2-3-R)3?_.3 (XO
MJE,QK!O)N2G)F2PB,<:+)A;0#.1 ()<Z;TJ9>SLU5[GKG6=Q\5<!R2GU;<9<
MEJ$V^C2;;N%Q"X8T\+$!0L1F(UGV(+#^4BP3%M#VNL2^AF-,4!]:-#OHC_-K
M$#(D!BA$T&[MY.RI76]';%L"AUC[7UC$#6N9=(]P0"?T<K%4-9&3'@ :M$-L
M 4@NB1FFVSJBW;+-3;V)?Y,8$]5'8ITA!669U10_@%EG$Q'WFN74_AZ_80C5
M3K"S39(0QYD\DB;7"+<'=%91X6;4"<F>[47' A7Q" ZGV5D&*G&/JM(O- >U
M\[.%SD.[M=![P!XCB?MN.>JL.6\4:6X: Q@3Z, (2S9-!(Y[-"!S(U9^ B8*
M'E8TOF(:)YL2-U>*")_2A;SJ>,/&L2)5;)P_/+OZ*QWSD%%&;&G@F!+Y+?P,
MAL+V@;ET3"OE7EDT$3OPUYB:?[9;,"T57H)@HT]E8D0=3A/37B%U!F,"HC"-
MHXD7(5VLG0)3#2+O-UJ-V#R,W'Z[T3>J)#UDO9"V!(PY$$JX\,2F.E[]?=X
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MA7?VP;N ^9_^<?[NS>FG"UV5^>;T[=G)V><M78.FLTR=*P*6V.T\:?S*KUX
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MG-2G!CXQOT29]3Z+9U=S,!/#.6CXX^%_LR )2-N?@#'I_/[+I[?6W 2IE W
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MIVZ[X"?F6VW/\(O-RM4WN LIDYPZ,E7.V8D_AV=X9PGVDGDLA[B)%=X:*_R
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M>-%42>;%\2[W^D<=.&0)QHOC\F/!MN+HN^+6.@IE(-E@0DD[! GH#%*^#>-
MAS8+4QDX#660XCTJ#>F,8S")T[T)[D6L^PW%BF/A('FSU!+;"#4'#IF>+/RH
M^/O++!@QA]-"SE:6 KJ*5K]0=T/"*MEK$)XP/+[H^ +GI1P9+TS$K/R0[QJ+
M'9(@LSB .? -G_I$DZ9GZ.0T;&<J&I0>)!?X^D,V:0.ZVE/Z"G/8PDG2V1@:
MI_OUKG=*L7:;.XK@*.)7+T%/^K ]"K-G"K:<!DR1>:UYXHX$^^E34 L<M@&/
M1TW(B>*C F>54P1:X%>DBTS2S>.<6\E"%C;84 6<SM)# &_OFK(N:(5=1Y-K
MI1T+R9)0C%'&0<&<\22Z2:R,+F0>GX2 N!<\K-_ P]8-#WO6P,,:?;V,>VTA
MJYH5_<;TM*;>$F7?M+'_3L#@:H)H<[7*JU>;KEA+^J[*2Z@Z018U=Y<A;KQ\
MQ24O*P7BZE WU^^\/'JDNKF[5%66AW&QY #\_^Q]:7/:2+?P=U?Y/^CFG;F5
M5&$/^S*9FRJ,<4)B@V/L),X72DB-42PDHL4V_/KWG.[6!@+$+AP]-?,,!BVG
MN\^^;JM(*I/*YZ:&F<2O1FIQ4<H?T[WW;2ZSL 1EJ]/9%R'Z1"'+E% ]\ *8
M?"I=SL6W "9&6L%!+@4]U"[*XE2553W4CAO:?^<#M>9EYQ)O!D9*Z-H6RY3$
M[[JP9&9Q\S1'3!<$-95(NJ8/%(GF#H+NZ@;O_&8\4NQ$D@US:GAPXJQ7D3I9
MO $J?& =R" -6P@/X)*^9Z(?'X4[>%$%=E:CXP+@B )+=N.-%O?9D!?T*9C^
MU0O1UWA\Y"0G8T1<4G73Y]#V1<&GG?^3Z<CNPGN$\!AJ9M*#[OOJW:G0<+S0
ML!GHH0FLA"7+^A<RYXQ2$QY?9]KU!+I@FA-;AV(*?^6FTX1RF";CYMBX<8E)
MYSXZ\%N. [_M.O!Y%+1+$0%V#?72H6Y:)U?$>$"_NL5U4QQGB-U7:6HL]9,[
M.XYN,QW]3=>-ZSIZRR>CRLY2NB,*!?K R L/0["K=<-,>MLE%53+AH$+,:R@
MJGEC[)>KH6K2F??7C LD3>[BOA34$:Y GF1+82DH/+D6HX)7H@DR0/#AA7"I
M Q!XWD)#,RW#ILS2GUA*&]\MNL,)=J>H7W^@6)97K.7*#AI,Y0.1V:,TBF=T
M0-U ?%$&]@ D)(C(!Y3MP.(U21EB33^=>80\WA[B@\*#RVE/-!X?W?9#W^1D
MH'DA[$C+8S-S4;!B'VC6<57LX5:Z8HTK.#@\D4@69@WA*UE$F!=%=#$.7/C;
M%<0I0=?4$0_Y#$7%];[X[G3D%KKP+!;5QPG36"0A=%E8I#NEX$Q52$TN\O@H
M;)4TJ#;Q,CZD!P/>@'6&K@IO68"0"FD.7*0]?)=R0LL>%-ZIX&#+)<\$^P+B
M"#<0#NK(>:[3K3:8'>!F4G&*@)M]@[D!9ZDV07YCY0OJT #!W]Z46GXJDRH'
M/3''Y3H /054+4V!OVE(SY>!IF@.6O 1G/WI;:4:L9M#[XPY!*6,*K5.7,J'
M&"G  ZQD(8XB.8WMCA:WVOZR1#UL^CLD&A8B,:5]TZ_!,:(\+*>FX&::LXEY
MWJ[-8;K9I8[U\"J8]BN2/X'R#XX&@110UWSQ%07,P20DN&>T7(8BK:%T%7.,
M'],*5)ZJQ;I5LV^R7/8='\&K"].OSGMOAJ^K]@/LC9 M^EJ\_E4L>0FR_+Y"
MVOV*WN<DW_#[)BO.O &A $9FVH"K%-*I=#K];@YMF%ZR-+6'96R\;5HBS1&;
M_;X9T&."N /^](;3-XE/HJ+2?4=FY@BTA,ABMA14\IJ@QS%'4)@?R*?H#593
M]++;5?0<^J:Y/<MI?+EI;I([3;NNAG=1A-.TYK=XO9$T/U:%$:[Z"3O3_%PQ
M.:GZ+5[E.IK?]-,13Q>H?A%4APAG$T$#Q%2T""J@L&T-$#/1HJB PM8U0(:L
MT39X QK@C+=@>X\E5$#AC]$ %V5DY9*,K$UG9)62C*Q$P9I4L(J.AN5QL^7E
M:E _X^QQ-O^D+!_EYWR5Z*_TM/O+9VV]$U@8T+&:7C&S/,RE!,QE@AU76$C0
M5Y2RBD.'3RE9C)4F6)$6"Z+R<<54FP1%0C>H.L]"KT'D!4XMV9@C9H84T,P%
MEV6:LP8\J/*8P9'? JV=8R]GBB4KUV3Y\2FLF$RYT4'>P94!Z!7?+%_%"AH'
MMN_IXN0K3>>0T?(:'V14ZQ(%R1U4+H%:HE@":HD*JD,77/>;4P^:G2K #M3L
MNHJ=%)B&[BM]FHT&(86VX5N'T=\E]HC@'O&E'1\M55P>96W"\DNC![.1M='S
M;X,I1VDBRTQ1T'<L-C- T6A- B][\C>=\Y_*@(@F:*C.&V<N(XDC)W'D96.V
MQ1C&D5&(F,M%D'<=.XZ_WK%T]\:MA8D7ESE3K<'M"F0&W(04&;SB9MI]X5D'
MJ:$QIX3;W@@8^$3C"GHK]Z@='^%=S*$VOS;6\Z"!H'8\:+Q&345 L7W.0)3]
MGNR)2FKN*.,P,FT"_7E8]2;U>7^,M\H[X:]<;LJ)GO.% -[#51$NHR##E7AI
MMCQU:;;@7>IM& U<A.Z8VZ\.I15UT9FL@K$GVBH5@Y)J(S=.H96 ^6<H*N$L
M0&BIU'NIPP8]HL-JQ,R2KJ@]&O;0DD:\#% [04&I*NC1]+7H")@\%)B9$8C
MAMLX+1I;5&&3D^!>NV/W:!-'>H"T*ANP@4\8#3D;FO>%F7@RO8-[QUC/2)7M
M$=<<1"L$-*9.>'N;R.5$+B\I TLQE,LMU\F]C&AF"9=)5E?<EU)EK&_!3.=
MEUS1!KEB4,8[F7/+XFCY-(T_X[^323(I;.S*;3/'IP2796B@CP<\_'K 1 *O
MVW'P5>S]GX)&(19]EB('_IBAGR83M2/@P+P,AI0;"0-[7!U-M!1CMV3"\#-B
MB\7L*9CV@>8I_*$3MU/?5YA/8[:"X]$=>HRP;8"LH%ZFR=A?[HDP;Y),)%6D
MX2N#!@@3@HC94CXY.9E<KYQ$<&1TM/I 96Y9;.'SA-XBEP\RCR;\Y+3L=O$
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MI("I _.9&[PQKF-X*1XM!(YS\QT0$A&\WE+.*4LY/OHL:C;*"3S3"](UZ!^
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MFZO[%@<G2%>W3&?NC9Y-,D:$@_)V/N4N1M#-M+,R83' ]*?GW^32Z52^$GE
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MQ#>^Y\QY)7N# !\O2->P@6B$4HH&K4^%J@FKD/HI>C_=3P;)6; #/05;4'7
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M45EF?GZ+[I7.S>5W_UBH-L#GXZ.UUC/YRG73-WA.G*F,B3/+>8)M#S</M$2
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MP X9IX ;]!6IC]0D@ZYB*%WLZDE4_3E%L=L$=)?Z^$1<+/5&L >&$2BE,)F
M%N@\9((M*K![N+\/1,,M)?[MA5<8Y(EH-FR"K5F*>GPD]D"SH^M%HE()8V\]
M@4VKF@N'16]#6@5*M$+ <$$ I>[$ P%Y_H!V<\/[<=<IWJ /!M0DR_F='C4_
M"#:G4(9]?2*R]\N,G0^"TD>61%2"9:M^Y,2-Q%7V0/6"9XQ@(<='1),3GA*C
MA5"_G4$>%"R#H[CI6CTN:YBDXQE8$9"[-_Y'NFIX0#61B02"%7"&JQ)/  E<
M?$&ZABV"H,TRKG(JM'Q?EL)8GBMW46[/1ELDNZ#67 E,)G7'2A#YW,8;6+LQ
M%MB +:4_F1T) 4AGX=8._U3J=+R'V%U3D16 %><I\5D5U1?%]%W3N&Y=42KI
MC.7G9[WT\V.WUL^_$2S%P@.EM]!YH; >F4+BL&<>X]+@?.GOYJ*J\VAKFA6B
M@7^*[J>2LX"."W_$D$VC>>$+VK!W8]PFE9T_:)$/]7/DP!W^Y7)]A_MQM06X
MI\/'*+?[:_*D"RM-3-SH85]FOXL?Q7P]>U5R#WMJ2"R#9M&YKCV3;T-'N\J,
MOI00(J]!6J$/1LCM0CPDHB!D(6UE8*N6J!'=-M41-[&HXJ+J)F>?<[CK?)9L
M\N%RDU29]_-?CX::-N(@_$%Y!>-?#>T6O7<,ES9 F)-SUQPJ_3YZ?/EU<5W(
M6QZ5.K/QJ-FZD.<NL8XER3,<YK78<*F0GT>LQT><"?N$.X="<,$0 JP9-5<1
MQPA*=,^F.'$Z_,RO\0803Q2PCM)PCWA3!RL]EGX.LK6S+\^%\(/E,(.L98)V
MB8,. #^C?='6CA(8[[4K5=.G\PX3UQ9^?'1V[N3H1VK+,2>4$.*#XGGVPN5E
M+8 @_'M/5E->0J4T@.!(O##<N C'#?3W*C(W86_ QD [I;4KAC#(-[^4[YKM
MH>CBS<> QL&$-U?.E(@B?*GE[9)/+#\Q,I'9>Y+9%[JJZL^T*":ZI!;T,(,*
M(!('NLT&%T[196G17%R#H3/VK+)&FU6;V]\^/F<_C\?WESF7_K!K_03U<4Y.
M* 2KZ,_!->Q><:ZD2I6Y9.8Y9C3_\OEI.QN GZD\/C[B+J!9>(#.,?Q]ACRG
M5CH5!;+C3+HU *]!!$B(*.&N,M#J@0N")LF;06A@CCT1HV=KL@\U P\*Q;@S
M+R>UY=W?ZMWV";V9W[M%OE^N?#6SO7'WOI5U\:XUO12++D5DX,S/E)RWD+UR
M^'RJ7)EKBI\*52?P8,*6TI0;RW'T.G[,>6><FC[AC.^$'><E;82W]9,=W)GJ
MU^&]U?Q)O)-U_:>TEU*T\PP!>Z_GF,4SG,M"D*99%@0MLJ I#V%./CUT.RC+
MF"L<0LNTMJ'-EYK-^D7W<IC19>\, QUG%LF 4%"WK[N''-H"XJ.'9ILL*CD4
M1Q.==9@['HG/%/I$#6?6H*J 3=]%8L5>:(PYWYVV3X4'9,\:9?LF$*1!VX8Q
ME9T_:$!$['(O8!07E@BJ//S0)FQ/LV_%=V\SQ7>>TH'/IX]SG %5B;+X3 6T
M2) 9QT=P#!HV"_+;#.'W39@0(BS#0A!']('E@B"+(Q-CLBK&3W2#B1P:D-%.
MV$L4[\%.)-7JB];Q45]791JB(&I/T&T+Q1F\0-?("!6[1URM3>-'/+C1'05\
M' -"*(&PX ZP/AI?0\!N;!#%6?&D-']3V&;(Q"+&@ G1P M2+(;DBP(9\+Q_
MA;?*NY" 4GB\&;?DK<)OD-$EKW1MYY9I)@U',Q5$2^(U:RXDK ;FF15';FZ%
M+="SFD#)-/A6#HN2T!PS2@\TMX$J;@J&7<(1I_I@$*8,!O(I:E4OB(,4"::K
M#.JR< W&[P#8H4USA &M+UDB!>"X4!-'L 2A8:HB\BCR@I4AK#:30O;636"A
MS_)H'J6-\X(KFF0B@,A( 3E)I\L\F-U[? 0W>\D?W@-I'@8<"1A3P#F>D1)-
M5S(YA,*W\=0%B-XT#"S;?;'*B!D;W1@*B\*S*Q%&R<9=-X'8@">(H)*;?<;:
M*;>AA$J>@/*&SAAYT+LD.)Z>K<(O0T/1D4>/<9TJ'"&^EV;8F )H]]A8@T=P
M5<!5$@ZA@E%Z)Y"/JCYYD53  D &&L1'1M97AERTP*%3$>2P;>"QGT6-!>G2
MV1RHA(0P[WTFS6+L,F.&\#Y%<\/^NV$D.Z"UU\]-[H:89,4%&\]I\F2&Y?FE
M3*8N@2 2?1(2$";EIR^:K4"SQ+@8US@;XK24"O(2TS:>E"=JH:*R$)$R5\_[
M0C*5>-)7%RD ]41Y-FM#]N.D9TRX7$)SOA*\/Q2\O[8-] 59KEE$,3EXU$&I
M:O8QVXX&XRE:RT0%+FHXIC'U":.B20RJ&3HXA=ZV!Y"P#S1]AT:)**=G+N0@
M8CLVV?$1YG31% T,5G!*\CWG">N,T $&?!?>/S_P$IX80$N5?"Y^GNZ0R:#=
MQC^5?=895NJT>E7#P$Q/E%?,>G/L>H<<?-3@ZA7<D/.>Y5SL>WWP:7SS)NB1
M*QJ.7?BC_C#X.20W/T:>7=CV//-$7C%E8FIG9ACZF0Q8BNZG,@>^$V$G^)41
M5KFJI5ED@?D%P7F6(2KU&38RK)*1",)\=!Y"^4*<X:&\V*/.MWSMZ;H_T+\]
M3J ."PPN1)Q9.S!KG,F^\6/%**(7(#T5JM,Q0[]Z<'S$^&.76<AVF!G-%0C=
M<%(/!#?S(-0P"42B&]=UP>WH[AD.0\['D0W29!.FS/A3%@/F$"H58//2%%=@
MJ'S?33XDWDT==3FMYU,P'6_+I /-\Z6$NK?+.^?%;=\:7=0RMT1*OWZU!Y5+
MG33:#W'BPG/W8/O\-UM:Q'[WY6S9G_[(RM*H_2F3#_-KJ;-)+?6F:ZF+AU-+
M36G&090_KK Z@J'W&GD&F.H& <L''M?%0@=T==D&ANNI%W^VF@#R.J@=,"^$
M+H%8%EA@6T-_ LIU"TNF$C,];EY[6IPPJ5?!C2)3;Z@:US5T4<;(AF2P4 A5
M'D'/&/)B.&J%PQ]*3Y$$<3A4@>_ZG5EAJ10S$B:.CYR,"2?78CISXKN(^I<%
MJQ)5JX\.5JI<6O =/!&46U]Q7N#5:&9@B0[UL#)'%(46_F*9[GBSI3^+AHR.
M@&B5AOA,<P;5!$J)\&TH ^'%/*Q$9D64/&^T.CH%Q)J3T1MBU(!V91FZVNI:
M(H:\SHFKC_$(<2:=X=IM-I?IC!]&UJ<[-5/Z/,BXBN192$DHCUH-W:/UY<Y]
M6+'P/:B1+K48BKQ>I!!C;.Z^^LM6YY6 F<)4E:L7E??5NR('8_Y_'B/MB8K!
M(YC'1Q-.(3A\E8@ 3CG]MQ\/^1-FQX_?3B;[O!/>,F'LQ$!EI^>F[>O<Z&O
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M B<T:NHUXXKW6Y$Z#Y]%A?E$%</O!>)1F[ XS,0SD3$&]5J,/A\?L1C68%8
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M2G4_,$,\ES3-LZ/9"=0]EO*1\J0FR-KI$N/$]&I14VX"+8U6F7WL)N)D2](
ML:ME^O-):)XT@,C:O8;DI7FIDC,R<A=DMC'O&:X;6.&3PNHY@7\2T=>^BB6N
MO*4IAA3AILLC_8._&AR2^LL0NYN$R]?F^>]OQOBC*GWU6KHUW"6P.Q<)T8D7
M;7UP\8)6;?Z9'7SG9,4T=96E&O)%8;(!"XRZN8Y>/P$\=%!W9F6B.6D=/L6#
MTHC#<%1L88,4:"MFF(]U4@** 7O>I'-CO 1QGH3$X\38XQ:PR:"RUDW;@2O]
M^90F]1H [?)F0$!]0?(39E!?SVF,RN2=MT"@$Q^SHI0R$;J8U#L-,@#^11_E
M7]M$<,J]O*N+!@V;RXI!YT29*7YL3RQ8[*R5^$!1-.;&QGF$LQ*M//W7Y+:]
M.\P+PRA,,:?)B,C")%54!FPJ%2Q>03A<D -!-LS]9@I/,"YS*K1 5C@=GE$4
MT4Q^BT?ZG7?Y@N>,-<!Y:6#8L*L&XB/A&H?+>!P&"Y@%^*O0D42WK,HK-'?-
MIU[-1).E,M4<K*=O RK"3*-G3*.F#$F9$,(]45'-*'4Q<W70)'H?/W/<#+/'
M)VQQ7S[A$L;XA!E#48A&J]?#(>&3$WKE+_"M:](=P(I.IFP"YH)<%)!+A65<
MAF2YSB%(5P,-YJXJ/'=_P]1%TW3<LB/<DCEGRL\1]5SVQ:+")>&MJW\6W\TI
MD>)?\M2=%>S80)5'B"%+)P J&CL=^IJ48\\A -X9,;GKY)90PY'E,2YH$DI]
MW?@0VBI4?(+3<<H"W>9TP=3<*7V59JMZV^"XP?W8D7+2"!UI[2;=N9U%6"*:
MF_#"J],\4>R!AN(D4(+A[ 'EYDSQGHWIOI$/M)[H[?R)!(M[W* RNG*G\\KG
MB^S79C=_8_8F&M#PE-1E!U0LVY$&U=D-C7F*W$[F7>*#B-%"&E1$R"P%!I0\
MB_#T)(?%S"EJ\B67",'<$B1'Q>$D?LY(M7O939]%E="B;BJFOU+_M0B_*:!3
MXS16-K#2),838#,R!.38K(H?@,50H,EJ H/O20E.R86;PS%9;LG#<*@83OI@
ML+K<!@XDX_Q"B_$-WD75E]CA]0U*L;Q4XMLWY(-</P[ENSHK IMR1A<V6DT=
MN5>0;_+(9!>J<?M)RY_E[JX?\^(.*K)]?(GWYYD-VYH5V^@9\M67^J6:ZRY&
M679\A*(%#29VM%,7SY:OHJN#^K/"_4IF>.]\3#1WQ1F#D<WR&?K?*]N$.X5M
MR8V)X-/<N@.6FD>+6*E$304M3Z>P*("VK@^"$0>F575948%LB,\L\]KUZJ0<
M-QHKV_(H69@BY.>^SKOA4L<FU=!8 AB;=4S]<ZZNQ@J]1-IZP"'N$,_3K+=[
M)="35B%RTH'&*V"M235RP205)]G+<7(BDU-4IV37\W[XOO>!XBO?\4+3N9FA
MZ>#E;O'UC/BO<*4;1&?60E O17\B')N[]WSGZ3@^FF?/&/;_9^]=F]-FEC70
M[Z[R?]#)V>M44H6]N8/?=^U48< QB0V.P7&2+RZ!!I M2T07V_#KSW3/C#02
M$A<;;'#8>ZVL!-!H+CU][Z<]DP!V;X^P-'>^TM 9AEF^WQJ7Q<GA4UUB^9RY
M\P,6.S+>W^N++&0<^8!1!SNWF(I_I -!Y8S%,CT21PM4R="L6,6))0Z;!Q\C
M],.O3YSG!+"<Z:.0HLCC0,R^H$/33=70R<.%DO",@/LKXE*.([T104GN5_%C
MZ0";$<+.Z?8]X-DE"RX>^V7Z/=IF.DF49FB(B"=3XOK)B'?"8)#J7%6.Q0N%
M67 =4XSKIP+.(/Q-XG#O=%85Q^*L]Q;B32=RQ7>K_RV3$9G?942N.B.RO,N(
M7 5I_[?KKZ3[2EE%6^(DI3MS[N.8!"C-%X;*<F:^0-XC0#Y3]<!\O=W;&;5Q
M1FU<]E-4((-2[#BB[0*FK?*T2XQ?!ST:G=@2VT!LMR'<IMK4W+L:H:8O8M:5
M]E50ID/-L_Q!II 2"EZ-VIF&!:60J'Y<F5RM9 7>7814,94ZR/A@SA6A^"":
M/GV[1UA^:(CZ4B)#- *\$Q0-8X*B[[:,>AZI<A@8((!(-29JM*965)F*JEN!
MA<( ^*CV[+>6=V:!DX7"+_XR :Z/.XI%9^%D5S%S $IM,^9XC\,%)5'SGZKQ
M'KJ'F8$!>IB8"=MN5"SI;_;W'$K5F/Z&V#@.0P?&?&3=%1E/JM1 %5>%O=54
MWC4/7T]-,<B@H&KE_IZM HB4A"%'E3BOZW)ZB*7B@")Z(8H($[302DUZ]13W
MD4!\,IH^(LY2.&*=&<<9^PT4T(!)P!W2S+;#0F4.B@ T=X]A8;;^X-UT>5@\
M[IMEXC:,WZW"N.D"@0J\2]VYXT!N(?ZT$V]O1TN!$H*UELBM3$B.(.#X4?TF
M93KE$[T@?[SUHU$[R!Q1K1:L8D#'I(?* OTB?,3B04,H)64AF[A<"U]N/.C4
MK*-/>Y!XS QDRET@9P%0 OI]<"5;\6CI >_ ) $,$C&&X B^&:1JL5P0ATH@
M:MXR,!UN%/>$NQ=SBSGJ)]T4MG"_,%G5Z#[[LH_Y-^(\<ZMF=US&+L#O=.?O
M8'A1W]7SJD.(TU-'8$G:'HDZ@=N!2 X4M NLV"5.AXY^;%B].S3BA-N]G#Z2
M@WX+#7 SR;C]JXO?/WNG5YD/F\WX*!MOMCIUJH"BY@FPZN&X0SE;NYFHX]KX
M^ OQ)MGAA\_MJ_/SRN4OI76BM!M?FHV31K72["B5:K5UU>PTFE^4B]99H]JH
MM_T3?B?R8/44>:PZNM/J1XAIS/Y,H,B\7*FUV  WD\)(/QMZ)7*;T3>?(B,4
M6"S=3+).WNJ8A5IFE/GP&1>->N@%Y9Q0S@"RX+U1VQ8R=LRP EL812]S6L=(
M1M0'$#ML9).1:L?#5$FN[Y%-I:@^ MR$   ; D"C)%15I(X*7E35M[B_5"H7
M ?*9#T;'<V/X,"?^C&.-^&/,Z10CGE3:Q_Z(<;\'W[G&JJ!D"+9*NRH%;=X!
ML:Y/>+/VVG5H&4AW]HMM/;I#KC+.9I,G04_Q19Z^F=Q6,Y?IX7=U^#C</AY9
MN9D\W&=_V]<]QW:U#Y_%DO?WV**%FKWCDIO!)?VL%T3JYFR!\$-3!NS,A TC
M/'9A^!49YEE8+'*QLT! OA< C;PFX*MW/Z+<V'8QK=OWF[7A(V_D!Z"SZ4PV
M,0#]M77<#C?EYN7X]QC^OP,YH#VH6&DHE_ZPOKQ!6NB#:D-EB(0I%\I(9Q%J
MF\@)Z8#RPZKR6 2^)[6QY;\&NXOX%R"TF3KFOO)@?,HOS3%83R<Z>(K'K:6Y
M:'Y6JM20+#YB*R85B=LJJNLB<!0#8 TGW?L'F4_G_7-4[:Y*C^6@]600#F;-
MPMRLPP7S#8<* :#&Q\84 [^Q,$Z:F X3/G3[P7AFH'U@"[--9T%C#E_D"^D4
M=W&&CRNF9  SCQE$#^7X75X?10]?=RR;X^%@B4KLG!#Z-!'X@=Z/ 7QL0HZ!
MVAM"@'JDCMFK(Y5%')MXEU[_5FSMA!7PI/;W?*")=/9C]]/'C,^=!-?@=.4H
M\0P/[BB2V^Q;:))'!AI)20U &'S%+;A\0%M"<V- BZ)'8?"FCPP %(% H,J/
M =B#B@H4-E0A(RF2GL/N.T<'\>\,Y+\:J,TR!Q?"0P'6VOX>&PF]8 @,B;G0
MP9@2_PA2@F3XB4\<:C*9'2VW&<QMY1]'%.!$@.]"JR4?-\NB) AQ!GZ6F,.C
M"4 K'L/P<].GYB=S#>[[ IZ.H0G*-PZ2*:'KN4&ULE]U*DV(BE" Y'JP4#Z$
M\X2PO2,')>68!<$ZH.@*QDQ>"<]S0R1S[@ E)F(,LHW$=[-\;&GSN2AD^:*0
M'X:9K%*_(0T;/X"[DHD++,68HLQ0^"G%>WHDJ0AX5JH&BXLA!W^^W#WKTJL\
M_4*0V7,&@-W5'93R6-"%S]JZ,U4''./.E2Q 7H(>(\?'HDDG>&@Y%'#RLNF9
MSOPZ@*JVT%3D].LYP@\^X^SAZ/2>9[AX.OI]4,Y+>JKG^-&HD07);!B-XX?=
M(WY0F.L $A=R7D=$;7R64V&7Y;3J+*>C79;3VK.<UA^EN')(JU^GEQ@2&YR(
M4T,N @C_\&:2-XWBG_Y0ZY[TM\]_4;Z9?"5&Z\N77JYY;WSX3!>'/CQ_?3O'
MQ9OS?'1<,)>M7Z$0*]X9Q@=4BK%F!="DHJV ^U7H@4ZLKB!E)(F*<2+.G]4!
M4%V+&Z1"B62Q9*9B@CD+^A>O3P(3DE4+LF+[(/$>_BV;T7V>'C- 32WA&7<J
MO\E?/*K68O5!;?WT? 12@\#$#7XGX>F_ U)Y-S1_KMZAZ130H4_!86JE)JW=
MP_PL*?'KUM,&B*VD--!.\9O7S4R>$._R32V>+T$-%C4 STG1-[F>*GHG.*Q@
MIZ?;/>^> :EQFX4\Z=A;;A8!ASP_HKK'7YY(>.1@\O1>>PP&BZKI8,7S^:98
MP@=O]B#B,B:D!T)ZA2A*DKM8]CUL_ /<0K<1\@U+4R 1#L-!]!.1AZ?V7 "U
M$:D@[%5,Y0YEV]$MY;XJL.;]<WL??J'UJQ]5U1E63 W^ITX)_4$UX#QFAUK2
MDE:RT/,WDQ^&.2Y_;5S^<;8P('U\,QE.?F>\ZYYM_"Y_^ R+98EP\#=%6O=.
M:WES#AX*MPA.YF#!EC.D@O< >5/0R=+W3E FI=.94YXC=\9TAS;QLV-%=TQT
M"P6 ][P3%= ""6CA<'\O[)K2IL&N*G-O4L6M\I8^:#Z'X08F#;?M9<XKI]^^
M=_V*7*1)],E%)C0/,V"A"<S"#W@N'%8N7TB52J5$."Q8S-36%9^[=1FV=96?
MXX9SU#\[2QMON769EVU=OIPJ% J).\<AXGB.8XWTL%I:R640W"^+:X5)A+VH
MFJXI@0L;'</A[4#HN]@!+7OJP\Q.%"^2\A#TM'5.B:$U3*R4Y$DFL^5Q/4A]
M6&:4F\G)T[=+]_'$ZCX5MD\JTSNLCX]&MZ?E3N[*@%(??^G[>Z>\Y#14;KJ3
MSF\NG2ON_EXR&XI6X,2P_:S$]BMHN4MTWK1,G@(?D9.5\Z/&4Z.@GW3+/K.O
M!'WO#\#="0- -H 88A[/G_'V=0C)3*Z8*I<RJ4PY-U-0SI*3<S9,>SJ3)>3I
MN5K]66E;X[/"PIOVSS\_:S__^><@0C,'#ND=Z$\'0UVCA/6/0J>6U9^ZMI'.
M%[,?/D^(;:4$LIK^0*@-&,:RQV0&267[^RK*URY_!+)%%8K7Z#%;/6AFH5U3
MY9AA7X@?S)9%1X$L>NZ(-Q-/.RW_*:JU+X/L]LFERLTD-ZC85Y76K?U'_? Y
MZ'6%&Z$$.Z%<,ZCZ"+;(3DR]^16,&)'W(\.'UHC+B8*\8.RSF\N+GKD'&>3&
MT&:O[:K]OIPN?.P9V&TO:.%7"=**.]:(TD*ALK\G*C3XC_ZK?ZX+=S)]IZ"6
M0_XD91"? W@:5H)*?S8E0,O!!0W?0J3.>(CE4KYUJ3=.<N=JT.XE_*HD8<EX
M2\R+U@VQ7$J5<N54IIA)$I98%^[P?H-Q&U67!"??^$MH!T"TCE638 =;=AOQ
M7^@XU 2\DH D3PA)V-#SI^K5K_SWZTKUR-]0^4FE3\A<H_/YDUKWYF=316K2
MST"XQEB?%UUP:OH0\@&UUCA69V0Q\1N<+==/JM?MNE<N2$TWXL ^Z8MG$V_"
M>]>]A_E4,5M.E0JS]S >P)2N2?G(W/JS4<F0HUWK!KCB74N82X+Q\0Y4 *D%
MGQ/RB?=(C'/&!!8H F9-7_GX@RJKWOVOT\JW0GL@H;?'MRE8@-,DOGWMQU7,
MI_*9&=P&>^+$8XGAN@[IOWGE*?X[YC(4@EV^9HC6#5ZEG[B_$B"IB/C4L6$[
MG+%EHI<JA/_'YL:'=P3RW\^KZ_'YY>C+?:OGGQ+_38#Z -.>?3HQLYYU+M,(
M@'&S>[9!E<H5RJE\(='OF$#KN=<X!9:K=P'MO^'7T?/X]91IW/[X6AU_(V][
M'C/G^>R3.4H5"\7D8WD$ !%H ]53.28]OU'B];&=:W.L<RV?LN+/>?93^4]A
MPW3GS%RP^!H!@-NLRT''.H>$2->RQT&#JBJ&C9V&&7R$;O+9]F5Y"I1Y!>^X
MF5@_L]^+3<][N#O:/HNS>#,9'SOF;>/KY/[\P^<JI)SO[U5 CM_3&X_0TTH[
MZ'UQ(5(0@EW9V9R;97/R9&*6-2XUF*1:!!ZO4D&4>HOW/I?;,/D))A)<>TR]
M+2B# P"?A4^("5=?9>6UE'2H*9LOIR7+L\8,)>@& QK+F90HA=D73)R!#<K-
MT4-!?5/SNQ?7-#1!AU5*L,HUR'W?W_.!0N5.>9AL[T"./J1R899+7]5M!G0+
M+S4#0"?>68EE",NSD;K3A#['_)D^@? O]*R9:D3B5YSQ3'6ICAAXIFWYK61X
M>1/BF_HKEP;T1AP.Q>HQSRE#S?*1/WA>#"LE<2R#\.(*/1Y$A;^=U8V$-Y*J
M&]"&D6XWP3,Z5"HN:X"%2W 948:V(7H8H9(MO_./& XBAP%UQLTNEF+Y-ONE
M@LF[S2UUEI#$BQK%/6&A=VAS!"UI$MXOS@:Q8\(M@)*VGR<J\>PD**Z4TI,2
M@I\<>^:E%S6,P1RG?@98WN)LN3;)H\T5?+KB,F\ D'_'NE!CPB+'G:/?I>R?
M]' 06,F="+U J0D;EL\*VI(%([/^5(O$2Y:>[+JB**79412J]F.O-82:B+]#
MJ2C%)=\/Y2-HE#W=_0058#$=](+V4:K! -><(2&O$LC8)@@59K"T>T.B>=!/
M@TD75&U\!5#H-8%:TT%ZBE<ECXX#0^YEX]Y,*A6W6?II& /ZDNW3/"H,/R.!
MH3V'C=FDSZOPN)@3U*T@<?/R1D ;TPT H.1L+^C=AHS@GW>@U;T;]31B=!P?
MWTRRAEWX=?GUVV"2\ZE>TYV1H=+QZ;TG'SZWJZ?UVM59'>"CJJWS\U93:7=:
MU6]*^^KX:[W:43HMY:+5;C>.Z6\NZ[7Z^46GT6HF=#)?JMAK\:U=K"SL Q8X
MS:@$8X5I=#BU=S>PH2L7#&G9_RCVH/LQF\ZGLKER*ELH?/H@:J6"(C'^HG+F
M/ZMEU1\^?['I!86:WQXA&E?7&Q<M?V^A5&QJ'MG_O."-$9JG+TA:;G2UO';N
MN2_^G]F+RA0BKT-%\P7OBXE6^+K9!=]P$'3"P1;KG;X9C=*C=-1OF"[FTE1!
MZST\7#WH/PM/M_/4JX7?-]?#ERX>Y-*+*UB\"WB,JI6EQ#ZST>F<XUHM<4Q3
M)59(/OM27P]UE\3<Y-7>WC/B./]$]FFM-W.].Q[_GI?>PX5?M&$DM(!<6"TU
M"28QTWO^KJC-9\YE"2!,;$-%[ +5\4.1I29Q6_V9B1&,/U]KY^/BA:%6.UG?
M@%YHCS^LXQI\G)F#L?R:5RXIZ"K_[\/!5+9 +I4M%6?+B;5=Z4_;)A!BS;%0
MS.^]7N"J=($9*E3(7)>CF G7M?%T\>/ZXO+<=8(\I@7V\PTNZ[SUO=+5+*9R
M1:K!%?+;?3-?7\X:WDYK>Z]:VQ)\_E^%.RI\U!I$M/GP^9+P"!;#[H>1 K1X
M+.P63G?6P3$</<+/HCN6\*9U4MU\S)Y7% _I0#Q$0@V57L\FZ+:U6KS&,Y(/
M4/'W/EYP-$<7W99S],7Z$;1G#AWATJ<7Q21:< ]?[+&8(71>L&NK%D>1^M!L
M*EO.+".&8N_"1GL3GBNBGN&=%P',<^RB(9S][T-,!>Q *D19+*9SH[?YY<]'
MG'#]%DD_W-:SM6*@-2ZQW5U"+X^)GK<U2-%9-WJQA2?$6=.Y%\59\ZGRT<P<
M\/<I\7=*XTYI7!U_3]0?G[VN)*V%S69!Q7-QF?L7Z9^%Y,0<296:IWA&9(]Z
M77K\WBR4?TH '^](\4S(#5IDOY)4SOQ*5$ZJ_Z=*Q<32@.W7-]_061FC+K%I
M2*3*--2OGDF47%HHJ.](,L:&)9;54TL^KS@"7O&E;E9^>S]/J^W<7Z6GONB>
M4SWUZ*BXS%W?X$N]\W/N5-;-\G.N04_=Z:C/%S:UE>BH$;E33S?L"[6HEDYO
M=SKJ0CIJR==1CUX@NXKIH]11=F'_RO;IJ*\NSEZHKK:A02'+H'[?.FO]V3IK
M)ATN_[_^\[W6-:SND=M[ELZJ$&Q M64:ZTMN?2972!73Q52Q_!XTUIUG=:>F
MOGO/ZDYC?5$8[^4::U3JD.,G33U^,O]<Y7<:ZR(::R8=@O]X/N1*!F!RCA*Q
M/;9?9WV1T9Q]X>6.TU_93.;4ZR54- OTS7G'\M)Y/Y<IX7L5S?+H<M9;2!2;
MA;JH[EN/YT)?U3,CK^:_:%IV);KODENTL>KQN@N\%Z+F5V,RO$%;+"R/5*U<
M*=],COYHG<+@:73[>PN+C%_<0;"XZR"XX@Z"N?2N@^#:2/L5:[Q?#]6KKMH0
M('0NB(W@6[.QNN2,B#E/WDS,],GD<73\57M8!X3"FA&X\C>37]\O3SLEM0J0
MKI^;A)I]#9/J843Y>$8%WR=H]N8#<L$&[!"WWEPDS4!YEIKY1IH')F(_,^#F
M;#&=$KA9@N852O3LT'UP+$H@BL[IPP#ZV-\# D'P(-:?,(+'1&?GN0S_B')*
M';&KS.@@ AWID8!N!]@U5-8  Z7Z$^CUT(;<AR<*O0+P;*!I,>*4 ^88MCHF
MV)]0\0U'Z)4HL,LE,&P?9&L.]A%=!^?@&H,A"$\>-D#\?HBX3ZKCOT$VMJ&Y
MMFT]\09]$OS7[B*]X46B&DT/^P0RB"---SR&)Q<]XW@BURSZ2D [$V!?X5Z(
MC*X%4B=OPLX:CYH<5PDH$MJ$TI?IGY+ =E-XGS_J]!=(XAP-=.2C@3HZJ$"L
M63AO\3C]=KE_: R4&[K\PA!B2F46:%@4"TJZCL%KHV@3)W('++AOK3ZOY6W9
ME\  6L$H-WJS<3/2M1M-EP' !K7'B]SQXY]A.4AM;\6\.[%<T6^ ->?]*S#U
M&LT3R=ACV)]@[Z6.2D>Q>>:B@)#UL>H28D;8CR!1$Z0UT*?"& [E)P@0Z"!5
M8>/)+C3"<O4#?$1_('B>*N].F9)'FL/4@'@0,8QN'[RNJSJ4.H/G]O>2'@QS
M92= *'L?;&\-$+0^J%=4^3R&3:^86HT=VTR4,+GAT#-'O)EHE;M*J_'TT[S:
M=.4667D$ATO >3'*C?!Y1L!,25KX$GRDG%L#R]FF4Z&7DM!-"$0#;Z#\Z37P
MO[92GJ\3UZMV,^D/'K1O/TGQ1R.S"*[7<:7=J"J59DVI-<ZN.O6:TJQWE$:S
MVCJO*V>M=ENYJ%_ZZ%^GE<MZ KS7>G9JF\##I,#!F@*Y.!"S#^"EAK8FMSW=
M!?CX_SX4/R2^.GQBS+'U@NF<< %Y@0*23:6-VARUQ FS'USK3?9E\9A23.AH
MS5.;\:+5!\F7))GY+MUU$Y50V-DT14O3Y<*5&TQ;*]VKK2"N[!J(*^+=9H[O
M]%2\(?W2T"Y;SJ+_)[PO(3&[S "+_-]KK!T=!-(J-N/:[4C[[4C[>$?:&R%1
MGIF/QXP0^/L_BN[2$7LK#;<?SS!)V5RB!NDN-W1C<T-WI[%)I['2W+CGSZS)
MVM7007>TLLB+EOUS=],WZ?2V[Z8O#GA?S,:@?*]>?^:HM[IE^D GH!. >WH>
M$/[K*O,+*_"OA* ? BJ0P>W[N@N)+1)Z?2:3SAQA@FLFJ>LE#Q-B8BCK>!E$
M,%$=PQ]41)O+T5?U[J'2'9P5=#\\&9RD?(A+6#[K;0; 'SQP2.] ?SH8ZII&
MZ.!T"[/Z4]<VTH5,YL/G@X4!\-\D WYW"Q:J1UGO+3@6M^!;\^'^=\Y,CZO#
MS;\%<_($@BV+K33)0*5)YHC]#1O-\@=OIC?F.1TJ$F".\ZE<.;%U\YM>SC7"
MD[_$)VY:][JYT[\W6X/;G<8FG<:Z]>E5B^=I)]I45BE+]^0*=9#KM:MDC=4<
MTI+F<,VWLL)VLHGIN50CP V5TN;P$-:D7.OI\[N3]'&Y]R4H/UOXT.7S?JO:
MUT7U[<)<??N-E>R__6:4-^-F^ KW<-QWK*NSJU^WVG;>C)DJ^%([_%I:>GQR
M;S95+BV%(;W]]>([#?#=:H"[T]BDTWA-S)GU^+1CP]QL'CS]>DZ8^V_1/V:X
M\W(S2E37J7R7TY7VG[N!.?DY2_D6?KVI@]QTE?MHIW)O+,G77Y?D?:UZ8OP9
MM >//^KJ+*UZTTA^CC\[=@-?56F.=6E?" TZ?;A)RG."-UN&0-GP:IGX$I_-
M*BU9_ 5+E2 L,N0:MSJ.I6[:M!**7A8[C!6FXL>#5IQ8O(H!BF1^$=56ZJ9&
MM! "Q:;L,IVNV.CP[.+T]G="\(EKWI;9S2_@Z<8GHF_(!8FM]<ENUVFLXW[$
M6<"/"3B'FW*<*Y0>KT!Y"]^LQ!*/S;Y94HE'&!-F99=K PYI^V;\CLCJ.(PF
ML_VG]%J,?,%RG5<7<#KS;_+>V(MX"*B=NWF">@NMF!?=D)?Y6_[*#=Q-:T=N
MRT_KM>1#$J#Y6^Q"?-G71DQM:^AF=_%VT]I-:T.G]3*FOE;E/EEF!)5\J]R<
MA(H]EMFP(H8V9T6K7=#R(>(7&=]SUI99Z=K^)WY90="Y-*]L*IO.A+ICO#S%
M@AAUI_?TY^O3S]MGEDVM=/\1Y7\]55>QYO,+JK XTF: LQD7JJX\OPHK7'R5
MRQ12A>+L*/7Z[OAJ[\%*U:T==WHM[I1Y->[D9\,\5OYD1T\_OF3_[+C3&KC3
M"VI$P]RIG$NE2T?OE#FM6MU\J:\@.4"_NEU(*E[=Z$F_@ES9FNE.M4O:9%?$
MUN_V;KH[6G[3W=Y"E\@J-R0A"+I \>$6G_D;F!ZOM:!XHV/YJM?5^TMN?]\/
MOWV=_*HYM^NI>EV]P?*&1LK+JVC7X&5):)&3314*Y52Z4'Y=,V8GQOXVEE;;
M#);F.UG,:V?XO=2_2C^H.Y:V*2QM%<  N50N7:3JVRM[C;=+T]T&;\S[X^M_
MS71WMNMNNN]ENCM:WOEAGN6'F9&,OK4GO>6FRMQH;W8A (35.UCT>G7R6&\Z
MWYLKQ?S8,AN$T]N*4!76[D2)@"GDI@P.3F'OZ+IOV73?&7<Z?EWNY/M*SD_.
M!XUV[?$J7=YQI]?D3B_QA[Q_[A2#$B,6R7N%A]IU5PHWDTM;/[[_<?20+V@;
MWFP[%DV&]4+GG>H___?_.3A03G1B:/\H%^J _$L'^^,1LT<'R69*_RH_5,.#
M 96# W&VFOZ0<!MCP)(BS>R*Z"=<"M!F,9B:.'=D,O3>U$WGR$/Q^'JL+#>"
MBG-R(.^=V+5_E<YX1&=0L=4NM)UKTJO-=K9IP1;F,O)3_RL>@Z\">A2T^-__
MI5L=M^LV4>\.NH3>:#KX"(]-[B'(-CG27A!)+J")47AT>5(P6S8AB5!6@)ZT
M?J"D]7;XCO*%T#]G\&?7"CCT!X4X/74$!&9[5*J%67\#JP\ZZM,%O3R]<8>.
M=VQ0^?HAQ(3R%4F&)ST"W6T>K&&E\V<X'FPXG_IOEP_F+[%8NIETVS]O2U^[
M:L7L?OC<X-T5Z4))T%))*FE?*P5L']GR#W53(S!D^K"@FZM<2&=(#X-J&72\
M,?W6,*Q'!X&?J,9!=3C0Z0R=LD!#=\?*/7&'E@9)QVJO9WFF2SD\J","1]2%
M0Z5:!V7S2J5=54KY=$KY__[?,E5#J:[$SU[A1Z]_/L2O,O\J-=(GMDVT_3TZ
M GNS$WJU3H>EVHMBDYXU,.GT-7PMS)/0;:+J$'SBN9Z-DX [['".3!]T75OO
M>DQ6N1;54?OT=>R[+G$?"3%QI+YNJF9/5XW]/4<HQTI/M>TQ+%.]AP4[L'A"
MM61<>M),Z;_I@+I-Y^N,"-6P'MBTNJI#G$-_N<KLU>[OW1/5\>"'G@.O(R;5
MUOAC-IV@0V<"P\-'EJ*.1L88_D*_QJ7R0]'9ZL9$M1WXQ^-0[PWI1Y9#)T7N
M1Y:MVN/0IL!.2R/O[W79SE/A2S^@^TYG3/5^[5#IP '0!WNN0M5?;8%U >TH
MO:%J#MC,_*7HCGRZ]*OP]*D=H5M ($,5B[M EFF, &!7\*PT.M A*CHJJN,J
M4+,:+,D!$M"=(=%2=!?HJ9N$?N?0Y:=@W^C,/2K!XU8!NPIW FG WQLZ&TO!
MO:%WEL[Z\!WP@W?#V"C_V=^C#$@9T4O8HPP J$"0&)*'.Z3?#"U#0R)5%7[;
MD)0$SR ^G_&Y@Q(P!WDT&$,>@1(Z$-#(<O![!WC;':4Y.IQ\:[O &>!S2N<J
MNPZ$LC'S4#G!%\,M[1*3]'5&AEV9":;X(^(ERCW=6_C)/54HZ;6[(\ 1Z&53
M3,ME3U/>1G^CZB9PE1%]A#RIF.8.CW?',!QR-H^^VL8KRVZY$!'^RQV0 53U
M@;M*E6IZN7 +1O0Z&GC3;6*H?)&>*5UM9(1\1?M[JB,)#]P9RKGQE70%C_!'
M6*,X2E<EI>E*&IB*E6,^[(W>N-$LY@!!M\?DB_7-N3[ZGOOF^4Z+JZ1)??@<
M?>714J]D0+@3N]5W?IWT3\]^W2WTSIF^A(2WAKT)%:?5ES54R5$ (,S@+'BD
M-IA#S$A12[B4974SR;QP)J85D[>1E,B!_Y-,:DB=T8,MQ2G@]>!&7 AJKIA:
M@Y-YA9']-(V=#"KC7T<G/X^.@@-O!+0=W R827!IV'#31%=?R=PX,5[_' [=
MP<^C;+'PK+G-)(DE9_<&1+N*&;X!,0N=4W!:IFK'<EL552N!3.F#4N[OT4>B
MGV;"+)UJ7CV/:CRF2Z4%" KU$=0ET-3P6\?SE7J;/.A4 J,21@T *CKI5#P#
M-#($F-;[>D^EPF^DCD$(4O&,4Z<;@A,!/=T&$:K1<9C(Z5,+6X'K*638U-P<
MKWL+"B:5(R%)X1^D W+K7KT%>3DEO>BTP"T#?XQP^'>@VKP;'2UD? Y!%8 7
M42+BJOT5O4#TKQBJ8*RI2B=(;X&IJT#Q0#>6::#60N=LZXZFXT5R%J,B7^M!
MZD'K<Q[Y*!7#X"P3#!)F65@C,"&M&%UJ2I%R2)AT[]6Q,&<4:K Z\"F= Q@Z
M=(KZ/<X'U%-F>M!+J8&9@@^G<)-,\N3AY>?KHK^DSSRH='KT\ZF=P='H#T?4
M*H.E/>KN4.D3>KOIO83O4+W%YPSUT3G<WY-V$@SV3.E?F+:I#IBBJUETFX!M
M,+66,0><O>7"D/[$DT7SHTXW53 '>IS</@2#4RS1I3OR2(P'T&U-=Q@Y8,H^
M*9.154ANT#J,P:"=Z&O=\J\\(HP[R2BE_WJ8MB+?+^M8OT.T:IG@?+=Q2R]U
MYZY*+6PJ'>G?(C[1HJ3VS'B*ZM?'I:K3./V5NR3;YQ:MWDP*%^6??QXNOE]7
M"Q\^AU9*965?84M58*T[-^F;WYN3P#>HFPZE<%1O&*\;62Y(+>1<OIB1F!/E
M+SUVF)0-WZ%O4J?ZV\BF#%L?X6/TO'NJ,^3:]P,5 VS\(3$TP9$Z-ACW%>9X
MI6RY"@_HP(JI2L@,>O AL.\=SM=]IP7,6G<]+C?0!TB5,Q=$#&%2B#SU")>[
M)UP<U AJ998]5AJFX]DH,*J6#3Y#Y(WH$Z2"8'_/H*(*N?S_1.T8.8V*#\S'
M]<>4AKRPR;WNW=<9?X[-89B4?CP^'G\]-\Y&?=^8$5/6V-"P7C[?GC3?$1M=
ML/]Y9L.RTYT5W _SRD7A)L(F1+:0GM7E,+4$_2B5>(,!AP ;(16BX:&J^3+>
MUL%-K-$SMQP'7+HX/A6F/NVA+RS0$+K$T F=5&A$W5<:+(=YB60# FX*CNQX
MO:$_\&M(X&V6MN=7ER=7U-@5!'!*C[]AXL'S<Y\=CZS=D![]K74/'H>%![F9
M%']Y;4U+#ZVON>T3Q?F;R3!?:)^-G&%NB!%*__[L[YWR"Q2Z/#MY_.;R6+8<
M?:.DL0CG8T[E*2E5D*14!8,^$MV#/TUR].EWI<SYKULU6\E)SK28=\.S\V3,
MU,L6=H\M(3@RN6*J7,JD,N7IU"].#?M[5!N(%P?1O2K/VZN163"+-UI/]D#V
MZGKQ5ZWPK70W>*U-6])C=U#PX9V*T0V<$#O.?2=V+E:69MZ'N'HOW(&J;&Z?
M2BZ+^4H"R@/_)_TM53D(YC9<';8/E0%HMB:J+Y1B/.;!2:%6S;G*/5'!4P/!
M<" PJFW3+]J$D6OVH_KI8Z;X"4TY^'5 ZKX&5.FY;$"(/:HNO ,M@4RYH&CJ
MV(%0H4$<^E9T^TH3-L$)0L!M9=_!VSU3X[8(^QG\(K**_;U@&7BI!\0$W=8
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MEI>$J1L]B/CCK<>$'SGS^^,9>2 &51*EG7 ^B61Y:G$\3L_ ZCK$?N#9[+!
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M1""X%V2\NZ0W-'6H1@AF:)DX/2PLE1/UA'RR0Y\RIX4&H]LL7"DO_S#^V@7
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MPBZLF]VMTNR7$=W],)O07J [@#JP"0G5Z+/P'WPG0H#B&QOB>E%"S<BB#ZB
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M=X+F#9[CW8JA^BP;S73*S0T=78Q]^6MT0?(4/Q_H,YH:P$2!S5B_R)IUP!W
M$J5%=P6+VHD#5C1FI12#TE78JF!-AAWF1Y"P0T4]PK5EWZ%BP-/.&6D&Q0AM
MX"#\1TKH-T$_-O( S2%ZS,2)^$1XBB?^-9@$FEC>E*"B"F3"[L+64W-.$;8Z
M[&%*0+L:&"GVMT[3'9"4^!SSF<S41,!/4?615UNV3@E3->!3YJ_(Q(N3LM=*
M$_//[Z=,/MY<YG"N]&@6\93,G,':90GDL,S44SB5AH[17U_T))&H$R)-]  M
MGB4_IQ0EF^BV8GOEZN!>\+<- RR1\I-)[EOAU_55L3JN!*5.P2/LY<OYL6:\
M>U9UQWJKT5"-]!#,!.\KVU__?@:M6[C/(2'Y^5!I\,QU\H!F-B*UQ9]CD!!O
M6 Y)3?DL/0=2Y!'VDNF@?M([YK&#:X9.*R:9':$WZ15B$XGG/ PH+C)D?&J\
MV .1&X]C*XE#1QUM^WM"245&''*YP1\Q]5,^^"\;GP\/HP-Q:I9,GU\>KW\V
M2\.KW%'9IT\Q+Q%A I[N?/@<DT:XT)NX=^_;I)51R>A7/YN;^Z89*N_TJQ:F
M^@-JP #E/U*YZQ!S)D-:P13BG(O+3,&T8FY;_/43MU TI8WW.\;3VWM0 )<
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MPPL MA+FWC&C0SSCC\3-(C4)LCL)<)Q!M(K<U<"6X69 >%U0D#;#4HFV )!
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M+U+IS-544>1<NAV<&>KQG]\3$D:EXFOP@0,60VW"*2Y4'QR:QXN5=.&1FP/
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M4=01M"] Y8[^962!JDSWA(IG#NX:?;H77J,NKQ&?!#4NM/T(HPPG@*N-&Y,
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M<6(D 0@-[BA!=4NWJ:&AVH3!SO=4ATJ(/QZ[$>QK^CYHGZ&RW_E^3W5 Q=,
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M:&J)9I/AD+QD(E4(V@1Q_$-ER)*7XQGG%'U85!N*EJM*0X3-377,-5A\#2\
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M>1<8"S"^MYEY#XL*EJJ< 8.*#],]F2T\"6&&3:]2=H$<JB&Y-)/"\#-A1TS
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M5@RR, @5Q8R06:\L\%V62T/OF8I2K8*9YX2>[E08N1[K*7&:M,MBQW%OY;(
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MX+&BR=&W9*7HHSW="E5K%Z)0G50/O^?NX7?AB;DOE<BX[ASA/P/OH99<^'-
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M;]57F$I\Y R6@RE,.U4SM#>$78,H%&!.H;,X)4CID"0!IKK"VAD2OP>B<50
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MJMRJ$9-J$Q7L4S?L-3_E*]T;['/=UZ6GT%MN!IVW]-Y"6N4A=+A@XA&?TVC
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M?JO[UP_ASZSYZ3$FD;*:>"LE.;EQ%B C454(EDFE<A$TM7VBV\&-U%D !GL
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M@C/F/J5M6_CZ<FT>:";M$-*WM^*P1._3$MVE1_LWR2JHSFRH^H65=U+.\J+
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MI=!F!SW=3^0_+:84;#S1(YL'T?[T^&MHF+$23F0W]7C4V=5.@1V.:NO[WB$
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M08:6\8'C$7LQ?3PR/0_KSU4<7M=<T"2#?)35%A4)QIEY?J65KT];OAVR1\&
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MD#W(D[JZK0? %6QQ#P.LL+ B""! *(AK#>%C:8WJ_CD%U:7I62HJBD+F=;4
MU?T7/AP4.FFB$/UX/-)P!(@:5!>EXLBBU9-(@06NJA[&Y(*E(:=V71B1OK_N
MUWM_:![(H\?/OO+2SG=8VK-SM)APIF:147"7\J*0GEJL(X&TF 5Y@X4GBWE9
MYZPQV;,"]^QU#,OMSLMME_6V;L3G15YRH8+6-U]XPQI[L&MLET4F*#=H&K+I
M-5DNUYZ'2 DTCUN26P>.X0AV5V.O#KK.<O\U87^YC;B.'Q^STJ^)M2*#@64)
MAF99R7+>BH2-I66V/.16"Z[()Y>3R:WWQG@T;([[N#DN=M@;8#%/BD)*O$VB
M; [ Q_D -B$)$I5IS@8/1^Y^/=\?OZK U+"L,Z$@X=Y(9A!@+HN=5\,>S-BP
M(NZ\(G:QP4RY.S/2[O[9(L$P:FX<\JK/U[*AW(K2A1TR"<9B79QQRZ*TGU@D
MXK.CQWYFL]_:<B/]3CTH7@,CVE&DL)1]$0SE<"+NR_-]B_4/E&16Z'H+5]_+
MY\\.SH/,^JO(DH$/Q^#]6@97K(/CHQ\/\BLK+'LP20]L$3!]XM=\YE\K5-K.
M.&W&<KOF[3/]87.>2),3>NBAN9<Z?29IKB>W"A"K4OI4.$9ELI?5II<Y^ ;I
M-PIV,YJ9\LK<K]$2P)_$@+$,GWAW'3D^3DI[S33<"%H;ZN%<:?LGKE=MI3TR
M#ZVD>,\7>XO>\SG8/6].X?>VO,CKRN18?A%F-4/W&>"2?<HXA[P&""=N40E;
MQN#PXJ 'CHU0FW0RL(Z9T2NBQ1O^X W@/@'-6R^U6Y2<H8ML-5#8WHOG:ZWG
M%[O1U?YB\&BL@(+^\H&[=@].O3^?CN^+'75\T;37]"/9Z>0\<2W?C!JMBD+4
M>E>;I6#C+1^"-)C;WFXP,ZQ\D;$9';LP_H B3>""]&K9&$Z^ X92;KLXEYOK
ML% .?*>%M-^&#?8VTR?3LJO*T=;-;K2.AMKY?=KT'-:!L,"PT!FJ-WC04QHB
MN0'84V8U#%G.>[<"=DEQ8JF,1Y9[)CCYQ$=% )BGBO^U'(B&1KLM.3:/%A4C
MZ.EI?C@^.HJ/Z']-,C0YHTN?B4KZA;*6'C\^7-#=SS4PW+-7]=VAG,<#E/,;
M0#F?#%#.O3[3'N0I_G6/\6:-AF<@\UM']IQK69P_6)&[V72.^)9FQ$V/^/%H
M../WXOG^Z(6Z"W*#"ZG&]8R,N'3"X@EESC[J(JO/LIJ"Q!F%6P+?B%U(AY5M
M$!\=CJ^0*J:/R;GT+\ME5!\ETEKI3;](5UY>5,6%TO-YKA'HP*0F3%ODA\?/
M>&.T6 BKVGQ@N0.D=U#'8BJY=2"P[=,8^GKCTK0L$Z8JP,IWJQ?A1F4;#<^%
M$I?UK' !Q+/<!JG"LKG,2+.>-JN$56VA7%,4)C9UW"D<+[M'TC9+"<%IT919
M/8GI"5:1QP]/7[ 1J.LA;;%#7/5V;&LG'G.]6"26+]KG?+&]EHY1O].,5)5G
M%;0\]FN?#N?0';$^.QQ#10'!RS)1'0.L(HF7%SY5>Q,('*P.N6W"_9$MI_L5
MGV9*1( O)4I:T&1D!SGGCRW*6'6;RZH* )04P-%,K""3NPF?6V5"IADD+;+E
M> ,4V*.2JVK]N9]U7KN)9[0]I?%C!::CDG<1;C(>%3ANV*P_.8K29-.HA+4"
M1.AGX#>0'4=74BD7GH8I#A@ZEW%0BL@##:#I.Q>/'S^S#H,*7[-\M\G1&:1I
M.TFW9XMYV*S?#H85.@T9%ETYTV+7&=EFV@=9)CDM39YFTY6PO/?+F,.2S+A(
MEK(2+"IV*:LVK1="<V@OFWJ630R>T75'X3RE&V5IR=*51IC72O*F=7(IQ&,B
M]Q!9D5RV8JPSE2HI27@IE84YXR'0""*P=:%VG7,V&E;8*A+1?J$3)9\:ZD7S
M+Y;S9!E.[=<*[A"RFO)!90"2X785+V;/%N>P^>Z, =O15N(()J^N.<^7+:6?
MHDBFAB;,JYE8+9/?R=-:11?T(:]$]PVK:V<]-@U,?<_7V[5[]HZ&-7AW -J.
MBW!K@<XR.V_IA;FF_A?[E&T2I\A7A M2;A>@+L8C_=.>O;1A4=XME?'EJRU)
M/MW,R59L!(3&EEWIE'U>(/=W#H<M+BV4)JS$K5;U59:W+S/NS7(G9NWV@@O/
ME9U(F)GQI[.L(M]B25L"!S#SI2M9HT<4I=QHL1?#"]T9?'QZ[CG+?=/H<6V_
M%-\W$R8>VGX%$30=-M2]VE [[:=N:O#@9").<&-0I+JH>9G6AJB0PM,9JY<J
M-(*50N?)184_EHG/#>UE#7FV>,L<O+:WX;7>Y!><D0OO&<H$M+:1D4^,51(.
MJQQ)3,.]5E=@2>#;9S74"O9L'0SK_&[K?/=:C3G63XQZF0]_<D<NN3!-YGQE
M#]31.H#+E.6$2W'$FX:>7E);GK>N"5\A]<!7T4ZK'Z;5;*U?:V7#W!7V[*5^
M]^+\XZ$X_PV*\T^'XOS^G'X/]'B_0ZQ:!2)$A@=)C__#]^0+E-!D?_=A>T;$
MV(K7ZN?'D:L"XH+O:+LQQF]-O_E@B-S%P1'Q2J%RMY(:988$']QP,YX/XJ&X
MW@-[L^ATTZRRA2U$JBZ]EB.=I:)W=!ZMRT65,J\[ZVV2#S3C^(:B FFY06)2
MW;1J/C^D:QTVYUDQ-P[::35?76(.X"J=4TSR^?"2?"R*=7B>),[Z#:W^I]6Z
MIF- )["9[-F2'#RJNVZY.^PYUL%C]PE$Q&=0/I(,I>R)&+GY,WJ@"E'#*J&X
M5_Y3<O>TT.=YW8 K8+YNI)%ZN5YY$8/;!ZTL5$P+?5%):<(0HI]ZM)A[]A*'
M17K'1;IST7F;77"=E3B1ZXP\^776QFK9HH_?9*; J_D:"?98(MPMN!57Y2&W
MGZGR<<,?I"*[9Z]N6)IW6YH[K\PB2V!?F<"\0?.M^6"NQMX7B0&K!7TRY<SE
M9ZBU\TG+C(R\SDJX(LMDH]6@N5EE?'W !YE\O04,C*:;H/P?*X4%G[=S"G0X
MU&U[1QXY=:MB!&=AO][ZL*KON*IWQ@W "\U7 M"I!"#HQ$9MNE$7#AK-0@X7
M34NS\H(!W/&Y;[O6O+9Y]',-+93W:<%-=UAN;SFOUVFWDT)CD9V!"^^"1B^@
MQ6FN#=L6IMBA3"_3V)QQ5\N%:$B6U*L\L_(XL51B6B5/52-%/F1VCN/U(J\*
M<_M8"'WG"8YQ!L](/KO[3"5$JZ\=F^AG;?HF18"<0,45HD<:/L?&J(.8BQG4
MC;L;BW]XO\#37?EDX]%-'JU?9\RRAC%[<J X ATP>\_@#H+^ U2V>Y=0J@VW
MF:_K4F26V 2#9MF$S)CI7];U\IRFJ5X+!(^I!% ,G%7+7,PT@(/=;D]?IKC=
M=PMK&S;>>JR1]$%J2GB\HGH2%'1M!A]FCR(L_YZ5PI!AZ9-ERHYRE?LX$)&$
MYND"Z/A*0>FM2_U1=-KO\K9!7YU7J9A&=KE9_SIF/I00&Z44"C$S6S.RA999
M=IX4\U9.A)<ABY1VYP'39P"7L:Y\H<;$D$HZDH*5XDIAO"G9NRJS,QHNWASN
MZ=P@NJSA4/$58SP?;9JI@I!T+T/L!T\&O'FZYOJS%(=;37J)MW-/T@MZ18:.
M12I;10&^%@YV =1>KTP)>=N&V+(9]LND/#"3^4=SK?RX&]?*N[)9,UK:\JN<
M.+]>V6M_XM6)3W+S[6A9%?D,9P+4LH$U<&;%UR"!)-N:SDDZD13+;,Y&UG!C
M1#.. '-9^CXO6@F;#<Q#J%3X#W7>?&:* /].WM8[9V9=V?J6.V!9KU/A.4@^
MLSP<.Z1"(JC/E:XAUYTUGFYDT,+ 04^F^5JZ!QWCS1I"E;FZNFP@E(O)Z[!X
MGUP^BO[5(FCBW<J/TYK0C5[>:KQT7T'7N; G4_<8:+$2\RV[WVKS1XG>WD;X
M7A&/UMDB7R\:T^)REE^H4(R<YX*C][3!S#$_UX.WT&(]>(GY\(5O1D=8 L8)
M ]6OK;(!=Q(!Q'\F&'[8?6Y/,2=ZT)[B&$8#_<)V+U)5TS3 6ND 'IR*TG75
MU2=#=?4;5%>?#=75?;*G@\M +L/+75T&V@^E<2BKHKG6=5"]=SJQ Q8??/&C
M7RZR>K0>>!*VA,RL? $109"RM'%J0E:.NZ[4J4A=$!?:36XJ,TX+A0X-EULQ
M[MP\ER<IH5UC;6-O/1?K>7"[IIIR! 5_C0Z2B<^/+J1&V9=LMM;"<%OFUC7(
MV:<Z(UM52T5,%;QG]*2,L_Z/Y&!?10?324"6;-B3<'&AD73E9PR=D=01TW37
M-A$RMYK C=4$5BM*KVN1&Y;)OYV<?)#@L/(F$2TR9M843OMJ/#J83? A=[E5
MIILU;W0$*^8$+S9?:R9>B81J*E25YO''HW!8DMZV0V&RZ5H[\AS')?M+\B56
M-K;OF)?(!3D/XJ<MD:"O)414UZ6!CYF5;9\*R:&-)]_<[!1#"_*,Y=N[ZO+I
M1=YTG._NOI#0>3R:U_21#2?= L#'KN"ED;)Q+6/M'>=6;';Z;2^G[3PQ6+F&
M+B(Q+UA+*YZUOJ'!T]8-9W<94QBXM4AK%)REY=E#\]4>E/UY?+2;_>DW&=8(
M02/3F*&<3R_%(G@@A8!V0)@ZVCLH[G3:"S 9)\I*55-<5BKXH4<#:LXJ3OI(
MYR$CGJ53P$&%E Z!,=:9!L)7F$<8,22<>5NSH4$U)5]D5_UHFH&4OM$('-P/
MDB7"3T[1N9ASDN\$Z28R*@%A()WU1E,:'W^HJR\;=VG&;C>K:O;9DR/5#"H
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MDHB0,IQN0L<VK3))MDAU"LE_YP2/1]IP2!?@_(L^S;+*T7J[S(O"/(2%^ 8
MWG+3)@%/,.HZ/52D:DUKDEML\G0]R^'T*E60GXCE]#&C;/=K)PTGQ5<]*9[M
M)B&FF M\3J$4N7+DI:DPWJOH!'O\-7IH:NET%\V[061L#];1]Q09HZ//$=_8
M%E8^6I$;EK[5G($>")5\5&6_?&( :]6V;PE6T*_%R_!-5==KN99H*QZ(\BV=
MS=4BGT4-74Y1*BD9.0B*,AEL5B:<_&#^-$Z4<X+O'X].'_73#.:9GP 1^G,<
M[<SLQH.*H]]^/GDCB I<9SSZ"9B7E58+I3QE,RM\I_ +;X11 9:4OU'RA7]5
MRZLE4^RX=3G+"_G2VS5Z-NEMT[>10_\?,G6_)+]3J.<!'U2E/+.$56(2:3ZS
M"S+8VW@5#YRT%#J1=U4F.[53[[D;1I6,7Q2]Q.P+UR\,(L,S<(*[XFEZ*U\Z
MT3>H>25/<CV.CI]%;Q[]_.CCHPAK\<4K^;_1BR=']*[1IO+O1XJEMH^/K--%
M4JAU%VB.6VST/OAK:#%$[1?O/X!JSWRVX:H$F%@2O7^IO 9N\Z?&\9[><5IU
M,A0,USNWXQ%D&\076U1EMHF*A*_ *[>5Q>._O[=_MQ<^D;[)XY<_/J?I_9'?
MQ)O6]!Z_?(8_OGSV8OOD<O9AV^Q&=G)?10=FR--J,Z-3SW//&A85]'>PR2I>
ML8T4H75!JRQ?8,X2U1V81V=5E08T*SRHK==_PX1O L)ZS7$N$ DK,:\X0U?T
M7,<OC<^L,X5ORYJ\\^1$O4T"WWKE!4X!3A5X!5>LP\$3N$^>P"Z]LKXG$+/)
M3VW)#5NA K@UJYL=FF =W(^9-0SO@+\?#GJ04@%ZEZR.MK%PC4?_4W[DL$DR
M5-M8ZF<EE:] :DAE-L^%+-)P2*K@3:SMY%P6^5T8)<>CT!PRNL7!+)7TTGHK
MA\;784G5FYY\[&'$V_ZZPDM15V#3-@-P700]QM"QGS(P#";._P &]3V-8.O5
MS:G;OO!K\CN2-;[Q3IJ>-M(3:MP9FV'^*2LQ$R9KCILI,S/'K'+S'O<FVO9(
M;ZQ<#EV6+T>#^-F"/>W[H$FA#99I]Q=^^<[ERE\GY6>]M_I.AF 4;R;P'6_L
M6(DQT\H>-YT"J<:@-OR'O9.A^+TLQ5$UXC[>[>8MY-8=3WBR:N?YE-W.#\@A
MM YT3J? P19"5(:!5/594M(YD4I"I>%%+?0?8KXVBBVI@0O>N#T",F.NDYS9
M2>+/.<W"+T1D5!;+.CO/R@8 PA6;'.?3RZ;UWJ3$ )Z;?KT6\9N:YCRA_[^>
MTO]]5^,L_)4S7'^G::6/3M<I$X>GT>FFSI-'=&CFVOH5 %ODI9F#CBV[GG/Q
M#1OJ\7M+ 6J.N9N<<OX7)NP72+"U\LYANU]L](4HZ(SN8:$&7G;+D\%*HO:R
ML"MT^QN^9#@".Y3H AR/#.UTO?7EMWX2A;^XP[+@ W=P1NZ3,S+;Q1FIQ FX
MVK]H]T!(8$HKWD,]I#@S4OT3GYX3.?4.S;=CW?^FY=[\*XXL6TV5L@EHE D1
M&+C9>5D5U9GL*V609I_?Y[B0A*]+B?3$@499AOD39OG24$*V]C9C]X)+BW$I
M!0]B*>:9RKY!.[/=_F1W^M(NYCSPAM>70?3'R@A",[&-PA@%L>[_$,<*&<UF
M(<BI]:S($CI*9^?9 I5"04;EF#W\,[K,DB5V/ VYR.>*0'EH6_^Z O*SH8#\
M#0K(+X8"\LTWRF .[V0.TQW,(?<!TN&["CS!/A-HF0XZ/ LW=6A+[8W*.5B7
MF#]VH3Q:BLZ,GI1?NO2KSNC_RZUIFQKF(!=:QRJ AIA-N;80 @  O/'R^^QC
MDEU07LS&Q%!^C#8>N>PW6')J6VFET8.'V#8R9JG]2+S-;6;Q.COXT(S3?FW$
M/[KL^GS75D/)^G"4%2#H+%KC5@#"YSL "'U*+]>WHKTJTKC"32SC4:$Y%4E!
M@%N%4Q".;<9#^@44C+6B\Y4NQV%*I/6N[/0%)\Q]7FQZOHI.YYWS'$Z5PYOC
M5K+CKYS%XX=QXI2^ +7(INH9R-D%:1R,^QC..)'(X3B.Q'/.>YJB@-_0$Q3H
M-)>O:<<%3AD[\([FL0"F^7>XO%8_D*P!<=P[3Q\R.I@C/[&H2I06[-R2 U97
MEY+(06V"8IM+EVJZU2##UM='T6\K2YF#S^T7N9A@USH#B5KW\ZZI5&C59=E(
M!Q*W20KSO>)8=7)L[^6)2EO7AN(6#S[-P K>[= =3N3[?"*_V.U$_I5.GY/2
MSPCK*NEM_[/5!7,B>:CKF4O# =.%*%O;41994GK-SNY>GHR0*<8^/0JRQP?X
MP>YUO/;#X/J= KW)AM=L%? OKR"+C;18%V<"R,"6Y!L,>^<^[YT=N?[>.K4U
M+-Z/+2@I5M2_I&6<CN-V'P42][8#-?N"GS;%QM'M\-Y!)A\1/_)-_XP.Z#>F
M>VX\:C6?][DZDU;<PQ!.[V8I?I/D6ODOF3:ST32]?(FS? MI+N]TQ$>F(7X\
MNCQ/5DV%WOOHP/@VR0H!@%(/B4S7I)<;K]V89FUAXWR(!8/S M()9P@7;5@-
M>L[F .5J8AU0@5P"IPMDAC"H?Z\37Z?2Z%+3C;E1+<?='76*O8*6@=:%U&<=
M>WMLY2L=\K1J88YKZVD:A6#G9_AL =OX<^/6_%A/9:Z==GIK% T^AC$F%DS<
M;D.)_=I,ZC@-VZAH]Z[9HZJSGD64I4+,6*T5-&;JE$HU)',MJ6I;T"-7J%ML
MLK4FGR<DK ?YH;PA4P#=A*[>[4O5$Q[O+O&XLSP343_\/3.>&T8^2QJ6HZ,C
M:F'>PG2=<HGUZC>7M-^<(::\\M4QGQ#K8UAEC=A]T+,4HP-;OUHLR1\/2#_T
MA_00Y]&<8IJ&N2WTT[X%O_UBG=)=6*!V1$^^'C;+U"^]0E:QT22$9>FTRV/2
MB93D#B[M[S$GM5^Y?N/VNXM+G#?<7E'/DC4N!KJF[[BS]LLL#V['5W4[7NZ&
M7?\9W!?.W'M$35><>VVN&NM>!(W!9>41 "D[4&;;RO6WXU%O6J6WIX3/#<2C
M3'61N785H]<9\L9+OL1]Y!A&ENNZ62?EJGN;H-"&5("_U=VE/!(I=]5K^'*N
M8)OJX><9CRQ!CZ56:K9Q*[69DV+#K=3<@5S)OC%M>KF>9\G'76Z4&[]+L?30
MCI_K"HS/AP+C-R@P_C@4&/>XP#BMBO2;;7Q96%_S&4\^?GKWYOW;\>B?#^QL
M^U[/]_5?(7E1']]^^/CV].VOGTX^O?OMU]/QZ.37GZ)_G7S\>/+KIW=O3Z/?
M?HY^^<?'#__S_R+\X9>W'__V]F-T^H_7[&_MQ[S<]_?^C5QJR:HQA6?0PFW(
M/%/GLC:.2D29[(36V<?1VDK7QE+<D7NL[$*GZVD_*8COEHY'M\I=Z]WZ/.P.
M6/G@O_+_[N&^_*^_Y/]M@T[WW)J;Z&0X:+YFMG&HS87Y$AW=Y%-/,P,.I)]P
MYFSN \(;VU#0=P7?B[8,EX+XKJNF.?0^G(CJEZ%+U=DX??L&\3:]TR:BX!RO
M:\7ZCO2B$8NGR:;96JZ,#O0SFG5-7I@G0# @^D\8.<?G;KXHK$!+)CG !0/_
M$JX""IQ=4HHK=>5%%J@S5.FA= K3_JO@)]8*<6ZK*3]7-<5KZ>'[JF)=%1M/
M-(828#S2KW[,F\_1SPFWG)B22]B$Y=].HX&H,Q/B\W,X0I%CFDMN V\F88HX
M!!MFAFJO074\FNM8"QVK"T,F\98]H_EG&Z3RWS5 [>2"&RVY-W_=KX-L.*B_
M7N[CV:/CW5(?;PQ;;O2;M&4D'K#AH46I^[50OF=CODA7.H[LMJUNN%G',8,S
M<Z5M[%%9RV+CB14(ER+::"/+(>TZZ KM8L5__[ZN\X8/3K9_%GCHW<[0TDI.
MW' !6N;G:$F66S@+$XO.XW^1X74YGS._URI1(D'.%E67-)\L=RS-AZ*M)2/Q
M\" J,S&C Y?Q-+G?.@L)KI74]R_)VJM6A[3>#AOK/FVL7?I<91.-1[J+5H:R
MDO[=Y"E3[MA=%S $NMUGG0%+%M3?08)5+)5GKA2+$+QT(AHF4R1Z;6N6^1#+
ME+-6JB=2,23VR^P<R#Q.G_&_LWH&"M(BLX+<V^\3Y66L%2^[B6-N.BFSNCG/
ME^2&_5[1MZ,+>D/J&WD[J:EFN4W ^P6A82/=8U=F1UKG?E/ENS5TS/^D51(/
M/<):@]LL':R,L%TAX1D64GSOVJ 0)-HRK.U.BM>+O;:-J$U%?-7H!41VS06=
MWO,-KGBE&*;K8-5;EL&)I!3RG=XSTT+>5H?XNE.Q7UODNY=27@REE&]02GDY
ME%+VN)1RK\WBDQTC?&$W'R+[_5D@WYURS^@2DA_3(;]7T\R,_*IU</!E@O,R
M/I+_%4Y27T+K#;/JGS"E"\LJT;7BZ&"#GVW]U7@D/WL=_$R:4/Y#O^SYX=)F
M>1NY!840BC_]X>@1??<8'!#*_WIPRTK!!WL3'E";HFH\.KF&(83;@(Z?Q"]?
MO+SY=(G_U31KU?ZHUBN3)XDY;T$_%V )OHA\B_\:7<9%+A&S'[>A^<F-@DAY
MR(C<1F(V3U7D]P"928^PY)2U<,T*/6+T)'YR]#Q^_.SF;W&7I_DJ8X>;V3=X
M&CU 6#=Z!U4=_KGGH5B31;%**^41<I>-M=H",CUO!>A%%;O>W'QVL M7.;,/
M3W-)FE730GM6_<<)4FD6%1RDTB3=95G\PB'%VJC'FUY;2PY.^"$>/W[F/\2'
M-0U@YCT+GO?U)'KQ[&GPM3J_X)S9!_(O95N$]SJXN.4F0:FCOE#A$$798C)%
MI#Y M65VD9I[<^ $<F@6>NO>M;7YM[PEC1I[9X15$EK9$73P\:W\G&K_ W(O
MD/X>1!HJ4__#,7GH1ZW[RA1'G1F^<@B\..XPA/VRK(/G\,U2ER>-A9-O8\9B
M-/I5OD60,F!.N!^>B9'G4OIZB6_I)Q5ZZ9$0U4UZN^J_EV_]S5R0.T4[W)/1
M23]B 3LGR$/X5^'4QY8S BD:[X-H^U@<48'HA]W<KG-]H6L>M:W0LY!=XRBF
M*F_$I#E<QIR^*=8 S#F<RR&3]#[/N"/'Z\=% ^Z<6XB:59T'3%H>K8\GW"J<
MJ9W4SG@TY';VXOGVB(+KI"CL:1/L(5FC8+JF6W6=AG8DT?:\6%>!=YJW:\_P
M-T&T=QC%,8YK5K/LB3;W.$,Q,N?H7;&M;KBKKAW(#3*KPXZZ3SMJ%Q8?#OS?
M%%6#;?0AV;##*)90NT0<=L\9 XUT]+!VT#4V4[3DK@_=G&42OS]C:$'O0-SU
MM^Z9CAFS=?W;&BA+++OS5I)&_OX995E?]R#])TLPBF:WDT7[0IGA-4'5U*^[
M>!522^*ITV6 :ZW66OE\T'2Y7^=#M@OD1_&^U^)P[?XX@:A$ 2?6_JVY1M(I
MNJ&BDT5E_B&23M$.BD[CT2TDG=H C3XU)[,A=Q%S"AKSOHZ:D]WXV\*?LE/Y
M'8^\<,B 3$PSW!5:JL/9<H^K4CL*RSG6/&8P8T[FB@RJ?]#L -$(@7U]\#^Z
M>O:%3*Q0DD$6FIV=;@JC0@D!_:["0>AE6RUG323J1"ZXYKR'42(.(0X?ZFI9
M-0F$:@ 5I.NL%PMEI0I)K,2?D$$:D*..<M-39 #OR)7S8HYI>\]<I)6[OPHW
MM P_I-=R85/'\_/R/2#^"EY$HGHGV@DMA[#/J*@D9#BP_+QDB"[A7&T@PVQN
MV=,?W9GDEB*UYQ_V,:>8?+'_VEHO%TW$O\NB,A1UYUEYZ$>I5\:EDT>M==[.
M_KC)!:4&K]G47PV!@]Y]Z;$00HB@O,O'*>ANR_H*F]ECK_! FVL\*K(S4"?S
ML/B'W6K$UH48&SY-R4Z=H8E[M;T)*)G1@9$Z/YD;N+-Z09:XM>,^HGT&_K*X
M+OD#U-N^#@STXP &^N/!0$^/!C#0  ;Z/F[7LUW)"4%-.J<8AP;_T9"J_IP7
M;(U9?XQ.41\?NU^3^\ 6SW<'"GT];S2M$ D[CDAULMG.W^!R4JSRKL<)-KXB
MT#8S7=3B,I ;*%CD[$9@8PWK;X U9OXJ!L0(2YAAQ,+AS:.-51C#@#82FK-Y
M@F\*YU<$MK&5@#N4&\U0I-<1FT">#'J-W %!SBI]JUJC/D<;>N%=<#(>\;[F
M.YYI_,3.K<=Q*Q$].4^:$(F%!E0B'7*TLD()SJ1!M82]-LY<['CY3!9X1H]I
M\XR<<(UP"BFE&[JBV'5GXC]\I[4B0J_>0VI(;PA-1!;3,\.#753U"D)#8-M)
MI24DUEPGF'T2%Z]QEQ9(!F>@5H]9-FB1TQ_FY/;/SO/&HTB"XUFO3:3@N:XT
M=8*WN7+$W/4FN16\G,TUOY%";YOPK#-1S%4_K=8E]V\GG.@9.L3NU[F[LQ+B
MG^'<54YV[>MBKR&V@7(<QIU,I,T;TYPL<_8Y['F-4Y 9S60[RHFP36A!SMC^
M Q^_>Y]<QDQ"''OI7=R5S\O?U^F9.0/(3>(24Y#VO>H08 M@M_YM=C9"<.[J
M@]WBUCEW<YU2S:3G7,V)39;AK;;@@7J9SKG70+V>?MZXFI!PG)F\._?42O9B
M66>'"WF$8)[]VYF[_,_I1[X!7U%?DC Y<UANCW^\YV4M5.QZ[=2U[S2.L3_(
M+"!:!S.U99J_9#0>4U0F>0$H'\S8%*1KP@*A*ZMQ2ZMIK:W&+:Z&Y04MF1M?
M8*[.;6N1-<:P\EI&-N,B3X767I@N.>US=E8SAV^,.;S016,XY$ HF17))LRP
M20W.@A>"[).Q1)<"K),KZB+J-3E,CJ%;%F\B9T)4I;#S<Y,&_^GOYL&&W./
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MF87,Z;D(@4!0:1-Y?04"]^>/A7&3G321RJX$?__PDJ77@1.>#."$;P!.>#:
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M"$A#-!J$N6M]YZ6P!],U+(>[+8==3"_SKLT,X:1_JDCHBP0<![CJY_4P.O7
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M9KU<%IGE&62PO@ &L<W WY(HH!_M9&OI[7=J$P[\.E?>PVHA$D?\O?&H_8U
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MT!GL^[N?H"WOJ-S'2J]5/>QV%ECMNLHLOMO: >.(1 ^/@+8J+(K;BKD MZ,
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MOEUJY%L< (#<,A2_GDFR8D-?/,+[-(\(Z^V#=T(""__9-'*OGP0MU9;WB="
M=(RN&AOC@%]=#8,3FS1Y15:[&R94KU,H4:HR\O@0- BC812DQ,NMR0 R-D)/
M5? DR E5*4\V_TI!7ZO/QLV2W_ [2[\TY@!&7^"JPDM4BM)]0VO@VYS;OHZT
MX _M%C=TF3C:!?=TH45(+TK=L?J>6S:^? >>\[AR#L3I5:#C'N36+V$S25XH
MC\_1.54\*"NF%\*>_047AAB<>%\^:$\4+'7$^!*F*:N,0<'-VWLJJ7-^Z<<D
M^<Y/.J4DGBJ" _F5M-BF-RK2&%-]VJ2MV>(Y/57T64-!8<V$\#4(T@QG*HCX
M"K",6>%A/;"4<&Q--A#D:373Z<R9*J R>Z!2VU;:2V3NN+$=((EZ5P*9GA/'
M]+TXC'*!7=-G+H9W.&>N'SINASHI@;X4% @[F"AHNII5O,;-H(?+A\TG,7[+
ML5H\?7^$":S#$&G/\-/PBERW>X <PJF*PYM7@W'$0>/H*D(>/:Y^Q"W@G&RI
MG &I_K@94D@#:> 4-96A$^2+$3=K 4U0W*UJVC_^K7?P:N<]/ES_]Q?X7D&X
M+CPC,QM6@9=A,";$&E!=P2AD5%1RM^6DE,1^(T*#G@:*^G)H(M^J;,<XWTK_
MS:]A:;<J$LYY)I6D(T](P8HR) Q-A4/0!&@(GZ"'R.QNG-7'1[ZXKI/UONZ7
M:9CKC,?NR5?A!.5W*L&URX]*'NVN43??T2$96-;EK)**@6N!FM(R4,Z,#?4/
MC-_LOO>]W>W=W;OZB^Y+M!%3ND)]#=-I5698FO6E'8_;LA.[37;B$;(3KYOL
MQ.KHV1=YD2S;JL5&D+2M\)U@B.DHPN $*55'C_,!#'$5L:K_8:QBMG\=+U2*
M^=UV:>YA0IL:T8Y-RW92MIY5A]<H2L'FXBM/&=GU4/*EN+FVM$LUNXJ@0+[V
MD]#S$N!3I-KEM6/WPEVP$K!#C67-SBN8CV1)6T7J[@U?*5A72T[]W<H.CE6U
M<&8^#*.F4.<F&>"R'EC!K.IVW$:,2M7S,B9RPH0+JIBHO$+NVFCC0^"TA>50
M5ZS4R:;&$0HPFU+QZ@)[=,ET"@.#]^4W5H>3.+:QPUV!TC"0+GN$:#'-A[<L
MCE/GM#FC7 ^K]3Q3KF?*7XPTPI<81A-WD>?".-#6DL$75 (#*\8""0-PX4W9
M@.-2JCCQQHR!CC#3'-<A @B>TPQSS"\5].G.E79+P9\H*@STM\+PNP(C,$.[
M46?NI1EK:WT%N<'OO>6"W]T?H-JRZ*H):Z^E;#Q46#L,0'ZX&H^TEH"2B"*:
M#T]?X^W69Z4MR\#FQN#0>$V@4#JN5+"ZC-//H7#):>,M$6'Y*]P7X#(D!5&&
M6C<]W#:3,* :2-"P'&65*4J0CVM"=51@TU>A7GHH?JC@H*"JM UGC<P72E2T
M2;BGG;+-GNK$AFN132VR"^ 8CS>KV#IS$]<?W&BQ%=-D$R6)7XEM68JBT=5'
M@=XZO@]?=PD.:FJ^PQ]33L\C%688#+D#YO9Q8@^+IO.6G#R'HHU%%Z0IVD\Z
MCT\J30>"C4E\^^NN-G7Q!DY&V>)9'DZS.C"]0%GAF,-.HRL^*MPO3\4O%/MD
M]@_+XBL9QXIKPO Y4W:=0K=)6OKTY@<*]\)(+1XEW9!H\:RH/<$N6JP.IC&B
M33*(IOQ1VK'O,16]8 &,EEC\O3D(- >R(<EAR!%GB-K[+7E@)CX<-E)PS.'E
M:[=JJB;JSK/)9WGUZ2PXM6 O#O$CV,04!B*_BCDE_ &3QFV7T\=%S*E3ZZY
M!\U$-BP2+OJ;<ELJK3T2\P*#NS2V3<631K7,5B.OC3!N'UGLG:"]8(,W<@K8
M3+,$U=.D$5='$,B!1*MO.TAN;8>!^D*.<DQMC6ZTJZ%31Y3]LHJ@;JN&J30=
M2.YJ&&:#-.J'4I,C?<6SFBT940,IR.:^BX (M!LQ#',D+"VU#[/A;'C9>'\S
MJ0MB]V?>2ZA7JMU"$G9"5A1WP]H9UHY,^1,HAFED 8KT7"I= ?1:UN.D]0T&
MQ6I9(D\>,MUK0J:/$#)]TX1,FX+N%<RRK83W88,!611S<_R06G/@/CT1"GPI
M5\1[,D\$35O;%?'F>")R;SZ0(U('8G4G1^2V8<[U0Q1UJ^6(>'/]D%O>=E<W
MA+R?LA_BS7-#%!K\K1Z(-!8LX'R [V$YA$_J>Y2Z&;?L='7Y1,\ZS??FAR"8
MZTQ'Q+O5#W&,ZY]P1JA1>YXWXOV\,S)'O+=FJ55&47.]$MM)GNN9S'FAA5-8
M)^54+U01\Y]T7^:.I\YY0;".I;V7.2]AH ?MN]CK>)L# U?,6G@P#VO-W,FG
M>=WX-(_@T[QM?)K&IWD:UJ@EV2:[5!1+UJ+V252U>BEF5^X.<(PN"\@"%+2V
MZ^&_KJ7PEJ'+]#OHOF?C:"H7RS@BZ!"X"19G-!0H!X\FSG"/I<CV@2F!5I]6
M4'$6DF[L>&[,C5E%:&.FXTRN1L(JDDJ!%;MYFC-UGV?JS7(Y[ /5FR)]*R1(
MQ]*QH7[7@\]/8FW7-,GN%1"CITQVGQ-UC@(*94>$T*U T]+,R/(-?PP*,*@4
MQX<C0L)B<A7H<J@111H(F%IGHFST.2KJEIP!_(8L\=0F_*!&&A%<XYKXML]4
M0NC%;Q"ZG/B0V%Z>A2EBZF!5E.[;4IU)\!^3$#OV?80GR*2M5P,'20)35<VE
MTT01G* K'\,[+J.I[_T!KG7N86<$=573D[ A2!#,59)6=X#TPS@<(7;?.(C9
MV0>]/B57,C"  EBX9B:-N#>S9GVG2O>#_Q-,IA^.C2: -1(?JP*9ESF](Y4V
MO,2% 1TJ&%"3BI8XFB,POGTSZT7*(I#V(+6O:E5I3]?IS%%;%D))0ARFK!)$
M:D#1)+Z)U35<'W!5589PE5_IMG[%/L-^,$AXP0"+!7P0Y%D* ?GQ,SK]2VO)
M-[Q;W#;%$&Z>E^LS&;[JC,#N^(BZN(:5 WJ!<-$YQAVP]"UCK"5]1BW_V^X/
ME(8L?7.,PA"1B/\HAA>"!#WBUBE8BXPZ%\=!A,'C83 !@YYK;)U..4&3HJP\
M>$U<PDK?LM/%&*G0$*!NWR@MJL*D(BV"7X;Y7B&G'3?2A3&MOPVW[T*WV1<L
MJ,HMY%7$,")HTV1(18/1#V_C[:9W$P:HBV:,I01\9; ^2_Q+ND'DC.0'5WG?
M*)1V2RCB:'R]V-(UPDE'\!\6%IDJFR1M2CM5#CQ;REI@7UQQ(-7FJ&Q2=UH>
MX!%S= 3'Y3 ^FX7$DH#!.UW7,2-G(0@FMZ '<V#,$*77?VJ9,W)^Z;!Y57'<
MWE0/-W5\,A.@33EA")]P[J#W>9<%_%D4LU+PB")K8JI]+95<F0RZR$9"G;/8
M&D+:U17X<R84$$[(L['CULF.6RIM2-5.=]!B,U63[LJ(6 >9ZW)8YV@DKJ/1
M;BG5#V;*W4T4.)>HI,J&R2"YX@1/?HDI,^7)H]6'IY/X6MG Q+Q$0DBAI3(=
MW=Q_R^ C-09OBHE*#<5,K 7.765[\<JDZ!,:"])P:N-6P1K6KOF& LLB?"P^
M_AHY:Y!,)7?%"0JA-  +B?MH,&1'5 M><!6 ,66QWUC-*)A L6 (*DF3GX';
M:;=NW;HD+M7_FXM,5__K"YLQ5,55,#M!.PIS>&GJ[K8H^YLFROX(4?9W392]
MB;*O8%OE)^7Q&BM4+&YUU]G^L7/_U=V+]>$8?T;?NS%UM4%N 3S7N'(&VQ"?
MA([S#9R#&^FK#"=1,6'>,G478;)8;I'JI4PQ*XE59/I^P <@*PV7XX!%] JM
M(64D$7H?&?2SW$U\/Z%EPF4TP&N(<:%G3^JG C+GE V?>7$JL$H!P\3.N#&7
MMEP%8R&5J*!\8@%6Z9857RRXN,"RG%RN75=0K,H-66 ,G5%SZ8R75R]G'&L1
M:TO$%P<IRRWK1%_D"&!IT"D=SUH9H"S;]F(9(V-F[,5W0S2P1)=)+,Z: 7D4
M1"':$[^:<4)0))%.E"=R]97G-PTBKG41F<UJR>CJ1_W2S)?U5M7#I3K@2]#S
M<&)SJF8LD9HY4101)L;C20GX\;9@AC<GEH$+,<*B2Q1NJOC7.KP?Q4S11A%N
M_K.78<,PGGOB!RM= _7NC"H$TX5&?)E@9=Q%7.:W<1Z#;1#Z.: >6&FQ4B--
MJ"*^LU\N)4\\Z3)^G!Z/%.KA<'"MT JFBC<ZQD0R@JN5F>)'Z>DVL6>G;U]M
M$*@;11RJ!S=P!V?*G-C-T6^7OT]XFU!;(73!B(A+&8_I*KS):&$9B]12R?3+
M$3EY!L5,+7K(T3.KU@Z'08J2V03!=*10&;\Q$()3F%.L$:0Q<B5(4QA(K]@#
M\V()84SY<'593YF-75ZIA8\\6)M68Z;T:$(-T>BU[_85Q!K%_1%#K1^:F#X\
MV< ^V#>"B6ZJ@V@=-(XL6A^G".I"*\%ID1DG5PF1 2]6,*\1:P1AF!$,KT 8
M2[@V;RR5A<$0&6#H4'.\AFL(R<EG8XL2;MK D_Y*-._F8%?H1(TJ/<7=X=6T
M\FO6L\HTR.9A\TPHJI&XOB1<Y=(247!73J;B7"YA;F@D9!XD;5.[)4D2Q7LE
M$Z#C-U8T*J40>>ID-+5Q8(04K2QAU.4RZIAQU A';A+E2N'Z1F?H@3 *'(\"
M5Y#B.$HNPEL#X Y;Q^P/*?5'FU::( B*J=?F(5JA\S$B#B-V!U>W7A1CO2JZ
M]GFAV#K&XL(?*'H9U5S:,7-R47R1V'1&A/QGMJHV<FY4B3\[BNX;IC*2Q @_
M90T?@21>,9 $SX/)9FI6H+'PUK@\Y^UR)6\6_I!W"(KCPBG J;%PN#U3L(TL
M>"(W.4V?B@?1>(PR.!?U""G8O3ZAM.?<*<(:^)]Q<@VGZR*T:RWRRS2$=XHE
MBMTN9!!*+MF"H$%3PXIN:_V?J5Z%2A@"S >'JS"E3WJ?T1DD[A]09)T"E'R*
M]I%S64B,O>0BZ@+YFN)YNS:]8SC+L#C<J0^HK0ZO\^60"[G0&+1;E9$PPK#U
M8+(L7+P?MR&DW=JPZOVP'!W69X+;R04F8*9C9M:41B *89$KZH0\382*07VP
M.F=E\%#OPK PB$(ZU9Q;(/(F-C2\B@;5##,]>*QEV+*"Z^8O?3K8NP5;!VYZ
M>372\"H*F9GV@KB>9PVP$J,2!-_, ?^BS'0^-G38[E*\-)U\6]+@;9,T>(2D
MP2]-TJ!)&CR-G?)NN3+B\^"']X50$;/5K Y^@O:FM9[Q4O7"70K_U-?DUJ>$
M:@D<;L,RM^.4\#LAO6$WFZN4P?AA\!CE>:-91:DGJBJDASCA/ZN;5:)F&H,?
M'Z-;C17'*%-Y,K&UL9!K^JK!6[0:J\&3O%*@D)-I*+:0;89SXDFFA":+JA[K
M*0\3C^ YFM^*8MHMILL<5QH-)7"/BSST=;F8AN(6@%7\%]K8=?1* 1(;J*05
M5R8CHZY=VZO2;L(91PVA;,WA9W&D69$BR94*%;1;HG\R,!3VWO[R:G?C@ALS
M^<<]*KSLBI.]L"B!GX[MT)4%M7'M2X2P;./7KRQH/<J-F89NC8=J YSJQ5%\
M 0NLB8H![.SMX%RM6-B0D#E5P2WH65@$;;=J@GC5?$O.5\T"FRB#65"/HR$:
MR^'KUMF6-PK1AJ;:X&0"HHH+<!KF11IKL<N#'W00*3?JI A63/$W:O[1R@G/
M+6_0"?%;9W2^4GD:G;):&]H([*,5O]C0"I;M@')*Q)3&JM!AF<2J"ZB)+8!
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M1TUI+RM)0G&UJ1I1V"@+^+#H#O'2**-,6ZZAE"*9-_(!)S7"0U("J0?@[*2
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M2L\M)$FIK F8IDH"":,PS&R"BU(.1*=.!!GK)1L]JR55#]T#LK,LOPK*3&>
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ML?0Y=U3P!XF\Q&XYI>MZ%DYU;M]93B"8PHQSR9[L4$R2FH$M^4P:1\U#P0;
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M#Q$U.F1V\1[;:AO[FZIDD89E(G0<E=:&VR!)IJHQ,@X'F+Q..2A):F(0H-3
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MF&A&X)F($IR%A/XKO S#6MJ0//CAY6D8Y$Q_P$\_1\AB)K_.-.^%PFJ5Z*1
M PN '?%:R2N1ZJ,/UYVV=GWU4OCD&*X?0PYQ#F_7%.,\]W&8Y\BO@QRSV2C
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M[LTL&CJDQ;O-#[Y'!!0*@KBYM-5+KCT7,39*Y-EJD9.OIR?'9XTB63%%,BU
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MB?1AOY+-^:8TY*8 2^QQV2,2Y6JEKCV4)G"TDI7)\3#K1^<I:]];[69(Y3#
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M9%*BF"5P:2X)LBIBO635C_)R2KO/O*)]NGR6*ZCI*<R^,)=I[J1*^2)9:$Z
MO7=CB57;B][E+&VZUYW4W71MD6;$CO!0^K6'-AZUQ]:5?N,71N6V()$EE(P3
M9R3YYJ6P::<_G;V.COFI!=W+C7ET0AGFPJ:X0H=5KZ&D.?;W-N?4=K+Q)D,U
MIVVZ-H02IT='DJ4-%YXDW(7X?5L=&8*<.SXD*].V8"P\PR!$DU?K9-XT::HN
M+<D[]$_\V;],<Y]-2>3E8#'D$C-'6B8Y8:1T8$5&TD&D9D!Q8]A?.3N<L"T&
M0>.L9<G"QT!*76H6;%K<R;9WR@YU$&%$XQ%U4?.I72<=YZX"_742;&YWV$$A
M'F6]1,MMWC)])DF;:YHC[, F:3/S0EE9'<=Y3[I:E/B?!O'"[F^U2F+V2,8L
M:+YI/M^J@7W/81Q"GAJ=0DJ((*"EFT!RR\>C$$K5F50R226#1,*%BV7")2F8
M\IC)NUJ;3*C#6@G;G,VFDZ@Y9I3@N44UA+Z+T5/<"ES&7Y,]AHE9X3\TB/:8
M!/(?,Z+_<ZIU<,G>P'A2@_L.@S31)$^*C__W,0W\$2[E&>$=*$Q/H;"?R&=2
M/_YENRVT_7((;7_IT/8W0VA["&T_?O/EY-UX]-O).69W1;_][?CT^/U/;38.
MXC!!%]YL.V 3ZZFS=7XCS"3R8Q!&17F=I[,+]JED6&*$'!Y<[)KB)Q(M8Y8?
MFR(I0:T&I)ZS?SU&C/P%7UI7^X,O<R\5K!1H2HFM1Q@(B5YA\A]TC(W(N/L+
M.H3+?ZA0\ )EZPZ_1,GSQ>8<1-D]=/%>>_CCS0\;NW?[K;_U %[<[PC:<TS7
MQ8[LK!W=3??9+5)S=JY7P[;XRMTZ1S:V'Z0KN]:Y3;M#],PAL/='Z< MHYS3
MRN^D#X*^=E(82M,_U)#_ZD;[-X/1_J6-]F\'HWTPVK^BN*4,G/OL_)\GTE@V
M^W__ Q.N/OU_SYZ]@,]Y.$?XR7CT^L]_FOSE/D?XA4=U_TORI3<1K /F@_YR
M<@ZWWM^.3G\^>GW\R_G)ZZ.W9YC_^?3/DRKZ$PSC\-GA<Z[9BQ\?OSL_^?4X
M^O#VZ-V77:&'<&K^@"5RR1L8I'M8\PV]__#+Z8?W9\</K>=?>J?\D=G"'_+$
M(]R7:U!4:T(<$T")@)/B&UW :V_<+Q6N@%"*%5$OQ$C7F&0,#5V4*\P12%U\
M'7FA%TC"@$3"")QBJ@Z.0.,7^^-1MD#4 0+=B<XAFZR%5Z2T74#W*+-("M"V
M9A0S?+!.<D:[14AN23D"4C7 T"]D]TD+)WII6SMZZ%OP"PNK$W=]O#G^Z>3=
MB;"K#6+@*XB!HWH\HD"'8/50(@@^VP'VKT%UE]SRRRI![D5"E5!2?)H45 Q=
M*GPC["F%QV*;3X4'&@813?,TJ8@R9D;VL6&D_>'!3^0CV0\(0Q7 Z18%M@WO
MOLR P%+'(]PAO VX1CW> "C-"23G&)($/.<J*-!O_<U47DLVD<3%0+I[)#UN
M6=Z1DQ2S35)$AVEV#R*_W-N>CD>_,?V1,";HZ\/7A5W<IA=<GJ>[*TAD1"4^
M*\H,D PIF]ZE6. 72-U,-!5IM=#5""999E< 7T(T)*.5IO?J?3V#G-ZXRG)-
MO:%>$8@3(YW4U2J]*C^F]\O=/YS#WW,.#[<_AR[+9CQZFUR')S'B@TCX]$8V
MCD\!;2-"?XCVDOT60A#UL9FDX(6)+'$K\XB9LPA)2WDL1"3CTUA\ZLJK:&^R
M[]G(XJAV+<=8!L@A)HGD)2;P_IK([ZCA6%G-I81K\!I3H4F0_OP\O 6A_KED
MD"%,_14CZ:?[VE\%P;IAII\\)PZ(@G)!1_Q_UJ74T:UOZE6ZB @TK-E59X3B
MA+D [3='5NQ93$\P>A1.]6PX?#LS#$2V;WWXKN$*Z;[\H('W2X97,[,1'-0*
MU"7>+:?H;8HI@(#I;([^"%-,9AV?8V*<?ODAK9 \APRU]K=OI(3Q>'0,!^,J
MR>E@T)>XZ=[3<>#'X,_727T9_9B@+DAC<:P[1!+X02M*P5457GK#KMV181P^
M??%YNW8\.M+2)SUWAJ^-$J6TIZ8,5>>=$HN<$PHMI$G M%]$O2-#0E46V91+
MAVFV0,V:".HWM6+29U3S"T4DJXN!PF.RH^.H6?>""C^$B=!=+>O5-6S:'1K&
MX=.76V]:TM9OM3/F(/\<C=G<.I&&Q=^1830'L#&<_.WO#"(_N)CQ]K'+[:*Z
MCW46OD@$=SCFOT?&?[.UC'^-\.NFC#=,#<;Y&"7*OZDN$+S]F3T!'2B8  CV
M;)Z /D(9>[%+JB2>[SQ=K7Q-2BX 5U.Z*N4\5NYI7R .$_,L=2DKS$>^@-PD
M75VC6X7T#:,Z>Q9S#F=(CNG9>E)G,Z0WLE57.1V2&TDFM:9@<L%@WW%E.;I+
MSVVZICB#YE02$HT3FG/6^>(.GG S#K;RN4:4= O-?$>RX7S'[#Y !9(Y+F99
M?5F"$K>ZX61TX0>Q4]215-_XB?/(8?=0%Z1P%"5OHOJ(^Y"RU#_P3(ICH:\1
M>-F58P6@7;/,TP0[^^?L+T69E^R_QJT)&S+["Y?,BN9I7OH%Q*K?6E@<ACT>
MS:MDC6RNBTGZKW_EJ2N3Y2L(\(0L2F0=6*VK9;9:HTN%G(_H4:B0ADL8P3F-
M53D*<&&)BP#+K6%(+77FG>[LHBR>_/+T[&E(5;/?-=_.YQHJW*:&LM>]*3/B
M,B'SD>AJF.S?]Q=^BC-18)HJ'[:H+)0"*PPB5NER+0X3+)RWKO$%]2ORO/2M
MU46%]:<768U:_7JZ@E_/^G^]+DP:Q9J*@H]'L .G>5ECB5E?>FU99>DJ(78F
MLJ<=&1CZ9=#U4Z6KIA;9X,;58O/7E\BHW)CC\IHRBPV9.R5K%FB;N.X093YL
MZ77NRFIU;WKQ:6%DTQV/#0)E+^V=HO'(<*P5-WX=;64'-O<I[UDL.R].J"#$
M55HDO@;AYK[,-_1%:PN3-8?)UROLRCS)<BD(O&1W1^_42)4*FLBF$("#8AA,
M[C35X]'R\J;.Q#THNQH$O]0X +E&3,7-Q<8S0O6HD90X<9,V2Q=$-,(ESYS;
MAHZ?1,^FE*];XU[CI!Z2I5S9 ):*BB J%5% H.4/<;,C0A*FL\GU$?#EG*J^
M<1JAM]@$+@!?KE-"P=*]@0(F&$;9EB%FR[HB"S7TMYXG7KB#P'K^S!U_Y@KC
M>>4Y=#<5)['#%KK89X'2U?5 7G9!%Z8ET\BE\.8I2!ND [OL%R%P/+D:HZM%
M#C;%-$MM\9">S4[UPPF_0*ED$9QRN%8O$U1-9LDBN9 J)R"@;TPF/DPJ5IL)
MI:,GT>N00>:=@V6[(\,X?/KM]BHO!16(\^$U0F#*O#>"TU*S'OR$?9UU/[CG
MXIF@ZQ*N"CV4Z\7"2:($-8FB]HRI-;0@I]E_48=WE*CYQ!4RIW@T/,ON>A$7
M%VE!"N%R#=?U%#XBQBFZVBY8").F0<HB7=?,ZN4N:A.Z0V'OHG84^Z8ZL/M<
M1TJ85F5',ZQ+=Z4I)BO?@Y:V7KJOY^%CM;/F]I+0#8S%O 6)(I'P.CIXC@H>
M=N[@!?QK[W!?][X-,>X+^6A^PR+5_25%PNL6LRTI3WM\_S!AH!J3T/PIQ?T.
MGL^>/.=7P[]>FJA'^.J>B\;$"Y<@^>%NP]8Q^L_+^_+9?^FCJW*%]_NT7$RH
MD,95232"A#>X0_-(CJK4DP&#&-VB7*X9YZ$F,\\:F)?P!B$T$O7!212PH_PS
ME@('M_8JP\ K@B1<Y6>16#\XHF#SN%H=3<69ZYZYVPO&\LH2 [OG0?6AI&A'
MYLNKN0)##3Y%]A.I0'+G]X0$OKZC',<@3D><63HHTQRO[QKM$A@;6-OTCVQ?
MP\3<DA+G>'OZE>/4;59[%G<!41OAR,AXR*9KM-0#([MG'LUOB/L3?T9GCKC>
M!'/I'11-M7!/'A%*HBFO7.[G+[!<[M)\H(OM/W0I_CBNHHE<12?%=+V8H/#W
MX9 IZ.,M@K-5&9[M1?)/QCB)!**PRD.?ED>QMEN%3;Y[)>"#^@=\A=RL]Y::
M]^"B*K=FXGU.'M[A'Y.']S!F^ %%; ;ITG%S3+N,F(9JM:=H.J=J.]]W4P4S
MZGCW;]1L,0!99D D51;5M7WRENY]VL=K*:TNJ"P=] XE4<*QBRHMJPO0X/\E
M?QN7<L2*M7RQAWZ[J$[RU.,)D06_%!T+-;2<?>R!VRS!"AL]RCA2?Z\<52<J
M^M!ZK\6GUE)@^:&N^"_V0UF-#WO#C9/3GWD?,=3"'6<5CN)9Y,:=XKT>,#6;
ME_SA3H+'<;KNV].!!A(/A:T-=D/7&NAK[BTQ!N]@[_'5P1:E7W7G5I?*-56J
M9??VTHQVRN3&\,?:QDOZ;I+BOS%*1O40\6B67;UJ.28]^S;9ES$ANYIN=]/3
M6$V1.NZQY^/F*\"6W_#CSSW' 3,KV,]8V\8EHCFITACP7J-KIE0R=UN\(&?8
M7EUC*.J83J\2>/<Y,6(L6IFG6,:HK91O]!FX5T7^39S@X!=Y/&HO9=N)T%BI
MAW\('XTL<<*$%XI%2E$:YF$VW;T#+*?,R"[!XD0#?D[^*9^NLOUNZW<T=73/
M,1>OI(0)A<DX(=6Q$H,H(U],Y#PP=6M<C:Y_UCG1TN8=XHH?'X_X>?+@A'(;
MRZ^6E0J+IA^X>8[0A_3@-^'C.4N9A'0Q603/T0;!NT!DAT>63A1SZDOG[LD5
MF!1)7EZ4:RV 1572RMG-?N_VN\:Z3^1N05@KO\<6+K8.&7]W+?&XH7][+AEU
M2$!I]AVY);%\LPO>^T1J5XDAV)PNF>_A+NKCL,AFSB);+//4!Y7R#"R%F8L2
M@QECRQ-]3<3SPU3][Y5X,"P*QD$F4Q4,K@VX!^%6+*1.7>-NJ!EVAM6E3"&M
MG\GZ]4A#U;-#6Y)P>60>!%@Z2K7#3K%MWQ_%X8J8V;SK.^,DKBET<2-I(2X=
MPX(&'392@PY!:8GQB+[<9[5 U 4+<<$2Y2S2<.MCH3J/=LEJF_3A<F>??7\4
M-[**)2^0,YFNRDR*WRW4YN="73-.$T$T7O(I5=A3H]W+EEW/ Y^Y&O!8L0$,
M#GEL+\':=A/\?]-],O)G7;&BB%?%S!Q)8S]U.FVTA.5\7Q2FLLAO;HG(=6A2
MJ5LUN$XDYNG?-QYE\]9E &9373:67@R:J7NCF&\\);$&@!,9*,_-.48;$/%R
MZI(SW1P?/,59?O(<+.2]E_M?7F;]FTLHNE)"T*<!6&-9&ZZ,E>&9<"GOFNSE
M-'90-*II5CMF:ZX_B[C&*F6S'K:S@Y!2B3VN*0A;5[R("-IM;US$G@G$>!;D
MR3,>&LMC6?3R2IFQ=3>W6]1$Y*R88A(;POFX8IJB*D5.0\=+;[ZPN*&(J0R5
MI)?C ."=_\]U8<N -?!Y5)&-/:9=0\U:YXE@0,&!^KWGR:]8,W^.9LLG2P\'
M[ZL QK[;'C!6SEHI$CX-#N'?T8G4V(7M 7MHS7G[7&SRNV_"8I-T.(A-PF?-
M1Q>H7Q;3-!90!&$]X6!<5(GD5[*WF?SU2^2 6E&A5G,ZZGK]Y2I4_AMAU;YN
M]MWW0\3X7B/&SX>(\8.,& _"I._^^OXS[B^A6.J^Q&P\>*H_K26B8S\P[C!+
M1< 0M31H1[VTWDV')AR[RJY25[@>=5:VV-..JHZ>9R=ZFUP_C<Y[K4VZ-&\\
MX#;DT4&<:73PS>3)\Q@49U0",TXT$Y430[KJ 30.'6'.DN+V<> :#'^R2CZF
MM2U)V[;/Q<;LL*AM[Y+Q2!87\SX<#E-G45534PBX :?EAE[Y0(#E .,1.D^F
M2?CYGS7LXKEXXCMZ@.E<VW7!5UF7<I)< /BFP7GBX0XZE3)!/C!(3^<W^LAX
M--"B[.0P#I\>//LLT82.(8+;=Z9A2%0),?F->IP#Q\0N#0.6?WM&0UG$[GOI
M->:>@KS^@+E<R31=D[938ZF'IRC87'EP4_DA5B!UK<&>88/LR#!@@VQ/M?<:
M [LYHDKZ*+]N'/@CI I(9J !$-U <9%<="<MV"Q"@NS0S5)S1FOMW,,"X,\T
MQ*U=HCQG>0\G9' +=30IBR2:9Y33[!O;\'I)R-#GW5-2#+DK49^Y"5!+2W*&
M#EAH"6+2I([QDRK)*"DF\#,7LVA6RAMZLGI BUJ4*U;J)/F#(K351ZZ&UX7M
M&8]\+X3AC^*]Y'FC^BZ81T4K-IS,'1D&G,SM>?C>I#45[$&-[$<%AU0W77=X
MC$<GT.S-QF&'\L2W0' X]R=NYF:NS$Q?73/#"$P?'(\JS!.V1&9TMBE1/$H6
MY1K9^6;K5$P2]C3WL@ @:V"M9S_H!7*<1[\)DV?2G=C.W P9N="YTW1)R63[
M.8S,%'H5&S1HG,#>SG$M)!P'%VJ_3+/J'GG7AV/U>X_5]D2!FCS4<]T)Z1I;
M<L-*[\@P8*6W9]=[D]52WZ%OK5%D)D6J=$:8O8KQ/JT*$0;.#P_WTOV]YR9/
M=G:_96J'#?*[-LCVU%R=M++=5 5\3?4SR9H+D#QHGL?H"H,-H*,5F--PB5<)
M,RCO,\B.>U!'RR3# LH80/85"(JU>LSXF:<(L;MT=+B1[W80$Q5\.Q%V\"L-
M)H1;$GHFDU!"V!3\>8(3HK^:W+"&CO0HZSSAV-I*4!69U'TVOC;ZPI-N$X6-
ML*DZ?<$I*$'(?CA*.S(,.$K;4WZ\.7W?)V2EJ5D);X7SXFF?(@K1=* !G/XZ
M(]6+2IQ&)XXO09VVI^E*2-*I..7"T4#<()\!QX:_?2'9&AH<%J.*&=&'6.[.
M#0-VW_;X@6,U L:C-Z"O-T3XI? PJQO=EYK/#,3DX.GS81/LR#!@$VP?A%.Y
MT._'<N&>'OZ[-KW&L"-V9!B'3P^WCWT<4_FT\8@J#ZRGJS5"B7OTNZ(LL)+!
MLJ(B&M:19QE0=<<0JA@1@A@PN2SS&85:F:$&6^- BFIW,?\]'M5+L"M0%W1^
M5"Q7 \^F\@3]8!]^O\R*)^5\SIQ$XF:4E&##CI3#FJ2Q]%V0TJ3#^3<SY(_D
M(TM!UBF);N5C5LR\<DGP7 9!Z3"]IW%?+\X:?XNY04SA&I Y;6Z ..R9@084
M3X\-E.Q*:9G591,C=JWSPMXT<SLIW#D<U%T9QC98+#C+ Q;K/K%8+P8LUH#%
M>D3"!&[][4/>2FHW'H$5V(MX(%"QH0VT5'AL.CY_L06LN!=![.'U<-D-".(=
M'09LM.U#YS\E&>A1/W.TENZQ[MA<XDJOS:A.&Z5?JYJ3L/9EO6/(5$SLA37'
MO+,.92BKI?A:5#)7"T:J)O#1)88+69G4ZFX];Q38'8?<\Y("V!CIKD6[FW,$
MG7X+7=(:;X6$[/6\N(Q;'AP&N)$/7(/FFO:BS_DIR#$?>99@%#R=IC-/Y(\1
MMQGIZH*!5)8;:8MFM$HQDXQ31_Z<80I0]!N>SK-5E<)R_'>YQFP!HKDG$('P
MS-3PN=2";I9E2A>4/)/AO2!H@9Z9QXB^G7T[^5$X]]%D36@[GCV8CX*C].R+
ME4B_4YN;E??N8>7">:?5&8]D>4Q64FMY"J&[UV7"(MCWOT[C4;A0T=;K1-24
M6ZS5S8;%(J/([_//7"C;?I>CNR>[;+@+=F08<!=L#];X*[%]@* Y1[:J@V?_
MQ3N070-]M>A\O7<Y<<SZL=<-_74)O(<O7.XM.\GW#1OO@6/C'8\XH-G+&(+'
M<)HC51!=4%W@3W6-+4&44,T5AP-4/B(!=P7?!$VP_]U<;P@HF<+O66\BM)4=
M6BI\M/-@B+&"O2G=<C@K.S(,."O;(S!."C1XR5O/8III/?M."7_+CJQ%FHH;
M*RB1VP#8%]JE3-^DFYN::D><R _E-^'A$.+?P6' 7ML> ^)(@\<CQQK<K:4K
MB? 27E^26_3@D*"HFE(#:L7JD@!Q*K5KK)'CTE8F*4Q.85D(N*G8\AJ07&:(
MT:J\X#QJ*?UY$Q4P%]I+K'H>D.B[;SPZ3TFWF8(*^F+3WLFGI"QW0>%3!;AZ
M*!_\0FH<A?S^ 1F$4E8E3/\P]?*YE07NL]F1=K^$IZA^JEP;1>FRR>>HF[OO
M; W[Z#I1*B =YU7).?%=9$:& M !**;R!'_:8!6"OS[=1*Z@0)-)#T<C] ">
M_H[TR63!)EK"XTA9W7:+HX7'2X)$R*BD[(L.V\V<)[*F^Q\V"7+Z986D;]&2
MRL"(2LG_OFO/X0<'AT]HG[IM7-VZ /XKG')0\J^R<EWG-V!&EFX%GD;O2JNO
M" =3?L-/<_%O:5?G1S.:FCI%@XV,:ZJMN3;1ZI(4*=03M%O,^PA:=2OIZXW-
M?6NU:NJ3M1NOJ?K-RBDLN!W0#31A-D:,^L!1FKO*6K3^L$G\@?0[U4%OX-,V
M2?EP?^S(,.#^V!XBQC1%M]65)AO/R5=47S%Q#C>/T!Q-.&28P-F\B'Y>5\O+
MF^@U;"S8:$>&)/<U:-%/75J./'NVGL24DL/(K+ZDG;<(NH*=/=,#"&]_!T>7
M$&3?Q='AL\/#82_NR#"VBI(=#%&R>XV2O1RB9$.4[!$)$[C8M@=LOBN+)\<N
M^;P[*<*!8[QV"PJI.%7A-?K\<*WLR#!@)VP/GH2=P,Z3#!TAVWID_&YP;IW(
MMC'LC1T9!NR-[3&57?O ([O#G C.ECG""P@NO5]/J,[MNII>)G4:;<IJ0&/6
M?L]!+(2$26B48TSV)YAZ,!ZQC?LT.G);4E(-Q&;NW92<_& W_K!G=W$8AT^?
M;X_Z?,]$C+R@L-"O$1#Y8X*\CHP5[!1KG/I"W\?R7[]#8P/OD.\HUC?#"S'G
MM&XJ?4<>$2I#@82O7*@BYM)V56HH5R;4'4Q4E2/@(HM:.'?8@SLR#-B#VV.0
MWE]A.=-<\JC8-O^<K(273P] GN7E]; ==F08L!VV1PJ93,&^N_2L6>4=5>U+
MJ@N1%NZ.59JK83OLR#!@.VP/%OC@R\WK/?5+T1(0=\P\M7S"*C:^ ['12,ST
M7QT&= UZP5$\2-FTB>07@Q\9D[>#?,*/UTM$Q4POLY1*GTWAGD+&DJ4?3G11
MHB_2WV;^JR=\YZTP96%5WXJ2&7;XC@P#=OCV(?X/RD4R'IUC/!&TH69BEL9=
M6TQ^[<K!\G8>@2'9DZK<#?*.N$$LC5__E>N+8Q%93@6B_%-XVT^P.Z.S)]\A
MZ[0K- [&@-89]U1X!BN,$&$M ^!HL"A%.A+.[7U'DR41(S<)+CB)JN)X9".<
M;:28U*Q*/G()!)R=Z13I59K,C0]^ESV>P[(]1@%C17WLUR" #Y\=/A?SU%NS
M S'C#@T#5GW[R"(E)6;3E7.Z=5[_ZB%!I:_K]F\Z74YB>^GK#7V%F?=<^Y!Y
M("SC>24=P8^'+;4CPX MM;U/O[6E-JB5!3PX7W-FRYI 3@@6ND77;.TVHTG&
M"AA/_-4$-NTJ%WR- -"+5('IY)]CMK#(L*/PIJ3*#O"R1'!(&ZE#L!<3@@:E
MZ- 3'#:'P EZT^['<$@>QR'9/MR!#,KC$5$H=YX,P[",](SK_"+QWFWB'S&9
M8L-6V)%AP%;8/KIQI@ SK"[3??V:HED6%,Q\801#=LF P7;Q.7XJL5 44YP!
M:15]M9LW*3J.432AW0(& :<;"J)-XAGZX1S>(/3H)?UWV'\[,HS#IR^VCU1X
MDW)SKFK#].3LU.?WFYTJY6VD:M20G;I+P]@*+78XH,7N%2WVS8 6&]!BCTB8
MP$VU?3Q3HE/CD8:G^HQ*A83%T6O+XCZ@X7=M&+ -MH]CLC>JVU=9"Y AY(0:
MUGM'A@'KO7V@\HQIRXZ6F/J?L2_F%%U$C>,/!WSKIH].[Q3O[$*5.:IY7[29
M_#ZN6#)&9%Q&%])T1):E@ZD4-N#1Q)%%! =DY%&/LMI4B"VOQ!O@^.T9M1:@
M."BF:MQA7)G))8H,9V-'A@%G8_L0IR\MLH%PDNN:[#72QB01;C]VI72)C8@R
MZ(HG^&\NNX ^VDE5?DP+Y,NCM$!NDC+57.J?*UCB<A?G4G%-3H![IM$/HO;0
MVBO\4>.%KDP$@=RNB<W&%&F3]H,*P;&MDE**P9G6JQJK@H,<J5/"$_@LSI>.
ML2#:DK"@^STX%*J4QVWRF-T49,5X1#YA&N!P!'=D&' $MP^<XA'DO&JXH_JA
MG?R5NU$< [M6]&W4+<*3!U\L!"D\9]:<@M@NZ&T"(+8,2 XR:M-GY86><YJN
M$0QQ3&!N$TT.7B0?L4CY"BL%*@ 57H<G&(,B*><T3STAA]G16 ]1BC1V5%^"
M_W@I12A4$A4,[=GX8SV#0ZQC5X8!!V3[&/-Y\NG)*=*MHV/O9)4N>JH;P-K3
M#81N0KV"HGF*\;<<R6NYM.3L3U@'A_EQDT_0>T]D&[N\=\_]3_7"D)4=?@R-
ME'B+P$?UNF+@&]6$SR9K\57.$2ZM=8I6_! 3-I.&QXVLDL42_\GN3D_I7-&'
MR G%E3MXBSOXI,)OJHZ@YOYX-*?,)F:PLN%.(EDCS:VC0IA(%9D6J<_PX+?9
MXSDMVX?/S[T20ZJ3.#VZCLP/#WZ&OLY"']SO()"+Y*A&HBLJPZL.I]AKJ->7
MPMS-10H5W1J><Z*.,/ZJS94$42RHOHLQ.;D\,: '0F\\(NE@F$"(\]H43^R6
ME90T8@J8(3'<)=-[S]*$6ZQ<P8N8> 5! Q$><:-_(RD-*,)<]-D,JLX6]*^4
MM!.J^(J.[)H;QO*#I#D;D5NZ2HUM$Z.E,?SAHN^>M]+C. \3<QYLAJ_SOS:/
M1G@0)+VWY]EH"EL\K05M8[*"&T? ;'4^#<V]GMC]VMKYIFKV)%5ZF<\\!4UL
M,-A^PS%X_,=@ZH^!#4ETW KRW1.G1[KJ1)?9TI5^:%P7@OWHMYZ"&X+UR^[S
MT7D5;#X>S8LAMA7K@N/Q*CP>,!^WGH_'>4OHIOY#=_.=@O7/AV#]O0;KOQV"
M]0\R6/\P;['[[/*YX6.,>RBB8Z&:<W!HOL.8N5'\XXMDM<("YWA)P>ZO6=CS
MK4;IZ"21C:D;>4OW=LU-XQ5)3POD<O'\W[?^G/GZ%-F8^,N-=,K7:#DA=SM#
MV_QP*#^1FZ:T^^DZ3[!$<W+%D8%D4M.Y-\2;?5UXBBE@F$2Y+"6L0%=BGM!%
MW%UR>K/24%:^@OWT)OS.404BC3D[HY#'W5N3$H9)K\CG=2G!%J-:\#OI.N<7
MK2HDZ]0P$(4V[(7N=7:^OD-3ENL,4#BFP,PZ))R+A<7=,4)[3#YS/*>6(Y2Z
MP=V]S1V8N+)6^S$]$N%O+BY;2@BB7M';3N)[16H(QHS69!-(2JDJ'37M%)PI
M6!ARB7]Y'>,AB2J^6N\5C3CYR]'I^<GKM\?CT<G)R=,_3ZKH3]#MX[<G?SWY
M\>3MR?D__ORG20NTN,M#>B1>SQ9*JR;:D10ZD:&VPM)&XV#BP/:)#2ST3&8,
MQ8A-+5]/!XRV0U80*6R+N,!S$*/HOI&P5_ANY3$(LM>U#QR&$ X?:TX4$DAK
ME%.H-:#& G6%)*^M;M5PHQD94X?YN<SOBI.1H7 9&.:_NF#YU<F5HS<_G[P[
M.3L_/3H_>?\N.GKW)GIS_/;XK_3G(&F^#B)]\I<73P_L022:L,E?AG.S$P80
M!D;(HB!YBBY=6:FTZN/;P-\W)"LJ\SY!!$2K-SPX7-H2L@Z:=R1 !A+XBLY@
M3I)T);(?V^+/?,IEZ_YI9&/:ZTAT94J%[^A]DM>E8UDR5=BP881<X"V53'W3
M"_TP@#.U+\A5Z9-HPCNK@>_C9M'BFI5+3._"7!WZK$J7*;)1\)/F$%U)97).
MW4DQ+LFM+$G+1W47!I2MI Q2,KM"WU^>=HT?M6A0V=%'CW085 "62:@G&;2.
M:"B<[>42L2KE(JMK7@!XH"RF&46]*0T7=@W\G083KM<G#SF8/KY1&Y/(7)':
M[R)%A"8:(-@,4F LJRQ9I>RR=5LUG%WWNKIKM'OX$\+,,#\(9^"5\WW";:)A
MD)-Z0+;U15G.,,Z WE.PS[@;4R6X*6X(JE96IN!35A"/#7/FKZN"B6MP*\#"
M7F8+_*76'Z!2TLC?7QFTSN;2T]XDB^W7WN9$.;%,25A0PK(P):Y!\9DJ*0BJ
M-8YW)/VD=2L0.92"N49]GP:H?$<Y-T]I]1/,'\-DZ#:>"!>FQKW@:O8F@?"W
MEG/'^NA(-A\N4E>[?1^T!;3PV1R>ST&AFV1< UAD"%B?-8X8?PT_5*4.5%&J
MD% A>!#DAUB["ACLW=9#+&<'!K%5[MN+P9U^K^[T[P9W^N!.?R2"!+$1O[%7
M<CPB-9+\X9?D:DXO2G);MKT+JD!2&)5N%X*CQT8Q)JVV<5NM2J[=ZFHU60=G
MS>5%QZ/0D;^"LTA88?@O>:)%:PY=)UBK*0F=O*^D!&;8G$]KZ6Q'H]C\,P:\
M,2P:?B=H2/72T+U+CFRJC'JUO\E+9*[3N-&E+HU?2^S0F]C9SV]JZ=-!X!Q#
MVUS;D\N>H&;7SL<1 T3_<'34\K>4]G'LA5-83]@^22R>*T/Z@@MC1RDY0M1%
M;JB>@DJ(Y"'HD!8RF3@BN81CA$_G:48H[V:[X=^%'8<$]FEY=#DDV7\*TE$(
M<I!&+X&]*960T,Z0PGBL!,.B7>T'UAL%3V)>Z@1! BMFH"@TXXH^GF;5=+VH
M,9!!=H@8<DI+P;0Z&+1P&/=&.I3IM3ZT3+*9\OW$CGZRQ7\LBFSX[!0[ F^,
M"5.!TRGP^AH#3MCO%*YP*A]Y!>>A99) SYRYUV6@R&NDMF"/=Y*9.5J2 D]S
MV[91 RWJ-FP&%7,G?#[DSCJ,WL#>XKP,.F]'*N')L16=:W8A'A44&\QPB892
MR,88F]I@8D]@2BS^.J4M-N/WI)%:@#F5I4.KARX78Q:)CP!V#Z4T55SIU37'
M5*ML;-8]MJ6T[$Q,L.1?X3%#CPV<GDMXXQ7) C+1"ZS=S?$\=N0G6HVN:M7(
MZW\!ASAYE+/0 8-C8:'LKJ7822W][!*4)IC86.YG#5*:THL_C$?HY&H48R0#
MLH/U]N ;G1S+WD3O1;U@^QFT.>V,-(.W+[I&V1J:)B7X^?&,*]%1X;8']MNS
M"+G(<>/FM7<'WYYT2]4^>.PVHM^$FOM:-[/YN+"W?[^$5AOL]7P-^VBU27$M
MJXNDR/Y%3Z.':U;"!9*28T(5CG9_F,G&-1+3(<&WHM\!>P:#!!N@N9'JTLPA
M.Y) B\-:$@6<?/TJ?0JWUHK.V(JE *<LRK?ZE*'XR@SO$T@%GGD,-Z><!D9Y
M66B5K&YT_I8YT3DY]XX;H^PF&2>50K8#;<U)\'N>ATF)-,DT&5/WC9T=5IF>
M7(DO Q8_S:5LH<M&,S/E)A FYJ=UQ8H :,#0@QQN+M7'_"YHRK.P@PZL8G$J
M3@V@>H]*382!0+E\UY2,R?<HK$^@<C=\0H$<J5*4"ICAO6S7@U2!HCO6W>.L
M^88UJ+']AM9N!9P,T/>%_+(Z.2;UU*4!XM2L5W#?8%>;!>*CLC!Y=\KJ6:52
MFSYV9>>)*QC.UA!(^;H!2!]_/#M___I_1T>_'IV\/?KQ[7'TT_O3Z.BWH],W
M9T/P\6MI:U@7XUW3<&4U[<S?C\D,>V1XO)5&XN3O3O*R24KG'N2^XYF(59B(
M2;" ,]D43%,D@4"U9+WDJ!)*E/4"&T/3_^ @?O']M_$WAX?2/[%,T%+'H%PQ
M13QXJAAK<E$7T7\GQ1J-AP.JV/E"C66$/['C&KZF9'S)$(8/R/##9\3:P]2?
MBH!5%!1Q1O-^V#@RR 6\&2C]V6&P=[0?O719^<J*L5ZA)3B3CCH"@5ERH[_,
M8"0S#.3D=/=,4\:=ST'"PFMNTJ3B*?AQ7WA9%S 6>&6[(E0=M3E?>R[)/?SS
M,PNT1+WU6?:?2O$6ER9.E;=SG.R #I2V L?:*%9&5P1?L?_"OJ]Q\TD3:NU*
MP^J.F.E\@NF+;1%5"=T$3!*I/1GNA!T9QE9!B9=#4.)>@Q+?#T&)!QF4&(3)
M!G5&=(3QZ#2=WDSACKH8T%0[X^5$1],)J%7DIV.7$*8=!-[M]-,RH[N=SCPS
M$MDLP-@9BIPR3FESZCX79[CQ8J-%[M2#V#F^%5<_'@FH@3Q)\S5JA(:<K(J,
M>YR8I&Z(2H;_@+DLBE0\.YR!X:(VZOEB6AE\@^@JI.P:[)A$:]#;PJY^#,9<
M(/36,DSQ5WOH]2!=G&WQ*IUC5B]UZQC>L[J)J'3!>KJB4I_['"205]G,@#GY
M^A%YYLHFPGO'(]2O%->QH<.Q<%RM:Z>,=?Z. EXMK]0D)3H3W $73(X5)5=)
MEM,M,<<(0">DFM$PIK36&_18HD<0QWZ5Y!2IT0H(S#3RSW5AJ$;(!VFT;WD-
M.Z9PWKDF$/4* 3KXY@X%=P@V[, @T-W\KESANNIZ\H(UHM#>Z7T'*P0D#9DA
M?D=T[U"EF2+/M DQ4ZS:V3LKD4%,/&6/G[!:B'>^R9IEMGAO*) +['+\.^IX
M'X<\[O9*D"2(:JOGC+E#!B#Z:9FSC>I9MEHUQD1J:^!<.^(=AT[VCD>-MU);
M4D9X6973-)TYR_[*-66\](D4;VJS:/H7XI+) G=0#=&D<#*6KV3BK/.^QM%#
MH$L@GH&GS:TG0KJ\DL"H^D%\_=%#V+ QQH1X8.,1^:1U=Y4T#WC+&'8U+59D
MHZ?]I9@SB3HD,N!R#2M-G"G\N18;+XD8 O_+19MOV)E.CA1I5_+5^ $^&\Z1
M?WAHZS<,HK!G$($B^,63WTCU?8Z:;@3_=!LDK$+/EQ>'Z=G%U]S$<"QAUW)V
MJV#&5Q7ZN3A-B;8OQ4U)+WGY;?SBN^_B@X-G>EA[]!,&@70K*.(6E#/;Q FX
M<P=;KGO;_P&^G >QW[Z"J?4BZN*-Q'UUTA:]\&+.*G4 9DZ2U2Q?],\D@:3>
M0 M2!NELKD74',-?NJ](#:\S!5BW>Z-P&;(G<']U8=APLP8A]R:;I1"4C$<L
M.TT!5Y<"3/^0&JY)2*C);A26UGVS,[GA[X6U$JTC# 7.YUF._N*G'6NB9\S=
M+!)[[021=2%R-$G"YQ>@) A%1P/2Y>?'82]LU_1[PL.U%.^H1^^.]C!QD76S
M3O6@T3ZI;3,I]T?]4*]XH,MU&ALX$8KMP-#Q5;KOPJ6D;6A3AC;42JO:]Z4A
MN,8CD5P\^O;(%\FG;+%>M)WY%EKU^0*3!\JZ,J_+T8Q7'^,A<4?FO"=-O3-)
MJJJ;=^%(109+)DDE3$?=7"->&#2/TR?IIXR+RRUIC4S15SI7J+(J:0-I[Y@P
MY'3!%2:/N"0+49:<7! > .R)B=:W>H,[1K"0C;EW$3!JN=W;O20X0_E-]UU)
M37E> '=%DJV]8;\B>-:9+;!&ZVD:Q,A]*,4/H=$&A;E4/S5'BP9DA(FJK63&
M;WN80GT2/79\O#R6BG<=MS0>K6N<05XM]RI9%C]@#2U*I=]+89T7":L#1B\%
MJL685,TNGT8\TD0QTV )QZ,E4UD@(P:?T^!.:6P=OQIED?O )Z6\A4"KZU3,
M%J77@FO7 :(8W:.91CB)&5YRNB3]/1@<GCLRC*TB7-\,$:Y[C7 =/!M"7$.(
MZS%)$[2[7@:LHN.1HP]EI5<P&#WVO7=2M8S\1OJFA#N6(%>F-TU +\,<L4VD
M.4]=7V:.XM0DR\86T8/_9.6#+N@Y%I7A.L-[!JF2U!V_Q1Y-IW!V*,>$U,N?
MX+XKB!#]B'-WZ:H^PP'3Q<]0%_]=Y+]Z7<ZR.9P@NCW/RV4VC;X]^,[E_<(%
MB_D'I21 K\I]909+R9$A)IQ)R+>Z.Y=C)DP512.,ZDY*TS*Y<=D,;>:7I Z3
MC>>>&[)FDN5N7MD9.54D2I6G.% ""X$RYQ0EM&&@W__Y[<MG\;-GSV*'GR(M
M]#\/Z$/XGVZ'H"&F?+9+[E[N+&FP&U>X($IF2?T-=XDK8M:3;4_Y)FQL<4Y)
MR=Y4,C)I-CK'SXR:GZ"A$O<FE5^PB3=Q3[X)IQ)H3D\'"C=43+&%[OEGT@:O
MKCJ[*EQ.?!\NQ5+=\[2W6?/7W!K:&72>&2=MG^?#Z>I[HUE35DPU&O[0)^ID
MQ5694\^Z9V[0%[\R2O:D 9-]_P%9><Z(I4> LQ\^G!Z_/F'RGM.3O_[M?,#-
M?K5;^)NG!]%?TP)=5'35CD?=DHQOK_?>&]@79:J;J4EMWJVH:9%W.?#&(PJ!
M><*1E7>HJBG>=O UZ#"[Y#(YJ_H28UL0@/&(0+42>""W0L_ N[)-J3[7'9]W
M5V\_P4U0.Z[#47;75SV-COJ[0?,C_"@MN,6>^H''(R;3L$PJ072Q]P7[MF ?
MUR\W^A@1KM@QF3'2L)&%Q;.+:&"H<SI%>6D AY'..EOF-QKLY.* ,88=B6EU
M4Y% W-?LQ[45 1%@[;O<4P=PF5;ZZ"UA6G%)MC9E,V9MLD=:38U'IZT2A<&Y
MP[D.7-WS0&=V^D%;$F0+)$9E#B)1_AK)NZP&@^X+>F/'- 8S9]:Z8O_LQ%"R
MDB?KNNP^ZZ&V4U:JW:C"-Q17W,UAT*US&!W+PB,Y)175H93:;G&=UFC48]*;
M$7$^)K9!U+D?-8XC^34IZ?$F.*T@U^C[GCUDDTG4\_O-TV\Z9;^+"4TXDX*#
MS>BUV"!C"F\K@A$J9X3"2$M5F?NE>A>6PZ"(G"%4A^";38U&3*1+-4":8:G.
M42\Y-=7(N5: RZ(X-KRZ";=C^R:8S.Y)-%T(90U-:],]WX=,NFF'X4B[&(]:
MF8--8WX5IL!*UB$3,!#1M# [O)!TGA?/OC_ZJF"4053=@]/[V\'I?;].[X/!
MZ3TXO1^3-$'%YWGT9ETE+KE<+.I6IFJ@7%B[;M-=K6R(UEZ"&XYM;.HL9=[7
MIM2YNNM:S$KM2Q)OO+OK#4[[$3\M6/#D>0VH1N;*-H O@0M^73#AP$J))=HY
MGZ%VB":_&4N7SA9'F*U1E-9RO&4(:CVQA94A"J QI9V%(/IJ6K!3@KSO'-47
MWWG0)L*%)_L<KN>.*L73'96T^^JG4!:@=*(<$LQB@:Z$FA1MJ;[Z&2>%\QC'
MW?PQ=QB283<S);O&(U>1CCSQG](%G'KGPT>/NJW<49*<Y3"% 4=0-5O2&]\F
M$^J$QE*.N&[*P??/OVL>)-B[>2:I+%@U[E.T@ -^60M2@USM5L^\71V?-]TK
M,>,BG&L']H0:P;UG;SSJTIR9%X30T D/B4JG$'3GMC/E^H 6N4.AW+*/;'W4
M?8H]764EDK9Q,6%<+/+HKV1;X >H]$S% R$ P3GFP6#4!3&!(0S=%_<EL+L6
M.HF;CS'G38%.M'J:ET3"DJ@P\#A&_Y'6=&OZNGJJNG5P_[ AY,H:>%OR;H9;
M)]M-6 6F 5-K=HWKH]3(!]RW6.-1JW]WM"NY.%ZVDFIUT$7L'9R%J]20"C7+
MM1 RR02&9A*'13P6@_O])AEP/KLS#%)27CCOC 0%U/&_R=7B\+D^[W!RH[E)
M!HROFW9/4_=LQ0W<% ()=DR9/@\H$%3[= FLU,TN+Y6,1JH(Q"SDDMIH3@^C
M+>MHCR]XZ?9UA?01R%6$^,6J++(IN4+AS^4E_<7MW7"E<D0.5BE, N+H$C\]
MH'V@^$<F(*GIY#G_NN0M2$L<IV3*K.'[ B]?<^IE9@SP\;.$S*J\X I9UT1S
MWI YJ"1IOE;&&:0]>5MS0:TW'=2V;+KIDW5!!]FF@>+F]=V73A?B7"Y) S)]
MTJ2KCKPN2KHT1>XCJG%_^VL/X!SU!/$[Z:PX@.\FINF:GU?<:R0\4]@J<7*1
M(TC R)(TC! #&_"XFWHT:;\41@@][P)<#\)U1X9!PO4EW)5TSL:C7S#:%8C:
MCCW85>)O 2>Y!'T5) 0?N+NG6GKB0$3RWE;A;ZAKOQ/I?2B=7V.(#>Z>RY03
M<*Y)E"# ?LZ'W9(M&3 [V#WU0Q__XUC$";-&D"> C5BIUR$,3WA_ZG41TG!Z
M[49<)(%ATG:70"^8;)R4KQM3B=%H-VC@4[*(5W'(YE_U\]J:U^XKAHXTL$X[
M +-@EGDR11U(QUBGQ)DQ$ST$OIA4Y4<$%"!_]7)EL0U!AK6YZ5P:$=HE=;WF
M[)HNY( !0[@>\OL,[2IAQUBKD@G#*""\>^4G0[M"IPG45N2'S5+.F4'G0EOH
M,I<L)I/WF<]N=1KOH'F=EDLF^<ZJ*KTJI\Y+M"X<0 0T!TRVPBQ4A1?J=$;]
ML^F'&?6-TF,G_$@I6Z-[J+@S& "PC4PBDQ^%63,BQP8BOQ]."5%_A!TDGA'G
MUD15MDG4'>[5ARXY'H7XVRJ8]MT03+O?8-KA$$Q[D,&T09)T*%+3_>B\9,]'
MGY82V%"QT82DC"Q2V4Q72';JOD+_"S11L^6S;Z!WY;7QEEL-AY%N=!W!5UG5
M#^G1V("^[:&OP>/82+.M-Y*C9#-,3!V*J%<^VP@T!X]L[YGQ*-@T[A'</0]]
MLA_'CDGWL20#:.8D1?+D>K[.F>EW)K5W;ME"KT#.//!)>!PK.=_Z[$O%A29"
MF=+^G0<.(P]_O,?U4:SPE_&W?F-X0<:C<R5&Z&$5Z?/"^B28/CH2(DC R(SR
M'S1R36,3/D8' P6.(L_!MX2[A#^H/?W(M*R6I:OI1='[N<).+8X4Y1+Z&^;[
M%D@:J]<$>IO?/(U.Y@'O6H-6*ZL#U$7T5R'O/&?<\G_Q>)F:9!O$\\%FQ+.-
M8+G+TF?+^IHH"H(PCITFRFB.RT(PHZ?1$7S5MU9[7=69L<AO[NN*8*:L(JJ"
MS E*4T*W2SJ+?'I2+GZJ/H*YZ,<;<<IP:FM/W^+Q*)N3'R.MM512@$K [I*K
MYX)J#Y('QWGA6HZD658ORUH+ZRGX03TT,!'RP27QYAFV*PX&8&T7+F8"7[Y&
MR$696\78\>AX<(VL#-&$8!-90;%%3..@A?$Y/R8CN@5RIR),!>Q0KA'@8"C6
MMV1Y7[4>FP73"+Y?H3?V169:VK/B-ISXH%9-"DHX%SG&86.?^=*L59> -KA8
MZBV! FX"JUD0NJWR*:]>:XA=*:&-?7LZ'KT3"\:N="$QV8[<"3R+F<_1#F9(
M(2W<^81ZGLW[-R<Q+C(_V113K6O#OA@Q^:+47>CF8)12"K=0,5+-JYX.(#Y)
M<'PK7]P"5&GNV1?HCG*A"?S%!,P8QT<^=8\3DW/3]E8+/W/"3 'B#6?" !9>
MND__\T 2UWT43GIX+N4?HM/T8BT$4"Z"_13Z_>1%K(L.-BFF2/-L8+3;3N,0
M$/[:6=(^3?KT^.S\].3U^;'D1[^*FI]$O[P[&7*DOYX*^>U6.=*G4G]/CYRK
MA.KP=Z[H;/NGDIG9S)D.4C=]W5@.WEVV"23=JSQO<21<]<I3CX]Q^9L;X\EP
M/@FBY5/T@.=^U,IZ:.2 !.(?C$?N2K>W)%PD)I6Y?3OYFH/=P&W'@\PXH,P3
M2S; L1[&A!J<JWZ(YEQ64G?Y7P:M&/;$I1="7QRA//6F 69N/]JU[JI6_U)D
M6.8P )F9=92*P*1MF%K 9LZ$!B4<8[1QB&0CU!Q+7EV"+EGXB@0&$D\9!HV\
M_'[LB4^_)#A:HV:R)D[+.$A%-\9PQ\3@+YM[GV=K0QW2.87+[:O18($_JPO.
M;4843/B]0[H499@T".97(FP]K<1OKU!._%AG+O#N@^T;"K[RMD%23%22X@CK
M%3:]1#Z9T 4M<;8HUX-\B04#=UH3U3][C<B]#88V^W?>/F^,WZ/W\S=;OES+
M8LK><R9;BYIU,[$#L7AW2(L&L\.#OU@>R_VX353W^R&J>[]1W>=#5/=!1G4'
M:;)!VSYLJPQ#[:N="0V@,^_.536-QUB2*FL9_E/0&K9+]I0\V !@*!D PJ+<
MI;"XG%C/4\1UNYQ)QMEEEG>[!3@TGL; %*,V3+WU@'K2>1&]ZM74PU$_5V=2
M8"(J/Q+I/%(=BO4HML1F."G99,UO)80<&2.S=EI J-,:]5"<C=(XI\UUM4Z9
M7 EV":0Z>U$UWY0=<@VJ:E?8FEY@EXOS7FN9-FI.)CSTYKXB_&6G&=!.>G!D
M(ZVE-PL5+!+FG8GMY;521XK?[06OEW =EO.Y,88S.#]@17!J:])M&82>Q>^?
M'L9F.7F6$@K],,11W;D!![SGRN9Y6Y1@N." @T$1H8U-F($?M$?9X/*VT$J[
M4.%&<5:S?2'L%RKQ,*E)Z<#P!W4-@0VR\3M>WWK&V_;Z5/]Z8GM#9'47!H'1
MF>WN@/'H->ISQ%.;^CO@O)'$&F1(-7?E+*6X")&CUM.JO&Z76-F3.B*<.YBF
M^Y$[3J"K^@YP@4 .HZHT01G4>X\TTN?TOHB6()TP8W%65I+?-@'9_W'8I3LP
M"(0)WGV7JL#_[CGN[N.<_W8[%4/GC23GCY36QPD5/DBCPI[;L8$D=BFMDD]2
MMK-Y2S?W''E"-&"IP4L3_^QZ)H*AN8!N\_&*_ELS0JWGCN9R:_XNPT@2=-D4
M,#$#3!IH@U9KS@/G?%$F^X"3'-S=[^:Q$<76) 68#E(TL$*0,A.[9YPD.$'3
M&C,C3O%B7GO^T20OX2GZ';2(Y!!SEV(#%Y&T*D'%X?SNA,%$YN#S/M?Z)JB.
M<D%R0DE0([''?4F&0CF=KBL^'R71E]=E2>?(<!\L*;E7X@U>]^UI%I662&/Q
MF*V3)E3/:9;"*::ZOJ4D)\^P\Z"6)756,Q:Y-W-(M[TS1D@]1(*-//,T= V?
M[X/?#0\^YNN#ON_/_W9\&IW_X\/Q6?3^I^CHMZ/3-T.$]ZL)F>^VBO!^2"N,
M<]%!\T==2C3%W=6<H8'W=#&?:?T\3.>-?DQ\[86XASD;"5(==;:"A!B:)&;?
M'>BT;PFZW(U-^\$O]6/9L5O$7)X_&V(N]QMS>3'$7(:8RV.2)GC_'=I;S6K9
MD:V'>TP.^ W7GS?XH+.ELI<1_4Z+SYZKOZSQV=3>E)Y/"'ZQ)B4:?9E<6LG[
MRY-HAAM<BRZYQ_:5IHF1K\5')1&\"2Y7!*F8@7BW+J.2IM&TRD!@9$G@I-=:
M0$V@==7@@S.A#+;Z3;W,GN &>K5P>IF>NR"?LS(5H=E.T\'V.W:6#&BTCEL@
MIUO"*(1-620?G0VMO]<D@VZ0DX)7QJ,]T#WT69XS=#ECU2)0(K*5%-FMP$:Y
M2IA,*N?R\VQONPE>@9BET MN'&9)(%(_#3QP\@*^=@*V.1%JN1 %E5HUA82D
MSB692FO<%,9J&M26'1D&"9KG3C\>CXR"+/6VYQV[3TQYA+8IDLUF+=R)+VL_
M< H$CCP)\72&W[I4^:?="KX('(JH3"E'%,,;2'$!1G[FF4P3+N'F6-0L'G\\
M8D_%3/,*(D,($RKZ=)) ,VE$M@KG($SHT-Q8=*'[J#9PR\ZJ(IR2TSE.#,YH
MEE"C3[(H/=6X/3"LK[9"1Y4_3!^Y<+$O5^$/G719T6-JM4*$NFLZL)>";^2$
M"F3,Z>>^(:)5XT^)-=-)HZ]NH97W!<7^=+I&H&S';&D7[&+*:Q,-D?*#@D3%
M?"84NEAVKF/8[N:E_C3Y4?J,.ZV!(6O2'ZL>I.B.#(.DZ OV)JBBUN5.8(EZ
MF]-!Y99)_#,2J;;9+O(  RGP _M#.J,J-ANBBS4@\?I[GFY)>R1*\J) )@:G
MA+$JP_R;Z+9_0JE_U.RD+-:UEL/>N[[DF!S7L,3PC5>:K'JGRIQ[!<8V]AM*
M5Z,\4G\=+@OS0-9V9&</YGD\:D\T.8"3O&9UT%$A455)FSNLC8=.:YX7=12A
M."7.ZAQ56GG:L;M[&L_Q*,_2-3X?J$NN>%08T<HLAD'Q,G??0B1W,"U5<#*Z
M"[1>F,F-ZQ!'GKHLX,$GM2[@@=:)[U)4.VJ[==>6<\72-H_-;G]2MAO0=[O%
M+LHDWZMA3[D0G;V:&1[? 3M!1G-<"I=IVKPF-XCDZ+@#LA+]+L0*<O!CD.\(
MMP6\\N3O%K'"Q*4*6'%$X3HLX6:]95(W8%!L)L<=\"B?!S"YK7M?!V8R7'?W
MX.L\&'R=]^OK?#GX.@=?YV.2)J@\OT35.()_!B[/O\+]S8K":U$668/^T+CC
M:_&UM75+GT;84UE#,\GYGA&U:898MFRBM7B4GD1<BT^NT6%1DCZ478GOS__E
M+F3'7"$JDW5MSJ5V'U.*\'U>$WI@LJXSXB1 -RMZ+=&#)LCD*KT0I\I\77C-
M0K22+L\G69&>_[VA6@HMRDS\OFZ@'=W%CV +H-JQ1LZ69E4.F3E5^MF:  E0
M7I,V(.OQ TP*08 0VYM4!7PGY!.HB*JW4_X-SV%T=,&$V%B=1W--DT_80('<
M7/H+TFSG\#K3L"LZB&Y+,&P*ZEBYPKR_9 F60VZ_R(HKIO?H^ Z=X:@F^T^2
M&K1"B@^O<#KD"PSWX@L%)VSZ(EUWT.P,KP-X7ZRCF:7>019C+!GF]U^).M'2
MH/*\9NHBV2R2Z6O'J"80CX-S2N>@EMJIH7^":@:"E@K!3V^FN9V\UG20T;*'
M-/OH(>.=8HTU6 -^VM'%HE?&+J9O&PT[*NS+QD]-1I2;;+_H+(ZHW-4\6[D_
MK2/:?2B(3U;]"Y Y4Q!:L"$JU.*9TAAF.OF(@\0W3IDO)=ADJ=#I3BE,0((!
MSMF47-<%M'29+>F,DQ&1B%O/1#W@T@0-&2PYS1PNURO_"1,&P]SE"!!"D]I;
M72 P88[!7JRML$ 6HJ2B*,!5FI=+7@//"0\B@MAEV/RE9W"RTFF>$5TT6U;Z
M1[V"IU(P@LC<FZVGJZ!=J<>QQG@!I3;'6$V8C5RW^PC%E*I;'YI!85=+?5]<
MT;0..MCFK(]=AT">5K1Q0;QEC>\B_BHM8(ERUST*L+1^!+.TSE>T]8EX W%:
M#H8X661UK0&+YM="PPR"K6:9JM_CX<2Z("61/"W(^DKYI";35:LYKEF2Y&)(
MZNS6:["8;O9CTPU:(6Q=GH!#$E/ZAK8U'DW*V<TMBTPRE>MDE27;3F^J]86]
MT)0C$YW:WD:5<6,'M)>QLITL4SC"0G<S'EVDY465+.&^\/=0^@F$/-]-=(16
MF-V-$R]-P96 >UE9L81+45RK-=9D42?W(D7;^]:M,AZEQ556E07M01 -=4FB
M#EN\P"!;09?2 HE!*[3N+]>P@U62W/4MOD*93=' >2E *^3D:W1)^/)6 C*D
MNTN?G<#TS3/>AF@(*[-YG<S3%6^")<8G:SD[&#2[<.<JIU)G17I1RE&@>R#)
MZ<80GWFP14A"$<&3X8^:961TH^<.CXD(P,:PO%AS"^N4)"-[NHO3P8U&;CK\
M+WMJ@C#@38.UZ,[:UV#1?UW\X\G?'?KQZ,U__W)V_O/QN_.SZ*?WI]'KOQV]
M^^OQ673R+GK]_N>?W[]CWAOW\W=OHM?'I^='\#T#)X]_Q6<'O.37LJ&^?WI
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M>_+ZZ,>WQ]'Y^Z%6[%?6-PZ>P05U'E99&B!8.V,_,P1K/ J2/T%^4QIL#?U
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MIQ[Q9GW=9BC6'1:Y-4'B_,FAO-U9LWP!G(*'F24KC]#3@!P.H=7CI]'1JO.
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M5"K/Q2HV=))EC)5%IKWI@092'=T3"O1XBQF=4#(WKJ=Z8I1-G#NR6_I.Y@$
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MF6G&[+/A>WQT;?D?(9W-EP"BK"51K=,E]TGXE'(]RL2IW=:5$C]EN)%%!_0
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MKDL5/KY$EG+$:Y=F Z$5R#1#N"%3L8@#;6O0QE8"Q]?<(O(J7DFI<,,+[\=
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M_&!@+R_0:R(+]2(<242GS']YWG^["<M[W/ DS*PU->^WB\][P(/,(W UKTV
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M>.]@^5R<_ ZY4A\2\8+>"_J?P61'OF*E18+^:+7@RL5$AD"6:@C^(P')[<9
M[A<4/_*)TO9<2R_[O>Q_ -GORV3:)/M[=Y?]9^EX3 (Y#;]7X^#W40&].ZL
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M7R#A[ZR(5 GVP3UZ_Q>W_<\5_YTL4D[\>J^AO(;R&FI#--2AUU!MTE#6_6I
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M62;E-[J$-J,U?^HM6;>V;-0*[[]%V;B]U>OM!W^ O ?A^QWN1?[+\_[;35A
MPUM=9SDN8Y*JIFQ:(8*>VMZ:XKD@4 )HGLPJ+8R9@VDS5:<F\]=K.K"CEW,+
M?2 #T\IO5UY7Y?G=W7!7G"\4^\\:C8'\4'Q#$=PX>S4;4]-$]AJF<J>[NQDQ
MC6\ITX9N1R<83#-$8Q8)6.GPA90,588O28=#N-%HM^<">P!$AB8M?GHL!O!5
M >9O7NQ)^%A8X$!QX[^8[%H]W,GK!XJ4."*A#8ZHEQ.5*_CB20J*:'^SY(3*
MGK.(L-EQ=!JCC ,7%R@ X(9W#W;$[L[A+GN=$G\.XJ6(X+VG(6%\=%\='JXW
MC/\#K-E27FPI68\AY^.99:FDVC11E<EAC$,7P811 &VVEF<6#$58D#DCKT#M
MHST3Y63[#,';IB]84P;'*FHI5F_$!#LI?VD,1A!\)C3%FHNM(G2&TN$NVU<T
M(".ZB@93BMW!TQ39XO(27@FOZ<!C)YDD?"01#,&'$ASJ"\(1QE'U%Z($D>84
M?5)1 3\J1OH3]4O8#SZE!48BX2<\I1(_BW&4RQ3^U:%= _&?29%+)' @U=_A
ML5=I/!W3'N56RI/)"#IA)QHR%?C (D62!VB(9,$5AM06?.LZG<:#($F+0-Z$
M$GY0C$2AC-%KH:U)_.@N%6<A>0-Y%?&RAEDZIO?%Z342.\(N?]AZ4[= )PR\
M-Z9BKK&XB<;3,;\<UTZA:?CQ#&/RBI,X;JMVA<:5.#S%<7N*Y.(GSM+Q.,IS
M)&4RS?*I8#L8TRS!4>]HI[^K].FP4W/2^$\^U=S975SE)(M"Z7!"D@++@2D.
MFY,$O0,TVT.*OI=X0B_/O,(L5#$I/16XI<PH./V[=_#F3,2A#DW#HK^Z[/-!
M2OI4%ZXU6;3JJY;C%W";E^2/@2RO]MMX*LVJ_4W3^ZZ+@M(]BT#AN%J1A#3(
M3Y3<!KZ5DI+#8("R*NI/Z8.H?$#07D7I- >E#+\+XS2W:J!>M"D5DY4)4 (9
M7I=/PU&)GN5J^8'"(]TH\=&1]D9'GF1P9*>W*5%4,$T[QM)F@3+-P/0GXW8@
M00:,HT2'5N-(]*,X*E0B9$EPI!-($8Y88BQT)/(1N QHI@YPIKRR< LJ)A%!
M FM8X+)D$FTZM/-9!-;8X 4W.73(],3/&/L8;7:DROF2*-A$!YM:,E%,BJ%,
M$<5."GP'I&(_3<"7B0;.DY5?Y W$1T&6-Q#;>"J-"NG#31'2)BXT3D& 4H2@
M)!K[8*Y)P?5;2])9*,)5 ,&1?IP+LT$)%:F EV%IV#3)TWC (E(J"4TZP7C5
MKG3ULN]1D.5E7QM/I5'9=[0ILF]E W5UXQ3-.4H#3C-P;G.9*6MU+BA:#8 R
M'1P%Q2Y</1-%K&*IDIO.8K(3I&@L<NRS_JL8)HYG9+ F*OAZ>/ K.N?T51V6
MAN];JJ6F.\*GPGY@$:+S]=-.U>16AJU9![<*FXF#2](& I6-#8Y3HB$J@@A)
MR/(BF&*T@5,21A4E,L_WL>_N"NSF02<8I=?R"G>?K.\D=1Z/I1E4:[SH_; 1
M=N%F-X@ .ZEF(?7P;?N&01I.Z:>E+FG*$] >E7[L=DW#;Y0'XKZ&B5E Z5V(
MO([BN(,;C<QCF96C0(*]%7B"+5<?4H4+QL33S#A3Y.R8,^E@K;7,X' H$S).
M!W!?Z3+8]W*Z MZKMVCY1E87=RU*J].FRZWG@#0@K?8XQK#[$7PTGO&:S')T
M6LLLR]L=CX(L;W>T\50:M3N.'['=41'G(,+N;(G87#B'F=RH?BD#;!TXI3Y)
ME8&8'(ML5HYVN=$Q^NZ"&F?7VEE2]M@Q$EUD@QA4>NFQU_@JK*V4Q2@=L!F
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M@1]"L/ )"(B)B&E)2&@%F!F8!?[7'TP]0(Z/98^5A(UU#;A CH5-CH5I B
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MK\F,$!=+A\G#O="!+#=*)4A][3(]QY6^?DUX6![\J%]Q]%MXNGO!2]7=LH2
MM2&NS8-U<6.>36[F./G*?:NW*0V\(^*>5T5RXB+O&CT9SMM/_K.<_)R9YDKP
M':NCBK&MA?YO'5??5;[>K#<]M.KAW".[A+)\P%MPYS.!U\S\K(A9%?4CO43)
M;_C[7._><UUZP'<=&NJER5\O6!6_%QF% ?B7^4:YFW8;2(K;N,+(R=4I.E4!
MQI/<BN=7X%\JA&D2[WZ1P<==> E0Z&$A8Q]B "RA<;O3>)#''- =-#[.Q<4
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M5Q=T<S@OR+FG?X3P&AO\#:7/3U(5XG/!D&^)!T/>$?08QR&E:2NAU"]BTSK
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M?9]K.><ZU]FN<QW.%*96Q2:(3X(<SQY8/?!G\S4P:-"9J&!,50%Y7J][!U@
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M+<PZG0O\2-7#_2UM*!()Z._/625$"(D&@Y+GSA,TX[)C;:KCZ$FZ=A+4IM%
M27 A0<;L97+$?AAWQ0F]9V?HPX("?('9$I6==PK9W 5P%9>#V:+.9!AL=R<(
M>3D7 ?2NU_)%7M485V?1GS1:&0=.\K0Z VG>*0DF0#$]&U]DOP+CBOX3>%1N
M"+N%@/FKN;4L*2O2XYA$IHO]K<#^[GOH 8TM7V!5TB=X0/<7Q3+Q5XJE+KO2
M4.IK(^(K=1GIUILH=]G .^O*]<'#-]U06[>YF4C0O9 49>*6Z9"";)EN"SPJ
ME@!J3O6')O'4!'749H!>>+]IKLK>D1,**(./TPN>*VH?7$]%F#[V '!F4DS+
M.H0'+0>(BG@?0X*4#-=,_Q[$%QY6%S"+(82O R5 &Z__N6!)6E^B_-JPTD-L
M0QIPZ53V<.?.'I?\D9.ERM0$*C?48>/[A8!I?K"(H7Z=L^F#4;C-%;UZ(RL-
MH)&U$''M9T;!_ 6C4&=?6]SXUKC=$%("3T4(/0F'_9TPKZ*(3&WSF/7D+'\,
M(<0,85A1? @7H2_G9!T+1TXC.Z-8!J@K5763-W^/S0HE6TO)Z1-:HD[TVL3[
M85$@I,7*!(OCIIRKYN\F39?%IK!K,ZR(MS!##7HZ![U-G87X1^:N2F>_M4S^
M^AQ^5S5 ?'BU[%3(+3>^_KD=*IF&I_[E>=>5WYYW&??+\3LRX"/R@3$7](KM
M_A[P T!P'MPR"5FY4Y U<FX%**[+PPQ;).C'YS?.)JP ,S55@1-LZ%5#'#5;
M)0\ONQ!1=B5KN[K8CE8%0SU9 TQZ6PXFT#;)3/D8X@(K(K8B60G&%TR<=@V\
M+ 9TR0T:;2)/Q"L .[4;#$0?,+ZT?-3S#>;O>7O&&>3'[TGR;G#[_?0^=F?\
M-%EA%'(H?/6_\M1+_H\<7F,**A-<@NK04W7 I2P72P<I0L# >Z(R.<$T_-@4
M9ED%@Y0#;39)9]3Y\W.M)LN/$X,->0#?GI\GF(?\QB,MRO^-/&*RM=5SX5/8
M_+RV*-7GWC.1\J\A:#3L',1@^/&*4X",)-W!\58^6Y,KGXU>;E1[OB3'5-Z?
MZ?;F#:ATLRG/V9?[->A^XHAN[O,(LKPP$B16YU/3Z!]SH?.N)"PU>_F5?,F!
M/D[!*Q/6=)]O:]&SV3M<J\<?73;B/"R:F=Y]M9F_UR8T*>_B=M[IL2+H 6&@
MP;^GY61 J>*=R/7A?CW-J^E#^_@NC:D5/.I"N\Q/<-%>W//S)]<E4<,AA!?N
M35MK8"#J2NL\UHP.GG?$;.Y1;@X%<C<Q2Q ?&^=UL)\,@U_+GW8D3L]_AKD]
MFM!@5GD0U;"B8#2$(80',2"E)&C=3(< JBW,"138<OBFKMW3C\(>,LUU8)[A
M(;X,&0;J13K""^B3 R0HY(CL1X6T(((INGW>E'HD%HRS84%Q,,X27CT?L6KC
M,3)XB X(%$KIE<1)T*W';F6]*WF\!F\#C1+T"Y>$_ 677,3N$R!'+PU17L;\
M> YV3&. (4,=F(224F +V?P/N<3C/^>2H9&75UQH*BG%2! ON (@BCW.UT7
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M=&I0.I9+>.&*BYFU.9H6[8ZY4H<)#Y-E">UF6CU[V;P,6],\&U'<M'C*2FD
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M:3P"W^O.I]0Z/:7B0ODRKWY;M4 V_SAPP.*ZM@>]TK)N!C:OH7,!00>@U5@
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MS%>$ FMCNPN+HTYSJY\(,!_& ],O!%AS3]\6 7;Q/ 3BJ3K]KK_0TG5]3>C
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M UCKW498YMVE#'P77@RTY=9_!*I0G781O+@KP,)B9]9A_/S0&,Y?A V[DTB
MR8K,:==OS$W L=BC[=04/H_LP1V(==CFO;\#$WW;4K>^&?\Q 9,BF6>F*A6)
M@>;\:U#[!NZL+@5A@&F?6+#!$9@?Y'DK#9&.*S)Q-J018.0DP(@4Z6]5GC"
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M_*HSZ/:A0&!W.S)NHX"2DB=KGQ_*P' H8Z$ZJ(L]7W^*=6U?V66DF7KWY+P
M5+;S9.X+<Q!@3^X<FEUA&U)W90!)\;]H#=<\*'J(U* IT 6VJ8U<(11F]8-4
M?T$.' _#O$')V2^S('A?'/+6_W2@[>0KV86?,BL8RL428)7&3%!+:DW@;5C6
M7;9]5ZDS6K^O7F&H 3_X(53XA#LR#JSMWYL9E84/.KI DY%0K*, J9]+BVC^
MK]1/0&$5)%2ZGYP#&\4 K,1[3#@PK8 !EAKM\;!^?B(R>&&^6_$QB SZCVJ6
MKVO:/E9'OKUL!AV7I9O$Y.$_I'?^:7$+"I!I@53@NQ)\VR!^OFQ.C '$= E
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MA-,"?PYE^N_!ZEKAJ"P5M]X@49&L.'CN(8- T7ERD@J]:;M28S'#/EOV2+6
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M"&4F'XTX(3TEQ!A@DRHDRC!="2B0&W! **]&="3V@10#V*C#X&H(Z&3KI+"
M?BCP/'OER%R,0TP#Q=\+7=](CP,<X?,)JW;A6-Y.1L+T/89=",8'!VP2%WS9
M20#Q#X+QGSW7X(:Q)+7(=X&*8(PM^-I;K6&4"C=*7%;\G$Z\(*V@1QT-*\"
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M:?+ (37R+0X 71#\%Q/841]'*[D@OYT_&5 "FB*N7!;/)8>R(TK:!BG#'7N
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M41G@""IG\"8?"%,2K:XA/I9ZY=NM<%' 86^%D:F>D;10<[3B#9+$/-R!Y(O
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M)V_!&@.\BMNA[$:YZ8*#R3  $KYG<$2U#C9*TDD,\*;@Y@X'3_*:;N 1!K
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M5J,C1I703^QZN).@-HX.<0>6$3?KP?+^91"Q=!>$0IZGUYF!;-3U(UA[GS6
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MY"+3/PH0X AB$I*QOWE*VO\L/P#YG[5F12Z8/@1]B'[^"X>1_,5 ^O^"4"6
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MQ;)?%EVNML"IY:"3RQ'7BT+N8KW6KNS]1,7#&=0#VIH\G/9V /D+YI8^T8]
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MWX36Q!/5GFCP@:#2[7BK&G-=_Z>=^7).NJ<%7L_JZI@[VFJPK"H8W_\Q)5,
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M1+RB>A A:SRWS)7F0@NM'/B/K*]KU)I%H@:J+T(DB-VT*)YHRZ:4#XO>MQ6
M8(U[B \5(:OIR8#5XYY*H[TDC2*LB\@K%*XP3GE)<X;:9?G!.UK?2=A/_[6T
MKF5GNY?7GK2AW-&<M/R>94CFM;<R:/C<@O"@'"O+.8>K*:.7/WGE=8(!4S.4
M'Y0-:!*!;02['7S-G1<2$]"(6=C/#:(FWNDS-+:X,[54X5CVTG(B2QKW)E1.
MR>\D,4.$-0RE.#Z,B;8'N=)J0-B(AD@4M&A$R#].PAW]8R.AT!*Y*%Z"RQID
M72%SB1JN$K7[(R-I3"23LH$>3%M  @VF920@$N<&]W,F@>H#*NA"5SEXBT;+
M=MSJ!NKM4;+@_4>1B)Y_F WP@(IDK!9MA_RI8O0-I+8^0Y(=F3G#'W0NNH*Y
M)TH(>?,EX'#5_N"?='W]A>ZV%6W\JNGPL/8$$%@Z/IGE5,@Z]WL-PJ?@J9-)
M$;DUS"*Z119<\]4\! XH<R>OQ#Q:EBS_C"(I0-(7;E#(B]-9ZS%.'1@*7%H%
MPW@-B"JC ?93,KB VC]@U5=.VUJ^F*G_42TAC:U^)"6<M3QL+?$LS[U;( \-
MF87H]G!>L219<K8H P:YO](!=5"!9,$M#S0@R^Q?+M5S?GJ':?B W7U &<!L
MV)8F&C<MMRN?A\+S#Y7I+H=59/CW<O)6]@X_C;#J\W6U]!^L=NV(K\'>;@?R
M6)>Y'*&0_:S3]XVDXVCH*@LLAD7+CP1J)[968V+ZBFR3CA3%L[\:V5Q);:%Z
M*N'@)*!+QJYZDEU+$//\RR)<*2XBFR_?_NH9*^ZGAXQ>+D)::8P-P_R?BH'3
ME:=Z#8.?+JYHA5H$4WJ(Q*_23?P^2L:6U\F Q6*(_-_-,W:^__FVL:1S#6.9
MIG\PK)$I1=O>GTULTTAE'-W[OK*MPW+F;?W,*UZ2G_:0C*UY!79V/JH'\R[6
M@5ETI#S8-(EOGT*?IQHQZYL3E=)935ZU,](KDY(^+5)>7L5HUN9UB9GQG.R6
M.$VWQ)38;\KJV^8L@7F3T4M=>>P\BX?N/IESRT93)5H8X/=DK^ZZ"0[0-"J5
M>Z57M#.)-21)DCILZBE0YRL5!E;T[<4Z>=.P=TCLW@*5_ELK1<WU\GZ/D;14
M]&UPJJ_3(7N=D%%=TA* %!.IG]GJPK:ST=?#X;N>X>NA.QN1 \31? 5DBZO:
MH!AOX^O[LM#J2/>'&^O&D-_9=QXP?- KD@^GZ>P&\L.XY&\"5]$)9VN.,;SS
MC5;'*E<,]2I';?CROSK(SY.R7Q6[GH!IN>$?O.V#!1!:.FR^&NG;WM^'W7'#
M]03AM?9ORLI=\IDSJSQ&I9\G!W.SM?.6+$OO2_M_E?%CL%'M^UJWPKXI3<$R
M/GZ=I(A -*'<4OJ[Q:Q8TH0\M%+70'?T1*W*D;;#MVD5%,6$^O&,XH(UP+/T
M3__0V"ZY3_1TRJ%WCK'W.T/J62=YA*5MM'^G>RT&U<S.BA)3S\M,0]^+;7<V
M3Y''_%,7F[AW.R.L(P;4D:C+2-2Y3R@ Y2A9H+_:LM11V$"W^LY;F+3S>O_#
M]7U(R8[)>5;,/%_QSF'#M><+@"-*KZ7M]1'K-?]272=>\2LA^GEP;+^8/-!D
M>QH?(2+G6[1R5!LKFF^*5XF_%E.'F1FIC9T"FQ4H9C*SSP.J_QU=PO9)";\8
MYBB2^ZT#6BE'K0.17^7#2HP3A2"0Y T/WFI[3*;\-@NABYV+6[1_0\$9B*K
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M%W--WQR(1>G9K"4CN&HKNS["B+W?7H3W<9ZOU LP?\_;F6]QQQ)V]5G2%7U
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M^9(]T]KTF@>2")/L52NLH&9,+N4M"3)6<JM$BLSG>NN-VP%>.EXR\UA#=,U
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MD4,_68;PG;91-I3)'WC^9A_,F^/;-L:R0(E*5&^'JV5#F/IW-A589'MZQY9
M+/@\JW2D8\5RY1,5YDI>K7@.("(N363;#!M"SW0*[NMXNC;.9D7C)6<V@]-P
M/@[.,4XMY85S=X@5HB7$/2Z@K\ARSY:6@#&<W^XK+ R_M)+#3$I/AZQ7":]=
M]90@L]B*2(.DR8T)]3H8NW3N)"CC43M+^CP>+5^76N=Z58]2'\-$EP_5X:G*
M U/L=#$< ,!%6HVS]!(E.DE>W7$YU_$ACA:M-U6^&:'+EN12)%0QKYQVF%^@
M#M7HKV9IR("9]Y#JQ4N1UPI!E<UN,$5&:Z\CN@6!GUQIK^-D;7]Z3TC(.N7O
MKY1 WV7H/@BT78C9:^(2\P41%!R;SO\;Z(0FX!"P!=V-+?'5,Q2F)Y>) N&'
M'O_(\__27/(L\FUE"59<$"%E)57W$\0PACXR9 ;YP1@NMA==%O>HY=T7E 1;
M>NN4&.S3RLL?B]Q6I<4*B$0Z0@#C@4XN&GAS1Y\UWC2_D6.C_@-HM,U+2RV'
MI$0TH$#'1'4Q=\L7HOJU0%Q+$C)%#HSKS%_3V&(GP73\_,.C?YV!$8QI8EF1
M9CP3H:</UB[@V+2'=&,X),([80H1,1C6AG4ZR(82FZ/!-U##UJ!6M6I _.E,
M33;K>3P]72J]O7O0Q$ !I6<K[?R6>:70N!;V/3I:-J$'35EL*UR%Y@.J3_>7
M(8M4\(:FD+E<.KNB;OBT_5[Z6NIX+F[2[IIIG>IL#S )IW>\,%Z/T 3KS \F
M(!U+>XO$_ \PC.(M=ZS]]]N9SI95)@>M(XCIOF>KUW0Y-^-C^>F)1#R8.L"Z
M;8X9PK'/:\CV'#M1E$**+>/#V[@W]9)A55MV".BCY^)89RYE*)JBAKJ#%OW*
MX, 5Y=K=DG_*D*E0FD^#\0I5T!S<GYYAH5_@ULH@HGA8#+EQVQBR5/DJA)10
MX71P,W!G)'*U?_#N1=KMT W#1PQZ,V(RI.%Q8RZU2< (B:-(2[9AH;NU302D
M(P,;_A@\0%5NDU#F:3RHLRX.XJ-_+H4[+)C2J*[BR9RHPGA%P,7\#Y[?/3!Y
M@"DM#=#A@T]ESB[ER@0K92W)/+9QD)(B<28GCGZ'J.EL0.??\4XS:U,,%+#C
M9*Z?EJ"*EE0P@O(I*)2)SX K""E%EM;;XW$\FP>!$@ VY0[DE.H+A1^.<XCU
M/]=LH9/FH_,OT7#?996>-CI=FQ]!1WQ)H^Y;#.,LUGF X7M$2XZC, (Q*:K<
MOSS@V<^+'(5Y:'$("+7;E@U=,U?5R$W2P;_Y38I>C/C99_UT.3]5-2(9)6H-
MNR37W8BE_$S4< =I!YO HE,B$#L6//M"FW%N':45>5R]'GN(4D 45P& 9&4.
M<5@^^3^INBNH#I]T^5SD(_YU&SR\>9(\:;O&/H]@9(X!8V6BO"7,^&QB+?BB
M)@^?BK< :I3=EQSQIL4"S&<QXD4::MCB4/YV;'Q]7Z9<?/'S02S X25D&_%=
MWE3+[:A.B41(E,JLQ;%/BCU"ED?R'%A+.<B1XR01G59LM,V@$6%;R?9[,A D
M6X4I3S0FD<A/# MPSSQH*UF0.B>F45\=/-F=C+5-7$'&TM["E['')I!>H_V!
M]O6#=2M,F-S(L4$QL68;W>3#KTU1!X]UK%TW M2M:?1<W$MWZN%V\U1R,Q^Q
M8[W_Z)B.#:;?=;'D;SG=XP3@-$_,FHK?6 T2*40S?/>\CE3M$:-YC)OZ:*CF
M:U0OTH)9Q, #=LC@Q#<QPFMGVI ]C?24!=:U+88U^YK\ 6Q3+(JN*Y':I8.M
M4@E8,4.>0^=.\-7$]AR*OO<.Y[^88\J>=1$G7B'L$1$M1>?S4#T_?1WF"@YM
MN%N.16I, $'OGLO\+EX@F-S+/"06/N+TSPL]N0S/S+ FV!HD T8Q)_$%)U"X
M7BF18G+F7-%T"'Q;[8 +K.N$P_5*VM7VM-K3UY&N?PZ->_!A3MG,&OH55K)\
M\L35<O$4^"HP1CY1Q^.)N.<3F[J7DPXHP'59G&TF(%LN;M/JTRY?[DC1RDPH
M%GBPL)_X4@93X,/8W[H8GOU^![4J 6LO4MEUY='TESQGTALK8XP6EZ/  %(W
M$R:M\Q-=9>Z.BZ):P"'WU536U(1(^4\Y?MH2T4SS<:&))?B%S*N]#4@04=AX
M'U+B],J;5S<V,D.GLB_^P\/OR^@CUZK4^C($)#HAD:'=MZ*U47RE/PBNH.-1
MD0)ZGN)2H9<A)6XY^]G_H)$-JR.B2WWAMA&I>3%TY3;T)+93L6GQS=3BS<L\
M3E.M,%SZ2_&(K[YS,\;$?)*[4:US!5>*.SL_]MOG#N'-'F[$J)9W3JT5)FK6
MHD@WASB]^1)4@,:J@%>^TB*<CA>KJ\:V@3;ITL<Q#ALC"3/U^:V6.M6:(;PV
MWD7'JVXE:-6WY.^#AZ18]-/@=9,@!VFPN+W-Y68==X=3A4[--V,.4Q*\RE$&
M.R7'O:TO"!+!70Q*?C:Q89"-R">3^;.EUR_:!J'<$UE>(OV6JACI%)1D93T8
MXM19*C0JNDA>!%@XXJCD@J9@IYSQF$5)/FRX<;DR+G+YQO"J]W)\ML\F95NZ
MK](\]^* '3B)]^S=J"U.TR?!M_R):UX2#D#]%Q(3YY?13<=<>L%K:WOX6N&)
M(JOB#N;7YX-^B2!+!5MRLK1:EW0OXU^5AIU/N)\W0/"F'*,4;95D6_52XTF3
M^7BRA_#N+;<)@%- F5Q;AF*LT)%M]@Y[UM+9X5BR>^A ZD,]G4TL:;*.=,*R
M#[NP-($F?$%S.I#H0!52!L/X%H_;IFYL20+MC&"]!-I>=/^VZ_"RH4X%.H@-
M5["A0%-Z6N1Q@MEJSXKG"O/%%R774*3J&XBB@/F6J\LH!PR)&K0_:7Q)_^>4
MX?]J)H+'C[E=#)$/O.=*\6HM9[7.9P_B8YRQR)$!P,)N5((.%].&6JF?S1\.
MXDQR<]3@:Q</.,CO@/C%AY3B0ZZV>\B>971UO_(.-A@R-:\A3^- \5TI?#YI
M=(D%EW.!NSL[V_885)O]R7PU;Y!< W)>GTOP5F*0?PU8_=JWEF",]-Z(VXM'
MGFM1XKP_I]1#$)%<.MN10DC]&FB8$6L/^_9J5JGY5MG\M[ZN2!&7GF D@A&$
M,;7UW/.=U!LZ4H 6AO9>R^A>AG;B-J(#/M-(8G5O;WL3%O0[(:WG$+BD5&J"
M)ZH);S348XAG>2522_OQF6G:CX)LT/AT9FW=A9MF8V/LH9T&L@I>"L^P2H\5
MS33&W0;T8&/M)7>JQ/"\7=D.%?"Z0;C8CIEQ<L5[1H(]\%).@GX4X#G_4\8(
MNC6M[&ED-+>INED89+/"F!B+T'!NV"R-+6G?^9X:,$[7,J3C9<<K$\6R*K<P
M%V?Z6*[]-IAB]@C"5S);$B8X.Q<N6?/2X(L7;FY*:7/X"1^L"J \C]\5'CRF
MVI4I*Q0>OYAI3K5F1GQ-Q_K$X3^R1T;KL9ON?1T!74IVT/#<GO/=X90V]2S)
MB.2KYCC^B;!&&B9QE]0]O(!(/QRDC_6)K/I5N/NZD.7R#U"79="4&U(G*5IZ
M5,3;>7@9:"N+C\_7L*0,W*DYA.$TCS,4*<Z#UJ&6^[\G"XK8_P#RJ^10PR51
M1*("_2'EX.,,>][L%VQENH'?L(>@G?ZJXCU><G2L&+[($E_^7@L5\^&Q(29@
M?-)H>@Z#04)6)F.XFK5GQ*DLL/G]NQJ?">G=>L3L68V%O,[R;1]>JQY [(/:
M?2+&1'LYD) ?7&&Y#8&6ZJ7/7L2CTI]CZB-[>05.AJGOWSKMML_:!W._VH_D
MEF>L=:F0WG/%*5\[_#H>JAZ/E.LEL7PEO<M379JC\>27,\%7TCIO&_L\7B$6
MBT1B2906@@;<\W)$47KF=V[+?0&_,ND=\9IK)2\"01=4F5Q@VF ,ADR;W(35
MO:J+6I]."TYP1NSG_ M%'4%=?QY5U'-\!,CWN@>[ (ZU9@[Y=R3+""V2/O/'
MH2WRMI\=3\'BGA48:Y9%N8\["32[K5;ONX+TFOX,<@*UDA^9HZ@N*:_(<LG<
MCLHEZ,CW0?.1CF0IVE@JW;=+9B&^Q3=ZH%B>LN8QR]"S#QL2B4AZQ4$I$R+W
M?40GY.H\-G.TMV!,W-(^?K@$NOP#_P]JT3"B@QR:T3<!_/U4\5W.)N\%5-AN
M/)N2_6US^8 B7BKT]U\>]Y;:?&_;(C4(6YX$,IQ^8,02<A)TM*L73)F@@W$#
M'I0 /M]5]GJ )AOU\H=+R,7E6RF3+8EFD,W"^F.HWC^N $.CRUSI,.XWD9NH
M%%\S@AGD1M&(09U1@XXN.+_8Z4WTS13\,S],\+5=&]K$1$>+BJUNQ/7+=+ S
MLN<-TJ0.:QV*2M2%TD1_T0!5'?&[;L+5?>QVT0"/0+>M_ ?I%J%@C-FFCQI8
M/,7MCDQ$6<4&AB'!;  C:O<PYZFJ ?\*1>[TPU\"%W,6V:^PW=W3;IK M.'O
MI 5A?)QU,W:"CG>SE%0&=@\@&]CQI[3&;TP8TD?(O_[.F^Q.@NPFSJZ:.]<]
ME+N91SN8QZ&'8GH4KM*!#ZW2G'J(KT3K"FB_:O-"N9N6Z:P3W*CXI080>@41
MK!0/V@&@W59 O4Q:U;ISO9E(M3.\DD1EGSG'7<\[0UD@#2^RB"LA'FCC62'$
MC6_^XMQ:R_#D6?MD[.[#SFL*S!<H8TH8%XF;^7O[SA)IJ?F<=6!S0_0\:$2<
M]*N/-@? -8+D&KGQ]VEK2<5=Z.T:>8R6*7(>Q&;" UW5+$74\)E<#7K4X'(*
MRGLAI/E_2#-(RC06LZ%ZYC+\7G.* I=W)HKF#:CM?B13LBNG1\X_O!X3TZK-
M+$ZTG/#R.@2[9RJ%3X=9Q;HW<!1MXJ_?6GT5H\05HPQZ&8Y6DVK3$3ET?I4,
M85%2%ODJ;K.?%L?7&1;]0OH(I:%K'G)[M!,<Q7MI2\0X@#,Z/O0K%?46-24>
M(. \RN=C2-F'&Q])L!=D1&>WM?S<JK4(+>J>GK2+8\/(_+ )YLW$H>]K)&-%
M^:D"6@*CVG,&%+G:$;(/U15@L?T?.D#_=V.G611R\,/^(J!VA,8M/&.; $T5
MJ*.O.%("V!&0.-GWG>?4P"E1Y07M^+(RX[>4&@-W61D\PW5DM<P1[8USU@D'
M=M',639F[ _%?MT4*!6L#REF40$*KWY/<85S+^6:6%(M+&/G^"7=QE/BBTO*
M1Q^Z(^87?!+\7Y''K#X.(KF-=+I!3 U37.,&>DQ(>>1OZ7\I:P'>A!$??\C@
M[=KOFMRFU)NT=Q ?NICGL:7$2%T7DTDK<9?R-[R:PG%+5,(M0_6\E4HJ\3:2
M8"GQA'B2PA=A#VR,C=>7^RU.Z%O^0A]R/M/C6FDXY"N[^*LW2/BE01RG#J14
M4<2X_$7UWEKKF/T /4VCC?X303@W-Q6LG.\%8]597Y'J<'ZR_(##?P=84)62
M*UW? *_U<=7<$\4R6;FSC!,EXYRO5B=M@T2;U:KP-(]A-<EUU(/=KZ5*A5&D
MDGOH,"@']>-W&>O_ .IJF>=O_RIUW-VX=UZS)>GE+>3)K>9;+"B?A2RBM0YN
M;J%8[YK4-\\3#SJ!2 3<AR-&D2(]S/"^:.,CT>=Z</P7NFD#CT^>^F&_WU("
M3>W*.TOUM[,KVOC[1 \!*>+;8^RZVH Q=+^\@HG2D[HQ' 2<J#7TO@$Q(H57
MG?QL>6F3+#>T*80T_?=1UR,F)=8&[&6;*J\3P0%@(+('UN,TNOB5<BI<SSR]
MG6B -8,QA_*^8M#KM?U6ZZ&?R&[N0F6U]>CDSBI6OM8]G<<03EO$<B,; ](4
MV@?TNM\3.X.S6;13ZJ(I.FV[5*D1%E(^AD\OQU8\FYX1#RW A;PWRAT+98TL
MFYB*7M9J-E^S/"EZAM+C*GE4F? ].@/W=-&;2RN=0@8L T4Q;/MZC]3,;,.[
M[0(IW-XSH2Z,'KY_O]>R4-C6Y$#TJZ CHM;NP8@F([FO?-FC@%"%@[/P'^")
MW5+3476-PXTME'O_VDP.973@YX.!@9KWU/>H>#J%!(Z!!2%$354S:2+%(<Q)
M3U5W4\TEDDPY9+G'1XJN_?;"$7E_L-8!4EI3<,X);D4+*:=5<;U%(B5G7<9-
M#&6'GF:'-&+.FF#Q<Q5D MEQ90'\%!LP&;,+2DH4X4\\"3Y=5+_'"16\0:KY
MX- N%^O+W/H;4J'8;ZCDK&+"IN[8$L<S7#Q3_C1=O4IGWZN2<O/EK+,.#RG?
MYN9B T[*R[>,5)G4J+V_A$_DEP'G4_]%]#%@:P:+-XO[W ;*S!".V;_ #/(
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M;9D<%YNTFX[]:.5W-N_V+W*%@#>J=3:A2<WI<(6[>)\;L8?ZR^S0KH\E)B/
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M";^.JS7XO8C7.@"!XF;3G23^LL.[R:9P"D#R[;@M85Z49?5B%B?67J]:"$\
M,^-S,@T!*VN-.%-V8^'*AM,C35K>6=V8-RXG=0?;*RP4(++:KS".@_TKPQ*W
MC*L)6E8C'()G]0O9C]PM%".B%, #*?1!L4F7+W-N;U=*U\P"/[\&6680-IE(
M_U9FSLA]+H-.3Z-]^0_YI2NBQN<IQX=>JEZ W2V+/M&%ZDDI?[=?)*->B6H
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M-^6H6IM3GA2".&R?&SA'<1!3N#UU? +\YEK_KQ'\;]-=\'&1MA?3.]M PGF
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MK*2,)  ! 0$8//T!X#G@)0 /"PL'"P,/!P>'@ "/B(R%@HR$A(R/^0P-BYB
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M4Q(1324X&=#\[A90K0QLM?'D:KPMTXVQGI/V2E:+7/F;&?4VV\*4]5/0F&#
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M,:/OFB&(UM7E>8P>9[Q$SZ*,+!GDIK47L:NFG(-":C[^8*SVC_K>]<A+>U;
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MN(8B<Y$-ZK=Z*WF/QNA<O:Q^#7I-<FL7^NQ;KU/ZCR<*B=X5EPTCL9R%Q<8
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MN_K,%RUH1P7_,-P5T1;YCOL69*AH2?X1.!:>#@$SN<K*<1K,KO#CJL'AQ'+
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M>V"R;^&*I*!23NX>4!:Y_=!_#WQ+!.HDQ<]TP)=+CV\/Z*]I(3?7[?? AP=
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MZ$VM[9)Y,0/"W8E(X[,R3F]YX,FK3WXBK#"0Z>T(=A'@K*T!#ZCEU(^'01H
M3E<*@ RKV0U;3ZQ1M6IL]S*E:%,6W8+E=_I$V$FA=[4@.ZK_21\T8_K5-:/K
MOA.PG6.9)"(KX\Y43(0M5/O](-A@ZW; <D-5U<1['=G(5PQOBT%*B%%OD(CG
MAA =L)4'C9B^LF!FV7?^JD5 \Z;BC%?(<I"JG;0A^>4:3!:2U(?;2?[*1UEF
M(1;D+2?<K":VR+J8O(*DP(*@:/M-%RK],=S9_NE>E-J+ O26HS@ZG[I4_G'"
M ZD2H;'8D0&C(#)E M?VP00V:'"Y/^@9X34BC^M*DO:[&J\\BT3K:*B.3L7@
MVB!9^_5XP+<(\*.A^@Q3/A!IA%OLFF=P@'5%THN"LKP(7AR_>4TYO^N9-]38
M2@*^HB\@GYB%N[-UF*XJ7(+$.8/:(X/WYZ@$J99(!M 4%OM9/D68>WC%U.ET
M,%&G(%V:!IK(?Y=L65QINCU5VM+.;J^_ I5.4<L:L,_K9#T)?/'-2'0*MF[3
MZ%O..8BO1YO*XC1C&0B#F)NHA62&?^6O0;"CN?1=CVX17 P"&D2\(;I:3)6;
M5>60:O//N$1*Z3$SD+2&SQU@*%U-']5!R+8K)4WM&('.#/%W4U_WLEWAM:YY
MPKLMH$Z:@BU,7OH>P&":FYUP4=*::N<\?HH1RVW 3L+ZCEICST^]VU8Y+#TA
MYY!@88IJIE1S1AH5F0$YSP>40#;#NU'W5M6^^E;=&Q37/(G7D"_GA74@=1B'
M3T.DY,>GF(00_PR#^N[[M[*#AZ=%?9,/"RNB:KI>$*]"4.?=KSN1A&?5A&S;
MXH@\NMBD25N0E02K\DCC')K+;_R%5E_&K+#OKD38!Z52$<N!M)7XF6H2CU;:
MFK&_IG^5KL'^F'6^:/JM']!,6MHF88I:4':S-HPQ-AN/=R!B:^);O9-:OVVR
ML;*@?%1;WUA3<[R3=?R,&?FP:]Z":C'Z$8+:8BX2%4M-[JD(;F5JMK,MA7]J
MI#AU8*K=8F<$>N1!%K*(DV.4_7[ GJ"<_<.*-]W94]J@4'+1V3TR8S;WT(C'
MO$B *P@6!/R81Y%]IO6^EN,58DGB-63I0WK#E0\9N#F-ZY4BBL5DE88UTUQE
M0SLL-@:1 Q5E^LXQ.BK;FQCV0/KC,UN\.;),6TH_V_4=R6N!O4=1K*\Y4JHQ
MXF92Z_&WD#4::6OO1AI'F9RN08GH,9)MI2F!#&Y#4?R[?9_#30:?>K-@H\BN
M23,T]BVI\R0]K,G$(+4>\/SL>*KOJ88I\N6\:O*'(G-N^><:_*9XBF <!QVR
MTIJ:07+[3QV826V3^#K;[9P!UK%=Q(L)8VR/=-.9JWGA6%(!34_;_5"\\\SZ
M2BW31IP&1;UOL\;_PG_>1\-]+@S]%-5;()'1N^F0\IOY]ZZR38\/C]O*.EO+
MB(Z&?5FZHZZS.G-Z.BM?I3XSJYA3T;*R-K;D4T%/?M):CE?CZ/WXNPR,I&4+
M ]C++293/)2;Z_MV8H88RK,;CL? ;@LEL^$^3/;FF*1+]GUNS:/4..&,B1Q$
MAKX;*_MNV8SF17E'?M)+HG=):<CG4W9F2.49]?/;[8\G>%C%;],(6\+,F;(?
MHK8(^HH*OPGKT<AYVP8WYR+L"]FH"<^ G%)938%>TD(ZUPC!T624#2*N]1H+
M8(^^1*3\D';O&[)#<8HEI8H)6T=2HM0Q'N_T(_0.S?42Q5<Q@G+.]M:,,YOJ
M+YKWU)^<=7RCF-9;Z8YTR:6VCT.J!%R=-' ++5283NS$V;5T@U&JY20@LJ3N
MR1&E1UD1W!'VX0W)004&RP4I"A<@;;4R<?+"/F3C^MS2<BOE,*HG'E<P<B6T
M]&'=A<^GSPY1$VCG)F)0JD#0)'3]5N#T#/1I3\"I:+],!SQ8KW?>G(Z1F_OQ
M[W-J^/_'V\C_QE+H8,HDN]QOJA(W"#Y#_]C8GXZQD1$$//_3,A^NWXI.B>(;
M[E\/_;&9RZQ]X?S;'YN;Q_2@4#N1PVM;./A'H8)>N=[< SIPFA91 F:6BI,Q
M/<7JVE')W1%T*-KU40DOLBGH0^=Q@=YTP=EJX[50&C2&^\6\UNSC49&T=:W:
M5IV%<J&J E."-*/4.=<JJ<T'^LF4:4]NMK%;/43.A+^A] \TF+Y0=@^BEB6S
M(8Y]V-VQ.C#<P1V]Z_WP""I59V]OOF;.4\Z :O:#PN>E-(U0(,T,ETWO:TC9
M;"PW](, 6NQ/XE*?2?/.2=[SXI?;K3\NZ79JYS*[J2.-Y1(2AL7EUC[NX+TT
MMK-CM>.%)18L*=623MT#/\4LURXW.<M ??Z&3W%O.J,C1 UN^8?0C 4YOA>^
M?))M;LA&'6<[W<'C<0^\2G"2<Z[ED3/19\;R?4,=O#;/,>#E+I*0!QOG/ G$
MV<)A4T*%47>?Y]P#EIL+Q[=_: W0>$N)7).Z9%6(/!IC;HQSM((C1C?E_3$C
M\L0,-!:G[,E(U*!KZ$BD:^33KW4W.=JT?K5P=_= I/)D__(. L\I?;WIX6+R
MZ1O*#"1\CQ]1Y%)M^=F4>Y-_0E2F@X&,.R,%<J39><G#MJ4H)/_G(9(^:TR!
MYP43]\#Y@1)R==W=R1\;ZDC97&\W?NUUYWK\)P+EVY(<\.!IT^T- 0(S\SW0
M@'U[!.X(>7L/>%#]VDH?*OD/ O"?.B<7W+0O_FL_WV'F8_#\E[M+$9CRGW[_
MS63PEO]5 _LW)$::VWL:FA4EYR2)7,Y*#0A$)_:Q?+?H-_$P&2E.,&:T9&BE
MN)5YDUIOBC0JE#\^GV=*F[R)LAN9D*F?:HF85-JQ-&M:I*\)U2GD5EFP('5<
M:/6PR4ZALH_X^MQ.@7L]# V@)T#(-1AE.@WPN>L)5]'4[$!'5*8"P9)A^Q\;
M3\3=O^M"9Z0?3D33-D[@/(_0>)#%/6_?#**RZ!CCW*@4V$Q]JZ,8-@];CS;H
M+0A(I4:@([.;%KZDN##:)'*-/>IVSS/O!G/6064PT(-HT-,1W5?%^$[UZ9$*
M*_T6*\,$E"TB4"Z)N)[83X996/U#R::;<6=G4"?6>8NJXX'TO>@^\B,[H0-6
MC@5"VVL]A7L@;1M\?4&/8)IH:>E.EZKCMAPH5_>#5PT)=%K8:XNG,ZLK;7/,
ME-V6Y:XT+V'@+K:ABM]U*VWW?&YW+1IL(I1U_B,^)Z3CV@18#+&S?'S-\CIJ
M?Y='&%1=[5C>AR>'@[U::G;Q@,V?#T8BY"A*VENL51_Y=*O64G! A9662N 1
M.OGQ((%T$?1UT.%6HF6FW$J>EABJXEZ8!RQ9G<:LEA/RH,RBZX519="T-<R)
M;!S#-AXFXO;I*'+(E(NK*OI;<U;CCZ/^U7K#]PF$7PG0N7<!Q'Q6=(I!W2'4
MQ.TS6ZYZMBUU=J&6".D?L6CZO4>/4!'0#@DRWU;:ENV.626_K9/&>*DI\#S6
M(,(3L,2;;)VGK"Q-';W6R@I:9LB,YRP-_2GJG0IT(!M1A3FJM&1L$$U@F#_*
M-U(J9Q1T>%I.(HI238X#=+"%>P"3=V,5=16#9_XI+_!\T\!/:AY(ZZDC'5)6
MI$%CU3'.#,#?17\0?NE]1"!E?U3,T4G1P$C9^O+@+G7"*C'/I;+:,_Y<)OZ8
MV" 00#C_J+S![]C/G//MPE/5[VF<*KVO.UT$*"^09 J_COH*P%;BW1<E/;2<
MB.:3&+/ZY/5MU]M0M2+?KH?=O64YXU-;U9NY?BO(62!(X]GD>1J]NRAROO%-
MFS'2GKU6M)DP>4U317V:BI9QE8LS-LB8VX3=VPV&Y:F?C+6673U2(1!(&/:C
MY]$^E[KJ[08[B9T".VMG%3N QHE0=%N*Z\L'JZM,Y*/3<39S6.Q28&NYN>7+
M=_58K7@GW]NYWL4,JOHL;:/56RSNUTW^(:>)%\8ICQIV91+SE31CQBN@0.R%
M0M+7_)AN9!PWNMQ]-6;.(DK8*WF!:P<)",(G;';N>3*48!L5'J)>FRT,7FI[
M4=))TC[UZ&EQ1V=;S/GU+KP\^3:C,)F62^_.=^9DNA4RV9&G\GPJ#()YQ-T_
MF\X5A3SNI,KW7S@%;UJ_LS;O\L7%I$Y@8_=7OPSCB%*3I0Z+26PD.CC2EK?A
MZAY,>]X-\C<[3\D77;=%BW+%3J+C2W]8EX:_.1$[HBM78-Y. \()KPE$$A =
MI(,6ZEJJ3S@*\O#'IF'E4<4/=S^;4#NE3ES=%21;\B2B,AU/(<B7?AKX]';'
MK"6&;'6 G8\&>64E<:Q^U"FXH,9&JOJ@? !"GP>2-(H'ZCI6^7B56!W0>!&]
M.;,FK99$1RQJ+1A"7F%\=?B2Z;SA27FR-E&DKLA4*<\I$KV^V",R#A.XNIUU
M3&R+EAK!98*53:C/2K._.MJ7BM@)R??6Q!T/=L &P0B:IH0IED5VQ<^4E/U*
M$Q[8J*G.NG7W%+,J\ G"_6Z2\DE9A;_6^[$=Q'8T*#%J]Q%\.O9VD*8Y)J2?
MH.:1M; MC'4G+K0O-\BB=JPPA<?O0DL\F,10L7-PBOQIW/$:,L+Z$W2,EZ)=
M R(NJ(^D,$YS&B._<?5%/S08>]4AJ_S^M<">B[J@Z2JS'4(G$O6R-Q=^&Q&>
M5-FSDN_LG*DJ93WH+"&[ QZ+X0,5I?\2*OKD,BZ\5B%.XZ_ED .V(GN\/P3E
MIY,;8U%O2(D9#$U*_A\7/?Y/B'?8=7.W2?9-9/7?!^93'OYY59!)7^E@]JPL
M?L&WP(,>!VS4M/_DBS:Q545X1^CN+@C<.>Z!07@O&U$ Q\3) "Y,%AQIE.P:
M3^*,:4=&:OJR+NR8Z.1%G/1%JM-D&&$D'$=_K,PVK]LW@-2G]512^Q_], Z=
M3N@&4'IV*==J@U.T&>7E7SRKKL7GC\-Z,=59802J?IN.%1+EUJ^I,^,2WO?V
MW>SWUF>+W:$)'3M7IB%#* +6ZG>W-JI:<@\N"Y =7O8,XM(3UZ']7"1""IWN
M?+7V)<3VQ,QIH^2]SG1QMVG4DL0[[5AZ]*GJYIGHL>.3XD:OEU HQK,D#3^:
M,'R!*(V SD,OH:V&,XAECD*DKI[<L10M<VS?1H "$@?]$^D:3@2Q&TE7UR5/
M:SF#T=?' >O,==!^=K$7Z,T&WH^D4!V["!6PB6=!43J=*Q:(]"L,C/B8?828
M@=R[4!K8^P,[G0BV=B<>_IBB^/Z.(BS]5T\,79;(?45M]PX$QH+=\8/+:J-X
MI@:8N7.%M:!D:<V?1,GOPI>W^U_.J-1'0;G#H/VF8?-,,W,^$=P8Y'GTK%)@
MTC39B5,F(_52Z%F!,1YLP-+A+1WCJA]]NW3O<9J"ZBEBA4UEL"5?1I#EIGA7
M_CW 5,[=;N0]("J (&A2NC T[M< >?^@MJ'FF2(]T-U[#[AN[XJ2&PNS-I6/
M^BW/%1?WH_/@6LFT)_N-B[XG1G"W\E]?W7XC!V/2X/G)RZ36'U_M3V<XB'$D
M^+._PB"SJT-L2[0X\UIE2%;0MJ"5;,;;!,_ZK7=4>O))]YN@<FN&^M LWY-:
MQ@KC@,[Y-Y^N@H!*_,N(S%4=AT]?^= V=Q5S!1/N@76X\<.3C&?@RTN17ZG'
MQO_RW>WD0Z+R7'-H6(RMJ:F &%>?I> FNC.T'V*J]_4X&>8M=#&=U.?[.%&N
M#(_K16<O&N#@H?[*+>RG+$WX]4N3R 4#Z0H3LP'1RQ:]:-JOB%,#4O1(=&J'
MS-G8@?/S/R429W7*I1^D&]&@KUCYG ?,YO,@^731@$@#N?IM=](L*AJ"E2K"
MI$+?XWB/WNVP42-\JH@E-]K#<;#,J1ZSWK45[A;^GB<2<8[RX!&-KHW1!E^^
M_46T0K3IS>LY3)M+DRICD^;!/G04!SZ2;:@W%V?=^)A3%W,$[R/L!220KYB@
M_0!'9 NA0\$+1WY&S%@@9+$#X29O_O4]<'P$WO<1Q=E^K#)M-@E1 DS\T9RZ
MNKK(3:'E.]:G E[BRK85\JZD8@^TLUN10^,1-?> 5%G=5"^T5Z,Q[^C?R=HB
M=@1I34>* L[/:F9$2#:CIQ3=A:ZU.I$^&SQ'M'-0;M0]4#6EJ!M".BWH=X%N
MF1<9)OAJ266@?V.G2SPR2'-AGT$\Z;";;B<5SEXF2PHF;"IG_6G5!F%:B?BP
M RX@/VQ!3E,2W6Z+N"B7K:E,7:-06_&?16)D*L?YG(PBPC(_:%,A$NSD-B1S
MU8++^5$_;F?W1^BWTCH;'OU/D!*:(&#02Z?=;GXSDBM)AC:\O\:XZHD2J]$/
M\F3"9O+(J-80IVSG/+<JJ(".4-@A5Y1MC5N"<93IFPW60BJSF<EB*7XG\38/
M^ZK*ZK?R4,;DK\80)F\R<R:?(^]9/#L.M8Q#"5LC6W?V=^($^SPQC0@ID8SX
M-/9'OH]#X"8+X<[.$RO2Q7@RG:VC0Y+J2,E36T+_R$/_4QV%&$6HB;E'6E#)
MDS!I;Y2COMTU[?C@'Y*W/;ZSB)T(@TK8I05RR[?T,]K=]GE"Y;I5[?Z>#L5D
MF!%B%*BGZSE/BRD\NBSD<E*D%"LXXL>\$JK*$1$02BLB9-#0@H".@]7SX'WF
MO3TN8D().VI(E1L4?>6];7SL<QG&$(0PL?-^]DFU0\''_!)P%-Z/WV'2D"CW
M$GVN(2C$B<%/B3\Y[*'9[$55#[JV1&WBXDVCMC@"[3G*3"JK=YQR+.Q98B/[
MR%HM]UEB'/2MYA=Z;Y1+WT]1?"AA".3.Z:@ITFU&8O[FN_-DW38/9$JU+XL0
M ;N7_I<0G/IU)/>3?J4X[4,'J&YU6<2K!\7CI88T^IW/T]CF'_@<>PW)K)-T
M)!S&!I6V[1?&MQ43(L?V^94AV;0HN2Q]W=OLUZH^?!A3V1>[[V4WDNGN:5CN
M.@^+RE>3>8\4A2JS/S2$@E["=0U&FU)DJ/&\G*WLO0UVBD"=G9$0/1-XDX?$
MM]DO%>T6!OUYK%R-?_M]>9G^)GZ)/5CSIW=?Y*=C$XCC'D87H8<BH;E]#\W=
M6$R@FGZWV4[U$YU]E$YI%2^$M32>P(IM>R?CL6QE*QD':QUD_RF7E"9N8GT8
M;_HC;7GQCCQDHB);.YHH>JC[!*K[&_?9';:.-P(OD9(9SKC&W1S>&BY[=E>J
MQTA-1=&_PW[A!&IZTSW+SM%"_+TIL.*@'5_9G:P'CX%H![?,9\QV)B1&WWX2
M+5L2._C$,NDSY),F>\_1Y:O2F=CNTT6G[4$%>J2<C/0C4WB.%?WK'X!_3&3>
M=/\_OX^Y?XDV"X<2S^ZD@O^^,3X/8A G7XTU$_[U!D;QKZQ8SMW\0G2<)O?'
M@N4"YGFI+W*-,:P4M-4F@[GOTS&;+/0N5WENKSB]\L#K7Q?.=R;Y3!YEV^=
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M0KDF^'=59>YX?+G%XD^[O:ZZ!V"J"#5_IY2&QMVYR\-9]1O<ABO!@?"7-_=
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M^! M37X.;1-->!KUGKM1U1'TG?OEG13;46QW)T4#(-#/]EAA]%L%DR-/+/;
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M'WD8\7;E_'K'_P\.NA-YUDOR*D=G4H=VD*HFW7?:.@MMI0,N5MU=+X1U$1&
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M*B41 X)*F-6O"I^_<^=-QY9)TATU0/\XC;1OHA<ER=M+V+W^?95F"SN;-BZ
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M!R+=B\BMEEE%9T4'.&:X^K5^?>"MU</O'IA^ZIDDI?HS*^B+0X$I%L^';Y>
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MR($T$O@"6<6=:_I) 62BRLT4VA"+KQZ-*<Q95P[OFB=S,<R00A>QC&&'5"F
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MMWP*790AJWLMQD'5'T.E%ESU,P#:4NK_T8%G]0</HZV\51]3.238 UNX6*[
M4JTK:4':0HWSH!7N@>_+UKYUWK]*9J74/:.XG!X?+2/-<"R5.YJ0PD2;R+YD
MA5B' .3?[Y-V# <L]^E< .5#%\!0H2E-2:OI5)>XA7V!Z RE5*5H]Z;);Y&+
MQ2C_+"SZ/.H1L,7Q'V@2M=_"/97R9@P'UF:+ZKM_1>PJUIK6R4TRGO;'!CJ)
M2HY;_'G6,=R561:_28A?+1PLT=M:4&#3B;?JWJAD,W\?*>_5 TF3 SR4O1T+
M*-AWQ]215RRM%5KH68R/1Q[?'':G4#&6>W:8->U\HJ5"1Z\?3,VWD8-6\ ,-
M"Z&6S^^Y?5$ZVUPY.AL>%HHR/F&G6[,7RP\OATI:*20@B?>N893H(/!!(MW$
ML&\\B5KA,ZTU1T'9^\O(JY ;/+?IT4R[&Z++^T%^S+<ZBL,.[9V]867?S.1)
MPPO> P3[:AT(*0FW?KN-<WCU& IE%B$&\Y)?H"OD3DGR-(/JQTLRL=H5G_-5
MHD7A"6.[HJL8@QXW(#.J!AMY)$5LXMX!&!O;%ZF3#U"L=DTA#."SB(6_^<C@
MC6(N@(+HLZ'3]ZDCVZX9,RHO'7QM)/F>^^5'HJD6]2^'1DW6D^Q?&D1/#G7F
M]Y#6F#OP3R[T6&$H3XJN/!5*7?,HRK)M8<W_E@,J+_+1K=L"C(I]!%XF62AS
MQ5L0UV8$.KAZYR )559-9C-L$SX9J$RL +V.H38[VP&<G-NHC#+2!#_LFV/L
MC<-#5.%(EU*89:>+3LR+[YMIK[X&"OU\8US$(RYZEU>NO5?-A')RX06X3$<8
M=\7=GFDSJC1C@4_TL'LY(CF0P]1 ZDN^K8LE$9=5; (,2Z\(,C@CNIS P<6*
MC7<$MG'Z1W&R<!'2]L[0KL^M]_UXR<UV->CVTN)+_(N4K-Y/3))=L3;&353F
MA MCH4I:,LT0>-",KOW M6ITIKL#;XJ3%HGD99]E)HV?H;:TX<*HP]WTI J
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M/P@NFJ#\[>2W#%]MCTOA\S#Y:# X]Y-VY%[KB6O8>F;)F?;9P_L'/ZC.PSC
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M'J'N5_PH0@=9D*:7;%IYU2 V9,#$@EF*4(;JU8[Y!U_]'^M*5C^L;5=M; T
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MTB;PFYP2F,9I]C_Y?O"IT):FG2$\,C3FW:IV0AP<TY6>G^\<"9*FF3^7G;H
MSD)*+@#L <[F7]T^^P/BS>__9\+.WU=0*Y\[[N"_+HF59J)E7'EU9R!' Q9R
MU"#[$^/?=M GCB?'3<N:9TV/3A32#Z<=!:P__VK+<]V^/($XK/EM=GHX?W00
MT!F-=Y X#\ W?=NZ *(N4_VL)#]@X QW=O9DKP!5)MA0*UDH1 +,T%%CP21B
M!$S'O\7MDY_SQY1*%T"0>=2QXQDQ_ )HKKAL1([# 1MBB'/"")'-II],<1<
MN./RPB;5"R!C)?VO&QSS>1? H(OZ*=GE&$)T)G(>@@E8,,A^<9GR,CWWOW-K
MR@&,_[<NYF0[2[2W.?3EJEWQ+H/%OTK]F!H9H;2-OXQAT]_*(K4&D=;LM-$V
M;=:25Q;W)9BEXY6G4AE-_^>80E@UOJY@$/;3YD/\5O><%A:BGSRPO0"FIG[[
MP4X'S(]>  P<&9 _WTWASR>*X #%V8F;?.^A3ASK8'Y4_B-P86];I\TV Q"J
MX[N_N7/Y?[S_'\+Y/[X8=%TXSI[B=&_K"D_[]^?6F 5^-ED'2/IARH^2%&FY
MMT D*T] //7?][8"+B;_!5!+ P04    " !,BJQ69'-^C'Y7  #78   #P
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MR3PT_W)H;UZ]UUSJ*Z=I)%<L$/9#Q&88?O1 3&G^73GPTV]]O-/^[0GCQH]
MN^#K^RC%>P9HX2\<G^U?-S6/ -RGU/978>/+-I,/1YL"O%',2EGX7>2"SI.'
MX4)#TGU7CJ+P\Y</T&_-_FJ$&>I!AX?;ZED?^9[GR,/]T#:BCJDW/IMR^G5)
ME/A-;%?X_4CE>5#,_>=-:TP[\=3!(*)7=WK?9W+;&L\M@PYS/4.0L%L$ FE'
MP++1GNXTD37C7K=UP1S!-E:UY[2!2AY(I@J8%HZ#X[0;I)2@6'6B1V"->E9J
MQVU>ZG@T\1%@F&'HTC,[K40-JW=Y.QD"=8&8MV6)8+8>+/8I"^>=U*^472<V
MI*3L)4<*P[&+OI@LFG4$W8GT_4C\^=UN=P>4^3_J9(<U"\?O?U!^CK_(;^LK
MUJO=4EZ.WYU;/@(#%_^LB8K ,&#[7[<^^0B@714_ G(9S8_ !X?V&^H6#-9_
M;TN(8?^_;"M_EKORD,=QZ%7,$T/'""3[$"73_#,9QON>\SY@HU@ F$DQSTWW
MN31P1+OS"OLQ]F:S](!A^.P1"'D$4)PE"_RY_EM[6RF7VBM?O2LS:7NR$(AE
MALOR 6R$>IW:SW*7U+%G7UK=)*1KR\&FMVE,@$.FK#6P/R!^*DWZ"/P+#+.^
M%2,5X=64JW>+)"(9S@$_&#-DV2NIA$&%E0)F80 'C^94)4\%L9$?GIVA#Q*&
M67WD\M>TS*2;&)%QX?U(5"I[S7]3]:.SK_;8'"P"X;TT4 VF<%I)4_-P K>
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M)Y_P"C,W^N72M EM#6U25(,.KAM\3.+KE_M\=]<:G\6^2$L?05$3/]?],.B
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MI%G#^!$T-[H\^'J!L_+P$VBJ>U/LLJ%<_W#":CPJBY.LTF[8S#2$L69Z/=!
MTT!!I<WE0+,GUJ/B)8H:B 74G+77XKJ4:NYGQX+W*ZO'RF1%[_HT[?!Z5S<
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MR#)R=EMY?4OSBJ,HQU^$[%[,-R%A1;5WX&T=C!$_J:UF+PN+F**1&I7%$6&
M;/2MH1[4KY;VSE"%<D%$V<!@QN(02SM:'PM11GP[;J[B3TQ6SILQ>G&447V4
M/^Q3F?-7G/Y)S^CFVVAV.U:0ORJ'L3H/]O>&>3 9$::Q8=G.P1.'6H<W9.I:
M%%JT_D(,U"DM!1&^B7S+L$$_YR9ER5',KF;(#W#?RRFQZI5E):@"1TF./WW]
M$TPE^4X4/R[?+E''?JER%7G"O\RJ_"%Z%-3))3TMZ26P/5P*1<FMA'4>[M76
MH]>,'(CA657#2(,,3-5-'MKJJ$26V7:>ZIS3*B6PE]/16[OE+VH*)H._]F#
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MV=O_/.S]A*],B(L\?%/SF7:SJG0SILZUK%_\- S%P=!.<'ZH8#GM*,*R^]F
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MQ_-_O1[[ 'PTD!1H!A%$#R#@@Q#Q08^#  T @)!!?R[@[P5"0$1"1D%%0\?
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M![H)9.<!^]P\U481UI9K>U_:0ZOV!8$XWF_N4<>,[UK;LLBL.R-8K$3,%%S
M,P6HM;C^]I0$T]^X:C0(FH1<6]&.T$\E*:ML-QE:E452,\^LKXKO9'$%"%T.
M0#/B);]\G5*7/WF\;TX-'?%&3"(.U@>-.G>]HMYL-?LS&6 ]<IT02/<D0M%@
M&QR/(,'8@G^';='4NB8<]D(<GSR3B_N)F?$E\85:JP4R7=\ZUAO<<9KM Y3=
M(6\WQ43Y.<6CMP7-O)0 JIM=C7!OMLM'=N'PFEB7TB_H/,FT5$I?9V3FYX*%
M#+$E!KF-;)-GJ/KQ19)Q\SL)>#;(,I^2K,4$?IG&87NNT/II^Y*DD'\I@]V$
M48)'96C,H0YEFXCUO@=Y)B#/7K_5D=\J@F2!0[:9H)$NTVV'  U1-"=4O*@T
MZG9Q>]N&KC,"5BB8QN>B+U[@48!^\!LZ_X#/B44/O9MD!X8TQ444KU]K301*
MQ'?C4N?Y?OM.]YB>[B(-G]J&;OG:]!8%C$[10Q6=Y-5S7K4H+-5UO@N=4S1/
M29@[6PG)[RJ-/\#6?5B?&\HR%KO&_W#< :;D%/:<D?F*.QW,1=K/V=8DR\^$
MR[TA&A4>,#SQ-7C=Y3M\KE0<Q^;$NC7T,J"3 29:J;W*V]*.A1@JCW$-.<-8
M<L8[C/1FJ#:FGR##VDH -%V[Q;AU:\],N]N5HWTU]8PLC7&D"G",OO-HIY*+
M*9!E6EHSKZV$RI=>D04\ MVB"?*4%_Z'*S8<EMML4W*<0'M'I#G)%U6B8 #"
M%,S]$1"ZOZTHP%$R05=VQ)RQ%;@;:M$C1"H[;0Q_X1Z,"&R(/*\3I>&[M52Y
M:IWXX;\IYZ6S^IH:$?%;1L<UK:ZN'.#VW$? U_EASE/>";HZ'6.,":D?]S;%
MS6>*4XI+I=Q$3ZTMB/BL@8=FN1D"<2S^EB3N==8O(1'$PSOB-/R7X/^AD4O.
M>,[.$@I%: 2+;-0AM&*J)0YNBT0=&-A%/N&,83+8'KJD&4Z^%9,6'G<&LX($
M(28HCH?W,<5EK"_R9QOCC!H;1RKQ19/7P#JCJ<.(=>Z&#'3R. ,.\P4>]%SP
M;@+7M B#58F21,RS@(CS <:K0%9SGX^OK!5CB;@*KL;K'004!>&TU]M=&%,=
M2^RUUJU1,BQ/Z?25AA4E!UG3'@Z@(3/N!EI_0!5HTN?-AZ3CKB35]$A'_'8?
M2Q;P5TK*+6LOC*]YF91;,1=CHAP^/Y^1T-B'R&KR33#K\U(T.IP,A')1A,*^
MU4;'NDVOZ4<KO>);AZ%GLX%9JWC')$(> :@6[_=LU3#EY@5E1=,>EX38;OU(
MI&L'\V"_CRBR#U@=:10E*HJREMF3TF\? 4Z9-TXFYPT)83&(<7GII!_.NF[*
MBC@O&N034U976$-"0[Z:)]SO4.>8E3J3VBHY$8$W"K+'+!5AT-C!Q!,$(8FS
MNYC-0*O9)R>GO'3VK1M8(>CR6VU/_;8('X%C,/#QM]?YP_, -9@T.+!R8[MD
MF:!Y*LG0#T<,@24HU\-G!>XKKH8W&5DWT=B2W3"\^>'#R<;4#UNY PN4-%?R
MDMQOPA1;8Z*'XFZ,=[_.4D18L0,3A,'*;C#1&[(A3ZYB!2R;*S"5%HH;EQZ\
MUMS0IUVITT:;6GV><T=']3VWD9\U[9VK8<H_96'05#RV$9]!EM@ZXNF:>Q,!
MPBD-2[_Y:0*7X!8"K*+D(HP'.KO)_O1N4S>/>11YY9L+;Q^8UOLP><A.81L3
MS'%>)NZ&2;+&TR/[]%D,3KG8FQ=R"JA1?!/1*>VZJ=8.N!QPVFJG5:V[L,5@
M 2)B.:RUMV1,BVE_"0"127N>L_[\Q"+.AF21%)=/#<Q!AP4.,I4'((*'.=9E
MK+G[$:*_!([&P6910G6]BT!,,!E/P_.6L%"M?21J>YT[K3#5).1<QC4VY*\$
M/*.O$XI=3Y,DJ])Z&1IZYSGY,4V$;6@=RRTLT@Y';_M1UWJ9$46_2Y9XQ3L&
MO.P.Y9=QJ7#; 7CD P'$]XC0)0U]DDV&><XS\_8(75L&60]DM'5*! EI]%J_
M/\VG_I7=$X^[:$T(O<V*A$]V>N*ZA440?6>U"?H1NK.YHW@IA0R2 ]D(!3J)
M3#=6'$R"V8'SY!L3$]FQ/9/Z)4E^Z1&+I<<<>RRB$2_:F);<M#+U!NX/^F V
MVSSRAZGVQF#CS.)FVYU(BQC0N^54*"?J./B-ZH_M&MM5XXW>>N] ;_Z>7IL5
MO#CZ"+YIKQO:G9WDA?R",D.?<I4N>PUP]B]((7<.HU[1F1B*'IZ8JR['C1XG
M/\L)PK/DP>[WOF#UXQQ+V!'O$/#B;\U#B"LO':J2(Q]CO^AQT(>&W#:,LLH'
MHD%U'/?#^/P_I8BZ<5Z2</U WPTM!G;<<'#K4$M-/K7ZM+P.A15;Q2FP*KG)
M$S7TG<& (/ZL7JY6?(B:O3M%4W-&J).'MK6.U0EP-2::]^X 8>"[H:K;;YT/
M[0 *7J7'Y9BWWU2OZF2BQ)<KF#O,D16/H<B/[20%Y?KA(%N,P1U9J<25EY13
MP\EPS/LM11J.>,?O8\]'E"S$>4/E=/PI*E*W>(JYD"S /@X>HV\3E^KM@,.*
MNJ#]H;1+VXB?;/H[;XU&</0<L&K6GD7G%02,-/ZPJ]D4:6QK2#KR]]4.FF7'
M=Z1K#Z=%%>MSG%B&\X$^:>B1;+(W]L2KWXFZM;1Q95IHEK#AX6@;%O:35<Q$
M%_K2QV&R15AUZ.7F.&JKY7L$?T,<=SV/5[5!+"[J]+B<SG4M'_.VMO=W;6),
M-XU^N2H 3Z-U[S!_!&HUWT>;&0ZWD[AU8R8Z"5##-BM4<;A 3KZG0X"'AS8;
MMN::)B]FX,Z'->AZQ^KZKEK'"&1=>_5?4%U8<\AU[.>^/,-^*;M#PM6 %"^3
M($6CH3_2[\>:2;Z)VI9X2\-#ND.\$<J;F/RNR7^OUB=:-UMV+G9'(-^.[I.^
M=RI&>34E@HM8R'VS5LDEU2K'=:2ES84AVKCR;1/Q1&Q_T/[FJF[X1M*6.O+(
MQ6XRS&YM'].!6).;:7RTA%CG!JB O-\WN GQW3:WK3A<='Q):U\"8^14Q$,Q
M+:!$X.V )XFWOO\SH@*W^S&TGC5:5ZI ]Y0E SH&[C-%G4:,?J'-!&S]!ERO
M37_FD]YYM[2*;-$6EZ>(.3OPG%"%J_X*_E>$C+$U,H[>0-S8%UOJTYQ@,HM3
M #%YQ(TWCS=,XTG4Y -)O%%;D[YZ\X]$]'[6JDD<C+#DD8_>@N "Y.1^8=FV
M;WA/\W=5CR:[^_N0XV83Y_>=5-7$?,@^.N*LG',XD1N&<JB:1;\:Q:5UC>M+
M/!]V#]&KANMFK->0NS5#7\OU!E:S@N@X<GL3!;@31W?<H\N'T#PGQ,1%=+G5
MB-SX3A31++ T_/"3&[[1Q (>1!IRP!]$'+=)V9RP^6/.Z-D378L/,-Z4'[VJ
MF7WK@3_=0Z*6:ZJQ7QC62C],&ZIQ*IO695ML[!4[]8,!Z]T312K>!!<0IH^A
M:E*?@9)5@I,U#R_VY(F;WF7, ]G.I2'>8(,,)4ONVT)=)B; O-;]U44ZCXPU
M_W NE&N=EE&&<5=A74I3<A\@'&E#]3LT3V2(M8@-@P2/]^W@^9$#GG^&UMI4
M"NKV*"U#W4K-ZU#V_C[\LP=(7L\M$4C+QVG><KOGFV9@_2][T4Y!\"IH.,AH
MA[JW9#O[:7C+<32T+7LZ@1&^QWM_,KF6&3FBZ7XZ-LS:0\W,<[B4[FQ!.!;)
M&(G4]^/M;J@%?%?H>>*TF(JLZ NS3,VKOK[L5<;LR0WJ&[?ZL/8$+K7Z"G !
M3J86/6N]'!GEW!P;BOJX%)(%_F;:G]$M;_VU3ROFG4@G)R=^+<PBELS!S.\,
MB=HU,:^ \%B[-H#;UM*6H[5U:%V9%K/3 JRMCA R(H<(4.X0YBS\S*L4R'>W
M)O*:$)ZAE4;J""IFT$7U0M';"0:.]2^^9_E>9U=77,]]':3WV8HS?C ;!SU/
MZ*&DEL=5Y94DL;IHRQ1+?5==DF?<A13S9@<(#%1[!*J)6XWF?'KI.-[G.^X:
M3D>-N>F=B")L:%$+4?$FCA+/??RSTZ?W<R2BAG^B@K'7=H-.1P,M@&YT6/'X
M=SYRGJ,3>SJPNCSC2L3H"Y&>(&A 'J7$RC?89[\W%MM?1EBF#ZQ$LR576*'L
M-(4P64DQ^*ZC\&X&<SYY[3$K5G(V/\;?W!)UUI?F);3N<X0K:NHB_&D-FUI,
M_.?9J9.35=)!1,*S_N"19ZX)J"]S,$;"AN8R6Q8ZYQ?I_.2']3.;P..%)@G6
M$"SW=M";%ZGE+VOY]ZKYLPW19@,&B$)5AN[;EU>, MX_5555* 7L_W'UV$.E
M[]:#C"?Q)W-BFYA?CM+>W$*#^/4._)1EB)A46KCEXCFPV,+[H>;Q.A*9-U4O
M()V?Z R96TK=V>=Y>@>EI5^;WUL /,CFY3'G\,Q3)X_1H4&>'ZJC9YK27 *%
M&$%N;M(Y+D*0#I3K%^!9LV:!_)6V.6D+GH8DKK6<?7;WA2L%N$ZZTOPB3[2Y
M$][^+GZ,>[?$3XI7GQ46.W,5AG6S'*.,)\K2;.GU28C9%1B^3W]^%T[IE_?K
M^'W\$Y+5;?@=P_O9C=1DWU7Y72!B;:Q?@OE<DLKM4-B-O:I-H-_J%8\D/9G7
MC7A9<;;4'"<!7_:SED1S:%$+J_3UX<@=Y(HZU>_I5WH80,L3%LHE'UBY -(1
M$QAFS"UN"5'I6^-&$W>-,?UYJ6J(R6=IV1JNKRJ%)GC\" P]_74=:#=$!(+Q
M!0H(4B,UM.GEZH.19)#5-.+5['3F//:FCRG<DSOVN)=H]X\3<+_H,A=@M)$'
M]N8210+.F^/SBI-NTR=N,(GRCQBM_]6,!^D\ JI-GSAB6W_5Z'*18#=IK_,(
MDSM.)Y>_D#3M: K5BX[$X#.-W3)]N@"@V/,."^=N)A:T;N1<#M"/!S>/O-]E
M2D!]EA^ LX(4-6!":'?%?YZW/<Z0JI"Q.#1591F\V5O[&LYT;BU6@5@OK),W
M)P71EWR!LD%(UL_L T9ME_J!T6G4.MT9Q.DAZAACA$RJSIK/->IE*4D;PPD3
M#8OSUWW^!Z)PO/"M;?$?.]T4W(MCM/ E:JH<T405+$ =*UM1J9![Q5#"X8N1
M$F<6YA>V@/C@EV\0Y4CZK&,DW]R9OI[.&*3N9DCK,0W;W^SX?J];\2XV;,BC
MWNM6\]G%F'WL=]P())J,I&*0#RV!:Z+FND^QM@K"L-XJQ!/:A&ZQDMBH[$ +
MFKXJ0.!"%S7_[:G%PTNZGL67K?),;L.DPEU.A E'F.KW NV<3R9H6D<\;P7%
M9ZE/DTXHTL5<7A'^R-J>B;J7Y-O0L9C?2=N&W'7 P[Q7ADWHAJ68,,H1)7PH
MM[:<UNU5 S1>OG3V)B-@L:W=9#<-&#C?/[< B+RPU.R  YN_73%KB;!E>$L]
M.XF+'#3)-VXTF,3)5_!\['[*L,Y  L_NV>JW7'..SE9)AR1%-PL1HQND\S&C
M+7,@9#%8&'6^IB18^C:A14KI-3,72 A"HXZMIZVE7H50009@ 6QOVR])NMKP
M7HPG3CEY5V? )_#J8^$%$ IY'\H[77NL4!OS%#9F3RSB8;31 P5S2=P_8K<R
M&)%;. %][R)6=X2+@LQ-^:PD4;+"O+F^-CM'JI65+1#S<@*+6[R3Z/V*P:N5
MI+43G0=ISJ'X"0K):1?4!41];_+:7VWYU2T1$%>DR;9^>@<'M-@<:W;Y;57A
M[::E0?))_ %/UMJI:"<$Q4*Z#9)GOAD'3[',VR?1"G ^ @!@BL%"W%[4AC8Z
MC=9/U/*G'FON/VOL[@H]VIX#.]$^ MJ0"O:<L/[349I4A5^1I6C08-O%(C"Z
MM13> &$HC+H'=U0;VUT[;4)KGL.T2W&G(YE:>2@UT0TTL;^[M04:@WJA-+V\
MI"Y9Q3X=F(RP6>6AE&H9QOG,+YT<^MR+1Y'Z'3;@J5:VW*-,J-]G+J>MQ1W#
MC$H+.F#]Y#JVC6VWP7Y6S^'N**K17:)!" WJI(JF7KD>\N+[T^C&7L;YO  7
MZ]-[LA[ Z4*.T*K4;0Q4VE?N<X4_87>1?:&G2WF^@/@]?_+G0E?.W-JA]W/)
M@V3HL]$Y%DLD''3,,1JE'0Y1W:HQ\Y(Q*$^TKWEJG?-4W<X7*&UP[4<B5,$?
M(63#-HCU@9P?8'3>S<$]Z$V,W#%%<#+J,*+C0/'I15_K]M8(EK*1C(-@7GB9
MFM\N>P#,FV]56J 8D2+"R],&X>PM-]@*%>/[R'CGOA"\["R7X7IUNL"BZRL[
M9+FA\NV327EXQ.^D3N-FYC>@S_YKI&>3MJ6S*VI9#JF="_IZQI'HX;FB0(*X
M0]P;U#^JTORU]\^)6^A9C#I3F_(L''<K5O%X>7;3*=II>F%D!3AU43LO&RY5
MWL5PE7Y-BWDS\</!<,<D(4G\['3]9L0ORY[#D]-31!'\6<6?1%ESCMDRW0EU
MZELD- ]&!J_]'7;HXOSTCN0X+0ND!SLLQ&\83O H'00]NYJ4Q(XX<XVY$2Q_
MUBM\1UT@]7:=+_K6\^TP FYVH7./^)80<$,?+&+']C92U,?J+0PJ+=&""'&,
MR<VQ,)?P<)_VIA:LV_Q?AW'9$(<%GG9%A'Y<5A!-CM0(E>.*%Q2;EE>H&!6[
M,ZMX9>$39;'8N^31V=D68QB8]67)O/)5BG6Y]MCY?;#P$5OV8HVG_92[2MXH
MC)(;%HF>CE%%!3-%Q#HSGAAU>H=J</A72E[2M]&-*#ALGW3)F%J]:?]QIKRV
M+_XD:7 .,_?MZ[ 80 H[Q^NWFC?'S)O-MF+6(GQ^]CY4ZDD>E+.9YZT9IUMA
M6)(>$Y4JCY!@ <Z'J*WR6<_?RAR!&0G/VD+SVCBUI,C)?+4(*&H&<^HF\ C6
M9I[P"P7(6;M%"X9R1>_Q]WVH^-S#@QCQ)&6?JML\ 2<IBKD X4]B2R%_%:EE
M_V YZ,BQ#;*&:N+1B^@%S@49!;P33E(!/#UT\7'"Z_JMD3["N++$!DZN9A*>
M!VD)4%#$^5.^=$TT+F&40;*RU$ZIV"3:08QS/?T+3?ZDSKMH;!C?KQ>;*'DP
M3BOK\-4@Z91G%4+C.Q&(5,)WBV8'JZ==,NYV5S_"O']"ERA2\6 IS_:34'AG
MS'C<):E^>[F.HG- 0 BQS-;FKPV;6]F4HZ-KA?6@B;*D%*7:R79-Q"]''S@5
MX9=U5DN*2_"+7[]J)MB4H6]GZ_.3OBB=K:]]_?HUA^?;76<!SF84/%GA$KM(
M?WW(Q8E35B/ZK47&#\LWDD(S5&KB[]RC3OZ^296=RYAKZ88,;N:>Z+/J75AC
MDX*5&.X[=[\7R=5#I;8F-K!/6Q$^N^VD<MXHSYM=UX.<<D*E;PMP>J-V6C8P
MKJF$E3M*39K&^ HHPMX[O?(&#Q!#]I@J:9C!M=@"<S\E"$PV8%B-!BID9$F!
M7W((QV-R7%Q\R/H0Q6P0O?Y^*2C-14W5PA'NX4A7JKPC7U1K-G3&S_:4A4Y*
M0QC;4CH("RU--5+BT(1^5.=G?UCMB5AD7#!/U#1JR1=.4<_6"GF?/B-TF+<
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MJ;'\8BA\L,M_W-+55"I$/P3 [D!*S,,(6Q+OK/VK\\^&]+U;54#WJ>N0+[O
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M66<M&QU1'EOTWV-"+UMXT.92:TXFJ;@<_8E!:P^[;K\*71_;X,3W_:CL5,V
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MW67N+^LA)OAGWNG,>'-J'JG&&D<J39W "L'>Q&[PTPP-,W)_Z0Z(*,.N=#Y
MV*2&$/DA4IRK.KK[*@^^G?M2#1R>IYV6KWT@[I\O-,\VLK<_WDY>*RS2TCZ^
MD\/=Z"4N:KDI17W@8:9B1,E2(I%3II?+0%@4+R;T!M6.4)8XM;X2N@6LJM,A
M;\-G9^$>:ICUH?F%4HQN<T6WP&NWXC>AP/+) O:"[F.>C )XC&AGJ.8J!N-+
MIR_>LR:)-*<7L@+/#X**"%M>EZ@B(@3HXEN\J.Z:V64KV@$4L$52U&;;[ZP
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M<!5">YSE+@8CQ+_]\2\:*#\1.\[!5\)<6LG=!.FA]U2/OSAP*ICZZ!-L9(+
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MQ.^+R2PI@J=7))P48Z$6GGL7(EO(]*I#W!">S+$B]!KZI[@.%U=V1 \?EDM
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M)IM+8"(282C0]Y9L$![OL2O@]'Q9K_*D,EL/"S%4Q2BFP/EV@[K'RQEC04T
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M,=@4P"2X<C]I5,#EZAD;J/1C_;Q1\ WC)<U!Q_+GI+5PLV-F=TFV9T08BP7
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M K\( 6%@8N)@XY#CXI(+,% S"/P/?^"M  $&2![DC QB!) (0,@$('@'0 <
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M?239G0\8##/>6\9>W"K1WT0 &Z>+I*H0+]L'/?C3/ZU?K$=[?K>U[UM"RN)
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M!ND-$03_^81*)!8Z9;_S:^ IZV=[I7PO05$:F^!"T;]GE?G9$"K=O^LR.K=
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M/*M77_EPI.1I6-PK*%JW0PC]E>7K.=QN[A[:A 3+Y3S>@R2]QM=8^Z/OG#X
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MY;/PA.P'(N,2WF"N2Z!Y2#DZW$H?S<S.-DYF1M?/SBJ+=!*.2MJR(/6?,OU
M?EW>G?AMR5]B0/<8+02>Y%)/\F%:?1";?%PT7>8U)$C]K-.)8 ^(7Y D6^+D
M502<"37BIKWMQCB+O*5<.-,8\2PF]UURZ_D^C1N=/I??O2G]1B; )=QJ?#=9
M7-;>G<3?<3&I$>L3^R)&K2*)(Y*11^\CSB0,,,=<YPN(]IMF-"9;\7L<RI9
M@R_Z<,8E$#(!&G%!+WY3!2[OO^FH1O[N4,U@_G**K)LLDR:X"3]U<&.?OP:9
M^.*#Y\'.%A:[ZWO=M\T;5^BZ43" #J$F'2<3OG_P]'5;G^OH55S>[0)U8WVR
M?B<+W@"O-/F",*YW#2.=D-%CRE?=[V\M[%;L\'>O]8J:Z$9]!U%:G1*Q\K3B
MHO)XRH@>JIV@T_I)LZ5--OB8@=Z*:N4O0EPQ9VU(U&WX]W(_/M;=B^?'<7R'
MHTMIN&IG(($K-,DO M['Y/LVDCX* \K6CYGJM0LW=G#YV2<^9?9D/#/]!#TT
MUV]PE+*(I(;$3+755658^<9O+]\]>N;.OE(9:)@\1\^7:C@;)6Z-0"8!D)Z7
MR)(G^*'<-;WG<)Z;G5/(E0"5-X^L)#UCEB762]5T17XO,<VX%':L=J[HU3)Y
M3-$Q6FC+=38OKI/R:' LC%YS?\I=QR)5K##+'\O$#V>YFP^A=PCNTZ1B'66M
M)8P6, "C=7@YI##+%._^R#4QTCW4>]4<\<)ZU1RB%B7Z'DD$ED[]!9%X^MOQ
M;UB70Q6",WYTR>68+_"IR5@'?G"B^BS1;O92\;@Y@/F=8H&6^8PE?V?X%JJ
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MW;:8X* &W;*%&]\8]]TH1EZ8W3(9',7X9'E=+;K=*<=5VRVL^D*3]_?U,Z0
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M9C2.6?ZYHE+J8[F9PP*JHZ.CTZ"BM#?+<E5#TA$$+"_XTN[TC8##8:P[W:4
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MG4UYZ=J)O(\RQ3+Q$:N<E9:",#0#[V$8P(UB8@ I>#(&*FN:R&]IGAG-%J#
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M)W!]AF>=Y4O6Z;8Q%O$W!M(*=?BKP_*&D@D3,@2ZU_1E_]H6B3T](8R09PC
M,X&W[)4CJ2MH([1"YGZN4U 4%8&L^LZMU+W;!2YCW[3$5=%07N!C<G#A>3+
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M;WV5;;]^9MP58_PJO]@)4JB73>OS&0<U[X#D"?C:JM(C.8>R5;KW3F!:,BJ
M9!_T+W6GN'>IS)DPMS#-RGYI?R<]AVI\B%91G\_"6I!*ZMX!\9@UN5E4#G-+
MY@YMM*#M%^I4ZF_[U_[E@U1A;J!6C4./VMB3-3C1!#*T/!9ZQ6$Y%O[%ALJV
M,I\QNJGB>2&S9RGO#3_2N\2%5-PAM<&>. C@4KX?$@$^Z)\=,OZF1G@MZ%Q0
M$,&]^*2"SFS)P@EY[& =&_%BW+E\$;-Q+ZZ!F4^D69F,8I7$\U:7W;S=0EB6
M0?]:5AD'QPB "3P2ZF6_%#%;+;8"&:FUTB\R)+O-'?K@5!D<:)W*%55U;S&;
M)2B(0Z'R1*,'2:I^T?TO3Y5;VX$K(0!CN9/N!%#3J)_P0W9:]0!HTS")Y+HA
M'7X&<=AQI5(@7; U[6@XS^MP+AQ<T*+YLL*_7E<*\F&*Y]:9($CE-;\2;MJ\
M(9\;[IK[GK)$*[0I.N?&K4T^]><Z'^DHF[E;5O_R,4ESL]]BQ9]VWME+ )O#
MZ?S4Y5A<'K;K2/O2A(OIB'1K-^W-((#X &3LN'QJ_0^%*?TJ>Z86#B5UI5M:
MQMR587N@A&O0?86S9:4?CG]*LK_T+W6N!D%BJX/^B-Q)Z#OH<>U2,F3J;N@/
M>"K( /^%#R0<)AS=.V."</[[$RG!,F ]\*_Z'1XM?]RZ#D&5+7O.^TSYDE!C
M1NCI$HDS^)=)"H97#MTL6/$BBVTD.ZMRS;UU .-]DK: IC.CR%PG QMS_+'J
M3:WD0);GFW\PWC7)8\B,I:,CZSWEOBCW+$>=GEWR5-W963$!7"QQ;?WM;&%"
MI+CH$$!= .0XNW_[)=2/O7:=Q1,!I'%IB(M1&D.90]$A/=C@[9OZ<.;08S7J
M2TAK)H),WZ^%JCDY*&*1([EE2CUH'U4!>BD: 02FP$FD?,'+Z G'A.P(@$0O
MCABE&=*0N2T% R(0 "H] IA%AEM_I>G04Q0&.+H< FC2,)8 ;!/^M!3PC*H+
M+=Q;!@'X$"& ';61WO^EQ3P)K2H#.<S&_0],]UIT4*UE,N-_9EW/'F*:9H[-
M:33S R9H(7_Z5.E/$^1W!0)S?Q*AZI]FR"E*?]GAS]GG+;#U^]9 ?U+%^G(B
M/O?O*Y;Z33250N8UC:Q!/5A4_TO&,)RRQ=HR(?!_)MD<[IG#",-DE[WFP^L.
MJ#B:,:UT!J\-.3\+ARLHF_?FO-A.@+Z=HH94&R* Y!CO.S&_]HCVIJB6#Z]O
MA7I<RUA5GW77DC@\;B?IHKTKB$Z=J)&D03*K?\($QSPU YW2FZ!,;6=!?]E%
M!7A&Y?B773C^,&G('X)D"SU6A?]#$7H_;2SA'QM\C=P@^!\;O/9C@QF_;G 9
M*5*%7T0Z]%VD_QN+X9UZC!YRG(A_Y_</I'Y[<*40(UK0G];8^Z<G_S#@W];H
M\*=]KA6EYVP:DYUE@-(A>8#M_XJX@T(7DBR,B5?_C<4E>PMT_SX!Z$\K_.%8
M?R.I*R=.NIZCCO\CZANR?*5#WO1OR"E$XM^S*=?%ZNW:^M)XZH'-Q[U*MP+[
MM BK3AZ2W:#9G2SI/^8PK*NA1DOLMZS=5_X6>A72FI4+&0J:.D7)%*9  #?Y
M7R* =0I+I(]%>?,M)P<"C#_&$O0&,@=KWSJ[/ 59>1#9HP&>(3C!U(<,JY\A
M %FC?-]_ZMH*N%2I0/ +2.+FDE/+N@I;B8&>7 LMA?(;#\VJJ#FK:UXKOQ#L
M(P_0*#86*Y<_T\3=EIXC/\@?U&-K<%2+ZKMVN:EY'@M77-DKE0A\G8VG$J=\
M\,YK@:<2>H'YWMY5MJ<$7[T%<:R)]>N%KR24F&$9S4IH$DM?/G%A#0&_VN4<
ML-4#O]QZ-N!PQ[PRZ.03)FM8D$>CZF&%>H)1-JO%S'/&QWPTE)3&>W70[ Z.
M%O2[C&%*UY(SZXB!8;=V. +8)V&5(-""3,%]TQ)QV^^TI0\>X!@_?N)OR,C9
M+]B]FR?D>T?Z9D7,PE6B#L"I;8D*'*>@K6IK/;$>$&AJ)L%P.HP KD<E1\ L
M(,%R6F^)E20 6L_^_70=!-!2K+])L*!@7>'UMAUR?/@:5@_-1)4]%UD 9&X&
M.5]F-%P4M,R(JGW^7L@<3.8T=$E9U1FTJC  $0+>."3[]'W72"#U)V2>!7F3
M9<:(7/,)_&Y:(FH@8R)JN34V FB3WUDZ&P2?,N5\SJ=H@.RJ>+C"#T+A@6;
MILDO6F4)W&&'OD4 :)Z\!#"BDM&AWZ 2K20YD!'X=>1:7WTTI6EZUQ)L/8K;
MFLC1:C#NQ5NDU(ZNDJFEI(N)BT)U:4N,DK4[> G>5AE/3F+,7W.?)MT)0^(9
MNO,2K>AL:G3C4!GWV".=R5>Y04I1TK,:7Z)N^"V]$2"KIUHK>/V@T'<A_V9)
MP*UGS]AR?.4,&79&:R,U( 0FNP\C1#]8]-UH-23KUD4 PC' TKJ'FKNC?89.
M24E#0 %=P.9U&EI'BH_$I]M@YK6,,S_8S ,="C7-2,LY5 8N&K3-PBYI:*<H
MI!P\28S":C]T6C)^K:^)PCM;4E1I10]/^8-L<;QZE'2;TZKS]=VB!Z+,U?24
MMT^>>AWVM4A2.\S<6F5)P3FS.X.[L<-V&>'C-4B:^QH!> 2.PAL+D?]+P<_
M<U*']*'07?#1"%+Y)UOK56MP" *8[X:&3.4:0"*V6;6E^[4E:&.+V.1OZZ\]
M0WX;LGPS@=*<V/PZ+G,0RH/7,(NIK5 8NL:(<E#*0^:'&_00'6JC&,MB.0EB
M]>?G^3^A+J2E$L:L'3@'%YE:4>Y!D2!6/!_H,O :A8:TS B81X*_W/<R@13X
M].6I:B0E E@%K8@14&&PTBPSF9PK$8V]<6J7V1QT,,</]S8CP$0 K<%(VGZ&
M.0993LN"RB-1(!VYIT?<D&7,Q&UKZ*M)$ +X:%D&#]0&QGXQ!K2$/]%2I&*>
M@^?)D5<&.ELPIO"*RW_8V<_!')*6H[TB76"G:87NG1-NPZV1<[51B"ZF[WX
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ME>1.2EYRT?[K]U9Y.!UC'VS)FTPT>@UR6@AE>9.*([N8ZAL>LB<J29!\1M<
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M( V ^U)_>C_@LLQDBB7^/6Z1>]U">K.*)@(H(*_=1U-TX8??MR9  ,-\8PA
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M\OSK%R=%P!EFBO^^^JY+:9VL,3^UY;GDP76E-G2$%WYE:#=TI'*WYMA4)--
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M/ *.G*(JYMK%9,@&(/D"!8S^GPRR^CG,"GSNI<RY'&AG\&)LT6^HM1$+^&:
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MOB4TN$8O;;.%GFGRVM1\W_58-':),TA0ZZ^K?_^4?Z_@8"?_"U!+ P04
M" !,BJQ6AMN(NTHC  ">*0  #P   &9O<FUS+31?,#$Q+FIP9ZUZ=UQ36]KU
M"0%"[PBA2X(@($B3WKN % 'IJ'2X]!90#*"@(@0" E*D2I$J2A60)@0$Z4CO
M2.]-FN2+]]YW9JXS[SCS_=Z=W_[KG+/W6NM9S_/LDP0[@IT!J*ZK::H!(! (
MN(W[ -AQ0!D@(B2$$!(002 08F(B$C(Z<C)24C(H#2TE'2L3.QLK$PL+!UR
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M%9H\SX' ,2<FNQ@:EJ%IN$05^]#4V=UZS1BPQ39WC<<./?5\)B;CO70,1BX
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M<HT7'[.L/(KTQ"\K?M9^-=XU"F)+/-=H%]FJ8,72F< L\\*8):9)^)!BXJ>
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MY[\JZ,'!@!4(^9Q=0E&?I76Y7&/.8F^3>1->*LP*_HQ$>?3R]&FX^G&2VD0
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M"1+^1N,^1H^2$'*#;4#O\YW9M_ZO _:>83\Q9D !**PQ=;%@;::H \IE B@
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M?<,XLSI02EI:DE00%Q''W32L:S2%2#9K1P.I :/Z+/KG1/*OL4I^FUD4LTQ
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M5G^=$Z1P&>,6'+%(VW-'R%WMS\3(%IHJJU@8]>1_/"MJB^8BYD(W"UJ7X$Q
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MN6%,DX"J(]N><!(9\ 41(>8'=>Z G+<+Z[%RP][8?NJN.X&[LI8X2+>XW\M
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MUQ+JSZ5'R_FF$#I>AKX^)J$(3B9O_7"8:_S[ZT"# )CRIO:+W#-  7>B35
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M_IIV/X2\'DY[=M*G\Q-DT8"K(PT7ZQFF@NQ F@LB-2J9,QHU<\13C-RMP!$
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M'E4@=GRC1'?_+$3'FF)_-=Z#T9W-D47?![RZ8\C[-8INT?)I>M49@!D3IPS
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M^#3;ZM3LY3[ZX2ZX;+9!VJ#QI>= YSCU<?:'3OBH@LO6'?>HI5^S_K!WWP.
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M._A-S>X$&H<*\\VNOWVEDT?,P0D!+9D/O*>EYAI?O23=%Y5F"Z]W\H?)#C;
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M\JOX-[<Y\:/1Y < [02JA/3O0,T8NZQSH8.LJ]WA!T#<[X,R_30> -GC!@^
M=G[CVYB7)*D_A-_?LF:P^^D<62O7#*0)@%RDA_PW@A=7?+3(U_W4KG4+:FTE
M.P/Q!JV="#+]U<A7;^_-\63%NY-_M0J55U[+UBO_)+\8_W5F^0 8. _L$BT)
MG-BK"%Q+X[B7+88U.QGWWY-37IW?BE>.-Z:M%UE';AI(^!!(#JTX(@\UK'AB
MWA3N_NH_W F7V$K]49KU%P%E;VD7"^]P?/?N;FH> -N^T$-@V;\E+Z!=%C\
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MP7BVWD=C*$_Y-JL9##="S.-&)QNKU16WZ*=6\K\&;J;>I= 4.IOPZ%\H@-V
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MG/SI2WAB^UVA_4R?SJ]5AA6,S1GM^_46ER/I=RD*"4;QEXN+9K5&YW\9F83
M1SMFPE0;ADH.'4N;\Z]&3(JF96)E]5%>PMGBCR[874UU5>8(KPZ8X#$Q5@W$
M;Z!B)*4D)CDCGX WUQ8/[DL,C>L.0G.U6WPBWA0Q-]-::*0'QP#6X(ZKVSK5
MI'[W(YDG+0^D*Y2#CRX> ^+4EK#.V9E3AT\KJG\).D^":]#LL!F.IF6>E]=6
M<<_OL'$HA"<BPW\KCM0-J).8HCL5MQ63X6TS-V--<^^$7:HC.%@IZ<Z#I-<L
MDY.:9VN@3OIT_4--(:YWK0G<&EDN6^?9O_<^JRIXF?E1B.:IE=L!F3B!C'.P
M">3[6ELGB+2>3?2$R;!+['*/P\ 1;&R5]_09<Y8@]_^W:HUA:,#&,8"..)(^
M!N3IE09Y!6^@%]R4]4NF$/K. >L91&Z$RD9C[&EL;FQ:>,7<_2\2S,> T"#Y
M;7D>$TZFA$Z!;;,XU-N9V[%IN0OGGE#G<T/6(,EQ;=5_#VHQQO_H>L_=2=YW
MW*EAG+D4$]3C5AH&DCMXQE: \-T,>D$5RSH<J3/0G"G?HGU^67V@LTJ>FM&*
MP4'\C@9[P/@+<J7<S_Q.D/[ W+P?I(2_RGL(1[E*5OVS[J$SZK'X2IUU"NAT
M<%'9L[P0,Q=?WH27-%<UK6P8GJY4QNHWOV4KJO.RWFT<.JGIVWQ55ZK!D7)%
MW3P0/V,9.^_H)N"QXH6\K)5\SD"W]9SAV].HKK+ O)20#5YZ D5A >W0Q+4R
MH&Q<."@+Q)9^Z6)BW 4&#O3!APX#*%>@C].G9M1BXUK2)G6D2BT*[1AT/*WW
M/@$Z_'W: ZIY#MMMG05O6F]HM0NXYI')AZ 10Q$[*]9>/SL)_Y:?>B;_YM-E
M5GFA6;>1&Y;M*)_!,?WU!'-?VWOQ]87\AM):^^CF<"(JT1&ZW#F=529AF,:?
MY2X_=X8.E@D7F@6<7X(L*8I_,E\7IO2T($_/3MO2'4 .W_P,K<,!'#,[P:G3
MJ-V"E^W[^1 YCT/^84I4L&Q_U.TT4*+BFG"R.@,?D&-\EO=7\D,:(U&N+&82
M/)"+4]*/:!(6A4^!L?I("*&94>(KQ@/ ^,/HWQUDAT6<U62CN S==+VQ&C<\
M.R-8N]Y=8('JA7+6ALN3.BF2FI)0"%\3IR]:[M7$X9=2-U#2RS@%>Y.[0B$,
M3)\$PYHB\U(2!<^[SI8$C1C"YD[H#,=([)WO>>ZYT9(47LZF!(]7 '*</0/Q
M_67A+%?I'J$JY&S$?3VB#UE.S'_-IIR=@4%FO2F>*"H$8WYLL(M1;L?*(?R$
MJ^@Z%.Z%K@48>,A<>_,6H,LN MO,N'3CI$"4/,$Z>$!T1.W.9WI[P!D>MO]3
M_;XK7H\0$)B#*K=OX0^S[JU\W"[J/"$IY$Q:!+\8(_\VI0F=%X]G;+.C1U)8
M"Q/'#X5&WFVYJG:*98#7FB06F7:!6?ZT#Y]\>RQJ0MHY6[-Y<^U\_"X>K>J
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MVP<'EO&WMS>=WS7T2(ZT0\3\CM?ST4.J,15@Q50[=LPTGPZ\;Z4#548%-72
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MC4PG%^H1GQU"!JU8&;U:7==Y%24[2^\C[SUB.N)]JN4F3_-:73QU,?PH,N"
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M<[N,GJI(NC&3,223>&7)+H7YSF,ASXY/@&.O:-3 [/&3VPK:Q-K"7LMP/N'
MZ^U W'QB9>^F',XI9Z1U)^^M^EE?"S=1=N$WLG>?;&0:M&^)XE*1RGMVYY#[
M]N+YW2TFGYUN[WM5H&882O)!/7[#U]=ZAZW6#.>HP</DCUGC$L$)W 3SB@:A
MQ_7F]O7@: %TQ"P)!M8=:$[PRTD8KNK-PP"--RC2-!T(;_G^VI9W9JTIC/A)
M?<3I;=]?3VK\Y[;_+V\SM"=(;5MS;WZ^M[O,E?1F74_$J>:UQ;_=9530X5Q<
M[W>P,^SYYZ0@H0]5$ #36\AE[$(7'1!.^?[Z0F_-.RF0S^W>TL&DW@;=\Z?"
M,W;&+%\RPQP2:6\(JFZIJ-;)*SS7_)EG6+]3<M3QM]EUZ/D3$A)M3R>9OK,,
M=MMGP;)95M)U,#+)LZ/'6<WQB4%*[HZTQ#CVF;#;*N\-"=LWA)X*/<H7&>7!
M%#RJNEU=N"8ZO?+ WLBR9+;+EQY4)CTK%#;5;)6^L;;YO*F&I.YFXQ/OM\]:
M!)0\L;?CV"?*[ZY1(&6;;FSU+%:XS3?>4R3K7Y;*^+63D,ILD L=F,Y2^UPC
MK5QI(UE==(OR^*%1$S.BVKA$,?MZ45*ZIU5&UBL'!YY;F:9# 1SG+X[2^CIR
ML".7<3"%X<'%LX:S&\"ZKDP0EXB%_*6]RK;)5AE\2O>/7N8ENYY\T:>TZ;R+
MOD/REQN/($]P,-]W\'P?M*G4U#DA\&O7]HR1(J5R? $UR*. YIGO+0]MO9G5
M>-962B]'&PIA)<,%TM[:],]%?1MVHN?NCQ$?,4\Y.A;0(LW:Z !^4)SFA/Q0
MA(9'3T[Y#E.8T'[-OGSLHPD/]WM$GZL6P6QE.*;#R$[.)EJN#O8GN&L7W@:I
M"<[2_+;!A4VJ11E<UG@WT6Z!0[;3>GMS^M$D7F<T>2$$+MEX]']Y=V8=@ANL
MTX/K-P*YC[QG@J"/AQ&5"A=WJ"PZ\"P)<X;)S*+0SH9W<>K2M2>QD<V3,BS<
MS*-=2:P6*IEYV6+&S0JF83HSYYV+MSV,79)Z&']AJ:QMPT$KFT'?/J%F%IR_
MX![YZ+VR?D%#NTZ4*AZES*BHQCP:# DSZC!7/2]>&*B[!9.T%)PE8==]>=.M
M=TW,6!/<'"%F./.ZG(7IL1LX8]7KZNRSAMMX]0X)1:U_X1+!==XV@-OM#3=W
MIE?4@0!@="USW5,.U!;='<VMYUX7MN^6MA<1R'JRUZ;&JU:X]M9^-V%)=DI#
MP^/\+#45G<M*5TKT['?<T!QMV++U$O58;KBG\;';_133ZOF/RS>[W"W%[#B*
MQ2199$,=:X7.V5,5TBUTA/URDH^'GWCVX*5.YK+ZQF^@)#!:39N*?6.+O?'N
M O<YTTNVQ<L^^I%6DL:X)Z/9MN]>/9J;]IU V*K>I(T]>;]35?_!1B%,ENT9
MEJTE:I,B@N+0/11%4V?2:W'1@3*$$\\&ZZY5HI:VT('. \961S>[CX_U+=>G
M-.EITH$R708DC*:G@'V[(U14MD$D!>D=%TM/($R B.\WB'AX*-+FKQ_]<)IY
MC4]>'A-?4E(8'?"*5UYY?%M^K2Y>J^*!V4GV/AT+<>LNNSR_RT(B1PF\.OM,
MI:+W:"K5?YE<O;5E=9B,,0\H<4!%N7<\6N#B%OYZ"8, 84VV)D<3%^GSSV=?
MBBZTMF!GH[6^CU*-#PQJK3!!+$5WEC9>/7'<NEQ;>L8VJ(#8RH.[J4;F&'OS
M(7)FH6VZN]PIHB8O;$_]80WKT&&C35&AB0DJZK^:8"(EIR:S8J3\ZAI@#N+!
MJFFMREZ)HL]VSETV*7?%5"]'/="^TG142N^]B'()WH5 R^\)/3C2*1]ILH?=
MOOO$C$JFL>9UD98L#D,/>Y]/*J>[?AOC(UXD>5]T?Y;>F3M2NG9V.S,0R9+/
M0SLTJV=_&9F-#O@7#/0DY*8M-E$]"^@ KT5+?ZFFG6FER=64FSRZ3G9"V9L<
MHYX^,6JW-DBU=RGT%])0P@W=S@%_&V]0V6&PY=MD\3;'=(4N<[&RX\EK_"6/
MT('2"S7[3K=T=YS5-_OLJF7^BXM'>P6)+^C >M;[T_*Q+;W=W;-596X7-[RP
M?[R$T4P_I+/QLY&EWZ#")S[GWT+#+1]7(VU_9#+CV><IKW?I40K28I?]+4OP
MTZ<3][2YWBM4L%6+*NF)N/RK#T=+U@^8HGF)SA.*1OCR XUS,6%!J$=""X3L
M^&08O9]=UQD+^<4JVUAB!&9"1&CN=6FKA?P[V\<#G*+V@.SA@9(*W$!@B"[M
MI?;MZ_@2? KF:\Z#1J9154*^$J^D1J/4\4OG-I]^TK:3<*WD]RB_Z"PTDSJ(
MX;3A:[H"OJQ<]_$B7]A"9&0DNN*5-;2WF; <)Y^E=B3-CWE[Z!8#H4%D)&83
M$9[]KFT7Z,!;)'F/[3.B%%RIT!R@TJ>PM$PJON*O_S33[%N =,.FL2[[])S5
M 5\*SKSLO.H+@AL<8GM9(WG;OCTX(#=M$A,TB"!Q*\"0^ B&1(6*I2.-;K;0
MGOV!"\Y)QJ[*02K(WFSTL?8$PSD(#2K=B!U8&]G.,[TVW'':#-;>M?"(V>#G
M(N0Z&(=CGC&0&X21^U$_M7)SB(M*"<;6]'AQ(O'#_O2&#P4'5[,-QSWP_-YD
M-?EFU*X'[ +WM^QV7*B=-.]QM!"':]K:TW!1*H!=/#39VFC^FM>NBZ#)CQH\
M_K&@X.U;O(4?OJM68&%(X,1[Y$3"YU*N[VMXTQ&L:X=G@G-'+I[#/<6);SPX
MMX'6-V(3!LF1-@NTL@8P[G)_>\?I^1XZD-8*CN$PNBJ<[DF^,(G$P!8P/LD^
M+4D'7 .)6$U;>"4VDX59[Z8:O&XK[X'7=H_'&D]IE^\A$#\G3O4E("GK3U)C
MBUZ2A?@H^<@Y3+V0H<]AC]PH?-7+)4'K;=@A,:XS6EE.9'Q-U"@47TT'4K86
M(87!.J0N'7@=BNPH_'0;.@;_W]P2KL!#4.))8%UC8 ,=T%$1$I\37Z!&:*^&
MJO9JG*<^*^N>CSABQ#D@[14*K_L  ;%8+SGKWRT>XF(V"BE/D^$2GR=&#[JJ
M"T)E,)UK[+*82Z>&%170W.%B9^PLKO(;=LC['-1+C9QHIP/.$753J^[HX O;
M;31W]17++''9H5^AQ8@K##MTLAT[V9,YG3Z7VV#Z9.B?!(W:\-&W0NG0#NQ@
MHTP_LH?WDQX=$#D XN2HF2_@X8(%D31WV-:GP<0R'CKP""O3MKB R%TXL&C$
MZ9T=B2:Q*:)^US#(O]8PN"Z1"U:5R'G)<21AE ^Z)Y'R\YNG&W[O7OS6W7BZ
M)ECBZ9H<!>R6KK&"@V_3>CT3$@+X@]=VJT6']27:X78-FN^>-3"5R1F?E&_Y
MZ+_/R$GHP4+3L=9DZ"%3UHO)6S:OMT6G]9RT$[)P_IS=,HSQ65^_W94'AS//
M5[]BDZ[G\O;0D+MABZ'ZJ/ )\;OQ']JY32)O+#8DJHZ0ZW>HWU8H%DV(8S6L
MW%\Q=)F\F(K+&Y?I5+=YIB>2LM-:M.R"X=KCSCT!$.(47"2$$&-YRJS+&@[G
MGXRTQGG=V)(D&SHJL/T:_R=[8R'RZ?0WYF)3J4\?G37-=2]U]>O=*2;0.!7J
MG%US9S^AB<1!M(4J&)0ZYM*CD1?&?*8M5E;,I*ND?/U[RY>GY8C&1S"<G;4!
M 2?H0- C!_+@+FOBY^W*7-F),V#SU8F^*4%@ 44T%VS\U/=ER5P.*L56E-H>
M;>NZ .?Z"V7+W44%VL',#U(#'.-)MZ'S=. ]F.J-^.9V=VY?P.UW=$ M) 5\
M(]52T^R_2T2C</B;K(+48:?2\*B2VX.GWF1G/JN)UKE_Z?&#*-ZUP]Z<'K-1
M2*PXC6!Q!)]XT%9)YF/M,K?+86AGMI?DZ;QS2CEA+[?8YC12E6*O$/V?RW2*
M2XZ<^? Y9ZW[#?>UN!:%!73E< ^>2U- ;.11.NW6=3*B'M$7#9&S'/'Z69>+
MQ/:6G3;@MB>_,2&=G834%/L(!$4H]#H9O7H7)F8F0(&]A0[HG0/':K)N]0T@
M]=HJ%2 >;U"]4Y43K$N$Z^9+Z\$HW#/C)UY"H8J^,^$CB/'Y1=4&"_^AB%DX
M4+V-.<&!AO8D?ZY^K18?+59\-'3\/AQ\9,2(;;4T=A!J@,KZ&9ELT8(/V%^V
M(73&"DKD.D? \!4(8-\@%@E<4*C)XAPXLT""M&+"Z8!'^CRU*5,B@QI)(R%G
M7^KM!'WT*!,E3EVJ/L0X&-T1!C NW03'<LQ9RQU(&R=1A&DNR(_0Y*5MCMWL
M<BS*YX02FGQ5"OQ6X8!SP<0%DN55-B*#)K^\@ ;*4 G*.N#\_D=-\UIY*^FL
MB0,G:QQH0$?3JA/.6RC<YV*>3/=$+PH4%5!VE_AYGB(5_W#QGF\@:;.S#!G/
M*))Y%U#4'#IP!T8FLGJY+/,W.XY91\B7#P;>R\:8N&E$W,"P:=,P.5'8#5>#
M(6VT!@G32,A?V)/UN[\/XY,/VL8C/M;2!'W2D=7"-_N1$=S--72@N*EYU$<8
MK-=L 7L3X*15\.9%':8JF_=MEK\4I6I3!.)V8Y*_+P]N/W1D4?.P Z6(<#E_
M/A5']7/ 3LXXT/C;"<C5<5!2/1S7^2JAI!'8"V$F5[!5/N@7L;94"3(4F$\5
M@J%FMQX92B ;/\4E4D5"%>\]/_(83-=MIDEAY[668<0IRPPHP.^:H -R+<GP
MMV3J^E5E81R*1-! =>HGMT0,U6\O=G("0>//GT;P6[%_>]PX@AQO)JB.E%A\
MN0K5@:UM2+*L;6LY6-PT2A+1/$(;03<LJ+YZEO+]^2^45VW!-]TDS0XH4A_:
M78.^P-"<FAWR#4,-)&#)2S ?J7F,JHKNZ[M?]+X>.>$!<]JN[$"&C_/+SH,I
MQYH'B4FEP>@9J6%2;F4J'1!;[T4'=GKJ6KK50L<_78-*AN$*0-?678PR#_89
MA@RRW9FS?W.[D ZH1V>";VQK/.6ZM92Q^#'D)'HQ.Z(<G-]EC26,(J![4D]0
MQ$4$H8EL1 =\+5G+/61[!VD;5<.@3UYZ&QQ,A\E)V9?R3@>\PW##:S*8#N+\
M^LA"+E^^#U3C%G/0K5:/]!B&?MVV4>(@)KD1.X0R;B5H;>4CMDAIP#,U@HTS
M'V*TFRQ\+=Q"BJL%V>H1V&A&-L^6K*[,8#]V>1W# V:W\>BZ!XL*(QY<U'O&
M4#',DRD6I=LK]ONXP[<MV %6)_3I@&X:_#2,68DA-,V%]PEME8'$%I7TUL <
M>P[FV(?8>MN7V2??M\R\;FL<0> //$I>,IGX[H.?6!L,DC%RLE""V<0'CL)+
M_&"64_PL]5X"5+1*VEQ"FELK=8_ IE75B*1/FD$E<L]A\$O+ <>J,=%-R*%K
MZO"BIXJ$<Q.YX=Q.:]%?712#[VNS-/KP)G+A@"TL,HE8\A[)97_DD!U,KXU]
ML+-C,R2G\5O+#NB1+0EPOFL;>^U+H)J^I'Y$-D^3A4">F#FB#(D!!078G1[Y
M8(_8_!&/?VKL&Z35(?P'3]R!&9SA9RW[+)0=TC_)I/L]&E*^##_S&LGX7+\>
MB4<>7%6]O T,SCZ[PMFI<Z^V$[6TCO1!R@.0S)*&%VH#V-#'4-P17TD/Y1U(
M;+;8I4T.M*TQ'C]1MJ!$EW=V:#0=X&:9I -FGS%]8)WJ*%2(G%=8JHT]/]=$
M#2[2^UX'2/SZ;LUOC<:,WQJ1&<"S8 G@^5X^@>V7!^--^J'M6DH-Z>;NPU/]
M,<I=Q]_M+SR26[))TVWM+0W =>ANV]WX TS,8KL+.:\XTTQ/YE%VGCWYPJ)+
M(G?OE BOF.JET>&:6WI.U0;M_5O "FTG)[F$4B6VLCI*G<1Q3U] Q?0P8?RH
M<(>F8R1:Q^0;T]7<1^=='3/WO7[@6S(D\SAS>##M8)0C$0<>Y?<8I09X*<#A
M(4-+V77=K0LZ;G<;*H%+D&;.*[9585:5Q]>  U>:09R E%9-E.R<:I%R&F),
MSJEVF1-H2@"'(ZBL9.///BSP\G$S#E[R8Q<WHPZ"#0@BUR(FA<HEQK5FS.J#
M%>3/IPPZ&^?$37/%#5Q9@=5=;GTPK'*,H0D5#B,QDQ <1TU\-*E:'[D<NVL:
M'WAI53U@KTY_!2@BG@RK@MOHY$]493H0%007XZ4R4/!U\KXR)Z+7"6)@RJ;G
MB9_GD)/1QLT_GF)629QMX1_&SDRV1^$^/$+-;RZ#)_<"NVAEW/;CGF'/)!?V
M7EDHAL&HK=)PCM%.Y:+ZM7"+*BG?<-0@'&IITR.2M,<N]]KRVBMSWLV;<\'T
MAKK:9[AD=PP=4$8M9@O2@>I'F2H;$!41SZCA7(/BU*#-,+(M(C_B@DW!6MHC
MFG<E(]=*4P;9<]TD]UM=H0.G Z,C//">/C)3Q7!VJ:]<5D902B P<M@*V_N"
MBI6;^"")A'TR&@(]3/JQ+"JYH[-!Z'E]@AYYE!4*X6WVV@IG]DP^';!HAK%6
MSVRY*LIT8%^&3@RM6PA!'H$)M)(7Y_)JA\.BM0=80IB"<\T1)?,I:1>2Q']R
ME"36*<5:TS<O9HLE#"I"=VRO?0)) _"$+KEU:*JRXK0>5M)8[-V@<<P.D595
M>SH0BYQ#C*-TW!#0<7-VJ 0N[ILUO.!R?"_X#?FY[,'<J5!ESN2(/1%D#C,\
MK<6B[%J>S[60A[/(1Q/.+H,H0>S0X61X9?+@!.%QF1+Y896JO*R=D_H'7CJ@
MB<906G ;N8EX%0X'2@D-6?=7'+K3ZWC+_;,^-N\0A/K,,7!UD6*R+U%OCX7>
MZEMVF:BW'3Z)(;'U@;CN/K)LYH3#]UOFJW%*_LO\=. D_#1-!9M8AA+R2;N
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M=V(Q3N.\ZD$XQ648C5G7[PU4I^A_,N6XER0CA[6TX!RN9>3P?YU&^9#VN-L
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MC"C\SK=7V3&V[MO!E&,K_7?LYJ.(S2YW .9E%1C)<1IS%PSSIQVV(Q:ME>A
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MY8O-[>CAK06LR8E"W4]?/K;8,356L#T_>N99IF%:K/I$ED07;?R#MGF ;D:
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MZ?F5@Q%A$G A8;6<!;O)V^$2S_8!]=D>)Y/2.F^\?-\2(QM<8-49(;<AW_4
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M'X%1\MA&-JCCYR+>YT=L[_D&KE<Y K\O*UK].A@VA".(7KLMHDI,+RXDT*:
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M">JCFR]@QP?(<\!D\KUPO+_TE=^G<CZ[7F.F!9<_U)1P_\$C-^!X^A"7KM=
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MF,V?8'AWC;\F+X@S^!+"7(4]QB)2I.8J*6&<(IB3/<[(Z#81?(SV!N4)P;I
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M1B[;WFA#^FW"T@QK\?6[J&[I>&A;@C,G"S)(+*XMLD89 #N?^']02P,$%
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M]+5.\'+8*K3ZJ#.1$=QL=)\+\I,3Z::8=YR$7.L.DX;@8C+7!-9J056IZK_
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MHXNAVU6R6+"3=SMTUO=X26KPT)@%+XGK!X[\(7]P6<0 (1#S1_O/%9NYJX9
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M&37M&+(-66\X(9:[+B!W[6PB]3K-VRH;YF%R\%*-5NQ^ Q$E$SKZ:P>*D\A
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MLMGM* T=VPDZH8#[X]-MD*0OWL+H*%]Z"[8BZG'*"=H)GH3V.A_OZ:ZP)A%
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MB'6>JK:#9#LD:N#AQ30@/P;SQ<@DG;B>B@!'R:FDPU>AA(N2Q!=;RVL)>*
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M'6@(0&X?867T:6GZSTIDCC0"$*=H)_)*ZP(85*"!P2XZMJG-!#>'GF@9TJ&
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MGM?-]K%'+XZ'E(,A^: -2^S2\"9)#_.2LQ:3_V11-L&DT%'>A_@LI>NUW=@
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M^9UN)L2+U*,^)+ 7]=OR* E["V/.N3)D %6]&N2I?UN7:OZ_-LTB/880B3I
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M]EM/\<(5JV(F8YD;7KC?;!&\D:R^*BXV^TI/H:LC'KLXBYBM*CE*GE*5=XX
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MQP'ZY56 7_WO__SG?W3H?W__K]>O.WT/^>Y/G0OLO!X$"_QS9VBOT$^=3RA
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M-P0*M2I"=H%"AWAWK,_2[DMN[<#[,^G!YW'H!2@,G[IT-W _8;H[Z&$Z;Y!
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MI%8/ZQ?LQT%DDR18EP@SZ.P4;00!/,R@XFMUIF9!Z9L5+'UX3*1_?HU&T""
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M=AB.%LFB![RXL"MIL4JEM"D]N"#6/D 1).N1\D;OPTL>(O@@0%:85_983P(
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M3\QYHTM "FW?D8%% 1&8F@D=64^&_18_Q$69LT/Y378^C1E3R+LV_5K8P[%
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MJOK1/VD^VI+F(VC2?-R+-*3AO=J:"_+/>;[*GF7!V4I)+Y01H4H)TXK!HXN
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M6M(Q"18YIB3$*;]4987IU4_S]5HZVNN$79'"#+@FAUH2!$F,\,04F/A-V-%
M7 4Q';^TF17%#N>CR"-1\40A)7@%D01YB'12@322BBOZY-82ASLR/KZ\_W"_
MBDMI6CI1Q-F8I #7C$B#YR"XH0 E7#Y.GZ%LC=Y_^/K^&U1K.6[^FVR5!Q$9
M$I<OF_LL462?DDJY(H$&8LT#B0@(*JAQ#=EPDZ%*%'%9']FI>F EU1D\=T4
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MTX32&_9";<WE*A:*L'=X@8\O+^!^SAP?/L!IJF\P)<AAZTS9XS&^'(ANV(\
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M:KVITW ;DVR$W@] 5HJ#89(9HQ@MW]%@]TDR#415'"SB#UW# UW"'[2"A[6
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MDO?.HDX:W&!3'>A9X#1(:')HLIJK Y;ICNX.1XJO,;H4+_=*CZNB]+IINR+
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M*!+-&#P66:]ZP*UD]ER=@%EQV-_EN_]BHA%$$S!+"-F$8,3<P?^4S'8J!MR
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M3MX4GI?-_Z2[.N5*KTP*Z1J!?(B>E;K!Y7QMFI2/+P08-?:O@?+4?U 7Q;9
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MGX1E_*1L2GMM0 VZ!VAA"HU+Q(),ZD)HFMFO:3FD=;]![9*G+<M3^U;;T73
MIU?QYKB3_4;6HCIY0&UH!5/8S:B4J*.F4D,=/5@]D /;MP=*M &UWAZ@1_;
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M8_ZG5Q???(,B9S;!R2@EJP0DZU)K?'FK9HQ<["46"M&_11)]\8\%Z]_Y',
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M76T)%3?VS5;%)XK(^XPUZH:CR">?_T&>53+?:PH5.O:-5LDIBM2G-.!>K_/
MT^\J^VVA<L>^QZIY11'\POT\\AF#PM.8RTLO?RD)% ;L2RR(<Q0TN$,??8Q+
M;]I][OA-G_NQK]S^-8109+!OMP920,&G8*+X#^?D0H5*;7.PI<L*+!0<6X+
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MY\Y-"/O-_P=02P$"% ,4    " !,BJQ6?-$P5V*Q  "910$ #@
M    @ $     86YN97AD7S P,2YJ<&=02P$"% ,4    " !,BJQ621L,V&RS
M!  )' 4 #@              @ &.L0  86YN97AD7S P,BYJ<&=02P$"% ,4
M    " !,BJQ6?*" G@OE! "Y2@4 #@              @ $F904 86YN97AD
M7S P,RYJ<&=02P$"% ,4    " !,BJQ6:K%7&A6G 0#++P( #@
M    @ %=2@H 86YN97AD7S P-"YJ<&=02P$"% ,4    " !,BJQ6-_&&OXCI
M!  C4@4 #@              @ &>\0L 86YN97AD7S P-2YJ<&=02P$"% ,4
M    " !,BJQ69/M@H)[&! "_, 4 #@              @ %2VQ  86YN97AD
M7S P-BYJ<&=02P$"% ,4    " !,BJQ6)/]WGEJ^! !&)P4 #@
M    @ $<HA4 86YN97AD7S P-RYJ<&=02P$"% ,4    " !,BJQ6>Q EP*SJ
M! #K4@4 #@              @ &B8!H 86YN97AD7S P."YJ<&=02P$"% ,4
M    " !,BJQ6*RU", Z'  "3'0$ #@              @ %Z2Q\ 86YN97AD
M7S P.2YJ<&=02P$"% ,4    " !,BJQ6\9(GPZPR   @2P$ "P
M    @ &TTA\ 97@Q,"TQ-RYH=&U02P$"% ,4    " !,BJQ6/IR6Q\5B  #4
M400 "P              @ &)!2  97@Q,"TR,"YH=&U02P$"% ,4    " !,
MBJQ6TFNGUTQ'  #VW ( "P              @ %W:"  97@Q,"TR,2YH=&U0
M2P$"% ,4    " !,BJQ6RI]4TFI'  #;WP( "P              @ 'LKR
M97@Q,"TR,BYH=&U02P$"% ,4    " !,BJQ6WU);#I@_  ",# ( "P
M        @ %_]R  97@Q,"TR,RYH=&U02P$"% ,4    " !,BJQ6%D0\E9P_
M  #!"P( "P              @ % -R$ 97@Q,"TR-"YH=&U02P$"% ,4
M" !,BJQ6:8GT0K9(  "'ZP( "P              @ $%=R$ 97@Q,"TR-2YH
M=&U02P$"% ,4    " !,BJQ60!=/5$$'  "D.0  "0              @ 'D
MOR$ 97@Q,#<N:'1M4$L! A0#%     @ 3(JL5D<(CH^- P  # \   H
M         ( !3,<A &5X,C,M,2YH=&U02P$"% ,4    " !,BJQ6;!VQ\&\#
M  "'#@  "@              @ $!RR$ 97@R,RTR+FAT;5!+ 0(4 Q0    (
M $R*K%:'%]A9@@4  "8>   *              "  9C.(0!E>#(S+34N:'1M
M4$L! A0#%     @ 3(JL5GY9="/X8@  ('<"  D              ( !0M0A
M &5X,RTU+FAT;5!+ 0(4 Q0    ( $R*K%8MXPG]WP,  "@6   *
M      "  6$W(@!E>#DY+3$N:'1M4$L! A0#%     @ 3(JL5J;&1@'6 P
MQ!(   H              ( !:#LB &5X.3DM,BYH=&U02P$"% ,4    " !,
MBJQ60%VR(<H#  #V%@  "@              @ %F/R( 97@Y.2TS+FAT;5!+
M 0(4 Q0    ( $R*K%:F@_ONI@,  & .   *              "  5A#(@!E
M>#DY+30N:'1M4$L! A0#%     @ 3(JL5HH\DPGO P  )1$   H
M     ( !)D<B &5X.3DM-2YH=&U02P$"% ,4    " !,BJQ6QGH\<KD#  "'
M#@  "@              @ $]2R( 97@Y.2TV+FAT;5!+ 0(4 Q0    ( $R*
MK%90=;/:MP,  'L.   *              "  1Y/(@!E>#DY+3<N:'1M4$L!
M A0#%     @ 3(JL5I)G\HVO\ @ /F-/  L              ( !_5(B &9O
M<FUS+30N:'1M4$L! A0#%     @ 3(JL5NK7Z+_G7P  YW$   \
M     ( !U4,K &9O<FUS+31?,# Q+FIP9U!+ 0(4 Q0    ( $R*K%:A\*[V
M\'(  &"2   /              "  >FC*P!F;W)M<RTT7S P,BYJ<&=02P$"
M% ,4    " !,BJQ6E[N#47%G  !=@0  #P              @ $&%RP 9F]R
M;7,M-%\P,#,N:G!G4$L! A0#%     @ 3(JL5O:XZ%X:D@  [IT   \
M         ( !I'XL &9O<FUS+31?,# T+FIP9U!+ 0(4 Q0    ( $R*K%:
M%NPZ\)L  'S!   /              "  >L0+0!F;W)M<RTT7S P-2YJ<&=0
M2P$"% ,4    " !,BJQ69'-^C'Y7  #78   #P              @ $(K2T
M9F]R;7,M-%\P,#8N:G!G4$L! A0#%     @ 3(JL5O+_DED'70  X&(   \
M             ( !LP0N &9O<FUS+31?,# W+FIP9U!+ 0(4 Q0    ( $R*
MK%8+A*?H'4,   )9   /              "  >=A+@!F;W)M<RTT7S P."YJ
M<&=02P$"% ,4    " !,BJQ6C$1,^5-!  !E5   #P              @ $Q
MI2X 9F]R;7,M-%\P,#DN:G!G4$L! A0#%     @ 3(JL5GHW[9<C60  C7\
M  \              ( !L>8N &9O<FUS+31?,#$P+FIP9U!+ 0(4 Q0    (
M $R*K%:&VXB[2B,  )XI   /              "  0% +P!F;W)M<RTT7S Q
M,2YJ<&=02P$"% ,4    " !,BJQ6Z>XBA366  #9KP  #P
M@ %X8R\ 9F]R;7,M-%\P,3(N:G!G4$L! A0#%     @ 3(JL5I)0Y-S)HP
M;ND   \              ( !VODO &9O<FUS+31?,#$S+FIP9U!+ 0(4 Q0
M   ( $R*K%:A+M! ^'X  (6L   /              "  ="=, !F;W)M<RTT
M7S Q-"YJ<&=02P$"% ,4    " !,BJQ6?2*1LK P   )/P  #P
M    @ 'U'#$ 9F]R;7,M-%\P,34N:G!G4$L! A0#%     @ 3(JL5EG.,^-0
M#0  .WD  !(              ( !TDTQ &UU<F9U+3(P,C(Q,C,Q+GAS9%!+
M 0(4 Q0    ( $R*K%:Z2LTS"0T  "B1   6              "  5);,0!M
M=7)F=2TR,#(R,3(S,5]C86PN>&UL4$L! A0#%     @ 3(JL5CEO97*_*0
MG\<" !8              ( !CV@Q &UU<F9U+3(P,C(Q,C,Q7V1E9BYX;6Q0
M2P$"% ,4    " !,BJQ6W/)5J"Q&   5T , %@              @ &"DC$
M;75R9G4M,C R,C$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( $R*K%;*J?^9T3,
M ,)I P 6              "  >+8,0!M=7)F=2TR,#(R,3(S,5]P<F4N>&UL
64$L%!@     Q #$ 90L  .<,,@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
